PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Goretsky, T; Bradford, EM; Ryu, H; Tahir, M; Moyer, MP; Gao, TY; Li, LH; Barrett, TA				Goretsky, Tatiana; Bradford, Emily M.; Ryu, Hyunji; Tahir, Maryam; Moyer, Mary Pat; Gao, Tianyan; Li, Linheng; Barrett, Terrence A.			A Cytosolic Multiprotein Complex Containing p85 alpha Is Required for beta-Catenin Activation in Colitis and Colitis-associated Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta-catenin (B-catenin); -catenin; colitis; colorectal cancer; phosphatidylinositide 3-kinase (PI 3-kinase); signal transduction; stem cells	PHOSPHOINOSITIDE 3-KINASE; MICE LACKING; WNT; CELLS; STEM; INSIGHTS; SUBUNIT; PI3K; HYPOGLYCEMIA; PERSPECTIVE	Wnt/-catenin signaling is required for crypt structure maintenance. We previously observed nuclear accumulation of Ser-552 phosphorylated -catenin (p-Cat(Ser-552)) in intestinal epithelial cells (IEC) during colitis and colitis-associated cancer. Data here delineate a novel multiprotein cytosolic complex (MCC) involved in -catenin signaling in the intestine. The MCC contains p85, the class IA subunit of PI3K, along with -catenin, 14-3-3, Akt, and p110. MCC levels in IEC increase in colitis and colitis-associated cancer patients. IEC-specific p85-deficient (p85(IEC)) mice develop more severe dextran sodium sulfate colitis due to delayed ulcer healing and reduced epithelial -catenin activation. In colonic IEC, p85 deficiency did not alter PI3K signaling. In vitro shRNA depletion of individual complex members disrupts the MCC and reduces -catenin signaling. Despite worse colitis, p85(IEC) mice have reduced tumor burden after azoxymethane/dextran sodium sulfate treatment. Together the data indicate that the -catenin MCC is needed for mucosal repair and carcinogenesis. This novel MCC may be an attractive therapeutic target in preventing cancer in colitis patients.	[Goretsky, Tatiana; Bradford, Emily M.; Tahir, Maryam; Barrett, Terrence A.] Univ Kentucky, Div Gastroenterol, Dept Internal Med, 800 Rose St,NM649, Lexington, KY 40536 USA; [Ryu, Hyunji] Washington Univ, Sch Med, St Louis, MO 63110 USA; [Moyer, Mary Pat] INCELL Corp, San Antonio, TX 78249 USA; [Gao, Tianyan] Univ Kentucky, Markey Canc Ctr, Lexington, KY 40536 USA; [Li, Linheng] Univ Kansas, Sch Med, Dept Pathol & Lab Med, Stowers Inst Med Res, Kansas City, KS 66160 USA	University of Kentucky; Washington University (WUSTL); University of Kentucky; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Barrett, TA (corresponding author), Univ Kentucky, Div Gastroenterol, Dept Internal Med, 800 Rose St,NM649, Lexington, KY 40536 USA.	t.barrett@uky.edu		Bradford, Emily/0000-0002-4711-5628; Barrett, Terrence/0000-0001-6428-3271; Ryu, Stacy Hyunji/0000-0002-5448-339X; Li, Linheng/0000-0001-9963-430X	Institutional Development Award (IDA) from NIGMS of the National Institutes of Health [8 P20 GM103527-05]; NATIONAL CANCER INSTITUTE [T32CA080621, P30CA177558, P30CA060553, R01CA133429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103527] Funding Source: NIH RePORTER	Institutional Development Award (IDA) from NIGMS of the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Tissue processing was supported by an Institutional Development Award (IDA) from the NIGMS of the National Institutes of Health under Grant 8 P20 GM103527-05.	Brantjes H, 2002, BIOL CHEM, V383, P255, DOI 10.1515/BC.2002.027; Brown JB, 2011, INFECT IMMUN, V79, P1863, DOI 10.1128/IAI.01025-10; Brown JB, 2010, GASTROENTEROLOGY, V138, P595, DOI 10.1053/j.gastro.2009.10.038; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; COOPER HS, 1993, LAB INVEST, V69, P238; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; Darling DL, 2005, CURR TOP DEV BIOL, V68, P281, DOI 10.1016/S0070-2153(05)68010-6; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fruman DA, 2000, NAT GENET, V26, P379, DOI 10.1038/81715; Garcia Z, 2006, EMBO J, V25, P4740, DOI 10.1038/sj.emboj.7601324; Gavert N, 2007, J CELL BIOCHEM, V102, P820, DOI 10.1002/jcb.21505; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Jin TR, 2008, CELL SIGNAL, V20, P1697, DOI 10.1016/j.cellsig.2008.04.014; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Lee G, 2010, GASTROENTEROLOGY, V139, P869, DOI 10.1053/j.gastro.2010.05.037; Liu JY, 2013, BIOCHEM BIOPH RES CO, V434, P760, DOI 10.1016/j.bbrc.2013.03.135; McCarthy FM, 2005, J PROTEOME RES, V4, P316, DOI 10.1021/pr049842d; Moyer MP, 1996, IN VITRO CELL DEV-AN, V32, P315; Neal CL, 2012, ONCOGENE, V31, P897, DOI 10.1038/onc.2011.284; Nusse R, 2012, COLD SPRING HARB PER, V4, P1192; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Polakis P, 2000, GENE DEV, V14, P1837; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Takahashi M, 2004, CANCER SCI, V95, P475, DOI 10.1111/j.1349-7006.2004.tb03235.x; Terauchi Y, 1999, NAT GENET, V21, P230, DOI 10.1038/6023; Tian Q, 2004, P NATL ACAD SCI USA, V101, P15370, DOI 10.1073/pnas.0406499101; Tureckova J, 2006, INT J MOL MED, V17, P69; Ueki K, 2002, MOL CELL BIOL, V22, P965, DOI 10.1128/MCB.22.3.965-977.2002; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; Wang FC, 2013, GASTROENTEROLOGY, V145, P383, DOI 10.1053/j.gastro.2013.04.050; Woodfield RJ, 2001, BIOCHEM J, V360, P335, DOI 10.1042/0264-6021:3600335; Wu P, 2010, CURR MED CHEM, V17, P4326, DOI 10.2174/092986710793361234; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103; Yeung TM, 2011, CELL MOL LIFE SCI, V68, P2513, DOI 10.1007/s00018-011-0687-5	37	6	8	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					4166	4177		10.1074/jbc.M115.669416	http://dx.doi.org/10.1074/jbc.M115.669416			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26565021	hybrid, Green Published			2022-12-26	WOS:000371338400040
J	Schmid-Burgk, JL; Chauhan, D; Schmidt, T; Ebert, TS; Reinhardt, J; Endl, E; Hornung, V				Schmid-Burgk, Jonathan L.; Chauhan, Dhruv; Schmidt, Tobias; Ebert, Thomas S.; Reinhardt, Julia; Endl, Elmar; Hornung, Veit			A Genome-wide CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) Screen Identifies NEK7 as an Essential Component of NLRP3 Inflammasome Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						caspase 1 (CASP1); cell death; inflammasome; inflammation; NLRP3; NEK7; genetic screen; pyroptosis	PROTEIN-KINASES; HUMAN-CELLS; CYTOKINESIS; RECOGNITION; FAMILY	Inflammasomes are high molecular weight protein complexes that assemble in the cytosol upon pathogen encounter. This results in caspase-1-dependent pro-inflammatory cytokine maturation, as well as a special type of cell death, known as pyroptosis. The Nlrp3 inflammasome plays a pivotal role in pathogen defense, but at the same time, its activity has also been implicated in many common sterile inflammatory conditions. To this effect, several studies have identified Nlrp3 inflammasome engagement in a number of common human diseases such as atherosclerosis, type 2 diabetes, Alzheimer disease, or gout. Although it has been shown that known Nlrp3 stimuli converge on potassium ion efflux upstream of Nlrp3 activation, the exact molecular mechanism of Nlrp3 activation remains elusive. Here, we describe a genome-wide CRISPR/Cas9 screen in immortalized mouse macrophages aiming at the unbiased identification of gene products involved in Nlrp3 inflammasome activation. We employed a FACS-based screen for Nlrp3-dependent cell death, using the ionophoric compound nigericin as a potassium efflux-inducing stimulus. Using a genome-wide guide RNA (gRNA) library, we found that targeting Nek7 rescued macrophages from nigericin-induced lethality. Subsequent studies revealed that murine macrophages deficient in Nek7 displayed a largely blunted Nlrp3 inflammasome response, whereas Aim2-mediated inflammasome activation proved to be fully intact. Although the mechanism of Nek7 functioning upstream of Nlrp3 yet remains elusive, these studies provide a first genetic handle of a component that specifically functions upstream of Nlrp3.	[Schmid-Burgk, Jonathan L.; Chauhan, Dhruv; Schmidt, Tobias; Ebert, Thomas S.; Endl, Elmar; Hornung, Veit] Univ Bonn, Univ Hosp, Inst Mol Med, D-53127 Bonn, Germany; [Reinhardt, Julia] Univ Bonn, Univ Hosp, Inst Clin Chem & Clin Pharmacol, D-53127 Bonn, Germany; [Hornung, Veit] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Hornung, Veit] Univ Munich, Dept Biochem, D-81377 Munich, Germany	University of Bonn; University of Bonn; University of Munich; University of Munich	Hornung, V (corresponding author), Univ Munich, Gene Ctr, D-81377 Munich, Germany.	hornung@genzentrum.lmu.de	Hornung, Veit/C-3565-2012; Schmid-Burgk, Jonathan/GSN-3512-2022	Hornung, Veit/0000-0002-4150-194X; Schmid-Burgk, Jonathan/0000-0003-0988-2487; Schmidt, Tobias/0000-0003-3102-3515	European Research Council [647858-GENESIS]; Deutsche Forschungsgemeinschaft [EXC1023]	European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported European Research Council Grant 647858-GENESIS and Deutsche Forschungsgemeinschaft Grant EXC1023. The authors declare that they have no conflicts of interest with the contents of this article.	Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Chang JF, 2009, J CELL SCI, V122, P2274, DOI 10.1242/jcs.048975; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Cohen S, 2013, BBA-MOL CELL RES, V1833, P1104, DOI 10.1016/j.bbamcr.2012.12.021; Franklin BS, 2014, NAT IMMUNOL, V15, P727, DOI 10.1038/ni.2913; Fry AM, 2012, J CELL SCI, V125, P4423, DOI 10.1242/jcs.111195; Gross O, 2011, IMMUNOL REV, V243, P136, DOI 10.1111/j.1600-065X.2011.01046.x; Jakobs Christopher, 2013, Methods Mol Biol, V1040, P103, DOI 10.1007/978-1-62703-523-1_9; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Masters SL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001902; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; O'Regan L, 2009, MOL CELL BIOL, V29, P3975, DOI 10.1128/MCB.01867-08; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Quarmby LM, 2005, J CELL SCI, V118, P5161, DOI 10.1242/jcs.02681; Salem H, 2010, ONCOGENE, V29, P4046, DOI 10.1038/onc.2010.162; Schmid-Burgk JL, 2014, GENOME RES, V24, P1719, DOI 10.1101/gr.176701.114; Schmidt T, 2015, SCI REP-UK, V5, DOI 10.1038/srep14987; Schmidt T, 2016, METHODS MOL BIOL, V1338, P261, DOI 10.1007/978-1-4939-2932-0_19; Schroder K, 2012, IMMUNOBIOLOGY, V217, P1325, DOI 10.1016/j.imbio.2012.07.020; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130	27	265	274	2	72	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					103	109		10.1074/jbc.C115.700492	http://dx.doi.org/10.1074/jbc.C115.700492			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26553871	Green Published, hybrid			2022-12-26	WOS:000367589500008
J	Lampinen, J; Ruokolainen, K; Huhta, AP				Lampinen, Jussi; Ruokolainen, Kalle; Huhta, Ari-Pekka			Urban Power Line Corridors as Novel Habitats for Grassland and Alien Plant Species in South-Western Finland	PLOS ONE			English	Article							ELLENBERG INDICATOR VALUES; RIGHTS-OF-WAY; SEMINATURAL MEADOWS; NEW-YORK; LAND-USE; DIVERSITY; COMMUNITIES; RICHNESS; PREDICTION; PATTERNS	Regularly managed electric power line corridors may provide habitats for both early-successional grassland plant species and disturbance-dependent alien plant species. These habitats are especially important in urban areas, where they can help conserve native grassland species and communities in urban greenspace. However, they can also provide further footholds for potentially invasive alien species that already characterize urban areas. In order to implement power line corridors into urban conservation, it is important to understand which environmental conditions in the corridors favor grassland species and which alien species. Likewise it is important to know whether similar environmental factors in the corridors control the species composition of the two groups. We conducted a vegetation study in a 43 kilometer long urban power line corridor network in south-western Finland, and used generalized linear models and distance-based redundancy analysis to determine which environmental factors best predict the occurrence and composition of grassland and alien plant species in the corridors. The results imply that old corridors on dry soils and steep slopes characterized by a history as open areas and pastures are especially suitable for grassland species. Corridors suitable for alien species, in turn, are characterized by productive soils and abundant light and are surrounded by a dense urban fabric. Factors controlling species composition in the two groups are somewhat correlated, with the most important factors including light abundance, soil moisture, soil calcium concentration and soil productivity. The results have implications for grassland conservation and invasive alien species control in urban areas.	[Lampinen, Jussi; Ruokolainen, Kalle; Huhta, Ari-Pekka] Univ Turku, Dept Biol, SF-20500 Turku, Finland	University of Turku	Lampinen, J (corresponding author), Univ Turku, Dept Biol, SF-20500 Turku, Finland.	jilamp@utu.fi			Finnish Foundation for Nature Conservation; Kone Foundation	Finnish Foundation for Nature Conservation; Kone Foundation	This study has been funded by a 3 month grant from The Finnish Foundation for Nature Conservation (http://luonnonsuojelunsaatio.fi), and a 12 month grant from The Kone Foundation (http://www.koneensaatio.fi/) to JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardos DC, 2015, METHODS ECOL EVOL, V6, P1137, DOI 10.1111/2041-210X.12402; Bennie J, 2006, J ECOL, V94, P355, DOI 10.1111/j.1365-2745.2006.01104.x; Bivand R, 2015, J STAT SOFTW, V63, P1; BRAMBLE WC, 1983, J ARBORICULT, V9, P67; Braun-blanquet J., 1932, PLANT SOCIOLOGY STUD, VFirst; Burke MJW, 1996, ECOLOGY, V77, P776, DOI 10.2307/2265501; Cameron DS, 1997, CAN J BOT, V75, P242, DOI 10.1139/b97-026; Chytry M, 2009, DIVERS DISTRIB, V15, P98, DOI 10.1111/j.1472-4642.2008.00515.x; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; Dube C, 2011, BOTANY, V89, P91, DOI 10.1139/B10-089; Ekstam U, 1996, GRASSLAND MANAGEMENT; Ellenberg H., 1988, Vegetation ecology of Central Europe.; Foster D, 2003, BIOSCIENCE, V53, P77, DOI 10.1641/0006-3568(2003)053[0077:TIOLUL]2.0.CO;2; Fox J., 2019, R COMPANION APPL REG, V.; Gardenfors U, 2010, RODLISTADE ARTER SVE; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Grime J. P., 1979, Plant strategies and vegetation processes.; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Gustavsson E, 2007, BIOL CONSERV, V138, P47, DOI 10.1016/j.biocon.2007.04.004; HAMETAHTI L, 1998, RETKEILYKASVIO; HILL JD, 1995, ECOL APPL, V5, P459, DOI 10.2307/1942036; Hill M. O., 1999, ELLENBERGS INDICATOR; Hill MO, 1997, J VEG SCI, V8, P579, DOI 10.2307/3237210; Huhta AP, 2005, ANN BOT FENN, V42, P81; Huhta AP, 1996, NORD J BOT, V16, P457, DOI 10.1111/j.1756-1051.1996.tb00257.x; Jonason D, 2014, ECOL EVOL, V4, P4287, DOI 10.1002/ece3.1288; Kalliola R, 1973, SUOMEN KASVIMAANTIED; Klaus VH, 2013, RESTOR ECOL, V21, P665, DOI 10.1111/rec.12051; Kuussaari M, 2003, FINNISH ENV, V638, P1; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Lehtomaa L, 2000, REGIONAL ENV PUBLICA, V160, P1; LUKEN JO, 1992, ECOL APPL, V2, P356, DOI 10.2307/1941870; Luoto M, 2003, AMBIO, V32, P447, DOI 10.1639/0044-7447(2003)032[0447:LOPSRA]2.0.CO;2; MARQUARDT DW, 1970, TECHNOMETRICS, V12, P591, DOI 10.2307/1267205; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Moeslund JE, 2013, BIODIVERS CONSERV, V22, P2151, DOI 10.1007/s10531-013-0442-3; Mossberg B, 2003, SURRI POHJOLAN KASVI; National Land Survey of Finland, 2015, TOP OP DAT LIC CC BY; Niemivuo-Lahti J, 2012, FINL NAT STRAT INV A; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Pykala J, 2005, BASIC APPL ECOL, V6, P25, DOI 10.1016/j.baae.2004.10.002; Pykala J., 2001, FINNISH ENV, V495, P1; R Core Team, 2021, R LANGUAGE ENV STAT; Rajaniemi TK, 2003, OIKOS, V101, P449, DOI 10.1034/j.1600-0706.2003.12128.x; Rassi P., 2010, 2010 RED LIST FINNIS; Raunio A., 2008, FINNISH ENV 8 2008; Rubino DL, 2002, J TORREY BOT SOC, V129, P125, DOI 10.2307/3088726; Schaffers AP, 2000, J VEG SCI, V11, P225, DOI 10.2307/3236802; Seidling W, 2008, ECOL INDIC, V8, P639, DOI 10.1016/j.ecolind.2007.09.004; Smallidge PJ, 1996, J APPL ECOL, V33, P1405, DOI 10.2307/2404780; The National Archives Service of Finland;, 2014, DAT DIG ARCH NAT ARC; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Wagner DL, 2014, FOREST ECOL MANAG, V327, P231, DOI 10.1016/j.foreco.2014.04.026; Wagner M, 2007, APPL VEG SCI, V10, P15, DOI 10.1111/j.1654-109X.2007.tb00499.x; Zink TA, 1995, RESTOR ECOL, V3, P304, DOI 10.1111/j.1526-100X.1995.tb00098.x	57	17	18	7	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142236	10.1371/journal.pone.0142236	http://dx.doi.org/10.1371/journal.pone.0142236			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26565700	Green Published, gold, Green Submitted			2022-12-26	WOS:000367628500013
J	Parolini, M; Romano, A; Khoriauli, L; Nergadze, SG; Caprioli, M; Rubolini, D; Santagostino, M; Saino, N; Giulotto, E				Parolini, Marco; Romano, Andrea; Khoriauli, Lela; Nergadze, Solomon G.; Caprioli, Manuela; Rubolini, Diego; Santagostino, Marco; Saino, Nicola; Giulotto, Elena			Early-Life Telomere Dynamics Differ between the Sexes and Predict Growth in the Barn Swallow (Hirundo rustica)	PLOS ONE			English	Article							LONG-LIVED BIRDS; HUMAN-CHROMOSOMES; MAMMALIAN TELOMERES; PHENOTYPIC QUALITY; SITU-HYBRIDIZATION; HUMAN FIBROBLASTS; SEXUAL SELECTION; TRADE-OFF; IN-VIVO; LENGTH	Telomeres are conserved DNA-protein structures at the termini of eukaryotic chromosomes which contribute to maintenance of genome integrity, and their shortening leads to cell senescence, with negative consequences for organismal functions. Because telomere erosion is influenced by extrinsic and endogenous factors, telomere dynamics may provide a mechanistic basis for evolutionary and physiological trade-offs. Yet, knowledge of fundamental aspects of telomere biology under natural selection regimes, including sex-and context-dependent variation in early-life, and the covariation between telomere dynamics and growth, is scant. In this study of barn swallows (Hirundo rustica) we investigated the sex-dependent telomere erosion during nestling period, and the covariation between relative telomere length and body and plumage growth. Finally, we tested whether any covariation between growth traits and relative telomere length depends on the social environment, as influenced by sibling sex ratio. Relative telomere length declined on average over the period of nestling maximal growth rate (between 7 and 16 days of age) and differently covaried with initial relative telomere length in either sex. The frequency distribution of changes in relative telomere length was bimodal, with most nestlings decreasing and some increasing relative telomere length, but none of the offspring traits predicted the a posteriori identified group to which individual nestlings belonged. Tail and wing length increased with relative telomere length, but more steeply in males than females, and this relationship held both at the within-and among-broods levels. Moreover, the increase in plumage phenotypic values was steeper when the sex ratio of an individual's siblings was female-biased. Our study provides evidence for telomere shortening during early life according to subtly different dynamics in either sex. Furthermore, it shows that the positive covariation between growth and relative telomere length depends on sex as well as social environment, in terms of sibling sex ratio.	[Parolini, Marco; Romano, Andrea; Caprioli, Manuela; Rubolini, Diego; Saino, Nicola] Univ Milan, Dept Biosci, Milan, Italy; [Khoriauli, Lela; Nergadze, Solomon G.; Santagostino, Marco; Giulotto, Elena] Univ Pavia, Dept Biol & Biotechnol, I-27100 Pavia, Italy	University of Milan; University of Pavia	Parolini, M (corresponding author), Univ Milan, Dept Biosci, Milan, Italy.	marco.parolini@unimi.it; andrea.romano@unimi.it	Santagostino, Marco/C-4097-2011; Romano, Andrea/B-3930-2012; Rubolini, Diego/F-2851-2011; Romano, Andrea/A-2780-2017	Santagostino, Marco/0000-0002-8777-3641; Rubolini, Diego/0000-0003-2703-5783; Romano, Andrea/0000-0002-0945-6018; Parolini, Marco/0000-0003-0226-1709; NERGADZE, SOLOMON/0000-0001-8121-0189; GIULOTTO, ELENA/0000-0002-4705-2049; Saino, Nicola/0000-0002-0230-3967				ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; [Anonymous], 2006, SAS MIXED MODELS; Azzalin CM, 1997, CYTOGENET CELL GENET, V78, P112, DOI 10.1159/000134640; Barrett ELB, 2013, MOL ECOL, V22, P249, DOI 10.1111/mec.12110; Barrett ELB, 2011, AGING CELL, V10, P913, DOI 10.1111/j.1474-9726.2011.00741.x; Beaulieu M, 2011, FUNCT ECOL, V25, P577, DOI 10.1111/j.1365-2435.2010.01825.x; Bhattacharyya MK, 2006, TRENDS BIOCHEM SCI, V31, P114, DOI 10.1016/j.tibs.2005.12.001; Bize P, 2009, P R SOC B, V276, P1679, DOI 10.1098/rspb.2008.1817; BLACKBURN EH, 1984, ANNU REV BIOCHEM, V53, P163, DOI 10.1146/annurev.bi.53.070184.001115; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Boncoraglio G, 2008, BEHAV ECOL SOCIOBIOL, V62, P729, DOI 10.1007/s00265-007-0498-8; Bonisoli-Alquati A, 2008, ECOLOGY, V89, P2315, DOI 10.1890/07-1066.1; Boonekamp JJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3287; Boonekamp JJ, 2013, AGING CELL, V12, P330, DOI 10.1111/acel.12050; Britt-Compton B, 2006, HUM MOL GENET, V15, P725, DOI 10.1093/hmg/ddi486; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Callicott RJ, 2006, COMPARATIVE MED, V56, P17; Caprioli M, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0340; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chan SRWL, 2004, PHILOS T R SOC B, V359, P109, DOI 10.1098/rstb.2003.1370; Cramp S., 1998, THE COMPLETE BIRDS O; Daniali L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2602; Delany ME, 2000, CYTOGENET CELL GENET, V90, P139, DOI 10.1159/000015649; Faravelli M, 2002, GENE, V283, P11, DOI 10.1016/S0378-1119(01)00877-0; Foote CG, 2011, J ZOOL, V283, P203, DOI 10.1111/j.1469-7998.2010.00774.x; Foote CG, 2013, MOL ECOL RESOUR, V13, P417, DOI 10.1111/1755-0998.12079; Foote CG, 2011, BEHAV ECOL, V22, P156, DOI 10.1093/beheco/arq178; Friedrich U, 2000, MECH AGEING DEV, V119, P89, DOI 10.1016/S0047-6374(00)00173-1; Gazzaniga FS, 2014, BLOOD, V124, P3675, DOI 10.1182/blood-2014-06-582254; Ge Z, 2006, MOL CELL BIOL, V26, P230, DOI 10.1128/MCB.26.1.230-237.2006; Geiger S, 2012, MOL ECOL, V21, P1500, DOI 10.1111/j.1365-294X.2011.05331.x; Graakjaer J, 2003, MECH AGEING DEV, V124, P629, DOI 10.1016/S0047-6374(03)00081-2; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Hall ME, 2010, FUNCT ECOL, V24, P365, DOI 10.1111/j.1365-2435.2009.01635.x; Hall ME, 2004, P ROY SOC B-BIOL SCI, V271, P1571, DOI 10.1098/rspb.2004.2768; Hande MP, 1999, J CELL BIOL, V144, P589, DOI 10.1083/jcb.144.4.589; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Haussmann MF, 2007, EXP GERONTOL, V42, P610, DOI 10.1016/j.exger.2007.03.004; Haussmann MF, 2005, BIOL LETTERS, V1, P212, DOI 10.1098/rsbl.2005.0301; Haussmann MF, 2003, P ROY SOC B-BIOL SCI, V270, P1387, DOI 10.1098/rspb.2003.2385; Heidinger BJ, 2012, P NATL ACAD SCI USA, V109, P1743, DOI 10.1073/pnas.1113306109; Herborn KA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3151; Horn T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017199; Kilgas P, 2010, COMP BIOCHEM PHYS B, V157, P288, DOI 10.1016/j.cbpb.2010.07.002; Kimura M, 2010, NAT PROTOC, V5, P1596, DOI 10.1038/nprot.2010.124; Lansdorp PM, HUM MOL GENET, V5, P685; Liker A, 2005, EVOLUTION, V59, P890, DOI 10.1554/04-560; Lin Y, 2015, CLIN SCI, V128, P367, DOI 10.1042/CS20140481; Lustig AJ, 2003, NAT REV GENET, V4, P916, DOI 10.1038/nrg1207; MEYNE J, 1989, P NATL ACAD SCI USA, V86, P7049, DOI 10.1073/pnas.86.18.7049; Mizutani Y, 2013, BIOL LETT, V9, P20130; Monaghan P, 2006, TRENDS ECOL EVOL, V21, P47, DOI 10.1016/j.tree.2005.11.007; Monaghan P, 2010, ANN NY ACAD SCI, V1206, P130, DOI 10.1111/j.1749-6632.2010.05705.x; Mondello C, 2000, GENOMICS, V68, P111, DOI 10.1006/geno.2000.6280; Mondello C, 1999, EXP CELL RES, V248, P234, DOI 10.1006/excr.1999.4398; Nanda I, 2002, CHROMOSOMA, V111, P215, DOI 10.1007/s00412-002-0206-4; Nergadze SG, 2004, GENOME RES, V14, P1704, DOI 10.1101/gr.2778904; Nergadze SG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r260; Nettle D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083617; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pauliny A, 2006, MOL ECOL, V15, P1681, DOI 10.1111/j.1365-294X.2006.02862.x; Pauliny A, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-257; Rasmussen R, 2001, RAPID CYCLE REAL TIM, P21, DOI [10.1007/978-3-642-59524-0_3, DOI 10.1007/978-3-642-59524-0_3]; Reichert S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081496; Ruiz-Herrera A, 2008, CYTOGENET GENOME RES, V122, P219, DOI 10.1159/000167807; Saino N, 2002, MOL ECOL, V11, P1533, DOI 10.1046/j.1365-294X.2002.01542.x; Saino N, 2004, P ROY SOC B-BIOL SCI, V271, P681, DOI 10.1098/rspb.2003.2656; Saino N, 2008, EVOL ECOL, V22, P659, DOI 10.1007/s10682-007-9189-1; Saino N, 2008, OECOLOGIA, V156, P441, DOI 10.1007/s00442-008-0971-8; Saino N, 2012, J ANIM ECOL, V81, P1004, DOI 10.1111/j.1365-2656.2012.01989.x; Saino N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019593; Salomons HM, 2009, P ROY SOC B-BIOL SCI, V276, P3157, DOI 10.1098/rspb.2009.0517; Salomons HM, 2009, THESIS; Scandolara C, 2014, ANIM BEHAV, V87, P187, DOI 10.1016/j.anbehav.2013.10.030; Shore D, 2009, EMBO J, V28, P2309, DOI 10.1038/emboj.2009.195; Smirnova A, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00115; Terai M, 2014, TISSUE CELL, V46, P470, DOI 10.1016/j.tice.2014.08.005; Tissier ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097705; Turner A., 2006, BARN SWALLOW; van de Pol MV, 2009, ANIM BEHAV, V77, P753, DOI 10.1016/j.anbehav.2008.11.006; Voillemot M, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-17; Weng NP, 2001, J LEUKOCYTE BIOL, V70, P861; West B. T., 2014, LINEAR MIXED MODELS; Wright WE, 1997, GENE DEV, V11, P2801, DOI 10.1101/gad.11.21.2801; Young RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074931; Zeichner SL, 1999, BLOOD, V93, P2824	88	28	28	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142530	10.1371/journal.pone.0142530	http://dx.doi.org/10.1371/journal.pone.0142530			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26565632	Green Submitted, Green Published, gold			2022-12-26	WOS:000367628500030
J	Salvadori, E; Blazsekova, T; Volein, A; Karap, Z; Tatone, D; Mascaro, O; Csibra, G				Salvadori, Eliala; Blazsekova, Tatiana; Volein, Agnes; Karap, Zsuzsanna; Tatone, Denis; Mascaro, Olivier; Csibra, Gergely			Probing the Strength of Infants' Preference for Helpers over Hinderers: Two Replication Attempts of Hamlin and Wynn (2011)	PLOS ONE			English	Article							PREVERBAL INFANTS; SOCIAL EVALUATION	Several studies indicate that infants prefer individuals who act prosocially over those who act antisocially toward unrelated third parties. In the present study, we focused on a paradigm published by Kiley Hamlin and Karen Wynn in 2011. In this study, infants were habituated to a live puppet show in which a protagonist tried to open a box to retrieve a toy placed inside. The protagonist was either helped by a second puppet (the "Helper"), or hindered by a third puppet (the "Hinderer"). At test, infants were presented with the Helper and the Hinderer, and encouraged to reach for one of them. In the original study, 75% of 9-month-olds selected the Helper, arguably demonstrating a preference for prosocial over antisocial individuals. We conducted two studies with the aim of replicating this result. Each attempt was performed by a different group of experimenters. Study 1 followed the methods of the published study as faithfully as possible. Study 2 introduced slight modifications to the stimuli and the procedure following the guidelines generously provided by Kiley Hamlin and her collaborators. Yet, in our replication attempts, 9-month-olds' preference for helpers over hinderers did not differ significantly from chance (62.5% and 50%, respectively, in Studies 1 and 2). Two types of factors could explain why our results differed from those of Hamlin and Wynn: minor methodological dissimilarities (in procedure, materials, or the population tested), or the effect size being smaller than originally assumed. We conclude that fine methodological details that are crucial to infants' success in this task need to be identified to ensure the replicability of the original result.	[Salvadori, Eliala; Blazsekova, Tatiana; Volein, Agnes; Karap, Zsuzsanna; Tatone, Denis; Mascaro, Olivier; Csibra, Gergely] Cent European Univ, Cognit Dev Ctr, Budapest, Hungary	Central European University	Tatone, D (corresponding author), Cent European Univ, Cognit Dev Ctr, Budapest, Hungary.	denis.tatone@gmail.com	Mascaro, Olivier/O-4306-2017; Salvadori, Eliala Alice/AAA-5281-2022; Csibra, Gergely/C-4345-2008	Mascaro, Olivier/0000-0002-1120-5955; Salvadori, Eliala Alice/0000-0001-9814-8625; Csibra, Gergely/0000-0002-7044-3056				Buon M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088612; Cowell JM, 2015, P NATL ACAD SCI US; Geraci A, 2011, DEVELOPMENTAL SCI, V14, P1012, DOI 10.1111/j.1467-7687.2011.01048.x; Hamlin JK, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01563; Hamlin JK, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00614; Hamlin J.K., 2014, NEW FRONTIERS SOCIAL, P165, DOI [10.1007/978-3-319-02904-7_10, DOI 10.1007/978-3-319-02904-7_10]; Hamlin JK, 2007, NATURE, V450, P557, DOI 10.1038/nature06288; Hamlin JK, 2015, MORAL BRAIN: A MULTIDISCIPLINARY PERSPECTIVE, P105; Hamlin JK, 2014, HUM DEV, V57, P250, DOI 10.1159/000365120; Hamlin JK, 2013, COGNITION, V128, P451, DOI 10.1016/j.cognition.2013.04.004; Hamlin JK, 2013, CURR DIR PSYCHOL SCI, V22, P186, DOI 10.1177/0963721412470687; Hamlin JK, 2013, PSYCHOL SCI, V24, P589, DOI 10.1177/0956797612457785; Hamlin JK, 2013, DEVELOPMENTAL SCI, V16, P209, DOI 10.1111/desc.12017; Hamlin JK, 2011, P NATL ACAD SCI USA, V108, P19931, DOI 10.1073/pnas.1110306108; Hamlin JK, 2011, COGNITIVE DEV, V26, P30, DOI 10.1016/j.cogdev.2010.09.001; Hetland L, 2000, J AESTHET EDUC, V34, P105, DOI 10.2307/3333640; Kanakogi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065292; Kuhlmeier V, 2003, PSYCHOL SCI, V14, P402, DOI 10.1111/1467-9280.01454; Pietschnig J, 2010, INTELLIGENCE, V38, P314, DOI 10.1016/j.intell.2010.03.001; Premack D, 1997, J COGNITIVE NEUROSCI, V9, P848, DOI 10.1162/jocn.1997.9.6.848; Scarf D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042698; Scola C, 2015, INFANCY; Wynn K., 2009, INNATE MIND FDN FUTU, P330	23	58	58	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0140570	10.1371/journal.pone.0140570	http://dx.doi.org/10.1371/journal.pone.0140570			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA2MI	26565412	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000367628500002
J	Clayton, ZE; Vickers, MH; Bernal, A; Yap, C; Sloboda, DM				Clayton, Zoe E.; Vickers, Mark H.; Bernal, Angelica; Yap, Cassandra; Sloboda, Deborah M.			Early Life Exposure to Fructose Alters Maternal, Fetal and Neonatal Hepatic Gene Expression and Leads to Sex-Dependent Changes in Lipid Metabolism in Rat Offspring	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; NLRP3 INFLAMMASOME ACTIVATION; URIC-ACID; INSULIN SENSITIVITY; ER STRESS; TRANSCRIPTION FACTOR; SWEETENED BEVERAGES; DIETARY FRUCTOSE; BLOOD-PRESSURE; ENERGY SENSOR	Aim Fructose consumption is associated with altered hepatic function and metabolic compromise and not surprisingly has become a focus for perinatal studies. We have previously shown that maternal fructose intake results in sex specific changes in fetal, placental and neonatal outcomes. In this follow-up study we investigated effects on maternal, fetal and neonatal hepatic fatty acid metabolism and immune modulation. Methods Pregnant rats were randomised to either control (CON) or high-fructose (FR) diets. Fructose was given in solution and comprised 20% of total caloric intake. Blood and liver samples were collected at embryonic day 21 (E21) and postnatal day (P) 10. Maternal liver samples were also collected at E21 and P10. Liver triglyceride and glycogen content was measured with standard assays. Hepatic gene expression was measured with qPCR. Results Maternal fructose intake during pregnancy resulted in maternal hepatic ER stress, hepatocellular injury and increased levels of genes that favour lipogenesis. These changes were associated with a reduction in the NLRP3 inflammasome. Fetuses of mothers fed a high fructose diet displayed increased hepatic fructose transporter and reduced fructokinase mRNA levels and by 10 days of postnatal age, also have hepatic ER stress, and elevated IL1 beta mRNA levels. At P10, FR neonates demonstrated increased hepatic triglyceride content and particularly in males, associated changes in the expression of genes regulating beta oxidation and the NLRP3 inflammasome. Further, prenatal fructose results in sex-dependant changes in levels of key clock genes. Conclusions Maternal fructose intake results in age and sex-specific alterations in maternal fetal and neonatal free fatty acid metabolism, which may be associated in disruptions in core clock gene machinery. How these changes are associated with hepatic inflammatory processes is still unclear, although suppression of the hepatic inflammasome, as least in mothers and male neonates may point to impaired immune sensing.	[Clayton, Zoe E.; Vickers, Mark H.; Bernal, Angelica; Yap, Cassandra] Univ Auckland, Liggins Inst, Auckland, New Zealand; [Clayton, Zoe E.; Vickers, Mark H.; Bernal, Angelica; Yap, Cassandra] Univ Auckland, Gravida Natl Ctr Growth & Dev, Auckland, New Zealand; [Sloboda, Deborah M.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Sloboda, Deborah M.] McMaster Univ, Dept Obstet & Gynaecol, Hamilton, ON L8N 3Z5, Canada; [Sloboda, Deborah M.] McMaster Univ, Dept Pediat, Hamilton, ON L8N 3Z5, Canada	University of Auckland; University of Auckland; McMaster University; McMaster University; McMaster University	Sloboda, DM (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada.	sloboda@mcmaster.ca		Clayton, Zoe/0000-0001-6108-092X	Health Research Council of New Zealand; Gravida: National Centre for Growth and Development; Marsden Fund of the Royal Society of New Zealand; Canada Research Chairs Program	Health Research Council of New Zealand(Health Research Council of New Zealand); Gravida: National Centre for Growth and Development; Marsden Fund of the Royal Society of New Zealand(Royal Society of New ZealandMarsden Fund (NZ)); Canada Research Chairs Program(Canada Research Chairs)	This work was supported by the Health Research Council of New Zealand and Gravida: National Centre for Growth and Development and The Marsden Fund of the Royal Society of New Zealand. DMS is supported by the Canada Research Chairs Program. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alwahsh SM, 2014, WORLD J GASTROENTERO, V20, P1807, DOI 10.3748/wjg.v20.i7.1807; Anuradha CV, 1999, CAN J PHYSIOL PHARM, V77, P749, DOI 10.1139/cjpp-77-10-749; Bantle JP, 2000, AM J CLIN NUTR, V72, P1128; Bergen WG, 2005, J NUTR, V135, P2499, DOI 10.1093/jn/135.11.2499; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bobridge KS, 2013, J HUM HYPERTENS, V27, P217, DOI 10.1038/jhh.2012.36; Boden G, 2005, DIABETES, V54, P3458, DOI 10.2337/diabetes.54.12.3458; Borengasser SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084209; Brandstatter A, 2008, DIABETES CARE, V31, P1662, DOI 10.2337/dc08-0349; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Carling D, 2011, NAT CHEM BIOL, V7, P512, DOI [10.1038/nchembio.610, 10.1038/NCHEMBIO.610]; Caton PW, 2011, J ENDOCRINOL, V208, P273, DOI 10.1530/JOE-10-0190; Ching RHH, 2011, J NUTR, V141, P1664, DOI 10.3945/jn.111.142299; DeBosch BJ, 2014, J BIOL CHEM, V289, P10989, DOI 10.1074/jbc.M113.527002; Desai M, 2009, J MATERN-FETAL NEO M, V22, P571, DOI 10.1080/14767050902874105; EMMERSON BT, 1974, ANN RHEUM DIS, V33, P276, DOI 10.1136/ard.33.3.276; EPSTEIN MF, 1977, AM J OBSTET GYNECOL, V127, P261, DOI 10.1016/0002-9378(77)90465-3; Ferre P, 2007, HORM RES, V68, P72, DOI 10.1159/000100426; FRAYN KN, 1995, AM J CLIN NUTR, V62, p250S, DOI 10.1093/ajcn/62.1.250S; Galipeau D, 2002, AM J PHYSIOL-HEART C, V283, pH2478, DOI 10.1152/ajpheart.00243.2002; Gonzalez-Contreras J, 2012, NUTR HOSP, V27, P1900, DOI 10.3305/nh.2012.27.6.6047; Goran MI, 2013, NAT REV ENDOCRINOL, V9, P494, DOI 10.1038/nrendo.2013.108; HALLFRISCH J, 1983, AM J CLIN NUTR, V37, P740, DOI 10.1093/ajcn/37.5.740; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hu QH, 2012, BIOCHEM PHARMACOL, V84, P113, DOI 10.1016/j.bcp.2012.03.005; Im SS, 2011, CELL METAB, V13, P540, DOI 10.1016/j.cmet.2011.04.001; JEN KLC, 1991, J NUTR, V121, P1999, DOI 10.1093/jn/121.12.1999; Jin CC, 2010, J CLIN IMMUNOL, V30, P628, DOI 10.1007/s10875-010-9440-3; Lanaspa MA, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047948, 10.1371/journal.pone.0048801]; Lane MD, 2009, BIOCHEM BIOPH RES CO, V382, P1, DOI 10.1016/j.bbrc.2009.02.145; Le KA, 2006, AM J CLIN NUTR, V84, P1374, DOI 10.1093/ajcn/84.6.1374; Lecoultre V, 2013, DIABETES CARE, V36, pE149, DOI 10.2337/dc13-0866; Lee JS, 2012, AM J TRANSL RES, V4, P102; Lerner AG, 2012, CELL METAB, V16, P250, DOI 10.1016/j.cmet.2012.07.007; Li M, 2015, J NUTR BIOCHEM, V26, P267, DOI 10.1016/j.jnutbio.2014.10.015; Li ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076961; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Melanson KJ, 2008, AM J CLIN NUTR, V88, p1738S, DOI 10.3945/ajcn.2008.25825E; Menu P, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.132; Miura K, 2013, HEPATOLOGY, V57, P577, DOI 10.1002/hep.26081; Miura K, 2010, GASTROENTEROLOGY, V139, P323, DOI 10.1053/j.gastro.2010.03.052; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; Mukai Y, 2014, CLIN EXP PHARMACOL P, V41, P331, DOI 10.1111/1440-1681.12225; Mukai Y, 2013, ENDOCRINE, V44, P79, DOI 10.1007/s12020-012-9815-8; Nakagawa T, 2006, AM J PHYSIOL-RENAL, V290, pF625, DOI 10.1152/ajprenal.00140.2005; Parks EJ, 2008, J NUTR, V138, P1039, DOI 10.1093/jn/138.6.1039; Patro B, 2013, ANN NUTR METAB, V63, P32, DOI 10.1159/000350313; PERHEENT.J, 1967, LANCET, V2, P528; Poston L, 2012, BEST PRACT RES CL EN, V26, P627, DOI 10.1016/j.beem.2012.03.010; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; RAIVIO KO, 1972, ACTA MED SCAND, P111; Rakhshandehroo M, 2010, PPAR RES, V2010, DOI 10.1155/2010/612089; RAWANA S, 1993, J NUTR, V123, P2158; Regnault TRH, 2013, CLIN EXP PHARMACOL P, V40, P824, DOI 10.1111/1440-1681.12162; Rho YH, 2011, SEMIN NEPHROL, V31, P410, DOI 10.1016/j.semnephrol.2011.08.004; Ribeiro RA, 2009, DIABETES-METAB RES, V25, P370, DOI 10.1002/dmrr.959; Ritze Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0101702, 10.1371/journal.pone.0080169]; Rodriguez L, 2013, J NUTR BIOCHEM, V24, P1709, DOI 10.1016/j.jnutbio.2013.02.011; ROEHRIG KL, 1974, ANAL BIOCHEM, V58, P414, DOI 10.1016/0003-2697(74)90210-3; Roncal-Jimenez CA, 2011, METABOLISM, V60, P1259, DOI 10.1016/j.metabol.2011.01.008; Ruby MA, 2010, J LIPID RES, V51, P2275, DOI 10.1194/jlr.M005561; Ruderman NB, 2010, AM J PHYSIOL-ENDOC M, V298, pE751, DOI 10.1152/ajpendo.00745.2009; Samuel VT, 2011, TRENDS ENDOCRIN MET, V22, P60, DOI 10.1016/j.tem.2010.10.003; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sloboda DM, 2014, J OBES, V2014, DOI 10.1155/2014/203474; Sridhar SB, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.02.030; Srinivasan M, 2008, AM J PHYSIOL-ENDOC M, V295, pE895, DOI 10.1152/ajpendo.90460.2008; Stanhope KL, 2015, AM J CLIN NUTR, V101, P1144, DOI 10.3945/ajcn.114.100461; STAVRIC B, 1976, EXPERIENTIA, V32, P373, DOI 10.1007/BF01940847; Sutton GM, 2010, ENDOCRINOLOGY, V151, P1570, DOI 10.1210/en.2009-1133; Vickers MH, 2011, ENDOCRINOLOGY, V152, P1378, DOI 10.1210/en.2010-1093; Vila L, 2011, J NUTR BIOCHEM, V22, P741, DOI 10.1016/j.jnutbio.2010.06.005; Viollet B, 2006, J PHYSIOL-LONDON, V574, P41, DOI 10.1113/jphysiol.2006.108506; Vos Miriam B, 2008, Medscape J Med, V10, P160; Yin SN, 2014, ENDOCR RES, V39, P67, DOI 10.3109/07435800.2013.828741; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zambrano E, 2013, NUTR REV, V71, pS42, DOI 10.1111/nure.12068; Zhang C, 2012, TOXICOL LETT, V212, P229, DOI 10.1016/j.toxlet.2012.06.002; Zhang QY, 2014, J NUTR BIOCHEM, V25, P420, DOI 10.1016/j.jnutbio.2013.11.014; Zhou B, 2014, HEPATOLOGY, V59, P2196, DOI 10.1002/hep.26992	81	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0141962	10.1371/journal.pone.0141962	http://dx.doi.org/10.1371/journal.pone.0141962			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562417	gold, Green Submitted, Green Published			2022-12-26	WOS:000364480900008
J	Miyamoto, S; Usami, S; Kuwabara, Y; Horie, T; Baba, O; Hakuno, D; Nakashima, Y; Nishiga, M; Izuhara, M; Nakao, T; Nishino, T; Ide, Y; Nakazeki, F; Wang, J; Ueyama, K; Kimura, T; Ono, K				Miyamoto, Shoichi; Usami, Shunsuke; Kuwabara, Yasuhide; Horie, Takahiro; Baba, Osamu; Hakuno, Daihiko; Nakashima, Yasuhiro; Nishiga, Masataka; Izuhara, Masayasu; Nakao, Tetsushi; Nishino, Tomohiro; Ide, Yuya; Nakazeki, Fumiko; Wang, Jun; Ueyama, Koji; Kimura, Takeshi; Ono, Koh			Expression Patterns of miRNA-423-5p in the Serum and Pericardial Fluid in Patients Undergoing Cardiac Surgery	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CIRCULATING MICRORNAS; HEART-FAILURE; BODY-FLUIDS; PROSTATE-CANCER; BIOMARKERS; PLASMA; CELLS; TRANSLATION	Background Recently, it has been reported that specific microRNA (miRNA) levels are elevated in serum and can be used as biomarkers in patients with cardiovascular diseases. However, miRNAs expression profiles and their sources in pericardial fluid (PF) are unclear. Methods and Results The purpose of this study was to identify the levels of miRNAs in PF in relation to those in the serum in patients undergoing cardiac surgery. Serum (S) and PF from patients undergoing coronary artery bypass graft (CABG) due to stable angina pectoris (sAP) and unstable AP (uAP) and aortic valve replacement due to aortic stenosis (AS) were analyzed for the detection of miRNAs. We named these samples S-sAP, S-uAP, S-AS, PF-sAP, PF-uAP, and PF-AS, respectively. We first measured the levels of miR-423-5p, which was recognized previously as a biomarker for heart failure. miR-423-5p levels were significantly higher in PF than serum. Although there was no difference in miR-423-5p levels among the PFAS, PF-sAP, and PF-uAP, its levels were significantly elevated in S-uAP compared with those in S-AS and S-sAP. In order to clarify the source of miR-423-5p in PF, we measured the levels of muscle-enriched miR-133a and vascular-enriched miR-126 and miR-92a in the same samples. miR-133a levels were significantly higher in serum than in PF, and it was elevated in S-uAP compared with S-AS. miR-126 level was significantly increased in serum compared with PF, and the level of miR-92a the similar tendency. miR-423-5p is located in the first intron of NSRP1. There is another miRNA, miR-3184, encoded in the opposite direction in the same region. In vitro experiments indicated that the duplex of miR-423-5p and miR-3184-3p was more resistant to RNase than the duplex of miR-423-5p and miR-133-3p, which may help to stabilize miR-423-5p in the PF. Conclusions Our results suggested that miR-423-5p is enriched in PF, and serum miR-423-5p may be associate with uAP. Its expression pattern was different to that of muscle-and vascular-enriched miRNAs, miR-133a, miR-126, and miR-92a.	[Miyamoto, Shoichi; Ueyama, Koji] Kitano Hosp, Tazuke Kofukai Med Res Inst, Cardiovasc Ctr, Osaka, Japan; [Usami, Shunsuke; Kuwabara, Yasuhide; Horie, Takahiro; Baba, Osamu; Hakuno, Daihiko; Nakashima, Yasuhiro; Nishiga, Masataka; Izuhara, Masayasu; Nakao, Tetsushi; Nishino, Tomohiro; Ide, Yuya; Nakazeki, Fumiko; Wang, Jun; Kimura, Takeshi; Ono, Koh] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, Kyoto, Japan	Kitano Hospital; Kyoto University	Ono, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto, Japan.	kohono@kuhp.kyoto-u.ac.jp	NAKAO, TETSUSHI/GRF-6084-2022	NAKAO, TETSUSHI/0000-0001-9979-2682; Nishiga, Masataka/0000-0001-5676-7671	Grants of the Japan Society for the Promotion of Science [26116716, 26293186]; Grants-in-Aid for Scientific Research [25293182] Funding Source: KAKEN	Grants of the Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported from the Grants of the Japan Society for the Promotion of Science (26116716 and 26293186). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai J, 2010, BIOCHEM BIOPH RES CO, V391, P73, DOI 10.1016/j.bbrc.2009.11.005; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bryant RJ, 2012, BRIT J CANCER, V106, P768, DOI 10.1038/bjc.2011.595; Chen TS, 2010, NUCLEIC ACIDS RES, V38, P215, DOI 10.1093/nar/gkp857; Cheng YH, 2010, CLIN SCI, V119, P87, DOI 10.1042/CS20090645; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; Fujita M, 1996, CIRCULATION, V94, P610, DOI 10.1161/01.CIR.94.4.610; Goldraich LA, 2014, BIOMARKERS, V19, P135, DOI 10.3109/1354750X.2013.870605; Goren Y, 2012, EUR J HEART FAIL, V14, P147, DOI 10.1093/eurjhf/hfr155; HANLEY F, 1983, AM J PHYSIOL, V245, pH327, DOI 10.1152/ajpheart.1983.245.2.H327; Hattori F, 2010, NAT METHODS, V7, P61, DOI [10.1038/NMETH.1403, 10.1038/nmeth.1403]; Heneghan HM, 2009, J ONCOL, V2009, DOI DOI 10.1155/2010/950201; Horie T, 2010, P NATL ACAD SCI USA, V107, P17321, DOI 10.1073/pnas.1008499107; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Kiriakidou M, 2007, CELL, V129, P1141, DOI 10.1016/j.cell.2007.05.016; Kuner R, 2013, METHODS, V59, P132, DOI 10.1016/j.ymeth.2012.05.004; Kuosmanen SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119646; Kuwabara Y, 2015, CIRC RES, V116, P279, DOI 10.1161/CIRCRESAHA.116.304707; Kuwabara Y, 2011, CIRC-CARDIOVASC GENE, V4, P446, DOI 10.1161/CIRCGENETICS.110.958975; Lai EC, 2004, RNA, V10, P171, DOI 10.1261/rna.5191904; Lao KQ, 2006, BIOCHEM BIOPH RES CO, V343, P85, DOI 10.1016/j.bbrc.2006.02.106; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nishi H, 2011, MOL CELL BIOL, V31, P744, DOI 10.1128/MCB.00581-10; Ono K, 2011, FEBS J; Tanaka T, 1998, J AM COLL CARDIOL, V31, P399, DOI 10.1016/S0735-1097(97)00482-8; Tijsen AJ, 2012, AM J PHYSIOL-HEART C, V303, pH1085, DOI 10.1152/ajpheart.00191.2012; Tijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Wang K, 2010, NUCLEIC ACIDS RES, V38, P7248, DOI 10.1093/nar/gkq601; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Weihrauch D, 1998, AM J PHYSIOL-HEART C, V275, pH969, DOI 10.1152/ajpheart.1998.275.3.H969; Xie SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016235	37	20	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142904	10.1371/journal.pone.0142904	http://dx.doi.org/10.1371/journal.pone.0142904			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562412	Green Published, Green Submitted, gold			2022-12-26	WOS:000364480900080
J	Dulo, F; Feleke, A; Szonyi, B; Fries, R; Baumann, MPO; Grace, D				Dulo, Fitsum; Feleke, Aklilu; Szonyi, Barbara; Fries, Reinhard; Baumann, Maximilian P. O.; Grace, Delia			Isolation of Multidrug-Resistant Escherichia coli O157 from Goats in the Somali Region of Ethiopia: A Cross-Sectional, Abattoir-Based Study	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; BEEF; PREVALENCE; PRODUCTS; CATTLE	Toxigenic Escherichia coli (E. coli) are an important cause of gastroenteritis in developing countries. In Ethiopia, gastroenteritis due to food-borne disease is a leading cause of death. Yet, there is no surveillance for E. coli O157 and little is known about the carriage of this pathogen in Ethiopia's livestock. This study aimed to assess the prevalence and levels of antimicrobial resistance of E. coli O157 in goat meat, feces, and environmental samples collected at a large abattoir in the Somali region of Ethiopia. The samples were enriched in modified tryptone broth containing novobiocin, and plated onto sorbitol MacConkey agar. Isolates were confirmed using indole test and latex agglutination. Antimicrobial susceptibility testing was conducted using the disk diffusion method. A total of 235 samples, including 93 goat carcass swabs, 93 cecal contents, 14 water, 20 hand, and 15 knife swabs were collected. Overall, six (2.5%) samples were contaminated with E. coli O157 of which two (2.1%) were isolated from cecal contents, three (3.2%) from carcass swabs, and one (7.1%) from water. All isolates were resistant to at least two of the 18 antimicrobials tested. Two isolates (33.3%) were resistant to more than five antimicrobials. Abattoir facilities and slaughter techniques were conducive to carcass contamination. This study highlights how poor hygiene and slaughter practice can result in contaminated meat, which is especially risky in Ethiopia because of the common practice of eating raw meat. We detect multi-resistance to drugs not used in goats, suggesting that drugs used to treat human infections may be the originators of antimicrobial resistance in livestock in this ecosystem. The isolation of multi-drug-resistant E. coli O157 from goats from a remote pastoralist system highlights the need for global action on regulating and monitoring antimicrobial use in both human and animal populations.	[Dulo, Fitsum; Feleke, Aklilu] Univ Addis Ababa, Fac Vet Med, Debre Zeit, Ethiopia; [Szonyi, Barbara] Int Livestock Res Inst, Addis Ababa, Ethiopia; [Fries, Reinhard] Free Univ Berlin, Inst Meat Hyg & Technol, Berlin, Germany; [Baumann, Maximilian P. O.] Free Univ Berlin, FAO Reference Ctr Vet Publ Hlth VPH, Berlin, Germany; [Grace, Delia] Int Livestock Res Inst, Nairobi, Kenya	Addis Ababa University; CGIAR; International Livestock Research Institute (ILRI); Free University of Berlin; Free University of Berlin; CGIAR; International Livestock Research Institute (ILRI)	Szonyi, B (corresponding author), Int Livestock Res Inst, Addis Ababa, Ethiopia.	b.szonyi@cgiar.org		Grace, Delia/0000-0002-0195-9489	International Agricultural Research, GTZ, Germany [11.7860.7-001.00]	International Agricultural Research, GTZ, Germany	This study was conducted under the Safe Food Fair Food project of the International Livestock Research Institute (ILRI), funded by International Agricultural Research, GTZ, Germany (Project no: 11.7860.7-001.00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Central Statistical Authority, 2007, CENS 2007 TABL SOM R; Central Statistical Authority, 2003, LIV AER SURV SOM REG; CHAPMAN PA, 1994, J MED MICROBIOL, V40, P424, DOI 10.1099/00222615-40-6-424; Chapman PA, 2001, INT J FOOD MICROBIOL, V64, P139, DOI 10.1016/S0168-1605(00)00453-0; CLSI, 2012, PERF STAND ANT SUSC; Farrokh C, 2013, INT J FOOD MICROBIOL, V162, P190, DOI 10.1016/j.ijfoodmicro.2012.08.008; GRIFFIN PM, 1991, EPIDEMIOL REV, V13, P60, DOI 10.1093/oxfordjournals.epirev.a036079; Harakeh S, 2005, SCI TOTAL ENVIRON, V341, P33, DOI 10.1016/j.scitotenv.2004.09.025; Hassen A., 2013, ANAL SHEEP GOAT VALU; Hiko A, 2008, J INFECT DEV COUNTR, V2, P389; Institute for Health Metrics and Evaluation (IHME), 2013, GLOB BURD DIS STUD 2; ISO, 2013, MICR FOOD AN FEED ST; McEvoy JM, 2003, J APPL MICROBIOL, V95, P256, DOI 10.1046/j.1365-2672.2003.01981.x; Mersha G, 2010, LETT APPL MICROBIOL, V50, P71, DOI 10.1111/j.1472-765X.2009.02757.x; Mulvey MR, 2005, ANTIMICROB AGENTS CH, V49, P358, DOI 10.1128/AAC.49.1.358-365.2005; Osaili TM, 2013, MEAT SCI, V93, P463, DOI 10.1016/j.meatsci.2012.11.023; Shahid M, 2008, INT J INFECT DIS, V12, P256, DOI 10.1016/j.ijid.2007.08.008; Thrusfield M., 2018, VET EPIDEMIOLOGY, DOI [10.1002/9781118280249, DOI 10.1002/9781118280249]; Van Boeckel T. P., 2015, P NATL ACAD SCI US	19	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142905	10.1371/journal.pone.0142905	http://dx.doi.org/10.1371/journal.pone.0142905			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26561414	gold, Green Submitted, Green Published			2022-12-26	WOS:000364433100137
J	Lopez-Martinez, LM; Santacruz-Ortega, H; Navarro, RE; Sotelo-Mundo, RR; Gonzalez-Aguilar, GA				Lopez-Martinez, Luis M.; Santacruz-Ortega, Hisila; Navarro, Rosa-Elena; Sotelo-Mundo, Rogerio R.; Gonzalez-Aguilar, Gustavo A.			A H-1 NMR Investigation of the Interaction between Phenolic Acids Found in Mango (Manguifera indica cv Ataulfo) and Papaya (Carica papaya cv Maradol) and 1,1-diphenyl-2-picrylhydrazyl (DPPH) Free Radicals	PLOS ONE			English	Article							NMR ANALYTICAL APPROACH; ANTIOXIDANT ACTIVITY; ANTAGONISM; SYNERGISM; PROFILES; EXTRACTS; CLARIFY; L.	The benefits of phenolic acids on human health are very often ascribed to their potential to counteract free radicals to provide antioxidant protection. This potential has been attributed to their acidic chemical structure, which possesses hydroxyl groups in different positions. Phenolic acids can interact between themselves and exhibit an additive, antagonistic or synergistic effect. In this paper, we used H-1 NMR to analyze the interactions and mechanisms that are present in major phenolic acids found in mango (gallic, protocatechuic, chlorogenic and vanillic acids) and papaya (caffeic, ferulic and p-coumaric acids), and the DPPH radical was used to evaluate the effect of the antioxidant mixtures. The interactions were found to occur via hydrogen bonds between the -OH and -COOH groups. Moreover, the phenolic acids exhibit two types of mechanisms for the neutralization of the DPPH radical. According to the results, these two mechanisms are Hydrogen Atom Transfer (HAT) and Single Electron Transfer (SET). The ability of the phenolic acid to neutralize the DPPH radical decreases in the following order in mango: gallic > chlorogenic > protocatechuic > vanillic. Moreover, within the acids found in papaya, the order was as follows: caffeic > p-coumaric > ferulic.	[Lopez-Martinez, Luis M.; Santacruz-Ortega, Hisila; Navarro, Rosa-Elena; Sotelo-Mundo, Rogerio R.; Gonzalez-Aguilar, Gustavo A.] Univ Sonora, DIPM, Hermosillo 83000, Sonora, Mexico; [Sotelo-Mundo, Rogerio R.; Gonzalez-Aguilar, Gustavo A.] CIAD, Hermosillo 83000, Sonora, Mexico	Universidad de Sonora; CIAD - Centro de Investigacion en Alimentacion y Desarrollo	Santacruz-Ortega, H (corresponding author), Univ Sonora, DIPM, Calle Rosales & Blvd Luis Encinas S-N, Hermosillo 83000, Sonora, Mexico.	hisila@polimeros.uson.mx; gustavo@ciad.mx	Sotelo-Mundo, Rogerio/A-6097-2011	Sotelo-Mundo, Rogerio/0000-0001-5543-6889	Mexican National Council CONACYT; University of Sonora; CIAD; Secretaria de Educacion Publica, Mexico (SES-SEP) [P/PIFI 2010-01]; project "Nutrigenomica e interacciones moleculares de fenoles y fibra dietaria del mango "Ataulfo" (Mangifera indica L.) en un sistema murino" [179574CB2012-01]	Mexican National Council CONACYT; University of Sonora; CIAD; Secretaria de Educacion Publica, Mexico (SES-SEP); project "Nutrigenomica e interacciones moleculares de fenoles y fibra dietaria del mango "Ataulfo" (Mangifera indica L.) en un sistema murino"	This study was financed by the Mexican National Council CONACYT, University of Sonora and CIAD. The NMR spectrometer is operated under the support of the Secretaria de Educacion Publica, Mexico (SES-SEP, programs No. P/PIFI 2010-01.) This work is part of the project "Nutrigenomica e interacciones moleculares de fenoles y fibra dietaria del mango "Ataulfo" (Mangifera indica L.) en un sistema murino" Project 179574CB2012-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbo M. O., 2014, Journal of Natural Products (India), V7, P48; Benavente-Garcia O, 2000, FOOD CHEM, V68, P457, DOI 10.1016/S0308-8146(99)00221-6; Borgert CJ, 2005, THROMB RES, V117, P123, DOI 10.1016/j.thromres.2005.06.008; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Chanda S, 2013, TURK J BIOL, V37, P81, DOI 10.3906/biy-1203-41; Charisiadis P, 2014, MOLECULES, V19, P13643, DOI 10.3390/molecules190913643; Charisiadis P, 2011, J NAT PROD, V74, P2462, DOI 10.1021/np200329a; Hidalgo M, 2010, FOOD CHEM, V121, P691, DOI 10.1016/j.foodchem.2009.12.097; Jain DP, 2011, J ADV PHARM TECHNOL, V2, P177, DOI 10.4103/2231-4040.85538; Kawabata J, 2002, J AGR FOOD CHEM, V50, P5468, DOI 10.1021/jf020347g; Kim KH, 2006, FOOD CHEM, V95, P466, DOI 10.1016/j.foodchem.2005.01.032; Palafox-Carlos H, 2012, MOLECULES, V17, P12657, DOI 10.3390/molecules171112657; Pekkarinen SS, 1999, J AGR FOOD CHEM, V47, P3036, DOI 10.1021/jf9813236; Rivera-Pastrana DM, 2010, J SCI FOOD AGR, V90, P2358, DOI 10.1002/jsfa.4092; Romano CS, 2009, FOOD CHEM, V115, P456, DOI 10.1016/j.foodchem.2008.12.029; Saito S, 2005, TETRAHEDRON, V61, P8101, DOI 10.1016/j.tet.2005.06.040; Sawai Y, 2005, J AGR FOOD CHEM, V53, P3598, DOI 10.1021/jf040423a; Sawai Y, 1998, J AGR FOOD CHEM, V46, P111, DOI 10.1021/jf970342x; Sawai Y, 2000, J AGR FOOD CHEM, V48, P6247, DOI 10.1021/jf000500b; Siquet C, 2006, FREE RADICAL RES, V40, P433, DOI 10.1080/10715760500540442; Tazaki H, 2001, BIOSCI BIOTECH BIOCH, V65, P2613, DOI 10.1271/bbb.65.2613; Villano D, 2005, ANAL CHIM ACTA, V538, P391, DOI 10.1016/j.aca.2005.02.016; Yin J, 2012, FOOD CHEM, V135, P2195, DOI 10.1016/j.foodchem.2012.07.025; Zhang M, 2013, MOLECULES, V18, P14096, DOI 10.3390/molecules181114096	24	55	58	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0140242	10.1371/journal.pone.0140242	http://dx.doi.org/10.1371/journal.pone.0140242			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559189	gold, Green Published, Green Submitted			2022-12-26	WOS:000364433100004
J	Shirima, DD; Pfeifer, M; Platts, PJ; Totland, O; Moe, SR				Shirima, Deo D.; Pfeifer, Marion; Platts, Philip J.; Totland, Orjan; Moe, Stein R.			Interactions between Canopy Structure and Herbaceous Biomass along Environmental Gradients in Moist Forest and Dry Miombo Woodland of Tanzania	PLOS ONE			English	Article							LEAF-AREA INDEX; TREE-GRASS INTERACTIONS; EASTERN ARC MOUNTAINS; ABOVEGROUND BIOMASS; TROPICAL FOREST; DIVERSITY; CARBON; HYPOTHESIS; ALLOMETRY; ALTITUDE	We have limited understanding of how tropical canopy foliage varies along environmental gradients, and how this may in turn affect forest processes and functions. Here, we analyse the relationships between canopy leaf area index (LAI) and above ground herbaceous biomass (AGBH) along environmental gradients in a moist forest and miombo woodland in Tanzania. We recorded canopy structure and herbaceous biomass in 100 permanent vegetation plots (20 m x 40 m), stratified by elevation. We quantified tree species richness, evenness, Shannon diversity and predominant height as measures of structural variability, and disturbance (tree stumps), soil nutrients and elevation as indicators of environmental variability. Moist forest and miombo woodland differed substantially with respect to nearly all variables tested. Both structural and environmental variables were found to affect LAI and AGBH, the latter being additionally dependent on LAI in moist forest but not in miombo, where other factors are limiting. Combining structural and environmental predictors yielded the most powerful models. In moist forest, they explained 76% and 25% of deviance in LAI and AGBH, respectively. In miombo woodland, they explained 82% and 45% of deviance in LAI and AGBH. In moist forest, LAI increased non-linearly with predominant height and linearly with tree richness, and decreased with soil nitrogen except under high disturbance. Miombo woodland LAI increased linearly with stem density, soil phosphorous and nitrogen, and decreased linearly with tree species evenness. AGBH in moist forest decreased with LAI at lower elevations whilst increasing slightly at higher elevations. AGBH in miombo woodland increased linearly with soil nitrogen and soil pH. Overall, moist forest plots had denser canopies and lower AGBH compared with miombo plots. Further field studies are encouraged, to disentangle the direct influence of LAI on AGBH from complex interrelationships between stand structure, environmental gradients and disturbance in African forests and woodlands.	[Shirima, Deo D.; Totland, Orjan; Moe, Stein R.] Norwegian Univ Life Sci, Dept Ecol & Nat Resource Management, N-1432 As, Norway; [Shirima, Deo D.] Sokoine Univ Agr, Fac Forestry & Nat Conservat, Dept Forest Biol, Morogoro, Tanzania; [Pfeifer, Marion] Imperial Coll London, Dept Life Sci, Ascot SL5 7PY, Berks, England; [Platts, Philip J.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England	Norwegian University of Life Sciences; Sokoine University of Agriculture; Imperial College London; University of York - UK	Shirima, DD (corresponding author), Norwegian Univ Life Sci, Dept Ecol & Nat Resource Management, POB 5003, N-1432 As, Norway.	dshirima2@gmail.com	Moe, Stein R./G-1507-2011; Platts, Philip J./C-2002-2009	Moe, Stein R./0000-0003-1005-3192; Platts, Philip J./0000-0002-0153-0121; Pfeifer, Marion/0000-0002-6775-3141	Norwegian State Education Loan Fund; Norwegian Government through the Climate Change Impacts, Adaptation and Mitigation programme at Sokoine University of Agriculture in Tanzania; European Research Council [281986]; Ministry for Foreign Affairs of Finland through the CHIESA project	Norwegian State Education Loan Fund; Norwegian Government through the Climate Change Impacts, Adaptation and Mitigation programme at Sokoine University of Agriculture in Tanzania; European Research Council(European Research Council (ERC)European Commission); Ministry for Foreign Affairs of Finland through the CHIESA project	The Norwegian State Education Loan Fund (http://www.lanekassen.no/) and Norwegian Government through the Climate Change Impacts, Adaptation and Mitigation programme at Sokoine University of Agriculture in Tanzania (http://www.drpgs.suanet.ac.tz/) funded DDS. MP is funded by European Research Council under the Project number 281986 and PJP was funded by the Ministry for Foreign Affairs of Finland through the CHIESA project (http://chiesa.icipe.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Breda NJJ, 2003, J EXP BOT, V54, P2403, DOI 10.1093/jxb/erg263; Callaway RM, 2007, INTERACTION COMPETIT; Campbell B., 1996, MIOMBO TRANSITION WO; Campbell B.M.B.M., 2007, CIFOR; Canty A, 2014, PACKAGE BOOT; Coomes DA, 2007, J ECOL, V95, P1084, DOI 10.1111/j.1365-2745.2007.01280.x; Crawley M. J., 2012, R BOOK, DOI DOI 10.1111/j.1365-294X.2008.03806.x; Crawley MJ, 2009, MIXED EFFECTS MODEL; DeRose RJ, 2010, CAN J FOREST RES, V40, P629, DOI 10.1139/X10-018; Dewees P.A., 2010, J NAT RESOUR POLICY, V2, P57, DOI DOI 10.1080/19390450903350846; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; FAO, 2010, GLOB FOR RES ASS ROM; Fischer R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123300; Fournier RA, 1996, AGR FOREST METEOROL, V82, P47, DOI 10.1016/0168-1923(96)02345-3; Frost P., 1996, MIOMBO TRANSITION WO, P11; Gatti RC, 2015, ECOL RES, V30, P119, DOI 10.1007/s11284-014-1217-3; Gibbs HK, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045023; Gilliam FS, 2007, BIOSCIENCE, V57, P845, DOI 10.1641/B571007; Gilliam Frank S., 2003, P198; Gonsamo Gosa A, 2009, REMOTE SENSING LEAF; Hardwick SR, 2015, AGR FOREST METEOROL, V201, P187, DOI 10.1016/j.agrformet.2014.11.010; Hoang VS, 2011, J TROP FOR SCI, V23, P328; Ishii H, 2013, ECOL RES, V28, P191, DOI 10.1007/s11284-012-1025-6; James G, 2013, SPRINGER TEXTS STAT, V103, P303, DOI 10.1007/978-1-4614-7138-7_8; Jonckheere I, 2004, AGR FOREST METEOROL, V121, P19, DOI 10.1016/j.agrformet.2003.08.027; Jonckheere I, 2005, TREE PHYSIOL, V25, P723, DOI 10.1093/treephys/25.6.723; Kissinger G, 2012, DRIVERS DEFORESTATIO; KOHYAMA T, 1993, J ECOL, V81, P131, DOI 10.2307/2261230; Lovett JC, 1993, ASSESSMENT CONDITION; Ludwig F, 2001, J VEG SCI, V12, P579, DOI 10.2307/3237009; Malkinson D, 2010, OIKOS, V119, P1546, DOI 10.1111/j.1600-0706.2010.18375.x; Marshall AR, 2012, BIOL CONSERV, V154, P20, DOI 10.1016/j.biocon.2012.03.017; Mograbi PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127093; Munishi PKT, 2004, J TROP FOR SCI, V16, P78; MURPHY PG, 1986, ANNU REV ECOL SYST, V17, P67, DOI 10.1146/annurev.es.17.110186.000435; Murtaugh PA, 2009, ECOL LETT, V12, P1061, DOI 10.1111/j.1461-0248.2009.01361.x; Pfeifer M, 2014, REMOTE SENS-BASEL, V6, P1973, DOI 10.3390/rs6031973; Pfeifer M, 2012, REMOTE SENS ENVIRON, V118, P103, DOI 10.1016/j.rse.2011.11.009; PIELOU E C, 1969, P286; Platts PJ, 2015, AFR J ECOL, V53, P103, DOI 10.1111/aje.12180; Price MF, 2013, MOUNTAIN GEOGRAPHY: PHYSICAL AND HUMAN DIMENSIONS, P1; Quinn GP, 2003, EXPT DESIGN DATA ANA; Reich PB, 2012, P ROY SOC B-BIOL SCI, V279, P2128, DOI 10.1098/rspb.2011.2270; Ribeiro NS, 2015, MIOMBO WOODLANDS RES; Runyan CW, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001841; Sagar R., 2012, Environmentalist, V32, P485, DOI 10.1007/s10669-012-9414-5; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; Scholes RJ, 1996, J GEOPHYS RES-ATMOS, V101, P23667, DOI 10.1029/96JD01623; Shannon C.E, 1949, MATH THEORY COMMUNIC, V1st; Shirima DD, 2011, AFR J ECOL, V49, P332, DOI 10.1111/j.1365-2028.2011.01269.x; Tanzania URo, 1998, NAT FOR POL; Thomas PA, 2007, ECOLOGY OF WOODLANDS AND FORESTS: DESCRIPTION, DYNAMICS AND DIVERSITY, P1, DOI 10.1017/CBO9780511805578; Turner I.M., 2001, CAM TROP B, DOI 10.1017/CBO9780511542206; Unger M, 2013, TROP ECOL, V54, P33; van Laar A, 2007, FOREST MENSURATION M; Veenendaal EM, 2015, BIOGEOSCIENCES, V12, P2927, DOI 10.5194/bg-12-2927-2015; Weiss M, 2000, AGRONOMIE, V20, P3, DOI 10.1051/agro:2000105; WEISS M., 2014, CAN EYE V6 313 USER; West P. W., 2009, TREE FOREST MEASUREM, DOI [DOI 10.1007/978-3-540-95966-3, 10.1007/978-3-540-95966-3]; Willcock Simon, 2014, Carbon Balance Manag, V9, P2, DOI 10.1186/1750-0680-9-2; Williams M, 2008, FOREST ECOL MANAG, V254, P145, DOI 10.1016/j.foreco.2007.07.033; Yuan Y, 2013, ADV METEOROL, V2013, P6, DOI [DOI 10.1155/2013/964323, DOI 10.1155/2013/908307]; Zuur A, 2009, MIXED EFFECTS MODELS; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	65	13	15	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142784	10.1371/journal.pone.0142784	http://dx.doi.org/10.1371/journal.pone.0142784			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559410	Green Published, Green Accepted, gold			2022-12-26	WOS:000364433100124
J	Zhao, SR; Xi, L; Zhang, BH				Zhao, Shanrong; Xi, Li; Zhang, Baohong			Union Exon Based Approach for RNA-Seq Gene Quantification: To Be or Not to Be?	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; HUMAN GENOME ANNOTATION; TRANSCRIPTOME; ABUNDANCE; ALIGNMENT; ENSEMBL; REFSEQ; READS	In recent years, RNA-seq is emerging as a powerful technology in estimation of gene and/or transcript expression, and RPKM (Reads Per Kilobase per Million reads) is widely used to represent the relative abundance of mRNAs for a gene. In general, the methods for gene quantification can be largely divided into two categories: transcript-based approach and 'union exon'-based approach. Transcript-based approach is intrinsically more difficult because different isoforms of the gene typically have a high proportion of genomic overlap. On the other hand, 'union exon'-based approach method is much simpler and thus widely used in RNA-seq gene quantification. Biologically, a gene is expressed in one or more transcript isoforms. Therefore, transcript-based approach is logistically more meaningful than 'union exon'-based approach. Despite the fact that gene quantification is a fundamental task in most RNA-seq studies, however, it remains unclear whether 'union exon'-based approach for RNA-seq gene quantification is a good practice or not. In this paper, we carried out a side-by-side comparison of 'union exon'-based approach and transcript-based method in RNA-seq gene quantification. It was found that the gene expression levels are significantly underestimated by 'union exon'-based approach, and the average of RPKM from 'union exons'-based method is less than 50% of the mean expression obtained from transcript-based approach. The difference between the two approaches is primarily affected by the number of transcripts in a gene. We performed differential analysis at both gene and transcript levels, respectively, and found more insights, such as isoform switches, are gained from isoform differential analysis. The accuracy of isoform quantification would improve if the read coverage pattern and exon-exon spanning reads are taken into account and incorporated into EM (Expectation Maximization) algorithm. Our investigation discourages the use of 'union exons'-based approach in gene quantification despite its simplicity.	[Zhao, Shanrong; Xi, Li; Zhang, Baohong] Pfizer Worldwide Res & Dev, Clin Genet & Bioinformat, Cambridge, MA 02139 USA	Pfizer	Zhao, SR (corresponding author), Pfizer Worldwide Res & Dev, Clin Genet & Bioinformat, Cambridge, MA 02139 USA.	Shanrong.Zhao@pfizer.com			Pfizer	Pfizer(Pfizer)	The authors received no specific funding for this work. The authors are employed by a commercial company: Pfizer. Pfizer provided support in the form of salaries for authors SZ, LX and BZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Angelini C, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-135; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bai Y, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S2-S9; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Borozan I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076935; Choudhury R, 2009, J BIOL CHEM, V284, P9965, DOI 10.1074/jbc.M807442200; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Engstrom PG, 2013, NAT METHODS, V10, P1185, DOI [10.1038/NMETH.2722, 10.1038/nmeth.2722]; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kanitz A, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0702-5; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Li HD, 2014, TRENDS GENET, V30, P340, DOI 10.1016/j.tig.2014.05.005; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355; Mills JD, 2013, CURR GENOMICS, V14, P173, DOI 10.2174/1389202911314030003; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mutz KO, 2013, CURR OPIN BIOTECH, V24, P22, DOI 10.1016/j.copbio.2012.09.004; Nicolae M, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-9; Oldmeadow C, 2014, J PSYCHIATR RES, V52, P44, DOI 10.1016/j.jpsychires.2014.01.011; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sigurgeirsson B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-631; Soneson C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-91; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu PY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S11-S8; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Zhao SR, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1876-7; Zhao SR, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1308-8; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101374; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644	43	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141910	10.1371/journal.pone.0141910	http://dx.doi.org/10.1371/journal.pone.0141910			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559532	Green Published, gold, Green Submitted			2022-12-26	WOS:000364433100045
J	Cuadros, J; Perez-Tanoira, R; Prieto-Perez, L; Martin-Martin, I; Berzosa, P; Gonzalez, V; Tisiano, G; Balcha, S; Ramos, JM; Gorgolas, M				Cuadros, Juan; Perez-Tanoira, Ramon; Prieto-Perez, Laura; Martin-Martin, Ines; Berzosa, Pedro; Gonzalez, Vicenta; Tisiano, Gebre; Balcha, Seble; Manuel Ramos, Jose; Gorgolas, Miguel			Field Evaluation of Malaria Microscopy, Rapid Malaria Tests and Loop-Mediated Isothermal Amplification in a Rural Hospital in South Western Ethiopia	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; DIAGNOSIS; PARASITES; POINT; VIVAX; ASSAY; LAMP; KIT	Background In up to one third of the hospitals in some rural areas of Africa, laboratory services in malaria diagnosis are limited to microscopy by thin film, as no capability to perform thick film exists (gold standard in terms of sensitivity for malaria diagnosis). A new rapid molecular malaria diagnostic test called Loop-mediated isothermal DNA amplification (LAMP) has been recently validated in clinical trials showing exceptional sensitivity and specificity features. It could be a reliable diagnostic tool to be implemented without special equipment or training. Objective The objective of this proof of concept study was to confirm the feasibility of using LAMP technique for diagnosis of malaria in a rural Ethiopian hospital with limited resources. Methodology/Principal Findings This study was carried out in Gambo General Hospital, West Arsi Province (Ethiopia), from November 1st to December 31st 2013. A total of 162 patients with a non-focal febrile syndrome were investigated. The diagnostic capability (sensitivity, specificity, positive predictive and negative predictive values) of rapid malaria tests and microscopy by thin film was evaluated in comparison with LAMP. Eleven (6.79%) out of the 162 patients with fever and suspected malaria, tested positive for LAMP, 3 (1.85%) for rapid malaria tests and none of the eleven cases was detected by thin film microscopy. Conclusions/Significance LAMP can be performed in basic rural laboratories without the need for specialized infrastructure and it may set a reliable tool for malaria control to detect a low level parasitemia.	[Cuadros, Juan] Univ Hosp Principe Asturias, Dept Microbiol, Madrid, Spain; [Perez-Tanoira, Ramon; Prieto-Perez, Laura; Martin-Martin, Ines; Tisiano, Gebre; Balcha, Seble; Manuel Ramos, Jose; Gorgolas, Miguel] Gambo Rural Gen Hosp, Dept Med & Lab, West Arsi, Gambo, Ethiopia; [Perez-Tanoira, Ramon; Prieto-Perez, Laura; Gorgolas, Miguel] Fdn Jimenez Diaz, Div Infect Dis, E-28040 Madrid, Spain; [Perez-Tanoira, Ramon; Prieto-Perez, Laura; Gorgolas, Miguel] Univ Autonoma Madrid, Dept Med, Madrid, Spain; [Perez-Tanoira, Ramon] Univ Helsinki, Dept Otorhinolaryngol Head & Neck Surg, Helsinki, Finland; [Perez-Tanoira, Ramon] Helsinki Univ Hosp, Helsinki, Finland; [Martin-Martin, Ines] Hlth Inst Carlos III, Med Entomol Unit, Dept Parasitol, Natl Ctr Microbiol, Madrid, Spain; [Berzosa, Pedro; Gonzalez, Vicenta] Hlth Insitute Carlos III, Natl Ctr Trop Med, Madrid, Spain; [Manuel Ramos, Jose] Miguel Hernandez Univ, Hosp Gen Univ Alicante, Dept Internal Med, Alicante, Spain	Prince of Asturias University Hospital; Autonomous University of Madrid; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Instituto de Salud Carlos III; Centro Nacional de Medicina Tropical (CNMT); General University Hospital of Alicante; Universidad Miguel Hernandez de Elche	Perez-Tanoira, R (corresponding author), Gambo Rural Gen Hosp, Dept Med & Lab, West Arsi, Gambo, Ethiopia.	ramontanoira@hotmail.com	Gonzalez, Juan Cuadros/E-8697-2015; Ramos, Jose M./B-6420-2018; Tanoira, Ramón Pérez/K-4898-2014; Martin Martin, Ines/I-9358-2012	Gonzalez, Juan Cuadros/0000-0003-4098-4377; Ramos, Jose M./0000-0002-6501-9867; Tanoira, Ramón Pérez/0000-0002-9816-3208; Martin Martin, Ines/0000-0002-0956-7324; Berzosa, Pedro/0000-0002-8768-717X	Master of Tropical diseases of Department of Medicine; Universidad Autonoma de Madrid; Rural Gambo Hospital, Ethiopia; Master of Tropical Diseases and International Health of the Department of Medicine	Master of Tropical diseases of Department of Medicine; Universidad Autonoma de Madrid; Rural Gambo Hospital, Ethiopia; Master of Tropical Diseases and International Health of the Department of Medicine	The study was funded by the Master of Tropical diseases of Department of Medicine, Universidad Autonoma de Madrid and Rural Gambo Hospital, Ethiopia. The RDTs were provided by the government of Ethiopia. Special thanks to Francisco Reyes, the managing director of Gambo Hospital and Iveth Gonzalez, of FIND diagnostics for her help in obtaining the reagents.; We thank all the members of the laboratory and clinical staff of Gambo General Rural Hospital. The study was funded by the Master of Tropical Diseases and International Health of the Department of Medicine, held by the Universidad Autonoma of Madrid. RDTs were provided by the government of Ethiopia. Special mention to Dr. Francisco Reyes, the managing director of Gambo Hospital and Iveth Gonzalez, of FIND diagnostics for her invaluable help in obtaining the reactives.	Abeku TA, 2003, ACTA TROP, V87, P331, DOI 10.1016/S0001-706X(03)00123-2; Abreha T, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-292; Aydin-Schmidt B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103905; Biadglegne F, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0529-x; Cook J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0573-y; Hopkins H, 2013, J INFECT DIS, V208, P645, DOI 10.1093/infdis/jit184; Hsiang MS, 2014, J INFECT DIS, V210, P1167, DOI 10.1093/infdis/jiu253; Institute of Medicine (US) Committee on the Economics of Antimalarial Drugs, 2004, SAVING LIVES BUYING; Lee PW, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-408; Mukadi P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-308; Najafabadi ZG, 2014, ACTA TROP, V136, P44, DOI 10.1016/j.actatropica.2014.03.029; Oriero EC, 2015, J ANTIMICROB CHEMOTH, V70, P2, DOI 10.1093/jac/dku343; Patel JC, 2014, J INFECT DIS, V210, P1180, DOI 10.1093/infdis/jiu252; Patel JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054986; Polley SD, 2013, J INFECT DIS, V208, P637, DOI 10.1093/infdis/jit183; Port JR, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-454; Shillcutt S, 2008, B WORLD HEALTH ORGAN, V86, P101, DOI 10.2471/BLT.07.042259; WHO, 2013, MAL RAP DIAGN TEST P; World Health Organization, 2010, BAS MAL MICR 1; Woyessa A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-218; Yongkiettrakul S, 2014, PARASITOL INT, V63, P777, DOI 10.1016/j.parint.2014.06.004; Zimmerman PA, 2015, CURR OPIN INFECT DIS, V28, P446, DOI 10.1097/QCO.0000000000000191	22	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142842	10.1371/journal.pone.0142842	http://dx.doi.org/10.1371/journal.pone.0142842			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555068	Green Published, Green Submitted, gold			2022-12-26	WOS:000364430700179
J	Garcia-Segura, L; Abreu-Goodger, C; Hernandez-Mendoza, A; Dinkova, TDD; Padilla-Noriega, L; Perez-Andrade, ME; Miranda-Rios, J				Garcia-Segura, Laura; Abreu-Goodger, Cei; Hernandez-Mendoza, Armando; Dimitrova Dinkova, Tzvetanka D.; Padilla-Noriega, Luis; Elva Perez-Andrade, Martha; Miranda-Rios, Juan			High-Throughput Profiling of Caenorhabditis elegans Starvation-Responsive microRNAs	PLOS ONE			English	Article							GERMLINE STEM-CELLS; LIFE-SPAN; C. ELEGANS; MESSENGER-RNA; MAMMALIAN MICRORNAS; GENE-EXPRESSION; DAUER FORMATION; LET-7 MICRORNA; RT-PCR; PROTEIN	MicroRNAs (miRNAs) are non-coding RNAs of -22 nucleotides in length that regulate gene expression by interfering with the stability and translation of mRNAs. Their expression is regulated during development, under a wide variety of stress conditions and in several pathological processes. In nature, animals often face feast or famine conditions. We observed that subjecting early L4 larvae from Caenorhabditis elegans to a 12-hr starvation period produced worms that are thinner and shorter than well-fed animals, with a decreased lipid accumulation, diminished progeny, reduced gonad size, and an increased lifespan. Our objective was to identify which of the 302 known miRNAs of C. elegans changed their expression under starvation conditions as compared to well-fed worms by means of deep sequencing in early L4 larvae. Our results indicate that 13 miRNAs (miR-34-3p, the family of miR-35-3p to miR-41-3p, miR-39-5p, miR-41-5p, miR-240-5p, miR-246-3p and miR-48135p) were upregulated, while 2 miRNAs (let-7-3p and miR-85-5p) were downregulated in 12hr starved vs. well-fed early L4 larvae. Some of the predicted targets of the miRNAs that changed their expression in starvation conditions are involved in metabolic or developmental process. In particular, miRNAs of the miR-35 family were upregulated 6-20 fold upon starvation. Additionally, we showed that the expression of gld-1, important in oogenesis, a validated target of miR-35-3p, was downregulated when the expression of miR-35-3p was upregulated. The expression of another reported target, the cell cycle regulator lin-23, was unchanged during starvation. This study represents a starting point for a more comprehensive understanding of the role of miRNAs during starvation in C. elegans.	[Garcia-Segura, Laura] Univ Nacl Autonoma Mexico, Programa Doctorado Ciencias Biomed, Mexico City, DF, Mexico; [Garcia-Segura, Laura; Elva Perez-Andrade, Martha; Miranda-Rios, Juan] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Biol Mol & Biotecnol, Unidad Genet Nutr, Mexico City, DF, Mexico; [Garcia-Segura, Laura; Elva Perez-Andrade, Martha; Miranda-Rios, Juan] Inst Nacl Pediat, Mexico City, DF, Mexico; [Abreu-Goodger, Cei] CINVESTAV, Unidad Genom Avanzada Langebio, Guanajuato, Mexico; [Hernandez-Mendoza, Armando] Univ Autonoma Edo Morelos, Ctr Invest Dinam Celular, Cuernavaca, Morelos, Mexico; [Dimitrova Dinkova, Tzvetanka D.] Univ Nacl Autonoma Mexico, Fac Quim, Dept Bioquim, Mexico City 04510, DF, Mexico; [Padilla-Noriega, Luis] Univ Nacl Autonoma Mexico, Fac Med, Dept Virol, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Universidad Autonoma del Estado de Morelos; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Miranda-Rios, J (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Biol Mol & Biotecnol, Unidad Genet Nutr, Mexico City, DF, Mexico.	riosjuanm@biomedicas.unam.mx	Abreu-Goodger, Cei/A-1268-2010; Dinkova, Tzvetanka/L-5678-2019; Miranda Ríos, Juan/ABB-7767-2021; Dinkova, Tzvetanka/AAE-6073-2020; Hernandez-Mendoza, Armando/A-8557-2018	Abreu-Goodger, Cei/0000-0001-8302-9893; Dinkova, Tzvetanka/0000-0001-7971-525X; Hernandez-Mendoza, Armando/0000-0002-7809-6888; Padilla-Noriega, Luis/0000-0002-1121-144X	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT); Direccion General de Asuntos del Personal Academico (DGAPA), Universidad Nacional Autonoma de Mexico [IN209310-3, IN203514]; Fondos Federales Instituto Nacional de Pediatria [036/2015]; Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico [384014]	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); Direccion General de Asuntos del Personal Academico (DGAPA), Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); Fondos Federales Instituto Nacional de Pediatria; Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Funding was provided by Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT), Direccion General de Asuntos del Personal Academico (DGAPA), Universidad Nacional Autonoma de Mexico, grants IN209310-3 and IN203514, dgapa.unam.mx, and Fondos Federales Instituto Nacional de Pediatria, grant 036/2015. This paper presents part of the PhD thesis of Laura Garcia-Segura, who is a doctoral student from Programa de Doctorado en Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico (UNAM), and received fellowship 384014 from Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Saavedra E, 2010, CURR BIOL, V20, P367, DOI 10.1016/j.cub.2009.12.051; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Angelo G, 2009, SCIENCE, V326, P954, DOI 10.1126/science.1178343; AUSTIN J, 1987, CELL, V51, P589, DOI 10.1016/0092-8674(87)90128-0; AVERY L, 1993, GENETICS, V133, P897; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berry LW, 1997, DEVELOPMENT, V124, P925; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Boulias K, 2012, CELL METAB, V15, P439, DOI 10.1016/j.cmet.2012.02.014; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Christodoulou F, 2010, NATURE, V463, P1084, DOI 10.1038/nature08744; Czech B, 2009, MOL CELL, V36, P445, DOI 10.1016/j.molcel.2009.09.028; Davis MPA, 2013, METHODS, V63, P41, DOI 10.1016/j.ymeth.2013.06.027; de Lencastre A, 2010, CURR BIOL, V20, P2159, DOI 10.1016/j.cub.2010.11.015; Dealy MJ, 1999, NAT GENET, V23, P245, DOI 10.1038/13886; Eichhorn SW, 2014, MOL CELL, V56, P104, DOI 10.1016/j.molcel.2014.08.028; FRANCIS R, 1995, GENETICS, V139, P579; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia-Segura L, 2013, J NUTRIGENET NUTRIGE, V6, P16, DOI 10.1159/000345826; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghildiyal M, 2010, RNA, V16, P43, DOI 10.1261/rna.1972910; Gong GY, 2015, MAR BIOTECHNOL, V17, P338, DOI 10.1007/s10126-015-9623-2; Grad Y, 2003, MOL CELL, V11, P1253, DOI 10.1016/S1097-2765(03)00153-9; Grosshans H, 2005, DEV CELL, V8, P321, DOI 10.1016/j.devcel.2004.12.019; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hackenberg M, 2009, NUCLEIC ACIDS RES, V37, pW68, DOI 10.1093/nar/gkp347; Hammell CM, 2009, P NATL ACAD SCI USA, V106, P18668, DOI 10.1073/pnas.0908131106; Hansen M, 2013, CELL METAB, V17, P10, DOI 10.1016/j.cmet.2012.12.003; Hebeisen M, 2008, DEVELOPMENT, V135, P1259, DOI 10.1242/dev.014969; HOLLIDAY R, 1989, BIOESSAYS, V10, P125, DOI 10.1002/bies.950100408; Hope IA, 2002, C ELEGANS PRACTICAL, Vxxi; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; JOHNSON TE, 1984, MECH AGEING DEV, V28, P23, DOI 10.1016/0047-6374(84)90150-7; Jones AR, 1996, DEV BIOL, V180, P165, DOI 10.1006/dbio.1996.0293; Jovanovic M, 2010, NAT METHODS, V7, P837, DOI [10.1038/NMETH.1504, 10.1038/nmeth.1504]; Kaeberlein TL, 2006, AGING CELL, V5, P487, DOI 10.1111/j.1474-9726.2006.00238.x; Karp X, 2011, GENETICS, V187, P345, DOI 10.1534/genetics.110.123992; Kato M, 2009, ONCOGENE, V28, P2419, DOI 10.1038/onc.2009.106; Kato M, 2013, AGEING RES REV, V12, P429, DOI 10.1016/j.arr.2012.03.012; Kato M, 2011, RNA, V17, P1804, DOI 10.1261/rna.2714411; Kato M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r54; Kipreos ET, 2000, DEVELOPMENT, V127, P5071; Kipreos ET, 1996, CELL, V85, P829, DOI 10.1016/S0092-8674(00)81267-2; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larance M, 2015, MOL CELL PROTEOMICS, V14, P1989, DOI 10.1074/mcp.M114.044289; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Leaman D, 2005, CELL, V121, P1097, DOI 10.1016/j.cell.2005.04.016; Lee MH, 2010, ADV EXP MED BIOL, V693, P106; Lehmann R, 2012, CELL STEM CELL, V10, P729, DOI 10.1016/j.stem.2012.05.016; Leung AKL, 2007, CELL, V130, P581, DOI 10.1016/j.cell.2007.08.010; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Liu M, 2011, CELL RES, V21, P1605, DOI 10.1038/cr.2011.102; Londin E, 2015, P NATL ACAD SCI USA, V112, pE1106, DOI 10.1073/pnas.1420955112; Lu XW, 1998, CELL, V95, P981, DOI 10.1016/S0092-8674(00)81722-5; Lu YC, 2009, RNA, V15, P1483, DOI 10.1261/rna.1702009; Lukowski SW, 2015, GENOMICS, V106, P107, DOI 10.1016/j.ygeno.2015.05.001; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Massirer KB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002536; McJunkin K, 2014, G3-GENES GENOM GENET, V4, P1747, DOI 10.1534/g3.114.011973; MENEELY PM, 1979, GENETICS, V92, P99; Minasaki R, 2014, RNA BIOL, V11, P111, DOI 10.4161/rna.27992; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; Mondol V, 2012, CURR TOP DEV BIOL, V99, P1, DOI 10.1016/B978-0-12-387038-4.00001-X; Motola DL, 2006, CELL, V124, P1209, DOI 10.1016/j.cell.2006.01.037; Okamura K, 2013, GENE DEV, V27, P778, DOI 10.1101/gad.211698.112; Okamura K, 2009, MOL CELL, V36, P431, DOI 10.1016/j.molcel.2009.09.027; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Pandit A, 2014, AGING-US, V6, P835, DOI 10.18632/aging.100697; Paradis S, 1999, GENE DEV, V13, P1438, DOI 10.1101/gad.13.11.1438; Parrish JZ, 2009, NEURON, V63, P788, DOI 10.1016/j.neuron.2009.08.006; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pincus Z, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002306; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roth LW, 2012, MATURITAS, V71, P315, DOI 10.1016/j.maturitas.2011.12.017; Roush SF, 2009, DEV BIOL, V334, P523, DOI 10.1016/j.ydbio.2009.07.012; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Schmid M, 2009, GENE DEV, V23, P824, DOI 10.1101/gad.494009; Seidel HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028074; Shen YD, 2012, SCIENCE, V338, P1472, DOI 10.1126/science.1228967; Shi Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075475; Simon DJ, 2008, CELL, V133, P903, DOI 10.1016/j.cell.2008.04.035; Smith-Vikos T, 2014, CURR BIOL, V24, P2238, DOI 10.1016/j.cub.2014.08.013; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; Song YQ, 2012, GENE DEV, V26, P1612, DOI 10.1101/gad.193243.112; Srinivasan S, 2015, ANNU REV PHYSIOL, V77, P161, DOI 10.1146/annurev-physiol-021014-071704; Suh N, 2009, GENETICS, V181, P1249, DOI 10.1534/genetics.108.099440; Than Minh, 2013, Worm, V2, pe26894, DOI 10.4161/worm.26894; Thondamal M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5879; Van Gilst MR, 2005, P NATL ACAD SCI USA, V102, P13496, DOI 10.1073/pnas.0506234102; Van Wynsberghe PM, 2011, NAT STRUCT MOL BIOL, V18, P302, DOI 10.1038/nsmb.1986; Vanfleteren JR, 1999, NEUROBIOL AGING, V20, P487, DOI 10.1016/S0197-4580(99)00087-1; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Wang JB, 2011, GENOME RES, V21, P1462, DOI 10.1101/gr.121426.111; Wang YS, 1999, CURR BIOL, V9, P1191, DOI 10.1016/S0960-9822(00)80024-X; Wen JY, 2015, NUCLEIC ACIDS RES, V43, P6207, DOI 10.1093/nar/gkv603; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Winter J, 2013, NUCLEIC ACIDS RES, V41, P5503, DOI 10.1093/nar/gkt251; Wood WB, 1988, NEMATODE CAENORHABDI, Vxiii; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911; Yook K, 2012, NUCLEIC ACIDS RES, V40, pD735, DOI 10.1093/nar/gkr954; Zhang PC, 2013, CELL METAB, V17, P85, DOI 10.1016/j.cmet.2012.12.013; Zhang XC, 2011, P NATL ACAD SCI USA, V108, P17997, DOI 10.1073/pnas.1105982108; Zisoulis DG, 2011, METHODS MOL BIOL, V732, P169, DOI 10.1007/978-1-61779-083-6_13	116	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142262	10.1371/journal.pone.0142262	http://dx.doi.org/10.1371/journal.pone.0142262			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554708	gold, Green Published, Green Submitted			2022-12-26	WOS:000364430700076
J	Katsaros, KM; Speidl, WS; Demyanets, S; Kastl, SP; Krychtiuk, KA; Wonnerth, A; Zorn, G; Tentzeris, L; Farhan, S; Maurer, G; Wojta, J; Huber, K				Katsaros, Katharina M.; Speidl, Walter S.; Demyanets, Svitlana; Kastl, Stefan P.; Krychtiuk, Konstantin A.; Wonnerth, Anna; Zorn, Gerlinde; Tentzeris, Loannis; Farhan, Serdar; Maurer, Gerald; Wojta, Johann; Huber, Kurt			G-CSF Predicts Cardiovascular Events in Patients with Stable Coronary Artery Disease	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; SMOOTH-MUSCLE-CELLS; NEOINTIMAL FORMATION; STEM-CELLS; PACLITAXEL; ATHEROSCLEROSIS; INFLAMMATION; NEUTROPHILS; ARREST	Granulocyte-colony-stimulating-factor (G-CSF) induces mobilization of progenitor cells but may also exert pro-inflammatory and pro-thrombotic effects. Treatment with recombinant G-CSF after acute myocardial infarction is currently under examination and has been associated with in-stent restenosis. However, it is not known whether plasma levels of endogenous G-CSF are also associated with an increased cardiovascular risk. Therefore we included 280 patients with angiographically proven stable coronary artery disease. G-CSF was measured by specific ELISA and patients were followed for a median of 30 months for the occurrence of major adverse cardiovascular events (MACE: death, myocardial infarction, re-hospitalization). Those with cardiac events during follow-up showed significant higher G-CSF levels (32.3 pg/mL IQR 21.4-40.5 pg/mL vs. 24.6 pg/mL IQR 16.4-34.9 pg/mL; p<0.05) at baseline. Patients with G-CSF plasma levels above the median had a 2-fold increased risk for MACE (p< 0.05). This was independent from established cardiovascular risk factors. In addition, G-CSF above the median was a predictor of clinical in-stent restenosis after implantation of bare-metal stents (6.6% vs. 19.4%; p< 0.05) but not of drug-eluting stents (7.7% vs. 7.6%; p = 0.98). This data suggests that endogenous plasma levels of G-CSF predict cardiovascular events independently from established cardiac risk factors and are associated with increased in-stent restenosis rates after implantation of bare metal stents.	[Katsaros, Katharina M.; Speidl, Walter S.; Demyanets, Svitlana; Kastl, Stefan P.; Krychtiuk, Konstantin A.; Wonnerth, Anna; Zorn, Gerlinde; Maurer, Gerald; Wojta, Johann] Med Univ Vienna, Dept Internal Med 2, Vienna, Austria; [Katsaros, Katharina M.; Kastl, Stefan P.; Krychtiuk, Konstantin A.; Wojta, Johann] Ludwig Boltzmann Cluster Cardiovasc Res, Vienna, Austria; [Tentzeris, Loannis; Farhan, Serdar; Huber, Kurt] Wilhelminenhosp, Cardiol & Intens Care Med, Dept Med 3, Vienna, Austria	Medical University of Vienna; Ludwig Boltzmann Institute; Wilhelminenspital	Wojta, J (corresponding author), Med Univ Vienna, Dept Internal Med 2, Vienna, Austria.	johann.wojta@meduniwien.ac.at	Speidl, Walter S./AAU-8830-2020; Kastl, Stefan P/B-2695-2009; Wojta, Johann/AAC-8433-2020	Speidl, Walter S./0000-0002-7267-3138; Kastl, Stefan P/0000-0002-9682-0200; Wojta, Johann/0000-0002-1282-9276; Krychtiuk, Konstantin/0000-0001-7792-2837; Maurer, Gerald/0000-0002-9043-7657	Ludwig Boltzmann Cluster for Cardiovascular Research; Association for the Promotion of Research in Arteriosclerosis, Thrombosis and Vascular Biology	Ludwig Boltzmann Cluster for Cardiovascular Research; Association for the Promotion of Research in Arteriosclerosis, Thrombosis and Vascular Biology	Funding: KMK, SPK, MK, and JW received funding from the Ludwig Boltzmann Cluster for Cardiovascular Research; KMK, SPK, and MK received funding from the Association for the Promotion of Research in Arteriosclerosis, Thrombosis and Vascular Biology.	Baetta R, 2010, ATHEROSCLEROSIS, V210, P1, DOI 10.1016/j.atherosclerosis.2009.10.028; Blagosklonny MV, 2006, CELL CYCLE, V5, P1574, DOI 10.4161/cc.5.14.3113; Blagosklonny MV, 2004, CELL CYCLE, V3, P1050; Chen X, 2004, ARTERIOSCL THROM VAS, V24, P1217, DOI 10.1161/01.ATV.0000130024.50058.de; Clever YP, 2011, EUROINTERVENTION, V7, pK32, DOI 10.4244/EIJV7SKA6; Deshpande D, 2008, PHARM RES-DORDR, V25, P1936, DOI 10.1007/s11095-008-9614-3; Di Gregoli K, 2012, CURR OPIN LIPIDOL, V23, P412, DOI 10.1097/MOL.0b013e328357ca6e; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Falanga A, 1999, BLOOD, V93, P2506, DOI 10.1182/blood.V93.8.2506.408k31_2506_2514; Guasti L, 2011, THROMB HAEMOSTASIS, V106, P591, DOI 10.1160/TH11-02-0096; Haghighat A, 2007, CIRCULATION, V115, P2049, DOI 10.1161/CIRCULATIONAHA.106.665570; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Hasegawa H, 2006, BIOCHEM BIOPH RES CO, V344, P370, DOI 10.1016/j.bbrc.2006.03.081; Kang HJ, 2004, LANCET, V363, P751, DOI 10.1016/S0140-6736(04)15689-4; Krychtiuk KA, 2013, HAMOSTASEOLOGIE, V33, P269, DOI 10.5482/HAMO-13-07-0039; Mansour S, 2006, J AM COLL CARDIOL, V47, P1727, DOI 10.1016/j.jacc.2006.01.039; Marino F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124565; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Steinwender C, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2006.03.012; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184; Uchiyama R, 2012, J MOL CELL CARDIOL, V52, P1038, DOI 10.1016/j.yjmcc.2011.12.016; Yoshioka T, 2006, CARDIOVASC RES, V70, P61, DOI 10.1016/j.cardiores.2005.12.013; Zohlnhofer D, 2008, J AM COLL CARDIOL, V51, P1429, DOI 10.1016/j.jacc.2007.11.073	23	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142532	10.1371/journal.pone.0142532	http://dx.doi.org/10.1371/journal.pone.0142532			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555480	Green Published, Green Submitted, gold			2022-12-26	WOS:000364430700123
J	Lee, JH; Park, KM; Han, DJ; Bang, NY; Kim, DH; Na, H; Lim, S; Kim, TB; Kim, DG; Kim, HJ; Chung, Y; Sung, SH; Surh, YJ; Kim, S; Han, BW				Lee, Ji-Hyun; Park, Kyoung Mii; Han, Dong-Jin; Bang, Nam Young; Kim, Do-Hee; Na, Hyeongjin; Lim, Semi; Kim, Tae Bum; Kim, Dae Gyu; Kim, Hyun-Jung; Chung, Yeonseok; Sung, Sang Hyun; Surh, Young-Joon; Kim, Sunghoon; Han, Byung Woo			PharmDB-K: Integrated Bio-Pharmacological Network Database for Traditional Korean Medicine	PLOS ONE			English	Article							NF-KAPPA-B; COX-2 EXPRESSION; CHINESE MEDICINE; INFORMATION; UPDATE; SCHIZANDRIN; MECHANISM; RESOURCE; CANCER; CELLS	Despite the growing attention given to Traditional Medicine (TM) worldwide, there is no wellknown, publicly available, integrated bio-pharmacological Traditional Korean Medicine (TKM) database for researchers in drug discovery. In this study, we have constructed PharmDB-K, which offers comprehensive information relating to TKM-associated drugs (compound), disease indication, and protein relationships. To explore the underlying molecular interaction of TKM, we integrated fourteen different databases, six Pharmacopoeias, and literature, and established a massive bio-pharmacological network for TKM and experimentally validated some cases predicted from the PharmDB-K analyses. Currently, PharmDB-K contains information about 262 TKMs, 7,815 drugs, 3,721 diseases, 32,373 proteins, and 1,887 side effects. One of the unique sets of information in PharmDB-K includes 400 indicator compounds used for standardization of herbal medicine. Furthermore, we are operating PharmDB-K via phExplorer (a network visualization software) and BioMart (a data federation framework) for convenient search and analysis of the TKM network. Database URL: http://pharmdb-k.org, http://biomart.i-pharm.org.	[Lee, Ji-Hyun; Han, Dong-Jin; Bang, Nam Young; Lim, Semi; Kim, Dae Gyu; Kim, Sunghoon] Seoul Natl Univ, Med Bioconvergence Res Ctr, Seoul 152742, South Korea; [Lee, Ji-Hyun; Park, Kyoung Mii; Kim, Do-Hee; Na, Hyeongjin; Kim, Tae Bum; Chung, Yeonseok; Sung, Sang Hyun; Surh, Young-Joon; Han, Byung Woo] Seoul Natl Univ, Pharmaceut Sci Res Inst, Coll Pharm, Seoul 151742, South Korea; [Lee, Ji-Hyun; Park, Kyoung Mii; Han, Byung Woo] Seoul Natl Univ, Informat Ctr Biopharmacol Network, Suwon 443270, South Korea; [Han, Dong-Jin; Bang, Nam Young; Kim, Sunghoon] Seoul Natl Univ, Dept Mol Med & Biopharmaceut Sci, Seoul 151742, South Korea; [Kim, Hyun-Jung] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Chung Ang University	Han, BW (corresponding author), Seoul Natl Univ, Pharmaceut Sci Res Inst, Coll Pharm, Seoul 151742, South Korea.	bwhan@snu.ac.kr	Kim, Sunghoon/AAE-8314-2020	kim, sunghoon/0000-0002-1570-3230	Basic Science Research Program - Ministry of Education; Ministry of Science, ICT and Future Planning through the National Research Foundation of Korea [NRF-2013R1A1A2058353, NRF-2013M3A6A4043695]	Basic Science Research Program - Ministry of Education; Ministry of Science, ICT and Future Planning through the National Research Foundation of Korea	This research was supported by the Basic Science Research Program funded by the Ministry of Education [JL] and Global Frontier Project funded by the Ministry of Science, ICT and Future Planning through the National Research Foundation of Korea [BH] (NRF-2013R1A1A2058353 and NRF-2013M3A6A4043695). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Administration KFaD, 2012, KOR PHARM; Administration KFaD, 2012, KOR HERB PHARM; [Anonymous], 2014, DEF DICT MED HERBS; [Anonymous], 2014, KOR TRAD KNOWL PORT; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Bolton E., 2008, PUBCHEM INTEGRATED P; Brown GR, 2015, NUCLEIC ACIDS RES, V43, pD36, DOI 10.1093/nar/gku1055; Chen CYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015939; Chen X, 2006, BRIT J PHARMACOL, V149, P1092, DOI 10.1038/sj.bjp.0706945; Chung MH, 2014, MUTAT RES-FUND MOL M, V768, P74, DOI [10.1016/j.mrfmmm.2014.04.003, 1]; Commission CP, 2011, PHARMACOPOEIA PEOPLE; Commission DPsRoKP, 2011, PHARM DEM PEOPL REP; Davis AP, 2015, NUCLEIC ACIDS RES, V43, pD914, DOI 10.1093/nar/gku935; Fang XL, 2005, J MED CHEM, V48, P1481, DOI 10.1021/jm049838d; Fang YC, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-58; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Gunther S, 2008, NUCLEIC ACIDS RES, V36, pD919, DOI 10.1093/nar/gkm862; Jang ES, 2007, KOREAN J OREINTAL ME, V13, P143; Kanphaet TKW, 2009, HERBAL PHARMACOPOEIA; Kasprzyk A, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar049; Khan AQ, 2012, FOOD CHEM TOXICOL, V50, P175, DOI 10.1016/j.fct.2011.10.043; Kim HY, 2011, TOXICOLOGY, V282, P104, DOI 10.1016/j.tox.2011.01.017; Kim SJ, 2010, PHYTOTHER RES, V24, P193, DOI 10.1002/ptr.2907; Kuhn M, 2014, NUCLEIC ACIDS RES, V42, pD401, DOI 10.1093/nar/gkt1207; Kuhn M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.98; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Lee B, 2007, BIOL PHARM BULL, V30, P1153, DOI 10.1248/bpb.30.1153; Lee HS, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-80; Lim E, 2010, NUCLEIC ACIDS RES, V38, pD781, DOI 10.1093/nar/gkp934; Liu YB, 2010, BIOINFORMATICS, V26, P587, DOI 10.1093/bioinformatics/btp697; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; Medicine M-NIoG, 2014, ONLINE MENDELIAN INH; Pharmaceutical Japan mdrsso, 2012, JAP PHARM ENGL VERS; Rahman S, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep076; ROGERS FB, 1963, B MED LIBR ASSOC, V51, P114; Ru JL, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-13; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Shen JH, 2003, CURR MED CHEM, V10, P2327, DOI 10.2174/0929867033456729; Sohn SH, 2009, NEUROTOXICOLOGY, V30, P368, DOI 10.1016/j.neuro.2009.02.006; Xue RC, 2013, NUCLEIC ACIDS RES, V41, pD1089, DOI 10.1093/nar/gks1100; Yu R, 2006, J INT MED RES, V34, P231, DOI 10.1177/147323000603400301; Zanzoni A, 2002, FEBS LETT, V513, P135, DOI 10.1016/S0014-5793(01)03293-8; Zhu F, 2012, NUCLEIC ACIDS RES, V40, pD1128, DOI 10.1093/nar/gkr797	43	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142624	10.1371/journal.pone.0142624	http://dx.doi.org/10.1371/journal.pone.0142624			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555441	gold, Green Published, Green Submitted			2022-12-26	WOS:000364430700143
J	Robinson, JE; St John, FAV; Griffiths, RA; Roberts, DL				Robinson, Janine E.; St John, Freya A. V.; Griffiths, Richard A.; Roberts, David L.			Captive Reptile Mortality Rates in the Home and Implications for the Wildlife Trade	PLOS ONE			English	Article							TORTOISES TESTUDO-GRAECA; RANDOMIZED-RESPONSE; UNITED-KINGDOM; LIFE-HISTORY; GLOBAL TRADE; CONSERVATION; MADAGASCAR; BIAS; CONSUMPTION; POPULATION	The trade in wildlife and keeping of exotic pets is subject to varying levels of national and international regulation and is a topic often attracting controversy. Reptiles are popular exotic pets and comprise a substantial component of the live animal trade. High mortality of traded animals raises welfare concerns, and also has implications for conservation if collection from the wild is required to meet demand. Mortality of reptiles can occur at any stage of the trade chain from collector to consumer. However, there is limited information on mortality rates of reptiles across trade chains, particularly amongst final consumers in the home. We investigated mortality rates of reptiles amongst consumers using a specialised technique for asking sensitive questions, additive Randomised Response Technique (aRRT), as well as direct questioning (DQ). Overall, 3.6% of snakes, chelonians and lizards died within one year of acquisition. Boas and pythons had the lowest reported mortality rates of 1.9% and chameleons had the highest at 28.2%. More than 97% of snakes, 87% of lizards and 69% of chelonians acquired by respondents over five years were reported to be captive bred and results suggest that mortality rates may be lowest for captive bred individuals. Estimates of mortality from aRRT and DQ did not differ significantly which is in line with our findings that respondents did not find questions about reptile mortality to be sensitive. This research suggests that captive reptile mortality in the home is rather low, and identifies those taxa where further effort could be made to reduce mortality rates.	[Robinson, Janine E.; St John, Freya A. V.; Griffiths, Richard A.; Roberts, David L.] Univ Kent, Durrell Inst Conservat & Ecol, Sch Anthropol & Conservat, Canterbury CT2 7NR, Kent, England	University of Kent	Robinson, JE (corresponding author), Univ Kent, Durrell Inst Conservat & Ecol, Sch Anthropol & Conservat, Canterbury CT2 7NR, Kent, England.	jr418@kent.ac.uk; D.L.Roberts@kent.ac.uk	Robinson, Janine/AAM-6714-2021	Roberts, David/0000-0001-6788-2691; Robinson, Janine/0000-0002-1207-0001	University of Kent	University of Kent	JER was funded through a University of Kent 50th Anniversary Scholarship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. FAVSJ, RAG and DLR received no specific funding for this work.	Anderson L, 2013, NORWAY SAYS NO WAY P; Andreone F, 2005, TROP ZOOL, V18, P209, DOI 10.1080/03946975.2005.10531221; Ashley S, 2014, J APPL ANIM WELF SCI, V17, P308, DOI 10.1080/10888705.2014.918511; Auliya M., 2003, HOT TRADE COOL CREAT; Baker SE, 2013, BIOSCIENCE, V63, P928, DOI 10.1525/bio.2013.63.12.6; Bartlett RD, 2006, BARRONS ED SERIES; BBC, 2015, EX PET RUL BE REV SC; BBC, 2014, 100S DEAD AN FOUND S; Bustard R, 1989, BRIT HERPETOLOGICAL, P27; CABI, 2014, NORW RET BAN REPT AM; Check E, 2004, NATURE, V427, P277, DOI 10.1038/427277a; Chomel BB, 2007, EMERG INFECT DIS, V13, P6, DOI 10.3201/eid1301.060480; CITES, 2013, CONV INT TRAD END SP; Clark B., 2013, REPORT LOOKING REPTI; de Volder S, 2013, ANAL NATL LEGISLATIO; Engler M., 2007, OPPORTUNITY THREAT R; EUARK, 2012, REPT AMPH COMP AN; Europe GN, 2014, 100S REPT FOUND DEAD; Gordon I., 2003, Journal of Environment & Development, V12, P82, DOI 10.1177/1070496502250439; Gupta S, 2013, AM J MATH MANAGEMENT, V22, P369; Hailey A, 2000, ANIM CONSERV, V3, P185, DOI 10.1111/j.1469-1795.2000.tb00102.x; Herrel A, 2014, HERPETOL J, V24, P103; Hoover C, 1998, US ROLE INT LIVE REP; Hutton J, 2003, TRADE IN WILDLIFE: REGULATION FOR CONSERVATION, P108; John FAVS, 2010, BIOL CONSERV, V143, P1025, DOI 10.1016/j.biocon.2010.01.018; Karsten KB, 2008, P NATL ACAD SCI USA, V105, P8980, DOI 10.1073/pnas.0802468105; Katz EM, HERPETOLOGICAL J, V23, P179; King MF, 2000, PSYCHOL MARKET, V17, P79, DOI 10.1002/(SICI)1520-6793(200002)17:2<79::AID-MAR2>3.0.CO;2-0; Lahaut VMHCJ, 2002, ALCOHOL ALCOHOLISM, V37, P256, DOI 10.1093/alcalc/37.3.256; LAWRENCE K, 1987, BRIT VET J, V143, P432, DOI 10.1016/0007-1935(87)90020-0; LAWRENCE K, 1988, BRIT VET J, V144, P187, DOI 10.1016/0007-1935(88)90052-8; LAWRENCE K, 1987, BRIT VET J, V143, P567, DOI 10.1016/0007-1935(87)90048-0; Lensvelt-Mulders GJLM, 2005, SOCIOL METHOD RES, V33, P319, DOI 10.1177/0049124104268664; Lyons JA, 2011, BIOL CONSERV, V144, P3073, DOI 10.1016/j.biocon.2011.10.002; Masin S, 2014, BIOL INVASIONS, V16, P217, DOI 10.1007/s10530-013-0515-y; New John C. Jr, 2004, Journal of Applied Animal Welfare Science, V7, P229, DOI 10.1207/s15327604jaws0704_1; Nuno A, 2015, BIOL CONSERV, V189, P5, DOI 10.1016/j.biocon.2014.09.047; O'Brien S, 2003, ORYX, V37, P338, DOI 10.1017/S0030605303000590; Pike DA, 2008, ECOLOGY, V89, P607, DOI 10.1890/06-2162.1; POLLOCK KH, 1976, J AM STAT ASSOC, V71, P884, DOI 10.2307/2286855; Prance G, 2011, CONDUCTING RESEARCH IN CONSERVATION: SOCIAL SCIENCE METHODS AND PRACTICE, P65; Razafimanahaka JH, 2012, ORYX, V46, P584, DOI 10.1017/S0030605312000579; Robinson JE, 2015, BIOL CONSERV, V184, P42, DOI 10.1016/j.biocon.2014.12.019; Scharf I, 2015, GLOBAL ECOL BIOGEOGR, V24, P396, DOI 10.1111/geb.12244; Schutz C, 2003, BFN SKRIPTEN, P90; Shi HT, 2007, CONSERV BIOL, V21, P5, DOI 10.1111/j.1523-1739.2006.00622_2.x; Smart AC, 1993, UK TRADE LIVE REPTIL; Tacutu R, 2013, NUCLEIC ACIDS RES, V41, pD1027, DOI 10.1093/nar/gks1155; Toland E, 2012, BIOLOGIST, V59, P14; U.S. Fish and Wildlife Service (USFWS), 2012, FED REG, V77; WARNER SL, 1965, J AM STAT ASSOC, V60, P63, DOI 10.2307/2283137; Warwick C., 2014, Journal of Animal Ethics, V4, P74, DOI 10.5406/janimalethics.4.1.0074; Webb JK, 2002, ORYX, V36, P170, DOI 10.1017/S0030605302000248	53	26	26	1	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141460	10.1371/journal.pone.0141460	http://dx.doi.org/10.1371/journal.pone.0141460			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556237	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000364430700029
J	Gupta, S; Prasad, GVRK; Mukhopadhaya, A				Gupta, Shelly; Prasad, G. V. R. Krishna; Mukhopadhaya, Arunika			Vibrio cholerae Porin OmpU Induces Caspase-independent Programmed Cell Death upon Translocation to the Host Cell Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE PROTEIN; CYTOCHROME-C; PHOSPHATIDYLSERINE EXPOSURE; MOLECULAR CHARACTERIZATION; NECROTIC CELLS; APOPTOSIS; RELEASE; ACTIVATION; NECROSIS; MECHANISMS	Porins, a major class of outer membrane proteins in Gram-negative bacteria, primarily act as transport channels. OmpU is one of the major porins of human pathogen, Vibrio cholerae. In the present study, we show that V. cholerae OmpU has the ability to induce target cell death. Although OmpU-mediated cell death shows some characteristics of apoptosis, such as flipping of phosphatidylserine in the membrane as well as cell size shrinkage and increased cell granularity, it does not show the caspase-3 activation and DNA laddering pattern typical of apoptotic cells. Increased release of lactate dehydrogenase in OmpU-treated cells indicates that the OmpU-mediated cell death also has characteristics of necrosis. Further, we show that the mechanism of OmpU-mediated cell death involves major mitochondrial changes in the target cells. We observe that OmpU treatment leads to the disruption of mitochondrial membrane potential, resulting in the release of cytochrome c and apoptosis-inducing factor (AIF). AIF translocates to the host cell nucleus, implying that it has a crucial role in OmpU-mediated cell death. Finally, we observe that OmpU translocates to the target cell mitochondria, where it directly initiates mitochondrial changes leading to mitochondrial membrane permeability transition and AIF release. Partial blocking of AIF release by cyclosporine A in OmpU-treated cells further suggests that OmpU may be inducing the opening of the mitochondrial permeability transition pore. All of these results lead us to the conclusion that OmpU induces cell death in target cells in a programmed manner in which mitochondria play a central role.	[Gupta, Shelly; Prasad, G. V. R. Krishna; Mukhopadhaya, Arunika] Indian Inst Sci Educ & Res Mohali, Dept Biol Sci, Mohali 140306, Punjab, India	Indian Institute of Science Education & Research (IISER) - Mohali	Mukhopadhaya, A (corresponding author), Indian Inst Sci Educ & Res Mohali, Dept Biol Sci, Sect 81, Mohali 140306, Punjab, India.	arunika@iisermohali.ac.in	Prasad, G V R Krishna/ABO-5555-2022	Gupta, Shelly/0000-0002-0814-9606; Mukhopadhaya, Arunika/0000-0003-2121-7885	Department of Biotechnology, India [BT/PR1205/MED/29/318/2011]; Indian Institute of Science Education and Research Mohali	Department of Biotechnology, India(Department of Biotechnology (DBT) India); Indian Institute of Science Education and Research Mohali	This work was supported by Department of Biotechnology, India, Grant BT/PR1205/MED/29/318/2011 (to A. M.) and funding from the Indian Institute of Science Education and Research Mohali. The authors declare that they have no conflicts of interest with the contents of this article.	Achouak W, 2001, FEMS MICROBIOL LETT, V199, P1; Alurkar V, 1997, INFECT IMMUN, V65, P2382, DOI 10.1128/IAI.65.6.2382-2388.1997; Andrade R, 2010, BIOL CELL, V102, P25, DOI 10.1042/BC20090077; Ashida H, 2011, J CELL BIOL, V195, P931, DOI 10.1083/jcb.201108081; Biswas T, 2000, FEMS IMMUNOL MED MIC, V29, P129; Bopp Stephanie K., 2008, BMC Pharmacology, V8, P8, DOI 10.1186/1471-2210-8-8; Boujrad H, 2007, CELL CYCLE, V6, P2612, DOI 10.4161/cc.6.21.4842; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; Buommino E, 1999, INFECT IMMUN, V67, P4794, DOI 10.1128/IAI.67.9.4794-4800.1999; Chakrabarti Sr, 1996, J BACTERIOL, V178, P524, DOI 10.1128/jb.178.2.524-530.1996; Chan Francis Ka-Ming, 2013, Methods Mol Biol, V979, P65, DOI 10.1007/978-1-62703-290-2_7; Chandra D, 2004, MOL CELL BIOL, V24, P6592, DOI 10.1128/mcb.24.15.6592-6607.2004; Coburn B, 2007, CLIN MICROBIOL REV, V20, P535, DOI 10.1128/CMR.00013-07; Cocco RE, 2001, MOL BIOL CELL, V12, P919, DOI 10.1091/mbc.12.4.919; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Crawford JA, 1998, MOL MICROBIOL, V29, P235, DOI 10.1046/j.1365-2958.1998.00925.x; Cregan SP, 2002, J CELL BIOL, V158, P507, DOI 10.1083/jcb.200202130; Dewson G, 2009, J CELL SCI, V122, P2801, DOI 10.1242/jcs.038166; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Estaquier J, 2012, ADV EXP MED BIOL, V942, P157, DOI 10.1007/978-94-007-2869-1_7; Goel AK, 2010, WORLD J MICROB BIOT, V26, P281, DOI 10.1007/s11274-009-0171-7; Hangen E, 2010, TRENDS BIOCHEM SCI, V35, P278, DOI 10.1016/j.tibs.2009.12.008; Hirt UA, 2000, J IMMUNOL, V164, P6520, DOI 10.4049/jimmunol.164.12.6520; Hu YM, 1999, EMBO J, V18, P3586, DOI 10.1093/emboj/18.13.3586; Jemmerson R, 2002, CELL DEATH DIFFER, V9, P538, DOI 10.1038/sj.cdd.4400981; Kennedy CL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000516; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Khan J, 2015, IMMUNOBIOLOGY, V220, P1199, DOI 10.1016/j.imbio.2015.06.009; Khan J, 2012, PROTEIN EXPRES PURIF, V85, P204, DOI 10.1016/j.pep.2012.08.005; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Li YZ, 1999, MOL MED, V5, P232, DOI 10.1007/BF03402120; Lin CF, 2010, TOXINS, V2, P2158, DOI 10.3390/toxins2082158; Lorenzo HK, 2004, FEBS LETT, V557, P14, DOI 10.1016/S0014-5793(03)01464-9; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Marino G, 2013, CELL RES, V23, P1247, DOI 10.1038/cr.2013.115; Massari P, 2000, P NATL ACAD SCI USA, V97, P9070, DOI 10.1073/pnas.97.16.9070; Mathur J, 2004, INFECT IMMUN, V72, P3577, DOI 10.1128/IAI.72.6.3577-3583.2004; Muller A, 2000, EMBO J, V19, P5332, DOI 10.1093/emboj/19.20.5332; Muller A, 1999, EMBO J, V18, P339, DOI 10.1093/emboj/18.2.339; Nakasone N, 1998, INFECT IMMUN, V66, P4726, DOI 10.1128/IAI.66.10.4726-4728.1998; Norberg E, 2010, BIOCHEM BIOPH RES CO, V396, P95, DOI 10.1016/j.bbrc.2010.02.163; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Paauw A, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-158; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Pawlowski J, 2000, P NATL ACAD SCI USA, V97, P529, DOI 10.1073/pnas.97.2.529; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Provenzano D, 2001, J BACTERIOL, V183, P3652, DOI 10.1128/JB.183.12.3652-3662.2001; Sakharwade SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076583; Saraste A, 2000, CARDIOVASC RES, V45, P528, DOI 10.1016/S0008-6363(99)00384-3; Shi YG, 2001, NAT STRUCT BIOL, V8, P394, DOI 10.1038/87548; Skorupski K, 1997, MOL MICROBIOL, V25, P1003, DOI 10.1046/j.1365-2958.1997.5481909.x; SPERANDIO V, 1995, INFECT IMMUN, V63, P4433, DOI 10.1128/IAI.63.11.4433-4438.1995; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Susin SA, 1999, J EXP MED, V189, P381, DOI 10.1084/jem.189.2.381; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Volbracht C, 2001, MOL MED, V7, P36, DOI 10.1007/BF03401837; Von Ahsen O, 2000, CELL DEATH DIFFER, V7, P1192, DOI 10.1038/sj.cdd.4400782; Waterhouse NJ, 2003, CELL DEATH DIFFER, V10, P853, DOI 10.1038/sj.cdd.4401263; Weiss JN, 2003, CIRC RES, V93, P292, DOI 10.1161/01.RES.0000087542.26971.D4; Wickman GR, 2013, CELL DEATH DIFFER, V20, P1293, DOI 10.1038/cdd.2013.69; Wolf BB, 1999, J BIOL CHEM, V274, P30651, DOI 10.1074/jbc.274.43.30651; Ziegler U, 2004, NEWS PHYSIOL SCI, V19, P124, DOI 10.1152/nips.01519.2004	67	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					31051	31068		10.1074/jbc.M115.670182	http://dx.doi.org/10.1074/jbc.M115.670182			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26559970	hybrid, Green Published			2022-12-26	WOS:000367199000034
J	Wu, JS; Xie, WD; Li, WF; Li, JC				Wu, Jiansheng; Xie, Wudan; Li, Weifeng; Li, Jiacheng			Effects of Urban Landscape Pattern on PM2.5 Pollution-A Beijing Case Study	PLOS ONE			English	Article							LAND-USE REGRESSION; PARTICULATE AIR-POLLUTION; TRAFFIC-INDUCED NOISE; SURFACE TEMPERATURE; SPATIOTEMPORAL VARIATIONS; DEPOSITION VELOCITY; FINE-PARTICLE; PM10; CONFIGURATION; URBANIZATION	PM2.5 refers to particulate matter (PM) in air that is less than 2.5 mu m in aerodynamic diameter, which has negative effects on air quality and human health. PM2.5 is the main pollutant source in haze occurring in Beijing, and it also has caused many problems in other cities. Previous studies have focused mostly on the relationship between land use and air quality, but less research has specifically explored the effects of urban landscape patterns on PM2.5. This study considered the rapidly growing and heavily polluted Beijing, China. To better understand the impact of urban landscape pattern on PM2.5 pollution, five landscape metrics including PLAND, PD, ED, SHEI, and CONTAG were applied in the study. Further, other data, such as street networks, population density, and elevation considered as factors influencing PM2.5, were obtained through RS and GIS. By means of correlation analysis and stepwise multiple regression, the effects of landscape pattern on PM2.5 concentration was explored. The results showed that (1) at class-level, vegetation and water were significant landscape components in reducing PM2.5 concentration, while cropland played a special role in PM2.5 concentration; (2) landscape configuration (ED and PD) features at class-level had obvious effects on particulate matter; and (3) at the landscape-level, the evenness (SHEI) and fragmentation (CONTAG) of the whole landscape related closely with PM2.5 concentration. Results of this study could expand our understanding of the role of urban landscape pattern on PM2.5 and provide useful information for urban planning.	[Wu, Jiansheng; Xie, Wudan; Li, Jiacheng] Peking Univ Shenzhen, Sch Urban Planning & Design, Key Lab Environm & Urban Sci, Shenzhen, Peoples R China; [Wu, Jiansheng] Peking Univ, Minist Educ, Coll Urban & Environm Sci, Lab Earth Surface Proc, Beijing 100871, Peoples R China; [Li, Weifeng] Univ Hong Kong, Dept Urban Planning & Design, Hong Kong, Hong Kong, Peoples R China; [Li, Jiacheng] Urban Planning & Design Inst Shenzhen, Dept Urban Dev & Land Policy, Shenzhen, Peoples R China	University Town of Shenzhen; Peking University; University of Hong Kong	Xie, WD (corresponding author), Peking Univ Shenzhen, Sch Urban Planning & Design, Key Lab Environm & Urban Sci, Shenzhen, Peoples R China.	wendyshaw753@gmail.com; wfli@hku.hk	LI, Weifeng/E-1478-2011; Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	LI, Weifeng/0000-0001-5386-3019; Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507	National Science Foundation of China [41330747]; University of Hong Kong [201311159209]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); University of Hong Kong(University of Hong Kong)	This work was supported by: (1) 41330747, http://www.nsfc.gov.cn/, National Science Foundation of China, JW. He had a role in study design and data collection. (2) 201311159209, http://www.hku.hk/, University of Hong Kong, WL. He had a role in study design and preparation of the manuscript.	Abernethy RC, 2013, ENVIRON SCI TECHNOL, V47, P5217, DOI 10.1021/es304495s; [Anonymous], 2002, COMPUTER SOFTWARE PR; Boyd PW, 2010, MAR CHEM, V120, P128, DOI 10.1016/j.marchem.2009.01.008; Briggs DJ, 1997, INT J GEOGR INF SCI, V11, P699, DOI 10.1080/136588197242158; Buyantuyev A, 2010, LANDSCAPE ECOL, V25, P17, DOI 10.1007/s10980-009-9402-4; Cao GL, 2011, CHINESE SCI BULL, V56, P781, DOI 10.1007/s11434-011-4373-7; Carter EM, 2014, ENVIRON SCI TECHNOL, V48, P6461, DOI 10.1021/es405723w; [陈爱莲 Chen Ailian], 2013, [生态学报, Acta Ecologica Sinica], V33, P2372; Chen J, 2007, PROCEEDINGS OF THE A, V43, P1; Chen LF, 2012, J ENVIRON SCI-CHINA, V24, P632, DOI 10.1016/S1001-0742(11)60805-X; Cheng Y, 2013, ATMOS CHEM PHYS, V13, P7765, DOI 10.5194/acp-13-7765-2013; Connors JP, 2013, LANDSCAPE ECOL, V28, P271, DOI 10.1007/s10980-012-9833-1; de Hoogh K, 2014, ENVIRON INT, V73, P382, DOI 10.1016/j.envint.2014.08.011; Ding AJ, 2013, ATMOS CHEM PHYS, V13, P5813, DOI 10.5194/acp-13-5813-2013; [丁宇 Ding Yu], 2011, [地理科学进展, Progress in Geography], V30, P1415; Dirgawati M, 2015, ENVIRON MODELL SOFTW, P1; Dockery DW, 2009, ANN EPIDEMIOL, V19, P257, DOI 10.1016/j.annepidem.2009.01.018; Duha JD, 2008, SCI TOTAL ENVIRON, V400, P238, DOI 10.1016/j.scitotenv.2008.05.002; Dzierzanowski K, 2011, INT J PHYTOREMEDIAT, V13, P1037, DOI 10.1080/15226514.2011.552929; Eeftens M, 2012, ENVIRON SCI TECHNOL, V46, P11195, DOI 10.1021/es301948k; Escobedo FJ, 2009, LANDSCAPE URBAN PLAN, V90, P102, DOI 10.1016/j.landurbplan.2008.10.021; Gong P, 2013, INT J REMOTE SENS, V34, P2607, DOI 10.1080/01431161.2012.748992; Gromke C, 2011, ENVIRON POLLUT, V159, P2094, DOI 10.1016/j.envpol.2010.11.012; Gulliver J, 2011, ENVIRON SCI TECHNOL, V45, P3526, DOI 10.1021/es103821y; Henderson SB, 2007, ENVIRON SCI TECHNOL, V41, P2422, DOI 10.1021/es0606780; Hoek G, 2008, ATMOS ENVIRON, V42, P7561, DOI 10.1016/j.atmosenv.2008.05.057; Howell CA, 2000, LANDSCAPE ECOL, V15, P547, DOI 10.1023/A:1008190029786; Hwang HJ, 2011, ATMOS ENVIRON, V45, P6987, DOI 10.1016/j.atmosenv.2011.09.019; Ji WJ, 2014, BUILD SIMUL-CHINA, V7, P417, DOI 10.1007/s12273-014-0180-9; Kashima S, 2009, SCI TOTAL ENVIRON, V407, P3055, DOI 10.1016/j.scitotenv.2008.12.038; Lee JH, 2015, SCI TOTAL ENVIRON, V514, P178, DOI 10.1016/j.scitotenv.2015.01.091; Lee SW, 2009, LANDSCAPE URBAN PLAN, V92, P80, DOI 10.1016/j.landurbplan.2009.02.008; Li L, 2010, J ENVIRON SCI-CHINA, V22, P405, DOI 10.1016/S1001-0742(09)60122-4; Li XM, 2013, LANDSCAPE URBAN PLAN, V114, P1, DOI 10.1016/j.landurbplan.2013.02.005; Li XM, 2012, LANDSCAPE ECOL, V27, P887, DOI 10.1007/s10980-012-9731-6; Lowicki D, 2012, ECOL INDIC, V23, P27, DOI 10.1016/j.ecolind.2012.03.004; Maimaitiyiming M, 2014, ISPRS J PHOTOGRAMM, V89, P59, DOI 10.1016/j.isprsjprs.2013.12.010; Matsuda K, 2010, ATMOS ENVIRON, V44, P4582, DOI 10.1016/j.atmosenv.2010.08.015; McKendry IG, 2000, J AIR WASTE MANAGE, V50, P443, DOI 10.1080/10473289.2000.10464025; Morani A, 2011, ENVIRON POLLUT, V159, P1040, DOI 10.1016/j.envpol.2010.11.022; Nowak DJ, 2013, ENVIRON POLLUT, V178, P395, DOI 10.1016/j.envpol.2013.03.050; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Pope CA, 2009, CIRCULATION, V120, P941, DOI 10.1161/CIRCULATIONAHA.109.857888; Prospero J. M., 2009, ENCY OCEAN SCI, P248, DOI DOI 10.1016/B978-012374473-9.00643-3; Pui DYH, 2014, PARTICUOLOGY, V13, P1, DOI 10.1016/j.partic.2013.11.001; Rosenlund M, 2008, J EXPO SCI ENV EPID, V18, P192, DOI 10.1038/sj.jes.7500571; Ross Z, 2007, ATMOS ENVIRON, V41, P2255, DOI 10.1016/j.atmosenv.2006.11.012; Saebo A, 2012, SCI TOTAL ENVIRON, V427, P347, DOI 10.1016/j.scitotenv.2012.03.084; Santos-Filho M, 2012, BIODIVERS CONSERV, V21, P1127, DOI 10.1007/s10531-012-0248-8; Saveraid EH, 2001, LANDSCAPE ECOL, V16, P71, DOI 10.1023/A:1008119219788; Schindler S, 2013, ECOL INDIC, V31, P41, DOI 10.1016/j.ecolind.2012.04.012; Schwarz N, 2010, LANDSCAPE URBAN PLAN, V96, P29, DOI 10.1016/j.landurbplan.2010.01.007; SHAO T, 2004, CHINESE J APPL ECOL, V15, P691; Shen ZY, 2014, LANDSCAPE URBAN PLAN, V123, P96, DOI 10.1016/j.landurbplan.2013.12.007; Sun Y, 2010, ADV ATMOS SCI, V27, P123, DOI 10.1007/s00376-009-8154-z; Sun YL, 2006, ENVIRON SCI TECHNOL, V40, P3148, DOI 10.1021/es051533g; Tallis M, 2011, LANDSCAPE URBAN PLAN, V103, P129, DOI 10.1016/j.landurbplan.2011.07.003; Tan PH, 2013, ATMOS ENVIRON, V70, P361, DOI 10.1016/j.atmosenv.2013.01.008; Tang R, 2013, ENVIRON SCI TECHNOL, V47, P11643, DOI 10.1021/es402156g; Tang UW, 2007, ENVIRON MODELL SOFTW, V22, P1750, DOI 10.1016/j.envsoft.2007.02.003; [陶宇 Tao Yu], 2013, [生态学报, Acta Ecologica Sinica], V33, P2330; Tu J, 2011, APPL GEOGR, V31, P376, DOI 10.1016/j.apgeog.2010.08.001; Uuemaa E., 2009, Living Reviews in Landscape Research, V3, P1; Wang H, 2008, INT SYM POW SEMICOND, P20; Wang JL, 2006, J ENVIRON SCI, V18, P475; Wang Y, 2007, ATMOS ENVIRON, V41, P417, DOI 10.1016/j.atmosenv.2006.07.043; Weber N, 2014, LANDSCAPE URBAN PLAN, V125, P105, DOI 10.1016/j.landurbplan.2014.02.018; Wu JG, 2011, ECOL COMPLEX, V8, P1, DOI 10.1016/j.ecocom.2010.03.002; Wu JS, 2015, ENVIRON SCI POLLUT R, V22, P7045, DOI 10.1007/s11356-014-3893-5; Wu SW, 2013, ATMOS ENVIRON, V77, P873, DOI 10.1016/j.atmosenv.2013.06.018; Xie YY, 2015, PARTICUOLOGY, V20, P141, DOI 10.1016/j.partic.2015.01.003; Yang J, 2005, URBAN FOR URBAN GREE, V3, P65; Yu LD, 2013, AEROSOL AIR QUAL RES, V13, P574, DOI 10.4209/aaqr.2012.07.0192; Yu M, 2014, ATMOS ENVIRON, V89, P169, DOI 10.1016/j.atmosenv.2014.01.034; Zhang M, 2010, ATMOS ENVIRON, V44, P5191, DOI 10.1016/j.atmosenv.2010.08.048; Zhang YW, 2011, INDOOR BUILT ENVIRON, V20, P206, DOI 10.1177/1420326X10387694; [张智胜 Zhang Zhisheng], 2013, [环境科学学报, Acta Scientiae Circumstantiae], V33, P2947; Zhou WQ, 2014, LANDSCAPE ECOL, V29, P153, DOI 10.1007/s10980-013-9950-5; Zhou WQ, 2011, LANDSCAPE URBAN PLAN, V102, P54, DOI 10.1016/j.landurbplan.2011.03.009	79	88	99	25	193	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142449	10.1371/journal.pone.0142449	http://dx.doi.org/10.1371/journal.pone.0142449			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA2MI	26565799	Green Published, Green Submitted, gold			2022-12-26	WOS:000367628500023
J	Jameson, SS; Mason, J; Baker, PN; Gregg, PJ; Deehan, DJ; Reed, MR				Jameson, Simon S.; Mason, James; Baker, Paul N.; Gregg, Paul J.; Deehan, David J.; Reed, Mike R.			Implant Optimisation for Primary Hip Replacement in Patients over 60 Years with Osteoarthritis: A Cohort Study of Clinical Outcomes and Implant Costs Using Data from England and Wales	PLOS ONE			English	Article							NATIONAL JOINT REGISTRY; RETROSPECTIVE COHORT; PATIENTS YOUNGER; ACTIVE PATIENTS; KNEE SCORES; OXFORD HIP; FOLLOW-UP; ARTHROPLASTY; REVISION; SURVIVORSHIP	Background Hip replacement is one of the most commonly performed surgical procedures worldwide; hundreds of implant configurations provide options for femoral head size, joint surface material and fixation method with dramatically varying costs. Robust comparative evidence to inform the choice of implant is needed. This retrospective cohort study uses linked national databases from England and Wales to determine the optimal type of replacement for patients over 60 years undergoing hip replacement for osteoarthritis. Methods and Findings Implants included were the commonest brand from each of the four types of replacement (cemented, cementless, hybrid and resurfacing); the reference prosthesis was the cemented hip procedure. Patient reported outcome scores (PROMs), costs and risk of repeat (revision) surgery were examined. Multivariable analyses included analysis of covariance to assess improvement in PROMs (Oxford hip score, OHS, and EQ5D index) (9159 linked episodes) and competing risksmodelling of implant survival (79,775 procedures). Cost of implants and ancillary equipment were obtained from National Health Service procurement data. Results EQ5D score improvements (at 6 months) were similar for all hip replacement types. In females, revision risk was significantly higher in cementless hip prostheses (hazard ratio, HR = 2.22, p<0.001), when compared to the reference hip. Although improvement in OHS was statistically higher (22.1 versus 20.5, p<0.001) for cementless implants, this small difference is unlikely to be clinically important. In males, revision risk was significantly higher in cementless (HR = 1.95, p = 0.003) and resurfacing implants, HR = 3.46, p<0.001), with no differences in OHS. Material costs were lowest with the reference implant (cemented, range 1103 pound to 1524) pound and highest with cementless implants (1928 pound to 4285) pound. Limitations include the design of the study, which is intrinsically vulnerable to omitted variables, a paucity of long-term implant survival data (reflecting the duration of data collection), the possibility of revision under-reporting, response bias within PROMs data, and issues associated with current outcome scoring systems, which may not accurately reflect level of improvement in some patients. Conclusions Cement fixation, using a polyethylene cup and a standard sized head offers good outcomes, with the lowest risks and at the lowest costs. The most commonly used cementless and resurfacing implants were associated with higher risk of revision and were more costly, while perceptions of improved function and longevity were unsupported.	[Jameson, Simon S.; Mason, James] Univ Durham, Sch Med Pharm & Hlth, Stockton On Tees TS17 6BH, England; [Jameson, Simon S.; Baker, Paul N.; Gregg, Paul J.] Natl Joint Registry England & Wales, London, England; [Jameson, Simon S.; Baker, Paul N.; Gregg, Paul J.] South Tees Hosp NHS Fdn Trust, Dept Orthopaed Surg, Middlesbrough TS4 3BW, Cleveland, England; [Deehan, David J.] Newcastle Hosp NHS Fdn Trust, Dept Orthopaed Surg, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England; [Reed, Mike R.] Northumbria Healthcare NHS Fdn Trust, Dept Orthopaed Surg, Ashington NE63 9JJ, Northumberland, England	Durham University; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust	Jameson, SS (corresponding author), Univ Durham, Sch Med Pharm & Hlth, Queens Campus,Univ Blvd, Stockton On Tees TS17 6BH, England.	simonjameson@doctors.org.uk	Mason, James M/D-9904-2011	Mason, James M/0000-0001-9210-4082; Reed, Michael/0000-0002-6309-2710; Deehan, David/0000-0001-5780-8818	National Joint Registry for England; Wales; National Joint Registry	National Joint Registry for England; Wales; National Joint Registry	The National Joint Registry for England and Wales is funded through a levy raised on the sale of hip and knee replacement implants. The cost of the levy is set by the NJR Steering Committee. The NJR Steering Committee is responsible for data collection. This work was funded by a fellowship from the National Joint Registry.	Andrew JG, 2008, J BONE JOINT SURG BR, V90B, P424, DOI 10.1302/0301-620X.90B4.20522; [Anonymous], 2009, EUROQOL EQ5D SCORE; Australian National Joint Registry, 2012, AUSTR NAT JOINT REPL; Barrack RL, 1996, J ARTHROPLASTY, V11, P373, DOI 10.1016/S0883-5403(96)80025-8; Beard DJ, 2015, J CLIN EPIDEMIOL, V68, P73, DOI 10.1016/j.jclinepi.2014.08.009; Berry DJ, 2002, J BONE JOINT SURG AM, V84A, P171, DOI 10.2106/00004623-200202000-00002; Browne J, 2007, PATIENT REPORTED OUT; Busch V, 2010, CLIN ORTHOP RELAT R, V468, P3214, DOI 10.1007/s11999-010-1355-z; Callaghan JJ, 2009, J BONE JOINT SURG AM, V91A, P2617, DOI 10.2106/JBJS.H.01201; CHANDLER HP, 1981, J BONE JOINT SURG AM, V63, P1426, DOI 10.2106/00004623-198163090-00008; Clement ND, 2011, J BONE JOINT SURG BR, V93B, P464, DOI 10.1302/0301-620X.93B4.25717; Cohen D, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2905; COLLIS DK, 1984, J BONE JOINT SURG AM, V66A, P353, DOI 10.2106/00004623-198466030-00006; Cuckler JM, 2004, J ARTHROPLASTY, V19, P41, DOI 10.1016/j.arth.2004.09.006; Dawson J, 1996, J BONE JOINT SURG BR, V78B, P185, DOI 10.1302/0301-620X.78B2.0780185; Delaunay CP, 2008, CLIN ORTHOP RELAT R, V466, P340, DOI 10.1007/s11999-007-0045-y; DORR LD, 1983, J BONE JOINT SURG AM, V65, P474, DOI 10.2106/00004623-198365040-00007; England-and-Wales-National-Joint-Registry, 2012, 9 ENGL WAL NAT JOINT; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Finnish National Arthoplasty Registry, 2006, ANN REP 2006; Fordham R, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000752; Haddad FS, 2011, J BONE JOINT SURG BR, V93B, P572, DOI 10.1302/0301-620X.93B4.26429; Hamilton DF, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002525; Heintzbergen S, 2013, VALUE HEALTH, V16, P942, DOI 10.1016/j.jval.2013.06.021; Hunt LP, 2013, LANCET, V382, P1097, DOI 10.1016/S0140-6736(13)61749-3; Jameson SS, 2012, J BONE JOINT SURG BR, V94B, P1611, DOI 10.1302/0301-620X.94B12.30040; Jameson SS, 2012, J BONE JOINT SURG BR, V94B, P746, DOI 10.1302/0301-620X.94B6.29239; Jameson SS, 2013, J ARTHROPLASTY; Jameson SS BP, 2013, BONE JOINT IN PRESS; Jameson SS MJ, 2013, ACTA ORTHOP UNPUB; Jenkins PJ, 2013, BONE JOINT J, V95B, P115, DOI 10.1302/0301-620X.95B1.29835; Judge A, 2013, BMJ OPEN, V3; Kallala R, 2013, BONE JOINT J, V95B, P874, DOI 10.1302/0301-620X.95B7.26931; Kendal AR, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6549; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Larsson S, 2012, HEALTH AFFAIR, V31, P220, DOI 10.1377/hlthaff.2011.0762; LORD GA, 1979, CLIN ORTHOP RELAT R, P2; McMinn DJW, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3319; Medicines- and- Healthcare- products- Regulatory- Agency, 2011, BMJ OPEN; Murray DW, 2007, J BONE JOINT SURG BR, V89B, P1010, DOI 10.1302/0301-620X.89B8; Murray DW, 2011, ORTHOPEDICS, V34, pE462, DOI 10.3928/01477447-20110714-25; New-Zealand-National-Joint-Registry, 2008, ANN REP 2008 8 YEARS; No-authors-listed, 2012, SCOTTISH ARTHROPLAST; *NORW ARTHR REG, 2008, ANN REP 2008; Pakvis D, 2011, INT ORTHOP, V35, P1109, DOI 10.1007/s00264-011-1234-6; Pennington M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1026; Pulikottil-Jacob R, 2015, BONE JOINT J, V97B, P449, DOI 10.1302/0301-620X.97B4.34242; RANAWAT CS, 1984, J BONE JOINT SURG AM, V66A, P745, DOI 10.2106/00004623-198466050-00014; Schmitz MWJL, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-37; SEDEL L, 1990, J BONE JOINT SURG BR, V72, P658, DOI 10.1302/0301-620X.72B4.2380223; Sedrakyan A, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7434; Sexton SA, 2009, J BONE JOINT SURG BR, V91B, P1448, DOI 10.1302/0301-620X.91B11.22100; SHARP DJ, 1985, CLIN ORTHOP RELAT R, P51; Spencer RF, 2011, J BONE JOINT SURG AM, V93A, P84, DOI 10.2106/JBJS.J.01716; Swedish-Hip-Registry, 2011, SWERD HIP REG ANN RE; Toossi N, 2013, J BONE JOINT SURG AM, V95A, P168, DOI 10.2106/JBJS.K.01652; Wroblewski BM, 2007, J BONE JOINT SURG BR, V89B, P1015, DOI 10.1302/0301-620X.89B8; Yates P, 2006, J ARTHROPLASTY, V21, P102, DOI 10.1016/j.arth.2005.05.006	58	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0140309	10.1371/journal.pone.0140309	http://dx.doi.org/10.1371/journal.pone.0140309			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26561859	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000364480900004
J	Liu, HP; Searle, IR; Watson-Haigh, NS; Baumann, U; Mather, DE; Able, AJ; Able, JA				Liu, Haipei; Searle, Iain R.; Watson-Haigh, Nathan S.; Baumann, Ute; Mather, Diane E.; Able, Amanda J.; Able, Jason A.			Genome-Wide Identification of MicroRNAs in Leaves and the Developing Head of Four Durum Genotypes during Water Deficit Stress	PLOS ONE			English	Article							DIFFERENTIALLY EXPRESSED MIRNAS; DROUGHT STRESS; ABIOTIC STRESS; COLD-STRESS; SMALL RNAS; RESPONSIVE MICRORNAS; PLANT; DEHYDRATION; GENES; SALT	MicroRNAs (miRNAs) are small non-coding RNAs that play critical roles in plant development and abiotic stress responses. The miRNA transcriptome (miRNAome) under water deficit stress has been investigated inmany plant species, but is poorly characterised in durum wheat (Triticum turgidum L. ssp. durum). Water stress during early reproductive stages can result in significant yield loss in durum wheat and this study describes genotypic differences in themiRNAome between water deficit tolerant and sensitive durum genotypes. Small RNA libraries (96 in total) were constructed from flag leaf and developing head tissues of four durum genotypes, with or without water stress to identify differentially abundantmiRNAs. Illumina sequencing detected 110 conserved miRNAs and 159 novel candidate miRNA hairpins with 66 conserved miRNAs and five novel miRNA hairpins differentially abundant under water deficit stress. Ten miRNAs (seven conserved, three novel) were validated through qPCR. Several conserved and novel miRNAs showed unambiguous inverted regulatory profiles between the durum genotypes. Several miRNAs also showed differential abundance between two tissue types regardless of treatment. Predicted mRNA targets (130) of four novel durum miRNAs were characterised using Gene Ontology (GO) which revealed functions common to stress responses and plant development. Negative correlation was observed between several target genes and the corresponding miRNA under water stress. For the first time, we present a comprehensive study of the durum miRNAome under water deficit stress. The identification of differentially abundantmiRNAs providesmolecular evidence thatmiRNAs are potential determinants of water stress tolerance in durum wheat. GO analysis of predicted targets contributes to the understanding of genotypic physiological responses leading to stress tolerance capacity. Further functional analysis of specific stress responsive miRNAs and their interaction with targets is ongoing and will assist in developing future durumwheat varieties with enhanced water deficit stress tolerance.	[Liu, Haipei; Searle, Iain R.; Mather, Diane E.; Able, Amanda J.; Able, Jason A.] Univ Adelaide, Waite Agr Res Inst, Sch Agr Food & Wine, Glen Osmond, SA 5064, Australia; [Searle, Iain R.] Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia; [Searle, Iain R.] Univ Adelaide, Waite Agr Res Inst, Sch Agr Food & Wine, Shanghai Jiao Tong Univ,Joint Int Ctr Agr & Hlth, Adelaide, SA, Australia; [Watson-Haigh, Nathan S.; Baumann, Ute] Univ Adelaide, Sch Agr Food & Wine, Australian Ctr Plant Funct Genom, Adelaide, SA, Australia	University of Adelaide; University of Adelaide; Shanghai Jiao Tong University; University of Adelaide; University of Adelaide	Able, JA (corresponding author), Univ Adelaide, Waite Agr Res Inst, Sch Agr Food & Wine, Glen Osmond, SA 5064, Australia.	jason.able@adelaide.edu.au	Searle, Iain/AAE-8869-2019; Watson-Haigh, Nathan S/B-9833-2008; Mather, Diane/AAB-6606-2019	Watson-Haigh, Nathan S/0000-0002-7935-6151; Mather, Diane/0000-0001-7506-2589; Able, Amanda/0000-0003-1135-6515; Able, Jason/0000-0003-3207-6301; Searle, Iain/0000-0003-4306-9756; Liu, Haipei/0000-0002-1852-4537	China Scholarship Council (CSC); University of Adelaide	China Scholarship Council (CSC)(China Scholarship Council); University of Adelaide	This research was funded in part by the Grains Research and Development Corporation (www.grdc.com.au) with a grant awarded to JAA. HL is supported by a China Scholarship Council (CSC) scholarship and the University of Adelaide. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Robin Hosking (University of Adelaide) for maintaining the glasshouse environment. We would also like to thank Ming Lin and Joel Geoghegan from Institute of Medical & Veterinary Sciences from SA Pathology for their help with Illumina sequencing. HL is supported by a China Scholarship Council (CSC) scholarship and the University of Adelaide.	Agharbaoui Z, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1490-8; Akdogan G, 2016, FUNCT INTEGR GENOMIC, V16, P221, DOI 10.1007/s10142-015-0452-1; Akpinar BA, 2013, SCI WORLD J, DOI 10.1155/2013/361921; Barrera-Figueroa BE, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-127; Bertolini E, 2013, MOL PLANT, V6, P423, DOI 10.1093/mp/sss160; Bhardwaj AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092456; Budak H, 2015, FUNCT INTEGR GENOMIC, V15, P523, DOI 10.1007/s10142-015-0451-2; Budak H, 2015, PLANT SCI, V235, P1, DOI 10.1016/j.plantsci.2015.02.008; Budak H, 2011, OMICS, V15, P791, DOI 10.1089/omi.2011.0073; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chapman EJ, 2009, ANNU REV GENET, V43, P265, DOI 10.1146/annurev-genet-102108-134148; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Ding D, 2009, ANN BOT-LONDON, V103, P29, DOI 10.1093/aob/mcn205; Eren H, 2015, ANN APPL BIOL, V167, P208, DOI 10.1111/aab.12219; Gupta OP, 2014, MOL BIOL REP, V41, P4623, DOI 10.1007/s11033-014-3333-0; Hackenberg M, 2015, PLANT BIOTECHNOL J, V13, P2, DOI 10.1111/pbi.12220; Han R, 2014, J INTEGR AGR, V13, P733, DOI 10.1016/S2095-3119(13)60362-7; Han R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-289; Havecker ER, 2011, METHODS MOL BIOL, V732, P55, DOI 10.1007/978-1-61779-083-6_5; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Inal B, 2014, PLANTA, V240, P1287, DOI 10.1007/s00425-014-2153-8; Islam MA, 2009, PLANT MOL BIOL, V70, P443, DOI 10.1007/s11103-009-9483-0; Jain M, 2009, FEBS J, V276, P3148, DOI 10.1111/j.1742-4658.2009.07033.x; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jung HW, 2003, PLANT CELL ENVIRON, V26, P915, DOI 10.1046/j.1365-3040.2003.01024.x; Kantar M, 2011, PLANTA, V233, P471, DOI 10.1007/s00425-010-1309-4; Kantar M, 2010, FUNCT INTEGR GENOMIC, V10, P493, DOI 10.1007/s10142-010-0181-4; Khraiwesh B, 2012, BBA-GENE REGUL MECH, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kong Y. Q. M., 2010, American Journal of Plant Sciences, V1, P69, DOI 10.4236/ajps.2010.12009; Kulcheski FR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-307; Kumar RR, 2015, FUNCT INTEGR GENOMIC, V15, P323, DOI 10.1007/s10142-014-0421-0; Lee SC, 2012, PLANT CELL ENVIRON, V35, P53, DOI 10.1111/j.1365-3040.2011.02426.x; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Li BS, 2011, J EXP BOT, V62, P3765, DOI 10.1093/jxb/err051; Li JS, 2013, J INTEGR AGR, V12, P1414, DOI 10.1016/S2095-3119(13)60311-1; Liu H, 2015, CROP PASTUR IN PRESS; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Long RC, 2015, PHYSIOL PLANTARUM, V154, P13, DOI 10.1111/ppl.12266; Lv DK, 2010, GENE, V459, P39, DOI 10.1016/j.gene.2010.03.011; Lv SZ, 2012, INT J MOL SCI, V13, P2973, DOI 10.3390/ijms13032973; Ma XL, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0413-9; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Pandey R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095800; Pasternak T, 2005, J EXP BOT, V56, P1991, DOI 10.1093/jxb/eri196; Pumplin N, 2013, NAT REV MICROBIOL, V11, P745, DOI 10.1038/nrmicro3120; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Schreiber AW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-129; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Su YH, 2011, MOL PLANT, V4, P616, DOI 10.1093/mp/ssr007; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Tang ZH, 2012, PLANT PHYSIOL, V159, P721, DOI 10.1104/pp.112.196048; Umezawa T, 2006, PLANT J, V46, P171, DOI 10.1111/j.1365-313X.2006.02683.X; Unver T, 2009, PLANTA, V230, P659, DOI 10.1007/s00425-009-0974-7; Urano K, 2010, CURR OPIN PLANT BIOL, V13, P132, DOI 10.1016/j.pbi.2009.12.006; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Verslues PE, 2006, PLANT J, V45, P523, DOI 10.1111/j.1365-313X.2005.02593.x; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang SK, 2010, FUNCT INTEGR GENOMIC, V10, P533, DOI 10.1007/s10142-010-0174-3; Wang TZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-367; Wang YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067423; Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048445; Wei LQ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r53; Wei LY, 2009, INT J PLANT SCI, V170, P979, DOI 10.1086/605122; Wicker T, 2002, TRENDS PLANT SCI, V7, P561, DOI 10.1016/S1360-1385(02)02372-5; Xin MM, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-61; Xin MM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-123; Xue TT, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-550; Yi R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057863; Zhang JH, 2006, FIELD CROP RES, V97, P111, DOI 10.1016/j.fcr.2005.08.018; Zhang JY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-449; Zhao BT, 2007, BIOCHEM BIOPH RES CO, V354, P585, DOI 10.1016/j.bbrc.2007.01.022; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237	78	37	38	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142799	10.1371/journal.pone.0142799	http://dx.doi.org/10.1371/journal.pone.0142799			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562166	Green Published, gold, Green Submitted			2022-12-26	WOS:000364480900069
J	Ohta, S; Hamada, M; Sato, N; Toramoto, I				Ohta, Shinya; Hamada, Mayako; Sato, Nobuko; Toramoto, Iyo			Polyglutamylated Tubulin Binding Protein C1orf96/CSAP Is Involved in Microtubule Stabilization in Mitotic Spindles	PLOS ONE			English	Article							MOUSE-BRAIN NEURONS; BETA-TUBULIN; ALPHA-TUBULIN; CYTOPLASMIC DYNEIN; VERTEBRATE CELLS; KUPFFERS VESICLE; CORTICAL DYNEIN; RING COMPLEX; CENTROSOME; DYNAMICS	The centrosome-associated C1orf96/Centriole, Cilia and Spindle-Associated Protein (CSAP) targets polyglutamylated tubulin in mitotic microtubules (MTs). Loss of CSAP causes critical defects in brain development; however, it is unclear how CSAP association with MTs affects mitosis progression. In this study, we explored the molecular mechanisms of the interaction of CSAP with mitotic spindles. Loss of CSAP caused MT instability in mitotic spindles and resulted in mislocalization of Nuclear protein that associates with the Mitotic Apparatus (NuMA), with defective MT dynamics. Thus, CSAP overload in the spindles caused extensive MT stabilization and recruitment of NuMA. Moreover, MT stabilization by CSAP led to high levels of polyglutamylation on MTs. MT depolymerization by cold or nocodazole treatment was inhibited by CSAP binding. Live-cell imaging analysis suggested that CSAP-dependent MT-stabilization led to centrosome-free MT aster formation immediately upon nuclear envelope breakdown without.-tubulin. We therefore propose that CSAP associates with MTs around centrosomes to stabilize MTs during mitosis, ensuring proper bipolar spindle formation and maintenance.	[Ohta, Shinya; Hamada, Mayako; Sato, Nobuko; Toramoto, Iyo] Kochi Univ, Sch Med, Ctr Innovat & Translat Med, Nankoku, Kochi, Japan	Kochi University	Ohta, S (corresponding author), Kochi Univ, Sch Med, Ctr Innovat & Translat Med, Nankoku, Kochi, Japan.	shinya.ohta@kochi-u.ac.jp		Ohta, Shinya/0000-0003-2424-1741	Japan Society for the Promotion of Science KAKENHI [25870487]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Support was provided by: Japan Society for the Promotion of Science KAKENHI [grant Number 25870487, http://www.jsps.go.jp/english/egrants/index.html] for the study design and preparation of the manuscript; The Nakajima foundation [http://www.nakajimafound.or.jp] for data collection and analysis; Takeda Science Foundation [http://www.takeda-sci.or.jp] for data collection and analysis; The Kanae Foundation for the Promotion of Medical Science [http://www.kanae-zaidan.com/index.html] for data collection and analysis.	AUDEBERT S, 1993, MOL BIOL CELL, V4, P615, DOI 10.1091/mbc.4.6.615; AUDEBERT S, 1994, J CELL SCI, V107, P2313; Backer CB, 2012, MOL BIOL CELL, V23, P2122, DOI 10.1091/mbc.E11-11-0931; Barr AR, 2010, J CELL BIOL, V189, P23, DOI 10.1083/jcb.200912163; Barrera JA, 2010, DEV CELL, V18, P913, DOI 10.1016/j.devcel.2010.05.017; Bobinnec Y, 1998, J CELL BIOL, V143, P1575, DOI 10.1083/jcb.143.6.1575; Bobinnec Y, 1999, EUR J CELL BIOL, V78, P671, DOI 10.1016/S0171-9335(99)80053-3; Bonnet C, 2001, J BIOL CHEM, V276, P12839, DOI 10.1074/jbc.M011380200; Booth DG, 2011, EMBO J, V30, P906, DOI 10.1038/emboj.2011.15; DEBRABANDER M, 1981, P NATL ACAD SCI-BIOL, V78, P5608; Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Dunsch AK, 2012, J CELL BIOL, V198, P1039, DOI 10.1083/jcb.201202112; EDDE B, 1990, SCIENCE, V247, P83, DOI 10.1126/science.1967194; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Fong KW, 2008, MOL BIOL CELL, V19, P115, DOI 10.1091/mbc.E07-04-0371; GAGLIO T, 1995, J CELL BIOL, V131, P693, DOI 10.1083/jcb.131.3.693; Gaglio T, 1997, J CELL BIOL, V138, P1055, DOI 10.1083/jcb.138.5.1055; Gergely F, 2000, P NATL ACAD SCI USA, V97, P14352, DOI 10.1073/pnas.97.26.14352; Hannak E, 2001, J CELL BIOL, V155, P1109, DOI 10.1083/jcb.200108051; Haren Laurence, 2009, BMC Res Notes, V2, P64, DOI 10.1186/1756-0500-2-64; HEUER JG, 1995, DEVELOPMENT, V121, P3861; Hudson DF, 2008, MOL BIOL CELL, V19, P3070, DOI 10.1091/mbc.E08-01-0057; Ikegami K, 2006, J BIOL CHEM, V281, P30707, DOI 10.1074/jbc.M603984200; Janke C, 2005, SCIENCE, V308, P1758, DOI 10.1126/science.1113010; Jia Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068523; JOHNSON MH, 1987, DEVELOPMENT, V100, P313; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Kiyomitsu T, 2013, CELL, V154, P391, DOI 10.1016/j.cell.2013.06.010; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Kubo T, 2010, CURR BIOL, V20, P441, DOI 10.1016/j.cub.2009.12.058; Laan L, 2012, CELL, V148, P502, DOI 10.1016/j.cell.2012.01.007; Larcher JC, 1996, J BIOL CHEM, V271, P22117, DOI 10.1074/jbc.271.36.22117; Li KJ, 1996, CELL, V85, P585, DOI 10.1016/S0092-8674(00)81258-1; Lin CH, 2010, J CELL BIOL, V189, P1097, DOI 10.1083/jcb.200911120; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Maiato H, 2014, NAT CELL BIOL, V16, P386, DOI 10.1038/ncb2958; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Merdes A, 2000, J CELL BIOL, V149, P851, DOI 10.1083/jcb.149.4.851; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; MITCHISON TJ, 1985, J CELL BIOL, V101, P766, DOI 10.1083/jcb.101.3.766; O'Connell CB, 2000, MOL BIOL CELL, V11, P1765, DOI 10.1091/mbc.11.5.1765; Ohta S, 2015, MOL BIOL CELL, V26, P1225, DOI 10.1091/mbc.E14-09-1366; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; Przyborski SA, 1997, DEV BRAIN RES, V100, P133, DOI 10.1016/S0165-3806(97)00031-X; Purohit A, 1999, J CELL BIOL, V147, P481, DOI 10.1083/jcb.147.3.481; Rodionov V, 1999, P NATL ACAD SCI USA, V96, P115, DOI 10.1073/pnas.96.1.115; SAWIN KE, 1994, MOL BIOL CELL, V5, P217, DOI 10.1091/mbc.5.2.217; van Dijk J, 2007, MOL CELL, V26, P437, DOI 10.1016/j.molcel.2007.04.012; Westermann S, 2002, J CELL SCI, V115, P5003, DOI 10.1242/jcs.00170; Wiese C, 2001, SCIENCE, V291, P653, DOI 10.1126/science.1057661; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; Zhang CM, 1999, J CELL SCI, V112, P2453; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0	54	4	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142798	10.1371/journal.pone.0142798	http://dx.doi.org/10.1371/journal.pone.0142798			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562023	Green Submitted, Green Published, gold			2022-12-26	WOS:000364480900068
J	Stadler, J; Eder, J; Pratscher, B; Brandt, S; Schneller, D; Mullegger, R; Vogl, C; Trautinger, F; Brem, G; Burgstaller, JP				Stadler, Julia; Eder, Johanna; Pratscher, Barbara; Brandt, Sabine; Schneller, Doris; Muellegger, Robert; Vogl, Claus; Trautinger, Franz; Brem, Gottfried; Burgstaller, Joerg P.			SNPase-ARMS qPCR: Ultrasensitive Mutation-Based Detection of Cell-Free Tumor DNA in Melanoma Patients	PLOS ONE			English	Article							COLORECTAL-CANCER PATIENTS; METASTATIC BREAST-CANCER; DROPLET DIGITAL PCR; BRAF MUTATIONS; PERIPHERAL-BLOOD; SURFACE-ANTIGENS; MUTANT-DNA; PLASMA; QUANTIFICATION; PIK3CA	Cell-free circulating tumor DNA in the plasma of cancer patients has become a common point of interest as indicator of therapy options and treatment response in clinical cancer research. Especially patient-and tumor-specific single nucleotide variants that accurately distinguish tumor DNA from wild type DNA are promising targets. The reliable detection and quantification of these single-base DNA variants is technically challenging. Currently, a variety of techniques is applied, with no apparent "gold standard". Here we present a novel qPCR protocol that meets the conditions of extreme sensitivity and specificity that are required for detection and quantification of tumor DNA. By consecutive application of two polymerases, one of them designed for extreme base-specificity, the method reaches unprecedented sensitivity and specificity. Three qPCR assays were tested with spike-in experiments, specific for point mutations BRAF V600E, PTEN T167A and NRAS Q61L of melanoma cell lines. It was possible to detect down to one copy of tumor DNA per reaction (Poisson distribution), at a background of up to 200 000 wild type DNAs. To prove its clinical applicability, the method was successfully tested on a small cohort of BRAF V600E positive melanoma patients.	[Stadler, Julia; Schneller, Doris; Brem, Gottfried; Burgstaller, Joerg P.] IFA Tulln, Dept Agrobiotechnol, Biotechnol Anim Prod, Tulln, Lower Austria, Austria; [Stadler, Julia; Schneller, Doris; Vogl, Claus; Brem, Gottfried; Burgstaller, Joerg P.] Univ Vet Med Vienna, Inst Anim Breeding & Genet, Vienna, Austria; [Eder, Johanna; Trautinger, Franz] Karl Landsteiner Univ Hlth Sci, Dept Dermatol & Venereol, St Polten, Lower Austria, Austria; [Eder, Johanna; Trautinger, Franz] Karl Landsteiner Inst Dermatol Res, St Polten, Lower Austria, Austria; [Pratscher, Barbara; Brandt, Sabine] Univ Vet Med Vienna, Dept Compan Anim & Horses, Res Grp Oncol, Equine Clin, Vienna, Austria; [Muellegger, Robert] Landesklinikum Wiener Neustadt, Dept Dermatol & Venereol, Wiener Neustadt, Lower Austria, Austria	University of Natural Resources & Life Sciences, Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Burgstaller, JP (corresponding author), IFA Tulln, Dept Agrobiotechnol, Biotechnol Anim Prod, Tulln, Lower Austria, Austria.	joerg.burgstaller@vetmeduni.ac.at	Trautinger, Franz/M-5041-2019	Pratscher, Barbara/0000-0001-5291-1365; Brandt, Sabine/0000-0002-3837-3422	Life Science Calls, Niederosterreichische Forschungs-und Bildungsgesellschaft (NFB) [LS10_028]	Life Science Calls, Niederosterreichische Forschungs-und Bildungsgesellschaft (NFB)	This work was supported by grant LS10_028 (to J.P.B.) from Life Science Calls, Niederosterreichische Forschungs-und Bildungsgesellschaft (NFB) (http://www.noe-fb.at/forschung/foerderung/life-science-calls/).	Abdel-Wahab O, 2014, CANCER DISCOV, V4, P538, DOI 10.1158/2159-8290.CD-13-1038; Beaver JA, 2014, CLIN CANCER RES, V20, P2643, DOI 10.1158/1078-0432.CCR-13-2933; Benesova L, 2013, ANAL BIOCHEM, V433, P227, DOI 10.1016/j.ab.2012.06.018; Berg M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122391; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Bidard FC, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006305; Board RE, 2009, BRIT J CANCER, V101, P1724, DOI 10.1038/sj.bjc.6605371; Board RE, 2008, CLIN CHEM, V54, P757, DOI 10.1373/clinchem.2007.098376; Board RE, 2010, BREAST CANCER RES TR, V120, P461, DOI 10.1007/s10549-010-0747-9; Bosserhoff AK, 2000, J INVEST DERMATOL, V114, P395, DOI 10.1046/j.1523-1747.2000.00889.x; Boursault L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070826; Burgstaller JP, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-141; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; CAREY TE, 1976, P NATL ACAD SCI USA, V73, P3278, DOI 10.1073/pnas.73.9.3278; Chen D, 2014, ANAL BIOANAL CHEM, V406, P2477, DOI 10.1007/s00216-014-7618-x; Coller HA, 2001, NAT GENET, V28, P147, DOI 10.1038/88859; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Diaz LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Diehl F, 2007, CURR OPIN ONCOL, V19, P36, DOI 10.1097/CCO.0b013e328011a8e7; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Guha M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067782; Haber DA, 2014, CANCER DISCOV, V4, P650, DOI 10.1158/2159-8290.CD-13-1014; Hall RD, 2014, CANCER CONTROL, V21, P221, DOI 10.1177/107327481402100307; Haluska FG, 2006, CLIN CANCER RES, V12, p2301S, DOI 10.1158/1078-0432.CCR-05-2518; Handsaker RE, 2015, NAT GENET, V47, P296, DOI 10.1038/ng.3200; Higgins MJ, 2012, CLIN CANCER RES, V18, P3462, DOI 10.1158/1078-0432.CCR-11-2696; Hoeller C, 2005, J INVEST DERMATOL, V124, P1293, DOI 10.1111/j.0022-202X.2005.23685.x; Hwang VJ, 2014, BMC MED GENET, V15, DOI 10.1186/s12881-014-0106-5; JOHNSON JP, 1981, EUR J IMMUNOL, V11, P825, DOI 10.1002/eji.1830111015; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Jung K, 2010, CLIN CHIM ACTA, V411, P1611, DOI 10.1016/j.cca.2010.07.032; Klein D, 2002, TRENDS MOL MED, V8, P257, DOI 10.1016/S1471-4914(02)02355-9; Kuhne BS, 2002, BIOTECHNIQUES, V33, P1078, DOI 10.2144/02335rr03; Menzies AM, 2014, AM J SURG PATHOL, V38, P377, DOI 10.1097/PAS.0000000000000136; Mouliere F, 2013, TRANSL ONCOL, V6, P319, DOI 10.1593/tlo.12445; Newman AM, 2014, NAT MED, V20, P552, DOI 10.1038/nm.3519; Nordgard O, 2012, DIAGN MOL PATHOL, V21, P9, DOI 10.1097/PDM.0b013e31821e59dc; Oxnard GR, 2014, CLIN CANCER RES, V20, P1698, DOI 10.1158/1078-0432.CCR-13-2482; Pekin D, 2011, LAB CHIP, V11, P2156, DOI 10.1039/c1lc20128j; Pinzani P, 2011, CLIN CHIM ACTA, V412, P901, DOI 10.1016/j.cca.2011.01.014; Pinzani P, 2010, CLIN CHIM ACTA, V411, P1319, DOI 10.1016/j.cca.2010.05.024; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Rossmanith P, 2011, J FOOD PROTECT, V74, P1404, DOI 10.4315/0362-028X.JFP-10-458; Ruijter JM, 2013, METHODS, V59, P32, DOI 10.1016/j.ymeth.2012.08.011; Salvianti F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049843; Sanmamed MF, 2015, CLIN CHEM, V61, P297, DOI 10.1373/clinchem.2014.230235; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Shinozaki M, 2007, CLIN CANCER RES, V13, P2068, DOI 10.1158/1078-0432.CCR-06-2120; Siravegna G, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0449-4; Spellman PT, 2014, NAT MED, V20, P474, DOI 10.1038/nm.3564; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Taly V, 2013, CLIN CHEM, V59, P1722, DOI 10.1373/clinchem.2013.206359; Taniguchi K, 2011, CLIN CANCER RES, V17, P7808, DOI 10.1158/1078-0432.CCR-11-1712; Thierry AR, 2014, NAT MED, V20, P430, DOI 10.1038/nm.3511; Werzowa J, 2009, BRIT J DERMATOL, V160, P955, DOI 10.1111/j.1365-2133.2008.08991.x; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yancovitz M, 2007, J MOL DIAGN, V9, P178, DOI 10.2353/jmoldx.2007.060135; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	61	22	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142273	10.1371/journal.pone.0142273	http://dx.doi.org/10.1371/journal.pone.0142273			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562020	Green Submitted, Green Published, gold			2022-12-26	WOS:000364480900023
J	Driller, C; Merker, S; Perwitasari-Farajallah, D; Sinaga, W; Anggraeni, N; Zischler, H				Driller, Christine; Merker, Stefan; Perwitasari-Farajallah, Dyah; Sinaga, Walberto; Anggraeni, Novita; Zischler, Hans			Stop and Go - Waves of Tarsier Dispersal Mirror the Genesis of Sulawesi Island	PLOS ONE			English	Article							MOLECULAR PHYLOGENETICS; SPECIES TREES; MITOCHONDRIAL; EVOLUTION; DIVERSIFICATION; BIODIVERSITY; BIOGEOGRAPHY; PATTERNS; NUCLEAR; RECONSTRUCTIONS	The Indonesian island of Sulawesi harbors a highly endemic and diverse fauna sparking fascination since long before Wallace's contemplation of biogeographical patterns in the region. Allopatric diversification driven by geological or climatic processes has been identified as the main mechanism shaping present faunal distribution on the island. There is both consensus and conflict among range patterns of terrestrial species pointing to the different effects of vicariant events on once co-distributed taxa. Tarsiers, small nocturnal primates with possible evidence of an Eocene fossil record on the Asian mainland, are at present exclusively found in insular Southeast Asia. Sulawesi is hotspot of tarsier diversity, whereby island colonization and subsequent radiation of this old endemic primate lineage remained largely enigmatic. To resolve the phylogeographic history of Sulawesi tarsiers we analyzed an island-wide sample for a set of five approved autosomal phylogenetic markers (ABCA1, ADORA3, AXIN1, RAG1, and TTR) and the paternally inherited SRY gene. We constructed ML and Bayesian phylogenetic trees and estimated divergence times between tarsier populations. We found that their arrival at the Proto-Sulawesi archipelago coincided with initial Miocene tectonic uplift and hypothesize that tarsiers dispersed over the region in distinct waves. Intra-island diversification was spurred by land emergence and a rapid succession of glacial cycles during the Plio-Pleistocene. Some tarsier range boundaries concur with spatial limits in other taxa backing the notion of centers of faunal endemism on Sulawesi. This congruence, however, has partially been superimposed by taxon-specific dispersal patterns.	[Driller, Christine; Zischler, Hans] Johannes Gutenberg Univ Mainz, Inst Anthropol, D-55122 Mainz, Germany; [Merker, Stefan] State Museum Nat Hist Stuttgart, Dept Zool, Stuttgart, Germany; [Perwitasari-Farajallah, Dyah; Sinaga, Walberto] Bogor Agr Univ, Primate Res Ctr, Bogor, Indonesia; [Perwitasari-Farajallah, Dyah] Bogor Agr Univ, Dept Biol, Bogor, Indonesia; [Anggraeni, Novita] Bogor Agr Univ, Sch Grad Studies, Bogor, Indonesia	Johannes Gutenberg University of Mainz; Bogor Agricultural University; Bogor Agricultural University; Bogor Agricultural University	Driller, C (corresponding author), Johannes Gutenberg Univ Mainz, Inst Anthropol, D-55122 Mainz, Germany.	driller@uni-mainz.de	Driller, Christine/AAW-2151-2020; Perwitasari-Farajallah, Dyah/CAE-9260-2022	Driller, Christine/0000-0003-2000-4095; Perwitasari-Farajallah, Dyah/0000-0001-6206-1675; Zischler, Hans/0000-0002-3440-8376; Merker, Stefan/0000-0003-3142-7720	Deutsche Forschungsgemeinschaft (DFG) [ZI568/6-1, ZI568/6-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (DFG, http://www.dfg.de). Grants ZI568/6-1 and ZI568/6-2 were allocated to HZ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEARD KC, 1994, NATURE, V368, P604, DOI 10.1038/368604a0; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Brandon-Jones D, 2004, INT J PRIMATOL, V25, P97, DOI 10.1023/B:IJOP.0000014647.18720.32; Bridle JR, 2004, EVOLUTION, V58, P1394; Bridle JR, 2001, BIOL J LINN SOC, V72, P373, DOI 10.1111/j.1095-8312.2001.tb01324.x; Burton JA, 2010, INT J PRIMATOL, V31, P1123, DOI 10.1007/s10764-010-9449-8; Butlin RK, 1998, BIOGEOGRAPHY GEOLOGI, P355; Campbell P, 2007, MOL PHYLOGENET EVOL, V44, P474, DOI 10.1016/j.ympev.2007.02.013; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chaimanee Y, 2010, P R SOC B, V278, P1956; Clement M., 2002, P 16 INT PARALLEL DI, P7; Clements B, 2009, PETROL GEOSCI, V15, P159, DOI 10.1144/1354-079309-831; Dagosto M, TARSIERS PRESENT FUT, P237; Driller C, 2009, INT J PRIMATOL, V30, P267, DOI 10.1007/s10764-009-9341-6; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Esselstyn JA, 2009, EVOLUTION, V63, P2595, DOI 10.1111/j.1558-5646.2009.00743.x; Evans Ben J., 2012, Systematics Association Special Volume Series, V82, P270; Evans BJ, 2003, EVOLUTION, V57, P1931; Evans BJ, 2003, EVOLUTION, V57, P1436; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Groves C, 2010, INT J PRIMATOL, V31, P1071, DOI 10.1007/s10764-010-9443-1; Grow N, 2010, INT J PRIMATOL, V31, P1174, DOI 10.1007/s10764-010-9456-9; Hall R, 2002, J ASIAN EARTH SCI, V20, P353, DOI 10.1016/S1367-9120(01)00069-4; Hall R, 2001, FAUNAL AND FLORAL MIGRATIONS AND EVOLUTION IN SE ASIA-AUSTRALASIA, P35; Hall R, 2009, BLUMEA, V54, P148, DOI 10.3767/000651909X475941; Hall R, 2013, J LIMNOL, V72, P1, DOI 10.4081/jlimnol.2013.s2.e1; Hall R, 2012, TECTONOPHYSICS, V570, P1, DOI 10.1016/j.tecto.2012.04.021; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hope G, 2001, PALAEOGEOGR PALAEOCL, V171, P129, DOI 10.1016/S0031-0182(01)00243-7; Horvath JE, 2008, GENOME RES, V18, P489, DOI 10.1101/gr.7265208; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Knowles LL, 2009, SYST BIOL, V58, P463, DOI 10.1093/sysbio/syp061; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Lohman DJ, 2011, ANNU REV ECOL EVOL S, V42, P205, DOI 10.1146/annurev-ecolsys-102710-145001; Lyrholm T, 1999, P ROY SOC B-BIOL SCI, V266, P347, DOI 10.1098/rspb.1999.0644; McGuire JA, 2007, HERPETOL MONOGR, V21, P179, DOI 10.1655/07-012.1; MELNICK DJ, 1992, INT J PRIMATOL, V13, P379, DOI 10.1007/BF02547824; Merker S, 2014, J MOL EVOL, V79, P40, DOI 10.1007/s00239-014-9631-2; Merker S, 2010, INT J PRIMATOL, V31, P1107, DOI 10.1007/s10764-010-9452-0; Merker S, 2009, P NATL ACAD SCI USA, V106, P8459, DOI 10.1073/pnas.0900319106; Michaux B, 2010, BIOL J LINN SOC, V101, P193, DOI 10.1111/j.1095-8312.2010.01473.x; Moen D, 2014, TRENDS ECOL EVOL, V29, P190, DOI 10.1016/j.tree.2014.01.010; Moss Steve J., 1998, P133; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Natus I.R, 2005, THESIS; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Rambaut A., 2007, TRACER V1 5; Ronquist F, 2011, MRBAYES VER IN PRESS; Ruedi M, 1998, MOL PHYLOGENET EVOL, V9, P567, DOI 10.1006/mpev.1998.0487; Sanders KL, 2014, BIOL CONSERV, V171, P200, DOI 10.1016/j.biocon.2014.01.013; Schmitz J, 2001, GENETICS, V157, P777; Seehausen O, 2008, MOL ECOL, V17, P30, DOI 10.1111/j.1365-294X.2007.03529.x; Setiadi MI, 2011, AM NAT, V178, P221, DOI 10.1086/660830; Shaul S, 2002, GENE, V300, P59, DOI 10.1016/S0378-1119(02)00851-X; Shekelle M, 2010, INT J PRIMATOL, V31, P1083, DOI 10.1007/s10764-010-9457-8; Shekelle Myron, 2008, Primate Conservation, V23, P55, DOI 10.1896/052.023.0106; Springer MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049521; Stelbrink B, 2012, EVOLUTION, V66, P2252, DOI 10.1111/j.1558-5646.2012.01588.x; van den Bergh GD, 2001, PALAEOGEOGR PALAEOCL, V171, P385, DOI 10.1016/S0031-0182(01)00255-3; VAWTER L, 1986, SCIENCE, V234, P194, DOI 10.1126/science.3018931; von Rintelen T, 2007, HYDROBIOLOGIA, V592, P11, DOI 10.1007/s10750-007-0765-8; von Rintelen T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098917; Whitten T, 2002, ECOLOGY SULAWESI; Zheng YC, 2011, MOL BIOL EVOL, V28, P2521, DOI 10.1093/molbev/msr072; Zwickl D. J, 2006, GENETIC ALGORITHM AP	69	16	16	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141212	10.1371/journal.pone.0141212	http://dx.doi.org/10.1371/journal.pone.0141212			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559527	gold, Green Published, Green Submitted			2022-12-26	WOS:000364433100025
J	Li, HL; Wang, YY; Zhang, Q; Wang, P; Zhang, MX; Yu, FH				Li, Hong-Li; Wang, Yong-Yang; Zhang, Qian; Wang, Pu; Zhang, Ming-Xiang; Yu, Fei-Hai			Vegetative Propagule Pressure and Water Depth Affect Biomass and Evenness of Submerged Macrophyte Communities	PLOS ONE			English	Article							PHOTOSYNTHETIC CHARACTERISTICS; SHALLOW LAKES; PLANT; ESTABLISHMENT; COMPETITION; RESTORATION; DISTURBANCE; RECRUITMENT; PERFORMANCE; STRATEGIES	Vegetative propagule pressure may affect the establishment and structure of aquatic plant communities that are commonly dominated by plants capable of clonal growth. We experimentally constructed aquatic communities consisting of four submerged macrophytes (Hydrilla verticillata, Ceratophyllum demersum, Elodea nuttallii and Myriophyllum spicatum) with three levels of vegetative propagule pressure (4, 8 and 16 shoot fragments for communities in each pot) and two levels of water depth (30 cm and 70 cm). Increasing vegetative propagule pressure and decreasing water level significantly increased the growth of the submerged macrophyte communities, suggesting that propagule pressure and water depth should be considered when utilizing vegetative propagules to re-establish submerged macrophyte communities in degraded aquatic ecosystems. However, increasing vegetative propagule pressure and decreasing water level significantly decreased evenness of the submerged macrophyte communities because they markedly increased the dominance of H. verticillata and E. nuttallii, but had little impact on that of C. demersum and M. spicatum. Thus, effects of vegetative propagule pressure and water depth are species-specific and increasing vegetative propagule pressure under lower water level can facilitate the establishment success of submerged macrophyte communities.	[Li, Hong-Li; Wang, Yong-Yang; Zhang, Qian; Wang, Pu; Zhang, Ming-Xiang; Yu, Fei-Hai] Beijing Forestry Univ, Sch Nat Conservat, Beijing 100083, Peoples R China	Beijing Forestry University	Yu, FH (corresponding author), Beijing Forestry Univ, Sch Nat Conservat, Beijing 100083, Peoples R China.	feihaiyu@bjfu.edu.cn	Yu, Fei-Hai/O-9395-2016	Yu, Fei-Hai/0000-0001-5007-1745; Zhang, Qian/0000-0003-4591-7755	Fundamental Research Funds for the Central Universities [TD-JC-2013-1, YX2011-34]; National Natural Science Foundation of China [31200313, 31470475]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Fundamental Research Funds for the Central Universities (TD-JC-2013-1 and YX2011-34) and the National Natural Science Foundation of China (Nos. 31200313 and 31470475).	Abernethy VJ, 1996, HYDROBIOLOGIA, V340, P219, DOI 10.1007/BF00012758; Barrat-Segretain MH, 2005, PLANT ECOL, V180, P153, DOI 10.1007/s11258-004-7374-7; Barrat-Segretain MH, 2002, AQUAT BOT, V74, P299, DOI 10.1016/S0304-3770(02)00106-7; Barrat-Segretain MH, 1998, AQUAT BOT, V60, P201, DOI 10.1016/S0304-3770(97)00091-0; Barrat-Segretain MH, 2001, ARCH HYDROBIOL, V152, P237; Beklioglu M, 2006, ARCH HYDROBIOL, V166, P535, DOI 10.1127/0003-9136/2006/0166-0535; CHAMBERS PA, 1990, FRESHWATER BIOL, V23, P541, DOI 10.1111/j.1365-2427.1990.tb00293.x; Combroux ICS, 2002, WETLANDS, V22, P234, DOI 10.1672/0277-5212(2002)022[0234:PRSAAM]2.0.CO;2; Coops H, 2002, LAKE RESERV MANAGE, V18, P293, DOI 10.1080/07438140209353935; Dhote S, 2009, ENVIRON MONIT ASSESS, V152, P149, DOI 10.1007/s10661-008-0303-9; Dong BL, 2014, J GREAT LAKES RES, V40, P646, DOI 10.1016/j.jglr.2014.04.007; Engelhardt KAM, 2001, NATURE, V411, P687, DOI 10.1038/35079573; Hofstra DE, 1999, AQUAT BOT, V63, P305, DOI 10.1016/S0304-3770(98)00125-9; Jin Xiangcan, 2006, Lakes & Reservoirs Research and Management, V11, P21, DOI 10.1111/j.1440-1770.2006.00291.x; Kempel A, 2013, P NATL ACAD SCI USA, V110, P12727, DOI 10.1073/pnas.1300481110; Lamb EG, 2008, AM NAT, V171, P777, DOI 10.1086/587528; Larios L, 2013, J VEG SCI, V24, P1043, DOI 10.1111/jvs.12039; Leung B, 2007, P ROY SOC B-BIOL SCI, V274, P2603, DOI 10.1098/rspb.2007.0841; Li W, 2013, ECOL ENG, V61, P358, DOI 10.1016/j.ecoleng.2013.09.028; Lin HF, 2012, AQUAT BOT, V99, P34, DOI 10.1016/j.aquabot.2012.01.004; Liu RH, 2014, SCI REP-UK, V4, DOI 10.1038/srep05507; Liu Y, 2006, ACTA ECOL SIN, V9; MABERLY SC, 1993, J AQUAT PLANT MANAGE, V31, P34; Maestre FT, 2006, J ECOL, V94, P17, DOI 10.1111/j.1365-2745.2005.01089.x; Maron JL, 2013, J ECOL, V101, P924, DOI 10.1111/1365-2745.12108; Miller AL, 2014, ECOLOGY, V95, P920, DOI 10.1890/13-0655.1; Noges T, 1999, HYDROBIOLOGIA, V408, P277; Paillisson JM, 2011, ECOL ENG, V37, P241, DOI 10.1016/j.ecoleng.2010.11.017; Pan G, 2011, ECOL ENG, V37, P302, DOI 10.1016/j.ecoleng.2010.11.019; Rolon AS, 2006, HYDROBIOLOGIA, V556, P221, DOI 10.1007/s10750-005-1364-1; Santamaria L, 2002, ACTA OECOL, V23, P137, DOI 10.1016/S1146-609X(02)01146-3; Slivitzky M, 2002, LIT REV; Sondergaard M, 2013, HYDROBIOLOGIA, V704, P165, DOI 10.1007/s10750-012-1389-1; Sondergaard M, 2010, FRESHWATER BIOL, V55, P893, DOI 10.1111/j.1365-2427.2009.02331.x; Sosnova M, 2010, AQUAT BOT, V92, P33, DOI 10.1016/j.aquabot.2009.09.005; Strand JA, 2001, J ECOL, V89, P166, DOI 10.1046/j.1365-2745.2001.00530.x; Van Geest GJ, 2005, HYDROBIOLOGIA, V539, P239, DOI 10.1007/s10750-004-4879-y; VAN TK, 1976, PLANT PHYSIOL, V58, P761, DOI 10.1104/pp.58.6.761; Vretare V, 2001, AQUAT BOT, V69, P127, DOI 10.1016/S0304-3770(01)00134-6; Wang P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039105; Wu Z., 2004, FLORA CHINA; Xie D, 2011, HYDROBIOLOGIA, V658, P221, DOI 10.1007/s10750-010-0475-5; Xie D, 2010, HYDROBIOLOGIA, V655, P37, DOI 10.1007/s10750-010-0402-9; Xie Y, 2007, ANN BOT-LONDON, V100, P1517, DOI 10.1093/aob/mcm236; Xu F, 2013, ECOL MODEL, V252, P167, DOI 10.1016/j.ecolmodel.2012.07.013; Xu Jing-Wei, 2007, Zhiwu Shengtai Xuebao, V31, P83; Zhang M, 2011, AQUAT BOT, V94, P151, DOI 10.1016/j.aquabot.2011.01.004; Zhang Q, 2014, SCI REP-UK, V4, DOI 10.1038/srep04888; Zhang XK, 2014, ECOL ENG, V68, P25, DOI 10.1016/j.ecoleng.2014.03.087; Zhu GR, 2012, HYDROBIOLOGIA, V696, P77, DOI 10.1007/s10750-012-1185-y	50	9	9	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142586	10.1371/journal.pone.0142586	http://dx.doi.org/10.1371/journal.pone.0142586			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560705	Green Published, gold, Green Submitted			2022-12-26	WOS:000364433100093
J	Priori, R; Casadei, L; Valerio, M; Scrivo, R; Valesini, G; Manetti, C				Priori, Roberta; Casadei, Luca; Valerio, Mariacristina; Scrivo, Rossana; Valesini, Guido; Manetti, Cesare			H-1-NMR-Based Metabolomic Study for Identifying Serum Profiles Associated with the Response to Etanercept in Patients with Rheumatoid Arthritis	PLOS ONE			English	Article							ANTITUMOR NECROSIS FACTOR; ERYTHROCYTE SEDIMENTATION-RATE; COBRA COMBINATION THERAPY; C-REACTIVE PROTEIN; CONCOMITANT METHOTREXATE; MONOCLONAL-ANTIBODY; DISEASE-ACTIVITY; JOINT DAMAGE; FOLLOW-UP; ADALIMUMAB	Objective A considerable proportion of patients with rheumatoid arthritis (RA) do not have a satisfactory response to biological therapies. We investigated the use of metabolomics approach to identify biomarkers able to anticipate the response to biologics in RA patients. Methods Due to gender differences in metabolomic profiling, the analysis was restricted to female patients starting etanercept as the first biological treatment and having a minimum of six months' follow-up. Each patient was evaluated by the same rheumatologist before and after six months of treatment. At this time, the clinical response (good, moderate, none) was determined according to the EUropean League Against Rheumatism (EULAR) criteria, based on both erythrocyte sedimentation rate (EULAR-ESR) and C-reactive protein (EULAR-CRP). Sera collected prior and after six months of etanercept were analyzed by H-1-nuclear magnetic resonance (NMR) spectroscopy in combination with multivariate data analysis. Results Twenty-seven patients were enrolled: 18 had a good/moderate response and 9 were non responders according to both EULAR-ESR and EULAR-CRP after six months of etanercept. Metabolomic analysis at baseline was able to discriminate good, moderate, and non-responders with a very good predictivity (Q(2) = 0.68) and an excellent sensitivity, specificity, and accuracy (100%). In good responders, we found an increase in isoleucine, leucine, valine, alanine, glutamine, tyrosine, and glucose levels and a decrease in 3-hydroxybutyrate levels after six months of treatment with etanercept with respect to baseline. Conclusion Our study confirms the potential of metabolomic analysis to predict the response to biological agents. Changes in metabolic profiles during treatment may help elucidate their mechanism of action.	[Priori, Roberta; Scrivo, Rossana; Valesini, Guido] Univ Roma La Sapienza, Dept Internal Med & Med Specialties, Rheumatol Unit, I-00185 Rome, Italy; [Casadei, Luca; Valerio, Mariacristina; Manetti, Cesare] Univ Roma La Sapienza, Dept Chem, I-00185 Rome, Italy	Sapienza University Rome; Sapienza University Rome	Valesini, G (corresponding author), Univ Roma La Sapienza, Dept Internal Med & Med Specialties, Rheumatol Unit, I-00185 Rome, Italy.	guido.valesini@uniroma1.it	priori, roberta/Z-6259-2019	priori, roberta/0000-0002-6695-1445; Valesini, Guido/0000-0002-7757-8092; Casadei, Luca/0000-0002-6977-5010; Valerio, Mariacristina/0000-0001-7740-9945	Progetti d'Ateneo (Sapienza Universita di Roma)	Progetti d'Ateneo (Sapienza Universita di Roma)	This work was supported by Progetti d'Ateneo (Sapienza Universita di Roma) 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SB, 2012, OSTEOARTHR CARTILAGE, V20, P64, DOI 10.1016/j.joca.2011.10.010; Aletaha D, 2005, NAT CLIN PRACT RHEUM, V1, P62, DOI 10.1038/ncprheum0050; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bathon JM, 2000, NEW ENGL J MED, V343, P1586, DOI 10.1056/NEJM200011303432201; BENIGNI R, 1994, AM J PHYSIOL, V266, pR1697, DOI 10.1152/ajpregu.1994.266.5.R1697; Boers M, 1997, LANCET, V350, P309, DOI 10.1016/S0140-6736(97)01300-7; Choy EH, 2013, NAT REV RHEUMATOL, V9, P154, DOI 10.1038/nrrheum.2013.8; Clair EWS, 2004, ARTHRITIS RHEUM-US, V50, P3432, DOI 10.1002/art.20568; Claxson A, 1999, BBA-MOL BASIS DIS, V1454, P57, DOI 10.1016/S0925-4439(99)00020-4; EGSMOSE C, 1995, J RHEUMATOL, V22, P2208; Fages A, 2014, INVESTIGATING SOURCE; Finckh A, 2006, ARTHRIT RHEUM-ARTHR, V55, P864, DOI 10.1002/art.22353; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; Goodacre R, 2007, METABOLOMICS, V3, P231, DOI 10.1007/s11306-007-0081-3; Kapoor SR, 2013, ARTHRITIS RHEUM-US, V65, P1448, DOI 10.1002/art.37921; Kawasaki Y, 2013, MOD RHEUMATOL, V23, P1192, DOI [10.3109/s10165-012-0822-7, 10.1007/s10165-012-0822-7]; Keystone EC, 2004, ARTHRITIS RHEUM, V50, P1400, DOI 10.1002/art.20217; Klaasen R, 2011, RHEUMATOLOGY, V50, P1487, DOI 10.1093/rheumatology/ker010; Krieckaert CL, 2012, ANN RHEUM DIS, V71, P1914, DOI 10.1136/annrheumdis-2012-201544; Landewe RBM, 2002, ARTHRITIS RHEUM-US, V46, P347, DOI 10.1002/art.10083; Lauridsen MB, 2010, J PROTEOME RES, V9, P4545, DOI 10.1021/pr1002774; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Madsen RK, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3243; Matsui T, 2007, ANN RHEUM DIS, V66, P1221, DOI 10.1136/ard.2006.063834; Meshitsuka S, 1999, CLIN CHIM ACTA, V281, P163, DOI 10.1016/S0009-8981(98)00200-9; Mittelstrass K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002215; NAUGHTON D, 1993, FEBS LETT, V317, P135, DOI 10.1016/0014-5793(93)81508-W; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Ouyang X, 2011, LUPUS, V20, P1411, DOI 10.1177/0961203311418707; Potter C, 2009, ANN RHEUM DIS, V68, P69, DOI 10.1136/ard.2007.084715; Priori R, 2013, AUTOIMMUN REV, V12, P1022, DOI 10.1016/j.autrev.2013.04.002; RANTAPAADAHLQVIST S, 1991, ANN RHEUM DIS, V50, P366, DOI 10.1136/ard.50.6.366; Scrivo R, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0445-5; Sellam J, 2014, ARTHRITIS RHEUMATOL, V66, P2015, DOI 10.1002/art.38671; Semerano L, 2015, ANN RHEUM DIS, V74, P1325, DOI 10.1136/annrheumdis-2014-206618; Siemons L, 2014, CLIN RHEUMATOL, V33, P783, DOI 10.1007/s10067-014-2538-x; Singh JA, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007848.pub2; Slupsky CM, 2007, ANAL CHEM, V79, P6995, DOI 10.1021/ac0708588; Smolen JS, 2010, ANN RHEUM DIS, V69, P964, DOI 10.1136/ard.2009.126532; Tsakonas E, 2000, J RHEUMATOL, V27, P623; van den Broek M, 2012, ANN RHEUM DIS, V71, P245, DOI 10.1136/annrheumdis-2011-200379; van Gestel AM, 1998, ARTHRITIS RHEUM-US, V41, P1845, DOI 10.1002/1529-0131(199810)41:10<1845::AID-ART17>3.3.CO;2-B; van Tuyl LHD, 2010, ANN RHEUM DIS, V69, P807, DOI 10.1136/ard.2009.108027; vanderHeide A, 1996, ANN INTERN MED, V124, P699, DOI 10.7326/0003-4819-124-8-199604150-00001; Wang ZG, 2012, EXP THER MED, V4, P165, DOI 10.3892/etm.2012.567; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401; Weinblatt ME, 2003, ARTHRITIS RHEUM-US, V48, P35, DOI 10.1002/art.10697; Weljie AM, 2007, J PROTEOME RES, V6, P3456, DOI 10.1021/pr070123j; Wu TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037210; Yazici Y, 2011, CLIN EXP RHEUMATOL, V29, P494; Young SP, 2013, ARTHRITIS RHEUM-US, V65, P2015, DOI 10.1002/art.38021	51	34	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0138537	10.1371/journal.pone.0138537	http://dx.doi.org/10.1371/journal.pone.0138537			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558759	Green Published, gold, Green Submitted			2022-12-26	WOS:000364433100001
J	Hao, SX; Hou, X; Wei, L; Li, J; Li, ZH; Wang, XT				Hao, Shixin; Hou, Xin; Wei, Lei; Li, Jian; Li, Zhonghu; Wang, Xiaotong			Extraction and Identification of the Pigment in the Adductor Muscle Scar of Pacific Oyster Crassostrea gigas	PLOS ONE			English	Article							MELANIN; BIOSYNTHESIS; MELANOGENESIS; PURIFICATION	In this study, UV (ultraviolet) and IR (infrared radiation) spectral analysis were integrated to identify the pigment in the adductor muscle scar of the Pacific oyster Crassostrea gigas. The pigment was extracted from the adductor muscle scars of cleaned oyster shells that were pulverized, hydrolyzed in hot hydrochloric acid, purified with diethyl ether, and dissolved in 0.01 mL/L NaOH. The maximum absorption of the pigment in the UV absorption spectrum within the range of 190-500 nm was observed between 210-220 nm. The UV absorbance decreased with increasing wavelength which was consistent with the UV spectral absorption characteristics of melanin. In addition, Fourier transform infrared spectroscopy scanning revealed characteristic absorption peaks that emerged near 3440 cm(-1) and 1630 cm(-1), which was consistent with infrared scanning features of eumelanin (a type of melanin). This study has demonstrated for the first time that the pigment in the adductor muscle scar of the Pacific oyster is melanin, hinting that the adductor muscle could be another organ pigmenting the mollusc shell with melanin other than mantle.	[Hao, Shixin; Wei, Lei; Li, Jian; Li, Zhonghu; Wang, Xiaotong] Ludong Univ, Sch Agr, Yantai, Shandong, Peoples R China; [Hou, Xin] Ludong Univ, Sch Life Sci, Yantai, Shandong, Peoples R China	Ludong University; Ludong University	Wang, XT (corresponding author), Ludong Univ, Sch Agr, Yantai, Shandong, Peoples R China.	wangxiaotong999@163.com						Aghajanyan AE, 2005, PIGM CELL RES, V18, P130, DOI 10.1111/j.1600-0749.2005.00211.x; Ahmed B, 2017, TRANSBOUND EMERG DIS, V64, P167, DOI 10.1111/tbed.12358; Araujo M, 2012, STRUCT CHEM, V23, P115, DOI 10.1007/s11224-011-9843-7; BELL AA, 1986, ANNU REV PHYTOPATHOL, V24, P411, DOI 10.1146/annurev.py.24.090186.002211; Deng WD, 2008, MOL BIOL REP, V35, P379, DOI 10.1007/s11033-007-9097-z; Deng WD, 2006, ANIM GENET, V37, P586, DOI 10.1111/j.1365-2052.2006.01530.x; Dubey S, 2014, PIGM CELL MELANOMA R, V27, P327, DOI 10.1111/pcmr.12231; El Bassam S, 2002, CAN J MICROBIOL, V48, P349, DOI 10.1139/w02-030; KOLLIAS N, 1991, J PHOTOCH PHOTOBIO B, V9, P135, DOI 10.1016/1011-1344(91)80147-A; Kumar R, 2015, FISH PHYSIOL BIOCHEM, V41, P761, DOI 10.1007/s10695-015-0044-y; Langfelder K, 2003, FUNGAL GENET BIOL, V38, P143, DOI 10.1016/S1087-1845(02)00526-1; Li N, 2010, FOOD CHEM, V118, P616, DOI 10.1016/j.foodchem.2009.05.043; Lu Y, 2014, APPL BIOCHEM BIOTECH, V174, P762, DOI 10.1007/s12010-014-1110-0; Magarelli M., 2010, Revista CES Medicina Veterinaria y Zootecnia, V5, P18; NICOLAUS RA, 1964, TETRAHEDRON, V20, P1163, DOI 10.1016/S0040-4020(01)98983-5; PROTA G, 1980, J INVEST DERMATOL, V75, P122, DOI 10.1111/1523-1747.ep12521344; Sharma S, 2002, PIGM CELL RES, V15, P127, DOI 10.1034/j.1600-0749.2002.1o076.x; Vrolijk MF, 2015, REDOX BIOL, V4, P272, DOI 10.1016/j.redox.2014.12.017; Wakamatsu K, 2002, PIGM CELL RES, V15, P174, DOI 10.1034/j.1600-0749.2002.02017.x; Yuan WL, 2007, PHYSIOL PLANTARUM, V131, P180, DOI 10.1111/j.1399-3054.2007.00948.x; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413	21	17	18	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142439	10.1371/journal.pone.0142439	http://dx.doi.org/10.1371/journal.pone.0142439			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555720	Green Published, gold, Green Submitted			2022-12-26	WOS:000364430700105
J	Lim, MCY; Wang, YF; Huang, SW; Yang, JY; Wang, JR				Lim, Matthew C. Y.; Wang, Ya-Fang; Huang, Sheng-Wen; Yang, Jyh-Yuan; Wang, Jen-Ren			High Incidence of Mammalian Orthoreovirus Identified by Environmental Surveillance in Taiwan	PLOS ONE			English	Article							HUMAN ADENOVIRUS; CELL-CULTURE; WASTE-WATER; RESPIRATORY ADENOVIRUS; ACUTE GASTROENTERITIS; POLIOVIRUS DETECTION; REOVIRUS; SEWAGE; ENTEROVIRUSES; TYPE-3	Wild poliovirus (WPV) persists in diverse locales worldwide, spreading outward from endemic areas. In response to the international threat of WPV transmission and changes in the national vaccination policy, we established an environmental surveillance system to monitor the circulation of wild and vaccine-related poliovirus in Taiwan. From July 2012 to December 2013, we collected sewage specimens every month from 10 sewage treatment plants located throughout Taiwan. The specimens were concentrated by the two-phase separation method and then inoculated into L20B, RD, and A549 cells for virus isolation. Viral isolates were identified and serotyped by immunofluorescence assay or molecular analysis. A total of 300 sewage samples were collected, and the results showed 163 samples (54.3%) were positive for virus, and 268 isolates were identified. Among these, 75 samples (25%) were positive for enterovirus (EV), but no poliovirus was found. In addition, 92 isolates were identified as enteroviruses and the most common serotypes were coxsackie-virus B4, coxsackievirus B3, and coxsackievirus B2. Interestingly, 102 (34%) and 82 (27.3%) specimens were positive for mammalian orthoreovirus (MRV) and adenovirus, respectively. This study confirmed that sewage surveillance can be a useful additional modality for monitoring the possible presence of wild-type or vaccine-derived poliovirus in wastewater, and can indicate the current types of viruses circulating in the population. Furthermore, since MRV was found in children with acute necrotizing encephalopathy and meningitis, the high incidence of MRV detected by environmental surveillance warrants further investigation.	[Lim, Matthew C. Y.; Wang, Jen-Ren] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan; [Huang, Sheng-Wen; Wang, Jen-Ren] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan; [Wang, Jen-Ren] Natl Cheng Kung Univ Hosp, Dept Pathol, Tainan 70428, Taiwan; [Yang, Jyh-Yuan] Minist Hlth & Welf, Ctr Dis Control, Ctr Res Diagnost & Vaccine Dev, Taipei, Taiwan; [Wang, Ya-Fang; Wang, Jen-Ren] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; Centers For Disease Control - Taiwan; National Health Research Institutes - Taiwan	Wang, JR (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan.	jrwang@mail.ncku.edu.tw	Wang, Jen-Ren/F-5254-2011	Wang, Jen-Ren/0000-0002-4127-4046	Centers for Disease Control, Taiwan [DOH102-DC-1106]; Ministry of Science and Technology (MOST) [MOST 104-2321-B006-002]; National Health Research Institutes [04A1-IVPP11-014]	Centers for Disease Control, Taiwan; Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China); National Health Research Institutes(National Health Research Institutes, Japan)	This study was funded by the Centers for Disease Control, Taiwan (grant no. DOH102-DC-1106), Ministry of Science and Technology (MOST) (grant no. MOST 104-2321-B006-002), and National Health Research Institutes (grant no. 04A1-IVPP11-014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams T, 2000, B WORLD HEALTH ORGAN, V78, P1375; Andre M, 2013, MMWR-MORBID MORTAL W, V62, P768; Anis E, 2013, EURO SURVEILL, V18; Antona D, 2007, EUR J CLIN MICROBIOL, V26, P403, DOI 10.1007/s10096-007-0306-4; Aslan A, 2011, J APPL MICROBIOL, V111, P1250, DOI 10.1111/j.1365-2672.2011.05130.x; AWWA. (American Water Works Association), 1999, AWWA MAN WAT PRACT M; Battistone A, 2014, APPL ENVIRON MICROB, V80, P4491, DOI 10.1128/AEM.00108-14; Biologicals DoVa, 2003, GUID ENV SURV POL CI; Blasiole DA, 2004, J CLIN MICROBIOL, V42, P1686, DOI 10.1128/JCM.42.4.1686-1693.2004; Cardemil CV, 2014, EPIDEMIOL INFECT, V142, P163, DOI 10.1017/S0950268813000800; Centers for Disease Control and Prevention (CDC), 2013, MMWR Morb Mortal Wkly Rep, V62, P484; Chang SY, 2008, J MED VIROL, V80, P102, DOI 10.1002/jmv.21045; Chua KB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003803; Costan-Longares A, 2008, J APPL MICROBIOL, V105, P1945, DOI 10.1111/j.1365-2672.2008.03954.x; DAHLING DR, 1989, APPL ENVIRON MICROB, V55, P503, DOI 10.1128/AEM.55.2.503-506.1989; Day JM, 2009, INFECT GENET EVOL, V9, P390, DOI 10.1016/j.meegid.2009.01.011; Duncan R, 1999, VIROLOGY, V260, P316, DOI 10.1006/viro.1999.9832; Fraenkel-Conrat H, 1988, VIROLOGY; Gallagher EM, 2007, J VIROL METHODS, V139, P195, DOI 10.1016/j.jviromet.2006.10.001; Global Polio Eradication Initiative, WHO S E AS REG DECL; Griffin DW, 2003, CLIN MICROBIOL REV, V16, P129, DOI 10.1128/CMR.16.1.129-143.2003; Hermann L, 2004, PEDIATR INFECT DIS J, V23, P373, DOI 10.1097/00006454-200404000-00026; Hewitt J, 2013, WATER RES, V47, P6750, DOI 10.1016/j.watres.2013.09.001; Hovi T, 2012, EPIDEMIOL INFECT, V140, P1, DOI 10.1017/S095026881000316X; Jiang J, 2006, VIRUS GENES, V33, P193, DOI 10.1007/s11262-005-0046-4; Johansson PJH, 1996, SCAND J INFECT DIS, V28, P117, DOI 10.3109/00365549609049060; Kajon AE, 2010, J INFECT DIS, V202, P93, DOI 10.1086/653083; Kaneko H, 2011, BRIT J OPHTHALMOL, V95, P32, DOI 10.1136/bjo.2009.178772; Kaneko H, 2009, J GEN VIROL, V90, P1471, DOI 10.1099/vir.0.009225-0; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; Kim YJ, 2003, J CLIN MICROBIOL, V41, P4594, DOI 10.1128/JCM.41.10.4594-4599.2003; Lago PM, 2003, INT J EPIDEMIOL, V32, P772, DOI 10.1093/ije/dyg185; Lelli D, 2013, ZOONOSES PUBLIC HLTH, V60, P84, DOI 10.1111/zph.12001; LERNER AM, 1962, PHYS REV, V126, P947, DOI 10.1056/NEJM196211082671901; Lin KH, 2004, J MED VIROL, V73, P274, DOI 10.1002/jmv.20087; Lodder WJ, 2012, APPL ENVIRON MICROB, V78, P3800, DOI 10.1128/AEM.07972-11; Lowther SA, 2013, RISK ANAL, V33, P664, DOI 10.1111/risa.12032; Manor Y, 1999, J CLIN MICROBIOL, V37, P1670, DOI 10.1128/JCM.37.6.1670-1675.1999; MATSUURA K, 1993, MICROBIOL IMMUNOL, V37, P305, DOI 10.1111/j.1348-0421.1993.tb03214.x; Melnick JL, 1990, VIROLOGY, P549; METCALF TG, 1995, ANNU REV MICROBIOL, V49, P461, DOI 10.1146/annurev.micro.49.1.461; Metzgar D, 2005, J CLIN MICROBIOL, V43, P5743, DOI 10.1128/JCM.43.11.5743-5752.2005; Moturi EK, 2014, MMWR-MORBID MORTAL W, V30, P468; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Ouattara LA, 2011, EMERG INFECT DIS, V17, P1436, DOI 10.3201/eid1708.101528; Paduch DA, 2007, CURR UROL REP, V8, P324, DOI 10.1007/s11934-007-0080-y; Piqueur MAC, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-95; RIDINGER DN, 1982, APPL ENVIRON MICROB, V43, P740, DOI 10.1128/AEM.43.4.740-746.1982; Rodriguez RA, 2013, WATER RES, V47, P3183, DOI 10.1016/j.watres.2013.03.022; ROSEN L, 1960, AM J HYG, V71, P242, DOI 10.1093/oxfordjournals.aje.a120107; SABIN AB, 1959, SCIENCE, V130, P1387, DOI 10.1126/science.130.3386.1387; Sherry B, 1998, CURR TOP MICROBIOL, V233, P51; Spinner ML, 2001, APPL ENVIRON MICROB, V67, P3016, DOI 10.1128/AEM.67.7.3016-3020.2001; Steyer A, 2013, J CLIN MICROBIOL, V51, P3818, DOI 10.1128/JCM.01531-13; Tansuphasiri Unchalee, 2000, Southeast Asian Journal of Tropical Medicine and Public Health, V31, P47; Tyler KL, 2004, J INFECT DIS, V189, P1664, DOI 10.1086/383129; Tyler KL, 1998, CURR TOP MICROBIOL, V233, P93; UHNOO I, 1984, J CLIN MICROBIOL, V20, P365, DOI 10.1128/JCM.20.3.365-372.1984; Wang SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075208; Watkins RE, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-162; Wen N, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-113; Wong MVM, 2013, J WATER HEALTH, V11, P659, DOI 10.2166/wh.2013.322; Wood DJ, 1999, J MED VIROL, V58, P188, DOI 10.1002/(SICI)1096-9071(199906)58:2<188::AID-JMV15>3.3.CO;2-8; Zheng HY, 2013, APPL ENVIRON MICROB, V79, P7679, DOI 10.1128/AEM.02058-13	64	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142745	10.1371/journal.pone.0142745	http://dx.doi.org/10.1371/journal.pone.0142745			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555962	Green Published, Green Submitted, gold			2022-12-26	WOS:000364430700167
J	Liu, HC; Zhu, DY; Wang, C; Guan, HG; Li, SL; Hu, C; Chen, ZC; Hu, YY; Lin, H; Lian, QQ; Ge, RS				Liu, Hua-Cheng; Zhu, Danyan; Wang, Chan; Guan, Hongguo; Li, Senlin; Hu, Cong; Chen, Zhichuan; Hu, Yuanyuan; Lin, Han; Lian, Qing-Quan; Ge, Ren-Shan			Effects of Etomidate on the Steroidogenesis of Rat Immature Leydig Cells	PLOS ONE			English	Article							BETA-HYDROXYSTEROID DEHYDROGENASE; ANESTHETIC ETOMIDATE; ADRENODOXIN; INHIBITORS; RECEPTORS	Background Etomidate is a rapid hypnotic intravenous anesthetic agent. The major side effect of etomidate is the reduced plasma concentration of corticosteroids, leading to the abnormal reaction of adrenals. Cortisol and testosterone biosynthesis has similar biosynthetic pathway, and shares several common steroidogenic enzymes, such as P450 side chain cleavage enzyme (CYP11A1) and 3 beta-hydroxysteroid dehydrogenase 1 (HSD3B1). The effect of etomidate on Leydig cell steroidogenesis during the cell maturation process is not well established. Methodology Immature Leydig cells isolated from 35 day-old rats were cultured with 30 mu M etomidate for 3 hours in combination with LH, 8Br-cAMP, 25R-OH-cholesterol, pregnenolone, progesterone, androstenedione, testosterone and dihydrotestosterone, respectively. The concentrations of 5a-androstanediol and testosterone in the media were measured by radioimmunoassay. Leydig cells were cultured with various concentrations of etomidate (0.3-30 mu M) for 3 hours, and total RNAs were extracted. Q-PCR was used to measure the mRNA levels of following genes: Lhcgr, Scarb1, Star, Cyp11a1, Hsd3b1, Cyp17a1, Hsd17b3, Srd5a1, and Akr1c14. The testis mitochondria and microsomes from 35-day-old rat testes were prepared and used to detect the direct action of etomidate on CYP11A1 and HSD3B1 activity. Results and Conclusions In intact Leydig cells, 30 mu M etomidate significantly inhibited androgen synthesis. Further studies showed that etomidate also inhibited the LH-stimulated androgen production. On purified testicular mitochondria and ER fractions, etomidate competitively inhibited both CYP11A1 and HSD3B1 activities, with the half maximal inhibitory concentration (IC50) values of 12.62 and 2.75 mu M, respectively. In addition, etomidate inhibited steroidogenesis-related gene expression. At about 0.3 mu M, etomidate significantly inhibited the expression of Akr1C14. At the higher concentration (30 mu M), it also reduced the expression levels of Cyp11a1, Hsd17b3 and Srd5a1. In conclusion, etomidate directly inhibits the activities of CYP11A1 and HSD3B1, and the expression levels of Cyp11a1 and Hsd17b3, leading to the lower production of androgen by Leydig cells.	[Liu, Hua-Cheng; Zhu, Danyan; Wang, Chan; Li, Senlin; Hu, Cong; Chen, Zhichuan; Hu, Yuanyuan; Lin, Han; Lian, Qing-Quan; Ge, Ren-Shan] Wenzhou Med Univ, Dept Anesthiol, Affiliated Hosp 2, Wenzhou 325027, Zhejiang, Peoples R China; [Liu, Hua-Cheng; Zhu, Danyan; Wang, Chan; Li, Senlin; Hu, Cong; Chen, Zhichuan; Hu, Yuanyuan; Lin, Han; Lian, Qing-Quan; Ge, Ren-Shan] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou 325027, Zhejiang, Peoples R China; [Guan, Hongguo] Wenzhou Med Univ, Sch Pharm, Wenzhou 325035, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Lian, QQ (corresponding author), Wenzhou Med Univ, Dept Anesthiol, Affiliated Hosp 2, Wenzhou 325027, Zhejiang, Peoples R China.	lianqingquanmz@163.com; r_ge@yahoo.com	Lin, Han/GRF-1081-2022	Chen, Zhichuan/0000-0002-4244-9469; Hu, Cong/0000-0001-9778-3141	Health Bureau of Zhejiang Province [WKJ2011-2-012, 2013ZDA017, 11-CX29]; National Natural Science Foundation [81471448]	Health Bureau of Zhejiang Province; National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was partially supported by the Health Bureau of Zhejiang Province (WKJ2011-2-012, 2013ZDA017 & 11-CX29), and the National Natural Science Foundation (No.81471448). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DIAGO MC, 1988, ANAESTHESIA, V43, P644, DOI 10.1111/j.1365-2044.1988.tb04148.x; Doenicke A, 1974, Acta Anaesthesiol Belg, V25, P307; Forman SA, 2011, ANESTHESIOLOGY, V114, P695, DOI 10.1097/ALN.0b013e3181ff72b5; Ge RS, 1998, ENDOCRINOLOGY, V139, P3787, DOI 10.1210/en.139.9.3787; Ge RS, 1997, ENDOCRINOLOGY, V138, P2435, DOI 10.1210/en.138.6.2435; GOODING JM, 1976, ANESTH ANALG, V55, P286; Guo JJ, 2013, REPRODUCTION, V145, P371, DOI 10.1530/REP-12-0465; HANUKOGLU I, 1987, EUR J BIOCHEM, V169, P449, DOI 10.1111/j.1432-1033.1987.tb13632.x; HANUKOGLU I, 1980, J BIOL CHEM, V255, P3057, DOI 10.1016/S0021-9258(19)85851-9; HEYTENS L, 1987, HUM REPROD, V2, P85, DOI 10.1093/oxfordjournals.humrep.a136506; Hu GX, 2009, J STEROID BIOCHEM, V115, P14, DOI 10.1016/j.jsbmb.2009.02.004; Husain SS, 2003, J MED CHEM, V46, P1257, DOI 10.1021/jm020465v; LAMBERT A, 1987, J ENDOCRINOL, V113, P457, DOI 10.1677/joe.0.1130457; Ledingham IM, 1983, LANCET, V321; Lin H, 2008, P NATL ACAD SCI USA, V105, P7218, DOI 10.1073/pnas.0709260105; PAYNE AH, 1980, J BIOL CHEM, V255, P7118; Payne AH, 1997, STEROIDS, V62, P169, DOI 10.1016/S0039-128X(96)00177-8; Rijk JCW, 2012, CHEM RES TOXICOL, V25, P1720, DOI 10.1021/tx3001779; SCHULTE HM, 1990, J CLIN ENDOCR METAB, V70, P1426, DOI 10.1210/jcem-70-5-1426; Tomlin SL, 1998, ANESTHESIOLOGY, V88, P708, DOI 10.1097/00000542-199803000-00022; WAGNER RL, 1984, NEW ENGL J MED, V310, P1415, DOI 10.1056/NEJM198405313102202; WAGNER RL, 1984, ANESTHESIOLOGY, V61, P647, DOI 10.1097/00000542-198412000-00003; Ye LP, 2011, MOLECULES, V16, P9983, DOI 10.3390/molecules16129983; Zolle IM, 2008, J MED CHEM, V51, P2244, DOI 10.1021/jm800012w	24	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0139311	10.1371/journal.pone.0139311	http://dx.doi.org/10.1371/journal.pone.0139311			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555702	Green Published, gold, Green Submitted			2022-12-26	WOS:000364430700005
J	Ramsey, NB; Andersen, OS				Ramsey, Nicole B.; Andersen, Olaf S.			Bilayer Effects of Antimalarial Compounds	PLOS ONE			English	Article							MODULATE CHANNEL FUNCTION; ACCESS MALARIA BOX; NMR-SPECTROSCOPY; SODIUM-CHANNELS; MEMBRANE; DRUGS; IDENTIFICATION; AMPHIPHILES; ANESTHETICS; INHIBITORS	Because of the perpetual development of resistance to current therapies for malaria, the Medicines for Malaria Venture developed the Malaria Box to facilitate the drug development process. We tested the 80 most potent compounds from the box for bilayer-mediated effects on membrane protein conformational changes (a measure of likely toxicity) in a gramicidin-based stopped flow fluorescence assay. Among the Malaria Box compounds tested, four compounds altered membrane properties (p< 0.05); MMV007384 stood out as a potent bilayer-perturbing compound that is toxic in many cell-based assays, suggesting that testing for membrane perturbation could help identify toxic compounds. In any case, MMV007384 should be approached with caution, if at all.	[Ramsey, Nicole B.] Weill Cornell Rockefeller Sloan Kettering Triinst, New York, NY USA; [Ramsey, Nicole B.] Weill Cornell Grad Sch Med Sci, Grad Program Pharmacol, New York, NY USA; [Andersen, Olaf S.] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA	Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Cornell University	Andersen, OS (corresponding author), Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA.	sparre@med.cornell.edu			National Institute of General Medical Sciences of the National Institutes of Health [GM021342, T32GM007739]; UNCF/Merck Science Initiative fellowship; NIH [GM021342]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021342, T32GM007739] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); UNCF/Merck Science Initiative fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: This work was supported by the National Institute of General Medical Sciences of the National Institutes of Health (http://www.nigms.nih.gov) grant GM021342 (OSA); NBR was supported by a Medical Scientist Training Program grant from the National Institute of General Medical Sciences of the National Institutes of Health (http://www.nigms.nih.gov) under award number T32GM007739 to the Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program (PD: OSA), and by a UNCF/Merck Science Initiative fellowship (http://umsi.uncf.org/).; This work was supported by NIH grant GM021342 (OSA); NBR was supported by a Medical Scientist Training Program grant from the National Institute of General Medical Sciences of the National Institutes of Health under award number T32GM007739 to the Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program, and by a UNCF/Merck Science Initiative fellowship; the Malaria Box compounds were a gift from the Medicines for Malaria Venture. We thank J. Fraser Glickman, Radda Rusinova, and R. Lea Sanford for advice and stimulating discussions.	Alejo JL, 2013, BIOPHYS J, V104, P2410, DOI 10.1016/j.bpj.2013.04.039; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000402; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Barry J, 2009, J AM CHEM SOC, V131, P4490, DOI 10.1021/ja809217u; Basore K, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00091; Berberan-Santos MN, 2005, CHEM PHYS, V315, P171, DOI 10.1016/j.chemphys.2005.04.006; Bickerton GR, 2012, NAT CHEM, V4, P90, DOI [10.1038/nchem.1243, 10.1038/NCHEM.1243]; Boyom FF, 2014, ANTIMICROB AGENTS CH, V58, P5848, DOI 10.1128/AAC.02541-14; Bruno MJ, 2007, P NATL ACAD SCI USA, V104, P9638, DOI 10.1073/pnas.0701015104; Bruno MJ, 2013, FARADAY DISCUSS, V161, P461, DOI 10.1039/c2fd20092a; Dandapani S, 2012, FUTURE MED CHEM, V4, P2279, DOI [10.4155/FMC.12.178, 10.4155/fmc.12.178]; Darby CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068942; Desai SA, 2012, CELL MICROBIOL, V14, P1003, DOI 10.1111/j.1462-5822.2012.01790.x; Finkelstein A, 1987, THEORY AND REALITY; Fletcher S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-343; Hain AUP, 2014, J MED CHEM, V57, P4521, DOI 10.1021/jm401675a; Herold KF, 2014, J GEN PHYSIOL, V144, P545, DOI 10.1085/jgp.201411172; HUANG HW, 1986, BIOPHYS J, V50, P1061, DOI 10.1016/S0006-3495(86)83550-0; Hwang TC, 2003, BIOCHEMISTRY-US, V42, P13646, DOI 10.1021/bi034887y; Ingolfsson HI, 2007, BIOCHEMISTRY-US, V46, P10384, DOI 10.1021/bi701013n; Ingolfsson HI, 2014, ACS CHEM BIOL, V9, P1788, DOI 10.1021/cb500086e; Ingolfsson Helgi I, 2010, J Vis Exp, DOI 10.3791/2131; Ingolfsson HI, 2010, ASSAY DRUG DEV TECHN, V8, P427, DOI 10.1089/adt.2009.0250; Kaiser M, 2015, J BIOMOL SCREEN, V20, P634, DOI 10.1177/1087057115569155; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Lucantoni L, 2013, ANTIMICROB AGENTS CH, V57, P6050, DOI 10.1128/AAC.00870-13; Lundb&AELIG;k JA, 2012, CHOLESTEROL REGULATI; Lundbaek JA, 2005, MOL PHARMACOL, V68, P680, DOI 10.1124/mol.105.013573; Lundbaek JA, 2004, J GEN PHYSIOL, V123, P599, DOI 10.1085/jgp.200308996; LUNDBAEK JA, 1994, J GEN PHYSIOL, V104, P645, DOI 10.1085/jgp.104.4.645; Lundbaek JA, 2008, J GEN PHYSIOL, V131, P421, DOI 10.1085/jgp.200709948; Lundbaek JA, 2010, J R SOC INTERFACE, V7, P373, DOI 10.1098/rsif.2009.0443; Momo F, 2005, BIOPHYS CHEM, V118, P15, DOI 10.1016/j.bpc.2005.06.006; Nielsen C, 2000, BIOPHYS J, V79, P2583, DOI 10.1016/S0006-3495(00)76498-8; Njuguna JT, 2014, BIOORGAN MED CHEM, V22, P4338, DOI 10.1016/j.bmc.2014.05.007; Paiardini A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115859; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Porcelli F, 2013, METHODS MOL BIOL, V1063, P159, DOI 10.1007/978-1-62703-583-5_9; Resto YA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111051; Rusinova R, 2011, J GEN PHYSIOL, V138, P249, DOI 10.1085/jgp.201010529; Sanford RLC-G J., 2015, BIOPHYS J, P108; Santos JS, 2004, MAGN RESON CHEM, V42, P105, DOI 10.1002/mrc.1327; SAWYER DB, 1989, BIOCHEMISTRY-US, V28, P6571, DOI 10.1021/bi00442a007; SAWYER DB, 1989, BIOCHIM BIOPHYS ACTA, V987, P129, DOI 10.1016/0005-2736(89)90464-1; SEEMAN P, 1972, PHARMACOL REV, V24, P583; Sogaard R, 2006, BIOCHEMISTRY-US, V45, P13118, DOI 10.1021/bi060734+; Spangenberg T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062906; Thennarasu S, 2010, BIOPHYS J, V98, P248, DOI 10.1016/j.bpj.2009.09.060; Torrecillas A, 2015, ACS CHEM NEUROSCI, V6, P1741, DOI 10.1021/acschemneuro.5b00168; VISWANADHAN VN, 1989, J CHEM INF COMP SCI, V29, P163, DOI 10.1021/ci00063a006; Walters WP, 2003, NAT REV DRUG DISCOV, V2, P259, DOI 10.1038/nrd1063; Wiese M, 2002, DRUG MEMBRANE INTERA; World Health Organization, WHO WORLD MALARIA RE; Zepik HH, 2008, CRIT REV TOXICOL, V38, P1, DOI 10.1080/10408440701524519	55	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0142401	10.1371/journal.pone.0142401	http://dx.doi.org/10.1371/journal.pone.0142401			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26551613	Green Submitted, Green Published, gold			2022-12-26	WOS:000364422800026
J	Kus, K; Rakus, K; Boutier, M; Tsigkri, T; Gabriel, L; Vanderplasschen, A; Athanasiadis, A				Kus, Krzysztof; Rakus, Krzysztof; Boutier, Maxime; Tsigkri, Theokliti; Gabriel, Luisa; Vanderplasschen, Alain; Athanasiadis, Alekos			The Structure of the Cyprinid herpesvirus 3 ORF112-Z alpha center dot Z-DNA Complex Reveals a Mechanism of Nucleic Acids Recognition Conserved with E3L, a Poxvirus Inhibitor of Interferon Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							Z-DNA-BINDING; Z-ALPHA DOMAIN; CRYSTAL-STRUCTURE; PROTEIN-KINASE; STRESS GRANULES; VIRUS; GENOME; PKR; KOI; STABILIZATION	In vertebrate species, the innate immune system down-regulates protein translation in response to viral infection through the action of the double-stranded RNA (dsRNA)-activated protein kinase (PKR). In some teleost species another protein kinase, Z-DNA-dependent protein kinase (PKZ), plays a similar role but instead of dsRNA binding domains, PKZ has Z alpha domains. These domains recognize the left-handed conformer of dsDNA and dsRNA known as Z-DNA/Z-RNA. Cyprinid herpesvirus 3 infects common and koi carp, which have PKZ, and encodes the ORF112 protein that itself bears a Z alpha domain, a putative competitive inhibitor of PKZ. Here we present the crystal structure of ORF112-Z alpha in complex with an 18-bpCpGDNA repeat, at 1.5 angstrom. We demonstrate that the bound DNA is in the left-handed conformation and identify key interactions for the specificity of ORF112. Localization of ORF112 protein in stress granules induced in Cyprinid herpesvirus 3-infected fish cells suggests a functional behavior similar to that of Z alpha domains of the interferon-regulated, nucleic acid surveillance proteins ADAR1 and DAI.	[Kus, Krzysztof; Tsigkri, Theokliti; Gabriel, Luisa; Athanasiadis, Alekos] Inst Gulbenkian Ciencias, P-2781156 Oeiras, Portugal; [Rakus, Krzysztof; Boutier, Maxime; Vanderplasschen, Alain] Univ Liege, Fundamental & Appl Res Anim & Hlth, Dept Infect & Parasit Dis, Immunol Vaccinol Lab,Fac Vet Med, B-4000 Liege, Belgium	Instituto Gulbenkian de Ciencia; University of Liege	Athanasiadis, A (corresponding author), Inst Gulbenkian Ciencias, Prot Nucle Acids Interact Grp, P-2781156 Oeiras, Portugal.	alekos@igc.gulbenkian.pt	Athanasiadis, Alekos/F-2038-2011	Athanasiadis, Alekos/0000-0003-1526-0000; Kus, Krzysztof/0000-0003-4791-9658; Gabriel, Luisa/0000-0001-9153-219X; Boutier, Maxime/0000-0001-7388-233X	Fundacao para a Ciencia ea Tecnologia [PTDC/BIA-PRO/112962/2009, IF/00641/2013]; European Community [283570]	Fundacao para a Ciencia ea Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); European Community(European Commission)	This work was supported by Fundacao para a Ciencia ea Tecnologia Grants PTDC/BIA-PRO/112962/2009 and IF/00641/2013 (to A. A.) and SFRH/BD/51626/2011 (to K. K.). The research leading to these results received funding from European Community Seventh Framework Program Grant FP7/2007-2013 under BioStruct-X Grant Agreement 283570. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aoki T, 2007, J VIROL, V81, P5058, DOI 10.1128/JVI.00146-07; Athanasiadis A, 2012, SEMIN CELL DEV BIOL, V23, P275, DOI 10.1016/j.semcdb.2011.11.001; Ban C, 1996, BIOPHYS J, V71, P1215, DOI 10.1016/S0006-3495(96)79350-5; Bergan V, 2008, FEBS J, V275, P184, DOI 10.1111/j.1742-4658.2007.06188.x; BRENNAN RG, 1986, J BIOMOL STRUCT DYN, V3, P649, DOI 10.1080/07391102.1986.10508453; Cole JL, 2007, TRENDS BIOCHEM SCI, V32, P57, DOI 10.1016/j.tibs.2006.12.003; Costes B, 2008, J VIROL, V82, P4955, DOI 10.1128/JVI.00211-08; Davison AJ, 2013, J VIROL, V87, P2908, DOI 10.1128/JVI.03206-12; de Rosa M, 2013, NUCLEIC ACIDS RES, V41, P9924, DOI 10.1093/nar/gkt743; Deigendesch N, 2006, NUCLEIC ACIDS RES, V34, P5007, DOI 10.1093/nar/gkl575; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gurtler C, 2013, TRENDS MICROBIOL, V21, P413, DOI 10.1016/j.tim.2013.04.004; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Ha SC, 2004, P NATL ACAD SCI USA, V101, P14367, DOI 10.1073/pnas.0405586101; Haig DM, 1998, IMMUNOLOGY, V93, P335, DOI 10.1046/j.1365-2567.1998.00438.x; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kahmann JD, 2004, P NATL ACAD SCI USA, V101, P2712, DOI 10.1073/pnas.0308612100; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Kim D, 2014, NUCLEIC ACIDS RES, V42, P5937, DOI 10.1093/nar/gku189; Kim YG, 2003, P NATL ACAD SCI USA, V100, P6974, DOI 10.1073/pnas.0431131100; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Le VH, 2013, ANAL BIOCHEM, V434, P233, DOI 10.1016/j.ab.2012.11.030; Michel B, 2010, J GEN VIROL, V91, P452, DOI 10.1099/vir.0.015198-0; Neukirch M, 1999, BULL EUR ASSN FISH P, V19, P221; Ng SK, 2013, NUCLEIC ACIDS RES, V41, P9786, DOI 10.1093/nar/gkt750; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Placido D, 2007, STRUCTURE, V15, P395, DOI 10.1016/j.str.2007.03.001; Rakus K, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-85; Rich A, 2003, NAT REV GENET, V4, P566, DOI 10.1038/nrg1115; Rothenburg S, 2005, P NATL ACAD SCI USA, V102, P1602, DOI 10.1073/pnas.0408714102; Schwartz T, 2001, NAT STRUCT BIOL, V8, P761, DOI 10.1038/nsb0901-761; Schwartz T, 1999, SCIENCE, V284, P1841, DOI 10.1126/science.284.5421.1841; Smith S, 2014, CYTOKINE GROWTH F R, V25, P745, DOI 10.1016/j.cytogfr.2014.07.019; Stelter P, 2015, MOL CELL, V58, P854, DOI 10.1016/j.molcel.2015.03.029; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Tome AR, 2013, J VIROL, V87, P3998, DOI 10.1128/JVI.03116-12; WANG AHJ, 1979, NATURE, V282, P680, DOI 10.1038/282680a0; White SD, 2012, J VIROL, V86, P5895, DOI 10.1128/JVI.06889-11	43	13	14	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30713	30725		10.1074/jbc.M115.679407	http://dx.doi.org/10.1074/jbc.M115.679407			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26559969	Green Published, hybrid			2022-12-26	WOS:000367199000005
J	Aboulenein-Djamshidian, F; Krssak, M; Serbecic, N; Rauschka, H; Beutelspacher, S; Kukurova, IJ; Valkovic, L; Khan, A; Prayer, D; Kristoferitsch, W				Aboulenein-Djamshidian, Fahmy; Krssak, Martin; Serbecic, Nermin; Rauschka, Helmut; Beutelspacher, Sven; Kukurova, Ivica Just; Valkovic, Ladislav; Khan, Adnan; Prayer, Daniela; Kristoferitsch, Wolfgang			CROP - The Clinico-Radiologico-Ophthalmological Paradox in Multiple Sclerosis: Are Patterns of Retinal and MRI Changes Heterogeneous and Thus Not Predictable?	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; NERVE-FIBER LAYER; BRAIN ATROPHY; HEALTHY EYES; AXONAL-LOSS; THICKNESS; NEURITIS; NO; INSTRUMENTS; DISABILITY	Background To date, no direct scientific evidence has been found linking tissue changes in multiple sclerosis (MS) patients, such as demyelination, axonal destruction or gliosis, with either steady progression and/or stepwise accumulation of focal CNS lesions. Tissue changes such as reduction of the retinal nerve fiber layer (RNFL) and the total macular volume (TMV), or brain-and spinal cord atrophy indicates an irreversible stage of tissue destruction. Whether these changes are found in all MS patients, and if there is a correlation with clinical disease state, remains controversial. The objective of our study was to determine, whether there was any correlation between the RNFL or TMV of patients with MS, and: (1) the lesion load along the visual pathways, (2) the ratios and absolute concentrations of metabolites in the normal-appearing white matter (NAWM), (3) standard brain atrophy indices, (4) disease activity or (5) disease duration. Methods 28 MS patients (RRMS, n = 23; secondary progressive MS (SPMS), n = 5) with moderately-high disease activity or long disease course were included in the study. We utilised: (1) magnetic resonance imaging (MRI) and (2) -spectroscopy (MRS), both operating at 3 Tesla, and (3) high-resolution spectral domain-OCT with locked reference images and eye tracking mode) to undertake the study. Results There was no consistency in the pattern of CNS metabolites, brain atrophy indices and the RNFL/TMV between individuals, which ranged from normal to markedly-reduced levels. Furthermore, there was no strict correlation between CNS metabolites, lesions along the visual pathways, atrophy indices, RNFL, TMV, disease duration or disability. Conclusions Based on the findings of this study, we recommend that the concept of 'clinico-radiologico paradox' in multiple sclerosis be extended to CROP-'clinico-radiologico-ophthalmological paradox'. Furthermore, OCT data of MS patients should be interpreted with caution.	[Aboulenein-Djamshidian, Fahmy; Rauschka, Helmut] SMZ Ost Donauspital, Dept Neurol, A-1220 Vienna, Austria; [Aboulenein-Djamshidian, Fahmy; Rauschka, Helmut; Kristoferitsch, Wolfgang] Karl Landsteiner Inst Neuroimmunol & Neurodegener, A-1220 Vienna, Austria; [Krssak, Martin; Kukurova, Ivica Just; Valkovic, Ladislav] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, High Field MR Ctr, A-1090 Vienna, Austria; [Krssak, Martin] Med Univ Vienna, Div Endocrinol & Metab, Dept Internal Med 3, A-1090 Vienna, Austria; [Serbecic, Nermin] Med Univ Vienna, Dept Ophthalmol, A-1090 Vienna, Austria; [Serbecic, Nermin; Beutelspacher, Sven] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, D-68167 Mannheim, Germany; [Khan, Adnan] Univ Oxford, Div Med Sci, Nuffield Dept Surg Sci, Oxford, England; [Prayer, Daniela] Med Univ Vienna, Div Neuroradiol & Musculoskeletal Radiol, Dept Biomed Imaging & Image Guided Therapy, A-1090 Vienna, Austria	Donauspital; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Ruprecht Karls University Heidelberg; University of Oxford; Medical University of Vienna	Aboulenein-Djamshidian, F (corresponding author), SMZ Ost Donauspital, Dept Neurol, Langobardenstr 122, A-1220 Vienna, Austria.	fahmy.aboulenein@meduniwien.ac.at	Krssak, Martin/AAU-8183-2020; Khan, Adnan/CAH-3285-2022; Valkovič, Ladislav/J-5731-2019	Krssak, Martin/0000-0001-9717-803X; Khan, Adnan/0000-0001-8153-8002; Valkovič, Ladislav/0000-0003-2567-3642	Multiple Sklerose Forschungsgesellschaft Wien; Karl Landsteiner Institute for Neuroimmunological and Neurodegenerative Disorders, Vienna, Austria	Multiple Sklerose Forschungsgesellschaft Wien; Karl Landsteiner Institute for Neuroimmunological and Neurodegenerative Disorders, Vienna, Austria	This study was funded by the Multiple Sklerose Forschungsgesellschaft Wien (www.msges.or.at) and by the Karl Landsteiner Institute for Neuroimmunological and Neurodegenerative Disorders, Vienna, Austria (http://www.karllandsteiner.at/institute/neuroimmunologische_neurodegenerative_erkrankungen.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboul-Enein F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011625; Akisaki T, 2006, DIABETES-METAB RES, V22, P376, DOI 10.1002/dmrr.632; ANDERSSON M, 1994, J NEUROL NEUROSUR PS, V57, P897, DOI 10.1136/jnnp.57.8.897; Balk LJ, 2014, J NEUROL SCI, V344, P88, DOI 10.1016/j.jns.2014.06.031; Balk LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048222; Balk LJ, 2012, INVEST OPHTH VIS SCI, V53, P1251, DOI 10.1167/iovs.11-8209; Barkhof F, 1997, BRAIN, V120, P2059, DOI 10.1093/brain/120.11.2059; Chan JW, 2012, ACTA OPHTHALMOL, V90, P203, DOI 10.1111/j.1755-3768.2011.02145.x; Chataway J, 2008, J NEUROL NEUROSUR PS, V79, P112, DOI 10.1136/jnnp.2007.125906; Collett J, 2011, DISABIL REHABIL, V33, P1822, DOI 10.3109/09638288.2010.549286; Dorr J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018132; Evans WA, 1942, ARCH NEURO PSYCHIATR, V47, P931, DOI 10.1001/archneurpsyc.1942.02290060069004; Fernandez O, 2013, REV NEUROLOGIA, V57, P269, DOI 10.33588/rn.5706.2013276; Fjeldstad Anette Simble, 2012, Expert Opin Med Diagn, V6, P593, DOI 10.1517/17530059.2012.719496; Galetta KM, 2011, NEUROTHERAPEUTICS, V8, P117, DOI 10.1007/s13311-010-0005-1; Gilmore CP, 2010, MULT SCLER J, V16, P756, DOI 10.1177/1352458510366014; Gordon-Lipkin E, 2007, NEUROLOGY, V69, P1603, DOI 10.1212/01.wnl.0000295995.46586.ae; Green AJ, 2010, BRAIN, V133, P1591, DOI 10.1093/brain/awq080; Guedes Marta Esteves, 2011, BMJ Case Rep, V2011, DOI 10.1136/bcr.08.2011.4653; Gupta P, 2013, INVEST OPHTH VIS SCI, V54, P7968, DOI 10.1167/iovs.13-12436; Hutchinson M, 2014, MULT SCLER J, V20, P1302, DOI 10.1177/1352458514545144; Hyland M, 2011, CURR OPIN NEUROL, V24, P255, DOI 10.1097/WCO.0b013e3283460542; Jenkins TM, 2014, MULT SCLER J, V20, P1299, DOI 10.1177/1352458514541510; Jindahra P, 2009, BRAIN, V132, P628, DOI 10.1093/brain/awp001; Kallenbach K, 2011, MULT SCLER, V17, P89, DOI 10.1177/1352458510382017; Korteweg T, 2009, MULT SCLER, V15, P465, DOI 10.1177/1352458508100505; Lange AP, 2013, MULT SCLER J, V19, P1275, DOI 10.1177/1352458512474706; Maes M, 2000, ALCOHOL, V20, P117, DOI 10.1016/S0741-8329(99)00066-X; Abalo-Lojo JM, 2014, J NEURO-OPHTHALMOL, V34, P23, DOI 10.1097/WNO.0000000000000057; Outteryck O, 2009, ARCH NEUROL-CHICAGO, V66, P1373, DOI 10.1001/archneurol.2009.265; Pierro L, 2012, INVEST OPHTH VIS SCI, V53, P5912, DOI 10.1167/iovs.11-8644; Popescu V, 2013, J NEUROL NEUROSUR PS, V84, P1082, DOI 10.1136/jnnp-2012-304094; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Rufa A, 2011, CEREBROVASC DIS, V31, P77, DOI 10.1159/000321339; Serbecic N, 2011, BRIT J OPHTHALMOL, V95, P804, DOI 10.1136/bjo.2010.186221; Serbecic N, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00020; Serbecic N, 2011, ACTA OPHTHALMOL, V89, pE451, DOI 10.1111/j.1755-3768.2011.02134.x; Serbecic N, 2012, ACTA OPHTHALMOL, V90, P540, DOI 10.1111/j.1755-3768.2010.02013.x; Serbecic N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019843; Serbecic N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013877; Siger M, 2008, J NEUROL, V255, P1555, DOI 10.1007/s00415-008-0985-5; Sriram P, 2012, INVEST OPHTH VIS SCI, V53, P1271, DOI 10.1167/iovs.11-8732; Stricker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023024; Tewarie P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034823; Trip SA, 2006, NEUROIMAGE, V31, P286, DOI 10.1016/j.neuroimage.2005.11.051; von Glehn F, 2014, MULT SCLER; Wolf-Schnurrbusch UEK, 2009, INVEST OPHTH VIS SCI, V50, P3432, DOI 10.1167/iovs.08-2970; Young KL, 2013, EUR J NEUROL, V20, P803, DOI 10.1111/ene.12070; Zimmermann H, 2013, MULT SCLER J, V19, P443, DOI 10.1177/1352458512457844; Zipp F, 2009, J NEUROL SCI, V287, pS24, DOI 10.1016/S0022-510X(09)71297-3	50	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142272	10.1371/journal.pone.0142272	http://dx.doi.org/10.1371/journal.pone.0142272			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26565967	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000367628500015
J	Schoner, A; Tyrrell, C; Wu, M; Gelow, JM; Hayes, AA; Lindner, JR; Thornburg, KL; Hasan, W				Schoner, Amanda; Tyrrell, Christina; Wu, Melinda; Gelow, Jill M.; Hayes, Alicia A.; Lindner, Jonathan R.; Thornburg, Kent L.; Hasan, Wohaib			Endocardial Endothelial Dysfunction Progressively Disrupts Initially Anti then Pro-Thrombotic Pathways in Heart Failure Mice	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; LEFT-VENTRICULAR THROMBUS; DILATED CARDIOMYOPATHY; THROMBOEMBOLISM; DAMAGE; CELLS; RISK; OUTPATIENTS; ACTIVATION; BIOMARKERS	Objective An experimental model of endocardial thrombosis has not been developed and endocardial endothelial dysfunction in heart failure (HF) is understudied. We sought to determine whether disruption of the endothelial anti-coagulant activated protein C (APC) pathway in CREBA133 HF mice promotes endocardial thrombosis in the acute decompensated phase of the disease, and whether alterations in von Willebrand factor (vWF) secretion from HF endocardium reduces thrombus formation as HF stabilizes. Approach and results Echocardiography was used to follow HF development and to detect endocardial thrombi in CREBA133 mice. Endocardial thrombi incidence was confirmed with immunohistochemistry and histology. In early and acute decompensated phases of HF, CREBA133 mice had the highest incidence of endocardial thrombi and these mice also had a shorter tail-bleeding index consistent with a pro-thrombotic milieu. Both APC generation, and expression of receptors that promote APC function (thrombomodulin, endothelial protein C receptor, protein S), were suppressed in the endocardium of acute decompensated HF mice. However, in stable compensated HF mice, an attenuation occurred for vWF protein content and secretion from endocardial endothelial cells, vWF-dependent platelet agglutination (by ristocetin), and thrombin generation on the endocardial surface. Conclusions CREBA133 mice develop HF and endocardial endothelial dysfunction. Attenuation of the anti-coagulant APC pathway promotes endocardial thrombosis in early and acute decompensated phases of HF. However, in stable compensated HF mice, disruptions in endothelial vWF expression and extrusion may actually reduce the incidence of endocardial thrombosis.	[Schoner, Amanda; Tyrrell, Christina; Wu, Melinda; Gelow, Jill M.; Hayes, Alicia A.; Lindner, Jonathan R.; Thornburg, Kent L.; Hasan, Wohaib] Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Portland, OR 97201 USA	Oregon Health & Science University	Hasan, W (corresponding author), Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Portland, OR 97201 USA.	hasan@ohsu.edu		Hasan, Wohaib/0000-0001-8362-1117	Knight Cardiovascular Institute; MJ Murdock Charitable Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL094294] Funding Source: NIH RePORTER	Knight Cardiovascular Institute; MJ Murdock Charitable Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	WH received funding from the Knight Cardiovascular Institute. AH received funding from the MJ Murdock Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baghai M, 2014, EUR J CARDIO-THORAC; BRISTOW MR, 1990, CIRCULATION, V82, P12; BRUTSAERT DL, 1988, CIRC RES, V62, P358, DOI 10.1161/01.RES.62.2.358; Cervero J, 2011, STROKE, V42, P2622, DOI 10.1161/STROKEAHA.111.614420; Chong AY, 2007, INT J CARDIOL, V119, P80, DOI 10.1016/j.ijcard.2006.07.085; Chong AY, 2006, AM J CARDIOL, V97, P671, DOI 10.1016/j.amjcard.2005.09.113; Chong AY, 2004, CIRCULATION, V110, P1794, DOI 10.1161/01.CIR.0000143073.60937.50; Cioffi G, 1996, EUR HEART J, V17, P1381; Cugno M, 2004, BRIT J HAEMATOL, V126, P85, DOI 10.1111/j.1365-2141.2004.04977.x; ESMON NL, 1982, J BIOL CHEM, V257, P859; Fentzke RC, 1998, J CLIN INVEST, V101, P2415, DOI 10.1172/JCI2950; Frantz S, 2013, FASEB J, V27, P871, DOI 10.1096/fj.12-214049; Fukuchi M, 2001, J AM COLL CARDIOL, V37, P1436, DOI 10.1016/S0735-1097(01)01125-1; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Gombos T, 2009, THROMB HAEMOSTASIS, V102, P573, DOI 10.1160/TH09-01-0036; GOTTDIENER JS, 1983, AM J CARDIOL, V52, P1281, DOI 10.1016/0002-9149(83)90588-X; Guellich A, 2014, PFLUG ARCH EUR J PHY, V466, P1163, DOI 10.1007/s00424-014-1515-1; Hasan W, 2006, BRAIN RES, V1124, P142, DOI 10.1016/j.brainres.2006.09.054; Hasan W, 2014, AUTON NEUROSCI-BASIC, V181, P13, DOI 10.1016/j.autneu.2013.11.001; Higuchi Y, 2012, AM J PHYSIOL-HEART C, V302, pH2352, DOI 10.1152/ajpheart.01026.2011; Huggins GS, 2007, AM J PHYSIOL-HEART C, V293, pH1877, DOI 10.1152/ajpheart.00516.2007; Jarvis Gavin E, 2004, Methods Mol Biol, V272, P65; Kapur NK, 2007, CIRCULATION, V115, P67, DOI 10.1161/CIRCULATIONAHA.106.640698; Katoh S, 2014, HEART VESSELS, V29, P263, DOI 10.1007/s00380-013-0369-3; KISHIMOTO C, 1992, Heart and Vessels, V7, P76, DOI 10.1007/BF01744452; Kleber ME, 2014, CIRC-HEART FAIL; KOSTER T, 1995, BLOOD, V85, P2756, DOI 10.1182/blood.V85.10.2756.bloodjournal85102756; Lip GYH, 2012, EUR J HEART FAIL, V14, P681, DOI 10.1093/eurjhf/hfs073; Liu Yang, 2012, World J Exp Med, V2, P30, DOI 10.5493/wjem.v2.i2.30; Mazzone M, 2005, PANMINERVA MED, V47, P157; Meyer AL, 2014, JACC-HEART FAIL, V2, P141, DOI 10.1016/j.jchf.2013.10.008; Mollet NR, 2002, CIRCULATION, V106, P2873, DOI 10.1161/01.CIR.0000044389.51236.91; NATTERSON PD, 1995, AM HEART J, V129, P564, DOI 10.1016/0002-8703(95)90286-4; Nightingale T, 2013, J THROMB HAEMOST, V11, P192, DOI 10.1111/jth.12225; Rao LVM, 2014, BLOOD, V124, P1553, DOI 10.1182/blood-2014-05-578328; ROBERTS WC, 1987, AM J CARDIOL, V60, P1340, DOI 10.1016/0002-9149(87)90618-7; Aispuru GR, 2012, EUR J INTERN MED, V23, P545, DOI 10.1016/j.ejim.2012.04.002; Scridon A, 2013, EUROPACE, V15, P1562, DOI 10.1093/europace/eut121; Sharma ND, 2000, CHEST, V117, P314, DOI 10.1378/chest.117.2.314; STRATTON JR, 1987, CIRCULATION, V75, P1004, DOI 10.1161/01.CIR.75.5.1004; Sugi Y, 1996, DEV BIOL, V175, P66, DOI 10.1006/dbio.1996.0096; TEICHHOLZ LE, 1976, AM J CARDIOL, V37, P7, DOI 10.1016/0002-9149(76)90491-4; Watson PA, 2010, AM J PHYSIOL-HEART C, V299, pH2056, DOI 10.1152/ajpheart.00394.2010; Weinsaft JW, 2009, JACC-CARDIOVASC IMAG, V2, P969, DOI 10.1016/j.jcmg.2009.03.017; Wilensky R L, 1995, J Cardiovasc Risk, V2, P91, DOI 10.1097/00043798-199504000-00002; Yagi S, 2010, HYPERTENSION, V55, P918, DOI 10.1161/HYPERTENSIONAHA.109.146076; Yamashita T, 2003, CIRCULATION, V108, P2450, DOI 10.1161/01.CIR.0000102969.09658.F2; YOKOTA Y, 1989, JPN HEART J, V30, P1	48	11	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142940	10.1371/journal.pone.0142940	http://dx.doi.org/10.1371/journal.pone.0142940			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26565707	Green Published, gold, Green Submitted			2022-12-26	WOS:000367628500076
J	Gu, WD; Zhang, XC; Gong, B; Zhang, W; Wang, L				Gu, Weidong; Zhang, Xinchang; Gong, Bin; Zhang, Wei; Wang, Lu			VMCast: A VM-Assisted Stability Enhancing Solution for Tree-Based Overlay Multicast	PLOS ONE			English	Article								Tree-based overlay multicast is an effective group communication method for media streaming applications. However, a group member's departure causes all of its descendants to be disconnected from the multicast tree for some time, which results in poor performance. The above problem is difficult to be addressed because overlay multicast tree is intrinsically instable. In this paper, we proposed a novel stability enhancing solution, VMCast, for tree-based overlay multicast. This solution uses two types of on-demand cloud virtual machines (VMs), i.e., multicast VMs (MVMs) and compensation VMs (CVMs). MVMs are used to disseminate the multicast data, whereas CVMs are used to offer streaming compensation. The used VMs in the same cloud datacenter constitute a VM cluster. Each VM cluster is responsible for a service domain (VMSD), and each group member belongs to a specific VMSD. The data source delivers the multicast data to MVMs through a reliable path, and MVMs further disseminate the data to group members along domain overlay multicast trees. The above approach structurally improves the stability of the overlay multicast tree. We further utilized CVM-based streaming compensation to enhance the stability of the data distribution in the VMSDs. VMCast can be used as an extension to existing tree-based overlay multicast solutions, to provide better services for media streaming applications. We applied VMCast to two application instances (i.e., HMTP and HCcast). The results show that it can obviously enhance the stability of the data distribution.	[Gu, Weidong; Gong, Bin] Shandong Univ, Dept Comp Sci & Technol, Jinan 250100, Peoples R China; [Gu, Weidong; Zhang, Xinchang; Zhang, Wei; Wang, Lu] Shandong Comp Sci Ctr, Natl Supercomp Ctr Jinan, Shandong Prov Key Lab Comp Networks, Jinan, Peoples R China	Shandong University; Qilu University of Technology	Gu, WD (corresponding author), Shandong Univ, Dept Comp Sci & Technol, Jinan 250100, Peoples R China.	guwd@sdas.org; zhangxc@sdas.org			National Natural Science Foundation of China [61272433, 61472230]; International Science & Technology Cooperation Program of China [2012DFR10500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science & Technology Cooperation Program of China	This work was supported by National Natural Science Foundation of China under Grant No. 61272433 (http://www.nsfc.gov.cn), National Natural Science Foundation of China under Grant No. 61472230 (http://www.nsfc.gov.cn), and International Science & Technology Cooperation Program of China, No. 2012DFR10500 (http://www.most.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkubeily M, 2011, COMPUT NETW, V55, P3332, DOI 10.1016/j.comnet.2011.06.002; [Anonymous], 2015, NETWORK SIMULATOR NS, V8, P15; Banerjee S, 2002, ACM SIGCOMM COMP COM, V32, P205, DOI 10.1145/964725.633045; Banerjee S, 2003, IEEE INFOCOM SER, P1521; Bonald T, 2008, P ACM SIGMETRICS 08, P891; Bustamante FE, 2004, WEB CONTENT CACHING AND DISTRIBUTION, P233, DOI 10.1007/1-4020-2258-1_16; Diot C, 2000, DEPLOYMENT ISSUES IP, P78; Feng C, 2009, IEEE INFOCOM SER, P891, DOI 10.1109/INFCOM.2009.5061999; Frey D, 2010, P IEEE 10 INT C PEER, P1; Lao L, 2007, IEEE T PARALL DISTR, V18, P449, DOI 10.1109/TPDS.2007.1008; Lin YY, 2010, IEEE T CIRC SYST VID, V20, P1018, DOI 10.1109/TCSVT.2010.2051280; Magharei N, 2007, IEEE INFOCOM SER, P1415; Ramzan HPN, 2012, SIGNAL PROCESSING IM; Rong B, 2006, C LOCAL COMPUT NETW, P483; Sripanidkulchai K, 2004, ACM SIGCOMM COMP COM, V34, P107, DOI 10.1145/1030194.1015480; Tan G, 2007, IEEE T PARALL DISTR, V18, P721, DOI 10.1109/TPDS.2007.1054; Tang Y, 2006, LECT NOTES COMPUT SC, V4261, P175; Tran DA, 2004, IEEE J SEL AREA COMM, V22, P121, DOI 10.1109/JSAC.2003.818803; Wang F, 2011, IEEE SYST J, V5, P440, DOI 10.1109/JSYST.2011.2165189; Zegura EW, 1996, IEEE INFOCOM SER, P594, DOI 10.1109/INFCOM.1996.493353; Zhang BC, 2002, IEEE INFOCOM SER, P1366, DOI 10.1109/INFCOM.2002.1019387; Zhang XC, 2009, COMPUT COMMUN, V32, P1095, DOI 10.1016/j.comcom.2008.12.041	22	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142888	10.1371/journal.pone.0142888	http://dx.doi.org/10.1371/journal.pone.0142888			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562152	gold, Green Published			2022-12-26	WOS:000364480900078
J	Bujakowska, KM; White, J; Place, E; Consugar, M; Comander, J				Bujakowska, Kinga M.; White, Joseph; Place, Emily; Consugar, Mark; Comander, Jason			Efficient In Silico Identification of a Common Insertion in the MAK Gene which Causes Retinitis Pigmentosa	PLOS ONE			English	Article							GENERATION; ELEMENTS; MUTATIONS; IDENTIFY	Background Next generation sequencing (NGS) offers a rapid and comprehensive method of screening for mutations associated with retinitis pigmentosa and related disorders. However, certain sequence alterations such as large insertions or deletions may remain undetected using standard NGS pipelines. One such mutation is a recently-identified Alu insertion into the Male Germ Cell-Associated Kinase (MAK) gene, which is missed by standard NGS-based variant callers. Here, we developed an in silico method of searching NGS raw sequence reads to detect this mutation, without the need to recalculate sequence alignments or to screen every sample by PCR. Methods The Linux program grep was used to search for a 23 bp "probe" sequence containing the known junction sequence of the insert. A corresponding search was performed with the wildtype sequence. The matching reads were counted and further compared to the known sequences of the full wildtype and mutant genomic loci. (See https://github.com/MEEIBioinformaticsCenter/grepsearch.) Results In a test sample set consisting of eleven previously published homozygous mutants, detection of the MAK-Alu insertion was validated with 100% sensitivity and specificity. As a discovery cohort, raw NGS reads from 1,847 samples (including custom and whole exome selective capture) were searched in similar to 1 hour on a local computer cluster, yielding an additional five samples with MAK-Alu insertions and solving two previously unsolved pedigrees. Of these, one patient was homozygous for the insertion, one compound heterozygous with a missense change on the other allele (c. 46G>A; p. Gly16Arg), and three were heterozygous carriers. Conclusions Using the MAK-Alu grep program proved to be a rapid and effective method of finding a known, disease-causing Alu insertion in a large cohort of patients with NGS data. This simple approach avoids wet-lab assays or computationally expensive algorithms, and could also be used for other known disease-causing insertions and deletions.	[Bujakowska, Kinga M.; White, Joseph; Place, Emily; Consugar, Mark; Comander, Jason] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Ocular Genom Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Comander, J (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Ocular Genom Inst, Boston, MA 02115 USA.	Jason_comander@meei.harvard.edu	Bujakowska, Kinga Maria/AGL-1293-2022	Bujakowska, Kinga/0000-0001-6809-9818; Comander, Jason/0000-0002-4257-7145	Fleming Family Foundation; NEI [K12 EY016335]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [K12EY016335] Funding Source: NIH RePORTER	Fleming Family Foundation; NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	KMB was supported by a fellowship with the Fleming Family Foundation. JC was supported by NEI K12 EY016335 and a Career Development Award from Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Audo I, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-8; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Berger W, 2010, PROG RETIN EYE RES, V29, P335, DOI 10.1016/j.preteyeres.2010.03.004; Braun TA, 2013, HUM MOL GENET, V22, P5136, DOI 10.1093/hmg/ddt367; Bujakowska KM, 2014, INVEST OPHTH VIS SCI, V55, P8488, DOI 10.1167/iovs.14-15169; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688]; Consugar MB, 2015, GENET MED, V17, P253, DOI 10.1038/gim.2014.172; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Erwin JA, 2014, NAT REV NEUROSCI, V15, P497, DOI 10.1038/nrn3730; Fields RR, 2002, AM J HUM GENET, V71, P607, DOI 10.1086/342098; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Jiang Y, 2012, BIOINFORMATICS, V28, P2576, DOI 10.1093/bioinformatics/bts484; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Li ST, 2013, GENOME RES, V23, P195, DOI 10.1101/gr.132480.111; Neidhardt J, 2007, HUM MUTAT, V28, P797, DOI 10.1002/humu.20521; Neveling K, 2013, HUM MUTAT, V34, P1721, DOI 10.1002/humu.22450; Neveling K, 2012, HUM MUTAT, V33, P963, DOI 10.1002/humu.22045; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nord AS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-184; Ozgul RK, 2011, AM J HUM GENET, V89, P253, DOI 10.1016/j.ajhg.2011.07.005; Price AL, 2004, GENOME RES, V14, P2245, DOI 10.1101/gr.2693004; Ratan A, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0483-6; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Tucker BA, 2011, P NATL ACAD SCI USA, V108, pE569, DOI 10.1073/pnas.1108918108; Venturini G, 2015, GENET MED, V17, P285, DOI 10.1038/gim.2014.132; Webb TR, 2012, HUM MOL GENET, V21, P3647, DOI 10.1093/hmg/dds194; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394	30	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142614	10.1371/journal.pone.0142614	http://dx.doi.org/10.1371/journal.pone.0142614			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558903	gold, Green Published, Green Submitted			2022-12-26	WOS:000364433100101
J	Cui, HB; Zhai, JJ; Ma, C				Cui, Haibo; Zhai, Jingjing; Ma, Chuang			miRLocator: Machine Learning-Based Prediction of Mature MicroRNAs within Plant Pre-miRNA Sequences	PLOS ONE			English	Article							IDENTIFICATION	MicroRNAs (miRNAs) are a class of short, non-coding RNA that play regulatory roles in a wide variety of biological processes, such as plant growth and abiotic stress responses. Although several computational tools have been developed to identify primary miRNAs and precursor miRNAs (pre-miRNAs), very few provide the functionality of locating mature miRNAs within plant pre-miRNAs. This manuscript introduces a novel algorithm for predicting miRNAs named miRLocator, which isbased on machine learning techniques and sequence and structural features extracted from miRNA: miRNA* duplexes. To address the class imbalance problem (few real miRNAs and a large number of pseudo miRNAs), the prediction models in miRLocator were optimized by considering critical (and often ignored) factors that can markedly affect the prediction accuracy of mature miRNAs, including the machine learning algorithm and the ratio between training positive and negative samples. Ten-fold cross-validation on 5854 experimentally validated miRNAs from 19 plant species showed that miRLocator performed better than the state-of-art miRNA predictor miRdup in locating mature miRNAs within plant pre-miRNAs. miRLocator will aid researchers interested in discovering miRNAs from model and non-model plant species.	[Cui, Haibo] Hubei Univ, Sch Comp Sci & Informat Engn, Wuhan 430070, Peoples R China; [Zhai, Jingjing; Ma, Chuang] Northwest A&F Univ, Ctr Bioinformat, Coll Life Sci, Yangling 712100, Peoples R China; [Ma, Chuang] Northwest A&F Univ, Biomass Energy Ctr Arid & Semiarid Lands, Yangling 712100, Shaanxi, Peoples R China	Hubei University; Northwest A&F University - China; Northwest A&F University - China	Cui, HB (corresponding author), Hubei Univ, Sch Comp Sci & Informat Engn, Wuhan 430070, Peoples R China.	child@hubu.edu.cn; cma@nwafu.edu.cn		Zhai, Jingjing/0000-0002-1535-3103	Fund of Northwest AF University [Z111021403]; National Natural Science Foundation of China [31570371]	Fund of Northwest AF University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Fund of Northwest A&F University (Z111021403) and the National Natural Science Foundation of China (31570371). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmer Jens, 2012, Frontiers in Genetics, V3, P209, DOI 10.3389/fgene.2012.00209; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Calle M Luz, 2011, Brief Bioinform, V12, P86, DOI 10.1093/bib/bbq011; Gkirtzou K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011843; He CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051673; Jensen LJ, 2011, BIOINFORMATICS, V27, P3331, DOI 10.1093/bioinformatics/btr585; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Karathanasis N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126151; Leclercq M, 2013, NUCLEIC ACIDS RES, V41, P7200, DOI 10.1093/nar/gkt466; Leung YY, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt426; Li F, 2012, P NATL ACAD SCI USA, V109, P1790, DOI 10.1073/pnas.1118282109; Luo Y, 2013, DEV BIOL, V380, P133, DOI 10.1016/j.ydbio.2013.05.009; Meng J, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0423-x; Nam JW, 2005, NUCLEIC ACIDS RES, V33, P3570, DOI 10.1093/nar/gki668; Rogers K, 2013, PLANT CELL, V25, P2383, DOI 10.1105/tpc.113.113159; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Tempel S, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks146; Wang XW, 2005, BIOINFORMATICS, V21, P3610, DOI 10.1093/bioinformatics/bti562; Wu YG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-107; Xuan P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027422	20	17	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142753	10.1371/journal.pone.0142753	http://dx.doi.org/10.1371/journal.pone.0142753			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558614	Green Published, gold, Green Submitted			2022-12-26	WOS:000364433100119
J	Hansen, TA; Fridholm, H; Froslev, TG; Kjartansdottir, KR; Willerslev, E; Nielsen, LP; Hansen, AJ				Hansen, Thomas Arn; Fridholm, Helena; Froslev, Tobias Guldberg; Kjartansdottir, Kristin Ros; Willerslev, Eske; Nielsen, Lars Peter; Hansen, Anders Johannes			New Type of Papillomavirus and Novel Circular Single Stranded DNA Virus Discovered in Urban Rattus norvegicus Using Circular DNA Enrichment and Metagenomics	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PHYLOGENETIC ANALYSIS; HIGH-THROUGHPUT; IDENTIFICATION; CLASSIFICATION; ACCURACY; RATS	Rattus norvegicus (R. norvegicus) are ubiquitous and their presence has several effects on the human populations in our urban areas on a global scale. Both historically and presently, this close interaction has facilitated the dissemination of many pathogens to humans, making screening for potentially zoonotic and emerging viruses in rats highly relevant. We have investigated faecal samples from R. norvegicus collected from urban areas using a protocol based on metagenomic enrichment of circular DNA genomes and subsequent sequencing. We found a new type of papillomavirus, with a L1 region 82% identical to that of the known R. norvegicus Papillomavirus 2. Additionally, we found 20 different circular replication associated protein (Rep)-encoding single stranded DNA (CRESS-DNA) virus-like genomes, one of which has homology to the replication-associated gene of Beak and feather disease virus. Papillomaviruses are a group of viruses known for their carcinogenic potential, and although they are known to infect several different vertebrates, they are mainly studied and characterised in humans. CRESS-DNA viruses are found in many different environments and tissue types. Both papillomaviruses and CRESS-DNA viruses are known to have pathogenic potential and screening for novel and known viruses in R. norvegicus could help identify viruses with pathogenic potential.	[Hansen, Thomas Arn; Fridholm, Helena; Froslev, Tobias Guldberg; Kjartansdottir, Kristin Ros; Willerslev, Eske; Hansen, Anders Johannes] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, DK-1350 Copenhagen, Denmark; [Nielsen, Lars Peter] Statens Serum Inst, Dept Autoimmunol & Biomarkers, DK-2300 Copenhagen S, Denmark	University of Copenhagen; Statens Serum Institut	Hansen, AJ (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, DK-1350 Copenhagen, Denmark.	ajhansen@snm.ku.dk	Willerslev, Eske/A-9619-2011; Willerslev, Eske/AAA-5686-2019; Hansen, Anders Johannes/A-5608-2013; Froslev, Tobias Guldberg/D-4940-2017	Willerslev, Eske/0000-0002-7081-6748; Hansen, Anders Johannes/0000-0002-1890-2702; Froslev, Tobias Guldberg/0000-0002-3530-013X	Innovation Fund Denmark (The GenomeDenmark platform) [019-2011-2]; VILLUM foundation (Biowide) [VKR-023343]	Innovation Fund Denmark (The GenomeDenmark platform); VILLUM foundation (Biowide)	This work was supported by the Innovation Fund Denmark (The GenomeDenmark platform, grant no. 019-2011-2) and a grant from VILLUM foundation (Biowide, VKR-023343).	Boisvert S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r122; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chandriani S, 2013, P NATL ACAD SCI USA, V110, pE1407, DOI 10.1073/pnas.1219217110; Cheung AK, 2014, AM SOC MICROBIOLOGY, V2, DOI [10.1128/genomeA.00347-14, DOI 10.1128/GENOMEA.00347-14]; Cheung AK, 2015, ARCH VIROL, V160, P353, DOI 10.1007/s00705-014-2234-9; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; de Villiers EM, 2013, VIROLOGY, V445, P2, DOI 10.1016/j.virol.2013.04.023; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eriksson A, 1988, Virus Genes, V1, P123, DOI 10.1007/BF00555932; Firth C, 2014, MBIO, V5, DOI 10.1128/mBio.01933-14; Grard G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002924; Himsworth CG, 2013, VECTOR-BORNE ZOONOT, V13, P349, DOI 10.1089/vbz.2012.1195; Jorgensen TS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087924; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lindgreen Stinus, 2012, BMC Res Notes, V5, P337, DOI 10.1186/1756-0500-5-337; Muhire BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108277; ORTH G, 1977, J VIROL, V24, P108, DOI 10.1128/JVI.24.1.108-120.1977; PATEL KR, 1987, J GEN VIROL, V68, P2117, DOI 10.1099/0022-1317-68-8-2117; Rector A, 2013, VIROLOGY, V445, P213, DOI 10.1016/j.virol.2013.05.007; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rombel IT, 2002, GENE, V282, P33, DOI 10.1016/S0378-1119(01)00819-8; Rosario K, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00696; Rosario K, 2012, J GEN VIROL, V93, P2668, DOI 10.1099/vir.0.045948-0; Rosario K, 2012, ARCH VIROL, V157, P1851, DOI 10.1007/s00705-012-1391-y; RUDOLPH RL, 1981, J COMP PATHOL, V91, P123, DOI 10.1016/0021-9975(81)90052-9; Sachsenroder J, 2014, J GEN VIROL, V95, P2734, DOI 10.1099/vir.0.070029-0; Schafer K, 2011, J GEN VIROL, V92, P383, DOI 10.1099/vir.0.023515-0; Schulz E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047164; Schulz E, 2009, J GEN VIROL, V90, P2609, DOI 10.1099/vir.0.012583-0; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Vinzon SE, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003924; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Zhu W, 2012, ARCH VIROL, V157, P85, DOI 10.1007/s00705-011-1140-7; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	35	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141952	10.1371/journal.pone.0141952	http://dx.doi.org/10.1371/journal.pone.0141952			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559957	Green Submitted, gold, Green Published			2022-12-26	WOS:000364433100048
J	Athreya, V; Srivathsa, A; Puri, M; Karanth, KK; Kumar, NS; Karanth, KU				Athreya, Vidya; Srivathsa, Arjun; Puri, Mahi; Karanth, Krithi K.; Kumar, N. Samba; Karanth, K. Ullas			Spotted in the News: Using Media Reports to Examine Leopard Distribution, Depredation, and Management Practices outside Protected Areas in Southern India	PLOS ONE			English	Article							HUMAN-CARNIVORE CONFLICT; PANTHERA-PARDUS; NATIONAL-PARK; OCCUPANCY ESTIMATION; SPECIES OCCURRENCE; MULTIPLE STATES; WESTERN-GHATS; PATTERNS; CONSERVATION; LANDSCAPE	There is increasing evidence of large carnivore presence outside protected areas, globally. Although this spells conservation success through population recoveries, it makes carnivore persistence in human-use landscapes tenuous. The widespread distribution of leopards in certain regions of India typifies this problem. We obtained information on leopard- human interactions at a regional scale in Karnataka State, India, based on systematic surveys of local media reports. We applied an innovative occupancy modelling approach to map their distribution patterns and identify hotspots of livestock/human depredation. We also evaluated management responses like removals of 'problem' leopards through capture and translocations. Leopards occupied around 84,000 km(2) or 47% of the State's geographic area, outside designated national parks and wildlife sanctuaries. Their presence was facilitated by extent of vegetative cover-including irrigated croplands, rocky escarpments, and prey base in the form of feral and free-ranging dogs. Higher probabilities of livestock/human attacks by leopards were associated with similar ecological features as well as with capture/removals of leopards. Of the 56 cases of leopard removals reported, 91% did not involve human attacks, but followed livestock predation or only leopard sightings. The lack of knowledge on leopard ecology in human-use areas has resulted in unscientific interventions, which could aggravate the problem rather than mitigating it. Our results establish the presence of resident, breeding leopards in human-use areas. We therefore propose a shift in management focus, from current reactive practices like removal and translocation of leopards, to proactive measures that ensure safety of human lives and livelihoods.	[Athreya, Vidya; Srivathsa, Arjun; Puri, Mahi; Kumar, N. Samba] India Program, Wildlife Conservat Soc, Bengaluru, Karnataka, India; [Srivathsa, Arjun; Puri, Mahi; Karanth, Krithi K.; Kumar, N. Samba; Karanth, K. Ullas] Ctr Wildlife Studies, Bengaluru, Karnataka, India; [Karanth, Krithi K.; Karanth, K. Ullas] Global Conservat Program, Wildlife Conservat Soc, Bronx, NY USA; [Karanth, Krithi K.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA	Wildlife Conservation Society; Duke University	Athreya, V (corresponding author), India Program, Wildlife Conservat Soc, Bengaluru, Karnataka, India.	vidye.athreya@gmail.com	Kumar, Samba/ADR-7829-2022	Kumar, Samba/0000-0002-1226-8552; Srivathsa, Arjun/0000-0003-2935-3857				Agarwala M, 2010, BIOL CONSERV, V143, P2945, DOI 10.1016/j.biocon.2010.05.003; [Anonymous], HUNTER AND HUNTED; Athreya V, 2014, ORYX; Athreya V, 2013, PRELIMINARY AS UNPUB; Athreya V, 2014, TROP CONSERV SCI, V7, P75, DOI 10.1177/194008291400700111; Athreya V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057872; Athreya V, 2011, CONSERV BIOL, V25, P133, DOI 10.1111/j.1523-1739.2010.01599.x; Banerjee K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049457; Barua M, 2013, BIOL CONSERV, V157, P309, DOI 10.1016/j.biocon.2012.07.014; Bateman PW, 2012, J ZOOL, V287, P1, DOI 10.1111/j.1469-7998.2011.00887.x; Bradley EH, 2005, CONSERV BIOL, V19, P1498, DOI 10.1111/j.1523-1739.2005.00102.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Butler JRA, 2004, BIOL CONSERV, V115, P369, DOI 10.1016/S0006-3207(03)00152-6; Carter NH, 2012, P NATL ACAD SCI USA, V109, P15360, DOI 10.1073/pnas.1210490109; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Chapron G, 2014, SCIENCE, V343, P1199, DOI 10.1126/science.343.6176.1199-b; Crooks KR, 2011, PHILOS T R SOC B, V366, P2642, DOI 10.1098/rstb.2011.0120; Dalerum F, 2008, BIODIVERS CONSERV, V17, P2939, DOI 10.1007/s10531-008-9406-4; Dar NI, 2009, BIOL CONSERV, V142, P2076, DOI 10.1016/j.biocon.2009.04.003; Das A, 2006, BIOL CONSERV, V133, P16, DOI 10.1016/j.biocon.2006.05.023; De Angelo C, 2013, BIOL CONSERV, V159, P422, DOI 10.1016/j.biocon.2012.12.021; De Angelo C, 2011, DIVERS DISTRIB, V17, P422, DOI 10.1111/j.1472-4642.2011.00746.x; Dickman AJ, 2014, BIOL CONSERV, V178, P19, DOI 10.1016/j.biocon.2014.07.011; Edgaonkar A, 2002, MAMMALIA, V66, P353, DOI 10.1515/mamm.2002.66.3.353; Fonturbel FE, 2011, WILDLIFE BIOL, V17, P217, DOI 10.2981/10-091; Gehrt SD., 2010, URBAN CARNIVORES ECO; Ghosal S, 2015, SOC NATUR RESOUR, V28, P1092, DOI 10.1080/08941920.2015.1014597; Ghosal S, 2013, BIODIVERS CONSERV, V22, P2665, DOI 10.1007/s10531-013-0549-6; Gilroy JJ, 2015, SCIENCE, V347, P381, DOI 10.1126/science.347.6220.382-a; Goswami VR, 2015, CONSERV BIOL, V29, P1100, DOI 10.1111/cobi.12475; Goswami VR, 2014, BIOL CONSERV, V177, P74, DOI 10.1016/j.biocon.2014.06.013; Goswami VR, 2013, PNAS, V110, P385; Gubbi Sanjay, 2014, Cat News, V60, P30; Henschel P., 2008, PANTHERA PARDUS IUCN; Hiby LR, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-46; Hines JE., 2006, PRESENCESOFTWARE EST; Holmern T, 2007, BIOL CONSERV, V135, P518, DOI 10.1016/j.biocon.2006.10.049; Inskip C, 2009, ORYX, V43, P18, DOI 10.1017/S003060530899030X; Jathanna D, 2015, BIOL CONSERV, V187, P212, DOI 10.1016/j.biocon.2015.04.030; Joshi AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044372; KARANTH K U, 1986, Journal of the Bombay Natural History Society, V83, P166; Karanth KU, 2013, P NATL ACAD SCI USA, V110, pE110, DOI 10.1073/pnas.1216623110; Karanth KK, 2013, BIOL CONSERV, V166, P175, DOI 10.1016/j.biocon.2013.06.027; Karanth KK, 2009, J APPL ECOL, V46, P1189, DOI 10.1111/j.1365-2664.2009.01710.x; Karanth KU, 2004, P NATL ACAD SCI USA, V101, P4854, DOI 10.1073/pnas.0306210101; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Mackenzie DI, 2009, ECOLOGY, V90, P823, DOI 10.1890/08-0141.1; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Madden F, 2014, BIOL CONSERV, V178, P97, DOI 10.1016/j.biocon.2014.07.015; Madhusudan M.D., 2003, P31; Marker LL, 2005, S AFR J WILDL RES, V35, P105; Mech D., 2003, WOLVES BEHAV ECOLOGY; Meena V, 2014, BIOL CONSERV, V174, P120, DOI 10.1016/j.biocon.2014.03.025; Miller B, 1999, ANIM CONSERV, V2, P59, DOI 10.1111/j.1469-1795.1999.tb00049.x; Miller JRB, 2015, ECOL EVOL, V5, P1354, DOI 10.1002/ece3.1440; Ministry of Environment and Forests, 2011, GUID HUM LEOP CONFL; Navya R, 2014, CURR SCI INDIA, V107, P1381; Nichols JD, 2007, ECOLOGY, V88, P1395, DOI 10.1890/06-1474; Odden M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112044; Patil N, 2011, ORYX, V45, P472, DOI 10.1017/S0030605311001591; Puri M, 2015, DIVERS DISTRIB; Raza R. H., 2012, ILLUMINATING BLIND S; Rota CT, 2009, J APPL ECOL, V46, P1173, DOI 10.1111/j.1365-2664.2009.01734.x; Roy PS, 2015, INT J APPL EARTH OBS, V39, P142, DOI 10.1016/j.jag.2015.03.003; Schuette P, 2013, BIOL CONSERV, V158, P301, DOI 10.1016/j.biocon.2012.08.008; Shehzad W, 2015, ORYX, V49, P248, DOI 10.1017/S0030605313001026; Srivathsa A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098803; Stahl P, 2001, BIOL CONSERV, V101, P15, DOI 10.1016/S0006-3207(01)00054-4; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Treves Adrian, 2006, Human Dimensions of Wildlife, V11, P383, DOI 10.1080/10871200600984265; Treves A, 2011, BIOSCIENCE, V61, P451, DOI 10.1525/bio.2011.61.6.7; Lopez-Bao JV, 2015, SCIENCE, V348, P871, DOI 10.1126/science.348.6237.871-b; Vynne C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028939; Weilenmann M, 2010, WILDLIFE RES, V37, P702, DOI 10.1071/WR10013; Weise FJ, 2015, BIODIVERS CONSERV, V24, P1755, DOI 10.1007/s10531-015-0895-7; Weise FJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105042; Wielgus RB, 2013, BIOL CONSERV, V167, P69, DOI 10.1016/j.biocon.2013.07.008; Woodroffe R, 2000, ANIM CONSERV, V3, P165, DOI 10.1111/j.1469-1795.2000.tb00241.x; Woodroffe R., 2005, CONSERV BIOL; Yirga G, 2013, MAMM BIOL, V78, P193, DOI 10.1016/j.mambio.2012.09.001; Yirga G, 2013, AFR J ECOL, V51, P78, DOI 10.1111/aje.12008; Zarco-Gonzalez MM, 2013, BIOL CONSERV, V159, P80, DOI 10.1016/j.biocon.2012.11.007	82	34	36	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142647	10.1371/journal.pone.0142647	http://dx.doi.org/10.1371/journal.pone.0142647			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556229	Green Published, Green Submitted, gold			2022-12-26	WOS:000364430700149
J	Chatrou, MLL; Cleutjens, JP; van der Vusse, GJ; Roijers, RB; Mutsaers, PHA; Schurgers, LJ				Chatrou, Martijn L. L.; Cleutjens, Jack P.; van der Vusse, Ger J.; Roijers, Ruben B.; Mutsaers, Peter H. A.; Schurgers, Leon J.			Intra-Section Analysis of Human Coronary Arteries Reveals a Potential Role for Micro-Calcifications in Macrophage Recruitment in the Early Stage of Atherosclerosis	PLoS One			English	Article							MATRIX GLA-PROTEIN; SMOOTH-MUSCLE-CELL; CALCIUM-PHOSPHATE CRYSTALS; VASCULAR CALCIFICATION; IN-VITRO; LESIONS; INFLAMMATION; INHIBITION; APOPTOSIS; CLASSIFICATION	Background Vascular calcification is associated with poor cardiovascular outcome. Histochemical analysis of calcification and the expression of proteins involved in mineralization are usually based on whole section analysis, thereby often ignoring regional differences in atherosclerotic lesions. At present, limited information is available about factors involved in the initiation and progression of atherosclerosis. Aim of This Study This study investigates the intra-section association of micro-calcifications with markers for atherosclerosis in randomly chosen section areas of human coronary arteries. Moreover, the possible causal relationship between calcifying vascular smooth muscle cells and inflammation was explored in vitro. Technical Approach To gain insights into the pathogenesis of atherosclerosis, we performed analysis of the distribution of micro-calcifications using a 3-MeV proton microbeam. Additionally, we performed systematic analyses of 30 to 40 regions of 12 coronary sections obtained from 6 patients including histology and immuno-histochemistry. Section areas were classified according to CD68 positivity. In vitro experiments using human vascular smooth muscle cells (hVSMCs) were performed to evaluate causal relationships between calcification and inflammation. Results From each section multiple areas were randomly chosen and subsequently analyzed. Depositions of calcium crystals at the micrometer scale were already observed in areas with early pre-atheroma type I lesions. Micro-calcifications were initiated at the elastica interna concomitantly with upregulation of the uncarboxylated form of matrix Gla-protein (ucMGP). Both the amount of calcium crystals and ucMGP staining increased from type I to IV atherosclerotic lesions. Osteochondrogenic markers BMP-2 and osteocalcin were only significantly increased in type IV atheroma lesions, and at this stage correlated with the degree of calcification. From atheroma area type III onwards a considerable number of CD68 positive cells were observed in combination with calcification, suggesting a pro-inflammatory effect of micro-calcifications. In vitro, invasion assays revealed chemoattractant properties of cell-culture medium of calcifying vascular smooth muscle cells towards THP-1 cells, which implies pro-inflammatory effect of calcium deposits. Additionally, calcifying hVSMCs revealed a pro-inflammatory profile as compared to non-calcifying hVSMCs. Conclusion Our data indicate that calcification of VSMCs is one of the earliest events in the genesis of atherosclerosis, which strongly correlates with ucMGP staining. Our findings suggest that loss of calcification inhibitors and/or failure of inhibitory capacity is causative for the early precipitation of calcium, with concomitant increased inflammation followed by osteochondrogenic transdifferentiation of VSMCs.	[Chatrou, Martijn L. L.; Schurgers, Leon J.] Maastricht Univ, Dept Biochem, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands; [Cleutjens, Jack P.] Maastricht Univ, Dept Pathol, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands; [van der Vusse, Ger J.] Maastricht Univ, Dept Physiol, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands; [Roijers, Ruben B.; Mutsaers, Peter H. A.] Eindhoven Univ Technol, Dept Appl Phys, Cyclotron Lab, NL-5600 MB Eindhoven, Netherlands	Maastricht University; Maastricht University; Maastricht University; Eindhoven University of Technology	Schurgers, LJ (corresponding author), Maastricht Univ, Dept Biochem, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands.	l.schurgers@maastrichtuniversity.nl	Schurgers, Leon/AAT-7100-2021; Cleutjens, Jack P.M./F-6242-2012	Cleutjens, Jack P.M./0000-0002-4346-1785; Schurgers, Leon/0000-0001-7867-6957				Ahmad PJ, 2009, AM J PATHOL, V175, P2686, DOI 10.2353/ajpath.2009.080734; Aikawa E, 2007, CIRCULATION, V116, P2841, DOI 10.1161/CIRCULATIONAHA.107.732867; Chatrou MLL, 2012, BLOOD REV, V26, P155, DOI 10.1016/j.blre.2012.03.002; Chung JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029100; Clarke MCH, 2008, CIRC RES, V102, P1529, DOI 10.1161/CIRCRESAHA.108.175976; Clarke MCH, 2010, CIRC RES, V106, P363, DOI 10.1161/CIRCRESAHA.109.208389; Ewence AE, 2008, CIRC RES, V103, pE28, DOI 10.1161/CIRCRESAHA.108.181305; Ikeda K, 2012, BIOCHEM BIOPH RES CO, V425, P39, DOI 10.1016/j.bbrc.2012.07.045; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; Joshi NV, 2014, LANCET, V383, P705, DOI 10.1016/S0140-6736(13)61754-7; Kapustin AN, 2015, CIRC RES, V116, P1312, DOI 10.1161/CIRCRESAHA.116.305012; Kapustin AN, 2011, CIRC RES, V109, pE1, DOI 10.1161/CIRCRESAHA.110.238808; Mous DJW, 1997, NUCL INSTRUM METH B, V130, P31, DOI 10.1016/S0168-583X(97)00186-9; Nadra I, 2005, CIRC RES, V96, P1248, DOI 10.1161/01.RES.0000171451.88616.c2; O'Young J, 2011, J AM CHEM SOC, V133, P18406, DOI 10.1021/ja207628k; Otsuka F, 2014, ARTERIOSCL THROM VAS, V34, P724, DOI 10.1161/ATVBAHA.113.302642; Pazar B, 2011, J IMMUNOL, V186, P2495, DOI 10.4049/jimmunol.1001284; Price PA, 1998, ARTERIOSCL THROM VAS, V18, P1400, DOI 10.1161/01.ATV.18.9.1400; Proudfoot D, 2000, CIRC RES, V87, P1055, DOI 10.1161/01.RES.87.11.1055; Proudfoot D, 1998, ARTERIOSCL THROM VAS, V18, P379, DOI 10.1161/01.ATV.18.3.379; Raggi P, 2004, J AM COLL CARDIOL, V43, P1663, DOI 10.1016/j.jacc.2003.09.068; Raggi P, 2004, ARTERIOSCL THROM VAS, V24, P1272, DOI 10.1161/01.ATV.0000127024.40516.ef; Roijers RB, 2008, ANAL CHEM, V80, P55, DOI 10.1021/ac0706628; Roijers RB, 2011, AM J PATHOL, V178, P2879, DOI 10.1016/j.ajpath.2011.02.004; Rosenhek R, 2000, NEW ENGL J MED, V343, P611, DOI 10.1056/NEJM200008313430903; ROSS R, 1973, SCIENCE, V180, P1332, DOI 10.1126/science.180.4093.1332; Schurgers LJ, 2007, J THROMB HAEMOST, V5, P2503, DOI 10.1111/j.1538-7836.2007.02758.x; Schurgers LJ, 2013, TRENDS MOL MED, V19, P217, DOI 10.1016/j.molmed.2012.12.008; Schurgers LJ, 2005, ARTERIOSCL THROM VAS, V25, P1629, DOI 10.1161/01.ATV.0000173313.46222.43; Shanahan CM, 2011, CIRC RES, V109, P697, DOI 10.1161/CIRCRESAHA.110.234914; SHANAHAN CM, 1994, J CLIN INVEST, V93, P2393, DOI 10.1172/JCI117246; Speer MY, 2009, CIRC RES, V104, P733, DOI 10.1161/CIRCRESAHA.108.183053; Spronk HMH, 2001, BIOCHEM BIOPH RES CO, V289, P485, DOI 10.1006/bbrc.2001.5996; Stary HC, 2000, ARTERIOSCL THROM VAS, V20, P1177, DOI 10.1161/01.ATV.20.5.1177; STARY HC, 1994, ARTERIOSCLER THROMB, V14, P840, DOI 10.1161/01.ATV.14.5.840; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Wallin R, 2000, THROMB HAEMOSTASIS, V84, P1039; Yao YC, 2010, CIRC RES, V107, P485, DOI 10.1161/CIRCRESAHA.110.219071	38	36	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142335	10.1371/journal.pone.0142335	http://dx.doi.org/10.1371/journal.pone.0142335			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555788	Green Published, Green Submitted, gold			2022-12-26	WOS:000364430700086
J	Chen, JHC; Wong, G; Chapman, JR; Lim, WH				Chen, Jenny H. C.; Wong, Germaine; Chapman, Jeremy R.; Lim, Wai H.			Cumulative Doses of T-Cell Depleting Antibody and Cancer Risk after Kidney Transplantation	PLOS ONE			English	Article							ANTITHYMOCYTE GLOBULINS; RENAL-TRANSPLANTATION; ACUTE REJECTION; RECIPIENTS; IMMUNOSUPPRESSION; MECHANISMS; THERAPY	T-cell depleting antibody is associated with an increased risk of cancer after kidney transplantation, but a dose-dependent relationship has not been established. This study aimed to determine the association between cumulative doses of T-cell depleting antibody and the risk of cancer after kidney transplantation. Using data from the Australian and New Zealand Dialysis and Transplant Registry between 1997-2012, we assessed the risk of incident cancer and cumulative doses of T-cell depleting antibody using adjusted Cox regression models. Of the 503 kidney transplant recipients with 2835 person-years of follow-up, 276 (55%), 209 (41%) and 18 (4%) patients received T-cell depleting antibody for induction, rejection or induction and rejection respectively. The overall cancer incidence rate was 1,118 cancers per 100,000 patient-years, with 975, 1093 and 1377 cancers per 100,000 patient-years among those who had received 1-5 doses, 6-10 doses and >10 doses, respectively. There was no association between cumulative doses of T cell depleting antibody and risk of incident cancer (1-5: referent, 6-10: adjusted hazard ratio (HR) 1.19, 95% CI 0.48-2.95, >10: HR 1.42, 95% CI 0.50-4.02, p = 0.801). This lack of association is contradictory to our hypothesis and is likely attributed to the low event rates resulting in insufficient power to detect significant differences.	[Chen, Jenny H. C.] Prince Wales Hosp, Dept Renal Med, Sydney, NSW, Australia; [Wong, Germaine; Chapman, Jeremy R.] Westmead Hosp, Ctr Transplant & Renal Res, Sydney, NSW, Australia; [Wong, Germaine] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Wong, Germaine] Childrens Hosp Westmead, Ctr Kidney Res, Westmead, NSW, Australia; [Lim, Wai H.] Sir Charles Gairdner Hosp, Perth, WA, Australia	University of Sydney; University of Sydney; University of Sydney; University of Western Australia	Lim, WH (corresponding author), Sir Charles Gairdner Hosp, Perth, WA, Australia.	wai.lim@health.wa.gov.au		Wong, Germaine/0000-0001-8422-7269				Bustami RT, 2004, AM J TRANSPLANT, V4, P87, DOI 10.1046/j.1600-6135.2003.00274.x; Cherikh WS, 2003, TRANSPLANTATION, V76, P1289, DOI 10.1097/01.TP.0000100826.58738.2B; Djamali A, 2000, TRANSPLANTATION, V69, P799; Halloran PF, 2004, NEW ENGL J MED, V351, P2715, DOI 10.1056/NEJMra033540; Hardinger KL, 2006, PHARMACOTHERAPY, V26, P1771, DOI 10.1592/phco.26.12.1771; Hung K, 1998, J EXP MED, V188, P2357, DOI 10.1084/jem.188.12.2357; Knutson KL, 2007, CANCER IMMUNOL IMMUN, V56, P271, DOI 10.1007/s00262-006-0194-y; Lim WH, 2014, TRANSPLANTATION, V97, P817, DOI 10.1097/01.TP.0000442773.38510.32; Midtvedt K, 2003, CLIN TRANSPLANT, V17, P69, DOI 10.1034/j.1399-0012.2003.02105.x; Mougiakakos D, 2010, ADV CANCER RES, V107, P57, DOI 10.1016/S0065-230X(10)07003-X; Nankivell BJ, 2010, NEW ENGL J MED, V363, P1451, DOI 10.1056/NEJMra0902927; Opelz G, 2006, TRANSPLANTATION, V81, P1227, DOI 10.1097/01.tp.0000219817.18049.36; Preville X, 2001, TRANSPLANTATION, V71, P460, DOI 10.1097/00007890-200102150-00021; Webster AC, 2006, TRANSPLANTATION, V81, P953, DOI 10.1097/01.tp.0000215178.72344.9d; Webster AC, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003897.pub3; Webster AC, 2010, NEPHROLOGY, V15, P491, DOI 10.1111/j.1440-1797.2010.01297.x; Zand MS, 2006, TRANSPLANTATION, V82, P1387, DOI 10.1097/01.tp.0000244063.05338.27	17	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0139479	10.1371/journal.pone.0139479	http://dx.doi.org/10.1371/journal.pone.0139479			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555791	gold, Green Published, Green Submitted			2022-12-26	WOS:000364430700006
J	Kaneko, T; Mashimo, T				Kaneko, Takehito; Mashimo, Tomoji			Simple Genome Editing of Rodent Intact Embryos by Electroporation	PLoS One			English	Article							ZINC-FINGER NUCLEASES; ENGINEERED ENDONUCLEASES; ZONA PELLUCIDA; KNOCKOUT RATS; MOUSE; GENE; MODELS; MICROINJECTION; GENERATION; PROGRESS	The clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas) system is a powerful tool for genome editing in animals. Recently, new technology has been developed to genetically modify animals without using highly skilled techniques, such as pronuclear microinjection of endonucleases. Technique for animal knockout system by electroporation (TAKE) method is a simple and effective technology that produces knockout rats by introducing endonuclease mRNAs into intact embryos using electroporation. Using TAKE method and CRISPR/Cas system, the present study successfully produced knockout and knock-in mice and rats. The mice and rats derived from embryos electroporated with Cas9 mRNA, gRNA and single-stranded oligodeoxynucleotide (ssODN) comprised the edited targeted gene as a knockout (67% of mice and 88% of rats) or knock-in (both 33%). The TAKE method could be widely used as a powerful tool to produce genetically modified animals by genome editing.	[Kaneko, Takehito] Kyoto Univ, Grad Sch Med, Inst Lab Anim, Kyoto 6068501, Japan; [Mashimo, Tomoji] Osaka Univ, Fac Med, Inst Expt Anim Sci, Suita, Osaka 5650871, Japan	Kyoto University; Osaka University	Kaneko, T (corresponding author), Kyoto Univ, Grad Sch Med, Inst Lab Anim, Kyoto 6068501, Japan.	tkaneko@anim.med.kyoto-u.ac.jp			Japan Society for the Promotion of Science [26290033]; Grants-in-Aid for Scientific Research [26290033] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (No. 26290033).	Aitman TJ, 2008, NAT GENET, V40, P516, DOI 10.1038/ng.147; Bedell MA, 1997, GENE DEV, V11, P11, DOI 10.1101/gad.11.1.11; BRONSON RA, 1970, J REPROD FERTIL, V22, P129, DOI 10.1530/jrf.0.0220129; Carbery ID, 2010, GENETICS, V186, P451, DOI 10.1534/genetics.110.117002; Charreau B, 1996, TRANSGENIC RES, V5, P223, DOI 10.1007/BF01972876; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Grabarek JB, 2002, GENESIS, V32, P269, DOI 10.1002/gene.10076; Jacob HJ, 1999, GENOME RES, V9, P1013, DOI 10.1101/gr.9.11.1013; JAENISCH R, 1988, SCIENCE, V240, P1468, DOI 10.1126/science.3287623; Kaneko T, 2015, METHODS MOL BIOL, V1239, P307, DOI 10.1007/978-1-4939-1862-1_18; Kaneko T, 2014, SCI REP-UK, V4, DOI 10.1038/srep06382; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Li W, 2013, NAT BIOTECHNOL, V31, P684, DOI 10.1038/nbt.2652; Mashimo T, 2012, CELL REP, V2, P685, DOI 10.1016/j.celrep.2012.08.009; MODLINSKI JA, 1970, J EMBRYOL EXP MORPH, V23, P539; MULLINS JJ, 1990, NATURE, V344, P541, DOI 10.1038/344541a0; Nagy A., 2003, MANIPULATING MOUSE E; Nakanishi Satoshi, 2009, Laboratory Animal Research, V25, P75; Peng H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043748; Russell WMS., 1959, MED J AUSTRALIA; Sakuma T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03379; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940	23	73	74	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142755	10.1371/journal.pone.0142755	http://dx.doi.org/10.1371/journal.pone.0142755			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556280	Green Submitted, Green Published, gold			2022-12-26	WOS:000364430700169
J	Matias, MG; Arenas, F; Rubal, M; Pinto, IS				Matias, Miguel G.; Arenas, Francisco; Rubal, Marcos; Pinto, Isabel S.			Macroalgal Composition Determines the Structure of Benthic Assemblages Colonizing Fragmented Habitats	PLOS ONE			English	Article							LANDSCAPE ECOLOGY; EPIFAUNAL ASSEMBLAGES; BIODIVERSITY PATTERNS; ARTIFICIAL SEAGRASS; SPECIES RICHNESS; MARINE HABITATS; MATRIX MATTERS; NEW-ZEALAND; PATCH SIZE; ROCK POOLS	Understanding the consequences of fragmentation of coastal habitats is an important topic of discussion in marine ecology. Research on the effects of fragmentation has revealed complex and context-dependent biotic responses, which prevent generalizations across different habitats or study organisms. The effects of fragmentation in marine environments have been rarely investigated across heterogeneous habitats, since most studies have focused on a single type of habitat or patch. In this study, we assessed the effects of different levels of fragmentation (i.e. decreasing size of patches without overall habitat loss). We measured these effects using assemblages of macro-invertebrates colonizing representative morphological groups of intertidal macroalgae (e.g. encrusting, turf and canopy-forming algae). For this purpose, we constructed artificial assemblages with different combinations of morphological groups and increasing levels of fragmentation by manipulating the amount of bare rock or the spatial arrangement of different species in mixed assemblages. In general, our results showed that 1) fragmentation did not significantly affect the assemblages of macroinvertebrates; 2) at greater levels of fragmentation, there were greater numbers of species in mixed algal assemblages, suggesting that higher habitat complexity promotes species colonization. Our results suggest that predicting the consequences of fragmentation in heterogeneous habitats is dependent on the type and diversity of morphological groups making up those habitats.	[Matias, Miguel G.] Univ London Imperial Coll Sci Technol & Med, Ascot SL5 7PY, Berks, England; [Arenas, Francisco] Univ Porto, Aquat Ecol & Evolut Grp, Ctr Marine & Environm Res CIIMAR, P-4050123 Oporto, Portugal; [Rubal, Marcos; Pinto, Isabel S.] Univ Porto, Coastal Biodivers Grp, Ctr Marine & Environm Res CIIMAR, P-4050123 Oporto, Portugal; [Pinto, Isabel S.] Univ Porto, Dept Biol, Fac Sci, P-4150181 Oporto, Portugal	Imperial College London; Universidade do Porto; Universidade do Porto; Universidade do Porto	Matias, MG (corresponding author), Univ London Imperial Coll Sci Technol & Med, Silwood Pk Campus,Buckhurst Rd, Ascot SL5 7PY, Berks, England.	m.matias@imperial.ac.uk	Matias, Miguel G/D-4294-2019; Rubal, Marcos/B-1859-2017; Pinto, Isabel Sousa/W-1591-2019; Arenas, Francisco/M-7095-2015	Matias, Miguel G/0000-0001-9198-2051; Pinto, Isabel Sousa/0000-0002-9231-0553; Arenas, Francisco/0000-0001-6925-3805; Rubal, Marcos/0000-0002-1106-6035	Fundacao para a Ciencia e Tecnologia (FCT) [SFRH/BD/27506/2006]; Marie Curie Intra-European Fellowship within the 7th European Community Framework Programme (FORECOMM); European Regional Development Fund (ERDF) through the 'Programa Operacional Factores de Competitividade (POFC-COMPETE) within the 'Quadro de Referencia Estrategico Nacional (OREN)); ERDF through the COMPETE Program [PEst-C/MAR/LA0015/2011]; national FCT funds	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Marie Curie Intra-European Fellowship within the 7th European Community Framework Programme (FORECOMM); European Regional Development Fund (ERDF) through the 'Programa Operacional Factores de Competitividade (POFC-COMPETE) within the 'Quadro de Referencia Estrategico Nacional (OREN)); ERDF through the COMPETE Program; national FCT funds(Portuguese Foundation for Science and Technology)	MGM was supported by funds from the Fundacao para a Ciencia e Tecnologia (FCT) SFRH/BD/27506/2006 and a Marie Curie Intra-European Fellowship within the 7th European Community Framework Programme (FORECOMM). FA, MR and ISP were funded by the European Regional Development Fund (ERDF) through the 'Programa Operacional Factores de Competitividade (POFC-COMPETE) within the 'Quadro de Referencia Estrategico Nacional (OREN)) and PEst-C/MAR/LA0015/2011 (by ERDF through the COMPETE Program and national FCT funds.	Airoldi L, 1997, J EXP MAR BIOL ECOL, V215, P269, DOI 10.1016/S0022-0981(96)02770-0; Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Araujo R, 2006, ACTA OECOL, V30, P192, DOI 10.1016/j.actao.2006.04.002; Archambault P, 1996, MAR ECOL PROG SER, V136, P111, DOI 10.3354/meps136111; Arenas F, 2006, ECOLOGY, V87, P2851, DOI 10.1890/0012-9658(2006)87[2851:TIOMAA]2.0.CO;2; Arenas F, 2009, MAR ECOL PROG SER, V381, P99, DOI 10.3354/meps07950; Attrill MJ, 2000, ECOGRAPHY, V23, P114, DOI 10.1034/j.1600-0587.2000.230112.x; Beesley PL, 1998, MOLLUSCA SO SYNTHE B; Bell SS, 2001, BIOL CONSERV, V100, P115, DOI 10.1016/S0006-3207(00)00212-3; BenedettiCecchi L, 1996, MAR ECOL PROG SER, V135, P145, DOI 10.3354/meps135145; Best RJ, 2014, ECOLOGY, V95, P1308, DOI 10.1890/13-1480.1; Bowden DA, 2001, J EXP MAR BIOL ECOL, V259, P133, DOI 10.1016/S0022-0981(01)00236-2; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Brown PJ, 1999, J EXP MAR BIOL ECOL, V235, P45, DOI 10.1016/S0022-0981(98)00186-5; Bulleri F, 2012, OIKOS, V121, P1801, DOI 10.1111/j.1600-0706.2011.19967.x; Cacabelos E, 2010, ESTUAR COAST SHELF S, V89, P43, DOI 10.1016/j.ecss.2010.05.012; Carr MH, 2003, ECOL APPL, V13, pS90; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; Collinge SK, 1996, LANDSCAPE URBAN PLAN, V36, P59, DOI 10.1016/S0169-2046(96)00341-6; Crowe T, 1996, J EXP MAR BIOL ECOL, V206, P83, DOI 10.1016/S0022-0981(96)02615-9; Crowe T. P., 2000, Journal of Aquatic Ecosystem Stress and Recovery, V7, P273, DOI 10.1023/A:1009911928100; Debinski DM, 2006, J BIOGEOGR, V33, P1791, DOI 10.1111/j.1365-2699.2006.01596.x; Downing J.A., 1991, Ecological Studies, P160; Eggleston DB, 1999, J EXP MAR BIOL ECOL, V236, P107, DOI 10.1016/S0022-0981(98)00192-0; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Goodsell PJ, 2008, MAR BIOL, V154, P117, DOI 10.1007/s00227-008-0906-2; Goodsell PJ, 2009, MAR ECOL PROG SER, V384, P23, DOI 10.3354/meps08037; Goodsell PJ, 2002, MAR ECOL PROG SER, V239, P37, DOI 10.3354/meps239037; Gray JS, 1997, BIODIVERS CONSERV, V6, P153, DOI 10.1023/A:1018335901847; GUNNILL FC, 1982, MAR BIOL, V69, P263, DOI 10.1007/BF00397492; HACKER SD, 1990, ECOLOGY, V71, P2269, DOI 10.2307/1938638; Holmquist JG, 1998, OIKOS, V81, P558, DOI 10.2307/3546776; Irving AD, 2007, J EXP MAR BIOL ECOL, V340, P40, DOI 10.1016/j.jembe.2006.08.010; KELAHER B, 2001, J MAR BIOL ASSOC UK, V81, P1; Keough MJ, 1998, ECOL APPL, V8, P141, DOI 10.1890/1051-0761(1998)008[0141:EOPDFT]2.0.CO;2; KOTLIAR NB, 1990, OIKOS, V59, P253, DOI 10.2307/3545542; LEVIN SA, 1974, P NATL ACAD SCI USA, V71, P2744, DOI 10.1073/pnas.71.7.2744; Lindenmayer DB, 2007, TRENDS ECOL EVOL, V22, P127, DOI 10.1016/j.tree.2006.11.006; Macreadie PI, 2009, CONSERV BIOL, V23, P644, DOI 10.1111/j.1523-1739.2008.01130.x; MARTEL A, 1991, J EXP MAR BIOL ECOL, V150, P131, DOI 10.1016/0022-0981(91)90111-9; Matias MG, 2010, AUSTRAL ECOL, V35, P743, DOI 10.1111/j.1442-9993.2009.02081.x; Matias MG, 2007, J ANIM ECOL, V76, P986, DOI 10.1111/j.1365-2656.2007.01277.x; Matias MG, 2013, MAR BIOL, V160, P493, DOI 10.1007/s00227-012-2155-7; Matias MG, 2011, MAR ECOL PROG SER, V437, P135, DOI 10.3354/meps09273; Matias MG, 2010, ECOLOGY, V91, P1908, DOI 10.1890/09-1083.1; Olabarria C, 2002, OECOLOGIA, V132, P159, DOI 10.1007/s00442-002-0940-6; Olabarria C, 2002, J EXP MAR BIOL ECOL, V269, P85, DOI 10.1016/S0022-0981(01)00394-X; Palmer MA, 2000, LANDSCAPE ECOL, V15, P563, DOI 10.1023/A:1008194130695; Parker JD, 2001, MAR ECOL PROG SER, V224, P55, DOI 10.3354/meps224055; Pereira SG, 2006, HYDROBIOLOGIA, V555, P185, DOI 10.1007/s10750-005-1115-3; Petchey OL, 2003, OIKOS, V101, P323, DOI 10.1034/j.1600-0706.2003.11828.x; Pickett S. T. A., 1985, ECOLOGY NATURAL DIST; RAY GC, 1991, BIOSCIENCE, V41, P490, DOI 10.2307/1311807; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; ROBBINS BD, 1994, TRENDS ECOL EVOL, V9, P301, DOI 10.1016/0169-5347(94)90041-8; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; Roberts DA, 2006, BIOL CONSERV, V127, P18, DOI 10.1016/j.biocon.2005.07.010; SANTELICES B, 1990, OCEANOGR MAR BIOL, V28, P177; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Schiel DR, 1999, J EXP MAR BIOL ECOL, V235, P213, DOI 10.1016/S0022-0981(98)00170-1; SCHROEDER RE, 1987, B MAR SCI, V41, P441; Skilleter GA, 2005, MAR BIOL, V147, P353, DOI 10.1007/s00227-005-1580-2; STEELE JH, 1991, ECOL RES, V6, P175, DOI 10.1007/BF02347160; SUCHANEK TH, 1994, AM ZOOL, V34, P100; Tanner JE, 2006, ESTUAR COAST SHELF S, V68, P404, DOI 10.1016/j.ecss.2006.01.029; Thompson RC, 2002, ENVIRON CONSERV, V29, P168, DOI 10.1017/S0376892902000115; Turner MG, 2005, ANNU REV ECOL EVOL S, V36, P319, DOI 10.1146/annurev.ecolsys.36.102003.152614; TURNER MG, 1989, ANNU REV ECOL SYST, V20, P171, DOI 10.1146/annurev.es.20.110189.001131; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Underwood AJ, 2006, J EXP MAR BIOL ECOL, V330, P221, DOI 10.1016/j.jembe.2005.12.029; VIRNSTEIN RW, 1986, MAR ECOL PROG SER, V29, P279, DOI 10.3354/meps029279; Warner RR, 2002, B MAR SCI, V70, P245; Warry FY, 2009, OECOLOGIA, V159, P883, DOI 10.1007/s00442-008-1258-9; WHITTAKER RH, 1977, THEOR POPUL BIOL, V12, P117, DOI 10.1016/0040-5809(77)90039-9; Wiens JA, 2002, FRESHWATER BIOL, V47, P501, DOI 10.1046/j.1365-2427.2002.00887.x; Wilcove D.S., 1986, P237; Williamson JE, 1996, NEW ZEAL J MAR FRESH, V30, P221	79	13	13	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142289	10.1371/journal.pone.0142289	http://dx.doi.org/10.1371/journal.pone.0142289			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554924	Green Published, Green Submitted, gold			2022-12-26	WOS:000364430700078
J	Richter, JP; Goroncy, AK; Ronimus, RS; Sutherland-Smith, AJ				Richter, Jan P.; Goroncy, Alexander K.; Ronimus, Ron S.; Sutherland-Smith, Andrew J.			The Structural and Functional Characterization of Mammalian ADP-dependent Glucokinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADP; AMP; enzyme structure; glucokinase; glucose metabolism; x-ray crystallography; ADP-dependent glucokinase; NMR spectroscopy; glucose-6-phosphate; ribokinase	PYROCOCCUS-FURIOSUS; CRYSTAL-STRUCTURE; BIOCHEMICAL-CHARACTERIZATION; HYPERTHERMOPHILIC ARCHAEON; CONFORMATIONAL-CHANGE; MOLECULAR-GRAPHICS; SUGAR KINASES; RESOLUTION; PROTEINS; HORIKOSHII	The enzyme-catalyzed phosphorylation of glucose to glucose-6-phosphate is a reaction central to the metabolism of all life. ADP-dependent glucokinase (ADPGK) catalyzes glucose-6-phosphate production, utilizing ADP as a phosphoryl donor in contrast to the more well characterized ATP-requiring hexokinases. ADPGK is found in Archaea and metazoa; in Archaea, ADPGK participates in a glycolytic role, but a function in most eukaryotic cell types remains unknown. We have determined structures of the eukaryotic ADPGK revealing a ribokinase-like tertiary fold similar to archaeal orthologues but with significant differences in some secondary structural elements. Both the unliganded and the AMP-bound ADPGK structures are in the open conformation. The structures reveal the presence of a disulfide bond between conserved cysteines that is positioned at the nucleotide-binding loop of eukaryotic ADPGK. The AMP-bound ADPGK structure defines the nucleotide-binding site with one of the disulfide bond cysteines coordinating the AMP with its main chain atoms, a nucleotide-binding motif that appears unique to eukaryotic ADPGKs. Key amino acids at the active site are structurally conserved between mammalian and archaeal ADPGK, and site-directed mutagenesis has confirmed residues essential for enzymatic activity. ADPGK is substrate inhibited by high glucose concentration and shows high specificity for glucose, with no activity for other sugars, as determined by NMR spectroscopy, including 2-deoxyglucose, the glucose analogue used for tumor detection by positron emission tomography.	[Richter, Jan P.; Goroncy, Alexander K.; Sutherland-Smith, Andrew J.] Massey Univ, Inst Fundamental Sci, Palmerston North 4410, New Zealand; [Ronimus, Ron S.] AgResearch Ltd, Palmerston North 4442, New Zealand	Massey University; AgResearch - New Zealand	Ronimus, RS (corresponding author), AgResearch Ltd, Grasslands Res Ctr, Anim Nutr & Hlth, Tennent Dr,Private Bag 11008, Palmerston North 4442, New Zealand.; Sutherland-Smith, AJ (corresponding author), Massey Univ, Inst Fundamental Sci, Tennent Dr, Palmerston North 4442, New Zealand.	ron.ronimus@agresearch.co.nz; A.J.Sutherland-Smith@massey.ac.nz	Sutherland-Smith, Andrew/F-1813-2011	Sutherland-Smith, Andrew/0000-0001-9485-1428; Goroncy, Alexander/0000-0002-9192-174X; Ronimus, Ron/0000-0001-8669-5840	Royal Society of New Zealand Marsden Fund; New Zealand Synchrotron Group; Massey University	Royal Society of New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); New Zealand Synchrotron Group; Massey University	This work was supported by the Royal Society of New Zealand Marsden Fund, New Zealand Synchrotron Group, and Massey University. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Rivas-Pardo JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066687; Currie MA, 2009, J BIOL CHEM, V284, P22664, DOI 10.1074/jbc.M109.012401; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fantini J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00031; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guixe V, 2009, IUBMB LIFE, V61, P753, DOI 10.1002/iub.217; Hulce JJ, 2013, NAT METHODS, V10, P259, DOI [10.1038/NMETH.2368, 10.1038/nmeth.2368]; Ito S, 2003, J MOL BIOL, V331, P871, DOI 10.1016/S0022-2836(03)00792-7; Ito S, 2001, STRUCTURE, V9, P205, DOI 10.1016/S0969-2126(01)00577-9; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaminski MM, 2012, CELL REP, V2, P1300, DOI 10.1016/j.celrep.2012.10.009; KENGEN SWM, 1994, J BIOL CHEM, V269, P17537; Koga S, 2000, J BIOCHEM-TOKYO, V128, P1079, DOI 10.1093/oxfordjournals.jbchem.a022836; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Labes A, 2003, ARCH MICROBIOL, V180, P69, DOI 10.1007/s00203-003-0563-2; Li J, 2012, J STRUCT BIOL, V177, P578, DOI 10.1016/j.jsb.2011.12.010; Matte A, 1998, STRUCT FOLD DES, V6, P413, DOI 10.1016/S0969-2126(98)00043-4; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Merino F, 2011, GENE DUPLICATION, P237; Merino F, 2012, BIOCHIMIE, V94, P516, DOI 10.1016/j.biochi.2011.08.021; Mosca R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-352; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Oriuchi N, 2006, CANCER SCI, V97, P1291, DOI 10.1111/j.1349-7006.2006.00341.x; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Richter S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065267; Richter S, 2012, MOL CELL BIOCHEM, V364, P131, DOI 10.1007/s11010-011-1212-8; Ronimus RS, 2004, BIOCHEM BIOPH RES CO, V315, P652, DOI 10.1016/j.bbrc.2004.01.103; Sigrell JA, 1998, STRUCTURE, V6, P183, DOI 10.1016/S0969-2126(98)00020-3; Tsuge H, 2002, PROTEIN SCI, V11, P2456, DOI 10.1110/ps.0215602; VEECH RL, 1979, J BIOL CHEM, V254, P6538; Verhees CH, 2002, BIOCHEM J, V366, P121, DOI 10.1042/BJ20011597; Zhu L, 2013, SCIENCE, V342, P429, DOI 10.1126/science.1245011	37	17	17	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3694	3704		10.1074/jbc.M115.679902	http://dx.doi.org/10.1074/jbc.M115.679902			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26555263	Green Published, hybrid			2022-12-26	WOS:000371338400002
J	Marty-Roix, R; Vladimer, GI; Pouliot, K; Weng, D; Buglione-Corbett, R; West, K; MacMicking, JD; Chee, JD; Wang, SX; Lu, S; Lien, E				Marty-Roix, Robyn; Vladimer, Gregory I.; Pouliot, Kimberly; Weng, Dan; Buglione-Corbett, Rachel; West, Kim; MacMicking, John D.; Chee, Jonathan D.; Wang, Shixia; Lu, Shan; Lien, Egil			Identification of QS-21 as an Inflammasome-activating Molecular Component of Saponin Adjuvants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOPHOSPHORYL-LIPID-A; PARTICULATE VACCINE ADJUVANTS; QUILLAJA-SAPONARIA MOLINA; HEALTHY ADULT VOLUNTEERS; NALP3 INFLAMMASOME; NLRP3 INFLAMMASOME; DENDRITIC CELLS; T-CELL; ADAPTIVE IMMUNITY; ISCOMATRIX ADJUVANT	Many immunostimulants act as vaccine adjuvants via activation of the innate immune system, although in many cases it is unclear which specific molecules contribute to the stimulatory activity. QS-21 is a defined, highly purified, and soluble saponin adjuvant currently used in licensed and exploratory vaccines, including vaccines against malaria, cancer, and HIV-1. However, little is known about the mechanisms of cellular activation induced by QS-21. We observed QS-21 to elicit caspase-1-dependent IL-1 beta and IL-18 release in antigen-presenting cells such as macrophages and dendritic cells when co-stimulated with the TLR4-agonist adjuvant monophosphoryl lipid A. Furthermore, our data suggest that the ASC-NLRP3 inflammasome is responsible for QS-21-induced IL-1 beta/IL-18 release. At higher concentrations, QS-21 induced macrophage and dendritic cell death in a caspase-1-, ASC-, and NLRP3-independent manner, whereas the presence of cholesterol rescued cell viability. A nanoparticulate adjuvant that contains QS-21 as part of a heterogeneous mixture of saponins also induced IL-1 beta in an NLRP3-dependent manner. Interestingly, despite the role NLRP3 plays for cellular activation in vitro, NLRP3-deficient mice immunized with HIV-1 gp120 and QS-21 showed significantly higher levels of Th1 and Th2 antigen-specific T cell responses and increased IgG1 and IgG2c compared with wild type controls. Thus, we have identified QS-21 as a nonparticulate single molecular saponin that activates the NLRP3 inflammasome, but this signaling pathway may contribute to decreased antigenspecific responses in vivo.	[Marty-Roix, Robyn; Vladimer, Gregory I.; Pouliot, Kimberly; Weng, Dan; Lien, Egil] Univ Massachusetts, Sch Med, Dept Med, Program Innate Immun,Div Infect Dis & Immunol, 364 Plantat St,LRB311, Worcester, MA 01605 USA; [Buglione-Corbett, Rachel; West, Kim; Wang, Shixia; Lu, Shan] Univ Massachusetts, Sch Med, Dept Med, Lab Nucle Acid Vaccines, Worcester, MA 01605 USA; [MacMicking, John D.; Chee, Jonathan D.] Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Microbial Pathogenesis, New Haven, CT 06510 USA; [Lien, Egil] NTNU, Dept Canc & Mol Med, Ctr Mol Inflammat Res, N-7491 Trondheim, Norway	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Yale University; Norwegian University of Science & Technology (NTNU)	Lien, E (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Program Innate Immun,Div Infect Dis & Immunol, 364 Plantat St,LRB311, Worcester, MA 01605 USA.	egil.lien@umassmed.edu	Psoinos, Rachel/AAV-7465-2021; Vladimer, Gregory/X-4547-2018	Psoinos, Rachel/0000-0001-7892-2070; Vladimer, Gregory/0000-0003-4205-7585	National Institutes of Health [5 U19 AI082676, 5 PO1 AI082274, AI095213]; National Institutes of Health through the American Recovery and Reinvestment Act [AI07538, AI117706, AI057588]; Norwegian Cancer Society; Research Council of Norway Center of Excellence [223255/F50]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI095213, P01AI082274, R21AI117706, R01AI057588, R01AI108834, T32AI007538, U19AI082676] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health through the American Recovery and Reinvestment Act(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway Center of Excellence(Research Council of Norway); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health Grants 5 U19 AI082676 and 5 PO1 AI082274; in part by National Institutes of Health Grants AI07538, AI117706, and AI057588 through the American Recovery and Reinvestment Act (to E.L.); National Institutes of Health Grant AI095213 (to G.I.V.); funds from the Norwegian Cancer Society; and Research Council of Norway Center of Excellence Funding Scheme Project 223255/F50. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; BANGHAM AD, 1962, NATURE, V196, P952, DOI 10.1038/196952a0; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Beck Z., BIOCH BIOPHYS ACTA, V1848, P775; Bejon P, 2013, LANCET INFECT DIS, V13, P319, DOI 10.1016/S1473-3099(13)70005-7; Bengtsson KL, 2013, EXPERT REV VACCINES, V12, P821, DOI 10.1586/14760584.2013.814822; Bengtsson KL, 2011, EXPERT REV VACCINES, V10, P401, DOI [10.1586/erv.11.25, 10.1586/ERV.11.25]; Bengtsson KL., 2013, NOVEL IMMUNE POTENTI, P309; BROWN LE, 1995, ARCH VIROL, V140, P635, DOI 10.1007/BF01309955; Buglione-Corbett R, 2014, HUM VACC IMMUNOTHER, V10, P1078, DOI 10.4161/hv.27907; Buglione-Corbett R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074820; CAMPBELL JB, 1992, RES IMMUNOL, V143, P526, DOI 10.1016/0923-2494(92)80064-R; Chea EK, 2012, J AM CHEM SOC, V134, P13448, DOI 10.1021/ja305121q; Chen MK, 2011, INT IMMUNOPHARMACOL, V11, P549, DOI 10.1016/j.intimp.2010.11.025; DALSGAARD K, 1974, ARCH GES VIRUSFORSCH, V44, P243, DOI 10.1007/BF01240612; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Didierlaurent AM, 2014, J IMMUNOL, V193, P1920, DOI 10.4049/jimmunol.1400948; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Duewell P, 2011, J IMMUNOL, V187, P55, DOI 10.4049/jimmunol.1004114; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Elinav E, 2011, IMMUNITY, V34, P665, DOI 10.1016/j.immuni.2011.05.007; Evans TG, 2001, VACCINE, V19, P2080, DOI 10.1016/S0264-410X(00)00415-1; Fernandez-Tejada A, 2014, NAT CHEM, V6, P636, DOI [10.1038/NCHEM.1963, 10.1038/nchem.1963]; Franchi L, 2008, EUR J IMMUNOL, V38, P2085, DOI 10.1002/eji.200838549; Garcon N, 2007, EXPERT REV VACCINES, V6, P723, DOI 10.1586/14760584.6.5.723; Garcon N, 2011, EXPERT REV VACCINES, V10, P471, DOI [10.1586/erv.11.29, 10.1586/ERV.11.29]; Gin DY, 2011, CURR DRUG THER, V6, P207, DOI 10.2174/157488511796391988; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kashala O, 2002, VACCINE, V20, P2263, DOI 10.1016/S0264-410X(02)00115-9; Kennedy JS, 2008, VACCINE, V26, P4420, DOI 10.1016/j.vaccine.2008.05.090; Kensil CR, 2004, FRONT BIOSCI-LANDMRK, V9, P2972, DOI 10.2741/1452; KENSIL CR, 1991, J IMMUNOL, V146, P431; Kensil CR, 1996, CRIT REV THER DRUG, V13, P1; Kim SK, 1999, VACCINE, V18, P597, DOI 10.1016/S0264-410X(99)00316-3; Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755; Krug LM, 2012, CANCER IMMUNOL IMMUN, V61, P9, DOI 10.1007/s00262-011-1083-6; Lambrecht BN, 2009, CURR OPIN IMMUNOL, V21, P23, DOI 10.1016/j.coi.2009.01.004; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Liu D, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00486; Liu G, 2002, VACCINE, V20, P2808, DOI 10.1016/S0264-410X(02)00209-8; Magnusson SE, 2013, VACCINE, V31, P1725, DOI 10.1016/j.vaccine.2013.01.039; Martin M, 2003, INFECT IMMUN, V71, P2498, DOI 10.1128/IAI.71.5.2498-2507.2003; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mckee AS, 2013, P NATL ACAD SCI USA, V110, pE1122, DOI 10.1073/pnas.1300392110; Mckee AS, 2009, J IMMUNOL, V183, P4403, DOI 10.4049/jimmunol.0900164; McKenzie A., 2010, HUM VACCINES, V6; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Montminy SW, 2006, NAT IMMUNOL, V7, P1066, DOI 10.1038/ni1386; MOREIN B, 1984, NATURE, V308, P457, DOI 10.1038/308457a0; Morelli AB, 2012, J MED MICROBIOL, V61, P935, DOI 10.1099/jmm.0.040857-0; Neumann S, 2014, IMMUNOL CELL BIOL, V92, P535, DOI 10.1038/icb.2014.21; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Oleszycka E, 2014, CURR OPIN IMMUNOL, V28, P1, DOI 10.1016/j.coi.2013.12.007; Oliveira-Freitas E, 2006, VACCINE, V24, P3909, DOI 10.1016/j.vaccine.2006.02.034; Olotu A, 2013, NEW ENGL J MED, V368, P1111, DOI 10.1056/NEJMoa1207564; Pouliot K, 2014, VACCINE, V32, P5049, DOI 10.1016/j.vaccine.2014.07.010; Ragupathi G, 2011, EXPERT REV VACCINES, V10, P463, DOI [10.1586/erv.11.18, 10.1586/ERV.11.18]; Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106; Shenoy AR, 2012, SCIENCE, V336, P481, DOI 10.1126/science.1217141; SOLTYSIK S, 1995, VACCINE, V13, P1403, DOI 10.1016/0264-410X(95)00077-E; Spreafico R, 2010, EUR J IMMUNOL, V40, P638, DOI 10.1002/eji.200940039; Sun HX, 2009, VACCINE, V27, P4388, DOI 10.1016/j.vaccine.2009.05.032; Tinto H, 2015, LANCET, V386, P31, DOI 10.1016/S0140-6736(15)60721-8; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Vandepapeliere P, 2008, VACCINE, V26, P1375, DOI 10.1016/j.vaccine.2007.12.038; Vladimer GI, 2012, IMMUNITY, V37, P96, DOI 10.1016/j.immuni.2012.07.006; Weeratna RD, 2005, VACCINE, V23, P5263, DOI 10.1016/j.vaccine.2005.06.024; Weng D, 2014, P NATL ACAD SCI USA, V111, P7391, DOI 10.1073/pnas.1403477111; Wilson NS, 2014, J IMMUNOL, V192, P3259, DOI 10.4049/jimmunol.1302011	75	102	110	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1123	1136		10.1074/jbc.M115.683011	http://dx.doi.org/10.1074/jbc.M115.683011			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26555265	Green Published, hybrid			2022-12-26	WOS:000368068300009
J	Sampey, GC; Saifuddin, M; Schwab, A; Barclay, R; Punya, S; Chung, MC; Hakami, RM; Zadeh, MA; Lepene, B; Klase, ZA; El-Hage, N; Young, M; Iordanskiy, S; Kashanchi, F				Sampey, Gavin C.; Saifuddin, Mohammed; Schwab, Angela; Barclay, Robert; Punya, Shreya; Chung, Myung-Chul; Hakami, Ramin M.; Zadeh, Mohammad Asad; Lepene, Benjamin; Klase, Zachary A.; El-Hage, Nazira; Young, Mary; Iordanskiy, Sergey; Kashanchi, Fatah			Exosomes from HIV-1-infected Cells Stimulate Production of Pro-inflammatory Cytokines through Trans-activating Response (TAR) RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; TUMOR-NECROSIS-FACTOR; IMMUNODEFICIENCY-VIRUS TYPE-1; SMALL NONCODING RNAS; TOLL-LIKE-RECEPTORS; NF-KAPPA-B; MULTIPLE-SCLEROSIS; MONONUCLEAR-CELLS; PROTEIN-KINASE; INFECTED-CELLS	HIV-1 infection results in a chronic illness because longterm highly active antiretroviral therapy can lower viral titers to an undetectable level. However, discontinuation of therapy rapidly increases virus burden. Moreover, patients under highly active antiretroviral therapy frequently develop various metabolic disorders, neurocognitive abnormalities, and cardiovascular diseases. We have previously shown that exosomes containing trans-activating response (TAR) element RNA enhance susceptibility of undifferentiated naive cells to HIV-1 infection. This study indicates that exosomes from HIV-1-infected primary cells are highly abundant with TAR RNA as detected by RT-real time PCR. Interestingly, up to a million copies of TAR RNA/ mu l were also detected in the serum from HIV-1-infected humanized mice suggesting that TAR RNA may be stable in vivo. Incubation of exosomes from HIV-1-infected cells with primary macrophages resulted in a dramatic increase of proinflammatory cytokines, IL-6 and TNF-beta, indicating that exosomes containing TAR RNA could play a direct role in control of cytokine gene expression. The intact TAR molecule was able to bind to PKR and TLR3 effectively, whereas the 5' and 3' stems (TAR microRNAs) bound best to TLR7 and -8 and none to PKR. Binding of TAR to PKR did not result in its phosphorylation, and therefore, TAR may be a dominant negative decoy molecule in cells. The TLR binding through either TAR RNA or TAR microRNA potentially can activate the NF-kB pathway and regulate cytokine expression. Collectively, these results imply that exosomes containing TAR RNA could directly affect the proinflammatory cytokine gene expression and may explain a possible mechanism of inflammation observed in HIV-1-infected patients under cART.	[Sampey, Gavin C.; Saifuddin, Mohammed; Schwab, Angela; Barclay, Robert; Punya, Shreya; Chung, Myung-Chul; Hakami, Ramin M.; Zadeh, Mohammad Asad; Iordanskiy, Sergey; Kashanchi, Fatah] George Mason Univ, Mol Virol Lab, Manassas, VA 20110 USA; [Lepene, Benjamin] Ceres Nanosci Inc, Manassas, VA 20110 USA; [Klase, Zachary A.] Univ Sci, Dept Biol Sci, Philadelphia, PA 19104 USA; [El-Hage, Nazira] Herbert Wertheim Coll Med, Dept Immunol, Miami, FL 33199 USA; [Young, Mary] Georgetown Univ, Dept Med, Womens Intra Agcy HIV Study, Washington, DC 20007 USA	George Mason University; Georgetown University	Iordanskiy, S (corresponding author), George Mason Univ, Natl Ctr Biodefense & Infect Dis, Discovery Hall,Room 254W,10900 Univ Blvd,MS 1H8, Manassas, VA 20110 USA.	siordans@gmu.edu; fkashanc@gmu.edu		Hakami, Ramin/0000-0001-7122-0164	National Institutes of Health from NIAID [U01-AI-34994]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI074410, U01AI034994, R21AI113140, R21AI078859, R01AI043894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS099029, F31NS086453] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the members of the Kashanchi laboratory, including Kinza Noor and Yao Akpamagbo, for experiments and assistance with the manuscript. We thank Dr. Aarthi Narayanan for MS experiments. We thank Dr. Jay Rappaport (Temple University) for the suggestion of experiments related to PKR and the RNA sizes. We also grateful to the National Institutes of Health AIDS Research and Reference Reagent Program for the contribution of important reagents. The following reagents were obtained through the AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, National Institutes of Health: U1, J1.1 and ACH-2 cells from Dr. Thomas Folks; HIV-189.6 dual-tropic viral strain from Dr. Ronald Collman; and anti-HIV-1 p24 mouse monoclonal antibody from Dr. Michael Malim. The antiretrovirals lamivudine/emtricitabine, tenofovir, indinavir, raltegravir, and maraviroc were also from AIDS Research and Reference Reagent Program. Four clinical samples utilized in this study were provided by the Washington, D.C., Metropolitan Site of the Women's Interagency HIV Study Collaborative Study Group (Principal Investigator, Mary Young). The Women's Interagency HIV Study is supported by National Institutes of Health Grant U01-AI-34994, from NIAID.	Althaus CF, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-27; Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Amaya M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086745; Banks WA, 1997, LIFE SCI, V61, pPL119, DOI 10.1016/S0024-3205(97)00597-3; Barth S, 2011, BBA-GENE REGUL MECH, V1809, P631, DOI 10.1016/j.bbagrm.2011.05.010; Bennasser Y, 2005, IMMUNITY, V22, P607, DOI 10.1016/j.immuni.2005.03.010; Bennasser Yamina, 2004, Retrovirology, V1, P43, DOI 10.1186/1742-4690-1-43; Bernard MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106006; Bohan Cindy A., 1992, Gene Expression, V2, P391; BREEN EC, 1990, J IMMUNOL, V144, P480; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Carpick BW, 1997, J BIOL CHEM, V272, P9510, DOI 10.1074/jbc.272.14.9510; Chen D, 1997, BBA-MOL CELL RES, V1355, P1, DOI 10.1016/S0167-4889(96)00169-3; Coffin J. M., 2013, FIELDS VIROLOGY, P1767; Collin D, 2000, NUCLEIC ACIDS RES, V28, P3386, DOI 10.1093/nar/28.17.3386; Deminice R, 2013, NUTRITION, V29, P1326, DOI 10.1016/j.nut.2013.04.017; EDERY I, 1989, CELL, V56, P303, DOI 10.1016/0092-8674(89)90904-5; Eiring AM, 2010, CELL, V140, P652, DOI 10.1016/j.cell.2010.01.007; Fabbri M, 2012, P NATL ACAD SCI USA, V109, pE2110, DOI 10.1073/pnas.1209414109; Feleke Yeweyenhareg, 2012, Ethiop Med J, V50, P221; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Gourzones C, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-271; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Heinicke LA, 2009, J MOL BIOL, V390, P319, DOI 10.1016/j.jmb.2009.05.005; Husain B, 2012, BIOCHEMISTRY-US, V51, P8764, DOI 10.1021/bi301226h; Islam A, 2007, J BIOL CHEM, V282, P9591, DOI 10.1074/jbc.M607122200; Jaworski E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096778; Kachhap SK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000844; Kalaydjieva L, 2000, AM J HUM GENET, V67, P47, DOI 10.1086/302978; KASHANCHI F, 1992, NUCLEIC ACIDS RES, V20, P4673, DOI 10.1093/nar/20.17.4673; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kiage JN, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-50; Klase Z, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-63; Klase Z, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-18; Laird GM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003398; Langland JO, 2006, VIRUS RES, V119, P100, DOI 10.1016/j.virusres.2005.10.014; LASPIA MF, 1989, CELL, V59, P283, DOI 10.1016/0092-8674(89)90290-0; Lenassi M, 2010, TRAFFIC, V11, P110, DOI 10.1111/j.1600-0854.2009.01006.x; Lotvall J, 2007, CELL ADHES MIGR, V1, P156, DOI 10.4161/cam.1.3.5114; LOTZ M, 1988, J EXP MED, V167, P1253, DOI 10.1084/jem.167.3.1253; LUO Y, 1993, J VIROL, V67, P5617, DOI 10.1128/JVI.67.9.5617-5622.1993; Macovei A, 2006, BIOCHEM BIOPH RES CO, V346, P1083, DOI 10.1016/j.bbrc.2006.06.023; Matusevicius D, 1996, J NEUROIMMUNOL, V66, P115, DOI 10.1016/0165-5728(96)00032-X; McArthur JC, 2005, LANCET NEUROL, V4, P543, DOI 10.1016/S1474-4422(05)70165-4; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Narayanan A, 2013, J BIOL CHEM, V288, P20014, DOI 10.1074/jbc.M112.438895; Narayanan A, 2012, VIROLOGY, V432, P219, DOI 10.1016/j.virol.2012.06.007; Narayanan A, 2011, EXPERT OPIN BIOL TH, V11, P17, DOI 10.1517/14712598.2011.540564; Navikas V, 1996, BRAIN, V119, P213, DOI 10.1093/brain/119.1.213; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; Omoto Shinya, 2004, Retrovirology, V1, P44, DOI 10.1186/1742-4690-1-44; Ouellet DL, 2008, NUCLEIC ACIDS RES, V36, P2353, DOI 10.1093/nar/gkn076; PAL R, 1991, AIDS RES HUM RETROV, V7, P707, DOI 10.1089/aid.1991.7.707; Pegtel DM, 2011, BBA-GENE REGUL MECH, V1809, P715, DOI 10.1016/j.bbagrm.2011.08.002; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; Schopman NCT, 2012, NUCLEIC ACIDS RES, V40, P414, DOI 10.1093/nar/gkr719; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Stone S F, 2002, HIV Med, V3, P21, DOI 10.1046/j.1464-2662.2001.00096.x; Stumptner-Cuvelette P, 2003, MOL BIOL CELL, V14, P4857, DOI 10.1091/mbc.E03-04-0211; Suen WE, 1997, J EXP MED, V186, P1233, DOI 10.1084/jem.186.8.1233; Suh HS, 2009, VIROLOGY, V392, P246, DOI 10.1016/j.virol.2009.07.001; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; UNAIDS, 2012, GLOBAL REPORT UNAIDS; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van der Sluis RM, 2013, CURR OPIN VIROL, V3, P700, DOI 10.1016/j.coviro.2013.07.006; Van Duyne R, 2008, VIROLOGY, V376, P308, DOI 10.1016/j.virol.2008.02.036; Van Duyne R, 2013, J MOL BIOL, V425, P812, DOI 10.1016/j.jmb.2012.12.005; Van Duyne R, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-76; Verweij FJ, 2011, EMBO J, V30, P2115, DOI 10.1038/emboj.2011.123; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Whisnant AW, 2013, MBIO, V4, DOI 10.1128/mBio.00193-13; Yeung ML, 2009, NUCLEIC ACIDS RES, V37, P6575, DOI 10.1093/nar/gkp707; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zomer Anoek, 2010, Commun Integr Biol, V3, P447, DOI 10.4161/cib.3.5.12339	77	139	146	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1251	1266		10.1074/jbc.M115.662171	http://dx.doi.org/10.1074/jbc.M115.662171			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26553869	hybrid, Green Published			2022-12-26	WOS:000368068300021
J	Grabner, GF; Eichmann, TO; Wagner, B; Gao, YQ; Farzi, A; Taschler, U; Radner, FPW; Schweiger, M; Lass, A; Holzer, P; Zinser, E; Tschop, MH; Yi, CX; Zimmermann, R				Grabner, Gernot F.; Eichmann, Thomas O.; Wagner, Bernhard; Gao, Yuanqing; Farzi, Aitak; Taschler, Ulrike; Radner, Franz P. W.; Schweiger, Martina; Lass, Achim; Holzer, Peter; Zinser, Erwin; Tschoep, Matthias H.; Yi, Chun-Xia; Zimmermann, Robert			Deletion of Monoglyceride Lipase in Astrocytes Attenuates Lipopolysaccharide-induced Neuroinflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TAIL SUSPENSION TEST; MONOACYLGLYCEROL LIPASE; ENDOCANNABINOID SYSTEM; BACTERIAL LIPOPOLYSACCHARIDE; CANNABINOID RECEPTORS; BRAIN-INJURY; ANXIETY-LIKE; MICE; INHIBITION; MEMORY	Monoglyceride lipase (MGL) is required for efficient hydrolysis of the endocannabinoid 2-arachidonoylglyerol (2-AG) in the brain generating arachidonic acid (AA) and glycerol. This metabolic function makes MGL an interesting target for the treatment of neuroinflammation, since 2-AG exhibits anti-inflammatory properties and AA is a precursor for pro-inflammatory prostaglandins. Astrocytes are an important source of AA and 2-AG, and highly express MGL. In the present study, we dissected the distinct contribution of MGL in astrocytes on brain 2-AG and AA metabolism by generating a mouse model with genetic deletion of MGL specifically in astrocytes (MKOGFAP). MKOGFAP mice exhibit moderately increased 2-AG and reduced AA levels in brain. Minor accumulation of 2-AG in the brain of MKOGFAP mice does not cause cannabinoid receptor desensitization as previously observed in mice globally lacking MGL. Importantly, MKOGFAP mice exhibit reduced brain prostaglandin E2 and pro-inflammatory cytokine levels upon peripheral lipopolysaccharide (LPS) administration. These observations indicate that MGL-mediated degradation of 2-AG in astrocytes provides AA for prostaglandin synthesis promoting LPS-induced neuroinflammation. The beneficial effect of astrocytespecific MGL-deficiency is not fully abrogated by the inverse cannabinoid receptor 1 agonist SR141716 (Rimonabant) suggesting that the anti-inflammatory effects are rather caused by reduced prostaglandin synthesis than by activation of cannabinoid receptors. In conclusion, our data demonstrate that MGL in astrocytes is an important regulator of 2-AG levels, AA availability, and neuroinflammation.	[Grabner, Gernot F.; Eichmann, Thomas O.; Taschler, Ulrike; Radner, Franz P. W.; Schweiger, Martina; Lass, Achim; Zimmermann, Robert] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Wagner, Bernhard; Zinser, Erwin] FH Joanneum Univ Appl Sci, Inst Biomed Sci, A-8020 Graz, Austria; [Gao, Yuanqing; Tschoep, Matthias H.; Yi, Chun-Xia] Helmholtz Ctr Munich, Inst Diabet & Obes, D-85748 Garching, Germany; [Farzi, Aitak; Holzer, Peter] Med Univ Graz, Inst Expt & Clin Pharmacol, A-8010 Graz, Austria; [Yi, Chun-Xia] Univ Amsterdam, Acad Med Ctr, Dept Endocrinol & Metab, NL-1105 AZ Amsterdam, Netherlands	University of Graz; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Medical University of Graz; University of Amsterdam; Academic Medical Center Amsterdam	Zimmermann, R (corresponding author), Graz Univ, Heinrichstr 31A, A-8010 Graz, Austria.	robert.zimmermann@uni-graz.at	Holzer, Peter/F-7578-2011; Lass, Achim/C-3332-2008; Yi, Chun-Xia/J-4068-2016	Holzer, Peter/0000-0002-5754-395X; Lass, Achim/0000-0002-8190-7151; Yi, Chun-Xia/0000-0003-1184-4615; Grabner, Gernot/0000-0002-7110-9957; Farzi, Aitak/0000-0001-9606-3871; Eichmann, Thomas O./0000-0002-8521-2795; Taschler, Ulrike/0000-0001-9000-1602; Schweiger, Martina/0000-0002-3419-1007; Tschoep, Matthias/0000-0002-4744-371X; Zimmermann, Robert/0000-0002-7354-870X; Radner, Franz/0000-0003-3466-0181	Austrian Science Funds, FWF [P24294, P25193]; DK Molecular Enzymology [W901-B05 DK]; NAWI Graz; Austrian Science Fund (FWF) [P 24294, W 901, P 25193] Funding Source: researchfish	Austrian Science Funds, FWF(Austrian Science Fund (FWF)); DK Molecular Enzymology(Austrian Science Fund (FWF)); NAWI Graz; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This research was supported by grants from the Austrian Science Funds, FWF, Projects P24294 (to R. Z.) and P25193 (to A. L.), and by the DK Molecular Enzymology W901-B05 DK (to R. Z.) and NAWI Graz. The authors declare that they have no conflicts of interest with the contents of this article.	Araque A, 2014, NEURON, V81, P728, DOI 10.1016/j.neuron.2014.02.007; Attar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080355; Bajenaru ML, 2002, MOL CELL BIOL, V22, P5100, DOI 10.1128/MCB.22.14.5100-5113.2002; Berrocoso E, 2013, INT J NEUROPSYCHOPH, V16, P151, DOI 10.1017/S1461145711001842; Blankman J. L., 2009, CHEM PHYS LIPIDS, V14, P1347; Brunner SM, 2014, P NATL ACAD SCI USA, V111, P7138, DOI 10.1073/pnas.1318066111; Buczynski MW, 2009, J LIPID RES, V50, P1015, DOI 10.1194/jlr.R900004-JLR200; Chanda PK, 2010, MOL PHARMACOL, V78, P996, DOI 10.1124/mol.110.068304; Choi SH, 2008, FASEB J, V22, P1491, DOI 10.1096/fj.07-9411com; Choi SH, 2009, AGING-US, V1, P234, DOI 10.18632/aging.100021; Crowe MS, 2015, BRIT J PHARMACOL, V172, P1700, DOI 10.1111/bph.13012; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Dinh TP, 2002, CHEM PHYS LIPIDS, V121, P149, DOI 10.1016/S0009-3084(02)00150-0; Farzi A, 2015, BRAIN BEHAV IMMUN, V44, P106, DOI 10.1016/j.bbi.2014.08.011; Han J, 2012, CELL, V148, P1039, DOI 10.1016/j.cell.2012.01.037; Harno E, 2013, CELL METAB, V18, P21, DOI 10.1016/j.cmet.2013.05.019; Hollis JH, 2010, NEUROPHARMACOLOGY, V58, P730, DOI 10.1016/j.neuropharm.2009.12.016; Hoogland ICM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0332-6; Kinsey SG, 2011, J PHARMACOL EXP THER, V338, P795, DOI 10.1124/jpet.110.175778; Knittelfelder OL, 2014, J CHROMATOGR B, V951, P119, DOI 10.1016/j.jchromb.2014.01.011; Kouchi Z, 2015, BIOCHEM BIOPH RES CO, V464, P603, DOI 10.1016/j.bbrc.2015.07.019; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Matousek SB, 2010, J NEUROCHEM, V114, P247, DOI 10.1111/j.1471-4159.2010.06759.x; Min R, 2012, NAT NEUROSCI, V15, P746, DOI 10.1038/nn.3075; MontagneClavel J, 1996, SOMATOSENS MOT RES, V13, P215, DOI 10.3109/08990229609052577; MOORE SA, 1991, J NEUROCHEM, V56, P518, DOI 10.1111/j.1471-4159.1991.tb08180.x; Moore SA, 2001, J MOL NEUROSCI, V16, P195, DOI 10.1385/JMN:16:2-3:195; Moreira FA, 2008, ADDICT BIOL, V13, P196, DOI 10.1111/j.1369-1600.2008.00104.x; Mulvihill MM, 2013, LIFE SCI, V92, P492, DOI 10.1016/j.lfs.2012.10.025; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Nomura DK, 2011, SCIENCE, V334, P809, DOI 10.1126/science.1209200; OTA K, 1990, NATURE, V346, P183, DOI 10.1038/346183a0; Painsipp E, 2008, GENES BRAIN BEHAV, V7, P532, DOI 10.1111/j.1601-183X.2008.00389.x; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Piro JR, 2012, CELL REP, V1, P617, DOI 10.1016/j.celrep.2012.05.001; Riebe CJ, 2011, STRESS, V14, P384, DOI 10.3109/10253890.2011.586753; RINALDICARMONA M, 1994, FEBS LETT, V350, P240, DOI 10.1016/0014-5793(94)00773-X; Rosenberger TA, 2004, J NEUROCHEM, V88, P1168, DOI 10.1046/j.1471-4159.2003.02246.x; Ruehle S, 2012, J PSYCHOPHARMACOL, V26, P23, DOI 10.1177/0269881111408958; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; Sofroniew MV, 2014, NEUROSCIENTIST, V20, P160, DOI 10.1177/1073858413504466; Steiner AA, 2011, J PHYSIOL-LONDON, V589, P2415, DOI 10.1113/jphysiol.2010.202465; Stella N, 2004, GLIA, V48, P267, DOI 10.1002/glia.20084; Strassburg K, 2012, ANAL BIOANAL CHEM, V404, P1413, DOI 10.1007/s00216-012-6226-x; Taschler U, 2015, BRIT J PHARMACOL, V172, P4419, DOI 10.1111/bph.13224; Taschler U, 2011, J BIOL CHEM, V286, P17467, DOI 10.1074/jbc.M110.215434; Tzeng Shun-Fen, 2005, Current Drug Targets - Inflammation and Allergy, V4, P335, DOI 10.2174/1568010054022051; Uchigashima M, 2011, J NEUROSCI, V31, P7700, DOI 10.1523/JNEUROSCI.5665-10.2011; Viader A, 2015, CELL REP, V12, P798, DOI 10.1016/j.celrep.2015.06.075; Walter L, 2004, J NEUROSCI, V24, P8068, DOI 10.1523/JNEUROSCI.2419-04.2004; Walter L, 2003, J NEUROSCI, V23, P1398, DOI 10.1523/JNEUROSCI.23-04-01398.2003; Yi CX, 2012, DIS MODEL MECH, V5, P686, DOI 10.1242/dmm.009464; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	54	37	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					913	923		10.1074/jbc.M115.683615	http://dx.doi.org/10.1074/jbc.M115.683615			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26565024	Green Accepted, hybrid, Green Published			2022-12-26	WOS:000367830500037
J	Junker, M; Zimmermann, M; Ramos, AA; Gros, P; Konvicka, M; Neve, G; Rakosy, L; Tammaru, T; Castilho, R; Schmitt, T				Junker, Marius; Zimmermann, Marie; Ramos, Ana A.; Gros, Patrick; Konvicka, Martin; Neve, Gabriel; Rakosy, Laszio; Tammaru, Toomas; Castilho, Rita; Schmitt, Thomas			Three in One-Multiple Faunal Elements within an Endangered European Butterfly Species	PLOS ONE			English	Article							EUPHYDRYAS-AURINIA LEPIDOPTERA; PLEISTOCENE EVOLUTIONARY HISTORY; POLYOMMATUS-CORIDON LEPIDOPTERA; CHIOGLOSSA-LUSITANICA AMPHIBIA; POPULATION GENETIC-STRUCTURE; EREBIA-MEDUSA LEPIDOPTERA; GOLDEN-STRIPED SALAMANDER; MITOCHONDRIAL-DNA; GLACIAL REFUGIA; CONTROL REGION	Ice ages within Europe forced many species to retreat to refugia, of which three major biogeographic basic types can be distinguished: "Mediterranean", "Continental" and "Alpine / Arctic" species. However, this classification often fails to explain the complex phylogeography of European species with a wide range of latitudinal and altitudinal distribution. Hence, we tested for the possibility that all three mentioned faunal elements are represented within one species. Our data was obtained by scoring 1,307 Euphydryas aurinia individuals (46 European locations) for 17 allozyme loci, and sequencing a subset of 492 individuals (21 sites) for a 626 base pairs COI fragment. Genetic diversity indices, F statistics, hierarchical analyses of molecular variance, individual-based clustering, and networks were used to explore the phylogeographic patterns. The COI fragment represented 18 haplotypes showing a strong geographic structure. All but one allozyme loci analysed were polymorphic with a mean F-ST of 0.20, supporting a pronounced among population structure. Interpretation of both genetic marker systems, using several analytical tools, calls for the recognition of twelve genetic groups. These analyses consistently distinguished different groups in Iberia (2), Italy, Provence, Alps (3), Slovenia, Carpathian Basin, the lowlands of West and Central Europe as well as Estonia, often with considerable additional substructures. The genetic data strongly support the hypothesis that E. aurinia survived the last glaciation in Mediterranean, extra-Mediterranean and perialpine refugia. It is thus a rare example of a model organism that combines attributes of faunal elements from all three of these sources. The observed differences between allozymes and mtDNA most likely result from recent introgression of mtDNA into nuclear allozyme groups. Our results indicate discrepancies with the morphologically-based subspecies models, underlining the need to revise the current taxonomy.	[Junker, Marius; Schmitt, Thomas] Univ Trier, Dept Biogeog, Trier, Germany; [Zimmermann, Marie] Univ Tours, CNRS, UMR 6035, IRBI, Tours, France; [Ramos, Ana A.; Castilho, Rita] Univ Algarve, Ctr Marine Sci, CCMAR CIMAR Associate Lab, Faro, Portugal; [Gros, Patrick] Haus Nat, Museum Nat & Tech, Salzburg, Austria; [Konvicka, Martin] Univ South Bohemia, Sch Biol Sci, Ceske Budejovice, Czech Republic; [Neve, Gabriel] Avignon Univ, Aix Marseille Univ, CNRS,IRD, Inst Mediterraneen Biodivers & Ecol Marine & Cont, Marseille 3, France; [Rakosy, Laszio] Univ Babes Bolyai, Fac Biol, Cluj Napoca, Romania; [Tammaru, Toomas] Univ Tartu, Inst Ecol & Earth Sci, EE-50090 Tartu, Estonia; [Schmitt, Thomas] Senckenberg German Entomol Inst, Muncheberg, Germany; [Schmitt, Thomas] Univ Halle Wittenberg, Inst Biol, Fac Nat Sci 1, Zool, D-06108 Halle, Saale, Germany	Universitat Trier; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; Universidade do Algarve; University of South Bohemia Ceske Budejovice; Avignon Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Babes Bolyai University from Cluj; University of Tartu; Tartu University Institute of Ecology & Earth Sciences; Senckenberg Gesellschaft fur Naturforschung (SGN); Martin Luther University Halle Wittenberg	Schmitt, T (corresponding author), Univ Trier, Dept Biogeog, Trier, Germany.	thomas.schmitt@senckenberg.de	Konvicka, Martin/H-1446-2014; Castilho, Rita/B-6185-2008; Ramos, Ana/I-1353-2012; Ramos, Ana/M-3815-2013; Laszlo, Rakosy/J-3541-2016; Tammaru, Toomas/N-3892-2019; Rakosy, Laszlo/K-8702-2013	Castilho, Rita/0000-0003-0727-3688; Ramos, Ana/0000-0003-1099-4005; Ramos, Ana/0000-0003-1099-4005; Laszlo, Rakosy/0000-0002-1866-3422; Rakosy, Laszlo/0000-0002-7793-6996; Tammaru, Toomas/0000-0002-6892-5910	Estonian targeted financing project [Sf0180122s08]; DFG graduate school [1319];  [Pest-C/MAR/LA0015/2011]	Estonian targeted financing project; DFG graduate school(German Research Foundation (DFG)); 	This work was supported by an Estonian targeted financing project Sf0180122s08, DFG graduate school 1319, and Pest-C/MAR/LA0015/2011.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alexandrino J, 2000, MOL ECOL, V9, P771, DOI 10.1046/j.1365-294x.2000.00931.x; Alexandrino J, 2002, HEREDITY, V88, P66, DOI 10.1038/sj.hdy.6800010; Alvarez N, 2012, FLORA, V207, P408, DOI [10.1016/j.f1ora.2012.03.006, 10.1016/j.flora.2012.03.006]; Babik W, 2004, MOL ECOL, V13, P1469, DOI 10.1111/j.1365-294X.2004.02157.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Batista Vasco, 2004, Herpetozoa, V16, P166; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Besold J, 2008, J BIOGEOGR, V35, P2090, DOI 10.1111/j.1365-2699.2008.01939.x; Besold J, 2008, ANN ZOOL FENN, V45, P217, DOI 10.5735/086.045.0307; Betzholtz PE, 2007, J INSECT CONSERV, V11, P343, DOI 10.1007/s10841-006-9048-3; Bhagwat SA, 2008, J BIOGEOGR, V35, P464, DOI 10.1111/j.1365-2699.2007.01861.x; Bulman CR, 2007, ECOL APPL, V17, P1460, DOI 10.1890/06-1032.1; Canestrelli D, 2008, MOL ECOL, V17, P3856, DOI 10.1111/j.1365-294X.2008.03870.x; Canestrelli D, 2006, MOL ECOL, V15, P3741, DOI 10.1111/j.1365-294X.2006.03055.x; Canestrelli D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041754; Canestrelli D, 2012, BIOL J LINN SOC, V105, P42, DOI 10.1111/j.1095-8312.2011.01767.x; Carranza S, 2006, J BIOGEOGR, V33, P1279, DOI 10.1111/j.1365-2699.2006.01491.x; Carranza S, 2004, ZOOTAXA, P1; Carranza S., 2004, SYST BIODIVERS, V1, P327; Cassel A, 2003, CONSERV GENET, V4, P83, DOI 10.1023/A:1021884832122; De Lattin G., 1949, VERH DT ZOOL GES, V42, P143; De Vlinderstichting A, 2006, DAGVLINDERS NEDERLAN, V7; DeChaine EG, 2004, EVOLUTION, V58, P113, DOI 10.1111/j.0014-3820.2004.tb01578.x; Descimon H, 2001, GENET SEL EVOL, V33, pS223, DOI 10.1186/BF03500882; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Francois O, 2010, MOL ECOL RESOUR, V10, P773, DOI 10.1111/j.1755-0998.2010.02868.x; Garcia-Paris M, 2003, EVOLUTION, V57, P129; Gompert Z, 2006, MOL ECOL, V15, P1759, DOI 10.1111/j.1365-294X.2006.02905.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gratton P, 2008, MOL ECOL, V17, P4248, DOI 10.1111/j.1365-294X.2008.03901.x; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Habel JC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-215; Habel JC, 2009, BIOL J LINN SOC, V98, P693, DOI 10.1111/j.1095-8312.2009.01300.x; Hammouti N, 2010, J ZOOL SYST EVOL RES, V48, P115, DOI 10.1111/j.1439-0469.2009.00544.x; Haubrich K, 2007, MOL ECOL, V16, P3643, DOI 10.1111/j.1365-294X.2007.03424.x; Hebert P.D.N, 1993, ZOOLOGY, V32; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Higgins L. G., 1950, Transactions of the Royal Entomological Society of London, V101, P435; Hopkinson, 1978, HDB ENZYME ELECTROPH; Hula V, 2004, ENTOMOL FENNICA, V15, P231; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Joyce DA, 2003, BIOL CONSERV, V114, P453, DOI 10.1016/S0006-3207(03)00087-9; Junker M, 2010, OECOLOGIA, V164, P971, DOI 10.1007/s00442-010-1720-3; Junker M, 2010, J INSECT CONSERV, V14, P237, DOI 10.1007/s10841-009-9250-1; Keenan K, 2013, METHODS ECOL EVOL, V4, P782, DOI 10.1111/2041-210X.12067; Kelly RP, 2010, J HERED, V101, P423, DOI 10.1093/jhered/esq022; Kindler C, 2013, ZOOL SCR, V42, P458, DOI 10.1111/zsc.12018; Konvicka M, 2003, EUR J ENTOMOL, V100, P313, DOI 10.14411/eje.2003.050; Lafranchis T., 2015, VIE PAPILLONS ECOLOG; Lai BCG, 2004, J INSECT CONSERV, V8, P27, DOI 10.1023/B:JICO.0000027478.35309.46; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lunt DH, 1996, INSECT MOL BIOL, V5, P153, DOI 10.1111/j.1365-2583.1996.tb00049.x; Magri D, 2007, MOL ECOL, V16, P5259, DOI 10.1111/j.1365-294X.2007.03587.x; Magri D, 2008, J BIOGEOGR, V35, P450, DOI 10.1111/j.1365-2699.2007.01803.x; Magri D, 2006, NEW PHYTOL, V171, P199, DOI 10.1111/j.1469-8137.2006.01740.x; MARAVALHAS E., 2003, BORBOLETAS PORTUGAL; Margraf N, 2007, MOL ECOL, V16, P2333, DOI 10.1111/j.1365-294X.2007.03318.x; Martinez-Solano I, 2006, MOL ECOL, V15, P3375, DOI 10.1111/j.1365-294X.2006.03013.x; Martinez-Solano I, 2004, J ZOOL SYST EVOL RES, V42, P298, DOI 10.1111/j.1439-0469.2004.00257.x; MAZEL R, 1986, Vie et Milieu, V36, P205; Munguira ML, 1997, ACTA OECOL, V18, P597, DOI 10.1016/S1146-609X(97)80044-6; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Neve G, 2008, EVOL ECOL, V22, P701, DOI 10.1007/s10682-007-9192-6; Neve Gabriel, 2009, P107; Paulo OS, 2001, P ROY SOC B-BIOL SCI, V268, P1625, DOI 10.1098/rspb.2001.1706; Pauls SU, 2006, MOL ECOL, V15, P2153, DOI 10.1111/j.1365-294X.2006.02916.x; Pelz Volker, 1995, Oedippus, V11, P1; Pinceel J, 2005, MOL ECOL, V14, P1133, DOI 10.1111/j.1365-294X.2005.02479.x; Podnar M, 2005, MOL ECOL, V14, P575, DOI 10.1111/j.1365-294X.2005.02427.x; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Reinig W., 1950, SYLLEGOMENA BIOL FES, P364; Reuter, 1994, CARABID BEETLES ECOL; RICHARDSON BJ, 1986, ALLOZYME ELECTROPHOR; Saarinen K, 2005, EUR J ENTOMOL, V102, P683, DOI 10.14411/eje.2005.097; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schmitt T, 2005, ORG DIVERS EVOL, V5, P297, DOI 10.1016/j.ode.2005.01.001; Schmitt T, 2006, J EVOLUTION BIOL, V19, P108, DOI 10.1111/j.1420-9101.2005.00980.x; Schmitt T, 2005, BIOL J LINN SOC, V85, P419, DOI 10.1111/j.1095-8312.2005.00504.x; Schmitt T, 2001, BIOL J LINN SOC, V74, P429, DOI 10.1006/bijl.2001.0584; Schmitt T, 2001, J BIOGEOGR, V28, P1129, DOI 10.1046/j.1365-2699.2001.00621.x; Schmitt T, 2008, MOL ECOL, V17, P2194, DOI 10.1111/j.1365-294X.2007.03687.x; Schmitt T, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-11; Schmitt T, 2007, J BIOGEOGR, V34, P939, DOI 10.1111/j.1365-2699.2006.01684.x; Schmitt T, 2014, GLOBAL CHANGE BIOL, V20, P2045, DOI 10.1111/gcb.12462; Schmitt T, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-22; Schmitt T, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-9; Schonswetter P, 2004, BIOL J LINN SOC, V81, P183, DOI 10.1111/j.1095-8312.2003.00289.x; Schonswetter P, 2005, MOL ECOL, V14, P3547, DOI 10.1111/j.1365-294X.2005.02683.x; Schonswetter P, 2003, BOT J LINN SOC, V141, P437, DOI 10.1046/j.0024-4074.2002.00134.x; Schonswetter P, 2002, MOL ECOL, V11, P2637, DOI 10.1046/j.1365-294X.2002.01651.x; Schonswetter P, 2003, PLANT BIOLOGY, V5, P623, DOI 10.1055/s-2003-44686; Schtickzelle N, 2005, BIOL CONSERV, V126, P569, DOI 10.1016/j.biocon.2005.06.030; Schweizer Bund fur Naturschutz (SBN), 1987, TAGF IHR LEB, V1; Siegismund HR., 1993, G STAT VER 3 GENETIC; Sigaard P, 2008, BIOL J LINN SOC, V95, P677, DOI 10.1111/j.1095-8312.2008.01078.x; Stehlik I, 2002, BIOL J LINN SOC, V77, P87, DOI 10.1046/j.1095-8312.2002.00094.x; Stewart JR, 2001, TRENDS ECOL EVOL, V16, P608, DOI 10.1016/S0169-5347(01)02338-2; Swaay C Van, 1999, COUNCIL EUROPE NATUR; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TABERLET P, 1994, P ROY SOC B-BIOL SCI, V255, P195, DOI 10.1098/rspb.1994.0028; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Thiel-Egenter C, 2009, MOL ECOL, V18, P4495, DOI 10.1111/j.1365-294X.2009.04360.x; Thissen D, 2002, J EDUC BEHAV STAT, V27, P77, DOI 10.3102/10769986027001077; Tolman T, 1997, BUTTERFLIES BRITAIN; Tribsch A, 2002, AM J BOT, V89, P2024, DOI 10.3732/ajb.89.12.2024; Tshikolovets V.V., 2011, BUTTERFLIES EUROPE M; Ujvarosi L, 2010, J N AM BENTHOL SOC, V29, P1075, DOI 10.1899/09-099.1; Ursenbacher S, 2006, MOL ECOL, V15, P3425, DOI 10.1111/j.1365-294X.2006.03031.x; Ursenbacher S, 2006, MOL PHYLOGENET EVOL, V38, P546, DOI 10.1016/j.ympev.2005.08.004; VARGA Z, 1977, Acta Biologica Debrecina, V14, P223; Vila M, 2004, J MOL EVOL, V58, P280, DOI 10.1007/s00239-003-2550-2; Vila M, 2011, J ZOOL SYST EVOL RES, V49, P119, DOI 10.1111/j.1439-0469.2010.00587.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Zimmermann K, 2011, EUR J ENTOMOL, V108, P243, DOI 10.14411/eje.2011.033; Zimmermann M, 2000, ANN ENTOMOL SOC AM, V93, P347, DOI 10.1603/0013-8746(2000)093[0347:POECBL]2.0.CO;2; Zinetti F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065746	124	15	15	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142282	10.1371/journal.pone.0142282	http://dx.doi.org/10.1371/journal.pone.0142282			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26566029	Green Published, Green Submitted, gold			2022-12-26	WOS:000367628500016
J	Rodriguez-Fernandez, IA; Dell'Angelica, EC				Rodriguez-Fernandez, Imilce A.; Dell'Angelica, Esteban C.			Identification of Atg2 and ArfGAP1 as Candidate Genetic Modifiers of the Eye Pigmentation Phenotype of Adaptor Protein-3 (AP-3) Mutants in Drosophila melanogaster	PLOS ONE			English	Article							HERMANSKY-PUDLAK-SYNDROME; BETA-3A SUBUNIT; INTRACELLULAR-TRANSPORT; ORGANELLE BIOGENESIS; GRANULE BIOGENESIS; SYNDROME TYPE-2; COMPLEX; LYSOSOME; TRAFFICKING; MUTATIONS	The Adaptor Protein (AP)-3 complex is an evolutionary conserved, molecular sorting device that mediates the intracellular trafficking of proteins to lysosomes and related organelles. Genetic defects in AP-3 subunits lead to impaired biogenesis of lysosome-related organelles (LROs) such as mammalian melanosomes and insect eye pigment granules. In this work, we have performed a forward screening for genetic modifiers of AP-3 function in the fruit fly, Drosophila melanogaster. Specifically, we have tested collections of large multi-gene deletions-which together covered most of the autosomal chromosomes-to identify chromosomal regions that, when deleted in single copy, enhanced or ameliorated the eye pigmentation phenotype of two independent AP-3 subunit mutants. Fine-mapping led us to define two non-overlapping, relatively small critical regions within fly chromosome 3. The first critical region included the Atg2 gene, which encodes a conserved protein involved in autophagy. Loss of one functional copy of Atg2 ameliorated the pigmentation defects of mutants in AP-3 subunits as well as in two other genes previously implicated in LRO biogenesis, namely Blos1 and lightoid, and even increased the eye pigment content of wild-type flies. The second critical region included the ArfGAP1 gene, which encodes a conserved GTPase-activating protein with specificity towards GTPases of the Arf family. Loss of a single functional copy of the ArfGAP1 gene ameliorated the pigmentation phenotype of AP-3 mutants but did not to modify the eye pigmentation of wild-type flies or mutants in Blos1 or lightoid. Strikingly, loss of the second functional copy of the gene did not modify the phenotype of AP-3 mutants any further but elicited early lethality in males and abnormal eye morphology when combined with mutations in Blos1 and lightoid, respectively. These results provide genetic evidence for new functional links connecting the machinery for biogenesis of LROs with molecules implicated in autophagy and small GTPase regulation.	[Rodriguez-Fernandez, Imilce A.; Dell'Angelica, Esteban C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Dell'Angelica, EC (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.	Edellangelica@mednet.ucla.edu		Rodriguez-Fernandez, Imilce A/0000-0002-5112-4834	National Institutes of Health [R01GM112942, T32HG002536]; American Heart Association [11GRNT7620115]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112942] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Institutes of Health grant R01GM112942 (ECD), American Heart Association grant 11GRNT7620115 (ECD), and National Institutes of Health training grant T32HG002536 (IAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin C, 2002, BIOCHEMISTRY-US, V41, P4669, DOI 10.1021/bi016064j; Benhra N, 2011, CURR BIOL, V21, P87, DOI 10.1016/j.cub.2010.12.010; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bultema JJ, 2012, J BIOL CHEM, V287, P19550, DOI 10.1074/jbc.M112.351908; Canagarajah BJ, 2013, PROTEIN SCI, V22, P517, DOI 10.1002/pro.2235; Cao W, 2008, GENETICS, V178, P1457, DOI 10.1534/genetics.107.078394; Cheli VT, 2010, HUM MOL GENET, V19, P861, DOI 10.1093/hmg/ddp555; Cook RK, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r21; Cullup T, 2013, NAT GENET, V45, P83, DOI 10.1038/ng.2497; Delahaye JL, 2014, MOL BIOL CELL, V25, P1073, DOI 10.1091/mbc.E13-09-0521; Delevoye C, 2009, J CELL BIOL, V187, P247, DOI 10.1083/jcb.200907122; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Dell'Angelica EC, 1998, SCIENCE, V280, P431, DOI 10.1126/science.280.5362.431; Dell'Angelica EC, 2009, CURR OPIN CELL BIOL, V21, P552, DOI 10.1016/j.ceb.2009.04.014; Di Pietro SM, 2006, MOL BIOL CELL, V17, P4027, DOI 10.1091/mbc.E06-05-0379; Dodson MW, 2014, DIS MODEL MECH, V7, P1351, DOI 10.1242/dmm.017020; Dodson MW, 2012, HUM MOL GENET, V21, P1350, DOI 10.1093/hmg/ddr573; Drake MT, 2000, MOL BIOL CELL, V11, P3723, DOI 10.1091/mbc.11.11.3723; East MP, 2011, SEMIN CELL DEV BIOL, V22, P3, DOI 10.1016/j.semcdb.2010.07.002; Enders A, 2006, BLOOD, V108, P81, DOI 10.1182/blood-2005-11-4413; Falcon-Perez JM, 2002, J BIOL CHEM, V277, P28191, DOI 10.1074/jbc.M204011200; Falcon-Perez JM, 2007, TRAFFIC, V8, P154, DOI 10.1111/j.1600-0854.2006.00514.x; Faundez V, 1998, CELL, V93, P423, DOI 10.1016/S0092-8674(00)81170-8; Feng LJ, 1999, HUM MOL GENET, V8, P323, DOI 10.1093/hmg/8.2.323; Feng LJ, 2002, BLOOD, V99, P1651, DOI 10.1182/blood.V99.5.1651.h8001651_1651_1658; Finley KD, 2003, J NEUROSCI, V23, P1254, DOI 10.1523/JNEUROSCI.23-04-01254.2003; Fontana S, 2006, BLOOD, V107, P4857, DOI 10.1182/blood-2005-11-4398; Frolov MV, 2001, DNA CELL BIOL, V20, P107, DOI 10.1089/104454901750070319; Ganesan AK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000298; Gautam R, 2006, TRAFFIC, V7, P779, DOI 10.1111/j.1600-0854.2006.00431.x; Gerondopoulos A, 2012, CURR BIOL, V22, P2135, DOI 10.1016/j.cub.2012.09.020; Gokhale A, 2012, J NEUROSCI, V32, P3697, DOI 10.1523/JNEUROSCI.5640-11.2012; Gomez-Suaga P, 2012, HUM MOL GENET, V21, P511, DOI 10.1093/hmg/ddr481; Gouras P, 2011, EXP EYE RES, V93, P937, DOI 10.1016/j.exer.2011.10.011; Hafen E., 1997, NATURE, V389, P559; Hermann GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043043; Hikita T, 2009, J NEUROCHEM, V110, P1567, DOI 10.1111/j.1471-4159.2009.06257.x; Hirst J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001170; Ho H, 2011, PIGM CELL MELANOMA R, V24, P595, DOI 10.1111/j.1755-148X.2011.00889.x; Ho HA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.200543; Holmes A, 2007, J CELL SCI, V120, P2741, DOI 10.1242/jcs.03474; Hoyle DJ, 2011, PIGM CELL MELANOMA R, V24, P275, DOI 10.1111/j.1755-148X.2010.00815.x; Huizing M, 2002, PEDIATR RES, V51, P150, DOI 10.1203/00006450-200202000-00006; Huizing M, 2001, MOL BIOL CELL, V12, P2075, DOI 10.1091/mbc.12.7.2075; Huizing M, 2008, ANNU REV GENOM HUM G, V9, P359, DOI 10.1146/annurev.genom.9.081307.164303; Inoue H, 2007, TRAFFIC, V8, P1465, DOI 10.1111/j.1600-0854.2007.00624.x; Ishikawa HO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042988; Jang CC, 2003, DEVELOPMENT, V130, P2939, DOI 10.1242/dev.00522; Jones ML, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-42; Jung J, 2006, BLOOD, V108, P362, DOI 10.1182/blood-2005-11-4377; Kalie E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075313; Kantheti P, 1998, NEURON, V21, P111, DOI 10.1016/S0896-6273(00)80519-X; Kretzschmar D, 2000, GENETICS, V155, P213; Kurnik K, 2013, PLATELETS, V24, P538, DOI 10.3109/09537104.2012.741275; Le Borgne R, 1998, J BIOL CHEM, V273, P29451, DOI 10.1074/jbc.273.45.29451; Lloyd V, 1998, TRENDS CELL BIOL, V8, P257, DOI 10.1016/S0962-8924(98)01270-7; Lloyd VK, 2002, GENOME, V45, P296, DOI 10.1139/G01-139; Lloyd VK, 1999, GENOME, V42, P1183, DOI 10.1139/gen-42-6-1183; Loftus SK, 2002, P NATL ACAD SCI USA, V99, P4471, DOI 10.1073/pnas.072087599; Ma JP, 2004, P NATL ACAD SCI USA, V101, P11652, DOI 10.1073/pnas.0401926101; Ma Y, 2006, NATURE, V443, P359, DOI 10.1038/nature05179; MacLeod DA, 2013, NEURON, V77, P425, DOI 10.1016/j.neuron.2012.11.033; Mead CLR, 2010, J NEUROCHEM, V113, P1491, DOI 10.1111/j.1471-4159.2010.06690.x; Moriyama K, 2002, TRAFFIC, V3, P666, DOI 10.1034/j.1600-0854.2002.30908.x; Mulakkal NC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/273473; Mullin AP, 2015, J NEUROSCI, V35, P325, DOI 10.1523/JNEUROSCI.3542-14.2015; Mullins C, 2000, MOL GEN GENET, V263, P1003, DOI 10.1007/PL00008688; Murase D, 2013, J INVEST DERMATOL, V133, P2416, DOI 10.1038/jid.2013.165; Nagy P, 2014, FEBS LETT, V588, P408, DOI 10.1016/j.febslet.2013.12.012; Newell-Litwa K, 2007, J CELL SCI, V120, P531, DOI 10.1242/jcs.03365; Nie ZZ, 2003, DEV CELL, V5, P513, DOI 10.1016/S1534-5807(03)00234-X; Oiso N, 2004, MAMM GENOME, V15, P307, DOI 10.1007/s00335-004-2337-9; Okamoto K, 2014, J CELL BIOL, V205, P435, DOI 10.1083/jcb.201402054; Ooi CE, 1997, EMBO J, V16, P4508; Ooi CE, 1998, J CELL BIOL, V142, P391, DOI 10.1083/jcb.142.2.391; Peden AA, 2004, J CELL BIOL, V164, P1065, DOI 10.1083/jcb.200311064; Peden AA, 2002, J CELL BIOL, V156, P327, DOI 10.1083/jcb.200107140; Rabbitts BM, 2008, GENETICS, V180, P857, DOI 10.1534/genetics.108.093534; Rawet M, 2010, BIOCHEM BIOPH RES CO, V394, P553, DOI 10.1016/j.bbrc.2010.03.017; RINCHIK EM, 1993, NATURE, V361, P72, DOI 10.1038/361072a0; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Salazar G, 2006, MOL BIOL CELL, V17, P4014, DOI 10.1091/mbc.E06-02-0103; Salazar G, 2009, J BIOL CHEM, V284, P1790, DOI 10.1074/jbc.M805991200; Schroeder LK, 2007, MOL BIOL CELL, V18, P995, DOI 10.1091/mbc.E06-08-0685; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Setty SRG, 2007, MOL BIOL CELL, V18, P768, DOI 10.1091/mbc.E06-12-1066; Silicheva M, 2010, NUCLEIC ACIDS RES, V38, P39, DOI 10.1093/nar/gkp877; Simonsen A, 2007, GENETICS, V176, P1283, DOI 10.1534/genetics.106.065011; Simpson F, 1997, J CELL BIOL, V137, P835, DOI 10.1083/jcb.137.4.835; Sitaram A, 2012, MOL BIOL CELL, V23, P3178, DOI 10.1091/mbc.E11-06-0509; Smith JW, 2005, PIGM CELL RES, V18, P417, DOI 10.1111/j.1600-0749.2005.00265.x; Stafa K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002526; Theos AC, 2005, MOL BIOL CELL, V16, P5356, DOI 10.1091/mbc.E05-07-0626; Tong YR, 2010, P NATL ACAD SCI USA, V107, P9879, DOI 10.1073/pnas.1004676107; Wang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032086; Waschbusch D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111632; Wasmeier C, 2006, J CELL BIOL, V175, P271, DOI 10.1083/jcb.200606050; Wenham M, 2010, HAEMATOL-HEMATOL J, V95, P333, DOI 10.3324/haematol.2009.012286; Wilkin M, 2008, DEV CELL, V15, P762, DOI 10.1016/j.devcel.2008.09.002; Xiong YL, 2012, J NEUROSCI, V32, P3877, DOI 10.1523/JNEUROSCI.4566-11.2012; Yang W, 2000, J CELL SCI, V113, P4077; Zhang CF, 2015, J INVEST DERMATOL, V135, P1348, DOI 10.1038/jid.2014.439	103	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0143026	10.1371/journal.pone.0143026	http://dx.doi.org/10.1371/journal.pone.0143026			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26565960	Green Published, Green Submitted, gold			2022-12-26	WOS:000367628500087
J	Pinsky, BA; Sahoo, MK; Sandlund, J; Kleman, M; Kulkarni, M; Grufman, P; Nygren, M; Kwiatkowski, R; Baron, EJ; Tenover, F; Denison, B; Higuchi, R; Van Atta, R; Beer, NR; Carrillo, AC; Naraghi-Arani, P; Mire, CE; Ranadheera, C; Grolla, A; Lagerqvist, N; Persing, DH				Pinsky, Benjamin A.; Sahoo, Malaya K.; Sandlund, Johanna; Kleman, Marika; Kulkarni, Medha; Grufman, Per; Nygren, Malin; Kwiatkowski, Robert; Baron, Ellen Jo; Tenover, Fred; Denison, Blake; Higuchi, Russell; Van Atta, Reuel; Beer, Neil Reginald; Carrillo, Alda Celena; Naraghi-Arani, Pejman; Mire, Chad E.; Ranadheera, Charlene; Grolla, Allen; Lagerqvist, Nina; Persing, David H.			Analytical Performance Characteristics of the Cepheid GeneXpert Ebola Assay for the Detection of Ebola Virus	PLOS ONE			English	Article							REVERSE TRANSCRIPTION-PCR; HEMORRHAGIC-FEVER; MARBURG VIRUSES; SIERRA-LEONE; TRANSMISSION; OUTBREAK; VACCINE; RISK	Background The recently developed Xpert (R) Ebola Assay is a novel nucleic acid amplification test for simplified detection of Ebola virus (EBOV) in whole blood and buccal swab samples. The assay targets sequences in two EBOV genes, lowering the risk for new variants to escape detection in the test. The objective of this report is to present analytical characteristics of the Xpert (R) Ebola Assay on whole blood samples. Methods and Findings This study evaluated the assay's analytical sensitivity, analytical specificity, inclusivity and exclusivity performance in whole blood specimens. EBOV RNA, inactivated EBOV, and infectious EBOV were used as targets. The dynamic range of the assay, the inactivation of virus, and specimen stability were also evaluated. The lower limit of detection (LoD) for the assay using inactivated virus was estimated to be 73 copies/mL (95% CI: 51-97 copies/mL). The LoD for infectious virus was estimated to be 1 plaque-forming unit/mL, and for RNA to be 232 copies/mL (95% CI 163-302 copies/mL). The assay correctly identified five different Ebola viruses, Yambuku-Mayinga, Makona-C07, Yambuku-Ecran, Gabon-Ilembe, and Kikwit-956210, and correctly excluded all non-EBOV isolates tested. The conditions used by Xpert (R) Ebola for inactivation of infectious virus reduced EBOV titer by >= 6 logs. Conclusion In summary, we found the Xpert (R) Ebola Assay to have high analytical sensitivity and specificity for the detection of EBOV in whole blood. It offers ease of use, fast turnaround time, and remote monitoring. The test has an efficient viral inactivation protocol, fulfills inclusivity and exclusivity criteria, and has specimen stability characteristics consistent with the need for decentralized testing. The simplicity of the assay should enable testing in a wide variety of laboratory settings, including remote laboratories that are not capable of performing highly complex nucleic acid amplification tests, and during outbreaks where time to detection is critical.	[Pinsky, Benjamin A.; Sahoo, Malaya K.; Sandlund, Johanna] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Pinsky, Benjamin A.] Stanford Univ, Sch Med, Dept Med, Div Infect Dis & Geog Med, Stanford, CA USA; [Sandlund, Johanna] Stanford Hlth Care, Clin Microbiol Lab, Palo Alto, CA USA; [Sandlund, Johanna] Stanford Childrens Hlth, Palo Alto, CA USA; [Kleman, Marika; Grufman, Per; Nygren, Malin] Cepheid, Solna, Sweden; [Kulkarni, Medha; Kwiatkowski, Robert; Baron, Ellen Jo; Tenover, Fred; Denison, Blake; Higuchi, Russell; Van Atta, Reuel; Persing, David H.] Cepheid, Sunnyvale, CA USA; [Beer, Neil Reginald; Carrillo, Alda Celena; Naraghi-Arani, Pejman] Lawrence Livermore Natl Lab, Livermore, CA USA; [Mire, Chad E.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Ranadheera, Charlene; Grolla, Allen] Publ Hlth Agcy Canada, Special Pathogens Program, Natl Microbiol Lab, Winnipeg, MB, Canada; [Lagerqvist, Nina] Publ Hlth Agcy Sweden, Solna, Sweden	Stanford University; Stanford University; Stanford University; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of Texas System; University of Texas Medical Branch Galveston; Public Health Agency of Canada; Public Health Agency of Sweden	Pinsky, BA (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	bpinsky@stanford.edu	Mire, Chad/Z-6338-2019; Sahoo, Malaya Kumar/AAS-6907-2020	Mire, Chad/0000-0001-7596-1808; Sahoo, Malaya Kumar/0000-0001-9837-4032; Pinsky, Benjamin/0000-0001-8751-4810	Bill and Melinda Gates Foundation; Paul Allen Family Foundation; U.S. Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Paul Allen Family Foundation; U.S. Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE))	This work was supported by a grant from the Bill and Melinda Gates Foundation, and the Paul Allen Family Foundation administered by the National Philanthropic Trust. Portions of this work were performed under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerlund E, 2015, NEW ENGL J MED, V372, P2467, DOI 10.1056/NEJMc1503275; Bausch DG, 2007, J INFECT DIS, V196, pS142, DOI 10.1086/520545; Broadhurst MJ, 2015, LANCET, V386, P867, DOI 10.1016/S0140-6736(15)61042-X; Bukreyev AA, 2014, ARCH VIROL, V159, P821, DOI 10.1007/s00705-013-1846-9; Cnops L, 2015, CLIN INFECT DIS, V60, P1725, DOI 10.1093/cid/civ131; Feldmann H, 2003, NAT REV IMMUNOL, V3, P677, DOI 10.1038/nri1154; FIND, 2014, SIT REV EB DIAGN OPP; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Gupta M, 2012, VIROLOGY, V423, P119, DOI 10.1016/j.virol.2011.11.027; Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258; Kuhn JH, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01178-14; Kuhn JH, 2014, VIRUSES-BASEL, V6, P4760, DOI 10.3390/v6114760; MITCHELL SW, 1984, J CLIN MICROBIOL, V20, P486, DOI 10.1128/JCM.20.3.486-489.1984; Niedrig M, 2004, J CLIN MICROBIOL, V42, P1753, DOI 10.1128/JCM.42.4.1753-1755.2004; Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007; Raja S, 2005, CLIN CHEM, V51, P882, DOI 10.1373/clinchem.2004.046474; Reusken C, 2015, J CLIN VIROL, V62, P124, DOI 10.1016/j.jcv.2014.11.007; Rougeron V, 2015, J CLIN VIROL, V64, P111, DOI 10.1016/j.jcv.2015.01.014; Tong YG, 2015, NATURE, V524, P93, DOI 10.1038/nature14490; Towner JS, 2007, J INFECT DIS, V196, pS205, DOI 10.1086/520601; Towner JS, 2004, J VIROL, V78, P4330, DOI 10.1128/JVI.78.8.4330-4341.2004; Trombley AR, 2010, AM J TROP MED HYG, V82, P954, DOI 10.4269/ajtmh.2010.09-0636; U.S. Food and Drug Administration Emergency Use Authorizations, 2015, EM US AUTH 2015	23	35	38	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142216	10.1371/journal.pone.0142216	http://dx.doi.org/10.1371/journal.pone.0142216			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562786	gold, Green Submitted, Green Published			2022-12-26	WOS:000364480900020
J	Berry, MS; Repke, MA; Nickerson, NP; Conway, LG; Odum, AL; Jordan, KE				Berry, Meredith S.; Repke, Meredith A.; Nickerson, Norma P.; Conway, Lucian G., III; Odum, Amy L.; Jordan, Kerry E.			Making Time for Nature: Visual Exposure to Natural Environments Lengthens Subjective Time Perception and Reduces Impulsivity	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; EPISODIC FUTURE THINKING; PATHOLOGICAL GAMBLERS; DELAY; REWARDS; ATTENTION; CHOICE; MONEY; PROBABILITY; MONETARY	Impulsivity in delay discounting is associated with maladaptive behaviors such as overeating and drug and alcohol abuse. Researchers have recently noted that delay discounting, even when measured by a brief laboratory task, may be the best predictor of human health related behaviors (e.g., exercise) currently available. Identifying techniques to decrease impulsivity in delay discounting, therefore, could help improve decision-making on a global scale. Visual exposure to natural environments is one recent approach shown to decrease impulsive decision-making in a delay discounting task, although the mechanism driving this result is currently unknown. The present experiment was thus designed to evaluate not only whether visual exposure to natural (mountains, lakes) relative to built (buildings, cities) environments resulted in less impulsivity, but also whether this exposure influenced time perception. Participants were randomly assigned to either a natural environment condition or a built environment condition. Participants viewed photographs of either natural scenes or built scenes before and during a delay discounting task in which they made choices about receiving immediate or delayed hypothetical monetary outcomes. Participants also completed an interval bisection task in which natural or built stimuli were judged as relatively longer or shorter presentation durations. Following the delay discounting and interval bisection tasks, additional measures of time perception were administered, including how many minutes participants thought had passed during the session and a scale measurement of whether time "flew" or "dragged" during the session. Participants exposed to natural as opposed to built scenes were less impulsive and also reported longer subjective session times, although no differences across groups were revealed with the interval bisection task. These results are the first to suggest that decreased impulsivity from exposure to natural as opposed to built environments may be related to lengthened time perception.	[Berry, Meredith S.; Nickerson, Norma P.] Univ Montana, Dept Soc & Conservat, Missoula, MT 59812 USA; [Repke, Meredith A.; Conway, Lucian G., III] Univ Montana, Dept Psychol, Missoula, MT 59812 USA; [Berry, Meredith S.; Odum, Amy L.; Jordan, Kerry E.] Utah State Univ, Dept Psychol, Logan, UT 84322 USA	University of Montana System; University of Montana; University of Montana System; University of Montana; Utah System of Higher Education; Utah State University	Berry, MS (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA.	mberry13@jhmi.edu						Anderson K, 2011, PHILOS T R SOC A, V369, P20, DOI 10.1098/rsta.2010.0290; Anokhin AP, 2011, BEHAV GENET, V41, P175, DOI 10.1007/s10519-010-9384-7; Arbuthnott KD, 2010, ANAL SOC ISS PUB POL, V10, P4, DOI 10.1111/j.1530-2415.2009.01196.x; Barkley RA, 2001, J ABNORM CHILD PSYCH, V29, P541, DOI 10.1023/A:1012233310098; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Baumann AA, 2012, BEHAV PROCESS, V90, P408, DOI 10.1016/j.beproc.2012.04.005; Berry MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097915; Berto R, 2005, J ENVIRON PSYCHOL, V25, P249, DOI 10.1016/j.jenvp.2005.07.001; Black AC, 2011, ADDICT BEHAV, V36, P125, DOI 10.1016/j.addbeh.2010.08.014; Blasing T. J., 2011, RECORD HIGH 2010 GLO; Bowler Diana E, 2010, BMC Public Health, V10, P456, DOI 10.1186/1471-2458-10-456; Centers for Disease Control and Prevention, 2014, AD OB FACTS; Chabris CF, 2008, J RISK UNCERTAINTY, V37, P237, DOI 10.1007/s11166-008-9053-x; Chivian E., 2008, SUSTAINING LIFE HUMA, pXI; Conway LG, 2004, J EXP SOC PSYCHOL, V40, P113, DOI 10.1016/S0022-1031(03)00089-1; Daniel TO, 2013, PSYCHOL SCI, V24, P2339, DOI 10.1177/0956797613488780; de Wit H, 2009, ADDICT BIOL, V14, P22, DOI 10.1111/j.1369-1600.2008.00129.x; Dixon MR, 2006, J APPL BEHAV ANAL, V39, P413, DOI 10.1901/jaba.2006.173-05; Dixon MR, 2003, J APPL BEHAV ANAL, V36, P449, DOI 10.1901/jaba.2003.36-449; Droit-Volet S, 2007, TRENDS COGN SCI, V11, P504, DOI 10.1016/j.tics.2007.09.008; Droit-Volet S, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00033; Friedel JE, 2014, PSYCHOPHARMACOLOGY, V231, P4517, DOI 10.1007/s00213-014-3597-z; Gilman JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101570; Green L, 2004, PSYCHOL BULL, V130, P769, DOI 10.1037/0033-2909.130.5.769; Hardisty DJ, 2009, J EXP PSYCHOL GEN, V138, P329, DOI 10.1037/a0016433; Hepburn C, 2010, ENVIRON RESOUR ECON, V46, P189, DOI 10.1007/s10640-010-9354-9; Johnson MW, 2008, EXP CLIN PSYCHOPHARM, V16, P264, DOI 10.1037/1064-1297.16.3.264; Johnson PS, 2015, J EXP ANAL BEHAV, V103, P87, DOI 10.1002/jeab.110; Kangas BD, 2009, BEHAV PROCESS, V82, P164, DOI 10.1016/j.beproc.2009.06.004; Kaplan BA, 2014, PSYCHOL REC, V64, P261, DOI 10.1007/s40732-014-0041-z; Koffarnus MN, 2013, J EXP ANAL BEHAV, V99, P32, DOI 10.1002/jeab.2; Lagorio CH, 2005, BEHAV PROCESS, V69, P173, DOI 10.1016/j.beproc.2005.02.003; Madden G.J., 2010, IMPULSIVITY BEHAV NE, P3; Mazur J.E., 1987, QUANTITATIVE ANAL BE, P55; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Myerson J, 2001, J EXP ANAL BEHAV, V76, P235, DOI 10.1901/jeab.2001.76-235; National Institutes on Drug Abuse, 2014, TRENDS STAT; Odum AL, 2011, J EXP ANAL BEHAV, V96, P427, DOI 10.1901/jeab.2011.96-423; Odum AL, 2011, BEHAV PROCESS, V87, P1, DOI 10.1016/j.beproc.2011.02.007; Peper JS, 2013, CEREB CORTEX, V23, P1695, DOI 10.1093/cercor/bhs163; Peters J, 2010, NEURON, V66, P138, DOI 10.1016/j.neuron.2010.03.026; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Rachlin H, 2006, J EXP ANAL BEHAV, V85, P425, DOI 10.1901/jeab.2006.85-05; RACHLIN H, 1991, J EXP ANAL BEHAV, V55, P233, DOI 10.1901/jeab.1991.55-233; Radu PT, 2011, J EXP ANAL BEHAV, V96, P363, DOI 10.1901/jeab.2011.96-363; Reed SC, 2012, EXP CLIN PSYCHOPHARM, V20, P454, DOI 10.1037/a0029087; Rodzon K, 2011, BEHAV PROCESS, V86, P164, DOI 10.1016/j.beproc.2010.09.007; Rubia K, 2009, PHILOS T R SOC B, V364, P1919, DOI 10.1098/rstb.2009.0014; Rudd M, 2012, PSYCHOL SCI, V23, P1130, DOI 10.1177/0956797612438731; Rung JM, 2015, J EXP ANAL BEHAV, V103, P108, DOI 10.1002/jeab.132; Sheffer CE, 2014, ADDICT BEHAV, V39, P1682, DOI 10.1016/j.addbeh.2014.04.019; Takahashi T, 2007, PHYSICA A, V385, P637, DOI 10.1016/j.physa.2007.07.020; Thompson CW, 2012, LANDSCAPE URBAN PLAN, V105, P221, DOI 10.1016/j.landurbplan.2011.12.015; ULRICH RS, 1981, ENVIRON BEHAV, V13, P523, DOI 10.1177/0013916581135001; Ungemach C, 2011, PSYCHOL SCI, V22, P253, DOI 10.1177/0956797610396225; van der Wal AJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2295; Weller RE, 2008, APPETITE, V51, P563, DOI 10.1016/j.appet.2008.04.010; White MP, 2013, PSYCHOL SCI, V24, P920, DOI 10.1177/0956797612464659; Wittmann M., 2009, J NEUROSCIENCE PSYCH, V2, P1, DOI [10.1037/a0015460, DOI 10.1037/A0015460]; Wittmann M, 2007, DRUG ALCOHOL DEPEN, V90, P183, DOI 10.1016/j.drugalcdep.2007.03.005; Wittmann M, 2011, BRAIN RES, V1406, P43, DOI 10.1016/j.brainres.2011.06.048	61	38	38	5	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141030	10.1371/journal.pone.0141030	http://dx.doi.org/10.1371/journal.pone.0141030			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7DR	26558610	Green Published, Green Submitted, gold			2022-12-26	WOS:000364433100019
J	Cunha, HA; de Castro, RL; Secchi, ER; Crespo, EA; Lailson-Brito, J; Azevedo, AF; Lazoski, C; Sole-Cava, AM				Cunha, Haydee A.; de Castro, Rocio Loizaga; Secchi, Eduardo R.; Crespo, Enrique A.; Lailson-Brito, Jose; Azevedo, Alexandre F.; Lazoski, Cristiano; Sole-Cava, Antonio M.			Molecular and Morphological Differentiation of Common Dolphins (Delphinus sp.) in the Southwestern Atlantic: Testing the Two Species Hypothesis in Sympatry	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; PHYLOGENETIC-RELATIONSHIPS; TAXONOMIC STATUS; MITOCHONDRIAL; CETACEANS; BIOGEOGRAPHY; ABUNDANCE; SOFTWARE; INSIGHTS; DENSITY	The taxonomy of common dolphins (Delphinus sp.) has always been controversial, with over twenty described species since the original description of the type species of the genus (Delphinus delphis Linnaeus, 1758). Two species and four subspecies are currently accepted, but recent molecular data have challenged this view. In this study we investigated the molecular taxonomy of common dolphins through analyses of cytochrome b sequences of 297 individuals from most of their distribution. We included 37 novel sequences from the Southwestern Atlantic Ocean, a region where the short-and long-beaked morphotypes occur in sympatry, but which had not been well sampled before. Skulls of individuals from the Southwestern Atlantic were measured to test the validity of the rostral index as a diagnostic character and confirmed the presence of the two morphotypes in our genetic sample. Our genetic results show that all common dolphins in the Atlantic Ocean belong to a single species, Delphinus delphis. According to genetic data, the species Delphinus capensis is invalid. Long-beaked common dolphins from the Northeastern Pacific Ocean may constitute a different species. Our conclusions prompt the need for revision of currently accepted common dolphin species and subspecies and of Delphinus delphis distribution.	[Cunha, Haydee A.; Lailson-Brito, Jose; Azevedo, Alexandre F.] Univ Estado Rio de Janeiro, Lab Mamiferos Aquat & Bioindicadores MAOUA, Fac Oceanog, BR-20550011 Rio De Janeiro, RJ, Brazil; [de Castro, Rocio Loizaga; Crespo, Enrique A.] Ctr Nacl Patagon CONICET, Lab Mamiferos Marinos, Puerto Madryn, Chubut, Argentina; [Secchi, Eduardo R.] Fundacao Univ Rio Grande, Inst Oceanog, Lab Ecol Conservacao Megafauna Marinh EcoMega, Rio Grande, RS, Brazil; [Cunha, Haydee A.; Lazoski, Cristiano; Sole-Cava, Antonio M.] Univ Fed Rio de Janeiro, Inst Biol, Lab Biodiversidade Mol, Rio De Janeiro, RJ, Brazil	Universidade do Estado do Rio de Janeiro; Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidade Federal do Rio Grande; Universidade Federal do Rio de Janeiro	Cunha, HA (corresponding author), Univ Estado Rio de Janeiro, Lab Mamiferos Aquat & Bioindicadores MAOUA, Fac Oceanog, BR-20550011 Rio De Janeiro, RJ, Brazil.	haydeecunha@yahoo.com.br	AZEVEDO, ALEXANDRE/HII-5648-2022; Azevedo, Alexandre/B-9660-2013; Cunha, Haydee/O-1940-2017; Secchi, Eduardo R./ABF-1191-2020; Sole-Cava, Antonio M/G-4209-2011; Brito, Jose Lailson/B-3572-2013; Lazoski, Cristiano/H-6192-2013; Lazoski, Cristiano/U-5549-2019	Azevedo, Alexandre/0000-0002-3754-9035; Secchi, Eduardo R./0000-0001-9087-9909; Sole-Cava, Antonio M/0000-0003-0363-5821; Brito, Jose Lailson/0000-0001-8366-458X; Lazoski, Cristiano/0000-0002-6322-4672	UERJ; FAPERJ; CENPAT; Cetacean Society International; Cetacean Specialist Group (IUCN); MEC-ICI (Agencia Espanola de Cooperacion Internacional); Center for Marine Conservation; MCTI/CNPq; UERJ ("Prociencia" Program); CNPq [305303/2010-4, 304826/2008-1, 305515/2009-8, 307843/2011-4]; FAPERJ (JCNE) [101.449/2010]	UERJ; FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CENPAT; Cetacean Society International; Cetacean Specialist Group (IUCN); MEC-ICI (Agencia Espanola de Cooperacion Internacional); Center for Marine Conservation; MCTI/CNPq; UERJ ("Prociencia" Program); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ (JCNE)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	Samples from Rio de Janeiro were collected from stranded specimens by the MAQUA (Laboratorio de Mamiferos Aquaticos e Bioindicadores/UERJ) team, with the financial support of UERJ and FAPERJ. Argentine samples were collected from incidentally caught individuals with partial funding by CENPAT, Cetacean Society International, Cetacean Specialist Group (IUCN), MEC- ICI (Agencia Espanola de Cooperacion Internacional) and the Center for Marine Conservation. Thanks are also given to Bill Rossiter, Randy Reeves, Toni Raga and Mary McLean for their continuous and encouraging help and support to CENPAT. Samples from Rio Grande do Sul were collected from stranded carcasses and through biopsy darting, by the EcoMega (Laboratorio de Ecologia e Conservacao da Megafauna Marinha/FURG) team. We are also grateful to Juliana Marigo, Carolina Bertozzi and Projeto Biopesca for the sample from Sao Paulo, and to two anonymous referees, for their suggestions to the manuscript. Molecular analyses were performed in the Laboratorio de Biodiversidade Molecular, UFRJ, and were funded by MCTI/CNPq. JLB has a research grant from UERJ ("Prociencia" Program), CNPq (grant #305303/2010-4) and FAPERJ (JCNE). AFA has a research grant from CNPq (grant #304826/2008-1), FAPERJ (JCNE #101.449/2010) and UERJ ("Prociencia" Program). AMSC and ERS have research grants from CNPq (grant #s 305515/2009-8 and 307843/2011-4, respectively).	Amaha A, 1994, GEOGRAPHIC VARIATION; Amaral AR, 2007, MAR BIOL, V151, P1967, DOI 10.1007/s00227-007-0635-y; Amaral AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083645; Amaral AR, 2012, MOL ECOL, V21, P4854, DOI 10.1111/j.1365-294X.2012.05728.x; Amos W, 1990, INDIVIDUAL RECOGNITI; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Artedi P, 1736, POSTH, V76; Avise John C., 1994, pi; BANKS RC, 1969, J MAMMAL, V50, P262, DOI 10.2307/1378342; Barabash I. I., 1935, Bulletin de la Societe des Naturalistes de Moscou Sect Biol, V44, P246; Barlow J, 2007, FISH B-NOAA, V105, P509; Bell Catherine H., 2002, Australian Mammalogy, V24, P1; Carretta J V, 2003, MAR FISH REV, V66, P21; Charland KM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017207, 10.1371/journal.pone.0024047]; COCKCROFT VG, 1990, S AFR J MARINE SCI, V9, P371; Cunha HA, 2005, MAR BIOL, V148, P449, DOI 10.1007/s00227-005-0078-2; Dall WH, 1873, ANN MAG NAT HIST, V11, P316; de Boer MN, 2010, J MAR BIOL ASSOC UK, V90, P1613, DOI 10.1017/S0025315410001165; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Duchene S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027138; Evans W., 1994, HDB MARINE MAMMALS, V5, P191; Filby NE, 2010, AQUAT MAMM, V36, P33, DOI 10.1578/AM.36.1.2010.33; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Gonzalez P., 2002, CRECIMIENTO DESARROL; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hammond PS, 2008, DELPHINUS DELPHIS; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hershkovitz P., 1966, Bulletin United States National Museum, VNo. 246, P1; Heyning John E., 1994, Contributions in Science (Los Angeles), V442, P1; Jefferson T.A., 2015, COMPREHENSIVE GUIDE; Jefferson TA, 2002, MAR MAMMAL SCI, V18, P787, DOI 10.1111/j.1748-7692.2002.tb01074.x; Jefferson TA, 2009, MAR BIOL, V156, P1109, DOI 10.1007/s00227-009-1152-y; Kingston SE, 2004, J HERED, V95, P1, DOI 10.1093/jhered/esh010; LeDuc RG, 1999, MAR MAMMAL SCI, V15, P619, DOI 10.1111/j.1748-7692.1999.tb00833.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Linnaeus C, 1767, SYSTEMA NATURAE REGN, VI, DOI 10.5962/bhl.title.542; Miller G. S., 1936, Proceedings of the Biological Society of Washington, V49, P145; Morin PA, 2010, GENOME RES, V20, P908, DOI 10.1101/gr.102954.109; Moura AE, 2014, HEREDITY EDINB, V114, P1; Murphy S, 2006, MAR MAMMAL SCI, V22, P573, DOI 10.1111/j.1748-7692.2006.00037.x; Natoli A, 2006, J EVOLUTION BIOL, V19, P943, DOI 10.1111/j.1420-9101.2005.01033.x; Natoli A, 2008, CONSERV GENET, V9, P627, DOI 10.1007/s10592-007-9379-y; Perrin W., 2017, ENCY MARINE MAMMALS, P245; Perrin WF, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P255; Pinela AM, 2011, J ZOOL, V284, P239, DOI 10.1111/j.1469-7998.2011.00798.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; RICE DW, 1998, MARINE MAMMALS WORLD; ROSEL PE, 1994, MAR BIOL, V119, P159, DOI 10.1007/BF00349552; Samaai T, 2005, AFR J MAR SCI, V27, P449, DOI 10.2989/18142320509504103; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Silva MA, 2014, MAR BIOL RES, V10, P123, DOI 10.1080/17451000.2013.793814; Stockin KA, 2014, MAR MAMMAL SCI, V30, P44, DOI 10.1111/mms.12027; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tavares M, 2010, MAMMAL REV, V40, P40, DOI 10.1111/j.1365-2907.2009.00154.x; Thompson Finlay N, 2013, PLoS One, V8, pe64438, DOI 10.1371/journal.pone.0064438; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; True FW., 1889, B US NATL MUSEUM, V36, P1; Van Bree P. J. H., 1971, Mammalia, V35, P345; VANBREE PJH, 1972, J MAMMAL, V53, P372, DOI 10.2307/1379178; Westgate AJ, 2007, J MAMMAL, V88, P678, DOI 10.1644/06-MAMM-A-177R.1; Xiong Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-20	61	28	30	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0140251	10.1371/journal.pone.0140251	http://dx.doi.org/10.1371/journal.pone.0140251			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559411	Green Submitted, Green Published, gold			2022-12-26	WOS:000364433100005
J	Fang, HW; Fazeli, M; Cheng, W; Huang, L; Hu, HY				Fang, Hongwei; Fazeli, Mehdi; Cheng, Wei; Huang, Lei; Hu, Hongying			Biostabilization and Transport of Cohesive Sediment Deposits in the Three Gorges Reservoir	PLOS ONE			English	Article							STABILITY; STABILIZATION; ERODIBILITY; MORPHOLOGY; VELOCITY; EROSION	Cohesive sediment deposits in the Three Gorges Reservoir, China, were used to investigate physical and geochemical properties, biofilm mass, and erosion and deposition characteristics. Biofilm cultivation was performed in a recirculating flume for three different periods (5, 10 and 15 days) under ambient temperature and with sufficient nutrients supply. Three groups of size-fractionated sediment were sequentially used, including 0-0.02 mm, 0.02-0.05 mm and 0.05-0.10 mm. Desired conditions for erosion and deposition were designed by managing high bed shear stress at the narrow part of upstream flume and low shear stress at the wide part of downstream flume. Biostabilization and transport characteristics of the biofilm coated sediment (bio-sediment) were strongly influenced by the cultivation period, and the results were compared with clean sediment. The bio-sediment was more resistant to erosion, and the mean shear stress was increased by factors of 2.65, 2.73 and 5.01 for sediment with 5, 10 and 15 days of biofilm growth compared with clean sediment, resulting in less sediment being eroded from the bed. Simultaneously, the settling velocity was smaller for bio-sediment due to higher organic content and porosity (i.e., lower density). Additionally, there was a smaller probability of deposition for sediment with a longer cultivation period after erosion, resulting in more retention time in aquatic systems. These results will benefit water management in natural rivers.	[Fang, Hongwei; Fazeli, Mehdi; Cheng, Wei; Huang, Lei] Tsinghua Univ, Dept Hydraul Engn, State Key Lab Hydrosci & Engn, Beijing 100084, Peoples R China; [Fazeli, Mehdi] Univ Yasuj, Dept Civil Engn, Yasuj, Iran; [Hu, Hongying] Tsinghua Univ, Sch Environm, Beijing 100084, Peoples R China	Tsinghua University; Yasouj University; Tsinghua University	Huang, L (corresponding author), Tsinghua Univ, Dept Hydraul Engn, State Key Lab Hydrosci & Engn, Beijing 100084, Peoples R China.	huangl05@mails.tsinghua.edu.cn	Fazeli, Mehdi/AAV-5695-2020	Fazeli, Mehdi/0000-0002-2787-3368	National Natural Science Foundation of China [51139003, 11372161]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 51139003 and 11372161). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CL, 2004, J MARINE SYST, V51, P211, DOI 10.1016/j.jmarsys.2004.05.013; Black KS, 2002, J HYDRAUL ENG, V128, P2, DOI 10.1061/(ASCE)0733-9429(2002)128:1(2); Chen MH, 2013, OCEAN DYNAM, V63, P1113, DOI 10.1007/s10236-013-0641-1; de Brouwer JFC, 2005, MICROB ECOL, V49, P501, DOI 10.1007/s00248-004-0020-z; Droppo IG, 2009, MAR FRESHWATER RES, V60, P690, DOI 10.1071/MF08019; Droppo IG, 2001, J SEDIMENT RES, V71, P717, DOI 10.1306/2DC40963-0E47-11D7-8643000102C1865D; Fang H. W., 2009, SURFACE CHARACTERIST; Fang HW, 2013, INT J SEDIMENT RES, V28, P246, DOI 10.1016/S1001-6279(13)60035-9; Fang HW, 2014, J HYDRO-ENVIRON RES, V8, P186, DOI 10.1016/j.jher.2014.04.003; Fang HW, 2014, SEDIMENTOLOGY, V61, P648, DOI 10.1111/sed.12065; Fang HW, 2000, J HYDRAUL ENG-ASCE, V126, P578, DOI 10.1061/(ASCE)0733-9429(2000)126:8(578); Fang HW, 2003, J HYDRAUL RES, V41, P379, DOI 10.1080/00221680309499983; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Friend PL, 2003, CONT SHELF RES, V23, P1899, DOI 10.1016/j.csr.2002.12.001; Gerbersdorf SU, 2008, GEOBIOLOGY, V6, P57, DOI 10.1111/j.1472-4669.2007.00120.x; GIBBS RJ, 1983, ENVIRON SCI TECHNOL, V17, P237, DOI 10.1021/es00110a011; Grabowski RC, 2011, EARTH-SCI REV, V105, P101, DOI 10.1016/j.earscirev.2011.01.008; Hagadorn JW, 2012, SEDIMENTOLOGY, V59, P795, DOI 10.1111/j.1365-3091.2011.01278.x; Headley JV, 1998, ENVIRON SCI TECHNOL, V32, P3968, DOI 10.1021/es980499l; Huang L, 2015, CHEMOSPHERE, V134, P374, DOI 10.1016/j.chemosphere.2015.05.009; Koster M, 2007, SEDIMENT DYNAMICS PO; Kuang Qi-jun, 2005, Acta Hydrobiologica Sinica, V29, P353; Liu C, 2013, INT J SEDIMENT RES, V28, P486, DOI 10.1016/S1001-6279(14)60007-X; Liu YY, 2009, PLANT SOIL, V317, P213, DOI 10.1007/s11104-008-9803-1; Neu TR., 1994, BIOSTABILIZATION; Samaras AG, 2014, INT J SEDIMENT RES, V29, P304, DOI 10.1016/S1001-6279(14)60046-9; Shang QQ, 2014, INT J SEDIMENT RES, V29, P471, DOI 10.1016/S1001-6279(14)60060-3; Stone M, 2011, WATER RES, V45, P521, DOI 10.1016/j.watres.2010.09.016; Sutherland TF, 1998, LIMNOL OCEANOGR, V43, P225, DOI 10.4319/lo.1998.43.2.0225; Underwood GJC, 2003, ADV BOT RES, V40, P183, DOI 10.1016/S0065-2296(05)40005-1; Viparelli E, 2015, SEDIMENTOLOGY, V62, P1384, DOI 10.1111/sed.12187; Watanabe R, 2008, P 4 INT C SCOUR ER T; Wingender J., 1999, MICROBIAL EXTRACELLU; [吴志超 Wu Zhichao], 2005, [环境污染与防治, Environmental Pollution & Control], V27, P177; Yao QZ, 2009, APPL GEOCHEM, V24, P2186, DOI 10.1016/j.apgeochem.2009.09.023; Zhao HM., 2009, 33 IAHR C WAT ENG SU; Zhao HM, 2011, SCANNING, V33, P437, DOI 10.1002/sca.20247	37	15	16	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142673	10.1371/journal.pone.0142673	http://dx.doi.org/10.1371/journal.pone.0142673			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560122	gold, Green Submitted, Green Published			2022-12-26	WOS:000364433100109
J	Pasotti, F; Saravia, LA; De Troch, M; Tarantelli, MS; Sahade, R; Vanreusel, A				Pasotti, Francesca; Ariel Saravia, Leonardo; De Troch, Marleen; Soledad Tarantelli, Maria; Sahade, Ricardo; Vanreusel, Ann			Benthic Trophic Interactions in an Antarctic Shallow Water Ecosystem Affected by Recent Glacier Retreat	PLOS ONE			English	Article							KING-GEORGE ISLAND; STABLE-ISOTOPE RATIOS; POTTER COVE; SIGNY ISLAND; PRIAPULUS-CAUDATUS; FEEDING ECOLOGY; COASTAL WATERS; ORGANIC-MATTER; MARTEL INLET; FOOD-WEB	The western Antarctic Peninsula is experiencing strong environmental changes as a consequence of ongoing regional warming. Glaciers in the area are retreating rapidly and increased sediment-laden meltwater runoff threatens the benthic biodiversity at shallow depths. We identified three sites with a distinct glacier-retreat related history and different levels of glacial influence in the inner part of Potter Cove (King George Island, South Shetland Islands), a fjord-like embayment impacted since the 1950s by a tidewater glacier retreat. We compared the soft sediment meio- and macrofauna isotopic niche widths (delta C-13 and delta N-15 stable isotope analysis) at the three sites to investigate possible glacier retreat-related influences on benthic trophic interactions. The isotopic niches were locally shaped by the different degrees of glacier retreat-related disturbance within the Cove. Wider isotopic niche widths were found at the site that has become ice-free most recently, and narrower niches at the older ice-free sites. At an intermediate state of glacier retreat-related disturbance (e.g. via ice-growler scouring) species with different strategies could settle. The site at the earliest stage of post-retreat development was characterized by an assemblage with lower trophic redundancy. Generally, the isotopic niche widths increased with increasing size spectra of organisms within the community, excepting the youngest assemblage, where the pioneer colonizer meiofauna size class displayed the highest isotopic niche width. Meiofauna at all sites generally occupied positions in the isotopic space that suggested a detrital-pool food source and/or the presence of predatory taxa. In general ice scour and glacial impact appeared to play a two-fold role within the Cove: i) either stimulating trophic diversity by allowing continuous re-colonization of meiofaunal species or, ii) over time driving the benthic assemblages into a more compact trophic structure with increased connectedness and resource recycling.	[Pasotti, Francesca; De Troch, Marleen; Vanreusel, Ann] Univ Ghent, Marine Biol Lab, B-9000 Ghent, Belgium; [Ariel Saravia, Leonardo] Natl Univ Gen Sarmiento, Inst Sci, RA-1613 Buenos Aires, DF, Argentina; [Soledad Tarantelli, Maria; Sahade, Ricardo] Univ Nacl Cordoba, CONICET, Inst Anim Div & Ecol, Fac Cs EF & Nat, RA-5000 Cordoba, Argentina	Ghent University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Pasotti, F (corresponding author), Univ Ghent, Marine Biol Lab, Krijgslaan 281-S8, B-9000 Ghent, Belgium.	Francesca.pasotti@ugent.be	Saravia, Leonardo A./AAM-3461-2021; De Troch, Marleen/AAB-9809-2019	Saravia, Leonardo A./0000-0002-7911-4398; De Troch, Marleen/0000-0002-6800-0299; Sahade, Ricardo/0000-0001-5650-8135	Belgian Science Policy Office (BELSPO) [BR/132/A1/vERSO]; EU project Imconet (FP7 IRSES) [319718]	Belgian Science Policy Office (BELSPO)(Belgian Federal Science Policy Office); EU project Imconet (FP7 IRSES)	The authors acknowledge the vERSO project (www.versoproject.be, funded by the Belgian Science Policy Office (BELSPO, contract no BR/132/A1/vERSO) and the EU project Imconet (FP7 IRSES, action no. 319718) for financial and networking support. We acknowledge the vERSO project (www.versoproject.be), funded by the Belgian Science Policy Office (BELSPO, contract no BR/132/A1/vERSO) and the EU project Imconet (FP7 IRSES, action no. 319718) for financial and networking support. We would like to thank all the military and scientific staff at Carlini base for their valuable assistance during the sampling process. A special thank goes to Oscar Gonzales and Doris Abele for their logistic support.	Abram NJ, 2013, NAT GEOSCI, V6, P404, DOI [10.1038/ngeo1787, 10.1038/NGEO1787]; Anisimov O.A., 2001, CLIMATE CHANGE 2001, P85; Barnes DKA, 2008, CLIM RES, V37, P149, DOI 10.3354/cr00760; Barnes DKA, 2011, NAT CLIM CHANGE, V1, P365, DOI 10.1038/NCLIMATE1232; Barrett JE, 2008, GLOBAL CHANGE BIOL, V14, P2249, DOI 10.1111/j.1365-2486.2008.01641.x; Batschelet E, 1981, CIRCULAR STAT BIOL; BEST BA, 1988, BIOL BULL-US, V175, P332, DOI 10.2307/1541723; Bick A, 2013, POLAR BIOL, V36, P673, DOI 10.1007/s00300-013-1293-9; Blazewicz-Paszkowycz M, 2002, ANTARCT SCI, V14, P11, DOI 10.1017/S0954102002000524; Bromberg S, 2000, B MAR SCI, V67, P175; Brown KM, 2004, OECOLOGIA, V141, P121, DOI 10.1007/s00442-004-1648-6; Brown LE, 2012, GLOBAL CHANGE BIOL, V18, P2195, DOI 10.1111/j.1365-2486.2012.02675.x; Convey P, 2009, ANTARCT SCI, V21, P541, DOI 10.1017/S0954102009990642; Convey P, 2011, POLAR BIOL, V34, P1629, DOI 10.1007/s00300-011-1068-0; Cook A. J., 2009, CRYOSPHERE DISCUSSIO, V3, P579; Cook AJ, 2005, SCIENCE, V308, P541, DOI 10.1126/science.1104235; Corbisier TN, 2004, POLAR BIOL, V27, P75, DOI 10.1007/s00300-003-0567-z; DAVENPORT J, 1988, PROC R SOC SER B-BIO, V232, P431, DOI 10.1098/rspb.1988.0005; De Troch M, 2005, AQUAT MICROB ECOL, V39, P135, DOI 10.3354/ame039135; Denny M, 2011, BIOL BULL-US, V221, P155, DOI 10.1086/BBLv221n2p155; Dierssen HM, 2002, P NATL ACAD SCI USA, V99, P1790, DOI 10.1073/pnas.032206999; Eraso A., 2007, KARST CRYOKARST STUD, V45, P111; Fauchald K., 1979, Oceanography and Marine Biology an Annual Review, V17, P193; Favero-Longo SE, 2012, ANTARCT SCI, V24, P323, DOI 10.1017/S0954102012000120; Gillies CL, 2013, MAR ECOL PROG SER, V478, P27, DOI 10.3354/meps10214; Gillies CL, 2012, ESTUAR COAST SHELF S, V97, P44, DOI 10.1016/j.ecss.2011.11.003; Gillies CL, 2012, THESIS; Grange LJ, 2013, PLOS ONE, V32, P20040; Gryziak G, 2009, PESQUI AGROPECU BRAS, V44, P891, DOI 10.1590/S0100-204X2009000800013; Guerra-Garcia JM, 2014, J SEA RES, V85, P508, DOI 10.1016/j.seares.2013.08.006; Gutt J, 2001, POLAR BIOL, V24, P553, DOI 10.1007/s003000100262; Gutt J, 2011, DEEP-SEA RES PT II, V58, P74, DOI 10.1016/j.dsr2.2010.05.024; Halliday N, 1939, J BIOL CHEM, V129, P65; HEIP C, 1974, MAR BIOL, V28, P79, DOI 10.1007/BF00389120; HEIP C, 1985, OCEANOGR MAR BIOL, V23, P399; Higgins R. P., 1988, INTRO STUDY MEIOFAUN; Husmann G, 2012, ESTUAR COAST SHELF S, V111, P48, DOI 10.1016/j.ecss.2012.06.003; Ilieva-Makulec K, 2009, POL J ECOL, V57, P811; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; JENSEN P, 1987, MAR ECOL PROG SER, V35, P187, DOI 10.3354/meps035187; Kaehler S, 2001, MAR ECOL PROG SER, V219, P299, DOI 10.3354/meps219299; Kaehler S, 2000, MAR ECOL PROG SER, V208, P13, DOI 10.3354/meps208013; KLOSER H, 1994, ESTUAR COAST SHELF S, V38, P523, DOI 10.1006/ecss.1994.1036; Kozloff E. N, 1990, INVERTEBRATES; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Ledger ME, 2008, OECOLOGIA, V155, P809, DOI 10.1007/s00442-007-0950-5; Lee HJ, 2001, POLAR BIOL, V24, P926; Lee HJ, 2001, POLAR BIOL, V24, P918, DOI 10.1007/s003000100300; Lehmann MF, 2002, GEOCHIM COSMOCHIM AC, V66, P3573, DOI 10.1016/S0016-7037(02)00968-7; Quartino ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058223; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; MACARTHUR RH, 1972, ECOLOGY, V53, P330, DOI 10.2307/1934090; Maddi P, THESIS, P1; McCarthy MA, 2007, BAYESIAN METHODS FOR ECOLOGY, P1, DOI 10.1017/CBO9780511802454; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; Moens T, 2002, MAR ECOL PROG SER, V234, P127, DOI 10.3354/meps234127; Nyssen F, 2005, ROLE BENTHIC AMPHIPO; Pasotti F, 2015, MAR ECOL-EVOL PERSP, V36, P716, DOI 10.1111/maec.12179; Pasotti F, 2012, POLAR BIOL, V35, P1629, DOI 10.1007/s00300-012-1203-6; Peck LS, 1999, MAR ECOL PROG SER, V186, P1, DOI 10.3354/meps186001; PECK LS, 1993, MAR BIOL, V117, P235, DOI 10.1007/BF00345668; Philipp EER, 2011, ANTARCT SCI, V23, P127, DOI 10.1017/S0954102010000970; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Pritchard HD, 2012, NATURE, V484, P502, DOI 10.1038/nature10968; Pugh PJA, 1997, J EXP MAR BIOL ECOL, V210, P1, DOI 10.1016/S0022-0981(96)02711-6; Quartino ML, 2008, POLAR BIOL, V31, P281, DOI 10.1007/s00300-007-0356-1; Raes M, 2010, GLOBAL CHANGE BIOL, V16, P1618, DOI 10.1111/j.1365-2486.2009.02137.x; Rennie MD, 2012, CAN J ZOOL, V90, P1320, DOI 10.1139/z2012-101; Ruckamp M, 2011, GLOBAL PLANET CHANGE, V79, P99, DOI 10.1016/j.gloplacha.2011.06.009; Ruppert EE, 1994, INVERTEBRATE ZOOLOGY; Sahade R, 1998, POLAR BIOL, V19, P85, DOI 10.1007/s003000050218; Sahade Ricardo, 2008, Berichte zur Polar- und Meeresforschung, V571, P331; Sahade Ricardo, 1998, Berichte zur Polarforschung, V299, P123; Sancho LG, 2011, POLAR BIOL, V34, P813, DOI 10.1007/s00300-010-0935-4; Sarakinos HC, 2002, CAN J ZOOL, V80, P381, DOI 10.1139/z02-007; Scambos TA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020670; Schloss IR, 2014, LIMNOL OCEANOGR, V59, P195, DOI 10.4319/lo.2014.59.1.0195; Schloss IR, 2002, J MARINE SYST, V36, P129, DOI 10.1016/S0924-7963(02)00183-5; Schratzberger M, 1999, MAR ECOL PROG SER, V181, P227, DOI 10.3354/meps181227; Servetto N, 2013, POLAR RES, V32, DOI 10.3402/polar.v32i0.20040; SHIRLEY TC, 1990, B MAR SCI, V47, P149; Slattery M, 1997, POLAR BIOL, V18, P172, DOI 10.1007/s003000050174; Smale DA, 2008, SCIENCE, V349, P89; Smale DA, 2008, ECOGRAPHY, V31, P289, DOI 10.1111/j.0906-7590.2008.05456.x; Smale DA, 2008, MAR ECOL PROG SER, V355, P85, DOI 10.3354/meps07311; Smale DA, 2007, MAR ECOL PROG SER, V349, P89, DOI 10.3354/meps07104; Steig EJ, 2013, NAT GEOSCI, V6, P372, DOI [10.1038/ngeo1778, 10.1038/NGEO1778]; Syvaranta J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056094; Tatian M, 2004, ANTARCT SCI, V16, P123, DOI 10.1017/S0954102004001890; Tatian M, 2008, BERICHTE POLAR MEERE, P571; Tation M, 2008, POLAR BIOL, V31, P509, DOI 10.1007/s00300-007-0379-7; Tatian Marcos, 2008, Berichte zur Polar- und Meeresforschung, V571, P118; Thomas ER, 2013, GEOPHYS RES LETT, V40, P5492, DOI 10.1002/2013GL057782; Thrush S. F., 2011, MAR ECOL, V2011, P1; Torre L, 2014, MAR ENVIRON RES, V99, P179, DOI 10.1016/j.marenvres.2014.05.014; Torre L, 2012, POLAR BIOL, V35, P1743, DOI 10.1007/s00300-012-1208-1; Townsend CR, 1997, LIMNOL OCEANOGR, V42, P938, DOI 10.4319/lo.1997.42.5.0938; Trott TJ, 1998, MAR FRESHW BEHAV PHY, V31, P251, DOI 10.1080/10236249809387076; USTACH JF, 1982, J EXP MAR BIOL ECOL, V64, P203, DOI 10.1016/0022-0981(82)90010-7; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Vaughan DG, 2003, CLIMATIC CHANGE, V60, P243, DOI 10.1023/A:1026021217991; Veit-Kohler G, 2008, J EXP MAR BIOL ECOL, V363, P58, DOI 10.1016/j.jembe.2008.06.018; Walkusz W, 2007, OCEANOLOGIA, V49, P369; WARWICK RM, 1990, J EXP MAR BIOL ECOL, V138, P119, DOI 10.1016/0022-0981(90)90180-K; Wittmann KJ, 1996, BIOSYST ECOL SER, P221; Wolfl AC, 2014, GEO-MAR LETT, V34, P435, DOI 10.1007/s00367-014-0375-1	106	35	36	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141742	10.1371/journal.pone.0141742	http://dx.doi.org/10.1371/journal.pone.0141742			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559062	Green Published, Green Submitted, gold			2022-12-26	WOS:000364433100042
J	Tamosaityte, S; Galli, R; Uckermann, O; Sitoci-Ficici, KH; Later, R; Beiermeister, R; Doberenz, F; Gelinsky, M; Leipnitz, E; Schackert, G; Koch, E; Sablinskas, V; Steiner, G; Kirsch, M				Tamosaityte, Sandra; Galli, Roberta; Uckermann, Ortrud; Sitoci-Ficici, Kerim H.; Later, Robert; Beiermeister, Rudolf; Doberenz, Falko; Gelinsky, Michael; Leipnitz, Elke; Schackert, Gabriele; Koch, Edmund; Sablinskas, Valdas; Steiner, Gerald; Kirsch, Matthias			Biochemical Monitoring of Spinal Cord Injury by FT-IR Spectroscopy-Effects of Therapeutic Alginate Implant in Rat Models	PLOS ONE			English	Article							PROMOTES FUNCTIONAL RECOVERY; CENTRAL-NERVOUS-SYSTEM; OF-THE-ART; ENHANCES ELONGATION; REPAIR STRATEGIES; HUMAN TISSUES; STEM-CELLS; ADULT-RATS; HYDROGEL; GROWTH	Spinal cord injury (SCI) induces complex biochemical changes, which result in inhibition of nervous tissue regeneration abilities. In this study, Fourier-transform infrared (FT-IR) spectroscopy was applied to assess the outcomes of implants made of a novel type of non-functionalized soft calcium alginate hydrogel in a rat model of spinal cord hemisection (n = 28). Using FT-IR spectroscopic imaging, we evaluated the stability of the implants and the effects on morphology and biochemistry of the injured tissue one and six months after injury. A semi-quantitative evaluation of the distribution of lipids and collagen showed that alginate significantly reduced injury-induced demyelination of the contralateral white matter and fibrotic scarring in the chronic state after SCI. The spectral information enabled to detect and localize the alginate hydrogel at the lesion site and proved its long-term persistence in vivo. These findings demonstrate a positive impact of alginate hydrogel on recovery after SCI and prove FT-IR spectroscopic imaging as alternative method to evaluate and optimize future SCI repair strategies.	[Tamosaityte, Sandra; Galli, Roberta; Koch, Edmund; Steiner, Gerald] Tech Univ Dresden, Fac Med, Dept Anesthesiol & Intens Care Med, Clin Sensoring & Monitoring, Dresden, Germany; [Tamosaityte, Sandra; Sablinskas, Valdas; Steiner, Gerald] Vilnius State Univ, Fac Phys, Dept Gen Phys & Spect, Vilnius, Lithuania; [Uckermann, Ortrud; Sitoci-Ficici, Kerim H.; Later, Robert; Leipnitz, Elke; Schackert, Gabriele; Kirsch, Matthias] Tech Univ Dresden, Carl Gustav Carus Univ Hosp, Neurosurg, Dresden, Germany; [Beiermeister, Rudolf; Doberenz, Falko; Gelinsky, Michael] Tech Univ Dresden, Ctr Translat Bone Joint & Soft Tissue Res, Dresden, Germany; [Kirsch, Matthias] Tech Univ Dresden, Cluster Excellence, CRTD DFG Ctr Regenerat Therapies Dresden, Dresden, Germany	Technische Universitat Dresden; Vilnius University; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Technische Universitat Dresden	Galli, R (corresponding author), Tech Univ Dresden, Fac Med, Dept Anesthesiol & Intens Care Med, Clin Sensoring & Monitoring, Dresden, Germany.	roberta.galli@tu-dresden.de; matthias.kirsch@uniklinikum-dresden.de	Gelinsky, Michael/A-9680-2012	Gelinsky, Michael/0000-0001-9075-5121; Koch, Edmund/0000-0003-0554-2178	German Federal Ministry of Education and Research (MediCARS project) [A.Z. 13N10777]; Medical Faculty of the TU Dresden (Habilitationsforderung fur Frauen); Saxon Development Bank (SAB)	German Federal Ministry of Education and Research (MediCARS project); Medical Faculty of the TU Dresden (Habilitationsforderung fur Frauen); Saxon Development Bank (SAB)	This research was partly funded by the German Federal Ministry of Education and Research (MediCARS project, A.Z. 13N10777). Moreover OU is recipient of a fellowship from the Medical Faculty of the TU Dresden (Habilitationsforderung fur Frauen) and RB is recipient of a scholarship from the Saxon Development Bank (SAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorena E, 2013, INT J PHARMACEUT, V455, P148, DOI 10.1016/j.ijpharm.2013.07.045; Arvanian VL, 2009, EXP NEUROL, V216, P471, DOI 10.1016/j.expneurol.2009.01.004; Awad BI, 2015, WORLD NEUROSURG, V83, P120, DOI 10.1016/j.wneu.2013.01.042; Belbachir K, 2009, ANAL BIOANAL CHEM, V395, P829, DOI 10.1007/s00216-009-3019-y; Boyce Vanessa S, 2014, Handb Exp Pharmacol, V220, P443, DOI 10.1007/978-3-642-45106-5_16; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Bradbury EJ, 2006, NAT REV NEUROSCI, V7, P644, DOI 10.1038/nrn1964; Bregman BS, 1997, EXP NEUROL, V148, P475, DOI 10.1006/exnr.1997.6705; Chanimov M, 2006, MED SCI MONITOR, V12, pBR63; Cheheltani R, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.5.056014; Christie SD, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E5; Daemi H, 2012, SCI IRAN, V19, P2023, DOI 10.1016/j.scient.2012.10.005; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Dhoot NO, 2004, J BIOMED MATER RES A, V71A, P191, DOI 10.1002/jbm.a.30103; Diem M, 2013, J BIOPHOTONICS, V6, P855, DOI 10.1002/jbio.201300131; Estrada V, 2014, NEUROBIOL DIS, V67, P165, DOI 10.1016/j.nbd.2014.03.018; Fajardo AR, 2012, RSC ADV, V2, P11095, DOI 10.1039/c2ra20785k; Galli R, 2012, ANAL CHEM, V84, P8707, DOI 10.1021/ac301938m; Hagg T, 2006, J NEUROTRAUM, V23, P264, DOI 10.1089/neu.2006.23.263; Hunanyan AS, 2011, J NEUROPHYSIOL, V105, P1033, DOI 10.1152/jn.00810.2010; Hurlbert RJ, 2013, NEUROSURGERY, V72, P93, DOI 10.1227/NEU.0b013e31827765c6; Kataoka K, 2004, TISSUE ENG, V10, P493, DOI 10.1089/107632704323061852; Kataoka K, 2001, J BIOMED MATER RES, V54, P373, DOI 10.1002/1097-4636(20010305)54:3<373::AID-JBM90>3.3.CO;2-H; Klapka N, 2006, J NEUROTRAUM, V23, P422, DOI 10.1089/neu.2006.23.422; Kong HJ, 2004, BIOMACROMOLECULES, V5, P1720, DOI 10.1021/bm049879r; Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003; Levin IW, 2005, ANNU REV PHYS CHEM, V56, P429, DOI 10.1146/annurev.physchem.56.092503.141205; Liu KZ, 2002, CLIN CHEM, V48, P499; Madigan NN, 2009, RESP PHYSIOL NEUROBI, V169, P183, DOI 10.1016/j.resp.2009.08.015; Martinon S, 2008, MINI-REV MED CHEM, V8, P222; Matyash M, 2014, TISSUE ENG PART C-ME, V20, P401, DOI [10.1089/ten.tec.2013.0252, 10.1089/ten.TEC.2013.0252]; Matyash M, 2012, TISSUE ENG PT A, V18, P55, DOI [10.1089/ten.tea.2011.0097, 10.1089/ten.TEA.2011.0097]; McKay CA, 2014, ACS APPL MATER INTER, V6, P1424, DOI 10.1021/am4027423; Meier RJ, 2005, CHEM SOC REV, V34, P743, DOI 10.1039/b503880d; Muse ED, 2001, J NEUROCHEM, V76, P77, DOI 10.1046/j.1471-4159.2001.00015.x; Novikov LN, 2002, BIOMATERIALS, V23, P3369, DOI 10.1016/S0142-9612(02)00037-6; Novikova LN, 2003, CURR OPIN NEUROL, V16, P711, DOI 10.1097/00019052-200312000-00011; Olsztynska-Janus S, 2012, ACTA BIOENG BIOMECH, V14, P121, DOI 10.5277/abb120414; Olsztynska-Janus S, 2012, ACTA BIOENG BIOMECH, V14, P101, DOI 10.5277/abb120314; Pakulska MM, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024101; Perale G, 2008, J APPL BIOMATER BIOM, V6, P1; Perale G, 2011, ACS CHEM NEUROSCI, V2, P336, DOI 10.1021/cn200030w; Prang P, 2006, BIOMATERIALS, V27, P3560, DOI 10.1016/j.biomaterials.2006.01.053; Profyris C, 2004, NEUROBIOL DIS, V15, P415, DOI 10.1016/j.nbd.2003.11.015; 최기환, 2006, [Tissue Engineering and Regenerative Medicine, 조직공학과 재생의학], V3, P472; Sarker B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107952; Saxena T, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3549700; Shearer MC, 2001, CELL TISSUE RES, V305, P267, DOI 10.1007/s004410100384; Shoichet MS, 1996, BIOTECHNOL BIOENG, V50, P374, DOI 10.1002/(SICI)1097-0290(19960520)50:4<374::AID-BIT4>3.0.CO;2-I; Smith GM, 2011, BRAIN RES BULL, V84, P300, DOI 10.1016/j.brainresbull.2010.05.013; Storer PD, 2003, J NEUROSCI RES, V74, P502, DOI 10.1002/jnr.10787; Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948; Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Tobias CA, 2005, J NEUROTRAUM, V22, P138, DOI 10.1089/neu.2005.22.138	55	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142660	10.1371/journal.pone.0142660	http://dx.doi.org/10.1371/journal.pone.0142660			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559822	Green Published, gold			2022-12-26	WOS:000364433100107
J	Wu, LJ; Zhao, TL; Yu, DJ; Chen, Q; Han, WY; Yu, WY; Sun, W				Wu, Lijun; Zhao, Tianlan; Yu, Daojiang; Chen, Qi; Han, Wenya; Yu, Wenyuan; Sun, Wei			Dynamic Change of CD34 Level during the Survival Process of Narrow Pedicle Flap	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; SKIN FLAPS; TRANSPLANTATION; PATHOPHYSIOLOGY; ANGIOGENESIS; THROMBOSIS	Objective To evaluate the dynamic change of CD34 level during the survival process of narrow pedicle flaps. Methods Twenty-five white pigs were randomly and equally divided into 5 experimental groups. Five different type of narrow pedicle with different length-to-width ratio were employed, and each type of narrow pedicle was covered with 5 different size random flaps and which was classified into A, B, C, D and E for 5 groups. Group A was control group. Each type narrow pedicle with 5 different skin flaps were implanted onto the back of the pigs along the midline of back with a reverse direction. A 0.3 cmx0.3 cm full thickness skin flap in the middle of distal segment was collected and on 3rd, 5th, 7th and 14th days of post-operation. The expression of CD34 was measured by immunohistochemistry and enzyme-linked immunosorbent (ELISA). Results Histological examination showed that with the increasing of length-to-width ratio of the narrow pedicle skin flaps, the expression of CD34 increased in the skin flaps. Increased level of CD34 was found on 3rd day post-operation, and the peak expression was found on 7th day. Persistent high level of CD34 was found until 14th day. Conclusion Increased CD34 level in the distal skin flap, there is the association between CD34 level and ischemia injury. Moreover, CD34 expression plays an important role during the repair processes of pedicle flaps.	[Wu, Lijun; Zhao, Tianlan; Yu, Daojiang; Chen, Qi; Han, Wenya; Yu, Wenyuan; Sun, Wei] Soochow Univ, Affiliated Hosp 2, Dept Plast & Cosmet Surg, Suzhou 215004, Peoples R China	Soochow University - China	Zhao, TL (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Plast & Cosmet Surg, Suzhou 215004, Peoples R China.	ljwu1986@163.com			Suzhou Science and Technology Development Planning Project [SYSD2012091]; Young Workers Scientific Pre-hospital Research Fund [SDFEYQN1308]; Clinical Science and Technology Projects [BL2014041]	Suzhou Science and Technology Development Planning Project; Young Workers Scientific Pre-hospital Research Fund; Clinical Science and Technology Projects	The following are supported by research funding: 1. Suzhou Science and Technology Development Planning Project (SYSD2012091) ((sic) 5000), 2. Young Workers Scientific Pre-hospital Research Fund (SDFEYQN1308) ((sic) 10000), 3. Clinical Science and Technology Projects (BL2014041) ((sic) 500000).	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Denburg JA, 2006, EUR RESPIR J, V27, P441, DOI 10.1183/09031936.06.00000706; GUBA AM, 1979, PLAST RECONSTR SURG, V64, P372, DOI 10.1097/00006534-197909000-00015; Hristov M, 2003, ARTERIOSCL THROM VAS, V23, P1185, DOI 10.1161/01.ATV.0000073832.49290.B5; Ishizawa K, 2004, BIOCHEM BIOPH RES CO, V324, P276, DOI 10.1016/j.bbrc.2004.09.049; KERRIGAN CL, 1982, PLAST RECONSTR SURG, V69, P986, DOI 10.1097/00006534-198206000-00014; Li XQ, 2007, CHINESE MED J-PEKING, V120, P2245, DOI 10.1097/00029330-200712020-00017; Liew A, 2006, BIOESSAYS, V28, P261, DOI 10.1002/bies.20372; [林渊 Lin Yuan], 2003, [中华整形外科杂志, Chinese Journal of Plastic Surgery], V19, P410; Meng QY, 2010, CHINESE MED J-PEKING, V123, P471, DOI 10.3760/cma.j.issn.0366-6999.2010.04.016; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Rabelink TJ, 2004, ARTERIOSCL THROM VAS, V24, P834, DOI 10.1161/01.ATV.0000124891.57581.9f; Rafat N, 2007, CRIT CARE MED, V35, P1677, DOI 10.1097/01.CCM.0000269034.86817.59; REINISCH JF, 1974, PLAST RECONSTR SURG, V54, P585, DOI 10.1097/00006534-197411000-00010; Santanelli F, 2015, ANN PLAS SURG, V74, P47, DOI 10.1097/SAP.0b013e31828d994d; Santanelli F, 2013, ANN SURG ONCOL, V20, P981, DOI 10.1245/s10434-012-2672-0; SASAKI GH, 1984, PLAST RECONSTR SURG, V74, P59, DOI 10.1097/00006534-198407000-00008; Wu Li-jun, 2012, Zhonghua Zheng Xing Wai Ke Za Zhi, V28, P199; Xiong SH, 2002, SURG RADIOL ANAT, V24, P258, DOI 10.1007/s00276-002-0061-2; Zhang QH, 2007, CHINESE MED J-PEKING, V120, P2297, DOI 10.1097/00029330-200712020-00027; Zhao Tian-lan, 2012, Zhonghua Zheng Xing Wai Ke Za Zhi, V28, P181; [赵天兰 Zhao Tianlan], 2011, [中华整形外科杂志, Chinese Journal of Plastic Surgery], V27, P40; Zhao Tianlan, 2002, Zhonghua Zheng Xing Wai Ke Za Zhi, V18, P148; Zhou YQ, 2006, J CRANIOFAC SURG, V17, P198, DOI 10.1097/01.scs.0000194171.91421.b8	24	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142417	10.1371/journal.pone.0142417	http://dx.doi.org/10.1371/journal.pone.0142417			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26561392	Green Submitted, Green Published, gold			2022-12-26	WOS:000364433100077
J	Convertino, M; Samoshkin, A; Viet, CT; Gauthier, J; Li Fraine, SP; Sharif-Naeini, R; Schmidt, BL; Maixner, W; Diatchenko, L; Dokholyan, NV				Convertino, Marino; Samoshkin, Alexander; Viet, Chi T.; Gauthier, Josee; Li Fraine, Steven P.; Sharif-Naeini, Reza; Schmidt, Brian L.; Maixner, William; Diatchenko, Luda; Dokholyan, Nikolay V.			Differential Regulation of 6-and 7-Transmembrane Helix Variants of mu-Opioid Receptor in Response to Morphine Stimulation	PLOS ONE			English	Article							DISCRETE MOLECULAR-DYNAMICS; MOR-1 SPLICE VARIANTS; OPIATE RECEPTOR; FORCE-FIELD; CRYSTAL-STRUCTURE; ACTIVATION; GENE; SIMULATIONS; BINDING; DESENSITIZATION	The pharmacological effect of opioids originates, at the cellular level, by their interaction with the mu-opioid receptor (mOR) resulting in the regulation of voltage-gated Ca2+ channels and inwardly rectifying K+ channels that ultimately modulate the synaptic transmission. Recently, an alternative six trans-membrane helix isoform of mOR, (6TM-mOR) has been identified, but its function and signaling are still largely unknown. Here, we present the structural and functional mechanisms of 6TM-mOR signaling activity upon binding to morphine. Our data suggest that despite the similarity of binding modes of the alternative 6TM-mOR and the dominant seven trans-membrane helix variant (7TM-mOR), the interaction with morphine generates different dynamic responses in the two receptors, thus, promoting the activation of different mOR-specific signaling pathways. We characterize a series of 6TM-mOR-specific cellular responses, and observed that they are significantly different from those for 7TM-mOR. Morphine stimulation of 6TM-mOR does not promote a cellular cAMP response, while it increases the intracellular Ca2+ concentration and reduces the cellular K+ conductance. Our findings indicate that 6TM-mOR has a unique contribution to the cellular opioid responses. Therefore, it should be considered as a relevant target for the development of novel pharmacological tools and medical protocols involving the use of opioids.	[Convertino, Marino; Dokholyan, Nikolay V.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Samoshkin, Alexander; Diatchenko, Luda] McGill Univ, Alan Edwards Ctr Res Pain, Montreal, PQ H3A 0G1, Canada; [Viet, Chi T.; Schmidt, Brian L.] NYU, Bluestone Ctr Clin Res, New York, NY 10010 USA; [Gauthier, Josee; Maixner, William; Dokholyan, Nikolay V.] Univ N Carolina, Ctr Pain Res & Innovat, 385 S Columbia St, Chapel Hill, NC 27599 USA; [Li Fraine, Steven P.; Sharif-Naeini, Reza] McGill Univ, Dept Physiol & Cell Informat Syst, Montreal, PQ H3G 0B1, Canada	University of North Carolina; University of North Carolina Chapel Hill; McGill University; New York University; University of North Carolina; University of North Carolina Chapel Hill; McGill University	Maixner, W (corresponding author), Univ N Carolina, Ctr Pain Res & Innovat, 385 S Columbia St, Chapel Hill, NC 27599 USA.	bill_maixner@dentistry.unc.edu; luda.diatchenko@mcgill.ca; dokh@unc.edu	Dokholyan, Nikolay/D-8081-2018	Dokholyan, Nikolay/0000-0002-8225-4025; Li Fraine, Steven/0000-0003-0333-4391; Samoshkin, Alexander/0000-0001-6296-2254	National Institutes of Health [P01 NS045685/NS/NINDS, STTR 1R41DA032293-01, R01DE019796]; Oral and Maxillofacial Surgery Research Support Grant; Canadian Institute of Health Research [G237818/CERC32151/CIHR]; Louise and Alan Edwards Foundation; Pfizer Canada Professorship in Pain Research; National Institutes of Health T90 training grant [1T90DE021986-01]; NIH [P01 NS045685/NS/NINDS, STTR 1R41DA032293-01, R01DE019796]; T90 training grant [1T90DE021986-01]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021986, R01DE019796] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS045685] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R41DA032293] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oral and Maxillofacial Surgery Research Support Grant; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Louise and Alan Edwards Foundation; Pfizer Canada Professorship in Pain Research; National Institutes of Health T90 training grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T90 training grant; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by National Institutes of Health grants P01 NS045685/NS/NINDS (LD, WM), STTR 1R41DA032293-01 (LD, NVD, WM and Algynomics Inc.) and R01DE019796 (BLS), Oral and Maxillofacial Surgery Research Support Grant (BLS, CTV), Canadian Institute of Health Research G237818/CERC32151/CIHR (LD), the Louise and Alan Edwards Foundation, and Pfizer Canada Professorship in Pain Research (LD), National Institutes of Health T90 training grant 1T90DE021986-01 (AS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported in part by NIH grants P01 NS045685/NS/NINDS (LD, WM), STTR 1R41DA032293-01 (LD, NVD, WM and Algynomics Inc.) and R01DE019796 (BLS), Oral and Maxillofacial Surgery Research Support Grant (BLS, CTV), G237818/CERC32151/CIHR (LD), the Louise and Alan Edwards Foundation, and Pfizer Canada Professorship in Pain Research (LD), T90 training grant 1T90DE021986-01 (AS).	ANDERSEN HC, 1980, J CHEM PHYS, V72, P2384, DOI 10.1063/1.439486; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bohn LM, 2004, MOL PHARMACOL, V66, P106, DOI 10.1124/mol.66.1.106; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Convertino M, 2014, PROG NEUROPSYCHOPHAR, VS0278-5846, P00235; Crain SM, 2000, PAIN, V84, P121, DOI 10.1016/S0304-3959(99)00223-7; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; Ding F, 2013, J CHEM INF MODEL, V53, P1871, DOI 10.1021/ci300478y; Ding F, 2010, J CHEM INF MODEL, V50, P1623, DOI 10.1021/ci100218t; Dokholyan NV, 1998, FOLD DES, V3, P577, DOI 10.1016/S1359-0278(98)00072-8; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; Eadie W.T., 1971, STAT METHODS EXPT PH; Eckhardt K, 2000, FEBS LETT, V470, P309, DOI 10.1016/S0014-5793(00)01329-6; Gharagozlou Parham, 2003, BMC Pharmacol, V3, P1, DOI 10.1186/1471-2210-3-1; Gris P, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-33; Groer CE, 2011, J BIOL CHEM, V286, P31731, DOI 10.1074/jbc.M111.248310; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Inturrisi CE, 2002, CLIN J PAIN, V18, pS3, DOI 10.1097/00002508-200207001-00002; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kleywegt GJ, 2004, ACTA CRYSTALLOGR D, V60, P2240, DOI 10.1107/S0907444904013253; Kota P, 2011, BIOINFORMATICS, V27, P2209, DOI 10.1093/bioinformatics/btr374; LAMBERT DG, 1993, BIOCHEM PHARMACOL, V46, P1145, DOI 10.1016/0006-2952(93)90462-6; Lazaridis T, 2000, CURR OPIN STRUC BIOL, V10, P139, DOI 10.1016/S0959-440X(00)00063-4; Majumdar S, 2012, J MED CHEM, V55, P6352, DOI 10.1021/jm300305c; Majumdar S, 2011, P NATL ACAD SCI USA, V108, P19778, DOI 10.1073/pnas.1115231108; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; Miao YL, 2013, P NATL ACAD SCI USA, V110, P10982, DOI 10.1073/pnas.1309755110; MIGNAT C, 1995, LIFE SCI, V56, P793, DOI 10.1016/0024-3205(95)00010-4; Mihara S, 2012, BMC PHARM, V88, P315; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Reisine T, 1996, GOODMAN GILMANS PHAR, P521; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Rowlingson JC, 2000, ANESTHESIA, P7351; Samoshkin A, 2014, INT NARC RES C 2014; Samoshkin A, 2015, SCI REPORTS UNPUB; SCHROEDER JE, 1993, J NEUROSCI, V13, P867; Serohijos AWR, 2011, STRUCTURE, V19, P1683, DOI 10.1016/j.str.2011.08.003; Shabalina SA, 2009, HUM MOL GENET, V18, P1037, DOI 10.1093/hmg/ddn439; Shim J, 2013, J PHYS CHEM B, V117, P7907, DOI 10.1021/jp404238n; Shirvanyants D, 2012, J PHYS CHEM B, V116, P8375, DOI 10.1021/jp2114576; Sora I, 2001, NEUROPSYCHOPHARMACOL, V25, P41, DOI 10.1016/S0893-133X(00)00252-9; Uhl GR, 1999, P NATL ACAD SCI USA, V96, P7752, DOI 10.1073/pnas.96.14.7752; Waldhoer M, 2004, ANNU REV BIOCHEM, V73, P953, DOI 10.1146/annurev.biochem.73.011303.073940; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; Yin S, 2008, J CHEM INF MODEL, V48, P1656, DOI 10.1021/ci8001167; Zhang J, 1998, P NATL ACAD SCI USA, V95, P7157, DOI 10.1073/pnas.95.12.7157; Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816	54	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142826	10.1371/journal.pone.0142826	http://dx.doi.org/10.1371/journal.pone.0142826			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554831	Green Published, Green Submitted, gold			2022-12-26	WOS:000364430700177
J	Nichols, BE; Gotz, HM; van Gorp, ECM; Verbon, A; Rokx, C; Boucher, CAB; van de Vijver, DAMC				Nichols, Brooke E.; Gotz, Hannelore M.; van Gorp, Eric C. M.; Verbon, Annelies; Rokx, Casper; Boucher, Charles A. B.; van de Vijver, David A. M. C.			Partner Notification for Reduction of HIV-1 Transmission and Related Costs among Men Who Have Sex with Men: A Mathematical Modeling Study	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; SAN-FRANCISCO; UNITED-STATES; INFECTION; OUTCOMES; RISK; ELIGIBILITY; POPULATION; DIAGNOSIS	Background Earlier antiretroviral treatment initiation prevents new HIV infections. A key problem in HIV prevention and care is the high number of patients diagnosed late, as these undiagnosed patients can continue forward HIV transmission. We modeled the impact on the Dutch men-who- have-sex-with-men (MSM) HIV epidemic and cost-effectiveness of an existing partner notification process for earlier identification of HIV-infected individuals to reduce HIV transmission. Methods Reduction in new infections and cost-effectiveness ratios were obtained for the use of partner notification to identify 5% of all new diagnoses (Scenario 1) and 20% of all new diagnoses (Scenario 2), versus no partner notification. Costs and quality adjusted life years (QALYs) were assigned to each disease state and calculated over 5 year increments for a 20 year period. Results Partner notification is predicted to avert 18-69 infections (interquartile range [IQR] 13-24; 51-93) over the course of 5 years countrywide to 221-830 (IQR 140-299; 530-1,127) over 20 years for Scenario 1 and 2 respectively. Partner notification was considered cost-effective in the short term, with increasing cost-effectiveness over time: from (sic)41,476-(sic)41, 736 (IQR (sic)40,529-(sic)42,147; (sic)40,791-(sic)42,397) to (sic)5,773 -(sic)5,887 ((sic)5,134-(sic)7,196; (sic)5,411(sic) 6,552) per QALY gained over a 5 and 20 year period, respectively. The full monetary benefits of partner notification by preventing new HIV infections become more apparent over time. Conclusions Partner notification will not lead to the end of the HIV epidemic, but will prevent new infections and be increasingly cost-effectiveness over time.	[Nichols, Brooke E.; van Gorp, Eric C. M.; Boucher, Charles A. B.; van de Vijver, David A. M. C.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Gotz, Hannelore M.] Publ Hlth Serv Rotterdam Rijnmond, Dept Infect Dis Control, Rotterdam, Netherlands; [Gotz, Hannelore M.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [van Gorp, Eric C. M.; Verbon, Annelies; Rokx, Casper] Erasmus MC, Dept Internal Med & Infect Dis, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Nichols, BE (corresponding author), Erasmus MC, Dept Virosci, Rotterdam, Netherlands.	b.nichols@erasmusmc.nl	Nichols, Brooke E./V-5496-2019; Rokx, Casper/ABG-2016-2021	Nichols, Brooke E./0000-0003-4682-4999; Gotz, Hannelore Martha/0000-0002-1236-6224; van de Vijver, David/0000-0001-5877-8526	Aids Fonds Netherlands [2010-035]; European Union: FP7 CHAIN [223131]; European Union: FP7 DynaNets [233847]	Aids Fonds Netherlands; European Union: FP7 CHAIN; European Union: FP7 DynaNets	This work was supported by Aids Fonds Netherlands (2010-035), http://doodzonde.aidsfonds.nl/, to BN; European Union: FP7 CHAIN (No. 223131), http://ec.europa.eu/research/fp7/index_en. cfm, to DvdV; and European Union: FP7 DynaNets (No. 233847), http://ec.europa.eu/research/fp7/index_en. cfm, to DvdV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens K, 2007, JAIDS-J ACQ IMM DEF, V46, P479, DOI 10.1097/QAI.0b013e3181594c61; [Anonymous], 2014, GAP REP; Bellan SE, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001801; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Braithwaite RS, 2008, MED CARE, V46, P349, DOI 10.1097/MLR.0b013e31815c31a7; Brinkhof MWG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000066; Brown LB, 2011, JAIDS-J ACQ IMM DEF, V56, P437, DOI 10.1097/QAI.0b013e318202bf7d; Cain LE, 2011, ANN INTERN MED, V154, P509, DOI 10.7326/0003-4819-154-8-201104190-00001; Champenois K, 2012, BMJ OPEN, V2, DOI [10.1136/bmjopen-2011-000693, DOI 10.1136/bmjopen-2011-000693]; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Colfax GN, 2002, AIDS, V16, P1529, DOI 10.1097/00002030-200207260-00010; de la Fuente L, 2009, AIDS PATIENT CARE ST, V23, P625, DOI 10.1089/apc.2009.0019; Donker G, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001834; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Eaton JW, 2014, LANCET GLOB HEALTH, V2, pE23, DOI 10.1016/S2214-109X(13)70172-4; Edelman EJ, 2014, AIDS BEHAV, V18, P1898, DOI 10.1007/s10461-014-0799-7; de Olalla PG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121536; Golden MR, 2004, SEX TRANSM DIS, V31, P709, DOI 10.1097/01.olq.0000145847.65523.43; Gotz HM, 2014, SEX TRANSM INFECT, V90, P195, DOI 10.1136/sextrans-2013-051254; Govindasamy D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080017; Hall HI, 2012, AIDS, V26, P893, DOI 10.1097/QAD.0b013e328351f73f; Hogben M, 2007, AM J PREV MED, V33, pS89, DOI 10.1016/j.amepre.2007.04.015; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Insurance FfH, 2006, GUID PHARM RES UPD V; Kall MM, 2012, EUR J GEN PRACT, V18, P181, DOI 10.3109/13814788.2012.685069; Lima VD, 2008, J INFECT DIS, V198, P59, DOI 10.1086/588673; Lipsitz MC, 2014, INT J STD AIDS, V25, P325, DOI 10.1177/0956462413507443; Lodi S, 2011, CLIN INFECT DIS, V53, P817, DOI 10.1093/cid/cir494; Long EF, 2010, ANN INTERN MED, V153, P778, DOI 10.7326/0003-4819-153-12-201012210-00004; Mabuto T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102267; Marcus JL, 2009, AIDS, V23, P1024, DOI 10.1097/QAD.0b013e32832921a7; Marcus U, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-919; Mattson CL, 2014, AIDS, V28, P1203, DOI 10.1097/QAD.0000000000000273; Mocroft A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001510; Muessig KE, 2012, AIDS, V26, P2267, DOI 10.1097/QAD.0b013e328355713d; Nakagawa F, 2012, AIDS, V26, P335, DOI 10.1097/QAD.0b013e32834dcec9; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Nichols BE, 2014, AIDS, V28, P73, DOI 10.1097/01.aids.0000433239.01611.52; Nichols BE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059549; NVHB, 2014, NVHB 2 1 WANN BEG; Pilcher CD, 2007, AIDS, V21, P1723, DOI 10.1097/QAD.0b013e3281532c82; ROSE KA, 1991, J FORECASTING, V10, P117, DOI 10.1002/for.3980100108; Rothenberg R, 2002, CLIN INFECT DIS, V35, pS138, DOI 10.1086/342101; Sood N, 2013, CLIN INFECT DIS, V56, P1789, DOI 10.1093/cid/cit158; Sorensen SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029098; Tan SS, 2012, INT J TECHNOL ASSESS, V28, P152, DOI 10.1017/S0266462312000062; The World Bank, 2014, NETH WORLD DEV IND 2; Therneau TM., 2015, INTRO RECURSIVE PART; van Aar F, 2015, INT J STD AIDS, V26, P565, DOI 10.1177/0956462414547398; van Bergen JEAM, 2012, EUR J GEN PRACT, V18, P133, DOI 10.3109/13814788.2012.704361; van Sighem A, 2014, MON REP 2014 HUM IMM; van Sighem A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044819; Varghese B, 1999, AIDS, V13, P1745, DOI 10.1097/00002030-199909100-00019; Venables WN, 2002, MODERN APPL STAT S, V4th, P211, DOI [10.1007/978-0-387-21706-2_8, DOI 10.1007/978-0-387-21706-2]; Walensky RP, 2013, ANN INTERN MED, V158, P84, DOI 10.7326/0003-4819-158-2-201301150-00002; Walensky RP, 2010, CLIN INFECT DIS, V51, P392, DOI 10.1086/655130; World Health Organization, GLOB HLTH OBS DAT RE; Zorginstituut Nederland, 2014, GIPEILINGEN 2013 ONT, P35	58	10	11	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142576	10.1371/journal.pone.0142576	http://dx.doi.org/10.1371/journal.pone.0142576			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554586	Green Published, Green Submitted, gold			2022-12-26	WOS:000364430700135
J	Sosa-Garcia, B; Vazquez-Rivera, V; Gonzalez-Flores, JN; Engel, BE; Cress, WD; Santiago-Cardona, PG				Sosa-Garcia, Bernadette; Vazquez-Rivera, Viviana; Gonzalez-Flores, Jonathan N.; Engel, Brienne E.; Cress, W. Douglas; Santiago-Cardona, Pedro G.			The Retinoblastoma Tumor Suppressor Transcriptionally Represses Pak1 in Osteoblasts	PLOS ONE			English	Article							E-CADHERIN; LUNG CARCINOMAS; PROTEIN-KINASES; BONE; EXPRESSION; CELLS; E2F; CANCER; DIFFERENTIATION; OSTEOSARCOMA	We previously characterized the retinoblastoma tumor suppressor protein (Rb) as a regulator of adherens junction assembly and cell-to-cell adhesion in osteoblasts. This is a novel function since Rb is predominantly known as a cell cycle repressor. Herein, we characterized the molecular mechanisms by which Rb performs this function, hypothesizing that Rb controls the activity of known regulators of adherens junction assembly. We found that Rb represses the expression of the p21-activated protein kinase (Pak1), an effector of the small Rho GTPase Rac1. Rac1 is a well-known regulator of adherens junction assembly whose increased activity in cancer is linked to perturbations of intercellular adhesion. Using nuclear run-on and luciferase reporter transcription assays, we found that Pak1 repression by Rb is transcriptional, without affecting Pak1 mRNA and protein stability. Pak1 promoter bioinformatics showed multiple E2F1 binding sites within 155 base pairs of the transcriptional start site, and a Pak1-promoter region containing these E2F sites is susceptible to transcriptional inhibition by Rb. Chromatin immunoprecipitations showed that an Rb-E2F complex binds to the region of the Pak1 promoter containing the E2F1 binding sites, suggesting that Pak1 is an E2F target and that the repressive effect of Rb on Pak1 involves blocking the trans-activating capacity of E2F. A bioinformatics analysis showed elevated Pak1 expression in several solid tumors relative to adjacent normal tissue, with both Pak1 and E2F increased relative to normal tissue in breast cancer, supporting a cancer etiology for Pak1 up-regulation. Therefore, we propose that by repressing Pak1 expression, Rb prevents Rac1 hyperactivity usually associated with cancer and related to cytoskeletal derangements that disrupt cell adhesion, consequently enhancing cancer cell migratory capacity. This de-regulation of cell adhesion due to Rb loss could be part of the molecular events associated with cancer progression and metastasis.	[Sosa-Garcia, Bernadette; Vazquez-Rivera, Viviana; Gonzalez-Flores, Jonathan N.; Santiago-Cardona, Pedro G.] Ponce Hlth Sci Univ, Div Biochem, Dept Basic Sci, Ponce, PR 00716 USA; [Engel, Brienne E.; Cress, W. Douglas] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Engel, Brienne E.; Cress, W. Douglas] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Thorac Oncol Dept, Tampa, FL 33612 USA	Ponce Health Sciences University; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Santiago-Cardona, PG (corresponding author), Ponce Hlth Sci Univ, Div Biochem, Dept Basic Sci, Ponce, PR 00716 USA.	psantiago@psm.edu			Ponce Health Sciences University (PHSU) RCMI Molecular and Genomics Core Grant [RR003050/MD007579]; National Cancer Institute, National Institute of Health [1U54CA163071-01A1]; NATIONAL CANCER INSTITUTE [U54CA163068, U54CA163071] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003050] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007579] Funding Source: NIH RePORTER	Ponce Health Sciences University (PHSU) RCMI Molecular and Genomics Core Grant; National Cancer Institute, National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Funding: We acknowledge the support with instrumentation and services of the Ponce Health Sciences University (PHSU) RCMI Molecular and Genomics Core (Grant RR003050/MD007579). This work was funded by National Cancer Institute, National Institute of Health (http://www.cancer.gov), grant 1U54CA163071-01A1, to WDC and PGSC.	ARAKI N, 1991, CLIN ORTHOP RELAT R, P271; Arima Y, 2008, CANCER RES, V68, P5104, DOI 10.1158/0008-5472.CAN-07-5680; Arima Y, 2012, J BIOL CHEM, V287, P7896, DOI 10.1074/jbc.M111.313759; Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Batsche E, 1998, MOL CELL BIOL, V18, P3647, DOI 10.1128/MCB.18.7.3647; Berman SD, 2008, MOL CANCER RES, V6, P1440, DOI 10.1158/1541-7786.MCR-08-0176; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Braga VMM, 2000, MOL BIOL CELL, V11, P3703, DOI 10.1091/mbc.11.11.3703; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Chen PL, 1996, GENE DEV, V10, P2794, DOI 10.1101/gad.10.21.2794; Cheng SL, 2000, J BONE MINER RES, V15, P2362, DOI 10.1359/jbmr.2000.15.12.2362; DAHLIN DC, 1975, CLIN ORTHOP RELAT R, P23; Diehl JA, 2002, CANCER BIOL THER, V1, P226, DOI 10.4161/cbt.72; Dummler B, 2009, CANCER METAST REV, V28, P51, DOI 10.1007/s10555-008-9168-1; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Engel BE, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.461; GU W, 1993, CELL, V72, P309, DOI 10.1016/0092-8674(93)90110-C; Gutierrez GM, 2008, P NATL ACAD SCI USA, V105, P18402, DOI 10.1073/pnas.0805925105; Han K, 2014, CELL BIOL INT, V38, P1394, DOI 10.1002/cbin.10351; Hay E, 2000, J CELL PHYSIOL, V183, P117, DOI 10.1002/(SICI)1097-4652(200004)183:1<117::AID-JCP14>3.0.CO;2-#; Hou J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010312; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; Johnson JL, 2012, CANCER RES, V72, P516, DOI 10.1158/0008-5472.CAN-11-2647; Kashima T, 1999, AM J PATHOL, V155, P1549, DOI 10.1016/S0002-9440(10)65471-5; Kaye FJ, 2002, ONCOGENE, V21, P6908, DOI 10.1038/sj.onc.1205834; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Knudsen ES, 2006, EXP BIOL MED, V231, P1271; Lallemand D, 2003, GENE DEV, V17, P1090, DOI 10.1101/gad.1054603; Lozano E, 2003, BIOESSAYS, V25, P452, DOI 10.1002/bies.10262; Lozano E, 2008, J CELL SCI, V121, P933, DOI 10.1242/jcs.016121; LUDLOW JW, 1993, MOL CELL BIOL, V13, P367, DOI 10.1128/MCB.13.1.367; LUEDER GT, 1986, ARCH OPHTHALMOL-CHIC, V104, P372; Marie PJ, 2002, J CELL PHYSIOL, V190, P297, DOI 10.1002/jcp.10073; McClatchey AI, 2005, GENE DEV, V19, P2265, DOI 10.1101/gad.1335605; Mirabello L, 2009, CANCER-AM CANCER SOC, V115, P1531, DOI 10.1002/cncr.24121; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Nola S, 2011, J CELL BIOL, V195, P855, DOI 10.1083/jcb.201107162; OTTERSON GA, 1994, ONCOGENE, V9, P3375; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Rodriguez-Salas N, 2001, HISTOL HISTOPATHOL, V16, P353, DOI 10.14670/HH-16.353; Ross JF, 1999, MOL CELL, V3, P195, DOI 10.1016/S1097-2765(00)80310-X; Sandberg AA, 2003, CANCER GENET CYTOGEN, V145, P1, DOI 10.1016/S0165-4608(03)00105-5; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Sosa-Garcia B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013954; Stains Joseph P, 2005, Birth Defects Res C Embryo Today, V75, P72, DOI 10.1002/bdrc.20034; Stearman RS, 2005, AM J PATHOL, V167, P1763, DOI 10.1016/S0002-9440(10)61257-6; Tang Y, 1998, P NATL ACAD SCI USA, V95, P5139, DOI 10.1073/pnas.95.9.5139; Thomas DM, 2001, MOL CELL, V8, P303, DOI 10.1016/S1097-2765(01)00327-6; Thomas DM, 2003, CANCER BIOL THER, V2, P2; TOKURAKU M, 1995, INT J CANCER, V64, P355, DOI 10.1002/ijc.2910640513; Tsukita Shoichiro, 1992, Current Opinion in Cell Biology, V4, P834, DOI 10.1016/0955-0674(92)90108-O; Van Aken EH, 2002, INVEST OPHTH VIS SCI, V43, P595; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WEINTRAUB SJ, 1992, NATURE, V358, P259, DOI 10.1038/358259a0; WEINTRAUB SJ, 1995, NATURE, V375, P812, DOI 10.1038/375812a0; Yoon JH, 2002, CANCER RES, V62, P6500	56	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142406	10.1371/journal.pone.0142406	http://dx.doi.org/10.1371/journal.pone.0142406			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555075	Green Published, Green Submitted, gold			2022-12-26	WOS:000364430700099
J	Wilson, H; Miles, AF; Daane, KM; Altieri, MA				Wilson, Houston; Miles, Albie F.; Daane, Kent M.; Altieri, Miguel A.			Landscape Diversity and Crop Vigor Influence Biological Control of the Western Grape Leafhopper (E. elegantula Osborn) in Vineyards	PLOS ONE			English	Article							HOMALODISCA-COAGULATA; POPULATION-DYNAMICS; OKANAGAN VALLEY; NATURAL ENEMIES; AMINO-ACIDS; ROOTSTOCKS; PERFORMANCE; HYMENOPTERA; HOMOPTERA; ABUNDANCE	This study evaluated how the proportional area of natural habitat surrounding a vineyard (i.e. landscape diversity) worked in conjunction with crop vigor, cultivar and rootstock selection to influence biological control of the western grape leafhopper (Erythroneura elegantula Osborn). The key natural enemies of E. elegantula are Anagrus erythroneurae S. Trjapitzin & Chiappini and A. daanei Triapitsyn, both of which are likely impacted by changes in landscape diversity due to their reliance on non-crop habitat to successfully overwinter. Additionally, E. elegantula is sensitive to changes in host plant quality which may influence densities on specific cultivars, rootstocks and/or vines with increased vigor. From 20102013, data were collected on natural enemy and leafhopper densities, pest parasitism rates and vine vigor from multiple vineyards that represented a continuum of landscape diversity. Early in the season, vineyards in more diverse landscapes had higher Anagrus spp. densities and lower E. elegantula densities, which led to increased parasitism of E. elegantula. Although late season densities of E. elegantula tended to be lower in vineyards with higher early season parasitism rates and lower total petiole nitrogen content, they were also affected by rootstock and cultivar. While diverse landscapes can support higher natural enemy populations, which can lead to increased biological control, leafhopper densities also appear to be mediated by cultivar, rootstock and vine vigor.	[Wilson, Houston; Miles, Albie F.; Daane, Kent M.; Altieri, Miguel A.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Wilson, H (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	houston@berkeley.edu	Wilson, Houston/AAY-1091-2020		Robert Van den Bosch Memorial Scholarship	Robert Van den Bosch Memorial Scholarship	This work was supported by grants to HW from the Robert Van den Bosch Memorial Scholarship.	Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Barbosa P., 2012, INSECT OUTBREAKS REV; Bellota E, 2013, ENTOMOL EXP APPL, V149, P185, DOI 10.1111/eea.12122; Bentley W, 2015, UN ANR PUBLICATION, V3448; Berenbaum MR, 2012, HERBIVORES THEIR INT; Bettiga LJ, 2003, UC ANR PUBLICATION, V3419; Bianchi FJJA, 2006, P ROY SOC B-BIOL SCI, V273, P1715, DOI 10.1098/rspb.2006.3530; BRODBECK BV, 1990, OECOLOGIA, V83, P338, DOI 10.1007/BF00317557; Chaplin-Kramer R, 2011, ECOL LETT, V14, P922, DOI 10.1111/j.1461-0248.2011.01642.x; CLARIDGE DW, 1986, ECOL ENTOMOL, V11, P31, DOI 10.1111/j.1365-2311.1986.tb00277.x; Cooper M, 2014, CALIF AGR, V68, P125, DOI 10.3733/ca.v068n04p125; Costello MJ, 1999, J ARACHNOL, V27, P531; Coyle DR, 2010, AGR FOREST ENTOMOL, V12, P89, DOI 10.1111/j.1461-9563.2009.00456.x; D'Alberto CF, 2012, BIOCONTROL, V57, P541, DOI 10.1007/s10526-011-9435-x; Daane K. M., 1998, California Agriculture, V52, P27, DOI 10.3733/ca.v052n05p27; Daane K.M., 2013, GRAPE PEST MANAGEMEN, V3rd ed., P202; de Valpine P, 2010, ECOL APPL, V20, P1926, DOI 10.1890/09-0468.1; DOUTT R L, 1973, Environmental Entomology, V2, P381, DOI 10.1093/ee/2.3.381; DOUTT RL, 1965, J ECON ENTOMOL, V58, P586, DOI 10.1093/jee/58.3.586; DUKE SO, 1994, INT J PLANT SCI, V155, P617, DOI 10.1086/297200; Eilers EJ, 2009, BIOL CONTROL, V51, P388, DOI 10.1016/j.biocontrol.2009.07.010; GOONEWARDENE HF, 1989, J ECON ENTOMOL, V82, P1426, DOI 10.1093/jee/82.5.1426; GOULD AB, 1991, PLANT DIS, V75, P767, DOI 10.1094/PD-75-0767; Hanley ME, 2007, PERSPECT PLANT ECOL, V8, P157, DOI 10.1016/j.ppees.2007.01.001; Hanna R, 2003, ENTOMOL EXP APPL, V107, P177, DOI 10.1046/j.1570-7458.2003.00051.x; HAWTHORNE DJ, 1994, ENTOMOL EXP APPL, V70, P63, DOI 10.1007/BF02380632; Hogg BN, 2015, ECOL ENTOMOL, V40, P69, DOI 10.1111/een.12162; Hogg BN, 2013, DIVERS DISTRIB, V19, P281, DOI 10.1111/j.1472-4642.2012.00935.x; Hogg BN, 2011, ECOL APPL, V21, P565, DOI 10.1890/10-0496.1; Hogg BN, 2010, AGR ECOSYST ENVIRON, V135, P260, DOI 10.1016/j.agee.2009.10.004; HOU RF, 1978, EXPERIENTIA, V34, P465, DOI 10.1007/BF01935929; Ibacache A, 2009, CHIL J AGR RES, V69, P503, DOI 10.4067/S0718-58392009000400004; Isaia M, 2006, ENVIRON ENTOMOL, V35, P297, DOI 10.1603/0046-225X-35.2.297; Jones JB, 2012, PLANT NUTRITION AND SOIL FERTILITY MANUAL, 2ND EDITION, P1, DOI 10.1201/b11577; Kidd N.A.C., 2005, P435, DOI 10.1007/1-4020-2625-0_7; Landis DA, 2000, ANNU REV ENTOMOL, V45, P175, DOI 10.1146/annurev.ento.45.1.175; Lowery D. Thomas, 2007, Journal of the Entomological Society of British Columbia, V104, P9; MATTSON WJ, 1987, BIOSCIENCE, V37, P110, DOI 10.2307/1310365; MCKENZIE LM, 1972, CAN ENTOMOL, V104, P1229, DOI 10.4039/Ent1041229-8; Munoz ST, 2008, INTEGRATED CONTROL C, V38, P197; Murphy BC, 1998, ENTOMOL EXP APPL, V87, P225, DOI 10.1023/A:1003294222162; Nicholls C. I., 2000, Agricultural and Forest Entomology, V2, P107, DOI 10.1046/j.1461-9563.2000.00054.x; Nicholls CI, 2001, LANDSCAPE ECOL, V16, P133, DOI 10.1023/A:1011128222867; Omer AD, 1999, J APPL ENTOMOL, V123, P341, DOI 10.1046/j.1439-0418.1999.00394.x; PILLEMER EA, 1978, ENTOMOL EXP APPL, V24, P83, DOI 10.1007/BF00334175; Powell G, 2006, ANNU REV ENTOMOL, V51, P309, DOI 10.1146/annurev.ento.51.110104.151107; PRICE PW, 1991, OIKOS, V62, P244, DOI 10.2307/3545270; Reisenauer HM, 1978, BULLETIN, V1879; Reynolds AG, 2001, HORTTECHNOLOGY, V11, P419, DOI 10.21273/HORTTECH.11.3.419; Rhoades D.F., 1979, HERBIVORES THEIR INT; Robinson TL, 2011, ACTA HORTIC, V903, P249, DOI 10.17660/ActaHortic.2011.903.31; RUHL EH, 1989, AUST J EXP AGR, V29, P707, DOI 10.1071/EA9890707; Saif Ullah, 2012, Journal of Agricultural Research (Lahore), V50, P217; SAKAI T, 1976, Applied Entomology and Zoology, V11, P82; Sandanayaka WRM, 2003, ENTOMOL EXP APPL, V109, P63, DOI 10.1046/j.1570-7458.2003.00095.x; Schoonhoven L. M., 2005, Insect-plant biology; Settle W. H., 1986, California Agriculture, V40, P30; Shiflet T. N., 1994, RANGELAND COVER TYPE; Smith MW, 2004, SCI HORTIC-AMSTERDAM, V102, P75, DOI 10.1016/j.scienta.2003.12.004; SOUTHEY J M, 1991, South African Journal for Enology and Viticulture, V12, P32; Thies C, 2005, P ROY SOC B-BIOL SCI, V272, P203, DOI 10.1098/rspb.2004.2902; Thomson LJ, 2013, BIOL CONTROL, V64, P57, DOI 10.1016/j.biocontrol.2012.09.019; Thomson LJ, 2010, BIOL CONTROL, V54, P248, DOI 10.1016/j.biocontrol.2010.05.018; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Triapitsyn SV, 1998, T AM ENTOMOL SOC, V124, P77; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Tscharntke T, 2002, ECOL RES, V17, P229, DOI 10.1046/j.1440-1703.2002.00482.x; Tscharntke T, 2004, ANNU REV ENTOMOL, V49, P405, DOI 10.1146/annurev.ento.49.061802.123339; Webster AD, 1995, NEW ZEAL J CROP HORT, V23, P373, DOI 10.1080/01140671.1995.9513913; WHITE TCR, 1984, OECOLOGIA, V63, P90, DOI 10.1007/BF00379790; WILLIAMS DW, 1984, HILGARDIA, V52, P1; Williams L, 2000, BIOL CONTROL, V18, P136, DOI 10.1006/bcon.2000.0817; Williams T, 2003, BIOCONTROL SCI TECHN, V13, P459, DOI 10.1080/0958315031000140956; Wilson H, 2015, DRYAD DIGITAL REPOSI; Wilson H, 2015, AGR ECOSYST ENVIRON, V211, P43, DOI 10.1016/j.agee.2015.04.021; Wolpert JA, 2005, AM J ENOL VITICULT, V56, P163	76	11	12	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141752	10.1371/journal.pone.0141752	http://dx.doi.org/10.1371/journal.pone.0141752			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555074	Green Published, gold, Green Submitted			2022-12-26	WOS:000364430700039
J	Zhu, FQ; Chen, T; Zhang, YQ; Sun, HX; Cao, H; Lu, JX; Zhao, LS; Li, G				Zhu, Fengqin; Chen, Tian; Zhang, Yeqiong; Sun, Haixia; Cao, Hong; Lu, Jianxi; Zhao, Linshan; Li, Gang			A Novel Adeno-Associated Virus-Based Genetic Vaccine Encoding the Hepatitis C Virus NS3/4 Protein Exhibits Immunogenic Properties in Mice Superior to Those of an NS3-Protein-Based Vaccine	PLOS ONE			English	Article							GENOTYPE 1 INFECTION; T-CELL RESPONSES; IN-VIVO; IMMUNE-RESPONSES; HCV INFECTION; NONSTRUCTURAL PROTEIN-3; LYMPHOCYTE RESPONSE; RHESUS-MONKEYS; PROGRESS; VECTORS	More than 170 million individuals worldwide are infected with hepatitis C virus (HCV), and up to an estimated 30% of chronically infected individuals will go on to develop progressive liver disease. Despite the recent advances in antiviral treatment of HCV infection, it remains a major public health problem. Thus, development of an effective vaccine is urgently required. In this study, we constructed novel adeno-associated virus (AAV) vectors expressing the full-length NS3 or NS3/4 protein of HCV genotype 1b. The expression of the NS3 or NS3/4 protein in HepG2 cells was confirmed by western blotting. C57BL/6 mice were intramuscularly immunised with a single injection of AAV vectors, and the resultant immune response was investigated. The AAV2/rh32.33. NS3/4 vaccine induced stronger humoral and cellular responses than did the AAV2/rh32.33. NS3 vaccine. Our results demonstrate that AAV-based vaccines exhibit considerable potential for the development of an effective anti-HCV vaccine.	[Zhu, Fengqin; Chen, Tian; Zhang, Yeqiong; Sun, Haixia; Cao, Hong; Lu, Jianxi; Zhao, Linshan; Li, Gang] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Infect Dis, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Li, G (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Infect Dis, Guangzhou 510275, Guangdong, Peoples R China.	lg3195@gmail.com	Chen, Tianfeng/AAG-6123-2019		Science and Technology Planning Project of Guangdong Province, China [2010B060900041]	Science and Technology Planning Project of Guangdong Province, China	This study was supported by grants from the Science and Technology Planning Project of Guangdong Province, China (Grant No: 2010B060900041, GL.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Barefoot B, 2008, VACCINE, V26, P6108, DOI 10.1016/j.vaccine.2008.09.007; Casimiro DR, 2003, J VIROL, V77, P6305, DOI 10.1128/JVI.77.11.6305-6313.2003; CERNY A, 1995, J CLIN INVEST, V95, P521, DOI 10.1172/JCI117694; Diepolder HM, 1997, J VIROL, V71, P6011, DOI 10.1128/JVI.71.8.6011-6019.1997; DIEPOLDER HM, 1995, LANCET, V346, P1006, DOI 10.1016/S0140-6736(95)91691-1; Dismuke DJ, 2013, CURR GENE THER, V13, P434; Draper SJ, 2010, NAT REV MICROBIOL, V8, P62, DOI 10.1038/nrmicro2240; Eisenstein M, 2011, NATURE, V474, pS16, DOI 10.1038/474S16a; Fournillier A, 2007, VACCINE, V25, P7339, DOI 10.1016/j.vaccine.2007.08.020; Fournillier A, 2006, VACCINE, V24, P3153, DOI 10.1016/j.vaccine.2006.01.039; Frelin L, 2003, GENE THER, V10, P686, DOI 10.1038/sj.gt.3301933; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Gerlach JT, 2005, J VIROL, V79, P12425, DOI 10.1128/JVI.79.19.12425-12433.2005; GRAKOUI A, 1993, J VIROL, V67, P1385, DOI 10.1128/JVI.67.3.1385-1395.1993; Habersetzer F, 2011, GASTROENTEROLOGY, V141, P890, DOI 10.1053/j.gastro.2011.06.009; Habersetzer F, 2009, CURR OPIN MOL THER, V11, P456; Huang Y, 2001, BIOCHEM BIOPH RES CO, V281, P732, DOI 10.1006/bbrc.2001.4424; Hugle T, 2001, VIROLOGY, V284, P70, DOI 10.1006/viro.2001.0873; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Lang KA, 2008, VACCINE, V26, P6225, DOI 10.1016/j.vaccine.2008.07.052; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Law LMJ, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.79; Li JA, 1997, J VIROL, V71, P5236, DOI 10.1128/JVI.71.7.5236-5243.1997; Li XL, 2012, MICROBES INFECT, V14, P1000, DOI 10.1016/j.micinf.2012.05.002; Liang TJ, 2013, NAT MED, V19, P869, DOI 10.1038/nm.3183; Lin JP, 2009, J VIROL, V83, P12738, DOI 10.1128/JVI.01441-09; Livingston BD, 2001, VACCINE, V19, P4652, DOI 10.1016/S0264-410X(01)00233-X; Logan GJ, 2010, IMMUNOL CELL BIOL, V88, P228, DOI 10.1038/icb.2009.92; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; Missale G, 1996, J CLIN INVEST, V98, P706, DOI 10.1172/JCI118842; Nieto K, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00005; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; Roohvand F, 2012, EXPERT OPIN THER PAT, V22, P391, DOI 10.1517/13543776.2012.673589; Simmonds P, 2013, CURR TOP MICROBIOL, V369, P1, DOI 10.1007/978-3-642-27340-7_1; Swadling L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009185; Tang HL, 2009, CLIN SCI, V117, P49, DOI 10.1042/CS20080631; TANJI Y, 1995, J VIROL, V69, P1575, DOI 10.1128/JVI.69.3.1575-1581.1995; Thammanichanond D, 2008, CLIN IMMUNOL, V128, P329, DOI 10.1016/j.clim.2008.04.002; Timm J, 2004, J EXP MED, V200, P1593, DOI 10.1084/jem.20041006; Torresi J, 2011, J HEPATOL, V54, P1273, DOI 10.1016/j.jhep.2010.09.040; Vandenberghe LH, 2009, GENE THER, V16, P1416, DOI 10.1038/gt.2009.101; Wedemeyer H, 2009, VACCINE, V27, P5142, DOI 10.1016/j.vaccine.2009.06.027; Weiland O, 2013, MOL THER, V21, P1796, DOI 10.1038/mt.2013.119; Xiao XA, 1996, J VIROL, V70, P8098, DOI 10.1128/JVI.70.11.8098-8108.1996	48	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142349	10.1371/journal.pone.0142349	http://dx.doi.org/10.1371/journal.pone.0142349			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556235	gold, Green Submitted, Green Published			2022-12-26	WOS:000364430700089
J	Chen, YC; Ho, WM; Lee, YS; Chen, HW; Chen, CM				Chen, Yi Chun; Ho, Wei Min; Lee, Yun Shien; Chen, Huei Wen; Chen, Chiung-Mei			Polymorphisms in the Promoters of the MMP-2 and TIMP-2 Genes Are Associated with Spontaneous Deep Intracerebral Hemorrhage in the Taiwan Population	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CHINESE HAN POPULATION; SMOOTH-MUSCLE-CELLS; MATRIX METALLOPROTEINASES; CEREBRAL ANEURYSMS; STROKE; RISK; EXPRESSION; INHIBITORS; GUIDELINES	Background Spontaneous intracerebral hemorrhage (ICH) is a devastating stroke subtype. Matrix metalloproteinases (MMPs) function in the degradation of extracellular matrix and the activities of MMPs are modulated by their endogenous inhibitors, tissue inhibitors of metalloproteinases (TIMPs). This study aimed to discuss relationship of MMP-2 and TIMP-2 to spontaneous deep ICH (SDICH) susceptibility and hematoma size. Methods Associations were tested by logistic regression and general linear models (GLM) where appropriate, adjusting with covariables of age, sex, hypertension, diabetes mellitus, smoking, and alcohol consumption. Association analyses were performed first by stratification of genders and then by the age of 65 years old (y/o). Elder population was defined as subjects who were older than 65 y/o. Results There were 396 SDICH patients and 376 control subjects in this study. In the elder group, rs7503607 C>A variant in TIMP-2 was associated with SDICH in male and overall patients (OR = 3.49, 95% CI 1.45 to 8.40, P = 0.005 and OR = 2.45, 95% CI 1.37 to 4.38, P = 0.003, respectively) in additive genetic model. In recessive genetic model, rs2285053 TT genotype in MMP-2 was correlated to SDICH in male patients and overall elder group (OR = 7.30, 95% CI 1.3 to 40, P = 0.02 and OR = 2.91, 95% CI 1.02 to 8.31, P = 0.046, respectively), and rs7503726 AA genotype in TIMP-2 was associated with SDICH in female patients (OR = 0.29, 95% CI 0.1 to 0.84, P = 0.02). In younger male and overall younger patients, SDICH patients who had supratentorial hemorrhage had significantly lower frequency of AA genotypes in rs7503726 than those with infratentorial hemorrhage (OR = 0.36, 95% CI 0.17 to 0.75, P = 0.006 and OR = 0.43, 95% CI 0.22 to 0.84, P = 0.014, respectively). Hemorrhage size increased by 9.7 (95% CI 2.1 to 43, P = 0.004) cm(3) per minor allele (A) of the rs7503607 variant in the elder female patients and increased by 4.3 (95% CI 1.4 to 12.9, P = 0.009) cm(3) per minor allele (A) in all elder patients. In younger patients, the hemorrhage size decreased by 3.3 (95% CI 1.2 to 9.5, P = 0.03) cm(3) per minor allele of the s7503726 variant in the female patients. Conclusions This study showed a significant association between the variants of MMP-2 and TIMP-2 promoters and SDICH susceptibility with significant age and gender differences. Hemorrhage location and size might be affected by TIMP-2 promoter variants in the SDICH patients.	[Chen, Yi Chun; Ho, Wei Min; Chen, Huei Wen; Chen, Chiung-Mei] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Neurol, Taoyuan, Taiwan; [Chen, Yi Chun; Ho, Wei Min; Chen, Huei Wen; Chen, Chiung-Mei] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Lee, Yun Shien] Ming Chuan Univ, Dept Biotechnol, Taoyuan, Taiwan; [Lee, Yun Shien] Chang Gung Mem Hosp, Genom Med Res Core Lab, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Ming Chuan University; Chang Gung Memorial Hospital	Chen, CM (corresponding author), Chang Gung Mem Hosp, Linkou Med Ctr, Dept Neurol, Taoyuan, Taiwan.	cmchen@adm.cgmh.org.tw	Chen, Chiung-Mei/AAL-6260-2020	Chen, Yi-Chun/0000-0001-9435-8596	National Science Council in Taiwan [NSC 101-2314-B-182A-064, 103-2314-B-182A-027]; Chang Gung Memorial Hospital, Taiwan [CMRPG3A0291, CMRPG3C174]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	Funding: This study was supported by National Science Council in Taiwan (NSC 101-2314-B-182A-064, 103-2314-B-182A-027) and by Chang Gung Memorial Hospital, Taiwan (CMRPG3A0291 and CMRPG3C174): YCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Alvarez-Sabin J, 2004, STROKE, V35, P1316, DOI 10.1161/01.STR.0000126827.69286.90; Aoki T, 2007, STROKE, V38, P2337, DOI 10.1161/STROKEAHA.107.481838; Baird AE, 2010, J AM COLL CARDIOL, V56, P245, DOI 10.1016/j.jacc.2010.02.051; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; Castellazzi M, 2010, ACTA NEUROCHIR SUPPL, V106, P137, DOI 10.1007/978-3-211-98811-4_24; Castoldi G, 2007, CLIN EXP PHARMACOL P, V34, P205, DOI 10.1111/j.1440-1681.2007.04573.x; Chen CM, 2008, EUR J NEUROL, V15, P1206, DOI 10.1111/j.1468-1331.2008.02294.x; Chen YC, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-41; Davis SM, 2006, NEUROLOGY, V66, P1175, DOI 10.1212/01.wnl.0000208408.98482.99; Florczak-Rzepka M, 2012, CEREBROVASC DIS, V34, P249, DOI 10.1159/000341686; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Hadler-Olsen E, 2011, FEBS J, V278, P28, DOI 10.1111/j.1742-4658.2010.07920.x; Hernandez-Guillamon M, 2010, THE JOURNAL OF BIOLO, V285, P27144, DOI [10.1074/jbc.M110.135228, DOI 10.1074/JBC.M110.135228]; Hernandez-Guillamon M, 2012, BRAIN PATHOL, V22, P133, DOI 10.1111/j.1750-3639.2011.00512.x; Ho WM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125397; Hopps E, 2015, EUR REV MED PHARMACO, V19, P2583; Hsieh FI, 2010, CIRCULATION, V122, P1116, DOI 10.1161/CIRCULATIONAHA.110.936526; Huang Y, 2014, J RENIN-ANGIO-ALDO S, V15, P32, DOI 10.1177/1470320313481838; Kim SK, 2012, J INTERF CYTOK RES, V32, P81, DOI 10.1089/jir.2011.0022; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; Miyazaki S, 2010, CIRC J, V74, P1158, DOI 10.1253/circj.CJ-09-0412; Mun-Bryce S, 1998, J CEREBR BLOOD F MET, V18, P1163, DOI 10.1097/00004647-199811000-00001; Onal IK, 2009, EUR J INTERN MED, V20, P369, DOI 10.1016/j.ejim.2008.10.003; Qin HJ, 2013, NEUROL RES, V35, P545, DOI 10.1179/1743132813Y.0000000184; Qin HW, 1999, J BIOL CHEM, V274, P29130, DOI 10.1074/jbc.274.41.29130; Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8; Reuter B, 2009, CEREBROVASC DIS, V28, P558, DOI 10.1159/000247599; Rosenberg GA, 1998, STROKE, V29, P2189, DOI 10.1161/01.STR.29.10.2189; Rost NS, 2008, STROKE, V39, P2166, DOI 10.1161/STROKEAHA.107.501650; Schoenborn CA, 2005, VITAL HLTH STAT, V10, P1; Sessa M, 2008, NEUROL SCI, V29, pS258, DOI 10.1007/s10072-008-0956-8; Steiner T, 2014, INT J STROKE, V9, P840, DOI 10.1111/ijs.12309; Sulter G, 1999, STROKE, V30, P1538, DOI 10.1161/01.STR.30.8.1538; Sun YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067402; Sutherland GR, 2006, J CLIN NEUROSCI, V13, P511, DOI 10.1016/j.jocn.2004.12.012; Todor DR, 1998, STROKE, V29, P1580, DOI 10.1161/01.STR.29.8.1580; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Vukasovic I, 2006, CLIN CHEM LAB MED, V44, P428, DOI 10.1515/CCLM.2006.079; Wang HX, 2014, INT J NEUROSCI, V124, P61, DOI 10.3109/00207454.2013.823604; Wingrove CS, 1998, BBA-MOL BASIS DIS, V1406, P169, DOI 10.1016/S0925-4439(97)00097-5; Woo D, 2002, STROKE, V33, P1190, DOI 10.1161/01.STR.0000014774.88027.22; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948; Yang J, 2014, J NEUROL SCI, V341, P55, DOI 10.1016/j.jns.2014.03.049; Yi YC, 2009, CLIN CHIM ACTA, V409, P127, DOI 10.1016/j.cca.2009.09.015; Yokota T, 2010, HEART VESSELS, V25, P460, DOI 10.1007/s00380-010-0013-4; Yu CY, 2004, CANCER RES, V64, P7622, DOI 10.1158/0008-5472.CAN-04-1521	47	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0142482	10.1371/journal.pone.0142482	http://dx.doi.org/10.1371/journal.pone.0142482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26551785	Green Published, gold, Green Submitted			2022-12-26	WOS:000364422800027
J	Kissine, M; Cano-Chervel, J; Carlier, S; De Brabanter, P; Ducenne, L; Pairon, MC; Deconinck, N; Delvenne, V; Leybaert, J				Kissine, Mikhail; Cano-Chervel, Julie; Carlier, Sophie; De Brabanter, Philippe; Ducenne, Lesley; Pairon, Marie-Charlotte; Deconinck, Nicolas; Delvenne, Veronique; Leybaert, Jacqueline			Children with Autism Understand Indirect Speech Acts: Evidence from a Semi-Structured Act-Out Task	PLOS ONE			English	Article							FALSE BELIEF; PRAGMATIC IMPAIRMENTS; ACTION ANTICIPATION; INDIRECT REQUESTS; MIND; LANGUAGE; ADULTS; COMPREHENSION; ATTRIBUTION; EXPLORATION	Children with Autism Spectrum Disorder are often said to present a global pragmatic impairment. However, there is some observational evidence that context-based comprehension of indirect requests may be preserved in autism. In order to provide experimental confirmation to this hypothesis, indirect speech act comprehension was tested in a group of 15 children with autism between 7 and 12 years and a group of 20 typically developing children between 2:7 and 3:6 years. The aim of the study was to determine whether children with autism can display genuinely contextual understanding of indirect requests. The experiment consisted of a three-pronged semi-structured task involving Mr Potato Head. In the first phase a declarative sentence was uttered by one adult as an instruction to put a garment on a Mr Potato Head toy; in the second the same sentence was uttered as a comment on a picture by another speaker; in the third phase the same sentence was uttered as a comment on a picture by the first speaker. Children with autism complied with the indirect request in the first phase and demonstrated the capacity to inhibit the directive interpretation in phases 2 and 3. TD children had some difficulty in understanding the indirect instruction in phase 1. These results call for a more nuanced view of pragmatic dysfunction in autism.	[Kissine, Mikhail; Carlier, Sophie; De Brabanter, Philippe; Deconinck, Nicolas; Delvenne, Veronique; Leybaert, Jacqueline] Univ Libre Bruxelles, Brussels, Belgium; [Cano-Chervel, Julie; Carlier, Sophie; Ducenne, Lesley; Pairon, Marie-Charlotte; Deconinck, Nicolas; Delvenne, Veronique] Univ Libre Bruxelles Autrement, Hop Univ Enfants Reine Fabiola, Ctr Ressource Autisme, Brussels, Belgium	Universite Libre de Bruxelles	Kissine, M (corresponding author), Univ Libre Bruxelles, Brussels, Belgium.	mkissine@ulb.ac.be	Kissine, Mikhail/AAE-9184-2020	Kissine, Mikhail/0000-0001-6693-9772	F.R.S.-FNRS [F.4502.15]; ARC	F.R.S.-FNRS(Fonds de la Recherche Scientifique - FNRS); ARC(Australian Research Council)	Funding: Work reported in this paper benefited from the Research Incentive Grant F.4502.15 (F.R.S.-FNRS) and a ARC-Consolidator Grant to Mikhail Kissine.	Baltaxe C., 1977, J PEDIATR PSYCHOL, V2, P176, DOI [10.1093/jpepsy/2.4.176, DOI 10.1093/JPEPSY/2.4.176]; Baron-Cohen S., 2000, UNDERSTANDING OTHER, V2, P102, DOI DOI 10.1093/ACPROF:OSO/9780199692972.001.0001; Bloom P, 2000, COGNITION, V77, pB25, DOI 10.1016/S0010-0277(00)00096-2; Capps L., 1998, AUTISM, V2, P325, DOI [10.1177/1362361398024002, DOI 10.1177/1362361398024002]; CARRELL PL, 1981, J CHILD LANG, V8, P329, DOI 10.1017/S0305000900003226; Carston, 2002, THOUGHTS UTTERANCES; Chevallier C, 2010, J AUTISM DEV DISORD, V40, P1104, DOI 10.1007/s10803-010-0960-8; CLARK HH, 1975, J VERB LEARN VERB BE, V14, P56, DOI 10.1016/S0022-5371(75)80006-5; CLEMENTS WA, 1994, COGNITIVE DEV, V9, P377, DOI 10.1016/0885-2014(94)90012-4; Cole Peter, 1975, SYNTAX SEMANTICSVOL, P59, DOI DOI 10.1017/CBO9780511609213.004; EALES MJ, 1993, J AUTISM DEV DISORD, V23, P593, DOI 10.1007/BF01046104; Gernsbacher MA, 2012, METAPHOR SYMBOL, V27, P93, DOI 10.1080/10926488.2012.656255; GIBBS RW, 1986, ACTA PSYCHOL, V62, P41, DOI 10.1016/0001-6918(86)90004-1; Giora R, 2012, METAPHOR SYMBOL, V27, P22, DOI 10.1080/10926488.2012.638823; Grice P., 1989, STUDIES WAY WORDS; HAPPE FGE, 1995, CHILD DEV, V66, P843, DOI 10.2307/1131954; Helloin M-C, 2006, BATTERIE INFORMATISE; Irwin JR, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00397; Jary M, 2014, KEY TOP SEMANT PRAGM, P1, DOI 10.1017/CBO9780511998126; Kissine M, 2013, FROM UTTERANCES TO SPEECH ACTS, P1, DOI 10.1017/CBO9780511842191; Kissine M, 2012, AUTISM, V16, P523, DOI 10.1177/1362361311406296; Kissine M, 2012, MIND LANG, V27, P1, DOI 10.1111/j.1468-0017.2011.01433.x; MacKay G, 2005, CHILD LANG TEACH THE, V20, P13; Morgan J.L., 1978, SYNTAX SEMANTICS VOL, P261; Nichols Shaun, 2003, MINDREADING INTEGRAT; Norbury CF, 2005, BRIT J DEV PSYCHOL, V23, P383, DOI 10.1348/026151005X26732; Onishi KH, 2005, SCIENCE, V308, P255, DOI 10.1126/science.1107621; Ozonoff S, 1996, BRAIN LANG, V52, P411, DOI 10.1006/brln.1996.0022; PAUL R, 1985, J SPEECH HEAR RES, V28, P475, DOI 10.1044/jshr.2804.475; Perkins, 2007, PRAGMATIC IMPAIRMENT; PERNER J, 1989, CHILD DEV, V60, P689, DOI 10.2307/1130734; Pijnacker J, 2009, J AUTISM DEV DISORD, V39, P607, DOI 10.1007/s10803-008-0661-8; Recanati Francois, 2004, LITERAL MEANING; REEDER K, 1980, J CHILD LANG, V7, P13, DOI 10.1017/S0305000900007005; Ruytenbeek N., DRAWING LINE PERSPEC; Schulze C, 2015, COGNITION, V136, P91, DOI 10.1016/j.cognition.2014.11.036; Senju A, 2010, DEV PSYCHOPATHOL, V22, P353, DOI 10.1017/S0954579410000106; SHATZ M, 1978, COGNITIVE PSYCHOL, V10, P271, DOI 10.1016/0010-0285(78)90001-4; Shintel H, 2009, TOP COGN SCI, V1, P260, DOI 10.1111/j.1756-8765.2009.01018.x; Southgate V, 2007, PSYCHOL SCI, V18, P587, DOI 10.1111/j.1467-9280.2007.01944.x; Sperber D, 2002, MIND LANG, V17, P3, DOI 10.1111/1468-0017.00186; Sperber Dan, 1986, RELEVANCE COMMUNICAT, V142; Surian L, 1996, Cogn Neuropsychiatry, V1, P55, DOI 10.1080/135468096396703; TAGERFLUSBERG H, 1991, J CHILD PSYCHOL PSYC, V32, P1123, DOI 10.1111/j.1469-7610.1991.tb00353.x; Terkourafi M, 2009, CURR RES SEMANT PRAG, V20, P27; Tomasello M, 2008, JEAN NICOD LECT, P1; Yirmiya N, 1998, PSYCHOL BULL, V124, P283, DOI 10.1037/0033-2909.124.3.283	47	19	19	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0142191	10.1371/journal.pone.0142191	http://dx.doi.org/10.1371/journal.pone.0142191			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7AC	26551648	Green Submitted, gold, Green Published			2022-12-26	WOS:000364422800018
J	Ellis, CD; Hodgson, DJ; Andre, C; Sordalen, TK; Knutsen, H; Griffiths, AGF				Ellis, Charlie D.; Hodgson, David J.; Andre, Carl; Sordalen, Tonje K.; Knutsen, Halvor; Griffiths, Amber G. F.			Genotype Reconstruction of Paternity in European Lobsters (Homarus gammarus)	PLOS ONE			English	Article							CHIONOECETES-OPILIO BRACHYURA; MICROSATELLITE NULL ALLELES; MULTIPLE PATERNITY; AMERICAN LOBSTER; SPERM COMPETITION; SNOW CRAB; SEXUAL SELECTION; MATING SYSTEMS; PARENTAGE; ECOLOGY	Decapod crustaceans exhibit considerable variation in fertilisation strategies, ranging from pervasive single paternity to the near-ubiquitous presence of multiple paternity, and such knowledge of mating systems and behaviour are required for the informed management of commercially-exploited marine fisheries. We used genetic markers to assess the paternity of individual broods in the European lobster, Homarus gammarus, a species for which paternity structure is unknown. Using 13 multiplexed microsatellite loci, three of which are newly described in this study, we genotyped 10 eggs from each of 34 females collected from an Atlantic peninsula in the south-western United Kingdom. Single reconstructed paternal genotypes explained all observed progeny genotypes in each of the 34 egg clutches, and each clutch was fertilised by a different male. Simulations indicated that the probability of detecting multiple paternity was in excess of 95% if secondary sires account for at least a quarter of the brood, and in excess of 99% where additional sire success was approximately equal. Our results show that multiple paternal fertilisations are either absent, unusual, or highly skewed in favour of a single male among H. gammarus in this area. Potential mechanisms upholding single paternal fertilisation are discussed, along with the prospective utility of parentage assignments in evaluations of hatchery stocking and other fishery conservation approaches in light of this finding.	[Ellis, Charlie D.; Griffiths, Amber G. F.] Univ Exeter, Environm & Sustainabil Inst, Penryn TR10 9FE, Cornwall, England; [Ellis, Charlie D.] Natl Lobster Hatchery, Padstow PL28 8BL, Cornwall, England; [Hodgson, David J.] Univ Exeter, Ctr Ecol & Conservat, Penryn TR10 9FE, Cornwall, England; [Andre, Carl] Univ Gothenburg, Dept Marine Ecol Tjarno, S-45296 Stromstad, Sweden; [Sordalen, Tonje K.; Knutsen, Halvor] Univ Agder, N-4604 Kristiansand, Norway; [Knutsen, Halvor] Inst Marine Res, N-4817 Flodevigen, His, Norway; [Knutsen, Halvor] Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, N-0316 Oslo, Norway	University of Exeter; University of Exeter; University of Gothenburg; University of Agder; Institute of Marine Research - Norway; University of Oslo	Ellis, CD (corresponding author), Univ Exeter, Environm & Sustainabil Inst, Penryn Campus, Penryn TR10 9FE, Cornwall, England.	cde204@exeter.ac.uk	Andre, Carl/B-4237-2010; Knutsen, Halvor/A-4261-2009	Andre, Carl/0000-0003-4404-7292; Knutsen, Halvor/0000-0002-7627-7634; Ellinas, Christos/0000-0001-5146-6554; Ellis, Charlie/0000-0001-9398-4579; Griffiths, Amber/0000-0002-7455-6795; Sordalen, Tonje Knutsen/0000-0001-5836-9327	European Social Fund; Fisheries Charitable Trust of the Fishmongers' Company, UK	European Social Fund(European Social Fund (ESF)); Fisheries Charitable Trust of the Fishmongers' Company, UK	CE was funded to carry out field work and the preparation of this manuscript by the European Social Fund (http://ec.europa.eu/esf/uk). Laboratory work was financed by a grant obtained by CE from the Fisheries Charitable Trust of the Fishmongers' Company, UK (http://www.fishhall.org.uk/fish-fisheries/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnalt A.-L., 2004, STOCK ENHANCEMENT SE, P415, DOI DOI 10.1002/9780470751329.CH30; Agnalt AL, 1999, STOCK ENHANCEMENT AND SEA RANCHING, P401; Agnalt AL, 2007, ICES J MAR SCI, V64, P288, DOI 10.1093/icesjms/fsl020; Aiken DE, 2004, J CRUSTACEAN BIOL, V24, P474, DOI 10.1651/C-2454; Andre C, 2010, CONSERV GENET RESOUR, V2, P233, DOI 10.1007/s12686-009-9151-3; [Anonymous], 2007, R200701 CORNW SEA FI; Avise JC, 2002, ANNU REV GENET, V36, P19, DOI 10.1146/annurev.genet.36.030602.090831; Bailie DA, 2014, J CRUSTACEAN BIOL, V34, P658, DOI 10.1163/1937240X-00002254; Bailie DA, 2011, MAR ECOL PROG SER, V421, P173, DOI 10.3354/meps08895; Bannister RCA, 1998, B MAR SCI, V62, P369; Berkeley SA, 2004, FISHERIES, V29, P23, DOI 10.1577/1548-8446(2004)29[23:FSVPOA]2.0.CO;2; Bernatchez L, 2000, CAN J FISH AQUAT SCI, V57, P1, DOI 10.1139/cjfas-57-1-1; Bilodeau AL, 2005, MAR BIOL, V146, P381, DOI 10.1007/s00227-004-1444-1; Butler M, 2015, IUCN RED LIST THREAT; CEFAS, ENGL REG STOCK STAT; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Chevolot M, 2007, J HERED, V98, P712, DOI 10.1093/jhered/esm077; Christie MR, 2012, P NATL ACAD SCI USA, V109, P238, DOI 10.1073/pnas.1111073109; COWAN DF, 1990, ANIM BEHAV, V39, P1199, DOI 10.1016/S0003-3472(05)80792-4; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; Davies CE, 2015, ICES J MAR SCI, V72, P128, DOI 10.1093/icesjms/fsu237; Dean MD, 2006, MOL ECOL, V15, P4141, DOI 10.1111/j.1365-294X.2006.03068.x; Debuse VJ, 2003, BEHAV ECOL, V14, P396, DOI 10.1093/beheco/14.3.396; Dodds KG, 1996, THEOR APPL GENET, V92, P966, DOI 10.1007/BF00224036; Ellis CD, 2015, ICES J MAR SCI, V72, P91, DOI 10.1093/icesjms/fsv044; Gosselin T, 2005, MOL ECOL, V14, P1517, DOI 10.1111/j.1365-294X.2005.02498.x; Gosselin T, 2003, BEHAV ECOL SOCIOBIOL, V55, P151, DOI 10.1007/s00265-003-0695-z; Hoffman JI, 2005, MOL ECOL, V14, P599, DOI 10.1111/j.1365-294X.2004.02419.x; Hoskin MG, 2011, CAN J FISH AQUAT SCI, V68, P185, DOI 10.1139/F10-143; Huserbraten MBO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073388; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Jensen PC, 2012, J CRUSTACEAN BIOL, V32, P443, DOI 10.1163/193724012X626458; Jeong DS, 2007, FISHERIES SCI, V73, P823, DOI 10.1111/j.1444-2906.2007.01402.x; Johnson KJ, 2011, J CRUSTACEAN BIOL, V31, P693, DOI 10.1651/11-3459.1; Jones AG, 2005, MOL ECOL NOTES, V5, P708, DOI 10.1111/j.1471-8286.2005.01029.x; Jones MW, 2003, GENOME, V46, P59, DOI 10.1139/G02-105; Kahrl AF, 2014, CAN J ZOOL, V92, P985, DOI 10.1139/cjz-2014-0132; Levitan DR, 2004, AM NAT, V164, P298, DOI 10.1086/423150; Linnane A, 1998, AQUACULTURE, V163, P195, DOI 10.1016/S0044-8486(98)00247-6; MacDiarmid AB, 1999, BEHAV ECOL SOCIOBIOL, V46, P14, DOI 10.1007/s002650050587; Mercer JP, 2001, MAR FRESHWATER RES, V52, P1291, DOI 10.1071/MF01216; Morrissey MB, 2005, MOL ECOL, V14, P4111, DOI 10.1111/j.1365-294X.2005.02708.x; Neenan STV, 2015, AQUAC RES, V46, P2913, DOI 10.1111/are.12445; Neff BD, 2002, J FISH BIOL, V61, P739, DOI 10.1111/j.1095-8649.2002.tb00908.x; Panova M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009640; Plough LV, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-81; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rowe S, 2003, TRENDS ECOL EVOL, V18, P567, DOI 10.1016/j.tree.2003.09.004; Sainte-Marie B, 1999, MAR ECOL PROG SER, V181, P141, DOI 10.3354/meps181141; Sandrin L, 2015, ECOL ENTOMOL, V40, P159, DOI 10.1111/een.12171; Schmalenbach I, 2011, FISH RES, V108, P22, DOI 10.1016/j.fishres.2010.11.016; Sekino M, 2005, AQUACULTURE, V244, P49, DOI 10.1016/j.aquaculture.2004.11.006; Sevigny JM, 1996, J SHELLFISH RES, V15, P437; Streiff R, 2004, MAR BIOTECHNOL, V6, P60, DOI 10.1007/s10126-003-0015-7; Talbot P., 1995, P177, DOI 10.1016/B978-012247570-2/50031-1; Thiel M, 2003, BEHAV ECOL SOCIOBIOL, V55, P113, DOI 10.1007/s00265-003-0677-1; Toonen RJ, 2004, MAR ECOL PROG SER, V270, P259, DOI 10.3354/meps270259; Tully O, 2001, J MAR BIOL ASSOC UK, V81, P61, DOI 10.1017/S002531540100340X; Urbani N, 1998, CAN J FISH AQUAT SCI, V55, P1104, DOI 10.1139/cjfas-55-5-1104; Van Doornik DM, 2008, ENVIRON BIOL FISH, V83, P269, DOI 10.1007/s10641-008-9331-0; WADDY SL, 1990, CAN J FISH AQUAT SCI, V47, P2402, DOI 10.1139/f90-267; Wahle RA, 2013, LOBSTERS: BIOLOGY, MANAGEMENT, AQUACULTURE AND FISHERIES, 2ND EDITION, P221; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8; Wootton EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051615	64	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0139585	10.1371/journal.pone.0139585	http://dx.doi.org/10.1371/journal.pone.0139585			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26566271	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000367628500001
J	Li, Q; Zhang, JH; Zhang, BY; Cressman, R; Tao, Y				Li, Qing; Zhang, Jiahua; Zhang, Boyu; Cressman, Ross; Tao, Yi			Effect of Spatial Dispersion on Evolutionary Stability: A Two-Phenotype and Two-Patch Model	PLOS ONE			English	Article							GAMES; DYNAMICS; STRATEGIES	In this paper, we investigate a simple two-phenotype and two-patch model that incorporates both spatial dispersion and density effects in the evolutionary game dynamics. The migration rates from one patch to another are considered to be patch-dependent but independent of individual's phenotype. Our main goal is to reveal the dynamical properties of the evolutionary game in a heterogeneous patchy environment. By analyzing the equilibria and their stabilities, we find that the dynamical behavior of the evolutionary game dynamics could be very complicated. Numerical analysis shows that the simple model can have twelve equilibria where four of them are stable. This implies that spatial dispersion can significantly complicate the evolutionary game, and the evolutionary outcome in a patchy environment should depend sensitively on the initial state of the patches.	[Li, Qing] Capital Normal Univ, Sch Math Sci, Beijing, Peoples R China; [Zhang, Jiahua; Tao, Yi] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Zhang, Boyu] Beijing Normal Univ, Sch Math Sci, Minist Educ, Lab Math & Complex Syst, Beijing 100875, Peoples R China; [Cressman, Ross] Wilfrid Laurier Univ, Dept Math, Waterloo, ON N2L 3C5, Canada	Capital Normal University; Chinese Academy of Sciences; Institute of Zoology, CAS; Beijing Normal University; Wilfrid Laurier University	Zhang, BY (corresponding author), Beijing Normal Univ, Sch Math Sci, Minist Educ, Lab Math & Complex Syst, Beijing 100875, Peoples R China.	zhangby@bnu.edu.cn		Tao, Yi/0000-0002-0749-6614	National Natural Science Foundation of China [11471221, 11301032, 31270439]; "the Fundamental Research Funds for the Central Universities" of China; Natural Science Foundation of Beijing Municipal [1132003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "the Fundamental Research Funds for the Central Universities" of China(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Beijing Municipal(Beijing Natural Science Foundation)	This work was supported by National Natural Science Foundation of China, No. 11471221, No. 11301032 and No. 31270439 (http://www.nsfc.gov.cn/); "the Fundamental Research Funds for the Central Universities" of China (http://www.gov.cn/); and Natural Science Foundation of Beijing Municipal. No. 1132003 (http://www.bjnsf.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COMINS HN, 1980, J THEOR BIOL, V82, P205, DOI 10.1016/0022-5193(80)90099-5; Cressman R, 2004, AM NAT, V164, P473, DOI 10.1086/423827; Cressman R., 1992, LECT NOTES BIOMATH, V94; Cressman R, 2006, AM NAT, V168, P384, DOI 10.1086/506970; Dieckmann U, 1999, TRENDS ECOL EVOL, V14, P88, DOI 10.1016/S0169-5347(98)01571-7; Fretwell S.D., 1970, ACTA BIOTHEOR, V19, P16, DOI DOI 10.1007/BF01601953; HINES WGS, 1979, J THEOR BIOL, V79, P19, DOI 10.1016/0022-5193(79)90254-6; Hofbauer J, 1999, ANN OPER RES, V89, P233, DOI 10.1023/A:1018979708014; Hofbauer J, 1997, NONLINEAR ANAL-THEOR, V30, P1235, DOI 10.1016/S0362-546X(96)00336-7; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Hugie DM, 1998, EVOL ECOL, V12, P1; HUTSON VCL, 1992, J MATH BIOL, V30, P457, DOI 10.1007/BF00160531; LEVIN SA, 1984, THEOR POPUL BIOL, V26, P165, DOI 10.1016/0040-5809(84)90028-5; LUDWIG D, 1991, THEOR POPUL BIOL, V40, P285, DOI 10.1016/0040-5809(91)90057-M; Maynard Smith J., 1982, pi; PRIOR TG, 1993, J MATH BIOL, V32, P55, DOI 10.1007/BF00160374; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Sun GQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11246; Sun GQ, 2014, COMMUN NONLINEAR SCI, V19, P1507, DOI 10.1016/j.cnsns.2013.09.016; Sun GQ, 2012, APPL MATH COMPUT, V218, P11151, DOI 10.1016/j.amc.2012.04.071; Sun GQ, 2012, NONLINEAR DYNAM, V69, P1631, DOI 10.1007/s11071-012-0374-6; TAYLOR PD, 1978, MATH BIOSCI, V40, P145, DOI 10.1016/0025-5564(78)90077-9; Travis JMJ, 1999, P ROY SOC B-BIOL SCI, V266, P1837, DOI 10.1098/rspb.1999.0854	23	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142929	10.1371/journal.pone.0142929	http://dx.doi.org/10.1371/journal.pone.0142929			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26566219	Green Submitted, Green Published, gold			2022-12-26	WOS:000367628500072
J	Ning, N; Yuan, XY; Dong, SQ; Wen, YY; Gao, ZP; Guo, MJ; Guo, PY				Ning, Na; Yuan, Xiangyang; Dong, Shuqi; Wen, Yinyuan; Gao, Zhenpan; Guo, Meijun; Guo, Pingyi			Grain Yield and Quality of Foxtail Millet (Setaria italica L.) in Response to Tribenuron-Methyl	PLOS ONE			English	Article							AMINO-ACID BIOSYNTHESIS; WEED-CONTROL; HERBICIDES; COMPONENTS; MAGNESIUM; SYSTEMS; GROWTH; SOIL	Foxtail millet (Setaria italica L.) is cultivated around the world for human and animal consumption. There is no suitable herbicide available for weed control in foxtail millet fields during the post-emergence stage. In this study, we investigated the effect and safety of the post-emergence herbicide tribenuron-methyl (TBM) on foxtail millet in terms of grain yield and quality using a split-plot field design. Field experiments were conducted using two varieties in 2013 and 2014, i.e., high-yielding hybrid Zhangzagu 10 and high-quality conventional Jingu 21. TBM treatments at 11.25 to 90 g ai ha(-1) reduced root and shoot biomass and grain yield to varying degrees. In each of the two years, grain yield declined by 50.2% in Zhangzagu 10 with a herbicide dosage of 45 g ai ha(-1) and by 45.2% in Jingu 21 with a herbicide dosage of 22.5 g ai ha(-1) (recommended dosage). Yield reduction was due to lower grains per panicle, 1000-grain weight, panicle length, and panicle diameter. Grain yield was positively correlated with grains per panicle and 1000-grain weight, but not with panicles ha(-1). With respect to grain protein content at 22.5 g ai ha(-1), Zhangzagu 10 was similar to the control, whereas Jingu 21 was markedly lower. An increase in TBM dosage led to a decrease in grain Mn, Cu, Fe, and Zn concentrations. In conclusion, the recommended dosage of TBM was relatively safe for Zhangzagu 10, but not for Jingu 21. Additionally, the hybrid variety Zhangzagu 10 had a greater tolerance to TBM than the conventional variety Jingu 21.	[Ning, Na; Yuan, Xiangyang; Dong, Shuqi; Wen, Yinyuan; Gao, Zhenpan; Guo, Meijun; Guo, Pingyi] Shanxi Agr Univ, Coll Agron, Lab Crop Chem Regulat & Chem Weed Control, Taigu, Shanxi, Peoples R China	Shanxi Agricultural University	Yuan, XY (corresponding author), Shanxi Agr Univ, Coll Agron, Lab Crop Chem Regulat & Chem Weed Control, Taigu, Shanxi, Peoples R China.	zhangkainingna@126.com; pyguo@sxau.edu.cn			National Natural Science Foundation of China [31301269]; National Key Technology RD Program [2014BAD07B01]; Scientific and Technological Project in Shanxi Province, China [20120311004-4]; Graduate Innovative Research Project in Shanxi Province, China [20143053]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology RD Program(National Key Technology R&D Program); Scientific and Technological Project in Shanxi Province, China; Graduate Innovative Research Project in Shanxi Province, China	This work was supported by the National Natural Science Foundation of China (31301269); the National Key Technology R&D Program (2014BAD07B01); the Scientific and Technological Project in Shanxi Province, China (20120311004-4); and the Graduate Innovative Research Project in Shanxi Province, China (20143053).	Chauhan BS, 2012, FIELD CROP RES, V137, P56, DOI 10.1016/j.fcr.2012.08.016; Derr JF, 2012, WEED TECHNOL, V26, P582, DOI 10.1614/WT-D-11-00166.1; Diao XM, 2014, FRONT AGRIC SCI ENG, V1, P16, DOI 10.15302/J-FASE-2014011; Doust AN, 2009, PLANT PHYSIOL, V149, P137, DOI 10.1104/pp.108.129627; Duggleby RG, 2000, J BIOCHEM MOL BIOL, V33, P1; Gaston S, 2002, PHYSIOL PLANTARUM, V114, P524, DOI 10.1034/j.1399-3054.2002.1140404.x; Grandoni JA, 1998, J ANTIMICROB CHEMOTH, V42, P475, DOI 10.1093/jac/42.4.475; Gu S. L., 1989, Acta Agriculturae Boreali-Sinica, V4, P8; Gugala M, 2012, J ELEMENTOL, V17, P247, DOI 10.5601/jelem.2012.17.2.07; Gugala M, 2010, J ELEMENTOL, V15, P269, DOI 10.5601/jelem.2010.15.2.269-280; Javaid MM, 2013, WEED TECHNOL, V27, P437, DOI 10.1614/WT-D-11-00130.1; Krishnan P, 2005, J AGR SCI-CAMBRIDGE, V143, P283, DOI 10.1017/S0021859605005496; Lata C, 2013, CRIT REV BIOTECHNOL, V33, P328, DOI 10.3109/07388551.2012.716809; Li PH, 2011, J EXP BOT, V62, P3031, DOI 10.1093/jxb/err096; Liang SH, 2010, J AM OIL CHEM SOC, V87, P63, DOI 10.1007/s11746-009-1475-3; LIU JL, 2006, AGROCHEINCALS, V45, P511; Liu Wei, 2005, Acta Phytophylacica Sinica, V32, P300; Lum AF, 2005, CROP PROT, V24, P41, DOI 10.1016/j.cropro.2004.06.006; Miao ZZ, 2013, J SHANXI AGR SCI, V41, P785; Muthamilarasan M, 2015, THEOR APPL GENET, V128, P1, DOI 10.1007/s00122-014-2399-3; Opena JL, 2014, FIELD CROP RES, V167, P119, DOI 10.1016/j.fcr.2014.07.014; Robinson AP, 2013, WEED SCI, V61, P526, DOI 10.1614/WS-D-12-00203.1; Ryan MH, 2004, J SCI FOOD AGR, V84, P207, DOI 10.1002/jsfa.1634; Shan SH, 2014, TOXICOL LETT, V227, P129, DOI 10.1016/j.toxlet.2014.03.008; Stavridou E, 2012, PLANT SOIL, V351, P149, DOI 10.1007/s11104-011-0940-6; Stoltz E, 2014, FIELD CROP RES, V169, P21, DOI 10.1016/j.fcr.2014.09.004; Suganthi M., 2013, Journal of Agronomy, V12, P59, DOI 10.3923/ja.2013.59.63; SWEETSER PB, 1982, PESTIC BIOCHEM PHYS, V17, P18, DOI 10.1016/0048-3575(82)90121-3; Wang JW, 2013, FIELD CROP RES, V150, P83, DOI 10.1016/j.fcr.2013.06.010; [王鑫 WANG Xin], 2006, [安徽农业科学, Journal of anhui agricultural sciences], V34; Wang Z., 2011, THESIS; Wang ZhengGui, 2010, Journal of Agro-Environment Science, V29, P1027; Wozniak A, 2013, J AGR SCI TECH-IRAN, V15, P1335; Xie LL, 2014, J SHANXI AGR SCI, V42, P223; Yuan HF, 2009, AGROCHEINCALS, V48, P218; Yuan XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105310; Zhang JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019726; Zhou HZ, 2012, J AGR, V2, P12; Zhou HZ, 2012, AGR SCI TECH, V13, P1014; Zhou Q, 2007, PESTIC BIOCHEM PHYS, V89, P89, DOI 10.1016/j.pestbp.2007.04.004	40	10	12	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142557	10.1371/journal.pone.0142557	http://dx.doi.org/10.1371/journal.pone.0142557			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26565992	Green Published, gold, Green Submitted			2022-12-26	WOS:000367628500033
J	Feneant, L; Ghosn, J; Fouquet, B; Helle, F; Belouzard, S; Vausselin, T; Seron, K; Delfraissy, JF; Dubuisson, J; Misrahi, M; Cocquerel, L				Feneant, Lucie; Ghosn, Jade; Fouquet, Baptiste; Helle, Francois; Belouzard, Sandrine; Vausselin, Thibaut; Seron, Karin; Delfraissy, Jean-Francois; Dubuisson, Jean; Misrahi, Micheline; Cocquerel, Laurence			Claudin-6 and Occludin Natural Variants Found in a Patient Highly Exposed but Not Infected with Hepatitis C Virus (HCV) Do Not Confer HCV Resistance In Vitro	PLOS ONE			English	Article							B TYPE-I; GENETIC-VARIATION; HOST FACTORS; ENTRY; CD81; RECEPTOR; CLEARANCE; IL28B; POLARIZATION; ASSOCIATION	The clinical course of Hepatitis C Virus (HCV) infection is highly variable between infected individual hosts: up to 80% of acutely HCV infected patients develop a chronic infection while 20% clear infection spontaneously. Spontaneous clearance of HCV infection can be predicted by several factors, including symptomatic acute infection, favorable IFNL3 polymorphisms and gender. In our study, we explored the possibility that variants in HCV cell entry factors might be involved in resistance to HCV infection. In a same case patient highly exposed but not infected by HCV, we previously identified one mutation in claudin-6 (CLDN6) and a rare variant in occludin (OCLN), two tight junction proteins involved in HCV entry into hepatocytes. Here, we conducted an extensive functional study to characterize the ability of these two natural variants to prevent HCV entry. We used lentiviral vectors to express Wildtype or mutated CLDN6 and OCLN in different cell lines and primary human hepatocytes. HCV infection was then investigated using cell culture produced HCV particles (HCVcc) as well as HCV pseudoparticles (HCVpp) expressing envelope proteins from different genotypes. Our results show that variants of CLDN6 and OCLN expressed separately or in combination did not affect HCV infection nor cell-to-cell transmission. Hence, our study highlights the complexity of HCV resistance mechanisms supporting the fact that this process probably not primarily involves HCV entry factors and that other unknown host factors may be implicated.	[Feneant, Lucie; Belouzard, Sandrine; Vausselin, Thibaut; Seron, Karin; Dubuisson, Jean; Cocquerel, Laurence] Univ Lille, CNRS, Inst Pasteur Lille,U1019,UMR 8204, Ctr Infect & Immun Lille,CHU Lille,CIIL,Inserm, F-59000 Lille, France; [Ghosn, Jade] Hopital Univ Hotel Dieu, AP HP, Unite Fonct Therapeut Immunoinfectiol, Paris, France; [Ghosn, Jade] Univ Paris 05, Fac Med Site Necker, EA 7327, Paris, France; [Fouquet, Baptiste; Misrahi, Micheline] Univ Paris 11, Hop Univ Paris Sud, Fac Med, Le Kremlin Bicetre, France; [Fouquet, Baptiste; Misrahi, Micheline] Hop Paul Brousse, INSERM, U1193, F-94800 Villejuif, France; [Helle, Francois] Amiens Univ Hosp, Dept Virol, Amiens, France; [Delfraissy, Jean-Francois] CHU Bicetre, AP HP, Serv Med Interne & Malad Infect, Le Kremlin Bicetre, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP	Cocquerel, L (corresponding author), Univ Lille, CNRS, Inst Pasteur Lille,U1019,UMR 8204, Ctr Infect & Immun Lille,CHU Lille,CIIL,Inserm, F-59000 Lille, France.	laurence.cocquerel@ibl.cnrs.fr	Seron, Karin/O-8481-2016; HELLE, Francois/G-7427-2011; Fouquet, Baptiste/GXH-8827-2022; Cocquerel, Laurence/P-1951-2016; Belouzard, Sandrine/O-8527-2016; Belouzard, Sandrine/AAX-1584-2021; Dubuisson, Jean/E-6813-2016	Seron, Karin/0000-0002-9667-133X; HELLE, Francois/0000-0001-6884-2456; Cocquerel, Laurence/0000-0002-2136-5178; Belouzard, Sandrine/0000-0002-9972-4054; Belouzard, Sandrine/0000-0002-9972-4054; Dubuisson, Jean/0000-0003-1626-7693	French National Agency for Research on AIDS and Viral Hepatitis (ANRS) [ANRS AO-2008-1, ANRS AO 2013-2]; French Ministry of Research; ANRS; Marie Curie International Reintegration Grant [PIRG-GA-2009-256300]	French National Agency for Research on AIDS and Viral Hepatitis (ANRS)(ANRSFrench National Research Agency (ANR)); French Ministry of Research(Ministry of Research, FranceEuropean Commission); ANRS(ANRSFrench National Research Agency (ANR)); Marie Curie International Reintegration Grant(European Commission)	This work was supported by the French National Agency for Research on AIDS and Viral Hepatitis (ANRS) (grants ANRS AO-2008-1 and ANRS AO 2013-2). L. F. and T. V. were supported by a fellowship from the French Ministry of Research. L. F. was also supported by a fellowship from the ANRS. S. B. was supported by a Marie Curie International Reintegration Grant (PIRG-GA-2009-256300).	Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Barth H, 2003, J BIOL CHEM, V278, P41003, DOI 10.1074/jbc.M302267200; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Benedicto I, 2009, J VIROL, V83, P8012, DOI 10.1128/JVI.00038-09; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Brimacombe CL, 2011, J VIROL, V85, P596, DOI 10.1128/JVI.01592-10; Castelain S, 2004, J CLIN VIROL, V31, P227, DOI 10.1016/j.jcv.2004.03.009; Ciesek S, 2011, J VIROL, V85, P7613, DOI 10.1128/JVI.00212-11; Cocquerel L, 1998, J VIROL, V72, P2183, DOI 10.1128/JVI.72.3.2183-2191.1998; Coller KE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000702; Cukierman L, 2009, J VIROL, V83, P5477, DOI 10.1128/JVI.02262-08; Da Costa D, 2012, J VIROL, V86, P11919, DOI 10.1128/JVI.01066-12; De Beeck AO, 2004, J VIROL, V78, P2994, DOI 10.1128/JVI.78.6.2994-3002.2004; Deest M, 2014, ANTIVIR RES, V101, P37, DOI 10.1016/j.antiviral.2013.10.018; Delgrange D, 2007, J GEN VIROL, V88, P2495, DOI 10.1099/vir.0.82872-0; DUBUISSON J, 1994, J VIROL, V68, P6147, DOI 10.1128/JVI.68.10.6147-6160.1994; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Farci P, 2000, SCIENCE, V288, P339, DOI 10.1126/science.288.5464.339; Fofana I, 2010, GASTROENTEROLOGY, V139, P953, DOI 10.1053/j.gastro.2010.05.073; Fouquet B, PLOS ONE IN PRESS; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Gentzsch J, 2011, ANTIVIR RES, V89, P136, DOI 10.1016/j.antiviral.2010.12.005; Gerlach JT, 2003, GASTROENTEROLOGY, V125, P80, DOI 10.1016/S0016-5085(03)00668-1; Ghosn J, 2015, J MED VIROL, V87, P619, DOI 10.1002/jmv.24088; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Goueslain L, 2010, J VIROL, V84, P773, DOI 10.1128/JVI.01190-09; Graw F, 2015, J VIROL, V89, P6551, DOI 10.1128/JVI.00016-15; Haid S, 2014, HEPATOLOGY, V59, P24, DOI 10.1002/hep.26567; Harris HJ, 2013, CELL MICROBIOL, V15, P430, DOI 10.1111/cmi.12047; Harris HJ, 2008, J VIROL, V82, P5007, DOI 10.1128/JVI.02286-07; Harris HJ, 2010, J BIOL CHEM, V285, P21092, DOI 10.1074/jbc.M110.104836; Helle F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070809; Hofer H, 2003, HEPATOLOGY, V37, P60, DOI 10.1053/jhep.2003.50019; Krieger SE, 2010, HEPATOLOGY, V51, P1144, DOI 10.1002/hep.23445; Larsen C, 2004, EURO SURVEILL, V13; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Lavillette D, 2005, HEPATOLOGY, V41, P265, DOI 10.1002/hep.20542; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Liu SF, 2010, VIROLOGY, V407, P160, DOI 10.1016/j.virol.2010.08.009; Liu SF, 2009, J VIROL, V83, P2011, DOI 10.1128/JVI.01888-08; Loko MA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-303; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Mailly L, 2015, NAT BIOTECHNOL, V33, P549, DOI 10.1038/nbt.3179; Martin DN, 2013, P NATL ACAD SCI USA, V110, P10777, DOI 10.1073/pnas.1301764110; Mee CJ, 2008, J VIROL, V82, P461, DOI 10.1128/JVI.01894-07; Mee CJ, 2009, J VIROL, V83, P6211, DOI 10.1128/JVI.00246-09; Meertens L, 2008, J VIROL, V82, P3555, DOI 10.1128/JVI.01977-07; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Michta ML, 2010, J VIROL, V84, P11696, DOI 10.1128/JVI.01555-10; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; O'Brien TR, 2015, J HEPATOLOG IN PRESS, P1; Park JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060333; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Potel J, 2013, CELL MICROBIOL, V15, P1234, DOI 10.1111/cmi.12112; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Ren QP, 2015, SCI REP-UK, V5, DOI 10.1038/srep08865; Restrepo C, 2011, AIDS REV, V13, P30; Rocha-Perugini V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001866; Sainz B, 2006, J VIROL, V80, P10253, DOI 10.1128/JVI.01059-06; Sainz B, 2012, NAT MED, V18, P281, DOI 10.1038/nm.2581; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Sourisseau M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003244; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Zheng AH, 2007, J VIROL, V81, P12465, DOI 10.1128/JVI.01457-07; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	72	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142539	10.1371/journal.pone.0142539	http://dx.doi.org/10.1371/journal.pone.0142539			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26561856	gold, Green Published			2022-12-26	WOS:000364480900040
J	Manzoor, I; Shafeeq, S; Kuipers, OP				Manzoor, Irfan; Shafeeq, Sulman; Kuipers, Oscar P.			Ni2+-Dependent and PsaR-Mediated Regulation of the Virulence Genes pcpA, psaBCA, and prtA in Streptococcus pneumoniae	PLOS ONE			English	Article							METALLOREGULATORY PROTEIN MNTR; ORPHAN RESPONSE REGULATOR; HYDROGEN-PEROXIDE; BACILLUS-SUBTILIS; BINDING PROTEINS; METAL-BINDING; STRAIN R6; MANGANESE; REPRESSOR; IRON	Previous studies have shown that the transcriptional regulator PsaR regulates the expression of the PsaR regulon consisting of genes encoding choline binding protein (PcpA), the extracellular serine protease (PrtA), and the Mn2+-uptake system (PsaBCA), in the presence of manganese (Mn2+), zinc (Zn2+), and cobalt (Co2+). In this study, we explore the Ni2+-dependent regulation of the PsaR regulon. We have demonstrated by qRT-PCR analysis, metal accumulation assays, beta-galactosidase assays, and electrophoretic mobility shift assays that an elevated concentration of Ni2+ leads to strong induction of the PsaR regulon. Our ICP-MS data show that the Ni2+-dependent expression of the PsaR regulon is directly linked to high, cell-associated, concentration of Ni2+, which reduces the cell-associated concentration of Mn2+. In vitro studies with the purified PsaR protein showed that Ni2+ diminishes the Mn2+-dependent interaction of PsaR to the promoter regions of its target genes, confirming an opposite effect of Mn2+ and Ni2+ in the regulation of the PsaR regulon. Additionally, the Ni2+-dependent role of PsaR in the regulation of the PsaR regulon was studied by transcriptome analysis.	[Manzoor, Irfan; Kuipers, Oscar P.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Genet, NL-9747 AG Groningen, Netherlands; [Manzoor, Irfan] Govt Coll Univ, Dept Bioinformat & Biotechnol, Faisalabad, Pakistan; [Shafeeq, Sulman] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17177 Stockholm, Sweden	University of Groningen; Government College University Faisalabad; Karolinska Institutet	Kuipers, OP (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Genet, Nijenborgh 7, NL-9747 AG Groningen, Netherlands.	o.p.kuipers@rug.nl	Shafeeq, Sulman/P-4473-2014; Kuipers, Oscar/B-6752-2009	Shafeeq, Sulman/0000-0003-1152-526X; Manzoor, Irfan/0000-0003-3850-2690; Kuipers, Oscar/0000-0001-5596-7735				Afzal M, 2015, JOVE-J VIS EXP, DOI 10.3791/52649; Afzal M, 2014, APPL ENVIRON MICROB, V80, P5349, DOI 10.1128/AEM.01370-14; Anjem A, 2012, J BIOL CHEM, V287, P15544, DOI 10.1074/jbc.M111.330365; Anjem A, 2009, MOL MICROBIOL, V72, P844, DOI 10.1111/j.1365-2958.2009.06699.x; AVERY OT, 1995, MOL MED, V1, P344, DOI 10.1007/BF03401572; Bayle L, 2011, MOL MICROBIOL, V82, P904, DOI 10.1111/j.1365-2958.2011.07862.x; Begg SL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7418; Bethe G, 2001, FEMS MICROBIOL LETT, V205, P99, DOI 10.1016/S0378-1097(01)00453-0; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Counago RM, 2014, NAT CHEM BIOL, V10, P35, DOI [10.1038/NCHEMBIO.1382, 10.1038/nchembio.1382]; Counago RM, 2012, CURR DRUG TARGETS, V13, P1400; D'Aquino JA, 2005, P NATL ACAD SCI USA, V102, P18408, DOI 10.1073/pnas.0500908102; Dintilhac A, 1997, MOL MICROBIOL, V25, P727, DOI 10.1046/j.1365-2958.1997.5111879.x; Eijkelkamp BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089427; Frolet C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-190; Golynskiy MV, 2006, BIOCHEMISTRY-US, V45, P15359, DOI 10.1021/bi0607406; Golynskiy MV, 2005, BIOCHEMISTRY-US, V44, P3380, DOI 10.1021/bi0480741; Gupta R, 2009, MICROB PATHOGENESIS, V47, P101, DOI 10.1016/j.micpath.2009.05.003; Harvie DR, 2006, MOL MICROBIOL, V59, P1341, DOI 10.1111/j.1365-2958.2006.05029.x; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; IRVING H, 1953, J CHEM SOC, P3192, DOI 10.1039/jr9530003192; Jacobsen FE, 2011, METALLOMICS, V3, P38, DOI 10.1039/c0mt00050g; Jakubovics NS, 2000, MOL MICROBIOL, V38, P140, DOI 10.1046/j.1365-2958.2000.02122.x; Johnston JW, 2006, INFECT IMMUN, V74, P1171, DOI 10.1128/IAI.74.2.1171-1180.2006; Jomaa M, 2006, VACCINE, V24, P5133, DOI 10.1016/j.vaccine.2006.04.012; Kitten T, 2000, INFECT IMMUN, V68, P4441, DOI 10.1128/IAI.68.8.4441-4451.2000; Kloosterman TG, 2008, J BACTERIOL, V190, P5382, DOI 10.1128/JB.00307-08; Kloosterman TG, 2007, MOL MICROBIOL, V65, P1049, DOI 10.1111/j.1365-2958.2007.05849.x; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; Lawrence MC, 1998, STRUCTURE, V6, P1553, DOI 10.1016/S0969-2126(98)00153-1; Lieser SA, 2003, BIOCHEMISTRY-US, V42, P12634, DOI 10.1021/bi0350248; Lisher JP, 2013, BIOCHEMISTRY-US, V52, P7689, DOI 10.1021/bi401132w; Lynch JP, 2009, SEMIN RESP CRIT CARE, V30, P189, DOI 10.1055/s-0029-1202938; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; Manzoor I, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00748; McAllister LJ, 2004, MOL MICROBIOL, V53, P889, DOI 10.1111/j.1365-2958.2004.04164.x; McDevitt CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002357; McGeer A, 2003, NAT MED, V9, P390, DOI 10.1038/nm0403-390; Mirza S, 2011, INFECT IMMUN, V79, P2440, DOI 10.1128/IAI.00489-10; Mitchell TJ, 2003, NAT REV MICROBIOL, V1, P219, DOI 10.1038/nrmicro771; Obaro S, 2002, J MED MICROBIOL, V51, P98, DOI 10.1099/0022-1317-51-2-98; Ong CLY, 2013, INFECT IMMUN, V81, P421, DOI 10.1128/IAI.00805-12; Oram DM, 2004, INFECT IMMUN, V72, P1885, DOI 10.1128/IAI.72.4.1885-1895.2004; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plumptre CD, 2014, INFECT IMMUN; Que Q, 2000, MOL MICROBIOL, V35, P1454, DOI 10.1046/j.1365-2958.2000.01811.x; Rajam G, 2008, CRIT REV MICROBIOL, V34, P163, DOI 10.1080/10408410802383610; Rosch JW, 2008, INFECT IMMUN, V76, P3187, DOI 10.1128/IAI.00054-08; Rosch JW, 2009, MOL MICROBIOL, V72, P12, DOI 10.1111/j.1365-2958.2009.06638.x; Saha SK, 2009, CLIN INFECT DIS, V48, pS75, DOI 10.1086/596544; Sanchez-Beato AR, 1998, FEMS MICROBIOL LETT, V164, P207, DOI 10.1016/S0378-1097(98)00206-7; Shafeeq S, 2015, GENOM DATA, V4, P57, DOI 10.1016/j.gdata.2015.02.004; Shafeeq S, 2011, MOL MICROBIOL, V81, P1255, DOI 10.1111/j.1365-2958.2011.07758.x; Shafeeq S, 2011, METALLOMICS, V3, P609, DOI 10.1039/c1mt00030f; Sun XS, 2013, METALLOMICS, V5, P928, DOI 10.1039/c3mt00126a; Ulijasz AT, 2004, J BACTERIOL, V186, P8123, DOI 10.1128/JB.186.23.8123-8136.2004; Wakeman CA, 2012, CURR OPIN MICROBIOL, V15, P169, DOI 10.1016/j.mib.2011.11.008; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; XU T, 1992, J BIOL CHEM, V267, P21761; Zaidi AKM, 2009, PEDIATR INFECT DIS J, V28, pS10, DOI 10.1097/INF.0b013e3181958769	61	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142839	10.1371/journal.pone.0142839	http://dx.doi.org/10.1371/journal.pone.0142839			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562538	gold, Green Published, Green Submitted			2022-12-26	WOS:000364480900072
J	Su, W; Li, WP; Chen, H; Liu, HR; Huang, HX; Li, HW				Su, Wen; Li, Weiping; Chen, Hui; Liu, Huirong; Huang, Haixia; Li, Hongwei			Advanced Glycation End Products Impair Voltage-Gated K plus Channels-Mediated Coronary Vasodilation in Diabetic Rats	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; POTASSIUM CHANNELS; OXIDATIVE STRESS; ENDOTHELIAL DYSFUNCTION; NITRIC-OXIDE; HIGH GLUCOSE; RECEPTOR; ARTERIOLES; RAGE; HYPERTENSION	Background We have previously reported that high glucose impairs coronary vasodilation by reducing voltage-gated K+ (K-v) channel activity. However, the underlying mechanisms remain unknown. Advanced glycation end products (AGEs) are potent factors that contribute to the development of diabetic vasculopathy. The aim of this study was to investigate the role of AGEs in high glucose-induced impairment of Kv channels-mediated coronary vasodilation. Methods Patch-clamp recording and molecular biological techniques were used to assess the function and expression of K-v channels. Vasodilation of isolated rat small coronary arteries was measured using a pressurized myograph. Treatment of isolated coronary vascular smooth muscle cells (VSMCs) and streptozotocin-induced diabetic rats with aminoguanidine, the chemical inhibitor of AGEs formation, was performed to determine the contribution of AGEs. Results Incubation of VSMCs with high glucose reduced K-v current density by 60.4 +/- 4.8%, and decreased expression of K(v)1.2 and K(v)1.5 both at the gene and protein level, whereas inhibiting AGEs formation or blocking AGEs interacting with their receptors prevented high glucose-induced impairment of K-v channels. In addition, diabetic rats manifested reduced K-v channels-mediated coronary dilation (9.3 +/- 1.4% vs. 36.9 +/- 1.4%, P < 0.05), which was partly corrected by the treatment with aminoguanidine (24.4 +/- 2.2% vs. 9.3 +/- 1.4%, P < 0.05). Conclusions Excessive formation of AGEs impairs K-v channels in VSMCs, then leading to attenuation of K-v channels-mediated coronary vasodilation.	[Su, Wen; Li, Weiping; Chen, Hui; Li, Hongwei] Capital Med Univ, Beijing Friendship Hosp, Dept Cardiol, Beijing, Peoples R China; [Liu, Huirong; Huang, Haixia] Capital Med Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Li, WP (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Dept Cardiol, Beijing, Peoples R China.	xueer_09@126.com; lhw19656@sina.com			National Natural Science Foundation of China [30971240]; Beijing Natural Science Foundation Program [7122053]; High-level Technical Talents Foundation in Beijing Health System [2013-3-060]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation Program(Beijing Natural Science Foundation); High-level Technical Talents Foundation in Beijing Health System	This work was supported by National Natural Science Foundation of China (Project 30971240) to Li.H, Beijing Natural Science Foundation Program (7122053) to Li.H, and High-level Technical Talents Foundation in Beijing Health System (No. 2013-3-060) to Li.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basta G, 2002, CIRCULATION, V105, P816, DOI 10.1161/hc0702.104183; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Bubolz AH, 2005, AM J PHYSIOL-HEART C, V289, pH1873, DOI 10.1152/ajpheart.00357.2005; Chang KC, 2006, EUR J CLIN INVEST, V36, P528, DOI 10.1111/j.1365-2362.2006.01672.x; Chapalamadugu KC, 2015, TOXICOL APPL PHARM, V282, P100, DOI 10.1016/j.taap.2014.10.019; Chen YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066611; Di BB, 2015, MOL MED REP, V11, P2601, DOI 10.3892/mmr.2014.3113; Elvira B, 2015, J MEMBRANE BIOL, V248, P59, DOI 10.1007/s00232-014-9741-1; Gao X, 2008, AM J PHYSIOL-HEART C, V295, pH491, DOI 10.1152/ajpheart.00464.2008; Garcia-Morales V, 2014, VASC PHARMACOL, V60, P95, DOI 10.1016/j.vph.2014.01.004; Genuth S, 2015, DIABETES, V64, P266, DOI 10.2337/db14-0215; Heaps CL, 2005, AM J PHYSIOL-HEART C, V288, pH568, DOI 10.1152/ajpheart.00157.2004; Hegab Z, 2012, WORLD J CARDIOL, V4, P90, DOI 10.4330/wjc.v4.i4.90; Henrion D, 2005, ARCH MAL COEUR VAISS, V98, P913; Horiuchi T, 2002, STROKE, V33, P2692, DOI 10.1161/01.STR.0000034791.52151.6B; Jackson WF, 2005, MICROCIRCULATION, V12, P113, DOI 10.1080/10739680590896072; Jackson WF, 1997, MICROCIRCULATION-LON, V4, P35, DOI 10.3109/10739689709148316; Joseph BK, 2013, PHARMACOL RES, V70, P126, DOI 10.1016/j.phrs.2013.01.008; Kajikawa M, 2015, DIABETES CARE, V38, P119, DOI 10.2337/dc14-1435; Korovkina VP, 2002, VASC PHARMACOL, V38, P3, DOI 10.1016/S1537-1891(02)00121-0; Kurokawa S, 2014, CIRC J, V78, P1950, DOI 10.1253/circj.CJ-13-1587; Lan KC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124418; Lander HM, 1997, J BIOL CHEM, V272, P17810, DOI 10.1074/jbc.272.28.17810; Li HW, 2004, DIABETES, V53, P2436, DOI 10.2337/diabetes.53.9.2436; Li HW, 2003, AM J PHYSIOL-HEART C, V285, pH1213, DOI 10.1152/ajpheart.00226.2003; Lv Y, 2013, AM J PHYSIOL-LUNG C, V305, pL856, DOI 10.1152/ajplung.00179.2013; Ma C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125776; Matsui T, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-014-0162-3; McVicar CM, 2015, DIABETOLOGIA, V58, P1129, DOI 10.1007/s00125-015-3523-x; Miura H, 2003, CIRC RES, V92, P151, DOI 10.1161/01.RES.0000052671.53256.49; Ohya Susumu, 2000, Journal of Smooth Muscle Research, V36, P101, DOI 10.1540/jsmr.36.101; Omae T, 2011, INVEST OPHTH VIS SCI, V52, P6749, DOI 10.1167/iovs.10-6826; Petrica L, 2015, J DIABETES COMPLICAT, V29, P230, DOI 10.1016/j.jdiacomp.2014.11.014; Pinterova M, 2014, PHYSIOL RES, V63, P275, DOI 10.33549/physiolres.932718; Qian C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136390; Rajasekar P, 2007, ACTA DIABETOL, V44, P83, DOI 10.1007/s00592-007-0247-5; Serban AI, 2015, J DIABETES, V7, P114, DOI 10.1111/1753-0407.12154; Shen XH, 2012, MOL CELL ENDOCRINOL, V363, P27, DOI 10.1016/j.mce.2012.07.005; Silva CDO, 2008, NUTR METAB CARDIOVAS, V18, P23, DOI 10.1016/j.numecd.2006.07.008; Soro-Paavonen A, 2010, J HYPERTENS, V28, P780, DOI 10.1097/HJH.0b013e328335043e; Su J, 2008, ARTERIOSCL THROM VAS, V28, P1432, DOI 10.1161/ATVBAHA.108.167205; Su W, 2014, J ENDOCRINOL INVEST, V37, P559, DOI 10.1007/s40618-014-0068-7; Wang HY, 2014, DIABETES, V63, P1506, DOI 10.2337/db13-1195; Wei Q, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-13; Zhao LM, 2014, PFLUG ARCH EUR J PHY, V466, P307, DOI 10.1007/s00424-013-1324-y	45	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142865	10.1371/journal.pone.0142865	http://dx.doi.org/10.1371/journal.pone.0142865			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562843	Green Submitted, gold, Green Published			2022-12-26	WOS:000364480900075
J	Bandyopadhyay, S; Mahapatra, SK; Chowdhury, BP; Jha, MK; Das, S; Halder, K; Majumdar, SB; Saha, B; Majumdar, S				Bandyopadhyay, Syamdas; Mahapatra, Santanu Kar; Chowdhury, Bidisha Paul; Jha, Mukesh Kumar; Das, Shibali; Halder, Kuntal; Majumdar, Suchandra Bhattacharyya; Saha, Bhaskar; Majumdar, Subrata			Toll-Like Receptor 2 Targeted Rectification of Impaired CD8(+) T Cell Functions in Experimental Leishmania donovani Infection Reinstates Host Protection	PLOS ONE			English	Article							INTERFERON-GAMMA; RESPONSES; ACTIVATION; VACCINE; CD4(+); IL-12; IFN	Leishmania donovani, a protozoan parasite, causes the disease visceral leishmanisis (VL), characterized by inappropriate CD8(+) T-cell activation. Therefore, we examined whether the Toll-like Receptor 2 (TLR2) ligand Ara-LAM, a cell wall glycolipid from non-pathogenic Mycobacterium smegmatis, would restore CD8(+) T-cell function during VL. We observed that by efficient upregulation of TLR2 signaling-mediated NF-kappa B translocation and MAPK signaling in CD8(+) T-cells (CD25(+) CD28(+) IL-12R(+) IFN-gamma R+), Ara-LAM triggered signaling resulted in the activation of T-bet, which in turn, induced transcription favourable histone modification at the IFN-gamma, perforin, granzyme-B promoter regions in CD8(+) T-cells. Thus, we conclude that Ara-LAM induced efficient activation of effector CD8(+) T-cells by upregulating the expression of IFN-gamma, perforin and granzyme-B in an NF-kappa B and MAPK induced T-bet dependent manner in VL.	[Bandyopadhyay, Syamdas; Mahapatra, Santanu Kar; Chowdhury, Bidisha Paul; Das, Shibali; Halder, Kuntal; Majumdar, Suchandra Bhattacharyya; Majumdar, Subrata] Bose Inst, Div Mol Med, Kolkata, India; [Jha, Mukesh Kumar; Saha, Bhaskar] Natl Ctr Cell Sci, Pune, Maharashtra, India	Department of Science & Technology (India); Bose Institute; Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Majumdar, S (corresponding author), Bose Inst, Div Mol Med, Kolkata, India.	subrata@jcbose.ac.in	Das, Shibali/AAA-2683-2021; Mahapatra, Santanu Kar/AAC-2594-2021	Das, Shibali/0000-0003-1263-8178; Mahapatra, Santanu Kar/0000-0002-2257-8538	Department of Biotechnology, Ministry of Science and technology [BT/PR14435/MED/29/201/2010]	Department of Biotechnology, Ministry of Science and technology	Funding was provided by the Department of Biotechnology, Ministry of Science and technology (IN), http://www.dbtindia.nic.in/, BT/PR14435/MED/29/201/2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P, 2009, J IMMUNOL, V183, P1695, DOI 10.4049/jimmunol.0900592; Ahmed S, 2003, INFECT IMMUN, V71, P401, DOI 10.1128/IAI.71.1.401-410.2003; Alexander J, 2005, IMMUNOL LETT, V99, P17, DOI 10.1016/j.imlet.2005.01.009; Bhattacharjee S, 2012, J ANTIMICROB CHEMOTH, V67, P1905, DOI 10.1093/jac/dks159; Bhattacharya P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024141; Bhattacharya P, 2010, J INFECT DIS, V202, P145, DOI 10.1086/653210; Bodas M, 2006, J IMMUNOL, V177, P4636, DOI 10.4049/jimmunol.177.7.4636; Colmenares M, 2003, INFECT IMMUN, V71, P3172, DOI 10.1128/IAI.71.6.3172-3182.2003; Das G, 1999, SCAND J IMMUNOL, V49, P307, DOI 10.1046/j.1365-3083.1999.00486.x; Das S, 2014, IMMUNE SUBVERSION MY, V9; Das S, 2015, TUBERCULOSIS, V95, P208, DOI 10.1016/j.tube.2014.11.007; Elloso MM, 2001, EUR J IMMUNOL, V31, P384, DOI 10.1002/1521-4141(200102)31:2<384::AID-IMMU384>3.0.CO;2-9; Ghosh S, 2002, INFECT IMMUN, V70, P6828, DOI 10.1128/IAI.70.12.6828-6838.2002; Gigley JP, 2012, TRENDS PARASITOL, V28, P377, DOI 10.1016/j.pt.2012.07.001; Gozalbo D, 2014, FRONT BIOSCI-LANDMRK, V19, P1279, DOI 10.2741/4281; Halder K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091656; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kared H, 2014, CURR OPIN IMMUNOL, V29, P79, DOI 10.1016/j.coi.2014.05.003; Kaushal H, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0653-6; Kumar R, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00251; MAJUMDAR S, 1993, BIOCHIM BIOPHYS ACTA, V1176, P276, DOI 10.1016/0167-4889(93)90056-U; Majumder N, 2006, GLYCOCONJUGATE J, V23, P675, DOI 10.1007/s10719-006-9017-9; Pandey SP, 2014, J IMMUNOL, V193, P3632, DOI 10.4049/jimmunol.1400672; Quigley M, 2009, BLOOD, V113, P2256, DOI 10.1182/blood-2008-03-148809; Rub A, 2009, NAT IMMUNOL, V10, P273, DOI 10.1038/ni.1705; Russ BE, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00371; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Sullivan BM, 2003, P NATL ACAD SCI USA, V100, P15818, DOI 10.1073/pnas.2636938100; Sutherland APR, 2013, J IMMUNOL, V190, P3977, DOI 10.4049/jimmunol.1201730; Tian S, 2007, J IMMUNOL, V179, P2952, DOI 10.4049/jimmunol.179.5.2952; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wakil AE, 1998, J EXP MED, V188, P1651, DOI 10.1084/jem.188.9.1651; Whitmire JK, 2005, J EXP MED, V201, P1053, DOI 10.1084/jem.20041463	34	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142800	10.1371/journal.pone.0142800	http://dx.doi.org/10.1371/journal.pone.0142800			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559815	Green Published, gold, Green Submitted			2022-12-26	WOS:000364433100127
J	Garcia-Seco, D; Zhang, Y; Gutierrez-Manero, FJ; Martin, C; Ramos-Solano, B				Garcia-Seco, Daniel; Zhang, Yang; Gutierrez-Manero, Francisco J.; Martin, Cathie; Ramos-Solano, Beatriz			Application of Pseudomonas fluorescens to Blackberry under Field Conditions Improves Fruit Quality by Modifying Flavonoid Metabolism	PLOS ONE			English	Article							GROWTH PROMOTING RHIZOBACTERIA; PATHOGENESIS-RELATED-PROTEIN; TRANSCRIPTION FACTOR; SYSTEMIC RESISTANCE; ANTHOCYANIN BIOSYNTHESIS; ISOFLAVONE METABOLISM; GENE-EXPRESSION; ABSCISIC-ACID; GRAPE BERRIES; ARABIDOPSIS	Application of a plant growth promoting rhizobacterium (PGPR), Pseudomonas fluorescens N21.4, to roots of blackberries (Rubus sp.) is part of an optimised cultivation practice to improve yields and quality of fruit throughout the year in this important fruit crop. Blackberries are especially rich in flavonoids and therefore offer potential benefits for human health in prevention or amelioration of chronic diseases. However, the phenylpropanoid pathway and its regulation during ripening have not been studied in detail, in this species. PGPR may trigger flavonoid biosynthesis as part of an induced systemic response (ISR) given the important role of this pathway in plant defence, to cause increased levels of flavonoids in the fruit. We have identified structural genes encoding enzymes of the phenylpropanoid and flavonoid biosynthetic pathways catalysing the conversion of phenylalanine to the final products including flavonols, anthocyanins and catechins from blackberry, and regulatory genes likely involved in controlling the activity of pathway branches. We have also measured the major flavonols, anthocyanins and catechins at three stages during ripening. Our results demonstrate the coordinated expression of flavonoid biosynthetic genes with the accumulation of anthocyanins, catechins, and flavonols in developing fruits of blackberry. Elicitation of blackberry plants by treatment of roots with P. fluorescens N21.4, caused increased expression of some flavonoid biosynthetic genes and an accompanying increase in the concentration of selected flavonoids in fruits. Our data demonstrate the physiological mechanisms involved in the improvement of fruit quality by PGPR under field conditions, and highlight some of the genetic targets of elicitation by beneficial bacteria.	[Garcia-Seco, Daniel; Gutierrez-Manero, Francisco J.; Ramos-Solano, Beatriz] Univ CEU San Pablo, Fac Farm, Madrid, Spain; [Zhang, Yang; Martin, Cathie] John Innes Ctr, Norwich, Norfolk, England	San Pablo CEU University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Garcia-Seco, D (corresponding author), Univ CEU San Pablo, Fac Farm, Ctra Boadilla del Monte Km 5-3, Madrid, Spain.	danielgsh@hotmail.com	Gutierrez-Mañero, Francisco Javier/C-1110-2016; Garcia-Seco, Daniel/AAC-7796-2020; Ramos-Solano, Beatriz/I-6545-2015	Gutierrez-Mañero, Francisco Javier/0000-0001-5230-6798; Garcia-Seco, Daniel/0000-0002-4560-4110; Ramos-Solano, Beatriz/0000-0003-0280-5198	Ministerio de Ciencia e Innovacion [BES-2010-038057]; Institute Strategic Program Understanding and Exploiting Plant and Microbial Secondary Metabolism from the BBSRC [BB/J004596/1]; European Union [245121]; John Innes Foundation;  [AGL 2009-08324];  [AGL 2013 45189-R]; Biotechnology and Biological Sciences Research Council [BBS/E/J/00000153, BBS/E/J/000CA535] Funding Source: researchfish; BBSRC [BBS/E/J/000CA535] Funding Source: UKRI	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Institute Strategic Program Understanding and Exploiting Plant and Microbial Secondary Metabolism from the BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union(European Commission); John Innes Foundation; ; ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	DGS, BR and FJG were supported by Ministerio de Ciencia e Innovacion (BES-2010-038057) and projects AGL 2009-08324 and AGL 2013 45189-R. YZ and CM were supported by the Institute Strategic Program Understanding and Exploiting Plant and Microbial Secondary Metabolism (BB/J004596/1) from the BBSRC and by the European Union FP7 ATHENA collaborative project (Grant Agreement 245121). YZ was also supported by a Rotation Studentship from the John Innes Foundation.	Algar E, 2014, PLANT PHYSIOL BIOCH, V82, P9, DOI 10.1016/j.plaphy.2014.05.001; Bassolino L, 2013, NEW PHYTOL, V200, P650, DOI 10.1111/nph.12524; Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; Bohm B, 1998, INTRO FLAVONOIDS CHE; Boss PK, 1996, PLANT PHYSIOL, V111, P1059, DOI 10.1104/pp.111.4.1059; Boue S M, 2008, J Food Sci, V73, pH43, DOI 10.1111/j.1750-3841.2008.00707.x; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506; Capanoglu E, 2010, TRENDS FOOD SCI TECH, V21, P399, DOI 10.1016/j.tifs.2010.05.001; Chen A, 2013, FOOD CHEM; Choudhary DK, 2009, MICROBIOL RES, V164, P493, DOI 10.1016/j.micres.2008.08.007; Choudhury S, 2010, PLANT CELL REP; Conrath U, 2011, TRENDS PLANT SCI, V16, P524, DOI 10.1016/j.tplants.2011.06.004; Cuevas-Rodriguez EO, 2010, J AGR FOOD CHEM, V58, P7458, DOI 10.1021/jf101485r; Dakora FD, 1996, PHYSIOL MOL PLANT P, V49, P1, DOI 10.1006/pmpp.1996.0035; Dangl J, 2006, NATURE, V444; Ding CK, 2002, PLANTA, V214, P895, DOI 10.1007/s00425-001-0698-9; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Domenech J, 2007, PLANT SOIL, V290, P43, DOI 10.1007/s11104-006-9089-0; Dornenburg H, 2004, PROCESS BIOCHEM, V39, P1369, DOI 10.1016/S0032-9592(03)00262-0; Elomaa P, 2003, PLANT PHYSIOL, V133, P1831, DOI 10.1104/pp.103.026039; Fraga CG, 2011, FREE RADICAL BIO MED, V51, P813, DOI 10.1016/j.freeradbiomed.2011.06.002; Garcia-Seco D, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1198-1; Garcia-Seco D, 2013, AGRON SUSTAIN DEV, V33, P385, DOI 10.1007/s13593-012-0103-z; Genty B, 1989, BIOCH BIOPHYS ACTA B; Giusti M. M., 2001, CURR PROTOC FOOD ANA, V00, DOI DOI 10.1002/0471142913.FAF0102S00; Gonzalez A, 2008, PLANT J; Gonzalez A, 2009, DEV BIOL, V325, P412, DOI 10.1016/j.ydbio.2008.10.005; Hammerschmidt R, 1999, ANNU REV PHYTOPATHOL, V37, P285, DOI 10.1146/annurev.phyto.37.1.285; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; Hassimotto NMA, 2011, J SCI FOOD AGR, V91, P523, DOI 10.1002/jsfa.4216; Hemm MR, 2001, TRENDS PLANT SCI, V6, P135, DOI 10.1016/S1360-1385(01)01915-X; Hoffmann-Sommergruber K, 2002, BIOCHEM SOC T, V30, P930, DOI 10.1042/BST0300930; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; Hummer K, 2010, HORTSCIENCE; Iriti M, 2009, PLANT SIGNAL BEHAV, V4, P66, DOI 10.4161/psb.4.1.7408; Jaakola L, 2002, PLANT PHYSIOL, V130, P729, DOI 10.1104/pp.006957; Jackson D, 1992, PLANT J; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; Kesari R, 2010, POSTHARVEST BIOL TEC, V56, P64, DOI 10.1016/j.postharvbio.2009.11.012; Kumar A, 2003, PHYTOCHEMISTRY, V62, P513, DOI 10.1016/S0031-9422(02)00572-1; Kumar D, 2013, P NATL A SCI INDIA B, V83, P1, DOI 10.1007/s40011-012-0059-4; Lakshmanan V, 2012, PLANT PHYSIOL, V160, P1642, DOI 10.1104/pp.112.200386; Lattanzio V., 2013, NATURAL PRODUCTS, P1543; Li XW, 2013, GENE, V532, P72, DOI 10.1016/j.gene.2013.09.015; Lin-Wang Kui, 2010, BMC Plant Biol, V10, P50, DOI 10.1186/1471-2229-10-50; Lucas Garcia J, 2004, PLANT SOIL, V39, P366; Martin C, 1997, TRENDS GENET, V13, P67, DOI 10.1016/S0168-9525(96)10049-4; Martin C, 2013, ANNU REV PLANT BIOL, V64, P19, DOI 10.1146/annurev-arplant-050312-120142; Medina-Puche L, 2014, J EXP BOT, V65, P401, DOI 10.1093/jxb/ert377; Mehrtens F, 2005, PLANT PHYSIOL, V138, P1083, DOI 10.1104/pp.104.058032; Nesi N, 2001, PLANT CELL, V13, P2099, DOI 10.1105/tpc.13.9.2099; Park KS, 2000, BIOL CONTROL, V18, P2, DOI 10.1006/bcon.2000.0815; QUATTROCCHIO F, 1993, PLANT CELL, V5, P1497, DOI 10.1105/tpc.5.11.1497; Ramamoorthy V, 2002, PLANT SOIL, V239, P55, DOI 10.1023/A:1014904815352; Ramirez V, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003445; Ramos-Solano B, 2014, PLANT PHYSIOL BIOCH, V74, P1, DOI 10.1016/j.plaphy.2013.10.029; Ramos-Solano B, 2015, LWT-FOOD SCI TECHNOL, V61, P437, DOI 10.1016/j.lwt.2014.11.051; Ramos-Solano B, 2010, J AGR FOOD CHEM, V58, P1484, DOI 10.1021/jf903299a; Rezzonico E, 1998, PLANT PHYSIOL, V117, P585, DOI 10.1104/pp.117.2.585; Robinson SP, 1997, PLANT PHYSIOL, V114, P771, DOI 10.1104/pp.114.3.771; Ruijters EJB, 2014, PHARMACOL RES, V79, P28, DOI 10.1016/j.phrs.2013.11.004; Salzman RA, 1998, PLANT PHYSIOL, V117, P465, DOI 10.1104/pp.117.2.465; Schiliro E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048646; Seeram NP, 2012, J AGR FOOD CHEM, V60, P5685, DOI 10.1021/jf203455z; Singh R, 2010, COMPR REV FOOD SCI F, V9, P398, DOI 10.1111/j.1541-4337.2010.00116.x; SOKAL RR, 1981, SYST ZOOL, V30, P309, DOI 10.2307/2413252; Solano BR, 2008, PHYTOPATHOLOGY, V98, P451, DOI 10.1094/PHYTO-98-4-0451; STAFFORD HA, 1991, PLANT PHYSIOL, V96, P680, DOI 10.1104/pp.96.3.680; Tahara S, 2007, BIOSCI BIOTECH BIOCH, V71, P1387, DOI 10.1271/bbb.70028; Uimari A, 1998, MOL GEN GENET, V257, P198, DOI 10.1007/s004380050639; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vaaje-Kolstad G, 2005, J BIOL; WEIDENBORNER M, 1990, PHYTOCHEMISTRY, V29, P1103, DOI 10.1016/0031-9422(90)85412-9; Xu BJ, 2007, J FOOD SCI, V72, pS159, DOI 10.1111/j.1750-3841.2006.00260.x; Zamioudis C, 2012, MOL PLANT MICROBE IN, V25, P139, DOI 10.1094/MPMI-06-11-0179; Zhang HM, 2008, PLANT J, V56, P264, DOI 10.1111/j.1365-313X.2008.03593.x; Zhang Y, 2013, CURR BIOL, V23, P1094, DOI 10.1016/j.cub.2013.04.072; Zhao JF, 2007, PLANT CELL, V19, P3805, DOI 10.1105/tpc.106.048900	80	58	60	6	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142639	10.1371/journal.pone.0142639	http://dx.doi.org/10.1371/journal.pone.0142639			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559418	Green Published, gold, Green Submitted			2022-12-26	WOS:000364433100104
J	Maunder, EMW; Nel, JH; Steyn, NP; Kruger, HS; Labadarios, D				Maunder, Eleni M. W.; Nel, Johanna H.; Steyn, Nelia P.; Kruger, H. Salome; Labadarios, Demetre			Added Sugar, Macro- and Micronutrient Intakes and Anthropometry of Children in a Developing World Context	PLOS ONE			English	Article							FOOD-CONSUMPTION SURVEY; SOUTH-AFRICA; SWEETENED BEVERAGES; WEIGHT-GAIN; BODY-WEIGHT; DIETARY; ASSOCIATIONS; QUALITY; GROWTH; CARIES	Objective The objective of this study was to determine the relationship between added sugar and dietary diversity, micronutrient intakes and anthropometric status in a nationally representative study of children, 1-8.9 years of age in South Africa. Methods Secondary analysis of a national survey of children (weighted n = 2,200; non weighted n = 2818) was undertaken. Validated 24-hour recalls of children were collected from mothers/caregivers and stratified into quartiles of percentage energy from added sugar (% EAS). A dietary diversity score (DDS) using 9 food groups, a food variety score (FVS) of individual food items, and a mean adequacy ratio (MAR) based on 11 micronutrients were calculated. The prevalence of stunting and overweight/obesity was also determined. Results Added sugar intake varied from 7.5-10.3% of energy intake for rural and urban areas, respectively. Mean added sugar intake ranged from 1.0% of energy intake in Quartile 1 (13 years) (Q1) to 19.3% in Q4 (4-8 years). Main sources of added sugar were white sugar (60.1%), cool drinks (squash type) (10.4%) and carbonated cool drinks (6.0%). Added sugar intake, correlated positively with most micronutrient intakes, DDS, FVS, and MAR. Significant negative partial correlations, adjusted for energy intake, were found between added sugar intake and intakes of protein, fibre, thiamin, pantothenic acid, biotin, vitamin E, calcium (1-3 years), phosphorus, iron (4-8 years), magnesium and zinc. The prevalence of overweight/obesity was higher in children aged 4-8 years in Q4 of % EAS than in other quartiles [mean (95% CI) % prevalence overweight 23.0 (16.2-29.8)% in Q4 compared to 13.0 (8.7-17.3)% in Q1, p = 0.0063]. Conclusion Although DDS, FVS, MAR and micronutrient intakes were positively correlated with added sugar intakes, overall negative associations between micronutrients and added sugar intakes, adjusted for dietary energy, indicate micronutrient dilution. Overweight/obesity was increased with higher added sugar intakes in the 4-8 year old children.	[Maunder, Eleni M. W.] Univ KwaZulu Natal, Sch Agr Earth & Environm Sci, Kwa Zulu, South Africa; [Nel, Johanna H.] Univ Stellenbosch, Dept Logist, ZA-7600 Stellenbosch, Western Cape, South Africa; [Steyn, Nelia P.] Univ Cape Town, Div Human Nutr, ZA-7925 Cape Town, South Africa; [Kruger, H. Salome] North West Univ, Potchefstroom, North West Prov, South Africa; [Labadarios, Demetre] Human Sci Res Council, Populat Hlth Hlth Syst & Innovat, Cape Town, Western Cape, South Africa	University of Kwazulu Natal; Stellenbosch University; University of Cape Town; North West University - South Africa; Human Sciences Research Council-South Africa	Maunder, EMW (corresponding author), Univ KwaZulu Natal, Sch Agr Earth & Environm Sci, Kwa Zulu, South Africa.	maundere@ukzn.ac.za	Nel, Johanna Helena/AFK-4431-2022; Nel, Johanna Helena/AAG-3151-2022; Kruger, Salome/R-2476-2019	Kruger, Herculina Salome/0000-0002-5365-1777; Nel, Johanna Helena/0000-0002-0263-0116	Department of Health; UNICEF; Micronutrient Initiative; USAID	Department of Health; UNICEF; Micronutrient Initiative; USAID(United States Agency for International Development (USAID))	Department of Health, UNICEF, Micronutrient Initiative, and USAID Micronutrient Program are thanked for funding the original study. The research reported here was a secondary data analysis and no funding was required. The funders of the initial study had no role in the secondary data analysis study design, of choice of the data analysed, decision to publish, or preparation of the manuscript.	Alexy U, 2003, BRIT J NUTR, V90, P441, DOI 10.1079/BJN2003904; Barroso GD, 2014, PUBLIC HEALTH NUTR, V17, P156, DOI 10.1017/S1368980012004624; BoltonSmith C, 1996, INT J OBESITY, V20, pS31; Bray GA, 2014, DIABETES CARE, V37, P950, DOI 10.2337/dc13-2085; Butte NF, 2007, AM J CLIN NUTR, V85, P1478, DOI 10.1093/ajcn/85.6.1478; Charlton KE, 2005, EUR J CLIN NUTR, V59, P1030, DOI 10.1038/sj.ejcn.1602208; Davis JN, 2009, OBESITY, V17, P1542, DOI 10.1038/oby.2009.19; De Coen V, 2012, APPETITE, V59, P76, DOI 10.1016/j.appet.2012.03.024; De Onis M., 2008, NUTR HLTH DEVEOPING; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; Erkkola M, 2009, BRIT J NUTR, V101, P1209, DOI 10.1017/S0007114508057619; Farris RP, 1998, J AM COLL NUTR, V17, P579, DOI 10.1080/07315724.1998.10718806; Forshee RA, 2001, J AM COLL NUTR, V20, P32, DOI 10.1080/07315724.2001.10719012; GIBNEY M, 1995, AM J CLIN NUTR, V62, p178S, DOI 10.1093/ajcn/62.1.178S; Gibson SA, 1997, BRIT J NUTR, V78, P367, DOI 10.1079/BJN19970157; Gibson SA, 1997, J HUM NUTR DIET, V10, P125, DOI 10.1046/j.1365-277X.1997.00265.x; Gibson S, 2009, BRIT J NUTR, V101, P100, DOI 10.1017/S0007114508981484; Gibson SA, 2007, NUTR RES REV, V20, P121, DOI 10.1017/S0954422407797846; Han E, 2013, J ACAD NUTR DIET, V113, P43, DOI 10.1016/j.jand.2012.09.016; Hatloy A, 1998, EUR J CLIN NUTR, V52, P891, DOI 10.1038/sj.ejcn.1600662; Herbst A, 2011, J NUTR, V141, P1348, DOI 10.3945/jn.110.137000; Joyce T, 2008, J HUM NUTR DIET, V21, P438, DOI 10.1111/j.1365-277X.2008.00895.x; Kakinami L, 2014, J EPIDEMIOL COMMUN H, V68, P987, DOI 10.1136/jech-2014-203951; Kennedy GL, 2009, EVALUATION DIETARY D; Kranz S, 2005, J PEDIATR-US, V146, P105, DOI 10.1016/j.jpeds.2004.08.077; Labadarios D, 2005, PUBLIC HEALTH NUTR, V8, P533, DOI 10.1079/PHN2005816; Labadarios D, 2000, NATL FOOD CONSUMPTIO; Labadarios D., 2007, NATL FOOD CONSUMPTIO; Lee JG, 2010, EUR ARCH PAEDIATR DE, V11, P5, DOI 10.1007/BF03262704; Lee RD, 1993, NUTR ASSESSMENT; Livingstone MBE, 2009, OBES REV, V10, P34, DOI 10.1111/j.1467-789X.2008.00563.x; Lyhne N., 1999, Scandinavian Journal of Nutrition/Naringsforskning, V43, P4; MacIntyre UE, 2012, S AFR J CLIN NUTR, V25, P122; Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362; Miyazaki H, 1996, EUR J ORAL SCI, V104, P452, DOI 10.1111/j.1600-0722.1996.tb00112.x; Moench-Pfanner R, 2012, FOOD NUTR BULL, V33, pS255, DOI 10.1177/15648265120334S301; Morenga LT, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7492; Moynihan PJ, 2014, J DENT RES, V93, P8, DOI 10.1177/0022034513508954; MRC, 1998, FOOD COMP TABL; Murphy SP, 2003, AM J CLIN NUTR, V78, p827S, DOI 10.1093/ajcn/78.4.827S; Must A, 2009, INT J OBESITY, V33, P705, DOI 10.1038/ijo.2009.60; Overby NC, 2004, PUBLIC HEALTH NUTR, V7, P285, DOI 10.1079/PHN2003515; Paineau DL, 2008, ARCH PEDIAT ADOL MED, V162, P34, DOI 10.1001/archpediatrics.2007.2; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Ramakrishnan U, 2008, NUTR HLTH DEVEOPING; Rennie KL, 2007, BRIT J NUTR, V97, P832, DOI 10.1017/S0007114507617206; Ruottinen S, 2008, PEDIATRICS, V121, pE1676, DOI 10.1542/peds.2007-1642; Ruxton CHS, 2003, BRIT J NUTR, V90, P245, DOI 10.1079/BJN2003922; Ruxton CHS, 1999, EUR J CLIN NUTR, V53, P503, DOI 10.1038/sj.ejcn.1600831; Schroeder DG, 2008, NUTR HEALTH SER, P341, DOI 10.1007/978-1-59745-464-3_12; Shisana O, 2014, S AFRICAN NATL HLTH; SREEBNY LM, 1982, COMMUNITY DENT ORAL, V10, P1, DOI 10.1111/j.1600-0528.1982.tb00352.x; Statistics SA., 2011, POVERTY TRENDS S AFR; Steyn N, 2014, TELEVISION ADVERTISI; Steyn N, 2002, NATL FOOD CONSUMPTIO; Steyn NP, 2005, NUTRITION, V21, P4, DOI 10.1016/j.nut.2004.09.003; Steyn NP, 2003, B WORLD HEALTH ORGAN, V81, P599; van Ansem WJC, 2014, BRIT J NUTR, V112, P467, DOI 10.1017/S0007114514001007; Vorster HH, 2014, AM J CLIN NUTR, V99, P1479, DOI 10.3945/ajcn.113.069005; Weijs PJM, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-95; WHO, 2003, WHO TECH REP SER, V916, P1; WHO, 2014, GUID SUG IN IN PRESS; World Health Organization, 2015, GUID SUG INT AD CHIL	64	18	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142059	10.1371/journal.pone.0142059	http://dx.doi.org/10.1371/journal.pone.0142059			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560481	Green Published, gold			2022-12-26	WOS:000364433100052
J	Asgari, E; Mofrad, MRK				Asgari, Ehsaneddin; Mofrad, Mohammad R. K.			Continuous Distributed Representation of Biological Sequences for Deep Proteomics and Genomics	PLOS ONE			English	Article							PROTEIN; LANGUAGE; CLASSIFICATION; VISUALIZATION; DATABASE	We introduce a new representation and feature extraction method for biological sequences. Named bio-vectors (BioVec) to refer to biological sequences in general with protein-vectors (ProtVec) for proteins (amino-acid sequences) and gene-vectors (GeneVec) for gene sequences, this representation can be widely used in applications of deep learning in proteomics and genomics. In the present paper, we focus on protein-vectors that can be utilized in a wide array of bioinformatics investigations such as family classification, protein visualization, structure prediction, disordered protein identification, and protein-protein interaction prediction. In this method, we adopt artificial neural network approaches and represent a protein sequence with a single dense n-dimensional vector. To evaluate this method, we apply it in classification of 324,018 protein sequences obtained from Swiss-Prot belonging to 7,027 protein families, where an average family classification accuracy of 93% +/- 0.06% is obtained, outperforming existing family classification methods. In addition, we use ProtVec representation to predict disordered proteins from structured proteins. Two databases of disordered sequences are used: the DisProt database as well as a database featuring the disordered regions of nucleoporins rich with phenylalanine-glycine repeats (FG-Nups). Using support vector machine classifiers, FG-Nup sequences are distinguished from structured protein sequences found in Protein Data Bank (PDB) with a 99.8% accuracy, and unstructured DisProt sequences are differentiated from structured DisProt sequences with 100.0% accuracy. These results indicate that by only providing sequence data for various proteins into this model, accurate information about protein structure can be determined. Importantly, this model needs to be trained only once and can then be applied to extract a comprehensive set of information regarding proteins of interest. Moreover, this representation can be considered as pre-training for various applications of deep learning in bioinformatics. The related data is available at Life Language Processing Website: http://llp.berkeley.edu and Harvard Dataverse: http://dx.doi.org/10.7910/DVN/JMFHTN.	[Asgari, Ehsaneddin; Mofrad, Mohammad R. K.] Univ Calif Berkeley, Mol Cell Biomech Lab, Dept Bioengn, Berkeley, CA 94720 USA; [Asgari, Ehsaneddin; Mofrad, Mohammad R. K.] Univ Calif Berkeley, Mol Cell Biomech Lab, Dept Mech Engn, Berkeley, CA 94720 USA; [Mofrad, Mohammad R. K.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Mofrad, MRK (corresponding author), Univ Calif Berkeley, Mol Cell Biomech Lab, Dept Bioengn, Berkeley, CA 94720 USA.	mofrad@berkeley.edu	Asgari, Ehsaneddin/AAJ-3680-2021		National Science Foundation through CAREER Award [CBET-0955291]	National Science Foundation through CAREER Award	Financial support from National Science Foundation through a CAREER Award (CBET-0955291) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073831; Aragues R, 2007, PLOS COMPUT BIOL, V3, P1761, DOI 10.1371/journal.pcbi.0030178; Azimi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081741; Bork P, 1998, J MOL BIOL, V283, P707, DOI 10.1006/jmbi.1998.2144; Cai CZ, 2003, NUCLEIC ACIDS RES, V31, P3692, DOI 10.1093/nar/gkg600; Cai YZ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000529; Collobert R, 2011, J MACH LEARN RES, V12, P2493; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Ganapathiraju M., 2002, P 2 INT C HUM LANG T, P76; Goldberg Y., 2014, WORD2VEC EXPLAINED D, V1402, P3722; He B, 2009, CELL RES, V19, P929, DOI 10.1038/cr.2009.87; Huynen M, 2000, GENOME RES, V10, P1204, DOI 10.1101/gr.10.8.1204; Jamali T, 2011, INT REV CEL MOL BIO, V287, P233, DOI 10.1016/B978-0-12-386043-9.00006-2; Lasko TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066341; LESLIE C, 2002, P PSB, V7, P566; McGregor E, 2004, J PROTEOME RES, V3, P694, DOI [10.1021/pr040022a, DOI 10.1021/PR040022A]; Mikolov T., 2013, COMPUTING RES REPOSI, V1301, P3781; Mikolov Tomas, 2013, P ADV NEUR INF PROC, P3111, DOI DOI 10.1162/JMLR.2003.3.4-5.951; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; Motomura K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050039; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Peyro M, 2015, SCI REPORTS IN PRESS; Platzer A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056883; Procter JB, 2010, NAT METHODS, V7, pS16, DOI [10.1038/NMETH.1434, 10.1038/nmeth.1434]; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Rose PW, 2013, NUCLEIC ACIDS RES, V41, pD475, DOI 10.1093/nar/gks1200; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Searls DB, 2002, NATURE, V420, P211, DOI 10.1038/nature01255; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Srinivasan SM, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-96; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Suykens JAK, 1999, NEURAL PROCESS LETT, V9, P293, DOI 10.1023/A:1018628609742; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vries JK, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-72; Xiong HY, 2015, SCIENCE, V347, DOI 10.1126/science.1254806; Yandell MD, 2002, NAT REV GENET, V3, P601, DOI 10.1038/nrg861	39	336	340	8	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141287	10.1371/journal.pone.0141287	http://dx.doi.org/10.1371/journal.pone.0141287			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555596	Green Submitted, Green Published, gold			2022-12-26	WOS:000364430700024
J	Bao, L; Messer, K; Schwab, R; Harismendy, O; Pu, MY; Crain, B; Yost, S; Frazer, KA; Rana, B; Hasteh, F; Wallace, A; Parker, BA				Bao, Lei; Messer, Karen; Schwab, Richard; Harismendy, Olivier; Pu, Minya; Crain, Brian; Yost, Shawn; Frazer, Kelly A.; Rana, Brinda; Hasteh, Farnaz; Wallace, Anne; Parker, Barbara A.			Mutational Profiling Can Establish Clonal or Independent Origin in Synchronous Bilateral Breast and Other Tumors	PLoS One			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; CARCINOMA IN-SITU; CANCER; RELATEDNESS; HETEROGENEITY; PROGRESSION; METASTASIS; DISEASE; LESIONS; TESTS	Background Synchronous tumors can be independent primary tumors or a primary-metastatic (clonal) pair, which may have clinical implications. Mutational profiling of tumor DNA is increasingly common in the clinic. We investigated whether mutational profiling can distinguish independent from clonal tumors in breast and other cancers, using a carefully defined test based on the Clonal Likelihood Score (CLS = 100 x # shared high confidence (HC) mutations/ # total HC mutations). Methods Statistical properties of a formal test using the CLS were investigated. A high CLS is evidence in favor of clonality; the test is implemented as a one-sided binomial test of proportions. Test parameters were empirically determined using 16,422 independent breast tumor pairs and 15 primary-metastatic tumor pairs from 10 cancer types using The Cancer Genome Atlas. Results We validated performance of the test with its established parameters, using five published data sets comprising 15,758 known independent tumor pairs (maximum CLS = 4.1%, minimum p-value = 0.48) and 283 known tumor clonal pairs (minimum CLS 13%, maximum p-value < 0.01), across renal cell, testicular, and colorectal cancer. The CLS test correctly classified all validation samples but one, which it appears may have been incorrectly classified in the published data. As proof-of-concept we then applied the CLS test to two new cases of invasive synchronous bilateral breast cancer at our institution, each with one hormone receptor positive (ER+/PR+/HER2-) lobular and one triple negative ductal carcinoma. High confidence mutations were identified by exome sequencing and results were validated using deep targeted sequencing. The first tumor pair had CLS of 81% (p-value < 10-15), supporting clonality. In the second pair, no common mutations of 184 variants were validated (p-value >0.99), supporting independence. A plausible molecular mechanism for the shift from hormone receptor positive to triple negative was identified in the clonal pair. Conclusion We have developed the statistical properties of a carefully defined Clonal Likelihood Score test from mutational profiling of tumor DNA. Under identified conditions, the test appears to reliably distinguish between synchronous tumors of clonal and of independent origin in several cancer types. This approach may have scientific and clinical utility.	[Bao, Lei; Messer, Karen; Pu, Minya; Crain, Brian; Yost, Shawn] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Messer, Karen] Univ Calif San Diego, Dept Family Med & Publ Hlth, Div Biostat, La Jolla, CA 92093 USA; [Schwab, Richard; Parker, Barbara A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Harismendy, Olivier; Frazer, Kelly A.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Rana, Brinda] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Hasteh, Farnaz] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Wallace, Anne] Univ Calif San Diego, Dept Surg, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Messer, K (corresponding author), Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA.	kmesser@ucsd.edu	Harismendy, Olivier/AAM-2072-2021; Schwab, Richard/AAX-9262-2020	Harismendy, Olivier/0000-0002-8098-9888; Yost, Shawn/0000-0001-6653-1056; Frazer, Kelly/0000-0002-6060-8902	Breast Cancer Research Foundation; National Cancer Institute [5R01CA166293]; NATIONAL CANCER INSTITUTE [R01CA166293, P30CA023100] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: This study is supported by a Breast Cancer Research Foundation grant (Parker, PI) and by 5R01CA166293 from the National Cancer Institute.	Agresti A, 2013, CATEGORICAL DATA ANA; Andrade VP, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3222; Balko JM, 2014, CANCER DISCOV, V4, P232, DOI 10.1158/2159-8290.CD-13-0286; Banelli B, 2010, ANN ONCOL, V21, P1237, DOI 10.1093/annonc/mdp470; Bao L, 2014, BIOINFORMATICS; Begg CB, 2007, BIOMETRICS, V63, P522, DOI 10.1111/j.1541-0420.2006.00681.x; Brennan ME, 2009, J CLIN ONCOL, V27, P5640, DOI 10.1200/JCO.2008.21.5756; Chunder N, 2004, PATHOL RES PRACT, V200, P735, DOI 10.1016/j.prp.2004.09.001; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; De Mattos-Arruda L, 2014, MOL ONCOL, V8, P150, DOI 10.1016/j.molonc.2013.10.006; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Hernandez L, 2012, J PATHOL, V227, P42, DOI 10.1002/path.3990; Heselmeyer-Haddad K, 2012, AM J PATHOL, V181, P1807, DOI 10.1016/j.ajpath.2012.07.012; Hu N, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-576; Imyanitov EN, 2002, INT J CANCER, V100, P557, DOI 10.1002/ijc.10530; Janschek E, 2001, BREAST CANCER RES TR, V67, P1, DOI 10.1023/A:1010661514306; Lee SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090459; LEIS HP, 1978, SURG CLIN N AM, V58, P833; Nemes S, 2013, GENE CHROMOSOME CANC, V52, P1007, DOI 10.1002/gcc.22096; Nichol AM, 2011, J CLIN ONCOL, V29, P4763, DOI 10.1200/JCO.2011.35.0165; Nilsen G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-591; Ostrovnaya I, 2011, BIOINFORMATICS, V27, P1698, DOI 10.1093/bioinformatics/btr267; Ostrovnaya I, 2010, STAT MED, V29, P1608, DOI 10.1002/sim.3866; Ostrovnaya I, 2010, CLIN CANCER RES, V16, P1358, DOI 10.1158/1078-0432.CCR-09-2398; Ostrovnaya I, 2008, BIOMETRICS, V64, P1018, DOI 10.1111/j.1541-0420.2008.00988.x; Poplawski AB, 2010, EUR J HUM GENET, V18, P560, DOI 10.1038/ejhg.2009.230; Saad RS, 2008, MODERN PATHOL, V21, P1200, DOI 10.1038/modpathol.2008.35; Schmid SM, 2011, EJSO-EUR J SURG ONC, V37, P623, DOI 10.1016/j.ejso.2011.05.006; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Soria JC, 2014, ANN ONCOL, V25, P2244, DOI 10.1093/annonc/mdu390; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Teixeira MR, 2004, BRIT J CANCER, V91, P775, DOI 10.1038/sj.bjc.6602021; Wagner PL, 2009, AM J CLIN PATHOL, V132, P871, DOI 10.1309/AJCP7AK1VWFNMCSW; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764	35	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142487	10.1371/journal.pone.0142487	http://dx.doi.org/10.1371/journal.pone.0142487			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554380	Green Published, gold			2022-12-26	WOS:000364430700114
J	De Gaetano, A; Gaz, C; Palumbo, P; Panunzi, S				De Gaetano, Andrea; Gaz, Claudio; Palumbo, Pasquale; Panunzi, Simona			A Unifying Organ Model of Pancreatic Insulin Secretion	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; BETA-CELL DYSFUNCTION; PLASMA-GLUCOSE; SUSTAINED OSCILLATIONS; MOUSE ISLETS; PULSATILE; SENSITIVITY; RESISTANCE; ENTRAINMENT; GLUCAGON	The secretion of insulin by the pancreas has been the object of much attention over the past several decades. Insulin is known to be secreted by pancreatic beta-cells in response to hyperglycemia: its blood concentrations however exhibit both high-frequency (period approx. 10 minutes) and low-frequency oscillations (period approx. 1.5 hours). Furthermore, characteristic insulin secretory response to challenge maneuvers have been described, such as frequency entrainment upon sinusoidal glycemic stimulation; substantial insulin peaks following minimal glucose administration; progressively strengthened insulin secretion response after repeated administration of the same amount of glucose; insulin and glucose characteristic curves after Intra-Venous administration of glucose boli in healthy and prediabetic subjects as well as in Type 2 Diabetes Mellitus. Previous modeling of beta-cell physiology has been mainly directed to the intracellular chain of events giving rise to single-cell or cell-cluster hormone release oscillations, but the large size, long period and complex morphology of the diverse responses to whole-body glucose stimuli has not yet been coherently explained. Starting with the seminal work of Grodsky it was hypothesized that the population of pancreatic beta-cells, possibly functionally aggregated in islets of Langerhans, could be viewed as a set of independent, similar, but not identical controllers (firing units) with distributed functional parameters. The present work shows how a single model based on a population of independent islet controllers can reproduce very closely a diverse array of actually observed experimental results, with the same set of working parameters. The model's success in reproducing a diverse array of experiments implies that, in order to understand the macroscopic behaviour of the endocrine pancreas in regulating glycemia, there is no need to hypothesize intrapancreatic pacemakers, influences between different islets of Langerhans, glycolitic-induced oscillations or beta-cell sensitivity to the rate of change of glycemia.	[De Gaetano, Andrea; Gaz, Claudio; Palumbo, Pasquale; Panunzi, Simona] UCSC, CNR IASI BioMatLab, Inst Anal Syst & Comp Sci, Italian Natl Res Council,Biomath Lab, I-00168 Rome, Italy; [Gaz, Claudio] Univ Roma La Sapienza, Dept Comp Control & Management Engn DIAG, I-00185 Rome, Italy	Catholic University of the Sacred Heart; Consiglio Nazionale delle Ricerche (CNR); Istituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti" (IASI-CNR); Sapienza University Rome	Gaz, C (corresponding author), UCSC, CNR IASI BioMatLab, Inst Anal Syst & Comp Sci, Italian Natl Res Council,Biomath Lab, Largo A Gemelli 8, I-00168 Rome, Italy.	claudior.gaz@biomatematica.it	De Gaetano, Andrea/AAC-4805-2021; Panunzi, Simona/AAK-9337-2020	PALUMBO, PASQUALE/0000-0002-9371-2802; Panunzi, Simona/0000-0003-0956-8578; De Gaetano, Andrea/0000-0001-7712-056X; GAZ, CLAUDIO ROBERTO/0000-0003-4659-5831				Abdul-Ghani MA, 2006, DIABETES CARE, V29, P1130, DOI 10.2337/dc05-2179; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; ANDERSON GE, 1967, METABOLISM, V16, P586, DOI 10.1016/0026-0495(67)90002-9; Bennett DL, 2004, APPL MATH COMPUT, V151, P189, DOI 10.1016/S0096-3003(03)00332-1; Bergman RN, 2002, EUR J CLIN INVEST, V32, P35, DOI 10.1046/j.1365-2362.32.s3.5.x; BERGMAN RN, 1979, AM J PHYSIOL, V236, pE667, DOI 10.1152/ajpendo.1979.236.6.E667; BERGSTEN P, 1993, DIABETES, V42, P670, DOI 10.2337/diabetes.42.5.670; Bertram R, 2004, BIOPHYS J, V87, P3074, DOI 10.1529/biophysj.104.049262; Bertram R, 2004, B MATH BIOL, V66, P1313, DOI 10.1016/j.bulm.2003.12.005; Bertuzzi A, 2007, AM J PHYSIOL-ENDOC M, V293, pE396, DOI 10.1152/ajpendo.00647.2006; Bugianesi E, 2005, HEPATOLOGY, V42, P987, DOI 10.1002/hep.20920; Cavaghan MK, 1997, J CLIN INVEST, V100, P530, DOI 10.1172/JCI119562; Chen YD, 2008, BIOPHYS J, V95, P2226, DOI 10.1529/biophysj.107.124990; CHOU HF, 1991, LIFE SCI, V48, P1463, DOI 10.1016/0024-3205(91)90183-C; CHOU HF, 1990, DIABETES, V39, P112, DOI 10.2337/diabetes.39.1.112; De Gaetano A, 2000, J MATH BIOL, V40, P136, DOI 10.1007/s002850050007; De Gaetano A, 2013, IEEE DECIS CONTR P, P3355, DOI 10.1109/CDC.2013.6760396; De Gaetano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070875; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; DIAMOND MP, 1995, J SOC GYNECOL INVEST, V2, P708, DOI 10.1016/1071-5576(95)00023-8; DOUGLAS WW, 1968, BRIT J PHARMACOL, V34, P451, DOI 10.1111/j.1476-5381.1968.tb08474.x; EDDLESTONE GT, 1984, J MEMBRANE BIOL, V77, P1, DOI 10.1007/BF01871095; EHRMANN DA, 1995, J CLIN INVEST, V96, P520, DOI 10.1172/JCI118064; Engelborghs K, 2001, J MATH BIOL, V42, P361, DOI 10.1007/s002850000072; Faerch K, 2008, DIABETOLOGIA, V51, P853, DOI 10.1007/s00125-008-0951-x; Festa A, 2004, DIABETES, V53, P1549, DOI 10.2337/diabetes.53.6.1549; GOODNER CJ, 1982, SCIENCE, V215, P1257, DOI 10.1126/science.7036347; GOODNER CJ, 1991, AM J PHYSIOL, V260, pE422, DOI 10.1152/ajpendo.1991.260.3.E422; GOODNER CJ, 1977, SCIENCE, V195, P177, DOI 10.1126/science.401543; GRODSKY GM, 1972, J CLIN INVEST, V51, P2047, DOI 10.1172/JCI107011; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Hansen KM, 1923, ACTA ENDOCRINOL COPE; Hollingdal M, 2000, DIABETES, V49, P1334, DOI 10.2337/diabetes.49.8.1334; Juhl C, 2002, DIABETES, V51, pS255, DOI 10.2337/diabetes.51.2007.S255; KAHN SE, 1993, DIABETES, V42, P1663, DOI 10.2337/diabetes.42.11.1663; KOERKER DJ, 1978, ENDOCRINOLOGY, V102, P1649, DOI 10.1210/endo-102-5-1649; LANG DA, 1982, DIABETES, V31, P22, DOI 10.2337/diabetes.31.1.22; LANG DA, 1979, NEW ENGL J MED, V301, P1023, DOI 10.1056/NEJM197911083011903; Larsen MO, 2002, DIABETOLOGIA, V45, P1389, DOI 10.1007/s00125-002-0928-0; Li JX, 2006, J THEOR BIOL, V242, P722, DOI 10.1016/j.jtbi.2006.04.002; Low JT, 2013, DIABETOLOGIA, V56, P2629, DOI 10.1007/s00125-013-3019-5; Man CD, 2007, IEEE T BIO-MED ENG, V54, P1740, DOI 10.1109/TBME.2007.893506; Mao CS, 2004, AM J PHYSIOL-ENDOC M, V287, pE50, DOI 10.1152/ajpendo.00555.2003; Mao CS, 1999, DIABETES, V48, P714, DOI 10.2337/diabetes.48.4.714; Mari A, 2002, DIABETES, V51, pS221, DOI 10.2337/diabetes.51.2007.S221; MATTHEWS DR, 1987, ENDOCRINOLOGY, V120, P2272, DOI 10.1210/endo-120-6-2272; Meda P, 2013, DIABETOLOGIA, V56, P2552, DOI 10.1007/s00125-013-3073-z; MEISSNER HP, 1976, NATURE, V262, P502, DOI 10.1038/262502a0; MILLSAPS K, 1975, Mathematical Biosciences, V23, P237, DOI 10.1016/0025-5564(75)90038-3; OMEARA NM, 1993, J CLIN INVEST, V92, P262, DOI 10.1172/JCI116560; Osei K, 1997, DIABETES CARE, V20, P396, DOI 10.2337/diacare.20.3.396; Overgaard RV, 2006, ANN BIOMED ENG, V34, P1343, DOI 10.1007/s10439-006-9154-0; Palumbo P, 2007, DISCRETE CONT DYN-B, V7, P399; Palumbo P, 2010, J MATH BIOL, V61, P171, DOI 10.1007/s00285-009-0297-0; Panunzi S, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-35; Pedersen MG, 2005, BIOPHYS J, V89, P107, DOI 10.1529/biophysj.104.055681; Pedersen MG, 2014, INTERFACE FOCUS; Pedersen MG, 2008, PHILOS T R SOC A, V366, P3525, DOI 10.1098/rsta.2008.0120; Pedersen MG, 2011, IEEE T BIO-MED ENG, V58, P3020, DOI 10.1109/TBME.2011.2164918; Pedersen MG, 2010, AM J PHYSIOL-ENDOC M, V298, pE597, DOI 10.1152/ajpendo.00670.2009; Pedersen MG, 2009, P NATL ACAD SCI USA, V106, P7432, DOI 10.1073/pnas.0901202106; PIPELEERS D, 1994, DIABETOLOGIA, V37, pS57, DOI 10.1007/BF00400827; POLONSKY KS, 1988, J CLIN INVEST, V81, P442, DOI 10.1172/JCI113339; Porksen N, 1997, AM J PHYSIOL-ENDOC M, V273, pE908; PORKSEN N, 1994, J CLIN INVEST, V94, P219, DOI 10.1172/JCI117310; PORKSEN N, 1995, AM J PHYSIOL-ENDOC M, V269, pE478, DOI 10.1152/ajpendo.1995.269.3.E478; Porksen N., 2000, AM J PHYSL ENDOCRINO, V278; Pratley RE, 2001, DIABETOLOGIA, V44, P929, DOI 10.1007/s001250100580; ROSSETTI L, 1990, DIABETES CARE, V13, P610, DOI 10.2337/diacare.13.6.610; SALOMON D, 1986, EXP CELL RES, V162, P507, DOI 10.1016/0014-4827(86)90354-X; SANDOW A, 1952, YALE J BIOL MED, V25, P176; SCHUIT FC, 1988, P NATL ACAD SCI USA, V85, P3865, DOI 10.1073/pnas.85.11.3865; SCOTT AM, 1981, DIABETOLOGIA, V21, P470; SHAPIRO ET, 1988, J CLIN ENDOCR METAB, V67, P307, DOI 10.1210/jcem-67-2-307; SIMON C, 1987, J CLIN ENDOCR METAB, V64, P669, DOI 10.1210/jcem-64-4-669; Simon C, 2000, AM J PHYSIOL-ENDOC M, V278, pE413, DOI 10.1152/ajpendo.2000.278.3.E413; Simon C, 2002, DIABETES, V51, pS258, DOI 10.2337/diabetes.51.2007.S258; SMOLEN P, 1995, J THEOR BIOL, V174, P137, DOI 10.1006/jtbi.1995.0087; STAGNER JI, 1985, AM J PHYSIOL, V248, pE522, DOI 10.1152/ajpendo.1985.248.5.E522; STAGNER JI, 1980, J CLIN INVEST, V65, P939, DOI 10.1172/JCI109750; STAGNER JI, 1985, AM J PHYSIOL, V248, pE516, DOI 10.1152/ajpendo.1985.248.5.E516; Stamper IJ, 2013, J THEOR BIOL, V318, P210, DOI 10.1016/j.jtbi.2012.11.002; STURIS J, 1994, AM J PHYSIOL, V267, pE250, DOI 10.1152/ajpendo.1994.267.2.E250; STURIS J, 1991, J CLIN INVEST, V87, P439, DOI 10.1172/JCI115015; TOFFOLO G, 1980, DIABETES, V29, P979, DOI 10.2337/diabetes.29.12.979; Toschi E, 2002, DIABETES, V51, pS130, DOI 10.2337/diabetes.51.2007.S130; Watson EM, 2011, COMPUT METH PROG BIO, V102, P119, DOI 10.1016/j.cmpb.2010.08.013; Weyer C, 1999, DIABETES, V48, P2197, DOI 10.2337/diabetes.48.11.2197	88	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142344	10.1371/journal.pone.0142344	http://dx.doi.org/10.1371/journal.pone.0142344			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555895	Green Published, Green Submitted, gold			2022-12-26	WOS:000364430700087
J	Niziolek, PJ; Bullock, W; Warman, ML; Robling, AG				Niziolek, Paul J.; Bullock, Whitney; Warman, Matthew L.; Robling, Alexander G.			Missense Mutations in LRP5 Associated with High Bone Mass Protect the Mouse Skeleton from Disuse- and Ovariectomy-Induced Osteopenia	PLOS ONE			English	Article							WNT SIGNALING PATHWAY; SCLEROSTIN; RECEPTOR; OSTEOBLASTS; INHIBITION; DENSITY; OSTEOPOROSIS; INCREASES; MUSCLE; LIGAND	The low density lipoprotein receptor-related protein-5 (LRP5), a co-receptor in the Wnt signaling pathway, modulates bone mass in humans and in mice. Lrp5 knock-out mice have severely impaired responsiveness to mechanical stimulation whereas Lrp5 gain-of-function knock-in and transgenic mice have enhanced responsiveness to mechanical stimulation. Those observations highlight the importance of Lrp5 protein in bone cell mechanotransduction. It is unclear if and how high bone mass-causing (HBM) point mutations in Lrp5 alter the bone-wasting effects of mechanical disuse. To address this issue we explored the skeletal effects of mechanical disuse using two models, tail suspension and Botulinum toxin-induced muscle paralysis, in two different Lrp5 HBM knock-in mouse models. A separate experiment employing estrogen withdrawal-induced bone loss by ovariectomy was also conducted as a control. Both disuse stimuli induced significant bone loss in WT mice, but Lrp5 A214V and G171V were partially or fully protected from the bone loss that normally results from disuse. Trabecular bone parameters among HBM mice were significantly affected by disuse in both models, but these data are consistent with DEXA data showing a failure to continue growing in HBM mice, rather than a loss of pre-existing bone. Ovariectomy in Lrp5 HBM mice resulted in similar protection from catabolism as was observed for the disuse experiments. In conclusion, the Lrp5 HBM alleles offer significant protection from the resorptive effects of disuse and from estrogen withdrawal, and consequently, present a potential mechanism to mimic with pharmaceutical intervention to protect against various bone-wasting stimuli.	[Niziolek, Paul J.; Bullock, Whitney; Robling, Alexander G.] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [Niziolek, Paul J.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Warman, Matthew L.] Childrens Hosp, Dept Orthopaed Surg, Boston, MA 02115 USA; [Warman, Matthew L.] Harvard Univ, Howard Hughes Med Inst, Sch Med, Dept Genet, Cambridge, MA 02138 USA; [Robling, Alexander G.] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA; [Robling, Alexander G.] Richard L Roudebush VA Med Ctr, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Harvard University; Boston Children's Hospital; Harvard University; Howard Hughes Medical Institute; Indiana University System; Indiana University-Purdue University Indianapolis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center	Robling, AG (corresponding author), Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA.	arobling@iupui.edu		Bullock, Whitney/0000-0001-9008-8314	PHS (NCCR) [5TL1RR025759-02]; NIH [AR53237]; VA [BX001478]; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR025759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053237] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001478] Funding Source: NIH RePORTER	PHS (NCCR)(Swiss National Science Foundation (SNSF)United States Department of Health & Human ServicesUnited States Public Health Service); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA(US Department of Veterans Affairs); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by PHS (NCCR) grant 5TL1RR025759-02 (A. Shekhar, PI; trainee recipient is PJN), NIH grant AR53237 and VA grant BX001478 (to AGR), and the Howard Hughes Medical Institute (to MLW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai M, 2005, MOL CELL BIOL, V25, P4946, DOI 10.1128/MCB.25.12.4946-4955.2005; Atti E, 2008, J BONE MINER RES, V23, pS362; Balemans W, 2006, BONE, V38, pS6, DOI 10.1016/j.bone.2005.01.064; Balemans W, 2008, CALCIFIED TISSUE INT, V82, P445, DOI 10.1007/s00223-008-9130-9; Bauman WA, 2015, PM&R, V7, P188, DOI 10.1016/j.pmrj.2014.08.948; Bex F, 2003, J BONE MINER RES, V18, pS60; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Choi HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007930; Cui Y, 2010, LRP5 FUNCTIONS BONE; Cui YJ, 2011, NAT MED, V17, P684, DOI 10.1038/nm.2388; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Ellies DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096257; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hens JR, 2005, J BONE MINER RES, V20, P1103, DOI 10.1359/JBMR.050210; Johnson ML, 2006, REV ENDOCR METAB DIS, V7, P41, DOI 10.1007/s1154-006-9003-3; Kang KS, 2015, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00246; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Koay MA, 2005, TRENDS MOL MED, V11, P129, DOI 10.1016/j.molmed.2005.01.004; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Levasseur R, 2005, JOINT BONE SPINE, V72, P207, DOI 10.1016/j.jbspin.2004.10.008; Li J, 2006, BONE, V39, P754, DOI 10.1016/j.bone.2006.03.017; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Lin CW, 2009, J BONE MINER RES, V24, P1651, DOI [10.1359/JBMR.090411, 10.1359/jbmr.090411]; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Manske SL, 2010, BONE, V46, P24, DOI 10.1016/j.bone.2009.10.016; Minisola S, 2014, EXPERT OPIN BIOL TH, V14, P1225, DOI 10.1517/14712598.2014.920815; Mulder E, 2015, EUR J APPL PHYSIOL, V115, P727, DOI 10.1007/s00421-014-3045-0; Nagaraja MP, 2013, J CELL BIOCHEM, V114, P1001, DOI 10.1002/jcb.24454; Nevill AM, 2003, BONE, V32, P62, DOI 10.1016/S8756-3282(02)00927-4; Niziolek PJ, 2015, J BONE MINER RES, V30, P1822, DOI 10.1002/jbmr.2514; Niziolek PJ, 2011, BONE, V49, P1010, DOI 10.1016/j.bone.2011.07.034; Oliver L., 2009, J BONE MINER RES, V24, pS77; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; Saxon LK, 2011, BONE, V49, P184, DOI 10.1016/j.bone.2011.03.683; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Seynnes OR, 2010, J MUSCULOSKEL NEURON, V10, P124; Shackelford LC, 2004, J APPL PHYSIOL, V97, P119, DOI 10.1152/japplphysiol.00741.2003; Shah AD, 2015, INT J WOMENS HEALTH, V7, P565, DOI 10.2147/IJWH.S73244; Spatz JM, 2013, J BONE MINER RES, V28, P865, DOI 10.1002/jbmr.1807; Tian XY, 2011, BONE, V48, P197, DOI 10.1016/j.bone.2010.09.009; Tu X, 2010, ASBMR; Warner SE, 2006, BONE, V38, P257, DOI 10.1016/j.bone.2005.08.009; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Williams BO, 2009, J BONE MINER RES, V24, P171, DOI [10.1359/JBMR.081235, 10.1359/jbmr.081235]; Xiong L, 2015, P NATL ACAD SCI USA, V112, P3487, DOI 10.1073/pnas.1419714112; Zehnder Y, 2004, OSTEOPOROSIS INT, V15, P180, DOI 10.1007/s00198-003-1529-6	47	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0140775	10.1371/journal.pone.0140775	http://dx.doi.org/10.1371/journal.pone.0140775			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554834	Green Published, gold			2022-12-26	WOS:000364430700017
J	Wang, R; Chen, L; Fan, L; Gao, DW; Liang, ZR; He, J; Gong, WQ; Gao, LG				Wang, Rong; Chen, Lei; Fan, Li; Gao, Dewei; Liang, Zhiru; He, Jing; Gong, Weiqin; Gao, Linggen			Incidence and Effects of Polypharmacy on Clinical Outcome among Patients Aged 80(+): A Five-Year Follow-Up Study	PLOS ONE			English	Article							ADVERSE DRUG EVENTS; OLDER-ADULTS; POTENTIALLY INAPPROPRIATE; ELDERLY-PATIENTS; MEDICATION USE; HIP FRACTURE; RISK-FACTOR; FALL-RISK; MORTALITY; FRAILTY	Objectives Polypharmacy is a problem of growing interest in geriatrics with the increase in drug consumption in recent years, is defined according to the WHO criteria as the, "concurrent use of five or more different prescription medication". We investigated the clinical characteristics of polypharmacy and identified the effects of polypharmacy on clinical outcome among patients aged 80+ admitted to Chinese PLA general hospital. Methods Older men aged >= 80 years (n = 1562) were included in this study. The included participants attended a structured clinical examination and an interview carried out by a geriatrician and trained nurses. A follow-up survey in 2014 was carried out on survivors in the same way as in 2009. The clinical outcome measured were adverse drug reactions, falls, frailty, disability, cognitive impairment, mortality. The association between polypharmacy and clinical outcome was assessed by logistic regression. Results The mean (range) age of the included participants was 85.2 (80-104) years. Medication exposure was reported by 100% of the population. Mean number of medications reported in this population was 9.56 +/- 5.68. The prevalence of polypharmacy (>= 6 medications) in the present study was 70%. At the time of the follow-up survey, an increase in the number of taken medicines had occurred among half of the survivors. The risk of different outcomes in relation to number of medications rises significantly, the odds ratios were 1.21 (95% confidence interval [CI] 1.17-1.28) for adverse drug reactions, 1.18 (95% CI 1.10-1.26) for falls, 1.16 (95% CI 1.09-1.24) for disability, and 1.19 (95% CI 1.12-1.23) for mortality. There was no association between increasing number of medications and cognitive impairment. Conclusions Our study demonstrates that polypharmacy is very common in the very old patients, and observed that number of medications was a factor associated with difference clinical outcome independently of the age, type of medications prescribed and accompanied comorbidities.	[Wang, Rong; Gao, Dewei; Liang, Zhiru; He, Jing; Gong, Weiqin; Gao, Linggen] Gen Hosp Chinese Peoples Liberat Army, Dept Comprehens Surg, Beijing, Peoples R China; [Chen, Lei] Gen Hosp Chinese Peoples Liberat Army, Dept Thorac Surg, Beijing, Peoples R China; [Fan, Li] Gen Hosp Chinese Peoples Liberat Army, Dept Geriatr Cardiol, Beijing, Peoples R China		Fan, L (corresponding author), Gen Hosp Chinese Peoples Liberat Army, Dept Geriatr Cardiol, Beijing, Peoples R China.	fanlighcpl@gmail.com; gaodeweigdw@163.com			China Postdoctoral Science Foundation [2012T50865]; Military Healthcare Fund [12BJZ39]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Military Healthcare Fund	This work was supported by a general financial grant from the China Postdoctoral Science Foundation (2012T50865, to L.Gao.) and a grant from the Military Healthcare Fund 12BJZ39 (to L. Fan).	Aparasu RR, 2000, ANN PHARMACOTHER, V34, P338, DOI 10.1345/aph.19006; Bergman H, 2007, J GERONTOL A-BIOL, V62, P731, DOI 10.1093/gerona/62.7.731; Bourgeois FT, 2010, PHARMACOEPIDEM DR S, V19, P901, DOI 10.1002/pds.1984; Caselli G., 2002, GENUS, P9; Damian J, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-6; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; Espino DV, 2006, J GERONTOL A-BIOL, V61, P170, DOI 10.1093/gerona/61.2.170; Fialova D, 2005, JAMA-J AM MED ASSOC, V293, P1348, DOI 10.1001/jama.293.11.1348; Field TS, 2004, J AM GERIATR SOC, V52, P1349, DOI 10.1111/j.1532-5415.2004.52367.x; Fletcher Paula C, 2009, J Patient Saf, V5, P61, DOI 10.1097/PTS.0b013e3181a551ed; Frazier Susan C, 2005, J Gerontol Nurs, V31, P4; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Fulton Maryann M, 2005, J Am Acad Nurse Pract, V17, P123, DOI 10.1111/j.1041-2972.2005.0020.x; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; Haider SI, 2007, INT J CLIN PHARM TH, V45, P643; Haleem S, 2008, INJURY, V39, P1157, DOI 10.1016/j.injury.2008.03.022; Harper K, 2010, INT J ENV RES PUB HE, V7, P675, DOI 10.3390/ijerph7020675; Hilmer SN, 2009, CLIN PHARMACOL THER, V85, P86, DOI 10.1038/clpt.2008.224; Hilmer SN, 2012, J GERONTOL A-BIOL, V67, P181, DOI 10.1093/gerona/glr066; Jyrkka J, 2009, DRUG AGING, V26, P493, DOI 10.2165/00002512-200926060-00006; KATZ S, 1970, GERONTOLOGIST, V10, P20, DOI 10.1093/geront/10.1_Part_1.20; Kojima T, 2011, GERIATR GERONTOL INT, V11, P438, DOI 10.1111/j.1447-0594.2011.00703.x; Lai SW, 2010, MEDICINE, V89, P295, DOI 10.1097/MD.0b013e3181f15efc; Lau DT, 2005, ARCH INTERN MED, V165, P68, DOI 10.1001/archinte.165.1.68; Lee CY, 2011, NEUROUROL URODYNAM, V30, P1286, DOI 10.1002/nau.21044; Maher RL, 2014, EXPERT OPIN DRUG SAF, V13, P57, DOI 10.1517/14740338.2013.827660; Mansur N, 2008, ANN PHARMACOTHER, V42, P783, DOI 10.1345/aph.1L070; Pozzi C, 2010, PHARMACOEPIDEM DR S, V19, P954, DOI 10.1002/pds.1997; Schafer I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015941; Tromp AM, 2001, J CLIN EPIDEMIOL, V54, P837, DOI 10.1016/S0895-4356(01)00349-3; United Nations, 2002, WORLD POP AG; US General Accounting Office, 1995, PUBL GAO HEHS; Ziere G, 2006, BRIT J CLIN PHARMACO, V61, P218, DOI 10.1111/j.1365-2125.2005.02543.x	34	46	46	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142123	10.1371/journal.pone.0142123	http://dx.doi.org/10.1371/journal.pone.0142123			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7CT	26554710	Green Published, gold, Green Submitted			2022-12-26	WOS:000364430700056
J	Gettins, PGW; Dolmer, K				Gettins, Peter G. W.; Dolmer, Klavs			The High Affinity Binding Site on Plasminogen Activator Inhibitor-1 (PAI-1) for the Low Density Lipoprotein Receptor-related Protein (LRP1) Is Composed of Four Basic Residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UROKINASE RECEPTOR; LIGAND-BINDING; ALPHA(2)-MACROGLOBULIN RECEPTOR; ENDOCYTOSIS RECEPTORS; COMPLEX-FORMATION; LDL RECEPTOR; ALPHA(1)-PROTEINASE INHIBITOR; COVALENT COMPLEX; TYPE-1 COMPLEX; RAP	Plasminogen activator inhibitor 1 (PAI-1) is a serpin inhibitor of the plasminogen activators urokinase-type plasminogen activator (uPA) and tissue plasminogen activator, which binds tightly to the clearance and signaling receptor low density lipoprotein receptor-related protein 1 (LRP1) in both proteinase-complexed and uncomplexed forms. Binding sites for PAI-1 within LRP1 have been localized to CR clusters II and IV. Within cluster II, there is a strong preference for the triple CR domain fragment CR456. Previous mutagenesis studies to identify the binding site on PAI-1 for LRP1 have given conflicting results or implied small binding contributions incompatible with the high affinity PAI-1/LRP1 interaction. Using a highly sensitive solution fluorescence assay, we have examined binding of CR456 to arginine and lysine variants of PAI-1 and definitively identified the binding site as composed of four basic residues, Lys-69, Arg-76, Lys-80, and Lys-88. These are highly conserved among mammalian PAI-1s. Individual mutations result in a 13-800-fold increase in K-d values. We present evidence that binding involves engagement of CR4 by Lys-88, CR5 by Arg-76 and Lys-80, and CR6 by Lys-69, with the strongest interactions to CR5 and CR6. Collectively, the individual binding contributions account quantitatively for the overall PAI-1/LRP1 affinity. We propose that the greater efficiency of PAI-1.uPA complex binding and clearance by LRP1, compared with PAI-1 alone, is due solely to simultaneous binding of the uPA moiety in the complex to its receptor, thereby making binding of the PAI-1 moiety to LRP1 a two-dimensional surface-localized association.	[Gettins, Peter G. W.; Dolmer, Klavs] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Gettins, PGW (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, 900 S Ashland,M-C 669, Chicago, IL 60607 USA.	pgettins@uic.edu			National Institutes of Health [R01 GM54414]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054414] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM54414. The authors declare no conflict of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andersen OM, 2001, BIOCHEM J, V357, P289, DOI 10.1042/0264-6021:3570289; Beglova N, 2001, BIOCHEMISTRY-US, V40, P2808, DOI 10.1021/bi0027276; BERKENPAS MB, 1995, EMBO J, V14, P2969, DOI 10.1002/j.1460-2075.1995.tb07299.x; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Blouse GE, 2003, BIOCHEMISTRY-US, V42, P12260, DOI 10.1021/bi034737n; Dementiev A, 2006, J BIOL CHEM, V281, P3452, DOI 10.1074/jbc.M510564200; Dolmer K, 2006, J BIOL CHEM, V281, P34189, DOI 10.1074/jbc.M604389200; Dolmer K, 2013, J BIOL CHEM, V288, P24081, DOI 10.1074/jbc.M113.473728; DUNN BM, 1981, BIOCHEMISTRY-US, V20, P7206, DOI 10.1021/bi00528a023; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; Florova G, 2013, BIOCHEMISTRY-US, V52, P4697, DOI 10.1021/bi400470s; Gettins PGW, 2012, BIOCHEM J, V443, P65, DOI 10.1042/BJ20111867; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Horn IR, 1997, J BIOL CHEM, V272, P13608, DOI 10.1074/jbc.272.21.13608; Horn IR, 1998, THROMB HAEMOSTASIS, V80, P822; Huai Q, 2006, SCIENCE, V311, P656, DOI 10.1126/science.1121143; Huai Q, 2008, NAT STRUCT MOL BIOL, V15, P422, DOI 10.1038/nsmb.1404; Huang W, 1999, J BIOL CHEM, V274, P14130, DOI 10.1074/jbc.274.20.14130; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Jensen JK, 2008, PROTEIN SCI, V17, P1844, DOI 10.1110/ps.036707.108; Jensen JK, 2006, BIOCHEM J, V399, P387, DOI 10.1042/BJ20060533; Jensen JK, 2009, J BIOL CHEM, V284, P17989, DOI 10.1074/jbc.M109.009530; Jensen JK, 2009, BIOCHEM J, V421, P273, DOI 10.1042/BJ20090175; Jensen JK, 2002, FEBS LETT, V521, P91, DOI 10.1016/S0014-5793(02)02830-2; JUHANVAGUE I, 1984, THROMB RES, V33, P523, DOI 10.1016/0049-3848(84)90018-5; Kasza A, 1997, EUR J BIOCHEM, V248, P270, DOI 10.1111/j.1432-1033.1997.00270.x; Lee D, 2006, MOL CELL, V22, P423, DOI 10.1016/j.molcel.2006.04.011; Neels JG, 1999, J BIOL CHEM, V274, P31305, DOI 10.1074/jbc.274.44.31305; NYKJAER A, 1994, J BIOL CHEM, V269, P25668; NYKJAER A, 1992, J BIOL CHEM, V267, P14543; OLSON D, 1992, J BIOL CHEM, V267, P9129; OLSON ST, 1992, J BIOL CHEM, V267, P12528; OSSOWSKI L, 1991, CANCER RES, V51, P274; Peterson FC, 2001, BIOCHEMISTRY-US, V40, P6284, DOI 10.1021/bi010100x; Rodenburg KW, 1998, BIOCHEM J, V329, P55; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; Skeldal S, 2006, FEBS J, V273, P5143, DOI 10.1111/j.1742-4658.2006.05511.x; Stefansson S, 1998, J BIOL CHEM, V273, P6358, DOI 10.1074/jbc.273.11.6358; STEIN P, 1991, J MOL BIOL, V221, P615, DOI 10.1016/0022-2836(91)80076-7; Stratikos E, 1997, P NATL ACAD SCI USA, V94, P453, DOI 10.1073/pnas.94.2.453; Stratikos E, 1999, P NATL ACAD SCI USA, V96, P4808, DOI 10.1073/pnas.96.9.4808; VANDERMEER BW, 1991, RESONANCE ENERGY TRA; Verdaguer N, 2004, NAT STRUCT MOL BIOL, V11, P429, DOI 10.1038/nsmb753; Xu X, 2012, J MOL BIOL, V416, P629, DOI 10.1016/j.jmb.2011.12.058; Yasui N, 2010, STRUCTURE, V18, P320, DOI 10.1016/j.str.2010.01.010	46	11	11	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					800	812		10.1074/jbc.M115.688820	http://dx.doi.org/10.1074/jbc.M115.688820			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26555266	hybrid, Green Published			2022-12-26	WOS:000367830500027
J	Williams, TL; Yin, YHW; Carter, CW				Williams, Tishan L.; Yin, Yuhui W.; Carter, Charles W., Jr.			Selective Inhibition of Bacterial Tryptophanyl-tRNA Synthetases by Indolmycin Is Mechanism-based	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aminoacyl-tRNA synthetase; enzyme catalysis; enzyme inhibitor; inhibition mechanism; x-ray crystallography; inhibition; thermofluor; inhibition by ground-state stabilization	CRYSTAL-STRUCTURE; MG2+-ASSISTED CATALYSIS; BACILLUS-SUBTILIS; BINDING; ACTIVATION; TRPRS; ACID; STOICHIOMETRY; RECOGNITION; RESISTANCE	Indolmycin is a natural tryptophan analog that competes with tryptophan for binding to tryptophanyl-tRNA synthetase (TrpRS) enzymes. Bacterial and eukaryotic cytosolic TrpRSs have comparable affinities for tryptophan (K-m approximate to 2 m), and yet only bacterial TrpRSs are inhibited by indolmycin. Despite the similarity between these ligands, Bacillus stearothermophilus (Bs)TrpRS preferentially binds indolmycin approximate to 1500-fold more tightly than its tryptophan substrate. Kinetic characterization and crystallographic analysis of BsTrpRS allowed us to probe novel aspects of indolmycin inhibitory action. Previous work had revealed that long range coupling to residues within an allosteric region called the D1 switch of BsTrpRS positions the Mg2+ ion in a manner that allows it to assist in transition state stabilization. The Mg2+ ion in the inhibited complex forms significantly closer contacts with non-bridging oxygen atoms from each phosphate group of ATP and three water molecules than occur in the (presumably catalytically competent) pre-transition state (preTS) crystal structures. We propose that this altered coordination stabilizes a ground state Mg(2+)ATP configuration, accounting for the high affinity inhibition of BsTrpRS by indolmycin. Conversely, both the ATP configuration and Mg2+ coordination in the human cytosolic (H-c)TrpRS preTS structure differ greatly from the BsTrpRS preTS structure. The effect of these differences is that catalysis occurs via a different transition state stabilization mechanism in H(c)TrpRS with a yet-to-be determined role for Mg2+. Modeling indolmycin into the tryptophan binding site points to steric hindrance and an inability to retain the interactions used for tryptophan substrate recognition as causes for the 1000-fold weaker indolmycin affinity to H(c)TrpRS.	[Williams, Tishan L.; Carter, Charles W., Jr.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Yin, Yuhui W.] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Texas Medical Branch Galveston	Williams, TL (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	tishan.williams@gmail.com			National Institutes of Health through the NIGMS [GM90406]; NIGMS diversity supplement; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078227, R01GM110591, R01GM090406] Funding Source: NIH RePORTER	National Institutes of Health through the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS diversity supplement; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM90406 through the NIGMS (to C. W. C.) and an NIGMS diversity supplement (to T. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ali K., 2002, THESIS; CALVIN M, 1959, J AM CHEM SOC, V81, P5048, DOI 10.1021/ja01528a009; Cleland WW, 1999, METHOD ENZYMOL, V308, P3; Doublie S., 1993, THESIS; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P1, DOI 10.1021/bi00672a001; Francklyn CS, 2008, METHODS, V44, P100, DOI 10.1016/j.ymeth.2007.09.007; Gangjee A, 1996, J MED CHEM, V39, P1438, DOI 10.1021/jm950786p; Hurdle JG, 2004, J ANTIMICROB CHEMOTH, V54, P549, DOI 10.1093/jac/dkh352; Ilyin VA, 2000, PROTEIN SCI, V9, P218; Institute SAS, 2013, JMP STAT DISC SOFTW; JENCKS WP, 1981, P NATL ACAD SCI-BIOL, V78, P4046, DOI 10.1073/pnas.78.7.4046; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kanamaru T, 2001, ANTIMICROB AGENTS CH, V45, P2455, DOI 10.1128/AAC.45.9.2455-2459.2001; Kitabatake M, 2002, J BIOL CHEM, V277, P23882, DOI 10.1074/jbc.M202639200; KONRAD I, 1977, FEBS LETT, V83, P341, DOI 10.1016/0014-5793(77)81037-5; Laowanapiban P, 2009, P NATL ACAD SCI USA, V106, P1790, DOI 10.1073/pnas.0812752106; Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v; Nakama T, 2001, J BIOL CHEM, V276, P47387, DOI 10.1074/jbc.M109089200; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; OGILVIE A, 1975, BIOCHEM J, V152, P511, DOI 10.1042/bj1520511; Retailleau P, 2003, J MOL BIOL, V325, P39, DOI 10.1016/S0022-2836(02)01156-7; Retailleau P, 2001, ACTA CRYSTALLOGR D, V57, P1595, DOI 10.1107/S090744490101215X; Retailleau P, 2007, J MOL BIOL, V369, P108, DOI 10.1016/j.jmb.2007.01.091; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shen N, 2008, NUCLEIC ACIDS RES, V36, P1288, DOI 10.1093/nar/gkm1153; Smith C, 1999, CARDIOVASC DRUG THER, V13, P123, DOI 10.1023/A:1007784109255; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; SUTHERLAND R, 1985, ANTIMICROB AGENTS CH, V27, P495, DOI 10.1128/AAC.27.4.495; Vecchione JJ, 2009, ANTIMICROB AGENTS CH, V53, P3972, DOI 10.1128/AAC.00723-09; WEBER PC, 1992, J AM CHEM SOC, V114, P3197, DOI 10.1021/ja00035a004; Weinreb V, 2012, STRUCTURE, V20, P128, DOI 10.1016/j.str.2011.10.020; Weinreb V, 2009, STRUCTURE, V17, P952, DOI 10.1016/j.str.2009.05.007; WERNER RG, 1976, EUR J BIOCHEM, V68, P1, DOI 10.1111/j.1432-1033.1976.tb10758.x; WERNER RG, 1979, ARZNEIMITTEL-FORSCH, V29-1, P59; Yang XL, 2007, STRUCTURE, V15, P793, DOI 10.1016/j.str.2007.05.009; Yang XL, 2003, P NATL ACAD SCI USA, V100, P15376, DOI 10.1073/pnas.2136794100; Yin Y., 1995, THESIS; Yu YD, 2004, J BIOL CHEM, V279, P8378, DOI 10.1074/jbc.M311284200; Zhou MY, 2010, NUCLEIC ACIDS RES, V38, P3399, DOI 10.1093/nar/gkp1254	41	28	30	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					255	265		10.1074/jbc.M115.690321	http://dx.doi.org/10.1074/jbc.M115.690321			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26555258	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000367589500020
J	Guan, HY; Wang, J; Wang, CR; Yang, MJ; Liu, LZ; Yang, GL; Ma, XJ				Guan, Hengyun; Wang, Ji; Wang, Chunrong; Yang, Mengjie; Liu, Lanzheng; Yang, Guoliang; Ma, Xuejun			Etiology of Multiple Non-EV71 and Non-CVA16 Enteroviruses Associated with Hand, Foot and Mouth Disease in Jinan, China, 2009-June 2013	PLOS ONE			English	Article							COXSACKIEVIRUS A6; INFECTIONS; OUTBREAK; PCR	Hand, foot, and mouth disease (HFMD) is an infectious disease caused by human enterovirus 71 (EV71), coxsackievirus A16 (CVA16) and other enteroviruses. It is of interest that other enteroviruses associated with HFMD in Jinan have been rarely reported. The aim of the present study is to detect and characterize the circulating serotypes of non-EV71 and non-CVA16 enteroviruses associated with HFMD in Jinan city, Shandong province, China. A total of 400 specimens were collected from clinically diagnosed HFMD cases in Jinan from January 2009 to June 2013. All specimens were infected with non-EV71 and non-CVA16 enteroviruses previously confirmed by RT-PCR or real-time PCR according to the protocols at that time. The GeXP-based multiplex RT-PCR assay (GeXP assay) was performed to investigate the pathogen spectrum of 15 enteroviruses (coxsackieviruses A4, A5, A6, A9, A10, A16; coxsackieviruses B1, B3, B5; Echoviruses 6, 7, 11, 13, 19 and EV71) infections associated with HMFD. For GeXP assay negative samples, reverse transcription nested PCR (nested RT-PCR) based on the 5'-untranslated region (5'-UTR) sequence and phylogenetic analysis were conducted to further explore the etiology of multiple enteroviruses. The results showed that a total of twenty serotypes of enteroviruses (including EV71 and CVA16) were identified by GeXP assay and nested RT-PCR. The most circulating twelve serotypes of enteroviruses with HFMD in Jinan from 2009 to June 2013 were EV71, CVA16, CVA10, CVA6, CVA12, CVA2, Echo3, CVA4, CVA9, CVB1, CVB3 and Echo6. CVA10 and CVA6 were the most prevalent pathogens other than EV71 and CVA16 in Jinan and their most prevalent seasons were spring and summer, and a slight increase was observed in autumn and early winter. It should be noted that mixed-infections were identified by GeXP assay and the phylogenetic tree clearly discriminated the multiple pathogens associated with HFMD. Our results thus demonstrate that there was a clear lack of a reliable testing method for EV71 and CVA16 and multiple non-EV71 and non-CVA16 enteroviruses associated with HFMD were present in Jinan. The GeXP assay combined with nested RT-PCR based on 5'-UTR region could meet the need for the national surveillance of multiple enteroviruses or the investigation of epidemic outbreaks triggered by enteroviruses in the future.	[Guan, Hengyun; Wang, Chunrong; Liu, Lanzheng; Yang, Guoliang] Jinan Municipal Ctr Dis Control & Prevent, Viral Dis Inspect Lab, Jinan, Peoples R China; [Wang, Ji; Yang, Mengjie; Ma, Xuejun] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Key Lab Med Virol, Minist Hlth, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Liu, LZ (corresponding author), Jinan Municipal Ctr Dis Control & Prevent, Viral Dis Inspect Lab, Jinan, Peoples R China.	jncdcllz@163.com; maxj@ivdc.chinacdc.cn	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257	Shandong medicine and health science technology development project [2011HW009]; China Mega-Project for Infectious Disease [2013ZX10004-001, 2012ZX10004-215, 2013ZX10004-202, 2014ZX10004002-004]	Shandong medicine and health science technology development project; China Mega-Project for Infectious Disease	This work was supported by the Shandong medicine and health science technology development project [2011HW009] and China Mega-Project for Infectious Disease [2013ZX10004-001, 2012ZX10004-215, 2013ZX10004-202, and 2014ZX10004002-004]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bracho MA, 2011, EMERG INFECT DIS, V17, P2223, DOI 10.3201/eid1712.110395; Di B, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-157; Fang QY, 2013, ARCH VIROL, V158, P895, DOI 10.1007/s00705-012-1566-6; FLEWETT TH, 1963, J CLIN PATHOL, V16, P53, DOI 10.1136/jcp.16.1.53; Ge SX, 2013, J VIROL METHODS, V193, P463, DOI 10.1016/j.jviromet.2013.06.009; Guan HengYun, 2013, Journal of Shandong University (Health Sciences), V51, P101; He FengLan, 2013, Disease Surveillance, V28, P905; Hu XM, 2012, J CLIN MICROBIOL, V50, P288, DOI 10.1128/JCM.05828-11; KAMAHORA T, 1985, J GEN VIROL, V66, P2627, DOI 10.1099/0022-1317-66-12-2627; Lee Dong Seong, 2015, Korean J Pediatr, V58, P112, DOI 10.3345/kjp.2015.58.3.112; Li J, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-189; LIU LZ, 2012, CHIN J EPIDEMIOL, V33, P658, DOI [10.3760/cma.j.issn.0254-6450.201207.026, DOI 10.3760/CMA.J.ISSN.0254-6450.201207.026]; Liu XL, 2014, ARCH VIROL, V159, P2497, DOI 10.1007/s00705-014-2067-6; Lu QB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052073; Mirand A, 2012, CLIN MICROBIOL INFEC, V18, pE110, DOI 10.1111/j.1469-0691.2012.03789.x; Osterback R, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01004-14; Pan Hao, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P339; Repass GL, 2014, CLEV CLIN J MED, V81, P537, DOI 10.3949/ccjm.81a.13132; Tian HF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084233; Wei SH, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-346; Wu HX, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24664; Wu Y, 2010, INT J INFECT DIS, V14, pE1076, DOI 10.1016/j.ijid.2010.07.006; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Yan XF, 2012, SCAND J INFECT DIS, V44, P297, DOI 10.3109/00365548.2011.634433; Yang MJ, 2012, J MED VIROL, V84, P957, DOI 10.1002/jmv.23275; Yao X, 2015, ARCH VIROL, V160, P1291, DOI 10.1007/s00705-015-2350-1; [张伟 Zhang Wei], 2011, [中国全科医学, Chinese General Practice], V14, P3341; ZHANG XL, 2011, J MICROBES INFECT, V6, P214, DOI [10.3969/j.issn.1673-6184.2011.04.004, DOI 10.3969/J.ISSN.1673-6184.2011.04.004]	28	38	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142733	10.1371/journal.pone.0142733	http://dx.doi.org/10.1371/journal.pone.0142733			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562154	Green Published, gold, Green Submitted			2022-12-26	WOS:000364480900060
J	Scholz, NB; Bolund, L; Nyegaard, M; Faaborg, L; Jorgensen, MW; Lund, H; Niemann, I; Sunde, L				Scholz, Nanna Brink; Bolund, Lars; Nyegaard, Mette; Faaborg, Louise; Jorgensen, Mette Warming; Lund, Helle; Niemann, Isa; Sunde, Lone			Triploidy-Observations in 154 Diandric Cases	PLOS ONE			English	Article							PARTIAL HYDATIDIFORM MOLES; GESTATIONAL TROPHOBLASTIC DISEASE; PARENTAL ORIGIN; DIAGNOSIS; ASSOCIATION; FEATURES; MOSAICISM; CHILD; RISK	Hydatidiform moles (HMs) are abnormal human pregnancies with vesicular chorionic villi, imposing two clinical challenges; miscarriage and a risk of gestational trophoblastic neoplasia (GTN). The parental type of most HMs are either diandric diploid (PP) or diandric triploid (PPM). We consecutively collected 154 triploid or near-triploid samples from conceptuses with vesicular chorionic villi. We used analysis of DNA markers and/or methylation sensitive-MLPA and collected data from registries and patients records. We performed whole genome SNP analysis of one case of twinning (PP+PM). In all 154 triploids or near-triploids we found two different paternal contributions to the genome (P1P2M). The ratios between the sex chromosomal constitutions XXX, XXY, and XYY were 5.7: 6.9: 1.0. No cases of GTN were observed. Our results corroborate that all triploid human conceptuses with vesicular chorionic villi have the parental type P1P2M. The sex chromosomal ratios suggest approximately equal frequencies of meiosis I and meiosis II errors with selection against the XYY conceptuses or a combination of dispermy, non-disjunction in meiosis I and meiosis II and selection against XYY conceptuses. Although single cases of GTN after a triploid HM have been reported, the results of this study combined with data from previous prospective studies estimate the risk of GTN after a triploid mole to 0% (95% CI: 0-1,4%).	[Scholz, Nanna Brink; Bolund, Lars; Nyegaard, Mette; Sunde, Lone] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Bolund, Lars] Beijing Genom Inst HuaDa Shenzhen, Shenzhen, Peoples R China; [Faaborg, Louise] Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus, Denmark; [Jorgensen, Mette Warming] Aarhus Univ Hosp, Inst Pathol, DK-8000 Aarhus, Denmark; [Lund, Helle] Aalborg Univ Hosp, Inst Pathol, Aalborg, Denmark; [Niemann, Isa] Aarhus Univ Hosp, Dept Gynecol & Obstet, DK-8000 Aarhus, Denmark; [Sunde, Lone] Aarhus Univ Hosp, Dept Clin Genet, DK-8000 Aarhus, Denmark	Aarhus University; Beijing Genomics Institute (BGI); Aarhus University; Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University; Aarhus University	Scholz, NB (corresponding author), Aarhus Univ, Dept Biomed, Aarhus, Denmark.	nannabrinkgade@gmail.com	Faaborg, Louise/AAE-6095-2019; Sunde, Lone/AAG-7303-2019; Nyegaard, Mette/M-3379-2019	Faaborg, Louise/0000-0002-9630-9648; Sunde, Lone/0000-0002-8479-165X; Nyegaard, Mette/0000-0003-4973-8543	Speciallaege Heinrich Kopps Legat; Fonden til Laegevidenskabens Fremme; SparNord Fonden; Herta Christensens Fond; Aarhus Universitets Forskningsfond	Speciallaege Heinrich Kopps Legat; Fonden til Laegevidenskabens Fremme; SparNord Fonden; Herta Christensens Fond; Aarhus Universitets Forskningsfond	This study was in part funded by "Speciallaege Heinrich Kopps Legat," "Fonden til Laegevidenskabens Fremme," "SparNord Fonden," "Herta Christensens Fond," and "Aarhus Universitets Forskningsfond." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumer A, 2000, EUR J HUM GENET, V8, P911, DOI 10.1038/sj.ejhg.5200572; Bifuleo C, 2008, AM J SURG PATHOL, V32, P445, DOI 10.1097/PAS.0b013e3181520034; Buza N, 2013, INT J GYNECOL PATHOL, V32, P307, DOI 10.1097/PGP.0b013e3182626011; Cheung ANY, 2004, CANCER-AM CANCER SOC, V100, P1411, DOI 10.1002/cncr.20107; FRANKE HR, 1983, OBSTET GYNECOL, V62, P613; Fukunaga M, 2005, AM J SURG PATHOL, V29, P942, DOI 10.1097/01.pas.0000157996.23059.c1; Golubovsky MD, 2003, HUM REPROD, V18, P236, DOI 10.1093/humrep/deg060; Hoffner L, 2012, CANCER GENET-NY, V205, P63, DOI 10.1016/j.cancergen.2012.01.004; JACOBS PA, 1980, NATURE, V286, P714, DOI 10.1038/286714a0; JACOBS PA, 1978, ANN HUM GENET, V42, P49, DOI 10.1111/j.1469-1809.1978.tb00930.x; Joergensen MW, 2013, PRENATAL DIAG, V33, P1131, DOI 10.1002/pd.4206; Joergensen MW, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.039; Joergensen MW, 2014, J ASSIST REPROD GEN, V31, P435, DOI 10.1007/s10815-014-0178-3; Kaneki E, 2010, CANCER SCI, V101, P1717, DOI 10.1111/j.1349-7006.2010.01602.x; Kang WD, 2012, GYNECOL ONCOL, V124, P250, DOI 10.1016/j.ygyno.2011.10.035; KOVACS BW, 1991, CANCER GENET CYTOGEN, V54, P143, DOI 10.1016/0165-4608(91)90202-6; LAWLER SD, 1991, AM J OBSTET GYNECOL, V164, P1270, DOI 10.1016/0002-9378(91)90698-Q; Lipata F, 2010, OBSTET GYNECOL, V115, P784, DOI 10.1097/AOG.0b013e3181d489ec; Makrydimas G, 2002, HUM REPROD, V17, P2459, DOI 10.1093/humrep/17.9.2459; McConnell TG, 2009, AM J SURG PATHOL, V33, P805, DOI 10.1097/PAS.0b013e318191f309; McFadden DE, 2002, HUM REPROD, V17, P3037, DOI 10.1093/humrep/17.12.3037; McWeeney DT, 2009, AM J PERINAT, V26, P641, DOI 10.1055/s-0029-1220794; Murphy KM, 2009, J MOL DIAGN, V11, P598, DOI 10.2353/jmoldx.2009.090039; Nagy ZP, 2000, MOL CELL ENDOCRINOL, V166, P59, DOI 10.1016/S0303-7207(00)00298-7; Narkuti V, 2008, CLIN CHIM ACTA, V395, P162, DOI 10.1016/j.cca.2008.04.022; Narkuti V, 2007, CLIN CHIM ACTA, V381, P171, DOI 10.1016/j.cca.2007.01.032; Nguyen-Nielsen Mary, 2013, Clin Epidemiol, V5, P249, DOI 10.2147/CLEP.S45228; Niemann I, 2008, HUM REPROD, V23, P2031, DOI 10.1093/humrep/den226; Niemann I, 2007, GYNECOL ONCOL, V104, P411, DOI 10.1016/j.ygyno.2006.08.025; OHAMA K, 1986, OBSTET GYNECOL, V68, P259; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sebire NJ, 2010, FETAL PEDIATR PATHOL, V29, P1, DOI [10.3109/5513810903266138, 10.3109/15513810903266138]; Seckl MJ, 2000, LANCET, V356, P36, DOI 10.1016/S0140-6736(00)02432-6; SUNDE L, 1989, CANCER GENET CYTOGEN, V37, P179, DOI 10.1016/0165-4608(89)90047-2; Sunde L, 2011, EUR J HUM GENET, V19, P1026, DOI 10.1038/ejhg.2011.93; SZULMAN AE, 1981, HUM PATHOL, V12, P1016, DOI 10.1016/S0046-8177(81)80259-6; UCHIDA IA, 1985, AM J OBSTET GYNECOL, V151, P65, DOI 10.1016/0002-9378(85)90426-0; Zaragoza MV, 2000, AM J HUM GENET, V66, P1807, DOI 10.1086/302951	38	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142545	10.1371/journal.pone.0142545	http://dx.doi.org/10.1371/journal.pone.0142545			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562155	Green Published, Green Submitted, gold			2022-12-26	WOS:000364480900042
J	Squires, AH; Atas, E; Meller, A				Squires, Allison H.; Atas, Evrim; Meller, Amit			Genomic Pathogen Typing Using Solid-State Nanopores	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; STAPHYLOCOCCUS-AUREUS; DNA TRANSLOCATION; SEQUENCE; TRANSPORT; STRAINS; MRSA	In clinical settings, rapid and accurate characterization of pathogens is essential for effective treatment of patients; however, subtle genetic changes in pathogens which elude traditional phenotypic typing may confer dangerous pathogenic properties such as toxicity, antibiotic resistance, or virulence. Existing options for molecular typing techniques characterize the critical genomic changes that distinguish harmful and benign strains, yet the wellestablished approaches, in particular those that rely on electrophoretic separation of nucleic acid fragments on a gel, have room for only incremental future improvements in speed, cost, and complexity. Solid-state nanopores are an emerging class of single-molecule sensors that can electrophoretically characterize charged biopolymers, and which offer significant advantages in terms of sample and reagent requirements, readout speed, parallelization, and automation. We present here the first application of nanopores for single- molecule molecular typing using length based "fingerprints" of critical sites in bacterial genomes. This technique is highly adaptable for detection of different types of genetic variation; as we illustrate using prototypical examples including Mycobacterium tuberculosis and methicillin-resistant Streptococcus aureus, the solid-state nanopore diagnostic platform may be used to detect large insertions or deletions, small insertions or deletions, and even single-nucleotide variations in bacterial DNA. We further show that Bayesian classification of test samples can provide highly confident pathogen typing results based on only a few tens of independent single-molecule events, making this method extremely sensitive and statistically robust.	[Squires, Allison H.; Atas, Evrim; Meller, Amit] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Meller, Amit] Technion Israel Inst Technol, Dept Biomed Engn, IL-32000 Haifa, Israel	Boston University; Technion Israel Institute of Technology	Meller, A (corresponding author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.	ameller@bm.technion.ac.il		Meller, Amit/0000-0001-7082-0985	National Institutes of Health (NHGRI) [R01 HG-005871]; National Institutes of Health (NIBIB) [R21 EB017377]; Israeli Centers of Research Excellence (I-CORE) program [1902/12]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005871] Funding Source: NIH RePORTER	National Institutes of Health (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Israeli Centers of Research Excellence (I-CORE) program; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study was supported by the National Institutes of Health (NHGRI grant no. R01 HG-005871 and NIBIB R21 EB017377) and from the Israeli Centers of Research Excellence (I-CORE) program (Center #1902/12).; We thank Tal Gilboa for useful comments on the manuscript and Sanford Squires for helpful discussions regarding the numerical simulations. We are grateful for financial support from the National Institutes of Health (NHGRI grant no. R01 HG-005871 and NIBIB grant no. R21 EB017377), and from the Israeli Centers of Research Excellence (I-CORE) program (Center #1902/12). We also thank the staff at the Harvard University Center for Nanoscale Sciences (CNS) and the Boston University Photonics Center Optoelectronic Processing Facility for their support.	Anderson BN, 2014, ACS NANO, V8, P11836, DOI 10.1021/nn505545h; Carson S, 2014, BIOPHYS J, V107, P2381, DOI 10.1016/j.bpj.2014.10.017; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Duda R.O., 2000, PATTERN CLASSIFICATI; Dunne WM, 2012, EUR J CLIN MICROBIOL, V31, P1719, DOI 10.1007/s10096-012-1641-7; FERRERO L, 1995, ANTIMICROB AGENTS CH, V39, P1554, DOI 10.1128/AAC.39.7.1554; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Gutacker MM, 2006, J INFECT DIS, V193, P121, DOI 10.1086/498574; Highlander SK, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-99; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Kim MJ, 2006, ADV MATER, V18, P3149, DOI 10.1002/adma.200601191; Larkin J, 2013, ACS NANO, V7, P10121, DOI 10.1021/nn404326f; Li M, 2012, NAT MED, V18, P816, DOI 10.1038/nm.2692; Lindsay JA, 2013, INT J MED MICROBIOL, V303, P318, DOI 10.1016/j.ijmm.2013.02.005; Lu LD, 2010, J BIOL CHEM, V285, P28076, DOI 10.1074/jbc.M109.088872; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Mohammad Mohammad M, 2012, Methods Mol Biol, V870, P21, DOI 10.1007/978-1-61779-773-6_2; Nir I, 2015, BIOPHYS J, V108, P2340, DOI 10.1016/j.bpj.2015.03.025; Plesa C, 2013, NANO LETT, V13, P658, DOI 10.1021/nl3042678; Sambrook J., 2001, MOL CLONING LAB MANU; Singer A, 2012, NANO LETT, V12, P1722, DOI 10.1021/nl300372a; Storm AJ, 2005, NANO LETT, V5, P1193, DOI 10.1021/nl048030d; Wanunu M, 2008, BIOPHYS J, V95, P4716, DOI 10.1529/biophysj.108.140475; Wanunu M, 2010, NAT NANOTECHNOL, V5, P160, DOI [10.1038/nnano.2009.379, 10.1038/NNANO.2009.379]; Wanunu M, 2009, NANO LETT, V9, P3498, DOI 10.1021/nl901691v; Wu J, 2007, CELL MOL LIFE SCI, V64, P2933, DOI 10.1007/s00018-007-7206-8; Yusko EC, 2012, ACS NANO, V6, P5909, DOI 10.1021/nn300542q; Zheng HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002375	30	16	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142944	10.1371/journal.pone.0142944	http://dx.doi.org/10.1371/journal.pone.0142944			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562833	Green Published, gold, Green Submitted			2022-12-26	WOS:000364480900084
J	Colquhoun, JM; Wozniak, RAF; Dunman, PM				Colquhoun, Jennifer M.; Wozniak, Rachel A. F.; Dunman, Paul M.			Clinically Relevant Growth Conditions Alter Acinetobacter baumannii Antibiotic Susceptibility and Promote Identification of Novel Antibacterial Agents	PLOS ONE			English	Article							IN-VITRO; RESISTANCE; OUTCOMES	Biological processes that govern bacterial proliferation and survival in the host-environment (s) are likely to be vastly different from those that are required for viability in nutrient-rich laboratory media. Consequently, growth-based antimicrobial screens performed in conditions modeling aspects of bacterial disease states have the potential to identify new classes of antimicrobials that would be missed by screens performed in conventional laboratory media. Accordingly, we performed screens of the Selleck library of 853 FDA approved drugs for agents that exhibit antimicrobial activity toward the Gram-negative bacterial pathogen Acinetobacter baumannii during growth in human serum, lung surfactant, and/or the organism in the biofilm state and compared those results to that of conventional laboratory medium. Results revealed that a total of 90 compounds representing 73 antibiotics and 17 agents that were developed for alternative therapeutic indications displayed antimicrobial properties toward the test strain in at least one screening condition. Of the active library antibiotics only four agents, rifampin, rifaximin, ciprofloxacin and tetracycline, exhibited antimicrobial activity toward the organism during all screening conditions, whereas the remainder were inactive in >= 1 condition; 56 antibiotics were inactive during serum growth, 25 and 38 were inactive toward lung surfactant grown and biofilm-associated cells, respectively, suggesting that subsets of antibiotics may outperform others in differing infection settings. Moreover, 9 antibiotics that are predominantly used for the treatment Gram-positive pathogens and 10 non-antibiotics lacked detectable antimicrobial activity toward A. baumannii grown in conventional medium but were active during >= 1 alternative growth condition( s). Such agents may represent promising anti-Acinetobacter agents that would have likely been overlooked by antimicrobial whole cell screening assays performed in traditional laboratory screening media.	[Colquhoun, Jennifer M.; Dunman, Paul M.] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Wozniak, Rachel A. F.] Univ Rochester, Sch Med & Dent, Dept Ophthalmol, Flaum Eye Inst, Rochester, NY USA	University of Rochester; University of Rochester	Dunman, PM (corresponding author), Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	paul_dunman@urmc.rochester.edu	Wozniak, Rachel A F/Y-9717-2019	Wozniak, Rachel A F/0000-0002-2693-1394; Colquhoun, Jennifer/0000-0002-2659-2919	National Institute of Allergy and Infectious Diseases (NIAID) [AI103507, GM068411-11]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI118689, R01AI103507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM068411] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of Allergy and Infectious Diseases (NIAID) (http://www.niaid.nih.gov/researchfunding/Pages/default.aspx) Grant number AI103507 awarded to PMD and (https://researchtraining.nih.gov/programs/training-grants?CFID=5926611&CFTOKEN=10dd7bed435a38d1-3D3CA4AB-5056-9439-7EC3989DDD4F9913) Grant number GM068411-11 awarded to JMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhady W, 2013, ANTIMICROB AGENTS CH, V57, P1447, DOI 10.1128/AAC.02073-12; Antoszczak M, 2014, EUR J MED CHEM, V76, P435, DOI 10.1016/j.ejmech.2014.02.031; Blanchard C, 2014, ANTIMICROB AGENTS CH, V58, P6360, DOI 10.1128/AAC.03535-14; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Burnett BP, 2008, CUTIS, V82, P273; Bush K, 2011, NAT REV MICROBIOL, V9, P894, DOI 10.1038/nrmicro2693; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; del Pozo JL, 2007, CLIN PHARMACOL THER, V82, P204, DOI 10.1038/sj.clpt.6100247; Doi Y, 2009, EMERG INFECT DIS, V15, P980, DOI 10.3201/eid1506.081006; Fahnoe KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051732; FERGUSON CA, 1979, CAN J MICROBIOL, V25, P545, DOI 10.1139/m79-080; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Gajadeera C, 2015, J ANTIBIOT, V68, P153, DOI 10.1038/ja.2014.131; Garcia LG, 2013, J ANTIMICROB CHEMOTH, V68, P1455, DOI 10.1093/jac/dkt072; GILLASPY AF, 1995, INFECT IMMUN, V63, P3373, DOI 10.1128/IAI.63.9.3373-3380.1995; HOLLOWAY BW, 1986, ANNU REV MICROBIOL, V40, P79, DOI 10.1146/annurev.mi.40.100186.000455; Hood MI, 2010, ANTIMICROB AGENTS CH, V54, P1029, DOI 10.1128/AAC.00963-09; Jacobs AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085729; Jacobs AC, 2013, ANTIMICROB AGENTS CH, V57, P26, DOI 10.1128/AAC.01640-12; Jacobs AC, 2012, FEMS IMMUNOL MED MIC, V64, P403, DOI 10.1111/j.1574-695X.2011.00926.x; Jacobs AC, 2010, INFECT IMMUN, V78, P1952, DOI 10.1128/IAI.00889-09; Kruszewska Hanna, 2002, Acta Pol Pharm, V59, P436; Lee SA, 2015, P NATL ACAD SCI USA, V112, P5189, DOI 10.1073/pnas.1422186112; Mathur H, 2014, GUT MICROBES, V5, P696, DOI 10.4161/19490976.2014.983768; McGann P, 2014, MBIO, V5, DOI 10.1128/mBio.00915-14; MILLER AK, 1971, APPL MICROBIOL, V22, P480, DOI 10.1128/AEM.22.3.480-481.1971; Mizutani Y, 1997, ONCOL REP, V4, P909; Ng TM, 2014, INFECT CONT HOSP EP, V35, P49, DOI 10.1086/674387; Niederman MS, 2001, CRIT CARE MED, V29, pN114, DOI 10.1097/00003246-200104001-00011; Pomakova DK, 2012, EUR J CLIN MICROBIOL, V31, P981, DOI 10.1007/s10096-011-1396-6; Queenan AM, 2012, DIAGN MICR INFEC DIS, V73, P267, DOI 10.1016/j.diagmicrobio.2012.04.002; Rangel-Vega A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00282; Rice LB, 2008, J INFECT DIS, V197, P1079, DOI 10.1086/533452; Schmitz FJ, 1997, EUR J EPIDEMIOL, V13, P709, DOI 10.1023/A:1007338906923; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; Silverman JA, 2005, J INFECT DIS, V191, P2149, DOI 10.1086/430352; Umland TC, 2012, MBIO, V3, DOI 10.1128/mBio.00113-12; Yang HF, 2015, INFECT DIS-NOR, V47, P433, DOI 10.3109/00365548.2014.997284	39	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0143033	10.1371/journal.pone.0143033	http://dx.doi.org/10.1371/journal.pone.0143033			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558753	Green Published, Green Submitted, gold			2022-12-26	WOS:000364433100140
J	Golosio, B; Cangelosi, A; Gamotina, O; Masala, GL				Golosio, Bruno; Cangelosi, Angelo; Gamotina, Olesya; Masala, Giovanni Luca			A Cognitive Neural Architecture Able to Learn and Communicate through Natural Language	PLOS ONE			English	Article							DEVELOPMENT SURVEY LDS; LARGE-SCALE MODEL; WORKING-MEMORY; INTEGRATION; KNOWLEDGE; NETWORKS	Communicative interactions involve a kind of procedural knowledge that is used by the human brain for processing verbal and nonverbal inputs and for language production. Although considerable work has been done on modeling human language abilities, it has been difficult to bring them together to a comprehensive tabula rasa system compatible with current knowledge of how verbal information is processed in the brain. This work presents a cognitive system, entirely based on a large-scale neural architecture, which was developed to shed light on the procedural knowledge involved in language elaboration. The main component of this system is the central executive, which is a supervising system that coordinates the other components of the working memory. In our model, the central executive is a neural network that takes as input the neural activation states of the short-term memory and yields as output mental actions, which control the flow of information among the working memory components through neural gating mechanisms. The proposed system is capable of learning to communicate through natural language starting from tabula rasa, without any a priori knowledge of the structure of phrases, meaning of words, role of the different classes of words, only by interacting with a human through a text-based interface, using an open-ended incremental learning process. It is able to learn nouns, verbs, adjectives, pronouns and other word classes, and to use them in expressive language. The model was validated on a corpus of 1587 input sentences, based on literature on early language assessment, at the level of about 4-years old child, and produced 521 output sentences, expressing a broad range of language processing functionalities.	[Golosio, Bruno; Gamotina, Olesya; Masala, Giovanni Luca] Univ Sassari, POLCOMING Dept, Sect Engn & Informat Technol, I-07100 Sassari, Italy; [Cangelosi, Angelo] Univ Plymouth, Sch Comp & Math, Ctr Robot & Neural Syst, Plymouth PL4 8AA, Devon, England	University of Sassari; University of Plymouth	Golosio, B (corresponding author), Univ Sassari, POLCOMING Dept, Sect Engn & Informat Technol, I-07100 Sassari, Italy.	golosio@uniss.it	Cangelosi, Angelo/D-6784-2011	Cangelosi, Angelo/0000-0002-4709-2243; masala, giovanni/0000-0001-6734-9424; Golosio, Bruno/0000-0001-5144-6932	Regione Autonoma della Sardegna [O. P. FSE 2007-2012 L.R.7/2007]; United Kingdom, Engineering and Physical Sciences Research Council, BABEL project; European Community, Seventh Framework Programme, POETICON++ project; EPSRC [EP/J004561/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/J004561/1] Funding Source: researchfish	Regione Autonoma della Sardegna(Regione Sardegna); United Kingdom, Engineering and Physical Sciences Research Council, BABEL project; European Community, Seventh Framework Programme, POETICON++ project; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This study was supported by Regione Autonoma della Sardegna, O. P. FSE 2007-2012 L.R.7/2007, BG, GLM; United Kingdom, Engineering and Physical Sciences Research Council, BABEL project, AC; European Community, Seventh Framework Programme, POETICON++ project, AC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthanarayanan R., 2007, P 2007 ACM IEEE C SU, P1, DOI DOI 10.1145/1362622.1362627; [Anonymous], 2013, P C EMP METH NAT LAN; [Anonymous], 1998, NEURAL NETWORKS COMP; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; Bryck RL, 2005, MEM COGNITION, V33, P611, DOI 10.3758/BF03195328; Cangelosi A., 2015, DEV ROBOTICS BABIES; Cangelosi A, 2010, IEEE T AUTON MENT DE, V2, P167, DOI 10.1109/TAMD.2010.2053034; CAPLAN D, 1985, COGNITION, V21, P117, DOI 10.1016/0010-0277(85)90048-4; Chomsky Noam, 1959, INFORM CONTR, V2, DOI [10.1016/S0019-9958(59)90362-6, DOI 10.1016/S0019-9958(59)90362-6]; Cowan N., 1995, ATTENTION MEMORY INT; Deryugina OV, 2010, SCI TECH INF PROCESS, V37, P143, DOI 10.3103/S0147688210020097; Devlin JT, 2003, J COGNITIVE NEUROSCI, V15, P71, DOI 10.1162/089892903321107837; Dominey PE, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00500; Dominey PF, 2005, ARTIF INTELL, V167, P31, DOI 10.1016/j.artint.2005.06.007; Duch W, 2008, FRONT ARTIF INTEL AP, V171, P122; Eliasmith C, 2012, SCIENCE, V338, P1202, DOI 10.1126/science.1225266; ELMAN JL, 1991, MACH LEARN, V7, P195, DOI 10.1007/BF00114844; Fidelman P, 2005, P 27 ANN M COGN SCI; Fodor J. A., 1975, LANGUAGE THOUGHT; Fodor J. A., 2010, LOT2 LANGUAGE THOUGH; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Gisiger T, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00001; Hagoort P, 2004, SCIENCE, V304, P438, DOI 10.1126/science.1095455; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; Hebb Donald O., 1949, ORG BEHAV; Hinaut X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052946; Izhikevich EM, 2008, P NATL ACAD SCI USA, V105, P3593, DOI 10.1073/pnas.0712231105; Jurafsky D., 2009, SPEECH LANGUAGE PROC; Kieras DE, 1997, HUM-COMPUT INTERACT, V12, P391, DOI 10.1207/s15327051hci1204_4; LAIRD JE, 1987, ARTIF INTELL, V33, P1, DOI 10.1016/0004-3702(87)90050-6; LANGLEY P, 2005, 2005 IEEEW INT C, P18; Langley P, 2009, COGN SYST RES, V10, P141, DOI 10.1016/j.cogsys.2006.07.004; MacWhinney B., 2000, CHILDES PROJECT, V2; McClelland J. L., 1986, PARALLEL DISTRIBUTED, V2; McElree B, 2001, J EXP PSYCHOL LEARN, V27, P817, DOI 10.1037/0278-7393.27.3.817; MIIKKULAINEN R, 1995, APPL INTELL, V5, P137, DOI 10.1007/BF00877229; Miikkulainen R, 1993, SUBSYMBOLIC NATURAL; Mikolov T, 2012, IEEE W SP LANG TECH, P234, DOI 10.1109/SLT.2012.6424228; Morse AF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116012; Newell A., 1990, UNIFIED THEORIES COG; O'reilly R.C., 2000, COMPUTATIONAL EXPLOR; Oberauer K, 2002, J EXP PSYCHOL LEARN, V28, P411, DOI 10.1037//0278-7393.28.3.411; Rescorla L, 2002, J SPEECH LANG HEAR R, V45, DOI 10.1044/1092-4388(2002/059); Rescorla L, 2001, J SPEECH LANG HEAR R, V44, P434, DOI 10.1044/1092-4388(2001/035); Roy D, 2005, ARTIF INTELL, V167, P1, DOI 10.1016/j.artint.2005.06.002; Socher R., 2013, P 51 ANN M ASS COMP, P455; Socher R, 2011, INT C MACHINE LEARNI; Sutskever I, 2014, ADV NEUR IN, V27; Vandierendonck A, 2012, PSYCHOL BELG, V52, P229, DOI 10.5334/pb-52-2-3-229; Warren-Leubecker A., 1982, THESIS; WARRENLEUBECKER A, 1984, CHILD DEV, V55, P1379, DOI 10.2307/1130007	54	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0140866	10.1371/journal.pone.0140866	http://dx.doi.org/10.1371/journal.pone.0140866			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7DR	26560154	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000364433100011
J	Graziani, C; Luzzi, I; Owczarek, S; Dionisi, AM; Busani, L				Graziani, Caterina; Luzzi, Ida; Owczarek, Slawomir; Dionisi, Anna Maria; Busani, Luca			Salmonella enterica Serovar Napoli Infection in Italy from 2000 to 2013: Spatial and Spatio-Temporal Analysis of Cases Distribution and the Effect of Human and Animal Density on the Risk of Infection	PLOS ONE			English	Article								Background Salmonella Napoli is uncommon in Europe. In Italy however, it has been growing in importance since 2000. To date, no risk factors have been identified to account for its rise. This study aims at describing the epidemiology, spatial and spatio-temporal patterns of S. Napoli in Italy from 2000 to 2013, and to explore the role of several environmental correlates, namely urbanization, altitude and number of livestock farms, on the risk of S. Napoli infection among humans. Method Data were obtained from Enter-Net Italy, a network of diagnostic laboratories. The data were aggregated at the municipality level. Descriptive epidemiology, multivariate regression models, spatial and spatio-temporal analyses were performed on the number of cases and incidence rates. Results S. Napoli showed an expanding trend at the national level, and an increasing number of cases. Compared to the other main serovars in Italy, the risk of S. Napoli infection was higher in the age group <1 year, and lower in the other age groups. Although urbanization and the number of farms were associated with the risk of S. Napoli infection to some extent, their role in the epidemiology of the disease remains inconclusive. S. Napoli cases showed a positive global spatial autocorrelation as well as a significant spatio-temporal interaction. Twenty-four spatial and spatio-temporal clusters were identified, seven purely spatial and 17 spatio-temporal, mainly in north-western Italy. Most of the clusters were in areas characterized by urban and industrial settlements surrounded by agricultural land and an abundance of freshwater bodies. Conclusions Our results point to the presence, in a number of areas in Italy, of a Salmonella of public health concern originating in the environment. This highlights the increasing relevance of environmental, non-food-related sources of human exposure to enteric pathogens.	[Graziani, Caterina; Busani, Luca] Ist Super Sanita, Dept Vet Publ Hlth & Food Safety, I-00161 Rome, Italy; [Luzzi, Ida; Owczarek, Slawomir; Dionisi, Anna Maria] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS)	Busani, L (corresponding author), Ist Super Sanita, Dept Vet Publ Hlth & Food Safety, Viale Regina Elena 299, I-00161 Rome, Italy.	luca.busani@iss.it	Dionisi, Anna Maria/B-8722-2016; Busani, Luca/J-9253-2012; LUZZI, IDA/B-8715-2016	Dionisi, Anna Maria/0000-0002-4492-8498; Busani, Luca/0000-0002-6081-2794; LUZZI, IDA/0000-0002-7614-601X	Centro Nazionale per la Prevenzione e il Controllo delle Malattie - Italian Ministry of Health [5M10-1616-2014, 8977-2014]	Centro Nazionale per la Prevenzione e il Controllo delle Malattie - Italian Ministry of Health	The study was supported by Grant Number 5M10-1616-2014 and Grant Number 8977-2014 from the Centro Nazionale per la Prevenzione e il Controllo delle Malattie - Italian Ministry of Health (www.ccm-network.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akil L, 2014, FOODBORNE PATHOG DIS, V11, P974, DOI 10.1089/fpd.2014.1802; Andreoletti O, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1826; Chiari M, 2014, ACTA VET SCAND, V56, DOI 10.1186/s13028-014-0086-7; Chiari M, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-42; David JM, 2014, EPIDEMIOL INFECT, V142, P28, DOI 10.1017/S0950268813000770; Domingues AR, 2014, EPIDEMIOL INFECT, V142, P1614, DOI 10.1017/S095026881300215X; European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3547; Fischer M.M., 2010, HDB APPL SPATIAL ANA, DOI [10.1007/978-3-642-03647-7, DOI 10.1007/978-3-642-03647-7]; Fisher IST, 2009, FOODBORNE PATHOG DIS, V6, P613, DOI 10.1089/fpd.2008.0206; Graziani C, 2013, EURO SURVEILL B EUR, V18; Graziani C, 2011, FOODBORNE PATHOG DIS, V8, P997, DOI 10.1089/fpd.2010.0833; Greene SK, 2008, FOODBORNE PATHOG DIS, V5, P669, DOI 10.1089/fpd.2008.0111; KNOX EG, 1964, ROY STAT SOC C-APP, V13, P25; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Levallois P, 2014, ZOONOSES PUBLIC HLTH, V61, P28, DOI 10.1111/zph.12039; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Moore DA, 1999, EPIDEMIOL REV, V21, P143, DOI 10.1093/oxfordjournals.epirev.a017993; Mughini-Gras L, 2012, EURO SURVEILL B EUR, V17; Mughini-Gras L, 2013, EPIDEMIOL INFECT, P1; Oggioni C, 2010, Ann Ig, V22, P327; Pardhan-Ali A, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-17; Pires SM, 2010, FOODBORNE PATHOG DIS, V7, P1351, DOI 10.1089/fpd.2010.0564; Rizzoli A, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00251; Robardet E, 2011, INT J PARASITOL, V41, P145, DOI 10.1016/j.ijpara.2010.08.007	24	20	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142419	10.1371/journal.pone.0142419	http://dx.doi.org/10.1371/journal.pone.0142419			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558381	Green Submitted, gold, Green Published			2022-12-26	WOS:000364433100078
J	Gruber, DF; Gaffney, JP; Mehr, S; DeSalle, R; Sparks, JS; Platisa, J; Pieribone, VA				Gruber, David F.; Gaffney, Jean P.; Mehr, Shaadi; DeSalle, Rob; Sparks, John S.; Platisa, Jelena; Pieribone, Vincent A.			Adaptive Evolution of Eel Fluorescent Proteins from Fatty Acid Binding Proteins Produces Bright Fluorescence in the Marine Environment	PLOS ONE			English	Article							VISUAL PIGMENTS; SELECTION; FAMILY; ALIGNMENT; MODELS; GFP	We report the identification and characterization of two new members of a family of bilirubin-inducible fluorescent proteins (FPs) from marine chlopsid eels and demonstrate a key region of the sequence that serves as an evolutionary switch from non-fluorescent to fluorescent fatty acid-binding proteins (FABPs). Using transcriptomic analysis of two species of brightly fluorescent Kaupichthys eels (Kaupichthys hyoproroides and Kaupichthys n. sp.), two new FPs were identified, cloned and characterized (Chlopsid FP I and Chlopsid FP II). We then performed phylogenetic analysis on 210 FABPs, spanning 16 vertebrate orders, and including 163 vertebrate taxa. We show that the fluorescent FPs diverged as a protein family and are the sister group to brain FABPs. Our results indicate that the evolution of this family involved at least three gene duplication events. We show that fluorescent FABPs possess a unique, conserved tripeptide Gly-Pro-Pro sequence motif, which is not found in non-fluorescent fatty acid binding proteins. This motif arose from a duplication event of the FABP brain isoforms and was under strong purifying selection, leading to the classification of this new FP family. Residues adjacent to the motif are under strong positive selection, suggesting a further refinement of the eel protein's fluorescent properties. We present a phylogenetic reconstruction of this emerging FP family and describe additional fluorescent FABP members from groups of distantly related eels. The elucidation of this class of fish FPs with diverse properties provides new templates for the development of protein-based fluorescent tools. The evolutionary adaptation from fatty acid-binding proteins to fluorescent fatty acid-binding proteins raises intrigue as to the functional role of bright green fluorescence in this cryptic genus of reclusive eels that inhabit a blue, nearly monochromatic, marine environment.	[Gruber, David F.; Gaffney, Jean P.] CUNY Bernard M Baruch Coll, Dept Nat Sci, New York, NY 10010 USA; [Gruber, David F.] CUNY, Grad Ctr, Program Biol, New York, NY USA; [Mehr, Shaadi] SUNY Coll Old Westbury, Dept Biol Sci, Old Westbury, NY 11568 USA; [Gruber, David F.; Mehr, Shaadi; DeSalle, Rob; Sparks, John S.] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Sparks, John S.] Amer Museum Nat Hist, Dept Ichthyol, Div Vertebrate Zool, New York, NY 10024 USA; [Platisa, Jelena; Pieribone, Vincent A.] John B Pierce Lab Inc, New Haven, CT USA; [Pieribone, Vincent A.] Yale Univ, Sch Med, Cellular & Mol Physiol, New Haven, CT USA; [Pieribone, Vincent A.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA	City University of New York (CUNY) System; Baruch College (CUNY); City University of New York (CUNY) System; State University of New York (SUNY) System; SUNY Old Westbury; American Museum of Natural History (AMNH); American Museum of Natural History (AMNH); Yale University; The John B Pierce Laboratory, Inc; Yale University; Yale University	Gruber, DF (corresponding author), CUNY Bernard M Baruch Coll, Dept Nat Sci, 17 Lexington Ave, New York, NY 10010 USA.	David.Gruber@baruch.cuny.edu	Platisa, Jelena/R-3785-2017; Platisa, Jelena/P-4987-2019	Platisa, Jelena/0000-0003-4813-609X; Platisa, Jelena/0000-0003-4813-609X	National Science Foundation [1007747, DEB-0444842, 1257555]; City University of New York Collaborative Incentive Research Grant [2064]; National Geographic Society [W101-10, W114-12]; National Institutes of Health [R01NS083875, U01NS090565-02]; American Museum of Natural History; Dalio Family Foundation; John B. Pierce Laboratory; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083875, U01NS090565] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); City University of New York Collaborative Incentive Research Grant; National Geographic Society(National Geographic Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Museum of Natural History; Dalio Family Foundation; John B. Pierce Laboratory; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Science Foundation (1007747 to D.F.G., DEB-0444842 and 1257555 to J.S.S.), City University of New York Collaborative Incentive Research Grant (#2064 to D.F.G.), National Geographic Society (Waitt Grant W101-10 to D.F.G. and W114-12 to J.S.S.), and National Institutes of Health (R01NS083875 and U01NS090565-02 to V.A.P.). Funding was also provided by the American Museum of Natural History (to J.S.S. and R.D.); the Dalio Family Foundation (to J.S.S.) and the The John B. Pierce Laboratory (to V.A.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrews S., 2010, FASTQC QUALITY CONTR; Atchley WR, 2005, P NATL ACAD SCI USA, V102, P6395, DOI 10.1073/pnas.0408677102; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bomati EK, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-77; Bou-Abdallah F, 2006, BBA-GEN SUBJECTS, V1760, P1690, DOI 10.1016/j.bbagen.2006.08.014; Bowmaker JK, 2008, VISUAL NEUROSCI, V25, P249, DOI 10.1017/S0952523808080152; Dann SG, 2004, J MOL EVOL, V58, P400, DOI 10.1007/s00239-003-2562-y; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Deheyn DD, 2007, BIOL BULL-US, V213, P95, DOI 10.2307/25066625; Dove SG, 2001, CORAL REEFS, V19, P197, DOI 10.1007/PL00006956; FANG LS, 1984, B I ZOOL ACAD SINICA, V23, P1; Field SF, 2006, J MOL EVOL, V62, P332, DOI 10.1007/s00239-005-0129-9; Gerlach T, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0787; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gruber DF, 2008, BIOL BULL-US, V215, P143, DOI 10.2307/25470695; Haddock SHD, 2010, P ROY SOC B-BIOL SCI, V277, P1155, DOI 10.1098/rspb.2009.1774; Hayashi S, 2009, FISHERIES SCI, V75, P1461, DOI 10.1007/s12562-009-0176-z; HEINERMANN PH, 1984, EXP BIOL, V43, P127; Kochiyama Y, 1966, B JPN SOC SCI FISH, V32, P867; Kumagai A, 2013, CELL, V153, P1602, DOI 10.1016/j.cell.2013.05.038; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee TW, 2008, MAR BIOL, V153, P285, DOI 10.1007/s00227-007-0804-z; Lukyanov KA, 2000, J BIOL CHEM, V275, P25879, DOI 10.1074/jbc.C000338200; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Mazel CH, 2003, LIMNOL OCEANOGR, V48, P390, DOI 10.4319/lo.2003.48.1_part_2.0390; Mehr S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1565-6; Mehr SFP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-546; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; MORIN JG, 1971, J CELL PHYSIOL, V77, P305, DOI 10.1002/jcp.1040770304; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Pieribone V., 2006, AGLOW DARK REVOLUTIO; Porter ML, 2007, MOL BIOL EVOL, V24, P253, DOI 10.1093/molbev/msl152; Porter ML, 2007, MOL BIOL EVOLUTION, V24; Posada D, 2006, NUCLEIC ACIDS RES, V34, pW700, DOI 10.1093/nar/gkl042; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roth MS, 2010, J EXP BIOL, V213, P3644, DOI 10.1242/jeb.040881; Roth MS, 2013, SCI REPORTS, V3; Salih A, 2000, NATURE, V408, P850, DOI 10.1038/35048564; Shagin DA, 2004, MOL BIOL EVOL, V21, P841, DOI 10.1093/molbev/msh079; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; Smathers Rebecca L., 2011, Human Genomics, V5, P170; Smith David G., 1989, P72; Sparks JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083259; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Storch J, 2009, J LIPID RES, V50, pS126, DOI 10.1194/jlr.R800084-JLR200; Swofford D.L., 2002, PHYLOGENETIC ANAL US; Tsukamoto K, 2006, NATURE, V439, P929, DOI 10.1038/439929a; TYLER JE, 1970, MEASUREMENTS SPECTRA; [No title captured]	51	22	22	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0140972	10.1371/journal.pone.0140972	http://dx.doi.org/10.1371/journal.pone.0140972			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26561348	Green Published, gold, Green Submitted			2022-12-26	WOS:000364433100017
J	Parraguez, VH; Mamani, S; Cofre, E; Castellaro, G; Urquieta, B; De los Reyes, M; Astiz, S; Gonzalez-Bulnes, A				Parraguez, Victor H.; Mamani, Sandra; Cofre, Eileen; Castellaro, Giorgio; Urquieta, Bessie; De los Reyes, Monica; Astiz, Susana; Gonzalez-Bulnes, Antonio			Disturbances in Maternal Steroidogenesis and Appearance of Intrauterine Growth Retardation at High-Altitude Environments Are Established from Early Pregnancy. Effects of Treatment with Antioxidant Vitamins	PLOS ONE			English	Article							FETAL CARDIOVASCULAR DEFENSE; BIRTH-WEIGHT; PROGESTERONE CONCENTRATIONS; OXIDATIVE STRESS; BLOOD-PLASMA; HYPOXIA; SHEEP; RESTRICTION; MODEL; PREECLAMPSIA	Pregnancies at high-altitudes are influenced by hypoxia and oxidative stress and frequently affected by IUGR. However, a common thought is that early pregnant women visiting altitude have no major complications for gestation development, since IUGR is developed during the second half of pregnancy. Thus, using a well-characterized sheep-model, we aimed to determine whether long-and/or short-term exposure to high-altitude may affect maternal steroidogenesis and therefore embryo-fetal growth from conception. The second aim was to differentiate the relative role of hypoxia and oxidative stress by assessing the effects of supplementation with antioxidant agents during this early-pregnancy stage, which were previously found to be useful to prevent IUGR. The results indicate that both long-and short-term exposure to high-altitude causes disturbances in maternal ovarian steroidogenesis and negatively affects embryo-fetal growth already during the very early stages of gestation, with the consequences being even worsened in newcomers to high-altitude. The supply of antioxidant during this period only showed discrete effects for preventing IUGR. In conclusion, the present study gives a warning for clinicians about the risks for early-pregnant women when visiting high-altitude regions and suggests the need for further studies on the effects of the length of exposure and on the interaction of the exposure with the pregnancy stage.	[Parraguez, Victor H.; Cofre, Eileen; Urquieta, Bessie; De los Reyes, Monica] Univ Chile, Fac Vet Sci, Santiago, Chile; [Parraguez, Victor H.; Mamani, Sandra; Castellaro, Giorgio] Univ Chile, Fac Agr Sci, Santiago, Chile; [Parraguez, Victor H.] Univ Chile, Int Ctr Andean Studies, Santiago, Chile; [Astiz, Susana; Gonzalez-Bulnes, Antonio] SGIT INIA, Comparat Physiol Lab, Madrid 28040, Spain; [Gonzalez-Bulnes, Antonio] Univ Sassari, Dept Vet Med, I-07100 Sassari, Italy	Universidad de Chile; Universidad de Chile; Universidad de Chile; University of Sassari	Parraguez, VH (corresponding author), Univ Chile, Fac Vet Sci, Casilla 2,Correo 15, Santiago, Chile.	vparragu@uchile.cl	Gonzalez-Bulnes, Antonio/K-7691-2015; Astiz, Susana/AAN-8769-2021; Parraguez, Victor/I-5415-2013	Gonzalez-Bulnes, Antonio/0000-0002-0917-4475; Parraguez, Victor/0000-0002-3621-2705	FONDECYT from CONICYT, Chile [1100189]; Spanish Agency for International Cooperation and Development (AECID) [A/023494/09, A/030536/10]	FONDECYT from CONICYT, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Spanish Agency for International Cooperation and Development (AECID)	The experimental work was supported by grant FONDECYT 1100189 from CONICYT, Chile and the Spanish Agency for International Cooperation and Development (AECID; Technical Cooperation Projects A/023494/09 and A/030536/10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry JS, 2008, THERIOGENOLOGY, V69, P55, DOI 10.1016/j.theriogenology.2007.09.021; Barry JS, 2008, SEMIN PERINATOL, V32, P225, DOI 10.1053/j.semperi.2007.11.004; BASSETT JM, 1969, J ENDOCRINOL, V45, P449, DOI 10.1677/joe.0.0450449; Bazer FW, 2013, REPROD FERT DEVELOP, V25, P129, DOI 10.1071/RD12266; Bazer FW, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-23; Charles SM, 2014, J CLIN ENDOCR METAB, V99, P2908, DOI 10.1210/jc.2013-4102; de Bulnes AG, 1998, SMALL RUMINANT RES, V27, P243, DOI 10.1016/S0921-4488(97)00062-X; FISCHER B, 1993, J REPROD FERTIL, V99, P673, DOI 10.1530/jrf.0.0990673; GAGIOTI S, 1996, J BRAZ ASS ADV, V48, P37; Garrel C, 2010, J ENDOCRINOL, V205, P107, DOI 10.1677/JOE-09-0362; Ghidini A, 1996, Obstet Gynecol Surv, V51, P376, DOI 10.1097/00006254-199606000-00023; Giussani DA, 2001, PEDIATR RES, V49, P490, DOI 10.1203/00006450-200104000-00009; Giussani DA, 2014, ADV EXP MED BIOL, V814, P77, DOI 10.1007/978-1-4939-1031-1_7; Gonzalez-Bulnes A, 2010, REPROD DOMEST ANIM, V45, P9, DOI 10.1111/j.1439-0531.2010.01640.x; Hancock SN, 2012, J PHYSIOL-LONDON, V590, P1273, DOI 10.1113/jphysiol.2011.220699; Hartinger S, 2006, INT J GYNECOL OBSTET, V93, P275, DOI 10.1016/j.ijgo.2006.02.023; Herrera EA, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00149; Huddleston B. A, 2003, 10 FOOD AGR ORG UN; Igwebuike UM, 2010, ANIM REPROD SCI, V121, P189, DOI 10.1016/j.anireprosci.2010.04.007; Jauniaux E, 2006, HUM REPROD UPDATE, V12, P747, DOI 10.1093/humupd/dml016; Jensen GM, 1997, AM J PUBLIC HEALTH, V87, P1003, DOI 10.2105/AJPH.87.6.1003; Jiang B, 2000, MOL ENDOCRINOL, V14, P1661, DOI 10.1210/me.14.10.1661; Julian CG, 2007, ARCH DIS CHILD-FETAL, V92, P372, DOI 10.1136/adc.2006.109579; Kane AD, 2014, J PHYSIOL-LONDON, V592, P475, DOI 10.1113/jphysiol.2013.264275; Keyes LE, 2003, PEDIATR RES, V54, P20, DOI 10.1203/01.PDR.0000069846.64389.DC; Krampl E, 2000, ULTRASOUND OBST GYN, V16, P9, DOI 10.1046/j.1469-0705.2000.00156.x; Krebs C, 1996, AM J OBSTET GYNECOL, V175, P1534, DOI 10.1016/S0002-9378(96)70103-5; Larstad M, 2002, J CHROMATOGR B, V766, P107, DOI 10.1016/S0378-4347(01)00437-6; Lemley CO, 2010, J ENDOCRINOL, V205, P233, DOI 10.1677/JOE-10-0042; LISSI E, 1992, FREE RADICAL RES COM, V17, P299, DOI 10.3109/10715769209079523; MONGE C, 1991, PHYSIOL REV, V71, P1135, DOI 10.1152/physrev.1991.71.4.1135; Moore LG, 1998, YEARB PHYS ANTHROPOL, V41, P25; Moore LG, 2004, PLACENTA, V25, pS60, DOI 10.1016/j.placenta.2004.01.008; Moore LG, 2001, AM J HUM BIOL, V13, P635, DOI 10.1002/ajhb.1102; Moore LG, 2011, RESP PHYSIOL NEUROBI, V178, P181, DOI 10.1016/j.resp.2011.04.017; MOORE NW, 1972, J ENDOCRINOL, V53, P187, DOI 10.1677/joe.0.0530187; Morrison JL, 2008, CLIN EXP PHARMACOL P, V35, P730, DOI 10.1111/j.1440-1681.2008.04975.x; Mortola JP, 2000, J PEDIATR-US, V136, P324, DOI 10.1067/mpd.2000.103507; Muhlhausler BS, 2011, PEDIATR RES, V70, P117, DOI 10.1203/PDR.0b013e31821f6cfd; Murphy VE, 2006, ENDOCR REV, V27, P141, DOI 10.1210/er.2005-0011; National Research Council, 1985, NUTR REQ SHEEP; Okazaki KM, 2006, REGEN MED, V1, P71, DOI 10.2217/17460751.1.1.71; Parraguez VH, 2014, REPROD DOMEST ANIM, V49, P977, DOI 10.1111/rda.12417; Parraguez VH, 2005, REPROD FERT DEVELOP, V17, P497, DOI 10.1071/RD04060; Parraguez VH, 2006, ANIM REPROD SCI, V95, P151, DOI 10.1016/j.anireprosci.2005.11.003; Parraguez VH, 2013, REPROD FERT DEVELOP, V25, P639, DOI 10.1071/RD12020; Parraguez VH, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-24; Parraguez VH, 2011, REPROD FERT DEVELOP, V23, P285, DOI 10.1071/RD10016; PAVIA CS, 1983, J INFECT DIS, V147, P1006, DOI 10.1093/infdis/147.6.1006; Poore KR, 2010, J PHYSIOL-LONDON, V588, P2219, DOI 10.1113/jphysiol.2010.187682; Redmer DA, 2004, DOMEST ANIM ENDOCRIN, V27, P199, DOI 10.1016/j.domaniend.2004.06.006; Reynolds LP, 2010, J ANIM SCI, V88, pE61, DOI 10.2527/jas.2009-2359; REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357; Rogers PAW, 2009, REPROD SCI, V16, P147, DOI 10.1177/1933719108325509; Salas SP, 2006, HYPERTENSION, V47, P203, DOI 10.1161/01.HYP.0000200042.64517.19; SCHILESINGER M, 1975, FERTIL STERIL, V18, P95; Sharma RK, 2013, SMALL RUMINANT RES, V115, P67, DOI 10.1016/j.smallrumres.2013.08.003; Thakor AS, 2015, J PINEAL RES, V59, P80, DOI 10.1111/jpi.12242; Thakor AS, 2010, J PINEAL RES, V49, P399, DOI 10.1111/j.1600-079X.2010.00813.x; WATSON AJ, 1994, BIOL REPROD, V50, P725, DOI 10.1095/biolreprod50.4.725; WAYNER DDM, 1985, FEBS LETT, V187, P33, DOI 10.1016/0014-5793(85)81208-4; ZAMUDIO S, 1994, J SOC GYNECOL INVEST, V1, P197, DOI 10.1177/107155769400100304	62	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0140902	10.1371/journal.pone.0140902	http://dx.doi.org/10.1371/journal.pone.0140902			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560325	Green Submitted, Green Published, gold			2022-12-26	WOS:000364433100012
J	Civardi, C; Schubert, M; Fey, A; Wick, P; Schwarze, FWMR				Civardi, Chiara; Schubert, Mark; Fey, Angelika; Wick, Peter; Schwarze, Francis W. M. R.			Micronized Copper Wood Preservatives: Efficacy of Ion, Nano, and Bulk Copper against the Brown Rot Fungus Rhodonia placenta	PLOS ONE			English	Article							ENGINEERED NANOPARTICLES; IN-VITRO; TOLERANCE; TOXICITY; LACCASE; OXIDE; TETRATHIOMOLYBDATE; CHEMISTRY; STRAIN; GROWTH	Recently introduced micronized copper (MC) formulations, consisting of a nanosized fraction of basic copper (Cu) carbonate (CuCO3 center dot Cu(OH)(2)) nanoparticles (NPs), were introduced to the market for wood protection. Cu NPs may presumably be more effective against wood-destroying fungi than bulk or ionic Cu compounds. In particular, Cu-tolerant wood-destroying fungi may not recognize NPs, which may penetrate into fungal cell walls and membranes and exert their impact. The objective of this study was to assess if MC wood preservative formulations have a superior efficacy against Cu-tolerant wood-destroying fungi due to nano effects than conventional Cu biocides. After screening a range of wood-destroying fungi for their resistance to Cu, we investigated fungal growth of the Cu-tolerant fungus Rhodonia placenta in solid and liquid media and on wood treated with MC azole (MCA). In liquid cultures we evaluated the fungal response to ion, nano and bulk Cu distinguishing the ionic and particle effects by means of the Cu2+ chelator ammonium tetrathiomolybdate (TTM) and measuring fungal biomass, oxalic acid production and laccase activity of R. placenta. Our results do not support the presence of particular nano effects of MCA against R. placenta that would account for an increased antifungal efficacy, but provide evidence that attribute the main effectiveness of MCA to azoles.	[Civardi, Chiara; Schubert, Mark; Fey, Angelika; Schwarze, Francis W. M. R.] Empa, Appl Wood Mat, St Gallen, Switzerland; [Civardi, Chiara] ETH, Inst Bldg Mat, Zurich, Switzerland; [Wick, Peter] Empa, Particles Biol Interact, St Gallen, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA)	Civardi, C (corresponding author), Empa, Appl Wood Mat, St Gallen, Switzerland.	chiara.civardi@empa.ch; francis.schwarze@empa.ch	Schwarze, Francis/Y-2157-2018	Schwarze, Francis/0000-0003-3306-8303; Schubert, Mark/0000-0002-6900-0370	Swiss National Research Foundation [NRP 64, 406440_141618]	Swiss National Research Foundation(Swiss National Science Foundation (SNSF))	The study was financially supported by the Swiss National Research Foundation (NRP 64, Grant No. 406440_141618). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese A, 2012, ANNU REV BIOMED ENG, V14, P1, DOI [10.1146/annurev-bioeng-071811-150124, 10.1146/annurev.bioeng-071811-150124]; Arantes V, 2011, J IND MICROBIOL BIOT, V38, P541, DOI 10.1007/s10295-010-0798-2; Bondarenko O, 2013, ARCH TOXICOL, V87, P1181, DOI 10.1007/s00204-013-1079-4; Brewer GJ, 2009, TRANSL RES, V154, P70, DOI 10.1016/j.trsl.2009.05.002; Brewer GJ, 2005, CURR CANCER DRUG TAR, V5, P195, DOI 10.2174/1568009053765807; Buerki-Thurnherr T, 2013, NANOTOXICOLOGY, V7, P402, DOI 10.3109/17435390.2012.666575; Bulcke F, 2014, NANOTOXICOLOGY, V8, P775, DOI 10.3109/17435390.2013.829591; Choi O, 2008, WATER RES, V42, P3066, DOI 10.1016/j.watres.2008.02.021; Civardi C, 2015, ENVIRON POLLUT, V200, P126, DOI 10.1016/j.envpol.2015.02.018; Cookson LJ, 2010, FOREST PROD J, V60, P6, DOI 10.13073/0015-7473-60.1.6; Dhyani S, 2012, WOOD SCI TECHNOL, V46, P1203, DOI 10.1007/s00226-012-0475-x; ENGLANDER CM, 1971, APPL MICROBIOL, V22, P1012, DOI 10.1128/AEM.22.6.1012-1016.1971; European Committee for Standardization, 1997, 113 EN EUR COMM STAN; European Committee for Standardization, 1992, 275 EN EUR COMM STAN; Fischer-Parton S, 2000, J MICROSC-OXFORD, V198, P246, DOI 10.1046/j.1365-2818.2000.00708.x; FLEMMING CA, 1989, WATER AIR SOIL POLL, V44, P143, DOI 10.1007/BF00228784; Gil-Allue C, 2015, ENVIRON SCI TECHNOL, V49, P1165, DOI 10.1021/es5050166; Goodell B, 2003, ACS SYM SER, V845, P97; Green F, 2003, INT BIODETER BIODEGR, V51, P145, DOI 10.1016/S0964-8305(02)00099-9; Habicht J, 2010, MIKRONISIERTES KUPFE, P161; Herpoel I, 2002, J PULP PAP SCI, V28, P67; Hughes A, 2006, ENV OPTIMISATION WOO; HUMPHRIES WR, 1986, VET REC, V119, P596; Jin L., 2010, 41st Annual Meeting of the International Research Group on Wood Protection, Biarritz, France, 9-13 May 2010, pIRG; JOSEPHHORNE T, 1995, FEBS LETT, V374, P174, DOI 10.1016/0014-5793(95)01102-K; Kim JH, 2000, ARCH BIOCHEM BIOPHYS, V382, P72, DOI 10.1006/abbi.2000.1996; Krumova EZ, 2009, PROCESS BIOCHEM, V44, P288, DOI 10.1016/j.procbio.2008.10.023; Kumar A., 1999, Acta Phytopathologica et Entomologica Hungarica, V34, P27; Limbach LK, 2007, ENVIRON SCI TECHNOL, V41, P4158, DOI 10.1021/es062629t; Lomascolo A, 2003, J APPL MICROBIOL, V94, P618, DOI 10.1046/j.1365-2672.2003.01879.x; MCCALLAN SEA, 1949, BOT REV, V15, P629, DOI 10.1007/BF02861716; McIntyre CR, 2010, P 105 ANN M AM WOOD, V105, P114; MCQUAID A, 1991, J INORG BIOCHEM, V41, P87, DOI 10.1016/0162-0134(91)80002-Y; Midander K, 2009, SMALL, V5, P389, DOI 10.1002/smll.200801220; Montag J, 2006, J PHYTOPATHOL, V154, P474, DOI 10.1111/j.1439-0434.2006.01132.x; Navarro E, 2008, ECOTOXICOLOGY, V17, P372, DOI 10.1007/s10646-008-0214-0; Obanda DN, 2008, THESIS; OHSUMI Y, 1988, J BACTERIOL, V170, P2676, DOI 10.1128/jb.170.6.2676-2682.1988; Park KH, 2005, BBA-GEN SUBJECTS, V1726, P115, DOI 10.1016/j.bbagen.2005.06.010; Platten WE, 2014, EPA600R14365; Ray M, 2010, P IRG ANN M 2010 MAY; SAGRIPANTI JL, 1991, TOXICOL APPL PHARM, V110, P477, DOI 10.1016/0041-008X(91)90048-J; Sharma SS, 2009, TRENDS PLANT SCI, V14, P43, DOI 10.1016/j.tplants.2008.10.007; Stirling R, 2010, P IRG ANN M 2010 MAY; Studer AM, 2010, TOXICOL LETT, V197, P169, DOI 10.1016/j.toxlet.2010.05.012; Sun FL, 2012, J WOOD SCI, V58, P51, DOI 10.1007/s10086-011-1223-9; SUTTER HP, 1983, MATER ORGANISMEN, V18, P241; Tang JD, 2013, APPL ENVIRON MICROB, V79, P1523, DOI 10.1128/AEM.02916-12; Watanabe T, 1998, J BIOTECHNOL, V62, P221, DOI 10.1016/S0168-1656(98)00063-7; WAZNY J, 1986, HOLZFORSCHUNG, V40, P383, DOI 10.1515/hfsg.1986.40.6.383; Wei DS, 2010, APPL ENVIRON MICROB, V76, P2091, DOI 10.1128/AEM.02929-09; WESSELS JGH, 1993, NEW PHYTOL, V123, P397, DOI 10.1111/j.1469-8137.1993.tb03751.x; Woo C, 2010, INT BIODETER BIODEGR, V64, P403, DOI 10.1016/j.ibiod.2010.01.009; Xue W, 2014, P IRG ANN M 2014 MAY; Xue W, 2013, HOLZFORSCHUNG, V67, P815, DOI 10.1515/hf-2012-0136; Xue W, 2012, HOLZFORSCHUNG, V66, P889, DOI 10.1515/HF.2011.188; Zhang J, 2009, CANADIAN WOOD PRESER, P69	57	30	30	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142578	10.1371/journal.pone.0142578	http://dx.doi.org/10.1371/journal.pone.0142578			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554706	gold, Green Published, Green Submitted			2022-12-26	WOS:000364430700136
J	Giordano, C; Vinet, J; Curia, G; Biagini, G				Giordano, Carmela; Vinet, Jonathan; Curia, Giulia; Biagini, Giuseppe			Repeated 6-Hz Corneal Stimulation Progressively Increases FosB/Delta FosB Levels in the Lateral Amygdala and Induces Seizure Generalization to the Hippocampus	PLOS ONE			English	Article							ACCESSORY BASAL NUCLEI; DELTA-FOSB; GLUTAMATE-DECARBOXYLASE; ANTIEPILEPTIC DRUGS; STATUS EPILEPTICUS; POSTICTAL STATE; KETOGENIC DIET; EPILEPSY; EFFICACY; DAMAGE	Exposure to repetitive seizures is known to promote convulsions which depend on specific patterns of network activity. We aimed at evaluating the changes in seizure phenotype and neuronal network activation caused by a modified 6-Hz corneal stimulation model of psychomotor seizures. Mice received up to 4 sessions of 6-Hz corneal stimulation with fixed current amplitude of 32 mA and inter-stimulation interval of 72 h. Video-electroencephalography showed that evoked seizures were characterized by a motor component and a non-motor component. Seizures always appeared in frontal cortex, but only at the fourth stimulation they involved the hippocampus, suggesting the establishment of an epileptogenic process. Duration of seizure non-motor component progressively decreased after the second session, whereas convulsive seizures remained unchanged. In addition, a more severe seizure phenotype, consisting of tonic-clonic generalized convulsions, was predominant after the second session. Immunohistochemistry and double immunofluorescence experiments revealed a significant increase in neuronal activity occurring in the lateral amygdala after the fourth session, most likely due to activity of principal cells. These findings indicate a predominant role of amygdala in promoting progressively more severe convulsions as well as the late recruitment of the hippocampus in the seizure spread. We propose that the repeated 6-Hz corneal stimulation model may be used to investigate some mechanisms of epileptogenesis and to test putative antiepileptogenic drugs.	[Giordano, Carmela; Vinet, Jonathan; Curia, Giulia; Biagini, Giuseppe] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Lab Expt Epileptol, Modena, Italy; [Biagini, Giuseppe] NOCSAE Hosp, AUSL Modena, Dept Neurosci, Modena, Italy	Universita di Modena e Reggio Emilia	Biagini, G (corresponding author), Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Lab Expt Epileptol, Modena, Italy.	gbiagini@unimore.it	Biagini, Giuseppe/I-3227-2013; Curia, Giulia/A-8863-2008; Vinet, Jonathan/O-2934-2015	Biagini, Giuseppe/0000-0002-7130-2511; Curia, Giulia/0000-0002-8472-350X; Vinet, Jonathan/0000-0001-9011-6207	Italian Ministry of Health [RF-2010-2309921]; Marie Sklodowska-Curie Fellowship [326651]	Italian Ministry of Health(Ministry of Health, Italy); Marie Sklodowska-Curie Fellowship	This study was supported by the Italian Ministry of Health (grant RF-2010-2309921 to GB). JV is recipient of a Marie Sklodowska-Curie Fellowship (FP7-PEOPLE-2012-IEF, #326651). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre V, 2000, NEUROSCIENCE, V99, P469, DOI 10.1016/S0306-4522(00)00209-8; Aroniadou-Anderjaska V, 2008, EPILEPSY RES, V78, P102, DOI 10.1016/j.eplepsyres.2007.11.011; Bankstahl M, 2013, EPILEPSY RES, V107, P205, DOI 10.1016/j.eplepsyres.2013.09.014; Barton ME, 2001, EPILEPSY RES, V47, P217, DOI 10.1016/S0920-1211(01)00302-3; Biagini G, 2005, NEUROMOL MED, V7, P325, DOI 10.1385/NMM:7:4:325; Biagini G, 2008, J NEUROPATH EXP NEUR, V67, P687, DOI 10.1097/NEN.0b013e318181b8ae; BROWN WC, 1953, J PHARMACOL EXP THER, V107, P273; CALDECOTTHAZARD S, 1987, PROG NEURO-PSYCHOPH, V11, P389, DOI 10.1016/0278-5846(87)90014-5; CHEN JS, 1995, MOL PHARMACOL, V48, P880; Curia G, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00046; Duncan GE, 2005, EPILEPSY RES, V67, P81, DOI 10.1016/j.eplepsyres.2005.08.009; Fisher RS, 2010, EPILEPSY BEHAV, V19, P100, DOI 10.1016/j.yebeh.2010.06.038; Fisher RS, 2000, EPILEPSY BEHAV, V1, P52, DOI 10.1006/ebeh.2000.0023; FRENK H, 1979, BRAIN RES, V167, P435, DOI 10.1016/0006-8993(79)90842-4; Giordano C, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00063; Gualtieri F, 2012, NEUROSCIENCE, V218, P278, DOI 10.1016/j.neuroscience.2012.05.018; Harris GC, 2007, NEUROSCIENCE, V147, P583, DOI 10.1016/j.neuroscience.2007.04.050; Hartman AL, 2008, EPILEPSIA, V49, P334, DOI 10.1111/j.1528-1167.2007.01430.x; Kaminski RM, 2004, EPILEPSIA, V45, P864, DOI 10.1111/j.0013-9580.2004.04504.x; KAUFMAN DL, 1991, J NEUROCHEM, V56, P720, DOI 10.1111/j.1471-4159.1991.tb08211.x; KAUFMAN DL, 1986, SCIENCE, V232, P1138, DOI 10.1126/science.3518061; KELLY ME, 1994, BRAIN RES, V634, P245, DOI 10.1016/0006-8993(94)91927-5; Kelz MB, 2000, CURR OPIN NEUROL, V13, P715, DOI 10.1097/00019052-200012000-00017; Kemppainen S, 2004, NEUROSCIENCE, V126, P485, DOI 10.1016/j.neuroscience.2004.03.015; Krishnan GP, 2011, J NEUROSCI, V31, P8870, DOI 10.1523/JNEUROSCI.6200-10.2011; Leclercq K, 2014, EPILEPSY RES, V108, P675, DOI 10.1016/j.eplepsyres.2014.02.013; Liu XB, 1996, P NATL ACAD SCI USA, V93, P7332, DOI 10.1073/pnas.93.14.7332; Lucchi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072716; Madsen TM, 2006, CELL MOL NEUROBIOL, V26, P87, DOI 10.1007/s10571-006-9202-1; Mares P, 2015, NEUROPHARMACOLOGY, V88, P99, DOI 10.1016/j.neuropharm.2014.09.007; Matagne A, 1998, EPILEPSY RES, V31, P59, DOI 10.1016/S0920-1211(98)00016-3; Mohapel P, 2001, EUR J NEUROSCI, V13, P1501, DOI 10.1046/j.0953-816x.2001.01532.x; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Morris TA, 2000, MOL BRAIN RES, V79, P138, DOI 10.1016/S0169-328X(00)00112-1; Neal EG, 2008, LANCET NEUROL, V7, P500, DOI 10.1016/S1474-4422(08)70092-9; Pikkarainen M, 1999, J COMP NEUROL, V403, P229; Rowley NM, 2010, EPILEPSY RES, V92, P163, DOI 10.1016/j.eplepsyres.2010.09.002; SANGDEE P, 1982, EPILEPSIA, V23, P471, DOI 10.1111/j.1528-1157.1982.tb05435.x; Savander V, 1997, NEUROSCIENCE, V77, P767, DOI 10.1016/S0306-4522(96)00513-1; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; VELISEK L, 1992, EPILEPSY RES, V12, P37, DOI 10.1016/0920-1211(92)90089-C; White SH., 2002, ANTIEPILEPTIC DRUGS, V5, P36	42	32	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141221	10.1371/journal.pone.0141221	http://dx.doi.org/10.1371/journal.pone.0141221			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555229	gold, Green Published, Green Submitted			2022-12-26	WOS:000364430700021
J	Huang, YT; Ko, WC; Chan, YJ; Lu, JJ; Tsai, HY; Liao, CH; Sheng, WH; Teng, LJ; Hsueh, PR				Huang, Yu-Tsung; Ko, Wen-Chien; Chan, Yu-Jiun; Lu, Jang-Jih; Tsai, Hsih-Yeh; Liao, Chun-Hsing; Sheng, Wang-Huei; Teng, Lee-Jene; Hsueh, Po-Ren			Disease Burden of Invasive Listeriosis and Molecular Characterization of Clinical Isolates in Taiwan, 2000-2013	PLoS One			English	Article							MONOCYTOGENES; CLONES; EPIDEMIOLOGY; PCR	The information about disease burden and epidemiology of invasive listeriosis in Asia is scarce. From 2000 to 2013, a total of 338 patients with invasive listeriosis (bacteremia, meningitis, and peritonitis) were treated at four medical centers in Taiwan. The incidence (per 10,000 admissions) of invasive listeriosis increased significantly during the 14-year period among the four centers (0.15 in 2000 and >1.25 during 2010-2012) and at each of the four medical centers. Among these patients, 45.9% were elderly (>65 years old) and 3.3% were less than one year of age. More than one-third (36.7%) of the patients acquired invasive listeriosis in the spring (April to June). Among the 132 preserved Listeria monocytogenes isolates analyzed, the most frequently isolated PCR serogroup-sequence type (ST) was IIb-ST87 (23.5%), followed by IIa-ST378 (19.7%) and IIa-ST155 (12.1%). Isolation of PCR serogroups IIb and IVb increased significantly with year, with a predominance of IIb-ST87 isolates (23.5%) and IIb-ST 228 isolates emerging in 2013. A total of 12 different randomly amplified polymorphic DNA (RAPD) patterns (Patterns I to XII) were identified among the 112 L. monocytogenes isolates belonging to eight main PCR serogroup-STs. Identical RAPD patterns were found among the isolates exhibiting the same PCR serogroup-ST. In conclusion, our study revealed that during 2000-2013, listeriosis at four medical centers in Taiwan was caused by heterogeneous strains and that the upsurge in incidence beginning in 2005 was caused by at least two predominant clones.	[Huang, Yu-Tsung; Tsai, Hsih-Yeh; Liao, Chun-Hsing] Far Eastern Mem Hosp, Dept Internal Med, New Taipei, Taiwan; [Ko, Wen-Chien] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70428, Taiwan; [Ko, Wen-Chien] Natl Cheng Kung Univ, Coll Med, Tainan 70101, Taiwan; [Lu, Jang-Jih] Chang Gung Mem Hosp, Dept Lab Med, Taoyuan, Taiwan; [Chan, Yu-Jiun] Taipei Vet Gen Hosp, Dept Lab Med, Taipei, Taiwan; [Chan, Yu-Jiun] Natl Yang Ming Univ, Taipei 112, Taiwan; [Huang, Yu-Tsung; Teng, Lee-Jene] Natl Taiwan Univ, Grad Inst Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Huang, Yu-Tsung; Sheng, Wang-Huei; Hsueh, Po-Ren] Natl Taiwan Univ, Dept Lab Med, Natl Taiwan Univ Hosp, Coll Med, Taipei 10764, Taiwan; [Hsueh, Po-Ren] Natl Taiwan Univ, Coll Med, Dept Internal Med, Natl Taiwan Univ Hosp, Taipei, Taiwan	Far Eastern Memorial Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; Chang Gung Memorial Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Hsueh, PR (corresponding author), Natl Taiwan Univ, Dept Lab Med, Natl Taiwan Univ Hosp, Coll Med, Taipei 10764, Taiwan.	hsporen@ntu.edu.tw	Ko, Wen-Chien/ABG-4316-2020; Hsueh, Po-Ren/ABE-1594-2021	Ko, Wen-Chien/0000-0001-7497-149X; Liao, Chun-Hsing/0000-0002-4099-3487; SHENG, WANG-HUEI/0000-0002-5605-7853; HSUEH, PO-REN/0000-0002-7502-9225; Huang, Yu-tsung/0000-0002-7805-4178; TENG, LEE-JENE/0000-0003-0104-741X	Ministry of Science and Technology [MOST 103-2300-B-002-054]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was financially supported by a grant from Ministry of Science and Technology (MOST 103-2300-B-002-054). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cantinelli T, 2013, J CLIN MICROBIOL, V51, P3770, DOI 10.1128/JCM.01874-13; Charlier C, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000105; Chenal-Francisque V, 2011, EMERG INFECT DIS, V17, P1110, DOI [10.3201/eid/1706.101778, 10.3201/eid1706.101778]; de Noordhout CM, 2014, LANCET INFECT DIS, V14, P1073, DOI 10.1016/S1473-3099(14)70870-9; Doumith M, 2004, J CLIN MICROBIOL, V42, P3819, DOI 10.1128/JCM.42.8.3819-3822.2004; Goulet V, 2008, EMERG INFECT DIS, V14, P734, DOI 10.3201/eid1405.071395; Guevara RE, 2009, CLIN INFECT DIS, V48, P1507, DOI 10.1086/598935; Haase JK, 2014, ENVIRON MICROBIOL, V16, P405, DOI 10.1111/1462-2920.12342; Hsieh WS, 2009, INT J INFECT DIS, V13, P193, DOI 10.1016/j.ijid.2008.06.006; Huang SL, 2010, J MICROBIOL IMMUNOL, V43, P485, DOI 10.1016/S1684-1182(10)60075-8; Huang YT, 2011, EMERG INFECT DIS, V17, P1731, DOI 10.3201/eid1709.110093; Kerouanton A, 2010, J MICROBIOL METH, V80, P134, DOI 10.1016/j.mimet.2009.11.008; Lado BH, 2003, APPL ENVIRON MICROB, V69, P2223, DOI 10.1128/AEM.69.4.2223-2229.2003; Louie M, 1996, J CLIN MICROBIOL, V34, P15, DOI 10.1128/JCM.34.1.15-19.1996; McCollum JT, 2013, NEW ENGL J MED, V369, P944, DOI 10.1056/NEJMoa1215837; Okutani A, 2004, EPIDEMIOL INFECT, V132, P769, DOI 10.1017/S0950268804001967; Ragon M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000146; Silk BJ, 2012, CLIN INFECT DIS, V54, pS396, DOI 10.1093/cid/cis268; Swaminathan B, 2007, MICROBES INFECT, V9, P1236, DOI 10.1016/j.micinf.2007.05.011; Wang HL, 2013, CLIN INFECT DIS, V56, P666, DOI 10.1093/cid/cis943; Wang JP, 2013, J FOOD PROTECT, V76, P1046, DOI 10.4315/0362-028X.JFP-12-448; Wang Y, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-119; WONG HC, 1990, APPL ENVIRON MICROB, V56, P3101, DOI 10.1128/AEM.56.10.3101-3104.1990; Yeh KS, 2005, J FOOD PROTECT, V68, P458, DOI 10.4315/0362-028X-68.3.458	24	36	38	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141241	10.1371/journal.pone.0141241	http://dx.doi.org/10.1371/journal.pone.0141241			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555445	gold, Green Published, Green Submitted			2022-12-26	WOS:000364430700023
J	Kegler, P; Baum, G; Indriana, LF; Wild, C; Kunzmann, A				Kegler, Pia; Baum, Gunilla; Indriana, Lisa F.; Wild, Christian; Kunzmann, Andreas			Physiological Response of the Hard Coral Pocillopora verrucosa from Lombok, Indonesia, to Two Common Pollutants in Combination with High Temperature	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; WATER-SOLUBLE FRACTION; SCLERACTINIAN CORALS; CLIMATE-CHANGE; RISK-ASSESSMENT; REEF ECOSYSTEM; FLORIDA-KEYS; PHOTOSYNTHESIS; OIL; SURFACTANTS	Knowledge on interactive effects of global (e.g. ocean warming) and local stressors (e.g. pollution) is needed to develop appropriate management strategies for coral reefs. Surfactants and diesel are common coastal pollutants, but knowledge of their effects on hard corals as key reef ecosystem engineers is scarce. This study thus investigated the physiological reaction of Pocillopora verrucosa from Lombok, Indonesia, to exposure with a) the water-soluble fraction of diesel (determined by total polycyclic aromatic hydrocarbons (PAH); 0.69 +/- 0.14 mg L-1), b) the surfactant linear alkylbenzene sulfonate (LAS; 0.95 +/- 0.02 mg L-1) and c) combinations of each pollutant with high temperature (+3 degrees C). To determine effects on metabolism, respiration, photosynthetic efficiency and coral tissue health were measured. Findings revealed no significant effects of diesel, while LAS resulted in severe coral tissue losses (16-95% after 84 h). High temperature led to an increase in photosynthetic yield of corals after 48 h compared to the control treatment, but no difference was detected thereafter. In combination, diesel and high temperature significantly increased coral dark respiration, whereas LAS and high temperature caused higher tissue losses (81-100% after 84 h) and indicated a severe decline in maximum quantum yield. These results confirm the hypothesized combined effects of high temperature with either of the two investigated pollutants. Our study demonstrates the importance of reducing import of these pollutants in coastal areas in future adaptive reef management, particularly in the context of ocean warming.	[Kegler, Pia; Baum, Gunilla; Kunzmann, Andreas] Leibniz Ctr Trop Marine Ecol, Dept Ecol, Bremen, Germany; [Indriana, Lisa F.] Indonesian Inst Sci, Res Ctr Oceanog, Mataram Marine Bio Ind Tech Implementat Unit, Pemenang, Indonesia; [Wild, Christian] Univ Bremen, Fac Biol & Chem, D-28359 Bremen, Germany	Leibniz Zentrum fur Marine Tropenforschung (ZMT); Indonesian Institute of Sciences; University of Bremen	Kegler, P (corresponding author), Leibniz Ctr Trop Marine Ecol, Dept Ecol, Bremen, Germany.	piakegler@gmx.de	Kunzmann, Andreas/O-1345-2013; Kunzmann, Andreas/O-5459-2019	Kunzmann, Andreas/0000-0002-9500-4332; Kunzmann, Andreas/0000-0002-9500-4332	AiF Projekt GmbH [2665803MD3]; German Federal Ministry of Education and Research [03F0641A]; A Kunzmann	AiF Projekt GmbH; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); A Kunzmann	This project was funded partly through AiF Projekt GmbH (www.aif-projekt-gmbh.de, project ILAR no. 2665803MD3) and through the German Federal Ministry of Education and Research (www.bmbf.de, project SPICE, grant no. 03F0641A) in the frame of the Indonesian German collaboration in marine research. Both grants were received through A Kunzmann. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL PD, 1974, J FISH BIOL, V6, P279, DOI 10.1111/j.1095-8649.1974.tb04545.x; Al-Dahash LM, 2013, MAR POLLUT BULL, V72, P364, DOI 10.1016/j.marpolbul.2012.08.029; Al-Horani FA, 2003, MAR BIOL, V142, P419, DOI 10.1007/s00227-002-0981-8; [Anonymous], SCI INPUT OIL SPILL; [Anonymous], 2003, OIL SEA; Baskett ML, 2010, GLOBAL CHANGE BIOL, V16, P1229, DOI 10.1111/j.1365-2486.2009.02062.x; Beer S, 1998, MAR BIOL, V131, P607, DOI 10.1007/s002270050352; Beyer J, 2014, MAR ENVIRON RES, V96, P81, DOI 10.1016/j.marenvres.2013.10.008; Bhagooli R, 2004, COMP BIOCHEM PHYS A, V137, P547, DOI 10.1016/j.cbpb.2003.11.008; Bourne DG, 2009, TRENDS MICROBIOL, V17, P554, DOI 10.1016/j.tim.2009.09.004; Braga J.K., 2014, AM J ANAL CHEM, V5, P8, DOI DOI 10.4236/AJAC.2014.51002; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Burke L, 2012, REEFS RISK REVISITED; Chupa J, 2007, KENT RIEGELS HDB IND, P1694; Clara M, 2007, WATER RES, V41, P4339, DOI 10.1016/j.watres.2007.06.027; COLES SL, 1977, MAR BIOL, V43, P209, DOI 10.1007/BF00402313; Cserhati T, 2002, ENVIRON INT, V28, P337, DOI 10.1016/S0160-4120(02)00032-6; DAVIES PS, 1984, CORAL REEFS, V2, P181; DeLeo DM, 2016, DEEP-SEA RES PT II, V129, P137, DOI 10.1016/j.dsr2.2015.02.028; Falahudin D., 2012, COAST MAR SCI, V35, P112; Fournie JW, 2012, DIS AQUAT ORGAN, V99, P85, DOI 10.3354/dao02459; George AL, 1999, ENVIRON TOXICOL CHEM, V18, P2232, DOI 10.1002/etc.5620181016; Guppy M, 1999, BIOL REV, V74, P1, DOI 10.1017/S0006323198005258; Haapkyla J, 2007, VIE MILIEU, V57, P95; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Isobe T, 2007, ENVIRON MONIT ASSESS, V135, P423, DOI 10.1007/s10661-007-9661-y; Ivankovic T, 2010, ARH HIG RADA TOKSIKO, V61, P95, DOI 10.2478/10004-1254-61-2010-1943; Johnson LL, 2002, AQUAT CONSERV, V12, P517, DOI 10.1002/aqc.522; Jones RJ, 1999, MAR POLLUT BULL, V38, P864, DOI 10.1016/S0025-326X(98)90160-6; Kaniewska P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034659; Kemp DW, 2011, GLOBAL CHANGE BIOL, V17, P3468, DOI 10.1111/j.1365-2486.2011.02487.x; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Ko FC, 2014, ENVIRON POLLUT, V185, P35, DOI 10.1016/j.envpol.2013.10.025; Lara-Martin PA, 2008, TRAC-TREND ANAL CHEM, V27, P684, DOI 10.1016/j.trac.2008.05.005; Lesser MP, 2013, CORAL REEFS, V32, P25, DOI 10.1007/s00338-012-0993-x; Logan DT, 2007, HUM ECOL RISK ASSESS, V13, P302, DOI 10.1080/10807030701226749; Maina J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023064; Maltby L, 1999, ECOL APPL, V9, P431, DOI 10.1890/1051-0761(1999)009[0431:SSTIOO]2.0.CO;2; MARSH J A JR, 1970, Ecology (Washington D C), V51, P255, DOI 10.2307/1933661; Masson-Delmotte V., 2018, GLOBAL WARMING 15 C; Mercurio P, 2004, ENVIRON POLLUT, V129, P183, DOI 10.1016/j.envpol.2003.11.008; Ministry of environment lands and parks Province of British Columbia, 1993, AMB WAT QUAL CRIT PO; MUSCATINE L, 1984, PROC R SOC SER B-BIO, V222, P181, DOI 10.1098/rspb.1984.0058; Negri AP, 2000, MAR POLLUT BULL, V41, P420, DOI 10.1016/S0025-326X(00)00139-9; Pampanin DM., 2013, HYDROCARBON, V5, P83, DOI [10.5772/48176, DOI 10.5772/48176]; Philipp E, 2003, J EXP MAR BIOL ECOL, V287, P57, DOI 10.1016/S0022-0981(02)00495-1; Portner HO, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P411; Porter JW, 1999, LIMNOL OCEANOGR, V44, P941, DOI 10.4319/lo.1999.44.3_part_2.0941; Redman AD, 2015, MAR POLLUT BULL, V98, P156, DOI 10.1016/j.marpolbul.2015.06.053; Reynaud S, 2003, GLOBAL CHANGE BIOL, V9, P1660, DOI 10.1046/j.1365-2486.2003.00678.x; RINKEVICH B, 1979, MAR POLLUT BULL, V10, P328, DOI 10.1016/0025-326X(79)90402-8; Risk MJ, 2001, B MAR SCI, V69, P443; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Santos CA, 2013, NEOTROP ICHTHYOL, V11, P193, DOI 10.1590/S1679-62252013000100022; Santos CA, 2010, ZOOLOGIA-CURITIBA, V27, P956, DOI 10.1590/S1984-46702010000600017; Shafir S, 2014, WATER AIR SOIL POLL, V225, DOI 10.1007/s11270-014-1890-4; Simonato JD, 2008, ECOTOX ENVIRON SAFE, V69, P112, DOI 10.1016/j.ecoenv.2007.01.012; Singer MM, 2000, MAR POLLUT BULL, V40, P1007, DOI 10.1016/S0025-326X(00)00045-X; Temara A, 2001, MAR POLLUT BULL, V42, P635, DOI 10.1016/S0025-326X(01)00061-3; U. S. Energy Information Administration, INT EN STAT; Ulstrup KE, 2011, AQUAT BIOL, V12, P241, DOI 10.3354/ab00338; Van Dam J., 2011, ECOL IMPACTS TOXIC C, P187, DOI DOI 10.2174/978160805121211101010187; Vanzella TP, 2007, MUTAT RES-GEN TOX EN, V631, P36, DOI 10.1016/j.mrgentox.2007.04.004; Walz H., 1998, SUBMERSIBLE PHOTOSYN; Whitall D, 2014, MAR POLLUT BULL, V80, P293, DOI 10.1016/j.marpolbul.2013.12.053; Wild C, 2011, MAR FRESHWATER RES, V62, P205, DOI 10.1071/MF10254; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x	70	13	13	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142744	10.1371/journal.pone.0142744	http://dx.doi.org/10.1371/journal.pone.0142744			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555818	gold, Green Published, Green Submitted			2022-12-26	WOS:000364430700166
J	von Loga, K; Kohlhaussen, J; Burkhardt, L; Simon, R; Steurer, S; Burdak-Rothkamm, S; Jacobsen, F; Sauter, G; Krech, T				von Loga, Katharina; Kohlhaussen, Jule; Burkhardt, Lia; Simon, Ronald; Steurer, Stefan; Burdak-Rothkamm, Susanne; Jacobsen, Frank; Sauter, Guido; Krech, Till			FGFR1 Amplification Is Often Homogeneous and Strongly Linked to the Squamous Cell Carcinoma Subtype in Esophageal Carcinoma	PLoS One			English	Article							TISSUE MICROARRAY ANALYSIS; ENDOTHELIAL GROWTH-FACTOR; RECEPTOR TYROSINE KINASE; 1 GENE AMPLIFICATION; LUNG-CANCER; BREAST-CANCER; TARGETED THERAPIES; SELECTIVE INHIBITOR; CIGARETTE-SMOKING; POOR-PROGNOSIS	Background and Aims Amplification of the fibroblast growth factor receptor 1 (FGFR1) is believed to predict response to multi-kinase inhibitors targeting FGFR1. Esophageal cancer is an aggressive disease, for which novel targeted therapies are highly warranted. Methods This study was designed to investigate the prevalence and clinical significance of FGFR1 amplification in a tissue microarray containing 346 adenocarcinomas and 254 squamous cell carcinomas of the esophagus, using dual-labeling fluorescence in situ hybridization (FISH) analysis. Results FGFR1 amplification, defined as a ratio of FGFR1: centromere 8 copy numbers >= 2.0, was more frequently seen in squamous cell carcinoma (8.9% of 202 interpretable cases) than in adenocarcinoma (1.6% of 308; p<0.0001). There was no association between FGFR1 amplification and tumor phenotype or clinical outcome. To study potential heterogeneity of FGFR1 amplification, all available tumor blocks from 23 FGFR1 amplified tumors were analyzed on conventional large sections. This analysis revealed complete homogeneity of FGFR1 amplification in 20 (86.9%) primary tumors and in all available lymph node metastases. Remarkably, FGFR1 amplification was also seen in dysplasia adjacent to tumor in 6 of 9 patients with FGFR1 amplified primary cancers. Conclusions In conclusion, FGFR1 amplification occurs in a relevant subgroup of carcinomas of the esophagus and may play a particular role for development of squamous cell cancers. The high homogeneity of FGFR1 amplification suggests that patients with FGFR1 amplified esophageal cancers may particularly benefit from anti-FGFR1 therapies and prompt for clinical studies in this tumor type.	[von Loga, Katharina; Kohlhaussen, Jule; Burkhardt, Lia; Simon, Ronald; Steurer, Stefan; Burdak-Rothkamm, Susanne; Jacobsen, Frank; Sauter, Guido; Krech, Till] Univ Med Ctr Hamburg Eppendorf, Dept Pathol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	von Loga, K (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Pathol, Hamburg, Germany.	kvonloga@uke.de	Burdak-Rothkamm, Susanne/I-2553-2012	Burdak-Rothkamm, Susanne/0000-0002-3840-2844				Al-Kuraya K, 2005, MODERN PATHOL, V18, P891, DOI 10.1038/modpathol.3800408; Arnold M, 2015, GUT, V64, P381, DOI 10.1136/gutjnl-2014-308124; Ashman LK, 2013, EXPERT OPIN INV DRUG, V22, P103, DOI 10.1517/13543784.2013.740010; Bandla S, 2012, ANN THORAC SURG, V93, P1101, DOI 10.1016/j.athoracsur.2012.01.064; Barlund M, 2000, J NATL CANCER I, V92, P1252, DOI 10.1093/jnci/92.15.1252; Bosman F., 2010, WHO CLASSIFICATION T, V4th; Brady NJ, 2013, EXPERT REV ENDOCRINO, V8, P391, DOI 10.1586/17446651.2013.811910; Brunello E, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-103; Chang JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105524; Cihoric N, 2014, BRIT J CANCER, V110, P2914, DOI 10.1038/bjc.2014.229; Courjal F, 1997, CANCER RES, V57, P4360; Delaney C, 2015, CHIN J CANCER, V34, DOI 10.1186/s40880-015-0007-9; Dienstmann R, 2014, ANN ONCOL, V25, P552, DOI 10.1093/annonc/mdt419; Ellis LM, 2008, CLIN CANCER RES, V14, P6371, DOI 10.1158/1078-0432.CCR-07-5287; Farrell J, 2013, INT J MOL SCI, V14, P15510, DOI 10.3390/ijms140815510; Ferrara N, 2004, ONCOLOGIST, V9, P2, DOI 10.1634/theoncologist.9-suppl_1-2; Freier K, 2007, ORAL ONCOL, V43, P60, DOI 10.1016/j.oraloncology.2006.01.005; Gavine PR, 2012, CANCER RES, V72, P2045, DOI 10.1158/0008-5472.CAN-11-3034; Goke F, 2012, CHEST, V142, P1020, DOI 10.1378/chest.11-2943; Goke F, 2015, CLIN CANC RES; Grob TJ, 2013, LUNG CANCER, V79, P221, DOI 10.1016/j.lungcan.2012.11.009; Guagnano V, 2012, CANCER DISCOV, V2, P1118, DOI 10.1158/2159-8290.CD-12-0210; Guagnano V, 2011, J MED CHEM, V54, P7066, DOI 10.1021/jm2006222; Heist RS, 2012, J THORAC ONCOL, V7, P1775, DOI 10.1097/JTO.0b013e31826aed28; Ishizuka T, 2002, BIOCHEM BIOPH RES CO, V296, P152, DOI 10.1016/S0006-291X(02)00836-7; Jiang T, 2015, LUNG CANCER, V87, P1, DOI 10.1016/j.lungcan.2014.11.009; Kim HR, 2013, J CLIN ONCOL, V31, P731, DOI 10.1200/JCO.2012.43.8622; Kim HS, 2015, ONCOTARGET, V6, P2562, DOI 10.18632/oncotarget.2944; Krishnaswamy S, 2009, CLIN CANCER RES, V15, P5714, DOI 10.1158/1078-0432.CCR-09-0070; Lin L, 2000, CANCER RES, V60, P1341; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubin JH, 2012, CANCER EPIDEMIOL, V36, P306, DOI 10.1016/j.canep.2012.03.001; Medical Advisory Secretariat, 2010, Ont Health Technol Assess Ser, V10, P1; Mirlacher M, 2010, METHODS MOL BIOL, V664, P37, DOI 10.1007/978-1-60761-806-5_4; Moch H, 1999, AM J PATHOL, V154, P981, DOI 10.1016/S0002-9440(10)65349-7; Murphy CG, 2012, ANTI-CANCER DRUG, V23, P765, DOI 10.1097/CAD.0b013e328352d292; Nocito A, 2001, J PATHOL, V194, P349, DOI 10.1002/1096-9896(200107)194:3<349::AID-PATH887>3.0.CO;2-D; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Preusser M, 2014, LUNG CANCER, V83, P83, DOI 10.1016/j.lungcan.2013.10.004; Reichelt U, 2007, MODERN PATHOL, V20, P120, DOI 10.1038/modpathol.3800712; Reis JS, 2006, CLIN CANCER RES, V12, P6652, DOI 10.1158/1078-0432.CCR-06-1164; Ruiz C, 2006, INT J CANCER, V118, P2190, DOI 10.1002/ijc.21581; Saito S, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1065-8; Schildhaus HU, 2012, MODERN PATHOL, V25, P1473, DOI 10.1038/modpathol.2012.102; Seo AN, 2014, VIRCHOWS ARCH, V465, P547, DOI 10.1007/s00428-014-1634-2; Simon R, 2001, J NATL CANCER I, V93, P1141, DOI 10.1093/jnci/93.15.1141; Sobin LH, 2010, TNM CLASSIFICATION M; Sugiura K, 2007, ONCOL REP, V17, P557; Tennstedt P, 2012, INT J ONCOL, V40, P261, DOI 10.3892/ijo.2011.1216; Torhorst J, 2001, AM J PATHOL, V159, P2249, DOI 10.1016/S0002-9440(10)63075-1; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Welm BE, 2002, J CELL BIOL, V157, P703, DOI 10.1083/jcb.200107119; Worni M, 2014, DIS ESOPHAGUS, V27, P662, DOI 10.1111/dote.12123; Yu QY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127404; Zhang JC, 2012, CLIN CANCER RES, V18, P6658, DOI 10.1158/1078-0432.CCR-12-2694; Zhang YW, 2013, WORLD J GASTROENTERO, V19, P5598, DOI 10.3748/wjg.v19.i34.5598	58	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141867	10.1371/journal.pone.0141867	http://dx.doi.org/10.1371/journal.pone.0141867			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555375	Green Published, gold, Green Submitted			2022-12-26	WOS:000364430700042
J	Weaver, JR; Nadler, JL; Taylor-Fishwick, DA				Weaver, Jessica R.; Nadler, Jerry L.; Taylor-Fishwick, David A.			Interleukin-12 (IL-12)/STAT4 Axis Is an Important Element for beta-Cell Dysfunction Induced by Inflammatory Cytokines	PLoS One			English	Article							NONOBESE DIABETIC MICE; NOD MICE; DOUBLE-BLIND; MONOCLONAL-ANTIBODY; INSULIN-RESISTANCE; IL-12/IL-23 INHIBITOR; STAT4-DEFICIENT MICE; PANCREATIC-ISLETS; IFN-GAMMA; IL-12	Pathology driving beta-cell loss in diabetes is poorly defined. Chronic subclinical inflammation is associated with beta-cell dysfunction. Acute in vitro exposure of islets and beta-cells to an inflammatory cytokine cocktail ( IL-1 beta/TNF-alpha/IFN-gamma) results in loss of cell function and viability. The contribution of each cytokine alone or in combination has been evaluated in homogeneous mouse beta-cell lines and primary mouse islets. Cytokine cooperation is required for beta-cell apoptosis with the most potent combinations including IL-1 beta. Single cytokine exposure did not induce beta-cell apoptosis. Expression of endogenous interleukin-12 in beta-cells correlated with inflammatory cytokine combinations that induced beta-cell apoptosis. Uncoupling of the IL-12 axis by a block of IL-12 production, inhibition of IL-12 receptor/ligand interaction or disruption of IL-12 receptor signaling conferred protection to beta-cells from apoptosis induced by inflammatory cytokine stimulation. Signaling through STAT4 is indicated since disruption of IL-12 concomitantly reduced inflammatory cytokine stimulation of endogenous IFN-gamma expression. Primary mouse islets isolated from mice deficient in STAT4 show resistance to inflammatory-cytokine-induced cell death when compared to islets isolated from wild type mice. Collectively, the data identify IL-12 as an important mediator of inflammation induced beta-cell apoptosis. Modulation of IL-12/STAT4 signaling may be a valuable therapeutic strategy to preserve islet/beta-cell viability in established diabetes.	[Weaver, Jessica R.; Taylor-Fishwick, David A.] Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA; [Nadler, Jerry L.; Taylor-Fishwick, David A.] Eastern Virginia Med Sch, Dept Internal Med, Norfolk, VA 23501 USA; [Nadler, Jerry L.; Taylor-Fishwick, David A.] Eastern Virginia Med Sch, Strelitz Diabet Ctr, Norfolk, VA 23501 USA	Eastern Virginia Medical School; Eastern Virginia Medical School; Eastern Virginia Medical School	Taylor-Fishwick, DA (corresponding author), Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA.	taylord@evms.edu	Taylor, David/S-5508-2019	Taylor, David/0000-0002-6720-7482	 [47-2013-519];  [W81XWH-10-1-0148];  [HL112605]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112605] Funding Source: NIH RePORTER	; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Support was provided by 47-2013-519 (jdrf.org), W81XWH-10-1-0148 (cdmrp.org), and HL112605 (NIH.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Maskari M, 2010, IRAN J IMMUNOL, V7, P124, DOI IJIv7i2A8; Altinova AE, 2010, J ENDOCRINOL INVEST, V33, P451, DOI [10.3275/6766, 10.1007/BF03346623]; Billich A, 2007, IDRUGS, V10, P53; Boyton RJ, 2005, INT IMMUNOL, V17, P1157, DOI 10.1093/intimm/dxh293; Burakoff R, 2006, INFLAMM BOWEL DIS, V12, P558, DOI 10.1097/01.ibd.0000225337.14356.31; Catalan V, 2007, OBES SURG, V17, P1464, DOI 10.1007/s11695-008-9424-z; Chen M, 2005, DIABETOLOGIA, V48, P486, DOI 10.1007/s00125-005-1673-y; Cieslak M, 2015, ACTA BIOCHIM POL, V62, P15; Coon ME, 1999, J IMMUNOL, V163, P6567; Donath MY, 2014, NAT REV DRUG DISCOV, V13, P465, DOI 10.1038/nrd4275; Ehses JA, 2009, P NATL ACAD SCI USA, V106, P13998, DOI 10.1073/pnas.0810087106; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; Gandhi M, 2010, SEMIN CUTAN MED SURG, V29, P48, DOI 10.1016/j.sder.2010.02.001; GILLESSEN S, 1995, EUR J IMMUNOL, V25, P200, DOI 10.1002/eji.1830250133; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Holz A, 2001, J CLIN INVEST, V108, P1749; Hultgren B, 1996, DIABETES, V45, P812, DOI 10.2337/diabetes.45.6.812; HUNTER CA, 1995, J IMMUNOL, V155, P4347; Igoillo-Esteve M, 2010, DIABETOLOGIA, V53, P1395, DOI 10.1007/s00125-010-1707-y; Imai Y, 2013, DIABETES OBES METAB, V15, P117, DOI 10.1111/dom.12161; Imai Y., 2015, ISLETS LANGERHANS, P989; Jorns A, 2005, DIABETES, V54, P2041, DOI 10.2337/diabetes.54.7.2041; Kang YS, 2010, DIABETES RES CLIN PR, V89, P141, DOI 10.1016/j.diabres.2010.03.020; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; KATZ JD, 1995, SCIENCE, V268, P1185, DOI 10.1126/science.7761837; Keino H, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2530; Kimball AB, 2008, ARCH DERMATOL, V144, P200, DOI 10.1001/archdermatol.2007.63; Korman BD, 2008, GENES IMMUN, V9, P267, DOI 10.1038/gene.2008.1; Korman BD, 2008, CURR ALLERGY ASTHM R, V8, P398, DOI 10.1007/s11882-008-0077-8; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lee HS, 2008, ANN NY ACAD SCI, V1150, P93, DOI 10.1196/annals.1447.013; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; Marzorati S, 2006, AM J TRANSPLANT, V6, P2791, DOI 10.1111/j.1600-6143.2006.01512.x; Morahan G, 2009, GENES IMMUN, V10, pS64, DOI 10.1038/gene.2009.94; Morahan G, 2001, NAT GENET, V27, P218, DOI 10.1038/84872; Moran A, 2013, LANCET, V381, P1905, DOI 10.1016/S0140-6736(13)60023-9; Papp KA, 2008, LANCET, V371, P1675, DOI 10.1016/S0140-6736(08)60726-6; Rabinovitch A, 1996, J AUTOIMMUN, V9, P645, DOI 10.1006/jaut.1996.0084; Rothe H, 1997, DIABETOLOGIA, V40, P641, DOI 10.1007/s001250050728; Serreze DV, 2000, DIABETES, V49, P2007, DOI 10.2337/diabetes.49.12.2007; Sloan-Lancaster J, 2013, DIABETES CARE, V36, P2239, DOI 10.2337/dc12-1835; Soleimanpour SA, 2013, TRENDS ENDOCRIN MET, V24, P324, DOI 10.1016/j.tem.2013.03.005; Steinberg GR, 2007, CELL CYCLE, V6, P888, DOI 10.4161/cc.6.8.4135; Su SC, 2011, ACTA DIABETOL, V48, P113, DOI 10.1007/s00592-009-0171-y; Taylor-Fishwick DA, 2013, DIABETOLOGIA, V56, P126, DOI 10.1007/s00125-012-2732-9; Taylor-Fishwick DA, 2010, DIABETES S1, V59; Tilg H, 2008, MOL MED, V14, P222, DOI 10.2119/2007-00119.Tilg; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; Trembleau S, 1999, J IMMUNOL, V163, P2960; Trembleau S, 1997, EUR J IMMUNOL, V27, P2330, DOI 10.1002/eji.1830270930; TREMBLEAU S, 1995, J EXP MED, V181, P817, DOI 10.1084/jem.181.2.817; Wada Y, 2007, BLOOD, V109, P1156, DOI 10.1182/blood-2006-04-019398; Weaver JR, 2013, MOL CELL ENDOCRINOL, V369, P35, DOI 10.1016/j.mce.2013.01.011; Weaver JR, 2012, MOL CELL ENDOCRINOL, V358, P88, DOI 10.1016/j.mce.2012.03.004; Weaver JR, 2015, ISLETS LANGERHANS, P923; Westwell-Roper C, 2014, DIABETOLOGIA, V57, P447, DOI 10.1007/s00125-013-3151-2; Yang ZD, 2004, J AUTOIMMUN, V22, P191, DOI 10.1016/j.jaut.2003.08.006; Yang ZD, 2002, DIABETOLOGIA, V45, P1307, DOI 10.1007/s00125-002-0901-y; Zervou MI, 2008, HUM IMMUNOL, V69, P647, DOI 10.1016/j.humimm.2008.07.004; Zipris D, 1996, J IMMUNOL, V156, P1315	60	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142735	10.1371/journal.pone.0142735	http://dx.doi.org/10.1371/journal.pone.0142735			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555476	Green Published, Green Submitted, gold			2022-12-26	WOS:000364430700163
J	Darzi, S; Islam, MT; Tiong, SK; Kibria, S; Singh, M				Darzi, Soodabeh; Islam, Mohammad Tariqul; Tiong, Sieh Kiong; Kibria, Salehin; Singh, Mandeep			Stochastic Leader Gravitational Search Algorithm for Enhanced Adaptive Beamforming Technique	PLOS ONE			English	Article								In this paper, stochastic leader gravitational search algorithm (SL-GSA) based on randomized k is proposed. Standard GSA (SGSA) utilizes the best agents without any randomization, thus it is more prone to converge at suboptimal results. Initially, the new approach randomly choses k agents from the set of all agents to improve the global search ability. Gradually, the set of agents is reduced by eliminating the agents with the poorest performances to allow rapid convergence. The performance of the SL-GSA was analyzed for six well-known benchmark functions, and the results are compared with SGSA and some of its variants. Furthermore, the SL-GSA is applied to minimum variance distortionless response (MVDR) beamforming technique to ensure compatibility with real world optimization problems. The proposed algorithm demonstrates superior convergence rate and quality of solution for both real world problems and benchmark functions compared to original algorithm and other recent variants of SGSA.	[Darzi, Soodabeh] Univ Kebangsaan Malaysia, Ctr Space Sci ANGKASA, Bangi, Malaysia; [Islam, Mohammad Tariqul; Kibria, Salehin; Singh, Mandeep] Univ Kebangsaan Malaysia, Dept Elect Elect & Syst Engn, Bangi, Malaysia; [Tiong, Sieh Kiong] Univ Tenaga Nas, Coll Engn, Ctr Syst & Machine Intelligence, Selangor, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia; Universiti Tenaga Nasional	Islam, MT (corresponding author), Univ Kebangsaan Malaysia, Dept Elect Elect & Syst Engn, Bangi, Malaysia.	titareq@gmail.com	Singh, Mandeep/AAC-8680-2020; Tiong, Sieh Kiong/GLR-1734-2022; Islam, Mohammad Tariqul/M-7377-2016; singh, mandeep/W-7242-2019; Islam, Mohammad Tariqul/E-6380-2012	Islam, Mohammad Tariqul/0000-0002-4929-3209; Islam, Mohammad Tariqul/0000-0002-4929-3209	University Research Grant [DIP-2014-029]	University Research Grant	Funding: This work was supported by University Research Grant with project code DIP-2014-029. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CAPON J, 1969, P IEEE, V57, P1408, DOI 10.1109/PROC.1969.7278; Dahrouj H, 2010, IEEE T WIREL COMMUN, V9, P1748, DOI 10.1109/TWC.2010.05.090936; Darzi S, 2014, SCI WORLD J, DOI 10.1155/2014/724639; Gu BJ, 2013, INT J INNOV COMPUT I, V9, P4531; Khajehzadeh M, 2013, STRUCT ENG MECH, V45, P111, DOI 10.12989/sem.2013.45.1.111; Khajehzadeh M, 2012, ENG APPL ARTIF INTEL, V25, P1589, DOI 10.1016/j.engappai.2012.01.011; Khodier MM, 2005, IEEE T ANTENN PROPAG, V53, P2674, DOI 10.1109/TAP.2005.851762; Liu F. L., 2011, Progress In Electromagnetics Research C, V20, P239; Omar O. Kaid, 2012, Progress In Electromagnetics Research C, V32, P65; Rashedi E, 2009, INFORM SCIENCES, V179, P2232, DOI 10.1016/j.ins.2009.03.004; Tiong S. K., 2014, SCI WORLD J; Zaharis ZD, 2011, PROG ELECTROMAGN RES, V117, P165, DOI 10.2528/PIER11041904	13	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0140526	10.1371/journal.pone.0140526	http://dx.doi.org/10.1371/journal.pone.0140526			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26552032	Green Submitted, Green Published, gold			2022-12-26	WOS:000364422800001
J	Iwasaki, A; Sakai, K; Moriya, K; Sasaki, T; Keene, DR; Akhtar, R; Miyazono, T; Yasumura, S; Watanabe, M; Morishita, S; Sakai, T				Iwasaki, Ayumi; Sakai, Keiko; Moriya, Kei; Sasaki, Takako; Keene, Douglas R.; Akhtar, Riaz; Miyazono, Takayoshi; Yasumura, Satoshi; Watanabe, Masatoshi; Morishita, Shin; Sakai, Takao			Molecular Mechanism Responsible for Fibronectin-controlled Alterations in Matrix Stiffness in Advanced Chronic Liver Fibrogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						extracellular matrix; fibronectin; liver injury; lysyl oxidase; transforming growth factor beta (TGF-B); chronic hepatic fibrogenesis; conditional knockout mouse; tissue stiffness	GROWTH-FACTOR-BETA; TGF-BETA; HEPATIC-FIBROSIS; LYSYL OXIDASE; EXTRACELLULAR-MATRIX; V COLLAGEN; PROTEOLYTIC ACTIVATION; INFLAMMATION; DEPOSITION; INJURY	Fibrosis is characterized by extracellular matrix (ECM) remodeling and stiffening. However, the functional contribution of tissue stiffening to noncancer pathogenesis remains largely unknown. Fibronectin (Fn) is an ECM glycoprotein substantially expressed during tissue repair. Here we show in advanced chronic liver fibrogenesis using a mouse model lacking Fn that, unexpectedly, Fn-null livers lead to more extensive liver cirrhosis, which is accompanied by increased liver matrix stiffness and deteriorated hepatic functions. Furthermore, Fn-null livers exhibit more myofibroblast phenotypes and accumulate highly disorganized/diffuse collagenous ECM networks composed of thinner and significantly increased number of collagen fibrils during advanced chronic liver damage. Mechanistically, mutant livers show elevated local TGF-beta activity and lysyl oxidase expressions. A significant amount of active lysyl oxidase is released in Fn-null hepatic stellate cells in response to TGF-1 through canonical and noncanonical Smad such as PI3 kinase-mediated pathways. TGF-1-induced collagen fibril stiffness in Fn-null hepatic stellate cells is significantly higher compared with wild-type cells. Inhibition of lysyl oxidase significantly reduces collagen fibril stiffness, and treatment of Fn recovers collagen fibril stiffness to wild-type levels. Thus, our findings indicate an indispensable role for Fn in chronic liver fibrosis/cirrhosis in negatively regulating TGF-beta bioavailability, which in turn modulates ECM remodeling and stiffening and consequently preserves adult organ functions. Furthermore, this regulatory mechanism by Fn could be translated for a potential therapeutic target in a broader variety of chronic fibrotic diseases.	[Iwasaki, Ayumi; Sakai, Keiko; Sakai, Takao] Univ Liverpool, MRC Ctr Drug Safety Sci, Inst Translat Med, Dept Mol & Clin Pharmacol, Liverpool L69 3GE, Merseyside, England; [Sakai, Keiko; Moriya, Kei; Sakai, Takao] Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44195 USA; [Sasaki, Takako] Oita Univ, Fac Med, Dept Biochem, Oita 8795593, Japan; [Keene, Douglas R.] Shriners Hosp Children, Microimaging Ctr, Portland, OR 97231 USA; [Akhtar, Riaz] Univ Liverpool, Ctr Mat & Struct, Sch Engn, Liverpool L69 3GE, Merseyside, England; [Miyazono, Takayoshi; Yasumura, Satoshi] Toyama Univ, Dept Gastroenterol & Hepatol & Transfus Med & Cel, Toyama 9300194, Japan; [Watanabe, Masatoshi] Yokohama Natl Univ, Grad Sch Biomed Engn, Yokohama, Kanagawa 2408501, Japan; [Morishita, Shin] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Yokohama, Kanagawa 2408501, Japan	University of Liverpool; Cleveland Clinic Foundation; Oita University; University of Liverpool; University of Toyama; Yokohama National University; Yokohama National University	Sakai, T (corresponding author), Univ Liverpool, MRC Ctr Drug Safety Sci, Inst Translat Med, Dept Mol & Clin Pharmacol, Sherrington Bldg,Ashton St, Liverpool L69 3GE, Merseyside, England.	sakait@liverpool.ac.uk		Akhtar, Riaz/0000-0002-7963-6874; Morishita, Shin/0000-0002-9447-2679	National Institute of Diabetes and Digestive and Kidney Diseases [DK074538]; Institute of Translational Medicine of the University of Liverpool; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074538] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Institute of Translational Medicine of the University of Liverpool; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute of Diabetes and Digestive and Kidney Diseases Grant DK074538 (to T. Sakai). We are also grateful to the Institute of Translational Medicine of the University of Liverpool for support (to T. Sakai). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; ADACHI E, 1986, CONNECT TISSUE RES, V14, P257, DOI 10.3109/03008208609017469; Altrock E, 2015, J HEPATOL, V62, P625, DOI 10.1016/j.jhep.2014.06.010; Barry-Hamilton V, 2010, NAT MED, V16, P1009, DOI 10.1038/nm.2208; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Birk DE, 2001, MICRON, V32, P223, DOI 10.1016/S0968-4328(00)00043-3; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; Castelletti F, 2008, P NATL ACAD SCI USA, V105, P2538, DOI 10.1073/pnas.0707730105; Constandinou C, 2005, METH MOLEC MED, V117, P237; Csiszar K, 2001, PROG NUCLEIC ACID RE, V70, P1, DOI 10.1016/S0079-6603(01)70012-8; Dallas SL, 2005, J BIOL CHEM, V280, P18871, DOI 10.1074/jbc.M410762200; Diehl AM, 2013, J CLIN INVEST, V123, P1858, DOI 10.1172/JCI69966; Drews F, 2008, BBA-MOL CELL RES, V1783, P34, DOI 10.1016/j.bbamcr.2007.08.004; Fogelgren B, 2005, J BIOL CHEM, V280, P24690, DOI 10.1074/jbc.M412979200; Forbes SJ, 2011, BEST PRACT RES CL GA, V25, P207, DOI 10.1016/j.bpg.2011.02.006; Friedman SL, 2010, NAT REV GASTRO HEPAT, V7, P425, DOI 10.1038/nrgastro.2010.97; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Georges PC, 2007, AM J PHYSIOL-GASTR L, V293, pG1147, DOI 10.1152/ajpgi.00032.2007; Gressner AM, 2002, FRONT BIOSCI-LANDMRK, V7, pD793, DOI 10.2741/gressner; Guyot C, 2006, INT J BIOCHEM CELL B, V38, P135, DOI 10.1016/j.biocel.2005.08.021; Hayashi H, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00012; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Honda K, 2007, CARCINOGENESIS, V28, P2074, DOI 10.1093/carcin/bgm112; Huang GR, 2009, J BIOL CHEM, V284, P25879, DOI 10.1074/jbc.M109.024125; Huang YM, 2015, AM J PATHOL, V185, P786, DOI 10.1016/j.ajpath.2014.11.002; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Hynes RO, 1990, FIBRONECTINS; Katoh K, 1999, P NATL ACAD SCI USA, V96, P7928, DOI 10.1073/pnas.96.14.7928; Kawelke N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028181; Kolacna L, 2007, PHYSIOL RES, V56, pS51, DOI 10.33549/physiolres.931302; Koli K, 2004, J CELL BIOL, V167, P123, DOI 10.1083/jcb.200403067; Kondou H, 2003, J HEPATOL, V39, P742, DOI 10.1016/S0168-8278(03)00377-5; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Loeys B. L., 2010, SCI TRANSL MED, V2, P20, DOI 10.1126/scitranslmed.3000488; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Madibally SV, 2003, J SURG RES, V109, P92, DOI 10.1016/S0022-4804(02)00036-7; Maeda T, 2011, CURR BIOL, V21, P933, DOI 10.1016/j.cub.2011.04.007; Mammoto A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2774; Margadant C, 2010, EMBO REP, V11, P97, DOI 10.1038/embor.2009.276; Maruhashi T, 2010, J BIOL CHEM, V285, P13294, DOI 10.1074/jbc.M109.088864; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Mazzieri R, 2005, J CELL SCI, V118, P2177, DOI 10.1242/jcs.02352; Moriya K, 2012, HEPATOLOGY, V56, P311, DOI 10.1002/hep.25624; Moriya K, 2011, GASTROENTEROLOGY, V140, P1653, DOI 10.1053/j.gastro.2011.02.005; Mosher DF, 1989, FIBRONECTIN; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Muro AF, 2003, J CELL BIOL, V162, P149, DOI 10.1083/jcb.200212079; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Nishimura SL, 2009, AM J PATHOL, V175, P1362, DOI 10.2353/ajpath.2009.090393; Nistala H, 2010, J CELL BIOL, V190, P1107, DOI 10.1083/jcb.201003089; NOWACK H, 1976, J IMMUNOL METHODS, V12, P117, DOI 10.1016/0022-1759(76)90101-0; Olsen AL, 2012, GASTROENTEROLOGY, V142, P928, DOI 10.1053/j.gastro.2011.12.038; Papi M, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4868388; Perepelyuk M, 2013, AM J PHYSIOL-GASTR L, V304, pG605, DOI 10.1152/ajpgi.00222.2012; Ramirez F, 2009, CURR OPIN CELL BIOL, V21, P616, DOI 10.1016/j.ceb.2009.05.005; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Sakai T, 2001, NAT MED, V7, P324, DOI 10.1038/85471; Sakai T, 2003, GENE DEV, V17, P926, DOI 10.1101/gad.255603; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Schuppan D, 2013, J CLIN INVEST, V123, P1887, DOI 10.1172/JCI66028; Sheppard Dean, 2006, Proc Am Thorac Soc, V3, P413, DOI 10.1513/pats.200601-008AW; Sottile J, 2007, AM J PHYSIOL-CELL PH, V293, pC1934, DOI 10.1152/ajpcell.00130.2007; TIMPL R, 1982, METHOD ENZYMOL, V82, P472; van der Slot AJ, 2005, BBA-MOL BASIS DIS, V1741, P95, DOI 10.1016/j.bbadis.2004.09.009; Varga J, 2009, NAT REV RHEUMATOL, V5, P200, DOI 10.1038/nrrheum.2009.26; Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200; Voloshenyuk TG, 2011, CYTOKINE, V55, P90, DOI 10.1016/j.cyto.2011.03.024; Wallace K, 2008, BIOCHEM J, V411, P1, DOI 10.1042/BJ20071570; Wang B, 2007, HEPATOLOGY, V46, P1404, DOI 10.1002/hep.21849; Wenstrup RJ, 2004, J BIOL CHEM, V279, P53331, DOI 10.1074/jbc.M409622200; Whittaker P, 2009, BLOOD CELL MOL DIS, V42, P51, DOI 10.1016/j.bcmd.2008.10.014; Yoshinaga K, 2008, P NATL ACAD SCI USA, V105, P18758, DOI 10.1073/pnas.0805411105; Zhao RG, 2014, BIOMATERIALS, V35, P5056, DOI 10.1016/j.biomaterials.2014.02.020	73	35	38	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					72	88		10.1074/jbc.M115.691519	http://dx.doi.org/10.1074/jbc.M115.691519			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26553870	hybrid, Green Published			2022-12-26	WOS:000367589500006
J	Garcia-Simon, M; Morales, JM; Modesto-Alapont, V; Gonzalez-Marrachelli, V; Vento-Rehues, R; Jorda-Minana, A; Blanquer-Olivas, J; Monleon, D				Garcia-Simon, Monica; Morales, Jose M.; Modesto-Alapont, Vicente; Gonzalez-Marrachelli, Vannina; Vento-Rehues, Rosa; Jorda-Minana, Angela; Blanquer-Olivas, Jose; Monleon, Daniel			Prognosis Biomarkers of Severe Sepsis and Septic Shock by H-1 NMR Urine Metabolomics in the Intensive Care Unit	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; LACTATE-DEHYDROGENASE; ARGININE; SERUM	Early diagnosis and patient stratification may improve sepsis outcome by a timely start of the proper specific treatment. We aimed to identify metabolomic biomarkers of sepsis in urine by H-1-NMR spectroscopy to assess the severity and to predict outcomes. Urine samples were collected from 64 patients with severe sepsis or septic shock in the ICU for a H-1 NMR spectra acquisition. A supervised analysis was performed on the processed spectra, and a predictive model for prognosis (30-days mortality/survival) of sepsis was constructed using partial least-squares discriminant analysis (PLS-DA). In addition, we compared the prediction power of metabolomics data respect the Sequential Organ Failure Assessment (SOFA) score. Supervised multivariate analysis afforded a good predictive model to distinguish the patient groups and detect specific metabolic patterns. Negative prognosis patients presented higher values of ethanol, glucose and hippurate, and on the contrary, lower levels of methionine, glutamine, arginine and phenylalanine. These metabolites could be part of a composite biopattern of the human metabolic response to sepsis shock and its mortality in ICU patients. The internal cross-validation showed robustness of the metabolic predictive model obtained and a better predictive ability in comparison with SOFA values. Our results indicate that NMR metabolic profiling might be helpful for determining the metabolomic phenotype of worst-prognosis septic patients in an early stage. A predictive model for the evolution of septic patients using these metabolites was able to classify cases with more sensitivity and specificity than the well-established organ dysfunction score SOFA.	[Garcia-Simon, Monica; Vento-Rehues, Rosa; Jorda-Minana, Angela; Blanquer-Olivas, Jose] Clin Univ Hosp Valencia, Dept Crit Care, Valencia, Spain; [Morales, Jose M.] Univ Valencia, Cent Unit Res Med, Valencia, Spain; [Modesto-Alapont, Vicente] Univ & Polytech Hosp La Fe, Dept Paediat Crit Care, Valencia, Spain; [Gonzalez-Marrachelli, Vannina; Monleon, Daniel] Clin Hosp Res Fdn INCLIVA, Valencia, Spain	University of Valencia	Monleon, D (corresponding author), Clin Hosp Res Fdn INCLIVA, Valencia, Spain.	Daniel.monleon@uv.es	Monleon, Daniel/A-5078-2010; tatay, jose manuel morales/L-7972-2014; Monleon, Daniel/GNP-4083-2022	Monleon, Daniel/0000-0002-4803-1573; tatay, jose manuel morales/0000-0002-4404-6735; Monleon, Daniel/0000-0002-4803-1573	Ministry of Economy and Competitiveness of Spain [SAF2011-23029, SAF2014-52875R]	Ministry of Economy and Competitiveness of Spain(Spanish Government)	JMM gratefully acknowledges a PTAMICINN2011 contract from the Ministry of Science of Spain. The authors gratefully acknowledge financial support from the Ministry of Economy and Competitiveness of Spain (SAF2011-23029 and SAF2014-52875R).	Antonelli M, 2009, INTENS CARE MED, V35, P405, DOI 10.1007/s00134-009-1433-4; Bodi V, 2012, J AM COLL CARDIOL, V59, P1629, DOI 10.1016/j.jacc.2011.09.083; Cabre L, 2005, INTENS CARE MED, V31, P927, DOI 10.1007/s00134-005-2640-2; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Eriksson L., 2006, MULTI MEGAVARIATE 1; Gaspar P, 2014, INFECT IMMUN, V82, P5099, DOI 10.1128/IAI.02005-14; Green R, 2004, FRONT BIOSCI-LANDMRK, V9, P1637, DOI 10.2741/1250; Griesdale DEG, 2009, CAN MED ASSOC J, V180, P821, DOI 10.1503/cmaj.090206; Holmes E, 1995, ANAL CHEM, V67, P793; Izquierdo-Garcia JL, 2014, ANESTHESIOLOGY, V120, P694, DOI 10.1097/ALN.0000000000000074; Lees HJ, 2013, J PROTEOME RES, V12, P1527, DOI 10.1021/pr300900b; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Lin ZY, 2009, NMR BIOMED, V22, P601, DOI 10.1002/nbm.1373; Luiking YC, 2005, JPEN-PARENTER ENTER, V29, pS70, DOI 10.1177/01486071050290S1S70; Luiking YC, 2012, AM J PHYSIOL-ENDOC M, V303, pE1177, DOI 10.1152/ajpendo.00284.2012; Mickiewicz B, 2014, CRIT CARE MED, V42, P1140, DOI 10.1097/CCM.0000000000000142; Mickiewicz B, 2013, AM J RESP CRIT CARE, V187, P967, DOI 10.1164/rccm.201209-1726OC; Minne L, 2008, CRIT CARE, V12, DOI 10.1186/cc7160; Noto A, 2014, J CHEMOTHERAPY, V26, P130, DOI 10.1179/1973947813Y.0000000149; Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872; Rana NF, 2013, INFECT IMMUN, V81, P2662, DOI 10.1128/IAI.01299-12; Richardson AR, 2008, SCIENCE, V319, P1672, DOI 10.1126/science.1155207; Rivers EP, 2008, CRIT CARE CLIN, V24, pS1, DOI 10.1016/j.ccc.2008.04.002; Serkova NJ, 2011, AM J RESP CRIT CARE, V184, P647, DOI 10.1164/rccm.201103-0474CI; Skibsted S, 2013, CRIT CARE, V17, DOI 10.1186/cc12693; Slupsky CM, 2009, J PROTEOME RES, V8, P5550, DOI 10.1021/pr9006427; Vincent JL, 2014, AM J RESP CRIT CARE, V190, P1081, DOI 10.1164/rccm.201410-1895ED; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wischmeyer PE, 2007, CRIT CARE MED, V35, pS541, DOI 10.1097/01.CCM.0000278064.32780.D3; Zhu LX, 2013, HEPATOLOGY, V57, P601, DOI 10.1002/hep.26093	31	49	51	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0140993	10.1371/journal.pone.0140993	http://dx.doi.org/10.1371/journal.pone.0140993			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26565633	Green Published, gold, Green Submitted			2022-12-26	WOS:000367628500003
J	Heidegger, S; Jarosch, A; Schmickl, M; Endres, S; Bourquin, C; Hotz, C				Heidegger, Simon; Jarosch, Alexander; Schmickl, Martina; Endres, Stefan; Bourquin, Carole; Hotz, Christian			Mycoplasma hyorhinis-Contaminated Cell Lines Activate Primary Innate Immune Cells via a Protease-Sensitive Factor	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; TOLL-LIKE RECEPTORS; NF-KAPPA-B; CPG-OLIGODEOXYNUCLEOTIDES; ANTIMICROBIAL PEPTIDE; DNA; LIPOPROTEINS; RECOGNITION; RESPONSES; TLR6	Mycoplasma are a frequent and occult contaminant of cell cultures, whereby these prokaryotic organisms can modify many aspects of cell physiology, rendering experiments that are conducted with such contaminated cells problematic. Chronic Mycoplasma contamination in human monocytic cells lines has been associated with suppressed Toll-like receptor (TLR) function. In contrast, we show here that components derived from a Mycoplasma hyorhinis-infected cell line can activate innate immunity in non-infected primary immune cells. Release of pro-inflammatory cytokines such as IL-6 by dendritic cells in response to Mycoplasma hyorhinis-infected cell components was critically dependent on the adapter protein MyD88 but only partially on TLR2. Unlike canonical TLR2 signaling that is triggered in response to the detection of Mycoplasma infection, innate immune activation by components of Mycoplasma-infected cells was inhibited by chloroquine treatment and sensitive to protease treatment. We further show that in plasmacytoid dendritic cells, soluble factors from Mycoplasma hyorhinis-infected cells induce the production of large amounts of IFN-alpha. We conclude that Mycoplasma hyorhinis-infected cell lines release protein factors that can potently activate co-cultured innate immune cells via a previously unrecognized mechanism, thus limiting the validity of such co-culture experiments.	[Heidegger, Simon; Jarosch, Alexander; Endres, Stefan; Bourquin, Carole; Hotz, Christian] Univ Munich, CIPSM, Div Clin Pharmacol, Med Klin & Poliklin 4, D-80336 Munich, Germany; [Heidegger, Simon; Schmickl, Martina] Tech Univ Munich, Klinikum Rechts Isar, Med Klin 3, D-81675 Munich, Germany; [Bourquin, Carole; Hotz, Christian] Univ Fribourg, Dept Med, Chair Pharmacol, Fac Sci, CH-1700 Fribourg, Switzerland	University of Munich; Technical University of Munich; University of Fribourg	Bourquin, C (corresponding author), Univ Munich, CIPSM, Div Clin Pharmacol, Med Klin & Poliklin 4, D-80336 Munich, Germany.	carole.bourquin@unifr.ch	Heidegger, Simon/ABF-7070-2021; Bourquin, Carole/AAU-1418-2020	Bourquin, Carole/0000-0003-3862-4583; Heidegger, Simon/0000-0001-6394-5130; Hotz, Christian/0000-0001-6148-9821	Swiss National Science Foundation [138284]; Swiss Foundation for Cancer Research [KFS-2910-02-2012]; German Research Foundation (DFG) Graduiertenkolleg 1202	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Foundation for Cancer Research; German Research Foundation (DFG) Graduiertenkolleg 1202(German Research Foundation (DFG))	This work was supported by grants from the Swiss National Science Foundation (project 138284 to C.B.), the Swiss Foundation for Cancer Research (grant KFS-2910-02-2012 to C.B. and C.H.), and the German Research Foundation (DFG) Graduiertenkolleg 1202 (to C.B., S.E., and S.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Aparicio CL, 1997, BIOTECHNIQUES, V23, P1056, DOI 10.2144/97236st01; Bourquin C, 2010, J IMMUNOTHER, V33, P935, DOI 10.1097/CJI.0b013e3181f5dfa7; Chauhan D, 2009, CANCER CELL, V16, P309, DOI 10.1016/j.ccr.2009.08.019; Choi YJ, 2010, J BIOL CHEM, V285, P21382, DOI 10.1074/jbc.M110.115022; Drexler HG, 2002, CYTOTECHNOLOGY, V39, P75, DOI 10.1023/A:1022913015916; FIDLER IJ, 1975, CANCER RES, V35, P218; Ganguly D, 2009, J EXP MED, V206, P1983, DOI 10.1084/jem.20090480; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Into T, 2004, CELL MICROBIOL, V6, P187, DOI 10.1046/j.1462-5822.2003.00356.x; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Love W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010739; Macfarlane DE, 1998, J IMMUNOL, V160, P1122; Nakao Y, 2005, J IMMUNOL, V174, P1566, DOI 10.4049/jimmunol.174.3.1566; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Sawahata R, 2011, MICROBES INFECT, V13, P350, DOI 10.1016/j.micinf.2010.12.003; Schmitt M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp581; Seregin SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022064; Shimizu T, 2005, J IMMUNOL, V175, P4641, DOI 10.4049/jimmunol.175.7.4641; Takeuchi O, 2000, J IMMUNOL, V164, P554, DOI 10.4049/jimmunol.164.2.554; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; WANG M, 1995, J IMMUNOL, V154, P4685; Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Yi AK, 1998, J IMMUNOL, V160, P4755; Young L, 2010, NAT PROTOC, V5, P929, DOI 10.1038/nprot.2010.43; Zakharova E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009900	33	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142523	10.1371/journal.pone.0142523	http://dx.doi.org/10.1371/journal.pone.0142523			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26565413	Green Published, gold			2022-12-26	WOS:000367628500029
J	Nussle, S; Matthews, KR; Carlson, SM				Nussle, Sebastien; Matthews, Kathleen R.; Carlson, Stephanie M.			Mediating Water Temperature Increases Due to Livestock and Global Change in High Elevation Meadow Streams of the Golden Trout Wilderness	PLOS ONE			English	Article							JUVENILE COHO SALMON; CLIMATE-CHANGE; EVOLUTIONARY RESPONSES; EXTINCTION RISK; RESTORATION; CALIFORNIA; WILD; BIODIVERSITY; COMMUNITIES; HABITAT	Rising temperatures due to climate change are pushing the thermal limits of many species, but how climate warming interacts with other anthropogenic disturbances such as land use remains poorly understood. To understand the interactive effects of climate warming and livestock grazing on water temperature in three high elevation meadow streams in the Golden Trout Wilderness, California, we measured riparian vegetation and monitored water temperature in three meadow streams between 2008 and 2013, including two "resting" meadows and one meadow that is partially grazed. All three meadows have been subject to grazing by cattle and sheep since the 1800s and their streams are home to the imperiled California golden trout (Oncorhynchus mykiss aguabonita). In 1991, a livestock exclosure was constructed in one of the meadows (Mulkey), leaving a portion of stream ungrazed to minimize the negative effects of cattle. In 2001, cattle were removed completely from two other meadows (Big Whitney and Ramshaw), which have been in a "resting" state since that time. Inside the livestock exclosure in Mulkey, we found that riverbank vegetation was both larger and denser than outside the exclosure where cattle were present, resulting in more shaded waters and cooler maximal temperatures inside the exclosure. In addition, between meadows comparisons showed that water temperatures were cooler in the ungrazed meadows compared to the grazed area in the partially grazed meadow. Finally, we found that predicted temperatures under different global warming scenarios were likely to be higher in presence of livestock grazing. Our results highlight that land use can interact with climate change to worsen the local thermal conditions for taxa on the edge and that protecting riparian vegetation is likely to increase the resiliency of these ecosystems to climate change.	[Nussle, Sebastien; Carlson, Stephanie M.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Matthews, Kathleen R.] US Forest Serv, Pacific Southwest Res Stn, USDA, Albany, CA USA	University of California System; University of California Berkeley; United States Department of Agriculture (USDA); United States Forest Service	Nussle, S (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	snussle@gmail.com		Carlson, Stephanie/0000-0003-3055-6483	USDA Pacific Southwest Research Station; National Fish and Wildlife Foundation [3017]; Sierra Flyfishers; Swiss National Science Foundation [P2LAP3_148434]	USDA Pacific Southwest Research Station; National Fish and Wildlife Foundation; Sierra Flyfishers; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The project and KRM were funded by the USDA Pacific Southwest Research Station (http://www.fs.fed.us/psw/), National Fish and Wildlife Foundation (Bring Back the Natives Grant #3017) (http://www.nfwf.org/bbn), and the Sierra Flyfishers. SN was funded by the Swiss National Science Foundation (P2LAP3_148434) (www.snf.ch).	[Anonymous], 2009, CLIMATE CHANGE IMPAC, DOI DOI 10.1111/j.1365-2664.2010.01827.x; Arismendi I, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/8/084015; Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Bates Douglas, 2014, LME4 LINEAR MIXED EF; BEACHAM TD, 1990, T AM FISH SOC, V119, P927, DOI 10.1577/1548-8659(1990)119&lt;0927:TESADO&gt;2.3.CO;2; Behnke RJ, 1976, USDA FOREST SERVICE, P45; Beitinger TL, 2000, ENVIRON BIOL FISH, V58, P237, DOI 10.1023/A:1007676325825; Belsky AJ, 1999, J SOIL WATER CONSERV, V54, P419; Beniston M, 1997, CLIMATIC CHANGE, V36, P233, DOI 10.1023/A:1005380714349; Beschta RL, 2013, ENVIRON MANAGE, V51, P474, DOI 10.1007/s00267-012-9964-9; Bevelhimer M., 2000, ENVIRON SCI POLICY, V3, P211, DOI DOI 10.1016/S1462-9011(00)00056-3; BIDGOOD BF, 1969, J FISH RES BOARD CAN, V26, P456, DOI 10.1139/f69-044; Bjornn T.C., 1991, American Fisheries Society Special Publication, P83; BONAN GB, 2008, AM ASS ADVANCEMENT S, V320, P1444, DOI DOI 10.1126/SCIENCE.1155121; Bowler DE, 2012, ENVIRON EVID, V1, DOI 10.1186/2047-2382-1-3; Brander KM, 2007, P NATL ACAD SCI USA, V104, P19709, DOI 10.1073/pnas.0702059104; Cairns MA, 2005, T AM FISH SOC, V134, P1471, DOI 10.1577/T04-151.1; CAR, 2014, UNITED STATE CLIMATE; Carlson SM, 2014, EVOLUTIONARY RESCUE; Christensen JH, 2003, NATURE, V421, P805, DOI 10.1038/421805a; Comte L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6053; Crozier LG, 2008, EVOL APPL, V1, P252, DOI 10.1111/j.1752-4571.2008.00033.x; Crozier LG, 2014, EVOL APPL, V7, P68, DOI 10.1111/eva.12135; Durance I, 2007, GLOBAL CHANGE BIOL, V13, P942, DOI 10.1111/j.1365-2486.2007.01340.x; Ficke AD, 2007, REV FISH BIOL FISHER, V17, P581, DOI 10.1007/s11160-007-9059-5; FLEISCHNER TL, 1994, CONSERV BIOL, V8, P629, DOI 10.1046/j.1523-1739.1994.08030629.x; Hammersmark CT, 2008, RIVER RES APPL, V24, P735, DOI 10.1002/rra.1077; Hansen AJ, 2001, BIOSCIENCE, V51, P765, DOI 10.1641/0006-3568(2001)051[0765:GCIFRO]2.0.CO;2; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Herbst DB, 2012, FRESHWATER BIOL, V57, P204, DOI 10.1111/j.1365-2427.2011.02706.x; Hughes B, 2014, FISHERIES, V39, P339, DOI 10.1080/03632415.2014.932775; Hunter M, 2010, CONSERV BIOL, V24, P1169, DOI 10.1111/j.1523-1739.2010.01569.x; Isaak DJ, 2015, GLOBAL CHANGE BIOL, V21, P2540, DOI 10.1111/gcb.12879; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jensen AJ, 1999, FUNCT ECOL, V13, P778, DOI 10.1046/j.1365-2435.1999.00358.x; Johnson SL, 2004, CAN J FISH AQUAT SCI, V61, P913, DOI [10.1139/f04-040, 10.1139/F04-040]; Johnson SL, 2003, HYDROL PROCESS, V17, P497, DOI 10.1002/hyp.5091; Kanno Y, 2014, RIVER RES APPL, V30, P745, DOI 10.1002/rra.2677; Kaushal SS, 2010, FRONT ECOL ENVIRON, V8, P461, DOI 10.1890/090037; Keith DA, 2014, CONSERV BIOL, V28, P810, DOI 10.1111/cobi.12234; Kirtman B., 2013, IPCC 2013 CLIMATE CH, P953; Knapp RA, 1998, ECOL APPL, V8, P1104, DOI 10.1890/1051-0761(1998)008[1104:EOSCMO]2.0.CO;2; Knapp Roland A., 1996, North American Journal of Fisheries Management, V16, P805, DOI 10.1577/1548-8675(1996)016<0805:LGGTAS>2.3.CO;2; Kristensen P.B., 2013, HYDROLOGY EARTH SYST, V10, P6081, DOI DOI 10.5194/HESSD-10-6081-2013; Kuznetsova A, 2014, TESTS IN LINEAR MIXE; Lapointe M, 2000, CAN J FISH AQUAT SCI, V57, P1120, DOI 10.1139/cjfas-57-6-1120; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; LIKENS GE, 1970, ECOL MONOGR, V40, P23, DOI 10.2307/1942440; Luce C, 2014, WATER RESOUR RES, V50, P3428, DOI 10.1002/2013WR014329; Matthews KR, 1997, J FISH BIOL, V50, P50, DOI 10.1111/j.1095-8649.1997.tb01339.x; Moore RD, 2005, J AM WATER RESOUR AS, V41, P813, DOI 10.1111/j.1752-1688.2005.tb04465.x; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Morrill JC, 2005, J ENVIRON ENG, V131, P139, DOI 10.1061/(ASCE)0733-9372(2005)131:1(139); Moyle PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063883; OSBORNE LL, 1993, FRESHWATER BIOL, V29, P243, DOI 10.1111/j.1365-2427.1993.tb00761.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pister EP, 2010, FISHERIES, V35, P550, DOI 10.1577/1548-8446-35.11.550; Pister EP, 2008, REPORT NO CENTRAL RE, P126; Poff N.L., 2002, AQUATIC ECOSYSTEMS G; Prato T, 2011, ENVIRON MANAGE, V48, P142, DOI 10.1007/s00267-011-9648-x; Purdy SE, 2012, ENVIRON MONIT ASSESS, V184, P6967, DOI 10.1007/s10661-011-2473-0; QUIGLEY T M, 1981, Wildlife Society Bulletin, V9, P22; R Core Team, 2013, R A LANGUAGE AND ENV; Ratliff RD, 1985, REPORT NO GENERAL TE; Richter A, 2005, REV FISH SCI, V13, P23, DOI 10.1080/10641260590885861; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; STEFAN HG, 1993, CLIMATIC CHANGE, V24, P353, DOI 10.1007/BF01091855; Sterud E, 2007, DIS AQUAT ORGAN, V77, P191, DOI 10.3354/dao01846; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tuffour H.O., 2014, IJSRES, V2, P139, DOI [10.12983/ijsres-2014-p0139-0149, DOI 10.12983/IJSRES-2014-P0139-0149]; Viers JH, 2013, CENTER FOR WATERSHED; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Weixelman DA, 1997, J RANGE MANAGE, V50, P315, DOI 10.2307/4003735; Welsh HH, 2001, N AM J FISH MANAGE, V21, P464, DOI 10.1577/1548-8675(2001)021&lt;0464:DOJCSI&gt;2.0.CO;2	77	15	17	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142426	10.1371/journal.pone.0142426	http://dx.doi.org/10.1371/journal.pone.0142426			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26565706	Green Submitted, Green Published, gold			2022-12-26	WOS:000367628500022
J	Vedelek, B; Blastyak, A; Boros, IM				Vedelek, Balazs; Blastyak, Andras; Boros, Imre M.			Cross-Species Interaction between Rapidly Evolving Telomere-Specific Drosophila Proteins	PLOS ONE			English	Article							HETEROCHROMATIN PROTEIN-1; CHROMOSOMAL-PROTEIN; COMPLEX; GENE; HOAP; HP1; IDENTIFICATION; MELANOGASTER; MAINTENANCE; ELONGATION	Telomere integrity in Drosophila melanogaster is maintained by a putative multisubunit complex called terminin that is believed to act in analogy to the mammalian shelterin complex in protecting chromosome ends from being recognized as sites of DNA damage. The five proteins supposed to form the terminin complex are HP1-ORC associated protein, HP1-HOAP interacting protein, Verrocchio, Drosophila Telomere Loss/Modigliani and Heterochromatic Protein 1. Four of these proteins evolve rapidly within the Drosophila genus. The accelerated evolution of terminin components may indicate the involvement of these proteins in the process by which new species arise, as the resulting divergence of terminin proteins might prevent hybrid formation, thus driving speciation. However, terminin is not an experimentally proven entity, and no biochemical studies have been performed to investigate its assembly and action in detail. Motivated by these facts in order to initiate biochemical studies on terminin function, we attempted to reconstitute terminin by co-expressing its subunits in bacteria and investigated the possible role of the fast-evolving parts of terminin components in complex assembly. Our results suggest formation of stable subcomplexes of terminin, but not of the whole complex in vitro. We found that the accelerated evolution is restricted to definable regions of terminin components, and that the divergence of D. melanogaster Drosophila Telomere Loss and D. yakuba Verrocchio proteins does not preclude their stable interaction.	[Vedelek, Balazs; Blastyak, Andras; Boros, Imre M.] Univ Szeged, Dept Biochem & Mol Biol, Szeged, Hungary; [Blastyak, Andras; Boros, Imre M.] Hungarian Acad Sci, Inst Biochem, Biol Res Ctr, Szeged, Hungary	Szeged University; Hungarian Academy of Sciences; Hungarian Biological Research Center	Boros, IM (corresponding author), Univ Szeged, Dept Biochem & Mol Biol, Szeged, Hungary.	borosi@bio.u-szeged.hu	Vedelek, Balázs/M-4274-2018	Vedelek, Balázs/0000-0001-6981-0026; Boros, Imre/0000-0001-8504-9687	Hungarian Scientific Research Fund [OTKA PD83660, OTKA K100969]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was funded by the Hungarian Scientific Research Fund (www.otka.hu) (OTKA PD83660 to BA; OTKA K100969 to IMB).	AASLAND R, 1995, NUCLEIC ACIDS RES, V23, P3168; Badugu R, 2003, J BIOL CHEM, V278, P34491, DOI 10.1074/jbc.M305262200; Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; Brideau NJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-57; Cenci G, 2005, CHROMOSOMA, V114, P135, DOI 10.1007/s00412-005-0005-9; Cenci G, 2003, NAT CELL BIOL, V5, P82, DOI 10.1038/ncb902; Diebold ML, 2011, J STRUCT BIOL, V175, P178, DOI 10.1016/j.jsb.2011.02.001; Dubruille Raphaelle, 2012, Int J Evol Biol, V2012, P708980, DOI 10.1155/2012/708980; EISSENBERG JC, 1990, P NATL ACAD SCI USA, V87, P9923, DOI 10.1073/pnas.87.24.9923; Fanti L, 1998, MOL CELL, V2, P527, DOI 10.1016/S1097-2765(00)80152-5; Fukagawa T, 2013, DEV CELL, V27, P367, DOI 10.1016/j.devcel.2013.11.005; Fulcher N, 2014, CELL MOL LIFE SCI, V71, P847, DOI 10.1007/s00018-013-1469-z; Gao G, 2011, P NATL ACAD SCI US; Gao GJ, 2010, EMBO J, V29, P819, DOI 10.1038/emboj.2009.394; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Guardino KM, 2009, INT J MOL SCI, V10, P2412, DOI 10.3390/ijms10052412; Hankeln T, 2002, J BIOL CHEM, V277, P29012, DOI 10.1074/jbc.M204009200; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; JAMES TC, 1986, MOL CELL BIOL, V6, P3862, DOI 10.1128/MCB.6.11.3862; James TC, NUCL ACIDS RES, V19, P789; Komonyi O, 2005, J BIOL CHEM, V280, P12397, DOI 10.1074/jbc.M409251200; Komonyi O, 2009, J CELL SCI, V122, P769, DOI 10.1242/jcs.035097; KOONIN EV, 1995, NUCLEIC ACIDS RES, V23, P4229, DOI 10.1093/nar/23.21.4229; Korber B, COMPUTATIONAL ANAL H, P55; Louis EJ, 2002, GENOME BIOL, V3; Lydall D, 2009, EMBO J, V28, P2174, DOI 10.1038/emboj.2009.176; Mason JM, 2008, BIOESSAYS, V30, P25, DOI 10.1002/bies.20688; MASON JM, 1995, TRENDS GENET, V11, P58, DOI 10.1016/S0168-9525(00)88998-2; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; OLOVNIKO.AM, 1971, DOKL AKAD NAUK SSSR+, V201, P1496; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pardue ML, 2003, ANNU REV GENET, V37, P485, DOI 10.1146/annurev.genet.38.072902.093115; Perrini B, 2004, MOL CELL, V15, P467, DOI 10.1016/j.molcel.2004.06.036; Raffa GD, 2011, NUCLEUS-PHILA, V2, P383, DOI 10.4161/nucl.2.5.17873; Raffa GD, 2010, GENE DEV, V24, P1596, DOI 10.1101/gad.574810; Raffa GD, 2009, P NATL ACAD SCI USA, V106, P2271, DOI 10.1073/pnas.0812702106; Reinhardt JA, 2013, J MOL EVOL, V77, P246, DOI 10.1007/s00239-013-9594-8; Satyaki PRV, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004240; Savitsky M, 2002, MOL CELL BIOL, V22, P3204, DOI 10.1128/MCB.22.9.3204-3218.2002; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Shareef MM, 2001, MOL BIOL CELL, V12, P1671, DOI 10.1091/mbc.12.6.1671; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; Sun W, 2006, MOL CELL PROTEOMICS, V5, P769, DOI 10.1074/mcp.T500022-MCP200; Suyama M, NUCL ACIDS RES, V34, pW609; Villasante A, 2008, CELL CYCLE, V7, P2134, DOI 10.4161/cc.7.14.6275; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; Yao N, 2003, J BIOL CHEM, V278, P50744, DOI 10.1074/jbc.M309206200; YASUDA GK, 1995, GENETICS, V140, P219	49	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142771	10.1371/journal.pone.0142771	http://dx.doi.org/10.1371/journal.pone.0142771			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26566042	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000367628500052
J	Lee, SJ; Choi, W; Seo, E; Yeom, E				Lee, Sang Joon; Choi, Woorak; Seo, Eunseok; Yeom, Eunseop			Association of Early Atherosclerosis with Vascular Wall Shear Stress in Hypercholesterolemic Zebrafish	PLOS ONE			English	Article							CELL-FREE LAYER; BLOOD-FLOW; CAROTID BIFURCATION; DISTURBED FLOW; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR-DISEASE; VELOCITY PROFILES; PLASMA VISCOSITY; ANIMAL-MODELS; PLAQUE	Although atherosclerosis is a multifactorial disease, the role of hemodynamic information has become more important. Low and oscillating wall shear stress (WSS) that changes its direction is associated with the early stage of atherosclerosis. Several in vitro and in vivo models were proposed to reveal the relation between the WSS and the early atherosclerosis. However, these models possess technical limitations in mimicking real physiological conditions and monitoring the developmental course of the early atherosclerosis. In this study, a hypercholesterolaemic zebrafish model is proposed as a novel experimental model to resolve these limitations. Zebrafish larvae are optically transparent, which enables temporal observation of pathological variations under in vivo condition. WSS in blood vessels of 15 days post-fertilisation zebrafish was measured using a micro particle image velocimetry (PIV) technique, and spatial distribution of lipid deposition inside the model was quantitatively investigated after feeding high cholesterol diet for 10 days. Lipids were mainly deposited in blood vessel of low WSS. The oscillating WSS was not induced by the blood flows in zebrafish models. The present hypercholesterolaemic zebrafish would be used as a potentially useful model for in vivo study about the effects of low WSS in the early atherosclerosis.	[Lee, Sang Joon; Choi, Woorak; Yeom, Eunseop] Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, Pohang 790784, South Korea; [Seo, Eunseok] DGIST, Dept New Biol, Dalseong 711873, Daegu, South Korea	Pohang University of Science & Technology (POSTECH); Daegu Gyeongbuk Institute of Science & Technology (DGIST)	Lee, SJ (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, San 31, Pohang 790784, South Korea.	sjlee@postech.ac.kr	Lee, Sang Joon/AAG-2448-2019; Yeom, Eunseop/AAR-8322-2020		National Research Foundation of Korea (NRF) - Korean government (MSIP) [2008-0061991]	National Research Foundation of Korea (NRF) - Korean government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) under a grant funded by the Korean government (MSIP) (No. 20080061991). URL: http://www.nrf.re.kr/nrf_eng_cms/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRIAN RJ, 1991, ANNU REV FLUID MECH, V23, P261, DOI 10.1146/annurev.fl.23.010191.001401; Al-Khazraji BK, 2012, MICROCIRCULATION, V19, P327, DOI 10.1111/j.1549-8719.2012.00165.x; Anton H, 2013, DEVELOPMENT, V140, P4426, DOI 10.1242/dev.096768; Ashfaq S, 2006, J AM COLL CARDIOL, V47, P1005, DOI 10.1016/j.jacc.2005.09.063; Baek JS, 2012, CHOLESTEROL, DOI 10.1155/2012/564705; Bagchi P, 2007, BIOPHYS J, V92, P1858, DOI 10.1529/biophysj.106.095042; Barakat AI, 2013, CR PHYS, V14, P479, DOI 10.1016/j.crhy.2013.05.003; Bassiouny HS, 1998, CIRCULATION, V98, P157, DOI 10.1161/01.CIR.98.2.157; Cecchi E, 2011, ATHEROSCLEROSIS, V214, P249, DOI 10.1016/j.atherosclerosis.2010.09.008; Chico TJA, 2008, TRENDS CARDIOVAS MED, V18, P150, DOI 10.1016/j.tcm.2008.04.002; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Cunningham KS, 2005, LAB INVEST, V85, P9, DOI 10.1038/labinvest.3700215; Egginton S, 1996, J FISH BIOL, V48, P513, DOI 10.1111/j.1095-8649.1996.tb01444.x; ERNST E, 1988, STROKE, V19, P634, DOI 10.1161/01.STR.19.5.634; Estrada R, 2011, ANAL CHEM, V83, P3170, DOI 10.1021/ac2002998; Fang LH, 2014, TRANSL RES, V163, P99, DOI 10.1016/j.trsl.2013.09.004; Fang LH, 2012, FREE RADICAL BIO MED, V53, P1411, DOI 10.1016/j.freeradbiomed.2012.08.004; Fedosov DA, 2010, MICROCIRCULATION, V17, P615, DOI 10.1111/j.1549-8719.2010.00056.x; Forouhar AS, 2006, SCIENCE, V312, P751, DOI 10.1126/science.1123775; Ganji SH, 2003, J NUTR BIOCHEM, V14, P298, DOI 10.1016/S0955-2863(02)00284-X; GIBSON CM, 1993, ARTERIOSCLER THROMB, V13, P310, DOI 10.1161/01.ATV.13.2.310; Gimbrone MA, 2013, CARDIOVASC PATHOL, V22, P9, DOI 10.1016/j.carpath.2012.06.006; Gnasso A, 1997, STROKE, V28, P993, DOI 10.1161/01.STR.28.5.993; Greve JM, 2006, AM J PHYSIOL-HEART C, V291, pH1700, DOI 10.1152/ajpheart.00274.2006; Ha HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111047; Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596; Hart D. P., 2000, Journal of Visualization, V3, P187, DOI 10.1007/BF03182411; Himburg HA, 2004, AM J PHYSIOL-HEART C, V286, pH1916, DOI 10.1152/ajpheart.00897.2003; Hove Jay R, 2004, Birth Defects Res C Embryo Today, V72, P277, DOI 10.1002/bdrc.20019; Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282; Iiyama K, 1999, CIRC RES, V85, P199, DOI 10.1161/01.RES.85.2.199; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Jamison RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075722; Kari G, 2007, CLIN PHARMACOL THER, V82, P70, DOI 10.1038/sj.clpt.6100223; Keller ET, 2004, COMP BIOCHEM PHYS C, V138, P335, DOI 10.1016/j.cca.2004.04.001; Kesmarky G, 2008, CLIN HEMORHEOL MICRO, V39, P243, DOI 10.3233/CH-2008-1088; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; KU DN, 1985, ARTERIOSCLEROSIS, V5, P293, DOI 10.1161/01.ATV.5.3.293; Lee SJ, 2011, MICROVASC RES, V82, P296, DOI 10.1016/j.mvr.2011.09.005; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; McGillicuddy FC, 2014, ADV EXP MED BIOL, V809, P83; MOORE JE, 1994, ATHEROSCLEROSIS, V110, P225, DOI 10.1016/0021-9150(94)90207-0; Nakashima Y, 1998, ARTERIOSCL THROM VAS, V18, P842, DOI 10.1161/01.ATV.18.5.842; Nam D, 2009, AM J PHYSIOL-HEART C, V297, pH1535, DOI 10.1152/ajpheart.00510.2009; Namgung B, 2011, ANN BIOMED ENG, V39, P359, DOI 10.1007/s10439-010-0130-3; Oshinski JN, 1995, JMRI-J MAGN RESON IM, V5, P640; Passerini AG, 2004, P NATL ACAD SCI USA, V101, P2482, DOI 10.1073/pnas.0305938101; Poelma C, 2010, J R SOC INTERFACE, V7, P91, DOI 10.1098/rsif.2009.0063; RIDLER TW, 1978, IEEE T SYST MAN CYB, V8, P630, DOI 10.1109/tsmc.1978.4310039; Sampaio D, 2015, EXP THERM FLUID SCI, V68, P205, DOI 10.1016/j.expthermflusci.2015.04.020; Shaaban AM, 2000, AM J ROENTGENOL, V174, P1657, DOI 10.2214/ajr.174.6.1741657; Stoletov K, 2009, CIRC RES, V104, P952, DOI 10.1161/CIRCRESAHA.108.189803; Suo J, 2007, ARTERIOSCL THROM VAS, V27, P346, DOI 10.1161/01.ATV.0000253492.45717.46; Tarbell JM, 2014, ANNU REV FLUID MECH, V46, P591, DOI 10.1146/annurev-fluid-010313-141309; TEXON M, 1965, J AMER MED ASSOC, V194, P1226; Ueki Y, 2010, BIOCHEM BIOPH RES CO, V394, P94, DOI 10.1016/j.bbrc.2010.02.115; Watkins SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044018; Windberger U, 2003, EXP PHYSIOL, V88, P431, DOI 10.1113/eph8802496; Winkel LC, 2015, ATHEROSCLEROSIS, V241, P100, DOI 10.1016/j.atherosclerosis.2015.04.796; Xie X, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1053; Yeom E, 2014, ULTRASONICS, V54, P2184, DOI 10.1016/j.ultras.2014.06.002; Yeom E, 2014, BIOMICROFLUIDICS, V8, DOI 10.1063/1.4883275; Young EWK, 2010, LAB CHIP, V10, P143, DOI 10.1039/b913390a; ZARINS CK, 1983, CIRC RES, V53, P502, DOI 10.1161/01.RES.53.4.502; Zeng LF, 2009, P NATL ACAD SCI USA, V106, P8326, DOI 10.1073/pnas.0903197106	67	8	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142945	10.1371/journal.pone.0142945	http://dx.doi.org/10.1371/journal.pone.0142945			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26561854	Green Published, Green Submitted, gold			2022-12-26	WOS:000364480900085
J	Mahajan, G; Mande, SC				Mahajan, Gaurang; Mande, Shekhar C.			From System-Wide Differential Gene Expression to Perturbed Regulatory Factors: A Combinatorial Approach	PLOS ONE			English	Article							SET ENRICHMENT ANALYSIS; FACTOR-BINDING SITES; TRANSCRIPTION FACTOR; ESCHERICHIA-COLI; FUNCTIONAL-ANALYSIS; INTEGRATED-SYSTEM; MICROARRAY DATA; DNA ELEMENTS; DATABASE; NETWORK	High-throughput experiments such as microarrays and deep sequencing provide large scale information on the pattern of gene expression, which undergoes extensive remodeling as the cell dynamically responds to varying environmental cues or has its function disrupted under pathological conditions. An important initial step in the systematic analysis and interpretation of genome-scale expression alteration involves identification of a set of perturbed transcriptional regulators whose differential activity can provide a proximate hypothesis to account for these transcriptomic changes. In the present work, we propose an unbiased and logically natural approach to transcription factor enrichment. It involves overlaying a list of experimentally determined differentially expressed genes on a background regulatory network coming from e.g. literature curation or computational motif scanning, and identifying that subset of regulators whose aggregated target set best discriminates between the altered and the unaffected genes. In other words, our methodology entails testing of all possible regulatory subnetworks, rather than just the target sets of individual regulators as is followed in most standard approaches. We have proposed an iterative search method to efficiently find such a combination, and benchmarked it on E. coli microarray and regulatory network data available in the public domain. Comparative analysis carried out on artificially generated differential expression profiles, as well as empirical factor overexpression data for M. tuberculosis, shows that our methodology provides marked improvement in accuracy of regulatory inference relative to the standard method that involves evaluating factor enrichment in an individual manner.	[Mahajan, Gaurang; Mande, Shekhar C.] Natl Ctr Cell Sci, Pune, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Mahajan, G (corresponding author), Natl Ctr Cell Sci, Pune, Maharashtra, India.	gaurang@nccs.res.in		Mahajan, Gaurang/0000-0002-6583-6269	Department of Biotechnology, Government of India [SM/BT/01/07/02/2008]; Department of Science and Technology, Government of India [INT/RUS/RFBR/P-154]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Science and Technology, Government of India(Department of Science & Technology (India))	1. Department of Biotechnology, Government of India (Grant SM/BT/01/07/02/2008): SCM 2. Department of Science and Technology, Government of India (Grant INT/RUS/RFBR/P-154): SCM The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, INTRO SYSTEMS BIOL D; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Auerbach RK, 2013, BIOINFORMATICS, V29, P1922, DOI 10.1093/bioinformatics/btt316; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Balaji S, 2006, J MOL BIOL, V360, P213, DOI 10.1016/j.jmb.2006.04.029; Ball CA, 2004, PLOS BIOL, V2, P1276, DOI 10.1371/journal.pbio.0020317; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blais A, 2005, GENE DEV, V19, P1499, DOI 10.1101/gad.1325605; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Bleda M, 2012, NUCLEIC ACIDS RES, V40, pW168, DOI 10.1093/nar/gks573; BOUNDS DG, 1987, NATURE, V329, P215, DOI 10.1038/329215a0; Bovolenta LA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-405; Box GEP., 2008, TIME SERIES ANAL, DOI [10.1002/9781118619193, DOI 10.1002/9781118619193]; Chen EY, 2012, BIOINFORMATICS, V28, P105, DOI 10.1093/bioinformatics/btr625; Chindelevitch L, 2012, BIOINFORMATICS, V28, P1114, DOI 10.1093/bioinformatics/bts090; Cho BK, 2009, NAT BIOTECHNOL, V27, P1043, DOI 10.1038/nbt.1582; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Chvatal V., 1979, Mathematics of Operations Research, V4, P233, DOI 10.1287/moor.4.3.233; D'haeseleer P, 2006, NAT BIOTECHNOL, V24, P959, DOI 10.1038/nbt0806-959; Daily K, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-495; de Visser JAGM, 2014, NAT REV GENET, V15, P480, DOI 10.1038/nrg3744; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dhand R, 2000, NATURE, V405, P819; Dubchak I, 2013, BIOINFORMATICS, V29, P2059, DOI 10.1093/bioinformatics/btt318; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elkon R, 2003, GENOME RES, V13, P773, DOI 10.1101/gr.947203; Faith JJ, 2008, NUCLEIC ACIDS RES, V36, pD866, DOI 10.1093/nar/gkm815; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Gotea V, 2010, GENOME RES, V20, P565, DOI 10.1101/gr.104471.109; Haverty PM, 2004, NUCLEIC ACIDS RES, V32, P179, DOI 10.1093/nar/gkh183; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hume MA, 2015, NUCLEIC ACIDS RES, V43, pD117, DOI 10.1093/nar/gku1045; Irizarry RA, 2009, STAT METHODS MED RES, V18, P565, DOI 10.1177/0962280209351908; Jahid MJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S6-S8; Jeffery IB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-359; KAUFFMAN S, 1987, J THEOR BIOL, V128, P11, DOI 10.1016/S0022-5193(87)80029-2; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kim HD, 2009, SCIENCE, V325, P429, DOI 10.1126/science.1171347; Kim J, 2012, NUCLEIC ACIDS RES, V40, P8849, DOI 10.1093/nar/gks664; KIRKPATRICK S, 1984, J STAT PHYS, V34, P975, DOI 10.1007/BF01009452; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kirkpatrick S., 1982, 9355 IBM RC; Kou Y, 2013, LECT NOTES COMPUT SC, V8127, P416; Kouyos RD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002551; Kulakovskiy IV, 2013, NUCLEIC ACIDS RES, V41, pD195, DOI 10.1093/nar/gks1089; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Lachmann A, 2009, BIOINFORMATICS, V25, P684, DOI 10.1093/bioinformatics/btp026; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lee HK, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-269; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Maurer LM, 2005, J BACTERIOL, V187, P304, DOI 10.1128/JB.187.1.304-319.2005; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Mouse ENCODE Consortium, 2012, Genome Biol, V13, P418, DOI 10.1186/gb-2012-13-8-418; Murali T, 2011, NUCLEIC ACIDS RES, V39, pD736, DOI 10.1093/nar/gkq1092; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Rohde KH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002769; Rustad TR, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0502-3; Salgado H, 2013, NUCLEIC ACIDS RES, V41, pD203, DOI 10.1093/nar/gks1201; Sanz J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022178; Shabala L, 2009, ENVIRON MICROBIOL, V11, P137, DOI 10.1111/j.1462-2920.2008.01748.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Soon WW, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.61; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tarca AL, 2007, PLOS COMPUT BIOL, V3, P953, DOI 10.1371/journal.pcbi.0030116; Teixeira MC, 2006, NUCLEIC ACIDS RES, V34, pD446, DOI 10.1093/nar/gkj013; Terada A, 2013, P NATL ACAD SCI USA, V110, P12996, DOI 10.1073/pnas.1302233110; Tuncbag N, 2012, NUCLEIC ACIDS RES, V40, pW505, DOI 10.1093/nar/gks445; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Weisbuch G, 1990, COMPLEX SYSTEMS DYNA; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Wu C, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-182; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	86	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142147	10.1371/journal.pone.0142147	http://dx.doi.org/10.1371/journal.pone.0142147			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562430	Green Published, Green Submitted, gold			2022-12-26	WOS:000364480900017
J	Schumacher, R; Cazzoli, D; Eggenberger, N; Preisig, B; Nef, T; Nyffeler, T; Gutbrod, K; Annoni, JM; Muri, RM				Schumacher, Rahel; Cazzoli, Dario; Eggenberger, Nomi; Preisig, Basil; Nef, Tobias; Nyffeler, Thomas; Gutbrod, Klemens; Annoni, Jean-Marie; Mueri, Rene M.			Cue Recognition and Integration - Eye Tracking Evidence of Processing Differences in Sentence Comprehension in Aphasia	PLOS ONE			English	Article							SYNTACTIC AMBIGUITY RESOLUTION; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; COGNITIVE CONTROL; TIME-COURSE; MOVEMENTS; LANGUAGE; DEFICITS; GERMAN; PERFORMANCE	Purpose We aimed at further elucidating whether aphasic patients' difficulties in understanding non-canonical sentence structures, such as Passive or Object-Verb-Subject sentences, can be attributed to impaired morphosyntactic cue recognition, and to problems in integrating competing interpretations. Methods A sentence-picture matching task with canonical and non-canonical spoken sentences was performed using concurrent eye tracking. Accuracy, reaction time, and eye tracking data (fixations) of 50 healthy subjects and 12 aphasic patients were analysed. Results Patients showed increased error rates and reaction times, as well as delayed fixation preferences for target pictures in non-canonical sentences. Patients' fixation patterns differed from healthy controls and revealed deficits in recognizing and immediately integrating morphosyntactic cues. Conclusion Our study corroborates the notion that difficulties in understanding syntactically complex sentences are attributable to a processing deficit encompassing delayed and therefore impaired recognition and integration of cues, as well as increased competition between interpretations.	[Schumacher, Rahel; Eggenberger, Nomi; Preisig, Basil; Nyffeler, Thomas; Mueri, Rene M.] Univ Hosp Bern, Inselspital, Dept Neurol, Percept & Eye Movement Lab, CH-3010 Bern, Switzerland; [Schumacher, Rahel; Eggenberger, Nomi; Preisig, Basil; Nyffeler, Thomas; Mueri, Rene M.] Univ Hosp Bern, Inselspital, Dept Clin Res, Percept & Eye Movement Lab, CH-3010 Bern, Switzerland; [Schumacher, Rahel; Eggenberger, Nomi; Preisig, Basil; Nyffeler, Thomas; Gutbrod, Klemens; Mueri, Rene M.] Univ Bern, Bern, Switzerland; [Schumacher, Rahel; Gutbrod, Klemens; Mueri, Rene M.] Univ Hosp Bern, Inselspital, Dept Neurol, Div Cognit & Restorat Neurol, CH-3010 Bern, Switzerland; [Cazzoli, Dario; Nef, Tobias; Mueri, Rene M.] Univ Bern, Gerontechnol & Rehabil Grp, Bern, Switzerland; [Cazzoli, Dario] Univ Bern, Univ Hosp Old Age Psychiat & Psychotherapy, Bern, Switzerland; [Nef, Tobias] Univ Bern, ARTORG Ctr Biomed Engn Res, Bern, Switzerland; [Nyffeler, Thomas] Luzerner Kantonsspital, Neurol & Neurorehabil Ctr, Luzern, Switzerland; [Annoni, Jean-Marie] Univ Fribourg, Fac Sci, Dept Med, Lab Cognit & Neurol Sci,Neurol Unit, CH-1700 Fribourg, Switzerland; [Mueri, Rene M.] Univ Bern, Ctr Cognit Learning & Memory, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Bern; Lucerne Cantonal Hospital; University of Fribourg; University of Bern	Muri, RM (corresponding author), Univ Hosp Bern, Inselspital, Dept Neurol, Percept & Eye Movement Lab, CH-3010 Bern, Switzerland.	rene.mueri@dkf.unibe.ch	Preisig, Basil/P-6823-2019; Muri, Rene/E-9320-2012	Preisig, Basil/0000-0002-8148-3555; Cazzoli, Dario/0000-0001-7217-7153; Nyffeler, Thomas/0000-0003-2504-8935; Schumacher, Rahel/0000-0001-7500-7491; Nef, Tobias/0000-0002-8069-9450; Muri, Rene/0000-0001-6990-4188; Gutbrod, Klemens/0000-0002-5723-3468	Swiss National Foundation [320030_138532]; Ernst Gohner Stiftung	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Ernst Gohner Stiftung	This study was supported by the Swiss National Foundation, grant no. 320030_138532 to RMM, Ernst Gohner Stiftung to RMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson DJ, 2013, J COGNITIVE NEUROSCI, V25, P1664, DOI 10.1162/jocn_a_00430; Allopenna PD, 1998, J MEM LANG, V38, P419, DOI 10.1006/jmla.1997.2558; Amici S, 2007, J NEUROSCI, V27, P6282, DOI 10.1523/JNEUROSCI.1331-07.2007; Bates E, 2001, ANNU REV PSYCHOL, V52, P369, DOI 10.1146/annurev.psych.52.1.369; Bickel C, 2000, BRAIN LANG, V71, P432, DOI 10.1006/brln.1999.2277; Brownsett SLE, 2014, BRAIN, V137, P242, DOI 10.1093/brain/awt289; Burchert F, 2003, BRAIN LANG, V87, P323, DOI 10.1016/S0093-934X(03)00132-9; Burkhardt P, 2003, BRAIN LANG, V86, P9, DOI 10.1016/S0093-934X(02)00526-6; Caplan D, 2007, BRAIN LANG, V101, P103, DOI 10.1016/j.bandl.2006.06.225; Caplan D, 2013, BRAIN LANG, V127, P21, DOI 10.1016/j.bandl.2013.07.007; Caplan D, 2013, PSYCHON B REV, V20, P243, DOI 10.3758/s13423-012-0369-9; Choy JJ, 2010, APHASIOLOGY, V24, P551, DOI 10.1080/02687030802634025; Crocker MW, 2010, BRAIN LANG, V112, P189, DOI 10.1016/j.bandl.2009.03.004; Delavier C., 1981, BASEL MINNESOTA TEST; Dick F, 2001, PSYCHOL REV, V108, P759, DOI 10.1037//0033-295X.108.4.759; Dickey MW, 2007, BRAIN LANG, V100, P1, DOI 10.1016/j.bandl.2006.06.004; Dickey MW, 2009, J NEUROLINGUIST, V22, P563, DOI 10.1016/j.jneuroling.2009.06.004; Ferreira F, 2003, COGNITIVE PSYCHOL, V47, P164, DOI 10.1016/S0010-0285(03)00005-7; FRIEDERICI AD, 1992, BRAIN LANG, V42, P1, DOI 10.1016/0093-934X(92)90053-H; Friederici AD, 2010, WIRES COGN SCI, V1, P150, DOI 10.1002/wcs.9; Grossman M, 2001, J NEUROL SCI, V184, P123, DOI 10.1016/S0022-510X(00)00491-3; Grossman M, 2001, NEUROPSYCHOLOGIA, V39, P1419, DOI 10.1016/S0028-3932(01)00059-8; Hanne S, 2015, J NEUROLINGUIST, V34, P83, DOI 10.1016/j.jneuroling.2014.12.003; Hanne S, 2011, APHASIOLOGY, V25, P221, DOI 10.1080/02687038.2010.489256; Henderson J. M., 2004, INTERFACE LANGUAGE V; Hochstadt J, 2009, CORTEX, V45, P991, DOI 10.1016/j.cortex.2009.03.010; Huber W, 1993, NEUROLINGUISTIK, V7, P43; Kamide Y, 2003, J PSYCHOLINGUIST RES, V32, P37, DOI 10.1023/A:1021933015362; Kamide Y, 2003, J MEM LANG, V49, P133, DOI 10.1016/S0749-596X(03)00023-8; Knoeferle Pia, 2007, P517, DOI 10.1016/B978-008044980-7/50026-4; Levelt WJM, 2001, P NATL ACAD SCI USA, V98, P13464, DOI 10.1073/pnas.231459498; Longoni F., 2010, SATZVERARBEITUNG BEI; Love T, 2008, BRAIN LANG, V107, P203, DOI 10.1016/j.bandl.2007.11.004; Luzzatti C, 2001, APHASIOLOGY, V15, P419, DOI 10.1080/02687040143000005; Mack JE, 2013, J NEUROLINGUIST, V26, P619, DOI 10.1016/j.jneuroling.2013.04.002; McNeil M, 2011, HANDBOOK OF PSYCHOLINGUISTIC AND COGNITIVE PROCESSES: PERSPECTIVES IN COMMUNICATION DISORDERS, P551; Meyer AM, 2012, J NEUROLINGUIST, V25, P31, DOI 10.1016/j.jneuroling.2011.08.001; Presson N, 2011, HANDBOOK OF PSYCHOLINGUISTIC AND COGNITIVE PROCESSES: PERSPECTIVES IN COMMUNICATION DISORDERS, P31; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Schipke CS, 2012, DEVELOPMENTAL SCI, V15, P762, DOI 10.1111/j.1467-7687.2012.01167.x; Spivey MJ, 2002, COGNITIVE PSYCHOL, V45, P447, DOI 10.1016/S0010-0285(02)00503-0; Tanenhaus Michael K., 2007, P443, DOI 10.1016/B978-008044980-7/50022-7; Thompson CK, 2009, J PSYCHOLINGUIST RES, V38, P255, DOI 10.1007/s10936-009-9105-7; Wendt D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100186; Willmes, 1983, AACHENER APHASIETEST; Ye Z, 2008, BRAIN RES, V1203, P103, DOI 10.1016/j.brainres.2008.01.090	46	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142853	10.1371/journal.pone.0142853	http://dx.doi.org/10.1371/journal.pone.0142853			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7UL	26562795	Green Published, Green Accepted, gold			2022-12-26	WOS:000364480900074
J	Bonatelli, IAS; Carstens, BC; Moraes, EM				Bonatelli, Isabel A. S.; Carstens, Bryan C.; Moraes, Evandro M.			Using Next Generation RAD Sequencing to Isolate Multispecies Microsatellites for Pilosocereus (Cactaceae)	PLOS ONE			English	Article							SPATIAL GENETIC-STRUCTURE; PHYLOGEOGRAPHIC STRUCTURE; COMPUTER-PROGRAM; PRIMER DESIGN; MARKERS; GENOME; TRANSCRIPTOME; EVOLUTION; SOFTWARE; REPEATS	Microsatellite markers (also known as SSRs, Simple Sequence Repeats) are widely used in plant science and are among the most informative molecular markers for population genetic investigations, but the development of such markers presents substantial challenges. In this report, we discuss how next generation sequencing can replace the cloning, Sanger sequencing, identification of polymorphic loci, and testing cross-amplification that were previously required to develop microsatellites. We report the development of a large set of microsatellite markers for five species of the Neotropical cactus genus Pilosocereus using a restriction-site-associated DNA sequencing (RAD-seq) on a Roche 454 platform. We identified an average of 165 microsatellites per individual, with the absolute numbers across individuals proportional to the sequence reads obtained per individual. Frequency distribution of the repeat units was similar in the five species, with shorter motifs such as diand trinucleotide being the most abundant repeats. In addition, we provide 72 microsatellites that could be potentially amplified in the sampled species and 22 polymorphic microsatellites validated in two populations of the species Pilosocereus machrisii. Although low coverage sequencing among individuals was observed for most of the loci, which we suggest to be more related to the nature of the microsatellite markers and the possible bias inserted by the restriction enzymes than to the genome size, our work demonstrates that an NGS approach is an efficient method to isolate multispecies microsatellites even in non-model organisms.	[Bonatelli, Isabel A. S.; Moraes, Evandro M.] Univ Fed Sao Carlos, Dept Biol, Sao Paulo, Brazil; [Carstens, Bryan C.] Ohio State Univ, Dept Ecol Evolut & Organismal Biol, Columbus, OH 43210 USA	Universidade Federal de Sao Carlos; University System of Ohio; Ohio State University	Moraes, EM (corresponding author), Univ Fed Sao Carlos, Dept Biol, Sao Paulo, Brazil.	emarsola@ufscar.br	Moraes, Evandro M./A-4387-2009; Bonatelli, Isabel A. S./D-2361-2015	Moraes, Evandro M./0000-0003-4197-0794; 	Sao Paulo Research Foundation (FAPESP) [2012/22857-8, 2012/22477-0]; CAPES [BEX: 5639/13-1]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported through grants from the Sao Paulo Research Foundation (FAPESP) (2012/22857-8 to IASB and 2012/22477-0 to EMM) and CAPES (BEX: 5639/13-1 to IASB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonatelli IAS, 2014, MOL ECOL, V23, P3044, DOI 10.1111/mec.12780; Buschiazzo E, 2006, BIOESSAYS, V28, P1040, DOI 10.1002/bies.20470; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Emerson KJ, 2010, P NATL ACAD SCI USA, V107, P16196, DOI 10.1073/pnas.1006538107; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; Garrick RC, 2015, MOL ECOL, V24, P1164, DOI 10.1111/mec.13108; Gompert Z, 2010, MOL ECOL, V19, P2455, DOI 10.1111/j.1365-294X.2010.04666.x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Hamblin MT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001367; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Huang DN, 2014, MOL ECOL RESOUR, V14, P569, DOI 10.1111/1755-0998.12197; Hunt D., 2006, NEW CACTUS LEXICON; Hyten DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-475; Jesus AA, 2014, TAXON, V63, P1150; Kelkar YD, 2008, GENOME RES, V18, P30, DOI 10.1101/gr.7113408; Kumar S, 2014, PLANT CELL REP, V33, P905, DOI 10.1007/s00299-014-1569-8; Laborda PR, 2009, CONSERV GENET RESOUR, V1, P297, DOI 10.1007/s12686-009-9070-3; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; McCormack JE, 2012, MOL PHYLOGENET EVOL, V62, P397, DOI 10.1016/j.ympev.2011.10.012; Meglecz E, 2014, MOL ECOL RESOUR, V14, P1302, DOI 10.1111/1755-0998.12271; Meglecz E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040861; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Oliveira EJ, 2006, GENET MOL BIOL, V29, P294, DOI 10.1590/S1415-47572006000200018; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perez MF, 2011, AM J BOT, V98, pE204, DOI 10.3732/ajb.1100033; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Vukosavljev M, 2015, MOL ECOL RESOUR, V15, P17, DOI 10.1111/1755-0998.12289; Williams Larissa M, 2010, BMC Genet, V11, P32, DOI 10.1186/1471-2156-11-32; Zalapa JE, 2012, AM J BOT, V99, P193, DOI 10.3732/ajb.1100394; Zappi D.C., 1994, PILOSOCEREUS CACTACE; Zellmer AJ, 2012, SYST BIOL, V61, P763, DOI 10.1093/sysbio/sys048	37	15	15	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142602	10.1371/journal.pone.0142602	http://dx.doi.org/10.1371/journal.pone.0142602			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26561396	Green Submitted, gold, Green Published			2022-12-26	WOS:000364433100097
J	De Falco, M; Catalano, F; Rossi, M; Ciaramella, M; De Felice, M				De Falco, Mariarosaria; Catalano, Federico; Rossi, Mose; Ciaramella, Maria; De Felice, Mariarita			NurA Is Endowed with Endo- and Exonuclease Activities that Are Modulated by HerA: New Insight into Their Role in DNA-End Processing	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; HYPERTHERMOPHILIC ARCHAEON; HOMOLOGOUS RECOMBINATION; SULFOLOBUS-SOLFATARICUS; RESECTION; MRE11; HELICASE; REPAIR; RAD50; COMPLEX	The nuclease NurA and the ATPase HerA are present in all known thermophilic archaea and cooperate with the highly conserved MRE11/RAD50 proteins to facilitate efficient DNA double-strand break end processing during homologous recombinational repair. However, contradictory results have been reported on the exact activities and mutual dependence of these two enzymes. To understand the functional relationship between these two enzymes we deeply characterized Sulfolobus solfataricus NurA and HerA proteins. We found that NurA is endowed with exo- and endonuclease activities on various DNA substrates, including linear (single-stranded and double stranded) as well as circular molecules (single stranded and supercoiled double-stranded). All these activities are not strictly dependent on the presence of HerA, require divalent ions (preferably Mn2+), and are inhibited by the presence of ATP. The endo-and exonculease activities have distinct requirements: whereas the exonuclease activity on linear DNA fragments is stimulated by HerA and depends on the catalytic D58 residue, the endonuclease activity on circular double-stranded DNA is HerA-independent and is not affected by the D58A mutation. On the basis of our results we propose a mechanism of action of NurA/HerA complex during DNA end processing.	[De Falco, Mariarosaria; Catalano, Federico; Rossi, Mose; Ciaramella, Maria; De Felice, Mariarita] CNR, Inst Biosci & Bioresources, I-80131 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR)	De Falco, M (corresponding author), CNR, Inst Biosci & Bioresources, I-80131 Naples, Italy.	mariarosaria.defalco@ibbr.cnr.it; mariarita.defelice@ibbr.cnr.it	Ciaramella, Maria/O-1152-2015	Ciaramella, Maria/0000-0003-1583-1694	MERIT Molecular Oncology [RBNE08YFN3]	MERIT Molecular Oncology	This work was supported by MERIT Molecular Oncology -RBNE08YFN3.	Bernstein KA, 2009, CELL, V137, P807, DOI 10.1016/j.cell.2009.05.007; Blackwood JK, 2012, NUCLEIC ACIDS RES, V40, P3183, DOI 10.1093/nar/gkr1157; Bonetti D, 2013, EMBO J, V32, P275, DOI 10.1038/emboj.2012.327; Cannavo E, 2013, P NATL ACAD SCI USA, V110, pE1661, DOI 10.1073/pnas.1305166110; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Chae J, 2012, NUCLEIC ACIDS RES, V40, P2258, DOI 10.1093/nar/gkr999; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Cheng KY, 2015, J BACTERIOL, V197, P2048, DOI 10.1128/JB.00018-15; Constantinesco F, 2004, NUCLEIC ACIDS RES, V32, P1439, DOI 10.1093/nar/gkh283; Constantinesco F, 2002, EMBO REP, V3, P537, DOI 10.1093/embo-reports/kvf112; Daley James M., 2013, Yale Journal of Biology and Medicine, V86, P453; Delmas S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000552; Frols S, 2007, J BACTERIOL, V189, P8708, DOI 10.1128/JB.01016-07; Fujikane R, 2010, GENES GENET SYST, V85, P243, DOI 10.1266/ggs.85.243; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Haldenby S, 2009, BIOCHEM SOC T, V37, P102, DOI 10.1042/BST0370102; Hopfner KP, 2000, J BACTERIOL, V182, P6036, DOI 10.1128/JB.182.21.6036-6041.2000; Hopkins BB, 2008, CELL, V135, P250, DOI 10.1016/j.cell.2008.09.054; Huang QH, 2015, BMC MOL BIOL, V16, DOI 10.1186/s12867-015-0030-z; Iyer LM, 2004, NUCLEIC ACIDS RES, V32, P5260, DOI 10.1093/nar/gkh828; Killelea T, 2014, ELECTROPHORESIS, V35, P1938, DOI 10.1002/elps.201400018; Kish A, 2008, J BACTERIOL, V190, P5210, DOI 10.1128/JB.00292-08; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Lestini R, 2010, DNA REPAIR, V9, P994, DOI 10.1016/j.dnarep.2010.06.012; Liang PJ, 2013, J GENET GENOMICS, V40, P533, DOI 10.1016/j.jgg.2013.05.004; Longhese MP, 2010, EMBO J, V29, P2864, DOI 10.1038/emboj.2010.165; Manzan A, 2004, EMBO REP, V5, P54, DOI 10.1038/sj.embor.7400037; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mimitou EP, 2011, DNA REPAIR, V10, P344, DOI 10.1016/j.dnarep.2010.12.004; Mimitou EP, 2009, DNA REPAIR, V8, P983, DOI 10.1016/j.dnarep.2009.04.017; Nicolette ML, 2010, NAT STRUCT MOL BIOL, V17, P1478, DOI 10.1038/nsmb.1957; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; Quaiser A, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-25; Rolfsmeier ML, 2010, J BACTERIOL, V192, P4954, DOI 10.1128/JB.00667-10; Sung S, 2014, EMBO J, V33, P2422, DOI 10.15252/embj.201488299; Wei T, 2008, BIOCHEM BIOPH RES CO, V367, P523, DOI 10.1016/j.bbrc.2007.10.019; White MF, 2011, BIOCHEM SOC T, V39, P15, DOI 10.1042/BST0390015; Zhang ST, 2008, DNA REPAIR, V7, P380, DOI 10.1016/j.dnarep.2007.10.010; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	40	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142345	10.1371/journal.pone.0142345	http://dx.doi.org/10.1371/journal.pone.0142345			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560692	Green Published, Green Submitted, gold			2022-12-26	WOS:000364433100073
J	Lu, Y; Hugenholtz, P; Batstone, DJ				Lu, Yang; Hugenholtz, Philip; Batstone, Damien John			Evaluating DNA Extraction Methods for Community Profiling of Pig Hindgut Microbial Community	PLOS ONE			English	Article							GUT MICROBIOTA; FECAL SAMPLES; BACTERIAL; FECES; GENE	Recovery of high quality PCR-amplifiable DNA has been the general minimal requirement for DNA extraction methods for bulk molecular analysis. However, modern high through-put community profiling technologies are more sensitive to representativeness and reproducibility of DNA extraction method. Here, we assess the impact of three DNA extraction methods (with different levels of extraction harshness) for assessing hindgut microbiomes from pigs fed with different diets (with different physical properties). DNA extraction from each sample was performed in three technical replicates for each extraction method and sequenced by 16S rRNA amplicon sequencing. Host was the primary driver of molecular sequencing outcomes, particularly on samples analysed by wheat based diets, but higher variability, with one failed extraction occurred on samples from a barley fed pig. Based on these results, an effective method will enable reproducible and quality outcomes on a range of samples, whereas an ineffective method will fail to generate extract, but host (rather than extraction method) remains the primary factor.	[Lu, Yang; Batstone, Damien John] Univ Queensland, Adv Water Management Ctr, St Lucia, Qld, Australia; [Hugenholtz, Philip] Univ Queensland, Australian Ctr Ecogen, Sch Chem & Mol Biosci, St Lucia, Qld, Australia; [Hugenholtz, Philip] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia	University of Queensland; University of Queensland; University of Queensland	Lu, Y (corresponding author), Univ Queensland, Adv Water Management Ctr, St Lucia, Qld, Australia.	y.lu@awmc.uq.edu.au	Lu, Yang/GSD-1477-2022; Hugenholtz, Philip/AAD-9138-2019; Batstone, Damien/N-1896-2014	Lu, Yang/0000-0003-1976-8872; Hugenholtz, Philip/0000-0001-5386-7925; Batstone, Damien/0000-0002-4294-3942	Australian Pork Limited [2010/1011.334]; Pork CRC [4C106]	Australian Pork Limited(Australian Pork Limited); Pork CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	Funding was provided by Australian Pork Limited, Grant numbers: 2010/1011.334, http://australianpork.com.au/; Pork CRC, Grant numbers: 4C106, http://porkcrc.com.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beja-Pereira A, 2009, MOL ECOL RESOUR, V9, P1279, DOI 10.1111/j.1755-0998.2009.02699.x; Bian GR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070103; Bragg L, 2012, NAT METHODS, V9, P425, DOI 10.1038/nmeth.1990; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Champely S., 2020, PWR BASIC FUNCTIONS; Clement BG, 2000, BIOTECHNIQUES, V28, P640, DOI 10.2144/00284bm06; de Jong A, 2014, VET MICROBIOL, V171, P298, DOI 10.1016/j.vetmic.2014.01.030; Deger G, 2010, MATH COMPUT APPL, V15, P1; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Dougal K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087424; Finegold SM, 2010, ANAEROBE, V16, P444, DOI 10.1016/j.anaerobe.2010.06.008; Hooda S, 2012, J NUTR, V142, P1259, DOI 10.3945/jn.112.158766; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Lamendella R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-103; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Levine TR, 2002, HUM COMMUN RES, V28, P612, DOI 10.1093/hcr/28.4.612; Li WZ, 2012, BRIEF BIOINFORM, V13, P656, DOI 10.1093/bib/bbs035; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Mackenzie BW, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00130; Morgan JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010209; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Niemi RM, 2001, J APPL MICROBIOL, V90, P850, DOI 10.1046/j.1365-2672.2001.01314.x; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; R Core Team, 2013, R LANG ENV STAT COMP; Rousselon N, 2004, J MICROBIOL METH, V59, P15, DOI 10.1016/j.mimet.2004.05.007; Rubin BER, 2014, MICROBIOLOGYOPEN, V3, P910, DOI 10.1002/mbo3.216; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x; Tang JN, 2006, J RAPID METH AUT MIC, V14, P201, DOI 10.1111/j.1745-4581.2006.00047.x; Tang JN, 2008, J MICROBIOL METH, V75, P432, DOI 10.1016/j.mimet.2008.07.014; Tringe SG, 2008, CURR OPIN MICROBIOL, V11, P442, DOI 10.1016/j.mib.2008.09.011; Wesolowska-Andersen A, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-19; Willner D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034605; Wu ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-444; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Zhang BW, 2006, BIOCHEM GENET, V44, P503, DOI 10.1007/s10528-006-9050-1; Zhang QS, 2013, GUT MICROBES, V4, P193, DOI 10.4161/gmic.23867	39	6	6	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142720	10.1371/journal.pone.0142720	http://dx.doi.org/10.1371/journal.pone.0142720			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560873	Green Submitted, gold, Green Published			2022-12-26	WOS:000364433100114
J	Moskaleva, N; Moysa, A; Novikova, S; Tikhonova, O; Zgoda, V; Archakov, A				Moskaleva, Natalia; Moysa, Alexander; Novikova, Svetlana; Tikhonova, Olga; Zgoda, Victor; Archakov, Alexander			Spaceflight Effects on Cytochrome P450 Content in Mouse Liver	PLOS ONE			English	Article							MASS-SPECTROMETRY; ABSOLUTE QUANTIFICATION; DEPLETED PLASMA; HEPG2 CELLS; PROTEOMICS; TISSUE; METABOLISM; EXPRESSION; MICROSOMES; HUMANS	Hard conditions of long-term manned spaceflight can affect functions of many biological systems including a system of drug metabolism. The cytochrome P450 (CYP) superfamily plays a key role in the drug metabolism. In this study we examined the hepatic content of some P450 isoforms in mice exposed to 30 days of space flight and microgravity. The CYP content was established by the mass-spectrometric method of selected reaction monitoring (SRM). Significant changes in the CYP2C29, CYP2E1 and CYP1A2 contents were detected in mice of the flight group compared to the ground control group. Within seven days after landing and corresponding recovery period changes in the content of CYP2C29 and CYP1A2 returned to the control level, while the CYP2E1 level remained elevated. The induction of enzyme observed in the mice in the conditions of the spaceflight could lead to an accelerated biotransformation and change in efficiency of pharmacological agents, metabolizing by corresponding CYP isoforms. Such possibility of an individual pharmacological response to medication during long-term spaceflights and early period of postflight adaptation should be taken into account in space medicine.	[Moskaleva, Natalia; Moysa, Alexander; Novikova, Svetlana; Tikhonova, Olga; Zgoda, Victor; Archakov, Alexander] Inst Biomed Chem, Moscow, Russia	Russian Academy of Medical Sciences; Institute of Biomedical Chemistry	Zgoda, V (corresponding author), Inst Biomed Chem, Moscow, Russia.	victor.zgoda@gmail.com	Tikhonova, Olga/F-5115-2017; Novikova, Svetlana E/F-5107-2017; Zgoda, Victor G/F-1791-2017	Tikhonova, Olga/0000-0002-2810-566X; Novikova, Svetlana E/0000-0003-2777-2476; Zgoda, Victor G/0000-0002-4532-4274; Moskaleva, Natalia/0000-0002-7309-8913; Moysa, Alexander/0000-0003-3618-9813	Russian Science Foundation, RSF grant [14-25-00132]; Russian Science Foundation [14-25-00132] Funding Source: Russian Science Foundation	Russian Science Foundation, RSF grant(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by the Russian Science Foundation, RSF grant. 14-25-00132, (http://www.rscf.ru/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson L, 2006, MOL CELL PROTEOMICS, V5, P573, DOI 10.1074/mcp.M500331-MCP200; Andreev-Andrievskiy A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104830; Aponte VM, 2006, LIFE SCI, V79, P1317, DOI 10.1016/j.lfs.2006.04.007; Archakov A, 2015, EXPERT REV PROTEOMIC, V12, P111, DOI 10.1586/14789450.2015.1018895; Bogaards JJP, 2000, XENOBIOTICA, V30, P1131, DOI 10.1080/00498250010021684; Court MH, 1997, BIOPHARM DRUG DISPOS, V18, P213, DOI 10.1002/(SICI)1099-081X(199704)18:3<213::AID-BDD15>3.0.CO;2-0; Fekkes D, 1996, J CHROMATOGR B, V682, P3, DOI 10.1016/0378-4347(96)00057-6; Hersman EM, 2014, J PHARMACOL EXP THER, V349, P221, DOI 10.1124/jpet.113.212456; Hood CA, 2008, J PEPT SCI, V14, P97, DOI 10.1002/psc.921; Hrycay EG, 2009, CURR DRUG METAB, V10, P1151, DOI 10.2174/138920009790820138; Kawakami H, 2011, J PHARM SCI-US, V100, P341, DOI 10.1002/jps.22255; Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61; Langenfeld E, 2009, PROTEOMICS, V9, P2313, DOI 10.1002/pmic.200800680; Ludwig C, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013987; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Mark S, 2014, J WOMENS HEALTH, V23, P941, DOI 10.1089/jwh.2014.4914; Moskaleva NE, BIOORG KHIM, V37, P149; Muruganandan S, 2008, CLIN PHARMACOL THER, V83, P818, DOI 10.1038/clpt.2008.50; Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/00008571-200401000-00001; Percy AJ, 2013, J PROTEOME RES, V12, P222, DOI 10.1021/pr300893w; Ponomarenko EA, 2014, J PROTEOME RES, V13, P183, DOI 10.1021/pr400883x; Renaud HJ, 2011, TOXICOL SCI, V124, P261, DOI 10.1093/toxsci/kfr240; Turpeinen M, 2007, XENOBIOTICA, V37, P1367, DOI 10.1080/00498250701658312; Walther TC, 2010, J CELL BIOL, V190, P491, DOI 10.1083/jcb.201004052; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Yu AM, 2009, DRUG METAB DISPOS, V37, P170, DOI 10.1124/dmd.108.024166; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007; Zgoda VG, 2013, J PROTEOME RES, V12, P123, DOI 10.1021/pr300821n; Zhu H, 2015, INT J OCCUP MED ENV, V28, P793, DOI 10.13075/ijomeh.1896.00301	29	17	21	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142374	10.1371/journal.pone.0142374	http://dx.doi.org/10.1371/journal.pone.0142374			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26561010	Green Submitted, Green Published, gold			2022-12-26	WOS:000364433100075
J	Nanri, A; Nakagawa, T; Kuwahara, K; Yamamoto, S; Honda, T; Okazaki, H; Uehara, A; Yamamoto, M; Miyamoto, T; Kochi, T; Eguchi, M; Murakami, T; Shimizu, C; Shimizu, M; Tomita, K; Nagahama, S; Imai, T; Nishihara, A; Sasaki, N; Hori, A; Sakamoto, N; Nishiura, C; Totsuzaki, T; Kato, N; Fukasawa, K; Hu, HH; Akter, S; Kurotani, K; Kabe, I; Mizoue, T; Sone, T; Dohi, S				Nanri, Akiko; Nakagawa, Tohru; Kuwahara, Keisuke; Yamamoto, Shuichiro; Honda, Toru; Okazaki, Hiroko; Uehara, Akihiko; Yamamoto, Makoto; Miyamoto, Toshiaki; Kochi, Takeshi; Eguchi, Masafumi; Murakami, Taizo; Shimizu, Chii; Shimizu, Makiko; Tomita, Kentaro; Nagahama, Satsue; Imai, Teppei; Nishihara, Akiko; Sasaki, Naoko; Hori, Ai; Sakamoto, Nobuaki; Nishiura, Chihiro; Totsuzaki, Takafumi; Kato, Noritada; Fukasawa, Kenji; Hu Huanhuan; Akter, Shamima; Kurotani, Kayo; Kabe, Isamu; Mizoue, Tetsuya; Sone, Tomofumi; Dohi, Seitaro		Japan Epidemiology Collaboration O	Development of Risk Score for Predicting 3-Year Incidence of Type 2 Diabetes: Japan Epidemiology Collaboration on Occupational Health Study	PLOS ONE			English	Article							FAMILY-HISTORY; MODELS; POPULATION	Objective Risk models and scores have been developed to predict incidence of type 2 diabetes in Western populations, but their performance may differ when applied to non-Western populations. We developed and validated a risk score for predicting 3-year incidence of type 2 diabetes in a Japanese population. Methods Participants were 37,416 men and women, aged 30 or older, who received periodic health checkup in 2008-2009 in eight companies. Diabetes was defined as fasting plasma glucose (FPG) >= 126 mg/dl, random plasma glucose >= 200 mg/dl, glycated hemoglobin (HbA1c) >= 6.5%, or receiving medical treatment for diabetes. Risk scores on non-invasive and invasive models including FPG and HbA1c were developed using logistic regression in a derivation cohort and validated in the remaining cohort. Results The area under the curve (AUC) for the non-invasive model including age, sex, body mass index, waist circumference, hypertension, and smoking status was 0.717 (95% CI, 0.703-0.731). In the invasive model in which both FPG and HbA1c were added to the non-invasive model, AUC was increased to 0.893 (95% CI, 0.883-0.902). When the risk scores were applied to the validation cohort, AUCs (95% CI) for the non-invasive and invasive model were 0.734 (0.715-0.753) and 0.882 (0.868-0.895), respectively. Participants with a non-invasive score of >= 15 and invasive score of >= 19 were projected to have >20% and >50% risk, respectively, of developing type 2 diabetes within 3 years. Conclusions The simple risk score of the non-invasive model might be useful for predicting incident type 2 diabetes, and its predictive performance may be markedly improved by incorporating FPG and HbA1c.	[Nanri, Akiko; Kuwahara, Keisuke; Hu Huanhuan; Akter, Shamima; Kurotani, Kayo; Mizoue, Tetsuya] Natl Ctr Global Hlth & Med, Dept Epidemiol & Prevent, Ctr Clin Sci, Tokyo, Japan; [Nakagawa, Tohru; Yamamoto, Shuichiro; Honda, Toru] Hitachi Ltd, Ibaraki, Japan; [Kuwahara, Keisuke] Teikyo Univ, Grad Sch Publ Hlth, Tokyo 173, Japan; [Okazaki, Hiroko; Dohi, Seitaro] Mitsui Chem Inc, Tokyo, Japan; [Uehara, Akihiko; Yamamoto, Makoto] YAMAHA CORP, Shizuoka, Japan; [Miyamoto, Toshiaki] Nippon Steel & Sumitomo Met Corp Kimitsu Works, Chiba, Japan; [Kochi, Takeshi; Eguchi, Masafumi; Kabe, Isamu] Furukawa Elect Corp Ltd, Tokyo, Japan; [Murakami, Taizo; Shimizu, Chii; Shimizu, Makiko] Keihin Occupat Hlth Ctr, Mizue Med Clin, Mizue, Kanagawa, Japan; [Tomita, Kentaro] Mitsubishi Plast Inc, Tokyo, Japan; [Nagahama, Satsue] All Japan Labour Welf Fdn, Tokyo, Japan; [Imai, Teppei; Nishihara, Akiko] Azbil Corp, Tokyo, Japan; [Sasaki, Naoko] Mitsubishi Fuso Truck & Bus Corp, Kawasaki, Kanagawa, Japan; [Hori, Ai; Nishiura, Chihiro] Tokyo Gas Co Ltd, Dept Safety & Hlth, Tokyo, Japan; [Sakamoto, Nobuaki] Hlth Design Inc, Tokyo, Japan; [Totsuzaki, Takafumi] Mizuho Hlth Insurance Soc, Tokyo, Japan; [Kato, Noritada] Fuji Elect Co Ltd, Kawasaki, Kanagawa, Japan; [Fukasawa, Kenji] ADVANTAGE Risk Management Co Ltd, Tokyo, Japan; [Sone, Tomofumi] Natl Inst Publ Hlth, Saitama, Japan	National Center for Global Health & Medicine - Japan; Hitachi Limited; Teikyo University; Mitsui Chemicals; Yamaha; Nippon Steel & Sumitomo Metal Corporation; Furukawa Electric; Daimler AG; Fuji Electric Co., LTD.; National Institute of Public Health - Japan	Nanri, A (corresponding author), Natl Ctr Global Hlth & Med, Dept Epidemiol & Prevent, Ctr Clin Sci, Tokyo, Japan.	nanri@ri.ncgm.go.jp	Nishiura, Chihiro/C-4132-2017; Nishiura, Chihiro/Q-7938-2019; Hori, Ai/G-5277-2019	Nishiura, Chihiro/0000-0002-8850-5446; Nishiura, Chihiro/0000-0002-8850-5446; Hori, Ai/0000-0002-0191-5996; Kochi, Takeshi/0000-0002-3411-1070; Kuwahara, Keisuke/0000-0002-7503-1333	Industrial Health Foundation; Japan Society for the Promotion of Science [25293146]	Industrial Health Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a grant from the Industrial Health Foundation and Grant-in-Aid for Scientific Research (B) (25293146) from the Japan Society for the Promotion of Science.	Aekplakorn W, 2006, DIABETES CARE, V29, P1872, DOI 10.2337/dc05-2141; Beagley J, 2014, DIABETES RES CLIN PR, V103, P150, DOI 10.1016/j.diabres.2013.11.001; Bianco A, 2014, ACTA DIABETOL, V51, P79, DOI 10.1007/s00592-013-0502-x; Chien K, 2009, DIABETOLOGIA, V52, P443, DOI 10.1007/s00125-008-1232-4; Chuang SY, 2011, DIABETES RES CLIN PR, V92, P128, DOI 10.1016/j.diabres.2010.12.022; Collins GS, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-103; Das Mithun, 2012, J Cardiovasc Dis Res, V3, P104, DOI 10.4103/0975-3583.95362; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Doi Y, 2012, DIABETIC MED, V29, P107, DOI 10.1111/j.1464-5491.2011.03376.x; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Guasch-Ferre M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033437; He S, 2012, DIABETES RES CLIN PR, V95, P291, DOI 10.1016/j.diabres.2011.10.039; Heianza Y, 2012, DIABETOLOGIA, V55, P3213, DOI 10.1007/s00125-012-2712-0; Kashiwagi A, 2012, DIABETOL INT, V3, P8, DOI 10.1007/s13340-012-0069-8; Lim NK, 2012, CIRC J, V76, P1904, DOI 10.1253/circj.CJ-11-1236; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Liu M, 2011, DIABETES TECHNOL THE, V13, P501, DOI 10.1089/dia.2010.0106; Ministry of Health Labour and Walfare, 2012, NAT HLTH NUTR SURV J; Ministry of Health Labour and Welfare Japan, 2010, NAT HLTH NUTR SURV J; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Noble D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7163; Pomara F, 2006, Minerva Med, V97, P379; Ramachandran A, 2010, LANCET, V375, P408, DOI 10.1016/S0140-6736(09)60937-5; Sasai Hiroyuki, 2008, Nihon Koshu Eisei Zasshi, V55, P287; Schulze MB, 2009, DIABETES CARE, V32, P2116, DOI 10.2337/dc09-0197; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Sun F, 2009, DIABETES RES CLIN PR, V85, P228, DOI 10.1016/j.diabres.2009.05.005; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Zamora-Ginez I, 2012, ANN HUM BIOL, V39, P102, DOI 10.3109/03014460.2011.645507; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	31	41	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142779	10.1371/journal.pone.0142779	http://dx.doi.org/10.1371/journal.pone.0142779			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558900	Green Submitted, gold, Green Published			2022-12-26	WOS:000364433100121
J	Thomas, R; Galanakis, C; Vezina, S; Longpre, D; Boissonnault, M; Huchet, E; Charest, L; Murphy, D; Trottier, B; Machouf, N				Thomas, Rejean; Galanakis, Chrissi; Vezina, Sylvie; Longpre, Daniele; Boissonnault, Michel; Huchet, Emmanuelle; Charest, Louise; Murphy, Daniel; Trottier, Benoit; Machouf, Nima			Adherence to Post-Exposure Prophylaxis (PEP) and Incidence of HIV Seroconversion in a Major North American Cohort	PLOS ONE			English	Article							COMMUNITY-HEALTH CENTER; SEXUAL EXPOSURE; RETROSPECTIVE ANALYSIS; EMERGENCY-DEPARTMENT; TRANSMISSION RISK; TENOFOVIR DF; MEN; EMTRICITABINE; METAANALYSIS; TOLERABILITY	Background There is limited evidence on the efficacy of post-exposure prophylaxis (PEP) for sexual exposures. We sought to determine the factors associated with adherence to treatment and describe the incidence of PEP failures in a Montreal clinic. Methods We prospectively assessed all patients consulting for PEP following sexual exposures from October 2000 to July 2014. Patients were followed at 4 and 16 weeks after starting PEP. Treatment adherence was determined by self-report at week 4. Multivariable logistic regression was used to estimate the factors predicting adherence to treatment. Results 3547 PEP consults were included. Patients were mainly male (92%), MSM (83%) and sought PEP for anal intercourse (72%). Seventy-eight percent (n = 2772) of patients received a prescription for PEP, consisting of Tenofovir/Emtracitabine (TVD) + Lopinavir/Ritonavir (LPV) in 74% of cases, followed by Zidovudine/Lamivudine (CBV) + LPV (10%) and TVD + Raltegravir (RAL) (8%). Seventy percent of patients were adherent to treatment. Compared to TVD + LPV, patients taking CBV + LPV were less likely to adhere to treatment (OR 0.58, 95% CI 0.44-0.75), while no difference was observed for patients taking TVD + RAL (OR 1.15, 95% CI 0.83-1.59). First-time PEP consults, older and male patients were also more adherent to treatment. Ten treated patients seroconverted (0.37%) during the study period, yet only 1 case can be attributed to PEP failure (failure rate = 0.04%). Conclusion PEP regimen was associated with treatment adherence. Patients were more likely to be adherent to TVD-based regimens. Ten patients seroconverted after taking PEP; however, only 1 case was a PEP failure as the remaining patients continued to engage in high-risk behavior during follow-up. One month PEP is an effective preventive measure to avoid HIV infection.	[Thomas, Rejean; Galanakis, Chrissi; Vezina, Sylvie; Longpre, Daniele; Boissonnault, Michel; Huchet, Emmanuelle; Charest, Louise; Murphy, Daniel; Trottier, Benoit; Machouf, Nima] Clin Med Actuel, Montreal, PQ, Canada		Machouf, N (corresponding author), Clin Med Actuel, Montreal, PQ, Canada.	nima.machouf@lactuel.ca			Abbvie	Abbvie(AbbVie)	The authors would like to thank Abbvie (www.abbvie.ca) for funding the creation of the PEP database. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arribas JR, 2008, JAIDS-J ACQ IMM DEF, V47, P74, DOI 10.1097/QAI.0b013e31815acab8; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Barber TJ, 2010, CURR OPIN HIV AIDS, V5, P322, DOI 10.1097/COH.0b013e32833a5e6c; Benn P, 2011, INT J STD AIDS, V22, P695, DOI 10.1258/ijsa.2011.171011; Bogoch II, 2014, CLIN INFECT DIS, V58, P1618, DOI 10.1093/cid/ciu118; Bryant J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13140; Cai J, 2014, CHINESE MED J-PEKING, V127, P2632, DOI 10.3760/cma.j.issn.0366-6999.20140538; Cardo DM, 1997, NEW ENGL J MED, V337, P1485, DOI 10.1056/NEJM199711203372101; Casalino E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104350; Chan ACH, 2013, INT J STD AIDS, V24, P393, DOI 10.1177/0956462412472826; Dilley JW, 2007, JAIDS-J ACQ IMM DEF, V44, P569, DOI 10.1097/QAI.0b013e318033ffbd; Fernandez-Balbuena S, 2013, HIV MED, V14, P252, DOI 10.1111/j.1468-1293.2012.01056.x; Ford N, 2014, AIDS, V28, P2721, DOI 10.1097/QAD.0000000000000505; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gulholm T, 2013, SEX HEALTH, V10, P438, DOI 10.1071/SH13018; Heuker J, 2012, AIDS, V26, P505, DOI 10.1097/QAD.0b013e32834f32d8; Irvine C, 2015, CLIN INFECT DIS, V60, pS165, DOI 10.1093/cid/civ069; Jain S, 2015, AIDS PATIENT CARE ST, V29, P20, DOI 10.1089/apc.2014.0154; Jain S, 2015, JAIDS-J ACQ IMM DEF, V68, P97, DOI 10.1097/QAI.0000000000000403; Jin FY, 2010, AIDS, V24, P907, DOI 10.1097/QAD.0b013e3283372d90; Joshi M, 2014, INT J STD AIDS, V25, P67, DOI 10.1177/0956462413491734; Krause KH, 2014, WOMEN HEALTH ISS, V24, pE407, DOI 10.1016/j.whi.2014.04.003; Landovitz RJ, 2012, AIDS PATIENT CARE ST, V26, P320, DOI 10.1089/apc.2011.0432; Lunding S, 2007, 4 INT AIDS SOC C HIV; Mayer KH, 2012, JAIDS-J ACQ IMM DEF, V59, P354, DOI 10.1097/QAI.0b013e31824a03b8; McAllister J, 2014, HIV MED, V15, P13, DOI 10.1111/hiv.12075; McCarty EJ, 2011, INT J STD AIDS, V22, P407, DOI 10.1258/ijsa.2009.009463; McDougal SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105030; Mehta SA, 2011, SEX TRANSM INFECT, V87, P344, DOI 10.1136/sti.2010.046284; Oldenburg CE, 2014, AIDS BEHAV, V18, P217, DOI 10.1007/s10461-013-0567-0; Patel P, 2014, AIDS, V28, P1509, DOI 10.1097/QAD.0000000000000298; Rodriguez AE, 2013, JAIDS-J ACQ IMM DEF, V64, pS68, DOI 10.1097/QAI.0b013e3182a901a2; Roland ME, 2005, CLIN INFECT DIS, V41, P1507, DOI 10.1086/497268; Sultan B, 2014, HIV AIDS-RES PALLIAT, V6, P147, DOI 10.2147/HIV.S46585; Tissot F, 2010, HIV MED, V11, P584, DOI 10.1111/j.1468-1293.2010.00826.x; Tosini W, 2010, AIDS, V24, P2375, DOI 10.1097/QAD.0b013e32833dfad1; Vives N, 2008, ENFERM INFEC MICR CL, V26, P546, DOI 10.1157/13128270	37	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142534	10.1371/journal.pone.0142534	http://dx.doi.org/10.1371/journal.pone.0142534			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7DR	26559816	Green Published, gold, Green Submitted			2022-12-26	WOS:000364433100087
J	Elovaara, H; Huusko, T; Maksimow, M; Elima, K; Yegutkin, GG; Skurnik, M; Dobrindt, U; Siitonen, A; McPherson, MJ; Salmi, M; Jalkanen, S				Elovaara, Heli; Huusko, Teija; Maksimow, Mikael; Elima, Kati; Yegutkin, Gennady G.; Skurnik, Mikael; Dobrindt, Ulrich; Siitonen, Anja; McPherson, Michael J.; Salmi, Marko; Jalkanen, Sirpa			Primary Amine Oxidase of Escherichia coli Is a Metabolic Enzyme that Can Use a Human Leukocyte Molecule as a Substrate	PLOS ONE			English	Article							VASCULAR ADHESION PROTEIN-1; PROPIONATE CATABOLIC GENES; ACTIVE-SITE BASE; MONOAMINE-OXIDASE; CATALYTIC MECHANISM; 2-HYDRAZINOPYRIDINE ADDUCT; ARTHROBACTER-GLOBIFORMIS; YERSINIA-ENTEROCOLITICA; DEGRADATION PATHWAY; MUTATIONAL VARIANTS	Escherichia coli amine oxidase (ECAO), encoded by the tynA gene, catalyzes the oxidative deamination of aromatic amines into aldehydes through a well-established mechanism, but its exact biological role is unknown. We investigated the role of ECAO by screening environmental and human isolates for tynA and characterizing a tynA-deletion strain using microarray analysis and biochemical studies. The presence of tynA did not correlate with pathogenicity. In tynA+ Escherichia coli strains, ECAO enabled bacterial growth in phenylethylamine, and the resultant H2O2 was released into the growth medium. Some aminoglycoside antibiotics inhibited the enzymatic activity of ECAO, which could affect the growth of tynA+ bacteria. Our results suggest that tynA is a reserve gene used under stringent environmental conditions in which ECAO may, due to its production of H2O2, provide a growth advantage over other bacteria that are unable to manage high levels of this oxidant. In addition, ECAO, which resembles the human homolog hAOC3, is able to process an unknown substrate on human leukocytes.	[Elovaara, Heli; Huusko, Teija; Maksimow, Mikael; Elima, Kati; Yegutkin, Gennady G.; Salmi, Marko; Jalkanen, Sirpa] Univ Turku, MediCity Res Lab, Turku, Finland; [Elovaara, Heli; Huusko, Teija; Yegutkin, Gennady G.; Salmi, Marko; Jalkanen, Sirpa] Univ Turku, Dept Med Microbiol & Immunol, Turku, Finland; [Huusko, Teija] Turku Grad Sch Biomed Sci, Turku, Finland; [Elima, Kati] Univ Turku, Dept Med Biochem & Genet, Turku, Finland; [Skurnik, Mikael] Univ Helsinki, Dept Bacteriol & Immunol, Res Programs Unit, Medicum,Immunobiol, Helsinki, Finland; [Skurnik, Mikael] Helsinki Univ Cent Hosp Lab Diagnost, Helsinki, Finland; [Dobrindt, Ulrich] Univ Munster, Inst Hyg, D-48149 Munster, Germany; [Siitonen, Anja] Natl Inst Hlth & Welf, Dept Infect Dis Surveillance & Control, Bacteriol Unit, Helsinki, Finland; [McPherson, Michael J.] Univ Leeds, Inst Mol & Cellular Biol, Fac Biol Sci, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England	University of Turku; University of Turku; University of Turku; University of Turku; University of Helsinki; University of Munster; Finland National Institute for Health & Welfare; University of Leeds	Salmi, M (corresponding author), Univ Turku, MediCity Res Lab, Turku, Finland.	marko.salmi@utu.fi; sirjal@utu.fi	Yegutkin, Gennady G./K-3815-2014; Dobrindt, Ulrich/AEU-2378-2022; Skurnik, Mikael/I-8477-2019	Yegutkin, Gennady G./0000-0001-6684-7982; Dobrindt, Ulrich/0000-0001-9949-1898; Skurnik, Mikael/0000-0001-8791-9260; McPherson, Michael/0000-0002-0719-6427	Academy of Finland [132701, 141136]; Turku Graduate School of Biomedical Sciences; University of Turku foundation; Maud Kuistila foundation	Academy of Finland(Academy of Finland); Turku Graduate School of Biomedical Sciences; University of Turku foundation; Maud Kuistila foundation	This work was supported by the Academy of Finland (www.aka.fi) #132701 (to HE), by the Academy of Finland (www.aka.fi) #141136 (to MS and SJ), by the Turku Graduate School of Biomedical Sciences (www.tubs.utu.fi, to TH), by the University of Turku foundation (https://www.utu.fi/fi/yksikot/yliopistosaatio/en/Sivut/home.aspx, to HE), and by the Maud Kuistila foundation (http://www.maudkuistilanmuistosaatio.fi/index.php?lang=en, to HE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto K, 2011, BLOOD, V118, P3725, DOI 10.1182/blood-2010-09-311076; AZAKAMI H, 1994, J FERMENT BIOENG, V77, P315, DOI 10.1016/0922-338X(94)90241-0; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; BLASCO F, 1992, MOL MICROBIOL, V6, P221, DOI 10.1111/j.1365-2958.1992.tb02003.x; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Brock M, 2002, EUR J BIOCHEM, V269, P6184, DOI 10.1046/j.1432-1033.2002.03336.x; Bunch PK, 1997, MICROBIOL-UK, V143, P187, DOI 10.1099/00221287-143-1-187; CAI DY, 1994, J BIOL CHEM, V269, P32039; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chiang SM, 2012, ARCH BIOCHEM BIOPHYS, V525, P161, DOI 10.1016/j.abb.2012.02.007; CHOI YH, 1995, J BIOL CHEM, V270, P4712, DOI 10.1074/jbc.270.9.4712; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; EDWARDS CQ, 1976, ANTIMICROB AGENTS CH, V9, P925, DOI 10.1128/AAC.9.6.925; Fernandez C, 2014, ENV MICROBIOL REP, V6, P239, DOI 10.1111/1758-2229.12117; Ferrandez A, 2000, J BIOL CHEM, V275, P12214, DOI 10.1074/jbc.275.16.12214; Fic E, 2009, J MOL MICROB BIOTECH, V17, P1, DOI 10.1159/000178014; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Hacisalihoglu A, 1997, MICROBIOL-UK, V143, P505, DOI 10.1099/00221287-143-2-505; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; Hara-Kudo Y, 2000, APPL ENVIRON MICROB, V66, P5540, DOI 10.1128/AEM.66.12.5540-5543.2000; Ho KK, 2005, J BACTERIOL, V187, P1067, DOI 10.1128/JB.187.3.1067-1073.2005; Holt A, 1997, ANAL BIOCHEM, V244, P384, DOI 10.1006/abio.1996.9911; Hovatta I, 2006, DNA MICROARRAY DATA; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Janion C, 2008, INT J BIOL SCI, V4, P338; Jansen WTM, 2002, INFECT IMMUN, V70, P5202, DOI 10.1128/IAI.70.9.5202-5207.2002; Jia WJ, 2009, BIOCHEM J, V417, P297, DOI 10.1042/BJ20080746; Jiang H, 2006, BIOTECHNOL LETT, V28, P1241, DOI 10.1007/s10529-006-9080-0; Kehres DG, 2002, J BACTERIOL, V184, P3151, DOI 10.1128/JB.184.12.3151-3158.2002; Kivi E, 2009, BLOOD, V114, P5385, DOI 10.1182/blood-2009-04-219253; KLINMAN JP, 1994, ANNU REV BIOCHEM, V63, P299, DOI 10.1146/annurev.bi.63.070194.001503; Koskinen K, 2004, BLOOD, V103, P3388, DOI 10.1182/blood-2003-09-3275; Kumar SR, 2013, J BACTERIOL, V195, P4569, DOI 10.1128/JB.00737-13; Kurtis CRP, 2011, J NEURAL TRANSM, V118, P1043, DOI 10.1007/s00702-011-0620-y; Layer G, 2005, BIOL CHEM, V386, P971, DOI 10.1515/BC.2005.113; Lee SK, 2005, J BACTERIOL, V187, P2793, DOI 10.1128/JB.187.8.2793-2800.2005; Lyles GA, 1995, PROG BRAIN RES, V106, P293; Lynnes T, 2014, MEAT SCI, V96, P165, DOI 10.1016/j.meatsci.2013.06.030; Maniatis T., 1982, MOL CLONING; Marttila-Ichihara F, 2006, ARTHRITIS RHEUM-US, V54, P2852, DOI 10.1002/art.22061; MILLER VL, 1988, INFECT IMMUN, V56, P1242, DOI 10.1128/IAI.56.5.1242-1248.1988; MORGAN RW, 1986, P NATL ACAD SCI USA, V83, P8059, DOI 10.1073/pnas.83.21.8059; MU D, 1994, J BIOL CHEM, V269, P9926; Mure M, 2005, BIOCHEMISTRY-US, V44, P1583, DOI 10.1021/bi0479860; Mure M, 2005, BIOCHEMISTRY-US, V44, P1568, DOI 10.1021/bi047988k; MUROOKA Y, 1978, J BACTERIOL, V136, P714, DOI 10.1128/JB.136.2.714-722.1978; Murray JM, 1999, BIOCHEMISTRY-US, V38, P8217, DOI 10.1021/bi9900469; Murray JM, 2001, BIOCHEMISTRY-US, V40, P12808, DOI 10.1021/bi011187p; O'Reilly EK, 2004, J BACTERIOL, V186, P7149, DOI 10.1128/JB.186.21.7149-7160.2004; Olivieri A, 2012, BBA-GEN SUBJECTS, V1820, P482, DOI 10.1016/j.bbagen.2011.12.009; Park JM, 2012, GENE, V504, P116, DOI 10.1016/j.gene.2012.04.074; PARSONS MR, 1995, STRUCTURE, V3, P1171, DOI 10.1016/S0969-2126(01)00253-2; Peter C, 2008, EUKARYOT CELL, V7, P1781, DOI 10.1128/EC.00230-08; Pomposiello PJ, 2001, TRENDS BIOTECHNOL, V19, P109, DOI 10.1016/S0167-7799(00)01542-0; R Development Core Team, 2006, R LANG ENV STAT COMP; Rahimpour M, 2013, BIOCHEM J, V452, P559, DOI 10.1042/BJ20130154; Rankin LD, 2008, J BACTERIOL, V190, P6170, DOI 10.1128/JB.00508-08; Reitzer L, 2001, MICROBIOL MOL BIOL R, V65, P422, DOI 10.1128/MMBR.65.3.422-444.2001; ROH JH, 1994, BIOSCI BIOTECH BIOCH, V58, P1652, DOI 10.1271/bbb.58.1652; Salmi M, 2005, NAT REV IMMUNOL, V5, P760, DOI 10.1038/nri1705; Salmi M, 2001, IMMUNITY, V14, P265, DOI 10.1016/S1074-7613(01)00108-X; Salmi M, 2014, SEMIN IMMUNOPATHOL, V36, P163, DOI 10.1007/s00281-014-0417-9; Salmi M, 2012, EUR J IMMUNOL, V42, P284, DOI 10.1002/eji.201142223; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Saysell CG, 2002, BIOCHEM J, V365, P809, DOI 10.1042/BJ20011435; Selva L, 2009, P NATL ACAD SCI USA, V106, P1234, DOI 10.1073/pnas.0809600106; Shimada T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020081; SHIMIZU E, 1990, AGR BIOL CHEM TOKYO, V54, P851, DOI 10.1080/00021369.1990.10870020; SKURNIK M, 1995, MOL MICROBIOL, V17, P575, DOI 10.1111/j.1365-2958.1995.mmi_17030575.x; Smith D, 2003, CHEM ABSTR, V138, P57890; Song F, 2006, J BIOL CHEM, V281, P11028, DOI 10.1074/jbc.M513896200; Stolen CM, 2005, IMMUNITY, V22, P105, DOI 10.1016/j.immuni.2004.12.006; SUGINO H, 1992, J BACTERIOL, V174, P2485, DOI 10.1128/jb.174.8.2485-2492.1992; Tao K, 1997, J BACTERIOL, V179, P5967, DOI 10.1128/jb.179.18.5967-5970.1997; Teufel R, 2010, P NATL ACAD SCI USA, V107, P14390, DOI 10.1073/pnas.1005399107; Wang GD, 1998, J FOOD PROTECT, V61, P662, DOI 10.4315/0362-028X-61.6.662; Wilmot CM, 1999, SCIENCE, V286, P1724, DOI 10.1126/science.286.5445.1724; Wilmot CM, 1997, BIOCHEMISTRY-US, V36, P1608, DOI 10.1021/bi962205j; Zeng J, 2013, J BACTERIOL, V195, P5141, DOI 10.1128/JB.00837-13; ZHANG XP, 1993, J BACTERIOL, V175, P5617, DOI 10.1128/JB.175.17.5617-5627.1993; Zimmer DP, 2000, P NATL ACAD SCI USA, V97, P14674, DOI 10.1073/pnas.97.26.14674	83	15	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142367	10.1371/journal.pone.0142367	http://dx.doi.org/10.1371/journal.pone.0142367			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556595	Green Published, gold			2022-12-26	WOS:000364430700091
J	Hamel, DL; Deloire, M; Ruet, A; Charre-Morin, J; Saubusse, A; Ouallet, JC; Brochet, B				Hamel, Delphine Lamargue; Deloire, Mathilde; Ruet, Aurelie; Charre-Morin, Julie; Saubusse, Aurore; Ouallet, Jean-Christophe; Brochet, Bruno			Deciphering Depressive Mood in Relapsing-Remitting and Progressive Multiple Sclerosis and Its Consequence on Quality of Life	PLOS ONE			English	Article							DIAGNOSTIC-CRITERIA; IMPAIRMENT; DISABILITY	Background Depressive mood and other emotional symptoms are common in multiple sclerosis (MS). The patient-reported outcome version of the "Echelle d'Humeur Depressive" (EHD-PRO) aims to differentiate between two dimensions of depressive mood in people living with MS (PwMS). Objectives First, to compare EHD-PRO assessment and its two dimensions, lack of emotional control and emotional blunting, between a large sample of healthy controls (HCs) and two samples of PwMS, relapsing-remitting MS (RRMS) and primary progressive MS (PPMS); and second, to analyse the relationships between EHD-PRO scores with neurological disability, cognitive function, fatigue and health-related quality of life (HR-QOL). Results Regardless of their phenotype, PwMS had significantly higher EHD-PRO scores than HCs. EHD-PRO scores did not differ between the two MS groups. EHD-PRO scores did not correlate with disability and fatigue scores, disease duration or cognitive z scores. In RRMS, the lack of emotional control was independently associated with a decrease in HR-QOL. Conclusion The EHD-PRO is able to easily detect depressive mood and to differentiate between two clinical dimensions, emotional blunting and lack of emotional control. The scale is sensitive and seems robust to confounding factors. Lack of emotional control seems to contribute significantly to altered HR-QOL in RRMS.	[Hamel, Delphine Lamargue; Ruet, Aurelie; Brochet, Bruno] Univ Bordeaux, INSERM, U862, Neuroctr Magendie, Bordeaux, France; [Deloire, Mathilde; Ruet, Aurelie; Charre-Morin, Julie; Saubusse, Aurore; Ouallet, Jean-Christophe; Brochet, Bruno] CHU Bordeaux, INSERM CHU CIC P 0005, F-33076 Bordeaux, France; [Deloire, Mathilde; Ruet, Aurelie; Charre-Morin, Julie; Saubusse, Aurore; Ouallet, Jean-Christophe; Brochet, Bruno] CHU Bordeaux, Serv Neurol, F-33076 Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Bordeaux	Brochet, B (corresponding author), Univ Bordeaux, INSERM, U862, Neuroctr Magendie, Bordeaux, France.	bruna.brochet@chubbordeaux.fr		Lamargue, Delphine/0000-0001-8415-889X; OUALLET, Jean-Christophe/0000-0003-3231-6416	Bayer Health Care, France	Bayer Health Care, France	The study was supported in part by Bayer Health Care, France. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no other funding source.	Beck AT, 1996, PSYCHOL ASSESS; Benedict RHB, 2003, MULT SCLER J, V9, P393, DOI 10.1191/1352458503ms902oa; Brochet B, 2009, REV NEUROL-FRANCE, V165, pS173, DOI 10.1016/S0035-3787(09)72131-9; Bungener C, 1996, J AM GERIATR SOC, V44, P1066, DOI 10.1111/j.1532-5415.1996.tb02939.x; Dulau C, 2015, NEUROPSYCH SYMP NEUR, P213, DOI 10.1007/978-3-319-18464-7_15; Feinstein A, 2001, J AFFECT DISORDERS, V66, P193, DOI 10.1016/S0165-0327(00)00298-6; Feinstein A, 2011, MULT SCLER J, V17, P1276, DOI 10.1177/1352458511417835; JOUVENT R, 1988, Psychiatrie and Psychobiologie, V3, P245; JOUVENT R, 1991, ROY SOC MED INT CONG, V183, P35; Lobentanz IS, 2004, ACTA NEUROL SCAND, V110, P6, DOI 10.1111/j.1600-0404.2004.00257.x; Patten SB, 2003, NEUROLOGY, V61, P1524, DOI 10.1212/01.WNL.0000095964.34294.B4; Perneger, 2001, QUESTIONNAIRE MOS SF; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Radat F, 2007, ENCEPHALE, V33, P49; Rao S, 1990, MANUAL BRIEF REPEATA; Ruet A, 2013, MULT SCLER J, V19, P1665, DOI 10.1177/1352458513480251; Ruet A, 2013, NEUROLOGY, V80, P1501, DOI 10.1212/WNL.0b013e31828cf82f; Ruet A, 2013, J NEUROL, V260, P776, DOI 10.1007/s00415-012-6705-1; Sharrack B, 1999, MULT SCLER, V5, P223, DOI 10.1191/135245899678846131; Spielberger C. D., 1973, MANUAL STATE TRAIT I; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zimmermann P, 2009, TESTS EVALUATION ATT	23	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142152	10.1371/journal.pone.0142152	http://dx.doi.org/10.1371/journal.pone.0142152			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555230	Green Submitted, Green Published, gold			2022-12-26	WOS:000364430700061
J	Jenkins, T; Delhaye, J; Christe, P				Jenkins, Tania; Delhaye, Jessica; Christe, Philippe			Testing Local Adaptation in a Natural Great Tit-Malaria System: An Experimental Approach	PLOS ONE			English	Article							AVIAN BLOOD PARASITES; PLASMODIUM-RELICTUM; OXIDATIVE STRESS; MODEL SELECTION; PRACTICAL GUIDE; METABOLIC-RATE; BLUE TITS; HOST SEX; WILD; HAEMOPROTEUS	Finding out whether Plasmodium spp. are coevolving with their vertebrate hosts is of both theoretical and applied interest and can influence our understanding of the effects and dynamics of malaria infection. In this study, we tested for local adaptation as a signature of coevolution between malaria blood parasites, Plasmodium spp. and its host, the great tit, Parus major. We conducted a reciprocal transplant experiment of birds in the field, where we exposed birds from two populations to Plasmodium parasites. This experimental set-up also provided a unique opportunity to study the natural history of malaria infection in the wild and to assess the effects of primary malaria infection on juvenile birds. We present three main findings: i) there was no support for local adaptation; ii) there was a male-biased infection rate; iii) infection occurred towards the end of the summer and differed between sites. There were also site-specific effects of malaria infection on the hosts. Taken together, we present one of the few experimental studies of parasite-host local adaptation in a natural malaria system, and our results shed light on the effects of avian malaria infection in the wild.	[Jenkins, Tania; Delhaye, Jessica; Christe, Philippe] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland	University of Lausanne	Jenkins, T (corresponding author), Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland.	tania.jenkins@unil.ch	; Christe, Philippe/X-4493-2018	Jenkins, Tania/0000-0002-6816-3848; Christe, Philippe/0000-0002-8605-7002	Swiss National Science Foundation [138187]; Herbette Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Herbette Foundation	Support was provided to PC by the Swiss National Science Foundation grant, number 138187 [http://www.snf.ch/en/Pages/default.aspx] and by the Herbette Foundation [http://www.unil.ch/herbette/fr/home.html].	[Anonymous], 1877, DIFFERENT FORMS FLOW; APPLEGATE J E, 1971, Journal of Wildlife Diseases, V7, P91; Atkinson CT, 2000, J WILDLIFE DIS, V36, P197, DOI 10.7589/0090-3558-36.2.197; ATKINSON CT, 1988, J MED ENTOMOL, V25, P45, DOI 10.1093/jmedent/25.1.45; Barton K., 2014, MUMIN MULTIMODEL INF; Bates D, LME4 LINEAR MIXED EF; Bensch S, 2000, P ROY SOC B-BIOL SCI, V267, P1583, DOI 10.1098/rspb.2000.1181; Bensch S, 2009, MOL ECOL RESOUR, V9, P1353, DOI 10.1111/j.1755-0998.2009.02692.x; Bize P, 2008, ECOLOGY, V89, P2584, DOI 10.1890/07-1135.1; Blanquart F, 2013, ECOL LETT, V16, P1195, DOI 10.1111/ele.12150; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bonneaud C, 2006, EVOLUTION, V60, P383, DOI 10.1111/j.0014-3820.2006.tb01114.x; Brockhurst MA, 2013, TRENDS ECOL EVOL, V28, P367, DOI 10.1016/j.tree.2013.02.009; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Buchanan KL, 2001, P ROY SOC B-BIOL SCI, V268, P1337, DOI 10.1098/rspb.2001.1669; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cellier-Holzem E, 2010, INT J PARASITOL, V40, P1447, DOI 10.1016/j.ijpara.2010.04.014; Christe P, 2007, J ANIM ECOL, V76, P703, DOI 10.1111/j.1365-2656.2007.01255.x; Christe P, 2012, P ROY SOC B-BIOL SCI, V279, P1142, DOI 10.1098/rspb.2011.1546; CRAN, 2012, R LANG ENV STAT COMP; DAVIDAR P, 1993, AUK, V110, P109; Dawson RD, 2000, AUK, V117, P373, DOI 10.1642/0004-8038(2000)117[0373:EOHPOC]2.0.CO;2; Del Hoyo J., 2007, HDB BIRDS WORLD, V12; Dietrich M, 2014, J ANIM ECOL, V83, P576, DOI 10.1111/1365-2656.12170; Duneau D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001271; Dybdahl MF, 2003, TRENDS ECOL EVOL, V18, P523, DOI 10.1016/S0169-5347(03)00223-4; EBERT D, 1994, SCIENCE, V265, P1084, DOI 10.1126/science.265.5175.1084; Ejiri H, 2011, J MED ENTOMOL, V48, P904, DOI 10.1603/ME11053; Galipaud M, 2014, METHODS ECOL EVOL, V5, P983, DOI 10.1111/2041-210X.12251; Gandon S, 2002, ECOL LETT, V5, P246, DOI 10.1046/j.1461-0248.2002.00305.x; Gandon S, 1996, P ROY SOC B-BIOL SCI, V263, P1003, DOI 10.1098/rspb.1996.0148; Garnham PCC., 1966, MALARIA PARASITES OT; Gelman A., 2014, ARM DATA ANAL USING; Glaizot O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034964; Graham AL, 2005, ANNU REV ECOL EVOL S, V36, P373, DOI 10.1146/annurev.ecolsys.36.102003.152622; Greischar MA, 2007, ECOL LETT, V10, P418, DOI 10.1111/j.1461-0248.2007.01028.x; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; HAYWORTH AM, 1987, J PARASITOL, V73, P850, DOI 10.2307/3282431; Hedrick PW, 2011, HEREDITY, V107, P283, DOI 10.1038/hdy.2011.16; Hellgren O, 2004, J PARASITOL, V90, P797, DOI 10.1645/GE-184R1; Hoeksema JD, 2008, AM NAT, V171, P275, DOI 10.1086/527496; Holt RD, 1997, AM NAT, V149, P563, DOI 10.1086/286005; Ishtiaq F, 2010, J BIOGEOGR, V37, P120, DOI 10.1111/j.1365-2699.2009.02189.x; Jenkins T, 2011, MOL ECOL, V20, P3910, DOI 10.1111/j.1365-294X.2011.05221.x; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Joy DA, 2008, MOL BIOL EVOL, V25, P1245, DOI 10.1093/molbev/msn073; Kaltz O, 1999, EVOLUTION, V53, P395, DOI [10.1111/j.1558-5646.1999.tb03775.x, 10.2307/2640776]; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kim KS, 2010, MOL ECOL, V19, P5545, DOI 10.1111/j.1365-294X.2010.04897.x; Kimura M, 2006, J PARASITOL, V92, P1043, DOI 10.1645/GE-639R.1; Knowles SCL, 2010, J EVOLUTION BIOL, V23, P557, DOI 10.1111/j.1420-9101.2009.01920.x; Knowles SCL, 2014, J ANIM ECOL, V83, P429, DOI 10.1111/1365-2656.12154; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Lachish S, 2011, J ANIM ECOL, V80, P1196, DOI 10.1111/j.1365-2656.2011.01836.x; Laine AL, 2005, J EVOLUTION BIOL, V18, P930, DOI 10.1111/j.1420-9101.2005.00933.x; Lajeunesse MJ, 2002, P ROY SOC B-BIOL SCI, V269, P703, DOI 10.1098/rspb.2001.1943; Lalubin F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-307; Lemoine M, 2012, AM NAT, V179, P270, DOI 10.1086/663699; Lively CM, 1999, AM NAT, V153, pS34, DOI 10.1086/303210; Lively CM, 2004, AM NAT, V164, pS6, DOI 10.1086/424605; Loiseau C, 2011, P ROY SOC B-BIOL SCI, V278, P1264, DOI 10.1098/rspb.2010.1968; Mackinnon MJ, 2004, PHILOS T R SOC B, V359, P965, DOI 10.1098/rstb.2003.1414; McCoy KD, 2002, EVOL ECOL RES, V4, P441; Merino S, 2000, P ROY SOC B-BIOL SCI, V267, P2507, DOI 10.1098/rspb.2000.1312; Moore SL, 2002, SCIENCE, V297, P2015, DOI 10.1126/science.1074196; Morgan AD, 2005, NATURE, V437, P253, DOI 10.1038/nature03913; Oppliger A, 1999, J EVOLUTION BIOL, V12, P951, DOI 10.1046/j.1420-9101.1999.00101.x; Palinauskas V, 2008, EXP PARASITOL, V120, P372, DOI 10.1016/j.exppara.2008.09.001; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; Perrins C.M., 1979, BRIT TITS; Poulin R, 1996, AM NAT, V147, P287, DOI 10.1086/285851; Py I, 2006, EVOL ECOL RES, V8, P483; Ricklefs RE, 2004, SYST BIOL, V53, P111, DOI 10.1080/10635150490264987; ROST R, 1990, J ORNITHOL, V131, P403, DOI 10.1007/BF01639816; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Sepil I, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0134; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Sorci G, 2013, PARASITE IMMUNOL, V35, P350, DOI 10.1111/pim.12047; Sorci G, 2009, PHILOS T R SOC B, V364, P71, DOI 10.1098/rstb.2008.0151; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Thompson J. N., 2005, INTERSPEC INTERACT; Tschirren B, 2003, J ANIM ECOL, V72, P839, DOI 10.1046/j.1365-2656.2003.00755.x; Valkinas G., 2005, AVIAN MALARIA PARASI; Valkiunas G, 2006, J PARASITOL, V92, P1123, DOI 10.1645/GE-3564-RN.1; van Rooyen J., 2013, CHARACTERISING AVIAN; van Rooyen J, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-139; WARNER RE, 1968, CONDOR, V70, P101, DOI 10.2307/1365954; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Williams RB, 2005, AVIAN PATHOL, V34, P29, DOI 10.1080/03079450400025430; Wood MJ, 2007, MOL ECOL, V16, P3263, DOI 10.1111/j.1365-294X.2007.03362.x; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569; Zuk M, 1996, INT J PARASITOL, V26, P1009, DOI [10.1016/S0020-7519(96)00086-0, 10.1016/S0020-7519(96)80001-4]	94	14	14	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141391	10.1371/journal.pone.0141391	http://dx.doi.org/10.1371/journal.pone.0141391			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555892	Green Published, Green Submitted, gold			2022-12-26	WOS:000364430700027
J	Zhang, SB; Chen, WY; Huang, JL; Bi, YF; Yang, XF				Zhang, Shi-Bao; Chen, Wen-Yun; Huang, Jia-Lin; Bi, Ying-Feng; Yang, Xue-Fei			Orchid Species Richness along Elevational and Environmental Gradients in Yunnan, China	PLOS ONE			English	Article							GEOMETRIC CONSTRAINTS; VASCULAR EPIPHYTES; RAPOPORTS RULE; DIVERSITY PATTERNS; ENDEMIC RICHNESS; PLANT DIVERSITY; AREA; CONSERVATION; CLIMATE; DETERMINANTS	The family Orchidaceae is not only one of the most diverse families of flowering plants, but also one of the most endangered plant taxa. Therefore, understanding how its species richness varies along geographical and environmental gradients is essential for conservation efforts. However, such knowledge is rarely available, especially on a large scale. We used a database extracted from herbarium records to investigate the relationships between orchid species richness and elevation, and to examine how elevational diversity in Yunnan Province, China, might be explained by mid-domain effect (MDE), species-area relationship (SAR), water-energy dynamics (WED), Rapoport's Rule, and climatic variables. This particular location was selected because it is one of the primary centers of distribution for orchids. We recorded 691 species that span 127 genera and account for 88.59% of all confirmed orchid species in Yunnan. Species richness, estimated at 200-m intervals along a slope, was closely correlated with elevation, peaking at 1395 to 1723 m. The elevational pattern of orchid richness was considerably shaped by MDE, SAR, WED, and climate. Among those four predictors, climate was the strongest while MDE was the weakest for predicting the elevational pattern of orchid richness. Species richness showed parabolic responses to mean annual temperature (MAT) and mean annual precipitation (MAP), with maximum richness values recorded at 13.7 to 17.7 degrees C for MAT and 1237 to 1414 mm for MAP. Rapoport's Rule also helped to explain the elevational pattern of species richness in Yunnan, but those influences were not entirely uniform across all methods. These results suggested that the elevational pattern of orchid species richness in Yunnan is collectively shaped by several mechanisms related to geometric constraints, size of the land area, and environments. Because of the dominant role of climate in determining orchid richness, our findings may contribute to a better understanding of the potential effects of climate change on orchid diversity, and the development of conservation strategies for orchids.	[Zhang, Shi-Bao; Huang, Jia-Lin; Bi, Ying-Feng; Yang, Xue-Fei] Chinese Acad Sci, Key Lab Econ Plants & Biotechnol, Kunming Inst Bot, Kunming, Peoples R China; [Zhang, Shi-Bao; Huang, Jia-Lin; Bi, Ying-Feng; Yang, Xue-Fei] Yunnan Key Lab Wild Plant Resources, Kunming, Peoples R China; [Chen, Wen-Yun] Chinese Acad Sci, Key Lab Plant Diversity & Biogeog East Asia, Kunming Inst Bot, Kunming, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Zhang, SB (corresponding author), Chinese Acad Sci, Key Lab Econ Plants & Biotechnol, Kunming Inst Bot, Kunming, Peoples R China.	sbzhang@mail.kib.ac.cn	Chen, Wen-yun/AAS-4433-2021; Yang, Xuefei/G-5656-2012; Bi, Yingfeng/AAO-8544-2020	Yang, Xuefei/0000-0002-0986-2745; Chen, Wen-Yun/0000-0001-5560-407X	National Natural Science Foundation of China [31170315, 31370362]; Natural Science Foundation of Yunnan Province [2013FA044]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province)	This work is financially supported by the National Natural Science Foundation of China (31170315, 31370362) and the Natural Science Foundation of Yunnan Province (2013FA044).	Acharya KP, 2011, J BIOGEOGR, V38, P1821, DOI 10.1111/j.1365-2699.2011.02511.x; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; Bachman S, 2004, ECOGRAPHY, V27, P299, DOI 10.1111/j.0906-7590.2004.03759.x; Baldi A, 2008, J BIOGEOGR, V35, P675, DOI 10.1111/j.1365-2699.2007.01825.x; Barthlott W, 2001, PLANT ECOL, V152, P145, DOI 10.1023/A:1011483901452; Benzing D., 1990, J TROP ECOL, V8, P55, DOI [10.1017/S0266467400006088, DOI 10.1017/S0266467400006088]; Bhattarai KR, 2006, DIVERS DISTRIB, V12, P373, DOI 10.1111/j.1366-9516.2006.00244.x; Bhattarai KR, 2004, J BIOGEOGR, V31, P389, DOI 10.1046/j.0305-0270.2003.01013.x; Bhattarai KR, 2003, GLOBAL ECOL BIOGEOGR, V12, P327, DOI 10.1046/j.1466-822X.2003.00044.x; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bowden JJ, 2010, ECOSCIENCE, V17, P287, DOI 10.2980/17-3-3308; Cardelus CL, 2006, J ECOL, V94, P144, DOI 10.1111/j.1365-2745.2005.01052.x; Carpenter C, 2005, J BIOGEOGR, V32, P999, DOI 10.1111/j.1365-2699.2005.01249.x; Chen SB, 2015, BIODIVERS CONSERV, V24, P593, DOI 10.1007/s10531-014-0838-8; Chi Xiu-Lian, 2011, Chinese Journal of Plant Ecology, V35, P362, DOI 10.3724/SP.J.1258.2011.00362; Colwell RK, 2008, ECOGRAPHY, V31, P4, DOI 10.1111/j.2008.0906-7590.05347.x; Crain BJ, 2014, DIVERS DISTRIB, V20, P652, DOI 10.1111/ddi.12179; Crain BJ., 2012, LANKESTERIANA, V12, P13; Currie DJ, 2008, ECOL MONOGR, V78, P3, DOI 10.1890/06-1302.1; Dorazio RM, 2011, BIODIVERSITY LOSS IN A CHANGING PLANET, P277; Drakare S, 2006, ECOL LETT, V9, P215, DOI 10.1111/j.1461-0248.2005.00848.x; Fan ZX, 2013, CLIMATIC CHANGE, V116, P309, DOI 10.1007/s10584-012-0479-4; Fan ZX, 2011, INT J CLIMATOL, V31, P2078, DOI 10.1002/joc.2214; Fay MF, 2009, ANN BOT-LONDON, V104, P359, DOI [10.1093/aob/mcp190, 10.1093/aob/mcp195]; Moreira ASP, 2008, BRAZ ARCH BIOL TECHN, V51, P83, DOI 10.1590/S1516-89132008000100011; Fu CZ, 2006, ECOGRAPHY, V29, P919, DOI 10.1111/j.2006.0906-7590.04802.x; Gotelli NJ, 2004, ECOSIM NULL MODELS S; Gravendeel B, 2004, PHILOS T ROY SOC B, V359, P1523, DOI 10.1098/rstb.2004.1529; Grytnes JA, 2002, AM NAT, V159, P294, DOI 10.1086/338542; Grytnes JA, 2006, J BIOGEOGR, V33, P1838, DOI 10.1111/j.1365-2699.2006.01554.x; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Jacquemyn H, 2005, J BIOGEOGR, V32, P1751, DOI 10.1111/j.1365-2699.2005.01307.x; Jalal Jeewan Singh, 2012, International Journal of Plant Biology, V3, pe5, DOI 10.4081/pb.2012.e5; Kluge J, 2006, GLOBAL ECOL BIOGEOGR, V15, P358, DOI [10.1111/j.1466-822X.2006.00223.x, 10.1111/j.1466-822x.2006.00223.x]; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; Kromer T, 2005, J BIOGEOGR, V32, P1799, DOI 10.1111/j.1365-2699.2005.01318.x; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; LETCHER AJ, 1994, AM NAT, V144, P30, DOI 10.1086/285659; Li H, 2003, FLORA YUNNANICA, V14; Li Z., 2015, STUDY CLIMATE CHANGE; Liu Q, 2015, CONSERV BIOL, V29, P1563, DOI 10.1111/cobi.12584; [刘仲健 LIU Zhong-Jian], 2009, [生态学报, Acta Ecologica Sinica], V29, P3443; Lobo JM, 2008, BIODIVERS CONSERV, V17, P873, DOI 10.1007/s10531-008-9333-4; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; Luo ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027975; McCain CM, 2007, GLOBAL ECOL BIOGEOGR, V16, P1, DOI 10.1111/j.1466-8238.2006.00263.x; Moreno RA, 2008, GLOBAL ECOL BIOGEOGR, V17, P415, DOI 10.1111/j.1466-8238.2007.00372.x; Myers Norman, 2000, Nature (London), V403, P853, DOI 10.1038/35002501; Nogues-Bravo D, 2008, NATURE, V453, P216, DOI 10.1038/nature06812; O'Brien EM, 1998, J BIOGEOGR, V25, P379, DOI 10.1046/j.1365-2699.1998.252166.x; PAGEL MD, 1991, AM NAT, V137, P791, DOI 10.1086/285194; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; R Core Team, 2014, R FDN STAT COMP; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; ROHDE K, 1993, AM NAT, V142, P1, DOI 10.1086/285526; ROSENZWEIG ML, 1992, J MAMMAL, V73, P715, DOI 10.2307/1382191; Schickhoff U, 2015, EARTH SYST DYNAM, V6, P245, DOI 10.5194/esd-6-245-2015; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Solow AR, 2006, DIVERS DISTRIB, V12, P423, DOI 10.1111/j.1366-9516.2006.00259.x; STEVENS GC, 1992, AM NAT, V140, P893, DOI 10.1086/285447; Swarts ND, 2009, ANN BOT-LONDON, V104, P543, DOI 10.1093/aob/mcp025; Telwala Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057103; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Tian Huaizhen, 2008, Shengwu Duoyangxing, V16, P75, DOI 10.3724/SP.J.1003.2008.07081; Triantis KA, 2003, J BIOGEOGR, V30, P19, DOI 10.1046/j.1365-2699.2003.00805.x; Trigas P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059425; Vetaas OR, 2002, GLOBAL ECOL BIOGEOGR, V11, P291, DOI 10.1046/j.1466-822X.2002.00297.x; Wang JJ, 2013, NAT HAZARDS, V67, P431, DOI 10.1007/s11069-013-0572-7; Wang ZH, 2007, DIVERS DISTRIB, V13, P845, DOI 10.1111/j.1472-4642.2007.00335.x; Wang ZH, 2011, P ROY SOC B-BIOL SCI, V278, P2122, DOI 10.1098/rspb.2010.1897; Watkins JE, 2006, AM J BOT, V93, P73, DOI 10.3732/ajb.93.1.73; Wolf JHD, 2003, J BIOGEOGR, V30, P1689, DOI 10.1046/j.1365-2699.2003.00902.x; Wu YJ, 2013, J BIOGEOGR, V40, P2310, DOI 10.1111/jbi.12177; Zhang SB, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00260; Zhang SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040080; Zhang ZJ, 2015, BIOL CONSERV, V181, P64, DOI 10.1016/j.biocon.2014.10.026; ZHAO M, 2015, CHINA PLOS ONE, V0010; Zhao SQ, 2006, GLOBAL ECOL BIOGEOGR, V15, P386, DOI 10.1111/j.1466-822x.2006.00236.x	81	59	62	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142621	10.1371/journal.pone.0142621	http://dx.doi.org/10.1371/journal.pone.0142621			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555336	Green Published, Green Submitted, gold			2022-12-26	WOS:000364430700142
J	Hulland, KRS; Chase, RP; Caruso, BA; Swain, R; Biswal, B; Sahoo, KC; Panigrahi, P; Dreibelbis, R				Hulland, Kristyna R. S.; Chase, Rachel P.; Caruso, Bethany A.; Swain, Rojalin; Biswal, Bismita; Sahoo, Krushna Chandra; Panigrahi, Pinaki; Dreibelbis, Robert			Sanitation, Stress, and Life Stage: A Systematic Data Collection Study among Women in Odisha, India	PLoS One			English	Article							LOCAL PERCEPTIONS; WATER INSECURITY; QUALITATIVE DATA; ACCESS; HEALTH; MANAGEMENT; DISTRESS; RANKING; AFRICA; GENDER	Emerging evidence demonstrates how inadequate access to water and sanitation is linked to psychosocial stress, especially among women, forcing them to navigate social and physical barriers during their daily sanitation routines. We examine sanitation-related psychosocial stress (SRPS) across women's reproductive lives in three distinct geographic sites (urban slums, rural villages, and rural tribal villages) in Odisha, India. We explored daily sanitation practices of adolescent, newly married, pregnant, and established adult women (n = 60) and identified stressors encountered during sanitation. Responding to structured data collection methods, women ranked seven sanitation activities (defecation, urination, menstruation, bathing, post-defecation cleaning, carrying water, and changing clothes) based on stress (high to low) and level of freedom (associated with greatest freedom to having the most restrictions). Women then identified common stressors they encountered when practicing sanitation and sorted stressors in constrained piles based on frequency and severity of each issue. The constellation of factors influencing SRPS varies by life stage and location. Overall, sanitation behaviors that were most restricted (i.e., menstruation) were the most stressful. Women in different sites encountered different stressors, and the level of perceived severity varied based on site and life stage. Understanding the influence of place and life stage on SRPS provides a nuanced understanding of sanitation, and may help identify areas for intervention.	[Hulland, Kristyna R. S.] Univ Chicago, Ctr Global Hlth, Chicago, IL 60637 USA; [Chase, Rachel P.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Caruso, Bethany A.] Emory Univ, Rollins Sch Publ Hlth, Ctr Global Safe Water, Dept Behav Sci & Hlth Educ, Atlanta, GA 30322 USA; [Swain, Rojalin; Biswal, Bismita; Sahoo, Krushna Chandra] Asian Inst Publ Hlth, Bhubaneswar, Orissa, India; [Panigrahi, Pinaki] Univ Nebraska Med Ctr, Coll Publ Hlth, Epidemiol & Pediat, Omaha, NE USA; [Panigrahi, Pinaki] Univ Nebraska Med Ctr, Coll Publ Hlth, Ctr Global Hlth & Dev, Omaha, NE USA; [Dreibelbis, Robert] Univ Oklahoma, Ctr Appl Social Res, Norman, OK 73019 USA	University of Chicago; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Emory University; Rollins School Public Health; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Oklahoma System; University of Oklahoma - Norman	Dreibelbis, R (corresponding author), Univ Oklahoma, Ctr Appl Social Res, Norman, OK 73019 USA.	rdreibe@ou.edu	Kuang, Jinyi/L-8488-2017; Sahoo, Krushna Chandra/AAF-2813-2020	Kuang, Jinyi/0000-0003-4173-3246; Dreibelbis, Robert/0000-0002-9716-0419; Chase, Rachel/0000-0002-1503-4954	Department for International Development (DfID) as part of the SHARE research programme; Water Supply and Sanitation Council (WSSCC)	Department for International Development (DfID) as part of the SHARE research programme; Water Supply and Sanitation Council (WSSCC)	Funding: This work was made possible with UK aid from the Department for International Development (DfID), as part of the SHARE research programme, and support from the Water Supply and Sanitation Council (WSSCC). However, the views expressed do not necessarily reflect DfID's official policies or the policies of WSSCC. The funding agencies had no involvement in study design, data collection, data analysis, and data interpretation.	Abrahams N, 2006, TROP MED INT HEALTH, V11, P751, DOI 10.1111/j.1365-3156.2006.01600.x; [Anonymous], RES GUID MAINSTR GEN; Biswas Soutik, BBC NEWS; Bolton P, 2001, J NERV MENT DIS, V189, P243, DOI 10.1097/00005053-200104000-00006; Bourey C, 2012, GLOB PUBLIC HEALTH, V7, P995, DOI 10.1080/17441692.2012.709259; Bradley EH, 2007, HEALTH SERV RES, V42, P1758, DOI 10.1111/j.1475-6773.2006.00684.x; Census Organization of India, 2011, OR POP CENS DAT; Crow B, 2002, SOC NATUR RESOUR, V15, P709, DOI 10.1080/08941920290069308; DeJordy R, 2007, FIELD METHOD, V19, P239, DOI 10.1177/1525822X07302104; Dohn MN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101007; Fisher Julie, 2006, WATER SANITATION HYG; Garg S, 2001, REPROD HEALTH MATTER, V9, P16, DOI 10.1016/S0968-8080(01)90004-7; Gruebner O, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-36; Hamal M, 2014, INT J HLTH SCI RES I, V4, P28; Hargreaves JR, 2007, WORLD DEV, V35, P212, DOI 10.1016/j.worlddev.2005.10.021; Henley P, 2014, CAN J PHYSIOL PHARM, V92, P725, DOI 10.1139/cjpp-2014-0035; Hossain Anushay, 2014, HUFFINGTON POST; Hueso A, 2013, WATER POLICY, V15, P1001, DOI 10.2166/wp.2013.032; KOLENDA PM, 1964, J ASIAN STUD, V23, P71, DOI 10.2307/2050622; Lennon S., 2011, FEAR ANGER PERCEPTIO; Massey K., 2011, INSECURITY SHAME EXP; McMahon SA, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-7; McPeak JG, 2009, J DEV STUD, V45, P1663, DOI 10.1080/00220380902890219; Nallari A., 2015, ENV URBANIZATION; Nord M., 2014, INTRO ITEM RESPONSE; Nyamongo IK, 1999, TROP MED INT HEALTH, V4, P736, DOI 10.1046/j.1365-3156.1999.00484.x; Panda SM, 2007, GEND TECHNOL DEV, V11, P321, DOI 10.1177/097185240701100302; ROMNEY AK, 1964, AM ANTHROPOL, V66, P146; Sahoo KC, 2015, SOC SCI MED, V139, P80, DOI 10.1016/j.socscimed.2015.06.031; Schmidt M., 2002, EARLY CHILD DEV CARE, V172, P451, DOI [DOI 10.1080/03004430214550, 10.1080/03004430214550]; Singh N, 2006, GEND TECHNOL DEV, V10, P61, DOI 10.1177/097185240501000104; Sommer M, 2013, COMPARE, V43, P323, DOI 10.1080/03057925.2012.693280; Sorenson SB, 2011, SOC SCI MED, V72, P1522, DOI 10.1016/j.socscimed.2011.03.010; Stevenson EGJ, 2012, SOC SCI MED, V75, P392, DOI 10.1016/j.socscimed.2012.03.022; Stopnitzky Y, 2012, SSRN ELECT J, DOI [10.2139/ssrn.2031273, DOI 10.2139/SSRN.2031273]; Sultana F, 2011, GEOFORUM, V42, P163, DOI 10.1016/j.geoforum.2010.12.002; Sumpter C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062004; Tewary A., 2013, BBC NEWS; VANCAMPENHOUT B, 2006, J AFRICAN EC, V16, P406, DOI DOI 10.1093/JAE/EJL041; WELLER SC, 1988, SYSTEMATIC DATA COLL; World Health Organization & UNICEF, 2015, PROGR SAN DRINK WAT; Wutich A, 2008, SOC SCI MED, V67, P2116, DOI 10.1016/j.socscimed.2008.09.042	42	56	56	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0141883	10.1371/journal.pone.0141883	http://dx.doi.org/10.1371/journal.pone.0141883			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7AC	26551866	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000364422800010
J	Schelpe, J; Monte, D; Dewitte, F; Sixma, TK; Rucktooa, P				Schelpe, Julien; Monte, Didier; Dewitte, Frederique; Sixma, Titia K.; Rucktooa, Prakash			Structure of UBE2Z Enzyme Provides Functional Insight into Specificity in the FAT10 Protein Conjugation Machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-LIKE PROTEIN; E1; ACTIVATION; E2; EXPRESSION; FAMILY; UBA6; IDENTIFICATION; DEGRADATION; PROGRESSION	FAT10 conjugation, a post-translational modification analogous to ubiquitination, specifically requires UBA6 and UBE2Z as its activating (E1) and conjugating (E2) enzymes. Interestingly, these enzymes can also function in ubiquitination. We have determined the crystal structure of UBE2Z and report how the different domains of this E2 enzyme are organized. We further combine our structural data with mutational analyses to understand how specificity is achieved in the FAT10 conjugation pathway. We show that specificity toward UBA6 and UBE2Z lies within the C-terminal CYCI tetrapeptide in FAT10. We also demonstrate that this motif slows down transfer rates for FAT10 from UBA6 onto UBE2Z.	[Schelpe, Julien; Monte, Didier; Dewitte, Frederique; Rucktooa, Prakash] Univ Lille, CNRS, UMR8576, F-59658 Villeneuve Dascq, France; [Sixma, Titia K.; Rucktooa, Prakash] Netherlands Canc Inst, Div Biochem, NL-1066 CX Amsterdam, Netherlands; [Sixma, Titia K.; Rucktooa, Prakash] Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Netherlands Cancer Institute; Netherlands Cancer Institute	Rucktooa, P (corresponding author), Univ Lille, CNRS, UMR8576, 50 Ave Halley, F-59658 Villeneuve Dascq, France.	prakash.rucktooa@univ-lille1.fr		Rucktooa, Prakash/0000-0003-2050-7389; Sixma, Titia K/0000-0001-6180-0632; monte, didier/0000-0002-0613-6203	French Agence Nationale de la Recherche [ANR-12-PDOC-0032-01]; Center for Biomedical Genetics; European Research Council [249997]	French Agence Nationale de la Recherche(French National Research Agency (ANR)); Center for Biomedical Genetics; European Research Council(European Research Council (ERC)European Commission)	This work was supported by the French Agence Nationale de la Recherche under Grant ANR-12-PDOC-0032-01 (to P. R.) and the Center for Biomedical Genetics as well as the European Research Council Advanced Grant 249997 (to T. K. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Aichem A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1012; Bates EFM, 1997, EUR J IMMUNOL, V27, P2471, DOI 10.1002/eji.1830271002; Bohnsack RN, 2003, J BIOL CHEM, V278, P26823, DOI 10.1074/jbc.M303177200; Bricogne G., 2011, BUSTER; Canaan A, 2014, P NATL ACAD SCI USA, V111, P5313, DOI 10.1073/pnas.1323426111; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chiu YH, 2007, MOL CELL, V27, P1014, DOI 10.1016/j.molcel.2007.08.020; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Durfee LA, 2008, J BIOL CHEM, V283, P23895, DOI 10.1074/jbc.M804069200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gavin JM, 2012, J BIOL CHEM, V287, P15512, DOI 10.1074/jbc.M111.336198; Groettrup M, 2008, TRENDS BIOCHEM SCI, V33, P230, DOI 10.1016/j.tibs.2008.01.005; Hibbert RG, 2012, J BIOL CHEM, V287, P39216, DOI 10.1074/jbc.M112.389890; Huang DT, 2008, NAT STRUCT MOL BIOL, V15, P280, DOI 10.1038/nsmb.1387; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Huang DT, 2005, MOL CELL, V17, P341, DOI 10.1016/j.molcel.2004.12.020; Jin JP, 2007, NATURE, V447, P1135, DOI 10.1038/nature05902; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; Joosten RP, 2012, ACTA CRYSTALLOGR D, V68, P484, DOI 10.1107/S0907444911054515; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lee CGL, 2003, ONCOGENE, V22, P2592, DOI 10.1038/sj.onc.1206337; Lin YQ, 2002, J BIOL CHEM, V277, P21913, DOI 10.1074/jbc.M109398200; Liu YC, 1999, P NATL ACAD SCI USA, V96, P4313, DOI 10.1073/pnas.96.8.4313; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Luna-Vargas MPA, 2011, J STRUCT BIOL, V175, P113, DOI 10.1016/j.jsb.2011.03.017; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merbl Y, 2013, CELL, V152, P1160, DOI 10.1016/j.cell.2013.02.007; Mooij WTM, 2009, NUCLEIC ACIDS RES, V37, pW402, DOI 10.1093/nar/gkp256; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Pelzer C, 2010, SUBCELL BIOCHEM, V54, P238, DOI 10.1007/978-1-4419-6676-6_19; Petoukhov MV, 2013, INT J BIOCHEM CELL B, V45, P429, DOI 10.1016/j.biocel.2012.10.017; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Qing X, 2011, EXP MOL PATHOL, V90, P51, DOI 10.1016/j.yexmp.2010.09.005; Raasi S, 2001, J BIOL CHEM, V276, P35334, DOI 10.1074/jbc.M105139200; Raasi S, 1999, EUR J IMMUNOL, V29, P4030, DOI 10.1002/(SICI)1521-4141(199912)29:12<4030::AID-IMMU4030>3.0.CO;2-Y; Schmidtke G, 2014, BBA-MOL CELL RES, V1843, P97, DOI 10.1016/j.bbamcr.2013.01.009; Sheng Y, 2012, MOL CELL PROTEOMICS, V11, P329, DOI 10.1074/mcp.O111.013706; Siepmann TJ, 2003, J BIOL CHEM, V278, P9448, DOI 10.1074/jbc.M211240200; Souphron J, 2008, BIOCHEMISTRY-US, V47, P8961, DOI 10.1021/bi800604c; Terwilliger Thomas C., 2012, Journal of Structural and Functional Genomics, V13, P81, DOI 10.1007/s10969-012-9129-3; Theng SS, 2014, P NATL ACAD SCI USA, V111, pE5282, DOI 10.1073/pnas.1403383111; Uversky VN, 2013, PROTEIN SCI, V22, P693, DOI 10.1002/pro.2261; van der Veen AG, 2012, ANNU REV BIOCHEM, V81, P323, DOI 10.1146/annurev-biochem-093010-153308; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Wang JH, 2007, MOL CELL, V27, P228, DOI 10.1016/j.molcel.2007.05.023; Wee KE, 2000, J PROTEIN CHEM, V19, P489, DOI 10.1023/A:1026501515450; Wenzel DM, 2011, BIOCHEM J, V433, P31, DOI 10.1042/BJ20100985; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yan DW, 2010, BRIT J CANCER, V103, P961, DOI 10.1038/sj.bjc.6605870; Zhao B, 2012, ACS CHEM BIOL, V7, P2027, DOI 10.1021/cb300339p	53	20	20	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					630	639		10.1074/jbc.M115.671545	http://dx.doi.org/10.1074/jbc.M115.671545			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26555268	Green Published, hybrid			2022-12-26	WOS:000367830500011
J	DeBerg, HA; Brzovic, PS; Flynn, GE; Zagotta, WN; Stoll, S				DeBerg, Hannah A.; Brzovic, Peter S.; Flynn, Galen E.; Zagotta, William N.; Stoll, Stefan			Structure and Energetics of Allosteric Regulation of HCN2 Ion Channels by Cyclic Nucleotides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; cyclic nucleotide; electron paramagnetic resonance (EPR); electrophysiology; fluorescence anisotropy; ion channel; nuclear magnetic resonance (NMR); double electron-electron resonance (DEER)	GATED CHANNELS; LIGAND-BINDING; PACEMAKER CHANNELS; TERMINAL REGION; C-HELIX; CAMP; MECHANISM; RESIDUE; DOMAIN; REARRANGEMENTS	Hyperpolarization-activated cyclic nucleotide-gated (HCN) ion channels play an important role in regulating electrical activity in the heart and brain. They are gated by the binding of cyclic nucleotides to a conserved, intracellular cyclic nucleotide-binding domain (CNBD), which is connected to the channel pore by a C-linker region. Binding of cyclic nucleotides increases the rate and extent of channel activation and shifts it to less hyperpolarized voltages. We probed the allosteric mechanism of different cyclic nucleotides on the CNBD and on channel gating. Electrophysiology experiments showed that cAMP, cGMP, and cCMP were effective agonists of the channel and produced similar increases in the extent of channel activation. In contrast, electron paramagnetic resonance (EPR) and nuclear magnetic resonance (NMR) on the isolated CNBD indicated that the induced conformational changes and the degrees of stabilization of the active conformation differed for the three cyclic nucleotides. We explain these results with a model where different allosteric mechanisms in the CNBD all converge to have the same effect on the C-linker and render all three cyclic nucleotides similarly potent activators of the channel.	[DeBerg, Hannah A.; Stoll, Stefan] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [DeBerg, Hannah A.; Flynn, Galen E.; Zagotta, William N.; Stoll, Stefan] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Brzovic, Peter S.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Zagotta, WN (corresponding author), Univ Washington, Box 357290, Seattle, WA 98195 USA.	zagotta@uw.edu; stst@uw.edu	Stoll, Stefan/C-5225-2008	Stoll, Stefan/0000-0003-4255-9550	National Institutes of Health [EY010329, GM098503]; American Heart Association [14IRG18770000, 14CSA20380095]; Sackler Scholars Program in Integrative Biophysics; NATIONAL EYE INSTITUTE [R01EY010329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098503] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Sackler Scholars Program in Integrative Biophysics; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant EY010329 (to W. N. Z. and S. S.), American Heart Association Grants 14IRG18770000 (to W. N. Z.) and 14CSA20380095 (to W. N. Z. and S. S.), and by a fellowship from the Sackler Scholars Program in Integrative Biophysics (to H. A. D.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by National Institutes of Health Grant GM098503.	Akimoto M, 2014, J BIOL CHEM, V289, P22205, DOI 10.1074/jbc.M114.572164; Altomare C, 2001, J GEN PHYSIOL, V117, P519, DOI 10.1085/jgp.117.6.519; Benndorf K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002721; Carlson AE, 2013, J BIOL CHEM, V288, P33136, DOI 10.1074/jbc.M113.501759; Chowdhury S, 2013, J GEN PHYSIOL, V141, P11, DOI 10.1085/jgp.201210860; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Craven KB, 2004, J GEN PHYSIOL, V124, P663, DOI 10.1085/jgp.200409178; Craven KB, 2008, J BIOL CHEM, V283, P14728, DOI 10.1074/jbc.M710463200; Cukkemane A, 2007, EMBO REP, V8, P749, DOI 10.1038/sj.embor.7401025; DeBerg HA, 2015, STRUCTURE, V23, P734, DOI 10.1016/j.str.2015.02.007; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Flynn GE, 2007, STRUCTURE, V15, P671, DOI 10.1016/j.str.2007.04.008; GORDON SE, 1995, NEURON, V14, P177; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2012, J CHEM THEORY COMPUT, V8, P3854, DOI 10.1021/ct300113z; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kusch J, 2012, NAT CHEM BIOL, V8, P162, DOI 10.1038/nchembio.747; Lolicato M, 2011, J BIOL CHEM, V286, P44811, DOI 10.1074/jbc.M111.297606; Matulef K, 1999, NEURON, V24, P443, DOI 10.1016/S0896-6273(00)80857-0; Matulef K, 2002, NEURON, V36, P93, DOI 10.1016/S0896-6273(02)00878-4; Mazzolini M, 2002, BIOPHYS J, V83, P3283, DOI 10.1016/S0006-3495(02)75329-0; MILOV AD, 1984, CHEM PHYS LETT, V110, P67, DOI 10.1016/0009-2614(84)80148-7; Pannier M, 2011, J Magn Reson, V213, P316, DOI 10.1016/j.jmr.2011.08.035; Paoletti P, 1999, J GEN PHYSIOL, V113, P17, DOI 10.1085/jgp.113.1.17; Polyhach Y, 2011, PHYS CHEM CHEM PHYS, V13, P2356, DOI 10.1039/c0cp01865a; Puljung MC, 2014, P NATL ACAD SCI USA, V111, P9816, DOI 10.1073/pnas.1405371111; Puljung MC, 2013, J BIOL CHEM, V288, P12944, DOI 10.1074/jbc.M113.464123; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Rossi AM, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2011.305; Saponaro A, 2014, P NATL ACAD SCI USA, V111, P14577, DOI 10.1073/pnas.1410389111; Taraska JW, 2009, NAT METHODS, V6, P532, DOI 10.1038/nmeth.1341; Tibbs GR, 1998, J BIOL CHEM, V273, P4497, DOI 10.1074/jbc.273.8.4497; Ulens C, 2003, NEURON, V40, P959, DOI 10.1016/S0896-6273(03)00753-0; Varnum MD, 1996, BIOPHYS J, V70, P2667, DOI 10.1016/S0006-3495(96)79836-3; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; WANG ZX, 1995, FEBS LETT, V360, P111, DOI 10.1016/0014-5793(95)00062-E; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; ZAGOTTA WN, 1989, P NATL ACAD SCI USA, V86, P7243, DOI 10.1073/pnas.86.18.7243; Zheng J, 2015, HDB ION CHANNELS; Zhou L, 2004, NEURON, V44, P823, DOI 10.1016/j.neuron.2004.11.012; Zhou L, 2007, STRUCTURE, V15, P655, DOI 10.1016/j.str.2007.04.012; Zong XG, 2012, J BIOL CHEM, V287, P26506, DOI 10.1074/jbc.M112.357129	45	33	33	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					371	381		10.1074/jbc.M115.696450	http://dx.doi.org/10.1074/jbc.M115.696450			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26559974	Green Published, hybrid			2022-12-26	WOS:000367589500030
J	Babben, S; Perovic, D; Koch, M; Ordon, F				Babben, Steve; Perovic, Dragan; Koch, Michael; Ordon, Frank			An Efficient Approach for the Development of Locus Specific Primers in Bread Wheat (Triticum aestivum L.) and Its Application to Re-Sequencing of Genes Involved in Frost Tolerance	PLOS ONE			English	Article							FREEZING TOLERANCE; MOLECULAR CHARACTERIZATION; EXPRESSION PATTERNS; COLD-RESPONSE; DRAFT GENOME; STS MARKERS; SSR MARKERS; CBF GENES; COR GENE; BARLEY	Recent declines in costs accelerated sequencing of many species with large genomes, including hexaploid wheat (Triticum aestivum L.). Although the draft sequence of bread wheat is known, it is still one of the major challenges to developlocus specific primers suitable to be used in marker assisted selection procedures, due to the high homology of the three genomes. In this study we describe an efficient approach for the development of locus specific primers comprising four steps, i.e. (i) identification of genomic and coding sequences (CDS) of candidate genes, (ii) intron-and exon-structure reconstruction, (iii) identification of wheat A, B and D sub-genome sequences and primer development based on sequence differences between the three sub-genomes, and (iv); testing of primers for functionality, correct size and localisation. This approach was applied to single, low and high copy genes involved in frost tolerance in wheat. In summary for 27 of these genes for which sequences were derived from Triticum aestivum, Triticum monococcum and Hordeum vulgare, a set of 119 primer pairs was developed and after testing on Nullitetrasomic (NT) lines, a set of 65 primer pairs (54.6%), corresponding to 19 candidate genes, turned out to be specific. Out of these a set of 35 fragments was selected for validation via Sanger's amplicon re-sequencing. All fragments, with the exception of one, could be assigned to the original reference sequence. The approach presented here showed a much higher specificity in primer development in comparison to techniques used so far in bread wheat and can be applied to other polyploid species with a known draft sequence.	[Babben, Steve; Perovic, Dragan; Ordon, Frank] JKI, Fed Res Ctr Cultivated Plants, Inst Resistance Res & Stress Tolerance, Quedlinburg, Sachsen Anhalt, Germany; [Koch, Michael] Deutsch Saatveredelung AG DSV, Lippstadt, Nordrhein Westf, Germany	Julius Kuhn-Institut	Perovic, D (corresponding author), JKI, Fed Res Ctr Cultivated Plants, Inst Resistance Res & Stress Tolerance, Quedlinburg, Sachsen Anhalt, Germany.	dragan.perovic@jki.bund.de	Perovic, Dragan G/C-1149-2008	Perovic, Dragan G/0000-0002-0292-1693	German Federal Ministry of Education and Research (BMBF) [0315953]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The authors thank the German Federal Ministry of Education and Research (BMBF) for funding the project FROWHEAT (0315953). This work was bioinformatically supported by Dr. Jens Keilwagen and Thomas Berner. Special thanks to Katy Niedung for technical support.; Deutsche Saatveredelung AG contributed to the study by providing support in collecting material, while direct funding was provided by the German Federal Ministry of Education and Research (BMBF) through funding the project FROWHEAT (0315953). Deutsche Saatveredelung AG has no competing interests regarding results of the study. So, there are no intellectual property claims from Deutsche Saatveredelung AG which affect the publication of results of the study in PLOS ONE. The funder provided support in the form of salaries for author SB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Allagulova CR, 2003, BIOCHEMISTRY-MOSCOW+, V68, P945, DOI 10.1023/A:1026077825584; Allen AM, 2011, PLANT BIOTECHNOL J, V9, P1086, DOI 10.1111/j.1467-7652.2011.00628.x; Badawi M, 2007, MOL GENET GENOMICS, V277, P533, DOI 10.1007/s00438-006-0206-9; Beales J, 2007, THEOR APPL GENET, V115, P721, DOI 10.1007/s00122-007-0603-4; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Bryan GJ, 1997, THEOR APPL GENET, V94, P557, DOI 10.1007/s001220050451; Chen J, 2014, CEREAL RES COMMUN, V42, P199, DOI 10.1556/CRC.2013.0056; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Choi DW, 1999, THEOR APPL GENET, V98, P1234, DOI 10.1007/s001220051189; Choulet F, 2010, PLANT CELL, V22, P1686, DOI 10.1105/tpc.110.074187; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Close TJ, 1997, PHYSIOL PLANTARUM, V100, P291, DOI 10.1034/j.1399-3054.1997.1000210.x; Distelfeld A, 2009, PLANT PHYSIOL, V149, P245, DOI 10.1104/pp.108.129353; Dubcovsky J, 1998, THEOR APPL GENET, V97, P968, DOI 10.1007/s001220050978; DUNN MA, 1990, J EXP BOT, V41, P1405, DOI 10.1093/jxb/41.11.1405; Dvorak J, 2005, GENETICS, V171, P323, DOI 10.1534/genetics.105.041632; Endo TR, 1996, J HERED, V87, P295, DOI 10.1093/oxfordjournals.jhered.a023003; Feldman M, 2007, ISR J PLANT SCI, V55, P207, DOI 10.1560/IJPS.55.3-4.207; Fu DL, 2005, MOL GENET GENOMICS, V273, P54, DOI 10.1007/s00438-004-1095-4; Gana JA, 1997, PLANT MOL BIOL, V34, P643, DOI 10.1023/A:1005852703506; Guo ZA, 2010, NEW PHYTOL, V185, P841, DOI 10.1111/j.1469-8137.2009.03099.x; Han ZG, 2006, THEOR APPL GENET, V112, P430, DOI 10.1007/s00122-005-0142-9; Huang S, 2002, P NATL ACAD SCI USA, V99, P8133, DOI 10.1073/pnas.072223799; Ishikawa G, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-135; Jaglo KR, 2001, PLANT PHYSIOL, V127, P910, DOI 10.1104/pp.010548; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Kato K, 1988, METHOD EVALUATION CH; Kaur N, 2008, EUR J PLANT PATHOL, V121, P387, DOI 10.1007/s10658-007-9252-3; Keddie JS, 1998, PLANT CELL, V10, P877, DOI 10.1105/tpc.10.6.877; Keilwagen J, 2014, SCI REP-UK, V4, DOI 10.1038/srep05231; Kilian B, 2012, BRIEF FUNCT GENOMICS, V11, P38, DOI 10.1093/bfgp/elr046; Knox AK, 2008, PLANT MOL BIOL, V67, P257, DOI 10.1007/s11103-008-9316-6; Knox AK, 2010, THEOR APPL GENET, V121, P21, DOI 10.1007/s00122-010-1288-7; Kocsy G, 2010, MOL GENET GENOMICS, V283, P351, DOI 10.1007/s00438-010-0520-0; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kosova K, 2008, BIOL PLANTARUM, V52, P601, DOI 10.1007/s10535-008-0120-6; LAW CN, 1978, HEREDITY, V41, P185, DOI 10.1038/hdy.1978.87; Li YL, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-6; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Liu J, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-34; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; McCormack E, 2003, NEW PHYTOL, V159, P585, DOI 10.1046/j.1469-8137.2003.00845.x; Mclntosh RA, 2013, MORPHOLOGICAL PHYSL, P45; Michalek W, 2002, THEOR APPL GENET, V104, P97, DOI 10.1007/s001220200011; Miller AK, 2006, MOL GENET GENOMICS, V275, P193, DOI 10.1007/s00438-005-0076-6; Mohseni S, 2012, GENOME, V55, P865, DOI 10.1139/gen-2012-0112; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Nicot N, 2004, THEOR APPL GENET, V109, P800, DOI 10.1007/s00122-004-1685-x; Ohno R, 2001, J EXP BOT, V52, P2367, DOI 10.1093/jexbot/52.365.2367; Peng JHH, 2011, MOL BREEDING, V28, P281, DOI 10.1007/s11032-011-9608-4; Peng PH, 2014, PLANT CELL PHYSIOL, V55, P1623, DOI 10.1093/pcp/pcu093; Perdiguero P, 2012, PLANTA, V236, P1863, DOI 10.1007/s00425-012-1737-4; Perovic J, 2013, MOL BREEDING, V32, P61, DOI 10.1007/s11032-013-9852-x; Poczai P, 2010, AM J BOT, V97, pE142, DOI 10.3732/ajb.1000360; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Raats D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r138; RODER MS, 1995, MOL GEN GENET, V246, P327, DOI 10.1007/BF00288605; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCARTH R, 1983, HEREDITY, V51, P607, DOI 10.1038/hdy.1983.73; Sears E. R., 1966, Chromosome manipulations and plant genetics., P29; Silvar C, 2011, PLANT BREEDING, V130, P394, DOI 10.1111/j.1439-0523.2011.01853.x; Skinner J, 2006, THEOR APPL GENET, V112, P832, DOI 10.1007/s00122-005-0185-y; Skinner JS, 2005, PLANT MOL BIOL, V59, P533, DOI 10.1007/s11103-005-2498-2; SMITH DB, 1975, CHROMOSOMA, V50, P223, DOI 10.1007/BF00283468; Song QJ, 2005, THEOR APPL GENET, V110, P550, DOI 10.1007/s00122-004-1871-x; Stein N, 2001, PLANT BREEDING, V120, P354, DOI 10.1046/j.1439-0523.2001.00615.x; Tan GM, 2006, J COMPUT SCI TECH-CH, V21, P973, DOI 10.1007/s11390-006-0973-0; Tsuda K, 2000, GENES GENET SYST, V75, P179, DOI 10.1266/ggs.75.179; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Upadhyay SK, 2013, G3-GENES GENOM GENET, V3, P2233, DOI 10.1534/g3.113.008847; Vagujfalvi A, 2005, MOL GENET GENOMICS, V274, P506, DOI 10.1007/s00438-005-0047-y; Wang LH, 2010, J CEREAL SCI, V51, P305, DOI 10.1016/j.jcs.2010.01.005; Wang YZ, 2014, PLANT SCI, V214, P113, DOI 10.1016/j.plantsci.2013.10.005; Welsh J. R., 1973, Proceedings of the fourth international wheat genetics symposium. Biochemical and physiological genetics., P879; Wilkinson PA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-219; Winfield MO, 2010, PLANT BIOTECHNOL J, V8, P749, DOI 10.1111/j.1467-7652.2010.00536.x; Wu JH, 2009, J MICROBIOL METH, V77, P267, DOI 10.1016/j.mimet.2009.03.001; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; Yan L, 2004, THEOR APPL GENET, V109, P1677, DOI 10.1007/s00122-004-1796-4; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305; Zhang CZ, 2009, J PLANT PHYSIOL, V166, P1436, DOI 10.1016/j.jplph.2009.03.001; Zhang HN, 2004, PLANT J, V40, P276, DOI 10.1111/j.1365-313X.2004.02209.x	86	4	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142746	10.1371/journal.pone.0142746	http://dx.doi.org/10.1371/journal.pone.0142746			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26565976	Green Published, Green Submitted, gold			2022-12-26	WOS:000367628500051
J	Corbett, L; Mann, J; Mann, DA				Corbett, Laura; Mann, Jelena; Mann, Derek A.			Non-Canonical Wnt Predominates in Activated Rat Hepatic Stellate Cells, Influencing HSC Survival and Paracrine Stimulation of Kupffer Cells	PLOS ONE			English	Article							BETA-CATENIN; SIGNALING PATHWAYS; LIVER; PHOSPHORYLATION; APOPTOSIS; ADIPOGENESIS; EXPRESSION; QUIESCENT; PROTEINS; BINDING	The Wnt system is highly complex and is comprised of canonical and non-canonical pathways leading to the activation of gene expression. Our aim was to examine changes in the expression of Wnt ligands and regulators during hepatic stellate cell (HSC) transdifferentiation and assess the relative contributions of the canonical and non-canonical Wnt pathways in fibrogenic activated HSC. The expression profile of Wnt ligands and regulators in HSC was not supportive for a major role for beta-catenin-dependent canonical Wnt signalling, this verified by inability to induce Topflash reporter activity in HSC even when expressing a constitutive active beta-catenin. We detected expression of Wnt5a in activated HSC which can signal via non-canonical mechanisms and showed evidence for non-canonical signalling in these cells involving phosphorylation of Dvl2 and pJNK. Stimulation of HSC or Kupffer cells with Wnt5a regulated HSC apoptosis and expression of TGF-beta 1 and MCP1 respectively. We were unable to confirm a role for beta-catenin-dependent canonical Wnt in HSC and instead propose autocrine and paracrine functions for Wnts expressed by activated HSC via non-canonical pathways. The data warrant detailed investigation of Wnt5a in liver fibrosis.	[Corbett, Laura; Mann, Jelena; Mann, Derek A.] Newcastle Univ, Fac Med Sci, Inst Cellular Med, Fibrosis Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Mann, DA (corresponding author), Newcastle Univ, Fac Med Sci, Inst Cellular Med, Fibrosis Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	Derek.Mann@ncl.ac.uk		Mann, Derek/0000-0003-0950-243X	UCB; MRC MICA Programme Grant [MK/K001949/1]; Wellcome Trust [WT086755MA]; MRC [MR/K001949/1] Funding Source: UKRI; Medical Research Council [MR/K001949/1] Funding Source: researchfish	UCB(UCB Pharma SA); MRC MICA Programme Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Laura Corbett was a BBSRC-CASE Student with financial contributions from UCB, (http://www.ucbpharma.co.uk/). Additional support was from MRC MICA Programme Grant MK/K001949/1 and Wellcome Trust Grant (WT086755MA) (www.mrc.ac.uk) funded to Derek Mann. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmetshina A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1734; Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Beyer C, 2013, ARCH DERMATOL RES, V305, P1, DOI 10.1007/s00403-012-1304-7; Beyer C, 2012, ANN RHEUM DIS, V71, P761, DOI 10.1136/annrheumdis-2011-200568; Biechele S, 2011, DEV BIOL, V355, P275, DOI 10.1016/j.ydbio.2011.04.029; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Bryja V, 2007, J CELL SCI, V120, P586, DOI 10.1242/jcs.03368; Cadigan KM, 2009, COLD SPRING HARBOR P, V1; Chen YP, 2012, GASTROENTEROLOGY, V143, P1319, DOI 10.1053/j.gastro.2012.07.115; Cheng JH, 2008, AM J PHYSIOL-GASTR L, V294, pG39, DOI 10.1152/ajpgi.00263.2007; Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002; de la Roche M, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-199; Ebrahimkhani MR, 2011, NAT MED, V17, P1668, DOI 10.1038/nm.2490; Eguchi M, 2005, MED CHEM, V1, P467, DOI 10.2174/1573406054864098; Elsharkawy AM, 2005, APOPTOSIS, V10, P927, DOI 10.1007/s10495-005-1055-4; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Gonzalez-Sancho JM, 2013, J BIOL CHEM, V288, P9428, DOI 10.1074/jbc.M112.448480; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Griesmann H, 2013, NEOPLASIA, V15, P11, DOI 10.1593/neo.121312; Jia LW, 2008, CELL BIOL INT, V32, P807, DOI 10.1016/j.cellbi.2008.03.011; Jiang F, 2006, J HEPATOL, V45, P401, DOI 10.1016/j.jhep.2006.03.016; Kim J, 2012, J IMMUNOL, V188, P182, DOI 10.4049/jimmunol.1102297; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Kordes C, 2008, BIOCHEM BIOPH RES CO, V367, P116, DOI 10.1016/j.bbrc.2007.12.085; Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mann J, 2010, GASTROENTEROLOGY, V138, P705, DOI 10.1053/j.gastro.2009.10.002; Marra F, 1999, HEPATOLOGY, V29, P140, DOI 10.1002/hep.510290107; Naskar D, 2014, J IMMUNOL, V192, P4386, DOI 10.4049/jimmunol.1302817; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Park JR, 2008, CELL PROLIFERAT, V41, P859, DOI 10.1111/j.1365-2184.2008.00565.x; Rashid ST, 2012, J PROTEOME RES, V11, P4052, DOI 10.1021/pr3000927; Selman M, 2008, PLOS MED, V5, P373, DOI 10.1371/journal.pmed.0050062; Solberg N, 2012, MOL CELL BIOCHEM, V365, P53, DOI 10.1007/s11010-012-1243-9; Tian X, 2012, J CELL SCI; Townsley FM, 2004, NAT CELL BIOL, V6, P626, DOI 10.1038/ncb1141; Tsukamoto H, 2012, J GASTROEN HEPATOL, V27, P94, DOI 10.1111/j.1440-1746.2011.07022.x; Vuga LJ, 2009, AM J RESP CELL MOL, V41, P583, DOI 10.1165/rcmb.2008-0201OC; Wu CI, 2012, DEVELOPMENT, V139, P2118, DOI 10.1242/dev.076067; Zeng G, 2007, HEPATOLOGY, V45, P195, DOI 10.1002/hep.21473; Zhang YN, 2009, NAT CHEM BIOL, V5, P217, DOI 10.1038/nchembio.152; Zhou BY, 2012, J BIOL CHEM, V287, P7026, DOI 10.1074/jbc.M111.276311	42	32	33	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142794	10.1371/journal.pone.0142794	http://dx.doi.org/10.1371/journal.pone.0142794			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26566235	Green Published, gold, Green Submitted			2022-12-26	WOS:000367628500054
J	Yu, D; Xu, ZY; Yin, XY; Zheng, FP; Lin, XH; Pan, QQ; Li, H				Yu, Dan; Xu, Zhiye; Yin, Xueyao; Zheng, Fenping; Lin, Xihua; Pan, Qianqian; Li, Hong			Inverse Relationship between Serum Lipoxin A4 Level and the Risk of Metabolic Syndrome in a Middle-Aged Chinese Population	PLOS ONE			English	Article							VISCERAL ADIPOSE-TISSUE; PRORESOLVING LIPID MEDIATORS; ARACHIDONIC-ACID; OBESITY; INFLAMMATION; MANAGEMENT; GLUCOSE; BLOOD; CELLS; A(4)	Metabolic syndrome (MetS) has been identified to be associated with a state of chronic, low-grade inflammation in adipose tissue. Lipoxins are endogenously generated from arachidonic acid, and exhibit anti-inflammatory actions. Currently, there is no available cohort study identifying the association between serum lipoxins level and MetS. Here we investigate the relationship between serum lipoxin A4 (LXA4) level and the risk of incident MetS in a middle-aged Chinese population. A total 624 participants aged 40-65 years were enrolled at baseline, with 417 (including 333 MetS absence) of them were followed up at 2.5 years. Abdominal visceral fat area (VFA) and abdominal subcutaneous fat area (SFA) were determined using MRI. Serum lipoxin A4 levels were measured by ELISA. At baseline, serum LXA4 levels were significantly correlated with a cluster of traditional MetS risk factors related to obesity (P <= 0.05). A higher incidence of new Mets was found in the participants of the lowest tertile of LXA4 levels as compared with that in participants of the highest tertile (P = 0.025). Low serum LXA4 levels [OR 2.607(1.151-5.909), P = 0.022] and high VFA [OR 2.571(1.176-5.620), P = 0.018] were associated with an increased incident Mets, respectively, which remained statistically significant after adjustment for age, gender, current smoking, and alcohol drinking status. Logistic regression analysis suggested a combination of low serum LXA4 levels and high WC/VFA might optimize the prediction of incident Mets in middle-aged Chinese population [OR 4.897/4.967, P = 0.009/0.003]. Decrease in serum LXA4 level and increase in VFA are independent predictors of incident Mets in a populationbased cohort, and a combination of them enhances the prognostic value of incident Mets. Taken together, our data suggest that serum LXA4 levels might be useful for early detection and prevention of Mets.	[Yu, Dan; Xu, Zhiye; Yin, Xueyao; Zheng, Fenping; Lin, Xihua; Pan, Qianqian; Li, Hong] Zhejiang Univ, Sch Med, Dept Endocrinol, Sir Run Run Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Li, H (corresponding author), Zhejiang Univ, Sch Med, Dept Endocrinol, Sir Run Run Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China.	lihongheyi@126.com	Lin, Xihua/HGB-1950-2022		National Key Technology R&D Program of China [2009BAI80B00, 2012BAI02B03]	National Key Technology R&D Program of China(National Key Technology R&D Program)	This study was supported by grants from the National Key Technology R&D Program of China (No. 2009BAI80B00), and the National Key Technology R&D Program of China (No. 2012BAI02B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P390; Bao YQ, 2013, J CLIN ENDOCR METAB, V98, P345, DOI 10.1210/jc.2012-2906; Bao YQ, 2008, ATHEROSCLEROSIS, V201, P378, DOI 10.1016/j.atherosclerosis.2008.03.001; Bluher M, 2012, DIABETES METAB J, V36, P317, DOI 10.4093/dmj.2012.36.5.317; Borgeson E, 2012, FASEB J, V26, P4287, DOI 10.1096/fj.12-208249; Brochu M, 2000, J CLIN ENDOCR METAB, V85, P2378, DOI 10.1210/jc.85.7.2378; Carr DB, 2004, DIABETES, V53, P2087, DOI 10.2337/diabetes.53.8.2087; Chiang N, 2005, PROSTAG LEUKOTR ESS, V73, P163, DOI 10.1016/j.plefa.2005.05.003; Chu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034710; Das UN, 2015, NUTRITION, V31, P283, DOI 10.1016/j.nut.2014.08.011; Das UN, 2013, PROSTAG LEUKOTR ESS, V88, P201, DOI 10.1016/j.plefa.2012.11.009; Das UN, 2010, J INFLAMM RES, V3, P143, DOI 10.2147/JIR.S9425; Demetz E, 2014, CELL METAB, V20, P787, DOI 10.1016/j.cmet.2014.09.004; Emanuela F, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/476380; Esser N, 2015, EXPERT OPIN INV DRUG, V24, P283, DOI 10.1517/13543784.2015.974804; Esser N, 2014, DIABETES RES CLIN PR, V105, P141, DOI 10.1016/j.diabres.2014.04.006; Ferrante AW, 2007, J INTERN MED, V262, P408, DOI 10.1111/j.1365-2796.2007.01852.x; Gutierrez AD, 2012, ATHEROSCLEROSIS, V223, P204, DOI 10.1016/j.atherosclerosis.2012.04.016; Kaviarasan K, 2015, METABOLISM, V64, P958, DOI 10.1016/j.metabol.2015.04.005; Khoo CM, 2013, ANN ACAD MED SINGAP, V42, P379; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lyon CJ, 2003, ENDOCRINOLOGY, V144, P2195, DOI 10.1210/en.2003-0285; Maderna P, 2009, BRIT J PHARMACOL, V158, P947, DOI 10.1111/j.1476-5381.2009.00386.x; Masoodi M, 2015, BBA-MOL CELL BIOL L, V1851, P503, DOI 10.1016/j.bbalip.2014.09.023; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mayer K, 2002, J LIPID RES, V43, P944; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Ohashi K, 2014, TRENDS ENDOCRIN MET, V25, P348, DOI 10.1016/j.tem.2014.03.009; Pickens CA, 2015, PROSTAG LEUKOTR ESS, V95, P31, DOI 10.1016/j.plefa.2014.12.001; Scheen AJ, 2014, LANCET DIABETES ENDO, V2, P911, DOI 10.1016/S2213-8587(14)70004-X; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Spite M, 2014, CELL METAB, V19, P21, DOI 10.1016/j.cmet.2013.10.006; Stanley TL, 2011, J CLIN ENDOCR METAB, V96, pE146, DOI 10.1210/jc.2010-1170; Su X, 2012, MOL MED, V18, P1481, DOI 10.2119/molmed.2012.00351; Vasconcelos DP, 2015, BIOMATERIALS, V37, P116, DOI 10.1016/j.biomaterials.2014.10.035; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Wang XZ, 2015, J LIPID RES, V56, P674, DOI 10.1194/jlr.P055418; Xu XJ, 2012, J LIPID RES, V53, P792, DOI 10.1194/jlr.P022905	41	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142848	10.1371/journal.pone.0142848	http://dx.doi.org/10.1371/journal.pone.0142848			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26565966	Green Published, gold, Green Submitted			2022-12-26	WOS:000367628500060
J	Moulton, E; Amor-Sahli, M; Perlbarg, V; Pires, C; Crozier, S; Galanaud, D; Valabregue, R; Yger, M; Baronnet-Chauvet, F; Samson, Y; Dormont, D; Rosso, C				Moulton, Eric; Amor-Sahli, Melika; Perlbarg, Vincent; Pires, Christine; Crozier, Sophie; Galanaud, Damien; Valabregue, Romain; Yger, Marion; Baronnet-Chauvet, Flore; Samson, Yves; Dormont, Didier; Rosso, Charlotte			Axial Diffusivity of the Corona Radiata at 24 Hours Post-Stroke: A New Biomarker for Motor and Global Outcome	PLOS ONE			English	Article							WHITE-MATTER; FRACTIONAL ANISOTROPY; WATER DIFFUSION; BRAIN-INJURY; STROKE; RECOVERY; OPTIMIZATION; REGISTRATION; SYSTEM; ROBUST	Fractional anisotropy (FA) is an effective marker of motor outcome at the chronic stage of stroke yet proves to be less efficient at early time points. This study aims to determine which diffusion metric in which location is the best marker of long-term stroke outcome after thrombolysis with diffusion tensor imaging (DTI) at 24 hours post-stroke. Twenty-eight thrombolyzed patients underwent DTI at 24 hours post-stroke onset. Ipsilesional and contralesional FA, mean (MD), axial (AD), and radial (RD) diffusivities values were calculated in different Regions-of-Interest (ROIs): (1) the white matter underlying the precentral gyrus (M1), (2) the corona radiata (CoRad), (3) the posterior limb of the internal capsule (PLIC) and (4) the cerebral peduncles (CP). NIHSS scores were acquired at admission, day 1, and day 7; modified Rankin Scores (mRS) at 3 months. Significant decreases were found in FA, MD, and AD of the ipsilesional CoRad and M1. MD and AD were also significantly lower in the PLIC. The ratio of ipsi and contralesional AD of the CoRad (CoRad-rAD) was the strongest diffusion parameter correlated with motor NIHSS scores on day 7 and with the mRS at 3 months. A Receiver-Operator Curve analysis yielded a model for the CoRad-rAD to predict good outcome based on upper limb NIHSS motor scores and mRS with high specificity and sensitivity. FA values were not correlated with clinical outcome. In conclusion, axial diffusivity of the CoRad from clinical DTI at 24 hours post-stroke is the most appropriate diffusion metric for quantifying stroke damage to predict outcome, suggesting the importance of early axonal damage.	[Moulton, Eric; Galanaud, Damien; Valabregue, Romain; Samson, Yves; Dormont, Didier; Rosso, Charlotte] Inst Cerveau & Moelle Epiniere, Ctr Rech, Paris, France; [Moulton, Eric; Galanaud, Damien; Valabregue, Romain; Samson, Yves; Dormont, Didier; Rosso, Charlotte] Univ Paris 06, INSERM, U1127, CNRS,UMR 7225, Paris, France; [Moulton, Eric; Rosso, Charlotte] Univ Paris 06, INSERM, U1127, CONAM,CNRS,UMR 7225, Paris, France; [Amor-Sahli, Melika; Galanaud, Damien; Dormont, Didier] Hop La Pitie Salpetriere, AP HP, Dept Neuroradiol, Paris, France; [Perlbarg, Vincent] UPMC Univ, Univ Sorbonne, Lab Imagerie Biomed, INSERM U1146,CNRS UMR7371,Paris 60 UMCR2,Hop Piti, Paris, France; [Perlbarg, Vincent] IHU A ICM, Bioinformat Biostat Plateform, Paris, France; [Pires, Christine; Crozier, Sophie; Yger, Marion; Baronnet-Chauvet, Flore; Samson, Yves; Rosso, Charlotte] Hop La Pitie Salpetriere, APHP, Urgences Cerebrovasc, Paris, France; [Galanaud, Damien; Valabregue, Romain; Samson, Yves; Dormont, Didier] Inst Cerveau & Moelle Epiniere, Ctr Rech, COGIMAGE, Paris, France; [Valabregue, Romain] Hop La Pitie Salpetriere, Ctr Neuroimagerie Rech, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Rosso, C (corresponding author), Inst Cerveau & Moelle Epiniere, Ctr Rech, Paris, France.	charlotte.rosso@gmail.com	samson, yves/C-5647-2013; valabregue, romain/GWQ-7484-2022	valabregue, romain/0000-0002-1814-9570	program "Investissements d'avenir" [ANR-10-IAIHU-06]	program "Investissements d'avenir"(French National Research Agency (ANR))	The research leading to these results has received funding from the program "Investissements d'avenir" ANR-10-IAIHU-06.	Andersson J.L.R., 2010, TR07JA2 FMRIB CTR; [Anonymous], 2014, R LANG ENV STAT COMP; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bhagat YA, 2008, MAGN RESON IMAGING, V26, P683, DOI 10.1016/j.mri.2008.01.015; Bhagat YA, 2006, J CEREBR BLOOD F MET, V26, P1442, DOI 10.1038/sj.jcbfm.9600294; Canty A., 2015, BOOT BOOTSTRAP R S P; Catani M, 2012, CORTEX, V48, P273, DOI 10.1016/j.cortex.2011.12.001; Gamer M, 2012, IRR VARIOUS COEFFICI; Groisser BN, 2014, NEUROREHAB NEURAL RE, V28, P751, DOI 10.1177/1545968314521896; Jang SH, 2010, NEUROREHABILITATION, V27, P367, DOI 10.3233/NRE-2010-0621; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kim S., 2012, PPCOR PARTIAL SEMIPA; Koyama T, 2013, J STROKE CEREBROVASC, V22, P1355, DOI 10.1016/j.jstrokecerebrovasdis.2013.02.017; Kuroiwa T, 1998, STROKE, V29, P859, DOI 10.1161/01.STR.29.4.859; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; Luyt CE, 2012, ANESTHESIOLOGY, V117, P1311, DOI 10.1097/ALN.0b013e318275148c; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Moustafa Ramez R, 2006, Curr Atheroscler Rep, V8, P281, DOI 10.1007/s11883-006-0005-0; Newton JM, 2006, BRAIN, V129, P1844, DOI 10.1093/brain/awl106; Pantoni L, 1996, STROKE, V27, P1641, DOI 10.1161/01.STR.27.9.1641; Prabhakaran S, 2008, NEUROREHAB NEURAL RE, V22, P64, DOI 10.1177/1545968307305302; Puig J, 2011, AM J NEURORADIOL, V32, P857, DOI 10.3174/ajnr.A2400; Puig J, 2013, STROKE, V44, P2016, DOI 10.1161/STROKEAHA.111.000382; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rosso C, 2014, CURR OPIN NEUROL, V27, P35, DOI 10.1097/WCO.0000000000000047; Schulz R, 2012, STROKE, V43, P2248, DOI 10.1161/STROKEAHA.112.662619; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sorensen AG, 1999, RADIOLOGY, V212, P785, DOI 10.1148/radiology.212.3.r99se24785; Sotak CH, 2002, NMR BIOMED, V15, P561, DOI 10.1002/nbm.786; Stinear CM, 2012, BRAIN, V135, P2527, DOI 10.1093/brain/aws146; Sun SW, 2006, NEUROIMAGE, V32, P1195, DOI 10.1016/j.neuroimage.2006.04.212; Tisserand M, 2014, STROKE, V45, P1167, DOI 10.1161/STROKEAHA.113.004000; van der Eerden AW, 2014, RADIOLOGY, V270, P506, DOI 10.1148/radiol.13122720; Ward NS, 2006, BRAIN, V129, P809, DOI 10.1093/brain/awl002; Yu CS, 2009, NEUROIMAGE, V47, P451, DOI 10.1016/j.neuroimage.2009.04.066	38	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142910	10.1371/journal.pone.0142910	http://dx.doi.org/10.1371/journal.pone.0142910			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562509	Green Published, gold, Green Submitted			2022-12-26	WOS:000364480900081
J	Wang, C; Gao, Q; Wang, X; Yu, M				Wang, Chao; Gao, Qiong; Wang, Xian; Yu, Mei			Decadal Trend in Agricultural Abandonment and Woodland Expansion in an Agro-Pastoral Transition Band in Northern China	PLOS ONE			English	Article							LAND-COVER CHANGE; TIME-SERIES; CLIMATE-CHANGE; RANDOM FOREST; RIVER-BASIN; CLASSIFICATION; MODIS; DEFORESTATION; MODELS; REGION	Land use land cover (LULC) changes frequently in ecotones due to the large climate and soil gradients, and complex landscape composition and configuration. Accurate mapping of LULC changes in ecotones is of great importance for assessment of ecosystem functions/services and policy-decision support. Decadal or sub-decadal mapping of LULC provides scenarios for modeling biogeochemical processes and their feedbacks to climate, and evaluating effectiveness of land-use policies, e.g. forest conversion. However, it remains a great challenge to produce reliable LULC maps in moderate resolution and to evaluate their uncertainties over large areas with complex landscapes. In this study we developed a robust LULC classification system using multiple classifiers based on MODIS (Moderate Resolution Imaging Spectroradiometer) data and posterior data fusion. Not only does the system create LULC maps with high statistical accuracy, but also it provides pixel-level uncertainties that are essential for subsequent analyses and applications. We applied the classification system to the Agro-pasture transition band in northern China (APTBNC) to detect the decadal changes in LULC during 2003-2013 and evaluated the effectiveness of the implementation of major Key Forestry Programs (KFPs). In our study, the random forest (RF), support vector machine (SVM), and weighted k-nearest neighbors (WKNN) classifiers outperformed the artificial neural networks (ANN) and naive Bayes (NB) in terms of high classification accuracy and low sensitivity to training sample size. The Bayesian-average data fusion based on the results of RF, SVM, and WKNN achieved the 87.5% Kappa statistics, higher than any individual classifiers and the majority-vote integration. The pixel-level uncertainty map agreed with the traditional accuracy assessment. However, it conveys spatial variation of uncertainty. Specifically, it pinpoints the southwestern area of APTBNC has higher uncertainty than other part of the region, and the open shrubland is likely to be mis-classified to the bare ground in some locations. Forests, closed shrublands, and grasslands in APTBNC expanded by 23%, 50%, and 9%, respectively, during 2003-2013. The expansion of these land cover types is compensated with the shrinkages in croplands (20%), bare ground (15%), and open shrublands (30%). The significant decline in agricultural lands is primarily attributed to the KFPs implemented in the end of last century and the nationwide urbanization in recent decade. The increased coverage of grass and woody plants would largely reduce soil erosion, improve mitigation of climate change, and enhance carbon sequestration in this region.	[Wang, Chao; Gao, Qiong; Wang, Xian; Yu, Mei] Univ Puerto Rico, Dept Environm Sci, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico Rio Piedras	Yu, M (corresponding author), Univ Puerto Rico, Dept Environm Sci, San Juan, PR 00936 USA.	meiyu@ites.upr.edu	wang, chao/AAZ-4906-2020	wang, chao/0000-0001-5170-1710	University of Puerto Rico, Rio Piedras	University of Puerto Rico, Rio Piedras	This work was supported by the starting fund from University of Puerto Rico, Rio Piedras. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by the starting fund from University of Puerto Rico, Rio Piedras. We appreciate the NASA's Earth Observing System Data and Information System (EOSDIS) to provide the MOD13Q1data (Collection 5) for free. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara C, 2012, REMOTE SENS ENVIRON, V124, P334, DOI 10.1016/j.rse.2012.05.019; Bai XM, 2014, NATURE, V509, P158, DOI 10.1038/509158a; Bartholome E, 2005, INT J REMOTE SENS, V26, P1959, DOI 10.1080/01431160412331291297; Blumstein M, 2015, J APPL ECOLOGY; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cao X, 2009, REMOTE SENS ENVIRON, V113, P2205, DOI 10.1016/j.rse.2009.06.001; Chan JCW, 2008, REMOTE SENS ENVIRON, V112, P2999, DOI 10.1016/j.rse.2008.02.011; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chazdon RL, 2008, SCIENCE, V320, P1458, DOI 10.1126/science.1155365; Chen C, 2013, J FOOD AGRIC ENVIRON, V11, P1012; Christensen RG, 2012, BIOINFORMATICS, V28, pI84, DOI 10.1093/bioinformatics/bts202; Clark ML, 2010, REMOTE SENS ENVIRON, V114, P2816, DOI 10.1016/j.rse.2010.07.001; Davidson EA, 2012, NATURE, V481, P321, DOI 10.1038/nature10717; DeFries RS, 2010, NAT GEOSCI, V3, P178, DOI 10.1038/NGEO756; Bui DT, 2012, MATH PROBL ENG, V2012, DOI 10.1155/2012/974638; Dieye AM, 2012, BIOGEOSCIENCES, V9, P631, DOI 10.5194/bg-9-631-2012; Ding HA, 2007, INT J SUST DEV WORLD, V14, P391; Du PJ, 2012, SENSORS-BASEL, V12, P4764, DOI 10.3390/s120404764; Eklundha L, 2012, TIMESAT 3 1 SOFTWARE; Entezarimaleki R., 2009, J CONVERG INF TECHNO, V4, P94, DOI DOI 10.4156/JCIT.VOL4.ISSUE3.14; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Friedl MA, 2002, REMOTE SENS ENVIRON, V83, P287, DOI 10.1016/S0034-4257(02)00078-0; Friedl MA, 2010, REMOTE SENS ENVIRON, V114, P168, DOI 10.1016/j.rse.2009.08.016; Gao Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113140; Gao Q, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2007JG000455; Gong P, 2013, INT J REMOTE SENS, V34, P2607, DOI 10.1080/01431161.2012.748992; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hechenbichler K, 2004, WEIGHTED K NEAREST N; Huang D, 2007, J ARID ENVIRON, V70, P120, DOI 10.1016/j.jaridenv.2006.12.009; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Jarvis A., 2008, HOLE FILLED SRTM GLO; Jia K, 2014, GEOCARTO INT, V29, P941, DOI 10.1080/10106049.2014.894586; Jonsson P, 2004, COMPUT GEOSCI-UK, V30, P833, DOI 10.1016/j.cageo.2004.05.006; Kim W, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD004825; Krinner G, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2003GB002199; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Lawrence RL, 2006, REMOTE SENS ENVIRON, V100, P356, DOI 10.1016/j.rse.2005.10.014; Lei JF, 2002, CHINAS IMPLEMENTATIO; [李悦 Li Yue], 2012, [北京师范大学学报. 自然科学版, Journal of Beijing Normal University. Natural Science], V48, P306; Liu JG, 2008, P NATL ACAD SCI USA, V105, P9477, DOI 10.1073/pnas.0706436105; Liu JG, 2007, AMBIO, V36, P639, DOI 10.1579/0044-7447(2007)36[639:CHANS]2.0.CO;2; Liu YS, 2010, J GEOGR SCI, V20, P876, DOI 10.1007/s11442-010-0817-2; Lu DS, 2004, PHOTOGRAMM ENG REM S, V70, P723, DOI 10.14358/PERS.70.6.723; Puertas OL, 2013, REMOTE SENS ENVIRON, V137, P112, DOI 10.1016/j.rse.2013.06.003; Mahmood R, 2010, B AM METEOROL SOC, V91, P37, DOI 10.1175/2009BAMS2769.1; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Moisen GG, 2002, ECOL MODEL, V157, P209, DOI 10.1016/S0304-3800(02)00197-7; MYNENI RB, 1994, REMOTE SENS ENVIRON, V47, P390, DOI 10.1016/0034-4257(94)90106-6; Pervez MS, 2014, REMOTE SENS ENVIRON, V149, P155, DOI 10.1016/j.rse.2014.04.008; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; R Core Team, 2021, R LANGUAGE ENV STAT; Rerkasem K, 2009, FOREST ECOL MANAG, V257, P2035, DOI 10.1016/j.foreco.2008.11.008; Ripley BD, 2006, PATTERN RECOGNITION; Rodriguez-Galiano VF, 2012, ISPRS J PHOTOGRAMM, V67, P93, DOI 10.1016/j.isprsjprs.2011.11.002; Samworth RJ, 2012, ANN STAT, V40; Schneider A, 2012, REMOTE SENS ENVIRON, V124, P689, DOI 10.1016/j.rse.2012.06.006; Siderelis K., 1994, STANDARD CLASSIFICAT; Song XZ, 2014, SCI REP-UK, V4, DOI 10.1038/srep04460; Tomaz C, 2013, FOREST ECOL MANAG, V308, P40, DOI 10.1016/j.foreco.2013.07.044; Turner BL, 2007, P NATL ACAD SCI USA, V104, P20666, DOI 10.1073/pnas.0704119104; Turner DP, 2004, BIOSCIENCE, V54, P573, DOI 10.1641/0006-3568(2004)054[0573:IRSAEP]2.0.CO;2; Venables WN., 2002, MODERN APPL STAT S, V4; Verburg PH, 2011, GLOBAL CHANGE BIOL, V17, P974, DOI 10.1111/j.1365-2486.2010.02307.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wu ZT, 2013, ECOL ENG, V52, P37, DOI 10.1016/j.ecoleng.2012.12.040; Xu ZW, 2010, RESTOR ECOL, V18, P217, DOI 10.1111/j.1526-100X.2009.00595.x; Yan D, 2013, AGR SYST, V119, P10, DOI 10.1016/j.agsy.2013.04.001; Yu M, 2004, J ENVIRON QUAL, V33, P1675, DOI 10.2134/jeq2004.1675; Zhang GL, 2012, ECOL ENG, V38, P20, DOI 10.1016/j.ecoleng.2011.09.005; Zhang ZX, 2014, REMOTE SENS ENVIRON, V149, P142, DOI 10.1016/j.rse.2014.04.004; Zhou FQ, 2013, ISPRS J PHOTOGRAMM, V84, P114, DOI 10.1016/j.isprsjprs.2013.07.008; Zhou Z, 2006, FUNCT ECOL, V20, P753, DOI 10.1111/j.1365-2435.2006.01175.x; Zhou ZY, 2007, BIOGEOCHEMISTRY, V82, P127, DOI 10.1007/s10533-006-9058-y; Zhu LK, 2013, CHINESE GEOGR SCI, V23, P716, DOI 10.1007/s11769-013-0642-5	75	17	17	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142113	10.1371/journal.pone.0142113	http://dx.doi.org/10.1371/journal.pone.0142113			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562303	Green Published, Green Submitted, gold			2022-12-26	WOS:000364480900016
J	Stiglic, G; Pajnkihar, M				Stiglic, Gregor; Pajnkihar, Majda			Evaluation of Major Online Diabetes Risk Calculators and Computerized Predictive Models	PLOS ONE			English	Article							CAROTID ATHEROSCLEROSIS; ASSESSMENT SCORE; LIFE-STYLE; VALIDATION; AUSTRALIA	Classical paper-and-pencil based risk assessment questionnaires are often accompanied by the online versions of the questionnaire to reach a wider population. This study focuses on the loss, especially in risk estimation performance, that can be inflicted by direct transformation from the paper to online versions of risk estimation calculators by ignoring the possibilities of more complex and accurate calculations that can be performed using the online calculators. We empirically compare the risk estimation performance between four major diabetes risk calculators and two, more advanced, predictive models. National Health and Nutrition Examination Survey (NHANES) data from 1999-2012 was used to evaluate the performance of detecting diabetes and pre-diabetes. American Diabetes Association risk test achieved the best predictive performance in category of classical paper-and-pencil based tests with an Area Under the ROC Curve (AUC) of 0.699 for undiagnosed diabetes (0.662 for pre-diabetes) and 47% (47% for pre-diabetes) persons selected for screening. Our results demonstrate a significant difference in performance with additional benefits for a lower number of persons selected for screening when statistical methods are used. The best AUC overall was obtained in diabetes risk prediction using logistic regression with AUC of 0.775 (0.734) and an average 34% (48%) persons selected for screening. However, generalized boosted regression models might be a better option from the economical point of view as the number of selected persons for screening of 30%(47%) lies significantly lower for diabetes risk assessment in comparison to logistic regression (p < 0.001), with a significantly higher AUC (p < 0.001) of 0.774 (0.740) for the pre-diabetes group. Our results demonstrate a serious lack of predictive performance in four major online diabetes risk calculators. Therefore, one should take great care and consider optimizing the online versions of questionnaires that were primarily developed as classical paper questionnaires.	[Stiglic, Gregor; Pajnkihar, Majda] Univ Maribor, Fac Hlth Sci, SLO-2000 Maribor, Slovenia; [Stiglic, Gregor] Univ Maribor, Fac Elect Engn & Comp Sci, SLO-2000 Maribor, Slovenia	University of Maribor; University of Maribor	Stiglic, G (corresponding author), Univ Maribor, Fac Hlth Sci, SLO-2000 Maribor, Slovenia.	gregor.stiglic@um.si	Stiglic, Gregor/E-5286-2011	Stiglic, Gregor/0000-0002-0183-8679; Pajnkihar, Majda/0000-0002-6298-045X	Swiss National Science Foundation through a SCOPES Joint Research Projects [IZ73Z0_152415]	Swiss National Science Foundation through a SCOPES Joint Research Projects	Both authors of this study were supported by the Swiss National Science Foundation through a SCOPES 2013 Joint Research Projects grant IZ73Z0_152415 (http://www.snf.ch/en/funding/programmes/scopes/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5900; [Anonymous], 2014, ADA DIABETES RISK TE; Bang HJ, 2009, ANN INTERN MED, V151, P775, DOI 10.7326/0003-4819-151-11-200912010-00005; Buijsse B, 2011, EPIDEMIOL REV; Cameron AJ, 2003, MED J AUSTRALIA, V178, P427, DOI 10.5694/j.1326-5377.2003.tb05283.x; Centers for Disease Control and Prevention National Health and Nutrition Examination Survey (NHANES), 1999, NAT HLTH NUTR EX SUR; Chen L, 2010, MED J AUSTRALIA, V192, P197, DOI 10.5694/j.1326-5377.2010.tb03478.x; Chomutare T, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1874; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Collins GS, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-40; Collins GS, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-103; Cook AJ, 2004, PAIN, V110, P310, DOI 10.1016/j.pain.2004.04.012; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Grant Janet F, 2006, Epidemiol Perspect Innov, V3, P4, DOI 10.1186/1742-5573-3-4; Gray LJ, 2013, DIABETIC MED, V30, P758, DOI 10.1111/dme.12115; Gray LJ, 2010, DIABETIC MED, V27, P887, DOI 10.1111/j.1464-5491.2010.03037.x; Hwang SJ, 1997, CIRCULATION, V96, P4219; Kaczorowski J, 2009, CAN J DIABETES, V33, P381, DOI 10.1016/S1499-2671(09)34008-3; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; MITCHELL P, 1995, OPHTHALMOLOGY, V102, P1450; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; OLEARY DH, 1991, STROKE, V22, P1155, DOI 10.1161/01.STR.22.9.1155; Shortliffe EH, 2014, J BIOMED INFORM, V48, P1, DOI 10.1016/j.jbi.2014.02.016; Penn L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057143; R Core Team, 2021, R LANGUAGE ENV STAT; Ridgeway G., 2013, GBM GEN BOOST REGR M; Robinson CA, 2011, CHRON DIS INJ CAN, V32, P19; Stiglic G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033812; Varma S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-91; Yu W, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-16	30	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142827	10.1371/journal.pone.0142827	http://dx.doi.org/10.1371/journal.pone.0142827			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560153	Green Submitted, Green Published, gold			2022-12-26	WOS:000364433100130
J	Bian, SZ; Jin, J; Zhang, JH; Li, QN; Yu, J; Yu, SY; Chen, JF; Yu, XJ; Qin, J; Huang, L				Bian, Shi-Zhu; Jin, Jun; Zhang, Ji-Hang; Li, Qian-Ning; Yu, Jie; Yu, Shi-Yong; Chen, Jian-Fei; Yu, Xue-Jun; Qin, Jun; Huang, Lan			Principal Component Analysis and Risk Factors for Acute Mountain Sickness upon Acute Exposure at 3700 m	PLOS ONE			English	Article							HIGH-ALTITUDE EXPOSURE; HEART-RATE-VARIABILITY; ANXIETY DISORDERS; HEADACHE; DEPRESSION; HYPOXIA; SYMPTOMS	Objective We aimed to describe the heterogeneity in the clinical presentation of acute mountain sickness (AMS) and to identify its primary risk factors. Methods The participants (n = 163) received case report form questionnaires, and their heart rate (HR), oxygen saturation (SpO(2)), echocardiographic and transcranial Doppler variables, ability to perform mental and physical work, mood and psychological factors were assessed within 18 to 22 hours after arriving at 3700 m from sea level (500 m) by plane. First, we examined the differences in all variables between the AMS-positive and the AMS-negative groups. Second, an adjusted regression analysis was performed after correlation and principal component analyses. Results The AMS patients had a higher diastolic vertebral artery velocity (V-d; p = 0.018), a higher HR (p = 0.006) and a lower SpO(2). The AMS subjects also experienced poorer sleep quality, as quantified using the Athens Insomnia Scale (AIS). Moreover, the AMS population exhibited more negative mood states, including anxiety, depression, hostility, fatigue and confusion. Five principal components focused on diverse aspects were also found to be significant. Additionally, more advanced age (p = 0.007), a higher HR (p = 0.034), a higher Vd (p = 0.014), a higher AIS score (p = 0.030), a decreased pursuit aiming capacity (p = 0.035) and decreased vigor (p = 0.015) were risk factors for AMS. Conclusions Mood states play critical roles in the development of AMS. Furthermore, an elevated HR and V-d, advanced age, elevated AIS sores, insufficient vigor and decreased mental work capacity are independent risk factors for AMS.	[Bian, Shi-Zhu; Jin, Jun; Zhang, Ji-Hang; Yu, Jie; Yu, Shi-Yong; Chen, Jian-Fei; Yu, Xue-Jun; Qin, Jun; Huang, Lan] Third Mil Med Univ, Inst Cardiovasc Dis PLA, Xingiao Hosp, Chongqing, Peoples R China; [Bian, Shi-Zhu; Jin, Jun; Zhang, Ji-Hang; Yu, Jie; Yu, Shi-Yong; Chen, Jian-Fei; Yu, Xue-Jun; Qin, Jun; Huang, Lan] Third Mil Med Univ, Dept Cardiol, Xingiao Hosp, Chongqing, Peoples R China; [Li, Qian-Ning] Third Mil Med Univ, Dept Neurol, Xingiao Hosp, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Huang, L (corresponding author), Third Mil Med Univ, Inst Cardiovasc Dis PLA, Xingiao Hosp, Chongqing, Peoples R China.	huanglan260@126.com		Huang, Lan/0000-0001-9594-4722	Ministry of Health of P.R. China [201002012]; Peoples Liberation Army P.R.C. grant [BWS14J040]	Ministry of Health of P.R. China; Peoples Liberation Army P.R.C. grant	Funding: This work was supported by the Special Health Research Project, Ministry of Health of P.R. China (grant No. 201002012) and Peoples Liberation Army P.R.C. (grant No. BWS14J040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1966, AEROSPACE MED, V37, P163; Bartsch P, 2013, NEW ENGL J MED, V369, P1666, DOI 10.1056/NEJMc1309747; Bailey DM, 2009, CELL MOL LIFE SCI, V66, P3583, DOI 10.1007/s00018-009-0145-9; Basnyat B, 2003, LANCET, V361, P1967, DOI 10.1016/S0140-6736(03)13591-X; Baumgartner RW, 1999, J APPL PHYSIOL, V86, P1578, DOI 10.1152/jappl.1999.86.5.1578; Bian SZ, 2015, J HEADACHE PAIN, V16, DOI 10.1186/s10194-015-0527-3; Bian SZ, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-35; Bian SZ, 2014, EUROPEAN J APPL PHYS; Blaauw BA, 2014, J HEADACHE PAIN, V15, DOI 10.1186/1129-2377-15-38; BONNON M, 1995, AVIAT SPACE ENVIR MD, V66, P330; Campbell MC, 2013, NEUROLOGY, V81, P520, DOI 10.1212/WNL.0b013e31829e6f94; Carod-Artal FJ, 2012, NEUROLOGIA; Das BB, 2004, ARCH PEDIAT ADOL MED, V158, P1170, DOI 10.1001/archpedi.158.12.1170; Dong JQ, 2013, PHYSIOL BEHAV, V112, P23, DOI 10.1016/j.physbeh.2013.02.001; Fabris C, 2014, DIABETES TECHNOL THE; Fagenholz PJ, 2007, WILD ENVIRON MED, V18, P312, DOI 10.1580/07-WEME-BR-102R1.1; Fukuda T, 2010, INT HEART J, V51, P170, DOI 10.1536/ihj.51.170; Huang HH, 2010, CLIN J SPORT MED, V20, P58, DOI 10.1097/JSM.0b013e3181cae6ba; Imray C, 2010, PROG CARDIOVASC DIS, V52, P467, DOI 10.1016/j.pcad.2010.02.003; Karinen HM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00336; Koehle MS, 2010, EUR J EMERG MED, V17, P119, DOI 10.1097/MEJ.0b013e32832fa099; Lemos VD, 2012, PSYCHOPHYSIOLOGY, V49, P1298, DOI 10.1111/j.1469-8986.2012.01411.x; Li X, 2011, ASIA PAC J PUBLIC HL; MISSOUM G, 1992, INT J SPORTS MED, V13, pS37, DOI 10.1055/s-2007-1024587; Naeije R, 2010, PROG CARDIOVASC DIS, V52, P456, DOI 10.1016/j.pcad.2010.03.004; Norcliffe LJ, 2005, J PHYSIOL-LONDON, V566, P287, DOI 10.1113/jphysiol.2005.086629; Oliver SJ, 2012, J TRAVEL MED, V19, P210, DOI 10.1111/j.1708-8305.2012.00609.x; Pasha MAQ, 2010, CHEST, V137, p13S, DOI 10.1378/chest.09-2445; REGARD M, 1991, AVIAT SPACE ENVIR MD, V62, P291; Roth WT, 2002, DEPRESS ANXIETY, V16, P51, DOI 10.1002/da.10059; Seifert CL, 2011, J NEUROL, V258, P123, DOI 10.1007/s00415-010-5704-3; Van Osta A, 2005, STROKE, V36, P557, DOI 10.1161/01.STR.0000155735.85888.13; Vigo DE, 2010, WILD ENVIRON MED, V21, P4, DOI 10.1016/j.wem.2009.12.022; WHITE AJ, 1984, AVIAT SPACE ENVIR MD, V55, P598; White KS, 2006, J PEDIATR PSYCHOL, V31, P582, DOI 10.1093/jpepsy/jsj050; Wu TY, 2012, CHINESE MED J-PEKING, V125, P1393, DOI 10.3760/cma.j.issn.0366-6999.2012.08.006; Zwart JA, 2003, EUR J NEUROL, V10, P147, DOI 10.1046/j.1468-1331.2003.00551.x	37	11	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142375	10.1371/journal.pone.0142375	http://dx.doi.org/10.1371/journal.pone.0142375			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554385	gold, Green Published, Green Submitted			2022-12-26	WOS:000364430700094
J	Egli, N; Zajonz, A; Burger, MT; Schweighoffer, T				Egli, Nicole; Zajonz, Alexandra; Burger, Matthew T.; Schweighoffer, Tamas			Human CD180 Transmits Signals via the PIM-1L Kinase	PLoS One			English	Article							PROSTATE-CANCER CELLS; B-CELLS; RP105; ACTIVATION; RECEPTOR; GROWTH; APOPTOSIS; PROLIFERATION; EXPRESSION; MOLECULE	Toll-like receptors (TLRs) are important sensors of the innate immune system that recognize conserved structural motifs and activate cells via a downstream signaling cascade. The CD180/MD1 molecular complex is an unusual member of the TLR family, since it lacks the components that are normally required for signal transduction by other TLRs. Therefore the CD180/MD 1 complex has been considered of being incapable of independently initiating cellular signals. Using chemogenetic approaches we identified specifically the membrane bound long form of PIM-1 kinase, PIM-1L as the mediator of CD180-dependent signaling. A dominant negative isoform of PIM-1L, but not of other PIM kinases, inhibited signaling elicited by cross-linking of CD180, and this effect was phenocopied by PIM inhibitors. PIM-1L was directed to the cell membrane by its N-terminal extension, where it colocalized and physically associated with CD180. Triggering CD180 also induced increased phosphorylation of the anti-apoptotic protein BAD in a PIM kinase-dependent fashion. Also in primary human B cells, which are the main cells expressing CD180 in man, cross-linking of CD180 by monoclonal antibodies stimulated cell survival and proliferation that was abrogated by specific inhibitors. By associating with PIM-1L, CD180 can thus obtain autonomous signaling capabilities, and this complex is then channeling inflammatory signals into B cell survival programs. Pharmacological inhibition of PIM-1 should therefore provide novel therapeutic options in diseases that respond to innate immune stimulation with subsequently increased B cell activity, such as lupus erythematosus or myasthenia gravis.	[Egli, Nicole; Zajonz, Alexandra; Schweighoffer, Tamas] Novartis Inst Biomed Res, Autoimmune Transplantat & Inflammatory Dis Area, Basel, Switzerland; [Burger, Matthew T.] Novartis Inst Biomed Res, Global Discovery Chem, Cambridge, MA USA	Novartis; Novartis	Schweighoffer, T (corresponding author), Novartis Inst Biomed Res, Autoimmune Transplantat & Inflammatory Dis Area, Basel, Switzerland.	tamas.schweighoffer@novartis.com			Novartis	Novartis(Novartis)	The authors are employees of Novartis and received no specific funding for this work. Novartis provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bhattacharya N, 2002, CHROMOSOMA, V111, P80, DOI 10.1007/s00412-002-0192-6; Blumenthal A, 2009, CELL HOST MICROBE, V5, P35, DOI 10.1016/j.chom.2008.12.002; Burger MT, 2013, ACS MED CHEM LETT, V4, P1193, DOI 10.1021/ml400307j; Chaplin JW, 2013, J EXP MED, V210, P2135, DOI 10.1084/jem.20130188; Chaplin JW, 2011, J IMMUNOL, V187, P4199, DOI 10.4049/jimmunol.1100198; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; Hammerman PS, 2004, CANCER RES, V64, P8341, DOI 10.1158/0008-5472.CAN-04-2284; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Hu XF, 2009, J CLIN INVEST, V119, P362, DOI 10.1172/JCI33216; Kim JH, 2010, CELL SIGNAL, V22, P1858, DOI 10.1016/j.cellsig.2010.07.013; Mikkers H, 2004, MOL CELL BIOL, V24, P6104, DOI 10.1128/MCB.24.13.6104-6115.2004; MIYAKE K, 1995, J IMMUNOL, V154, P3333; MIYAKE K, 1994, J EXP MED, V180, P1217, DOI 10.1084/jem.180.4.1217; Nagai Y, 2013, ADIPOCYTE, V2, P61, DOI 10.4161/adip.22929; Nagai Y, 2012, INT IMMUNOL, V24, P389, DOI 10.1093/intimm/dxs040; Ogata H, 2000, J EXP MED, V192, P23, DOI 10.1084/jem.192.1.23; Peltola K, 2009, NEOPLASIA, V11, P629, DOI 10.1593/neo.81038; Porakishvili N, 2011, BRIT J HAEMATOL, V153, P486, DOI 10.1111/j.1365-2141.2011.08605.x; SARIS CJM, 1991, EMBO J, V10, P655, DOI 10.1002/j.1460-2075.1991.tb07994.x; Tao ZF, 2009, J MED CHEM, V52, P6621, DOI 10.1021/jm900943h; VALENTINE MA, 1988, J IMMUNOL, V140, P4071; Xie Y, 2006, ONCOGENE, V25, P70, DOI 10.1038/sj.onc.1209058; Xie Y, 2008, J BIOL CHEM, V283, P3349, DOI 10.1074/jbc.M707773200; Xu DP, 2011, CARCINOGENESIS, V32, P488, DOI 10.1093/carcin/bgr007; Yang J, 2010, IMMUNOLOGY; Yazawa N, 2003, BLOOD, V102, P1374, DOI 10.1182/blood-2002-11-3573; Yoon SI, 2011, NAT STRUCT MOL BIOL, V18, P1028, DOI 10.1038/nsmb.2106; Zhu N, 2002, J IMMUNOL, V168, P744, DOI 10.4049/jimmunol.168.2.744	28	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142741	10.1371/journal.pone.0142741	http://dx.doi.org/10.1371/journal.pone.0142741			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555723	Green Published, Green Submitted, gold			2022-12-26	WOS:000364430700165
J	Li, KL; Wan, PJ; Wang, WX; Lai, FX; Fu, Q				Li, Kai-Long; Wan, Pin-Jun; Wang, Wei-Xia; Lai, Feng-Xiang; Fu, Qiang			Ran Involved in the Development and Reproduction Is a Potential Target for RNA-Interference-Based Pest Management in Nilaparvata lugens	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; HEMIPTERA DELPHACIDAE; BROWN PLANTHOPPER; CYTOCHROME-P450 CYP6AY1; INSECTICIDE RESISTANCE; ECDYSONE RECEPTOR; TRANSPORT FACTOR; NUCLEAR IMPORT; WING-MORPHS; GENE	Ran (RanGTPase) in insects participates in the 20-hydroxyecdysone signal transduction pathway in which downstream genes, FTZ-F1, Krupp-molog 1 (Kr-h1) and vitellogenin, are involved. A putative Ran gene (NlRan) was cloned from Nilaparvata lugens, a destructive phloem-feeding pest of rice. NlRan has the typical Ran primary structure features that are conserved in insects. NlRan showed higher mRNA abundance immediately after molting and peaked in newly emerged female adults. Among the examined tissues ovary had the highest transcript level, followed by fat body, midgut and integument, and legs. Three days after dsNlRan injection the NlRan mRNA abundance in the third-, fourth-, and fifth-instar nymphs was decreased by 94.3%, 98.4% and 97.0%, respectively. NlFTZ-F1 expression levels in treated third-and fourth-instar nymphs were reduced by 89.3% and 23.8%, respectively. In contrast, NlKr-h1 mRNA levels were up-regulated by 67.5 and 1.5 folds, respectively. NlRan knockdown significantly decreased the body weights, delayed development, and killed >85% of the nymphs at day seven. Two apparent phenotypic defects were observed: (1) Extended body form, and failed to molt; (2) The cuticle at the notum was split open but cannot completely shed off. The newly emerged female adults from dsNlRan injected fifth-instar nymphs showed lower levels of NlRan and vitellogenin, lower weight gain and honeydew excretion comparing with the blank control, and no offspring. Those results suggest that NlRan encodes a functional protein that was involved in development and reproduction. The study established proof of concept that NlRan could serve as a target for dsRNA-based pesticides for N. lugens control.	[Li, Kai-Long; Wan, Pin-Jun; Wang, Wei-Xia; Lai, Feng-Xiang; Fu, Qiang] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou 310006, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS	Fu, Q (corresponding author), China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou 310006, Zhejiang, Peoples R China.	fuqiang@caas.cn	Li, Kailong/AGZ-1532-2022	Li, Kailong/0000-0003-2386-6897	Zhejiang Provincial Natural Science Foundation of China [LY15C140004]; National Natural Science Foundation of China [31201512, 31371939, 31501637]; National Rice Industrial Technology System [CARS-1-18]; China National Rice Institute; Agricultural Science and Technology Innovation Program (ASTIP) of Chinese Academy of Agricultural Sciences	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Rice Industrial Technology System; China National Rice Institute; Agricultural Science and Technology Innovation Program (ASTIP) of Chinese Academy of Agricultural Sciences	This research was supported by grants of the Zhejiang Provincial Natural Science Foundation of China (LY15C140004), the National Natural Science Foundation of China (31201512 and 31371939), and the National Rice Industrial Technology System (CARS-1-18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors confirm that China National Rice Institute provided support in the form of salaries for authors Kai-Long Li, Pin-Jun Wan, Wei-Xia Wang, and Qiang Fu, but did not have any additional role in the study design, data collection and analysis and decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This research was supported by grants of the Zhejiang Provincial Natural Science Foundation of China (LY15C140004), the National Natural Science Foundation of China (31501637), the Agricultural Science and Technology Innovation Program (ASTIP) of Chinese Academy of Agricultural Sciences and the National Rice Industrial Technology System (CARS-1-18). We thank Prof. Zhi-Tao Zhang from China National Rice Research Institute and Prof. Guo-Qing Li from Nanjing Agricultural University for their insightful discussions during the course of this research.	Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Belles X, 2014, INSECT BIOCHEM MOLEC, V52, P60, DOI 10.1016/j.ibmb.2014.06.009; Belles X, 2010, ANNU REV ENTOMOL, V55, P111, DOI 10.1146/annurev-ento-112408-085301; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; Chen X N., 2003, BROWN PLANTHOPPER OC, P1; Cheng DJ, 2005, TISSUE CELL, V37, P37, DOI 10.1016/j.tice.2004.09.003; Cruz J, 2008, DEV DYNAM, V237, P3179, DOI 10.1002/dvdy.21728; Ding ZP, 2013, INSECT BIOCHEM MOLEC, V43, P1021, DOI 10.1016/j.ibmb.2013.08.005; Han F, 2007, FISH SHELLFISH IMMUN, V23, P937, DOI 10.1016/j.fsi.2007.01.022; Han F, 2012, GENE, V495, P65, DOI 10.1016/j.gene.2011.11.048; He HJ, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-1; Heong K.L., 2009, PLANTHOPPERS NEW THR; Hughes M, 1998, J CELL SCI, V111, P3017; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Kalab P, 1999, CURR BIOL, V9, P481, DOI 10.1016/S0960-9822(99)80213-9; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu SH, 2010, INSECT BIOCHEM MOLEC, V40, P666, DOI 10.1016/j.ibmb.2010.06.007; Liu S, 2015, PEST MANAG SCI, V71, P32, DOI 10.1002/ps.3760; Liu XP, 2014, INSECT BIOCHEM MOLEC, V55, P51, DOI 10.1016/j.ibmb.2014.10.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu K, 2015, J INSECT PHYSIOL, V73, P20, DOI 10.1016/j.jinsphys.2015.01.007; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; MELCHIOR F, 1993, J CELL BIOL, V123, P1649, DOI 10.1083/jcb.123.6.1649; Mello TRP, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00445; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Pang R, 2014, INSECT MOL BIOL, V23, P768, DOI 10.1111/imb.12121; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; Riddiford LM, 2012, GEN COMP ENDOCR, V179, P477, DOI 10.1016/j.ygcen.2012.06.001; Sanderson HS, 2006, CURR BIOL, V16, pR466, DOI 10.1016/j.cub.2006.05.032; Sinha VB, 2014, MOL BIOL REP, V41, P5989, DOI 10.1007/s11033-014-3476-z; Smith A, 1998, CURR BIOL, V8, P1403, DOI 10.1016/S0960-9822(98)00023-2; Smykal V, 2014, INSECT BIOCHEM MOLEC, V45, P69, DOI 10.1016/j.ibmb.2013.12.003; Song JS, 2014, INSECT BIOCHEM MOLEC, V52, P94, DOI 10.1016/j.ibmb.2014.07.001; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Tang QY, 2013, INSECT SCI, V20, P254, DOI 10.1111/j.1744-7917.2012.01519.x; Tufail M, 2010, INSECT MOL BIOL, V19, P787, DOI 10.1111/j.1365-2583.2010.01035.x; Tufail M, 2009, J INSECT PHYSIOL, V55, P87, DOI 10.1016/j.jinsphys.2008.11.007; Tufail M, 2008, J INSECT PHYSIOL, V54, P1447, DOI 10.1016/j.jinsphys.2008.08.007; Wan PJ, 2015, PEST MANAG SCI, V71, P1387, DOI 10.1002/ps.3941; Wan PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127789; Wang WX, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev046; Wang Y, 2012, INSECT BIOCHEM MOLEC, V42, P637, DOI 10.1016/j.ibmb.2012.04.009; Wang ZX, 2011, ARCH INSECT BIOCHEM, V78, P30, DOI 10.1002/arch.20437; Wilkins MR, 1999, METH MOL B, V112, P531; Wu WJ, 2012, J INSECT PHYSIOL, V58, P420, DOI 10.1016/j.jinsphys.2012.01.012; Xia F, 2008, CANCER RES, V68, P1826, DOI 10.1158/0008-5472.CAN-07-5279; Xu HJ, 2015, NATURE, V519, P464, DOI 10.1038/nature14286; Xu PP, 2014, J EXP BOT, V65, P3277, DOI 10.1093/jxb/eru178; Xue J, 2013, INSECT BIOCHEM MOLEC, V43, P433, DOI 10.1016/j.ibmb.2013.02.006; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Yu R, 2014, INT J BIOL SCI, V10, P1171, DOI 10.7150/ijbs.9598; Yuan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086503; Yuen HF, 2012, CLIN CANCER RES, V18, P380, DOI 10.1158/1078-0432.CCR-11-2035; Zhang BX, 2015, J INSECT PHYSIOL, V79, P19, DOI 10.1016/j.jinsphys.2015.05.006; Zhou WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056604	56	10	12	5	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142142	10.1371/journal.pone.0142142	http://dx.doi.org/10.1371/journal.pone.0142142			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554926	Green Published, gold, Green Submitted			2022-12-26	WOS:000364430700058
J	Miller, M; Zorn, J; Brielmeier, M				Miller, Manuel; Zorn, Julia; Brielmeier, Markus			High-Resolution Melting Curve Analysis for Identification of Pasteurellaceae Species in Experimental Animal Facilities	PLOS ONE			English	Article							LABORATORY MICE; LISTERIA-MONOCYTOGENES; STAPHYLOCOCCUS-AUREUS; PNEUMOTROPICA; BACTERIA; RODENTS; RATS; HRM	Pasteurellaceae are among the most prevalent bacterial pathogens isolated from mice housed in experimental animal facilities. Reliable detection and differentiation of Pasteurellaceae are essential for high-quality health monitoring. In this study, we combined a realtime PCR assay amplifying a variable region in the 16S rRNA sequence with high-resolution melting curve analysis (HRM) to identify and differentiate among the commonly isolated species Pasteurella pneumotropica biotypes "Jawetz" and "Heyl", Actinobacillus muris, and Haemophilus influenzaemurium. We used a set of six reference strains for assay development, with the melting profiles of these strains clearly distinguishable due to DNA sequence variations in the amplicon. For evaluation, we used real-time PCR/HRM to test 25 unknown Pasteurellaceae isolates obtained from an external diagnostic laboratory and found the results to be consistent with those of partial 16S rRNA sequencing. The real-time PCR/HRM method provides a sensitive, rapid, and closed-tube approach for Pasteurellaceae species identification for health monitoring of laboratory mice.	[Miller, Manuel; Zorn, Julia; Brielmeier, Markus] German Res Ctr Environm Hlth, Res Unit Comparat Med, Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Miller, M (corresponding author), German Res Ctr Environm Hlth, Res Unit Comparat Med, Neuherberg, Germany.	manuel.miller@helmholtz-muenchen.de						Benga L, 2013, J MICROBIOL METH, V95, P256, DOI 10.1016/j.mimet.2013.09.005; Boot R, 2004, SCAND J LAB ANIM SCI, V31, P177; Bootz F, 1998, LAB ANIM SCI, V48, P542; Chen JHK, 2013, J MICROBIOL METH, V92, P99, DOI 10.1016/j.mimet.2012.11.006; Cheng JC, 2006, CLIN CHEM, V52, P1997, DOI 10.1373/clinchem.2006.069286; Council NR, 1991, INF DIS MIC RATS; Dole VS, 2010, COMPARATIVE MED, V60, P427; Hayashimoto N, 2005, EXP ANIM TOKYO, V54, P123, DOI 10.1538/expanim.54.123; Hayashimoto N, 2013, EXP ANIM TOKYO, V62, P41, DOI 10.1538/expanim.62.41; Iacumin L, 2015, FOOD MICROBIOL, V46, P357, DOI 10.1016/j.fm.2014.08.007; Kodjo A, 1999, LAB ANIM SCI, V49, P49; Mahler M, 2014, LAB ANIM-UK, V48, P178, DOI 10.1177/0023677213516312; Ohshima C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099223; Patten CC, 2010, COMPARATIVE MED, V60, P18; Pritchett-Corning KR, 2009, LAB ANIM-UK, V43, P165, DOI 10.1258/la.2008.008009; Rebelo AR, 2011, J VET DIAGN INVEST, V23, P932, DOI 10.1177/1040638711416846; Reed GH, 2007, PHARMACOGENOMICS, V8, P597, DOI 10.2217/14622416.8.6.597; Sakaridis I, 2014, BIOTECHNOL BIOTEC EQ, V28, P107, DOI 10.1080/13102818.2014.901681; Scharmann W, 2001, LAB ANIM-UK, V35, P163, DOI 10.1258/0023677011911543; Wang RF, 1996, LAB ANIM SCI, V46, P81; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Xiao XL, 2014, FOOD ANAL METHOD, V7, P1960, DOI 10.1007/s12161-014-9875-x; Zahidi JM, 2015, DIAGN MICR INFEC DIS, V81, P227, DOI 10.1016/j.diagmicrobio.2014.12.012	23	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142560	10.1371/journal.pone.0142560	http://dx.doi.org/10.1371/journal.pone.0142560			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556281	Green Published, gold, Green Submitted			2022-12-26	WOS:000364430700129
J	Xu, PJ; Li, ZG; Wang, H; Zhang, XC; Yang, Z				Xu, Pengjuan; Li, Zhigui; Wang, Hui; Zhang, Xiaochen; Yang, Zhuo			Triptolide Inhibited Cytotoxicity of Differentiated PC12 Cells Induced by Amyloid-Beta(25-35) via the Autophagy Pathway	PLOS ONE			English	Article							WILFORDII HOOK-F; NF-KAPPA-B; ALZHEIMERS-DISEASE; NEURONAL DEATH; AMYLOID-BETA; EXPRESSION; APOPTOSIS; LC3; NEURODEGENERATION; EPIDEMIOLOGY	Evidence shows that an abnormal deposition of amyloid beta-peptide(25-35) (A beta(25-35)) was the primary cause of the pathogenesis of Alzheimer's disease (AD). And the elimination of A beta(25-35) is considered an important target for the treatment of AD. Triptolide (TP), isolated from Tripterygium wilfordii Hook. f. (TWHF), has been shown to possess a broad spectrum of biological profiles, including neurotrophic and neuroprotective effects. In our study investigating the effect and potential mechanism of triptolide on cytotoxicity of differentiated rat pheochromocytoma cell line (the PC12 cell line is often used as a neuronal developmental model) induced by Amyloid-Beta(25-35) (A beta(25-35)), we used 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay, flow cytometry, Western blot, and acridine orange staining to detect whether triptolide could inhibit A beta(25-35)-induced cell apoptosis. We focused on the potential role of the autophagy pathway in A beta(25-35)-treated differentiated PC12 cells. Our experiments show that cell viability is significantly decreased, and the apoptosis increased in A beta(25-35)-treated differentiated PC12 cells. Meanwhile, A beta(25-35) treatment increased the expression of microtubule-associated protein light chain 3 II (LC3 II), which indicates an activation of autophagy. However, triptolide could protect differentiated PC12 cells against A beta(25-35)-induced cytotoxicity and attenuate A beta(25-35)-induced differentiated PC12 cell apoptosis. Triptolide could also suppress the level of autophagy. In order to assess the effect of autophagy on the protective effects of triptolide in differentiated PC12 cells treated with A beta(25-35), we used 3-Methyladenine (3-MA, an autophagy inhibitor) and rapamycin (an autophagy activator). MTT assay showed that 3-MA elevated cell viability compared with the A beta(25-35)-treated group and rapamycin inhibits the protection of triptolide. These results suggest that triptolide will repair the neurological damage in AD caused by deposition of A beta(25-35) via the autophagy pathway, all of which may provide an exciting view of the potential application of triptolide or TWHF as a future research for AD.	[Xu, Pengjuan] Tianjin Univ Tradit Chinese Med, Sch Integrat Med, Tianjin 300193, Peoples R China; [Li, Zhigui; Zhang, Xiaochen; Yang, Zhuo] Nankai Univ, Tianjin Key Lab Tumor Microenvironm & Neurovasc R, State Key Lab Med Chem Biol, Coll Med, Tianjin 300071, Peoples R China; [Wang, Hui] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China	Tianjin University of Traditional Chinese Medicine; Nankai University; Nankai University	Xu, PJ (corresponding author), Tianjin Univ Tradit Chinese Med, Sch Integrat Med, Tianjin 300193, Peoples R China.	pjxu1984@tjutcm.edu.cn	Li, Zhigui/I-9108-2019	Li, Zhigui/0000-0003-1317-8679				Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Adlard PA, 2009, DRUG TODAY, V45, P293, DOI [10.1358/dot.2009.045.004.1353853, 10.1358/dot.2009.45.4.1353853]; Banerjee R, 2010, TRENDS NEUROSCI, V33, P541, DOI 10.1016/j.tins.2010.09.001; Banerjee R, 2009, BBA-MOL BASIS DIS, V1792, P651, DOI 10.1016/j.bbadis.2008.11.007; Baregamian N, 2009, OXID MED CELL LONGEV, V2, P297, DOI 10.4161/oxim.2.5.9541; Bates KA, 2009, MOL PSYCHIATR, V14, P469, DOI 10.1038/mp.2008.96; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Brinker AM, 2007, PHYTOCHEMISTRY, V68, P732, DOI 10.1016/j.phytochem.2006.11.029; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Chen T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118645; Chen YQ, 2008, AUTOPHAGY, V4, P246, DOI 10.4161/auto.5432; Chen YQ, 2011, J CELL SCI, V124, P161, DOI 10.1242/jcs.064576; De Duve C, 1963, CIB FDN S LYS; Gao Jun-Peng, 2008, Neurosci Bull, V24, P133, DOI 10.1007/s12264-008-1225-9; Geng Y, 2012, PHYTOTHER RES, V26, P337, DOI 10.1002/ptr.3538; Ghavami S, 2014, PROG NEUROBIOL, V112, P24, DOI 10.1016/j.pneurobio.2013.10.004; Gu Ming, 2004, Shengli Xuebao, V56, P73; Hamaguchi T, 2006, CELL MOL LIFE SCI, V63, P1538, DOI 10.1007/s00018-005-5599-9; Han YG, 2013, J MOL NEUROSCI, V50, P577, DOI 10.1007/s12031-013-0004-x; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; He Qihua, 2003, Beijing Da Xue Xue Bao Yi Xue Ban, V35, P252; Huang D, 2007, AM J PHYSIOL-CELL PH, V292, pC1339, DOI 10.1152/ajpcell.00144.2006; Hung SY, 2009, AUTOPHAGY, V5, P502, DOI 10.4161/auto.5.4.8096; Jaeger PA, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-16; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kirkland RA, 2002, NEUROSCIENCE, V115, P587, DOI 10.1016/S0306-4522(02)00512-2; KUPCHAN SM, 1972, J AM CHEM SOC, V94, P7194, DOI 10.1021/ja00775a078; Lee EA, 2005, KIDNEY INT, V67, P1762, DOI 10.1111/j.1523-1755.2005.00274.x; Lin MH, 2010, ORAL ONCOL, V46, P822, DOI 10.1016/j.oraloncology.2010.08.002; Lin N, 2001, ARTHRITIS RHEUM-US, V44, P2193, DOI 10.1002/1529-0131(200109)44:9&lt;2193::AID-ART373&gt;3.0.CO;2-5; Luo TF, 2014, INT J MOL SCI, V15, P15426, DOI 10.3390/ijms150915426; Martinez-Vicente M, 2007, LANCET NEUROL, V6, P352, DOI 10.1016/S1474-4422(07)70076-5; Mielke MM, 2014, CLIN EPIDEMIOL, V6, P37, DOI 10.2147/CLEP.S37929; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nelson Michael P, 2013, Curr Pathobiol Rep, V1, P239; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2008, AUTOPHAGY, V4, P590, DOI 10.4161/auto.6259; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI [10.1038/nrneurol.2011.2, 10.1101/cshperspect.a006239]; Ristica B, 2014, EXP CELL RES, V326, P90, DOI 10.1016/j.yexcr.2014.05.021; Sawa A, 2005, NEUROBIOL DIS, V20, P267, DOI 10.1016/j.nbd.2005.02.013; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Tao XL, 2000, RHEUM DIS CLIN N AM, V26, P29, DOI 10.1016/S0889-857X(05)70118-6; TAO XL, 1991, ARTHRITIS RHEUM, V34, P1274, DOI 10.1002/art.1780341011; TELLEZNAGEL I, 1974, J NEUROPATH EXP NEUR, V33, P308, DOI 10.1097/00005072-197404000-00008; Tischler AS, 2002, ANN NY ACAD SCI, V971, P366, DOI 10.1111/j.1749-6632.2002.tb04498.x; Tooze SA, 2008, CURR OPIN NEUROBIOL, V18, P504, DOI 10.1016/j.conb.2008.09.015; Ulamek-Koziol M, 2013, NEUROCHEM RES, V38, P1769, DOI 10.1007/s11064-013-1082-4; Wang H, 2015, LISS 2013, P1, DOI 10.1007/978-3-642-40660-7_1; Wei MM, 2014, MOL CELL BIOCHEM, V394, P261, DOI 10.1007/s11010-014-2102-7; Xu PJ, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0906-5; Xu YN, 2011, J REPROD DEVELOP, V57, P143, DOI 10.1262/jrd.10-110H; Xue LZ, 1999, MOL CELL NEUROSCI, V14, P180, DOI 10.1006/mcne.1999.0780; Zhang R, 2013, CHINESE MED J-PEKING, V126, P1884, DOI 10.3760/cma.j.issn.0366-6999.20130095; Zheng Y, 2013, CNS NEUROSCI THER, V19, P76, DOI 10.1111/cns.12039	58	27	29	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142719	10.1371/journal.pone.0142719	http://dx.doi.org/10.1371/journal.pone.0142719			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554937	Green Published, gold, Green Submitted			2022-12-26	WOS:000364430700158
J	Strickfaden, H; McDonald, D; Kruhlak, MJ; Haince, JF; Th'ng, JPH; Rouleau, M; Ishibashi, T; Corry, GN; Ausio, J; Underhill, DA; Poirier, GG; Hendzel, MJ				Strickfaden, Hilmar; McDonald, Darin; Kruhlak, Michael J.; Haince, Jean-Francois; Th'ng, John P. H.; Rouleau, Michele; Ishibashi, Toytaka; Corry, Gareth N.; Ausio, Juan; Underhill, D. Alan; Poirier, Guy G.; Hendzel, Michael J.			Poly(ADP-ribosyl)ation-dependent Transient Chromatin Decondensation and Histone Displacement following Laser Microirradiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; DNA-DAMAGE RESPONSE; BINDING-PROPERTIES; ADP-RIBOSYLATION; LIVING CELLS; REPAIR; POLY(ADP-RIBOSE); RECRUITMENT; PARP-1; ATM	Chromatin undergoes a rapid ATP-dependent, ATM and H2AX-independent decondensation when DNA damage is introduced by laser microirradiation. Although the detailed mechanism of this decondensation remains to be determined, the kinetics of decondensation are similar to the kinetics of poly(ADP-ribosyl)ation. We used laser microirradiation to introduce DNA strand breaks into living cells expressing a photoactivatable GFP-tagged histone H2B. We find that poly(ADPribosyl)ation mediated primarily by poly(ADP-ribose) polymerase 1 (PARP1) is responsible for the rapid decondensation of chromatin at sites of DNA damage. This decondensation of chromatin correlates temporally with the displacement of histones, which is sensitive to PARP inhibition and is transient in nature. Contrary to the predictions of the histone shuttle hypothesis, we did not find that histone H1 accumulated on poly(ADP-ribose) (PAR) in vivo. Rather, histone H1, and to a lessor extent, histones H2A and H2B were rapidly depleted from the sites of PAR accumulation. However, histone H1 returns to chromatin and the chromatin recondenses. Thus, the PARP-dependent relaxation of chromatin closely correlates with histone displacement.	[Strickfaden, Hilmar; McDonald, Darin; Corry, Gareth N.; Underhill, D. Alan; Poirier, Guy G.; Hendzel, Michael J.] Univ Alberta, Fac Dent & Med, Dept Oncol, Edmonton, AB T6G IZ2, Canada; [Kruhlak, Michael J.] NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA; [Th'ng, John P. H.] Northern Ontario Sch Med, Thunder Bay, ON P7B 5E1, Canada; [Ishibashi, Toytaka; Ausio, Juan] Univ Victoria, Dept Biochem & Microbiol, POB 3055, Victoria, BC V8W 3P6, Canada; [Ishibashi, Toytaka] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China; [Haince, Jean-Francois; Rouleau, Michele] Univ Laval, Fac Med, CHUQ, Oncol Axis,Laval Univ Hosp,Res Ctr, Quebec City, PQ G1V 4G2, Canada	University of Alberta; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Northern Ontario School of Medicine; University of Victoria; Hong Kong University of Science & Technology; Laval University	Hendzel, MJ (corresponding author), Univ Alberta, Dept Oncol, 11560 Univ Ave NW, Edmonton, AB T6G 1Z2, Canada.	mhendzel@ualberta.ca	Strickfaden, Hilmar/AAW-3522-2021; Ishibashi, Toyotaka/AAW-2687-2020; Hendzel, Michael/C-3391-2009	Ishibashi, Toyotaka/0000-0001-8015-2319; Hendzel, Michael/0000-0002-9603-7945; Underhill, Darrell/0000-0003-0957-7407; Poirier, Guy/0000-0002-4869-1424	Canadian Institutes of Health Research; Canadian Cancer Society; Alberta Cancer Research Institute; Alberta Cancer foundation; Bayrische Forschungsallianz; NATIONAL CANCER INSTITUTE [ZICBC010915] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Alberta Cancer Research Institute; Alberta Cancer foundation; Bayrische Forschungsallianz; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the Canadian Institutes of Health Research, the Canadian Cancer Society, and the Alberta Cancer Research Institute. The authors declare that they have no conflicts of interest with the contents of this article.r Holds a postdoctoral fellowship by the Alberta Cancer foundation and supported by the Bayrische Forschungsallianz.	Aguilar-Quesada R, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-29; Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Altaf M, 2007, MUTAT RES-FUND MOL M, V618, P81, DOI 10.1016/j.mrfmmm.2006.09.009; ALTHAUS FR, 1992, J CELL SCI, V102, P663; Altmeyer M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9088; Ayoub N, 2008, NATURE, V453, P682, DOI 10.1038/nature06875; Ayoub N, 2009, CELL CYCLE, V8, P2945; Baldeyron C, 2011, J CELL BIOL, V193, P81, DOI 10.1083/jcb.201101030; Bao YH, 2007, CURR OPIN GENET DEV, V17, P126, DOI 10.1016/j.gde.2007.02.010; Bryant HE, 2009, EMBO J, V28, P2601, DOI 10.1038/emboj.2009.206; Burgess RC, 2014, CELL REP, V9, P1703, DOI 10.1016/j.celrep.2014.10.060; DEMURCIA G, 1986, J BIOL CHEM, V261, P7011; Fernandez-Capetillo O, 2003, CELL CYCLE, V2, P426, DOI 10.4161/cc.2.5.509; Gagne JP, 2005, BIOCHEM J, V392, P499, DOI 10.1042/BJ20050792; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Haince JF, 2008, J BIOL CHEM, V283, P1197, DOI 10.1074/jbc.M706734200; Haince JF, 2007, J BIOL CHEM, V282, P16441, DOI 10.1074/jbc.M608406200; Hansen JC, 2006, J BIOL CHEM, V281, P1853, DOI 10.1074/jbc.R500022200; Ismail IH, 2008, ENVIRON MOL MUTAGEN, V49, P73, DOI 10.1002/em.20358; Izhar L, 2015, CELL REP, V11, P1486, DOI 10.1016/j.celrep.2015.04.053; Jungmichel S, 2013, MOL CELL, V52, P272, DOI 10.1016/j.molcel.2013.08.026; Khurana S, 2014, CELL REP, V8, P1049, DOI 10.1016/j.celrep.2014.07.024; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kleinbaum D., 2013, APPL REGRESSION ANAL; Kolesnikova TD, 2011, FLY, V5, P181, DOI 10.4161/fly.5.3.16729; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Krishnakumar R, 2010, MOL CELL, V39, P736, DOI 10.1016/j.molcel.2010.08.014; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; Lavin MF, 2007, ONCOGENE, V26, P7749, DOI 10.1038/sj.onc.1210880; Luijsterburg MS, 2009, J CELL BIOL, V185, P577, DOI 10.1083/jcb.200810035; Malanga M, 1998, BBA-GENE STRUCT EXPR, V1399, P154, DOI 10.1016/S0167-4781(98)00110-9; Maser RS, 1997, MOL CELL BIOL, V17, P6087, DOI 10.1128/MCB.17.10.6087; Messner S, 2011, TRENDS CELL BIOL, V21, P534, DOI 10.1016/j.tcb.2011.06.001; Morisaki T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107730; Mortusewicz O, 2007, NUCLEIC ACIDS RES, V35, P7665, DOI 10.1093/nar/gkm933; PANZETER PL, 1993, J BIOL CHEM, V268, P17662; POIRIER GG, 1982, P NATL ACAD SCI-BIOL, V79, P3423, DOI 10.1073/pnas.79.11.3423; Sehnalova P, 2014, BIOL CELL, V106, P151, DOI 10.1111/boc.201300076; Shen YQ, 2013, CLIN CANCER RES, V19, P5003, DOI 10.1158/1078-0432.CCR-13-1391; Smeenk G, 2013, J CELL SCI, V126, P889, DOI 10.1242/jcs.109413; Strickfaden H, 2010, NUCLEUS-PHILA, V1, P284, DOI 10.4161/nucl.1.3.11969; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Thomas CJ, 2014, MOL CELL, V53, P831, DOI 10.1016/j.molcel.2014.01.005; Timinszky G, 2009, NAT STRUCT MOL BIOL, V16, P923, DOI 10.1038/nsmb.1664; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	47	63	66	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1789	1802		10.1074/jbc.M115.694992	http://dx.doi.org/10.1074/jbc.M115.694992			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26559976	Green Published, hybrid			2022-12-26	WOS:000368620700020
J	Chai, M; Zhu, XP; Cui, HX; Jiang, CD; Zhang, JZ; Shi, L				Chai, Min; Zhu, Xiaopei; Cui, Hongxia; Jiang, Chuangdao; Zhang, Jinzheng; Shi, Lei			Lily Cultivars Have Allelopathic Potential in Controlling Orobanche aegyptiaca Persoon	PLOS ONE			English	Article							CHINESE MEDICINAL HERBS; ROOT PARASITIC PLANTS; GERMINATION STIMULANTS; SEED-GERMINATION; STRIGA SPP.; STRIGOLACTONES; WEEDS; SOIL; INHIBITION; INDUCTION	As a devastating holoparasitic weed, Orobanche aegyptiaca Persoon. (Egyptian broom-rape) causes serious damage to agricultural production and threatens economic development, which has raised widespread concern. The present study was conducted to determine whether lilies have the potential to be used as 'trap crops' for controlling O. aegyptiaca Persoon. In the experiments, the ability of three popular lily cultivars (Lilium Oriental hybrids 'Sorbonne', Lilium LA (Longiflorum hybrids x Asiatic hybrids) hybrids 'Ceb Dazzle', and Lilium Longiflorum hybrids (L. formosanum x L. longiflorum) 'L. formolongo') to induce O. aegyptiaca Persoon. seed germination was assessed. Parts of the three lily cultivars, including the rhizosphere soil and underground and above-ground organs, all induced "suicidal germination" of parasitic O. aegyptiaca Persoon. seed at four growth stages. Specifically, Sorbonne and Ceb Dazzle behaved with similar allelopathy, and the bulb, scale leaf and aerial stem exhibited stronger allelopathic effects on O. aegyptiaca Pers. germination compared to other organs. Aqueous L. formolongo leaf extracts may contain more stable, effective stimulants given that they induced the highest germination rate at 76.7% even though the extracts were serially diluted. We speculate that these organs may be advantageous in further isolating and purifying economical active substances that can be substitutes for GR24. These results indicate that lilies have the potential to be used as a trap crops or can be processed into green herbicide formulations that can be applied in agriculture production to rapidly deplete the seed bank of O. aegyptiaca Persoon. parasitic weeds in soil.	[Chai, Min; Zhu, Xiaopei; Cui, Hongxia; Jiang, Chuangdao; Zhang, Jinzheng; Shi, Lei] Chinese Acad Sci, Inst Bot, Key Lab Plant Resources, Beijing 100093, Peoples R China; [Chai, Min; Zhu, Xiaopei; Cui, Hongxia; Jiang, Chuangdao; Zhang, Jinzheng; Shi, Lei] Chinese Acad Sci, Inst Bot, Beijing Bot Garden, Beijing 100093, Peoples R China; [Chai, Min; Zhu, Xiaopei] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Shi, L (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Plant Resources, Beijing 100093, Peoples R China.	shilei@ibcas.ac.cn			National High-tech Research and Development Projects (863 Program) [2011AA10020805, 2012BAC01B05]	National High-tech Research and Development Projects (863 Program)	This work was supported by grants 2011AA10020805 [LS] and 2012BAC01B05 [HXC] from National High-tech Research and Development Projects (863 Program) (http://www.863.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awad AA, 2006, PLANT GROWTH REGUL, V48, P221, DOI 10.1007/s10725-006-0009-3; BABIKER AGT, 1987, WEED RES, V27, P173, DOI 10.1111/j.1365-3180.1987.tb00751.x; Beveridge CA, 2006, CURR OPIN PLANT BIOL, V9, P35, DOI 10.1016/j.pbi.2005.11.006; Botanga CJ, 2003, CROP SCI, V43, P483, DOI 10.2135/cropsci2003.0483; Bouwmeester HJ, 2007, TRENDS PLANT SCI, V12, P224, DOI 10.1016/j.tplants.2007.03.009; Bouwmeester HJ, 2003, CURR OPIN PLANT BIOL, V6, P358, DOI 10.1016/S1369-5266(03)00065-7; BROWN R, 1951, BIOCHEM J, V48, P559, DOI 10.1042/bj0480559; Cheng ZH, 2013, ACTA AGR SCAND B-S P, V63, P169, DOI 10.1080/09064710.2012.734323; Dong SQ, 2012, ALLELOPATHY J, V30, P247; EDWARDS WG, 1976, Z PFLANZENPHYSIOL, V80, P105, DOI 10.1016/S0044-328X(76)80147-X; FOY C L, 1989, Reviews of Weed Science, V4, P123; Goldwasser Y, 1997, WEED SCI, V45, P756, DOI 10.1017/S0043174500088937; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Hooper AM, 2009, PEST MANAG SCI, V65, P546, DOI 10.1002/ps.1731; Joel D. M., 2007, Horticultural Reviews, V33, P267, DOI 10.1002/9780470168011.ch4; Joel DM, 2000, CROP PROT, V19, P753, DOI 10.1016/S0261-2194(00)00100-9; JOHNSON AW, 1976, WEED RES, V16, P223, DOI 10.1111/j.1365-3180.1976.tb00406.x; Kgosi RL, 2012, WEED RES, V52, P197, DOI 10.1111/j.1365-3180.2012.00912.x; Khanh TD, 2005, CROP PROT, V24, P421, DOI 10.1016/j.cropro.2004.09.020; Klee H, 2008, NATURE, V455, P176, DOI 10.1038/455176a; KOHKI A, 2005, NATURE, V435, P824; Lins RD, 2006, WEED RES, V46, P313, DOI 10.1111/j.1365-3180.2006.00515.x; Lopez-Raez JA, 2008, NEW PHYTOL, V178, P863, DOI 10.1111/j.1469-8137.2008.02406.x; Ma YQ, 2014, J PLANT INTERACT, V9, P722, DOI 10.1080/17429145.2014.912358; Ma YQ, 2013, CROP SCI, V53, P260, DOI 10.2135/cropsci2012.03.0197; Ma YQ, 2012, AGRON J, V104, P569, DOI 10.2134/agronj2011.0372; Ma YQ, 2012, SCI CHINA LIFE SCI, V55, P250, DOI 10.1007/s11427-012-4302-2; Ma YQ, 2004, AGRON J, V96, P1349, DOI 10.2134/agronj2004.1349; Manschadi AM, 2001, WEED RES, V41, P311, DOI 10.1046/j.1365-3180.2001.00240.x; Mediene S, 2011, AGRON SUSTAIN DEV, V31, P491, DOI 10.1007/s13593-011-0009-1; Mwakaboko AS, 2011, PLANT CELL PHYSIOL, V52, P699, DOI 10.1093/pcp/pcr031; Parker C., 1993, PARASITIC WEEDS WORL; Parker C, 2012, WEED SCI, V60, P269, DOI 10.1614/WS-D-11-00068.1; Ratnadass A, 2012, AGRON SUSTAIN DEV, V32, P273, DOI 10.1007/s13593-011-0022-4; RILEY D, 1969, SOIL SCI SOC AM PRO, V33, P905, DOI 10.2136/sssaj1969.03615995003300060031x; Romanova V., 2001, P 7 INT PAR WEED S N, P80; Rubiales D, 2009, WEED RES, V49, P23, DOI 10.1111/j.1365-3180.2009.00742.x; SHAY FJ, 1973, PLANT PHYSIOL, V51, P1061, DOI 10.1104/pp.51.6.1061; WEGMANN K, 2002, 2 JOINT M WORK GROUP, P29; Westerdahl B. B., 1998, Journal of Nematology, V30, P581; WHITNEY PJ, 1981, ANN BOT-LONDON, V48, P919, DOI 10.1093/oxfordjournals.aob.a086201; WHITNEY PJ, 1978, ANN APPL BIOL, V89, P475, DOI 10.1111/j.1744-7348.1978.tb05976.x; Xie X, 2007, J AGR FOOD CHEM, V55, P8067, DOI 10.1021/jf0715121; Xie XN, 2010, ANNU REV PHYTOPATHOL, V48, P93, DOI 10.1146/annurev-phyto-073009-114453; Xu Peng, 2011, Journal of Northwest A & F University - Natural Science Edition, V39, P167; Yoneyama K, 2010, PLANT CELL PHYSIOL, V51, P1095, DOI 10.1093/pcp/pcq055; Yu M, 2004, CHINESE J SOIL SCI, V35, P377; Zhang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059715	48	9	9	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142811	10.1371/journal.pone.0142811	http://dx.doi.org/10.1371/journal.pone.0142811			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26565398	Green Published, Green Submitted, gold			2022-12-26	WOS:000367628500056
J	Herek, TA; Shew, TD; Spurgin, HN; Cutucache, CE				Herek, Tyler A.; Shew, Timothy D.; Spurgin, Heather N.; Cutucache, Christine E.			Conserved Molecular Underpinnings and Characterization of a Role for Caveolin-1 in the Tumor Microenvironment of Mature T-Cell Lymphomas	PLOS ONE			English	Article							POTENTIAL-THERAPEUTIC-TARGETS; ACUTE LYMPHOBLASTIC-LEUKEMIA; CHRONIC LYMPHOCYTIC-LEUKEMIA; HERPESVIRUS ENTRY MEDIATOR; NF-KAPPA-B; THYMOCYTE DEVELOPMENT; SIGNAL-TRANSDUCTION; EXPRESSION ANALYSIS; BREAST-CANCER; GENE-FUNCTION	Neoplasms of extra-thymic T-cell origin represent a rare and difficult population characterized by poor clinical outcome, aggressive presentation, and poorly defined molecular characteristics. Much work has been done to gain greater insights into distinguishing features among malignant subtypes, but there also exists a need to identify unifying characteristics to assist in rapid diagnosis and subsequent potential treatment. Herein, we investigated gene expression data of five different mature T-cell lymphoma subtypes (n = 187) and found 21 genes to be up-and down-regulated across all malignancies in comparison to healthy CD4(+) and CD8(+) T-cell controls (n = 52). From these results, we sought to characterize a role for caveolin-1 (CAV1), a gene with previous description in the progression of both solid and hematological tumors. Caveolin-1 was upregulated, albeit with a heterogeneous nature, across all mature T-cell lymphoma subtypes, a finding confirmed using immunohistochemical staining on an independent sampling of mature T-cell lymphoma biopsies (n = 65 cases). Further, stratifying malignant samples in accordance with high and low CAV1 expression revealed that higher expression of CAV1 in mature T-cell lymphomas is analogous with an enhanced inflammatory and invasive gene expression profile. Taken together, these results demonstrate a role for CAV1 in the tumor microenvironment of mature T-cell malignancies and point toward potential prognostic implications.	[Herek, Tyler A.; Shew, Timothy D.; Spurgin, Heather N.; Cutucache, Christine E.] Univ Nebraska, Dept Biol, Omaha, NE 68182 USA	University of Nebraska System	Cutucache, CE (corresponding author), Univ Nebraska, Dept Biol, Omaha, NE 68182 USA.	ccutucache@unomaha.edu			University of Nebraska at Omaha Omaha Sponsored Program Office; University of Nebraska Foundation; Department of Biology; College of Arts and Sciences	University of Nebraska at Omaha Omaha Sponsored Program Office; University of Nebraska Foundation; Department of Biology; College of Arts and Sciences	This work was supported by the University of Nebraska at Omaha Omaha Sponsored Program Office (TAH, TDS, HNS), Dr. George Haddix and the University of Nebraska Foundation (CEC), the Department of Biology, and the College of Arts and Sciences (TAH, CEC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnelli L, 2012, BLOOD, V120, P1274, DOI 10.1182/blood-2012-01-405555; Agostinelli C, 2014, AM J SURG PATHOL, V38, P1349, DOI 10.1097/PAS.0000000000000309; Ayala G, 2013, J PATHOL, V231, P77, DOI 10.1002/path.4217; Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743; Folgueira MAAK, 2013, BIOSCIENCE REP, V33, P921, DOI 10.1042/BSR20130060; Ballester B, 2006, ONCOGENE, V25, P1560, DOI 10.1038/sj.onc.1209178; Bisig B, 2013, HAEMATOLOGICA, V98, P1250, DOI 10.3324/haematol.2012.081935; Bonzheim I, 2004, BLOOD, V104, P3358, DOI 10.1182/blood-2004-03-1037; Briones J, 2009, HISTOPATHOLOGY, V54, P478, DOI 10.1111/j.1365-2559.2009.03250.x; Cannarile L, 2006, BLOOD, V107, P1039, DOI 10.1182/blood-2005-05-2183; Carpino N, 2004, IMMUNITY, V20, P37, DOI 10.1016/S1074-7613(03)00351-0; Chou PC, 2014, J IMMUNOL, V193, P1162, DOI 10.4049/jimmunol.1303162; Cocco C, 2012, LEUKEMIA, V26, P1365, DOI 10.1038/leu.2011.363; Cocco C, 2012, CRIT REV ONCOL HEMAT, V83, P310, DOI 10.1016/j.critrevonc.2011.11.006; Cocco C, 2010, BLOOD, V116, P3887, DOI 10.1182/blood-2009-10-248245; Conroy BD, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00599; CRAWFORD JM, 1986, LAB INVEST, V54, P122; Cutucache CE, 2013, INT IMMUNOPHARMACOL, V17, P35, DOI 10.1016/j.intimp.2013.05.021; de Brevern AG, 2000, PROTEINS, V41, P271, DOI 10.1002/1097-0134(20001115)41:3<271::AID-PROT10>3.0.CO;2-Z; de Leval L, 2007, BLOOD, V109, P4952, DOI 10.1182/blood-2006-10-055145; del Rio ML, 2010, J LEUKOCYTE BIOL, V87, P223, DOI 10.1189/jlb.0809590; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Feng XM, 2011, NAT IMMUNOL, V12, P544, DOI 10.1038/ni.2034; Feng XM, 2010, BLOOD, V115, P510, DOI 10.1182/blood-2009-07-232694; Fujita N, 1996, INT J CANCER, V66, P544; Geissinger E, 2010, HAEMATOL-HEMATOL J, V95, P1697, DOI 10.3324/haematol.2009.021428; Geman D., 2004, STAT APPL GENET MOL, V3, P1, DOI [10.2202/1544-6115.1071, DOI 10.2202/1544-6115.1071]; Gilling CE, 2012, BRIT J HAEMATOL, V158, P216, DOI 10.1111/j.1365-2141.2012.09148.x; Gisselbrecht C, 1998, BLOOD, V92, P76; Gonda TA, 2009, CELL CYCLE, V8, P2005, DOI 10.4161/cc.8.13.8985; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hao YB, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1179-z; Howlader N, 2014, SEER CANC STAT REV 1; Hu Y, 2014, ONCOTARGET, V5, P2230, DOI 10.18632/oncotarget.1895; Huang YL, 2009, AM J SURG PATHOL, V33, P682, DOI 10.1097/PAS.0b013e3181971591; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; Iqbal J, 2014, BLOOD, V123, P2915, DOI 10.1182/blood-2013-11-536359; Iqbal J, 2010, BLOOD, V115, P1026, DOI 10.1182/blood-2009-06-227579; Ishiura Y, 2010, BIOCHEM BIOPH RES CO, V396, P329, DOI 10.1016/j.bbrc.2010.04.092; Jaffe ES, 2009, HEMATOL-AM SOC HEMAT, V2009, P523, DOI DOI 10.1182/ASHEDUCATI0N-2009.1.523; Jin KZ, 2015, DRUG DES DEV THER, V9, P1247, DOI 10.2147/DDDT.S77597; Kagami S, 2001, BLOOD, V97, P2358, DOI 10.1182/blood.V97.8.2358; Khalil AM, 2011, SEMIN CELL DEV BIOL, V22, P359, DOI 10.1016/j.semcdb.2011.02.016; Klima M, 2011, MOL IMMUNOL, V48, P1439, DOI 10.1016/j.molimm.2011.03.021; Korhan P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105278; Krause M, 2000, J CELL BIOL, V149, P181, DOI 10.1083/jcb.149.1.181; Krenacs L, 2006, BLOOD, V108, P1110, DOI 10.1182/blood-2006-01-0394; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Lee K, 2010, IMMUNITY, V32, P743, DOI 10.1016/j.immuni.2010.06.002; Liu JQ, 2001, IMMUNITY, V15, P23, DOI 10.1016/S1074-7613(01)00162-5; Lobos-Gonzalez L, 2014, MELANOMA RES, V24, P108, DOI 10.1097/CMR.0000000000000046; Lu BF, 2004, P NATL ACAD SCI USA, V101, P3023, DOI 10.1073/pnas.0307743100; Lu QS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-651; MCKENZIE JL, 1981, J IMMUNOL, V126, P843; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Mittal AK, 2014, MOL MED, V20, P290, DOI 10.2119/molmed.2012.00303; Muppirala UK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-489; Nagel S, 2014, GENE CHROMOSOME CANC, V53, P917, DOI 10.1002/gcc.22204; Nelson M, 2008, BRIT J HAEMATOL, V141, P461, DOI 10.1111/j.1365-2141.2008.07042.x; Nishiu M, 2002, JPN J CANCER RES, V93, P894, DOI 10.1111/j.1349-7006.2002.tb01335.x; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Offmann B, 2007, CURR BIOINFORM, V2, P165, DOI 10.2174/157489307781662105; Ohnuma K, 2007, J BIOL CHEM, V282, P10117, DOI 10.1074/jbc.M609157200; Pan GH, 1998, FEBS LETT, V431, P351, DOI 10.1016/S0014-5793(98)00791-1; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Perez-Villar JJ, 1999, MOL CELL BIOL, V19, P2903; Piccaluga PP, 2007, J CLIN INVEST, V117, P823, DOI 10.1172/JCI26833; Raff MC, 1971, IMMUNOL REV, V6, P52; Re A, 2014, ANONYMOUS RNA SEQUEN, P491; Rossi M, 2012, HUM PATHOL, V43, P2266, DOI 10.1016/j.humpath.2012.03.024; Rudiger T, 2002, ANN ONCOL, V13, P140, DOI 10.1093/annonc/mdf033; Sorensen KP, 2013, BREAST CANCER RES TR, V142, P529, DOI 10.1007/s10549-013-2776-7; Soroosh P, 2011, J EXP MED, V208, P797, DOI 10.1084/jem.20101562; Sousa BR, 2014, CYTOM PART A, V85A, P43, DOI 10.1002/cyto.a.22402; Suresh V, 2015, NUCLEIC ACIDS RES, V43, P1370, DOI 10.1093/nar/gkv020; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; TARAKHOVSKY A, 1995, SCIENCE, V269, P535, DOI 10.1126/science.7542801; Thorns C, 2007, GENE CHROMOSOME CANC, V46, P37, DOI 10.1002/gcc.20386; Tomassian T, 2011, J IMMUNOL, V187, P2993, DOI 10.4049/jimmunol.1101447; Travert M, 2012, BLOOD, V119, P5795, DOI 10.1182/blood-2011-12-396150; Tseng GC, 2012, NUCLEIC ACIDS RES, V40, P3785, DOI 10.1093/nar/gkr1265; Vito P, 1997, J BIOL CHEM, V272, P28315, DOI 10.1074/jbc.272.45.28315; Vito P, 1996, J BIOL CHEM, V271, P31025, DOI 10.1074/jbc.271.49.31025; Wang TJ, 2014, BLOOD, V123, P3007, DOI 10.1182/blood-2013-12-544809; Wang Y, 2005, J CLIN INVEST, V115, P711, DOI 10.1172/JCI200522982; Went P, 2006, J CLIN ONCOL, V24, P2472, DOI 10.1200/JCO.2005.03.6327; Wolozin B, 1996, SCIENCE, V274, P1710, DOI 10.1126/science.274.5293.1710; Yamada S, 2012, HUM PATHOL, V43, P1322, DOI 10.1016/j.humpath.2011.10.013; Yamazaki H, 2009, BIOCHEM BIOPH RES CO, V383, P172, DOI 10.1016/j.bbrc.2009.03.127; Yu HX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106451; Zettl A, 2004, AM J PATHOL, V164, P1837, DOI 10.1016/S0002-9440(10)63742-X; Zhu JJ, 2013, SCI CHINA LIFE SCI, V56, P876, DOI 10.1007/s11427-013-4553-6	93	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142682	10.1371/journal.pone.0142682	http://dx.doi.org/10.1371/journal.pone.0142682			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26566034	Green Published, Green Submitted, gold			2022-12-26	WOS:000367628500043
J	Chiang, YL; Chang, YC; Chiang, IC; Mak, HM; Hwang, IS; Shih, YL				Chiang, Ya-Ling; Chang, Yuan-Chih; Chiang, I-Chen; Mak, Huey-Ming; Hwang, Ing-Shouh; Shih, Yu-Ling			Atomic Force Microscopy Characterization of Protein Fibrils Formed by the Amyloidogenic Region of the Bacterial Protein MinE on Mica and a Supported Lipid Bilayer	PLOS ONE			English	Article							DIVISION SITE; ALPHA-SYNUCLEIN; MEMBRANE INTERACTION; RING; PLACEMENT; VISUALIZATION; DISRUPTION; MECHANISM; FIBERS; RIBBON	Amyloid fibrils play a crucial role in many human diseases and are found to function in a range of physiological processes from bacteria to human. They have also been gaining importance in nanotechnology applications. Understanding the mechanisms behind amyloid formation can help develop strategies towards the prevention of fibrillation processes or create new technological applications. It is thus essential to observe the structures of amyloids and their self-assembly processes at the nanometer-scale resolution under physiological conditions. In this work, we used highly force-sensitive frequency-modulation atomic force microscopy (FM-AFM) to characterize the fibril structures formed by the N-terminal domain of a bacterial division protein MinE in solution. The approach enables us to investigate the fibril morphology and protofibril organization over time progression and in response to changes in ionic strength, molecular crowding, and upon association with different substrate surfaces. In addition to comparison of the fibril structure and behavior of MinE(1-31) under varying conditions, the study also broadens our understanding of the versatile behavior of amyloid-substrate surface interactions.	[Chiang, Ya-Ling; Hwang, Ing-Shouh] Acad Sinica, Inst Phys, Taipei, Taiwan; [Chiang, Ya-Ling; Hwang, Ing-Shouh] Natl Tsing Hua Univ, Dept Mat Sci & Engn, Hsinchu, Taiwan; [Chang, Yuan-Chih] Acad Sinica, Inst Cellular & Organism Biol, Taipei, Taiwan; [Chiang, I-Chen; Mak, Huey-Ming; Shih, Yu-Ling] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Shih, Yu-Ling] Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan	Academia Sinica - Taiwan; National Tsing Hua University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University	Hwang, IS (corresponding author), Acad Sinica, Inst Phys, Taipei, Taiwan.	ishwang@phys.sinica.edu.tw; ylshih10@gate.sinica.edu.tw	Shih, Yu-Ling/F-8396-2011; Hwang, Ing-Shouh/AAP-3963-2021; CHANG, Yuan-Chih/J-2609-2016	Shih, Yu-Ling/0000-0002-8232-2569; Hwang, Ing-Shouh/0000-0002-7670-1212; CHANG, Yuan-Chih/0000-0002-0289-3768	Academia Sinica, Taiwan [AS-98-CDA-L07, AS-102-TP-A09]; Ministry of Science and Technology, Taiwan [NSC 101-2311-B-001-006, NSC 102-2112-M-001-024-MY3, MOST 103-2627-M-001-011, MOST 104-2627-M-001-005]	Academia Sinica, Taiwan(Academia Sinica - Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was funded by a career development award AS-98-CDA-L07 to YLS, and by the Thematic Research Program (AS-102-TP-A09) to YLS and ISH from Academia Sinica, Taiwan and by grants NSC 101-2311-B-001-006 to YLS, NSC 102-2112-M-001-024-MY3, MOST 103-2627-M-001-011, and MOST 104-2627-M-001-005 to ISH from Ministry of Science and Technology, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Kayal T, 2012, SOFT MATTER, V8, P9115, DOI 10.1039/c2sm25992c; Biancalana M, 2010, P NATL ACAD SCI USA, V107, P3469, DOI 10.1073/pnas.0912654107; Blanco LP, 2012, TRENDS MICROBIOL, V20, P66, DOI 10.1016/j.tim.2011.11.005; Boyle AL, 2012, RATIONAL DESIGN PEPT; Burke KA, 2013, BIOCHEMISTRY-US, V52, P808, DOI 10.1021/bi301070v; Cacace MG, 1997, Q REV BIOPHYS, V30, P241, DOI 10.1017/S0033583597003363; DEBOER PAJ, 1988, J BACTERIOL, V170, P2106, DOI 10.1128/jb.170.5.2106-2112.1988; Drolle E, 2014, DRUG METAB REV, V46, P207, DOI 10.3109/03602532.2014.882354; Engel MFM, 2006, J MOL BIOL, V356, P783, DOI 10.1016/j.jmb.2005.12.020; Forman CJ, 2012, ACS NANO, V6, P1332, DOI 10.1021/nn204140a; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Fu XL, 2001, P NATL ACAD SCI USA, V98, P980, DOI 10.1073/pnas.031549298; Fukuma T, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/38/384010; Hane F, 2011, J ALZHEIMERS DIS, V26, P485, DOI 10.3233/JAD-2011-102112; Harries D, 2008, METHOD CELL BIOL, V84, P679, DOI 10.1016/S0091-679X(07)84022-2; Hsieh CW, 2010, MOL MICROBIOL, V75, P499, DOI 10.1111/j.1365-2958.2009.07006.x; Ido S, 2013, ACS NANO, V7, P1817, DOI 10.1021/nn400071n; Jarvis S, 2012, FUNCTIONAL FOLD: AMYLOID STRUCTURES IN NATURE, P1; Keller A, 2011, ACS NANO, V5, P2770, DOI 10.1021/nn1031998; Knight JD, 2004, J MOL BIOL, V341, P1175, DOI 10.1016/j.jmb.2004.06.086; Last NB, 2013, P NATL ACAD SCI USA, V110, P6382, DOI 10.1073/pnas.1219059110; Lee JS, 2012, PLOS ONE, V7; Lu YH, 2012, LANGMUIR, V28, P12691, DOI 10.1021/la301671a; Makabe K, 2006, P NATL ACAD SCI USA, V103, P17753, DOI 10.1073/pnas.0606690103; Milanesi L, 2012, P NATL ACAD SCI USA, V109, P20455, DOI 10.1073/pnas.1206325109; Milhiet PE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013240; Minton AP, 2005, J PHARM SCI-US, V94, P1668, DOI 10.1002/jps.20417; Moores B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025954; Necula M, 2003, J BIOL CHEM, V278, P46674, DOI 10.1074/jbc.M308231200; Ouberai MM, 2013, J BIOL CHEM, V288, P20883, DOI 10.1074/jbc.M113.478297; Park KT, 2011, CELL, V146, P396, DOI 10.1016/j.cell.2011.06.042; Raskin DM, 1997, CELL, V91, P685, DOI 10.1016/S0092-8674(00)80455-9; Renner LD, 2012, J BIOL CHEM, V287, P38835, DOI 10.1074/jbc.M112.407817; Reynolds NP, 2011, J AM CHEM SOC, V133, P19366, DOI 10.1021/ja2029848; Sader JE, 2004, APPL PHYS LETT, V84, P1801, DOI 10.1063/1.1667267; Selivanova OM, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1237, DOI 10.1134/S0006297912110028; Shih YL, 2002, EMBO J, V21, P3347, DOI 10.1093/emboj/cdf323; Shih YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021425; Stefanis L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009399; Sweers KKM, 2012, ACS NANO, V6, P5952, DOI 10.1021/nn300863n; Vecchiarelli AG, 2014, MOL MICROBIOL, V93, P453, DOI 10.1111/mmi.12669; Wegmann S, 2010, J BIOL CHEM, V285, P27302, DOI 10.1074/jbc.M110.145318; Yang CW, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/8/084009; Yip CM, 2001, BIOPHYS J, V80, P1359, DOI 10.1016/S0006-3495(01)76109-7; Zhang S, 2013, P NATL ACAD SCI USA, V110, P2798, DOI 10.1073/pnas.1209955110; Zhao HX, 2004, BIOCHEMISTRY-US, V43, P10302, DOI 10.1021/bi049002c; Zheng M, 2014, J BIOL CHEM, V289, P21252, DOI 10.1074/jbc.M114.571976	47	12	12	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142506	10.1371/journal.pone.0142506	http://dx.doi.org/10.1371/journal.pone.0142506			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562523	Green Published, gold, Green Submitted			2022-12-26	WOS:000364480900036
J	Jochems, B; Phillips, TE				Jochems, Brian; Phillips, Thomas E.			Histological and Ultrastructural Studies on the Conjunctiva of the Barred Owl (Strix varia)	PLOS ONE			English	Article							LYMPHOID-TISSUE CALT; M-CELLS; LECTIN; BIRDS; PURIFICATION; EPITHELIUM; PLANTS; BIND; EYE	This report is the first characterization of the histology and ultrastructure of the barred owl conjunctiva. The inferior eyelid was dominated by a large disk-shaped plate covered by a non-keratinized stratified squamous or cuboidal epithelium of variable thickness. The apical surface of the plate epithelium varied from flat to long microvilli or even short cytoplasmic extensions similar to those seen in the third eyelid. All specimens had a few goblet cells filled with mucous secretory granules in the plate region. The underlying connective tissue was a dense fibroelastic stroma. Eosinophils were surprisingly common in the epithelial layer and underlying connective tissue in the plate and more distal orbital mucosal region. The orbital mucosa contained goblet cells with heterogeneous glycosylation patterns. The leading edge and marginal plait of the third eyelid are designed to collect fluid and particulate matter as they sweep across the surface of the eye. The palpebral conjunctival surface of the third eyelid was covered by an approximately five-cell-deep stratified squamous epithelium without goblet cells. The bulbar surface of the third eyelid was a bilayer of epithelial cells whose superficial cells have elaborate cytoplasmic tapering extensions reaching out 25 mu m. Narrow cytofilia radiated outwards up to an additional 15-20 mu m from the cytoplasmic extensions. Lectin labeling demonstrated heterogeneous glycosylation of the apical membrane specializations but only small amounts of glycoprotein-filled secretory granules in the third eyelid.	[Jochems, Brian; Phillips, Thomas E.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Jochems, Brian] Univ Missouri, Coll Vet Med, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Phillips, TE (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.	phillipst@missouri.edu		Phillips, Thomas/0000-0002-9709-0684				BASKIN TI, 1992, PLANTA, V187, P405, DOI 10.1007/BF00195665; Bielek E., 1976, VERH ANAT GES, V70, P977; Campbell T. W., 2007, AVIAN EXOTIC ANIMAL; FIX AS, 1991, AM J VET RES, V52, P1852; FIX AS, 1989, VET PATHOL, V26, P222, DOI 10.1177/030098588902600306; Giuliano EA, 2002, GRAEF ARCH CLIN EXP, V240, P220, DOI 10.1007/s00417-002-0429-3; Giuliano EA, 2011, VET OPHTHALMOL, V14, P60, DOI 10.1111/j.1463-5224.2011.00917.x; Goldstein I., 1983, J BIOSCI, V5, P65; Goldstein I J, 1978, Adv Carbohydr Chem Biochem, V35, P127; GREINER JV, 1985, ACTA OPHTHALMOL, V63, P89; Gultiken ME, 2010, KAFKAS UNIV VET FAK, V16, P1001; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; HAMMARSTROM S, 1977, BIOCHEMISTRY-US, V16, P2750, DOI 10.1021/bi00631a025; Harris MC, 2008, VET OPHTHALMOL, V11, P186, DOI 10.1111/j.1463-5224.2008.00618.x; Kajikawa J., 1923, A VONGRAEFES ARCH OP, V112, P260, DOI DOI 10.1007/BF01861096; Kern Thomas J., 1996, Journal of Avian Medicine and Surgery, V10, P12; KILPATRICK DC, 1980, BIOCHEM J, V185, P269, DOI 10.1042/bj1850269; Knop N, 2000, INVEST OPHTH VIS SCI, V41, P1270; Kolmer W., 1923, Anatomischer Anzeiger, V57, P122; Kuhnel W, 1989, Prog Clin Biol Res, V295, P521; LEESON CR, 1961, ANAT REC, V140, P359, DOI 10.1002/ar.1091400411; Liu HS, 2005, INVEST OPHTH VIS SCI, V46, P4217, DOI 10.1167/iovs.05-0280; Maggs DJ, 2013, SLATTERS FUNDAMENTAL, P151; Mazur KM, 2000, BARRED OWL STRIX VAR; McCormack JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054848; Meagher CK, 2005, EXP EYE RES, V80, P545, DOI 10.1016/j.exer.2004.11.005; MURPHY CJ, 1987, COMP CONT EDUC PRACT, V9, P241; MURPHY CJ, 1982, J AM VET MED ASSOC, V181, P1302; Petris CK, 2007, INVEST OPHTH VIS SCI, V48, P2172, DOI 10.1167/iovs.06-1202; PILLER V, 1990, EUR J BIOCHEM, V191, P461, DOI 10.1111/j.1432-1033.1990.tb19144.x; SHIBUYA N, 1987, J BIOL CHEM, V262, P1596; Sivak JG, 1985, CAN J ZOOL, V64, P963; Slonaker JR, 1918, J MORPHOL, V31, P351, DOI 10.1002/jmor.1050310302; Stettenheim PR, 2000, AM ZOOL, V40, P461, DOI 10.1668/0003-1569(2000)040[0461:TIMOMB]2.0.CO;2; WILLINGHAM MC, 1984, J HISTOCHEM CYTOCHEM, V32, P455, DOI 10.1177/32.4.6323574; Wood C. A., 1915, OPHTHALMOLOGY, V11, P641; Wu AM, 2007, GLYCOCONJUGATE J, V24, P591, DOI 10.1007/s10719-007-9063-y; Yamamoto K, 1997, J BIOCHEM-TOKYO, V121, P756; ZHU BCR, 1989, PREP BIOCHEM, V19, P341, DOI 10.1080/10826068908544922	39	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142783	10.1371/journal.pone.0142783	http://dx.doi.org/10.1371/journal.pone.0142783			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562834	Green Published, gold, Green Submitted			2022-12-26	WOS:000364480900066
J	Wade, AJ; Macdonald, DM; Doyle, JS; Gordon, A; Roberts, SK; Thompson, AJ; Hellard, ME				Wade, Amanda J.; Macdonald, Diana M.; Doyle, Joseph S.; Gordon, Adam; Roberts, Stuart K.; Thompson, Alexander J.; Hellard, Margaret E.			The Cascade of Care for an Australian Community-Based Hepatitis C Treatment Service	PLOS ONE			English	Article							VIRUS-INFECTION; INJECT DRUGS; PEOPLE; EPIDEMIOLOGY; BARRIERS; PROGRAM; COHORT	Background Hepatitis C treatment uptake in Australia is low. To increase access to hepatitis C virus treatment for people who inject drugs, we developed a community-based, nurse-led service that linked a viral hepatitis service in a tertiary hospital to primary care clinics, and resulted in hepatitis C treatment provision in the community. Methods A retrospective cohort study of patients referred to the community hepatitis service was undertaken to determine the cascade of care. Logistic regression analyses were used to identify predictors of hepatitis C treatment uptake. Results Four hundred and sixty-two patients were referred to the community hepatitis service; 344 attended. Among the 279 attendees with confirmed chronic hepatitis C, 257 (99%) reported ever injecting drugs, and 124 (48%) injected in the last month. Of 201 (72%) patients who had their fibrosis staged, 63 (31%) had F3-F4 fibrosis. Fifty-five patients commenced hepatitis C treatment; 26 (47%) were current injectors and 25 (45%) had F3-F4 fibrosis. Nineteen of the 27 (70%) genotype 1 patients and 14 of the 26 (54%) genotype 3 patients eligible for assessment achieved a sustained virologic response. Advanced fibrosis was a significant predictor of treatment uptake in adjusted analysis (AOR 2.56, CI 1.30-5.00, p = 0.006). Conclusions Our community hepatitis service produced relatively high rates of fibrosis assessment, hepatitis C treatment uptake and cure, among people who inject drugs. These findings highlight the potential benefits of providing community-based hepatitis C care to people who inject drugs in Australia-benefits that should be realised as direct-acting antiviral agents become available.	[Wade, Amanda J.; Doyle, Joseph S.; Hellard, Margaret E.] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia; [Wade, Amanda J.; Hellard, Margaret E.] Monash Univ, Alfred Hosp, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3181, Australia; [Macdonald, Diana M.; Doyle, Joseph S.; Hellard, Margaret E.] Alfred, Dept Infect Dis, Melbourne, Vic, Australia; [Thompson, Alexander J.] St Vincents Hosp, Dept Gastroenterol, Melbourne, Vic, Australia; [Gordon, Adam; Roberts, Stuart K.] Alfred, Dept Gastroenterol, Melbourne, Vic, Australia; [Roberts, Stuart K.; Thompson, Alexander J.] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia; [Doyle, Joseph S.] Univ Melbourne, Dept Med, Melbourne, Vic, Australia	Burnet Institute; Florey Institute of Neuroscience & Mental Health; Monash University; St Vincent's Hospital Melbourne; Monash University; University of Melbourne	Wade, AJ (corresponding author), Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia.	amanda.wade@burnet.edu.au		Doyle, Joseph S/0000-0001-7198-0833	National Health and Medical Research Council postgraduate scholarship [GNT1093846]; National Health and Medical Research Council; Burnet Institute	National Health and Medical Research Council postgraduate scholarship(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Burnet Institute	AW is a recipient of a National Health and Medical Research Council postgraduate scholarship (GNT1093846). JD, MH, and AT acknowledge support from the National Health and Medical Research Council. The authors gratefully acknowledge the contribution to this work of Victorian Operational Infrastructure Support Program funding for the Burnet Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi M, 2013, CLIN INFECT DIS, V57, pS62, DOI 10.1093/cid/cit305; [Anonymous], AUSTR NOT DIS STAT 2; Arora S, 2011, NEW ENGL J MED, V364, P2199, DOI 10.1056/NEJMoa1009370; Aspinall EJ, 2013, CLIN INFECT DIS, V57, pS80, DOI 10.1093/cid/cit306; Australian Government DoH, 2015, PHARM BEN SCHEM; Bruce RD, 2012, AM J DRUG ALCOHOL AB, V38, P206, DOI 10.3109/00952990.2011.643975; Crespo J, 2015, LIVER INT, V35, P401, DOI 10.1111/liv.12536; Dore GJ, 2014, J VIRAL HEPATITIS, V21, P1, DOI 10.1111/jvh.12253; Gidding HF, 2009, J GASTROEN HEPATOL, V24, P1648, DOI 10.1111/j.1440-1746.2009.05910.x; Gigi E, 2013, J ADDICT MED, V7, P52, DOI 10.1097/ADM.0b013e318279756f; Grady BP, 2013, CLIN INFECT DIS, V57, pS105, DOI 10.1093/cid/cit301; Grebely J, 2010, DRUG ALCOHOL DEPEN, V107, P244, DOI 10.1016/j.drugalcdep.2009.09.015; Grebely J, 2009, J VIRAL HEPATITIS, V16, P352, DOI 10.1111/j.1365-2893.2009.01080.x; Hill WD, 2008, CAN J GASTROENTEROL, V22, P27, DOI 10.1155/2008/369827; Iversen J, 2014, J VIRAL HEPATITIS, V21, P198, DOI 10.1111/jvh.12129; Jack K, 2009, ALIMENT PHARM THER, V29, P38, DOI 10.1111/j.1365-2036.2008.03872.x; Lloyd AR, 2013, CLIN INFECT DIS, V56, P1078, DOI 10.1093/cid/cis1202; Martin NK, 2013, HEPATOLOGY, V58, P1598, DOI 10.1002/hep.26431; Martinez AD, 2012, J VIRAL HEPATITIS, V19, P47, DOI 10.1111/j.1365-2893.2010.01411.x; Mehta SH, 2008, J COMMUN HEALTH, V33, P126, DOI 10.1007/s10900-007-9083-3; Moussalli J, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/261472; Mutimer D, 2014, J HEPATOL, V60, P392, DOI 10.1016/j.jhep.2013.11.003; Myles A, 2011, CAN J GASTROENTEROL, V25, P135, DOI 10.1155/2011/810108; Nazareth S, 2013, J TELEMED TELECARE, V19, P101, DOI 10.1258/jtt.2012.120612; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Robaeys G, 2013, CLIN INFECT DIS, V57, pS129, DOI 10.1093/cid/cit302; Strathdee SA, 2005, CLIN INFECT DIS, V40, pS304, DOI 10.1086/427445; Sublette VA, 2015, PSYCHOL HEALTH, V30, P987, DOI 10.1080/08870446.2015.1012195; Treloar C, 2012, DRUG ALCOHOL REV, V31, P918, DOI 10.1111/j.1465-3362.2012.00468.x; Yehia BR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101554	30	45	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142770	10.1371/journal.pone.0142770	http://dx.doi.org/10.1371/journal.pone.0142770			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562516	Green Published, gold			2022-12-26	WOS:000364480900063
J	Wang, L; Li, QT; Lei, Q; Feng, C; Gao, Y; Zheng, XD; Zhao, Y; Wang, Z; Kong, J				Wang, Lin; Li, Qingtian; Lei, Qiong; Feng, Chao; Gao, Yinan; Zheng, Xiaodong; Zhao, Yu; Wang, Zhi; Kong, Jin			MzPIP2;1: An Aquaporin Involved in Radial Water Movement in Both Water Uptake and Transportation, Altered the Drought and Salt Tolerance of Transgenic Arabidopsis	PLOS ONE			English	Article							PLASMA-MEMBRANE AQUAPORINS; EXPRESSION ANALYSIS; INTRINSIC PROTEINS; HIGHLY DIVERGENT; GENE-EXPRESSION; CHANNEL PROTEIN; JASMONIC ACID; OVEREXPRESSION; SALINITY; STRESS	Background Plants are unavoidably subjected to various abiotic stressors, including high salinity, drought and low temperature, which results in water deficit and even death. Water uptake and transportation play a critical role in response to these stresses. Many aquaporin proteins, localized at different tissues, function in various transmembrane water movements. We targeted at the key aquaporin in charge of both water uptake in roots and radial water transportation from vascular tissues through the whole plant. Results The MzPIP2; 1 gene encoding a plasma membrane intrinsic protein was cloned from salt-tolerant apple rootstock Malus zumi Mats. The GUS gene was driven by MzPIP2; 1 promoter in transgenic Arabidopsis. It indicated that MzPIP2; 1 might function in the epidermal and vascular cells of roots, parenchyma cells around vessels through the stems and vascular tissues of leaves. The ectopically expressed MzPIP2; 1 conferred the transgenic Arabidopsis plants enhanced tolerance to slight salt and drought stresses, but sensitive to moderate salt stress, which was indicated by root length, lateral root number, fresh weight and K+/Na+ ratio. In addition, the possible key cis-elements in response to salt, drought and cold stresses were isolated by the promoter deletion experiment. Conclusion The MzPIP2; 1 protein, as a PIP2 aquaporins subgroup member, involved in radial water movement, controls water absorption and usage efficiency and alters transgenic plants drought and salt tolerance.	[Wang, Lin; Li, Qingtian; Lei, Qiong; Feng, Chao; Gao, Yinan; Zheng, Xiaodong; Zhao, Yu; Kong, Jin] China Agr Univ, Coll Hort Plants, Beijing 100094, Peoples R China; [Wang, Zhi] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China	China Agricultural University; China Agricultural University	Kong, J (corresponding author), China Agr Univ, Coll Hort Plants, Beijing 100094, Peoples R China.	jinkong@cau.edu.cn	Li, Qingtian/AAB-4624-2020	Li, Qingtian/0000-0001-5217-9813	NSFC (National Natural Science Research Foundation of China) [31372034]	NSFC (National Natural Science Research Foundation of China)(National Natural Science Foundation of China (NSFC))	This research was supported by the NSFC (National Natural Science Research Foundation of China) Project No: 31372034.	Aharon R, 2003, PLANT CELL, V15, P439, DOI 10.1105/tpc.009225; Almeida-Rodriguez AM, 2012, AM J BOT, V99, P1249, DOI 10.3732/ajb.1200088; Aroca R, 2001, PLANT PHYSIOL BIOCH, V39, P1067, DOI 10.1016/S0981-9428(01)01335-3; Aroca R, 2007, NEW PHYTOL, V173, P808, DOI 10.1111/j.1469-8137.2006.01961.x; Aroca R, 2012, J EXP BOT, V63, P43, DOI 10.1093/jxb/err266; Augustine SM, 2015, PLANT SCI, V232, P23, DOI 10.1016/j.plantsci.2014.12.012; AZAIZEH H, 1991, PLANT PHYSIOL, V97, P1136, DOI 10.1104/pp.97.3.1136; Barrieu F, 1998, PLANT PHYSIOL, V117, P1153, DOI 10.1104/pp.117.4.1153; Besserer A, 2012, PLANT CELL, V24, P3463, DOI 10.1105/tpc.112.101758; Bienert GP, 2011, PLANT J, V66, P306, DOI 10.1111/j.1365-313X.2011.04496.x; Bonetta D, 1998, TRENDS PLANT SCI, V3, P231, DOI 10.1016/S1360-1385(98)01241-2; Boursiac Y, 2008, PLANT J, V56, P207, DOI 10.1111/j.1365-313X.2008.03594.x; Chaumont F, 2000, PLANT PHYSIOL, V122, P1025, DOI 10.1104/pp.122.4.1025; Chaumont F, 2001, PLANT PHYSIOL, V125, P1206, DOI 10.1104/pp.125.3.1206; Chaumont F, 2014, PLANT PHYSIOL, V164, P1600, DOI 10.1104/pp.113.233791; Choi HI, 2000, J BIOL CHEM, V275, P1723, DOI 10.1074/jbc.275.3.1723; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; CREELMAN RA, 1995, P NATL ACAD SCI USA, V92, P4114, DOI 10.1073/pnas.92.10.4114; Cui XH, 2008, J PLANT RES, V121, P207, DOI 10.1007/s10265-007-0130-z; Dhonukshe P, 2007, CURR BIOL, V17, P520, DOI 10.1016/j.cub.2007.01.052; DIAZDELEON F, 1993, PLANT PHYSIOL, V101, P1117, DOI 10.1104/pp.101.3.1117; Ding X, 2004, PLANT CELL ENVIRON, V27, P177, DOI 10.1046/j.0016-8025.2003.01130.x; DITYATKIN SY, 1972, BIOCHIM BIOPHYS ACTA, V281, P319, DOI 10.1016/0005-2787(72)90444-3; Gomes D, 2009, BBA-BIOMEMBRANES, V1788, P1213, DOI 10.1016/j.bbamem.2009.03.009; He YH, 2001, PLANT MOL BIOL, V47, P595, DOI 10.1023/A:1012211011538; Heinen RB, 2009, J EXP BOT, V60, P2971, DOI 10.1093/jxb/erp171; Ishikawa F, 2005, FEBS LETT, V579, P5814, DOI 10.1016/j.febslet.2005.09.076; Javot H, 2003, PLANT CELL, V15, P509, DOI 10.1105/tpc.008888; Johanson U, 2001, PLANT PHYSIOL, V126, P1358, DOI 10.1104/pp.126.4.1358; KALDENHOFF R, 1995, PLANT J, V7, P87, DOI 10.1046/j.1365-313X.1995.07010087.x; Kaldenhoff R, 1998, PLANT J, V14, P121, DOI 10.1046/j.1365-313X.1998.00111.x; Kaldenhoff R, 2006, BBA-BIOMEMBRANES, V1758, P1134, DOI 10.1016/j.bbamem.2006.03.012; Katsuhara M, 2003, PLANT CELL PHYSIOL, V44, P1378, DOI 10.1093/pcp/pcg167; Laur J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111751; Li GW, 2008, PLANT CELL PHYSIOL, V49, P1851, DOI 10.1093/pcp/pcn166; Li GW, 2008, J PLANT PHYSIOL, V165, P1879, DOI 10.1016/j.jplph.2008.05.002; Li QT, 2013, INT J MOL SCI, V14, P21053, DOI 10.3390/ijms141021053; Li XJ, 2011, PLANT CELL, V23, P3780, DOI 10.1105/tpc.111.091454; Luu DT, 2012, PLANT J, V69, P894, DOI 10.1111/j.1365-313X.2011.04841.x; Maathuis FJM, 1999, ANN BOT-LONDON, V84, P123, DOI 10.1006/anbo.1999.0912; Mahdieh M, 2008, PLANT CELL PHYSIOL, V49, P801, DOI 10.1093/pcp/pcn054; Martinez-Ballesta MD, 2000, AUST J PLANT PHYSIOL, V27, P685, DOI 10.1071/PP99203; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Narusaka Y, 2003, PLANT J, V34, P137, DOI 10.1046/j.1365-313X.2003.01708.x; Peng YH, 2007, PLANTA, V226, P729, DOI 10.1007/s00425-007-0520-4; Perez-Salamo I, 2014, PLANT PHYSIOL, V165, P319, DOI 10.1104/pp.114.237891; Perrone I, 2012, PLANT PHYSIOL, V160, P965, DOI 10.1104/pp.112.203455; Prado K, 2013, PLANT CELL, V25, P1029, DOI 10.1105/tpc.112.108456; Sade N, 2010, PLANT PHYSIOL, V152, P245, DOI 10.1104/pp.109.145854; Shen QX, 1996, PLANT CELL, V8, P1107, DOI 10.1105/tpc.8.7.1107; SHEN QX, 1995, PLANT CELL, V7, P295, DOI 10.1105/tpc.7.3.295; Sun QH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-90; Vera-Estrella R, 2004, PLANT PHYSIOL, V135, P2318, DOI 10.1104/pp.104.044891; Xiang CB, 1996, PLANT MOL BIOL, V32, P415, DOI 10.1007/BF00019093; Yang GY, 2014, MOL BIOL REP, V41, P1279, DOI 10.1007/s11033-013-2973-9; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhu CF, 2005, J EXP BOT, V56, P2971, DOI 10.1093/jxb/eri294; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	58	20	22	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142446	10.1371/journal.pone.0142446	http://dx.doi.org/10.1371/journal.pone.0142446			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562158	Green Submitted, Green Published, gold			2022-12-26	WOS:000364480900033
J	Cai, Y; Kimura, S				Cai, Yan; Kimura, Shioko			Secretoglobin 3A2 Exhibits Anti-Fibrotic Activity in Bleomycin-Induced Pulmonary Fibrosis Model Mice	PLOS ONE			English	Article							SURFACTANT PROTEIN-A; UTEROGLOBIN-RELATED PROTEIN-1; LUNG; MOUSE; GENE; INFLAMMATION; EXPRESSION; MARKER	Objective Secretoglobin (SCGB) 3A2 is a novel lung-enriched cytokine, previously shown to exhibit anti-inflammatory, growth factor, and anti-fibrotic activities. The latter activity was demonstrated using exogenously-administered recombinant SCGB3A2 in the bleomycin (BLM)induced pulmonary fibrosis model. Whether SCGB3A2 exhibits anti-fibrotic activity in vivo is not known. Methods Mice null for the Scgb3a2 gene were subjected to the BLM-induced pulmonary fibrosis model, and the severity of pulmonary fibrosis determined using histological and biochemical methods. Results BLM treatment caused weight loss of both Scgb3a2-null and wild-type mice, however, the loss was far more pronounced in BLM-treated Scgb3a2-null than wild-type mice, and the weight of day 21 of BLM-treated Scgb3a2-null mice was about half of that of BLM-treated wild-type mice. Hematoxylin & Eosin, Masson Trichrome, and Sirius Red staining of lung sections, Ashcroft fibrosis scores, hydroxyproline contents, and the levels of mRNAs encoding various collagens demonstrated that BLM-treated Scgb3a2-null mouse lungs had more severe fibrosis than those of wild-type mouse lungs. Total and differential inflammatory cell numbers in bronchoalveolar lavage fluids, and levels of lung mRNAs including those encoding Th2 cytokines such as IL-4 and profibrotic cytokines such as TGF beta were higher in BLM-treated Scgb3a2-null mouse lungs as compared to those of wild-type mouse lungs. In contrast, mRNAs encoding surfactant proteins A, B, C, and D, and SCGB1A1 did not differ between BLM-treated Scgb3a2-null and wild-type mouse lungs. Conclusion The role of SCGB3A2 in fibrosis was revisited using Scgb3a2-null mice and littermate controls in the BLM-induced pulmonary fibrosis model. The pulmonary fibrosis in the Scgb3a2-null mice was more severe than the wild-type controls, thus establishing that SCGB3A2 has anti-fibrotic activity in vivo. Importantly, surfactant proteins and SCGB1A1 appear not to be involved in the susceptibility of Scgb3a2-null mice to BLM-induced pulmonary fibrosis.	[Cai, Yan; Kimura, Shioko] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kimura, S (corresponding author), NCI, Lab Metab, NIH, Bethesda, MD 20892 USA.	kimuras@mail.nih.gov	Cai, Yan/P-4383-2015		Intramural Research Program of the National Cancer Institute [ZIABC010449]; NATIONAL CANCER INSTITUTE [ZIABC010449] Funding Source: NIH RePORTER	Intramural Research Program of the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding provided by ZIABC010449, Intramural Research Program of the National Cancer Institute, http://www.cancer.gov/, SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano Y, 2001, ARTHRITIS RHEUM-US, V44, P1363, DOI 10.1002/1529-0131(200106)44:6<1363::AID-ART229>3.0.CO;2-5; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Cai Y, 2014, AM J PHYSIOL-LUNG C, V306, pL10, DOI 10.1152/ajplung.00037.2013; Chiba Y, 2006, AM J RESP CRIT CARE, V173, P958, DOI 10.1164/rccm.200503-456OC; Chiba Y, 2005, IMMUNOL LETT, V97, P123, DOI 10.1016/j.imlet.2004.10.013; Chiba Y, 2004, AM J PHYSIOL-LUNG C, V287, pL1193, DOI 10.1152/ajplung.00263.2004; Della Latta V, 2015, PHARMACOL RES, V97, P122, DOI 10.1016/j.phrs.2015.04.012; Fujita M, 2005, CYTOKINE, V31, P25, DOI 10.1016/j.cyto.2005.02.006; Guha A, 2012, P NATL ACAD SCI USA, V109, P12592, DOI 10.1073/pnas.1204710109; Harrod KS, 1998, AM J PHYSIOL-LUNG C, V275, pL924, DOI 10.1152/ajplung.1998.275.5.L924; Hasegawa M, 2011, J RHEUMATOL, V38, P877, DOI 10.3899/jrheum.100591; Jackson Brian C., 2011, Human Genomics, V5, P691; Kido T, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/216465; Kinder BW, 2009, CHEST, V135, P1557, DOI 10.1378/chest.08-2209; Kingma PS, 2006, CURR OPIN PHARMACOL, V6, P277, DOI 10.1016/j.coph.2006.02.003; Klug J, 2000, ANN NY ACAD SCI, V923, P348; Kurotani R, 2008, AM J RESP CRIT CARE, V178, P389, DOI 10.1164/rccm.200707-1104OC; Kurotani R, 2011, J BIOL CHEM, V286, P19682, DOI 10.1074/jbc.M111.239046; Kurotani R, 2011, LUNG CANCER, V71, P42, DOI 10.1016/j.lungcan.2010.04.001; Lawson WE, 2005, AM J PATHOL, V167, P1267, DOI 10.1016/S0002-9440(10)61214-X; Lee YC, 2006, FEBS LETT, V580, P4515, DOI 10.1016/j.febslet.2006.07.031; Liu W, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-101; Luzina I.G., 2014, CYTOKINE; Mandal AK, 2004, J EXP MED, V199, P1317, DOI 10.1084/jem.20031666; MCCORMAC FX, 1995, AM J RESP CRIT CARE, V152, P751, DOI 10.1164/ajrccm.152.2.7633738; Mukherjee AB, 2007, ENDOCR REV, V28, P707, DOI 10.1210/er.2007-0018; Mulugeta S, 2006, MICROBES INFECT, V8, P2317, DOI 10.1016/j.micinf.2006.04.009; Niimi T, 2001, MOL ENDOCRINOL, V15, P2021, DOI 10.1210/me.15.11.2021; Reynolds SD, 2002, AM J RESP CRIT CARE, V166, P1498, DOI 10.1164/rccm.200204-285OC; Saha A, 2010, J BIOL CHEM, V285, P10822, DOI 10.1074/jbc.M109.083550; Tachihara-Yoshikawa Motoko, 2008, Fukushima J Med Sci, V54, P61; Tomita T, 2008, J BIOL CHEM, V283, P25617, DOI 10.1074/jbc.M805140200; Whitsett Jeffrey A, 2005, Biol Neonate, V87, P283, DOI 10.1159/000084875; Yang YP, 2004, J BIOL CHEM, V279, P29336, DOI 10.1074/jbc.C400162200	34	14	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142497	10.1371/journal.pone.0142497	http://dx.doi.org/10.1371/journal.pone.0142497			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559674	gold, Green Published, Green Submitted			2022-12-26	WOS:000364433100086
J	Gupta, J; Pathak, M; Misra, S; Misra-Bhattacharya, S				Gupta, Jyoti; Pathak, Manisha; Misra, Sweta; Misra-Bhattacharya, Shailja			Immunogenicity and Protective Efficacy of Brugia malayi Heavy Chain Myosin as Homologous DNA, Protein and Heterologous DNA/Protein Prime Boost Vaccine in Rodent Model	PLOS ONE			English	Article							IMMUNE-RESPONSES; ONCHOCERCA-VOLVULUS; CLINICAL-TRIALS; HIGH-LEVEL; IMMUNIZATION; INDUCTION; INFECTIONS; EXPRESSION; CHALLENGE; VECTOR	We earlier demonstrated the immunoprophylactic efficacy of recombinant heavy chain myosin (Bm-Myo) of Brugia malayi (B. malayi) in rodent models. In the current study, further attempts have been made to improve this efficacy by employing alternate approaches such as homologous DNA (pcD-Myo) and heterologous DNA/protein prime boost (pcD-Myo+BmMyo) in BALB/c mouse model. The gene bm-myo was cloned in a mammalian expression vector pcDNA 3.1(+) and protein expression was confirmed in mammalian Vero cell line. A significant degree of protection (79.2%+/- 2.32) against L3 challenge in pcD-Myo+Bm-Myo immunized group was observed which was much higher than that exerted by Bm-Myo (66.6%+/- 2.23) and pcD-Myo (41.6%+/- 2.45). In the heterologous immunized group, the percentage of peritoneal leukocytes such as macrophages, neutrophils, B cells and T cells marginally increased and their population augmented further significantly following L3 challenge. pcD-Myo+Bm-Myo immunization elicited robust cellular and humoral immune responses as compared to pcD-Myo and Bm-Myo groups as evidenced by an increased accumulation of CD4+, CD8+T cells and CD19+B cells in the mouse spleen and activation of peritoneal macrophages. Though immunized animals produced antigen-specific IgG antibodies and isotypes, sera of mice receiving pcD-Myo+Bm-Myo or Bm-Myo developed much higher antibody levels than other groups and there was profound antibody-dependent cellular adhesion and cytotoxicity (ADCC) to B. malayi infective larvae (L3). pcD-Myo+Bm-Myo as well as BmMyo mice generated a mixed T helper cell phenotype as evidenced by the production of both pro-inflammatory (IL-2, IFN-gamma) and anti-inflammatory (IL-4, IL-10) cytokines. Mice receiving pcD-Myo on contrary displayed a polarized pro-inflammatory immune response. The findings suggest that the priming of animals with DNA followed by protein booster generates heightened and mixed pro-and anti-inflammatory immune responses that are capable of providing high degree of protection against filarial larval invasion.	[Gupta, Jyoti; Pathak, Manisha; Misra, Sweta; Misra-Bhattacharya, Shailja] CSIR, Cent Drug Res Inst, Div Parasitol, Lucknow 226031, Uttar Pradesh, India; [Gupta, Jyoti; Misra, Sweta; Misra-Bhattacharya, Shailja] Acad Sci & Innovat Res, New Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Academy of Scientific & Innovative Research (AcSIR)	Misra-Bhattacharya, S (corresponding author), CSIR, Cent Drug Res Inst, Div Parasitol, BS 10-1,Sect 10,Sitapur Rd, Lucknow 226031, Uttar Pradesh, India.	shailja_cdri@rediffmail.com			Council of Scientific and Industrial Research (CSIR); Indian Council of Medical Research (ICMR), New Delhi	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research (ICMR), New Delhi(Indian Council of Medical Research (ICMR))	The authors thank the Council of Scientific and Industrial Research (CSIR) and Indian Council of Medical Research (ICMR), New Delhi for financial support in the form of research fellowships to JG, SM and MP and CSIR Network project SPlenDID. The funders have no role in study design, data collection, analysis and decision to publish or preparation of the manuscript.	Anuradha R, 2014, CLIN VACCINE IMMUNOL, V21, P1620, DOI 10.1128/CVI.00598-14; Babayan SA, 2006, INT J PARASITOL, V36, P903, DOI 10.1016/j.ijpara.2006.04.013; Babu S, 2000, INFECT IMMUN, V68, P3034, DOI 10.1128/IAI.68.5.3034-3035.2000; Babu S, 2006, J IMMUNOL, V176, P3885, DOI 10.4049/jimmunol.176.7.3885; Balazs DA, 2011, J DRUG DELIV, V2011, DOI 10.1155/2011/326497; Bennuru S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000410; Bourguinat C, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000072; Cao SN, 2013, ACTA PARASITOL, V58, P619, DOI 10.2478/s11686-013-0183-1; Catmull J, 1999, VACCINE, V17, P31, DOI 10.1016/S0264-410X(98)00147-9; Dakshinamoorthy G, 2013, VACCINE, V31, P1616, DOI 10.1016/j.vaccine.2012.09.055; Dakshinamoorthy G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034077; Darquet AM, 1997, GENE THER, V4, P1341, DOI 10.1038/sj.gt.3300540; Davtyan H, 2010, GENE THER, V17, P261, DOI 10.1038/gt.2009.140; De Filette M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087837; Eberl G, 2000, EUR J IMMUNOL, V30, P985, DOI 10.1002/(SICI)1521-4141(200004)30:4<985::AID-IMMU985>3.0.CO;2-E; Feng GZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061135; Galioto AM, 2006, INFECT IMMUN, V74, P5730, DOI 10.1128/IAI.01958-05; Gil A, 2013, HUM VACC IMMUNOTHER, V9, P2120, DOI 10.4161/hv.25750; Goyal R, 2012, NANOMED-NANOTECHNOL, V8, P167, DOI 10.1016/j.nano.2011.06.001; Harrison RA, 1999, VACCINE, V18, P647, DOI 10.1016/S0264-410X(99)00274-1; Hartikka J, 1996, HUM GENE THER, V7, P1205, DOI 10.1089/hum.1996.7.10-1205; Irvine KR, 1996, J IMMUNOL, V156, P238; Jones S, 2009, VACCINE, V27, P2506, DOI 10.1016/j.vaccine.2009.02.061; Klencke B, 2002, CLIN CANCER RES, V8, P1028; Kushwaha S, 2012, PARASITE IMMUNOL, V34, P199, DOI 10.1111/j.1365-3024.2012.01352.x; Kushwaha S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072585; Kushwaha S, 2012, MICROBES INFECT, V14, P1330, DOI 10.1016/j.micinf.2012.08.006; Law M, 2007, J VIROL, V81, P4272, DOI 10.1128/JVI.02536-06; Li BW, 1999, VACCINE, V18, P76, DOI 10.1016/S0264-410X(99)00182-6; Li L, 2012, J BIOTECHNOL, V162, P171, DOI 10.1016/j.jbiotec.2012.08.012; Li YH, 2010, VACCINE, V28, P5370, DOI 10.1016/j.vaccine.2010.04.067; Liu MA, 2005, ADV GENET, V55, P25, DOI 10.1016/S0065-2660(05)55002-8; Lustigman S, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000076; Madhumathi J, 2010, VACCINE, V28, P5038, DOI 10.1016/j.vaccine.2010.05.012; Mazumder S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014644; Mellstedt H, 1999, Curr Opin Hematol, V6, P169, DOI 10.1097/00062752-199905000-00008; Min J, 2012, VACCINE, V30, P5631, DOI 10.1016/j.vaccine.2012.06.081; Murray J, 2001, MOL BIOCHEM PARASIT, V118, P89, DOI 10.1016/S0166-6851(01)00374-7; Nag JK, 2013, COMP IMMUNOL MICROB, V36, P25, DOI 10.1016/j.cimid.2012.09.004; Nishimura T, 2000, INT IMMUNOL, V12, P987, DOI 10.1093/intimm/12.7.987; Nolan T, 2014, J INFECT DIS, V210, P1800, DOI 10.1093/infdis/jiu359; Obwaller A, 2001, PARASITOL RES, V87, P383, DOI 10.1007/s004360000352; Pertmer TM, 1996, J VIROL, V70, P6119, DOI 10.1128/JVI.70.9.6119-6125.1996; Pokharel DR, 2006, VACCINE, V24, P6208, DOI 10.1016/j.vaccine.2006.05.103; Ramachandran S, 2004, MICROBIOL IMMUNOL, V48, P945, DOI 10.1111/j.1348-0421.2004.tb03624.x; Ramalingam T, 2003, EXP PARASITOL, V105, P131, DOI 10.1016/j.exppara.2003.09.001; Ramalingam T, 2003, INFECT IMMUN, V71, P4361, DOI 10.1128/IAI.71.8.4361-4367.2003; Ramesh M, 2007, PARASITE IMMUNOL, V29, P395, DOI 10.1111/j.1365-3024.2007.00954.x; Ramshaw IA, 2000, IMMUNOL TODAY, V21, P163, DOI 10.1016/S0167-5699(00)01612-1; Sahu BR, 2008, J INFECT DIS, V198, P434, DOI 10.1086/589881; Shrivastava N, 2013, COMP IMMUNOL MICROB, V36, P507, DOI 10.1016/j.cimid.2013.05.003; Simons JE, 2005, EUR J IMMUNOL, V35, P189, DOI 10.1002/eji.200425541; Smith LR, 2010, VACCINE, V28, P2565, DOI 10.1016/j.vaccine.2010.01.029; Thirugnanam S, 2007, EXP PARASITOL, V116, P483, DOI 10.1016/j.exppara.2007.02.017; Vedi S, 2008, VACCINE, V26, P5997, DOI 10.1016/j.vaccine.2008.08.073; Veerapathran A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000457; Verma SK, 2008, PARASITOL RES, V102, P481, DOI 10.1007/s00436-007-0786-2; Wang S, 2008, VACCINE, V26, P1098, DOI 10.1016/j.vaccine.2007.12.024; Wolstenholme AJ, 2004, TRENDS PARASITOL, V20, P469, DOI 10.1016/j.pt.2004.07.010; Yan J, 2009, VACCINE, V27, P431, DOI 10.1016/j.vaccine.2008.10.078; Zheng C, 2006, VACCINE, V24, P4625, DOI 10.1016/j.vaccine.2005.08.046	61	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142548	10.1371/journal.pone.0142548	http://dx.doi.org/10.1371/journal.pone.0142548			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560102	gold, Green Published, Green Submitted			2022-12-26	WOS:000364433100089
J	Kobayashi, M; Kim, SH; Nakamura, H; Kaneda, S; Fujii, T				Kobayashi, Marina; Kim, Soo Hyeon; Nakamura, Hiroko; Kaneda, Shohei; Fujii, Teruo			Cancer Cell Analyses at the Single Cell-Level Using Electroactive Microwell Array Device	PLOS ONE			English	Article							CIRCULATING TUMOR-CELLS; PROSTATE-CANCER; BLOOD; DIELECTROPHORESIS; ACOUSTOPHORESIS; CENTRIFUGATION; ENUMERATION; EXPRESSION; ENRICHMENT; SEPARATION	Circulating tumor cells (CTCs), shed from primary tumors and disseminated into peripheral blood, are playing a major role in metastasis. Even after isolation of CTCs from blood, the target cells are mixed with a population of other cell types. Here, we propose a new method for analyses of cell mixture at the single-cell level using a microfluidic device that contains arrayed electroactive microwells. Dielectrophoretic (DEP) force, induced by the electrodes patterned on the bottom surface of the microwells, allows efficient trapping and stable positioning of single cells for high-throughput biochemical analyses. We demonstrated that various on-chip analyses including immunostaining, viability/apoptosis assay and fluorescent in situ hybridization (FISH) at the single-cell level could be conducted just by applying specific reagents for each assay. Our simple method should greatly help discrimination and analysis of rare cancer cells among a population of blood cells.	[Kobayashi, Marina; Kim, Soo Hyeon; Nakamura, Hiroko; Kaneda, Shohei; Fujii, Teruo] Univ Tokyo, Inst Ind Sci, Tokyo, Japan; [Kaneda, Shohei; Fujii, Teruo] Univ Tokyo, LIMMS CNRS IIS UMI 2820, Tokyo, Japan; [Kobayashi, Marina; Kim, Soo Hyeon; Nakamura, Hiroko; Kaneda, Shohei; Fujii, Teruo] JST CREST, Tokyo, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Fujii, T (corresponding author), Univ Tokyo, Inst Ind Sci, Tokyo, Japan.	tfujii@iis.u-tokyo.ac.jp	Kim, Soo Hyeon/L-8991-2016	Kim, Soo Hyeon/0000-0001-9842-9523	Japan Science and Technology Agency for Core Research for Evolutional Science and Technology (CREST); Strategic International Research Cooperative Program (SICP)	Japan Science and Technology Agency for Core Research for Evolutional Science and Technology (CREST); Strategic International Research Cooperative Program (SICP)	This work was partially supported by the Japan Science and Technology Agency for Core Research for Evolutional Science and Technology (CREST) and for Strategic International Research Cooperative Program (SICP).	Albrecht DR, 2006, NAT METHODS, V3, P369, DOI 10.1038/NMETH873; Antfolk M, 2015, LAB CHIP, V15, P2102, DOI 10.1039/c5lc00078e; Asbury CL, 2002, ELECTROPHORESIS, V23, P2658, DOI 10.1002/1522-2683(200208)23:16<2658::AID-ELPS2658>3.0.CO;2-O; Augustsson P, 2012, ANAL CHEM, V84, P7954, DOI 10.1021/ac301723s; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; Dharmasiri U, 2009, ELECTROPHORESIS, V30, P3289, DOI 10.1002/elps.200900141; El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063; Gascoyne PRC, 2009, ELECTROPHORESIS, V30, P1388, DOI 10.1002/elps.200800373; Huang Y, 2003, BIOMED MICRODEVICES, V5, P217, DOI 10.1023/A:1025760209483; Karabacak NM, 2014, NAT PROTOC, V9, P694, DOI 10.1038/nprot.2014.044; Kim SH, 2014, LAB CHIP, V14, P730, DOI 10.1039/c3lc51086g; Kim SH, 2011, SMALL, V7, P3239, DOI 10.1002/smll.201101028; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Li P, 2015, P NATL ACAD SCI USA, V112, P4970, DOI 10.1073/pnas.1504484112; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Nordin M, 2012, LAB CHIP, V12, P4610, DOI 10.1039/c2lc40629b; Ozkumur E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005616; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Tan SJ, 2009, BIOMED MICRODEVICES, V11, P883, DOI 10.1007/s10544-009-9305-9; WANG DIC, 1968, BIOTECHNOL BIOENG, V10, P641, DOI 10.1002/bit.260100509; Yang J, 2002, CLIN DIAGN LAB IMMUN, V9, P1142, DOI 10.1128/CDLI.9.5.1142-1143.2002; Zhang C, 2010, ANAL BIOANAL CHEM, V396, P401, DOI 10.1007/s00216-009-2922-6	23	21	22	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0139980	10.1371/journal.pone.0139980	http://dx.doi.org/10.1371/journal.pone.0139980			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558904	gold, Green Published, Green Submitted			2022-12-26	WOS:000364433100002
J	Peng, H; Zhuang, YG; Harbeck, MC; He, DH; Xie, LS; Chen, WG				Peng, Hu; Zhuang, Yugang; Harbeck, Mark C.; He, Donghong; Xie, Lishi; Chen, Weiguo			Serine 1179 Phosphorylation of Endothelial Nitric Oxide Synthase Increases Superoxide Generation and Alters Cofactor Regulation	PLOS ONE			English	Article							NADPH OXIDASE; TETRAHYDROBIOPTERIN; CELLS; ENOS; HEAT-SHOCK-PROTEIN-90; INHIBITION; ACTIVATION; PEROXYNITRITE; ISCHEMIA; BINDING	Endothelial nitric oxide synthase (eNOS) is responsible for maintaining systemic blood pressure, vascular remodeling and angiogenesis. In addition to producing NO, eNOS can also generate superoxide (O-2(-center dot)) in the absence of the cofactor tetrahydrobiopterin (BH4). Previous studies have shown that bovine eNOS serine 1179 (Serine 1177/human) phosphorylation critically modulates NO synthesis. However, the effect of serine 1179 phosphorylation on eNOS superoxide generation is unknown. Here, we used the phosphomimetic form of eNOS (S1179D) to determine the effect of S1179 phosphorylation on superoxide generating activity, and its sensitivity to regulation by BH4, Ca2+, and calmodulin (CAM). S1179D eNOS exhibited significantly increased superoxide generating activity and NADPH consumption compared to wild-type eNOS (WT eNOS). The superoxide generating activities of S1179D eNOS and WT eNOS did not differ significantly in their sensitivity to regulation by either Ca2+ or CaM. The sensitivity of the superoxide generating activity of S1179D eNOS to inhibition by BH4 was significantly reduced compared to WT eNOS. In eNOS-overexpressing 293 cells, BH4 depletion with 10mM DAHP for 48 hours followed by 50ng/ml VEGF for 30 min to phosphorylate eNOS S1179 increased ROS accumulation compared to DAHP-only treated cells. Meanwhile, MTT assay indicated that overexpression of eNOS in HEK293 cells decreased cellular viability compared to control cells at BH4 depletion condition (P<0.01). VEGF-mediated Serine 1179 phosphorylation further decreased the cellular viability in eNOS-overexpressing 293 cells (P<0.01). Our data demonstrate that eNOS serine 1179 phosphorylation, in addition to enhancing NO production, also profoundly affects superoxide generation: S1179 phosphorylation increases superoxide production while decreasing sensitivity to the inhibitory effect of BH4 on this activity.	[Peng, Hu; Zhuang, Yugang; Chen, Weiguo] Tongji Univ, Shanghai Peoples Hosp 10, Dept Emergency Med, Shanghai 200092, Peoples R China; [Peng, Hu; Zhuang, Yugang; Harbeck, Mark C.; He, Donghong; Xie, Lishi; Chen, Weiguo] Univ Illinois, Coll Med, Dept Med, Div Pulm Crit Care Sleep & Allergy, Chicago, IL USA	Tongji University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Chen, WG (corresponding author), Tongji Univ, Shanghai Peoples Hosp 10, Dept Emergency Med, Shanghai 200092, Peoples R China.	weiguo@uic.edu	Xie, Lishi/C-2334-2019	Xie, Lishi/0000-0003-2376-6685; Zhuang, Yu-Gang/0000-0002-6304-6765	National Natural Scientific Foundation of China [NSFC-81270133]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Scientific Foundation of China (NSFC-81270133). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; Brennan LA, 2003, CIRC RES, V92, P683, DOI 10.1161/01.RES.0000063424.28903.BB; Das A, 2014, BRIT J PHARMACOL, V171, P2321, DOI 10.1111/bph.12572; Dimmeler S, 2000, FEBS LETT, V477, P258, DOI 10.1016/S0014-5793(00)01657-4; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dumitrescu C, 2007, P NATL ACAD SCI USA, V104, P15081, DOI 10.1073/pnas.0702986104; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Forstermann U, 2012, EUR HEART J, V33, p37a, DOI [10.1093/ eurheartj/ ehr304, DOI 10.1093/EURHEARTJ/EHR304]; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Goligorsky MS, 2002, AM J PHYSIOL-RENAL, V283, pF1, DOI 10.1152/ajprenal.00377.2001; Hu QH, 2002, J BIOL CHEM, V277, P32546, DOI 10.1074/jbc.M201550200; Karuppiah K, 2011, AM J PHYSIOL-HEART C, V301, pH903, DOI 10.1152/ajpheart.00936.2010; Kawashima S, 2001, ARTERIOSCL THROM VAS, V21, P201, DOI 10.1161/01.ATV.21.2.201; Kone BC, 2000, ACTA PHYSIOL SCAND, V168, P27; Kukor Zoltan, 2010, Orvosi Hetilap, V151, P2125, DOI 10.1556/OH.2010.29012; Kuzkaya N, 2003, J BIOL CHEM, V278, P22546, DOI 10.1074/jbc.M302227200; Lane P, 2002, J BIOL CHEM, V277, P19087, DOI 10.1074/jbc.M200258200; Lee MH, 2001, J NEUROCHEM, V78, P32, DOI 10.1046/j.1471-4159.2001.00416.x; Li HG, 2002, CIRCULATION, V106, P2250, DOI 10.1161/01.CIR.0000035650.05921.50; List BM, 1997, BIOCHEM J, V323, P159, DOI 10.1042/bj3230159; Lowe ER, 2005, DRUG METAB DISPOS, V33, P131, DOI 10.1124/dmd.104.001891; Martasek P, 1996, BIOCHEM BIOPH RES CO, V219, P359, DOI 10.1006/bbrc.1996.0238; McCabe TJ, 2000, J BIOL CHEM, V275, P6123, DOI 10.1074/jbc.275.9.6123; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Park JH, 2013, BIOCHEM BIOPH RES CO, V436, P601, DOI 10.1016/j.bbrc.2013.06.003; Song Y, 2002, BIOCHEMISTRY-US, V41, P10616, DOI 10.1021/bi026060u; Song Y, 2001, BIOCHEM J, V355, P357, DOI 10.1042/0264-6021:3550357; VasquezVivar J, 1997, BIOCHEMISTRY-US, V36, P11293, DOI 10.1021/bi971475e; Wei Q, 2005, J BIOL CHEM, V280, P18081, DOI 10.1074/jbc.M413607200; Wu KK, 2002, ANN NY ACAD SCI, V962, P122, DOI 10.1111/j.1749-6632.2002.tb04062.x; Xia Y, 1998, J BIOL CHEM, V273, P25804, DOI 10.1074/jbc.273.40.25804; Xia Y, 1996, P NATL ACAD SCI USA, V93, P6770, DOI 10.1073/pnas.93.13.6770; Xia Y, 1998, J BIOL CHEM, V273, P22635, DOI 10.1074/jbc.273.35.22635	35	4	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142854	10.1371/journal.pone.0142854	http://dx.doi.org/10.1371/journal.pone.0142854			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560496	gold, Green Published, Green Submitted			2022-12-26	WOS:000364433100132
J	Tang, JR; Isa, NAM; Ch'ng, ES				Tang, Jing Rui; Isa, Nor Ashidi Mat; Ch'ng, Ewe Seng			A Fuzzy-C-Means-Clustering Approach: Quantifying Chromatin Pattern of Non-Neoplastic Cervical Squamous Cells	PLOS ONE			English	Article							TEXTURE ANALYSIS; CANCER; SEGMENTATION; CYTOLOGY; NUCLEI	Despite the effectiveness of Pap-smear test in reducing the mortality rate due to cervical cancer, the criteria of the reporting standard of the Pap-smear test are mostly qualitative in nature. This study addresses the issue on how to define the criteria in a more quantitative and definite term. A negative Pap-smear test result, i.e. negative for intraepithelial lesion or malignancy (NILM), is qualitatively defined to have evenly distributed, finely granular chromatin in the nuclei of cervical squamous cells. To quantify this chromatin pattern, this study employed Fuzzy C-Means clustering as the segmentation technique, enabling different degrees of chromatin segmentation to be performed on sample images of non-neoplastic squamous cells. From the simulation results, a model representing the chromatin distribution of non-neoplastic cervical squamous cell is constructed with the following quantitative characteristics: at the best representative sensitivity level 4 based on statistical analysis and human experts' feedbacks, a nucleus of non-neoplastic squamous cell has an average of 67 chromatins with a total area of 10.827 mu m(2); the average distance between the nearest chromatin pair is 0.508 mu m and the average eccentricity of the chromatin is 0.47.	[Tang, Jing Rui; Isa, Nor Ashidi Mat] Univ Sains Malaysia, Sch Elect & Elect Engn, Imaging & Intelligent Syst Res Team ISRT, Nibong Tebal, Pulau Pinang, Malaysia; [Ch'ng, Ewe Seng] Univ Sains Malaysia, Adv Med & Dent Inst, Kepala Batas, Pulau Pinang, Malaysia	Universiti Sains Malaysia; Universiti Sains Malaysia	Isa, NAM (corresponding author), Univ Sains Malaysia, Sch Elect & Elect Engn, Imaging & Intelligent Syst Res Team ISRT, Nibong Tebal, Pulau Pinang, Malaysia.	ashidi@usm.my	Ch'ng, Ewe Seng/F-2630-2010; Isa, Nor Ashidi Mat/I-7826-2017	Ch'ng, Ewe Seng/0000-0001-8831-8678; Isa, Nor Ashidi Mat/0000-0002-2675-4914	National Cancer Council Malaysia (MAKNA), Malaysia; Ministry of Higher Education (MOHE), Malaysia	National Cancer Council Malaysia (MAKNA), Malaysia; Ministry of Higher Education (MOHE), Malaysia	This study was partially supported by National Cancer Council Malaysia (MAKNA), Malaysia, under project entitled "Development of an Intelligent Screening System for Cervical Cancer" (http://makna.org.my/). The fund is received by NAMI. The study was also partially supported by the Ministry of Higher Education (MOHE), Malaysia under MyPhD Scholarship [https://biasiswa.mohe.gov.my/MyBrain15/v2/index_myphd.php]. The fund is received by TJR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partially supported by National Cancer Council Malaysia ( MAKNA), Malaysia, under project entitled " Development of an Intelligent Screening System for Cervical Cancer" and by Ministry of Higher Education ( MOHE), Malaysia under MyPhD Scholarship. Credits are given to Dr. Yasmin Sulaiman, Dr. Soo Peng Yen, Dr. Farisyah Syakirah Mohd Zain and Dr. Hairulhasliza Harun for providing the ThinPrep slides. Sincere thanks to Mr. Mohd Sobriey Zakaria for his assistance on capturing the sample images.	Abulafia O, 2003, GYNECOL ONCOL, V90, P137, DOI 10.1016/S0090-8258(03)00176-8; Albregtsen F., 1995, Computer Analysis of Images and Patterns. 6th International Conference, CAIP'95. Proceedings, P496; Beil M, 1995, COMPUT METH PROG BIO, V48, P211, DOI 10.1016/0169-2607(96)81866-9; Chen YF, 2014, IEEE J BIOMED HEALTH, V18, P94, DOI 10.1109/JBHI.2013.2250984; Cibas E.S., 2019, CYTOLOGY DIAGNOSTIC; Denton KJ, 2008, CYTOPATHOLOGY, V19, P137, DOI 10.1111/j.1365-2303.2008.00585.x; Dey P, 2010, DIAGN CYTOPATHOL, V38, P382, DOI 10.1002/dc.21234; Drezek R, 2003, J BIOMED OPT, V8, P7, DOI 10.1117/1.1528950; Fischer AH, 2010, J CELL BIOCHEM, V110, P795, DOI 10.1002/jcb.22585; Franco EL, 2006, VACCINE, V24, P171, DOI 10.1016/j.vaccine.2006.05.061; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; Jingu R, 2011, ACTA CYTOL, V55, P455, DOI 10.1159/000330672; Koss L. G., 2005, KOSS DIAGNOSTIC CYTO; MADACHY RJ, 1988, PROCEEDINGS OF THE ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, PTS 1-4, P372, DOI 10.1109/IEMBS.1988.94564; McKee GT, 2004, ATLAS GYNECOLOGIC CY; Mehnert AJH, 2003, IMAGE ANAL STUDY CHR; Murata S, 2002, CYTOMETRY, V49, P91, DOI 10.1002/cyto.10162; Nayar R., 2015, BETHESDA SYSTEM REPO, V3rd; Nemec E, 2002, HISTOLOGY HISTOPATHO, V17; Qiu CY, 2014, PATTERN RECOGN LETT, V38, P86, DOI 10.1016/j.patrec.2013.11.011; Reyes M, 2014, CERVICAL CANC BIOPSY, P364; ROWINSKI J, 1972, HISTOCHEMISTRY, V32, P75; Sankaranarayanan R, 2001, B WORLD HEALTH ORGAN, V79, P954; Sherris J, 2001, WESTERN J MED, V175, P231, DOI 10.1136/ewjm.175.4.231; Silva TM, 2015, EXPERT SYST APPL, V42, P6315, DOI 10.1016/j.eswa.2015.04.032; SMEULDERS AWM, 1979, J HISTOCHEM CYTOCHEM, V27, P199, DOI 10.1177/27.1.374575; Smeulders AWM, 1978, ACTA HISTOCHEMICA S, V20, P217; Venkatesh S, 2015, NAT REV MOL CELL BIO, V16, P178, DOI 10.1038/nrm3941; Walker RF, 1996, STAT GEOMETRIC FEATU, P790; Watanabe S, 2004, ACTA CYTOL, V48, P505, DOI 10.1159/000326412; Witoszynskyj S, 2009, MED IMAGE ANAL, V13, P257, DOI 10.1016/j.media.2008.10.004; Yin Z, 2015, MED IMAGE ANAL; YOUNG IT, 1986, CYTOMETRY, V7, P467, DOI 10.1002/cyto.990070513; Yu ZD, 2010, PATTERN RECOGN, V43, P1889, DOI 10.1016/j.patcog.2009.11.015	34	6	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142830	10.1371/journal.pone.0142830	http://dx.doi.org/10.1371/journal.pone.0142830			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560331	Green Submitted, Green Published, gold			2022-12-26	WOS:000364433100131
J	Almuhayawi, M; Altun, O; Abdulmajeed, AD; Ullberg, M; Ozenci, V				Almuhayawi, Mohammed; Altun, Osman; Abdulmajeed, Adam Dilshad; Ullberg, Mans; Ozenci, Volkan			The Performance of the Four Anaerobic Blood Culture Bottles BacT/ALERT-FN, -FN Plus, BACTEC-Plus and -Lytic in Detection of Anaerobic Bacteria and Identification by Direct MALDI-TOF MS	PLoS One			English	Article							FLIGHT MASS-SPECTROMETRY; DESORPTION-IONIZATION-TIME; CLINICAL-SIGNIFICANCE; RAPID IDENTIFICATION; STREAM INFECTIONS; CANCER-PATIENTS; FA PLUS; MICROORGANISMS; MULTICENTER; BACTEROIDES	Detection and identification of anaerobic bacteria in blood cultures (BC) is a well-recognized challenge in clinical microbiology. We studied 100 clinical anaerobic BC isolates to evaluate the performance of BacT/ALERT-FN, -FN Plus (BioMerieux), BACTEC-Plus and -Lytic (Becton Dickinson BioSciences) BC bottles in detection and time to detection (TTD) of anaerobic bacteria. BACTEC Lytic had higher detection rate (94/100, 94%) than Bad/ALERT FN Plus (80/100, 80%) (p<0.01) in the studied material. There was no significant difference in detection of anaerobic bacteria among the remaining bottle types. The 67 anaerobic bacteria that signalled positive in all four bottle types were analyzed to compare the time to detection (TTD) and isolates were directly identified by MALDI-TOF MS. There was a significant difference in TTD among the four bottle types (p<0.0001). The shortest median TTD was 18 h in BACTEC Lytic followed by BacT/ALERT FN (23.5 h), BACTEC Plus (27 h) and finally BacT/ALERT FN Plus (38 h) bottles. In contrast, MALDI-TOF MS performed similarly in all bottle types with accurate identification in 51/67 (76%) BacT/ALERT FN, 51/67 (76%) BacT/ALERT FN Plus, 53/67 (79%) BACTEC Plus and 50/67 (75%) BACTEC Lytic bottles. In conclusion, BACTEC Lytic bottles have significantly better detection rates and shorter TTD compared to the three other bottle types. The anaerobic BC bottles are equally suitable for direct MALDI-TOF MS for rapid and reliable identification of common anaerobic bacteria. Further clinical studies are warranted to investigate the performance of anaerobic BC bottles in detection of anaerobic bacteria and identification by direct MALDI-TOF MS.	[Almuhayawi, Mohammed; Altun, Osman; Abdulmajeed, Adam Dilshad; Ullberg, Mans; Ozenci, Volkan] Karolinska Inst, Div Clin Microbiol F 72, Karolinska Univ Hosp, SE-14186 Stockholm, Sweden; [Almuhayawi, Mohammed] King Abdulaziz Univ, Dept Microbiol, Jeddah 21413, Saudi Arabia	Karolinska Institutet; Karolinska University Hospital; King Abdulaziz University	Ozenci, V (corresponding author), Karolinska Inst, Div Clin Microbiol F 72, Karolinska Univ Hosp, SE-14186 Stockholm, Sweden.	volkan.ozenci@karolinska.se	Özenci, Volkan/H-3116-2019; Almuhayawi, Mohammed/AAY-1778-2020	Özenci, Volkan/0000-0002-8069-4027; Almuhayawi, Mohammed/0000-0002-4792-066X				Angeletti S, 2015, NEW MICROBIOL, V38, P379; Awadel-Kariem FM, 2010, ANAEROBE, V16, P223, DOI 10.1016/j.anaerobe.2010.01.001; Brook I, 2010, ANAEROBE, V16, P183, DOI 10.1016/j.anaerobe.2009.12.001; Chen JHK, 2013, J CLIN MICROBIOL, V51, P1733, DOI 10.1128/JCM.03259-12; Christner M, 2010, J CLIN MICROBIOL, V48, P1584, DOI 10.1128/JCM.01831-09; Coltella L, 2013, EUR J CLIN MICROBIOL, V32, P1183, DOI 10.1007/s10096-013-1865-1; Farina C, 2015, NEW MICROBIOL, V38, P245; Fenner L, 2007, EMERG INFECT DIS, V13, P1260, DOI 10.3201/eid1308.060662; Fiori B, 2014, J CLIN MICROBIOL, V52, P3558, DOI 10.1128/JCM.01171-14; Goldstein EJC, 1996, CLIN INFECT DIS, V23, pS97, DOI 10.1093/clinids/23.Supplement_1.S97; Grohs P, 2007, J CLIN MICROBIOL, V45, P2711, DOI 10.1128/JCM.00059-07; Kirn TJ, 2014, J CLIN MICROBIOL, V52, P839, DOI 10.1128/JCM.03063-13; Lee DH, 2013, J CLIN MICROBIOL, V51, P4150, DOI 10.1128/JCM.01935-13; Leli C, 2013, INT J MED MICROBIOL, V303, P205, DOI 10.1016/j.ijmm.2013.03.002; Mirrett S, 2003, J CLIN MICROBIOL, V41, P2391, DOI 10.1128/JCM.41.6.2391-2394.2003; Moussaoui W, 2010, CLIN MICROBIOL INFEC, V16, P1631, DOI 10.1111/j.1469-0691.2010.03356.x; Nagy E, 2009, CLIN MICROBIOL INFEC, V15, P796, DOI 10.1111/j.1469-0691.2009.02788.x; Nagy E, 2014, FUTURE MICROBIOL, V9, P217, DOI 10.2217/fmb.13.150; Nguyen MH, 2000, CLIN INFECT DIS, V30, P870, DOI 10.1086/313805; NORIEGA LM, 1993, SUPPORT CARE CANCER, V1, P250, DOI 10.1007/BF00366044; PERAINO VA, 1993, CLIN INFECT DIS, V16, pS288, DOI 10.1093/clinids/16.Supplement_4.S288; ROHNER P, 1995, J CLIN MICROBIOL, V33, P313, DOI 10.1128/JCM.33.2.313-317.1995; Romero-Gomez MP, 2011, J INFECTION, V62, P251, DOI 10.1016/j.jinf.2010.12.008; Spanu T, 2012, J CLIN MICROBIOL, V50, P176, DOI 10.1128/JCM.05742-11; Stefani Stefania, 2009, Int J Antimicrob Agents, V34 Suppl 4, pS9, DOI 10.1016/S0924-8579(09)70558-8; Veloo AC, 2014, CLIN MICROBIOL INFEC; Wieser A, 2012, APPL MICROBIOL BIOT, V93, P965, DOI 10.1007/s00253-011-3783-4; WILSON ML, 1992, J CLIN MICROBIOL, V30, P63, DOI 10.1128/JCM.30.1.63-66.1992; Wuppenhorst N, 2012, EUR J CLIN MICROBIOL, V31, P2843, DOI 10.1007/s10096-012-1638-2; Zahar JR, 2005, CLIN MICROBIOL INFEC, V11, P724, DOI 10.1111/j.1469-0691.2005.01214.x	30	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142398	10.1371/journal.pone.0142398	http://dx.doi.org/10.1371/journal.pone.0142398			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554930	gold, Green Published, Green Submitted			2022-12-26	WOS:000364430700098
J	FitzGerald, JA; Allen, E; Wall, DM; Jackson, SA; Murphy, JD; Dobson, ADW				FitzGerald, Jamie A.; Allen, Eoin; Wall, David M.; Jackson, Stephen A.; Murphy, Jerry D.; Dobson, Alan D. W.			Methanosarcina Play an Important Role in Anaerobic Co-Digestion of the Seaweed Ulva lactuca: Taxonomy and Predicted Metabolism of Functional Microbial Communities	PLOS ONE			English	Article							METHANOGENIC POPULATION-DYNAMICS; RNA GENE DATABASE; SP-NOV.; FATTY-ACIDS; BACTERIAL; DIVERSITY; INHIBITION; SEQUENCES; ARCHAEAL; NICKEL	Macro-algae represent an ideal resource of third generation biofuels, but their use necessitates a refinement of commonly used anaerobic digestion processes. In a previous study, contrasting mixes of dairy slurry and the macro-alga Ulva lactuca were anaerobically digested in mesophilic continuously stirred tank reactors for 40 weeks. Higher proportions of U. lactuca in the feedstock led to inhibited digestion and rapid accumulation of volatile fatty acids, requiring a reduced organic loading rate. In this study, 16S pyrosequencing was employed to characterise the microbial communities of both the weakest (R1) and strongest (R6) performing reactors from the previous work as they developed over a 39 and 27-week period respectively. Comparing the reactor communities revealed clear differences in taxonomy, predicted metabolic orientation and mechanisms of inhibition, while constrained canonical analysis (CCA) showed ammonia and biogas yield to be the strongest factors differentiating the two reactor communities. Significant biomarker taxa and predicted metabolic activities were identified for viable and failing anaerobic digestion of U. lactuca. Acetoclastic methanogens were inhibited early in R1 operation, followed by a gradual decline of hydrogenotrophic methanogens. Near-total loss of methanogens led to an accumulation of acetic acid that reduced performance of R1, while a slow decline in biogas yield in R6 could be attributed to inhibition of acetogenic rather than methanogenic activity. The improved performance of R6 is likely to have been as a result of the large Methanosarcina population, which enabled rapid removal of acetic acid, providing favourable conditions for substrate degradation.	[FitzGerald, Jamie A.; Allen, Eoin; Wall, David M.; Jackson, Stephen A.; Murphy, Jerry D.; Dobson, Alan D. W.] Natl Univ Ireland Univ Coll Cork, Environm Res Inst, Cork, Ireland; [FitzGerald, Jamie A.; Jackson, Stephen A.; Dobson, Alan D. W.] Natl Univ Ireland Univ Coll Cork, Sch Microbiol, Cork, Ireland; [Allen, Eoin; Wall, David M.; Murphy, Jerry D.] Natl Univ Ireland Univ Coll Cork, Sch Engn, Cork, Ireland; [FitzGerald, Jamie A.; Allen, Eoin; Wall, David M.; Murphy, Jerry D.] Natl Univ Ireland Univ Coll Cork, Sci Fdn Ireland, MaREI Ctr, Cork, Ireland	University College Cork; University College Cork; University College Cork; University College Cork	Murphy, JD (corresponding author), Natl Univ Ireland Univ Coll Cork, Environm Res Inst, Lee Rd, Cork, Ireland.	jerry.murphy@ucc.ie; a.dobson@ucc.ie	Murphy, Jerry D/ABH-3038-2020; Dobson, Alan D W/M-7844-2017; Jackson, Stephen/J-4368-2019	Murphy, Jerry D/0000-0003-2120-1357; Dobson, Alan D W/0000-0002-7713-5574; Jackson, Stephen/0000-0001-7869-9032; Wall, David/0000-0001-5802-2884; FitzGerald, Jamie A/0000-0003-1060-816X	Science Foundation Ireland (SFI) [11/RFP.1/ENM/3213, 12/RC/2302]; Teagasc through a Walsh Fellowship; Beaufort Marine Research Award, part of the Sea Change Strategy; Strategy for Science Technology and Innovation; Marine Institute under the Marine Research Sub-Programme of the National Development Plan	Science Foundation Ireland (SFI)(Science Foundation Ireland); Teagasc through a Walsh Fellowship; Beaufort Marine Research Award, part of the Sea Change Strategy; Strategy for Science Technology and Innovation; Marine Institute under the Marine Research Sub-Programme of the National Development Plan	The work was supported by Science Foundation Ireland (SFI) under Grant Numbers 11/RFP.1/ENM/3213 and (12/RC/2302), and by Teagasc through a Walsh Fellowship and support by the Beaufort Marine Research Award, part of the Sea Change Strategy and the Strategy for Science Technology and Innovation (2006-2012), with the support of The Marine Institute under the Marine Research Sub-Programme of the National Development Plan 2007-2013. Although the funding bodies provided support in the form of salaries for authors JAF, EA, DMW and JDM, they did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358; Allen E, 2013, WASTE MANAGE, V33, P2425, DOI 10.1016/j.wasman.2013.06.017; Allen E, 2014, BIORESOURCE TECHNOL, V170, P436, DOI 10.1016/j.biortech.2014.08.005; Baena S, 2000, INT J SYST EVOL MICR, V50, P259, DOI 10.1099/00207713-50-1-259; Baena S, 1998, ANAEROBE, V4, P241, DOI 10.1006/anae.1998.0170; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Blankenberg D, 2001, CURRENT PROTOCOLS IN; Bragg L, 2012, NAT METHODS, V9, P425, DOI 10.1038/nmeth.1990; Briand X, 1997, J APPL PHYCOL, V9, P511; Briones A, 2003, CURR OPIN BIOTECH, V14, P270, DOI 10.1016/S0958-1669(03)00065-X; Calli B, 2005, ENZYME MICROB TECH, V37, P448, DOI 10.1016/j.enzmictec.2005.03.013; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Carballa M, 2015, CURR OPIN BIOTECH, V33, P103, DOI 10.1016/j.copbio.2015.01.008; Chen SY, 2005, INT J SYST EVOL MICR, V55, P2257, DOI 10.1099/ijs.0.63807-0; Chen Y, 2008, BIORESOURCE TECHNOL, V99, P4044, DOI 10.1016/j.biortech.2007.01.057; Chumpitazi BP, 2015, ALIMENT PHARM THER, V42, P418, DOI 10.1111/apt.13286; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Conklin A, 2006, WATER ENVIRON RES, V78, P486, DOI 10.2175/106143006X95393; Dave A, 2013, BIORESOURCE TECHNOL, V135, P120, DOI 10.1016/j.biortech.2013.01.005; De Vrieze J, 2012, BIORESOURCE TECHNOL, V112, P1, DOI 10.1016/j.biortech.2012.02.079; Delbes C, 2000, ENVIRON MICROBIOL, V2, P506, DOI 10.1046/j.1462-2920.2000.00132.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dridi B, 2012, INT J SYST EVOL MICR, V62, P1902, DOI 10.1099/ijs.0.033712-0; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; FEIJOO G, 1995, ENZYME MICROB TECH, V17, P180, DOI 10.1016/0141-0229(94)00011-F; Fernandez A, 1999, APPL ENVIRON MICROB, V65, P3697; Fotidis IA, 2013, FEMS MICROBIOL ECOL, V83, P38, DOI 10.1111/j.1574-6941.2012.01456.x; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gonzalez-Gil G, 1999, APPL ENVIRON MICROB, V65, P1789; Gottschalk G, 2001, BBA-BIOENERGETICS, V1505, P28, DOI 10.1016/S0005-2728(00)00274-7; Grabowski A, 2005, INT J SYST EVOL MICR, V55, P1113, DOI 10.1099/ijs.0.63426-0; Green SJ, 2015, PLOS ONE, V10; Griffin ME, 1998, BIOTECHNOL BIOENG, V57, P342, DOI 10.1002/(SICI)1097-0290(19980205)57:3<342::AID-BIT11>3.0.CO;2-I; Hinks J, 2013, BIORESOURCE TECHNOL, V143, P221, DOI 10.1016/j.biortech.2013.05.124; Hori T, 2006, APPL ENVIRON MICROB, V72, P1623, DOI 10.1128/AEM.72.2.1623-1630.2006; HUSER BA, 1982, ARCH MICROBIOL, V132, P1, DOI 10.1007/BF00690808; Jimenez DJ, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-92; Jumas-Bilak E, 2014, THE PROKARYTOES OTHE; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Karatan E, 2013, BIOTECHNOL LETT, V35, P1715, DOI 10.1007/s10529-013-1286-3; Koch C, 2014, CURR OPIN BIOTECH, V27, P65, DOI 10.1016/j.copbio.2013.11.006; Krober M, 2009, J BIOTECHNOL, V142, P38, DOI 10.1016/j.jbiotec.2009.02.010; Lee KCY, 2014, THE PROKARYOTES OTHE; Lee SH, 2013, BIORESOURCE TECHNOL, V145, P25, DOI 10.1016/j.biortech.2013.02.070; Li A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-3; Loudon AH, 2014, ISME J, V8, P830, DOI 10.1038/ismej.2013.200; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Martini M, 2014, THE PROKARYTOES FIRM; MCCARTY PL, 1961, J WATER POLLUT CON F, V33, P399; MCCARTY PL, 1961, J WATER POLLUT CON F, V33, P223; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mhuantong W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128043; Morand P, 2005, J COASTAL RES, V21, P1009, DOI 10.2112/04-700A.1; MURRAY WD, 1981, APPL ENVIRON MICROB, V42, P502, DOI 10.1128/AEM.42.3.502-505.1981; Nelson MC, 2012, BIORESOURCE TECHNOL, V107, P135, DOI 10.1016/j.biortech.2011.12.070; Nordmann W., 1977, KA INFORMATIONEN FUR, V3; Nyonyo T, 2014, FEMS MICROBIOL ECOL, V88, P528, DOI 10.1111/1574-6941.12318; Ohkuma M, 1999, FEMS MICROBIOL LETT, V171, P147, DOI 10.1111/j.1574-6968.1999.tb13425.x; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Oren A., 2014, THE PROKARYOTES OTHE, P1028; Pelmenschikov V, 2002, J AM CHEM SOC, V124, P4039, DOI 10.1021/ja011664r; PERCIVAL E, 1979, BRIT PHYCOL J, V14, P103, DOI 10.1080/00071617900650121; Pope PB, 2013, 3 BIOTECH, V3, P407, DOI 10.1007/s13205-012-0097-x; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pullammanappallil PC, 2001, BIORESOURCE TECHNOL, V78, P165, DOI 10.1016/S0960-8524(00)00187-5; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2021, R LANGUAGE ENV STAT; RINZEMA A, 1994, WATER ENVIRON RES, V66, P40, DOI 10.2175/WER.66.1.7; Rodriguez C, FUEL PROCESS TECHNOL; ROMESSER JA, 1979, ARCH MICROBIOL, V121, P147, DOI 10.1007/BF00689979; Santana RH, 2015, MICROB ECOL, V70, P545, DOI 10.1007/s00248-015-0581-z; Schluter A, 2008, J BIOTECHNOL, V136, P77, DOI 10.1016/j.jbiotec.2008.05.008; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Seppala M, 2013, FUEL, V107, P209, DOI 10.1016/j.fuel.2012.12.069; Solli L, 2014, BIOTECHNOL BIOFUELS, V14, DOI 10.1186/s13068-014-0146-2; SPROTT GD, 1986, SYST APPL MICROBIOL, V7, P358; SPROTT GD, 1984, J BIOL CHEM, V259, P2602; St-Pierre B, 2014, APPL MICROBIOL BIOT, V98, P2709, DOI 10.1007/s00253-013-5220-3; Sundberg C, 2013, FEMS MICROBIOL ECOL, V85, P612, DOI 10.1111/1574-6941.12148; Tauch A, 2014, THE PROKARYOTES ACTI; Teixiera LM, 2014, THE PROKARYTOES GAMM; Thauer RK, 2010, ANNU REV BIOCHEM, V79, P507, DOI 10.1146/annurev.biochem.030508.152103; Vanegas CH, 2013, ENVIRON TECHNOL, V34, P2277, DOI 10.1080/09593330.2013.765922; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Werner JJ, 2011, P NATL ACAD SCI USA, V108, P4158, DOI 10.1073/pnas.1015676108; Whitford M F, 2001, BMC Microbiol, V1, P5, DOI 10.1186/1471-2180-1-5; Wijekoon KC, 2011, BIORESOURCE TECHNOL, V102, P5353, DOI 10.1016/j.biortech.2010.12.081; Wilkins D, 2015, APPL ENVIRON MICROB, V81, P604, DOI 10.1128/AEM.02566-14; Williams J, 2013, BIORESOURCE TECHNOL, V140, P234, DOI 10.1016/j.biortech.2013.04.089; Wirth R, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0243-x; Wong KH, 2000, FOOD CHEM, V71, P475, DOI 10.1016/S0308-8146(00)00175-8; Yamada T, 2006, INT J SYST EVOL MICR, V56, P1331, DOI 10.1099/ijs.0.64169-0; Yenigun O, 2013, PROCESS BIOCHEM, V48, P901, DOI 10.1016/j.procbio.2013.04.012; Zandvoort MH, 2006, ENG LIFE SCI, V6, P293, DOI 10.1002/elsc.200620129; Zhang JX, 2015, BIORESOURCE TECHNOL, V179, P43, DOI 10.1016/j.biortech.2014.11.102	98	25	25	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142603	10.1371/journal.pone.0142603	http://dx.doi.org/10.1371/journal.pone.0142603			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555136	gold, Green Submitted, Green Published			2022-12-26	WOS:000364430700140
J	Notch, EG; Goodale, BC; Barnaby, R; Coutermarsh, B; Berwin, B; Taylor, VF; Jackson, BP; Stanton, BA				Notch, Emily G.; Goodale, Britton C.; Barnaby, Roxanna; Coutermarsh, Bonita; Berwin, Brent; Taylor, Vivien F.; Jackson, Brian P.; Stanton, Bruce A.			Monomethylarsonous Acid (MMA(III)) Has an Adverse Effect on the Innate Immune Response of Human Bronchial Epithelial Cells to Pseudomonas aeruginosa	PLOS ONE			English	Article							UTERO ARSENIC EXPOSURE; IN-UTERO; DRINKING-WATER; KAPPA-B; TRIVALENT; RICE; METABOLISM; EXPRESSION; INFECTION; TOXICITY	Arsenic is the number one contaminant of concern with regard to human health according to the World Health Organization. Epidemiological studies on Asian and South American populations have linked arsenic exposure with an increased incidence of lung disease, including pneumonia, and chronic obstructive pulmonary disease, both of which are associated with bacterial infection. However, little is known about the effects of low dose arsenic exposure, or the contributions of organic arsenic to the innate immune response to bacterial infection. This study examined the effects on Pseudomonas aeruginosa (P. aeruginosa) induced cytokine secretion by human bronchial epithelial cells (HBEC) by inorganic sodium arsenite (iAs(III)) and two major metabolites, monomethylarsonous acid (MMA(III)) and dimethylarsenic acid (DMA(v)), at concentrations relevant to the U.S. population. Neither iAs(III) nor DMAv altered P. aeruginosa induced cytokine secretion. By contrast, MMAIII increased P. aeruginosa induced secretion of IL-8, IL-6 and CXCL2. A combination of iAs(III), MMAIII and DMAv (10 pbb total) reduced IL-8 and CXCL1 secretion. These data demonstrate for the first time that exposure to MMAIII alone, and a combination of iAs(III), MMAIII and DMAv at levels relevant to the U.S. may have negative effects on the innate immune response of human bronchial epithelial cells to P. aeruginosa.	[Notch, Emily G.; Goodale, Britton C.; Barnaby, Roxanna; Coutermarsh, Bonita; Berwin, Brent; Stanton, Bruce A.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Ctr Environm Hlth Sci, Hanover, NH 03755 USA; [Notch, Emily G.] Western New England Univ, Dept Phys & Biol Sci, Springfield, MA USA; [Taylor, Vivien F.; Jackson, Brian P.] Dartmouth Coll, Dept Earth Sci, Hanover, NH 03755 USA	Dartmouth College; Western New England University; Dartmouth College	Notch, EG (corresponding author), Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Ctr Environm Hlth Sci, Hanover, NH 03755 USA.	emily.notch@wne.edu		Berwin, Brent/0000-0001-9196-3256	National Institute of Environmental Health Sciences [P42 ES007373];  [R01 HL074175]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES007373] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding: This work was supported by grant P42 ES007373 from the National Institute of Environmental Health Sciences (http://www.niehs.nih.gov/) [B.A.S.; Superfund Research Program (SRP) Project 3]. E.G.N. was supported by a postdoctoral fellowship from P42 ES007373 (SRP, Training Core), and by grant R01 HL074175 (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.1351; ATSDR, 2007, TOX PROF ARS; Bailey KA, 2014, TOXICOL SCI, V139, P328, DOI 10.1093/toxsci/kfu053; Bomberger JM, 2012, J BIOL CHEM, V287, P17130, DOI 10.1074/jbc.M111.338855; Burke SJ, 2014, AM J PHYSIOL-ENDOC M, V306, pE131, DOI 10.1152/ajpendo.00347.2013; Calatayud M, 2014, TOXICOL LETT, V224, P40, DOI 10.1016/j.toxlet.2013.09.016; Calatayud M, 2015, ARCH TOXICOL, V89, P555, DOI 10.1007/s00204-014-1271-1; Dangleben NL, 2013, ENV HLTH, V12; Dodmane PR, 2013, TOXICOLOGY, V312, P18, DOI 10.1016/j.tox.2013.07.008; Dubin Patricia J, 2007, Expert Rev Respir Med, V1, P121, DOI 10.1586/17476348.1.1.121; Escudero-Lourdes C, 2010, TOXICOL APPL PHARM, V244, P162, DOI 10.1016/j.taap.2009.12.029; Farzan SF, 2013, ENVIRON RES, V126, P24, DOI 10.1016/j.envres.2013.05.001; Fry RC, 2007, PLOS GENET, V3, P2180, DOI 10.1371/journal.pgen.0030207; Gosse JA, 2014, J APPL TOXICOL, V34, P498, DOI 10.1002/jat.2898; Guo L, 2014, TOXICOL APPL PHARM, V277, P21, DOI 10.1016/j.taap.2014.02.020; Hall M, 2007, ENVIRON HEALTH PERSP, V115, P1503, DOI 10.1289/ehp.9906; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Hughes MF, 2002, TOXICOL LETT, V133, P1, DOI 10.1016/S0378-4274(02)00084-X; Hughes MF, 2011, TOXICOL SCI, V123, P305, DOI 10.1093/toxsci/kfr184; Jackson BP, 2012, ENVIRON HEALTH PERSP, V120, P623, DOI 10.1289/ehp.1104619; Jackson BP, 2012, PURE APPL CHEM, V84, P215, DOI 10.1351/PAC-CON-11-09-17; Kozul CD, 2009, ENVIRON HEALTH PERSP, V117, P1441, DOI 10.1289/ehp.0900911; Kube D, 2001, AM J PHYSIOL-LUNG C, V280, pL493, DOI 10.1152/ajplung.2001.280.3.L493; Kurzius-Spencer M, 2013, J EXPOS SCI ENV EPID, V24, P156; LANTZ RC, 1994, ENVIRON RES, V67, P183, DOI 10.1006/enrs.1994.1073; Lavoie EG, 2011, MICROBES INFECT, V13, P1133, DOI 10.1016/j.micinf.2011.07.011; Lieberman David, 2003, Am J Respir Med, V2, P459; Lovewell RR, 2014, AM J PHYSIOL-LUNG C, V306, pL591, DOI 10.1152/ajplung.00335.2013; Mandal BK, 2002, TALANTA, V58, P201, DOI 10.1016/S0039-9140(02)00268-0; Mayer AK, 2007, J IMMUNOL, V178, P3134, DOI 10.4049/jimmunol.178.5.3134; Meharg AA, 2008, J ENVIRON MONITOR, V10, P428, DOI 10.1039/b800981c; MILLAR IT, 1960, INORG SYN, V6, P113, DOI 10.1002/9780470132371.ch36; Moreau-Marquis Sophie, 2010, J Vis Exp, DOI 10.3791/2186; Nadeau KC, 2014, CLIN IMMUNOL, V155, P188, DOI 10.1016/j.clim.2014.09.004; Nayak AS, 2007, TOXICOL SCI, V98, P118, DOI 10.1093/toxsci/kfm072; Nielsen MGL PJ, 2010, 201051992010 US GEOL; Parvez F, 2008, ENVIRON HEALTH PERSP, V116, P190, DOI 10.1289/ehp.9507; Ryu JH, 2010, MOL CELLS, V30, P173, DOI 10.1007/s10059-010-0146-4; Sanders AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031354; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Sherwood CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082970; Smith AH, 2006, ENVIRON HEALTH PERSP, V114, P1293, DOI 10.1289/ehp.8832; Styblo M, 1999, CHEM RES TOXICOL, V12, P560, DOI 10.1021/tx990050l; Styblo M, 2000, ARCH TOXICOL, V74, P289, DOI 10.1007/s002040000134; Welch AH, 1999, ARSENIC EXPOSURE AND HEALTH EFFECTS, P9, DOI 10.1016/B978-008043648-7/50004-2; Williams BJ, 2010, RESPIROLOGY, V15, P1037, DOI 10.1111/j.1440-1843.2010.01819.x; Zhao FJ, 2013, ENVIRON SCI TECHNOL, V47, P3957, DOI 10.1021/es304295n; Zhu YG, 2008, ENVIRON POLLUT, V154, P169, DOI 10.1016/j.envpol.2008.03.015	48	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142392	10.1371/journal.pone.0142392	http://dx.doi.org/10.1371/journal.pone.0142392			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554712	Green Published, Green Submitted, gold			2022-12-26	WOS:000364430700096
J	Sun, HY; Liu, P; Nolan, LK; Lamont, SJ				Sun, Hongyan; Liu, Peng; Nolan, Lisa K.; Lamont, Susan J.			Novel Pathways Revealed in Bursa of Fabricius Transcriptome in Response to Extraintestinal Pathogenic Escherichia coli (ExPEC) Infection	PLOS ONE			English	Article							CELL-ADHESION; MOLECULAR-BASIS; CHICKEN; COLIBACILLOSIS; ACTIVATION; SYK; IMMUNOGLOBULIN; VIRULENCE; RECEPTOR; VIRUS	Extraintestinal pathogenic Escherichia coli (ExPEC) has major negative impacts on human and animal health. Recent research suggests food-borne links between human and animal ExPEC diseases with particular concern for poultry contaminated with avian pathogenic E. coli (APEC), the avian ExPEC. APEC is also a very important animal pathogen, causing colibacillosis, one of the world's most widespread bacterial diseases of poultry. Previous studies showed marked atrophy and lymphocytes depletion in the bursa during APEC infection. Thus, a more comprehensive understanding of the avian bursa response to APEC infection will facilitate genetic selection for disease resistance. Four-week-old commercial male broiler chickens were infected with APEC O1 or given saline as a control. Bursas were collected at 1 and 5 days post-infection (dpi). Based on lesion scores of liver, pericardium and air sacs, infected birds were classified as having mild or severe pathology, representing resistant and susceptible phenotypes, respectively. Twenty-two individual bursa RNA libraries were sequenced, each yielding an average of 27 million single-end, 100-bp reads. There were 2469 novel genes in the total of 16,603 detected. Large numbers of significantly differentially expressed (DE) genes were detected when comparing susceptible and resistant birds at 5 dpi, susceptible and non-infected birds at 5 dpi, and susceptible birds at 5 dpi and 1 dpi. The DE genes were associated with signal transduction, the immune response, cell growth and cell death pathways. These data provide considerable insight into potential mechanisms of resistance to ExPEC infection, thus paving the way to develop strategies for ExPEC prevention and treatment, as well as enhancing innate resistance by genetic selection in animals.	[Sun, Hongyan; Lamont, Susan J.] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA; [Liu, Peng] Iowa State Univ, Dept Stat, Ames, IA 50011 USA; [Nolan, Lisa K.] Iowa State Univ, Dept Vet Microbiol & Prevent Med, Ames, IA 50011 USA	Iowa State University; Iowa State University; Iowa State University	Lamont, SJ (corresponding author), Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA.	sjlamont@iastate.edu			United States Department of Agriculture National Institute of Food and Agriculture [5357]; USDA National Institute of Food and Agriculture [2008-35604-18805]	United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This work was supported by The United States Department of Agriculture National Institute of Food and Agriculture, Hatch Project number 5357 and Grant no. 2008-35604-18805 from the USDA National Institute of Food and Agriculture.	Antao EM, 2008, MICROB PATHOGENESIS, V45, P361, DOI 10.1016/j.micpath.2008.08.005; Baba Y, 2001, P NATL ACAD SCI USA, V98, P2582, DOI 10.1073/pnas.051626198; BARBU V, 1989, NUCLEIC ACIDS RES, V17, P7115, DOI 10.1093/nar/17.17.7115; Bastiani M, 2005, FEMS MICROBIOL LETT, V253, P133, DOI 10.1016/j.femsle.2005.09.024; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergmann A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3145re8; Davani D, 2014, J IMMUNOL, V192, P3207, DOI 10.4049/jimmunol.1302394; Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013; Dziva F, 2008, AVIAN PATHOL, V37, P355, DOI 10.1080/03079450802216652; Ewers C, 2007, INT J MED MICROBIOL, V297, P163, DOI 10.1016/j.ijmm.2007.01.003; Gao QX, 2012, VET MICROBIOL, V160, P395, DOI 10.1016/j.vetmic.2012.06.009; Ge XKZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112048; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; Horn F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041031; Ishiai M, 1999, IMMUNITY, V10, P117, DOI 10.1016/S1074-7613(00)80012-6; Johnson TJ, 2007, J BACTERIOL, V189, P3228, DOI 10.1128/JB.01726-06; Johnson TJ, 2009, FOODBORNE PATHOG DIS, V6, P657, DOI 10.1089/fpd.2009.0266; Kariyawasam S, 2004, AVIAN DIS, V48, P287, DOI 10.1637/7093; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Keshvara LM, 1998, J IMMUNOL, V161, P5276; La Ragione RM, 2002, RES VET SCI, V73, P27, DOI 10.1016/S0034-5288(02)00075-9; Lammers A, 2010, DEV COMP IMMUNOL, V34, P1254, DOI 10.1016/j.dci.2010.07.001; Li HL, 1997, J BIOL CHEM, V272, P18200, DOI 10.1074/jbc.272.29.18200; Luo HL, 2012, BIOMATERIALS, V33, P4277, DOI 10.1016/j.biomaterials.2012.02.042; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Masum MA, 2014, INT J VET SCI MED, V2, P103, DOI 10.1016/j.ijvsm.2014.06.001; Matthijs MGR, 2003, AVIAN PATHOL, V32, P473, DOI 10.1080/0307945031000154062; Matulova M, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-37; Matulova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048101; Nair KS, 2005, J CLIN PATHOL, V58, P343, DOI 10.1136/jcp.2004.018036; NAKAMURA K, 1986, VET PATHOL, V23, P712, DOI 10.1177/030098588602300610; NAKAMURA K, 1985, VET PATHOL, V22, P592, DOI 10.1177/030098588502200614; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Nolan LK., 2020, DIS POULTRY, P770, DOI 10.1002/9781119421481.ch18; Okegawa T, 2002, J UROLOGY, V167, P1836, DOI 10.1016/S0022-5347(05)65245-7; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Pan HP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125868; Peighambari SM, 2000, AVIAN DIS, V44, P759, DOI 10.2307/1593047; Pike KA, 2004, J IMMUNOL, V172, P2210, DOI 10.4049/jimmunol.172.4.2210; REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9; Ricci M. Stacey, 2007, P31; Rodriguez-Siek KE, 2005, VET RES, V36, P241, DOI 10.1051/vetres:2004057; ROSENBERGER JK, 1985, AVIAN DIS, V29, P1108, DOI 10.2307/1590465; Rozen S, 2000, Methods Mol Biol, V132, P365; Salehi TZ, 2012, BRAZ J MICROBIOL, V43, P363, DOI [10.1590/S1517-838220120001000043, 10.1590/S1517-83822012000100043]; Samba-Louaka A, 2008, CELL MICROBIOL, V10, P2496, DOI 10.1111/j.1462-5822.2008.01224.x; Sandford Erin E, 2012, Results Immunol, V2, P44, DOI 10.1016/j.rinim.2012.02.003; Sandford EE, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-469; Sarson AJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-260; Sayegh CE, 1999, EMBO J, V18, P6319, DOI 10.1093/emboj/18.22.6319; Sayegh CE, 2000, IMMUNOL REV, V175, P187, DOI 10.1034/j.1600-065X.2000.017507.x; Shinohara Hisaaki, 2006, Subcell Biochem, V40, P145; Skyberg JA, 2006, INFECT IMMUN, V74, P6287, DOI 10.1128/IAI.00363-06; THOMPSON CB, 1987, CELL, V48, P369, DOI 10.1016/0092-8674(87)90188-7; Tivendale KA, 2010, INFECT IMMUN, V78, P3412, DOI 10.1128/IAI.00347-10; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Weber M, 2008, J EXP MED, V205, P853, DOI 10.1084/jem.20072619; Wei L, 2011, VIROLOGY, V420, P156, DOI 10.1016/j.virol.2011.08.027; Wieland WH, 2004, BIOCHEM J, V380, P669, DOI [10.1042/BJ20040200, 10.1042/bj20040200]; YOKOYAMA H, 1992, INFECT IMMUN, V60, P998, DOI 10.1128/IAI.60.3.998-1007.1992; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14	64	22	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142570	10.1371/journal.pone.0142570	http://dx.doi.org/10.1371/journal.pone.0142570			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556806	Green Published, Green Submitted, gold			2022-12-26	WOS:000364430700133
J	Wilson, CS; Chang, AJ; Greene, R; Machado, S; Parsons, MW; Takats, TA; Zambetti, LJ; Springer, AL				Wilson, Corinne S.; Chang, Alex J.; Greene, Rebecca; Machado, Sulynn; Parsons, Matthew W.; Takats, Taylor A.; Zambetti, Luke J.; Springer, Amy L.			Knockdown of Inner Arm Protein IC138 in Trypanosoma brucei Causes Defective Motility and Flagellar Detachment	PLOS ONE			English	Article							DYNEIN REGULATORY COMPLEX; AFRICAN TRYPANOSOMES; AXONEMAL DYNEIN; PARAFLAGELLAR ROD; I1 DYNEIN; CHLAMYDOMONAS-REINHARDTII; CRYOELECTRON TOMOGRAPHY; CELL MORPHOGENESIS; ATTACHMENT ZONE; TSETSE-FLY	Motility in the protozoan parasite Trypanosoma brucei is conferred by a single flagellum, attached alongside the cell, which moves the cell forward using a beat that is generated from tip-to-base. We are interested in characterizing components that regulate flagellar beating, in this study we extend the characterization of TbIC138, the ortholog of a dynein intermediate chain that regulates axonemal inner arm dynein f/I1. TbIC138 was tagged In situ-and shown to fractionate with the inner arm components of the flagellum. RNAi knockdown of TbIC138 resulted in significantly reduced protein levels, mild growth defect and significant motility defects. These cells tended to cluster, exhibited slow and abnormal motility and some cells had partially or fully detached flagella. Slight but significant increases were observed in the incidence of mis-localized or missing kinetoplasts. To document development of the TbIC138 knockdown phenotype over time, we performed a detailed analysis of flagellar detachment and motility changes over 108 hours following induction of RNAi. Abnormal motility, such as slow twitching or irregular beating, was observed early, and became progressively more severe such that by 72 hours-post-induction, approximately 80% of the cells were immotile. Progressively more cells exhibited flagellar detachment over time, but this phenotype was not as prevalent as immotility, affecting less than 60% of the population. Detached flagella had abnormal beating, but abnormal beating was also observed in cells with no flagellar detachment, suggesting that TbIC138 has a direct, or primary, effect on the flagellar beat, whereas detachment is a secondary phenotype of TbIC138 knockdown. Our results are consistent with the role of TbIC138 as a regulator of motility, and has a phenotype amenable to more extensive structure-function analyses to further elucidate its role in the control of flagellar beat in T. brucei.	[Wilson, Corinne S.; Takats, Taylor A.; Springer, Amy L.] Siena Coll, Dept Biol, Loudonville, NY 12211 USA; [Chang, Alex J.; Machado, Sulynn; Parsons, Matthew W.; Zambetti, Luke J.] Amherst Coll, Dept Biol, Amherst, MA 01002 USA; [Greene, Rebecca] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA	Amherst College; University of Massachusetts System; University of Massachusetts Amherst	Springer, AL (corresponding author), Siena Coll, Dept Biol, Loudonville, NY 12211 USA.	aspringer@siena.edu		Parsons, Matthew/0000-0003-1543-5309	National Institutes of Health AREA Award [7R15AI101941-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI101941] Funding Source: NIH RePORTER	National Institutes of Health AREA Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health AREA Award No 7R15AI101941-02, (http://www.niaid.nih.gov) (ALS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absalon S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000437; Alsford S, 2011, GENOME RES, V21, P915, DOI 10.1101/gr.115089.110; Baker N, 2013, TRENDS PARASITOL, V29, P110, DOI 10.1016/j.pt.2012.12.005; Baron DM, 2007, J CELL SCI, V120, P478, DOI 10.1242/jcs.03352; Bastin P, 1999, MOL CELL BIOL, V19, P8191; Bastin P, 1999, J CELL SCI, V112, P3769; Bastin P, 1998, NATURE, V391, P548, DOI 10.1038/35300; Bayly PV, 2010, CYTOSKELETON, V67, P56, DOI 10.1002/cm.20424; Bower R, 2009, MOL BIOL CELL, V20, P3055, DOI 10.1091/mbc.E09-04-0277; Branche C, 2006, J CELL SCI, V119, P3443, DOI 10.1242/jcs.03078; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; BROKAW CJ, 1987, CELL MOTIL CYTOSKEL, V8, P68, DOI 10.1002/cm.970080110; BRUN R, 1979, ACTA TROP, V36, P289; Brun R, 2012, INFECT DIS CLIN N AM, V26, P261, DOI 10.1016/j.idc.2012.03.003; Bui KH, 2008, J CELL BIOL, V183, P923, DOI 10.1083/jcb.200808050; Chandler J, 2008, EUKARYOT CELL, V7, P2141, DOI 10.1128/EC.00199-08; Cnops J, 2014, PARASITOLOGY, P1, DOI DOI 10.1017/S0031182013001224; Davidge JA, 2006, J CELL SCI, V119, P3935, DOI 10.1242/jcs.03203; Engstler M, 2007, CELL, V131, P505, DOI 10.1016/j.cell.2007.08.046; Gadelha C, 2007, CELL MOTIL CYTOSKEL, V64, P629, DOI 10.1002/cm.20210; Habermacher G, 1997, J CELL BIOL, V136, P167, DOI 10.1083/jcb.136.1.167; Hammarton TC, 2007, CURR OPIN MICROBIOL, V10, P520, DOI 10.1016/j.mib.2007.10.005; Hayes P, 2014, J CELL BIOL, V206, P377, DOI 10.1083/jcb.201312067; Heddergott N, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003023; Hendrickson TW, 2013, BBA-MOL CELL RES, V1833, P3265, DOI 10.1016/j.bbamcr.2013.09.011; Hendrickson TW, 2004, MOL BIOL CELL, V15, P5431, DOI 10.1091/mbc.E04-08-0694; Heuser T, 2012, P NATL ACAD SCI USA, V109, pE2067, DOI 10.1073/pnas.1120690109; Heuser T, 2009, J CELL BIOL, V187, P921, DOI 10.1083/jcb.200908067; Hill KL, 2000, J BIOL CHEM, V275, P39369, DOI 10.1074/jbc.M006907200; Hoog JL, 2012, J STRUCT BIOL, V178, P189, DOI 10.1016/j.jsb.2012.01.009; Hughes LC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0025700; Hutchings NR, 2002, J CELL BIOL, V156, P867, DOI 10.1083/jcb.200201036; Ikeda KN, 2012, J CELL SCI, V125, P3173, DOI 10.1242/jcs.101162; Inaba K, 2007, ANN NY ACAD SCI, V1101, P506, DOI 10.1196/annals.1389.017; Ishikawa T, 2007, J MOL BIOL, V368, P1249, DOI 10.1016/j.jmb.2007.02.072; Kamiya R, 2014, ZOOL SCI, V31, P633, DOI 10.2108/zs140066; King SJ, 1997, J CELL BIOL, V136, P177, DOI 10.1083/jcb.136.1.177; King SM, 2012, J STRUCT BIOL, V179, P222, DOI 10.1016/j.jsb.2012.02.013; Kohl L, 2003, EMBO J, V22, P5336, DOI 10.1093/emboj/cdg518; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; Kotani N, 2007, BIOPHYS J, V93, P886, DOI 10.1529/biophysj.106.101964; Koyfman AY, 2011, P NATL ACAD SCI USA, V108, P11105, DOI 10.1073/pnas.1103634108; LaCount DJ, 2000, MOL BIOCHEM PARASIT, V111, P67, DOI 10.1016/S0166-6851(00)00300-5; LaCount DJ, 2002, J BIOL CHEM, V277, P17580, DOI 10.1074/jbc.M200873200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langousis G, 2014, NAT REV MICROBIOL, V12, P505, DOI 10.1038/nrmicro3274; Matthews KR, 2005, J CELL SCI, V118, P283, DOI 10.1242/jcs.01649; McDonald J.H., 2014, HDB BIOL STAT; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Oberholzer M, 2006, MOL BIOCHEM PARASIT, V145, P117, DOI 10.1016/j.molbiopara.2005.09.002; Oberholzer M, 2009, METHOD CELL BIOL, V93, P21, DOI 10.1016/S0091-679X(08)93002-8; Oda T, 2014, J CELL BIOL, V204, P807, DOI 10.1083/jcb.201312014; Pays E, 2014, NAT REV MICROBIOL, V12, P575, DOI 10.1038/nrmicro3298; PIPERNO G, 1994, J CELL BIOL, V125, P1109, DOI 10.1083/jcb.125.5.1109; Porter ME, 2000, J CELL BIOL, V151, pF37, DOI 10.1083/jcb.151.5.F37; Ralston KS, 2011, EUKARYOT CELL, V10, P884, DOI 10.1128/EC.00298-10; Ralston KS, 2009, ANNU REV MICROBIOL, V63, P335, DOI 10.1146/annurev.micro.091208.073353; Ralston KS, 2006, EUKARYOT CELL, V5, P696, DOI 10.1128/EC.5.4.696-711.2006; Ralston KS, 2006, PLOS PATHOG, P2; ROBINSON D, 1991, METHOD ENZYMOL, V196, P285; Rocha GM, 2006, J STRUCT BIOL, V154, P89, DOI 10.1016/j.jsb.2005.11.008; Rodriguez JA, 2009, P NATL ACAD SCI USA, V106, P19322, DOI 10.1073/pnas.0907001106; Rotureau B, 2014, CELL MICROBIOL, V16, P425, DOI 10.1111/cmi.12230; Rotureau B, 2014, J CELL SCI, V127, P204, DOI 10.1242/jcs.136424; Rotureau B, 2011, CELL MICROBIOL, V13, P705, DOI 10.1111/j.1462-5822.2010.01566.x; Santrich C, 1997, MOL BIOCHEM PARASIT, V90, P95, DOI 10.1016/S0166-6851(97)00149-7; Selvapandiyan A, 2007, MOL BIOL CELL, V18, P3290, DOI 10.1091/mbc.E07-01-0022; SHERWIN T, 1989, PHILOS T R SOC B, V323, P573, DOI 10.1098/rstb.1989.0037; Shimizu Y, 2014, BIOPHYS J, V106, P2157, DOI 10.1016/j.bpj.2014.04.009; Simarro PP, 2013, RES REP TROP MED, V4, P1, DOI 10.2147/RRTM.S40157; Springer AL, 2011, MOL BIOCHEM PARASIT, V175, P68, DOI 10.1016/j.molbiopara.2010.09.005; Stellamanns E, 2014, SCI REP-UK, V4, DOI 10.1038/srep06515; SUMMERS KE, 1971, P NATL ACAD SCI USA, V68, P3092, DOI 10.1073/pnas.68.12.3092; Sun SY, 2013, J CELL SCI, V126, P520, DOI 10.1242/jcs.113621; Sunter JD, 2015, J CELL SCI, V128, P1580, DOI 10.1242/jcs.166447; Sunter JD, 2015, J CELL SCI; Ueno H, 2014, CYTOSKELETON, V71, P412, DOI 10.1002/cm.21180; Uppaluri S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002058; Van den Abbeele J, 1999, PARASITOLOGY, V118, P469, DOI 10.1017/S0031182099004217; VanderWaal KE, 2011, MOL BIOL CELL, V22, P2862, DOI 10.1091/mbc.E11-03-0270; Vaughan S, 2008, PROTIST, V159, P127, DOI 10.1016/j.protis.2007.08.005; VICKERMAN K, 1985, BRIT MED BULL, V41, P105, DOI 10.1093/oxfordjournals.bmb.a072036; VICKERMAN K, 1988, BIOL CELL, V64, P109, DOI 10.1016/0248-4900(88)90070-6; Vincensini L, 2011, BIOL CELL, V103, P109, DOI 10.1042/BC20100104; Viswanadha R, 2014, CYTOSKELETON, V71, P573, DOI 10.1002/cm.21192; Weisse S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037296; Wheeler RJ, 2013, MOL MICROBIOL, V90, P1339, DOI 10.1111/mmi.12436; Wheeler RJ, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-1; Wheeler RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079581; Wickstead B, 2007, TRAFFIC, V8, P1708, DOI 10.1111/j.1600-0854.2007.00646.x; Wirschell M, 2007, CELL MOTIL CYTOSKEL, V64, P569, DOI 10.1002/cm.20211; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Yamamoto R, 2013, J CELL BIOL, V201, P263, DOI 10.1083/jcb.201211048; Zhou Q, 2011, J CELL SCI, V124, P3848, DOI 10.1242/jcs.087676; Zukas R, 2012, BIOCELL, V36, P133	96	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0139579	10.1371/journal.pone.0139579	http://dx.doi.org/10.1371/journal.pone.0139579			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555902	gold, Green Published, Green Submitted			2022-12-26	WOS:000364430700007
J	Realini, N; Palese, F; Pizzirani, D; Pontis, S; Basit, A; Bach, A; Ganesan, A; Piomelli, D				Realini, Natalia; Palese, Francesca; Pizzirani, Daniela; Pontis, Silvia; Basit, Abdul; Bach, Anders; Ganesan, Anand; Piomelli, Daniele			Acid Ceramidase in Melanoma EXPRESSION, LOCALIZATION, AND EFFECTS OF PHARMACOLOGICAL INHIBITION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER; TUMOR-GROWTH; SYNTHASE ACTIVITY; COLON-CANCER; CELLS; THERAPY; SPHINGOLIPIDS; RESISTANCE; APOPTOSIS; TARGET	Acid ceramidase (AC) is a lysosomal cysteine amidase that controls sphingolipid signaling by lowering the levels of ceramides and concomitantly increasing those of sphingosine and its bioactive metabolite, sphingosine 1-phosphate. In the present study, we evaluated the role of AC-regulated sphingolipid signaling in melanoma. We found that AC expression is markedly elevated in normal human melanocytes and proliferative melanoma cell lines, compared with other skin cells (keratinocytes and fibroblasts) and non-melanoma cancer cells. High AC expression was also observed in biopsies from human subjects with Stage II melanoma. Immunofluorescence studies revealed that the subcellular localization of AC differs between melanocytes (where it is found in both cytosol and nucleus) and melanoma cells (where it is primarily localized to cytosol). In addition to having high AC levels, melanoma cells generate lower amounts of ceramides than normal melanocytes do. This down-regulation in ceramide production appears to result from suppression of the de novo biosynthesis pathway. To test whether AC might contribute to melanoma cell proliferation, we blocked AC activity using a new potent (IC50 = 12 nM) and stable inhibitor. AC inhibition increased cellular ceramide levels, decreased sphingosine 1-phosphate levels, and acted synergistically with several, albeit not all, antitumoral agents. The results suggest that AC-controlled sphingolipid metabolism may play an important role in the control of melanoma proliferation.	[Realini, Natalia; Palese, Francesca; Pizzirani, Daniela; Pontis, Silvia; Basit, Abdul; Bach, Anders; Piomelli, Daniele] Fdn Ist Italiano Tecnol, Dept Drug Discovery & Dev, I-16163 Genoa, Italy; [Bach, Anders] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, DK-2100 Copenhagen, Denmark; [Ganesan, Anand] Univ Calif Irvine, Dept Dermatol, Irvine, CA 92617 USA; [Piomelli, Daniele] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92617 USA	Istituto Italiano di Tecnologia - IIT; University of Copenhagen; University of California System; University of California Irvine; University of California System; University of California Irvine	Piomelli, D (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, 3101 Gillespie NRF, Irvine, CA 92697 USA.	piomelli@uci.edu	Basit, Abdul/H-9903-2019	Basit, Abdul/0000-0002-1164-5520; Palese, Francesca/0000-0002-8426-8228; Bach, Anders/0000-0003-4305-9910	NCI NIH HHS [P30 CA062203, R01 CA151513] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA151513, P30CA062203] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Basit A, 2015, ANAL BIOANAL CHEM, V407, P5189, DOI 10.1007/s00216-015-8585-6; Bedia C, 2011, J BIOL CHEM, V286, P28200, DOI 10.1074/jbc.M110.216382; Bedia C, 2008, CHEM PHYS LIPIDS, V156, P33, DOI 10.1016/j.chemphyslip.2008.07.012; Camacho L, 2013, J LIPID RES, V54, P1207, DOI 10.1194/jlr.M032375; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Cheng JC, 2013, J CLIN INVEST, V123, P4344, DOI 10.1172/JCI64791; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Feng LX, 2014, INT J MOL SCI, V15, P4201, DOI 10.3390/ijms15034201; Flowers M, 2012, BREAST CANCER RES TR, V133, P447, DOI 10.1007/s10549-011-1768-8; Furuya H, 2011, CANCER METAST REV, V30, P567, DOI 10.1007/s10555-011-9304-1; Gangoiti P, 2010, PROG LIPID RES, V49, P316, DOI 10.1016/j.plipres.2010.02.004; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Grosch S, 2012, PROG LIPID RES, V51, P50, DOI 10.1016/j.plipres.2011.11.001; Halder K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091656; Han WS, 2002, J DERMATOL SCI, V30, P10, DOI 10.1016/S0923-1811(02)00044-0; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Hara S, 2004, CELL DEATH DIFFER, V11, P853, DOI 10.1038/sj.cdd.4401428; Hartman ML, 2015, CELL MOL LIFE SCI, V72, P1249, DOI 10.1007/s00018-014-1791-0; Hoath SB, 2003, J INVEST DERMATOL, V121, P1440, DOI 10.1046/j.1523-1747.2003.12606.x; Hoek KS, 2008, PIGM CELL MELANOMA R, V21, P665, DOI 10.1111/j.1755-148X.2008.00505.x; Hoek KS, 2006, PIGM CELL RES, V19, P290, DOI 10.1111/j.1600-0749.2006.00322.x; Hoek KS, 2010, PIGM CELL MELANOMA R, V23, P746, DOI 10.1111/j.1755-148X.2010.00757.x; Kemper K, 2014, CANCER RES, V74, P5937, DOI 10.1158/0008-5472.CAN-14-1174; Kim HJ, 2012, J LIPID RES, V53, P1701, DOI 10.1194/jlr.D025627; Laviad EL, 2012, J BIOL CHEM, V287, P21025, DOI 10.1074/jbc.M112.363580; Leon F, 2008, CHEM BIODIVERS, V5, P120, DOI 10.1002/cbdv.200890002; Li FZ, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00031; Liu YS, 2010, J PROTEOME RES, V9, P6044, DOI 10.1021/pr100856k; Mao CG, 2008, BBA-MOL CELL BIOL L, V1781, P424, DOI 10.1016/j.bbalip.2008.06.002; Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398; Morales A, 2007, ONCOGENE, V26, P905, DOI 10.1038/sj.onc.1209834; Musumarra G, 2003, BIOL CHEM, V384, P321, DOI 10.1515/BC.2003.037; O'Connell MP, 2013, J INVEST DERMATOL, V133, P2316, DOI 10.1038/jid.2013.208; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pizzirani D, 2015, ANGEW CHEM INT EDIT, V54, P485, DOI 10.1002/anie.201409042; Pizzirani D, 2013, J MED CHEM, V56, P3518, DOI 10.1021/jm301879g; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Raisova M, 2000, FEBS LETT, V473, P27, DOI 10.1016/S0014-5793(00)01491-5; Realini N, 2013, SCI REP-UK, V3, DOI 10.1038/srep01035; Rutti MF, 2009, J LIPID RES, V50, P1237, DOI 10.1194/jlr.D900001-JLR200; Saddoughi Sahar A., 2008, V49, P413, DOI 10.1007/978-1-4020-8831-5_16; Saied EM, 2014, CELL PHYSIOL BIOCHEM, V34, P197, DOI 10.1159/000362995; Samsel L, 2004, PROSTATE, V58, P382, DOI 10.1002/pros.10350; Selzner M, 2001, CANCER RES, V61, P1233; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Tran MA, 2008, CLIN CANCER RES, V14, P3571, DOI 10.1158/1078-0432.CCR-07-4881; Trotter Shannon C, 2013, J Clin Aesthet Dermatol, V6, P18; Tsao H, 2012, GENE DEV, V26, P1131, DOI 10.1101/gad.191999.112; Wang CN, 2010, J HISTOCHEM CYTOCHEM, V58, P611, DOI 10.1369/jhc.2010.954842; Weiss B, 1997, EUR J BIOCHEM, V249, P239, DOI 10.1111/j.1432-1033.1997.00239.x; Widmer DS, 2015, EXP DERMATOL, V24, P659, DOI 10.1111/exd.12757; Widmer DS, 2012, PIGM CELL MELANOMA R, V25, P343, DOI 10.1111/j.1755-148X.2012.00986.x; Yu T, 2010, CANCER CHEMOTH PHARM, V66, P999, DOI 10.1007/s00280-010-1374-1	56	60	64	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2422	2434		10.1074/jbc.M115.666909	http://dx.doi.org/10.1074/jbc.M115.666909			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26553872	Green Published, hybrid			2022-12-26	WOS:000369610400031
J	Bate, C; Nolan, W; Williams, A				Bate, Clive; Nolan, William; Williams, Alun			Sialic Acid on the Glycosylphosphatidylinositol Anchor Regulates PrP-mediated Cell Signaling and Prion Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cholesterol; glycosylphosphatidylinositol (GPI anchor); phospholipase A; prion; sialic acid	LIPID RAFTS; MEMBRANE DOMAINS; PROTEIN; SCRAPIE; RESISTANT; GANGLIOSIDES; DISTINCT; A(2); GLYCOSPHINGOLIPIDS; MICRODOMAINS	The prion diseases occur following the conversion of the cellular prion protein (PrPC) into disease-related isoforms (PrPSc). In this study, the role of the glycosylphosphatidylinositol (GPI) anchor attached to PrPC in prion formation was examined using a cell painting technique. PrPSc formation in two prion-infected neuronal cell lines (ScGT1 and ScN2a cells) and in scrapie-infected primary cortical neurons was increased following the introduction of PrPC. In contrast, PrPC containing a GPI anchor from which the sialic acid had been removed (desialylated PrPC) was not converted to PrPSc. Furthermore, the presence of desialylated PrPC inhibited the production of PrPSc within prion-infected cortical neurons and ScGT1 and ScN2a cells. The membrane rafts surrounding desialylated PrPC contained greater amounts of sialylated gangliosides and cholesterol than membrane rafts surrounding PrPC. Desialylated PrPC was less sensitive to cholesterol depletion than PrPC and was not released from cells by treatment with glimepiride. The presence of desialylated PrPC in neurons caused the dissociation of cytoplasmic phospholipase A(2) from PrP-containing membrane rafts and reduced the activation of cytoplasmic phospholipase A(2). These findings show that the sialic acid moiety of the GPI attached to PrPC modifies local membrane microenvironments that are important in PrP-mediated cell signaling and PrPSc formation. These results suggest that pharmacological modification of GPI glycosylation might constitute a novel therapeutic approach to prion diseases.	[Bate, Clive; Nolan, William] Royal Vet Coll, Dept Pathol & Pathogen Biol, N Mymms AL9 7TA, Herts, England; [Williams, Alun] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England	University of London; University of London Royal Veterinary College; University of Cambridge	Bate, C (corresponding author), Royal Vet Coll, Dept Pathol & Pathogen Biol, N Mymms AL9 7TA, Herts, England.	cbate@rvc.ac.uk			European Commission FP6 "Neuroprion" Network of Excellence	European Commission FP6 "Neuroprion" Network of Excellence	This work was supported by a grant from the European Commission FP6 "Neuroprion" Network of Excellence. The authors declare that they have no conflicts of interest with the contents of this article.	Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; BARBONI E, 1995, J CELL SCI, V108, P487; Bate C, 2004, J BIOL CHEM, V279, P36405, DOI 10.1074/jbc.M404086200; BATE CAW, 1994, INFECT IMMUN, V62, P5261, DOI 10.1128/IAI.62.12.5261-5266.1994; Bate C, 2012, J BIOL CHEM, V287, P7935, DOI 10.1074/jbc.M111.275743; Bate C, 2011, J BIOL CHEM, V286, P37955, DOI 10.1074/jbc.M111.248724; Bate C, 2011, J BIOL CHEM, V286, P8752, DOI 10.1074/jbc.M110.186833; Bate C, 2010, BIOCHEM J, V428, P95, DOI 10.1042/BJ20091469; Bate C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008221; BIANCO ID, 1989, BIOCHEM J, V258, P95, DOI 10.1042/bj2580095; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Brugger B, 2004, J BIOL CHEM, V279, P7530, DOI 10.1074/jbc.M310207200; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Cantu L, 2011, CHEM PHYS LIPIDS, V164, P796, DOI 10.1016/j.chemphyslip.2011.09.005; Chatterjee S, 2001, CELL MOL LIFE SCI, V58, P1969, DOI 10.1007/PL00000831; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Eisenberg S, 2006, MOL CELL BIOL, V26, P7190, DOI 10.1128/MCB.01059-06; FIELD KA, 1995, P NATL ACAD SCI USA, V92, P9201, DOI 10.1073/pnas.92.20.9201; Galvan C, 2005, MOL CELL NEUROSCI, V30, P304, DOI 10.1016/j.mcn.2005.07.003; Gri G, 2004, IMMUNOL LETT, V94, P247, DOI 10.1016/j.imlet.2004.05.012; HARAGUCHI T, 1989, ARCH BIOCHEM BIOPHYS, V274, P1, DOI 10.1016/0003-9861(89)90409-8; HOMANS SW, 1988, NATURE, V333, P269, DOI 10.1038/333269a0; Legler DF, 2004, FASEB J, V18, P73, DOI 10.1096/fj.03-1338fje; Liu T, 2002, J BIOL CHEM, V277, P47671, DOI 10.1074/jbc.M207458200; Madore N, 1999, EMBO J, V18, P6917, DOI 10.1093/emboj/18.24.6917; MAGGIO B, 1994, BBA-BIOMEMBRANES, V1190, P137, DOI 10.1016/0005-2736(94)90043-4; MCCONVILLE MJ, 1993, BIOCHEM J, V294, P305, DOI 10.1042/bj2940305; McNally KL, 2009, J VIROL, V83, P4469, DOI 10.1128/JVI.02412-08; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; MULLER G, 1993, BIOCHEM J, V289, P509; Nagafuku M, 2003, J BIOL CHEM, V278, P51920, DOI 10.1074/jbc.M307674200; NALEFSKI EA, 1994, J BIOL CHEM, V269, P18239; Naslavsky N, 1999, J BIOL CHEM, V274, P20763, DOI 10.1074/jbc.274.30.20763; Nicholson TB, 2006, J CELL BIOL, V175, P647, DOI 10.1083/jcb.200605001; Ohmi Y, 2012, NEUROCHEM RES, V37, P1185, DOI 10.1007/s11064-012-0764-7; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Puig B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024624; Schiff E, 2008, TRAFFIC, V9, P1101, DOI 10.1111/j.1600-0854.2008.00746.x; Simons M, 1999, MOL BIOL CELL, V10, P3187, DOI 10.1091/mbc.10.10.3187; Slotte JP, 1999, CHEM PHYS LIPIDS, V102, P13, DOI 10.1016/S0009-3084(99)00071-7; STAHL N, 1992, BIOCHEMISTRY-US, V31, P5043, DOI 10.1021/bi00136a600; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Sunyach C, 2003, EMBO J, V22, P3591, DOI 10.1093/emboj/cdg344; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; Taylor DR, 2006, MOL MEMBR BIOL, V23, P89, DOI 10.1080/09687860500449994; Taylor DR, 2005, J CELL SCI, V118, P5141, DOI 10.1242/jcs.02627; Wilson BS, 2004, MOL BIOL CELL, V15, P2580, DOI 10.1091/mbc.E03-08-0574; YANG HC, 1994, BIOCHEM J, V299, P91, DOI 10.1042/bj2990091	49	28	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					160	170		10.1074/jbc.M115.672394	http://dx.doi.org/10.1074/jbc.M115.672394			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26553874	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000367589500013
J	Becker, PP; Rau, M; Schmitt, J; Malsch, C; Hammer, C; Bantel, H; Mullhaupt, B; Geier, A				Becker, Philip P.; Rau, Monika; Schmitt, Johannes; Malsch, Carolin; Hammer, Christian; Bantel, Heike; Muellhaupt, Beat; Geier, Andreas			Performance of Serum microRNAs-122,-192 and-21 as Biomarkers in Patients with Non-Alcoholic Steatohepatitis	PLOS ONE			English	Article							FATTY LIVER-DISEASE; CIRCULATING MICRORNAS; INDEPENDENT MARKER; CASPASE ACTIVATION; FIBROSIS; EXPRESSION; MIR-122; EPIDEMIOLOGY; INHIBITION; APOPTOSIS	Objectives Liver biopsies are the current gold standard in non-alcoholic steatohepatitis (NASH) diagnosis. Their invasive nature, however, still carries an increased risk for patients' health. The development of non-invasive diagnostic tools to differentiate between bland steatosis (NAFL) and NASH remains crucial. The aim of this study is the evaluation of investigated circulating microRNAs in combination with new targets in order to optimize the discrimination of NASH patients by non-invasive serum biomarkers. Methods Serum profiles of four microRNAs were evaluated in two cohorts consisting of 137 NAFLD patients and 61 healthy controls. In a binary logistic regression model microRNAs of relevance were detected. Correlation of microRNA appearance with known biomarkers like ALT and CK18-Asp396 was evaluated. A simplified scoring model was developed, combining the levels of microRNA in circulation and CK18-Asp396 fragments. Receiver operating characteristics were used to evaluate the potential of discriminating NASH. Results The new finding of our study is the different profile of circulating miR-21 in NASH patients (p<0.0001). Also, it validates recently published results of miR-122 and miR-192 to be differentially regulated in NAFL and NASH. Combined microRNA expression profiles with CK18-Asp396 fragment level scoring model had a higher potential of NASH prediction compared to other risk biomarkers (AUROC = 0.83, 95% CI = 0.754-0.908; p<0.001). Evaluation of score model for NAFL (Score = 0) and NASH (Score = 4) had shown high rates of sensitivity (91%) and specificity (83%). Conclusions Our study defines candidates for a combined model of miRNAs and CK18-Asp396 levels relevant as a promising expansion for diagnosis and in turn treatment of NASH.	[Becker, Philip P.; Muellhaupt, Beat; Geier, Andreas] Univ Hosp Zurich USZ, Dept Gastroenterol & Hepatol, Zurich, Switzerland; [Rau, Monika; Schmitt, Johannes; Geier, Andreas] Univ Hosp Wurzburg UKW, Div Hepatol, Wurzburg, Germany; [Malsch, Carolin] Univ Wurzburg, Inst Clin Epidemiol & Biometry, D-97070 Wurzburg, Germany; [Hammer, Christian] Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland; [Bantel, Heike] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Geier, Andreas] Univ Zurich UZH, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Wurzburg; University of Wurzburg; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Hannover Medical School; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Geier, A (corresponding author), Univ Hosp Zurich USZ, Dept Gastroenterol & Hepatol, Zurich, Switzerland.	Geier_A2@ukw.de	Hammer, Christian/C-5827-2014; Mullhaupt, Beat/O-3744-2016; Rau, Monika/O-3212-2015	Hammer, Christian/0000-0003-4548-7548; Mullhaupt, Beat/0000-0002-9020-8192; Rau, Monika/0000-0003-1219-4044	Zurich Center of Integrative Human Physiology	Zurich Center of Integrative Human Physiology	This study was supported by the Zurich Center of Integrative Human Physiology (to AG). There are no conflicts of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 1999, HEPATOLOGY, V30, P1356, DOI 10.1002/hep.510300604; Angulo P, 2013, GASTROENTEROLOGY, V145, P782, DOI 10.1053/j.gastro.2013.06.057; Argo CK, 2009, J HEPATOL, V51, P371, DOI 10.1016/j.jhep.2009.03.019; Arrese M, 2015, SEMIN LIVER DIS, V35, P43, DOI 10.1055/s-0034-1397348; Bala S, 2012, HEPATOLOGY, V56, P1946, DOI 10.1002/hep.25873; Bantel H, 2004, HEPATOLOGY, V40, P1078, DOI 10.1002/hep.20411; Bantel H, 2001, EUR J CELL BIOL, V80, P230, DOI 10.1078/0171-9335-00154; Bhala N, 2013, CURR PHARM DESIGN, V19, P5169, DOI 10.2174/13816128113199990336; Bihrer V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026971; Brunt EM, 2011, HEPATOLOGY, V53, P810, DOI 10.1002/hep.24127; Bye A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057496; Caulin C, 1997, J CELL BIOL, V138, P1379, DOI 10.1083/jcb.138.6.1379; Cermelli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023937; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Chen YN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003248; Cheung O, 2008, HEPATOLOGY, V48, P1810, DOI 10.1002/hep.22569; Choi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076501; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; Cusi K, 2014, J HEPATOL, V60, P167, DOI 10.1016/j.jhep.2013.07.042; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Giray BG, 2014, MOL BIOL REP, V41, P4513, DOI 10.1007/s11033-014-3322-3; Gori M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/741465; Haider BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089565; Harrison SA, 2008, GUT, V57, P1441, DOI 10.1136/gut.2007.146019; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Kirschner Michaela B., 2013, Frontiers in Genetics, V4, P94, DOI 10.3389/fgene.2013.00094; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Li J, 2013, J HEPATOL, V58, P522, DOI 10.1016/j.jhep.2012.11.011; Liu WH, 2011, BBA-GENE REGUL MECH, V1809, P678, DOI 10.1016/j.bbagrm.2011.04.008; Mestdagh P, 2012, METHODS MOL BIOL, V815, P121, DOI 10.1007/978-1-61779-424-7_10; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Meyer SU, 2010, BIOTECHNOL LETT, V32, P1777, DOI 10.1007/s10529-010-0380-z; Milic S, 2012, DIGEST DIS, V30, P158, DOI 10.1159/000336669; Miyaaki H, 2014, LIVER INT, V34, pE302, DOI 10.1111/liv.12429; Pihlajamaki J, 2012, J HEPATOL, V56, P663, DOI 10.1016/j.jhep.2011.10.005; Pirola CJ, 2015, GUT, V64, P800, DOI 10.1136/gutjnl-2014-306996; Pirola CJ, 2013, HEPATOLOGY, V57, P2545, DOI 10.1002/hep.26116; Ratziu V, 2000, GASTROENTEROLOGY, V118, P1117, DOI 10.1016/S0016-5085(00)70364-7; Roderburg C, 2015, LIVER INT, V35, P1172, DOI 10.1111/liv.12627; Schramedei K, 2011, ONCOGENE, V30, P2975, DOI 10.1038/onc.2011.15; Sobolewski C, 2015, SEMIN LIVER DIS, V35, P12, DOI 10.1055/s-0034-1397345; Song JN, 2012, DIGEST DIS SCI, V57, P897, DOI 10.1007/s10620-011-1981-7; Tan YW, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0105192, 10.1371/journal.pone.0094264]; Vinciguerra M, 2009, HEPATOLOGY, V49, P1176, DOI 10.1002/hep.22737; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Wang X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086792; Wang Y, 2013, J APPL TOXICOL, V33, P1330, DOI 10.1002/jat.2864; Weiland M, 2012, RNA BIOL, V9, P850, DOI 10.4161/rna.20378; Yamada H, 2013, CLIN CHIM ACTA, V424, P99, DOI 10.1016/j.cca.2013.05.021; Yang ZY, 2007, CIRCULATION, V115, P1269, DOI 10.1161/CIRCULATIONAHA.106.665836; Younossi ZM, 2008, OBES SURG, V18, P1430, DOI 10.1007/s11695-008-9506-y; Zhang J, 2015, CANCER RES, V75, P1859, DOI 10.1158/0008-5472.CAN-14-1254; Zhang Y, 2010, CLIN CHEM, V56, P1830, DOI 10.1373/clinchem.2010.147850	53	95	96	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142661	10.1371/journal.pone.0142661	http://dx.doi.org/10.1371/journal.pone.0142661			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26565986	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000367628500042
J	Foti, F; Sdoia, S; Menghini, D; Vicari, S; Petrosini, L; Ferlazzo, F				Foti, Francesca; Sdoia, Stefano; Menghini, Deny; Vicari, Stefano; Petrosini, Laura; Ferlazzo, Fabio			Out with the Old and in with the New-Is Backward Inhibition a Domain-Specific Process?	PLOS ONE			English	Article							SPATIAL WORKING-MEMORY; CUE-TARGET TRANSLATION; CONTROL MECHANISMS; COGNITIVE CONTROL; WILLIAMS-SYNDROME; TASK-SET; EXECUTIVE FUNCTIONS; CAUDATE-NUCLEUS; SWITCH COST; CONFLICT	Effective task switching is supported by the inhibition of the just executed task, so that potential interference from previously executed tasks is adaptively counteracted. This inhibitory mechanism, named Backward Inhibition (BI), has been inferred from the finding that switching back to a recently executed task (A-B-A task sequence) is harder than switching back to a less recently executed task (C-B-A task sequence). Despite the fact that BI effects do impact performance on everyday life activities, up to now it is still not clear whether the BI represents an amodal and material-independent process or whether it interacts with the task material. To address this issue, a group of individuals with Williams syndrome (WS) characterized by specific difficulties in maintaining and processing visuo-spatial, but not verbal, information, and a mental age-and gender-matched group of typically developing (TD) children were subjected to three task-switching experiments requiring verbal or visuo-spatial material to be processed. Results showed that individuals with WS exhibited a normal BI effect during verbal task-switching, but a clear deficit during visuo-spatial task-switching. Overall, our findings demonstrating that the BI is a material-specific process have important implications for theoretical models of cognitive control and its architecture.	[Foti, Francesca; Sdoia, Stefano; Petrosini, Laura; Ferlazzo, Fabio] Univ Roma La Sapienza, Dept Psychol, I-00185 Rome, Italy; [Foti, Francesca; Petrosini, Laura] IRCCS Fdn Santa Lucia, Rome, Italy; [Menghini, Deny; Vicari, Stefano] Childrens Hosp Bambino Gesu, Neurosci Dept, Child Neuropsychiat Unit, Rome, Italy	Sapienza University Rome; IRCCS Santa Lucia; IRCCS Bambino Gesu	Foti, F (corresponding author), Univ Roma La Sapienza, Dept Psychol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	francesca.foti@uniroma1.it; stefano.sdoia@uniroma1.it	Foti, Francesca/AAB-9878-2019; Vicari, Stefano/J-3008-2012; Menghini, Deny/AAB-4343-2020	Menghini, Deny/0000-0002-3459-2601; SDOIA, STEFANO/0000-0001-9275-8350; FOTI, FRANCESCA IRENE/0000-0002-7094-7078; Vicari, Stefano/0000-0002-5395-2262	Fondation Jerome Lejeune [1136-FF2013A]	Fondation Jerome Lejeune	This research was supported by funding from the Fondation Jerome Lejeune to F. Foti (1136-FF2013A). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcay C, 2011, PSYCHON B REV, V18, P505, DOI 10.3758/s13423-011-0084-y; ALLPORT A, 1994, ATTENTION PERFORM, V15, P421; Allport A, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P35; Allport DA, 1998, ATTENTION SPACE ACTI, P273; Altmann EM, 2007, J EXP PSYCHOL LEARN, V33, P892, DOI 10.1037/0278-7393.33.5.892; Arbuthnott K, 2000, CAN J EXP PSYCHOL, V54, P33, DOI 10.1037/h0087328; Arbuthnott K, 2008, MEM COGNITION, V36, P534, DOI 10.3758/MC.36.3.534; Arbuthnott KD, 2005, J EXP PSYCHOL LEARN, V31, P1030, DOI 10.1037/0278-7393.31.5.1030; Arbuthnott KD, 2002, CAN J EXP PSYCHOL, V56, P18, DOI 10.1037/h0087382; ARNOLD R, 1985, DEV MED CHILD NEUROL, V27, P49; Atkinson J, 2001, DEV MED CHILD NEUROL, V43, P330, DOI 10.1017/S0012162201000615; Beery KE, 2000, DEV TEST VISUAL MOTO; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; COOK D, 1988, BEHAV NEURAL BIOL, V49, P332, DOI 10.1016/S0163-1047(88)90338-X; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Costa RE, 2012, PSYCHON B REV, V19, P1193, DOI 10.3758/s13423-012-0311-1; Costanzo F, 2013, RES DEV DISABIL, V34, P1770, DOI 10.1016/j.ridd.2013.01.024; Dreher JC, 2002, P NATL ACAD SCI USA, V99, P14595, DOI 10.1073/pnas.222193299; Druey MD, 2007, PSYCHON B REV, V14, P749, DOI 10.3758/BF03196832; Eckert MA, 2005, NEUROLOGY, V64, P152, DOI 10.1212/01.WNL.0000148598.63153.8A; Eckert MA, 2006, NEUROIMAGE, V33, P39, DOI 10.1016/j.neuroimage.2006.05.062; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Egner T, 2008, TRENDS COGN SCI, V12, P374, DOI 10.1016/j.tics.2008.07.001; Egner T, 2008, CEREB CORTEX, V18, P1475, DOI 10.1093/cercor/bhm179; Egner T, 2007, NEUROIMAGE, V35, P940, DOI 10.1016/j.neuroimage.2006.11.061; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Fales CL, 2006, NEUROPSYCHOLOGIA, V44, P1041, DOI 10.1016/j.neuropsychologia.2005.11.002; Farran EK, 2005, BRAIN COGNITION, V59, P159, DOI 10.1016/j.bandc.2005.05.011; Farran EK, 2001, J CHILD PSYCHOL PSYC, V42, P719, DOI 10.1111/1469-7610.00768; Foti F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053782; Gade M, 2014, ACTA PSYCHOL, V148, P12, DOI 10.1016/j.actpsy.2013.12.009; GOSCH A, 1994, AM J MED GENET, V52, P291, DOI 10.1002/ajmg.1320520308; Goschke T, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P331; Grange JA, 2010, J EXP PSYCHOL LEARN, V36, P1003, DOI 10.1037/a0019129; Grange JA, 2009, Q J EXP PSYCHOL, V62, P2068, DOI 10.1080/17470210802696096; Greenberg J, 2013, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00618; Harris MA, 2014, NEUROBIOL AGING, V35, P1095, DOI 10.1016/j.neurobiolaging.2013.10.086; Harris MA, 2012, FRONT AGING NEUROSCI, V4, DOI 10.3389/fnagi.2012.00029; Hartley T, 2003, NEURON, V37, P877, DOI 10.1016/S0896-6273(03)00095-3; Hoffmann JE, 2003, COGNITIVE PSYCHOL, V46, P260, DOI 10.1016/S0010-0285(02)00518-2; Holinger DP, 2005, BRAIN RES, V1037, P35, DOI 10.1016/j.brainres.2004.11.038; Houghton G, 2009, J EXP PSYCHOL LEARN, V35, P466, DOI 10.1037/a0014648; Iaria G, 2003, J NEUROSCI, V23, P5945; Jiang JF, 2014, CEREB CORTEX, V24, P1793, DOI 10.1093/cercor/bht029; Kan IP, 2013, COGNITION, V129, P637, DOI 10.1016/j.cognition.2013.09.001; Kelley TA, 2011, CEREB CORTEX, V21, P659, DOI 10.1093/cercor/bhq139; Kiesel A, 2010, PSYCHOL BULL, V136, P849, DOI 10.1037/a0019842; Koch I, 2004, EXP PSYCHOL, V51, P52, DOI 10.1027/1618-3169.51.1.52; Koch I, 2010, PSYCHON B REV, V17, P1, DOI 10.3758/PBR.17.1.1; Lavie N, 2004, J EXP PSYCHOL GEN, V133, P339, DOI 10.1037/0096-3445.133.3.339; Lin SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098260; Logan GD, 2004, J EXP PSYCHOL GEN, V133, P218, DOI 10.1037/0096-3445.133.2.218; MACDONALD GW, 1988, J CLIN EXP NEUROPSYC, V10, P125, DOI 10.1080/01688638808408229; Mayr U, 2000, J EXP PSYCHOL GEN, V129, P4, DOI 10.1037/0096-3445.129.1.4; Mayr U, 2006, J COGNITIVE NEUROSCI, V18, P14, DOI 10.1162/089892906775250085; Meiran N, 2000, PSYCHOL RES-PSYCH FO, V63, P234, DOI 10.1007/s004269900004; Meiran N, 2010, J EXP PSYCHOL LEARN, V36, P992, DOI 10.1037/a0019761; Menghini D, 2010, J INTELL DISABIL RES, V54, P418, DOI 10.1111/j.1365-2788.2010.01287.x; Menghini D, 2011, BEHAV GENET, V41, P394, DOI 10.1007/s10519-010-9419-0; Mervis CB, 2007, MENT RETARD DEV D R, V13, P3, DOI 10.1002/mrdd.20140; Meyer-Lindenberg A, 2004, NEURON, V43, P623, DOI 10.1016/j.neuron.2004.08.014; Moritz S, 2004, J CLIN EXP NEUROPSYC, V26, P677, DOI 10.1080/13803390490504317; Oh SH, 2004, PSYCHON B REV, V11, P275, DOI 10.3758/BF03196570; OKEEFE J, 1990, PROG BRAIN RES, V83, P301; Palermo L, 2014, NEUROPSYCHOLOGY, V28, P135, DOI 10.1037/neu0000021; Palladino P, 2003, BRAIN COGNITION, V53, P263, DOI 10.1016/S0278-2626(03)00123-4; Philipp AM, 2005, Q J EXP PSYCHOL-A, V58, P1325, DOI 10.1080/02724980443000656; Redish A. D., 1999, COGNITIVE MAP PLACE, DOI DOI 10.1038/nature14445; Reiss AL, 2004, J NEUROSCI, V24, P5009, DOI 10.1523/JNEUROSCI.5272-03.2004; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Roid G.H., 2002, LEITER INT PERFORMAN; Ruge H, 2009, NEUROPSYCHOLOGIA, V47, P1670, DOI 10.1016/j.neuropsychologia.2009.02.004; Rushworth MFS, 2001, J NEUROSCI, V21, P5262, DOI 10.1523/JNEUROSCI.21-14-05262.2001; Scheil J, 2014, J EXP PSYCHOL LEARN, V40, P865, DOI 10.1037/a0035281; Schuch S, 2003, J EXP PSYCHOL HUMAN, V29, P92, DOI 10.1037/0096-1523.29.1.92; Sdoia S, 2008, EXP PSYCHOL, V55, P322, DOI 10.1027/1618-3169.55.5.322; Sdoia S, 2012, ACTA PSYCHOL, V139, P501, DOI 10.1016/j.actpsy.2012.01.005; Sinai M, 2007, PSYCHOPHYSIOLOGY, V44, P596, DOI 10.1111/j.1469-8986.2007.00527.x; Slagter HA, 2006, COGN AFFECT BEHAV NE, V6, P175, DOI 10.3758/CABN.6.3.175; Stoppel CM, 2013, CEREB CORTEX, V23, P1351, DOI 10.1093/cercor/bhs116; Towse JN, 1998, BEHAV RES METH INS C, V30, P583, DOI 10.3758/BF03209475; Vandierendonck A, 2010, PSYCHOL BULL, V136, P601, DOI 10.1037/a0019791; Vicari S, 2006, DEV MED CHILD NEUROL, V48, P126, DOI 10.1017/S0012162206000272; Vicari S, 2005, DEV MED CHILD NEUROL, V47, P305, DOI 10.1017/S0012162205000599; Vicari S, 2003, DEV MED CHILD NEUROL, V45, P269, DOI 10.1017/S0012162203000513; Vicari S, 2002, NEUROPSYCHOLOGIA, V40, P2461, DOI 10.1016/S0028-3932(02)00083-0; Vicari S., 2007, PROMEA PROVE MEMORIA; Volterra V, 1996, CORTEX, V32, P663, DOI 10.1016/S0010-9452(96)80037-2; Waszak F, 2003, COGNITIVE PSYCHOL, V46, P361, DOI 10.1016/S0010-0285(02)00520-0; Whitmer AJ, 2012, J ABNORM PSYCHOL, V121, P570, DOI 10.1037/a0027474; Woodman GF, 2001, PSYCHOL SCI, V12, P219, DOI 10.1111/1467-9280.00339; Yeung N, 2003, J EXP PSYCHOL HUMAN, V29, P455, DOI 10.1037/0096-1523.29.2.455	92	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142613	10.1371/journal.pone.0142613	http://dx.doi.org/10.1371/journal.pone.0142613			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA2MI	26565628	gold, Green Submitted, Green Published			2022-12-26	WOS:000367628500039
J	Bergmann, GT; Craine, JM; Robeson, MS; Fierer, N				Bergmann, Gaddy T.; Craine, Joseph M.; Robeson, Michael S., II; Fierer, Noah			Seasonal Shifts in Diet and Gut Microbiota of the American Bison (Bison bison)	PLOS ONE			English	Article							PLANT-HERBIVORE INTERACTIONS; MIXED-GRASS PRAIRIE; TALLGRASS PRAIRIE; SPATIAL-DISTRIBUTION; GEOGRAPHIC-VARIATION; FORAGING ECOLOGY; HOLOCENE BISON; BACTERIAL; COMMUNITY; QUALITY	North American bison (Bison bison) are becoming increasingly important to both grassland management and commercial ranching. However, a lack of quantitative data on their diet constrains conservation efforts and the ability to predict bison effects on grasslands. In particular, we know little about the seasonality of the bison diet, the degree to which bison supplement their diet with eudicots, and how changes in diet influence gut microbial communities, all of which play important roles in ungulate performance. To address these knowledge gaps, we quantified seasonal patterns in bison diet and gut microbial community composition for a bison herd in Kansas using DNA sequencing-based analyses of both chloroplast and microbial DNA contained in fecal matter. Across the 11 sampling dates that spanned 166 days, we found that diet shifted continuously over the growing season, allowing bison to take advantage of the seasonal availability of high-protein plant species. Bison consumed more woody shrubs in spring and fall than in summer, when forb and grass intake predominated. In examining gut microbiota, the bacterial phylum Tenericutes shifted significantly in relative abundance over the growing season. This work suggests that North American bison can continuously adjust their diet with a high reliance on non-grasses throughout the year. In addition, we find evidence for seasonal patterns in gut community composition that are likely driven by the observed dietary changes.	[Bergmann, Gaddy T.; Fierer, Noah] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Bergmann, Gaddy T.; Fierer, Noah] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Craine, Joseph M.] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; [Robeson, Michael S., II] Colorado State Univ, Fish & Wildlife Conservat Biol, Ft Collins, CO 80523 USA; [Robeson, Michael S., II] Natl Wildlife Res Ctr, USDA, APHIS, Ft Collins, CO USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Kansas State University; Colorado State University; United States Department of Agriculture (USDA)	Bergmann, GT (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	Gaddy.Bergmann@colorado.edu	Robeson, Michael Scott/J-5211-2019; Craine, Joseph/D-4569-2009; Facility, BioFrontiers Next Generation Sequencing/AAJ-8616-2020	Robeson, Michael Scott/0000-0001-7119-6301; Craine, Joseph/0000-0001-6561-3244; FIERER, NOAH/0000-0002-6432-4261				ALBON SD, 1992, OIKOS, V65, P502, DOI 10.2307/3545568; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2014, R LANG ENV STAT COMP; Beck JL, 2005, WEST N AM NATURALIST, V65, P516; Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; Biondini ME, 1999, J RANGE MANAGE, V52, P454, DOI 10.2307/4003772; Bischof R, 2012, AM NAT, V180, P407, DOI 10.1086/667590; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Christianson D, 2013, J WILDLIFE MANAGE, V71, P164; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Coppedge BR, 1998, PLANT ECOL, V139, P235, DOI 10.1023/A:1009728104508; Coppedge BR, 1998, J RANGE MANAGE, V51, P258, DOI 10.2307/4003408; Coppedge BR, 1998, J RANGE MANAGE, V51, P379, DOI 10.2307/4003321; COPPOCK DL, 1983, OECOLOGIA, V56, P1, DOI 10.1007/BF00378210; COPPOCK DL, 1986, J WILDLIFE MANAGE, V50, P452, DOI 10.2307/3801103; COPPOCK DL, 1983, OECOLOGIA, V56, P10, DOI 10.1007/BF00378211; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; Craine JM., 2009, RESOURCE STRATEGIES; Craine JM, 2013, OIKOS, V122, P191, DOI 10.1111/j.1600-0706.2012.20400.x; Craine JM, 2012, NEW PHYTOL, V193, P673, DOI 10.1111/j.1469-8137.2011.03953.x; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; de Menezes AB, 2011, FEMS MICROBIOL ECOL, V78, P256, DOI 10.1111/j.1574-6941.2011.01151.x; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Dittmer J, 2012, MICROB ECOL, V64, P814, DOI 10.1007/s00248-012-0056-4; Drent R., 1981, Verhandlungen der Ornithologischen Gesellschaft in Bayern, V23, P239; Drent RH, 2007, J ORNITHOL, V148, pS501, DOI 10.1007/s10336-007-0223-4; Feranec RS, 2004, PALAEOGEOGR PALAEOCL, V207, P359, DOI 10.1016/j.palaeo.2003.09.031; Fortin D, 2003, OECOLOGIA, V134, P219, DOI 10.1007/s00442-002-1112-4; Fortin D, 2002, ECOLOGY, V83, P970, DOI 10.1890/0012-9658(2002)083[0970:TTSOFD]2.0.CO;2; Fortin D, 2009, ANIM BEHAV, V78, P887, DOI 10.1016/j.anbehav.2009.06.026; Frey JC, 2010, J APPL MICROBIOL, V108, P1982, DOI 10.1111/j.1365-2672.2009.04602.x; Gad SD, 2011, ZOOL SCI, V28, P264, DOI 10.2108/zsj.28.264; Ganskopp D, 1999, APPL ANIM BEHAV SCI, V62, P293, DOI 10.1016/S0168-1591(98)00233-0; Garcia-Robledo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052967; Glasby JS, 1991, DICT PLANTS CONTAINI; GREEN RH, 1993, AUST J ECOL, V18, P81, DOI 10.1111/j.1442-9993.1993.tb00436.x; HJELJORD O, 1990, HOLARCTIC ECOL, V13, P281; HOFMANN RR, 1989, OECOLOGIA, V78, P443, DOI 10.1007/BF00378733; HUDSON RJ, 1987, J RANGE MANAGE, V40, P71, DOI 10.2307/3899365; Ismail NA, 2011, ARCH MED SCI, V7, P501, DOI 10.5114/aoms.2011.23418; Jurado-Rivera JA, 2009, P ROY SOC B-BIOL SCI, V276, P639, DOI 10.1098/rspb.2008.1264; Kamada N, 2013, NAT IMMUNOL, V14, P685, DOI 10.1038/ni.2608; KIE JG, 1986, J RANGE MANAGE, V39, P521, DOI 10.2307/3898763; Knapp AK, 1999, BIOSCIENCE, V49, P39, DOI 10.2307/1313492; Kohl KD, 2012, ECOL LETT, V15, P1008, DOI 10.1111/j.1461-0248.2012.01822.x; Kowalczyk R, 2011, FOREST ECOL MANAG, V261, P821, DOI 10.1016/j.foreco.2010.11.026; KRUEGER K, 1986, ECOLOGY, V67, P760, DOI 10.2307/1937699; KRUEGER WC, 1972, J RANGE MANAGE, V25, P471, DOI 10.2307/3897012; Larson L, 1989, N AM PRAIRIE C P, V50, P243; LARTER NC, 1991, CAN J ZOOL, V69, P2677, DOI 10.1139/z91-376; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Leff JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059310; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; MANURUNG S., 2012, FERMENTED WHEY PERME; McCann JC, 2014, BIOINFORM BIOL INSIG, V8, P109, DOI 10.4137/BBI.S15389; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Mysterud A, 2007, ANIM CONSERV, V10, P77, DOI 10.1111/j.1469-1795.2006.00075.x; Odo BI, 2001, SMALL RUMINANT RES, V42, P163, DOI 10.1016/S0921-4488(01)00228-0; Painter LE, 2012, FOREST ECOL MANAG, V264, P150, DOI 10.1016/j.foreco.2011.10.010; Palmqvist P, 2003, PALEOBIOLOGY, V29, P205, DOI 10.1666/0094-8373(2003)029<0205:PROALP>2.0.CO;2; Palo R.T., 1991, PLANT DEFENSES MAMMA; PEDEN DG, 1974, J APPL ECOL, V11, P489, DOI 10.2307/2402203; Pettorelli N, 2005, BIOL LETT-UK, V1, P24, DOI 10.1098/rsbl.2004.0262; Redford AJ, 2010, ENVIRON MICROBIOL, V12, P2885, DOI 10.1111/j.1462-2920.2010.02258.x; RENECKER LA, 1986, J WILDLIFE MANAGE, V50, P143, DOI 10.2307/3801504; REYNOLDS HW, 1978, J WILDLIFE MANAGE, V42, P581, DOI 10.2307/3800821; Rivals F, 2007, QUATERNARY RES, V68, P338, DOI 10.1016/j.yqres.2007.07.012; Romero-Perez GA, 2011, APPL ENVIRON MICROB, V77, P258, DOI 10.1128/AEM.01289-09; Sawyer H, 2011, J ANIM ECOL, V80, P1078, DOI 10.1111/j.1365-2656.2011.01845.x; Schuler KL, 2006, J MAMMAL, V87, P539, DOI 10.1644/05-MAMM-A-115R2.1; Schwab C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027905; Shrader AM, 2006, FUNCT ECOL, V20, P376, DOI 10.1111/j.1365-2435.2006.01107.x; SIDAHMED AE, 1983, ANIM FEED SCI TECH, V8, P47, DOI 10.1016/0377-8401(83)90042-1; SIDAHMED AE, 1981, J RANGE MANAGE, V34, P33, DOI 10.2307/3898448; Smallidge Samuel T., 2010, International Journal of Ecology, V2010, P1, DOI 10.1155/2010/579808; Stecher B, 2011, CURR OPIN MICROBIOL, V14, P82, DOI 10.1016/j.mib.2010.10.003; Steuer P, 2010, COMP BIOCHEM PHYS A, V156, P380, DOI 10.1016/j.cbpa.2010.03.006; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Tilg H, 2011, J CLIN INVEST, V121, P2126, DOI 10.1172/JCI58109; Tshabalala T, 2010, AFR J ECOL, V48, P438, DOI 10.1111/j.1365-2028.2009.01132.x; Udeh I., 2013, Online Journal of Animal and Feed Research (OJAFR), V3, P197; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; de Oliveira MNV, 2013, VET MICROBIOL, V164, P307, DOI 10.1016/j.vetmic.2013.02.013; van der Graaf SAJ, 2006, ARDEA, V94, P567; Van der Merwe J, 2012, AUSTRAL ECOL, V37, P401, DOI 10.1111/j.1442-9993.2011.02297.x; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; van Wijk RE, 2012, OIKOS, V121, P655, DOI 10.1111/j.1600-0706.2011.20083.x; VANVREEDE G, 1989, J WILDLIFE MANAGE, V53, P210, DOI 10.2307/3801334; VAREL VH, 1989, APPL ENVIRON MICROB, V55, P148, DOI 10.1128/AEM.55.1.148-153.1989; Villalba JJ, 2002, OIKOS, V97, P282, DOI 10.1034/j.1600-0706.2002.970214.x; Villalba JJ, 2004, OIKOS, V107, P100, DOI 10.1111/j.0030-1299.2004.12983.x; von Rosenvinge EC, 2013, ISME J, V7, P1354, DOI 10.1038/ismej.2013.33; WAGGONER V, 1986, J WILDLIFE MANAGE, V50, P322, DOI 10.2307/3801921; Waldram MS, 2008, ECOSYSTEMS, V11, P101, DOI 10.1007/s10021-007-9109-9; Watson LH, 2002, AFR J ECOL, V40, P65, DOI 10.1046/j.0141-6707.2001.00341.x; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; WHITE RG, 1980, ARCTIC ALPINE RES, V12, P511, DOI 10.2307/1550498; Widga C, 2006, J ARCHAEOL SCI, V33, P1237, DOI 10.1016/j.jas.2005.12.011; Willerslev E, 2014, NATURE, V506, P47, DOI 10.1038/nature12921; Wilmshurst JF, 2000, P ROY SOC B-BIOL SCI, V267, P345, DOI 10.1098/rspb.2000.1007; Wilmshurst JF, 1999, CAN J ZOOL, V77, P1223, DOI 10.1139/cjz-77-8-1223; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zar JH, 1999, BIOSTATISTICAL ANAL	108	69	71	3	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142409	10.1371/journal.pone.0142409	http://dx.doi.org/10.1371/journal.pone.0142409			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562019	Green Published, Green Submitted, gold			2022-12-26	WOS:000364480900032
J	Lin, YM; Sung, WW; Hsieh, MJ; Tsai, SC; Lai, HW; Yang, SM; Shen, KH; Chen, MK; Lee, H; Yeh, KT; Chen, CJ				Lin, Yueh-Min; Sung, Wen-Wei; Hsieh, Ming-Ju; Tsai, Shih-Chen; Lai, Hung-Wen; Yang, Shu-Mei; Shen, Ko-Hong; Chen, Mu-Kuan; Lee, Huei; Yeh, Kun-Tu; Chen, Chih-Jung			High PD-L1 Expression Correlates with Metastasis and Poor Prognosis in Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							CLINICAL-SIGNIFICANCE; TUMOR AGGRESSIVENESS; POTENTIAL MECHANISM; COLORECTAL-CANCER; B7-H1; HEAD; BLOCKADE; SURVIVAL; IMMUNOTHERAPY; TOLERANCE	PD-L1 has been widely demonstrated to contribute to failed antitumor immunity. Blockade of PD-L1 with monoclonal antibody could modulate the tumor immune environment to augment immunotherapy. PD-L1 expression is also detected in several types of cancer and is associated with poor prognosis. However, the prognostic role of PD-L1 in oral squamous cell carcinoma (OSCC) is still controversial. Our aim was to determine the role of PD-L1 in the prognosis of OSCC patients to identify its potential therapeutic relevance. PD-L1 immunoreactivity was analyzed by immunohistochemistry in 305 cancer specimens from primary OSCC patients. The medium follow-up time after surgery was 3.8 years (range from 0.1 to 11.1 years). The prognostic value of PD-L1 on overall survival was determined by Kaplan-Meier analysis and Cox proportional hazard models. Higher PD-L1 expression is more likely in tumor tissues of female than male OSCC patients (P = 0.0062). Patients with distant metastasis also had high PD-L1 expression (P = 0.0103). Multivariate analysis identified high PD-L1 expression as an independent risk factor in males and smokers (males: hazard ratio = 1.556, P = 0.0077; smokers: hazard ratio = 2.058, P = 0.0004). We suggest that PD-L1 expression, determined by IHC staining, could be an independent prognostic marker for OSCC patients who are male or who have a smoking habit.	[Lin, Yueh-Min; Shen, Ko-Hong; Yeh, Kun-Tu; Chen, Chih-Jung] Changhua Christian Hosp, Dept Surg Pathol, Changhua, Taiwan; [Lin, Yueh-Min; Sung, Wen-Wei; Tsai, Shih-Chen; Yeh, Kun-Tu; Chen, Chih-Jung] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Lin, Yueh-Min; Sung, Wen-Wei; Chen, Chih-Jung] Jen Teh Jr Coll Med Nursing & Management, Dept Med Technol, Miaoli, Taiwan; [Sung, Wen-Wei] Chung Shan Med Univ Hosp, Dept Med Educ, Taichung 40201, Taiwan; [Hsieh, Ming-Ju] Changhua Christian Hosp, Canc Res Ctr, Changhua, Taiwan; [Hsieh, Ming-Ju] Chung Shan Med Univ, Sch Optometry, Taichung, Taiwan; [Hsieh, Ming-Ju] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Lai, Hung-Wen] Changhua Christian Hosp, Div Gen Surg, Changhua, Taiwan; [Lai, Hung-Wen] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Yang, Shu-Mei] Taipei Med Univ, Sch Publ Hlth, Coll Publ Hlth & Nutr, Taipei, Taiwan; [Chen, Mu-Kuan] Changhua Christian Hosp, Dept Otorhinolaryngol Head & Neck Surg, Changhua, Taiwan; [Lee, Huei] Taipei Med Univ, Grad Inst Canc Biol & Drug Discovery, Taipei, Taiwan	Changhua Christian Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Changhua Christian Hospital; Chung Shan Medical University; Chung Shan Medical University; Changhua Christian Hospital; National Yang Ming Chiao Tung University; Taipei Medical University; Changhua Christian Hospital; Taipei Medical University	Chen, CJ (corresponding author), Changhua Christian Hosp, Dept Surg Pathol, Changhua, Taiwan.	132540@cch.org.tw	Sung, Wen-Wei/P-5053-2019; Hsieh, Ming-Ju/GQB-3025-2022	Sung, Wen-Wei/0000-0002-2375-0029; Hsieh, Ming-Ju/0000-0001-9726-3234	 [103-CCH-IRP-091]		This work was jointly supported by grants from 103-CCH-IRP-091 (Dr. CJ Chen, Changhua Christian Hospital, Changhua, Taiwan) (http://www2.cch.org.tw/cch_english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma T, 2008, BLOOD, V111, P3635, DOI 10.1182/blood-2007-11-123141; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Chen CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050104; Chen CJ, 2013, CLIN CHIM ACTA, V415, P25, DOI 10.1016/j.cca.2012.09.009; CHEN LP, 1992, CELL, V71, P1093, DOI 10.1016/S0092-8674(05)80059-5; Chin D, 2005, INT J CANCER, V113, P789, DOI 10.1002/ijc.20608; Curiel TJ, 2003, NAT MED, V9, P562, DOI 10.1038/nm863; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Ferrand F, 2013, EUR J CANCER, V49, P90, DOI 10.1016/j.ejca.2012.07.006; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Ghebeh H, 2006, NEOPLASIA, V8, P190, DOI 10.1593/neo.05733; Gildener-Leapman N, 2013, ORAL ONCOL, V49, P1089, DOI 10.1016/j.oraloncology.2013.09.009; Greaves P, 2013, BLOOD, V121, P734, DOI 10.1182/blood-2012-10-385591; Greenberg JS, 2003, CANCER, V98, P508, DOI 10.1002/cncr.11526; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Keir ME, 2006, J EXP MED, V203, P883, DOI 10.1084/jem.20051776; Konishi J, 2004, CLIN CANCER RES, V10, P5094, DOI 10.1158/1078-0432.CCR-04-0428; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Nomi T, 2007, CLIN CANCER RES, V13, P2151, DOI 10.1158/1078-0432.CCR-06-2746; Ohigashi Y, 2005, CLIN CANCER RES, V11, P2947, DOI 10.1158/1078-0432.CCR-04-1469; Ribas A, 2012, NEW ENGL J MED, V366, P2517, DOI 10.1056/NEJMe1205943; Shingaki S, 2003, AM J SURG, V185, P278, DOI 10.1016/S0002-9610(02)01378-8; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Srivastava RM, 2013, CLIN CANCER RES, V19, P1858, DOI 10.1158/1078-0432.CCR-12-2426; Strome SE, 2007, ONCOLOGIST, V12, P1084, DOI 10.1634/theoncologist.12-9-1084; Strome SE, 2003, CANCER RES, V63, P6501; Sung WW, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-951; Sung WW, 2013, CLIN CANCER RES, V19, P4092, DOI 10.1158/1078-0432.CCR-12-3439; Sung WW, 2011, CLIN CANCER RES, V17, P5991, DOI 10.1158/1078-0432.CCR-11-0227; Swanson MS, 2015, ORAL ONCOL, V51, P12, DOI 10.1016/j.oraloncology.2014.10.010; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Thompson RH, 2006, CANCER RES, V66, P3381, DOI 10.1158/0008-5472.CAN-05-4303; Thompson RH, 2004, P NATL ACAD SCI USA, V101, P17174, DOI 10.1073/pnas.0406351101; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Torre LA, 2012, CA CANC J CLIN; Vermorken JB, 2010, ANN ONCOL, V21, P252, DOI 10.1093/annonc/mdq453; Wintterle S, 2003, CANCER RES, V63, P7462; Yang CY, 2014, EUR J CANCER, V50, P1361, DOI 10.1016/j.ejca.2014.01.018; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	39	75	79	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142656	10.1371/journal.pone.0142656	http://dx.doi.org/10.1371/journal.pone.0142656			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562534	Green Published, gold, Green Submitted			2022-12-26	WOS:000364480900054
J	Yang, BL; Li, L; Yan, WH; Chen, JY; Chen, Y; Hu, Z; Liu, GY; Shen, ZZ; Shao, ZM; Wu, J				Yang, Benlong; Li, Lin; Yan, Wenhui; Chen, Jiaying; Chen, Ying; Hu, Zhen; Liu, Guangyu; Shen, Zhenzhou; Shao, Zhimin; Wu, Jiong			The Type of Breast Reconstruction May Not Influence Patient Satisfaction in the Chinese Population: A Single Institutional Experience	PLOS ONE			English	Article							EPIGASTRIC PERFORATOR FLAP; SKIN-SPARING MASTECTOMY; IRRADIATED BREAST; RISK-FACTORS; DIEP; TRAM; COMPLICATIONS; DETERMINANTS; CANCER; COHORT	Background The goal of this study was to evaluate patient satisfaction with four common types of breast reconstruction performed at our institution: latissimus dorsi myocutaneous (LDM) flap reconstruction with or without implants, pedicled transverse rectus abdominis musculocutaneous (TRAM) flap reconstruction, and free deep inferior epigastric perforator (DIEP) flap reconstruction. Methods A custom survey consisting of questions that assessed general and aesthetic satisfaction was sent to patients who had undergone breast reconstruction in the last 5 years. The clinical data and details of the surgery were also collected from the patients who returned the surveys. We compared satisfaction rates across the four breast reconstruction types and analyzed the effects of various factors on overall general and aesthetic satisfaction rates using a binary logistic regression model. Result A total of 207 (72%) patients completed the questionnaires. Overall, significant differences in general and aesthetic satisfaction among the four procedures were not observed. A multi-variate analysis revealed that the factor "complications" (p = 0.001) played a significant role in general satisfaction and that the factors "> 2 years since reconstruction" (p = 0.043) and "age > 35 years" (p = 0.05) played significant roles in overall aesthetic satisfaction. Conclusion The present study demonstrated that the type of breast reconstruction might not influence satisfaction in Chinese patients.	[Yang, Benlong; Li, Lin; Yan, Wenhui; Chen, Jiaying; Chen, Ying; Hu, Zhen; Liu, Guangyu; Shen, Zhenzhou; Shao, Zhimin; Wu, Jiong] Fudan Univ, Dept Breast Surg, Canc Ctr, Inst Canc, Shanghai 200032, Peoples R China; [Yang, Benlong; Li, Lin; Chen, Jiaying; Chen, Ying; Hu, Zhen; Liu, Guangyu; Shen, Zhenzhou; Shao, Zhimin; Wu, Jiong] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Yan, Wenhui] Jinan Univ, Clin Med Coll 2, ShenZhen Peoples Hosp, Dept Thyroid & Breast Surg, Shenzhen, Peoples R China; [Yan, Wenhui] Southern Med Univ, Dept Plast Surg, Zhujiang Hosp, Guangzhou, Guangdong, Peoples R China	Fudan University; Fudan University; Jinan University; Southern Medical University - China	Wu, J (corresponding author), Fudan Univ, Dept Breast Surg, Canc Ctr, Inst Canc, 270 Dongan Rd, Shanghai 200032, Peoples R China.	wujiong1122@vip.sina.com			Shanghai Science and Technology Committee Yang'fan project [15YF1402300]	Shanghai Science and Technology Committee Yang'fan project	This research is supported in part by grants from the Shanghai Science and Technology Committee Yang'fan project (15YF1402300).	Alderman AK, 2000, PLAST RECONSTR SURG, V106, P769, DOI 10.1097/00006534-200009040-00003; Alderman AK, 2002, PLAST RECONSTR SURG, V109, P2265, DOI 10.1097/00006534-200206000-00015; Alderman AK, 2012, PLAST RECONSTR SURG, V130, P21, DOI 10.1097/PRS.0b013e318254c8b8; ANDERSON SG, 1994, ANN PLAS SURG, V33, P263, DOI 10.1097/00000637-199409000-00006; Andrade WN, 2001, PLAST RECONSTR SURG, V107, P46, DOI 10.1097/00006534-200101000-00008; Baker R R, 1992, Adv Surg, V25, P51; BLOOM JR, 1987, CANCER-AM CANCER SOC, V59, P189; Colakoglu S, 2011, PLAST RECONSTR SURG, V127, P1428, DOI 10.1097/PRS.0b013e318208d0d4; Ducic I, 2005, ANN PLAS SURG, V55, P559, DOI 10.1097/01.sap.0000184463.90172.04; Eltahir Y, 2013, PLAST RECONSTR SURG, V132, p201E, DOI 10.1097/PRS.0b013e31829586a7; Garvey PB, 2006, PLAST RECONSTR SURG, V117, P1711, DOI 10.1097/01.prs.0000210679.77449.7d; Garvey PB, 2005, PLAST RECONSTR SURG, V115, P447, DOI 10.1097/01.PRS.0000149588.09148.53; Hu ES, 2009, PLAST RECONSTR SURG, V124, P1, DOI 10.1097/PRS.0b013e3181ab10b2; Jagsi R, 2015, ANN SURG, V261, P1198, DOI 10.1097/SLA.0000000000000908; Kim EK, 2009, ANN PLAS SURG, V63, P378, DOI 10.1097/SAP.0b013e3181951708; Leung GM, 2002, BRIT J CANCER, V87, P982, DOI 10.1038/sj.bjc.6600583; Levine SM, 2012, ANN PLAS SURG, V69, P376, DOI 10.1097/SAP.0b013e31824b26d2; Lindegren A, 2012, PLAST RECONSTR SURG, V130, P10, DOI 10.1097/PRS.0b013e3182547aaf; MA Jianxun, 2010, J TISSUE ENG RECONST, P334; Ng SK, 2016, ANN PLAS SURG, V76, P640, DOI 10.1097/SAP.0000000000000242; Pusic AL, 2012, PLAST RECONSTR SURG, V130, P19, DOI 10.1097/PRS.0b013e3182547b90; Reaby LL, 1998, PLAST RECONSTR SURG, V101, P1810, DOI 10.1097/00006534-199806000-00006; Santanelli di Pompeo F, 2014, PLAST RECONSTR SURG, V134, p871E, DOI 10.1097/PRS.0000000000000859; Santanelli F, 2013, ANN SURG ONCOL, V20, P981, DOI 10.1245/s10434-012-2672-0; Santanelli F, 2010, ANN PLAS SURG, V65, P135, DOI 10.1097/SAP.0b013e3181c60f41; Saulis AS, 2007, PLAST RECONSTR SURG, V119, P1669, DOI 10.1097/01.prs.0000258827.21635.84; SCHOVER LR, 1995, CANCER-AM CANCER SOC, V75, P54, DOI 10.1002/1097-0142(19950101)75:1<54::AID-CNCR2820750111>3.0.CO;2-I; Selber JC, 2006, ANN PLAS SURG, V56, P492, DOI 10.1097/01.sap.0000210180.72721.4a; Shin HR, 2010, CANCER CAUSE CONTROL, V21, P1777, DOI 10.1007/s10552-010-9604-8; Spear SL, 2007, PLAST RECONSTR SURG, V119, P788, DOI 10.1097/01.prs.0000252003.14537.d2; Tzafetta K, 2001, PLAST RECONSTR SURG, V107, P1694, DOI 10.1097/00006534-200106000-00009; Vyas RM, 2008, PLAST RECONSTR SURG, V121, P1519, DOI 10.1097/PRS.0b013e31816b1458; Yap YL, 2010, ANN ACAD MED SINGAP, V39, P680; Yu KD, 2007, ANN SURG ONCOL, V14, P2502, DOI 10.1245/s10434-007-9436-2; Yueh JH, 2010, PLAST RECONSTR SURG, V125, P1585, DOI 10.1097/PRS.0b013e3181cb6351	35	4	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142900	10.1371/journal.pone.0142900	http://dx.doi.org/10.1371/journal.pone.0142900			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562294	Green Published, gold, Green Submitted			2022-12-26	WOS:000364480900079
J	Faber-Hammond, J; Samanta, MP; Whitchurch, EA; Manning, D; Sisneros, JA; Coffin, AB				Faber-Hammond, Joshua; Samanta, Manoj P.; Whitchurch, Elizabeth A.; Manning, Dustin; Sisneros, Joseph A.; Coffin, Allison B.			Saccular Transcriptome Profiles of the Seasonal Breeding Plainfin Midshipman Fish (Porichthys notatus), a Teleost with Divergent Sexual Phenotypes	PLOS ONE			English	Article							SENSORY HAIR-CELLS; INNER-EAR; GENE-EXPRESSION; ACOUSTIC-SIGNALS; STEROID-LEVELS; HUMAN HOMOLOG; PLASTICITY; NOTCH; REGENERATION; SENSITIVITY	Acoustic communication is essential for the reproductive success of the plainfin midshipman fish (Porichthys notatus). During the breeding season, type I males use acoustic cues to advertise nest location to potential mates, creating an audible signal that attracts reproductive females. Type II (sneaker) males also likely use this social acoustic signal to find breeding pairs from which to steal fertilizations. Estrogen-induced changes in the auditory system of breeding females are thought to enhance neural encoding of the advertisement call, and recent anatomical data suggest the saccule (the main auditory end organ) as one possible target for this seasonal modulation. Here we describe saccular transcriptomes from all three sexual phenotypes (females, type I and II males) collected during the breeding season as a first step in understanding the mechanisms underlying sexual phenotype-specific and seasonal differences in auditory function. We used RNA-Seq on the Ion Torrent platform to create a combined transcriptome dataset containing over 79,000 assembled transcripts representing almost 9,000 unique annotated genes. These identified genes include several with known inner ear function and multiple steroid hormone receptors. Transcripts most closely matched to published genomes of nile tilapia and large yellow croaker, inconsistent with the phylogenetic relationship between these species but consistent with the importance of acoustic communication in their life-history strategies. We then compared the RNA-Seq results from the saccules of reproductive females with a separate transcriptome from the non-reproductive female phenotype and found over 700 differentially expressed transcripts, including members of the Wnt and Notch signaling pathways that mediate cell proliferation and hair cell addition in the inner ear. These data constitute a valuable resource for furthering our understanding of the molecular basis for peripheral auditory function as well as a range of future midshipman and cross-species comparative studies of the auditory periphery.	[Faber-Hammond, Joshua; Manning, Dustin; Coffin, Allison B.] Washington State Univ, Coll Arts & Sci, Vancouver, WA 98686 USA; [Samanta, Manoj P.] Systemix Inst, Redmond, WA USA; [Whitchurch, Elizabeth A.] Humboldt State Univ, Dept Biol Sci, Arcata, CA 95521 USA; [Sisneros, Joseph A.] Univ Washington, Dept Psychol, Seattle, WA 98195 USA; [Coffin, Allison B.] Washington State Univ, Dept Integrat Physiol & Neurosci, Vancouver, WA USA	Washington State University; California State University System; California State Polytechnic University, Humboldt; University of Washington; University of Washington Seattle; Washington State University	Coffin, AB (corresponding author), Washington State Univ, Coll Arts & Sci, Vancouver, WA 98686 USA.	Allison.coffin@wsu.edu	Sisneros, Joseph/AAU-9965-2020	Sisneros, Joseph/0000-0002-3114-773X	Capita Foundation; Washington State University Vancouver	Capita Foundation; Washington State University Vancouver	This work was funded by a Capita Foundation (http://www.capitafoundation.org/) grant and by start-up funds and a mini-grant from Washington State University Vancouver (http://www.vancouver.wsu.edu/), all to ABC. No grant numbers are available. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arch VS, 2009, HEARING RES, V252, P15, DOI 10.1016/j.heares.2009.01.001; Avraham KB, 1997, HUM MOL GENET, V6, P1225, DOI 10.1093/hmg/6.8.1225; Bass AH, 1999, DESIGN OF ANIMAL COMMUNICATION, P493; Bass AH, 2007, FISH PHYSL SENSORY S, V25; Bass AH, 2012, P NATL ACAD SCI USA, V109, P10677, DOI 10.1073/pnas.1201886109; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Betancur-R R, 2013, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.53ba26640df0ccaee75bb165c8c26288; BRANTLEY RK, 1994, ETHOLOGY, V96, P213, DOI 10.1111/j.1439-0310.1994.tb01011.x; BRANTLEY RK, 1993, HORM BEHAV, V27, P332, DOI 10.1006/hbeh.1993.1025; Cai TT, 2015, J NEUROSCI, V35, P5870, DOI 10.1523/JNEUROSCI.5083-14.2015; Caras ML, 2012, J NEUROSCI, V32, P17597, DOI 10.1523/JNEUROSCI.3938-12.2012; Coffin AB, 2012, J NEUROSCI, V32, P1366, DOI 10.1523/JNEUROSCI.4928-11.2012; Ernest S, 2000, HUM MOL GENET, V9, P2189, DOI 10.1093/hmg/9.14.2189; Fan JZ, 2014, MOL CELL BIOCHEM, V392, P85, DOI 10.1007/s11010-014-2021-7; Feng NY, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1577-2; Fergus DJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1940-3; Forlano PM, 2010, J COMP NEUROL, V518, P493, DOI 10.1002/cne.22233; Forlano PM, SPRINGER HDB AUDITOR, V57; Fraser BA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-202; Haddon C, 1998, DEVELOPMENT, V125, P4637; Hertzano R, 2012, HEARING RES, V288, P77, DOI 10.1016/j.heares.2012.01.002; Jacques BE, 2014, DEV NEUROBIOL, V74, P438, DOI 10.1002/dneu.22134; Johnson J, 1999, DEV DYNAM, V216, P499, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<499::AID-DVDY18>3.0.CO;2-S; Kang YJ, 2008, JARO-J ASSOC RES OTO, V9, P436, DOI 10.1007/s10162-008-0137-8; Kazmierczak P, 2012, TRENDS NEUROSCI, V35, P220, DOI 10.1016/j.tins.2011.10.007; Kouzmenko AP, 2004, J BIOL CHEM, V279, P40255, DOI 10.1074/jbc.C400331200; Li WY, 2015, P NATL ACAD SCI USA, V112, P166, DOI 10.1073/pnas.1415901112; Liang Y, 1999, GENOMICS, V61, P243, DOI 10.1006/geno.1999.5976; Longrie N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061467; Ma EY, 2008, J NEUROSCI, V28, P2261, DOI 10.1523/JNEUROSCI.4372-07.2008; MayerGostan N, 1997, CELL TISSUE RES, V289, P53, DOI 10.1007/s004410050851; McDermott BM, 2007, P NATL ACAD SCI USA, V104, P11820, DOI 10.1073/pnas.0704476104; McKibben JR, 1998, J ACOUST SOC AM, V104, P3520, DOI 10.1121/1.423938; McKibben JR, 2001, J COMP PHYSIOL A, V187, P271, DOI 10.1007/s003590100199; Melchionda S, 2001, AM J HUM GENET, V69, P635, DOI 10.1086/323156; Moeller G, 2009, MOL CELL ENDOCRINOL, V301, P7, DOI 10.1016/j.mce.2008.10.040; Mora C, 1999, SCAND J UROL NEPHROL, V33, P63; Murayama E, 2005, MECH DEVELOP, V122, P791, DOI 10.1016/j.mod.2005.03.002; Nelson JS., 2016, FISHES WORLD, DOI DOI 10.1002/9781119174844.FMATTER; Pan BF, 2013, NEURON, V79, P504, DOI 10.1016/j.neuron.2013.06.019; Patel M, 2013, NEUROSCIENCE, V248, P1, DOI 10.1016/j.neuroscience.2013.05.038; Payan P, 1997, J EXP BIOL, V200, P1905; Powers TR, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-225; Ramcharttar J, 2006, T AM FISH SOC, V135, P1409, DOI 10.1577/T05-207.1; Rohmann KN, 2013, CURR BIOL, V23, P678, DOI 10.1016/j.cub.2013.03.014; Rohmann KN, 2011, J EXP BIOL, V214, P1931, DOI 10.1242/jeb.054114; Rohmann KN, 2009, MOL BIOL EVOL, V26, P1509, DOI 10.1093/molbev/msp060; Romero-Carvajal A, 2015, DEV CELL, V34, P267, DOI 10.1016/j.devcel.2015.05.025; Ruiz-Palmero I, 2011, J NEUROENDOCRINOL, V23, P355, DOI 10.1111/j.1365-2826.2011.02110.x; SAIDEL WM, 1990, HEARING RES, V47, P139, DOI 10.1016/0378-5955(90)90171-K; Scheffer DI, 2015, J NEUROSCI, V35, P6366, DOI 10.1523/JNEUROSCI.5126-14.2015; Schuck JB, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-88; Seiler C, 2004, DEV BIOL, V272, P328, DOI 10.1016/j.ydbio.2004.05.004; Sisneros JA, 2004, SCIENCE, V305, P404, DOI 10.1126/science.1097218; Sisneros JA, 2004, GEN COMP ENDOCR, V136, P101, DOI 10.1016/j.ygcen.2003.12.007; Sisneros JA, 2003, J NEUROSCI, V23, P1049; Sisneros JA, 2007, J COMP PHYSIOL A, V193, P413, DOI 10.1007/s00359-006-0195-5; Sisneros JA, 2009, J NEUROPHYSIOL, V102, P1121, DOI 10.1152/jn.00236.2009; Sollner C, 2004, NATURE, V428, P955, DOI 10.1038/nature02484; Steigelman KA, 2011, J NEUROSCI, V31, P12241, DOI 10.1523/JNEUROSCI.6531-10.2011; Stooke-Vaughan GA, 2015, DEVELOPMENT, V142, P1137, DOI 10.1242/dev.116632; Tomkins JL, 2002, ANIM BEHAV, V63, P1009, DOI 10.1006/anbe.2001.1994; Vahava O, 1998, SCIENCE, V279, P1950, DOI 10.1126/science.279.5358.1950; Varea O, 2010, STEROIDS, V75, P565, DOI 10.1016/j.steroids.2009.09.006; Wainwright PC, 2012, SYST BIOL, V61, P1001, DOI 10.1093/sysbio/sys060; Wang SZ, 2013, J NEUROSCI, V33, P12242, DOI 10.1523/JNEUROSCI.5736-12.2013; Woods C, 2004, NAT NEUROSCI, V7, P1310, DOI 10.1038/nn1349; Yin XH, 2015, EXP CELL RES, V335, P107, DOI 10.1016/j.yexcr.2015.04.020	69	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142814	10.1371/journal.pone.0142814	http://dx.doi.org/10.1371/journal.pone.0142814			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560106	Green Published, gold, Green Submitted			2022-12-26	WOS:000364433100129
J	Kanda, R; Nagao, T; Tho, NV; Ogawa, E; Murakami, Y; Osawa, M; Saika, Y; Doi, K; Nakano, Y				Kanda, Rie; Nagao, Taishi; Nguyen Van Tho; Ogawa, Emiko; Murakami, Yoshitaka; Osawa, Makoto; Saika, Yoshinori; Doi, Kenji; Nakano, Yasutaka			Factors Affecting Time to Sputum Culture Conversion in Adults with Pulmonary Tuberculosis: A Historical Cohort Study without Censored Cases	PLOS ONE			English	Article							CIGARETTE-SMOKING; RELAPSE; SMEAR	Background In patients with pulmonary tuberculosis (TB), shortening the time to sputum culture conversion is desirable to reduce the likelihood of mycobacterial transmission. A persistent positive sputum culture after 2 months of treatment is reported to be associated with the presence of cavitation and the extent of disease on chest X-ray, high colony count, diabetes mellitus, and smoking. However, little is known about factors affecting the time to sputum culture conversion. This study was conducted to evaluate factors affecting the time to sputum culture conversion throughout the course of treatment in adults with pulmonary TB. Methods This study was performed using a database of the medical records of patients with active pulmonary TB who were treated at Hirakata Kohsai Hospital in Hirakata City, Osaka, Japan, from October 2000 to October 2002. Cox proportional-hazards analysis was used to evaluate factors affecting the time to sputum culture conversion after adjusting for potential confounders. Results The data of 86 patients with pulmonary TB were analyzed. The median time to sputum culture conversion was 39 days, and the maximum time was 116 days. The Cox proportional-hazards analysis showed that a higher smear grading (HR, 0.40; 95% CI, 0.23-0.71) and a history of ever smoking (HR, 0.48; 95% CI, 0.25-0.94) were associated with delayed sputum culture conversion. Conclusion High smear grading and smoking prolonged the time to sputum culture conversion in adults with pulmonary TB. To effectively control TB, measures to decrease the cigarette smoking rate should be implemented, in addition to early detection and timely anti-TB treatment.	[Kanda, Rie; Nagao, Taishi; Nguyen Van Tho; Nakano, Yasutaka] Shiga Univ Med Sci, Dept Med, Div Resp Med, Otsu, Shiga, Japan; [Ogawa, Emiko] Shiga Univ Med Sci, Hlth Adm Ctr, Otsu, Shiga, Japan; [Murakami, Yoshitaka] Shiga Univ Med Sci, Dept Med Stat, Otsu, Shiga, Japan; [Osawa, Makoto] Shiga Univ Med Sci Hosp, Div Infect Control & Prevent, Otsu, Shiga, Japan; [Saika, Yoshinori] Hirakata Kohsai Hosp, Dept Radiol, Osaka, Japan; [Doi, Kenji] Morinomiya Hosp, Dept Radiol, Osaka, Japan	Shiga University of Medical Science; Shiga University of Medical Science; Shiga University of Medical Science; Shiga University of Medical Science	Nakano, Y (corresponding author), Shiga Univ Med Sci, Dept Med, Div Resp Med, Otsu, Shiga, Japan.	nakano@belle.shiga-med.ac.jp		Nguyen, Tho/0000-0002-0198-6284				Mota PC, 2012, REV PORT PNEUMOL, V18, P72, DOI 10.1016/j.rppneu.2011.12.005; de Boer RN, 2014, TUBERCULOSIS, V94, P87, DOI 10.1016/j.tube.2013.10.005; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Guler M, 2007, INT J CLIN PRACT, V61, P231, DOI 10.1111/j.1742-1241.2006.01131.x; Leung CC, 2015, EUR RESPIR J, V45, P738, DOI 10.1183/09031936.00114214; Maciel EL, 2013, INT J TUBERC LUNG D, V17, P225, DOI 10.5588/ijtld.12.0426; MITCHISON DA, 1993, AM REV RESPIR DIS, V147, P1062, DOI 10.1164/ajrccm/147.4.1062; O'Leary SM, 2014, AM J RESP CRIT CARE, V190, P1430, DOI 10.1164/rccm.201407-1385OC; Shaler CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059185; Shang SB, 2011, J INFECT DIS, V203, P1240, DOI 10.1093/infdis/jir009; Slam K, 2007, INT J TUBERC LUNG D, V11, P1049; The Committee for Classification of Tuberculosis, 1959, KEKKAKU, V34, P885; The Japanese Society for Tuberculosis, 1996, MAN MED CAR STAND TU; Visser ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029588; Wallis RS, 2009, LANCET INFECT DIS, V9, P162, DOI 10.1016/S1473-3099(09)70042-8; World Health Organization, 2014, FACT SHEET TUB	16	21	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142607	10.1371/journal.pone.0142607	http://dx.doi.org/10.1371/journal.pone.0142607			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558764	Green Published, gold, Green Submitted			2022-12-26	WOS:000364433100100
J	Li, X; Li, X; Li, YX; Zhang, Y; Chen, D; Sun, MZ; Zhao, X; Chen, DY; Feng, XZ				Li, Xiang; Li, Xu; Li, Yi-Xiang; Zhang, Yuan; Chen, Di; Sun, Ming-Zhu; Zhao, Xin; Chen, Dong-Yan; Feng, Xi-Zeng			The Difference between Anxiolytic and Anxiogenic Effects Induced by Acute and Chronic Alcohol Exposure and Changes in Associative Learning and Memory Based on Color Preference and the Cause of Parkinson-Like Behaviors in Zebrafish	PLOS ONE			English	Article							DANIO-RERIO; LARVAL ZEBRAFISH; PREFERRING RATS; NATIONAL-SURVEY; ETHANOL; SENSITIVITY; RESPONSES; DISEASE; SYSTEM; FISH	We describe an interdisciplinary comparison of the effects of acute and chronic alcohol exposure in terms of their disturbance of light, dark and color preferences and the occurrence of Parkinson-like behavior in zebrafish through computer visual tracking, data mining, and behavioral and physiological analyses. We found that zebrafish in anxiolytic and anxious states, which are induced by acute and chronic repeated alcohol exposure, respectively, display distinct emotional reactions in light/dark preference tests as well as distinct learning and memory abilities in color-enhanced conditional place preference (CPP) tests. Additionally, compared with the chronic alcohol (1.0%) treatment, acute alcohol exposure had a significant, dose-dependent effect on anxiety, learning and memory (color preference) as well as locomotive activities. Acute exposure doses (0.5%, 1.0%, and 1.5%) generated an "inverted V" dose-dependent pattern in all of the behavioral parameters, with 1.0% having the greatest effect, while the chronic treatment had a moderate effect. Furthermore, by measuring locomotive activity, learning and memory performance, the number of dopaminergic neurons, tyrosine hydroxylase expression, and the change in the photo-receptors in the retina, we found that acute and chronic alcohol exposure induced varying degrees of Parkinson-like symptoms in zebrafish. Taken together, these results illuminated the behavioral and physiological mechanisms underlying the changes associated with learning and memory and the cause of potential Parkinson-like behaviors in zebrafish due to acute and chronic alcohol exposure.	[Li, Xiang; Li, Yi-Xiang; Zhang, Yuan; Feng, Xi-Zeng] Nankai Univ, Coll Life Sci, Minist Educ, State Key Lab Med Chem Biol,Key Lab Bioact Mat, Tianjin 300071, Peoples R China; [Chen, Di; Sun, Ming-Zhu; Zhao, Xin] Nankai Univ, Inst Robot & Automat Informat Syst, Tianjin 300071, Peoples R China; [Li, Xu; Chen, Dong-Yan] Nankai Univ, Sch Med, Dept Physiol, Key Lab Anim Models & Degenerat Dis, Tianjin 300071, Peoples R China	Nankai University; Nankai University; Nankai University	Zhao, X (corresponding author), Nankai Univ, Inst Robot & Automat Informat Syst, Tianjin 300071, Peoples R China.	zhaoxin@nankai.edu.cn; chendy@nankai.edu.cn; xzfeng@nankai.edu.cn	Li, Yixiang/J-9407-2019	xu, li/0000-0001-8051-9141	Special Fund for Basic Research on Scientific Instruments of the Chinese National Natural Science Foundation [61327802]; National Basic Research Program (973 program) of China "The fundamental and frontier studies of the new topology of molecular functional carbon materials" [2015CB856500]; Tianjin Science Technology Research Funds of China [10JCYBJC25300]; State Key Laboratory of Medicinal Chemical Biology [20130301]	Special Fund for Basic Research on Scientific Instruments of the Chinese National Natural Science Foundation; National Basic Research Program (973 program) of China "The fundamental and frontier studies of the new topology of molecular functional carbon materials"; Tianjin Science Technology Research Funds of China; State Key Laboratory of Medicinal Chemical Biology	This project was initiated in the State Key Laboratory of Medicinal Chemical Biology at Nankai University. X.Z., D.Y.C., and X.Z.F. were supported by the Special Fund for Basic Research on Scientific Instruments of the Chinese National Natural Science Foundation (grant no: 61327802). The work performed in the laboratory of X.Z.F. was supported by the National Basic Research Program (973 program) of China "The fundamental and frontier studies of the new topology of molecular functional carbon materials" (2015CB856500). The work performed by the group of D.Y.C. was supported by the Tianjin Science Technology Research Funds of China (grant no: 10JCYBJC25300) and the fund from the State Key Laboratory of Medicinal Chemical Biology (grant no: 20130301).	Al-Imari L, 2008, BEHAV BRAIN RES, V189, P216, DOI 10.1016/j.bbr.2007.12.007; [Anonymous], 2012, J VIS EXP, pii; Avdesh A, 2010, P MEAS BEHAV, V2010, P155; Avdesh A, 2012, J ALZHEIMERS DIS, V28, P459, DOI 10.3233/JAD-2011-110704; Best JD, 2008, NEUROPSYCHOPHARMACOL, V33, P1206, DOI 10.1038/sj.npp.1301489; Bretaud S, 2004, NEUROTOXICOL TERATOL, V26, P857, DOI 10.1016/j.ntt.2004.06.014; Brockerhoff SE, 2011, CELL MOL LIFE SCI, V68, P651, DOI 10.1007/s00018-010-0563-8; Cachat J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017597; Casu MA, 2002, BRAIN RES, V924, P242, DOI 10.1016/S0006-8993(01)03296-6; Chacon DM, 2014, PROG NEURO-PSYCHOPH, V53, P109, DOI 10.1016/j.pnpbp.2014.03.009; Chatterjee D, 2014, AMINO ACIDS, V46, P921, DOI 10.1007/s00726-013-1658-y; Chatterjee D, 2009, BEHAV BRAIN RES, V200, P208, DOI 10.1016/j.bbr.2009.01.016; Darland T, 2001, P NATL ACAD SCI USA, V98, P11691, DOI 10.1073/pnas.191380698; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Echevarria DJ, 2011, PROG NEURO-PSYCHOPH, V35, P1416, DOI 10.1016/j.pnpbp.2011.01.020; Echevarria DJ, 2011, REV NEUROSCIENCE, V22, P85, DOI 10.1515/RNS.2011.010; Gao HM, 2002, J NEUROCHEM, V81, P1285, DOI 10.1046/j.1471-4159.2002.00928.x; Gerlai R, 2009, GENES BRAIN BEHAV, V8, P586, DOI 10.1111/j.1601-183X.2009.00488.x; Gerlai R., 2012, USING ZEBRAFISH UNRA, P3; Gerlai R, 2008, ALCOHOL CLIN EXP RES, V32, P1763, DOI 10.1111/j.1530-0277.2008.00761.x; Gerlai R, 2011, METHOD CELL BIOL, V101, P249, DOI 10.1016/B978-0-12-387036-0.00012-8; Gerlai R, 2011, REV NEUROSCIENCE, V22, P3, DOI 10.1515/RNS.2011.002; Grella SL, 2010, INT J COMP PSYCHOL, V23; Guarnieri DJ, 2003, INT REV NEUROBIOL, V54, P54; GUO S, 2009, COMMUN INTEGR BIOL, V2, P512; Harwood HJ, 1998, RECENT DEV ALCOHOL, V14, P307, DOI 10.1007/0-306-47148-5_14; Howarth DL, 2011, ALCOHOL CLIN EXP RES, V35, P826, DOI 10.1111/j.1530-0277.2010.01407.x; Huang JTJ, 2008, MOL PSYCHIATR, V13, P1118, DOI 10.1038/sj.mp.4002108; Hughes A, 1998, VISUAL NEUROSCI, V15, P1029, DOI 10.1017/S095252389815602X; JAFFE JH, 1983, CLIN PHARMACOL THER, V34, P623, DOI 10.1038/clpt.1983.224; KUSHNER MG, 1990, AM J PSYCHIAT, V147, P685; Ladu F, 2014, ALCOHOLISM CLIN EXPT; Li X, 2014, SCI REP-UK, V4, DOI 10.1038/srep03810; Lockwood B, 2004, PHARMACOL BIOCHEM BE, V77, P647, DOI 10.1016/j.pbb.2004.01.003; Mathur P, 2011, BEHAV BRAIN RES, V219, P234, DOI 10.1016/j.bbr.2011.01.019; Maximino C, 2010, NAT PROTOC, V5, P209, DOI 10.1038/nprot.2009.225; Oliveira J., 2015, ZEBRAFISH; Pather S, 2009, BEHAV BRAIN RES, V196, P323, DOI 10.1016/j.bbr.2008.09.013; Reimers MJ, 2004, J BIOL CHEM, V279, P38303, DOI 10.1074/jbc.M401165200; Shannon W, 2003, PHARMACOGENOMICS, V4, P41, DOI 10.1517/phgs.4.1.41.22581; Shohat-Ophir G, 2012, SCIENCE, V335, P1351, DOI 10.1126/science.1215932; Sison M, 2010, BEHAV BRAIN RES, V207, P99, DOI 10.1016/j.bbr.2009.09.043; Spence R, 2008, ETHOLOGY, V114, P582, DOI 10.1111/j.1439-0310.2008.01515.x; Tran S, 2013, BEHAV BRAIN RES, V252, P204, DOI 10.1016/j.bbr.2013.05.065; Sun YP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035645; Teesson M, 2000, AUST NZ J PSYCHIAT, V34, P206, DOI 10.1080/j.1440-1614.2000.00715.x; Tropepe V, 2003, GENES BRAIN BEHAV, V2, P268, DOI 10.1034/j.1601-183X.2003.00038.x; Vengeliene V, 2008, BRIT J PHARMACOL, V154, P299, DOI 10.1038/bjp.2008.30; Ward A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005946; Weber DN, 2012, CURR TOP NEUROTOX, P335, DOI 10.1007/978-1-4614-2383-6_19; WECHSLER H, 1994, JAMA-J AM MED ASSOC, V272, P1672, DOI 10.1001/jama.272.21.1672; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wullimann MF, 1996, NEUROANATOMY ZEBRAFI, DOI 10.1007/978-3-0348-8979-7_6; Zandy SL, 2014, PSYCHOPHARMACOLOGY, P1; ZHOU FC, 1995, ALCOHOL, V12, P403, DOI 10.1016/0741-8329(95)00010-O; Zhu W, 2004, ALCOHOL ALCOHOLISM, V39, P53, DOI 10.1093/alcalc/agh023	56	15	15	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141134	10.1371/journal.pone.0141134	http://dx.doi.org/10.1371/journal.pone.0141134			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558894	Green Published, gold, Green Submitted			2022-12-26	WOS:000364433100021
J	Miura, Y; Hashii, N; Tsumoto, H; Takakura, D; Ohta, Y; Abe, Y; Arai, Y; Kawasaki, N; Hirose, N; Endo, T				Miura, Yuri; Hashii, Noritaka; Tsumoto, Hiroki; Takakura, Daisuke; Ohta, Yuki; Abe, Yukiko; Arai, Yasumichi; Kawasaki, Nana; Hirose, Nobuyoshi; Endo, Tamao		SONIC	Change in N-Glycosylation of Plasma Proteins in Japanese Semisupercentenarians	PLOS ONE			English	Article							LIQUID CHROMATOGRAPHY/MASS SPECTROMETRY; ALPHA-2-6-LINKED SIALIC ACIDS; GLYCANS; BIOMARKERS; CARCINOMA; PROFILES; IGG; AGE	An N-glycomic analysis of plasma proteins was performed in Japanese semisupercentenarians (SSCs) (mean 106.7 years), aged controls (mean 71.6 years), and young controls (mean 30.2 years) by liquid chromatography/mass spectrometry (LC/MS) using a graphitized carbon column. Characteristic N-glycans in SSCs were discriminated using a multivariate analysis; orthogonal projections to latent structures (O-PLS). The results obtained showed that multi-branched and highly sialylated N-glycans as well as agalacto-and/or bisecting N-glycans were increased in SSCs, while biantennary N-glycans were decreased. Since multi-branched and highly sialylated N-glycans have been implicated in anti-inflammatory activities, these changes may play a role in the enhanced chronic inflammation observed in SSCs. The levels of inflammatory proteins, such as CRP, adiponectin, IL-6, and TNF-a, were elevated in SSCs. These results suggested that responses to inflammation may play an important role in extreme longevity and healthy aging in humans. This is the first study to show that the N-glycans of plasma proteins were associated with extreme longevity and healthy aging in humans.	[Miura, Yuri; Tsumoto, Hiroki; Endo, Tamao] Tokyo Metropolitan Inst Gerontol, Res Team Mech Aging, Tokyo, Japan; [Hashii, Noritaka; Takakura, Daisuke; Ohta, Yuki; Kawasaki, Nana] Natl Inst Hlth Sci, Div Biol Chem & Biol, Tokyo, Japan; [Abe, Yukiko; Arai, Yasumichi; Hirose, Nobuyoshi] Keio Univ, Sch Med, Ctr Supercentenarian Res, Tokyo, Japan	Tokyo Metropolitan Institute of Gerontology; National Institute of Health Sciences - Japan; Keio University	Endo, T (corresponding author), Tokyo Metropolitan Inst Gerontol, Res Team Mech Aging, Tokyo, Japan.	endo@tmig.or.jp			Japan Society for the Promotion of Science [24659141]; Mitsui Sumitomo Insurance Welfare Foundation [18]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mitsui Sumitomo Insurance Welfare Foundation(Mitsui Sumitomo Insurance Welfare Foundation)	The Japan Society for the Promotion of Science (No. 24659141 to TE) (http://www.jsps.go.jp/j-grantsinaid/index.html), and Mitsui Sumitomo Insurance Welfare Foundation (No. 18 to YM)(http://www.ms-ins.com/welfare/): The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldredge D, 2012, J PROTEOME RES, V11, P1958, DOI 10.1021/pr2011439; Arai Y, 2014, J GERONTOL A-BIOL, V69, P486, DOI 10.1093/gerona/glt146; Callewaert N, 2003, GLYCOBIOLOGY, V13, P367, DOI 10.1093/glycob/cwg040; Ding N, 2011, AGE AGEING, V40, P568, DOI 10.1093/ageing/afr084; Dutta M, 2015, J PROTEOMICS, V114, P182, DOI 10.1016/j.jprot.2014.10.021; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Freeze HH, 2005, CURR OPIN STRUC BIOL, V15, P490, DOI 10.1016/j.sbi.2005.08.010; Gagneux P, 2003, J BIOL CHEM, V278, P48245, DOI 10.1074/jbc.M309813200; Gierman HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112430; Hashii N, 2005, PROTEOMICS, V5, P4665, DOI 10.1002/pmic.200401330; Hashii N, 2014, RAPID COMMUN MASS SP, V28, P921, DOI 10.1002/rcm.6858; Hedlund M, 2008, CANCER RES, V68, P388, DOI 10.1158/0008-5472.CAN-07-1340; Holm T, 2014, ALLERGY, V69, P104, DOI 10.1111/all.12308; Huffman JE, 2011, HUM MOL GENET, V20, P5000, DOI 10.1093/hmg/ddr414; Itoh S, 2006, J CHROMATOGR A, V1103, P296, DOI 10.1016/j.chroma.2005.11.043; Kaneshiro N, 2009, RAPID COMMUN MASS SP, V23, P3720, DOI 10.1002/rcm.4315; Knezevic A, 2010, GLYCOBIOLOGY, V20, P959, DOI 10.1093/glycob/cwq051; Langereis MA, 2015, CELL REP, V11, P1966, DOI 10.1016/j.celrep.2015.05.044; Lauc G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003225; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lu JP, 2011, J PROTEOME RES, V10, P4959, DOI 10.1021/pr2004067; Miura Y, 2011, EXP GERONTOL, V46, P81, DOI 10.1016/j.exger.2010.10.002; Miyahara K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074861; PAREKH R, 1988, J EXP MED, V167, P1731, DOI 10.1084/jem.167.5.1731; PAWLOWSKI T, 1986, Behring Institute Mitteilungen, P11; Ruhaak LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073082; Ruhaak LR, 2012, ANAL CHEM, V84, P396, DOI 10.1021/ac202775t; Ruhaak LR, 2011, J PROTEOME RES, V10, P1667, DOI 10.1021/pr1009959; Saldova R, 2014, J PROTEOME RES, V13, P2314, DOI 10.1021/pr401092y; Sarrats A, 2010, PROTEOM CLIN APPL, V4, P432, DOI 10.1002/prca.200900150; Sato Y, 2010, GERIATR GERONTOL INT, V10, pS32, DOI 10.1111/j.1447-0594.2010.00602.x; Sebastiani P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029848; Taniguchi N, 2015, ADV CANCER RES, V126, P11, DOI 10.1016/bs.acr.2014.11.001; TSUCHIYA N, 1993, J IMMUNOL, V151, P1137; Tsutsui H, 2011, CLIN CHIM ACTA, V412, P861, DOI 10.1016/j.cca.2010.12.023; Vanhooren V, 2008, BIOGERONTOLOGY, V9, P351, DOI 10.1007/s10522-008-9140-z; Vanhooren V, 2007, REJUV RES, V10, P521, DOI 10.1089/rej.2007.0556; Vanhooren V, 2010, EXP GERONTOL, V45, P738, DOI 10.1016/j.exger.2010.08.009; Vanhooren V, 2009, MECH AGEING DEV, V130, P92, DOI 10.1016/j.mad.2008.11.008	39	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142645	10.1371/journal.pone.0142645	http://dx.doi.org/10.1371/journal.pone.0142645			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559536	Green Published, Green Submitted, gold			2022-12-26	WOS:000364433100105
J	Udroiu, I; Antoccia, A; Tanzarella, C; Giuliani, L; Pacchierotti, F; Cordelli, E; Eleuteri, P; Villani, P; Sgura, A				Udroiu, Ion; Antoccia, Antonio; Tanzarella, Caterina; Giuliani, Livio; Pacchierotti, Francesca; Cordelli, Eugenia; Eleuteri, Patrizia; Villani, Paola; Sgura, Antonella			Genotoxicity Induced by Foetal and Infant Exposure to Magnetic Fields and Modulation of Ionising Radiation Effects	PLOS ONE			English	Article							DNA-DAMAGE; TESTICULAR DEVELOPMENT; PERIPHERAL-BLOOD; 60 HZ; FREQUENCY; ADULT; MICRONUCLEI; MICE; SPERMATOGENESIS; CELLS	Background Few studies have investigated the toxicity and genotoxicity of extremely low frequency magnetic fields (ELF-MF) during prenatal and neonatal development. These phases of life are characterized by cell proliferation and differentiation, which might make them sensitive to environmental stressors. Although in vitro evidences suggest that ELF-MF may modify the effects of ionizing radiation, no research has been conducted so far in vivo on the genotoxic effects of ELF-MF combined with X-rays. Aim and methods Aim of this study was to investigate in somatic and germ cells the effects of chronic ELF-MF exposure from mid gestation until weaning, and any possible modulation produced by ELF-MF exposure on ionizing radiation-induced damage. Mice were exposed to 50 Hz, 65 mu T magnetic field, 24 hours/day, for a total of 30 days, starting from 12 days post-conception. Another group was irradiated with 1 Gy X-rays immediately before ELF-MF exposure, other groups were only X-irradiated or sham-exposed. Micronucleus test on blood erythrocytes was performed at multiple times from 1 to 140 days after birth. Additionally, 42 days after birth, genotoxic and cytotoxic effects on male germ cells were assessed by comet assay and flow cytometric analysis. Results ELF-MF exposure had no teratogenic effect and did not affect survival, growth and development. The micronucleus test indicated that ELF-MF induced a slight genotoxic damage only after the maximum exposure time and that this effect faded away in the months following the end of exposure. ELF-MF had no effects on ionizing radiation (IR)-induced genotoxicity in erythrocytes. Differently, ELF-MF appeared to modulate the response of male germ cells to X-rays with an impact on proliferation/differentiation processes. These results point to the importance of tissue specificity and development on the impact of ELF-MF on the early stages of life and indicate the need of further research on the molecular mechanisms underlying ELF-MF biological effects.	[Udroiu, Ion; Antoccia, Antonio; Tanzarella, Caterina; Sgura, Antonella] Univ Rome Roma Tre, Dept Sci, Rome, Italy; [Giuliani, Livio] INAIL, Res Ctr Monteporzio Catone, Rome, Italy; [Pacchierotti, Francesca; Cordelli, Eugenia; Eleuteri, Patrizia; Villani, Paola] ENEA, Tech Unit Radiat Biol & Human Hlth, Rome, Italy	Italfarmaco; Roma Tre University; Italian National Agency New Technical Energy & Sustainable Economics Development	Udroiu, I (corresponding author), Univ Rome Roma Tre, Dept Sci, Rome, Italy.	ion.udroiu@uniroma1.it	Sgura, Antonella/H-3274-2019		Istituto nazionale per l'assicurazione contro gli infortuni sul lavoro [B23/DIPIA/2009]	Istituto nazionale per l'assicurazione contro gli infortuni sul lavoro	This work was supported by "Istituto nazionale per l'assicurazione contro gli infortuni sul lavoro", grant number B23/DIPIA/2009 (www.inail.it). LG (INAIL).	Abramsson-Zetterberg L, 2001, BIOELECTROMAGNETICS, V22, P351, DOI 10.1002/bem.61; Alcaraz M, 2014, ELECTROMAGN BIOL MED, V33, P51, DOI 10.3109/15368378.2013.783851; BRENT RL, 1980, TERATOLOGY, V21, P281, DOI 10.1002/tera.1420210304; CHERNOFF N, 1992, TOXICOLOGY, V74, P91, DOI 10.1016/0300-483X(92)90132-X; Chung MK, 2005, ASIAN J ANDROL, V7, P189, DOI 10.1111/j.1745-7262.2005.00007.x; COLE RJ, 1981, MUTAT RES, V80, P141, DOI 10.1016/0027-5107(81)90184-6; Cordelli E, 2003, RADIAT RES, V160, P443, DOI 10.1667/RR3053; Cordelli E, 2012, ENVIRON MOL MUTAGEN, V53, P429, DOI 10.1002/em.21703; Duan WX, 2014, BIOELECTROMAGNETICS, V35, P58, DOI 10.1002/bem.21816; Ema H, 2000, BLOOD, V95, P2284, DOI 10.1182/blood.V95.7.2284.007k14_2284_2288; Erdal N, 2007, MUTAT RES-GEN TOX EN, V630, P69, DOI 10.1016/j.mrgentox.2007.03.001; Gharamaleki H, 2014, ACTA ENDOCRINOL-BUCH, V10, P577, DOI 10.4183/aeb.2014.577; Haines GA, 2002, BIOL REPROD, V67, P854, DOI 10.1095/biolreprod.102.004382; Haines GA, 2001, MUTAT RES-GEN TOX EN, V495, P21, DOI 10.1016/S1383-5718(01)00181-4; HINTENLANG DE, 1993, BIOELECTROMAGNETICS, V14, P545, DOI 10.1002/bem.2250140606; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2002, IARC Monogr Eval Carcinog Risks Hum, V80, P1; JANCA FC, 1986, BIOL REPROD, V34, P613, DOI 10.1095/biolreprod34.4.613; Karotki AV, 2012, CELL MOL LIFE SCI, V69, P3351, DOI 10.1007/s00018-012-1148-5; Kim AS, 2006, MUTAT RES-REV MUTAT, V613, P138, DOI 10.1016/j.mrrev.2006.09.001; Lee SK, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/567183; Li PZ, 2009, CANCER CAUSE CONTROL, V20, P945, DOI 10.1007/s10552-009-9311-5; Luukkonen J, 2014, MUTAT RES-FUND MOL M, V760, P33, DOI 10.1016/j.mrfmmm.2013.12.002; Marshall GM, 2014, NAT REV CANCER, V14, P277, DOI 10.1038/nrc3679; Mattsson MO, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00132; MCGIVERN RF, 1990, TERATOLOGY, V41, P1, DOI 10.1002/tera.1420410102; Miyakoshi J, 2000, J RADIAT RES, V41, P293, DOI 10.1269/jrr.41.293; Morita T, 1997, MUTAT RES-GEN TOX EN, V389, P3, DOI 10.1016/S1383-5718(96)00070-8; Neri M, 2005, ENVIRON HEALTH PERSP, V113, P1226, DOI 10.1289/ehp.7806; Okudan N, 2010, NEUROENDOCRINOL LETT, V31, P208; Paashuis-Lew YRM, 1998, MUTAGENESIS, V13, P613, DOI 10.1093/mutage/13.6.613; Pafkova Hana, 1994, Reviews on Environmental Health, V10, P235; Repacholi M, 2012, SCI TOTAL ENVIRON, V426, P454, DOI 10.1016/j.scitotenv.2012.03.030; Ryan BM, 1999, TERATOLOGY, V59, P156; SANDERSON BJS, 1993, MUTAT RES, V285, P27, DOI 10.1016/0027-5107(93)90048-K; Svedenstal BM, 1998, ELECTRO MAGNETOBIOL, V17, P127, DOI 10.3109/15368379809022558; Teepen JC, 2012, INT J CANCER, V131, P769, DOI 10.1002/ijc.27542; Tenorio BM, 2011, J APPL TOXICOL, V31, P223, DOI 10.1002/jat.1584; Udroiu I, 2006, INT J RADIAT BIOL, V82, P561, DOI 10.1080/09553000600876660; Udroiu I, 2010, NONTHERMAL EFFECTS M, P123; Udroiu I, 2006, ENVIRON MOL MUTAGEN, V47, P320, DOI 10.1002/em.20209; Udrou I, 2008, EUR J ONCOL, V13, P239; VERGOUWEN RPFA, 1991, J REPROD FERTIL, V93, P233, DOI 10.1530/jrf.0.0930233; VERGOUWEN RPFA, 1995, RADIAT RES, V141, P66, DOI 10.2307/3579091; WERTHEIMER N, 1979, AM J EPIDEMIOL, V109, P273, DOI 10.1093/oxfordjournals.aje.a112681; World Health Organization, 2007, ENV HLTH CRIT, V238; XI WG, 1994, IEEE T BIO-MED ENG, V41, P1018, DOI 10.1109/10.335839; Yoon HE, 2014, INT J RADIAT BIOL, V90, P291, DOI 10.3109/09553002.2014.887866; Zhang XJ, 2007, ELECTROMAGN BIOL MED, V26, P167, DOI 10.1080/15368370701580756; Zuniga-Gonzalez G, 1998, MUTAT RES-GEN TOX EN, V413, P187, DOI 10.1016/S1383-5718(97)00184-8	49	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142259	10.1371/journal.pone.0142259	http://dx.doi.org/10.1371/journal.pone.0142259			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559811	gold, Green Published, Green Submitted			2022-12-26	WOS:000364433100067
J	Baker, EC; Layden, MJ; van Rossum, DB; Kamel, B; Medina, M; Simpson, E; Jegla, T				Baker, Emma C.; Layden, Michael J.; van Rossum, Damian B.; Kamel, Bishoy; Medina, Monica; Simpson, Eboni; Jegla, Timothy			Functional Characterization of Cnidarian HCN Channels Points to an Early Evolution of I-h	PLOS ONE			English	Article							HYPERPOLARIZATION-ACTIVATED CHANNEL; VOLTAGE-SENSOR MOVEMENT; K+ CHANNELS; ION CHANNELS; POTASSIUM CHANNEL; MOLECULAR CHARACTERIZATION; DISTAL DENDRITES; TERMINAL REGION; CATION CHANNEL; SEA-ANEMONE	HCN channels play a unique role in bilaterian physiology as the only hyperpolarizationgated cation channels. Their voltage-gating is regulated by cyclic nucleotides and phosphatidylinositol 4,5-bisphosphate (PIP2). Activation of HCN channels provides the depolarizing current in response to hyperpolarization that is critical for intrinsic rhythmicity in neurons and the sinoatrial node. Additionally, HCN channels regulate dendritic excitability in a wide variety of neurons. Little is known about the early functional evolution of HCN channels, but the presence of HCN sequences in basal metazoan phyla and choanoflagellates, a protozoan sister group to the metazoans, indicate that the gene family predates metazoan emergence. We functionally characterized two HCN channel orthologs from Nematostella vectensis (Cnidaria, Anthozoa) to determine which properties of HCN channels were established prior to the emergence of bilaterians. We find Nematostella HCN channels share all the major functional features of bilaterian HCNs, including reversed voltage-dependence, activation by cAMP and PIP2, and block by extracellular Cs+. Thus bilaterian-like HCN channels were already present in the common parahoxozoan ancestor of bilaterians and cnidarians, at a time when the functional diversity of voltage-gated K+ channels was rapidly expanding. NvHCN1 and NvHCN2 are expressed broadly in planulae and in both the endoderm and ectoderm of juvenile polyps.	[Baker, Emma C.; van Rossum, Damian B.; Kamel, Bishoy; Medina, Monica; Jegla, Timothy] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Layden, Michael J.] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA; [van Rossum, Damian B.; Jegla, Timothy] Huck Inst Life Sci, University Pk, PA USA; [Simpson, Eboni] Penn State Univ, Grad Sch, SROP, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Lehigh University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Jegla, T (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	tjj3@psu.edu	Kamel, Bishoy/H-6166-2019	Kamel, Bishoy/0000-0003-2934-3827; van Rossum, Damian/0000-0003-1011-2586; Jegla, Timothy/0000-0001-8616-2390	Eberly College of Science at Penn State University; Summer Research Opportunities Program (SROP)	Eberly College of Science at Penn State University; Summer Research Opportunities Program (SROP)	This study was funded by start-up funds provided by the Eberly College of Science at Penn State University to TJ. ES was funded by the Summer Research Opportunities Program (SROP) run by the Penn State University Graduate School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Baruscotti M, 2005, PHARMACOL THERAPEUT, V107, P59, DOI 10.1016/j.pharmthera.2005.01.005; Barzilai MG, 2012, CELL REP, V2, P242, DOI 10.1016/j.celrep.2012.06.016; Brams M, 2014, P NATL ACAD SCI USA, V111, P7855, DOI 10.1073/pnas.1401917111; Brelidze TI, 2013, P NATL ACAD SCI USA, V110, P11648, DOI 10.1073/pnas.1306887110; Brelidze TI, 2012, NATURE, V481, P530, DOI 10.1038/nature10735; Brelidze TI, 2009, J BIOL CHEM, V284, P27989, DOI 10.1074/jbc.M109.016337; Bright SR, 2007, MOL PHARMACOL, V71, P176, DOI 10.1124/mol.106.026401; Budde T, 2005, J NEUROSCI, V25, P9871, DOI 10.1523/JNEUROSCI.2590-05.2005; Cai XJ, 2012, GENOMICS, V99, P241, DOI 10.1016/j.ygeno.2012.01.007; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Chen S, 2007, J GEN PHYSIOL, V129, P175, DOI 10.1085/jgp.200609585; Clancy SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006330; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Er F, 2003, CIRCULATION, V107, P485, DOI 10.1161/01.CIR.0000045672.32920.CB; Flynn GE, 2011, J BIOL CHEM, V286, P15535, DOI 10.1074/jbc.M110.214650; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; George MS, 2009, NAT NEUROSCI, V12, P577, DOI 10.1038/nn.2307; Gisselmann G, 2003, INSECT BIOCHEM MOLEC, V33, P1123, DOI 10.1016/S0965-1748(03)00132-2; Gustincich S, 2003, GENOME RES, V13, P1395, DOI 10.1101/gr.1135303; Haitin Y, 2013, NATURE, V501, P444, DOI 10.1038/nature12487; Halaszovich CR, 2009, J BIOL CHEM, V284, P2106, DOI 10.1074/jbc.M803543200; Hedrich R, 2012, PHYSIOL REV, V92, P1777, DOI 10.1152/physrev.00038.2011; Horwitz GC, 2011, J NEUROSCI, V31, P16814, DOI 10.1523/JNEUROSCI.3064-11.2011; Ishii TM, 1999, J BIOL CHEM, V274, P12835, DOI 10.1074/jbc.274.18.12835; Jackson HA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047590; Jegla T, 1995, J NEUROSCI, V15, P7989; JEGLA T, 1994, SOC GEN PHY, V49, P213; JEGLA T, 1995, RECEPTOR CHANNEL, V3, P51; Jegla T, 1997, J NEUROSCI, V17, P32, DOI 10.1523/JNEUROSCI.17-01-00032.1997; Jegla T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051366; Jegla TJ, 2009, COMB CHEM HIGH T SCR, V12, P2, DOI 10.2174/138620709787047957; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Kuo MMC, 2005, FEMS MICROBIOL REV, V29, P961, DOI 10.1016/j.femsre.2005.03.003; Layden MJ, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-30; Layden MJ, 2012, DEVELOPMENT, V139, P1013, DOI 10.1242/dev.073221; Li X, 2015, P NATL ACAD SCI USA, V112, pE1010, DOI 10.1073/pnas.1422941112; Li XF, 2015, J EXP BIOL, V218, P526, DOI 10.1242/jeb.110080; Li Y, 2011, P NATL ACAD SCI USA, V108, P9095, DOI 10.1073/pnas.1100872108; Loukin SH, 2005, J GEN PHYSIOL, V125, P521, DOI 10.1085/jgp.200509261; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; MacKinnon R, 1998, SCIENCE, V280, P106, DOI 10.1126/science.280.5360.106; Mannikko R, 2002, NATURE, V419, P837, DOI 10.1038/nature01038; Marlow H, 2012, DEV BIOL, V362, P295, DOI 10.1016/j.ydbio.2011.11.012; Marlow HQ, 2009, DEV NEUROBIOL, V69, P235, DOI 10.1002/dneu.20698; Martinson AS, 2014, P NATL ACAD SCI USA, V111, P5712, DOI 10.1073/pnas.1321716111; Mistrik P, 2005, J BIOL CHEM, V280, P27056, DOI 10.1074/jbc.M502696200; Moran Y, 2015, J EXP BIOL, V218, P515, DOI 10.1242/jeb.110270; Moran Y, 2014, GENOME BIOL EVOL, V6, P2210, DOI 10.1093/gbe/evu177; Moroz LL, 2014, NATURE, V510, P109, DOI 10.1038/nature13400; Moya A, 2012, MOL ECOL, V21, P2440, DOI 10.1111/j.1365-294X.2012.05554.x; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Nolan MF, 2004, CELL, V119, P719, DOI 10.1016/S0092-8674(04)01055-4; Ouyang Q, 2007, J NEUROPHYSIOL, V97, P3880, DOI 10.1152/jn.00246.2007; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Pian P, 2006, J GEN PHYSIOL, V128, P593, DOI 10.1085/jgp.200609648; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Renfer E, 2010, P NATL ACAD SCI USA, V107, P104, DOI 10.1073/pnas.0909148107; Riesgo A, 2014, MOL BIOL EVOL, V31, P1102, DOI 10.1093/molbev/msu057; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Rodriguez-Menchaca AA, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00170; Rodriguez-Menchaca AA, 2012, P NATL ACAD SCI USA, V109, pE2399, DOI 10.1073/pnas.1207901109; Ryan JF, 2013, SCIENCE, V342, P1336, DOI 10.1126/science.1242592; Ryan JF, 2010, EVODEVO, V1, DOI 10.1186/2041-9139-1-9; Salichos L, 2013, NATURE, V497, P327, DOI 10.1038/nature12130; Sand RM, 2011, J EXP BIOL, V214, P3124, DOI 10.1242/jeb.057000; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; SCHACHTMAN DP, 1992, SCIENCE, V258, P1654, DOI 10.1126/science.8966547; Seifert R, 1999, P NATL ACAD SCI USA, V96, P9391, DOI 10.1073/pnas.96.16.9391; SENTENAC H, 1992, SCIENCE, V256, P663, DOI 10.1126/science.1585180; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Stieber J, 2005, J BIOL CHEM, V280, P34635, DOI 10.1074/jbc.M502508200; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tsay D, 2007, NEURON, V56, P1076, DOI 10.1016/j.neuron.2007.11.015; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Whelan NV, 2015, P NATL ACAD SCI USA, V112, P5773, DOI 10.1073/pnas.1503453112; Ying SW, 2007, J NEUROSCI, V27, P8719, DOI 10.1523/JNEUROSCI.1630-07.2007; Yu Frank H, 2004, Sci STKE, V2004, pre15, DOI 10.1126/stke.2532004re15; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zaydman MA, 2013, P NATL ACAD SCI USA, V110, P13180, DOI 10.1073/pnas.1305167110; Zhainazarov AB, 2004, J MEMBRANE BIOL, V201, P51, DOI 10.1007/s00232-004-0707-4; Zolles G, 2006, NEURON, V52, P1027, DOI 10.1016/j.neuron.2006.12.005	90	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142730	10.1371/journal.pone.0142730	http://dx.doi.org/10.1371/journal.pone.0142730			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555239	Green Submitted, Green Published, gold			2022-12-26	WOS:000364430700161
J	Bellavia, D; Cataliotti, A; Clemenza, F; Baravoglia, CH; Luca, A; Traina, M; Gridelli, B; Bertani, T; Burnett, JC; Scardulla, C				Bellavia, Diego; Cataliotti, Alessandro; Clemenza, Francesco; Baravoglia, Cesar Hernandez; Luca, Angelo; Traina, Marcello; Gridelli, Bruno; Bertani, Tullio; Burnett, John C.; Scardulla, Cesare			Long-Term Structural and Functional Myocardial Adaptations in Healthy Living Kidney Donors: A Pilot Study	PLOS ONE			English	Article							SPECKLE-TRACKING ECHOCARDIOGRAPHY; CARDIOVASCULAR-DISEASE; DIASTOLIC DYSFUNCTION; TISSUE DOPPLER; ASSOCIATION; PROPEPTIDE; FIBROSIS; STIFFNESS; MARKERS; UTILITY	Background and Aims Compensatory renal hypertrophy following unilateral nephrectomy (UNX) occurs in the remaining kidney. However, the long-term cardiac adaptive process to UNX remains poorly defined in humans. Our goal was to characterize myocardial structure and function in living kidney donors (LKDs), approximately 12 years after UNX. Methods and Results Cardiac function and structure in 15 Italian LKDs, at least 5 years after UNX (median time from donation = 8.4 years) was investigated and compared to those of age and sex matched U.S. citizens healthy controls (n = 15). Standard and speckle tracking echocardiography (STE) was performed in both LKDs and controls. Plasma angiotensin II, aldosterone, atrial natriuretic peptide (ANP), N terminus pro B-type natriuretic peptide (NT-proBNP), cyclic guanylyl monophosphate (cGMP), and amino-terminal peptide of procollagen III (PIIINP) were also collected. Median follow-up was 11.9 years. In LKDs, LV geometry and function by STE were similar to controls, wall thickness and volumes were within normal limits also by CMR. In LKDs, CMR was negative for myocardial fibrosis, but apical rotation and LV torsion obtained by STE were impaired as compared to controls (21.4 +/- 7.8 vs 32.7 +/- 8.9 degrees, p = 0.04). Serum creatinine and PIIINP levels were increased [1.1 (0.9-1.3) mg/dL, and 5.8 (5.4-7.6)] mu g/L, respectively), while urinary cGMP was reduced [270 (250-355) vs 581 (437-698) pmol/mL] in LKDs. No LKD developed cardiovascular or renal events during follow-up. Conclusions Long-term kidney donors have no apparent structural myocardial abnormalities as assessed by contrast enhanced CMR. However, myocardial deformation of the apical segments, as well as apical rotation, and LV torsion are reduced. The concomitant increase in circulating PIIINP level is suggestive of fibrosis. Further studies, focused on US and EU patients are warranted to evaluate whether these early functional modifications will progress to a more compromised cardiac function and structure at a later time.	[Bellavia, Diego; Clemenza, Francesco; Baravoglia, Cesar Hernandez; Gridelli, Bruno; Scardulla, Cesare] Mediterranean Inst Transplantat & Adv Specialized, Div Cardiovasc Dis, Palermo, Italy; [Bellavia, Diego; Burnett, John C.] Mayo Clin, Cardiorenal Res Lab, Div Cardiovasc Dis, Rochester, MN USA; [Cataliotti, Alessandro] Univ Oslo, Inst Clin Med, Oslo, Norway; [Cataliotti, Alessandro] Univ Oslo, Expt Med Res Inst, Oslo, Norway; [Cataliotti, Alessandro] Oslo Univ Hosp, Oslo, Norway; [Luca, Angelo] Mediterranean Inst Transplantat & Adv Specialized, Dept Radiol, Palermo, Italy; [Traina, Marcello] Univ Palermo, Sport & Exercise Sci DISMOT Res Unit, Palermo, Italy; [Bertani, Tullio] Mediterranean Inst Transplantat & Adv Specialized, Div Nephrol, Palermo, Italy	IRCCS Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione (ISMETT); Mayo Clinic; University of Oslo; University of Oslo; University of Oslo; IRCCS Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione (ISMETT); University of Palermo; IRCCS Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione (ISMETT)	Bellavia, D (corresponding author), Mediterranean Inst Transplantat & Adv Specialized, Div Cardiovasc Dis, Palermo, Italy.	dbellavia@ismett.edu	traina, mario/A-1309-2012; Bellavia, Diego/K-3072-2018	Traina, Marcello/0000-0003-2373-3621; Bellavia, Diego/0000-0003-3808-2868	Doris Duke Charitable Foundation [2006064]	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF))	This work was supported by the grant Clinical Scientific Development Award (CSDA) 2006064 (A.C.) from the Doris Duke Charitable Foundation.	Abraham TP, 2007, CIRCULATION, V116, P2597, DOI 10.1161/CIRCULATIONAHA.106.647172; Bellavia D, 2008, HEART; Bellavia D, 2010, HEART, V96, P440, DOI 10.1136/hrt.2009.182170; Cataliotti A, 2002, AM J PHYSIOL-RENAL, V283, pF464, DOI 10.1152/ajprenal.00372.2001; Chatzikyriakou SV, 2008, EUR J HEART FAIL, V10, P1181, DOI 10.1016/j.ejheart.2008.09.007; Cicoira M, 2004, J CARD FAIL, V10, P403, DOI 10.1016/j.cardfail.2004.01.010; Dellegrottaglie S, 2011, NEPHROL DIAL TRANSPL, V26, P2891, DOI 10.1093/ndt/gfr186; Diagnostica O. PIIINP RIA*. Intact N-terminal propeptide of type III procollagen, 2009, RADIOIMMUNOASSAY KIT; Ellims AH, 2014, CIRC-HEART FAIL, V7, P271, DOI 10.1161/CIRCHEARTFAILURE.113.000665; FehrmanEkholm I, 1997, TRANSPLANTATION, V64, P976, DOI 10.1097/00007890-199710150-00007; Garg AX, 2006, KIDNEY INT, V70, P1801, DOI 10.1038/sj.ki.5001819; Garg AX, 2012, BMJ-BRIT MED J, P344; Go A, 2013, HEAR DIS STROKE STAT, V127, pe1; Ibrahim HN, 2009, NEW ENGL J MED, V360, P459, DOI 10.1056/NEJMoa0804883; Kido R, 2009, AM J TRANSPLANT, V9, P2514, DOI 10.1111/j.1600-6143.2009.02795.x; Kottgen A, 2008, AM J KIDNEY DIS, V51, P385, DOI 10.1053/j.ajkd.2007.11.019; Kwon DH, 2008, INT J CARDIOVAS IMAG, V24, P617, DOI 10.1007/s10554-008-9292-6; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Martin FL, 2012, AM J PHYSIOL-REG I, V302, pR292, DOI 10.1152/ajpregu.00194.2011; Marwick TH, 2009, JACC-CARDIOVASC IMAG, V2, P80, DOI 10.1016/j.jcmg.2007.12.007; Mjoen G, 2014, KIDNEY INT, V86, P162, DOI 10.1038/ki.2013.460; Muzaale AD, 2014, JAMA-J AM MED ASSOC, V311, P579, DOI 10.1001/jama.2013.285141; Nichols M, 2013, EUR HEART J, V34, P3028, DOI 10.1093/eurheartj/eht356; OHYAMA K, 1990, BIOCHIM BIOPHYS ACTA, V1053, P173, DOI 10.1016/0167-4889(90)90010-B; Ommen SR, 2000, CIRCULATION, V102, P1788; Park SJ, 2008, J AM SOC ECHOCARDIOG, V21, P1129, DOI 10.1016/j.echo.2008.04.002; Reese PP, 2015, AM J TRANSPLANT, V15, P287, DOI 10.1111/ajt.13015; RISTELI J, 1988, CLIN CHEM, V34, P715; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Segev DL, 2010, JAMA-J AM MED ASSOC, V303, P959, DOI 10.1001/jama.2010.237; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Teppo AM, 2003, TRANSPLANTATION, V75, P2113, DOI 10.1097/01.TP.0000066809.60389.48; World Health Organization, 2022, GLOB HLTH OBS	34	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142103	10.1371/journal.pone.0142103	http://dx.doi.org/10.1371/journal.pone.0142103			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556804	Green Published, gold, Green Submitted			2022-12-26	WOS:000364430700053
J	Dickinson-Copeland, CM; Wilson, NO; Liu, ML; Driss, A; Salifu, H; Adjel, AA; Wilson, M; Gyan, B; Oduro, D; Badu, K; Botchway, F; Anderson, W; Bond, V; Bacanamwo, M; Singh, S; Stiles, JK				Dickinson-Copeland, Carmen M.; Wilson, Nana O.; Liu, Mingli; Driss, Adel; Salifu, Hassana; Adjel, Andrew A.; Wilson, Michael; Gyan, Ben; Oduro, Daniel; Badu, Kingsley; Botchway, Felix; Anderson, Winston; Bond, Vincent; Bacanamwo, Methode; Singh, Shailesh; Stiles, Jonathan K.			Heme-Mediated Induction of CXCL10 and Depletion of CD34+Progenitor Cells Is Toll-Like Receptor 4 Dependent	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; CEREBRAL MALARIA; PLASMODIUM-FALCIPARUM; OXYGENASE-1; ACTIVATION; EXPRESSION; PATHOGENESIS; NEOVASCULARIZATION; SUSCEPTIBILITY; MOBILIZATION	Plasmodium falciparum infection can cause microvascular dysfunction, cerebral encephalopathy and death if untreated. We have previously shown that high concentrations of free heme, and C-X-C motif chemokine 10 (CXCL10) in sera of malaria patients induce apoptosis in microvascular endothelial and neuronal cells contributing to vascular dysfunction, blood-brain barrier (BBB) damage and mortality. Endothelial progenitor cells (EPC) are microvascular endothelial cell precursors partly responsible for repair and regeneration of damaged BBB endothelium. Studies have shown that EPC's are depleted in severe malaria patients, but the mechanisms mediating this phenomenon are unknown. Toll-like receptors recognize a wide variety of pathogen-associated molecular patterns generated by pathogens such as bacteria and parasites. We tested the hypothesis that EPC depletion during malaria pathogenesis is a function of heme-induced apoptosis mediated by CXCL10 induction and toll-like receptor (TLR) activation. Heme and CXCL10 concentrations in plasma obtained from malaria patients were elevated compared with non-malaria subjects. EPC numbers were significantly decreased in malaria patients (P < 0.02) and TLR4 expression was significantly elevated in vivo. These findings were confirmed in EPC precursors in vitro; where it was determined that heme-induced apoptosis and CXCL10 expression was TLR4-mediated. We conclude that increased serum heme mediates depletion of EPC during malaria pathogenesis.	[Dickinson-Copeland, Carmen M.; Wilson, Nana O.; Liu, Mingli; Driss, Adel; Salifu, Hassana; Bond, Vincent; Singh, Shailesh; Stiles, Jonathan K.] Morehouse Sch Med, Dept Biochem & Immunol, Atlanta, GA 30310 USA; [Adjel, Andrew A.; Botchway, Felix] Univ Ghana, Sch Med, Korle Bu Teaching Hosp, Dept Pathol, Accra, Ghana; [Adjel, Andrew A.; Wilson, Michael; Gyan, Ben; Oduro, Daniel] Univ Ghana, Noguchi Mem Inst Med Res, Dept Parasitol, Accra, Ghana; [Badu, Kingsley] Univ Ghana, Noguchi Mem Inst Med Res, Dept Immunol, Accra, Ghana; [Anderson, Winston] Howard Univ, Dept Biol, Washington, DC 20059 USA; [Bacanamwo, Methode] Morehouse Sch Med, Cardiovasc Res Inst, Atlanta, GA 30310 USA	Morehouse School of Medicine; University of Ghana; University of Ghana; University of Ghana; Howard University; Morehouse School of Medicine	Dickinson-Copeland, CM (corresponding author), Morehouse Sch Med, Dept Biochem & Immunol, Atlanta, GA 30310 USA.	cdcopeland@msm.edu; jstiles@msm.edu	Stiles, Jonathan K./AFM-1940-2022; Driss, Adel/X-6772-2019; Driss, Adel/A-4151-2008; Badu, Kingsley/AAE-8418-2020	Badu, Kingsley/0000-0002-7886-5528; Adjei, Andrew Anthony/0000-0001-5109-2919; Stiles, Jonathan Kwamina/0000-0003-0829-1482	National Institute of Minority Health and Health Disparities (NIMHD) [8G12MD007602, 1R56NS091616-01]; T-32 Sleep/Cardiovascular Grant [5T32HL103104-02]; Clinical Research Education and Career Development (CRECD) Grant [2R25RR017694-06A1]; Minority Biomedical Research Support Program (NIH/NIGMS) Grant [2R25GM058268]; National Institutes of Health Fogarty International Center [1R25TW009340]; National Institute of Neurological Disorders and Stroke (NINDS) [R21TW006804]; American Society for Microbiology Robert D. Watkins Graduate Fellowship; FOGARTY INTERNATIONAL CENTER [R25TW009340, R21TW006804] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R25RR017694] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL103104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM058268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS091616, R01NS091616] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007588, T37MD008639, G12MD007602] Funding Source: NIH RePORTER	National Institute of Minority Health and Health Disparities (NIMHD); T-32 Sleep/Cardiovascular Grant; Clinical Research Education and Career Development (CRECD) Grant; Minority Biomedical Research Support Program (NIH/NIGMS) Grant; National Institutes of Health Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Society for Microbiology Robert D. Watkins Graduate Fellowship; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by Grants # 8G12MD007602 and 1R56NS091616-01 from the National Institute of Minority Health and Health Disparities (NIMHD), T-32 Sleep/Cardiovascular Grant # 5T32HL103104-02, Clinical Research Education and Career Development (CRECD) Grant # 2R25RR017694-06A1, Minority Biomedical Research Support Program (NIH/NIGMS) Grant # 2R25GM058268, National Institutes of Health Fogarty International Center #1R25TW009340, National Institute of Neurological Disorders and Stroke (NINDS) #R21TW006804, and the American Society for Microbiology Robert D. Watkins Graduate Fellowship. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIMHD or the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDALLA SH, 1990, BLOOD CELLS, V16, P401; Andrade BB, 2010, J IMMUNOL, V185, P1196, DOI 10.4049/jimmunol.0904179; Apinjohr TO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081071; Armah H, 2005, ANN TROP MED PARASIT, V99, P629, DOI 10.1179/136485905X51508; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Baldridge MT, 2011, TRENDS IMMUNOL, V32, P57, DOI 10.1016/j.it.2010.12.003; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Belcher JD, 2013, ISRN OXIDATIVE MED, V2013, P1; Belcher JD, 2014, BLOOD, V123, P377, DOI 10.1182/blood-2013-04-495887; Blann AD, 2006, ATHEROSCLEROSIS, V188, P12, DOI 10.1016/j.atherosclerosis.2005.12.024; Campos MA, 2001, J IMMUNOL, V167, P416, DOI 10.4049/jimmunol.167.1.416; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; Coban C, 2007, INT IMMUNOL, V19, P67, DOI 10.1093/intimm/dxl123; Couper KN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000744; Crosby HA, 2009, J HEPATOL, V51, P734, DOI 10.1016/j.jhep.2009.06.021; Cunnington AJ, 2012, J IMMUNOL, V189, P5336, DOI 10.4049/jimmunol.1201028; Datta D, 2007, AM J PHYSIOL-RENAL, V293, pF1222, DOI 10.1152/ajprenal.00164.2007; Dey S, 2012, J BIOL CHEM, V287, P26630, DOI 10.1074/jbc.M112.341255; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; DORMER P, 1983, BLUT, V46, P279, DOI 10.1007/BF00319868; Driss A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-271; Egan CG, 2008, DIABETOLOGIA, V51, P1296, DOI 10.1007/s00125-008-0939-6; Esamai F, 2003, J TROP PEDIATRICS, V49, P216, DOI 10.1093/tropej/49.4.216; Esplin BL, 2011, J IMMUNOL, V186, P5367, DOI 10.4049/jimmunol.1003438; Fadini GP, 2006, DIABETOLOGIA, V49, P3075, DOI 10.1007/s00125-006-0401-6; Fortes GB, 2012, BLOOD, V119, P2368, DOI 10.1182/blood-2011-08-375303; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; Gyan B, 2009, AM J TROP MED HYG, V80, P541, DOI 10.4269/ajtmh.2009.80.541; Herrmann M, 2014, STEM CELL RES, V13, P465, DOI 10.1016/j.scr.2014.10.005; Hunt NH, 2007, NAT MED, V13, P667, DOI 10.1038/nm0607-667; Hunt NH, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00113; Hwang SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101558; Idro Richard, 2010, BMC Res Notes, V3, P104, DOI 10.1186/1756-0500-3-104; Imaizumi T, 2013, NEUROSCI RES, V76, P195, DOI 10.1016/j.neures.2013.05.002; Ingram DA, 2005, BLOOD, V105, P2783, DOI 10.1182/blood-2004-08-3057; Jain V, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-83; Jain V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-383; Jialal I, 2010, AM J CARDIOL, V106, P1606, DOI 10.1016/j.amjcard.2010.07.039; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; Lapergue B, 2007, PROG NEUROBIOL, V83, P349, DOI 10.1016/j.pneurobio.2007.08.001; Lin YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084731; Liu ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071366; Liu ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034280; Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001; Lucchi NW, 2011, DIS MARKERS, V31, P327, DOI [10.1155/2011/345706, 10.3233/DMA-2011-0854]; Maratheftis CI, 2007, CLIN CANCER RES, V13, P1154, DOI 10.1158/1078-0432.CCR-06-2108; May L, 2010, EUR J HUM GENET, V18, P490, DOI 10.1038/ejhg.2009.182; Mockenhaupt FP, 2006, P NATL ACAD SCI USA, V103, P177, DOI 10.1073/pnas.0506803102; Murayama T, 2002, EXP HEMATOL, V30, P967, DOI 10.1016/S0301-472X(02)00867-6; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Pamplona A, 2009, INT J BIOCHEM CELL B, V41, P711, DOI 10.1016/j.biocel.2008.09.020; Rodriguez S, 2009, BLOOD, V114, P4064, DOI 10.1182/blood-2009-04-214916; Schaer DJ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00415; Schroder NW, 2005, LANCET INFECT DIS, V5, P156, DOI 10.1016/S1473-3099(05)70023-2; Seixas E, 2009, P NATL ACAD SCI USA, V106, P15837, DOI 10.1073/pnas.0903419106; Service GS, 2011, GHAN MULT IND CLUST; Shih RH, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-86; Takeda M, 2005, JPN J INFECT DIS, V58, P268; Tolosano E, 2010, ANTIOXID REDOX SIGN, V12, P305, DOI 10.1089/ars.2009.2787; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Vinchi F, 2008, AM J PATHOL, V173, P289, DOI 10.2353/ajpath.2008.071130; Vinchi F, 2013, CIRCULATION, V127, P1317, DOI 10.1161/CIRCULATIONAHA.112.130179; Wagener FADTG, 2003, PHARMACOL REV, V55, P551, DOI 10.1124/pr.55.3.5; White NJ, 1996, NEW ENGL J MED, V335, P800, DOI 10.1056/NEJM199609123351107; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wilson N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081329; Wilson NO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060898; Wilson NO, 2011, AM J TROP MED HYG, V85, P12, DOI 10.4269/ajtmh.2011.10-0512; Yanagibashi T, 2015, IMMUNOL LETT, V163, P22, DOI 10.1016/j.imlet.2014.11.012; Young PP, 2007, PROG CARDIOVASC DIS, V49, P421, DOI 10.1016/j.pcad.2007.02.004	72	11	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142328	10.1371/journal.pone.0142328	http://dx.doi.org/10.1371/journal.pone.0142328			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555697	gold, Green Submitted, Green Published			2022-12-26	WOS:000364430700085
J	Fernandez-Lansac, V; Crespo, M				Fernandez-Lansac, Violeta; Crespo, Maria			Narrative Length and Speech Rate in Battered Women	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC MEMORIES; AUTOBIOGRAPHICAL MEMORY; LINGUISTIC PREDICTORS; SYMPTOMS; DEPRESSION; DISSOCIATION; ORGANIZATION; QUALITIES; PTSD	Narrative length and speech rate of traumatic recollections have been previously associated with different emotions and adjustment trajectories after trauma. However, the evidence is limited and the results are mixed. The present study aimed to evaluate length (i.e., word count) and speech rate (i.e., words per minute) in narratives of events with different valence (i.e., neutral, positive, and negative/traumatic) by 50 battered women (trauma group) and 50 non-traumatized women (controls). The results showed that traumatic narratives by the trauma group were longer than those by the control group. Moreover, they were inversely related to time since the event and anxiety during disclosure, whereas the speech rate was also inversely associated with anxiety, as well as with peritraumatic dissociation and avoidance. The shorter narratives for positive events and a decelerated speech pattern for traumatic experiences predicted psychological symptoms. Additionally, the individual's emotional state predicted narrative aspects, with bidirectional effects. Our findings showed that linguistic characteristics of traumatic narratives (but also of narratives of positive events) revealed information about how the victims elaborated autobiographical memories and coped with the trauma.	[Fernandez-Lansac, Violeta; Crespo, Maria] Univ Complutense Madrid, Fac Psicol, Madrid, Spain	Complutense University of Madrid	Crespo, M (corresponding author), Univ Complutense Madrid, Fac Psicol, Campus Somosaguas, Madrid, Spain.	mcrespo@psi.ucm.es	Fernández-Lansac, Violeta/P-3072-2016; CRESPO, MARIA/C-8623-2011	Fernández-Lansac, Violeta/0000-0002-5157-7083; CRESPO, MARIA/0000-0001-8762-7874	Spanish Ministry of Economy and Competitiveness Grant from the Complutense University at Madrid [PSI2012-31952]	Spanish Ministry of Economy and Competitiveness Grant from the Complutense University at Madrid	This work was supported by the Project PSI2012-31952 from the Spanish Ministry of Economy and Competitiveness Grant 2011/2015 from the Complutense University at Madrid (awarded to V. Fernandez-Lansac). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Conrad J, 2001, APPL COGNITIVE PSYCH, V15, pS159, DOI 10.1002/acp.839; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Beaudreau SA, 2006, PSYCINFO; Beaudreau SA, 2007, J TRAUMA STRESS, V20, P353, DOI 10.1002/jts.20206; Beck A.T., 1990, MANUAL BECK ANXIETY; Beck AT, 1996, BDI 2 BECK DEPRESSIO; Berntsen D, 2006, BEHAV RES THER, V44, P219, DOI 10.1016/j.brat.2005.01.009; Berntsen D, 2003, APPL COGNITIVE PSYCH, V17, P675, DOI 10.1002/acp.894; Brewin CR, 1996, PSYCHOL REV, V103, P670, DOI 10.1037/0033-295X.103.4.670; Brewin CR, 2003, CLIN PSYCHOL REV, V23, P339, DOI 10.1016/S0272-7358(03)00033-3; Crespo M., 2012, EGEP EVALUACION GLOB; Crespo M, 2016, PSYCHOL TRAUMA-US, V8, P149, DOI 10.1037/tra0000041; D'Andrea W, 2012, APPL COGNITIVE PSYCH, V26, P316, DOI 10.1002/acp.1830; Dekel S, 2013, PSYCHOL TRAUMA-US, V5, P26, DOI 10.1037/a0022750; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Foa E. B., 1993, AM PSYCHIAT PRESS RE, V12, P273; FOA EB, 1995, J TRAUMA STRESS, V8, P675, DOI 10.1007/BF02102894; Freer BD, 2010, VIOLENCE VICTIMS, V25, P742, DOI 10.1891/0886-6708.25.6.742; Gray MJ, 2001, APPL COGNITIVE PSYCH, V15, pS171, DOI 10.1002/acp.840; Greenhoot AF, 2013, MEMORY, V21, P125, DOI 10.1080/09658211.2012.712975; Hashemi B, 2008, B MENNINGER CLIN, V72, P179, DOI 10.1521/bumc.2008.72.3.179; Jelinek L, 2009, J ABNORM PSYCHOL, V118, P288, DOI 10.1037/a0015633; Kensinger E.A., 2008, HDB EMOTIONS, V3rd ed., P601; KUYKEN W, 1995, BRIT J CLIN PSYCHOL, V34, P89, DOI 10.1111/j.2044-8260.1995.tb01441.x; Lindblom KM, 2010, APPL COGNITIVE PSYCH, V24, P1, DOI 10.1002/acp.1547; Marmar CR, 1998, PROG PSYCH, P229; Marmar CR, 2004, ASSESSING PSYCHOL TR, P144; O'Kearney R, 2006, J TRAUMA STRESS, V19, P81, DOI 10.1002/jts.20099; O'Kearney R, 2011, J TRAUMA STRESS, V24, P716, DOI 10.1002/jts.20690; Pennebaker J. W., 2001, LINGUISTIC INQUIRY W; Ramirez-Esparza N, 2007, REV MEX PSICOL, V24, P85; Romisch S, 2014, PSYCHOL TRAUMA-US, V6, P465, DOI 10.1037/a0035169; SIEGMAN AW, 1993, J ABNORM PSYCHOL, V102, P430, DOI 10.1037/0021-843X.102.3.430; VANDERKOLK BA, 1995, J TRAUMA STRESS, V8, P505, DOI 10.1002/jts.2490080402; Wechsler D., 1997, WECHSLER ADULT INTEL; WILLIAMS JMG, 1988, PSYCHOL MED, V18, P689, DOI 10.1017/S0033291700008370	36	12	12	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142651	10.1371/journal.pone.0142651	http://dx.doi.org/10.1371/journal.pone.0142651			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7CT	26556474	gold, Green Published, Green Submitted			2022-12-26	WOS:000364430700150
J	Huang, YW; Zhang, H; Li, XD; Hu, SX; Cai, L; Sun, QL; Li, WC; Deng, ZH; Xiang, XY; Zhang, HJ; Li, FC; Gao, LD				Huang, Yiwei; Zhang, Hong; Li, Xiaodan; Hu, Shixiong; Cai, Liang; Sun, Qianlai; Li, Wenchao; Deng, Zhihong; Xiang, Xingyu; Zhang, Hengjiao; Li, Fangcai; Gao, Lidong			Detection and Genetic Characteristics of H9N2 Avian Influenza Viruses from Live Poultry Markets in Hunan Province, China	PLOS ONE			English	Article							HUMAN INFECTION; A VIRUSES; INTERNAL GENES; BIRD MARKETS; H5N1; H7N9; TRANSMISSION; REPLICATION; EVOLUTION; CHICKENS	H9N2 avian influenza viruses (AIVs) are highly prevalent and of low pathogenicity in domestic poultry. These viruses show a high genetic compatibility with other subtypes of AIVs and have been involved in the genesis of H5N1, H7N9 and H10N8 viruses causing severe infection in humans. The first case of human infection with H9N2 viruses in Hunan province of China have been confirmed in November 2013 and identified that H9N2 viruses from live poultry markets (LPMs) near the patient's house could be the source of infection. However, the prevalence, distribution and genetic characteristics of H9N2 viruses in LPMs all over the province are not clear. We collected and tested 3943 environmental samples from 380 LPMs covering all 122 counties/districts of Hunan province from February to April, 2014. A total of 618 (15.7%) samples were H9 subtype positive and 200 (52.6%) markets in 98 (80.3%) counties/districts were contaminated with H9 subtype AIVs. We sequenced the entire coding sequences of the genomes of eleven H9N2 isolates from environmental samples. Phylogenetic analysis showed that the gene sequences of the H9N2 AIVs exhibited high homology (94.3%-100%). All eleven viruses were in a same branch in the phylogenetic trees and belonged to a same genotype. No gene reassortment had been found. Molecular analysis demonstrated that all the viruses had typical molecular characteristics of contemporary avian H9N2 influenza viruses. Continued surveillance of AIVs in LPMs is warranted for identification of further viral evolution and novel reassortants with pandemic potential.	[Huang, Yiwei; Zhang, Hong; Hu, Shixiong; Cai, Liang; Sun, Qianlai; Li, Wenchao; Deng, Zhihong; Xiang, Xingyu; Zhang, Hengjiao; Li, Fangcai; Gao, Lidong] Hunan Prov Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China; [Li, Xiaodan] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Gao, LD (corresponding author), Hunan Prov Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China.	810173358@qq.com			Hunan Provincial Health and Family Planning Commission, China [C2015-63]; National Science and Technology Key Project of China [2013ZX10004-202]	Hunan Provincial Health and Family Planning Commission, China; National Science and Technology Key Project of China	This work was supported by the grant from Hunan Provincial Health and Family Planning Commission, China (C2015-63), and by the National Science and Technology Key Project of China (2013ZX10004-202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; BEAN WJ, 1989, J INFECT DIS, V159, P1050, DOI 10.1093/infdis/159.6.1050; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Chen HY, 2014, LANCET, V383, P714, DOI 10.1016/S0140-6736(14)60111-2; Chen ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107266; Deng GH, 2013, J VIROL, V87, P9452, DOI 10.1128/JVI.00776-13; Dong GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017212; Fournie G, 2011, J R SOC INTERFACE, V8, P1079, DOI 10.1098/rsif.2010.0510; Fusaro A, 2011, J VIROL, V85, P8413, DOI 10.1128/JVI.00219-11; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gu M, 2014, VET MICROBIOL, V174, P309, DOI 10.1016/j.vetmic.2014.09.029; Guan Y, 1999, P NATL ACAD SCI USA, V96, P9363, DOI 10.1073/pnas.96.16.9363; Guo YJ, 2000, VIROLOGY, V267, P279, DOI 10.1006/viro.1999.0115; Huang Yi-wei, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P709; Huang YW, 2015, J MED VIROL, V87, P1641, DOI 10.1002/jmv.24231; Hurt AC, 2009, DRUGS, V69, P2523, DOI 10.2165/11531450-000000000-00000; Indriani R, 2010, EMERG INFECT DIS, V16, P1889, DOI 10.3201/eid1612.100402; Kang M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126335; Ke CW, 2014, EMERG INFECT DIS, V20, P2034, DOI 10.3201/eid2012.140765; Lam TTY, 2013, NATURE, V502, P241, DOI 10.1038/nature12515; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Lin YP, 2000, P NATL ACAD SCI USA, V97, P9654, DOI 10.1073/pnas.160270697; Massin P, 2001, J VIROL, V75, P5398, DOI 10.1128/JVI.75.11.5398-5404.2001; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Matrosovich MN, 1997, VIROLOGY, V233, P224, DOI 10.1006/viro.1997.8580; Matrosovich MN, 2001, VIROLOGY, V281, P156, DOI 10.1006/viro.2000.0799; Ni XS, 2015, MICROBES INFECT, V17, P48, DOI 10.1016/j.micinf.2014.09.007; Nili H, 2002, AVIAN PATHOL, V31, P247, DOI 10.1080/03079450220136567; Peiris JSM, 2001, J VIROL, V75, P9679, DOI 10.1128/JVI.75.20.9679-9686.2001; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Ping JH, 2010, J VIROL, V84, P10606, DOI 10.1128/JVI.01187-10; Pu J, 2015, P NATL ACAD SCI USA, V112, P548, DOI 10.1073/pnas.1422456112; Tian J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038233; To KKW, 2013, LANCET INFECT DIS, V13, P809, DOI 10.1016/S1473-3099(13)70167-1; Wan HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002923; Wang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101287; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; World Health Organization (WHO), WHO INF MOL DIAGN IN; Yu HJ, 2006, LANCET, V367, P84, DOI 10.1016/S0140-6736(05)67894-4; Yu HJ, 2014, LANCET, V383, P541, DOI 10.1016/S0140-6736(13)61904-2; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; Zhang PH, 2009, J VIROL, V83, P8428, DOI 10.1128/JVI.00659-09; Zhu Y, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-77	43	9	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142584	10.1371/journal.pone.0142584	http://dx.doi.org/10.1371/journal.pone.0142584			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554921	gold, Green Submitted, Green Published			2022-12-26	WOS:000364430700138
J	Zhang, YD; Peng, WS; Ao, X; Dai, HY; Yuan, L; Huang, XZ; Zhou, QL				Zhang, Yide; Peng, Weisheng; Ao, Xiang; Dai, Houyong; Yuan, Li; Huang, Xinzhong; Zhou, Qiaoling			TAK-242, a Toll-Like Receptor 4 Antagonist, Protects against Aldosterone-Induced Cardiac and Renal Injury	PLoS One			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; ACUTE KIDNEY INJURY; DIABETIC-NEPHROPATHY; BLOOD-PRESSURE; INFLAMMATION; FIBROSIS; DAMAGE; TLR4; EPLERENONE; EXPRESSION	Cardiovascular and renal inflammation induced by Aldosterone (Aldo) plays an important role in the pathogenesis of hypertension and renal fibrosis. Toll-like receptor 4 (TLR4) signaling contributes to inflammatory cardiovascular and renal diseases, but its role in Aldo-induced hypertension and renal damage is not clear. In the current study, rats were treated with Aldo-salt combined with TAK-242 (a TLR4 signaling antagonist) for 4 weeks. Hemodynamic, cardiac and renal parameters were assayed at the indicated time. We found that Aldosalt-treated rats present cardiac and renal hypertrophy and dysfunction. Cardiac and renal expression levels of TLR4 as well as levels of molecular markers attesting inflammation and fibrosis are increased by Aldo infusion, whereas the treatment of TAK-242 reverses these alterations. TAK-242 suppresses cardiac and renal inflammatory cytokines levels (TNF-a, IL-1 beta and MCP-1). Furthermore, TAK-242 inhibits hypertension, cardiac and renal fibrosis, and also attenuates the Aldo-induced Epithelial-Mesenchymal Transition (EMT). In experimental hyperaldosteronism, upregulation of TLR4 is correlated with cardiac and renal fibrosis and dysfunction, and a TLR4 signaling antagonist, TAK-242, can reverse these alterations. TAK-242 may be a therapeutic option for salt-sensitive hypertension and renal fibrosis.	[Zhang, Yide; Dai, Houyong; Yuan, Li; Huang, Xinzhong] Nantong Univ, Dept Nephrol, Affiliated Hosp, Nantong, Jiangsu, Peoples R China; [Peng, Weisheng; Ao, Xiang; Zhou, Qiaoling] Cent S Univ, Affiliated Xiangya Hosp, Dept Nephrol, Changsha, Hunan, Peoples R China	Nantong University; Central South University	Zhou, QL (corresponding author), Cent S Univ, Affiliated Xiangya Hosp, Dept Nephrol, Changsha, Hunan, Peoples R China.	zqling8315@163.com						Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Beg AA, 2002, TRENDS IMMUNOL, V23, P509, DOI 10.1016/S1471-4906(02)02317-7; Briet M, 2010, NAT REV NEPHROL, V6, P261, DOI 10.1038/nrneph.2010.30; Brown NJ, 2013, NAT REV NEPHROL, V9, P459, DOI 10.1038/nrneph.2013.110; Brown NJ, 2000, KIDNEY INT, V58, P1219, DOI 10.1046/j.1523-1755.2000.00277.x; Clemitson JR, 2002, HYPERTENSION, V40, P292, DOI 10.1161/01.HYP.0000029106.10586.4C; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Dange RB, 2014, CARDIOVASC RES, V103, P17, DOI 10.1093/cvr/cvu067; de las Hera N, 2007, J HYPERTENS, V25, P629, DOI 10.1097/HJH.0b013e3280112ce5; Devaraj S, 2011, ARTERIOSCL THROM VAS, V31, P1796, DOI 10.1161/ATVBAHA.111.228924; Devaraj S, 2011, METABOLISM, V60, P256, DOI 10.1016/j.metabol.2010.01.005; Doi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093513; Echem C, 2015, INT J CARDIOL, V187, P243, DOI 10.1016/j.ijcard.2015.03.190; Eissler R, 2011, HYPERTENS RES, V34, P551, DOI 10.1038/hr.2010.270; Elmarakby AA, 2007, HYPERTENSION, V50, P1069, DOI 10.1161/HYPERTENSIONAHA.107.098806; Frangogiannis NG, 2014, NAT REV CARDIOL, V11, P255, DOI 10.1038/nrcardio.2014.28; Garate I, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-8; Ha TZ, 2005, CARDIOVASC RES, V68, P224, DOI 10.1016/j.cardiores.2005.05.025; Hernanz R., 2015, BR J PHARM; Irita J, 2011, AM J PHYSIOL-RENAL, V301, pF833, DOI 10.1152/ajprenal.00557.2010; Jenke A, 2013, CARDIOVASC RES, V99, P422, DOI 10.1093/cvr/cvt118; Jia LN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117757; Jialal I, 2014, J DIABETES COMPLICAT, V28, P755, DOI 10.1016/j.jdiacomp.2014.07.003; Kapinas K, 2010, J BIOL CHEM, V285, P25221, DOI 10.1074/jbc.M110.116137; Lee SB, 2010, KIDNEY INT, V78, pS22, DOI 10.1038/ki.2010.418; Li JJ, 2005, MED HYPOTHESES, V64, P925, DOI 10.1016/j.mehy.2004.10.016; Masola V, 2012, J BIOL CHEM, V287, P1478, DOI 10.1074/jbc.M111.279836; Matsuda S, 2015, J ATHEROSCLER THROMB; Meng XM, 2014, NAT REV NEPHROL, V10, P493, DOI 10.1038/nrneph.2014.114; Moreth K, 2014, MATRIX BIOL, V35, P143, DOI 10.1016/j.matbio.2014.01.010; Parissis JT, 2002, INT J CARDIOL, V83, P13, DOI 10.1016/S0167-5273(02)00021-9; Paulus P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094366; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Rafiq K, 2011, J PHARMACOL SCI, V115, P1, DOI 10.1254/jphs.10R07CR; Savoia C, 2006, CURR OPIN NEPHROL HY, V15, P152, DOI 10.1097/01.mnh.0000203189.57513.76; Sha T, 2007, EUR J PHARMACOL, V571, P231, DOI 10.1016/j.ejphar.2007.06.027; Sha T, 2011, SHOCK, V35, P205, DOI 10.1097/SHK.0b013e3181f48942; Shah N, 2013, LIVER INT, V33, P398, DOI 10.1111/liv.12047; Shirali AC, 2008, J AM SOC NEPHROL, V19, P1444, DOI 10.1681/ASN.2008010123; Stribos EGD, 2015, MOL IMMUNOL, V64, P82, DOI 10.1016/j.molimm.2014.11.003; Summers SA, 2010, AM J PATHOL, V177, P2234, DOI 10.2353/ajpath.2010.100153; Sun CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034026; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tang SCW, 2015, J RENAL NUTR, V25, P230, DOI 10.1053/j.jrn.2014.10.020; White WB, 2003, HYPERTENSION, V41, P1021, DOI 10.1161/01.HYP.0000067463.13172.EA; Williams GH, 2004, AM J CARDIOL, V93, P990, DOI 10.1016/j.amjcard.2004.01.007; Yao LL, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-23; Zhang YD, 2013, CLIN NEPHROL, V80, P249, DOI 10.5414/CN107875	48	39	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142456	10.1371/journal.pone.0142456	http://dx.doi.org/10.1371/journal.pone.0142456			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556241	Green Submitted, gold, Green Published			2022-12-26	WOS:000364430700109
J	Musille, PM; Kossmann, BR; Kohn, JA; Ivanov, I; Ortlund, EA				Musille, Paul M.; Kossmann, Bradley R.; Kohn, Jeffrey A.; Ivanov, Ivaylo; Ortlund, Eric A.			Unexpected Allosteric Network Contributes to LRH-1 Co-regulator Selectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTOR LRH-1; DRIVEN GENE-REGULATION; STEROIDOGENIC FACTOR-I; MOLECULAR-DYNAMICS; LIGAND-BINDING; CRYSTAL-STRUCTURES; HORMONE-RECEPTORS; LIVER; ACTIVATION; HOMOLOG-1	Phospholipids (PLs) are unusual signaling hormones sensed by the nuclear receptor liver receptor homolog-1 (LRH-1), which has evolved a novel allosteric pathway to support appropriate interaction with co-regulators depending on ligand status. LRH-1 plays an important role in controlling lipid and cholesterol homeostasis and is a potential target for the treatment of metabolic and neoplastic diseases. Although the prospect of modulating LRH-1 via small molecules is exciting, the molecular mechanism linking PL structure to transcriptional co-regulator preference is unknown. Previous studies showed that binding to an activating PL ligand, such as dilauroylphosphatidylcholine, favors LRH-1's interaction with transcriptional co-activators to up-regulate gene expression. Both crystallographic and solution-based structural studies showed that dilauroylphosphatidylcholine binding drives unanticipated structural fluctuations outside of the canonical activation surface in an alternate activation function (AF) region, encompassing the beta-sheet-H6 region of the protein. However, the mechanism by which dynamics in the alternate AF influences co-regulator selectivity remains elusive. Here, we pair x-ray crystallography with molecular modeling to identify an unexpected allosteric network that traverses the protein ligand binding pocket and links these two elements to dictate selectivity. We show that communication between the alternate AF region and classical AF2 is correlated with the strength of the co-regulator interaction. This work offers the first glimpse into the conformational dynamics that drive this unusual PL-mediated nuclear hormone receptor activation.	[Musille, Paul M.; Kohn, Jeffrey A.; Ortlund, Eric A.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Kossmann, Bradley R.; Ivanov, Ivaylo] Georgia State Univ, Dept Chem, Ctr Diagnost & Therapeut, Atlanta, GA 30302 USA	Emory University; University System of Georgia; Georgia State University	Ortlund, EA (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.	eortlun@emory.edu	Ortlund, Eric Anthony/F-4672-2014; Ortlund, Eric Anthony/P-3121-2019; Ivanov, Ivaylo/A-7613-2013; Kossmann, Bradley/O-5016-2016	Ortlund, Eric Anthony/0000-0001-8855-3029; Ortlund, Eric Anthony/0000-0001-8855-3029; Ivanov, Ivaylo/0000-0002-5306-1005; Kossmann, Bradley/0000-0001-5368-0976	United States Department of Energy Office of Science [DE-AC02-05CH11231]; Div Of Molecular and Cellular Bioscience [1149521] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES012870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110387] Funding Source: NIH RePORTER	United States Department of Energy Office of Science(United States Department of Energy (DOE)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Computational resources were provided in part by National Science Foundation XSEDE Allocation CHE110042 and Allocation m1254 at the National Energy Research Scientific Computing Center supported by the United States Department of Energy Office of Science Contract DE-AC02-05CH11231.	Atkins WM, 2015, J STEROID BIOCHEM, V151, P3, DOI 10.1016/j.jsbmb.2014.09.010; Batista MRB, 2013, BIOPHYS J, V105, P1670, DOI 10.1016/j.bpj.2013.07.032; Benod C, 2013, J BIOL CHEM, V288, P19830, DOI 10.1074/jbc.M112.411686; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; Blind RD, 2014, P NATL ACAD SCI USA, V111, P15054, DOI 10.1073/pnas.1416740111; Blind RD, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003111; Bolado-Carrancio A, 2014, BIOCHEM BIOPH RES CO, V446, P614, DOI 10.1016/j.bbrc.2014.03.010; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Burendahl S, 2008, BIOCHEMISTRY-US, V47, P5205, DOI 10.1021/bi7025084; Chalkiadaki A, 2005, MOL CELL BIOL, V25, P5095, DOI 10.1128/MCB.25.12.5095-5105.2005; Chanda D, 2010, NUCLEIC ACIDS RES, V38, P4607, DOI 10.1093/nar/gkq227; Corzo CA, 2015, MOL PHARMACOL, V87, P296, DOI 10.1124/mol.114.095554; Echols N, 2012, J APPL CRYSTALLOGR, V45, P581, DOI 10.1107/S0021889812017293; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fernandez-Marcos PJ, 2011, BBA-MOL BASIS DIS, V1812, P947, DOI 10.1016/j.bbadis.2010.12.010; Gee AC, 2001, MOL ENDOCRINOL, V15, P421, DOI 10.1210/me.15.3.421; Gerrits H, 2014, REPROD FERT DEVELOP, V26, P293, DOI 10.1071/RD12131; Glykos NM, 2006, J COMPUT CHEM, V27, P1765, DOI 10.1002/jcc.20482; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Goodwin B, 2003, MOL ENDOCRINOL, V17, P386, DOI 10.1210/me.2002-0246; Hughes TS, 2012, STRUCTURE, V20, P139, DOI 10.1016/j.str.2011.10.018; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kang HW, 2010, BBA-MOL CELL BIOL L, V1801, P496, DOI 10.1016/j.bbalip.2009.12.013; Kanno K, 2007, BBA-MOL CELL BIOL L, V1771, P654, DOI 10.1016/j.bbalip.2007.04.003; Kelly VR, 2010, MOL ENDOCRINOL, V24, P2281, DOI 10.1210/me.2010-0133; Kojetin DJ, 2013, MOL PHARMACOL, V83, P1, DOI 10.1124/mol.112.079285; Krylova IN, 2005, CELL, V120, P343, DOI 10.1016/j.cell.2005.01.024; Lee JM, 2011, NATURE, V474, P506, DOI 10.1038/nature10111; Lee YK, 2006, J BIOL CHEM, V281, P7850, DOI 10.1074/jbc.M509115200; LEVY RM, 1984, BIOPOLYMERS, V23, P1099, DOI 10.1002/bip.360230610; Li Y, 2003, STRUCTURE, V11, P741, DOI 10.1016/S0969-2126(03)00133-3; Liu SH, 2013, NATURE, V502, P550, DOI 10.1038/nature12710; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Mackinnon JAG, 2014, MOL CELL ENDOCRINOL, V393, P75, DOI 10.1016/j.mce.2014.05.017; Mamrosh JL, 2014, ELIFE, V3, DOI 10.7554/eLife.01694; Martinez L, 2008, J PHYS CHEM B, V112, P10741, DOI 10.1021/jp803403c; Moore DD, 2010, ENDOCR J, V57, pS260; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Musille PM, 2013, J BIOL CHEM, V288, P20702, DOI 10.1074/jbc.M113.472837; Musille PM, 2013, FEBS LETT, V587, P1238, DOI 10.1016/j.febslet.2013.01.004; Musille PM, 2012, NAT STRUCT MOL BIOL, V19, P532, DOI 10.1038/nsmb.2279; Nagy L, 2004, TRENDS BIOCHEM SCI, V29, P317, DOI 10.1016/j.tibs.2004.04.006; Nicholls RA, 2014, ACTA CRYSTALLOGR D, V70, P2487, DOI 10.1107/S1399004714016241; Nile AH, 2010, CLIN LIPIDOL, V5, P867, DOI 10.2217/CLP.10.67; Oosterveer MH, 2014, CELL MOL LIFE SCI, V71, P1453, DOI 10.1007/s00018-013-1505-z; Ortlund EA, 2005, NAT STRUCT MOL BIOL, V12, P357, DOI 10.1038/nsmb910; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Sablin EP, 2003, MOL CELL, V11, P1575, DOI 10.1016/S1097-2765(03)00236-3; Schaaf G, 2008, MOL CELL, V29, P191, DOI 10.1016/j.molcel.2007.11.026; Schouten A, 2002, EMBO J, V21, P2117, DOI 10.1093/emboj/21.9.2117; Sethi A, 2009, P NATL ACAD SCI USA, V106, P6620, DOI 10.1073/pnas.0810961106; Skjaerven L, 2011, PROTEINS, V79, P232, DOI 10.1002/prot.22875; Stein S, 2015, CURR OPIN CELL BIOL, V33, P26, DOI 10.1016/j.ceb.2014.10.007; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Venteclef N, 2011, TRENDS ENDOCRIN MET, V22, P333, DOI 10.1016/j.tem.2011.04.004; Walker AK, 2011, CELL, V147, P840, DOI 10.1016/j.cell.2011.09.045; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Wang W, 2005, P NATL ACAD SCI USA, V102, P7505, DOI 10.1073/pnas.0409482102; Whitby RJ, 2006, J MED CHEM, V49, P6652, DOI 10.1021/jm060990k; Whitby RJ, 2011, J MED CHEM, V54, P2266, DOI 10.1021/jm1014296; Zhang C, 2013, NAT MED, V19, P1061, DOI 10.1038/nm.3192; Zhi XY, 2014, P NATL ACAD SCI USA, V111, P839, DOI 10.1073/pnas.1322827111	63	17	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1411	1426		10.1074/jbc.M115.662874	http://dx.doi.org/10.1074/jbc.M115.662874			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26553876	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000368068300032
J	Norkett, R; Modi, S; Birsa, N; Atkin, TA; Ivankovic, D; Pathania, M; Trossbach, SV; Korth, C; Hirst, WD; Kittler, JT				Norkett, Rosalind; Modi, Souvik; Birsa, Nicol; Atkin, Talia A.; Ivankovic, Davor; Pathania, Manav; Trossbach, Svenja V.; Korth, Carsten; Hirst, Warren D.; Kittler, Josef T.			DISC1-dependent Regulation of Mitochondrial Dynamics Controls the Morphogenesis of Complex Neuronal Dendrites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; PROGENITOR PROLIFERATION; MITOFUSIN 2; DISC1; SCHIZOPHRENIA; TRANSPORT; PROTEIN; FUSION; TRAFFICKING; KINESIN	The DISC1 protein is implicated in major mental illnesses including schizophrenia, depression, bipolar disorder, and autism. Aberrant mitochondrial dynamics are also associated with major mental illness. DISC1 plays a role in mitochondrial transport in neuronal axons, but its effects in dendrites have yet to be studied. Further, the mechanisms of this regulation and its role in neuronal development and brain function are poorly understood. Here we have demonstrated that DISC1 couples to the mitochondrial transport and fusion machinery via interaction with the outer mitochondrial membrane GTPase proteins Miro1 and Miro2, the TRAK1 and TRAK2 mitochondrial trafficking adaptors, and the mitochondrial fusion proteins (mitofusins). Using live cell imaging, we show that disruption of the DISC1-Miro-TRAK complex inhibits mitochondrial transport in neurons. Wealso show that the fusion protein generated from the originally described DISC1 translocation (DISC1-Boymaw) localizes to the mitochondria, where it similarly disrupts mitochondrial dynamics. We also show by super resolution microscopy that DISC1 is localized to endoplasmic reticulum contact sites and that the DISC1-Boymaw fusion protein decreases the endoplasmic reticulum-mitochondria contact area. Moreover, disruption of mitochondrial dynamics by targeting the DISC1-Miro-TRAK complex or upon expression of the DISC1-Boymaw fusion protein impairs the correct development of neuronal dendrites. Thus, DISC1 acts as an important regulator of mitochondrial dynamics in both axons and dendrites to mediate the transport, fusion, and cross-talk of these organelles, and pathological DISC1 isoforms disrupt this critical function leading to abnormal neuronal development.	[Norkett, Rosalind; Modi, Souvik; Birsa, Nicol; Atkin, Talia A.; Ivankovic, Davor; Pathania, Manav; Kittler, Josef T.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England; [Hirst, Warren D.] Pfizer, Neurosci Res Unit, Cambridge, MA 02139 USA; [Trossbach, Svenja V.; Korth, Carsten] Heinrich Heine Univ, Dept Neuropathol, D-40225 Dusseldorf, Germany	University of London; University College London; Pfizer; Heinrich Heine University Dusseldorf	Kittler, JT (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6BT, England.	j.kittler@ucl.ac.uk	Cohen Solal, Talia/GQO-9853-2022; Kittler, Josef/N-7589-2019; Kittler, Josef T/E-9113-2010	Cohen Solal, Talia/0000-0001-9525-5732; Kittler, Josef/0000-0002-3437-9456; Kittler, Josef T/0000-0002-3437-9456; Modi, Souvik/0000-0001-5474-7765; Birsa, Nicol/0000-0002-8271-540X; Ivankovic, Davor/0000-0002-4881-9096; Pathania, Manav/0000-0001-5635-5028; Norkett, Rosalind/0000-0001-9460-9973; Hirst, Warren/0000-0003-0389-8891	European Research Council (ERC) [282430]; Wellcome Trust; Medical Research Council (MRC); Pfizer; EMBO Long-term Fellowship; Marie Curie International Incoming Fellowship (IIF) award; Brain Behavior and Research Foundation (NARSAD) [20350]; EU-FP7 (MC-ITN "IN-SENS") [607616]; Medical Research Council [MR/K015826/1, G0802377, 1069309] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH018870] Funding Source: NIH RePORTER; MRC [G0802377, MR/K015826/1] Funding Source: UKRI	European Research Council (ERC)(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Pfizer(Pfizer); EMBO Long-term Fellowship(European Molecular Biology Organization (EMBO)); Marie Curie International Incoming Fellowship (IIF) award; Brain Behavior and Research Foundation (NARSAD)(NARSAD); EU-FP7 (MC-ITN "IN-SENS"); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Starting Grant 282430 from the European Research Council (ERC), a Research Prize from the Lister Institute of Preventive Medicine, the Wellcome Trust, and a Medical Research Council (MRC) senior non-clinical fellowship (to J. T. K.). The authors declare that they have no conflicts of interest with the contents of this article.; An MRC CASE Award Ph.D. student sponsored by Pfizer.; Recipient of an EMBO Long-term Fellowship and Marie Curie International Incoming Fellowship (IIF) award.; Supported by a grant from the Brain Behavior and Research Foundation (NARSAD Independent Investigator Award 20350) and EU-FP7 (MC-ITN "IN-SENS" 607616).	Atkin TA, 2011, MOL PSYCHIATR, V16, P122, DOI 10.1038/mp.2010.110; Atkin TA, 2012, HUM MOL GENET, V21, P2017, DOI 10.1093/hmg/dds018; Baker MJ, 2007, TRENDS CELL BIOL, V17, P456, DOI 10.1016/j.tcb.2007.07.010; Birsa N, 2014, J BIOL CHEM, V289, P14569, DOI 10.1074/jbc.M114.563031; Birsa N, 2013, BIOCHEM SOC T, V41, P1525, DOI 10.1042/BST20130234; Brandon NJ, 2011, NAT REV NEUROSCI, V12, P707, DOI 10.1038/nrn3120; Brandon NJ, 2005, MOL CELL NEUROSCI, V28, P613, DOI 10.1016/j.mcn.2004.11.003; Cagalinec M, 2013, J CELL SCI, V126, P2187, DOI 10.1242/jcs.118844; Cali T, 2012, J BIOL CHEM, V287, P18478, DOI [10.1074/jbc.M111.304733, 10.1074/jbc.M111.302794]; Camargo LM, 2007, MOL PSYCHIATR, V12, P74, DOI 10.1038/sj.mp.4001880; Carlyle BC, 2011, MOL PSYCHIATR, V16, P693, DOI 10.1038/mp.2011.17; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Eykelenboom JE, 2012, HUM MOL GENET, V21, P3374, DOI 10.1093/hmg/dds169; Flores R, 2011, NEUROSCI RES, V71, P71, DOI 10.1016/j.neures.2011.05.014; Fransson A, 2006, BIOCHEM BIOPH RES CO, V344, P500, DOI 10.1016/j.bbrc.2006.03.163; Fransson A, 2003, J BIOL CHEM, V278, P6495, DOI 10.1074/jbc.M208609200; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Hattori T, 2010, MOL PSYCHIATR, V15, P798, DOI 10.1038/mp.2010.60; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Ishizuka K, 2011, NATURE, V473, P92, DOI 10.1038/nature09859; James R, 2004, MOL CELL NEUROSCI, V26, P112, DOI 10.1016/j.mcn.2004.01.013; Ji BH, 2014, HUM MOL GENET, V23, P5683, DOI 10.1093/hmg/ddu285; Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082; Kimura T, 2014, J NEUROSCI, V34, P6938, DOI 10.1523/JNEUROSCI.5095-13.2014; Kornmann B, 2011, P NATL ACAD SCI USA, V108, P14151, DOI 10.1073/pnas.1111314108; Kvajo M, 2011, P NATL ACAD SCI USA, V108, pE1349, DOI 10.1073/pnas.1114113108; Lee FHF, 2011, J NEUROSCI, V31, P3197, DOI 10.1523/JNEUROSCI.4219-10.2011; Lee SA, 2015, J BIOL CHEM, V290, P7087, DOI 10.1074/jbc.M114.614750; Lepagnol-Bestel AM, 2013, MOL CELL NEUROSCI, V54, P84, DOI 10.1016/j.mcn.2013.01.006; Loss O, 2015, J NEUROSCI RES, V93, P1056, DOI 10.1002/jnr.23549; Luisier F, 2011, IEEE T IMAGE PROCESS, V20, P696, DOI 10.1109/TIP.2010.2073477; MacAskill AF, 2010, TRENDS CELL BIOL, V20, P102, DOI 10.1016/j.tcb.2009.11.002; MacAskill AF, 2009, MOL CELL NEUROSCI, V40, P301, DOI 10.1016/j.mcn.2008.10.016; Malavasi ELV, 2012, HUM MOL GENET, V21, P2779, DOI 10.1093/hmg/dds106; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Millar JK, 2005, MOL CELL NEUROSCI, V30, P477, DOI 10.1016/j.mcn.2005.08.021; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010; Muir J, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00151; Muir J, 2010, P NATL ACAD SCI USA, V107, P16679, DOI 10.1073/pnas.1000589107; Murdoch H, 2007, J NEUROSCI, V27, P9513, DOI 10.1523/JNEUROSCI.1493-07.2007; Ogawa F, 2014, HUM MOL GENET, V23, P906, DOI 10.1093/hmg/ddt485; Ottis P, 2011, BIOL PSYCHIAT, V70, P604, DOI 10.1016/j.biopsych.2011.03.027; Park YU, 2010, P NATL ACAD SCI USA, V107, P17785, DOI 10.1073/pnas.1004361107; Pathania M, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.16; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Porteous DJ, 2011, TRENDS MOL MED, V17, P699, DOI 10.1016/j.molmed.2011.09.002; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rowland AA, 2012, NAT REV MOL CELL BIO, V13, P607, DOI 10.1038/nrm3440; Rui YF, 2006, J NEUROSCI, V26, P10480, DOI 10.1523/JNEUROSCI.3231-06.2006; Russo GJ, 2009, J NEUROSCI, V29, P5443, DOI 10.1523/JNEUROSCI.5417-08.2009; Saotome M, 2008, P NATL ACAD SCI USA, V105, P20728, DOI 10.1073/pnas.0808953105; Shen SB, 2008, J NEUROSCI, V28, P10893, DOI 10.1523/JNEUROSCI.3299-08.2008; Sheng ZH, 2012, NAT REV NEUROSCI, V13, P77, DOI 10.1038/nrn3156; Singh KK, 2010, NEURON, V67, P33, DOI 10.1016/j.neuron.2010.06.002; Smith KR, 2014, CELL REP, V9, P298, DOI 10.1016/j.celrep.2014.08.061; Smith MJ, 2006, J BIOL CHEM, V281, P27216, DOI 10.1074/jbc.M600522200; Soda T, 2013, MOL PSYCHIATR, V18, P898, DOI 10.1038/mp.2013.38; Somerville SM, 2011, WORLD J BIOL PSYCHIA, V12, P48, DOI 10.3109/15622975.2010.505662; Stephen TL, 2015, J NEUROSCI, V35, P15996, DOI 10.1523/JNEUROSCI.2068-15.2015; Stoica R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4996; Taya S, 2007, J NEUROSCI, V27, P15, DOI 10.1523/JNEUROSCI.3826-06.2006; Trossbach S. V., 2015, MOL PSYCHIA IN PRESS; van Spronsen M, 2013, NEURON, V77, P485, DOI 10.1016/j.neuron.2012.11.027; Vonesch C, 2008, IEEE T IMAGE PROCESS, V17, P539, DOI 10.1109/TIP.2008.917103; Wang Q, 2011, MOL PSYCHIATR, V16, P1006, DOI 10.1038/mp.2010.87; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Zhou X, 2010, MOL PSYCHIATR, V15, P670, DOI 10.1038/mp.2009.127	75	64	66	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					613	629		10.1074/jbc.M115.699447	http://dx.doi.org/10.1074/jbc.M115.699447			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26553875	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000367830500010
J	Chen, RJ; Zhang, GF; Garfield, SH; Shi, YJ; Chen, KG; Robey, PG; Leapman, RD				Chen, Richard J.; Zhang, Guofeng; Garfield, Susan H.; Shi, Yi-Jun; Chen, Kevin G.; Robey, Pamela G.; Leapman, Richard D.			Variations in Glycogen Synthesis in Human Pluripotent Stem Cells with Altered Pluripotent States	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; GROUND-STATE; SELF-RENEWAL; HUMAN ES; INDUCTION; DIFFERENTIATION; MAINTENANCE; EXPRESSION; NAIVE; LINES	Human pluripotent stem cells (hPSCs) represent very promising resources for cell-based regenerative medicine. It is essential to determine the biological implications of some fundamental physiological processes (such as glycogen metabolism) in these stem cells. In this report, we employ electron, immunofluorescence microscopy, and biochemical methods to study glycogen synthesis in hPSCs. Our results indicate that there is a high level of glycogen synthesis (0.28 to 0.62 mu g/mu g proteins) in undifferentiated human embryonic stem cells (hESCs) compared with the glycogen levels (0 to 0.25 mu g/mu g proteins) reported in human cancer cell lines. Moreover, we found that glycogen synthesis was regulated by bone morphogenetic protein 4 (BMP-4) and the glycogen synthase kinase 3 (GSK-3) pathway. Our observation of glycogen bodies and sustained expression of the pluripotent factor Oct-4 mediated by the potent GSK-3 inhibitor CHIR-99021 reveals an altered pluripotent state in hPSC culture. We further confirmed glycogen variations under different naive pluripotent cell growth conditions based on the addition of the GSK-3 inhibitor BIO. Our data suggest that primed hPSCs treated with naive growth conditions acquire altered pluripotent states, similar to those naive-like hPSCs, with increased glycogen synthesis. Furthermore, we found that suppression of phosphorylated glycogen synthase was an underlying mechanism responsible for altered glycogen synthesis. Thus, our novel findings regarding the dynamic changes in glycogen metabolism provide new markers to assess the energetic and various pluripotent states in hPSCs. The components of glycogen metabolic pathways offer new assays to delineate previously unrecognized properties of hPSCs under different growth conditions.	[Chen, Richard J.; Zhang, Guofeng; Leapman, Richard D.] Natl Inst Biomed Imaging & Bioengn, Lab Cellular Imaging & Macromol Biophys, NIH, Bethesda, MD 20892 USA; [Garfield, Susan H.] NCI, Expt Carcinogenesis, NIH, Bethesda, MD 20892 USA; [Shi, Yi-Jun; Chen, Kevin G.] NINDS, Stem Cell Unit, NIH, Bethesda, MD 20892 USA; [Robey, Pamela G.] Natl Inst Dent & Craniofacial Res, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Leapman, RD (corresponding author), Natl Inst Biomed Imaging & Bioengn, Lab Cellular Imaging & Macromol Biophys, NIH, Bethesda, MD 20892 USA.	leapmanr@mail.nih.gov	Chen, Kevin/GYU-8963-2022; Robey, Pamela Gehron/H-1429-2011; Chen, Kevin G/D-6769-2011	Robey, Pamela Gehron/0000-0002-5316-5576; Chen, Kevin G/0000-0003-2983-6330; Leapman, Richard/0000-0002-8575-4084	National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZICBC010858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZICEB000080, ZIAEB000017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZICNS003008] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was funded by the Intramural Program of the National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health.	Abdelli S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035997; Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boyd NL, 2007, EXP BIOL MED, V232, P833; Louzao MC, 2008, GLYCOCONJUGATE J, V25, P503, DOI 10.1007/s10719-007-9075-7; Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; Chen KG, 2014, JOVE-J VIS EXP, DOI 10.3791/51519; Chen KG, 2012, STEM CELL RES, V9, P237, DOI 10.1016/j.scr.2012.06.003; Chou BK, 2011, CELL RES, V21, P518, DOI 10.1038/cr.2011.12; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Davidson KC, 2012, P NATL ACAD SCI USA, V109, P4485, DOI 10.1073/pnas.1118777109; Favaro E, 2012, CELL METAB, V16, P751, DOI 10.1016/j.cmet.2012.10.017; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Gottlieb E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001040; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; KOCHAN RG, 1981, AM J PHYSIOL, V240, pE197, DOI 10.1152/ajpendo.1981.240.2.E197; Lee WNP, 2004, BRIT J CANCER, V91, P2094, DOI 10.1038/sj.bjc.6602243; MacDonald BT, 2007, CELL, V131, DOI 10.1016/j.cell.2007.11.036; Mallon BS, 2013, STEM CELL RES, V10, P57, DOI 10.1016/j.scr.2012.09.002; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Miwa I, 2002, ANN CLIN BIOCHEM, V39, P612, DOI 10.1258/000456302760413432; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Padmanabhan R, 2012, STEM CELLS, V30, P2175, DOI 10.1002/stem.1195; Pelletier J, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00018; Pescador N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009644; Prigione A, 2010, INT J DEV BIOL, V54, P1729, DOI 10.1387/ijdb.103198ap; ROUSSET M, 1981, CANCER RES, V41, P1165; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Sharova LV, 2007, DEV BIOL, V307, P446, DOI 10.1016/j.ydbio.2007.05.004; Shen GM, 2010, FEBS LETT, V584, P4366, DOI 10.1016/j.febslet.2010.09.040; Stanfield CL, 2013, PRINCIPLES HUMAN PHY, P57; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Theunissen TW, 2014, CELL STEM CELL, V15, P471, DOI 10.1016/j.stem.2014.07.002; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Valamehr B, 2014, STEM CELL REP, V2, P366, DOI 10.1016/j.stemcr.2014.01.014; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Ware CB, 2014, REGEN MED, V9, P401, DOI [10.2217/RME.14.31, 10.2217/rme.14.31]; Wilson KD, 2009, STEM CELLS DEV, V18, P749, DOI 10.1089/scd.2008.0247; Wolfrum K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013703; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yamada K, 2007, NAT PROTOC, V2, P753, DOI 10.1038/nprot.2007.76; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang J, 2012, CELL STEM CELL, V11, P589, DOI 10.1016/j.stem.2012.10.005; Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401; Zhou WY, 2012, EMBO J, V31, P2103, DOI 10.1038/emboj.2012.71	50	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142554	10.1371/journal.pone.0142554	http://dx.doi.org/10.1371/journal.pone.0142554			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26565809	Green Submitted, Green Published, gold			2022-12-26	WOS:000367628500032
J	Dilucca, M; Cimini, G; Semmoloni, A; Deiana, A; Giansanti, A				Dilucca, Maddalena; Cimini, Giulio; Semmoloni, Andrea; Deiana, Antonio; Giansanti, Andrea			Codon Bias Patterns of E. coli's Interacting Proteins	PLOS ONE			English	Article							TRANSFER-RNA GENES; ESCHERICHIA-COLI; TRANSLATION ELONGATION; INTERACTION NETWORKS; ADAPTATION INDEX; SELECTION; USAGE; FIDELITY; DATABASE; RATES	Synonymous codons, i.e., DNA nucleotide triplets coding for the same amino acid, are used differently across the variety of living organisms. The biological meaning of this phenomenon, known as codon usage bias, is still controversial. In order to shed light on this point, we propose a new codon bias index, CompAI, that is based on the competition between cognate and near-cognate tRNAs during translation, without being tuned to the usage bias of highly expressed genes. We perform a genome-wide evaluation of codon bias for E. coli, comparing CompAI with other widely used indices: tAI, CAI, and Nc. We show that CompAI and tAI capture similar information by being positively correlated with gene conservation, measured by the Evolutionary Retention Index (ERI), and essentiality, whereas, CAI and Nc appear to be less sensitive to evolutionary-functional parameters. Notably, the rate of variation of tAI and CompAI with ERI allows to obtain sets of genes that consistently belong to specific clusters of orthologous genes (COGs). We also investigate the correlation of codon bias at the genomic level with the network features of protein-protein interactions in E. coli. We find that the most densely connected communities of the network share a similar level of codon bias (as measured by CompAI and tAI). Conversely, a small difference in codon bias between two genes is, statistically, a prerequisite for the corresponding proteins to interact. Importantly, among all codon bias indices, CompAI turns out to have the most coherent distribution over the communities of the interactome, pointing to the significance of competition among cognate and near-cognate tRNAs for explaining codon usage adaptation. Notably, CompAI may potentially correlate with translation speed measurements, by accounting for the specific delay induced by wobble-pairing between codons and anticodons.	[Dilucca, Maddalena; Semmoloni, Andrea; Deiana, Antonio; Giansanti, Andrea] Univ Roma La Sapienza, Dipartimento Fis, Rome, Italy; [Cimini, Giulio] UoS Sapienza Univ Rome, CNR, ISC, Rome, Italy; [Giansanti, Andrea] Ist Nazl Fis Nucl, Unit Roma1, Rome, Italy	Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR); Istituto Nazionale di Fisica Nucleare (INFN)	Dilucca, M (corresponding author), Univ Roma La Sapienza, Dipartimento Fis, Rome, Italy.	Maddalena.Dilucca@roma1.infn.it	GIANSANTI, ANDREA/O-2686-2014; Giansanti, Andrea/K-2543-2019; Cimini, Giulio/I-7413-2019; Cimini, Giulio/HGC-2758-2022	GIANSANTI, ANDREA/0000-0002-8113-8188; Cimini, Giulio/0000-0001-5698-8597; 				Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; BENNETZEN JL, 1982, J BIOL CHEM, V257, P3026; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; Daubin V, 2003, MOL BIOL EVOL, V20, P471, DOI 10.1093/molbev/msg022; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; EyreWalker A, 1996, MOL BIOL EVOL, V13, P864, DOI 10.1093/oxfordjournals.molbev.a025646; Fluitt A, 2007, COMPUT BIOL CHEM, V31, P335, DOI 10.1016/j.compbiolchem.2007.07.003; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; GOUY M, 1982, NUCLEIC ACIDS RES, V10, P7055, DOI 10.1093/nar/10.22.7055; Gromadski KB, 2004, MOL CELL, V13, P191, DOI 10.1016/S1097-2765(04)00005-X; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Hric D, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.062805; Huang H, 2007, PLOS COMPUT BIOL, V3, P2155, DOI 10.1371/journal.pcbi.0030214; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; Jansen R, 2003, NUCLEIC ACIDS RES, V31, P2242, DOI 10.1093/nar/gkg306; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; Kanaya S, 1999, GENE, V238, P143, DOI 10.1016/S0378-1119(99)00225-5; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Park J, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066117; Percudani R, 1997, J MOL BIOL, V268, P322, DOI 10.1006/jmbi.1997.0942; PHIZICKY EM, 1995, MICROBIOL REV, V59, P94, DOI 10.1128/MMBR.59.1.94-123.1995; Pigliucci M, 2008, NAT REV GENET, V9, P75, DOI 10.1038/nrg2278; Pop C, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145524; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rodnina MV, 2001, ANNU REV BIOCHEM, V70, P415, DOI 10.1146/annurev.biochem.70.1.415; Roth A, 2012, CODON EVOLUTION: MECHANISMS AND MODELS, P189; Shabalina SA, 2013, NUCLEIC ACIDS RES, V41, P2073, DOI 10.1093/nar/gks1205; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; SORENSEN MA, 1991, J MOL BIOL, V222, P265, DOI 10.1016/0022-2836(91)90211-N; Spencer PS, 2012, J MOL BIOL, V422, P328, DOI 10.1016/j.jmb.2012.06.010; Squartini T, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/8/083001; Stadler M, 2011, RNA, V17, P2063, DOI 10.1261/rna.02890211; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Tuller T, 2014, BIOCHEM SOC T, V42, P155, DOI 10.1042/BST20130095; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Zhang G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005036	45	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142127	10.1371/journal.pone.0142127	http://dx.doi.org/10.1371/journal.pone.0142127			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26566157	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000367628500008
J	Huang, M; Chen, JN; Cao, FB; Jiang, LG; Zou, YB				Huang, Min; Chen, Jiana; Cao, Fangbo; Jiang, Ligeng; Zou, Yingbin			Root Morphology Was Improved in a Late-Stage Vigor Super Rice Cultivar	PLOS ONE			English	Article							YIELD; PRODUCTIVITY; TRAITS; SHOOT	This study aimed to test the hypothesis that root morphology might be improved and consequently contributing to superior post-heading shoot growth and grain yield in late-stage vigor super rice. A pot experiment was carried out to compare yield attributes, shoot growth and physiological properties and root morphological traits between a late-stage vigor super rice cultivar (Y-liangyou 087) and an elite rice cultivar (Teyou 838). Grain yield and total shoot biomass were 7-9% higher in Y-liangyou 087 than in Teyou 838. Y-liangyou 087 had 60-64% higher post-heading shoot growth rate and biomass production than Teyou 838. Average relative chlorophyll concentration and net photosynthetic rate in flag leaves were 7-11% higher in Y-liangyou 087 than in Teyou 838 during heading to 25 days after heading. Y-liangyou 087 had 41% higher post-heading shoot N uptake but 17-25% lower root biomass and root-shoot ratio at heading and maturity than Teyou 838. Specific root length and length and surface area of fine roots were higher in Y-liangyou 087 than in Teyou 838 at heading and maturity by more than 15%. These results indicated that root-shoot relationships were well balanced during post-heading phase in the late-stage vigor super rice cultivar Y-liangyou 087 by improving root morphology including avoiding a too great root biomass and developing a large fine root system.	[Huang, Min; Chen, Jiana; Cao, Fangbo; Jiang, Ligeng; Zou, Yingbin] Hunan Agr Univ, Collaborat Innovat Ctr Grain & Oil Crops South Ch, Changsha, Hunan, Peoples R China; [Jiang, Ligeng] Guangxi Univ, Key Lab Crop Cultivat & Farming Syst, Nanning 530004, Peoples R China	Hunan Agricultural University; Guangxi University	Huang, M (corresponding author), Hunan Agr Univ, Collaborat Innovat Ctr Grain & Oil Crops South Ch, Changsha, Hunan, Peoples R China.	jxhuangmin@163.com		Huang, Min/0000-0002-6944-8538	Guangxi Natural Science Foundation [2013GXNSFBA019051]; Scientific Research Foundation of Guangxi University [XBZ120741]; Earmarked Fund for China Agriculture Research System [CARS-01-30]	Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); Scientific Research Foundation of Guangxi University; Earmarked Fund for China Agriculture Research System	This work was supported by the Guangxi Natural Science Foundation (Grant No. 2013GXNSFBA019051), the Scientific Research Foundation of Guangxi University (Grant No. XBZ120741), and the Earmarked Fund for China Agriculture Research System (Grant No. CARS-01-30).	[蔡昆争 Cai Kunzheng], 2003, [生态学报, Acta Ecologica Sinica], V23, P1109; Cheng SH, 2007, J INTEGR PLANT BIOL, V49, P805, DOI [10.1111/j.1744-7909.2007.00514.x, 10.1111/j.1672-9072.2007.00514.x]; Cheng ShiHua, 2005, Chinese Journal of Rice Science, V19, P280; Comas LH, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00442; Costa C, 2000, AGRON J, V92, P621, DOI 10.2134/agronj2000.924621x; Evans LT., 1993, CROP EVOLUTION ADAPT; Fitter A., 2002, PLANT ROOTS HIDDEN H, P15; Henry A, 2011, FIELD CROP RES, V120, P205, DOI 10.1016/j.fcr.2010.10.003; Huang M, 2011, AGR SCI CHINA, V10, P1537, DOI 10.1016/S1671-2927(11)60149-1; Lukac M, 2012, MEASURING ROOTS: AN UPDATED APPROACH, P363, DOI 10.1007/978-3-642-22067-8_18; NEMOTO K, 1995, CROP SCI, V35, P24, DOI 10.2135/cropsci1995.0011183X003500010005x; Normile D, 2008, SCIENCE, V321, P330, DOI 10.1126/science.321.5887.330; PASSIOURA JB, 1983, AGR WATER MANAGE, V7, P265, DOI 10.1016/0378-3774(83)90089-6; Peng SB, 2008, FIELD CROP RES, V108, P32, DOI 10.1016/j.fcr.2008.04.001; Samejima H, 2005, J PLANT NUTR, V28, P835, DOI 10.1081/PLN-200055550; Samejima H, 2004, SOIL SCI PLANT NUTR, V50, P545, DOI 10.1080/00380768.2004.10408511; Shu-Qing C, 2004, J AGRON CROP SCI, V190, P73, DOI 10.1046/j.1439-037X.2003.00078.x; Tabata M., 2008, Japanese Journal of Crop Science, V77, P198, DOI 10.1626/jcs.77.198; Wang Q, 2006, J PLANT PHYSIOL, V163, P529, DOI 10.1016/j.jplph.2005.04.035; Wang Qiang, 2004, Chinese Journal of Rice Science, V18, P437; Wei WenFang, 2009, Guangxi Agricultural Sciences, V40, P650; Yang JC, 2012, J INTEGR AGR, V11, P920, DOI 10.1016/S2095-3119(12)60082-3; Zhai H, 2002, SCI CHINA SER C, V45, P637, DOI 10.1007/BF02879752; Zhang H, 2009, FIELD CROP RES, V113, P31, DOI 10.1016/j.fcr.2009.04.004; Zhang QF, 2007, P NATL ACAD SCI USA, V104, P16402, DOI 10.1073/pnas.0708013104; Zhang YB, 2009, FIELD CROP RES, V114, P91, DOI 10.1016/j.fcr.2009.07.008	26	13	13	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142977	10.1371/journal.pone.0142977	http://dx.doi.org/10.1371/journal.pone.0142977			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26566229	gold, Green Published, Green Submitted			2022-12-26	WOS:000367628500081
J	Korenromp, EL; Gobet, B; Fazito, E; Lara, J; Bollinger, L; Stover, J				Korenromp, Eline L.; Gobet, Benjamin; Fazito, Erika; Lara, Joseph; Bollinger, Lori; Stover, John			Impact and Cost of the HIV/AIDS National Strategic Plan for Mozambique, 2015-2019-Projections with the Spectrum/Goals Model	PLOS ONE			English	Article							HIV TRENDS	Introduction Mozambique continues to face a severe HIV epidemic and high cost for its control, largely born by international donors. We assessed feasible targets, likely impact and costs for the 2015-2019 national strategic HIV/AIDS plan (NSP). Methods The HIV epidemic and response was modelled in the Spectrum/Goals/Resource Needs dynamical simulation model, separately for North/Center/South regions, fitted to antenatal clinic surveillance data, household and key risk group surveys, program statistics, and financial records. Intervention targets were defined in collaboration with the National AIDS Council, Ministry of Health, technical partners and implementing NGOs, considering existing commitments. Results Implementing the NSP to meet existing coverage targets would reduce annual new infections among all ages from 105,000 in 2014 to 78,000 in 2019, and reduce annual HIV/AIDS-related deaths from 80,000 to 56,000. Additional scale-up of prevention interventions targeting high-risk groups, with improved patient retention on ART, could further reduce burden to 65,000 new infections and 51,000 HIV-related deaths in 2019. Program cost would increase from US$ 273 million in 2014, to US$ 433 million in 2019 for 'Current targets', or US$ 495 million in 2019 for 'Accelerated scale-up'. The 'Accelerated scale-up' would lower cost per infection averted, due to an enhanced focus on behavioural prevention for high-risk groups. Cost and mortality impact are driven by ART, which accounts for 53% of resource needs in 2019. Infections averted are driven by scale-up of interventions targeting sex work (North, rising epidemic) and voluntary male circumcision (Center & South, generalized epidemics). Conclusion The NSP could aim to reduce annual new HIV infections and deaths by 2019 by 30% and 40%, respectively, from 2014 levels. Achieving incidence and mortality reductions corresponding to UNAIDS' 'Fast track' targets will require increased ART coverage and additional behavioural prevention targeting key risk groups.	[Korenromp, Eline L.; Bollinger, Lori; Stover, John] Avenir Hlth, Geneva, Switzerland; [Korenromp, Eline L.; Bollinger, Lori; Stover, John] Avenir Hlth, Glastonbury, CT USA; [Gobet, Benjamin; Fazito, Erika] UNAIDS, Mozamb Country Off, Maputo, Mozambique; [Lara, Joseph] Mozamb Minist Hlth, Maputo, Mozambique		Korenromp, EL (corresponding author), Avenir Hlth, Geneva, Switzerland.	ekorenromp@avenirhealth.org			UNAIDS Technical Support Facility Eastern and Southern Africa	UNAIDS Technical Support Facility Eastern and Southern Africa	Avenir Health's work was supported by a grant from the UNAIDS Technical Support Facility Eastern and Southern Africa managed by Health & Development Africa (Pty) Limited. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin A., 2013, DISTRIBUICAO INCIDEN; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Avenir Health, 2011, GOALS MAN MOD EST EF; Avenir Health, 2014, AV HLTH HIV UN COST; Bollinger L, 2010, GRADING GOALS SYSTEM; Bollinger LA, 2008, AIDS, V22, pS51, DOI 10.1097/01.aids.0000327623.31856.45; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Conselho Nacional de Combate ao SIDA (CNCS) UNAIDS, 2014, MED GAST SIDA 2010; Country Coordinating Mechanism of Mozambique, 2014, GLOB FUND TB HIV CON; Danel C, 2015, EARLY ART IPT HIV IN; Dutta A, 2014, ESTIMATED RESOURCE N; Figueroa ME, 2014, AIDS CARE, V26, pS50, DOI 10.1080/09540121.2014.907386; Ghani AC, 2005, J INFECT DIS, V191, pS34, DOI 10.1086/425276; Granich R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030216; Grupo tecnico multisectoral de apoio a luta contra o HIV/SIDA em Mocambique, 2013, ROND VIG EP HIV SIF; Health Avenir, 2014, SPECTRUM MANUAL SPEC; ICF Macro Ministry of Health (Mozambique) National Health Institute (Mozambique) National Statistics Institute (Mozambique), 2010, MOZ AIDS IND SURV 20; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Instituto Nacional de Estatistica MdSM MEASURE DHS / ICF International, 2013, MOZ DEM HLTH SURV 20; Joint United Nations Programme on HIV/AIDS, 2014, FAST TRACK ENDING AI; Joint United Nations Programme on HIV/AIDS, 2012, KEY PROGR RED STIGM; Justman J, 2013, 20 C RETR OPP INF AT; Kingdom of Swaziland Ministry of Health, 2012, SWAZ HIV INC MEAS SU; Korenromp EL, 2002, SEX TRANSM INFECT, V78, pI55, DOI 10.1136/sti.78.suppl_1.i55; Korenromp EL, 2015, IMPACT COST HIV AIDS; Lafort Y, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-144; Mahy M, 2010, SEX TRANSM INFECT, V86, pI28, DOI 10.1136/sti.2010.044255; Mozambique Instituto Nacional de Saude (INS) Centros de Controle e Prevencao de Doencas dos EUA (CDC) Universidade de California SFU Pathfinder International Centro Internacional de Formacao e Educacao para a Saude (I-TECH), 2013, INQ INT BIOL COMP EN; Mozambique Ministerio da Saude, 2013, PLAN ETR SECT SAUD P; Mozambique Ministerio da Saude, 2014, REL SEM 2014 ACT REL; Mozambique Ministry of health (MISAU) Instituto Nacional de Saude (INS) Centros de Controle e Prevencao de Doencas dos EUA (CDC) Universidade de California SFU Mozambique Ministerio do Trabalho (MITRAB), 2013, INQ INT BIOL COMP EN; National Institute of Allergy and Infectious Diseases (NIAID), 2015, START ANT TREATM EAR; Republic of Mozambique Conselho de Ministros / Conselho Nacional de Combate ao HIV/SIDA, 2010, PLAN ESTR NAC RESP H; Republic of Mozambique Conselho Nacional de Combate ao HIV e SIDA (CNCS)/National AIDS Council, 2012, GLOB AIDS RESP PROGR; Republic of Mozambique Conselho Nacional de Combate ao HIV e SIDA (CNCS) / National AIDS Council, 2014, GLOB AIDS RESP PROGR; Republic of Mozambique Ministry of Health, 2013, PLAN AC RESP HIV SID; Republica de Mocambique Ministerio dau Saude Direccao Nacional de Saude Publica Departamento de Saude da mulher e da crianca, 2012, NAT PLAN ELIM MOTH T; Resch S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025310; Ruperez M, 2015, J ANTIMICROB CHEMOTH; Stoneburner R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100431; Stover J, 2004, SEX TRANSM INFECT, V80, DOI 10.1136/sti.2004.010157; Stover J, 2007, FINANCIAL RESOURCES; Stover J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111956; Stover J, 2012, SEX TRANSM INFECT, V88, pI11, DOI 10.1136/sextrans-2012-050640; Stover J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021048; Stover J, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/738271; Stover J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003729; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; UNAIDS Mozambique, 2011, MED GAST SIDA MEGAS; United States President's Emergency Plan for Aids Relief, 2015, SUPPL CHAIN MAN SYST; van Schalkwyk C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069437; WHO & UNAIDS, 2011, JOINT STRAT ACT FRAM; World Health Organization, 2019, GLOBAL HLTH EXPENDIT	53	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142908	10.1371/journal.pone.0142908	http://dx.doi.org/10.1371/journal.pone.0142908			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26565696	gold, Green Published, Green Submitted			2022-12-26	WOS:000367628500067
J	Watanabe, K; Kakeda, S; Yoshimura, R; Ide, S; Hayashi, K; Katsuki, A; Umene-Nakano, W; Watanabe, R; Abe, O; Korogi, Y				Watanabe, Keita; Kakeda, Shingo; Yoshimura, Reiji; Ide, Satoru; Hayashi, Kenji; Katsuki, Asuka; Umene-Nakano, Wakako; Watanabe, Rieko; Abe, Osamu; Korogi, Yukunori			Genetic Variation in the Catechol-O-Methyl Transferase Val108/158Met Is Linked to the Caudate and Posterior Cingulate Cortex Volume in Healthy Subjects: Voxel-Based Morphometry Analysis of Brain Magnetic Resonance Imaging	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; RAT PREFRONTAL CORTEX; GRAY-MATTER VOLUME; METHYLTRANSFERASE POLYMORPHISM; FUNCTIONAL POLYMORPHISM; DOPAMINE TRANSMISSION; WORKING-MEMORY; NEURONS; COMT; MODULATION	The effect of the catechol-O-methyltransferase (COMT) Val158Met polymorphism on brain morphology has been investigated but remains controversial. We hypothesized that a comparison between Val/Val and Val/Met individuals, which may represent the most different combinations concerning the effects of the COMT genotype, may reveal new findings. We investigated the brain morphology using 3-Tesla magnetic resonance imaging in 27 Val/Val and 22 Val/Met individuals. Voxel-based morphometry revealed that the volumes of the bilateral caudate and posterior cingulate cortex were significantly smaller in Val/Val individuals than in Val/Met individuals [right caudate: false discovery rate (FDR)-corrected p = 0.048; left caudate: FDR-corrected p = 0.048; and bilateral posterior cingulate cortex: FDR-corrected p = 0.048]. This study demonstrates that interacting functional variants of COMT affect gray matter regional volumes in healthy subjects.	[Watanabe, Keita; Kakeda, Shingo; Ide, Satoru; Watanabe, Rieko] Univ Occupat & Environm Hlth, Dept Radiol, Fukuoka, Japan; [Yoshimura, Reiji; Hayashi, Kenji; Katsuki, Asuka; Umene-Nakano, Wakako] Univ Occupat & Environm Hlth, Dept Psychiat, Fukuoka, Japan; [Abe, Osamu; Korogi, Yukunori] Nihon Univ, Sch Med, Dept Radiol, Tokyo, Japan	University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; Nihon University	Watanabe, K (corresponding author), Univ Occupat & Environm Hlth, Dept Radiol, Fukuoka, Japan.	sapient@med.uoeh-u.ac.jp	Ide, Satoru/AAJ-6850-2021	Abe, Osamu/0000-0002-1180-2629; Watanabe, Keita/0000-0001-9592-8802				Akil M, 2003, J NEUROSCI, V23, P2008; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Ashburner J, 2012, NEUROIMAGE, V62, P791, DOI 10.1016/j.neuroimage.2011.10.025; Ashburner J, 2009, MAGN RESON IMAGING, V27, P1163, DOI 10.1016/j.mri.2009.01.006; Barnes A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033964; Carr DB, 2000, J NEUROSCI, V20, P3864, DOI 10.1523/JNEUROSCI.20-10-03864.2000; Cerasa A, 2010, NEUROSCIENCE, V167, P809, DOI 10.1016/j.neuroscience.2010.02.040; Cerasa A, 2008, NEUROREPORT, V19, P405, DOI 10.1097/WNR.0b013e3282f5f784; Chumbley J, 2010, NEUROIMAGE, V49, P3057, DOI 10.1016/j.neuroimage.2009.10.090; Chumbley JR, 2009, NEUROIMAGE, V44, P62, DOI 10.1016/j.neuroimage.2008.05.021; Dutt A, 2009, PSYCHOL MED, V39, P1783, DOI 10.1017/S0033291709990316; FISHELL G, 1987, J NEUROSCI, V7, P1969; Floresco SB, 2003, NAT NEUROSCI, V6, P968, DOI 10.1038/nn1103; Fumagalli F, 2003, MOL PSYCHIATR, V8, P898, DOI 10.1038/sj.mp.4001370; Goldman-Rakic P S, 1998, Adv Pharmacol, V42, P707; Granon S, 2000, J NEUROSCI, V20, P1208, DOI 10.1523/JNEUROSCI.20-03-01208.2000; GROSSMAN MH, 1992, GENOMICS, V12, P822, DOI 10.1016/0888-7543(92)90316-K; Ho BC, 2005, MOL PSYCHIATR, V10, P287, DOI 10.1038/sj.mp.4001616; Honea R, 2009, NEUROIMAGE, V45, P44, DOI 10.1016/j.neuroimage.2008.10.064; Jaber M, 1997, MOVEMENT DISORD, V12, P629, DOI 10.1002/mds.870120502; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Krugel LK, 2009, P NATL ACAD SCI USA, V106, P17951, DOI 10.1073/pnas.0905191106; Kuppers E, 2001, NEUROREPORT, V12, P1175; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; Massat I, 2005, MOL PSYCHIATR, V10, P598, DOI 10.1038/sj.mp.4001615; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; Meyer-Lindenberg A, 2005, NAT NEUROSCI, V8, P594, DOI 10.1038/nn1438; Ohnishi T, 2006, BRAIN, V129, P399, DOI 10.1093/brain/awh702; Santiago M, 2000, BRAIN RES, V858, P26, DOI 10.1016/S0006-8993(99)02485-3; Shaw P, 2009, MOL PSYCHIATR, V14, P348, DOI 10.1038/mp.2008.121; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Takahata R, 2000, J NEUROCHEM, V75, P1775, DOI 10.1046/j.1471-4159.2000.0751775.x; Tian T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078697; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Wahlstrom D, 2007, BIOL PSYCHIAT, V61, P626, DOI 10.1016/j.biopsych.2006.05.045; Weinshilboum RM, 1999, ANNU REV PHARMACOL, V39, P19, DOI 10.1146/annurev.pharmtox.39.1.19; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0; Xie T, 1999, MOL PHARMACOL, V56, P31, DOI 10.1124/mol.56.1.31; XU M, 1994, CELL, V79, P729, DOI 10.1016/0092-8674(94)90557-6	39	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142862	10.1371/journal.pone.0142862	http://dx.doi.org/10.1371/journal.pone.0142862			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26566126	Green Submitted, gold, Green Published			2022-12-26	WOS:000367628500062
J	Shao, HW; Kong, RR; Ferrari, ML; Radtke, F; Capobianco, AJ; Liu, ZJ				Shao, Hongwei; Kong, Ranran; Ferrari, Massimiliano L.; Radtke, Freddy; Capobianco, Anthony J.; Liu, Zhao-Jun			Notch1 Pathway Activity Determines the Regulatory Role of Cancer-Associated Fibroblasts in Melanoma Growth and Invasion	PLOS ONE			English	Article							STROMAL FIBROBLASTS; METASTASIS; ACTIVATION; CELLS; PROGRESSION; MICE	Cancer-associated fibroblasts (CAF) play a crucial role in regulating cancer progression, yet the molecular determinant that governs the tumor regulatory role of CAF remains unknown. Using a mouse melanoma model in which exogenous melanoma cells were grafted on the skin of two lines of mice where the genetic activation or inactivation of Notch1 signaling specifically occurs in natural host stromal fibroblasts, we demonstrated that Notch1 pathway activity could determine the tumor-promoting or tumor-suppressing phenotype in CAF. CAF carrying elevated Notch1 activity significantly inhibited melanoma growth and invasion, while those with a null Notch1 promoted melanoma invasion. These findings identify the Notch1 pathway as a molecular determinant that controls the regulatory role of CAF in melanoma skin growth and invasion, unveiling Notch1 signaling as a potential therapeutic target for melanoma and potentially other solid tumors.	[Shao, Hongwei; Kong, Ranran; Ferrari, Massimiliano L.; Capobianco, Anthony J.; Liu, Zhao-Jun] Univ Miami, Sch Med, Dept Surg, Miami, FL 33101 USA; [Radtke, Freddy] Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res, Lausanne, Switzerland; [Kong, Ranran] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 2, Dept Thorac Surg, Xian 710049, Peoples R China	University of Miami; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Xi'an Jiaotong University	Liu, ZJ (corresponding author), Univ Miami, Sch Med, Dept Surg, Miami, FL 33101 USA.	zliu@med.miami.edu	Radtke, Freddy/Q-3198-2017; kong, Ranran/AAT-7513-2021; Kong, Ranran/AAA-2052-2020	Radtke, Freddy/0000-0003-4315-4045; Shao, Hongwei/0000-0001-9770-4132; Capobianco, Anthony/0000-0002-3706-6797	Bankhead-Coley Cancer Research Program [09BN-11]; University of Miami	Bankhead-Coley Cancer Research Program; University of Miami	This study was supported by Bankhead-Coley Cancer Research Program (Award# 09BN-11), Women's Cancer Association and internal funds from the University of Miami to Z. Liu.	Balint K, 2005, J CLIN INVEST, V115, P3166, DOI 10.1172/JCI25001; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Duda DG, 2010, P NATL ACAD SCI USA, V107, P21677, DOI 10.1073/pnas.1016234107; Ishikawa Y, 2008, ONCOGENE, V27, P6164, DOI 10.1038/onc.2008.216; Kraman M, 2010, SCIENCE, V330, P827, DOI 10.1126/science.1195300; Liu ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038811; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Mishra PJ, 2008, CANCER RES, V68, P4331, DOI 10.1158/0008-5472.CAN-08-0943; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Pinchot SN, 2011, CANCER-AM CANCER SOC, V117, P1386, DOI 10.1002/cncr.25652; Price J E, 2001, Methods Mol Med, V58, P205, DOI 10.1385/1-59259-137-X:205; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Shao H, 2011, ONCOGENE, V30, P4316, DOI 10.1038/onc.2011.142; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Teng YQ, 2011, BIOCHEM BIOPH RES CO, V407, P633, DOI 10.1016/j.bbrc.2011.02.142; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; Tsutsumi R, 2009, J BONE MINER RES, V24, P1753, DOI [10.1359/JBMR.090412, 10.1359/jbmr.090412]; Zhang XHF, 2013, CELL, V154, P1060, DOI 10.1016/j.cell.2013.07.036	21	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142815	10.1371/journal.pone.0142815	http://dx.doi.org/10.1371/journal.pone.0142815			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562315	Green Submitted, Green Published, gold			2022-12-26	WOS:000364480900070
J	Huang, S; Lv, YJ; Peng, YJ; Zhang, LF; Xiu, LW				Huang, Shuai; Lv, Yuejun; Peng, Yanju; Zhang, Lifang; Xiu, Liwei			Effect of Different Groundwater Levels on Seismic Dynamic Response and Failure Mode of Sandy Slope	PLOS ONE			English	Article							STABILITY ANALYSIS; EMBANKMENT SLOPES; WATER; EARTHQUAKES; FREQUENCY; BEHAVIOR	Heavy seismic damage tends to occur in slopes when groundwater is present. The main objectives of this paper are to determine the dynamic response and failure mode of sandy slope subjected simultaneously to seismic forces and variable groundwater conditions. This paper applies the finite element method, which is a fast and efficient design tool in modern engineering analysis, to evaluate dynamic response of the slope subjected simultaneously to seismic forces and variable groundwater conditions. Shaking table test is conducted to analyze the failure mode and verify the accuracy of the finite element method results. The research results show that dynamic response values of the slope have different variation rules under near and far field earthquakes. And the damage location and pattern of the slope are different in varying groundwater conditions. The destruction starts at the top of the slope when the slope is in no groundwater, which shows that the slope appears obvious whipping effect under the earthquake. The destruction starts at the toe of the slope when the slope is in the high groundwater levels. Meanwhile, the top of the slope shows obvious seismic subsidence phenomenon after earthquake. Furthermore, the existence of the groundwater has a certain effect of damping.	[Huang, Shuai; Lv, Yuejun; Peng, Yanju; Zhang, Lifang; Xiu, Liwei] China Earthquake Adm, Inst Crustal Dynam, Beijing 100085, Peoples R China	China Earthquake Administration	Huang, S (corresponding author), China Earthquake Adm, Inst Crustal Dynam, Beijing 100085, Peoples R China.	huangshuai3395@163.com			National Key Technology Support Program of China [2011AA11A102]; Institute of Crustal Dynamics, China Earthquake Administration [ZDJ2015-03]	National Key Technology Support Program of China(National Key Technology R&D Program); Institute of Crustal Dynamics, China Earthquake Administration	This work is financially supported by the National Key Technology Support Program of China (2011AA11A102) and research grant from Institute of Crustal Dynamics, China Earthquake Administration (No. ZDJ2015-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausilio E, 2000, SOIL DYN EARTHQ ENG, V19, P159, DOI 10.1016/S0267-7261(00)00005-1; Bi ZW, 2009, ROCK SOIL MECH, V30, P180; Cai D, 2015, RAILWAY ENG, V1, P56; [董建华 Dong Jianhua], 2011, [工程力学, Engineering Mechanics], V28, P101; Griffiths DV, 1999, GEOTECHNIQUE, V49, P387, DOI 10.1680/geot.1999.49.3.387; Jia GW, 2009, ENG GEOL, V106, P92, DOI 10.1016/j.enggeo.2009.03.003; Jibson RW, 2011, ENG GEOL, V122, P43, DOI 10.1016/j.enggeo.2010.09.017; [金艳丽 JIN Yanli], 2007, [工程地质学报, Journal of Engineering Geology], V15, P599; Katz O, 2006, EARTH PLANET SC LETT, V247, P280, DOI 10.1016/j.epsl.2006.05.009; Kim JM, 2013, SOIL DYN EARTHQ ENG, V44, P67, DOI 10.1016/j.soildyn.2012.09.001; Kokusho I, 2007, J GEOTECH GEOENVIRON, V133, P828, DOI 10.1061/(ASCE)1090-0241(2007)133:7(828); Lin Yu-Bang, 2012, Journal of Central South University (Science and Technology), V43, P3631; Lin YL, 2015, NAT HAZARDS, V76, P791, DOI 10.1007/s11069-014-1517-5; Lin YL, 2013, DISASTER ADV, V6, P69; Lin YL, 2013, NAT HAZARDS, V69, P219, DOI 10.1007/s11069-013-0701-3; Lin YL, 2013, DISASTER ADV, V6, P12; Lu L, 2015, ENG GEOL, V193, P288, DOI 10.1016/j.enggeo.2015.05.001; Ministry of Railways of the People's Republic of China, 2006, COD SEISM DES RAILW; Ng CWW, 2001, CAN GEOTECH J, V38, P1049, DOI 10.1139/cgj-38-5-1049; Shuai Huang, 2015, ELECT J GEOTECHNICAL, V20, P1; Srilatha N, 2013, GEOTEXT GEOMEMBRANES, V36, P27, DOI 10.1016/j.geotexmem.2012.10.004; Stamatopoulos CA, 2007, SOIL DYN EARTHQ ENG, V27, P1082, DOI 10.1016/j.soildyn.2007.01.012; Tong FG, 2008, ROCK SOIL MECH, V29, P1035; Viratjandr C, 2006, CAN GEOTECH J, V43, P802, DOI 10.1139/T06-042; Wang JX, 2007, ROCK SOIL MECH, V28, P213; Wright SG, 2003, PURE APPL GEOPHYS, V160, P1865, DOI 10.1007/s00024-003-2410-4; Ye HL, 2012, CHINA CIVIL ENG J, V45, P129; Zhang Luming, 2009, J RAILWAY ENG SOC, V07, P15; Zhao Lianheng, 2010, Journal of Highway and Transportation Research and Development, V27, P1	29	3	3	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142268	10.1371/journal.pone.0142268	http://dx.doi.org/10.1371/journal.pone.0142268			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560103	Green Published, Green Submitted, gold			2022-12-26	WOS:000364433100069
J	Koskela, S; Laine, O; Makela, S; Pessi, T; Tuomisto, S; Huhtala, H; Karhunen, PJ; Porsti, I; Mustonen, J				Koskela, Sirpa; Laine, Outi; Makela, Satu; Pessi, Tanja; Tuomisto, Sari; Huhtala, Heini; Karhunen, Pekka J.; Porsti, Ilkka; Mustonen, Jukka			Endothelial Nitric Oxide Synthase G894T Polymorphism Associates with Disease Severity in Puumala Hantavirus Infection	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; HEMORRHAGIC-FEVER; GLU298ASP POLYMORPHISM; RENAL SYNDROME; NEPHROPATHIA-EPIDEMICA; GENE POLYMORPHISMS; RISK-FACTOR; VARIANT; CELLS; THROMBOCYTOPENIA	Introduction Hantavirus infections are characterized by both activation and dysfunction of the endothelial cells. The underlying mechanisms of the disease pathogenesis are not fully understood. Here we tested the hypothesis whether the polymorphisms of endothelial nitric oxide synthase, eNOS G894T, and inducible nitric oxide synthase, iNOS G2087A, are associated with the severity of acute Puumala hantavirus (PUUV) infection. Patients and Methods Hospitalized patients (n = 172) with serologically verified PUUV infection were examined. Clinical and laboratory variables reflecting disease severity were determined. The polymorphisms of eNOS G894T (Glu298Asp, rs1799983) and iNOS G2087A (Ser608Leu, rs2297518) were genotyped. Results The rare eNOS G894T genotype was associated with the severity of acute kidney injury (AKI). The non-carriers of G-allele (TT-homozygotes) had higher maximum level of serum creatinine than the carriers of G-allele (GT-heterozygotes and GG-homozygotes; median 326, range 102-1041 vs. median 175, range 51-1499 mu mol/l; p = 0.018, respectively). The length of hospital stay was longer in the non-carriers of G-allele than in G-allele carriers (median 8, range 3-14 vs. median 6, range 2-15 days; p = 0.032). The rare A-allele carriers (i.e. AA-homozygotes and GA-heterozygotes) of iNOS G2087A had lower minimum systolic and diastolic blood pressure than the non-carriers of A-allele (median 110, range 74-170 vs. 116, range 86-162 mmHg, p = 0.019, and median 68, range 40-90 vs. 72, range 48-100 mmHg; p = 0.003, respectively). Conclusions Patients with the TT-homozygous genotype of eNOS G894T had more severe PUUV-induced AKI than the other genotypes. The eNOS G894T polymorphism may play role in the endothelial dysfunction observed during acute PUUV infection.	[Koskela, Sirpa; Laine, Outi; Makela, Satu; Porsti, Ilkka; Mustonen, Jukka] Tampere Univ Hosp, Dept Internal Med, Tampere, Finland; [Laine, Outi; Makela, Satu; Pessi, Tanja; Tuomisto, Sari; Karhunen, Pekka J.; Porsti, Ilkka; Mustonen, Jukka] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Pessi, Tanja] Pirkanmaa Hosp Dist, Ctr Sci, Tampere, Finland; [Huhtala, Heini] Univ Tampere, Sch Hlth Sci, FIN-33101 Tampere, Finland; [Tuomisto, Sari; Karhunen, Pekka J.] Fimlab Labs Ltd, Tampere, Finland	Tampere University; Tampere University Hospital; Tampere University; Pirkanmaa Hospital District; Tampere University	Koskela, S (corresponding author), Tampere Univ Hosp, Dept Internal Med, Tampere, Finland.	Koskela.Sirpa.M@student.uta.fi		Makela, Satu/0000-0001-6967-2401	Competetive State Research Financing of the Expert Responsibility Area of Tampere University Hospital; European Union 7th Framework Program [201668]; NIH/NIAID [U19 A157319]; Finnish Kidney Foundation; Maud Kuistila Foundation; Sigrid Juselius Foundation	Competetive State Research Financing of the Expert Responsibility Area of Tampere University Hospital; European Union 7th Framework Program(European Commission); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Finnish Kidney Foundation; Maud Kuistila Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	The study was financially supported by the Competetive State Research Financing of the Expert Responsibility Area of Tampere University Hospital, European Union 7th Framework Program grant number 201668 for the AtheroRemo Project, the grant NIH/NIAID U19 A157319, the Finnish Kidney Foundation, and the Maud Kuistila Foundation and Sigrid Juselius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Fimlab Laboratories Ltd., provided support in the form of salaries for authors (ST, PJK), but did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'authors contributions' section.	Angeline T, 2010, EXP MOL PATHOL, V89, P205, DOI 10.1016/j.yexmp.2010.08.009; Antonen J, 2013, SCAND J INFECT DIS, V45, P494, DOI 10.3109/00365548.2012.755268; Berger K, 2007, HUM GENET, V121, P169, DOI 10.1007/s00439-006-0302-2; Cherney DZI, 2009, KIDNEY INT, V75, P327, DOI 10.1038/ki.2008.574; Connolly-Andersen AM, 2015, J INFECT DIS, V212, P1061, DOI 10.1093/infdis/jiv161; Connolly-Andersen AM, 2014, CIRCULATION, V129, P1295, DOI 10.1161/CIRCULATIONAHA.113.001870; Davis IC, 2002, J VIROL, V76, P8347, DOI 10.1128/JVI.76.16.8347-8359.2002; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Gavrilovskaya IN, 2008, J VIROL, V82, P5797, DOI 10.1128/JVI.02397-07; GROENEVELD PHP, 1995, SCAND J INFECT DIS, V27, P453, DOI 10.3109/00365549509047045; Hepojoki J, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00727; Hingorani AD, 1999, CIRCULATION, V100, P1515, DOI 10.1161/01.CIR.100.14.1515; Jachymova M, 2001, BIOCHEM BIOPH RES CO, V284, P426, DOI 10.1006/bbrc.2001.5007; Klingstrom J, 2006, EUR J IMMUNOL, V36, P2649, DOI 10.1002/eji.200535587; Kobashi G, 2001, AM J MED GENET, V103, P241, DOI 10.1002/ajmg.1535.abs; Kolb H, 1998, IMMUNOL TODAY, V19, P556, DOI 10.1016/S0167-5699(98)01366-8; Laine O, 2015, INFECT DIS-NOR, V47, P107, DOI 10.3109/00365548.2014.969304; Laine O, 2012, THROMB RES, V129, P611, DOI 10.1016/j.thromres.2011.11.007; Latus J, 2015, INFECTION, V43, P83, DOI 10.1007/s15010-014-0699-9; Latus J, 2015, NEPHROL DIAL TRANSPL, V30, P245, DOI 10.1093/ndt/gfu319; Li JY, 2010, CARDIOLOGY, V116, P271, DOI 10.1159/000316063; Libraty DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035402; Linderholm M, 1996, INFECTION, V24, P337, DOI 10.1007/BF01716075; Linderholm M, 1996, J INFECT DIS, V173, P38, DOI 10.1093/infdis/173.1.38; LUCKHOFF A, 1988, BRIT J PHARMACOL, V95, P189; Luo JQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087196; Mackow ER, 2009, THROMB HAEMOSTASIS, V102, P1030, DOI 10.1160/TH09-09-0640; MACNAUL KL, 1993, BIOCHEM BIOPH RES CO, V196, P1330, DOI 10.1006/bbrc.1993.2398; Makela S, 2004, AM J KIDNEY DIS, V43, P809, DOI 10.1053/j.ajkd.2003.12.044; Makela S, 2002, J INFECT DIS, V186, P843, DOI 10.1086/342413; Makela S, 2010, EUR J CLIN MICROBIOL, V29, P705, DOI 10.1007/s10096-010-0918-y; Makela S, 2001, NEPHROL DIAL TRANSPL, V16, P1368, DOI 10.1093/ndt/16.7.1368; Mansur TDS, 2012, MOL CELL BIOCHEM, V364, P303, DOI 10.1007/s11010-012-1231-0; MARSDEN PA, 1992, FEBS LETT, V307, P287, DOI 10.1016/0014-5793(92)80697-F; MARSDEN PA, 1993, J BIOL CHEM, V268, P17478; Modlinger PS, 2004, SEMIN NEPHROL, V24, P354, DOI 10.1016/j.semnephrol.2004.04.007; Mustonen J, 1996, KIDNEY INT, V49, P217, DOI 10.1038/ki.1996.29; Mustonen J, 2013, ANTIVIR RES, V100, P589, DOI 10.1016/j.antiviral.2013.10.001; Qidwai T, 2010, SCAND J IMMUNOL, V72, P375, DOI 10.1111/j.1365-3083.2010.02458.x; Rasche FM, 2004, EMERG INFECT DIS, V10, P1420, DOI 10.3201/eid1008.031069; Sane J, 2012, ANN MED, V44, P468, DOI 10.3109/07853890.2011.573500; Taylor SL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003470; Terajima M, 2007, IMMUNOL LETT, V113, P117, DOI 10.1016/j.imlet.2007.08.003; Vaheri A, 2013, NAT REV MICROBIOL, V11, P539, DOI 10.1038/nrmicro3066; Vapalahti O, 1996, J CLIN MICROBIOL, V34, P119, DOI 10.1128/JCM.34.1.119-125.1996; Veldman BA, 2002, J HYPERTENS, V20, P2023, DOI 10.1097/00004872-200210000-00022; Wang SS, 2006, CARCINOGENESIS, V27, P1828, DOI 10.1093/carcin/bgl013; Wang ZF, 2013, HUM GENET, V132, P337, DOI 10.1007/s00439-012-1253-4; Xue C, 2014, NEPHROLOGY, V19, P630, DOI 10.1111/nep.12310; Yoshimura M, 1998, HUM GENET, V103, P65, DOI 10.1007/s004390050785; Zhang K, 2012, THROMB RES, V130, P192, DOI 10.1016/j.thromres.2012.02.015; Zhu Y, 2014, RENAL FAILURE, V36, P987, DOI 10.3109/0886022X.2014.900601	54	6	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142872	10.1371/journal.pone.0142872	http://dx.doi.org/10.1371/journal.pone.0142872			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26561052	Green Published, gold, Green Submitted			2022-12-26	WOS:000364433100135
J	Moulis, G; Palmaro, A; Sailler, L; Lapeyre-Mestre, M				Moulis, Guillaume; Palmaro, Aurore; Sailler, Laurent; Lapeyre-Mestre, Maryse			Corticosteroid Risk Function of Severe Infection in Primary Immune Thrombocytopenia Adults. A Nationwide Nested Case-Control Study	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; GLUCOCORTICOID THERAPY; CEREBRAL ASPERGILLOSIS; SERIOUS INFECTION; OLDER PATIENTS; SPLENECTOMY; RITUXIMAB; PURPURA; EFFICACY; PATIENT	Corticosteroid (CS)-related infection risk in immune thrombocytopenia (ITP) is unknown. The aim of this study was to assess the adjusted CS risk function of severe infection in persistent or chronic primary ITP adults. We designed a nested case-control study in the FAITH cohort. This cohort is built through the French national health insurance database named SNIIRAM and includes all treated incident persistent or chronic primary ITP adults in France (ENCePP no4574). Patients who entered the FAITH cohort between 2009 and 2012 were eligible (n = 1805). Cases were patients with infection as primary diagnosis code during hospitalization. Index date was the date of first hospitalization for infection. A 2: 1 matching was performed on age and entry date in the cohort. Various CS exposure time-windows were defined: current user, exposure during the 1/3/6 months preceding index date and from the entry date. CS doses were converted in prednisone equivalent (PEQ). The cumulative CS doses were averaged in each time-window to obtain daily PEQ dosages. Each CS exposure definition was assessed using multivariate conditional regression models. During the study period, 161 cases (9 opportunistic) occurred. The model with the best goodness of fit was CS exposure during the month before the index date (OR: 2.48, 95% CI: 1.613.83). The dose-effect relation showed that the risk existed from averaged daily doses >= 5 mg PEQ (vs. <5 mg: 2.09, 95% CI: 1.17-3.71). The risk of infection was mainly supported by current or recent exposure to CS, even with low doses.	[Moulis, Guillaume; Palmaro, Aurore; Sailler, Laurent; Lapeyre-Mestre, Maryse] Univ Toulouse 3, INSERM, Fac Med, UMR 1027, F-31062 Toulouse, France; [Moulis, Guillaume; Sailler, Laurent] Ctr Hosp Univ Toulouse, Serv Med Interne, Toulouse, France; [Moulis, Guillaume; Palmaro, Aurore; Sailler, Laurent; Lapeyre-Mestre, Maryse] Ctr Hosp Univ Toulouse, CIC 1436, Toulouse, France; [Lapeyre-Mestre, Maryse] Ctr Hosp Univ Toulouse, Serv Pharmacol Med & Clin, Fac Med, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse	Moulis, G (corresponding author), Univ Toulouse 3, INSERM, Fac Med, UMR 1027, F-31062 Toulouse, France.	guillaume.moulis@univ-tlse3.fr	Lapeyre-Mestre, Maryse/C-8710-2012; Palmaro, Aurore/N-3112-2015	Lapeyre-Mestre, Maryse/0000-0002-5494-5873; Palmaro, Aurore/0000-0002-5660-9224				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Apostolidis J, 2001, BLOOD, V98, P2875, DOI 10.1182/blood.V98.9.2875a; Arnold DM, 2007, ANN INTERN MED, V146, P25, DOI 10.7326/0003-4819-146-1-200701020-00006; Bannay A, 2013, REV DEPIDEMIOLOGIE S, VS9; Boyle S, 2013, BLOOD, V121, P4782, DOI 10.1182/blood-2012-12-467068; Collins AJ, 2009, AM J KIDNEY DIS, V53, pS27, DOI 10.1053/j.ajkd.2008.07.055; Cutolo M, 2008, AUTOIMMUN REV, V8, P153, DOI 10.1016/j.autrev.2008.07.010; de Stoppelaar SF, 2014, BLOOD, V124, P3781, DOI 10.1182/blood-2014-05-573915; Dixon WG, 2011, ANN RHEUM DIS, V70, P956, DOI 10.1136/ard.2010.144741; Dixon WG, 2012, ANN RHEUM DIS, V71, P1128, DOI 10.1136/annrheumdis-2011-200702; Fianchi L, 2007, ANN HEMATOL, V86, P225, DOI 10.1007/s00277-006-0206-1; Frederiksen H, 2014, BRIT J HAEMATOL, V166, P260, DOI 10.1111/bjh.12869; George JN, 1996, BLOOD, V88, P3, DOI 10.1182/blood.V88.1.3.3; Ghanima W, 2012, BLOOD, V120, P960, DOI 10.1182/blood-2011-12-309153; Godeau B, 2008, BLOOD, V112, P999, DOI 10.1182/blood-2008-01-131029; Gottenberg JE, 2010, ARTHRITIS RHEUM-US, V62, P2625, DOI 10.1002/art.27555; Grossi O, 2013, REV MED INTERNE, V34, P269, DOI 10.1016/j.revmed.2012.12.008; Hu MH, 2014, ANN HEMATOL, V93, P1023, DOI 10.1007/s00277-014-2014-3; Khellaf M, 2005, HAEMATOLOGICA, V90, P829; Khellaf M, 2014, BLOOD, V124, P3228, DOI 10.1182/blood-2014-06-582346; Kojouri K, 2004, BLOOD, V104, P2623, DOI 10.1182/blood-2004-03-1168; Kyaw MH, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.07.044; Listing J, 2013, RHEUMATOLOGY, V52, P53, DOI 10.1093/rheumatology/kes305; Lo E, 2014, AUTOIMMUN REV, V13, P577, DOI 10.1016/j.autrev.2014.01.026; Morrell CN, 2014, BLOOD, V123, P2759, DOI 10.1182/blood-2013-11-462432; Moulis G, 2015, REV MED INTERNE, V36, P411, DOI 10.1016/j.revmed.2014.11.009; Moulis G, 2015, AUTOIMMUN REV, V14, P168, DOI 10.1016/j.autrev.2014.10.017; Moulis G, 2014, BLOOD, V124, P3308, DOI 10.1182/blood-2014-05-578336; Moulis G, 2014, THERAPIE, V69, P437, DOI 10.2515/therapie/2014056; Moulis G, 2014, AM J HEMATOL, V89, P41, DOI 10.1002/ajh.23580; Nakano Takako, 2002, Nihon Kokyuki Gakkai Zasshi, V40, P945; Neunert C, 2011, BLOOD, V117, P4190, DOI 10.1182/blood-2010-08-302984; Nikkels AF, 1999, DERMATOLOGY, V199, P361, DOI 10.1159/000018292; Norgaard M, 2011, BLOOD, V117, P3514, DOI 10.1182/blood-2010-10-312819; Papadopoulos A, 2008, ANN HEMATOL, V87, P685, DOI 10.1007/s00277-008-0452-5; Portielje JEA, 2001, BLOOD, V97, P2549, DOI 10.1182/blood.V97.9.2549; Provan D, 2010, BLOOD, V115, P168, DOI 10.1182/blood-2009-06-225565; Rodeghiero F, 2009, BLOOD, V113, P2386, DOI 10.1182/blood-2008-07-162503; Schoonen WM, 2009, BRIT J HAEMATOL, V145, P235, DOI 10.1111/j.1365-2141.2009.07615.x; STASI R, 1995, AM J MED, V98, P436, DOI 10.1016/S0002-9343(99)80342-8; Stasi R, 2011, BRIT J HAEMATOL, V153, P437, DOI 10.1111/j.1365-2141.2010.08562.x; STUCK AE, 1989, REV INFECT DIS, V11, P954; Thomsen RW, 2009, ANN INTERN MED, V151, P546, DOI 10.7326/0003-4819-151-8-200910200-00008; Tsai Hung-Chin, 2006, J Chin Med Assoc, V69, P278, DOI 10.1016/S1726-4901(09)70257-6; Wu Q, 2015, CLIN APPL T IN PRESS	45	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142217	10.1371/journal.pone.0142217	http://dx.doi.org/10.1371/journal.pone.0142217			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559054	Green Published, gold, Green Submitted			2022-12-26	WOS:000364433100062
J	Stuhldreier, I; Sanchez-Noguera, C; Rixen, T; Cortes, J; Morales, A; Wild, C				Stuhldreier, Ines; Sanchez-Noguera, Celeste; Rixen, Tim; Cortes, Jorge; Morales, Alvaro; Wild, Christian			Effects of Seasonal Upwelling on Inorganic and Organic Matter Dynamics in the Water Column of Eastern Pacific Coral Reefs	PLOS ONE			English	Article							GREAT-BARRIER-REEF; TROPICAL PACIFIC; BIOGEOCHEMICAL RESPONSES; BAHIA CULEBRA; GULF; PAPAGAYO; CARBONATE; MARINE; BAY; VARIABILITY	The Gulf of Papagayo at the northern Pacific coast of Costa Rica experiences pronounced seasonal changes in water parameters caused by wind-driven coastal upwelling. While remote sensing and open water sampling already described the physical nature of this upwelling, the spatial and temporal effects on key parameters and processes in the water column have not been investigated yet, although being highly relevant for coral reef functioning. The present study investigated a range of water parameters on two coral reefs with different exposure to upwelling (Matapalo and Bajo Rojo) in a weekly to monthly resolution over one year (May 2013 to April 2014). Based on air temperature, wind speed and water temperature, three time clusters were defined: a) May to November 2013 without upwelling, b) December 2013 to April 2014 with moderate upwelling, punctuated by c) extreme upwelling events in February, March and April 2014. During upwelling peaks, water temperatures decreased by 7 degrees C (Matapalo) and 9 degrees C (Bajo Rojo) to minima of 20.1 and 15.3 degrees C respectively, while phosphate, ammonia and nitrate concentrations increased 3 to 15-fold to maxima of 1.3 mu mol PO43- L-1, 3.0 mu mol NH4+ L-1 and 9.7 mu mol NO3- L-1. This increased availability of nutrients triggered several successive phytoplankton blooms as indicated by 3-(Matapalo) and 6-fold (Bajo Rojo) increases in chlorophyll a concentrations. Particulate organic carbon and nitrogen (POC and PON) increased by 40 and 70% respectively from February to April 2014. Dissolved organic carbon (DOC) increased by 70% in December and stayed elevated for at least 4 months, indicating high organic matter release by primary producers. Such strong cascading effects of upwelling on organic matter dynamics on coral reefs have not been reported previously, although likely impacting many reefs in comparable upwelling systems.	[Stuhldreier, Ines; Sanchez-Noguera, Celeste; Rixen, Tim; Wild, Christian] Leibniz Ctr Trop Marine Ecol, Bremen, Germany; [Stuhldreier, Ines; Wild, Christian] Univ Bremen, Fac Biol & Chem, D-28359 Bremen, Germany; [Sanchez-Noguera, Celeste; Cortes, Jorge; Morales, Alvaro] Univ Costa Rica, Ctr Invest Ciencias Mar & Limnol, San Jose, Costa Rica	Leibniz Zentrum fur Marine Tropenforschung (ZMT); University of Bremen; Universidad Costa Rica	Stuhldreier, I (corresponding author), Leibniz Ctr Trop Marine Ecol, Bremen, Germany.	ines.stuhldreier@uni-bremen.de	Cortés, Jorge/AAC-9782-2020; Lange, Ines D/Q-4722-2019	Cortés, Jorge/0000-0001-7004-8649; Lange, Ines D/0000-0001-9888-2694	Leibniz Association (DE) as part of the ZMT project COSTACID	Leibniz Association (DE) as part of the ZMT project COSTACID	This study was funded by the Leibniz Association (DE) as part of the ZMT project COSTACID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro EJ, 2012, REV BIOL TROP, V60, P173; Amador JA, 2006, PROG OCEANOGR, V69, P101, DOI 10.1016/j.pocean.2006.03.007; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Arar EJ, 1997, 4450 UN EPA NAT EXP; AZAM F, 1994, MICROBIAL ECOL, V28, P167, DOI 10.1007/BF00166806; Bayraktarov E, 2014, ENVIRON MONIT ASSESS, V186, P3641, DOI 10.1007/s10661-014-3647-3; Benzoni F, 2003, CORAL REEFS, V22, P475, DOI 10.1007/s00338-003-0342-1; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Chao Y, 2009, J ATMOS OCEAN TECH, V26, P1415, DOI 10.1175/2009JTECHO592.1; Chollett I, 2010, MAR ECOL PROG SER, V416, P47, DOI 10.3354/meps08775; Cortes J, 2003, LATIN AMERICAN CORAL REEFS, P361, DOI 10.1016/B978-044451388-5/50017-5; D'Croz L, 2007, ESTUAR COAST SHELF S, V73, P325, DOI 10.1016/j.ecss.2007.01.013; Diaz-Pulido G, 2002, BOT MAR, V45, P284, DOI 10.1515/BOT.2002.028; Dickson A., 2007, PICES SPECIAL PUBLIC, V3, DOI 10.25607/OBP-1342; DUCKLOW HW, 1986, SCIENCE, V232, P865, DOI 10.1126/science.232.4752.865; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Fawcett SE, 2011, MAR ECOL PROG SER, V428, P13, DOI 10.3354/meps09070; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Fernandez-Garcia C, 2012, REV BIOL TROP, V60, P93; Ferrier-Pages C, 1998, MAR ECOL PROG SER, V172, P265, DOI 10.3354/meps172265; Fiedler PC, 2006, PROG OCEANOGR, V69, P143, DOI 10.1016/j.pocean.2006.03.008; Garcia-Robledo E, 2014, MAR CHEM, V162, P30, DOI 10.1016/j.marchem.2014.03.002; Glud RN, 2008, LIMNOL OCEANOGR, V53, P1014, DOI 10.4319/lo.2008.53.3.1014; Gove JM, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003161; Haas AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027973; Hansell D.A., 2005, EOS T AM GEOPHYS UN, V86, P318, DOI DOI 10.1029/2005EO350003; HANSELL DA, 1993, MAR CHEM, V41, P195, DOI 10.1016/0304-4203(93)90119-9; Hanson CE, 2005, CONT SHELF RES, V25, P1561, DOI 10.1016/j.csr.2005.04.003; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoegh-Guldberg O, 2011, REG ENVIRON CHANGE, V11, pS215, DOI 10.1007/s10113-010-0189-2; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Holmes RM, 1999, CAN J FISH AQUAT SCI, V56, P1801, DOI 10.1139/cjfas-56-10-1801; Jimenez C, 2001, REV BIOL TROP, V49, P153; Kessler WS, 2006, PROG OCEANOGR, V69, P181, DOI 10.1016/j.pocean.2006.03.009; Kleypas JA, 2001, INT J EARTH SCI, V90, P426, DOI 10.1007/s005310000125; Kleypas JA, 1999, AM ZOOL, V39, P146; Lavin MF, 2006, PROG OCEANOGR, V69, P391, DOI 10.1016/j.pocean.2006.03.005; LEGECKIS R, 1988, J GEOPHYS RES-OCEANS, V93, P15485, DOI 10.1029/JC093iC12p15485; Leichter JJ, 1996, LIMNOL OCEANOGR, V41, P1490, DOI 10.4319/lo.1996.41.7.1490; Leichter JJ, 2003, LIMNOL OCEANOGR, V48, P1394, DOI 10.4319/lo.2003.48.4.1394; Loucaides S, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004216; Malerba ME, 2012, LIMNOL OCEANOGR, V57, P1555, DOI 10.4319/lo.2012.57.5.1555; McClanahan TR, 2009, MAR ECOL PROG SER, V380, P117, DOI 10.3354/meps07879; MCCREARY JP, 1989, J MAR RES, V47, P81, DOI 10.1357/002224089785076343; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Pennington JT, 2006, PROG OCEANOGR, V69, P285, DOI 10.1016/j.pocean.2006.03.012; Riegl B, 2003, INT J EARTH SCI, V92, P520, DOI 10.1007/s00531-003-0328-9; Rixen T, 2012, REV BIOL TROP, V60, P187; Schmidt GM, 2012, MAR ECOL PROG SER, V456, P113, DOI 10.3354/meps09682; Selman M, 2008, WRI POLICY NOTE; Shaw EC, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007655; SMITH SV, 1975, LIMNOL OCEANOGR, V20, P493, DOI 10.4319/lo.1975.20.3.0493; Taylor BW, 2007, J N AM BENTHOL SOC, V26, P167, DOI 10.1899/0887-3593(2007)26[167:ITFAMM]2.0.CO;2; U.S. Environmental Protection Agency, 1983, 4151 UN EPA OFF RES; Wild C, 2008, CORAL REEFS, V27, P123, DOI 10.1007/s00338-007-0298-7; Wild C, 2005, MAR ECOL PROG SER, V298, P69, DOI 10.3354/meps298069; Wild C, 2004, NATURE, V428, P66, DOI 10.1038/nature02344; Wild C, 2009, AQUAT BIOL, V7, P71, DOI 10.3354/ab00185; Wyatt ASJ, 2012, LIMNOL OCEANOGR, V57, P401, DOI 10.4319/lo.2012.57.2.0401; Wyatt ASJ, 2010, MAR ECOL PROG SER, V405, P113, DOI 10.3354/meps08508; Yates KK, 2007, MAR CHEM, V104, P110, DOI 10.1016/j.marchem.2006.12.008; Zuta S., 1970, B I MAR PERU, V2, P157	64	20	21	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142681	10.1371/journal.pone.0142681	http://dx.doi.org/10.1371/journal.pone.0142681			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560464	gold, Green Published, Green Submitted			2022-12-26	WOS:000364433100112
J	Axelsson, EP; Iason, GR; Julkunen-Tiitto, R; Whitham, TG				Axelsson, E. Petter; Iason, Glenn R.; Julkunen-Tiitto, Riitta; Whitham, Thomas G.			Host Genetics and Environment Drive Divergent Responses of Two Resource Sharing Gall-Formers on Norway Spruce: A Common Garden Analysis	PLOS ONE			English	Article							PICEA-ABIES CLONES; PLANT GENOTYPE; COMMUNITY STRUCTURE; ARTHROPOD COMMUNITY; HERBIVORE COMMUNITY; FOLIAR CHEMISTRY; LEAF-LITTER; RESISTANCE; GENES; APHID	A central issue in the field of community genetics is the expectation that trait variation among genotypes play a defining role in structuring associated species and in forming community phenotypes. Quantifying the existence of such community phenotypes in two common garden environments also has important consequences for our understanding of gene-by-environment interactions at the community level. The existence of community phenotypes has not been evaluated in the crowns of boreal forest trees. In this study we address the influence of tree genetics on needle chemistry and genetic x environment interactions on two gall-inducing adelgid aphids (Adelges spp. and Sacchiphantes spp.) that share the same elongating bud/shoot niche. We examine the hypothesis that the canopies of different genotypes of Norway spruce (Picea abies L.) support different community phenotypes. Three patterns emerged. First, the two gallers show clear differences in their response to host genetics and environment. Whereas genetics significantly affected the abundance of Adelges spp. galls, Sacchiphantes spp. was predominately affected by the environment suggesting that the genetic influence is stronger in Adelges spp. Second, the among family variation in genetically controlled resistance was large, i.e. fullsib families differed as much as 10 fold in susceptibility towards Adelges spp. (0.57 to 6.2 galls/branch). Also, the distribution of chemical profiles was continuous, showing both overlap as well as examples of significant differences among fullsib families. Third, despite the predicted effects of host chemistry on galls, principal component analyses using 31 different phenolic substances showed only limited association with galls and a similarity test showed that trees with similar phenolic chemical characteristics, did not host more similar communities of gallers. Nonetheless, the large genetic variation in trait expression and clear differences in how community members respond to host genetics supports our hypothesis that the canopies of Norway spruce differ in their community phenotypes.	[Axelsson, E. Petter] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden; [Iason, Glenn R.] James Hutton Inst, Aberdeen AB15 8QH, Scotland; [Julkunen-Tiitto, Riitta] Univ Eastern Finland, Dept Biol, Joensuu 80101, Finland; [Whitham, Thomas G.] No Arizona Univ, Merriam Powell Ctr Environm Res, Flagstaff, AZ 86011 USA; [Whitham, Thomas G.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA	Swedish University of Agricultural Sciences; James Hutton Institute; University of Eastern Finland; Northern Arizona University; Northern Arizona University	Axelsson, EP (corresponding author), Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden.	petter.axelsson@slu.se	Julkunen-Tiitto, Riitta/GRR-9781-2022		King Carl XVI Gustaf's 50-Year Fund; Fonden for skogsvetenskaplig forskning; Scottish Government's Rural and Environment Science and Analytical Services; BBSRC [BB/L012227/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L012227/1] Funding Source: researchfish	King Carl XVI Gustaf's 50-Year Fund; Fonden for skogsvetenskaplig forskning; Scottish Government's Rural and Environment Science and Analytical Services; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by King Carl XVI Gustaf's 50-Year Fund and Fonden for skogsvetenskaplig forskning (EPA). GRI was funded by the Scottish Government's Rural and Environment Science and Analytical Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala-Roberts L, 2013, OIKOS, V122, P1157, DOI 10.1111/j.1600-0706.2012.00159.x; Agrawal AA, 2015, ECOL LETT, V18, P985, DOI 10.1111/ele.12482; [Anonymous], 2014, SWED STAT YB FOR; Axelsson EP, 2011, J APPL ECOL, V48, P1472, DOI 10.1111/j.1365-2664.2011.02046.x; Axelsson EP, 2010, ECOSYSTEMS, V13, P1049, DOI 10.1007/s10021-010-9373-y; Bailey JK, 2006, ECOL LETT, V9, P78, DOI 10.1111/j.1461-0248.2005.00844.x; Bains B, 2009, CAN J FOREST RES, V39, P2536, DOI 10.1139/X09-164; Bangert RK, 2006, MOL ECOL, V15, P1379, DOI 10.1111/j.1365-294X.2005.02749.x; Bernhardsson C, 2013, ECOL LETT, V16, P791, DOI 10.1111/ele.12114; Bjorkman C, 2000, OECOLOGIA, V123, P223, DOI 10.1007/s004420051009; Busby PE, 2014, ECOLOGY; Carmona D, 2011, FUNCT ECOL, V25, P358, DOI 10.1111/j.1365-2435.2010.01794.x; Compson ZG, 2011, OECOLOGIA, V167, P711, DOI 10.1007/s00442-011-2033-x; Danielsson M, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-154; DENNO RF, 1995, ANNU REV ENTOMOL, V40, P297, DOI 10.1146/annurev.en.40.010195.001501; Evans LM, 2012, OECOLOGIA, V168, P483, DOI 10.1007/s00442-011-2108-8; Gehring C, 2014, MOL ECOL, V23, P1379, DOI 10.1111/mec.12503; Goslee SC, 2007, J STAT SOFTWARE, V22; Hartmann G, 2010, SKADOR SIUKDOMAR TRA; Hertel H, 1999, PHYTON AUSTRIA, V36, P65; Hjalten J, 2007, OIKOS, V116, P751, DOI [10.1111/j.2007.0030-1299.15365.x, 10.1111/j.0030-1299.2007.15365.x]; Holeski LM, 2009, ECOLOGY, V90, P2969, DOI 10.1890/08-2378.1; Iason GR, 2005, ECOL LETT, V8, P364, DOI 10.1111/j.1461-0248.2005.00732.x; Johnson MTJ, 2008, ECOLOGY, V89, P145, DOI 10.1890/07-0395.1; Johnson MTJ, 2005, ECOLOGY, V86, P874, DOI 10.1890/04-1068; Johnson MTJ, 2006, ECOL LETT, V9, P24, DOI 10.1111/j.1461-0248.2005.00833.x; Julkunen-Tiitto R, 2001, J CHEM ECOL, V27, P779, DOI 10.1023/A:1010358120482; Keith AR, 2010, ECOLOGY, V91, P3398, DOI 10.1890/09-1236.1; Khudr MS, 2014, ADV ECOLOGICAL RES, V50, P243; Korkama T, 2006, NEW PHYTOL, V171, P815, DOI 10.1111/j.1469-8137.2006.01786.x; Korkama-Rajala T, 2008, MICROB ECOL, V56, P76, DOI 10.1007/s00248-007-9326-y; Leimu R, 2006, AM NAT, V168, pE15, DOI 10.1086/505766; LeRoy CJ, 2007, J N AM BENTHOL SOC, V26, P426, DOI 10.1899/06-113.1; Leski T, 2010, MYCORRHIZA, V20, P473, DOI 10.1007/s00572-010-0298-2; MADDOX GD, 1990, ECOLOGY, V71, P2115, DOI 10.2307/1938625; Mattson WJ, 1998, BIOL GALL INDUCING A, V199, P304; McKinnon ML, 1999, FUNCT ECOL, V13, P859, DOI 10.1046/j.1365-2435.1999.00376.x; Pakeman RJ, 2006, ECOGRAPHY, V29, P451, DOI 10.1111/j.2006.0906-7590.04617.x; Payne R.W., 2009, GENSTAT WINDOWS, V12nd; Roche BM, 1997, EVOLUTION, V51, P1490, DOI 10.1111/j.1558-5646.1997.tb01472.x; Roder J, 2010, FOREST ECOL MANAG, V259, P1513, DOI 10.1016/j.foreco.2010.01.027; Savolainen O, 2013, NAT REV GENET, V14, P807, DOI 10.1038/nrg3522; Shuster SM, 2006, EVOLUTION, V60, P991, DOI 10.1111/j.0014-3820.2006.tb01177.x; Stenberg JA, 2011, ECOL ENTOMOL, V36, P442, DOI 10.1111/j.1365-2311.2011.01285.x; Tack AJM, 2012, OIKOS, V121, P481, DOI 10.1111/j.1600-0706.2011.19926.x; Tack AJM, 2010, ECOLOGY, V91, P2660, DOI 10.1890/09-1027.1; Taulavuori K, 2013, NAT PROD COMMUN, V8, P791; TJIA B, 1975, FOREST SCI, V21, P180; Velmala SM, 2013, MYCORRHIZA, V23, P21, DOI 10.1007/s00572-012-0446-y; Viswanathan DV, 2005, ECOLOGY, V86, P886, DOI 10.1890/04-0313; Wellendorf H, 2008, SILVAE GENET, V57, P312, DOI 10.1515/sg-2008-0047; WHITHAM TG, 1989, SCIENCE, V244, P1490, DOI 10.1126/science.244.4911.1490; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; Whitham TG, 2012, TRENDS PLANT SCI, V17, P271, DOI 10.1016/j.tplants.2012.01.005; Wimp GM, 2004, ECOL LETT, V7, P776, DOI 10.1111/j.1461-0248.2004.00635.x; Zhao BG, 1998, ENVIRON ENTOMOL, V27, P984, DOI 10.1093/ee/27.4.984; Zytynska SE, 2010, ECOLOGY, V91, P1563, DOI 10.1890/09-2070.1	57	9	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142257	10.1371/journal.pone.0142257	http://dx.doi.org/10.1371/journal.pone.0142257			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554587	gold, Green Published, Green Submitted			2022-12-26	WOS:000364430700075
J	Deng, X; Zhang, GL; Zhang, L; Feng, Y; Li, ZH; Wu, GM; Yue, YH; Li, GS; Cao, Y; Zhu, P				Deng, Xin; Zhang, Guoli; Zhang, Ling; Feng, Yan; Li, Zehong; Wu, GuangMou; Yue, Yuhuan; Li, Gensong; Cao, Yu; Zhu, Ping			Developing a Novel Gene-Delivery Vector System Using the Recombinant Fusion Protein of Pseudomonas Exotoxin A and Hyperthermophilic Archaeal Histone HPhA	PLoS One			English	Article							PYROCOCCUS-HORIKOSHII OT3; ARGININE-RICH PEPTIDES; X-RAY ANALYSIS; AERUGINOSA EXOTOXIN; DNA DELIVERY; EXPRESSION; CELLS; THERAPY; CANCER; COMPLEX	Non-viral gene delivery system with many advantages has a great potential for the future of gene therapy. One inherent obstacle of such approach is the uptake by endocytosis into vesicular compartments. Receptor-mediated gene delivery method holds promise to overcome this obstacle. In this study, we developed a receptor-mediated gene delivery system based on a combination of the Pseudomonas exotoxin A (PE), which has a receptor binding and membrane translocation domain, and the hyperthermophilic archaeal histone (HPhA), which has the DNA binding ability. First, we constructed and expressed the rPE-HPhA fusion protein. We then examined the cytotoxicity and the DNA binding ability of rPE-HPhA. We further assessed the efficiency of transfection of the pEGF-C1 plasmid DNA to CHO cells by the rPE-HPhA system, in comparison to the cationic liposome method. The results showed that the transfection efficiency of rPE-HPhA was higher than that of cationic liposomes. In addition, the rPE-HPhA gene delivery system is non-specific to DNA sequence, topology or targeted cell type. Thus, the rPE-HPhA system can be used for delivering genes of interest into mammalian cells and has great potential to be applied for gene therapy.	[Deng, Xin; Li, Gensong] China Med Univ, Basic Med Sci Res Coll, Expt Ctr Funct Subjects, Shenyang 110001, Liaoning, Peoples R China; [Zhang, Guoli; Zhang, Ling; Wu, GuangMou; Yue, Yuhuan; Zhu, Ping] PLA, Inst Vet Med, Acad Mil Med Sci, Changchun, Jilin, Peoples R China; [Feng, Yan] Jilin Univ, Key Lab Mol Enzymol, Changchun 130023, Jilin, Peoples R China; [Li, Zehong] Jilin Agr Univ, Dept Biol & Technol, Changchun, Jilin, Peoples R China; [Cao, Yu] China Med Univ, Dept Physiol, Shenyang 110001, Liaoning, Peoples R China	China Medical University; Academy of Military Medical Sciences - China; Jilin University; Jilin Agricultural University; China Medical University	Deng, X (corresponding author), China Med Univ, Basic Med Sci Res Coll, Expt Ctr Funct Subjects, Shenyang 110001, Liaoning, Peoples R China.	dengxin@mail.cmu.edu.cn; zhangguoli2001@126.com	Deng, Xin/GVU-4397-2022	Deng, Xin/0000-0001-7846-7389	National Nature Science Foundation of China [81370712, 31172165]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: This work was supported by the National Nature Science Foundation of China (http://www.nsfc.gov.cn), Grant numbers: 81370712 (XD) and 31172165 (GLZ). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu J, 2005, J BIOCHEM, V138, P159, DOI 10.1093/jb/mvi115; Arote RB, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/044102; Askou AL, 2015, MOL THER-METH CLIN D, V2, DOI 10.1038/mtm.2014.64; Boland EL, 2014, J MOL BIOL, V426, P645, DOI 10.1016/j.jmb.2013.11.002; Chen TY, 2000, APPL MICROBIOL BIOT, V53, P558, DOI 10.1007/s002530051657; Chen W, 2014, J CONTROL RELEASE, V190, P398, DOI 10.1016/j.jconrel.2014.05.023; Chung M, 2013, ANAL CHEM, V85, P7753, DOI 10.1021/ac401012j; Daddaoua A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039390; Davis ME, 2002, CURR OPIN BIOTECH, V13, P128, DOI 10.1016/S0958-1669(02)00294-X; Deng X, 2008, J DRUG TARGET, V16, P379, DOI [10.1080/10611860802102324, 10.1080/10611860802102324 ]; Du Toit A, 2015, NAT REV MOL CELL BIO, V16, DOI 10.1038/nrm3939; El-Aneed A, 2004, J CONTROL RELEASE, V94, P1, DOI 10.1016/j.jconrel.2003.09.013; Eshita Y, 2015, DRUG DELIV TRANSL RE, V5, P38, DOI 10.1007/s13346-014-0213-z; Felgner PL, 1997, HUM GENE THER, V8, P511, DOI 10.1089/hum.1997.8.5-511; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; Harutyunyan S, 2014, J VIROL, V88, P6307, DOI 10.1128/JVI.00539-14; Hashida H, 2004, BRIT J CANCER, V90, P1252, DOI 10.1038/sj.bjc.6601680; Hung CF, 2001, CANCER RES, V61, P3698; Johnsen KB, 2014, BBA-REV CANCER, V1846, P75, DOI 10.1016/j.bbcan.2014.04.005; Jorgensen R, 2005, NATURE, V436, P979, DOI 10.1038/nature03871; Kang HJ, 2011, ACTA CRYSTALLOGR F, V67, P144, DOI 10.1107/S1744309110048426; Kanzawa T, 2003, J BIOMED BIOTECHNOL, P25; Kawarabayasi Y, 1998, DNA Res, V5, P55, DOI 10.1093/dnares/5.2.55; Khabou H, 2015, M S-MED SCI, V31, P529, DOI 10.1051/medsci/20153105015; Kreppel F, 2002, INVEST OPHTH VIS SCI, V43, P1965; Li AX, 2006, TALANTA, V70, P330, DOI 10.1016/j.talanta.2006.02.056; Li T, 2003, J MOL BIOL, V325, P1031, DOI 10.1016/S0022-2836(02)01285-8; Li T, 2002, ACTA CRYSTALLOGR D, V58, P870, DOI 10.1107/S0907444902005036; Lorenz C, 2011, RNA BIOL, V8, P627, DOI 10.4161/rna.8.4.15394; Mazor R, 2012, P NATL ACAD SCI USA, V109, pE3597, DOI 10.1073/pnas.1218138109; Miyoshi D, 2014, CHEMMEDCHEM, V9, P2156, DOI 10.1002/cmdc.201402157; Motioch LJ, 2015, EXPERT OPIN BIOL TH, V15, P803, DOI [10.1517/14712598.2015.1036734, DOI 10.1517/14712598.2015.1036734]; Paulsson M, 2015, J CYST FIBROS, V14, P600, DOI 10.1016/j.jcf.2015.05.005; Roe K, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-75; Sauer H, 2013, STEM CELLS DEV, V22, P1443, DOI 10.1089/scd.2012.0640; Suzuki T, 2002, J BIOL CHEM, V277, P2437, DOI 10.1074/jbc.M110017200; Tafesse FG, 2014, J BIOL CHEM, V289, P24005, DOI 10.1074/jbc.M114.589275; Tolmachov Oleg E, 2012, Med Hypotheses, V78, P632, DOI 10.1016/j.mehy.2012.01.042; WAGNER E, 1991, P NATL ACAD SCI USA, V88, P4255, DOI 10.1073/pnas.88.10.4255; Wedekind JE, 2001, J MOL BIOL, V314, P823, DOI 10.1006/jmbi.2001.5195; Weldon JE, 2011, FEBS J, V278, P4683, DOI 10.1111/j.1742-4658.2011.08182.x; Weng L, 2004, PROTEIN EXPRES PURIF, V33, P145, DOI 10.1016/j.pep.2003.09.004; Weng L, 2004, BIOCHIM BIOPHYS ACTA, V1720, P209; Yang N, 2012, INT J PHARM INVESTIG, V2, P97, DOI 10.4103/2230-973X.104388; Ye MP, 2014, INFECT IMMUN, V82, P1840, DOI 10.1128/IAI.00030-14	45	5	6	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142558	10.1371/journal.pone.0142558	http://dx.doi.org/10.1371/journal.pone.0142558			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556098	gold, Green Submitted, Green Published			2022-12-26	WOS:000364430700128
J	Hanusch, AL; de Oliveira, GR; de Saboia-Morais, SMT; Machado, RC; dos Anjos, MM; Chen, LC				Hanusch, Alex Lucas; de Oliveira, Guilherme Roberto; Teixeira de Saboia-Morais, Simone Maria; Machado, Rafael Cosme; dos Anjos, Murilo Machado; Chen, Lee Chen			Genotoxicity and Cytotoxicity Evaluation of the Neolignan Analogue 2-(4-Nitrophenoxy)-1 Phenylethanone and its Protective Effect Against DNA Damage	PLOS ONE			English	Article							IN-VITRO; MICRONUCLEUS TEST; COMET ASSAY; CELLS; EXTRACT; LIGNAN; (-)-HINOKININ; INHIBITION; BLOOD; SEEDS	Neolignans are secondary metabolites found in various groups of Angiosperms. They belong to a class of natural compounds with great diversity of chemical structures and pharmacological activities. These compounds are formed by linking two phenylpropanoid units. Several compounds that have ability to prevent genetic damage have been isolated from plants, and can be used to prevent or delay the development of tumor cells. Genetic toxicology evaluation is widely used in risk assessment of new drugs in preclinical screening tests. In this study, we evaluated the genotoxicity and cytotoxicity of the neolignan analogue 2-(4nitrophenoxy)-1-phenylethanone (4NF) and its protective effect against DNA damage using the mouse bone marrow micronucleus test and the comet assay in mouse peripheral blood. Our results showed that this neolignan analogue had no genotoxic activity and was able to reduce induced damage both in mouse bone marrow and peripheral blood. Although the neolignan analogue 4NF was cytotoxic, it reduced cyclophosphamide-induced cytotoxicity. In conclusion, it showed no genotoxic action, but exhibited cytotoxic, antigenotoxic, and anticytotoxic activities.	[Hanusch, Alex Lucas; Teixeira de Saboia-Morais, Simone Maria; Machado, Rafael Cosme; Chen, Lee Chen] Univ Fed Goias, Inst Ciencias Biol, Goiania, Go, Brazil; [de Oliveira, Guilherme Roberto; dos Anjos, Murilo Machado] Univ Fed Goias, Inst Quim, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias	Hanusch, AL (corresponding author), Univ Fed Goias, Inst Ciencias Biol, Goiania, Go, Brazil.	bioalh@hotmail.com	Sabóia-Morais, Simone M. T./M-8014-2017; Sabóia-Morais, Simone/AAL-8001-2021; Chen, Lee Chen/B-1668-2013; Chen-Chen, Lee/Q-9797-2019	Sabóia-Morais, Simone/0000-0001-7729-499X; Chen, Lee Chen/0000-0002-0386-247X; Chen-Chen, Lee/0000-0002-0386-247X; Cosme Machado, Rafael/0000-0002-2050-3487	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by grants from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) to ALH, RCM. http://www.capes.gov/br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Rezende AAA, 2013, FOOD CHEM TOXICOL, V55, P645, DOI 10.1016/j.fct.2013.01.050; [Anonymous], BIOMED PREV NUTR; Antunes L. M. G., 2000, Revista de Nutricao, V13, P81, DOI 10.1590/S1415-52732000000200002; Aveniente M, 2007, BIOORGAN MED CHEM, V15, P7337, DOI 10.1016/j.bmc.2007.08.016; Barata LES, 2000, PHYTOCHEMISTRY, V55, P589, DOI 10.1016/S0031-9422(00)00240-5; Brambilla G, 2009, PHARMACOL RES, V60, P1, DOI 10.1016/j.phrs.2009.03.007; Cao GY, 2015, FOOD CHEM, V173, P231, DOI 10.1016/j.foodchem.2014.09.170; Collins AR, 2008, MUTAGENESIS, V23, P143, DOI 10.1093/mutage/gem051; Cordell J L, 1995, MLO Med Lab Obs, V27, P35; HEDDLE JA, 1973, MUTAT RES, V18, P187, DOI 10.1016/0027-5107(73)90035-3; Huang XX, 2013, BIOORG MED CHEM LETT, V23, P5599, DOI 10.1016/j.bmcl.2013.08.045; Jena G. B., 2002, Indian Journal of Pharmacology, V34, P86; Kahl VFS, 2012, MUTAT RES-GEN TOX EN, V744, P140, DOI 10.1016/j.mrgentox.2012.01.008; Kang K, 2011, NEOPLASIA, V13, P1043, DOI 10.1593/neo.11972; Konya K, 2001, PHYTOMEDICINE, V8, P454, DOI 10.1078/S0944-7113(04)70064-1; Kumar BS, 2014, BIOORGAN MED CHEM, V22, P1342, DOI 10.1016/j.bmc.2013.12.067; Lee JS, 2004, ARCH PHARM RES, V27, P1043, DOI 10.1007/BF02975429; Lee WS, 2004, BIOORG MED CHEM LETT, V14, P5623, DOI 10.1016/j.bmcl.2004.08.054; Li N, 2007, REGUL TOXICOL PHARM, V49, P154, DOI 10.1016/j.yrtph.2007.06.005; Lourenço J.A., 2010, Rev. bras. plantas med., V12, P414, DOI 10.1590/S1516-05722010000400003; Medola JF, 2007, FOOD CHEM TOXICOL, V45, P638, DOI 10.1016/j.fct.2006.10.012; Olfert E.D, 1993, GUIDE CARE USE EXPT, V1; Oliveira Junior LM, 2007, REV ELETRON FARM, V4, P82; Pinheiro AAC, 2004, J MOL STRUC-THEOCHEM, V672, P215, DOI 10.1016/j.theochem.2003.11.027; Resende FA, 2010, MUTAT RES-GEN TOX EN, V700, P62, DOI 10.1016/j.mrgentox.2010.04.023; Rhee CH, 2001, APPL ENVIRON MICROB, V67, P3445, DOI 10.1128/AEM.67.8.3445-3449.2001; Saeed M, 2014, PHYTOMEDICINE, V21, P689, DOI 10.1016/j.phymed.2014.01.006; Saito J, 2006, MUTAT RES-GEN TOX EN, V609, P68, DOI 10.1016/j.mrgentox.2006.06.021; Salto J, 2008, FOOD CHEM TOXICOL, V46, P694, DOI 10.1016/j.fct.2007.09.097; SCHMID W, 1975, MUTAT RES, V31, P9, DOI 10.1016/0165-1161(75)90058-8; Schnaider Taylor Brandão, 2003, Rev. Bras. Anestesiol., V53, P278, DOI 10.1590/S0034-70942003000200014; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Sinigaglia M, 2006, MUTAT RES-GEN TOX EN, V607, P225, DOI 10.1016/j.mrgentox.2006.04.012; Souza V. A., 2012, REV VIRTUAL QUIM, V4, P197; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; VONLEDEB.M, 1973, MUTAT RES, V19, P109, DOI 10.1016/0027-5107(73)90118-8; Yamamoto ML, 2013, MUTAT RES-FUND MOL M, V749, P58, DOI 10.1016/j.mrfmmm.2013.05.003; Yang Q, 2014, FOOD CHEM TOXICOL, V70, P40, DOI 10.1016/j.fct.2014.04.039	38	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142284	10.1371/journal.pone.0142284	http://dx.doi.org/10.1371/journal.pone.0142284			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554835	Green Published, Green Submitted, gold			2022-12-26	WOS:000364430700077
J	Liebrenz, M; Schneider, M; Buadze, A; Gehring, MT; Dube, A; Caflisch, C				Liebrenz, Michael; Schneider, Marcel; Buadze, Anna; Gehring, Marie-Therese; Dube, Anish; Caflisch, Carlo			High-Dose Benzodiazepine Dependence: A Qualitative Study of Patients' Perceptions on Initiation, Reasons for Use, and Obtainment	PLOS ONE			English	Article							CASE REGISTER ANALYSIS; LONG-TERM USE; ESSENTIAL TREMOR; STANDARDS SUBCOMMITTEE; METHADONE PROGRAM; AMERICAN-ACADEMY; THERAPEUTIC-USE; ABUSE; DISCONTINUATION; PRESCRIPTION	Background High-dose benzodiazepine (BZD) dependence is associated with a wide variety of negative health consequences. Affected individuals are reported to suffer from severe mental disorders and are often unable to achieve long-term abstinence via recommended discontinuation strategies. Although it is increasingly understood that treatment interventions should take subjective experiences and beliefs into account, the perceptions of this group of individuals remain under-investigated. Methods We conducted an exploratory qualitative study with 41 adult subjects meeting criteria for (high-dose) BZD-dependence, as defined by ICD-10. One-on-one in-depth interviews allowed for an exploration of this group's views on the reasons behind their initial and then continued use of BZDs, as well as their procurement strategies. Mayring's qualitative content analysis was used to evaluate our data. Results In this sample, all participants had developed explanatory models for why they began using BZDs. We identified a multitude of reasons that we grouped into four broad categories, as explaining continued BZD use: (1) to cope with symptoms of psychological distress or mental disorder other than substance use, (2) to manage symptoms of physical or psychological discomfort associated with somatic disorder, (3) to alleviate symptoms of substance-related disorders, and (4) for recreational purposes, that is, sensation-seeking and other social reasons. Subjects often considered BZDs less dangerous than other substances and associated their use more often with harm reduction than as recreational. Specific obtainment strategies varied widely: the majority of participants oscillated between legal and illegal methods, often relying on the black market when faced with treatment termination. Conclusions Irrespective of comorbidity, participants expressed a clear preference for medically related explanatory models for their BZD use. We therefore suggest that clinicians consider patients' motives for long-term, high-dose BZD use when formulating treatment plans for this patient group, especially since it is known that individuals are more compliant with approaches they perceive to be manageable, tolerable, and effective.	[Liebrenz, Michael; Buadze, Anna; Caflisch, Carlo] Univ Zurich, Hosp Psychiat, Dept Psychiat Psychotherapy & Psychosomat, Zurich, Switzerland; [Liebrenz, Michael] Univ Bern, Inst Legal Med, Dept Forens Psychiat, Bern, Switzerland; [Schneider, Marcel] Univ Zurich Hosp, Dept Surg, Div Visceral & Transplantat Surg, CH-8091 Zurich, Switzerland; [Gehring, Marie-Therese] Ulmenhof, Sozialtherapie, Offenbach, Switzerland; [Dube, Anish] Univ Penn Hlth Syst, Philadelphia, PA USA	University of Zurich; University of Bern; University of Zurich; University Zurich Hospital; University of Pennsylvania	Liebrenz, M (corresponding author), Univ Zurich, Hosp Psychiat, Dept Psychiat Psychotherapy & Psychosomat, Zurich, Switzerland.	Michael.Liebrenz@fpd.unibe.ch	Schneider, Marcel André/AAW-9712-2020	Schneider, Marcel André/0000-0002-6723-8879; Buadze, Ana/0000-0002-8683-6807; Liebrenz, Michael/0000-0001-8040-2744	Prof. Dr. Max Cloetta foundation, Zurich, Switzerland; Uniscientia foundation, Vaduz, Principality of Liechtenstein	Prof. Dr. Max Cloetta foundation, Zurich, Switzerland; Uniscientia foundation, Vaduz, Principality of Liechtenstein	Michael Liebrenz was financially supported by the Prof. Dr. Max Cloetta foundation, Zurich, Switzerland, and the Uniscientia foundation, Vaduz, Principality of Liechtenstein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi-Severini Silvia, 2014, CMAJ Open, V2, pE208, DOI 10.9778/cmajo.20130076; Angermeyer MC, 1999, SOC PSYCH PSYCH EPID, V34, P202, DOI 10.1007/s001270050134; [Anonymous], QUALITATIVE INHALTSA; Ashton H, 2005, CURR OPIN PSYCHIATR, V18, P249, DOI 10.1097/01.yco.0000165594.60434.84; ASHTON H, 1994, DRUGS, V48, P25, DOI 10.2165/00003495-199448010-00004; Baandrup L, 2015, PHARM INTERVENTIONS; Barker MJ, 2004, CNS DRUGS, V18, P37, DOI 10.2165/00023210-200418010-00004; Benavides S, 2009, ANN PHARMACOTHER, V43, P85, DOI 10.1345/aph.1K612; Buadze A, 2010, HARM REDUCT J, V7, DOI 10.1186/1477-7517-7-22; Carter BL, 2008, J CLIN HYPERTENS, V10, P260, DOI 10.1111/j.1751-7176.2008.07434.x; Chebib M, 1999, CLIN EXP PHARMACOL P, V26, P937, DOI 10.1046/j.1440-1681.1999.03151.x; Chen KW, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-90; Clark RE, 2004, J CLIN PSYCHIAT, V65, P151; COLE JO, 1990, J PSYCHIAT RES, V24, P135, DOI 10.1016/0022-3956(90)90045-R; COSTA E, 1979, ANNU REV PHARMACOL, V19, P531, DOI 10.1146/annurev.pa.19.040179.002531; Costello Daniel J, 2007, J Intensive Care Med, V22, P319, DOI 10.1177/0885066607307506; Dearing RL, 2005, ADDICT BEHAV, V30, P1392, DOI 10.1016/j.addbeh.2005.02.002; Dell'osso B, 2013, EUR PSYCHIAT, V28, P7, DOI 10.1016/j.eurpsy.2011.11.003; Dilling H, 1994, INT KLASSIFIKATION P; Fang SY, 2009, DRUG ALCOHOL DEPEN, V104, P140, DOI 10.1016/j.drugalcdep.2009.04.017; Gallagher RM, 2012, ADV HEALTH SCI EDUC, V17, P247, DOI 10.1007/s10459-010-9260-5; HARRISON M, 1984, CLIN PHARMACOL THER, V36, P527, DOI 10.1038/clpt.1984.214; Heberlein A, 2009, FORTSCHR NEUROL PSYC, V77, P7, DOI 10.1055/s-0028-1100831; Jena AB, 2011, ANN INTERN MED, V155, P848, DOI 10.7326/0003-4819-155-12-201112200-00008; KING MB, 1990, BRIT J GEN PRACT, V40, P194; Klingemann HKH, 1996, ADDICTION, V91, P723, DOI 10.1046/j.1360-0443.1996.9157238.x; Lader M, 2014, BRIT J CLIN PHARMACO, V77, P295, DOI 10.1111/j.1365-2125.2012.04418.x; Ladewig D, 1996, SUCHT, V42, P167; Lagnaoui R, 2004, EUR J CLIN PHARMACOL, V60, P523, DOI 10.1007/s00228-004-0808-2; Lee JWY, 2010, J CLIN PSYCHOPHARM, V30, P3, DOI 10.1097/JCP.0b013e3181c9bfe6; Liebrenz M, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0493-y; Liebrenz M, 2014, HARM REDUCT J, V11, DOI 10.1186/1477-7517-11-23; Liebrenz M, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-141; Liebrenz M, 2010, ADDICTION, V105, P1870, DOI 10.1111/j.1360-0443.2010.02933.x; Louis ED, 2010, J NEUROL SCI, V289, P144, DOI 10.1016/j.jns.2009.08.029; Lyons KE, 2003, DRUG SAFETY, V26, P461, DOI 10.2165/00002018-200326070-00003; Maremmani AGI, 2013, CLONAZEPAM AGONIST S, V2013; Marlatt G A, 1997, NIDA Res Monogr, V165, P44; Mavring P, 2000, FORUM QUALITATIVE SO, P2; Mayring P., 2000, QUALITATIVE CONTENT; Nakao M, 2007, INT J CLIN PHARM TH, V45, P30; Newman Robert G, 2006, Harm Reduct J, V3, P20, DOI 10.1186/1477-7517-3-20; Nordt C, 2006, LANCET, V367, P1830, DOI 10.1016/S0140-6736(06)68804-1; O'Brien CP, 2005, J CLIN PSYCHIAT, V66, P28; Olfson M, 2015, JAMA PSYCHIAT, V72, P136, DOI 10.1001/jamapsychiatry.2014.1763; ONG LML, 1995, SOC SCI MED, V40, P903, DOI 10.1016/0277-9536(94)00155-M; Parr JM, 2009, ADDICTION, V104, P13, DOI 10.1111/j.1360-0443.2008.02364.x; Parr JM, 2006, SOC SCI MED, V62, P1237, DOI 10.1016/j.socscimed.2005.07.016; Patten SB, 2009, J AFFECT DISORDERS, V117, pS5, DOI 10.1016/j.jad.2009.06.044; Paulose-Ram R, 2007, PHARMACOEPIDEM DR S, V16, P560, DOI 10.1002/pds.1367; Petitjean S, 2007, INT CLIN PSYCHOPHARM, V22, P292, DOI 10.1097/YIC.0b013e328105e0f2; Quaglio G, 2012, PSYCHIAT RES, V198, P457, DOI 10.1016/j.psychres.2012.02.008; REVES JG, 1985, ANESTHESIOLOGY, V62, P310, DOI 10.1097/00000542-198503000-00017; Richards BL, 2012, J RHEUMATOL, V39, P34, DOI 10.3899/jrheum.120340; RICKELS K, 1990, ARCH GEN PSYCHIAT, V47, P899; RICKELS K, 1983, JAMA-J AM MED ASSOC, V250, P767, DOI 10.1001/jama.250.6.767; Rosenbaum JF, 2005, J CLIN PSYCHIAT, V66, P4; Roy-Byrne PP, 2005, J CLIN PSYCHIAT, V66, P14; Saari TI, 2011, PHARMACOL REV, V63, P243, DOI 10.1124/pr.110.002717; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Vermeire E, 2001, J CLIN PHARM THER, V26, P331, DOI 10.1046/j.1365-2710.2001.00363.x; Voshaar RCO, 2006, CAN J PSYCHIAT, V51, P445, DOI 10.1177/070674370605100706; Wild TC, 2006, ADDICT BEHAV, V31, P1858, DOI 10.1016/j.addbeh.2006.01.002; WOODY GE, 1975, J PSYCHEDEL DRUG, V7, P373, DOI 10.1080/02791072.1975.10471526; Zesiewicz TA, 2011, NEUROLOGY, V77, P1752, DOI 10.1212/WNL.0b013e318236f0fd; Zesiewicz TA, 2005, NEUROLOGY, V64, P2008, DOI 10.1212/01.WNL.0000163769.28552.CD	66	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142057	10.1371/journal.pone.0142057	http://dx.doi.org/10.1371/journal.pone.0142057			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7CT	26556055	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000364430700048
J	Wu, CS; Zou, L				Wu, Ching-Shyi; Zou, Lee			The SUMO (Small Ubiquitin-like Modifier) Ligase PIAS3 Primes ATR for Checkpoint Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						checkpoint control; DNA damage response; DNA repair; DNA replication; small ubiquitin-like modifier (SUMO)	E3 LIGASE; INDUCED SUMOYLATION; DNA; REPAIR; REPLICATION; PATHWAY; COMPLEX; PCNA; RECOMBINATION; EXPRESSION	The maintenance of genomic stability relies on the concerted action of DNA repair and DNA damage signaling pathways. The PIAS (protein inhibitor of activated STAT) family of SUMO (small ubiquitin-like modifier) ligases has been implicated in DNA repair, but whether it plays a role in DNA damage signaling is still unclear. Here, we show that the PIAS3 SUMO ligase is important for activation of the ATR (ataxia telangiectasia and Rad3 related)-regulated DNA damage signaling pathway. PIAS3 is the only member of the PIAS family that is indispensable for ATR activation. In response to different types of DNA damage and replication stress, PIAS3 plays multiple roles in ATR activation. In cells treated with camptothecin (CPT), PIAS3 contributes to formation of DNA double-stranded breaks. In UV (ultraviolet light)- or HU (hydroxyurea)-treated cells, PIAS3 is required for efficient ATR autophosphorylation, one of the earliest events during ATR activation. Although PIAS3 is dispensable for ATRIP (ATR-interacting protein) SUMOylation and the ATR-ATRIP interaction, it is required for maintaining the basal kinase activity of ATR prior to DNA damage. In the absence of PIAS3, ATR fails to display normal kinase activity after DNA damage, which accompanies with reduced phosphorylation of ATR substrates. Together, these results suggest that PIAS3 primes ATR for checkpoint activation by sustaining its basal kinase activity, revealing a new function of the PIAS family in DNA damage signaling.	[Wu, Ching-Shyi; Zou, Lee] Harvard Univ, Sch Med, MGH Canc Ctr, Charlestown, MA 02129 USA; [Zou, Lee] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Zou, L (corresponding author), Harvard Univ, Sch Med, MGH Canc Ctr, Bldg 149-7408,13th St, Charlestown, MA 02129 USA.	zou.lee@mgh.harvard.edu		Zou, Lee/0000-0003-3094-1058; Wu, Ching-Shyi/0000-0001-9800-9844	NIH [GM076388, CA197779]; NATIONAL CANCER INSTITUTE [R01CA197779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076388] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH Grants GM076388 and CA197779 (to L. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbas R, 2015, CANCER MED-US, V4, P325, DOI 10.1002/cam4.372; Chaudhuri AR, 2012, NAT STRUCT MOL BIOL, V19, P417, DOI 10.1038/nsmb.2258; Chung I, 2015, GENE DEV, V29, P1593, DOI 10.1101/gad.265058.115; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Cremona CA, 2012, MOL CELL, V45, P422, DOI 10.1016/j.molcel.2011.11.028; Dabir S, 2014, CLIN CANCER RES, V20, P5124, DOI 10.1158/1078-0432.CCR-14-1233; Danielsen JR, 2012, J CELL BIOL, V197, P179, DOI 10.1083/jcb.201106152; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Gibbs-Seymour I, 2015, MOL CELL, V57, P150, DOI 10.1016/j.molcel.2014.12.001; Hammer E, 2007, FEBS LETT, V581, P5418, DOI 10.1016/j.febslet.2007.10.040; Heffernan TP, 2002, MOL CELL BIOL, V22, P8552, DOI 10.1128/MCB.22.24.8552-8561.2002; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Li JW, 2015, INT J CLIN EXP MED, V8, P682; Li M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7720; Liu SC, 2013, ONCOL LETT, V6, P1045, DOI 10.3892/ol.2013.1472; Liu SZ, 2013, P NATL ACAD SCI USA, V110, P2175, DOI 10.1073/pnas.1217781110; Liu SZ, 2011, MOL CELL, V43, P192, DOI 10.1016/j.molcel.2011.06.019; Luo KT, 2012, EMBO J, V31, P3008, DOI 10.1038/emboj.2012.158; Mohni KN, 2014, CANCER RES, V74, P2835, DOI 10.1158/0008-5472.CAN-13-3229; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Ouyang J, 2015, MOL CELL, V57, P108, DOI 10.1016/j.molcel.2014.11.015; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Park Ju Young, 2014, Brain Tumor Res Treat, V2, P1, DOI 10.14791/btrt.2014.2.1.1; Pastuszak-Lewandoska D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104265; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Pommier Yves, 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P429, DOI 10.2174/1568011043352777; Psakhye I, 2012, CELL, V151, P807, DOI 10.1016/j.cell.2012.10.021; Regairaz M, 2011, J CELL BIOL, V195, P739, DOI 10.1083/jcb.201104003; Sarangi P, 2015, TRENDS BIOCHEM SCI, V40, P233, DOI 10.1016/j.tibs.2015.02.006; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Schimmel J, 2014, MOL CELL, V53, P1053, DOI 10.1016/j.molcel.2014.02.001; Shiotani B, 2013, CELL REP, V3, P1651, DOI 10.1016/j.celrep.2013.04.018; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Takai H, 2010, GENE DEV, V24, P2019, DOI 10.1101/gad.1956410; Wang HY, 2004, CANCER RES, V64, P7139, DOI 10.1158/0008-5472.CAN-04-1289; Wu CS, 2014, GENE DEV, V28, P1472, DOI 10.1101/gad.238535.114; Yin YL, 2012, GENE DEV, V26, P1196, DOI 10.1101/gad.189274.112; Yunus AA, 2009, MOL CELL, V35, P669, DOI 10.1016/j.molcel.2009.07.013	40	14	15	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					279	290		10.1074/jbc.M115.691170	http://dx.doi.org/10.1074/jbc.M115.691170			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26565033	hybrid, Green Published			2022-12-26	WOS:000367589500022
J	Kamano, S; Kume, S; Iida, K; Lei, KJ; Nakano, M; Nakayama, Y; Iida, H				Kamano, Shumpei; Kume, Shinichiro; Iida, Kazuko; Lei, Kai-Jian; Nakano, Masataka; Nakayama, Yoshitaka; Iida, Hidetoshi			Transmembrane Topologies of Ca2+-permeable Mechanosensitive Channels MCA1 and MCA2 in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE PROTEIN; CA2+ INFLUX; MECHANICAL-STRESS; PLANT; TOUCH; MSCS; EXPRESSION; PREDICTION; HOMOLOG; SYSTEM	Sensing mechanical stresses, including touch, stretch, compression, and gravity, is crucial for growth and development in plants. A good mechanosensor candidate is the Ca2+-permeable mechanosensitive (MS) channel, the pore of which opens to permeate Ca2+ in response to mechanical stresses. However, the structure-function relationships of plant MS channels are poorly understood. Arabidopsis MCA1 and MCA2 form a homotetramer and exhibit Ca2+-permeable MS channel activity; however, their structures have only been partially elucidated. The transmembrane topologies of these ion channels need to be determined in more detail to elucidate the underlying regulatory mechanisms. We herein determined the topologies of MCA1 and MCA2 using two independent methods, the Suc2C reporter and split-ubiquitin yeast two-hybrid methods, and found that both proteins are single-pass type I integral membrane proteins with extracellular N termini and intracellular C termini. These results imply that an EF hand-like motif, coiled-coil motif, and plac8 motif are all present in the cytoplasm. Thus, the activities of both channels can be regulated by intracellular Ca2+ and protein interactions.	[Kamano, Shumpei; Kume, Shinichiro; Lei, Kai-Jian; Nakano, Masataka; Nakayama, Yoshitaka; Iida, Hidetoshi] Tokyo Gakugei Univ, Dept Biol, Koganei, Tokyo 1848501, Japan; [Iida, Kazuko] Tokyo Metropolitan Inst Med Sci, Lab Biomembrane, Setagaya Ku, Tokyo 1568506, Japan	Tokyo Gakugei University; Tokyo Metropolitan Institute of Medical Science	Iida, H (corresponding author), Tokyo Gakugei Univ, Dept Biol, 4-1-1 Nukui Kita Machi, Koganei, Tokyo 1848501, Japan.	iida@u-gakugei.ac.jp	Nakayama, Yoshitaka/J-4973-2014; Nakayama, Yoshitaka/AAT-9699-2020; Iida, Hidetoshi/AAO-5506-2020	Nakayama, Yoshitaka/0000-0001-6797-5556; Nakayama, Yoshitaka/0000-0001-6797-5556; 	Ministry of Education, Culture, Sports, Science, and Technology of Japan [25120708]; Japan Society for the Promotion of Science [26291026, 10J02008]; Grants-in-Aid for Scientific Research [26291026] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-aid for Scientific Research on Priority Area 25120708 (to H. I.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and Grant-in-Aid for Scientific Research B 26291026 (to H. I.) from the Japan Society for the Promotion of Science. The authors declare that they have no conflicts of interest with the contents of this article.; A Japan Society for the Promotion of Science Fellow (Grant 10J02008). Present address: Molecular Cardiology and Biophysics Division, Victor Chang Cardiac Research Institute, Darlinghurst, NSW 2010, Australia.	Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Benikhlef L, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-133; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Braam J, 2005, NEW PHYTOL, V165, P373, DOI 10.1111/j.1469-8137.2004.01263.x; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Chauhan JS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067008, 10.1371/journal.pone.0080000]; Chehab EW, 2012, CURR BIOL, V22, P701, DOI 10.1016/j.cub.2012.02.061; Coutand C, 2010, PLANT SCI, V179, P168, DOI 10.1016/j.plantsci.2010.05.001; Fetchko M, 2004, METHODS, V32, P349, DOI 10.1016/j.ymeth.2003.10.010; Furuichi T, 2012, PLANT SIGNAL BEHAV, V7, P1022, DOI 10.4161/psb.20783; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Goodchild SC, 2011, BIOCHEMISTRY-US, V50, P10887, DOI 10.1021/bi2012564; Goodchild SC, 2009, EUR BIOPHYS J BIOPHY, V39, P129, DOI 10.1007/s00249-009-0450-0; Guo M, 2010, PLANT CELL, V22, P1057, DOI 10.1105/tpc.109.073676; Haswell ES, 2007, CURR TOP MEMBR, V58, P329, DOI 10.1016/S1063-5823(06)58013-5; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Iida H, 2014, PLANT BIOLOGY, V16, P39, DOI 10.1111/plb.12044; IIDA H, 1994, MOL CELL BIOL, V14, P8259, DOI 10.1128/MCB.14.12.8259; Iida H, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00453; Iyer Kavitha, 2005, Sci STKE, V2005, ppl3, DOI 10.1126/stke.2752005pl3; JAFFE MJ, 1973, PLANTA, V114, P143, DOI 10.1007/BF00387472; Johns S. J., TOPO2 TRANSMEMBRANE; Johnson ME, 2012, EUKARYOT CELL, V11, P952, DOI 10.1128/EC.00082-12; Kim H, 2003, J BIOL CHEM, V278, P10208, DOI 10.1074/jbc.M300163200; KNIGHT MR, 1991, NATURE, V352, P524, DOI 10.1038/352524a0; Kurusu T, 2013, TRENDS PLANT SCI, V18, P227, DOI 10.1016/j.tplants.2012.12.002; Kurusu T, 2012, J PLANT RES, V125, P555, DOI 10.1007/s10265-011-0462-6; Kurusu T, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-11; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LATIMER JG, 1991, HORTSCIENCE, V26, P1456, DOI 10.21273/HORTSCI.26.12.1456; Nacken V, 1996, GENE, V175, P253, DOI 10.1016/0378-1119(96)00171-0; Nakagawa Y, 2007, P NATL ACAD SCI USA, V104, P3639, DOI 10.1073/pnas.0607703104; Nakano M, 2011, PLANT CELL PHYSIOL, V52, P1915, DOI 10.1093/pcp/pcr131; Pagac M, 2011, J BIOL CHEM, V286, P36438, DOI 10.1074/jbc.M111.256511; Peter B, 2014, BIOCHEMISTRY-US, V53, P57, DOI 10.1021/bi401433f; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Sambrook J., 2001, MOL CLONING LAB MANU, V3, P2; Sengstag C, 2000, METHOD ENZYMOL, V327, P175, DOI 10.1016/S0076-6879(00)27275-3; Shigematsu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087724; Singh H, 2010, FEBS LETT, V584, P2112, DOI 10.1016/j.febslet.2010.03.013; Song WY, 2004, PLANT PHYSIOL, V135, P1027, DOI 10.1104/pp.103.037739; Telewski FW, 2006, AM J BOT, V93, P1466, DOI 10.3732/ajb.93.10.1466; Teng J, 2013, MICROBIOL-SGM, V159, P970, DOI 10.1099/mic.0.064030-0; Wilson ME, 2013, BIOCHEMISTRY-US, V52, P5708, DOI 10.1021/bi400804z; Yamanaka T, 2010, PLANT PHYSIOL, V152, P1284, DOI 10.1104/pp.109.147371; Yuan F, 2014, NATURE, V514, P367, DOI 10.1038/nature13593	48	21	22	1	35	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30901	30909		10.1074/jbc.M115.692574	http://dx.doi.org/10.1074/jbc.M115.692574			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26555262	Green Published, hybrid			2022-12-26	WOS:000367199000022
J	Gonzalez-Andrades, M; Cardona, JD; Ionescu, AM; Mosse, CA; Brown, RA				Gonzalez-Andrades, Miguel; de la Cruz Cardona, Juan; Maria Ionescu, Ana; Mosse, Charles A.; Brown, Robert A.			Photographic-Based Optical Evaluation of Tissues and Biomaterials Used for Corneal Surface Repair: A New Easy-Applied Method	PLOS ONE			English	Article							PLASTIC COMPRESSED COLLAGEN; AMNIOTIC MEMBRANE; CELL-CULTURE; RECONSTRUCTION; SCATTERING; MATRIX; PERSPECTIVE; ABSORPTION; EQUIVALENT; SUBSTRATE	Purpose Tissues and biomaterials used for corneal surface repair require fulfilling specific optical standards prior to implantation in the patient. However, there is not a feasible evaluation method to be applied in clinical or Good Manufacturing Practice settings. In this study, we describe and assess an innovative easy-applied photographic-based method (PBM) for measuring functional optical blurring and transparency in corneal surface grafts. Methods Plastic compressed collagen scaffolds (PCCS) and multilayered amniotic membranes (AM) samples were optically and histologically evaluated. Transparency and image blurring measures were obtained by PBM, analyzing photographic images of a standardized band pattern taken through the samples. These measures were compared and correlated to those obtained applying the Inverse Adding-Doubling (IAD) technique, which is the gold standard method. Results All the samples used for optical evaluation by PBM or IAD were histological suitable. PCCS samples presented transmittance values higher than 60%, values that increased with increasing wavelength as determined by IAD. The PBM indicated that PCCS had a transparency ratio (TR) value of 80.3 +/- 2.8%, with a blurring index (BI) of 50.6 +/- 4.2%. TR and BI obtained from the PBM showed a high correlation (rho>vertical bar 0.6 vertical bar) with the diffuse transmittance and the diffuse reflectance, both determined using the IAD (p<0.005). The AM optical properties showed that there was a largely linear relationship between the blurring and the number of amnion layers, with more layers producing greater blurring. Conclusions This innovative proposed method represents an easy-applied technique for evaluating transparency and blurriness of tissues and biomaterials used for corneal surface repair.	[Gonzalez-Andrades, Miguel; Brown, Robert A.] UCL, Tissue Repair & Engn Ctr, London, England; [Gonzalez-Andrades, Miguel] Univ Granada, Dept Histol, Tissue Engn Grp, Granada, Spain; [Gonzalez-Andrades, Miguel] San Cecilio Univ Hosp, Dept Ophthalmol, Granada, Spain; [de la Cruz Cardona, Juan; Maria Ionescu, Ana] Univ Granada, Dept Opt, Lab Biomat & Opt, Granada, Spain; [Mosse, Charles A.] UCL, Dept Opt, London, England	University of London; University College London; University of Granada; Hospital Universitario San Cecilio; University of Granada; University of London; University College London	Gonzalez-Andrades, M (corresponding author), UCL, Tissue Repair & Engn Ctr, London, England.	mgandrades@gmail.com	Ionescu, Adrian M./A-9014-2010; Andrades, Miguel González/N-3670-2018; Gonzalez-Andrades, Miguel/AAI-4293-2020; DE LA CRUZ CARDONA PEREZ, JUAN/I-9351-2018	Andrades, Miguel González/0000-0003-4632-1267; DE LA CRUZ CARDONA PEREZ, JUAN/0000-0003-2867-9708				Ananta M, 2012, TISSUE ENG PT A, V18, P353, DOI [10.1089/ten.tea.2011.0208, 10.1089/ten.TEA.2011.0208]; Bargo PR, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1921907; Bashkatov AN, 2005, J PHYS D APPL PHYS, V38, P2543, DOI 10.1088/0022-3727/38/15/004; Cheema U, 2009, INT J ARTIF ORGANS, V32, P318, DOI 10.1177/039139880903200602; CHEONG WF, 1990, IEEE J QUANTUM ELECT, V26, P2166, DOI 10.1109/3.64354; Connon CJ, 2010, BRIT J OPHTHALMOL, V94, P1057, DOI 10.1136/bjo.2008.153064; Cardona JD, 2011, CORNEA, V30, P1428, DOI 10.1097/ICO.0b013e31821bdfd4; Dua HS, 2010, BRIT J OPHTHALMOL, V94, P963, DOI 10.1136/bjo.2009.157941; Dua HS, 2004, SURV OPHTHALMOL, V49, P51, DOI 10.1016/j.survophthal.2003.10.004; East E, 2010, TISSUE ENG PT A, V16, P3173, DOI 10.1089/ten.tea.2010.0017; Fu Y, 2010, CELLS TISSUES ORGANS, V191, P193, DOI 10.1159/000235680; Gonzalez-Andrades M, 2009, J TISSUE ENG REGEN M, V3, P442, DOI 10.1002/term.178; Hadjipanayi E, 2011, J TISSUE ENG REGEN M, V5, P505, DOI 10.1002/term.343; Hadjipanayi E, 2010, J CONTROL RELEASE, V146, P309, DOI 10.1016/j.jconrel.2010.05.037; Levis HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050993; Levis HJ, 2013, CURR EYE RES, V38, P41, DOI 10.3109/02713683.2012.725799; Levis HJ, 2010, BIOMATERIALS, V31, P7726, DOI 10.1016/j.biomaterials.2010.07.012; Menzel-Severing J, 2013, CAN J OPHTHALMOL, V48, P13, DOI 10.1016/j.jcjo.2012.11.009; Mi Shengli, 2013, Methods Mol Biol, V1014, P143, DOI 10.1007/978-1-62703-432-6_9; Micol LA, 2011, BIOMATERIALS, V32, P1543, DOI 10.1016/j.biomaterials.2010.10.028; Nakamura T, 2011, CURR OPIN OPHTHALMOL, V22, P274, DOI 10.1097/ICU.0b013e3283477d4d; Pedraza CE, 2010, TISSUE ENG PT A, V16, P781, DOI [10.1089/ten.tea.2009.0351, 10.1089/ten.TEA.2009.0351]; PICKERING JW, 1992, J OPT SOC AM A, V9, P621, DOI 10.1364/JOSAA.9.000621; PRAHL SA, 1993, APPL OPTICS, V32, P559, DOI 10.1364/AO.32.000559; Proulx S, 2010, MOL VIS, V16, P2192; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Reinhard T, 2006, CORNEA EXTERNAL EYE; Rotth A, 1940, ARCH OPHTHALMOL-CHIC, V23, P522; Sardar DK, 2009, LASER MED SCI, V24, P839, DOI 10.1007/s10103-009-0677-0; Sardar DK, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2065867; Shortt AJ, 2010, OCUL SURF, V8, P80, DOI 10.1016/S1542-0124(12)70072-1; SORSBY A, 1947, BRIT J OPHTHALMOL, V31, P409, DOI 10.1136/bjo.31.7.409; VANDENBERG TJTP, 1994, VISION RES, V34, P1453, DOI 10.1016/0042-6989(94)90146-5; Ventura L, 2000, PHYSIOL MEAS, V21, P197, DOI 10.1088/0967-3334/21/1/323; Wang X J, 1996, J Biomed Opt, V1, P212, DOI 10.1117/12.227699; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; Xu YG, 2008, MOL VIS, V14, P2180; Yust BG, 2012, LASER MED SCI, V27, P413, DOI 10.1007/s10103-011-0927-9	38	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142099	10.1371/journal.pone.0142099	http://dx.doi.org/10.1371/journal.pone.0142099			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26566050	Green Published, gold, Green Submitted			2022-12-26	WOS:000367628500007
J	NurWaliyuddin, HZA; Norazmi, MN; Edinur, HA; Chambers, GK; Panneerchelvam, S; Zafarina, Z				NurWaliyuddin, Hanis Z. A.; Norazmi, Mohd N.; Edinur, Hisham A.; Chambers, Geoffrey K.; Panneerchelvam, Sundararajulu; Zafarina, Zainuddin			Ancient Genetic Signatures of Orang Asli Revealed by Killer Immunoglobulin-Like Receptor Gene Polymorphisms	PLOS ONE			English	Article							MALAY SUBETHNIC GROUPS; CELL-RECEPTOR; ALLELE FREQUENCIES; KIR GENES; DIVERSITY; POPULATIONS; HLA; ASSOCIATION; CONTINENTS; SELECTION	The aboriginal populations of Peninsular Malaysia, also known as Orang Asli (OA), comprise three major groups; Semang, Senoi and Proto-Malays. Here, we analyzed for the first time KIR gene polymorphisms for 167 OA individuals, including those from four smallest OA subgroups (CheWong, Orang Kanaq, Lanoh and Kensiu) using polymerase chain reaction-sequence specific primer (PCR-SSP) analyses. The observed distribution of KIR profiles of OA is heterogenous; Haplotype B is the most frequent in the Semang subgroups (especially Batek) while Haplotype A is the most common type in the Senoi. The Semang subgroups were clustered together with the Africans, Indians, Papuans and Australian Aborigines in a principal component analysis (PCA) plot and shared many common genotypes (AB6, BB71, BB73 and BB159) observed in these other populations. Given that these populations also display high frequencies of Haplotype B, it is interesting to speculate that Haplotype B may be generally more frequent in ancient populations. In contrast, the two Senoi subgroups, Che Wong and Semai are displaced toward Southeast Asian and African populations in the PCA scatter plot, respectively. Orang Kanaq, the smallest and the most endangered of all OA subgroups, has lost some degree of genetic variation, as shown by their relatively high frequency of the AB2 genotype (0.73) and a total absence of KIR2DL2 and KIR2DS2 genes. Orang Kanaq tradition that strictly prohibits intermarriage with outsiders seems to have posed a serious threat to their survival. This present survey is a demonstration of the value of KIR polymorphisms in elucidating genetic relationships among human populations.	[NurWaliyuddin, Hanis Z. A.; Norazmi, Mohd N.; Edinur, Hisham A.; Panneerchelvam, Sundararajulu; Zafarina, Zainuddin] Univ Sains Malaysia, Sch Hlth Sci, Human Identificat DNA Unit, Kelantan, Malaysia; [Norazmi, Mohd N.] Univ Sains Malaysia, Inst Res Mol Med, Kelantan, Malaysia; [Chambers, Geoffrey K.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Zafarina, Zainuddin] Minist Sci Technol & Innovat, Natl Inst Biotechnol Malaysia, Malaysian Inst Pharmaceut & Nutraceut, George Town, Malaysia	Universiti Sains Malaysia; Universiti Sains Malaysia; Victoria University Wellington	Zafarina, Z (corresponding author), Univ Sains Malaysia, Sch Hlth Sci, Human Identificat DNA Unit, Hlth Campus, Kelantan, Malaysia.	zafarina@usm.my	atan, edinur hisham/F-3946-2014; Zainuddin, Zafarina/AAU-9021-2020; Abidin, Nur Waliyuddin Hanis Zainal/W-7646-2019	atan, edinur hisham/0000-0002-3379-6063; Zainuddin, Zafarina/0000-0003-3672-5196; Abidin, Nur Waliyuddin Hanis Zainal/0000-0001-6734-9061; Chambers, Geoffrey/0000-0003-1019-6855	Ministry of Higher Education of Malaysia [304/PPSK/6150115/U132]	Ministry of Higher Education of Malaysia(Ministry of Education, Malaysia)	Long Term Research Grant Scheme: 304/PPSK/6150115/U132 by Ministry of Higher Education of Malaysia; http://jpt.moe.gov.my/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali O, 1991, Med J Malaysia, V46, P221; Andaya LY, 2001, J SOUTHEAST ASIAN ST, V32, P315, DOI 10.1017/S0022463401000169; [Anonymous], 2004, SE ASIA PREHISTORY H; BARKER G, 2002, P PREHIST SOC, V68, P147, DOI [10.1017/s0079497x00001481, DOI 10.1017/S0079497X00001481]; Bellwood P, 1993, ASIAN PERSPECT, V32, P37; BENJAMIN G, 1985, CULTURAL VALUES HUMA, P219; Carrington M, 2006, CURR TOP MICROBIOL, V298, P225; Chambers GK., 2013, CHANGING VALUES MALA, P6; Diamond JM, 2000, NATURE, V403, P709, DOI 10.1038/35001685; Edinur HA, 2009, HUM IMMUNOL, V70, P518, DOI 10.1016/j.humimm.2009.04.003; FIX AG, 1975, AM J PHYS ANTHROPOL, V43, P47, DOI 10.1002/ajpa.1330430108; Gonzalez-Galarza FF, 2015, NUCLEIC ACIDS RES, V43, pD784, DOI 10.1093/nar/gku1166; Hill C, 2006, MOL BIOL EVOL, V23, P2480, DOI 10.1093/molbev/msl124; Hollenbach JA, 2015, J AUTOIMMUN IN PRESS; Jamaiah I., 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P200; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; Lipson M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5689; Lu ZM, 2008, CELL MOL IMMUNOL, V5, P457, DOI 10.1038/cmi.2008.57; Middleton D, 2008, TISSUE ANTIGENS, V71, P105, DOI 10.1111/j.1399-0039.2007.00973.x; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Moretta L, 2014, INT ARCH ALLERGY IMM, V164, P253, DOI 10.1159/000365632; Norman PJ, 2007, NAT GENET, V39, P1092, DOI 10.1038/ng2111; NurWaliyuddin HZA, 2014, INT J IMMUNOGENET, V41, P472, DOI 10.1111/iji.12161; Oppenheimer S., 2004, OUT EDEN PEOPLING WO; Oppenheimer S, 2012, PHILOS T R SOC B, V367, P770, DOI 10.1098/rstb.2011.0306; Parham P, 2012, PLACENTA, V33, pS71, DOI 10.1016/j.placenta.2011.11.020; Parham P, 2012, PHILOS T R SOC B, V367, P800, DOI 10.1098/rstb.2011.0266; Rajalingam R, 2002, IMMUNOGENETICS, V53, P1009, DOI 10.1007/s00251-001-0425-5; Rajalingam R, 2008, IMMUNOGENETICS, V60, P207, DOI 10.1007/s00251-008-0286-2; Robinson J, 2013, NUCLEIC ACIDS RES, V41, pD1234, DOI 10.1093/nar/gks1140; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; Santin I, 2006, HUM IMMUNOL, V67, P118, DOI 10.1016/j.humimm.2006.02.036; Selvakumar A, 1996, TISSUE ANTIGENS, V48, P285, DOI 10.1111/j.1399-0039.1996.tb02647.x; SUMITHRAN E, 1977, CANCER-AM CANCER SOC, V40, P1618, DOI 10.1002/1097-0142(197710)40:4<1618::AID-CNCR2820400434>3.0.CO;2-1; Taniguchi M, 2009, IMMUNOGENETICS, V61, P717, DOI 10.1007/s00251-009-0401-z; Toneva M, 2001, TISSUE ANTIGENS, V57, P358, DOI 10.1034/j.1399-0039.2001.057004358.x; Trowsdale J, 2001, IMMUNITY, V15, P363, DOI 10.1016/S1074-7613(01)00197-2; Uhrberg M, 1997, IMMUNITY, V7, P753, DOI 10.1016/S1074-7613(00)80394-5; Velickovic M, 2009, TISSUE ANTIGENS, V73, P9, DOI 10.1111/j.1399-0039.2008.01149.x; Vilches C, 2007, TISSUE ANTIGENS, V70, P415, DOI 10.1111/j.1399-0039.2007.00923.x; Vilches C, 2002, ANNU REV IMMUNOL, V20, P217, DOI 10.1146/annurev.immunol.20.092501.134942; Vivier E, 1997, IMMUNOL TODAY, V18, P286, DOI 10.1016/S0167-5699(97)80025-4; Williams F, 2004, HUM IMMUNOL, V65, P1084, DOI 10.1016/j.humimm.2004.08.120; Yao YF, 2011, IMMUNOGENETICS, V63, P475, DOI 10.1007/s00251-011-0530-z; Yawata M, 2006, J EXP MED, V203, P633, DOI 10.1084/jem.20051884; Yawata M, 2002, CRIT REV IMMUNOL, V22, P463; Yusof Rohani Mohd, 2014, JURNAL BAHASA, V14, P45	48	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0141536	10.1371/journal.pone.0141536	http://dx.doi.org/10.1371/journal.pone.0141536			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26565719	Green Submitted, gold, Green Published			2022-12-26	WOS:000367628500004
J	Sekizuka, T; Yamashita, A; Murase, Y; Iwamoto, T; Mitarai, S; Kato, S; Kuroda, M				Sekizuka, Tsuyoshi; Yamashita, Akifumi; Murase, Yoshiro; Iwamoto, Tomotada; Mitarai, Satoshi; Kato, Seiya; Kuroda, Makoto			TGS-TB: Total Genotyping Solution for Mycobacterium tuberculosis Using Short-Read Whole-Genome Sequencing	PLOS ONE			English	Article							TANDEM REPEATS; WEB TOOL; EPIDEMIOLOGY; IDENTIFICATION; TRANSMISSION; PROPOSAL; STRAINS; LOCI	Whole-genome sequencing (WGS) with next-generation DNA sequencing (NGS) is an increasingly accessible and affordable method for genotyping hundreds of Mycobacterium tuberculosis (Mtb) isolates, leading to more effective epidemiological studies involving single nucleotide variations (SNVs) in core genomic sequences based on molecular evolution. We developed an all-in-one web-based tool for genotyping Mtb, referred to as the Total Genotyping Solution for TB (TGS-TB), to facilitate multiple genotyping platforms using NGS for spoligotyping and the detection of phylogenies with core genomic SNVs, IS6110 insertion sites, and 43 customized loci for variable number tandem repeat (VNTR) through a user-friendly, simple click interface. This methodology is implemented with a KvarQ script to predict MTBC lineages/sublineages and potential antimicrobial resistance. Seven Mtb isolates (JP01 to JP07) in this study showing the same VNTR profile were accurately discriminated through median-joining network analysis using SNVs unique to those isolates. An additional IS6110 insertion was detected in one of those isolates as supportive genetic information in addition to core genomic SNVs. The results of in silico analyses using TGS-TB are consistent with those obtained using conventional molecular genotyping methods, suggesting that NGS short reads could provide multiple genotypes to discriminate multiple strains of Mtb, although longer NGS reads (>= 300-mer) will be required for full genotyping on the TGS-TB web site. Most available short reads (similar to 100-mer) can be utilized to discriminate the isolates based on the core genome phylogeny. TGS-TB provides a more accurate and discriminative strain typing for clinical and epidemiological investigations; NGS strain typing offers a total genotyping solution for Mtb outbreak and surveillance. TGS-TB web site: https://gph.niid.go.jp/tgs-tb/.	[Sekizuka, Tsuyoshi; Yamashita, Akifumi; Kuroda, Makoto] Natl Inst Infect Dis, Pathogen Genom Ctr, Shinjuku Ku, Tokyo, Japan; [Murase, Yoshiro] Japan AntiTB Assoc, Res Inst TB, Mol Epidemiol Div, Tokyo, Japan; [Iwamoto, Tomotada] Kobe Inst Hlth, Dept Infect Dis, Chuo Ku, Kobe, Hyogo, Japan; [Mitarai, Satoshi] Japan AntiTB Assoc, Res Inst TB, Dept Mycobacterium Reference & Res, Bacteriol Div, Tokyo, Japan; [Kato, Seiya] Japan AntiTB Assoc, Res Inst TB, Tokyo, Japan	National Institute of Infectious Diseases (NIID)	Kuroda, M (corresponding author), Natl Inst Infect Dis, Pathogen Genom Ctr, Shinjuku Ku, Tokyo, Japan.	makokuro@niid.go.jp	Iwamoto, Tomotada/I-8944-2019	Iwamoto, Tomotada/0000-0002-2650-0308; Sekizuka, Tsuyoshi/0000-0002-1302-5472	Ministry of Health Labour and Welfare Programs of Japan [H25-Shinko-Ippan-015]; Japan Agency for Medical Research and development, AMED [15fk0108011h0003, 15fk0108004h0001]; Grants-in-Aid for Scientific Research [15K08488] Funding Source: KAKEN	Ministry of Health Labour and Welfare Programs of Japan; Japan Agency for Medical Research and development, AMED(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was funded through a Grant-in-Aid for Research on Emerging and Re-emerging Infectious Diseases (H25-Shinko-Ippan-015) from the Ministry of Health Labour and Welfare Programs of Japan, and also through Research Program on Emerging and Re-emerging Infectious Diseases (15fk0108011h0003 and 15fk0108004h0001) from Japan Agency for Medical Research and development, AMED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allix-Beguec C, 2014, J CLIN MICROBIOL, V52, P164, DOI 10.1128/JCM.02519-13; [Anonymous], 2013, GLOB TUB REP; Barnes PF, 2003, NEW ENGL J MED, V349, P1149, DOI 10.1056/NEJMra021964; Benavente ED, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0603-3; Bryant JM, 2013, LANCET RESP MED, V1, P786, DOI 10.1016/S2213-2600(13)70231-5; Bryant JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-110; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Coll F, 2014, TUBERCULOSIS, V94, P346, DOI 10.1016/j.tube.2014.02.005; Coll F, 2012, BIOINFORMATICS, V28, P2991, DOI 10.1093/bioinformatics/bts544; Denoeud F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-4; Didelot X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/nrg3226; Feuerriegel S, 2015, J CLIN MICROBIOL, V53, P1908, DOI 10.1128/JCM.00025-15; Ford C, 2012, TUBERCULOSIS, V92, P194, DOI 10.1016/j.tube.2011.11.003; Ford CB, 2011, NAT GENET, V43, P482, DOI 10.1038/ng.811; Jiang HS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-182; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kohl TA, 2014, J CLIN MICROBIOL, V52, P2479, DOI 10.1128/JCM.00567-14; Kremer K, 1999, J CLIN MICROBIOL, V37, P2607, DOI 10.1128/JCM.37.8.2607-2618.1999; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Luo T, 2014, TUBERCULOSIS, V94, P434, DOI 10.1016/j.tube.2014.04.005; Murase Y, 2008, J MED MICROBIOL, V57, P873, DOI 10.1099/jmm.0.47564-0; Niemann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007407; Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387; Sandgren A, 2009, PLOS MED, V6, P132, DOI 10.1371/journal.pmed.1000002; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Steiner A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-881; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Walker TM, 2014, LANCET RESP MED, V2, P285, DOI 10.1016/S2213-2600(14)70027-X; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351	33	57	58	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142951	10.1371/journal.pone.0142951	http://dx.doi.org/10.1371/journal.pone.0142951			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26565975	Green Submitted, Green Published, gold			2022-12-26	WOS:000367628500078
J	Silvis, JD; Belopolsky, AV; Murris, JWI; Donk, M				Silvis, Jeroen D.; Belopolsky, Artem V.; Murris, Jozua W. I.; Donk, Mieke			The Effects of Feature-Based Priming and Visual Working Memory on Oculomotor Capture	PLOS ONE			English	Article							GOAL-DRIVEN CONTROL; POP-OUT; NEURAL MECHANISMS; STIMULUS-DRIVEN; EYE-MOVEMENTS; TOP-DOWN; ATTENTION; SALIENCE; SEARCH; INFORMATION	Recently, it has been demonstrated that objects held in working memory can influence rapid oculomotor selection. This has been taken as evidence that perceptual salience can be modified by active working memory representations. The goal of the present study was to examine whether these results could also be caused by feature-based priming. In two experiments, participants were asked to saccade to a target line segment of a certain orientation that was presented together with a to-be-ignored distractor. Both objects were given a task-irrelevant color that varied per trial. In a secondary task, a color had to be memorized, and that color could either match the color of the target, match the color of the distractor, or it did not match the color of any of the objects in the search task. The memory task was completed either after the search task (Experiment 1), or before it (Experiment 2). The results showed that in both experiments the memorized color biased oculomotor selection. Eye movements were more frequently drawn towards objects that matched the memorized color, irrespective of whether the memory task was completed after (Experiment 1) or before (Experiment 2) the search task. This bias was particularly prevalent in short-latency saccades. The results show that early oculomotor selection performance is not only affected by properties that are actively maintained in working memory but also by those previously memorized. Both working memory and feature priming can cause early biases in oculomotor selection.	[Silvis, Jeroen D.; Belopolsky, Artem V.; Murris, Jozua W. I.; Donk, Mieke] Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Silvis, JD (corresponding author), Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands.	j.d.silvis@vu.nl		Belopolsky, Artem/0000-0003-3606-2134; Donk, Mieke/0000-0001-9310-8210	Netherlands Organisation for Scientific Research (NWO) [464-11-015]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Netherlands Organisation for Scientific Research (NWO), http://www.nwo.nl/en, an open research area (ORA) grant (464-11-015 to MD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NC, 2015, J VISION, V15, DOI 10.1167/15.5.9; Asgeirsson AG, 2015, ACTA PSYCHOL, V160, P35, DOI 10.1016/j.actpsy.2015.06.008; Awh E, 2006, NEUROSCIENCE, V139, P201, DOI 10.1016/j.neuroscience.2005.08.023; Awh E, 2001, TRENDS COGN SCI, V5, P119, DOI 10.1016/S1364-6613(00)01593-X; Awh E, 2012, TRENDS COGN SCI, V16, P437, DOI 10.1016/j.tics.2012.06.010; Belopolsky A. V., 2015, PERCEPTION, P1, DOI [DOI 10.1177/0301006615596866, 10.1177/0301006615596866]; Belopolsky AV, 2013, J NEUROPHYSIOL, V110, P2370, DOI 10.1152/jn.00293.2013; Brascamp JW, 2011, J EXP PSYCHOL HUMAN, V37, P1700, DOI 10.1037/a0025636; BRAVO MJ, 1992, PERCEPT PSYCHOPHYS, V51, P465, DOI 10.3758/BF03211642; Cousineau D, 2005, TUTORIALS QUANTITATI, V1, P3; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; Donk M, 2008, PSYCHOL SCI, V19, P733, DOI 10.1111/j.1467-9280.2008.02149.x; Donk M, 2011, VISION RES, V51, P2156, DOI 10.1016/j.visres.2011.08.013; Donk M, 2011, PERCEPTION, V40, P63, DOI 10.1068/p6718; Donk M, 2010, J EXP PSYCHOL HUMAN, V36, P286, DOI 10.1037/a0017605; Downing PE, 2000, PSYCHOL SCI, V11, P467, DOI 10.1111/1467-9280.00290; Duncan M, 1998, ART AM, V86, P45; Godijn R, 2002, J EXP PSYCHOL HUMAN, V28, P1039, DOI 10.1037//0096-1523.28.5.1039; Goolsby BA, 2001, PERCEPT PSYCHOPHYS, V63, P929, DOI 10.3758/BF03194513; Hillstrom AP, 2000, PERCEPT PSYCHOPHYS, V62, P800, DOI 10.3758/BF03206924; Hollingworth A, 2013, PSYCHOL SCI, V24, P790, DOI 10.1177/0956797612459767; Hunt AR, 2007, J EXP PSYCHOL HUMAN, V33, P271, DOI 10.1037/0096-1523.33.2.271; Kristjansson A, 2013, PSYCHON B REV, V20, P514, DOI 10.3758/s13423-013-0375-6; Ludwig CJH, 2002, J EXP PSYCHOL HUMAN, V28, P902, DOI 10.1037//0096-1523.28.4.902; MALJKOVIC V, 1994, MEM COGNITION, V22, P657, DOI 10.3758/BF03209251; Maljkovic V, 1996, PERCEPT PSYCHOPHYS, V58, P977, DOI 10.3758/BF03206826; Mathot S, 2012, BEHAV RES METHODS, V44, P314, DOI 10.3758/s13428-011-0168-7; Morey RD, 2008, TUTORIALS QUANTITATI, V4, P3; NIEMI P, 1981, PSYCHOL BULL, V89, P133, DOI 10.1037/0033-2909.89.1.133; Oberauer K, 2001, J EXP PSYCHOL LEARN, V27, P948, DOI 10.1037/0278-7393.27.4.948; Oberauer K, 2012, CURR DIR PSYCHOL SCI, V21, P164, DOI 10.1177/0963721412444727; Olivers CNL, 2008, FRONT BIOSCI-LANDMRK, V13, P1182, DOI 10.2741/2754; Olivers CNL, 2006, J EXP PSYCHOL HUMAN, V32, P1243, DOI 10.1037/0096-1523.32.5.1243; Olivers CNL, 2011, NEUROPSYCHOLOGIA, V49, P1553, DOI 10.1016/j.neuropsychologia.2010.11.033; Siebold A, 2014, ATTEN PERCEPT PSYCHO, V76, P1655, DOI 10.3758/s13414-013-0493-2; Siebold A, 2013, J EXP PSYCHOL HUMAN, V39, P1516, DOI 10.1037/a0032182; Silvis JD, 2014, PSYCHON B REV, V21, P357, DOI 10.3758/s13423-013-0498-9; Soto D, 2006, VISION RES, V46, P1010, DOI 10.1016/j.visres.2005.09.008; Soto D, 2005, J EXP PSYCHOL HUMAN, V31, P248, DOI 10.1037/0096-1523.31.2.248; Theeuwes J, 2009, ACTA PSYCHOL, V132, P106, DOI 10.1016/j.actpsy.2009.01.005; Thomson DR, 2013, J EXP PSYCHOL HUMAN, V39, P202, DOI 10.1037/a0028069; van Zoest W, 2004, J EXP PSYCHOL HUMAN, V30, P746, DOI 10.1037/0096-1523.30.4.749	43	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142696	10.1371/journal.pone.0142696	http://dx.doi.org/10.1371/journal.pone.0142696			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA2MI	26566137	gold, Green Published, Green Submitted			2022-12-26	WOS:000367628500044
J	Bar, C; Zadro, C; Diene, G; Oliver, I; Pienkowski, C; Jouret, B; Cartault, A; Ajaltouni, Z; Salles, JP; Sevely, A; Tauber, M; Edouard, T				Bar, Celine; Zadro, Charline; Diene, Gwenaelle; Oliver, Isabelle; Pienkowski, Catherine; Jouret, Beatrice; Cartault, Audrey; Ajaltouni, Zeina; Salles, Jean-Pierre; Sevely, Annick; Tauber, Maithe; Edouard, Thomas			Pituitary Stalk Interruption Syndrome from Infancy to Adulthood: Clinical, Hormonal, and Radiological Assessment According to the Initial Presentation	PLOS ONE			English	Article							MAGNETIC-RESONANCE; GH DEFICIENCY; IMAGING ABNORMALITIES; GROWTH; CHILDREN; TRANSECTION; HYPOPITUITARISM; PROGNOSIS; LOBE	Background Patients with pituitary stalk interruption syndrome (PSIS) are initially referred for hypoglycemia during the neonatal period or growth retardation during childhood. PSIS is either isolated (nonsyndromic) or associated with extra-pituitary malformations (syndromic). Objective To compare baseline characteristics and long-term evolution in patients with PSIS according to the initial presentation. Study Design Sixty-seven patients with PSIS were included. Data from subgroups were compared: neonates (n = 10) versus growth retardation patients (n = 47), and syndromic (n = 32) versus nonsyndromic patients (n = 35). Results Neonates displayed a more severe hormonal and radiological phenotype than children referred for growth retardation, with a higher incidence of multiple hormonal deficiencies (100% versus 34%; P = 0.0005) and a nonvisible anterior pituitary lobe (33% versus 2%; P = 0.0017). Regular follow-up of growth might have allowed earlier diagnosis in the children with growth retardation, as decreased growth velocity and growth retardation were present respectively 3 and 2 years before referral. We documented a progressive worsening of endocrine impairment throughout childhood in these patients. Presence of extra-pituitary malformations (found in 48%) was not associated with more severe hormonal and radiological characteristics. Growth under GH treatment was similar in the patient groups and did not vary according to the pituitary MRI findings. Conclusions PSIS diagnosed in the neonatal period has a particularly severe hormonal and radiological phenotype. The progressive worsening of endocrine impairment throughout childhood justifies periodic follow-up to check for additional hormonal deficiencies.	[Bar, Celine; Diene, Gwenaelle; Oliver, Isabelle; Pienkowski, Catherine; Jouret, Beatrice; Cartault, Audrey; Ajaltouni, Zeina; Salles, Jean-Pierre; Tauber, Maithe; Edouard, Thomas] Univ Hosp, Childrens Hosp, Endocrine Bone Dis Genet Obes & Gynecol Unit Chil, Toulouse, France; [Zadro, Charline; Sevely, Annick] Purpan Univ Hosp, Neuroradiol Unit, Toulouse, France; [Salles, Jean-Pierre; Tauber, Maithe; Edouard, Thomas] Univ Toulouse Paul Sabatier, Ctr Pathophysiol Toulouse Purpan CPTP, INSERM, UMR 1043, Toulouse, France	CHU de Toulouse; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Edouard, T (corresponding author), Univ Hosp, Childrens Hosp, Endocrine Bone Dis Genet Obes & Gynecol Unit Chil, Toulouse, France.	edouard.t@chu-toulouse.fr	Edouard, Thomas/M-3155-2014; Jouret, Béatrice/AAC-8146-2019	Edouard, Thomas/0000-0002-9222-5009; 				ARGYROPOULOU M, 1992, J PEDIATR-US, V120, P886, DOI 10.1016/S0022-3476(05)81955-9; Arrigo T, 2006, J ENDOCRINOL INVEST, V29, P208, DOI 10.1007/BF03345541; Bozzola M, 2000, EUR J ENDOCRINOL, V143, P493, DOI 10.1530/eje.0.1430493; Chen S, 1999, J CLIN ENDOCR METAB, V84, P2408, DOI 10.1210/jc.84.7.2408; Coutant R, 2001, J CLIN ENDOCR METAB, V86, P4649, DOI 10.1210/jc.86.10.4649; Deal C, 2013, HORM RES PAEDIAT, V79, P283, DOI 10.1159/000350829; Feigerlova E, 2010, J CLIN ENDOCR METAB, V95, P4600, DOI 10.1210/jc.2009-1831; FUJISAWA I, 1987, RADIOLOGY, V165, P487, DOI 10.1148/radiology.165.2.3659371; Gascoin-Lachambre G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016367; Guo QH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053579; Hamilton J, 1998, AM J NEURORADIOL, V19, P1609; Hellstrom A, 1998, ACTA PAEDIATR, V87, P528; Ioachimescu AG, 2012, PITUITARY, V15, P405, DOI 10.1007/s11102-011-0337-9; Jagtap VS, 2012, PITUITARY, V15, P243, DOI 10.1007/s11102-011-0321-4; KIKUCHI K, 1988, J CLIN ENDOCR METAB, V67, P817, DOI 10.1210/jcem-67-4-817; Louvel M, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-29; Maghnie M, 1999, J CLIN ENDOCR METAB, V84, P1324, DOI 10.1210/jc.84.4.1324; MAGHNIE M, 1991, HORM RES, V35, P104, DOI 10.1159/000181883; Masse N, 1967, Pediatrie, V22, P593; Melo ME, 2007, CLIN ENDOCRINOL, V66, P95, DOI 10.1111/j.1365-2265.2006.02692.x; Murray PG, 2009, CLIN ENDOCRINOL, V71, P215, DOI 10.1111/j.1365-2265.2009.03554.x; Pinto G, 1997, J CLIN ENDOCR METAB, V82, P3450, DOI 10.1210/jc.82.10.3450; Reynaud R, 2011, EUR J ENDOCRINOL, V164, P457, DOI 10.1530/EJE-10-0892; ROLLANDCACHERA MF, 1991, EUR J CLIN NUTR, V45, P13; Rottembourg D, 2008, CLIN ENDOCRINOL, V69, P105, DOI 10.1111/j.1365-2265.2007.03155.x; Simon D, 2006, CLIN ENDOCRINOL, V64, P416, DOI 10.1111/j.1365-2265.2006.02484.x; Tauber M, 2005, HORM RES, V64, P266, DOI 10.1159/000089425; TRIULZI F, 1994, PEDIATRICS, V93, P409; USHER R, 1969, J PEDIATR-US, V74, P901, DOI 10.1016/S0022-3476(69)80224-6; Zenaty D, 2003, CLIN ENDOCRINOL, V58, P647	30	34	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142354	10.1371/journal.pone.0142354	http://dx.doi.org/10.1371/journal.pone.0142354			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562670	gold, Green Published, Green Submitted			2022-12-26	WOS:000364480900028
J	Gerum, RC; Fabry, B; Metzner, C				Gerum, Richard Carl; Fabry, Ben; Metzner, Claus			Emergence of Asynchronous Local Clocks in Excitable Media	PLOS ONE			English	Article								Excitable media such as the myocardium or the brain consist of arrays of coupled excitable elements, in which the local excitation of a single element can propagate to its neighbors in the form of a non-linear autowave. Since each element has to pass through a refractory period immediately after excitation, the frequency of autowaves is self-limiting. In this work, we consider the case where each element is spontaneously excited at a fixed average rate and thereby initiates a new autowave. Although these spontaneous self-excitation events are modelled as independent Poisson point processes with exponentially distributed waiting times, the travelling autowaves lead collectively to a non-exponential, unimodal waiting time distribution for the individual elements. With increasing system size, a global 'clock' period T emerges as the most probable waiting time for each element, which fluctuates around T with an increasingly small but non-zero variance. This apparent synchronization between asynchronous, temporally uncorrelated point processes differs from synchronization effects between perfect oscillators interacting in a phase-aligning manner. Finally, we demonstrate that asynchronous local clocks also emerge in non-homogeneous systems in which the rates of self-excitation are different for all individuals, suggesting that this novel mechanism can occur in a wide range of excitable media.	[Gerum, Richard Carl; Fabry, Ben; Metzner, Claus] Univ Erlangen Nurnberg, Dept Phys, Erlangen, Germany	University of Erlangen Nuremberg	Gerum, RC (corresponding author), Univ Erlangen Nurnberg, Dept Phys, Erlangen, Germany.	rgerum@biomed.uni-erlangen.de	Gerum, Richard Carl/AAW-8732-2021; Fabry, Ben/AAT-5717-2020; Fabry, Ben/C-5496-2013; Metzner, Claus/D-9707-2013	Gerum, Richard Carl/0000-0001-5893-2650; Fabry, Ben/0000-0003-1737-0465; Fabry, Ben/0000-0003-1737-0465; 	Deutsche Forschungsgemeinschaft [FA 336/5-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (grant number FA 336/5-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALKAREY YI, 1991, P SOC PHOTO-OPT INS, V1621, P238, DOI 10.1117/12.50431; Belousov B. P., 1959, COMPILATION ABSTRACT; Christensen K, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.028104; DROSSEL B, 1992, PHYS REV LETT, V69, P1629, DOI 10.1103/PhysRevLett.69.1629; Durrett R, 1991, J THEORETICAL PROBAB, V4, P669, DOI 10.1007/BF01259549; Encinas LH, 2007, APPL MATH MODEL, V31, P1213, DOI 10.1016/j.apm.2006.04.001; Fisch R., 1993, ANN APPL PROBAB, V3, P935, DOI [10.1214/aoap/1177005268, DOI 10.1214/AOAP/1177005268]; FRISCH U, 1986, PHYS REV LETT, V56, P1505, DOI 10.1103/PhysRevLett.56.1505; Gerum RC, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/12/125022; GREENBERG JM, 1978, SIAM J APPL MATH, V34, P515, DOI 10.1137/0134040; Jalife J, 2000, ANNU REV PHYSIOL, V62, P25, DOI 10.1146/annurev.physiol.62.1.25; Kaneko T, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-21; Kuramoto Y., 1975, INT S MATH PROBL 197; Lu W, 2004, IEEE T CIRCUITS SY 1; Mainzer K., 2011, UNIVERSE AUTOMATON S; Min N, 2012, ABSTR APPL ANAL, DOI 10.1155/2012/948480; Sirakoulis G, 2000, ECOLOGICAL MODELLING, DOI [10.1016/S0304-3800(00)002945, DOI 10.1016/S0304-3800(00)002945]; Toffoli T, 1987, CELLULAR AUTOMATA MA; Vasiliev VA, 1987, MATH ITS APPL, V11; White SH, 2007, APPL MATH COMPUT, V186, P193, DOI 10.1016/j.amc.2006.06.126; Wu A, 2007, PHYS REV E; ZAIKIN AN, 1970, NATURE, V225, P535, DOI 10.1038/225535b0; Zhou DM, 2009, NEUROCOMPUTING, V72, P2331, DOI 10.1016/j.neucom.2008.12.008; Zitterbart DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020260	24	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142490	10.1371/journal.pone.0142490	http://dx.doi.org/10.1371/journal.pone.0142490			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559528	Green Submitted, Green Published, gold			2022-12-26	WOS:000364433100085
J	Khan, MU; Ahmad, A; Aqeel, T; Akbar, N; Salman, S; Idress, J				Khan, Muhammad Umair; Ahmad, Akram; Aqeel, Talieha; Akbar, Naila; Salman, Saad; Idress, Jawaria			A Cross-Sectional Survey of Healthcare Workers on the Knowledge and Attitudes towards Polio Vaccination in Pakistan	PLOS ONE			English	Article							IMMUNIZATION; PROGRAM; KARACHI	Introduction Pakistan accounts for 85.2% of the total polio cases reported worldwide. Healthcare workers (HCWs) are an integral part of immunization campaigns and source of education for the general public. This study aimed to assess the knowledge and attitudes towards polio vaccination among HCWs providing immunisation and education to general public in Quetta and Peshawar divisions of Pakistan. Methods A cross-sectional survey of 490 HCWs was conducted in two major referral public teaching hospitals of Quetta and Peshawar divisions. During February to April, 2015, a random sample of 490 HCWs was invited to participate in this study. Knowledge and attitudes were assessed by using self-administered, anonymous and pretested questionnaire. Descriptive and logistic regression analyses were used to express the results. Results A total of 468 participants responded to the questionnaire, giving a response rate of 95.5%. Overall, participants demonstrated good knowledge and positive attitudes towards polio vaccination. The mean knowledge score of HCWs about polio was 13.42 +/- 2.39 (based on 18 knowledge questions) while the mean attitude score was 28.75 +/- 5.5 (based on 9 attitudes statements). Knowledge gaps were identified about the incubation period of poliovirus (19.5%), management issues (31.9%), use of polio vaccine in mild illnesses (34.7%) and the consequences of the polio virus (36.9%). The majority of participants agreed that all children should be vaccinated for polio (95.1%), while reservations were noted about the need of a booster (38.9%), and sterility issues associated with polio vaccines (43.6%). Internet (n = 167, 37%) and Posters (n = 158, 35%) were the main sources used by HCWs to educate themselves about polio. Conclusion Participants in this study had good knowledge and positive attitudes towards polio vaccination. Although the data are indicative of gaps in the knowledge of HCWs, the findings may not be generalized to other hospitals in Pakistan.	[Khan, Muhammad Umair; Ahmad, Akram] UCSI Univ, Fac Pharmaceut Sci, Dept Clin Pharm, Kuala Lumpur, Malaysia; [Aqeel, Talieha; Akbar, Naila] Univ Baluchistan, Fac Pharm, Dept Pharm Practice, Quetta, Pakistan; [Salman, Saad] Univ Peshawar, Dept Pharm, Peshawar, Pakistan; [Idress, Jawaria] Post Grad Nursing Coll, Dept Integrated Sci, Peshawar, Pakistan	UCSI University; University of Balochistan; University of Peshawar	Ahmad, A (corresponding author), UCSI Univ, Fac Pharmaceut Sci, Dept Clin Pharm, Kuala Lumpur, Malaysia.	akrampharma67@gmail.com	Salman, Saad/C-8398-2016; Ahmad, PhD, Akram/P-7368-2015	Salman, Saad/0000-0001-6592-9812; Ahmad, PhD, Akram/0000-0002-9998-5860				Ahmad K, 2007, LANCET INFECT DIS, V7, P247, DOI 10.1016/S1473-3099(07)70066-X; Ahmad Nisar, 1999, JPMA (Journal of the Pakistan Medical Association), V49, P301; Ahmed I, 2015, THE TRIBUNE REV; Ahmed S I, 2001, J Pak Med Assoc, V51, P367; Anand S, 2004, LANCET, V364, P1603, DOI 10.1016/S0140-6736(04)17313-3; [Anonymous], 2010, POL AND PREV; April C, 2012, ERADICATING POLIO AF; Azira B, 2013, INT J COLLAB RES INT, V5, P157; Chhnang K, 2002, ATTITUDES IMMUNIZATI; Chumakov K, 2007, NAT REV MICROBIOL, V5, P952, DOI 10.1038/nrmicro1769; Hussain T, 2014, J PAK MED ASSOC, V64, P725; Jalal S, 2011, EUR J PUBLIC HEALTH, V21, P143, DOI 10.1093/eurpub/ckq199; Khowaja AR, 2012, B WORLD HEALTH ORGAN, V90, P822, DOI 10.2471/BLT.12.106260; Mangrio Nawab Khan, 2008, J Pak Med Assoc, V58, P64; Mushtaq MU, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-60; Naeem Mohammad, 2011, J Ayub Med Coll Abbottabad, V23, P98; Nishtar S, 2010, B WORLD HEALTH ORGAN, V88, P159, DOI 10.2471/BLT.09.066480; Obute JA, 2007, INT J HEALTH PROMOT, V45, P81, DOI 10.1080/14635240.2007.10708108; Owais A, 2013, VACCINE, V31, P3313, DOI 10.1016/j.vaccine.2013.05.015; Raosoft, 2008, ONL SAMPL SIZ CALC; Shah M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-457; Shrivastava A, 2012, INDIAN J MED RES, V135, P520; World Health Organization, 2008, KNOWL ATT BEL STUD U; World Health Organization, 2014, POL; World Health Organization, 1999, GLOB ACT PLAN LAB CO; Yakum Martin Ndinakie, 2015, BMC Res Notes, V8, P145, DOI 10.1186/s13104-015-1109-9; Zeleke SA, 2000, LANCET, V356, pS21, DOI 10.1016/S0140-6736(00)92007-5	28	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142485	10.1371/journal.pone.0142485	http://dx.doi.org/10.1371/journal.pone.0142485			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559184	Green Submitted, gold, Green Published			2022-12-26	WOS:000364433100083
J	Nargis, N; Thompson, ME; Fong, GT; Driezen, P; Hussain, AKMG; Ruthbah, UH; Quah, ACK; Abdullah, AS				Nargis, Nigar; Thompson, Mary E.; Fong, Geoffrey T.; Driezen, Pete; Hussain, A. K. M. Ghulam; Ruthbah, Ummul H.; Quah, Anne C. K.; Abdullah, Abu S.			Prevalence and Patterns of Tobacco Use in Bangladesh from 2009 to 2012: Evidence from International Tobacco Control (ITC) Study	PLOS ONE			English	Article								Background Smoking and passive smoking are collectively the biggest preventable cause of death in Bangladesh, with major public health burden of morbidity, disability, mortality and community costs. The available studies of tobacco use in Bangladesh, however, do not necessarily employ nationally representative samples needed to monitor the problem at a national scale. This paper examines the prevalence and patterns of tobacco use among adults in Bangladesh and the changes over time using large nationally representative comparable surveys. Methods Using data from two enumerations of the International Tobacco Control (ITC) Bangladesh Project conducted in 2009 and 2012, prevalence estimates are obtained for all tobacco products by socio-economic determinants and sample types of over 90,000 individuals drawn from over 30,000 households. Household level sample weights are used to obtain nationally representative prevalence estimates and standard errors. Statistical tests of difference in the estimates between two time periods are based on a logistic regression model that accounts for the complex sampling design. Using a multinomial logit model, the time trend in tobacco use status is identified to capture the effects of macro level determinants including changes in tobacco control policies. Results Between 2009 and 2012, overall tobacco use went down from 42.4% to 36.3%. The decline is more pronounced with respect to smokeless tobacco use than smoking. The prevalence of exclusive cigarette smoking went up from 7.2% to 10.6%; exclusive bidi smoking remained stable at around 2%; while smoking both cigarette and bidi went down from 4.6% to 1.8%; exclusive smokeless tobacco use went down from 20.2% to 16.9%; and both smokeless tobacco use and smoking went down from 8.4% to 5.1%. In general, the prevalence of tobacco use is higher among men, increases from younger to older age groups, and is higher among poorer people. Smoking prevalence is the highest among the slum population, followed by the tribal population, the national population and the border area population, suggesting greater burden of tobacco use among the disadvantaged groups. Conclusions The overall decline in tobacco use can be viewed as a structural shift in the tobacco market in Bangladesh from low value products such as bidi and smokeless tobacco to high value cigarettes, which is expected with the growth in income and purchasing power of the general population. Despite the reduction in overall tobacco use, the male smoking prevalence in Bangladesh is still high at 37%. The world average of daily smoking among men is 31.1%. The Tobacco Control Act 2005 and the Amendment have yet to make a significant impact in curbing tobacco usage in Bangladesh. The findings in this paper further suggest that the tobacco control policies in Bangladesh need to include targeted interventions to restrain the use of particular types of tobacco products among specific demographic and socio-economic groups of the population, such as smoked tobacco among men, smokeless tobacco among women, and both smoked and smokeless tobacco among those living in rural areas, those in low socio-economic status and those belonging to the tribal and the slum population.	[Nargis, Nigar; Hussain, A. K. M. Ghulam; Ruthbah, Ummul H.] Univ Dhaka, Dhaka 1000, Bangladesh; [Thompson, Mary E.; Fong, Geoffrey T.; Driezen, Pete; Quah, Anne C. K.] Univ Waterloo, Waterloo, ON N2L 3G1, Canada; [Abdullah, Abu S.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Abdullah, Abu S.] Duke Kunshan Univ, Global Hlth Program, Suzhou, Jiangsu, Peoples R China	University of Dhaka; University of Waterloo; Boston University; Duke Kunshan University		nigar.nargis@cancer.org	Fong, Geoffrey T/H-2810-2014; Driezen, Pete/AAX-2804-2020; Nargis, Nigar/ABV-7173-2022; PAN, ZEQIANG/X-6341-2018	Fong, Geoffrey T/0000-0001-9098-6472; Driezen, Pete/0000-0003-2320-0999; Nargis, Nigar/0000-0003-4501-1398; Ruthbah, Ummul/0000-0002-5720-371X	International Development Research Centre (IDRC) [104831-002]; Canadian Institutes for Health Research [79551, 115016]; US National Cancer Institute [P01 CA138389]; Senior Investigator Award from Ontario Institute for Cancer Research; Prevention Scientist Award from the Canadian Cancer Research Institute; NATIONAL CANCER INSTITUTE [P01CA138389] Funding Source: NIH RePORTER	International Development Research Centre (IDRC); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Senior Investigator Award from Ontario Institute for Cancer Research; Prevention Scientist Award from the Canadian Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by the International Development Research Centre (IDRC Grant 104831-002, http://www.idrc.ca) (funding to NN), Canadian Institutes for Health Research (Operating Grants 79551 and 115016, http://www.cihr-irsc.gc.ca) (funding to GTF), the US National Cancer Institute (P01 CA138389, http://www.cancer.gov/) (funding to GTF), and a Senior Investigator Award from Ontario Institute for Cancer Research (http://oicr.on.ca/) and a Prevention Scientist Award from the Canadian Cancer Research Institute (http://www.cancer.ca/research) to GTF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam DS, 2013, B WORLD HEALTH ORGAN, V91, P757, DOI 10.2471/BLT.13.120196; Efroymson D, 2001, TOB CONTROL, V10, P212, DOI 10.1136/tc.10.3.212; Esson K. M, 2004, MILLENNIUM DEV GOALS; Flora MS, 2009, TOB CONTROL, V18, P445, DOI 10.1136/tc.2008.028142; ITC Project, 2015, TECHNICAL REPORT; ITC Project, 2010, TECHNICAL REPORT; ITC Project, 2012, TOB PRIC TAX ITC CRO; Khan MMH, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-149; Marie N, 2014, JAMA-J AM MED ASSOC, V311, P183, DOI [10. 1001/ jama. 2013.284692, DOI 10.1001/JAMA.2013.284692]; Ministry of Health and Family Welfare, 2009, GLOBAL ADULT TOBACCO; Nargis N, 2014, INDIAN J CANC S1, V51; Sreeramareddy CT, 2014, POPUL HEALTH METR, V12, DOI 10.1186/s12963-014-0022-0; WHO, 2015, WHO GLOB REP TRENDS; World Bank, 2013, WORLD DEV IND DAT; World Bank, 2003, TOB CONTR POL STRAT; World Health Organization (WHO), 2010, NONC DIS RISK FACT S; World Health Organization (WHO), 2007, IMP TOB REL ILLN BAN	17	41	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141135	10.1371/journal.pone.0141135	http://dx.doi.org/10.1371/journal.pone.0141135			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559051	gold, Green Published, Green Submitted			2022-12-26	WOS:000364433100022
J	van Elk, M; Ozbakir, B; Barten-Rijbroek, AD; Storm, G; Nijsen, F; Hennink, WE; Vermonden, T; Deckers, R				van Elk, Merel; Ozbakir, Burcin; Barten-Rijbroek, Angelique D.; Storm, Gert; Nijsen, Frank; Hennink, Wim E.; Vermonden, Tina; Deckers, Roel			Alginate Microspheres Containing Temperature Sensitive Liposomes (TSL) for MR-Guided Embolization and Triggered Release of Doxorubicin	PLOS ONE			English	Article							DRUG-ELUTING BEADS; HEPATOCELLULAR-CARCINOMA; IN-VITRO; TRANSARTERIAL CHEMOEMBOLIZATION; ACID) MICROSPHERES; LIVER-CANCER; NECK-CANCER; DC BEAD; DELIVERY; HYPERTHERMIA	Objective The objective of this study was to develop and characterize alginate microspheres suitable for embolization with on-demand triggered doxorubicin (DOX) release and whereby the microspheres as well as the drug releasing process can be visualized in vivo using MRI. Methods and Findings For this purpose, barium crosslinked alginate microspheres were loaded with temperature sensitive liposomes (TSL/TSL-Ba-ms), which release their payload upon mild hyperthermia. These TSL contained DOX and [Gd(HPDO3A)(H2O)], a T-1 MRI contrast agent, for real time visualization of the release. Empty alginate microspheres crosslinked with holmium ions (T-2* MRI contrast agent, Ho-ms) were mixed with TSL-Ba-ms to allow microsphere visualization. TSL-Ba-ms and Ho-ms were prepared with a homemade spray device and sized by sieving. Encapsulation of TSL in barium crosslinked microspheres changed the triggered release properties only slightly: 95% of the loaded DOX was released from free TSL vs. 86% release for TSL-Ba-ms within 30 seconds in 50% FBS at 42 degrees C. TSL-Ba-ms (76 +/- 41 mu m) and Ho-ms (64 +/- 29 mu m) had a comparable size, which most likely will result in a similar in vivo tissue distribution after an i.v. co-injection and therefore Ho-ms can be used as tracer for the TSL-Ba-ms. MR imaging of a TSL-Ba-ms and Ho-ms mixture (ratio 95: 5) before and after hyperthermia allowed in vitro and in vivo visualization of microsphere deposition (T-2*-weighted images) as well as temperature-triggered release (T-1-weighted images). The [Gd(HPDO3A)(H2O)] release and clusters of microspheres containing holmium ions were visualized in a VX2 tumor model in a rabbit using MRI. Conclusions In conclusion, these TSL-Ba-ms and Ho-ms are promising systems for real-time, MRguided embolization and triggered release of drugs in vivo.	[van Elk, Merel; Ozbakir, Burcin; Storm, Gert; Hennink, Wim E.; Vermonden, Tina] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Pharmaceut, Utrecht, Netherlands; [Barten-Rijbroek, Angelique D.; Deckers, Roel] Univ Med Ctr Utrecht, Imaging Div, Utrecht, Netherlands; [Nijsen, Frank] Univ Med Ctr Utrecht, Dept Radiol & Nucl Med, Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Deckers, R (corresponding author), Univ Med Ctr Utrecht, Imaging Div, Utrecht, Netherlands.	r.deckers-2@umcutrecht.nl	Storm, Gerrit/O-8696-2016; Vermonden, Tina/I-9491-2016; Hennink, Wim/O-8632-2016; Nijsen, Frank/C-2839-2018	Nijsen, Frank/0000-0001-7625-2253; Vermonden, Tina/0000-0002-6047-5900	CTMM, the Center for Translational Molecular Medicine, project HIFU-CHEM [030-301]	CTMM, the Center for Translational Molecular Medicine, project HIFU-CHEM	This research was performed within the framework of CTMM, the Center for Translational Molecular Medicine (www.ctmm.nl), project HIFU-CHEM (grant 030-301).	Al-Jamal WT, 2012, BIOMATERIALS, V33, P4608, DOI 10.1016/j.biomaterials.2012.03.018; ALLEN TM, 1980, BIOCHIM BIOPHYS ACTA, V597, P418, DOI 10.1016/0005-2736(80)90118-2; Baron P, 2014, MAGN RESON MED, V72, P1057, DOI 10.1002/mrm.25025; Bastian P, 1998, EUR J PHARM BIOPHARM, V46, P243, DOI 10.1016/S0939-6411(98)00047-2; Brown DB, 2009, J VASC INTERV RADIOL, V20, pS425, DOI 10.1016/j.jvir.2009.04.021; COHEN S, 1991, BIOCHIM BIOPHYS ACTA, V1063, P95, DOI 10.1016/0005-2736(91)90358-F; de Smet M, 2010, J CONTROL RELEASE, V143, P120, DOI 10.1016/j.jconrel.2009.12.002; Dhanasekaran R, 2010, J SURG ONCOL, V101, P476, DOI 10.1002/jso.21522; Dreher MR, 2012, J VASC INTERV RADIOL, V23, P257, DOI 10.1016/j.jvir.2011.10.019; Eroglu M, 2006, J MICROENCAPSUL, V23, P367, DOI 10.1080/02652040500286318; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Forster REJ, 2010, J MATER SCI-MATER M, V21, P2243, DOI 10.1007/s10856-010-4080-y; GREENE RF, 1983, CANCER RES, V43, P3417; Grull H, 2012, J CONTROL RELEASE, V161, P317, DOI 10.1016/j.jconrel.2012.04.041; Hong K, 2006, CLIN CANCER RES, V12, P2563, DOI 10.1158/1078-0432.CCR-05-2225; Imai N, 2014, WORLD J HEPATOL, V6, P844, DOI 10.4254/wjh.v6.i12.844; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kettenbach J, 2008, CARDIOVASC INTER RAD, V31, P468, DOI 10.1007/s00270-007-9280-6; Kong G, 2000, CANCER RES, V60, P6950; Kooijman H, 2000, ACTA CRYSTALLOGR C, V56, P156, DOI 10.1107/S0108270199013566; Landon Chelsea D, 2011, Open Nanomed J, V3, P38; Lencioni R, 2010, ONCOLOGY-BASEL, V78, P107, DOI 10.1159/000315238; Lewandowski RJ, 2011, RADIOLOGY, V259, P641, DOI 10.1148/radiol.11081489; Lewis AL, 2006, J VASC INTERV RADIOL, V17, P335, DOI 10.1097/01.RVI.0000195323.46152.B3; Lewis AL, 2011, EXPERT OPIN DRUG DEL, V8, P153, DOI 10.1517/17425247.2011.545388; Lewis AL, 2012, J CONTROL RELEASE, V161, P338, DOI 10.1016/j.jconrel.2012.01.018; Li S, 2002, J CONTROL RELEASE, V84, P87, DOI 10.1016/S0168-3659(02)00214-6; Liapi E, 2007, TECH VASC INTERV RAD, V10, P261, DOI 10.1053/j.tvir.2008.03.003; Liu YH, 2013, NANOTOXICOLOGY, V7, P97, DOI 10.3109/17435390.2011.634079; Louguet S, 2014, ACTA BIOMATER, V10, P1194, DOI 10.1016/j.actbio.2013.11.028; Namur J, 2010, J VASC INTERV RADIOL, V21, P259, DOI 10.1016/j.jvir.2009.10.026; Needham D, 2000, CANCER RES, V60, P1197; Negussie AH, 2011, INT J HYPERTHER, V27, P140, DOI 10.3109/02656736.2010.528140; Nicolini A, 2011, EXPERT OPIN DRUG DEL, V8, P1071, DOI 10.1517/17425247.2011.590472; Nicolini D, 2013, WORLD J GASTROENTERO, V19, P5622, DOI 10.3748/wjg.v19.i34.5622; Oerlemans C, 2013, ACTA BIOMATER, V9, P4681, DOI 10.1016/j.actbio.2012.08.038; Peller M, 2002, MAGN RESON MED, V47, P1194, DOI 10.1002/mrm.10155; Polson C, 2003, J CHROMATOGR B, V785, P263, DOI 10.1016/S1570-0232(02)00914-5; Poon RTP, 2007, CLIN GASTROENTEROL H, V5, P1100, DOI 10.1016/j.cgh.2007.04.021; SCHERPHOF G, 1978, BIOCHIM BIOPHYS ACTA, V542, P296, DOI 10.1016/0304-4165(78)90025-9; SENIOR J, 1982, FEBS LETT, V145, P109, DOI 10.1016/0014-5793(82)81216-7; Staruch RM, 2015, INT J HYPERTHER, P1; Tagami T, 2011, J CONTROL RELEASE, V152, P303, DOI 10.1016/j.jconrel.2011.02.009; van Elk M, 2015, EUR POLYM J IN PRESS; van Elk M, 2014, BIOMACROMOLECULES, V15, P1002, DOI 10.1021/bm401904u; van Es RJJ, 2001, INT J ORAL MAX SURG, V30, P407, DOI 10.1054/ijom.2001.0129; van Es RJJ, 2001, J CRANIO MAXILL SURG, V29, P289, DOI 10.1054/jcms.2001.0234; Varela M, 2007, J HEPATOL, V46, P474, DOI 10.1016/j.jhep.2006.10.020; Wei XD, 1998, INORG CHEM, V37, P2255, DOI 10.1021/ic970741+; Weng LH, 2013, ACTA BIOMATER, V9, P8182, DOI 10.1016/j.actbio.2013.06.020; Weng LH, 2013, ACTA BIOMATER, V9, P6823, DOI 10.1016/j.actbio.2013.02.017; Yarmolenko PS, 2010, INT J HYPERTHER, V26, P485, DOI 10.3109/02656731003789284; Zucker D, 2009, J CONTROL RELEASE, V139, P73, DOI 10.1016/j.jconrel.2009.05.036	54	17	18	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141626	10.1371/journal.pone.0141626	http://dx.doi.org/10.1371/journal.pone.0141626			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26561370	Green Published, gold, Green Submitted			2022-12-26	WOS:000364433100037
J	Chen, F; Wang, TJ; Feng, CP; Lin, G; Zhu, YH; Wu, GY; Johnson, G; Wang, JJ				Chen, Fang; Wang, Taiji; Feng, Cuiping; Lin, Gang; Zhu, Yuhua; Wu, Guoyao; Johnson, Gregory; Wang, Junjun			Proteome Differences in Placenta and Endometrium between Normal and Intrauterine Growth Restricted Pig Fetuses	PLOS ONE			English	Article							MATERNAL NUTRITION; OXIDATIVE STRESS; IN-VIVO; FETAL; ANGIOGENESIS; PREGNANCY; TRANSPORT; CELLS; METABOLISM; EXPRESSION	Uteroplacental tissue plays a key role in substance exchanges between maternal and fetal circulation, and, therefore, in the growth and development of fetuses. In this study, proteomics and western blotting were applied to investigate the changes of proteome in the placenta and endometrium of normal and intrauterine growth restriction (IUGR) porcine fetuses during mid to late pregnancy (D60, 90, and 110 of gestation). Our results showed that proteins participating in cell structure, energy metabolism, stress response, cell turnover, as well as transport and metabolism of nutrients were differentially expressed in placenta and endometrium between normal and IUGR fetuses. Analysis of functions of these proteins suggests reductions in ATP production and nutrients transport, increases in oxidative stress and apoptosis, and impairment of cell metabolism in IUGR fetuses. Collectively, our findings aid in understanding of the mechanisms responsible for uteroplacental dysfunction in IUGR fetus, and are expected to provide new strategies to reduce fetal growth restriction in pigs and other mammals.	[Chen, Fang; Wang, Taiji; Lin, Gang; Zhu, Yuhua; Wu, Guoyao; Wang, Junjun] China Agr Univ, State Key Lab Anim Nutr, Coll Anim Sci & Technol, Alltech MAFIC Res Alliance, Beijing 100094, Peoples R China; [Chen, Fang] South China Agr Univ, Dept Anim Sci, Guangzhou, Guangdong, Peoples R China; [Feng, Cuiping] China Japan Friendship Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China; [Wu, Guoyao] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA; [Johnson, Gregory] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX USA	China Agricultural University; South China Agricultural University; China-Japan Friendship Hospital; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Wang, JJ (corresponding author), China Agr Univ, State Key Lab Anim Nutr, Coll Anim Sci & Technol, Alltech MAFIC Res Alliance, Beijing 100094, Peoples R China.	jkywjj@hotmail.com	Lin, Gang/AAH-6873-2020		National Natural Science Foundation of China [30810103902, 31272449, 31422052]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: This study was supported by fundings from National Natural Science Foundation of China (no. 30810103902, 31272449, and 31422052). URL of National Natural Science Foundation of China: http://www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTOSIK D, 1987, AM J OBSTET GYNECOL, V156, P11, DOI 10.1016/0002-9378(87)90194-3; Bax BE, 1997, BBA-BIOENERGETICS, V1319, P283, DOI 10.1016/S0005-2728(96)00169-7; BAZER FW, 1992, P SOC EXP BIOL MED, V199, P373, DOI 10.3181/00379727-199-43371A; BISCHOF P, 1994, HUM REPROD, V9, P1652, DOI 10.1093/oxfordjournals.humrep.a138768; Burton Graham J, 2003, Reprod Biomed Online, V6, P84; Caraglia M, 2001, AMINO ACIDS, V20, P91, DOI 10.1007/s007260170050; Chen F, 2011, J ANIM SCI, V89, P743, DOI 10.2527/jas.2010-3146; Chiosis G, 2013, NAT STRUCT MOL BIOL, V20, P1, DOI 10.1038/nsmb.2481; Clarke L, 1998, BRIT J NUTR, V79, P359, DOI 10.1079/BJN19980060; FORD SP, 1995, J ANIM SCI, V73, P1852; Gandin V, 2008, NATURE, V455, P684, DOI 10.1038/nature07267; GODFREY KM, 1995, EUR J OBSTET GYN R B, V61, P15, DOI 10.1016/0028-2243(95)02148-L; Hempstock J, 2003, HUM PATHOL, V34, P1265, DOI 10.1016/j.humpath.2003.08.006; Jansson T, 1998, PEDIATR RES, V44, P532, DOI 10.1203/00006450-199810000-00011; Jauniaux E, 2006, HUM REPROD UPDATE, V12, P747, DOI 10.1093/humupd/dml016; Jiang PP, 2009, J PROTEOME RES, V8, P72, DOI 10.1021/pr800638w; Johansson S, 2001, BIOL REPROD, V64, P60, DOI 10.1095/biolreprod64.1.60; Kalis M, 2010, ISLETS, V2, P185, DOI 10.4161/isl.2.3.11654; KNIGHT JW, 1977, J ANIM SCI, V44, P620, DOI 10.2527/jas1977.444620x; Lachmann P J, 1979, Ciba Found Symp, P231; Lin G, 2012, J NUTR, V142, P990, DOI 10.3945/jn.111.153411; Liu C, 2012, J NUTR BIOCH, V24, P945; Magnusson AL, 2004, PLACENTA, V25, P337, DOI 10.1016/j.placenta.2003.08.021; Majumder S, 2014, NITRIC OXIDE-BIOL CH, V36, P76, DOI 10.1016/j.niox.2013.12.002; Marconi AM, 2008, SEMIN PERINATOL, V32, P178, DOI 10.1053/j.semperi.2008.02.007; Mateo RD, 2007, J NUTR, V137, P652, DOI 10.1093/jn/137.3.652; Matsuyama W, 2001, INTERNAL MED, V40, P1254, DOI 10.2169/internalmedicine.40.1254; McArdle HJ, 2008, J NEUROENDOCRINOL, V20, P427, DOI 10.1111/j.1365-2826.2008.01658.x; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; Reynolds LP, 2002, INT J EXP PATHOL, V83, P151, DOI 10.1046/j.1365-2613.2002.00277.x; REYNOLDS LP, 1992, FASEB J, V6, P886, DOI 10.1096/fasebj.6.3.1371260; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; Shibata E, 2001, PLACENTA, V22, P566, DOI 10.1053/plac.2001.0693; Szlosarek PW, 2006, CLIN CANCER RES, V12, P7126, DOI 10.1158/1078-0432.CCR-06-1101; Tavaria M, 1996, CELL STRESS CHAPERON, V1, P23, DOI 10.1379/1466-1268(1996)001<0023:AHSGTT>2.3.CO;2; Vourtsis D, 2013, EUR J PHARMACOL, V698, P122, DOI 10.1016/j.ejphar.2012.11.007; Wang JJ, 2008, J NUTR, V138, P60, DOI 10.1093/jn/138.1.60; Wang XQ, 2010, J PROTEOME RES, V9, P924, DOI 10.1021/pr900747d; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156; Zamudio S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008551; Zhang S, 2015, NUTRIENTS, V7, P360, DOI 10.3390/nu7010360	43	29	35	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142396	10.1371/journal.pone.0142396	http://dx.doi.org/10.1371/journal.pone.0142396			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554841	Green Published, Green Submitted, gold			2022-12-26	WOS:000364430700097
J	Dionne, MD; Deneux-Tharaux, C; Dupont, C; Basso, O; Rudigoz, RC; Bouvier-Colle, MH; Le Ray, C				Dionne, Marie-Danielle; Deneux-Tharaux, Catherine; Dupont, Corinne; Basso, Olga; Rudigoz, Rene-Charles; Bouvier-Colle, Marie-Helene; Le Ray, Camille			Duration of Expulsive Efforts and Risk of Postpartum Hemorrhage in Nulliparous Women: A Population-Based Study	PLOS ONE			English	Article							BLOOD-LOSS; 3RD STAGE; LABOR; 2ND-STAGE; MORBIDITY; INCREASE; LONG	Objective To assess the specific association between the duration of expulsive efforts and the risk of postpartum hemorrhage. Methods Population-based cohort-nested case-control study of nulliparous women delivering vaginally in 106 French maternity units between December 2004 and November 2006, including 3,852 women with PPH (blood loss >= 500 mL and/or peripartum Hb decrease >= 2 g/dL), 1,048 of them severe (peripartum Hb decrease >= 4 g/dL or transfusion of >= 2 units of red blood cells), and 762 controls from a representative sample of deliveries without hemorrhage in the same population. The association between duration of expulsive efforts and postpartum hemorrhage was estimated by multilevel logistic regression models adjusted for individual and hospital characteristics. Results Median duration of expulsive efforts was 18 minutes among controls, 20 minutes among postpartum hemorrhage and 23 minutes among severe postpartum hemorrhage (p<0.01). Duration of expulsive efforts was significantly, positively, and linearly associated with both postpartum hemorrhage and severe postpartum hemorrhage. After adjustment for other risk factors, every additional 10 minutes of expulsive efforts was associated with about a 10% increase in the risk of postpartum hemorrhage (aOR = 1.11 [1.02-1.21]) and severe postpartum hemorrhage (aOR = 1.14 [1.03-1.27]). Oxytocin during labor, duration of active phase of labor, forceps use, episiotomy, perineal tears, and birth weight were also independently associated with both risks. Conclusion Duration of expulsive efforts was independently associated with postpartum hemorrhage and severe postpartum hemorrhage. Interventions to shorten the duration of this stage, such as oxytocin, forceps, and episiotomy, are also associated with higher risks of postpartum hemorrhage. Beyond duration, other aspects of the management of active second stage should be evaluated as some might allow it to last longer with a minimal increase in postpartum hemorrhage risk.	[Dionne, Marie-Danielle; Deneux-Tharaux, Catherine; Bouvier-Colle, Marie-Helene; Le Ray, Camille] Paris Descartes Univ, Ctr Epidemiol & Stat Sorbonne Paris Cite, Obstet Perinatal & Pediat Epidemiol Res Team Epop, DHU Risks Pregnancy,Inserm,UMR 1153, Paris, France; [Dionne, Marie-Danielle; Basso, Olga] McGill Univ, Dept Obstet & Gynecol, Montreal, PQ H3A 2T5, Canada; [Dionne, Marie-Danielle] Univ Montreal, Ctr Hlth, Montreal, PQ, Canada; [Dupont, Corinne; Rudigoz, Rene-Charles] Univ Lyon 1, Hosp Civils Lyon, Hop Croix Rousse, Aurore Perinatal Network,EA 4129, F-69365 Lyon, France; [Basso, Olga] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Le Ray, Camille] Paris Descartes Univ, Cochin Broca Hotel Dieu Hosp, AP HP, Port Royal Matern, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; McGill University; Universite de Montreal; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; McGill University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	Le Ray, C (corresponding author), Paris Descartes Univ, Ctr Epidemiol & Stat Sorbonne Paris Cite, Obstet Perinatal & Pediat Epidemiol Res Team Epop, DHU Risks Pregnancy,Inserm,UMR 1153, Paris, France.	camille.le-ray@cch.aphp.fr	Basso, Olga/E-5384-2010; DUPONT, Corinne/ABD-5045-2020; deneux-tharaux, catherine/R-1111-2016	Basso, Olga/0000-0001-9298-4921; deneux-tharaux, catherine/0000-0002-6561-3321; Le Ray, Camille/0000-0003-0891-1063	French Ministry of Health under its Clinical Research Hospital Program [27-35]; Caisse Nationale d'Assurance Maladie (CNAMTS); foundation of the Centre hospitalier universitaire de l'Universite de Montreal (CHUM); McGill University health centre (MUHC)	French Ministry of Health under its Clinical Research Hospital Program; Caisse Nationale d'Assurance Maladie (CNAMTS); foundation of the Centre hospitalier universitaire de l'Universite de Montreal (CHUM); McGill University health centre (MUHC)	The PITHAGORE6 project was funded by the French Ministry of Health under its Clinical Research Hospital Program (contract no.27-35) and the Caisse Nationale d'Assurance Maladie (CNAMTS). Marie-Danielle Dionne was financially supported by the foundation of the Centre hospitalier universitaire de l'Universite de Montreal (CHUM) and McGill University health centre (MUHC). These funders had no role in the design and conduct of the study, no role in the collection, analysis, or interpretation of the data, and no role in the writing of the manuscript or in the decision to submit for publication.	Al-Zirqi I, 2008, BJOG-INT J OBSTET GY, V115, P1265, DOI 10.1111/j.1471-0528.2008.01859.x; Bais JMJ, 2004, EUR J OBSTET GYN R B, V115, P166, DOI 10.1016/j.ejogrb.2003.12.008; Bateman BT, 2010, ANESTH ANALG, V110, P1368, DOI 10.1213/ANE.0b013e3181d74898; Belghiti J, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000514; Brace V, 2007, BJOG-INT J OBSTET GY, V114, P1388, DOI 10.1111/j.1471-0528.2007.01533.x; Buhimschi CS, 2002, AM J OBSTET GYNECOL, V186, P1339, DOI 10.1067/mob.2002.122402; Callaghan WM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.011; Caughey AB, 2014, AM J OBSTET GYNECOL, V210, P179, DOI 10.1016/j.ajog.2014.01.026; Cheng YW, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.05.024; Cheng YW, 2004, AM J OBSTET GYNECOL, V191, P933, DOI 10.1016/j.ajog.2004.05.044; Deneux-Tharaux C, 2010, BJOG-INT J OBSTET GY, V117, P1278, DOI 10.1111/j.1471-0528.2010.02648.x; Ford JB, 2007, INT J GYNECOL OBSTET, V98, P237, DOI 10.1016/j.ijgo.2007.03.011; Joseph KS, 2007, BJOG-INT J OBSTET GY, V114, P751, DOI 10.1111/j.1471-0528.2007.01316.x; Kramer MS, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.07.007; Le Ray C, 2011, EUR J OBSTET GYN R B, V158, P167, DOI 10.1016/j.ejogrb.2011.04.035; Le Ray C, 2008, J GYNECOL OBST BIO R, V37, P325, DOI 10.1016/j.jgyn.2008.02.009; Le Ray C, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.08.002; Lutomski JE, 2012, BJOG-INT J OBSTET GY, V119, P306, DOI 10.1111/j.1471-0528.2011.03198.x; Mehrabadi A, 2013, BJOG-INT J OBSTET GY, V120, P853, DOI 10.1111/1471-0528.12149; Naime-Alix AF, 2008, J GYNECOL OBST BIO R, V37, P268, DOI 10.1016/j.jgyn.2007.12.010; Prasertcharoensuk W, 2000, INT J GYNECOL OBSTET, V71, P69, DOI 10.1016/S0020-7292(00)00294-0; Razvi K, 1996, AUST NZ J OBSTET GYN, V36, P152, DOI 10.1111/j.1479-828X.1996.tb03273.x; Schaal J-P, 2008, J Gynecol Obstet Biol Reprod (Paris), V37 Suppl 1, pS3, DOI 10.1016/j.jgyn.2007.11.004; Sheiner E, 2005, J MATERN-FETAL NEO M, V18, P149, DOI 10.1080/14767050500170088; Sosa CG, 2009, OBSTET GYNECOL, V113, P1313, DOI 10.1097/AOG.0b013e3181a66b05; Werkoff G, 2010, GYNECOL OBSTET FERTI, V38, P653, DOI 10.1016/j.gyobfe.2010.08.009; World Health Organization WHO, 2012, RECOMMENDATIONS PREV; Yeomans ER, 2010, OBSTET GYNECOL, V115, P645, DOI 10.1097/AOG.0b013e3181cfbefd; Zwart JJ, 2008, BJOG-INT J OBSTET GY, V115, P842, DOI 10.1111/j.1471-0528.2008.01713.x	29	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142171	10.1371/journal.pone.0142171	http://dx.doi.org/10.1371/journal.pone.0142171			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555447	gold, Green Submitted, Green Published			2022-12-26	WOS:000364430700063
J	Harkes, R; Keizer, VIP; Schaaf, MJM; Schmidt, T				Harkes, Rolf; Keizer, Veer I. P.; Schaaf, Marcel J. M.; Schmidt, Thomas			Depth-of-Focus Correction in Single-Molecule Data Allows Analysis of 3D Diffusion of the Glucocorticoid Receptor in the Nucleus	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-BINDING; LIVING CELLS; PARTICLE TRACKING; PLASMA-MEMBRANE; HIGH-DENSITY; LIVE CELLS; MICROSCOPY; MICRODOMAINS; PROTEIN; DNA	Single-molecule imaging of proteins in a 2D environment like membranes has been frequently used to extract diffusive properties of multiple fractions of receptors. In a 3D environment the apparent fractions however change with observation time due to the movements of molecules out of the depth-of-field of the microscope. Here we developed a mathematical framework that allowed us to correct for the change in fraction size due to the limited detection volume in 3D single-molecule imaging. We applied our findings on the mobility of activated glucocorticoid receptors in the cell nucleus, and found a freely diffusing fraction of 0.49 +/- 0.02. Our analysis further showed that interchange between this mobile fraction and an immobile fraction does not occur on time scales shorter than 150 ms.	[Harkes, Rolf; Schmidt, Thomas] Leiden Univ, Phys Life Proc, Huygens Kamerlingh Onnes Lab, Leiden, Netherlands; [Keizer, Veer I. P.; Schaaf, Marcel J. M.] Leiden Univ, IBL, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	Schmidt, T (corresponding author), Leiden Univ, Phys Life Proc, Huygens Kamerlingh Onnes Lab, Leiden, Netherlands.	schmidt@physics.leidenuniv.nl	Schmidt, Thomas/B-6296-2009	Schmidt, Thomas/0000-0002-0045-1851; Schaaf, Marcel/0000-0002-5859-8936; Harkes, Rolf/0000-0001-6592-654X				Beato M, 2000, HUM REPROD UPDATE, V6, P225, DOI 10.1093/humupd/6.3.225; Becker M, 2002, EMBO REP, V3, P1188, DOI 10.1093/embo-reports/kvf244; Biddie SC, 2012, RHEUMATOLOGY, V51, P403, DOI 10.1093/rheumatology/ker215; Cambi A, 2007, NANO LETT, V7, P970, DOI 10.1021/nl0700503; Coppola S, 2012, SOFT MATTER, V8, P7919, DOI 10.1039/c2sm25532d; Courty S, 2006, NANO LETT, V6, P1491, DOI 10.1021/nl060921t; de Keijzer S, 2008, J CELL SCI, V121, P1750, DOI 10.1242/jcs.030692; Demtroder W., 1988, LASER SPECTROSCOPY; Dietrich C, 2002, BIOPHYS J, V82, P274, DOI 10.1016/S0006-3495(02)75393-9; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; Gebhardt JCM, 2013, NAT METHODS, V10, P421, DOI [10.1038/NMETH.2411, 10.1038/nmeth.2411]; Giannone G, 2010, BIOPHYS J, V99, P1303, DOI 10.1016/j.bpj.2010.06.005; Groeneweg FL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090532; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; Holtzer L, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2437066; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Kues T, 2001, BIOPHYS J, V80, P2954, DOI 10.1016/S0006-3495(01)76261-3; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Lenne PF, 2006, EMBO J, V25, P3245, DOI 10.1038/sj.emboj.7601214; Lill Y, 2005, CHEMPHYSCHEM, V6, P1633, DOI 10.1002/cphc.200500111; Lommerse PHM, 2005, J CELL SCI, V118, P1799, DOI 10.1242/jcs.02300; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Mazza D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks701; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; Morisaki T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5456; Pinaud F, 2009, TRAFFIC, V10, P691, DOI 10.1111/j.1600-0854.2009.00902.x; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Schaaf MJM, 2009, BIOPHYS J, V97, P1206, DOI 10.1016/j.bpj.2009.05.044; Schmidt T, 1996, P NATL ACAD SCI USA, V93, P2926, DOI 10.1073/pnas.93.7.2926; Schutz GJ, 2000, EMBO J, V19, P892, DOI 10.1093/emboj/19.5.892; Schutz GJ, 1997, BIOPHYS J, V73, P1073, DOI 10.1016/S0006-3495(97)78139-6; Semrau S, 2007, BIOPHYS J, V92, P613, DOI 10.1529/biophysj.106.092577; Ueda M, 2001, SCIENCE, V294, P864, DOI 10.1126/science.1063951; Van Royen ME, 2014, J CELL SCI, V127, P1406, DOI 10.1242/jcs.135228; Wennmalm S, 1997, P NATL ACAD SCI USA, V94, P10641, DOI 10.1073/pnas.94.20.10641	35	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141080	10.1371/journal.pone.0141080	http://dx.doi.org/10.1371/journal.pone.0141080			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555072	Green Submitted, gold, Green Published			2022-12-26	WOS:000364430700019
J	LeClaire, LL; Fortwendel, JR				LeClaire, Lawrence L.; Fortwendel, Jarrod R.			Differential Support of Aspergillus fumigatus Morphogenesis by Yeast and Human Actins	PLoS One			English	Article							F-ACTIN; CANDIDA-ALBICANS; PHALLOIDIN BINDING; CRYPTOCOCCUS-NEOFORMANS; LATRUNCULIN-A; CELL POLARITY; TIP GROWTH; WILD-TYPE; CYTOSKELETON; NIDULANS	The actin cytoskeleton is highly conserved among eukaryotes and is essential for cellular processes regulating growth and differentiation. In fungi, filamentous actin (F-actin) orchestrates hyphal tip structure and extension via organization of exocytic and endocytic processes at the hyphal tip. Although highly conserved, there are key differences among actins of fungal species as well as between mammalian and fungal actins. For example, the F-actin stabilizing molecules, phalloidin and jasplakinolide, bind to actin structures in yeast and human cells, whereas phalloidin does not bind actin structures of Aspergillus. These discrepancies suggest structural differences between Aspergillus actin filaments and those of human and yeast cells. Additionally, fungal actin kinetics are much faster than those of humans, displaying 5-fold faster nucleation and 40-fold faster nucleotide exchange rates. Limited published studies suggest that these faster actin kinetics are required for normal growth and morphogenesis of yeast cells. In the current work, we show that replacement of Aspergillus actin with yeast actin generates a morphologically normal strain, suggesting that Aspergillus actin kinetics are similar to those of yeast. In contrast to wild type A. fumigatus, F-actin in this strain binds phalloidin, and pharmacological stabilization of these actin structures with jasplakinolide inhibits germination and alters morphogenesis in a dose-dependent manner. We also show that human beta-actin cannot support Aspergillus viability, even though the amino acid sequences of human and Aspergillus actins are 89.3% identical. Our findings show that minor differences in actin protein sequence account for loss of phalloidin and jasplakinolide sensitivity in Aspergillus species.	[LeClaire, Lawrence L.] Univ S Alabama, Coll Med, Dept Biochem & Mol Biol, Mobile, AL USA; [Fortwendel, Jarrod R.] Univ S Alabama, Coll Med, Dept Microbiol & Immunol, Mobile, AL 36688 USA	University of South Alabama; University of South Alabama	Fortwendel, JR (corresponding author), Univ S Alabama, Coll Med, Dept Microbiol & Immunol, Mobile, AL 36688 USA.	jfortwendel@southalabama.edu		Fortwendel, Jarrod/0000-0003-2301-4272	University of South Alabama; University of South Alabama Office of Research and Economic Development Research and Scholarly Development Award; University of South Alabama Faculty Development Council Grant	University of South Alabama; University of South Alabama Office of Research and Economic Development Research and Scholarly Development Award; University of South Alabama Faculty Development Council Grant	Funding: This project was funded by two University of South Alabama internal sources. They are: 1) The University of South Alabama Office of Research and Economic Development Research and Scholarly Development Award, and 2) The University of South Alabama Faculty Development Council Grant.	AKASHI T, 1994, MICROBIOL-SGM, V140, P271, DOI 10.1099/13500872-140-2-271; ANDERSON JM, 1986, J GEN MICROBIOL, V132, P2035; Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Ayscough KR, 1996, ANNU REV CELL DEV BI, V12, P129, DOI 10.1146/annurev.cellbio.12.1.129; Ayscough KR, 2000, CURR BIOL, V10, P1587, DOI 10.1016/S0960-9822(00)00859-9; Belmont LD, 1998, J CELL BIOL, V142, P1289, DOI 10.1083/jcb.142.5.1289; Berepiki A, 2011, NAT REV MICROBIOL, V9, P876, DOI 10.1038/nrmicro2666; Berepiki A, 2010, EUKARYOT CELL, V9, P547, DOI 10.1128/EC.00253-09; BROWN SS, 1981, J CELL BIOL, V88, P487, DOI 10.1083/jcb.88.3.487; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Buzan J, 1999, P NATL ACAD SCI USA, V96, P2823, DOI 10.1073/pnas.96.6.2823; Buzan JM, 1996, P NATL ACAD SCI USA, V93, P91, DOI 10.1073/pnas.93.1.91; CANO ML, 1992, CELL MOTIL CYTOSKEL, V21, P147, DOI 10.1002/cm.970210208; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; COVE DJ, 1966, BIOCHIM BIOPHYS ACTA, V113, P51, DOI 10.1016/S0926-6593(66)80120-0; De La Cruz EM, 1996, BIOCHEMISTRY-US, V35, P14054, DOI 10.1021/bi961047t; DE LA CRUZ EM, 1994, BIOCHEMISTRY-US, V33, P14387, DOI 10.1021/bi00252a003; Delgado-Alvarez DL, 2010, FUNGAL GENET BIOL, V47, P573, DOI 10.1016/j.fgb.2010.03.004; Fortwendel JR, 2008, EUKARYOT CELL, V7, P1530, DOI 10.1128/EC.00080-08; Fortwendel JR, 2012, EUKARYOT CELL, V11, P966, DOI 10.1128/EC.00091-12; Heath IB, 2003, FUNGAL GENET BIOL, V38, P85, DOI 10.1016/S1087-1845(02)00511-X; Juvvadi PR, 2011, MOL MICROBIOL, V82, P1235, DOI 10.1111/j.1365-2958.2011.07886.x; KARLSSON R, 1991, MOL CELL BIOL, V11, P213, DOI 10.1128/MCB.11.1.213; Knechtle P, 2003, MOL BIOL CELL, V14, P4140, DOI 10.1091/mbc.E03-03-0167; Kopecka M, 2001, EUR J CELL BIOL, V80, P303, DOI 10.1078/0171-9335-00157; Kopecka M, 2013, MICROSCOPY-JPN, V62, P295, DOI 10.1093/jmicro/dfs074; Kopecka M, 2009, CHEMOTHERAPY, V55, P278, DOI 10.1159/000224655; McKane M, 2006, J BIOL CHEM, V281, P29916, DOI 10.1074/jbc.M602251200; Moseley JB, 2006, MICROBIOL MOL BIOL R, V70, P605, DOI 10.1128/MMBR.00013-06; Murakoshi H, 2008, BRAIN CELL BIOL, V36, P31, DOI 10.1007/s11068-008-9024-9; Roca MG, 2010, EUKARYOT CELL, V9, P1171, DOI 10.1128/EC.00329-09; Scott RW, 2010, J CELL BIOL, V191, P169, DOI 10.1083/jcb.201002041; SCOTT VR, 1988, ANTIMICROB AGENTS CH, V32, P1154, DOI 10.1128/AAC.32.8.1154; Steinberg G, 2007, EUKARYOT CELL, V6, P351, DOI 10.1128/EC.00381-06; Taheri-Talesh N, 2008, MOL BIOL CELL, V19, P1439, DOI 10.1091/mbc.E07-05-0464; Ti SC, 2011, J BIOL CHEM, V286, P5784, DOI 10.1074/jbc.M110.199794; Toenjes KA, 2009, J MED MICROBIOL, V58, P779, DOI 10.1099/jmm.0.006841-0; Torralba S, 1998, MICROBIOL-SGM, V144, P45, DOI 10.1099/00221287-144-1-45; Upadhyay S, 2008, MOL MICROBIOL, V68, P690, DOI 10.1111/j.1365-2958.2008.06178.x; Wolkow TD, 1996, J CELL SCI, V109, P2179; Wolyniak MJ, 2007, EUKARYOT CELL, V6, P1824, DOI 10.1128/EC.00188-07	42	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142535	10.1371/journal.pone.0142535	http://dx.doi.org/10.1371/journal.pone.0142535			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555617	Green Submitted, Green Published, gold			2022-12-26	WOS:000364430700124
J	Lehmann, SJ; Scherberger, H				Lehmann, Sebastian J.; Scherberger, Hansjoerg			Spatial Representations in Local Field Potential Activity of Primate Anterior Intraparietal Cortex (AIP)	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; MACAQUE PARIETAL; MOTOR CORTEX; MOVEMENT DIRECTION; VISUAL GUIDANCE; HAND ACTION; MONKEY; PREMOTOR; GRASP; REACH	The execution of reach-to-grasp movements in order to interact with our environment is an important subset of the human movement repertoire. To coordinate such goal-directed movements, information about the relative spatial position of target and effector (in this case the hand) has to be continuously integrated and processed. Recently, we reported the existence of spatial representations in spiking-activity of the cortical fronto-parietal grasp network (Lehmann & Scherberger 2013), and in particular in the anterior intraparietal cortex (AIP). To further investigate the nature of these spatial representations, we explored in two rhesus monkeys (Macaca mulatta) how different frequency bands of the local field potential (LFP) in AIP are modulated by grip type, target position, and gaze position, during the planning and execution of reach-to-grasp movements. We systematically varied grasp type, spatial target, and gaze position and found that both spatial and grasp information were encoded in a variety of frequency bands (1-13Hz, 13-30Hz, 30-60Hz, and 60-100Hz, respectively). Whereas the representation of grasp type strongly increased towards and during movement execution, spatial information was represented throughout the task. Both spatial and grasp type representations could be readily decoded from all frequency bands. The fact that grasp type and spatial (reach) information was found not only in spiking activity, but also in various LFP frequency bands of AIP, might significantly contribute to the development of LFP-based neural interfaces for the control of upper limb prostheses.	[Lehmann, Sebastian J.; Scherberger, Hansjoerg] Deutsch Primatenzentrum GmbH, D-37077 Gottingen, Germany; [Lehmann, Sebastian J.; Scherberger, Hansjoerg] Univ Zurich, Inst Neuroinformat, CH-8057 Zurich, Switzerland; [Lehmann, Sebastian J.; Scherberger, Hansjoerg] Swiss Fed Inst Technol, CH-8057 Zurich, Switzerland; [Scherberger, Hansjoerg] Univ Gottingen, Dept Biol, D-37077 Gottingen, Germany; [Lehmann, Sebastian J.] Univ Western Ontario, Robarts Res Inst, Dept Physiol & Pharmacol, London, ON N6A 5B7, Canada	Deutsches Primatenzentrum (DPZ); University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Gottingen; Western University (University of Western Ontario)	Scherberger, H (corresponding author), Deutsch Primatenzentrum GmbH, D-37077 Gottingen, Germany.	hscherberger@dpz.eu			Swiss National Science Foundation [108323/1, 120652/1]; European Commission [13072]; University of Zurich [FK2004]; German Research Foundation [SCHE 1575/1-1, SCHE 1575/3-1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); University of Zurich; German Research Foundation(German Research Foundation (DFG))	This work was supported by the Swiss National Science Foundation (# 108323/1 and 120652/1), the European Commission (IRG # 13072 'NeuroGrasp'), the University of Zurich (Grant FK2004), and the German Research Foundation (SCHE 1575/1-1 & /3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agashe HA, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00121; Andersen RA, 2004, P ANN INT IEEE EMBS, V26, P5352; Asher I, 2007, J NEUROPHYSIOL, V97, P3684, DOI 10.1152/jn.00886.2006; Baker SN, 1997, J PHYSIOL-LONDON, V501, P225, DOI 10.1111/j.1469-7793.1997.225bo.x; Bansal AK, 2012, J NEUROPHYSIOL, V107, P1337, DOI 10.1152/jn.00781.2011; Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; Baumann MA, 2009, J NEUROSCI, V29, P6436, DOI 10.1523/JNEUROSCI.5479-08.2009; Bokil H, 2010, J NEUROSCI METH, V192, P146, DOI 10.1016/j.jneumeth.2010.06.020; Borra E, 2008, CEREB CORTEX, V18, P1094, DOI 10.1093/cercor/bhm146; Bremner LR, 2012, NEURON, V75, P342, DOI 10.1016/j.neuron.2012.03.041; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Chang SWC, 2010, P NATL ACAD SCI USA, V107, P7951, DOI 10.1073/pnas.0913209107; Chang SWC, 2009, NEURON, V64, P744, DOI 10.1016/j.neuron.2009.11.005; Hwang EJ, 2009, J NEUROSCI, V29, P14363, DOI 10.1523/JNEUROSCI.2081-09.2009; Kilavik BE, 2012, CEREB CORTEX, V22, P2148, DOI 10.1093/cercor/bhr299; Lehmann SJ, 2013, J NEUROSCI, V33, P7038, DOI 10.1523/JNEUROSCI.5568-12.2013; Logothetis NK, 2002, PHILOS T R SOC B, V357, P1003, DOI 10.1098/rstb.2002.1114; Luppino G, 1999, EXP BRAIN RES, V128, P181, DOI 10.1007/s002210050833; Marzocchi N, 2008, EUR J NEUROSCI, V27, P775, DOI 10.1111/j.1460-9568.2008.06021.x; MATELLI M, 1986, J COMP NEUROL, V251, P281, DOI 10.1002/cne.902510302; Mehring C, 2004, J PHYSIOL-PARIS, V98, P498, DOI 10.1016/j.jphysparis.2005.09.016; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; O'Leary JG, 2006, J NEUROPHYSIOL, V96, P1492, DOI 10.1152/jn.00106.2006; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Rickert J, 2005, J NEUROSCI, V25, P8815, DOI 10.1523/JNEUROSCI.0816-05.2005; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Romero MC, 2014, J NEUROSCI, V34, P4006, DOI 10.1523/JNEUROSCI.4095-13.2014; Sakata H, 1997, TRENDS NEUROSCI, V20, P350, DOI 10.1016/S0166-2236(97)01067-9; SAKATA H, 1995, CEREB CORTEX, V5, P429, DOI 10.1093/cercor/5.5.429; Schaffelhofer S, 2015, J NEUROSCI, V35, P1068, DOI 10.1523/JNEUROSCI.3594-14.2015; Scherberger H, 2005, NEURON, V46, P347, DOI 10.1016/j.neuron.2005.03.004; Spinks RL, 2008, J NEUROSCI, V28, P10961, DOI 10.1523/JNEUROSCI.1956-08.2008; TAIRA M, 1990, EXP BRAIN RES, V83, P29; Tanne-Gariepy J, 2002, EXP BRAIN RES, V145, P91, DOI 10.1007/s00221-002-1078-9; Townsend BR, 2011, J NEUROSCI, V31, P14386, DOI 10.1523/JNEUROSCI.2451-11.2011; Zhuang J, 2010, IEEE T BIO-MED ENG, V57, P1774, DOI 10.1109/TBME.2010.2047015	38	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142679	10.1371/journal.pone.0142679	http://dx.doi.org/10.1371/journal.pone.0142679			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554592	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000364430700155
J	Nnko, S; Bukenya, D; Kavishe, BB; Biraro, S; Peck, R; Kapiga, S; Grosskurth, H; Seeley, J				Nnko, Soori; Bukenya, Dominic; Kavishe, Bazil Balthazar; Biraro, Samuel; Peck, Robert; Kapiga, Saidi; Grosskurth, Heiner; Seeley, Janet			Chronic Diseases in North-West Tanzania and Southern Uganda. Public Perceptions of Terminologies, Aetiologies, Symptoms and Preferred Management	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; NONCOMMUNICABLE DISEASES; TRADITIONAL MEDICINE; HEALTH-SERVICES; HIV-INFECTION; EPILEPSY; STROKE; STIGMA; KNOWLEDGE; HIV/AIDS	Background Research has shown that health system utilization is low for chronic diseases (CDs) other than HIV. We describe the knowledge and perceptions of CDs identified from rural and urban communities in north-west Tanzania and southern Uganda. Methods Data were collected through a quantitative population survey, a quantitative health facility survey and focus group discussions (FGDs) and in-depth interviews (IDIs) in subgroups of population survey participants. The main focus of this paper is the findings from the FGDs and IDIs. Results We conducted 24 FGDs, involving approximately 180 adult participants and IDIs with 116 participants (>= 18 years). CDs studied included: asthma/chronic obstructive lung disease (COPD), diabetes, epilepsy, hypertension, cardiac failure and HIV-related disease. The understanding of most chronic conditions involved a combination of biomedical information, gleaned from health facility visits, local people who had suffered from a complaint or knew others who had and beliefs drawn from information shared in the community. The biomedical contribution shows some understanding of the aetiology of a condition and the management of that condition. However, local beliefs for certain conditions (such as epilepsy) suggest that biomedical treatment may be futile and therefore work counter to biomedical prescriptions for management. Conclusion Current perceptions of selected CDs may represent a barrier that prevents people from adopting efficacious health and treatment seeking behaviours. Interventions to improve this situation must include efforts to improve the quality of existing health services, so that people can access relevant, reliable and trustworthy services.	[Nnko, Soori] Natl Inst Med Res, Mwanza, Tanzania; [Bukenya, Dominic; Biraro, Samuel; Seeley, Janet] MRC UVRI Uganda Res Unit AIDS, Entebbe, Uganda; [Grosskurth, Heiner; Seeley, Janet] London Sch Hyg & Trop Med, London WC1, England; [Kavishe, Bazil Balthazar; Peck, Robert; Kapiga, Saidi] Mwanza Intervent Trials Unit, Mwanza, Tanzania; [Peck, Robert] Weill Buganda Sch Med, Mwanza, Tanzania; [Peck, Robert] Weill Cornell Med Coll, New York, NY USA	National Institute of Medical Research; University of London; London School of Hygiene & Tropical Medicine; Cornell University	Seeley, J (corresponding author), MRC UVRI Uganda Res Unit AIDS, POB 49, Entebbe, Uganda.	janet.seeley@mrcuganda.org	Kavishe, Bazil/H-4458-2017	Kavishe, Bazil/0000-0003-4839-4590; Kapiga, Saidi/0000-0003-1753-4060; Grosskurth, Heiner/0000-0001-9960-7280; Seeley, Janet/0000-0002-0583-5272; Peck, Robert/0000-0002-4526-2480	UK Government Medical Research Council (MRC UK) [99430]; Department for International Development (DFID) under the MRC/DFID Concordat agreement; Medical Research Council [G0901756, G1002650, MC_UP_A910_1112] Funding Source: researchfish; MRC [MC_UP_A910_1112, G0901756, G1002650] Funding Source: UKRI	UK Government Medical Research Council (MRC UK); Department for International Development (DFID) under the MRC/DFID Concordat agreement; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by a grant from the UK Government Medical Research Council (MRC UK; grant id-nu 99430) provided with support from the Department for International Development (DFID) under the MRC/DFID Concordat agreement. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aalto AM, 2005, J PSYCHOSOM RES, V58, P393, DOI 10.1016/j.jpsychores.2005.03.001; Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Ahlberg BM, 2004, AFRICAN SOCIOLOGICAL, V7, P18; Aikins AD, 2012, ETHNIC HEALTH, V17, P551, DOI 10.1080/13557858.2012.782209; Aikins AD, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-5; Akinyemi RO, 2009, EUR J NEUROL, V16, P998, DOI 10.1111/j.1468-1331.2009.02666.x; Amuri M, 2011, AIDS CARE, V23, P378, DOI 10.1080/09540121.2010.507739; Ayanniyi O, 2006, Afr J Med Med Sci, V35, P447; Backman G, 2008, LANCET, V372, P2047, DOI 10.1016/S0140-6736(08)61781-X; Baskind R, 2005, EPILEPSY BEHAV, V7, P68, DOI 10.1016/j.yebeh.2005.04.009; Baumann LC, 2010, DIABETES EDUCATOR, V36, P293, DOI 10.1177/0145721709358460; Benjamin LA, 2012, LANCET NEUROL, V11, P878, DOI 10.1016/S1474-4422(12)70205-3; Beune EJAJ, 2006, J HUM HYPERTENS, V20, P946, DOI 10.1038/sj.jhh.1002094; Boozary AS, 2014, JAMA-J AM MED ASSOC, V312, P1859, DOI 10.1001/jama.2014.14387; Boutayeb A, 2006, T ROY SOC TROP MED H, V100, P191, DOI 10.1016/j.trstmh.2005.07.021; BROWNER CH, 1988, CURR ANTHROPOL, V29, P681, DOI 10.1086/203688; Chan BT, 2015, AIDS, V29, P83, DOI 10.1097/QAD.0000000000000495; Cooper M, 2012, ETHNIC HEALTH, V17, P597, DOI 10.1080/13557858.2012.740003; Dalal S, 2011, INT J EPIDEMIOL, V40, P885, DOI 10.1093/ije/dyr050; Donkor ES, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-196; Dugbartey AT, 2013, ETHNIC DIS, V23, P1; Dzudie A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001217; El Sharkawy G, 2006, EPILEPSY BEHAV, V8, P201, DOI 10.1016/j.yebeh.2005.09.011; Farmer P, 2004, CURR ANTHROPOL, V45, P305, DOI 10.1086/382250; Hjelm K, 2008, INT NURS REV, V55, P434, DOI 10.1111/j.1466-7657.2008.00665.x; Hnizdo E, 2001, CLIN EXP ALLERGY, V31, P32, DOI 10.1046/j.1365-2222.2001.00981.x; Hundt GL, 2004, J BIOSOC SCI, V36, P433, DOI 10.1017/S0021932004006662; Kalyango JN, 2008, AFRICAN HLTH SCI, V8; KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973; Katende D, 2015, TROP MED INT HEALTH, V20, P1385, DOI 10.1111/tmi.12560; Kavishe B, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0357-9; Keikelame MJ, 2013, EPILEPSY BEHAV, V28, P512, DOI 10.1016/j.yebeh.2013.05.025; Kiwanuka SN, 2008, T ROY SOC TROP MED H, V102, P1067, DOI 10.1016/j.trstmh.2008.04.023; KLEINMAN A, 1978, SOC SCI MED-MED ANTH, V12, P85, DOI 10.1016/0160-7987(78)90014-5; Kolapo KO, 2011, TROP MED INT HEALTH, V16, P707, DOI 10.1111/j.1365-3156.2011.02759.x; Komolafe M, 2011, AFRICAN J NEUROLOGIC, V30; Langwick S., 2011, BODIES POLITICS AFRI; Langwick SA, 2008, AM ETHNOL, V35, P428, DOI 10.1111/j.1548-1425.2008.00044.x; Legg C, 2013, APHASIOLOGY, V27, P126, DOI 10.1080/02687038.2012.684338; Leone T, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-39; Levitt NS, 2011, AM J CLIN NUTR, V94, p1690S, DOI 10.3945/ajcn.111.019075; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; Maher D, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-355; Maiga Y, 2014, EPILEPSY BEHAV, V33, P115, DOI 10.1016/j.yebeh.2014.02.031; Marquez PV, 2013, CHALLENGE NONCOMMUNI; Marshall IJ, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e3953; Marsland R, 2012, MED ANTHROPOL Q, V26, P453, DOI 10.1111/maq.12001; Mayega RW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047632; Millogo A, 2004, ACTA NEUROL SCAND, V109, P250, DOI 10.1111/j.1600-0404.2004.00248.x; Mshana G, 2009, STROKE DISCOURSES RE; Mugumbate J, 2013, EPILEPSY BEHAV, V27, P144, DOI 10.1016/j.yebeh.2012.12.036; Mushi D, 2011, EPILEPSY BEHAV, V20, P338, DOI 10.1016/j.yebeh.2010.11.016; Musoke D, 2014, AFR HEALTH SCI, V14, DOI 10.4314/ahs.v14i4.36; Nakibuuka J, 2014, ISRN STROKE, V2014; Njamnshi AK, 2009, EPILEPSY BEHAV, V15, P179, DOI 10.1016/j.yebeh.2009.03.013; Nriagu J, 1999, EUR J EPIDEMIOL, V15, P747, DOI 10.1023/A:1007653709188; Nugent R, 2008, ANN NY ACAD SCI, V1136, P70, DOI 10.1196/annals.1425.027; Peck R, 2014, LANCET GLOB HEALTH, V2, pE285, DOI 10.1016/S2214-109X(14)70033-6; Prince R, 2012, MED ANTHROPOL Q, V26, P534, DOI 10.1111/maq.12006; Rabkin M, 2011, GLOB PUBLIC HEALTH, V6, P247, DOI 10.1080/17441692.2011.552068; Russell S, 2010, SOC SCI MED, V70, P375, DOI 10.1016/j.socscimed.2009.10.039; RWIZA HT, 1993, EPILEPSIA, V34, P1017, DOI 10.1111/j.1528-1157.1993.tb02127.x; Scholten F, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-886; Settumba SN, 2015, TROP MED INT HEALTH, V20, P781, DOI 10.1111/tmi.12487; Stoner B.P., 1986, MED ANTHROPOL Q, V17, P44, DOI DOI 10.1111/j.1937-6219.1986.tb01021.x; Strahl Hilde, 2003, Anthropol Med, V10, P309, DOI 10.1080/1364847032000133834; van Gemert F, 2011, PRIM CARE RESP J, V20, P240, DOI 10.4104/pcrj.2011.00027; Wang C, 2009, PREV MED, V48, P197, DOI 10.1016/j.ypmed.2008.11.008; Whyte SR, 2012, ANTHROPOL MED, V19, P63, DOI 10.1080/13648470.2012.660465; Young F, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-9	70	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142194	10.1371/journal.pone.0142194	http://dx.doi.org/10.1371/journal.pone.0142194			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7CT	26555896	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000364430700067
J	Tellez, M; Merchant, M				Tellez, Marisa; Merchant, Mark			Biomonitoring Heavy Metal Pollution Using an Aquatic Apex Predator, the American Alligator, and Its Parasites	PLOS ONE			English	Article							MORELETS CROCODILE EGGS; FALSE DISCOVERY RATE; FOOD-WEB; ORGANOCHLORINE PESTICIDES; SMALL-INTESTINE; DANUBE RIVER; MERCURY; ZINC; METALLOTHIONEIN; TOXICITY	Monitoring the bioaccumulation of chemical elements within various organismal tissues has become a useful tool to survey current or chronic levels of heavy metal exposure within an environment. In this study, we compared the bioaccumulations of As, Cd, Cu, Fe, Pb, Se, and Zn between the American alligator, Alligator mississippiensis, and its parasites in order to establish their use as bioindicators of heavy metal pollution. Concomitant with these results, we were interested to determine if parasites were more sensitive bioindicators of heavy metals relative to alligators. We found parasites collectively accumulated higher levels of As, Cu, Se, and Zn in comparison to their alligator hosts, whereas Fe, Cd, and Pb concentrations were higher in alligators. Interestingly, Fe levels were significantly greater in intestinal trematodes than their alligator hosts when analyzed independently from other parasitic taxa. Further analyses showed alligator intestinal trematodes concentrated As, Cu, Fe, Se, and Zn at significantly higher levels than intestinal nematodes and parasites from other organs. However, pentastomids also employed the role as a good biomagnifier of As. Interestingly, parasitic abundance decreased as levels of As increased. Stomach and intestinal nematodes were the poorest bioaccumulators of metals, yet stomach nematodes showed their ability to concentrate Pb at orders of magnitude higher in comparison to other parasites. Conclusively, we suggest that parasites, particularly intestinal trematodes, are superior biomagnifiers of As, Cu, Se, and Zn, whereas alligators are likely good biological indicators of Fe, Cd, and Pb levels within the environment.	[Tellez, Marisa] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Merchant, Mark] McNeese State Univ, Dept Chem, Lake Charles, LA 70605 USA	University of California System; University of California Santa Barbara; University of Louisiana System; McNeese State University	Tellez, M (corresponding author), Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA.	marisatellez13@gmail.com		Merchant, Mark/0000-0001-6444-4012	NSF-Graduate Research Fellowship Program Award [DGE-0946816]; IUCN/Species Survival Committee-Crocodile Specialist Group; Chicago Herpetological Society; Sigma Xi Student Research-in-Aid Award	NSF-Graduate Research Fellowship Program Award; IUCN/Species Survival Committee-Crocodile Specialist Group; Chicago Herpetological Society; Sigma Xi Student Research-in-Aid Award	Funding: This study was funded by NSF-Graduate Research Fellowship Program Award No. DGE-0946816, https://www.nsfgrfp.org/, Funding assisted in data collecting and heavy metal analysis; IUCN/Species Survival Committee-Crocodile Specialist Group's Student Research Assistant Scheme, http://www.lucncsg.org/pages/General-Information.html, funding assisted in data collection and heavy metal analysis; Chicago Herpetological Society Graduate Student Research in Herpetology Award, http://www.chicagoherp.org/index.php?link=grants, funding assisted in data collection; Sigma Xi Student Research-in-Aid Award, https://www.sigmaxi.org/programs/grants-in-aid, funding assisted in data collection.	Abernathy CO, 2003, J NUTR, V133, p1536S, DOI 10.1093/jn/133.5.1536S; Altindag A, 2005, CHEMOSPHERE, V60, P552, DOI 10.1016/j.chemosphere.2005.01.009; BELL JU, 1985, COMP BIOCHEM PHYS C, V82, P123, DOI 10.1016/0742-8413(85)90218-X; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergey L, 2002, MAR POLLUT BULL, V44, P1046, DOI 10.1016/S0025-326X(02)00154-6; Brozova A, 2015, ENVIRON SCI POLLUT R, V22, P3175, DOI 10.1007/s11356-014-3733-7; Burger J, 2000, ARCH ENVIRON CON TOX, V38, P501, DOI 10.1007/s002449910066; Campbell Kym Rouse, 2003, Applied Herpetology, V1, P45, DOI 10.1163/157075403766451225; Campbell LM, 2005, SCI TOTAL ENVIRON, V351, P247, DOI 10.1016/j.scitotenv.2005.02.043; Chen CY, 2008, ENVIRON HEALTH PERSP, V116, P1706, DOI 10.1289/ehp.11211; Choong TSY, 2007, DESALINATION, V217, P139, DOI 10.1016/j.desal.2007.01.015; Coeurdassier M, 2010, ENVIRON POLLUT, V158, P2078, DOI 10.1016/j.envpol.2010.03.008; Crossgrove J, 2004, NMR BIOMED, V17, P544, DOI 10.1002/nbm.931; DIAMOND J, 1991, NEWS PHYSIOL SCI, V6, P92, DOI 10.1152/physiologyonline.1991.6.2.92; FAIRBROTHER A, 1994, J WILDLIFE DIS, V30, P222, DOI 10.7589/0090-3558-30.2.222; FLOS R, 1986, COMP BIOCHEM PHYS C, V83, P93, DOI 10.1016/0742-8413(86)90018-6; FRIEDEN E, 1973, NUTR REV, V31, P41; Garcia-Hernandez Jaqueline, 2007, Toxicological and Environmental Chemistry, V89, P507, DOI 10.1080/02772240601165594; Guillory G, 2011, INSTRUM SCI TECHNOL, V39, P368, DOI 10.1080/10739149.2011.585196; Halmetoja A, 2000, INT J PARASITOL, V30, P1437, DOI 10.1016/S0020-7519(00)00115-6; Hopkins WA, 2005, ENVIRON POLLUT, V134, P447, DOI 10.1016/j.envpol.2004.09.010; Ibs KH, 2003, J NUTR, V133, p1452S, DOI 10.1093/jn/133.5.1452S; Ikemoto T, 2004, ARCH ENVIRON CON TOX, V47, P402, DOI 10.1007/s00244-004-3188-9; Kannan K, 2006, CHEMOSPHERE, V65, P2160, DOI 10.1016/j.chemosphere.2006.06.003; Kelly EJ, 1996, J NUTR, V126, P1782; KLAASSEN CD, 1978, AM J PHYSIOL, V234, pE47, DOI 10.1152/ajpendo.1978.234.1.E47; Lafferty KD, 1999, LIMNOL OCEANOGR, V44, P925, DOI 10.4319/lo.1999.44.3_part_2.0925; Lafferty KD, 2004, PARASITISM ECOSYSTEM; Lafferty KD, 2006, P NATL ACAD SCI USA, V103, P11211, DOI 10.1073/pnas.0604755103; Lance VA, 2006, COMP BIOCHEM PHYS C, V142, P30, DOI 10.1016/j.cbpc.2005.09.008; Law K, 2006, ENVIRON TOXICOL CHEM, V25, P2177, DOI 10.1897/05-500R.1; Liu JH, 2005, MAR POLLUT BULL, V51, P857, DOI 10.1016/j.marpolbul.2005.04.014; LSUAg Center [Internet], SUMM AGR NAT RES; Martin PA, 2011, ECOTOXICOLOGY, V20, P1701, DOI 10.1007/s10646-011-0763-5; Moss JC, 2010, MICROCHEM J, V95, P5, DOI 10.1016/j.microc.2009.07.008; Nachev M, 2010, PARASITOLOGY, V137, P1239, DOI 10.1017/S0031182010000065; Nachev M, 2009, PARASITOLOGY, V136, P545, DOI 10.1017/S003118200900571X; Orescanin V, 2006, NUCL INSTRUM METH B, V245, P495, DOI 10.1016/j.nimb.2005.11.050; OTVOS JD, 1980, P NATL ACAD SCI-BIOL, V77, P7094, DOI 10.1073/pnas.77.12.7094; PAPPENHEIMER JR, 1987, J MEMBRANE BIOL, V100, P123, DOI 10.1007/BF02209145; Pepper CB, 2004, J WILDLIFE DIS, V40, P493, DOI 10.7589/0090-3558-40.3.493; Pietrock M, 2002, PARASITOL RES, V88, P225, DOI 10.1007/s00436-001-0529-8; R Development Core Team, 2012, R LANG ENV STAT COMP; Rabalais NN, 2009, ICES J MAR SCI, V66, P1528, DOI 10.1093/icesjms/fsp047; Rai PK, 2008, INT J PHYTOREMEDIAT, V10, P133, DOI 10.1080/15226510801913918; Rainwater TR, 2007, SCI TOTAL ENVIRON, V373, P146, DOI 10.1016/j.scitotenv.2006.11.010; Rainwater TR, 2002, ARCH ENVIRON CON TOX, V42, P319, DOI 10.1007/s00244-001-0020-7; Rink L, 2000, P NUTR SOC, V59, P541, DOI 10.1017/S0029665100000781; Salla V, 2011, MICROCHEM J, V97, P207, DOI 10.1016/j.microc.2010.09.005; SANDBERG AS, 1981, BRIT J NUTR, V45, P283, DOI 10.1079/BJN19810105; Sato M, 2002, TOHOKU J EXP MED, V196, P9, DOI 10.1620/tjem.196.9; Schludermann C, 2003, PARASITOLOGY, V126, pS61, DOI 10.1017/S0031182003003743; Seed, 2001, PARASITISM DIVERSITY; Siva PRM, 2010, INSTRUM SCI TECHNOL, V38, P448, DOI 10.1080/10739149.2010.511661; Sures B, 1998, INT J PARASITOL, V28, P1173, DOI 10.1016/S0020-7519(98)00105-2; Sures B, 1997, B ENVIRON CONTAM TOX, V59, P14, DOI 10.1007/s001289900437; Sures B, 1999, PARASITOL TODAY, V15, P16, DOI 10.1016/S0169-4758(98)01358-1; Sures B, 2004, TRENDS PARASITOL, V20, P170, DOI 10.1016/j.pt.2004.01.014; Sures B, 2003, ENVIRON POLLUT, V122, P401, DOI 10.1016/S0269-7491(02)00306-8; SURES B, 1995, ANAL CHIM ACTA, V311, P135, DOI 10.1016/0003-2670(95)00191-2; Sures Bernd, 2001, Aquatic Ecology, V35, P245, DOI 10.1023/A:1011422310314; Thielen F, 2004, ENVIRON POLLUT, V129, P421, DOI 10.1016/j.envpol.2003.11.011; THOMAS P, 1994, COMP BIOCHEM PHYS C, V107, P221, DOI 10.1016/1367-8280(94)90044-2; Wu TH, 2000, J AGR FOOD CHEM, V48, P6416, DOI 10.1021/jf000321u; Zhou QF, 2008, ANAL CHIM ACTA, V606, P135, DOI 10.1016/j.aca.2007.11.018	66	25	28	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142522	10.1371/journal.pone.0142522	http://dx.doi.org/10.1371/journal.pone.0142522			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555363	Green Submitted, gold, Green Published			2022-12-26	WOS:000364430700122
J	Liu, Y; Roth, JP				Liu, Yi; Roth, Justine P.			A Revised Mechanism for Human Cyclooxygenase-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTAGLANDIN H SYNTHASE; OXYGEN REACTIVITY; COUPLED ELECTRON; ARACHIDONIC-ACID; SUBSTRATE; OXIDATION; HEME; STEPS; LIPOXYGENASES; ACTIVATION	The mechanism of omega-6 polyunsaturated fatty acid oxidation by wild-type cyclooxygenase 2 and the Y334F variant, lacking a conserved hydrogen bond to the catalytic tyrosyl radical/tyrosine, was examined for the first time under physiologically relevant conditions. The enzymes show apparent bimolecular rate constants and deuterium kinetic isotope effects that increase in proportion to co-substrate concentrations before converging to limiting values. The trends exclude multiple dioxygenase mechanisms as well as the proposal that initial hydrogen atom abstraction from the fatty acid is the first irreversible step in catalysis. Temperature dependent kinetic studies reinforce the novel finding that hydrogen transfer from the reduced catalytic tyrosine to a terminal peroxyl radical is the first irreversible step that controls regio- and stereospecific product formation.	[Liu, Yi; Roth, Justine P.] Johns Hopkins Univ, Dept Chem, Baltimore, MD 21218 USA	Johns Hopkins University	Roth, JP (corresponding author), Johns Hopkins Univ, Dept Chem, 3400 North Charles St, Baltimore, MD 21218 USA.	jproth@jhu.edu			National Science Foundation [MCB0919898]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB0919898. The authors declare that they have no conflicts of interest with the contents of this article.	BROUWER AC, 1982, BIOCHEMISTRY-US, V21, P1302, DOI 10.1021/bi00535a030; Danish HH, 2011, J AM CHEM SOC, V133, P15846, DOI 10.1021/ja2059523; Dorlet P, 2002, BIOCHEMISTRY-US, V41, P6107, DOI 10.1021/bi015871f; EDWARD JT, 1970, J CHEM EDUC, V47, P261, DOI 10.1021/ed047p261; GLICKMAN MH, 1995, BIOCHEMISTRY-US, V34, P14077, DOI 10.1021/bi00043a013; Goodwin DC, 2000, BIOCHEMISTRY-US, V39, P5422, DOI 10.1021/bi992752f; Halliwell B., 2006, FREE RADICAL BIO MED, P3; Hammes-Schiffer S, 2010, CHEM REV, V110, P6939, DOI 10.1021/cr1001436; HASINOFF BB, 1982, BIOCHEMISTRY-US, V21, P4275, DOI 10.1021/bi00261a015; Hoffmann I, 2012, BBA-MOL CELL BIOL L, V1821, P1508, DOI 10.1016/j.bbalip.2012.09.001; Huff GS, 2011, BIOCHEMISTRY-US, V50, P7375, DOI 10.1021/bi201016h; KLINMAN JP, 1980, J BIOL CHEM, V255, P1648; Knapp MJ, 2003, BIOCHEMISTRY-US, V42, P11466, DOI 10.1021/bi0300884; Kulmacz RJ, 2003, PROG LIPID RES, V42, P377, DOI 10.1016/S0163-7827(03)00023-7; Layfield JP, 2014, CHEM REV, V114, P3466, DOI 10.1021/cr400400p; Lewis ER, 1999, J AM CHEM SOC, V121, P1395, DOI 10.1021/ja983083g; Ludlow MK, 2009, J AM CHEM SOC, V131, P7094, DOI 10.1021/ja9001184; Marnett LJ, 2009, ANNU REV PHARMACOL, V49, P265, DOI 10.1146/annurev.pharmtox.011008.145638; McGinley CM, 2003, CHEM COMMUN, P2843, DOI 10.1039/b311008g; Mukherjee A, 2007, BIOCHEMISTRY-US, V46, P3975, DOI 10.1021/bi602502j; Mukherjee A, 2011, J AM CHEM SOC, V133, P227, DOI 10.1021/ja104180v; Peng S, 2003, J AM CHEM SOC, V125, P8988, DOI 10.1021/ja035977t; Poulos TL, 2014, CHEM REV, V114, P3919, DOI 10.1021/cr400415k; Rogge CE, 2006, BIOCHEMISTRY-US, V45, P523, DOI 10.1021/bi051235w; Rogge CE, 2004, BIOCHEMISTRY-US, V43, P1560, DOI 10.1021/bi035717o; Roth JP, 2003, P NATL ACAD SCI USA, V100, P62, DOI 10.1073/pnas.252644599; Roth JP, 2009, ACCOUNTS CHEM RES, V42, P399, DOI 10.1021/ar800169z; Rouzer CA, 2003, CHEM REV, V103, P2239, DOI 10.1021/cr000068x; Rouzer CA, 2011, CHEM REV, V111, P5899, DOI 10.1021/cr2002799; Schneider C, 2000, J BIOL CHEM, V275, P4743, DOI 10.1074/jbc.275.7.4743; Smirnov VV, 2014, J BIOL INORG CHEM, V19, P1137, DOI 10.1007/s00775-014-1169-7; Smith WL, 2011, CHEM REV, V111, P5821, DOI 10.1021/cr2002992; Smith WL, 2002, PROSTAG OTH LIPID M, V68-9, P115, DOI 10.1016/S0090-6980(02)00025-4; Tsai AL, 2010, ARCH BIOCHEM BIOPHYS, V493, P103, DOI 10.1016/j.abb.2009.08.019; Vecchio AJ, 2012, J BIOL CHEM, V287, P24619, DOI 10.1074/jbc.M112.372243; Vecchio AJ, 2010, J BIOL CHEM, V285, P22152, DOI 10.1074/jbc.M110.119867; Wilson JC, 2005, J AM CHEM SOC, V127, P1618, DOI 10.1021/ja043853q; Wu G, 2014, CATALYSTS, V4, P174, DOI 10.3390/catal4020174; Wu G, 2011, J INORG BIOCHEM, V105, P382, DOI 10.1016/j.jinorgbio.2010.11.015; Wu G, 2009, BIOCHEMISTRY-US, V48, P11902, DOI 10.1021/bi901600f	40	12	12	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					948	958		10.1074/jbc.M115.668038	http://dx.doi.org/10.1074/jbc.M115.668038			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26565028	hybrid, Green Published			2022-12-26	WOS:000367830500040
J	Harmancey, R; Haight, DL; Watts, KA; Taegtmeyer, H				Harmancey, Romain; Haight, Derek L.; Watts, Kayla A.; Taegtmeyer, Heinrich			Chronic Hyperinsulinemia Causes Selective Insulin Resistance and Down-regulates Uncoupling Protein 3 (UCP3) through the Activation of Sterol Regulatory Element-binding Protein (SREBP)-1 Transcription Factor in the Mouse Heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; SKELETAL-MUSCLE; GENE-EXPRESSION; DIABETES-MELLITUS; MYOCARDIAL-INFARCTION; ISCHEMIA-REPERFUSION; CARDIAC EFFICIENCY; RECEPTOR-ALPHA; SHORT-TERM; MITOCHONDRIAL	The risk for heart failure and death after myocardial infarction is abnormally high in diabetic subjects. We and others have shown previously that mitochondrial uncoupling protein 3 (UCP3) improves functional recovery of the rodent heart during reperfusion. Here, we demonstrate that pharmacological induction of hyperinsulinemia in mice down-regulates myocardial UCP3. Decreased UCP3 expression was linked to the development of selective insulin resistance in the heart, characterized by decreased basal activity of Akt but preserved activity of the p44/42 mitogen-activated protein kinase, and overactivation of the sterol regulatory element-binding protein (SREBP)-1-mediated lipogenic program. In cultured myocytes, insulin treatment and SREBP-1 overexpression decreased, whereas SREBP-1 interference increased, peroxisome proliferator-activated receptor-stimulated expression of UCP3. Promoter deletion and site-directed mutagenesis identified three functional sterol regulatory elements in the vicinity of a known complex intronic enhancer. Increased binding of SREBP-1 to this DNA region was confirmed in the heart of hyperinsulinemic mice. In conclusion, we describe a hitherto unknown regulatory mechanism by which insulin inhibits cardiac UCP3 expression through activation of the lipogenic factor SREBP-1. Sustained down-regulation of cardiac UCP3 by hyperinsulinemia may partly explain the poor prognosis of type 2 diabetic patients after myocardial infarction.	[Harmancey, Romain; Haight, Derek L.; Taegtmeyer, Heinrich] Univ Texas Hlth Sci Ctr Houston, Univ Texas Houston, Sch Med, Dept Internal Med,Div Cardiol, Houston, TX 77030 USA; [Watts, Kayla A.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Mississippi Ctr Obes Res, Jackson, MS 39216 USA; [Watts, Kayla A.] Univ Mississippi, Med Ctr, Cardiovasc Renal Res Ctr, Jackson, MS 39216 USA	University of Texas System; University of Texas Health Science Center Houston; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center	Harmancey, R (corresponding author), Univ Mississippi, Med Ctr, Dept Physiol & Biophys, 2500 N State St, Jackson, MS 39216 USA.	rharmancey@umc.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [K99/R00 HL112952, R01 HL061483, P01 HL051971, P20 GM104357, P30 DK-079638]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL112952, R01HL061483, R00HL112952, P01HL051971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104357] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants K99/R00 HL112952 (to R. H.), R01 HL061483 (to H. T.), and P01 HL051971 and P20 GM104357. The Mouse Metabolism Core at Baylor College of Medicine under the Diabetes Research Center is supported by National Institutes of Health Grant P30 DK-079638. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbasi F, 2002, J AM COLL CARDIOL, V40, P937, DOI 10.1016/S0735-1097(02)02051-X; Arikawa E, 2007, DIABETES, V56, P1410, DOI 10.2337/db06-0655; Azzu V, 2010, BBA-BIOENERGETICS, V1797, P785, DOI 10.1016/j.bbabio.2010.02.035; Battiprolu PK, 2012, J CLIN INVEST, V122, P1109, DOI 10.1172/JCI60329; Berti JA, 2003, J LIPID RES, V44, P1870, DOI 10.1194/jlr.M300036-JLR200; Boss O, 1997, FEBS LETT, V408, P39, DOI 10.1016/S0014-5793(97)00384-0; Boudina S, 2006, PHYSIOLOGY, V21, P250, DOI 10.1152/physiol.00008.2006; Boudina S, 2012, DIABETES, V61, P3260, DOI 10.2337/db12-0063; Brener SJ, 2012, AM J CARDIOL, V109, P1111, DOI 10.1016/j.amjcard.2011.11.046; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Bugge A, 2010, J BIOL CHEM, V285, P17310, DOI 10.1074/jbc.M110.120584; Bugger H, 2008, DIABETES, V57, P2924, DOI 10.2337/db08-0079; Bugger H, 2008, CLIN SCI, V114, P195, DOI 10.1042/CS20070166; Carson JL, 2002, J AM COLL CARDIOL, V40, P418, DOI 10.1016/S0735-1097(02)01969-1; Chakravarty K, 2004, J BIOL CHEM, V279, P15385, DOI 10.1074/jbc.M309905200; Chen YX, 2015, CARDIOVASC RES, V105, P192, DOI 10.1093/cvr/cvu256; Cole MA, 2011, BASIC RES CARDIOL, V106, P447, DOI 10.1007/s00395-011-0156-1; Cook SA, 2002, J BIOL CHEM, V277, P22528, DOI 10.1074/jbc.M201462200; Creager MA, 2003, CIRCULATION, V108, P1527, DOI 10.1161/01.CIR.0000091257.27563.32; Cusi K, 2000, J CLIN INVEST, V105, P311, DOI 10.1172/JCI7535; Dentin R, 2005, BIOCHIMIE, V87, P81, DOI 10.1016/j.biochi.2004.11.008; Despres JP, 1996, NEW ENGL J MED, V334, P952, DOI 10.1056/NEJM199604113341504; Duncan JG, 2007, CIRCULATION, V115, P909, DOI 10.1161/CIRCULATIONAHA.106.662296; Fleischmann M, 2000, BIOCHEM J, V349, P13, DOI 10.1042/bj3490013; Gargiulo S, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-98; Gerber LK, 2006, AM J PHYSIOL-CELL PH, V291, pC1198, DOI 10.1152/ajpcell.00246.2006; Girousse A, 2009, DIABETOLOGIA, V52, P1638, DOI 10.1007/s00125-009-1385-9; Goldberg IJ, 2012, CELL METAB, V15, P805, DOI 10.1016/j.cmet.2012.04.006; Guillet-Deniau I, 2002, DIABETES, V51, P1722, DOI 10.2337/diabetes.51.6.1722; Harmancey R, 2013, FASEB J, V27, P3966, DOI 10.1096/fj.13-234914; Harmancey R, 2010, J LIPID RES, V51, P1380, DOI 10.1194/jlr.M001230; Hidaka S, 1999, DIABETES, V48, P430, DOI 10.2337/diabetes.48.2.430; Hoffmann C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083426; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Huppertz C, 2001, J BIOL CHEM, V276, P12520, DOI 10.1074/jbc.M011708200; Jiang ZY, 1999, J CLIN INVEST, V104, P447, DOI 10.1172/JCI5971; KOBAYASHI M, 1978, AM J PHYSIOL, V235, pE53, DOI 10.1152/ajpendo.1978.235.1.E53; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Lecomte V, 2010, MOL CELL BIOL, V30, P1182, DOI 10.1128/MCB.00690-09; Li H, 2013, CARDIOVASC DIABETOL, V12, DOI [10.1186/1475-2840-12-133, 10.1186/1475-2840-12-91]; Lockridge JB, 2008, J LIPID RES, V49, P1395, DOI 10.1194/jlr.M700517-JLR200; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Luciani N, 2003, ANN THORAC SURG, V76, P1149, DOI 10.1016/S0003-4975(03)00838-5; MacLellan JD, 2005, DIABETES, V54, P2343, DOI 10.2337/diabetes.54.8.2343; Mahoney DJ, 2008, AM J PHYSIOL-REG I, V294, pR1901, DOI 10.1152/ajpregu.00847.2007; Marfella R, 2009, J LIPID RES, V50, P2314, DOI 10.1194/jlr.P900032-JLR200; McGavock JM, 2007, CIRCULATION, V116, P1170, DOI 10.1161/CIRCULATIONAHA.106.645614; Murray AJ, 2005, DIABETES, V54, P3496, DOI 10.2337/diabetes.54.12.3496; Murray AJ, 2008, J MOL CELL CARDIOL, V44, P694, DOI 10.1016/j.yjmcc.2008.01.008; Nabben M, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0447-4; Nadeau KJ, 2004, J BIOL CHEM, V279, P34380, DOI 10.1074/jbc.M403596200; Ozcan C, 2013, AM J PHYSIOL-HEART C, V304, pH1192, DOI 10.1152/ajpheart.00592.2012; PEREIRA JN, 1967, J LIPID RES, V8, P239; Perrino C, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000086; Rome S, 2008, PHYSIOL GENOMICS, V34, P327, DOI 10.1152/physiolgenomics.90211.2008; Safari F, 2014, LIFE SCI, V98, P68, DOI 10.1016/j.lfs.2013.12.230; Schrauwen P, 2001, DIABETES, V50, P2870, DOI 10.2337/diabetes.50.12.2870; Sewter C, 2002, DIABETES, V51, P1035, DOI 10.2337/diabetes.51.4.1035; Sharma S, 2004, FASEB J, V18, P1692, DOI 10.1096/fj.04-2263com; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Solanes G, 2003, MOL ENDOCRINOL, V17, P1944, DOI 10.1210/me.2002-0395; Son C, 2001, ENDOCRINOLOGY, V142, P4189, DOI 10.1210/en.142.10.4189; Stavinoha MA, 2004, AM J PHYSIOL-ENDOC M, V287, pE878, DOI 10.1152/ajpendo.00189.2004; Sussman MA, 2011, PHYSIOL REV, V91, P1023, DOI 10.1152/physrev.00024.2010; Szabo Z, 2002, ANN THORAC SURG, V74, P712, DOI 10.1016/S0003-4975(02)03778-5; Tabor DE, 1999, J BIOL CHEM, V274, P20603, DOI 10.1074/jbc.274.29.20603; Taegtmeyer H, 2002, CIRCULATION, V105, P1727, DOI 10.1161/01.CIR.0000012466.50373.E8; TONTONOZ P, 1993, MOL CELL BIOL, V13, P4753, DOI 10.1128/MCB.13.8.4753; Utz W, 2011, HEART, V97, P1585, DOI 10.1136/hrt.2011.224451; VidalPuig A, 1997, BIOCHEM BIOPH RES CO, V235, P79, DOI 10.1006/bbrc.1997.6740; Wang CM, 2011, STRESS, V14, P66, DOI 10.3109/10253890.2010.506931; Woodfield SL, 1996, J AM COLL CARDIOL, V28, P1661, DOI 10.1016/S0735-1097(96)00397-X; Yadav HN, 2010, MOL CELL BIOCHEM, V343, P75, DOI 10.1007/s11010-010-0500-z; Yamamoto T, 2004, J BIOL CHEM, V279, P12027, DOI 10.1074/jbc.M310333200; Young ME, 2001, FASEB J, V15, P833, DOI 10.1096/fj.00-0351com	75	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30947	30961		10.1074/jbc.M115.673988	http://dx.doi.org/10.1074/jbc.M115.673988			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26555260	hybrid, Green Published			2022-12-26	WOS:000367199000026
J	Karlsson, J; Morgillo, CM; Deplano, A; Smaldone, G; Pedone, E; Luque, FJ; Svensson, M; Novellino, E; Congiu, C; Onnis, V; Catalanotti, B; Fowler, CJ				Karlsson, Jessica; Morgillo, Carmine M.; Deplano, Alessandro; Smaldone, Giovanni; Pedone, Emilia; Javier Luque, F.; Svensson, Mona; Novellino, Ettore; Congiu, Cenzo; Onnis, Valentina; Catalanotti, Bruno; Fowler, Christopher J.			Interaction of the N-(3-Methylpyridin-2-yl) amide Derivatives of Flurbiprofen and Ibuprofen with FAAH: Enantiomeric Selectivity and Binding Mode	PLOS ONE			English	Article							ACTIVE-SITE; ANANDAMIDE HYDROLYSIS; HYDROLASE INHIBITORS; ENZYME; CYCLOOXYGENASE; DESIGN	Background Combined fatty acid amide hydrolase (FAAH) and cyclooxygenase (COX) inhibition is a promising approach for pain-relief. The Flu-AM1 and Ibu-AM5 derivatives of flurbiprofen and ibuprofen retain similar COX-inhibitory properties and are more potent inhibitors of FAAH than the parent compounds. However, little is known as to the nature of their interaction with FAAH, or to the importance of their chirality. This has been explored here. Methodology/Principal Findings FAAH inhibitory activity was measured in rat brain homogenates and in lysates expressing either wild-type or FAAH(T488A)-mutated enzyme. Molecular modelling was undertaken using both docking and molecular dynamics. The (R)-and (S)-enantiomers of Flu-AM1 inhibited rat FAAH with similar potencies (IC50 values of 0.74 and 0.99 mu M, respectively), whereas the (S)-enantiomer of Ibu-AM5 (IC50 0.59 mu M) was more potent than the (R)-enantiomer (IC50 5.7 mu M). Multiple inhibition experiments indicated that both (R)-Flu-AM1 and (S)-Ibu-AM5 inhibited FAAH in a manner mutually exclusive to carprofen. Computational studies indicated that the binding site for the Flu-AM1 and Ibu-AM5 enantiomers was located between the acyl chain binding channel and the membrane access channel, in a site overlapping the carprofen binding site, and showed a binding mode in line with that proposed for carprofen and other non-covalent ligands. The potency of (R)-Flu-AM1 was lower towards lysates expressing FAAH mutated at the proposed carprofen binding area than in lysates expressing wild-type FAAH. Conclusions/Significance The study provides kinetic and structural evidence that the enantiomers of Flu-AM1 and Ibu-AM5 bind in the substrate channel of FAAH. This information will be useful in aiding the design of novel dual-action FAAH: COX inhibitors.	[Karlsson, Jessica; Svensson, Mona; Fowler, Christopher J.] Umea Univ, Pharmacol Unit, Dept Pharmacol & Clin Neurosci, Umea, Sweden; [Morgillo, Carmine M.; Novellino, Ettore; Catalanotti, Bruno] Univ Naples Federico II, Dept Pharm, Naples, Italy; [Deplano, Alessandro; Congiu, Cenzo; Onnis, Valentina] Univ Cagliari, Dept Life & Environm Sci, Unit Pharmaceut Pharmacol & Nutraceut Sci, I-09124 Cagliari, Italy; [Smaldone, Giovanni; Pedone, Emilia] CNR, Inst Biostruct & Bioimaging, I-80125 Naples, Italy; [Javier Luque, F.] Univ Barcelona, Fac Farm, Dept Quim Fis, Santa Coloma De Gramenet, Spain; [Javier Luque, F.] Univ Barcelona, Fac Farm, Inst Biomed IBUB, Santa Coloma De Gramenet, Spain	Umea University; University of Naples Federico II; University of Cagliari; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Barcelona; University of Barcelona	Fowler, CJ (corresponding author), Umea Univ, Pharmacol Unit, Dept Pharmacol & Clin Neurosci, Umea, Sweden.	cf@pharm.umu.se	Luque, F. Javier/L-9652-2014; Fowler, Christopher J./M-6313-2019; Catalanotti, Bruno/D-4025-2016; Smaldone, Giovanni/K-8782-2016; Smaldone, Giovanni/AAA-8034-2020; Onnis, Valentina/B-1649-2008; Pedone, Emilia/HDN-2342-2022; Deplano, Alessandro/T-8589-2018	Luque, F. Javier/0000-0002-8049-3567; Fowler, Christopher J./0000-0002-6658-7874; Catalanotti, Bruno/0000-0002-7532-6959; Smaldone, Giovanni/0000-0002-1989-4740; Onnis, Valentina/0000-0002-2438-725X; Pedone, Emilia/0000-0003-0203-8611; Deplano, Alessandro/0000-0002-8451-5831; Karlsson, Jessica/0000-0001-8572-5841; Morgillo, Carmine Marco/0000-0002-6164-7647; Novellino, Ettore/0000-0002-2181-2142	Swedish Research Council [12158]; Medical Faculty, Umea University; Italian Ministero Dell'Istruzione, Universita e della Ricerca [20105YY2HL_002]; Regione Autonoma della Sardegna [L.R. 7/2007, 2012_CRP-59473]; Regione Campania under POR Campania FESR [O.O. 2.1]; Generalitat de Catalunya [2014SGR1189]; ICREA Academia; Consorci de Serveis Universitaris de Catalunya; CINECA (ISCRA C projects) [HP10C4VWRB, HP10CMKHGX]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Medical Faculty, Umea University; Italian Ministero Dell'Istruzione, Universita e della Ricerca; Regione Autonoma della Sardegna(Regione Sardegna); Regione Campania under POR Campania FESR(Regione Campania); Generalitat de Catalunya(Generalitat de Catalunya); ICREA Academia(ICREA); Consorci de Serveis Universitaris de Catalunya; CINECA (ISCRA C projects)(CINECA, Italy)	This work was supported by grants from the Swedish Research Council (Grant no. 12158, medicine) and the Research Funds of the Medical Faculty, Umea University to CJF; the Italian Ministero Dell'Istruzione, Universita e della Ricerca (PRIN 2010-2011, Prot. no. 20105YY2HL_002) and the Regione Autonoma della Sardegna (Project L.R. 7/2007, no. 2012_CRP-59473) to VO and CC; Regione Campania under POR Campania FESR 2007-2013 -O.O. 2.1 (FarmaBioNet) to BC; and the Generalitat de Catalunya (2014SGR1189), ICREA Academia, and Consorci de Serveis Universitaris de Catalunya to FJL. CMM and BC acknowledge the CINECA (ISCRA C projects ID HP10C4VWRB and HP10CMKHGX) for the access to high performance computing resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JP, 2005, CHEM BIOL, V12, P1179, DOI 10.1016/j.chembiol.2005.08.011; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Bertolacci L, 2013, J AM CHEM SOC, V135, P22, DOI 10.1021/ja308733u; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Blat Y, 2010, CHEM BIOL DRUG DES, V75, P535, DOI 10.1111/j.1747-0285.2010.00972.x; Boldrup L, 2004, J BIOCHEM BIOPH METH, V60, P171, DOI 10.1016/j.jbbm.2004.04.020; Bracey MH, 2002, SCIENCE, V298, P1793, DOI 10.1126/science.1076535; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Case DA, 2012, AMBER 12; Cipriano M, 2013, EUR J PHARMACOL, V720, P383, DOI 10.1016/j.ejphar.2013.09.065; Cocco MT, 2003, EUR J MED CHEM, V38, P513, DOI 10.1016/S0223-5234(03)00074-6; De Wael F, 2010, EUR J MED CHEM, V45, P3564, DOI 10.1016/j.ejmech.2010.04.040; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; EISENTHAL R, 1974, BIOCHEM J, V139, P715, DOI 10.1042/bj1390715; Estiarte MA, 2012, MEDCHEMCOMM, V3, P611, DOI 10.1039/c2md00307d; Favia AD, 2012, J MED CHEM, V55, P8807, DOI 10.1021/jm3011146; Fowler CJ, 2009, BRIT J PHARMACOL, V156, P412, DOI 10.1111/j.1476-5381.2008.00029.x; Fowler CJ, 2013, J ENZYM INHIB MED CH, V28, P172, DOI 10.3109/14756366.2011.643304; Fowler CJ, 1999, ARCH BIOCHEM BIOPHYS, V362, P191, DOI 10.1006/abbi.1998.1025; Fowler CJ, 1997, J PHARMACOL EXP THER, V283, P729; Frisch G. W., 2013, GAUSSIAN 09; Gouveia-Figueira S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139212; Gustin DJ, 2011, BIOORG MED CHEM LETT, V21, P2492, DOI 10.1016/j.bmcl.2011.02.052; Hart T, 2009, BIOORG MED CHEM LETT, V19, P4241, DOI 10.1016/j.bmcl.2009.05.097; Holt S, 2007, EUR J PHARMACOL, V565, P26, DOI 10.1016/j.ejphar.2007.02.051; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; McKinney MK, 2003, J BIOL CHEM, V278, P37393, DOI 10.1074/jbc.M303922200; Mei G, 2007, J BIOL CHEM, V282, P3829, DOI 10.1074/jbc.M605653200; Mileni M, 2008, P NATL ACAD SCI USA, V105, P12820, DOI 10.1073/pnas.0806121105; Mor M, 2004, J MED CHEM, V47, P4998, DOI 10.1021/jm031140x; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Motulsky HJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-123; Myllymaki MJ, 2009, EUR J MED CHEM, V44, P4179, DOI 10.1016/j.ejmech.2009.05.012; Naidu PS, 2009, J PHARMACOL EXP THER, V329, P48, DOI 10.1124/jpet.108.143487; Otrubova K, 2013, J AM CHEM SOC, V135, P6289, DOI 10.1021/ja4014997; Palermo G, 2015, EUR J MED CHEM, V91, P15, DOI 10.1016/j.ejmech.2014.09.037; Palermo G, 2015, J PHYS CHEM B, V119, P789, DOI 10.1021/jp5052276; Paria BC, 1996, MOL REPROD DEV, V45, P183, DOI 10.1002/(SICI)1098-2795(199610)45:2&lt;183::AID-MRD11&gt;3.0.CO;2-2; Patel JZ, 2013, J MED CHEM, V56, P8484, DOI 10.1021/jm400923s; ROME LH, 1975, P NATL ACAD SCI USA, V72, P4863, DOI 10.1073/pnas.72.12.4863; Sasso O, 2015, FASEB J, V29, P2616, DOI 10.1096/fj.15-270637; Segel IH, 1975, ENZYME KINETICS BEHA; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035	43	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142711	10.1371/journal.pone.0142711	http://dx.doi.org/10.1371/journal.pone.0142711			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26565710	Green Published, gold, Green Submitted			2022-12-26	WOS:000367628500049
J	Pyatnitskiy, M; Karpov, D; Poverennaya, E; Lisitsa, A; Moshkovskii, S				Pyatnitskiy, Mikhail; Karpov, Dmitriy; Poverennaya, Ekaterina; Lisitsa, Andrey; Moshkovskii, Sergei			Bringing Down Cancer Aircraft: Searching for Essential Hypomutated Proteins in Skin Melanoma	PLOS ONE			English	Article							EMERGING ROLE; CELLS; CCR5; MUTATIONS; RECEPTORS; SEMAPHORINS; PROGRESSION; METASTASIS; LANDSCAPE; DISCOVERY	We propose an approach to detection of essential genes/ proteins required for cancer cell survival. A gene is considered essential if a mutation with high impact upon the function of encoded protein causes death of the cancer cell. We draw an analogy between essential cancer proteins and well-known Abraham Wald's work on estimating the plane critical areas using data on survivability of aircraft encountering enemy fire. Wald reasoned that parts with no bullet holes on the airplanes returned to the airbase from a combat flight are the most crucial ones for the airplane functioning: a hit in one of these parts downs an airplane, so it does not return back for the survey. We have envisaged that the airplane surface is a cancer genome and the bullets are somatic mutations with high impact upon protein function. Similarly we propose that genes specifically essential for tumor cell survival should carry less high-impact mutations in cancer cells compared to polymorphisms found in normal cells. We used data on mutations from the Cancer Genome Atlas and polymorphisms found in healthy humans ( from 1000 Genomes Project) to predict 91 protein-coding genes essential for melanoma. These genes were selected according to several criteria, including negative selection, expression in melanocytes and decrease in the proportion of high-impact mutations in cancer compared with normal cells. The Gene Ontology analysis revealed enrichment of essential proteins related to membrane and cell periphery. We speculate that this could be a sign of immune system-driven negative selection of cancer neo-antigens. Another finding is the overrepresentation of semaphorin receptors, which can mediate distinctive signaling cascades and are involved in various aspects of tumor development. Cytokine receptors CCR5 and CXCR1 were also identified as cancer essential proteins and this is confirmed by other studies. Overall, our goal was to illustrate the idea of detecting proteins whose sequence integrity and functioning is important for cancer cell survival. Hopefully, this prediction of essential cancer proteins may point to new targets for anti-tumor therapies.	[Pyatnitskiy, Mikhail; Karpov, Dmitriy; Poverennaya, Ekaterina; Lisitsa, Andrey; Moshkovskii, Sergei] Inst Biomed Chem, Moscow 119121, Russia; [Pyatnitskiy, Mikhail] ZAO Personal Biomed, Moscow 129164, Russia; [Pyatnitskiy, Mikhail; Moshkovskii, Sergei] Pirogov Russian Natl Res Med Univ, Moscow 117997, Russia; [Karpov, Dmitriy] Engelhardt Inst Mol Biol, Moscow 119991, Russia	Russian Academy of Medical Sciences; Institute of Biomedical Chemistry; Pirogov Russian National Research Medical University; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS	Pyatnitskiy, M (corresponding author), Inst Biomed Chem, Pogodinskaya Str 10, Moscow 119121, Russia.	mpyat@bioinformatics.ru	Poverennaya, Ekaterina/L-7517-2016; Moshkovskii, Sergei/F-2777-2017; Dmitry, Karpov S/E-6305-2014; Лисица, Андрей/ABD-2934-2020; Pyatnitskiy, Mikhail/F-1588-2017	Poverennaya, Ekaterina/0000-0003-1838-3604; Moshkovskii, Sergei/0000-0003-1697-9201; Dmitry, Karpov S/0000-0001-5203-0787; Pyatnitskiy, Mikhail/0000-0002-4803-8150	Russian Scientific Fund [14-15-00395]	Russian Scientific Fund(Russian Science Foundation (RSF))	The work was supported by the Russian Scientific Fund, grant # 14-15-00395, to SM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas W, 2014, BBA-BIOMEMBRANES, V1838, P1132, DOI 10.1016/j.bbamem.2013.06.020; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bielas JH, 2006, P NATL ACAD SCI USA, V103, P18238, DOI 10.1073/pnas.0607057103; Cagnoni G, 2014, ONCOGENE, V33, P4795, DOI 10.1038/onc.2013.474; ClinicalTrials.gov, 2014, SERV US NAT I HLTH; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Fritsch EF, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.29311; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gangadhar TC, 2013, INVEST NEW DRUG, V31, P769, DOI 10.1007/s10637-012-9897-4; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jourquin J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S20; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kim R, 2007, IMMUNOLOGY, V121, P1, DOI 10.1111/j.1365-2567.2007.02587.x; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Linnemann C, 2015, NAT MED, V21, P81, DOI 10.1038/nm.3773; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; McDougall I, 2005, NATURE, V433, P733, DOI 10.1038/nature03258; McFarland CD, 2013, P NATL ACAD SCI USA, V110, P2910, DOI 10.1073/pnas.1213968110; Mendez R, 2009, CANCER IMMUNOL IMMUN, V58, P1507, DOI 10.1007/s00262-009-0701-z; Nasarre P, 2014, ONCOTARGETS THER, V7, P1663, DOI 10.2147/OTT.S37744; Nasser MW, 2005, J IMMUNOL, V174, P6927, DOI 10.4049/jimmunol.174.11.6927; Ostrow SL, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004239; Polak P, 2014, NAT BIOTECHNOL, V32, P71, DOI 10.1038/nbt.2778; Quast SA, 2014, EUR J CELL BIOL, V93, P42, DOI 10.1016/j.ejcb.2013.11.003; Rossi M, 2014, BRIT J DERMATOL, V171, P403, DOI 10.1111/bjd.12801; Saito YD, 2010, CANCER-AM CANCER SOC, V116, P1629, DOI 10.1002/cncr.24879; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shostak K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6232; Sicoli D, 2014, CANCER RES, V74, P7103, DOI 10.1158/0008-5472.CAN-14-0612; Singh S, 2010, FUTURE ONCOL, V6, P111, DOI 10.2217/FON.09.128; Song JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033747; Tamagnone L, 2012, CANCER CELL, V22, P145, DOI 10.1016/j.ccr.2012.06.031; Tang Q, 2015, INFLAMMATION, V38, P2049, DOI 10.1007/s10753-015-0186-1; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Uen WC, 2015, MELANOMA RES, V25, P35, DOI 10.1097/CMR.0000000000000134; Varshavsky A, 2007, P NATL ACAD SCI USA, V104, P14935, DOI 10.1073/pnas.0706546104; Velasco-Velazquez M, 2012, CANCER RES, V72, P3839, DOI 10.1158/0008-5472.CAN-11-3917; Vivanco BC, 2014, IMMUNOBIOLOGY, V219, P845, DOI 10.1016/j.imbio.2014.07.013; Wald A, 1980, CRC432 OP EV GROUP C; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Weitzenfeld P, 2014, CANCER LETT, V352, P36, DOI 10.1016/j.canlet.2013.10.006; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yeang CH, 2008, FASEB J, V22, P2605, DOI 10.1096/fj.08-108985; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhu L, 2015, ONCOGENE, V34, P4547, DOI 10.1038/onc.2014.399	52	9	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142819	10.1371/journal.pone.0142819	http://dx.doi.org/10.1371/journal.pone.0142819			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26565620	gold, Green Submitted, Green Published			2022-12-26	WOS:000367628500057
J	Bennett, BW; Marshall, BDL; Gjelsvik, A; McGarvey, ST; Lurie, MN				Bennett, Brady W.; Marshall, Brandon D. L.; Gjelsvik, Annie; McGarvey, Stephen T.; Lurie, Mark N.			HIV Incidence Prior to, during, and after Violent Conflict in 36 Sub-Saharan African Nations, 1990-2012: An Ecological Study	PLOS ONE			English	Article							SEXUAL VIOLENCE; HIV/AIDS; WAR; PREVALENCE; PREVENTION; SETTINGS; SPREAD; PEOPLE; IMPACT	Objectives The aim of this study was to determine the association between violent conflict and HIV incidence within and across 36 sub-Saharan Africa countries between 1990 and 2012. Methods We used generalized linear mixed effect modeling to estimate the effect of conflict periods on country-level HIV incidence. We specified random intercepts and slopes to account for across and within country variation over time. We also conducted a sub-analysis of countries who experienced conflict to assess the effect of conflict intensity on country-level HIV incidence. All models controlled for level of economic development, number of refugees present in the country, and year. Results We found that, compared to times of peace, the HIV incidence rate increased by 2.1 per 1000 infections per year (95% CI: 0.39, 3.87) in the 5 years prior to conflict. Additionally, we found a decrease of 0.7 new infections per 1000 people per year (95% CI: -1.44, -0.01) in conflicts with 25 to 1000 battle-related deaths and a decrease of 1.5 new infections per 1000 people per year (95% CI:-2.50, -0.52) for conflict with more than 1000 battle-related deaths, compared to conflicts with less than 25 battle-related deaths Conclusions Our results demonstrate that HIV infection rates increase in the years immediately prior to times of conflict; however, we did not identify a significant increase during and immediately following periods of violent conflict. Further investigation, including more rigorous data collection, is needed, as is increased aid to nations at risk of violent conflict to help in the fight against HIV/AIDS in sub-Saharan Africa.	[Bennett, Brady W.; Marshall, Brandon D. L.; Gjelsvik, Annie; McGarvey, Stephen T.; Lurie, Mark N.] Brown Univ, Sch Publ Hlth, Dept Epidemiol, Providence, RI 02912 USA	Brown University	Bennett, BW (corresponding author), Brown Univ, Sch Publ Hlth, Dept Epidemiol, Providence, RI 02912 USA.	brady_bennett@alumni.brown.edu	Gjelsvik, Annie/I-1011-2014	Gjelsvik, Annie/0000-0002-5632-6435				Amowitz LL, 2002, JAMA-J AM MED ASSOC, V287, P513, DOI 10.1001/jama.287.4.513; Becker Joseph U, 2008, J Int AIDS Soc, V11, P3, DOI 10.1186/1758-2652-11-3; Brown T, 2008, SEX TRANSM INFECT, V84, pI5, DOI 10.1136/sti.2008.030437; Elbe S, 2002, INT SECURITY, V27, P159, DOI 10.1162/016228802760987851; Flechner D, 2005, INT SOC SCI J, V57, P627, DOI 10.1111/j.1468-2451.2005.00580.x; Ghobarah HA, 2004, INT STUD QUART, V48, P73, DOI 10.1111/j.0020-8833.2004.00292.x; Gisselquist David, 2004, SAHARA J, V1, P114; Gleditsch NP, 2014, ARMED CONFLICT DATAS; Hankins CA, 2002, AIDS, V16, P2245, DOI 10.1097/00002030-200211220-00003; Hanson BW, 2008, AIDS, V22, pS95, DOI 10.1097/01.aids.0000327441.66656.da; Iqbal Z, 2010, J POLIT, V72, P149, DOI 10.1017/S0022381609990533; Khaw AJ, 2000, DISASTERS, V24, P181, DOI 10.1111/1467-7717.00141; Mendelsohn JB, 2012, CONFLICT HLTH, V6; Mills EJ, 2006, INT J STD AIDS, V17, P713, DOI 10.1258/095646206778691077; Mock Nancy B, 2004, Emerg Themes Epidemiol, V1, P6, DOI 10.1186/1742-7622-1-6; Nunn AS, 2009, HEALTH AFFAIR, V28, P1103, DOI 10.1377/hlthaff.28.4.1103; Piot P, 2000, COMMUNICATION   0110, P1; Schabenger O., INTRO GLIMMIX PROCED; Spiegel PB, 2007, LANCET, V369, P2187, DOI 10.1016/S0140-6736(07)61015-0; Spiegel PB, 2004, DISASTERS, V28, P322, DOI 10.1111/j.0361-3666.2004.00261.x; Strand RT, 2007, INT J STD AIDS, V18, P467, DOI 10.1258/095646207781147300; Strategic Information and Monitoring Division, 2013, METH UND HIV EST; Supervie V, 2010, AIDS, V24, P2841, DOI 10.1097/QAD.0b013e32833fed78; The United Nations Security Council, 2008, RES WOM PEAC SEC; Themner L, 2014, J PEACE RES, V51, P541, DOI 10.1177/0022343314542076; UNAIDS, 2004, AIDS CONFL GROW PROB; UNAIDS, 2014, AIDSINFO ONL DAT; United Nations High Commissioner for Refugees, UNHCR STAT ONL POP D; Uppsala Conflict Data Program, 2014, UCDP BATTL REL DEATH; Vreeman RC, 2009, CONFLICT HLTH, V3; WHO, 2014, HIV AIDS DAT STAT; World Bank, 2014, GNI PER CAP ATL METH	33	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142343	10.1371/journal.pone.0142343	http://dx.doi.org/10.1371/journal.pone.0142343			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7UL	26562434	Green Submitted, Green Published, gold			2022-12-26	WOS:000364480900026
J	Pandini, A; Kleinjung, J; Rasool, S; Khan, S				Pandini, Alessandro; Kleinjung, Jens; Rasool, Shafqat; Khan, Shahid			Coevolved Mutations Reveal Distinct Architectures for Two Core Proteins in the Bacterial Flagellar Motor	PLOS ONE			English	Article							INVERSE COVARIANCE ESTIMATION; C-TERMINAL DOMAIN; RHODOBACTER-SPHAEROIDES; MOLECULAR-MECHANISM; SIGNALING PROTEINS; TORQUE RING; FLIG; SEQUENCE; SWITCH; ROTOR	Switching of bacterial flagellar rotation is caused by large domain movements of the FliG protein triggered by binding of the signal protein CheY to FliM. FliG and FliM form adjacent multi-subunit arrays within the basal body C-ring. The movements alter the interaction of the FliG C-terminal (FliG(C)) "torque" helix with the stator complexes. Atomic models based on the Salmonella entrovar C-ring electron microscopy reconstruction have implications for switching, but lack consensus on the relative locations of the FliG armadillo (ARM) domains (amino-terminal (FliG(N)), middle (FliG(M)) and FliG(C)) as well as changes during chemotaxis. The generality of the Salmonella model is challenged by the variation in motor morphology and response between species. We studied coevolved residue mutations to determine the unifying elements of switch architecture. Residue interactions, measured by their coevolution, were formalized as a network, guided by structural data. Our measurements reveal a common design with dedicated switch and motor modules. The FliM middle domain (FliM(M)) has extensive connectivity most simply explained by conserved intra and inter-subunit contacts. In contrast, FliG has patchy, complex architecture. Conserved structural motifs form interacting nodes in the coevolution network that wire FliM(M) to the FliG(C) C-terminal, fourhelix motor module (C3-6). FliG C3-6 coevolution is organized around the torque helix, differently from other ARM domains. The nodes form separated, surface-proximal patches that are targeted by deleterious mutations as in other allosteric systems. The dominant node is formed by the EHPQ motif at the FliM(M)FliG(M) contact interface and adjacent helix residues at a central location within FliG(M). The node interacts with nodes in the N-terminal FliG(c) alpha-helix triad (ARM-C) and FliG(N). ARM-C, separated from C3-6 by the MFVF motif, has poor intra-network connectivity consistent with its variable orientation revealed by structural data. ARM-C could be the convertor element that provides mechanistic and species diversity.	[Pandini, Alessandro] Brunel Univ London, Dept Comp Sci & Synthet Biol Theme, Uxbridge UB8 3PH, Middx, England; [Kleinjung, Jens] Francis Crick Inst, Math Biol, London NW7 1AA, England; [Rasool, Shafqat] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Khan, Shahid] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Biol Consortium, Berkeley, CA 94720 USA	Brunel University; Francis Crick Institute; McGill University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Khan, S (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Biol Consortium, Berkeley, CA 94720 USA.	khan@mbc-als.org	Pandini, Alessandro/F-9854-2012; Pandini, Alessandro/P-5200-2019	Pandini, Alessandro/0000-0002-4158-233X; Pandini, Alessandro/0000-0002-4158-233X; Khan, Shahid/0000-0002-0361-6068; Kleinjung, Jens/0000-0002-7875-5724	Medical Research Council [U117581331]; Lahore University of Managment Sciences (LUMS); Molecular Biology Consortium; LUMS	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lahore University of Managment Sciences (LUMS); Molecular Biology Consortium; LUMS	JK was supported by Medical Research Council grant U117581331. SK was supported by seed funds from Lahore University of Managment Sciences (LUMS) and the Molecular Biology Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr Willie R. Taylor suggested the use of PSICOV. Drs David Blair and Michael Sadowski commented on the manuscript. The study was started as a senior undergraduate thesis project of Anam Ejaz (LUMS School of Science and Engineering. Pakistan). LUMS undergraduate Annum Munir assisted with the phylogenetic tree analysis. JK was supported by Medical Research Council grant U117581331. SK was supported by seed funds from LUMS and the Molecular Biology Consortium.	Armitage JP, 1997, MICROBIOL-UK, V143, P3671, DOI 10.1099/00221287-143-12-3671; Armitage JR, 2003, MOL MICROBIOL, V47, P583, DOI 10.1046/j.1365-2958.2003.03324.x; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Ashkenazy H, 2010, PROTEIN ENG DES SEL, V23, P321, DOI 10.1093/protein/gzp078; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; BISCHOFF DS, 1992, MOL MICROBIOL, V6, P2715, DOI 10.1111/j.1365-2958.1992.tb01448.x; Branch RW, 2014, J MOL BIOL, V426, P3314, DOI 10.1016/j.jmb.2014.07.009; Brown PN, 2007, J BACTERIOL, V189, P305, DOI 10.1128/JB.01281-06; Brown PN, 2002, EMBO J, V21, P3225, DOI 10.1093/emboj/cdf332; Cavallo L, 2003, NUCLEIC ACIDS RES, V31, P3364, DOI 10.1093/nar/gkg601; Chen SY, 2011, EMBO J, V30, P2972, DOI 10.1038/emboj.2011.186; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; de Juan D, 2013, NAT REV GENET, V14, P249, DOI 10.1038/nrg3414; Delalez NJ, 2010, P NATL ACAD SCI USA, V107, P11347, DOI 10.1073/pnas.1000284107; Duke TAJ, 2001, J MOL BIOL, V308, P541, DOI 10.1006/jmbi.2001.4610; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Dyer CM, 2009, J MOL BIOL, V388, P71, DOI 10.1016/j.jmb.2009.02.004; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Guzman DL, 2010, P NATL ACAD SCI USA, V107, P1989, DOI 10.1073/pnas.0905796107; IRIKURA VM, 1993, J BACTERIOL, V175, P802, DOI 10.1128/JB.175.3.802-810.1993; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Lam KH, 2013, MOL MICROBIOL, V88, P798, DOI 10.1111/mmi.12222; Lam KH, 2012, STRUCTURE, V20, P315, DOI 10.1016/j.str.2011.11.020; Lee LK, 2010, NATURE, V466, P996, DOI 10.1038/nature09300; Livesay DR, 2012, METHODS MOL BIOL, V796, P385, DOI 10.1007/978-1-61779-334-9_21; Lloyd SA, 1999, NATURE, V400, P472, DOI 10.1038/22794; Lowder BJ, 2005, J BACTERIOL, V187, P5640, DOI 10.1128/JB.187.16.5640-5647.2005; Lowenthal AC, 2009, J BACTERIOL, V191, P7147, DOI 10.1128/JB.00749-09; Ma Q, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002523; Minamino T, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000616; Pandini A, 2015, BIOPHYS J, V109, P975, DOI 10.1016/j.bpj.2015.07.005; Pandini A, 2013, BIOINFORMATICS, V29, P2053, DOI 10.1093/bioinformatics/btt326; Park SY, 2006, P NATL ACAD SCI USA, V103, P11886, DOI 10.1073/pnas.0602811103; Park SY, 2004, P NATL ACAD SCI USA, V101, P11646, DOI 10.1073/pnas.0401038101; Parkinson JS, 2015, TRENDS MICROBIOL, V23, P257, DOI 10.1016/j.tim.2015.03.003; Paul K, 2011, P NATL ACAD SCI USA, V108, P17171, DOI 10.1073/pnas.1110111108; Paul K, 2011, EMBO J, V30, P2962, DOI 10.1038/emboj.2011.188; Paul K, 2010, MOL CELL, V38, P128, DOI 10.1016/j.molcel.2010.03.001; Pazos F, 2001, PROTEIN ENG, V14, P609, DOI 10.1093/protein/14.9.609; Pazos F, 2008, METHODS MOL BIOL, V484, P523, DOI 10.1007/978-1-59745-398-1_31; Pilizota T, 2009, P NATL ACAD SCI USA, V106, P11582, DOI 10.1073/pnas.0813164106; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Reynolds KA, 2011, CELL, V147, P1564, DOI 10.1016/j.cell.2011.10.049; Rosenberg NA, 2003, EVOLUTION, V57, P1465, DOI 10.1554/03-012; Ruhnau B, 2000, SOC NETWORKS, V22, P357, DOI 10.1016/S0378-8733(00)00031-9; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Sarkar MK, 2010, P NATL ACAD SCI USA, V107, P9370, DOI 10.1073/pnas.1000935107; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; SOCKETT H, 1992, J BACTERIOL, V174, P793, DOI 10.1128/jb.174.3.793-806.1992; Stock D, 2012, CURR OPIN BIOTECH, V23, P545, DOI 10.1016/j.copbio.2012.01.008; Szurmant L, 2004, MICROBIOL MOL BIOL R, V68, P301, DOI 10.1128/MMBR.68.2.301-319.2004; Taylor WR, 2013, CURR OPIN STRUC BIOL, V23, P473, DOI 10.1016/j.sbi.2013.04.001; Taylor WR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028265; Thomas DR, 2006, J BACTERIOL, V188, P7039, DOI 10.1128/JB.00552-06; Thomas DR, 1999, P NATL ACAD SCI USA, V96, P10134, DOI 10.1073/pnas.96.18.10134; Tsai CJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003394; Tu Y, 2008, P NATL ACAD SCI USA, V105, P11737, DOI 10.1073/pnas.0804641105; Van Way SM, 2004, J BACTERIOL, V186, P3173, DOI 10.1128/JB.186.10.3173-3181.2004; Vartanian AS, 2012, J BIOL CHEM, V287, P35779, DOI 10.1074/jbc.C112.378380; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yuan JH, 2013, J MOL BIOL, V425, P1760, DOI 10.1016/j.jmb.2013.02.016; Zhao XW, 2014, BIOCHEMISTRY-US, V53, P4323, DOI 10.1021/bi500059y	67	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142407	10.1371/journal.pone.0142407	http://dx.doi.org/10.1371/journal.pone.0142407			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26561852	gold, Green Published, Green Submitted			2022-12-26	WOS:000364480900031
J	Lubinga, SJ; Atukunda, EC; Wasswa-Ssalongo, G; Babigumira, JB				Lubinga, Solomon J.; Atukunda, Esther C.; Wasswa-Ssalongo, George; Babigumira, Joseph B.			Potential Cost-Effectiveness of Prenatal Distribution of Misoprostol for Prevention of Postpartum Hemorrhage in Uganda	PLOS ONE			English	Article							MATERNAL MORTALITY; ORAL MISOPROSTOL; UTERINE RUPTURE; SYSTEMATIC ANALYSIS; CONTROLLED-TRIAL; GLOBAL BURDEN; HOME BIRTHS; HEALTH; LABOR; INDUCTION	Background In settings where home birth rates are high, prenatal distribution of misoprostol has been advocated as a strategy to increase access to uterotonics during the third stage of labor to prevent postpartum hemorrhage (PPH). Our objective was to project the potential costeffectiveness of this strategy in Uganda from both governmental (the relevant payer) and modified societal perspectives. Methods and Findings To compare prenatal misoprostol distribution to status quo (no misoprostol distribution), we developed a decision analytic model that tracked the delivery pathways of a cohort of pregnant women from the prenatal period, labor to delivery without complications or delivery with PPH, and successful treatment or death. Delivery pathway parameters were derived from the Uganda Demographic and Health Survey. Incidence of PPH, treatment efficacy, adverse event and case fatality rates, access to misoprostol, and health resource use and cost data were obtained from published literature and supplemented with expert opinion where necessary. We computed the expected incidence of PPH, mortality, disability adjusted life years (DALYs), costs and incremental cost effectiveness ratios (ICERs). We conducted univariate and probabilistic sensitivity analyses to examine robustness of our results. In the base-case analysis, misoprostol distribution lowered the expected incidence of PPH by 1.0% (95% credibility interval (CrI): 0.55%, 1.95%), mortality by 0.08% (95% CrI: 0.04%, 0.13%) and DALYs by 0.02 (95% CrI: 0.01, 0.03). Mean costs were higher with prenatal misoprostol distribution from governmental by US$3.3 (95% CrI: 2.1, 4.2) and modified societal (by US$1.3; 95% CrI: -1.6, 2.8) perspectives. ICERs were US$191 (95% CrI: 82, 443) per DALY averted from a governmental perspective, and US$73 (95% CI: -86, 256) per DALY averted from a modified societal perspective. Conclusions Prenatal distribution of misoprostol is potentially cost-effective in Uganda and should be considered for national-level scale up for prevention of PPH.	[Lubinga, Solomon J.; Babigumira, Joseph B.] Univ Washington, Dept Pharm, Pharmaceut Outcomes Res & Policy Program, Seattle, WA 98195 USA; [Lubinga, Solomon J.; Babigumira, Joseph B.] Univ Washington, Dept Global Hlth, Global Med Program, Seattle, WA 98195 USA; [Atukunda, Esther C.] Mbarara Univ Sci & Technol, Dept Pharmacol, Mbarara, Uganda; [Wasswa-Ssalongo, George] Mbarara Reg Referral Hosp, Dept Obstet & Gynecol, Mbarara, Uganda	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Mbarara University of Science & Technology	Lubinga, SJ (corresponding author), Univ Washington, Dept Pharm, Pharmaceut Outcomes Res & Policy Program, Seattle, WA 98195 USA.	slubinga@uw.edu	Babigumira, Joseph/T-4208-2019; Lubinga, Solomon James/AAD-6637-2019; Lubinga, Solomon James/B-6590-2018	Lubinga, Solomon James/0000-0003-0539-9156; Lubinga, Solomon James/0000-0003-0539-9156				Abdel-Aleem H, 2010, INT J GYNECOL OBSTET, V111, P32, DOI 10.1016/j.ijgo.2010.04.036; Adam Taghreed, 2003, Cost Eff Resour Alloc, V1, P3, DOI 10.1186/1478-7547-1-3; Akhan S. E., 2001, Clinical and Experimental Obstetrics and Gynecology, V28, P118; Babigumira JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030735; Babigumira JB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-904; Bank of Uganda, 2013, EXCH RAT; Begley CM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007412.pub2; Bradley SEK, 2007, INT J GYNECOL OBSTET, V97, P52, DOI 10.1016/j.ijgo.2006.12.005; Calvert C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041114; Chu CS, 2012, J ROY SOC MED, V105, P336, DOI 10.1258/jrsm.2012.120044; Derman RJ, 2006, LANCET, V368, P1248, DOI 10.1016/S0140-6736(06)69522-6; Ezegwui H U, 2006, J Obstet Gynaecol, V26, P160; Garrison LP, 2010, VALUE HEALTH, V13, P8, DOI 10.1111/j.1524-4733.2009.00660.x; Geller S, 2014, BJOG-INT J OBSTET GY, V121, P319, DOI 10.1111/1471-0528.12447; Geller SE, 2006, INT J GYNECOL OBSTET, V92, P202, DOI 10.1016/j.ijgo.2005.12.009; Gulmezoglu AM, 2001, LANCET, V358, P689, DOI 10.1016/S0140-6736(01)05835-4; Hoj L, 2005, BMJ-BRIT MED J, V331, P723, DOI 10.1136/bmj.331.7519.723; Hundley VA, 2013, BJOG-INT J OBSTET GY, V120, P277, DOI 10.1111/1471-0528.12049; Hutubessy Raymond, 2003, Cost Eff Resour Alloc, V1, P8, DOI 10.1186/1478-7547-1-8; Ifakara Health Institute Venture Strategies Innovations Bixby Center for Population Health and Sustainability PSI/Tanzania, 2011, PREV POSTP HEM HOM B; Joint Medical Stores, 2013, CAT PRIC IND; Kaye D, 2003, East Afr Med J, V80, P144; Khosla AH, 2002, AUST NZ J OBSTET GYN, V42, P412; Lara AM, 2007, J CLIN PATHOL, V60, P1117, DOI 10.1136/jcp.2006.042309; Levin A, 2003, INT J HEALTH PLAN M, V18, P3, DOI 10.1002/hpm.690; Majoko F, 2002, INT J GYNECOL OBSTET, V76, P77, DOI 10.1016/S0020-7292(01)00553-7; Management Sciences for Health, 2014, INT DRUG PRIC IND GU; Matsiko CW, 2003, HLTH POLICY DEV, V1, P15; Mazzone Michael E, 2006, WMJ, V105, P64; Mbonye AK, 2007, INT J GYNECOL OBSTET, V98, P285, DOI 10.1016/j.ijgo.2007.05.019; Mbonye AK, 2007, INT J GYNECOL OBSTET, V96, P220, DOI 10.1016/j.ijgo.2006.12.017; Mobeen N, 2011, BJOG-INT J OBSTET GY, V118, P353, DOI 10.1111/j.1471-0528.2010.02807.x; Mrisho M, 2007, TROP MED INT HEALTH, V12, P862, DOI 10.1111/j.1365-3156.2007.01855.x; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; National Medical Stores, 2010, PRIC IND; Ninci A, 2004, HLTH POLICY DEV, V2, P114; Oladapo OT, 2012, INT J GYNECOL OBSTET, V119, P105, DOI 10.1016/j.ijgo.2012.08.004; Pagel C, 2009, LANCET, V374, P1441, DOI 10.1016/S0140-6736(09)61566-X; Potts M, 2010, LANCET, V375, P1762, DOI 10.1016/S0140-6736(10)60750-7; Prata N, 2005, INT J GYNECOL OBSTET, V90, P51, DOI 10.1016/j.ijgo.2005.03.007; Rajasingham R, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001316; Rajbhandari S, 2010, INT J GYNECOL OBSTET, V108, P282, DOI 10.1016/j.ijgo.2009.11.006; Rutaremwa G, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0943-8; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; Sanghvi H., 2004, PREVENTION POSTPARTU; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Sempa J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-736; Smith JM, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-189; Stanton CK, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001524; Sutherland T, 2010, INT J GYNECOL OBSTET, V108, P289, DOI 10.1016/j.ijgo.2009.11.007; Sutherland T, 2009, INT J GYNECOL OBSTET, V104, P189, DOI 10.1016/j.ijgo.2008.10.011; Tang J, 2013, INT J GYNECOL OBSTET, V121, P186, DOI 10.1016/j.ijgo.2012.12.009; Thomas A, 2003, BJOG-INT J OBSTET GY, V110, P217, DOI 10.1016/S1470-0328(02)02605-8; Uganda Bureau of Statistics, 2013, CONS PRIC IND; Uganda Bureau of Statistics ICF International Inc, 2012, UG DEM HLTH SURV 201; Verguet S, 2015, HEALTH ECON, V24, P318, DOI 10.1002/hec.3019; Weeks AD, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0650-9; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Weissman E, 1999, UGANDA SAFE MOTHERHO; Westhoff G, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001808.pub2; World Health Organization (WHO), 2012, REC PREV TREATM POST	62	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142550	10.1371/journal.pone.0142550	http://dx.doi.org/10.1371/journal.pone.0142550			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560140	Green Published, gold, Green Submitted			2022-12-26	WOS:000364433100090
J	Manat, G; El Ghachi, M; Auger, R; Baouche, K; Olatunji, S; Kerff, F; Touze, T; Mengin-Lecreulx, D; Bouhss, A				Manat, Guillaume; El Ghachi, Meriem; Auger, Rodolphe; Baouche, Karima; Olatunji, Samir; Kerff, Frederic; Touze, Thierry; Mengin-Lecreulx, Dominique; Bouhss, Ahmed			Membrane Topology and Biochemical Characterization of the Escherichia coli BacA Undecaprenyl-Pyrophosphate Phosphatase	PLOS ONE			English	Article							PEPTIDOGLYCAN; BIOSYNTHESIS; PROTEINS; CARRIER; GENE; IDENTIFICATION; CONSERVATION; BACITRACIN; PRECURSORS; PREDICTION	Several integral membrane proteins exhibiting undecaprenyl-pyrophosphate (C-55-PP) phosphatase activity were previously identified in Escherichia coli that belonged to two distinct protein families: the BacA protein, which accounts for 75% of the C-55-PP phosphatase activity detected in E. coli cell membranes, and three members of the PAP2 phosphatidic acid phosphatase family, namely PgpB, YbjG and LpxT. This dephosphorylation step is required to provide the C-55-P carrier lipid which plays a central role in the biosynthesis of various cell wall polymers. We here report detailed investigations of the biochemical properties and membrane topology of the BacA protein. Optimal activity conditions were determined and a narrow-range substrate specificity with a clear preference for C-55-PP was observed for this enzyme. Alignments of BacA protein sequences revealed two particularly well-conserved regions and several invariant residues whose role in enzyme activity was questioned by using a site-directed mutagenesis approach and complementary in vitro and in vivo activity assays. Three essential residues Glu21, Ser27, and Arg174 were identified, allowing us to propose a catalytic mechanism for this enzyme. The membrane topology of the BacA protein determined here experimentally did not validate previous program-based predicted models. It comprises seven transmembrane segments and contains in particular two large periplasmic loops carrying the highly-conserved active site residues. Our data thus provide evidence that all the different E. coli C-55-PP phosphatases identified to date (BacA and PAP2) catalyze the dephosphorylation of C-55-PP molecules on the same (outer) side of the plasma membrane.	[Manat, Guillaume; Auger, Rodolphe; Baouche, Karima; Touze, Thierry; Mengin-Lecreulx, Dominique; Bouhss, Ahmed] Univ Paris 11, CNRS, CEA, Inst Integrat Biol Cell I2BC,UMR 9198, F-91400 Orsay, France; [El Ghachi, Meriem; Olatunji, Samir; Kerff, Frederic] Univ Liege, Inst Phys B5a, Ctr Ingn Prot, B-4000 Liege, Belgium; [El Ghachi, Meriem; Olatunji, Samir; Kerff, Frederic] Inst Chim B6a, B-4000 Liege, Belgium	CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; University of Liege	Mengin-Lecreulx, D (corresponding author), Univ Paris 11, CNRS, CEA, Inst Integrat Biol Cell I2BC,UMR 9198, Bat 430, F-91400 Orsay, France.	dominique.mengin-lecreulx@i2bc.paris-saclay.fr; ahmed.bouhss@i2bc.paris-saclay.fr	Touzé, Thierry/GLT-1308-2022	MENGIN-LECREULX, Dominique/0000-0003-3205-0275; Touze, Thierry/0000-0002-2176-6537; Olatunji, Samir/0000-0001-9958-7689	Agence Nationale de la Recherche (Bactoprenyl project) [ANR-11-BSV3-002]; Belgian State-Federal Science Policy (InterUniversity Attraction Poles Program, iProS project) [P7/44]; Centre National de la Recherche Scientifique; University of Paris Sud	Agence Nationale de la Recherche (Bactoprenyl project)(French National Research Agency (ANR)); Belgian State-Federal Science Policy (InterUniversity Attraction Poles Program, iProS project); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); University of Paris Sud	This work was supported by grants from the Agence Nationale de la Recherche (Bactoprenyl project, ANR-11-BSV3-002), the Belgian State-Federal Science Policy (InterUniversity Attraction Poles Program, iProS P7/44 project), the Centre National de la Recherche Scientifique, and the University of Paris Sud. F.K. is a research associate of the FRS-FNRS (Brussels, Belgium).	Apfel CM, 1999, J BACTERIOL, V181, P483, DOI 10.1128/JB.181.2.483-492.1999; Bickford JS, 2013, MICROBIOL-SGM, V159, P2444, DOI 10.1099/mic.0.070474-0; Bouhss A, 1999, MOL MICROBIOL, V34, P576, DOI 10.1046/j.1365-2958.1999.01623.x; Bouhss A, 2008, FEMS MICROBIOL REV, V32, P208, DOI 10.1111/j.1574-6976.2007.00089.x; BROOMESMITH JK, 1990, MOL MICROBIOL, V4, P1637, DOI 10.1111/j.1365-2958.1990.tb00540.x; CAIN BD, 1993, J BACTERIOL, V175, P3784, DOI 10.1128/JB.175.12.3784-3789.1993; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; Chang HY, 2014, J BIOL CHEM, V289, P18719, DOI 10.1074/jbc.M114.575076; DAGERT M, 1979, GENE, V6, P23, DOI 10.1016/0378-1119(79)90082-9; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; El Ghachi M, 2005, J BIOL CHEM, V280, P18689, DOI 10.1074/jbc.M412277200; El Ghachi M, 2004, J BIOL CHEM, V279, P30106, DOI 10.1074/jbc.M401701200; Fan JP, 2014, P NATL ACAD SCI USA, V111, P7636, DOI 10.1073/pnas.1403097111; Guo RT, 2005, J BIOL CHEM, V280, P20762, DOI 10.1074/jbc.M502121200; Hartley MD, 2012, ARCH BIOCHEM BIOPHYS, V517, P83, DOI 10.1016/j.abb.2011.10.018; Kato JI, 1999, J BACTERIOL, V181, P2733, DOI 10.1128/JB.181.9.2733-2738.1999; LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8; LOUBENS I, 1993, MOL MICROBIOL, V10, P329, DOI 10.1111/j.1365-2958.1993.tb01959.x; Lu YH, 2011, J BIOL CHEM, V286, P5506, DOI 10.1074/jbc.M110.199265; Manat G, 2014, MICROB DRUG RESIST, V20, P199, DOI 10.1089/mdr.2014.0035; MILLER JH, 1972, COLD SPRING HARBOR L, P431; Mohammadi T, 2011, EMBO J, V30, P1425, DOI 10.1038/emboj.2011.61; PERSSON B, 1994, J MOL BIOL, V237, P182, DOI 10.1006/jmbi.1994.1220; Persson B, 1996, PROTEIN SCI, V5, P363; Press WH, 1986, NUMERICAL RECIPES AR, P521; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sham LT, 2014, SCIENCE, V345, P220, DOI 10.1126/science.1254522; SIEWERT G, 1967, P NATL ACAD SCI USA, V57, P767, DOI 10.1073/pnas.57.3.767; Tatar LD, 2007, MICROBIOL-SGM, V153, P2518, DOI 10.1099/mic.0.2007/006312-0; Touze T, 2008, J BIOL CHEM, V283, P16573, DOI 10.1074/jbc.M800394200; Touze T, 2008, MOL MICROBIOL, V67, P264, DOI 10.1111/j.1365-2958.2007.06044.x; Valvano MA, 2008, MOL MICROBIOL, V67, P232, DOI 10.1111/j.1365-2958.2007.06052.x	32	20	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142870	10.1371/journal.pone.0142870	http://dx.doi.org/10.1371/journal.pone.0142870			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560897	Green Published, Green Submitted, gold			2022-12-26	WOS:000364433100134
J	Garcia-Martin, JA; Clote, P				Garcia-Martin, Juan Antonio; Clote, Peter			RNA Thermodynamic Structural Entropy	PLOS ONE			English	Article							SECONDARY STRUCTURE PREDICTION; CONFIGURATIONAL ENTROPY; CONFORMATIONAL ENTROPY; PARTITION-FUNCTION; SEQUENCE LOGOS; WEB SERVER; INFORMATION; HYBRIDIZATION; ALIGNMENTS; ALGORITHM	Conformational entropy for atomic-level, three dimensional biomolecules is known experimentally to play an important role in protein-ligand discrimination, yet reliable computation of entropy remains a difficult problem. Here we describe the first two accurate and efficient algorithms to compute the conformational entropy for RNA secondary structures, with respect to the Turner energy model, where free energy parameters are determined from UV absorption experiments. An algorithm to compute the derivational entropy for RNA secondary structures had previously been introduced, using stochastic context free grammars (SCFGs). However, the numerical value of derivational entropy depends heavily on the chosen context free grammar and on the training set used to estimate rule probabilities. Using data from the Rfam database, we determine that both of our thermodynamic methods, which agree in numerical value, are substantially faster than the SCFG method. Thermodynamic structural entropy is much smaller than derivational entropy, and the correlation between length-normalized thermodynamic entropy and derivational entropy is moderately weak to poor. In applications, we plot the structural entropy as a function of temperature for known thermoswitches, such as the repression of heat shock gene expression (ROSE) element, we determine that the correlation between hammerhead ribozyme cleavage activity and total free energy is improved by including an additional free energy term arising from conformational entropy, and we plot the structural entropy of windows of the HIV-1 genome. Our software RNAentropy can compute structural entropy for any user-specified temperature, and supports both the Turner'99 and Turner'04 energy parameters. It follows that RNAentropy is state-of-the-art software to compute RNA secondary structure conformational entropy. Source code is available at https://github.com/clotelab/RNAentropy/; a full web server is available at http://bioinformatics.bc.edu/clotelab/RNAentropy, including source code and ancillary programs.	[Garcia-Martin, Juan Antonio; Clote, Peter] Boston Coll, Dept Biol, Chestnut Hill, MA 02467 USA	Boston College	Clote, P (corresponding author), Boston Coll, Dept Biol, Chestnut Hill, MA 02467 USA.	clote@bc.edu	Garcia-Martin, Juan Antonio/K-5956-2017; Garcia-Martin, Juan Antonio/HDN-5951-2022	Garcia-Martin, Juan Antonio/0000-0003-0993-4064; 	National Science Foundation [DBI-1262439]; Div Of Biological Infrastructure [1262439] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation DBI-1262439.	ALTSCHUL SF, 1985, MOL BIOL EVOL, V2, P526; Anderson JWJ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-149; Bernhart SH, 2006, ALGORITHM MOL BIOL, V1, DOI 10.1186/1748-7188-1-3; Bindewald E, 2006, NUCLEIC ACIDS RES, V34, pW405, DOI 10.1093/nar/gkl269; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Choi HMT, 2010, NAT BIOTECHNOL, V28, P1208, DOI 10.1038/nbt.1692; Clote P, 2005, RNA, V11, P578, DOI 10.1261/rna.7220505; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dill K.A., 2002, MOLECULAR DRIVING FO; Dimitrov RA, 2004, BIOPHYS J, V87, P215, DOI 10.1529/biophysj.103.020743; Ding Y, 2003, NUCLEIC ACIDS RES, V31, P7280, DOI 10.1093/nar/gkg938; Ding Y, 2004, NUCL ACIDS RES, V32, pW135, DOI 10.1093/nar/gkh449; Dirks RM, 2004, NUCLEIC ACIDS RES, V32, P1392, DOI 10.1093/nar/gkh291; Dotu I, 2014, NUCLEIC ACIDS RES, V42, P11752, DOI 10.1093/nar/gku740; Dowell RD, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-71; Fusy E, 2014, J MATH BIOL, V68, P341, DOI 10.1007/s00285-012-0631-9; Giegerich R, 1999, Pac Symp Biocomput, P126; Gorodkin J, 1997, COMPUT APPL BIOSCI, V13, P583; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hammell M, 2008, NAT METHODS, V5, P813, DOI 10.1038/NMETH.1247; Harpole KW, 2011, J PHYS CHEM B, V115, P9461, DOI 10.1021/jp111176x; Higgs PG, 2000, Q REV BIOPHYS, V33, P199, DOI 10.1017/S0033583500003620; Huynen M, 1997, J MOL BIOL, V267, P1104, DOI 10.1006/jmbi.1997.0889; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; KARPLUS M, 1987, BIOPHYS J, V52, P1083, DOI 10.1016/S0006-3495(87)83303-9; Kazan H, 2013, NUCLEIC ACIDS RES, V41, pW180, DOI 10.1093/nar/gkt463; Kazan H, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000832; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lorenz WA, 2008, J COMPUT BIOL, V15, P31, DOI 10.1089/cmb.2006.0153; Lu K, 2011, J MOL BIOL, V410, P609, DOI 10.1016/j.jmb.2011.04.029; Manzourolajdad A, 2013, J THEOR BIOL, V318, P140, DOI 10.1016/j.jtbi.2012.10.023; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Marlow MS, 2010, NAT CHEM BIOL, V6, P352, DOI 10.1038/nchembio.347; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Mathews DH, 2004, RNA, V10, P1178, DOI 10.1261/rna.7650904; MCCASKILL JS, 1990, BIOPOLYMERS, V29, P1105, DOI 10.1002/bip.360290621; Miklos I, 2005, B MATH BIOL, V67, P1031, DOI 10.1016/j.bulm.2004.12.003; Morgan SR, 1998, J PHYS A-MATH GEN, V31, P3153, DOI 10.1088/0305-4470/31/14/005; Nawrocki EP, 2015, NUCLEIC ACIDS RES, V43, pD130, DOI 10.1093/nar/gku1063; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; Ng KLS, 2007, BIOINFORMATICS, V23, P1321, DOI 10.1093/bioinformatics/btm026; NUSSINOV R, 1980, P NATL ACAD SCI-BIOL, V77, P6309, DOI 10.1073/pnas.77.11.6309; Rivas E, 2000, BIOINFORMATICS, V16, P583, DOI 10.1093/bioinformatics/16.7.583; Rivas E, 2012, RNA, V18, P193, DOI 10.1261/rna.030049.111; Salari R, 2013, NUCLEIC ACIDS RES, V41, P44, DOI 10.1093/nar/gks1009; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Shao Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-469; Sukosd Z, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S2-S22; Sukosd Z, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-103; Tinoco Jr I., 2000, THERMODYNAMICS BIOL, P131; Turner DH, 2010, NUCLEIC ACIDS RES, V38, pD280, DOI 10.1093/nar/gkp892; Wand AJ, 2013, CURR OPIN STRUC BIOL, V23, P75, DOI 10.1016/j.sbi.2012.11.005; Wuchty S, 1999, BIOPOLYMERS, V49, P145, DOI 10.1002/(SICI)1097-0282(199902)49:2<145::AID-BIP4>3.3.CO;2-7; Zadeh JN, 2011, J COMPUT CHEM, V32, P439, DOI 10.1002/jcc.21633; Zarringhalam K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045160; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; Zuker M, 1999, NATO ASI 3 HIGH TECH, V70, P11	58	16	17	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0137859	10.1371/journal.pone.0137859	http://dx.doi.org/10.1371/journal.pone.0137859			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555444	gold, Green Submitted, Green Published			2022-12-26	WOS:000364430700003
J	Langer, SM; Hopfensperger, K; Iyer, SS; Kreider, EF; Learn, GH; Lee, LH; Hahn, BH; Sauter, D				Langer, Simon M.; Hopfensperger, Kristina; Iyer, Shilpa S.; Kreider, Edward F.; Learn, Gerald H.; Lee, Lan-Hui; Hahn, Beatrice H.; Sauter, Daniel			A Naturally Occurring rev1-vpu Fusion Gene Does Not Confer a Fitness Advantage to HIV-1	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ACCESSORY PROTEIN VPU; MESSENGER-RNA; KAPPA-B; TRANSLATION INITIATION; CELL-SURFACE; ENV; EXPRESSION; REPLICATION; TAT	Background Pandemic strains of HIV-1 (group M) encode a total of nine structural (gag, pol, env), regulatory (rev, tat) and accessory (vif, vpr, vpu, nef) genes. However, some subtype A and C viruses exhibit an unusual gene arrangement in which the first exon of rev (rev1) and the vpu gene are placed in the same open reading frame. Although this rev1-vpu gene fusion is present in a considerable fraction of HIV-1 strains, its functional significance is unknown. Results Examining infectious molecular clones (IMCs) of HIV-1 that encode the rev1-vpu polymorphism, we show that a fusion protein is expressed in infected cells. Due to the splicing pattern of viral mRNA, however, these same IMCs also express a regular Vpu protein, which is produced at much higher levels. To investigate the function of the fusion gene, we characterized isogenic IMC pairs differing only in their ability to express a Rev1-Vpu protein. Analysis in transfected HEK293T and infected CD4+ T cells showed that all of these viruses were equally active in known Vpu functions, such as down-modulation of CD4 or counteraction of tetherin. Furthermore, the polymorphism did not affect Vpu-mediated inhibition of NF-kappa B activation or Rev-dependent nuclear export of incompletely spliced viral mRNAs. There was also no evidence for enhanced replication of Rev1-Vpu expressing viruses in primary PBMCs or ex vivo infected human lymphoid tissues. Finally, the frequency of HIV-1 quasis-pecies members that encoded a rev1-vpu fusion gene did not change in HIV-1 infected individuals over time. Conclusions Expression of a rev1-vpu fusion gene does not affect regular Rev and Vpu functions or alter HIV-1 replication in primary target cells. Since there is no evidence for increased replication fitness of rev1-vpu encoding viruses, this polymorphism likely emerged in the context of other mutations within and/or outside the rev1-vpu intergenic region, and may have a neutral phenotype.	[Langer, Simon M.; Hopfensperger, Kristina; Lee, Lan-Hui; Sauter, Daniel] Univ Ulm, Inst Mol Virol, Med Ctr, D-89081 Ulm, Germany; [Iyer, Shilpa S.; Kreider, Edward F.; Learn, Gerald H.; Hahn, Beatrice H.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Lee, Lan-Hui] Taipei City Hosp, Kunming Branch, Dept Lab, Taipei 10844, Taiwan	Ulm University; University of Pennsylvania; Pennsylvania Medicine; Taipei City Hospital	Sauter, D (corresponding author), Univ Ulm, Inst Mol Virol, Med Ctr, D-89081 Ulm, Germany.	daniel.sauter@uni-ulm.de	Learn, Jerry/E-3356-2012; Kreider, Edward/GSD-5998-2022	Kreider, Edward/0000-0003-2330-8430; Hahn, Beatrice/0000-0002-9400-9887; Hopfensperger, Kristina/0000-0002-6381-7988; Langer, Simon/0000-0002-9660-8058	Deutsche Forschungsgemeinschaft; EU; NIH (National Institutes of Health (US)) [UM1 AI 100645, P01 AI 088564, R01 AI 114266, R01 AI111789]; International Graduate School in Molecular Medicine Ulm; NIH [F30 AI112426-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F30AI112426, UM1AI100645, T32AI007632, P01AI088564, R01AI114266, R01AI111789, P30AI045008] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EU(European Commission); NIH (National Institutes of Health (US))(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Graduate School in Molecular Medicine Ulm; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/), the EU (http://erc.europa.eu/), and the NIH (National Institutes of Health (US)) (http://www.nih.gov/) (UM1 AI 100645, P01 AI 088564, R01 AI 114266 and R01 AI111789). SL was funded by the International Graduate School in Molecular Medicine Ulm (http://www.uni-ulm.de/einrichtungen/mm.html). EFK was supported by the NIH (F30 AI112426-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Akari H, 2001, J EXP MED, V194, P1299, DOI 10.1084/jem.194.9.1299; Anderson JL, 2007, J VIROL, V81, P4664, DOI 10.1128/JVI.01028-06; BENKO DM, 1990, J VIROL, V64, P2505, DOI 10.1128/JVI.64.6.2505-2518.1990; Bour S, 2001, J BIOL CHEM, V276, P15920, DOI 10.1074/jbc.M010533200; COHEN EA, 1990, J ACQ IMMUN DEF SYND, V3, P601; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Fouchier RAM, 1997, EMBO J, V16, P4531, DOI 10.1093/emboj/16.15.4531; FURTADO MR, 1991, VIROLOGY, V185, P258, DOI 10.1016/0042-6822(91)90773-5; GLUSHAKOVA S, 1995, NAT MED, V1, P1320, DOI 10.1038/nm1295-1320; GOTTLINGER HG, 1992, VIROLOGY, V189, P618, DOI 10.1016/0042-6822(92)90585-D; Guerrero S, 2015, VIRUSES-BASEL, V7, P199, DOI 10.3390/v7010199; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Kraus MH, 2010, VIROLOGY, V397, P346, DOI 10.1016/j.virol.2009.11.019; Krummheuer J, 2007, VIROLOGY, V363, P261, DOI 10.1016/j.virol.2007.01.022; Leulier F, 2003, EMBO REP, V4, P976, DOI 10.1038/sj.embor.embor936; Liu MKP, 2013, J CLIN INVEST, V123, P380, DOI 10.1172/JCI65330; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; Moll M, 2010, BLOOD, V116, P1876, DOI 10.1182/blood-2009-09-243667; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Ocwieja KE, 2012, NUCLEIC ACIDS RES, V40, P10345, DOI 10.1093/nar/gks753; Parrish NF, 2013, P NATL ACAD SCI USA, V110, P6626, DOI 10.1073/pnas.1304288110; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; PURCELL DFJ, 1993, J VIROL, V67, P6365, DOI 10.1128/JVI.67.11.6365-6378.1993; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; SALFELD J, 1990, EMBO J, V9, P965, DOI 10.1002/j.1460-2075.1990.tb08195.x; Sauter D, 2015, CELL REP, V10, P586, DOI 10.1016/j.celrep.2014.12.047; SCHWARTZ S, 1990, J VIROL, V64, P5448, DOI 10.1128/JVI.64.11.5448-5456.1990; SCHWARTZ S, 1992, MOL CELL BIOL, V12, P207, DOI 10.1128/MCB.12.1.207; Shah AH, 2010, CELL HOST MICROBE, V8, P397, DOI 10.1016/j.chom.2010.10.008; SHUGARS DC, 1993, J VIROL, V67, P4639, DOI 10.1128/JVI.67.8.4639-4650.1993; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; WILLEY RL, 1992, J VIROL, V66, P7193, DOI 10.1128/JVI.66.12.7193-7200.1992; Wu YT, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-12; Yue L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004565; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	37	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142118	10.1371/journal.pone.0142118	http://dx.doi.org/10.1371/journal.pone.0142118			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554585	Green Published, Green Submitted, gold			2022-12-26	WOS:000364430700055
J	Pahi, Z; Kiss, Z; Komonyi, O; Borsos, BN; Tora, L; Boros, IM; Pankotal, T				Pahi, Zoltan; Kiss, Zsuzsanna; Komonyi, Orban; Borsos, Barbara N.; Tora, Laszlo; Boros, Imre M.; Pankotal, Tibor			dTAF10-and dTAF10b-Containing Complexes Are Required for Ecdysone-Driven Larval-Pupal Morphogenesis in Drosophila melanogaster	PLOS ONE			English	Article							HISTONE H4 ACETYLATION; TRANSCRIPTIONAL ACTIVATION; GENE-EXPRESSION; HUMAN TAF(II)30; ADA2 HOMOLOGS; TFIID COMPLEX; P450 ENZYMES; DISTINCT; SAGA; METAMORPHOSIS	In eukaryotes the TFIID complex is required for preinitiation complex assembly which positions RNA polymerase II around transcription start sites. On the other hand, histone acetyltransferase complexes including SAGA and ATAC, modulate transcription at several steps through modification of specific core histone residues. In this study we investigated the function of Drosophila melanogaster proteins TAF10 and TAF10b, which are subunits of dTFIID and dSAGA, respectively. We generated a mutation which eliminated the production of both Drosophila TAF10 orthologues. The simultaneous deletion of both dTaf10 genes impaired the recruitment of the dTFIID subunit dTAF5 to polytene chromosomes, while binding of other TFIID subunits, dTAF1 and RNAPII was not affected. The lack of both dTAF10 proteins resulted in failures in the larval-pupal transition during metamorphosis and in transcriptional reprogramming at this developmental stage. Surprisingly, unlike dSAGA mutations, dATAC subunit mutations resulted in very similar changes in the steady state mRNA levels of approximately 5000 genes as did ablation of both dTaf10 genes, indicating that dTAF10 and/or dTAF10b-containing complexes and dATAC affect similar pathways. Importantly, the phenotype resulting from dTaf10+dTaf10b mutation could be rescued by ectopically added ecdysone, suggesting that dTAF10- and/or dTAF10b-containing complexes are involved in the expression of ecdysone biosynthetic genes. Indeed, in dTaf10+dTaf10b mutants, cytochrome genes, which regulate ecdysone synthesis in the ring gland, were underrepresented. Therefore our data support the idea that the presence of dTAF10 proteins in dTFIID and/or dSAGA is required only at specific developmental steps. We propose that distinct forms of dTFIID and/or dSAGA exist during Drosophila metamorphosis, wherein different TAF compositions serve to target RNAPII at different developmental stages and tissues.	[Pahi, Zoltan; Kiss, Zsuzsanna; Komonyi, Orban; Borsos, Barbara N.; Boros, Imre M.; Pankotal, Tibor] Univ Szeged, Dept Biochem & Mol Biol, Szeged, Hungary; [Boros, Imre M.; Pankotal, Tibor] Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary; [Tora, Laszlo] Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France	Szeged University; Hungarian Academy of Sciences; Hungarian Biological Research Center; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Pankotal, T (corresponding author), Univ Szeged, Dept Biochem & Mol Biol, Szeged, Hungary.	pankotai@bio.u-szeged.hu	Pankotai, Tibor/A-5942-2015; Tora, Laszlo/E-9999-2018	Pankotai, Tibor/0000-0001-9810-5465; Tora, Laszlo/0000-0001-7398-2250; Boros, Imre/0000-0001-8504-9687; Borsos, Barbara Nikolett/0000-0002-5537-8612	European Union; State of Hungary; European Social Fund [TAMOP 4.2.4. A/2-11-1-2012-0001, HURO/1101/173/2.2.1]	European Union(European Commission); State of Hungary; European Social Fund(European Social Fund (ESF))	This research was supported by the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP 4.2.4. A/2-11-1-2012-0001 "National Excellence Program" and HURO/1101/173/2.2.1 Hungary-Romania Cross-Border Co-operation Program 2007-2013. The grants provided for the financial support for the reagents used in this study.	Baehrecke EH, 1996, ARCH INSECT BIOCHEM, V33, P231, DOI 10.1002/(SICI)1520-6327(1996)33:3/4&lt;231::AID-ARCH5&gt;3.0.CO;2-V; Beckstead RB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r99; Bieniossek C, 2013, NATURE, V493, P699, DOI 10.1038/nature11791; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Ciurciu A, 2006, MOL CELL BIOL, V26, P9413, DOI 10.1128/MCB.01401-06; Demeny MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000316; Durand A, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-S1-S4; Gegonne A, 2012, MOL CELL BIOL, V32, P1984, DOI 10.1128/MCB.06305-11; Georgieva S, 2000, MOL CELL BIOL, V20, P1639, DOI 10.1128/MCB.20.5.1639-1648.2000; Gilbert LI, 2004, MOL CELL ENDOCRINOL, V215, P1, DOI 10.1016/j.mce.2003.11.003; Grant PA, 1998, CELL, V94, P45, DOI 10.1016/S0092-8674(00)81220-9; GRUNSTEIN M, 1990, ANNU REV CELL BIOL, V6, P643, DOI 10.1146/annurev.cellbio.6.1.643; Indra AK, 2005, DEV BIOL, V285, P28, DOI 10.1016/j.ydbio.2005.05.043; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; JACQ X, 1994, CELL, V79, P107, DOI 10.1016/0092-8674(94)90404-9; Johnson CA, 1998, NUCLEIC ACIDS RES, V26, P994, DOI 10.1093/nar/26.4.994; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; Kandiah E, 2014, CURR OPIN STRUC BIOL, V24, P91, DOI 10.1016/j.sbi.2013.12.005; Kaufmann J, 1998, MOL CELL BIOL, V18, P233, DOI 10.1128/MCB.18.1.233; Kirschner DB, 2002, MOL CELL BIOL, V22, P3178, DOI 10.1128/MCB.22.9.3178-3193.2002; Kusch T, 2003, MOL CELL BIOL, V23, P3305, DOI 10.1128/MCB.23.9.3305-3319.2003; Lebedeva LA, 2005, P NATL ACAD SCI USA, V102, P18087, DOI 10.1073/pnas.0509063102; Leurent C, 2002, EMBO J, V21, P3424, DOI 10.1093/emboj/cdf342; Martinez E, 1998, J BIOL CHEM, V273, P23781, DOI 10.1074/jbc.273.37.23781; Martinez E, 1998, MOL CELL BIOL, V18, P6571, DOI 10.1128/MCB.18.11.6571; Metzger D, 1999, EMBO J, V18, P4823, DOI 10.1093/emboj/18.17.4823; Mohan WS, 2003, MOL CELL BIOL, V23, P4307, DOI 10.1128/MCB.23.12.4307-4318.2003; Moriniere J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397; Morse RH, 2007, J CELL BIOCHEM, V102, P560, DOI 10.1002/jcb.21493; Muratoglu S, 2003, MOL CELL BIOL, V23, P306, DOI 10.1128/MCB.23.1.306-321.2003; Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2; Pankotai T, 2005, MOL CELL BIOL, V25, P8215, DOI 10.1128/MCB.25.18.8215-8227.2005; Pankotai T, 2010, MOL CELL BIOL, V30, P4254, DOI 10.1128/MCB.00142-10; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Sanders SL, 2002, MOL CELL BIOL, V22, P6000, DOI 10.1128/MCB.22.16.6000-6013.2002; Spedale G, 2012, GENE DEV, V26, P527, DOI 10.1101/gad.184705.111; Struhl Kevin, 1997, Genes and Function, V1, P5; Tatarakis A, 2008, MOL CELL, V31, P531, DOI 10.1016/j.molcel.2008.07.013; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; THUMMEL CS, 1995, CELL, V83, P871, DOI 10.1016/0092-8674(95)90203-1; Timmers HTM, 2005, TRENDS BIOCHEM SCI, V30, P7, DOI 10.1016/j.tibs.2004.11.007; Walker AK, 2001, EMBO J, V20, P5269, DOI 10.1093/emboj/20.18.5269; Wang YL, 2008, J BIOL CHEM, V283, P33808, DOI 10.1074/jbc.M806936200; Warren JT, 2002, P NATL ACAD SCI USA, V99, P11043, DOI 10.1073/pnas.162375799; Weake VM, 2009, GENE DEV, V23, P2818, DOI 10.1101/gad.1846409; White KP, 1999, SCIENCE, V286, P2179, DOI 10.1126/science.286.5447.2179; Wieczorek E, 1998, NATURE, V393, P187, DOI 10.1038/30283; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; Zsindely N, 2009, NUCLEIC ACIDS RES, V37, P6665, DOI 10.1093/nar/gkp722	49	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142226	10.1371/journal.pone.0142226	http://dx.doi.org/10.1371/journal.pone.0142226			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556600	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000364430700071
J	Quah, S; Breuker, CJ; Holland, PWH				Quah, Shan; Breuker, Casper J.; Holland, Peter W. H.			A Diversity of Conserved and Novel Ovarian MicroRNAs in the Speckled Wood (Pararge aegeria)	PLOS ONE			English	Article							MESSENGER-RNA; EVOLUTION; IDENTIFICATION; EXPRESSION; TRANSCRIPTION; TRANSITION; GENOMICS; MOSQUITO; RECEPTOR; HORMONE	microRNAs (miRNAs) are important regulators of animal development and other processes, and impart robustness to living systems through post-transcriptional regulation of specific mRNA transcripts. It is postulated that newly emergent miRNAs are generally expressed at low levels and with spatiotemporally restricted expression domains, thus minimising effects of spurious targeting on animal transcriptomes. Here we present ovarian miRNA transcriptome data for two geographically distinct populations of the Speckled Wood butterfly (Pararge aegeria). A total of 74 miRNAs were identified, including 11 newly discovered and evolutionarily-young miRNAs, bringing the total of miRNA genes known from P. aegeria up to 150. We find a positive correlation between miRNA age and expression level. A common set of 55 miRNAs are expressed in both populations. From this set, we identify seven that are consistently either ovary-specific or highly upregulated in ovaries relative to other tissues. This 'ovary set' includes miRNAs with known contributions to ovarian function in other insect species with similar ovaries and mode of oogenesis, including miR-989 and miR2763, plus new candidates for ovarian function. We also note that conserved miRNAs are overrepresented in the ovary relative to the whole body.	[Quah, Shan; Holland, Peter W. H.] Univ Oxford, Dept Zool, Oxford, England; [Breuker, Casper J.] Oxford Brookes Univ, Fac Hlth & Life Sci, Dept Biol & Med Sci, Evolutionary Dev Biol Res Grp, Oxford OX3 0BP, England	University of Oxford; Oxford Brookes University	Holland, PWH (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford, England.	peter.holland@zoo.ox.ac.uk	Breuker, Casper/N-6582-2013; Breuker, Casper/P-8270-2019	Breuker, Casper/0000-0001-7909-1950; Breuker, Casper/0000-0001-7909-1950; Holland, Peter/0000-0003-1533-9376	European Research Council under the European Union's Seventh Framework Programme (FP7)/ERC [268513]; A*STAR National Science PhD Scholarship	European Research Council under the European Union's Seventh Framework Programme (FP7)/ERC(European Research Council (ERC)); A*STAR National Science PhD Scholarship	This study was funded by the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant 268513 to PWHH and an A*STAR National Science PhD Scholarship to SQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ables ET, 2015, DEV BIOL, V400, P33, DOI 10.1016/j.ydbio.2015.01.013; Barckmann B, 2013, BBA-GENE REGUL MECH, V1829, P714, DOI 10.1016/j.bbagrm.2012.12.011; Bastock R, 2008, CURR BIOL, V18, pR1082, DOI 10.1016/j.cub.2008.09.011; Behura SK, 2007, INSECT BIOCHEM MOLEC, V37, P3, DOI 10.1016/j.ibmb.2006.10.006; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Carter JM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-283; Charles JP, 1999, EUR J BIOCHEM, V266, P181, DOI 10.1046/j.1432-1327.1999.00842.x; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chen W, 2013, MOL GENET GENOMICS, V288, P627, DOI 10.1007/s00438-013-0777-1; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cristino AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019350; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Ferguson L, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004698; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Gibbs M, 2010, PHYSIOL ENTOMOL, V35, P29, DOI 10.1111/j.1365-3032.2009.00706.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Homma T, 2006, BIOCHEM BIOPH RES CO, V344, P386, DOI 10.1016/j.bbrc.2006.03.085; Jagadeeswaran G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-52; Jones CI, 2010, BIOCHEM SOC T, V38, P1137, DOI 10.1042/BST0381137; KADONOOKUDA K, 1994, ARCH INSECT BIOCHEM, V25, P121, DOI 10.1002/arch.940250205; Kenny NJ, 2013, GEN COMP ENDOCR, V188, P16, DOI 10.1016/j.ygcen.2013.02.013; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kugler JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067075; Lasko P, 2011, WIRES RNA, V2, P408, DOI 10.1002/wrna.70; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lozano J, 2015, P NATL ACAD SCI USA, V112, P3740, DOI 10.1073/pnas.1418522112; Lucas KJ, 2013, TRENDS PARASITOL, V29, P295, DOI 10.1016/j.pt.2013.04.003; Lyu Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004096; McBride D, 2012, REPRODUCTION, V144, P221, DOI 10.1530/REP-12-0025; McDonald JA, 2003, DEVELOPMENT, V130, P3469, DOI 10.1242/dev.00574; Mead EA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-244; Meunier J, 2013, GENOME RES, V23, P34, DOI 10.1101/gr.140269.112; Montell DJ, 2003, NAT REV MOL CELL BIO, V4, P13, DOI 10.1038/nrm1006; Mukherjee K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-705; Ninova M, 2014, RNA, V20, P360, DOI 10.1261/rna.041657.113; Papantonis A, 2015, ANNU REV ENTOMOL, V60, P177, DOI 10.1146/annurev-ento-010814-020810; Pasquinelli AE, 2005, CURR OPIN GENET DEV, V15, P200, DOI 10.1016/j.gde.2005.01.002; Pinheiro EM, 2004, DEVELOPMENT, V131, P5243, DOI 10.1242/dev.01412; Preuss KM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-671; Quah S, 2015, MOL BIOL EVOL, V32, P1161, DOI 10.1093/molbev/msv004; Saunders C, 1999, MOL CELL, V3, P43, DOI 10.1016/S1097-2765(00)80173-2; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Swevers L, 2003, INSECT BIOCHEM MOLEC, V33, P1285, DOI 10.1016/j.ibmb.2003.06.012; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Wei J, 2004, DEV DYNAM, V230, P800, DOI 10.1002/dvdy.20108; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zhang XF, 2012, INSECT BIOCHEM MOLEC, V42, P381, DOI 10.1016/j.ibmb.2012.01.006	53	12	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142243	10.1371/journal.pone.0142243	http://dx.doi.org/10.1371/journal.pone.0142243			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556800	gold, Green Published, Green Submitted			2022-12-26	WOS:000364430700073
J	Wang, H; Luo, Y; Lin, Z; Lee, IW; Kwon, J; Cui, XS; Kim, NH				Wang, HaiYang; Luo, Yibo; Lin, Zili; Lee, In-Won; Kwon, Jeongwoo; Cui, Xiang-Shun; Kim, Nam-Hyung			Effect of ATM and HDAC Inhibition on Etoposide-Induced DNA Damage in Porcine Early Preimplantation Embryos	PLoS One			English	Article							DOUBLE-STRAND-BREAK; OOCYTE MEIOTIC MATURATION; IN-VITRO DEVELOPMENT; NUCLEAR TRANSFER; HISTONE H2AX; MAMMALIAN-CELLS; KINASE ATM; REPAIR; CAFFEINE; RECOMBINATION	Oocyte maturation and embryonic development are sensitive to DNA damage. Compared with somatic cells or oocytes, little is known about the response to DNA damage in early preimplantation embryos. In this study, we examined DNA damage checkpoints and DNA repair mechanisms in parthenogenetic preimplantation porcine embryos. We found that most of the etoposide-treated embryos showed delay in cleavage and ceased development before the blastocyst stage. In DNA-damaged embryos, the earliest positive TUNEL signals were detected on Day 5 of in vitro culture. Caffeine, which is an ATM (ataxia telangiectasia mutated) and ATR (ataxia telangiectasia and Rad3-related protein) kinase inhibitor, and KU55933, which is an ATM kinase inhibitor, were equally effective in rescuing the etoposide- induced cell-cycle blocks. This indicates that ATM plays a central role in the regulation of the checkpoint mechanisms. Treating the embryos with histone deacetylase inhibitors (HDACi) increased embryonic development and reduced etoposide-induced double-strand breaks (DSBs). The mRNA expression of genes involved in non-homologous end-joining (NHEJ) or homologous recombination (HR) pathways for DSB repair was reduced upon HDACi treatment in 5-day-old embryos. Furthermore, HDACi treatment increased the expression levels of pluripotency-related genes (OCT4, SOX2 and NANOG) and decreased the expression levels of apoptosis-related genes (CASP3 and BAX). These results indicate that early embryonic cleavage and development are disturbed by etoposide-induced DNA damage. ATMi (caffeine or KU55933) treatment bypasses the checkpoint while HDACi treatment improves the efficiency of DSB repair to increase the cleavage and blastocyst rate in porcine early preimplantation embryos.	[Wang, HaiYang; Luo, Yibo; Lin, Zili; Lee, In-Won; Kwon, Jeongwoo; Cui, Xiang-Shun; Kim, Nam-Hyung] Chungbuk Natl Univ, Dept Anim Sci, Cheongju 362763, Chungcheongbuk, South Korea	Chungbuk National University	Kim, NH (corresponding author), Chungbuk Natl Univ, Dept Anim Sci, Cheongju 362763, Chungcheongbuk, South Korea.	nhkim@chungbuk.ac.kr		WANG, HAIYANG/0000-0002-6362-6022	BioGreen 21 Program of the Rural Development Administration (RDA) of the Republic of Korea [PJ009594]	BioGreen 21 Program of the Rural Development Administration (RDA) of the Republic of Korea	Funding: This study was supported by a grant from the BioGreen 21 Program (No. PJ009594 to NK) of the Rural Development Administration (RDA) of the Republic of Korea.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Blasina A, 1999, CURR BIOL, V9, P1135, DOI 10.1016/S0960-9822(99)80486-2; Bohgaki Toshiyuki, 2010, Genome Integr, V1, P15, DOI 10.1186/2041-9414-1-15; Bohrer RC, 2014, CELL CYCLE, V13, P2138, DOI 10.4161/cc.29215; Brandsma Inger, 2012, Genome Integr, V3, P9, DOI 10.1186/2041-9414-3-9; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Cao SY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-4; Cortez D, 2003, J BIOL CHEM, V278, P37139, DOI 10.1074/jbc.M307088200; De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Haber JE, 2000, TRENDS GENET, V16, P259, DOI 10.1016/S0168-9525(00)02022-9; Hao YH, 2003, BIOL REPROD, V69, P501, DOI 10.1095/biolreprod.103.016170; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Karran P, 2000, CURR OPIN GENET DEV, V10, P144, DOI 10.1016/S0959-437X(00)00069-1; Korwek Z, 2012, DNA REPAIR, V11, P864, DOI 10.1016/j.dnarep.2012.08.006; Lee HS, 2010, EMBO J, V29, P1434, DOI 10.1038/emboj.2010.27; Ma JY, 2013, CELL CYCLE, V12, P1233, DOI 10.4161/cc.24311; Marangos P, 2012, CURR BIOL, V22, P989, DOI 10.1016/j.cub.2012.03.063; McManus KJ, 2005, MOL BIOL CELL, V16, P5013, DOI 10.1091/mbc.E05-01-0065; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Mu XF, 2011, BIOL REPROD, V85, P524, DOI 10.1095/biolreprod.110.089334; Niemann H, 2008, REPRODUCTION, V135, P151, DOI 10.1530/REP-07-0397; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Sarkaria JN, 1999, CANCER RES, V59, P4375; Sharma GG, 2010, MOL CELL BIOL, V30, P3582, DOI 10.1128/MCB.01476-09; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; Soleimani R, 2011, AGING-US, V3, P782, DOI 10.18632/aging.100363; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Su GH, 2000, CANCER RES, V60, P3137; Tjeertes JV, 2009, EMBO J, V28, P1878, DOI 10.1038/emboj.2009.119; Turinetto V, 2015, NUCLEIC ACIDS RES, V43, P2489, DOI 10.1093/nar/gkv061; Van Thuan N, 2009, REPRODUCTION, V138, P309, DOI 10.1530/REP-08-0299; Wanczyk M, 2011, FRONT BIOSCI-LANDMRK, V16, P340, DOI 10.2741/3691; Wang LJ, 2011, CELL REPROGRAM, V13, P431, DOI 10.1089/cell.2011.0024; Wang ZW, 2013, CELL CYCLE, V12, P3336, DOI 10.4161/cc.26327; Wu CC, 2011, SCIENCE, V333, P459, DOI 10.1126/science.1204117; Xie AY, 2004, MOL CELL, V16, P1017, DOI 10.1016/j.molcel.2004.12.007; Yang MY, 2002, ANIM REPROD SCI, V70, P159, DOI 10.1016/S0378-4320(01)00186-5; Yang XH, 2013, J BIOL CHEM, V288, P18271, DOI 10.1074/jbc.M113.473199; Yukawa M, 2007, BIOCHEM BIOPH RES CO, V358, P578, DOI 10.1016/j.bbrc.2007.04.162; Zhang T, 2014, HISTOCHEM CELL BIOL, V142, P185, DOI 10.1007/s00418-014-1182-5	42	27	27	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142561	10.1371/journal.pone.0142561	http://dx.doi.org/10.1371/journal.pone.0142561			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556501	Green Submitted, Green Published, gold			2022-12-26	WOS:000364430700130
J	Capoferri, L; Verkade-Vreeker, MCA; Buitenhuis, D; Commandeur, JNM; Pastor, M; Vermeulen, NPE; Geerke, DP				Capoferri, Luigi; Verkade-Vreeker, Marlies C. A.; Buitenhuis, Danny; Commandeur, Jan N. M.; Pastor, Manuel; Vermeulen, Nico P. E.; Geerke, Daan P.			Linear Interaction Energy Based Prediction of Cytochrome P450 1A2 Binding Affinities with Reliability Estimation	PLOS ONE			English	Article							IN-VITRO INHIBITION; COMPUTATIONAL PREDICTION; DRUG-INTERACTIONS; MOLECULAR-DYNAMICS; LIVER-MICROSOMES; METABOLISM; ENZYMES; PROTEIN; QSAR; CYP1A2	Prediction of human Cytochrome P450 (CYP) binding affinities of small ligands, i.e., substrates and inhibitors, represents an important task for predicting drug-drug interactions. A quantitative assessment of the ligand binding affinity towards different CYPs can provide an estimate of inhibitory activity or an indication of isoforms prone to interact with the substrate of inhibitors. However, the accuracy of global quantitative models for CYP substrate binding or inhibition based on traditional molecular descriptors can be limited, because of the lack of information on the structure and flexibility of the catalytic site of CYPs. Here we describe the application of a method that combines protein-ligand docking, Molecular Dynamics (MD) simulations and Linear Interaction Energy (LIE) theory, to allow for quantitative CYP affinity prediction. Using this combined approach, a LIE model for human CYP 1A2 was developed and evaluated, based on a structurally diverse dataset for which the estimated experimental uncertainty was 3.3 kJ mol(-1). For the computed CYP 1A2 binding affinities, the model showed a root mean square error (RMSE) of 4.1 kJ mol(-1) and a standard error in prediction (SDEP) in cross-validation of 4.3 kJ mol(-1). A novel approach that includes information on both structural ligand description and protein-ligand interaction was developed for estimating the reliability of predictions, and was able to identify compounds from an external test set with a SDEP for the predicted affinities of 4.6 kJ mol(-1) (corresponding to 0.8 pKi units).	[Capoferri, Luigi; Verkade-Vreeker, Marlies C. A.; Buitenhuis, Danny; Commandeur, Jan N. M.; Vermeulen, Nico P. E.; Geerke, Daan P.] Vrije Univ Amsterdam, Dept Chem & Pharmaceut Sci, AIMMS Div Mol Toxicol, NL-1081 HV Amsterdam, Netherlands; [Pastor, Manuel] Univ Pompeu Fabra, Med Res Inst, IMIM Hosp del Mar, Res Programme Biomed Informat GRIB,Dept Expt & Hl, E-08003 Barcelona, Spain	Vrije Universiteit Amsterdam; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University	Geerke, DP (corresponding author), Vrije Univ Amsterdam, Dept Chem & Pharmaceut Sci, AIMMS Div Mol Toxicol, De Boelelaan 1083, NL-1081 HV Amsterdam, Netherlands.	d.p.geerke@vu.nl	Pastor, Manuel/A-1566-2010; Gasull, Martina/J-4076-2019	Pastor, Manuel/0000-0001-8850-1341; Vermeulen, Nico P.E./0000-0003-4194-6401; Geerke, Daan/0000-0002-5262-6166	Innovative Medicines Initiative Joint Undertaking (IMI-JU) [115002]; European Union; Netherlands Organisation for Scientific Research (NWO, VIDI) [723.012.105]	Innovative Medicines Initiative Joint Undertaking (IMI-JU); European Union(European Commission); Netherlands Organisation for Scientific Research (NWO, VIDI)(Netherlands Organization for Scientific Research (NWO))	Funding: The work was supported by Innovative Medicines Initiative Joint Undertaking (IMI-JU) under grant agreement no. 115002 (eTOX), resources of which are composed of financial contribution from the European Union Seventh Framework Programme (FP7/20072013) and EFPIA companies in kind contribution; www.etoxproject.eu. The work was also supported by The Netherlands Organisation for Scientific Research (NWO, VIDI grant 723.012.105); www.nwo.nl. Except for manuscript approval from the eTOX executive committee, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, MOL OP ENV MOE VERS; AQVIST J, 1994, PROTEIN ENG, V7, P385, DOI 10.1093/protein/7.3.385; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Breinholt VM, 2002, FOOD CHEM TOXICOL, V40, P609, DOI 10.1016/S0278-6915(01)00125-9; BURKE MD, 1983, CHEM-BIOL INTERACT, V45, P243; Busby WF, 1999, DRUG METAB DISPOS, V27, P246; CARLSON HA, 1995, J PHYS CHEM-US, V99, P10667, DOI 10.1021/j100026a034; Carrio P, 2014, J CHEM INF MODEL, V54, P1500, DOI 10.1021/ci500172z; Case D. A., 2012, AMBER 13; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cho US, 2003, BBA-PROTEINS PROTEOM, V1648, P195, DOI 10.1016/S1570-9639(03)00148-1; Cohen LH, 2003, DRUG METAB DISPOS, V31, P1005, DOI 10.1124/dmd.31.8.1005; Correia M.A., 2005, CYTOCHROME P450 STRU, V3rd ed., P247, DOI DOI 10.1007/0-387-27447-2_7; De Maesschalck R, 2000, CHEMOMETR INTELL LAB, V50, P1, DOI 10.1016/S0169-7439(99)00047-7; Durant JL, 2002, J CHEM INF COMP SCI, V42, P1273, DOI 10.1021/ci010132r; Ekins S, 2001, DRUG METAB DISPOS, V29, P936; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Feenstra KA, 1999, J COMPUT CHEM, V20, P786, DOI 10.1002/(SICI)1096-987X(199906)20:8<786::AID-JCC5>3.0.CO;2-B; Gleeson MP, 2007, J COMPUT AID MOL DES, V21, P559, DOI 10.1007/s10822-007-9139-6; Guengerich FP, 2006, P NATL ACAD SCI USA, V103, P13565, DOI 10.1073/pnas.0606333103; Guengerich FP, 2006, AAPS J, V8, pE101, DOI 10.1208/aapsj080112; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hockney RW, 1970, POTENTIAL CALCULATIO; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hritz J, 2009, J PHYS CHEM B, V113, P12711, DOI 10.1021/jp902968m; Hubert M, 2005, TECHNOMETRICS, V47, P64, DOI 10.1198/004017004000000563; Iori F, 2005, BIOORGAN MED CHEM, V13, P4366, DOI 10.1016/j.bmc.2005.04.066; Jakalian A, 2000, J COMPUT CHEM, V21, P132, DOI 10.1002/(SICI)1096-987X(20000130)21:2<132::AID-JCC5>3.0.CO;2-P; JORGENSEN WL, 1983, J AM CHEM SOC, V105, P1407, DOI 10.1021/ja00344a001; Karjalainen MJ, 2008, BASIC CLIN PHARMACOL, V103, P157, DOI 10.1111/j.1742-7843.2008.00252.x; Katoh M, 2000, EUR J CLIN PHARMACOL, V55, P843, DOI 10.1007/s002280050706; Kazui M, 2010, DRUG METAB DISPOS, V38, P92, DOI 10.1124/dmd.109.029132; Kirchmair J, 2012, J CHEM INF MODEL, V52, P617, DOI 10.1021/ci200542m; Ko JW, 2000, BRIT J CLIN PHARMACO, V49, P343; Korb Oliver, 2007, Swarm Intelligence, V1, P115, DOI 10.1007/s11721-007-0006-9; Korb O, 2009, J CHEM INF MODEL, V49, P84, DOI 10.1021/ci800298z; Korhonen LE, 2005, J MED CHEM, V48, P3808, DOI 10.1021/jm0489713; Lautraite S, 2002, MUTAGENESIS, V17, P45, DOI 10.1093/mutage/17.1.45; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Masimirembwa CM, 1999, DRUG METAB DISPOS, V27, P1117; MASUBUCHI Y, 1994, DRUG METAB DISPOS, V22, P909; Nikolova N, 2004, QSAR COMB SCI, V22, P1006, DOI 10.1002/qsar.200330831; Novotarskyi S, 2011, J CHEM INF MODEL, V51, P1271, DOI 10.1021/ci200091h; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Obach RS, 2006, J PHARMACOL EXP THER, V316, P336, DOI 10.1124/jpet.105.093229; Oldham HG, 1997, DRUG METAB DISPOS, V25, P970; OMURA T, 1964, J BIOL CHEM, V239, P2370; Peric-Hassler L, 2013, INT J MOL SCI, V14, P24514, DOI 10.3390/ijms141224514; Racha JK, 1998, BIOCHEMISTRY-US, V37, P7407, DOI 10.1021/bi973011m; Rendic S, 2002, DRUG METAB REV, V34, P83, DOI 10.1081/DMR-120001392; Roy K, 2008, CHEM BIOL DRUG DES, V72, P370, DOI 10.1111/j.1747-0285.2008.00717.x; Sahigara F, 2012, MOLECULES, V17, P4791, DOI 10.3390/molecules17054791; Sanderink GJ, 1997, J PHARMACOL EXP THER, V282, P1465; Sansen S, 2007, J BIOL CHEM, V282, P14348, DOI 10.1074/jbc.M611692200; Shahrokh K, 2012, J COMPUT CHEM, V33, P119, DOI 10.1002/jcc.21922; Smith DA, 1997, DRUG DISCOV TODAY, V2, P406, DOI 10.1016/S1359-6446(97)01081-7; Sousa da Silva Alan W, 2012, BMC Res Notes, V5, P367, DOI 10.1186/1756-0500-5-367; SPALDIN V, 1995, DRUG METAB DISPOS, V23, P929; Sridhar J, 2011, SAR QSAR ENVIRON RES, V22, P681, DOI 10.1080/1062936X.2011.623320; Sridhar J, 2012, MOLECULES, V17, P9283, DOI 10.3390/molecules17089283; Stjernschantz E, 2008, EXPERT OPIN DRUG MET, V4, P513, DOI 10.1517/17425255.4.5.513 ; Stjernschantz E, 2010, BIOPHYS J, V98, P2682, DOI 10.1016/j.bpj.2010.02.034; Vasanthanathan P, 2010, DRUG METAB DISPOS, V38, P1347, DOI 10.1124/dmd.110.032946; Vasanthanathan P, 2009, DRUG METAB DISPOS, V37, P658, DOI 10.1124/dmd.108.023507; Vosmeer CR, 2014, INT J MOL SCI, V15, P798, DOI 10.3390/ijms15010798; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wei XX, 1999, J PHARMACOL EXP THER, V289, P853; Wienkers LC, 2005, NAT REV DRUG DISCOV, V4, P825, DOI 10.1038/nrd1851; Yang YC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087749, 10.1371/journal.pone.0100677, 10.1371/journal.pone.0085863, 10.1371/journal.pone.0102942]; Yuan R, 2002, DRUG METAB DISPOS, V30, P1311, DOI 10.1124/dmd.30.12.1311	72	22	22	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0142232	10.1371/journal.pone.0142232	http://dx.doi.org/10.1371/journal.pone.0142232			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26551865	Green Published, Green Submitted, gold			2022-12-26	WOS:000364422800019
J	Haruki, H; Hovius, R; Pedersen, MG; Johnsson, K				Haruki, Hirohito; Hovius, Ruud; Pedersen, Miriam Gronlund; Johnsson, Kai			Tetrahydrobiopterin Biosynthesis as a Potential Target of the Kynurenine Pathway Metabolite Xanthurenic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEPIAPTERIN REDUCTASE; TRYPTOPHAN-HYDROXYLASE; PLASMA PHENYLALANINE; BRAIN; INHIBITION; DEGRADATION; TRANSPORT; REVEALS; LIVER	Tryptophan metabolites in the kynurenine pathway are up-regulated by pro-inflammatory cytokines or glucocorticoids, and are linked to anti-inflammatory and immunosuppressive activities. In addition, they are up-regulated in pathologies such as cancer, autoimmune diseases, and psychiatric disorders. The molecular mechanisms of how kynurenine pathway metabolites cause these effects are incompletely understood. On the other hand, pro-inflammatory cytokines also up-regulate the amounts of tetrahydrobiopterin (BH4), an enzyme cofactor essential for the synthesis of several neurotransmitter and nitric oxide species. Here we show that xanthurenic acid is a potent inhibitor of sepiapterin reductase (SPR), the final enzyme in de novo BH4 synthesis. The crystal structure of xanthurenic acid bound to the active site of SPR reveals why among all kynurenine pathway metabolites xanthurenic acid is the most potent SPR inhibitor. Our findings suggest that increased xanthurenic acid levels resulting from up-regulation of the kynurenine pathway could attenuate BH4 biosynthesis and BH4-dependent enzymatic reactions, linking two major metabolic pathways known to be highly up-regulated in inflammation.	[Haruki, Hirohito; Hovius, Ruud; Pedersen, Miriam Gronlund; Johnsson, Kai] Ecole Polytech Fed Lausanne, Natl Ctr Competence Res NCCR Chem Biol, Inst Bioengn, Inst Chem Sci & Engn, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Johnsson, K (corresponding author), Ecole Polytech Fed Lausanne, Natl Ctr Competence Res NCCR Chem Biol, Inst Bioengn, Inst Chem Sci & Engn, CH-1015 Lausanne, Switzerland.	kai.johnsson@epfl.ch			EPFL; Swiss National Science Foundation; NCCR in Chemical Biology	EPFL; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NCCR in Chemical Biology	This work was supported by the EPFL, the Swiss National Science Foundation, and the NCCR in Chemical Biology. The authors declare that they have no conflicts of interest with the contents of this article.	ANDREWS TM, 1976, CLIN CHIM ACTA, V68, P17, DOI 10.1016/0009-8981(76)90284-9; Auerbach G, 1997, EMBO J, V16, P7219, DOI 10.1093/emboj/16.24.7219; Bartlett RD, 1998, NEUROPHARMACOLOGY, V37, P839, DOI 10.1016/S0028-3908(98)00080-X; Chidley C, 2011, NAT CHEM BIOL, V7, P375, DOI [10.1038/NCHEMBIO.557, 10.1038/nchembio.557]; Costigan M, 2012, CURR OPIN PHARMACOL, V12, P92, DOI 10.1016/j.coph.2011.10.019; Dantzer R, 2011, PSYCHONEUROENDOCRINO, V36, P426, DOI 10.1016/j.psyneuen.2010.09.012; ENGLAND JM, 1972, LANCET, V2, P1341; Felger JC, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu084; Felger JC, 2013, BRAIN BEHAV IMMUN, V31, P153, DOI 10.1016/j.bbi.2012.10.010; Friedman J, 2012, ANN NEUROL, V71, P520, DOI 10.1002/ana.22685; Gobaille S, 2008, J NEUROCHEM, V105, P982, DOI 10.1111/j.1471-4159.2008.05219.x; GUIDETTI P, 1995, J NEUROCHEM, V65, P2621; Han Q, 2007, J INSECT PHYSIOL, V53, P254, DOI 10.1016/j.jinsphys.2006.09.004; Haruki H, 2013, SCIENCE, V340, P987, DOI 10.1126/science.1232972; Hirakawa H, 2009, J BIOCHEM, V146, P51, DOI 10.1093/jb/mvp042; JEQUIER E, 1967, MOL PHARMACOL, V3, P274; KATOH S, 1982, BIOCHEM BIOPH RES CO, V105, P75, DOI 10.1016/S0006-291X(82)80012-0; Klassen P, 2001, AM J CLIN NUTR, V73, P647; Latremoliere A, 2015, NEURON, V86, P1393, DOI 10.1016/j.neuron.2015.05.033; Colin-Gonzalez AL, 2013, NEUROTOXICOLOGY, V34, P189, DOI 10.1016/j.neuro.2012.11.007; Lopansri BK, 2006, INFECT IMMUN, V74, P3355, DOI 10.1128/IAI.02106-05; Munn DH, 2013, TRENDS IMMUNOL, V34, P137, DOI 10.1016/j.it.2012.10.001; Nasser A, 2015, NEUROSCI LETT, V584, P247, DOI 10.1016/j.neulet.2014.10.050; Ocampo JR, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/646909; PATNAIK SK, 1980, J BIOCHEM-TOKYO, V87, P1249; Platten M, 2012, CANCER RES, V72, P5435, DOI 10.1158/0008-5472.CAN-12-0569; Raison CL, 2010, MOL PSYCHIATR, V15, P393, DOI 10.1038/mp.2009.116; SCHIMKE RT, 1965, J BIOL CHEM, V240, P322; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; SMITH GK, 1992, J BIOL CHEM, V267, P5599; Sperner-Unterweger B, 2014, PROG NEURO-PSYCHOPH, V48, P268, DOI 10.1016/j.pnpbp.2012.10.006; TAKIKAWA O, 1986, J BIOL CHEM, V261, P3648; Taleb O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048553; TONG JH, 1975, J BIOL CHEM, V250, P4152; Werner ER, 1998, P SOC EXP BIOL MED, V219, P171; Werner ER, 2011, BIOCHEM J, V438, P397, DOI 10.1042/BJ20110293; YAMAZAKI F, 1985, BIOCHEM J, V230, P635, DOI 10.1042/bj2300635; Yang SJ, 2013, J BIOL CHEM, V288, P19221, DOI 10.1074/jbc.M112.402164; Zoller H, 2012, J INTERF CYTOK RES, V32, P216, DOI 10.1089/jir.2011.0093	39	39	41	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					652	657		10.1074/jbc.C115.680488	http://dx.doi.org/10.1074/jbc.C115.680488			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26565027	Green Published, hybrid			2022-12-26	WOS:000367830500013
J	Yan, XH; Liao, HW; Cheng, MZ; Shi, XJ; Lin, X; Feng, XH; Chen, YG				Yan, Xiaohua; Liao, Hongwei; Cheng, Minzhang; Shi, Xiaojing; Lin, Xia; Feng, Xin-Hua; Chen, Ye-Guang			Smad7 Protein Interacts with Receptor-regulated Smads (R-Smads) to Inhibit Transforming Growth Factor-beta (TGF-beta/Smad Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; protein degradation; protein-protein interaction; SMAD transcription factor; transforming growth factor beta (TGF-B); ubiquitylation (ubiquitination); Smad7; signaling regulation	TGF-BETA; NEGATIVE REGULATION; TUMOR-SUPPRESSOR; STRUCTURAL BASIS; CANCER; PATHWAYS; DOMAIN; DEGRADATION; PROGRESSION; NUCLEUS	TGF-beta is a pleiotropic cytokine that regulates a wide range of cellular actions and pathophysiological processes. TGF-beta signaling is spatiotemporally fine-tuned. As a key negative regulator of TGF-beta signaling, Smad7 exerts its inhibitory effects by blocking receptor activity, inducing receptor degradation or interfering with Smad-DNA binding. However, the functions and the molecular mechanisms underlying the actions of Smad7 in TGF-beta signaling are still not fully understood. In this study we report a novel mechanism whereby Smad7 antagonizes TGF-beta signaling at the Smad level. Smad7 oligomerized with R-Smad proteins upon TGF-beta signaling and directly inhibited R-Smad activity, as assessed by Gal4-luciferase reporter assays. Mechanistically, Smad7 competes with Smad4 to associate with R-Smads and recruits the E3 ubiquitin ligase NEDD4L to activated R-Smads, leading to their polyubiquitination and proteasomal degradation. Similar to the R-Smad-Smad4 oligomerization, the interaction between R-Smads and Smad7 is mediated by their mad homology 2 (MH2) domains. A positive-charged basic region including the L3/beta 8 loop-strand module and adjacent amino acids in the MH2 domain of Smad7 is essential for the interaction. These results shed new light on the regulation of TGF-beta signaling by Smad7.	[Yan, Xiaohua; Liao, Hongwei; Cheng, Minzhang; Shi, Xiaojing; Chen, Ye-Guang] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Sch Life Sci, State Key Lab Membrane Biol, Beijing 100084, Peoples R China; [Feng, Xin-Hua] Zhejiang Univ, Life Sci Inst & Innovat Ctr Cell Signaling Networ, Hangzhou 310058, Zhejiang, Peoples R China; [Lin, Xia] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Lin, Xia] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Tsinghua University; Zhejiang University; Baylor College of Medicine; Baylor College of Medicine	Yan, XH (corresponding author), Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Sch Life Sci, State Key Lab Membrane Biol, Beijing 100084, Peoples R China.	yanxiaohua06@126.com; ygchen@tsinghua.edu.cn	Yan, Xiaohua/J-4922-2015; Chen, Ye-Guang/L-6998-2019	Yan, Xiaohua/0000-0002-7528-5771; 	National Natural Science Foundation of China (NSFC) [31401198, 31330049]; Ministry of Science and Technology-973 Program [2013CB933700]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology-973 Program(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China (NSFC) Grants 31401198 (to X.Y.) and 31330049 and the Ministry of Science and Technology-973 Program (2013CB933700; to Y.-G.C.). The authors declare that they have no conflicts of interest with the contents of this article.	Aragon E, 2012, STRUCTURE, V20, P1726, DOI 10.1016/j.str.2012.07.014; Beppu H, 2013, J BIOCHEM, V153, P399, DOI 10.1093/jb/mvt020; Bian L, 2015, PROTEIN CELL, V6, P160, DOI 10.1007/s13238-014-0130-4; Briones-Orta Marco A, 2011, Curr Mol Pharmacol, V4, P141; Chacko BM, 2004, MOL CELL, V15, P813, DOI 10.1016/j.molcel.2004.07.016; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Ding YJ, 2014, J CELL SCI, V127, P4833, DOI 10.1242/jcs.146977; Ding Y, 2013, J BIOL CHEM, V288, P8289, DOI 10.1074/jbc.M112.433185; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Feng XH, 2002, MOL CELL, V9, P133, DOI 10.1016/S1097-2765(01)00430-0; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Herhaus L, 2014, CELL SIGNAL, V26, P2186, DOI 10.1016/j.cellsig.2014.06.012; Thi HTH, 2015, MOL CELL BIOL, V35, P2841, DOI 10.1128/MCB.00274-15; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Komuro A, 2004, ONCOGENE, V23, P6914, DOI 10.1038/sj.onc.1207885; Kuratomi G, 2005, BIOCHEM J, V386, P461, DOI 10.1042/BJ20040738; Lonn P, 2009, CELL RES, V19, P21, DOI 10.1038/cr.2008.308; Luo LY, 2014, TUMOR BIOL, V35, P8379, DOI 10.1007/s13277-014-2203-7; Macias MJ, 2015, TRENDS BIOCHEM SCI, V40, P296, DOI 10.1016/j.tibs.2015.03.012; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Mochizuki T, 2004, J BIOL CHEM, V279, P31568, DOI 10.1074/jbc.M313977200; Monteleone G, 2004, TRENDS IMMUNOL, V25, P513, DOI 10.1016/j.it.2004.07.008; Moren A, 2005, J BIOL CHEM, V280, P22115, DOI 10.1074/jbc.M414027200; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Pardali E, 2010, TRENDS CELL BIOL, V20, P556, DOI 10.1016/j.tcb.2010.06.006; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Stolfi C, 2013, INT J MOL SCI, V14, P23774, DOI 10.3390/ijms141223774; Tang LY, 2011, EMBO J, V30, P4777, DOI 10.1038/emboj.2011.393; Wakefield LM, 2013, NAT REV CANCER, V13, P328, DOI 10.1038/nrc3500; Wtighton KH, 2008, CELL SIGNAL, V20, P1579, DOI 10.1016/j.cellsig.2008.02.003; Xu PL, 2012, FEBS LETT, V586, P1871, DOI 10.1016/j.febslet.2012.05.010; Yan XH, 2014, SCI CHINA LIFE SCI, V57, P128, DOI 10.1007/s11427-013-4581-2; Yan XH, 2012, J BIOL CHEM, V287, P13705, DOI 10.1074/jbc.M112.346221; Yan XH, 2011, MOL CELL BIOL, V31, P3700, DOI 10.1128/MCB.05448-11; Yan XH, 2011, BIOCHEM J, V434, P1, DOI 10.1042/BJ20101827; Yan XH, 2009, J BIOL CHEM, V284, P30097, DOI 10.1074/jbc.M109.049304; Zhang J, 2014, PROTEIN CELL, V5, P503, DOI 10.1007/s13238-014-0058-8; Zhang L, 2013, TRENDS BIOCHEM SCI, V38, P612, DOI 10.1016/j.tibs.2013.10.001; Zhang SP, 2007, MOL CELL BIOL, V27, P4488, DOI 10.1128/MCB.01636-06; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhao X, 2008, J BIOL CHEM, V283, P3272, DOI 10.1074/jbc.M708033200; Zhu L, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-44	47	117	132	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					382	392		10.1074/jbc.M115.694281	http://dx.doi.org/10.1074/jbc.M115.694281			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26555259	Green Published, hybrid			2022-12-26	WOS:000367589500031
J	Ainscough, JS; Gerberick, GF; Kimber, I; Dearman, RJ				Ainscough, Joseph S.; Gerberick, G. Frank; Kimber, Ian; Dearman, Rebecca J.			Interleukin-1 beta Processing Is Dependent on a Calcium-mediated Interaction with Calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATTERN-RECOGNITION RECEPTORS; LIGHT-CHAIN KINASE; NALP3 INFLAMMASOME; NLRP3 INFLAMMASOME; INNATE IMMUNITY; ACTIVATION; IL-1-BETA; IL-1-ALPHA; PROTEINS; CRYSTALS	The secretion of IL-1 beta is a central event in the initiation of inflammation. Unlike most other cytokines, the secretion of IL-1 beta requires two signals: one signal to induce the intracellular up-regulation of pro-IL-1 beta and a second signal to drive secretion of the bioactive molecule. The release of pro-IL-1 beta is a complex process involving proteolytic cleavage by caspase-1. However, the exact mechanism of secretion is poorly understood. Here we sought to identify novel proteins involved in IL-1 beta secretion and intracellular processing to gain further insights into the mechanism of IL-1 release. A human proteome microarray containing 19,951 unique proteins was used to identify proteins that bind human recombinant pro-IL-1 beta. Probes with a signal-to-noise ratio of >3 were defined as biologically relevant. In these analyses, calmodulin was identified as a particularly strong hit, with a signal-to-noise ratio of similar to 11. Using an ELISA-based protein-binding assay, the interaction of recombinant calmodulin with pro-IL-1 beta, but not mature IL-1 beta, was confirmed and shown to be calcium-dependent. Finally, using small molecule inhibitors, it was demonstrated that both calcium and calmodulin were required for nigericin-induced IL-1 beta secretion in THP-1 cells and primary human monocytes. Together, these data suggest that, following calcium influx into the cell, pro-IL-1 beta interacts with cahnodulin and that this interaction is important for IL-1 beta processing and release.	[Ainscough, Joseph S.; Kimber, Ian; Dearman, Rebecca J.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Gerberick, G. Frank] Procter & Gamble Co, Cincinnati, OH 45253 USA	University of Manchester; Procter & Gamble	Ainscough, JS (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	joseph.ainscough@postgrad.manchester.ac.uk		Ainscough, Joseph/0000-0002-8823-3508	Medical Research Council; Procter Gamble Company; Medical Research Council [1067566] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Procter Gamble Company(Procter & Gamble); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by the Medical Research Council and The Procter & Gamble Company.	Ainscough JS, 2014, J BIOL CHEM, V289, P35582, DOI 10.1074/jbc.M114.595686; Ainscough JS, 2013, J IMMUNOTOXICOL, V10, P223, DOI 10.3109/1547691X.2012.711782; Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; Benko S, 2008, CYTOKINE, V43, P368, DOI 10.1016/j.cyto.2008.07.013; BLUMENTHAL DK, 1980, BIOCHEMISTRY-US, V19, P5608, DOI 10.1021/bi00565a023; Brough D, 2003, J IMMUNOL, V170, P3029, DOI 10.4049/jimmunol.170.6.3029; Browne GJ, 2004, MOL CELL BIOL, V24, P2986, DOI 10.1128/MCB.24.7.2986-2997.2004; BUCHAN G, 1988, CLIN EXP IMMUNOL, V73, P449; CACABELOS R, 1994, METHOD FIND EXP CLIN, V16, P141; Chen CJ, 2006, J CLIN INVEST, V116, P2262, DOI 10.1172/JCI28075; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; COGSWELL JP, 1994, J IMMUNOL, V153, P712; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Eder C, 2009, IMMUNOBIOLOGY, V214, P543, DOI 10.1016/j.imbio.2008.11.007; Ferrari D, 1997, J IMMUNOL, V159, P1451; Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4; Gunther M, 2000, MOL CELL BIOCHEM, V210, P131, DOI 10.1023/A:1007177623283; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; IKURA M, 1983, BIOCHEMISTRY-US, V22, P2573, DOI 10.1021/bi00279a039; Ikura M, 1996, TRENDS BIOCHEM SCI, V21, P14, DOI 10.1016/0968-0004(96)80879-6; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; Lee GS, 2012, NATURE, V492, P123, DOI 10.1038/nature11588; Lopez-Castejon G, 2013, J BIOL CHEM, V288, P2721, DOI 10.1074/jbc.M112.422238; Lopez-Castejon G, 2011, CYTOKINE GROWTH F R, V22, P189, DOI 10.1016/j.cytogfr.2011.10.001; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Meixenberger K, 2010, J IMMUNOL, V184, P922, DOI 10.4049/jimmunol.0901346; Moynagh PN, 2005, TRENDS IMMUNOL, V26, P469, DOI 10.1016/j.it.2005.06.009; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Murakami T, 2012, P NATL ACAD SCI USA, V109, P11282, DOI 10.1073/pnas.1117765109; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; RUBARTELLI A, 1990, EMBO J, V9, P1503, DOI 10.1002/j.1460-2075.1990.tb08268.x; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shao SC, 2011, CELL, V147, P1576, DOI 10.1016/j.cell.2011.11.048; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Toutenhoofd SL, 2000, CELL CALCIUM, V28, P83, DOI 10.1054/ceca.2000.0136; Weiss B, 2004, GENES IMMUN, V5, P330, DOI 10.1038/sj.gene.6364104; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007	45	10	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					31151	31161		10.1074/jbc.M115.680694	http://dx.doi.org/10.1074/jbc.M115.680694			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26559977	Green Published, hybrid			2022-12-26	WOS:000367199000042
J	Hao, DR; Zhang, ZL; Cheng, YJ; Chen, GQ; Lu, HH; Mao, YX; Shi, ML; Huang, XL; Zhou, GF; Xue, L				Hao, Derong; Zhang, Zhenliang; Cheng, Yujing; Chen, Guoqing; Lu, Huhua; Mao, Yuxiang; Shi, Mingliang; Huang, Xiaolan; Zhou, Guangfei; Xue, Lin			Identification of Genetic Differentiation between Waxy and Common Maize by SNP Genotyping	PLOS ONE			English	Article							POST-DOMESTICATION SELECTION; LINKAGE DISEQUILIBRIUM; INBRED LINES; POPULATION; TRANSCRIPTION; TOLERANCE; DIVERSITY; SOFTWARE; CHLOROPLAST; ADAPTATION	Waxy maize (Zea mays L. var. ceratina) is an important vegetable and economic crop that is thought to have originated from cultivated flint maize and most recently underwent divergence from common maize. In this study, a total of 110 waxy and 110 common maize inbred lines were genotyped with 3072 SNPs to evaluate the genetic diversity, population structure, and linkage disequilibrium decay as well as identify putative loci that are under positive selection. The results revealed abundant genetic diversity in the studied panel and that genetic diversity was much higher in common than in waxy maize germplasms. Principal coordinate analysis and neighbor-joining cluster analysis consistently classified the 220 accessions into two major groups and a mixed group with mixed ancestry. Subpopulation structure in both waxy and common maize sets were associated with the germplasm origin and corresponding heterotic groups. The LD decay distance (1500-2000 kb) in waxy maize was lower than that in common maize. Fourteen candidate loci were identified as under positive selection between waxy and common maize at the 99% confidence level. The information from this study can assist waxy maize breeders by enhancing parental line selection and breeding program design.	[Hao, Derong; Zhang, Zhenliang; Cheng, Yujing; Chen, Guoqing; Lu, Huhua; Mao, Yuxiang; Shi, Mingliang; Huang, Xiaolan; Zhou, Guangfei; Xue, Lin] Jiangsu Yanjiang Inst Agr Sci, Nantong Key Lab Exploitat Crop Genet Resources &, Nantong, Peoples R China	Jiangsu Academy of Agricultural Sciences	Xue, L (corresponding author), Jiangsu Yanjiang Inst Agr Sci, Nantong Key Lab Exploitat Crop Genet Resources &, Nantong, Peoples R China.	417803648@qq.com			Natural Science Foundation of Jiangsu Province [BK20141241]; Jiangsu Province Science and Technology Agency, China; Scientific and Technological Platform Construction Program of Nantong City [CP12012002]; Nantong Science and Technology Agency, China; Six Major Talent Project of Jiangsu Province [2014-NY-032]; Jiangsu Province Talent Resources and Social Security Department, China	Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Jiangsu Province Science and Technology Agency, China; Scientific and Technological Platform Construction Program of Nantong City; Nantong Science and Technology Agency, China; Six Major Talent Project of Jiangsu Province; Jiangsu Province Talent Resources and Social Security Department, China	This research was funded by Natural Science Foundation of Jiangsu Province under the grant BK20141241, provided by Jiangsu Province Science and Technology Agency, China, by the Scientific and Technological Platform Construction Program of Nantong City under the grant CP12012002, provided by Nantong Science and Technology Agency, China, and by the Six Major Talent Project of Jiangsu Province under the grant 2014-NY-032, provided by Jiangsu Province Talent Resources and Social Security Department, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrama HA, 2008, EUPHYTICA, V160, P339, DOI 10.1007/s10681-007-9535-y; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Bao JD, 2012, MOL BREEDING, V30, P1707, DOI 10.1007/s11032-012-9754-3; Barrero RA, 2011, FUNCT INTEGR GENOMIC, V11, P37, DOI 10.1007/s10142-010-0208-x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Bouchet S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033470; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Castillo A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-266; Collins, 1909, NEW TYPE INDIAN CORN; Collins GN, 1920, SCIENCE, V52, P48, DOI 10.1126/science.52.1333.48; Corrado G, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-835; Du H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037463; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fan LJ, 2008, MOL BREEDING, V22, P329, DOI 10.1007/s11032-008-9178-2; Fan LJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007612; Fan W, 2014, PLANT CELL ENVIRON, V37, P1586, DOI 10.1111/pce.12258; Fernie AR, 2006, CURR OPIN PLANT BIOL, V9, P196, DOI 10.1016/j.pbi.2006.01.010; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Hamilton JP, 2012, PLANT GENOME-US, V5, P17, DOI 10.3835/plantgenome2011.12.0033; Hamma T, 2010, J BIOL CHEM, V285, P805, DOI 10.1074/jbc.R109.076893; Hao DR, 2015, EUPHYTICA, V203, P109, DOI 10.1007/s10681-014-1277-z; Hao DR, 2012, THEOR APPL GENET, V124, P447, DOI 10.1007/s00122-011-1719-0; Harakotr B, 2011, EUPHYTICA, V122, P63; Hejatko J, 2009, PLANT CELL, V21, P2008, DOI 10.1105/tpc.109.066696; Hoban S, 2012, NAT REV GENET, V13, P110, DOI 10.1038/nrg3130; Huang YB, 1998, CROPS S, P134; Hwang SO, 2008, J BIOL CHEM, V283, P13063, DOI 10.1074/jbc.M709656200; KULESHOV N. N., 1954, Ann. Mo. Bot. Gdn., V41, P271, DOI 10.2307/2394586; LADIZINSKY G, 1985, ECON BOT, V39, P191, DOI 10.1007/BF02907844; Leegood RC, 2003, ARCH BIOCHEM BIOPHYS, V414, P204, DOI 10.1016/S0003-9861(03)00093-6; Lin Z, 2009, J EXP BOT; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu YongJian, 2005, Agricultural Sciences in China, V4, P648; Lu YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024861; Lv HX, 2014, J PLANT BIOL, V57, P291, DOI 10.1007/s12374-014-0041-1; Murray M, 1980, NUCL ACIDS RES, P4321; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; O'Brien JA, 2012, PLANTA, V236, P765, DOI 10.1007/s00425-012-1696-9; OHMETAKAGI M, 1995, PLANT CELL, V7, P173, DOI 10.1105/tpc.7.2.173; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Quesada V, 2011, PLANT J, V68, P738, DOI 10.1111/j.1365-313X.2011.04726.x; Ren GL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057525, 10.1371/journal.pone.0066606]; Reyes JC, 2002, PLANT PHYSIOL, V130, P1090, DOI 10.1104/pp.006791; Sa KJ, 2010, GENES GENOM, V32, P375, DOI 10.1007/s13258-010-0025-6; Sa KyuJin, 2011, Korean Journal of Breeding Science, V43, P430; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; Shen JinGen, 2007, Jiangsu Journal of Agricultural Sciences, V23, P401; Silva NF, 2002, PLANT MOL BIOL, V50, P667, DOI 10.1023/A:1019951120788; Sim SC, 2011, HEREDITY, V106, P927, DOI 10.1038/hdy.2010.139; Sim SC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045520, 10.1371/journal.pone.0040563]; Strigens A, 2013, PLANT CELL ENVIRON, V36, P1871, DOI 10.1111/pce.12096; Sun XL, 2013, J PLANT PHYSIOL, V170, P505, DOI 10.1016/j.jplph.2012.11.017; Tian ML, 2009, GENET RESOUR CROP EV, V56, P247, DOI 10.1007/s10722-008-9360-8; Tian MengLiang, 2008, Acta Agronomica Sinica, V34, P729, DOI 10.3724/SP.J.1006.2008.00729; Tian MengLiang, 2003, Journal of Sichuan Agricultural University, V21, P213; Vahisalu T, 2008, NATURE, V452, P487, DOI 10.1038/nature06608; Van Inghelandt D, 2011, THEOR APPL GENET, V123, P11, DOI 10.1007/s00122-011-1562-3; WALKER JC, 1994, PLANT MOL BIOL, V26, P1599, DOI 10.1007/BF00016492; Wu YuSheng, 2004, Acta Agronomica Sinica, V30, P36; Xia H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106352; Yan JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008451; ZENG M, 1981, Acta Genetica Sinica, V8, P91; Zeng M. Q., 1994, Maize Genetics Cooperation Newsletter, P12; Zeng MQ, 1987, CROP GERMPL RESOUR, V3, P21, DOI DOI 10.19462/J.CNKI.1671-895X.1987.03.004; Zhang JinYu, 2007, Scientia Agricultura Sinica, V40, P234; Zhou ZK, 2015, NAT BIOTECHNOL, V33, P408, DOI 10.1038/nbt.3096	68	16	19	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142585	10.1371/journal.pone.0142585	http://dx.doi.org/10.1371/journal.pone.0142585			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26566240	Green Submitted, Green Published, gold			2022-12-26	WOS:000367628500036
J	Heath, CJ; Cendra, MD; Watson, A; Auger, JP; Pandey, A; Tighe, P; Christodoulides, M				Heath, Claire J.; Cendra, Maria del Mar; Watson, Alastair; Auger, Jean-Philippe; Pandey, Anish; Tighe, Paddy; Christodoulides, Myron			Co-Transcriptomes of Initial Interactions In Vitro between Streptococcus Pneumoniae and Human Pleural Mesothelial Cells	PLOS ONE			English	Article							EPITHELIAL-CELLS; GENE-EXPRESSION; VIRULENCE FACTORS; OXIDATIVE STRESS; PHOSPHORYLATION; PNEUMOLYSIN; METABOLISM; GLUTAMINE; ADHERENCE; RECEPTOR	Streptococcus pneumoniae (Spn) is a major causative organism of empyema, an inflammatory condition occurring in the pleural sac. In this study, we used human and Spn cDNA microarrays to characterize the transcriptional responses occurring during initial contact between Spn and a human pleural mesothelial cell line (PMC) in vitro. Using stringent filtering criteria, 42 and 23 Spn genes were up-and down-regulated respectively. In particular, genes encoding factors potentially involved in metabolic processes and Spn adherence to eukaryotic cells were up-regulated e.g. glnQ, glnA, aliA, psaB, lytB and nox. After Spn initial contact, 870 human genes were differentially regulated and the largest numbers of significant gene expression changes were found in canonical pathways for eukaryotic initiation factor 2 signaling (60 genes out of 171), oxidative phosphorylation (32/103), mitochondrial dysfunction (37/164), eIF4 and p70S6K signaling (28/142), mTOR signaling (27/182), NRF2-mediated oxidative stress response (20/177), epithelial adherens junction remodeling (11/66) and ubiquitination (22/254). The cellular response appeared to be directed towards host cell survival and defense. Spn did not activate NF-kB or phosphorylate p38 MAPK or induce cytokine production from PMC. Moreover, Spn infection of TNF-alpha pre-stimulated PMC inhibited production of IL-6 and IL-8 secretion by >50% (p<0.01). In summary, this descriptive study provides datasets and a platform for examining further the molecular mechanisms underlying the pathogenesis of empyema.	[Heath, Claire J.; Cendra, Maria del Mar; Watson, Alastair; Pandey, Anish; Christodoulides, Myron] Univ Southampton, Southampton Gen Hosp, Sir Henry Wellcome Labs,Fac Med, Neisseria Res Grp,Mol Microbiol Clin & Expt Sci, Southampton, Hants, England; [Auger, Jean-Philippe] Univ Montreal, Fac Vet Med, Dept Pathol & Microbiol, St Hyacinthe, PQ J2S 7C6, Canada; [Tighe, Paddy] Queens Med Ctr, Nottingham NG7 2UH, England	University of Southampton; Universite de Montreal; University of Nottingham	Christodoulides, M (corresponding author), Univ Southampton, Southampton Gen Hosp, Sir Henry Wellcome Labs,Fac Med, Neisseria Res Grp,Mol Microbiol Clin & Expt Sci, Southampton, Hants, England.	mc4@soton.ac.uk	Cendra, M/A-6821-2019; Christodoulides, Myron/C-6699-2011; del Mar Cendra, Maria/AAX-8114-2020	Cendra, M/0000-0002-2100-2406; Christodoulides, Myron/0000-0002-9663-4731; del Mar Cendra, Maria/0000-0002-2100-2406; Tighe, Patrick/0000-0001-8326-093X; Watson, Alastair/0000-0002-6735-2567	Medical Research Council 4 year PhD studentship; Asthma, Allergy & Inflammation Research charity, Southampton, United Kingdom; Maison internationale of the University of Montreal; Medical Research Council; Asthma, Allergy & Inflammation Research charity; Medical Research Council [1085361] Funding Source: researchfish	Medical Research Council 4 year PhD studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Asthma, Allergy & Inflammation Research charity, Southampton, United Kingdom; Maison internationale of the University of Montreal; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Asthma, Allergy & Inflammation Research charity; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	CH was the recipient of a Medical Research Council 4 year PhD studentship and the studentship was also supported by the Asthma, Allergy & Inflammation Research charity, Southampton, United Kingdom. JPA was a visiting postgraduate student sponsored on a Bourse de mobilite from the Maison internationale of the University of Montreal. We are grateful to Jason Hinds, B mu G@S group, Division of Clinical Sciences, St George's, University of London for technical help and expertise with the Spn microarray. Part of this study was presented at the XIX Lancefield International Symposium on Streptococci and Streptococcal Diseases, Buenos Aires, Nov 2104. The BuG@S SPv1.1.0 array design used in this study has been submitted to ArrayExpress and BuG@ Sbase (http://www.ebi.ac.uk/arrayexpress/arrays/A-BUGS-14/; http://bugs.sgul.ac.uk/A-BUGS-14). Spn microarray data are available in the ArrayExpress database (www.ebi.ac.uk/arrayexpress) under accession number E-MTAB-3931. The human microarray data have been deposited in NCBI's Gene Expression Omnibus and are accessible through GEO Series accession number GSE73538 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE73538).; Funding was provided by Medical Research Council PhD studentship to CJH. Asthma, Allergy & Inflammation Research charity funding support to CJH. JPA was a visiting postgraduate student sponsored on a Bourse de mobilite from the Maison internationale of the University of Montreal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akha AAS, 2013, IMMUNOLOGY, V140, P111, DOI 10.1111/imm.12122; Alkuwaity K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042660; Andrew A, 2011, J INTERF CYTOK RES, V31, P137, DOI 10.1089/jir.2010.0108; Ashida H, 2014, NAT REV MICROBIOL, V12, P399, DOI 10.1038/nrmicro3259; Attali C, 2008, INFECT IMMUN, V76, P5350, DOI 10.1128/IAI.00184-08; Balsalobre L, 2006, J CLIN MICROBIOL, V44, P4163, DOI 10.1128/JCM.01137-06; Barel M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014193; Belyi Y, 2006, P NATL ACAD SCI USA, V103, P16953, DOI 10.1073/pnas.0601562103; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergmann S, 2004, INFECT IMMUN, V72, P2416, DOI 10.1128/IAI.72.4.2416-2419.2004; Brockstedt E, 1998, J BIOL CHEM, V273, P28057, DOI 10.1074/jbc.273.43.28057; Chakravarti D, 2003, CELL, V112, P589, DOI 10.1016/S0092-8674(03)00151-X; Ciruela P, 2013, HUM VACC IMMUNOTHER, V9, P23270; CUNDELL DR, 1995, NATURE, V377, P435, DOI 10.1038/377435a0; Desa MNM, 2008, FEMS MICROBIOL LETT, V288, P125, DOI 10.1111/j.1574-6968.2008.01345.x; Feldman C, 2007, INT J INFECT DIS, V11, P11, DOI 10.1016/j.ijid.2005.09.002; Feldman Charles, 2014, F1000Prime Rep, V6, P82, DOI 10.12703/P6-82; Fletcher MA, 2014, EUR J CLIN MICROBIOL, V33, P879, DOI 10.1007/s10096-014-2062-6; Flynn A, 1996, CANCER SURV, V27, P293; Fowler MI, 2004, CELL MICROBIOL, V6, P555, DOI 10.1111/j.1462-5822.2004.00382.x; Garcia P, 1999, MOL MICROBIOL, V31, P1275, DOI 10.1046/j.1365-2958.1999.01238.x; Gupta R, 2013, INFECT IMMUN, V81, P3903, DOI 10.1128/IAI.00778-13; Hartel T, 2012, J BIOL CHEM, V287, P4260, DOI 10.1074/jbc.M111.304311; Hames C, 2009, J BACTERIOL, V191, P747, DOI 10.1128/JB.01103-08; Hammerschmidt S, 2005, INFECT IMMUN, V73, P4653, DOI 10.1128/IAI.73.8.4653-4667.2005; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Hendriksen WT, 2008, INFECT IMMUN, V76, P1230, DOI 10.1128/IAI.01004-07; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Johnston JW, 2006, INFECT IMMUN, V74, P1171, DOI 10.1128/IAI.74.2.1171-1180.2006; Kloosterman TG, 2006, J BIOL CHEM, V281, P25097, DOI 10.1074/jbc.M601661200; Lau GW, 2001, MOL MICROBIOL, V40, P555, DOI 10.1046/j.1365-2958.2001.02335.x; Lau JS, 2000, J CELL BIOCHEM, V79, P395, DOI 10.1002/1097-4644(20001201)79:3<395::AID-JCB50>3.0.CO;2-M; LeMessurier KS, 2006, MICROBIOL-SGM, V152, P305, DOI 10.1099/mic.0.28438-0; Li-Korotky HS, 2009, INT J PEDIATR OTORHI, V73, P1417, DOI 10.1016/j.ijporl.2009.07.007; Liu GY, 2006, APOPTOSIS, V11, P1773, DOI 10.1007/s10495-006-9512-2; Liu X, 2010, BMC GENOMICS, P11; Marion C, 2012, INFECT IMMUN, V80, P1390, DOI 10.1128/IAI.05756-11; Marra A, 2002, MICROBIOL-SGM, V148, P1483, DOI 10.1099/00221287-148-5-1483; Marriott HM, 2012, INFECT IMMUN, V80, P1140, DOI 10.1128/IAI.05697-11; Martner A, 2009, INFECT IMMUN, V77, P3826, DOI 10.1128/IAI.00290-09; Miron M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-333; Mitchell AM, 2010, CLIN MICROBIOL INFEC, V16, P411, DOI 10.1111/j.1469-0691.2010.03183.x; Mittal S, 2011, MOL BIOL CELL, V22, P748, DOI 10.1091/mbc.E10-11-0898; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Muchnik L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061128; Noppen M, 2000, AM J RESP CRIT CARE, V162, P1023, DOI 10.1164/ajrccm.162.3.9910050; Ogunniyi AD, 2010, J BACTERIOL, V192, P4489, DOI 10.1128/JB.00064-10; Orihuela CJ, 2004, J INFECT DIS, V190, P1661, DOI 10.1086/424596; Orihuela CJ, 2004, INFECT IMMUN, V72, P5582, DOI 10.1128/IAI.72.10.5582-5596.2004; Owen KA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004159; PANG JH, 1993, J BIOL CHEM, V268, P2909; Pellegrino MW, 2014, NATURE, V516, P414, DOI 10.1038/nature13818; Quadri Amal, 2002, Paediatr Respir Rev, V3, P349, DOI 10.1016/S1526054202002646; Ramos-Sevillano E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023626; Reiling JH, 2013, NAT CELL BIOL, V15, P1473, DOI 10.1038/ncb2865; Rottner K, 2005, DEV CELL, V9, P3, DOI 10.1016/j.devcel.2005.06.002; Saleh M, 2013, EMBO MOL MED, V5, P1852, DOI 10.1002/emmm.201202435; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Shin HS, 2010, FEMS IMMUNOL MED MIC, V60, P171, DOI 10.1111/j.1574-695X.2010.00733.x; Shrestha N, 2012, J BIOL CHEM, V287, P28738, DOI 10.1074/jbc.M112.375915; Simsir A, 1999, DIAGN CYTOPATHOL, V20, P125, DOI 10.1002/(SICI)1097-0339(199903)20:3<125::AID-DC3>3.0.CO;2-V; Song Xin-Ming, 2008, BMC Res Notes, V1, P64, DOI 10.1186/1756-0500-1-64; Tamura GS, 2002, INFECT IMMUN, V70, P2877, DOI 10.1128/IAI.70.6.2877-2885.2002; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Luong TT, 2015, INFECT IMMUN, V83, P108, DOI 10.1128/IAI.02434-14; Thach TT, 2014, FEBS OPEN BIO, V4, P672, DOI 10.1016/j.fob.2014.07.002; Wang C, 2014, NAT BIOTECHNOL, V32, P926, DOI 10.1038/nbt.3001; Wiedmaier N, 2008, INT J MED MICROBIOL, V298, P231, DOI 10.1016/j.ijmm.2007.06.001; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Wilkosz S, 2012, AM J RESP CELL MOL, V46, P180, DOI 10.1165/rcmb.2011-0182OC; Xuan BQ, 2009, J VIROL, V83, P3463, DOI 10.1128/JVI.02307-08; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yu J, 2001, MICROBIOL-UK, V147, P431, DOI 10.1099/00221287-147-2-431	73	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142773	10.1371/journal.pone.0142773	http://dx.doi.org/10.1371/journal.pone.0142773			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26566142	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000367628500053
J	Kisch, T; Weber, C; Rapoport, DH; Kruse, C; Schumann, S; Stang, FH; Siemers, F; Matthiessen, AE				Kisch, Tobias; Weber, Caroline; Rapoport, Daniel H.; Kruse, Charli; Schumann, Sandra; Stang, Felix H.; Siemers, Frank; Matthiessen, Anna E.			LPS-Stimulated Human Skin-Derived Stem Cells Enhance Neo-Vascularization during Dermal Regeneration	PLOS ONE			English	Article							HINDLIMB ISCHEMIA; IMPROVE VASCULARIZATION; ENDOTHELIAL-CELLS; GENE-THERAPY; MOUSE MODEL; TNF-ALPHA; IN-VITRO; ANGIOGENESIS; ENDOTOXIN; LIPOPOLYSACCHARIDE	High numbers of adult stem cells are still required to improve the formation of new vessels in scaffolds to accelerate dermal regeneration. Recent data indicate a benefit for vascularization capacity by stimulating stem cells with lipopolysaccharide (LPS). In this study, stem cells derived from human skin (SDSC) were activated with LPS and seeded in a commercially available dermal substitute to examine vascularization in vivo. Besides, in vitro assays were performed to evaluate angiogenic factor release and tube formation ability. Results showed that LPS-activated SDSC significantly enhanced vascularization of the scaffolds, compared to unstimulated stem cells in vivo. Further, in vitro assays confirmed higher secretion rates of proangiogenic as well as proinflammatoric factors in the presence of LPSactivated SDSC. Our results suggest that combining activated stem cells and a dermal substitute is a promising option to enhance vascularization in scaffold-mediated dermal regeneration.	[Kisch, Tobias; Stang, Felix H.] Med Univ Lubeck, Dept Plast Surg & Hand Surg, D-23538 Lubeck, Germany; [Weber, Caroline; Rapoport, Daniel H.; Kruse, Charli; Schumann, Sandra; Matthiessen, Anna E.] Fraunhofer Res Inst Marine Biotechnol, Lubeck, Germany; [Siemers, Frank] BG Kliniken Bergmannstrost, Dept Plast Surg & Hand Surg, Halle, Germany	University of Lubeck	Kisch, T (corresponding author), Med Univ Lubeck, Dept Plast Surg & Hand Surg, D-23538 Lubeck, Germany.	tobias.kisch@uksh.de	Kisch, Tobias/AAR-4695-2021; Kisch, Tobias/CAH-2458-2022	Kisch, Tobias/0000-0002-0655-2119; Schumann, Sandra/0000-0001-5316-6424	European Union, European Regional Development Fund (ERDF)	European Union, European Regional Development Fund (ERDF)	This work was sponsored by European Union, European Regional Development Fund (ERDF) [http://ec.europa.eu/regional_policy/en/projects/germany/science-as-a-growth-engine].	Brat DJ, 2005, NEURO-ONCOLOGY, V7, P122, DOI 10.1215/S1152851704001061; Bruns S, 2007, J BIOMED MATER RES A, V81A, P736, DOI 10.1002/jbm.a.31120; BUCHMAN TG, 1993, AM J PHYSIOL, V265, pH165, DOI 10.1152/ajpheart.1993.265.1.H165; Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848; Carpentier G, 2012, 4 IMAGEJ US DEV C P, P198; Cho HH, 2009, CELL PHYSIOL BIOCHEM, V24, P511, DOI 10.1159/000257495; Choi JH, 1998, J BIOL CHEM, V273, P29915, DOI 10.1074/jbc.273.45.29915; COLBURN P, 1994, J CELL PHYSIOL, V159, P121, DOI 10.1002/jcp.1041590116; Connolly JO, 2002, MOL BIOL CELL, V13, P2474, DOI 10.1091/mbc.E02-01-0006; Crisostomo PR, 2008, AM J PHYSIOL-CELL PH, V294, pC675, DOI 10.1152/ajpcell.00437.2007; Danner S, 2012, J INVEST DERMATOL, V132, P1707, DOI 10.1038/jid.2012.31; Dunzendorfer S, 2004, J IMMUNOL, V173, P1166, DOI 10.4049/jimmunol.173.2.1166; Egana JT, 2009, BIOMATERIALS, V30, P5918, DOI 10.1016/j.biomaterials.2009.07.023; EPSTEIN J, 1990, IN VITRO CELL DEV B, V26, P1121; Ferrari G, 2009, J CELL PHYSIOL, V219, P449, DOI 10.1002/jcp.21706; Gerharz M, 2007, WOUND REPAIR REGEN, V15, P105, DOI 10.1111/j.1524-475X.2006.00191.x; Grochot-Przeczek A, 2013, GENE, V525, P220, DOI 10.1016/j.gene.2013.03.097; Kajahn J, 2008, EUR J CELL BIOL, V87, P39, DOI 10.1016/j.ejcb.2007.07.004; Kostarnoy AV, 2013, J INTERF CYTOK RES, V33, P514, DOI 10.1089/jir.2012.0108; Kruse C, 2006, EXP DERMATOL, V15, P794, DOI 10.1111/j.1600-0625.2006.00471.x; Kruse C, 2006, ANN ANAT, V188, P503, DOI 10.1016/j.aanat.2006.07.012; Lim JH, 2012, MOL THER, V20, P778, DOI 10.1038/mt.2011.302; Liu Y, 2011, J BIOL CHEM, V286, P25007, DOI 10.1074/jbc.M110.213108; Loryman C, 2008, WOUND REPAIR REGEN, V16, P45, DOI 10.1111/j.1524-475X.2007.00290.x; Lugo LM, 2011, TISSUE ENG PT A, V17, P665, DOI [10.1089/ten.tea.2010.0125, 10.1089/ten.TEA.2010.0125]; Machens HG, 2006, PLAST RECONSTR SURG, V118, P820, DOI 10.1097/01.prs.0000233442.86110.87; MacNeil S, 2007, NATURE, V445, P874, DOI 10.1038/nature05664; MATTERN T, 1994, J IMMUNOL, V153, P2996; Nagel S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078365; Neal MD, 2006, J IMMUNOL, V176, P3070, DOI 10.4049/jimmunol.176.5.3070; Petschnik AE, 2010, BRIT J DERMATOL, V162, P380, DOI 10.1111/j.1365-2133.2009.09512.x; Petschnik AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024944; Plociennikowska A, 2015, CELL MOL LIFE SCI, V72, P557, DOI 10.1007/s00018-014-1762-5; Powell RJ, 2010, J VASC SURG, V52, P1525, DOI 10.1016/j.jvs.2010.07.044; Reckhenrich AK, 2011, BIOMATERIALS, V32, P1996, DOI 10.1016/j.biomaterials.2010.11.022; Reuwer AQ, 2012, J CELL MOL MED, V16, P2035, DOI 10.1111/j.1582-4934.2011.01499.x; Salem H, 2009, BIOMATERIALS, V30, P789, DOI 10.1016/j.biomaterials.2008.10.050; Salvucci O, 2004, J LEUKOCYTE BIOL, V76, P217, DOI 10.1189/jlb.1203609; SIBLEY CH, 1988, J BIOL CHEM, V263, P5098; SUGIURA M, 1989, BIOCHEM BIOPH RES CO, V161, P1220, DOI 10.1016/0006-291X(89)91372-7; TAO SY, 1994, AM J PHYSIOL-HEART C, V267, pH1745, DOI 10.1152/ajpheart.1994.267.5.H1745; Egana JT, 2009, TISSUE ENG PT A, V15, P1191, DOI 10.1089/ten.tea.2008.0097; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Yu M, 2014, RESPIRATION, V87, P317, DOI 10.1159/000357438; Zhang ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019192	45	7	7	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142907	10.1371/journal.pone.0142907	http://dx.doi.org/10.1371/journal.pone.0142907			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26565617	gold, Green Published, Green Submitted			2022-12-26	WOS:000367628500066
J	Qi, L; Sun, X; Li, FE; Zhu, BS; Braun, FK; Liu, ZQ; Tang, JL; Wu, C; Xu, F; Wang, HH; Velasquez, LA; Zhao, K; Lei, FR; Zhang, JG; Shen, YT; Zou, JX; Meng, HM; An, GL; Yang, L; Zhang, XD				Qi, Lin; Sun, Xue; Li, Feng-E; Zhu, Bao-Song; Braun, Frank K.; Liu, Zhi-Qiang; Tang, Jin-Le; Wu, Chao; Xu, Fei; Wang, Hui-Han; Velasquez, Luis A.; Zhao, Kui; Lei, Feng-Rui; Zhang, Ji-Gang; Shen, Yun-Tian; Zou, Jian-Xuan; Meng, Hui-Min; An, Gang-Li; Yang, Lin; Zhang, Xing-Ding			HMGB1 Promotes Mitochondrial Dysfunction-Triggered Striatal Neurodegeneration via Autophagy and Apoptosis Activation	PLOS ONE			English	Article							3-NITROPROPIONIC ACID; CELL-DEATH; PROTEINS; TOXIN; P53; RESISTANCE; JNK; ERK	Impairments in mitochondrial energy metabolism are thought to be involved in many neurodegenerative diseases. The mitochondrial inhibitor 3-nitropropionic acid (3-NP) induces striatal pathology mimicking neurodegeneration in vivo. Previous studies showed that 3-NP also triggered autophagy activation and apoptosis. In this study, we focused on the high-mobility group box 1 (HMGB1) protein, which is important in oxidative stress signaling as well as in autophagy and apoptosis, to explore whether the mechanisms of autophagy and apoptosis in neurodegenerative diseases are associated with metabolic impairment. To elucidate the role of HMGB1 in striatal degeneration, we investigated the impact of HMGB1 on autophagy activation and cell death induced by 3-NP. We intoxicated rat striata with 3-NP by stereotaxic injection and analyzed changes in expression HMGB1, proapoptotic proteins caspase-3 and phospho-c-Jun amino-terminal kinases (p-JNK). 3-NP-induced elevations in p-JNK, cleaved caspase-3, and autophagic marker LC3-II as well as reduction in SQSTM1 (p62), were significantly reduced by the HMGB1 inhibitor glycyrrhizin. Glycyrrhizin also significantly inhibited 3-NP-induced striatal damage. Neuronal death was replicated by exposing primary striatal neurons in culture to 3-NP. It was clear that HMGB1 was important for basal autophagy which was shown by rescue of cells through HMGB1 targeting shRNA approach. 3-NP also induced the expression of HMGB1, p-JNK, and LC3-II in striatal neurons, and p-JNK expression was significantly reduced by shRNA knockdown of HMGB1, an effect that was reversed by exogenously increased expression of HMGB1. These results suggest that HMGB1 plays important roles in signaling for both autophagy and apoptosis in neurodegeneration induced by mitochondrial dysfunction.	[Qi, Lin; Tang, Jin-Le; Wu, Chao; Xu, Fei; Zou, Jian-Xuan; Meng, Hui-Min; An, Gang-Li; Yang, Lin; Zhang, Xing-Ding] Soochow Univ, Cyrus Tang Med Inst, Hematol Ctr, Suzhou, Jiangsu, Peoples R China; [Braun, Frank K.; Liu, Zhi-Qiang; Wang, Hui-Han; Velasquez, Luis A.; Zhang, Xing-Ding] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA; [Qi, Lin; Braun, Frank K.] Texas Childrens Hosp, Baylor Coll Med, Lab Mol Neurooncol, Houston, TX 77030 USA; [Sun, Xue; Zhang, Ji-Gang] Soochow Univ, Affiliated Hosp 1, Dept Emergency, Suzhou, Jiangsu, Peoples R China; [Li, Feng-E] Tianjin Med Univ, Canc Hosp & Inst, Dept Intervent Treatment, Lab Canc Prevent & Therapy, Tianjin, Peoples R China; [Zhu, Bao-Song; Zhao, Kui] Soochow Univ, Affiliated Hosp 2, Dept Gen Surg, Suzhou, Jiangsu, Peoples R China; [Lei, Feng-Rui] Soochow Univ, Affiliated Hosp 2, Dept Vasc Surg, Suzhou, Jiangsu, Peoples R China; [Shen, Yun-Tian] Soochow Univ, Affiliated Hosp 2, Dept Radiotherapy Oncol, Suzhou, Jiangsu, Peoples R China	Soochow University - China; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Soochow University - China; Tianjin Medical University; Soochow University - China; Soochow University - China; Soochow University - China	Yang, L (corresponding author), Soochow Univ, Cyrus Tang Med Inst, Hematol Ctr, Suzhou, Jiangsu, Peoples R China.	yanglin@suda.edu.cn; ading5@hotmail.com	Zhang, Xingding/C-8780-2014; Zou, Jianxuan/AAD-9761-2019; Tang, Jinle/AAR-4056-2020	Zhang, Xingding/0000-0002-2759-5185; Zou, Jianxuan/0000-0001-7241-9191; Tang, Jinle/0000-0002-1844-6516	MD Anderson Cancer Center SPORE in Multiple Myeloma [5P50CA142509-04]; Priority Academic Program Development of Jiangsu Higher Education Institutions of China; National Natural Science Foundation of China [81201861, 31471283, 81101909]; Postdoctoral Science Foundation of China [2011M500949]; Multiple Myeloma Research Foundation; NATIONAL CANCER INSTITUTE [P50CA142509] Funding Source: NIH RePORTER	MD Anderson Cancer Center SPORE in Multiple Myeloma; Priority Academic Program Development of Jiangsu Higher Education Institutions of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Multiple Myeloma Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by The MD Anderson Cancer Center SPORE in Multiple Myeloma (5P50CA142509-04), by the Priority Academic Program Development of Jiangsu Higher Education Institutions of China, by the National Natural Science Foundation of China (Nos. 81201861, 31471283 and 81101909), by the Postdoctoral Science Foundation of China (2011M500949), and by the Multiple Myeloma Research Foundation 2013 Research Fellow Award (to X-D Zhang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonawich FJ, 2002, BRAIN RES BULL, V57, P647, DOI 10.1016/S0361-9230(01)00761-4; BEAL MF, 1993, J NEUROSCI, V13, P4181; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Boya P, 2003, ONCOGENE, V22, P6220, DOI 10.1038/sj.onc.1206827; Brouillet E, 2005, J NEUROCHEM, V95, P1521, DOI 10.1111/j.1471-4159.2005.03515.x; Garcia M, 2002, J NEUROSCI, V22, P2174, DOI 10.1523/JNEUROSCI.22-06-02174.2002; Guan JJ, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.546; Huang J, 2012, CANCER RES, V72, P230, DOI 10.1158/0008-5472.CAN-11-2001; Imamura T, 2001, J BIOL CHEM, V276, P7534, DOI 10.1074/jbc.M008143200; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Liu L, 2011, LEUKEMIA, V25, P23, DOI 10.1038/leu.2010.225; Livesey KM, 2012, CANCER RES, V72, P1996, DOI 10.1158/0008-5472.CAN-11-2291; Mollica L, 2007, CHEM BIOL, V14, P431, DOI 10.1016/j.chembiol.2007.03.007; OBERHAMMER F, 1993, J CELL SCI, V104, P317; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Qi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046834; Qin ZH, 1996, BRAIN RES, V725, P166, DOI 10.1016/S0006-8993(96)00200-4; Vis JC, 2002, NEUROSCI LETT, V329, P86, DOI 10.1016/S0304-3940(02)00581-5; Zhang XY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060781, 10.1371/journal.pone.0053931, 10.1371/journal.pone.0061922]; Zhang XD, 2010, ACTA PHARMACOL SIN, V31, P1208, DOI 10.1038/aps.2010.151; Zhang XD, 2009, J NEUROSCI RES, V87, P3600, DOI 10.1002/jnr.22152; Zhang XD, 2009, AUTOPHAGY, V5, P339, DOI 10.4161/auto.5.3.8174; Zhang XD, 2012, INT J BIOCHEM CELL B, V44, P1166, DOI 10.1016/j.biocel.2012.04.005; Zhao MY, 2011, BMB REP, V44, P601, DOI 10.5483/BMBRep.2011.44.9.601	25	21	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142901	10.1371/journal.pone.0142901	http://dx.doi.org/10.1371/journal.pone.0142901			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26565401	gold, Green Published, Green Submitted			2022-12-26	WOS:000367628500065
J	Qing, P; Li, XL; Zhang, Y; Li, YL; Xu, RX; Guo, YL; Li, S; Wu, NQ; Li, JJ				Qing, Ping; Li, Xiao-Lin; Zhang, Yan; Li, Yi-Lin; Xu, Rui-Xia; Guo, Yuan-Lin; Li, Sha; Wu, Na-Qiong; Li, Jian-Jun			Association of Big Endothelin-1 with Coronary Artery Calcification	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; ELECTRON-BEAM CT; CARDIOVASCULAR-DISEASE; COMPUTED-TOMOGRAPHY; HEART-ASSOCIATION; CARDIAC EVENTS; ATHEROSCLEROSIS; CALCIUM; RECEPTOR; CELLS	Background The coronary artery calcification (CAC) is clinically considered as one of the important predictors of atherosclerosis. Several studies have confirmed that endothelin-1(ET-1) plays an important role in the process of atherosclerosis formation. The aim of this study was to investigate whether big ET-1 is associated with CAC. Methods and Results A total of 510 consecutively admitted patients from February 2011 to May 2012 in Fu Wai Hospital were analyzed. All patients had received coronary computed tomography angiography and then divided into two groups based on the results of coronary artery calcium score (CACS). The clinical characteristics including traditional and calcification-related risk factors were collected and plasma big ET-1 level was measured by ELISA. Patients with CAC had significantly elevated big ET-1 level compared with those without CAC (0.5 +/- 0.4 vs. 0.2 +/- 0.2, P<0.001). In the multivariate analysis, big ET-1 (Tertile 2, HR = 3.09, 95% CI 1.66-5.74, P <0.001, Tertile3 HR = 10.42, 95% CI 3.62-29.99, P<0.001) appeared as an independent predictive factor of the presence of CAC. There was a positive correlation of the big ET-1 level with CACS (r = 0.567, p<0.001). The 10-year Framingham risk (%) was higher in the group with CACS>0 and the highest tertile of big ET-1 (P<0.01). The area under the receiver operating characteristic curve for the big ET-1 level in predicting CAC was 0.83 (95% CI 0.79-0.87, p<0.001), with a sensitivity of 70.6% and specificity of 87.7%. Conclusions The data firstly demonstrated that the plasma big ET-1 level was a valuable independent predictor for CAC in our study.	[Qing, Ping; Li, Xiao-Lin; Zhang, Yan; Xu, Rui-Xia; Guo, Yuan-Lin; Li, Sha; Wu, Na-Qiong; Li, Jian-Jun] Chinese Acad Med Sci, Peking Union Med Coll, Natl Ctr Cardiovasc Dis, Div Dyslipidemia,State Key Lab Cardiovasc Dis,Fu, Beijing 100037, Peoples R China; [Li, Yi-Lin] Xingtai Peoples Hosp, Dept Cardiol, Xingtai 054000, Hebei, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College	Li, JJ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Natl Ctr Cardiovasc Dis, Div Dyslipidemia,State Key Lab Cardiovasc Dis,Fu, Bei Li Shi Rd 167, Beijing 100037, Peoples R China.	lijianjun938@126.com			National Natural Scientific Foundation [81070171, 81241121]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20111106110013]; Capital Special Foundation of Clinical Application Research [Z121107001012015]; Capital Health Development Fund [2011400302]; Beijing Natural Science Foundation [7131014]	National Natural Scientific Foundation(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Capital Special Foundation of Clinical Application Research; Capital Health Development Fund; Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was partly supported by National Natural Scientific Foundation (81070171, 81241121), Specialized Research Fund for the Doctoral Program of Higher Education of China (20111106110013), Capital Special Foundation of Clinical Application Research (Z121107001012015), Capital Health Development Fund (2011400302), and Beijing Natural Science Foundation (7131014) awarded to Dr. Jian-Jun Li, MD, PhD.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Barton M, 1998, P NATL ACAD SCI USA, V95, P14367, DOI 10.1073/pnas.95.24.14367; Barton M, 2014, LIFE SCI; Budoff MJ, 2009, J AM COLL CARDIOL, V53, P345, DOI 10.1016/j.jacc.2008.07.072; Cattaruzza M, 2000, FASEB J, V14, P991, DOI 10.1096/fasebj.14.7.991; Coylewright M, 2011, ATHEROSCLEROSIS, V219, P616, DOI 10.1016/j.atherosclerosis.2011.08.038; Dao HH, 2002, J HYPERTENS, V20, P1597, DOI 10.1097/00004872-200208000-00023; Essalihi R, 2004, J CARDIOVASC PHARM, V44, pS147, DOI 10.1097/01.fjc.0000166250.81733.a5; Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001; Huang PH, 2005, CHEST, V128, P810, DOI 10.1378/chest.128.2.810; Ihling C, 2001, CIRCULATION, V104, P864, DOI 10.1161/hc3301.094742; Ishibazawa A, 2011, INVEST OPHTH VIS SCI, V52, P8496, DOI 10.1167/iovs.11-7686; Ivey ME, 2008, ATHEROSCLEROSIS, V199, P237, DOI 10.1016/j.atherosclerosis.2008.03.006; Jordan W, 2002, NEUROSCI RES, V43, P127, DOI 10.1016/S0168-0102(02)00022-6; Kawanabe Y, 2011, CELL MOL LIFE SCI, V68, P195, DOI 10.1007/s00018-010-0518-0; Kelly-Arnold A, 2013, P NATL ACAD SCI USA, V110, P10741, DOI 10.1073/pnas.1308814110; Kolettis T. M., 2014, LIFE SCI; Lerman A, 2005, CIRCULATION, V111, P363, DOI 10.1161/01.CIR.0000153339.27064.14; Li JJ, 2009, CYTOKINE, V46, P61, DOI 10.1016/j.cyto.2008.12.012; Li J, 2012, CIRC J, V76, P2705, DOI 10.1253/circj.CJ-12-0683; Lin YJ, 2014, BIOCHEM BIOPH RES CO, V451, P263, DOI 10.1016/j.bbrc.2014.07.119; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Martin SS, 2014, CIRCULATION, V129, P77, DOI 10.1161/CIRCULATIONAHA.113.003625; MAUTNER GC, 1994, RADIOLOGY, V192, P619, DOI 10.1148/radiology.192.3.8058924; Moe SM, 2005, KIDNEY INT, V67, P2295, DOI 10.1111/j.1523-1755.2005.00333.x; Mustonen E, 2009, BLOOD PRESSURE, V18, P286, DOI 10.1080/08037050903244643; Nicholls SJ, 2007, J AM COLL CARDIOL, V49, P263, DOI 10.1016/j.jacc.2006.10.038; Otsuka F, 2013, ATHEROSCLEROSIS, V229, P34, DOI 10.1016/j.atherosclerosis.2012.12.032; Peltonen T, 2009, EUR HEART J, V30, P242, DOI 10.1093/eurheartj/ehn482; Rapoport RM, 2014, HYPERTENSION; RUMBERGER JA, 1995, CIRCULATION, V92, P2157, DOI 10.1161/01.CIR.92.8.2157; Sage AP, 2010, NAT REV CARDIOL, V7, P528, DOI 10.1038/nrcardio.2010.115; Sangiorgi G, 1998, J AM COLL CARDIOL, V31, P126, DOI 10.1016/S0735-1097(97)00443-9; Schuijf JD, 2009, HEART, V95, P1038, DOI 10.1136/hrt.2008.164582; Wexler L, 1996, CIRCULATION, V94, P1175, DOI 10.1161/01.CIR.94.5.1175; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wu SY, 2003, PEPTIDES, V24, P1149, DOI 10.1016/j.peptides.2003.07.008; Yamamoto H, 2011, CIRC J, V75, P2424, DOI 10.1253/circj.CJ-11-0087; ZEIHER AM, 1994, LANCET, V344, P1405, DOI 10.1016/S0140-6736(94)90571-1; Zhang XL, 2014, CORONARY ARTERY DIS, V25, P40, DOI 10.1097/MCA.0000000000000054	40	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142458	10.1371/journal.pone.0142458	http://dx.doi.org/10.1371/journal.pone.0142458			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26565974	Green Submitted, Green Published, gold			2022-12-26	WOS:000367628500024
J	Morris, JR; Vandermeer, J; Perfecto, I				Morris, Jonathan R.; Vandermeer, John; Perfecto, Ivette			A Keystone Ant Species Provides Robust Biological Control of the Coffee Berry Borer Under Varying Pest Densities	PLOS ONE			English	Article							HYPOTHENEMUS-HAMPEI COLEOPTERA; ECOSYSTEM SERVICES; ECOLOGICAL ROLE; SHADE COFFEE; SUN COFFEE; BIODIVERSITY; PREDATORS; CURCULIONIDAE; CONSERVATION; DIVERSITY	Species' functional traits are an important part of the ecological complexity that determines the provisioning of ecosystem services. In biological pest control, predator response to pest density variation is a dynamic trait that impacts the provision of this service in agroecosystems. When pest populations fluctuate, farmers relying on biocontrol services need to know how natural enemies respond to these changes. Here we test the effect of variation in coffee berry borer (CBB) density on the biocontrol efficiency of a keystone ant species (Azteca sericeasur) in a coffee agroecosystem. We performed exclosure experiments to measure the infestation rate of CBB released on coffee branches in the presence and absence of ants at four different CBB density levels. We measured infestation rate as the number of CBB bored into fruits after 24 hours, quantified biocontrol efficiency (BCE) as the proportion of infesting CBB removed by ants, and estimated functional response from ant attack rates, measured as the difference in CBB infestation between branches. Infestation rates of CBB on branches with ants were significantly lower (71%-82%) than on those without ants across all density levels. Additionally, biocontrol efficiency was generally high and did not significantly vary across pest density treatments. Furthermore, ant attack rates increased linearly with increasing CBB density, suggesting a Type I functional response. These results demonstrate that ants can provide robust biological control of CBB, despite variation in pest density, and that the response of predators to pest density variation is an important factor in the provision of biocontrol services. Considering how natural enemies respond to changes in pest densities will allow for more accurate biocontrol predictions and better-informed management of this ecosystem service in agroecosystems.	[Morris, Jonathan R.; Perfecto, Ivette] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; [Vandermeer, John] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Morris, JR (corresponding author), Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA.	jonno@umich.edu			University of Michigan, International Institute Individual Fellowship; University of Michigan, School of Natural Resources Thesis Research Grant; National Science Foundation [DEB-1262086, DEB-1144923]	University of Michigan, International Institute Individual Fellowship; University of Michigan, School of Natural Resources Thesis Research Grant; National Science Foundation(National Science Foundation (NSF))	Funding for this project was provided by the University of Michigan, International Institute Individual Fellowship and the University of Michigan, School of Natural Resources Thesis Research Grant to JRM, and National Science Foundation grant (DEB-1262086) to Stacy M. Philpott, and National Science Foundation Grant (DEB-1144923) to IP (http://www.ii.umich.edu/ii/fellowshipsandgrants/internationalinstituteindividualfellowshipsiiif_ci; http://www.snre.umich.edu/; http://www.nsf.gov/funding/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbrecht I, 2007, ENTOMOL EXP APPL, V124, P261, DOI 10.1111/j.1570-7458.2007.00574.x; Barbosa P.A., 1998, CONSERVATION BIOL CO; Barrera J. F., 2002, TRES PLAGAS CAFE CHI, P17; Barrera J.F., 2008, ENCY ENTOMOLOGY, P961, DOI [10.1007/978-1-4020-6359-6_751, DOI 10.1007/978-1-4020-6359-6_751]; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; BREENE RG, 1990, ENTOMOPHAGA, V35, P393, DOI 10.1007/BF02375263; Burbano E, 2010, NEW RECORD COFFEE BE, V11, P1; BUSTILLO ALEX E., 2002, Neotrop. entomol., V31, P635, DOI 10.1590/S1519-566X2002000400018; Chapin FS, 1997, SCIENCE, V277, P500, DOI 10.1126/science.277.5325.500; Damon A, 2000, B ENTOMOL RES, V90, P453, DOI 10.1017/S0007485300000584; de Bello F, 2010, BIODIVERS CONSERV, V19, P2873, DOI 10.1007/s10531-010-9850-9; Del Toro I, 2012, MYRMECOL NEWS, V17, P133; Gallego Ropero M. C., 2005, Manejo Integrado de Plagas y Agroecologia, P32; Gayahan GG, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3901; Gonthier DJ, 2013, BIOCONTROL, V58, P815, DOI 10.1007/s10526-013-9541-z; Haines-Young R., 2010, ECOSYSTEM ECOLOGY NE, DOI DOI 10.1017/CBO9780511750458.007; HASSELL MP, 1977, J ANIM ECOL, V46, P249, DOI 10.2307/3959; Holldobler B., 1982, Psyche (Cambridge), V89, P3, DOI 10.1155/1982/28390; HOLLING C. S., 1959, CANADIAN ENT, V91, P293; Holling C. S., 1965, Mem ent Soc Canada Ottawa, Vno. 45, P1; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Iverson AL, 2014, J APPL ECOL, V51, P1593, DOI 10.1111/1365-2664.12334; Jaramillo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024528; Jha S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043510; Jha S, 2011, ISS AGROECOL PRES, V1, P141, DOI 10.1007/978-94-007-1309-3_4; Jimenez-Soto E, 2013, ENVIRON ENTOMOL, V42, P915, DOI 10.1603/EN12202; Johnson MD, 2010, ANIM CONSERV, V13, P140, DOI 10.1111/j.1469-1795.2009.00310.x; Johnson S, 2015, PACIFIC BUSINESS NEW; Karp DS, 2013, ECOL LETT, V16, P1339, DOI 10.1111/ele.12173; Kellermann JL, 2008, CONSERV BIOL, V22, P1177, DOI 10.1111/j.1523-1739.2008.00968.x; Kremen C, 2005, FRONT ECOL ENVIRON, V3, P540, DOI 10.1890/1540-9295(2005)003[0540:ACTEMA]2.0.CO;2; Kremen C, 2005, ECOL LETT, V8, P468, DOI 10.1111/j.1461-0248.2005.00751.x; Kremen C, 2012, ECOL SOC, P17; Larsen A, 2010, BIOTROPICA, V42, P342, DOI 10.1111/j.1744-7429.2009.00603.x; Letourneau DK, 2011, ECOL APPL, V21, P9, DOI 10.1890/09-2026.1; LUFF ML, 1983, AGR ECOSYST ENVIRON, V10, P159, DOI 10.1016/0167-8809(83)90060-9; Martin-Wilkins A, 2012, JAMAICA OBSERVER, P1; Moguel P, 1999, CONSERV BIOL, V13, P11, DOI 10.1046/j.1523-1739.1999.97153.x; MURDOCH W W, 1975, P1; Naylor R. L., 1997, Nature's services: societal dependence on natural ecosystems., P151; Pardee GL, 2011, ENVIRON ENTOMOL, V40, P581, DOI 10.1603/EN11015; Perfecto I, 1996, BIOSCIENCE, V46, P598, DOI 10.2307/1312989; Perfecto I., 2009, NATURES MATRIX LINKI; Perfecto I, 2015, COFFEE AGROECOLOGY N; Perfecto I, 2006, AGR ECOSYST ENVIRON, V117, P218, DOI 10.1016/j.agee.2006.04.007; Perfecto I, 2014, ANNU REV ECOL EVOL S, V45, P137, DOI 10.1146/annurev-ecolsys-120213-091923; Perfecto Ivette, 1998, P269, DOI 10.1016/B978-012078147-8/50061-X; Philpott SM, 2008, ENVIRON ENTOMOL, V37, P181, DOI 10.1603/0046-225X(2008)37[181:BDOPAA]2.0.CO;2; Philpott SM, 2006, ECOL ENTOMOL, V31, P369, DOI 10.1111/j.1365-2311.2006.00793.x; RIECHERT SE, 1984, ANNU REV ENTOMOL, V29, P299, DOI 10.1146/annurev.en.29.010184.001503; RISCH SJ, 1982, OECOLOGIA, V55, P114, DOI 10.1007/BF00386726; Rosumek FB, 2009, OECOLOGIA, V160, P537, DOI 10.1007/s00442-009-1309-x; Schenk D, 2002, J ANIM ECOL, V71, P524, DOI 10.1046/j.1365-2656.2002.00620.x; Schmitz OJ, 2008, SCIENCE, V319, P952, DOI 10.1126/science.1152355; Straub CS, 2008, BIOL CONTROL, V45, P225, DOI 10.1016/j.biocontrol.2007.05.013; Styrsky JD, 2007, P ROY SOC B-BIOL SCI, V274, P151, DOI 10.1098/rspb.2006.3701; Symondson WOC, 2002, ANNU REV ENTOMOL, V47, P561, DOI 10.1146/annurev.ento.47.091201.145240; Team RDC, 2014, R LANG ENV STAT COMP; Trible W, 2014, ECOL ENTOMOL, V39, P603, DOI 10.1111/een.12139; Vandermeer J, 2010, BIOSCIENCE, V60, P527, DOI 10.1525/bio.2010.60.7.8; VARON EH, 2004, MANEJO INTEGRADO PLA, V73, P42; Vazquez Moreno Luis L., 2009, Fitosanidad, V13, P163; Vega F, 2008, ENCY ENTOMOLOGY, P959; Vega FE, 2003, NATURE, V425, P343, DOI 10.1038/425343a; Vega Fernando E., 2009, Terrestrial Arthropod Reviews, V2, P129; Velmourougane K, 2010, FOODBORNE PATHOG DIS, V7, P1279, DOI 10.1089/fpd.2010.0571; WAY MJ, 1992, ANNU REV ENTOMOL, V37, P479, DOI 10.1146/annurev.en.37.010192.002403; Wood SA, 2015, TRENDS ECOL EVOL, V30, P531, DOI 10.1016/j.tree.2015.06.013; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Zhang W, 2007, ECOL ECON, V64, P253, DOI 10.1016/j.ecolecon.2007.02.024	70	17	17	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142850	10.1371/journal.pone.0142850	http://dx.doi.org/10.1371/journal.pone.0142850			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562676	gold, Green Published, Green Submitted			2022-12-26	WOS:000364480900073
J	Zhang, XS				Zhang, Xu-Sheng			Strain Interactions as a Mechanism for Dominant Strain Alternation and Incidence Oscillation in Infectious Diseases: Seasonal Influenza as a Case Study	PLOS ONE			English	Article							CROSS-PROTECTIVE IMMUNITY; PANDEMIC H1N1; TRANSMISSION DYNAMICS; HUMAN COINFECTION; DUAL INFECTION; H3N2 VIRUSES; B VIRUSES; A H3N2; A/H1N1; PATTERNS	Background Many human infectious diseases are caused by pathogens that have multiple strains and show oscillation in infection incidence and alternation of dominant strains which together are referred to as epidemic cycling. Understanding the underlying mechanisms of epidemic cycling is essential for forecasting outbreaks of epidemics and therefore important for public health planning. Current theoretical effort is mainly focused on the factors that are extrinsic to the pathogens themselves ("extrinsic factors") such as environmental variation and seasonal change in human behaviours and susceptibility. Nevertheless, co-circulation of different strains of a pathogen was usually observed and thus strains interact with one another within concurrent infection and during sequential infection. The existence of these intrinsic factors is common and may be involved in the generation of epidemic cycling of multi-strain pathogens. Methods and Findings To explore the mechanisms that are intrinsic to the pathogens themselves ("intrinsic factors") for epidemic cycling, we consider a multi-strain SIRS model including cross-immunity and infectivity enhancement and use seasonal influenza as an example to parameterize the model. The Kullback-Leibler information distance was calculated to measure the match between the model outputs and the typical features of seasonal flu (an outbreak duration of 11 weeks and an annual attack rate of 15%). Results show that interactions among strains can generate seasonal influenza with these characteristic features, provided that: the infectivity of a single strain within concurrent infection is enhanced 2-7 times that within a single infection; cross-immunity as a result of past infection is 0.5-0.8 and lasts 2-9 years; while other parameters are within their widely accepted ranges (such as a 2-3 day infectious period and the basic reproductive number of 1.8-3.0). Moreover, the observed alternation of the dominant strain among epidemics emerges naturally from the best fit model. Alternative modelling that also includes seasonal forcing in transmissibility shows that both external mechanisms (i.e. seasonal forcing) and the intrinsic mechanisms (i.e., strain interactions) are equally able to generate the observed time-series in seasonal flu. Conclusions The intrinsic mechanism of strain interactions alone can generate the observed patterns of seasonal flu epidemics, but according to Kullback-Leibler information distance the importance of extrinsic mechanisms cannot be excluded. The intrinsic mechanism illustrated here to explain seasonal flu may also apply to other infectious diseases caused by polymorphic pathogens.	[Zhang, Xu-Sheng] Publ Hlth England, Ctr Infect Dis Surveillance & Control, Dept Stat Modelling & Econ, Modelling & Econ Unit, London, England; [Zhang, Xu-Sheng] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Ctr Outbreak Anal & Modelling, Dept Infect Dis Epidemiol,Med Res Council, London, England	Public Health England; Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Zhang, XS (corresponding author), Publ Hlth England, Ctr Infect Dis Surveillance & Control, Dept Stat Modelling & Econ, Modelling & Econ Unit, London, England.	xu-sheng.zhang@phe.gov.uk		Zhang, Xu-Sheng/0000-0002-6596-4500	Public Health England	Public Health England	Funding was provided by Public Health England. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by the Public Health England. The author would like to thank Tom Nichols and two anonymous referees for their helpful comments. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almajhdi FN, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/290609; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Axelsen JB, 2014, P NATL ACAD SCI USA, V111, P9538, DOI 10.1073/pnas.1321656111; Barry JM, 2008, J INFECT DIS, V198, P1427, DOI 10.1086/592454; Bedford T, 2014, ELIFE, V3, DOI 10.7554/eLife.01914; Birrell PJ, 2011, P NATL ACAD SCI USA, V108, P18238, DOI 10.1073/pnas.1103002108; Bodewes R, 2013, J VIROL, V87, P4293, DOI 10.1128/JVI.02536-12; Boelle PY, 2011, INFLUENZA OTHER RESP, V5, P306, DOI 10.1111/j.1750-2659.2011.00234.x; Brundage JF, 2006, LANCET INFECT DIS, V6, P303, DOI 10.1016/S1473-3099(06)70466-2; Bush RM, 2007, INFLUENZA EVOLUTION, P199; Calistri A, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-502; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; DAVIES JR, 1989, EPIDEMIOL INFECT, V102, P325, DOI 10.1017/S0950268800030004; Denoeud L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000464; Dowell SF, 2001, EMERG INFECT DIS, V7, P369; Dutry I., 2011, BMC P, V5, pP62, DOI DOI 10.1186/1753-6561-5-S1-P62; Epstein SL, 2010, EXPERT REV VACCINES, V9, P1325, DOI 10.1586/ERV.10.123; Falchi A, 2008, J CLIN VIROL, V41, P148, DOI 10.1016/j.jcv.2007.11.003; Fange Y, 2012, J VIROL, V86, P2229, DOI 10.1128/JVI.05540-11; Ferguson N, 1999, P NATL ACAD SCI USA, V96, P790, DOI 10.1073/pnas.96.2.790; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Finkelman BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001296; Ghedin E, 2009, J VIROL, V83, P8832, DOI 10.1128/JVI.00773-09; Goeyvaerts N, 2015, EPIDEMICS-NETH, V13, P1, DOI 10.1016/j.epidem.2015.04.002; Gog JR, 2002, P NATL ACAD SCI USA, V99, P17209, DOI 10.1073/pnas.252512799; Goldstein E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001051; Grassly NC, 2005, NATURE, V433, P417, DOI 10.1038/nature03072; Grassly NC, 2006, P ROY SOC B-BIOL SCI, V273, P2541, DOI 10.1098/rspb.2006.3604; Grenfell B, 2005, NATURE, V433, P366, DOI 10.1038/433366a; Gupta S, 1998, SCIENCE, V280, P912, DOI 10.1126/science.280.5365.912; Gupta V, 2006, VACCINE, V24, P3881, DOI 10.1016/j.vaccine.2006.01.010; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Huppert A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045107; Jackson C, 2013, BMJ OPEN, V3, pe002149, DOI [10.1136/bmjopen-2012-002149, DOI 10.1136/BMJOPEN-2012-002149]; Jang YH, 2012, J VIROL, V86, P5953, DOI 10.1128/JVI.07149-11; Ju LW, 2010, J MED VIROL, V82, P1299, DOI 10.1002/jmv.21807; Kamo M, 2002, PHYSICA D, V165, P228, DOI 10.1016/S0167-2789(02)00389-5; Khurana S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006366; Koelle K, 2006, P ROY SOC B-BIOL SCI, V273, P2879, DOI 10.1098/rspb.2006.3668; Kucharski AJ, 2015, EPIDEMIOL INFECT, V143, P1119, DOI 10.1017/S0950268814001976; Laurie KL, 2010, J INFECT DIS, V202, P1011, DOI 10.1086/656188; Lee N, 2010, ANN INTERN MED, V152, P618, DOI 10.7326/0003-4819-152-9-201005040-00021; Li J, 2014, EMERG INFECT DIS, V20, P1953, DOI 10.3201/eid2011.140897; Lipsitch M, 2009, P NATL ACAD SCI USA, V106, P3645, DOI 10.1073/pnas.0900933106; Liu JM, 2011, CHIN J NOSOCOMIOLOGY, V15, P52; Liu W, 2010, CLIN INFECT DIS, V50, P1359, DOI 10.1086/652143; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; Lopez-Perez D., 2009, VTC SPRING 2009 IEEE, P1, DOI [10.1371/currentsRRN1011, DOI 10.1109/VETECS.2009.5073515]; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Minayev P, 2009, J R SOC INTERFACE, V6, P509, DOI 10.1098/rsif.2008.0333; Myers CA, 2011, AM J TROP MED HYG, V85, P961, DOI 10.4269/ajtmh.2011.11-0098; OCHIAI H, 1992, J MED VIROL, V36, P217, DOI 10.1002/jmv.1890360312; Peacey M, 2010, EMERG INFECT DIS, V16, P1618, DOI 10.3201/eid1610.100116; Pitzer VE, 2011, P NATL ACAD SCI USA, V108, P19353, DOI 10.1073/pnas.1110507108; Qiu C, 2012, CLIN INFECT DIS, V54, P17, DOI 10.1093/cid/cir753; Recker M, 2007, P NATL ACAD SCI USA, V104, P7711, DOI 10.1073/pnas.0702154104; Recker M, 2009, P ROY SOC B-BIOL SCI, V276, P2541, DOI 10.1098/rspb.2009.0331; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Shimada S, 2006, JPN J INFECT DIS, V59, P67; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; Skowronski DM, 2013, EURO SURVEILL, V8; SONOGUCHI T, 1986, J INFECT DIS, V153, P33, DOI 10.1093/infdis/153.1.33; SONOGUCHI T, 1985, J INFECT DIS, V151, P81, DOI 10.1093/infdis/151.1.81; Stone L, 2007, NATURE, V446, P533, DOI 10.1038/nature05638; STRIKAS RA, 1986, J INFECT DIS, V153, P346, DOI 10.1093/infdis/153.2.346; TAMURA M, 1994, J VIROL, V68, P3499, DOI 10.1128/JVI.68.6.3499-3504.1994; Toda S, 2006, JPN J INFECT DIS, V59, P142; Tramuto F, 2014, INFECT GENET EVOL, V23, P95, DOI 10.1016/j.meegid.2014.01.032; Truscott J, 2012, J R SOC INTERFACE, V9, P304, DOI 10.1098/rsif.2011.0309; Tsuchihashi Y, 2012, CLIN INFECT DIS, V54, P381, DOI 10.1093/cid/cir787; Vaccarella S, 2011, J INFECT DIS, V204, P385, DOI 10.1093/infdis/jir286; White LJ, 2005, EPIDEMIOL INFECT, V133, P279, DOI 10.1017/S0950268804003450; World Health Organization, 2009, INFL FACT SHEET; Zhang W, 2009, IITSI 2009: SECOND INTERNATIONAL SYMPOSIUM ON INTELLIGENT INFORMATION TECHNOLOGY AND SECURITY INFORMATICS, P21, DOI 10.1109/IITSI.2009.11; Zhang X-S, 2015, BMC INFECT DIS UNPUB; Zhang XS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/375862; Zhang XS, 2013, EPIDEMICS-NETH, V5, P20, DOI 10.1016/j.epidem.2012.10.003; Zhao H, 2014, EURO SURVEILL, V19; Zhu YF, 2013, LANCET, V381, P2134, DOI 10.1016/S0140-6736(13)61135-6	80	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142170	10.1371/journal.pone.0142170	http://dx.doi.org/10.1371/journal.pone.0142170			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562668	Green Submitted, gold, Green Published			2022-12-26	WOS:000364480900019
J	Mageean, CJ; Griffiths, JR; Smith, DL; Clague, MJ; Prior, IA				Mageean, Craig J.; Griffiths, John R.; Smith, Duncan L.; Clague, Michael J.; Prior, Ian A.			Absolute Quantification of Endogenous Ras Isoform Abundance	PLOS ONE			English	Article							ALLELE-SPECIFIC IMBALANCE; COLORECTAL-CANCER; HIGH-SENSITIVITY; MUTANT PROTEINS; PLASMA-MEMBRANE; CELLS; LOCALIZATION; REPLACEMENT; ACTIVATION; MUTATIONS	Ras proteins are important signalling hubs situated near the top of networks controlling cell proliferation, differentiation and survival. Three almost identical isoforms, HRAS, KRAS and NRAS, are ubiquitously expressed yet have differing biological and oncogenic properties. In order to help understand the relative biological contributions of each isoform we have optimised a quantitative proteomics method for accurately measuring Ras isoform protein copy number per cell. The use of isotopic protein standards together with selected reaction monitoring for diagnostic peptides is sensitive, robust and suitable for application to sub-milligram quantities of lysates. We find that in a panel of isogenic SW48 colorectal cancer cells, endogenous Ras proteins are highly abundant with >= 260,000 total Ras protein copies per cell and the rank order of isoform abundance is KRAS>NRAS >= HRAS. A subset of oncogenic KRAS mutants exhibit increased total cellular Ras abundance and altered the ratio of mutant versus wild type KRAS protein. These data and methodology are significant because Ras protein copy number is required to parameterise models of signalling networks and informs interpretation of isoform-specific Ras functional data.	[Mageean, Craig J.; Clague, Michael J.; Prior, Ian A.] Univ Liverpool, Inst Translat Med, Div Cellular & Mol Physiol, Liverpool L69 3BX, Merseyside, England; [Griffiths, John R.; Smith, Duncan L.] Univ Manchester, Canc Res UK Manchester Inst, Manchester M20 4BX, Lancs, England	University of Liverpool; Cancer Research UK; University of Manchester	Prior, IA (corresponding author), Univ Liverpool, Inst Translat Med, Div Cellular & Mol Physiol, Liverpool L69 3BX, Merseyside, England.	iprior@liv.ac.uk	Clague, Michael J/A-7199-2008	Clague, Michael J/0000-0003-3355-9479; Prior, Ian/0000-0002-4055-5161	Wellcome Trust [WT089137]; European Union [259015]; Cancer Research UK [22308] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); Cancer Research UK(Cancer Research UK)	This work was supported by funding from the Wellcome Trust (IAP; ref. WT089137) and by European Union Seventh Framework Programme funding (MJC; grant no. 259015 COLTHERES). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Brun V, 2009, J PROTEOMICS, V72, P740, DOI 10.1016/j.jprot.2009.03.007; BUDAY L, 1993, MOL CELL BIOL, V13, P1903, DOI 10.1128/MCB.13.3.1903; Buhrman G, 2007, STRUCTURE, V15, P1618, DOI 10.1016/j.str.2007.10.011; Chiosea SI, 2011, MODERN PATHOL, V24, P1571, DOI 10.1038/modpathol.2011.109; Cox AD, 2011, SMALL GTPASES, V1, P2; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; Di Nicolantonio F, 2008, P NATL ACAD SCI USA, V105, P20864, DOI 10.1073/pnas.0808757105; Dupuis A, 2008, PROTEOMICS, V8, P4633, DOI 10.1002/pmic.200800326; Feng ZH, 2002, J NATL CANCER I, V94, P1527; FINNEY RE, 1993, SCIENCE, V260, P1524, DOI 10.1126/science.8502998; Halvey PJ, 2012, J PROTEOME RES, V11, P3908, DOI 10.1021/pr300161j; Henis YI, 2009, MOL MEMBR BIOL, V26, P80, DOI 10.1080/09687680802649582; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Lampson BL, 2013, CURR BIOL, V23, P70, DOI 10.1016/j.cub.2012.11.031; Laude AJ, 2008, J CELL SCI, V121, P421, DOI 10.1242/jcs.020107; LEON J, 1987, MOL CELL BIOL, V7, P1535, DOI 10.1128/MCB.7.4.1535; Lowenthal MS, 2014, ANAL CHEM, V86, P551, DOI 10.1021/ac4027274; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Markevich N. I., 2004, Systems Biology, V1, P104, DOI 10.1049/sb:20045003; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Omerovic J, 2008, ONCOGENE, V27, P2754, DOI 10.1038/sj.onc.1210925; Omerovic J, 2007, CELL MOL LIFE SCI, V64, P2575, DOI 10.1007/s00018-007-7133-8; Pershing NLK, 2015, J CLIN INVEST, V125, P222, DOI 10.1172/JCI77627; Plowman SJ, 2006, J EXP CLIN CANC RES, V25, P259; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Pritchard C, 2014, ANAL CHEM, V86, P6525, DOI 10.1021/ac501032q; Quinlan MP, 2009, FUTURE ONCOL, V5, P105, DOI 10.2217/14796694.5.1.105; Ruppen-Canas I, 2012, PROTEOMICS, V12, P1319, DOI 10.1002/pmic.201100611; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; SEEBURG PH, 1984, NATURE, V312, P71, DOI 10.1038/312071a0; Soh J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007464; Stites EC, 2007, SCIENCE, V318, P463, DOI 10.1126/science.1144642; Stites EC, 2010, ADV EXP MED BIOL, V680, P661, DOI 10.1007/978-1-4419-5913-3_73; Tian TH, 2007, NAT CELL BIOL, V9, P905, DOI 10.1038/ncb1615; Tian TH, 2010, BIOPHYS J, V99, P534, DOI 10.1016/j.bpj.2010.04.055; To MD, 2008, NAT GENET, V40, P1240, DOI 10.1038/ng.211; Unwin RD, 2005, MOL CELL PROTEOMICS, V4, P1134, DOI 10.1074/mcp.M500113-MCP200; Valtorta E, 2013, INT J CANCER, V133, P1259, DOI 10.1002/ijc.28106; Wang Q, 2011, P NATL ACAD SCI USA, V108, P2444, DOI 10.1073/pnas.1019203108; Xu J, 2013, CANCER DISCOV, V3, P993, DOI 10.1158/2159-8290.CD-13-0096; Zhou Y, 2015, BBA-MOL CELL RES, V1853, P841, DOI 10.1016/j.bbamcr.2014.09.008	44	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142674	10.1371/journal.pone.0142674	http://dx.doi.org/10.1371/journal.pone.0142674			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560143	gold, Green Published, Green Submitted			2022-12-26	WOS:000364433100110
J	Xiao, WQ; Jiang, WL; Shen, J; Yin, GJ; Fan, YT; Wu, DQ; Qiu, L; Yu, G; Xing, M; Hu, GY; Wang, XP; Wan, R				Xiao, Wenqin; Jiang, Weiliang; Shen, Jie; Yin, Guojian; Fan, Yuting; Wu, Deqing; Qiu, Lei; Yu, Ge; Xing, Miao; Hu, Guoyong; Wang, Xingpeng; Wan, Rong			Retinoic Acid Ameliorates Pancreatic Fibrosis and Inhibits the Activation of Pancreatic Stellate Cells in Mice with Experimental Chronic Pancreatitis via Suppressing the Wnt/beta-Catenin Signaling Pathway	PLOS ONE			English	Article							LIVER FIBROSIS; GENE-EXPRESSION; DUCTAL ADENOCARCINOMA; PULMONARY-FIBROSIS; BETA-CATENIN/TCF; BINDING-PROTEIN; DOWN-REGULATION; STEM-CELLS; IN-VITRO; WNT	Pancreatic fibrosis, a prominent feature of chronic pancreatitis (CP), induces persistent and permanent damage in the pancreas. Pancreatic stellate cells (PSCs) provide a major source of extracellular matrix (ECM) deposition during pancreatic injury, and persistent activation of PSCs plays a vital role in the progression of pancreatic fibrosis. Retinoic acid (RA), a retinoid, has a broad range of biological functions, including regulation of cell differentiation and proliferation, attenuating progressive fibrosis of multiple organs. In the present study, we investigated the effects of RA on fibrosis in experimental CP and cultured PSCs. CP was induced in mice by repetitive cerulein injection in vivo, and mouse PSCs were isolated and activated in vitro. Suppression of pancreatic fibrosis upon administration of RA was confirmed based on reduction of histological damage, a-smooth muscle actin (alpha-SMA) expression and mRNA levels of beta-catenin, platelet-derived growth factor (PDGF)-R beta transforming growth factor (TGF)-beta RII and collagen 1 alpha 1 in vivo. Wnt 2 and beta-catenin protein levels were markedly down-regulated, while Axin 2 expression level was up-regulated in the presence of RA, both in vivo and in vitro. Nuclear translation of beta-catenin was significantly decreased following RA treatment, compared with cerulein-induced CP in mice and activated PSCs. Furthermore, RA induced significant PSC apoptosis, inhibited proliferation, suppressed TCF/LEF-dependent transcriptional activity and ECM production of PSC via down-regulation of TGF beta RII, PDGFR beta and collagen 1 alpha 1 in vitro. These results indicate a critical role of the Wnt/beta-catenin signaling pathway in RA-induced effects on CP and PSC regulation and support the potential of RA as a suppressor of pancreatic fibrosis in mice.	[Xiao, Wenqin; Yin, Guojian; Fan, Yuting; Wu, Deqing; Qiu, Lei; Wan, Rong] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Gastroenterol, Shanghai 200092, Peoples R China; [Jiang, Weiliang; Yu, Ge; Xing, Miao; Hu, Guoyong; Wang, Xingpeng; Wan, Rong] Shanghai Jiao Tong Univ, Dept Gastroenterol, Shanghai Peoples Hosp 1, Sch Med, Shanghai 200030, Peoples R China; [Shen, Jie] Shanghai Second Mil Med Univ, Dept Gastroenterol, Shanghai Changzheng Hosp, Shanghai, Peoples R China	Tongji University; Shanghai Jiao Tong University; Naval Medical University	Wan, R (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Gastroenterol, Shanghai 200092, Peoples R China.	wanrong1970@163.com			National Natural Science Foundation of China [81270543]; Shanghai Science and Technology Committee Foundation [12ZR1423100, XBR2013082]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee Foundation(Shanghai Science & Technology Committee)	This study was partly supported by National Natural Science Foundation of China (No. 81270543), and partly supported by Shanghai Science and Technology Committee Foundation (No. 12ZR1423100 and XBR2013082). The funder designed the study and decided to publish the manuscript.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Apte MV, 1999, GUT, V44, P534, DOI 10.1136/gut.44.4.534; Apte MV, 2004, DIGEST DIS, V22, P273, DOI 10.1159/000082799; Apte MV, 1998, GUT, V43, P128, DOI 10.1136/gut.43.1.128; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Cheng JH, 2008, AM J PHYSIOL-GASTR L, V294, pG39, DOI 10.1152/ajpgi.00263.2007; Cheng SL, 2010, CIRC RES, V107, P271, DOI 10.1161/CIRCRESAHA.110.219899; Cisternas P, 2014, CURR MOL MED, V14, P510, DOI 10.2174/1566524014666140414210346; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Detlefsen S, 2006, MODERN PATHOL, V19, P1019, DOI 10.1038/modpathol.3800613; Dey P, 2014, ONCOTARGET, V5, P4480, DOI 10.18632/oncotarget.2041; Erkan M, 2012, CURR MOL MED, V12, P288, DOI 10.2174/156652412799218921; Erkan M, 2012, GUT, V61, P172, DOI 10.1136/gutjnl-2011-301220; Froeling FEM, 2011, GASTROENTEROLOGY, V141, P1486, DOI 10.1053/j.gastro.2011.06.047; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Haber PS, 1999, AM J PATHOL, V155, P1087, DOI 10.1016/S0002-9440(10)65211-X; He H, 2011, HEPATOLOGY, V53, P548, DOI 10.1002/hep.24047; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Henderson WR, 2010, P NATL ACAD SCI USA, V107, P14309, DOI 10.1073/pnas.1001520107; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hisamori S, 2008, LIVER INT, V28, P1217, DOI 10.1111/j.1478-3231.2008.01745.x; Hu GY, 2011, GUT, V60, P820, DOI 10.1136/gut.2010.215178; Hu Q, 2009, NEPHROL DIAL TRANSPL, V24, P3033, DOI 10.1093/ndt/gfp245; Hu YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095145; Huang GC, 2000, WORLD J GASTROENTERO, V6, P819, DOI 10.3748/wjg.v6.i6.819; Huang GL, 2013, MOL CELL BIOL, V33, P3416, DOI 10.1128/MCB.00384-13; Jaster R, 2003, BIOCHEM PHARMACOL, V66, P633, DOI 10.1016/S0006-2952(03)00390-3; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jiang F, 2006, J HEPATOL, V45, P401, DOI 10.1016/j.jhep.2006.03.016; Kim DM, 2013, BIOCHEM BIOPH RES CO, V434, P455, DOI 10.1016/j.bbrc.2013.03.095; Kobayashi H, 2002, GASTROENTEROLOGY, V123, P1331, DOI 10.1053/gast.2002.35949; Lim YC, 2012, EUR J CANCER, V48, P3310, DOI 10.1016/j.ejca.2012.04.013; Liu Y, 2014, INT J BIOCHEM CELL B, V47, P47, DOI 10.1016/j.biocel.2013.11.018; LONGNECKER DS, 1982, AM J PATHOL, V107, P103; LOTAN R, 1980, BIOCHIM BIOPHYS ACTA, V605, P33, DOI 10.1016/0304-419X(80)90021-9; Manolescu DC, 2014, APPL PHYSIOL NUTR ME, V39, P1127, DOI 10.1139/apnm-2014-0005; Masamune A, 2013, PANCREATOLOGY, V13, P102, DOI 10.1016/j.pan.2012.12.058; Masamune A, 2009, CLIN GASTROENTEROL H, V7, pS48, DOI 10.1016/j.cgh.2009.07.038; Masamune A, 2009, J GASTROENTEROL, V44, P249, DOI 10.1007/s00535-009-0013-2; Nagashio Y, 2004, LAB INVEST, V84, P1610, DOI 10.1038/labinvest.3700191; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Neuschwander-Tetri BA, 2000, LAB INVEST, V80, P143, DOI 10.1038/labinvest.3780018; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Okuno M, 1997, HEPATOLOGY, V26, P913, DOI 10.1002/hep.510260417; Okuno M, 2002, FRONT BIOSCI-LANDMRK, V7, pD204, DOI 10.2741/okuno; Omary MB, 2007, J CLIN INVEST, V117, P50, DOI 10.1172/JCI30082; PINZANI M, 1992, J HEPATOL, V14, P211, DOI 10.1016/0168-8278(92)90160-Q; Puig-Divi V, 1999, DIGESTION, V60, P166, DOI 10.1159/000007643; Rennoll SA, 2014, BIOCHEM BIOPH RES CO, V443, P217, DOI 10.1016/j.bbrc.2013.11.089; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; RUSSELL RM, 1974, NEW ENGL J MED, V291, P435, DOI 10.1056/NEJM197408292910903; SATO T, 1995, EXP CELL RES, V217, P72, DOI 10.1006/excr.1995.1065; SOLOMON TE, 1984, AM J PHYSIOL, V247, pG105, DOI 10.1152/ajpgi.1984.247.1.G105; Tabata C, 2006, AM J RESP CRIT CARE, V174, P1352, DOI 10.1164/rccm.200606-862OC; VANLAETHEM JL, 1995, GASTROENTEROLOGY, V108, P1873, DOI 10.1016/0016-5085(95)90152-3; von Toerne C, 2012, AM J TRANSPLANT, V12, P55, DOI 10.1111/j.1600-6143.2011.03776.x; Wang Q, 2008, ONCOGENE, V27, P1527, DOI 10.1038/sj.onc.1210793; Wang Q, 2010, ONCOGENE, V29, P128, DOI 10.1038/onc.2009.302; Wehr AY, 2011, PANCREAS, V40, P557, DOI 10.1097/MPA.0b013e318214efaf; Xi YM, 2014, CANCER LETT, V353, P8, DOI 10.1016/j.canlet.2014.07.010; Yang LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031807; Ye B, 2013, CARDIOVASC PATHOL, V22, P54, DOI 10.1016/j.carpath.2012.03.004; Zhou TB, 2013, INT J MOL SCI, V14, P226, DOI 10.3390/ijms14010226; Zhou TB, 2012, INT J MOL SCI, V13, P2769, DOI 10.3390/ijms13032769	64	32	34	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141462	10.1371/journal.pone.0141462	http://dx.doi.org/10.1371/journal.pone.0141462			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556479	gold, Green Published, Green Submitted			2022-12-26	WOS:000364430700030
J	Javed, A; Leuchte, N; Neumann, B; Sopper, S; Sauermann, U				Javed, Aneela; Leuchte, Nicole; Neumann, Bent; Sopper, Sieghart; Sauermann, Ulrike			Noncytolytic CD8(+) Cell Mediated Antiviral Response Represents a Strong Element in the Immune Response of Simian Immunodeficiency Virus-Infected Long-Term Non-Progressing Rhesus Macaques	PLOS ONE			English	Article							CD8+ T-CELLS; CONTROL HIV-INFECTION; SOLUBLE FACTORS; POPULATION-LEVEL; CLINICAL STATE; IN-VITRO; REPLICATION; SUPPRESSION; LYMPHOCYTES; INHIBITION	The ability of long term non progressors to maintain very low levels of HIV/SIV and a healthy state, involves various host genetic and immunological factors. CD8+ non-cytolytic antiviral response (CNAR) most likely plays an important role in this regard. In order to gain a deeper insight into this unique phenomenon, the ability of CD8+ T cells to suppress viral replication in vitro was investigated in 16 uninfected, longitudinally in 23 SIV-infected long-term non-progressing (LTNPs), and 10 SIV-infected rhesus macaques with progressing disease. An acute infection assay utilizing CD4(+) cells from MHC-mismatched monkeys to avoid cytolytic responses was employed. The study has identified CNAR as a long-term stable activity that inversely correlated with plasma viral load. The activity was also detected in CD8(+) cells of uninfected macaques, which indicates that CNAR is not necessarily a virus specific response but increases after SIV-infection. Physical contact between CD4(+) and CD8(+) cells was mainly involved in mediating viral inhibition. Loss of this activity appeared to be due to a loss of CNAR-expressing CD8+ cells as well as a reduction of CNAR-responsive CD4+ cells. In contrast, in vitro viral replication did not differ in CD4+ cells from un-infected macaques, CNAR(+) and CNAR(-) LTNPs. A role for transitional memory cells in supporting CNAR in the macaque model of AIDS was questionable. CNAR appears to represent an important part of the immune response displayed by CD8+ T cells which might be underestimated up to now.	[Javed, Aneela] Natl Univ Sci & Technol, Atta Ur Rahman Sch Appl Biosci ASAB, Islamabad, Pakistan; [Javed, Aneela; Leuchte, Nicole; Neumann, Bent; Sauermann, Ulrike] Deutsch Primatenzentrum GmbH, Leibniz Inst Primatenforsch, Abt Infekt Modelle, Gottingen, Germany; [Sopper, Sieghart] Med Univ Innsbruck, Tumor Immunol Lab, Hematol & Oncol, A-6020 Innsbruck, Austria; [Sopper, Sieghart] Tyrolean Canc Res Inst, Innsbruck, Austria	National University of Sciences & Technology - Pakistan; Deutsches Primatenzentrum (DPZ); Medical University of Innsbruck	Sauermann, U (corresponding author), Deutsch Primatenzentrum GmbH, Leibniz Inst Primatenforsch, Abt Infekt Modelle, Gottingen, Germany.	usauerm@dpz.eu	javed, Aneela/ABE-8794-2021; Sopper, Sieghart/I-3155-2018	javed, Aneela/0000-0003-0280-0610; Sopper, Sieghart/0000-0003-2265-1974	EU [262443]; Higher Education commission of Pakistan	EU(European Commission); Higher Education commission of Pakistan(Higher Education Commission of Pakistan)	Funding: This work was funded by EU-grant no. 262443. AJ was recipient of a scholarship by Higher Education commission of Pakistan.	Abdelwahab SF, 2003, P NATL ACAD SCI USA, V100, P15006, DOI 10.1073/pnas.2035075100; al Basatena NKS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003656; Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Bailey JR, 2008, J VIROL, V82, P7395, DOI 10.1128/JVI.00800-08; Barker E, 1998, BLOOD, V92, P3105, DOI 10.1182/blood.V92.9.3105.421k46_3105_3114; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Blackbourn DJ, 1996, P NATL ACAD SCI USA, V93, P13125, DOI 10.1073/pnas.93.23.13125; Blackbourn DJ, 1997, AIDS, V11, P737, DOI 10.1097/00002030-199706000-00006; Boaz MJ, 2002, J IMMUNOL, V169, P6376, DOI 10.4049/jimmunol.169.11.6376; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Buckheit RW, 2012, J VIROL, V86, P13679, DOI 10.1128/JVI.02439-12; Buzon MJ, 2014, JAIDS-J ACQ IMM DEF, V65, P1, DOI 10.1097/QAI.0b013e3182a1bc81; Carlson JM, 2012, J VIROL, V86, P13202, DOI 10.1128/JVI.01998-12; Castelli JC, 2002, BLOOD, V99, P4225, DOI 10.1182/blood-2001-11-0078; CASTRO BA, 1991, CELL IMMUNOL, V132, P246, DOI 10.1016/0008-8749(91)90023-5; Chauhan NK, 2012, J MED VIROL, V84, P845, DOI 10.1002/jmv.23289; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Cocchi F, 2012, P NATL ACAD SCI USA, V109, P5411, DOI 10.1073/pnas.1202240109; Daza-Vamenta R, 2004, GENOME RES, V14, P1501, DOI 10.1101/gr.2134504; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; DeVico AL, 2004, NAT REV MICROBIOL, V2, P401, DOI 10.1038/nrmicro878; Dioszeghy V, 2006, J VIROL, V80, P236, DOI 10.1128/JVI.80.1.236-245.2006; ENNEN J, 1994, P NATL ACAD SCI USA, V91, P7207, DOI 10.1073/pnas.91.15.7207; Flynn JN, 2002, VET IMMUNOL IMMUNOP, V85, P159, DOI 10.1016/S0165-2427(01)00425-1; Freel SA, 2012, J VIROL, V86, P6835, DOI 10.1128/JVI.00437-12; Freel SA, 2010, J VIROL, V84, P4998, DOI 10.1128/JVI.00138-10; Guan Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003481; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hayden EC, 2013, NATURE, V504, P192; Hutter G, 2011, CLIN EXP IMMUNOL, V163, P284, DOI 10.1111/j.1365-2249.2010.04312.x; KANNAGI M, 1988, J IMMUNOL, V140, P2237; Kaur G, 2007, VIROLOGY, V369, P214, DOI 10.1016/j.virol.2007.07.031; Killian MS, 2013, J INTERF CYTOK RES, V33, P632, DOI 10.1089/jir.2012.0067; Killian MS, 2011, J VIROL, V85, P1696, DOI 10.1128/JVI.01120-10; Klatt NR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000747; Koga M, 2010, MICROBIOL IMMUNOL, V54, P196, DOI 10.1111/j.1348-0421.2010.00206.x; Le Borgne S, 2000, J VIROL, V74, P4456, DOI 10.1128/JVI.74.10.4456-4464.2000; Leslie A, 2010, J VIROL, V84, P9879, DOI 10.1128/JVI.00320-10; Levy JA, 2003, TRENDS IMMUNOL, V24, P628, DOI 10.1016/j.it.2003.10.005; Lu W, 2012, CELL REP, V2, P1736, DOI 10.1016/j.celrep.2012.11.016; Mackewicz CE, 2003, P NATL ACAD SCI USA, V100, P3433, DOI 10.1073/pnas.0630379100; MACKEWICZ CE, 1991, J CLIN INVEST, V87, P1462, DOI 10.1172/JCI115153; MACKEWICZ CE, 1994, CELL IMMUNOL, V153, P329, DOI 10.1006/cimm.1994.1032; Negri DRM, 2004, J GEN VIROL, V85, P1191, DOI 10.1099/vir.0.79794-0; O'Connor DH, 2004, J VIROL, V78, P14012, DOI 10.1128/JVI.78.24.14012-14022.2004; Ochieng W, 2009, JAIDS-J ACQ IMM DEF, V52, P162, DOI 10.1097/QAI.0b013e3181b22f4a; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; POWELL JD, 1993, CLIN EXP IMMUNOL, V91, P473; Raposo RAS, 2011, J IMMUNOL, V187, P748, DOI 10.4049/jimmunol.1003678; Sauermann U, 2008, GENES IMMUN, V9, P69, DOI 10.1038/sj.gene.6364448; Schultheiss T, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-24; SHEPPARD HW, 1993, AIDS, V7, P1159, DOI 10.1097/00002030-199309000-00002; Stephenson KE, 2012, J VIROL, V86, P9583, DOI 10.1128/JVI.00996-12; Tumne A, 2009, J VIROL, V83, P4354, DOI 10.1128/JVI.02629-08; Varadarajan N, 2011, J CLIN INVEST, V121, P4322, DOI 10.1172/JCI58653; Vella C., 2003, Current Drug Targets - Infectious Disorders, V3, P97, DOI 10.2174/1568005033481196; WALKER CM, 1991, CELL IMMUNOL, V137, P420, DOI 10.1016/0008-8749(91)90090-X; WALKER CM, 1986, SCIENCE, V234, P1563, DOI 10.1126/science.2431484; WALKER CM, 1991, J VIROL, V65, P5921, DOI 10.1128/JVI.65.11.5921-5927.1991; Wiseman RW, 2009, NAT MED, V15, P1322, DOI 10.1038/nm.2038; Wong JK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000748; Yamamoto T, 2012, J VIROL, V86, P5877, DOI 10.1128/JVI.00315-12; Yang HB, 2012, J INFECT DIS, V206, P552, DOI 10.1093/infdis/jis379; Yuan L, 2009, CURR HIV RES, V7, P437, DOI 10.2174/157016209788680561	66	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0142086	10.1371/journal.pone.0142086	http://dx.doi.org/10.1371/journal.pone.0142086			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26551355	Green Submitted, Green Published, gold			2022-12-26	WOS:000364422800016
J	Burgos-Silva, M; Semedo-Kuriki, P; Donizetti-Oliveira, C; Costa, PB; Cenedeze, MA; Hiyane, MI; Pacheco-Silva, A; Camara, NOS				Burgos-Silva, Marina; Semedo-Kuriki, Patricia; Donizetti-Oliveira, Cassiano; Costa, Priscilla Barbosa; Cenedeze, Marco Antonio; Hiyane, Meire Ioshie; Pacheco-Silva, Alvaro; Saraiva Camara, Niels Olsen			Adipose Tissue-Derived Stem Cells Reduce Acute and Chronic Kidney Damage in Mice	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; ACID-INDUCED NEPHROTOXICITY; HORMONE-RELATED PROTEIN; FOLIC-ACID; INJURY; DISEASE; PROGRESSION; FIBROSIS; RECOVERY; RATS	Acute and chronic kidney injuries (AKI and CKI) constitute syndromes responsible for a large part of renal failures, and are today still associated with high mortality rates. Given the lack of more effective therapies, there has been intense focus on the use stem cells for organ protective and regenerative effects. Mesenchymal stem cells (MSCs) have shown great potential in the treatment of various diseases of immune character, although there is still debate on its mechanism of action. Thus, for a greater understanding of the role of MSCs, we evaluated the effect of adipose tissue-derived stem cells (AdSCs) in an experimental model of nephrotoxicity induced by folic acid (FA) in FVB mice. AdSC-treated animals displayed kidney functional improvement 24h after therapy, represented by reduced serum urea after FA. These data correlated with cell cycle regulation and immune response modulation via reduced chemokine expression and reduced neutrophil infiltrate. Long-term analyses, 4 weeks after FA, indicated that AdSC treatment reduced kidney fibrosis and chronic inflammation. These were demonstrated by reduced interstitial collagen deposition and tissue chemokine and cytokine expression. Thus, we concluded that AdSC treatment played a protective role in the framework of nephrotoxic injury via modulation of inflammation and cell cycle regulation, resulting in reduced kidney damage and functional improvement, inhibiting organ fibrosis and providing long-term immune regulation.	[Burgos-Silva, Marina; Semedo-Kuriki, Patricia; Donizetti-Oliveira, Cassiano; Costa, Priscilla Barbosa; Cenedeze, Marco Antonio; Pacheco-Silva, Alvaro; Saraiva Camara, Niels Olsen] Univ Fed Sao Paulo, Div Nephrol, Sao Paulo, Brazil; [Burgos-Silva, Marina; Hiyane, Meire Ioshie; Saraiva Camara, Niels Olsen] Univ Fed Sao Paulo, Dept Immunol, Inst Biomed Sci 4, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Camara, NOS (corresponding author), Univ Fed Sao Paulo, Div Nephrol, Sao Paulo, Brazil.	niels@icb.usp.br	Semedo-Kuriki, Patricia/D-2429-2010; da Silva, Marina Burgos/C-3026-2012; da Silva, Marina Burgos/AAR-5639-2020; camara, niels olsen saraiva/AAX-3269-2020; Camara, Niels OS/G-8336-2011	da Silva, Marina Burgos/0000-0001-8630-7211; camara, niels olsen saraiva/0000-0001-5436-1248; Camara, Niels OS/0000-0001-5436-1248; Semedo-Kuriki, Patricia/0000-0002-2136-3308	Sao Paulo Research Foundation (FAPESP) [2012/02270-2]; National Council for Scientific and Technological Development [134212/2010-0, 132730/2010-3]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Sao Paulo Research Foundation (FAPESP) (http://www.fapesp.br/en/) Grant number: 2012/02270-2 to MB, and National Council for Scientific and Technological Development (http://www.cnpq.br) Grant numbers: 134212/2010-0 and 132730/2010-3 to MB.	Chawla LS, 2011, KIDNEY INT, V79, P1361, DOI 10.1038/ki.2011.42; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Doi K, 2006, AM J PATHOL, V168, P1413, DOI 10.2353/ajpath.2006.050634; Donizetti-Oliveira C, 2012, CELL TRANSPLANT, V21, P1727, DOI 10.3727/096368911X623925; Fang TC, 2005, J AM SOC NEPHROL, V16, P1723, DOI 10.1681/ASN.2004121089; Fang TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046504; Furuichi K, 2012, CLIN EXP NEPHROL, V16, P679, DOI 10.1007/s10157-012-0614-6; Gatti S, 2011, NEPHROL DIAL TRANSPL, V26, P1474, DOI 10.1093/ndt/gfr015; Hauser PV, 2010, AM J PATHOL, V177, P2011, DOI 10.2353/ajpath.2010.091245; He J, 2012, NEPHROLOGY, V17, P493, DOI 10.1111/j.1440-1797.2012.01589.x; Kim JH, 2012, AM J PHYSIOL-RENAL, V302, pF1141, DOI 10.1152/ajprenal.00060.2011; KLINGLER EL, 1980, ARCH PATHOL LAB MED, V104, P87; Long DA, 2001, J AM SOC NEPHROL, V12, P2721, DOI 10.1681/ASN.V12122721; Morigi M, 2008, STEM CELLS, V26, P2075, DOI 10.1634/stemcells.2007-0795; Ortega A, 2006, J AM SOC NEPHROL, V17, P1594, DOI 10.1681/ASN.2005070690; PARCHURE M, 1985, EXPERIENTIA, V41, P72, DOI 10.1007/BF02005881; Santos S, 2001, KIDNEY INT, V60, P982, DOI 10.1046/j.1523-1755.2001.060003982.x; Semedo P, 2010, LAB INVEST, V90, P685, DOI 10.1038/labinvest.2010.45; SHIRAI T, 1984, J NATL CANCER I, V72, P477; Stagg J, 2007, TISSUE ANTIGENS, V69, P1, DOI 10.1111/j.1399-0039.2006.00739.x; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Wan B, 2006, EXP MOL PATHOL, V81, P211, DOI 10.1016/j.yexmp.2006.02.005; Zarjou A, 2011, AM J PHYSIOL-RENAL, V300, pF254, DOI 10.1152/ajprenal.00594.2010	23	28	32	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142183	10.1371/journal.pone.0142183	http://dx.doi.org/10.1371/journal.pone.0142183			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26565621	Green Submitted, Green Published, gold			2022-12-26	WOS:000367628500012
J	Chu, XQ; Wang, C; Chen, XB; Lu, WJ; Li, H; Wang, XL; Hao, LL; Guo, XQ				Chu, Xiaoqian; Wang, Chen; Chen, Xiaobo; Lu, Wenjing; Li, Han; Wang, Xiuling; Hao, Lili; Guo, Xingqi			The Cotton WRKY Gene GhWRKY41 Positively Regulates Salt and Drought Stress Tolerance in Transgenic Nicotiana benthamiana	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; ABSCISIC-ACID; ARABIDOPSIS-THALIANA; DISEASE RESISTANCE; HIGH-SALINITY; DNA-BINDING; ABA; TOBACCO; FAMILY; EXPRESSION	WRKY transcription factors constitute a very large family of proteins in plants and participate in modulating plant biological processes, such as growth, development and stress responses. However, the exact roles of WRKY proteins are unclear, particularly in non-model plants. In this study, Gossypium hirsutum WRKY41 (GhWRKY41) was isolated and transformed into Nicotiana benthamiana. Our results showed that overexpression of GhWRKY41 enhanced the drought and salt stress tolerance of transgenic Nicotiana benthamiana. The transgenic plants exhibited lower malondialdehyde content and higher antioxidant enzyme activity, and the expression of antioxidant genes was upregulated in transgenic plants exposed to osmotic stress. A beta-glucuronidase (GUS) staining assay showed that GhWRKY41 was highly expressed in the stomata when plants were exposed to osmotic stress, and plants overexpressing GhWRKY41 exhibited enhanced stomatal closure when they were exposed to osmotic stress. Taken together, our findings demonstrate that GhWRKY41 may enhance plant tolerance to stress by functioning as a positive regulator of stoma closure and by regulating reactive oxygen species (ROS) scavenging and the expression of antioxidant genes.	[Chu, Xiaoqian; Wang, Chen; Chen, Xiaobo; Lu, Wenjing; Li, Han; Wang, Xiuling; Hao, Lili; Guo, Xingqi] Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Guo, XQ (corresponding author), Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	xqguo@sdau.edu.cn			National Science Foundation of China [31171837, 31471424]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Science Foundation of China (grant nos. 31171837 and 31471424).; This work was financially supported by the National Science Foundation of China (grant Nos. 31171837 and 31471424).	Ariel FD, 2007, TRENDS PLANT SCI, V12, P419, DOI 10.1016/j.tplants.2007.08.003; Besseau S, 2012, J EXP BOT, V63, P2667, DOI 10.1093/jxb/err450; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Cheng Y, 2012, PLANT PHYSIOL, V159, P810, DOI 10.1104/pp.112.196816; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Dow GJ, 2014, NEW PHYTOL, V201, P1205, DOI 10.1111/nph.12586; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Fujita M, 2004, PLANT J, V39, P863, DOI 10.1111/j.1365-313X.2004.02171.x; Gao XQ, 2011, PLANT J, V66, P293, DOI 10.1111/j.1365-313X.2011.04491.x; Geilfus CM, 2015, NEW PHYTOL, V208, P803, DOI 10.1111/nph.13507; Hirayama T, 2007, TRENDS PLANT SCI, V12, P343, DOI 10.1016/j.tplants.2007.06.013; ISHIGURO S, 1994, MOL GEN GENET, V244, P563, DOI 10.1007/BF00282746; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Jiang WB, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-96; Jiang YQ, 2009, PLANT MOL BIOL, V69, P91, DOI 10.1007/s11103-008-9408-3; Johnson CS, 2002, PLANT CELL, V14, P1359, DOI 10.1105/tpc.001404; JONES RJ, 1970, J EXP BOT, V21, P714, DOI 10.1093/jxb/21.3.714; Kalde M, 2003, MOL PLANT MICROBE IN, V16, P295, DOI 10.1094/MPMI.2003.16.4.295; Krasensky J, 2012, J EXP BOT, V63, P1593, DOI 10.1093/jxb/err460; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Li HM, 2007, PLANT MOL BIOL, V65, P655, DOI 10.1007/s11103-007-9230-3; Li HE, 2010, PLANTA, V232, P1325, DOI 10.1007/s00425-010-1258-y; Li J, 2013, NEW PHYTOL, V200, P455, DOI 10.1111/nph.12378; Li YZ, 2013, FEBS J, V280, P5128, DOI 10.1111/febs.12488; Liang WW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-392; Liu QL, 2013, PLANT PHYSIOL BIOCH, V69, P27, DOI 10.1016/j.plaphy.2013.04.016; Lu WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068503; Luo M, 2005, P NATL ACAD SCI USA, V102, P17531, DOI 10.1073/pnas.0508418102; Luo X, 2013, J EXP BOT, V64, P2155, DOI 10.1093/jxb/ert073; Maeo K, 2001, BIOSCI BIOTECH BIOCH, V65, P2428, DOI 10.1271/bbb.65.2428; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Niu CF, 2012, PLANT CELL ENVIRON, V35, P1156, DOI 10.1111/j.1365-3040.2012.02480.x; Osakabe Y, 2014, NEW PHYTOL, V202, P35, DOI 10.1111/nph.12613; Pantin F, 2013, NEW PHYTOL, V197, P65, DOI 10.1111/nph.12013; Rabbani MA, 2003, PLANT PHYSIOL, V133, P1755, DOI 10.1104/pp.103.025742; Ramamoorthy R, 2008, PLANT CELL PHYSIOL, V49, P865, DOI 10.1093/pcp/pcn061; Ren XJ, 2010, BIOL PLANTARUM, V54, P684, DOI 10.1007/s10535-010-0121-0; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Shi J, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-22; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Sunilkumar G, 2006, P NATL ACAD SCI USA, V103, P18054, DOI 10.1073/pnas.0605389103; Torres MA, 1998, PLANT J, V14, P365, DOI 10.1046/j.1365-313X.1998.00136.x; Wang F, 2012, MOL BIOL REP, V39, P4553, DOI 10.1007/s11033-011-1245-9; Xiong L, 2002, PLANT CELL S; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	45	84	100	11	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0143022	10.1371/journal.pone.0143022	http://dx.doi.org/10.1371/journal.pone.0143022			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562293	Green Published, gold, Green Submitted			2022-12-26	WOS:000364480900088
J	Snow, JT; Polyviou, D; Skipp, P; Chrismas, NAM; Hitchcock, A; Geider, R; Moore, CM; Bibby, TS				Snow, Joseph T.; Polyviou, Despo; Skipp, Paul; Chrismas, Nathan A. M.; Hitchcock, Andrew; Geider, Richard; Moore, C. Mark; Bibby, Thomas S.			Quantifying Integrated Proteomic Responses to Iron Stress in the Globally Important Marine Diazotroph Trichodesmium	PLOS ONE			English	Article							CHLOROPHYLL-BINDING-PROTEIN; NITROGEN-FIXATION; CYANOBACTERIUM TRICHODESMIUM; ERYTHRAEUM IMS101; ATLANTIC-OCEAN; PHOTOSYSTEM-II; CROCOSPHAERA-WATSONII; ESCHERICHIA-COLI; N-2 FIXATION; HEME-UPTAKE	Trichodesmium is a biogeochemically important marine cyanobacterium, responsible for a significant proportion of the annual 'new' nitrogen introduced into the global ocean. These non-heterocystous filamentous diazotrophs employ a potentially unique strategy of near-concurrent nitrogen fixation and oxygenic photosynthesis, potentially burdening Trichodesmium with a particularly high iron requirement due to the iron-binding proteins involved in these processes. Iron availability may therefore have a significant influence on the biogeography of Trichodesmium. Previous investigations of molecular responses to iron stress in this keystone marine microbe have largely been targeted. Here a holistic approach was taken using a label-free quantitative proteomics technique (MSE) to reveal a sophisticated multi-faceted proteomic response of Trichodesmium erythraeum IMS101 to iron stress. Increased abundances of proteins known to be involved in acclimation to iron stress and proteins known or predicted to be involved in iron uptake were observed, alongside decreases in the abundances of iron-binding proteins involved in photosynthesis and nitrogen fixation. Preferential loss of proteins with a high iron content contributed to overall reductions of 55-60% in estimated proteomic iron requirements. Changes in the abundances of iron-binding proteins also suggested the potential importance of alternate photosynthetic pathways as Trichodesmium reallocates the limiting resource under iron stress. Trichodesmium therefore displays a significant and integrated proteomic response to iron availability that likely contributes to the ecological success of this species in the ocean.	[Snow, Joseph T.; Polyviou, Despo; Hitchcock, Andrew; Moore, C. Mark; Bibby, Thomas S.] Univ Southampton, Natl Oceanog Ctr Southampton, Ocean & Earth Sci, Southampton, Hants, England; [Snow, Joseph T.] Univ Manchester, Wolfson Mol Imaging Ctr, Manchester Acad Hlth Sci Ctr, Stem Cell & Leukaemia Prote Lab, Manchester, Lancs, England; [Skipp, Paul] Univ Southampton, Ctr Prote Res, Southampton, Hants, England; [Chrismas, Nathan A. M.] Univ Bristol, Sch Geog Sci, Bristol, Avon, England; [Hitchcock, Andrew] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Geider, Richard] Univ Essex, Sch Biol Sci, Colchester CO4 3SQ, Essex, England	NERC National Oceanography Centre; University of Southampton; University of Manchester; University of Southampton; University of Bristol; University of Sheffield; University of Essex	Snow, JT (corresponding author), Univ Southampton, Natl Oceanog Ctr Southampton, Ocean & Earth Sci, Southampton, Hants, England.	joseph.snow@manchester.ac.uk	Hitchcock, Andrew/AAM-2855-2020	Hitchcock, Andrew/0000-0001-6572-434X; Moore, Mark/0000-0002-9541-6046; Geider, Richard/0000-0003-3276-047X; Chrismas, Nathan/0000-0002-2165-3102; Bibby, Thomas/0000-0003-1743-473X	Natural Environment Research Council (NERC) U.K. [NE/F019254/1, NE/G015732/1]; NERC studentship; NERC [NE/F019254/1, NE/G015732/1] Funding Source: UKRI; Natural Environment Research Council [1272503, NE/F019254/1, NE/C001737/1, NE/G015732/1] Funding Source: researchfish	Natural Environment Research Council (NERC) U.K.(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC studentship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the Natural Environment Research Council (NERC) U.K. through grants NE/F019254/1 and NE/G015732/1 to T.S.B. and C.M.M. and a NERC studentship to J.T.S.; This work was supported by the Natural Environment Research Council (NERC) U.K. through grants NE/F019254/1 and NE/G015732/1 to T.S.B. and C.M.M. and a NERC studentship to J.T.S. We acknowledge Dominic Burg (University of Southampton), Maria Huerte-Ortega (University of Sheffield), Metodi Metodiev and Gergana Metodieva (University of Essex) for useful discussions relating to the development of some of the methods used in the current work. Two anonymous reviewers are thanked for comments which improved this manuscript.	Achilles KM, 2003, LIMNOL OCEANOGR, V48, P2250, DOI 10.4319/lo.2003.48.6.2250; Adams DG, 2000, CURR OPIN MICROBIOL, V3, P618, DOI 10.1016/S1369-5274(00)00150-8; Alldridge L, 2008, J PROTEOME RES, V7, P1458, DOI 10.1021/pr7007829; Allen AE, 2012, MOL BIOL EVOL, V29, P367, DOI 10.1093/molbev/msr223; Andreini C, 2013, NUCLEIC ACIDS RES, V41, pD312, DOI 10.1093/nar/gks1063; Behrenfeld MJ, 2008, PHILOS T R SOC B, V363, P2687, DOI 10.1098/rstb.2008.0019; Behrenfeld MJ, 2013, ANNU REV MAR SCI, V5, P217, DOI 10.1146/annurev-marine-121211-172356; Bergman B, 1997, FEMS MICROBIOL REV, V19, P139, DOI 10.1016/S0168-6445(96)00028-9; Berman-Frank I, 2001, SCIENCE, V294, P1534, DOI 10.1126/science.1064082; Berman-Frank I, 2007, LIMNOL OCEANOGR, V52, P2260, DOI 10.4319/lo.2007.52.5.2260; Bibby TS, 2001, NATURE, V412, P743, DOI 10.1038/35089098; BRICKMAN TJ, 1992, J BIOL CHEM, V267, P12350; Brown CM, 2008, MAR BIOL, V154, P413, DOI 10.1007/s00227-008-0933-z; Capone DG, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002331; Castruita M, 2006, APPL ENVIRON MICROB, V72, P2918, DOI 10.1128/AEM.72.4.2918-2924.2006; Cereda A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091484; Chappell PD, 2010, ENVIRON MICROBIOL, V12, P13, DOI 10.1111/j.1462-2920.2009.02026.x; Chappell PD, 2012, ISME J, V6, P1728, DOI 10.1038/ismej.2012.13; Chen YB, 1996, J PHYCOL, V32, P916, DOI 10.1111/j.0022-3646.1996.00916.x; Clarke AK, 1996, PLANT PHYSIOL, V112, P1551, DOI 10.1104/pp.112.4.1551; Dekker HL, 2004, BIOCHEMISTRY-US, V43, P10308, DOI [10.1021/bi048772lPMID:15301529, DOI 10.1021/BI048772L]; Dutkiewicz S., 2014, BIOGEOSCI DISCUSS, V11, P7113, DOI [10.5194/bgd-11-7113-2014, DOI 10.5194/BGD-11-7113-2014]; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; Fraser JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059861; Frederick RE, 2011, J AM CHEM SOC, V133, P12338, DOI 10.1021/ja203397s; GALLON JR, 1981, TRENDS BIOCHEM SCI, V6, P19, DOI 10.1016/0968-0004(81)90008-6; Geromanos SJ, 2009, PROTEOMICS, V9, P1683, DOI 10.1002/pmic.200800562; Glantz S., 1990, PRIMER APPL REGRESSI; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Gorby YA, 2006, P NATL ACAD SCI USA, V103, P11358, DOI 10.1073/pnas.0604517103; Grosskopf T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00236; GUERINOT ML, 1994, ANNU REV MICROBIOL, V48, P743, DOI 10.1146/annurev.micro.48.1.743; Guieu C, 2014, GLOBAL BIOGEOCHEM CY, V28, P1179, DOI 10.1002/2014GB004852; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Ho TY, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00139; Ho TY, 2013, LIMNOL OCEANOGR, V58, P112, DOI 10.4319/lo.2013.58.1.0112; Hopkinson BM, 2008, APPL ENVIRON MICROB, V74, P6263, DOI 10.1128/AEM.00964-08; Hopkinson BM, 2009, BIOMETALS, V22, P659, DOI 10.1007/s10534-009-9235-2; Izard T, 2004, J BIOL CHEM, V279, P11825, DOI 10.1074/jbc.M311375200; Jickells TD, 2005, SCIENCE, V308, P67, DOI 10.1126/science.1105959; KAMMLER M, 1993, J BACTERIOL, V175, P6212, DOI 10.1128/JB.175.19.6212-6219.1993; KANA TM, 1993, LIMNOL OCEANOGR, V38, P18, DOI 10.4319/lo.1993.38.1.0018; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kolber D, 2011, BIOCHEMISTRY-US, V50, P686, DOI [10.1021/bi1009425, DOI 10.1021/BI1009425]; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; KOSTER WL, 1991, J BIOL CHEM, V266, P23829; Kramer DM, 2011, PLANT PHYSIOL, V155, P70, DOI 10.1104/pp.110.166652; Kranzler C, 2013, ADV BOT RES, V65, P57, DOI 10.1016/B978-0-12-394313-2.00003-2; Kranzler C, 2011, ENVIRON MICROBIOL, V13, P2990, DOI 10.1111/j.1462-2920.2011.02572.x; Krauk JM, 2006, AQUAT MICROB ECOL, V42, P243, DOI 10.3354/ame042243; Kupper H, 2004, PLANT PHYSIOL, V135, P2120, DOI 10.1104/pp.104.045963; Kustka A, 2003, J PHYCOL, V39, P12, DOI 10.1046/j.1529-8817.2003.01156.x; Lamb JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105761; LaRoche J, 1996, NATURE, V382, P802; Latifi A, 2009, FEMS MICROBIOL REV, V33, P258, DOI 10.1111/j.1574-6976.2008.00134.x; Leuschner C, 1996, BIOCHEMISTRY-US, V35, P4551, DOI 10.1021/bi9522615; Li GZ, 2009, PROTEOMICS, V9, P1696, DOI 10.1002/pmic.200800564; Lohscheider J, 2008, NEW PHYTOL, V179, P784, DOI [10.1111/j.1469-8137.2008.02497.x, DOI 10.1111/J.1469-8137.2008.02497.X]; Lommer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r66; MacKenzie TDB, 2005, ARCH MICROBIOL, V183, P190, DOI 10.1007/s00203-005-0761-1; MARSH JJ, 1992, TRENDS BIOCHEM SCI, V17, P110, DOI 10.1016/0968-0004(92)90247-7; McKew BA, 2013, NEW PHYTOL, V200, P61, DOI 10.1111/nph.12352; Milligan AJ, 2007, J PHYCOL, V43, P845, DOI 10.1111/j.1529-8817.2007.00395.x; Mills MM, 2004, NATURE, V429, P292, DOI 10.1038/nature02550; Moore CM, 2009, NAT GEOSCI, V2, P867, DOI 10.1038/ngeo667; Nuester J, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00150; PAERL HW, 1987, LIMNOL OCEANOGR, V32, P525, DOI 10.4319/lo.1987.32.3.0525; Pfreundt U, 2014, SCI REP-UK, V4, DOI 10.1038/srep06187; Pirbadian S, 2014, P NATL ACAD SCI USA, V111, P12883, DOI 10.1073/pnas.1410551111; Polyviou D, 2015, ENV MICROBIOL REP, V7, P824, DOI 10.1111/1758-2229.12308; Popelkova L, 2011, J PHOTOCH PHOTOBIO B, V104, P179, DOI 10.1016/j.jphotobiol.2011.01.015; Reguera G, 2005, NATURE, V435, P1098, DOI 10.1038/nature03661; Richier S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035571; Rivers AR, 2009, ENVIRON MICROBIOL, V11, P382, DOI 10.1111/j.1462-2920.2008.01778.x; Roe KL, 2014, METALLOMICS, V6, P2042, DOI 10.1039/c4mt00026a; Roe KL, 2013, APPL ENVIRON MICROB, V79, P5753, DOI 10.1128/AEM.01562-13; Roe KL, 2012, ENVIRON MICROBIOL, V14, P1681, DOI 10.1111/j.1462-2920.2011.02653.x; Rubin M, 2011, NAT GEOSCI, V4, P529, DOI 10.1038/NGEO1181; Ryan-Keogh TJ, 2012, J PHYCOL, V48, P145, DOI 10.1111/j.1529-8817.2011.01092.x; Saito MA, 2011, P NATL ACAD SCI USA, V108, P2184, DOI 10.1073/pnas.1006943108; Sandh G, 2011, PROTEOMICS, V11, P406, DOI 10.1002/pmic.201000382; Sandh G, 2009, FEMS MICROBIOL LETT, V295, P281, DOI 10.1111/j.1574-6968.2009.01608.x; Sanudo-Wilhelmy SA, 2001, NATURE, V411, P66, DOI 10.1038/35075041; Schlosser C, 2014, P NATL ACAD SCI USA, V111, P1438, DOI 10.1073/pnas.1318670111; Schrader PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018753; Septer AN, 2011, ENVIRON MICROBIOL, V13, P2855, DOI 10.1111/j.1462-2920.2011.02558.x; Shaked Y, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00123; Sherrell RM, 2001, LIMNOL OCEANOGR, V46, P1249, DOI [10.4319/lo.2001.46.6.1249, DOI 10.4319/LO.2001.46.6.1249]; Shi DL, 2012, P NATL ACAD SCI USA, V109, pE3094, DOI 10.1073/pnas.1216012109; Shi T, 2007, ENVIRON MICROBIOL, V9, P2945, DOI 10.1111/j.1462-2920.2007.01406.x; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Silva JC, 2005, ANAL CHEM, V77, P2187, DOI 10.1021/ac048455k; Snow JT, 2015, GLOBAL BIOGEOCHEM CY, V29, P865, DOI 10.1002/2015GB005090; Sunda W. G., 2005, ALGAL CULTURING TECH, V2005, P35, DOI 10.1016/b978-012088426-1/50005-6; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; vandenBergh ERE, 1996, J BACTERIOL, V178, P888, DOI 10.1128/jb.178.3.888-893.1996; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Weaver RS, 2003, AQUAT MICROB ECOL, V31, P227, DOI 10.3354/ame031227; Webb EA, 2001, APPL ENVIRON MICROB, V67, P5444, DOI 10.1128/AEM.67.12.5444-5452.2001; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; Zehr JP, 2011, TRENDS MICROBIOL, V19, P162, DOI 10.1016/j.tim.2010.12.004	101	15	16	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142626	10.1371/journal.pone.0142626	http://dx.doi.org/10.1371/journal.pone.0142626			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562022	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000364480900050
J	Lee, YK; Lee, PY; Cheong, AT; Ng, CJ; Abdullah, KL; Ong, TA; Razack, AHA				Lee, Yew Kong; Lee, Ping Yein; Cheong, Ai Theng; Ng, Chirk Jenn; Abdullah, Khatijah Lim; Ong, Teng Aik; Razack, Azad Hassan Abdul			To Share or Not to Share: Malaysian Healthcare Professionals' Views on Localized Prostate Cancer Treatment Decision Making Roles	PLOS ONE			English	Article							BREAST-CANCER; TREATMENT OPTIONS; PATIENT AUTONOMY; PREFERENCES; PARTICIPATION; CULTURES; DOCTORS; JAPAN; WOMEN	Aim To explore the views of Malaysian healthcare professionals (HCPs) on stakeholders' decision making roles in localized prostate cancer (PCa) treatment. Methods Qualitative interviews and focus groups were conducted with HCPs treating PCa. Data was analysed using a thematic approach. Four in-depth interviews and three focus group discussions were conducted between December 2012 and March 2013 using a topic guide. Interviews were audio-recorded, transcribed verbatim, and analysed thematically. Findings The participants comprised private urologists (n = 4), government urologists (n = 6), urology trainees (n = 6), government policy maker (n = 1) and oncologists (n = 3). HCP perceptions of the roles of the three parties involved (HCPs, patients, family) included: HCP as the main decision maker, HCP as a guide to patients' decision making, HCP as a facilitator to family involvement, patients as main decision maker and patient prefers HCP to decide. HCPs preferred to share the decision with patients due to equipoise between prostate treatment options. Family culture was important as family members often decided on the patient's treatment due to Malaysia's close-knit family culture. Conclusions A range of decision making roles were reported by HCPs. It is thus important that stake-holder roles are clarified during PCa treatment decisions. HCPs need to cultivate an awareness of sociocultural norms and family dynamics when supporting non-Western patients in making decisions about PCa.	[Lee, Yew Kong; Ng, Chirk Jenn] Univ Malaya, Dept Primary Care Med, Fac Med, Kuala Lumpur 50603, Malaysia; [Lee, Ping Yein; Cheong, Ai Theng] Univ Putra Malaysia, Dept Family Med, Serdang 43400, Selangor, Malaysia; [Abdullah, Khatijah Lim] Univ Malaya, Dept Nursing Sci, Fac Med, Kuala Lumpur 50603, Malaysia; [Ong, Teng Aik; Razack, Azad Hassan Abdul] Univ Malaya, Dept Surg, Fac Med, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Universiti Putra Malaysia; Universiti Malaya; Universiti Malaya	Lee, PY (corresponding author), Univ Putra Malaysia, Dept Family Med, Serdang 43400, Selangor, Malaysia.	pylee02@gmail.com	NG, CHIRK JENN/C-1344-2010; Lee, Yew Kong/K-4339-2013; Cheong, Ai Theng/H-9884-2014; Ong, Teng Aik/B-5321-2010; Abdullah, Khatijah Lim/B-8782-2010; Razack, Azad HA/B-8152-2009; Lee, Ping Yein/C-1923-2012	Lee, Yew Kong/0000-0002-3034-8601; Cheong, Ai Theng/0000-0002-3895-530X; Ong, Teng Aik/0000-0002-0207-8966; Abdullah, Khatijah Lim/0000-0002-7185-6004; Razack, Azad HA/0000-0002-4237-6511; Lee, Ping Yein/0000-0002-0912-6043; Ng, Chirk Jenn/0000-0002-8320-1603	Universiti Putra Malaysia [04-02-12-2093RU]	Universiti Putra Malaysia	We thank Universiti Putra Malaysia for funding the study via PYL (Grant number 04-02-12-2093RU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alden DL, 2012, ASIA-PAC J PUBLIC HE, V24, P173, DOI 10.1177/1010539510365098; Aning JJ, 2012, CURR ONCOL, V19, pS37, DOI 10.3747/co.19.1287; Au AHY, 2011, HEALTH EXPECT, V14, P405, DOI 10.1111/j.1369-7625.2010.00655.x; Baider L, 2012, ANN ONCOL, V23, P62, DOI 10.1093/annonc/mds090; Bogdan R., 1975, INTRO QUALITATIVE RE; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Claramita M, 2013, ADV HEALTH SCI EDUC, V18, P15, DOI 10.1007/s10459-012-9352-5; Claramita M, 2011, PATIENT EDUC COUNS, V85, pE169, DOI 10.1016/j.pec.2011.02.002; Dai Qingkang, 2003, Med Law Int, V6, P53; Davison BJ, 2004, BJU INT, V93, P47, DOI 10.1111/j.1464-410X.2004.04553.x; Davison BJ, 2002, CANCER NURS, V25, P42, DOI 10.1097/00002820-200202000-00009; Gwede CK, 2005, CANCER-AM CANCER SOC, V104, P1381, DOI 10.1002/cncr.21330; Humayun Ayesha, 2008, BMC Med Ethics, V9, P14, DOI 10.1186/1472-6939-9-14; Ilic D, 2015, PSYCHO-ONCOLOGY, V24, P1303, DOI 10.1002/pon.3815; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Keyes M, 2013, CAN FAM PHYSICIAN, V59, P1269; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Lam W, 2003, BREAST CANCER RES TR, V80, P171, DOI 10.1023/A:1024568732213; Lam WW, 2005, PSYCHO-ONCOLOGY, V14, P1, DOI 10.1002/pon.803; Lee YK, 2015, INT J NURS PRACT, V21, P125, DOI 10.1111/ijn.12355; Ministry of Health Malaysia, 2007, MAL CANC STAT DAT FI; Ng CJ, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-408; Nomura K, 2007, INTERNAL MED, V46, P1403, DOI 10.2169/internalmedicine.46.0141; O'Connor AM, 1998, PATIENT EDUC COUNS, V33, P267, DOI 10.1016/S0738-3991(98)00026-3; Obeidat RF, 2013, ONCOL NURS FORUM, V40, P454, DOI 10.1188/13.ONF.454-463; Patton M. Q., 1980, QUALITATIVE EVALUATI; Pickles T, 2004, CAN FAM PHYSICIAN, V50, P65; POPE C, 1995, BRIT MED J, V311, P42, DOI 10.1136/bmj.311.6996.42; Ruhnke GW, 2000, CHEST, V118, P1172, DOI 10.1378/chest.118.4.1172; Schouten BC, 2006, PATIENT EDUC COUNS, V64, P21, DOI 10.1016/j.pec.2005.11.014; Singh JA, 2010, AM J MANAG CARE, V16, P688; Tariman JD, 2010, ANN ONCOL, V21, P1145, DOI 10.1093/annonc/mdp534; Teh YC, 2014, ASIAN PAC J CANCER P, V15, P3163, DOI 10.7314/APJCP.2014.15.7.3163; Tong WT, 2014, ASIA-PAC J PUBLIC HE, V26, P536, DOI 10.1177/1010539513514434; Yousuf R. M., 2007, SMJ Singapore Medical Journal, V48, P559; Zhang YH, 2011, MED DECIS MAKING, V31, P245, DOI 10.1177/0272989X10375990	36	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142812	10.1371/journal.pone.0142812	http://dx.doi.org/10.1371/journal.pone.0142812			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7DR	26559947	gold, Green Published, Green Submitted			2022-12-26	WOS:000364433100128
J	Lendvai, AZ; Akcay, C; Ouyang, JQ; Dakin, R; Domalik, AD; St John, PS; Stanback, M; Moore, IT; Bonier, F				Lendvai, Adam Z.; Akcay, Caglar; Ouyang, Jenny Q.; Dakin, Roslyn; Domalik, Alice D.; St John, Prianka S.; Stanback, Mark; Moore, Ignacio T.; Bonier, Frances			Analysis of the Optimal Duration of Behavioral Observations Based on an Automated Continuous Monitoring System in Tree Swallows (Tachycineta bicolor): Is One Hour Good Enough?	PLOS ONE			English	Article							PARENTAL CARE; BROOD-SIZE; BLUE TITS; NEST; SEX; ALLOCATION; NESTLINGS; SPARROWS; PATTERNS; FITNESS	Studies of animal behavior often rely on human observation, which introduces a number of limitations on sampling. Recent developments in automated logging of behaviors make it possible to circumvent some of these problems. Once verified for efficacy and accuracy, these automated systems can be used to determine optimal sampling regimes for behavioral studies. Here, we used a radio-frequency identification (RFID) system to quantify parental effort in a bi-parental songbird species: the tree swallow (Tachycineta bicolor). We found that the accuracy of the RFID monitoring system was similar to that of video-recorded behavioral observations for quantifying parental visits. Using RFID monitoring, we also quantified the optimum duration of sampling periods for male and female parental effort by looking at the relationship between nest visit rates estimated from sampling periods with different durations and the total visit numbers for the day. The optimum sampling duration (the shortest observation time that explained the most variation in total daily visits per unit time) was 1h for both sexes. These results show that RFID and other automated technologies can be used to quantify behavior when human observation is constrained, and the information from these monitoring technologies can be useful for evaluating the efficacy of human observation methods.	[Lendvai, Adam Z.; Akcay, Caglar; Ouyang, Jenny Q.; Moore, Ignacio T.; Bonier, Frances] Virginia Tech, Dept Biol Sci, Blacksburg, VA USA; [Lendvai, Adam Z.] Univ Debrecen, Dept Evolutionary Zool & Human Biol, Debrecen, Hungary; [Ouyang, Jenny Q.] Netherlands Inst Ecol NIOO KNAW, Wageningen, Netherlands; [Dakin, Roslyn] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Dakin, Roslyn; Domalik, Alice D.; St John, Prianka S.; Bonier, Frances] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Stanback, Mark] Davidson Coll, Dept Biol, Davidson, NC 28035 USA	Virginia Polytechnic Institute & State University; University of Debrecen; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); University of British Columbia; Queens University - Canada; Davidson College	Lendvai, AZ (corresponding author), Univ Debrecen, Dept Evolutionary Zool & Human Biol, Debrecen, Hungary.	lendvai@vt.edu	Akcay, Caglar/F-7145-2010; Akcay, Caglar/X-5112-2019; Lendvai, Adam Z/B-8546-2008; KNAW, NIOO-KNAW/A-4320-2012	Akcay, Caglar/0000-0003-0635-9586; Akcay, Caglar/0000-0003-0635-9586; Lendvai, Adam Z/0000-0002-8953-920X; Moore, Ignacio/0000-0001-8875-8913; KNAW, NIOO-KNAW/0000-0002-3835-159X	U.S. National Science Foundation (NSF) grant [IOS-1145625]; Natural Sciences and Engineering Research Council of Canada; Banting Postdoctoral Fellowship; Hungarian Scientific Research Fund [OTKA K113108]; NSF postdoctoral grant [DBI-1306025]; Direct For Biological Sciences [1145625] Funding Source: National Science Foundation	U.S. National Science Foundation (NSF) grant(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Banting Postdoctoral Fellowship; Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); NSF postdoctoral grant; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by a U.S. National Science Foundation (NSF) grant (FB, ITM, and MFH; IOS-1145625), the Natural Sciences and Engineering Research Council of Canada, and a Banting Postdoctoral Fellowship (FB). During the preparation of the manuscript, AZL was supported by a Hungarian Scientific Research Fund (OTKA K113108) and JQO by a NSF postdoctoral grant (DBI-1306025).	Ardia DR, 2007, CAN J ZOOL, V85, P847, DOI 10.1139/Z07-070; Ardia DR, 2006, CONDOR, V108, P601, DOI 10.1650/0010-5422(2006)108[601:gvittb]2.0.co;2; Bonier F, 2009, GEN COMP ENDOCR, V163, P208, DOI 10.1016/j.ygcen.2008.12.013; Bonter DN, 2011, J FIELD ORNITHOL, V82, P1, DOI 10.1111/j.1557-9263.2010.00302.x; Bortolotti LE, 2011, CAN J ZOOL, V89, P921, DOI 10.1139/Z11-068; Bridge ES, 2011, J FIELD ORNITHOL, V82, P52, DOI 10.1111/j.1557-9263.2010.00307.x; CAREY M, 1990, AUK, V107, P580; DeVries MS, 2013, ANIM BEHAV, V85, P957, DOI 10.1016/j.anbehav.2013.02.019; Froud R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114468; Garcia-Navas V, 2012, CONDOR, V114, P612, DOI 10.1525/cond.2012.110120; Gomez J, 2014, J ORNITHOL, V155, P37, DOI 10.1007/s10336-013-0984-x; Haccou P., 1992, STAT ANAL BEHAV DATA; Hogle NC, 2014, J ORNITHOL, V155, P91, DOI 10.1007/s10336-013-0991-y; Johnsen A, 2005, ANIM BEHAV, V70, P877, DOI 10.1016/j.anbehav.2005.01.005; Leonard M, 1996, BEHAV ECOL SOCIOBIOL, V38, P341, DOI 10.1007/s002650050250; McCarty JP, 2002, J FIELD ORNITHOL, V73, P9, DOI 10.1648/0273-8570-73.1.9; Murphy MT, 2015, J FIELD ORNITHOL, V86, P41, DOI 10.1111/jofo.12087; Niederhauser JM, 2014, J FIELD ORNITHOL, V85, P180, DOI 10.1111/jofo.12059; Ouyang JQ, 2013, HORM BEHAV, V63, P776, DOI 10.1016/j.yhbeh.2013.03.002; Pagani-Nunez E, 2013, ACTA ORNITHOL, V48, P194, DOI 10.3161/000164513X678847; R Core Team, 2014, LANG ENV STAT COMP; Ritz C, 2005, J STAT SOFTW, V12, P1; Rose AP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004111; Schwagmeyer PL, 1997, ANIM BEHAV, V54, P470, DOI 10.1006/anbe.1997.0483; Shutler D, 2012, AVIAN CONSERV ECOL, V7, DOI 10.5751/ACE-00517-070103; Tuyttens FAM, 2014, ANIM BEHAV, V90, P273, DOI 10.1016/j.anbehav.2014.02.007; Verspoor JJ, 2007, BEHAV ECOL, V18, P967, DOI 10.1093/beheco/arm089; WHEELWRIGHT NT, 1992, BEHAV ECOL SOCIOBIOL, V31, P279; Whittingham LA, 2003, ANIM BEHAV, V65, P1203, DOI 10.1006/anbe.2003.2178	29	21	22	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141194	10.1371/journal.pone.0141194	http://dx.doi.org/10.1371/journal.pone.0141194			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559407	Green Published, Green Submitted, gold			2022-12-26	WOS:000364433100024
J	Oprea, TI; Sklar, LA; Agola, JO; Guo, Y; Silberberg, M; Roxby, J; Vestling, A; Romero, E; Surviladze, Z; Murray-Krezan, C; Waller, A; Ursu, O; Hudson, LG; Wandinger-Ness, A				Oprea, Tudor I.; Sklar, Larry A.; Agola, Jacob O.; Guo, Yuna; Silberberg, Melina; Roxby, Joshua; Vestling, Anna; Romero, Elsa; Surviladze, Zurab; Murray-Krezan, Cristina; Waller, Anna; Ursu, Oleg; Hudson, Laurie G.; Wandinger-Ness, Angela			Novel Activities of Select NSAID R-Enantiomers against Rac1 and Cdc42 GTPases	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; SMALL-MOLECULE INHIBITOR; CHRONIC LYMPHOCYTIC-LEUKEMIA; NUCLEOTIDE EXCHANGE FACTORS; GROWTH-FACTOR RECEPTOR; FAMILY SMALL GTPASES; HUMAN BREAST-CANCER; RHO-GTPASES; FLOW-CYTOMETRY; OVARIAN-CANCER	Rho family GTPases (including Rac, Rho and Cdc42) collectively control cell proliferation, adhesion and migration and are of interest as functional therapeutic targets in numerous epithelial cancers. Based on high throughput screening of the Prestwick Chemical Library1 and cheminformatics we identified the R-enantiomers of two approved drugs (naproxen and ketorolac) as inhibitors of Rac1 and Cdc42. The corresponding S-enantiomers are considered the active component in racemic drug formulations, acting as non-steroidal anti-inflammatory drugs (NSAIDs) with selective activity against cyclooxygenases. Here, we show that the S-enantiomers of naproxen and ketorolac are inactive against the GTPases. Additionally, more than twenty other NSAIDs lacked inhibitory action against the GTPases, establishing the selectivity of the two identified NSAIDs. R-naproxen was first identified as a lead compound and tested in parallel with its S-enantiomer and the non-chiral 6-methoxy-naphthalene acetic acid (active metabolite of nabumetone, another NSAID) as a structural series. Cheminformatics-based substructure analyses-using the rotationally constrained carboxylate in R-naproxen-led to identification of racemic [R/S] ketorolac as a suitable FDA-approved candidate. Cell based measurement of GTPase activity (in animal and human cell lines) demonstrated that the R-enantiomers specifically inhibit epidermal growth factor stimulated Rac1 and Cdc42 activation. The GTPase inhibitory effects of the R-enantiomers in cells largely mimic those of established Rac1 (NSC23766) and Cdc42 (CID2950007/ML141) specific inhibitors. Docking predicts that rotational constraints position the carboxylate moieties of the R-enantiomers to preferentially coordinate the magnesium ion, thereby destabilizing nucleotide binding to Rac1 and Cdc42. The S-enantiomers can be docked but are less favorably positioned in proximity to the magnesium. R-naproxen and R-ketorolac have potential for rapid translation and efficacy in the treatment of several epithelial cancer types on account of established human toxicity profiles and novel activities against Rho-family GTPases.	[Oprea, Tudor I.; Sklar, Larry A.; Guo, Yuna; Surviladze, Zurab; Waller, Anna; Hudson, Laurie G.; Wandinger-Ness, Angela] Univ New Mexico, Hlth Sci Ctr, Ctr Comprehens Canc, Albuquerque, NM 87131 USA; [Oprea, Tudor I.; Ursu, Oleg] Univ New Mexico, Hlth Sci Ctr, Translat Informat Div, Dept Internal Med, Albuquerque, NM 87131 USA; [Sklar, Larry A.; Agola, Jacob O.; Guo, Yuna; Vestling, Anna; Romero, Elsa; Wandinger-Ness, Angela] Univ New Mexico, Hlth Sci Ctr, Dept Pathol, Albuquerque, NM 87131 USA; [Sklar, Larry A.; Surviladze, Zurab; Waller, Anna] Univ New Mexico, Hlth Sci Ctr, Ctr Mol Discovery, Albuquerque, NM 87131 USA; [Murray-Krezan, Cristina] Univ New Mexico, Hlth Sci Ctr, Div Epidemiol Biostat & Prevent Med, Dept Internal Med, Albuquerque, NM 87131 USA; [Silberberg, Melina; Roxby, Joshua; Hudson, Laurie G.] Univ New Mexico, Hlth Sci Ctr, Dept Pharmaceut Sci, Coll Pharm, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center	Wandinger-Ness, A (corresponding author), Univ New Mexico, Hlth Sci Ctr, Ctr Comprehens Canc, Albuquerque, NM 87131 USA.	wness@unm.edu	aubertin, rebeckah/O-9624-2015; Oprea, Tudor/A-5746-2011	aubertin, rebeckah/0000-0002-0558-7571; Oprea, Tudor/0000-0002-6195-6976	Department of Defense [OC093205, OC110514]; University of New Mexico Cancer Center [0990MD, 0990VW]; National Cancer Institute [R21 CA170375, P30 CA1181000, R25 CA153825]; National Institute of Mental Health [R03MH081231, U54 MH074425, U54 MH084690]; National Institute of Neurological Disorders and Stroke [R21 NS7740241]; National Science Foundation [MCB0956027]; National Institute of General Medical Sciences [R25 GM060201]; NATIONAL CANCER INSTITUTE [P30CA118100, R25CA153825, R21CA170375] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001449, UL1TR000041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM060201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084690, U54MH074425, R03MH081231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077402] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); University of New Mexico Cancer Center; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Science Foundation(National Science Foundation (NSF)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the following sources of funding to: AWN LGH (Department of Defense [http://www.defense.gov] Concept Award OC093205 and Teal Expansion Award OC110514; University of New Mexico Cancer Center [http://cancer.unm.edu] Focus Interactive Group Awards 0990MD and 0990VW; National Cancer Institute [http://www.cancer.gov] R21 CA170375); AWN, ER and JOA (National Institute of Mental Health [http://www.nimh.nih.gov/index.shtml] R03MH081231 and National Institute of Neurological Disorders and Stroke [http://www.ninds.nih.gov] R21 NS7740241; National Science Foundation [http://www.nsf.gov/funding/] MCB0956027); AWN, LAS and TIO (National Cancer Institute [http://www.cancer.gov] P30 CA1181000); LAS, ZS, AW, OU, and TIO (National Institute of Mental Health [http://www.nimh.nih.gov/index.shtml] U54 MH074425 and U54 MH084690); AV (National Institute of General Medical Sciences [www.nigms.nih.gov] R25 GM060201); and YG (National Cancer Institute [http://www.cancer.gov] R25 CA153825). HeLaT4+ cells were obtained through the NIH AIDS Reagent Program [https://www.aidsreagent.org/reagentdetail.cfm?t=cell_lines&id=253], Division of AIDS, NIAID, originally deposited by Dr. Richard Axel.	Agola JO, 2012, ACS CHEM BIOL, V7, P1095, DOI 10.1021/cb3001099; ARIENS EJ, 1984, EUR J CLIN PHARMACOL, V26, P663, DOI 10.1007/BF00541922; BARNETT J, 1994, BBA-PROTEIN STRUCT M, V1209, P130, DOI 10.1016/0167-4838(94)90148-1; BAST RC, 1981, J CLIN INVEST, V68, P1331, DOI 10.1172/JCI110380; Baugher PJ, 2005, BREAST CANCER RES, V7, pR965, DOI 10.1186/bcr1329; Bid HK, 2013, MOL CANCER THER, V12, P1925, DOI 10.1158/1535-7163.MCT-13-0164; Blum R, 2008, RECENT PAT ANTI-CANC, V3, P31; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Bosetti C, 2009, RECENT RESULTS CANC, V181, P231; Buchanan FG, 2003, J BIOL CHEM, V278, P35451, DOI 10.1074/jbc.M302474200; Buranda T, 2013, ANAL BIOCHEM, V442, P149, DOI 10.1016/j.ab.2013.07.039; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Caino MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031714; Carabaza A, 1996, J CLIN PHARMACOL, V36, P505, DOI 10.1002/j.1552-4604.1996.tb05040.x; Carter JH, 2004, CLIN CANCER RES, V10, P3448, DOI 10.1158/1078-0432.CCR-03-0210; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Cook DR, 2014, ONCOGENE, V33, P4021, DOI 10.1038/onc.2013.362; CYaNMCCA Muller, 2012, AVAILABILITY EFFECT; Dahl KDC, 2007, MOL CANCER RES, V5, P413, DOI 10.1158/1541-7786.MCR-07-0019; Daugherty SE, 2011, AM J EPIDEMIOL, V173, P721, DOI 10.1093/aje/kwq437; Duggan KC, 2010, J BIOL CHEM, V285, P34950, DOI 10.1074/jbc.M110.162982; Durant JL, 2002, J CHEM INF COMP SCI, V42, P1273, DOI 10.1021/ci010132r; Ellenbroek SIJ, 2007, CLIN EXP METASTAS, V24, P657, DOI 10.1007/s10585-007-9119-1; Elwood PC, 2009, LANCET, V373, P1301, DOI 10.1016/S0140-6736(09)60243-9; Engers R, 2001, J BIOL CHEM, V276, P41889, DOI 10.1074/jbc.M105049200; Evans AM, 1996, J CLIN PHARMACOL, V36, pS7; Feng R, 2007, DRUG NEWS PERSPECT, V20, P431, DOI 10.1358/dnp.2007.20.7.1149631; Ferri N, 2009, J MED CHEM, V52, P4087, DOI 10.1021/jm8015987; Forget P, 2014, BRIT J ANAESTH, V113, P82, DOI 10.1093/bja/aet464; Forget P, 2013, MED HYPOTHESES, V81, P707, DOI 10.1016/j.mehy.2013.07.033; Fortin SP, 2012, MOL CANCER RES, V10, P958, DOI 10.1158/1541-7786.MCR-11-0616; Friesland A, 2013, P NATL ACAD SCI USA, V110, P1261, DOI 10.1073/pnas.1116051110; Fritz G, 2006, CURR CANCER DRUG TAR, V6, P1, DOI 10.2174/156800906775471752; Furmaniak-Kazmierczak E, 2007, CIRC RES, V100, P1328, DOI 10.1161/CIRCRESAHA.106.147744; FURST DE, 1987, ARTHRITIS RHEUM, V30, P1157, DOI 10.1002/art.1780301011; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Garcia-Mata R, 2007, TRENDS CELL BIOL, V17, P36, DOI 10.1016/j.tcb.2006.11.004; Gassmann P, 2009, NEOPLASIA, V11, P651, DOI 10.1593/neo.09272; Geerts H, 2007, IDRUGS, V10, P121; GLASER K, 1995, EUR J PHARMACOL, V281, P107, DOI 10.1016/0014-2999(95)00302-2; Gould CM, 2014, CELL ADHES MIGR, V8, P226, DOI 10.4161/cam.28346; Govek EE, 2011, DEV NEUROBIOL, V71, P528, DOI 10.1002/dneu.20850; Grant JA, 1996, J COMPUT CHEM, V17, P1653, DOI 10.1002/(SICI)1096-987X(19961115)17:14<1653::AID-JCC7>3.0.CO;2-K; Guo Y, 2015, CLIN CANCER RES, DOI [10.1158/1078-0432.CCR-15-0461, DOI 10.1158/1078-0432]; Guo YN, 2015, MOL CANCER THER, V14, P2215, DOI 10.1158/1535-7163.MCT-15-0419; Hales DB, 2008, ENDOCRINE, V33, P235, DOI 10.1007/s12020-008-9080-z; Hall A, 2012, BIOCHEM SOC T, V40, P1378, DOI 10.1042/BST20120103; Handley DA, 1998, J CLIN PHARMACOL, V38, p25S, DOI 10.1002/j.1552-4604.1998.tb04414.x; Hannibal CG, 2008, AM J EPIDEMIOL, V167, P1430, DOI 10.1093/aje/kwn082; Harman CA, 2007, J BIOL CHEM, V282, P28096, DOI 10.1074/jbc.M701335200; Hawkins PCD, 2007, J MED CHEM, V50, P74, DOI 10.1021/jm0603365; Hawkins PCD, 2012, J CHEM INF MODEL, V52, P2919, DOI 10.1021/ci300314k; Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hong L, 2010, PROBE REPORTS NIH MO; Hong L, 2013, J BIOL CHEM, V288, P8531, DOI 10.1074/jbc.M112.435941; Horiguchi A, 2004, CLIN CANCER RES, V10, P8648, DOI 10.1158/1078-0432.CCR-04-1568; Huntjens DRH, 2006, BRIT J PHARMACOL, V148, P396, DOI 10.1038/sj.bjp.0706737; Inoue T, 2010, ONCOL REP, V24, P1487, DOI 10.3892/or_00001009; Janssen A, 2006, EUR J PHARMACOL, V540, P24, DOI 10.1016/j.ejphar.2006.04.030; Jett MF, 1999, J PHARMACOL EXP THER, V288, P1288; Kamai T, 2004, CLIN CANCER RES, V10, P4799, DOI 10.1158/1078-0432.CCR-0436-03; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; KEAN WF, 1989, J PHARM SCI, V78, P324, DOI 10.1002/jps.2600780413; KEAN WF, 1991, LANCET, V338, P1565, DOI 10.1016/0140-6736(91)92382-C; KENDALL MJ, 1989, EUR J CLIN PHARMACOL, V36, P299, DOI 10.1007/BF00558163; Kim HJ, 2014, BIOMOL THER, V22, P540, DOI 10.4062/biomolther.2014.081; Kolluri SK, 2005, P NATL ACAD SCI USA, V102, P2525, DOI 10.1073/pnas.0409721102; Kulkarni K, 2011, J BIOL CHEM, V286, P25341, DOI 10.1074/jbc.M111.236455; LANEUVILLE O, 1994, J PHARMACOL EXP THER, V271, P927; Lawson Campbell D, 2014, Small GTPases, V5, pe27958, DOI 10.4161/sgtp.27958; Lehmann FP., 1978, CHEM-BIOL INTERACT, V20, P239; Liggett JL, 2014, CANCER LETT, V346, P217, DOI 10.1016/j.canlet.2014.01.021; Lin Y, 2015, EXPERT OPIN DRUG DIS, V10, P991, DOI 10.1517/17460441.2015.1058775; Lindhagen E, 2007, CANCER CHEMOTH PHARM, V60, P545, DOI 10.1007/s00280-006-0400-9; Liu JK, 2012, J NEURO-ONCOL, V106, P561, DOI 10.1007/s11060-011-0712-4; Lu DS, 2004, P NATL ACAD SCI USA, V101, P3118, DOI 10.1073/pnas.0308648100; Machesky LM, 2008, FEBS LETT, V582, P2102, DOI 10.1016/j.febslet.2008.03.039; Mack NA, 2011, CELL CYCLE, V10, P1571, DOI 10.4161/cc.10.10.15612; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; Mills JEJ, 1996, J COMPUT AID MOL DES, V10, P607, DOI 10.1007/BF00134183; MITCHELL JA, 1993, P NATL ACAD SCI USA, V90, P11693, DOI 10.1073/pnas.90.24.11693; Montalvo-Ortiz BL, 2012, J BIOL CHEM, V287, P13228, DOI 10.1074/jbc.M111.334524; Mroszczak E, 1996, J CLIN PHARMACOL, V36, P521, DOI 10.1002/j.1552-4604.1996.tb05042.x; Muller O, 2004, ANGEW CHEM INT EDIT, V43, P450, DOI 10.1002/anie.200352587; Murray DW, 2014, BRIT J CANCER, V110, P1307, DOI 10.1038/bjc.2014.39; Nassar N, 2006, CURR TOP MED CHEM, V6, P1109, DOI 10.2174/156802606777812095; Ni SB, 2013, CANCER SCI, V104, P817, DOI 10.1111/cas.12157; Nicholls A, 2007, J MED CHEM, V50, P74; Onesto C, 2008, METHOD ENZYMOL, V439, P111, DOI 10.1016/S0076-6879(07)00409-0; OpenEye, 2014, OMEGA 2 4 6 SCI SOFT; OpenEye, 2014, ROCS 2 4 2 SCI SOFTW; Oprea Tudor I, 2011, Drug Discov Today Ther Strateg, V8, P61; Orgaz Jose L, 2014, Small GTPases, V5, pe29019, DOI 10.4161/sgtp.29019; Ortiz-Sanchez JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040809; Pinheiro SP, 2009, AM J EPIDEMIOL, V169, P1378, DOI 10.1093/aje/kwp062; Retsky M, 2013, CURR MED CHEM, V20, P4163; Retsky M, 2012, BREAST CANCER RES TR, V134, P881, DOI 10.1007/s10549-012-2094-5; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Robak P, 2008, LEUKEMIA LYMPHOMA, V49, P1452, DOI 10.1080/10428190802108854; Sahin IH, 2014, CANCER LETT, V345, P249, DOI 10.1016/j.canlet.2013.09.001; Schmitz K, 2014, EMBO MOL MED, V6, P1398, DOI 10.15252/emmm.201404168; Schnelzer A, 2000, ONCOGENE, V19, P3013, DOI 10.1038/sj.onc.1203621; Schwartz SL, 2008, ANAL BIOCHEM, V381, P258, DOI 10.1016/j.ab.2008.06.039; Shigemasa K, 2003, INT J ONCOL, V22, P99; Singh A, 2004, ONCOGENE, V23, P9369, DOI 10.1038/sj.onc.1208182; Skvortsov S, 2014, BRIT J CANCER, V110, P2677, DOI 10.1038/bjc.2014.221; Smith SW, 2009, TOXICOL SCI, V110, P4, DOI 10.1093/toxsci/kfp097; Spiering D, 2011, CELL ADHES MIGR, V5, P170, DOI 10.4161/cam.5.2.14403; Spuul P, 2014, SMALL GTPASES, V5, DOI [10.4161/sgtp.28713, DOI 10.4161/SGTP.28713]; Stengel K, 2011, CELL SIGNAL, V23, P1415, DOI 10.1016/j.cellsig.2011.04.001; Stolfi C, 2013, INT J MOL SCI, V14, P17972, DOI 10.3390/ijms140917972; SUESA N, 1993, CHIRALITY, V5, P589, DOI 10.1002/chir.530050805; Sun D, 2006, DRUG RESIST UPDATE, V9, P274, DOI 10.1016/j.drup.2006.12.001; Surviladze Z., 2010, PROBE REPORTS NIH MO; Surviladze Z, 2012, METHODS MOL BIOL, V827, P253, DOI 10.1007/978-1-61779-442-1_17; Surviladze Z, 2010, J BIOMOL SCREEN, V15, P10, DOI 10.1177/1087057109352240; TANIMOTO TT, 1961, T NEW YORK ACAD SCI, V23, P576, DOI 10.1111/j.2164-0947.1961.tb01390.x; Thomas EK, 2007, CANCER CELL, V12, P467, DOI 10.1016/j.ccr.2007.10.015; Thorat MA, 2013, CURR ONCOL REP, V15, P533, DOI 10.1007/s11912-013-0351-3; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Waldmann H, 2004, ANGEW CHEM INT EDIT, V43, P454, DOI 10.1002/anie.200353089; Warner TD, 1999, P NATL ACAD SCI USA, V96, P7563, DOI 10.1073/pnas.96.13.7563; Weaver AM, 2006, CLIN EXP METASTAS, V23, P97, DOI 10.1007/s10585-006-9014-1; WECHTER WJ, 1994, J CLIN PHARMACOL, V34, P1036, DOI 10.1002/j.1552-4604.1994.tb01977.x; Wiemer AJ, 2011, CLIN PHARMACOL THER, V90, P804, DOI 10.1038/clpt.2011.215; Wilson JC, 2011, CANCER CAUSE CONTROL, V22, P803, DOI 10.1007/s10552-011-9751-6; Yang J, 2009, SCIENCE, V325, P1398, DOI 10.1126/science.1174468; Yasui H, 2007, LEUKEMIA, V21, P535, DOI 10.1038/sj.leu.2404561; Yasui H, 2005, BLOOD, V106, P706, DOI 10.1182/blood-2005-02-0838; Zhou C, 2013, ONCOGENE, V32, P903, DOI 10.1038/onc.2012.99; Zins K, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-295; Zins K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074924	133	32	32	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142182	10.1371/journal.pone.0142182	http://dx.doi.org/10.1371/journal.pone.0142182			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558612	gold, Green Submitted, Green Published			2022-12-26	WOS:000364433100059
J	Sassa, A; Kamoshita, N; Kanemaru, Y; Honma, M; Yasui, M				Sassa, Akira; Kamoshita, Nagisa; Kanemaru, Yuki; Honma, Masamitsu; Yasui, Manabu			Xeroderma Pigmentosum Group A Suppresses Mutagenesis Caused by Clustered Oxidative DNA Adducts in the Human Genome	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; DOUBLE-STRAND BREAKS; IN-VITRO REPAIR; ESCHERICHIA-COLI; DAMAGE SITE; HUMAN-CELLS; IONIZING-RADIATION; TANDEM LESIONS; ABASIC SITE; BASE DAMAGE	Clustered DNA damage is defined as multiple sites of DNA damage within one or two helical turns of the duplex DNA. This complex damage is often formed by exposure of the genome to ionizing radiation and is difficult to repair. The mutagenic potential and repair mechanisms of clustered DNA damage in human cells remain to be elucidated. In this study, we investigated the involvement of nucleotide excision repair (NER) in clustered oxidative DNA adducts. To identify the in vivo protective roles of NER, we established a human cell line lacking the NER gene xeroderma pigmentosum group A (XPA). XPA knockout (KO) cells were generated from TSCER122 cells derived from the human lymphoblastoid TK6 cell line. To analyze the mutagenic events in DNA adducts in vivo, we previously employed a system of tracing DNA adducts in the targeted mutagenesis (TATAM), in which DNA adducts were sitespecifically introduced into intron 4 of thymidine kinase genes. Using the TATAM system, one or two tandem7,8-dihydro-8-oxoguanine (8-oxoG) adducts were introduced into the genomes of TSCER122 or XPA KO cells. In XPA KO cells, the proportion ofmutants induced by a single 8-oxoG (7.6%) was comparable with that in TSCER122 cells (8.1%). In contrast, the lack of XPA significantly enhanced the mutant proportion of tandem8-oxoG in the transcribed strand (12%) compared with that in TSCER122 cells (7.4%) but not in the non-transcribed strand (12% and 11% in XPA KO and TSCER122 cells, respectively). By sequencing the tandem 8-oxoG- integrated loci in the transcribed strand, we found that the proportion of tandem mutations was markedly increased in XPA KO cells. These results indicate that NER is involved in repairing clustered DNA adducts in the transcribed strand in vivo.	[Sassa, Akira; Kamoshita, Nagisa; Kanemaru, Yuki; Honma, Masamitsu; Yasui, Manabu] Natl Inst Hlth Sci, Div Genet & Mutagenesis, Setagaya Ku, Tokyo, Japan	National Institute of Health Sciences - Japan	Sassa, A (corresponding author), Natl Inst Hlth Sci, Div Genet & Mutagenesis, Setagaya Ku, Tokyo, Japan.	a-sassa@nihs.go.jp; m-yasui@nihs.go.jp		Sassa, Akira/0000-0003-2454-0223; Kanemaru, Yuki/0000-0001-9934-9488	Ministry of Education, Culture, Sports, Science and Technology in Japan [25281022]; Ministry of Health, Welfare and Labor in Japan	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Welfare and Labor in Japan	The work was supported by the following: 25281022, Grant-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science and Technology in Japan, MY, http://www.mext.go.jp/english/; and H27-food-general-002, Grant-in-Aid for Health Science Foundation from the Ministry of Health, Welfare and Labor in Japan, MH, http://www.mhlw.go.jp/english/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES BN, 1991, MUTAT RES, V250, P3, DOI 10.1016/0027-5107(91)90157-J; Arakawa T, 2011, ANAL BIOCHEM, V416, P211, DOI 10.1016/j.ab.2011.05.017; Bellon S, 2009, NUCLEIC ACIDS RES, V37, P4430, DOI 10.1093/nar/gkp422; Budworth H, 2005, J MOL BIOL, V351, P1020, DOI 10.1016/j.jmb.2005.06.069; Cunniffe S, 2014, MUTAT RES-FUND MOL M, V762, P32, DOI 10.1016/j.mrfmmm.2014.02.005; Cunniffe SMT, 2007, DNA REPAIR, V6, P1839, DOI 10.1016/j.dnarep.2007.07.003; D'Errico M, 2006, EMBO J, V25, P4305, DOI 10.1038/sj.emboj.7601277; David-Cordonnier MH, 2001, BIOCHEMISTRY-US, V40, P11811, DOI 10.1021/bi0112356; de Waard H, 2003, DNA REPAIR, V2, P13, DOI 10.1016/S1568-7864(02)00188-X; Eccles LJ, 2010, NUCLEIC ACIDS RES, V38, P1123, DOI 10.1093/nar/gkp1070; Fujimoto H, 2005, J COMPUT CHEM, V26, P788, DOI 10.1002/jcc.20184; GROSOVSKY AJ, 1993, MUTAT RES, V289, P231, DOI 10.1016/0027-5107(93)90074-P; Guo J, 2013, NUCLEIC ACIDS RES, V41, P7700, DOI 10.1093/nar/gkt524; Harrison L, 1999, J MOL BIOL, V290, P667, DOI 10.1006/jmbi.1999.2892; Imoto S, 2008, BIOCHEMISTRY-US, V47, P4306, DOI 10.1021/bi7021427; Itoh M, 1999, BRAIN DEV-JPN, V21, P326, DOI 10.1016/S0387-7604(99)00033-9; Jiang Y, 2009, CHEM RES TOXICOL, V22, P574, DOI 10.1021/tx8003449; Kalam MA, 2005, CHEM RES TOXICOL, V18, P1187, DOI 10.1021/tx050119r; Kozmin SG, 2009, NUCLEIC ACIDS RES, V37, P1767, DOI 10.1093/nar/gkp010; Liu MM, 2013, MUTAT RES-FUND MOL M, V743, P4, DOI 10.1016/j.mrfmmm.2012.12.003; Maasho K, 2004, J IMMUNOL METHODS, V284, P133, DOI 10.1016/j.jim.2003.10.010; Malyarchuk S, 2004, NUCLEIC ACIDS RES, V32, P5721, DOI 10.1093/nar/gkh911; Malyarchuk S, 2009, DNA REPAIR, V8, P1343, DOI 10.1016/j.dnarep.2009.08.008; MICHAELS ML, 1992, BIOCHEMISTRY-US, V31, P10964, DOI 10.1021/bi00160a004; Nilsen H, 2001, CARCINOGENESIS, V22, P987, DOI 10.1093/carcin/22.7.987; Noguchi M, 2012, MUTAT RES-FUND MOL M, V732, P34, DOI 10.1016/j.mrfmmm.2011.12.009; ODA Y, 1991, NUCLEIC ACIDS RES, V19, P1407, DOI 10.1093/nar/19.7.1407; Parsons JL, 2005, NUCLEIC ACIDS RES, V33, P4849, DOI 10.1093/nar/gki816; Pearson CG, 2004, NUCLEIC ACIDS RES, V32, P263, DOI 10.1093/nar/gkh150; Reardon JT, 1997, P NATL ACAD SCI USA, V94, P9463, DOI 10.1073/pnas.94.17.9463; ROBINS P, 1991, EMBO J, V10, P3913, DOI 10.1002/j.1460-2075.1991.tb04961.x; Rosenquist TA, 1997, P NATL ACAD SCI USA, V94, P7429, DOI 10.1073/pnas.94.14.7429; Sassa A, 2014, J BIOL CHEM, V289, P13996, DOI 10.1074/jbc.M114.557769; Sassa A, 2012, J BIOL CHEM, V287, P36702, DOI 10.1074/jbc.M112.397786; SATOKATA I, 1993, GENE, V136, P345; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; Shikazono N, 2006, NUCLEIC ACIDS RES, V34, P3722, DOI 10.1093/nar/gkl503; Shikazono N, 2013, MUTAT RES-FUND MOL M, V749, P9, DOI 10.1016/j.mrfmmm.2013.07.010; Stevnsner T, 2002, ONCOGENE, V21, P8675, DOI 10.1038/sj.onc.1205994; Sutherland BM, 2002, RADIAT RES, V157, P611, DOI 10.1667/0033-7587(2002)157[0611:CDDIBX]2.0.CO;2; Sutherland BM, 2000, P NATL ACAD SCI USA, V97, P103, DOI 10.1073/pnas.97.1.103; Torres-Ramos CA, 2000, MOL CELL BIOL, V20, P3522, DOI 10.1128/MCB.20.10.3522-3528.2000; Yasui M, 2014, DNA REPAIR, V15, P11, DOI 10.1016/j.dnarep.2014.01.003; Yuan BF, 2010, CHEM RES TOXICOL, V23, P11, DOI 10.1021/tx9004264; Zhang Y, 2009, CURR GENOMICS, V10, P250, DOI 10.2174/138920209788488544	45	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142218	10.1371/journal.pone.0142218	http://dx.doi.org/10.1371/journal.pone.0142218			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559182	Green Published, Green Submitted, gold			2022-12-26	WOS:000364433100063
J	Shah, AD; Bouchard, MJ; Shieh, AC				Shah, Arpit D.; Bouchard, Michael J.; Shieh, Adrian C.			Interstitial Fluid Flow Increases Hepatocellular Carcinoma Cell Invasion through CXCR4/CXCL12 and MEK/ERK Signaling	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; STELLATE CELLS; SHEAR-STRESS; CANCER CELLS; TGF-BETA; IN-VITRO; MATRIX; EXPRESSION; MIGRATION; ACTIVATION	Hepatocellular carcinoma (HCC) is the most common form of liver cancer (similar to 80%), and it is one of the few cancer types with rising incidence in the United States. This highly invasive cancer is very difficult to detect until its later stages, resulting in limited treatment options and low survival rates. There is a dearth of knowledge regarding the mechanisms associated with the effects of biomechanical forces such as interstitial fluid flow (IFF) on hepatocellular carcinoma invasion. We hypothesized that interstitial fluid flow enhanced hepatocellular carcinoma cell invasion through chemokine-mediated autologous chemotaxis. Utilizing a 3D in vitro invasion assay, we demonstrated that interstitial fluid flow promoted invasion of hepatocellular carcinoma derived cell lines. Furthermore, we showed that autologous chemotaxis influences this interstitial fluid flow-induced invasion of hepatocellular carcinoma derived cell lines via the C-X-C chemokine receptor type 4 (CXCR4)/C-X-C motif chemokine 12 (CXCL12) signaling axis. We also demonstrated that mitogen-activated protein kinase (MEK)/extracellular signal-regulated kinase (ERK) signaling affects interstitial fluid flow-induced invasion; however, this pathway was separate from CXCR4/CXCL12 signaling. This study demonstrates, for the first time, the potential role of interstitial fluid flow in hepatocellular carcinoma invasion. Uncovering the mechanisms that control hepatocellular carcinoma invasion will aid in enhancing current liver cancer therapies and provide better treatment options for patients.	[Shah, Arpit D.; Shieh, Adrian C.] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA; [Bouchard, Michael J.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19104 USA	Drexel University; Drexel University	Shieh, AC (corresponding author), Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA.	Adrian.C.Shieh@drexel.edu		Shieh, Adrian/0000-0001-9569-361X; Shah, Arpit/0000-0002-0680-1306	Pennsylvania Department of Health; Drexel University	Pennsylvania Department of Health; Drexel University	This work was supported by a CURE award from the Pennsylvania Department of Health and Drexel University to Adrian C. Shieh and Michael J. Bouchard.	Albus U., 2012, GUIDE CARE USE LAB A, DOI DOI 10.1258/LA.2012.150312; Amann T, 2009, CANCER SCI, V100, P646, DOI 10.1111/j.1349-7006.2009.01087.x; Brand S, 2005, EXP CELL RES, V310, P117, DOI 10.1016/j.yexcr.2005.07.006; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Callejas NA, 2001, HEPATOLOGY, V33, P860, DOI 10.1053/jhep.2001.23002; Carloni V, 2001, HEPATOLOGY, V34, P42, DOI 10.1053/jhep.2001.25224; CHARY SR, 1989, P NATL ACAD SCI USA, V86, P5385, DOI 10.1073/pnas.86.14.5385; Dafni H, 2002, CANCER RES, V62, P6731; Domanska UM, 2013, EUR J CANCER, V49, P219, DOI 10.1016/j.ejca.2012.05.005; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fleury ME, 2006, BIOPHYS J, V91, P113, DOI 10.1529/biophysj.105.080192; Gearhart TL, 2010, J VIROL, V84, P2675, DOI 10.1128/JVI.02196-09; Goodnough JB, 2012, HEPATOLOGY, V56, P291, DOI 10.1002/hep.25615; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Hompland T, 2012, CANCER RES, V72, P4899, DOI 10.1158/0008-5472.CAN-12-0903; Honma N, 2006, LAB INVEST, V86, P687, DOI 10.1038/labinvest.3700427; HORI K, 1986, JPN J CANCER RES, V77, P65; Howlader N, SEER CANC STAT REV; Huynh H, 2003, BMC GASTROENTEROL, V3, DOI 10.1186/1471-230X-3-19; JAIN RK, 1987, CANCER RES, V47, P3039; Katyal S, 2000, RADIOLOGY, V216, P698, DOI 10.1148/radiology.216.3.r00se24698; KONDO Y, 1991, HUM PATHOL, V22, P125, DOI 10.1016/0046-8177(91)90033-L; Le Pabic H, 2003, HEPATOLOGY, V37, P1056, DOI 10.1053/jhep.2003.50205; Leelawat K, 2007, WORLD J GASTROENTERO, V13, P1561, DOI 10.3748/wjg.v13.i10.1561; Liang Z, 2007, BIOCHEM BIOPH RES CO, V359, P716, DOI 10.1016/j.bbrc.2007.05.182; Liu EB, 2000, CANCER RES, V60, P2361; Liu H, 2008, CELL MOL IMMUNOL, V5, P373, DOI 10.1038/cmi.2008.46; Matsuo M, 2006, CANCER SCI, V97, P155, DOI 10.1111/j.1349-7006.2006.00152.x; Maurer G, 2011, ONCOGENE, V30, P3477, DOI 10.1038/onc.2011.160; Mayoral R, 2005, CARCINOGENESIS, V26, P753, DOI 10.1093/carcin/bgi022; Mitra P, 2001, CELL SIGNAL, V13, P311, DOI 10.1016/S0898-6568(01)00156-5; Munson JM, 2013, CANCER RES, V73, P1536, DOI 10.1158/0008-5472.CAN-12-2838; Ng CP, 2004, MICROVASC RES, V68, P258, DOI 10.1016/j.mvr.2004.08.002; Park JW, 2010, EXP MOL MED, V42, P105, DOI 10.3858/emm.2010.42.2.012; Pedersen JA, 2007, J BIOMECH, V40, P1484, DOI 10.1016/j.jbiomech.2006.06.023; Pedersen JA, 2010, J BIOMECH, V43, P900, DOI 10.1016/j.jbiomech.2009.11.007; Polacheck WJ, 2014, P NATL ACAD SCI USA, V111, P2447, DOI 10.1073/pnas.1316848111; Polacheck WJ, 2011, P NATL ACAD SCI USA, V108, P11115, DOI 10.1073/pnas.1103581108; Polacheck WJ, 2012, CELLULAR MOL LIFE SC, P1; Poon RTP, 2000, ANN SURG, V232, P10, DOI 10.1097/00000658-200007000-00003; Qazi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020348; Risks NIoHOfPfR Welfare NIoHOoLA, 2002, PUBL HLTH SERV POL H; Schimanski CC, 2006, BRIT J CANCER, V95, P210, DOI 10.1038/sj.bjc.6603251; Schmidt CM, 1997, BIOCHEM BIOPH RES CO, V236, P54, DOI 10.1006/bbrc.1997.6840; Shi ZD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015956; Shibuta K, 2002, JPN J CANCER RES, V93, P789, DOI 10.1111/j.1349-7006.2002.tb01321.x; Shieh AC, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015012; Shieh AC, 2011, CANCER RES, V71, P790, DOI 10.1158/0008-5472.CAN-10-1513; Shields JD, 2007, ONCOGENE, V26, P2997, DOI 10.1038/sj.onc.1210114; Shields JD, 2007, CANCER CELL, V11, P526, DOI 10.1016/j.ccr.2007.04.020; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Siggers JH, 2014, BIOMECH MODEL MECHAN, V13, P363, DOI 10.1007/s10237-013-0516-x; Society AC, 2013, LIVER CANC; Sutton A, 2007, MOL CANCER RES, V5, P21, DOI 10.1158/1541-7786.MCR-06-0103; Tarbell JM, 2006, J INTERN MED, V259, P339, DOI 10.1111/j.1365-2796.2006.01620.x; Tchafa AM, 2015, MOL CANCER RES, V13, P755, DOI 10.1158/1541-7786.MCR-14-0471; Tchafa AM, 2012, JOVE-J VIS EXP, DOI 10.3791/4159; Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05; Wells RG, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.110pe13; Wiesenauer CA, 2004, J AM COLL SURGEONS, V198, P410, DOI 10.1016/j.jamcollsurg.2003.10.004; Xiang ZL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-176; Yang JD, 2011, SEMIN CANCER BIOL, V21, P35, DOI 10.1016/j.semcancer.2010.10.007; Zhu AX, 2008, CANCER-AM CANCER SOC, V112, P250, DOI 10.1002/cncr.23175	63	30	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142337	10.1371/journal.pone.0142337	http://dx.doi.org/10.1371/journal.pone.0142337			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560447	Green Published, Green Submitted, gold			2022-12-26	WOS:000364433100072
J	Xie, L; Altindal, T; Wu, XL				Xie, Li; Altindal, Tuba; Wu, Xiao-Lun			An Element of Determinism in a Stochastic Flagellar Motor Switch	PLOS ONE			English	Article							VIBRIO-ALGINOLYTICUS; CONFORMATIONAL SPREAD; ESCHERICHIA-COLI; PROTEINS; MECHANISM; CHEMOTAXIS; DIRECTION; BACTERIA; MODELS; POLAR	Marine bacterium Vibrio alginolyticus uses a single polar flagellum to navigate in an aqueous environment. Similar to Escherichia coli cells, the polar flagellar motor has two states; when the motor is counter-clockwise, the cell swims forward and when the motor is clockwise, the cell swims backward. V. alginolyticus also incorporates a direction randomization step at the start of the forward swimming interval by flicking its flagellum. To gain an understanding on how the polar flagellar motor switch is regulated, distributions of the forward Delta(f) and backward Delta(b) intervals are investigated herein. We found that the steady-state probability density functions, P(Delta(f)) and P(Delta(b)), of freely swimming bacteria are strongly peaked at a finite time, suggesting that the motor switch is not Poissonian. The short-time inhibition is sufficiently strong and long lasting, i.e., several hundred milliseconds for both intervals, which is readily observed and characterized. Treating motor reversal dynamics as a first-passage problem, which results from conformation fluctuations of the motor switch, we calculated P(Delta(f)) and P(Delta(b)) and found good agreement with the measurements.	[Xie, Li; Wu, Xiao-Lun] Univ Pittsburgh, Dept Phys & Astron, Pittsburgh, PA 15260 USA; [Altindal, Tuba] Simon Fraser Univ, Dept Phys, Burnaby, BC V5A 1S6, Canada	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Simon Fraser University	Xie, L (corresponding author), Univ Pittsburgh, Dept Phys & Astron, Pittsburgh, PA 15260 USA.	lix11@pitt.edu	Xie, Li/N-1724-2019	Xie, Li/0000-0003-3397-2407	National Science Fundation [DMR-1305006]; University of Pittsburgh; Direct For Mathematical & Physical Scien [1305006] Funding Source: National Science Foundation	National Science Fundation(National Science Foundation (NSF)); University of Pittsburgh(University of Pittsburgh); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	X-LW and TA are supported by the National Science Fundation grant No. DMR-1305006, received by X-LW (http://www.nsf.gov/). LX is supported by the Andrew Mellon Predoctoral Fellowship from the University of Pittsburgh (http www.asgraduate.pitt.edu/node/336). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER J, 1967, J GEN MICROBIOL, V46, P161, DOI 10.1099/00221287-46-2-161; Alexander RP, 2010, TRENDS MICROBIOL, V18, P494, DOI 10.1016/j.tim.2010.07.004; Altindal T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018231; [Anonymous], 1965, QUANTUM OPTICS ELECT; Bai F, 2010, SCIENCE, V327, P685, DOI 10.1126/science.1182105; BATCHELOR GK, 1959, J FLUID MECH, V5, P113, DOI 10.1017/S002211205900009X; Berg H C, 1974, Antibiot Chemother (1971), V19, P55; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Berry MJ, 1998, J NEUROSCI, V18, P2200; BLAKE PA, 1980, ANNU REV MICROBIOL, V34, P341, DOI 10.1146/annurev.mi.34.100180.002013; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; Chen SY, 2011, EMBO J, V30, P2972, DOI 10.1038/emboj.2011.186; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; COLQUHOUN D, 1981, PROC R SOC SER B-BIO, V211, P205, DOI 10.1098/rspb.1981.0003; Darling DA, 1953, 1 PASSAGE PROBLEM CO; Duke TAJ, 2001, J MOL BIOL, V308, P541, DOI 10.1006/jmbi.2001.4610; FIENBERG SE, 1974, BIOMETRICS, V30, P399, DOI 10.2307/2529198; Homma M, 1996, MICROBIOL-UK, V142, P2777, DOI 10.1099/13500872-142-10-2777; HOTANI H, 1982, J MOL BIOL, V156, P791, DOI 10.1016/0022-2836(82)90142-5; KAWAGISHI I, 1995, J BACTERIOL, V177, P5158, DOI 10.1128/jb.177.17.5158-5160.1995; Kojima M, 2007, MOL MICROBIOL, V64, P57, DOI 10.1111/j.1365-2958.2007.05623.x; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; KUO SC, 1989, J BACTERIOL, V171, P6279, DOI 10.1128/jb.171.11.6279-6287.1989; LEIFSON E, 1964, J BACTERIOL, V87, P652, DOI 10.1128/JB.87.3.652-666.1964; Li N, 2011, GENES CELLS, V16, P985, DOI 10.1111/j.1365-2443.2011.01545.x; Luchsinger RH, 1999, BIOPHYS J, V77, P2377, DOI 10.1016/S0006-3495(99)77075-X; MITCHELL JG, 1991, MICROBIAL ECOL, V22, P227, DOI 10.1007/BF02540225; Mochrie SGJ, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.031913; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Naber H, 1996, J THEOR BIOL, V181, P343, DOI 10.1006/jtbi.1996.0136; Paul K, 2011, P NATL ACAD SCI USA, V108, P17171, DOI 10.1073/pnas.1110111108; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; PURCELL EM, 1956, NATURE, V178, P1448; Scharf BE, 1998, P NATL ACAD SCI USA, V95, P201, DOI 10.1073/pnas.95.1.201; Schrodinger E, 1915, PHYS Z, V16, P289; Sen A, 2004, J ELECTRON MICROSC, V53, P305, DOI 10.1093/jmicro/53.3.305; Son K, 2013, NAT PHYS, V9, P494, DOI 10.1038/NPHYS2676; SPRINGER MS, 1979, NATURE, V280, P279, DOI 10.1038/280279a0; Takano Y, 2003, JSME INT J C-MECH SY, V46, P1241, DOI 10.1299/jsmec.46.1241; Terashima H, 2006, MOL MICROBIOL, V62, P1170, DOI 10.1111/j.1365-2958.2006.05435.x; Tu Y, 2008, P NATL ACAD SCI USA, V105, P11737, DOI 10.1073/pnas.0804641105; Tumer L, 1996, BIOPHYS J, V71, P2227, DOI 10.1016/S0006-3495(96)79425-0; Turner L, 2000, J BACTERIOL, V182, P2793, DOI 10.1128/JB.182.10.2793-2801.2000; Wang FB, 2014, P NATL ACAD SCI USA, V111, P15752, DOI 10.1073/pnas.1418548111; Xie L, 2015, BIOPHYS J, V108, P766, DOI 10.1016/j.bpj.2014.11.3479; Xie L, 2011, P NATL ACAD SCI USA, V108, P2246, DOI 10.1073/pnas.1011953108; YAMAMOTO K, 1990, J BACTERIOL, V172, P383, DOI 10.1128/JB.172.1.383-388.1990	47	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141654	10.1371/journal.pone.0141654	http://dx.doi.org/10.1371/journal.pone.0141654			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554590	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000364430700035
J	Brandmaier, P; Purz, S; Bremicker, K; Hockel, M; Barthel, H; Kluge, R; Kahn, T; Sabri, O; Stumpp, P				Brandmaier, P.; Purz, S.; Bremicker, K.; Hoeckel, M.; Barthel, H.; Kluge, R.; Kahn, T.; Sabri, O.; Stumpp, P.			Simultaneous [F-18]FDG-PET/MRI: Correlation of Apparent Diffusion Coefficient (ADC) and Standardized Uptake Value (SUV) in Primary and Recurrent Cervical Cancer	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; F-18 FLUORODEOXYGLUCOSE UPTAKE; NONMETASTATIC LYMPH-NODES; FDG PET/CT; THERAPY; DIFFERENTIATION; CARCINOMA; ACCURACY; MRI	Objectives Previous non simultaneous PET/MR studies have shown heterogeneous results about the correlation between standardized uptake values (SUVs) and apparent diffusion coefficients (ADCs). The aim of this study was to investigate correlations in patients with primary and recurrent tumors using a simultaneous PET/MRI system which could lead to a better understanding of tumor biology and might play a role in early response assessment. Methods We included 31 patients with histologically confirmed primary (n = 14) or recurrent cervical cancer (n = 17) who underwent simultaneous whole-body 18F-FDG-PET/MRI comprising DWI. Image analysis was performed by a radiologist and a nuclear physician who identified tumor margins and quantified ADC and SUV. Pearson correlations were calculated to investigate the association between ADC and SUV. Results 92 lesions were detected. We found a significant inverse correlation between SUVmax and ADCmia (r = -0.532, p = 0.05) in primary tumors as well as in primary metastases (r = -0.362, p = 0.05) and between SUVmean and ADCmin (r = -0.403,p = 0.03). In recurrent local tumors we found correlations for SUVmax and ADCmia (r = -0.747, p = 0.002) and SUVmean and ADCmia (r = -0.773, p = 0.001). Associations for recurrent metastases were not significant (p>0.05). Conclusions Our study demonstrates the feasibility of fast and reliable measurement of SUV and ADC with simultaneous PET/MRI. In patients with cervical cancer we found significant inverse correlations for SUV and ADC which could play a major role for further tumor characterization and therapy decisions.	[Brandmaier, P.; Bremicker, K.; Kahn, T.; Stumpp, P.] Univ Hosp Leipzig, Dept Diagnost & Intervent Radiol, Leipzig, Germany; [Purz, S.; Barthel, H.; Kluge, R.; Sabri, O.] Univ Hosp Leipzig, Dept Nucl Med, Leipzig, Germany; [Hoeckel, M.] Univ Hosp Leipzig, Dept Gynecol & Obstet, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University	Brandmaier, P (corresponding author), Univ Hosp Leipzig, Dept Diagnost & Intervent Radiol, Leipzig, Germany.	philipe.brandmaier@medizin.uni-leipzig.de		Sabri, Osama/0000-0002-6425-3504				Baba S, 2014, J NUCL MED, V55, P736, DOI 10.2967/jnumed.113.129395; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Choi BB, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-126; Chung M. K., 2007, ENCY MEASUREMENT STA, V1, P189; Colombo N, 2012, ANN ONCOL, V23, P27, DOI 10.1093/annonc/mds268; Folpe AL, 2000, CLIN CANCER RES, V6, P1279; Furth C, 2009, J CLIN ONCOL, V27, P4385, DOI 10.1200/JCO.2008.19.7814; Grueneisen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096751; Hagemann T, 2007, BRIT J CANCER, V96, P321, DOI 10.1038/sj.bjc.6603543; Heusch P, 2013, ROFO-FORTSCHR RONTG, V185, P1059, DOI 10.1055/s-0033-1350110; Ho KC, 2009, EUR J NUCL MED MOL I, V36, P200, DOI 10.1007/s00259-008-0936-5; Hoekstra CJ, 2005, J CLIN ONCOL, V23, P8362, DOI 10.1200/JCO.2005.01.1189; Horger M, 2014, EUR J RADIOL, V83, P1655, DOI 10.1016/j.ejrad.2014.05.027; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jung SH, 2012, J MAGN RESON IMAGING, V35, P110, DOI 10.1002/jmri.22749; Kidd EA, 2010, CANCER-AM CANCER SOC, V116, P1469, DOI 10.1002/cncr.24972; Kim JK, 2008, J MAGN RESON IMAGING, V28, P714, DOI 10.1002/jmri.21480; Kuang F, 2013, EUR RADIOL, V23, P1050, DOI 10.1007/s00330-012-2681-1; Le Bihan D, 1985, ANN M RSNA CHIC; Lee YY, 2009, GYNECOL ONCOL, V115, P65, DOI 10.1016/j.ygyno.2009.06.022; Levy A, 2011, GYNECOL ONCOL, V123, P110, DOI 10.1016/j.ygyno.2011.06.009; Liu Y, 2011, GYNECOL ONCOL, V122, P19, DOI 10.1016/j.ygyno.2011.03.023; Martin CM, 2006, EXPERT REV MOL DIAGN, V6, P217, DOI 10.1586/14737159.6.2.217; Martinez-Moller A, 2009, J NUCL MED, V50, P520, DOI 10.2967/jnumed.108.054726; Mori T, 2008, J THORAC ONCOL, V3, P358, DOI 10.1097/JTO.0b013e318168d9ed; Nakajo M, 2012, CLIN NUCL MED, V37, P475, DOI 10.1097/RLU.0b013e318248524a; Nakajo M, 2010, EUR J NUCL MED MOL I, V37, P2011, DOI 10.1007/s00259-010-1529-7; Pahk K, 2014, ANTICANCER RES, V34, P4447; Punwani S, 2013, EUR J NUCL MED MOL I, V40, P373, DOI 10.1007/s00259-012-2293-7; Rakheja R, 2013, AM J ROENTGENOL, V201, P1120, DOI 10.2214/AJR.13.11305; Rakheja R, 2012, AM J ROENTGENOL, V198, P1409, DOI 10.2214/AJR.11.7560; Schmidt H, 2013, INVEST RADIOL, V48, P247, DOI 10.1097/RLI.0b013e31828d56a1; Vanderhoek M, 2013, J NUCL MED, V54, P1188, DOI 10.2967/jnumed.112.113332; Varoquaux A, 2013, EUR J NUCL MED MOL I, V40, P842, DOI 10.1007/s00259-013-2351-9; Xue FY, 2006, GYNECOL ONCOL, V101, P147, DOI 10.1016/j.ygyno.2005.10.005; Xue HD, 2014, ARCH GYNECOL OBSTET, V290, P341, DOI 10.1007/s00404-014-3221-9; Yankeelov TE, 2012, MAGN RESON IMAGING, V30, P1342, DOI 10.1016/j.mri.2012.06.001; Zhang Jie, 2014, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V36, P73, DOI 10.3881/j.issn.1000-503X.2014.01.014	38	36	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0141684	10.1371/journal.pone.0141684	http://dx.doi.org/10.1371/journal.pone.0141684			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26551527	Green Published, Green Submitted, gold			2022-12-26	WOS:000364422800008
J	Monaco, F; Cosseddu, GM; Doumbia, B; Madani, H; El Mellouli, F; Jimenez-Clavero, MA; Sghaier, S; Marianneau, P; Cetre-Sossah, C; Polci, A; Lacote, S; Lakhdar, M; Fernandez-Pinero, J; Nassim, CS; Pinoni, C; Dondona, AC; Gallardo, C; Bouzid, T; Conte, A; Bortone, G; Savini, G; Petrini, A; Puech, L				Monaco, Federica; Cosseddu, Gian Mario; Doumbia, Baba; Madani, Hafsa; El Mellouli, Fatiha; Angel Jimenez-Clavero, Miguel; Sghaier, Soufien; Marianneau, Philippe; Cetre-Sossah, Catherine; Polci, Andrea; Lacote, Sandra; Lakhdar, Magtouf; Fernandez-Pinero, Jovita; Nassim, Chabane Sari; Pinoni, Chiara; Dondona, Andrea Capobianco; Gallardo, Carmina; Bouzid, Taoufiq; Conte, Annamaria; Bortone, Grazia; Savini, Giovanni; Petrini, Antonio; Puech, Lilian			First External Quality Assessment of Molecular and Serological Detection of Rift Valley Fever in the Western Mediterranean Region	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; REVERSE TRANSCRIPTION-PCR; VIRUS; ANTIBODY; SERA; RUMINANTS; ELISA; IGG	Rift Valley fever (RVF) is a mosquito-borne viral zoonosis which affects humans and a wide range of domestic and wild ruminants. The large spread of RVF in Africa and its potential to emerge beyond its geographic range requires the development of surveillance strategies to promptly detect the disease outbreaks in order to implement efficient control measures, which could prevent the widespread of the virus to humans. The Animal Health Mediterranean Network (REMESA) linking some Northern African countries as Algeria, Egypt, Libya, Mauritania, Morocco, Tunisia with Southern European ones as France, Italy, Portugal and Spain aims at improving the animal health in the Western Mediterranean Region since 2009. In this context, a first assessment of the diagnostic capacities of the laboratories involved in the RVF surveillance was performed. The first proficiency testing (external quality assessment-EQA) for the detection of the viral genome and antibodies of RVF virus (RVFV) was carried out from October 2013 to February 2014. Ten laboratories participated from 6 different countries (4 from North Africa and 2 from Europe). Six laboratories participated in the ring trial for both viral RNA and antibodies detection methods, while four laboratories participated exclusively in the antibodies detection ring trial. For the EQA targeting the viral RNA detection methods 5 out of 6 laboratories reported 100% of correct results. One laboratory misidentified 2 positive samples as negative and 3 positive samples as doubtful indicating a need for corrective actions. For the EQA targeting IgG and IgM antibodies methods 9 out of the 10 laboratories reported 100% of correct results, whilst one laboratory reported all correct results except one false-positive. These two ring trials provide evidence that most of the participating laboratories are capable to detect RVF antibodies and viral RNA thus recognizing RVF infection in affected ruminants with the diagnostic methods currently available.	[Monaco, Federica; Cosseddu, Gian Mario; Polci, Andrea; Pinoni, Chiara; Dondona, Andrea Capobianco; Conte, Annamaria; Bortone, Grazia; Savini, Giovanni; Petrini, Antonio] Ist Zooprofilatt Sperimentale Abruzzo & Molise G, Teramo, Italy; [Doumbia, Baba] Ctr Natl Elevage & Rech Vet, Nouakchott, Mauritania; [Madani, Hafsa] Inst Natl Med Vet, Lab Cent Vet Alger, Algiers, Algeria; [El Mellouli, Fatiha] Off Natl Secur Sanit Prod Alimentaires ONSSA, Lab Reg Anal & Rech Casablanca, Casablanca, Morocco; [Angel Jimenez-Clavero, Miguel; Fernandez-Pinero, Jovita; Gallardo, Carmina] Ctr Invest Sanidad Anim CISA INIA, Valdeolmos, Madrid, Spain; [Sghaier, Soufien] Univ Tunis El Manar, Inst Rech Vet Tunisie, Tunis, Tunisia; [Marianneau, Philippe; Lacote, Sandra] Agence Natl Secur Sanit Alimentat Environm & Trav, Lyon, France; [Cetre-Sossah, Catherine] INRA, UMR CMAEE, UMR 1309, Ctr Cooperat Int Rech Agron Dev CIRAD, F-34398 Montpellier, France; [Lakhdar, Magtouf] Inst Natl Med Vet, Lab Vet Reg Laghouat, Laghouat, Algeria; [Nassim, Chabane Sari] Inst Natl Med Vet, Lab Vet Reg Tlemcen, Tilimsen, Algeria; [Bouzid, Taoufiq] Off Natl Secur Sanit Prod Alimentaires ONSSA, Lab Reg Anal & Rech Agadir, Agadir, Morocco; [Puech, Lilian] Minist Affaires Etrangeres & Dev Int, Paris, France	IZS Dell'abruzzo E Del Molise Giuseppe Caporale; Ecole Nationale Superieure Veterinaire; Universite de Tunis-El-Manar; CIRAD; INRAE; Ecole Nationale Superieure Veterinaire; Ecole Nationale Superieure Veterinaire	Cosseddu, GM (corresponding author), Ist Zooprofilatt Sperimentale Abruzzo & Molise G, Teramo, Italy.	g.cosseddu@izs.it	Savini, Giovanni/AAT-7897-2020; Petrini, Antonio/F-4819-2017; gallardo, Carmina/AAB-2386-2019; Savini, Giovanni/D-8416-2016; Capobianco Dondona, Andrea/B-3832-2017; Jimenez-Clavero, Miguel Angel/E-3048-2010; Petrini, Antonio/ABF-4885-2020; Monaco, Federica/G-9282-2016; Sghaier, Soufien/AAT-1943-2020; Cosseddu, Gian Mario/J-1046-2014; Conte, Annamaria/H-5869-2016; Gallardo+Frontaura, Carmina/ABE-6878-2021; Polci, Andrea/G-9267-2016; Pinoni, Chiara/G-9223-2016; Monaco, Federica/ABC-9526-2021; Fernández-Pinero, Jovita/H-4515-2015; Dondona, Andrea Capobianco/AAJ-6651-2021	Savini, Giovanni/0000-0001-7933-7367; Petrini, Antonio/0000-0002-2089-4123; gallardo, Carmina/0000-0003-3293-306X; Savini, Giovanni/0000-0001-7933-7367; Capobianco Dondona, Andrea/0000-0002-5970-8383; Jimenez-Clavero, Miguel Angel/0000-0003-2125-9743; Petrini, Antonio/0000-0002-2089-4123; Monaco, Federica/0000-0002-7827-2642; Sghaier, Soufien/0000-0003-3608-9919; Cosseddu, Gian Mario/0000-0001-8031-1762; Conte, Annamaria/0000-0001-6975-2698; Polci, Andrea/0000-0003-3124-9223; Pinoni, Chiara/0000-0002-6538-5453; Monaco, Federica/0000-0002-7827-2642; Fernández-Pinero, Jovita/0000-0001-9919-0112; Dondona, Andrea Capobianco/0000-0002-5970-8383	project "Renforcement des capacites des pays pour la mise en place d'un dispositif de prevention et de lutte contre la fievre de la Vallee du Rift dans la zone de la Mediterranee occidentale" [GCP/SNE/001/FRA]; Italian Ministry of Health; FAO subregional representation for North Africa; OIE subregional representation for North Africa; CVOs of REMESA	project "Renforcement des capacites des pays pour la mise en place d'un dispositif de prevention et de lutte contre la fievre de la Vallee du Rift dans la zone de la Mediterranee occidentale"; Italian Ministry of Health(Ministry of Health, Italy); FAO subregional representation for North Africa; OIE subregional representation for North Africa; CVOs of REMESA	This EQA study was funded by the project "Renforcement des capacites des pays pour la mise en place d'un dispositif de prevention et de lutte contre la fievre de la Vallee du Rift dans la zone de la Mediterranee occidentale" (GCP/SNE/001/FRA). Partial funding was also provided by the Italian Ministry of Health. he funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the support of FAO and OIE subregional representations for North Africa and the CVOs of REMESA for the organization of the EQA trial. We also acknowledge the Central Veterinary Laboratory of Windhoek, Namibia, for providing some of the samples included in the trial.	Balkhy HH, 2003, INT J ANTIMICROB AG, V21, P153, DOI 10.1016/S0924-8579(02)00295-9; Bird BH, 2007, J CLIN MICROBIOL, V45, P3506, DOI 10.1128/JCM.00936-07; Bird BH, 2007, J VIROL, V81, P2805, DOI 10.1128/JVI.02095-06; Cetre-Sossah C, 2009, PREV VET MED, V90, P146, DOI 10.1016/j.prevetmed.2009.03.011; Chevalier V, 2010, EUROSURVEILLANCE, V15, P18; Daubney R, 1932, LANCET, V1, P611; Daubney R, 1931, J PATHOL BACTERIOL, V34, P545, DOI 10.1002/path.1700340418; Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002; El Mamy ABO, 2011, EMERG INFECT DIS, V17, P1894, DOI 10.3201/eid1710.110397; Escadafal C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002244; Fafetine JM, 2007, VET MICROBIOL, V121, P29, DOI 10.1016/j.vetmic.2006.11.008; Garcia S, 2001, J CLIN MICROBIOL, V39, P4456, DOI 10.1128/JCM.39.12.4456-4461.2001; Gerdes GH, 2004, REV SCI TECH OIE, V23, P613, DOI 10.20506/rst.23.2.1500; LaBeaud AD, 2011, EMERG INFECT DIS, V17, P233, DOI 10.3201/eid1702.091666; Monaco F, 2013, EMERG INFECT DIS, V19, P2025, DOI 10.3201/eid1912.130593; MULLER R, 1995, AM J TROP MED HYG, V53, P405, DOI 10.4269/ajtmh.1995.53.405; PARKER J, 1975, VET REC, V96, P284, DOI 10.1136/vr.96.13.284; Paweska JT, 2008, VET MICROBIOL, V127, P21, DOI 10.1016/j.vetmic.2007.07.031; Paweska JT, 2005, J VIROL METHODS, V127, P10, DOI 10.1016/j.jviromet.2005.02.008; Paweska JT, 2003, ONDERSTEPOORT J VET, V70, P49; Pepin M, 2010, VET RES, V41, DOI 10.1051/vetres/2010033; Sall AA, 2001, J VIROL METHODS, V91, P85, DOI 10.1016/S0166-0934(00)00252-4; Sivia D.S, 1996, DATA ANAL; van Vuren PJ, 2010, VECTOR-BORNE ZOONOT, V10, P697, DOI 10.1089/vbz.2009.0213	24	11	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142129	10.1371/journal.pone.0142129	http://dx.doi.org/10.1371/journal.pone.0142129			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26566248	Green Published, gold, Green Submitted			2022-12-26	WOS:000367628500009
J	Zhong, XQ; Wu, JJ; Yang, JY; Sun, ZC; Huang, YL; Li, ZY				Zhong, Xuqi; Wu, Junjie; Yang, Jianyu; Sun, Zhichao; Huang, Yuling; Li, Zhongyu			A Localization Method for Multistatic SAR Based on Convex Optimization	PLOS ONE			English	Article							ALGORITHM; TIME	In traditional localization methods for Synthetic Aperture Radar (SAR), the bistatic range sum (BRS) estimation and Doppler centroid estimation (DCE) are needed for the calculation of target localization. However, the DCE error greatly influences the localization accuracy. In this paper, a localization method for multistatic SAR based on convex optimization without DCE is investigated and the influence of BRS estimation error on localization accuracy is analysed. Firstly, by using the information of each transmitter and receiver (T/R) pair and the target in SAR image, the model functions of T/R pairs are constructed. Each model function's maximum is on the circumference of the ellipse which is the iso-range for its model function's T/R pair. Secondly, the target function whose maximum is located at the position of the target is obtained by adding all model functions. Thirdly, the target function is optimized based on gradient descent method to obtain the position of the target. During the iteration process, principal component analysis is implemented to guarantee the accuracy of the method and improve the computational efficiency. The proposed method only utilizes BRSs of a target in several focused images from multistatic SAR. Therefore, compared with traditional localization methods for SAR, the proposed method greatly improves the localization accuracy. The effectivity of the localization approach is validated by simulation experiment.	[Zhong, Xuqi; Wu, Junjie; Yang, Jianyu; Sun, Zhichao; Huang, Yuling; Li, Zhongyu] Univ Elect Sci & Technol China, Sch Elect Engn, 2006 Xiyuan Ave, Chengdu 611731, Peoples R China	University of Electronic Science & Technology of China	Wu, JJ (corresponding author), Univ Elect Sci & Technol China, Sch Elect Engn, 2006 Xiyuan Ave, Chengdu 611731, Peoples R China.	junjie_wu@uestc.edu.cn	yang, jian/HIK-0188-2022		Research Fund for High-technology Project [9140A07020614DZ02099]; Pre-Research Project [51307030302]; Research Startup Fund of the University of Electronic Science and Technology of China [Y02002010201089]; National Natural Science Foundation of China [61401078]	Research Fund for High-technology Project; Pre-Research Project; Research Startup Fund of the University of Electronic Science and Technology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the Research Fund for High-technology Project (No. 9140A07020614DZ02099), the Pre-Research Project 51307030302, the Research Startup Fund of the University of Electronic Science and Technology of China (Y02002010201089), and the National Natural Science Foundation of China (No. 61401078).	Antoniou M, 2012, IEEE GEOSCI REMOTE S, V9, P477, DOI 10.1109/LGRS.2011.2172571; Bamler R, 2007, IEEE T GEOSCI REMOTE, V45, P3350, DOI 10.1109/TGRS.2007.895436; Bialer O, 2012, IEEE T SIGNAL PROCES, V60, P1241, DOI 10.1109/TSP.2011.2174055; Caffery JJ, 2000, IEEE VTS VEH TECHNOL, P1943, DOI 10.1109/VETECF.2000.886153; CURLANDER JC, 1982, IEEE T GEOSCI REMOTE, V20, P359, DOI 10.1109/TGRS.1982.350455; FOY WH, 1976, IEEE T AERO ELEC SYS, V12, P187, DOI 10.1109/TAES.1976.308294; Jeon NR, 2010, IEEE T VEH TECHNOL, V59, P4139, DOI 10.1109/TVT.2010.2063044; Johnsen T, 2002, RADAR CONF, P141, DOI 10.1109/NRC.2002.999711; Liu J, 2006, 2006 6TH INTERNATIONAL CONFERENCE ON ITS TELECOMMUNICATIONS PROCEEDINGS, P979, DOI 10.1109/ITST.2006.288717; Rigling BD, 2005, IEEE T IMAGE PROCESS, V14, P1159, DOI 10.1109/TIP.2005.851690; Sun W., 2006, P 2006 CO INT C RADA, P1; WANG WQ, 1945, AEROSPACE ELECT SYST, V3, P1040, DOI DOI 10.1109/TAES.2009.5259181; Wu JJ, 2014, IEEE T GEOSCI REMOTE, V52, P6699, DOI 10.1109/TGRS.2014.2301433	13	0	0	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142470	10.1371/journal.pone.0142470	http://dx.doi.org/10.1371/journal.pone.0142470			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26566031	Green Submitted, gold, Green Published			2022-12-26	WOS:000367628500025
J	Amoah, LE; Kakaney, C; Kwansa-Bentum, B; Kusi, KA				Amoah, Linda Eva; Kakaney, Courage; Kwansa-Bentum, Bethel; Kusi, Kwadwo Asamoah			Activity of Herbal Medicines on Plasmodium falciparum Gametocytes: Implications for Malaria Transmission in Ghana	PLOS ONE			English	Article							DIHYDROARTEMISININ; ATOVAQUONE; RESISTANCE; PROGUANIL; PARASITES	Background Malaria still remains a major health issue in Ghana despite the introduction of Artemisinin-based combination therapy (ACT) coupled with other preventative measures such as the use of insecticide treated nets (ITNs). The global quest for eradication of malaria has heightened the interest of identifying drugs that target the sexual stage of the parasite, referred to as transmission-blocking drugs. This study aimed at assessing the efficacy and gametocydal effects of some commonly used herbal malaria products in Ghana. Methodology/Principal Findings After identifying herbal anti-malarial products frequently purchased on the Ghanaian market, ten of them were selected and lyophilized. In vitro drug sensitivity testing of different concentrations of the herbal products was carried out on asexual and in vitro generated gametocytes of the 3D7 strain of Plasmodium falciparum. The efficacies of the products were assessed by microscopy. Cultures containing low dose of RT also produced the least number of late stage gametocytes. Two of the herbal products CM and RT inhibited the growth of late stage gametocytes by >80% at 100 mu g/ml whilst KG was the most inhibitory to early stage gametocytes at that same concentration. However at 1 mu g/ml, only YF significantly inhibited the survival of late stage gametocytes although at that same concentration YF barely inhibited the survival of early stage gametocytes. Conclusions/Significance Herbal product RT (Aloe schweinfurthii, Khaya senegalensis, Piliostigma thonningii and Cassia siamea) demonstrated properties of a highly efficacious gametocydal product. Low dose of herbal product RT exhibited the highest gametocydal activity and at 100 mu g/ml, RT exhibited >80% inhibition of late stage gametocytes. However inhibition of asexual stage parasite by RT was not optimal. Improving the asexual inhibition of RT could convert RT into an ideal antimalarial herbal product. We also found that generally C. sanguinolenta containing herbal products exhibited gametocydal activity in addition to high asexual efficacy. Herbal products with high gametocydal activity can help in the fight to reduce malaria transmission.	[Amoah, Linda Eva; Kusi, Kwadwo Asamoah] Univ Ghana, Noguchi Mem Inst Med Res, Dept Immunol, Coll Hlth Sci, Legon, Ghana; [Kakaney, Courage; Kwansa-Bentum, Bethel] Univ Ghana, Dept Anim Biol & Conservat Sci, Coll Basic & Appl Sci, Legon, Ghana	University of Ghana; University of Ghana	Amoah, LE (corresponding author), Univ Ghana, Noguchi Mem Inst Med Res, Dept Immunol, Coll Hlth Sci, Legon, Ghana.	LEvaAmoah@noguchi.ug.edu.gh	Amoah, Linda/AAY-6198-2021; Kwansa-Bentum, Bethel/ABD-9984-2021; Kusi, Kwadwo Asamoah/J-5941-2019	Amoah, Linda/0000-0002-1652-8489; Kusi, Kwadwo Asamoah/0000-0001-5483-9985	University of Ghana Research Fund [URF/5/ILG-013/2011-2012]	University of Ghana Research Fund	This work was funded by the University of Ghana Research Fund Grant to LEA (Research Grant No. URF/5/ILG-013/2011-2012). The funders had no role in study design, data collection, decision to publish, or preparation of the manuscript.	Ajayi NA, 2013, REV SOC BRAS MED TRO, V46, P525, DOI 10.1590/0037-8682-0098-2013; Akompong T, 2000, ANTIMICROB AGENTS CH, V44, P88, DOI [10.1128/AAC.44.11.3107-3111.2000, 10.1128/AAC.44.1.88-96.2000]; Benoit-Vical F, 2007, ANTIMICROB AGENTS CH, V51, P1463, DOI 10.1128/AAC.00967-06; Beutler E, 2007, AM J TROP MED HYG, V77, P779, DOI 10.4269/ajtmh.2007.77.779; Bousema T, 2011, CLIN MICROBIOL REV, V24, P377, DOI 10.1128/CMR.00051-10; Bugyei K A, 2010, Ghana Med J, V44, P3; Cui L, 2012, MOL MICROBIOL, V86, P111, DOI 10.1111/j.1365-2958.2012.08180.x; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Fivelman QL, 2004, ANTIMICROB AGENTS CH, V48, P4097, DOI 10.1128/AAC.48.11.4097-4102.2004; Kariuki MM, 1998, AM J TROP MED HYG, V59, P505, DOI 10.4269/ajtmh.1998.59.505; Kwansa-Bentum B, 2011, TROP MED INT HEALTH, V16, P1215, DOI 10.1111/j.1365-3156.2011.02833.x; Mawili-Mboumba DP, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-375; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Nichter M., 2008, GLOBAL HLTH WHY CULT; Okell LC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-125; Ouedraogo AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008410; Peatey CL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-34; Price RN, 1996, LANCET, V347, P1654, DOI 10.1016/S0140-6736(96)91488-9; SMALLEY ME, 1981, T ROY SOC TROP MED H, V75, P103, DOI 10.1016/0035-9203(81)90019-5; Srivastava IK, 1999, ANTIMICROB AGENTS CH, V43, P1334, DOI 10.1128/AAC.43.6.1334; Tanaka TQ, 2001, MOL BIOCHEM PARASIT, V177, P160; THOMSON J. G., 1935, TRANS ROY SOC TROP MED AND HYG, V29, P31, DOI 10.1016/S0035-9203(35)90015-3; TITANJI VPK, 1990, ACT LEIDENS, V59, P377; Tiwari A. K., 2013, Lifesciences Leaflets, V1, P31; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Ubalee Ratawan, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P225; Udeinya JI, 2008, AM J THER, V15, P108, DOI 10.1097/MJT.0b013e31804c6d1d; UMASS AMHERST, 2015, WHOL PLANT THER SHOW; WHO, 2001, PROM ROL TRAD MED HL; Wilson DW, 2013, ANTIMICROB AGENTS CH, V57, P1455, DOI 10.1128/AAC.01881-12; World Health Organization, 2002, WHO ANT CAR RAND TRI, P2002; Wright CW, 2007, J PHARM PHARMACOL, V59, P899, DOI 10.1211/jpp.59.6.0017	33	20	20	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142587	10.1371/journal.pone.0142587	http://dx.doi.org/10.1371/journal.pone.0142587			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562778	Green Published, gold, Green Submitted			2022-12-26	WOS:000364480900047
J	Braz, SV; Monge-Fuentes, V; da Silva, JR; Tomaz, C; Tavares, MC; Garcia, MP; Bao, SN; Lozzi, SP; de Azevedo, RB				Braz, Shelida Vasconcelos; Monge-Fuentes, Victoria; da Silva, Jaqueline Rodrigues; Tomaz, Carlos; Tavares, Maria Clotilde; Garcia, Monica Pereira; Bao, Sonia Nair; Lozzi, Silene Paulino; de Azevedo, Ricardo Bentes			Morphological Analysis of Reticuloendothelial System in Capuchin Monkeys (Sapajus spp.) after Meso-2,3-Dimercaptosuccinic Acid (DMSA) Coated Magnetic Nanoparticles Administration	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; DRUG-DELIVERY; IN-VIVO; POLYMERIC NANOPARTICLES; MITOCHONDRIAL DYSFUNCTION; MAGHEMITE NANOPARTICLES; SURFACE MODIFICATION; OXIDATIVE INJURY; BLOCK-COPOLYMER; BIODISTRIBUTION	Magnetic nanoparticles can be used for numerous in vitro and in vivo applications. However, since uptake by the reticuloendothelial system represents an obstacle for the achievement of nanoparticle diagnostic and therapeutic goals, the aim of the present study was to evaluate the uptake of dimercaptosuccinic acid coated magnetic nanoparticles by reticulo-endothelial system phagocytic cells present in lymph nodes, spleen, and liver tissue and how the presence of these particles could have an impact on the morphology of these organs in capuchin monkeys (Sapajus spp.). Animals were intravenously injected with dimercaptosuccinic acid coated magnetic nanoparticles and euthanized 12 hours and 90 days post-injection. Organs were processed by transmission electron microscopy and histological techniques. Samples of spleen and lymph nodes showed no morphological changes. Nevertheless, liver samples collected 90 days post-administration showed slight morphological alteration in space of Disse. Moreover, morphometrical analysis of hepatic mitochondria was performed, suggesting a clear positive correlation between mitochondrial area and dimercaptosuccinic acid coated magnetic nanoparticles administration time. The present results are directly relevant to current safety considerations in clinical diagnostic and therapeutic uses of magnetic nanoparticles.	[Monge-Fuentes, Victoria; da Silva, Jaqueline Rodrigues; Garcia, Monica Pereira; de Azevedo, Ricardo Bentes] Univ Brasilia, Inst Biol Sci, Dept Genet & Morphol, Lab Nanobiotechnol, BR-70910900 Brasilia, DF, Brazil; [Braz, Shelida Vasconcelos; Lozzi, Silene Paulino] Univ Brasilia, Inst Biol Sci, Dept Genet & Morphol, BR-70910900 Brasilia, DF, Brazil; [Tomaz, Carlos; Tavares, Maria Clotilde] Univ Brasilia, Ctr Primate, BR-70910900 Brasilia, DF, Brazil; [Tomaz, Carlos; Tavares, Maria Clotilde] Univ Brasilia, Inst Biol, Dept Physiol Sci, Lab Neurosci & Behav, BR-70910900 Brasilia, DF, Brazil; [Bao, Sonia Nair] Univ Brasilia, Dept Cell Biol, Lab Electron Microscopy, BR-70919970 Brasilia, DF, Brazil; [Tomaz, Carlos] Univ CEUMA, Neurocience Grad Program, Sao Luis, MA, Brazil	Universidade de Brasilia; Universidade de Brasilia; Universidade de Brasilia; Universidade de Brasilia; Universidade de Brasilia; Universidade Ceuma	de Azevedo, RB (corresponding author), Univ Brasilia, Inst Biol Sci, Dept Genet & Morphol, Lab Nanobiotechnol, BR-70910900 Brasilia, DF, Brazil.	razevedo@unb.br	Tomaz, Carlos A B/F-8626-2012; Báo, Sônia/V-1214-2019	Azevedo, Ricardo/0000-0002-2137-9588; Bao, Sonia/0000-0002-9873-3098; Da Silva, Jaqueline R/0000-0002-6017-7057; Garcia, Monica/0000-0003-0114-5319	Brazilian agency: Ministerio da Ciencia, Tecnologia e Inovacao (MCTI); Brazilian agency: Financiadora de Estudos e Projetos (FINEP); Brazilian agency: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Brazilian agency: Instituto Nacional de Ciencia e Tecnologia-Nanobiotecnologia (INCT-Nanobiotechnology); Brazilian agency: Coordenacao de Aperfeicoamento de Pessoal do Nivel Superior (CAPES); CNPq; CAPES	Brazilian agency: Ministerio da Ciencia, Tecnologia e Inovacao (MCTI); Brazilian agency: Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Brazilian agency: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian agency: Instituto Nacional de Ciencia e Tecnologia-Nanobiotecnologia (INCT-Nanobiotechnology); Brazilian agency: Coordenacao de Aperfeicoamento de Pessoal do Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the following Brazilian agencies: Ministerio da Ciencia, Tecnologia e Inovacao (MCTI); Financiadora de Estudos e Projetos (FINEP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Instituto Nacional de Ciencia e Tecnologia-Nanobiotecnologia (INCT-Nanobiotechnology); and Coordenacao de Aperfeicoamento de Pessoal do Nivel Superior (CAPES). The funders participated in the purchase of equipment and reagents used in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Student scholarships were provided to VMF and JRS (CNPq) and SVB (CAPES).	Alexis F, 2008, MOL PHARMACEUT, V5, P505, DOI 10.1021/mp800051m; Allkemper T, 2002, RADIOLOGY, V223, P432, DOI 10.1148/radiol.2232010241; Andreas K, 2012, BIOMATERIALS, V33, P4515, DOI 10.1016/j.biomaterials.2012.02.064; Auffan M, 2006, ENVIRON SCI TECHNOL, V40, P4367, DOI 10.1021/es060691k; Brigger I, 2002, ADV DRUG DELIVER REV, V54, P631, DOI 10.1016/S0169-409X(02)00044-3; Britton RS, 2002, INT J HEMATOL, V76, P219, DOI 10.1007/BF02982791; Cai XH, 2014, J BIOMED NANOTECHNOL, V10, P251, DOI 10.1166/jbn.2014.1787; Cegnar M, 2004, EXP CELL RES, V301, P223, DOI 10.1016/j.yexcr.2004.07.021; Center SA, 1999, J SMALL ANIM PRACT, V40, P106, DOI 10.1111/j.1748-5827.1999.tb03050.x; Chang JM, 2006, INVEST RADIOL, V41, P168, DOI 10.1097/01.rli.0000192417.33989.7a; Chastellain A, 2004, J COLLOID INTERF SCI, V278, P353, DOI 10.1016/j.jcis.2004.06.025; Chaves SB, 2002, IEEE T MAGN, V38, P3231, DOI 10.1109/TMAG.2002.802495; Clement O, 1999, J COMPUT ASSIST TOMO, V23, pS45, DOI 10.1097/00004728-199911001-00007; Elloumi Hela, 2003, Tunis Med, V81, P763; Emerit J, 2001, BIOMED PHARMACOTHER, V55, P333, DOI 10.1016/S0753-3322(01)00068-3; Estevanato LLC, 2012, INT J NANOMED, V7, P5287, DOI 10.2147/IJN.S35279; Fauconnier N, 1999, J MOL LIQ, V83, P233, DOI 10.1016/S0167-7322(99)00088-4; Garcia MP, 2005, J MAGN MAGN MATER, V293, P277, DOI 10.1016/j.jmmm.2005.02.053; Gaucher G, 2009, BIOMACROMOLECULES, V10, P408, DOI 10.1021/bm801178f; Ge Y, 2010, COLLOID SURFACE B, V73, P294; Ghosh D, 2012, NAT NANOTECHNOL, V7, P677, DOI [10.1038/NNANO.2012.146, 10.1038/nnano.2012.146]; Green JBA, 2008, NAT CELL BIOL, V10, P375, DOI 10.1038/ncb0408-375; Hamid AA, 2011, RES CHEM INTERMEDIAT, V37, P791, DOI 10.1007/s11164-011-0317-8; Huh YM, 2005, J AM CHEM SOC, V127, P12387, DOI 10.1021/ja052337c; Jain TK, 2008, MOL PHARMACEUT, V5, P316, DOI 10.1021/mp7001285; Jun YW, 2005, J AM CHEM SOC, V127, P5732, DOI 10.1021/ja0422155; Kedziorek DA, 2010, MAGN RESON MED, V63, P1031, DOI 10.1002/mrm.22290; Khandhar AP, 2012, J BIOMED MATER RES A, V100A, P728, DOI 10.1002/jbm.a.34011; Kim JE, 2012, ARCH TOXICOL, V86, P685, DOI 10.1007/s00204-011-0773-3; Kulkarni SA, 2013, PHARM RES-DORDR, V30, P2512, DOI 10.1007/s11095-012-0958-3; Levy M, 2011, BIOMATERIALS, V32, P3988, DOI 10.1016/j.biomaterials.2011.02.031; Li SD, 2009, BBA-BIOMEMBRANES, V1788, P2259, DOI 10.1016/j.bbamem.2009.06.022; Liu YX, 2013, TOXICOL SCI, V131, P521, DOI 10.1093/toxsci/kfs300; Madrigal JLM, 2001, NEUROPSYCHOPHARMACOL, V24, P420, DOI 10.1016/S0893-133X(00)00208-6; Moghimi SM, 2001, PHARMACOL REV, V53, P283; Monge-Fuentes V, 2011, NANOMEDICINE-UK, V6, P1529, DOI [10.2217/NNM.11.47, 10.2217/nnm.11.47]; Owens DE, 2006, INT J PHARMACEUT, V307, P93, DOI 10.1016/j.ijpharm.2005.10.010; Pawelczyk E, 2006, NMR BIOMED, V19, P581, DOI 10.1002/nbm.1038; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; Ramadori G, 2008, J PHYSIOL PHARMACOL, V59, P107; Rety F, 2000, J MAGN RESON IMAGING, V12, P734, DOI 10.1002/1522-2586(200011)12:5<734::AID-JMRI10>3.0.CO;2-R; Romberg B, 2008, PHARM RES, V25, P55, DOI 10.1007/s11095-007-9348-7; Saxena G, 2005, TOXICOLOGY, V214, P39, DOI 10.1016/j.tox.2005.05.026; Schladt TD, 2012, J MATER CHEM, V22, P9253, DOI 10.1039/c2jm15320c; Schulze F, 2014, SMALL, V10, P4340, DOI 10.1002/smll.201400707; Soler MAG, 2007, J NANOSCI NANOTECHNO, V7, P1069, DOI 10.1166/jnn.2007.423; STORM G, 1995, ADV DRUG DELIVER REV, V17, P31, DOI 10.1016/0169-409X(95)00039-A; Tietze R, 2013, NANOMED-NANOTECHNOL, V9, P961, DOI 10.1016/j.nano.2013.05.001; Unsoy G, 2014, EUR J PHARM SCI, V62, P243, DOI 10.1016/j.ejps.2014.05.021; Valois CRA, 2010, BIOMATERIALS, V31, P366, DOI 10.1016/j.biomaterials.2009.09.053; Wang N, 2013, J COLLOID INTERF SCI, V395, P50, DOI 10.1016/j.jcis.2012.11.062; Weissleder R, 1992, REV MAGN RESON MED, V4, P1; Wilhelm C, 2003, BIOMATERIALS, V24, P1001, DOI 10.1016/S0142-9612(02)00440-4; WISNER ER, 1995, ACAD RADIOL, V2, P405, DOI 10.1016/S1076-6332(05)80343-5; Wu QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043729; Yamamoto Y, 2001, J CONTROL RELEASE, V77, P27, DOI 10.1016/S0168-3659(01)00451-5; Yin PT, 2014, SMALL, V10, P4106, DOI 10.1002/smll.201400963; Zborowski Maciej, 2005, Methods Mol Biol, V295, P291	58	4	4	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0140233	10.1371/journal.pone.0140233	http://dx.doi.org/10.1371/journal.pone.0140233			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559061	Green Published, gold, Green Submitted			2022-12-26	WOS:000364433100003
J	Watanabe, MTC; Hensold, N; Sano, PT				Coutinho Watanabe, Mauricio Takashi; Hensold, Nancy; Sano, Paulo Takeo			Syngonanthus androgynus, a Striking New Species from South America, its Phylogenetic Placement and Implications for Evolution of Bisexuality in Eriocaulaceae	PLOS ONE			English	Article							PAEPALANTHOIDEAE	In the present study, we describe and illustrate a remarkable new species of Syngonanthus from South America (Bolivia, Brazil and Peru). This new species is quickly distinguished from all species in the genus by trimerous and bisexual flowers, a unique set of characteristics in Syngonanthus. Complementary to this study, sequences of 33 species were down-loaded from GenBank and four species had sequences newly generated for this study. Molecular phylogenetic analyses based on nuclear ribosomal ITS and the plastid regions psbA-trnH and trnL-F were performed to determine its systematic position. The results have shown S. androgynus closely related to a well-supported clade that has been treated as Syngonanthus sect. Carphocephalus. Floral traits associated with this new plant also were surveyed. Character reconstruction suggests that the bisexual flowers originated independently more than once in the genus. However, trimerous flowers appear to be an ancestral condition of the whole genus.	[Coutinho Watanabe, Mauricio Takashi; Sano, Paulo Takeo] Univ Sao Paulo, Inst Biociencias, Dept Bot, Sao Paulo, SP, Brazil; [Hensold, Nancy] Field Museum Nat Hist, Keller Sci Act Ctr, Chicago, IL 60605 USA	Universidade de Sao Paulo; Field Museum of Natural History (Chicago)	Watanabe, MTC (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Bot, Sao Paulo, SP, Brazil.	mtcwatanabe@gmail.com	WATANABE, MAURICIO TAKASHI COUTINHO/S-4018-2019; WATANABE, MAURICIO T. C./R-1336-2018	WATANABE, MAURICIO TAKASHI COUTINHO/0000-0001-9690-5565; WATANABE, MAURICIO T. C./0000-0001-9690-5565	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [process 142172/2011-1]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [PDSE-0594/13-0]; Integrative Research Center Publication Fund	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Integrative Research Center Publication Fund	This project was funded by a scholarship at the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (granted to Mauricio Takashi Coutinho Watanabe, process 142172/2011-1) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (granted to Mauricio Takashi Coutinho Watanabe, process PDSE-0594/13-0). The Field Museum has offered support to Nancy Hensold for publications costs of this paper, through the Integrative Research Center Publication Fund (2015).	Bachman S, 2011, ZOOKEYS, P117, DOI 10.3897/zookeys.150.2109; Doyle J. J., 1987, PHYTOCHEM B, P11; Echternacht L, 2015, SYST BOT, V40, P136, DOI 10.1600/036364415X686431; Echternacht L, 2014, TAXON, V63, P47, DOI 10.12705/631.36; Echternacht L, 2011, BOT J LINN SOC, V167, P137, DOI 10.1111/j.1095-8339.2011.01170.x; Giulietti A.M., 1990, ACTA BOT BRAS, V4, P133, DOI [10.1590/S0102-33061990000100010, DOI 10.1590/S0102-33061990000100010]; Giulietti AM, 1997, THESIS; Giulietti AM, 1987, B BOT U SAO PAULO, V9, P1, DOI DOI 10.11606/ISSN.2316-9052.V9I0P1-151; Giulietti Ana M., 2012, Rodriguésia, V63, P001; Giulietti AM, 2012, PHYTOTAXA, V60, P50, DOI 10.11646/phytotaxa.60.1.7; Giulietti N., 1988, ACTA BOT BRAS, V1, P179; de Andrade MJG, 2010, TAXON, V59, P379, DOI 10.1002/tax.592004; HENSOLD N, 1991, ANN MO BOT GARD, V78, P424, DOI 10.2307/2399571; HENSOLD N, 1991, ANN MO BOT GARD, V78, P441, DOI 10.2307/2399572; IUCN, 2022, GUID US IUCN RED LIS; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Moldenke H., 1958, PHYTOLOGIA, V6, P329; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Pagel M., 2014, BAYESTRAITS V 2 0; Parra L.R., 1997, WILLDENOWIA, V27, P227; Parra LR, 2010, TAXON, V59, P1135, DOI 10.1002/tax.594013; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2013, TRACER VERSION 1 6; Remizowa MV, 2010, ANN MO BOT GARD, V97, P617, DOI 10.3417/2009142; Ricci CV, 1996, BIOCHEM SYST ECOL, V24, P577, DOI 10.1016/0305-1978(96)00056-7; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rosa MM, 2007, ANN BOT-LONDON, V99, P131, DOI 10.1093/aob/mcl231; Ruhland W., 1903, PFLANZENREICH 4, V30, P1, DOI DOI 10.11606/ISSN.2316-9052.V28I2P125-140; Sano PT, 2015, LISTA ESPECIES FLORA; Schmidt IB, 2007, ECON BOT, V61, P73, DOI 10.1663/0013-0001(2007)61[73:EAEOHO]2.0.CO;2; Stutzel T., 1998, FAMILIES GENERA VASC, P197; Trovo M, 2013, BOT J LINN SOC, V171, P225, DOI 10.1111/j.1095-8339.2012.01310.x; Watanabe MTC, 2015, PHYTOTAXA, V212, P271, DOI 10.11646/phytotaxa.212.4.3; Weiblen GD, 2000, AM NAT, V155, P46, DOI 10.1086/303303	34	9	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141187	10.1371/journal.pone.0141187	http://dx.doi.org/10.1371/journal.pone.0141187			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559183	Green Published, Green Submitted, gold			2022-12-26	WOS:000364433100023
J	Gonzalez, CR; Gonzalez, B; Matzkin, ME; Muniz, JA; Cadet, JL; Garcia-Rill, E; Urbano, FJ; Vitullo, AD; Bisagno, V				Gonzalez, Candela R.; Gonzalez, Betina; Matzkin, Maria E.; Muniz, Javier A.; Cadet, Jean Lud; Garcia-Rill, Edgar; Urbano, Francisco J.; Vitullo, Alfredo D.; Bisagno, Veronica			Psychostimulant-Induced Testicular Toxicity in Mice: Evidence of Cocaine and Caffeine Effects on the Local Dopaminergic System	PLOS ONE			English	Article							ADENOSINE RECEPTOR EXPRESSION; TYROSINE-HYDROXYLASE; LIPID-PEROXIDATION; EXPOSURE; TESTIS; ADULT; SPERMATOGENESIS; CELLS; RATS; STEROIDOGENESIS	Several organ systems can be affected by psychostimulant toxicity. However, there is not sufficient evidence about the impact of psychostimulant intake on testicular physiology and catecholaminergic systems. The aim of the present study was to further explore potential toxic consequences of chronic exposure to cocaine, caffeine, and their combination on testicular physiology. Mice were injected with a 13-day chronic binge regimen of caffeine (3x5mg/kg), cocaine (3x10mg/kg), or combined administration. Mice treated with cocaine alone or combined with caffeine showed reduced volume of the seminiferous tubule associated to a reduction in the number of spermatogonia. Cocaine-only and combined treatments induced increased lipid peroxidation evaluated by TBARS assay and decreased glutathione peroxidase mRNA expression. Importantly, caffeine-cocaine combination potentiated the cocaine-induced germ cell loss, and induced pro-apoptotic BAX protein expression and diminished adenosine receptor A1 mRNA levels. We analyzed markers of dopaminergic function in the testis and detected the presence of tyrosine hydroxylase (TH) in the cytoplasm of androgen-producing Leydig cells, but also in meiotic germs cells within seminiferous tubules. Moreover, using transgenic BAC-Drd1a-tdTomato and D2R-eGFP mice, we report for the first time the presence of dopamine receptors (DRs) D1 and D2 in testicular mouse Leydig cells. Interestingly, the presence of DRD1 was also detected in the spermatogonia nearest the basal lamina of the seminiferous tubules, which did not show TH staining. We observed that psychostimulants induced downregulation of DRs mRNA expression and upregulation of TH protein expression in the testis. These findings suggest a potential role of the local dopaminergic system in psychostimulant-induced testicular pathology.	[Gonzalez, Candela R.; Vitullo, Alfredo D.] Univ Buenos Aires, Ctr Estudios Biomed Biotecnol Ambientales & Diagn, Buenos Aires, DF, Argentina; [Gonzalez, Betina; Muniz, Javier A.; Bisagno, Veronica] Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn, Inst Invest Farmacol, Buenos Aires, DF, Argentina; [Matzkin, Maria E.] Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt, Buenos Aires, DF, Argentina; [Cadet, Jean Lud] NIDA, Intramural Program, Mol Neuropsychiat Res Branch, Baltimore, MD USA; [Garcia-Rill, Edgar] Univ Arkansas Med Sci, Dept Neurobiol & Dev Sci, Ctr Translat Neurosci, Little Rock, AR 72205 USA; [Urbano, Francisco J.] Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn, Inst Fisiol Biol Mol & Neurociencias, Lab Fisiol & Biol Mol, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Buenos Aires; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University of Arkansas System; University of Arkansas Medical Sciences; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Bisagno, V (corresponding author), Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn, Inst Invest Farmacol, Buenos Aires, DF, Argentina.	vbisagno@ffyb.uba.ar	Vitullo, Alfredo/F-9744-2015	Vitullo, Alfredo/0000-0002-4833-5147	 [PICT 2012-0924];  [PICT-2012-1769]	; 	This work is supported by grants PICT 2012-0924 and PICT-2012-1769 (FU and VB), Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ade KK, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00032; Atanassova NN, 2005, J ENDOCRINOL, V184, P107, DOI 10.1677/joe.1.05884; Balda MA, 2009, NEUROSCI LETT, V457, P120, DOI 10.1016/j.neulet.2009.04.011; BARROSOMOGUEL R, 1994, J APPL TOXICOL, V14, P37, DOI 10.1002/jat.2550140108; Bhat SG, 1999, EUR J PHARMACOL, V382, P35, DOI 10.1016/S0014-2999(99)00584-1; Bisagno V, 2010, PSYCHOPHARMACOLOGY, V212, P205, DOI 10.1007/s00213-010-1947-z; BRACKEN MB, 1990, FERTIL STERIL, V53, P315; Brown TT, 2006, AM J INFECT DIS, V2, P130, DOI 10.3844/ajidsp.2006.130.135; Buttner A, 2011, NEUROPATH APPL NEURO, V37, P118, DOI 10.1111/j.1365-2990.2010.01131.x; Cadet JL, 2014, ACTA NEUROPATHOL, V127, P91, DOI 10.1007/s00401-013-1221-7; Cadet JL, 1998, NEUROCHEM INT, V32, P117, DOI 10.1016/S0197-0186(97)00031-4; Chin J, 2002, BRAIN RES, V945, P123, DOI 10.1016/S0006-8993(02)02807-X; Cole C, 2011, DRUG TEST ANAL, V3, P89, DOI 10.1002/dta.220; Csaba Z, 1998, J NEUROENDOCRINOL, V10, P371; Davidoff MS, 2005, HISTOCHEM CELL BIOL, V124, P313, DOI 10.1007/s00418-005-0024-x; Devasagayam TPA, 1996, BBA-BIOMEMBRANES, V1282, P63, DOI 10.1016/0005-2736(96)00040-5; Devi BG, 1997, LIFE SCI, V60, P849, DOI 10.1016/S0024-3205(97)00013-1; FERRE S, 1991, EUR J PHARMACOL, V192, P31, DOI 10.1016/0014-2999(91)90065-X; Frungieri MB, 2000, NEUROENDOCRINOLOGY, V71, P43, DOI 10.1159/000054519; GAUVIN DV, 1990, PHARMACOL BIOCHEM BE, V36, P195, DOI 10.1016/0091-3057(90)90149-C; George VK, 1996, J UROLOGY, V155, P327, DOI 10.1016/S0022-5347(01)66654-0; Goitia B, 2013, J NEUROCHEM, V124, P602, DOI 10.1111/jnc.12113; Gonzalez CR, 2015, REPROD BIOL, V15, P48, DOI 10.1016/j.repbio.2014.10.003; Gonzalez CR, 2010, J REPROD DEVELOP, V56, P400, DOI 10.1262/jrd.09-167N; Guerriero G, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00056; He F, 2006, NEUROTOXICOL TERATOL, V28, P198, DOI 10.1016/j.ntt.2005.12.003; Heard Kennon, 2008, Open Pharmacol J, V2, P70, DOI 10.2174/1874143600802010070; HORGER BA, 1991, NEUROREPORT, V2, P53, DOI 10.1097/00001756-199101000-00013; James P, 2008, J NEUROENDOCRINOL, V20, P173, DOI 10.1111/j.1365-2826.2007.01630.x; Kreek MJ, 2012, J CLIN INVEST, V122, P3387, DOI 10.1172/JCI60390; Li HK, 1997, J UROLOGY, V158, P962, DOI 10.1016/S0022-5347(01)64371-4; Li HK, 2003, UROLOGY, V61, P646, DOI 10.1016/S0090-4295(02)02263-X; Li HK, 1999, UROLOGY, V54, P925, DOI 10.1016/S0090-4295(99)00292-7; Lopez-Hill X, 2011, BEHAV BRAIN RES, V221, P134, DOI 10.1016/j.bbr.2011.03.005; Manna PR, 2006, J MOL ENDOCRINOL, V37, P81, DOI 10.1677/jme.1.02065; Mayerhofer A, 1999, J ANDROL, V20, P341; Mayerhofer A, 1996, BIOL REPROD, V55, P509, DOI 10.1095/biolreprod55.3.509; Mendelson JH, 2001, J PHARMACOL EXP THER, V296, P972; MISRA AL, 1977, DRUG ALCOHOL DEPEN, V2, P261, DOI 10.1016/0376-8716(77)90004-7; Nader MA, 2008, PHILOS T R SOC B, V363, P3223, DOI 10.1098/rstb.2008.0092; Nie ZZ, 1998, MOL PHARMACOL, V53, P663, DOI 10.1124/mol.53.4.663; Otth C, 2007, J CELL BIOCH, V100, P141; Park M, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/368475; Pires A, 2012, INHAL TOXICOL, V24, P439, DOI 10.3109/08958378.2012.684450; Prieto JP, 2015, AM J ADDICTION, V24, P475, DOI 10.1111/ajad.12245; Raineri M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046599; Reissig CJ, 2009, DRUG ALCOHOL DEPEN, V99, P1, DOI 10.1016/j.drugalcdep.2008.08.001; Rice ME, 2008, BRAIN RES REV, V58, P303, DOI 10.1016/j.brainresrev.2008.02.004; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; RIVKEES SA, 1994, ENDOCRINOLOGY, V135, P2307, DOI 10.1210/en.135.6.2307; RODRIGUEZ MC, 1992, REPROD TOXICOL, V6, P51, DOI 10.1016/0890-6238(92)90020-T; Rubi B, 2010, ENDOCRINOLOGY, V151, P5570, DOI 10.1210/en.2010-0745; Saad SY, 2004, CLIN EXP PHARMACOL P, V31, P862, DOI 10.1111/j.1440-1681.2004.04127.x; Saunders PTK, 2003, REPRODUCTION, V126, P589, DOI 10.1530/rep.0.1260589; Silverberg JI, 2012, J DRUGS DERMATOL, V11, P1342; Valente MJ, 2012, CURR MED CHEM, V19, P5601, DOI 10.2174/092986712803988938; Vangompel Michael J W, 2011, Spermatogenesis, V1, P36; Vassoler FM, 2013, NAT NEUROSCI, V16, P42, DOI 10.1038/nn.3280; Vazquez-Memije ME, 2008, MOL CELL BIOCHEM, V307, P23, DOI 10.1007/s11010-007-9580-9; VOLKOW ND, 1990, AM J PSYCHIAT, V147, P719; Yang GS, 2006, ASIAN J ANDROL, V8, P569, DOI 10.1111/j.1745-7262.2006.00191.x; Zhang Y, 2013, NEUROPHARMACOLOGY, V67, P259, DOI 10.1016/j.neuropharm.2012.10.015; ZIEHER LM, 1971, ENDOCRINOLOGY, V88, P351, DOI 10.1210/endo-88-2-351	63	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142713	10.1371/journal.pone.0142713	http://dx.doi.org/10.1371/journal.pone.0142713			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560700	Green Published, Green Submitted, gold			2022-12-26	WOS:000364433100113
J	Lau, WH; Pandey, V; Kong, XJ; Wang, XN; Wu, ZS; Zhu, T; Lobie, PE				Lau, Wai-Hoe; Pandey, Vijay; Kong, Xiangjun; Wang, Xiao-Nan; Wu, ZhengSheng; Zhu, Tao; Lobie, Peter E.			Trefoil Factor-3 (TFF3) Stimulates De Novo Angiogenesis in Mammary Carcinoma both Directly and Indirectly via IL-8/CXCR2	PLOS ONE			English	Article							NEGATIVE BREAST-CANCER; GROWTH-HORMONE HGH; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; IN-VITRO; INTERLEUKIN-8 RECEPTORS; TUMOR-METASTASIS; BLADDER-CANCER; HUMAN-MELANOMA; EGF RECEPTOR	Mammary carcinoma cells produce pro-angiogenic factors to stimulate angiogenesis and tumor growth. Trefoil factor-3 (TFF3) is an oncogene secreted from mammary carcinoma cells and associated with poor prognosis. Herein, we demonstrate that TFF3 produced in mammary carcinoma cells functions as a promoter of tumor angiogenesis. Forced expression of TFF3 in mammary carcinoma cells promoted proliferation, survival, invasion and in vitro tubule formation of human umbilical vein endothelial cells (HUVEC). MCF7-TFF3 cells with forced expression of TFF3 generated tumors with enhanced microvessel density as compared to tumors formed by vector control cells. Depletion of TFF3 in mammary carcinoma cells by siRNA concordantly decreased the angiogenic behavior of HUVEC. Forced expression of TFF3 in mammary carcinoma cells stimulated IL-8 transcription and subsequently enhanced IL-8 expression in both mammary carcinoma cells and HUVEC. Depletion of IL-8 in mammary carcinoma cells with forced expression of TFF3, or antibody inhibition of IL-8, partially abrogated mammary carcinoma cell TFF3-stimulated HUVEC angiogenic behavior in vitro, as did inhibition of the IL-8 receptor, CXCR2. Depletion of STAT3 by siRNA in MCF-7 cells with forced expression of TFF3 partially diminished the angiogenic capability of TFF3 on stimulation of cellular processes of HUVEC. Exogenous recombinant hTFF3 also directly promoted the angiogenic behavior of HUVEC. Hence, TFF3 is a potent angiogenic factor and functions as a promoter of de novo angiogenesis in mammary carcinoma, which may co-coordinate with the growth promoting and metastatic actions of TFF3 in mammary carcinoma to enhance tumor progression.	[Lau, Wai-Hoe; Lobie, Peter E.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117595, Singapore; [Lau, Wai-Hoe; Pandey, Vijay; Lobie, Peter E.] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Kong, Xiangjun; Zhu, Tao] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Kong, Xiangjun; Zhu, Tao] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Wang, Xiao-Nan; Wu, ZhengSheng] Anhui Med Univ, Dept Pathol, Hefei, Anhui, Peoples R China; [Wang, Xiao-Nan] Anhui Med Univ, Lab Pathogen Microbiol & Immunol, Hefei 230032, Anhui, Peoples R China; [Lobie, Peter E.] Natl Univ Singapore, Natl Hlth Syst, Natl Univ Canc Inst Singapore, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Anhui Medical University; Anhui Medical University; National University of Singapore	Zhu, T (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.	zhut@ustc.edu.cn; csipel@nus.edu.sg	Pandey, Vijay/P-2767-2016		Ministry of Education; National Research Foundation of Singapore; National Medical Research Council of Singapore [R-713-000-163-511]; National Key Scientific Program of China [2012CB934002, 2010CB912804]; National Natural Science Foundation of China [81272925, 31201022, 81302322]; Chinese Academy of Sciences President's International Fellowship Initiative (PIFI) [2015VBA031]	Ministry of Education; National Research Foundation of Singapore(National Research Foundation, Singapore); National Medical Research Council of Singapore(National Medical Research Council, Singapore); National Key Scientific Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences President's International Fellowship Initiative (PIFI)	This work was supported by the Cancer Science Institute of Singapore through grants from the Ministry of Education and the National Research Foundation of Singapore, by a grant from the National Medical Research Council of Singapore [R-713-000-163-511], the National Key Scientific Program of China (2012CB934002, 2010CB912804), National Natural Science Foundation of China (81272925, 31201022, 81302322). PEL was also supported by The Chinese Academy of Sciences President's International Fellowship Initiative (PIFI) (Grant No. 2015VBA031).	Addison CL, 2000, J IMMUNOL, V165, P5269, DOI 10.4049/jimmunol.165.9.5269; Ahmed ARH, 2012, AM J PATHOL, V180, P904, DOI 10.1016/j.ajpath.2011.11.022; Babyatsky M, 2009, CLIN EXP METASTAS, V26, P143, DOI 10.1007/s10585-008-9224-9; Baeriswyl V, 2009, SEMIN CANCER BIOL, V19, P329, DOI 10.1016/j.semcancer.2009.05.003; Bagley RG, 2003, CANCER RES, V63, P5866; Banerjee A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050098; Benoy IH, 2004, CLIN CANCER RES, V10, P7157, DOI 10.1158/1078-0432.CCR-04-0812; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bouis Diane, 2001, Angiogenesis, V4, P91, DOI 10.1023/A:1012259529167; Brunet-Dunand SE, 2009, ENDOCRINOLOGY, V150, P1341, DOI 10.1210/en.2008-0608; Calnan DP, 1999, J PATHOL, V188, P312, DOI 10.1002/(SICI)1096-9896(199907)188:3<312::AID-PATH360>3.0.CO;2-P; Chan VYW, 2005, REGUL PEPTIDES, V127, P87, DOI 10.1016/j.regpep.2004.10.016; Chen YH, 2000, BIOCHEM BIOPH RES CO, V274, P576, DOI 10.1006/bbrc.2000.3176; Chen YZ, 2011, CANCER LETT, V302, P63, DOI 10.1016/j.canlet.2010.12.014; CHINERY R, 1995, PEPTIDES, V16, P749, DOI 10.1016/0196-9781(95)00045-L; Christine R, 2005, CANCER RES, V65, P195; Czabotar PE, 2009, CELL DEATH DIFFER, V16, P1187, DOI 10.1038/cdd.2009.83; De Larco JE, 2001, AM J PATHOL, V158, P639, DOI 10.1016/S0002-9440(10)64005-9; Devalaraja RM, 2000, J INVEST DERMATOL, V115, P234, DOI 10.1046/j.1523-1747.2000.00034.x; Dhar DK, 2005, CLIN CANCER RES, V11, P6472, DOI 10.1158/1078-0432.CCR-05-0671; Doane AS, 2006, ONCOGENE, V25, P3994, DOI 10.1038/sj.onc.1209415; Efstathiou JA, 1998, P NATL ACAD SCI USA, V95, P3122, DOI 10.1073/pnas.95.6.3122; Emami S, 2004, PEPTIDES, V25, P885, DOI 10.1016/j.peptides.2003.10.019; Emami S, 2001, FASEB J, V15, P351, DOI 10.1096/fj.00-0355com; Farmer P, 2005, ONCOGENE, V24, P4660, DOI 10.1038/sj.onc.1208561; Folkman J, 1992, Semin Cancer Biol, V3, P65; Fox SB, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1796; Gelao L, 2013, ECANCERMEDICALSCIENC, V7, DOI 10.3332/ecancer.2013.320; Gharavi NM, 2007, J BIOL CHEM, V282, P31460, DOI 10.1074/jbc.M704267200; Graness A, 2002, J BIOL CHEM, V277, P18440, DOI 10.1074/jbc.M200468200; Hayes E, 2011, FRONT BIOSCI-LANDMRK, V16, P838, DOI 10.2741/3723; Heidemann J, 2003, J BIOL CHEM, V278, P8508, DOI 10.1074/jbc.M208231200; Huang SY, 2002, AM J PATHOL, V161, P125, DOI 10.1016/S0002-9440(10)64164-8; Inoue K, 2000, CANCER RES, V60, P2290; Kahn HJ, 2002, LAB INVEST, V82, P1255, DOI 10.1097/01.LAB.0000028824.03032.AB; Kannan N, 2010, NEOPLASIA, V12, P1041, DOI 10.1593/neo.10916; Kaulsay KK, 2001, ENDOCRINOLOGY, V142, P767, DOI 10.1210/en.142.2.767; Kim SW, 2010, J AM COLL CARDIOL, V56, P593, DOI 10.1016/j.jacc.2010.01.070; Kinoshita K, 2000, MOL CELL BIOL, V20, P4680, DOI 10.1128/MCB.20.13.4680-4690.2000; Kitadai Y, 1998, AM J PATHOL, V152, P93; Lau WH, 2014, CANCER RES, V74, DOI 10.1158/1538-7445.AM2014-1020; Lee YS, 2012, BRIT J CANCER, V106, P1833, DOI 10.1038/bjc.2012.177; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Li Aihua, 2005, Angiogenesis, V8, P63, DOI 10.1007/s10456-005-5208-4; Li J, 2011, MOL BIOL REP, V38, P4787, DOI 10.1007/s11033-010-0616-y; Lin Y, 2004, INT J CANCER, V109, P507, DOI 10.1002/ijc.11724; Lubka M, 2009, J APPL GENET, V50, P167, DOI 10.1007/BF03195669; Madsen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064441; May FEB, 1997, J PATHOL, V182, P404; McKenzie C, 1997, AM J PHYSIOL-GASTR L, V273, pG112, DOI 10.1152/ajpgi.1997.273.1.G112; Mertani HC, 2001, J BIOL CHEM, V276, P21464, DOI 10.1074/jbc.M100437200; Mian BM, 2003, CLIN CANCER RES, V9, P3167; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Miller LJ, 1998, ANTICANCER RES, V18, P77; Naderi A, 2008, NEOPLASIA, V10, P542, DOI 10.1593/neo.08274; Ning Y, 2011, INT J CANCER, V128, P2038, DOI 10.1002/ijc.25562; Oertel M, 2001, AM J RESP CELL MOL, V25, P418, DOI 10.1165/ajrcmb.25.4.4429; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Pandey V, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0429-3; Poulsom R, 1997, J PATHOL, V183, P30, DOI 10.1002/(SICI)1096-9896(199709)183:1<30::AID-PATH1085>3.0.CO;2-K; Prest SJ, 2002, FASEB J, V16, P592, DOI 10.1096/fj.01-0498fje; Richards BL, 1997, AM J SURG, V174, P507; Rodrigues S, 2003, FASEB J, V17, P7, DOI 10.1096/fj.02-0201com; Schneider BP, 2005, J CLIN ONCOL, V23, P1782, DOI 10.1200/JCO.2005.12.017; Scholz A, 2003, GASTROENTEROLOGY, V125, P891, DOI 10.1016/S0016-5085(03)01064-3; Schraufstatter IU, 2001, AM J PHYSIOL-LUNG C, V280, pL1094, DOI 10.1152/ajplung.2001.280.6.L1094; Singh S, 2010, FUTURE ONCOL, V6, P111, DOI 10.2217/FON.09.128; Singh S, 2009, CLIN CANCER RES, V15, P2380, DOI 10.1158/1078-0432.CCR-08-2387; Strieter RM, 2004, SEMIN CANCER BIOL, V14, P195, DOI 10.1016/j.semcancer.2003.10.006; Taupin D, 1999, J CLIN INVEST, V103, pR31, DOI 10.1172/JCI3304; Taupin DR, 2000, P NATL ACAD SCI USA, V97, P799, DOI 10.1073/pnas.97.2.799; Taylor KJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2593; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Varney ML, 2006, AM J CLIN PATHOL, V125, P209, DOI 10.1309/VPL5R.JR7F1D6V03; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Weigelt B, 2004, BRIT J CANCER, V90, P1531, DOI 10.1038/sj.bjc.6601659; Xu XM, 2011, BRAZ J MED BIOL RES, V44, P634, DOI [10.1590/S0100-879X2011007500070, 10.1590/S0100-879X2011000700004]; Yip KW, 2008, ONCOGENE, V27, P6398, DOI 10.1038/onc.2008.307; Youngs SJ, 1997, INT J CANCER, V71, P257, DOI 10.1002/(SICI)1097-0215(19970410)71:2<257::AID-IJC22>3.0.CO;2-D; Yu H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020334; Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074669; zum Buschenfelde DM, 2004, PEPTIDES, V25, P873, DOI 10.1016/j.peptides.2003.11.024	82	32	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141947	10.1371/journal.pone.0141947	http://dx.doi.org/10.1371/journal.pone.0141947			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559818	Green Published, gold, Green Submitted			2022-12-26	WOS:000364433100047
J	Kim, CS; Kim, IJ; Bae, EH; Ma, SK; Lee, J; Kim, SW				Kim, Chang Seong; Kim, In Jin; Bae, Eun Hui; Ma, Seong Kwon; Lee, JongUn; Kim, Soo Wan			Angiotensin-(1-7) Attenuates Kidney Injury Due to Obstructive Nephropathy in Rats	PLOS ONE			English	Article							UNILATERAL URETERAL OBSTRUCTION; PROXIMAL TUBULAR CELLS; GROWTH-FACTOR-BETA; RECEPTOR MAS; RENAL FIBROSIS; SYSTEM; DISEASE; INFLAMMATION; ACTIVATION; MODEL	Background Angiotensin-(1-7) [Ang-(1-7)] counteracts many actions of the renin-angiotensin-aldosterone system. Despite its renoprotective effects, extensive controversy exists regarding the role of Ang-(1-7) in obstructive nephropathy, which is characterized by renal tubulointerstitial fibrosis and apoptosis. Methods To examine the effects of Ang-(1-7) in unilateral ureteral obstruction (UUO), male Sprague-Dawley rats were divided into three groups: control, UUO, and Ang-(1-7)-treated UUO rats. Ang-(1-7) was continuously infused (24 mu g/[kg.h]) using osmotic pumps. We also treated NRK-52E cells in vitro with Ang II (1 mu M) in the presence or absence of Ang-(1-7) (1 mu M), Mas receptor antagonist A779 (1 mu M), and Mas receptor siRNA (50 nM) to examine the effects of Ang-(1-7) treatment on Ang II-stimulated renal injury via Mas receptor. Results Angiotensin II (Ang II) and angiotensin type 1 receptor (AT(1)R) protein expression was higher in UUO kidneys than in controls. Ang-(1-7) treatment also decreased proapoptotic protein expression in UUO kidneys. Ang-(1-7) also significantly ameliorated TUNEL positive cells in UUO kidneys. Additionally, Ang-(1-7) reduced profibrotic protein expression and decreased the increased tumor growth factor (TGF)-beta 1/Smad signaling present in UUO kidneys. In NRK-52E cells, Ang II induced the expression of TGF-beta 1/Smad signaling effectors and proapoptotic and fibrotic proteins, as well as cell cycle arrest, which were attenuated by Ang-(1-7) pretreatment. However, treatment with A779 and Mas receptor siRNA enhanced Ang II-induced apoptosis and fibrosis. Moreover, Ang II increased tumor necrosis factor-alpha converting enzyme (TACE) and decreased angiotensin-converting enzyme 2 (ACE2) expression in NRK-52E cells, while pretreatment with Ang-(1-7) or A779 significantly inhibited or enhanced these effects, respectively. Conclusion Ang-(1-7) prevents obstructive nephropathy by suppressing renal apoptosis and fibrosis, possibly by regulating TGF-beta 1/Smad signaling and cell cycle arrest via suppression of AT(1)R expression. In addition, Ang-(1-7) increased and decreased ACE2 and TACE expression, respectively, which could potentially mediate a positive feedback mechanism via the Mas receptor.	[Kim, Chang Seong; Bae, Eun Hui; Ma, Seong Kwon; Kim, Soo Wan] Chonnam Natl Univ, Sch Med, Dept Internal Med, Gwangju, South Korea; [Kim, In Jin; Lee, JongUn] Chonnam Natl Univ, Sch Med, Dept Physiol, Gwangju, South Korea	Chonnam National University; Chonnam National University	Kim, SW (corresponding author), Chonnam Natl Univ, Sch Med, Dept Internal Med, Gwangju, South Korea.	skanw@chonnam.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning [2013R1A2A2A01067611]; Pioneer Research Center Program through the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning [2014M3C1A3053036]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI); Ministry of Health & Welfare, Republic of Korea [HI14C2084]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning(National Research Foundation of Korea); Pioneer Research Center Program through the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and future Planning (2013R1A2A2A01067611), by the Pioneer Research Center Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning (2014M3C1A3053036), and by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C2084).	Bhaskaran M, 2003, AM J PHYSIOL-RENAL, V284, pF955, DOI 10.1152/ajprenal.00246.2002; Brosnihan KB, 1998, AM J CARDIOL, V82; Chappell MC, 2012, COMPR PHYSIOL, V2, P2733, DOI 10.1002/cphy.c120002; Dilauro M, 2010, AM J PHYSIOL-RENAL, V298, pF1523, DOI 10.1152/ajprenal.00426.2009; Esteban V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005406; Fraga-Silva RA, 2014, THROMB HAEMOSTASIS, V111, P736, DOI 10.1160/TH13-06-0448; Giani JF, 2012, AM J PHYSIOL-RENAL, V302, pF1606, DOI 10.1152/ajprenal.00063.2012; Hao PP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062788; Jawen J, 2012, J PHYSIOL PHARMACOL, V63, P77; Kim CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063186; Kim S, 2000, PHARMACOL REV, V52, P11; Kim SW, 2001, KIDNEY INT, V59, P1274, DOI 10.1046/j.1523-1755.2001.0590041274.x; KLAHR S, 1995, AM J KIDNEY DIS, V26, P141, DOI 10.1016/0272-6386(95)90167-1; Kostenis E, 2005, CIRCULATION, V111, P1806, DOI 10.1161/01.CIR.0000160867.23556.7D; Li P, 2013, HYPERTENSION, V61, P820, DOI 10.1161/HYPERTENSIONAHA.111.00191; Liu Z, 2012, AM J PHYSIOL-RENAL, V302, pF986, DOI 10.1152/ajprenal.00595.2011; Ma Seong Kwon, 2012, Chonnam Med J, V48, P150, DOI 10.4068/cmj.2012.48.3.150; Meng WX, 2014, AM J HYPERTENS, V27, P775, DOI 10.1093/ajh/hpt270; Mordwinkin NM, 2012, J PHARM SCI-US, V101, P373, DOI 10.1002/jps.22730; Park JW, 2010, KIDNEY INT, V77, P1076, DOI 10.1038/ki.2010.69; Patel VB, 2014, J MOL CELL CARDIOL, V66, P167, DOI 10.1016/j.yjmcc.2013.11.017; Pinheiro SVB, 2009, KIDNEY INT, V75, P1184, DOI 10.1038/ki.2009.61; Price PM, 2009, KIDNEY INT, V76, P604, DOI 10.1038/ki.2009.224; Robles NR, 2014, J CARDIOVASC PHARM T, V19, P14, DOI 10.1177/1074248413501018; Rocheville M, 2000, SCIENCE, V288, P154, DOI 10.1126/science.288.5463.154; Santos RAS, 2006, HYPERTENSION, V47, P996, DOI 10.1161/01.HYP.0000215289.51180.5c; Silveira KD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066082; van der Wouden EA, 2005, J RENIN-ANGIO-ALDO S, V6, P96, DOI 10.3317/jraas.2005.016; Velkoska E, 2011, CLIN SCI, V120, P335, DOI 10.1042/CS20100280; Wolf G, 2006, KIDNEY INT, V70, P1914, DOI 10.1038/sj.ki.5001846; WOLF G, 1993, J CLIN INVEST, V92, P1366, DOI 10.1172/JCI116710; Wu WP, 2010, AM J PHYSIOL-RENAL, V299, pF929, DOI 10.1152/ajprenal.00192.2010; Xu CY, 2013, NEPHROLOGY, V18, P761, DOI 10.1111/nep.12146; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Yoon HE, 2014, KOREAN J INTERN MED, V29, P291, DOI 10.3904/kjim.2014.29.3.291; Zhang JD, 2010, AM J PHYSIOL-RENAL, V298, pF579, DOI 10.1152/ajprenal.00548.2009; Zhang Y, 2010, J AM SOC NEPHROL, V21, P966, DOI 10.1681/ASN.2009080872; Zimmerman D, 2012, CLIN SCI, V123, P333, DOI 10.1042/CS20120111; Zimmerman DL, 2015, AM J PATHOL, V185, P729, DOI 10.1016/j.ajpath.2014.11.013	39	31	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142664	10.1371/journal.pone.0142664	http://dx.doi.org/10.1371/journal.pone.0142664			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556707	Green Published, Green Submitted, gold			2022-12-26	WOS:000364430700152
J	Kim, M; Piaia, A; Shenoy, N; Kagan, D; Gapp, B; Kueng, B; Weber, D; Dietrich, W; Ksiazek, I				Kim, Munkyung; Piaia, Alessandro; Shenoy, Neeta; Kagan, David; Gapp, Berangere; Kueng, Benjamin; Weber, Delphine; Dietrich, William; Ksiazek, Iwona			Progression of Alport Kidney Disease in Col4a3 Knock Out Mice Is Independent of Sex or Macrophage Depletion by Clodronate Treatment	PLOS ONE			English	Article							DELAYS RENAL-FAILURE; MOUSE MODEL; HEREDITARY NEPHROPATHY; IN-VIVO; COLLAGEN; FIBROSIS; INJURY; BLOCKADE; CELLS; MYOFIBROBLASTS	Alport syndrome is a genetic disease of collagen IV (alpha 3, 4, 5) resulting in renal failure. This study was designed to investigate sex-phenotype correlations and evaluate the contribution of macrophage infiltration to disease progression using Col4a3 knock out (Col4a3KO) mice, an established genetic model of autosomal recessive Alport syndrome. No sex differences in the evolution of body mass loss, renal pathology, biomarkers of tubular damage KIM-1 and NGAL, or deterioration of kidney function were observed during the life span of Col4a3KO mice. These findings confirm that, similar to human autosomal recessive Alport syndrome, female and male Col4a3KO mice develop renal failure at the same age and with similar severity. The specific contribution of macrophage infiltration to Alport disease, one of the prominent features of the disease in human and Col4a3KO mice, remains unknown. This study shows that depletion of kidney macrophages in Col4a3KO male mice by administration of clodronate liposomes, prior to clinical onset of disease and throughout the study period, does not protect the mice from renal failure and interstitial fibrosis, nor delay disease progression. These results suggest that therapy targeting macrophage recruitment to kidney is unlikely to be effective as treatment of Alport syndrome.	[Kim, Munkyung; Gapp, Berangere; Kueng, Benjamin; Weber, Delphine; Ksiazek, Iwona] Novartis Inst Biomed Res, Dev & Mol Pathways, Basel, Switzerland; [Piaia, Alessandro] Novartis Inst Biomed Res, Preclin Safety, Basel, Switzerland; [Shenoy, Neeta; Kagan, David] Novartis Inst Biomed Res, Preclin Safety, Cambridge, MA USA; [Dietrich, William] Novartis Inst Biomed Res, Dev & Mol Pathways, Cambridge, MA USA	Novartis; Novartis; Novartis; Novartis	Ksiazek, I (corresponding author), Novartis Inst Biomed Res, Dev & Mol Pathways, Basel, Switzerland.	iwona.ksiazek@novartis.ch			Novartis Institute of Biomedical Research (NIBR)	Novartis Institute of Biomedical Research (NIBR)	Funding for this work was provided by the Novartis Institute of Biomedical Research (NIBR). The funder provided support in the form of salaries and research materials for authors (MK, AP, NS, DK, BG, BK, DW, WD and IK), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Clauss S, 2009, J PATHOL, V218, P40, DOI 10.1002/path.2505; Clayton A, 1997, J AM SOC NEPHROL, V8, P604; Cosgrove D, 1996, GENE DEV, V10, P2981, DOI 10.1101/gad.10.23.2981; Dennis J, 2010, AM J PATHOL, V177, P2527, DOI 10.2353/ajpath.2010.100017; Dudas J, 2007, CELL TISSUE RES, V329, P503, DOI 10.1007/s00441-007-0437-z; Flinter F, 1997, J MED GENET, V34, P326, DOI 10.1136/jmg.34.4.326; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gross O, 2003, KIDNEY INT, V63, P438, DOI 10.1046/j.1523-1755.2003.00779.x; Gross O, 2014, NEPHROL DIAL TRANSPL, V29, P124, DOI 10.1093/ndt/gfu028; Gross O, 2012, KIDNEY INT, V81, P494, DOI 10.1038/ki.2011.407; HASSTEDT SJ, 1983, AM J HUM GENET, V35, P1241; Hertz JM, 2012, EUR J HUM GENET, V20, DOI 10.1038/ejhg.2011.237; Ichimura T, 1998, J BIOL CHEM, V273, P4135, DOI 10.1074/jbc.273.7.4135; Jedlicka J, 2010, HUM PATHOL, V41, P582, DOI 10.1016/j.humpath.2009.08.024; Jo SK, 2006, NEPHROL DIAL TRANSPL, V21, P1231, DOI 10.1093/ndt/gfk047; Kalluri R, 2000, J BIOL CHEM, V275, P12719, DOI 10.1074/jbc.275.17.12719; Kitamoto K, 2009, J PHARMACOL SCI, V111, P285, DOI 10.1254/jphs.09227FP; Koepke ML, 2007, NEPHROL DIAL TRANSPL, V22, P1062, DOI 10.1093/ndt/gfl810; Korstanje R, 2014, KIDNEY INT, V85, P1461, DOI 10.1038/ki.2013.493; Kruegel J, 2013, NAT REV NEPHROL, V9, P170, DOI 10.1038/nrneph.2012.259; Kushiyama T, 2011, NEPHROLOGY, V16, P522, DOI 10.1111/j.1440-1797.2010.01439.x; LeBleu VS, 2008, LAB INVEST, V88, P284, DOI 10.1038/labinvest.3700715; Lee S, 2011, J AM SOC NEPHROL, V22, P317, DOI 10.1681/ASN.2009060615; Lin SL, 2009, J IMMUNOL, V183, P6733, DOI 10.4049/jimmunol.0901473; Mak RH, 2011, J CACHEXIA SARCOPENI, V2, P9, DOI 10.1007/s13539-011-0019-5; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Miner JH, 1996, J CELL BIOL, V135, P1403, DOI 10.1083/jcb.135.5.1403; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; MOCHIZUKI T, 1994, NAT GENET, V8, P77, DOI 10.1038/ng0994-77; Nabity MB, 2012, J VET INTERN MED, V26, P282, DOI 10.1111/j.1939-1676.2012.00891.x; Ninichuk V, 2005, J AM SOC NEPHROL, V16, P977, DOI 10.1681/ASN.2004100871; Rheault MN, 2004, J AM SOC NEPHROL, V15, P1466, DOI 10.1097/01.ASN.0000130562.90255.8F; Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150; Rodgers KD, 2003, KIDNEY INT, V63, P1338, DOI 10.1046/j.1523-1755.2003.00871.x; Sampson NS, 2001, J BIOL CHEM, V276, P34182, DOI 10.1074/jbc.M102859200; Stubbs JR, 2012, J BONE MINER RES, V27, P38, DOI 10.1002/jbmr.516; Temme J, 2012, KIDNEY INT, V81, P779, DOI 10.1038/ki.2011.452; vanRooijen N, 1996, J IMMUNOL METHODS, V193, P93, DOI 10.1016/0022-1759(96)00056-7; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Wang YP, 2011, J AM SOC NEPHROL, V22, P21, DOI 10.1681/ASN.2010030269; WHALEN RE, 1961, AM J MED, V31, P171, DOI 10.1016/0002-9343(61)90107-3; Wu XS, 2014, J INVEST DERMATOL, V134, P2814, DOI 10.1038/jid.2014.206	43	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141231	10.1371/journal.pone.0141231	http://dx.doi.org/10.1371/journal.pone.0141231			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555339	gold, Green Published, Green Submitted			2022-12-26	WOS:000364430700022
J	Sung, HH; Jeon, HG; Han, DH; Jeong, BC; Seo, SI; Lee, HM; Choi, HY; Jeon, SS				Sung, Hyun Hwan; Jeon, Hwang Gyun; Han, Deok Hyun; Jeong, Byong Chang; Seo, Seong Il; Lee, Hyun Moo; Choi, Han-Yong; Jeon, Seong Soo			Diagnostic Ureterorenoscopy Is Associated with Increased Intravesical Recurrence following Radical Nephroureterectomy in Upper Tract Urothelial Carcinoma	PLOS ONE			English	Article							UPPER URINARY-TRACT; TRANSITIONAL-CELL CARCINOMA; LAPAROSCOPIC NEPHROURETERECTOMY; ONCOLOGICAL OUTCOMES; BLADDER RECURRENCE; RENAL PELVIS; IMPACT; URETEROSCOPY; PREVENTION; GUIDELINES	Diagnostic ureterorenoscopy is powerful tool to confirm upper tract urothelial cancer (UTUC). However, URS and associated manipulation may be related to the risk of intravesical recurrence (IVR) following radical nephroureterectomy (RNU). We aimed to investigate whether preoperative ureterorenoscopy would increase IVR after RNU in patients with UTUC. We performed a retrospective analysis of 630 patients who had RNU with bladder cuff excision due to UTUC. Diagnostic URS was performed in 282 patients (44.7%). Patients were divided into two groups according to the URS. Survival analysis and multivariate Cox regression model were performed to address risk factors for the IVR. The interval from URS to RNU was measured. During URS, manipulation such as biopsy and resection was determined. The median age was 64 (IQR 56-72) years with follow-up duration of 34.3 (15.7-64.9) months. Median time from URS to RNU was 16 (0-38) days. The IVR developed in 42.5%(n = 268) patients at 8.2 (4.9-14.7) months. The five-year IVR-free survival rate was 42.6 +/- 8.0% and 63.6 +/- 6.9% in patients with and without preoperative URS, respectively (P < 0.001). In multivariate analysis, previous history of bladder tumour, extra-vesical excision of distal ureter, multifocal tumour, and URS (HR, 95% CI; 1.558, 1.204-2.016, P = 0.001) were independent predictors for higher IVR. The IVR rate in patients without manipulation during URS was not different to those with manipulation (P = 0.658). The duration from URS to RNU was not associated with IVR (P = 0.799). Diagnostic URS for UTUC increased IVR rate after RNU. However, the lessening of interval from URS to radical surgery or URS without any manipulation could not reduce the IVR rate.	[Sung, Hyun Hwan; Jeon, Hwang Gyun; Han, Deok Hyun; Jeong, Byong Chang; Seo, Seong Il; Lee, Hyun Moo; Choi, Han-Yong; Jeon, Seong Soo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Urol,Samsung Biomed Res Inst, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Jeon, SS (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Urol,Samsung Biomed Res Inst, Seoul, South Korea.	seongsoo.jeon@samsung.com	sung, hh/O-6246-2014		Samsung Medical Center [CRS11115]	Samsung Medical Center(Samsung)	This study was supported by Samsung Medical Center, grant# CRS11115. The funder provided support in the form of salaries for authors [Jeon HH], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard CB, 2013, WORLD J UROL, V31, P175, DOI 10.1007/s00345-012-0915-0; Azemar MD, 2011, UROL ONCOL-SEMIN ORI, V29, P130, DOI 10.1016/j.urolonc.2009.06.003; Babjuk M, 2011, EUR UROL, V59, P997, DOI 10.1016/j.eururo.2011.03.017; Chromecki TF, 2012, EUR UROL, V61, P245, DOI 10.1016/j.eururo.2011.09.017; Hanna N, 2012, EUR UROL, V61, P715, DOI 10.1016/j.eururo.2011.12.026; Hattori R, 2006, UROLOGY, V67, P701, DOI 10.1016/j.urology.2005.10.022; Ishikawa S, 2010, J UROLOGY, V184, P883, DOI 10.1016/j.juro.2010.05.027; Ito A, 2013, J CLIN ONCOL, V31, P1422, DOI 10.1200/JCO.2012.45.2128; Kang CH, 2003, CANCER-AM CANCER SOC, V98, P1620, DOI 10.1002/cncr.11691; Kume H, 2006, J SURG ONCOL, V93, P318, DOI 10.1002/jso.20459; Li WM, 2010, EUR UROL, V57, P963, DOI 10.1016/j.eururo.2009.12.032; Liu YQ, 2014, UROL ONCOL-SEMIN ORI, V32, P146, DOI 10.1016/j.urolonc.2013.02.018; Lughezzani G, 2012, EUR UROL, V62, P100, DOI 10.1016/j.eururo.2012.02.030; Luo HL, 2013, ANN SURG ONCOL, V20, P3121, DOI 10.1245/s10434-013-3000-z; Margulis V, 2009, CANCER-AM CANCER SOC, V115, P1224, DOI 10.1002/cncr.24135; Ni SB, 2012, EUR UROL, V61, P1142, DOI 10.1016/j.eururo.2012.02.019; Nison L, 2013, WORLD J UROL, V31, P69, DOI 10.1007/s00345-012-0959-1; O'Brien T, 2011, EUR UROL, V60, P703, DOI 10.1016/j.eururo.2011.05.064; Pignot G, 2014, UROL ONCOL-SEMIN ORI, V32, DOI 10.1016/j.urolonc.2012.08.010; Raman JD, 2011, BJU INT, V107, P1059, DOI 10.1111/j.1464-410X.2010.09675.x; Ristau BT, 2012, UROLOGY, V79, P749, DOI 10.1016/j.urology.2011.12.024; Roupret M, 2013, EUR UROL, V63, P1059, DOI 10.1016/j.eururo.2013.03.032; Terakawa T, 2008, UROLOGY, V71, P123, DOI 10.1016/j.urology.2007.08.054; Wu WJ, 2010, J UROLOGY, V183, P56, DOI 10.1016/j.juro.2009.08.154; Xylinas E, 2014, EUR UROL, V65, P650, DOI 10.1016/j.eururo.2013.09.003; Xylinas E, 2014, EUR UROL, V65, P210, DOI 10.1016/j.eururo.2012.04.052; Xylinas E, 2013, WORLD J UROL, V31, P61, DOI 10.1007/s00345-012-0957-3; Zou LJ, 2014, WORLD J UROL, V32, P565, DOI 10.1007/s00345-013-1160-x	28	38	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0139976	10.1371/journal.pone.0139976	http://dx.doi.org/10.1371/journal.pone.0139976			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556239	Green Published, gold, Green Submitted			2022-12-26	WOS:000364430700009
J	Zhu, DH; Wang, P; Zhang, WZ; Yuan, Y; Li, B; Wang, J				Zhu, Dan H.; Wang, Ping; Zhang, Wei Z.; Yuan, Yue; Li, Bin; Wang, Jiang			Sampling and Complementarity Effects of Plant Diversity on Resource Use Increases the Invasion Resistance of Communities	PLoS One			English	Article							GRASSLAND COMMUNITIES; SPECIES-DIVERSITY; REDUCES INVASIBILITY; ECOSYSTEM FUNCTION; BIODIVERSITY; RICHNESS; IDENTITY; PATTERN; DYNAMICS; ABSENCE	Background Although plant diversity is postulated to resist invasion, studies have not provided consistent results, most of which were ascribed to the influences of other covariate environmental factors. Methodology/Principal Findings To explore the mechanisms by which plant diversity influences community invasibility, an experiment was conducted involving grassland sites varying in their species richness (one, two, four, eight, and sixteen species). Light interception efficiency and soil resources (total N, total P, and water content) were measured. The number of species, biomass, and the number of seedlings of the invading species decreased significantly with species richness. The presence of Patrinia scabiosaefolia Fisch. ex Trev. and Mosla dianthera (Buch.-Ham. ex Roxburgh) Maxim. significantly increased the resistance of the communities to invasion. A structural equation model showed that the richness of planted species had no direct and significant effect on invasion. Light interception efficiency had a negative effect on the invasion whereas soil water content had a positive effect. In monocultures, Antenoron filiforme (Thunb.) Rob. et Vaut. showed the highest light interception efficiency and P. scabiosaefolia recorded the lowest soil water content. With increased planted-species richness, a greater percentage of pots showed light use efficiency higher than that of A. filiforme and a lower soil water content than that in P. scabiosaefolia. Conclusions/Significance The results of this study suggest that plant diversity confers resistance to invasion, which is mainly ascribed to the sampling effect of particular species and the complementarity effect among species on resources use.	[Zhu, Dan H.; Wang, Ping; Zhang, Wei Z.; Yuan, Yue; Li, Bin; Wang, Jiang] Taizhou Univ, Dept Life Sci, Taizhou, Zhejiang, Peoples R China	Taizhou University	Wang, J (corresponding author), Taizhou Univ, Dept Life Sci, Taizhou, Zhejiang, Peoples R China.	wangjiang@tzc.edu.cn			national college students innovation and entrepreneurship training project [201410350007]; student project of Taizhou University [14XS24]; student project of life science department of Taizhou University [2014xszd01]; National Natural Science Foundation of China [31000256]; Natural Science Foundation of Zhejiang Province, China [LY13C030003]	national college students innovation and entrepreneurship training project; student project of Taizhou University; student project of life science department of Taizhou University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province)	The Ecology Key Disciplines of Zhejiang Province in Taizhou University (EKD2013-04); The national college students innovation and entrepreneurship training project(201410350007), the student project of Taizhou University(14XS24) and the student project of life science department of Taizhou University(2014xszd01) support the experiment. The National Natural Science Foundation of China (Project 31000256) and the Natural Science Foundation of Zhejiang Province, China (LY13C030003) support the seeding collection and the work prepare for the experiment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2004, OECOLOGIA, V141, P612, DOI 10.1007/s00442-004-1679-z; [Anonymous], 2002, CAUSE CORRELATION BI; Byun C, 2013, J ECOL, V101, P128, DOI 10.1111/1365-2745.12016; Crawley MJ, 1999, ECOL LETT, V2, P140; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Dimitrakopoulos PG, 2005, OECOLOGIA, V143, P428, DOI 10.1007/s00442-004-1808-8; Elton C. S., 1958, ECOLOGY INVASIONS AN; Emery SM, 2007, J ECOL, V95, P1027, DOI 10.1111/j.1365-2745.2007.01274.x; Emery SM, 2006, OIKOS, V115, P549, DOI 10.1111/j.2006.0030-1299.15172.x; Fargione JE, 2005, ECOL LETT, V8, P604, DOI 10.1111/j.1461-0248.2005.00753.x; Hector A, 2001, ECOL RES, V16, P819, DOI 10.1046/j.1440-1703.2001.00443.x; Hector A, 2002, ECOL LETT, V5, P502, DOI 10.1046/j.1461-0248.2002.00337.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Iriondo JM, 2003, BIOL CONSERV, V113, P367, DOI 10.1016/S0006-3207(03)00129-0; Kellner JB, 2009, CONSERV LETT, V2, P115, DOI 10.1111/j.1755-263X.2009.00056.x; Kennedy TA, 2002, NATURE, V417, P636, DOI 10.1038/nature00776; Knight KS, 2008, DIVERS DISTRIB, V14, P666, DOI 10.1111/j.1472-4642.2008.00468.x; Knops JMH, 1999, ECOL LETT, V2, P286, DOI 10.1046/j.1461-0248.1999.00083.x; Levine JM, 1999, OIKOS, V87, P15, DOI 10.2307/3546992; Levine JM, 2000, SCIENCE, V288, P852, DOI 10.1126/science.288.5467.852; Liao CZ, 2008, NEW PHYTOL, V177, P706, DOI 10.1111/j.1469-8137.2007.02290.x; Lonsdale WM, 1999, ECOLOGY, V80, P1522, DOI 10.2307/176544; Losure DA, 2007, OIKOS, V116, P87, DOI 10.1111/j.2006.0030-1299.15341.x; Lyons KG, 2001, ECOL LETT, V4, P358, DOI 10.1046/j.1461-0248.2001.00235.x; Maron J, 2007, ECOLOGY, V88, P2651, DOI 10.1890/06-1993.1; Mason TJ, 2012, J VEG SCI, V23, P657, DOI 10.1111/j.1654-1103.2012.01393.x; Meiners SJ, 2004, ECOL LETT, V7, P121, DOI 10.1111/j.1461-0248.2003.00563.x; Mwangi PN, 2007, J ECOL, V95, P65, DOI 10.1111/j.1365-2745.2006.01189.x; Naeem S, 2000, OIKOS, V91, P97, DOI 10.1034/j.1600-0706.2000.910108.x; Page AL, 1982, SOIL ANAL PART, V2, P595; Parker IM, 2000, ECOL APPL, V10, P726, DOI 10.1890/1051-0761(2000)010[0726:IDOCSA]2.0.CO;2; Reinhart KO, 2006, BIOL INVASIONS, V8, P231, DOI 10.1007/s10530-004-5163-9; Roscher C, 2009, J ECOL, V97, P32, DOI 10.1111/j.1365-2745.2008.01451.x; Schuster MJ, 2014, OIKOS, V123, P1101, DOI 10.1111/oik.01078; Shea K, 1998, ECOL APPL, V8, P824, DOI 10.1890/1051-0761(1998)008[0824:EBAIWM]2.0.CO;2; SILVERTOWN J, 1993, J ECOL, V81, P465, DOI 10.2307/2261525; Smith MD, 2004, OKIOS, V103, P253; Souza L, 2011, FUNCT ECOL, V25, P1106, DOI 10.1111/j.1365-2435.2011.01857.x; Stachowicz JJ, 2002, ECOLOGY, V83, P2575; Stohlgren TJ, 1999, ECOL MONOGR, V69, P25, DOI 10.1890/0012-9615(1999)069[0025:EPSIHS]2.0.CO;2; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Van der Putten WH, 2000, OECOLOGIA, V124, P91, DOI 10.1007/s004420050028; van Ruijven J, 2003, ECOL LETT, V6, P910, DOI 10.1046/j.1461-0248.2003.00516.x; van Ruijven J, 2003, ECOL LETT, V6, P170, DOI 10.1046/j.1461-0248.2003.00427.x; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wardle DA, 2001, OIKOS, V95, P161, DOI 10.1034/j.1600-0706.2001.950119.x	47	9	10	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141559	10.1371/journal.pone.0141559	http://dx.doi.org/10.1371/journal.pone.0141559			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556713	Green Submitted, Green Published, gold			2022-12-26	WOS:000364430700032
J	Zheng, M; Mitra, RN; Filonov, NA; Han, ZC				Zheng, Min; Mitra, Rajendra N.; Filonov, Nazar A.; Han, Zongchao			Nanoparticle-mediated rhodopsin cDNA but not intron-containing DNA delivery causes transgene silencing in a rhodopsin knockout model	FASEB JOURNAL			English	Article						genomic DNA; epigenetic; gene therapy; gene expression	ALZHEIMERS-DISEASE; NONVIRAL VECTORS; GENE-EXPRESSION; IN-VITRO; MUTATION; MICE; METHYLOME; DYSTROPHY; VARIANTS; ISLANDS	Previously, we compared the efficacy of nanoparticle (NP)-mediated intron-containing rhodopsin (sgRho) vs. intronless cDNA in ameliorating retinal disease phenotypes in a rhodopsin knockout (RKO) mouse model of retinitis pigmentosa. We showed that NP-mediated sgRho delivery achieved long-term expression and phenotypic improvement in RKO mice, but not NP housing cDNA. However, the protein level of the NP-sgRho construct was only 5-10% of wild-type at 8 mo postinjection. To have a better understanding of the reduced levels of long-term expression of the vectors, in the present study, we evaluated the epigenetic changes of subretinal delivering NP-cDNA vs. NP-sgRho in the RKO mouse eyes. Following the administration, DNA methylation and histone status of specific regions (bacteria plasmid backbone, promoter, rhodopsin gene, and scaffold/matrix attachment region) of the vectors were evaluated at various time points. We documented that epigenetic transgene silencing occurred in vector-mediated gene transfer, which were caused by the plasmid backbone and the cDNA of the transgene, but not the intron-containing transgene. No toxicity or inflammation was found in the treated eyes. Our results suggest that cDNA of the rhodopsin transgene and bacteria backbone interfered with the host defense mechanism of DNA methylation-mediated transgene silencing through heterochromatin-associated modifications.	[Zheng, Min; Mitra, Rajendra N.; Han, Zongchao] Univ N Carolina, Dept Ophthalmol, 125 Mason Farm Rd,2208 Marsico Hall, Chapel Hill, NC 27599 USA; [Filonov, Nazar A.; Han, Zongchao] Univ N Carolina, Carolina Inst NanoMed, Chapel Hill, NC 27599 USA; [Han, Zongchao] Univ N Carolina, Eshelman Sch Pharm, Mol Therapeut, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Han, ZC (corresponding author), Univ N Carolina, Dept Ophthalmol, 125 Mason Farm Rd,2208 Marsico Hall, Chapel Hill, NC 27599 USA.; Han, ZC (corresponding author), Univ N Carolina, Carolina Inst NanoMed, Chapel Hill, NC 27599 USA.	zongchao@med.unc.edu	Mitra, Rajendra/G-5502-2011	Mitra, Rajendra/0000-0003-0654-9654; Han, Zongchao/0000-0002-2019-395X	U.S. National Institutes of Health/National Eye Institute Grant [R21 EY024059]; Carolina Center of Cancer Nanotechnology Excellence; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R21EY024059, R01EY026564] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Eye Institute Grant; Carolina Center of Cancer Nanotechnology Excellence; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank Sandy Janowski Barnhart, M.P.H. (Department of Ophthalmology, University of North Carolina at Chapel Hill) for her critical reading of the manuscript. The authors thank Drs. Alexander V. Kabanov (Center for Nanotechnology in Drug Delivery, University of North Carolina at Chapel Hill) and Muna I. Naash (Department of Cell Biology, University of Oklahoma Health Sciences Center) for their generous technical support. The authors also thank Dr. Muayyad Al-Ubaidi (Department of Cell Biology, University of Oklahoma Health Sciences Center) for providing plasmid pMOPS1. The authors acknowledge the financial support of the U.S. National Institutes of Health/National Eye Institute Grant R21 EY024059 (to Z.H.), the Carolina Center of Cancer Nanotechnology Excellence (to Z.H.), and the Research to Prevent Blindness to the University of North Carolina Department of Ophthalmology. The authors declare no conflicts of interests.	Agrawal A, 2012, PEDIATR RES, V71, P633, DOI 10.1038/pr.2012.21; Ares M, 1999, RNA, V5, P1138, DOI 10.1017/S1355838299991379; Bird A, 2001, SCIENCE, V294, P2113, DOI 10.1126/science.1066726; BRINSTER RL, 1988, P NATL ACAD SCI USA, V85, P836, DOI 10.1073/pnas.85.3.836; Burgess A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045726; Chen ZY, 2005, HUM GENE THER, V16, P126, DOI 10.1089/hum.2005.16.126; Chen ZY, 2001, MOL THER, V3, P403, DOI 10.1006/mthe.2001.0278; Choi JK, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r70; Christie M, 2011, PLANT J, V68, P159, DOI 10.1111/j.1365-313X.2011.04676.x; Dumesic PA, 2013, RNA BIOL, V10, P1653, DOI 10.4161/rna.26800; Ehrhardt A, 2003, HUM GENE THER, V14, P215, DOI 10.1089/10430340360535779; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Farinelli P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.512; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Gelfman S, 2013, GENOME RES, V23, P789, DOI 10.1101/gr.143503.112; Gibson TJ, 2013, NAT METHODS, V10, P715, DOI 10.1038/nmeth.2534; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Han ZC, 2015, FASEB J, V29, P2535, DOI 10.1096/fj.15-270363; Han ZC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052189; Han ZC, 2012, J CLIN INVEST, V122, P3221, DOI 10.1172/JCI64833; Han ZC, 2012, NANOMEDICINE-UK, V7, P521, DOI [10.2217/NNM.11.158, 10.2217/nnm.11.158]; Harland M, 2001, HUM MOL GENET, V10, P2679, DOI 10.1093/hmg/10.23.2679; Huang Y, 2000, BLOOD CELL MOL DIS, V26, P598, DOI 10.1006/bcmd.2000.0339; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Janssen JC, 2000, BRAIN, V123, P894, DOI 10.1093/brain/123.5.894; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Jovin IS, 2007, CARDIOVASCULAR GENETICS AND GENOMICS FOR THE CARDIOLOGIST, P195, DOI 10.1002/9780470691977.ch9; Koirala A, 2014, ADV EXP MED BIOL, V801, P703, DOI 10.1007/978-1-4614-3209-8_88; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; LAMB BT, 1995, NAT GENET, V9, P4, DOI 10.1038/ng0195-4; Lamb BT, 1997, HUM MOL GENET, V6, P1535, DOI 10.1093/hmg/6.9.1535; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Luo MJ, 1999, P NATL ACAD SCI USA, V96, P14937, DOI 10.1073/pnas.96.26.14937; Mahen R, 2014, MOL BIOL CELL, V25, P3610, DOI 10.1091/mbc.E14-06-1091; Manson AL, 1997, EMBO J, V16, P4238, DOI 10.1093/emboj/16.14.4238; Mao HY, 2011, HUM GENE THER, V22, P567, DOI 10.1089/hum.2010.140; Maunakea AK, 2013, CELL RES, V23, P1256, DOI 10.1038/cr.2013.110; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McVicker G, 2013, SCIENCE, V342, P747, DOI 10.1126/science.1242429; Movassagh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008564; Nott A, 2003, RNA, V9, P607, DOI 10.1261/rna.5250403; Palfi A, 2010, HUM GENE THER, V21, P311, DOI 10.1089/hum.2009.119; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Schedl A, 1996, CELL, V86, P71, DOI 10.1016/S0092-8674(00)80078-1; Schiedner G, 1998, NAT GENET, V18, P180, DOI 10.1038/ng0298-180; Sears JE, 2001, AM J OPHTHALMOL, V132, P693, DOI 10.1016/S0002-9394(01)01179-5; Wahlin KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079140; Wang LN, 2014, J INTEGR MED-JIM, V12, P20, DOI 10.1016/S2095-4964(14)60003-0; Webb TR, 2012, HUM MOL GENET, V21, P3647, DOI 10.1093/hmg/dds194; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Zhang YH, 2014, J INTEGR MED-JIM, V12, P483, DOI 10.1016/S2095-4964(14)60057-1; Zhao CY, 2007, J BIOL CHEM, V282, P20230, DOI 10.1074/jbc.M700180200	54	11	11	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1076	1086		10.1096/fj.15-280511	http://dx.doi.org/10.1096/fj.15-280511			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26564956	Green Published			2022-12-26	WOS:000370387800007
J	Kolodney, G; Dumin, E; Safory, H; Rosenberg, D; Mori, H; Radzishevisky, I; Wolosker, H				Kolodney, Goren; Dumin, Elena; Safory, Hazem; Rosenberg, Dina; Mori, Hisashi; Radzishevisky, Inna; Wolosker, Herman			Nuclear Compartmentalization of Serine Racemase Regulates D-Serine Production IMPLICATIONS FOR N-METHYL-D-ASPARTATE (NMDA) RECEPTOR ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; NEUROMODULATOR D-SERINE; AMINO-ACID TRANSPORTER; PROGRAMMED CELL-DEATH; ENDOGENOUS D-SERINE; NEURONAL D-SERINE; GLUTAMATE-NEUROTRANSMISSION; CEREBRAL-ISCHEMIA; MOUSE MODEL; APOPTOSIS	D-Serine is a physiological co-agonist that activates N-methyl D-aspartate receptors (NMDARs) and is essential for neurotransmission, synaptic plasticity, and behavior. D-Serine may also trigger NMDAR-mediated neurotoxicity, and its dysregulation may play a role in neurodegeneration. D-Serine is synthesized by the enzyme serine racemase (SR), which directly converts L-serine to D-serine. However, many aspects concerning the regulation of D-serine production under physiological and pathological conditions remain to be elucidated. Here, we investigate possible mechanisms regulating the synthesis of D-serine by SR in paradigms relevant to neurotoxicity. We report that SR undergoes nucleocytoplasmic shuttling and that this process is dysregulated by several insults leading to neuronal death, typically by apoptotic stimuli. Cell death induction promotes nuclear accumulation of SR, in parallel with the nuclear translocation of GAPDH and Siah proteins at an early stage of the cell death process. Mutations in putative SR nuclear export signals (NESs) elicit SR nuclear accumulation and its depletion from the cytosol. Following apoptotic insult, SR associates with nuclear GAPDH along with other nuclear components, and this is accompanied by complete inactivation of the enzyme. As a result, extracellular D-serine concentration is reduced, even though extracellular glutamate concentration increases several-fold. Our observations imply that nuclear translocation of SR provides a fail-safe mechanism to prevent or limit secondary NMDAR-mediated toxicity in nearby synapses.	[Wolosker, Herman] Technion Israel Inst Technol, Rappaport Fac Med, Dept Biochem, IL-31096 Haifa, Israel; [Wolosker, Herman] Technion Israel Inst Technol, Res Inst, Haifa, Israel; [Dumin, Elena] Rambam Hlth Care Campus, Lab Clin Biochem, Metab Unit, IL-31096 Haifa, Israel; [Mori, Hisashi] Toyama Univ, Dept Mol Neurosci, Grad Sch Med & Pharmaceut Sci, Toyama 9300194, Japan	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rambam Health Care Campus; University of Toyama		vinna@tx.technion.ac.il; hwolosker@tx.technion.ac.il		Radzishevsky, Inna/0000-0001-7748-7599; Wolosker, Herman/0000-0001-5508-9194	Israel Science Foundation; Legacy Heritage Fund; ALS Research Fund; Allen and Jewel Prince Center for Neurodegenerative Processes of the Brain	Israel Science Foundation(Israel Science Foundation); Legacy Heritage Fund; ALS Research Fund; Allen and Jewel Prince Center for Neurodegenerative Processes of the Brain	This work was supported by the Israel Science Foundation, Legacy Heritage Fund, ALS Research Fund in the memory of Dr. David S. David, and the Allen and Jewel Prince Center for Neurodegenerative Processes of the Brain (to H. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Abe T, 2014, J CEREBR BLOOD F MET, V34, P1928, DOI 10.1038/jcbfm.2014.164; Balan L, 2009, P NATL ACAD SCI USA, V106, P7589, DOI 10.1073/pnas.0809442106; Balu DT, 2014, CELL MOL NEUROBIOL, V34, P419, DOI 10.1007/s10571-014-0027-z; Balu DT, 2013, P NATL ACAD SCI USA, V110, pE2400, DOI 10.1073/pnas.1304308110; Balu DT, 2012, NEUROSCI LETT, V517, P77, DOI 10.1016/j.neulet.2012.04.020; Basu AC, 2009, MOL PSYCHIATR, V14, P719, DOI 10.1038/mp.2008.130; Benneyworth MA, 2012, CELL MOL NEUROBIOL, V32, P613, DOI 10.1007/s10571-012-9808-4; Billard JM, 2013, EUR J NEUROSCI, V37, P1931, DOI 10.1111/ejn.12226; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Chen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032971; Crampton N, 2009, MOL BIOL CELL, V20, P5106, DOI 10.1091/mbc.E09-05-0397; De Miranda J, 2000, GENE, V256, P183, DOI 10.1016/S0378-1119(00)00356-5; Dikopoltsev E, 2014, J BIOL CHEM, V289, P33904, DOI 10.1074/jbc.M114.618405; Dumin E, 2006, J BIOL CHEM, V281, P20291, DOI 10.1074/jbc.M601971200; Ehmsen JT, 2013, J NEUROSCI, V33, P12464, DOI 10.1523/JNEUROSCI.4914-12.2013; Esposito S, 2012, AGING CELL, V11, P588, DOI 10.1111/j.1474-9726.2012.00822.x; Fujii K, 2006, MOL PSYCHIATR, V11, P150, DOI 10.1038/sj.mp.4001776; Fukasawa Y, 2000, J BIOL CHEM, V275, P9690, DOI 10.1074/jbc.275.13.9690; Hara MR, 2006, P NATL ACAD SCI USA, V103, P3887, DOI 10.1073/pnas.0511321103; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Harlow E., 1988, ANTIBODIES LAB MANUA, P343; HARTLEY DM, 1993, J NEUROSCI, V13, P1993; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Inoue R, 2014, J INVEST DERMATOL, V134, P1618, DOI 10.1038/jid.2014.22; Inoue R, 2008, J NEUROSCI, V28, P14486, DOI 10.1523/JNEUROSCI.5034-08.2008; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kartvelishvily E, 2006, J BIOL CHEM, V281, P14151, DOI 10.1074/jbc.M512927200; Katsuki H, 2004, J PHARMACOL EXP THER, V311, P836, DOI 10.1124/jpet.104.070912; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kim PM, 2005, P NATL ACAD SCI USA, V102, P2105, DOI 10.1073/pnas.0409723102; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Labrie V, 2009, HUM MOL GENET, V18, P3227, DOI 10.1093/hmg/ddp261; Li X, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1292-z; Ma TM, 2013, MOL PSYCHIATR, V18, P557, DOI 10.1038/mp.2012.97; Ma TM, 2014, J BIOL CHEM, V289, P29631, DOI 10.1074/jbc.M114.571604; Maucler C, 2013, ACS CHEM NEUROSCI, V4, P772, DOI 10.1021/cn4000549; Miya K, 2008, J COMP NEUROL, V510, P641, DOI 10.1002/cne.21822; MIZUMOTO K, 1994, MOL PHARMACOL, V46, P890; Mothet JP, 2005, P NATL ACAD SCI USA, V102, P5606, DOI 10.1073/pnas.0408483102; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Mustafa AK, 2007, P NATL ACAD SCI USA, V104, P2950, DOI 10.1073/pnas.0611620104; Mustafa AK, 2010, J NEUROSCI, V30, P1413, DOI 10.1523/JNEUROSCI.4297-09.2010; Mustafaa AK, 2009, P NATL ACAD SCI USA, V106, P2921, DOI 10.1073/pnas.0813105106; Nguyen BA, 2009, BMC BIOINFORMATICS, V10, P202, DOI [10.1186/1471-2105-10-202, DOI 10.1186/1471-2105-10-202]; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; O'Brien KB, 2006, ELECTROPHORESIS, V27, P1949, DOI 10.1002/elps.200500770; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Price P.J., 2001, PROTOCOLS NEURAL CEL, P255, DOI 10.1385/1-59259-207-4:255; Radzishevsky I, 2013, CURR OPIN CLIN NUTR, V16, P72, DOI 10.1097/MCO.0b013e32835a3466; Radzishevsky I, 2012, METHODS MOL BIOL, V794, P291, DOI 10.1007/978-1-61779-331-8_19; Ribeiro CS, 2002, BRAIN RES, V929, P202, DOI 10.1016/S0006-8993(01)03390-X; Rosenberg D, 2013, J NEUROSCI, V33, P3533, DOI 10.1523/JNEUROSCI.3836-12.2013; Rosenberg D, 2010, FASEB J, V24, P2951, DOI 10.1096/fj.09-147967; Rott R, 2008, J BIOL CHEM, V283, P3316, DOI 10.1074/jbc.M704809200; Rutter AR, 2007, EUR J NEUROSCI, V25, P1757, DOI 10.1111/j.1460-9568.2007.05446.x; Safory H, 2015, EMBO REP, V16, P590, DOI 10.15252/embr.201439561; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Schoenmann Z, 2010, J NEUROSCI, V30, P6375, DOI 10.1523/JNEUROSCI.0922-10.2010; Shackelford DB, 2013, CANCER CELL, V23, P143, DOI 10.1016/j.ccr.2012.12.008; Shleper M, 2005, J NEUROSCI, V25, P9413, DOI 10.1523/JNEUROSCI.3190-05.2005; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Suzuki M, 2015, P NATL ACAD SCI USA, V112, pE2217, DOI 10.1073/pnas.1416117112; Szargel R, 2009, J BIOL CHEM, V284, P11706, DOI 10.1074/jbc.M805990200; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tanaka K, 2015, J CLIN INVEST, V125, P1591, DOI 10.1172/JCI78239; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P721, DOI 10.1073/pnas.96.2.721; Wolosker H, 2008, FEBS J, V275, P3514, DOI 10.1111/j.1742-4658.2008.06515.x; Wysocka J, 2001, MOL CELL BIOL, V21, P3820, DOI 10.1128/MCB.21.11.3820-3829.2001; Yamamoto T, 2004, NEUROSCI RES, V49, P101, DOI 10.1016/j.neures.2004.02.004; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yoshida H, 2001, MOL CELL BIOL, V21, P1239, DOI 10.1128/MCB.21.4.1239-1248.2001; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zhang Y, 2006, EMBO J, V25, P5896, DOI 10.1038/sj.emboj.7601445; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	85	15	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					31037	31050		10.1074/jbc.M115.699496	http://dx.doi.org/10.1074/jbc.M115.699496			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26553873	hybrid, Green Published			2022-12-26	WOS:000367199000033
J	Schummer, M; Thorpe, J; Giraldez, M; Bergan, L; Tewari, M; Urban, N				Schummer, Michel; Thorpe, Jason; Giraldez, Maria; Bergan, Lindsay; Tewari, Muneesh; Urban, Nicole			Evaluating Serum Markers for Hormone Receptor-Negative Breast Cancer	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; M2 PYRUVATE-KINASE; GENE-EXPRESSION; SCREENING MAMMOGRAPHY; PROTEIN EXPRESSION; PROGNOSTIC VALUE; TUMOR-MARKERS; OVARIAN; OSTEOPONTIN; PLASMA	Introduction Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death in females worldwide. Death rates have been declining, largely as a result of early detection through mammography and improved treatment, but mammographic screening is controversial because of over-diagnosis of breast disease that might not require treatment, and under-diagnosis of cancer in women with dense breasts. Breast cancer screening could be improved by pairing mammography with a tumor circulating marker, of which there are currently none. Given genomic similarities between the basal breast cancer subtype and serous ovarian cancer, and given our success in identifying circulating markers for ovarian cancer, we investigated the performance in hormone receptor-negative breast cancer detection of both previously identified ovarian serum markers and circulating markers associated with transcripts that were differentially expressed in breast cancer tissue compared to healthy breast tissue from reduction mammaplasties. Methods We evaluated a total of 15 analytes (13 proteins, 1 miRNA, 1 autoantibody) in sera drawn at or before breast cancer surgery from 43 breast cancer cases (28 triple-negative-TN-and 15 hormone receptor-negative-HRN-/HER2-positive) and 87 matched controls. Results In the analysis of our whole cohort of breast cancer cases, autoantibodies to TP53 performed significantly better than the other selected 14 analytes showing 25.6% and 34.9% sensitivity at 95% and 90% specificity respectively with AUC: 0.7 (p<0.001). The subset of 28 TN cancers showed very similar results. We observed no correlation between anti-TP53 and the 14 other markers; however, anti-TP53 expression correlated with Body-Mass-Index. It did not correlate with tumor size, positive lymph nodes, tumor stage, the presence of metastases or recurrence. Conclusion None of the 13 serum proteins nor miRNA 135b identified women with HRN or TN breast cancer. TP53 autoantibodies identified women with HRN breast cancer and may have potential for early detection, confirming earlier reports. TP53 autoantibodies are long lasting in serum but may be affected by storage duration. Autoantibodies to TP53 might correlate with Body-Mass-Index.	[Schummer, Michel; Thorpe, Jason; Bergan, Lindsay; Urban, Nicole] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Giraldez, Maria; Tewari, Muneesh] Univ Michigan, Dept Internal Med, Div Hematol Oncol, Ann Arbor, MI 48109 USA; [Tewari, Muneesh] Univ Michigan, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA; [Tewari, Muneesh] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Tewari, Muneesh] Univ Michigan, Biointerfaces Inst, Ann Arbor, MI 48109 USA; [Tewari, Muneesh] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA	Fred Hutchinson Cancer Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Schummer, M (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N, Seattle, WA 98104 USA.	mschummer@me.com	Giraldez, Maria D/E-7395-2018	Giraldez, Maria D/0000-0001-6829-7603	US Department of Defense [DAMD17-02-1-0691]; National Institutes of Health [P50 CA083636, U01 CA152637, R01 DK085714]; Rio Hortega [CM10/00084]; Fundacion Martin Escudero; NATIONAL CANCER INSTITUTE [P50CA083636, U01CA152637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085714] Funding Source: NIH RePORTER	US Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rio Hortega; Fundacion Martin Escudero; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the US Department of Defense (http://cdmrp.army.mi/funding/): DAMD17-02-1-0691; National Institutes of Health (http://grants.nih.gov/): P50 CA083636, U01 CA152637 and R01 DK085714; Rio Hortega (http://www.eng.isciii.es/ISCIII/es/contenidos/fdinvestigacion/fd-financiacion/fd-convocatorias-ayudas-accionestrategica-salud/fdseguimiento-cientifico-economico/seguimiento-ayudas-para-contratos-post-formacionriohortega.shtml): CM10/00084; Fundacion Martin Escudero (www.fundame.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba MC, 2004, BREAST CANCER RES, V6, pR499, DOI 10.1186/bcr899; Amatschek S, 2004, CANCER RES, V64, P844, DOI 10.1158/0008-5472.CAN-03-2361; American Cancer Society, 2012, GLOB CANC FACTS FIG; Anderson KS, 2009, BRIT J DERMATOL, V160, P325, DOI 10.1111/j.1365-2133.2008.08904.x; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Blixt O, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2841; Bramwell VHC, 2006, CLIN CANCER RES, V12, P3337, DOI 10.1158/1078-0432.CCR-05-2354; Brown DA, 2012, CANCER EPIDEM BIOMAR, V21, P337, DOI 10.1158/1055-9965.EPI-11-0786; Burford B, 2013, BRIT J CANCER, V108, P2045, DOI 10.1038/bjc.2013.214; Casiano CA, 2006, MOL CELL PROTEOMICS, V5, P1745, DOI 10.1074/mcp.R600010-MCP200; Checka CM, 2012, AM J ROENTGENOL, V198, pW292, DOI 10.2214/AJR.10.6049; Cohen A, 2013, J PROTEOMICS, V81, P135, DOI 10.1016/j.jprot.2012.11.004; Coppola D, 2004, CLIN CANCER RES, V10, P184, DOI 10.1158/1078-0432.CCR-1405-2; Cramer DW, 2011, CANCER PREV RES, V4, P365, DOI 10.1158/1940-6207.CAPR-10-0195; CRAWFORD LV, 1982, INT J CANCER, V30, P403, DOI 10.1002/ijc.2910300404; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Enerly E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016915; Ferraro S, 2013, J CLIN PATHOL, V66, P273, DOI 10.1136/jclinpath-2012-201031; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Geiger T, 2012, CANCER RES, V72, P2428, DOI 10.1158/0008-5472.CAN-11-3711; Gonzalez RM, 2011, CANCER EPIDEM BIOMAR, V20, P1543, DOI 10.1158/1055-9965.EPI-10-1248; Gressner OA, 2013, CLIN CHIM ACTA, V421, P126, DOI 10.1016/j.cca.2013.02.029; Grigoriadis A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1604; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Helleman J, 2008, CLIN CANCER RES, V14, P5555, DOI 10.1158/1078-0432.CCR-08-0555; Hellstrom I, 2003, CANCER RES, V63, P3695; Henderson GS, 2006, CELL ONCOL, V28, P305; Hertlein L, 2012, CLIN CHEM LAB MED, V50, P2181, DOI 10.1515/cclm-2012-0097; Hoopmann M, 2002, CANCER LETT, V187, P223, DOI 10.1016/S0304-3835(02)00404-4; Jacobson A, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S8; Jatoi I, 2007, J CLIN ONCOL, V25, P1683, DOI 10.1200/JCO.2006.09.2106; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jonsson JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107643; Kamei M, 2010, ANTICANCER RES, V30, P4779; Kennedy JJ, 2014, NAT METHODS, V11, P149, DOI [10.1038/NMETH.2763, 10.1038/nmeth.2763]; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Lowery AJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2257; Lu D, 2011, GYNECOL ONCOL, V122, P560, DOI 10.1016/j.ygyno.2011.05.039; Lu HL, 2012, CANCER PREV RES, V5, P1036, DOI 10.1158/1940-6207.CAPR-11-0558; Luftner D, 2000, ANTICANCER RES, V20, P5077; Madrid MF, 2005, CANCER LETT, V230, P187, DOI 10.1016/j.canlet.2004.12.017; Mannisto T, 2007, CLIN CHEM, V53, P1986, DOI 10.1373/clinchem.2007.091371; Marks JR, 2014, CANCER EPIDEM BIOMAR, P3; Milner JJ, 2012, P NUTR SOC, V71, P298, DOI 10.1017/S0029665112000158; Mirza M, 2008, INT J CANCER, V122, P889, DOI 10.1002/ijc.23204; Molina R, 2005, TUMOR BIOL, V26, P281, DOI 10.1159/000089260; Muller M, 2006, INT J ONCOL, V29, P973; Nagai MA, 2011, BREAST CANCER RES TR, V126, P1, DOI 10.1007/s10549-010-0867-2; National Cancer Institute, SEER CANC STAT REV 1; Niwa Y, 2001, CLIN CANCER RES, V7, P285; Norum LF, 2001, TUMOR BIOL, V22, P223, DOI 10.1159/000050620; Nozoe T, 2012, BREAST CANCER-TOKYO, V19, P11, DOI 10.1007/s12282-010-0244-3; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; Opstal-van Winden AWJ, 2012, INT J MOL SCI, V13, P13587, DOI 10.3390/ijms131013587; Ozkan H, 2011, PANCREATOLOGY, V11, P295, DOI 10.1159/000328963; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Paruchuri V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001741; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pietrowska M, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-60; Prat A, 2013, ONCOLOGIST, V18, P123, DOI 10.1634/theoncologist.2012-0397; Pucci-Minafra I, 2008, J PROTEOME RES, V7, P1412, DOI 10.1021/pr700748m; R Core Team, 2021, R LANGUAGE ENV STAT; Reinholz MM, 2002, BREAST CANCER RES TR, V74, P255, DOI 10.1023/A:1016339120506; Ruiz-Garcia E, 2010, BRIT J CANCER, V102, P462, DOI 10.1038/sj.bjc.6605511; Scholler N, 2006, CLIN CANCER RES, V12, P2117, DOI 10.1158/1078-0432.CCR-05-2007; Schummer M, 1999, GENE, V238, P375, DOI 10.1016/S0378-1119(99)00342-X; Schummer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009122; Schwartz SM, 2014, CANC SURVEILLANCE SY; Sinclair N, 2011, AM J ROENTGENOL, V197, P1268, DOI 10.2214/AJR.10.5442; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Srour N, 2008, PATHOBIOLOGY, V75, P112, DOI 10.1159/000123849; Turashvili G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-55; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; van 't Veer LJ, 2003, BREAST CANCER RES, V5, P57, DOI 10.1186/bcr562; Vargas AC, 2012, BREAST CANCER RES TR, V135, P153, DOI 10.1007/s10549-012-2123-4; Venables WN., 2002, MODERN APPL STAT S, V4; Wang X, 2008, EUR J CLIN INVEST, V38, P438, DOI 10.1111/j.1365-2362.2008.01956.x; Westbury CB, 2009, J PATHOL, V219, P131, DOI 10.1002/path.2581; Wickerham DL, 2013, JNCI-J NATL CANCER I, V105, P1521, DOI 10.1093/jnci/djt268; Yang C, 2013, TRANSPL INT, V26, P15; Zhao HJ, 2004, MOL BIOL CELL, V15, P2523, DOI 10.1091/mbc.E03-11-0786	84	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142911	10.1371/journal.pone.0142911	http://dx.doi.org/10.1371/journal.pone.0142911			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26565788	Green Submitted, gold, Green Published			2022-12-26	WOS:000367628500068
J	Smith, CM; Downs, SH; Mitchell, A; Hayward, AC; Fry, H; Le Comber, SC				Smith, Catherine M.; Downs, Sara H.; Mitchell, Andy; Hayward, Andrew C.; Fry, Hannah; Le Comber, Steven C.			Spatial Targeting for Bovine Tuberculosis Control: Can the Locations of Infected Cattle Be Used to Find Infected Badgers?	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS; COOLING-TOWERS; MOVEMENT; OUTBREAK; DENSITY; SPREAD; IMPACT; RISK	Bovine tuberculosis is a disease of historical importance to human health in the UK that remains a major animal health and economic issue. Control of the disease in cattle is complicated by the presence of a reservoir species, the Eurasian badger. In spite of uncertainty in the degree to which cattle disease results from transmission from badgers, and opposition from environmental groups, culling of badgers has been licenced in two large areas in England. Methods to limit culls to smaller areas that target badgers infected with TB whilst minimising the number of uninfected badgers culled is therefore of considerable interest. Here, we use historical data from a large-scale field trial of badger culling to assess two alternative hypothetical methods of targeting TB-infected badgers based on the distribution of cattle TB incidents: (i) a simple circular 'ring cull'; and (ii) geographic profiling, a novel technique for spatial targeting of infectious disease control that predicts the locations of sources of infection based on the distribution of linked cases. Our results showed that both methods required coverage of very large areas to ensure a substantial proportion of infected badgers were removed, and would result in many uninfected badgers being culled. Geographic profiling, which accounts for clustering of infections in badger and cattle populations, produced a small but non-significant increase in the proportion of setts with TBinfected compared to uninfected badgers included in a cull. It also provided no overall improvement at targeting setts with infected badgers compared to the ring cull. Cattle TB incidents in this study were therefore insufficiently clustered around TB-infected badger setts to design an efficient spatially targeted cull; and this analysis provided no evidence to support a move towards spatially targeted badger culling policies for bovine TB control.	[Smith, Catherine M.; Hayward, Andrew C.] UCL, Farr Inst Hlth Informat Res, UCL Dept Infect Dis Informat, London, England; [Downs, Sara H.; Mitchell, Andy] Anim & Plant Hlth Agcy, Addlestone, Surrey, England; [Fry, Hannah] UCL, Ctr Adv Spatial Anal, London, England; [Le Comber, Steven C.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England	University of London; University College London; Animal & Plant Health Agency UK; University of London; University College London; University of London; Queen Mary University London	Le Comber, SC (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.	s.c.lecomber@qmul.ac.uk	Hayward, Andrew C/C-3268-2013	Hayward, Andrew C/0000-0002-3549-6232; Smith, Catherine/0000-0003-3959-8479; Fry, Hannah/0000-0003-0601-9100	Medical Research Council [MR/K006584/1] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bielby J, 2014, P NATL ACAD SCI USA, V111, P9193, DOI 10.1073/pnas.1401503111; Bivand R., 2014, RGEOS INTERFACE GEOM; Bourne FJ, 2007, FINAL REPORT INDEPEN; Brown CM, 1999, INT J EPIDEMIOL, V28, P353, DOI 10.1093/ije/28.2.353; Carruthers JI, 2010, PAP REG SCI, V89, P65, DOI 10.1111/j.1435-5957.2009.00242.x; Conlan AJK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002730; Crawshaw TR, 2008, VET REC, V163, P473, DOI 10.1136/vr.163.16.473; Department for Environment Food and Rural Affairs, 2012, CHANG TB CATTL MOV C; Department for Environment Food and Rural Affairs, 2014, STRAT ACH OFF BOV TU; Department for Environment Food and Rural Affairs, 2015, MONTHL PUBL NAT STAT; Donnelly CA, 2003, NATURE, V426, P834, DOI 10.1038/nature02192; Donnelly CA, 2013, PLOS CURRENTS; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; Godfray HCJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1634; Green DM, 2008, P R SOC B, V275, P1001, DOI 10.1098/rspb.2007.1601; Independent Expert Panel, 2014, PIL BADG CULLS SOM G; Kauhala K, 2011, ANN ZOOL FENN, V48, P221, DOI 10.5735/086.048.0403; Krebs J., 1997, PB3423 HMSO; Le Comber SC, 2012, TRENDS ECOL EVOL, V27, P307, DOI 10.1016/j.tree.2012.03.004; Le Comber SC, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-35; Murhead RH, 1974, VET RECORD, V95; Nguyen TMN, 2006, J INFECT DIS, V193, P102, DOI 10.1086/498575; Pope LC, 2007, MOL ECOL, V16, P4919, DOI 10.1111/j.1365-294X.2007.03553.x; R Core Team, 2021, R LANGUAGE ENV STAT; Ramos DF, 2014, BRAZ J MICROBIOL, V45, P365, DOI 10.1590/S1517-83822014000200001; Reader S, 2000, SOC SCI MED, V50, P985, DOI 10.1016/S0277-9536(99)00349-4; Rogers LM, 1997, J ZOOL, V242, P705, DOI 10.1111/j.1469-7998.1997.tb05821.x; Rossmo DK., 2000, GEOGRAPHIC PROFILING; Schimmer B, 2010, CLIN MICROBIOL INFEC, V16, pS391; Stevenson MD, 2013, RGEOPROFILE GENERATE; Sutmoller P, 2003, VIRUS RES, V91, P101, DOI 10.1016/S0168-1702(02)00262-9; Themeau T., 2012, COXME MIXED EFFECTS; Themeau T, 2014, PACKAGE SURVIVAL ANA; Verity R, 2014, METHODS ECOL EVOL, V5, P647, DOI 10.1111/2041-210X.12190; Vial F, 2012, BIOL LETTERS, V8, P50, DOI 10.1098/rsbl.2011.0554; Woodroffe R, 2006, J APPL ECOL, V43, P1, DOI 10.1111/j.1365-2664.2005.01144.x; Woodroffe R, 2005, J APPL ECOL, V42, P852, DOI 10.1111/j.1365-2664.2005.01081.x; Woodroffe R, 2006, P NATL ACAD SCI USA, V103, P14713, DOI 10.1073/pnas.0606251103; ZUCKERMAN S, 1980, BADGERS CATTLE TUBER; [No title captured]	40	2	2	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142710	10.1371/journal.pone.0142710	http://dx.doi.org/10.1371/journal.pone.0142710			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26565626	Green Submitted, Green Published, gold			2022-12-26	WOS:000367628500048
J	Lin, JZ; Zou, YX; Ma, CJ; She, QX; Liang, YX; Chen, ZJ; Ge, XY				Lin, Jinzhong; Zou, Yexia; Ma, Chengjie; She, Qunxin; Liang, Yunxiang; Chen, Zhengjun; Ge, Xiangyang			Heterologous Expression of Mannanase and Developing a New Reporter Gene System in Lactobacillus casei and Escherichia coli	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; PROMOTER SEQUENCES; MONITOR LACTOBACILLUS; LACTOCOCCUS; VACCINE; VECTORS; STRAINS; CLONING; CONSTRUCTION; PROBIOTICS	Reporter gene systems are useful for studying bacterial molecular biology, including the regulation of gene expression and the histochemical analysis of protein products. Here, two genes, beta-1,4-mannanase (manB) from Bacillus pumilus and beta-glucuronidase (gusA) from Escherichia coli K12, were cloned into the expression vector pELX1. The expression patterns of these reporter genes in Lactobacillus casei were investigated by measuring their enzymatic activities and estimating their recombinant protein yields using western blot analysis. Whereas mannanase activity was positively correlated with the accumulation of ManB during growth, GusA activity was not; western blot analysis indicated that while the amount of GusA protein increased during later growth stages, GusA activity gradually decreased, indicating that the enzyme was inactive during cell growth. A similar trend was observed in E. coli JM109. We chose to use the more stable mannanase gene as the reporter to test secretion expression in L. casei. Two pELX1-based secretion vectors were constructed: one carried the signal peptide of the unknown secretion protein Usp45 from Lactococcus lactis (pELSH), and the other contained the full-length SlpA protein from the S-layer of L. acidophilus (pELWH). The secretion of ManB was detected in the supernatant of the pELSH-ManB transformants and in the S-layer of the cell surface of the pELWH-ManB transformants. This is the first report demonstrating that the B. pumilus manB gene is a useful reporter gene in L. casei and E. coli.	[Lin, Jinzhong; Zou, Yexia; She, Qunxin; Liang, Yunxiang; Chen, Zhengjun; Ge, Xiangyang] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Peoples R China; [Lin, Jinzhong; Ma, Chengjie] Technol Ctr Bright Dairy & Food Co Ltd, State Key Lab Dairy Biotechnol, Shanghai 200436, Peoples R China; [She, Qunxin] Univ Copenhagen, Dept Biol, Bioctr, DK-2200 Copenhagen N, Denmark	Huazhong Agricultural University; Bright Dairy & Food Co Ltd; University of Copenhagen	Chen, ZJ (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Peoples R China.	Zhengjun.chen@gmail.com; gxy@mail.hzau.edu.cn	She, Qunxin/E-4311-2012	She, Qunxin/0000-0002-4448-6669; Lin, Jinzhong/0000-0002-2759-3243	National Natural Science Foundation of China [31128011]; Bright Dairy Food Co., Ltd.	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Bright Dairy Food Co., Ltd.	This work was supported by the National Natural Science Foundation of China (31128011, URL of funder: http://www.nsfc.gov.cn/), and Bright Dairy & Food Co., Ltd. Both funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder (Bright Dairy & Food Co., Ltd) provided support in the form of salaries for authors JL and CM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ACHEN MG, 1986, GENE, V45, P45, DOI 10.1016/0378-1119(86)90130-7; Adachi K, 2010, VACCINE, V28, P2810, DOI 10.1016/j.vaccine.2010.02.005; Altermann E, 2005, P NATL ACAD SCI USA, V102, P3906, DOI 10.1073/pnas.0409188102; ARAUJO A, 1990, APPL ENVIRON MICROB, V56, P1954, DOI 10.1128/AEM.56.6.1954-1956.1990; Bai X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111622; Boot HJ, 1996, J BACTERIOL, V178, P5388, DOI 10.1128/jb.178.18.5388-5394.1996; Borrero J, 2011, APPL MICROBIOL BIOT, V89, P131, DOI 10.1007/s00253-010-2849-z; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chen YS, 2005, J APPL MICROBIOL, V98, P64, DOI 10.1111/j.1365-2672.2004.02433.x; Chen ZJ, 2014, APPL MICROBIOL BIOT, V98, P5977, DOI 10.1007/s00253-014-5649-z; Davidson LE, 2011, EUR J CLIN NUTR, V65, P501, DOI 10.1038/ejcn.2010.289; EATON TJ, 1993, J GEN MICROBIOL, V139, P1495, DOI 10.1099/00221287-139-7-1495; Geoffroy MC, 2000, APPL ENVIRON MICROB, V66, P383, DOI 10.1128/AEM.66.1.383-391.2000; Gory L, 2001, FEMS MICROBIOL LETT, V194, P127, DOI 10.1111/j.1574-6968.2001.tb09457.x; Gusakov AV, 2011, INT J ANAL CHEM, V2011, DOI 10.1155/2011/283658; Hagen KE, 2005, APPL ENVIRON MICROB, V71, P6633, DOI 10.1128/AEM.71.11.6633-6643.2005; HARWOOD CR, 1983, GENE, V24, P163, DOI 10.1016/0378-1119(83)90076-8; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; HOLS P, 1992, GENE, V118, P21, DOI 10.1016/0378-1119(92)90244-J; ISRAELSEN H, 1995, APPL ENVIRON MICROB, V61, P2540, DOI 10.1128/AEM.61.7.2540-2547.1995; Li YN, 2006, Z NATURFORSCH C, V61, P840; McCracken A, 2000, ARCH MICROBIOL, V173, P383, DOI 10.1007/s002030000159; Moeini H, 2011, APPL MICROBIOL BIOT, V90, P77, DOI 10.1007/s00253-010-3050-0; Perez-Arellano I, 2003, FEMS MICROBIOL LETT, V222, P123, DOI 10.1016/S0378-1097(03)00244-1; Peterbauer C, 2011, BIOTECHNOL J, V6, P1147, DOI 10.1002/biot.201100034; PLATTEEUW C, 1994, APPL ENVIRON MICROB, V60, P587, DOI 10.1128/AEM.60.2.587-593.1994; Poquet I, 1998, J BACTERIOL, V180, P1904, DOI 10.1128/JB.180.7.1904-1912.1998; Saad N, 2013, LWT-FOOD SCI TECHNOL, V50, P1, DOI 10.1016/j.lwt.2012.05.014; Sambrook J., 2001, MOL CLONING LAB MANU; Sanders ME, 2001, J DAIRY SCI, V84, P319, DOI 10.3168/jds.S0022-0302(01)74481-5; Singh VP, 2013, J PAK MED ASSOC, V63, P253; Soccol CR, 2010, FOOD TECHNOL BIOTECH, V48, P413; Stoeker L, 2011, CLIN VACCINE IMMUNOL, V18, P1834, DOI 10.1128/CVI.05277-11; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Yu QH, 2007, FEMS MICROBIOL LETT, V275, P207, DOI 10.1111/j.1574-6968.2007.00877.x	36	5	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142886	10.1371/journal.pone.0142886	http://dx.doi.org/10.1371/journal.pone.0142886			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562012	Green Submitted, gold, Green Published			2022-12-26	WOS:000364480900077
J	Takahashi, K; Nishida, A; Shioya, M; Imaeda, H; Bamba, S; Inatomi, O; Shimizu, T; Kitoh, K; Andoh, A				Takahashi, Kenichiro; Nishida, Atsushi; Shioya, Makoto; Imaeda, Hirotsugu; Bamba, Shigeki; Inatomi, Osamu; Shimizu, Tomoharu; Kitoh, Katsuyuki; Andoh, Akira			Interleukin (IL)-1 beta Is a Strong Inducer of IL-36. Expression in Human Colonic Myofibroblasts	PLOS ONE			English	Article							NF-KAPPA-B; INFLAMMATORY-BOWEL-DISEASE; PROTEIN-KINASE KINASE; IN-VITRO; SUBEPITHELIAL MYOFIBROBLASTS; CROHNS-DISEASE; CELLS; INHIBITOR; RESPONSES; IL-1F8	Backgrounds and aims Interleukin (IL)-36 cytokines are members of the IL-1 cytokine family. In this study, we investigated the expression of IL-36 gamma in human colonic myofibroblasts to explore the molecular mechanisms underlying IL-36 gamma induction. Materials and methods IL-36 mRNA was analyzed by real-time PCR method. Secretion of IL-36 gamma protein was evaluated by Western blot and ELISA analyses. Molecular mechanism of IL-36 gamma induction was evaluated by siRNA analyses and immunofluorescence experiments. Results IL-36 gamma mRNA expression was scarcely detected in the cells without stimulation. IL-1 beta induced a marked increase of IL-36 gamma mRNA expression. TNF-alpha markedly enhanced IL-1 beta-induced IL36 gamma mRNA expression. These responses were confirmed at the protein levels. The inhibitors for ERK1/2 (PD98059 and U0216) and a p38 MAPK (SB203580) significantly reduced the IL1 beta- induced IL-36 gamma mRNA expression. In addition, the siRNAs specific for NF-kappa B p65 andAP1 (c-Jun) significantly reduced the expression of IL-1 beta-induced IL-36 gamma mRNA. Conclusions Colonic myofibroblasts are cellular source of IL-36 gamma in the intestine. IL-36 gamma expression was induced by the combination of IL-1 beta and TNF-alpha via activation of MAPKs and transcription factors, NF-kappa B and AP-1.	[Takahashi, Kenichiro; Nishida, Atsushi; Shioya, Makoto; Imaeda, Hirotsugu; Bamba, Shigeki; Inatomi, Osamu; Kitoh, Katsuyuki; Andoh, Akira] Shiga Univ Med Sci, Dept Med, Otsu, Shiga 5202192, Japan; [Shimizu, Tomoharu] Shiga Univ Med Sci, Dept Surg, Otsu, Shiga 5202192, Japan	Shiga University of Medical Science; Shiga University of Medical Science	Nishida, A (corresponding author), Shiga Univ Med Sci, Dept Med, Otsu, Shiga 5202192, Japan.	astuda@belle.shiga-med.ac.jp	Andoh, Akira/AAB-9303-2022	Inatomi, Osamu/0000-0002-5837-6575; Bamba, Shigeki/0000-0002-4108-5894	Ministry of Education, Culture, Sports, Science and Technology of Japan [15K08967]; Ministry of Health, Labor and Welfare of Japan [067]; Japan Agency for Medical Research and development, AMED (The Japan Agency of Medical Research and Development) [15AeK0109047h0002]; Smoking Research Foundation [1848]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and development, AMED (The Japan Agency of Medical Research and Development)(Japan Agency for Medical Research and Development (AMED)); Smoking Research Foundation	This study was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (15K08967), a grant for the Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan (067), a grant from the Practical Research Project for Rare/Intractable Diseases from Japan Agency for Medical Research and development, AMED (The Japan Agency of Medical Research and Development) (15AeK0109047h0002), and a grant from Smoking Research Foundation (1848) (www.srf.or.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Bachmann M, 2012, J BIOL CHEM, V287, P41684, DOI 10.1074/jbc.M112.385443; Blumberg H, 2007, J EXP MED, V204, P2603, DOI 10.1084/jem.20070157; Blumberg H, 2010, J IMMUNOL, V185, P4354, DOI 10.4049/jimmunol.1000313; Carrier Y, 2011, J INVEST DERMATOL, V131, P2428, DOI 10.1038/jid.2011.234; Chustz RT, 2011, AM J RESP CELL MOL, V45, P145, DOI 10.1165/rcmb.2010-0075OC; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Dinarello C, 2010, NAT IMMUNOL, V11, P973, DOI 10.1038/ni1110-973; Epstein J, 2010, BRIT J NUTR, V103, P1545, DOI 10.1017/S0007114509993667; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Frey S, 2013, ANN RHEUM DIS, V72, P1569, DOI 10.1136/annrheumdis-2012-202264; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Goldsmith JR, 2014, J GASTROENTEROL, V49, P785, DOI 10.1007/s00535-014-0953-z; Gresnigt MS, 2013, EUR J IMMUNOL, V43, P416, DOI 10.1002/eji.201242711; Hata K, 2002, AM J PHYSIOL-GASTR L, V282, pG1035, DOI 10.1152/ajpgi.00494.2001; Imaeda H, 2014, J GASTROENTEROL, V49, P674, DOI 10.1007/s00535-013-0829-7; Kobori A, 2010, J GASTROENTEROL, V45, P999, DOI 10.1007/s00535-010-0245-1; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; Lin C. H., 2015, IMMUNOL RES; Magne D, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1946; Mahida YR, 1997, AM J PHYSIOL-GASTR L, V273, pG1341, DOI 10.1152/ajpgi.1997.273.6.G1341; Mayer L, 2010, J GASTROENTEROL, V45, P9, DOI 10.1007/s00535-009-0138-3; Mukai A, 2014, J GASTROENTEROL, V49, P1524, DOI 10.1007/s00535-013-0923-x; Mutamba S, 2012, EUR J IMMUNOL, V42, P607, DOI 10.1002/eji.201142035; Okuno T, 2002, SCAND J GASTROENTERO, V37, P317, DOI 10.1080/003655202317284228; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC1, DOI 10.1152/ajpcell.1999.277.1.C1; Ramadas RA, 2011, AM J RESP CELL MOL, V44, P134, DOI 10.1165/rcmb.2009-0315OC; Sheehan D, 2015, J GASTROENTEROL, V50, P495, DOI 10.1007/s00535-015-1064-1; Shimada M, 2002, J IMMUNOL, V168, P861, DOI 10.4049/jimmunol.168.2.861; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Smith DE, 2000, J BIOL CHEM, V275, P1169, DOI 10.1074/jbc.275.2.1169; Towne JE, 2004, J BIOL CHEM, V279, P13677, DOI 10.1074/jbc.M400117200; Towne JE, 2011, J BIOL CHEM, V286, P42594, DOI 10.1074/jbc.M111.267922; Tripodi D, 2012, J BIOL REG HOMEOS AG, V26, P7; Vigne S, 2012, BLOOD, V120, P3478, DOI 10.1182/blood-2012-06-439026	37	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0138423	10.1371/journal.pone.0138423	http://dx.doi.org/10.1371/journal.pone.0138423			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562662	Green Published, Green Submitted, gold			2022-12-26	WOS:000364480900001
J	Veeranagouda, Y; Rival, P; Prades, C; Mariet, C; Leonard, JF; Gautier, JC; Zhou, XB; Wang, JF; Li, B; Ozoux, ML; Boitier, E				Veeranagouda, Yaligara; Rival, Pierrick; Prades, Catherine; Mariet, Claire; Leonard, Jean-Francois; Gautier, Jean-Charles; Zhou, Xiaobing; Wang, Jufeng; Li, Bo; Ozoux, Marie-Laure; Boitier, Eric			Identification of microRNAs in Macaca fascicularis (Cynomolgus Monkey) by Homology Search and Experimental Validation by Small RNA-Seq and RT-qPCR Using Kidney Cortex Tissues	PLOS ONE			English	Article							CIRCULATING MICRORNAS; EXPRESSION; BIOMARKERS; EVOLUTION; MIRNA; GENERATION	MicroRNAs (miRNAs) present in tissues and biofluids are emerging as sensitive and specific safety biomarkers. MiRNAs have not been thoroughly described in M. fascicularis, an animal model used in pharmaceutical industry especially in drug safety evaluation. Here we investigated the miRNAs in M. fascicularis. For Macaca mulatta, a closely related species of M. fascicularis, 619 stem-loop precursor miRNAs (pre-miRNAs) and 914 mature miRNAs are available in miRBase version 21. Using M. mulatta miRNAs as a reference list and homology search tools, we identified 604 pre-miRNAs and 913 mature miRNAs in the genome of M. fascicularis. In order to validate the miRNAs identified by homology search we attempted to sequence miRNAs expressed in kidney cortex from M. fascicularis. MiRNAs expressed in kidney cortex may indeed be released in urine upon kidney cortex damage and be potentially used to monitor drug induced kidney injury. Hence small RNA sequencing libraries were prepared using kidney cortex tissues obtained from three naive M. fascicularis and sequenced. Analysis of sequencing data indicated that 432 out of 913 mature miRNAs were expressed in kidney cortex tissues. Assigning these 432 miRNAs to pre-miRNAs revealed that 273 were expressed from both the -5p and -3p arms of 150 pre-miRNAs and 159 miRNAs expressed from either the -5p or -3p arm of 176 pre-miRNAs. Mapping sequencing reads to pre-miRNAs also facilitated the detection of twenty-two new miRNAs. To substantiate miRNAs identified by small RNA sequencing, 313 miRNAs were examined by RT-qPCR. Expression of 262 miRNAs in kidney cortex tissues ware confirmed by TaqMan microRNA RT-qPCR assays. Analysis of kidney cortex miRNA targeted genes suggested that they play important role in kidney development and function. Data presented in this study may serve as a valuable resource to assess the renal safety biomarker potential of miRNAs in Cynomolgus monkeys.	[Veeranagouda, Yaligara; Mariet, Claire; Leonard, Jean-Francois; Gautier, Jean-Charles; Ozoux, Marie-Laure; Boitier, Eric] Disposit Safety & Anim Res, Sanofi R&D, Vitry Sur Seine, France; [Rival, Pierrick; Prades, Catherine] Global Biotherapeut, Sanofi R&D, Vitry Sur Seine, France; [Zhou, Xiaobing; Wang, Jufeng; Li, Bo] Natl Inst Food & Drug Control, NCSED, Beijing, Peoples R China	Sanofi-Aventis; Sanofi France; Sanofi-Aventis; Sanofi France; National Institute of Food & Drug Control - China	Veeranagouda, Y (corresponding author), Disposit Safety & Anim Res, Sanofi R&D, Vitry Sur Seine, France.	veereshagy@gmail.com		/0000-0001-7372-1528	Ministry of Science and Technology, People's Republic of China [2012ZX09302001, 2012ZX09505001-004]; Sanofi	Ministry of Science and Technology, People's Republic of China(Ministry of Science and Technology, China); Sanofi(Sanofi-Aventis)	This work was partially supported by the National Major Scientific and Technological Special Project for "Significant New Drugs Development" (No. 2012ZX09302001) and "Key Technological Study" (No. 2012ZX09505001-004) during the Twelfth Five-year Plan Period from the Ministry of Science and Technology, People's Republic of China. Sanofi provided support in the form of salaries for authors and research materials [VY, PR, CP, CM, JFL, JCG, MLO and EB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R, 2009, DEVELOPMENT, V136, P3927, DOI 10.1242/dev.037432; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Cheng L, 2014, KIDNEY INT, V86, P433, DOI 10.1038/ki.2013.502; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; Dannemann M, 2012, GENOME BIOL EVOL, V4, P552, DOI 10.1093/gbe/evs033; Ebeling M, 2011, GENOME RES, V21, P1746, DOI 10.1101/gr.123117.111; Griffiths-Jones S, 2011, EMBO REP, V12, P172, DOI 10.1038/embor.2010.191; Guo ZY, 2014, SCI REP-UK, V4, DOI 10.1038/srep05150; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hayes J, 2014, TRENDS MOL MED, V20, P460, DOI 10.1016/j.molmed.2014.06.005; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Higashino A, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r58; Ho J, 2008, J AM SOC NEPHROL, V19, P2069, DOI 10.1681/ASN.2008020162; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Kanki M, 2014, TOXICOLOGY, V324, P158, DOI 10.1016/j.tox.2014.05.004; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Li ZH, 2014, NAT REV DRUG DISCOV, V13, P622, DOI 10.1038/nrd4359; Liang H, 2009, MOL BIOL EVOL, V26, P1195, DOI 10.1093/molbev/msp053; Meunier J, 2013, GENOME RES, V23, P34, DOI 10.1101/gr.140269.112; Mikaelian I, 2013, TOXICOL PATHOL, V41, P18, DOI 10.1177/0192623312448939; Nassirpour R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-485; Osada N, 2015, GENOME BIOL EVOL, V7, P821, DOI 10.1093/gbe/evv033; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rogers J, 2014, NAT REV GENET, V15, P347, DOI 10.1038/nrg3707; Saikumar J, 2012, TOXICOL SCI, V129, P256, DOI 10.1093/toxsci/kfs210; Sun YQ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh186; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Yan GM, 2011, NAT BIOTECHNOL, V29, P1019, DOI 10.1038/nbt.1992; Yang H, 2014, GENE, V536, P308, DOI 10.1016/j.gene.2013.12.006; Yang H, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/957607; Yue JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-8; Zeng L, 2014, AUTOIMMUNITY, V47, P419, DOI 10.3109/08916934.2014.929667	34	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142708	10.1371/journal.pone.0142708	http://dx.doi.org/10.1371/journal.pone.0142708			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562842	Green Published, Green Submitted, gold			2022-12-26	WOS:000364480900057
J	Climie, RED; Moran, C; Callisaya, M; Blizzard, L; Sharman, JE; Venn, A; Phan, TG; Beare, R; Forbes, J; Blackburn, NB; Srikanth, V				Climie, Rachel E. D.; Moran, Chris; Callisaya, Michele; Blizzard, Leigh; Sharman, James E.; Venn, Alison; Phan, Thanh G.; Beare, Richard; Forbes, Josephine; Blackburn, Nicholas B.; Srikanth, Velandai			Abdominal Obesity and Brain Atrophy in Type 2 Diabetes Mellitus	PLOS ONE			English	Article							COGNITIVE FUNCTION; PHYSICAL-ACTIVITY; HIPPOCAMPAL NEUROGENESIS; INSULIN-RESISTANCE; VISCERAL FAT; VOLUME; ADIPOSITY; PROTEIN	Aim Type 2 diabetes mellitus (T2D) is associated with gray matter atrophy. Adiposity and physical inactivity are risk factors for T2D and brain atrophy. We studied whether the associations of T2D with total gray matter volume (GMV) and hippocampal volume (HV) are dependent on obesity and physical activity. Materials and Methods In this cross-sectional study, we measured waist-hip ratio (WHR), body mass index (BMI), mean steps/day and brain volumes in a community dwelling cohort of people with and without T2D. Using multivariable linear regression, we examined whether WHR, BMI and physical activity mediated or modified the association between T2D, GMV and HV. Results There were 258 participants with (mean age 67 +/- 7 years) and 302 without (mean age 72 +/- 7 years) T2D. Adjusting for age, sex and intracranial volume, T2D was independently associated with lower total GMV (p = 0.001) and HV (p < 0.001), greater WHR (p < 0.001) and BMI (p < 0.001), and lower mean steps/day (p = 0.002). After adjusting for covariates, the inclusion of BMI and mean steps/day did not significantly affect the T2D-GMV association, but WHR attenuated it by 32% while remaining independently associated with lower GMV (p < 0.01). The T2D-HV association was minimally changed by the addition of BMI, steps/day or WHR in the model. No statistical interactions were observed between T2D and measures of obesity and physical activity in explaining brain volumes. Conclusions Abdominal obesity or its downstream effects may partially mediate the adverse effect of T2D on brain atrophy. This requires confirmation in longitudinal studies.	[Climie, Rachel E. D.; Callisaya, Michele; Blizzard, Leigh; Sharman, James E.; Venn, Alison; Blackburn, Nicholas B.; Srikanth, Velandai] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia; [Moran, Chris; Callisaya, Michele; Phan, Thanh G.; Beare, Richard; Srikanth, Velandai] Monash Univ, Monash Med Ctr, Stroke & Ageing Res Grp, Clayton, Vic, Australia; [Moran, Chris] Alfred Hlth, Caulfield Gen Med Ctr, Aged Care, Melbourne, Vic, Australia; [Beare, Richard] Murdoch Childrens Res Inst, Dev Imaging, Melbourne, Vic, Australia; [Forbes, Josephine] Univ Queensland, Mater Res Inst, TRI, Brisbane, Qld, Australia	University of Tasmania; Menzies Institute for Medical Research; Monash University; Murdoch Children's Research Institute; Mater Research; University of Queensland	Srikanth, V (corresponding author), Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia.	velandai.srikanth@monash.edu	Blackburn, Nicholas B./GLQ-6342-2022; Sharman, James/B-2755-2009; Venn, Alison J/J-2803-2013; Forbes, Josephine M/A-4569-2012; Callisaya, Michele/I-2333-2013; Blackburn, Nicholas B./G-5114-2014	Blackburn, Nicholas B./0000-0002-9774-1539; Sharman, James/0000-0003-2792-0811; Forbes, Josephine M/0000-0002-5595-8174; Callisaya, Michele/0000-0003-2122-1622; Blackburn, Nicholas B./0000-0002-9774-1539; Moran, Chris/0000-0003-1872-3314; Srikanth, Velandai/0000-0002-8442-8981; Beare, Richard/0000-0002-7530-5664; Climie, Rachel/0000-0002-7960-360X	National Health and Medical Research Council (NHMRC), Australia [403000, 436797]	National Health and Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by the National Health and Medical Research Council (NHMRC) (Project grant 403000 & 436797), Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alosco ML, 2014, AM J SURG, V207, P870, DOI 10.1016/j.amjsurg.2013.05.018; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Brooks SJ, 2013, INT J OBESITY, V37, P230, DOI 10.1038/ijo.2012.13; Bruehl H, 2009, BRAIN RES, V1280, P186, DOI 10.1016/j.brainres.2009.05.032; Carnell S, 2012, OBES REV, V13, P43, DOI 10.1111/j.1467-789X.2011.00927.x; Chaston TB, 2008, INT J OBESITY, V32, P619, DOI 10.1038/sj.ijo.0803761; Cleland VJ, 2011, J SCI MED SPORT, V14, P496, DOI 10.1016/j.jsams.2011.04.006; Climie RED, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0143-6; Colcombe S, 2006, J GERONTOL A-BIOL, V61A, P166; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; Debette S, 2013, NEUROBIOL AGING, P1; Debette S, 2010, ANN NEUROL, V68, P136, DOI 10.1002/ana.22062; Dore GA, 2008, ANN BEHAV MED, V35, P341, DOI 10.1007/s12160-008-9038-7; Driscoll I, 2012, HUM BRAIN MAPP, V33, P2204, DOI 10.1002/hbm.21353; Erickson KI, 2010, NEUROLOGY, V75, P1415, DOI 10.1212/WNL.0b013e3181f88359; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Gons RAR, 2013, NEUROLOGY, V81, P971, DOI 10.1212/WNL.0b013e3182a43e33; Gunstad J, 2008, INT J NEUROSCI, V118, P1582, DOI 10.1080/00207450701392282; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Jagust W, 2005, ARCH NEUROL-CHICAGO, V62, P1545, DOI 10.1001/archneur.62.10.1545; Jennersjo P, 2012, DIABETIC MED, V29, P1119, DOI 10.1111/j.1464-5491.2012.03621.x; Karlsson HK, 2013, OBESITY, V21, P2530, DOI 10.1002/oby.20386; Lindstrom J, 2003, DIABETES CARE, V26, P3230, DOI 10.2337/diacare.26.12.3230; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Jorge MLMP, 2011, METABOLISM, V60, P1244, DOI 10.1016/j.metabol.2011.01.006; Moran C, 2015, DIABETES, V64, P279, DOI 10.2337/db14-0506; Moran C, 2013, DIABETES CARE, V36, P4036, DOI 10.2337/dc13-0143; Pasquali R, 2000, J CLIN ENDOCR METAB, V85, P2767, DOI 10.1210/jc.85.8.2767; Razay G, 2006, DEMENT GERIATR COGN, V22, P173, DOI 10.1159/000094586; Sato N, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00143; Speisman RB, 2013, BRAIN BEHAV IMMUN, V28, P25, DOI 10.1016/j.bbi.2012.09.013; Suridjan I, 2014, NEUROIMAGE, V84, P868, DOI 10.1016/j.neuroimage.2013.09.021; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Tudor-Locke CE, 2001, SPORTS MED, V31, P91, DOI 10.2165/00007256-200131020-00002; van Harten B, 2006, DIABETES CARE, V29, P2539, DOI 10.2337/dc06-1637; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; Veit R, 2014, NEUROIMAGE-CLIN, V6, P307, DOI 10.1016/j.nicl.2014.09.013; Waldstein SR, 2008, HYPERTENSION, V51, P99, DOI 10.1161/HYPERTENSIONAHA.107.093674; Windham BG, 2010, AM J HYPERTENS, V23, P501, DOI 10.1038/ajh.2010.8; Wolf PA, 2007, CURR ALZHEIMER RES, V4, P111, DOI 10.2174/156720507780362263; Wrench JM, 2009, J NEUROL NEUROSUR PS, V80, P539, DOI 10.1136/jnnp.2008.152165; Yarchoan M, 2014, ACTA NEUROPATHOL BER, P1; Yarchoan M, 2014, DIABETES, V63, P2253, DOI 10.2337/db14-0287; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5	46	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142589	10.1371/journal.pone.0142589	http://dx.doi.org/10.1371/journal.pone.0142589			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560876	Green Published, gold, Green Submitted			2022-12-26	WOS:000364433100094
J	Dekeyster, E; Geeraerts, E; Buyens, T; Van den Haute, C; Baekelandt, V; De Groef, L; Salinas-Navarro, M; Moons, L				Dekeyster, Eline; Geeraerts, Emiel; Buyens, Tom; Van den Haute, Chris; Baekelandt, Veerle; De Groef, Lies; Salinas-Navarro, Manuel; Moons, Lieve			Tackling Glaucoma from within the Brain: An Unfortunate Interplay of BDNF and TrkB	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; INDUCED OCULAR HYPERTENSION; OPTIC-NERVE INJURY; ALBINO SWISS MICE; NEUROTROPHIC FACTOR; INTRAOCULAR-PRESSURE; AXONAL-TRANSPORT; ADULT ALBINO; COMPUTERIZED ANALYSIS; SPATIAL-DISTRIBUTION	According to the neurotrophin deprivation hypothesis, diminished retrograde delivery of neurotrophic support during an early stage of glaucoma pathogenesis is one of the main triggers that induce retinal ganglion cell (RGC) degeneration. Therefore, interfering with neurotrophic signaling seems an attractive strategy to achieve neuroprotection. Indeed, exogenous neurotrophin administration to the eye has been shown to reduce loss of RGCs in animal models of glaucoma; however, the neuroprotective effect was mostly insufficient for sustained RGC survival. We hypothesized that treatment at the level of neurotrophinreleasing brain areas might be beneficial, as signaling pathways activated by target-derived neurotrophins are suggested to differ from pathways that are initiated at the soma membrane. In our study, first, the spatiotemporal course of RGC degeneration was characterized in mice subjected to optic nerve crush (ONC) or laser induced ocular hypertension (OHT). Subsequently, the well-known neurotrophin brain-derived neurotrophic factor (BDNF) was chosen as the lead molecule, and the levels of BDNF and its high-affinity receptor, tropomyosin receptor kinase B (TrkB), were examined in the mouse retina and superior colliculus (SC) upon ONC and OHT. Both models differentially influenced BDNF and TrkB levels. Next, we aimed for RGC protection through viral vector-mediated upregulation of collicular BDNF, thought to boost the retrograde neurotrophin delivery. Although the previously reported temporary neuroprotective effect of intravitreally delivered recombinant BDNF was confirmed, viral vector-induced BDNF overexpression in the SC did not result in protection of the RGCs in the glaucoma models used. These findings most likely relate to decreased neurotrophin responsiveness upon vector-mediated BDNF overexpression. Our results highlight important insights concerning the complexity of neurotrophic factor treatments that should surely be considered in future neuroprotective strategies.	[Dekeyster, Eline; Geeraerts, Emiel; Buyens, Tom; De Groef, Lies; Salinas-Navarro, Manuel; Moons, Lieve] Katholieke Univ Leuven, Dept Biol, Neural Circuit Dev & Regenerat Res Grp, Leuven, Belgium; [Van den Haute, Chris; Baekelandt, Veerle] Katholieke Univ Leuven, Dept Neurosci, Neurobiol & Gene Therapy Res Grp, Leuven, Belgium; [Van den Haute, Chris] Katholieke Univ Leuven, Leuven Viral Vector Core, Leuven, Belgium	KU Leuven; KU Leuven; KU Leuven	Moons, L (corresponding author), Katholieke Univ Leuven, Dept Biol, Neural Circuit Dev & Regenerat Res Grp, Leuven, Belgium.	lieve.moons@bio.kuleuven.be	Baekelandt, Veerle/ABB-9736-2020; De Groef, Lies/K-3296-2015	Baekelandt, Veerle/0000-0001-8966-2921; De Groef, Lies/0000-0002-3329-3474; Moons, Lieve (Godelieve)/0000-0003-0186-1411	Research Foundation Flanders (FWO); Flemisch Institute for the Promotion of Scientific Research (IWT) [110086]; Belgian Fonds for Research in Ophtalmology (FRO)	Research Foundation Flanders (FWO)(FWO); Flemisch Institute for the Promotion of Scientific Research (IWT); Belgian Fonds for Research in Ophtalmology (FRO)	Eline Dekeyster is supported by a Ph.D. fellowship of the Research Foundation Flanders (FWO). This study was also supported by the Flemisch Institute for the Promotion of Scientific Research (IWT) [SBO Optobrain 110086], and the Belgian Fonds for Research in Ophtalmology (FRO).	Agarwal N, 2007, MOL VIS, V13, P1311; Almasieh M, 2012, PROG RETIN EYE RES, V31, P152, DOI 10.1016/j.preteyeres.2011.11.002; Aschauer DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076310; Baekelandt V, 2003, GENE THER, V10, P1933, DOI 10.1038/sj.gt.3302094; Buyens T, 2014, METHODS MOL BIOL, V1162, P57, DOI 10.1007/978-1-4939-0777-9_5; Chen H, 2004, BRAIN RES, V1011, P99, DOI 10.1016/j.brainres.2004.03.024; Cheng L, 2002, J NEUROSCI, V22, P3977, DOI 10.1523/JNEUROSCI.22-10-03977.2002; Chowdary PD, 2012, ANNU REV PHYS CHEM, V63, P571, DOI 10.1146/annurev-physchem-032511-143704; Cosker KE, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a020669; Crish SD, 2013, NEUROSCIENCE, V229, P55, DOI 10.1016/j.neuroscience.2012.10.069; Cuenca N, 2010, EXP EYE RES, V91, P273, DOI 10.1016/j.exer.2010.05.020; Dekeyster E, 2015, CURR EYE RES, V23, P1; Domenici L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115579; Fayard B, 2005, J NEUROSCI RES, V80, P18, DOI 10.1002/jnr.20432; Fenner BM, 2012, CYTOKINE GROWTH F R, V23, P15, DOI 10.1016/j.cytogfr.2012.01.002; Friesema ECH, 2006, MOL ENDOCRINOL, V20, P2761, DOI 10.1210/me.2005-0256; Fu CT, 2010, INVEST OPHTH VIS SCI, V51, P980, DOI 10.1167/iovs.09-4324; Galindo-Romero C, 2011, EXP EYE RES, V92, P377, DOI 10.1016/j.exer.2011.02.008; Galindo-Romero C, 2013, INVEST OPHTH VIS SCI, V54, P974, DOI 10.1167/iovs.12-11207; Gao GP, 2005, CURR GENE THER, V5, P285, DOI 10.2174/1566523054065057; Gao H, 1997, INVEST OPHTH VIS SCI, V38, P1840; Garcia M, 2003, INVEST OPHTH VIS SCI, V44, P4532, DOI 10.1167/iovs.03-0419; Gaublomme D, 2013, J BIOMOL SCREEN, V18, P534, DOI 10.1177/1087057112471989; Guo Y, 2009, EXP EYE RES, V89, P921, DOI 10.1016/j.exer.2009.08.003; Gupta V, 2014, BBA-MOL BASIS DIS, V1842, P1567, DOI 10.1016/j.bbadis.2014.05.026; Harada C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1190; Harada T, 2002, J NEUROSCI, V22, P9228, DOI 10.1523/jneurosci.22-21-09228.2002; HOFBAUER A, 1985, J COMP NEUROL, V234, P465, DOI 10.1002/cne.902340405; Ito Y, 2008, BRAIN RES, V1212, P89, DOI 10.1016/j.brainres.2008.03.021; Jakobs TC, 2005, J CELL BIOL, V171, P313, DOI 10.1083/jcb.200506099; Johnson EC, 2000, INVEST OPHTH VIS SCI, V41, P431; Johnson EC, 2009, EXP EYE RES, V88, P808, DOI 10.1016/j.exer.2009.02.004; Johnson TV, 2011, EXP EYE RES, V93, P196, DOI 10.1016/j.exer.2010.05.016; Johnson TV, 2010, BRAIN RES BULL, V81, P349, DOI 10.1016/j.brainresbull.2009.04.004; Kalb R, 2005, TRENDS NEUROSCI, V28, P5, DOI 10.1016/j.tins.2004.11.003; Kim HS, 2007, VISUAL NEUROSCI, V24, P127, DOI 10.1017/S0952523807070150; Ko ML, 2001, NEUROSCI LETT, V305, P139, DOI 10.1016/S0304-3940(01)01830-4; Lei Y, 2009, BRIT J OPHTHALMOL, V93, P1676, DOI 10.1136/bjo.2009.159210; Li Y, 1999, INVEST OPHTH VIS SCI, V40, P1004; Lindqvist N, 2010, UPSALA J MED SCI, V115, P65, DOI 10.3109/03009731003597119; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; MANSOURROBAEY S, 1994, P NATL ACAD SCI USA, V91, P1632, DOI 10.1073/pnas.91.5.1632; Martin KRG, 2003, INVEST OPHTH VIS SCI, V44, P4357, DOI 10.1167/iovs.02-1332; Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Nickells RW, 2007, CAN J OPHTHALMOL, V42, P278, DOI 10.3129/canjophthalmol.i07-036; Parrilla-Reverter G, 2009, VISION RES, V49, P2808, DOI 10.1016/j.visres.2009.08.020; Parrilla-Reverter G, 2009, EXP EYE RES, V89, P32, DOI 10.1016/j.exer.2009.02.015; Pease ME, 2000, INVEST OPHTH VIS SCI, V41, P764; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; QUIGLEY HA, 1980, INVEST OPHTH VIS SCI, V19, P137; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Ren RT, 2012, INVEST OPHTH VIS SCI, V53, P1003, DOI 10.1167/iovs.11-8484; Rudzinski M, 2004, J NEUROBIOL, V58, P341, DOI 10.1002/neu.10293; Salinas-Navarro M, 2009, VISION RES, V49, P637, DOI 10.1016/j.visres.2009.01.010; Salinas-Navarro M, 2009, VISION RES, V49, P115, DOI 10.1016/j.visres.2008.09.029; Salinas-Navarro M, 2009, MOL VIS, V15, P2578; Scheyltjens I, 2015, J COMP NEUROL, DOI [10.1002/cne.23878, DOI 10.1002/CNE.23878]; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schlamp CL, 2013, MOL VIS, V19, P1387; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; Sharma TP, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-14; Tanaka H, 2009, MOL VIS, V15, P662; Tang AD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126949; Taylor S, 2003, MOL BRAIN RES, V111, P189, DOI 10.1016/S0169-328X(03)00030-5; Taymans JM, 2007, HUM GENE THER, V18, P195, DOI 10.1089/hum.2006.178; Templeton JP, 2012, MOL VIS, V18, P2147; Valiente-Soriano FJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121134; Valiente-Soriano FJ, 2015, INVEST OPHTH VIS SCI, V56, P1924, DOI 10.1167/iovs.15-16454; Van der Perren A, 2011, GENE THER, V18, P517, DOI 10.1038/gt.2010.179; Vandenberghe LH, 2012, GENE THER, V19, P162, DOI 10.1038/gt.2011.151; Vidal-Sanz M, 2012, PROG RETIN EYE RES, V31, P1, DOI 10.1016/j.preteyeres.2011.08.001; Weber AJ, 2013, INVEST OPHTH VIS SCI, V54, P6594, DOI 10.1167/iovs.13-12683; Weber AJ, 2010, INVEST OPHTH VIS SCI, V51, P327, DOI 10.1167/iovs.09-3740	74	33	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142067	10.1371/journal.pone.0142067	http://dx.doi.org/10.1371/journal.pone.0142067			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560713	Green Published, gold, Green Submitted			2022-12-26	WOS:000364433100053
J	Kim, KH; Liu, JG; Galvin, RJS; Dage, JL; Egeland, JA; Smith, RC; Merchant, KM; Paul, SM				Kim, Kwi Hye; Liu, Jiangang; Galvin, Rachelle J. Sells; Dage, Jeffrey L.; Egeland, Janice A.; Smith, Rosamund C.; Merchant, Kalpana M.; Paul, Steven M.			Transcriptomic Analysis of Induced Pluripotent Stem Cells Derived from Patients with Bipolar Disorder from an Old Order Amish Pedigree	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; GENOME-WIDE ASSOCIATION; GENE-EXPRESSION; RISK-FACTORS; IPS CELLS; SUICIDE; LITHIUM; IDENTIFICATION; PATHWAYS; TYROSINE	Fibroblasts from patients with Type I bipolar disorder (BPD) and their unaffected siblings were obtained from an Old Order Amish pedigree with a high incidence of BPD and reprogrammed to induced pluripotent stem cells (iPSCs). Established iPSCs were subsequently differentiated into neuroprogenitors (NPs) and then to neurons. Transcriptomic microarray analysis was conducted on RNA samples from iPSCs, NPs and neurons matured in culture for either 2 weeks (termed early neurons, E) or 4 weeks (termed late neurons, L). Global RNA profiling indicated that BPD and control iPSCs differentiated into NPs and neurons at a similar rate, enabling studies of differentially expressed genes in neurons from controls and BPD cases. Significant disease-associated differences in gene expression were observed only in L neurons. Specifically, 328 genes were differentially expressed between BPD and control L neurons including GAD1, glutamate decarboxylase 1 (2.5 fold) and SCN4B, the voltage gated type IV sodium channel beta subunit (-14.6 fold). Quantitative RT-PCR confirmed the up-regulation of GAD1 in BPD compared to control L neurons. Gene Ontology, GeneGo and Ingenuity Pathway Analysis of differentially regulated genes in L neurons suggest that alterations in RNA biosynthesis and metabolism, protein trafficking as well as receptor signaling pathways may play an important role in the pathophysiology of BPD.	[Kim, Kwi Hye; Liu, Jiangang; Galvin, Rachelle J. Sells; Dage, Jeffrey L.; Smith, Rosamund C.; Merchant, Kalpana M.] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; [Egeland, Janice A.] Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Miami, FL 33136 USA; [Paul, Steven M.] Weill Cornell Med Coll, Mind & Brain Inst, New York, NY USA	Eli Lilly; University of Miami; Cornell University	Smith, RC (corresponding author), Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA.	smith_rosamund_c@lilly.com	Paul, Steve/ABE-5400-2020	Dage, Jeffrey/0000-0002-2192-1699	Eli Lilly and Company	Eli Lilly and Company(Eli Lilly)	Eli Lilly and Company fully funded this project. The funder provided support in the form of salaries for authors [KHK, JL, RJSG, JLD, RCS, KMM, SMP], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Akbarian S, 2006, BRAIN RES REV, V52, P293, DOI 10.1016/j.brainresrev.2006.04.001; Altar CA, 2009, NEUROPSYCHOPHARMACOL, V34, P18, DOI 10.1038/npp.2008.172; Bavamian S, 2015, MOL PSYCHIATR, V20, P573, DOI 10.1038/mp.2014.176; BEDDINGTON RSP, 1992, CIBA F SYMP, V165, P61; Benedetti F, 2005, NEUROSCI LETT, V376, P51, DOI 10.1016/j.neulet.2004.11.022; Brennand K, MOL PSYCHIAT, V20, P361; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Breunig JJ, 2008, P NATL ACAD SCI USA, V105, P13127, DOI 10.1073/pnas.0804558105; Cassidy F, 2011, SUICIDE LIFE-THREAT, V41, P6, DOI 10.1111/j.1943-278X.2010.00007.x; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chen B, 2008, P NATL ACAD SCI USA, V105, P11382, DOI 10.1073/pnas.0804918105; Chen HM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.12; Chen HM, 2013, BIPOLAR DISORD, V15, P177, DOI 10.1111/bdi.12039; Chung CY, 2013, SCIENCE, V342, P983, DOI 10.1126/science.1245296; Connolly KR, 2011, PRIMARY CARE COMPANI, V13; Conti L, 2010, NAT REV NEUROSCI, V11, P176, DOI 10.1038/nrn2761; Cooper O, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003985; Craddock N, 2013, LANCET, V381, P1654, DOI 10.1016/S0140-6736(13)60855-7; Dage JL, 2014, PSYCHOPHARMACOLOGY, V231, P1105, DOI 10.1007/s00213-013-3384-2; EGELAND JA, 1984, AM J PSYCHIAT, V141, P1049; EGELAND JA, 1987, NATURE, V325, P783, DOI 10.1038/325783a0; Egeland JA, 1994, GENETIC STUDIES AFFE, P70; Egeland Janice A., 1990, Psychiatric Genetics, V1, P5; Elashoff M, 2007, J MOL NEUROSCI, V31, P221, DOI 10.1385/JMN/31:03:221; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Fiorentino A, 2014, BIPOLAR DISORD, V16, P583, DOI 10.1111/bdi.12203; Georgi B, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004229; Ginns E.L., 2014, MOL PSYCHIATR, P1; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Guillozet-Bongaarts AL, 2014, MOL PSYCHIATR, V19, P478, DOI 10.1038/mp.2013.30; Hauser M, 2013, BIPOLAR DISORD, V15, P507, DOI 10.1111/bdi.12094; Hostetler JA, 1993, AMISH SOC, Vxi, P322; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; Katsetos CD, 2003, CELL MOTIL CYTOSKEL, V55, P77, DOI 10.1002/cm.10116; Kerner B, 2014, APPL CLIN GENET, V7, P33, DOI 10.2147/TACG.S39297; Kiskinis E, 2014, CELL STEM CELL, V14, P781, DOI 10.1016/j.stem.2014.03.004; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Konradi C, 2004, ARCH GEN PSYCHIAT, V61, P300, DOI 10.1001/archpsyc.61.3.300; Kwon GS, 2008, DEV CELL, V15, P509, DOI 10.1016/j.devcel.2008.07.017; MACCIONI RB, 1995, PHYSIOL REV, V75, P835, DOI 10.1152/physrev.1995.75.4.835; Madison JM, 2015, MOL PSYCHIATR, V20, P703, DOI 10.1038/mp.2015.7; Manuel MN, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-9; Muhleisen TW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4339; Odawara A, 2014, BIOCHEM BIOPH RES CO, V443, P1176, DOI 10.1016/j.bbrc.2013.12.142; Ogden CA, 2004, MOL PSYCHIATR, V9, P1007, DOI 10.1038/sj.mp.4001547; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Patino GA, 2010, NEUROSCI LETT, V486, P53, DOI 10.1016/j.neulet.2010.06.050; PAULS DL, 1992, ARCH GEN PSYCHIAT, V49, P703; Post RM, 2010, J CLIN PSYCHIAT, V71, P864, DOI 10.4088/JCP.08m04994yel; Rallu M, 2002, DEVELOPMENT, V129, P4963; Ramaswami M, 2013, CELL, V154, P727, DOI 10.1016/j.cell.2013.07.038; Ryan MM, 2006, MOL PSYCHIATR, V11, P965, DOI 10.1038/sj.mp.4001875; Schlaeger TM, 2015, NAT BIOTECHNOL, V33, P58, DOI 10.1038/nbt.3070; Schubert KO, 2012, MOL PSYCHIATR, V17, P669, DOI 10.1038/mp.2011.123; Sibille E, 2004, NEUROPSYCHOPHARMACOL, V29, P351, DOI 10.1038/sj.npp.1300335; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vitale AM, 2012, STEM CELL TRANSL MED, V1, P641, DOI 10.5966/sctm.2012-0043; WANG QM, 1994, J BIOL CHEM, V269, P14566	61	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142693	10.1371/journal.pone.0142693	http://dx.doi.org/10.1371/journal.pone.0142693			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554713	Green Submitted, Green Published, gold			2022-12-26	WOS:000364430700156
J	Xie, T; Musteanu, M; Lopez-Casas, PP; Shields, DJ; Olson, P; Rejto, PA; Hidalgo, M				Xie, Tao; Musteanu, Monica; Lopez-Casas, Pedro P.; Shields, David J.; Olson, Peter; Rejto, Paul A.; Hidalgo, Manuel			Whole Exome Sequencing of Rapid Autopsy Tumors and Xenograft Models Reveals Possible Driver Mutations Underlying Tumor Progression	PLOS ONE			English	Article							PANCREATIC DUCTAL ADENOCARCINOMA; ULTRACONSERVED ELEMENTS; SOMATIC ALTERATIONS; CANCER METASTASIS; MOUSE MODELS; GENOMES; PATTERNS; PATIENT; MUCINS; HETEROGENEITY	Pancreatic Ductal Adenocarcinoma (PDAC) is a highly lethal malignancy due to its propensity to invade and rapidly metastasize and remains very difficult to manage clinically. One major hindrance towards a better understanding of PDAC is the lack of molecular data sets and models representative of end stage disease. Moreover, it remains unclear how molecularly similar patient-derived xenograft (PDX) models are to the primary tumor from which they were derived. To identify potential molecular drivers in metastatic pancreatic cancer progression, we obtained matched primary tumor, metastases and normal (peripheral blood) samples under a rapid autopsy program and performed whole exome sequencing (WES) on tumor as well as normal samples. PDX models were also generated, sequenced and compared to tumors. Across the matched data sets generated for three patients, there were on average approximately 160 single-nucleotide mutations in each sample. The majority of mutations in each patient were shared among the primary and metastatic samples and, importantly, were largely retained in the xenograft models. Based on the mutation prevalence in the primary and metastatic sites, we proposed possible clonal evolution patterns marked by functional mutations affecting cancer genes such as KRAS, TP53 and SMAD4 that may play an important role in tumor initiation, progression and metastasis. These results add to our understanding of pancreatic tumor biology, and demonstrate that PDX models derived from advanced or end-stage likely closely approximate the genetics of the disease in the clinic and thus represent a biologically and clinically relevant pre-clinical platform that may enable the development of effective targeted therapies for PDAC.	[Xie, Tao; Shields, David J.; Olson, Peter; Rejto, Paul A.] Pfizer Worldwide Res & Dev, Oncol Res, San Diego, CA USA; [Musteanu, Monica; Lopez-Casas, Pedro P.; Hidalgo, Manuel] CNIO Spanish Natl Canc Res Ctr, E-28029 Madrid, Spain	Pfizer	Xie, T (corresponding author), Pfizer Worldwide Res & Dev, Oncol Res, San Diego, CA USA.	tao.xie@pfizer.com; mhidalgo@cnio.es	Rejto, Paul/M-4782-2019; Musteanu, Monica/R-5252-2018; Lopez-Casas, Pedro P./AAF-4146-2019; Lopez-Casas, Pedro P/S-8547-2017	Musteanu, Monica/0000-0002-1753-3765; Lopez-Casas, Pedro P./0000-0001-9866-7361; 	Pfizer Inc.	Pfizer Inc.(Pfizer)	This research was funded by Pfizer Inc. The funder provided support in the form of salaries for authors TX, DJS, PO, and PAR and/or research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio S, 2015, NAT REV CANCER, V15, P311, DOI 10.1038/nrc3944; Azzoni C, 2006, VIRCHOWS ARCH, V448, P119, DOI 10.1007/s00428-005-0058-4; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chen SH, 2013, SCI REP-UK, V3, DOI 10.1038/srep01870; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Conway T, 2012, BIOINFORMATICS, V28, pI172, DOI 10.1093/bioinformatics/bts236; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Eirew P, 2015, NATURE, V518, P422, DOI 10.1038/nature13952; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gu Q, 2015, ONCOTARGET, DOI 10.18632/oncotarget.3969; Haridas D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026839; He YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079769; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hidalgo M, 2012, CLIN CANCER RES, V18, P4249, DOI 10.1158/1078-0432.CCR-12-1327; Hirbe AC, 2015, CLIN CANCER RES, V21, P4201, DOI 10.1158/1078-0432.CCR-14-3049; Inaba T, 2003, P NATL ACAD SCI USA, V100, P2736, DOI 10.1073/pnas.0435410100; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jones FS, 2000, DEV DYNAM, V218, P235, DOI 10.1002/(SICI)1097-0177(200006)218:2<235::AID-DVDY2>3.3.CO;2-7; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kaur S, 2013, NAT REV GASTRO HEPAT, V10, P607, DOI 10.1038/nrgastro.2013.120; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Majumder B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7169; Mardis ER, 2012, NAT REV GASTRO HEPAT, V9, P477, DOI 10.1038/nrgastro.2012.126; Moniaux N, 2004, BRIT J CANCER, V91, P1633, DOI 10.1038/sj.bjc.6602163; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Rossello FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074432; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Setlur SR, 2012, CELL, V149, P959, DOI 10.1016/j.cell.2012.05.010; Shimizu A, 2012, CANCER SCI, V103, P739, DOI 10.1111/j.1349-7006.2012.02214.x; Siolas D, 2013, CANCER RES, V73, P5315, DOI 10.1158/0008-5472.CAN-13-1069; Smith BT, 2014, SYST BIOL, V63, P83, DOI 10.1093/sysbio/syt061; Vignot S, 2013, J CLIN ONCOL, V31, P2167, DOI 10.1200/JCO.2012.47.7737; Von Hoff DD, 2011, J CLIN ONCOL, V29, P4548, DOI 10.1200/JCO.2011.36.5742; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Winter JM, 2006, J GASTROINTEST SURG, V10, P1199, DOI 10.1016/j.gassur.2006.08.018; Xie T, 2014, GENOMICS, V104, P234, DOI 10.1016/j.ygeno.2014.07.012; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	46	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142631	10.1371/journal.pone.0142631	http://dx.doi.org/10.1371/journal.pone.0142631			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555578	gold, Green Submitted, Green Published			2022-12-26	WOS:000364430700144
J	Boloori, A; Saghafian, S; Chakkera, HA; Cook, CB				Boloori, Alireza; Saghafian, Soroush; Chakkera, Harini A.; Cook, Curtiss B.			Characterization of Remitting and Relapsing Hyperglycemia in Post-Renal-Transplant Recipients	PLOS ONE			English	Article							POSTTRANSPLANT DIABETES-MELLITUS; COMPARING CYCLOSPORINE MICROEMULSION; HEPATITIS-C INFECTION; NEW-ONSET; RISK-FACTORS; METABOLIC SYNDROME; LIVER-TRANSPLANTATION; KIDNEY-TRANSPLANTATION; GLUCOSE-METABOLISM; SINGLE-CENTER	Background Hyperglycemia following solid organ transplant is common among patients without preexisting diabetes mellitus (DM). Post-transplant hyperglycemia can occur once or multiple times, which if continued, causes new-onset diabetes after transplantation (NODAT). Objective To study if the first and recurrent incidence of hyperglycemia are affected differently by immunosuppressive regimens, demographic and medical-related risk factors, and inpatient hyperglycemic conditions (i.e., an emphasis on the time course of post-transplant complications). Methods We conducted a retrospective analysis of 407 patients who underwent kidney transplantation at Mayo Clinic Arizona. Among these, there were 292 patients with no signs of DM prior to transplant. For this category of patients, we evaluated the impact of (1) immunosuppressive drugs (e.g., tacrolimus, sirolimus, and steroid), (2) demographic and medical-related risk factors, and (3) inpatient hyperglycemic conditions on the first and recurrent incidence of hyperglycemia in one year post-transplant. We employed two versions of Cox regression analyses: (1) a time-dependent model to analyze the recurrent cases of hyperglycemia and (2) a time-independent model to analyze the first incidence of hyperglycemia. Results Age (P = 0.018), HDL cholesterol (P = 0.010), and the average trough level of tacrolimus (P< 0.0001) are significant risk factors associated with the first incidence of hyperglycemia, while age (P< 0.0001), non-White race (P = 0.002), BMI (P = 0.002), HDL cholesterol (P = 0.003), uric acid (P = 0.012), and using steroid (P = 0.007) are the significant risk factors for the recurrent cases of hyperglycemia. Discussion This study draws attention to the importance of analyzing the risk factors associated with a disease (specially a chronic one) with respect to both its first and recurrent incidence, as well as carefully differentiating these two perspectives: a fact that is currently overlooked in the literature.	[Boloori, Alireza] Arizona State Univ, Dept Ind Engn, Sch Comp Informat & Decis Syst Engn, Tempe, AZ USA; [Saghafian, Soroush] Harvard Univ, Harvard Kennedy Sch, Cambridge, MA 02138 USA; [Chakkera, Harini A.] Mayo Clin, Sch Med, Div Nephrol & Transplantat, Scottsdale, AZ USA; [Cook, Curtiss B.] Mayo Clin, Sch Med, Div Endocrinol, Scottsdale, AZ USA	Arizona State University; Arizona State University-Tempe; Harvard University; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix	Saghafian, S (corresponding author), Harvard Univ, Harvard Kennedy Sch, Cambridge, MA 02138 USA.	Soroush_Saghafian@hks.harvard.edu		Chakkera, Harini/0000-0002-9456-0863; Saghafian, Soroush/0000-0002-9781-6561				Bayer ND, 2010, TRANSPLANTATION, V90, P861, DOI 10.1097/TP.0b013e3181f1543c; Bee YM, 2011, ANN ACAD MED SINGAP, V40, P160; BENDING JJ, 1987, BRIT MED J, V294, P401, DOI 10.1136/bmj.294.6569.401; Bloom Roy D, 2008, Transplant Rev (Orlando), V22, P39, DOI 10.1016/j.trre.2007.06.001; Borda B, 2011, TRANSPL P, V43, P1254, DOI 10.1016/j.transproceed.2011.03.091; Bulanowski M, 2012, ANN TRANSPL, V17, P61; Cardoso F, 2012, ANN ONCOL, V23, P11, DOI 10.1093/annonc/mds232; Carter SA, 2014, PEDIATR TRANSPLANT, V18, P698, DOI 10.1111/petr.12332; Chakkera HA, 2010, CLIN J AM SOC NEPHRO, V5, P1669, DOI 10.2215/CJN.09481209; Chakkera HA, 2009, CLIN J AM SOC NEPHRO, V4, P853, DOI 10.2215/CJN.05471008; Chien YS, 2008, TRANSPL P, V40, P2409, DOI 10.1016/j.transproceed.2008.06.034; Cohen EEW, 2012, CLIN CANCER RES, V18, P4785, DOI 10.1158/1078-0432.CCR-12-0110; Cosio FG, 2001, KIDNEY INT, V59, P732, DOI 10.1046/j.1523-1755.2001.059002732.x; Davidson JA, 2004, DIABETES CARE, V27, P805, DOI 10.2337/diacare.27.3.805; DRESNER LS, 1989, SURGERY, V106, P163; Duvoux C, 2013, TRANSPL INT, V26, P358, DOI 10.1111/tri.12065; Farris AB, 2010, VIRCHOWS ARCH, V457, P329, DOI 10.1007/s00428-010-0948-y; Furth S, 1996, PEDIATR NEPHROL, V10, P64, DOI 10.1007/BF00863448; Gaynor JJ, 2015, CLIN TRANSPLANT, V29, P301, DOI 10.1111/ctr.12510; Gelens MACJ, 2008, NEPHROL DIAL TRANSPL, V23, P701, DOI 10.1093/ndt/gfm544; Ghanta M, 2015, CARDIOL REV, V23, P109, DOI 10.1097/CRD.0000000000000044; Ghisdal L, 2012, DIABETES CARE, V35, P181, DOI 10.2337/dc11-1230; Herrero JI, 2003, TRANSPLANT P, V35, P1877, DOI 10.1016/S0041-1345(03)00644-4; Hjelmes&AELIG;th J, 2001, NEPHROL DIAL TRANSPL, V16, P374; Honda M, 2013, CLIN TRANSPLANT, V27, P426, DOI 10.1111/ctr.12103; HRICIK DE, 1991, TRANSPLANTATION, V51, P374, DOI 10.1097/00007890-199102000-00020; Johnston O, 2008, J AM SOC NEPHROL, V19, P1411, DOI 10.1681/ASN.2007111202; Kaposztas Z, 2011, TRANSPL P, V43, P1375, DOI 10.1016/j.transproceed.2011.04.008; Kappe C, 2015, CLIN SCI, V129, P405, DOI 10.1042/CS20140719; Kesiraju S, 2014, TRANSPL IMMUNOL, V30, P52, DOI 10.1016/j.trim.2013.10.006; Kuo HT, 2010, LIVER TRANSPLANT, V16, P1249, DOI 10.1002/lt.22139; Kurzawski M, 2012, EUR J CLIN PHARMACOL, V68, P1587, DOI 10.1007/s00228-012-1292-8; Lane JT, 2011, J CLIN ENDOCR METAB, V96, P3289, DOI 10.1210/jc.2011-0657; Levy G, 2004, TRANSPLANTATION, V77, P1632, DOI 10.1097/01.TP.0000129095.51031.42; Levy G, 2006, LIVER TRANSPLANT, V12, P1464, DOI 10.1002/lt.20802; Liu XX, 2014, ANN NUTR METAB, V65, P324, DOI 10.1159/000365892; Luan FL, 2010, CLIN TRANSPLANT, V24, P778, DOI 10.1111/j.1399-0012.2009.01194.x; Lv C, 2014, PLOS ONE; Marchetti P, 2004, J HEART LUNG TRANSPL, V23, pS194, DOI 10.1016/j.healun.2004.03.007; Matias P, 2008, TRANSPL P, V40, P3601, DOI 10.1016/j.transproceed.2008.07.138; Mecule A, 2010, TRANSPL P, V42, P1317, DOI 10.1016/j.transproceed.2010.03.123; Meerwein C, 2011, EUR J PHARMACOL, V671, P113, DOI 10.1016/j.ejphar.2011.09.166; Mohler JL, 2004, CLIN CANCER RES, V10, P440, DOI 10.1158/1078-0432.CCR-1146-03; Montero N, 2015, CURR DIABETES REV, V11, P144, DOI 10.2174/1573399811666150331160846; Mora PF, 2010, J INVEST MED, V58, P755, DOI 10.231/JIM.0b013e3181e61a64; Mozaffarian D, 2007, LANCET, V370, P667, DOI 10.1016/S0140-6736(07)61343-9; O'Grady JG, 2002, LANCET, V360, P1119, DOI 10.1016/S0140-6736(02)11196-2; Palepu S, 2015, WORLD J DIABETES, V6, P445, DOI 10.4239/wjd.v6.i3.445; Park SC, 2015, TRANSPL P, V47, P666, DOI 10.1016/j.transproceed.2014.11.053; Parvizi Z, 2014, MOL BIOL REP, V41, P6063, DOI 10.1007/s11033-014-3483-0; Pirsch JD, 2015, AM J TRANSPLANT, V15, P1982, DOI 10.1111/ajt.13247; Rakel A, 2011, DIABETES METAB, V37, P1, DOI 10.1016/j.diabet.2010.09.003; Rafacho A, 2014, J ENDOCRINOL, V223, pR49, DOI 10.1530/JOE-14-0373; Rajab A, 2007, TRANSPLANTATION, V84, P1131, DOI 10.1097/01.tp.0000287117.98785.54; Ramachandran R, 2014, NEPHROL DIAL TRANSPL, V29, P1918, DOI 10.1093/ndt/gfu097; Ramos-Cebrian M, 2007, TRANSPL P, V39, P2251, DOI 10.1016/j.transproceed.2007.06.035; Rodrigo E, 2006, J AM SOC NEPHROL, V17, pS291, DOI 10.1681/ASN.2006080929; Romagnoli J, 2006, TRANSPL P, V38, P1034, DOI 10.1016/j.transproceed.2006.03.072; Saliba F, 2007, LIVER TRANSPLANT, V13, P136, DOI 10.1002/lt.21010; Salifu Moro O, 2005, Curr Diab Rep, V5, P194, DOI 10.1007/s11892-005-0009-0; Sharif A, 2010, TRANSPLANTATION, V89, P327, DOI 10.1097/TP.0b013e3181bbf2c4; Soule JL, 2005, AM J SURG, V189, P552, DOI 10.1016/j.amjsurg.2005.01.033; Stevens RB, 2012, CLIN TRANSPLANT, V26, P123, DOI 10.1111/j.1399-0012.2011.01425.x; Taylor AL, 2005, CRIT REV ONCOL HEMAT, V56, P23, DOI 10.1016/j.critrevonc.2005.03.012; Taylor DO, 1999, J HEART LUNG TRANSPL, V18, P336, DOI 10.1016/S1053-2498(98)00060-6; Teutonico A, 2005, J AM SOC NEPHROL, V16, P3128, DOI 10.1681/ASN.2005050487; Tokodai K, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/436725; van Buuren S, 2011, J STAT SOFTW, V45, P1; van den Hoogen MWF, 2013, EXP CLIN TRANSPLANT, V11, P234, DOI 10.6002/ect.2012.0221; van Genugten RE, 2014, EUR J ENDOCRINOL, V170, P429, DOI 10.1530/EJE-13-0610; Van Laecke S, 2009, AM J TRANSPLANT, V9, P2140, DOI 10.1111/j.1600-6143.2009.02752.x; van Raalte DH, 2014, NETH J MED, V72, P62; Vodenik B, 2009, Transplant Proc, V41, pS31, DOI 10.1016/j.transproceed.2009.06.159; WAJNGOT A, 1992, P NATL ACAD SCI USA, V89, P6035, DOI 10.1073/pnas.89.13.6035; Wauters RP, 2012, TRANSPLANTATION, V94, P377, DOI 10.1097/TP.0b013e3182584831; WISE JK, 1973, J CLIN INVEST, V52, P2774, DOI 10.1172/JCI107473; Wissing KM, 2014, TRANSPLANT REV-ORLAN, V28, P37, DOI 10.1016/j.trre.2013.12.004; Wyzgal J, 2003, TRANSPLANT P, V35, P2216, DOI 10.1016/S0041-1345(03)00819-4; Yadav AD, 2013, J TRANSPLANT, V2013, DOI 10.1155/2013/269096	79	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0142363	10.1371/journal.pone.0142363	http://dx.doi.org/10.1371/journal.pone.0142363			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26551468	Green Submitted, Green Published, gold			2022-12-26	WOS:000364422800025
J	Tannetta, DS; Hunt, K; Jones, CI; Davidson, N; Coxon, CH; Ferguson, D; Redman, CW; Gibbins, JM; Sargent, IL; Tucker, KL				Tannetta, Dionne S.; Hunt, Kathryn; Jones, Chris I.; Davidson, Naomi; Coxon, Carmen H.; Ferguson, David; Redman, Christopher W.; Gibbins, Jonathan M.; Sargent, Ian L.; Tucker, Katherine L.			Syncytiotrophoblast Extracellular Vesicles from Pre-Eclampsia Placentas Differentially Affect Platelet Function	PLOS ONE			English	Article							AGGREGATION INHIBITING ACTIVITY; BORDER MEMBRANE-VESICLES; CARDIOVASCULAR-DISEASE; PREGNANCY; PATHOPHYSIOLOGY; MICROPARTICLES; MANAGEMENT; COLLAGEN	Pre-eclampsia (PE) complicates around 3% of all pregnancies and is one of the most common causes of maternal mortality worldwide. The pathophysiology of PE remains unclear however its underlying cause originates from the placenta and manifests as raised blood pressure, proteinuria, vascular or systemic inflammation and hypercoagulation in the mother. Women who develop PE are also at significantly higher risk of subsequently developing cardiovascular (CV) disease. In PE, the failing endoplasmic reticulum, oxidative and inflammatory stressed syncytiotrophoblast layer of the placenta sheds increased numbers of syncytiotrophoblast extracellular vesicles (STBEV) into the maternal circulation. Platelet reactivity, size and concentration are also known to be altered in some women who develop PE, although the underlying reasons for this have not been determined. In this study we show that STBEV from disease free placenta isolated ex vivo by dual placental perfusion associate rapidly with platelets. We provide evidence that STBEV isolated from normal placentas cause platelet activation and that this is increased with STBEV from PE pregnancies. Furthermore, treatment of platelets with aspirin, currently prescribed for women at high risk of PE to reduce platelet aggregation, also inhibits STBEV-induced reversible aggregation of washed platelets. Increased platelet reactivity as a result of exposure to PE placenta derived STBEVs correlates with increased thrombotic risk associated with PE. These observations establish a possible direct link between the clotting disturbances of PE and dysfunction of the placenta, as well as the known increased risk of thromboembolism associated with this condition.	[Tannetta, Dionne S.; Hunt, Kathryn; Davidson, Naomi; Redman, Christopher W.; Sargent, Ian L.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Womens Ctr, Oxford OX3 9DU, England; [Jones, Chris I.; Gibbins, Jonathan M.] Univ Reading, Sch Biol Sci, Inst Cardiovasc & Metab Res, Reading, Berks, England; [Coxon, Carmen H.] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England; [Ferguson, David] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England; [Tucker, Katherine L.] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England	University of Oxford; University of Reading; University of Bristol; University of Oxford; University of Oxford	Tucker, KL (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England.	katherine.tucker@phc.ox.ac.uk		Jones, Chris/0000-0001-7537-1509; Gibbins, Jonathan/0000-0002-0372-5352	Medical Research Council [MR/J003360/1]; British Heart Foundation [RG/09/011/28094]; British Heart Foundation [RG/15/2/31224] Funding Source: researchfish; MRC [MR/J003360/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding: This work was funded by the Medical Research Council Programme grant MR/J003360/1 (DT) and the British Heart Foundation programme grant RG/09/011/28094. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselin J, 1997, BLOOD, V89, P1235, DOI 10.1182/blood.V89.4.1235; Baig S, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-40; Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; Chen Y, 2012, INT J GYNECOL OBSTET, V119, P234, DOI 10.1016/j.ijgo.2012.07.010; Dragovic RA, 2015, METHODS, V87, P64, DOI 10.1016/j.ymeth.2015.03.028; Dragovic RA, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.113266; Duley L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004659.pub2; Duley L, 2006, BMJ-BRIT MED J, V332, P463, DOI 10.1136/bmj.332.7539.463; Erez O, 2008, J MATERN-FETAL NEO M, V21, P345, DOI 10.1080/14767050802034859; Fox KAA, 2004, HEART, V90, P698, DOI 10.1136/hrt.2003.020321; Gardiner C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026313; Germain SJ, 2007, J IMMUNOL, V178, P5949, DOI 10.4049/jimmunol.178.9.5949; Gibbins JM, 1998, J BIOL CHEM, V273, P34437, DOI 10.1074/jbc.273.51.34437; Gilbert JS, 2008, AM J PHYSIOL-HEART C, V294, pH541, DOI 10.1152/ajpheart.01113.2007; Hedlund M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016899; IIOKA H, 1994, PLACENTA, V15, P291, DOI 10.1016/0143-4004(94)90020-5; IIOKA H, 1993, PLACENTA, V14, P75, DOI 10.1016/S0143-4004(05)80250-4; JANES SL, 1994, CLIN SCI, V86, P731, DOI 10.1042/cs0860731; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Knight M, 1998, BRIT J OBSTET GYNAEC, V105, P632, DOI 10.1111/j.1471-0528.1998.tb10178.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lopez-Vilchez I, 2007, THROMB HAEMOSTASIS, V97, P202, DOI 10.1160/TH06-04-0216; Mincheva-Nilsson L, 2014, AM J REPROD IMMUNOL, V72, P440, DOI 10.1111/aji.12311; Morel O, 2011, SEMIN IMMUNOPATHOL, V33, P469, DOI 10.1007/s00281-010-0239-3; Powe CE, 2011, CIRCULATION, V123, P2856, DOI 10.1161/CIRCULATIONAHA.109.853127; Redman CWG, 2012, PLACENTA, V33, pS48, DOI 10.1016/j.placenta.2011.12.006; Schafer Andrew I., 1999, American Journal of Medicine, V106, p25S, DOI 10.1016/S0002-9343(99)00114-X; Shankar H, 2006, BLOOD, V108, P3027, DOI 10.1182/blood-2006-03-010330; Southcombe J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020245; Spyridon M, 2011, BLOOD, V117, P5751, DOI 10.1182/blood-2010-09-306142; Tannetta D, 2014, CELL MOL IMMUNOL, V11, P548, DOI 10.1038/cmi.2014.42; Tannetta D, 2013, CURR HYPERTENS REP, V15, P590, DOI 10.1007/s11906-013-0395-7; Tannetta DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056754; Tucker KL, 2012, METHODS MOL BIOL, V788, P101, DOI 10.1007/978-1-61779-307-3_8	34	48	52	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0142538	10.1371/journal.pone.0142538	http://dx.doi.org/10.1371/journal.pone.0142538			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26551971	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000364422800028
J	Nagano, S; Seki, E; Lin, TY; Shirouzu, M; Yokoyama, S; Heddle, JG				Nagano, Soshichiro; Seki, Eiko; Lin, Ting-Yu; Shirouzu, Mikako; Yokoyama, Shigeyuki; Heddle, Jonathan G.			Investigating the Roles of the C-Terminal Domain of Plasmodium falciparum GyrA	PLOS ONE			English	Article							TUBERCULOSIS DNA GYRASE; MYCOBACTERIUM-TUBERCULOSIS; TOPOISOMERASE; MALARIA; BINDING; SUBUNIT; CIPROFLOXACIN; EXPRESSION; SURFACE; GENES	Malaria remains as one of the most deadly diseases in developing countries. The Plasmodium causative agents of human malaria such as Plasmodium falciparum possess an organelle, the apicoplast, which is the result of secondary endosymbiosis and retains its own circular DNA. A type II topoisomerase, DNA gyrase, is present in the apicoplast. In prokaryotes this enzyme is a proven, effective target for antibacterial agents, and its discovery in P. falciparum opens up the prospect of exploiting it as a drug target. Basic characterisation of P. falciparum gyrase is important because there are significant sequence differences between it and the prokaryotic enzyme. However, it has proved difficult to obtain soluble protein. Here we have predicted a new domain boundary in P. falciparum GyrA that corresponds to the C-terminal domain of prokaryotic GyrA and successfully purified it in a soluble form. Biochemical analyses revealed many similarities between the C-terminal domains of GyrA from E. coli and P. falciparum, suggesting that despite its considerably larger size, the malarial protein carries out a similar DNA wrapping function. Removal of a unique Asn-rich region in the P. falciparum protein did not result in a significant change, suggesting it is dispensable for DNA wrapping.	[Nagano, Soshichiro; Lin, Ting-Yu; Heddle, Jonathan G.] RIKEN, Heddle Initiat Res Unit, Wako, Saitama 3510198, Japan; [Seki, Eiko; Yokoyama, Shigeyuki] RIKEN, Struct Biol Lab, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Shirouzu, Mikako] RIKEN, Ctr Life Sci Technol, Div Struct & Synthet Biol, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	RIKEN; RIKEN; RIKEN	Heddle, JG (corresponding author), Jagiellonian Univ, Malopolska Ctr Biotechnol, Gronostajowa 7, PL-30387 Krakow, Poland.	jonathan.heddle@uj.edu.pl	Yokoyama, Shigeyuki/N-6911-2015; Heddle, Jonathan G/H-4586-2014; Shirouzu, Mikako/A-6521-2016; Heddle, Jonathan/AAP-7167-2020	Yokoyama, Shigeyuki/0000-0003-3133-7338; Lin, Ting-Yu/0000-0001-7914-2164	RIKEN Initiative Research Funding; Platform for Drug Discovery, Informatics, and Structural Life Science; Ministry of Education, Culture, Sports, Science and Technology, Japan	RIKEN Initiative Research Funding; Platform for Drug Discovery, Informatics, and Structural Life Science; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	J.G.H. and S.N. were funded by RIKEN Initiative Research Funding awarded to J.G.H. This work was supported by Platform for Drug Discovery, Informatics, and Structural Life Science funded by the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubry A, 2004, ANTIMICROB AGENTS CH, V48, P1281, DOI 10.1128/AAC.48.4.1281-1288.2004; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bouige A, 2013, BIOCHEM J, V455, P285, DOI 10.1042/BJ20130430; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Collin F, 2011, APPL MICROBIOL BIOT, V92, P479, DOI 10.1007/s00253-011-3557-z; Corbett KD, 2005, J MOL BIOL, V351, P545, DOI 10.1016/j.jmb.2005.06.029; Corbett KD, 2004, P NATL ACAD SCI USA, V101, P7293, DOI 10.1073/pnas.0401595101; Dar MA, 2007, EUKARYOT CELL, V6, P398, DOI 10.1128/EC.00357-06; Fichera ME, 1997, NATURE, V390, P407, DOI 10.1038/37132; Garcia-Estrada C, 2010, P ROY SOC B-BIOL SCI, V277, P1777, DOI 10.1098/rspb.2009.2176; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Girdwood SCT, 2015, BIOCHEM PHARMACOL, V95, P227, DOI 10.1016/j.bcp.2015.03.018; Goodman CD, 2013, EXPERT OPIN THER TAR, V17, P167, DOI 10.1517/14728222.2013.739158; Hsieh TJ, 2010, NUCLEIC ACIDS RES, V38, P4173, DOI 10.1093/nar/gkq153; Karkare S, 2012, NUCLEIC ACIDS RES, V40, P9774, DOI 10.1093/nar/gks704; Khor V, 2005, MOL BIOCHEM PARASIT, V140, P107, DOI 10.1016/j.molbiopara.2004.12.013; Kigawa Takanori, 2004, Journal of Structural and Functional Genomics, V5, P63, DOI 10.1023/B:JSFG.0000029204.57846.7d; Kramlinger VM, 2006, J BIOL CHEM, V281, P3738, DOI 10.1074/jbc.M511160200; Lanz MA, 2014, J BIOL CHEM, V289, P12275, DOI 10.1074/jbc.M114.547745; Lanz MA, 2012, NUCLEIC ACIDS RES, V40, P10893, DOI 10.1093/nar/gks852; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Lim L, 2010, PHILOS T R SOC B, V365, P749, DOI 10.1098/rstb.2009.0273; Lin TY, 2015, SCI REP-UK, V5, DOI 10.1038/srep14491; MCCLEAN KL, 1992, J INFECT DIS, V165, P904, DOI 10.1093/infdis/165.5.904; Moon AF, 2010, PROTEIN SCI, V19, P901, DOI 10.1002/pro.368; Mudeppa DG, 2015, J BIOL CHEM, V290, P20313, DOI 10.1074/jbc.M115.639039; Muralidharan V, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003488; Muralidharan V, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2306; Nagano S, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0416-9; Noack S, 2007, METHOD ENZYMOL, V423, P203, DOI 10.1016/S0076-6879(07)23009-5; Papillon J, 2013, NUCLEIC ACIDS RES, V41, P7815, DOI 10.1093/nar/gkt560; Price WN, 2009, NAT BIOTECHNOL, V27, P51, DOI 10.1038/nbt.1514; REECE RJ, 1989, J BIOL CHEM, V264, P19648; REECE RJ, 1991, NUCLEIC ACIDS RES, V19, P1399, DOI 10.1093/nar/19.7.1399; Ruthenburg AJ, 2005, J BIOL CHEM, V280, P26177, DOI 10.1074/jbc.M502838200; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schrodinger L., 2020, PYMOL; STROMBERG A, 1992, T ROY SOC TROP MED H, V86, P373, DOI 10.1016/0035-9203(92)90223-Y; Tretter EM, 2012, J BIOL CHEM, V287, P18636, DOI 10.1074/jbc.M112.345678; Tretter EM, 2010, P NATL ACAD SCI USA, V107, P22055, DOI 10.1073/pnas.1012938107; Vos SM, 2013, J MOL BIOL, V425, P3029, DOI 10.1016/j.jmb.2013.04.033; Ward D, 1997, MOL MICROBIOL, V26, P897, DOI 10.1046/j.1365-2958.1997.6242005.x; WATT G, 1991, J INFECT DIS, V164, P602, DOI 10.1093/infdis/164.3.602; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; WHO, 2013, WORLD MALARIA REPORT 2013, P1	47	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142313	10.1371/journal.pone.0142313	http://dx.doi.org/10.1371/journal.pone.0142313			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26566222	Green Published, Green Submitted, gold			2022-12-26	WOS:000367628500018
J	Pereira, AE; Wang, HC; Zukoff, SN; Meinke, LJ; French, BW; Siegfried, BD				Pereira, Adriano E.; Wang, Haichuan; Zukoff, Sarah N.; Meinke, Lance J.; French, B. Wade; Siegfried, Blair D.			Evidence of Field-Evolved Resistance to Bifenthrin in Western Corn Rootworm (Diabrotica virgifera virgifera LeConte) Populations in Western Nebraska and Kansas	PLOS ONE			English	Article							CHRYSOMELIDAE LARVAL INJURY; COLEOPTERA; SUSCEPTIBILITY; ADAPTATION; EVOLUTION; INSECTICIDES; ALDRIN; HOSTS	Pyrethroid insecticides have been used to control larvae or adults of the western corn root-worm (WCR), Diabrotica virgifera virgifera LeConte, a key pest of field corn in the United States. In response to reports of reduced efficacy of pyrethroids in WCR management programs in southwestern areas of Nebraska and Kansas the present research was designed to establish a baseline of susceptibility to the pyrethroid insecticide, bifenthrin, using susceptible laboratory populations and to compare this baseline with susceptibility of field populations. Concentration-response bioassays were performed to estimate the baseline susceptibility. From the baseline data, a diagnostic concentration (LC99) was determined and used to test adults of both laboratory and field populations. Larval susceptibility was also tested using both laboratory and field populations. Significant differences were recorded in adult and larval susceptibility among WCR field and laboratory populations. The highest LC50 for WCR adults was observed in populations from Keith 2 and Chase Counties, NE, with LC(50)s of 2.2 and 1.38 mu g/vial, respectively, and Finney County 1, KS, with 1.43 mu g/vial, as compared to a laboratory non-diapause population (0.24 mu g/vial). For larvae, significant differences between WCR field and laboratory populations were also recorded. Significant differences in mortalities at the diagnostic bifenthrin concentration (LC99) were observed among WCR adult populations with western Corn Belt populations exhibiting lower susceptibility to bifenthrin, especially in southwestern Nebraska and southwestern Kansas. This study provides evidence that resistance to bifenthrin is evolving in field populations that have been exposed for multiple years to pyrethroid insecticides. Implications to sustainable rootworm management are discussed.	[Pereira, Adriano E.; Wang, Haichuan; Meinke, Lance J.; Siegfried, Blair D.] Univ Nebraska, Dept Entomol, Lincoln, NE 68583 USA; [Zukoff, Sarah N.] Kansas State Univ, Southwest Res & Extens Ctr, Garden City, KS USA; [French, B. Wade] ARS, North Cent Agr Res Lab, USDA, Brookings, SD USA	University of Nebraska System; University of Nebraska Lincoln; Kansas State University; United States Department of Agriculture (USDA)	Pereira, AE (corresponding author), Univ Nebraska, Dept Entomol, Lincoln, NE 68583 USA.	aelias374@yahoo.com.br		Zukoff, Sarah/0000-0002-4918-3667	Monsanto Corn Rootworm Knowledge Grant [69292]; Department of Entomology/Institute of Agriculture and Natural Resources	Monsanto Corn Rootworm Knowledge Grant; Department of Entomology/Institute of Agriculture and Natural Resources	This work was supported by: 1- Monsanto Corn Rootworm Knowledge Grant (No. 69292): The recipients were BDS and LJM. Monsanto staff provided some field insect collections. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 2- Department of Entomology/Institute of Agriculture and Natural Resources: The recipient was AEP as an assistantship for the PhD program.	Alyokhin A, 2008, AM J POTATO RES, V85, P395, DOI 10.1007/s12230-008-9052-0; [Anonymous], 1986, METHODS STUDY PEST D; BALL HJ, 1962, J ECON ENTOMOL, V55, P439, DOI 10.1093/jee/55.4.439; BALL HJ, 1963, J ECON ENTOMOL, V56, P553, DOI 10.1093/jee/56.5.553; BRANSON TF, 1970, J ECON ENTOMOL, V63, P800, DOI 10.1093/jee/63.3.800; BRANSON TF, 1976, ENTOMOL EXP APPL, V19, P148, DOI 10.1007/BF00345776; Campbell LA, 2006, ENVIRON ENTOMOL, V35, P922, DOI 10.1603/0046-225X-35.4.922; Chandler LD, 2003, PEST MANAG SCI, V59, P605, DOI 10.1002/ps.683; Chu CC, 2013, P NATL ACAD SCI USA, V110, P11917, DOI 10.1073/pnas.1301886110; Ciosi M, 2009, J APPL ENTOMOL, V133, P307, DOI 10.1111/j.1439-0418.2008.01363.x; Clark TL, 2004, ENVIRON ENTOMOL, V33, P681, DOI 10.1603/0046-225X-33.3.681; Curzi MJ, 2012, ECOL EVOL, V2, P2005, DOI 10.1002/ece3.331; Darnell SJ, 2000, ENVIRON ENTOMOL, V29, P587, DOI 10.1603/0046-225X-29.3.587; Dun Z, 2010, J APPL ENTOMOL, V134, P409, DOI 10.1111/j.1439-0418.2009.01487.x; EPA. Environmental Protection Agency, 2012, BACKGR SUMM N METH C; EPA. Environmental Protection Agency, 2006, ORG CUM RISK ASS UPD; FINNEY D J, 1971, P333; Frank DL, 2015, J ECON ENTOMOL, V108, P1260, DOI 10.1093/jee/tov081; Gassmann AJ, 2014, P NATL ACAD SCI USA, V111, P5141, DOI 10.1073/pnas.1317179111; Gassmann AJ, 2012, J INVERTEBR PATHOL, V110, P287, DOI 10.1016/j.jip.2012.04.006; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gray ME, 2014, THE BULLETIN    0403; Gray ME, 2009, ANNU REV ENTOMOL, V54, P303, DOI 10.1146/annurev.ento.54.110807.090434; HILL RE, 1948, J ECON ENTOMOL, V41, P392, DOI 10.1093/jee/41.3.392; Hou X, 1997, AGRON J, V89, P709, DOI 10.2134/agronj1997.00021962008900050001x; Jackson J.J., 1986, METHODS STUDY PEST D, P25; Leora Software, 1987, POLO PC US GUID PROB; Levine E, 1996, J ECON ENTOMOL, V89, P1010, DOI 10.1093/jee/89.4.1010; Levine Eli, 2002, American Entomologist, V48, P94; Magalhaes LC, 2007, J APPL ENTOMOL, V131, P251, DOI 10.1111/j.1439-0418.2007.01153.x; Meinke LJ, 1998, J ECON ENTOMOL, V91, P594, DOI 10.1093/jee/91.3.594; Mendelsohn M, 2003, NAT BIOTECHNOL, V21, P1003, DOI 10.1038/nbt0903-1003; Miller N, 2005, SCIENCE, V310, P992, DOI 10.1126/science.1115871; Miller NJ, 2009, AGR FOREST ENTOMOL, V11, P47, DOI 10.1111/j.1461-9563.2008.00398.x; MUMA MH, 1949, J ECON ENTOMOL, V42, P822, DOI 10.1093/jee/42.5.822; Onstad DW, 2001, ENTOMOL EXP APPL, V100, P195, DOI 10.1023/A:1019289030248; Oyediran IO, 2004, ENVIRON ENTOMOL, V33, P740, DOI 10.1603/0046-225X-33.3.740; Parimi S, 2006, CROP PROT, V25, P269, DOI 10.1016/j.cropro.2005.04.017; PRUESS KP, 1974, J ECON ENTOMOL, V67, P525, DOI 10.1093/jee/67.4.525; RIEDELL WE, 1990, CROP SCI, V30, P628, DOI 10.2135/cropsci1990.0011183X003000030031x; Robertson J.L., 2007, BIOASSAYS ARTHROPODS, V2nd; Rondon SI, 2004, J ECON ENTOMOL, V97, P390, DOI 10.1603/0022-0493-97.2.390; SAS Institute, 2011, SAS STAT US GUID 9 3; Scharf ME, 1999, J ECON ENTOMOL, V92, P33, DOI 10.1093/jee/92.1.33; Shelton AM, 2002, ANNU REV ENTOMOL, V47, P845, DOI 10.1146/annurev.ento.47.091201.145309; TABASHNIK BE, 1992, J ECON ENTOMOL, V85, P1551, DOI 10.1093/jee/85.5.1551; Tinsley NA, 2012, J APPL ENTOMOL, V135, P361, DOI 10.1111/j.1439-0418.2011.01656.x; Urias-Lopez MA, 2001, J ECON ENTOMOL, V94, P106, DOI 10.1603/0022-0493-94.1.106; Wang H, 2013, INSECT MOL BIOL, V22, P473, DOI 10.1111/imb.12037; Wangila DS, 2015, J ECON ENTOMOL, V108, P742, DOI 10.1093/jee/tou063; Wheeler MW, 2006, ENVIRON TOXICOL CHEM, V25, P1441, DOI 10.1897/05-320R.1; Zhou XG, 2002, J ECON ENTOMOL, V95, P1261, DOI 10.1603/0022-0493-95.6.1261; Zhu KY, 2005, J ECON ENTOMOL, V98, P2181, DOI 10.1603/0022-0493-98.6.2181; Zhu KY, 2001, J ECON ENTOMOL, V94, P929, DOI 10.1603/0022-0493-94.4.929	54	47	47	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142299	10.1371/journal.pone.0142299	http://dx.doi.org/10.1371/journal.pone.0142299			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26566127	gold, Green Published			2022-12-26	WOS:000367628500017
J	Songstad, NT; Kaspersen, KHF; Hafstad, AD; Basnet, P; Ytrehus, K; Acharya, G				Songstad, Nils Thomas; Kaspersen, Knut-Helge Frostmo; Hafstad, Anne Dragoy; Basnet, Purusotam; Ytrehus, Kirsti; Acharya, Ganesh			Effects of High Intensity Interval Training on Pregnant Rats, and the Placenta, Heart and Liver of Their Fetuses	PLOS ONE			English	Article							CARDIAC-HYPERTROPHY; PHYSICAL-ACTIVITY; FETAL-GROWTH; EXERCISE; EXPRESSION; OXYGEN; OVERWEIGHT; HYPOXIA; STRESS; VO2MAX	Objective To investigate the effects of high intensity interval training (HIIT) on the maternal heart, fetuses and placentas of pregnant rats. Methods Female Sprague-Dawley rats were randomly assigned to HIIT or sedentary control groups. The HIIT group was trained for 6 weeks with 10 bouts of high intensity uphill running on a treadmill for four minutes (at 85-90% of maximal oxygen consumption) for five days/week. After three weeks of HIIT, rats were mated. After six weeks (gestational day 20 in pregnant rats), echocardiography was performed to evaluate maternal cardiac function. Real-time PCR was performed for the quantification of gene expression, and oxidative stress and total antioxidant capacity was assessed in the tissue samples. Results Maternal heart weight and systolic function were not affected by HIIT or pregnancy. In the maternal heart, expression of 11 of 22 genes related to cardiac remodeling was influenced by pregnancy but none by HIIT. Litter size, fetal weight and placental weight were not affected by HIIT. Total antioxidant capacity, malondialdehyde content, peroxidase and superoxide dismutase activity measured in the placenta, fetal heart and liver were not influenced by HIIT. HIIT reduced the expression of eNOS (p = 0.03), hypoxia-inducible factor 1 alpha (p = 0.04) and glutathione peroxidase 4.2 (p = 0.02) in the fetal liver and increased the expression of vascular endothelial growth factor-beta (p = 0.014), superoxide dismutase 1 (p = 0.001) and tissue inhibitor of metallopeptidase 3 (p = 0.049) in the fetal heart. Conclusions Maternal cardiac function and gene expression was not affected by HIIT. Although HIIT did not affect fetal growth, level of oxidative stress and total antioxidant capacity in the fetal tissues, some genes related to oxidative stress were altered in the fetal heart and liver indicating that protective mechanisms may be activated.	[Songstad, Nils Thomas; Basnet, Purusotam; Acharya, Ganesh] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Clin Med, Womens Hlth & Perinatol Res Grp, Tromso, Norway; [Songstad, Nils Thomas; Kaspersen, Knut-Helge Frostmo] Univ Hosp Northern Norway, Dept Pediat, Tromso, Norway; [Kaspersen, Knut-Helge Frostmo] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Clin Med, Pediat Res Grp, Tromso, Norway; [Hafstad, Anne Dragoy; Ytrehus, Kirsti] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Med Biol, Cardiovasc Res Grp, Tromso, Norway; [Basnet, Purusotam; Acharya, Ganesh] Univ Hosp Northern Norway, Dept Obstet & Gynecol, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway	Songstad, NT (corresponding author), UiT Arctic Univ Norway, Fac Hlth Sci, Dept Clin Med, Womens Hlth & Perinatol Res Grp, Tromso, Norway.	nilsthomass@gmail.com	Hafstad, Anne D/AAK-4269-2021; Basnet, Purusotam/A-5613-2012	Basnet, Purusotam/0000-0001-8612-9558; Hafstad, Anne/0000-0003-0711-9736				Aljabri MB, 2011, ACTA PHYSIOL, V201, P445, DOI 10.1111/j.1748-1716.2010.02234.x; American College of Obstetricians and Gynecologists, 2013, Obstet Gynecol, V121, P213, DOI http://10.1097/01.AOG.0000425667.10377.60; Artal R, 2003, CLIN OBSTET GYNECOL, V46, P479, DOI 10.1097/00003081-200306000-00026; Bassien-Capsa V, 2006, CARDIOVASC RES, V69, P423, DOI 10.1016/j.cardiores.2005.10.017; Burton GJ, 2009, J ANAT, V215, P27, DOI 10.1111/j.1469-7580.2008.00978.x; BUTTRICK PM, 1987, AM J PHYSIOL, V252, pH846, DOI 10.1152/ajpheart.1987.252.4.H846; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Cindrova-Davies T, 2007, AM J PATHOL, V171, P1168, DOI 10.2353/ajpath.2007.070528; Clapp JF, 1996, J PEDIATR-US, V129, P856, DOI 10.1016/S0022-3476(96)70029-X; Clapp lii JF, 2008, AM J OBSTET GYNECOL, V199; D'Souza A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4775; Eghbali M, 2005, CIRC RES, V96, P1208, DOI 10.1161/01.RES.0000170652.71414.16; Evenson KR, 2014, AM J LIFESTYLE MED, V8, P102, DOI 10.1177/1559827613498204; Gilbert JS, 2012, HYPERTENSION, V60, P1545, DOI 10.1161/HYPERTENSIONAHA.112.202275; Hafstad AD, 2011, J APPL PHYSIOL, V111, P1235, DOI 10.1152/japplphysiol.00594.2011; Hamilton BE, 2013, PEDIATRICS, V131, P548, DOI 10.1542/peds.2012-3769; Helgerud J, 2007, MED SCI SPORT EXER, V39, P665, DOI 10.1249/mss.0b013e3180304570; Hoydal MA, 2007, EUR J CARDIOV PREV R, V14, P753, DOI 10.1097/HJR.0b013e3281eacef1; Kardel KR, 2005, SCAND J MED SCI SPOR, V15, P79, DOI 10.1111/j.1600-0838.2004.00426.x; Kasawara KT, 2012, ACTA OBSTET GYN SCAN, V91, P1147, DOI 10.1111/j.1600-0412.2012.01483.x; Kemi OJ, 2010, J CARDIOPULM REHABIL, V30, P2, DOI 10.1097/HCR.0b013e3181c56b89; Mates JM, 1999, CLIN BIOCHEM, V32, P595, DOI 10.1016/S0009-9120(99)00075-2; Melzer K, 2010, SPORTS MED, V40, P493, DOI 10.2165/11532290-000000000-00000; MITTAL MK, 1994, AM J PHYSIOL, V267, pG416, DOI 10.1152/ajpgi.1994.267.3.G416; MOTTOLA MF, 1992, CAN J PHYSIOL PHARM, V70, P1634, DOI 10.1139/y92-234; Nowicki MJ, 2003, PEDIATR RES, V54, P732, DOI 10.1203/01.PDR.0000086904.52847.2A; Oliveira AO, 2004, BRAZ J MED BIOL RES, V37, P907, DOI 10.1590/S0100-879X2004000600017; Ovesen P, 2011, OBSTET GYNECOL, V118, P305, DOI 10.1097/AOG.0b013e3182245d49; Ramirez-Velez R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080225; Rosa BV, 2011, AM J PHYSIOL-REG I, V300, pR1134, DOI 10.1152/ajpregu.00683.2010; Salvesen KA, 2012, BRIT J SPORT MED, V46, P279, DOI 10.1136/bjsm.2010.080259; SCHNEIDEREIT M, 1985, LAB ANIM, V19, P240, DOI 10.1258/002367785780893674; Simmons LA, 2002, AM J PHYSIOL-HEART C, V283, pH1627, DOI 10.1152/ajpheart.00966.2001; Smith TG, 2008, BRIT J HAEMATOL, V141, P325, DOI 10.1111/j.1365-2141.2008.07029.x; Songstad NT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089559; Tjonna AE, 2009, CLIN SCI, V116, P317, DOI 10.1042/CS20080249; Trapp EG, 2008, INT J OBESITY, V32, P684, DOI 10.1038/sj.ijo.0803781; Ufer C, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00012; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Volpe JJ, 2001, PEDIATR RES, V50, P553, DOI 10.1203/00006450-200111000-00003; Wang Y, 2010, PHYSIOL RES, V59, P633, DOI 10.33549/physiolres.931928; Wiebe HW, 2015, OBSTET GYNECOL, V125, P1185, DOI 10.1097/AOG.0000000000000801; Wilson ME, 2001, J REP FER S, P223; Wisloff U, 2001, AM J PHYSIOL-HEART C, V280, pH1301, DOI 10.1152/ajpheart.2001.280.3.H1301; Yon JM, 2008, J MOL HISTOL, V39, P95, DOI 10.1007/s10735-007-9134-1	45	21	23	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0143095	10.1371/journal.pone.0143095	http://dx.doi.org/10.1371/journal.pone.0143095			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26566220	Green Published, Green Submitted, gold			2022-12-26	WOS:000367628500090
J	Pest, MA; Pest, CA; Bellini, MR; Feng, QP; Beier, F				Pest, Michael Andrew; Pest, Courtney Alice; Bellini, Melina Rodrigues; Feng, Qingping; Beier, Frank			Deletion of Dual Specificity Phosphatase 1 Does Not Predispose Mice to Increased Spontaneous Osteoarthritis	PLOS ONE			English	Article							GENE-EXPRESSION; GROWTH-FACTORS; KINASE; PROTEIN; MOUSE; SOX9; P38; CARTILAGE; COLLAGEN; ALPHA	Background Osteoarthritis (OA) is a degenerative joint disease with poorly understood etiology and pathobiology. Mitogen activated protein kinases (MAPKs) including ERK and p38 play important roles in the mediation of downstream pathways involved in cartilage degenerative processes. Dual specificity phosphatase 1 (DUSP1) dephosphorylates the threonine/serine and tyrosine sites on ERK and p38, causing deactivation of downstream signalling. In this study we examined the role of DUSP1 in spontaneous OA development at 21 months of age using a genetically modified mouse model deficient in Dusp1 (DUSP1 knockout mouse). Results Utilizing histochemical stains of paraffin embedded knee joint sections in DUSP1 knockout and wild type female and male mice, we showed similar structural progression of cartilage degeneration associated with OA at 21 months of age. A semi-quantitative cartilage degeneration scoring system also demonstrated similar scores in the various aspects of the knee joint articular cartilage in DUSP1 knockout and control mice. Examination of overall articular cartilage thickness in the knee joint demonstrated similar results between DUSP1 knockout and wild type mice. Immunostaining for cartilage neoepitopes DIPEN, TEGE and C1,2C was similar in the cartilage lesion sites and chondrocyte pericellular matrix of both experimental groups. Likewise, immunostaining for phosphoERK and MMP13 showed similar intensity and localization between groups. SOX9 immunostaining demonstrated a decreased number of positive cells in DUSP1 knockout mice, with correspondingly decreased staining intensity. Analysis of animal walking patterns (gait) did not show a discernable difference between groups. Conclusion Loss of DUSP1 does not cause changes in cartilage degeneration and gait in a mouse model of spontaneous OA at 21 months of age. Altered staining was observed in SOX9 immunostaining which may prove promising for future studies examining the role of DUSPs in cartilage and OA, as well as models of post-traumatic OA.	[Pest, Michael Andrew; Pest, Courtney Alice; Bellini, Melina Rodrigues; Feng, Qingping; Beier, Frank] Western Univ, Dept Physiol & Pharmacol, London, ON, Canada; [Beier, Frank] Childrens Hlth Res Inst, London, ON, Canada	Western University (University of Western Ontario)	Beier, F (corresponding author), Western Univ, Dept Physiol & Pharmacol, London, ON, Canada.	fbeier@uwo.ca	Beier, Frank/T-4734-2019; Beier, Frank/G-4595-2013; Bellini, Melina/F-7140-2017; Pest, Michael/S-1986-2016	Beier, Frank/0000-0002-8505-7537; Beier, Frank/0000-0002-8505-7537; Bellini, Melina/0000-0002-4619-6964; Pest, Michael/0000-0003-0832-4504; Feng, Qingping/0000-0001-9739-2765	Canadian Institute of Health Research (CIHR) Operating Grant [MOP 86574]	Canadian Institute of Health Research (CIHR) Operating Grant(Canadian Institutes of Health Research (CIHR))	Support was provided by the Canadian Institute of Health Research (CIHR) Operating Grant MOP 86574 [http://www.cihr-irsc.gc.ca/] to FB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S, 2009, CANCER LETT, V277, P108, DOI 10.1016/j.canlet.2008.11.034; Appleton CTG, 2007, ARTHRITIS RHEUM-US, V56, P1854, DOI 10.1002/art.22711; Appleton CTG, 2007, ARTHRITIS RHEUM-US, V56, P3693, DOI 10.1002/art.22968; Appleton CTG, 2010, LAB INVEST, V90, P20, DOI 10.1038/labinvest.2009.111; Appleton CT, 2015, ARTHRITIS R IN PRESS; Billinghurst RC, 1997, J CLIN INVEST, V99, P1534, DOI 10.1172/JCI119316; Bliss SP, 2009, MOL ENDOCRINOL, V23, P1092, DOI 10.1210/me.2009-0030; Brown KK, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-22; Civinini R, 2013, CLIN CASES MINER BON, V10, P26, DOI 10.11138/ccmbm/2013.10.1.026; Dorfman K, 1996, ONCOGENE, V13, P925; Fang H, 2014, NAT REV RHEUMATOL, V10, P413, DOI 10.1038/nrrheum.2014.46; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Goldring MB, 2015, CURR OPIN PHARMACOL, V22, P51, DOI 10.1016/j.coph.2015.03.004; Hashizume M, 2010, BIOCHEM BIOPH RES CO, V403, P184, DOI 10.1016/j.bbrc.2010.10.135; Hunter DJ, 2011, BEST PRACT RES CL RH, V25, P801, DOI 10.1016/j.berh.2011.11.008; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Lee ER, 1998, ANAT REC, V252, P117; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Ling SZ, 2011, CANCER RES, V71, P3812, DOI 10.1158/0008-5472.CAN-10-3072; Little CB, 2009, ARTHRITIS RHEUM-US, V60, P3723, DOI 10.1002/art.25002; Long DL, 2015, OSTEOARTHR CARTILAGE, V23, P1523, DOI 10.1016/j.joca.2015.04.019; Malfait AM, 2013, OSTEOARTHR CARTILAGE, V21, P1316, DOI 10.1016/j.joca.2013.06.003; Malfait AM, 2010, OSTEOARTHR CARTILAGE, V18, P572, DOI 10.1016/j.joca.2009.11.013; Murakami S, 2000, P NATL ACAD SCI USA, V97, P1113, DOI 10.1073/pnas.97.3.1113; Oh CD, 2000, J BIOL CHEM, V275, P5613, DOI 10.1074/jbc.275.8.5613; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Parvathy SS, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-14; Pelletier JP, 2003, ARTHRITIS RHEUM-US, V48, P1582, DOI 10.1002/art.11014; Pest MA, 2014, ARTHRITIS RHEUMATOL, V66, P2816, DOI 10.1002/art.38758; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Ratneswaran A, 2015, ARTHRITIS RHEUMATOL, V67, P454, DOI 10.1002/art.38915; Sahebjam S, 2007, ARTHRITIS RHEUM, V56, P905, DOI 10.1002/art.22427; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Sartori R, 2009, J DENT RES, V88, P1125, DOI 10.1177/0022034509349306; Schneider MR, 2009, TRENDS ENDOCRIN MET, V20, P517, DOI 10.1016/j.tem.2009.06.008; Shen JZ, 2010, CIRC RES, V106, P902, DOI 10.1161/CIRCRESAHA.109.198069; Solomon LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085526; Solomon LA, 2013, HUM MOL GENET, V22, P5015, DOI 10.1093/hmg/ddt351; Sondergaard BC, 2010, OSTEOARTHR CARTILAGE, V18, P279, DOI 10.1016/j.joca.2009.11.005; Sorge RE, 2014, NAT METHODS, V11, P629, DOI [10.1038/nmeth.2935, 10.1038/NMETH.2935]; Tew SR, 2006, J BIOL CHEM, V281, P39471, DOI 10.1074/jbc.M604322200; Theodosiou A, 2002, GENOME BIOL, V3; Ulici V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008866; Vattakuzhi Y, 2012, ARTHRITIS RHEUM-US, V64, P2201, DOI 10.1002/art.34403; WILHELMI G, 1976, PHARMACOLOGY, V14, P289, DOI 10.1159/000136607; Yoon HS, 2004, J KOREAN MED SCI, V19, P567, DOI 10.3346/jkms.2004.19.4.567; Yoon YM, 2000, J BIOL CHEM, V275, P12353, DOI 10.1074/jbc.275.16.12353; Zhang T, 2012, CARDIOVASC RES, V93, P471, DOI 10.1093/cvr/cvr346	48	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142822	10.1371/journal.pone.0142822	http://dx.doi.org/10.1371/journal.pone.0142822			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562438	Green Published, gold, Green Submitted			2022-12-26	WOS:000364480900071
J	Sum, CH; Nafissi, N; Slavcev, RA; Wettig, S				Sum, Chi Hong; Nafissi, Nafiseh; Slavcev, Roderick A.; Wettig, Shawn			Physical Characterization of Gemini Surfactant-Based Synthetic Vectors for the Delivery of Linear Covalently Closed (LCC) DNA Ministrings	PLOS ONE			English	Article							GENE-THERAPY; PLASMID DNA; TRANSFECTION	In combination with novel linear covalently closed (LCC) DNA minivectors, referred to as DNA ministrings, a gemini surfactant-based synthetic vector for gene delivery has been shown to exhibit enhanced delivery and bioavailability while offering a heightened safety profile. Due to topological differences from conventional circular covalently closed (CCC) plasmid DNA vectors, the linear topology of LCC DNA ministrings may present differences with regards to DNA interaction and the physicochemical properties influencing DNA-surfactant interactions in the formulation of lipoplexed particles. In this study, N,N-bis(dimethyl-hexadecyl)-alpha,omega-propanediammonium(16-3-16)gemini-based synthetic vectors, incorporating either CCC plasmid or LCC DNA ministrings, were characterized and compared with respect to particle size, zeta potential, DNA encapsulation, DNase sensitivity, and in vitro transgene delivery efficacy. Through comparative analysis, differences between CCC plasmid DNA and LCC DNA ministrings led to variations in the physical properties of the resulting lipoplexes after complexation with 16-3-16 gemini surfactants. Despite the size disparities between the plasmid DNA vectors (CCC) and DNA ministrings (LCC), differences in DNA topology resulted in the generation of lipoplexes of comparable particle sizes. The capacity for ministring (LCC) derived lipoplexes to undergo complete counterion release during lipoplex formation contributed to improved DNA encapsulation, protection from DNase degradation, and in vitro transgene delivery.	[Sum, Chi Hong; Nafissi, Nafiseh; Slavcev, Roderick A.; Wettig, Shawn] Univ Waterloo, Sch Pharm, Kitchener, ON, Canada; [Nafissi, Nafiseh; Slavcev, Roderick A.; Wettig, Shawn] Univ Waterloo, Waterloo Inst Nanotechnol, Waterloo, ON N2L 3G1, Canada	University of Waterloo; University of Waterloo	Slavcev, RA (corresponding author), Univ Waterloo, Sch Pharm, 10 Victoria St S, Kitchener, ON, Canada.	slavcev@uwaterloo.ca; wettig@uwaterloo.ca	Wettig, Shawn/ABE-5382-2020	Wettig, Shawn/0000-0002-6490-264X	NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by NSERC (http://www.nserc-crsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar J, 2012, J COLLOID INTERF SCI, V377, P237, DOI 10.1016/j.jcis.2012.03.048; Badea I, 2005, J GENE MED, V7, P1200, DOI 10.1002/jgm.763; Badea I, 2007, EUR J PHARM BIOPHARM, V65, P414, DOI 10.1016/j.ejpb.2007.01.002; Bombelli C, 2009, CURR MED CHEM, V16, P171, DOI 10.2174/092986709787002808; Bryant LM, 2013, HUM GENE THER CL DEV, V24, P55, DOI 10.1089/humc.2013.087; Donkuru M, 2010, NANOMEDICINE-UK, V5, P1103, DOI [10.2217/nnm.10.80, 10.2217/NNM.10.80]; Fischer A, 2010, NAT IMMUNOL, V11, P457, DOI 10.1038/ni0610-457; Foldvari M., 2005, 2005 NSTI Nanotechnology Conference and Trade Show. NSTI Nanotech 2005, P128; Foldvari M., 2006, NSTI NANOTECH, P400; Gill DR, 2009, GENE THER, V16, P165, DOI 10.1038/gt.2008.183; Ginn SL, 2013, J GENE MED, V15, P65, DOI 10.1002/jgm.2698; Heinrich J, 2002, J MOL MED-JMM, V80, P648, DOI 10.1007/s00109-002-0362-2; Hyde SC, 2008, NAT BIOTECHNOL, V26, P549, DOI 10.1038/nbt1399; Kamiya H, 2002, GENE THER, V9, P1500, DOI 10.1038/sj.gt.3301831; Kumar M, 2010, CRIT REV THER DRUG, V27, P237, DOI 10.1615/CritRevTherDrugCarrierSyst.v27.i3.20; Melchiorri D, 2013, NAT REV DRUG DISCOV, V12, P719, DOI 10.1038/nrd3835-c1; Mohammed-Saeid W, 2012, J PHARM PHARM SCI, V15, P548, DOI 10.18433/J3X60D; Munoz-Ubeda M, 2012, BIOMACROMOLECULES, V13, P3926, DOI 10.1021/bm301066w; Munoz-Ubeda M, 2011, J AM CHEM SOC, V133, P18014, DOI 10.1021/ja204693f; Nafissi N, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.16; Nafissi N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089345; Nafissi N, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-154; Seow Y, 2009, MOL THER, V17, P767, DOI 10.1038/mt.2009.41; Somia N, 2000, NAT REV GENET, V1, P91, DOI 10.1038/35038533; Takahashi Yuki, 2012, Front Biosci (Schol Ed), V4, P133; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; Wang CZ, 2007, PHYS CHEM CHEM PHYS, V9, P1616, DOI 10.1039/b618579g; Wang HT, 2013, PHYS CHEM CHEM PHYS, V15, P20510, DOI 10.1039/c3cp52621f; Wang HT, 2011, PHYS CHEM CHEM PHYS, V13, P637, DOI 10.1039/c0cp00146e; Wettig SD, 2001, J COLLOID INTERF SCI, V235, P310, DOI 10.1006/jcis.2000.7348; Wettig SD, 2008, CURR GENE THER, V8, P9, DOI 10.2174/156652308783688491; Wettig SD, 2007, J GENE MED, V9, P649, DOI 10.1002/jgm.1060; Wettig SD, 2010, PHYS CHEM CHEM PHYS, V12, P4821, DOI 10.1039/b923817d; Wilson JM, 2009, MOL GENET METAB, V96, P151, DOI 10.1016/j.ymgme.2008.12.016; Wirth T, 2013, GENE, V525, P162, DOI 10.1016/j.gene.2013.03.137; Yew NS, 2000, MOL THER, V1, P255, DOI 10.1006/mthe.2000.0036; Zana R., 2003, GEMINI SURFACTANTS S, P108	37	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142875	10.1371/journal.pone.0142875	http://dx.doi.org/10.1371/journal.pone.0142875			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26561857	Green Published, Green Submitted, gold			2022-12-26	WOS:000364480900076
J	Wang, LG; Tao, T; Fan, CL; Gao, WB; Wei, CG				Wang, Ligang; Tao, Ting; Fan, Chunlei; Gao, Wenbin; Wei, Chuguang			The Influence of Chronic Ego Depletion on Goal Adherence: An Experience Sampling Study	PLOS ONE			English	Article							SELF-CONTROL; RESOURCE-DEPLETION; LIMITED RESOURCES; MOTIVATION; BEHAVIOR; FAILURE; MODEL; STRENGTH; FATIGUE; LIFE	Although ego depletion effects have been widely observed in experiments in which participants perform consecutive self-control tasks, the process of ego depletion remains poorly understood. Using the strength model of self-control, we hypothesized that chronic ego depletion adversely affects goal adherence and that mental effort and motivation are involved in the process of ego depletion. In this study, 203 students reported their daily performance, mental effort, and motivation with respect to goal directed behavior across a 3-week time period. People with high levels of chronic ego depletion were less successful in goal adherence than those with less chronic ego depletion. Although daily effort devoted to goal adherence increased with chronic ego depletion, motivation to adhere to goals was not affected. Participants with high levels of chronic ego depletion showed a stronger positive association between mental effort and performance, but chronic ego depletion did not play a regulatory role in the effect of motivation on performance. Chronic ego depletion increased the likelihood of behavior regulation failure, suggesting that it is difficult for people in an ego-depletion state to adhere to goals. We integrate our results with the findings of previous studies and discuss possible theoretical implications.	[Wang, Ligang; Tao, Ting; Fan, Chunlei; Gao, Wenbin] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Wei, Chuguang] Chinese Acad Sci, Inst Psychol, Core Facilies, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; Institute of Psychology, CAS	Gao, WB (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China.	gaowb@psych.ac.cn			Natural Sciences Foundation of China [31400885]; Key Laboratory of Mental Health, Chinese Academy of Sciences [KLMH2014ZG12]	Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Mental Health, Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the Natural Sciences Foundation of China (No. 31400885; URL: http://www.nsfc.gov.cn/publish/portal1/). This funder had a role in study design, data collection and analysis. The work was also supported by Key Laboratory of Mental Health, Chinese Academy of Sciences (No. KLMH2014ZG12; URL: http://www.psych.ac.cn/jkzdsys/). This funder had a role in the decision to publish and preparation of the manuscript.	Aiken JS, 1991, MULTIPLE REGRESSION; Baumeister RF, 1996, PSYCHOL INQ, V7, P1, DOI 10.1207/s15327965pli0701_1; Baumeister RF, 2009, SOCIAL PSYCHOL HDB B, P516; Bertrams A, 2010, J RES PERS, V44, P738, DOI 10.1016/j.jrp.2010.09.005; BREHM JW, 1989, ANNU REV PSYCHOL, V40, P109, DOI 10.1146/annurev.ps.40.020189.000545; Burkard C, 2014, NEUROPSYCHOL REHABIL, V24, P266, DOI 10.1080/09602011.2014.887023; Clarkson JJ, 2010, J PERS SOC PSYCHOL, V98, P29, DOI 10.1037/a0017539; Hagger MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076888; Hagger MS, 2010, PSYCHOL BULL, V136, P495, DOI 10.1037/a0019486; Heatherton TF, 1998, PSYCHOL INQ, V9, P212, DOI 10.1207/s15327965pli0903_4; Hofmann W, 2012, PSYCHOL SCI, V23, P582, DOI 10.1177/0956797612437426; Hofmann W, 2009, J EXP SOC PSYCHOL, V45, P431, DOI 10.1016/j.jesp.2008.09.013; Inzlicht M, 2012, PERSPECT PSYCHOL SCI, V7, P450, DOI 10.1177/1745691612454134; Liu X.C., 1997, CHIN J CLIN PSYCHOL, V5, P39, DOI DOI 10.16128/J.CNKI.1005-3611.1997.01.011; Masicampo EJ, 2014, SOC PERSONAL PSYCHOL, V8, P638, DOI 10.1111/spc3.12139; Muraven M, 2000, PSYCHOL BULL, V126, P247, DOI 10.1037/0033-2909.126.2.247; Muraven M, 2003, PERS SOC PSYCHOL B, V29, P894, DOI 10.1177/0146167203029007008; Muraven M, 2007, MOTIV EMOTION, V31, P322, DOI 10.1007/s11031-007-9073-x; Muraven M, 2006, J PERS SOC PSYCHOL, V91, P524, DOI 10.1037/0022-3514.91.3.524; Neal DT, 2013, J PERS SOC PSYCHOL, V104, P959, DOI 10.1037/a0032626; Nes LS, 2013, J PAIN RES, V6, P181, DOI 10.2147/JPR.S40014; Nes LS, 2010, PAIN, V151, P37, DOI 10.1016/j.pain.2010.05.009; Norris FH, 1996, J PERS SOC PSYCHOL, V71, P498, DOI 10.1037/0022-3514.71.3.498; OBRIST PA, 1976, PSYCHOPHYSIOLOGY, V13, P95, DOI 10.1111/j.1469-8986.1976.tb00081.x; Park CL, 1997, J PERS, V65, P421, DOI 10.1111/j.1467-6494.1997.tb00960.x; Salmon SJ, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00647; Schmeichel BJ, 2010, J PERS SOC PSYCHOL, V99, P162, DOI 10.1037/a0019797; Stewart CC, 2009, PSYCHOPHYSIOLOGY, V46, P1141, DOI 10.1111/j.1469-8986.2009.00862.x; Vohs KD, 2000, PSYCHOL SCI, V11, P249, DOI 10.1111/1467-9280.00250; [王利刚 Wang LiGang], 2015, [中国心理卫生杂志, Chinese Mental Health Journal], V29, P290; Wills TA, 2002, J CONSULT CLIN PSYCH, V70, P986, DOI 10.1037//0022-006X.70.4.986; Wood W, 2009, J CONSUM PSYCHOL, V19, P579, DOI 10.1016/j.jcps.2009.08.003; Wright RA, 2013, BIOL PSYCHOL, V93, P316, DOI 10.1016/j.biopsycho.2013.02.016	33	5	6	8	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142220	10.1371/journal.pone.0142220	http://dx.doi.org/10.1371/journal.pone.0142220			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7UL	26562839	gold, Green Submitted, Green Published			2022-12-26	WOS:000364480900021
J	Williams, HA; Gaines, J; Patrick, M; Berendes, D; Fitter, D; Handzel, T				Williams, Holly Ann; Gaines, Joanna; Patrick, Molly; Berendes, David; Fitter, David; Handzel, Thomas			Perceptions of Health Communication, Water Treatment and Sanitation in Artibonite Department, Haiti, March-April 2012	PLOS ONE			English	Article							RURAL POOR; CHOLERA; INTERVENTIONS; COUNTRIES; EPIDEMIC; MODEL; CARE	The international response to Haiti's ongoing cholera outbreak has been multifaceted, including health education efforts by community health workers and the distribution of free water treatment products. Artibonite Department was the first region affected by the outbreak. Numerous organizations have been involved in cholera response efforts in Haiti with many focusing on efforts to improve water, sanitation, and hygiene (WASH). Multiple types of water treatment products have been distributed, creating the potential for confusion over correct dosage and water treatment methods. We utilized qualitative methods in Artibonite to determine the population's response to WASH messages, use and acceptability of water treatment products, and water treatment and sanitation knowledge, attitudes and practices at the household level. We conducted eighteen focus group discussions (FGDs): 17 FGDs were held with community members (nine among females, eight among males); one FGD was held with community health workers. Health messages related to WASH were well-retained, with reported improvements in hand-washing. Community health workers were identified as valued sources of health information. Most participants noted a paucity of water-treatment products. Sanitation, specifically the construction of latrines, was the most commonly identified need. Lack of funds was the primary reason given for not constructing a latrine. The construction and maintenance of potable water and sanitation services is needed to ensure a sustainable change.	[Williams, Holly Ann; Patrick, Molly; Berendes, David; Fitter, David; Handzel, Thomas] Ctr Dis Control & Prevent, Emergency Response & Recovery Branch, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA USA; [Gaines, Joanna] Ctr Dis Control & Prevent, Travelers Hlth Branch, Div Global Migrat & Quarantine, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Williams, HA (corresponding author), Ctr Dis Control & Prevent, Emergency Response & Recovery Branch, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA USA.	hbw2@cdc.gov		Patrick, Molly/0000-0002-9623-5909				Ackers ML, 1998, INT J EPIDEMIOL, V27, P330, DOI 10.1093/ije/27.2.330; Albert J, 2010, ENVIRON SCI TECHNOL, V44, P4426, DOI 10.1021/es1000566; [Anonymous], 2015, RAPP DE CAS; Arvai J, 2012, RISK ANAL, V32, P67, DOI 10.1111/j.1539-6924.2011.01675.x; De Rochars VEMB, 2011, EMERG INFECT DIS, V17, P2158, DOI 10.3201/eid1711.110818; Farmer P, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001145; Fiebelkorn AP, 2012, SOC SCI MED, V75, P622, DOI 10.1016/j.socscimed.2012.02.011; Figueroa ME, 2010, CTR PUBLICATION HCI; Griffith DC, 2006, AM J TROP MED HYG, V75, P973, DOI 10.4269/ajtmh.2006.75.973; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Hunter PR, 2009, ENVIRON SCI TECHNOL, V43, P8991, DOI 10.1021/es9028217; Husain F, EVALUATION GAYDEN DI; Jacobson LM, 2010, SURVEY KNOWLEDGE ATT; Jenkins M., 2006, RETHINKING SANITATIO; Jenkins MW, 2005, SOC SCI MED, V61, P2446, DOI 10.1016/j.socscimed.2005.04.036; Luoto J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026132; Mosler HJ, 2012, INT J ENVIRON HEAL R, V22, P431, DOI 10.1080/09603123.2011.650156; Patrick M, 2013, AM J TROP MED HYG, V89, P647, DOI 10.4269/ajtmh.13-0308; Rajasingham A, 2011, EMERG INFECT DIS, V17, P2162, DOI 10.3201/eid1711.110806; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Ryan ET, 2000, CLIN INFECT DIS, V31, P561, DOI 10.1086/313951; Tappero JW, 2011, EMERG INFECT DIS, V17, P2087, DOI 10.3201/eid1711.110827; WHO, 2013, PREV CONTR CHOL OUTB; Wood S, 2012, SOC SCI MED, V75, P634, DOI 10.1016/j.socscimed.2011.09.018; World Bank, 2004, WORLD BANK GROUPS PR	25	14	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142778	10.1371/journal.pone.0142778	http://dx.doi.org/10.1371/journal.pone.0142778			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7UL	26562658	Green Published, Green Submitted, gold			2022-12-26	WOS:000364480900064
J	Avila-Rios, S; Garcia-Morales, C; Tapia-Trejo, D; Meza, RI; Nunez, SM; Parham, L; Flores, NA; Valladares, D; Pineda, LM; Flores, D; Motino, R; Umanzor, V; Carbajal, C; Murillo, W; Lorenzana, I; Palou, EY; Reyes-Teran, G				Avila-Rios, Santiago; Garcia-Morales, Claudia; Tapia-Trejo, Daniela; Meza, Rita I.; Nunez, Sandra M.; Parham, Leda; Flores, Norma A.; Valladares, Diana; Pineda, Luisa M.; Flores, Dixiana; Motino, Roxana; Umanzor, Victor; Carbajal, Candy; Murillo, Wendy; Lorenzana, Ivette; Palou, Elsa Y.; Reyes-Teran, Gustavo			HIV Drug Resistance Surveillance in Honduras after a Decade of Widespread Antiretroviral Therapy	PLOS ONE			English	Article							MUTATIONS; EPIDEMIOLOGY; TRANSMISSION; INDIVIDUALS	Introduction We assessed HIV drug resistance (DR) in individuals failing ART (acquired DR, ADR) and in ART-naive individuals (pre-ART DR, PDR) in Honduras, after 10 years of widespread availability of ART. Methods 365 HIV-infected, ART-naive, and 381 ART-experienced Honduran individuals were enrolled in 5 reference centres in Tegucigalpa, San Pedro Sula, La Ceiba, and Choluteca between April 2013 and April 2015. Plasma HIV protease-RT sequences were obtained. HIVDR was assessed using the WHO HIVDR mutation list and the Stanford algorithm. Recently infected (RI) individuals were identified using a multi-assay algorithm. Results PDR to any ARV drug was 11.5%(95% CI 8.4-15.2%). NNRTI PDR prevalence (8.2%) was higher than NRTI (2.2%) and PI (1.9%, p < 0.0001). No significant trends in time were observed when comparing 2013 and 2014, when using a moving average approach along the study period or when comparing individuals with > 500 vs. < 350 CD4+ T cells/mu L. PDR in recently infected individuals was 13.6%, showing no significant difference with PDR in individuals with longstanding infection (10.7%). The most prevalent PDR mutations were M46IL (1.4%), T215 revertants (0.5%), and K103NS (5.5%). The overall ADR prevalence in individuals with < 48 months on ART was 87.8% and for the >= 48 months on ART group 81.3%. ADR to three drug families increased in individuals with longer time on ART (p = 0.0343). M184V and K103N were the most frequent ADR mutations. PDR mutation frequency correlated with ADR mutation frequency for PI and NNRTI (p < 0.01), but not for NRTI. Clusters of viruses were observed suggesting transmission of HIVDR both from ART-experienced to ART-naive individuals and between ART-naive individuals. Conclusions The global PDR prevalence in Honduras remains at the intermediate level, after 10 years of widespread availability of ART. Evidence of ADR influencing the presence of PDR was observed by phylogenetic analyses and ADR/PDR mutation frequency correlations.	[Avila-Rios, Santiago; Garcia-Morales, Claudia; Tapia-Trejo, Daniela; Reyes-Teran, Gustavo] Natl Inst Resp Dis, Ctr Res Infect Dis, Mexico City, DF, Mexico; [Meza, Rita I.; Nunez, Sandra M.; Parham, Leda] Honduran Minist Hlth, HIV Natl Programme, Tegucigalpa, Honduras; [Meza, Rita I.; Nunez, Sandra M.; Parham, Leda] Honduran Minist Hlth, HIV Natl Lab, Tegucigalpa, Honduras; [Flores, Norma A.] Inst Nacl Cardio Pulm, Tegucigalpa, Honduras; [Valladares, Diana; Pineda, Luisa M.] Hosp Mario Catarino Rivas, San Pedro Sula, Honduras; [Flores, Dixiana; Motino, Roxana] Unidad Salud Metropolitana, Le Ceiba, Honduras; [Umanzor, Victor] Hosp Sur, Choluteca, Honduras; [Carbajal, Candy; Murillo, Wendy; Lorenzana, Ivette; Palou, Elsa Y.] Univ Nacl Autonoma Honduras, Tegucigalpa, Honduras; [Palou, Elsa Y.] Hosp Escuela Univ, Tegucigalpa, Honduras	Universidad Nacional Autonoma de Honduras	Lorenzana, I (corresponding author), Univ Nacl Autonoma Honduras, Tegucigalpa, Honduras.	ivettelorenzana@yahoo.com; palouey@yahoo.com.mx; gustavo.reyesteran@gmail.com	Avila-Rios, Santiago/AAB-4383-2020	Murillo, Wendy/0000-0002-8326-7223; Reyes-Teran, Gustavo/0000-0002-4115-4888; Lorenzana, Ivette/0000-0002-8128-8602	Mexican Government (Comision de Equidad y Genero de las Legislaturas LX-LXI y Comision de Igualdad de Genero de la Legislatura LXII de la H. Camara de Diputados de la Republica Mexicana); CONACYT [SALUD-2013-01-202475]	Mexican Government (Comision de Equidad y Genero de las Legislaturas LX-LXI y Comision de Igualdad de Genero de la Legislatura LXII de la H. Camara de Diputados de la Republica Mexicana); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by grants from the Mexican Government (Comision de Equidad y Genero de las Legislaturas LX-LXI y Comision de Igualdad de Genero de la Legislatura LXII de la H. Camara de Diputados de la Republica Mexicana), and CONACYT (SALUD-2013-01-202475). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], STANF HIV DRUG RES D; [Anonymous], RIP TOOL; [Anonymous], REGA HIV SUBT TOOL V; Avila-Rios S, 2015, AIDS RES HUM RETROV, V31, P401, DOI 10.1089/aid.2014.0057; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Frentz D, 2012, AIDS REV, V14, P17; Jain V, 2011, J INFECT DIS, V203, P1174, DOI 10.1093/infdis/jiq167; Laeyendecker O, 2013, J INFECT DIS, V207, P232, DOI 10.1093/infdis/jis659; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Lloyd B, 2008, AIDS RES HUM RETROV, V24, P529, DOI 10.1089/aid.2007.0172; Mourad R, 2015, AIDS, V29, P1917, DOI 10.1097/QAD.0000000000000768; Murillo W, 2010, HIV MED, V11, P95, DOI 10.1111/j.1468-1293.2009.00747.x; Murillo W, 2010, J CLIN VIROL, V49, P239, DOI 10.1016/j.jcv.2010.03.013; ONUSIDA, ONUSIDA HOND; Pineda-Pena AC, 2012, AIDS REV, V14, P256; Rhee SY, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001810; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Shafer RW, 2006, J INFECT DIS, V194, pS51, DOI 10.1086/505356; Strathdee SA, 2012, ANN EPIDEMIOL, V22, P426, DOI 10.1016/j.annepidem.2012.04.002; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; UNAIDS, 2014, 2014 PROGR REP SUBM; UNAIDS, UNAIDS GAP REP 2014; UNAIDS, UNAIDS HOND; UNDP, 2015, UN DEV PROGR REP; WHO, SURV HIV DRUG RES AD; WHO, WHO HIV DRUG RES STR; World Health Organization, WHO HIV DRUG RES REP; Yang WL, 2015, J INFECT DIS, V212, P28, DOI 10.1093/infdis/jiv012	28	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142604	10.1371/journal.pone.0142604	http://dx.doi.org/10.1371/journal.pone.0142604			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558396	gold, Green Published, Green Submitted			2022-12-26	WOS:000364433100098
J	Falace, A; Kaleb, S; Curiel, D; Miotti, C; Galli, G; Querin, S; Ballesteros, E; Solidoro, C; Bandelj, V				Falace, Annalisa; Kaleb, Sara; Curiel, Daniele; Miotti, Chiara; Galli, Giovanni; Querin, Stefano; Ballesteros, Enric; Solidoro, Cosimo; Bandelj, Vinko			Calcareous Bio-Concretions in the Northern Adriatic Sea: Habitat Types, Environmental Factors that Influence Habitat Distributions, and Predictive Modeling	PLOS ONE			English	Article							ROCKY OUTCROPS MACROALGAE; VENICE LAGOON; WATER; CONSERVATION; VARIABILITY; COMMUNITIES; BIOTOPES	Habitat classifications provide guidelines for mapping and comparing marine resources across geographic regions. Calcareous bio-concretions and their associated biota have not been exhaustively categorized. Furthermore, for management and conservation purposes, species and habitat mapping is critical. Recently, several developments have occurred in the field of predictive habitat modeling, and multiple methods are available. In this study, we defined the habitats constituting northern Adriatic biogenic reefs and created a predictive habitat distribution model. We used an updated dataset of the epibenthic assemblages to define the habitats, which we verified using the fuzzy k-means (FKM) clustering method. Redundancy analysis was employed to model the relationships between the environmental descriptors and the FKM membership grades. Predictive modelling was carried out to map habitats across the basin. Habitat A (opportunistic macroalgae, encrusting Porifera, bioeroders) characterizes reefs closest to the coastline, which are affected by coastal currents and river inputs. Habitat B is distinguished by massive Porifera, erect Tunicata, and noncalcareous encrusting algae (Peyssonnelia spp.). Habitat C (non-articulated coralline, Polycitor adriaticus) is predicted in deeper areas. The onshore-offshore gradient explains the variability of the assemblages because of the influence of coastal freshwater, which is the main driver of nutrient dynamics. This model supports the interpretation of Habitat A and C as the extremes of a gradient that characterizes the epibenthic assemblages, while Habitat B demonstrates intermediate characteristics. Areas of transition are a natural feature of the marine environment and may include a mixture of habitats and species. The habitats proposed are easy to identify in the field, are related to different environmental features, and may be suitable for application in studies focused on other geographic areas. The habitat model outputs provide insight into the environmental drivers that control the distribution of the habitat and can be used to guide future research efforts and cost-effective management and conservation plans.	[Falace, Annalisa; Kaleb, Sara; Bandelj, Vinko] Univ Trieste, Dept Life Sci, Trieste, Italy; [Curiel, Daniele; Miotti, Chiara] SELC Soc Marghera, Venice, Italy; [Galli, Giovanni; Querin, Stefano; Solidoro, Cosimo] Natl Inst Oceanog & Expt Geophys OGS, Trieste, Italy; [Ballesteros, Enric] CSIC, Ctr Estudis Avancats Blanes, Girona, Spain	University of Trieste; Istituto Nazionale di Oceanografia e di Geofisica Sperimentale; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB)	Falace, A (corresponding author), Univ Trieste, Dept Life Sci, Trieste, Italy.	falace@univ.trieste.it	Bandelj, Vinko/J-2129-2019; Querin, Stefano/AAC-6149-2022; FALACE, Annalisa/O-9473-2015; Kaleb, Sara/O-9409-2015	Bandelj, Vinko/0000-0003-0455-1806; Querin, Stefano/0000-0002-4658-860X; FALACE, Annalisa/0000-0002-9671-5283; Kaleb, Sara/0000-0002-8584-7280; solidoro, cosimo/0000-0003-2354-4302	Italian Ministry of Education, Universities and Research [2010Z8HJ5M_003]; INTERREG Ita-Slo Program	Italian Ministry of Education, Universities and Research(Ministry of Education, Universities and Research (MIUR)); INTERREG Ita-Slo Program	This study has been funded by the Italian Ministry of Education, Universities and Research within the scientific research program of national interest "Coastal bioconstructions: structures, functions, and management" (2010-11 PRIN prot. 2010Z8HJ5M_003) and by the INTERREG Ita-Slo 2007-2013 Program (Project TRECORALA - TREzze e CORalligeno dell'ALto Adriatico: valorizzazione e gestione sostenibile nel Golfo di Trieste.http://www.trecorala.eu/it-IT/7-avvio-del-progetto-trecorala). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Two authors are employed by a commercial company: 'SELC Soc. Coop'. The funder provided support in the form of salaries for DC and CM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions' section.	[Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; ARPAV-Fondazione Musei Civici Venezia, 2010, TEGN ALT ADR VAL RIS; Artegiani A, 1997, J PHYS OCEANOGR, V27, P1515, DOI 10.1175/1520-0485(1997)027<1515:TASGCP>2.0.CO;2; Balata D, 2005, MAR ENVIRON RES, V60, P403, DOI 10.1016/j.marenvres.2004.12.005; Ballesteros E, 1992, ARXIUS SECCIO CIENCI, V101, P1; Ballesteros E, 2006, OCEANOGR MAR BIOL, V44, P123; Bandelj Vinko, 2012, PLoS ONE, V7, pe52395; Bezdek J.C., 1981, PATTERN RECOGN, DOI 10.1007/978-1-4757-0450-1; Bianchi C.N., 2001, Biologia Marina Mediterranea, V8, P112; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bosence D.W.J., 1985, PALEOALGOLOGY CONT R, P216; BOSENCE DWJ, 1983, J GEOL SOC LONDON, V140, P365, DOI 10.1144/gsjgs.140.3.0365; Boudouresque C.F., 1973, B MUS HIST NAT MARSE, V33, P147; Bracchi V, 2015, ITAL J GEOSCI, V134, P32, DOI 10.3301/IJG.2014.16; Braga G, 1969, ATTI I VENETO SCI LE, V77, P351; Canals M, 1997, DEEP-SEA RES PT II, V44, P611, DOI 10.1016/S0967-0645(96)00095-1; Carballo J. L., 1994, Beaufortia, V44, P11; Casellato S., 2005, Biologia Marina Mediterranea, V12, P69; Casellato S, 2008, MAR ECOL-EVOL PERSP, V29, P321, DOI 10.1111/j.1439-0485.2008.00236.x; Casellato S, 2007, CENT EUR J BIOL, V2, P122, DOI 10.2478/s11535-007-0004-3; Colantoni P, 1998, P 5 INT C GAS MAR SE, P28; Connor DW, 2002, RATIONALE CRITERIA; Conti A, 2002, CONT SHELF RES, V22, P2333, DOI 10.1016/S0278-4343(02)00059-6; Costello MJ., 2001, OCEANIS, V24, P25; Costello MJ, 2005, INTERTIDAL ECOSYSTEM, P25; CURIEL D, 2009, B MUS CIVICO STORIA, V59, P3; Curiel D, 2010, TEGNUE ALTO ADRIATIC, P62; CURIEL D, 1999, ACTA ADRIAT, V40, P111; Curiel D, 2012, BOT MAR, V55, P625, DOI 10.1515/bot-2012-0166; Curiel Daniele, 2010, Bollettino del Museo di Storia Naturale di Venezia, V61, P5; Curiel Danile, 2010, Societa Veneziana di Scienze Naturali Lavori, V35, P39; Davies AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018483; Davies CE, 1999, EUNIS HABITAT CLASSI; DEFRA, 2002, STRAT CONS SUST DEV; Di Geronimo I., 2001, Biologia Marina Mediterranea, V8, P229; Di Geronimo I, 2001, GEOBIOS MEM SPEC, V24, P86; Di Geronimo I, 2002, GEOBIOS-LYON, V35, P86, DOI 10.1016/S0016-6995(02)00050-5; Diaz RJ, 2004, J ENVIRON MANAGE, V73, P165, DOI 10.1016/j.jenvman.2004.06.004; Dray S, 2013, BIOL MARINA MEDITERR; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; EZEKIEL M, 1930, METHODS CORRELATION; Falace A, 2010, CHEM ECOL, V26, P77, DOI 10.1080/02757541003689837; FALACE A, 2009, BIOL MAR MEDITERR, V16, P82; Falace A, 2009, MAR ECOL-EVOL PERSP, V30, P480, DOI 10.1111/j.1439-0485.2009.00300.x; Faresi L., 2010, TREZZE GREBENI BIOTO, P69; Ferraro MB, 2015, FUZZY SET SYST, V279, P1, DOI 10.1016/j.fss.2015.05.001; Fransson Johan, 2009, V480, P113, DOI 10.1007/978-1-59745-429-2_8; Gabriele M, 1999, CAH BIOL MAR, V40, P65; Giakoumi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076449; Gordini E, 2012, ELSEV INSIGHT, P185, DOI 10.1016/B978-0-12-385140-6.00009-8; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hong JS, 1980, THESIS; Kipson S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027103; Laborel J, 1987, SCI REP PORT CROS NA, V13, P97; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Magistrato Alle Acque di Venezia-Corila-SELC, 2006, RAPP VAR ATT; Martin CS, 2014, SCI REP-UK, V4, DOI [10.1038/srep05073, 10.1038/srep06646]; McCune B, 1997, ECOLOGY, V78, P2617; MOSS D, 1994, APPL GEOGR, V14, P327, DOI 10.1016/0143-6228(94)90026-4; Naranjo SA, 1996, MAR ECOL PROG SER, V144, P119, DOI 10.3354/meps144119; NEWTON RS, 1975, MAR GEOL, V19, pM27, DOI 10.1016/0025-3227(75)90054-7; Oksanen J, 2015, VEAGN COMM; Orlando-Bonaca M, 2012, REPORT ARTICLE; Peres J. M., 1958, Ann Inst Oceanogr Paris NS, V34, P213; Peres J.M, 1964, RECUEIL TRAVAUX STAT, V31, P1; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Ponti M, 2008, MERAVIGLIE SOMMERSE; Ponti M, 2014, P 2 MED S CONS COR O, P147; Ponti M, 2011, MAR BIOL, V158, P1447, DOI 10.1007/s00227-011-1661-3; QGIS Development Team, 2015, QGIS GEOGR INF SYST; Querin S, 2013, J GEOPHYS RES-OCEANS, V118, P885, DOI 10.1002/jgrc.20092; Rao C.R., 1964, SANKHYA A, V26, P329, DOI DOI 10.1214/AOMS/1177704248; Russo A, 1996, SCI MAR, V60, P33; Salomidi M, 2012, MEDITERR MAR SCI, V13, P49, DOI 10.12681/mms.23; Sfriso A, 2007, BOT MAR, V50, P22, DOI 10.1515/BOT.2007.004; Sfriso A, 2009, FLORA AND VEGETATION OF THE ITALIAN TRANSITIONAL WATER SYSTEMS, P17; SOLAZZI A, 1981, Studi Trentini di Scienze Naturali Acta Biologica, V58, P463; Solidoro C, 2004, J MARINE SYST, V51, P7, DOI 10.1016/j.jmarsys.2004.05.024; Solidoro C, 2007, SCI RES SAFEGARUDING, V2006, P371; Solidoro C, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003553; Solidoro C, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004838; Stefanon A, 2000, HYDROGEOLOGIE, V4, P3; UNEP-MAP-RAC/SPA, 2008, ACT PLAN CONS COR OT; VANDENWOLLENBERG AL, 1977, PSYCHOMETRIKA, V42, P207, DOI 10.1007/BF02294050; ZOREARMANDA M, 1969, DEEP-SEA RES, V16, P171, DOI 10.1016/0011-7471(69)90072-2	93	28	31	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0140931	10.1371/journal.pone.0140931	http://dx.doi.org/10.1371/journal.pone.0140931			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560891	Green Published, gold, Green Submitted			2022-12-26	WOS:000364433100015
J	Lai, SH; Liao, SL; Yao, TC; Tsai, MH; Hua, MC; Yeh, KW; Huang, JL				Lai, Shen-Hao; Liao, Sui-Ling; Yao, Tsung-Chieh; Tsai, Ming-Han; Hua, Man-Chin; Yeh, Kuo-Wei; Huang, Jing-Long			Respiratory Function in Healthy Taiwanese Infants: Tidal Breathing Analysis, Passive Mechanics, and Tidal Forced Expiration	PLOS ONE			English	Article							LUNG-FUNCTION; AIRWAY FUNCTION; CHILDREN; FLOW; BIRTH; ETHNICITY; GENDER; GROWTH; AGE	Background Although infant lung function (ILF) testing is widely practiced in developed Western countries it is not typically performed in Eastern countries, and lung measurements are scarce for Asian infants. Therefore, this study aimed to establish normal reference values for Taiwanese infants. Materials and Methods Full-term infants without any chronic diseases and major anomalies were enrolled in the Prediction of Allergies in Taiwanese Children (PATCH) cohort study. Detailed medical data, such as body weight and length, birth history, and histories of previous illness and hospitalization were recorded. Lung function measurements such as analysis of tidal breathing, passive respiratory mechanics, and forced tidal expiratory flow-volume curves were obtained through Jaeger Masterscreen BabyBody Paediatrics System. Multiple linear analyses were performed to determine various parameters of the lung function tests. Results ILF test parameters were collected from 126 infants, and 189 tests were performed. The results revealed that the ratio of time to peak expiratory flow to total expiratory time, the ratio of volume to peak expiratory flow to total expiratory volume, and the ratio of inspiratory time to total respiratory time remained relatively constant despite differences in age. However, body length is the strongest independent variable influencing tidal volume, respiratory rate, resistance, compliance, and maximal expiratory flow at functional residual capacity. Conclusion According to our review of relevant literature, this is the first study to establish a reference data of ILF tests in the Asian population. This study provided reference values and regression equations for several variables of lung function measurements in healthy infants aged less than 2 years. With these race-specific reference data, ILF can more precisely and efficiently diagnose respiratory diseases in infants of Chinese ethnicity.	[Lai, Shen-Hao; Yao, Tsung-Chieh; Yeh, Kuo-Wei; Huang, Jing-Long] Chang Gung Univ, Chang Gung Mem Hosp, Dept Pediat, Taoyuan, Taiwan; [Lai, Shen-Hao; Liao, Sui-Ling; Yao, Tsung-Chieh; Tsai, Ming-Han; Hua, Man-Chin; Yeh, Kuo-Wei; Huang, Jing-Long] Chang Gung Univ, Dept Pediat, Taoyuan, Taiwan; [Liao, Sui-Ling; Tsai, Ming-Han; Hua, Man-Chin] Chang Gung Mem Hosp, Dept Pediat, Keelung, Taiwan; [Liao, Sui-Ling; Tsai, Ming-Han; Hua, Man-Chin] Chang Gung Univ, Keelung, Taiwan; [Lai, Shen-Hao; Liao, Sui-Ling; Yao, Tsung-Chieh; Tsai, Ming-Han; Hua, Man-Chin; Yeh, Kuo-Wei; Huang, Jing-Long] Predict Allergies Taiwanese Children PATCH Cohort, Keelung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Huang, JL (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Dept Pediat, Taoyuan, Taiwan.	hjlong0182@gmail.com	Yeh, Kuo-Wei/V-3725-2019	Huang, Jing-Long/0000-0001-9280-920X; Huang, Jing-Long/0000-0002-3530-7753	Chang Gung Medical Hospital [CMRPG2B0061, CMRPG2B0062, CMRPG2B0063, CMRPG3E1211]	Chang Gung Medical Hospital	This work was supported by Chang Gung Medical Hospital (CMRPG2B0061, CMRPG2B0062, CMRPG2B0063, and CMRPG3E1211).	American Thoracic Society, 2005, Am J Respir Crit Care Med, V172, P1463; Baraldi E, 2007, NEW ENGL J MED, V357, P1946, DOI 10.1056/NEJMra067279; Bates JHT, 2000, EUR RESPIR J, V16, P1180, DOI 10.1034/j.1399-3003.2000.16f26.x; Carlsen KCL, 1997, PEDIATR PULM, V24, P391, DOI 10.1002/(SICI)1099-0496(199712)24:6<391::AID-PPUL3>3.0.CO;2-K; CARLSEN KCL, 1994, EUR RESPIR J, V7, P1660, DOI 10.1183/09031936.94.07091660; CARLSEN KH, 1994, EUR RESPIR J, V7, P2154, DOI 10.1183/09031936.94.07122154; Cazzato S, 2013, PEDIATR PULM, V48, P830, DOI 10.1002/ppul.22676; Chavasse RJ, 2001, EUR RESPIR J, V18, P330, DOI 10.1183/09031936.01.00018401; Chen W, 2010, PEDIATR NEONATOL, V51, P69, DOI 10.1016/S1875-9572(10)60014-9; Colin AA, 2001, AM J RESP CRIT CARE, V163, P865, DOI 10.1164/ajrccm.163.4.9901040; Davis SD, 2010, AM J RESP CRIT CARE, V182, P1387, DOI 10.1164/rccm.200908-1236OC; Dezateux C, 2001, THORAX, V56, P680, DOI 10.1136/thorax.56.9.680; Ducharme FM, 2014, LANCET, V383, P1593, DOI 10.1016/S0140-6736(14)60615-2; Frey U, 2000, EUR RESPIR J, V16, P731, DOI 10.1034/j.1399-3003.2000.16d28.x; Frey U, 2001, J APPL PHYSIOL, V91, P1687, DOI 10.1152/jappl.2001.91.4.1687; Gappa M, 2001, EUR RESPIR J, V17, P141, DOI 10.1183/09031936.01.17101410; Hanrahan JP, 1996, AM J RESP CRIT CARE, V154, P670, DOI 10.1164/ajrccm.154.3.8810604; HANRAHAN JP, 1990, AM REV RESPIR DIS, V141, P1127, DOI 10.1164/ajrccm/141.5_Pt_1.1127; HATCH D, 1992, BRIT J ANAESTH, V68, P398, DOI 10.1093/bja/68.4.398; Hegde S, 2013, PEDIATR PULM, V48, P1148, DOI 10.1002/ppul.22799; Henschen M, 1999, AM J RESP CRIT CARE, V159, P480, DOI 10.1164/ajrccm.159.2.9801083; Hoo AF, 1998, AM J RESP CRIT CARE, V158, P700, DOI 10.1164/ajrccm.158.3.9711057; Hoo AF, 2002, AM J RESP CRIT CARE, V165, P1084, DOI 10.1164/ajrccm.165.8.2103035; Hoo AF, 2014, PEDIATR PULM, V49, P679, DOI 10.1002/ppul.22882; Katier N, 2006, PEDIATR PULM, V41, P1058, DOI 10.1002/ppul.20492; Liao SL, 2014, PEDIAT ALLERG IMM-UK, V25, P456, DOI 10.1111/pai.12247; Liao SL, 2013, EARLY HUM DEV, V89, P473, DOI 10.1016/j.earlhumdev.2013.03.013; Lum S, 2010, EUR RESPIR MONOGR, P46, DOI 10.1183/1025448x.00020909; Lum S, 2010, PEDIATR PULM, V45, P906, DOI 10.1002/ppul.21255; MASTERS IB, 1987, PEDIATR PULM, V3, P3, DOI 10.1002/ppul.1950030104; Shih SF, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-67; Sly PD, 2000, EUR RESPIR J, V16, P741, DOI 10.1034/j.1399-3003.2000.16d29.x; STOCKS J, 1994, AM J RESP CRIT CARE, V150, P1347, DOI 10.1164/ajrccm.150.5.7952563; Stocks J, 1997, AM J RESP CRIT CARE, V156, P1855, DOI 10.1164/ajrccm.156.6.9607056; Nguyen TTD, 2013, PEDIATR PULM, V48, P370, DOI 10.1002/ppul.22656; vanderEnt CK, 1996, AM J RESP CRIT CARE, V153, P1253, DOI 10.1164/ajrccm.153.4.8616550; Vilozni D, 2011, CHEST, V139, P1439, DOI 10.1378/chest.10-0625; Yao TC, 2014, J PEDIATR-US, V165, P1098, DOI 10.1016/j.jpeds.2014.08.048	38	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142797	10.1371/journal.pone.0142797	http://dx.doi.org/10.1371/journal.pone.0142797			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559673	Green Published, gold, Green Submitted			2022-12-26	WOS:000364433100126
J	Nakae, S; Sasaki, H; Hayashi, S; Hattori, N; Kumon, M; Nishiyama, Y; Adachi, K; Nagahisa, S; Hayashi, T; Inamasu, J; Abe, M; Hasegawa, M; Hirose, Y				Nakae, Shunsuke; Sasaki, Hikaru; Hayashi, Saeko; Hattori, Natsuki; Kumon, Masanobu; Nishiyama, Yuya; Adachi, Kazuhide; Nagahisa, Shinya; Hayashi, Takuro; Inamasu, Joji; Abe, Masato; Hasegawa, Mitsuhiro; Hirose, Yuichi			PCR-Based Simple Subgrouping Is Validated for Classification of Gliomas and Defines Negative Prognostic Copy Number Aberrations in IDH Mutant Gliomas	PLOS ONE			English	Article							TP53 MUTATIONS; SURVIVAL; OLIGODENDROGLIOMAS; MARKERS; 19Q	Genetic subgrouping of gliomas has been emphasized recently, particularly after the finding of isocitrate dehydrogenase 1 (IDH1) mutations. In a previous study, we investigated whole-chromosome copy number aberrations (CNAs) of gliomas and have described genetic subgrouping based on CNAs and IDH1 mutations. Subsequently, we classified gliomas using simple polymerase chain reaction (PCR)-based methods to improve the availability of genetic subgrouping. We selected IDH1/2 and TP53 as markers and analyzed 237 adult supratentorial gliomas using Sanger sequencing. Using these markers, we classified gliomas into three subgroups that were strongly associated with patient prognoses. These included IDH mutant gliomas without TP53 mutations, IDH mutant gliomas with TP53 mutations, and IDH wild-type gliomas. IDH mutant gliomas without TP53 mutations, which mostly corresponded to gliomas carrying 1p19q co-deletions, showed lower recurrence rates than the other 2 groups. In the other high-recurrence groups, the median progression- free survival (PFS) and overall survival (OS) of patients with IDH mutant gliomas with TP53 mutations were significantly longer than those of patients with IDH wild-type gliomas. Notably, most IDH mutant gliomas with TP53 mutations had at least one of the CNAs +7q, +8q, -9p, and -11p. Moreover, IDH mutant gliomas with at least one of these CNAs had a significantly worse prognosis than did other IDH mutant gliomas. PCR-based mutation analyses of IDH and TP53 were sufficient for simple genetic diagnosis of glioma that were strongly associated with prognosis of patients and enabled us to detect negative CNAs in IDH mutant gliomas.	[Nakae, Shunsuke; Hattori, Natsuki; Kumon, Masanobu; Nishiyama, Yuya; Adachi, Kazuhide; Nagahisa, Shinya; Hayashi, Takuro; Inamasu, Joji; Hasegawa, Mitsuhiro; Hirose, Yuichi] Fujita Hlth Univ, Dept Neurosurg, Toyoake, Aichi, Japan; [Sasaki, Hikaru; Hayashi, Saeko] Keio Univ, Dept Neurosurg, Tokyo, Japan; [Abe, Masato] Fujita Hlth Univ, Dept Pathol, Toyoake, Aichi, Japan	Fujita Health University; Keio University; Fujita Health University	Hirose, Y (corresponding author), Fujita Hlth Univ, Dept Neurosurg, Toyoake, Aichi, Japan.	yhirose@fujita-hu.ac.jp	Inamasu, Joji/R-7314-2019; Hirose, Yuichi/P-1731-2019	Hirose, Yuichi/0000-0002-1305-1830; ADACHI, KAZUHIDE/0000-0002-5275-8572; nishiyama, yuya/0000-0001-9715-6607	Grants-in-Aid for Scientific Research [25462278] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Alentorn A, 2014, NEURO-ONCOLOGY, V16, P400, DOI 10.1093/neuonc/not227; Cairncross JG, 1998, J NATL CANCER I, V90, P1473, DOI 10.1093/jnci/90.19.1473; de Carcer G, 2014, NAT CELL BIOL, V16, P504, DOI 10.1038/ncb2978; Hartmann C, 2013, CLIN CANCER RES, V19, P5146, DOI 10.1158/1078-0432.CCR-13-0017; Hirose Y, 2013, BRAIN TUMOR PATHOL, V30, P203, DOI 10.1007/s10014-013-0148-y; Hirose Y, 2011, NEUROSURGERY, V69, P376, DOI 10.1227/NEU.0b013e318212bcd8; Holstege H, 2009, CANCER RES, V69, P3625, DOI 10.1158/0008-5472.CAN-08-3426; Huse JT, 2014, CLIN CANCER RES, V20, P5601, DOI 10.1158/1078-0432.CCR-14-0831; Jiao YC, 2012, ONCOTARGET, V3, P709, DOI 10.18632/oncotarget.588; Killela PJ, 2014, ONCOTARGET, V5, P1515, DOI 10.18632/oncotarget.1765; Kitange G, 2005, GENE CHROMOSOME CANC, V42, P68, DOI 10.1002/gcc.20108; Koga Y, 2009, JPN J CLIN ONCOL, V39, P62, DOI 10.1093/jjco/hyn129; Leroy B, 2014, HUM MUTAT, V35, P672, DOI 10.1002/humu.22552; McLendon RE, 2005, CANCER, V104, P1693, DOI 10.1002/cncr.21362; Nam HJ, 2014, NAT CELL BIOL, V16, P535, DOI 10.1038/ncb2952; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Shatz M, 2012, CANCER RES, V72, P3948, DOI 10.1158/0008-5472.CAN-11-4134; Solis OE, 2011, J NEURO-ONCOL, V102, P477, DOI 10.1007/s11060-010-0335-1; Trost D, 2007, INT J CANCER, V120, P2368, DOI 10.1002/ijc.22574; Ueki K, 2002, CLIN CANCER RES, V8, P196; van Thuijl HF, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0471-6; Vegran F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055103; Walker DR, 1999, ONCOGENE, V18, P211, DOI 10.1038/sj.onc.1202298; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yip S, 2012, J PATHOL, V226, P7, DOI 10.1002/path.2995	26	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142750	10.1371/journal.pone.0142750	http://dx.doi.org/10.1371/journal.pone.0142750			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558387	gold, Green Published, Green Submitted			2022-12-26	WOS:000364433100118
J	Pajarinen, J; Lin, TH; Sato, TS; Loi, F; Yao, ZY; Konttinen, YT; Goodman, SB				Pajarinen, Jukka; Lin, Tzu-hua; Sato, Taishi; Loi, Florence; Yao, Zhenyu; Konttinen, Yrjo T.; Goodman, Stuart B.			Establishment of Green Fluorescent Protein and Firefly Luciferase Expressing Mouse Primary Macrophages for In Vivo Bioluminescence Imaging	PLoS One			English	Article							UHMWPE PARTICLES; CELLS; ACTIVATION; INFUSION; CANCER	Macrophages play a key role in tissue homeostasis as well as in a range of pathological conditions including atherosclerosis, cancer, and autoimmunity. Many aspects of their in vivo behavior are, however, poorly understood. Bioluminescence imaging (BLI) with green fluorescent protein (GFP) and firefly luciferase (FLUC) labelled autologous reporter macrophages could potentially offer a powerful tool to study macrophage biology, but this approach has been hindered by the relative difficulty of efficient gene transfer into primary macrophages. Here we describe a straightforward method for producing large numbers of GFP/FLUC expressing mouse primary macrophages utilizing lentivirus vector, cyclosporine, and a double infection strategy. Using this method we achieved up to 60% of macrophages to express GFP with correspondingly high FLUC signal. When injected into the circulation using a mouse model of local biomaterial induced inflammation and osteolysis, macrophages were initially detectable within the lungs, followed by systemic homing to the local area of chronic inflammation in the distal femur. In addition, transduced macrophages maintained their ability to assume M1 and M2 phenotypes although the GFP/FLUC expression was altered by the polarizing signals. These reporter macrophages could prove to be valuable tools to study the role of macrophages in health and disease.	[Pajarinen, Jukka; Lin, Tzu-hua; Sato, Taishi; Loi, Florence; Yao, Zhenyu; Goodman, Stuart B.] Stanford Univ, Orthopaed Res Labs, Dept Orthopaed Surg, Sch Med, Stanford, CA 94305 USA; [Konttinen, Yrjo T.] Univ Helsinki, Dept Med, Inst Clin Med, Helsinki, Finland	Stanford University; University of Helsinki	Goodman, SB (corresponding author), Stanford Univ, Orthopaed Res Labs, Dept Orthopaed Surg, Sch Med, Stanford, CA 94305 USA.	goodbone@stanford.edu	Goodman, Stuart/AAZ-7499-2020	Goodman, Stuart/0000-0002-1919-3717	National Institutes of Health [2R01 AR055650, 1R01AR063717]; Ellenburg Chair in Surgery in Stanford University; Jane and Aatos Erkko foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063717, R01AR055650] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellenburg Chair in Surgery in Stanford University; Jane and Aatos Erkko foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The study was supported by National Institutes of Health grants 2R01 AR055650 and 1R01AR063717 (SBG), the Ellenburg Chair in Surgery in Stanford University (SBG), and Jane and Aatos Erkko foundation (JP) (http://www.jaes.fi/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Yutaka, TFSEARCH SEARCHING T; Brown BN, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00510; Cao YA, 2005, TRANSPLANTATION, V80, P134, DOI 10.1097/01.TP.0000164347.50559.A3; Cao YA, 2004, P NATL ACAD SCI USA, V101, P221, DOI 10.1073/pnas.2637010100; Creusot RJ, 2009, BLOOD, V113, P6638, DOI 10.1182/blood-2009-02-204321; Escolano A, 2014, EMBO J, V33, P1117, DOI 10.1002/embj.201386369; Gibon E, 2012, J ORTHOP RES, V30, P547, DOI 10.1002/jor.21548; Goodman SB, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0962; Hoffman RM, 2005, NAT REV CANCER, V5, P796, DOI 10.1038/nrc1717; Hoffman RM, 2015, LAB INVEST, V95, P432, DOI 10.1038/labinvest.2014.154; Kang YJ, 2007, J IMMUNOL, V179, P4598, DOI 10.4049/jimmunol.179.7.4598; Ma T, 2008, BIOMATERIALS, V29, P3738, DOI 10.1016/j.biomaterials.2008.05.031; Martinez FO, 2013, BLOOD, V121, pE57, DOI 10.1182/blood-2012-06-436212; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nich C, 2013, J BIOMED MATER RES A, V101, P3033, DOI 10.1002/jbm.a.34599; Noser JA, 2006, J VIROL, V80, P7769, DOI 10.1128/JVI.02427-05; Pajarinen J, 2014, J MATER CHEM B, V2, P7094, DOI [10.1039/C4TB01005A, 10.1039/c4tb01005a]; Ren PG, 2011, CLIN ORTHOP RELAT R, V469, P113, DOI 10.1007/s11999-010-1645-5; Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Weischenfeldt J, 2008, CSH PROTOC; Zhang Xia, 2009, V531, P123, DOI 10.1007/978-1-59745-396-7_9	23	25	26	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142736	10.1371/journal.pone.0142736	http://dx.doi.org/10.1371/journal.pone.0142736			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555613	Green Published, gold, Green Submitted			2022-12-26	WOS:000364430700164
J	Perez-Kohler, B; Garcia-Moreno, F; Brune, T; Pascual, G; Bellon, JM				Perez-Koehler, Barbara; Garcia-Moreno, Francisca; Brune, Thierry; Pascual, Gemma; Manuel Bellon, Juan			Preclinical Bioassay of a Polypropylene Mesh for Hernia Repair Pretreated with Antibacterial Solutions of Chlorhexidine and Allicin: An In Vivo Study	PLOS ONE			English	Article							INFECTIONS; VITRO; ANTIBIOTICS; RELEASE; SUTURE; RISK; CONTAMINATION; PREVENTION; MANAGEMENT; BIOFILMS	Introduction Prosthetic mesh infection constitutes one of the major complications following hernia repair. Antimicrobial, non-antibiotic biomaterials have the potential to reduce bacterial adhesion to the mesh surface and adjacent tissues while avoiding the development of novel antibiotic resistance. This study assesses the efficacy of presoaking reticular polypropylene meshes in chlorhexidine or a chlorhexidine and allicin combination (a natural antibacterial agent) for preventing bacterial infection in a short-time hernia-repair rabbit model. Methods Partial hernia defects (5 x 2 cm) were created on the lateral right side of the abdominal wall of New Zealand White rabbits (n = 21). The defects were inoculated with 0.5 mL of a 106 CFU/mL Staphylococcus aureus ATCC25923 strain and repaired with a DualMesh Plus antimicrobial mesh or a Surgipro mesh presoaked in either chlorhexidine (0.05%) or allicin-chlorhexidine (900 mu g/mL-0.05%). Fourteen days post-implant, mesh contraction was measured and tissue specimens were harvested to evaluate bacterial adhesion to the implant surface (via sonication, S. aureus immunolabeling), host-tissue incorporation (via staining, scanning electron microscopy) and macrophage response (via RAM-11 immunolabeling). Results The polypropylene mesh showed improved tissue integration relative to the DualMesh Plus. Both the DualMesh Plus and the chlorhexidine-soaked polypropylene meshes exhibited high bacterial clearance, with the latter material showing lower bacterial yields. The implants from the allicin-chlorhexidine group displayed a neoformed tissue containing differently sized abscesses and living bacteria, as well as a diminished macrophage response. The allicin-chlorhexidine coated implants exhibited the highest contraction. Conclusions The presoaking of reticular polypropylene materials with a low concentration of chlorhexidine provides the mesh with antibacterial activity without disrupting tissue integration. Due to the similarities found with the antimicrobial DualMesh Plus material, the chlorhexidine concentration tested could be utilized as a prophylactic treatment to resist infection by prosthetic mesh during hernia repair.	[Perez-Koehler, Barbara; Garcia-Moreno, Francisca; Manuel Bellon, Juan] Univ Alcala, Dept Surg Med & Social Sci, Fac Med & Hlth Sci, Madrid, Spain; [Brune, Thierry] Covidien Sofradim Prod, Trevoux, France; [Pascual, Gemma] Univ Alcala, Dept Med & Med Specialties, Fac Med & Hlth Sci, Madrid, Spain; [Perez-Koehler, Barbara; Garcia-Moreno, Francisca; Pascual, Gemma; Manuel Bellon, Juan] Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Madrid, Spain	Universidad de Alcala; Covidien; Universidad de Alcala; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN	Bellon, JM (corresponding author), Univ Alcala, Dept Surg Med & Social Sci, Fac Med & Hlth Sci, Madrid, Spain.	juanm.bellon@uah.es	nisa, francisca f garcia-moreno/J-3906-2015; Köhler, Bárbara Pérez/M-1858-2019; PASCUAL, GEMMA/M-6564-2016	nisa, francisca f garcia-moreno/0000-0001-5360-0577; Köhler, Bárbara Pérez/0000-0002-5061-1526; garcia-moreno nisa, francisca/0000-0002-2194-4647; PASCUAL, GEMMA/0000-0002-1623-4384	Covidien - Sofradim Production	Covidien - Sofradim Production	Covidien - Sofradim Production provided support in the form of a financial research grant and salaries for TB, but the funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Agarwal A, 2012, BIOMATERIALS, V33, P6783, DOI 10.1016/j.biomaterials.2012.05.068; An YH, 1997, J MICROBIOL METH, V30, P141, DOI 10.1016/S0167-7012(97)00058-4; Ankri S, 1999, MICROBES INFECT, V1, P125, DOI 10.1016/S1286-4579(99)80003-3; Aydinuraz K, 2009, J SURG RES, V157, pE79, DOI 10.1016/j.jss.2009.04.008; Bellon JM, 2004, BRIT J SURG, V91, P489, DOI 10.1002/bjs.4451; Bellon JM, 2014, REV HISPANOAM HERNIA, V2, P49, DOI 10.1016/j.rehah.2014.02.002; Binnebosel M, 2011, SEMIN IMMUNOPATHOL, V33, P235, DOI 10.1007/s00281-010-0237-5; Burger JWA, 2004, ANN SURG, V240, P578; Carbonell AM, 2005, SURG ENDOSC, V19, P430, DOI 10.1007/s00464-004-8810-4; Cobb WS, 2009, AM SURGEON, V75, P762; Costerton JW, 2005, INT J ARTIF ORGANS, V28, P1062, DOI 10.1177/039139880502801103; Cruz-Villalon G, 2011, J APPL MICROBIOL, V110, P723, DOI 10.1111/j.1365-2672.2010.04929.x; Cutler RR, 2004, BRIT J BIOMED SCI, V61, P71, DOI 10.1080/09674845.2004.11732646; Deysine M, 1998, SURG CLIN N AM, V78, P1105, DOI 10.1016/S0039-6109(05)70372-8; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Edmiston CE, 2013, AM J INFECT CONTROL, V41, pS49, DOI 10.1016/j.ajic.2012.10.030; Engelsman AF, 2007, BIOMATERIALS, V28, P2314, DOI 10.1016/j.biomaterials.2007.01.028; Falagas ME, 2005, CLIN MICROBIOL INFEC, V11, P3, DOI 10.1111/j.1469-0691.2004.01014.x; Fernandez-Gutierrez M, 2013, ACTA BIOMATER, V9, P6006, DOI 10.1016/j.actbio.2012.12.012; Garcia-Pumarino R, 2014, J BIOMED MATER RES B, V102, P366, DOI 10.1002/jbm.b.33015; Giannelli M, 2008, TOXICOL IN VITRO, V22, P308, DOI 10.1016/j.tiv.2007.09.012; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; GRISTINA A G, 1988, Medical Progress Through Technology, V14, P205; Guillaume O, 2015, ADV HEALTHC MATER, V4, P1763, DOI 10.1002/adhm.201500201; Guillaume O, 2012, J CONTROL RELEASE, V162, P492, DOI 10.1016/j.jconrel.2012.08.003; Haase H, 2012, FOOD CHEM, V134, P141, DOI 10.1016/j.foodchem.2012.02.080; Harrell A G, 2006, Hernia, V10, P120, DOI 10.1007/s10029-005-0056-0; Harth KC, 2010, J SURG RES, V163, P337, DOI 10.1016/j.jss.2010.03.065; Hodge G, 2002, CYTOMETRY, V48, P209, DOI 10.1002/cyto.10133; Katsikogianni M, 2004, Eur Cell Mater, V8, P37; Keiss HP, 2003, J NUTR, V133, P2171, DOI 10.1093/jn/133.7.2171; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kockerling F, 2015, SURG ENDOSC; Lindsay D, 2006, J HOSP INFECT, V64, P313, DOI 10.1016/j.jhin.2006.06.028; Luijendijk RW, 2000, NEW ENGL J MED, V343, P392, DOI 10.1056/NEJM200008103430603; Mann TJ, 2001, ANAESTH INTENS CARE, V29, P600, DOI 10.1177/0310057X0102900606; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Perez-Kohler B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126711; Sanabria A, 2007, ANN SURG, V245, P392, DOI 10.1097/01.sla.0000250412.08210.8e; Sanchez-Manuel Francisco Javier, 2012, Cochrane Database Syst Rev, pCD003769, DOI 10.1002/14651858.CD003769.pub4; Sanders D, 2013, HERNIA, V17, P779, DOI 10.1007/s10029-013-1124-5; Sanders DL, 2013, SURG ENDOSC, V27, P978, DOI 10.1007/s00464-012-2545-4; Sistla SC, 2010, CHEMOTHERAPY, V56, P261, DOI 10.1159/000319901; Stoikes Nathaniel, 2013, Surg Technol Int, V23, P107; Tambe SM, 2001, J ANTIMICROB CHEMOTH, V47, P589, DOI 10.1093/jac/47.5.589; von Eiff C, 2005, DRUGS, V65, P179, DOI 10.2165/00003495-200565020-00003; Wiegering A, 2014, HERNIA, V18, P691, DOI 10.1007/s10029-014-1293-x; Yurko Y, 2012, SURG INNOV, V19, P20, DOI 10.1177/1553350611410716; Zhai HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102760	49	24	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142768	10.1371/journal.pone.0142768	http://dx.doi.org/10.1371/journal.pone.0142768			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556805	Green Submitted, Green Published, gold			2022-12-26	WOS:000364430700173
J	Tie, CM; Gao, KL; Zhang, N; Zhang, SZ; Shen, JL; Xie, XJ; Wang, JA				Tie, Chunmiao; Gao, Kanglu; Zhang, Na; Zhang, Songzhao; Shen, Jiali; Xie, Xiaojie; Wang, Jian-an			Ezetimibe Attenuates Atherosclerosis Associated with Lipid Reduction and Inflammation Inhibition	PLoS One			English	Article							INTESTINAL CHOLESTEROL ABSORPTION; PLUS EZETIMIBE; DEFICIENT MICE; STATINS; SIMVASTATIN; ANEURYSMS	Background Ezetimibe, as a cholesterol absorption inhibitor, has been shown protecting against atherosclerosis when combined with statin. However, side by side comparison has not been made to evaluate the beneficial effects of ezetimibe alone versus statin. Herein, the study aimed to test whether ezetimibe alone would exhibit similar effects as statin and the combination therapy would be necessary in a moderate lesion size. Methods and Results ApoE-/-male mice that were fed a saturated-fat supplemented diet were randomly assigned to different therapeutic regimens: vehicle, ezetimibe alone (10 mg/kg/day), atorvastatin (20 mg/kg/day) or combination of ezetimibe and atorvastatin through the drinking water. On 28 days, mice were sacrificed and aorta and sera were collected to analyze the atherosclerotic lesion and blood lipid and cholesterol levels. As a result, ezetimibe alone exerted similar protective effects on atherosclerotic lesion sizes as atorvastatin, which was mediated by lowering serum cholesterol concentrations, inhibiting macrophage accumulation in the lesions and reducing circulatory inflammatory cytokines, such as monocyte chemoattractant protein (MCP-1) and tumor necrosis factor (TNF-alpha). In contrast to ezetimibe administration, atorvastatin alone attenuated atherosclerotic lesion which is dependent on its anti-inflammation effects. There were no significance differences in lesion areas and serum concentrations of cholesterol, oxidized LDL and inflammatory cytokines between combination therapy and monotherapy (either ezetimibe or atorvastatin). There were significant correlations between the lesion areas and serum concentrations of cholesterol, MCP-1 and TNF-alpha, respectively. However, there were no significant correlations between the lesion areas and serum concentrations of TGF-beta 1 and oxLDL. Conclusions Ezetimibe alone played the same protection against a moderate atherosclerotic lesion as atorvastatin, which was associated with lowering serum cholesterol, decreasing circulating inflammatory cytokines, and inhibiting macrophage accumulation in the lesions.	[Tie, Chunmiao; Gao, Kanglu; Zhang, Na; Shen, Jiali; Xie, Xiaojie; Wang, Jian-an] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Cardiol,Cardiovasc Key Lab Zhejiang Prov, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Songzhao] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Clin Lab, Hangzhou 310003, Zhejiang, Peoples R China; [Tie, Chunmiao] Shaoxing Univ, Dept Cardiol, Affiliated Boai Hosp, Shaoxing, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Shaoxing University	Xie, XJ (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Cardiol,Cardiovasc Key Lab Zhejiang Prov, Hangzhou 310003, Zhejiang, Peoples R China.	xiaojiexie@hotmail.com; jian_an_wang@yahoo.com	Shen, Jialie/AAX-6851-2020	Xie, Xiaojie/0000-0001-8421-2737	National Natural Science Foundation of China [31371475, 31171392, 81571932]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: This work was supported by grants from the National Natural Science Foundation of China (31371475, 31171392 and 81571932). The funder had no role in the study design, data collection and analysis, decision to publish, or presentation of the manuscript.	Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Bot I, 2011, ATHEROSCLEROSIS, V214, P295, DOI 10.1016/j.atherosclerosis.2010.11.008; Cannon CP, 2015, NEW ENGL J MED, V372, P2387, DOI 10.1056/NEJMoa1410489; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Davis HR, 2011, ATHEROSCLEROSIS, V215, P266, DOI 10.1016/j.atherosclerosis.2011.02.010; Davis HR, 2001, ARTERIOSCL THROM VAS, V21, P2032, DOI 10.1161/hq1201.100260; Fleg JL, 2008, J AM COLL CARDIOL, V52, P2198, DOI 10.1016/j.jacc.2008.10.031; Gierman LM, 2014, ANN RHEUM DIS, V73, P921, DOI 10.1136/annrheumdis-2013-203248; Jia L, 2011, ANNU REV PHYSIOL, V73, P239, DOI 10.1146/annurev-physiol-012110-142233; Kastelein JJP, 2008, NEW ENGL J MED, V358, P1431, DOI 10.1056/NEJMoa0800742; Kouvelos GN, 2013, J CARDIOVASC PHARM T, V18, P5, DOI 10.1177/1074248412445506; Lin CF, 2011, CLIN THER, V33, P1120, DOI 10.1016/j.clinthera.2011.08.002; Lu H, 2013, CURR OPIN LIPIDOL, V24, P455, DOI 10.1097/MOL.0b013e3283654ef9; Meaney A, 2009, J CLIN PHARMACOL, V49, P838, DOI 10.1177/0091270009337011; Morrone D, 2012, ATHEROSCLEROSIS, V223, P251, DOI 10.1016/j.atherosclerosis.2012.02.016; Nakagami H, 2009, ATHEROSCLEROSIS, V203, P51, DOI 10.1016/j.atherosclerosis.2008.05.026; Rafieian-Kopaei M, 2014, INT J PREVENTIVE MED, V5, P927; Rodriguez-Vita J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003959; Stoletov K, 2009, CIRC RES, V104, P952, DOI 10.1161/CIRCRESAHA.108.189803; Sudhop T, 2002, CIRCULATION, V106, P1943, DOI 10.1161/01.CIR.0000034044.95911.DC; Umemoto T, 2012, J LIPID RES, V53, P2380, DOI 10.1194/jlr.M029264; Van Rooyen DM, 2013, J HEPATOL, V59, P144, DOI 10.1016/j.jhep.2013.02.024; Wang JA, 2011, ATHEROSCLEROSIS, V217, P90, DOI 10.1016/j.atherosclerosis.2011.03.005; Xie XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046411; Xie XJ, 2012, J NUTR BIOCHEM, V23, P549, DOI 10.1016/j.jnutbio.2011.02.011	25	27	29	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142430	10.1371/journal.pone.0142430	http://dx.doi.org/10.1371/journal.pone.0142430			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555472	Green Published, Green Submitted, gold			2022-12-26	WOS:000364430700103
J	Torres, GL; Cooper, WR; Horton, DR; Swisher, KD; Garczynski, SF; Munyaneza, JE; Barcenas, NM				Torres, Glenda L.; Cooper, W. Rodney; Horton, David R.; Swisher, Kylie D.; Garczynski, Stephen F.; Munyaneza, Joseph E.; Barcenas, Nina M.			Horizontal Transmission of "Candidatus Liberibacter solanacearum" by Bactericera cockerelli (Hemiptera: Triozidae) on Convolvulus and Ipomoea (Solanales: Convolvulaceae)	PLOS ONE			English	Article							UNITED-STATES; PCR ASSAY; POTATO; TOMATO; SULC; HAPLOTYPES; DISEASE; PLANTS; TIME	"Candidatus Liberibacter solanacearum" (Proteobacteria) is an important pathogen of solanaceous crops (Solanales: Solanaceae) in North America and New Zealand, and is the putative causal agent of zebra chip disease of potato. This phloem-limited pathogen is transmitted to potato and other solanaceous plants by the potato psyllid, Bactericera cockerelli (Hemiptera: Triozidae). While some plants in the Convolvulaceae (Solanales) are also known hosts for B. cockerelli, previous efforts to detect Liberibacter in Convolvulaceae have been unsuccessful. Moreover, studies to determine whether Liberibacter can be acquired from these plants by B. cockerelli are lacking. The goal of this study was to determine whether horizontal transmission of Liberibacter occurs among potato psyllids on two species of Convolvulaceae, sweet potato (Ipomoea batatas) and field bindweed (Convolvulus arvensis), which grows abundantly in potato growing regions of the United States. Results indicated that uninfected psyllids acquired Liberibacter from both I. batatas and C. arvensis if infected psyllids were present on plants concurrently with the uninfected psyllids. Uninfected psyllids did not acquire Liberibacter from plants if the infected psyllids were removed from the plants before the uninfected psyllids were allowed access. In contrast with previous reports, PCR did detect the presence of Liberibacter DNA in some plants. However, visible amplicons were faint and did not correspond with acquisition of the pathogen by uninfected psyllids. None of the plants exhibited disease symptoms. Results indicate that horizontal transmission of Liberibacter among potato psyllids can occur on Convolvulaceae, and that the association between Liberibacter and Convolvulaceae merits additional attention.	[Torres, Glenda L.; Barcenas, Nina M.] Heritage Univ, Dept Nat Sci, Toppenish, WA 98948 USA; [Cooper, W. Rodney; Horton, David R.; Swisher, Kylie D.; Garczynski, Stephen F.; Munyaneza, Joseph E.] ARS, USDA, Yakima Agr Res Lab, Wapato, WA 98951 USA	United States Department of Agriculture (USDA)	Cooper, WR (corresponding author), ARS, USDA, Yakima Agr Res Lab, Wapato, WA 98951 USA.	Rodney.Cooper@ars.usda.gov	Cooper, William/ABB-1389-2020	Cooper, William/0000-0001-7983-3627	National Science Foundation Research Experience for Undergraduates Award [DBI-1156603]; NSF-REU [DBI-1156603]	National Science Foundation Research Experience for Undergraduates Award; NSF-REU(National Science Foundation (NSF)NSF - Office of the Director (OD))	Glenda Torres was supported by National Science Foundation Research Experience for Undergraduates Award DBI-1156603 to NMB. (http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5517 NMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Heather Headrick and Pauline Anderson provided technical assistance. Glenda Torres was supported by NSF-REU Award DBI-1156603 to Heritage University (PI Nina Barcenas). Mention of trade names or commercial products in this article is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the United States Department of Agriculture. USDA is an equal opportunity provider and employer.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bove JM, 2002, PLANT SCI, V163, P1083, DOI 10.1016/S0168-9452(02)00276-5; Cooper WR, 2015, AM J POTATO RES, V92, P91, DOI 10.1007/s12230-014-9416-6; Crosslin JM, 2011, SOUTHWEST ENTOMOL, V36, P125, DOI 10.3958/059.036.0202; Crosslin J. M., 2011, P 11 ANN ZEBR CHIP R, P17; Hansen AK, 2008, APPL ENVIRON MICROB, V74, P5862, DOI 10.1128/AEM.01268-08; Horton DR, 2015, AM ENTOMOLO IN PRESS; Jagoueix S, 1996, MOL CELL PROBE, V10, P43, DOI 10.1006/mcpr.1996.0006; JONES LD, 1987, SCIENCE, V237, P775, DOI 10.1126/science.3616608; KNOWLTON GEORGE F., 1934, JOUR ECON ENT, V27, P547, DOI 10.1093/jee/27.2.547; Levy J, 2011, PHYTOPATHOLOGY, V101, P1285, DOI 10.1094/PHYTO-04-11-0121; Lin H, 2012, EUR J PLANT PATHOL, V132, P297, DOI 10.1007/s10658-011-9874-3; Lin H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019135; List GM, 1939, J ECON ENTOMOL, V32, P30, DOI 10.1093/jee/32.1.30; Mann RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029197; Munyaneza JE, 2012, AM J POTATO RES, V89, P329, DOI 10.1007/s12230-012-9262-3; Sengoda VG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093475; Sengoda VG, 2013, J ECON ENTOMOL, V106, P1964, DOI 10.1603/EC13129; Swisher KD, 2012, ENVIRON ENTOMOL, V41, P1019, DOI 10.1603/EN12066; Trivedi P, 2009, EUR J PLANT PATHOL, V124, P553, DOI 10.1007/s10658-009-9439-x; Wallis R. L., 1955, USDA TECHNICAL B, V1107; Wen AM, 2013, AM J POTATO RES, V90, P229, DOI 10.1007/s12230-012-9293-9; Zhang YP, 1998, J VIROL METHODS, V71, P45, DOI 10.1016/S0166-0934(97)00190-0	23	14	15	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142734	10.1371/journal.pone.0142734	http://dx.doi.org/10.1371/journal.pone.0142734			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555359	Green Submitted, Green Published, gold			2022-12-26	WOS:000364430700162
J	Tyukhtenko, S; Karageorgos, I; Rajarshi, G; Zvonok, N; Pavlopoulos, S; Janero, DR; Makriyannis, A				Tyukhtenko, Sergiy; Karageorgos, Ioannis; Rajarshi, Girija; Zvonok, Nikolai; Pavlopoulos, Spiro; Janero, David R.; Makriyannis, Alexandros			Specific Inter-residue Interactions as Determinants of Human Monoacylglycerol Lipase Catalytic Competency A ROLE FOR GLOBAL CONFORMATIONAL CHANGES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-15 NMR-SPECTROSCOPY; SERINE-PROTEASE; INTERFACIAL ACTIVATION; CRYSTAL-STRUCTURE; MODULATION; HISTIDINE; ENZYMES; SITE	The serine hydrolase monoacylglycerol lipase (MGL) functions as the main metabolizing enzyme of 2-arachidonoyl glycerol, an endocannabinoid signaling lipid whose elevation through genetic or pharmacological MGL ablation exerts therapeutic effects in various preclinical disease models. To inform structure-based MGL inhibitor design, we report the direct NMR detection of a reversible equilibrium between active and inactive states of human MGL (hMGL) that is slow on the NMR time scale and can be modulated in a controlled manner by pH, temperature, and select point mutations. Kinetic measurements revealed that hMGL substrate turnover is rate-limited across this equilibrium. Weidentify a network of aromatic interactions and hydrogen bonds that regulates hMGL active-inactive state interconversion. The data highlight specific inter-residue interactions within hMGL modulating the enzymes function and implicate transitions between active (open) and inactive (closed) states of the hMGL lid domain in controlling substrate access to the enzymes active site.	[Makriyannis, Alexandros] Northeastern Univ, Ctr Drug Discovery, Boston, MA 02115 USA; [Makriyannis, Alexandros] Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA; [Makriyannis, Alexandros] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA; [Makriyannis, Alexandros] King Abdulaziz Univ, Jeddah 22254, Saudi Arabia	Northeastern University; Northeastern University; Northeastern University; King Abdulaziz University	Makriyannis, A (corresponding author), Ctr Drug Discovery, 116 Mugar Hall,360 Huntington Ave, Boston, MA 02115 USA.	a.makriyannis@neu.edu	Makriyannis, Alexandros/GRF-1518-2022	Makriyannis, Alexandros/0000-0003-3272-3687; TYUKHTENKO, SERGIY/0000-0002-0446-9979	National Institutes of Health-National Institute on Drug Abuse [DA09158, DA03801]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA003801, R37DA003801, P01DA009158] Funding Source: NIH RePORTER	National Institutes of Health-National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health-National Institute on Drug Abuse Grants DA09158 and DA03801 (to A. M.). The authors declare that they have no conflicts of interest with the contents of this article.	BACHOVCHIN WW, 1985, P NATL ACAD SCI USA, V82, P7948, DOI 10.1073/pnas.82.23.7948; BACHOVCHIN WW, 1986, BIOCHEMISTRY-US, V25, P7751, DOI 10.1021/bi00371a070; Bachovchin WW, 2001, MAGN RESON CHEM, V39, pS199, DOI 10.1002/mrc.951; BACHOVCHIN WW, 1988, BIOCHEMISTRY-US, V27, P7689, DOI 10.1021/bi00420a018; Bertrand T, 2010, J MOL BIOL, V396, P663, DOI 10.1016/j.jmb.2009.11.060; BRZOZOWSKI AM, 1991, NATURE, V351, P491, DOI 10.1038/351491a0; Cleary JA, 2014, BBA-PROTEINS PROTEOM, V1844, P1119, DOI 10.1016/j.bbapap.2014.03.008; Crow JA, 2012, TOXICOL APPL PHARM, V258, P145, DOI 10.1016/j.taap.2011.10.017; DEREWENDA U, 1994, J LIPID RES, V35, P524; Geraldine J, 2008, ANAL CHEM INSIGHTS, V3, P9; Glusker J. P., 1994, CRYSTAL STRUCTURE AN, P799; Janero DR, 2009, INT REV PSYCHIATR, V21, P122, DOI 10.1080/09540260902782778; Karageorgos I, 2012, ACS CHEM NEUROSCI, V3, P393, DOI 10.1021/cn3000263; Karageorgos I, 2010, MOL BIOSYST, V6, P1381, DOI 10.1039/c004515b; Labar G, 2010, CHEMBIOCHEM, V11, P218, DOI 10.1002/cbic.200900621; Makriyannis A, 2005, NEUROPHARMACOLOGY, V48, P1068, DOI 10.1016/j.neuropharm.2005.03.012; Miled N, 2005, ANAL BIOCHEM, V338, P171, DOI 10.1016/j.ab.2004.11.046; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; Nasr ML, 2013, PROTEIN SCI, V22, P774, DOI 10.1002/pro.2257; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; POLGAR L, 1982, BIOCHEM J, V207, P1; Schalk-Hihi C, 2011, PROTEIN SCI, V20, P670, DOI 10.1002/pro.596; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; SMITH SO, 1989, SCIENCE, V244, P961, DOI 10.1126/science.2499045; Trodler P, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-38; Turner NA, 2001, BIOTECHNOL BIOENG, V72, P108, DOI 10.1002/1097-0290(20010105)72:1<108::AID-BIT14>3.0.CO;2-7; Xu TT, 2012, J STRUCT BIOL, V178, P363, DOI 10.1016/j.jsb.2012.03.006; Yang YQ, 2000, J LIPID RES, V41, P48; Zvonok N, 2008, CHEM BIOL, V15, P854, DOI 10.1016/j.chembiol.2008.06.008	29	10	10	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2556	2565		10.1074/jbc.M115.670257	http://dx.doi.org/10.1074/jbc.M115.670257			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26555264	hybrid, Green Published			2022-12-26	WOS:000369626900002
J	Futai, E; Osawa, S; Cai, T; Fujisawa, T; Ishiura, S; Tomita, T				Futai, Eugene; Osawa, Satoko; Cai, Tetsuo; Fujisawa, Tomoya; Ishiura, Shoichi; Tomita, Taisuke			Suppressor Mutations for Presenilin 1 Familial Alzheimer Disease Mutants Modulate -Secretase Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid- (A); -secretase; intramembrane proteolysis; Saccharomyces cerevisiae; yeast	AMYLOID-BETA-PROTEIN; TRANSMEMBRANE DOMAIN 1; TERMINAL PAL MOTIF; GAMMA-SECRETASE; CATALYTIC PORE; C-TERMINUS; TALKING POINT; ACTIVE-SITE; SUBSTRATE; COMPLEX	-Secretase is a multisubunit membrane protein complex containing presenilin (PS1) as a catalytic subunit. Familial Alzheimer disease (FAD) mutations within PS1 were analyzed in yeast cells artificially expressing membrane-bound substrate, amyloid precursor protein, or Notch fused to Gal4 transcriptional activator. The FAD mutations, L166P and G384A (Leu-166 to Pro and Gly-384 to Ala substitution, respectively), were loss-of-function in yeast. We identified five amino acid substitutions that suppress the FAD mutations. The cleavage of amyloid precursor protein or Notch was recovered by the secondary mutations. We also found that secondary mutations alone activated the -secretase activity. FAD mutants with suppressor mutations, L432M or S438P within TMD9 together with a missense mutation in the second or sixth loops, regained -secretase activity when introduced into presenilin null mouse fibroblasts. Notably, the cells with suppressor mutants produced a decreased amount of A42, which is responsible for Alzheimer disease. These results indicate that the yeast system is useful to screen for mutations and chemicals that modulate -secretase activity.	[Futai, Eugene; Fujisawa, Tomoya] Tohoku Univ, Grad Sch Agr Sci, Dept Mol & Cell Biol, Sendai, Miyagi 9818555, Japan; [Futai, Eugene; Ishiura, Shoichi] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan; [Osawa, Satoko; Cai, Tetsuo; Tomita, Taisuke] Univ Tokyo, Fac Pharmaceut Sci, Grad Sch Pharmaceut Sci, Lab Neuropathol & Neurosci, Tokyo 1130033, Japan; [Cai, Tetsuo; Tomita, Taisuke] Univ Tokyo, Fac Pharmaceut Sci, Lab Neuropathol & Neurosci, Bunkyo Ku, Tokyo 1130033, Japan	Tohoku University; University of Tokyo; University of Tokyo; University of Tokyo	Futai, E (corresponding author), 1-1 Amamiya,Aoba Ku, Sendai, Miyagi 9818555, Japan.	futai@biochem.tohoku.ac.jp	Tomita, Taisuke/L-5427-2015	Tomita, Taisuke/0000-0002-0075-5943; Futai, Eugene/0000-0002-0879-6117	Ministry of Education, Culture, Sports, Science, and Technology; Japanese Foundation for Applied Enzymology; Tokyo Biochemical Research Foundation; Nagase Science and Technology Foundation; Daiichi Sankyo Foundation of Life Science; Grants-in-Aid for Scientific Research [15H02492] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Foundation for Applied Enzymology; Tokyo Biochemical Research Foundation; Nagase Science and Technology Foundation; Daiichi Sankyo Foundation of Life Science; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by research grants from the Ministry of Education, Culture, Sports, Science, and Technology (to E. F., T. T., and S. I.), a research grant from Japanese Foundation for Applied Enzymology (to E. F.), the Tokyo Biochemical Research Foundation (to T. T.), Nagase Science and Technology Foundation (to T. T.), and Daiichi Sankyo Foundation of Life Science (to T. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Annaert WG, 2001, NEURON, V32, P579, DOI 10.1016/S0896-6273(01)00512-8; ASAMIODAKA A, 1995, BIOCHEMISTRY-US, V34, P10272, DOI 10.1021/bi00032a022; Bergman A, 2004, J BIOL CHEM, V279, P45564, DOI 10.1074/jbc.M407717200; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; Funamoto S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3529; Futai E, 2009, J BIOL CHEM, V284, P13013, DOI 10.1074/jbc.M807653200; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Imamura Y, 2009, J AM CHEM SOC, V131, P7353, DOI 10.1021/ja9001458; Isoo N, 2007, J BIOL CHEM, V282, P12388, DOI 10.1074/jbc.M611549200; James P, 1996, GENETICS, V144, P1425; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kaether C, 2004, EMBO J, V23, P4738, DOI 10.1038/sj.emboj.7600478; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kim SH, 2005, J BIOL CHEM, V280, P41953, DOI 10.1074/jbc.M509070200; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Kornilova AY, 2005, P NATL ACAD SCI USA, V102, P3230, DOI 10.1073/pnas.0407640102; Laudon H, 2005, J BIOL CHEM, V280, P35352, DOI 10.1074/jbc.M507217200; Lazarov VK, 2006, P NATL ACAD SCI USA, V103, P6889, DOI 10.1073/pnas.0602321103; Leem JY, 2002, J BIOL CHEM, V277, P19236, DOI 10.1074/jbc.C200148200; Li XC, 2013, NATURE, V493, P56, DOI 10.1038/nature11801; Li Y, 2014, STRUCTURE, V22, P125, DOI 10.1016/j.str.2013.09.018; Lichtenthaler SF, 1999, FEBS LETT, V453, P288, DOI 10.1016/S0014-5793(99)00730-9; Lu PL, 2014, NATURE, V512, P166, DOI 10.1038/nature13567; Miller CA, 1998, NUCLEIC ACIDS RES, V26, P3577, DOI 10.1093/nar/26.15.3577; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Oh YS, 2005, BIOCHEMISTRY-US, V44, P11821, DOI 10.1021/bi0509494; Ohki Y, 2011, EMBO J, V30, P4815, DOI 10.1038/emboj.2011.372; Ono Y, 2006, J BIOL CHEM, V281, P18519, DOI 10.1074/jbc.M601029200; Page RM, 2008, J BIOL CHEM, V283, P677, DOI 10.1074/jbc.M708754200; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Selkoe DJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004457; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Spasic D, 2006, J BIOL CHEM, V281, P26569, DOI 10.1074/jbc.M600592200; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Takagi S, 2010, J NEUROSCI, V30, P15943, DOI 10.1523/JNEUROSCI.3318-10.2010; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Tolia A, 2008, J BIOL CHEM, V283, P19793, DOI 10.1074/jbc.M802461200; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Tomita T, 1999, J NEUROSCI, V19, P10627, DOI 10.1523/JNEUROSCI.19-24-10627.1999; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; Tomita T, 2014, J BIOCHEM, V156, P195, DOI 10.1093/jb/mvu049; Wang J, 2006, J NEUROCHEM, V96, P218, DOI 10.1111/j.1471-4159.2005.03548.x; Watanabe N, 2005, J BIOL CHEM, V280, P41967, DOI 10.1074/jbc.M509066200; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Wolfe MS, 2007, EMBO REP, V8, P136, DOI 10.1038/sj.embor.7400896; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179; Yagishita S, 2008, BIOCHEM BIOPH RES CO, V377, P141, DOI 10.1016/j.bbrc.2008.09.090; Yonemura Y, 2011, J BIOL CHEM, V286, P44569, DOI 10.1074/jbc.M111.270108	57	12	14	3	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					435	446		10.1074/jbc.M114.629287	http://dx.doi.org/10.1074/jbc.M114.629287			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26559975	hybrid, Green Published			2022-12-26	WOS:000367589500039
J	Alam, MK; Noor, NFM; Basri, R; Yew, TF; Wen, TH				Alam, Mohammad Khursheed; Noor, Nor Farid Mohd; Basri, Rehana; Yew, Tan Fo; Wen, Tay Hui			Multiracial Facial Golden Ratio and Evaluation of Facial Appearance	PLOS ONE			English	Article							SOFT-TISSUE PROFILE; CEPHALOMETRIC ANALYSIS; DIVINE PROPORTION; PREFERENCES; AESTHETICS; ATTRACTIVENESS; PERCEPTION; POSITIONS; ADULTS; NORMS	This study aimed to investigate the association of facial proportion and its relation to the golden ratio with the evaluation of facial appearance among Malaysian population. This was a cross-sectional study with 286 randomly selected from Universiti Sains Malaysia (USM) Health Campus students (150 females and 136 males; 100 Malaysian Chinese, 100 Malaysian Malay and 86 Malaysian Indian), with the mean age of 21.54 +/- 1.56 (Age range, 18-25). Facial indices obtained from direct facial measurements were used for the classification of facial shape into short, ideal and long. A validated structured questionnaire was used to assess subjects' evaluation of their own facial appearance. The mean facial indices of Malaysian Indian (MI), Malaysian Chinese (MC) and Malaysian Malay (MM) were 1.59 +/- 0.19, 1.57 +/- 0.25 and 1.54 +/- 0.23 respectively. Only MC showed significant sexual dimorphism in facial index (P = 0.047; P<0.05) but no significant difference was found between races. Out of the 286 subjects, 49 (17.1%) were of ideal facial shape, 156 (54.5%) short and 81 (28.3%) long. The facial evaluation questionnaire showed that MC had the lowest satisfaction with mean score of 2.18 +/- 0.97 for overall impression and 2.15 +/- 1.04 for facial parts, compared to MM and MI, with mean score of 1.80 +/- 0.97 and 1.64 +/- 0.74 respectively for overall impression; 1.75 +/- 0.95 and 1.70 +/- 0.83 respectively for facial parts. In conclusion: 1) Only 17.1% of Malaysian facial proportion conformed to the golden ratio, with majority of the population having short face (54.5%); 2) Facial index did not depend significantly on races; 3) Significant sexual dimorphism was shown among Malaysian Chinese; 4) All three races are generally satisfied with their own facial appearance; 5) No significant association was found between golden ratio and facial evaluation score among Malaysian population.	[Alam, Mohammad Khursheed] Univ Sains Malaysia, Sch Dent Sci, Orthodont Unit, Kota Baharu, Kelantan, Malaysia; [Noor, Nor Farid Mohd; Yew, Tan Fo; Wen, Tay Hui] Univ Sains Malaysia, Sch Dent Sci, Dept Anat, Kota Baharu, Kelantan, Malaysia; [Basri, Rehana] Univ Sains Malaysia, Sch Dent Sci, Craniofacial Biol, Kota Baharu, Kelantan, Malaysia	Universiti Sains Malaysia; Universiti Sains Malaysia; Universiti Sains Malaysia	Alam, MK (corresponding author), Univ Sains Malaysia, Sch Dent Sci, Orthodont Unit, Kota Baharu, Kelantan, Malaysia.	dralam@gmail.com	alam, mohammed/GXH-3645-2022; Alam, Mohammad Khursheed/D-3062-2012; Alam, Mohammad/GQR-2648-2022; Basri, Rehana/ABD-2007-2020	Alam, Mohammad Khursheed/0000-0001-7131-1752; Mohd Noor, Nor Farid/0000-0001-6432-781X				Alam MK, 2006, 65 ANN M JAP ORTH SO; Alam MK, 2006, IADR 84 BRISB AUSTR; Alam MK, 2013, INT MED J, V120, P201; Alam MK, 2012, INT MED J, V19, P333; Alley TR, 1988, SOCIAL APPL ASPECTS, P101; Almeida Marina Dórea de, 2010, Dental Press J. Orthod., V15, P87; [Anonymous], 48 U TENN DEP ANTHR; [Anonymous], 2005, ACTA MED LITU; Bashour M, 2006, PLAST RECONSTR SURG, V118, P757, DOI 10.1097/01.prs.0000207382.60636.1c; Bull R., 1988, SOCIAL PSYCHOL FACIA; CZARNECKI ST, 1993, AM J ORTHOD DENTOFAC, V104, P180, DOI 10.1016/S0889-5406(05)81008-X; Downs WB., 1956, ANGLE ORTHOD, V26, P191, DOI [10.1043/0003-3219(1956)0262.0.co10.1111/j.1746-1561.1956.tb00805.x, DOI 10.1043/0003-3219(1956)0262.0.CO10.1111/J.1746-1561.1956.TB00805.X]; Erbay EF, 2002, AM J ORTHOD DENTOFAC, V121, P65, DOI 10.1067/mod.2002.119573; Farkas LG, 2005, J CRANIOFAC SURG, V16, P615, DOI 10.1097/01.scs.0000171847.58031.9e; FERRARIO VF, 1995, J ORAL MAXIL SURG, V53, P1008, DOI 10.1016/0278-2391(95)90115-9; FOSTER EJ, 1973, ANGLE ORTHOD, V43, P34; Husein OF, 2010, J PLAST RECONSTR AES, V63, P1825, DOI 10.1016/j.bjps.2009.10.032; ILIFFE AH, 1960, BRIT J PSYCHOL, V51, P267, DOI 10.1111/j.2044-8295.1960.tb00749.x; Ioi H, 2005, AM J ORTHOD DENTOFAC, V128, P206, DOI 10.1016/j.ajodo.2004.04.030; Jefferson Y, 1993, J Gen Orthod, V4, P18; Jefferson Yosh, 2004, Int J Orthod Milwaukee, V15, P9; Jeremic D, 2013, ARCH BIOL SCI, V65, P1163, DOI 10.2298/ABS1303163J; Kiekens RMA, 2008, AM J ORTHOD DENTOFAC, V134, P480, DOI 10.1016/j.ajodo.2006.10.041; Kumar M, 2013, IJSR, V2, P51; Kuroda S, 2009, AM J ORTHOD DENTOFAC, V135, P73, DOI 10.1016/j.ajodo.2006.12.021; LEGAN HL, 1980, J ORAL SURG, V38, P744; Leonardo SE, 2006, 65 ANN M JAP ORTH SO; LEW KKK, 1992, J ORAL MAXIL SURG, V50, P1184, DOI 10.1016/0278-2391(92)90151-O; LINES PA, 1978, AM J ORTHOD DENTOFAC, V73, P648, DOI 10.1016/0002-9416(78)90225-7; Livio M., 2008, GOLDEN RATIO STORY P; Luppanapornlarp S, 2014, IADR GEN SESS EXH CA; Maganzini AL, 2000, ANGLE ORTHOD, V70, P393; Mantzikos T, 1998, AM J ORTHOD DENTOFAC, V114, P1, DOI 10.1016/S0889-5406(98)70230-6; MARTIN JG, 1964, J SOC PSYCHOL, V63, P59, DOI 10.1080/00224545.1964.9922213; Medici Filho Edmundo, 2007, World J Orthod, V8, P103; Mejia-Maidl M, 2005, ANGLE ORTHOD, V75, P953; Milutinovic J, 2014, SCI WORLD J, DOI 10.1155/2014/428250; Mizumoto Y, 2009, AM J ORTHOD DENTOFAC, V136, P168, DOI 10.1016/j.ajodo.2007.07.029; Moss J P, 1995, Semin Orthod, V1, P94, DOI 10.1016/S1073-8746(95)80096-4; Naini FB, 2012, INT J ORAL MAX SURG, V41, P839, DOI 10.1016/j.ijom.2012.01.012; Naini FB, 2006, AM J ORTHOD DENTOFAC, V130, P277, DOI 10.1016/j.ajodo.2005.09.027; Naini FB, 2011, FACIAL AESTHETICS CO; NANDA R, 1969, ANGLE ORTHOD, V39, P22; Ngeow W C, 2009, Indian J Dent Res, V20, P313, DOI 10.4103/0970-9290.57372; Ngeow WC, 2009, SINGAP MED J, V50, P525; Packiriswamy V, 2012, N AM J MED SCI, V4, P624, DOI 10.4103/1947-2714.104312; Pancherz Hans, 2010, World J Orthod, V11, P27; PEERLINGS RHJ, 1995, EUR J ORTHODONT, V17, P101, DOI 10.1093/ejo/17.2.101; Peron Ana Paula Lazzari Marques, 2012, Dental Press J. Orthod., V17, P124; POLK MS, 1995, AM J ORTHOD DENTOFAC, V108, P90, DOI 10.1016/S0889-5406(95)70071-4; Preston J D, 1993, J Esthet Dent, V5, P247, DOI 10.1111/j.1708-8240.1993.tb00788.x; Pumal K, 2013, INT MED J, V20, P192; Raji JM, 2010, AUST J BASIC APPL SC, V4, P3338; Ricketts R M, 1981, J Clin Orthod, V15, P752; RICKETTS RM, 1982, AM J ORTHOD DENTOFAC, V81, P351, DOI 10.1016/0002-9416(82)90073-2; RICKETTS RM, 1982, CLIN PLAST SURG, V9, P401; Rossetti A, 2013, ANGLE ORTHOD, V83, P801, DOI 10.2319/111812-883.1; Saraf S, 2013, INTERNET J PLAST SUR, V9; Saraswathi P, 2007, EUR J ANAT, V11, P177; Schmid K, 2006, 12 U NEBR DEP STAT; Seghers MJ., 1964, PLAST RECONSTR SURG, V34, P382; Soh J, 2005, AM J ORTHOD DENTOFAC, V128, P201, DOI 10.1016/j.ajodo.2004.07.041; Soh J, 2005, AM J ORTHOD DENTOFAC, V127, P692, DOI 10.1016/j.ajodo.2004.02.018; STONER M. M., 1955, AMER JOUR ORTHODONT, V41, P453, DOI 10.1016/0002-9416(55)90156-1; Sunilkumar L N, 2013, J Int Oral Health, V5, P48; Thareja V, 2012, J IND ORTHOD SOC, V46, P9; Tripathi AA, 2014, WORLD J DENT, V4, P41; Vegter F, 2000, PLAST RECONSTR SURG, V106, P1090, DOI 10.1097/00006534-200010000-00021; Zimbler MS, 2005, CUMMINGS OTOLARYNGOL, P513	69	13	15	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142914	10.1371/journal.pone.0142914	http://dx.doi.org/10.1371/journal.pone.0142914			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562655	Green Published, gold, Green Submitted			2022-12-26	WOS:000364480900082
J	Ramalho, SD; Sharma, R; White, JK; Aggarwal, N; Chalasani, A; Sameni, M; Moin, K; Vieira, PC; Turro, C; Kodanko, JJ; Sloane, BF				Ramalho, Suelem D.; Sharma, Rajgopal; White, Jessica K.; Aggarwal, Neha; Chalasani, Anita; Sameni, Mansoureh; Moin, Kamiar; Vieira, Paulo C.; Turro, Claudia; Kodanko, Jeremy J.; Sloane, Bonnie F.			Imaging Sites of Inhibition of Proteolysis in Pathomimetic Human Breast Cancer Cultures by Light-Activated Ruthenium Compound	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX DEGRADATION; CATHEPSIN-B; CYSTEINE CATHEPSINS; ASSOCIATION; CELLS; IDENTIFICATION; CHEMISTRY; MEMBRANE; MODELS; ROLES	The cysteine protease cathepsin B has been causally linked to progression and metastasis of breast cancers. We demonstrate inhibition by a dipeptidyl nitrile inhibitor (compound 1) of cathepsin B activity and also of pericellular degradation of dye-quenched collagen IV by living breast cancer cells. To image, localize and quantify collagen IV degradation in real-time we used 3D pathomimetic breast cancer models designed to mimic the in vivo microenvironment of breast cancers. We further report the synthesis and characterization of a caged version of compound 1, [Ru(bpy)(2)(1)(2)](BF4)(2) (compound 2), which can be photoactivated with visible light. Upon light activation, compound 2, like compound 1, inhibited cathepsin B activity and pericellular collagen IV degradation by the 3D pathomimetic models of living breast cancer cells, without causing toxicity. We suggest that caged inhibitor 2 is a prototype for cathepsin B inhibitors that can control both the site and timing of inhibition in cancer.	[Ramalho, Suelem D.; Vieira, Paulo C.] Univ Fed Sao Carlos, Dept Chem, Sao Paulo, Brazil; [Sharma, Rajgopal; Kodanko, Jeremy J.] Wayne State Univ, Dept Chem, Detroit, MI 48202 USA; [White, Jessica K.; Turro, Claudia] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA; [Aggarwal, Neha] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA; [Chalasani, Anita; Sameni, Mansoureh; Moin, Kamiar; Sloane, Bonnie F.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Moin, Kamiar; Sloane, Bonnie F.] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI USA	Universidade Federal de Sao Carlos; Wayne State University; University System of Ohio; Ohio State University; Wayne State University; Wayne State University; Wayne State University	Kodanko, JJ (corresponding author), Wayne State Univ, Dept Chem, Detroit, MI 48202 USA.	jkodanko@chem.wayne.edu; bsloane@med.wayne.edu	Sloane, Bonnie F/A-1050-2009; Vieira, Paulo C/B-9504-2012; Demuner Ramalho, Suelem/P-4082-2014	Vieira, Paulo C/0000-0003-4207-6217; Demuner Ramalho, Suelem/0000-0001-5314-4487	National Institutes of Health [R01 CA131990, R01 EB016072]; NIH Center [P30 CA022453]; Perinatology Research Branch of the National Institutes of Child Health and Development at Wayne State University; CNPq; CAPES [99999.004414/2013-06]; FAPESP [2010/52326-9]; NATIONAL CANCER INSTITUTE [R01CA131990, P30CA022453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB016072] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Perinatology Research Branch of the National Institutes of Child Health and Development at Wayne State University; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Studies described here were supported by R01 CA131990 (BFS) and R01 EB016072 (JJK and CT) from the National Institutes of Health. The Microscopy, Imaging and Cytometry Resources Core is supported, in part, by NIH Center grant P30 CA022453 to the Karmanos Cancer Institute at Wayne State University, and the Perinatology Research Branch of the National Institutes of Child Health and Development at Wayne State University. The authors also thank CNPq and CAPES (99999.004414/2013-06) for Ms. Ramalho's scholarship and financial support. FAPESP #2010/52326-9 financial support in Brazil.	Aggarwal N, 2014, PROTEOM CLIN APPL, V8, P427, DOI 10.1002/prca.201300105; Anderson KN, 2014, BREAST CANCER RES TR, V144, P1, DOI 10.1007/s10549-014-2852-7; Araya R, 2013, ACS CHEM NEUROSCI, V4, P1163, DOI 10.1021/cn4000692; Brieke C, 2012, ANGEW CHEM INT EDIT, V51, P8446, DOI 10.1002/anie.201202134; Brisson L, 2013, J CELL SCI, V126, P4835, DOI 10.1242/jcs.123901; Busco G, 2010, FASEB J, V24, P3903, DOI 10.1096/fj.09-149518; Cavallo-Medved D, 2005, J CELL SCI, V118, P1493, DOI 10.1242/jcs.02278; Cavallo-Medved D, 2009, EXP CELL RES, V315, P1234, DOI 10.1016/j.yexcr.2009.01.021; Chiorean R, 2013, BREAST, V22, P1026, DOI 10.1016/j.breast.2013.08.007; de Ruijter TC, 2011, J CANCER RES CLIN, V137, P183, DOI 10.1007/s00432-010-0957-x; Deiters A, 2010, CHEMBIOCHEM, V11, P47, DOI 10.1002/cbic.200900529; DURHAM B, 1980, J AM CHEM SOC, V102, P600, DOI 10.1021/ja00522a026; Elliott NT, 2011, J PHARM SCI-US, V100, P59, DOI 10.1002/jps.22257; Estrella V, 2013, CANCER RES, V73, P1524, DOI 10.1158/0008-5472.CAN-12-2796; Farrer NJ, 2008, AUST J CHEM, V61, P669, DOI 10.1071/CH08088; Fino E, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.002.2009; FORD PC, 1982, COORDIN CHEM REV, V44, P61, DOI 10.1016/S0010-8545(00)80517-2; Garner RN, 2011, INORG CHEM, V50, P9213, DOI 10.1021/ic201615u; Gocheva V, 2007, CELL CYCLE, V6, P60, DOI 10.4161/cc.6.1.3669; Greenspan PD, 2001, J MED CHEM, V44, P4524, DOI 10.1021/jm010206q; Jedeszko Christopher, 2008, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0420s39; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Klan P, 2013, CHEM REV, V113, P119, DOI 10.1021/cr300177k; Lankelma JM, 2010, LIFE SCI, V86, P225, DOI 10.1016/j.lfs.2009.11.016; Lee HM, 2009, ACS CHEM BIOL, V4, P409, DOI 10.1021/cb900036s; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Linebaugh BE, 1999, EUR J BIOCHEM, V264, P100, DOI 10.1046/j.1432-1327.1999.00582.x; Lovitt CJ, 2015, J CANCER RES CLIN, V141, P951, DOI 10.1007/s00432-015-1950-1; Lovitt CJ, 2013, ASSAY DRUG DEV TECHN, V11, P435, DOI 10.1089/adt.2012.483; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Montalti M., 2006, HDB PHOTOCHEMISTRY; Montaser M, 2002, BIOL CHEM, V383, P1305, DOI 10.1515/BC.2002.147; Park YH, 2013, BIOCHEM BIOPH RES CO, V439, P275, DOI 10.1016/j.bbrc.2013.08.043; Respondek T, 2014, CHEMMEDCHEM, V9, P1306, DOI 10.1002/cmdc.201400081; Respondek T, 2011, J AM CHEM SOC, V133, P17164, DOI 10.1021/ja208084s; Rothberg JM, 2013, NEOPLASIA, V15, P1111, DOI 10.1593/neo.13946; ROZHIN J, 1994, CANCER RES, V54, P6517; Salierno M, 2008, EUR J INORG CHEM, P1125, DOI 10.1002/ejic.200700963; Sameni M., 2012, J VIS EXP; Sameni Mansoureh, 2003, Mol Imaging, V2, P159, DOI 10.1162/153535003322556903; Sameni M, 2009, CLIN EXP METASTAS, V26, P299, DOI 10.1007/s10585-008-9218-7; Schmeichel KL, 2003, J CELL SCI, V116, P2377, DOI 10.1242/jcs.00503; Sloane BF, 2006, ANNU REV PHARMACOL, V46, P301, DOI 10.1146/annurev.pharmtox.45.120403.095853; SLOANE BF, 1994, J CELL SCI, V107, P373; SLOANE BF, 1986, P NATL ACAD SCI USA, V83, P2483, DOI 10.1073/pnas.83.8.2483; Smith NA, 2013, PHIL T R SOC, V371, P1; Tu C, 2008, CANCER RES, V68, P9147, DOI 10.1158/0008-5472.CAN-07-5127; Vasiljeva O, 2007, CURR PHARM DESIGN, V13, P387, DOI 10.2174/138161207780162962; Watson CJ, 2009, J MAMMARY GLAND BIOL, V14, P171, DOI 10.1007/s10911-009-9126-8; Withana NP, 2012, CANCER RES, V72, P1199, DOI 10.1158/0008-5472.CAN-11-2759; Zayat L, 2006, INORG CHEM, V45, P1728, DOI 10.1021/ic0512983; Zayat L, 2003, J AM CHEM SOC, V125, P882, DOI 10.1021/ja0278943; Zayat L., 2005, IMAGING NEUROSCIENCE, P391	53	22	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142527	10.1371/journal.pone.0142527	http://dx.doi.org/10.1371/journal.pone.0142527			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562785	Green Submitted, Green Published, gold			2022-12-26	WOS:000364480900038
J	Clemente-Vicario, F; Alvarez, CE; Rowell, JL; Roy, S; London, CA; Kisseberth, WC; Lorch, G				Clemente-Vicario, Francisco; Alvarez, Carlos E.; Rowell, Jennie L.; Roy, Satavisha; London, Cheryl A.; Kisseberth, William C.; Lorch, Gwendolen			Human Genetic Relevance and Potent Antitumor Activity of Heat Shock Protein 90 Inhibition in Canine Lung Adenocarcinoma Cell Lines	PLOS ONE			English	Article							IN-VITRO; HSP90 INHIBITOR; STROMAL FIBROBLASTS; CHAPERONE HSP90; CANCER-CELLS; TUMOR-CELLS; DOGS; HSP70; CHEMOTHERAPY; GEMCITABINE	Background It has been an open question how similar human and canine lung cancers are. This has major implications in availability of human treatments for dogs and in establishing translational models to test new therapies in pet dogs. The prognosis for canine advanced lung cancer is poor and new treatments are needed. Heat shock protein 90 (HSP90) is an ATPase-dependent molecular chaperone ubiquitously expressed in eukaryotic cells. HSP90 is essential for posttranslational conformational maturation and stability of client proteins including protein kinases and transcription factors, many of which are important for the proliferation and survival of cancer cells. We investigated the activity of STA-1474, a HSP90 inhibitor, in two canine lung cancer cell lines, BACA and CLAC. Results Comparative genomic hybridization analysis of both cell lines revealed genetic relevance to human non-small cell lung cancer. STA-1474 inhibited growth and induced apoptosis of both cell lines in a dose-and time-dependent manner. The ICs50 after 72 h treatment with STA-1474 were 0.08 and 0.11 mu M for BACA and CLAC, respectively. When grown as spheroids, the IC50 of STA-1474 for BACA cells was approximately two-fold higher than when grown as a monolayer (0.348 mu M vs. 0.168 mu M), whereas CLAC spheroids were relatively drug resistant. Treatment of tumor-stromal fibroblasts with STA-1474 resulted in a dose-dependent decrease in their relative cell viability with a low IC50 of 0.28 mu M. Conclusions Here we first established that lung adenocarcinoma in people and dogs are genetically and biochemically similar. STA1474 demonstrated biological activity in both canine lung cancer cell lines and tumor-stromal fibroblasts. As significant decreases in relative cell viability can be achieved with nanomolar concentrations of STA-1474, investigation into the clinical efficacy of this drug in canine lung cancer patients is warranted.	[Clemente-Vicario, Francisco; Roy, Satavisha; Kisseberth, William C.; Lorch, Gwendolen] Ohio State Univ, Coll Vet Med, Dept Vet Clin Sci, Columbus, OH 43210 USA; [Alvarez, Carlos E.] Nationwide Childrens Hosp, Res Inst, Ctr Mol & Human Genet, Columbus, OH USA; [Rowell, Jennie L.] Ohio State Univ, Coll Nursing, Columbus, OH 43210 USA; [London, Cheryl A.] Ohio State Univ, Coll Vet Med, Dept Vet Biosci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Lorch, G (corresponding author), Ohio State Univ, Coll Vet Med, Dept Vet Clin Sci, Columbus, OH 43210 USA.	lorch.2@osu.edu	Fiumefreddo, Andrea/T-2977-2019; London, Cheryl/E-6561-2012; Kisseberth, William/A-2587-2013; Roy, sashwati/E-3990-2011	Jaramillo Garcia, Luis Fernando/0000-0003-2909-9318	National Canine Cancer Foundation [GL15OH-005]; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001070] Funding Source: NIH RePORTER	National Canine Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	These studies were funded by the National Canine Cancer Foundation; Grant GL15OH-005 to GL (http://www.wearethecure.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams VJ, 2010, J SMALL ANIM PRACT, V51, P512, DOI 10.1111/j.1748-5827.2010.00974.x; Alvarez CE, 2014, ILAR J, V55, P16, DOI 10.1093/ilar/ilu010; Alvarez CE, 2012, MAMM GENOME, V23, P144, DOI 10.1007/s00335-011-9369-8; Barrott JJ, 2013, FEBS J, V280, P1381, DOI 10.1111/febs.12147; Berge EM, 2014, SEMIN ONCOL, V41, P110, DOI 10.1053/j.seminoncol.2013.12.006; Bettini G, 2009, VET COMP ONCOL, V7, P28, DOI 10.1111/j.1476-5829.2008.00166.x; Budman DR, 2002, ANTI-CANCER DRUG, V13, P1011, DOI 10.1097/00001813-200211000-00005; Chari R, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-32; Chatterjee M, 2013, HAEMATOLOGICA, V98, P1132, DOI 10.3324/haematol.2012.066175; Chen WK, 2009, GENOME RES, V19, P500, DOI 10.1101/gr.083741.108; CHOU TC, 1981, EUR J BIOCHEM, V115, P207, DOI 10.1111/j.1432-1033.1981.tb06218.x; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Davidson MR, 2013, J THORAC DIS, V5, pS463, DOI 10.3978/j.issn.2072-1439.2013.08.43; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; De Luca A, 2004, ANTICANCER RES, V24, P2985; Dobson JM, 2002, J SMALL ANIM PRACT, V43, P240, DOI 10.1111/j.1748-5827.2002.tb00066.x; Ekert JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092248; Endo H, 2013, J THORAC ONCOL, V8, P131, DOI 10.1097/JTO.0b013e3182779ccf; Fleming JM, 2011, J VET INTERN MED, V25, P187, DOI 10.1111/j.1939-1676.2011.0695.x; Freise KJ, 2006, J VET PHARMACOL THER, V29, P137, DOI 10.1111/j.1365-2885.2006.00725.x; Garcia-Carbonero R, 2013, LANCET ONCOL, V14, pE358, DOI 10.1016/S1470-2045(13)70169-4; GAVER RC, 1988, CANCER CHEMOTH PHARM, V21, P197; Gorn M, 2008, ONKOLOGIE, V31, P185, DOI 10.1159/000118626; Griffey SM, 1998, CARCINOGENESIS, V19, P959, DOI 10.1093/carcin/19.6.959; Jung DW, 2011, CHEM BIOL, V18, P1581, DOI 10.1016/j.chembiol.2011.10.001; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Kent MS, 2009, AM J VET RES, V70, P263, DOI 10.2460/ajvr.70.2.263; Kharaishvili G, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-41; KNAPP DW, 1995, AM J VET RES, V56, P801; Laederich MB, 2011, J BIOL CHEM, V286, P19597, DOI 10.1074/jbc.M110.206151; Lin TY, 2008, EXP HEMATOL, V36, P1266, DOI 10.1016/j.exphem.2008.05.001; London CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027018; Lotti F, 2013, J EXP MED, V210, P2851, DOI 10.1084/jem.20131195; Lwin Z, 2013, J THORAC DIS, V5, pS556, DOI 10.3978/j.issn.2072-1439.2013.08.47; Mariotti ET, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-19; McCleese JK, 2009, INT J CANCER, V125, P2792, DOI 10.1002/ijc.24660; McMahon MB, 2010, AM J VET RES, V71, P799, DOI 10.2460/ajvr.71.7.799; MOULTON JE, 1981, VET PATHOL, V18, P513, DOI 10.1177/030098588101800409; Nemoto Y, 2011, VET PATHOL, V48, P1029, DOI 10.1177/0300985810396106; O'Neill DG, 2013, VET J, V198, P638, DOI 10.1016/j.tvjl.2013.09.020; OGILVIE GK, 1989, J AM VET MED ASSOC, V195, P106; Park Young-Kyu, 2012, Genomics & Informatics, V10, P33, DOI 10.5808/GI.2012.10.1.33; Poirier VJ, 2004, J VET INTERN MED, V18, P536, DOI 10.1892/0891-6640(2004)18&lt;536:TDAEOV&gt;2.0.CO;2; Polton GA, 2008, J SMALL ANIM PRACT, V49, P66, DOI 10.1111/j.1748-5827.2007.00403.x; Powers MV, 2009, CELL CYCLE, V8, P518, DOI 10.4161/cc.8.4.7583; Proia DA, 2014, CANCER RES, V74, P1294, DOI 10.1158/0008-5472.CAN-13-3263; Qi Y, 2004, NATURE, V431, P712, DOI 10.1038/nature02958; Rathore K, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-465; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; Sakashita S, 2014, SEMIN ONCOL, V41, P28, DOI 10.1053/j.seminoncol.2013.12.008; Sang J, 2013, CANCER DISCOV, V3, P430, DOI 10.1158/2159-8290.CD-12-0440; Shimamura T, 2012, CLIN CANCER RES, V18, P4973, DOI 10.1158/1078-0432.CCR-11-2967; Shin HC, 2011, MOL PHARMACEUT, V8, P1257, DOI 10.1021/mp2000549; Simon D, 2001, AM J VET RES, V62, P1825, DOI 10.2460/ajvr.2001.62.1825; Socinski MA, 2013, CLIN CANCER RES, V19, P3068, DOI 10.1158/1078-0432.CCR-12-3381; Stokol T, 2011, AM J VET RES, V72, P1097, DOI 10.2460/ajvr.72.8.1097; SUPKO JG, 1995, CANCER CHEMOTH PHARM, V36, P305, DOI 10.1007/BF00689048; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Tripathi M, 2012, CELL ADHES MIGR, V6, P231, DOI 10.4161/cam.20419; Vail DM, 2004, SEMIN ONCOL, V31, P16, DOI 10.1053/j.seminoncol.2004.08.002; Vinci M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-29; Wang Y, 2015, ORG BIOMOL CHEM, V13, P2108, DOI 10.1039/c4ob02531h; Ware Kathryn E, 2010, PLoS One, V5, pe14117, DOI 10.1371/journal.pone.0014117; Wen W, 2014, EXP BIOL MED, V239, P638, DOI 10.1177/1535370214527899; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Wu ZX, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.016675; Yamaguchi T, 2013, CANCER CELL, V23, P718, DOI 10.1016/j.ccr.2013.04.002	68	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142007	10.1371/journal.pone.0142007	http://dx.doi.org/10.1371/journal.pone.0142007			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560147	gold, Green Published, Green Submitted			2022-12-26	WOS:000364433100050
J	Endlein, T; Federle, W				Endlein, Thomas; Federle, Walter			On Heels and Toes: How Ants Climb with Adhesive Pads and Tarsal Friction Hair Arrays	PLOS ONE			English	Article							EFFECTIVE ELASTIC-MODULUS; DIVISION-OF-LABOR; ATTACHMENT PADS; DETACHMENT; SMOOTH; BIOMECHANICS; COCKROACHES; HYMENOPTERA; MECHANISMS; INSECTS	Ants are able to climb effortlessly on vertical and inverted smooth surfaces. When climbing, their feet touch the substrate not only with their pretarsal adhesive pads but also with dense arrays of fine hairs on the ventral side of the 3rd and 4th tarsal segments. To understand what role these different attachment structures play during locomotion, we analysed leg kinematics and recorded single-leg ground reaction forces in Weaver ants (Oecophylla smaragdina) climbing vertically on a smooth glass substrate. We found that the ants engaged different attachment structures depending on whether their feet were above or below their Centre of Mass (CoM). Legs above the CoM pulled and engaged the arolia ('toes'), whereas legs below the CoM pushed with the 3rd and 4th tarsomeres ('heels') in surface contact. Legs above the CoM carried a significantly larger proportion of the body weight than legs below the CoM. Force measurements on individual ant tarsi showed that friction increased with normal load as a result of the bending and increasing side contact of the tarsal hairs. On a rough sandpaper substrate, the tarsal hairs generated higher friction forces in the pushing than in the pulling direction, whereas the reverse effect was found on the smooth substrate. When the tarsal hairs were pushed, buckling was observed for forces exceeding the shear forces found in climbing ants. Adhesion forces were small but not negligible, and higher on the smooth substrate. Our results indicate that the dense tarsal hair arrays produce friction forces when pressed against the substrate, and help the ants to push outwards during horizontal and vertical walking.	[Endlein, Thomas] Max Planck Inst Intelligent Syst, D-70569 Stuttgart, Germany; [Federle, Walter] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	Max Planck Society; University of Cambridge	Federle, W (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	wf222@cam.ac.uk			UK Biotechnology and Biological Sciences Research Council [BB/I008667/1]; Human Frontier Science Programme [RGP0034/2012]; German Research council [DFG FE 547/1-3]; BBSRC [BB/E004156/1, BB/I008667/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I008667/1, BB/E004156/1] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Human Frontier Science Programme(Human Frontier Science Program); German Research council(German Research Foundation (DFG)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by research grants from the UK Biotechnology and Biological Sciences Research Council (BB/I008667/1, http://www.bbsrc.ac.uk/), the Human Frontier Science Programme (RGP0034/2012, http://www.hfsp.org/), and the German Research council (DFG FE 547/1-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aziz Y. I., 1971, P ASP UI S CLOS RANG, P1, DOI [DOI 10.1080/10671188.1967.10616517, 10.14358/PERS.81.2.103]; Autumn K, 2006, J EXP BIOL, V209, P3558, DOI 10.1242/jeb.02469; Autumn K, 2000, NATURE, V405, P681, DOI 10.1038/35015073; Beutel RG, 2008, SYST ENTOMOL, V33, P501, DOI 10.1111/j.1365-3113.2008.00428.x; Bullock JMR, 2008, J EXP BIOL, V211, P3333, DOI 10.1242/jeb.020941; Bullock JMR, 2009, J EXP BIOL, V212, P1876, DOI 10.1242/jeb.030551; Clemente CJ, 2008, P ROY SOC B-BIOL SCI, V275, P1329, DOI 10.1098/rspb.2007.1660; Clemente CJ, 2009, J COMP PHYSIOL A, V195, P805, DOI 10.1007/s00359-009-0457-0; Drechsler P, 2006, J COMP PHYSIOL A, V192, P1213, DOI 10.1007/s00359-006-0150-5; Endlein T, 2008, J COMP PHYSIOL A, V194, P49, DOI 10.1007/s00359-007-0287-x; Federle W, 2004, ARTHROPOD STRUCT DEV, V33, P67, DOI 10.1016/j.asd.2003.11.001; Federle W, 2001, P NATL ACAD SCI USA, V98, P6215, DOI 10.1073/pnas.111139298; Frantsevich L, 2004, ARTHROPOD STRUCT DEV, V33, P77, DOI 10.1016/j.asd.2003.10.003; Goldman DI, 2006, J EXP BIOL, V209, P2990, DOI 10.1242/jeb.02322; Gorb S, 2000, J COMP PHYSIOL A, V186, P821, DOI 10.1007/s003590000135; Gorb SN, 2002, INTEGR COMP BIOL, V42, P1127, DOI 10.1093/icb/42.6.1127; Gravish N, 2008, J R SOC INTERFACE, V5, P339, DOI 10.1098/rsif.2007.1077; HANNA G, 1991, J EXP BIOL, V155, P103; HILL DE, 1977, ZOOL J LINN SOC-LOND, V60, P319, DOI 10.1111/j.1096-3642.1977.tb00838.x; KENDALL K, 1975, J PHYS D APPL PHYS, V8, P1449, DOI 10.1088/0022-3727/8/13/005; Labonte D, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0034; Labonte D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081943; Niederegger S, 2003, J INSECT PHYSIOL, V49, P611, DOI 10.1016/S0022-1910(03)00048-9; Niederegger S, 2006, J COMP PHYSIOL A, V192, P1223, DOI 10.1007/s00359-006-0157-y; Rivlin RS., 1944, COLLECTED PAPERS RS, V9, P215; ROTH LM, 1952, J EXP ZOOL, V119, P483, DOI 10.1002/jez.1401190307; Schulmeister S, 2003, ZOOL SCR, V32, P153, DOI 10.1046/j.1463-6409.2003.00118.x; Snodgrass R.E., 1956, ANATOMY HONEY BEE; Snodgrass RE, 1935, PRINCIPLES INSECT MO; Wolff JO, 2013, SCI REP-UK, V3, DOI 10.1038/srep01101; YOSHIZAWA H, 1993, J PHYS CHEM-US, V97, P4128, DOI 10.1021/j100118a033	31	32	32	5	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141269	10.1371/journal.pone.0141269	http://dx.doi.org/10.1371/journal.pone.0141269			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559941	Green Published, gold, Green Submitted			2022-12-26	WOS:000364433100028
J	Harris, G; Sanderson, JG; Erz, J; Lehnen, SE; Butler, MJ				Harris, Grant; Sanderson, James G.; Erz, Jon; Lehnen, Sarah E.; Butler, Matthew J.			Weather and Prey Predict Mammals' Visitation to Water	PLOS ONE			English	Article							KRUGER-NATIONAL-PARK; NORTHERN CHIHUAHUAN DESERT; HERBACEOUS VEGETATION; FOOD-HABITS; DISTRIBUTION PATTERNS; WILDLIFE; IMPACT; HERBIVORES; PROVISION; DYNAMICS	Throughout many arid lands of Africa, Australia and the United States, wildlife agencies provide water year-round for increasing game populations and enhancing biodiversity, despite concerns that water provisioning may favor species more dependent on water, increase predation, and reduce biodiversity. In part, understanding the effects of water provisioning requires identifying why and when animals visit water. Employing this information, by matching water provisioning with use by target species, could assist wildlife management objectives while mitigating unintended consequences of year-round watering regimes. Therefore, we examined if weather variables (maximum temperature, relative humidity [RH], vapor pressure deficit [VPD], long and short-term precipitation) and predator-prey relationships (i.e., prey presence) predicted water visitation by 9 mammals. We modeled visitation as recorded by trail cameras at Sevilleta National Wildlife Refuge, New Mexico, USA (June 2009 to September 2014) using generalized linear modeling. For 3 native ungulates, elk (Cervus Canadensis), mule deer (Odocoileus hemionus), and pronghorn (Antilocapra americana), less long-term precipitation and higher maximum temperatures increased visitation, including RH for mule deer. Less long-term precipitation and higher VPD increased oryx (Oryx gazella) and desert cottontail rabbits (Sylvilagus audubonii) visitation. Long-term precipitation, with RH or VPD, predicted visitation for black-tailed jackrabbits (Lepus californicus). Standardized model coefficients demonstrated that the amount of long-term precipitation influenced herbivore visitation most. Weather (especially maximum temperature) and prey (cottontails and jackrabbits) predicted bobcat (Lynx rufus) visitation. Mule deer visitation had the largest influence on coyote (Canis latrans) visitation. Puma (Puma concolor) visitation was solely predicted by prey visitation (elk, mule deer, oryx). Most ungulate visitation peaked during May and June. Coyote, elk and puma visitation was relatively consistent throughout the year. Within the diel-period, activity patterns for predators corresponded with prey. Year-round water management may favor species with consistent use throughout the year, and facilitate predation. Providing water only during periods of high use by target species may moderate unwanted biological costs.	[Harris, Grant; Lehnen, Sarah E.; Butler, Matthew J.] US Fish & Wildlife Serv, Albuquerque, NM 87102 USA; [Sanderson, James G.] Small Wild Cat Conservat Fdn, Corrales, NM USA; [Erz, Jon] US Fish & Wildlife Serv, Sevilleta Natl Wildlife Refuge, Socorro, NM USA	United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service	Harris, G (corresponding author), US Fish & Wildlife Serv, Albuquerque, NM 87102 USA.	grant_harris@fws.gov		Lehnen, Sarah/0000-0003-0337-5070	United States Fish and Wildlife Service	United States Fish and Wildlife Service(US Fish & Wildlife Service)	Funding was supplied by the United States Fish and Wildlife Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Ballard WB, 2001, WILDLIFE SOC B, V29, P99; Bender LC, 2010, J FISH WILDL MANAG, V1, P152, DOI 10.3996/102009-JFWM-013; Bobbink R, 1998, J ECOL, V86, P717, DOI 10.1046/j.1365-2745.1998.8650717.x; BOEKER EL, 1972, J WILDLIFE MANAGE, V36, P56, DOI 10.2307/3799188; Brown D E, 1998, ENV EC LEG ISS REL R; Broyles B, 1995, WILDLIFE SOC B, V23, P663; Burnham K. P., 2002, MODEL SELECTION MULT, VSecond; Cain J. W., 2008, WILDLIFE MONOGRAPHS; CAIN J. W., 2013, WILDLIFE MANAGEMENT, P174; Cain JW, 2006, WILDLIFE SOC B, V34, P570, DOI 10.2193/0091-7648(2006)34[570:MOTAWB]2.0.CO;2; DANIEL A, 1993, J RANGE MANAGE, V46, P296, DOI 10.2307/4002461; Davidson Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055182; DAWSON T, 1966, J CELL PHYSIOL, V67, P463, DOI 10.1002/jcp.1040670311; de Boer WF, 2010, J MAMMAL, V91, P1280, DOI 10.1644/09-MAMM-A-392.1; de Leeuw J, 2001, BIOL CONSERV, V100, P297, DOI 10.1016/S0006-3207(01)00034-9; DELIBES M, 1987, SOUTHWEST NAT, V32, P457, DOI 10.2307/3671478; Dobson AJ., 2008, INTRO GEN LINEAR MOD, DOI 10.1201/9780367807849; ELDER JAMES B., 1956, JOUR WILDLIFE MANAGEMENT, V20, P368, DOI 10.2307/3797147; Gates D. M., 1980, BIOPHYSICAL ECOLOGY; Gaylard A., 2003, KRUGER EXPERIENCE EC, P171; GESE EM, 1995, AM MIDL NAT, V133, P36, DOI 10.2307/2426345; Griffith G.E., 2006, ECOREGIONS NEW MEXIC; HANLEY TA, 1982, J RANGE MANAGE, V35, P146, DOI 10.2307/3898379; Harpole WS, 2007, GLOBAL CHANGE BIOL, V13, P2341, DOI 10.1111/j.1365-2486.2007.01447.x; Harrington R, 1999, BIOL CONSERV, V90, P69, DOI 10.1016/S0006-3207(98)00120-7; Harris G., 2010, B ECOL SOC AM, V91, P352, DOI DOI 10.1890/0012-9623-91.3.352; Harris Grant, 2009, Endangered Species Research, V7, P55, DOI 10.3354/esr00173; Harrison RL, 2010, SOUTHWEST NAT, V55, P374, DOI 10.1894/SGM-03.1; Hopcraft JGC, 2005, J ANIM ECOL, V74, P559, DOI 10.1111/j.1365-2656.2005.00955.x; Hornocker M.G., 1970, WILDLIFE MONOGR, V21, P3; IRIARTE JA, 1990, OECOLOGIA, V85, P185, DOI 10.1007/BF00319400; James CD, 1999, J ARID ENVIRON, V41, P87, DOI 10.1006/jare.1998.0467; Jarman P.J., 1973, East African Agricultural and Forestry Journal, V38, P343; Kie John G., 1994, P663; Krausman PR, 2006, WILDLIFE SOC B, V34, P563, DOI 10.2193/0091-7648(2006)34[563:DWFWSP]2.0.CO;2; LIMA SL, 1995, ANIM BEHAV, V49, P11, DOI 10.1016/0003-3472(95)80149-9; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Longshore KM, 2009, J ARID ENVIRON, V73, P280, DOI 10.1016/j.jaridenv.2008.09.021; Louw G.N., 1984, P106; Lowry W.P., 1989, FUNDAMENTALS BIOMETE, V1; Maloiy GMO, 2008, COMP BIOCHEM PHYS A, V151, P185, DOI 10.1016/j.cbpa.2008.06.019; Marquez MJ, 2010, J ARID ENVIRON, V74, P928, DOI 10.1016/j.jaridenv.2010.01.004; Mills M.G.L., 1984, Koedoe, V27, P107; Mosser A, 2009, ECOL LETT, V12, P1050, DOI 10.1111/j.1461-0248.2009.01359.x; Muldavin EH, 2002, TAXON, V51, P453, DOI 10.2307/1554858; Muldavin EH, 2008, OECOLOGIA, V155, P123, DOI 10.1007/s00442-007-0880-2; NAGY KA, 1988, J ARID ENVIRON, V14, P201; Newsome AE, 1972, P 2 US AUSTR RANG PA, P331; OwenSmith N, 1996, S AFR J WILDL RES, V26, P107; Parker AH, 1999, J ARID ENVIRON, V41, P309, DOI 10.1006/jare.1998.0484; RAUTENSTRAUCH KR, 1989, J MAMMAL, V70, P197, DOI 10.2307/1381689; Redfern JV, 2003, ECOLOGY, V84, P2092, DOI 10.1890/01-0625; Rosenstock SS, 1999, J RANGE MANAGE, V52, P302, DOI 10.2307/4003538; ROWLAND MM, 1983, J WILDLIFE MANAGE, V47, P924, DOI 10.2307/3808151; SAIZ RB, 1975, ECOLOGY BEHAV GEMSBO; Sanderson J., 2013, J INDONESIAN NATURAL, V1, P11; Short, 1987, KANGAROOS THEIR ECOL, DOI 10.1017/CBO9780511898082; SKARPE C, 1986, VEGETATIO, V68, P3; Smit IPJ, 2007, BIOL CONSERV, V136, P85, DOI 10.1016/j.biocon.2006.11.009; Smit IPJ, 2011, ECOGRAPHY, V34, P67, DOI 10.1111/j.1600-0587.2010.06029.x; Smith AP, 1996, BIOL CONSERV, V77, P243, DOI 10.1016/0006-3207(96)00002-X; Smithers RHN, 1983, MAMMALS SO AFRICAN S; SMUTS GL, 1978, BIOSCIENCE, V28, P316, DOI 10.2307/1307372; Smuts GL, 1976, POPULATION CHARACTER, V19, P13; STEPHENSON TE, 1985, SOUTHWEST NAT, V30, P437, DOI 10.2307/3671277; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; TAYLOR CR, 1970, AM J PHYSIOL, V219, P1136, DOI 10.1152/ajplegacy.1970.219.4.1136; THOMAS JW, 1982, ELK N AM ECOLOGY MAN; Thrash I, 1998, J ARID ENVIRON, V38, P315, DOI 10.1006/jare.1997.0331; Thrash I, 1998, J ARID ENVIRON, V38, P437, DOI 10.1006/jare.1997.0318; Thrash I., 1993, African Journal of Range and Forage Science, V10, P31, DOI 10.1080/10220119.1993.9638318; Thrash I, 2000, J ARID ENVIRON, V44, P61, DOI 10.1006/jare.1999.0452; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; TURKOWSKI FJ, 1975, J WILDLIFE MANAGE, V39, P748, DOI 10.2307/3800237; Turner CL, 1997, ECOLOGY, V78, P1832, DOI 10.1890/0012-9658(1997)078[1832:SNAPRT]2.0.CO;2; Valeix M, 2011, J TROP ECOL, V27, P163, DOI 10.1017/S0266467410000647; Valeix M, 2010, LANDSCAPE ECOL, V25, P337, DOI 10.1007/s10980-009-9425-x; Vaughan TA, 1986, MAMMALOGY; Vorhies CT, 1945, COLL AGR TECHNICAL B, V107; Walker B.H., 1979, Developments in Agricultural and Managed-Forest Ecology, V7, P55; Western D., 1975, E AFR WILDL J, V13, P265, DOI DOI 10.1111/J.1365-2028.1975.TB00139.X; Zuur Alain F., 2009, P1	84	15	15	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141355	10.1371/journal.pone.0141355	http://dx.doi.org/10.1371/journal.pone.0141355			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560518	Green Published, Green Submitted, gold			2022-12-26	WOS:000364433100033
J	Hsieh, YH				Hsieh, Ying-Hen			Temporal Course of 2014 Ebola Virus Disease (EVD) Outbreak in West Africa Elucidated through Morbidity and Mortality Data: A Tale of Three Countries	PLOS ONE			English	Article							TRANSMISSION; DYNAMICS	The explosive outbreak of Ebola virus disease (EVD) in West Africa in 2014 appeared to have lessened in 2015, but potentially continues be a global public health threat. A simple mathematical model, the Richards model, is utilized to gauge the temporal variability in the spread of the Ebola virus disease (EVD) in West Africa in terms of its reproduction number R and its temporal changes via detection of epidemic waves and turning points during the 2014 outbreaks in the three most severely affected countries; namely, Guinea, Liberia, and Sierra Leone. The results reveal multiple waves of infection in each of these three countries, of varying lengths from a little more than one week to more than one month. All three countries exhibit marginally fluctuating reproduction numbers during June-October before gradually declining. Although high mobility continues between neighboring populations of these countries across the borders, outbreak in these three countries exhibits decidedly different temporal patterns. Guinea had the most waves but maintained consistently low transmissibility and hence has the smallest number of reported cases. Liberia had highest level of transmission before October, but has remained low since, with no detectable wave after the New Year. Sierra Leone has gradually declining waves since October, but still generated detectable waves up to mid-March 2015, and hence has cumulated the largest number of cases-exceeding that of Guinea and Liberia combined. Analysis indicates that, despite massive amount of international relief and intervention efforts, the outbreak is persisting in these regions in waves, albeit more sparsely and at a much lower level since the beginning of 2015.	[Hsieh, Ying-Hen] China Med Univ, Dept Publ Hlth, Taichung 40402, Taiwan; [Hsieh, Ying-Hen] China Med Univ, Ctr Infect Dis Educ & Res, Taichung 40402, Taiwan	China Medical University Taiwan; China Medical University Taiwan	Hsieh, YH (corresponding author), China Med Univ, Dept Publ Hlth, Taichung 40402, Taiwan.	hsieh@mail.cmu.edu.tw	Hsieh, Ying-Hen/E-9685-2010		Taiwan Ministry of Science and Technology (MOST) [103-2314-B-039-010-MY3, 103-2115-M-039-002-MY2]	Taiwan Ministry of Science and Technology (MOST)	YHH is funded by Taiwan Ministry of Science and Technology (MOST) grants (103-2314-B-039-010-MY3 and 103-2115-M-039-002-MY2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althaus Christian L, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.91afb5e0f279e7f29e7056095255b288; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Camacho A, 2015, PLOS CURRENTS OUTBRE; Chowell G, 2014, PLOS CURRENTS OUTBRE; Chowell G, 2015, PLOS CURRENTS OUTBRE; Fisman D, 2014, PLOS CURRENTS OUTBRE; Getz WM, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/736507; Gomes MFC, 2014, PLOS CURRENTS OUTBRE; Hsieh YH, 2009, TROP MED INT HEALTH, V14, P628, DOI 10.1111/j.1365-3156.2009.02277.x; Hsieh YH, 2006, EMERG INFECT DIS, V12, P122, DOI 10.3201/eid1201.050396; Hsieh YH, 2004, EMERG INFECT DIS, V10, P1165, DOI 10.3201/eid1006.031023; Hsieh YH, 2013, INT J INFECT DIS, V17, pE838, DOI 10.1016/j.ijid.2013.01.002; Hsieh YH, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-332; Hsieh YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023853; Hsieh Ying-Hen, 2010, BMC Res Notes, V3, P283, DOI 10.1186/1756-0500-3-283; Hsieh YH, 2010, INFLUENZA OTHER RESP, V4, P187, DOI 10.1111/j.1750-2659.2010.00147.x; Lewnard JA, 2014, LANCET INFECT DIS, V14, P1189, DOI [10.1016/S1473-3099(14)70995-8, 10.1016/s1473-3099(14)70995-8]; Nishiura H, 2014, EUROSURVEILLANCE, V19, P5, DOI 10.2807/1560-7917.ES2014.19.36.20894; Pandey A, 2014, SCIENCE, V346, P991, DOI 10.1126/science.1260612; Plachouras D, 2014, EUROSURVEILLANCE, V19, P22, DOI 10.2807/1560-7917.ES2014.19.37.20907; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; Rivers C. M., 2014, PLOS CURRENTS OUTBRE; Stadler Tanja, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.02bc6d927ecee7bbd33532ec8ba6a25f; Towers S., 2014, PLOS CURRENTS OUTBRE; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; Webb G, 2015, PLOS CURRENTS OUTBRE; World Health Organization, 2015, ON YEAR EB EP DEADL; World Health Organization (WHO), 2014, EB VIR DIS UPD W AF; World Health Organization (WHO), 2015, SIT REP; World Health Organization (WHO), 2015, SIT SUMM; Yamin D, 2015, ANN INTERN MED, V162, P11, DOI 10.7326/M14-2255	31	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0140810	10.1371/journal.pone.0140810	http://dx.doi.org/10.1371/journal.pone.0140810			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559945	Green Published, Green Submitted, gold			2022-12-26	WOS:000364433100009
J	Munar, E; Gomez-Puerto, G; Call, J; Nadal, M				Munar, Enric; Gomez-Puerto, Gerardo; Call, Josep; Nadal, Marcos			Common Visual Preference for Curved Contours in Humans and Great Apes	PLOS ONE			English	Article							CHIMPANZEES PAN-TROGLODYTES; TOP-DOWN FACILITATION; HOMO-SAPIENS; PERCEPTION; RECOGNITION; MONKEYS; COLOR; ATTRACTIVENESS; AESTHETICS; COGNITION	Among the visual preferences that guide many everyday activities and decisions, from consumer choices to social judgment, preference for curved over sharp-angled contours is commonly thought to have played an adaptive role throughout human evolution, favoring the avoidance of potentially harmful objects. However, because nonhuman primates also exhibit preferences for certain visual qualities, it is conceivable that humans' preference for curved contours is grounded on perceptual and cognitive mechanisms shared with extant nonhuman primate species. Here we aimed to determine whether nonhuman great apes and humans share a visual preference for curved over sharp-angled contours using a 2-alternative forced choice experimental paradigm under comparable conditions. Our results revealed that the human group and the great ape group indeed share a common preference for curved over sharp-angled contours, but that they differ in the manner and magnitude with which this preference is expressed behaviorally. These results suggest that humans' visual preference for curved objects evolved from earlier primate species' visual preferences, and that during this process it became stronger, but also more susceptible to the influence of higher cognitive processes and preference for other visual features.	[Munar, Enric; Gomez-Puerto, Gerardo] Univ Balearic Isl, CSIC, Human Evolut & Cognit Grp, Associated Grp IFISC, Palma De Mallorca, Balearic Island, Spain; [Call, Josep] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland; [Call, Josep] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Nadal, Marcos] Univ Vienna, Dept Basic Psychol Res & Res Methods, Vienna, Austria	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; University of St Andrews; Max Planck Society; University of Vienna	Munar, E (corresponding author), Fac Psychol, Campus Univ, Palma De Mallorca, Balearic Island, Spain.	enric.munar@uib.cat	Munar, Enric/C-7397-2011; Munar, Enric/AAK-4175-2021; Nadal, Marcos/A-5817-2009	Munar, Enric/0000-0001-7330-8389; Nadal, Marcos/0000-0002-9341-4688; Call Balaguer, Josep/0000-0002-8597-8336	Spanish Government Ministerio de Economia y Competitividad [FFI2010-20759, FFI2013-43270-P];  [BES-2011-047441]	Spanish Government Ministerio de Economia y Competitividad(Spanish Government); 	This study was funded by research grants FFI2010-20759 and FFI2013-43270-P from the Spanish Government Ministerio de Economia y Competitividad (http://www.mineco.gob.es). Gerardo Gomez-Puerto was supported by the grant BES-2011-047441. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 1999, NEUROPSYCHOLOGIA, V37, P1111, DOI 10.1016/S0028-3932(99)00039-1; Anderson JR, 2005, J EXP PSYCHOL-ANIM B, V31, P71, DOI 10.1037/0097-7403.31.1.71; Appleton J., 1975, EXPERIENCE LANDSCAPE; Aust U, 2015, J COMP PSYCHOL, V129, P1, DOI 10.1037/a0037691; BALLING JD, 1982, ENVIRON BEHAV, V14, P5, DOI 10.1177/0013916582141001; Bar M, 2003, J COGNITIVE NEUROSCI, V15, P600, DOI 10.1162/089892903321662976; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Bar M., 2008, J CONSUMER BEHAVIOUR, V7, P319, DOI [10.1002/cb.254, DOI 10.1002/CB.254]; Bar M, 2007, NEUROPSYCHOLOGIA, V45, P2191, DOI 10.1016/j.neuropsychologia.2007.03.008; Bar M, 2006, PSYCHOL SCI, V17, P645, DOI 10.1111/j.1467-9280.2006.01759.x; Carbon CC, 2010, ACTA PSYCHOL, V134, P233, DOI 10.1016/j.actpsy.2010.02.004; Deaner RO, 2005, CURR BIOL, V15, P543, DOI 10.1016/j.cub.2005.01.044; Fagot J, 1999, J COMP PSYCHOL, V113, P3, DOI 10.1037/0735-7036.113.1.3; Fagot J, 2000, PICTURE PERCEPTION A, P295; FANTZ RL, 1975, CHILD DEV, V46, P224, DOI 10.2307/1128853; Fillon CM, 1994, CURRENT PRIMATOLOGY, VII, P111; Fink B, 2006, EVOL HUM BEHAV, V27, P433, DOI 10.1016/j.evolhumbehav.2006.08.007; Fitch WT, 2004, SCIENCE, V303, P377, DOI 10.1126/science.1089401; Gomez-Puerto G, 2015, FRONTIERS H IN PRESS; GUTHRIE G, 1966, J PERS SOC PSYCHOL, V3, P619, DOI 10.1037/h0023197; HUMPHREY N, 1971, NATURE, V229, P615, DOI 10.1038/229615a0; Isbell LA, 2006, J HUM EVOL, V51, P1, DOI 10.1016/j.jhevol.2005.12.012; KAPLAN S, 1987, ENVIRON BEHAV, V19, P3, DOI 10.1177/0013916587191001; Kaplan Stephen., 1992, ADAPTED MIND EVOLUTI, P581; Killinger KM, 2004, J ANIM SCI, V82, P3288; Leder H, 2005, APPL COGNITIVE PSYCH, V19, P603, DOI 10.1002/acp.1088; Leder H, 2011, PERCEPTION, V40, P649, DOI 10.1068/p6845; Leder H, 2010, Q J EXP PSYCHOL, V63, P1858, DOI 10.1080/17470211003605142; Lobue V, 2014, EMOTION, V14, P701, DOI 10.1037/a0035898; MacLean EL, 2012, ANIM COGN, V15, P223, DOI 10.1007/s10071-011-0448-8; Matsuno T, 2008, PERCEPTION, V37, P1258, DOI 10.1068/p5859; Matsuno T, 2009, PRIMATES, V50, P121, DOI 10.1007/s10329-008-0128-8; Mende-Siedlecki P, 2013, SOC COGN AFFECT NEUR, V8, P285, DOI 10.1093/scan/nsr090; MIRANDA SB, 1973, CHILD DEV, V44, P555; Munar E, 2014, PHILOS HIST CULTURE, V34, P3; Orians GH, 1992, ADAPTED MIND EVOLUTI, P556; Palmer SE, 2013, ANNU REV PSYCHOL, V64, P77, DOI 10.1146/annurev-psych-120710-100504; Rosen LH, 2010, J SCHOOL PSYCHOL, V48, P313, DOI 10.1016/j.jsp.2010.03.001; Schaefer K., 2006, PSYCHOL SCI, V48, P187; Silvia P.J., 2009, EMPIR STUD ARTS, V27, P25, DOI [DOI 10.2190/EM.27.1.B, 10.2190/em.27.1.b]; Tanaka M, 2003, PRIMATES, V44, P157, DOI 10.1007/s10329-002-0022-8; Townsend C, 2014, J CONSUM RES, V40, P993, DOI 10.1086/673521; Ulrich RogerS., 1977, MAN ENV SYSTEMS, V7, P279; Vartanian O, 2013, P NATL ACAD SCI USA, V110, P10446, DOI 10.1073/pnas.1301227110; Westerman SJ, 2012, PSYCHOL MARKET, V29, P595, DOI 10.1002/mar.20546	45	49	49	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141106	10.1371/journal.pone.0141106	http://dx.doi.org/10.1371/journal.pone.0141106			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7DR	26558754	Green Submitted, Green Published, gold			2022-12-26	WOS:000364433100020
J	Votavova, A; Tomcala, A; Kofronova, E; Kudzejova, M; Sobotnik, J; Jiros, P; Komzakova, O; Valterova, I				Votavova, Alena; Tomcala, Ales; Kofronova, Edita; Kudzejova, Michaela; Sobotnik, Jan; Jiros, Pavel; Komzakova, Olga; Valterova, Irena			Seasonal Dynamics in the Chemistry and Structure of the Fat Bodies of Bumblebee Queens	PLOS ONE			English	Article							MALE LABIAL GLAND; BOMBUS-TERRESTRIS; FUNCTIONAL-DIFFERENTIATION; PYRRHOCORIS-APTERUS; BODY; INSECT; TRIACYLGLYCEROLS; TEMPERATURE; METABOLISM; DIAPAUSE	Insects' fat bodies are responsible for nutrient storage and for a significant part of intermediary metabolism. Thus, it can be expected that the structure and content of the fat body will adaptively change, if an insect is going through different life stages. Bumblebee queens belong to such insects as they dramatically change their physiology several times over their lives in relation to their solitary overwintering, independent colony foundation stage, and during the colony life-cycle ending in the senescent stage. Here, we report on changes in the ultrastructure and lipid composition of the peripheral fat body of Bombus terrestris queens in relation to seasonal changes in the queens' activity. Six life stages are defined and evaluated in particular: pharate, callow, before and after hibernation, egg-laying, and senescence. Transmission electron microscopy revealed that the fat body contained two main cell types-adipocytes and oenocytes. Only adipocytes reveal important changes related to the life phase, and mostly the ration between inclusion and cytoplasm volume varies among particular stages. Both electron microscopy and chemical analyses of lipids highlighted seasonal variability in the quantity of the stored lipids, which peaked prior to hibernation. Triacylglycerols appeared to be the main energy source during hibernation, while the amount of glycogen before and after hibernation remained unchanged. In addition, we observed that the representation of some fatty acids within the triacylglycerols change during the queen's life. Last but not least, we show that fat body cell membranes do not undergo substantial changes concerning phospholipid composition in relation to overwintering. This finding supports the hypothesis that the cold-adaptation strategy of bumblebee queens is more likely to be based on polyol accumulation than on the restructuring of lipid membranes.	[Votavova, Alena; Komzakova, Olga] Agr Res Ltd, Troubsko, Czech Republic; [Tomcala, Ales; Kofronova, Edita; Kudzejova, Michaela; Jiros, Pavel; Valterova, Irena] Acad Sci Czech Republic, Inst Organ Chem & Biochem, Prague, Czech Republic; [Tomcala, Ales] Acad Sci Czech Republic, Ctr Biol, Inst Parasitol, Ceske Budejovice, Czech Republic; [Sobotnik, Jan] Czech Univ Life Sci, Fac Forestry & Wood Sci, Prague, Czech Republic	Research Institute for Fodder Crops, Ltd. Troubsko; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Czech University of Life Sciences Prague	Valterova, I (corresponding author), Acad Sci Czech Republic, Inst Organ Chem & Biochem, Prague, Czech Republic.	irena@uochb.cas.cz	Kofronova, Edita/H-7018-2014; Tomčala, Aleš/G-5717-2014	Tomčala, Aleš/0000-0002-5232-8441; Sobotnik, Jan/0000-0002-8581-637X; Valterova, Irena/0000-0001-5723-6143	Czech Science Foundation [14-04291S]; Institute of Organic Chemistry and Biochemistry [61388963]; Internal Grant Agency of Faculty of Forestry and Wood Sciences [20134359]; Agricultural Research, Ltd.	Czech Science Foundation(Grant Agency of the Czech Republic); Institute of Organic Chemistry and Biochemistry; Internal Grant Agency of Faculty of Forestry and Wood Sciences; Agricultural Research, Ltd.	This work was supported by the Czech Science Foundation (14-04291S); http://www.gacr.cz/; IV OK AV, Institute of Organic Chemistry and Biochemistry (61388963); http://www.uochb.cz/web/structure/31.html; IV AT EK MK PJ, Internal Grant Agency of Faculty of Forestry and Wood Sciences (20134359); http://www.fld.czu.cz/cs/; JS, and Agricultural Research, Ltd. The funder provided support in the form of salaries for authors [A.V., O.K.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ALFORD D V, 1969, Journal of Apicultural Research, V8, P37; ALFORD DV, 1969, J ANIM ECOL, V38, P149, DOI 10.2307/2743; Banda H. J., 1991, Acta Horticulturae, P194; BEENAKKERS AMT, 1985, PROG LIPID RES, V24, P19; Benett VA, 1997, J COMP PHYSIOL B, V167, P249; BUCHMANN SL, 1978, J THEOR BIOL, V72, P639, DOI 10.1016/0022-5193(78)90277-1; Burmester T, 1999, EUR J ENTOMOL, V96, P213; Canavoso LE, 2001, ANNU REV NUTR, V21, P23, DOI 10.1146/annurev.nutr.21.1.23; Coppee A, 2011, CHEMOECOLOGY, V21, P75, DOI 10.1007/s00049-011-0070-x; Cvacka J, 2006, J CHROMATOGR A, V1101, P226, DOI 10.1016/j.chroma.2005.10.001; Cvacka J, 2008, LIPIDS, V43, P441, DOI 10.1007/s11745-008-3174-5; DANKS SM, 1979, J THERM BIOL, V4, P183, DOI 10.1016/0306-4565(79)90035-4; Downer GHR, 1978, BIOCH INSECTS, P58; DUCHATEAU MJ, 1988, BEHAVIOUR, V107, P186, DOI 10.1163/156853988X00340; Fliszkiewicz Monika, 2007, Journal of Apicultural Science, V51, P55; Hahn DA, 2011, ANNU REV ENTOMOL, V56, P103, DOI 10.1146/annurev-ento-112408-085436; HARWOOD JL, 1994, PORTL PR P, P107; HAUNERLAND NH, 1995, ANNU REV ENTOMOL, V40, P121, DOI 10.1146/annurev.en.40.010195.001005; HOLM S N, 1972, Entomologica Scandinavica, V3, P313; Jensen PV, 2000, ARTHROPOD STRUCT DEV, V29, P171, DOI 10.1016/S1467-8039(00)00021-9; Jiros P, 2011, LIPIDS, V46, P863, DOI 10.1007/s11745-011-3581-x; Kofronova E, 2009, EUR J LIPID SCI TECH, V111, P519, DOI 10.1002/ejlt.200800228; Kostal V, 2004, PHYSIOL ENTOMOL, V29, P344, DOI 10.1111/j.0307-6962.2004.00396.x; Kostal V, 2004, J INSECT PHYSIOL, V50, P303, DOI 10.1016/j.jinsphys.2004.01.006; Kostal V, 1998, J COMP PHYSIOL B, V168, P453, DOI 10.1007/s003600050165; Martin SJ, 2010, J CHEM ECOL, V36, P855, DOI 10.1007/s10886-010-9805-3; Ptacek V, 2010, ZAKLADY HROMADNEHO C, P34; ROSELER PF, 1986, INSECT BIOCHEM, V16, P501, DOI 10.1016/0020-1790(86)90027-2; Schmid-Hempel R, 2000, INSECT SOC, V47, P36, DOI 10.1007/s000400050006; Sladen FWL, 1912, THE BUMBLEBEE; Sobotnik J, 2008, J INSECT PHYSIOL, V54, P204, DOI 10.1016/j.jinsphys.2007.09.003; Sobotnik J, 2006, MICRON, V37, P648, DOI 10.1016/j.micron.2006.01.012; STANLEYSAMUELSON DW, 1988, ARCH INSECT BIOCHEM, V9, P1, DOI 10.1002/arch.940090102; STOREY JM, 1986, J INSECT PHYSIOL, V32, P549, DOI 10.1016/0022-1910(86)90070-3; Storey K.B., 1991, P64; Tomcala A, 2006, J EXP BIOL, V209, P4102, DOI 10.1242/jeb.02484; Tomcala A, 2010, COMP BIOCHEM PHYS B, V156, P26, DOI 10.1016/j.cbpb.2010.01.015; Vesterlund SR, 2014, INSECT SOC, V61, P265, DOI 10.1007/s00040-014-0351-9; Zacek P, 2009, J CHEM ECOL, V35, P698, DOI 10.1007/s10886-009-9650-4	39	16	16	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142261	10.1371/journal.pone.0142261	http://dx.doi.org/10.1371/journal.pone.0142261			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559946	Green Published, Green Submitted, gold			2022-12-26	WOS:000364433100068
J	Gross, AM; Kreisberg, JF; Ideker, T				Gross, Andrew M.; Kreisberg, Jason F.; Ideker, Trey			Analysis of Matched Tumor and Normal Profiles Reveals Common Transcriptional and Epigenetic Signals Shared across Cancer Types	PLOS ONE			English	Article							CELL-PROLIFERATION; GENE-EXPRESSION; SYSTEM; LANDSCAPE; PATHWAYS	To identify the transcriptional regulatory changes that are most widespread in solid tumors, we performed a pan-cancer analysis using over 600 pairs of tumors and adjacent normal tissues profiled in The Cancer Genome Atlas (TCGA). Frequency of upregulation was calculated across mRNA expression levels, microRNA expression levels and CpG methylation sites and is provided here as a resource. Frequent tumor-associated alterations were identified using a simple statistical approach. Many of the identified changes were consistent with the increased rate of cell division in cancer, such as the overexpression of cell cycle genes and hypermethylation of PRC2 binding sites. However, we also identified proliferation-independent alterations, which highlight novel pathways essential to tumor formation. Nearly all of the GABA receptors are frequently downregulated, with the gene encoding the delta subunit (GABRD) strongly upregulated as the notable exception. Metabolic genes are also frequently downregulated, particularly alcohol dehydrogenases and others consistent with the decreased role of oxidative phosphorylation in cancerous cells. Alterations in the composition of GABA receptors and metabolism may play a key role in the differentiation of cancer cells, independent of proliferation.	[Gross, Andrew M.; Ideker, Trey] Univ Calif San Diego, Bioinformat & Syst Biol Program, La Jolla, CA 92093 USA; [Kreisberg, Jason F.; Ideker, Trey] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Ideker, T (corresponding author), Univ Calif San Diego, Bioinformat & Syst Biol Program, La Jolla, CA 92093 USA.	tideker@ucsd.edu		Kreisberg, Jason/0000-0002-3616-079X; Ideker, Trey/0000-0002-1708-8454	US National Institute of General Medical Sciences [P50 GM085764, P41 GM103504-04]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085764, P41GM103504] Funding Source: NIH RePORTER	US National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the US National Institute of General Medical Sciences, Grant # P50 GM085764 to TI and JFK and the US National Institute of General Medical Sciences, Grant # P41 GM103504-04 to TI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bottos A, 2009, P NATL ACAD SCI USA, V106, P20782, DOI 10.1073/pnas.0809510106; Broad Institute TCGA Genome Data Analysis Center, 2015, AN READ STAND TCGA D; Cheng WY, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002920; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Evan GI, 2001, NATURE, P411; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Geigerseder C, 2003, NEUROENDOCRINOLOGY, V77, P314, DOI 10.1159/000070897; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Hamfjord J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034150; Bueno MJ, 2008, CELL CYCLE, V7, P3143, DOI 10.4161/cc.7.20.6833; Kobayashi Y, 2011, GENOME RES, V21, P1017, DOI 10.1101/gr.119487.110; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355; Notterman DA, 2001, CANCER RES, V61, P3124; NUSSER Z, 1995, J NEUROSCI, V15, P2948; Perez F, 2007, COMPUT SCI ENG, V9, P21, DOI 10.1109/MCSE.2007.53; Rahman M, 2015, BIOINFORMATICS, pbtv377; Schell JC, 2014, MOL CELL, V56, P400, DOI 10.1016/j.molcel.2014.09.026; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Seo JS, 2012, GENOME RES, V22, P2109, DOI 10.1101/gr.145144.112; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tamagnone L, 2012, CANCER CELL, V22, P145, DOI 10.1016/j.ccr.2012.06.031; Terunuma A, 2014, J CLIN INVEST, V124, P398, DOI 10.1172/JCI71180; Tian JD, 2004, J IMMUNOL, V173, P5298, DOI 10.4049/jimmunol.173.8.5298; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wierstra I, 2007, BIOL CHEM, V388, P1257, DOI 10.1515/BC.2007.159; Young SZ, 2009, PHYSIOLOGY, V24, P171, DOI 10.1152/physiol.00002.2009	31	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142618	10.1371/journal.pone.0142618	http://dx.doi.org/10.1371/journal.pone.0142618			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555223	Green Published, Green Submitted, gold			2022-12-26	WOS:000364430700141
J	Kraan, C; Dormann, CF; Greenfield, BL; Thrush, SF				Kraan, Casper; Dormann, Carsten F.; Greenfield, Barry L.; Thrush, Simon F.			Cross-Scale Variation in Biodiversity-Environment Links Illustrated by Coastal Sandflat Communities	PLOS ONE			English	Article							SPATIAL STRUCTURE; ECOLOGICAL DATA; SPECIES DISTRIBUTIONS; BIVALVES; AUTOCORRELATION; PATTERNS	Spatial variation in the composition of communities is the product of many biotic and environmental interactions. A neglected factor in the analysis of community distribution patterns is the multi-scale nature of the data, which has implications for understanding ecological processes and the development of conservation and environmental management practice. Drawing on recently established multivariate spatial analyses, we investigate whether including relationships between spatial structure and abiotic variables enable us to better discern patterns of species and communities across scales. Data comprised 1200 macro-zoobenthic samples collected over an array of distances (30 cm to 1 km) in three New Zealand harbours, as well as commonly used abiotic variables, such as sediment characteristics and chlorophyll a concentrations, measured at the same scales. Moran's eigenvector mapping was used to extract spatial scales at which communities were structured. Benthic communities, representing primarily bivalves, polychaetes and crustaceans, were spatially structured at four spatial scales, i.e. > 100 m, 50-100 m, 50-15 m, and < 15 m. A broad selection of abiotic variables contributed to the large-scale variation, whereas a more limited set explained part of the fine-scale community structure. Across all scales, less than 30% of the variation in spatial structure was captured by our analysis. The large number of species (48) making up the 10 highest species scores based on redundancy analyses illustrate the variability of species-scale associations. Our results emphasise that abiotic variables and biodiversity are related at all scales investigated and stress the importance of assessing the relationship between environmental variables and the abundance and distribution of biological assemblages across a range of different scales.	[Kraan, Casper; Greenfield, Barry L.; Thrush, Simon F.] Natl Inst Water & Atmospher Res, Hamilton, New Zealand; [Kraan, Casper; Dormann, Carsten F.] Univ Freiburg, Biometry & Environm Syst Anal, D-79106 Freiburg, Germany; [Thrush, Simon F.] Univ Auckland, Inst Marine Sci, Auckland 1, New Zealand	National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Freiburg; University of Auckland	Kraan, C (corresponding author), Natl Inst Water & Atmospher Res, Hamilton, New Zealand.	casper.kraan@gmail.com		Thrush, Simon/0000-0002-4005-3882; Kraan, Casper/0000-0003-2062-6222; Dormann, Carsten/0000-0002-9835-1794	Marie-Curie International Outgoing Fellowship [298380]; Marsden fund of the Royal Society of New Zealand [NIW1102]	Marie-Curie International Outgoing Fellowship; Marsden fund of the Royal Society of New Zealand(Royal Society of New ZealandMarsden Fund (NZ))	Funding: CK was funded by a Marie-Curie International Outgoing Fellowship (298380). CK, CFD, BLG, and SFT were funded by the Marsden fund of the Royal Society of New Zealand (NIW1102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Bellier E, 2007, ECOGRAPHY, V30, P385, DOI [10.1111/j.2007.0906-7590.04911.x, 10.1111/j.0906-7590.2007.04911.x]; Belmaker J, 2011, GLOBAL ECOL BIOGEOGR, V20, P464, DOI 10.1111/j.1466-8238.2010.00615.x; Benedetti-Cecchi L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012946; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Chapman MG, 2008, MAR ECOL PROG SER, V354, P147, DOI 10.3354/meps07205; Cressie NAC, 1993, SPATIAL STAT SPATIAL; Dormann CF, 2007, BASIC APPL ECOL, V8, P387, DOI 10.1016/j.baae.2006.11.001; Dray S, 2012, ECOL MONOGR, V82, P257, DOI 10.1890/11-1183.1; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Gray J.S., 2009, ECOLOGY MARINE SEDIM, Vsecond; Hewitt JE, 1997, J EXP MAR BIOL ECOL, V216, P77, DOI 10.1016/S0022-0981(97)00091-9; Jombart T, 2009, ECOGRAPHY, V32, P161, DOI 10.1111/j.1600-0587.2008.05567.x; Jones HFE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027065; Jones MM, 2011, GLOBAL ECOL BIOGEOGR, V20, P558, DOI 10.1111/j.1466-8238.2010.00627.x; Keil P, 2014, DIVERS DISTRIB, V20, P797, DOI 10.1111/ddi.12199; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Kraan C, 2010, ECOLOGY, V91, P1583, DOI 10.1890/09-2040.1; Kraan C, 2009, MAR ECOL PROG SER, V383, P211, DOI 10.3354/meps07994; Legendre P, 1997, J EXP MAR BIOL ECOL, V216, P99, DOI 10.1016/S0022-0981(97)00092-0; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Legendre P, 2013, NUMERICAL ECOLOGY; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Lohrer AM, 2015, SCI REP-UK, V5, DOI 10.1038/srep10349; McGill BJ, 2010, SCIENCE, V328, P575, DOI 10.1126/science.1188528; Murphy RJ, 2008, MAR ECOL PROG SER, V365, P45, DOI 10.3354/meps07456; Needham HR, 2011, ECOSYSTEMS, V14, P1096, DOI 10.1007/s10021-011-9468-0; Peres-Neto PR, 2010, GLOBAL ECOL BIOGEOGR, V19, P174, DOI 10.1111/j.1466-8238.2009.00506.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Rietkerk M, 2008, TRENDS ECOL EVOL, V23, P169, DOI 10.1016/j.tree.2007.10.013; Schneider DC, 2001, BIOSCIENCE, V51, P545, DOI 10.1641/0006-3568(2001)051[0545:TROTCO]2.0.CO;2; Sharma S, 2011, ECOGRAPHY, V34, P762, DOI 10.1111/j.1600-0587.2010.06811.x; Thrush SF, 2012, ECOL APPL, V22, P1213, DOI 10.1890/11-1403.1; THRUSH SF, 1989, MAR BIOL, V102, P529, DOI 10.1007/BF00438355; Thrush SF, 2003, MAR ECOL PROG SER, V263, P101, DOI 10.3354/meps263101; THRUSH SF, 1991, TRENDS ECOL EVOL, V6, P75, DOI 10.1016/0169-5347(91)90178-Z; Thrush SF, 2009, P ROY SOC B-BIOL SCI, V276, P3209, DOI 10.1098/rspb.2009.0661; Underwood AJ, 1998, OECOLOGIA, V117, P570, DOI 10.1007/s004420050694; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x	44	15	15	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142411	10.1371/journal.pone.0142411	http://dx.doi.org/10.1371/journal.pone.0142411			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555237	Green Published, Green Submitted, gold			2022-12-26	WOS:000364430700101
J	Meissner, C; Jahn, N; Brantl, S				Meissner, Christin; Jahn, Natalie; Brantl, Sabine			In Vitro Characterization of the Type I Toxin-Antitoxin System bsrE/SR5 from Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED TRANSCRIPTIONAL ATTENUATION; ANTISENSE RNA REGULATION; FAECALIS PLASMID PAD1; BACTERIAL TYPE-I; REGULATORY RNAS; EFFICIENT INHIBITION; MESSENGER-RNA; SOLUBLE-RNAS; TARGET; MECHANISM	BsrE/SR5 is a new type I toxin/antitoxin system located on the prophage-like region P6 of the Bacillus subtilis chromosome. The bsrE gene encoding a 30-amino acid hydrophobic toxin and the antitoxin gene sr5 overlap at their 3' ends by 112 bp. Overexpression of bsrE causes cell lysis on agar plates. Here, we present a detailed in vitro analysis of bsrE/SR5. The secondary structures of SR5, bsrE mRNA, and the SR5/bsrE RNA complex were determined. Apparent binding rate constants (kappa(app)) of wild-type and mutated SR5 species with wild-type bsrE mRNA were calculated, and SR5 regions required for efficient inhibition of bsrE mRNA narrowed down. In vivo studies confirmed the in vitro data but indicated that a so far unknown RNA binding protein might exist in B. subtilis that can promote antitoxin/toxin RNA interaction. Using time course experiments, the binding pathway of SR5 and bsrE RNA was elucidated. A comparison with the previously well characterized type I TA system from the B. subtilis chromosome, bsrG/SR4, reveals similarities but also significant differences.	[Meissner, Christin; Jahn, Natalie; Brantl, Sabine] Univ Jena, AG Bakteriengenet, Lehrstuhl Genet, D-07743 Jena, Germany	Friedrich Schiller University of Jena	Brantl, S (corresponding author), Univ Jena, AG Bakteriengenet, Philosophenweg 12, D-07743 Jena, Germany.	Sabine.Brantl@rz.uni-jena.de			Deutsche Forschungsgemeinschaft [BR1552/10-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Grant BR1552/10-1 from the Deutsche Forschungsgemeinschaft (to S. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Brantl S, 2000, MOL MICROBIOL, V35, P1469, DOI 10.1046/j.1365-2958.2000.01813.x; Brantl S, 2007, CURR OPIN MICROBIOL, V10, P102, DOI 10.1016/j.mib.2007.03.012; Brantl S, 2015, FEMS MICROBIOL REV, V39, P413, DOI 10.1093/femsre/fuv003; Brantl S, 2014, RNA BIOL, V11, P443, DOI 10.4161/rna.28036; Brantl S, 2012, RNA BIOL, V9, P1488, DOI 10.4161/rna.23045; Brantl S, 2012, FUTURE MICROBIOL, V7, P853, DOI [10.2217/FMB.12.59, 10.2217/fmb.12.59]; Brantl S, 2009, FUTURE MICROBIOL, V4, P85, DOI 10.2217/17460913.4.1.85; Dambach M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055156; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; Durand S, 2012, RNA BIOL, V9, P1491, DOI 10.4161/rna.22358; Durand S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003181; Fozo EM, 2012, RNA BIOL, V9, P1504, DOI 10.4161/rna.22568; Franch T, 2000, CURR OPIN MICROBIOL, V3, P159, DOI 10.1016/S1369-5274(00)00069-2; Franch T, 1999, J MOL BIOL, V294, P1115, DOI 10.1006/jmbi.1999.3306; GERDES K, 1986, P NATL ACAD SCI USA, V83, P3116, DOI 10.1073/pnas.83.10.3116; Gerdes K, 2007, CURR OPIN MICROBIOL, V10, P117, DOI 10.1016/j.mib.2007.03.003; Gottesman S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003798; Greenfield TJ, 2001, MOL MICROBIOL, V42, P527, DOI 10.1046/j.1365-2958.2001.02663.x; Guo YX, 2014, NUCLEIC ACIDS RES, V42, P6448, DOI 10.1093/nar/gku279; Gurnev PA, 2012, FEBS LETT, V586, P2529, DOI 10.1016/j.febslet.2012.06.021; Han K, 2010, NUCLEIC ACIDS RES, V38, P5851, DOI 10.1093/nar/gkq292; Heidrich N, 2003, J MOL BIOL, V333, P917, DOI 10.1016/j.jmb.2003.09.020; Heidrich N, 2007, NUCLEIC ACIDS RES, V35, P4331, DOI 10.1093/nar/gkm439; Heidrich N, 2007, MICROBIOL-SGM, V153, P420, DOI 10.1099/mic.0.2006/002329-0; Heidrich N, 2006, MOL MICROBIOL, V62, P520, DOI 10.1111/j.1365-2958.2006.05384.x; Irnov I, 2010, NUCLEIC ACIDS RES, V38, P6637, DOI 10.1093/nar/gkq454; Jahn N, 2015, MOL MICROBIOL, V98, P651, DOI 10.1111/mmi.13146; Jahn N, 2013, NUCLEIC ACIDS RES, V41, P9870, DOI 10.1093/nar/gkt735; Jahn N, 2012, MOL MICROBIOL, V83, P579, DOI 10.1111/j.1365-2958.2011.07952.x; Jorgensen MG, 2013, GENE DEV, V27, P1132, DOI 10.1101/gad.214734.113; Kawano M, 2007, MOL MICROBIOL, V64, P738, DOI 10.1111/j.1365-2958.2007.05688.x; Kawano M, 2012, RNA BIOL, V9, P1520, DOI 10.4161/rna.22757; Kolb FA, 2000, EMBO J, V19, P5905, DOI 10.1093/emboj/19.21.5905; Koyanagi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054291; Kwong SM, 2015, PLASMID, V78, P17, DOI 10.1016/j.plasmid.2015.01.002; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Mukherjee S, 2011, MOL MICROBIOL, V82, P447, DOI 10.1111/j.1365-2958.2011.07822.x; Nielsen JS, 2010, NUCLEIC ACIDS RES, V38, P907, DOI 10.1093/nar/gkp1081; Papenfort K, 2015, FEMS MICROBIOL REV, V39, P362, DOI 10.1093/femsre/fuv016; Preis H, 2009, J BACTERIOL, V191, P5446, DOI 10.1128/JB.00602-09; Romeo T, 2013, ENVIRON MICROBIOL, V15, P313, DOI 10.1111/j.1462-2920.2012.02794.x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Shokeen S, 2010, PLASMID, V64, P26, DOI 10.1016/j.plasmid.2010.03.002; Silvaggi JM, 2005, J BACTERIOL, V187, P6641, DOI 10.1128/JB.187.19.6641-6650.2005; THISTED T, 1992, J MOL BIOL, V223, P41, DOI 10.1016/0022-2836(92)90714-U; THISTED T, 1994, EMBO J, V13, P1960, DOI 10.1002/j.1460-2075.1994.tb06465.x; Verstraeten N, 2015, MOL CELL, V59, P9, DOI 10.1016/j.molcel.2015.05.011; Wagner EGH, 2012, RNA BIOL, V9, P1513, DOI 10.4161/rna.22578; Weaver KE, 2004, J BACTERIOL, V186, P6400, DOI 10.1128/JB.186.19.6400-6408.2004; Weaver KE, 2015, PLASMID, V78, P65, DOI 10.1016/j.plasmid.2014.10.001; Weaver KE, 2012, RNA BIOL, V9, P1498, DOI 10.4161/rna.22311; Weel-Sneve R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003260; Wen J, 2014, NUCLEIC ACIDS RES, V42, P1930, DOI 10.1093/nar/gkt1018	53	11	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					560	571		10.1074/jbc.M115.697524	http://dx.doi.org/10.1074/jbc.M115.697524			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26565032	hybrid, Green Published			2022-12-26	WOS:000367830500005
J	Xie, LL; Wartchow, C; Shia, S; Uehara, K; Steffek, M; Warne, R; Sutton, J; Muiru, GT; Leonard, VHJ; Bussiere, DE; Ma, XL				Xie, Lili; Wartchow, Charles; Shia, Steven; Uehara, Kyoko; Steffek, Micah; Warne, Robert; Sutton, James; Muiru, Gladys T.; Leonard, Vincent H. J.; Bussiere, Dirksen E.; Ma, Xiaolei			Molecular Basis of mRNA Cap Recognition by Influenza B Polymerase PB2 Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biophysics; crystal structure; influenza virus; isothermal titration calorimetry (ITC); ligand-binding protein; DSF; PB2; cap-binding domain; mRNA cap analog	VIRUS POLYMERASE; CRYSTAL-STRUCTURE; A VIRUS; BINDING; TRANSCRIPTION; ENDONUCLEASE; SOFTWARE; PROTEINS; REVEALS; PRIMERS	Influenza virus polymerase catalyzes the transcription of viral mRNAs by a process known as cap-snatching, where the 5-cap of cellular pre-mRNA is recognized by the PB2 subunit and cleaved 10-13 nucleotides downstream of the cap by the endonuclease PA subunit. Although this mechanism is common to both influenza A (FluA) and influenza B (FluB) viruses, FluB PB2 recognizes a wider range of cap structures including m(7)GpppGm-, m(7)GpppG-, and GpppG-RNA, whereas FluA PB2 utilizes methylated G-capped RNA specifically. Biophysical studies with isolated PB2 cap-binding domain (PB2(cap)) confirm that FluB PB2 has expanded mRNA cap recognition capability, although the affinities toward m(7)GTP are significantly reduced when compared with FluA PB2. The x-ray co-structures of the FluB PB2(cap) with bound cap analogs m(7)GTP and GTP reveal an inverted GTP binding mode that is distinct from the cognate m(7)GTP binding mode shared between FluA and FluB PB2. These results delineate the commonalities and differences in the cap-binding site between FluA and FluB PB2 and will aid structure-guided drug design efforts to identify dual inhibitors of both FluA and FluB PB2.	[Xie, Lili; Uehara, Kyoko] Novartis Inst BioMed Res, Div Prot Sci, Emeryville, CA 94608 USA; [Wartchow, Charles; Shia, Steven; Steffek, Micah; Bussiere, Dirksen E.; Ma, Xiaolei] Novartis Inst BioMed Res, Div Struct & Biophys Chem, Global Discovery Chem, Emeryville, CA 94608 USA; [Warne, Robert] Novartis Inst BioMed Res, Div Virol Lead Discovery, Emeryville, CA 94608 USA; [Sutton, James] Novartis Inst BioMed Res, Div Global Discovery Chem, Emeryville, CA 94608 USA; [Muiru, Gladys T.; Leonard, Vincent H. J.] Novartis Inst BioMed Res, Div Virol, Emeryville, CA 94608 USA	Novartis; Novartis; Novartis; Novartis; Novartis	Ma, XL (corresponding author), Novartis Inst BioMed Res, Struct & Biophys Chem, 5300 Chiron Way, Emeryville, CA 94608 USA.	xiaolei.ma@novartis.com	Wartchow, Charles A./W-4985-2019	Ma, Xiaolei/0000-0002-5307-827X; Wartchow, Charles/0000-0002-0123-1455				Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; BOULOY M, 1978, P NATL ACAD SCI USA, V75, P4886, DOI 10.1073/pnas.75.10.4886; Byrn RA, 2015, ANTIMICROB AGENTS CH, V59, P1574, DOI 10.1128/AAC.04623-14; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowling VH, 2010, BIOCHEM J, V425, P295, DOI 10.1042/BJ20091352; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fechter P, 2005, J GEN VIROL, V86, P1239, DOI 10.1099/vir.0.80755-0; Glezen WP, 2013, AM J PUBLIC HEALTH, V103, pE43, DOI 10.2105/AJPH.2012.301137; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Harris A, 2006, P NATL ACAD SCI USA, V103, P19123, DOI 10.1073/pnas.0607614103; Hodel AE, 1997, NAT STRUCT BIOL, V4, P350, DOI 10.1038/nsb0597-350; HSU MT, 1987, P NATL ACAD SCI USA, V84, P8140, DOI 10.1073/pnas.84.22.8140; Liu Y, 2015, J BIOL CHEM, V290, P9141, DOI 10.1074/jbc.M115.636464; Liu Y, 2013, J BIOL CHEM, V288, P11013, DOI 10.1074/jbc.M112.392878; Mazza C, 2002, EMBO J, V21, P5548, DOI 10.1093/emboj/cdf538; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Pflug A, 2014, NATURE, V516, P355, DOI 10.1038/nature14008; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; PLOTCH SJ, 1979, P NATL ACAD SCI USA, V76, P1618, DOI 10.1073/pnas.76.4.1618; Reich S, 2014, NATURE, V516, P361, DOI 10.1038/nature14009; ROTA PA, 1990, VIROLOGY, V175, P59, DOI 10.1016/0042-6822(90)90186-U; Tsurumura T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082020; Wakai C, 2011, J VIROL, V85, P7504, DOI 10.1128/JVI.02375-10; Worch R, 2008, PROTEINS, V71, P2026, DOI 10.1002/prot.21882; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720	27	12	13	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					363	370		10.1074/jbc.M115.693051	http://dx.doi.org/10.1074/jbc.M115.693051			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26559973	Green Published, hybrid			2022-12-26	WOS:000367589500029
J	Brandstetter, C; Holz, FG; Krohne, TU				Brandstetter, Carolina; Holz, Frank G.; Krohne, Tim U.			Complement Component C5a Primes Retinal Pigment Epithelial Cells for Inflamrnasome Activation by Lipofuscin-mediated Photooxidative Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NLRP3 INFLAMMASOME ACTIVATION; MACULAR DEGENERATION; ENDOTHELIAL-CELLS; ARPE-19; DRUSEN; RELEASE; C3A	Complement activation, oxidative damage, and activation of the NLRP3 inflammasome have been implicated in retinal pigment epithelium (RPE) pathology in age-related macular degeneration (AMD). Following priming of RPE cells, the NLRP3 inflammasome can be activated by various stimuli such as lipofuscin-mediated photooxidative damage to lysosomal membranes. We investigated whether products of complement activation are capable of providing the priming signal for inflammasome activation in RPE cells. We found that incubation of primary human RPE cells and ARPE-19 cells with complement-competent human serum resulted in up-regulation of C5a receptor, but not C3a receptor. Furthermore, human serum induced expression of pro-IL-1 beta and enabled IL-1 beta secretion in response to lipoluscin phototoxicity, thus indicating inflammasome priming. Complement heat-inactivation, C5 depletion, and C5a receptor inhibition suppressed the priming effect of human serum whereas recombinant C5a likewise induced priming. Conditioned medium of inflammasome-activated RPE cells provided an additional priming effect that was mediated by the IL-1 receptor. These results identify complement activation product C5a as a priming signal for RPE cells that allows for subsequent inflammasome activation by stimuli such as lipofuscin-mediated photooxidative damage. This molecular pathway provides a functional link between key factors of AMD pathogenesis including lipofuscin accumulation, photooxidative damage, complement activation, and RPE degeneration and may provide novel therapeutic targets in this disease.	[Brandstetter, Carolina; Holz, Frank G.; Krohne, Tim U.] Univ Bonn, Dept Ophthalmol, D-53127 Bonn, Germany	University of Bonn	Krohne, TU (corresponding author), Univ Bonn, Dept Ophthalmol, Ernst Abbe Str 2, D-53127 Bonn, Germany.	krohne@uni-bonn.de	Krohne, Tim/D-1497-2013; Krohne, Tim/AAG-4412-2020	Krohne, Tim/0000-0003-2280-925X; 	German Research Foundation (DFG), Bonn, Germany [KR 2863/7-1]; Pro Retina Foundation, Bonn, Germany; University of Bonn, BONFOR and SciMed Programs, Bonn, Germany; Acucela; Alcon; Allergan; Bayer; Carl Zeiss Meditec; Genentech; Heidelberg Engineering; Novartis; Optos; Roche	German Research Foundation (DFG), Bonn, Germany(German Research Foundation (DFG)); Pro Retina Foundation, Bonn, Germany; University of Bonn, BONFOR and SciMed Programs, Bonn, Germany; Acucela; Alcon(Novartis); Allergan(AbbVieAllergan); Bayer(Bayer AG); Carl Zeiss Meditec; Genentech(Roche HoldingGenentech); Heidelberg Engineering; Novartis(Novartis); Optos; Roche(Roche Holding)	The study was supported by German Research Foundation (DFG), Bonn, Germany, Grant KR 2863/7-1; Pro Retina Foundation, Bonn, Germany; University of Bonn, BONFOR and SciMed Programs, Bonn, Germany; and Dr. Eberhard and Hilde Rudiger Foundation, Bonn, Germany (all to T. U. K.). The paper was presented at the 2014 annual meeting of the Association of Research in Vision and Ophthalmology (ARVO) in Orlando, FL (Brandstetter, C., Holz, F. G., Krohne, T.U. (2014) Complement Component C5a Primes the NLRP3 Inflammasome in Retinal Pigment Epithelial Cells. Invest. Ophthalmol. Vis. Sci. 55: [-Abstract 3444). Conflict of interest: CB, none. FGH, research grants: Acucela, Alcon, Allergan, Bayer, Carl Zeiss Meditec, Genentech, Heidelberg Engineering, Novartis, Optos; consultancy honoraria, lecture fees, travel grants: Acucela, Alcon, Allergan, Bayer, Genentech, Heidelberg Engineering, Novartis, Roche. TUK, research grants: Alcon, Novartis; consultancy honoraria, lecture fees, travel grants: Bayer, Heidelberg Engineering, Novartis.	An LL, 2014, EUR J IMMUNOL, V44, P3669, DOI 10.1002/eji.201444560; Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Anderson OA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067263; Brandstetter C, 2015, J MOL MED, V93, P905, DOI 10.1007/s00109-015-1275-1; Cao SJ, 2013, AM J OPHTHALMOL, V156, P1176, DOI 10.1016/j.ajo.2013.08.003; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Cortright DN, 2009, CURR EYE RES, V34, P57, DOI 10.1080/02713680802546658; Davies S, 2001, FREE RADICAL BIO MED, V31, P256, DOI 10.1016/S0891-5849(01)00582-2; Doyle SL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007616; Doyle SL, 2012, NAT MED, V18, P791, DOI 10.1038/nm.2717; Fukuoka Y, 2001, CURR EYE RES, V23, P320, DOI 10.1076/ceyr.23.5.320.5437; Hornung V, 2010, EUR J IMMUNOL, V40, P620, DOI 10.1002/eji.200940185; Hu MJ, 2011, BRIT J OPHTHALMOL, V95, P1738, DOI 10.1136/bjophthalmol-2011-300235; Ijima R, 2014, INVEST OPHTH VIS SCI, V55, DOI 10.1167/iovs.14-15367; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Kauppinen A, 2012, IMMUNOL LETT, V147, P29, DOI 10.1016/j.imlet.2012.05.005; Kim Y, 2014, P NATL ACAD SCI USA, V111, P16082, DOI 10.1073/pnas.1403814111; Krohne TU, 2010, EXP EYE RES, V90, P465, DOI 10.1016/j.exer.2009.12.011; Krohne TU, 2010, EXP EYE RES, V90, P261, DOI 10.1016/j.exer.2009.10.014; Laudisi F, 2013, J IMMUNOL, V191, P1006, DOI 10.4049/jimmunol.1300489; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Liu RZT, 2014, EXP EYE RES, V127, P49, DOI 10.1016/j.exer.2014.07.003; Mohr LKM, 2015, INVEST OPHTH VIS SCI, V56, P6404, DOI 10.1167/iovs.15-16898; MOLLNES TE, 1988, CLIN EXP IMMUNOL, V73, P484; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; ROZANOWSKA M, 1995, J BIOL CHEM, V270, P18825, DOI 10.1074/jbc.270.32.18825; Saeed AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106421; Samstad EO, 2014, J IMMUNOL, V192, P2837, DOI 10.4049/jimmunol.1302484; Scholl HPN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002593; Schutt F, 2000, INVEST OPHTH VIS SCI, V41, P2303; Skeie JM, 2010, INVEST OPHTH VIS SCI, V51, P5336, DOI 10.1167/iovs.10-5322; Sparrow JR, 2000, INVEST OPHTH VIS SCI, V41, P1981; Stutz A, 2009, J CLIN INVEST, V119, P3502, DOI 10.1172/JCI40599; Tarallo V, 2012, CELL, V149, P847, DOI 10.1016/j.cell.2012.03.036; Tseng WA, 2013, INVEST OPHTH VIS SCI, V54, P110, DOI 10.1167/iovs.12-10655; WARNER SJC, 1987, J IMMUNOL, V139, P1911; Zhao M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125150	38	48	52	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					31189	31198		10.1074/jbc.M115.671180	http://dx.doi.org/10.1074/jbc.M115.671180			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26565031	hybrid, Green Published			2022-12-26	WOS:000367199000045
J	Granata, V; Fusco, R; Catalano, O; Filice, S; Amato, DM; Nasti, G; Avallone, A; Izzo, F; Petrillo, A				Granata, Vincenza; Fusco, Roberta; Catalano, Orlando; Filice, Salvatore; Amato, Daniela Maria; Nasti, Guglielmo; Avallone, Antonio; Izzo, Francesco; Petrillo, Antonella			Early Assessment of Colorectal Cancer Patients with Liver Metastases Treated with Antiangiogenic Drugs: The Role of Intravoxel Incoherent Motion in Diffusion-Weighted Imaging	PLOS ONE			English	Article							RESPONSE EVALUATION; SOLID TUMORS; VERSION 1.1; PERFUSION; BEVACIZUMAB; COEFFICIENT; REPRODUCIBILITY; FLUOROURACIL; CHEMOTHERAPY; LEUCOVORIN	Purpose To assess the feasibility and effectiveness of quantitative intravoxel incoherent motion (IVIM) of Diffusion-weighted imaging (DWI) in the assessment of liver metastases treated with targeted chemotherapy agents. Methods 12 patients with unresectable liver metastases from colorectal cancer were enrolled and received neoadjuvant FOLFIRI (5-fluorouracil, leucovorin, irinotecan) plus bevacizumab therapy. DWI was performed for 36 metastases at baseline and after 14 days from starting the treatment. In addition to the basic IVIM metrics, the product between pseudo-diffusivity and perfusion fraction was considered as a descriptor roughly analogous to the flow. Median diffusion parameters of Region of Interest (ROI) were used as representative values for each lesion. Normalized parameters in comparison with the median value of spleen were also collected. The percentual change of the diffusion parameters was calculated. The response to chemotherapy was evaluated according the Response Evaluation Criteria in Solid Tumors (RECIST) as calculated on whole-body CT scan obtained three months after treatment. Mann Whitney test and Receiver operating characteristic (ROC) analysis were performed. Results 24 lesions were categorized as responding and 12 as not responding. There was no statistically significant difference among absolute and normalized diffusion parameters between the pretreatment and the post-treatment findings. Instead, the perfusion fraction ( fp) values showed a statistical difference between responder and non-responder lesions: sensitivity and specificity of fp variation was 62% and 93%, respectively. Conclusions IVIM parameters represent a valuable tool in the evaluation of the anti-angiogenic therapy in patients with liver metastases from colorectal cancer. A percentage change of fp represents the most effective DWI marker in the assessment of tumor response.	[Granata, Vincenza; Fusco, Roberta; Catalano, Orlando; Filice, Salvatore; Amato, Daniela Maria; Petrillo, Antonella] Ist Nazl Tumori IRCCS Fdn Pascale, Dept Radiol, I-80131 Naples, Italy; [Nasti, Guglielmo; Avallone, Antonio] Ist Nazl Tumori IRCCS Fdn Pascale, Dept Abdominal Oncol, I-80131 Naples, Italy; [Izzo, Francesco] Ist Nazl Tumori IRCCS Fdn Pascale, Dept Hepatobiliary Surg Oncol, I-80131 Naples, Italy	IRCCS Fondazione Pascale; IRCCS Fondazione Pascale; IRCCS Fondazione Pascale	Fusco, R (corresponding author), Ist Nazl Tumori IRCCS Fdn Pascale, Dept Radiol, Via Mariano Semmola, I-80131 Naples, Italy.	r.fusco@istitutotumori.na.it	Avallone, Antonio/K-4662-2016; Fusco, Roberta/I-4062-2018; Granata, Vincenza/K-6733-2016; Petrillo, Antonella/J-5450-2018; Izzo, Francesco/K-5261-2016	Avallone, Antonio/0000-0001-6188-5664; Fusco, Roberta/0000-0002-0469-9969; Granata, Vincenza/0000-0002-6601-3221; Petrillo, Antonella/0000-0003-2465-5370; nasti, guglielmo/0000-0002-3590-382X; Izzo, Francesco/0000-0003-3093-5408				Andreou A, 2013, EUR RADIOL, V23, P428, DOI 10.1007/s00330-012-2604-1; Burotto M, 2012, COLORECTAL CANCER, V1, P433, DOI [10.2217/crc.12.52, 10.2217/CRC.12.52]; Cai J, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-306; Chiaradia M, 2014, J MAGN RESON IMAGING, V39, P317, DOI 10.1002/jmri.24172; Chung WS, 2012, AM J ROENTGENOL, V199, P809, DOI 10.2214/AJR.11.7910; Constantinidou A, 2013, CLIN COLORECTAL CANC, V12, P15, DOI 10.1016/j.clcc.2012.07.002; Cui Y, 2008, RADIOLOGY, V248, P894, DOI 10.1148/radiol.2483071407; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Do RKG, 2010, AM J ROENTGENOL, V195, P671, DOI 10.2214/AJR.09.3448; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Granata V, 2015, ABDOM IMAGING, V40, P2364, DOI 10.1007/s00261-015-0488-7; Heijmen L, 2013, INVEST NEW DRUG, V31, P881, DOI 10.1007/s10637-012-9920-9; Heijmen L, 2013, EUR RADIOL, V23, P748, DOI 10.1007/s00330-012-2654-4; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Kabbinavar FF, 2005, J CLIN ONCOL, V23, P3697, DOI 10.1200/JCO.2005.05.112; Kele PG, 2010, WORLD J GASTROENTERO, V16, P1567, DOI 10.3748/wjg.v16.i13.1567; Koh DM, 2007, AM J ROENTGENOL, V188, P1001, DOI 10.2214/AJR.06.0601; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; Lee HJ, 2014, MAGN RESON MED, V71, P1554, DOI 10.1002/mrm.24810; Li SP, 2012, J MAGN RESON IMAGING, V35, P745, DOI 10.1002/jmri.22838; Nasti G, 2013, BRIT J CANCER, V108, P1566, DOI 10.1038/bjc.2013.140; O'Flynn EAM, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2815; Obuchowski NA, 2005, AM J ROENTGENOL, V184, P364, DOI 10.2214/ajr.184.2.01840364; Schisterman EF, 2005, EPIDEMIOLOGY, V16, P73, DOI 10.1097/01.ede.0000147512.81966.ba; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Wybranski C, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-43	28	66	74	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142876	10.1371/journal.pone.0142876	http://dx.doi.org/10.1371/journal.pone.0142876			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26566221	Green Published, Green Submitted, gold			2022-12-26	WOS:000367628500063
J	Baer, ML; Henderson, SC; Colello, RJ				Baer, Matthew L.; Henderson, Scott C.; Colello, Raymond J.			Elucidating the Role of Injury-Induced Electric Fields (EFs) in Regulating the Astrocytic Response to Injury in the Mammalian Central Nervous System	PLOS ONE			English	Article							SPINAL-CORD-INJURY; CHONDROITIN SULFATE PROTEOGLYCANS; PARTIAL LIMB REGENERATION; NEURAL STEM-CELLS; FAST FOURIER-TRANSFORM; IN-VIVO; REACTIVE ASTROCYTES; NOTOPHTHALMUS-VIRIDESCENS; INTRACELLULAR CALCIUM; AXONAL REGENERATION	Injury to the vertebrate central nervous system (CNS) induces astrocytes to change their morphology, to increase their rate of proliferation, and to display directional migration to the injury site, all to facilitate repair. These astrocytic responses to injury occur in a clear temporal sequence and, by their intensity and duration, can have both beneficial and detrimental effects on the repair of damaged CNS tissue. Studies on highly regenerative tissues in nonmammalian vertebrates have demonstrated that the intensity of direct-current extracellular electric fields (EFs) at the injury site, which are 50-100 fold greater than in uninjured tissue, represent a potent signal to drive tissue repair. In contrast, a 10-fold EF increase has been measured in many injured mammalian tissues where limited regeneration occurs. As the astrocytic response to CNS injury is crucial to the reparative outcome, we exposed purified rat cortical astrocytes to EF intensities associated with intact and injured mammalian tissues, as well as to those EF intensities measured in regenerating non-mammalian vertebrate tissues, to determine whether EFs may contribute to the astrocytic injury response. Astrocytes exposed to EF intensities associated with uninjured tissue showed little change in their cellular behavior. However, astrocytes exposed to EF intensities associated with injured tissue showed a dramatic increase in migration and proliferation. At EF intensities associated with regenerating non-mammalian vertebrate tissues, these cellular responses were even more robust and included morphological changes consistent with a regenerative phenotype. These findings suggest that endogenous EFs may be a crucial signal for regulating the astrocytic response to injury and that their manipulation may be a novel target for facilitating CNS repair.	[Baer, Matthew L.; Henderson, Scott C.; Colello, Raymond J.] Virginia Commonwealth Univ, Sch Med, Dept Anat & Neurobiol, Richmond, VA 23284 USA	Virginia Commonwealth University	Colello, RJ (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Anat & Neurobiol, Richmond, VA 23284 USA.	Raymond.Colello@vcuhealth.org	Henderson, Scott/AAP-2785-2021	Henderson, Scott/0000-0002-1076-3867	Commonwealth Health and Research Board of Virginia [236-04-12]; National Institutes of Health/National Institute of Neurological Disorders and Stroke [5R21NS067364, 5T32NS07288, 5P30NS047463]; Gerry Bertier Foundation [42]; National Institutes of Health/National Cancer Institute [P30CA016059]; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS067364, T32NS007288, P30NS047463] Funding Source: NIH RePORTER	Commonwealth Health and Research Board of Virginia; National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Gerry Bertier Foundation; National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by RJC: Commonwealth Health and Research Board of Virginia, grant number CHRB#236-04-12; RJC: National Institutes of Health/National Institute of Neurological Disorders and Stroke (www.ninds.nih.gov), grant number 5R21NS067364; National Institutes of Health/National Institute of Neurological Disorders and Stroke (www.ninds.nih.gov), grant number 5T32NS07288; RJC: Gerry Bertier #42 Foundation (www.gerrybertier.com), no grant number applicable; SCH: National Institutes of Health/National Institute of Neurological Disorders and Stroke (www.ninds.nih.gov), grant number 5P30NS047463; SCH: National Institutes of Health/National Cancer Institute (www.cancer.gov), grant number P30CA016059; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinelli C., 2013, R PACKAGE CIRCULAR C; Alexander JK, 2006, NEURON GLIA BIOL, V2, P93, DOI 10.1017/S1740925X0600010X; Altizer AM, 2002, J EXP ZOOL, V293, P467, DOI 10.1002/jez.10141; Amat JA, 1996, GLIA, V16, P368, DOI 10.1002/(SICI)1098-1136(199604)16:4<368::AID-GLIA9>3.0.CO;2-W; Andrews EM, 2012, EXP NEUROL, V235, P174, DOI 10.1016/j.expneurol.2011.09.008; [Anonymous], J APPL BIOMED; [Anonymous], 2014, R LANG ENV STAT COMP; Ariza CA, 2010, STEM CELL REV REP, V6, P585, DOI 10.1007/s12015-010-9171-0; ARMSTRONG PF, 1988, J ORTHOP RES, V6, P265, DOI 10.1002/jor.1100060214; Auguste KI, 2007, FASEB J, V21, P108, DOI 10.1096/fj.06-6848com; Ayres C, 2006, BIOMATERIALS, V27, P5524, DOI 10.1016/j.biomaterials.2006.06.014; Ayres CE, 2008, J BIOMAT SCI-POLYM E, V19, P603, DOI 10.1163/156856208784089643; Babona Pilipos R, 2012, GALVANOTAXIS ASSAY A, DOI [10.3791/4193, DOI 10.3791/4193]; Babona-Pilipos R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023808; BARKER AT, 1982, AM J PHYSIOL, V242, pR358, DOI 10.1152/ajpregu.1982.242.3.R358; Barres BA, 1999, CELL, V97, P667, DOI 10.1016/S0092-8674(00)80777-1; Barreto GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027881; BASSETT CAL, 1962, SCIENCE, V137, P1063, DOI 10.1126/science.137.3535.1063; BECKER RO, 1972, NATURE, V235, P109, DOI 10.1038/235109a0; BECKER RO, 1972, B NEW YORK ACAD MED, V48, P627; BECKER RO, 1961, J BONE JOINT SURG AM, V43, P643, DOI 10.2106/00004623-196143050-00002; Becker T, 1997, J COMP NEUROL, V377, P577, DOI 10.1002/(SICI)1096-9861(19970127)377:4<577::AID-CNE8>3.0.CO;2-#; BINGGELI R, 1986, J THEOR BIOL, V123, P377, DOI 10.1016/S0022-5193(86)80209-0; Blackiston DJ, 2009, CELL CYCLE, V8, P3527, DOI 10.4161/cc.8.21.9888; BLAUGRUND E, 1993, J COMP NEUROL, V330, P105, DOI 10.1002/cne.903300109; BORGENS RB, 1984, SCIENCE, V225, P478, DOI 10.1126/science.6740320; Borgens RB, 1999, J NEUROTRAUM, V16, P639, DOI 10.1089/neu.1999.16.639; BORGENS RB, 1980, P NATL ACAD SCI-BIOL, V77, P1209, DOI 10.1073/pnas.77.2.1209; BORGENS RB, 1981, SCIENCE, V213, P611, DOI 10.1126/science.7256258; BORGENS RB, 1977, J EXP ZOOL, V200, P403, DOI 10.1002/jez.1402000310; BORGENS RB, 1979, J EXP ZOOL, V209, P49, DOI 10.1002/jez.1402090106; BORGENS RB, 1979, J EXP ZOOL, V209, P377, DOI 10.1002/jez.1402090304; BORGENS RB, 1977, P NATL ACAD SCI USA, V74, P4528, DOI 10.1073/pnas.74.10.4528; BORGENS RB, 1986, J COMP NEUROL, V250, P168, DOI 10.1002/cne.902500204; BORGENS RB, 1994, EXP NEUROL, V128, P41, DOI 10.1006/exnr.1994.1111; Borgens RB, 1997, EXP NEUROL, V145, P376, DOI 10.1006/exnr.1997.6499; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; CANDIA OA, 1968, INVEST OPHTH VISUAL, V7, P405; Cao L, 2015, STEM CELL REV REP, V11, P75, DOI 10.1007/s12015-014-9524-1; Cao L, 2013, EMBO REP, V14, P184, DOI 10.1038/embor.2012.215; CHAN CY, 1986, J PHYSIOL-LONDON, V371, P89, DOI 10.1113/jphysiol.1986.sp015963; CHIANG M, 1991, DEV BIOL, V146, P377, DOI 10.1016/0012-1606(91)90239-Y; CHIANG MC, 1992, EXP EYE RES, V54, P999, DOI 10.1016/0014-4835(92)90164-N; Colello RJ, 2003, ADV SEMICONDUCTOR OR, P319; CONE CD, 1969, T NEW YORK ACAD SCI, V31, P404, DOI 10.1111/j.2164-0947.1969.tb02926.x; CONE CD, 1971, ONCOLOGY-BASEL, V25, P168; Cone CD J, 1976, SCIENCE; COOPER MS, 1989, DEV BIOL, V132, P179, DOI 10.1016/0012-1606(89)90216-9; CORK RJ, 1994, J NEUROBIOL, V25, P1509, DOI 10.1002/neu.480251204; Cortese B, 2014, INTEGR BIOL-UK, V6, P817, DOI 10.1039/c4ib00142g; Dawley EM, 2012, J MORPHOL, V273, P211, DOI 10.1002/jmor.11019; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Dimou L, 2014, PHYSIOL REV, V94, P709, DOI 10.1152/physrev.00036.2013; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; ELTINGE EM, 1986, COMP BIOCHEM PHYS A, V84, P39, DOI 10.1016/0300-9629(86)90039-3; ERSKINE L, 1995, J NEUROBIOL, V26, P523, DOI 10.1002/neu.480260406; ERSKINE L, 1995, DEV BIOL, V171, P330, DOI 10.1006/dbio.1995.1285; Erskine L, 1997, J CELL SCI, V110, P1957; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Fang KS, 1999, J CELL SCI, V112, P1967; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Feng JF, 2012, STEM CELLS, V30, P349, DOI 10.1002/stem.779; FOULDS IS, 1983, BRIT J DERMATOL, V109, P515, DOI 10.1111/j.1365-2133.1983.tb07673.x; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Gnanaguru G, 2013, DEVELOPMENT, V140, P2050, DOI 10.1242/dev.087817; Goldshmit Y, 2012, J NEUROSCI, V32, P7477, DOI 10.1523/JNEUROSCI.0758-12.2012; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Grosjean P., 2014, PASTECS PACKAGE ANAL; GROSS D, 1986, BIOPHYS J, V50, P339, DOI 10.1016/S0006-3495(86)83467-1; Haan N, 2014, ADV WOUND CARE, V3, P156, DOI 10.1089/wound.2013.0450; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; HINKLE L, 1981, J PHYSIOL-LONDON, V314, P121, DOI 10.1113/jphysiol.1981.sp013695; Ho KW, 2014, GLIA, V62, P1435, DOI 10.1002/glia.22691; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Illingworth C. M., 1980, Clinical Physics and Physiological Measurement, V1, P87, DOI 10.1088/0143-0815/1/1/007; JAFFE LF, 1979, J EXP ZOOL, V209, P115, DOI 10.1002/jez.1402090114; Jahanshahi A, 2014, MOL NEUROBIOL, V49, P1005, DOI 10.1007/s12035-013-8575-7; Jenkins LS, 1996, DEV BIOL, V178, P251, DOI 10.1006/dbio.1996.0216; Karimi-Abdolrezaee S, 2012, MOL NEUROBIOL, V46, P251, DOI 10.1007/s12035-012-8287-4; KATZ U, 1986, BIOCHIM BIOPHYS ACTA, V861, P480, DOI 10.1016/0005-2736(86)90457-8; KHAN T, 1994, J NEUROTRAUM, V11, P699, DOI 10.1089/neu.1994.11.699; King LA, 2000, GENE THER, V7, P1103, DOI 10.1038/sj.gt.3301198; Koppes AN, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/4/046002; Kornyei Z, 2000, J NEUROSCI RES, V61, P421, DOI 10.1002/1097-4547(20000815)61:4<421::AID-JNR8>3.0.CO;2-4; Laabs TL, 2007, J NEUROSCI, V27, P14494, DOI 10.1523/JNEUROSCI.2807-07.2007; Lee-Liu D, 2013, GENESIS, V51, P529, DOI 10.1002/dvg.22406; Levin M, 2007, TRENDS CELL BIOL, V17, P261, DOI 10.1016/j.tcb.2007.04.007; Levin M, 2012, BIOESSAYS, V34, P205, DOI 10.1002/bies.201100136; Levin M, 2014, J PHYSIOL-LONDON, V592, P2295, DOI 10.1113/jphysiol.2014.271940; Li YC, 2014, STEM CELL REV REP, V10, P653, DOI 10.1007/s12015-014-9518-z; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Lin F, 2008, J IMMUNOL, V181, P2465, DOI 10.4049/jimmunol.181.4.2465; Liu J, 2014, EXP NEUROL; Lois N, 2010, EXP EYE RES, V90, P316, DOI 10.1016/j.exer.2009.11.007; LURIE DI, 1994, J COMP NEUROL, V344, P559, DOI 10.1002/cne.903440406; Magnusson JP, 2014, SCIENCE, V346, P237, DOI 10.1126/science.346.6206.237; Massey JM, 2008, EXP NEUROL, V209, P426, DOI 10.1016/j.expneurol.2007.03.029; Massey JM, 2006, J NEUROSCI, V26, P4406, DOI 10.1523/JNEUROSCI.5467-05.2006; Mathias RT, 1997, PHYSIOL REV, V77, P21, DOI 10.1152/physrev.1997.77.1.21; Matic M, 2009, LASER MED SCI, V24, P321, DOI 10.1007/s10103-008-0564-0; McCaig CD, 1997, BIOESSAYS, V19, P819, DOI 10.1002/bies.950190912; McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004; McCaig CD, 2002, TRENDS NEUROSCI, V25, P354, DOI 10.1016/S0166-2236(02)02174-4; MCCAIG CD, 1987, DEVELOPMENT, V100, P31; McCaig CD, 2009, J CELL SCI, V122, P4267, DOI 10.1242/jcs.023564; MCGINNIS ME, 1986, DEV BIOL, V116, P184, DOI 10.1016/0012-1606(86)90055-2; McKasson MJ, 2008, EXP NEUROL, V211, P585, DOI 10.1016/j.expneurol.2008.02.015; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Mie M, 2003, J BIOTECHNOL, V100, P231, DOI 10.1016/S0168-1656(02)00284-5; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Moulin VJ, 2012, ADV WOUND CARE, V1, P81, DOI 10.1089/wound.2011.0318; Mutterer J, 2013, J MICROSC-OXFORD, V252, P89, DOI 10.1111/jmi.12069; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nuccitelli R, 2011, WOUND REPAIR REGEN, V19, P645, DOI 10.1111/j.1524-475X.2011.00723.x; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; ORIDA N, 1982, CELL MOTIL CYTOSKEL, V2, P243, DOI 10.1002/cm.970020305; Pappalardo LW, 2014, GLIA, V62, P1162, DOI 10.1002/glia.22671; PARMELEE JT, 1986, EXP EYE RES, V42, P433, DOI 10.1016/0014-4835(86)90003-5; PARMELEE JT, 1985, INVEST OPHTH VIS SCI, V26, P1343; PATEL N, 1982, J NEUROSCI, V2, P483; Pelletier SJ, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu090; POO MM, 1981, ANNU REV BIOPHYS BIO, V10, P245, DOI 10.1146/annurev.bb.10.060181.001333; Rajnicek AM, 1998, DEV BIOL, V203, P412, DOI 10.1006/dbio.1998.9039; Reid B, 2007, NAT PROTOC, V2, P661, DOI 10.1038/nprot.2007.91; Reid B, 2009, DEV BIOL, V335, P198, DOI 10.1016/j.ydbio.2009.08.028; Rubinacci A, 1996, CALCIFIED TISSUE INT, V58, P423, DOI 10.1007/s002239900070; Sauer H, 1999, J CELL BIOCHEM, V75, P710, DOI 10.1002/(SICI)1097-4644(19991215)75:4<710::AID-JCB16>3.0.CO;2-Z; Scheffey C., 1986, Progress in Clinical and Biological Research, V210, P213; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SHI R, 1994, DEV BIOL, V165, P105, DOI 10.1006/dbio.1994.1238; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; SMITH SD, 1967, ANAT REC, V158, P89, DOI 10.1002/ar.1091580110; SMITH SD, 1974, ANN NY ACAD SCI, V238, P500, DOI 10.1111/j.1749-6632.1974.tb26816.x; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Song B, 2004, J CELL SCI, V117, P4681, DOI 10.1242/jcs.01341; Song B, 2002, P NATL ACAD SCI USA, V99, P13577, DOI 10.1073/pnas.202235299; Song B, 2007, NAT PROTOC, V2, P1479, DOI 10.1038/nprot.2007.205; Spence DW, 1996, PHYSIOL MEAS, V17, P57, DOI 10.1088/0967-3334/17/2/001; STANIMIROVIC DB, 1995, GLIA, V15, P119, DOI 10.1002/glia.440150204; STEWART R, 1995, DEV BIOL, V171, P340, DOI 10.1006/dbio.1995.1286; Stewart S, 2007, BIOESSAYS, V29, P1133, DOI 10.1002/bies.20656; STILLWELL EF, 1973, NATURE-NEW BIOL, V246, P110, DOI 10.1038/newbio246110a0; Sun YH, 2011, J APPL PHYSIOL, V111, P1031, DOI 10.1152/japplphysiol.00915.2010; Suzuki T, 2012, EUR J NEUROSCI, V36, P3653, DOI 10.1111/j.1460-9568.2012.08280.x; Tai GP, 2009, METHODS MOL BIOL, V571, P77, DOI 10.1007/978-1-60761-198-1_5; Tanaka EM, 2009, NAT REV NEUROSCI, V10, P713, DOI 10.1038/nrn2707; Thompson DM, 2014, ANNU REV BIOMED ENG, V16, P397, DOI 10.1146/annurev-bioeng-121813-120655; Trollinger DR, 2002, J CELL PHYSIOL, V193, P1, DOI 10.1002/jcp.10144; Tseng AS, 2010, J NEUROSCI, V30, P13192, DOI 10.1523/JNEUROSCI.3315-10.2010; Tweedell KS, 2010, THESCIENTIFICWORLDJO, V10, P954, DOI 10.1100/tsw.2010.115; Ud-Din S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124502; Wang ET, 2010, CHIN J TRAUMATOL, V13, P55, DOI 10.3760/cma.j.issn.1008-1275.2010.01.011; Wang ET, 2005, FASEB J, V19, P842, DOI 10.1096/fj.04-2733fje; Wang ET, 2003, FASEB J, V17, P458, DOI 10.1096/fj.02-0510fje; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; Wickham and Hadley, 2007, RESHAPING DATA RESHA, P21; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; Wood MD, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046003; Yao L, 2008, J CELL PHYSIOL, V216, P527, DOI 10.1002/jcp.21431; Yao L, 2009, HIPPOCAMPUS, V19, P855, DOI 10.1002/hipo.20569; Zhang F, 2000, DEV BIOL, V225, P381, DOI 10.1006/dbio.2000.9843; Zhao M, 1996, J CELL SCI, V109, P1405; Zhao M, 2002, FASEB J, V16, P857, DOI 10.1096/fj.01-0811fje; Zhao M, 1999, P NATL ACAD SCI USA, V96, P4942, DOI 10.1073/pnas.96.9.4942; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925; Zhao M, 2009, SEMIN CELL DEV BIOL, V20, P674, DOI 10.1016/j.semcdb.2008.12.009; Zuberi Mahvash, 2008, J Biol Eng, V2, P17, DOI 10.1186/1754-1611-2-17	172	13	14	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142740	10.1371/journal.pone.0142740	http://dx.doi.org/10.1371/journal.pone.0142740			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562295	gold, Green Submitted, Green Published			2022-12-26	WOS:000364480900061
J	Lateef, DM; Xiao, CY; Reitman, ML				Lateef, Dalya M.; Xiao, Cuiying; Reitman, Marc L.			Search for an Endogenous Bombesin-Like Receptor 3 (BRS-3) Ligand Using Parabiotic Mice	PLOS ONE			English	Article							SUBTYPE-3 BRS-3; OBESE; MOUSE; PHARMACOLOGY; EXPRESSION; CLONING; LEPTIN; GENES; RATS	Bombesin-like receptor 3 (BRS-3) is an X-linked G protein-coupled receptor involved in the regulation of energy homeostasis. Brs3 null (Brs3(-/y)) mice become obese. To date, no high affinity endogenous ligand has been identified. In an effort to detect a circulating endogenous BRS-3 ligand, we generated parabiotic pairs of mice between Brs3(-/y) and wild type (WT) mice or between WT controls. Successful parabiosis was demonstrated by circulatory dye exchange. The Brs3(-/y)-WT and WT-WT pairs lost similar weight immediately after surgery. After 9 weeks on a high fat diet, the Brs3(-/y)-WT pairs weighed more than the WT-WT pairs. Within the Brs3(-/y)-WT pairs, the Brs3(-/y) mice had greater adiposity than the WT mice, but comparable lean and liver weights. Compared to WT mice in WT-WT pairs, Brs3(-/y) and WT mice in Brs3(-/y)-WT pairs each had greater lean mass, and the Brs3(-/y) mice also had greater adiposity. These results contrast to those reported for parabiotic pairs of leptin receptor null (Lepr(db/db)) and WT mice, where high leptin levels in the Lepr(db/db) mice cause the WT parabiotic partners to lose weight. Our data demonstrate that a circulating endogenous BRS-3 ligand, if present, is not sufficient to reduce adiposity in parabiotic partners of Brs3(-/y) mice.	[Lateef, Dalya M.; Xiao, Cuiying; Reitman, Marc L.] NIDDK, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Reitman, ML (corresponding author), NIDDK, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA.	marc.reitman@nih.gov	Reitman, Marc/B-4448-2013	Reitman, Marc/0000-0002-0426-9475	Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health [DK075057]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075057, ZIADK075062] Funding Source: NIH RePORTER	Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (DK075057).	Brommage R, 2008, OBESITY, V16, P2362, DOI 10.1038/oby.2008.361; Civelli O, 2013, ANNU REV PHARMACOL, V53, P127, DOI 10.1146/annurev-pharmtox-010611-134548; COLEMAN DL, 1973, DIABETOLOGIA, V9, P294, DOI 10.1007/BF01221857; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; Doevendans PA, 1998, CARDIOVASC RES, V39, P34, DOI 10.1016/S0008-6363(98)00073-X; Feng Y, 2011, ENDOCRINOLOGY, V152, P4106, DOI 10.1210/en.2011-1440; Gbahou F, 2010, J PHARMACOL EXP THER, V333, P51, DOI 10.1124/jpet.109.162131; Guan XM, 2011, J PHARMACOL EXP THER, V336, P356, DOI 10.1124/jpet.110.174763; Guan XM, 2010, CELL METAB, V11, P101, DOI 10.1016/j.cmet.2009.12.008; Hansen KK, 2011, BIOCHEM BIOPH RES CO, V404, P184, DOI 10.1016/j.bbrc.2010.11.089; Harris RBS, 1997, AM J PHYSIOL-REG I, V272, pR1800, DOI 10.1152/ajpregu.1997.272.6.R1800; HARRIS RBS, 1984, AM J PHYSIOL, V247, pR380, DOI 10.1152/ajpregu.1984.247.2.R380; Harris RBS, 2013, BBA-MOL BASIS DIS, V1832, P1449, DOI 10.1016/j.bbadis.2013.02.021; HERVEY GR, 1959, J PHYSIOL-LONDON, V145, P336, DOI 10.1113/jphysiol.1959.sp006145; Ida Takanori, 2012, Front Endocrinol (Lausanne), V3, P177, DOI 10.3389/fendo.2012.00177; Ikeda Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127445; Jennings CA, 2003, NEUROSCIENCE, V120, P309, DOI 10.1016/S0306-4522(03)00260-4; Jensen RT, 2008, PHARMACOL REV, V60, P1, DOI 10.1124/pr.107.07108; Ladenheim EE, 2008, ENDOCRINOLOGY, V149, P971, DOI 10.1210/en.2007-1319; Lammerich HP, 2003, BRIT J PHARMACOL, V138, P1431, DOI 10.1038/sj.bjp.0705177; Lateef DM, 2014, AM J PHYSIOL-ENDOC M, V306, pE681, DOI 10.1152/ajpendo.00615.2013; Liu J, 2002, BIOCHEMISTRY-US, V41, P8954, DOI 10.1021/bi0202777; Majumdar ID, 2012, CURR OPIN ENDOCRINOL, V19, P3, DOI 10.1097/MED.0b013e32834ec77d; OhkiHamazaki H, 1997, BRAIN RES, V762, P165, DOI 10.1016/S0006-8993(97)00380-6; OhkiHamazaki H, 1997, NATURE, V390, P165, DOI 10.1038/36568; Xu XH, 2012, CELL, V148, P596, DOI 10.1016/j.cell.2011.12.018; Zeng WW, 2015, P NATL ACAD SCI USA, V112, pE3874, DOI 10.1073/pnas.1510378112; Zhang L, 2013, J COMP NEUROL, V521, P1020, DOI 10.1002/cne.23216; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	29	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142637	10.1371/journal.pone.0142637	http://dx.doi.org/10.1371/journal.pone.0142637			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562312	Green Published, Green Submitted, gold			2022-12-26	WOS:000364480900052
J	Nozaki, H; Matsuzaki, R; Yamamoto, K; Kawachi, M; Takahashi, F				Nozaki, Hisayoshi; Matsuzaki, Ryo; Yamamoto, Kayoko; Kawachi, Masanobu; Takahashi, Fumio			Delineating a New Heterothallic Species of Volvox (Volvocaceae, Chlorophyceae) Using New Strains of "Volvox africanus"	PLOS ONE			English	Article							SECONDARY STRUCTURE; MOLECULAR PHYLOGENY; MORPHOLOGY; EVOLUTION; TAXONOMY; PLEODORINA; ORIGIN; REPRODUCTION; GONIACEAE; MULTIPLE	The volvocine algae represent an excellent model lineage in which to study evolution of female and male genders based on comparative analyses of related species. Among these species, Volvox carteri has been extensively studied as a model of an oogamous and complex organism. However, it may have unique derived features that are not present in other species of Volvox. Therefore, information regarding the characteristics of sexual reproduction of other species of Volvox is also important. In 1971, Starr studied four types of sexuality in several global strains identified as Volvox africanus; however, further taxonomic studies of these strains have been lacking, and strains of three of the four sexual types are not available. Here, we studied the morphology, sexual reproduction, and taxonomy of two V. africanus-like species isolated recently from Lake Biwa, Japan. These two species were very similar to two sexual types described by Starr in 1971: one producing dioecious sexual spheroids in heterothallic strains and the other forming both male spheroids and monoecious spheroids in a single strain. The former species produced zygotes with a reticulate cell wall, whereas a smooth zygote wall was observed in the latter species as in V. africanus previously reported from various localities around the world. Our multigene phylogenetic analysis demonstrated that these are sister species to each other. However, the presence of a compensatory base change in the most conserved region of the secondary structure of nuclear ribosomal DNA internal transcribed spacer-2, hybrid inviability demonstrated by intercrossing experiments, and morphological differences in the density of abutment between the gelatinous material of adjacent cells (individual sheaths) in the spheroid supported the recognition of the two species, V. africanus having a smooth zygote wall and V. reticuliferus Nozaki sp. nov. having a reticulate zygote wall.	[Nozaki, Hisayoshi; Matsuzaki, Ryo; Yamamoto, Kayoko] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan; [Kawachi, Masanobu] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki, Japan; [Takahashi, Fumio] Ritsumeikan Univ, Coll Life Sci, Kusatsu, Shiga, Japan	University of Tokyo; National Institute for Environmental Studies - Japan; Ritsumeikan University	Nozaki, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan.	nozaki@bs.s.u-tokyo.ac.jp		Nozaki, Hisayoshi/0000-0002-9308-4498; Matsuzaki, Ryo/0000-0002-8989-5933	MEXT/JSPS KAKENHI [24247042, 25304012, 15K14580]; Grants-in-Aid for Scientific Research [25304012, 15H06148] Funding Source: KAKEN	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (Nos. 24247042, 25304012 and 15K14580 to HN) from MEXT/JSPS KAKENHI (http://www.jsps.go.jp/english/e-grants/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Grants-in-Aid for Scientific Research (Nos. 24247042, 25304012 and 15K14580 to HN) from MEXT/JSPS KAKENHI. We are grateful to Prof. Masahiro Kasahara of Ritsumeikan University for his kind help in our field collection in Lake Biwa.	Anonymous, 2009, Japanese Journal of Phycology, V57, P1; Caisova L, 2013, PROTIST, V164, P482, DOI 10.1016/j.protis.2013.04.005; Coleman AW, 2009, MOL PHYLOGENET EVOL, V50, P197, DOI 10.1016/j.ympev.2008.10.008; Coleman AW, 1999, P NATL ACAD SCI USA, V96, P13892, DOI 10.1073/pnas.96.24.13892; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferris P, 2010, SCIENCE, V328, P351, DOI 10.1126/science.1186222; Geng S, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001904; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Hamada M, 2009, BIOINFORMATICS, V25, P465, DOI 10.1093/bioinformatics/btn601; Hayama M, 2010, PHYCOLOGIA, V49, P221, DOI 10.2216/PH09-56.1; Herron MD, 2009, P NATL ACAD SCI USA, V106, P3254, DOI 10.1073/pnas.0811205106; Hiraide R, 2013, MOL BIOL EVOL, V30, P1038, DOI 10.1093/molbev/mst018; IYENGAR M.O.P., 1933, J LINN SOC BOT, V49, P323; KATO S, 1982, Japanese Journal of Phycology, V30, P63; Kirk DL, 2006, CURR BIOL, V16, pR1028, DOI 10.1016/j.cub.2006.11.015; Kirk DL., 1998, VOLVOX MOL GENETIC O; Linnaeus C, 1766, SYSTEMA NATURAE REGN; Mai JC, 1997, J MOL EVOL, V44, P258, DOI 10.1007/PL00006143; NOZAKI H, 1992, PHYCOLOGIA, V31, P529, DOI 10.2216/i0031-8884-31-6-529.1; Nozaki H, 2000, MOL PHYLOGENET EVOL, V17, P256, DOI 10.1006/mpev.2000.0831; Nozaki H, 2003, BIOLOGIA, V58, P425; Nozaki H, 2001, EUR J PHYCOL, V36, P23, DOI 10.1080/09670260110001735158; NOZAKI H, 1994, J PHYCOL, V30, P279, DOI 10.1111/j.0022-3646.1994.00279.x; NOZAKI H, 1988, PHYCOLOGIA, V27, P209, DOI 10.2216/i0031-8884-27-2-209.1; Nozaki H, 2008, BIOLOGIA, V63, P774; Nozaki H, 2006, J PHYCOL, V42, P1072, DOI 10.1111/j.1529-8817.2006.00255.x; Nozaki H, 2006, CURR BIOL, V16, pR1018, DOI 10.1016/j.cub.2006.11.019; Nozaki H, 2015, PHYCOLOGIA, V54, P316, DOI 10.2216/15-14.1; Nozaki H, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-37; Nozaki H, 2011, J PHYCOL, V47, P673, DOI 10.1111/j.1529-8817.2011.00975.x; Nylander J.A.A., 2004, MRMODELTEST 2 3 PROG; Pringsheim E.G., 1946, PURE CULTURES ALGAE; Printz H., 1927, NATURL PFLANZ, V2, P1; RICH FLORENCE, 1933, ANN S AFRICAN MUS, V16, P427; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sato K, 2009, NUCLEIC ACIDS RES, V37, pW277, DOI 10.1093/nar/gkp367; Shaw W. R., 1923, Philippine Journal of Science, V22, P185; Shaw W. R., 1920, Philippine Journal of Science, V15; Shaw W. R., 1922, Philippine Journal of Science, V21, P87; Smith Gilbert M., 1944, TRANS AMER MICROSC SOC, V63, P265, DOI 10.2307/3223302; Spencer MA, 2009, TAXON, V58, P237, DOI 10.1002/tax.581023; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STARR R. C., 1971, CONTRIBUTIONS PHYCOL, P59; STARR RC, 1993, J PHYCOL, V29, P1, DOI 10.1111/j.0022-3646.1993.00001.x; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; West G. S., 1910, J QUECETT MICROSC 2, V11, P99; West G. S, 1918, J QUEK MIC CLUB, V13, P425	48	20	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142632	10.1371/journal.pone.0142632	http://dx.doi.org/10.1371/journal.pone.0142632			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562165	gold, Green Submitted, Green Published			2022-12-26	WOS:000364480900051
J	Pahwa, M; Kusner, M; Hacker, CD; Bundy, DT; Weinberger, KQ; Leuthardt, EC				Pahwa, Mrinal; Kusner, Matthew; Hacker, Carl D.; Bundy, David T.; Weinberger, Kilian Q.; Leuthardt, Eric C.			Optimizing the Detection of Wakeful and Sleep-Like States for Future Electrocorticographic Brain Computer Interface Applications	PLOS ONE			English	Article							HUMAN SENSORIMOTOR CORTEX; CORTICAL ACTIVITY; SPECTRAL-ANALYSIS; MOTOR IMAGERY; OSCILLATIONS; TOPOGRAPHY; DYNAMICS; PATTERNS; SIGNALS	Previous studies suggest stable and robust control of a brain-computer interface (BCI) can be achieved using electrocorticography (ECoG). Translation of this technology from the laboratory to the real world requires additional methods that allow users operate their ECoG-based BCI autonomously. In such an environment, users must be able to perform all tasks currently performed by the experimenter, including manually switching the BCI system on/off. Although a simple task, it can be challenging for target users (e.g., individuals with tetraplegia) due to severe motor disability. In this study, we present an automated and practical strategy to switch a BCI system on or off based on the cognitive state of the user. Using a logistic regression, we built probabilistic models that utilized sub-dural ECoG signals from humans to estimate in pseudo real-time whether a person is awake or in a sleep-like state, and subsequently, whether to turn a BCI system on or off. Furthermore, we constrained these models to identify the optimal anatomical and spectral parameters for delineating states. Other methods exist to differentiate wake and sleep states using ECoG, but none account for practical requirements of BCI application, such as minimizing the size of an ECoG implant and predicting states in real time. Our results demonstrate that, across 4 individuals, wakeful and sleep-like states can be classified with over 80% accuracy (up to 92%) in pseudo real-time using high gamma (70-110 Hz) band limited power from only 5 electrodes (platinum discs with a diameter of 2.3 mm) located above the precentral and posterior superior temporal gyrus.	[Pahwa, Mrinal; Hacker, Carl D.; Bundy, David T.; Leuthardt, Eric C.] Washington Univ, Dept Biomed Engn, St Louis, MO 63110 USA; [Kusner, Matthew; Weinberger, Kilian Q.] Washington Univ, Dept Comp Sci & Engn, St Louis, MO USA; [Hacker, Carl D.; Leuthardt, Eric C.] Washington Univ, Sch Med, St Louis, MO USA; [Leuthardt, Eric C.] Washington Univ, Dept Neurol Surg, St Louis, MO USA; [Leuthardt, Eric C.] Washington Univ, Ctr Innovat Neurosci & Technol, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Pahwa, M (corresponding author), Washington Univ, Dept Biomed Engn, St Louis, MO 63110 USA.	pahwam@wustl.edu		Bundy, David/0000-0001-6491-044X	National Science Foundation Emerging Frontiers in Research and Innovation [EFRI1137211]; National Institute of Mental Health Fellowship [1F30MH099877-01-A1]; Washington University Institute of Clinical and Translational Sciences [UL1 TR000448]; National Center for Advancing Translational Sciences [TL1 TR000449]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000449, UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH099877] Funding Source: NIH RePORTER	National Science Foundation Emerging Frontiers in Research and Innovation(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); National Institute of Mental Health Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Washington University Institute of Clinical and Translational Sciences; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was generously supported by the National Science Foundation Emerging Frontiers in Research and Innovation grant #EFRI1137211 (MP, MK, KW, & ECL), the National Institute of Mental Health Fellowship #1F30MH099877-01-A1 (CDH), the Washington University Institute of Clinical and Translational Sciences grants #UL1 TR000448 (DTB), and the National Center for Advancing Translational Sciences grant #TL1 TR000449 (DTB). The contents of this study are solely the responsibility of the authors and do not necessarily represent the views of the funding institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman N, 2007, J NEURAL ENG, V4, P336, DOI 10.1088/1741-2560/4/3/018; Aflalo T, 2015, SCIENCE, V348, P906, DOI 10.1126/science.aaa5417; Botella-Soler V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030757; Cantero JL, 2004, NEUROIMAGE, V22, P1271, DOI 10.1016/j.neuroimage.2004.03.014; Chao Zenas C, 2010, Front Neuroeng, V3, P3, DOI 10.3389/fneng.2010.00003; Chesson Jr A. L., 2007, THE AASM MANUAL FOR; Crone NE, 2001, CLIN NEUROPHYSIOL, V112, P565, DOI 10.1016/S1388-2457(00)00545-9; Crone NE, 1998, BRAIN, V121, P2271, DOI 10.1093/brain/121.12.2271; Crone NE, 1998, BRAIN, V121, P2301, DOI 10.1093/brain/121.12.2301; Della Marca G, 2007, SLEEP MED, V8, P96, DOI 10.1016/j.sleep.2006.08.004; Ferrara M, 2006, BEHAV BRAIN RES, V167, P237, DOI 10.1016/j.bbr.2005.09.012; Finelli LA, 2001, EUR J NEUROSCI, V13, P2282, DOI 10.1046/j.0953-816x.2001.01597.x; Green D. M., 1966, SIGNAL DETECTION THE, DOI DOI 10.1086/405615; Gross DW, 1999, NEUROSCIENCE, V94, P1005, DOI 10.1016/S0306-4522(99)00343-7; Hangya B, 2011, J NEUROSCI, V31, P8770, DOI 10.1523/JNEUROSCI.1498-11.2011; Hermes D, 2010, J NEUROSCI METH, V185, P293, DOI 10.1016/j.jneumeth.2009.10.005; Kelsey M, 2012, IEEE ENG MED BIO, P4336, DOI 10.1109/EMBC.2012.6346926; Kurth S, 2010, J NEUROSCI, V30, P13211, DOI 10.1523/JNEUROSCI.2532-10.2010; Leuthardt EC, 2004, J NEURAL ENG, V1, P63, DOI 10.1088/1741-2560/1/2/001; Leuthardt EC, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036004; Leuthardt EC, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.4.FOCUS0979; Mason SG, 2000, IEEE T BIO-MED ENG, V47, P1297, DOI 10.1109/10.871402; Mendez M, 2001, J CLIN NEUROPHYSIOL, V18, P106; Miller KJ, 2010, P NATL ACAD SCI USA, V107, P4430, DOI 10.1073/pnas.0913697107; Nishida M, 2005, NEUROSCI LETT, V379, P110, DOI 10.1016/j.neulet.2004.12.069; Nishida M, 2004, NEUROSCI RES, V50, P331, DOI 10.1016/j.neures.2004.08.004; Pfurtscheller G, 2009, Comput Intell Neurosci, P104180, DOI 10.1155/2009/104180; Pfurtscheller G, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnpro.2010.00003; Ramot M, 2013, J NEUROSCI, V33, P14715, DOI 10.1523/JNEUROSCI.0232-13.2013; Schalk G, 2008, J NEURAL ENG, V5, P75, DOI 10.1088/1741-2560/5/1/008; Schalk Gerwin, 2011, IEEE Rev Biomed Eng, V4, P140, DOI 10.1109/RBME.2011.2172408; TallonBaudry C, 1997, J NEUROSCI, V17, P722; Tassi P, 2000, SLEEP MED REV, V4, P341, DOI 10.1053/smrv.2000.0098; Tinguely G, 2006, NEUROIMAGE, V32, P283, DOI 10.1016/j.neuroimage.2006.03.017; Uchida S, 2001, BRAIN RES, V891, P7, DOI 10.1016/S0006-8993(00)03154-1; Wang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055344; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Williams JJ, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/4/046001; Wilson JA, 2006, IEEE T NEUR SYS REH, V14, P246, DOI 10.1109/TNSRE.2006.875570; Zempel John M, 2012, Front Neurol, V3, P76, DOI 10.3389/fneur.2012.00076	40	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142947	10.1371/journal.pone.0142947	http://dx.doi.org/10.1371/journal.pone.0142947			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562013	Green Published, Green Submitted, gold			2022-12-26	WOS:000364480900086
J	Shiraishi, Y; Kohsaka, S; Harada, K; Sakai, T; Takagi, A; Miyamoto, T; Iida, K; Tanimoto, S; Fukuda, K; Nagao, K; Sato, N; Takayama, M				Shiraishi, Yasuyuki; Kohsaka, Shun; Harada, Kazumasa; Sakai, Tetsuro; Takagi, Atsutoshi; Miyamoto, Takamichi; Iida, Kiyoshi; Tanimoto, Shuzou; Fukuda, Keiichi; Nagao, Ken; Sato, Naoki; Takayama, Morimasa		Sci Comm Tokyo CCU Network	Time Interval from Symptom Onset to Hospital Care in Patients with Acute Heart Failure: A Report from the Tokyo Cardiac Care Unit Network Emergency Medical Service Database	PLOS ONE			English	Article							RISK STRATIFICATION; TASK-FORCE; MORTALITY; ASSOCIATION; GUIDELINES; MANAGEMENT; THERAPY; LENGTH; DELAY; ESC	Aims There seems to be two distinct patterns in the presentation of acute heart failure (AHF) patients; early-vs. gradual-onset. However, whether time-dependent relationship exists in outcomes of patients with AHF remains unclear. Methods The Tokyo Cardiac Care Unit Network Database prospectively collects information of emergency admissions via EMS service to acute cardiac care facilities from 67 participating hospitals in the Tokyo metropolitan area. Between 2009 and 2011, a total of 3811 AHF patients were registered. The documentation of symptom onset time was mandated by the on-site ambulance team. We divided the patients into two groups according to the median on-set-to-hospitalization (OH) time for those patients (2h); early-(presenting <= 2h after symptom onset) vs. gradual-onset (late) group (>2h). The primary outcome was in-hospital mortality. Results The early OH group had more urgent presentation, as demonstrated by a higher systolic blood pressure (SBP), respiratory rate, and higher incidence of pulmonary congestion (48.6% vs. 41.6%; P<0.001); whereas medical comorbidities such as stroke (10.8% vs. 7.9%; P<0.001) and atrial fibrillation (30.0% vs. 26.0%; P<0.001) were more frequently seen in the late OH group. Overall, 242 (6.5%) patients died during hospitalization. Notably, a shorter OH time was associated with a better in-hospital mortality rate (odds ratio, 0.71; 95% confidence interval, 0.51 - 0.99; P = 0.043). Conclusions Early-onset patients had rather typical AHF presentations (e.g., higher SBP or pulmonary congestion) but had a better in-hospital outcome compared to gradual-onset patients.	[Shiraishi, Yasuyuki; Kohsaka, Shun; Harada, Kazumasa; Sakai, Tetsuro; Takagi, Atsutoshi; Miyamoto, Takamichi; Iida, Kiyoshi; Tanimoto, Shuzou; Fukuda, Keiichi; Nagao, Ken; Sato, Naoki; Takayama, Morimasa; Sci Comm Tokyo CCU Network] Tokyo CCU Network Sci Comm, Tokyo, Japan; [Shiraishi, Yasuyuki] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan	Keio University	Kohsaka, S (corresponding author), Tokyo CCU Network Sci Comm, Tokyo, Japan.	kohsaka@cpnet.med.keio.ac.jp	Fukuda, Keiichi/L-3777-2013	Kohsaka, Shun/0000-0003-3779-2972; Shibui, Takashi/0000-0002-0676-5595	Pfizer Japan Inc.; Department of Cardiology, Keio University School of Medicine from Bayer Pharmaceutical Co., Ltd.	Pfizer Japan Inc.(Pfizer); Department of Cardiology, Keio University School of Medicine from Bayer Pharmaceutical Co., Ltd.	Dr. Kohsaka received lecture fees from Pfizer Japan Inc., and he received unrestricted research grant for Department of Cardiology, Keio University School of Medicine from Bayer Pharmaceutical Co., Ltd. Other authors have no conflicts of interest to disclose. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Brodie BR, 2006, J AM COLL CARDIOL, V48, P2600, DOI 10.1016/j.jacc.2006.09.023; Chen J, 2011, JAMA-J AM MED ASSOC, V306, P1669, DOI 10.1001/jama.2011.1474; Collins S, 2008, ANN EMERG MED, V51, P45, DOI 10.1016/j.annemergmed.2007.07.007; Cotter G, 2008, EUR J HEART FAIL, V10, P165, DOI 10.1016/j.ejheart.2008.01.007; Cotter G, 2008, AM HEART J, V155, P9, DOI 10.1016/j.ahj.2006.02.038; Dib JE, 2012, J EMERG MED, V42, P553, DOI 10.1016/j.jemermed.2011.06.002; Fonarow GC, 2005, JAMA-J AM MED ASSOC, V293, P572, DOI 10.1001/jama.293.5.572; Gravely-Witte S, 2010, EUR J HEART FAIL, V12, P1122, DOI 10.1093/eurjhf/hfq122; Johnson W, 2002, J AM COLL CARDIOL, V39, P1623, DOI 10.1016/S0735-1097(02)01814-4; Kawaguchi M, 2003, CIRCULATION, V107, P714, DOI 10.1161/01.CIR.0000048123.22359.A0; Lee DS, 2003, JAMA-J AM MED ASSOC, V290, P2581, DOI 10.1001/jama.290.19.2581; Maggioni AP, 2013, EUR J HEART FAIL, V15, P808, DOI 10.1093/eurjhf/hft050; Magid DJ, 2005, JAMA-J AM MED ASSOC, V294, P803, DOI 10.1001/jama.294.7.803; Maisel AS, 2008, J AM COLL CARDIOL, V52, P534, DOI 10.1016/j.jacc.2008.05.010; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Mebazaa Alexandre, 2008, Crit Care Med, V36, pS129, DOI 10.1097/01.CCM.0000296274.51933.4C; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; O'Connor CM, 2012, EUR J HEART FAIL, V14, P605, DOI 10.1093/eurjhf/hfs029; Obayashi T, 2010, CIRC J, V74, P289, DOI 10.1253/circj.CJ-09-0623; Ohta T, 1974, No Shinkei Geka, V2, P623; Ono K, 2007, NEUROL MED-CHIR, V47, P291, DOI 10.2176/nmc.47.291; Peacock William Frank, 2009, Congest Heart Fail, V15, P256, DOI 10.1111/j.1751-7133.2009.00112.x; Peterson PN, 2010, CIRC-CARDIOVASC QUAL, V3, P25, DOI 10.1161/CIRCOUTCOMES.109.854877; Takahashi M, 2011, J CARD FAIL, V17, P742, DOI 10.1016/j.cardfail.2011.05.005; Wong YW, 2013, AM HEART J, V166, P349, DOI 10.1016/j.ahj.2013.05.014; WUERZ RC, 1992, ANN EMERG MED, V21, P669, DOI 10.1016/S0196-0644(05)82777-5; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019	27	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142017	10.1371/journal.pone.0142017	http://dx.doi.org/10.1371/journal.pone.0142017			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562780	gold, Green Submitted, Green Published			2022-12-26	WOS:000364480900011
J	Valera, P; Zavattari, P; Sanna, A; Pretti, S; Marcello, A; Mannu, C; Targhetta, C; Bruno, G; Songini, M				Valera, Paolo; Zavattari, Patrizia; Sanna, Alessandro; Pretti, Salvatore; Marcello, Alberto; Mannu, Carla; Targhetta, Clara; Bruno, Graziella; Songini, Marco			Zinc and Other Metals Deficiencies and Risk of Type 1 Diabetes: An Ecological Study in the High Risk Sardinia Island	PLOS ONE			English	Article							SUPPLEMENTATION; CHROMIUM; CHILDREN; COPPER; MELLITUS	Background Type 1 diabetes incidence presents a decreasing gradient in Europe from the Nordic countries to the Mediterranean ones. Exception to this gradient is represented by Sardinia, the second largest Mediterranean island whose population shows the highest incidence in Europe, after Finland. The genetic features of this population have created a fertile ground for the epidemic of the disease, however, as well as being strikingly high, the incidence rate has suddenly presented a continuous increase from the '50s, not explainable by accumulation of new genetic variants. Several environmental factors have been taken into account, possibly interacting with the genetic/epigenetic scenario, but there are no strong evidences to date. Methods The present study investigated the hypothesis that geochemical elements could create permissive environmental conditions for autoimmune diabetes. An ecological analysis was performed to test possible correlations between the values of eight elements in stream sediments and type 1 diabetes incidence rate in Sardinia. Results Analyses revealed negative associations between elements, such as Co, Cr, Cu, Mn, Ni, Zn, and type 1 diabetes incidence. Conclusions The results suggest a possible protective role of some elements against the onset of the disease.	[Valera, Paolo; Sanna, Alessandro; Pretti, Salvatore; Marcello, Alberto] Univ Cagliari, Dept Civil Environm Engn & Architecture, Cagliari, Italy; [Zavattari, Patrizia] Univ Cagliari, Dept Biomed Sci, Cagliari, Italy; [Mannu, Carla; Targhetta, Clara; Songini, Marco] St Michele Hosp, Ctr Study Diabet Complicat & Metab Dis, Cagliari, Italy; [Bruno, Graziella] Univ Turin, Dept Med Sci, Turin, Italy	University of Cagliari; University of Cagliari; University of Turin	Valera, P (corresponding author), Univ Cagliari, Dept Civil Environm Engn & Architecture, Cagliari, Italy.	pvalera@unica.it; pzavattari@unica.it	Valera, Paolo/E-5082-2010	Valera, Paolo/0000-0002-6812-5921; Mannu, Carla/0000-0002-5421-9193; BRUNO, Graziella/0000-0002-3011-8304; Songini, Marco/0000-0003-3524-645X; Sanna, Alessandro/0000-0001-5663-4254				Adewumi M. T., 2007, Asian Journal of Biochemistry, V2, P284; Anderson RA, 1997, DIABETES, V46, P1786, DOI 10.2337/diabetes.46.11.1786; Besser L, 2009, J NEUROSCI, V29, P2890, DOI 10.1523/JNEUROSCI.5093-08.2009; Bruno G, 2013, DIABETES, V62, P3542, DOI 10.2337/db12-1771; Casu A, 2000, DIABETES CARE, V23, P1043, DOI 10.2337/diacare.23.7.1043; Casu A, 2004, DIABETES CARE, V27, P1623, DOI 10.2337/diacare.27.7.1623; Chora AA, 2007, J CLIN INVEST, V117, P438, DOI 10.1172/JCI28844; Cunningham JJ, 1998, J AM COLL NUTR, V17, P7, DOI 10.1080/07315724.1998.10718729; Ekin S, 2003, BIOL TRACE ELEM RES, V94, P193, DOI 10.1385/BTER:94:3:193; Flem B, 2015, APPL GEOCHEM, V59, P211, DOI 10.1016/j.apgeochem.2015.01.016; Forte G, 2013, BIOL TRACE ELEM RES, V156, P79, DOI 10.1007/s12011-013-9858-6; Fraker PJ, 2004, ANNU REV NUTR, V24, P277, DOI 10.1146/annurev.nutr.24.012003.132454; Fukada T, 2011, J BIOL INORG CHEM, V16, P1123, DOI 10.1007/s00775-011-0797-4; Gilbert ER, 2012, EPIGENETICS-US, V7, P841, DOI 10.4161/epi.21238; GREEN A, 1992, LANCET, V339, P905, DOI 10.1016/0140-6736(92)90938-Y; Green A, 2001, DIABETOLOGIA, V44, pB3, DOI 10.1007/PL00002950; Haase H, 2014, METALLOMICS, V6, P1175, DOI 10.1039/c3mt00353a; Hellerstein MK, 1998, NUTR REV, V56, P302, DOI 10.1111/j.1753-4887.1998.tb01664.x; Jakovac Hrvoje, 2013, Curr Aging Sci, V6, P37; Kabu K, 2006, J IMMUNOL, V177, P1296, DOI 10.4049/jimmunol.177.2.1296; Kazi TG, 2008, BIOL TRACE ELEM RES, V122, P1, DOI 10.1007/s12011-007-8062-y; Kitabayashi C, 2010, INT IMMUNOL, V22, P375, DOI 10.1093/intimm/dxq017; KORC M, 1983, AM J PHYSIOL, V245, pG628, DOI 10.1152/ajpgi.1983.245.5.G628; Majithia AR, 2011, DIABETOLOGIA, V54, P2570, DOI 10.1007/s00125-011-2234-1; Marcello A, 1978, B SERV GEOL ITAL, V99, P277; Marcello A, 2008, GEOBASI 2 FOGLIO IGM; Marcello A, 2003, GEOCHEMICAL BASELINE; Maruthur NM, 2015, DIABETOLOGIA, V58, P295, DOI 10.1007/s00125-014-3419-1; Masala S, 2014, ACTA DIABETOL, V51, P577, DOI 10.1007/s00592-014-0558-2; Massilamany C, 2013, J NEUROIMMUNOL, V256, P19, DOI 10.1016/j.jneuroim.2012.12.004; Palmas C, 2003, J HELMINTHOL, V77, P147, DOI 10.1079/JOH2003176; Prasad AS, 1998, MOL CELL BIOCHEM, V188, P63, DOI 10.1023/A:1006868305749; Reimann C., 2010, GEOCHEMISTRY EUROPEA; Rink L, 2007, TRENDS IMMUNOL, V28, P1, DOI 10.1016/j.it.2006.11.005; Flores CR, 2011, DIABETES RES CLIN PR, V91, P333, DOI 10.1016/j.diabres.2010.12.014; Samuelsson U, 2011, PEDIATR DIABETES, V12, P156, DOI 10.1111/j.1399-5448.2010.00678.x; Shankar AH, 1998, AM J CLIN NUTR, V68, p447S, DOI 10.1093/ajcn/68.2.447S; Simmons Rebecca A, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P13, DOI 10.1097/MED.0b013e328013da5b; Sitasawad S, 2001, DIABETES RES CLIN PR, V52, P77, DOI 10.1016/S0168-8227(00)00249-7; Songini M, 1998, DIABETOLOGIA, V41, P221, DOI 10.1007/s001250050893; Songini Marco, 2010, J Diabetes Sci Technol, V4, P1248; Sun Q, 2009, DIABETES CARE, V32, P629, DOI 10.2337/dc08-1913; Temple Victor J., 2004, Papua New Guinea Medical Journal, V47, P146; Valera P, 2014, ENVIRON GEOCHEM HLTH, V36, P79, DOI 10.1007/s10653-013-9520-4; Valera RG, 2002, ANFANGE METALLURGIE; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Zavattari P, 2000, HUM MOL GENET, V9, P2947, DOI 10.1093/hmg/9.20.2947	47	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141262	10.1371/journal.pone.0141262	http://dx.doi.org/10.1371/journal.pone.0141262			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559814	Green Published, gold, Green Submitted			2022-12-26	WOS:000364433100027
J	Abdul-Kreem, LI; Neumann, H				Abdul-Kreem, Luma Issa; Neumann, Heiko			Neural Mechanisms of Cortical Motion Computation Based on a Neuromorphic Sensory System	PLOS ONE			English	Article							TEMPORAL VISUAL AREA; FIGURE-GROUND SEGREGATION; DIRECTION SELECTIVITY; MACAQUE MONKEY; IMAGE VELOCITY; MODEL; MT; SPEED; DYNAMICS; NEURONS	The visual cortex analyzes motion information along hierarchically arranged visual areas that interact through bidirectional interconnections. This work suggests a bio-inspired visual model focusing on the interactions of the cortical areas in which a new mechanism of feed-forward and feedback processing are introduced. The model uses a neuromorphic vision sensor (silicon retina) that simulates the spike-generation functionality of the biological retina. Our model takes into account two main model visual areas, namely V1 and MT, with different feature selectivities. The initial motion is estimated in model area V1 using spatiotemporal filters to locally detect the direction of motion. Here, we adapt the filtering scheme originally suggested by Adelson and Bergen to make it consistent with the spike representation of the DVS. The responses of area V1 are weighted and pooled by area MT cells which are selective to different velocities, i.e. direction and speed. Such feature selectivity is here derived from compositions of activities in the spatio-temporal domain and integrating over larger space-time regions (receptive fields). In order to account for the bidirectional coupling of cortical areas we match properties of the feature selectivity in both areas for feedback processing. For such linkage we integrate the responses over different speeds along a particular preferred direction. Normalization of activities is carried out over the spatial as well as the feature domains to balance the activities of individual neurons in model areas V1 and MT. Our model was tested using different stimuli that moved in different directions. The results reveal that the error margin between the estimated motion and synthetic ground truth is decreased in area MT comparing with the initial estimation of area V1. In addition, the modulated V1 cell activations shows an enhancement of the initial motion estimation that is steered by feedback signals from MT cells.	[Abdul-Kreem, Luma Issa; Neumann, Heiko] Univ Ulm, Inst Neural Informat Proc, D-89069 Ulm, Germany; [Abdul-Kreem, Luma Issa] Univ Technol Baghdad, Control & Syst Engn Dept, Baghdad, Iraq	Ulm University; University of Technology- Iraq	Abdul-Kreem, LI (corresponding author), Univ Ulm, Inst Neural Informat Proc, D-89069 Ulm, Germany.	luma.issa@uni-ulm.de	Abdul-Kreem, luma Issa/AAW-9283-2020	Abdul-Kreem, luma Issa/0000-0002-6161-2428	Ministry of Higher Education and Scientific Research (MoHESR) Iraq; German Academic Exchange Service (DAAD); DFG in the Collaborative Research Center [SFB/TR-62]	Ministry of Higher Education and Scientific Research (MoHESR) Iraq; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); DFG in the Collaborative Research Center(German Research Foundation (DFG))	Funding: LIAK has been supported by grants from the Ministry of Higher Education and Scientific Research (MoHESR) Iraq and from the German Academic Exchange Service (DAAD). HN acknowledges support from DFG in the Collaborative Research Center SFB/TR-62 (A companion technology for cognitive technical systems).	Abdul-Kreem LI, 2015, 10 INT C COMP VIS TH; Adelson E, 1985, J OPT SOC AM, V2, P90; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; ALBRIGHT TD, 1987, EXP BRAIN RES, V65, P582; Bastos AM, VISUAL AREAS EXERT F; Bastos AM, 2012, NEURON, V76, P695, DOI 10.1016/j.neuron.2012.10.038; Bayerl P, 2004, NEURAL COMPUT, V16, P2041, DOI 10.1162/0899766041732404; Benosman R, 2012, NEURAL NETWORKS, V27, P32, DOI 10.1016/j.neunet.2011.11.001; Born RT, 2000, J NEUROPHYSIOL, V84, P2658, DOI 10.1152/jn.2000.84.5.2658; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Bouecke JD, 2011, EURASIP J ADV SIG PR, DOI 10.1155/2011/781561; Brosch T, 2015, FRONTIERS NEUROSCIEN, V137; Brosch T, 2014, NEURAL COMPUT, V26, P2735, DOI 10.1162/NECO_a_00675; Brox T, 2004, LECT NOTES COMPUT SC, V2034, P25, DOI 10.1007/978-3-540-24673-2_3; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; Carandini M., 1999, CEREB CORTEX, V13, P401, DOI DOI 10.1007/978-1-4615-4903-1_7; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; Chalupa L.M., 2004, VISUAL NEUROSCIENCES; Chey J, 1997, J OPT SOC AM A, V14, P2570, DOI 10.1364/JOSAA.14.002570; Chey J, 1998, VISION RES, V38, P2769, DOI 10.1016/S0042-6989(97)00372-6; Churchland MM, 2005, J NEUROPHYSIOL, V93, P1235, DOI 10.1152/jn.00767.2004; Crick F, 1998, NATURE, V391, P245, DOI 10.1038/34584; Crouzet SM, 2011, J NEUROSCI, V31, P8706, DOI 10.1523/JNEUROSCI.1878-11.2011; Davis J., 1994, LARGE SCALE NEURONAL; De Valois RL, 2000, VISION RES, V40, P3685, DOI 10.1016/S0042-6989(00)00210-8; Delbruck T, 2007, IEEE INT SYMP CIRC S, P845, DOI 10.1109/ISCAS.2007.378038; Delbruck T, 2010, IEEE INT SYMP CIRC S, P2426, DOI 10.1109/ISCAS.2010.5537149; Desimone R, 1998, PHILOS T R SOC B, V353, P1245, DOI 10.1098/rstb.1998.0280; Drulea M, 2013, IEEE T IMAGE PROCESS, V22, P3260, DOI 10.1109/TIP.2013.2263149; EDELMAN GM, 1993, NEURON, V10, P115, DOI 10.1016/0896-6273(93)90304-A; Escobar MJ, 2012, COMPUT VIS IMAGE UND, V116, P593, DOI 10.1016/j.cviu.2012.01.002; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FELLEMAN DJ, 1984, J NEUROPHYSIOL, V52, P488, DOI 10.1152/jn.1984.52.3.488; FLEET DJ, 1990, INT J COMPUT VISION, V5, P77, DOI 10.1007/BF00056772; Foldiak P, 1991, NEURAL COMPUT, V3, P194, DOI 10.1162/neco.1991.3.2.194; Friston KJ, 2000, P NATL ACAD SCI USA, V97, P7591, DOI 10.1073/pnas.97.13.7591; GIRARD P, 1989, J NEUROPHYSIOL, V62, P1287, DOI 10.1152/jn.1989.62.6.1287; GROSSBERG S, 1988, NEURAL NETWORKS, V1, P17, DOI 10.1016/0893-6080(88)90021-4; GROSSBERG S, 1994, PERCEPT PSYCHOPHYS, V55, P48, DOI 10.3758/BF03206880; GROSSBERG S, 1980, PSYCHOL REV, V87, P1, DOI 10.1037/0033-295X.87.1.1; Grossberg S, 2001, VISION RES, V41, P2521, DOI 10.1016/S0042-6989(01)00131-6; GRZYWACZ NM, 1990, PROC R SOC SER B-BIO, V239, P129, DOI 10.1098/rspb.1990.0012; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; HILDRETH EC, 1987, ANNU REV NEUROSCI, V10, P477, DOI 10.1146/annurev.ne.10.030187.002401; HORN BKP, 1981, ARTIF INTELL, V17, P185, DOI 10.1016/0004-3702(81)90024-2; Johnson RR, 1997, J NEUROSCI, V17, P7129; Koivisto M, 2011, J NEUROSCI, V31, P2488, DOI 10.1523/JNEUROSCI.3074-10.2011; Konig P, 1998, Z NATURFORSCH C, V53, P542; Kouh M, 2008, NEURAL COMPUT, V20, P1427, DOI 10.1162/neco.2008.02-07-466; LAGAE L, 1993, J NEUROPHYSIOL, V69, P19, DOI 10.1152/jn.1993.69.1.19; Lamme VAF, 1998, CURR OPIN NEUROBIOL, V8, P529, DOI 10.1016/S0959-4388(98)80042-1; Larkum M, 2013, TRENDS NEUROSCI, V36, P141, DOI 10.1016/j.tins.2012.11.006; Layher G, 2013, P 35 ANN C COGN SCI, P870; Layher G, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01287; Lichtsteiner P, 2008, IEEE J SOLID-ST CIRC, V43, P566, DOI 10.1109/JSSC.2007.914337; Liu SC, 2010, CURR OPIN NEUROBIOL, V20, P288, DOI 10.1016/j.conb.2010.03.007; Lucas B, 1981, P IM UND WORKSH, P121, DOI DOI 10.5334/JORS.BL; Markov NT, 2014, J COMP NEUROL, V522, P225, DOI 10.1002/cne.23458; MAUNSELL JHR, 1987, J COMP NEUROL, V266, P535, DOI 10.1002/cne.902660407; MUMFORD D, 1991, BIOL CYBERN, V65, P135, DOI 10.1007/BF00202389; Neumann H, 1999, BIOL CYBERN, V81, P425, DOI 10.1007/s004220050573; Perrone JA, 2004, VISION RES, V44, P1733, DOI 10.1016/j.visres.2004.03.003; Perrone JA, 2001, NAT NEUROSCI, V4, P526, DOI 10.1038/87480; Perrone JA, 2002, J VISION, V2, P38, DOI [10.1167/2.7.38, DOI 10.1167/2.7.38]; Poort J, 2012, NEURON, V75, P143, DOI 10.1016/j.neuron.2012.04.032; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; ROCKLAND KS, 1989, J COMP NEUROL, V285, P54, DOI 10.1002/cne.902850106; Roelfsema PR, 2002, J COGNITIVE NEUROSCI, V14, P525, DOI 10.1162/08989290260045756; Rolls ET, 2007, NEURAL COMPUT, V19, P139, DOI 10.1162/neco.2007.19.1.139; SCHWARTZ EL, 1990, COMPUTATIONAL NEUROS; Self MW, 2012, P NATL ACAD SCI USA, V109, P11031, DOI 10.1073/pnas.1119527109; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; Sullivan TJ, 2004, NEUROCOMPUTING, V58, P827, DOI 10.1016/j.neucom.2004.01.134; Tschechne S., 2014, P 8 INT C BIOINSP IN, P298; Tschechne S, 2014, SPRINGER LNAI, V8774, P171, DOI DOI 10.1007/978-3-319-11656-3_16; ULLMAN S, 1995, CEREB CORTEX, V5, P1, DOI 10.1093/cercor/5.1.1; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; Wallach H., 1976, ON PERCEPTION; Watson A, 1983, NASA TECH MEMO, P84352; WATSON AB, 1985, J OPT SOC AM A, V2, P322, DOI 10.1364/JOSAA.2.000322	81	5	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142488	10.1371/journal.pone.0142488	http://dx.doi.org/10.1371/journal.pone.0142488			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554589	gold, Green Published, Green Submitted			2022-12-26	WOS:000364430700115
J	Daci, A; Beretta, G; Vilasaliu, D; Shala, A; Govori, V; Norata, GD; Krasniqi, S				Daci, Armond; Beretta, Giangiacomo; Vilasaliu, Driton; Shala, Aida; Govori, Valbona; Norata, Giuseppe Danilo; Krasniqi, Shaip			Polymorphic Variants of SCN1A and EPHX1 Influence Plasma Carbamazepine Concentration, Metabolism and Pharmacoresistance in a Population of Kosovar Albanian Epileptic Patients	PLOS ONE			English	Article							MICROSOMAL EPOXIDE HYDROLASE; ANTIEPILEPTIC DRUGS; GENE POLYMORPHISMS; STEADY-STATE; CHINESE PATIENTS; MULTIDRUG-RESISTANCE; ABCB1 POLYMORPHISMS; JAPANESE PATIENTS; ILAE-COMMISSION; P-GLYCOPROTEIN	Aim The present study aimed to evaluate the effects of gene variants in key genes influencing pharmacokinetic and pharmacodynamic of carbamazepine (CBZ) on the response in patients with epilepsy. Materials & Methods Five SNPs in two candidate genes influencing CBZ transport and metabolism, namely ABCB1 or EPHX1, and CBZ response SCN1A (sodium channel) were genotyped in 145 epileptic patients treated with CBZ as monotherapy and 100 age and sex matched healthy controls. Plasma concentrations of CBZ, carbamazepine-10,11-epoxide (CBZE) and carbamazepine-10,11-trans dihydrodiol (CBZD) were determined by HPLC-UV-DAD and adjusted for CBZ dosage/kg of body weight. Results The presence of the SCN1A IVS5-91G> A variant allele is associated with increased epilepsy susceptibility. Furthermore, carriers of the SCN1A IVS5-91G> A variant or of EPHX1 c.337T>C variant presented significantly lower levels of plasma CBZ compared to carriers of the common alleles (0.71 +/- 0.28 vs 1.11 +/- 0.69 mu g/mL per mg/Kg for SCN1A IVS5-91 AA vs GG and 0.76 +/- 0.16 vs 0.94 +/- 0.49 mu g/mL per mg/Kg for EPHX1 c.337 CC vs TT; P<0.05 for both). Carriers of the EPHX1 c.416A>G showed a reduced microsomal epoxide hydrolase activity as reflected by a significantly decreased ratio of CBZD to CBZ (0.13 +/- 0.08 to 0.26 +/- 0.17, p<0.05) also of CBZD to CBZE (1.74 +/- 1.06 to 3.08 +/- 2.90; P<0.05) and CDRCBZD (0.13 +/- 0.08 vs 0.24 +/- 0.19 mu g/mL per mg/Kg; P<0.05). ABCB1 3455C>T SNP and SCN1A 3148A>G variants were not associated with significant changes in CBZ pharmacokinetic. Patients resistant to CBZ treatment showed increased dosage of CBZ (657 +/- 285 vs 489 +/- 231 mg/day; P< 0.001) but also increased plasma levels of CBZ (9.84 +/- 4.37 vs 7.41 +/- 3.43 mu g/mL; P< 0.001) compared to patients responsive to CBZ treatment. CBZ resistance was not related to any of the SNPs investigated. Conclusions The SCN1A IVS5-91G> A SNP is associated with susceptibility to epilepsy. SNPs in EPHX1 gene are influencing CBZ metabolism and disposition. CBZ plasma levels are not an indicator of resistance to the therapy.	[Daci, Armond; Shala, Aida] Univ Prishtina, Dept Pharm, Fac Med, Prishtina, Kosovo; [Daci, Armond; Krasniqi, Shaip] Univ Prishtina, Inst Pharmacol & Toxicol & Clin Pharmacol, Fac Med, Prishtina, Kosovo; [Beretta, Giangiacomo] Univ Milan, Dept Pharmaceut Sci, Milan, Italy; [Vilasaliu, Driton] Lincoln Univ, Sch Pharm, Joseph Banks Labs, Lincoln LN6 7DL, England; [Govori, Valbona] Univ Clin Ctr Kosova, Neurol Clin, Prishtina, Kosovo; [Norata, Giuseppe Danilo] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy; [Norata, Giuseppe Danilo] Osped Bassini, Ctr Study Atherosclerosis, Cinisello Balsamo, Italy	University of Milan; University of Lincoln; Universiteti i Prishtines; University of Milan	Krasniqi, S (corresponding author), Univ Prishtina, Inst Pharmacol & Toxicol & Clin Pharmacol, Fac Med, Prishtina, Kosovo.	shaip.krasniqi@uni-pr.edu	Krasniqi, Shaip/C-2623-2019; Vllasaliu, Driton/AAV-3848-2020; Daci, Armond/J-8529-2019; Norata, Giuseppe Danilo/AAC-2863-2019	Krasniqi, Shaip/0000-0003-0312-5258; Daci, Armond/0000-0003-1276-4561; Vllasaliu, Driton/0000-0002-4379-6171; Norata, Giuseppe Danilo/0000-0002-6081-1257	Ministry of Education, Science and Technology of Kosovo [4409]; SIGMA Project for academic exchange program [SIGM1200261, SIGM1200277]	Ministry of Education, Science and Technology of Kosovo; SIGMA Project for academic exchange program	Funding: This project was supported by a grant from the Ministry of Education, Science and Technology of Kosovo (No 4409). AD and GB received two scholarships from SIGMA Project for academic exchange program founded by the European Commission (Critical Skills Learning for Innovation, Sustainable Growth Mobility and Employ Ability in the Multicultural Environment of the Western Balkans; contract numbers: SIGM1200261, SIGM1200277). Facilities and infrastructure were provided by Kosovo Interdisciplinary Knowledge Triangle Center (KIKTC, Tempus IV Grant). The authors have no other relevant affiliations or financial in-volvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2008, BRIT J CLIN PHARMACO, V66, P304, DOI 10.1111/j.1365-2125.2008.03203.x; Abou-Khalil B, 2001, NEUROLOGY, V57, P2265, DOI 10.1212/WNL.57.12.2265; Alexopoulos AV., 2013, EPILEPTOLOGY, V1, P38, DOI [10.1016/j.epilep.2013.01.001, DOI 10.1016/J.EPILEP.2013.01.001]; Arroyo S, 2002, EPILEPSIA, V43, P437, DOI 10.1046/j.1528-1157.2002.38501.x; Balan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089253; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; BERTILSSON L, 1986, CLIN PHARMACOKINET, V11, P177, DOI 10.2165/00003088-198611030-00001; BOURGEOIS BFD, 1984, THER DRUG MONIT, V6, P259, DOI 10.1097/00007691-198409000-00001; Caruso A, 2014, PHARMACOGN PERS MED, V7, P117, DOI 10.2147/PGPM.S55548; Du J, 2006, PHARMACOGENOMICS, V7, P831, DOI 10.2217/14622416.7.6.831; Eiselt R, 2001, PHARMACOGENETICS, V11, P447, DOI 10.1097/00008571-200107000-00008; Fendri-Kriaa N, 2011, BIOCHEM BIOPH RES CO, V408, P654, DOI 10.1016/j.bbrc.2011.04.079; Ferraro TN, 2005, EPILEPSY BEHAV, V7, P18, DOI 10.1016/j.yebeh.2005.04.010; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; Fox J, 2005, J STAT SOFTW, V14; Ghosh C, 2012, NEUROBIOL DIS, V46, P692, DOI 10.1016/j.nbd.2012.03.010; Haerian BS, 2010, SEIZURE-EUR J EPILEP, V19, P339, DOI 10.1016/j.seizure.2010.05.004; Haerian BS, 2013, PHARMACOGENOMICS, V14, P1153, DOI [10.2217/PGS.13.104, 10.2217/pgs.13.104]; Hashi S, 2015, EUR J CLIN PHARMACOL, V71, P51, DOI 10.1007/s00228-014-1773-z; Hassett C, 1997, ARCH BIOCHEM BIOPHYS, V337, P275, DOI 10.1006/abbi.1996.9794; HASSETT C, 1994, HUM MOL GENET, V3, P421, DOI 10.1093/hmg/3.3.421; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; Hung CC, 2012, PHARMACOGENOMICS, V13, P159, DOI [10.2217/PGS.11.141, 10.2217/pgs.11.141]; Jandova K, 2006, BRAIN, V129, P3290, DOI 10.1093/brain/awl218; KERR BM, 1994, BIOCHEM PHARMACOL, V47, P1969, DOI 10.1016/0006-2952(94)90071-X; Kim DW, 2009, EPILEPSY RES, V84, P86, DOI 10.1016/j.eplepsyres.2008.12.001; Kitteringham NR, 1996, J PHARMACOL EXP THER, V278, P1018; Krasniqi Shaip, 2010, Med Arh, V64, P80; KUDRIAKOVA TB, 1992, BRIT J CLIN PHARMACO, V33, P611, DOI 10.1111/j.1365-2125.1992.tb04089.x; Kumari R, 2013, BIOCHIMIE, V95, P1350, DOI 10.1016/j.biochi.2013.02.006; Kwan P, 2001, EPILEPSIA, V42, P1255, DOI 10.1046/j.1528-1157.2001.04501.x; Lakhan R, 2009, BRIT J CLIN PHARMACO, V68, P214, DOI 10.1111/j.1365-2125.2009.03437.x; Luna-Tortos C, 2008, NEUROPHARMACOLOGY, V55, P1364, DOI 10.1016/j.neuropharm.2008.08.032; Ma CL, 2015, PHARMACOGENOMICS, V16, P1499, DOI [10.2217/PGS.15.94, 10.2217/pgs.15.94]; Ma CL, 2014, PHARMACOGENOMICS, V15, P1323, DOI [10.2217/pgs.14.89, 10.2217/PGS.14.89]; Maekawa K, 2003, XENOBIOTICA, V33, P277, DOI 10.1080/0049825021000061615; Makmor-Bakry M, 2009, CLIN NEUROPHARMACOL, V32, P205, DOI 10.1097/WNF.0b013e318187972a; Manna I, 2011, EPILEPSIA, V52, pE40, DOI 10.1111/j.1528-1167.2011.03097.x; Marino SE, 2012, CLIN PHARMACOL THER, V91, P483, DOI 10.1038/clpt.2011.251; Meng HM, 2011, EPILEPSY BEHAV, V21, P27, DOI 10.1016/j.yebeh.2011.02.015; Menzler K, 2014, EPILEPSIA, V55, P362, DOI 10.1111/epi.12515; Milovanovic D. D., 2015, Serbian Journal of Experimental and Clinical Research, V16, P93; Nakajima Y, 2005, EUR J CLIN PHARMACOL, V61, P25, DOI 10.1007/s00228-004-0878-1; Oby E, 2006, BRAIN RES, V1086, P201, DOI 10.1016/j.brainres.2006.02.068; Ozgon GO, 2008, EUR NEUROL, V59, P67, DOI 10.1159/000109264; Panomvana D, 2013, J PHARM PHARM SCI, V16, P502, DOI 10.18433/J3Q888; Park PW, 2009, J CLIN PHARM THER, V34, P569, DOI 10.1111/j.1365-2710.2009.01057.x; Patsalos PN, 2008, EPILEPSIA, V49, P1239, DOI 10.1111/j.1528-1167.2008.01561.x; Patsalos PN, 2000, THER DRUG MONIT, V22, P127, DOI 10.1097/00007691-200002000-00027; Puranik YG, 2013, PHARMACOGENOMICS, V14, P35, DOI [10.2217/pgs.12.180, 10.2217/PGS.12.180]; Remy S, 2003, ANN NEUROL, V53, P469, DOI 10.1002/ana.10473; Sachse C, 2002, CARCINOGENESIS, V23, P1839, DOI 10.1093/carcin/23.11.1839; Seo T, 2006, CLIN PHARMACOL THER, V79, P509, DOI 10.1016/j.clpt.2006.02.009; Seo T, 2006, PHARMACOGENOMICS, V7, P551, DOI 10.2217/14622416.7.4.551; Seven M, 2014, MOL BIOL REP, V41, P331, DOI 10.1007/s11033-013-2866-y; Shaheen U, 2014, EPILEPSY RES, V108, P251, DOI 10.1016/j.eplepsyres.2013.11.009; Shorvon S, 2010, HANDBOOK OF EPILEPSY TREATMENT, 3RD EDITION, P1; Siddiqui A, 2003, NEW ENGL J MED, V348, P1442, DOI 10.1056/NEJMoa021986; Sisodiya SM, 2005, EPILEPSIA, V46, P33, DOI 10.1111/j.1528-1167.2005.00356.x; Smith CAD, 1997, LANCET, V350, P630, DOI 10.1016/S0140-6736(96)08061-0; Sterjev Z, 2012, BALK J MED GENET, V15, P19, DOI 10.2478/v10034-012-0003-1; Sterjev Z, 2012, NEUROPSYCH DIS TREAT, V8, P191, DOI 10.2147/NDT.S28285; Subenthiran S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064827; Szoeke CEI, 2006, LANCET NEUROL, V5, P189, DOI 10.1016/S1474-4422(06)70352-0; Tan NCK, 2004, NEUROLOGY, V63, P1090, DOI 10.1212/01.WNL.0000137051.33486.C7; Tate SK, 2005, P NATL ACAD SCI USA, V102, P5507, DOI 10.1073/pnas.0407346102; Taur SR, 2014, J POSTGRAD MED, V60, P265, DOI 10.4103/0022-3859.138739; Thompson CH, 2011, EPILEPSIA, V52, P1000, DOI 10.1111/j.1528-1167.2011.03040.x; Touw DJ, 2005, THER DRUG MONIT, V27, P10, DOI 10.1097/00007691-200502000-00004; Yu FH, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-207; Yun WT, 2013, EPILEPSY RES, V107, P231, DOI 10.1016/j.eplepsyres.2013.09.011; Zhang CB, 2012, ADV DRUG DELIVER REV, V64, P930, DOI 10.1016/j.addr.2011.12.003; Zhu X, 2014, PHARMACOGENOMICS, V15, P1867, DOI [10.2217/PGS.14.142, 10.2217/pgs.14.142]; Zimprich F, 2008, EPILEPSIA, V49, P1108, DOI 10.1111/j.1528-1167.2008.01549_4.x	74	26	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142408	10.1371/journal.pone.0142408	http://dx.doi.org/10.1371/journal.pone.0142408			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555147	Green Published, Green Accepted, gold			2022-12-26	WOS:000364430700100
J	Murata, H; Takamatsu, H; Lie, SL; Kataoka, K; Huh, NH; Sakaguchi, M				Murata, Hitoshi; Takamatsu, Hitoshi; Lie, Sulai; Kataoka, Ken; Huh, Nam-ho; Sakaguchi, Masakiyo			NRF2 Regulates PINK1 Expression under Oxidative Stress Conditions	PLOS ONE			English	Article							TRANSCRIPTION FACTOR NRF2; GENE; MUTATIONS; PROMOTES; PROTEIN; NEUROPROTECTION; DETOXIFICATION; PARKINSONISM; MITOCHONDRIA; PROTECTION	Mutations of the PTEN-induced putative kinase 1 (PINK1) gene are a cause of autosomal recessive forms of Parkinson's disease. Recent studies have revealed that PINK1 is an essential factor for controlling mitochondrial quality, and that it protects cells from oxidative stresses. Although there has been considerable progress in the elucidation of various aspects of PINK1 protein regulation such as activation, stability and degradation, the transcriptional regulation of PINK1 mRNA under stress conditions remains unclear. In this study, we found that nuclear factor (erythroid-derived 2)-like 2 (NRF2), an antioxidant transcription factor, regulates PINK1 expression under oxidative stress conditions. Damaged mitochondria arising from stress conditions induced NRF2-dependent transcription of the PINK1 gene through production of reactive oxygen species (ROS). Either an ROS scavenger or forced expression of KEAP1, a potent inhibitory partner to NRF2, restricted PINK1 expression induced by activated NRF2. Transcriptionally up-regulated PINK1 diminished oxidative stress-associated cell death. The results indicate that PINK1 expression is positively regulated by NRF2 and that the NRF2-PINK1 signaling axis is deeply involved in cell survival.	[Murata, Hitoshi; Takamatsu, Hitoshi; Lie, Sulai; Huh, Nam-ho; Sakaguchi, Masakiyo] Okayama Univ, Dept Cell Biol, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama 7008558, Japan; [Kataoka, Ken] Okayama Univ Sci, Fac Sci, Dept Life Sci, Kita Ku, Okayama 7000005, Japan	Okayama University; Okayama University of Science	Sakaguchi, M (corresponding author), Okayama Univ, Dept Cell Biol, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	masa-s@md.okayama-u.ac.jp	Sakaguchi, Masakiyo/B-2280-2011; MURATA, Hitoshi/B-2327-2011	Liu, Sulai/0000-0002-5257-3922	Ministry of Education, Culture, Sports, Science, and Technology of Japan [25860216]; Okayama Medical Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Okayama Medical Foundation	Funding: Funding was provided by The Ministry of Education, Culture, Sports, Science, and Technology of Japan (25860216); The Okayama Medical Foundation.	Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Arena G, 2013, CELL DEATH DIFFER; Balogun E, 2003, BIOCHEM J, V371, P887, DOI 10.1042/BJ20021619; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Bonifati V, 2005, NEUROLOGY, V65, P87, DOI 10.1212/01.wnl.0000167546.39375.82; Chen PC, 2009, P NATL ACAD SCI USA, V106, P2933, DOI 10.1073/pnas.0813361106; Cho HY, 2002, AM J RESP CELL MOL, V26, P175, DOI 10.1165/ajrcmb.26.2.4501; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Dinkova-Kostova AT, 2008, PLANTA MED, V74, P1548, DOI 10.1055/s-2008-1081296; Gomez-Sanchez R, 2014, NEUROBIOL DIS, V62, P426, DOI 10.1016/j.nbd.2013.10.021; Imhoff BR, 2010, CELL BIOL TOXICOL, V26, P541, DOI 10.1007/s10565-010-9162-6; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Jin Y, 2012, ONCOL REP, V27, P695, DOI 10.3892/or.2011.1543; Katoh Y, 2001, GENES CELLS, V6, P857, DOI 10.1046/j.1365-2443.2001.00469.x; Kensler T W, 2000, Drug Metabol Drug Interact, V17, P3; Klinkenberg M, 2012, NEUROGENETICS, V13, P9, DOI 10.1007/s10048-011-0303-8; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Lee JM, 2004, P NATL ACAD SCI USA, V101, P9751, DOI 10.1073/pnas.0403620101; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Li J, 2005, TOXICOL SCI, V83, P313, DOI 10.1093/toxsci/kfi027; Lou HY, 2014, NEUROPHARMACOLOGY, V79, P380, DOI 10.1016/j.neuropharm.2013.11.026; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; McMahon M, 2001, CANCER RES, V61, P3299; Mei Y, 2009, P NATL ACAD SCI USA, V106, P5153, DOI 10.1073/pnas.0901104106; Meissner C, 2011, J NEUROCHEM, V117, P856, DOI 10.1111/j.1471-4159.2011.07253.x; Murata H, 2013, MOL BIOL CELL, V24, P2772, DOI 10.1091/mbc.E13-01-0016; Murata H, 2011, J BIOL CHEM, V286, P7182, DOI 10.1074/jbc.M110.179390; Nakajima A, 2003, CANCER LETT, V201, P195, DOI 10.1016/S0304-3835(03)00443-9; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nioi P, 2003, BIOCHEM J, V374, P337, DOI 10.1042/BJ20030754; Priyadarshini M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081851; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Ryu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071178; Sekhar KR, 2010, TOXICOL APPL PHARM, V244, P21, DOI 10.1016/j.taap.2009.06.016; Siebert A, 2009, J NEUROSCI RES, V87, P1659, DOI 10.1002/jnr.21975; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Wild AC, 1999, J BIOL CHEM, V274, P33627, DOI 10.1074/jbc.274.47.33627; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Wu ZH, 2013, GENE DEV, V27, P157, DOI 10.1101/gad.203406.112	42	92	95	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142438	10.1371/journal.pone.0142438	http://dx.doi.org/10.1371/journal.pone.0142438			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555609	Green Published, gold, Green Submitted			2022-12-26	WOS:000364430700104
J	Nadkarni, A; Burns, JA; Gandolfi, A; Chowdhury, MA; Cartularo, L; Berens, C; Geacintov, NE; Scicchitano, DA				Nadkarni, Aditi; Burns, John A.; Gandolfi, Alberto; Chowdhury, Moinuddin A.; Cartularo, Laura; Berens, Christian; Geacintov, Nicholas E.; Scicchitano, David A.			Nucleotide Excision Repair and Transcription-coupled DNA Repair Abrogate the Impact of DNA Damage on Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; OLIGONUCLEOTIDE-DIRECTED CONSTRUCTION; ADDUCT OPPOSITE DT; MOLECULAR-MECHANISMS; SOLUTION CONFORMATION; SITE; RECOGNITION; DUPLEX; STRAND; MUTATIONS	DNA adducts derived from carcinogenic polycyclic aromatic hydrocarbons like benzo[a] pyrene (B[a]P) and benzo[c]phenanthrene (B[c]Ph) impede replication and transcription, resulting in aberrant cell division and gene expression. Global nucleotide excision repair (NER) and transcription-coupled DNA repair (TCR) are among the DNA repair pathways that evolved to maintain genome integrity by removing DNA damage. The interplay between global NER and TCR in repairing the polycyclic aromatic hydrocarbon-derived DNA adducts (+)-trans-anti-B[a]P-N6-dA, which is subject to NER and blocks transcription in vitro, and (+)-trans-anti-B[c]Ph-N6-dA, which is a poor substrate for NER but also blocks transcription in vitro, was tested. The results show that both adducts inhibit transcription in human cells that lack both NER and TCR. The (+)-trans-anti-B[a]P-N6-dA lesion exhibited no detectable effect on transcription in cells proficient in NER but lacking TCR, indicating that NER can remove the lesion in the absence of TCR, which is consistent with in vitro data. In primary human cells lacking NER, (+)-trans-anti-B[a] P-N6-dA exhibited a deleterious effect on transcription that was less severe than in cells lacking both pathways, suggesting that TCR can repair the adduct but not as effectively as global NER. In contrast, (+)-trans-anti-B[c] Ph-N6-dA dramatically reduces transcript production in cells proficient in global NER but lacking TCR, indicating that TCR is necessary for the removal of this adduct, which is consistent with in vitro data showing that it is a poor substrate for NER. Hence, both global NER and TCR enhance the recovery of gene expression following DNA damage, and TCR plays an important role in removing DNA damage that is refractory to NER.	[Nadkarni, Aditi; Burns, John A.; Chowdhury, Moinuddin A.; Cartularo, Laura; Geacintov, Nicholas E.; Scicchitano, David A.] NYU, Dept Biol, New York, NY 10003 USA; [Nadkarni, Aditi; Burns, John A.; Chowdhury, Moinuddin A.; Cartularo, Laura; Geacintov, Nicholas E.; Scicchitano, David A.] NYU, Dept Chem, New York, NY 10003 USA; [Gandolfi, Alberto] Univ Florence, Dipartimento Matemat & Informat Ulisse Dini, I-50134 Florence, Italy; [Berens, Christian] Friedrich Loeffler Inst, Inst Mol Pathogenesis, D-07743 Jena, Germany; [Gandolfi, Alberto; Scicchitano, David A.] New York Univ Abu Dhabi, Div Sci, Abu Dhabi, U Arab Emirates	New York University; New York University; University of Florence; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Friedrich Loeffler Institute	Scicchitano, DA (corresponding author), NYU, Dept Biol, 1009 Silver Ctr,100 Washington Sq E, New York, NY 10003 USA.	das2@nyu.edu		Gandolfi, Alberto/0000-0001-6956-7513; Nadkarni, Aditi/0000-0002-1508-6957; Burns, John/0000-0002-2348-8438	National Institutes of Health [ES-010581]; New York University Abu Dhabi; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010581] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York University Abu Dhabi; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grant ES-010581 (to D. A. S.) and funds from New York University Abu Dhabi (to D. A. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altieri F, 2008, ANTIOXID REDOX SIGN, V10, P891, DOI 10.1089/ars.2007.1830; BAGWELL CB, 1993, ANN NY ACAD SCI, V677, P167, DOI 10.1111/j.1749-6632.1993.tb38775.x; Batty DP, 2000, GENE, V241, P193, DOI 10.1016/S0378-1119(99)00489-8; Benaglia T, 2009, J STAT SOFTW, V32, P1; Blitzblau HG, 2011, METHODS MOL BIOL, V745, P47, DOI 10.1007/978-1-61779-129-1_4; Brueckner F, 2007, SCIENCE, V315, P859, DOI 10.1126/science.1135400; Bruzel A, 2006, GENOMICS, V87, P286, DOI 10.1016/j.ygeno.2005.09.021; Burns JA, 2010, NUCLEIC ACIDS RES, V38, P8178, DOI 10.1093/nar/gkq706; Buterin T, 2000, CANCER RES, V60, P1849; Cai YQ, 2012, BIOCHEMISTRY-US, V51, P1486, DOI 10.1021/bi201794x; COSMAN M, 1993, BIOCHEMISTRY-US, V32, P12488, DOI 10.1021/bi00097a029; COSMAN M, 1995, BIOCHEMISTRY-US, V34, P1295, DOI 10.1021/bi00004a024; Danke C, 2010, J GENE MED, V12, P501, DOI 10.1002/jgm.1461; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; Dimitri A, 2008, NUCLEIC ACIDS RES, V36, P6459, DOI 10.1093/nar/gkn657; Doetsch PW, 2002, MUTAT RES-FUND MOL M, V510, P131, DOI 10.1016/S0027-5107(02)00258-0; DONAHUE BA, 1994, P NATL ACAD SCI USA, V91, P8502, DOI 10.1073/pnas.91.18.8502; Dreij K., 2010, CHEM BIOL DNA DAMAGE, P399; Elovaara E, 2007, ARCH TOXICOL, V81, P169, DOI 10.1007/s00204-006-0135-8; Fousteri M, 2008, CELL RES, V18, P73, DOI 10.1038/cr.2008.6; Furgason JM, 2013, PHARMACOL THERAPEUT, V137, P298, DOI 10.1016/j.pharmthera.2012.10.009; Geacintov NE, 1997, CHEM RES TOXICOL, V10, P111, DOI 10.1021/tx9601418; Geacintov Nicholas E., 2006, P263; Guescini M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-326; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; HARVEY RG, 1982, AM SCI, V70, P386; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; HSU TM, 1995, CARCINOGENESIS, V16, P2263, DOI 10.1093/carcin/16.9.2263; Huang WD, 2002, CHEM RES TOXICOL, V15, P118, DOI 10.1021/tx010135y; Ischenko AA, 2002, NATURE, V415, P183, DOI 10.1038/415183a; Iyama T, 2013, DNA REPAIR, V12, P620, DOI 10.1016/j.dnarep.2013.04.015; Izhar L, 2013, P NATL ACAD SCI USA, V110, pE1462, DOI 10.1073/pnas.1216894110; Khobta A, 2012, MUTAT RES-FUND MOL M, V736, P5, DOI 10.1016/j.mrfmmm.2011.07.014; Khobta A, 2010, NUCLEIC ACIDS RES, V38, P4285, DOI 10.1093/nar/gkq170; Kitsera N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094405; Kontanis EJ, 2006, J FORENSIC SCI, V51, P795, DOI 10.1111/j.1556-4029.2006.00182.x; KRAMER W, 1987, METHOD ENZYMOL, V154, P350; KRAMER W, 1984, NUCLEIC ACIDS RES, V12, P9441, DOI 10.1093/nar/12.24.9441; Langie SAS, 2015, CARCINOGENESIS, V36, pS61, DOI 10.1093/carcin/bgv031; Levsky JM, 2007, J CELL BIOCHEM, V102, P609, DOI 10.1002/jcb.21495; Lindsey-Boltz LA, 2007, P NATL ACAD SCI USA, V104, P13213, DOI 10.1073/pnas.0706316104; Liu TM, 1996, CHEM RES TOXICOL, V9, P255, DOI 10.1021/tx9501086; Marietta C, 2007, EMBO REP, V8, P388, DOI 10.1038/sj.embor.7400932; Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822; Marti TM, 2006, P NATL ACAD SCI USA, V103, P9891, DOI 10.1073/pnas.0603779103; McKay BC, 2002, DNA REPAIR, V1, P811, DOI 10.1016/S1568-7864(02)00109-X; Meijer M, 1999, BIOESSAYS, V21, P596, DOI 10.1002/(SICI)1521-1878(199907)21:7<596::AID-BIES8>3.0.CO;2-5; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; Perlow RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng040; Perlow RA, 2002, J MOL BIOL, V321, P29, DOI 10.1016/S0022-2836(02)00593-4; R Team C, 2013, R LANG ENV STAT COMP; Rechkunova NI, 2010, SUBCELL BIOCHEM, V50, P251, DOI 10.1007/978-90-481-3471-7_13; Ridley AJ, 2005, J HUM GENET, V50, P151, DOI 10.1007/s10038-004-0228-2; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; Ritz C, 2008, BIOINFORMATICS, V24, P1549, DOI 10.1093/bioinformatics/btn227; Rodriguez Y, 2015, DNA REPAIR, V32, P113, DOI 10.1016/j.dnarep.2015.04.021; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Saxowsky TT, 2006, CHEM REV, V106, P474, DOI 10.1021/cr040466q; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schinecker TM, 2003, NUCLEIC ACIDS RES, V31, P6004, DOI 10.1093/nar/gkg771; Scicchitano DA, 2004, DNA REPAIR, V3, P1537, DOI 10.1016/j.dnarep.2004.06.004; Shimada T, 1996, CANCER RES, V56, P2979; Shimada T, 2013, CHEM RES TOXICOL, V26, P529, DOI 10.1021/tx3004906; STANSSENS P, 1989, NUCLEIC ACIDS RES, V17, P4441, DOI 10.1093/nar/17.12.4441; Sugasawa K, 2011, BIOCHEMISTRY-MOSCOW+, V76, P16, DOI 10.1134/S0006297911010044; Svejstrup JQ, 2002, NAT REV MOL CELL BIO, V3, P21, DOI 10.1038/nrm703; Tornaletti S, 2009, CELL MOL LIFE SCI, V66, P1010, DOI 10.1007/s00018-009-8738-x; Tornaletti S, 2006, CHEM RES TOXICOL, V19, P1215, DOI 10.1021/tx060103g; vanGool AJ, 1997, EMBO J, V16, P4155, DOI 10.1093/emboj/16.14.4155; Vasquez KM, 2013, MUTAT RES-FUND MOL M, V743, P118, DOI 10.1016/j.mrfmmm.2012.11.005; Vermeulen W, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012625; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; Williams K, 2013, MUTAT RES-FUND MOL M, V743, P1, DOI 10.1016/j.mrfmmm.2013.04.009; Wu JX, 1999, MOL CELL BIOL, V19, P8292; Zhang XD, 2009, PHARMACOGENOMICS, V10, P345, DOI 10.2217/14622416.10.3.345; ZHOU W, 1993, P NATL ACAD SCI USA, V90, P6601, DOI 10.1073/pnas.90.14.6601	76	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					848	861		10.1074/jbc.M115.685271	http://dx.doi.org/10.1074/jbc.M115.685271			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26559971	Green Published, hybrid			2022-12-26	WOS:000367830500031
J	Silva, APG; Ryan, DP; Galanty, Y; Low, JKK; Vandevenne, M; Jackson, SP; Mackay, JP				Silva, Ana P. G.; Ryan, Daniel P.; Galanty, Yaron; Low, Jason K. K.; Vandevenne, Marylene; Jackson, Stephen P.; Mackay, Joel P.			The N-terminal Region of Chromodomain Helicase DNA-binding Protein 4 (CHD4) Is Essential for Activity and Contains a High Mobility Group (HMG) Box-like-domain That Can Bind Poly(ADP-ribose)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-REMODELING COMPLEX; CELL-CYCLE PROGRESSION; HISTONE DEACETYLASE; MI-2/NURD COMPLEX; DAMAGE; TRANSCRIPTION; NURD; ACTIVATION; SUBUNIT; ATPASE	Chromodomain Helicase DNA-binding protein 4(CHD4) is a chromatin-remodeling enzyme that has been reported to regulate DNA-damage responses through its N-terminal region in a poly(ADP-ribose) polymerase-dependent manner. We have identified and determined the structure of a stable domain (CHD4-N) in this N-terminal region. The-fold consists of a four-alpha-helix bundle with structural similarity to the high mobility group box, a domain that is well known as a DNA binding module. We show that the CHD4-N domain binds with higher affinity to poly(ADP-ribose) than to DNA. We also show that the N-terminal region of CHD4, although not CHD4-N alone, is essential for full nucleosome remodeling activity and is important for localizing CHD4 to sites of DNA damage. Overall, these data build on our understanding of how CHD4-NuRD acts to regulate gene expression and participates in the DNA-damage response.	[Silva, Ana P. G.; Low, Jason K. K.; Vandevenne, Marylene; Mackay, Joel P.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Ryan, Daniel P.] Australian Natl Univ, John Curtin Sch Med Res, Dept Genome Sci, Canberra, ACT 2601, Australia; [Galanty, Yaron; Jackson, Stephen P.] Univ Cambridge, Wellcome Trust & Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England	University of Sydney; Australian National University; John Curtin School of Medical Research; University of Cambridge	Silva, APG (corresponding author), Univ Sydney, Sch Mol Biosci, Bldg G08,Corner Butlin Ave & Maze Crescent, Sydney, NSW 2006, Australia.	ana.silva@sydney.edu.au; joel.mackay@sydney.edu.au	Jackson, Stephen Philip/R-4548-2019; Mackay, Joel/D-6834-2011	Jackson, Stephen Philip/0000-0001-9317-7937; Low, Jason/0000-0003-0862-0012; Galanty, Yaron/0000-0001-7167-9004; Mackay, Joel/0000-0001-7508-8033; Ryan, Daniel/0000-0001-9842-2620	National Health and Medical Research Council of Australia; Cancer Research UK [11224] Funding Source: researchfish	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Research UK(Cancer Research UK)	This work was supported by Fellowships and Project Grants (to J. P. M. and D. P. R.) from the National Health and Medical Research Council of Australia. The authors declare that they have no conflicts of interest with the contents of this article.	Allain FHT, 1999, EMBO J, V18, P2563, DOI 10.1093/emboj/18.9.2563; Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Brown JS, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150018; Burd CJ, 2008, J BIOL CHEM, V283, P34976, DOI 10.1074/jbc.M805383200; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Dow LK, 2000, BIOCHEMISTRY-US, V39, P9725, DOI 10.1021/bi000723v; Feng Q, 2003, CURR TOP MICROBIOL, V274, P269; Formosa T, 2001, EMBO J, V20, P3506, DOI 10.1093/emboj/20.13.3506; Gerlitz G, 2009, BIOCHEM CELL BIOL, V87, P127, DOI 10.1139/O08-110; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gottschalk AJ, 2012, J BIOL CHEM, V287, P43527, DOI 10.1074/jbc.M112.401141; Gottschalk AJ, 2009, P NATL ACAD SCI USA, V106, P13770, DOI 10.1073/pnas.0906920106; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hauk G, 2010, MOL CELL, V39, P711, DOI 10.1016/j.molcel.2010.08.012; Hopfner KP, 2012, CURR OPIN STRUC BIOL, V22, P225, DOI 10.1016/j.sbi.2012.02.007; Jungmichel S, 2013, MOL CELL, V52, P272, DOI 10.1016/j.molcel.2013.08.026; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Li B, 2007, GENE DEV, V21, P1422, DOI 10.1101/gad.1539307; Li GY, 2010, P NATL ACAD SCI USA, V107, P9129, DOI 10.1073/pnas.1000556107; LIMOLI CL, 1993, RADIAT RES, V134, P160, DOI 10.2307/3578455; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; Luger K, 1999, METHOD ENZYMOL, V304, P3; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Malarkey CS, 2012, TRENDS BIOCHEM SCI, V37, P553, DOI 10.1016/j.tibs.2012.09.003; Mansfield RE, 2011, J BIOL CHEM, V286, P11779, DOI 10.1074/jbc.M110.208207; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mu JJ, 2007, J BIOL CHEM, V282, P17330, DOI 10.1074/jbc.C700079200; Musselman CA, 2009, BIOCHEM J, V423, P179, DOI 10.1042/BJ20090870; Muthurajan UM, 2014, P NATL ACAD SCI USA, V111, P12752, DOI 10.1073/pnas.1405005111; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Ng Patricia Miang-Lon, 2011, Biomol Concepts, V2, P13; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Papoulas O, 2001, P NATL ACAD SCI USA, V98, P5728, DOI 10.1073/pnas.091533398; Pile LA, 2002, MOL CELL BIOL, V22, P4965, DOI 10.1128/MCB.22.14.4965-4976.2002; Pinnola A, 2007, J BIOL CHEM, V282, P32511, DOI 10.1074/jbc.M705989200; Polo SE, 2010, EMBO J, V29, P3130, DOI 10.1038/emboj.2010.188; Ray S, 2009, NUCLEIC ACIDS RES, V37, P6389, DOI 10.1093/nar/gkp695; Rouleau M, 2004, J CELL SCI, V117, P815, DOI 10.1242/jcs.01080; Ryan DP, 2011, EMBO J, V30, P2596, DOI 10.1038/emboj.2011.166; Sala A, 2008, PLOS BIOL, V6, P2329, DOI 10.1371/journal.pbio.0060252; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Sharma A, 2011, J BIOL CHEM, V286, P42099, DOI 10.1074/jbc.C111.294462; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Silva APG, 2014, BIOMOL NMR ASSIGN, V8, P137, DOI 10.1007/s12104-013-9469-3; Sims JK, 2011, MOL BIOL CELL, V22, P3094, DOI 10.1091/mbc.E11-03-0258; Smeenk G, 2010, J CELL BIOL, V190, P741, DOI 10.1083/jcb.201001048; Stokes MP, 2007, P NATL ACAD SCI USA, V104, P19855, DOI 10.1073/pnas.0707579104; Stros M, 2007, CELL MOL LIFE SCI, V64, P2590, DOI 10.1007/s00018-007-7162-3; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Thastrom A, 1999, J MOL BIOL, V288, P213, DOI 10.1006/jmbi.1999.2686; Timinszky G, 2009, NAT STRUCT MOL BIOL, V16, P923, DOI 10.1038/nsmb.1664; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Wade PA, 1998, CURR BIOL, V8, P843, DOI 10.1016/S0960-9822(98)70328-8; Wang WD, 1998, P NATL ACAD SCI USA, V95, P492, DOI 10.1073/pnas.95.2.492; Wang YF, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2000902; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yamada K, 2011, NATURE, V472, P448, DOI 10.1038/nature09947; Yang JG, 2006, NAT STRUCT MOL BIOL, V13, P1078, DOI 10.1038/nsmb1170; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4; Zhang YJ, 2013, NAT METHODS, V10, P981, DOI 10.1038/nmeth.2603	72	35	35	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					924	938		10.1074/jbc.M115.683227	http://dx.doi.org/10.1074/jbc.M115.683227			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26565020	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000367830500038
J	Rozycki, M; Bialik, JF; Speight, P; Dan, QH; Knudsen, TET; Szeto, SG; Yuen, DA; Szaszi, K; Pedersen, SF; Kapus, A				Rozycki, Matthew; Bialik, Janne Folke; Speight, Pam; Dan, Qinghong; Knudsen, Teresa E. T.; Szeto, Stephen G.; Yuen, Darren A.; Szaszi, Katalin; Pedersen, Stine F.; Kapus, Andras			Myocardin-related Transcription Factor Regulates Nox4 Protein Expression: LINKING CYTOSKELETAL ORGANIZATION TO REDOX STATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytoskeleton; epithelium; kidney; myocardin; myofibroblast; NADPH oxidase; promoter; transforming growth factor (TGF-); Yes-associated protein (YAP)	PERICYTE-MYOFIBROBLAST TRANSITION; CELL-CELL CONTACTS; NADPH OXIDASE 4; NAD(P)H OXIDASE; TGF-BETA; KAPPA-B; TUBULOINTERSTITIAL FIBROSIS; TYROSINE PHOSPHORYLATION; ACTIN CYTOSKELETON; OXIDATIVE STRESS	Background: Generation of myofibroblasts, the culprit of fibrosis, requires cytoskeleton remodeling and Nox4 (NADPH oxidase) expression. The link between these events is unknown. Results: Down-regulation/inhibition of the cytoskeleton-controlled transcriptional coactivators, myocardin-related transcription factor (MRTF), and TAZ/YAP abrogates Nox4 expression. Conclusion: MRTF and TAZ/YAP are essential for Nox4 expression. Significance: We show new mechanisms whereby the cytoskeleton regulates cellular redox state and fibrogenesis. TGF-induced expression of the NADPH oxidase Nox4 is essential for fibroblast-myofibroblast transition. Rho has been implicated in Nox4 regulation, but the underlying mechanisms are largely unknown. Myocardin-related transcription factor (MRTF), a Rho/actin polymerization-controlled coactivator of serum response factor, drives myofibroblast transition from various precursors. We have shown that TGF is necessary but insufficient for epithelial-myofibroblast transition in intact epithelia; the other prerequisite is the uncoupling of intercellular contacts, which induces Rho-dependent nuclear translocation of MRTF. Because the Nox4 promoter harbors a serum response factor/MRTF cis-element (CC(A/T)(6)GG box), we asked if MRTF (and thus cytoskeleton organization) could regulate Nox4 expression. We show that Nox4 protein is robustly induced in kidney tubular cells exclusively by combined application of contact uncoupling and TGF. Nox4 knockdown abrogates epithelial-myofibroblast transition-associated reactive oxygen species production. Laser capture microdissection reveals increased Nox4 expression in the tubular epithelium also during obstructive nephropathy. MRTF down-regulation/inhibition suppresses TGF/contact disruption-provoked Nox4 protein and mRNA expression, Nox4 promoter activation, and reactive oxygen species production. Mutation of the CC(A/T)(6)GG box eliminates the synergistic activation of the Nox4 promoter. Jasplakinolide-induced actin polymerization synergizes with TGF to facilitate MRTF-dependent Nox4 mRNA expression/promoter activation. Moreover, MRTF inhibition prevents Nox4 expression during TGF-induced fibroblast-myofibroblast transition as well. Although necessary, MRTF is insufficient; Nox4 expression also requires TGF-activated Smad3 and TAZ/YAP, two contact- and cytoskeleton-regulated Smad3-interacting coactivators. Down-regulation/inhibition of TAZ/YAP mitigates injury-induced epithelial Nox4 expression in vitro and in vivo. These findings uncover new MRTF- and TAZ/YAP-dependent mechanisms, which link cytoskeleton remodeling and redox state and impact epithelial plasticity and myofibroblast transition.	[Yuen, Darren A.; Szaszi, Katalin; Kapus, Andras] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON M5B 1T8, Canada; [Szaszi, Katalin; Kapus, Andras] Univ Toronto, Dept Surg, Toronto, ON M5B IT8, Canada; [Kapus, Andras] Univ Toronto, Dept Biochem, Toronto, ON M5B IT8, Canada; [Bialik, Janne Folke; Knudsen, Teresa E. T.; Pedersen, Stine F.] Univ Copenhagen, Dept Biol, Sect Cell Biol & Physiol, DK-2100 Copenhagen, Denmark	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Copenhagen	Kapus, A (corresponding author), Keenan Res Ctr Biomed Sci, Rm 621,209 Victoria St, Toronto, ON M5B 1T8, Canada.	kapusa@smh.ca	Pedersen, Stine Falsig/O-1133-2019; Bialik, Janne Folke/F-5200-2017	Pedersen, Stine Falsig/0000-0002-3044-7714; Kapus, Andras/0000-0002-6610-9530; Bialik, Janne Folke/0000-0003-1042-8169; Knudsen, Teresa/0000-0002-8080-8928	Canadian Institute of Health Research [MOP-86535, MOP-106625, MOP-130463]; Kidney Foundation of Canada; Natural Sciences and Engineering Research Council of Canada [RGPIN227-908-13, RGPIN 327407]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Kidney Foundation of Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Canadian Institute of Health Research Grants MOP-86535, MOP-106625, and MOP-130463 (to A. K.), the Kidney Foundation of Canada (to A. K. and K. S.), and by Natural Sciences and Engineering Research Council of Canada Grant RGPIN227-908-13 (to A. K.) and Grant RGPIN 327407 (to K. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Babelova A, 2012, FREE RADICAL BIO MED, V53, P842, DOI 10.1016/j.freeradbiomed.2012.06.027; Bai GX, 2014, GENE, V540, P62, DOI 10.1016/j.gene.2014.02.026; BarcellosHoff MH, 1996, MOL ENDOCRINOL, V10, P1077, DOI 10.1210/me.10.9.1077; Barnes JL, 2011, KIDNEY INT, V79, P944, DOI 10.1038/ki.2010.516; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bengtsson T, 2006, CELL BIOL INT, V30, P154, DOI 10.1016/j.cellbi.2005.10.017; Block K, 2008, J BIOL CHEM, V283, P24061, DOI 10.1074/jbc.M803964200; Bondi CD, 2010, J AM SOC NEPHROL, V21, P93, DOI 10.1681/ASN.2009020146; Bonello S, 2007, ARTERIOSCL THROM VAS, V27, P755, DOI 10.1161/01.ATV.0000258979.92828.bc; Boudreau HE, 2012, FREE RADICAL BIO MED, V53, P1489, DOI 10.1016/j.freeradbiomed.2012.06.016; Busche S, 2008, J CELL SCI, V121, P1025, DOI 10.1242/jcs.014456; Charbonney E, 2011, MOL BIOL CELL, V22, P4472, DOI 10.1091/mbc.E11-04-0335; Chen YT, 2011, KIDNEY INT, V80, P1170, DOI 10.1038/ki.2011.208; Choy JS, 2014, AM J PHYSIOL-HEART C, V306, pH69, DOI 10.1152/ajpheart.00402.2013; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; Diebold I, 2010, MOL BIOL CELL, V21, P2087, DOI 10.1091/mbc.E09-12-1003; Dikalov SI, 2008, FREE RADICAL BIO MED, V45, P1340, DOI 10.1016/j.freeradbiomed.2008.08.013; Ding Y, 2015, J ENDOCRINOL, V224, pR15, DOI 10.1530/JOE-14-0437; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Etoh T, 2003, DIABETOLOGIA, V46, P1428, DOI 10.1007/s00125-003-1205-6; Fabian SL, 2012, AM J PATHOL, V180, P1441, DOI 10.1016/j.ajpath.2011.12.039; Fan LZ, 2007, MOL BIOL CELL, V18, P1083, DOI 10.1091/mbc.E06-07-0602; Fan LZ, 2004, BIOCHEM J, V380, P581, DOI 10.1042/BJ20040178; Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897; Ghosh AK, 2013, EXP BIOL MED, V238, P461, DOI 10.1177/1535370213489441; Goettsch C, 2011, BASIC RES CARDIOL, V106, P551, DOI 10.1007/s00395-011-0170-3; Gourlay CW, 2006, MOL CELL BIOL, V26, P6487, DOI 10.1128/MCB.00117-06; Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682; Hanna M, 2009, J BIOL CHEM, V284, P23125, DOI 10.1074/jbc.M109.019059; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Hiemer SE, 2014, J BIOL CHEM, V289, P13461, DOI 10.1074/jbc.M113.529115; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Holterman CE, 2015, CLIN SCI, V128, P465, DOI 10.1042/CS20140361; Jha JC, 2014, J AM SOC NEPHROL, V25, P1237, DOI 10.1681/ASN.2013070810; Jiang F, 2014, REDOX BIOL, V2, P267, DOI 10.1016/j.redox.2014.01.012; Khodo SN, 2012, J AM SOC NEPHROL, V23, P1967, DOI 10.1681/ASN.2012040373; Kim HJ, 2008, AM J RESP CELL MOL, V39, P598, DOI 10.1165/rcmb.2007-0262OC; Kim JH, 2012, STEM CELLS DEV, V21, P2212, DOI 10.1089/scd.2011.0561; Kohda Y, 2000, KIDNEY INT, V57, P321, DOI 10.1046/j.1523-1755.2000.00824.x; Kramann R, 2014, SEMIN NEPHROL, V34, P374, DOI 10.1016/j.semnephrol.2014.06.004; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; Liu F, 2015, AM J PHYSIOL-LUNG C, V308, pL344, DOI 10.1152/ajplung.00300.2014; Ly DL, 2013, AM J PHYSIOL-CELL PH, V304, pC115, DOI 10.1152/ajpcell.00290.2012; Lyle AN, 2009, CIRC RES, V105, P249, DOI 10.1161/CIRCRESAHA.109.193722; Mahadev K, 2004, MOL CELL BIOL, V24, P1844, DOI 10.1128/MCB.24.5.1844-1854.2004; Manea A, 2010, BIOCHEM BIOPH RES CO, V396, P901, DOI 10.1016/j.bbrc.2010.05.019; Manea A, 2010, ARTERIOSCL THROM VAS, V30, P105, DOI 10.1161/ATVBAHA.109.193896; Manickam N, 2014, AM J PHYSIOL-RENAL, V307, pF159, DOI 10.1152/ajprenal.00546.2013; Maranchie JK, 2005, CANCER RES, V65, P9190, DOI 10.1158/0008-5472.CAN-05-2105; Masszi A, 2004, AM J PATHOL, V165, P1955, DOI 10.1016/S0002-9440(10)63247-6; Masszi A, 2010, J CELL BIOL, V188, P383, DOI 10.1083/jcb.200906155; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Nagatoya K, 2002, KIDNEY INT, V61, P1684, DOI 10.1046/j.1523-1755.2002.00328.x; Nisimoto Y, 2010, BIOCHEMISTRY-US, V49, P2433, DOI 10.1021/bi9022285; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Pendyala S, 2011, FREE RADICAL BIO MED, V50, P1749, DOI 10.1016/j.freeradbiomed.2011.03.022; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Quaggin SE, 2011, KIDNEY INT, V80, P41, DOI 10.1038/ki.2011.77; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Rozycki M, 2014, MOL BIOL CELL, V25, P643, DOI 10.1091/mbc.E13-07-0429; Sakai N, 2013, FASEB J, V27, P1830, DOI 10.1096/fj.12-219378; Sancho P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045285; Sasazuki T, 2002, J BIOL CHEM, V277, P28853, DOI 10.1074/jbc.M203190200; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Schilder YDC, 2009, FREE RADICAL BIO MED, V46, P1598, DOI 10.1016/j.freeradbiomed.2009.03.013; Sebe A, 2008, FEBS LETT, V582, P291, DOI 10.1016/j.febslet.2007.12.021; Sedeek M, 2010, AM J PHYSIOL-RENAL, V299, pF1348, DOI 10.1152/ajprenal.00028.2010; Sedeek M, 2013, CLIN SCI, V124, P191, DOI 10.1042/CS20120330; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; Shu XZ, 2015, GENE, V563, P17, DOI 10.1016/j.gene.2015.02.076; Sisson TH, 2015, AM J PATHOL, V185, P969, DOI 10.1016/j.ajpath.2014.12.005; Small EM, 2012, J CARDIOVASC TRANSL, V5, P794, DOI 10.1007/s12265-012-9397-0; Sobhakumari A, 2013, TOXICOL APPL PHARM, V272, P736, DOI 10.1016/j.taap.2013.07.013; Speight P, 2013, MOL BIOL CELL, V24, P3326, DOI 10.1091/mbc.E13-04-0220; Stanger BZ, 2012, GENE DEV, V26, P1263, DOI 10.1101/gad.196501.112; Takac I, 2011, J BIOL CHEM, V286, P13304, DOI 10.1074/jbc.M110.192138; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang WQ, 2015, NAT CELL BIOL, V17, P490, DOI 10.1038/ncb3113; Wingler K, 2012, CELL MOL LIFE SCI, V69, P3159, DOI 10.1007/s00018-012-1107-1; Wu CF, 2013, AM J PATHOL, V182, P118, DOI 10.1016/j.ajpath.2012.09.009; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Xu HH, 2015, J AM SOC NEPHROL, V26, P1648, DOI 10.1681/ASN.2014070678; Xu YF, 2013, INT J MOL MED, V31, P628, DOI 10.3892/ijmm.2013.1232; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1247, DOI 10.1681/ASN.2010060616; Zhang L, 2008, FREE RADICAL BIO MED, V45, P679, DOI 10.1016/j.freeradbiomed.2008.05.019; Zhao QD, 2015, CIRCULATION, V131, P643, DOI 10.1161/CIRCULATIONAHA.114.011079	90	21	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					227	243		10.1074/jbc.M115.674606	http://dx.doi.org/10.1074/jbc.M115.674606			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26555261	Green Published, hybrid			2022-12-26	WOS:000367589500018
J	Valley-Omar, Z; Nindo, F; Mudau, M; Hsiao, M; Martin, DP				Valley-Omar, Ziyaad; Nindo, Fredrick; Mudau, Maanda; Hsiao, Marvin; Martin, Darren Patrick			Phylogenetic Exploration of Nosocomial Transmission Chains of 2009 Influenza A/H1N1 among Children Admitted at Red Cross War Memorial Children's Hospital, Cape Town, South Africa in 2011	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HEALTH-CARE WORKERS; MOLECULAR EPIDEMIOLOGY; AEROSOL TRANSMISSION; SEXUAL TRANSMISSION; GROWTH-RATES; A VIRUS; OUTBREAK; HIV; VACCINATION	Traditional modes of investigating influenza nosocomial transmission have entailed a combination of confirmatory molecular diagnostic testing and epidemiological investigation. Common hospital-acquired infections like influenza require a discerning ability to distinguish between viral isolates to accurately identify patient transmission chains. We assessed whether influenza hemagglutinin sequence phylogenies can be used to enrich epidemiological data when investigating the extent of nosocomial transmission over a four-month period within a paediatric Hospital in Cape Town South Africa. Possible transmission chains/channels were initially determined through basic patient admission data combined with Maximum likelihood and time-scaled Bayesian phylogenetic analyses. These analyses suggested that most instances of potential hospital-acquired infections resulted from multiple introductions of Influenza A into the hospital, which included instances where virus hemagglutinin sequences were identical between different patients. Furthermore, a general inability to establish epidemiological transmission linkage of patients/viral isolates implied that identified isolates could have originated from asymptomatic hospital patients, visitors or hospital staff. In contrast, a traditional epidemiological investigation that used no viral phylogenetic analyses, based on patient co-admission into specific wards during a particular time-frame, suggested that multiple hospital acquired infection instances may have stemmed from a limited number of identifiable index viral isolates/patients. This traditional epidemiological analysis by itself could incorrectly suggest linkage between unrelated cases, underestimate the number of unique infections and may overlook the possible diffuse nature of hospital transmission, which was suggested by sequencing data to be caused by multiple unique introductions of influenza A isolates into individual hospital wards. We have demonstrated a functional role for viral sequence data in nosocomial transmission investigation through its ability to enrich traditional, non-molecular observational epidemiological investigation by teasing out possible transmission pathways and working toward more accurately enumerating the number of possible transmission events.	[Valley-Omar, Ziyaad] Natl Inst Communicable Dis, Ctr Resp Dis & Meningitis, Virol, Johannesburg, South Africa; [Valley-Omar, Ziyaad; Hsiao, Marvin] Univ Cape Town, Fac Hlth Sci, Dept Clin Lab Sci Med Virol, ZA-7925 Cape Town, South Africa; [Nindo, Fredrick; Martin, Darren Patrick] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Computat Biol Grp, ZA-7925 Cape Town, South Africa; [Mudau, Maanda] Natl Inst Communicable Dis, Ctr TB, Johannesburg, South Africa; [Hsiao, Marvin] Natl Hlth Lab Serv, Dept Clin Virol, Cape Town, South Africa	National Institute for Communicable Diseases (NICD); University of Cape Town; University of Cape Town; National Institute for Communicable Diseases (NICD)	Valley-Omar, Z (corresponding author), Natl Inst Communicable Dis, Ctr Resp Dis & Meningitis, Virol, Johannesburg, South Africa.	z.valley-omar@uct.ac.za	Martin, Darren/ABE-3614-2021; Mudau, Maanda/U-9649-2017; Martin, Darren P/C-4599-2008	Mudau, Maanda/0000-0003-0697-2460; Nindo, Fredrick/0000-0003-3871-8643				Amodio E, 2014, J HOSP INFECT, V86, P182, DOI 10.1016/j.jhin.2014.01.005; Atkinson MP, 2008, B MATH BIOL, V70, P820, DOI 10.1007/s11538-007-9281-2; Bearden A, 2012, INFLUENZA OTHER RESP, V6, P374, DOI 10.1111/j.1750-2659.2011.00322.x; Benet T, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-30; Blachere FM, 2009, CLIN INFECT DIS, V48, P438, DOI 10.1086/596478; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Brown AJL, 2011, J INFECT DIS, V204, P1463, DOI 10.1093/infdis/jir550; Cottam EM, 2008, P ROY SOC B-BIOL SCI, V275, P887, DOI 10.1098/rspb.2007.1442; Cotten M, 2013, LANCET, V382, P1993, DOI 10.1016/S0140-6736(13)61887-5; de Ledinghen V, 2005, J MED VIROL, V76, P279, DOI 10.1002/jmv.20356; de Oliveira T, 2006, NATURE, V444, P836, DOI 10.1038/444836a; de Silva E, 2012, J R SOC INTERFACE, V9, P1797, DOI 10.1098/rsif.2011.0850; de-Paris F, 2014, REV SOC BRAS MED TRO, V47, P223, DOI 10.1590/0037-8682-0080-2013; Dearlove B, 2013, BIOL SCI, V368, DOI [10.1098/rstb.2012.0314, DOI 10.1098/RSTB.2012.0314]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eibach D, 2014, J HOSP INFECT, V86, P188, DOI 10.1016/j.jhin.2013.11.009; Faria NR, 2014, SCIENCE, V346, P56, DOI 10.1126/science.1256739; Gifford RJ, 2007, J VIROL, V81, P13050, DOI 10.1128/JVI.00889-07; Gonzalez-Candelas F, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-217; Grund S, 2010, ARCH VIROL, V155, P1797, DOI 10.1007/s00705-010-0771-4; Gubareva LV, 2002, J INFECT DIS, V186, P1575, DOI 10.1086/345372; Hayward AC, 2006, BRIT MED J, V333, P1241, DOI 10.1136/bmj.39010.581354.55; Hedge J, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0331; Hughes GJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000590; Jonges M, 2012, J HOSP INFECT, V82, P187, DOI 10.1016/j.jhin.2012.08.004; Kahvejian A, 2008, NAT BIOTECHNOL, V26, P1125, DOI 10.1038/nbt1494; Katzenstein TL, 1999, AIDS, V13, P1737, DOI 10.1097/00002030-199909100-00018; Lam TTY, 2013, NATURE, V502, P241, DOI 10.1038/nature12515; Lemey P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003932; Leventhal GE, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002413; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Maltezou HC, 2012, J INFECTION, V64, P319, DOI 10.1016/j.jinf.2011.12.004; Morlighem JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018956; Oguma T, 2011, INFECT CONT HOSP EP, V32, P267, DOI 10.1086/658671; Organisation WH, 2011, REV 2011 WINT INFL S, V44; Piralla A, 2009, HAEMATOL-HEMATOL J, V94, P833, DOI 10.3324/haematol.2008.003319; Poon LLM, 2011, J CLIN VIROL, V52, P146, DOI 10.1016/j.jcv.2011.06.022; Pybus OG, 2000, GENETICS, V155, P1429; Pybus OG, 2002, SYST BIOL, V51, P881, DOI 10.1080/10635150290155881; Pybus OG, 2003, MOL BIOL EVOL, V20, P381, DOI 10.1093/molbev/msg043; Pybus OG, 2001, SCIENCE, V292, P2323, DOI 10.1126/science.1058321; Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583; Rambaut A, 2009, PLOS CURRENTS, P1; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Rodriguez-Sanchez B, 2011, J CLIN VIROL, V52, P129, DOI 10.1016/j.jcv.2011.07.001; Salgado CD, 2004, INFECT CONT HOSP EP, V25, P923, DOI 10.1086/502321; Saludes V, 2013, J CLIN VIROL, V57, P263, DOI 10.1016/j.jcv.2013.03.007; Sansonetti P, 2014, J INFECT DEV COUNTR, V8, P101, DOI 10.3855/jidc.3147; Sartor C, 2002, INFECT CONT HOSP EP, V23, P615, DOI 10.1086/501981; Sayers G, 2013, EPIDEMIOL INFECT, V141, P357, DOI 10.1017/S0950268812000659; Sheth Agam R, 2011, PDA J Pharm Sci Technol, V65, P71; Stadler T, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0198; Stadler T, 2010, J THEOR BIOL, V267, P396, DOI 10.1016/j.jtbi.2010.09.010; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Talbot TR, 2010, INFECT CONT HOSP EP, V31, P456, DOI 10.1086/651666; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; Teo SSS, 2007, PEDIATR INFECT DIS J, V26, P645, DOI 10.1097/INF.0b013e3180616cfb; Thomas RE, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005187.pub2; Vanhems P, 2011, ARCH INTERN MED, V171, P151, DOI 10.1001/archinternmed.2010.500; Viboud C, 2013, BIOL SCI, V368, DOI [10.1098/rstb.2012.0199, DOI 10.1098/RSTB.2012.0199]; Walker Polly R., 2005, Infection Genetics and Evolution, V5, P199, DOI 10.1016/j.meegid.2004.06.011; Walker PR, 2003, NATURE, V422, P679, DOI 10.1038/422679a; Wong BCK, 2010, CLIN INFECT DIS, V51, P1176, DOI 10.1086/656743; Ypma RJF, 2012, P ROY SOC B-BIOL SCI, V279, P444, DOI 10.1098/rspb.2011.0913	66	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0141744	10.1371/journal.pone.0141744	http://dx.doi.org/10.1371/journal.pone.0141744			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26565994	Green Published, gold, Green Submitted			2022-12-26	WOS:000367628500006
J	Crommert, ME; Halvorsen, K; Ekblom, MM				Crommert, M. Eriksson; Halvorsen, K.; Ekblom, M. M.			Trunk Muscle Activation at the Initiation and Braking of Bilateral Shoulder Flexion Movements of Different Amplitudes	PLOS ONE			English	Article							UPPER-LIMB MOVEMENT; LOW-BACK-PAIN; VOLUNTARY ARM MOVEMENTS; TRANSVERSUS ABDOMINIS; POSTURAL ADJUSTMENTS; HUMAN DIAPHRAGM; CONTRACTION; ELECTROMYOGRAPHY; RESPONSES; ORGANIZATION	The aim of this study was to investigate if trunk muscle activation patterns during rapid bilateral shoulder flexions are affected by movement amplitude. Eleven healthy males performed shoulder flexion movements starting from a position with arms along sides (0 degrees) to either 45 degrees, 90 degrees or 180 degrees. EMG was measured bilaterally from transversus abdominis (TrA), obliquus internus (OI) with intra-muscular electrodes, and from rectus abdominis (RA), erector spinae (ES) and deltoideus with surface electrodes. 3D kinematics was recorded and inverse dynamics was used to calculate the reactive linear forces and torque about the shoulders and the linear and angular impulses. The sequencing of trunk muscle onsets at the initiation of arm movements was the same across movement amplitudes with ES as the first muscle activated, followed by TrA, RA and OI. All arm movements induced a flexion angular impulse about the shoulders during acceleration that was reversed during deceleration. Increased movement amplitude led to shortened onset latencies of the abdominal muscles and increased level of activation in TrA and ES. The activation magnitude of TrA was similar in acceleration and deceleration where the other muscles were specific to acceleration or deceleration. The findings show that arm movements need to be standardized when used as a method to evaluate trunk muscle activation patterns and that inclusion of the deceleration of the arms in the analysis allow the study of the relationship between trunk muscle activation and direction of perturbing torque during one and the same arm movement.	[Crommert, M. Eriksson] Univ Orebro, Fac Med & Hlth, SE-70182 Orebro, Sweden; [Crommert, M. Eriksson; Ekblom, M. M.] Swedish Sch Sport & Hlth Sci GIH, Stockholm, Sweden; [Halvorsen, K.] KTH Royal Inst Technol, Sch Technol & Hlth, Stockholm, Sweden; [Halvorsen, K.] Uppsala Univ, Dept Informat Technol, Uppsala, Sweden; [Ekblom, M. M.] Karolinska Inst, Dept Neurosci, Stockholm, Sweden	Orebro University; Swedish School of Sport & Health Sciences; Royal Institute of Technology; Uppsala University; Karolinska Institutet	Crommert, ME (corresponding author), Univ Orebro, Fac Med & Hlth, SE-70182 Orebro, Sweden.	martin.eriksson-crommert@regionorebrolan.se		Ekblom, Maria/0000-0002-7879-9188				Allison GT, 2008, J ORTHOP SPORT PHYS, V38, P228, DOI 10.2519/jospt.2008.2703; ARUIN AS, 1995, EXP BRAIN RES, V103, P323; BOUISSET S, 1987, J BIOMECH, V20, P735, DOI 10.1016/0021-9290(87)90052-2; Crommert AEME, 2008, EXP BRAIN RES, V185, P383, DOI 10.1007/s00221-007-1159-x; Crommert AEME, 2009, EXP BRAIN RES, V196, P385, DOI 10.1007/s00221-009-1860-z; Crommert ME, 2011, GAIT POSTURE, V33, P473, DOI 10.1016/j.gaitpost.2010.12.028; Dempster W. J., 1955, WADCTR55159 WRIGHT P; Duchateau J, 2014, J APPL PHYSIOL, V116, P1418, DOI 10.1152/japplphysiol.00002.2013; ENG JJ, 1992, NEUROSCI RES COMMUN, V11, P73; Hodges P, 1999, EXP BRAIN RES, V124, P69, DOI 10.1007/s002210050601; Hodges PW, 2000, J PHYSIOL-LONDON, V522, P165, DOI 10.1111/j.1469-7793.2000.t01-1-00165.xm; Hodges PW, 1997, J PHYSIOL-LONDON, V505, P539, DOI 10.1111/j.1469-7793.1997.539bb.x; Hodges PW, 1996, ELECTROMYOGR MOTOR C, V101, P511, DOI 10.1016/S0013-4694(96)95190-5; Hodges PW, 1999, ARCH PHYS MED REHAB, V80, P1005, DOI 10.1016/S0003-9993(99)90052-7; Hodges PW, 2000, GAIT POSTURE, V11, P92, DOI 10.1016/S0966-6362(99)00055-7; Hodges PW, 2003, EXP BRAIN RES, V151, P262, DOI 10.1007/s00221-003-1457-x; Hodges PW, 1999, NEUROSCI LETT, V265, P91, DOI 10.1016/S0304-3940(99)00216-5; Hodges PW, 1997, EXP BRAIN RES, V114, P362, DOI 10.1007/PL00005644; Hodges PW, 1996, SPINE, V21, P2640, DOI 10.1097/00007632-199611150-00014; Hodges PW, 2001, J BIOMECH, V34, P347, DOI 10.1016/S0021-9290(00)00206-2; Hodges PW, 1997, ERGONOMICS, V40, P1220, DOI 10.1080/001401397187469; Jacobs JV, 2010, CLIN NEUROPHYSIOL, V121, P431, DOI 10.1016/j.clinph.2009.11.076; LEE WA, 1987, EXP BRAIN RES, V66, P257; Moseley G Lorimer, 2002, Spine (Phila Pa 1976), V27, pE29, DOI 10.1097/00007632-200201150-00013; Radebold A, 2000, SPINE, V25, P947, DOI 10.1097/00007632-200004150-00009; Sjodahl J, 2009, CLIN BIOMECH, V24, P183, DOI 10.1016/j.clinbiomech.2008.11.004; Tokuno CD, 2006, EXP BRAIN RES, V174, P19, DOI 10.1007/s00221-006-0414-x; Tsao H, 2007, EXP BRAIN RES, V181, P537, DOI 10.1007/s00221-007-0950-z; Vasseljen O, 2009, J ELECTROMYOGR KINES, V19, pE23, DOI 10.1016/j.jelekin.2007.07.013; Yamazaki Y, 2005, BRAIN RES BULL, V67, P30, DOI 10.1016/j.brainresbull.2005.05.015; Zatsiorsky VM., 2002, KINETICS HUMAN MOTIO; ZATTARA M, 1988, J NEUROL NEUROSUR PS, V51, P956, DOI 10.1136/jnnp.51.7.956	32	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0141777	10.1371/journal.pone.0141777	http://dx.doi.org/10.1371/journal.pone.0141777			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562017	Green Published, Green Submitted, gold			2022-12-26	WOS:000364480900005
J	Hopkins, LS; Schultz, DH; Hannula, DE; Helmstetter, FJ				Hopkins, Lauren S.; Schultz, Douglas H.; Hannula, Deborah E.; Helmstetter, Fred J.			Eye Movements Index Implicit Memory Expression in Fear Conditioning	PLOS ONE			English	Article							CONTINGENCY AWARENESS; RELATIONAL MEMORY; MASKED STIMULI; RESPONSES; DELAY; HUMANS; DISSOCIATION; SYSTEMS; TRACE; BRAIN	The role of contingency awareness in simple associative learning experiments with human participants is currently debated. Since prior work suggests that eye movements can index mnemonic processes that occur without awareness, we used eye tracking to better understand the role of awareness in learning aversive Pavlovian conditioning. A complex realworld scene containing four embedded household items was presented to participants while skin conductance, eye movements, and pupil size were recorded. One item embedded in the scene served as the conditional stimulus (CS). One exemplar of that item (e.g. a white pot) was paired with shock 100 percent of the time (CS+) while a second exemplar (e.g. a gray pot) was never paired with shock (CS-). The remaining items were paired with shock on half of the trials. Participants rated their expectation of receiving a shock during each trial, and these expectancy ratings were used to identify when (i.e. on what trial) each participant became aware of the programmed contingencies. Disproportionate viewing of the CS was found both before and after explicit contingency awareness, and patterns of viewing distinguished the CS+ from the CS-. These observations are consistent with " dual process" models of fear conditioning, as they indicate that learning can be expressed in patterns of viewing prior to explicit contingency awareness.	[Hopkins, Lauren S.; Schultz, Douglas H.; Hannula, Deborah E.; Helmstetter, Fred J.] Univ Wisconsin, Dept Psychol, Milwaukee, WI 53211 USA	University of Wisconsin System; University of Wisconsin Milwaukee	Helmstetter, FJ (corresponding author), Univ Wisconsin, Dept Psychol, Milwaukee, WI 53211 USA.	fjh@uwm.edu	Schultz, Douglas/AAB-2365-2020	Schultz, Douglas/0000-0003-0809-9036	NIH [R01MH060668]; UWM Advanced Opportunity Fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060668] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UWM Advanced Opportunity Fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding provided by NIH R01MH060668. Work reported in this manuscript was supported by a UWM Advanced Opportunity Fellowship awarded to LSH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff RR, 1999, J EXP PSYCHOL LEARN, V25, P997, DOI 10.1037/0278-7393.25.4.997; Anders S, 2005, EXP BRAIN RES, V162, P213, DOI 10.1007/s00221-004-2145-1; Balderston NL, 2013, JOVE-J VIS EXP, DOI 10.3791/50212; Balderston NL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096803; Balderston NL, 2010, BEHAV NEUROSCI, V124, P478, DOI 10.1037/a0019927; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; Beck MR, 2007, MEM COGNITION, V35, P610, DOI 10.3758/BF03193299; Belopolsky AV, 2011, VIS COGN, V19, P27, DOI 10.1080/13506285.2010.536186; Bitsios P, 1996, J PSYCHOPHARMACOL, V10, P279, DOI 10.1177/026988119601000404; Carrillo MC, 2000, PSYCHOBIOLOGY, V28, P293; Carter RM, 2006, NEUROIMAGE, V29, P1007, DOI 10.1016/j.neuroimage.2005.09.011; Carter RM, 2003, P NATL ACAD SCI USA, V100, P1399, DOI 10.1073/pnas.0334049100; Chua EF, 2012, MEMORY, V20, P48, DOI 10.1080/09658211.2011.633919; Clark RE, 1998, SCIENCE, V280, P77, DOI 10.1126/science.280.5360.77; Cornwell BR, 2007, PSYCHOPHYSIOLOGY, V44, P403, DOI 10.1111/j.1469-8986.2007.00519.x; DAWSON ME, 1970, J EXP PSYCHOL, V85, P389, DOI 10.1037/h0029715; DAWSON ME, 1985, ADV PSYCHOPHYSIOLOGY, V1, P89; Dunsmoor JE, 2007, BEHAV NEUROSCI, V121, P635, DOI 10.1037/0735-7044.121.4.635; Gerdes ABM, 2008, BEHAV RES THER, V46, P174, DOI 10.1016/j.brat.2007.10.010; Hamm AO, 2005, INT J PSYCHOPHYSIOL, V57, P5, DOI 10.1016/j.ijpsycho.2005.01.006; Hamm AO, 1996, PSYCHOPHYSIOLOGY, V33, P698, DOI 10.1111/j.1469-8986.1996.tb02366.x; Hannula DE, 2007, J COGNITIVE NEUROSCI, V19, P1690, DOI 10.1162/jocn.2007.19.10.1690; Hannula DE, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00080; Hannula DE, 2012, PSYCHOL SCI, V23, P278, DOI 10.1177/0956797611429799; Hannula DE, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00166; Hannula DE, 2010, BIOL PSYCHIAT, V68, P610, DOI 10.1016/j.biopsych.2010.06.001; Hannula DE, 2009, NEURON, V63, P592, DOI 10.1016/j.neuron.2009.08.025; Hollingworth A, 2001, PSYCHON B REV, V8, P761, DOI 10.3758/BF03196215; Kafkas A, 2012, NEUROPSYCHOLOGIA, V50, P3080, DOI 10.1016/j.neuropsychologia.2012.08.001; Katkin ES, 2001, PSYCHOL SCI, V12, P366, DOI 10.1111/1467-9280.00368; Klucken T, 2009, HUM BRAIN MAPP, V30, P3636, DOI 10.1002/hbm.20791; Knight DC, 2006, COGN AFFECT BEHAV NE, V6, P157, DOI 10.3758/CABN.6.2.157; Knight DC, 2009, NEUROIMAGE, V45, P208, DOI 10.1016/j.neuroimage.2008.11.015; LaBar KS, 1998, HIPPOCAMPUS, V8, P620, DOI 10.1002/(SICI)1098-1063(1998)8:6<620::AID-HIPO4>3.0.CO;2-6; LeDoux JE, 2014, P NATL ACAD SCI USA, V111, P2871, DOI 10.1073/pnas.1400335111; Lovibond PF, 2013, BIOL PSYCHOL, V92, P9, DOI 10.1016/j.biopsycho.2011.09.007; Lovibond PF, 2011, BIOL PSYCHOL, V87, P393, DOI 10.1016/j.biopsycho.2011.05.002; Lovibond PF, 2002, J EXP PSYCHOL-ANIM B, V28, P3, DOI 10.1037//0097-7403.28.1.3; Manns JR, 2001, COGN AFFECT BEHAV NE, V1, P192, DOI 10.3758/CABN.1.2.192; Marcos JL, 1998, PSICOTHEMA, V10, P175; Miskovic V, 2013, J NEUROSCI, V33, P72, DOI 10.1523/JNEUROSCI.3692-12.2013; Mitchell CJ, 2009, BEHAV BRAIN SCI, V32, P183, DOI 10.1017/S0140525X09000855; Ohman A, 1998, J EXP PSYCHOL GEN, V127, P69, DOI 10.1037/0096-3445.127.1.69; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Pavlov I.P., 1927, CONDITIONED REFLEXES; Phelps EA, 1998, NEUROCASE, V4, P527, DOI 10.1080/13554799808410645; Pineles SL, 2009, PSYCHOPHYSIOLOGY, V46, P984, DOI 10.1111/j.1469-8986.2009.00852.x; Purkis HM, 2001, LEARN MOTIV, V32, P84, DOI 10.1006/lmot.2000.1066; Reinhard G, 2006, PSYCHOPHYSIOLOGY, V43, P73, DOI 10.1111/j.1469-8986.2006.00374.x; Reinhard G, 2002, BIOL PSYCHOL, V60, P51, DOI 10.1016/S0301-0511(02)00011-X; Ryan JD, 2000, PSYCHOL SCI, V11, P454, DOI 10.1111/1467-9280.00288; Ryan JD, 2007, MEMORY, V15, P508, DOI 10.1080/09658210701391022; Schultz DH, 2010, J EXP PSYCHOL-ANIM B, V36, P495, DOI 10.1037/a0020263; Sevenster D, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00032; SHANKS DR, 1994, BEHAV BRAIN SCI, V17, P367, DOI 10.1017/S0140525X00035032; Simons DJ, 2007, CAMB HANDB PSYCHOL, P207; Singh K, 2013, BIOL PSYCHOL, V93, P197, DOI 10.1016/j.biopsycho.2013.02.007; Smith CN, 2005, BEHAV NEUROSCI, V119, P78, DOI 10.1037/0735-7044.119.1.78; Squire LR, 2004, NEUROBIOL LEARN MEM, V82, P171, DOI 10.1016/j.nlm.2004.06.005; Tabbert K, 2006, NEUROIMAGE, V32, P761, DOI 10.1016/j.neuroimage.2006.03.038; Tabbert K, 2011, SOC COGN AFFECT NEUR, V6, P495, DOI 10.1093/scan/nsq070; Vervliet B, 2004, LEARN MEMORY, V11, P555, DOI 10.1101/lm.77404; Visser RM, 2013, NAT NEUROSCI, V16, P388, DOI 10.1038/nn.3345; Weike AI, 2005, J NEUROSCI, V25, P11117, DOI 10.1523/JNEUROSCI.2032-05.2005; Weike AI, 2007, PSYCHOPHYSIOLOGY, V44, P170, DOI 10.1111/j.1469-8986.2006.00469.x; Wiens S, 2002, J EXP PSYCHOL-ANIM B, V28, P27, DOI 10.1037//0097-7403.28.1.27; Yates A, 2010, EMOTION, V10, P822, DOI 10.1037/a0020325	67	10	10	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0141949	10.1371/journal.pone.0141949	http://dx.doi.org/10.1371/journal.pone.0141949			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7UL	26562298	Green Published, Green Submitted, gold			2022-12-26	WOS:000364480900007
J	Astale, T; Chenault, M				Astale, Tigist; Chenault, Michelene			Help-Seeking Behavior for Children with Acute Respiratory Infection in Ethiopia: Results from 2011 Ethiopia Demographic and Health Survey	PLOS ONE			English	Article							CARE-SEEKING; CHILDHOOD PNEUMONIA; SYSTEMATIC ANALYSIS; NATIONAL CAUSES; DETERMINANTS; MORTALITY; SLUMS; INDIA	Background Acute respiratory infection is a major contributor to morbidity and mortality among children under five years of age in Ethiopia. While facilities have been implemented to address this problem they are underused due to a lack in help-seeking behavior. This study investigates factors related to the help-seeking behavior of mothers for children with acute respiratory infection using data from the 2011 Ethiopia Demographic and Health Survey. Methods Data on 11,030 children aged 0-59 months obtained through interviewing women aged 1549 years throughout Ethiopia was available. Descriptive statistics and logistic regression analyses were performed to determine which factors are related to help-seeking behavior for acute respiratory infection. Results In the two weeks prior to the survey, 773(7%) of the children were reported to have symptoms of acute respiratory infection while treatment was sought for only 209 (27.2%). The odds ratio for acute respiratory infection was 1.6 (95% CI: 1.2-2.0) for rural residence with only 25.2% of these mothers seeking help compared to 46.4% for mothers with an urban residence. Smaller family size, younger mothers' age and having had prenatal care had a statistically significant odds ratio greater than 1 for both urban and rural residences. Highest wealth index had a statistically significant odds ratio greater than 1 for rural residence only, whereas primary education or higher had a statistically significant odds ratio greater than 1 for urban residence. Conclusions Children from rural areas are more at risk for acute respiratory infection while their mothers are less likely to seek help. Nevertheless, there is also underuse of available services in urban areas. Interventions should target mothers with less education and wealth and older mothers. Expanding prenatal care among these groups would encourage a better use of available facilities and subsequently better care for their children.	[Astale, Tigist] Jimma Univ, Dept Hlth Educ & Behav Sci, Jimma, Ethiopia; [Chenault, Michelene] Maastricht Univ, Dept Methodol & Stat, Maastricht, Netherlands	Jimma University; Maastricht University	Astale, T (corresponding author), Jimma Univ, Dept Hlth Educ & Behav Sci, Jimma, Ethiopia.	tgmulu@gmail.com						Abdulraheem IS, 2009, EARLY CHILD DEV CARE, V179, P671, DOI 10.1080/03004430701500885; Amin R, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-9; [Anonymous], 2013, INT COMM CAS MAN ICC, P1; BHUIYA A, 1995, HEALTH POLICY PLANN, V10, P304, DOI 10.1093/heapol/10.3.304; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Central Statistical Agency [Ethiopia] ICF International, 2012, ETH DEM HLTH SURV 20; Federal Democratic Republic of Ethiopia Ministry of Health, HLTH SECT DEV PROGR; Halim N, 2011, HEALTH POLICY PLANN, V26, P242, DOI 10.1093/heapol/czq040; Islam A, 2002, HEALTH POLICY, V60, P151, DOI 10.1016/S0168-8510(01)00211-1; Joseph LM, 2011, INDIAN PEDIATR, V48, P191; Kamgia B, 2004, J AM EC, V13, P142; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Luque JS, 2008, MATERN CHILD HLTH J, V12, P287, DOI 10.1007/s10995-007-0249-5; Manna B, 2013, AM J TROP MED HYG, V89, P56, DOI 10.4269/ajtmh.12-0756; Mbonye Anthony K, 2003, ScientificWorldJournal, V3, P721; MoFED, ETH 2010 MDGS REP TR; Navaneetham K, 2002, SOC SCI MED, V55, P1849, DOI 10.1016/S0277-9536(01)00313-6; NoorAli R, 1999, HEALTH POLICY PLANN, V14, P191, DOI 10.1093/heapol/14.2.191; Okwaraji YB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033564; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Shiferaw S, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-5; Taffa N, 2005, TROP MED INT HEALTH, V10, P240, DOI 10.1111/j.1365-3156.2004.01381.x; Tessema F, 2002, ETHIOP J HEAL DEV, P51; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; *WHO UNICEF, 2006, PNEUM FORG KILL CHIL	25	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142553	10.1371/journal.pone.0142553	http://dx.doi.org/10.1371/journal.pone.0142553			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7DR	26560469	Green Published, Green Submitted, gold			2022-12-26	WOS:000364433100092
J	Debrand, E; Lykoudi, A; Bradshaw, E; Allen, SK				Debrand, Emmanuel; Lykoudi, Alexandra; Bradshaw, Elizabeth; Allen, Stephanie K.			A Non-Invasive Droplet Digital PCR (ddPCR) Assay to Detect Paternal CFTR Mutations in the Cell-Free Fetal DNA (cffDNA) of Three Pregnancies at Risk of Cystic Fibrosis via Compound Heterozygosity	PLOS ONE			English	Article							MATERNAL PLASMA; DIAGNOSIS; QUANTIFICATION	Introduction Non-invasive prenatal diagnosis (NIPD) makes use of cell-free fetal DNA (cffDNA) in the mother's bloodstream as an alternative to invasive sampling methods such as amniocentesis or CVS, which carry a 0.5-1% risk of fetal loss. We describe a droplet digital PCR (ddPCR) assay designed to inform the testing options for couples whose offspring are at risk of suffering from cystic fibrosis via compound heterozygosity. By detecting the presence or absence of the paternal mutation in the cffDNA, it is possible to predict whether the fetus will be an unaffected carrier (absence) or whether further invasive testing is indicated (presence). Methods We selected a family in which the parents were known to carry different mutated CFTR alleles as our test system. NIPD was performed for three of their pregnancies during the first trimester (at around 11-12 weeks of gestation). Taqman probes were designed against an amplicon in exon 11 of the CFTR gene, to quantify the proportion of mutant (Delta F508-MUT; FAM) and normal (Delta F508-NOR; VIC) alleles at position c.1521_1523 of the CFTR gene. Discussion The assay correctly and unambiguously recognized the Delta F508-MUT CFTR allele in the cffDNA of all three proband fetuses and none of the six unaffected control fetuses. In conclusion, the Bio-Rad QX100 was found to be a cost-effective and technically undemanding platform for designing bespoke NIPD assays.	[Debrand, Emmanuel; Lykoudi, Alexandra; Bradshaw, Elizabeth; Allen, Stephanie K.] Birmingham Womens NHS Fdn Trust, West Midlands Reg Genet Lab, Birmingham B15 2TG, W Midlands, England; [Lykoudi, Alexandra] Univ Athens, Agia Sofia Childrens Hosp, Dept Med Genet, Athens 11527, Greece	National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital	Allen, SK (corresponding author), Birmingham Womens NHS Fdn Trust, West Midlands Reg Genet Lab, Mindelsohn Way, Birmingham B15 2TG, W Midlands, England.	Stephanie.Allen@bwnft.nhs.uk						Azuara D, 2012, CLIN CHEM, V58, P1332, DOI 10.1373/clinchem.2012.186577; Barrett AN, 2014, METHODS MOL BIOL, V1160, P215, DOI 10.1007/978-1-4939-0733-5_17; Barrett AN, 2012, CLIN CHEM, V58, P1026, DOI 10.1373/clinchem.2011.178939; Beck J, 2013, CLIN CHEM, V59, P1732, DOI 10.1373/clinchem.2013.210328; Bruno F, 2009, CLIN CHEM LAB MED, V47, P818, DOI 10.1515/CCLM.2009.187; Bustamante-Aragones A, 2008, J CYST FIBROS, V7, P505, DOI 10.1016/j.jcf.2008.05.006; Dube S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002876; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Guissart C, 2015, CLIN CHEM LAB MED, V53, P205, DOI 10.1515/cclm-2014-0501; Hahn S, 2010, GENOME MED, V2, DOI 10.1186/gm171; Lo YD, 2006, NAT REV GENET, V8, P71; Lun FMF, 2008, CLIN CHEM, V54, P1664, DOI 10.1373/clinchem.2008.111385; Mazaika E, 2014, CURR PROTOC HUM GENE, V82, p[7, 241], DOI DOI 10.1002/0471142905.HG0724S82; Papageorgiou EA, 2012, GENOME MED, V4, DOI 10.1186/gm345; Pornprasert S, 2014, EUR J HAEMATOL, V92, P244, DOI 10.1111/ejh.12246; Tsui NBY, 2013, PRENATAL DIAG, V33, P1214, DOI 10.1002/pd.4230; Tsui NBY, 2011, BLOOD, V117, P3684, DOI 10.1182/blood-2010-10-310789; Xiong L, 2015, PRENATAL DIAG, V35, P258, DOI 10.1002/pd.4536; Zimmermann BG, 2008, PRENATAL DIAG, V28, P1087, DOI 10.1002/pd.2150	19	26	29	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142729	10.1371/journal.pone.0142729	http://dx.doi.org/10.1371/journal.pone.0142729			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26561302	Green Submitted, Green Published, gold			2022-12-26	WOS:000364433100116
J	Fehlbaum, S; Chassard, C; Haug, MC; Fourmestraux, C; Derrien, M; Lacroix, C				Fehlbaum, Sophie; Chassard, Christophe; Haug, Martina C.; Fourmestraux, Candice; Derrien, Muriel; Lacroix, Christophe			Design and Investigation of PolyFermS In Vitro Continuous Fermentation Models Inoculated with Immobilized Fecal Microbiota Mimicking the Elderly Colon	PLOS ONE			English	Article							HUMAN GUT MODEL; INTESTINAL MICROBIOTA; CHILD GUT; TOXIN PRODUCTION; BOWEL-DISEASE; HEALTH; PH; COMMUNITIES; POPULATIONS; PREBIOTICS	In vitro gut modeling is a useful approach to investigate some factors and mechanisms of the gut microbiota independent of the effects of the host. This study tested the use of immobilized fecal microbiota to develop different designs of continuous colonic fermentation models mimicking elderly gut fermentation. Model 1 was a three-stage fermentation mimicking the proximal, transverse and distal colon. Models 2 and 3 were based on the new PolyFermS platform composed of an inoculum reactor seeded with immobilized fecal microbiota and used to continuously inoculate with the same microbiota different second-stage reactors mounted in parallel. The main gut bacterial groups, microbial diversity and metabolite production were monitored in effluents of all reactors using quantitative PCR, 16S rRNA gene 454-pyrosequencing, and HPLC, respectively. In all models, a diverse microbiota resembling the one tested in donor's fecal sample was established. Metabolic stability in inoculum reactors seeded with immobilized fecal microbiota was shown for operation times of up to 80 days. A high microbial and metabolic reproducibility was demonstrated for downstream control and experimental reactors of a PolyFermS model. The PolyFermS models tested here are particularly suited to investigate the effects of environmental factors, such as diet and drugs, in a controlled setting with the same microbiota source.	[Fehlbaum, Sophie; Chassard, Christophe; Haug, Martina C.; Lacroix, Christophe] ETH, Inst Food Nutr & Hlth, Lab Food Biotechnol, Zurich, Switzerland; [Fourmestraux, Candice; Derrien, Muriel] Danone Nutr Res, Palaiseau, France	Swiss Federal Institutes of Technology Domain; ETH Zurich; Danone Nutricia	Lacroix, C (corresponding author), ETH, Inst Food Nutr & Hlth, Lab Food Biotechnol, Zurich, Switzerland.	christophe.lacroix@hest.ethz.ch	Derrien, Muriel/AAS-6845-2021; Lacroix, Christophe/B-5139-2016	Derrien, Muriel/0000-0001-8841-9153; Lacroix, Christophe/0000-0003-4360-2020; Haug, Martina/0000-0002-4801-3236	Danone Research (Palaiseau, France)	Danone Research (Palaiseau, France)	Funding for this study was provided by Danone Research (Palaiseau, France). The funder supported the salary for SF. The authors MD and CF are employees of Danone Research. The specific roles of these authors are articulated in the 'author contributions' section.	Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Baines SD, 2005, J ANTIMICROB CHEMOTH, V55, P974, DOI 10.1093/jac/dki120; Baines SD, 2009, J ANTIMICROB CHEMOTH, V63, P520, DOI 10.1093/jac/dkn502; Belenguer A, 2006, APPL ENVIRON MICROB, V72, P3593, DOI 10.1128/AEM.72.5.3593-3599.2006; Berner AZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077772; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; Biagi E, 2013, PHARMACOL RES, V69, P11, DOI 10.1016/j.phrs.2012.10.005; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chassard C, 2013, CURR OPIN CLIN NUTR, V16, P453, DOI 10.1097/MCO.0b013e3283619e63; Cinquin C, 2004, MICROB ECOL, V48, P128, DOI 10.1007/s00248-003-2022-7; Cinquin C, 2006, FEMS MICROBIOL ECOL, V57, P324, DOI 10.1111/j.1574-6941.2006.00117.x; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Cleusix V, 2008, FEMS MICROBIOL ECOL, V63, P56, DOI 10.1111/j.1574-6941.2007.00412.x; Crowther GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088396; CUMMINGS JH, 1991, J APPL BACTERIOL, V70, P443, DOI 10.1111/j.1365-2672.1991.tb02739.x; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Dostal A, 2013, FEMS MICROBIOL ECOL, V83, P161, DOI 10.1111/j.1574-6941.2012.01461.x; Duncan SH, 2002, APPL ENVIRON MICROB, V68, P5186, DOI 10.1128/AEM.68.10.5186-5190.2002; Duncan SH, 2013, MATURITAS, V75, P44, DOI 10.1016/j.maturitas.2013.02.004; Duncan SH, 2009, ENVIRON MICROBIOL, V11, P2112, DOI 10.1111/j.1462-2920.2009.01931.x; Evans JM, 1998, J AM GERIATR SOC, V46, P83, DOI 10.1111/j.1532-5415.1998.tb01018.x; Freeman J, 2007, J ANTIMICROB CHEMOTH, V60, P83, DOI 10.1093/jac/dkm113; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Lacroix C, 2015, CURR OPIN BIOTECH, V32, P149, DOI 10.1016/j.copbio.2014.12.009; Lahti L, 2013, PEERJ, V1, DOI 10.7717/peerj.32; Lawley TD, 2013, IMMUNOLOGY, V138, P1, DOI 10.1111/j.1365-2567.2012.03616.x; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Likotrafiti E, 2014, ANAEROBE, V27, P50, DOI 10.1016/j.anaerobe.2014.03.009; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Macfarlane GT, 1998, MICROB ECOL, V35, P180, DOI 10.1007/s002489900072; Madsen JL, 2004, AGE AGEING, V33, P154, DOI 10.1093/ageing/afh040; MADSEN JL, 1992, DIGEST DIS SCI, V37, P1548, DOI 10.1007/BF01296501; MERKEL IS, 1993, AM J GASTROENTEROL, V88, P1854; Michel C, 1998, ANAEROBE, V4, P257, DOI 10.1006/anae.1998.0178; Montassier E, 2014, MICROB ECOL, V67, P690, DOI 10.1007/s00248-013-0355-4; NAGENGAST FM, 1988, DIGEST DIS SCI, V33, P673, DOI 10.1007/BF01540429; Nugent SG, 2001, GUT, V48, P571, DOI 10.1136/gut.48.4.571; Nyangale EP, 2012, J PROTEOME RES, V11, P5573, DOI 10.1021/pr300637d; O'Toole PW, 2010, INT DAIRY J, V20, P281, DOI 10.1016/j.idairyj.2009.11.010; Ottman N, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00104; Payne AN, 2012, FEMS MICROBIOL ECOL, V80, P608, DOI 10.1111/j.1574-6941.2012.01330.x; Payne AN, 2012, TRENDS BIOTECHNOL, V30, P17, DOI 10.1016/j.tibtech.2011.06.011; Power SE, 2014, BRIT J NUTR, V111, P387, DOI 10.1017/S0007114513002560; Alonso VR, 2013, BRIT J NUTR, V109, pS21, DOI 10.1017/S0007114512005235; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Sun DL, 2013, APPL ENVIRON MICROB, V79, P5962, DOI 10.1128/AEM.01282-13; Tanner SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094123; Tanner SA, 2014, GUT PATHOG, V6, DOI 10.1186/s13099-014-0044-y; Tiihonen K, 2008, BRIT J NUTR, V100, P130, DOI 10.1017/S000711450888871X; Van den Abbeele P, 2010, APPL ENVIRON MICROB, V76, P5237, DOI 10.1128/AEM.00759-10; Walker AW, 2005, APPL ENVIRON MICROB, V71, P3692, DOI 10.1128/AEM.71.7.3692-3700.2005; Woodmansey EJ, 2007, J APPL MICROBIOL, V102, P1178, DOI 10.1111/j.1365-2672.2007.03400.x; Zhang J, 2015, ISME J, V9, P1979, DOI 10.1038/ismej.2015.11; Zihler A, 2010, MICROBIOL-SGM, V156, P3342, DOI 10.1099/mic.0.042036-0	56	40	40	6	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142793	10.1371/journal.pone.0142793	http://dx.doi.org/10.1371/journal.pone.0142793			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559530	Green Published, gold, Green Submitted			2022-12-26	WOS:000364433100125
J	Massara, RL; Paschoal, AMD; Doherty, PF; Hirsch, A; Chiarello, AG				Massara, Rodrigo Lima; de Oliveira Paschoal, Ana Maria; Doherty, Paul Francis, Jr.; Hirsch, Andre; Chiarello, Adriano Garcia			Ocelot Population Status in Protected Brazilian Atlantic Forest	PLOS ONE			English	Article							SOUTH-EASTERN BRAZIL; LEOPARDUS-PARDALIS; CAMERA-TRAP; HABITAT USE; FRAGMENTED LANDSCAPE; SOUTHEASTERN BRAZIL; CAPTURE EXPERIMENTS; VIABILITY ANALYSIS; ACTIVITY PATTERNS; TROPHIC CASCADES	Forest fragmentation and habitat loss are detrimental to top carnivores, such as jaguars (Panthera onca) and pumas (Puma concolor), but effects on mesocarnivores, such as ocelots (Leopardus pardalis), are less clear. Ocelots need native forests, but also might benefit from the local extirpation of larger cats such as pumas and jaguars through mesopredator release. We used a standardized camera trap protocol to assess ocelot populations in six protected areas of the Atlantic forest in southeastern Brazil where over 80% of forest remnants are < 50 ha. We tested whether variation in ocelot abundance could be explained by reserve size, forest cover, number of free-ranging domestic dogs and presence of top predators. Ocelot abundance was positively correlated with reserve size and the presence of top predators (jaguar and pumas) and negatively correlated with the number of dogs. We also found higher detection probabilities in less forested areas as compared to larger, intact forests. We suspect that smaller home ranges and higher movement rates in smaller, more degraded areas increased detection. Our data do not support the hypothesis of mesopredator release. Rather, our findings indicate that ocelots respond negatively to habitat loss, and thrive in large protected areas inhabited by top predators.	[Massara, Rodrigo Lima; de Oliveira Paschoal, Ana Maria] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil; [Massara, Rodrigo Lima; de Oliveira Paschoal, Ana Maria] Inst SerraDiCal Pesquisa & Conservacao, Belo Horizonte, MG, Brazil; [Doherty, Paul Francis, Jr.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Hirsch, Andre] Univ Fed Sao Joao Del Rei, Programa Inst Bioengn, Sete Lagoas, MG, Brazil; [Chiarello, Adriano Garcia] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Biol, BR-14049 Ribeirao Preto, SP, Brazil	Universidade Federal de Minas Gerais; Colorado State University; Universidade Federal de Sao Joao del-Rei; Universidade de Sao Paulo	Massara, RL (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil.	rmassara@gmail.com	Paschoal, Ana Maria O/N-6631-2016; Chiarello, Adriano Garcia/G-2510-2012; Hirsch, André/F-4543-2012; Massara, Rodrigo Lima/Q-2223-2015	Paschoal, Ana Maria O/0000-0001-8560-1056; Chiarello, Adriano Garcia/0000-0003-1914-5480; Hirsch, André/0000-0001-9237-201X; Massara, Rodrigo Lima/0000-0003-1221-2185	Brazilian Science Council (CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [472802/2010-0]; Minas Gerais Science Foundation (FAPEMIG - Fundacao de Amparo a Pesquisa do Estado de Minas Gerais) [APQ 01145-10]; Brazilian Coordination of Higher Studies (CAPES-Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; CNPq; FAPEMIG	Brazilian Science Council (CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Minas Gerais Science Foundation (FAPEMIG - Fundacao de Amparo a Pesquisa do Estado de Minas Gerais); Brazilian Coordination of Higher Studies (CAPES-Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	The study was funded by The Brazilian Science Council (CNPq 472802/2010-0 - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - http://www.cnpq.br) and Minas Gerais Science Foundation (FAPEMIG APQ 01145-10 - Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - http://www.fapemig.br). The Brazilian Coordination of Higher Studies (CAPES-Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - http://www.capes.gov.br) and CNPq provided grants to AMOP. CNPq and FAPEMIG provided grants to RLM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo GR, 2013, ARQ BRAS MED VET ZOO, V65, P1, DOI 10.1590/S0102-09352013000100001; BIANCHI RC, 2007, AM J PRIMATOL, V69, P1; Bianchi RD, 2014, ACTA THERIOL, V59, P13, DOI 10.1007/s13364-013-0137-x; Bianchi RD, 2010, STUD NEOTROP FAUNA E, V45, P111, DOI 10.1080/01650521.2010.514791; Boas Goulart Fernando Vilas, 2009, Neotropical Biology and Conservation, V4, P137, DOI 10.4013/nbc.2009.43.03; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2002, J APPL STAT, V29, P245, DOI 10.1080/02664760120108755; Canale GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041671; Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; Cassano CR, 2014, BIOL CONSERV, V169, P14, DOI 10.1016/j.biocon.2013.10.006; Chiarello AG, 1999, BIOL CONSERV, V89, P71, DOI 10.1016/S0006-3207(98)00130-X; Chinchilla FA, 1997, REV BIOL TROP, V45, P1223; CRAWSHAW PG, 1989, BIOTROPICA, V21, P377, DOI 10.2307/2388291; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Cullen L, 2001, ORYX, V35, P137, DOI 10.1017/S0030605300031690; Davis ML, 2011, ANIM CONSERV, V14, P56, DOI 10.1111/j.1469-1795.2010.00389.x; de Oliveira Tadeu G., 2002, P265; deAlmeida Curi NH, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0104003, DOI 10.1371/journal.pone.0104003]; Di Bitetti MS, 2006, J ZOOL, V270, P153, DOI 10.1111/j.1469-7998.2006.00102.x; Di Bitetti MS, 2008, J TROP ECOL, V24, P189, DOI 10.1017/S0266467408004847; Di Bitetti MS, 2010, ACTA OECOL, V36, P403, DOI 10.1016/j.actao.2010.04.001; Dillon A, 2008, J ZOOL, V275, P391, DOI 10.1111/j.1469-7998.2008.00452.x; Dillon A, 2007, ORYX, V41, P469, DOI 10.1017/S0030605307000518; Doherty PF, 2012, J ORNITHOL, V152, pS317, DOI 10.1007/s10336-010-0598-5; EMMONS LH, 1988, REV ECOL-TERRE VIE, V43, P133; EMMONS LH, 1987, BEHAV ECOL SOCIOBIOL, V20, P271, DOI 10.1007/BF00292180; Erdas, 1997, ERD IM V 8 4 FIELD G; Espartosa KD, 2011, BIODIVERS CONSERV, V20, P2815, DOI 10.1007/s10531-011-0110-4; ESRI, 2008, ARCG V 9 2; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Foster RJ, 2010, J ZOOL, V280, P309, DOI 10.1111/j.1469-7998.2009.00663.x; Foster R. J, 2012, J WILDLIFE MANAGE, V9999, P1, DOI DOI 10.1002/JWMG.275&ARTICLEID=915261; Foster VC, 2013, BIOTROPICA, V45, P373, DOI 10.1111/btp.12021; Fusco-Costa R, 2010, MAMM BIOL, V75, P358, DOI 10.1016/j.mambio.2009.09.001; Galetti M, 2009, BIOL CONSERV, V142, P1229, DOI 10.1016/j.biocon.2009.01.023; Gascon C, 2000, SCIENCE, V288, P1356, DOI 10.1126/science.288.5470.1356; Gerber BD, 2014, POPUL ECOL, V56, P463, DOI 10.1007/s10144-014-0431-8; Goulart FVB, 2009, MAMM BIOL, V74, P182, DOI 10.1016/j.mambio.2009.02.006; Haines AM, 2006, BIOL CONSERV, V132, P424, DOI 10.1016/j.biocon.2006.04.035; Haines AM, 2006, EUR J WILDLIFE RES, V52, P216, DOI 10.1007/s10344-006-0043-5; Haines AM, 2005, BIOL CONSERV, V126, P512, DOI 10.1016/j.biocon.2005.06.032; Hanski Ilkka, 1997, P5, DOI 10.1016/B978-012323445-2/50003-1; Harmsen BJ, 2011, POPUL ECOL, V53, P253, DOI 10.1007/s10144-010-0211-z; Harveson PM, 2004, WILDLIFE SOC B, V32, P948, DOI 10.2193/0091-7648(2004)032[0948:HUBOIS]2.0.CO;2; Horne JS, 2009, SOUTHWEST NAT, V54, P119, DOI 10.1894/PS-49.1; HUGGINS RM, 1991, BIOMETRICS, V47, P725, DOI 10.2307/2532158; HUGGINS RM, 1989, BIOMETRIKA, V76, P133, DOI 10.1093/biomet/76.1.133; IBGE, 2005, MAP TEM MUN BRAS; IBGE, 2012, MAP INT IDG; IEF, 2014, PLAN MAN PARQ EST RI; Janecka JE, 2011, ANIM CONSERV, V14, P608, DOI 10.1111/j.1469-1795.2011.00475.x; Janecka JE, 2008, CONSERV GENET, V9, P869, DOI 10.1007/s10592-007-9412-1; Janecka JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089384; Jorge MLSP, 2013, BIOL CONSERV, V163, P49, DOI 10.1016/j.biocon.2013.04.018; Konecny M.J., 1989, P243; LUDLOW ME, 1987, NATL GEOGR RES, V3, P447; Lyra-Jorge MC, 2008, BIODIVERS CONSERV, V17, P1573, DOI 10.1007/s10531-008-9366-8; Machado ABM, 2008, LIVRO VERMELHO FAUNA; Maffei L, 2005, J TROP ECOL, V21, P349, DOI 10.1017/S0266467405002397; Maffei L, 2008, BIOTROPICA, V40, P71, DOI 10.1111/j.1744-7429.2007.00341.x; Miranda EE, 2005, EMBR MON SAT; Moreno RS, 2006, J MAMMAL, V87, P808, DOI 10.1644/05-MAMM-A-360R2.1; Negroes N, 2010, J WILDLIFE MANAGE, V74, P1195, DOI 10.2193/2009-256; Noss AJ, 2012, ANIM CONSERV, V15, P527, DOI 10.1111/j.1469-1795.2012.00545.x; Oliveira T.G., 2010, BIOL CONSERVATION WI, P559; Oliveira-Santos LGR, 2012, ZOOLOGIA-CURITIBA, V29, P115, DOI 10.1590/S1984-46702012000200003; OTIS DL, 1978, WILDLIFE MONOGR, P1; Paolino RM, 2015, THESIS; Paschoal AMO, 2012, MAMMALIA, V76, P67, DOI 10.1515/mammalia-2012-0501; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Ripple WJ, 2008, BIOL CONSERV, V141, P1249, DOI 10.1016/j.biocon.2008.02.028; Ripple WJ, 2007, FRONT ECOL ENVIRON, V5, P241, DOI 10.1890/1540-9295(2007)5[241:HTDFLC]2.0.CO;2; Roemer GW, 2009, BIOSCIENCE, V59, P165, DOI 10.1525/bio.2009.59.2.9; Santos JL, 2014, BRAZ J BIOL, V74, P632, DOI 10.1590/bjb.2014.0094; Schipper J., 2007, SMALL CARNIVORE CONS, V36, P38; Schwarz CJ, 1996, BIOMETRICS, V52, P860, DOI 10.2307/2533048; Sergio F, 2008, ANNU REV ECOL EVOL S, V39, P1, DOI 10.1146/annurev.ecolsys.39.110707.173545; Silva-Pereira JE, 2011, MAMM BIOL, V76, P308, DOI 10.1016/j.mambio.2010.09.001; Soisalo MK, 2006, BIOL CONSERV, V129, P487, DOI 10.1016/j.biocon.2005.11.023; SOS Mata Atlantica, 2011, REL TECN ATL REM FLO, Vhttp://mapas.sosma.org.br/; Sos Mata Atlantica, 2014, ATL REM FLOR MAT ATL; Srbek-Araujo AC, 2008, BRAZ J BIOL, V68, P771, DOI 10.1590/S1519-69842008000400011; Srbek-Araujo AC, 2013, BIOTA NEOTROP, V13, P51, DOI 10.1590/S1676-06032013000200005; Srbek-Araujo AC, 2009, ZOOLOGIA-CURITIBA, V26, P461, DOI 10.1590/S1984-46702009000300010; Sunquist ME, 2002, WILD CATS WORLD; Tabarelli M, 2010, BIOL CONSERV, V143, P2328, DOI 10.1016/j.biocon.2010.02.005; Tokolyi J, 2014, BIOL J LINN SOC, V111, P719, DOI 10.1111/bij.12238; Trolle M, 2005, MAMMALIA, V69, P409, DOI 10.1515/mamm.2005.032; Vanak AT, 2010, J APPL ECOL, V47, P1225, DOI 10.1111/j.1365-2664.2010.01870.x; Vanak AT, 2009, MAMMAL REV, V39, P265, DOI 10.1111/j.1365-2907.2009.00148.x; Wegge P, 2004, ANIM CONSERV, V7, P251, DOI 10.1017/S1367943004001441; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; White GC, 2000, METH C CONS, P288; White GC, 2002, J APPL STAT, V29, P103, DOI 10.1080/02664760120108476; Young JK, 2011, BIOSCIENCE, V61, P125, DOI 10.1525/bio.2011.61.2.7	97	37	38	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141333	10.1371/journal.pone.0141333	http://dx.doi.org/10.1371/journal.pone.0141333			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560347	Green Submitted, Green Published, gold			2022-12-26	WOS:000364433100032
J	Segev, E; Tellez, A; Vlamakis, H; Kolter, R				Segev, Einat; Tellez, Adele; Vlamakis, Hera; Kolter, Roberto			Morphological Heterogeneity and Attachment of Phaeobacter inhibens	PLOS ONE			English	Article							BIOFILM FORMATION; ROSEOBACTER CLADE; MARINE; HOLDFAST; MOTILITY; CELLS; GENE; COLONIZATION; CHEMOTAXIS; GENOMICS	The Roseobacter clade is a key group of bacteria in the ocean exhibiting diverse metabolic repertoires and a wide range of symbiotic life-styles. Many Roseobacters possess remarkable capabilities of attachment to both biotic and abiotic surfaces. When attached to each other, these bacteria form multi-cellular structures called rosettes. Phaeobacter inhibens, a well-studied Roseobacter, exhibits various cell sizes and morphologies that are either associated with rosettes or occur as single cells. Here we describe the distribution of P. inhibens morphologies and rosettes within a population. We detect an N-acetylglucosamine-containing polysaccharide on the poles of some cells and at the center of all rosettes. We demonstrate that rosettes are formed by the attachment of individual cells at the polysaccharide-containing pole rather than by cell division. Finally, we show that P. inhibens attachment to abiotic surfaces is hindered by the presence of DNA from itself, but not from other bacteria. Taken together, our findings demonstrate that cell adhesiveness is likely to play a significant role in the life cycle of P. inhibens as well as other Roseobacters.	[Segev, Einat; Tellez, Adele; Vlamakis, Hera; Kolter, Roberto] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Segev, E (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.	Einat_Segev@hms.harvard.edu; roberto_kolter@hms.harvard.edu			European Molecular Biology Organization; Human Frontier Science Program; NIH [GM58213, GM82137]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058213, R01GM082137] Funding Source: NIH RePORTER	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontier Science Program(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by fellowships from the European Molecular Biology Organization and from the Human Frontier Science Program granted to E.S. and NIH grants GM58213 and GM82137 to R.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Amin SA, 2015, NATURE, V522, P98, DOI 10.1038/nature14488; Avery SV, 2006, NAT REV MICROBIOL, V4, P577, DOI 10.1038/nrmicro1460; Babic A, 2011, MBIO, V2, DOI 10.1128/mBio.00027-11; Berne C, 2013, J PHYS CHEM B, V117, P10492, DOI 10.1021/jp405802e; Berne C, 2010, MOL MICROBIOL, V77, P815, DOI 10.1111/j.1365-2958.2010.07267.x; Brinkhoff T, 2004, APPL ENVIRON MICROB, V70, P2560, DOI 10.1128/AEM.70.4.2560-2565.2003; Brinkhoff T, 2008, ARCH MICROBIOL, V189, P531, DOI 10.1007/s00203-008-0353-y; Bruhn JB, 2006, APPL ENVIRON MICROB, V72, P3011, DOI 10.1128/AEM.72.4.3011-3015.2006; Bruhn JB, 2005, APPL ENVIRON MICROB, V71, P7263, DOI 10.1128/AEM.71.11.7263-7270.2005; Bruhn JB, 2007, APPL ENVIRON MICROB, V73, P442, DOI 10.1128/AEM.02238-06; Curtis PD, 2010, MICROBIOL MOL BIOL R, V74, P13, DOI 10.1128/MMBR.00040-09; Dang HY, 2000, APPL ENVIRON MICROB, V66, P467, DOI 10.1128/AEM.66.2.467-475.2000; Frank O, 2015, SYST APPL MICROBIOL, V38, P120, DOI 10.1016/j.syapm.2014.12.001; Heindl JE, 2014, FRONT PLANT SCI, V5; Janakiraman RS, 1999, J BACTERIOL, V181, P1118, DOI 10.1128/JB.181.4.1118-1125.1999; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Levi A, 2006, J BACTERIOL, V188, P5315, DOI 10.1128/JB.01725-05; Li GL, 2012, MOL MICROBIOL, V83, P41, DOI 10.1111/j.1365-2958.2011.07909.x; Luo HW, 2014, MICROBIOL MOL BIOL R, V78, P573, DOI 10.1128/MMBR.00020-14; MERKER RI, 1988, APPL ENVIRON MICROB, V54, P2078, DOI 10.1128/AEM.54.8.2078-2085.1988; Miller TR, 2006, ENVIRON MICROBIOL, V8, P1648, DOI 10.1111/j.1462-2920.2006.01071.x; Miller TR, 2004, APPL ENVIRON MICROB, V70, P4692, DOI 10.1128/AEM.70.8.4692-4701.2004; Moran MA, 2007, APPL ENVIRON MICROB, V73, P4559, DOI 10.1128/AEM.02580-06; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Patzelt D, 2013, ISME J, V7, P2274, DOI 10.1038/ismej.2013.107; RUGER HJ, 1992, INT J SYST BACTERIOL, V42, P133, DOI 10.1099/00207713-42-1-133; Seyedsayamdost MR, 2011, NAT CHEM, V3, P331, DOI [10.1038/nchem.1002, 10.1038/NCHEM.1002]; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; Sonnenschein EC, 2012, APPL ENVIRON MICROB, V78, P6900, DOI 10.1128/AEM.01790-12; Sule P, 2013, J BACTERIOL, V195, P637, DOI 10.1128/JB.01777-12; Team RDC, 2010, R LANG ENV STAT COMP; Tsang PH, 2006, P NATL ACAD SCI USA, V103, P5764, DOI 10.1073/pnas.0601705103; Verstrepen KJ, 2006, MOL MICROBIOL, V60, P5, DOI 10.1111/j.1365-2958.2006.05072.x; Wagner-Dobler I, 2006, ANNU REV MICROBIOL, V60, P255, DOI 10.1146/annurev.micro.60.080805.142115; Xu J, 2012, RES MICROBIOL, V163, P674, DOI 10.1016/j.resmic.2012.10.013	37	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141300	10.1371/journal.pone.0141300	http://dx.doi.org/10.1371/journal.pone.0141300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560130	Green Published, gold, Green Submitted			2022-12-26	WOS:000364433100030
J	Spiric, J; Engin, AM; Karas, M; Reuter, A				Spiric, Jelena; Engin, Anna M.; Karas, Michael; Reuter, Andreas			Quality Control of Biomedicinal Allergen Products - Highly Complex Isoallergen Composition Challenges Standard MS Database Search and Requires Manual Data Analyses	PLOS ONE			English	Article							BIRCH POLLEN ALLERGEN; IN-VITRO DIAGNOSIS; MASS-SPECTROMETRY; LIQUID-CHROMATOGRAPHY; CARROT ALLERGY; IDENTIFICATION; ISOFORMS; BET-V-1; ELECTROPHORESIS; QUANTIFICATION	Allergy against birch pollen is among the most common causes of spring pollinosis in Europe and is diagnosed and treated using extracts from natural sources. Quality control is crucial for safe and effective diagnosis and treatment. However, current methods are very difficult to standardize and do not address individual allergen or isoallergen composition. MS provides information regarding selected proteins or the entire proteome and could overcome the afore-mentioned limitations. We studied the proteome of birch pollen, focusing on allergens and isoallergens, to clarify which of the 93 published sequence variants of the major allergen, Bet v 1, are expressed as proteins within one sourcematerial in parallel. The unexpectedly complex Bet v 1 isoallergen composition required manual data interpretation and a specific design of databases, as current database search engines fail to unambiguously assign spectra to highly homologous, partially identical proteins. We identified 47 non-allergenic proteins and all 5 known birch pollen allergens, and unambiguously proved the existence of 18 Bet v 1 iso-allergens and variants by manual data analysis. This highly complex isoallergen composition raises questions whether isoallergens can be ignored or must be included for the quality control of allergen products, and which data analysis strategies are to be applied.	[Spiric, Jelena; Engin, Anna M.; Reuter, Andreas] Paul Ehrlich Inst, Div Allergol, Langen, Germany; [Karas, Michael] Goethe Univ Frankfurt, Inst Pharmaceut Chem, D-60054 Frankfurt, Germany	Paul Ehrlich Institute; Goethe University Frankfurt	Reuter, A (corresponding author), Paul Ehrlich Inst, Div Allergol, Langen, Germany.	Andreas.Reuter@pei.de		Reuter, Andreas/0000-0002-6082-9000				[Anonymous], 2014, MONOGRAPH ALLERGEN P, P1063; Ballmer-Weber BK, 2012, ALLERGY, V67, P758, DOI 10.1111/j.1398-9995.2012.02827.x; Ballmer-Weber BK, 2005, CLIN EXP ALLERGY, V35, P970, DOI 10.1111/j.1365-2222.2005.02294.x; Bollen MA, 2007, MOL NUTR FOOD RES, V51, P1527, DOI 10.1002/mnfr.200700119; Breitenbach M, 1996, ADV EXP MED BIOL, V409, P117; Cadot P, 2006, MOL IMMUNOL, V43, P226, DOI 10.1016/j.molimm.2005.02.001; CHMP, 2007, GUID ALL PROD PROD Q; Claassen M, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O110.007088; EBNER C, 1995, J ALLERGY CLIN IMMUN, V95, P962, DOI 10.1016/S0091-6749(95)70096-X; Engel E, 1997, J BIOL CHEM, V272, P28630, DOI 10.1074/jbc.272.45.28630; Erler A, 2011, PROTEOMICS, V11, P1486, DOI 10.1002/pmic.201000624; Foetisch K, 2011, ANAL BIOANAL CHEM, V399, P935, DOI 10.1007/s00216-010-4348-6; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; He ZY, 2011, IEEE ACM T COMPUT BI, V8, P368, DOI 10.1109/TCBB.2009.54; Helsper JPFG, 2002, J ALLERGY CLIN IMMUN, V110, P131, DOI 10.1067/mai.2002.125599; Herbert B, 1999, ELECTROPHORESIS, V20, P660, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<660::AID-ELPS660>3.0.CO;2-Q; IPSEN H, 1983, J ALLERGY CLIN IMMUN, V72, P150, DOI 10.1016/0091-6749(83)90523-7; Karamloo F, 2001, EUR J BIOCHEM, V268, P5310, DOI 10.1046/j.0014-2956.2001.02463.x; Karamloo F, 1999, J ALLERGY CLIN IMMUN, V104, P991, DOI 10.1016/S0091-6749(99)70080-1; Lukasse PNJ, 2014, J PROTEOME RES, V13, P3191, DOI 10.1021/pr401072g; Ma ZQ, 2009, J PROTEOME RES, V8, P3872, DOI 10.1021/pr900360j; Marzban G, 2008, EXPERT REV PROTEOMIC, V5, P61, DOI 10.1586/14789450.5.1.61; Meyer-Arendt K, 2011, J PROTEOME RES, V10, P3060, DOI 10.1021/pr200039p; Monaci L, 2008, J CHROMATOGR A, V1192, P113, DOI 10.1016/j.chroma.2008.03.041; Nesvizhskii AI, 2005, MOL CELL PROTEOMICS, V4, P1419, DOI 10.1074/mcp.R500012-MCP200; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Radauer C, 2014, ALLERGY, V69, P413, DOI 10.1111/all.12348; Reuter A, 2005, PROTEOMICS, V5, P282, DOI 10.1002/pmic.200400874; Sander I, 1998, J ALLERGY CLIN IMMUN, V102, P256, DOI 10.1016/S0091-6749(98)70109-5; Schenk MF, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-168; Schenk MF, 2011, J PROTEOMICS, V74, P1290, DOI 10.1016/j.jprot.2011.03.021; Schenk MF, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-24; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SWOBODA I, 1995, J BIOL CHEM, V270, P2607, DOI 10.1074/jbc.270.6.2607; VALENTA R, 1991, SCIENCE, V253, P557, DOI 10.1126/science.1857985; Van Ree R, 2008, ALLERGY, V63, P310, DOI 10.1111/j.1398-9995.2007.01612.x	36	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142404	10.1371/journal.pone.0142404	http://dx.doi.org/10.1371/journal.pone.0142404			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26561299	Green Published, Green Submitted, gold			2022-12-26	WOS:000364433100076
J	Zhang, WP; Schmelzeisen, S; Parthier, D; Frings, S; Mohrlen, F				Zhang, Weiping; Schmelzeisen, Steffen; Parthier, Daniel; Frings, Stephan; Moehrlen, Frank			Anoctamin Calcium-Activated Chloride Channels May Modulate Inhibitory Transmission in the Cerebellar Cortex	PLOS ONE			English	Article							CA2+-ACTIVATED CL-CURRENTS; PURKINJE-CELLS; CLIMBING FIBER; REBOUND POTENTIATION; EXPRESSION PATTERNS; SYNAPTIC INHIBITION; MESSENGER-RNAS; TMEM16A; PLASTICITY; SIGNALS	Calcium-activated chloride channels of the anoctamin (alias TMEM16) protein family fulfill critical functions in epithelial fluid transport, smooth muscle contraction and sensory signal processing. Little is known, however, about their contribution to information processing in the central nervous system. Here we examined the recent finding that a calcium-dependent chloride conductance impacts on GABAergic synaptic inhibition in Purkinje cells of the cerebellum. We asked whether anoctamin channels may underlie this chloride conductance. We identified two anoctamin channel proteins, ANO1 and ANO2, in the cerebellar cortex. ANO1 was expressed in inhibitory interneurons of the molecular layer and the granule cell layer. Both channels were expressed in Purkinje cells but, while ANO1 appeared to be retained in the cell body, ANO2 was targeted to the dendritic tree. Functional studies confirmed that ANO2 was involved in a calcium-dependent mode of ionic plasticity that reduces the efficacy of GABAergic synapses. ANO2 channels attenuated GABAergic transmission by increasing the postsynaptic chloride concentration, hence reducing the driving force for chloride influx. Our data suggest that ANO2 channels are involved in a Ca2+-dependent regulation of synaptic weight in GABAergic inhibition. Thus, in balance with the chloride extrusion mechanism via the co-transporter KCC2, ANO2 appears to regulate ionic plasticity in the cerebellum.	[Zhang, Weiping; Schmelzeisen, Steffen; Parthier, Daniel; Frings, Stephan; Moehrlen, Frank] Heidelberg Univ, Dept Anim Mol Physiol, Ctr Organismal Studies, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Mohrlen, F (corresponding author), Heidelberg Univ, Dept Anim Mol Physiol, Ctr Organismal Studies, Neuenheimer Feld 504, Heidelberg, Germany.	moehrlen@uni-hd.de		Parthier, Daniel/0000-0001-8775-024X	China Scholarship Council	China Scholarship Council(China Scholarship Council)	This project was funded by a grant of the China Scholarship Council to WZ.	ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Almaca J, 2009, J BIOL CHEM, V284, P28571, DOI 10.1074/jbc.M109.010074; Amjad A, 2015, J GEN PHYSL; Berglund K, 2008, BRAIN CELL BIOL, V36, P101, DOI 10.1007/s11068-008-9031-x; Bill A, 2015, J BIOL CHEM, V290, P889, DOI 10.1074/jbc.M114.618140; Billig GM, 2011, NAT NEUROSCI, V14, P763, DOI 10.1038/nn.2821; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Bradley E, 2014, CHANNELS, V8, P308, DOI 10.4161/chan.28065; Bregestovski P, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.015.2009; Brenowitz SD, 2005, NEURON, V45, P419, DOI 10.1016/j.neuron.2004.12.045; Brunner JD, 2014, NATURE, V516, P207, DOI 10.1038/nature13984; Bunger S, 2009, CYTOTECHNOLOGY, V61, P153, DOI 10.1007/s10616-009-9249-1; Bulley S, 2012, CIRC RES, V111, P1027, DOI 10.1161/CIRCRESAHA.112.277145; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Cho H, 2012, NAT NEUROSCI, V15, P1015, DOI 10.1038/nn.3111; Cho SJ, 2014, CELL TISSUE RES, V357, P563, DOI 10.1007/s00441-014-1897-6; Dauner K, 2013, INVEST OPHTH VIS SCI, V54, P3126, DOI 10.1167/iovs.13-11711; Dauner K, 2012, CELL TISSUE RES, V347, P327, DOI 10.1007/s00441-012-1324-9; De Zeeuw CI, 2011, NAT REV NEUROSCI, V12, P327, DOI 10.1038/nrn3011; Diana MA, 2002, J NEUROSCI, V22, P200, DOI 10.1523/JNEUROSCI.22-01-00200.2002; Dibattista M, 2012, J GEN PHYSIOL, V140, P3, DOI 10.1085/jgp.201210780; Duguid IC, 2007, J NEUROSCI, V27, P12464, DOI 10.1523/JNEUROSCI.0178-07.2007; Duguid IC, 2004, NAT NEUROSCI, V7, P525, DOI 10.1038/nn1227; ECCLES JC, 1967, P NATL ACAD SCI USA, V58, P336, DOI 10.1073/pnas.58.1.336; Eilers J, 1996, CELL CALCIUM, V20, P215, DOI 10.1016/S0143-4160(96)90108-6; Ferrera L, 2009, J BIOL CHEM, V284, P33360, DOI 10.1074/jbc.M109.046607; Finch EA, 2012, CEREBELLUM, V11, P706, DOI 10.1007/s12311-011-0314-x; Garcia G, 2014, BRAIN RES, V1579, P35, DOI 10.1016/j.brainres.2014.07.011; Hartmann J, 2005, CELL CALCIUM, V37, P459, DOI 10.1016/j.ceca.2005.01.014; Hashimoto T, 1996, J PHYSIOL-LONDON, V497, P611, DOI 10.1113/jphysiol.1996.sp021794; Hengl T, 2010, P NATL ACAD SCI USA, V107, P6052, DOI 10.1073/pnas.0909032107; Huang SW, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00048; Huang WC, 2012, NEURON, V74, P179, DOI 10.1016/j.neuron.2012.01.033; Huang Y, 2012, EXP NEUROL, V233, P791, DOI 10.1016/j.expneurol.2011.11.043; Isomura Y, 2003, J NEUROPHYSIOL, V90, P2752, DOI 10.1152/jn.00142.2003; ITO M, 1970, INT J NEUROL, V7, P162; Jedlicka P, 2011, HIPPOCAMPUS, V21, P885, DOI 10.1002/hipo.20804; Jeon JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067989; Jeon JH, 2011, CELL TISSUE RES, V345, P223, DOI 10.1007/s00441-011-1206-6; Jin X, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004184; Kaila K, 2014, NAT REV NEUROSCI, V15, P637, DOI 10.1038/nrn3819; Kaila K, 2014, CURR OPIN NEUROBIOL, V26, P34, DOI 10.1016/j.conb.2013.11.004; Kanaka C, 2001, NEUROSCIENCE, V104, P933, DOI 10.1016/S0306-4522(01)00149-X; Kanazawa T, 2014, BRAIN RES BULL, V106, P17, DOI 10.1016/j.brainresbull.2014.04.015; KANO M, 1992, NATURE, V356, P601, DOI 10.1038/356601a0; Kano M, 1996, P NATL ACAD SCI USA, V93, P13351, DOI 10.1073/pnas.93.23.13351; Kawaguchi S, 2002, J NEUROSCI, V22, P3969, DOI 10.1523/JNEUROSCI.22-10-03969.2002; Kawakita I, 2013, EUR J NEUROSCI, V37, P532, DOI 10.1111/ejn.12076; Kellendonk C, 1999, J MOL BIOL, V285, P175, DOI 10.1006/jmbi.1998.2307; Kitamura K, 2013, NEURAL NETWORKS, V47, P11, DOI 10.1016/j.neunet.2012.08.001; Kitamura K, 2011, J NEUROSCI, V31, P10847, DOI 10.1523/JNEUROSCI.2525-10.2011; KONNERTH A, 1992, P NATL ACAD SCI USA, V89, P7051, DOI 10.1073/pnas.89.15.7051; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; Kreitzer AC, 2002, CURR OPIN NEUROBIOL, V12, P324, DOI 10.1016/S0959-4388(02)00328-8; Kullmann DM, 2012, NEURON, V75, P951, DOI 10.1016/j.neuron.2012.07.030; Kuner T, 2000, NEURON, V27, P447, DOI 10.1016/S0896-6273(00)00056-8; Lee B, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-5; Liu BY, 2010, J CLIN INVEST, V120, P1240, DOI 10.1172/JCI41084; Liu YN, 2015, PFLUG ARCH EUR J PHY, V467, P1417, DOI 10.1007/s00424-014-1572-5; LLANO I, 1991, NEURON, V6, P565, DOI 10.1016/0896-6273(91)90059-9; Marandi N, 2002, PFLUG ARCH EUR J PHY, V445, P357, DOI 10.1007/s00424-002-0933-7; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Mercer AJ, 2011, J NEUROPHYSIOL, V105, P321, DOI 10.1152/jn.00332.2010; Mikawa S, 2002, DEV BRAIN RES, V136, P93, DOI 10.1016/S0165-3806(02)00345-0; MIYAKAWA H, 1992, J NEUROPHYSIOL, V68, P1178, DOI 10.1152/jn.1992.68.4.1178; Namkung W, 2011, J BIOL CHEM, V286, P2365, DOI 10.1074/jbc.M110.175109; Pedemonte N, 2014, PHYSIOL REV, V94, P419, DOI 10.1152/physrev.00039.2011; Peters CJ, 2015, P NATL ACAD SCI USA, V112, P3547, DOI 10.1073/pnas.1502291112; Pifferi S, 2009, PFLUG ARCH EUR J PHY, V458, P1023, DOI 10.1007/s00424-009-0684-9; Qian Z, 2012, NEUROSCIENCE, V201, P34, DOI 10.1016/j.neuroscience.2011.11.021; Raimondo Joseph V, 2012, Front Synaptic Neurosci, V4, P5, DOI 10.3389/fnsyn.2012.00005; Rasche S, 2010, CHEM SENSES, V35, P239, DOI 10.1093/chemse/bjq007; Reisert J, 2003, J GEN PHYSIOL, V122, P349, DOI 10.1085/jgp.200308888; Rivera C, 2005, J PHYSIOL-LONDON, V562, P27, DOI 10.1113/jphysiol.2004.077495; Roth A, 2001, J PHYSIOL-LONDON, V535, P445, DOI 10.1111/j.1469-7793.2001.00445.x; Saidu SP, 2013, J GEN PHYSIOL, V141, P691, DOI 10.1085/jgp.201210937; Satoh H, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.61; Schmolesky MT, 2002, ANN NY ACAD SCI, V978, P359, DOI 10.1111/j.1749-6632.2002.tb07581.x; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Seja P, 2012, EMBO J, V31, P1217, DOI 10.1038/emboj.2011.488; Sinkkonen ST, 2003, MOL PHARMACOL, V64, P753, DOI 10.1124/mol.64.3.753; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Stohr H, 2009, J NEUROSCI, V29, P6809, DOI 10.1523/JNEUROSCI.5546-08.2009; Takayama Y, 2014, FASEB J, V28, P2238, DOI 10.1096/fj.13-243436; Thomas-Gatewood C, 2011, AM J PHYSIOL-HEART C, V301, pH1819, DOI 10.1152/ajpheart.00404.2011; Tien J, 2014, ELIFE, V3, DOI 10.7554/eLife.02772; Tolu S, 2010, FASEB J, V24, P723, DOI 10.1096/fj.09-139790; Vocke K, 2013, J GEN PHYSIOL, V142, P381, DOI 10.1085/jgp.201311015; Xiao QH, 2011, P NATL ACAD SCI USA, V108, P8891, DOI 10.1073/pnas.1102147108; Yang TT, 2014, P NATL ACAD SCI USA, V111, P18213, DOI 10.1073/pnas.1420984111; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yoshida T, 2002, J NEUROSCI, V22, P1690, DOI 10.1523/JNEUROSCI.22-05-01690.2002; Yu K, 2012, CIRC RES, V110, P990, DOI 10.1161/CIRCRESAHA.112.264440; Zhang XD, 2015, P NATL ACAD SCI USA, V112, P2575, DOI 10.1073/pnas.1414741112	95	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142160	10.1371/journal.pone.0142160	http://dx.doi.org/10.1371/journal.pone.0142160			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558388	Green Submitted, gold, Green Published			2022-12-26	WOS:000364433100058
J	Antwi-Agyei, P; Cairncross, S; Peasey, A; Price, V; Bruce, J; Baker, K; Moe, C; Ampofo, J; Armah, G; Ensink, J				Antwi-Agyei, Prince; Cairncross, Sandy; Peasey, Anne; Price, Vivien; Bruce, Jane; Baker, Kelly; Moe, Christine; Ampofo, Joseph; Armah, George; Ensink, Jeroen			A Farm to Fork Risk Assessment for the Use of Wastewater in Agriculture in Accra, Ghana	PLoS One			English	Article							URBAN VEGETABLE PRODUCTION; NORWALK VIRUS; CONTAMINATION; QUALITY; FOOD; REDUCTION; INFECTION; LETTUCE; PRODUCE	The need to minimise consumer risk, especially for food that can be consumed uncooked, is a continuing public health concern, particularly in places where safe sanitation and hygienic practices are absent. The use of wastewater in agriculture has been associated with disease risks, though its relative significance in disease transmission remains unclear. This study aimed at identifying key risk factors for produce contamination at different entry points of the food chain. Over 500 produce and ready-to-eat salad samples were collected from fields, markets, and kitchens during the dry and wet seasons in Accra, Ghana, and over 300 soil and irrigation water samples were collected. All samples were analysed for E. coli, human adenovirus and norovirus using standard microbiological procedures, and real time RT-PCR. Finally, critical exposures associated with microbial quality of produce were assessed through observations and interviews. The study found that over 80% of produce samples were contaminated with E. coli, with median concentrations ranging from 0.64 to 3.84 Log E. coli/g produce. Prepared salad from street food vendors was found to be the most contaminated (4.23 Log E. coli/g), and that consumption of salad exceeded acceptable health limits. Key risk factors identified for produce contamination were irrigation water and soil at the farm level. Storage duration and temperature of produce had a significant influence on the quality of produce sold at markets, while observations revealed that the washed water used to rinse produce before sale was dirty. The source of produce and operating with a hygiene permit were found to influence salad microbial quality at kitchens. This study argues for a need to manage produce risk factors at all domains along the food chain, though it would be more effective to prioritise at markets and kitchens due to cost, ease of implementation and public health significance.	[Antwi-Agyei, Prince; Cairncross, Sandy; Ensink, Jeroen] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Environm Hlth Grp, Dept Dis Control, London WC1E 7HT, England; [Peasey, Anne] UCL, Dept Epidemiol & Publ Hlth, London, England; [Price, Vivien] London Sch Hyg & Trop Med, London WC1, England; [Bruce, Jane] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England; [Baker, Kelly; Moe, Christine] Emory Univ, Ctr Global Safe Water, Atlanta, GA 30322 USA; [Ampofo, Joseph] Council Sci & Ind Res CSIR, Water Res Inst WRI, Accra, Ghana; [Armah, George] Univ Ghana Legon, Noguchi Mem Inst Med Res, Coll Hlth Sci, Accra, Ghana	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Emory University; University of Ghana	Antwi-Agyei, P (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Environm Hlth Grp, Dept Dis Control, Keppel St, London WC1E 7HT, England.	Prince.AntwiAgyei@lshtm.ac.uk		Price, Vivien/0000-0003-3573-5106; Antwi-Agyei, Prince/0000-0001-6940-2428; Peasey, Anne/0000-0001-7434-2079; Baker, Kelly/0000-0002-3774-2628	Sanitation and Hygiene Applied Research for Equity (SHARE) Research consortium through a UK aid from the Department for International Development (DFID)	Sanitation and Hygiene Applied Research for Equity (SHARE) Research consortium through a UK aid from the Department for International Development (DFID)	The study was funded by the Sanitation and Hygiene Applied Research for Equity (SHARE) Research consortium (www.shareresearch.org) through a UK aid from the Department for International Development (DFID). PM received this funding for this study as part of his PhD scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo K. K., 2007, AFRICAN J FOOD AGR N, V7, P1; Adu-Gyamfi A, 2008, GHANA J SCI, V47, P3; Ali M, 2012, BANGLADESH J SCI RES, V24, P127; Allende A, 2008, POSTHARVEST BIOL TEC, V49, P155, DOI 10.1016/j.postharvbio.2007.12.010; AMA, 2007, MED TERM DEV PLAN 20; Ameko E., 2012, African Journal of Biotechnology, V11, P11078; Amoah P, 2007, TROP MED INT HEALTH, V12, P40, DOI 10.1111/j.1365-3156.2007.01940.x; Amoah P, 2007, J WATER HEALTH, V5, P455, DOI 10.2166/wh.2007.041; Amoah P, 2005, IRRIG DRAIN, V54, pS49, DOI 10.1002/ird.185; Amoah P, 2008, THESIS K NKRUMAH U S; Annor GA, 2011, FOOD NUTR SCI, V2; [Anonymous], 1989, HLTH GUID US WAST AG; [Anonymous], 2005, ESSENTIAL MED STAT; Antwi-Agyei P, QUANTITATIV IN PRESS; Antwi-Agyei P, RISK PERCEP IN PRESS; Barbarosa-Canovas GV, 2003, HANDLING PRESERVATIO; Bosch A, 2006, FOOD MICROBIOL FOOD, P151; Brackett RE, 1999, POSTHARVEST BIOL TEC, V15, P305, DOI 10.1016/S0925-5214(98)00096-9; Camelo A.F.L., 2004, MANUAL PREPARATION S; Carter MJ, 2005, J APPL MICROBIOL, V98, P1354, DOI 10.1111/j.1365-2672.2005.02635.x; Drechsel P., 2014, IRRIGATED URBAN VEGE, DOI [10.5337/2014.219, DOI 10.5337/2014.219]; Drechsel P, 2000, URBAN AGR MAG, V2, P25; Ensink JHJ, 2007, TROP MED INT HEALTH, V12, P2, DOI 10.1111/j.1365-3156.2007.01935.x; [FAO WHO], 2009, WHO MICR RISK ASS SE, V17; Fegloi P, 2012, J MED BIOMED SCI, V1, P1; Fung J., 2011, International Journal of Food Safety, Nutrition and Public Health, V4, P152, DOI 10.1504/IJFSNPH.2011.044544; Garbutt J., 1997, ESSENTIALS FOOD MICR; Ghana Standard Board (Authority) G, 2009, GHAN STAND BOARD GS; Ghana Statistical Service, 2012, 2010 POP HOUS CENS F; Gil MI, 2009, INT J FOOD MICROBIOL, V134, P37, DOI 10.1016/j.ijfoodmicro.2009.05.021; Gilbert R J, 2000, Commun Dis Public Health, V3, P163; Hamilton L.C., 2012, STAT STATA VERSION 1; Harris L.J., 2003, COMPR REV FOOD SCI F, V2, P78, DOI [10.1111/j.1541-4337.2003.tb00031, DOI 10.1111/J.1541-4337.2003.TB00031]; ICMSF. International Commission on Microbiological Specification for Food, 1974, INT COMM MICR SPEC F; Karavarsamis N, 2010, J WATER HEALTH, V8, P365, DOI 10.2166/wh.2010.045; Keraita B, 2008, THESIS U COPENHAGEN; Keraita B, 2008, WATER SCI TECHNOLOGY, V57; Keraita B, 2008, J RISK RES, V11, P1047, DOI 10.1080/13669870802380825; Keraita B, 2008, J ENVIRON SCI HEAL A, V43, P749, DOI 10.1080/10934520801959948; Keraita B, 2007, TROP MED INT HEALTH, V12, P15, DOI 10.1111/j.1365-3156.2007.01937.x; Liu PB, 2010, J MED VIROL, V82, P1612, DOI 10.1002/jmv.21851; Mara D., 2010, DISCUSSION PAPER OPT; Mara D., 2010, QUANTITATIVE MICROBI; Mensah P, 2002, B WORLD HEALTH ORGAN, V80, P546; Minhas PS, 2006, BIORESOURCE TECHNOL, V97, P1174, DOI 10.1016/j.biortech.2005.05.006; Muinde O, 2005, HYGIENIC SANITARY PR; Newell DG, 2010, INT J FOOD MICROBIOL, V139, pS3, DOI 10.1016/j.ijfoodmicro.2010.01.021; Olmez H, 2009, LWT-FOOD SCI TECHNOL, V42, P686, DOI 10.1016/j.lwt.2008.08.001; Olaimat AN, 2012, FOOD MICROBIOL, V32, P1, DOI 10.1016/j.fm.2012.04.016; Oshiro, 2002, 1604 US EPA; Parish M. E., 2003, COMPR REV FOOD SCI F, V2, P161, DOI DOI 10.1111/J.1541-4337.2003.TB00033.X; Pepper I.L., 2015, ENVIRON MICROBIOL, V3rd, P509; Rodriguez-Lazaro D, 2012, FEMS MICROBIOL REV, V36, P786, DOI 10.1111/j.1574-6976.2011.00306.x; Scallan E., 2011, EMERGING INFECT DIS, V17; Shuval H, 1997, WATER SCI TECHNOL, V35, P15, DOI 10.1016/S0273-1223(97)00228-X; Silverman AI, 2013, J WATER HLTH, V11; Stevens M., 2003, REV COLIFORMS MICROB; Teunis PFM, 2008, J MED VIROL, V80, P1468, DOI 10.1002/jmv.21237; Vaz da Costa Vargas S, 1996, TROPICAL PUBLIC HLTH, V8; WHO, 2006, WHO GUID SAF US WAST; World Health Organization, 2006, FOOD SAF RISK ANAL G; World Health Organization, 2006, GUID SAF US WAST EXC, V2; Yeboah-Manu D, 2010, RES J MICROBIOLOGY, V5	63	27	27	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142346	10.1371/journal.pone.0142346	http://dx.doi.org/10.1371/journal.pone.0142346			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556044	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000364430700088
J	Ghaffari-Nazari, H; Tavakkol-Afshari, J; Jaafari, MR; Tahaghoghi-Hajghorbani, S; Masoumi, E; Jalali, SA				Ghaffari-Nazari, Haniyeh; Tavakkol-Afshari, Jalil; Jaafari, Mahmoud Reza; Tahaghoghi-Hajghorbani, Sahar; Masoumi, Elham; Jalali, Seyed Amir			Improving Multi-Epitope Long Peptide Vaccine Potency by Using a Strategy that Enhances CD4+T Help in BALB/c Mice	PLOS ONE			English	Article							B-CELL EPITOPE; INCOMPLETE FREUNDS-ADJUVANT; CANCER-PATIENTS; ANTITUMOR IMMUNITY; CTL RESPONSE; CPG; DNA; INDUCTION; LYMPHOCYTE; ANTIGEN	Peptide-based vaccines are attractive approaches for cancer immunotherapy; but the success of these vaccines in clinical trials have been limited. Our goal is to improve immune responses and anti-tumor effects against a synthetic, multi-epitope, long peptide from rat Her2/neu (rHer2/neu) using the help of CD4+ T cells and appropriate adjuvant in a mouse tumor model. Female BALB/c mice were vaccinated with P5+435 multi-epitope long peptide that presents epitopes for cytotoxic T lymphocytes (CTL) in combination with a universal Pan DR epitope (PADRE) or CpG-oligodeoxynucleotides (CpG-ODNs) as a Toll-like receptor agonist adjuvant. The results show that vaccination with the multi-epitope long peptide in combination with the PADRE peptide and CpG-ODN induced expansion of subpopulations of CD4+ and CD8+ cells producing IFN-gamma, the average tumor size in the vaccinated mice was less than that of the other groups, and tumor growth was inhibited in 40% of the mice in the vaccinated group. The mean survival time was 82.6 +/- 1.25 days in mice vaccinated with P5+435 + CpG+ PADRE. Our results demonstrate that inclusion of PADRE and CpG with the peptide vaccine enhanced significant tumor specific-immune responses in vaccinated mice.	[Ghaffari-Nazari, Haniyeh; Tavakkol-Afshari, Jalil; Tahaghoghi-Hajghorbani, Sahar; Masoumi, Elham] Mashhad Univ Med Sci, Immunol Res Ctr, Sch Med, Immunogenet & Cell Culture Dept, Mashhad, Iran; [Jaafari, Mahmoud Reza] Mashhad Univ Med Sci, Biotechnol Res Ctr, Nanotechnol Res Ctr, Sch Pharm, Mashhad, Iran; [Jalali, Seyed Amir] Shahid Beheshti Univ Med Sci, Sch Med, Dept Immunol, Tehran, Iran	Mashhad University Medical Science; Mashhad University Medical Science; Shahid Beheshti University Medical Sciences	Jalali, SA (corresponding author), Shahid Beheshti Univ Med Sci, Sch Med, Dept Immunol, Tehran, Iran.	Jalalia@sbmu.ac.ir	Masoumi, Elham/AAP-8427-2020; Afshari, Jalil Tavakol/AAH-7891-2021; Ghaffari-nazari, Haniyeh/X-7035-2018	Ghaffari-nazari, Haniyeh/0000-0002-4129-6018; Masoumi, Elham/0000-0002-8312-955X; jalali, seyed amir/0000-0003-1174-4905	research council of Mashhad University of Medical Sciences in Iran [910444]	research council of Mashhad University of Medical Sciences in Iran	This research was financially supported by a grant (No. 910444) of the research council of Mashhad University of Medical Sciences in Iran.	Adamsson J, 2006, J IMMUNOL, V176, P4902, DOI 10.4049/jimmunol.176.8.4902; Agadjanyan MG, 2005, J IMMUNOL, V174, P1580, DOI 10.4049/jimmunol.174.3.1580; Alexander J, 1998, IMMUNOL RES, V18, P79, DOI 10.1007/BF02788751; Alexander J, 2004, VACCINE, V22, P2362, DOI 10.1016/j.vaccine.2003.11.061; Alexander J, 2000, J IMMUNOL, V164, P1625, DOI 10.4049/jimmunol.164.3.1625; BARR PJ, 1991, CELL, V66, P1, DOI 10.1016/0092-8674(91)90129-M; Baxevanis CN, 2006, CANCER IMMUNOL IMMUN, V55, P85, DOI 10.1007/s00262-005-0692-3; Bijker MS, 2007, J IMMUNOL, V179, P5033, DOI 10.4049/jimmunol.179.8.5033; Bode C, 2011, EXPERT REV VACCINES, V10, P499, DOI [10.1586/erv.10.174, 10.1586/ERV.10.174]; Dakappagari NK, 2000, CANCER RES, V60, P3782; Ghochikyan A, 2009, CNS NEUROL DISORD-DR, V8, P128, DOI 10.2174/187152709787847298; Gritzapis AD, 2006, CANCER RES, V66, P5452, DOI 10.1158/0008-5472.CAN-05-4018; Hung CF, 2007, MOL THER, V15, P1211, DOI 10.1038/sj.mt.6300121; Jager E, 2000, P NATL ACAD SCI USA, V97, P12198, DOI 10.1073/pnas.220413497; Jalali SA, 2012, NANOMED-NANOTECHNOL, V8, P692, DOI 10.1016/j.nano.2011.09.010; Jalali Seyed Amir, 2011, Recent Pat Biotechnol, V5, P108; Kenter GG, 2008, CLIN CANCER RES, V14, P169, DOI 10.1158/1078-0432.CCR-07-1881; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; Kochenderfer JN, 2007, CLIN IMMUNOL, V124, P119, DOI 10.1016/j.clim.2007.04.003; Lai YP, 2011, ISRN IMMUNOLOGY, V2011; Mansourian M, 2014, IMMUNOL LETT, V162, P87, DOI 10.1016/j.imlet.2014.07.008; Meng WJ, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-88; Miconnet I, 2002, J IMMUNOL, V168, P1212, DOI 10.4049/jimmunol.168.3.1212; Morse MA, 2010, INT J CANCER, V126, P2893, DOI 10.1002/ijc.24995; Muranski P, 2009, CURR OPIN IMMUNOL, V21, P200, DOI 10.1016/j.coi.2009.02.004; Nava-Parada P, 2007, CANCER RES, V67, P1326, DOI 10.1158/0008-5472.CAN-06-3290; Pakravan N, 2010, CELL STRESS CHAPERON, V15, P977, DOI 10.1007/s12192-010-0208-8; Park JM, 2005, J IMMUNOL, V174, P4228, DOI 10.4049/jimmunol.174.7.4228; Peoples GE, 2008, CLIN CANCER RES, V14, P797, DOI 10.1158/1078-0432.CCR-07-1448; Perez SA, 2010, CANCER-AM CANCER SOC, V116, P2071, DOI 10.1002/cncr.24988; Renard V, 2003, J IMMUNOL, V171, P1588, DOI 10.4049/jimmunol.171.3.1588; Riemer AB, 2004, J IMMUNOL, V173, P394, DOI 10.4049/jimmunol.173.1.394; Rosa DS, 2004, IMMUNOL LETT, V92, P259, DOI 10.1016/j.imlet.2004.01.006; Rovero S, 2000, J IMMUNOL, V165, P5133, DOI 10.4049/jimmunol.165.9.5133; Salazar LG, 2003, CLIN CANCER RES, V9, P5559; Shargh VH, 2012, VACCINE, V30, P3957, DOI 10.1016/j.vaccine.2012.03.040; Shariat S, 2014, CANCER LETT, V355, P54, DOI 10.1016/j.canlet.2014.09.016; Sotiriadou NN, 2007, CANCER IMMUNOL IMMUN, V56, P601, DOI 10.1007/s00262-006-0213-z; Sundaram R, 2003, VACCINE, V21, P2767, DOI 10.1016/S0264-410X(03)00179-8; Tsang RY, 2012, BRIT J CANCER, V106, P6, DOI 10.1038/bjc.2011.516; Ulrich JT, 2000, J IMMUNOL, V164, P5492, DOI 10.4049/jimmunol.164.10.5492; Vambutas A, 2005, VACCINE, V23, P5271, DOI 10.1016/j.vaccine.2005.04.049; van der Bruggen P, 2002, IMMUNOL REV, V188, P51, DOI 10.1034/j.1600-065X.2002.18806.x; van der Burg SH, 2006, ADV DRUG DELIVER REV, V58, P916, DOI 10.1016/j.addr.2005.11.003; van Poelgeest MIE, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-88; Velders MP, 2001, J IMMUNOL, V166, P5366, DOI 10.4049/jimmunol.166.9.5366; Weber JS, 1999, J IMMUNOTHER, V22, P431, DOI 10.1097/00002371-199909000-00007; Weiner GJ, 1997, P NATL ACAD SCI USA, V94, P10833, DOI 10.1073/pnas.94.20.10833; Wu CY, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-88; Yang B, 1996, J EXP MED, V183, P1545, DOI 10.1084/jem.183.4.1545; Zaks TZ, 1998, CANCER RES, V58, P4902; Zwaveling S, 2002, J IMMUNOL, V169, P350, DOI 10.4049/jimmunol.169.1.350	52	66	68	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142563	10.1371/journal.pone.0142563	http://dx.doi.org/10.1371/journal.pone.0142563			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556756	gold, Green Published, Green Submitted			2022-12-26	WOS:000364430700132
J	Yamada, A; Futagi, M; Fukumoto, E; Saito, K; Yoshizaki, K; Ishikawa, M; Arakaki, M; Hino, R; Sugawara, Y; Ishikawa, M; Naruse, M; Miyazaki, K; Nakamura, T; Fukumoto, S				Yamada, Aya; Futagi, Masaharu; Fukumoto, Emiko; Saito, Kan; Yoshizaki, Keigo; Ishikawa, Masaki; Arakaki, Makiko; Hino, Ryoko; Sugawara, Yu; Ishikawa, Momoko; Naruse, Masahiro; Miyazaki, Kanako; Nakamura, Takashi; Fukumoto, Satoshi			Connexin 43 Is Necessary for Salivary Gland Branching Morphogenesis and FGF10-induced ERK1/2 Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IP3 RECEPTOR/CA2+ CHANNEL; GAP-JUNCTION CHANNELS; OCULODENTODIGITAL DYSPLASIA; DIFFERENTIAL EXPRESSION; GJA1 MUTATIONS; PROLIFERATION; HEMICHANNELS; DYSFUNCTION; PHENOTYPE; GROWTH	Cell-cell interaction via the gap junction regulates cell growth and differentiation, leading to formation of organs of appropriate size and quality. To determine the role of connexin43 in salivary gland development, we analyzed its expression in developing submandibular glands (SMGs). Connexin43 (Cx43) was found to be expressed in salivary gland epithelium. In ex vivo organ cultures of SMGs, addition of the gap junctional inhibitors 18 alpha-glycyrrhetinic acid (18 alpha-GA) and oleamide inhibited SMG branching morphogenesis, suggesting that gap junctional communication contributes to salivary gland development. In Cx43(-/-) salivary glands, submandibular and sublingual gland size was reduced as compared with those from heterozygotes. The expression of Pdgfa, Pdgfb, Fgf7, and Fgf10, which induced branching of SMGs in Cx43(-/-) samples, were not changed as compared with those from heterozygotes. Furthermore, the blocking peptide for the hemichannel and gap junction channel showed inhibition of terminal bud branching. FGF10 induced branching morphogenesis, while it did not rescue the Cx43(-/-) phenotype, thus Cx43 may regulate FGF10 signaling during salivary gland development. FGF10 is expressed in salivary gland mesenchyme and regulates epithelial proliferation, and was shown to induce ERK1/2 phosphorylation in salivary epithelial cells, while ERK1/2 phosphorylation in HSY cells was dramatically inhibited by 18 alpha-GA, a Cx43 peptide or siRNA. On the other hand, PDGF-AA and PDGF-BB separately induced ERK1/2 phosphorylation in primary cultured salivary mesenchymal cells regardless of the presence of 18 alpha-GA. Together, our results suggest that Cx43 regulates FGF10-induced ERK1/2 phosphorylation in salivary epithelium but not in mesenchyme during the process of SMG branching morphogenesis.	[Yamada, Aya; Futagi, Masaharu; Fukumoto, Emiko; Saito, Kan; Arakaki, Makiko; Hino, Ryoko; Sugawara, Yu; Ishikawa, Momoko; Naruse, Masahiro; Nakamura, Takashi; Fukumoto, Satoshi] Tohoku Univ, Grad Sch Dent, Dept Oral Hlth & Dev Sci, Div Pediat Dent, Sendai, Miyagi 9808575, Japan; [Ishikawa, Masaki] Tohoku Univ, Grad Sch Dent, Dept Restorat Dent, Operat Dent, Sendai, Miyagi 9808575, Japan; [Yoshizaki, Keigo; Miyazaki, Kanako] Kyushu Univ, Fac Dent Sci, Div Oral Hlth Growth & Dev, Div Orthodont, Fukuoka 8128582, Japan	Tohoku University; Tohoku University; Kyushu University	Fukumoto, S (corresponding author), Tohoku Univ, Grad Sch Dent, Dept Oral Hlth & Dev Sci, Div Pediat Dent, Sendai, Miyagi 9808575, Japan.	fukumoto@dent.tohoku.ac.jp	Kim, Ji-Youn/A-5779-2017; Nakamura, Takashi/A-8931-2012; Nakamura, Takashi/P-7796-2016; Saito, Kan/AFS-5564-2022; Saito, Kan/AAG-3507-2020	Nakamura, Takashi/0000-0001-9904-1037; Nakamura, Takashi/0000-0001-9904-1037; Saito, Kan/0000-0002-2151-6204; Saito, Kan/0000-0002-2151-6204; Yoshizaki, Keigo/0000-0002-0598-5879; Fukumoto, Satoshi/0000-0002-5046-6891	Ministry of Education, Science, and Culture of Japan [20679006, 26670880]; NEXT [LS010];  [24390460];  [15H05032];  [15K15752];  [24792294]	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; ; 	This work was supported in part by Grants-in-aid from the Ministry of Education, Science, and Culture of Japan (20679006 and 26670880, to S. F.) and the NEXT program (LS010, to S. F.), a Grant-in-Aid for Scientific Research (24390460, to A. Y.), a Grant-in-Aid for Scientific Research (15H05032 and 15K15752, to T. N.), and a Grant-in-Aid for Young Scientists (24792294, to K. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Alexander DB, 2003, CURR MED CHEM, V10, P2045, DOI 10.2174/0929867033456927; Batra N, 2014, J BIOL CHEM, V289, P10582, DOI 10.1074/jbc.M114.550608; Caufield PW, 2012, J DENT RES, V91, P544, DOI 10.1177/0022034512444929; Chaytor AT, 1997, J PHYSIOL-LONDON, V503, P99, DOI 10.1111/j.1469-7793.1997.099bi.x; Chung DJ, 2006, J CELL SCI, V119, P4187, DOI 10.1242/jcs.03162; Cullen PJ, 2002, NAT REV MOL CELL BIO, V3, P339, DOI 10.1038/nrm808; Desplantez T, 2012, PHARMACOL RES, V65, P546, DOI 10.1016/j.phrs.2012.02.002; Dobrowolski R, 2008, HUM MOL GENET, V17, P539, DOI 10.1093/hmg/ddm329; Flenniken AM, 2005, DEVELOPMENT, V132, P4375, DOI 10.1242/dev.02011; Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072; Hashida Y, 2014, BONE, V61, P19, DOI 10.1016/j.bone.2013.12.031; Hoffman MP, 2002, DEVELOPMENT, V129, P5767, DOI 10.1242/dev.00172; Hogan BLM, 1999, CELL, V96, P225, DOI 10.1016/S0092-8674(00)80562-0; Ihara A, 2000, ARCH ORAL BIOL, V45, P227, DOI 10.1016/S0003-9969(99)00128-4; Ishikawa M, 2014, J BIOL CHEM, V289, P2839, DOI 10.1074/jbc.M113.523241; Lecanda F, 2000, J CELL BIOL, V151, P931, DOI 10.1083/jcb.151.4.931; MEDA P, 1993, ENDOCRINOLOGY, V133, P2371, DOI 10.1210/en.133.5.2371; Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635; Mikoshiba K, 2007, BIOCHEM SOC SYMP, V74, P9, DOI 10.1042/BSS2007c02; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Muramatsu T, 1996, J HISTOCHEM CYTOCHEM, V44, P49, DOI 10.1177/44.1.8543782; Nagata K, 2009, J PEDIATR SURG, V44, P2296, DOI 10.1016/j.jpedsurg.2009.07.070; NISWANDER L, 1993, NATURE, V361, P68, DOI 10.1038/361068a0; Patel VN, 2006, DIFFERENTIATION, V74, P349, DOI 10.1111/j.1432-0436.2006.00088.x; Paznekas WA, 2003, AM J HUM GENET, V72, P408, DOI 10.1086/346090; Paznekas WA, 2009, HUM MUTAT, V30, P724, DOI 10.1002/humu.20958; Sakai T, 2003, NATURE, V423, P876, DOI 10.1038/nature01712; Solan JL, 2014, FEBS LETT, V588, P1423, DOI 10.1016/j.febslet.2014.01.049; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Stains JP, 2005, BBA-BIOMEMBRANES, V1719, P69, DOI 10.1016/j.bbamem.2005.10.012; Stains JP, 2005, MOL BIOL CELL, V16, P64, DOI 10.1091/mbc.E04-04-0339; Steinberg Z, 2005, DEVELOPMENT, V132, P1223, DOI 10.1242/dev.01690; Stephen M, 1997, J Indian Soc Pedod Prev Dent, V15, P109; Yamamoto S, 2008, J BIOL CHEM, V283, P23139, DOI 10.1074/jbc.M710308200; Zappitelli T, 2015, MOL BIOL CELL, V26, P832, DOI 10.1091/mbc.E14-06-1136	35	20	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					904	912		10.1074/jbc.M115.674663	http://dx.doi.org/10.1074/jbc.M115.674663			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26565022	hybrid, Green Published			2022-12-26	WOS:000367830500036
J	Das, R; Xu, S; Nguyen, TT; Quan, X; Choi, SK; Kim, SJ; Lee, EY; Cha, SK; Park, KS				Das, Ranjan; Xu, Shanhua; Tuyet Thi Nguyen; Quan, Xianglan; Choi, Seong-Kyung; Kim, Soo-Jin; Lee, Eun Young; Cha, Seung-Kuy; Park, Kyu-Sang			Transforming Growth Factor beta 1-induced Apoptosis in Podocytes via the Extracellular Signal-regulated Kinase-Mammalian Target of Rapamycin Complex 1-NADPH Oxidase 4 Axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TGF-BETA; DIABETIC-NEPHROPATHY; TUBEROUS SCLEROSIS; MTORC1 ACTIVATION; OXIDATIVE STRESS; NADPH OXIDASE; UP-REGULATION; PHOSPHORYLATION; PATHWAY	TGF-beta is a pleiotropic cytokine that accumulates during kidney injuries, resulting in various renal diseases. We have reported previously that TGF-beta 1 induces the selective up-regulation of mitochondrial Nox4, playing critical roles in podocyte apoptosis. Here we investigated the regulatory mechanism of Nox4 up-regulation by mTORC1 activation on TGF-beta 1-induced apoptosis in immortalized podocytes. TGF-beta 1 treatment markedly increased the phosphorylation of mammalian target of rapamycin (mTOR) and its downstream targets p70S6K and 4EBP1. Blocking TGF-beta receptor I with SB431542 completely blunted the phosphorylation of mTOR, p70S6K, and 4EBP1. Transient adenoviral overexpression of mTOR-WT and constitutively active mTOR Delta augmented TGF-beta 1-treated Nox4 expression, reactive oxygen species (ROS) generation, and apoptosis, whereas mTOR kinase-dead suppressed the above changes. In addition, knockdown of mTOR mimicked the effect of mTOR-KD. Inhibition ofmTORC1by low-dose rapamycin or knockdown of p70S6K protected podocytes through attenuation of Nox4 expression and subsequent oxidative stress-induced apoptosis by TGF-beta 1. Pharmacological inhibition of the MEK-ERK cascade, but not the PI3K-Akt-TSC2 pathway, abolished TGF-beta 1-induced mTOR activation. Inhibition of either ERK1/2 or mTORC1 did not reduce the TGF-beta 1-stimulated increase in Nox4 mRNA level but significantly inhibited total Nox4 expression, ROS generation, and apoptosis induced by TGF-beta 1. Moreover, double knockdown of Smad2 and 3 or only Smad4 completely suppressed TGF-beta 1-induced ERK1/2-mTOR activation. Our data suggest that TGF-beta 1 increases translation of Nox4 through the Smad-ERK1/2-mTORC1 axis, which is independent of transcriptional regulation. Activation of this pathway plays a crucial role in ROS generation and mitochondrial dysfunction, leading to podocyte apoptosis. Therefore, inhibition of the ERK1/2-mTORC1 pathway could be a potential therapeutic and preventive target in proteinuric and chronic kidney diseases.	[Das, Ranjan; Xu, Shanhua; Tuyet Thi Nguyen; Quan, Xianglan; Choi, Seong-Kyung; Kim, Soo-Jin; Cha, Seung-Kuy; Park, Kyu-Sang] Yonsei Univ, Wonju Coll Med, Dept Physiol, Inst Lifestyle Med, Wonju 220701, Gangwon Do, South Korea; [Lee, Eun Young] Soonchunhyang Univ, Cheonan Hosp, Dept Internal Med, Cheonan 330721, South Korea	Yonsei University; Soonchunhyang University	Das, R (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Physiol, Wonju 220701, Gangwon Do, South Korea.	ranjan@yonsei.ac.kr; qsang@yonsei.ac.kr	Das, Ranjan/AFQ-6329-2022; DAS, RANJAN/ABE-4002-2021	Das, Ranjan/0000-0002-7951-4121; Lee, Eun Young/0000-0002-4513-9888; Park, Kyu-Sang/0000-0003-0322-9807	National Research Foundation [NRF-2013R1A1A4A01010780]; Yonsei University Future leading Research Initiative [2014-22-0127]	National Research Foundation; Yonsei University Future leading Research Initiative	This work was supported by National Research Foundation (NRF-2013R1A1A4A01010780) and Yonsei University Future leading Research Initiative of 2014 (2014-22-0127). The authors declare that they have no conflicts of interest with the contents of this article.	Abe Y, 2013, AM J PHYSIOL-RENAL, V305, pF1477, DOI 10.1152/ajprenal.00182.2013; Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Bar-Peled L, 2014, TRENDS CELL BIOL, V24, P400, DOI 10.1016/j.tcb.2014.03.003; Bondi CD, 2010, J AM SOC NEPHROL, V21, P93, DOI 10.1681/ASN.2009020146; Bonegio RGB, 2005, J AM SOC NEPHROL, V16, P2063, DOI 10.1681/ASN.2004030180; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Briaud I, 2005, J BIOL CHEM, V280, P2282, DOI 10.1074/jbc.M412179200; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Carriere A, 2011, J BIOL CHEM, V286, P567, DOI 10.1074/jbc.M110.159046; Chiluiza D, 2013, J BIOL CHEM, V288, P18407, DOI 10.1074/jbc.M113.463059; Cutler NS, 1999, MOL CELL ENDOCRINOL, V155, P135, DOI 10.1016/S0303-7207(99)00121-5; Daehn I, 2014, J CLIN INVEST, V124, P1608, DOI 10.1172/JCI71195; Das F, 2013, J BIOL CHEM, V288, P7756, DOI 10.1074/jbc.M113.455782; Das R, 2014, AM J PHYSIOL-RENAL, V306, pF155, DOI 10.1152/ajprenal.00438.2013; Dong JX, 2004, GENE DEV, V18, P2479, DOI 10.1101/gad.1240504; Efeyan A, 2013, BIOCHEM SOC T, V41, P902, DOI 10.1042/BST20130063; Eid AA, 2013, DIABETES, V62, P2935, DOI 10.2337/db12-1504; Eid AA, 2010, J BIOL CHEM, V285, P37503, DOI 10.1074/jbc.M110.136796; Eid AA, 2009, DIABETES, V58, P1201, DOI 10.2337/db08-1536; Gallagher DT, 2009, J BIOL CHEM, V284, P8228, DOI 10.1074/jbc.C800215200; Ghayur A, 2012, AM J PATHOL, V180, P940, DOI 10.1016/j.ajpath.2011.11.023; Godel M, 2011, J CLIN INVEST, V121, P2197, DOI 10.1172/JCI44774; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Inoki K, 2011, J CLIN INVEST, V121, P2181, DOI 10.1172/JCI44771; Ito N, 2011, LAB INVEST, V91, P1584, DOI 10.1038/labinvest.2011.135; Jefferson JA, 2011, AM J KIDNEY DIS, V58, P835, DOI 10.1053/j.ajkd.2011.03.033; Kim JH, 2003, KIDNEY INT, V64, P1715, DOI 10.1046/j.1523-1755.2003.00288.x; Kriz W, 2013, AM J PHYSIOL-RENAL, V304, pF333, DOI 10.1152/ajprenal.00478.2012; Lamming DW, 2013, CELL METAB, V18, P465, DOI 10.1016/j.cmet.2013.08.002; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Lamouille S, 2012, J CELL SCI, V125, P1259, DOI 10.1242/jcs.095299; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Letavernier E, 2007, CLIN J AM SOC NEPHRO, V2, P326, DOI 10.2215/CJN.03751106; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Ma L, 2007, CANCER RES, V67, P7106, DOI 10.1158/0008-5472.CAN-06-4798; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Martin KA, 2002, ADV CANCER RES, V86, P1, DOI 10.1016/S0065-230X(02)86001-8; Mathieson PW, 2012, NAT REV NEPHROL, V8, P52, DOI 10.1038/nrneph.2011.171; Moore SF, 2011, J BIOL CHEM, V286, P24553, DOI 10.1074/jbc.M110.202341; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Park KS, 2008, J BIOL CHEM, V283, P33347, DOI 10.1074/jbc.M806251200; Rangan GK, 2007, NEPHROL DIAL TRANSPL, V22, P2175, DOI 10.1093/ndt/gfm191; Rozen-Zvi B, 2013, AM J PHYSIOL-RENAL, V305, pF485, DOI 10.1152/ajprenal.00215.2013; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schiffer M, 2001, J CLIN INVEST, V108, P807, DOI 10.1172/JCI12367; Sedeek M, 2010, AM J PHYSIOL-RENAL, V299, pF1348, DOI 10.1152/ajprenal.00028.2010; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Simeone DM, 2001, AM J PHYSIOL-CELL PH, V281, pC311, DOI 10.1152/ajpcell.2001.281.1.C311; Tabatabaian F, 2010, J BIOL CHEM, V285, P18991, DOI 10.1074/jbc.M110.111542; Tejada T, 2008, KIDNEY INT, V73, P1385, DOI 10.1038/ki.2008.109; Thakur S, 2015, AM J PATHOL, V185, P2168, DOI 10.1016/j.ajpath.2015.04.014; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Vollenbroker B, 2009, AM J PHYSIOL-RENAL, V296, pF418, DOI 10.1152/ajprenal.90319.2008; Wang D, 2007, BBA-MOL CELL RES, V1773, P1248, DOI 10.1016/j.bbamcr.2006.11.009; Wang ZY, 2009, CELL PHYSIOL BIOCHEM, V24, P619, DOI 10.1159/000257517; Xavier S, 2009, J AM SOC NEPHROL, V20, P2127, DOI 10.1681/ASN.2008070806; Yang Y, 2007, AM J NEPHROL, V27, P495, DOI 10.1159/000106782; Yu LX, 2010, CELL PHYSIOL BIOCHEM, V26, P869, DOI 10.1159/000323996	63	35	41	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30830	30842		10.1074/jbc.M115.703116	http://dx.doi.org/10.1074/jbc.M115.703116			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26565025	hybrid, Green Published			2022-12-26	WOS:000367199000016
J	Mochizuki, S; Nishiyama, R; Inoue, A; Ojima, T				Mochizuki, Shogo; Nishiyama, Ryuji; Inoue, Akira; Ojima, Takao			A Novel Aldo-Keto Reductase, HdRed, from the Pacific Abalone Haliotis discus hannai, Which Reduces Alginate-derived 4-Deoxy-L-erythro-5-hexoseulose Uronic Acid to 2-Keto-3-deoxy-D-gluconate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CDNA CLONING; SULFOLOBUS-SOLFATARICUS; ENZYMATIC-PROPERTIES; APLYSIA-KURODAI; LYASE; SUPERFAMILY; METABOLISM; BACTERIA; GROWTH; OLIGOSACCHARIDES	Abalone feeds on brown seaweeds and digests seaweeds' alginate with alginate lyases (EC 4.2.2.3). However, it has been unclear whether the end product of alginate lyases (i.e. unsaturated monouronate-derived 4-deoxy-L-erythro-5-hexoseulose uronic acid (DEH)) is assimilated by abalone itself, because DEH cannot be metabolized via the Embden-Meyerhof pathway of animals. Under these circumstances, we recently noticed the occurrence of an NADPH-dependent reductase, which reduced DEH to 2-keto-3-deoxy-D-gluconate, in hepatopancreas extract of the pacific abalone Haliotis discus hannai. In the present study, we characterized this enzyme to some extent. The DEH reductase, named HdRed in the present study, could be purified from the acetone-dried powder of hepatopancreas by ammonium sulfate fractionation followed by conventional column chromatographies. HdRed showed a single band of similar to 40 kDa on SDS-PAGE and reduced DEH to 2-keto-3-deoxy-D-gluconate with an optimal temperature and pH at around 50 degrees C and 7.0, respectively. HdRed exhibited no appreciable activity toward 28 authentic compounds, including aldehyde, aldose, ketose, alpha-keto-acid, uronic acid, deoxy sugar, sugar alcohol, carboxylic acid, ketone, and ester. The amino acid sequence of 371 residues of HdRed deduced from the cDNA showed 18-60% identities to those of aldo-keto reductase (AKR) superfamily enzymes, such as human aldose reductase, halophilic bacterium reductase, and sea hare norsolorinic acid (a polyketide derivative) reductase-like protein. Catalytic residues and cofactor binding residues known in AKR superfamily enzymes were fairly well conserved in HdRed. Phylogenetic analysis for HdRed and AKR superfamily enzymes indicated that HdRed is an AKR belonging to a novel family.	[Mochizuki, Shogo; Nishiyama, Ryuji; Inoue, Akira; Ojima, Takao] Hokkaido Univ, Fac Fisheries Sci, Lab Marine Biotechnol & Microbiol, Hakodate, Hokkaido 0418611, Japan	Hokkaido University	Ojima, T (corresponding author), Hokkaido Univ, Fac Fisheries Sci, Hakodate, Hokkaido 0418611, Japan.	ojima@fish.hokudai.ac.jp			Program for Constructing "Tohoku Marine Science Bases" - Ministry of Education, Culture, Sports, Science, and Technology, Japan; Regional Innovation Cluster Program "Universal Marine Industry for Green Innovation" - Ministry of Education, Culture, Sports, Science, and Technology, Japan	Program for Constructing "Tohoku Marine Science Bases" - Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Regional Innovation Cluster Program "Universal Marine Industry for Green Innovation" - Ministry of Education, Culture, Sports, Science, and Technology, Japan	This work was supported by the Program for Constructing "Tohoku Marine Science Bases" and the Regional Innovation Cluster Program "Universal Marine Industry for Green Innovation" supported by the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The authors declare that they have no conflicts of interest with the contents of this article.	AKIYAMA H, 1992, BIOSCI BIOTECH BIOCH, V56, P355, DOI 10.1271/bbb.56.355; Buchanan CL, 1999, BIOCHEM J, V343, P563, DOI 10.1042/0264-6021:3430563; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; ELKABBANI O, 1994, ACTA CRYSTALLOGR D, V50, P859, DOI 10.1107/S0907444994005275; Enquist-Newman M, 2014, NATURE, V505, P239, DOI 10.1038/nature12771; Erasmus JH, 1997, AQUACULTURE, V155, P377, DOI 10.1016/S0044-8486(97)00112-9; GACESA P, 1992, INT J BIOCHEM, V24, P545, DOI 10.1016/0020-711X(92)90325-U; GACESA P, 1988, CARBOHYD POLYM, V8, P161, DOI 10.1016/0144-8617(88)90001-X; GORNALL AG, 1949, J BIOL CHEM, V177, P751; HARA S, 1988, ANAL CHIM ACTA, V215, P267, DOI 10.1016/S0003-2670(00)85285-X; Hata M, 2009, FISHERIES SCI, V75, P755, DOI 10.1007/s12562-009-0079-z; HAUG A, 1967, ACTA CHEM SCAND, V21, P691, DOI 10.3891/acta.chem.scand.21-0691; Inoue A, 2014, MAR DRUGS, V12, P4693, DOI 10.3390/md12084693; Jez JM, 1997, BIOCHEM J, V326, P625, DOI 10.1042/bj3260625; Jez JM, 1997, BIOCHEM PHARMACOL, V54, P639, DOI 10.1016/S0006-2952(97)84253-0; Johnston D, 2005, AQUACULTURE, V250, P341, DOI 10.1016/j.aquaculture.2005.03.012; Kavanagh KL, 2002, BIOCHEMISTRY-US, V41, P8785, DOI 10.1021/bi025786n; Kawada A, 1999, ARCH DERMATOL RES, V291, P542, DOI 10.1007/s004030050451; Kozma E, 2002, J BIOL CHEM, V277, P16285, DOI 10.1074/jbc.M110808200; Kumagai Y, 2013, COMP BIOCHEM PHYS B, V164, P80, DOI 10.1016/j.cbpb.2012.11.001; Kumagai Y, 2009, COMP BIOCHEM PHYS B, V154, P113, DOI 10.1016/j.cbpb.2009.05.005; Lamble HJ, 2003, J BIOL CHEM, V278, P34066, DOI 10.1074/jbc.M305818200; LANNING MC, 1951, J BIOL CHEM, V189, P109; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAI KS, 1995, AQUACULTURE, V134, P65, DOI 10.1016/0044-8486(95)00043-2; Ootsuka S, 2006, J BIOTECHNOL, V125, P269, DOI 10.1016/j.jbiotec.2006.03.008; Penning TM, 2015, CHEM-BIOL INTERACT, V234, P236, DOI 10.1016/j.cbi.2014.09.024; Persson B, 2013, CHEM-BIOL INTERACT, V202, P111, DOI 10.1016/j.cbi.2012.11.009; PORZIO MA, 1977, BIOCHIM BIOPHYS ACTA, V490, P27, DOI 10.1016/0005-2795(77)90102-7; PREISS J, 1962, J BIOL CHEM, V237, P309; PREISS J, 1962, J BIOL CHEM, V237, P317; Rahman MM, 2011, BIOCHIMIE, V93, P1720, DOI 10.1016/j.biochi.2011.06.004; Rahman MM, 2010, COMP BIOCHEM PHYS B, V157, P317, DOI 10.1016/j.cbpb.2010.07.006; Sawabe T, 2003, AQUACULTURE, V219, P671, DOI 10.1016/S0044-8486(02)00618-X; Shimizu E, 2003, CARBOHYD RES, V338, P2841, DOI 10.1016/j.carres.2003.08.009; Suzuki H, 2006, CARBOHYD RES, V341, P1809, DOI 10.1016/j.carres.2006.04.032; Suzuki K, 2003, EUR J BIOCHEM, V270, P771, DOI 10.1046/j.1432-1033.2003.03443.x; Takami H, 1998, J SHELLFISH RES, V17, P723; Takase R, 2014, J BIOL CHEM, V289, P33198, DOI 10.1074/jbc.M114.585661; Takase R, 2010, BBA-PROTEINS PROTEOM, V1804, P1925, DOI 10.1016/j.bbapap.2010.05.010; Takeda H, 2011, ENERG ENVIRON SCI, V4, P2575, DOI 10.1039/c1ee01236c; TOMODA Y, 1994, BIOSCI BIOTECH BIOCH, V58, P202, DOI 10.1271/bbb.58.202; Wargacki AJ, 2012, SCIENCE, V335, P308, DOI 10.1126/science.1214547; Wong TY, 2000, ANNU REV MICROBIOL, V54, P289, DOI 10.1146/annurev.micro.54.1.289; Xu X, 2003, BIOSCI BIOTECH BIOCH, V67, P2022, DOI 10.1271/bbb.67.2022	45	14	17	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30962	30974		10.1074/jbc.M115.686725	http://dx.doi.org/10.1074/jbc.M115.686725			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26555267	Green Published, hybrid			2022-12-26	WOS:000367199000027
J	Nakajima-Koyama, M; Lee, J; Ohta, S; Yamamoto, T; Nishida, E				Nakajima-Koyama, May; Lee, Joonseong; Ohta, Sho; Yamamoto, Takuya; Nishida, Eisuke			Induction of Pluripotency in Astrocytes through a Neural Stem Cell-like State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE FIBROBLASTS; SELF-RENEWAL; IPS CELLS; HIPPOCAMPAL NEUROGENESIS; REPROGRAMMING FACTORS; TRANSCRIPTION FACTORS; SOMATIC-CELLS; C-MYC; EXPRESSION; GENERATION	It remains controversial whether the routes from somatic cells to induced pluripotent stem cells (iPSCs) are related to the reverse order of normal developmental processes. Specifically, it remains unaddressed whether or not the differentiated cells become iPSCs through their original tissue stem cell-like state. Previous studies analyzing the reprogramming process mostly used fibroblasts; however, the stem cell characteristics of fibroblasts made it difficult to address this. Here, we generated iPSCs from mouse astrocytes, a type of glial cells, by three (OCT3/4, KI,F4, and SOX2), two (OCT3/4 and KLF4), or four (OCT3/4, KLF, and SOX2 plus c-MYC) factors. Sox1, a neural stein cell (NSC)-specific transcription factor, is transiently up-regulated during reprogramming, and Sox1-positive cells become iPSCs. The up-regulation of Sox1 is essential for OCT3/4- and KLF4-induced reprogramming. Genome-wide analysis revealed that the gene expression profile of Sox1-expressing intermediate-state cells resembles that of NSCs. Furthermore, the intermediate-state cells are able to generate neurospheres, which can differentiate into both neurons and glial cells. Remarkably, during fibroblast reprogramming, neither Sox1 up-regulation nor an increase in neurogenic potential occurs. Our results thus demonstrate that astrocytes are reprogrammed through an NSC-like state.	[Nakajima-Koyama, May; Lee, Joonseong; Ohta, Sho; Nishida, Eisuke] Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan; [Ohta, Sho; Yamamoto, Takuya] Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Reprogramming Sci, Sakyo Ku, Kyoto 6068507, Japan; [Ohta, Sho; Yamamoto, Takuya] Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Sakyo Ku, Kyoto 6068507, Japan; [Nakajima-Koyama, May; Yamamoto, Takuya; Nishida, Eisuke] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1020075, Japan	Kyoto University; Kyoto University; Kyoto University; Japan Science & Technology Agency (JST)	Nishida, E (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan.	nishida@lif.kyoto-u.ac.jp	Yamamoto, Takuya/H-2792-2017	Yamamoto, Takuya/0000-0002-0022-3947	Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japanese Government (Ministry of Education, Culture, Sports, Science and Technology) Scholarship Program; iPS Cell Research Fund	Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Government (Ministry of Education, Culture, Sports, Science and Technology) Scholarship Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); iPS Cell Research Fund	This work was supported in part by grants from Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency, and from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to E. N.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Japanese Government (Ministry of Education, Culture, Sports, Science and Technology) Scholarship Program.; Supported by the iPS Cell Research Fund.	Aubert J, 2003, P NATL ACAD SCI USA, V100, P11836, DOI 10.1073/pnas.1734197100; Bergsland M, 2011, GENE DEV, V25, P2453, DOI 10.1101/gad.176008.111; Buganim Y, 2013, NAT REV GENET, V14, P427, DOI 10.1038/nrg3473; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Chen TT, 2010, STEM CELLS, V28, P1315, DOI 10.1002/stem.456; Efe JA, 2011, NAT CELL BIOL, V13, P215, DOI 10.1038/ncb2164; Eminli S, 2008, STEM CELLS, V26, P2467, DOI 10.1634/stemcells.2008-0317; Golipour A, 2012, CELL STEM CELL, V11, P769, DOI 10.1016/j.stem.2012.11.008; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197; Imura T, 2006, GLIA, V53, P277, DOI 10.1002/glia.20281; Imura T, 2003, J NEUROSCI, V23, P2824; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Koga M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4197; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li T, 2015, MOL NEUROBIOL, V51, P142, DOI 10.1007/s12035-014-8734-5; Matsui T, 2012, STEM CELLS, V30, P1109, DOI 10.1002/stem.1091; Matsumata M, 2012, STEM CELLS, V30, P1532, DOI 10.1002/stem.1124; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Noguchi H, 2015, CELL DEATH DIFFER, V22, P145, DOI 10.1038/cdd.2014.132; O'Malley J, 2013, NATURE, V499, P88, DOI 10.1038/nature12243; Okada Y, 2008, STEM CELLS, V26, P3086, DOI 10.1634/stemcells.2008-0293; Okamoto K, 2006, GENES CELLS, V11, P177, DOI 10.1111/j.1365-2443.2006.00927.x; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pereira JD, 2010, P NATL ACAD SCI USA, V107, P15957, DOI 10.1073/pnas.1002530107; Pevny LH, 1998, DEVELOPMENT, V125, P1967; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Raverot G, 2005, DEV BIOL, V283, P215, DOI 10.1016/j.ydbio.2005.04.013; Ruiz S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015526; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Smith ZD, 2010, NAT BIOTECHNOL, V28, P521, DOI 10.1038/nbt.1632; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takahashi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4678; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; Tian CH, 2011, PROTEIN CELL, V2, P128, DOI 10.1007/s13238-011-1012-7; Wang Y, 2013, DEV DYNAM, V242, P638, DOI 10.1002/dvdy.23962; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1; Yagi H, 2012, J BIOL CHEM, V287, P24356, DOI 10.1074/jbc.M112.365643; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhang RR, 2013, CELL STEM CELL, V13, P237, DOI 10.1016/j.stem.2013.05.006	55	11	11	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					31173	31188		10.1074/jbc.M115.683466	http://dx.doi.org/10.1074/jbc.M115.683466			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26553868	hybrid, Green Published			2022-12-26	WOS:000367199000044
J	Abu Choudhury, M; Lott, WB; Banu, S; Cheng, AY; Teo, YY; Ong, RTH; Aaskov, J				Abu Choudhury, Md; Lott, William B.; Banu, Shahera; Cheng, Anthony Youzhi; Teo, Yik-Ying; Ong, Rick Twee-Hee; Aaskov, John			Nature and Extent of Genetic Diversity of Dengue Viruses Determined by 454 Pyrosequencing	PLOS ONE			English	Article							GENERATION SEQUENCING DATA; ERROR-CORRECTION; RAPID EVOLUTION; RNA VIRUSES; POPULATION; FITNESS; EXTINCTION; EMERGENCE; INFECTION; MOSQUITOS	Dengue virus (DENV) populations are characteristically highly diverse. Regular lineage extinction and replacement is an important dynamic DENV feature, and most DENV lineage turnover events are associated with increased incidence of disease. The role of genetic diversity in DENV lineage extinctions is not understood. We investigated the nature and extent of genetic diversity in the envelope (E) gene of DENV serotype 1 representing different lineages histories. A region of the DENV genome spanning the E gene was amplified and sequenced by Roche/454 pyrosequencing. The pyrosequencing results identified distinct sub-populations (haplotypes) for each DENV-1 E gene. A phylogenetic tree was constructed with the consensus DENV-1 E gene nucleotide sequences, and the sequences of each constructed haplotype showed that the haplotypes segregated with the Sanger consensus sequence of the population from which they were drawn. Haplotypes determined through pyrosequencing identified a recombinant DENV genome that could not be identified through Sanger sequencing. Nucleotide level sequence diversities of DENV-1 populations determined from SNP analysis were very low, estimated from 0.009-0.01. There were also no stop codon, frameshift or non-frameshift mutations observed in the E genes of any lineage. No significant correlations between the accumulation of deleterious mutations or increasing genetic diversity and lineage extinction were observed (p>0.5). Although our hypothesis that accumulation of deleterious mutations over time led to the extinction and replacement of DENV lineages was ultimately not supported by the data, our data does highlight the significant technical issues that must be resolved in the way in which population diversity is measured for DENV and other viruses. The results provide an insight into the within-population genetic structure and diversity of DENV-1 populations.	[Abu Choudhury, Md] Griffith Univ, Menzies Hlth Inst Queensland, Brisbane, Qld 4111, Australia; [Abu Choudhury, Md; Lott, William B.; Banu, Shahera; Aaskov, John] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Lott, William B.] Queensland Univ Technol, Fac Sci & Engn, Sch Chem Phys & Mech Engn, Brisbane, Qld 4001, Australia; [Cheng, Anthony Youzhi; Teo, Yik-Ying; Ong, Rick Twee-Hee] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Teo, Yik-Ying] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Teo, Yik-Ying] Natl Univ Singapore, Inst Life Sci, Singapore 117548, Singapore; [Teo, Yik-Ying] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore, Singapore	Griffith University; Menzies Health Institute Queensland; Queensland University of Technology (QUT); Queensland University of Technology (QUT); National University of Singapore; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Abu Choudhury, M (corresponding author), Griffith Univ, Menzies Hlth Inst Queensland, Brisbane, Qld 4111, Australia.	nahid.choudhury@griffith.edu.au	Choudhury/T-2659-2019	Choudhury, Nahid/0000-0002-6527-4876	National Health and Medical Research Council of Australia [497203]; QUT Postgraduate Research Scholarships; Queensland University of Technology; Cook Estate; QUT Postgraduate Research Award, Queensland University of Technology, Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); QUT Postgraduate Research Scholarships; Queensland University of Technology; Cook Estate; QUT Postgraduate Research Award, Queensland University of Technology, Australia	The work was supported by National Health and Medical Research Council of Australia, under grant 497203, Cook Estate and QUT Postgraduate Research Scholarships, Queensland University of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work was supported by QUT Postgraduate Research Award, Queensland University of Technology, Australia. The authors sincerely thank Dr. Francesca Frentiu for their valuable comments on previous version of this manuscript.	Aaskov J, 2006, SCIENCE, V311, P236, DOI 10.1126/science.1115030; Abu Choudhury M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107264; Andrews S, FASTQC A QUALITY CON; Astrovskaya I, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S6-S1; Bull RA, 2012, J VIROL, V86, P3219, DOI 10.1128/JVI.06712-11; Bull RA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002243; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; Chao DY, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-72; Coffey LL, 2011, P NATL ACAD SCI USA, V108, P16038, DOI 10.1073/pnas.1111650108; Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151; DOMINGO E, 1976, GENE, V1, P3, DOI 10.1016/0378-1119(76)90003-2; Domingo Esteban, 1994, P161; Droege M, 2008, J BIOTECHNOL, V136, P3, DOI 10.1016/j.jbiotec.2008.03.021; DUARTE EA, 1994, J VIROL, V68, P4295, DOI 10.1128/JVI.68.7.4295-4301.1994; Eigen M, 2002, P NATL ACAD SCI USA, V99, P13374, DOI 10.1073/pnas.212514799; Eriksson N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000074; HOLLAND J, 1982, SCIENCE, V215, P1577, DOI 10.1126/science.7041255; Holland JJ, 1992, RNA VIRUS POPULATION, P1; Holmes EC, 2000, TRENDS MICROBIOL, V8, P74, DOI 10.1016/S0966-842X(99)01669-8; Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08; Li DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019447; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; Macalalad AR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002417; OhAinle M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003084; Parameswaran P, 2012, J VIROL, V86, P8546, DOI 10.1128/JVI.00736-12; Pfeiffer JK, 2005, PLOS PATHOG, V1, P102, DOI 10.1371/journal.ppat.0010011; Poh WT, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-355; Rice CM., 1986, TOGAVIRIDAE FLAVIVIR, P279, DOI 10.1007/978-1-4757-0785-4_10; Romano CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070318; STEINHAUER DA, 1987, ANNU REV MICROBIOL, V41, P409, DOI 10.1146/annurev.mi.41.100187.002205; Thai KTD, 2012, J VIROL, V86, P835, DOI 10.1128/JVI.05985-11; Thu HM, 2005, VIROLOGY, V336, P163, DOI 10.1016/j.virol.2005.03.018; Thu HM, 2004, EMERG INFECT DIS, V10, P593, DOI 10.3201/eid1004.030216; Twiddy SS, 2003, INFECT GENET EVOL, V3, P87, DOI 10.1016/S1567-1348(02)00153-3; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Wang WK, 2002, VIROLOGY, V303, P181, DOI 10.1006/viro.2002.1635; Wang WK, 2002, J VIROL, V76, P4662, DOI 10.1128/JVI.76.9.4662-4665.2002; Wilm A, 2012, NUCLEIC ACIDS RES, V40, P11189, DOI 10.1093/nar/gks918; Wittke V, 2002, VIROLOGY, V301, P148, DOI 10.1006/viro.2002.1549; Worobey M, 1999, P NATL ACAD SCI USA, V96, P7352, DOI 10.1073/pnas.96.13.7352; Zagordi O, 2012, RESEARCH IN COMPUTAT; Zagordi O, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-119; Zagordi O, 2010, NUCLEIC ACIDS RES, V38, P7400, DOI 10.1093/nar/gkq655; Zagordi O, 2010, J COMPUT BIOL, V17, P417, DOI 10.1089/cmb.2009.0164; Zhang CL, 2006, J GEN VIROL, V87, P873, DOI 10.1099/vir.0.81486-0	46	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142473	10.1371/journal.pone.0142473	http://dx.doi.org/10.1371/journal.pone.0142473			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26566128	Green Published, gold, Green Submitted			2022-12-26	WOS:000367628500026
J	Hoy, YE; Bik, EM; Lawley, TD; Holmes, SP; Monack, DM; Theriot, JA; Relman, DA				Hoy, Yana Emmy; Bik, Elisabeth M.; Lawley, Trevor D.; Holmes, Susan P.; Monack, Denise M.; Theriot, Julie A.; Relman, David A.			Variation in Taxonomic Composition of the Fecal Microbiota in an Inbred Mouse Strain across Individuals and Time	PLOS ONE			English	Article							PATHOGEN-FREE MICE; GUT MICROBIOTA; INTESTINAL MICROBIOTA; HOST GENETICS; FLORA; BACTERIA; MICROFLORA; EXPRESSION; STABILITY; PROFILES	Genetics, diet, and other environmental exposures are thought to be major factors in the development and composition of the intestinal microbiota of animals. However, the relative contributions of these factors in adult animals, as well as variation with time in a variety of important settings, are still not fully understood. We studied a population of inbred, female mice fed the same diet and housed under the same conditions. We collected fecal samples from 46 individual mice over two weeks, sampling four of these mice for periods as long as 236 days for a total of 190 samples, and determined the phylogenetic composition of their microbial communities after analyzing 1,849,990 high-quality pyrosequencing reads of the 16S rRNA gene V3 region. Even under these controlled conditions, we found significant inter-individual variation in community composition, as well as variation within an individual over time, including increases in alpha diversity during the first 2 months of co-habitation. Some variation was explained by mouse membership in different cage and vendor shipment groups. The differences among individual mice from the same shipment group and cage were still significant. Overall, we found that 23% of the variation in intestinal microbiota composition was explained by changes within the fecal microbiota of a mouse over time, 12% was explained by persistent differences among individual mice, 14% by cage, and 18% by shipment group. Our findings suggest that the microbiota of controlled populations of inbred laboratory animals may not be as uniform as previously thought, that animal rearing and handling may account for some variation, and that as yet unidentified factors may explain additional components of variation in the composition of the microbiota within populations and individuals over time. These findings have implications for the design and interpretation of experiments involving laboratory animals.	[Hoy, Yana Emmy; Bik, Elisabeth M.; Lawley, Trevor D.; Monack, Denise M.; Theriot, Julie A.; Relman, David A.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Holmes, Susan P.] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Theriot, Julie A.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Theriot, Julie A.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Relman, David A.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Relman, David A.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Relman, DA (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	relman@stanford.edu	Theriot, Julie/HHN-2034-2022	Relman, David A./0000-0001-8331-1354; Holmes, Susan/0000-0002-2208-8168; Theriot, Julie/0000-0002-2334-2535	National Institutes of Health [DP1OD000964]; Thomas C. and Joan M. Merigan Endowment at Stanford University; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107615] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000964] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thomas C. and Joan M. Merigan Endowment at Stanford University; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health [DP1OD000964 to D.A.R.], by the Thomas C. and Joan M. Merigan Endowment at Stanford University [D.A.R.], and by the Howard Hughes Medical Institute [J.A.T.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AD, 2006, MAMM GENOME, V17, P1093, DOI 10.1007/s00335-006-0063-1; Alpert C, 2008, CURR ISSUES MOL BIOL, V10, P17; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Buhnik-Rosenblau K, 2011, APPL ENVIRON MICROB, V77, P6531, DOI 10.1128/AEM.00324-11; Campbell JH, 2012, ISME J, V6, P2033, DOI 10.1038/ismej.2012.54; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Clayton TA, 2006, NATURE, V440, P1073, DOI 10.1038/nature04648; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dewhirst FE, 1999, APPL ENVIRON MICROB, V65, P3287; Dollive S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071806; Duran-Pinedo AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028438; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Frese SA, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0091-8; Friswell MK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008584; Fujiwara R, 2008, BJN, V99, P1; Hildebrand F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r4; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; HIRAYAMA K, 1990, EXP ANIM TOKYO, V39, P263, DOI 10.1538/expanim1978.39.2_263; Hufeldt MR, 2010, LAB ANIM-UK, V44, P283, DOI 10.1258/la.2010.010058; Hufeldt MR, 2010, COMPARATIVE MED, V60, P336; Jussi V, 2005, ANTON LEEUW INT J G, V88, P67, DOI 10.1007/s10482-004-7837-9; Kovacs A, 2011, MICROB ECOL, V61, P423, DOI 10.1007/s00248-010-9787-2; Lawley TD, 2008, INFECT IMMUN, V76, P403, DOI 10.1128/IAI.01189-07; Leamy LJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0552-6; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Li HK, 2007, J PROTEOME RES, V6, P1364, DOI 10.1021/pr060513q; Loh G, 2008, ENVIRON MICROBIOL, V10, P709, DOI 10.1111/j.1462-2920.2007.01493.x; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; McCafferty J, 2013, ISME J, V7, P2116, DOI 10.1038/ismej.2013.106; McKnite AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039191; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Orcutt R.P., 1987, MICROECOL THER, V17; OROURKE J, 1988, LAB ANIM-UK, V22, P297, DOI 10.1258/002367788780746142; Rogers GB, 2014, SCI REP-UK, V4, DOI 10.1038/srep05437; Saric J, 2008, J PROTEOME RES, V7, P352, DOI 10.1021/pr070340k; Sarma-Rupavtarm RB, 2004, APPL ENVIRON MICROB, V70, P2791, DOI 10.1128/AEM.70.5.2791-2800.2004; SCHAEDLER RW, 1965, J EXP MED, V122, P59, DOI 10.1084/jem.122.1.59; SCHAEDLER RW, 1965, J EXP MED, V122, P77, DOI 10.1084/jem.122.1.77; Schloss PD, 2012, GUT MICROBES, V3, P383, DOI 10.4161/gmic.21008; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Shade A, 2013, ISME J, V7, P1493, DOI 10.1038/ismej.2013.54; Smith P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030273; STARK PL, 1982, J MED MICROBIOL, V15, P189, DOI 10.1099/00222615-15-2-189; Staubach F, 2012, ISME J, V6, P1345, DOI 10.1038/ismej.2011.204; Stecher B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000711; Stewart JA, 2005, J MED MICROBIOL, V54, P1239, DOI 10.1099/jmm.0.46189-0; Thompson CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010335; Tims S, 2013, ISME J, V7, P707, DOI 10.1038/ismej.2012.146; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vaahtovuo J, 2001, ANTON LEEUW INT J G, V80, P35, DOI 10.1023/A:1012058107731; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Zeng BH, 2013, CURR MICROBIOL, V67, P313, DOI 10.1007/s00284-013-0360-3; Zeng BH, 2012, EXP ANIM TOKYO, V61, P453, DOI 10.1538/expanim.61.453; Zhang CH, 2012, ISME J, V6, P1848, DOI 10.1038/ismej.2012.27; Zhang CH, 2010, ISME J, V4, P232, DOI 10.1038/ismej.2009.112; Zoetendal EG, 2001, MICROBIAL ECOLOGY HL, P1	62	52	52	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142825	10.1371/journal.pone.0142825	http://dx.doi.org/10.1371/journal.pone.0142825			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26565698	Green Published, gold, Green Submitted			2022-12-26	WOS:000367628500058
J	Jobson, MA; Hogan, SL; Maxwell, CS; Hu, YC; Hladik, GA; Falk, RJ; Beuhler, MC; Pendergraft, WF				Jobson, Meghan A.; Hogan, Susan L.; Maxwell, Colin S.; Hu, Yichun; Hladik, Gerald A.; Falk, Ronald J.; Beuhler, Michael C.; Pendergraft, William F., III			Clinical Features of Reported Ethylene Glycol Exposures in the United States	PLOS ONE			English	Article							BITTERING AGENTS; DENATONIUM BENZOATE; INGESTIONS; FATALITIES; FOMEPIZOLE; METHANOL; IMPACT	Background Ethylene glycol is highly toxic and represents an important cause of poisonings worldwide. Toxicity can result in central nervous system dysfunction, cardiovascular compromise, elevated anion gap metabolic acidosis and acute kidney injury. Many states have passed laws requiring addition of the bittering agent, denatonium benzoate, to ethylene glycol solutions to reduce severity of exposures. The objectives of this study were to identify differences between unintentional and intentional exposures and to evaluate the utility of denatonium benzoate as a deterrent. Methods and Findings Using the National Poison Data System, we performed a retrospective analysis of reported cases of ethylene glycol exposures from January 2006 to December 2013. Outcome classification was summed for intentionality and used as a basis for comparison of effect groups. There were 45,097 cases of ethylene glycol exposures resulting in 154 deaths. Individuals more likely to experience major effects or death were older, male, and presented with more severe symptoms requiring higher levels of care. Latitude and season did not correlate with increased exposures; however, there were more exposures in rural areas. Denatonium benzoate use appeared to have no effect on exposure severity or number. Conclusion Deaths due to ethylene glycol exposure were uncommon; however, there were major clinical effects and more exposures in rural areas. Addition of denatonium benzoate was not associated with a reduction in exposures. Alternative means to deter ingestion are needed. These findings suggest the need to consider replacing ethylene glycol with alternative and less toxic agents.	[Jobson, Meghan A.; Hogan, Susan L.; Hu, Yichun; Hladik, Gerald A.; Falk, Ronald J.; Pendergraft, William F., III] Univ N Carolina, Sch Med, Chapel Hill, NC 27514 USA; [Jobson, Meghan A.; Hogan, Susan L.; Hu, Yichun; Hladik, Gerald A.; Falk, Ronald J.; Pendergraft, William F., III] UNC Kidney Ctr, Div Nephrol & Hypertens, Dept Med, Chapel Hill, NC USA; [Maxwell, Colin S.] Duke Univ, Dept Biol, Duke Ctr Syst Biol, Durham, NC USA; [Beuhler, Michael C.] Carolinas Med Ctr, Carolinas Poison Ctr, Charlotte, NC 28203 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Duke University; Carolinas Medical Center	Pendergraft, WF (corresponding author), Univ N Carolina, Sch Med, Chapel Hill, NC 27514 USA.	wfp3@med.unc.edu		Maxwell, Colin/0000-0002-8756-6255				Alkahtani S, 2010, ARCH DIS CHILD, V95, P1062, DOI 10.1136/adc.2010.183392; [Anonymous], 2011, NAT HIST GEOGR INF S; [Anonymous], 2013, PROCESSING MAGA 0808; BAUD FJ, 1988, NEW ENGL J MED, V319, P97, DOI 10.1056/NEJM198807143190206; BERMAN LB, 1957, ANN INTERN MED, V46, P611, DOI 10.7326/0003-4819-46-3-611; Berning C K, 1982, Fundam Appl Toxicol, V2, P44, DOI 10.1016/S0272-0590(82)80063-8; Beuhler MC, 2011, CLIN TOXICOL, V49, P684, DOI 10.3109/15563650.2011.598530; Brent J, 1999, NEW ENGL J MED, V340, P832, DOI 10.1056/NEJM199903183401102; Brent J, 2001, DRUGS, V61, P979, DOI 10.2165/00003495-200161070-00006; Brent J, 2009, NEW ENGL J MED, V360, P2216, DOI 10.1056/NEJMct0806112; Bronstein AC, 2012, CLIN TOXICOL, V50, P911, DOI 10.3109/15563650.2012.746424; Caravati EM, 2005, CLIN TOXICOL, V43, P327, DOI 10.1080/07313820500184971; Carr BG, 2012, J TRAUMA ACUTE CARE, V73, P1006, DOI 10.1097/TA.0b013e318265d10a; Cavender FL, 1994, PATTYS IND HYGIENE T, P4645; Chinn H, 2013, MONO DI TRIETHYLENE; Consumer Safety Product Association, MAK ANT ENG COOL UNP; Coulter CV, 2011, CLIN TOXICOL, V49, P900, DOI 10.3109/15563650.2011.630320; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; Fleegler EW, 2013, JAMA INTERN MED, V173, DOI [10.1001/jamainternmed.2013.9957, 10.1001/jamainternmed.2013.1286]; Fontanella CA, 2015, JAMA PEDIATR, V169, P466, DOI 10.1001/jamapediatrics.2014.3561; Ghannoum M, 2014, SEMIN DIALYSIS, V27, P1; Guinness World Records, 2013, GUINN WORLD REC 2013; HAGGERTY RJ, 1959, NEW ENGL J MED, V261, P1296, DOI 10.1056/NEJM195912172612514; Hoffinan RS, 2007, CLIN TOXICOL, V45, P943, DOI 10.1080/15563650701233370; Hudgens RD, 2007, EVALUATION GLYCERIN, DOI [10.4271/2007-01-4000, DOI 10.4271/2007-01-4000]; JACKSON MH, 1995, VET HUM TOXICOL, V37, P323; KAHN HS, 1950, ANN INTERN MED, V32, P284, DOI 10.7326/0003-4819-32-2-284; KLEINSCHWARTZ W, 1991, VET HUM TOXICOL, V33, P545; Levy A, 2007, CLIN TOXICOL, V45, P946, DOI 10.1080/15563650701197096; Lung DD, 2015, J INTENSIVE CARE MED, V30, P270, DOI 10.1177/0885066613516594; Mullins ME, 2004, VET HUM TOXICOL, V46, P150; PETERSON CD, 1981, NEW ENGL J MED, V304, P21, DOI 10.1056/NEJM198101013040105; Porter WH, 2001, J TOXICOL-CLIN TOXIC, V39, P607, DOI 10.1081/CLT-100108493; Sasser H, 2008, J MED TOXICOL, V4, P77, DOI 10.1007/BF03160959; SIBERT JR, 1991, ARCH EMERG MED, V8, P1; SIBERT JR, 1977, LANCET, V2, P289; Synder JP, 2011, 1395 US DEP INT US G, P1; WACKER WEC, 1965, J AMER MED ASSOC, V194, P1231, DOI 10.1001/jama.194.11.1231; WAX PM, 1995, ANN INTERN MED, V122, P456, DOI 10.7326/0003-4819-122-6-199503150-00009; White NC, 2008, CLIN TOXICOL, V46, P507, DOI 10.1080/15563650802119700; White NC, 2009, CLIN PEDIATR, V48, P913, DOI 10.1177/0009922809339522; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Wurtz A., 1856, COMPTES RENDUS, V43, P199	43	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0143044	10.1371/journal.pone.0143044	http://dx.doi.org/10.1371/journal.pone.0143044			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26566024	Green Published, gold, Green Submitted			2022-12-26	WOS:000367628500088
J	Shariq, M; Kumar, N; Kumari, R; Kumar, A; Subbarao, N; Mukhopadhyay, G				Shariq, Mohd; Kumar, Navin; Kumari, Rajesh; Kumar, Amarjeet; Subbarao, Naidu; Mukhopadhyay, Gauranga			Biochemical Analysis of CagE: A VirB4 Homologue of Helicobacter pylori Cag-T4SS	PLOS ONE			English	Article							IV SECRETION SYSTEM; AGROBACTERIUM-TUMEFACIENS; BACTERIAL CONJUGATION; COUPLING PROTEIN; PLASMID R388; C-TERMINUS; ATPASE; SEQUENCE; PATHOGENICITY; TRANSLOCATION	Helicobacter pylori are among the most successful human pathogens that harbour a distinct genomic segment called cag Pathogenicity Island (cag-PAI). This genomic segment codes for a type IV secretion system (Cag-T4SS) related to the prototypical VirB/D4 system of Agrobacterium tumefaciens (Ag), a plant pathogen. Some of the components of Cag-T4SS share homology to that of VirB proteins including putative energy providing CagE (HP0544), the largest VirB4 homologue. In Ag, VirB4 is required for the assembly of the system, substrate translocation and pilus formation, however, very little is known about CagE. Here we have characterised the protein biochemically, genetically, and microscopically and report that CagE is an inner membrane associated active NTPase and has multiple interacting partners including the inner membrane proteins CagV and Cag beta. Through CagV it is connected to the outer membrane sub-complex proteins. Stability of CagE is not dependent on several of the cag-PAI proteins tested. However, localisation and stability of the pilus associated CagI, CagL and surface associated CagH are affected in its absence. Stability of the inner membrane associated energetic component Cag beta, a VirD4 homologue seems to be partially affected in its absence. Additionally, CagA failed to cross the membrane barriers in its absence and no IL-8 induction is observed under infection condition. These results thus suggest the importance of CagE in Cag-T4SS functions. In future it may help in deciphering the mechanism of substrate translocation by the system.	[Shariq, Mohd; Kumari, Rajesh; Mukhopadhyay, Gauranga] Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi 110067, India; [Shariq, Mohd] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Kumar, Navin] All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India; [Kumar, Amarjeet; Subbarao, Naidu] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; Jawaharlal Nehru University, New Delhi	Shariq, M (corresponding author), Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi 110067, India.	shariq.jh@gmail.com; gmukho1@gmail.com	Shariq, Mohd/AAF-4328-2020; Subbarao, Prof Naidu/AAZ-1832-2020	Shariq, Mohd/0000-0002-4438-8612; Subbarao, Prof Naidu/0000-0002-1720-2165; Kumar, Amarjeet/0000-0001-7740-9881	PURSE; UPOE II programmes; Council of Scientific and Industrial Research (CSIR); University Grant Commission (UGC) India; UGC-SAP [DRS-1]; ICMR grants	PURSE; UPOE II programmes; Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); University Grant Commission (UGC) India(University Grants Commission, India); UGC-SAP(University Grants Commission, India); ICMR grants	The present work was supported partially by financial assistance from the University under PURSE and UPOE II programmes. The University had no role in study design, data collection, analysis, preparation of the manuscript, and decision to publish.; Mohd Shariq, Navin Kumar and Rajesh Kumari, acknowledge Council of Scientific and Industrial Research (CSIR) and University Grant Commission (UGC) India for the award of research fellowships. Infrastructural facilities supported by UGC-SAP (DRS-1), and ICMR grants to SCMM are acknowledged. Dr. W. Fischer is gratitudely acknowledged for his kind gift of pJP99 and advice in complementation experiments.	Andrzejewska J, 2006, J BACTERIOL, V188, P5865, DOI 10.1128/JB.00060-06; Arechaga I, 2008, J BACTERIOL, V190, P5472, DOI 10.1128/JB.00321-08; Atmakuri K, 2004, MOL MICROBIOL, V54, P1199, DOI 10.1111/j.1365-2958.2004.04345.x; Batchelor RA, 2004, MICROBIOL-SGM, V150, P3507, DOI 10.1099/mic.0.27112-0; BERGER BR, 1993, J BACTERIOL, V175, P1723, DOI 10.1128/JB.175.6.1723-1734.1993; Buhrdorf R, 2003, INT J MED MICROBIOL, V293, P213, DOI 10.1078/1438-4221-00260; Cao TB, 2001, MICROBIOL-SGM, V147, P3201, DOI 10.1099/00221287-147-12-3201; Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753; Cendron L, 2011, FEBS J, V278, P1223, DOI 10.1111/j.1742-4658.2011.08038.x; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; Couturier MR, 2006, INFECT IMMUN, V74, P273, DOI 10.1128/IAI.74.1.273-281.2006; Covacci A, 2000, Eur J Gastroenterol Hepatol, V12, P1050, DOI 10.1097/00042737-200012090-00018; Dang TAT, 1997, J BACTERIOL, V179, P453, DOI 10.1128/jb.179.2.453-462.1997; Draper O, 2006, J BIOL CHEM, V281, P37628, DOI 10.1074/jbc.M606403200; Durand E, 2010, J BACTERIOL, V192, P2315, DOI 10.1128/JB.01384-09; Fernandez-Lopez R, 2006, FEMS MICROBIOL REV, V30, P942, DOI 10.1111/j.1574-6976.2006.00042.x; Fischer W, 2001, MOL MICROBIOL, V42, P1337, DOI 10.1046/j.1365-2958.2001.02714.x; Fischer W, 2011, FEBS J, V278, P1203, DOI 10.1111/j.1742-4658.2011.08036.x; Fronzes R, 2009, NAT REV MICROBIOL, V7, P703, DOI 10.1038/nrmicro2218; Galli DM, 2001, J BACTERIOL, V183, P1585, DOI 10.1128/JB.183.5.1585-1594.2001; Gomis-Ruth FX, 2001, NATURE, V409, P637, DOI 10.1038/35054586; Goodwin CS, 1997, CLIN INFECT DIS, V25, P1017, DOI 10.1086/516077; Haley KP, 2014, JOVE-J VIS EXP, DOI 10.3791/52122; Johnson EM, 2014, INFECT IMMUN, V82, P3457, DOI 10.1128/IAI.01640-14; Jurik A, 2010, INFECT IMMUN, V78, P5244, DOI 10.1128/IAI.00796-10; Kerr JE, 2010, J BACTERIOL, V192, P4923, DOI 10.1128/JB.00557-10; Kumar N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074620; Kutter S, 2008, J BACTERIOL, V190, P2161, DOI 10.1128/JB.01341-07; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Middleton R, 2005, P NATL ACAD SCI USA, V102, P1685, DOI 10.1073/pnas.0409399102; Mossey P, 2010, J BACTERIOL, V192, P2830, DOI 10.1128/JB.01331-09; PARSONNET J, 1994, WESTERN J MED, V161, P60; Pattis I, 2007, MICROBIOL-SGM, V153, P2896, DOI 10.1099/mic.0.2007/007385-0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinto-Santini DM, 2009, J BACTERIOL, V191, P7343, DOI 10.1128/JB.00946-09; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Rabel C, 2003, J BACTERIOL, V185, P1045, DOI 10.1128/JB.185.3.1045-1058.2003; Ripoll-Rozada J, 2012, J BIOL CHEM, V287, P17408, DOI 10.1074/jbc.M112.357905; Rivas S, 1997, J BIOL CHEM, V272, P25583, DOI 10.1074/jbc.272.41.25583; Shaffer CL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002237; Sivanesan D, 2011, J BACTERIOL, V193, P2097, DOI 10.1128/JB.00907-10; Tanaka J, 2003, CELL MICROBIOL, V5, P395, DOI 10.1046/j.1462-5822.2003.00286.x; Tato I, 2005, P NATL ACAD SCI USA, V102, P8156, DOI 10.1073/pnas.0503402102; Tolia NH, 2006, NAT METHODS, V3, P55, DOI 10.1038/nmeth0106-55; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Wallden K, 2012, P NATL ACAD SCI USA, V109, P11348, DOI 10.1073/pnas.1201428109; Ward DV, 2002, P NATL ACAD SCI USA, V99, P11493, DOI 10.1073/pnas.172390299; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Yuan Q, 2005, J BIOL CHEM, V280, P26349, DOI 10.1074/jbc.M502347200; Zahrl D, 2005, MICROBIOL-SGM, V151, P3455, DOI 10.1099/mic.0.28141-0	52	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142606	10.1371/journal.pone.0142606	http://dx.doi.org/10.1371/journal.pone.0142606			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26565397	Green Submitted, Green Published, gold			2022-12-26	WOS:000367628500038
J	Atik, T; Onay, H; Aykut, A; Bademci, G; Kirazli, T; Tekin, M; Ozkinay, F				Atik, Tahir; Onay, Huseyin; Aykut, Ayca; Bademci, Guney; Kirazli, Tayfun; Tekin, Mustafa; Ozkinay, Ferda			Comprehensive Analysis of Deafness Genes in Families with Autosomal Recessive Nonsyndromic Hearing Loss	PLOS ONE			English	Article							CHUDLEY-MCCULLOUGH SYNDROME; MYOSIN-VIIA GENE; MEDICAL GENETICS; GPSM2 MUTATIONS; VARIANTS; FREQUENCY; TMIE; GENOMICS; SPECTRUM; DEFECTS	Comprehensive genetic testing has the potential to become the standard of care for individuals with hearing loss. In this study, we investigated the genetic etiology of autosomal recessive nonsyndromic hearing loss (ARNSHL) in a Turkish cohort including individuals with cochlear implant, who had a pedigree suggestive of an autosomal recessive inheritance. A workflow including prescreening of GJB2 and a targeted next generation sequencing panel (Illumina TruSight (TM) Exome) covering 2761 genes that we briefly called as mendelian exome sequencing was used. This panel includes 102 deafness genes and a number of genes causing Mendelian disorders. Using this approach, we identified causative variants in 21 of 29 families. Three different GJB2 variants were present in seven families. Remaining 14 families had 15 different variants in other known NSHL genes (MYO7A, MYO15A, MARVELD2, TMIE, DFNB31, LOXHD1, GPSM2, TMC1, USH1G, CDH23). Of these variants, eight are novel. Mutation detection rate of our workflow is 72.4%, confirming the usefulness of targeted sequencing approach in NSHL.	[Atik, Tahir; Ozkinay, Ferda] Ege Univ, Div Pediat Genet, Dept Pediat, Sch Med, Izmir, Turkey; [Onay, Huseyin; Aykut, Ayca; Ozkinay, Ferda] Ege Univ, Dept Med Genet, Sch Med, Izmir, Turkey; [Bademci, Guney; Tekin, Mustafa] Univ Miami, Dr John T Macdonald Fdn Dept Human Genet, Miami, FL USA; [Bademci, Guney; Tekin, Mustafa] Univ Miami, John P Hussman Inst Human Genom, Miller Sch Med, Miami, FL USA; [Kirazli, Tayfun] Ege Univ, Dept Otolarynghol, Sch Med, Izmir, Turkey	Ege University; Ege University; University of Miami; University of Miami; Ege University	Atik, T (corresponding author), Ege Univ, Div Pediat Genet, Dept Pediat, Sch Med, Izmir, Turkey.	tahiratik@yahoo.com	Aykut, Ayca/B-1698-2018; AYKUT, Ayça/ABH-6257-2020; Tekin, Mustafa/ABG-7627-2020	AYKUT, Ayça/0000-0002-1460-0053; Bademci, Guney/0000-0002-4052-8833; Tekin, Mustafa/0000-0002-3525-7960	Ege University Scientific Research Projects (EGEBAP) [2014-TIP057]; NIH NIDCD [R01DC009645]; Scientific and Technological Research Council of Turkey (TUBITAK) [1059B191401904]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009645] Funding Source: NIH RePORTER	Ege University Scientific Research Projects (EGEBAP)(Ege University); NIH NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This project was supported by Ege University Scientific Research Projects (EGEBAP) with grant number 2014-TIP057 and NIH NIDCD grant R01DC009645 to MT. TA was supported by The Scientific and Technological Research Council of Turkey (TUBITAK) (project no: 1059B191401904).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Atik T, 2015, GENET RES, V97, DOI 10.1017/S001667231500004X; Bademci G, 2016, GENET MED, V18, P364, DOI 10.1038/gim.2015.89; Choi BY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068692; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Diaz-Horta O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050628; Diaz-Horta O, 2012, AM J MED GENET A, V158A, P2972, DOI 10.1002/ajmg.a.35636; Doherty D, 2012, AM J HUM GENET, V90, P1088, DOI 10.1016/j.ajhg.2012.04.008; Duman D, 2012, FRONT BIOSCI-LANDMRK, V17, P2213, DOI 10.2741/4046; Ebermann I, 2007, HUM GENET, V121, P203, DOI 10.1007/s00439-006-0304-0; Fattahi Z, 2012, AM J MED GENET A, V158A, P1857, DOI 10.1002/ajmg.a.34411; Finsterer J, 2005, INT J PEDIATR OTORHI, V69, P621, DOI 10.1016/j.ijporl.2004.12.002; GUILFORD P, 1994, HUM MOL GENET, V3, P989, DOI 10.1093/hmg/3.6.989; Janecke AR, 1999, HUM MUTAT, V13, P133, DOI 10.1002/(SICI)1098-1004(1999)13:2<133::AID-HUMU5>3.0.CO;2-U; Kalay E, 2005, Hum Mutat, V26, P591, DOI 10.1002/humu.9384; Kelley PM, 1998, AM J HUM GENET, V62, P792, DOI 10.1086/301807; Kemperman MH, 2002, J ROY SOC MED, V95, P171, DOI 10.1258/jrsm.95.4.171; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kurima K, 2003, GENOMICS, V82, P300, DOI 10.1016/S0888-7543(03)00154-X; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Mburu P, 2003, NAT GENET, V34, P421, DOI 10.1038/ng1208; Mizutari K, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0276-z; Mori K, 2015, ANN OTO RHINOL LARYN, V124, p135S, DOI 10.1177/0003489415574067; Nakanishi H, 2014, AURIS NASUS LARYNX, V41, P399, DOI 10.1016/j.anl.2014.04.001; Nal N, 2007, HUM MUTAT, V28, P1014, DOI 10.1002/humu.20556; Nayak G, 2015, HUM GENET, V134, P423, DOI 10.1007/s00439-015-1532-y; Naz S, 2002, AM J HUM GENET, V71, P632, DOI 10.1086/342193; Oonk AMM, 2015, EAR HEARING, V36, P205, DOI 10.1097/AUD.0000000000000095; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Rabbani B, 2014, J HUM GENET, V59, P5, DOI 10.1038/jhg.2013.114; Riazuddin S, 2006, AM J HUM GENET, V79, P1040, DOI 10.1086/510022; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Roux AF, 2006, J MED GENET, V43, P763, DOI 10.1136/jmg.2006.041954; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shearer AE, 2014, AM J HUM GENET, V95, P445, DOI 10.1016/j.ajhg.2014.09.001; Shearer AE, 2013, J MED GENET, V50, P627, DOI 10.1136/jmedgenet-2013-101749; Sirmaci A, 2009, CLIN GENET, V75, P562, DOI 10.1111/j.1399-0004.2009.01183.x; Sirmaci A, 2009, INT J PEDIATR OTORHI, V73, P699, DOI 10.1016/j.ijporl.2009.01.005; Tlili Abdelaziz, 2005, Hum Mutat, V25, P503, DOI 10.1002/humu.9333; Vozzi D, 2014, GENE, V542, P209, DOI 10.1016/j.gene.2014.03.033; Weil D, 1997, NAT GENET, V16, P191, DOI 10.1038/ng0697-191; Yang JJ, 2010, INT J PEDIATR OTORHI, V74, P489, DOI 10.1016/j.ijporl.2010.02.001	43	49	54	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142154	10.1371/journal.pone.0142154	http://dx.doi.org/10.1371/journal.pone.0142154			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26561413	Green Published, Green Submitted, gold			2022-12-26	WOS:000364433100057
J	Schauperl, M; Fuchs, JE; Waldner, BJ; Huber, RG; Kramer, C; Liedl, KR				Schauperl, Michael; Fuchs, Julian E.; Waldner, Birgit J.; Huber, Roland G.; Kramer, Christian; Liedl, Klaus R.			Characterizing Protease Specificity: How Many Substrates Do We Need?	PLOS ONE			English	Article							RECOGNIZE BETA-STRANDS; ENTROPY; ESTIMATORS; MECHANISM; LIBRARIES; DATABASE; EVENTS; SITES	Calculation of cleavage entropies allows to quantify, map and compare protease substrate specificity by an information entropy based approach. The metric intrinsically depends on the number of experimentally determined substrates (data points). Thus a statistical analysis of its numerical stability is crucial to estimate the systematic error made by estimating specificity based on a limited number of substrates. In this contribution, we show the mathematical basis for estimating the uncertainty in cleavage entropies. Sets of cleavage entropies are calculated using experimental cleavage data and modeled extreme cases. By analyzing the underlying mathematics and applying statistical tools, a linear dependence of the metric in respect to 1/n was found. This allows us to extrapolate the values to an infinite number of samples and to estimate the errors. Analyzing the errors, a minimum number of 30 substrates was found to be necessary to characterize substrate specificity, in terms of amino acid variability, for a protease (S4-S4') with an uncertainty of 5 percent. Therefore, we encourage experimental researchers in the protease field to record specificity profiles of novel proteases aiming to identify at least 30 peptide substrates of maximum sequence diversity. We expect a full characterization of protease specificity helpful to rationalize biological functions of proteases and to assist rational drug design.	[Fuchs, Julian E.] Univ Innsbruck, Inst Gen Inorgan & Theoret Chem, A-6020 Innsbruck, Tyrol, Austria; Univ Innsbruck, Ctr Mol Biosci Innsbruck, A-6020 Innsbruck, Tyrol, Austria	University of Innsbruck; University of Innsbruck	Fuchs, JE (corresponding author), Univ Innsbruck, Inst Gen Inorgan & Theoret Chem, Innrain 80-82, A-6020 Innsbruck, Tyrol, Austria.	Julian.Fuchs@uibk.ac.at	Liedl, Klaus R/F-3099-2015; Huber, Roland G/AAG-6353-2019; Liedl, Klaus/ABB-4725-2021; Schauperl, Michael/D-7104-2018	Liedl, Klaus R/0000-0002-0985-2299; Huber, Roland G/0000-0001-5093-5988; Liedl, Klaus/0000-0002-0985-2299; Schauperl, Michael/0000-0001-5648-8170	Austrian Science Fund FWF [P23051, P26997]; Austrian Academy of Sciences (OEAW); Austrian Science Fund (FWF) [P 23051] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Academy of Sciences (OEAW); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported in part by the Austrian Science Fund FWF via the grants P23051 "Targeting Influenza Neuraminidase" and P26997 "Influence of Protein Folding on Allergenicity and Immunogenicity". BJW is thankful to the Austrian Academy of Sciences (OEAW) for being a recipient of the DOC-grant for the project "Molecular Determinants of Serine Protease Specificity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonachela JA, 2008, J PHYS A, V41, P9; Boulware KT, 2006, P NATL ACAD SCI USA, V103, P7583, DOI 10.1073/pnas.0511108103; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Diamond SL, 2007, CURR OPIN CHEM BIOL, V11, P46, DOI 10.1016/j.cbpa.2006.11.021; Drag M, 2010, NAT REV DRUG DISCOV, V9, P690, DOI 10.1038/nrd3053; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Fortelny N, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001869; Fuchs JE, 2014, PROTEINS, V82, P546, DOI 10.1002/prot.24417; Fuchs JE, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003353; Fuchs JE, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003007; GRASSBERGER P, 1988, PHYS LETT A, V128, P369, DOI 10.1016/0375-9601(88)90193-4; Grassberger P., 2003, ARXIV; Griffin MA, 2013, BIOCHEMISTRY-US, V52, P8633, DOI 10.1021/bi401325c; GYORFI L, 1987, COMPUT STAT DATA AN, V5, P425, DOI 10.1016/0167-9473(87)90065-X; Gyorfi L., 1997, INT J MATH STAT SCI, V6, P17; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Hedstrom L, 2002, CHEM REV, V102, P4429, DOI 10.1021/cr0101712; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; HERZEL H, 1995, PHYSICA A, V216, P518, DOI 10.1016/0378-4371(95)00104-F; Holste D, 1998, J PHYS A-MATH GEN, V31, P2551, DOI 10.1088/0305-4470/31/11/007; Igarashi Y, 2007, NUCLEIC ACIDS RES, V35, pD546, DOI 10.1093/nar/gkl813; Igarashi Y, 2009, NUCLEIC ACIDS RES, V37, pD611, DOI 10.1093/nar/gkn683; Ilya Nemenman FS, 2002, ADV NEURAL INFORM PR, P14; Ji HK, 2010, NAT BIOTECHNOL, V28, P337, DOI 10.1038/nbt.1619; Kielbasa SM, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-237; KOLMOGOROV AN, 1983, LECT NOTES MATH, V1021, P1; Madala PK, 2010, CHEM REV, V110, pPR1, DOI 10.1021/cr900368a; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; MATTHEWS DJ, 1993, SCIENCE, V260, P1113, DOI 10.1126/science.8493554; MCCALDON P, 1988, PROTEINS, V4, P99, DOI 10.1002/prot.340040204; Meissner F, 2014, NAT IMMUNOL, V15, P112, DOI 10.1038/ni.2781; Miller GA., 1955, NOTE BIAS INFORM EST, P95; MULLEREBERHARD HJ, 1988, ANNU REV BIOCHEM, V57, P321, DOI 10.1146/annurev.biochem.57.1.321; Nar H, 2001, STRUCTURE, V9, P29, DOI 10.1016/S0969-2126(00)00551-7; Nemenman I, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.056111; O'Donoghue AJ, 2012, NAT METHODS, V9, P1095, DOI [10.1038/NMETH.2182, 10.1038/nmeth.2182]; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Poreba M, 2010, CURR MED CHEM, V17, P3968, DOI 10.2174/092986710793205381; Poschel T, 2003, EUR PHYS J E, V12, P531, DOI 10.1140/epje/e2004-00025-4; Puente XS, 2005, BIOCHEM SOC T, V33, P331, DOI 10.1042/BST0330331; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Rawlings ND, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap015; Richter C, 1998, BIOCHEM J, V335, P481, DOI 10.1042/bj3350481; Roulston MS, 1999, PHYSICA D, V125, P285, DOI 10.1016/S0167-2789(98)00269-3; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schilling O, 2008, NAT BIOTECHNOL, V26, P685, DOI 10.1038/nbt1408; SCHMITT AO, 1993, EUROPHYS LETT, V23, P303, DOI 10.1209/0295-5075/23/5/001; Schmitt AO, 1997, J THEOR BIOL, V188, P369, DOI 10.1006/jtbi.1997.0493; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schurmann T, 1996, CHAOS, V6, P414, DOI 10.1063/1.166191; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; TARASENKO FP, 1968, PR INST ELECTR ELECT, V56, P2052, DOI 10.1109/PROC.1968.6784; Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Tyndall JDA, 2005, CHEM REV, V105, P973, DOI 10.1021/cr040669e; Wagner AB, 2011, IEEE T INFORM THEORY, V57, P3207, DOI 10.1109/TIT.2011.2137210; Wolfram Research Inc, 2015, MATH VERS 10 1	58	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142658	10.1371/journal.pone.0142658	http://dx.doi.org/10.1371/journal.pone.0142658			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559682	Green Submitted, Green Published, gold			2022-12-26	WOS:000364433100106
J	Alonso, N; Julian, MT; Carrascal, J; Colobran, R; Pujol-Autonell, I; Rodriguez-Fernandez, S; Tenlente, A; Fernandez, MA; Minarro, A; de Villa, MCR; Vives-Pi, M; Puig-Domingo, M				Alonso, Nuria; Julian, Maria Teresa; Carrascal, Jorge; Colobran, Roger; Pujol-Autonell, Irma; Rodriguez-Fernandez, Silvia; Tenlente, Aina; Fernandez, Marco Antonio; Minarro, Antoni; Ruiz de Villa, Maria Carmen; Vives-Pi, Marta; Puig-Domingo, Manel			Type 1 Diabetes Prevention in NOD Mice by Targeting DPPIV/CD26 Is Associated with Changes in CD8(+)T Effector Memory Subset	PLOS ONE			English	Article							DIPEPTIDYL PEPTIDASE-IV; ANTIGEN-PRESENTING CELLS; ISLET GRAFT-SURVIVAL; REGULATORY T-CELLS; CD26 EXPRESSION; CD8+T CELLS; MOUSE MODEL; INHIBITORS; LYMPHOCYTES; MECHANISMS	CD26 is a T cell activation marker consisting in a type II transmembrane glycoprotein with dipeptidyl peptidase IV (DPPIV) activity in its extracellular domain. It has been described that DPPIV inhibition delays the onset of type 1 diabetes and reverses the disease in nonobese diabetic (NOD) mice. The aim of the present study was to assess the effect of MK626, a DPPIV inhibitor, in type 1 diabetes incidence and in T lymphocyte subsets at central and peripheral compartments. Pre-diabetic NOD mice were treated with MK626. Diabetes incidence, insulitis score, and phenotyping of T lymphocytes in the thymus, spleen and pancreatic lymph nodes were determined after 4 and 6 weeks of treatment, as well as alterations in the expression of genes encoding beta-cell autoantigens in the islets. The effect of MK626 was also assessed in two in vitro assays to determine proliferative and immunosuppressive effects. Results show that MK626 treatment reduces type 1 diabetes incidence and after 6 weeks of treatment reduces insulitis. No differences were observed in the percentage of T lymphocyte subsets from central and peripheral compartments between treated and control mice. MK626 increased the expression of CD26 in CD8(+) T effector memory (TEM) from spleen and pancreatic lymph nodes and in CD8(+) T cells from islet infiltration. CD8(+) TEM cells showed an increased proliferation rate and cytokine secretion in the presence of MK626. Moreover, the combination of CD8(+) TEM cells and MK626 induces an immunosuppressive response. In conclusion, treatment with the DPPIV inhibitor MK626 prevents experimental type 1 diabetes in association to increase expression of CD26 in the CD8(+) TEM lymphocyte subset. In vitro assays suggest an immunoregulatory role of CD8(+) TEM cells that may be involved in the protection against autoimmunity to beta pancreatic islets associated to DPPIV inhibitor treatment.	[Alonso, Nuria; Julian, Maria Teresa; Puig-Domingo, Manel] Hosp Badalona Germans Trias & Pujol, Dept Endocrinol & Nutr, Badalona, Spain; [Alonso, Nuria; Julian, Maria Teresa; Puig-Domingo, Manel] Autonomous Univ Barcelona, Dept Med, Barcelona, Spain; [Carrascal, Jorge; Pujol-Autonell, Irma; Rodriguez-Fernandez, Silvia; Tenlente, Aina; Vives-Pi, Marta] Autonomous Univ Barcelona, Germans Trias & Pujol Res Inst, Dept Immunol, Badalona, Spain; [Colobran, Roger] Vall dHebron Univ Hosp, Vall dHebron Res Inst, Serv Immunol, Barcelona, Spain; [Fernandez, Marco Antonio] Germans Trias & Pujol Res Inst, Cytometry Unit, Badalona, Spain; [Minarro, Antoni; Ruiz de Villa, Maria Carmen] Univ Barcelona, Fac Biol, Dept Stat, Barcelona, Spain; [Alonso, Nuria; Vives-Pi, Marta; Puig-Domingo, Manel] Inst Salud Carlos III ISCIII, GIBER Diabet & Associated Metab Dis CIBERDEM, Madrid, Spain	Hospital Germans Trias i Pujol; Autonomous University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM	Alonso, N (corresponding author), Hosp Badalona Germans Trias & Pujol, Dept Endocrinol & Nutr, Badalona, Spain.	naionso32416@yahoo.es	Vives-Pi, Marta/AAM-8158-2020; Julian, Maria Teresa/AAD-7906-2020; Fernandez, Marco/R-3964-2019; Miñarro, Antonio/G-1740-2015; Pedrol, Nuria Alonso/AAA-8987-2021; Julián, María Teresa/AAY-4138-2020; Colobran, Roger/HGB-6371-2022; Puig-Domingo, Manel/S-2169-2019	Vives-Pi, Marta/0000-0003-3735-0779; Fernandez, Marco/0000-0002-3921-2209; Miñarro, Antonio/0000-0001-7747-5299; Pedrol, Nuria Alonso/0000-0001-9687-8050; Julián, María Teresa/0000-0003-2524-1823; Puig-Domingo, Manel/0000-0002-6744-7195; Teniente Serra, Aina/0000-0003-3440-804X; Alonso, Nuria/0000-0001-5844-2221; Rodriguez-Fernandez, Silvia/0000-0001-8429-4293; Colobran, Roger/0000-0002-5964-536X	European Foundation for the Study of Diabetes; Fondo de Investigaciones Sanitarias of the Carlos III Institute of Health [PI 1102621]; Spanish Society of Endocrinology; Carlos III Institute of Health [PI 1102621]	European Foundation for the Study of Diabetes; Fondo de Investigaciones Sanitarias of the Carlos III Institute of Health; Spanish Society of Endocrinology; Carlos III Institute of Health(Instituto de Salud Carlos III)	This work was supported by grants from European Foundation for the Study of Diabetes, the Fondo de Investigaciones Sanitarias (PI 1102621) of the Carlos III Institute of Health as well as the Spanish Society of Endocrinology. JC was supported by a grant from Carlos III Institute of Health (PI 1102621). The funders had no role in study design, data collection and analysis, decision to publish, or preparation the manuscript.	Atkinson MA, 1999, NAT MED, V5, P601, DOI 10.1038/9442; ATKINSON MA, 1994, NEW ENGL J MED, V331, P1428; Biton A, 2011, IMMUNOBIOLOGY, V216, P1295, DOI 10.1016/j.imbio.2011.07.001; Boonacker E, 2003, EUR J CELL BIOL, V82, P53, DOI 10.1078/0171-9335-00302; Boonacker EP, 2002, J HISTOCHEM CYTOCHEM, V50, P1169, DOI 10.1177/002215540205000903; BREZINSCHEK RI, 1995, J IMMUNOL, V154, P3062; Cabrera SM, 2013, CLIN EXP IMMUNOL, V172, P375, DOI 10.1111/cei.12068; Cho JM, 2011, DIABETES RES CLIN PR, V91, P72, DOI 10.1016/j.diabres.2010.10.012; Ding L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107935; Endharti AT, 2005, J IMMUNOL, V175, P7093, DOI 10.4049/jimmunol.175.11.7093; Guleria I, 2007, CLIN IMMUNOL, V125, P16, DOI 10.1016/j.clim.2007.05.013; Hatano R, 2013, IMMUNOLOGY, V138, P165, DOI 10.1111/imm.12028; Ibegbu CC, 2009, IMMUNOLOGY, V126, P346, DOI 10.1111/j.1365-2567.2008.02899.x; Jelsing J, 2012, J ENDOCRINOL, V214, P381, DOI 10.1530/JOE-11-0479; Jurczyk A, 2013, DIABETES METAB SYNDR, V6, P493, DOI 10.2147/DMSO.S53154; Kim SC, 2015, ANN RHEUM DIS, V74, P1968, DOI 10.1136/annrheumdis-2014-205216; Kim SJ, 2008, DIABETES, V57, P1331, DOI 10.2337/db07-1639; Kim SJ, 2010, DIABETES, V59, P1739, DOI 10.2337/db09-1618; Kim SJ, 2009, DIABETES, V58, P641, DOI 10.2337/db08-1101; Klemann C, 2009, CLIN EXP IMMUNOL, V155, P357, DOI 10.1111/j.1365-2249.2008.03839.x; Lee SA, 2013, J CLIN ENDOCR METAB, V98, P2553, DOI 10.1210/jc.2012-4288; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Li SS, 2014, CELL MOL IMMUNOL, V11, P326, DOI 10.1038/cmi.2014.25; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Makdissi A, 2012, J CLIN ENDOCR METAB, V97, P3333, DOI 10.1210/jc.2012-1544; Matteucci E, 2010, SCAND J IMMUNOL, V71, P123, DOI 10.1111/j.1365-3083.2009.02357.x; Matteucci E, 2011, J CLIN IMMUNOL, V31, P977, DOI 10.1007/s10875-011-9573-z; Ohnuma K, 2004, P NATL ACAD SCI USA, V101, P14186, DOI 10.1073/pnas.0405266101; Ohnuma K, 2008, TRENDS IMMUNOL, V29, P295, DOI 10.1016/j.it.2008.02.010; Petrelli A, 2011, DIABETES, V60, P3223, DOI 10.2337/db11-0880; Pospisilik JA, 2003, DIABETES, V52, P741, DOI 10.2337/diabetes.52.3.741; Pujol-Autonell I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063296; Reinhold D, 1998, J NEUROIMMUNOL, V87, P203, DOI 10.1016/S0165-5728(98)00100-3; Ruiz P, 1996, CYTOMETRY, V23, P322, DOI 10.1002/(SICI)1097-0320(19960401)23:4<322::AID-CYTO8>3.0.CO;2-I; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Serreze DV, 1998, J IMMUNOL, V161, P3912; Shameli A, 2011, J IMMUNOL, V187, P2859, DOI 10.4049/jimmunol.1101117; Simeoni L, 2002, HUM IMMUNOL, V63, P719, DOI 10.1016/S0198-8859(02)00433-0; Steinbrecher A, 2001, J IMMUNOL, V166, P2041, DOI 10.4049/jimmunol.166.3.2041; Suzuki H, 2008, HUM IMMUNOL, V69, P751, DOI 10.1016/j.humimm.2008.08.285; Suzuki M, 2008, HUM IMMUNOL, V69, P781, DOI 10.1016/j.humimm.2008.08.283; TANAKA T, 1993, P NATL ACAD SCI USA, V90, P4586, DOI 10.1073/pnas.90.10.4586; TANAKA T, 1992, J IMMUNOL, V149, P481; Tian L, 2010, ENDOCRINOLOGY, V151, P3049, DOI 10.1210/en.2010-0068; Tsai S, 2008, ADV IMMUNOL, V100, P79, DOI 10.1016/S0065-2776(08)00804-3; Varga T, 2011, PATHOL ONCOL RES, V17, P925, DOI 10.1007/s12253-011-9404-9; Vergani A, 2010, DIABETES, V59, P2253, DOI 10.2337/db09-1264; Yamazaki H, 2012, BIOCHEM BIOPH RES CO, V138, P165; Yin H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065777; Zhang X, 2011, DIABETES OBES METAB, V13, P337, DOI 10.1111/j.1463-1326.2010.01354.x; Zhao YJ, 2014, DIABETES-METAB RES, V30, P646, DOI 10.1002/dmrr.2530; Zhao YJ, 2014, J CLIN ENDOCR METAB, V99, pE876, DOI 10.1210/jc.2013-3633	52	9	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142186	10.1371/journal.pone.0142186	http://dx.doi.org/10.1371/journal.pone.0142186			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555789	Green Published, Green Submitted, gold			2022-12-26	WOS:000364430700066
J	Botwe, PK; Barmuta, LA; Magierowski, R; McEvoy, P; Goonan, P; Carver, S				Botwe, Paul K.; Barmuta, Leon A.; Magierowski, Regina; McEvoy, Paul; Goonan, Peter; Carver, Scott			Temporal Patterns and Environmental Correlates of Macroinvertebrate Communities in Temporary Streams	PLOS ONE			English	Article							LAND-USE; WESTERN-AUSTRALIA; WHEAT-BELT; ASSEMBLAGES; RIVER; CONNECTIVITY; DIVERSITY; IMPACTS; BIOASSESSMENT; COLONIZATION	Temporary streams are characterised by short periods of seasonal or annual stream flow after which streams contract into waterholes or pools of varying hydrological connectivity and permanence. Although these streams are widespread globally, temporal variability of their ecology is understudied, and understanding the processes that structure community composition in these systems is vital for predicting and managing the consequences of anthropogenic impacts. We used multivariate and univariate approaches to investigate temporal variability in macroinvertebrate compositional data from 13 years of sampling across multiple sites from autumn and spring, in South Australia, the driest state in the driest inhabited continent in the world. We examined the potential of land-use, geographic and environmental variables to predict the temporal variability in macroinvertebrate assemblages, and also identified indicator taxa, that is, those highly correlated with the most significantly associated physical variables. Temporal trajectories of macroinvertebrate communities varied within site in both seasons and across years. A combination of land-use, geographic and environmental variables accounted for 24% of the variation in community structure in autumn and 27% in spring. In autumn, community composition among sites were more closely clustered together relative to spring suggesting that communities were more similar in autumn than in spring. In both seasons, community structure was most strongly correlated with conductivity and latitude, and community structure was more associated with cover by agriculture than urban land-use. Maintaining temporary streams will require improved catchment management aimed at sustaining seasonal flows and critical refuge habitats, while also limiting the damaging effects from increased agriculture and urban developments.	[Botwe, Paul K.; Barmuta, Leon A.; Magierowski, Regina; Carver, Scott] Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia; [Magierowski, Regina] La Trobe Univ, Dept Ecol Environm & Evolut, Melbourne, Vic, Australia; [McEvoy, Paul] Dept Environm Water & Nat Resources, Adelaide, SA, Australia; [Goonan, Peter] South Australia Environm Protect Author, Dept Environm, Adelaide, SA, Australia	University of Tasmania; La Trobe University	Botwe, PK (corresponding author), Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia.	Paul.Botwe@utas.edu.au	Carver, Scott/J-7654-2014; Barmuta, Leon/J-2413-2013; Botwe, Paul/R-5709-2019; Magierowski, Regina/B-4588-2013	Carver, Scott/0000-0002-3579-7588; Barmuta, Leon/0000-0002-8946-3727; Magierowski, Regina/0000-0002-7547-8549; Botwe, Paul K./0000-0002-0300-2736	Holsworth Wildlife Research Endowment	Holsworth Wildlife Research Endowment	Funding: Holsworth Wildlife Research Endowment (http://www.eqt.com.au/not-for-profit-organisations/confirmed-2015-programs/holsworth-grants.aspx) funded this research. PKB received this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; Amoros C, 2002, FRESHWATER BIOL, V47, P761, DOI 10.1046/j.1365-2427.2002.00905.x; BELBIN L, 1991, J VEG SCI, V2, P491, DOI 10.2307/3236031; Berk RA, 2003, ADVANCED QUANTITATIV, V11; Blanchette ML, 2013, FRESHWATER BIOL, V58, P742, DOI 10.1111/fwb.12080; Blanchette ML, 2012, FRESHW SCI, V31, P865, DOI 10.1899/11-068.1; Boulton AJ, 2003, FRESHWATER BIOL, V48, P1173, DOI 10.1046/j.1365-2427.2003.01084.x; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Carver S, 2009, ENVIRON ENTOMOL, V38, P1585, DOI 10.1603/022.038.0609; Chessman BC, 2004, J N AM BENTHOL SOC, V23, P599, DOI 10.1899/0887-3593(2004)023&lt;0599:BWRSUO&gt;2.0.CO;2; Chessman BC, 2010, FRESHWATER BIOL, V55, P1780, DOI 10.1111/j.1365-2427.2010.02403.x; Clarke K.R., 2001, CHANGE IN MARINE COM; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; Collier KJ, 2008, FRESHWATER BIOL, V53, P603, DOI 10.1111/j.1365-2427.2007.01923.x; Davies PE, 2000, DEVELOPMENT OF A NAT; Eng K, 2016, RIVER RES APPL, V32, P885, DOI 10.1002/rra.2939; Gorley C.K., 2006, GETTING STARTED PRIM; Heino J, 2007, FRESHWATER BIOL, V52, P1846, DOI 10.1111/j.1365-2427.2007.01801.x; Johnson LB, 2010, J N AM BENTHOL SOC, V29, P41, DOI 10.1899/09-030.1; Kefford BJ, 2011, ENVIRON POLLUT, V159, P302, DOI 10.1016/j.envpol.2010.08.025; Lake PS, 2007, FRESHWATER BIOL, V52, P597, DOI 10.1111/j.1365-2427.2006.01709.x; Larned ST, 2010, FRESHWATER BIOL, V55, P717, DOI 10.1111/j.1365-2427.2009.02322.x; Laut P, 1977, COMMONWEALTH SCIENTI; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Leigh C, 2009, FRESHWATER BIOL, V54, P549, DOI 10.1111/j.1365-2427.2008.02130.x; Leigh C, 2016, FRESHWATER BIOL, V61, P1181, DOI 10.1111/fwb.12646; Magierowski RH, 2012, MAR FRESHWATER RES, V63, P762, DOI 10.1071/MF11267; Magurran A. E, 2013, MEASURING BIOLOGICAL; MALMQVIST B, 1994, ECOGRAPHY, V17, P9, DOI 10.1111/j.1600-0587.1994.tb00072.x; MARGALEF R, 1958, SCIENTIA, V93, P41; Marshall JC, 2006, MAR FRESHWATER RES, V57, P61, DOI 10.1071/MF05021; Mason NWH, 2013, J VEG SCI, V24, P777, DOI 10.1111/jvs.12097; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; McRae SE, 2004, FRESHWATER BIOL, V49, P127, DOI 10.1046/j.1365-2426.2003.01165.x; Norris RH, 2007, FRESHWATER BIOL, V52, P959, DOI 10.1111/j.1365-2427.2006.01701.x; Oksanen J., 2017, COMMUNITY ECOLOGY PA; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Pinder AM, 2005, HYDROBIOLOGIA, V543, P1, DOI 10.1007/s10750-004-5712-3; R Core Team, 2013, R LANG ENV STAT COMP; Raupach MR, 2012, AUSTRALIAN WATER AVA; Raupach MR, 2009, CAWCR TECHNICAL REPO; Reid DJ, 2013, AQUAT SCI, V75, P285, DOI 10.1007/s00027-012-0273-4; Rose P, 2008, FRESHWATER BIOL, V53, P2626, DOI 10.1111/j.1365-2427.2008.02074.x; Sheldon F, 2006, RIVER RES APPL, V22, P219, DOI 10.1002/rra.907; Sheldon F, 2005, HYDROBIOLOGIA, V552, P45, DOI 10.1007/s10750-005-1504-7; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Simpson JC, 2000, BIOLOGICAL ASSESSMEN; Somerfield PJ, 2000, MAR BIOL, V136, P1133, DOI 10.1007/s002270000311; Steel E. A., 2010, Living Reviews in Landscape Research, V4; Tooth S, 2000, EARTH-SCI REV, V51, P67, DOI 10.1016/S0012-8252(00)00014-3; UNDERWOOD AJ, 1988, MAR ECOL PROG SER, V46, P227, DOI 10.3354/meps046227; Warfe DM, 2013, FRESHWATER BIOL, V58, P292, DOI 10.1111/fwb.12058	52	11	11	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142370	10.1371/journal.pone.0142370	http://dx.doi.org/10.1371/journal.pone.0142370			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556711	Green Submitted, Green Published, gold			2022-12-26	WOS:000364430700092
J	Clark, PJ; Amat, J; McConnell, SO; Ghasem, PR; Greenwood, BN; Maier, SF; Fleshner, M				Clark, Peter J.; Amat, Jose; McConnell, Sara O.; Ghasem, Parsa R.; Greenwood, Benjamin N.; Maier, Steven F.; Fleshner, Monika			Running Reduces Uncontrollable Stress-Evoked Serotonin and Potentiates Stress-Evoked Dopamine Concentrations in the Rat Dorsal Striatum	PLOS ONE			English	Article							ALTER EXTRACELLULAR LEVELS; RAPHE NUCLEUS; LEARNED HELPLESSNESS; DORSOMEDIAL STRIATUM; AEROBIC FITNESS; HABIT FORMATION; EXERCISE; BRAIN; DEPRESSION; RECEPTORS	Accumulating evidence from both the human and animal literature indicates that exercise reduces the negative consequences of stress. The neurobiological etiology for this stress protection, however, is not completely understood. Our lab reported that voluntary wheel running protects rats from expressing depression-like instrumental learning deficits on the shuttle box escape task after exposure to unpredictable and inescapable tail shocks (uncontrollable stress). Impaired escape behavior is a result of stress-sensitized serotonin (5-HT) neuron activity in the dorsal raphe (DRN) and subsequent excessive release of 5-HT into the dorsal striatum following exposure to a comparatively mild stressor. However, the possible mechanisms by which exercise prevents stress-induced escape deficits are not well characterized. The purpose of this experiment was to test the hypothesis that exercise blunts the stress-evoked release of 5-HT in the dorsal striatum. Changes to dopamine (DA) levels were also examined, since striatal DA signaling is critical for instrumental learning and can be influenced by changes to 5-HT activity. Adult male F344 rats, housed with or without running wheels for 6 weeks, were either exposed to tail shock or remained undisturbed in laboratory cages. Twenty-four hours later, microdialysis was performed in the medial (DMS) and lateral (DLS) dorsal striatum to collect extracellular 5-HT and DA before, during, and following 2 mild foot shocks. We report wheel running prevents foot shock-induced elevation of extracellular 5-HT and potentiates DA concentrations in both the DMS and DLS approximately 24 h following exposure to uncontrollable stress. These data may provide a possible mechanism by which exercise prevents depression-like instrumental learning deficits following exposure to acute stress.	[Clark, Peter J.; McConnell, Sara O.; Ghasem, Parsa R.; Fleshner, Monika] Univ Colorado, Integrat Physiol, Boulder, CO 80309 USA; [Amat, Jose; Maier, Steven F.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Greenwood, Benjamin N.] Univ Colorado, Dept Psychol, Denver, CO 80217 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Denver	Clark, PJ (corresponding author), Univ Colorado, Integrat Physiol, 354 UCB, Boulder, CO 80309 USA.	peter.clark@nih.gov		Fleshner, Monika/0000-0002-0470-0827	NIH [RO1MH068283]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068283] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Experiments completed in this manuscript were funded by NIH RO1MH068283.	Alex KD, 2005, SYNAPSE, V55, P242, DOI 10.1002/syn.20109; Amat J, 1998, BRAIN RES, V797, P12, DOI 10.1016/S0006-8993(98)00368-0; Amat J, 1998, BRAIN RES, V812, P113, DOI 10.1016/S0006-8993(98)00960-3; AZMITIA EC, 1978, J COMP NEUROL, V179, P641, DOI 10.1002/cne.901790311; Balleine BW, 2009, BEHAV BRAIN RES, V199, P43, DOI 10.1016/j.bbr.2008.10.034; BLOMSTRAND E, 1989, ACTA PHYSIOL SCAND, V136, P473, DOI 10.1111/j.1748-1716.1989.tb08689.x; CHAOULOFF F, 1987, NEUROPHARMACOLOGY, V26, P1099, DOI 10.1016/0028-3908(87)90254-1; CHAOULOFF F, 1989, ACTA PHYSIOL SCAND, V137, P1, DOI 10.1111/j.1748-1716.1989.tb08715.x; Christianson JP, 2008, BEHAV BRAIN RES, V193, P87, DOI 10.1016/j.bbr.2008.04.024; Christianson JP, 2010, BIOL PSYCHIAT, V67, P339, DOI 10.1016/j.biopsych.2009.09.011; CREWS DJ, 1987, MED SCI SPORT EXER, V19, pS114; Davis JM, 2000, AM J CLIN NUTR, V72, p573S, DOI 10.1093/ajcn/72.2.573S; De Deurwaerdere P, 1998, J NEUROSCI, V18, P6528; Di Giovanni G, 2010, CNS NEUROSCI THER, V16, P179, DOI 10.1111/j.1755-5949.2010.00135.x; Di Giovanni G, 2008, PROG BRAIN RES, V172, P45, DOI 10.1016/S0079-6123(08)00903-5; Dias-Ferreira E, 2009, SCIENCE, V325, P621, DOI 10.1126/science.1171203; Dishman RK, 1998, PHYSIOL BEHAV, V63, P911, DOI 10.1016/S0031-9384(98)00017-1; Dishman RK, 2006, OBESITY, V14, P345, DOI 10.1038/oby.2006.46; Faure A, 2005, J NEUROSCI, V25, P2771, DOI 10.1523/JNEUROSCI.3894-04.2005; Foley TE, 2008, NEUROMOL MED, V10, P67, DOI 10.1007/s12017-008-8032-3; Gervais J, 2000, SYNAPSE, V35, P281, DOI 10.1002/(SICI)1098-2396(20000315)35:4<281::AID-SYN6>3.0.CO;2-A; Goekint M, 2012, J APPL PHYSIOL, V112, P535, DOI 10.1152/japplphysiol.00306.2011; Grahn RE, 1999, BRAIN RES, V826, P35, DOI 10.1016/S0006-8993(99)01208-1; Greenwood BN, 2008, NEUROMOL MED, V10, P81, DOI 10.1007/s12017-008-8029-y; Greenwood BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046118; Greenwood BN, 2012, BEHAV BRAIN RES, V233, P314, DOI 10.1016/j.bbr.2012.05.017; Greenwood BN, 2011, EXERC SPORT SCI REV, V39, P140, DOI 10.1097/JES.0b013e31821f7e45; Greenwood BN, 2011, BEHAV BRAIN RES, V217, P354, DOI 10.1016/j.bbr.2010.11.005; Greenwood BN, 2005, BIOL PSYCHIAT, V57, P559, DOI 10.1016/j.biopsych.2004.11.025; Greenwood BN, 2005, BRAIN RES, V1033, P164, DOI 10.1016/j.brainres.2004.11.037; Greenwood BN, 2003, J NEUROSCI, V23, P2889; Heninger GR, 1996, PHARMACOPSYCHIATRY, V29, P2, DOI 10.1055/s-2007-979535; Lacasse JR, 2005, PLOS MED, V2, P1211, DOI 10.1371/journal.pmed.0020392; Lex B, 2010, CEREB CORTEX, V20, P873, DOI 10.1093/cercor/bhp151; Maier SF, 2005, NEUROSCI BIOBEHAV R, V29, P829, DOI 10.1016/j.neubiorev.2005.03.021; MAIER SF, 1995, BEHAV NEUROSCI, V109, P404, DOI 10.1037/0735-7044.109.3.404; Maroteaux M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081868; Maswood S, 1998, BRAIN RES, V783, P115, DOI 10.1016/S0006-8993(97)01313-9; Nutt DJ, 2006, J CLIN PSYCHIAT, V67, P3; Nutt DJ, 2005, CNS SPECTRUMS, V10, P49, DOI 10.1017/S1092852900009901; Olvera-Cortes ME, 2008, PROGRESS IN BRAIN RE, V172, P567, DOI [10.1016/S0079-6123(08)00927-8, DOI 10.1016/S0079-6123(08)00927-8]; Rimmele U, 2007, PSYCHONEUROENDOCRINO, V32, P627, DOI 10.1016/j.psyneuen.2007.04.005; Rozeske RR, 2011, J NEUROSCI, V31, P14107, DOI 10.1523/JNEUROSCI.3095-11.2011; Rozeske RR, 2011, BEHAV BRAIN RES, V219, P378, DOI 10.1016/j.bbr.2011.01.030; Schwabe L, 2011, BEHAV BRAIN RES, V219, P321, DOI 10.1016/j.bbr.2010.12.038; Shiflett MW, 2010, J NEUROSCI, V30, P2951, DOI 10.1523/JNEUROSCI.1778-09.2010; SINYOR D, 1983, PSYCHOSOM MED, V45, P205, DOI 10.1097/00006842-198306000-00003; Strong PV, 2011, NEUROSCIENCE, V197, P132, DOI 10.1016/j.neuroscience.2011.09.041; van Praag H, 2014, J NEUROSCI, V34, P15139, DOI 10.1523/JNEUROSCI.2814-14.2014; Wickens JR, 2007, J NEUROSCI, V27, P8181, DOI 10.1523/JNEUROSCI.1671-07.2007; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x	52	28	29	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141898	10.1371/journal.pone.0141898	http://dx.doi.org/10.1371/journal.pone.0141898			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555633	Green Published, Green Submitted, gold			2022-12-26	WOS:000364430700044
J	Groen, BBL; Horstman, AM; Hamer, HM; de Haan, M; van Kranenburg, J; Bierau, J; Poeze, M; Wodzig, WKWH; Rasmussen, BB; van Loon, LJC				Groen, Bart B. L.; Horstman, Astrid M.; Hamer, Henrike M.; de Haan, Michiel; van Kranenburg, Janneau; Bierau, Jorgen; Poeze, Martijn; Wodzig, Will K. W. H.; Rasmussen, Blake B.; van Loon, Luc J. C.			Post-Prandial Protein Handling: You Are What You Just Ate	PLOS ONE			English	Article							INTRINSICALLY LABELED MILK; AMINO-ACID-METABOLISM; RATES IN-VIVO; SKELETAL-MUSCLE; PHENYLALANINE KINETICS; BLOOD-FLOW; YOUNG; DIGESTION; INGESTION; LEUCINE	Background Protein turnover in skeletal muscle tissue is highly responsive to nutrient intake in healthy adults. Objective To provide a comprehensive overview of post-prandial protein handling, ranging from dietary protein digestion and amino acid absorption, the uptake of dietary protein derived amino acids over the leg, the post-prandial stimulation of muscle protein synthesis rates, to the incorporation of dietary protein derived amino acids in de novo muscle protein. Design 12 healthy young males ingested 20 g intrinsically [1-C-13]-phenylalanine labeled protein. In addition, primed continuous L-[ring-H-2(5)]-phenylalanine, L-[ring-H-2(2)]-tyrosine, and L-[1-C-13]-leucine infusions were applied, with frequent collection of arterial and venous blood samples, and muscle biopsies throughout a 5 h post-prandial period. Dietary protein digestion, amino acid absorption, splanchnic amino acid extraction, amino acid uptake over the leg, and subsequent muscle protein synthesis were measured within a single in vivo human experiment. Results 55.3 +/- 2.7% of the protein-derived phenylalanine was released in the circulation during the 5 h post-prandial period. The post-prandial rise in plasma essential amino acid availability improved leg muscle protein balance (from -291 +/- 72 to 103 +/- 66 mu M.min(-1).100 mL leg volume(-1); P<0.001). Muscle protein synthesis rates increased significantly following protein ingestion (0.029 +/- 0.002 vs 0.044 +/- 0.004%.h(-1) based upon the muscle protein bound L[ring-H-2(5)]-phenylalanine enrichments (P<0.01)), with substantial incorporation of dietary protein derived L-[1-C-13]-phenylalanine into de novo muscle protein (from 0 to 0.0201 +/- 0.0025 MPE). Conclusion Ingestion of a single meal-like amount of protein allows similar to 55% of the protein derived amino acids to become available in the circulation, thereby improving whole-body and leg protein balance. About 20% of the dietary protein derived amino acids released in the circulation are taken up in skeletal muscle tissue following protein ingestion, thereby stimulating muscle protein synthesis rates and providing precursors for de novo muscle protein synthesis.	[Groen, Bart B. L.; Horstman, Astrid M.; Hamer, Henrike M.; van Loon, Luc J. C.] Top Inst Food & Nutr, Wageningen, Netherlands; [Groen, Bart B. L.; Horstman, Astrid M.; Hamer, Henrike M.; van Kranenburg, Janneau; van Loon, Luc J. C.] Maastricht Univ, Dept Human Movement Sci, Med Ctr, NL-6200 MD Maastricht, Netherlands; [de Haan, Michiel] Maastricht Univ, Dept Radiol, Med Ctr, NL-6200 MD Maastricht, Netherlands; [Bierau, Jorgen] Maastricht Univ, Lab Biochem Genet, Med Ctr, Dept Clin Genet, NL-6200 MD Maastricht, Netherlands; [Poeze, Martijn] Maastricht Univ, Dept Surg, Med Ctr, NL-6200 MD Maastricht, Netherlands; [Wodzig, Will K. W. H.] Maastricht Univ, Cent Diagnost Lab, Med Ctr, NL-6200 MD Maastricht, Netherlands; [Rasmussen, Blake B.] Univ Texas Med Branch, Dept Nutr & Metab, Galveston, TX 77555 USA	Top Institute Food & Nutrition; Maastricht University; Maastricht University; Maastricht University; Maastricht University; Maastricht University; University of Texas System; University of Texas Medical Branch Galveston	van Loon, LJC (corresponding author), Top Inst Food & Nutr, Wageningen, Netherlands.	L.vanLoon@maastrichtuniversity.nl	van Loon, Luc J C/G-5920-2010; van Loon, Luc J.C./ABG-9158-2020	van Loon, Luc J C/0000-0002-6768-9231; van Loon, Luc J.C./0000-0002-6768-9231; Rasmussen, Blake/0000-0001-7854-5375	TI Food and Nutrition; Danone; FrieslandCampina; Kellogs	TI Food and Nutrition; Danone(Danone Nutricia); FrieslandCampina; Kellogs	This work was funded by TI Food and Nutrition, a public-private partnership on precompetitive research in food and nutrition. The researchers are responsible for the study design, data collection and analysis, decision to publish, and preparation of the manuscript. The industrial partners have contributed to the project through regular discussion. Funding was realized by TI Food and Nutrition: (http://www.tifn.nl/). The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript. The sponsors Danone, FrieslandCampina and Kellogs did have a role in the study design. More specifically: the choice of stimuli, which were produced by these sponsors.	Amer Diabet Assoc, 2006, DIABETES CARE, V29, pS43; BANOS G, 1973, J PHYSIOL-LONDON, V235, P459, DOI 10.1113/jphysiol.1973.sp010397; BERGSTROM J, 1975, SCAND J CLIN LAB INV, V35, P606, DOI 10.3109/00365517509095787; BIOLO G, 1992, AM J PHYSIOL, V262, pE455, DOI 10.1152/ajpendo.1992.262.4.E455; BIOLO G, 1995, AM J PHYSIOL-ENDOC M, V268, pE75, DOI 10.1152/ajpendo.1995.268.1.E75; Boirie Y, 1997, AM J CLIN NUTR, V65, P489; Boirie Y, 1997, P NATL ACAD SCI USA, V94, P14930, DOI 10.1073/pnas.94.26.14930; Boirie Y, 1996, AM J PHYSIOL-ENDOC M, V271, pE1083, DOI 10.1152/ajpendo.1996.271.6.E1083; BOIRIE Y, 1995, J NUTR, V125, P92; Breen L, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-68; Burd NA, 2014, J APPL PHYSIOL, V117, P1363, DOI 10.1152/japplphysiol.00411.2014; Burd NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068109; Burd NA, 2012, J APPL PHYSIOL, V113, P896, DOI 10.1152/japplphysiol.00513.2012; Coppack SW, 1996, J CLIN INVEST, V98, P692, DOI 10.1172/JCI118840; Cuthbertson D, 2004, FASEB J, V18, P422, DOI 10.1096/fj.04-2640fje; Dangin M, 2002, J NUTR, V132, p3228S, DOI 10.1093/jn/131.10.3228S; Deutz NEP, 1998, J NUTR, V128, P2435, DOI 10.1093/jn/128.12.2435; English KL, 2010, CURR OPIN CLIN NUTR, V13, P34, DOI 10.1097/MCO.0b013e328333aa66; FELIG P, 1975, ANNU REV BIOCHEM, V44, P933, DOI 10.1146/annurev.bi.44.070175.004441; Fry CS, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-11; Fujita S, 2006, AM J PHYSIOL-ENDOC M, V291, pE745, DOI 10.1152/ajpendo.00271.2005; Gorissen SHM, 2014, J CLIN ENDOCR METAB, V99, P2250, DOI 10.1210/jc.2013-3970; Groen BBL, 2014, J APPL PHYSIOL, V116, P998, DOI 10.1152/japplphysiol.00919.2013; Groen BB, 2011, AM J PHYSL ENDOCRINO; HEYS SD, 1990, BIOMED ENVIRON MASS, V19, P176, DOI 10.1002/bms.1200190314; JONES PRM, 1969, J PHYSIOL-LONDON, V204, pP63; JORFELDT L, 1971, CLIN SCI, V41, P459, DOI 10.1042/cs0410459; Koopman R, 2005, AM J PHYSIOL-ENDOC M, V288, pE645, DOI 10.1152/ajpendo.00413.2004; Koopman R, 2005, AM J PHYSIOL-ENDOC M, V288, P53; Koopman R, 2007, AM J PHYSIOL-ENDOC M, V293, pE833, DOI 10.1152/ajpendo.00135.2007; Koopman R, 2009, J NUTR, V139, P1707, DOI 10.3945/jn.109.109173; Koopman R, 2009, AM J CLIN NUTR, V90, P106, DOI 10.3945/ajcn.2009.27474; LANDSMAN MLJ, 1976, J APPL PHYSIOL, V40, P575, DOI 10.1152/jappl.1976.40.4.575; Mari A, 2001, DIABETES CARE, V24, P539, DOI 10.2337/diacare.24.3.539; Matthews DE, 2007, J NUTR, V137, p1549S, DOI 10.1093/jn/137.6.1549S; Paddon-Jones D, 2004, AM J PHYSIOL-ENDOC M, V286, pE321, DOI 10.1152/ajpendo.00368.2003; Pennings B, 2011, J DAIRY SCI, V94, P4366, DOI 10.3168/jds.2011-4451; Pennings B, 2012, AM J PHYSL ENDOCRINO; Pennings B, 2013, AM J CLIN NUTR, V98, P121, DOI 10.3945/ajcn.112.051201; Pennings B, 2012, AM J PHYSIOL-ENDOC M, V302, pE992, DOI 10.1152/ajpendo.00517.2011; Pennings B, 2011, AM J CLIN NUTR, V93, P997, DOI 10.3945/ajcn.110.008102; Pennings B, 2011, AM J CLIN NUTR, V93, P322, DOI 10.3945/ajcn.2010.29649; Rasmussen BB, 2006, FASEB J, V20, P768, DOI 10.1096/fj.05-4607fje; Reitelseder S, 2010, AM J PHYSL ENDOCRINO; Res PT, 2012, MED SCI SPORTS EXERC; Rodriguez PO, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.04.010; Schnitzer JE, 1998, WHOLE ORGAN APPROACHES TO CELLULAR METABOLISM, P31; SILK DBA, 1985, P NUTR SOC, V44, P63, DOI 10.1079/PNS19850011; SKELTON DA, 1994, AGE AGEING, V23, P371, DOI 10.1093/ageing/23.5.371; Smith GI, 2010, J APPL PHYSIOL, V108, P363, DOI 10.1152/japplphysiol.00957.2009; van Hall G, 1999, P NUTR SOC, V58, P899, DOI 10.1017/S0029665199001202; van Loon LJC, 2009, J DAIRY SCI, V92, P4812, DOI 10.3168/jds.2009-2317; Volpi E, 1998, J CLIN INVEST, V101, P2000, DOI 10.1172/JCI939; Volpi E, 2001, JAMA-J AM MED ASSOC, V286, P1206, DOI 10.1001/jama.286.10.1206; Volpi E, 1999, AM J PHYSIOL-ENDOC M, V277, pE513, DOI 10.1152/ajpendo.1999.277.3.E513; Wagenmakers AJM, 1999, P NUTR SOC, V58, P987, DOI 10.1017/S0029665199001305; Wall BT, 2012, CLIN NUTR; Waterval WAH, 2009, CLIN CHIM ACTA, V407, P36, DOI 10.1016/j.cca.2009.06.023; Wolfe R R, 1984, Lab Res Methods Biol Med, V9, P1; Wolfe RR, 1992, RADIOACTIVE STABLE I; Zhang HR, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0237-1	61	65	65	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141582	10.1371/journal.pone.0141582	http://dx.doi.org/10.1371/journal.pone.0141582			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556791	Green Submitted, Green Published, gold			2022-12-26	WOS:000364430700033
J	Hortells, L; Sosa, C; Millan, A; Sorribas, V				Hortells, Luis; Sosa, Cecilia; Millan, Angel; Sorribas, Victor			Critical Parameters of the In Vitro Method of Vascular Smooth Muscle Cell Calcification	PLOS ONE			English	Article							CALCIUM-PHOSPHATE DEPOSITION; CHRONIC KIDNEY-DISEASE; POTENTIAL MECHANISM; PYROPHOSPHATE; OSTEOPONTIN; EXPRESSION; PROTEINS; RISK; NMR	Background Vascular calcification (VC) is primarily studied using cultures of vascular smooth muscle cells. However, the use of very different protocols and extreme conditions can provide findings unrelated to VC. In this work we aimed to determine the critical experimental parameters that affect calcification in vitro and to determine the relevance to calcification in vivo. Experimental Procedures and Results Rat VSMC calcification in vitro was studied using different concentrations of fetal calf serum, calcium, and phosphate, in different types of culture media, and using various volumes and rates of change. The bicarbonate content of the media critically affected pH and resulted in supersaturation, depending on the concentration of Ca2+ and Pi. Such supersaturation is a consequence of the high dependence of bicarbonate buffers on CO2 vapor pressure and bicarbonate concentration at pHs above 7.40. Such buffer systems cause considerable pH variations as a result of minor experimental changes. The variations are more critical for DMEM and are negligible when the bicarbonate concentration is reduced to 1/4. Particle nucleation and growth were observed by dynamic light scattering and electronmicroscopy. Using 2mM Pi, particles of similar to 200nm were observed at 24 hours in MEM and at 1 hour in DMEM. These nuclei grew over time, were deposited in the cells, and caused osteogene expression or cell death, depending on the precipitation rate. TEM observations showed that the initial precipitate was amorphous calcium phosphate (ACP), which converts into hydroxyapatite over time. In blood, the scenario is different, because supersaturation is avoided by a tightly controlled pH of 7.4, which prevents the formation of PO43--containing ACP. Conclusions The precipitation of ACP in vitro is unrelated to VC in vivo. The model needs to be refined through controlled pH and the use of additional procalcifying agents other than Pi in order to reproduce calcium phosphate deposition in vivo.	[Hortells, Luis; Sosa, Cecilia; Sorribas, Victor] Univ Zaragoza, Dept Toxicol, Fac Vet, Zaragoza, Spain; [Millan, Angel] Univ Zaragoza, Inst Mat Sci Aragon, CSIC, Zaragoza, Spain	University of Zaragoza; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Quimica y Materiales de Aragon (CEQMA); CSIC - Instituto de Ciencia de Materiales de Aragon (ICMA); University of Zaragoza	Millan, A (corresponding author), Univ Zaragoza, Inst Mat Sci Aragon, CSIC, Zaragoza, Spain.	amillan@unizar.es; sorribas@unizar.es	Millan, Angel/N-6157-2016; Sosa, Cecilia/B-8374-2013	Sosa, Cecilia/0000-0003-2907-0427; Millan Escolano, Angel/0000-0003-0828-3212; Hortells Garcia, Luis/0000-0003-1923-4918; Sorribas, Victor/0000-0003-3457-323X	Spanish Ministry of Economy and Competitiveness [SAF2012-33898, MAT2014-54975-R]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	Funding was provided by a research grant SAF2012-33898 to VS, http://www.mineco.gob.es/portal/site/mineco/idi, Spanish Ministry of Economy and Competitiveness; research grant MAT2014-54975-R to AM, http://www.mineco.gob.es/portal/site/mineco/idi, Spanish Ministry of Economy and Competitiveness. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balica M, 1997, CIRCULATION, V95, P1954; Betts F., 1974, T AM CRYST ASS, V10, P73; CHAMLEY JH, 1977, CELL TISSUE RES, V177, P503; Chen NX, 2006, KIDNEY INT, V70, P1046, DOI 10.1038/sj.ki.5001663; Coto B, 2012, FLUID PHASE EQUILIBR, V324, P1, DOI 10.1016/j.fluid.2012.03.020; Davies C.W., 1962, ION ASS; Demer LL, 2008, CIRCULATION, V117, P2938, DOI 10.1161/CIRCULATIONAHA.107.743161; Hruska K, 2011, KIDNEY INT, V79, pS9, DOI 10.1038/ki.2011.24; Jaeger C, 2006, KEY ENG MATER, V309-311, P69, DOI 10.4028/www.scientific.net/KEM.309-311.69; Jono S, 2000, CIRC RES, V87, pE10, DOI 10.1161/01.RES.87.7.e10; Kestenbaum B, 2005, J AM SOC NEPHROL, V16, P520, DOI 10.1681/ASN.2004070602; Kiffer-Moreira T, 2013, J BONE MINER RES, V28, P81, DOI 10.1002/jbmr.1733; Kovesdy CP, 2012, NEPHROL DIAL TRANSPL, V27, P3056, DOI 10.1093/ndt/gfs291; Lanzer P, 2014, EUR HEART J, V35, P1515, DOI 10.1093/eurheartj/ehu163; Lomashvili KA, 2008, KIDNEY INT, V73, P1024, DOI 10.1038/ki.2008.26; Lomashvili KA, 2004, J AM SOC NEPHROL, V15, P1392, DOI 10.1097/01.ASN.0000128955.83129.9C; Martin-Pardillos A, 2014, TOXICOLOGY, V318, P40, DOI 10.1016/j.tox.2014.01.012; Martin-Pardillos A, 2013, TOXICOL SCI, V131, P641, DOI 10.1093/toxsci/kfs313; Niederhoffer N, 1997, HYPERTENSION, V29, P999, DOI 10.1161/01.HYP.29.4.999; O'Neill WC, 2007, KIDNEY INT, V72, P792, DOI 10.1038/sj.ki.5002412; Reynolds JL, 2004, J AM SOC NEPHROL, V15, P2857, DOI 10.1097/01.ASN.0000141960.01035.28; Sage AP, 2011, KIDNEY INT, V79, P414, DOI 10.1038/ki.2010.390; Shanahan CM, 1999, CIRCULATION, V100, P2168, DOI 10.1161/01.CIR.100.21.2168; SHANAHAN CM, 1993, CIRC RES, V73, P193, DOI 10.1161/01.RES.73.1.193; Shroff RC, 2010, J AM SOC NEPHROL, V21, P103, DOI 10.1681/ASN.2009060640; Sonou T, 2015, J ATHEROSCLER THROMB; TROPP J, 1983, J AM CHEM SOC, V105, P22, DOI 10.1021/ja00339a006; Villa-Bellosta R, 2011, AM J PHYSIOL-CELL PH, V300, pC210, DOI 10.1152/ajpcell.00229.2010; Villa-Bellosta R, 2009, ARTERIOSCL THROM VAS, V29, P761, DOI 10.1161/ATVBAHA.108.183384; Wang LJ, 2008, CHEM REV, V108, P4628, DOI 10.1021/cr0782574	30	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141751	10.1371/journal.pone.0141751	http://dx.doi.org/10.1371/journal.pone.0141751			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554928	Green Submitted, Green Published, gold			2022-12-26	WOS:000364430700038
J	Hou, DX; Su, M; Li, XW; Li, ZY; Yun, T; Zhao, YH; Zhang, L; Zhao, LH; Li, RF; Yu, HQ; Li, XL				Hou, Dongxia; Su, Min; Li, Xiawei; Li, Zhiying; Yun, Ting; Zhao, Yuhang; Zhang, Ling; Zhao, Lihua; Li, Rongfeng; Yu, Haiquan; Li, Xueling			The Efficient Derivation of Trophoblast Cells from Porcine In Vitro Fertilized and Parthenogenetic Blastocysts and Culture with ROCK Inhibitor Y-27632	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; DEVELOPMENTAL COMPETENCE; TROPHECTODERM LINEAGES; EXPRESSION PATTERNS; BOVINE; OOCYTES; GENES; DIFFERENTIATION; KINASE; INSTABILITY	Trophoblasts (TR) are specialized cells of the placenta and play an important role in embryo implantation. The in vitro culture of trophoblasts provided an important tool to investigate the mechanisms of implantation. In the present study, porcine trophoblast cells were derived from pig in vitro fertilized (IVF) and parthenogenetically activated (PA) blastocysts via culturing in medium supplemented with KnockOut serum replacement (KOSR) and basic fibroblast growth factor (bFGF) on STO feeder layers, and the effect of ROCK (Rho-associated coiled-coil protein kinases) inhibiter Y-27632 on the cell lines culture was tested. 5 PA blastocyst derived cell lines and 2 IVF blastocyst derived cell lines have been cultured more than 20 passages; one PA cell lines reached 110 passages without obvious morphological alteration. The derived trophoblast cells exhibited epithelium-like morphology, rich in lipid droplets, and had obvious defined boundaries with the feeder cells. The cells were histochemically stained positive for alkaline phosphatase. The expression of TR lineage markers, such as CDX2, KRT7, KRT18, TEAD4, ELF5 and HAND1, imprinted genes such as IGF2, PEG1 and PEG10, and telomerase activity related genes TERC and TERF2 were detected by immunofluorescence staining, reverse transcription PCR and quantitative real-time PCR analyses. Both PA and IVF blastocysts derived trophoblast cells possessed the ability to differentiate into mature trophoblast cells in vitro. The addition of Y-27632 improved the growth of both PA and IVF blastocyst derived cell lines and increased the expression of trophoblast genes. This study has provided an alternative highly efficient method to establish trophoblast for research focused on peri-implantation and placenta development in IVF and PA embryos.	[Hou, Dongxia; Su, Min; Li, Xiawei; Li, Zhiying; Yun, Ting; Zhao, Yuhang; Yu, Haiquan; Li, Xueling] Inner Mongolia Univ, Key Lab Natl Educ, Minist Mammalian Reprod Biol & Biotechnol, Hohhot, Inner Mongolia, Peoples R China; [Zhang, Ling; Zhao, Lihua; Li, Rongfeng] Nanjing Med Univ, State Key Labs Reprod Med, Nanjing, Jiangsu, Peoples R China; [Zhang, Ling; Zhao, Lihua; Li, Rongfeng] Nanjing Med Univ, Jiangsu Key Lab Xenotransplantat, Nanjing, Jiangsu, Peoples R China	Inner Mongolia University; Nanjing Medical University; Nanjing Medical University	Li, RF (corresponding author), Nanjing Med Univ, State Key Labs Reprod Med, Nanjing, Jiangsu, Peoples R China.	lirongfeng@njmu.edu.cn; haiquan_yu@163.com; lixueling@hotmail.com		Li, Xiawei/0000-0002-6775-4099	National Transgenic Project of China [2013ZX08010-001, 2014ZX08010-001]; National Natural Science Foundation of China [31460309, 81471001, 30871408, 31371487]	National Transgenic Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: This work was supported by National Transgenic Project of China (2013ZX08010-001 and 2014ZX08010-001) and National Natural Science Foundation of China (31460309, 81471001, 30871408 and 31371487). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjaye J, 2007, PHYSIOL GENOMICS, V31, P315, DOI 10.1152/physiolgenomics.00041.2007; Bai H, 2011, J REPROD DEVELOP, V57, P518, DOI 10.1262/jrd.10-186K; Berg DK, 2011, DEV CELL, V20, P244, DOI 10.1016/j.devcel.2011.01.003; Blaschitz A, 2000, PLACENTA, V21, P733, DOI 10.1053/plac.2000.0559; Brevini TAL, 2012, STEM CELL REV REP, V8, P1076, DOI 10.1007/s12015-012-9379-2; Carey TS, 2015, MOL CELL BIOL, V35, P4158, DOI 10.1128/MCB.00546-15; Clayton L, 1999, DEV BIOL, V205, P322, DOI 10.1006/dbio.1998.9117; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Donnison M, 2005, DEVELOPMENT, V132, P2299, DOI 10.1242/dev.01819; Elling U, 2011, CELL STEM CELL, V9, P563, DOI 10.1016/j.stem.2011.10.012; Ezashi T, 2011, BIOL REPROD, V85, P779, DOI 10.1095/biolreprod.111.092809; Finan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068528; FLECHON JE, 1995, PLACENTA, V16, P643, DOI 10.1016/0143-4004(95)90033-0; FRASER LR, 1979, ENVIRON HEALTH PERSP, V31, P141, DOI 10.2307/3429152; Fujii T, 2013, J REPROD DEVELOP, V59, P151, DOI 10.1262/jrd.2012-122; Fujii T, 2010, CELL REPROGRAM, V12, P617, DOI 10.1089/cell.2010.0017; Gauthaman K, 2010, STEM CELL REV REP, V6, P86, DOI [10.1007/s12015-010-9166-x, 10.1007/s12015-009-9107-8]; Goossens K, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-64; Goossens K, 2010, REPROD FERT DEVELOP, V22, P395, DOI 10.1071/RD09080; Haigh T, 1999, PLACENTA, V20, P615, DOI 10.1053/plac.1999.0441; Hao YH, 2006, MOL REPROD DEV, V73, P77, DOI 10.1002/mrd.20358; Hao YH, 2004, BIOL REPROD, V70, P1644, DOI 10.1095/biolreprod.103.026005; Hardy K, 1996, MOL REPROD DEV, V43, P313, DOI 10.1002/(SICI)1098-2795(199603)43:3&lt;313::AID-MRD5&gt;3.0.CO;2-T; Huang XH, 2014, STEM CELLS DEV, V23, P1501, DOI 10.1089/scd.2013.0329; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Kaibuchi K, 1999, CURR OPIN CELL BIOL, V11, P591, DOI 10.1016/S0955-0674(99)00014-9; Kaufman MH, 1983, METHODOLOGY IN VITRO; Kidder BL, 2009, STEM CELLS, V27, P317, DOI 10.1634/stemcells.2008-0710; Kure-Bayashi S, 2000, THERIOGENOLOGY, V53, P1105, DOI 10.1016/S0093-691X(00)00256-9; La Bonnardiere C, 2002, PLACENTA, V23, P716, DOI 10.1053/plac.2002.0848; Lathi RB, 2011, SEMIN REPROD MED, V29, P463, DOI 10.1055/s-0031-1293200; Leeb M, 2011, NATURE, V479, P131, DOI 10.1038/nature10448; Li W, 2014, CELL STEM CELL, V14, P404, DOI 10.1016/j.stem.2013.11.016; Li W, 2012, NATURE, V490, P407, DOI 10.1038/nature11435; Liu Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097974; McCauley TC, 2003, THERIOGENOLOGY, V60, P1569, DOI 10.1016/S0093-691X(03)00172-9; Meyer-Ter-Vehn T, 2006, INVEST OPHTH VIS SCI, V47, P4895, DOI 10.1167/iovs.06-0118; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niemann H, 2001, THERIOGENOLOGY, V56, P1291, DOI 10.1016/S0093-691X(01)00630-6; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Odiatis C, 2010, PLACENTA, V31, P630, DOI 10.1016/j.placenta.2010.05.001; Pearton DJ, 2014, DEV BIOL, V392, P344, DOI 10.1016/j.ydbio.2014.05.012; Pearton DJ, 2011, DEV BIOL, V360, P343, DOI 10.1016/j.ydbio.2011.10.007; PEDERSEN RA, 1986, EXPT APPROACHES MAMM; Petr J, 1996, THERIOGENOLOGY, V45, P1473, DOI 10.1016/0093-691X(96)00115-X; Pfeffer PL, 2012, REPRODUCTION, V143, P231, DOI 10.1530/REP-11-0374; Polydorou C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2646; PRATHER RS, 1991, MOL REPROD DEV, V28, P405, DOI 10.1002/mrd.1080280413; Ralston A, 2010, DEVELOPMENT, V137, P395, DOI 10.1242/dev.038828; RAMSOONDAR J, 1993, BIOL REPROD, V49, P681, DOI 10.1095/biolreprod49.4.681; Ray S, 2009, J BIOL CHEM, V284, P4978, DOI 10.1074/jbc.M807329200; REIMA I, 1993, DIFFERENTIATION, V54, P35; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Roberts R Michael, 2003, J Reprod Dev, V52, pS87; Saadeldin IM, 2014, PLACENTA, V35, P286, DOI 10.1016/j.placenta.2014.02.003; Shi JJ, 2013, CELL CYCLE, V12, P1492, DOI 10.4161/cc.24699; Shiokawa S, 2002, J CLIN ENDOCR METAB, V87, P5808, DOI 10.1210/jc.2002-020376; Sivasubramaiyan K, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-88; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; Sritanaudomchai H, 2009, DEV BIOL, V335, P179, DOI 10.1016/j.ydbio.2009.08.025; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; TAYLOR AS, 1994, HUM REPROD, V9, P2389, DOI 10.1093/oxfordjournals.humrep.a138457; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Wang K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010622; Wen F, 2007, DEV BIOL, V312, P284, DOI 10.1016/j.ydbio.2007.09.024; Zhao HB, 2010, BIOL REPROD, V83, P370, DOI 10.1095/biolreprod.110.083402; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zhou C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091728; Zhu J, 2003, CLONING STEM CELLS, V5, P355, DOI 10.1089/153623003772032853	69	13	14	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142442	10.1371/journal.pone.0142442	http://dx.doi.org/10.1371/journal.pone.0142442			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555939	Green Published, gold, Green Submitted			2022-12-26	WOS:000364430700107
J	Lee, DM; Rodrigues, FF; Yu, CG; Swan, M; Harris, TJC				Lee, Donghoon M.; Rodrigues, Francisco F.; Yu, Cao Guo; Swan, Michael; Harris, Tony J. C.			PH Domain-Arf G Protein Interactions Localize the Arf-GEF Steppke for Cleavage Furrow Regulation in Drosophila	PLoS One			English	Article							PLECKSTRIN-HOMOLOGY DOMAINS; EXCHANGE FACTORS; NUCLEOTIDE EXCHANGE; PLASMA-MEMBRANE; FAMILY; ACTIVATION; CYTOSKELETON; ENDOCYTOSIS; BINDING; EMBRYO	The recruitment of GDP/GTP exchange factors (GEFs) to specific subcellular sites dictates where they activate small G proteins for the regulation of various cellular processes. Cytohesins are a conserved family of plasma membrane GEFs for Arf small G proteins that regulate endocytosis. Analyses of mammalian cytohesins have identified a number of recruitment mechanisms for these multi-domain proteins, but the conservation and developmental roles for these mechanisms are unclear. Here, we report how the pleckstrin homology (PH) domain of the Drosophila cytohesin Steppke affects its localization and activity at cleavage furrows of the early embryo. We found that the PH domain is necessary for Steppke furrow localization, and for it to regulate furrow structure. However, the PH domain was not sufficient for the localization. Next, we examined the role of conserved PH domain amino acid residues that are required for mammalian cytohesins to bind PIP3 or GTP-bound Arf G proteins. We confirmed that the Steppke PH domain preferentially binds PIP3 in vitro through a conserved mechanism. However, disruption of residues for PIP3 binding had no apparent effect on GFP-Steppke localization and effects. Rather, residues for binding to GTP-bound Arf G proteins made major contributions to this Steppke localization and activity. By analyzing GFP-tagged Arf and Arf-like small G proteins, we found that Arf1-GFP, Arf6-GFP and Arl4-GFP, but not Arf4-GFP, localized to furrows. However, analyses of embryos depleted of Arf1, Arf6 or Arl4 revealed either earlier defects than occur in embryos depleted of Steppke, or no detectable furrow defects, possibly because of redundancies, and thus it was difficult to assess how individual Arf small G proteins affect Steppke. Nonetheless, our data show that the Steppke PH domain and its conserved residues for binding to GTP-bound Arf G proteins have substantial effects on Steppke localization and activity in early Drosophila embryos.	[Lee, Donghoon M.; Rodrigues, Francisco F.; Yu, Cao Guo; Swan, Michael; Harris, Tony J. C.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada	University of Toronto	Harris, TJC (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.	tony.harris@utoronto.ca		Lee, Donghoon/0000-0002-1078-6655	Canadian Institutes of Health Research (CIHR) [MOP82829]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	The work was supported by a Canadian Institutes of Health Research (CIHR) operating grant to TJCH (MOP82829) (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizel K, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001652; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; Cronin TC, 2004, EMBO J, V23, P3711, DOI 10.1038/sj.emboj.7600388; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DiNitto JP, 2007, MOL CELL, V28, P569, DOI 10.1016/j.molcel.2007.09.017; DiNitto JP, 2010, BIOCHEMISTRY-US, V49, P6083, DOI 10.1021/bi1000454; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Dyer N, 2007, DEVELOPMENT, V134, P4437, DOI 10.1242/dev.010983; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Hahn I, 2013, J CELL SCI, V126, P2470, DOI 10.1242/jcs.120964; Hiester KG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082084; Hofmann I, 2007, CURR BIOL, V17, P711, DOI 10.1016/j.cub.2007.03.007; Huang J, 2009, P NATL ACAD SCI USA, V106, P8284, DOI 10.1073/pnas.0900641106; Hunter MV, 2015, J CELL BIOL, V210, P801, DOI 10.1083/jcb.201501076; Ikenouchi J, 2010, P NATL ACAD SCI USA, V107, P748, DOI 10.1073/pnas.0908423107; Jackson CL, 2014, J CELL SCI, V127, P4103, DOI 10.1242/jcs.144899; Jacobs S, 1999, FEBS LETT, V456, P384, DOI 10.1016/S0014-5793(99)00759-0; Kitano J, 2002, J NEUROSCI, V22, P1280, DOI 10.1523/JNEUROSCI.22-04-01280.2002; Klarlund JK, 2000, J BIOL CHEM, V275, P32816, DOI 10.1074/jbc.M002435200; Krahn MP, 2010, CURR BIOL, V20, P636, DOI 10.1016/j.cub.2010.01.065; Lecuit T, 2004, J CELL SCI, V117, P3427, DOI 10.1242/jcs.01312; Lee DM, 2015, GENETICS, V200, P863, DOI 10.1534/genetics.115.176867; Lee Donghoon M, 2014, Bioarchitecture, V4, P68, DOI 10.4161/bioa.28949; Lee DM, 2013, CURR BIOL, V23, P2110, DOI 10.1016/j.cub.2013.08.058; Lim J, 2010, GENE DEV, V24, P1496, DOI 10.1101/gad.1904610; Liu JS, 2015, MOL BIOL CELL, V26, P711, DOI 10.1091/mbc.E14-11-1554; Mazumdar A, 2002, BIOESSAYS, V24, P1012, DOI 10.1002/bies.10184; Moravec R, 2012, J BIOL CHEM, V287, P31138, DOI 10.1074/jbc.M112.383117; Myers KR, 2008, TRENDS CELL BIOL, V18, P184, DOI 10.1016/j.tcb.2008.02.002; Nevrivy DJ, 2000, J BIOL CHEM, V275, P16827, DOI 10.1074/jbc.275.22.16827; Padovani D, 2014, P NATL ACAD SCI USA, V111, P12378, DOI 10.1073/pnas.1409832111; Reversi A, 2014, J CELL BIOL, V205, P395, DOI 10.1083/jcb.201309079; Sarantis H, 2012, METHOD CELL BIOL, V108, P429, DOI 10.1016/B978-0-12-386487-1.00019-5; Shao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009938; Stalder D, 2011, J BIOL CHEM, V286, P3873, DOI 10.1074/jbc.M110.145532; Teuliere J, 2014, GENETICS, V198, P229, DOI 10.1534/genetics.114.167189; Torii T, 2010, J BIOL CHEM, V285, P24270, DOI 10.1074/jbc.M110.125658; Varnai P, 2005, J CELL SCI, V118, P4879, DOI 10.1242/jcs.02606; Vert JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-520; Yu CG, 2012, MOL BIOL CELL, V23, P3743, DOI 10.1091/mbc.E12-03-0196; Zhu WQ, 2012, NATURE, V492, P252, DOI 10.1038/nature11603	44	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142562	10.1371/journal.pone.0142562	http://dx.doi.org/10.1371/journal.pone.0142562			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556630	Green Published, Green Submitted, gold			2022-12-26	WOS:000364430700131
J	Liu, TJ; Yu, HF; Ding, L; Wu, Z; De Los Santos, FG; Liu, JH; Ullenbruch, M; Hu, B; Martins, V; Phan, SH				Liu, Tianju; Yu, Hongfeng; Ding, Lin; Wu, Zhe; De Los Santos, Francina Gonzalez; Liu, Jianhua; Ullenbruch, Matthew; Hu, Biao; Martins, Vanessa; Phan, Sem H.			Conditional Knockout of Telomerase Reverse Transcriptase in Mesenchymal Cells Impairs Mouse Pulmonary Fibrosis	PLOS ONE			English	Article							LUNG INJURY; DUAL ROLES; STEM-CELLS; CANCER; MYOFIBROBLAST; MUTATIONS; PROLIFERATION; DYSFUNCTION; EXPRESSION; INDUCTION	Telomerase is typically expressed in cellular populations capable of extended replication, such as germ cells, tumor cells, and stem cells, but is also induced in tissue injury, repair and fibrosis. Its catalytic component, telomerase reverse transcriptase (TERT) is induced in lung fibroblasts from patients with fibrotic interstitial lung disease and in rodents with bleomycin- induced pulmonary fibrosis. To evaluate the fibroblast specific role of TERT in pulmonary fibrosis, transgenic mice bearing a floxed TERT allele were generated, and then crossed with an inducible collagen alpha 2(I)-Cre mouse line to generate fibroblast specific TERT conditional knockout mice. TERT-specific deficiency in mesenchymal cells caused attenuation of pulmonary fibrosis as manifested by reduced lung hydroxyproline content, type I collagen and a-smooth muscle actin mRNA levels. The TERT-deficient mouse lung fibroblasts displayed decreased cell proliferative capacity and higher susceptibility to induced apoptosis compared with control cells. Additionally TERT deficiency was associated with heightened a-smooth muscle actin expression indicative of myofibroblast differentiation. However the impairment of cell proliferation and increased susceptibility to apoptosis would cause a reduction in the myofibroblast progenitor population necessary to mount a successful myofibroblast-dependent fibrotic response. These findings identified a key role for TERT in fibroblast proliferation and survival essential for pulmonary fibrosis.	[Liu, Tianju; Yu, Hongfeng; Ding, Lin; Wu, Zhe; De Los Santos, Francina Gonzalez; Liu, Jianhua; Ullenbruch, Matthew; Hu, Biao; Phan, Sem H.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Martins, Vanessa] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil	University of Michigan System; University of Michigan; Universidade de Sao Paulo	Phan, SH (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	shphan@umich.edu	Phan, Sem H/A-7033-2009	Phan, Sem H/0000-0002-3711-2159	NIH [HL052285, HL091775, HL112880]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112880, R01HL052285, P01HL091775] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding: This study is supported by NIH grants HL052285, HL091775 and HL112880. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder JK, 2008, P NATL ACAD SCI USA, V105, P13051, DOI 10.1073/pnas.0804280105; Alder JK, 2015, CHEST, V147, P1361, DOI 10.1378/chest.14-1947; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Bauer Y, 2015, AM J RESP CELL MOL, V52, P217, DOI 10.1165/rcmb.2013-0310OC; de Jesus BB, 2013, TRENDS GENET, V29, P513, DOI 10.1016/j.tig.2013.06.007; Buseman CM, 2012, MUTAT RES-FUND MOL M, V730, P90, DOI 10.1016/j.mrfmmm.2011.07.006; Cao K, 2011, J CLIN INVEST, V121, P2833, DOI 10.1172/JCI43578; Choi JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040010; Cogan JD, 2015, AM J RESP CRIT CARE, V191, P646, DOI 10.1164/rccm.201408-1510OC; Cronkhite JT, 2008, AM J RESP CRIT CARE, V178, P729, DOI 10.1164/rccm.200804-550OC; Driscoll B, 2000, AM J PHYSIOL-LUNG C, V279, pL1191, DOI 10.1152/ajplung.2000.279.6.L1191; Fridlender ZG, 2007, EUR RESPIR J, V30, P205, DOI 10.1183/09031936.00009407; Gazzaniga FS, 2014, BLOOD, V124, P3675, DOI 10.1182/blood-2014-06-582254; Gonzalez-Suarez E, 2001, EMBO J, V20, P2619, DOI 10.1093/emboj/20.11.2619; Gordon DM, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/390791; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; Hackett JA, 2002, ONCOGENE, V21, P619, DOI 10.1038/sj.onc.1205061; Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370; Hu BA, 2012, AM J PATHOL, V180, P2257, DOI 10.1016/j.ajpath.2012.02.010; Huaux F, 2003, J IMMUNOL, V170, P2083, DOI 10.4049/jimmunol.170.4.2083; Kim JK, 2000, TOXICOL LETT, V111, P263, DOI 10.1016/S0378-4274(99)00195-2; Kropski JA, 2014, CHEST, V146, pE1, DOI 10.1378/chest.13-2224; Liu T, 2006, AM J RESP CELL MOL, V34, P625, DOI 10.1165/rcmb.2005-0252OC; Liu TJ, 2007, J CLIN INVEST, V117, P3800, DOI 10.1172/JCI32369; Liu TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088362; Liu TJ, 2013, AM J RESP CELL MOL, V49, P260, DOI 10.1165/rcmb.2012-0514OC; Morrison SJ, 1996, IMMUNITY, V5, P207, DOI 10.1016/S1074-7613(00)80316-7; Mouraret N, 2015, CIRCULATION, V131, P742, DOI 10.1161/CIRCULATIONAHA.114.013258; Nozaki Y, 2000, AM J RESP CELL MOL, V23, P460, DOI 10.1165/ajrcmb.23.4.3958; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Peng RQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059348; Phan Sem H, 2012, Proc Am Thorac Soc, V9, P148, DOI 10.1513/pats.201201-011AW; Richardson GD, 2012, FASEB J, V26, P4832, DOI 10.1096/fj.12-208843; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Santos JH, 2004, AGING CELL, V3, P399, DOI 10.1111/j.1474-9728.2004.00124.x; Saretzki G, 2014, CURR PHARM DESIGN, V20, P6386, DOI 10.2174/1381612820666140630095606; Sarin KY, 2005, NATURE, V436, P1048, DOI 10.1038/nature03836; Seimiya H, 2000, EMBO J, V19, P2652, DOI 10.1093/emboj/19.11.2652; Shang Y, 2015, CELL BIOCHEM BIOPHYS, V72, P405, DOI 10.1007/s12013-014-0476-5; Simonicova L, 2015, CURR GENET, V61, P517, DOI 10.1007/s00294-014-0472-8; Sirma H, 2011, GASTROENTEROLOGY, V141, P326, DOI 10.1053/j.gastro.2011.03.047; Stuart BD, 2015, NAT GENET, V47, P512, DOI 10.1038/ng.3278; Thannickal Victor J, 2006, Proc Am Thorac Soc, V3, P350, DOI 10.1513/pats.200601-001TK; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Ujike-Asai A, 2007, J LEUKOCYTE BIOL, V82, P429, DOI 10.1189/jlb.1006638; Waisberg DR, 2012, CLINICS, V67, P1039, DOI 10.6061/clinics/2012(09)10; Westin ER, 2007, AGING CELL, V6, P383, DOI 10.1111/j.1474-9726.2007.00288.x; Wong JMY, 2006, GENE DEV, V20, P2848, DOI 10.1101/gad.1476206; Yang J, 2013, AM J PATHOL, V183, P1559, DOI 10.1016/j.ajpath.2013.07.016; Yui J, 1998, BLOOD, V91, P3255, DOI 10.1182/blood.V91.9.3255.3255_3255_3262	50	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142547	10.1371/journal.pone.0142547	http://dx.doi.org/10.1371/journal.pone.0142547			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555817	Green Published, Green Submitted, gold			2022-12-26	WOS:000364430700126
J	Nakagawa, T; Ikehara, T; Dolguchi, M; Imamura, Y; Higashi, M; Yoneda, M; Ito, T				Nakagawa, Takeya; Ikehara, Tsuyoshi; Dolguchi, Masamichi; Imamura, Yuko; Higashi, Miki; Yoneda, Mitsuhiro; Ito, Takashi			Enhancer of Acetyltransferase Chameau (EAChm) Is a Novel Transcriptional Co-Activator	PLOS ONE			English	Article							HISTONE ACETYLATION; CHROMATIN; ACTIVATION; COMPLEXES; CHAPERONE	Acetylation of nucleosomal histones by diverse histone acetyltransferases (HAT) plays pivotal roles in many cellular events. Discoveries of novel HATs and HAT related factors have provided new insights to understand the roles and mechanisms of histone acetylation. In this study, we identified prominent Histone H3 acetylation activity in vitro and purified its activity, showing that it is composed of the MYST acetyltransferase Chameau and Enhancer of the Acetyltransferase Chameau (EAChm) family. EAChm is a negatively charged acidic protein retaining aspartate and glutamate. Furthermore, we identified that Chameau and EAChm stimulate transcription in vitro together with purified general transcription factors. In addition, RNA-seq analysis of Chameu KD and EAChm KD S2 cells suggest that Chameau and EAChm regulate transcription of common genes in vivo. Our results suggest that EAChm regulates gene transcription in Drosophila embryos by enhancing Acetyltransferase Chameau activity.	[Nakagawa, Takeya; Ikehara, Tsuyoshi; Dolguchi, Masamichi; Imamura, Yuko; Higashi, Miki; Yoneda, Mitsuhiro; Ito, Takashi] Nagasaki Univ, Sch Med, Dept Biochem, Nagasaki 8528523, Japan	Nagasaki University	Ito, T (corresponding author), Nagasaki Univ, Sch Med, Dept Biochem, Nagasaki 8528523, Japan.	tito@nagasaki-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24118003]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (T.I.). Grant number is 24118003. The URL is: https://www.jsps.go.jp/english/e-grants/ .	Asahara H, 2002, MOL CELL BIOL, V22, P2974, DOI 10.1128/MCB.22.9.2974-2983.2002; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Brownell JE, 1996, CURR OPIN GENET DEV, V6, P176, DOI 10.1016/S0959-437X(96)80048-7; Carrozza MJ, 2003, TRENDS GENET, V19, P321, DOI 10.1016/S0168-9525(03)00115-X; Chen SD, 2010, SCIENCE, V330, P1682, DOI 10.1126/science.1196380; DINGWALL C, 1987, EMBO J, V6, P69, DOI 10.1002/j.1460-2075.1987.tb04720.x; Grienenberger A, 2002, CURR BIOL, V12, P762, DOI 10.1016/S0960-9822(02)00814-X; Hong T, 2004, BIOCHEM BIOPH RES CO, V317, P259, DOI 10.1016/j.bbrc.2004.03.041; Ito T, 2000, GENE DEV, V14, P1899; Ito T, 1996, MOL CELL BIOL, V16, P3112; KAMAKAKA RT, 1994, METHOD CELL BIOL, V44, P225, DOI 10.1016/S0091-679X(08)60916-4; Kimura A, 2005, J BIOCHEM, V138, P647, DOI 10.1093/jb/mvi184; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kueh AJ, 2011, MOL CELL BIOL, V31, P845, DOI 10.1128/MCB.00159-10; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Miotto B, 2006, GENE DEV, V20, P101, DOI 10.1101/gad.359506; Mizuguchi G, 2001, J BIOL CHEM, V276, P14773, DOI 10.1074/jbc.M100125200; Mousson F, 2005, P NATL ACAD SCI USA, V102, P5975, DOI 10.1073/pnas.0500149102; Pillus L, 2008, CURR OPIN CELL BIOL, V20, P326, DOI 10.1016/j.ceb.2008.04.009; Ruiz-Garcia AB, 1998, J BIOL CHEM, V273, P12599, DOI 10.1074/jbc.273.20.12599; STUDITSKY VM, 1995, CELL, V83, P19, DOI 10.1016/0092-8674(95)90230-9; van Holde KE., 1989, SPRINGER SERIES MOL; Voss AK, 2009, BIOESSAYS, V31, P1050, DOI 10.1002/bies.200900051; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	26	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142305	10.1371/journal.pone.0142305	http://dx.doi.org/10.1371/journal.pone.0142305			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555228	Green Published, Green Submitted, gold			2022-12-26	WOS:000364430700081
J	Varughese, EA; Kasper, S; Anneken, EM; Yadav, JS				Varughese, Eunice A.; Kasper, Susan; Anneken, Emily M.; Yadav, Jagjit S.			SHP-2 Mediates Cryptosporidium parvum Infectivity in Human Intestinal Epithelial Cells	PLOS ONE			English	Article							TYROSINE-PHOSPHATASE SHP-2; FOCAL ADHESION KINASE; IN-VITRO; INCREASED EXPRESSION; CELLULAR INVASION; PROTEIN; PAXILLIN; SRC; PHOSPHORYLATION; ACTIVATION	The parasite, Cryptosporidium parvum, induces human gastroenteritis through infection of host epithelial cells in the small intestine. During the initial stage of infection, C. parvum is reported to engage host mechanisms at the host cell-parasite interface to form a parasitophorous vacuole. We determined that upon infection, the larger molecular weight proteins in human small intestinal epithelial host cells (FHs 74 Int) appeared to globally undergo tyrosine dephosphorylation. In parallel, expression of the cytoplasmic protein tyrosine phosphatase Src homology-2 domain-containing phosphatase 2 (SHP-2) increased in a time-dependent manner. SHP-2 co-localized with the C. parvum sporozoite and this interaction increased the rate of C. parvum infectivity through SH2-mediated SHP-2 activity. Furthermore, we show that one potential target that SHP-2 acts upon is the focal adhesion protein, paxillin, which undergoes moderate dephosphorylation following infection, with inhibition of SHP-2 rescuing paxillin phosphorylation. Importantly, treatment with an inhibitor to SHP-2 and with an inhibitor to paxillin and Src family kinases, effectively decreased the multiplicity of C. parvum infection in a dose-dependent manner. Thus, our study reveals an important role for SHP-2 in the pathogenesis of C. parvum. Furthermore, while host proteins can be recruited to participate in the development of the electron dense band at the host cell-parasite interface, our study implies for the first time that SHP-2 appears to be recruited by the C. parvum sporozoite to regulate infectivity. Taken together, these findings suggest that SHP-2 and its down-stream target paxillin could serve as targets for intervention.	[Varughese, Eunice A.; Kasper, Susan; Yadav, Jagjit S.] Univ Cincinnati, Coll Med, Dept Environm Hlth, Div Environm Genet & Mol Toxicol, Cincinnati, OH 45267 USA; [Varughese, Eunice A.; Anneken, Emily M.] US EPA, Natl Exposure Res Lab, Cincinnati, OH 45268 USA	University of Cincinnati; United States Environmental Protection Agency	Varughese, EA (corresponding author), Univ Cincinnati, Coll Med, Dept Environm Hlth, Div Environm Genet & Mol Toxicol, Cincinnati, OH 45267 USA.	varughese.eunice@epa.gov; Jagjit.yadav@uc.edu	Yadav, Jagjit S./AAN-8805-2020	Yadav, Jagjit S./0000-0001-5036-3609	U.S. Environmental Protection Agency, through its Office of Research and Development; University of Cincinnati	U.S. Environmental Protection Agency, through its Office of Research and Development(United States Environmental Protection Agency); University of Cincinnati	The research was supported by the U.S. Environmental Protection Agency, through its Office of Research and Development, and in part by the University of Cincinnati. Commercial entities had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakken T, 2010, VIROLOGY, V397, P379, DOI 10.1016/j.virol.2009.11.030; Bauer B, 2012, CELL HOST MICROBE, V11, P576, DOI 10.1016/j.chom.2012.04.013; Bhat N, 2007, J BIOL CHEM, V282, P34877, DOI 10.1074/jbc.M706950200; Bohmer F, 2013, FEBS J, V280, P413, DOI 10.1111/j.1742-4658.2012.08655.x; Brown MC, 2005, MOL BIOL CELL, V16, P4316, DOI 10.1091/mbc.E05-02-0131; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Carruthers Vern B., 2008, V47, P33; Chalmers RM, 2013, TRENDS PARASITOL, V29, P237, DOI 10.1016/j.pt.2013.03.001; Chang YM, 2008, ONCOGENE, V27, P6365, DOI 10.1038/onc.2008.250; Chen XM, 2004, J BIOL CHEM, V279, P31671, DOI 10.1074/jbc.M401592200; Chen XM, 2004, INFECT IMMUN, V72, P3011, DOI 10.1128/IAI.72.5.3011-3021.2004; Chen XM, 2003, GASTROENTEROLOGY, V125, P216, DOI 10.1016/S0016-5085(03)00662-0; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Elliott DA, 2000, INFECT IMMUN, V68, P2315, DOI 10.1128/IAI.68.4.2315-2322.2000; Feng GS, 1999, EXP CELL RES, V253, P47, DOI 10.1006/excr.1999.4668; Feng M, 2008, J CHILD NEUROL, V23, P287, DOI 10.1177/0883073807309247; Forney JR, 1999, INFECT IMMUN, V67, P844, DOI 10.1128/IAI.67.2.844-852.1999; Gandji LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123472; Gut J, 1999, J EUKARYOT MICROBIOL, V46, p56S; Higashi H, 2004, J BIOL CHEM, V279, P17205, DOI 10.1074/jbc.M309964200; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Inagaki K, 2000, ONCOGENE, V19, P75, DOI 10.1038/sj.onc.1203204; Jacot D, 2012, INT J MED MICROBIOL, V302, P195, DOI 10.1016/j.ijmm.2012.07.012; Jiang J, 2013, WORLD J GASTROENTERO, V19, P575, DOI 10.3748/wjg.v19.i4.575; Kim M, 2010, VIRULENCE, V1, P52, DOI 10.4161/viru.1.1.10486; Li J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102847; Manes S, 1999, MOL CELL BIOL, V19, P3125; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Philpott N, 2011, J VIROL, V85, P1140, DOI 10.1128/JVI.01362-10; Ren Y, 2004, J BIOL CHEM, V279, P8497, DOI 10.1074/jbc.M312575200; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Smith HV, 2005, TRENDS PARASITOL, V21, P133, DOI 10.1016/j.pt.2005.01.007; Tsubouchi A, 2002, J CELL BIOL, V159, P673, DOI 10.1083/jcb.200202117; Tsuda M, 1998, J BIOL CHEM, V273, P13223, DOI 10.1074/jbc.273.21.13223; Valigurova A, 2008, INT J PARASITOL, V38, P913, DOI 10.1016/j.ijpara.2007.11.003; Varughese EA, 2014, J MICROBIOL METH, V106, P47, DOI 10.1016/j.mimet.2014.07.017; von Wichert G, 2003, EMBO J, V22, P5023, DOI 10.1093/emboj/cdg492; Walter AO, 1999, ONCOGENE, V18, P1911, DOI 10.1038/sj.onc.1202513; Ware MW, 2010, VET PARASITOL, V168, P329, DOI 10.1016/j.vetpar.2009.11.019; WHO, 2012, RES PRIOR ZOON MARG; Wilhelm CL, 2014, PARASITE IMMUNOL, V36, P409, DOI 10.1111/pim.12115; Yan DP, 2013, CELL SIGNAL, V25, P1887, DOI 10.1016/j.cellsig.2013.05.020; Zhang HL, 2012, INFECT IMMUN, V80, P1753, DOI 10.1128/IAI.05862-11; Zhang J, 2015, J CELL MOL MED, V19, P2075, DOI 10.1111/jcmm.12618	45	4	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142219	10.1371/journal.pone.0142219	http://dx.doi.org/10.1371/journal.pone.0142219			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556238	gold, Green Submitted, Green Published			2022-12-26	WOS:000364430700069
J	Wah, W; Earnest, A; Sabanayagam, C; Cheng, CY; Ong, MEH; Wong, TY; Lamoureux, EL				Wah, Win; Earnest, Arul; Sabanayagam, Charumathi; Cheng, Ching-Yu; Ong, Marcus Eng Hock; Wong, Tien Y.; Lamoureux, Ecosse L.			Composite Measures of Individual and Area-Level Socio-Economic Status Are Associated with Visual Impairment in Singapore	PLOS ONE			English	Article							URBAN ASIAN POPULATION; RISK-FACTORS; MACULAR DEGENERATION; SOCIAL INEQUALITIES; VISION IMPAIRMENT; EYE DISEASES; MALAY-EYE; PREVALENCE; DEPRIVATION; NEIGHBORHOOD	Purpose To investigate the independent relationship of individual-and area-level socio-economic status (SES) with the presence and severity of visual impairment (VI) in an Asian population. Methods Cross-sectional data from 9993 Chinese, Malay and Indian adults aged 40-80 years who participated in the Singapore Epidemiology of eye Diseases (2004-2011) in Singapore. Based on the presenting visual acuity (PVA) in the better-seeing eye, VI was categorized into normal vision (logMAR <= 0.30), low vision (logMAR>0.30<1.00), and blindness (logMAR >= 1.00). Any VI was defined as low vision/blindness in the PVA of better-seeing eye. Individual-level low-SES was defined as a composite of primary-level education, monthly income<2000 SGD and residing in 1 or 2-room public apartment. An area-level SES was assessed using a socio-economic disadvantage index (SEDI), created using 12 variables from the 2010 Singapore census. A high SEDI score indicates a relatively poor SES. Associations between SES measures and presence and severity of VI were examined using multi-level, mixed-effects logistic and multinomial regression models. Results The age-adjusted prevalence of any VI was 19.62% (low vision = 19%, blindness = 0.62%). Both individual-and area-level SES were positively associated with any VI and low vision after adjusting for confounders. The odds ratio (95% confidence interval) of any VI was 2.11 (1.88-2.37) for low-SES and 1.07(1.02-1.13) per 1 standard deviation increase in SEDI. When stratified by unilateral/bilateral categories, while low SES showed significant associations with all categories, SEDI showed a significant association with bilateral low vision only. The association between low SES and any VI remained significant among all age, gender and ethnic sub-groups. Although a consistent positive association was observed between area-level SEDI and any VI, the associations were significant among participants aged 40-65 years and male. Conclusion In this community-based sample of Asian adults, both individual-and area-level SES were independently associated with the presence and severity of VI.	[Wah, Win] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Ctr Infect Dis Epidemiol & Res, Singapore 117548, Singapore; [Earnest, Arul; Sabanayagam, Charumathi; Cheng, Ching-Yu; Ong, Marcus Eng Hock; Wong, Tien Y.; Lamoureux, Ecosse L.] Duke NUS Grad Med Sch, Singapore, Singapore; [Earnest, Arul] Monash Univ, Dept Epidemiol & Prevent Med, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia; [Sabanayagam, Charumathi; Cheng, Ching-Yu; Wong, Tien Y.; Lamoureux, Ecosse L.] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Cheng, Ching-Yu] Natl Univ Singapore, Dept Ophthalmol, Singapore 117548, Singapore; [Cheng, Ching-Yu] Natl Univ Hlth Syst, Singapore, Singapore; [Ong, Marcus Eng Hock] Singapore Gen Hosp, Dept Emergency Med, Singapore, Singapore; [Lamoureux, Ecosse L.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia	National University of Singapore; National University of Singapore; Monash University; National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore; Singapore General Hospital; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne	Lamoureux, EL (corresponding author), Duke NUS Grad Med Sch, Singapore, Singapore.	ecosse.lamoureux@duke-nus.edu.sg	Lamoureux, Ecosse/Z-5482-2019; Sabanayagam, Charumathi/C-1294-2011; Wong, Tien Yin/AAC-9724-2020; Cheng, Ching-Yu/Y-2229-2019	Sabanayagam, Charumathi/0000-0002-4042-4719; Wong, Tien Yin/0000-0002-8448-1264; Cheng, Ching-Yu/0000-0003-0655-885X; Wah, Win/0000-0002-4242-5651	Biomedical Research Council (BMRC) [08/1/35/19/550]; National Medical Research Council (NMRC), Singapore [STaR/0003/2008]	Biomedical Research Council (BMRC)(Agency for Science Technology & Research (A*STAR)); National Medical Research Council (NMRC), Singapore(National Medical Research Council, Singapore)	This study was funded by Biomedical Research Council (BMRC), 08/1/35/19/550 and National Medical Research Council (NMRC), STaR/0003/2008, Singapore. The funding agencies had no role in the research presented in the paper, and the researchers were fully independent in pursuing this research.	Abou-Gareeb I, 2001, Ophthalmic Epidemiol, V8, P39, DOI 10.1076/opep.8.1.39.1540; Acharya N, 2009, BRIT J OPHTHALMOL, V93, P627, DOI 10.1136/bjo.2008.147231; Anderson CJ, 2010, APPL GEN LINEAR MIXE; BAILEY IL, 1976, AM J OPTOM PHYS OPT, V53, P740; Cheung CMG, 2013, AM J OPHTHALMOL, V155, P764, DOI 10.1016/j.ajo.2012.10.013; Cheung N, 2013, BRIT J OPHTHALMOL, V97, P785, DOI 10.1136/bjophthalmol-2012-302253; Chiang PPC, 2013, DIABETIC MED, V30, pE32, DOI 10.1111/dme.12053; Chong EW, 2009, ARCH OPHTHALMOL-CHIC, V127, P1640, DOI 10.1001/archophthalmol.2009.298; Cockburn N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030718; Crampton P SC, 1997, SOC POLICY J N Z, V9, P186; Department of Statistics, 2015, LIF EXP BIRTH 2015; Diez-Roux AV, 1998, AM J PUBLIC HEALTH, V88, P216, DOI 10.2105/AJPH.88.2.216; DiezRoux AV, 1997, AM J EPIDEMIOL, V146, P48, DOI 10.1093/oxfordjournals.aje.a009191; Earnest A, PREVENTIVE MED REPOR; Evans JMM, 2000, DIABETIC MED, V17, P478, DOI 10.1046/j.1464-5491.2000.00309.x; Foong AWP, 2007, OPHTHAL EPIDEMIOL, V14, P25, DOI 10.1080/09286580600878844; Fraser S, 2001, BMJ-BRIT MED J, V322, P639, DOI 10.1136/bmj.322.7287.639; Galster GC, 2012, NEIGHBOURHOOD EFFECT, DOI [DOI 10.1007/978-94-007-2309-2_2, 10.1007/978-94-007-2309-2_2]; Grilli L., 2006, REV RANDOM EFFECTS M; Halonen JI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032937; Jollife I. T., 1986, PRINCIPAL COMPONENT; Kelaher M, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-51; Lamoreux EL, 2008, INVEST OPHTH VIS SCI, V49, P528, DOI 10.1167/iovs.07-1036; Lavanya R, 2009, BRIT J OPHTHALMOL, V93, P299, DOI 10.1136/bjo.2008.148650; Lavanya R, 2009, OPHTHAL EPIDEMIOL, V16, P325, DOI 10.3109/09286580903144738; Leow BG, 2001, CENSUS POPULATION 20; Li YJ, 2013, JAMA OPHTHALMOL, V131, P499, DOI 10.1001/jamaophthalmol.2013.1165; Malik ANJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001496; Marmamula S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005125; McCarty CA, 2006, BRIT J OPHTHALMOL, V90, P521, DOI 10.1136/bjo.2006.090233; Ministry Of Education, 2014, ED STAT DIG 2014 MOU; Ministry Of Health, 2013, COSTS FIN 2013; Ministry Of Health, 2014, POP VIT STAT 2014; Ministry Of Health, 2014, HOSP BILL SIZ 2014; Morenoff JD, 2007, SOC SCI MED, V65, P1853, DOI 10.1016/j.socscimed.2007.05.038; MORRIS R, 1991, J PUBLIC HEALTH MED, V13, P318; Ng WS, 2010, BRIT J OPHTHALMOL, V94, P85, DOI 10.1136/bjo.2008.153312; Ostler K, 2001, BRIT J PSYCHIAT, V178, P12, DOI 10.1192/bjp.178.1.12; Pampalon R, 2009, HEALTH REP, V20, P85; Pujades-Rodriguez M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104671; Ulldemolins AR, 2012, INDIAN J OPHTHALMOL, V60, P368, DOI 10.4103/0301-4738.100529; Roux AVD, 2001, NEW ENGL J MED, V345, P99, DOI 10.1056/NEJM200107123450205; Singapore Department of Statistics, 2010, SING CENS POP 2010; Stata Corp L, STAT MULT MIX EFF RE; Su DHW, 2008, OPHTHALMOLOGY, V115, P964, DOI 10.1016/j.ophtha.2007.08.021; Thiagalingam S, 2002, BRIT J OPHTHALMOL, V86, P1041, DOI 10.1136/bjo.86.9.1041; TIELSCH JM, 1990, ARCH OPHTHALMOL-CHIC, V108, P286, DOI 10.1001/archopht.1990.01070040138048; TIELSCH JM, 1991, ARCH OPHTHALMOL-CHIC, V109, P637, DOI 10.1001/archopht.1991.01080050051027; Turrell G, 2001, INT J EPIDEMIOL, V30, P231, DOI 10.1093/ije/30.2.231; WHO, 2014, SOC ASP BLINDN VIS I; Wong TY, 2008, ARCH OPHTHALMOL-CHIC, V126, P1091, DOI 10.1001/archopht.126.8.1091; Wong TY, 2001, ARCH OPHTHALMOL-CHIC, V119, P727, DOI 10.1001/archopht.119.5.727; Wu RY, 2010, ARCH OPHTHALMOL-CHIC, V128, P1029, DOI 10.1001/archophthalmol.2010.147; Yip JL, 2013, J EPIDEMIOL COMMUNIT; Yip W, 2013, J HYPERTENS, V31, P1539, DOI 10.1097/HJH.0b013e328361d52b; Zheng Y, 2011, INVEST OPHTHALMOL, V52, P612; Zheng YF, 2011, INVEST OPHTH VIS SCI, V52, P8799, DOI 10.1167/iovs.11-7700; Zheng YF, 2011, INVEST OPHTH VIS SCI, V52, P7634, DOI 10.1167/iovs.11-7725; Zhuang J, 2014, E ASIAN BUREAU EC RE	59	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142302	10.1371/journal.pone.0142302	http://dx.doi.org/10.1371/journal.pone.0142302			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7CT	26555141	gold, Green Published			2022-12-26	WOS:000364430700080
J	Xu, H; Bao, JD; Dai, JS; Li, YQ; Zhu, Y				Xu, Heng; Bao, Jian-Dong; Dai, Ji-Song; Li, Yongqing; Zhu, Ying			Genome-Wide Identification of New Reference Genes for qRT-PCR Normalization under High Temperature Stress in Rice Endosperm	PLoS One			English	Article							REAL-TIME PCR; DEFINING REFERENCE GENES; ALPHA-AMYLASE GENES; HOUSEKEEPING GENES; RT-PCR; INTERNAL CONTROL; EXPRESSION; VALIDATION; SELECTION; QUALITY	qRT-PCR is one of the most popular approaches to analyze specific gene expression level, and stably expressed reference genes are essential to obtain reliable results. However, many reference genes are only stable under certain circumstances and different reference genes might be required in different experiments. High temperature is a common stress that affects rice endosperm development and it has become a hot topic recently. Although study about reference genes at different developmental stages in rice has been reported, these genes may not be suitable to study high temperature mediated responses especially in endosperm. In our quest for proper reference genes to quantify gene expression in rice endosperm under high temperature, we studied 6 candidate genes selected from the transcriptome data and 11 housekeeping genes. All genes were analyzed with qRT-PCR and the expression stability was assessed with software geNorm and NormFinder. Fb15 and eIF-4a were identified as the two most stable genes in endosperm at different developmental stages, while high temperature treatment has a least effect on expression of Fb15 and UBQ5 in rice endosperm. Our results provide some good candidate reference genes for qRT-PCR normalization in rice endosperm under different temperatures.	[Xu, Heng; Dai, Ji-Song; Zhu, Ying] Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Hangzhou 310021, Zhejiang, Peoples R China; [Bao, Jian-Dong] Fujian Agr & Forestry Univ, Coll Life Sci, Fujian Taiwan Joint Ctr Ecol Control Crop Pests, Fuzhou 350002, Peoples R China; [Li, Yongqing] Chinese Acad Sci, Key Lab South China Agr Plant Mol Anal & Genet Im, South China Bot Garden, Guangzhou 510650, Guangdong, Peoples R China	Zhejiang Academy of Agricultural Sciences; Fujian Agriculture & Forestry University; Chinese Academy of Sciences; South China Botanical Garden, CAS	Zhu, Y (corresponding author), Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Hangzhou 310021, Zhejiang, Peoples R China.	yzhuzaas@163.com	Bao, Jiandong/AAG-7303-2020	Bao, Jiandong/0000-0003-3423-5118	Ministry of Science and Technology [2012CB944803, 2012AA10A302]; Zhejiang Province Natural Science Foundation [LQ13C020002]; Zhejiang Natural Science Funds for Distinguished Young Scientists [LR14C020001]; National Natural Science Foundation of China [31400230]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Zhejiang Province Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Zhejiang Natural Science Funds for Distinguished Young Scientists; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants from Ministry of Science and Technology (2012CB944803 and 2012AA10A302) to YZ, Zhejiang Province Natural Science Foundation (LQ13C020002) to HX, Zhejiang Natural Science Funds for Distinguished Young Scientists (LR14C020001) to YZ and National Natural Science Foundation of China (31400230) to HX.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen PW, 2006, PLANT CELL, V18, P2326, DOI 10.1105/tpc.105.038844; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hakata M, 2012, PLANT BIOTECHNOL J, V10, P1110, DOI 10.1111/j.1467-7652.2012.00741.x; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jain M, 2009, PLANT SCI, V176, P702, DOI 10.1016/j.plantsci.2009.02.001; Ji YX, 2014, ACTA BIOCH BIOPH SIN, V46, P305, DOI 10.1093/abbs/gmu002; Kim BR, 2003, BIOTECHNOL LETT, V25, P1869, DOI 10.1023/A:1026298032009; Lee PD, 2002, GENOME RES, V12, P292, DOI 10.1101/gr.217802; Li HX, 2011, PLANT CELL REP, V30, P1641, DOI 10.1007/s00299-011-1074-2; Li QF, 2010, PLANT MOL BIOL REP, V28, P49, DOI 10.1007/s11105-009-0124-1; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Narsai R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-56; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; She KC, 2010, PLANT CELL, V22, P3280, DOI 10.1105/tpc.109.070821; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang JC, 2013, J EXP BOT, V64, P3453, DOI 10.1093/jxb/ert187; Xue LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031081; Yamakawa H, 2007, PLANT PHYSIOL, V144, P258, DOI 10.1104/pp.107.098665	25	19	22	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142015	10.1371/journal.pone.0142015	http://dx.doi.org/10.1371/journal.pone.0142015			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555942	Green Published, gold, Green Submitted			2022-12-26	WOS:000364430700047
J	Yv, FL; Hai, XX; Wang, ZG; Yan, AH; Liu, BX; Bi, YG				Yv, Fei L.; Hai, Xiaoxia; Wang, Zhigang; Yan, Aihua; Liu, Bingxiang; Bi, Yongguo			Integration of Visual and Olfactory Cues in Host Plant Identification by the Asian Longhorned Beetle, Anoplophora glabripennis (Motschulsky) (Coleoptera: Cerambycidae)	PLOS ONE			English	Article							SPOTTED LONGICORN BEETLE; MALE-PRODUCED PHEROMONE; MALASIACA THOMSON COLEOPTERA; ORIENTATION BEHAVIOR; RECOGNITION; POPULATIONS; ATTRACTION; VOLATILES; FECUNDITY; TRAP	Some insects use host and mate cues, including odor, color, and shape, to locate and recognize their preferred hosts and mates. Previous research has shown that the Asian longicorn beetle, Anoplophora glabripennis (Motschulsky), uses olfactory cues to locate host plants and differentiate them from non-host plants. However, whether A. glabripennis adults use visual cues or a combination of visual and olfactory cues remains unclear. In this study, we tested the host location and recognition behavior in A. glabripennis, which infests a number of hardwood species and causes considerable economic losses in North America, Europe and Asia. We determined the relative importance of visual and olfactory cues from Acer negundo in host plant location and recognition, as well as in the discrimination of non-host plants (Sabina chinensis and Pinus bungeana), by female and male A. glabripennis. Visual and olfactory cues from the host plants (A. negundo), alone and combined, attracted significantly more females and males than equivalent cues from non-host plants (S. chinensis and P. bungeana). Furthermore, the combination of visual and olfactory cues of host plants attracted more adults than either cue alone, and visual cues alone attracted significantly more adults than olfactory cues alone. This finding suggests that adult A. glabripennis has an innate preference for the visual and/or olfactory cues of its host plants (A. negundo) over those of the non-host plant and visual cues are initially more important than olfactory cues for orientation; furthermore, this finding also suggests that adults integrate visual and olfactory cues to find their host plants. Our results indicate that different modalities of host plant cues should be considered together to understand fully the communication between host plants and Asian longhorned beetles.	[Yv, Fei L.; Hai, Xiaoxia; Wang, Zhigang; Yan, Aihua; Liu, Bingxiang; Bi, Yongguo] Univ Agr, Coll Forestry, Baoding 071000, Hebei, Peoples R China; [Yv, Fei L.; Hai, Xiaoxia; Wang, Zhigang; Yan, Aihua; Liu, Bingxiang; Bi, Yongguo] Key Labs Germplasm Resources Forest Trees & Fores, Baoding 071000, Peoples R China		Wang, ZG (corresponding author), Univ Agr, Coll Forestry, Baoding 071000, Hebei, Peoples R China.	wzhg432@163.com			Program of National Natural Science of China [C30571501]	Program of National Natural Science of China(National Natural Science Foundation of China (NSFC))	This project was supported by the Program of National Natural Science of China (No. C30571501).	Andersson P, 2011, ARTHROPOD-PLANT INTE, V5, P269, DOI 10.1007/s11829-011-9148-1; [Anonymous], 2012, IBM SPSS STAT VERS 2; Bahlai CA, 2008, ENVIRON ENTOMOL, V37, P973, DOI 10.1603/0046-225X(2008)37[973:ROVAOC]2.0.CO;2; Benelli G, 2013, BIOL CONTROL, V64, P116, DOI 10.1016/j.biocontrol.2012.10.010; Burger H, 2010, FUNCT ECOL, V24, P1234, DOI 10.1111/j.1365-2435.2010.01744.x; Campbell SA, 2009, OIKOS, V118, P553, DOI 10.1111/j.1600-0706.2009.16761.x; Crook DJ, 2014, J CHEM ECOL, V40, P1241, DOI 10.1007/s10886-014-0520-3; Dotterl S, 2011, J COMP PHYSIOL A, V197, P1119, DOI 10.1007/s00359-011-0673-2; Fischer S, 2001, J COMP PHYSIOL A, V187, P785, DOI 10.1007/s00359-001-0249-7; Fukaya M, 2005, APPL ENTOMOL ZOOL, V40, P63, DOI 10.1303/aez.2005.63; Fukaya M, 2004, ENTOMOL EXP APPL, V111, P111, DOI 10.1111/j.0013-8703.2004.00147.x; Ginzel MD, 2003, J INSECT BEHAV, V16, P181, DOI 10.1023/A:1023911701159; Guo FZ, 2005, SCIENCE, V309, P307, DOI 10.1126/science.1111280; Haack RA, 2010, ANNU REV ENTOMOL, V55, P521, DOI 10.1146/annurev-ento-112408-085427; Hanks LM, 1999, ANNU REV ENTOMOL, V44, P483, DOI 10.1146/annurev.ento.44.1.483; He Ping, 1993, Acta Entomologica Sinica, V36, P51; Henneman ML, 2002, J CHEM ECOL, V28, P2221, DOI 10.1023/A:1021097215572; Hu JF, 2009, AGR FOREST ENTOMOL, V11, P359, DOI 10.1111/j.1461-9563.2009.00443.x; Jin Youju, 2004, Scientia Silvae Sinicae, V40, P99; Keena MA, 2002, ENVIRON ENTOMOL, V31, P490, DOI 10.1603/0046-225X-31.3.490; Kerr JL, 2010, THESIS U CANTERBURY, P57; Li Dejia, 1999, Journal of Beijing Forestry University, V21, P33; Li HX, 2008, J HEILONGJIANG VOCAT, V21, P23; Liu Bo, 2012, Zhejiang Nonglin Daxue Xuebao, V29, P617; Lu W, 2007, ENVIRON ENTOMOL, V36, P864, DOI 10.1603/0046-225X(2007)36[864:MLARIG]2.0.CO;2; McIntosh RL, 2001, AGR FOREST ENTOMOL, V3, P113, DOI 10.1046/j.1461-9563.2001.00095.x; McQuate GT, 2014, SCI REP-UK, V4, DOI 10.1038/srep04499; Meng PS, 2014, ENVIRON ENTOMOL, V43, P1379, DOI 10.1603/EN14129; Milet-Pinheiro P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128577; Milet-Pinheiro P, 2012, BEHAV ECOL, V23, P531, DOI 10.1093/beheco/arr219; Nehme ME, 2010, ENVIRON ENTOMOL, V39, P169, DOI 10.1603/EN09177; Nehme ME, 2009, ENVIRON ENTOMOL, V38, P1745, DOI 10.1603/022.038.0628; Otalora-Luna F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053120; Raguso RA, 2002, ANIM BEHAV, V64, P685, DOI 10.1006/anbe.2002.4010; Schaefer HM, 2004, TRENDS ECOL EVOL, V19, P577, DOI 10.1016/j.tree.2004.08.003; Smith MT, 2002, ENVIRON ENTOMOL, V31, P76, DOI 10.1603/0046-225X-31.1.76; Song B, 2015, J PLANT ECOL, V8, P173, DOI 10.1093/jpe/rtv012; van der Gaag D. J., 2014, Bulletin OEPP, V44, P518, DOI 10.1111/epp.12151; Wang PY, 2015, ENTOMOL EXP APPL, V155, P162, DOI 10.1111/eea.12295; Wang T, 2004, FOREST PEST DIS, V5, P42; Wang Z.G., 2004, STUDY OCCURRENCE DYN; Webster B, 2010, ANIM BEHAV, V79, P451, DOI 10.1016/j.anbehav.2009.11.028; Wickham JD, 2012, INSECT SCI, V19, P355, DOI 10.1111/j.1744-7917.2012.01504.x; Yasui H, 2008, CHEMOECOLOGY, V18, P233, DOI 10.1007/s00049-008-0410-7; Yasui H, 2011, CHEMOECOLOGY, V21, P51, DOI 10.1007/s00049-010-0065-z; Zhang AJ, 2003, NATURWISSENSCHAFTEN, V90, P410, DOI 10.1007/s00114-003-0452-1; Zhang AJ, 2002, Z NATURFORSCH C, V57, P553; [张风娟 ZHANG FengJuan], 2006, [生态学报, Acta Ecologica Sinica], V26, P870; Zhou ZhongShi, 2011, Entomologia Experimentalis et Applicata, V138, P48, DOI 10.1111/j.1570-7458.2010.01074.x	49	6	6	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142752	10.1371/journal.pone.0142752	http://dx.doi.org/10.1371/journal.pone.0142752			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556100	Green Submitted, gold, Green Published			2022-12-26	WOS:000364430700168
J	Song, KD; Wang, R; Liu, Y; Qian, DP; Zhang, H; Cai, JH				Song, Kaida; Wang, Rui; Liu, Yi; Qian, Depei; Zhang, Han; Cai, Jihong			Game Theoretical Analysis on Cooperation Stability and Incentive Effectiveness in Community Networks	PLOS ONE			English	Article							EVOLUTION	Community networks, the distinguishing feature of which is membership admittance, appear on P2P networks, social networks, and conventional Web networks. Joining the network costs money, time or network bandwidth, but the individuals get access to special resources owned by the community in return. The prosperity and stability of the community are determined by both the policy of admittance and the attraction of the privileges gained by joining. However, some misbehaving users can get the dedicated resources with some illicit and low-cost approaches, which introduce instability into the community, a phenomenon that will destroy the membership policy. In this paper, we analyze on the stability using game theory on such a phenomenon. We propose a game-theoretical model of stability analysis in community networks and provide conditions for a stable community. We then extend the model to analyze the effectiveness of different incentive policies, which could be used when the community cannot maintain its members in certain situations. Then we verify those models through a simulation. Finally, we discuss several ways to promote community network's stability by adjusting the network's properties and give some proposal on the designs of these types of networks from the points of game theory and stability.	[Song, Kaida; Wang, Rui] Beihang Univ, State Key Lab Software Dev Environm, Beijing 100191, Peoples R China; [Song, Kaida; Wang, Rui; Liu, Yi; Qian, Depei] Beihang Univ, Sch Comp Sci & Engn, Beijing 100191, Peoples R China; [Zhang, Han; Cai, Jihong] Beijing Simulat Ctr, Sci & Technol Special Syst Simulat Lab, Beijing, Peoples R China	Beihang University; Beihang University	Wang, R (corresponding author), Beihang Univ, State Key Lab Software Dev Environm, Beijing 100191, Peoples R China.	wangrui@buaa.edu.cn						Acres J., 2001, U.S. Patent, Patent No. [6,244,958, 6244958]; Aggarwal V., 2008, PAR DISTR NETW BAS P; Andrade N., 2005, P 2005 ACM IGCOMM WO; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Ballester C, 2006, ECONOMETRICA, V74, P1403, DOI 10.1111/j.1468-0262.2006.00709.x; Bharambe A R, 2008, BITTORRENT IS AUCTIO; Challet D, 1997, PHYSICA A, V246, P407, DOI 10.1016/S0378-4371(97)00419-6; Chen B. B., 2010, NEUR NETW IJCNN 2010, P1; Chen X, 2012, IET COMMUN, V6, P1640, DOI 10.1049/iet-com.2011.0196; Cohen B., 2003, WORKSH EC PEER TO PE, V6, P68; Cohill A M, 1997, COMMUNITY NETWORKS L; DASPREMONT C, 1983, CAN J ECON, V16, P17, DOI 10.2307/134972; FRIEDMAN JW, 1971, REV ECON STUD, V38, P1, DOI 10.2307/2296617; Goyal S, 2001, RAND J ECON, V32, P686, DOI 10.2307/2696388; Habib A, 2004, INT WORKSH QUAL SERV, P171; Huang K., 2015, PLOS ONE, V10; Huang KK, 2015, APPL MATH COMPUT, V266, P501, DOI 10.1016/j.amc.2015.05.065; Lian Q., 2006, 5 INT WORKSH PEER TO; Ma R. T. B., 2003, Performance Evaluation Review, V31, P23, DOI 10.1145/959143.959157; Mougi A, 2014, J THEOR BIOL, V360, P54, DOI 10.1016/j.jtbi.2014.06.030; NOE R, 1990, ANIM BEHAV, V39, P78, DOI 10.1016/S0003-3472(05)80728-6; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Peng Z., 2007, DIG SOC 2007 ICDS 07; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Rand DG, 2011, P NATL ACAD SCI USA, V108, P19193, DOI 10.1073/pnas.1108243108; Rapoport A., 1965, PRISONERS DILEMMA ST; Roos Patrick, 2009, EVOLUTIONARY GAME TH; Rozario Fabian, 2011, WIR COMM NETW C WCNC; Schlessinger D, 1993, MECH MICROBIAL DIS, P162; Tan G, 2006, INT WORKSH QUAL SERV, P41, DOI 10.1109/IWQOS.2006.250450; Wang T. M., 2012, ADV INF NETW APPL WO; Wang Z, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.021115; Weibull J W, 1997, EVOLUTIONARY GAME TH; Wu TY, 2014, J NETW COMPUT APPL, V41, P47, DOI 10.1016/j.jnca.2013.10.006; Wu WJ, 2012, IEEE T PARALL DISTR, V23, P1492, DOI 10.1109/TPDS.2011.295; Yao L., 2011, EL COMM CONTR ICECC; Zhang C, 2011, IEEE T PARALL DISTR, V22, P1164, DOI 10.1109/TPDS.2010.123	38	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0141755	10.1371/journal.pone.0141755	http://dx.doi.org/10.1371/journal.pone.0141755			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7AC	26551649	Green Published, Green Submitted, gold			2022-12-26	WOS:000364422800009
J	Uchime, O; Dai, Z; Biris, N; Lee, D; Sidhu, SS; Li, S; Lai, JR; Gavathiotis, E				Uchime, Onyinyechukwu; Dai, Zhou; Biris, Nikolaos; Lee, David; Sidhu, Sachdev S.; Li, Sheng; Lai, Jonathan R.; Gavathiotis, Evripidis			Synthetic Antibodies Inhibit Bcl-2-associated X Protein (BAX) through Blockade of the N-terminal Activation Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody engineering; B cell lymphoma 2 (Bcl-2) family; BAX; mitochondrial apoptosis; protein structure; structure-function; protein targeting; synthetic antibody; phage display	PROAPOPTOTIC BAX; CELL-DEATH; MASS-SPECTROMETRY; APOPTOSIS; BCL-2; MECHANISM; MEMBRANE; FAMILY; PERMEABILIZATION; MITOCHONDRIA	The BCL-2 protein family plays a critical role in regulating cellular commitment to mitochondrial apoptosis. Pro-apoptotic Bcl-2-associated X protein (BAX) is an executioner protein of the BCL-2 family that represents the gateway to mitochondrial apoptosis. Following cellular stresses that induce apoptosis, cytosolic BAX is activated and translocates to the mitochondria, where it inserts into the mitochondrial outer membrane to form a toxic pore. How the BAX activation pathway proceeds and how this may be inhibited is not yet completely understood. Here we describe synthetic antibody fragments (Fabs) as structural and biochemical probes to investigate the potential mechanisms of BAX regulation. These synthetic Fabs bind with high affinity to BAX and inhibit its activation by the BH3-only protein tBID (truncated Bcl2 interacting protein) in assays using liposomal membranes. Inhibition of BAX by a representative Fab, 3G11, prevented mitochondrial translocation of BAX and BAX-mediated cytochrome c release. Using NMR and hydrogen-deuterium exchange mass spectrometry, we showed that 3G11 forms a stoichiometric and stable complex without inducing a significant conformational change on monomeric and inactive BAX. We identified that the Fab-binding site on BAX involves residues of helices 1/6 and the 1-2 loop. Therefore, the inhibitory binding surface of 3G11 overlaps with the N-terminal activation site of BAX, suggesting a novel mechanism of BAX inhibition through direct binding to the BAX N-terminal activation site. The synthetic Fabs reported here reveal, as probes, novel mechanistic insights into BAX inhibition and provide a blueprint for developing inhibitors of BAX activation.	[Uchime, Onyinyechukwu; Biris, Nikolaos; Gavathiotis, Evripidis] Albert Einstein Coll Med, Albert Einstein Canc Ctr, Wilf Family Cardiovasc Res Inst, Dept Biochem, Bronx, NY 10461 USA; [Uchime, Onyinyechukwu; Biris, Nikolaos; Gavathiotis, Evripidis] Albert Einstein Coll Med, Albert Einstein Canc Ctr, Wilf Family Cardiovasc Res Inst, Dept Med, Bronx, NY 10461 USA; [Dai, Zhou; Lai, Jonathan R.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Lee, David; Li, Sheng] Univ Calif San Diego, Sch Med, San Diego, CA 92093 USA; [Sidhu, Sachdev S.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Sidhu, Sachdev S.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California San Diego; University of Toronto; University of Toronto	Lai, JR (corresponding author), Albert Einstein Coll Med, 1300 Morris Pk, Bronx, NY 10461 USA.	jon.lai@einstein.yu.edu; evripidis.gavathiotis@einstein.yu.edu		Lee, David/0000-0001-7232-0968; Dai, Zhou/0000-0001-5333-1178; Biris, Nikolaos/0000-0003-4055-5521; Gavathiotis, Evripidis/0000-0001-6319-8331	National Institutes of Health [R00HL095929, R01CA178394, R21CA155472, R01 GM020501, R56AI110750, R01AI101436, 1S10OD016305, P30 CA013330]; New York Structural Biology Center (NYSBC); Empire State Development's Division of Science, Technology and Innovation (NYSTAR); National Institutes of Health MSTP Training Grant [T32GM007288]; NCI/National Institutes of Health Individual Training Fellowship [F31CA186672]; Sidney Kimmel Foundation for Cancer Research; Gabrielle's Angel Foundation for Cancer Research; Alexandrine and Alexander L. Sinsheimer Foundation; NATIONAL CANCER INSTITUTE [R01CA178394, F31CA186672, R21CA155472, P30CA013330] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL095929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101436, R56AI110750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020501] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016305] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Structural Biology Center (NYSBC); Empire State Development's Division of Science, Technology and Innovation (NYSTAR); National Institutes of Health MSTP Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI/National Institutes of Health Individual Training Fellowship; Sidney Kimmel Foundation for Cancer Research; Gabrielle's Angel Foundation for Cancer Research; Alexandrine and Alexander L. Sinsheimer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by National Institutes of Health Grants R00HL095929 and R01CA178394 (to E. G.); R21CA155472 (to J. R. L.); and R01 GM020501, R56AI110750, and R01AI101436 (to S. L.). This work was partially supported by contributions to the Albert Einstein Center for Experimental Therapeutics by Pamela and Edward S. Pantzer. NMR data were collected at the Einstein NMR Resource with support from National Institutes of Health Awards 1S10OD016305 and P30 CA013330 and at New York Structural Biology Center (NYSBC) with support from a grant from Empire State Development's Division of Science, Technology and Innovation (NYSTAR). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health MSTP Training Grant T32GM007288 and NCI/National Institutes of Health Individual Training Fellowship F31CA186672.; Supported by the Sidney Kimmel Foundation for Cancer Research, Gabrielle's Angel Foundation for Cancer Research, and the Alexandrine and Alexander L. Sinsheimer Foundation. To whom correspondence may be addressed: Albert Einstein College of Medicine, 1300 Morris Park, Forchheimer G46, Bronx, NY 10461. Tel.: 718-430-3725; Fax: 718-430-8989; E-mail: evripidis.gavathiotis@einstein.yu.edu.	Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; Barclay LA, 2015, MOL CELL, V57, P873, DOI 10.1016/j.molcel.2015.01.014; Bleicken S, 2014, MOL CELL, V56, P496, DOI 10.1016/j.molcel.2014.09.022; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Czabotar PE, 2013, CELL, V152, P519, DOI 10.1016/j.cell.2012.12.031; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Ding JZ, 2014, J BIOL CHEM, V289, P11873, DOI 10.1074/jbc.M114.552562; Ding JZ, 2010, J BIOL CHEM, V285, P28749, DOI 10.1074/jbc.M110.148361; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Edwards AL, 2013, CHEM BIOL, V20, P888, DOI 10.1016/j.chembiol.2013.06.007; Fellouse FA, 2007, J MOL BIOL, V373, P924, DOI 10.1016/j.jmb.2007.08.005; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Gahl RF, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.593897; Gao JJ, 2009, P NATL ACAD SCI USA, V106, P3071, DOI 10.1073/pnas.0812952106; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Gavathiotis E, 2012, NAT CHEM BIOL, V8, P639, DOI [10.1038/NCHEMBIO.995, 10.1038/nchembio.995]; Gavathiotis E, 2010, MOL CELL, V40, P481, DOI 10.1016/j.molcel.2010.10.019; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Koellhoffer JF, 2012, CHEMBIOCHEM, V13, P2549, DOI 10.1002/cbic.201200493; Koerber JT, 2013, NAT BIOTECHNOL, V31, P916, DOI 10.1038/nbt.2672; Leshchiner ES, 2013, P NATL ACAD SCI USA, V110, pE986, DOI 10.1073/pnas.1214313110; Li S, 2011, J BIOL CHEM, V286, P17889, DOI 10.1074/jbc.M111.224535; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Ma JH, 2012, P NATL ACAD SCI USA, V109, P20901, DOI 10.1073/pnas.1217094110; Marcatili P, 2014, NAT PROTOC, V9, P2771, DOI 10.1038/nprot.2014.189; Marsh JJ, 2013, BIOCHEMISTRY-US, V52, P5491, DOI 10.1021/bi4007995; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Paduch M, 2013, METHODS, V60, P3, DOI 10.1016/j.ymeth.2012.12.010; Persson H, 2013, J MOL BIOL, V425, P803, DOI 10.1016/j.jmb.2012.11.037; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Sidhu SS, 2006, NAT CHEM BIOL, V2, P682, DOI 10.1038/nchembio843; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tsai CJ, 2015, STRUCTURE, V23, P139, DOI 10.1016/j.str.2014.10.016; Walensky LD, 2011, TRENDS BIOCHEM SCI, V36, P642, DOI 10.1016/j.tibs.2011.08.009; Westphal D, 2014, CELL DEATH DIFFER, V21, P196, DOI 10.1038/cdd.2013.139; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522	42	22	23	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					89	102		10.1074/jbc.M115.680918	http://dx.doi.org/10.1074/jbc.M115.680918			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26565029	Green Published, hybrid			2022-12-26	WOS:000367589500007
J	Huang, F; Qiao, HM; Yin, JN; Gao, Y; Ju, YH; Li, YN				Huang, Fei; Qiao, Hong-mei; Yin, Jia-ning; Gao, Yang; Ju, Yang-hua; Li, Ya-nan			Early-Life Exposure to Clostridium leptum Causes Pulmonary Immunosuppression	PLOS ONE			English	Article							REGULATORY T-CELLS; ALLERGIC AIRWAY INFLAMMATION; CESAREAN-SECTION; CHILDHOOD ASTHMA; B-CELLS; DELIVERY; MICE; MICROBIOTA; CYTOKINE; INDUCTION	Introduction Low Clostridium leptum levels are a risk factor for the development of asthma. C. leptum deficiency exacerbates asthma; however, the impact of early-life C. leptum exposure on cesarean-delivered mice remains unclear. This study is to determine the effects of early-life C. leptum exposure on asthma development in infant mice. Methods We exposed infant mice to C. leptum (fed-CL) and then induced asthma using the allergen ovalbumin (OVA). Results Fed-CL increased regulatory T (Treg) cells in cesarean-delivered mice compared with vaginally delivered mice. Compared with OVA-exposed mice, mice exposed to C. leptum + OVA did not develop the typical asthma phenotype, which includes airway hyper-responsiveness, cell infiltration, and T helper cell subset (Th1, Th2, Th9, Th17) inflammation. Early-life C. leptum exposure induced an immunosuppressive environment in the lung concurrent with increased Treg cells, resulting in the inhibition of Th1, Th2, Th9, and Th17 cell responses. Conclusion These findings demonstrate a mechanism whereby C. leptum exposure modulates adaptive immunity and leads to failure to develop asthma upon OVA sensitization later in life.	[Huang, Fei] Jilin Univ, China Japan Union Hosp, Dept Orthoped, Changchun 130023, Jilin, Peoples R China; [Qiao, Hong-mei; Yin, Jia-ning; Gao, Yang; Ju, Yang-hua; Li, Ya-nan] Jilin Univ, Hosp 1, Dept Pediat, Changchun 130023, Jilin, Peoples R China; [Yin, Jia-ning; Li, Ya-nan] Jilin Univ, Basic Med Coll, Dept Mol Biol, Changchun 130023, Jilin, Peoples R China	Jilin University; Jilin University; Jilin University	Li, YN (corresponding author), Jilin Univ, Hosp 1, Dept Pediat, Changchun 130023, Jilin, Peoples R China.	lyanan2008@sina.com			National Natural Science Foundation of China [81200013]; Jilin University [2014202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jilin University(Jilin University)	This work was sponsored by grants awarded to Ya-nan Li from the National Natural Science Foundation of China (No. 81200013) and the Bethune Program of Jilin University (No. 2014202).	Ashour HM, 2007, INT ARCH ALLERGY IMM, V144, P343, DOI 10.1159/000106461; Ashour HM, 2007, J LEUKOCYTE BIOL, V82, P1033, DOI 10.1189/jlb.0507310; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Barros FC, 2012, AM J CLIN NUTR, V95, P465, DOI 10.3945/ajcn.111.026401; Bhattacharya P, 2014, CLIN IMMUNOL, V153, P187, DOI 10.1016/j.clim.2014.04.014; Biasucci G, 2008, J NUTR, V138, p1796S, DOI 10.1093/jn/138.9.1796S; Bihouee T, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0142-x; Collado MC, 2015, PEDIATR RES, V77, P182, DOI 10.1038/pr.2014.173; CHEN Z, 2013, NOVEL ROLE IL 7 LIGA, V190, P5256, DOI DOI 10.4049/JIMMUNOL.1201675; Debley JS, 2005, ANN ALLERG ASTHMA IM, V94, P228, DOI 10.1016/S1081-1206(10)61300-2; Decker E, 2010, PEDIATRICS, V125, pE1433, DOI 10.1542/peds.2009-2260; Elshabrawy HA, 2014, J VIROL, V88, P4353, DOI 10.1128/JVI.03050-13; Elshabrawy HA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050366; Ganguli K, 2011, J CLIN GASTROENTEROL, V45, pS133, DOI 10.1097/MCG.0b013e318228b799; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Gronlund MM, 1999, J PEDIATR GASTR NUTR, V28, P19, DOI 10.1097/00005176-199901000-00007; Gunzer M, 2001, J IMMUNOL METHODS, V258, P55, DOI 10.1016/S0022-1759(01)00466-5; Hartl D, 2007, J ALLERGY CLIN IMMUN, V119, P1258, DOI 10.1016/j.jaci.2007.02.023; Horka H, 2012, J IMMUNOL, V188, P2669, DOI 10.4049/jimmunol.1100529; Hyde MJ, 2012, EARLY HUM DEV, V88, P943, DOI 10.1016/j.earlhumdev.2012.09.006; Li YN, 2014, HUM IMMUNOL, V75, P1232, DOI 10.1016/j.humimm.2014.09.017; Li YN, 2012, ANN ALLERG ASTHMA IM, V109, P201, DOI 10.1016/j.anai.2012.06.017; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma CH, 2014, PHYTOTHER RES, V28, P231, DOI 10.1002/ptr.4983; Magnus MC, 2011, AM J EPIDEMIOL, V174, P1275, DOI 10.1093/aje/kwr242; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Neu J, 2011, CLIN PERINATOL, V38, P321, DOI 10.1016/j.clp.2011.03.008; Raphael I, 2015, CYTOKINE, V74, P5, DOI 10.1016/j.cyto.2014.09.011; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Salzman NH, 2014, ANN ALLERG ASTHMA IM, V113, P593, DOI 10.1016/j.anai.2014.08.020; Schnyder B, 2010, CYTOKINE, V50, P220, DOI 10.1016/j.cyto.2010.02.003; Sghir A, 2000, APPL ENVIRON MICROB, V66, P2263, DOI 10.1128/AEM.66.5.2263-2266.2000; Shurin MR, 2014, ACS NANO, V8, P5585, DOI 10.1021/nn406454u; Smith AJP, 2009, CYTOKINE GROWTH F R, V20, P43, DOI 10.1016/j.cytogfr.2008.11.006; Takemura M, 2012, RESPIRATION, V83, P308, DOI 10.1159/000332835; Tamachi T, 2006, J ALLERGY CLIN IMMUN, V118, P606, DOI 10.1016/j.jaci.2006.04.051; Temann UA, 2002, J CLIN INVEST, V109, P29, DOI 10.1172/JCI13696; Thavagnanam S, 2008, CLIN EXP ALLERGY, V38, P629, DOI 10.1111/j.1365-2222.2007.02780.x; Tian T, 2013, EXPERT OPIN THER TAR, V17, P113, DOI 10.1517/14728222.2013.736497; van Nimwegen FA, 2011, J ALLERGY CLIN IMMUN, V128, P948, DOI 10.1016/j.jaci.2011.07.027; Wakashin H, 2008, AM J RESP CRIT CARE, V178, P1023, DOI 10.1164/rccm.200801-086OC; Wisniewski JA, 2011, ALLERGY ASTHMA PROC, V32, P83, DOI 10.2500/aap.2011.32.3428; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Xing JC, 2011, J ASTHMA, V48, P115, DOI 10.3109/02770903.2011.554944; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	48	11	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0141717	10.1371/journal.pone.0141717	http://dx.doi.org/10.1371/journal.pone.0141717			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26565810	Green Published, Green Submitted, gold			2022-12-26	WOS:000367628500005
J	D'Amato, F; Noli, B; Angioni, L; Cossu, E; Incani, M; Messana, I; Manconi, B; Solinas, P; Isola, R; Mariotti, S; Ferri, GL; Cocco, C				D'Amato, Filomena; Noli, Barbara; Angioni, Laura; Cossu, Efisio; Incani, Michela; Messana, Irene; Manconi, Barbara; Solinas, Paola; Isola, Raffaella; Mariotti, Stefano; Ferri, Gian-Luca; Cocco, Cristina			VGF Peptide Profiles in Type 2 Diabetic Patients' Plasma and in Obese Mice	PLOS ONE			English	Article							RECEPTOR C3AR1; TLQP-21; PROTEIN; TISSUE; GENE; MASS; IDENTIFICATION; EXPRESSION; SECRETION; PRECURSOR	To address the possible involvement of VGF peptides in obesity and diabetes, we studied type 2 diabetes (T2D) and obese patients, and high-fat diet induced obese mice. Two VGF peptides (NAPP-19 and QQET-30) were identified in human plasma by HPLC-ESI-MS. The VGF C-terminus, the above two cleaved peptides, and the TLQP-21 related peptide/s were studied using ELISA and immunohistochemistry. In euglycemic patients, plasma NAPPE and TLQP like peptides were significantly reduced with obesity (74 +/- 10 vs. 167 +/- 28, and 92 +/- 10 vs. 191 +/- 19 pmol/ml, mean+SEM, n = 10 and 6, obese vs. normal BMI, respectively, p<0.03). Upon a standard glucose load, a distinct response was shown for VGF C-terminus, TLQP and QQET-like (ERVW immunoreactive) peptides in euglycemic normal BMI patients, but was virtually abolished in euglycemic obese, and in T2D patients independently of BMI. High-fat diet induced obese mice showed reduced plasma VGF C-terminus, NAPPE and QQET-like (ERVW) peptide/s (3 +/- 0.2 vs. 4.6 +/- 0.3, 22 +/- 3.5 vs. 34 +/- 1.3, and 48 +/- 7 vs. 100 +/- 7 pmol/ml, mean+SEM, n = 8/group, obese vs. slim, respectively, p<0.03), with a loss of the response to glucose for all VGF peptides studied. In immunohistochemistry, TLQP and/or VGF C-terminus antibodies labelled VGF containing perikarya in mouse celiac ganglia, pancreatic islet cells and thin beaded nerve fibres in brown adipose tissues, with fewer in white adipose tissue. Upon the glucose load, tyrosine hydroxylase and VGF C-terminus immunoreactive axons became apparent in pancreatic islets of slim animals, but not in obese animals. Alltogether, a significant loss of VGF peptide immunoreactivity and/or their response to glucose was demonstrated in obese patients, with or without T2D, in parallel with a similar loss in high-fat diet induced obese mice. An involvement of VGF in metabolic regulations, including those of brown and/or white adipose tissues is underlined, and may point out specific VGF peptides as potential targets for diagnosis and/or treatment.	[D'Amato, Filomena; Noli, Barbara; Angioni, Laura; Solinas, Paola; Isola, Raffaella; Ferri, Gian-Luca; Cocco, Cristina] Univ Cagliari, Dept Biomed Sci, I-09042 Monserrato, Italy; [Cossu, Efisio; Incani, Michela; Mariotti, Stefano] Univ Cagliari, Dept Med Sci, I-09042 Monserrato, Italy; [Messana, Irene; Manconi, Barbara] Univ Cagliari, Dept Life & Environm Sci, I-09042 Monserrato, Italy	University of Cagliari; University of Cagliari; University of Cagliari	D'Amato, F (corresponding author), Univ Cagliari, Dept Biomed Sci, I-09042 Monserrato, Italy.	mena_damato@yahoo.it	Messana, Irene/L-2478-2019; Ferri, Luca Angelo/AAC-5890-2022; Mariotti, Stefano/AAN-1948-2020	Messana, Irene/0000-0002-1436-6105; Ferri, Luca Angelo/0000-0001-9031-6284; Mariotti, Stefano/0000-0002-1208-7057; FERRI, Gian-Luca/0000-0003-2768-349X; INCANI, MICHELA/0000-0003-1623-5376	ARS (Autonomous Region of Sardinia) [L.R. 7/2007]	ARS (Autonomous Region of Sardinia)(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This study was sponsored by the ARS (Autonomous Region of Sardinia) through the 'Sardinia PO FSE 2007-1013' funds (the L.R. 7/2007 for the 'Promotion of the Scientific Research and of the Technological Innovation in Sardinia'). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Bartolomucci A, 2006, P NATL ACAD SCI USA, V103, P14584, DOI 10.1073/pnas.0606102103; Bell JA, 2014, OBES REV, V15, P504, DOI 10.1111/obr.12157; Brancia C, 2010, J ENDOCRINOL, V207, P329, DOI 10.1677/JOE-10-0189; Cero C, 2014, STRUCTURE, V22, P1744, DOI 10.1016/j.str.2014.10.001; Christiansen CB, 2015, HORM METAB RES, V47, P537, DOI 10.1055/s-0034-1395615; Cocco C, 2003, APPL IMMUNOHISTO M M, V11, P274; Cocco C, 2007, J HISTOCHEM CYTOCHEM, V55, P619, DOI 10.1369/jhc.6A7040.2007; Cocco C, 2010, J ANAT, V217, P683, DOI 10.1111/j.1469-7580.2010.01309.x; D'Amato F, 2008, J ENDOCRINOL, V197, P359, DOI 10.1677/JOE-07-0346; D'Amato F, 2012, J CHEM NEUROANAT, V44, P57, DOI 10.1016/j.jchemneu.2012.05.001; DeFronzo RA, 2004, MED CLIN N AM, V88, P787, DOI 10.1016/j.mcna.2004.04.013; Ferri GL, 2011, J CHEM NEUROANAT, V42, P249, DOI 10.1016/j.jchemneu.2011.05.007; FERRI GL, 1995, ENDOCRINOLOGY, V136, P2244, DOI 10.1210/en.136.5.2244; Hahm S, 1999, NEURON, V23, P537, DOI 10.1016/S0896-6273(00)80806-5; Hahm S, 2002, J NEUROSCI, V22, P6929; Hannedouche S, 2013, J BIOL CHEM, V288, P27434, DOI 10.1074/jbc.M113.497214; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Lecube A, 2012, J NEUROENDOCRINOL, V24, P944, DOI 10.1111/j.1365-2826.2012.02288.x; Levi A, 2004, CELL MOL NEUROBIOL, V24, P517, DOI 10.1023/B:CEMN.0000023627.79947.22; Moin ASM, 2012, BIOCHEM BIOPH RES CO, V428, P512, DOI 10.1016/j.bbrc.2012.10.073; Montanya E, 2014, DIABETES, V63, P832, DOI 10.2337/db13-1843; Noli B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108456; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Petrocchi-Passeri P, 2015, J MOL ENDOCRINOL, V54, P227, DOI 10.1530/JME-14-0313; POSSENTI R, 1989, EMBO J, V8, P2217, DOI 10.1002/j.1460-2075.1989.tb08345.x; Possenti R, 2012, BIOCHEM J, V441, P511, DOI 10.1042/BJ20111165; Sadahiro M, 2015, ENDOCRINOLOGY, V156, P1724, DOI 10.1210/en.2014-1826; Saderi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040070; Salton SRJ, 2000, FRONT NEUROENDOCRIN, V21, P199, DOI 10.1006/frne.2000.0199; Sasaki K, 2013, MOL CELL PROTEOMICS, V12, P700, DOI 10.1074/mcp.M112.017400; Sasaki K, 2010, J PROTEOME RES, V9, P5047, DOI 10.1021/pr1003455; SEIDELL JC, 1989, INT J OBESITY, V13, P289; Snyder SE, 1998, J COMP NEUROL, V394, P91; Stephens SB, 2012, CELL METAB, V16, P33, DOI 10.1016/j.cmet.2012.05.011; Toshinai K, 2010, AM J PHYSIOL-ENDOC M, V299, pE394, DOI 10.1152/ajpendo.00768.2009; Trani E, 2002, J NEUROCHEM, V81, P565, DOI 10.1046/j.1471-4159.2002.00842.x; TRANI E, 1995, J NEUROCHEM, V65, P2441; Vazquez G, 2007, EPIDEMIOL REV, V29, P115, DOI 10.1093/epirev/mxm008; Verrotti A, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00205; Watson E, 2005, ENDOCRINOLOGY, V146, P5151, DOI 10.1210/en.2005-0588; Zhao Zhong, 2008, Int J Med Sci, V5, P92	42	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142333	10.1371/journal.pone.0142333	http://dx.doi.org/10.1371/journal.pone.0142333			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562304	Green Submitted, Green Published, gold			2022-12-26	WOS:000364480900025
J	He, XW; Liu, XT; Liu, WJ; Wang, B; Liu, YJ; Li, ZX; Wang, T; Tan, R; Gao, B; Zeng, HS				He, Xingwei; Liu, Xintian; Liu, Wanjun; Wang, Bei; Liu, Yujian; Li, Zhuxi; Wang, Tao; Tan, Rong; Gao, Bo; Zeng, Hesong			Association between Diabetes and Risk of Aortic Dissection: A Case-Control Study in a Chinese Population	PLOS ONE			English	Article							INTERNATIONAL REGISTRY; CARDIAC AUTOPHAGY; AMERICAN-COLLEGE; MELLITUS; MORTALITY; PERSPECTIVES; DISEASE	Background It is well-recognized that diabetes represents a powerful independent risk factor for cardiovascular diseases. However, very few studies have investigated the relationship between diabetes and risk of aortic dissection (AD). Aim The aim of this case-control study was to evaluate the association between diabetes and risk of AD in Chinese population. Methods A hospital-based case-control study, consisting of 2160 AD patients and 4320 controls, was conducted in a Chinese population. Demographic, clinical characteristics and risk factors were collected. Diabetes rate of patients with overall AD, Stanford type A AD and type B AD group was compared with that of corresponding matched control groups. Logistic regression analysis was used to estimate the odds ratios (OR) and 95% confidence intervals (95% CI) for relationship between diabetes and AD risk. Results The prevalence of diabetes was lower in AD cases than that of control subjects, whether it is the overall AD, type A AD or type B AD group (4.7% vs. 10.0%, 2.9% vs. 8.8%, 5.9% vs. 10.9%, all P<0.001). Furthermore, in multivariate model, diabetes was found to be associated with lower AD risk, which not only applies to the overall AD (OR = 0.2, 95% CI: 0.15-0.26), but also type A AD (OR = 0.12, 95% CI: 0.07-0.20) and type B AD (OR = 0.25, 95% CI: 0.18-0.33). Conclusions We observed the paradoxical inverse relationship between DM and risk of AD in the Chinese population. These results suggest diabetes may play a protective role in the development of AD. However, further studies are needed to enrich related evidence, especially with regard to underlying mechanisms for these trends.	[He, Xingwei; Liu, Xintian; Liu, Wanjun; Wang, Bei; Liu, Yujian; Li, Zhuxi; Wang, Tao; Tan, Rong; Zeng, Hesong] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Cardiol, Wuhan 430074, Peoples R China; [Gao, Bo] Hubei Med Coll, Suizhou Affiliated Hosp, Dept Cardiol, Suizhou, Peoples R China	Huazhong University of Science & Technology	Zeng, HS (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Cardiol, Wuhan 430074, Peoples R China.	zenghesong@163.com						Astrand H, 2007, EUR J VASC ENDOVASC, V33, P592, DOI 10.1016/j.ejvs.2006.11.011; Azim S, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-014-0541-0; Barr ELM, 2007, CIRCULATION, V116, P151, DOI 10.1161/CIRCULATIONAHA.106.685628; Capoccia L, 2014, VASCULAR, V22, P439, DOI 10.1177/1708538113504400; Daily P O, 1970, Ann Thorac Surg, V10, P237; de Ceniga MV, 2006, EUR J VASC ENDOVASC, V31, P231, DOI 10.1016/j.ejvs.2005.10.007; De Rango P, 2014, EUR J VASC ENDOVASC, V47, P243, DOI 10.1016/j.ejvs.2013.12.007; Dua MM, 2010, SURGERY, V148, P429, DOI 10.1016/j.surg.2010.05.014; Gavin JR, 1997, DIABETES CARE, V20, P1183; Golledge J, 2008, LANCET, V372, P55, DOI 10.1016/S0140-6736(08)60994-0; Golledge J, 2008, EUR HEART J, V29, P665, DOI 10.1093/eurheartj/ehm557; Gordon-Dseagu VLZ, 2014, J DIABETES COMPLICAT, V28, P791, DOI 10.1016/j.jdiacomp.2014.06.016; He CY, 2013, DIABETES, V62, P1270, DOI 10.2337/db12-0533; Hiratzka LF, 2010, CIRCULATION, V121, pE266, DOI 10.1161/CIR.0b013e3181d4739e; Kurukulasuriya LR, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-45; Lederle FA, 1997, ANN INTERN MED, V126, P441, DOI 10.7326/0003-4819-126-6-199703150-00004; Loeys BL, 2010, J MED GENET, V47, P476, DOI 10.1136/jmg.2009.072785; Morgan CL, 2000, DIABETES CARE, V23, P1103, DOI 10.2337/diacare.23.8.1103; Nienaber CA, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.001404; Prakash SK, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.111.000323; Rogers AM, 2011, CIRCULATION, V123, DOI 10.1161/CIRCULATIONAHA.110.988568; Sanon S, 2012, AM J CARDIOL, V110, p13B, DOI 10.1016/j.amjcard.2012.08.035; Sheikh AS, 2013, CIRCULATION, V128, P1122, DOI 10.1161/CIRCULATIONAHA.112.000170; Skyler JS, 2009, J AM COLL CARDIOL, V53, P298, DOI [10.1016/j.jacc.2008.10.008, 10.2337/dc08-9026]; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Theivacumar NS, 2014, ANN VASC SURG, V28, P427, DOI 10.1016/j.avsg.2013.03.024; Tsai CL, 2015, DIABETES-METAB RES, V31, P190, DOI 10.1002/dmrr.2585; Tsai TT, 2009, EUR J VASC ENDOVASC, V37, P149, DOI 10.1016/j.ejvs.2008.11.032; Wang C, 2015, DIABETES RES CLIN PR, V107, P424, DOI 10.1016/j.diabres.2014.09.059; Xie ZL, 2011, DIABETES, V60, P1770, DOI 10.2337/db10-0351	30	17	19	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142697	10.1371/journal.pone.0142697	http://dx.doi.org/10.1371/journal.pone.0142697			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562793	Green Published, Green Submitted, gold			2022-12-26	WOS:000364480900056
J	Hsu, JJ; Finkelstein, DM; Schoenfeld, DA				Hsu, Jessie J.; Finkelstein, Dianne M.; Schoenfeld, David A.			Outcome-Driven Cluster Analysis with Application to Microarray Data	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; REGRESSION SHRINKAGE; VARIABLE SELECTION; MODEL	One goal of cluster analysis is to sort characteristics into groups (clusters) so that those in the same group are more highly correlated to each other than they are to those in other groups. An example is the search for groups of genes whose expression of RNA is correlated in a population of patients. These genes would be of greater interest if their common level of RNA expression were additionally predictive of the clinical outcome. This issue arose in the context of a study of trauma patients on whom RNA samples were available. The question of interest was whether there were groups of genes that were behaving similarly, and whether each gene in the cluster would have a similar effect on who would recover. For this, we develop an algorithm to simultaneously assign characteristics (genes) into groups of highly correlated genes that have the same effect on the outcome (recovery). We propose a random effects model where the genes within each group (cluster) equal the sum of a random effect, specific to the observation and cluster, and an independent error term. The outcome variable is a linear combination of the random effects of each cluster. To fit the model, we implement a Markov chain Monte Carlo algorithm based on the likelihood of the observed data. We evaluate the effect of including outcome in the model through simulation studies and describe a strategy for prediction. These methods are applied to trauma data from the Inflammation and Host Response to Injury research program, revealing a clustering of the genes that are informed by the recovery outcome.	[Hsu, Jessie J.; Finkelstein, Dianne M.; Schoenfeld, David A.] Massachusetts Gen Hosp, Ctr Biostat, Boston, MA 02114 USA; [Hsu, Jessie J.; Finkelstein, Dianne M.; Schoenfeld, David A.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Hsu, Jessie J.] Genentech Inc, San Francisco, CA 94080 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Roche Holding; Genentech	Finkelstein, DM (corresponding author), Massachusetts Gen Hosp, Ctr Biostat, Boston, MA 02114 USA.	dfinkelstein@mgh.harvard.edu			National Institute of General Medical Sciences [T32GM074897, 2-U54-GM062119]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062119, T32GM074897] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Joint Interdisciplinary Training Program in 376 Biostatistics and Computational Biology (T32GM074897) and Inflammation and the 377 Host Response to Injury Large-Scale Collaborative Project (2-U54-GM062119) from the 378 National Institute of General Medical Sciences.	Bondell HD, 2008, BIOMETRICS, V64, P115, DOI 10.1111/j.1541-0420.2007.00843.x; Booth JG, 2008, J R STAT SOC B, V70, P119, DOI 10.1111/j.1467-9868.2007.00629.x; Dettling M, 2004, J MULTIVARIATE ANAL, V90, P106, DOI 10.1016/j.jmva.2004.02.012; Dettling M, 2002, GENOME BIOL, V3; Dunson DB, 2008, J AM STAT ASSOC, V103, P534, DOI 10.1198/016214507000000554; Dupuy A, 2007, JNCI-J NATL CANCER I, V99, P147, DOI 10.1093/jnci/djk018; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fraley C, 1998, COMPUT J, V41, P578, DOI 10.1093/comjnl/41.8.578; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Ghosh D, 2002, BIOINFORMATICS, V18, P275, DOI 10.1093/bioinformatics/18.2.275; Hartigan J., 1975, CLUSTERING ALGORITHM; Hastie T, 2001, GENOME BIOL, V2; Jornsten R, 2003, BIOINFORMATICS, V19, P1100, DOI 10.1093/bioinformatics/btg039; Ng SK, 2006, BIOINFORMATICS, V22, P1745, DOI 10.1093/bioinformatics/btl165; Park PJ, 2002, BIOINFORMATICS, V18, P1576, DOI 10.1093/bioinformatics/18.12.1576; Rajicic N, 2006, BIOINFORMATICS, V22, P2643, DOI 10.1093/bioinformatics/btl450; Tadesse MG, 2005, J AM STAT ASSOC, V100, P602, DOI 10.1198/016214504000001565; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Vogl C, 2005, BIOINFORMATICS, V21, P130, DOI 10.1093/bioinformatics/bti1122	20	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0141874	10.1371/journal.pone.0141874	http://dx.doi.org/10.1371/journal.pone.0141874			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562156	Green Submitted, Green Published, gold			2022-12-26	WOS:000364480900006
J	Korn, A; Miller, D; Dong, L; Buckles, EL; Wagner, B; Ainsworth, DM				Korn, Alexandra; Miller, Donald; Dong, Lynn; Buckles, Elizabeth Louise; Wagner, Bettina; Ainsworth, Dorothy Marie			Differential Gene Expression Profiles and Selected Cytokine Protein Analysis of Mediastinal Lymph Nodes of Horses with Chronic Recurrent Airway Obstruction (RAO) Support an Interleukin-17 Immune Response	PLOS ONE			English	Article							BRONCHOALVEOLAR LAVAGE CELLS; MESSENGER-RNA EXPRESSION; PULMONARY-DISEASE; LUNG DYSFUNCTION; EQUINE HEAVES; T-LYMPHOCYTES; IFN-GAMMA; ASTHMA; IL-22; IL-17	Recurrent airway obstruction (RAO) is a pulmonary inflammatory condition that afflicts certain mature horses exposed to organic dust particulates in hay. Its clinical and pathological features, manifested by reversible bronchoconstriction, excessive mucus production and airway neutrophilia, resemble the pulmonary alterations that occur in agricultural workers with occupational asthma. The immunological basis of RAO remains uncertain although its chronicity, its localization to a mucosal surface and its domination by a neutrophilic, nonseptic inflammatory response, suggest involvement of Interleukin-17 (IL-17). We examined global gene expression profiles in mediastinal (pulmonary-draining) lymph nodes isolated from RAO-affected and control horses. Differential expression of >200 genes, coupled with network analysis, supports an IL-17 response centered about NF-kappa B. Immunohistochemical analysis of mediastinal lymph node sections demonstrated increased IL-17 staining intensity in diseased horses. This result, along with the finding of increased IL-17 concentrations in lymph node homogenates from RAO-affected horses (P = 0.1) and a down-regulation of IL-4 gene and protein expression, provides additional evidence of the involvement of IL-17 in the chronic stages of RAO. Additional investigations are needed to ascertain the cellular source of IL-17 in this equine model of occupational asthma. Understanding the immuno-pathogenesis of this disorder likely will enhance the development of therapeutic interventions beneficial to human and animal pulmonary health.	[Korn, Alexandra; Ainsworth, Dorothy Marie] Cornell Univ, Coll Vet Med, Dept Clin Serv, Ithaca, NY 14853 USA; [Miller, Donald] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA; [Dong, Lynn; Buckles, Elizabeth Louise] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [Wagner, Bettina] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University; Cornell University	Ainsworth, DM (corresponding author), Cornell Univ, Coll Vet Med, Dept Clin Serv, Ithaca, NY 14853 USA.	dma2@cornell.edu			Morris Animal Foundation; Harry M. Zweig Equine Memorial Fund	Morris Animal Foundation; Harry M. Zweig Equine Memorial Fund	Funds from the Morris Animal Foundation (www.morrisanimalfoundation.org) supported development of the custom-designed equine microarray used in this study. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. Funds from the Harry M. Zweig Equine Memorial Fund (www.vet.cornell.edu/zweig) were used to support the experimental design, sample collection and analysis.	Ainsworth DM, 2006, AM J VET RES, V67, P669, DOI 10.2460/ajvr.67.4.669; Ainsworth DM, 2003, VET IMMUNOL IMMUNOP, V96, P83, DOI 10.1016/S0165-2427(03)00142-9; Alcorn JF, 2010, ANNU REV PHYSIOL, V72, P495, DOI 10.1146/annurev-physiol-021909-135926; [Anonymous], 2005, IPA NETWORK GENERATI; Bajenoff M, 2003, J EXP MED, V198, P715, DOI 10.1084/jem.20030167; Benson M, 2004, CLIN EXP ALLERGY, V34, P1001, DOI 10.1111/j.1365-2222.2004.02007.x; Bowie A, 2000, BIOCHEM PHARMACOL, V59, P13, DOI 10.1016/S0006-2952(99)00296-8; Brackett CM, 2013, J IMMUNOL, V191, P4348, DOI 10.4049/jimmunol.1103621; Brosnahan MM, 2012, J IMMUNOL, V188, P4181, DOI 10.4049/jimmunol.1103509; Brucklacher-Waldert V, 2009, J IMMUNOL, V183, P5494, DOI 10.4049/jimmunol.0901000; Bureau F, 2000, AM J RESP CRIT CARE, V161, P1314, DOI 10.1164/ajrccm.161.4.9907010; Choy DF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab3142; Cordeau ME, 2004, VET IMMUNOL IMMUNOP, V97, P87, DOI 10.1016/j.vetimm.2003.08.013; Debrue M, 2005, VET IMMUNOL IMMUNOP, V105, P25, DOI 10.1016/j.vetimm.2004.12.013; Diniz SN, 2004, J LEUKOCYTE BIOL, V75, P649, DOI 10.1189/jlb.0803371; Franchini M, 2000, AM J VET RES, V61, P1369, DOI 10.2460/ajvr.2000.61.1369; Giguere S, 2002, VET IMMUNOL IMMUNOP, V85, P147, DOI 10.1016/S0165-2427(01)00420-2; Glader P, 2010, EUR RESPIR J, V36, P1155, DOI 10.1183/09031936.00170609; Hansson M, 2013, INFLAMM RES, V62, P561, DOI 10.1007/s00011-013-0608-1; Imamura M, 2007, CELL IMMUNOL, V248, P86, DOI 10.1016/j.cellimm.2007.09.003; Inforzato A, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00407; Kleiber C, 2005, VET IMMUNOL IMMUNOP, V104, P91, DOI 10.1016/j.vetimm.2004.10.002; Lavoie JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029440; Leclere M, 2011, RESPIROLOGY, V16, P1027, DOI 10.1111/j.1440-1843.2011.02033.x; Lee CC, 2013, BIOCHEM PHARMACOL, V86, P940, DOI 10.1016/j.bcp.2013.08.003; Manni ML, 2014, EXPERT REV RESP MED, V8, P25, DOI 10.1586/17476348.2014.854167; McAleer JP, 2014, IMMUNOL REV, V260, P129, DOI 10.1111/imr.12183; Medoff BD, 2008, ANNU REV IMMUNOL, V26, P205, DOI 10.1146/annurev.immunol.26.021607.090312; Nishikori M, 2005, J CLIN EXP HEMATOP, V45, P15, DOI 10.3960/jslrt.45.15; Onishi RM, 2010, IMMUNOLOGY, V129, P311, DOI 10.1111/j.1365-2567.2009.03240.x; Padoan E, 2013, VET IMMUNOL IMMUNOP, V156, P190, DOI 10.1016/j.vetimm.2013.09.020; Perkins GA, 2014, VET IMMUNOL IMMUNOP, V161, P141, DOI 10.1016/j.vetimm.2014.07.009; Peroni JF, 2001, EQUINE VET J, V33, P231, DOI 10.2746/042516401776249688; Pirie RS, 2001, EQUINE VET J, V33, P311, DOI 10.2746/042516401776249732; Poole JA, 2012, CURR OPIN ALLERGY CL, V12, P126, DOI 10.1097/ACI.0b013e3283511d0e; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Ramery E, 2008, VET J, V177, P216, DOI 10.1016/j.tvjl.2007.04.020; Ramery E, 2010, VET RES, V41, DOI 10.1051/vetres/2009066; Riihimaki M, 2008, VET IMMUNOL IMMUNOP, V122, P256, DOI 10.1016/j.vetimm.2007.12.001; Robbe P, 2014, THORAX, V69, P630, DOI 10.1136/thoraxjnl-2013-204295; Robinson NE, 1966, BR VET J, V152, P283; Sandersen C, 2001, VET IMMUNOL IMMUNOP, V80, P315, DOI 10.1016/S0165-2427(01)00329-4; Shebl FM, 2010, CANCER EPIDEM BIOMAR, V19, P978, DOI 10.1158/1055-9965.EPI-10-0064; Sonnenberg GF, 2010, J EXP MED, V207, P1293, DOI 10.1084/jem.20092054; Sun DX, 2011, NAT IMMUNOL, V12, P853, DOI 10.1038/ni.2081; Traves SL, 2008, CURR MOL MED, V8, P416, DOI 10.2174/156652408785160998; Wagner B, 2009, VET IMMUNOL IMMUNOP, V133, P309	47	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142622	10.1371/journal.pone.0142622	http://dx.doi.org/10.1371/journal.pone.0142622			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26561853	Green Published, Green Submitted, gold			2022-12-26	WOS:000364480900049
J	Zorzan, E; Hanssens, K; Giantin, M; Dacasto, M; Dubreuil, P				Zorzan, Eleonora; Hanssens, Katia; Giantin, Mery; Dacasto, Mauro; Dubreuil, Patrice			Mutational Hotspot of TET2, IDH1, IDH2, SRSF2, SF3B1, KRAS, and NRAS from Human Systemic Mastocytosis Are Not Conserved in Canine Mast Cell Tumors	PLOS ONE			English	Article							C-KIT; RECEPTOR; PROLIFERATION; DOMAIN; COMMON; FORMS; LEADS; RISK	Introduction Both canine cutaneous mast cell tumor (MCT) and human systemic mastocytosis (SM) are characterized by abnormal proliferation and accumulation of mast cells in tissues and, frequently, by the presence of activating mutations in the receptor tyrosine kinase V-Kit HardyZuckerman 4 Feline Sarcoma Viral Oncogene Homolog (c-KIT), albeit at different incidence (> 80% in SM and 10-30% in MCT). In the last few years, it has been discovered that additional mutations in other genes belonging to the methylation system, the splicing machinery and cell signaling, contribute, with c-KIT, to SM pathogenesis and/or phenotype. In the present study, the mutational profile of the Tet methylcytosine dioxygenase 2 (TET2), the isocitrate dehydrogenases 1 and 2 (IDH1 and IDH2), the serine/arginine-rich splicing factor 2 (SRSF2), the splicing factor 3b subunit 1 (SF3B1), the Kirsten rat sarcoma viral oncogene homolog (KRAS) and the neuroblastoma RAS viral oncogene homolog (NRAS), commonly mutated in human myeloid malignancies and mastocytosis, was investigated in canine MCTs. Methods Using the Sanger sequencing method, a cohort of 75 DNA samples extracted from MCT biopsies already investigated for c-KIT mutations were screened for the " human-like" hot spot mutations of listed genes. Results No mutations were ever identified except for TET2 even if with low frequency (2.7%). In contrast to what is observed in human TET2 no frame-shift mutations were found in MCT samples. Conclusion Results obtained in this preliminary study are suggestive of a substantial difference between human SM and canine MCT if we consider some target genes known to be involved in the pathogenesis of human SM.	[Zorzan, Eleonora; Giantin, Mery; Dacasto, Mauro] Univ Padua, Dept Comparat Biomed & Food Sci, Padua, Italy; [Hanssens, Katia; Dubreuil, Patrice] Aix Marseille Univ, Ctr Reference Mastocytoses, Ctr Rech Cancerol Marseille Signalisat Hematopoie, Inst J Paoli I Calmettes,CNRS,Inserm,U1068, Marseille, France	University of Padua; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC)	Dubreuil, P (corresponding author), Aix Marseille Univ, Ctr Reference Mastocytoses, Ctr Rech Cancerol Marseille Signalisat Hematopoie, Inst J Paoli I Calmettes,CNRS,Inserm,U1068, Marseille, France.	patrice.dubreuil@inserm.fr	Dubreuil, Patrice/V-4816-2019; Giantin, Mery/AAX-3235-2020; dubreuil, patrice/F-5346-2011	Dubreuil, Patrice/0000-0003-1155-1150; dubreuil, patrice/0000-0003-1155-1150	Universita degli Studi di Padova, Italy	Universita degli Studi di Padova, Italy	Dr. Zorzan's PhD fellowship was provided by the Universita degli Studi di Padova, Italy.	Arock M, 2015, EUR J HAEMATOL, V94, P474, DOI 10.1111/ejh.12544; Blackwood L, 2012, VET COMP ONCOL, V10, pe1, DOI 10.1111/j.1476-5829.2012.00341.x; Da Ros S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103876; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Devine S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084988; Gleixner KV, 2007, EXP HEMATOL, V35, P1510, DOI 10.1016/j.exphem.2007.06.005; Hahn KA, 2008, J VET INTERN MED, V22, P1301, DOI 10.1111/j.1939-1676.2008.0190.x; Hanssens K, 2014, HAEMATOLOGICA, V99, P830, DOI 10.3324/haematol.2013.095133; Ingles SA, 1997, J NATL CANCER I, V89, P166, DOI 10.1093/jnci/89.2.166; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Itzykson R, 2013, BEST PRACT RES CL HA, V26, P355, DOI 10.1016/j.beha.2014.01.001; Kadouri L, 2004, INT J CANCER, V108, P399, DOI 10.1002/ijc.11531; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; Letard S, 2008, MOL CANCER RES, V6, P1137, DOI 10.1158/1541-7786.MCR-08-0067; Li Z, 2011, BLOOD, V118, P4509, DOI 10.1182/blood-2010-12-325241; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Ohmori K, 2008, VET IMMUNOL IMMUNOP, V126, P43, DOI 10.1016/j.vetimm.2008.06.014; PATNAIK AK, 1984, VET PATHOL, V21, P469, DOI 10.1177/030098588402100503; Ranieri G, 2015, CRIT REV ONCOL HEMAT, V93, P159, DOI 10.1016/j.critrevonc.2014.10.010; Reitman ZJ, 2010, INT J CANCER, V127, P245, DOI 10.1002/ijc.25017; Richter A, 2005, J HERED, V96, P764, DOI 10.1093/jhered/esi121; Soucie E, 2012, BLOOD, V120, P4846, DOI 10.1182/blood-2011-12-397588; Takeuchi Y, 2013, VET J, V196, P492, DOI 10.1016/j.tvjl.2012.11.018; Takeuchi Y, 2010, VET IMMUNOL IMMUNOP, V137, P208, DOI 10.1016/j.vetimm.2010.05.009; Tefferi A, 2009, LEUKEMIA, V23, P905, DOI 10.1038/leu.2009.47; Tefferi A, 2009, LEUKEMIA, V23, P900, DOI 10.1038/leu.2009.37; Terragni R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085388; Traina F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043090; Warland J, 2013, VET J, V197, P496, DOI 10.1016/j.tvjl.2013.02.017; Watzinger F, 2001, MOL CARCINOGEN, V30, P190, DOI 10.1002/mc.1027; Webster JD, 2007, VET PATHOL, V44, P298, DOI 10.1354/vp.44-3-298; Webster JD, 2006, NEOPLASIA, V8, P104, DOI 10.1593/neo.05622; Wilson TM, 2011, HAEMATOL-HEMATOL J, V96, P459, DOI 10.3324/haematol.2010.031690; Yoo S, 2014, CANCER EPIDEM BIOMAR, V23, P2027, DOI 10.1158/1055-9965.EPI-14-0020; Zemke D, 2002, VET PATHOL, V39, P529, DOI 10.1354/vp.39-5-529	35	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142450	10.1371/journal.pone.0142450	http://dx.doi.org/10.1371/journal.pone.0142450			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562302	Green Published, gold			2022-12-26	WOS:000364480900034
J	da Silva, MG; Vinaud, MC; de Castro, AM				da Silva, Marcos Gontijo; Vinaud, Marina Clare; de Castro, Ana Maria			Prevalence of toxoplasmosis in pregnant women and vertical transmission of Toxoplasma gondii in patients from basic units of health from Gurupi, Tocantins, Brazil, from 2012 to 2014	PLOS ONE			English	Article							CONGENITAL TOXOPLASMOSIS; RISK-FACTORS; SEROLOGIC PROFILE; CHILDBEARING AGE; GLOBAL BURDEN; STATE; DIAGNOSIS; PREVENTION; INFECTION; PROGRAM	Introduction Toxoplasmosis is a parasitary disease that presents high rates of gestational and congenital infection worldwide being therefore considered a public health problem and a neglected disease. Objective To determine the prevalence of toxoplasmosis amongst pregnant women and vertical transmission of Toxoplasma gondii in their newborns attended in the Basic Units of Health (BUH) from the city of Gurupi, state of Tocantins, Brazil. Methods A prevalence study was performed, including 487 pregnant women and their newborns attended in the BUH of the urban zone of the city of Gurupi, state of Tocantins, Brazil, during the period from February 2012 to February 2014. The selection of the pregnant women occurred by convenience. In the antenatal admission they were invited to participate in this study. Three samples of peripheral blood were collected for the detection of specific anti-T. gondii IgG, IgM and IgA through ELISA, for the polimerase chain reaction (PCR) and IgG avidity during pregnancy. When IgM antibodies were detected the fetal and newborn infection investigation took place. The newborn was investigated right after birth and after one year of age through serology and PCR to confirm/exclude the vertical transmission. The analyses were performed in the Studies of the Host-Parasite Relationship Laboratory (LAERPH, IPTSP-UFG), Goiania, state of Goias, Brazil. The results were inserted in a data bank in Epi-Info 3.3.2 statistic software in which the analysis was performed with p <= 5%. Results The toxoplasmosis infection was detected in 68.37% (333/487, CI95%: 64.62-72.86). The toxoplasmosis chronic infection prevalence was of 63.03% (307/487, CI95%: 58.74-67.32). The prevalence of maternal acute infection was of 5.33% (26/487; CI95%: 3.3-7.3) suspected by IgM antibodies detection in the peripheral blood. The prevalence of confirmed vertical transmission was of 28% (7/25; CI95%: 10.4-45.6). Conclusions These results show an elevated prevalence of toxoplasmosis in pregnant women and vertical transmission of T. gondii in the city of Gurupi, state of Tocantins, Brazil.	[da Silva, Marcos Gontijo] Univ Ctr UNIRG, Parasitol Lab, Gurupi, TO, Brazil; [Vinaud, Marina Clare; de Castro, Ana Maria] Univ Fed Goias, Trop Med & Publ Hlth Inst IPTSP, Trop Med & Publ Hlth Postgrad Programme, Studies Host Parasite Relationship Lab LAERPH, BR-74605050 Goiania, Go, Brazil	Universidade Federal de Goias	da Silva, MG (corresponding author), Univ Ctr UNIRG, Parasitol Lab, Ave Rio de Janeiro Entre Ruas 9 & 10, Gurupi, TO, Brazil.	gontijobio@yahoo.com.br	Gontijo da Silva, Marcos/AGZ-3178-2022; Vinaud, Marina Clare/X-3380-2019	Gontijo da Silva, Marcos/0000-0002-6474-6640; 	financimento the Research Foundation of the State of Goias (FAPEG) [001/2012, 201200141120254]	financimento the Research Foundation of the State of Goias (FAPEG)	This work received financimento the Research Foundation of the State of Goias (FAPEG) Call No. 001/2012, Case No. 201200141120254. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali-Heydari S, 2013, PARASITE, V20, DOI 10.1051/parasite/2013017; Andrade ALSS, 1998, MET INV EP DOENC TRA; Andreucci CB, 2011, CAD SAUDE PUBLICA, V27, P1053, DOI 10.1590/S0102-311X2011000600003; Araujo AFV, 2012, BOLETIM CONJUNTURA T; Dantas SBA, 2013, CIENC RURAL, V43, P2042, DOI 10.1590/S0103-84782013001100020; Areal K. R., 2008, NEWS LAB, V87, P122; Avelino M. M., 2009, Revista de Ciencias Medicas e Biologicas, V8, P325; Avelino MM, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-33; Avelino Mariza Martins, 2004, Braz J Infect Dis, V8, P164, DOI 10.1590/S1413-86702004000200007; Barbosa IR, 2009, T ROY SOC TROP MED H, V103, P377, DOI 10.1016/j.trstmh.2008.11.025; Bollani L, 2014, J Pediat Neonatal Individualized Medicine, V3; Brasil. Ministerio da Saude Secretaria de Atencao a Saude Departamento de Acoes Programaticas Estrategicas, 2010, GEST ALT RISC MAN TE, V5; Brasil. Ministerio da Saude. Secretaria de Atencao a Saxde. Departamento de Acoes Programaticas Estrategicas, 2012, GEST RISC MAN TECN; Campos FA, 2014, BRAZ J INFECT DIS, V18, P609, DOI 10.1016/j.bjid.2014.05.008; Bichara CNC, 2012, REV SOC BRAS MED TRO, V45, P122, DOI 10.1590/S0037-86822012000100024; Carral L, 2008, MEDICINA-BUENOS AIRE, V68, P417; Carvalheiro CG, 2005, EPIDEMIOL INFECT, V133, P485, DOI 10.1017/S095026880400353X; Costa CSC, 2013, REV ELETR ENF, V15, P516, DOI [10.5216/ree.v15i2.15635, DOI 10.5216/REE.V15I2.15635]; da Silva MG, 2014, REV SOC BRAS MED TRO, V47, P469, DOI 10.1590/0037-8682-0127-2014; de Figueiredo H. R., 2010, SCI MED, V20, P71; de Jong EP, 2013, ARCH DIS CHILDHOOD-E, V98, P93, DOI 10.1136/archdischild-2012-303327; Inagaki ADD, 2012, TROP MED INT HEALTH, V17, P1349, DOI 10.1111/j.1365-3156.2012.03079.x; de Moura FL, 2013, REV SOC BRAS MED TRO, V46, P200, DOI 10.1590/0037-8682-1613-2013; De Paschale M, 2014, TROP MED INT HEALTH, V19, P743, DOI 10.1111/tmi.12296; Diaz-Suarez O, 2009, REV INST MED TROP SP, V51, P13, DOI 10.1590/S0036-46652009000100003; Elmore SA, 2010, TRENDS PARASITOL, V26, P190, DOI 10.1016/j.pt.2010.01.009; Elsheikha HM, 2008, PUBLIC HEALTH, V122, P335, DOI 10.1016/j.puhe.2007.08.009; Porto AMF, 2008, REV ASSOC MED BRAS, V54, P242, DOI 10.1590/S0104-42302008000300018; Fialho CG, 2009, ACTA SCI VET, V37, P1; Figueiro EA, 2005, REV BRAS GINECOL OBS, V27, P442, DOI 10.1590/S0100-72032005000800002; Foulon W, 2000, J PERINAT MED, V28, P337, DOI 10.1515/JPM.2000.043; Bittencourt LHFD, 2012, REV BRAS GINECOL OBS, V34, P63, DOI 10.1590/S0100-72032012000200004; Jones JL, 2009, CLIN INFECT DIS, V49, P878, DOI 10.1086/605433; Kaye A, 2011, J PEDIATR HEALTH CAR, V25, P355, DOI 10.1016/j.pedhc.2010.04.008; Khalil Mohamed, 2013, African Journal of Microbiology Research, V7, P5227; Kompalic-Cristo A, 2004, T ROY SOC TROP MED H, V98, P92, DOI 10.1016/S0035-9203(03)00012-9; Lago EG, 2014, J PEDIAT-BRAZIL, V90, P363, DOI [10.1016/j.jped.2013.12.006, 10.1016/j.jpedp.2013.12.005]; Lago EG, 2007, PAEDIATR PERINAT EP, V21, P525, DOI 10.1111/j.1365-3016.2007.00869.x; Lopes AP, 2014, PARASITOLOGY, V141, P1699, DOI 10.1017/S0031182014001413; Carellos EV, 2008, CAD SAUDE PUBLICA, V24, P391, DOI 10.1590/S0102-311X2008000200018; Carellos EVM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088588; Maggi P, 2009, NEW MICROBIOL, V32, P89; Margonato Fabiana Burdini, 2007, Rev. Bras. Saude Mater. Infant., V7, P381, DOI 10.1590/S1519-38292007000400005; Monsalve-Castillo FM, 2012, BIOMEDICA, V32, P519, DOI [10.1590/S0120-41572012000400007, 10.7705/biomedica.v32i4.749]; Ministerio da Saude (MS), 2012, AT PREN BAIX RISC; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Mussi-Pinhata M, 1999, J PEDIAT RIO J, V75, P15; Neto Eurico Camargo, 2004, Emerg Infect Dis, V10, P1068; Nicolle MC, 2009, MEM I O CRUZ, V104, P1; Oz HS, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00385; Paquet C, 2013, J OBSTET GYNAECOL CA, V35, P78, DOI 10.1016/S1701-2163(15)31053-7; Rahbari AH, 2012, KOREAN J PARASITOL, V50, P99, DOI 10.3347/kjp.2012.50.2.99; Reis MM, 2006, REV BRAS GINECOL OBS, V28, P158, DOI 10.1590/S0100-72032006000300004; Remington JS., 1995, INFECT DIS FETUS NEW, V4, P140; Robert-Gangneux F, 2012, CLIN MICROBIOL REV, V25, P264, DOI 10.1128/CMR.05013-11; Rodrigues IMX, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-349; Sartori AL, 2011, REV BRAS GINECOL OBS, V33, P93, DOI 10.1590/S0100-72032011000200007; Silva MG, 2013, U CI SAUDE, V11, P1, DOI [10.5102/ucs.v11i2.2564, DOI 10.5102/UCS.V11I2.2564]; SINIBALDI J, 1992, EUR J EPIDEMIOL, V8, P516, DOI 10.1007/BF00146369; Spalding Silvia Maria, 2002, J. Bras. Patol. Med. Lab., V38, P105, DOI 10.1590/S1676-24442002000200006; Splendore A, 2009, MEM I O CRUZ, V104, P1; Stein C, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000161; Torgerson PR, 2013, B WORLD HEALTH ORGAN, V91, P501, DOI 10.2471/BLT.12.111732; Uttah E, 2013, IJSRP, V3, P1; Varella IS, 2009, MEM I OSWALDO CRUZ, V104, P383, DOI 10.1590/S0074-02762009000200037; Vasconcelos-Santos DV, 2009, OPHTHALMOLOGY, V116, P2199, DOI 10.1016/j.ophtha.2009.04.042; Vaz RS, 2011, FACTS REPORTS, V3, P1	67	42	44	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141700	10.1371/journal.pone.0141700	http://dx.doi.org/10.1371/journal.pone.0141700			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558622	Green Published, gold			2022-12-26	WOS:000364433100039
J	Ram, MR; Goh, KL; Leow, AHR; Poh, BH; Loke, MF; Harrison, R; Shankar, EM; Vadivelu, J				Ram, M. Ravishankar; Goh, Khean Lee; Leow, Alex Hwong Ruey; Poh, Bee Hoon; Loke, Mun Fai; Harrison, Richard; Shankar, Esaki M.; Vadivelu, Jamuna			Polymorphisms at Locus 4p14 of Toll-Like Receptors TLR-1 and TLR-10 Confer Susceptibility to Gastric Carcinoma in Helicobacter pylori Infection	PLOS ONE			English	Article							GHRELIN EXPRESSION; CANCER; LEPTIN; DISEASE; INFLAMMATION; PATHOGENESIS; RECOGNITION; ASSOCIATION; OBESITY; CELLS	Helicobacter pylori (H. pylori) -induced gastric inflammation impacts the functions of leptin-and ghrelin-producing cells in the gastroduodenum. Inflammation resulting from H. pylori sensing via Toll-like receptors (TLRs) and the associated downstream signaling largely remain ambiguous. Here, we investigated the role of gut hormones, pro-inflammatory cytokines and single nucleotide polymorphisms (SNPs) associated with TLR 4p14 in H. pylori disease in 30 subjects with non-ulcer dyspepsia (NUD), 40 with peptic ulcer disease (PUD) and 15 with gastric cancer (GC) subjects positive and negative for H. pylori infection. The level of pro-inflammatory cytokines was directly proportional to the severity of gastritis, and disease status influenced the levels of gut hormones and pro-inflammatory cytokines. TLR-1 SNPs rs4833095 and TLR-10 SNPs rs10004195 and were directly associated with H. pylori disease, and were up-regulated in the presence of H. pylori in a genotype-independent manner. We concluded that TLR-1 rs4833095 and TLR10 rs10004195 confer susceptibility to development of gastroduodenal disease, especially GC in H. pylori disease.	[Ram, M. Ravishankar; Loke, Mun Fai; Vadivelu, Jamuna] Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur 50603, Malaysia; [Goh, Khean Lee; Leow, Alex Hwong Ruey] Univ Malaya, Dept Med, Fac Med, Kuala Lumpur 50603, Malaysia; [Poh, Bee Hoon] BP Diagnost Ctr Sdn Bhd, Dept Pathol, Ipoh 30250, Perak, Malaysia; [Harrison, Richard] Biorad Labs Pty Ltd, Life Sci Res Div, Gladesville, NSW 2111, Australia; [Shankar, Esaki M.] Univ Malaya, Fac Med, Dept Med Microbiol, TIDREC, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Vadivelu, J (corresponding author), Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur 50603, Malaysia.	jamuna@ummc.edu.my	Loke, Mun Fai/B-1060-2011; VADIVELU, JAMUNARANI S/B-8696-2010; Goh, Khean-Lee/B-6404-2009; Leow, Alex HR/B-1626-2017; Mani, Ravishankar Ram/N-7456-2019; Muthu, Shankar Esaki/B-3132-2019; Shankar, EM/G-6444-2011	Loke, Mun Fai/0000-0002-3554-5313; VADIVELU, JAMUNARANI S/0000-0001-7322-3676; Goh, Khean-Lee/0000-0002-9965-1561; Leow, Alex HR/0000-0003-1752-0435; Mani, Ravishankar Ram/0000-0003-4229-5778; Muthu, Shankar Esaki/0000-0002-7866-9818; 	University of Malaya - Ministry of Education (UM-MOE) High Impact Research (HIR) [UM.C/625/1/HIR/MOE/CHAN-13/4, H-50001-A000029]	University of Malaya - Ministry of Education (UM-MOE) High Impact Research (HIR)	This work was supported by a grant from the University of Malaya - Ministry of Education (UM-MOE) High Impact Research (HIR) (Grant. No. UM.C/625/1/HIR/MOE/CHAN-13/4; Account No. H-50001-A000029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Azuma T, 2001, GUT, V49, P324, DOI 10.1136/gut.49.3.324; Carabotti M, 2014, WORLD J GASTROENTERO, V20, P647, DOI 10.3748/wjg.v20.i3.647; Castano-Rodriguez N, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00336; Castano-Rodriguez N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060327; Chen MY, 2013, WORLD J GASTROENTERO, V19, P4242, DOI 10.3748/wjg.v19.i26.4242; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Devaux M, 2011, EC STUDIES, V1; Fernandez-Riejos P, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/568343; Fock K. M., 1997, Annals Academy of Medicine Singapore, V26, P637; Franceschi F, 2014, WORLD J GASTROENTERO, V20, P12809, DOI 10.3748/wjg.v20.i36.12809; Garcia JM, 2008, ENDOCRINOLOGY, V149, P455, DOI 10.1210/en.2007-0828; Isomoto H, 2004, AM J MED, V117, P429, DOI 10.1016/j.amjmed.2004.01.030; Jun DW, 2007, DIGEST DIS SCI, V52, P2866, DOI 10.1007/s10620-006-9651-x; Jung UJ, 2014, INT J MOL SCI, V15, P6184, DOI 10.3390/ijms15046184; Jurinke Christian, 2002, Adv Biochem Eng Biotechnol, V77, P57; Konturek PC, 2006, J PHYSIOL PHARMACOL, V57, P67; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Le Beyec J, 2014, INT J OBESITY, V38, P1357, DOI 10.1038/ijo.2014.14; Lina TT, 2014, WORLD J GASTROENTERO, V20, P12753, DOI 10.3748/wjg.v20.i36.12753; Mayerle J, 2013, JAMA-J AM MED ASSOC, V309, P1912, DOI 10.1001/jama.2013.4350; Michaud M, 2013, J AM MED DIR ASSOC, V14, P877, DOI 10.1016/j.jamda.2013.05.009; Mitchell H, 2008, ALIMENT PHARM THER, V28, P903, DOI 10.1111/j.1365-2036.2008.03792.x; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Nwokolo CU, 2003, GUT, V52, P637, DOI 10.1136/gut.52.5.637; Pacifico L, 2014, WORLD J GASTROENTERO, V20, P1379, DOI 10.3748/wjg.v20.i6.1379; Paoluzi OA, 2014, WORLD J GASTROENTERO, V20, P639, DOI 10.3748/wjg.v20.i3.639; Paz-Filho G, 2012, ARQ BRAS ENDOCRINOL, V56, P9; Pilotto A, 2014, WORLD J GASTROENTERO, V20, P6364, DOI 10.3748/wjg.v20.i21.6364; Salles N, 2006, J GERONTOL A-BIOL, V61, P1144, DOI 10.1093/gerona/61.11.1144; Sanchez-Margalet V, 2003, CLIN EXP IMMUNOL, V133, P11, DOI 10.1046/j.1365-2249.2003.02190.x; Santini D, 2008, CLIN EXP IMMUNOL, V154, P360, DOI 10.1111/j.1365-2249.2008.03776.x; Schmidt HMA, 2011, J GASTROEN HEPATOL, V26, P1725, DOI 10.1111/j.1440-1746.2011.06799.x; Shiotani A, 2005, HELICOBACTER, V10, P373, DOI 10.1111/j.1523-5378.2005.00343.x; Slomiany BL, 2010, MEDIAT INFLAMM, V2010, P7, DOI DOI 10.1155/2010/280464; Suresh R, 2013, ADV PHYSIOL EDUC, V37, P284, DOI 10.1152/advan.00058.2013; Wroblewski LE, 2010, CLIN MICROBIOL REV, V23, P713, DOI 10.1128/CMR.00011-10; Xu J, 2014, SCI WORLD J, V2014, P926; Yang CA, 2013, HELICOBACTER, V18, P13, DOI 10.1111/hel.12001; Zeng Hong-Mei, 2011, Zhonghua Yu Fang Yi Xue Za Zhi, V45, P588	40	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141865	10.1371/journal.pone.0141865	http://dx.doi.org/10.1371/journal.pone.0141865			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559190	Green Published, gold, Green Submitted			2022-12-26	WOS:000364433100043
J	Rowbottom, R; Carver, S; Barmuta, LA; Weinstein, P; Foo, D; Allen, GR				Rowbottom, Raylea; Carver, Scott; Barmuta, Leon A.; Weinstein, Philip; Foo, Dahlia; Allen, Geoff R.			Resource Limitation, Controphic Ostracod Density and Larval Mosquito Development	PLOS ONE			English	Article							ROSS-RIVER-VIRUS; EPHEMERAL WATER BODIES; AEDES-AEGYPTI DIPTERA; SALT-MARSH MOSQUITO; ADULT SIZE; WHEAT-BELT; COMPETITION; CULICIDAE; FOOD; CAMPTORHYNCHUS	Aquatic environments can be restricted with the amount of available food resources especially with changes to both abiotic and biotic conditions. Mosquito larvae, in particular, are sensitive to changes in food resources. Resource limitation through inter-, and intra-specific competition among mosquitoes are known to affect both their development and survival. However, much less is understood about the effects of non-culicid controphic competitors (species that share the same trophic level). To address this knowledge gap, we investigated and compared mosquito larval development, survival and adult size in two experiments, one with different densities of non-culicid controphic conditions and the other with altered resource conditions. We used Aedes camptorhynchus, a salt marsh breeding mosquito and a prominent vector for Ross River virus in Australia. Aedes camptorhynchus usually has few competitors due to its halo-tolerance and distribution in salt marshes. However, sympatric ostracod micro-crustaceans often co-occur within these salt marshes and can be found in dense populations, with field evidence suggesting exploitative competition for resources. Our experiments demonstrate resource limiting conditions caused significant increases in mosquito developmental times, decreased adult survival and decreased adult size. Overall, non-culicid exploitation experiments showed little effect on larval development and survival, but similar effects on adult size. We suggest that the alterations of adult traits owing to nonculicid controphic competition has potential to extend to vector-borne disease transmission.	[Rowbottom, Raylea; Allen, Geoff R.] Univ Tasmania, Sch Land & Food, TIA, Hobart, Tas, Australia; [Carver, Scott; Barmuta, Leon A.; Foo, Dahlia] Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia; [Weinstein, Philip] Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia	University of Tasmania; University of Tasmania; University of South Australia	Rowbottom, R (corresponding author), Univ Tasmania, Sch Land & Food, TIA, Hobart, Tas, Australia.	raylea.rowbottom@utas.edu.au	Carver, Scott/J-7654-2014; Barmuta, Leon/J-2413-2013	Carver, Scott/0000-0002-3579-7588; Barmuta, Leon/0000-0002-8946-3727; Rowbottom, Raylea/0000-0002-3162-9368; Weinstein, Philip/0000-0001-9860-7166	Holsworth Wildlife Research Fund, ANZ Trustees Foundation; Joan Woodberry Postgraduate Fellowship, University of Tasmania	Holsworth Wildlife Research Fund, ANZ Trustees Foundation; Joan Woodberry Postgraduate Fellowship, University of Tasmania	This work was supported by The Holsworth Wildlife Research Fund, ANZ Trustees Foundation http://www.eqt.com.au/not-for-profit-organisations/confirmed-2015-programs/holsworth-grants.aspx (RR), The Joan Woodberry Postgraduate Fellowship, University of Tasmania http://www.utas.edu.au/research/graduate-research/future-students/scholarships-and-fees (RR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaskov J, 2012, FUTURE VIROL, V7, P173, DOI 10.2217/FVL.11.139; Amarasekare P, 2003, ECOL LETT, V6, P1109, DOI 10.1046/j.1461-0248.2003.00530.x; Bader CA, 2011, MED VET ENTOMOL, V25, P70, DOI 10.1111/j.1365-2915.2010.00908.x; BALLARD JWO, 1986, AUST J EXP BIOL MED, V64, P197, DOI 10.1038/icb.1986.21; Barrera R, 1996, ECOL ENTOMOL, V21, P117, DOI 10.1111/j.1365-2311.1996.tb01178.x; Barton PS, 2005, P LINN SOC N S W, V126, P261; Beketov MA, 2007, ECOL ENTOMOL, V32, P405, DOI 10.1111/j.1365-2311.2007.00889.x; Bevins SN, 2007, J VECTOR ECOL, V32, P252, DOI 10.3376/1081-1710(2007)32[252:TORIAL]2.0.CO;2; Blackmore MS, 2000, J VECTOR ECOL, V25, P212; Blaustein L, 2007, ANNU REV ENTOMOL, V52, P489, DOI 10.1146/annurev.ento.52.110405.091431; Campos RE, 2006, MEMORIAS I O CRUZ, V101, P47; Carver S, 2011, AUST J ENTOMOL, V50, P344, DOI 10.1111/j.1440-6055.2011.00825.x; Carver S, 2010, ENVIRON ENTOMOL, V39, P798, DOI 10.1603/EN09235; Carver S, 2009, ENVIRON ENTOMOL, V38, P1585, DOI 10.1603/022.038.0609; Chapman HF, 1999, MED VET ENTOMOL, V13, P423, DOI 10.1046/j.1365-2915.1999.00195.x; Chase JM, 2003, ECOL LETT, V6, P1017, DOI 10.1046/j.1461-0248.2003.00533.x; Clements A. N., 1992, BIOL MOSQUITOES, V1; Costanzo KS, 2005, ECOLOGY, V86, P3289, DOI 10.1890/05-0583; Daugherty MP, 2003, AM MIDL NAT, V150, P181, DOI 10.1674/0003-0031(2003)150[0181:LSBFAA]2.0.CO;2; Duquesne S, 2011, J MED ENTOMOL, V48, P554, DOI 10.1603/ME09282; Eitam A, 2004, PHYSIOL ENTOMOL, V29, P188, DOI 10.1111/j.0307-6962.2004.0372.x; Farjana T, 2012, MED VET ENTOMOL, V26, P210, DOI 10.1111/j.1365-2915.2011.00971.x; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; Gilles JRL, 2011, J MED ENTOMOL, V48, P296, DOI 10.1603/ME09209; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Jennings CD, 1999, MED VET ENTOMOL, V13, P431, DOI 10.1046/j.1365-2915.1999.00196.x; Juliano SA, 1998, ECOLOGY, V79, P255, DOI 10.1890/0012-9658(1998)079[0255:SIARAM]2.0.CO;2; Juliano SA, 2007, J AM MOSQUITO CONTR, V23, P265, DOI 10.2987/8756-971X(2007)23[265:PD]2.0.CO;2; Juliano SA, 2009, ANNU REV ENTOMOL, V54, P37, DOI 10.1146/annurev.ento.54.110807.090611; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Khatchikian CE, 2010, EVOL ECOL, V24, P1159, DOI 10.1007/s10682-010-9359-4; Knight JM, 2011, ECOSYSTEMS, V14, P1382, DOI 10.1007/s10021-011-9487-x; Knight TM, 2004, J VECTOR ECOL, V29, P277; LOUNIBOS LP, 1994, ECOL ENTOMOL, V19, P138, DOI 10.1111/j.1365-2311.1994.tb00403.x; MERRITT RW, 1992, ANNU REV ENTOMOL, V37, P349, DOI 10.1146/annurev.en.37.010192.002025; Mitchell-Foster K, 2012, J VECTOR ECOL, V37, P221, DOI 10.1111/j.1948-7134.2012.00220.x; Mogi M, 1996, J MED ENTOMOL, V33, P53, DOI 10.1093/jmedent/33.1.53; Mokany A, 2003, AUSTRAL ECOL, V28, P33, DOI 10.1046/j.1442-9993.2003.01239.x; Mokany A, 2003, OECOLOGIA, V135, P615, DOI 10.1007/s00442-003-1215-6; Mokany A, 2002, AUST J ZOOL, V50, P549, DOI 10.1071/ZO01082; Morin P., 1999, COMMUNITY ECOL; Muturi EJ, 2011, TROP MED INT HEALTH, V16, P955, DOI 10.1111/j.1365-3156.2011.02796.x; NASCI RS, 1994, J MED ENTOMOL, V31, P123, DOI 10.1093/jmedent/31.1.123; PACKER MJ, 1989, ECOL ENTOMOL, V14, P297, DOI 10.1111/j.1365-2311.1989.tb00960.x; Padmanabha H, 2011, J MED ENTOMOL, V48, P974, DOI 10.1603/ME11020; Reiskind MH, 2009, MED VET ENTOMOL, V23, P62, DOI 10.1111/j.1365-2915.2008.00782.x; Rossi V, 2011, J LIMNOL, V70, P102, DOI 10.4081/jlimnol.2011.102; Rowbottom R, THESIS; Russell RC, 2002, ANNU REV ENTOMOL, V47, P1, DOI 10.1146/annurev.ento.47.091201.145100; Schneider JR, 2011, INFECT GENET EVOL, V11, P11, DOI 10.1016/j.meegid.2010.10.019; Silberbush A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088650; Stav G, 2005, ECOL APPL, V15, P587, DOI 10.1890/03-5191; Telang A, 2006, J EXP BIOL, V209, P645, DOI 10.1242/jeb.02026; Tilman D., 1982, Monographs in Population Biology, pi; Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x; van Schie C, 2009, AUST J ENTOMOL, V48, P293, DOI 10.1111/j.1440-6055.2009.00719.x; Walsh R, 2015, AQUATIC MICROINVERTE; Werner AK, 2012, EPIDEMIOL INFECT, V140, P359, DOI 10.1017/S0950268811000446; Williams DD, 1997, AQUAT CONSERV, V7, P105	59	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142472	10.1371/journal.pone.0142472	http://dx.doi.org/10.1371/journal.pone.0142472			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558896	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000364433100081
J	Stagg, HR; Brown, J; Ibraim, E; Riekstina, V; Viiklepp, P; Cirule, A; Cocei, H; Danilovits, M; Dravniece, G; Jackson, C; White, PJ				Stagg, Helen R.; Brown, James; Ibraim, Elmira; Riekstina, Vija; Viiklepp, Piret; Cirule, Andra; Cocei, Horia; Danilovits, Manfred; Dravniece, Gunta; Jackson, Charlotte; White, Peter J.			Drug Susceptibility Patterns in MDR-TB Patients: Challenges for Future Regimen Design. A Cross-Sectional Study	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; COUNTRIES	Globally, there is substantial concern regarding the challenges of treating complex drug resistance patterns in multidrug resistant tuberculosis cases. Utilising data from three different settings (Estonia, Latvia, Romania) we sought to contrast drug susceptibility profiles for multidrug resistant tuberculosis cases, highlight the difficulties in designing universal regimen, and inform future regimen selection. Demographic and microbiological surveillance data for multidrug resistant tuberculosis cases from 2004-13 were analysed. High levels of additional resistance to currently recommended second line drugs were seen in all settings, with extensive variability between countries. Accurate drug susceptibility testing and drug susceptibility testing data are vital to inform the development of comprehensive, flexible, multidrug resistant tuberculosis guidance.	[Stagg, Helen R.; Jackson, Charlotte] UCL, Res Dept Infect & Populat Hlth, London, England; [Brown, James] Royal Free London NHS Fdn Trust, Ctr Resp Med, London, England; [Brown, James] UCL, Div Med, London, England; [Ibraim, Elmira] Marius Nasta Inst Pulmonol, Bucharest, Romania; [Riekstina, Vija; Cirule, Andra] Riga East Univ Hosp, Ctr TB & Lung Dis, Riga, Latvia; [Riekstina, Vija] Univ Latvia, Riga, Latvia; [Viiklepp, Piret] Natl Inst Hlth Dev, Estonian TB Registry, Tallinn, Estonia; [Danilovits, Manfred] Tartu Univ Hosp, Lung Clin, Tartu, Estonia; [Dravniece, Gunta] KNCV TB Fdn, The Hague, Netherlands; [White, Peter J.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Infect Dis Epidemiol, MRC,Ctr Outbreak Anal & Modelling, London, England; [White, Peter J.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Infect Dis Epidemiol, NIHR Hlth Protect Res Unit Modelling Methodol, London, England; [White, Peter J.] Publ Hlth England, Ctr Infect Dis Surveillance & Control, Modelling & Econ Unit, London, England	University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; University of London; University College London; "Marius Nasta" Pneumophtisiology Institute; Riga East University Hospital; University of Latvia; National Institute for Health Development - Estonia; KNCV Tuberculosis Foundation; Imperial College London; Imperial College London; Public Health England	Stagg, HR (corresponding author), UCL, Res Dept Infect & Populat Hlth, London, England.	h.stagg@ucl.ac.uk		Stagg, Helen/0000-0003-4022-3447	Otsuka SA; MRC [MR/K010174/1] Funding Source: UKRI; Medical Research Council [MR/K010174/1, MR/K010174/1B] Funding Source: researchfish; National Institute for Health Research [HPRU-2012-10080] Funding Source: researchfish	Otsuka SA; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The collation of data for this paper and its compilation was sponsored by Otsuka SA. In her previous role as an employee of Otsuka SA, GD played a role in the study design, analysis, decision to publish, and manuscript preparation.	Chedore P, 2010, J CLIN MICROBIOL, V48, P300, DOI 10.1128/JCM.01775-09; Dalton T, 2012, LANCET, V380, P1406, DOI 10.1016/S0140-6736(12)60734-X; Kurbatova EV, 2015, EMERG INFECT DIS, V21, P977, DOI 10.3201/eid2106.141329; WHO, 2014, GLOB TUB REP 2014; World Health Organization, 2011, GUID PROGR MAN DRUG; World Health organization, 2008, POL GUID DRUG SUSC T; Zignol M, 2013, DRUG RESIST UPDATE, V16, P108, DOI 10.1016/j.drup.2014.02.003; Zumla A, 2013, NAT REV DRUG DISCOV, V12, P388, DOI 10.1038/nrd4001	8	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142425	10.1371/journal.pone.0142425	http://dx.doi.org/10.1371/journal.pone.0142425			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558611	Green Published, gold, Green Submitted			2022-12-26	WOS:000364433100079
J	Yoshioka, A; Mishima, Y; Fukasawa, K				Yoshioka, Akira; Mishima, Yoshio; Fukasawa, Keita			Pollinators and Other Flying Insects inside and outside the Fukushima Evacuation Zone	PLOS ONE			English	Article							CLIMATE-CHANGE; NUCLEAR-POWER; CARPENTER BEE; HYMENOPTERA; LANDSCAPE; JAPAN	Following the accident at the Fukushima Daiichi nuclear power plants in 2011, a large evacuation zone was imposed in an area where residents had historically managed forests and farmlands. Thus, the human activities that had maintained biodiversity and ecosystem services in the zone were discontinued. Such change can affect insects, a biodiversity component that is relatively tolerant to radiation exposure. In this study, we investigated flying insects, including pollinators, important ecosystem providers inside and outside the zone, using Malaise traps. The results showed that the number of individuals of Xylocopa appendiculata, the largest Apidae species in the region, was significantly lower inside the evacuation zone than outside it, whereas those of other insects were not lower significantly. Although we suggest that flying insects and their ecosystem services (i.e., benefits from them such as pollination) 3 years after the disaster were not critically impacted, it is important to monitor the long-term effects of the evacuation in the future.	[Yoshioka, Akira; Mishima, Yoshio; Fukasawa, Keita] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki 3058506, Japan	National Institute for Environmental Studies - Japan	Yoshioka, A (corresponding author), Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan.	yoshioka.akira@nies.go.jp	Fukasawa, Keita/AAH-1395-2019		research program on Disaster Environment; National Institute for Environmental Studies	research program on Disaster Environment; National Institute for Environmental Studies	The authors received no competing grant that has a particular number for this work. However, this work was financially supported by the research program on Disaster Environment, an internal budget of National Institute for Environmental Studies. The internal budget was originally issued by the Ministry of environment, Japan (http://www.nies.go.jp/shinsai/index-e.html).	[Anonymous], 2014, ILLUSTRATED GUIDE JA; Bauer N, 2012, P NATL ACAD SCI USA, V109, P16805, DOI 10.1073/pnas.1201264109; Bellwood P, 2011, CURR ANTHROPOL, V52, pS363, DOI 10.1086/658181; Cabinet Office Government of Japan, 2014, DIS MAN WHIT PAP 201; Cabinet Office Government of Japan, 2013, REV EV ZON; Corner A, 2011, ENERG POLICY, V39, P4823, DOI 10.1016/j.enpol.2011.06.037; Garnier-Laplace J, 2013, J ENVIRON RADIOACTIV, V121, P12, DOI 10.1016/j.jenvrad.2012.01.013; Garnier-Laplace J, 2011, ENVIRON SCI TECHNOL, V45, P5077, DOI 10.1021/es201637c; Gelman A., 2003, BAYESIAN DATA ANAL; Gerland P, 2014, SCIENCE, V346, P234, DOI 10.1126/science.1257469; Hayashi Toshihiko, 2012, Medical Entomology and Zoology, V63, P85; Hidaka T, 1998, ENCY ANIMALS JAPAN, V10; Hiyama A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00570; ICRP, 2008, ANN ICRP, V38; Inoue MN, 2008, J INSECT CONSERV, V12, P135, DOI 10.1007/s10841-007-9071-z; Japan Biodiversity Outlook Science Committee (JBOSC), 2010, REP COMPR ASS BIOD J; Jenic Aljaz, 2010, Acta Entomologica Slovenica, V18, P168; Kadoya T, 2010, BIOL CONSERV, V143, P1228, DOI 10.1016/j.biocon.2010.02.030; Katoh K, 2009, BIOL CONSERV, V142, P1930, DOI 10.1016/j.biocon.2009.02.030; Keasar Tamar, 2010, Psyche (Cambridge), V2010, P1, DOI 10.1155/2010/927463; Koyama S., 1978, SENRI ETHNOL STUD, V2, P1; Kusumoto Y., 2007, J JPN, V70, P445; Latimer AM, 2006, ECOL APPL, V16, P33, DOI 10.1890/04-0609; Makita K., 2014, ENVIRON POLLUT, V3, P1; Malko MV, 1998, RES ACTIVITIES RADIO, P240; Matsuda M, 1980, GEOJOURNAL, V4, P313, DOI [10.1007/BF00219578, DOI 10.1007/BF00219578]; Meiners SJ, 2001, ECOGRAPHY, V24, P633, DOI 10.1034/j.1600-0587.2001.240602.x; Ministry of Environment Japan (MOE), 2014, PROGR OFF SIT CLEAN; Miyamoto S., 1961, KONTYU, V29, P4; Moller AP, 2012, OECOLOGIA, V170, P1155, DOI 10.1007/s00442-012-2374-0; Moller AP, 2013, ECOL INDIC, V24, P75, DOI 10.1016/j.ecolind.2012.06.001; National and Regional Planning Bureau of the Ministry of Land Infrastructure Trans-port and Tourism of Japan (NRPB), 2009, NAT LAND NUM INF LAN; National and Regional Planning Bureau of the Ministry of Land Infrastructure Trans-port and Tourism of Japan (NRPB), 2011, NAT LAND NUM INF EL; National and Regional Planning Bureau of the Ministry of Land Infrastructure Trans-port and Tourism of Japan (NRPB), 2012, NAT LAND NUM INF SCH; Ogawa M., 2013, Japanese Journal of Conservation Ecology, V18, P69; QGIS Development Team, 2009, QGIS GEOGR INF SYST; Queiroz C, 2014, FRONT ECOL ENVIRON, V12, P288, DOI 10.1890/120348; Reconstruction Agency, 2012, PRED AIR RAD DOS RAT; Spiegelhalter DJ, 2003, WINBUGS VERSION 1 4; STYRON CE, 1973, RADIAT RES, V55, P487, DOI 10.2307/3573854; SUGIURA N, 1995, J KANSAS ENTOMOL SOC, V68, P116; Sugiura N, 2013, BOT J LINN SOC, V171, P730, DOI 10.1111/j.1095-8339.2012.01324.x; Terayama M., 2004, MEMOIRS MYRMECOLOGIC, V2, P1; Uchida K, 2014, ECOL MONOGR, V84, P637, DOI 10.1890/13-2170.1; Yoshioka A, 2014, J INSECT SCI, V14, DOI 10.1673/031.014.110	45	10	11	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0140957	10.1371/journal.pone.0140957	http://dx.doi.org/10.1371/journal.pone.0140957			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26561045	Green Published, gold, Green Submitted			2022-12-26	WOS:000364433100016
J	Zaton, M; Broda, K				Zaton, Michal; Broda, Krzysztof			First Record of Soft Tissue Preservation in the Upper Devonian of Poland	PLOS ONE			English	Article							HOLY CROSS MOUNTAINS; MUSCLE-TISSUE; REMARKABLE PRESERVATION; UPPER ORDOVICIAN; HUNSRUCK SLATE; MINERALIZATION; LAGERSTATTE; FOSSILIZATION; ANIMALS; FOSSILS	Soft tissue preservation is reported from Upper Devonian deposits of the Holy Cross Mountains, central Poland, for the first time. The preserved soft tissues are muscles associated with arthropod cuticle fragments. The muscles are phosphatized with variable states of preservation. Well-preserved specimens display the typical banding of striated muscles. Other muscle fragments are highly degraded and/or recrystallized such that their micro-structure is barely visible. The phosphatized muscles and associated cuticle are fragmented, occur in patches and some are scattered on the bedding plane. Due to the state of preservation and the lack of diagnostic features, the cuticle identification is problematic; however, it may have belonged to a phyllocarid crustacean. Taphonomic features of the remains indicate that they do not represent fossilized fecal matter (coprolite) but may represent a regurgitate, but the hypothesis is difficult to test. Most probably they represent the leftover remains after arthropod or fish scavenging. The present study shows that soft tissues, which even earlier were manipulated by scavenger, may be preserved if only special microenvironmental conditions within and around the animal remains are established.	[Zaton, Michal; Broda, Krzysztof] Silesian Univ, Fac Earth Sci, Sosnowiec, Poland	University of Silesia in Katowice	Zaton, M (corresponding author), Silesian Univ, Fac Earth Sci, Bedzinska 60, Sosnowiec, Poland.	mzaton@wnoz.us.edu.pl		Zaton, Michal/0000-0001-5136-5286				Aldridge RJ, 2006, PALAEONTOLOGY, V49, P857, DOI 10.1111/j.1475-4983.2006.00570.x; ALLISON PA, 1993, GEOLOGY, V21, P527, DOI 10.1130/0091-7613(1993)021<0527:EFRDOS>2.3.CO;2; ALLISON PA, 1988, PALEOBIOLOGY, V14, P331, DOI 10.1017/S0094837300012082; Bond Dave, 2003, Acta Geologica Polonica, V53, P93; Briggs DEG, 2005, P ROY SOC B-BIOL SCI, V272, P627, DOI 10.1098/rspb.2004.3006; BRIGGS DEG, 1994, PALAIOS, V9, P431, DOI 10.2307/3515135; Briggs DEG, 1996, NATURE, V382, P248, DOI 10.1038/382248a0; Briggs DEG, 1996, J GEOL SOC LONDON, V153, P665, DOI 10.1144/gsjgs.153.5.0665; Briggs DEG, 1996, AM J SCI, V296, P633, DOI 10.2475/ajs.296.6.633; Broda K, 2015, P GEOLOGIST ASSOC, V126, P589, DOI 10.1016/j.pgeola.2015.05.005; Chin K, 2003, PALAIOS, V18, P286, DOI 10.1669/0883-1351(2003)018<0286:RPOUMT>2.0.CO;2; Crowther P.R, 2001, PALAEOBIOLOGY, P328; Cunningham JA, 2012, P ROY SOC B-BIOL SCI, V279, P1857, DOI 10.1098/rspb.2011.2064; Feldmann RM, 2010, J CRUSTACEAN BIOL, V30, P629, DOI 10.1651/09-3268.1; Filipiak P, 2009, REV PALAEOBOT PALYNO, V157, P326, DOI 10.1016/j.revpalbo.2009.06.006; GABBOTT SE, 1995, NATURE, V374, P800, DOI 10.1038/374800a0; Gabbott SE, 2004, GEOLOGY, V32, P901, DOI 10.1130/G20640.1; Ginter M, 2002, ACTA PALAEONTOL POL, V47, P329; Hattin DE, 1996, CRETACEOUS RES, V17, P443, DOI 10.1006/cres.1996.0027; Kellner AWA, 1996, NATURE, V379, P32, DOI 10.1038/379032a0; Maas Andreas, 2006, Palaeoworld, V15, P266, DOI 10.1016/j.palwor.2006.10.005; Martill D.M., 1989, Geology Today, V5, P201, DOI 10.1111/j.1365-2451.1989.tb00671.x; MARTILL DM, 1990, NATURE, V346, P171, DOI 10.1038/346171a0; MARTILL DM, 1988, PALAEONTOLOGY, V31, P1; MARTILL DM, 1989, NATURE, V340, P138, DOI 10.1038/340138a0; Martill DM, 1995, PALAEONTOLOGY, V38, P897; Martill DM, 2003, PALAEOBIOLOGY, P351; Martin D, 2003, GEOLOGY, V31, P39, DOI 10.1130/0091-7613(2003)031<0039:EMOIEA>2.0.CO;2; Marynowski L, 2011, PALAEOGEOGR PALAEOCL, V306, P1, DOI 10.1016/j.palaeo.2011.03.018; Montalvo CI, 2016, LETHAIA, V49, P219, DOI 10.1111/let.12140; Moore RA, 2011, J PALEONTOL, V85, P83, DOI 10.1666/10-057.1; Myhrvold NP, 2012, HIST BIOL, V24, P505, DOI 10.1080/08912963.2011.631703; Orr PJ, 1998, SCIENCE, V281, P1173, DOI 10.1126/science.281.5380.1173; Racheboeuf Patrick R., 1994, Revue de Paleobiologie, V13, P281; RACKI G, 1996, 6 EUR CON S ECOS 6 E, P27; Raff EC, 2008, P NATL ACAD SCI USA, V105, P19360, DOI 10.1073/pnas.0810106105; Raiswell R, 2008, AM J SCI, V308, P105, DOI 10.2475/02.2008.01; Sagemann J, 1999, GEOCHIM COSMOCHIM AC, V63, P1083, DOI 10.1016/S0016-7037(99)00087-3; Schiffbauer JD, 2012, PALAIOS, V27, P275, DOI 10.2110/palo.2012.SO3; Schultze H.-P., 1989, Revista Geologica de Chile, V16, P183; Seilacher A., 1970, NEUES JAHRB GEOL P-M, V1970, P34, DOI DOI 10.1080/17451000500456262; Trinajstic K, 2007, BIOL LETTERS, V3, P197, DOI 10.1098/rsbl.2006.0604; Trinajstic K, 2013, SCIENCE, V341, P160, DOI 10.1126/science.1237275; Vannier J, 2005, PALAIOS, V20, P3, DOI 10.2110/palo.2003.p03-40; Wilby P.R., 1992, Historical Biology, V6, P25; Wilby Philip R., 1997, Geobios Memoire Special (Villeurbanne), V20, P493; Wilby PR, 1996, GEOLOGY, V24, P787, DOI 10.1130/0091-7613(1996)024<0787:ROMMIT>2.3.CO;2; Xiao SH, 1999, LETHAIA, V32, P219, DOI 10.1111/j.1502-3931.1999.tb00541.x; Xiao SH, 1998, NATURE, V391, P553, DOI 10.1038/35318; Zaton M, 2007, LETHAIA, V40, P139, DOI 10.1111/j.1502-3931.2007.00017.x; Zaton M, 2014, LETHAIA, V47, P352, DOI 10.1111/let.12062; Zaton M, 2014, PALAEOGEOGR PALAEOCL, V394, P1, DOI 10.1016/j.palaeo.2013.11.019	52	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142619	10.1371/journal.pone.0142619	http://dx.doi.org/10.1371/journal.pone.0142619			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559060	gold, Green Published, Green Submitted			2022-12-26	WOS:000364433100102
J	Bastin, JF; Fayolle, A; Tarelkin, Y; Van den Buicke, J; de Haulleville, T; Mortier, F; Beeckman, H; Van Acker, J; Serckx, A; Bogaert, J; De Canniere, C				Bastin, Jean-Francois; Fayolle, Adeline; Tarelkin, Yegor; Van den Buicke, Jan; de Haulleville, Tholes; Mortier, Frederic; Beeckman, Hans; Van Acker, Joris; Serckx, Adeline; Bogaert, Jan; De Canniere, Charles			Wood Specific Gravity Variations and Biomass of Central African Tree Species: The Simple Choice of the Outer Wood	PLOS ONE			English	Article							ABOVEGROUND BIOMASS; ERROR PROPAGATION; RADIAL VARIATION; RAIN-FOREST; DENSITY; GROWTH; MORTALITY; HYPERDOMINANCE; BIOMECHANICS; PATTERNS	Wood specific gravity is a key element in tropical forest ecology. It integrates many aspects of tree mechanical properties and functioning and is an important predictor of tree biomass. Wood specific gravity varies widely among and within species and also within individual trees. Notably, contrasted patterns of radial variation of wood specific gravity have been demonstrated and related to regeneration guilds (light demanding vs. shade-bearing). However, although being repeatedly invoked as a potential source of error when estimating the biomass of trees, both intraspecific and radial variations remain little studied. In this study we characterized detailed pith-to-bark wood specific gravity profiles among contrasted species prominently contributing to the biomass of the forest, i.e., the dominant species, and we quantified the consequences of such variations on the biomass.	[Bastin, Jean-Francois; Tarelkin, Yegor; De Canniere, Charles] Univ Libre Bruxelles, Landscape Ecol & Plant Prod Syst Unit, B-1050 Brussels, Belgium; [Bastin, Jean-Francois; Fayolle, Adeline; de Haulleville, Tholes; Bogaert, Jan] Univ Liege, BIOSE Dept, Gembloux Agrobio Tech, B-5030 Gembloux, Belgium; [Bastin, Jean-Francois; Serckx, Adeline] Ecole Reg Postuniv Amenagement & Gest Integres Fo, Kinshasa, DEM REP CONGO; [Van den Buicke, Jan; Van Acker, Joris] Univ Ghent Ctr Xray Tomog, UGCT, B-9000 Ghent, Belgium; [de Haulleville, Tholes; Beeckman, Hans] Royal Museum Cent Africa, Lab Wood Biol & Xylarium, Tervuren, Belgium; [Mortier, Frederic] CIRAD, UPR BSEF, F-34398 Montpellier, France; [Serckx, Adeline] Univ Liege, Behav Biol Unit, Liege, Belgium; [Serckx, Adeline] Royal Belgian Inst Nat Sci, Conservat Biol Unit, Brussels, Belgium	Universite Libre de Bruxelles; University of Liege; Ghent University; Royal Museum for Central Africa; CIRAD; University of Liege; Royal Belgian Institute of Natural Sciences	Bastin, JF (corresponding author), Univ Libre Bruxelles, Landscape Ecol & Plant Prod Syst Unit, CP264-2, B-1050 Brussels, Belgium.	bastin.jf@gmail.com	Beeckman, Hans/I-7653-2019; Van Acker, Joris/AAS-6030-2020	Beeckman, Hans/0000-0001-8954-6277; Van Acker, Joris/0000-0002-8961-0176; Mortier, Frederic/0000-0001-5473-709X; FAYOLLE, Adeline/0000-0002-6770-0031; Van den Bulcke, Jan/0000-0003-2939-5408	FNRS (Fonds National pour la Recherche Scientifique) [FC-89142]; ERAIFT (Ecole Regionale post-universitaire d'Amenagement et de gestion Integres des Forets et Territoires tropicaux) [ER/JPM/BM/281/Not./2012]; FRIA (FNRS); ERAIFT	FNRS (Fonds National pour la Recherche Scientifique)(Fonds de la Recherche Scientifique - FNRS); ERAIFT (Ecole Regionale post-universitaire d'Amenagement et de gestion Integres des Forets et Territoires tropicaux); FRIA (FNRS)(Fonds de la Recherche Scientifique - FNRS); ERAIFT	The authors are supported by the FNRS (Fonds National pour la Recherche Scientifique; FC-89142; www.fnrs.be). Additional funds for field support were provided by the ERAIFT (Ecole Regionale post-universitaire d'Amenagement et de gestion Integres des Forets et Territoires tropicaux; ER/JPM/BM/281/Not./2012; http://www.eraift-rdc.org). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the FRIA (FNRS) and the ERAIFT for support and funding, to the WWF Belgium and DRC, to MbouMonTour NGOs for logistical support. We also would like to thank J.Lejoly, L.Pauwels, J-.L.Doucet and J-.F.Gillet (ULg-Gembloux, Belgium) for advice and aid in botanical identifications, to J.Hebert and P.Thibaut (ULg-Gembloux, Belgium) for general advice and water displacement analysis on the samples and to Nicholas Rowe (CNRS, AMAP, France), Olivier Hardy and Marius Gilbert (ULB, Belgium) for their insightful comments. Finally, we are very grateful to the local community chiefs from Nkala and Mpelu villages, and particularly, to P.Eyiano, N.Mongama, Leboncoeur and Bovik for fieldwork assistance.	Agrawal A, 2011, ANNU REV ENV RESOUR, V36, P373, DOI 10.1146/annurev-environ-042009-094508; Bastin JF, 2015, SCI REP-UK, V5, DOI 10.1038/srep13156; Bastin JF, 2014, ECOL APPL, V24, P1984, DOI 10.1890/13-1574.1; Bates D, 2005, R NEWS, V5, P27, DOI DOI 10.1111/J.1523-1739.2005.00280.X; Brienen RJW, 2006, J ECOL, V94, P481, DOI 10.1111/j.1365-2745.2005.01080.x; Chao KJ, 2008, J ECOL, V96, P281, DOI 10.1111/j.1365-2745.2007.01343.x; Chave J, 2004, PHILOS T R SOC B, V359, P409, DOI 10.1098/rstb.2003.1425; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chave J, 2001, J TROP ECOL, V17, P79, DOI 10.1017/S0266467401001055; Chave J, 2006, ECOL APPL, V16, P2356, DOI 10.1890/1051-0761(2006)016[2356:RAPVOW]2.0.CO;2; Chave J, 2014, GLOBAL CHANGE BIOL, V20, P3177, DOI 10.1111/gcb.12629; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; De Ridder M, 2011, ANN BOT-LONDON, V107, P293, DOI 10.1093/aob/mcq224; Detienne P., 1996, Bois et Forets des Tropiques, P19; Fauset S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7857; Fayolle A, 2014, J BIOGEOGR, V41, P2320, DOI 10.1111/jbi.12382; Fayolle A, 2014, FOREST ECOL MANAG, V329, P195, DOI 10.1016/j.foreco.2014.06.014; Fournier M, 2013, J EXP BOT, V64, P4793, DOI 10.1093/jxb/ert279; Gourlet-Fleury S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0302; Gourlet-Fleury S, 2011, J ECOL, V99, P981, DOI 10.1111/j.1365-2745.2011.01829.x; Hawthorne W.D., 1995, ECOLOGICAL PROFILES; King DA, 2006, J ECOL, V94, P670, DOI 10.1111/j.1365-2745.2006.01112.x; King DA, 2005, FUNCT ECOL, V19, P445, DOI 10.1111/j.1365-2435.2005.00982.x; Maniatis D, 2011, IFOREST, V4, P150, DOI 10.3832/ifor0575-004; McCulloh KA, 2011, OECOLOGIA, V167, P27, DOI 10.1007/s00442-011-1973-5; Molto Q, 2013, METHODS ECOL EVOL, V4, P175, DOI 10.1111/j.2041-210x.2012.00266.x; MORSE DR, 1985, NATURE, V314, P731, DOI 10.1038/314731a0; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nock CA, 2009, ANN BOT-LONDON, V104, P297, DOI 10.1093/aob/mcp118; Nogueira EM, 2008, FOREST ECOL MANAG, V256, P990, DOI 10.1016/j.foreco.2008.06.001; Onoda Y, 2010, NEW PHYTOL, V185, P493, DOI 10.1111/j.1469-8137.2009.03088.x; Osazuwa-Peters OL, 2014, AM J BOT, V101, P803, DOI 10.3732/ajb.1400040; Panshin A.J., 1980, TXB WOOD TECHNOLOGY; Pinheiro J, 2001, MIXED EFFECTS MODELS; Plourde BT, 2015, FUNCT ECOL, V29, P111, DOI 10.1111/1365-2435.12305; Ramananantoandro T, 2015, J FORESTRY RES, V26, P47, DOI 10.1007/s11676-015-0029-9; Reich PB, 2014, J ECOL, V102, P275, DOI 10.1111/1365-2745.12211; Sallenave, 1955, PROPRIETES PHYS MECA; Sallenave P., 1964, PROPRIETES PHYS MECA; SALLENAVE P, 1971, PROPRIETES PHYS MECA; Serckx A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093742; Slik JWF, 2006, J TROP ECOL, V22, P481, DOI 10.1017/S0266467406003324; Slik JWF, 2010, GLOBAL ECOL BIOGEOGR, V19, P50, DOI 10.1111/j.1466-8238.2009.00489.x; Slik JWF, 2013, GLOBAL ECOL BIOGEOGR, V22, P1261, DOI 10.1111/geb.12092; Stephenson NL, 2014, NATURE, V507, P90, DOI 10.1038/nature12914; Swenson NG, 2007, AM J BOT, V94, P451, DOI 10.3732/ajb.94.3.451; ter Steege H, 2013, SCIENCE, V342, P325, DOI 10.1126/science.1243092; Turner I.M., 2001, CAM TROP B, DOI 10.1017/CBO9780511542206; Urquiza-Haas T, 2007, FOREST ECOL MANAG, V247, P80, DOI 10.1016/j.foreco.2007.04.015; Van den Bulcke J, 2014, DENDROCHRONOLOGIA, V32, P39, DOI 10.1016/j.dendro.2013.07.001; Vancutsem C, 2006, REPUBLIQUE DEMOCRATI; Vieilledent G, 2012, ECOL APPL, V22, P572, DOI 10.1890/11-0039.1; Wassenberg M, 2015, TREES-STRUCT FUNCT, V29, P551, DOI 10.1007/s00468-014-1134-7; WIEMANN MC, 1988, WOOD FIBER SCI, V20, P344; Williamson GB, 2010, AM J BOT, V97, P519, DOI 10.3732/ajb.0900243; Woodcock DW, 2002, TREES-STRUCT FUNCT, V16, P437, DOI 10.1007/s00468-002-0173-7; Zanne A.E., 2009, GLOBAL WOOD DENSITY, DOI [DOI 10.5061/DRYAD.234, 10.5061/dryad.234]; Zuur Alain F., 2009, P1	58	34	34	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142146	10.1371/journal.pone.0142146	http://dx.doi.org/10.1371/journal.pone.0142146			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555144	Green Published, Green Submitted, gold			2022-12-26	WOS:000364430700060
J	Daniels, JF; Khogali, M; Mohr, E; Cox, V; Moyo, S; Edginton, M; Hinderaker, SG; Meintjes, G; Hughes, J; De Azevedo, V; van Cutsem, G; Cox, HS				Daniels, Johnny Flippie; Khogali, Mohammed; Mohr, Erika; Cox, Vivian; Moyo, Sizulu; Edginton, Mary; Hinderaker, Sven Gudmund; Meintjes, Graeme; Hughes, Jennifer; De Azevedo, Virginia; van Cutsem, Gilles; Cox, Helen Suzanne			Time to ART Initiation among Patients Treated for Rifampicin-Resistant Tuberculosis in Khayelitsha, South Africa: Impact on Mortality and Treatment Success	PLOS ONE			English	Article							HIV-INFECTED ADULTS; ANTIRETROVIRAL THERAPY; TREATMENT OUTCOMES	Setting Khayelitsha, South Africa, with high burdens of rifampicin-resistant tuberculosis (RR-TB) and HIV co-infection. Objective To describe time to antiretroviral treatment (ART) initiation among HIV-infected RR-TB patients initiating RR-TB treatment and to assess the association between time to ART initiation and treatment outcomes. Design A retrospective cohort study of patients with RR-TB and HIV co-infection not on ART at RR-TB treatment initiation. Results Of the 696 RR-TB and HIV-infected patients initiated on RR-TB treatment between 2009 and 2013, 303 (44%) were not on ART when RR-TB treatment was initiated. The median CD4 cell count was 126 cells/mm(3). Overall 257 (85%) patients started ART during RR-TB treatment, 33 (11%) within 2 weeks, 152 (50%) between 2-8 weeks and 72 (24%) after 8 weeks. Of the 46 (15%) who never started ART, 10 (21%) died or stopped RR-TB treatment within 4 weeks and 16 (37%) had at least 4 months of RR-TB treatment. Treatment success and mortality during treatment did not vary by time to ART initiation: treatment success was 41%, 43%, and 50% among patients who started ART within 2 weeks, between 2-8 weeks, and after 8 weeks (p = 0.62), while mortality was 21%, 13% and 15% respectively (p = 0.57). Mortality was associated with never receiving ART (adjusted hazard ratio (aHR) 6.0, CI 2.1-18.1), CD4 count <= 100 (aHR 2.1, CI 1.0-4.5), and multidrug-resistant tuberculosis (MDR-TB) with second-line resistance (aHR 2.5, CI 1.1-5.4). Conclusions Despite wide variation in time to ART initiation among RR-TB patients, no differences in mortality or treatment success were observed. However, a significant proportion of patients did not initiate ART despite receiving >4 months of RR-TB treatment. Programmatic priorities should focus on ensuring all patients with RR-TB/HIV co-infection initiate ART regardless of CD4 count, with special attention for patients with CD4 counts <= 100 to initiate ART as soon as possible after RR-TB treatment initiation.	[Daniels, Johnny Flippie; Mohr, Erika; Cox, Vivian; Moyo, Sizulu; Hughes, Jennifer; van Cutsem, Gilles] Med Sans Frontieres, Cape Town, South Africa; [Khogali, Mohammed] Med Sans Frontieres, Luxembourg, Luxembourg; [Moyo, Sizulu] Human Sci Res Council, HIV AIDS STIs & TB Programme, Cape Town, South Africa; [Edginton, Mary] Int Union TB & Lung Dis, Paris, France; [Edginton, Mary] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa; [Hinderaker, Sven Gudmund] Univ Bergen, Bergen, Norway; [Meintjes, Graeme; Cox, Helen Suzanne] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Meintjes, Graeme] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa; [De Azevedo, Virginia] City Cape Town Dept Hlth, Cape Town, South Africa; [van Cutsem, Gilles] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, ZA-7925 Cape Town, South Africa; [Cox, Helen Suzanne] Univ Cape Town, Div Med Microbiol, ZA-7925 Cape Town, South Africa	Doctors Without Borders; Human Sciences Research Council-South Africa; University of Witwatersrand; University of Bergen; University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town	Daniels, JF (corresponding author), Med Sans Frontieres, Cape Town, South Africa.	msfocb-khayelitsha-tbdata@brussels.msf.org	Van Cutsem, Gilles/ABB-1171-2021	Van Cutsem, Gilles/0000-0002-8972-4480; Hughes, Jennifer/0000-0002-5349-9509; Cox, Helen/0000-0002-6538-7192; Meintjes, Graeme/0000-0003-1196-4414	Union; MSF; Department for International Development (DFID); WHO; Wellcome Trust	Union; MSF; Department for International Development (DFID); WHO(World Health Organization); Wellcome Trust(Wellcome Trust)	The research for this study was unfunded. The SORT IT programme was funded by The Union, MSF, the Department for International Development (DFID) and WHO. HC is supported by the Wellcome Trust.	[Anonymous], 2011, ACT REP 10 YEARS HIV; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Boulle A, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001718; Cox H, 2014, INT J TUBERC LUNG D, V18, P441, DOI 10.5588/ijtld.13.0742; Dheda K, 2010, LANCET, V375, P1798, DOI 10.1016/S0140-6736(10)60492-8; Farley JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020436; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Howard AA, 2010, CLIN INFECT DIS, V50, pS238, DOI 10.1086/651497; Isaakidis P, 2015, INT J TUBERC LUNG D, V19, P969, DOI 10.5588/ijtld.15.0123; Isaakidis P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040781; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Kerschberger B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046988; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Meintjes G, 2014, S AFR J HIV MED, V15, P121, DOI [10.7196/sajhivmed.1130, 10.7196/SAJHIVMED.1130]; Meintjes G, 2011, CONTIN MED ED, V29, P410; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Meintjes G, 2012, S AFR J HIV MED, DOI 10.7196/SAJHIVMED.862; Mohr E, 2015, T ROY SOC TROP MED H, V109, P425, DOI 10.1093/trstmh/trv037; Nathanson E, 2004, INT J TUBERC LUNG D, V8, P1382; National Department of Health South Africa, 2011, MAN DRUG RES TUB POL; National Department of Health South Africa, 2013, MAN DRUG RES TUB POL; National Department of Health South Africa, 2009, MAN DRUG RES TB S AF; National Department of Health South Africa, 2009, NAT TUB MAN GUID 200; National Department of Health South Africa, 2010, S AFR ANT TREATM GUI; National Department of Health South Africa, 2014, NAT TUB MAN GUID 201; National Department of Health South Africa, 2013, S AFR ANT TREATM GUI; O'Donnell MR, 2013, EMERG INFECT DIS, V19, P416, DOI 10.3201/eid1903.120998; Padayatchi N, 2014, INT J TUBERC LUNG D, V18, P147, DOI 10.5588/ijtld.13.0627; Satti H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046943; Shisana O, 2014, COMMUNICATION; Southern African HIV Clinicians Society, 2008, S AFR J HIV MED; Southern African HIV Clinicians Society, 2012, S AFR J HIV MED, V13, P144; Strategic Development Information and GIS Department CoCT, 2013, CIT CAP TOWN 2011 CE; Uthman OA, 2015, ANN INTERN MED, V163, P32, DOI 10.7326/M14-2979; von Elm E, 2007, B WORLD HEALTH ORGAN, V85, P867, DOI 10.2471/BLT.07.045120; Western Cape Department of Health, 2010, W CAP ANT HIV SURV 2; World Health Organization, 2014, COMP HDB WHO GUID PR; World Health Organization, 2014, WHOHTMTB201402; World Health Organization, 2011, GUID PROGR MAN DRUG	40	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142873	10.1371/journal.pone.0142873	http://dx.doi.org/10.1371/journal.pone.0142873			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555134	Green Submitted, Green Published, gold			2022-12-26	WOS:000364430700180
J	Vo, U; Vajpai, N; Flavell, L; Bobby, R; Breeze, AL; Embrey, KJ; Golovanov, AP				Vo, Uybach; Vajpai, Navratna; Flavell, Liz; Bobby, Romel; Breeze, Alexander L.; Embrey, Kevin J.; Golovanov, Alexander P.			Monitoring Ras Interactions with the Nucleotide Exchange Factor Son of Sevenless (Sos) Using Site-specific NMR Reporter Signals and Intrinsic Fluorescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATOR SON; STRUCTURAL BASIS; COLORECTAL-CANCER; HISTONE DOMAIN; TARGETING RAS; K-RAS; BINDING; PROTEIN; GTP; DYNAMICS	The activity of Ras is controlled by the interconversion between GTP- and GDP-bound forms partly regulated by the binding of the guanine nucleotide exchange factor Son of Sevenless (Sos). The details of Sos binding, leading to nucleotide exchange and subsequent dissociation of the complex, are not completely understood. Here, we used uniformly N-15-labeled Ras as well as [C-13] methyl-Met, Ile-labeled Sos for observing site-specific details of Ras-Sos interactions in solution. Binding of various forms of Ras (loaded with GDP and mimics of GTP or nucleotide-free) at the allosteric and catalytic sites of Sos was comprehensively characterized by monitoring signal perturbations in the NMR spectra. The overall affinity of binding between these protein variants as well as their selected functional mutants was also investigated using intrinsic fluorescence. The data support a positive feedback activation of Sos by Ras-GTP with Ras-GTP binding as a substrate for the catalytic site of activated Sos more weakly than Ras-GDP, suggesting that Sos should actively promote unidirectional GDP -> GTP exchange on Ras in preference of passive homonucleotide exchange. Ras-GDP weakly binds to the catalytic but not to the allosteric site of Sos. This confirms that Ras-GDP cannot properly activate Sos at the allosteric site. The novel site-specific assay described may be useful for design of drugs aimed at perturbing Ras-Sos interactions.	[Vo, Uybach; Golovanov, Alexander P.] Univ Manchester, Manchester Inst Biotechnol, 131 Princess St, Manchester M1 7DN, Lancs, England; [Vo, Uybach; Golovanov, Alexander P.] Univ Manchester, Fac Life Sci, 131 Princess St, Manchester M1 7DN, Lancs, England; [Vajpai, Navratna; Flavell, Liz; Bobby, Romel; Breeze, Alexander L.; Embrey, Kevin J.] AstraZeneca, Discovery Sci, Alderley Pk SK10 4TF, Cheshire, England; [Breeze, Alexander L.] Univ Leeds, Sch Mol & Cellular Biol, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England	University of Manchester; University of Manchester; AstraZeneca; University of Leeds	Golovanov, AP (corresponding author), Univ Manchester, Manchester Inst Biotechnol, 131 Princess St, Manchester M1 7DN, Lancs, England.; Golovanov, AP (corresponding author), Univ Manchester, Fac Life Sci, 131 Princess St, Manchester M1 7DN, Lancs, England.; Embrey, KJ (corresponding author), AstraZeneca, Discovery Sci, Alderley Pk SK10 4TF, Cheshire, England.	Kevin.Embrey@astrazeneca.com; A.Golovanov@manchester.ac.uk	Golovanov, Alexander P./ABN-0572-2022	Golovanov, Alexander P./0000-0002-8592-3984; Breeze, Alexander/0000-0001-9723-3350	Medical Research Council Industrial CASE Studentship [G1000399-3/1]; Medical Research Council [1089592] Funding Source: researchfish	Medical Research Council Industrial CASE Studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Medical Research Council Industrial CASE Studentship G1000399-3/1 (to A. P. G. and K. J. E.). The authors declare that they have no conflicts of interest with the contents of this article.	Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Buday L, 2008, BBA-REV CANCER, V1786, P178, DOI 10.1016/j.bbcan.2008.05.001; Burns MC, 2014, P NATL ACAD SCI USA, V111, P3401, DOI 10.1073/pnas.1315798111; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Ford B, 2005, J BIOL CHEM, V280, P25697, DOI 10.1074/jbc.M502240200; Freedman TS, 2006, P NATL ACAD SCI USA, V103, P16692, DOI 10.1073/pnas.0608127103; Gelis I, 2007, CELL, V131, P756, DOI 10.1016/j.cell.2007.09.039; Golovanov AP, 2004, J AM CHEM SOC, V126, P8933, DOI 10.1021/ja049297h; Gureasko J, 2008, NAT STRUCT MOL BIOL, V15, P452, DOI 10.1038/nsmb.1418; Gureasko J, 2010, P NATL ACAD SCI USA, V107, P3430, DOI 10.1073/pnas.0913915107; Hall BE, 2001, J BIOL CHEM, V276, P27629, DOI 10.1074/jbc.M101727200; Ito Y, 1997, BIOCHEMISTRY-US, V36, P9109, DOI 10.1021/bi970296u; Iversen L, 2014, SCIENCE, V345, P50, DOI 10.1126/science.1250373; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kovrigin EL, 2012, J BIOMOL NMR, V53, P257, DOI 10.1007/s10858-012-9636-3; Krishnarjuna B, 2011, J BIOMOL NMR, V49, P39, DOI 10.1007/s10858-010-9459-z; Kunzelmann S, 2011, BIOCHEM J, V440, P43, DOI 10.1042/BJ20110349; Leatherbarrow R. J, 1992, GRAFIT VERSION 3 0 D; Lenzen C, 1998, BIOCHEMISTRY-US, V37, P7420, DOI 10.1021/bi972621j; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Mas G, 2013, J BIOMOL NMR, V57, P251, DOI 10.1007/s10858-013-9785-z; Mazhab-Jafari MT, 2010, J BIOL CHEM, V285, P5132, DOI 10.1074/jbc.C109.064766; Mou TC, 2005, J BIOL CHEM, V280, P7253, DOI 10.1074/jbc.M409076200; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Quinlan MP, 2008, MOL CELL BIOL, V28, P2659, DOI 10.1128/MCB.01661-07; Rojas Jose M, 2011, Genes Cancer, V2, P298, DOI 10.1177/1947601911408078; Shah BH, 2004, TRENDS NEUROSCI, V27, P48, DOI 10.1016/j.tins.2003.11.003; Smith MJ, 2013, P NATL ACAD SCI USA, V110, P4574, DOI 10.1073/pnas.1218173110; Sondermann H, 2005, P NATL ACAD SCI USA, V102, P16632, DOI 10.1073/pnas.0508315102; Sondermann H, 2004, CELL, V119, P393, DOI 10.1016/j.cell.2004.10.005; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Spoerner M, 2007, FEBS J, V274, P1419, DOI 10.1111/j.1742-4658.2007.05681.x; Spoerner M, 2010, J BIOL CHEM, V285, P39768, DOI 10.1074/jbc.M110.145235; Sprangers R, 2007, NATURE, V445, P618, DOI 10.1038/nature05512; Stoffregen MC, 2012, STRUCTURE, V20, P573, DOI 10.1016/j.str.2012.02.012; Tan C, 2012, WORLD J GASTROENTERO, V18, P5171, DOI 10.3748/wjg.v18.i37.5171; Vo U, 2013, BIOMOL NMR ASSIGN, V7, P215, DOI 10.1007/s12104-012-9413-y; Williams JG, 2000, J BIOL CHEM, V275, P22172, DOI 10.1074/jbc.M000397200; Winter JJG, 2015, J MED CHEM, V58, P2265, DOI 10.1021/jm501660t	42	21	22	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1703	1718		10.1074/jbc.M115.691238	http://dx.doi.org/10.1074/jbc.M115.691238			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26565026	hybrid, Green Published			2022-12-26	WOS:000368620700014
J	He, QX; Liu, KC; Tian, ZJ; Du, SJ				He, Qiuxia; Liu, Kechun; Tian, Zhenjun; Du, Shao Jun			The Effects of Hsp90 alpha 1 Mutations on Myosin Thick Filament Organization	PLOS ONE			English	Article							POSTTRANSLATIONAL MODIFICATIONS; TYROSINE PHOSPHORYLATION; ATPASE ACTIVITY; MIDDLE DOMAIN; HSP90; ACTIVATION; SKELETAL; BINDING; HYDROLYSIS; SITE	Heat shock protein 90 alpha plays a key role in myosin folding and thick filament assembly in muscle cells. To assess the structure and function of Hsp90 alpha and its potential regulation by post-translational modification, we developed a combined knockdown and rescue assay in zebrafish embryos to systematically analyze the effects of various mutations on Hsp90 alpha function in myosin thick filament organization. DNA constructs expressing the Hsp90 alpha 1 mutants with altered putative ATP binding, phosphorylation, acetylation or methylation sites were co-injected with Hsp90 alpha 1 specific morpholino into zebrafish embryos. Myosin thick filament organization was analyzed in skeletal muscles of the injected embryos by immunostaining. The results showed that mutating the conserved D90 residue in the Hsp90 alpha 1 ATP binding domain abolished its function in thick filament organization. In addition, phosphorylation mimicking mutations of T33D, T33E and T87E compromised Hsp90 alpha 1 function in myosin thick filament organization. Similarly, K287Q acetylation mimicking mutation repressed Hsp90 alpha 1 function in myosin thick filament organization. In contrast, K206R and K608R hypomethylation mimicking mutations had not effect on Hsp90 alpha 1 function in thick filament organization. Given that T33 and T87 are highly conserved residues involved post-translational modification (PTM) in yeast, mouse and human Hsp90 proteins, data from this study could indicate that Hsp90 alpha 1 function in myosin thick filament organization is potentially regulated by PTMs involving phosphorylation and acetylation.	[He, Qiuxia; Du, Shao Jun] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Inst Marine & Environm Technol, Baltimore, MD 21202 USA; [He, Qiuxia; Liu, Kechun] Shandong Acad Sci, Inst Biol, Jinan 250014, Shandong, Peoples R China; [Tian, Zhenjun] Shaanxi Normal Univ, Inst Sports & Exercise Biol, Xian 710062, Shaanxi, Peoples R China	University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology; Qilu University of Technology; Shaanxi Normal University	Du, SJ (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Inst Marine & Environm Technol, Baltimore, MD 21202 USA.	sdu@som.umaryland.edu			TEDCO Maryland Stem Cell Research [MSCRFE-0232]; United States - Israel Binational Agricultural Research and Development Fund [IS-4493-12]; National Natural Science Foundation of China [31400979]	TEDCO Maryland Stem Cell Research; United States - Israel Binational Agricultural Research and Development Fund(US-Israel Binational Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by: 1. TEDCO Maryland Stem Cell Research. Award number: MSCRFE-0232. Recipient: Shao Jun Du, Ph.D. Website: http://www.mscrf.org/; and 2. United States - Israel Binational Agricultural Research and Development Fund. Award number: IS-4493-12. Recipient: Shao Jun Du, Ph.D. Website: https://www.bard-isus.com/; and 3. National Natural Science Foundation of China. Award number: 31400979. Recipient: Qiuxia He, Ph.D. Website: http://www.nsfc.gov.cn/publish/portal1/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Farha M, 2011, J MOL CELL BIOL, V3, P301, DOI 10.1093/jmcb/mjr025; Bernick EP, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-70; Chadli A, 2000, P NATL ACAD SCI USA, V97, P12524, DOI 10.1073/pnas.220430297; Cloutier P, 2013, BBA-GENE REGUL MECH, V1829, P443, DOI 10.1016/j.bbagrm.2013.02.010; Cloutier P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003210; Donlin LT, 2012, GENE DEV, V26, P114, DOI 10.1101/gad.177758.111; Du SJ, 2008, P NATL ACAD SCI USA, V105, P554, DOI 10.1073/pnas.0707330105; Du SJ, 2006, DEV DYNAM, V235, P3306, DOI 10.1002/dvdy.20984; Etard C, 2007, DEV BIOL, V308, P133, DOI 10.1016/j.ydbio.2007.05.014; Hawkins TA, 2008, DEVELOPMENT, V135, P1147, DOI 10.1242/dev.018150; Huai Q, 2005, STRUCTURE, V13, P579, DOI 10.1016/j.str.2004.12.018; Jackson SE, 2013, TOP CURR CHEM, V328, P155, DOI 10.1007/128_2012_356; Li HQ, 2013, MOL BIOL CELL, V24, P3511, DOI 10.1091/mbc.E13-06-0352; Li J, 2012, ACTA BIOCH BIOPH SIN, V44, P300, DOI 10.1093/abbs/gms001; Li Jing, 2013, Biomed J, V36, P106, DOI 10.4103/2319-4170.113230; Lotz GP, 2003, J BIOL CHEM, V278, P17228, DOI 10.1074/jbc.M212761200; Mollapour M, 2012, BBA-MOL CELL RES, V1823, P648, DOI 10.1016/j.bbamcr.2011.07.018; Mollapour M, 2011, MOL CELL, V41, P672, DOI 10.1016/j.molcel.2011.02.011; Mollapour M, 2010, MOL CELL, V37, P333, DOI 10.1016/j.molcel.2010.01.005; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Scroggins BT, 2007, MOL CELL, V25, P151, DOI 10.1016/j.molcel.2006.12.008; Srikakulam R, 2004, J CELL SCI, V117, P641, DOI 10.1242/jcs.00899; Srikakulam R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002137; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Voelkel T, 2013, BBA-MOL CELL RES, V1833, P812, DOI 10.1016/j.bbamcr.2012.09.012; Xu WP, 2012, MOL CELL, V47, P434, DOI 10.1016/j.molcel.2012.05.015	31	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142573	10.1371/journal.pone.0142573	http://dx.doi.org/10.1371/journal.pone.0142573			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562659	Green Submitted, Green Published, gold			2022-12-26	WOS:000364480900046
J	Giroux, MA; Valiquette, E; Tremblay, JP; Cote, SD				Giroux, Marie-Andree; Valiquette, Eliane; Tremblay, Jean-Pierre; Cote, Steeve D.			Isotopic Differences between Forage Consumed by a Large Herbivore in Open, Closed, and Coastal Habitats: New Evidence from a Boreal Study System	PLOS ONE			English	Article							TEMPORAL VARIATION; STABLE-ISOTOPES; NUTRITIONAL QUALITY; MARINE SUBSIDIES; DEER BROWSE; TRADE-OFFS; DELTA-C-13; CARBON; RESPONSES; SELECTION	Documenting habitat-related patterns in foraging behaviour at the individual level and over large temporal scales remains challenging for large herbivores. Stable isotope analysis could represent a valuable tool to quantify habitat-related foraging behaviour at the scale of individuals and over large temporal scales in forest dwelling large herbivores living in coastal environments, because the carbon (delta C-13) or nitrogen (delta N-15) isotopic signatures of forage can differ between open and closed habitats or between terrestrial and littoral forage, respectively. Here, we examined if we could detect isotopic differences between the different assemblages of forage taxa consumed by white-tailed deer that can be found in open, closed, supralittoral, and littoral habitats. We showed that delta C-13 of assemblages of forage taxa were 3.0 parts per thousand lower in closed than in open habitats, while delta N-15 were 2.0 parts per thousand and 7.4 parts per thousand higher in supralittoral and littoral habitats, respectively, than in terrestrial habitats. Stable isotope analysis may represent an additional technique for ecologists interested in quantifiying the consumption of terrestrial vs. marine autotrophs. Yet, given the relative isotopic proximity and the overlap between forage from open, closed, and supralittoral habitats, the next step would be to determine the potential to estimate their contribution to herbivore diet.	[Giroux, Marie-Andree; Valiquette, Eliane; Tremblay, Jean-Pierre; Cote, Steeve D.] Univ Laval, Dept Biol, NSERC Ind Res Chair Integrated Management Resourc, Quebec City, PQ G1K 7P4, Canada; [Giroux, Marie-Andree; Valiquette, Eliane; Tremblay, Jean-Pierre; Cote, Steeve D.] Univ Laval, Ctr Etud Nordiques, NSERC Ind Res Chair Integrated Management Resourc, Quebec City, PQ, Canada; [Tremblay, Jean-Pierre] Univ Laval, Ctr Forest Res, Quebec City, PQ, Canada	Laval University; Laval University; Laval University	Giroux, MA (corresponding author), Univ Quebec, Dept Biol, Rimouski, PQ G5L 3A1, Canada.	marie.a.giroux@gmail.com; steeve.cote@bio.ulaval.ca		Tremblay, Jean-Pierre/0000-0003-0978-529X	Natural Sciences and Engineering Research Council of Canada (NSERC); Produits forestiers Anticosti Inc.; Natural Sciences and Engineering Research Council of Canada (NSERC)-Produits forestiers Anticosti Industrial Research Chair; Universite Laval; NSERC	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Produits forestiers Anticosti Inc.; Natural Sciences and Engineering Research Council of Canada (NSERC)-Produits forestiers Anticosti Industrial Research Chair(Natural Sciences and Engineering Research Council of Canada (NSERC)); Universite Laval; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC, www.nserc-crsng.gc.ca; scholarships to MAG [Alexander Graham Bell, Michael Smith, and EnviroNorth scholarships] and grants to SDC) and by Produits forestiers Anticosti Inc. that provided matching funds for the NSERC grants to SDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC)-Produits forestiers Anticosti Industrial Research Chair (to S.D.C), Universite Laval. MAG received scholarships from NSERC (Alexander Graham Bell, Michael Smith, and EnviroNorth scholarships). We thank J.-F. Adam, J. Arsenault-Hetu, C. Bajzak, C. Hins, A. Hemery, F. Lebel, S. Menard, G. Reuchet, M. Sicilia, and M. Veilleux-Nolin for their valuable assistance in the field. We are grateful to S. De Bellefeuille and C. Hins for logistical support, as well as to D. Gallant, E. Sotka, A. Stien, M.-A. Villard, and two anonymous reviewers for insightful comments on earlier versions of the manuscript. MAG is grateful to N.G. Yoccoz and R.A. Ims for hosting her during her research stay in Tromso (Norway).	Anderson WB, 1998, OIKOS, V81, P75, DOI 10.2307/3546469; Balasse M, 2006, J ZOOL, V270, P170, DOI 10.1111/j.1469-7998.2006.00104.x; Bessa F, 2014, ECOL INDIC, V36, P694, DOI 10.1016/j.ecolind.2013.09.026; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carlton JT, 2003, MAR ECOL PROG SER, V256, P271, DOI 10.3354/meps256271; Conradt L, 2000, J ZOOL, V250, P541, DOI 10.1111/j.1469-7998.2000.tb00795.x; Croll DA, 2005, SCIENCE, V307, P1959, DOI 10.1126/science.1108485; Dalerum F, 2005, OECOLOGIA, V144, P647, DOI 10.1007/s00442-005-0118-0; Darling AF, 2010, ECOSCIENCE, V17, P73, DOI 10.2980/17-1-3287; Dussault C, 2005, ECOGRAPHY, V28, P619, DOI 10.1111/j.2005.0906-7590.04263.x; Environment Canada, 1982, CAN CLIM NORM TEMP P; Environment Canada, 2006, CLIM NORM AV DAIL DA; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; FORD WM, 1994, FOREST ECOL MANAG, V67, P149, DOI 10.1016/0378-1127(94)90013-2; France R, 1996, ENVIRON MANAGE, V20, P249, DOI 10.1007/BF01204009; Gannes LZ, 1998, COMP BIOCHEM PHYS A, V119, P725, DOI 10.1016/S1095-6433(98)01016-2; Godvik IMR, 2009, ECOLOGY, V90, P699, DOI 10.1890/08-0576.1; Hansen BB, 2012, POLAR RES, V31, DOI 10.3402/polar.v31i0.17258; HAPPE PJ, 1990, J WILDLIFE MANAGE, V54, P557, DOI 10.2307/3809349; HEATON THE, 1987, OECOLOGIA, V74, P236, DOI 10.1007/BF00379365; Hebblewhite M, 2008, ECOL MONOGR, V78, P141, DOI 10.1890/06-1708.1; Hidding B, 2013, ECOLOGY, V94, P2852, DOI 10.1890/12-2015.1; HUOT J, 1982, BODY CONDITION FOOD; JOHNSON AS, 1995, AM MIDL NAT, V133, P18, DOI 10.2307/2426344; Ladin ZS, 2014, J WILDLIFE MANAGE, V78, P1206, DOI 10.1002/jwmg.761; Lastra M, 2014, J SEA RES, V88, P1, DOI 10.1016/j.seares.2013.12.011; LEAVITT SW, 1993, CAN J FOREST RES, V23, P210, DOI 10.1139/x93-028; Li SG, 2007, TREES-STRUCT FUNCT, V21, P479, DOI 10.1007/s00468-007-0142-2; Litvaitis JA, 2000, RES TECHNIQUES ANIMA; Masse A, 2009, J MAMMAL, V90, P961, DOI 10.1644/08-MAMM-A-148.1; Mcloughlin PD, 2007, ECOLOGY, V88, P3192, DOI 10.1890/06-1974.1; MEDINA E, 1986, Journal of Tropical Ecology, V2, P207; Montoya JP., 2008, NATURAL ABUNDANCE 15, P176; Mysterud A, 1999, WILDLIFE SOC B, V27, P385; OLEARY MH, 1988, BIOSCIENCE, V38, P328, DOI 10.2307/1310735; Owen-Smith N, 2010, PHILOS T R SOC B, V365, P2267, DOI 10.1098/rstb.2010.0095; Parnell AC, SIAR STABLE ISOTOPE; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Pellerin S, 2006, BIOL CONSERV, V128, P316, DOI 10.1016/j.biocon.2005.09.039; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; R Development Core Team, 2012, R LANG ENV STAT COMP; Saucier J.P., 2009, ORDRE INGENIEURS FOR, V2, P165; Simard A, 2014, WILDLIFE MONOGR, V187, P1, DOI 10.1002/wmon.1010; Smith BN, 1971, PLANT PHYSIOL, P47; Spiller DA, 2010, ECOLOGY, V91, P1424, DOI 10.1890/09-0715.1; Tremblay JP, 2006, OECOLOGIA, V150, P78, DOI 10.1007/s00442-006-0504-2; Tremblay JP, 2005, CAN J ZOOL, V83, P1087, DOI [10.1139/Z05-090, 10.1139/z05-090]; VANDERMERWE NJ, 1989, GEOCHIM COSMOCHIM AC, V53, P1091, DOI 10.1016/0016-7037(89)90213-5; Verdolin JL, 2006, BEHAV ECOL SOCIOBIOL, V60, P457, DOI 10.1007/s00265-006-0172-6; VIRGINIA RA, 1982, OECOLOGIA, V54, P317, DOI 10.1007/BF00380000; West AG, 2001, FOREST ECOL MANAG, V147, P139, DOI 10.1016/S0378-1127(00)00474-6; Winnie J, 2007, ANIM BEHAV, V73, P215, DOI 10.1016/j.anbehav.2006.07.007; Zuur Alain F., 2009, P1	54	2	2	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142781	10.1371/journal.pone.0142781	http://dx.doi.org/10.1371/journal.pone.0142781			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559186	Green Submitted, Green Published, gold			2022-12-26	WOS:000364433100123
J	Kim, HT; Kim, JS; Moore, MJ; Neubig, KM; Williams, NH; Whitten, WM; Kim, JH				Kim, Hyoung Tae; Kim, Jung Sung; Moore, Michael J.; Neubig, Kurt M.; Williams, Norris H.; Whitten, W. Mark; Kim, Joo-Hwan			Seven New Complete Plastome Sequences Reveal Rampant Independent Loss of the ndh Gene Family across Orchids and Associated Instability of the Inverted Repeat/Small Single-Copy Region Boundaries	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; CHLOROPLAST GENOME; MIXOTROPHIC PLANTS; EVOLUTION; CYPRIPEDIOIDEAE; ORGANIZATION; INDIVIDUALS; ANNOTATION; INSIGHTS; GREEN	Earlier research has revealed that the ndh loci have been pseudogenized, truncated, or deleted from most orchid plastomes sequenced to date, including in all available plastomes of the two most species-rich subfamilies, Orchidoideae and Epidendroideae. This study sought to resolve deeper-level phylogenetic relationships among major orchid groups and to refine the history of gene loss in the ndh loci across orchids. The complete plastomes of seven orchids, Oncidium sphacelatum (Epidendroideae), Masdevallia coccinea (Epidendroideae), Sobralia callosa (Epidendroideae), Sobralia aff. bouchei (Epidendroideae), Elleanthus sodiroi (Epidendroideae), Paphiopedilum armeniacum (Cypripedioideae), and Phragmipedium longifolium (Cypripedioideae) were sequenced and analyzed in conjunction with all other available orchid and monocot plastomes. Most ndh loci were found to be pseudogenized or lost in Oncidium, Paphiopedilum and Phragmipedium, but surprisingly, all ndh loci were found to retain full, intact reading frames in Sobralia, Elleanthus and Masdevallia. Character mapping suggests that the ndh genes were present in the common ancestor of orchids but have experienced independent, significant losses at least eight times across four subfamilies. In addition, ndhF gene loss was correlated with shifts in the position of the junction of the inverted repeat (IR) and small single-copy (SSC) regions. The Orchidaceae have unprecedented levels of homoplasy in ndh gene presence/absence, which may be correlated in part with the unusual life history of orchids. These results also suggest that ndhF plays a role in IR/SSC junction stability.	[Kim, Hyoung Tae; Kim, Jung Sung; Kim, Joo-Hwan] Gachon Univ, Dept Life Sci, Songnam, Gyeonggi Do, South Korea; [Moore, Michael J.] Oberlin Coll, Dept Biol, Oberlin, OH 44074 USA; [Neubig, Kurt M.; Williams, Norris H.; Whitten, W. Mark] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA	Gachon University; Oberlin College; State University System of Florida; University of Florida	Moore, MJ (corresponding author), Oberlin Coll, Dept Biol, Oberlin, OH 44074 USA.	mmoore@oberlin.edu; kimjh2009@gachon.ac.kr		HyoungTae, Kim/0000-0002-2482-6064; Moore, Michael/0000-0003-2222-8332	American Orchid Society; National Research Foundation of Korea [MEST 2012-044048, MEST 2010-0029131]	American Orchid Society; National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by a grant from the American Orchid Society (http://www.aos.org/default.aspx?id= 1) and grants MEST 2012-044048 and MEST 2010-0029131 from the National Research Foundation of Korea (http://www.nrf.re.kr/nrf_eng_cms/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert Victor A., 1994, Lindleyana, V9, P115; Barrett CF, 2014, MOL BIOL EVOL, V31, P3095, DOI 10.1093/molbev/msu252; Barrett CF, 2013, CLADISTICS, V29, P65, DOI 10.1111/j.1096-0031.2012.00418.x; Barrett CF, 2012, AM J BOT, V99, P1513, DOI 10.3732/ajb.1200256; Bellino A, 2014, OECOLOGIA, V175, P875, DOI 10.1007/s00442-014-2940-8; Braukmann T, 2012, PLANT MOL BIOL, V79, P5, DOI 10.1007/s11103-012-9884-3; Braukmann TWA, 2009, CURR GENET, V55, P323, DOI 10.1007/s00294-009-0249-7; Burrows PA, 1998, EMBO J, V17, P868, DOI 10.1093/emboj/17.4.868; Cai J, 2015, NAT GENET, V47, P65, DOI 10.1038/ng.3149; Cai ZQ, 2008, J MOL EVOL, V67, P696, DOI 10.1007/s00239-008-9180-7; Cameron KM, 1999, AM J BOT, V86, P208, DOI 10.2307/2656938; Chang CC, 2006, MOL BIOL EVOL, V23, P279, DOI 10.1093/molbev/msj029; Chase MW, 2015, BOT J LINN SOC, V177, P151, DOI 10.1111/boj.12234; Blazier J, 2011, PLANT MOL BIOL, V76, P263, DOI 10.1007/s11103-011-9753-5; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; Cox AV, 1998, AM J BOT, V85, P681, DOI 10.2307/2446538; da Rocha Perini V., 2015, MITOCHONDR DNA, DOI [10.3109/19401736.2014.1003850, DOI 10.3109/19401736.2014.1003850]; De las Rivas J, 2002, GENOME RES, V12, P567, DOI 10.1101/gr.209402; Delannoy E, 2011, MOL BIOL EVOL, V28, P2077, DOI 10.1093/molbev/msr028; Freudenstein JV, 2015, ANN BOT-LONDON, V115, P665, DOI 10.1093/aob/mcu253; Funk HT, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-45; Givnish TJ, 2010, ANN MO BOT GARD, V97, P584, DOI 10.3417/2010023; Gonneau C, 2014, J ECOL, V102, P1183, DOI 10.1111/1365-2745.12274; Govaerts R., WORLD CHECKLIST ORCH; HABERHAUSEN G, 1994, PLANT MOL BIOL, V24, P217, DOI 10.1007/BF00040588; Heath TA, 2008, J SYST EVOL, V46, P239, DOI 10.3724/SP.J.1002.2008.08016; Henriquez CL, 2014, MOL PHYLOGENET EVOL, V75, P91, DOI 10.1016/j.ympev.2014.02.017; Jheng CF, 2012, PLANT SCI, V190, P62, DOI 10.1016/j.plantsci.2012.04.001; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kim GB, 2016, MITOCHONDRIAL DNA A, V27, P1300, DOI 10.3109/19401736.2014.945566; Kim HT, 2014, MOL CELLS, V37, P372, DOI 10.14348/molcells.2014.2296; Kim JS, 2015, PLANT MOL BIOL REP, V33, P1210, DOI 10.1007/s11105-014-0833-y; Kocyan A, 2004, PLANT SYST EVOL, V247, P203, DOI 10.1007/s00606-004-0133-3; Kores Paul J., 1997, Lindleyana, V12, P1; Lanfear R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-82; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lin CS, 2015, SCI REP-UK, V5, DOI 10.1038/srep09040; Logacheva MD, 2014, GENOME BIOL EVOL, V6, P238, DOI 10.1093/gbe/evu001; Logacheva MD, 2011, GENOME BIOL EVOL, V3, P1296, DOI 10.1093/gbe/evr102; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Luo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099016; Maddison W.P., MESQUITE MODULAR SYS; Martin M, 2010, PLANT PHYSIOL BIOCH, V48, P636, DOI 10.1016/j.plaphy.2010.04.009; Mccoy SR, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-130; McNeal JR, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-57; Miller M.A., 2010, P GAT COMP ENV WORKS; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Moore MJ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-17; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Motomura H, 2010, ANN BOT-LONDON, V106, P573, DOI 10.1093/aob/mcq156; Neyland R, 1996, AM J BOT, V83, P1195, DOI 10.2307/2446204; Neyland Ray, 1996, Lindleyana, V11, P47; Pan IC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034738; Pemberton Robert W., 2013, Lankesteriana, V13, P65; Peredo EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068591; Rokas A, 2005, MOL BIOL EVOL, V22, P1337, DOI 10.1093/molbev/msi121; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Roy M, 2013, ECOL MONOGR, V83, P95, DOI 10.1890/11-2120.1; Ruhlman TA, 2014, METHODS MOL BIOL, V1132, P3, DOI 10.1007/978-1-62703-995-6_1; Schelkunov MI, 2015, GENOME BIOL EVOL, V7, P1179, DOI 10.1093/gbe/evv019; Selosse MA, 2014, NEW PHYTOL, V202, P337, DOI 10.1111/nph.12769; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P419, DOI 10.1016/B978-012370526-6.50014-3; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Steele PR, 2012, AM J BOT, V99, P330, DOI 10.3732/ajb.1100491; Stockel M, 2011, NEW PHYTOL, V189, P790, DOI 10.1111/j.1469-8137.2010.03510.x; Straub SCK, 2012, AM J BOT, V99, P349, DOI 10.3732/ajb.1100335; WAKASUGI T, 1994, P NATL ACAD SCI USA, V91, P9794, DOI 10.1073/pnas.91.21.9794; WOLFE KH, 1992, P NATL ACAD SCI USA, V89, P10648, DOI 10.1073/pnas.89.22.10648; Wu FH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-68; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yang JB, 2014, MOL ECOL RESOUR, V14, P1024, DOI 10.1111/1755-0998.12251; Yang JB, 2013, BMC EVOL BIOL, V13, DOI [10.1186/1471-2148-13-84, 10.1186/1471-244X-13-150]; Yukawa T, 1996, J PLANT RES, V109, P169, DOI 10.1007/BF02344542	75	72	74	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142215	10.1371/journal.pone.0142215	http://dx.doi.org/10.1371/journal.pone.0142215			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558895	Green Published, gold, Green Submitted			2022-12-26	WOS:000364433100061
J	Noordeen, F; Scougall, CA; Grosse, A; Qiao, Q; Ajilian, BB; Reaiche-Miller, G; Finnie, J; Werner, M; Broering, R; Schlaak, JF; Vaillant, A; Jilbert, AR				Noordeen, Faseeha; Scougall, Catherine A.; Grosse, Arend; Qiao, Qiao; Ajilian, Behzad B.; Reaiche-Miller, Georget; Finnie, John; Werner, Melanie; Broering, Ruth; Schlaak, Joerg F.; Vaillant, Andrew; Jilbert, Allison R.			Therapeutic Antiviral Effect of the Nucleic Acid Polymer REP 2055 against Persistent Duck Hepatitis B Virus Infection	PLOS ONE			English	Article							AMPHIPATHIC DNA POLYMERS; DOSE-RELATED OUTCOMES; CLOSED CIRCULAR DNA; IMMUNE-RESPONSES; PHOSPHOROTHIOATE OLIGONUCLEOTIDES; RAPID RESOLUTION; SURFACE-ANTIGEN; LAMIVUDINE; ENTECAVIR; REPLICATION	Previous studies have demonstrated that nucleic acid polymers (NAPs) have both entry and post-entry inhibitory activity against duck hepatitis B virus (DHBV) infection. The inhibitory activity exhibited by NAPs prevented DHBV infection of primary duck hepatocytes in vitro and protected ducks from DHBV infection in vivo and did not result from direct activation of the immune response. In the current study treatment of primary human hepatocytes with NAP REP 2055 did not induce expression of the TNF, IL6, IL10, IFNA4 or IFNB1 genes, confirming the lack of direct immunostimulation by REP 2055. Ducks with persistent DHBV infection were treated with NAP 2055 to determine if the post-entry inhibitory activity exhibited by NAPs could provide a therapeutic effect against established DHBV infection in vivo. In all REP 2055-treated ducks, 28 days of treatment lead to initial rapid reductions in serum DHBsAg and DHBV DNA and increases in anti-DHBs antibodies. After treatment, 6/11 ducks experienced a sustained virologic response: DHBsAg and DHBV DNA remained at low or undetectable levels in the serum and no DHBsAg or DHBV core antigen positive hepatocytes and only trace amounts of DHBV total and covalently closed circular DNA (cccDNA) were detected in the liver at 9 or 16 weeks of follow-up. In the remaining 5/11 REP 2055-treated ducks, all markers of DHBV infection rapidly rebounded after treatment withdrawal: At 9 and 16 weeks of follow-up, levels of DHBsAg and DHBcAg and DHBV total and cccDNA in the liver had rebounded and matched levels observed in the control ducks treated with normal saline which remained persistently infected with DHBV. These data demonstrate that treatment with the NAP REP 2055 can lead to sustained control of persistent DHBV infection. These effects may be related to the unique ability of REP 2055 to block release of DHBsAg from infected hepatocytes.	[Noordeen, Faseeha; Scougall, Catherine A.; Grosse, Arend; Qiao, Qiao; Ajilian, Behzad B.; Reaiche-Miller, Georget; Jilbert, Allison R.] Univ Adelaide, Sch Biol Sci, Dept Mol & Cellular Biol, Adelaide, SA, Australia; [Noordeen, Faseeha] Univ Peradeniya, Dept Microbiol, Fac Med, Peradeniya, Sri Lanka; [Finnie, John] SA Pathol, Hanson Inst, Ctr Neurol Dis, Adelaide, SA, Australia; [Werner, Melanie; Broering, Ruth; Schlaak, Joerg F.] Univ Duisburg Essen, Univ Hosp, Dept Gastroenterol & Hepatol, Essen, Germany; [Vaillant, Andrew] Replicor Inc, Montreal, PQ, Canada	University of Adelaide; University of Peradeniya; Hanson Institute; SA Pathology; University of Duisburg Essen	Vaillant, A (corresponding author), Replicor Inc, Montreal, PQ, Canada.	availlant@replicor.com; allison.jilbert@adelaide.edu.au	Broering, Ruth/W-9401-2019; Jilbert, Allison R/L-3335-2013	Broering, Ruth/0000-0002-7125-3246; VAILLANT, Andrew/0000-0002-1433-0700; Jilbert, Allison/0000-0003-3855-1679	Replicor Inc.	Replicor Inc.	This work was supported by Replicor Inc. The funder provided support in the form of salaries for author AV and funds required to conduct all experiments, but did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	AGRAWAL S, 1990, J CHROMATOGR, V509, P396, DOI 10.1016/S0021-9673(01)93098-5; Belloni L, 2012, J CLIN INVEST, V122, P529, DOI 10.1172/JCI58847; Bernstein DI, 2008, ANTIMICROB AGENTS CH, V52, P2727, DOI 10.1128/AAC.00279-08; Broering R, 2014, J VIRAL HEPATITIS, V21, P480, DOI 10.1111/jvh.12174; Burda MR, 2001, ANTIVIR RES, V52, P125, DOI 10.1016/S0166-3542(01)00177-2; Cardin RD, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-214; Chang TT, 2006, NEW ENGL J MED, V354, P1001, DOI 10.1056/NEJMoa051285; Cheng JD, 2005, J HEPATOL, V43, P465, DOI 10.1016/j.jhep.2005.02.033; Cooreman MP, 2001, J BIOMED SCI, V8, P237, DOI 10.1007/BF02256597; Foster WK, 2005, J VIROL, V79, P5819, DOI 10.1128/JVI.79.9.5819-5832.2005; Foster WK, 2003, ANTIMICROB AGENTS CH, V47, P2624, DOI 10.1128/AAC.47.8.2624-2635.2003; Franke C, 2007, VIROLOGY, V359, P126, DOI 10.1016/j.virol.2006.09.006; Frenette CT, 2009, AM J GASTROENTEROL, V104, P1948, DOI 10.1038/ajg.2009.204; GALBRAITH WM, 1994, ANTISENSE RES DEV, V4, P201, DOI 10.1089/ard.1994.4.201; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Guidotti LG, 1996, IMMUNITY, V4, P25, DOI 10.1016/S1074-7613(00)80295-2; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; Guzman EM, 2007, ANTIVIR THER, V12, P1147; Hsu CW, 2011, HEPATOLOGY, V54, P101, DOI 10.1002/hep.24363; Jilbert AR, 1998, VIROLOGY, V244, P273, DOI 10.1006/viro.1998.9095; JILBERT AR, 1992, J VIROL, V66, P1377, DOI 10.1128/JVI.66.3.1377-1388.1992; Jilbert AR, 1996, VIROLOGY, V226, P338, DOI 10.1006/viro.1996.0661; KAJINO K, 1994, J VIROL, V68, P5792, DOI 10.1128/JVI.68.9.5792-5803.1994; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; Kowdley KV, 2004, J CLIN GASTROENTEROL, V38, pS132, DOI 10.1097/00004836-200411003-00002; Lai CL, 2006, NEW ENGL J MED, V354, P1011, DOI 10.1056/NEJMoa051287; Lamb RA, 2007, CURR OPIN STRUC BIOL, V17, P427, DOI 10.1016/j.sbi.2007.08.016; Lau GKK, 2005, NEW ENGL J MED, V352, P2682, DOI 10.1056/NEJMoa043470; Le Mire MF, 2005, J VIROL, V79, P12242, DOI 10.1128/JVI.79.19.12242-12252.2005; Lee AM, 2008, VIROLOGY, V372, P107, DOI 10.1016/j.virol.2007.10.016; Lin E, 1998, ANTIMICROB AGENTS CH, V42, P2132, DOI 10.1128/AAC.42.8.2132; Marcellin P, 2004, NEW ENGL J MED, V351, P1206, DOI 10.1056/NEJMoa040431; Marcellin P, 2008, NEW ENGL J MED, V359, P2442, DOI 10.1056/NEJMoa0802878; Matsumura T, 2009, GASTROENTEROLOGY, V137, P673, DOI 10.1053/j.gastro.2009.04.048; Miller DS, 2006, VIROLOGY, V351, P159, DOI 10.1016/j.virol.2006.02.037; Miller DS, 2006, VIROLOGY, V348, P297, DOI 10.1016/j.virol.2005.12.032; Miller Darren S, 2004, Methods Mol Med, V96, P3; Moucari R, 2009, HEPATOLOGY, V49, P1151, DOI 10.1002/hep.22744; Nicoll AJ, 1998, ANTIMICROB AGENTS CH, V42, P3130, DOI 10.1128/AAC.42.12.3130; Noordeen F, 2013, ANTIMICROB AGENTS CH, V57, P5299, DOI 10.1128/AAC.01005-13; Noordeen F, 2013, ANTIMICROB AGENTS CH, V57, P5291, DOI 10.1128/AAC.01003-13; Op den Brouw M.L., 2008, IMMUNOLOGY, V126, P280, DOI DOI 10.1111/J.1365-2567.2008.02896.X; Protzer-Knolle U, 1998, HEPATOLOGY, V27, P254, DOI 10.1002/hep.510270138; PUGH JC, 1995, J VIROL, V69, P4814, DOI 10.1128/JVI.69.8.4814-4822.1995; Raal FJ, 2010, LANCET, V375, P998, DOI 10.1016/S0140-6736(10)60284-X; Reaiche GY, 2010, VIROLOGY, V406, P286, DOI 10.1016/j.virol.2010.07.013; Reaiche-Miller GY, 2013, VIROLOGY, V446, P357, DOI 10.1016/j.virol.2013.08.014; Ruan P, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-333; Shi BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044900; Sunyach C, 1997, VIROLOGY, V234, P291, DOI 10.1006/viro.1997.8665; Vaillant A, 2006, ANTIMICROB AGENTS CH, V50, P1393, DOI 10.1128/AAC.50.4.1393-1401.2006; Vanlandschoot P, 2002, J GEN VIROL, V83, P1281, DOI 10.1099/0022-1317-83-6-1281; Wieland SF, 2004, P NATL ACAD SCI USA, V101, P2129, DOI 10.1073/pnas.0308478100; Wu J, 2007, HEPATOLOGY, V46, P1769, DOI 10.1002/hep.21897; Wu J, 2009, HEPATOLOGY, V49, P1132, DOI 10.1002/hep.22751; Xu Y, 2009, MOL IMMUNOL, V46, P2640, DOI 10.1016/j.molimm.2009.04.031	56	57	59	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0140909	10.1371/journal.pone.0140909	http://dx.doi.org/10.1371/journal.pone.0140909			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560490	gold, Green Published, Green Submitted			2022-12-26	WOS:000364433100013
J	Piple, J; Gora, R; Purbiya, P; Puliyel, A; Chugh, P; Bahl, P; Puliyel, J				Piple, Jitendra; Gora, Ranjeet; Purbiya, Pragati; Puliyel, Ashish; Chugh, Parul; Bahl, Pinky; Puliyel, Jacob			Food Choices and Consequences for the Nutritional Status: Insights into Nutrition Transition in an Hospital Community	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; OBESITY	Introduction Although economic development is generally accompanied by improvements in the overall nutritional status of the country's population the 'nutritional transition' often involves a shift to high energy diets and less exercise with negative consequences. This pilot study was done to examine if education of parents operates at the household level to influence dietary choices and the nutritional status of children in a small community of hospital workers. Material and Methods 3 groups of persons with varying skill and education levels participated. Weighed food logs were used in all households to calculate 'adult equivalent' per-capita-consumption. Nutrients were calculated using nutrients calculator software. BMI was used to classify children as underweight, normal weight and overweight. Results 128 individuals participated from 30 families included 47 children. 10 children (21%) were underweight, 29 (62%) were normal and 8 (17%) were overweight. Energy consumption was highest in families with overweight children 2692 +/-502 compared to 2259 +/-359 in families with normal weight and 2031+/-354 in the family of underweight children. These differences were statistically significant. 42% underweight children belonged to Class 1 at the lowest skill level and there were no overweight children in this group. Most of the overweight children belonged to Class 2. In Class 3 there were no underweight children and the majority was normal weight children. Conclusion Underweight children came from the poorer households. Per capita intake of the family as a whole correlated well with BMI in the children. There was increased obesity in middle income families belonging to Class 2-probably in families who move up the scale from deprivation. Nutritional status in children correlated mostly with maternal education status.	[Piple, Jitendra; Gora, Ranjeet; Purbiya, Pragati; Bahl, Pinky; Puliyel, Jacob] St Stephens Hosp, Dept Pediat, Delhi 110054, India; [Puliyel, Ashish] The Franklin, DocuBuzz Comp Solut 02 12 25, Singapore 118223, Singapore; [Chugh, Parul] Sir Ganga Ram Hosp, Statistician Dept Res, Delhi, India	St. Stephen's Hospital	Puliyel, J (corresponding author), St Stephens Hosp, Dept Pediat, Delhi 110054, India.	Puliyel@gmail.com						Abuya BA, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-80; [Anonymous], 2014, GLOBAL EPIDEMIC OBES, DOI DOI 10.7243/2052-5966-2-2; Claro RM, 2010, CAD SAUDE PUBLICA, V26, P2188, DOI 10.1590/S0102-311X2010001100020; de Onis M, LEVELS TRENDS CHILD; Drewnowski A, 1997, NUTR REV, V55, P31, DOI 10.1111/j.1753-4887.1997.tb01593.x; FerroLuzzi A, 1996, CIBA F SYMP, V201, P207; Gaiha Raghav, 2012, J Asian Afr Stud, V47, P3; Gopalan C, 1989, NUTR VALUE INDIAN FO; Griffiths C, 2014, INT J OBESITY, V38, P161, DOI 10.1038/ijo.2013.66; Gupta N, 2012, ENDOCR REV, V33, P48, DOI 10.1210/er.2010-0028; Guruswamy M, POVERTY LINE IS STAR; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Ravishankar AK, 2012, J HEALTH MANAG, V14, P313, DOI 10.1177/0972063412457513; Sathyamala C, 2014, J CLIN DIAGN RES, V8, pPC6, DOI 10.7860/JCDR/2014/7369.4389; Singh MK, 2014, TNN             0707; Venkatesan J, 2011, THE HINDU       0515	16	1	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0140807	10.1371/journal.pone.0140807	http://dx.doi.org/10.1371/journal.pone.0140807			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559817	Green Published, Green Submitted, gold			2022-12-26	WOS:000364433100008
J	Ram, MS; Marne, M; Gaur, A; Kumara, HN; Singh, M; Kumar, A; Umapathy, G				Ram, Muthuvarmadam S.; Marne, Minal; Gaur, Ajay; Kumara, Honnavalli N.; Singh, Mewa; Kumar, Ajith; Umapathy, Govindhaswamy			Pre-Historic and Recent Vicariance Events Shape Genetic Structure and Diversity in Endangered Lion-Tailed Macaque in the Western Ghats: Implications for Conservation	PLOS ONE			English	Article							HABITAT FRAGMENTATION; POPULATION-STRUCTURE; ANAMALAI HILLS; MACACA-SILENUS; DIFFERENTIATION; CONSEQUENCES; MECHANISMS; EVOLUTION; HISTORY; SIZE	Genetic isolation of populations is a potent force that helps shape the course of evolution. However, small populations in isolation, especially in fragmented landscapes, are known to lose genetic variability, suffer from inbreeding depression and become genetically differentiated among themselves. In this study, we assessed the genetic diversity of lion-tailed macaques (Macaca silenus) inhabiting the fragmented landscape of Anamalai hills and examined the genetic structure of the species across its distributional range in the Western Ghats. We sequenced around 900 bases of DNA covering two mitochondrial regionshypervariable region-I and partial mitochondrial cytochrome b-from individuals sampled both from wild and captivity, constructed and dated phylogenetic trees. We found that the lion-tailed macaque troops in the isolated forest patches in Anamalai hills have depleted mitochondrial DNA diversity compared to troops in larger and continuous forests. Our results also revealed an ancient divergence in the lion-tailed macaque into two distinct populations across the Palghat gap, dating to 2.11 million years ago. In light of our findings, we make a few suggestions on the management of wild and captive populations.	[Ram, Muthuvarmadam S.; Marne, Minal; Gaur, Ajay; Umapathy, Govindhaswamy] CSIR, Ctr Cellular & Mol Biol, Lab Conservat Endangered Species, Hyderabad 500007, Andhra Pradesh, India; [Kumara, Honnavalli N.] Salim Ali Ctr Ornithol & Nat Hist, Coimbatore 641108, Tamil Nadu, India; [Singh, Mewa] Univ Mysore, Biopsychol Lab, Mysore 570006, Karnataka, India; [Singh, Mewa] Univ Mysore, Inst Excellence, Mysore 570006, Karnataka, India; [Kumar, Ajith] Wildlife Conservat Soc India, Ctr Wildlife Studies, Bangalore 560070, Karnataka, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Salim Ali Center for Ornithology & Natural History (SACON); University of Mysore; University of Mysore	Umapathy, G (corresponding author), CSIR, Ctr Cellular & Mol Biol, Lab Conservat Endangered Species, Uppal Rd, Hyderabad 500007, Andhra Pradesh, India.	guma@ccmb.res.in		Kumara, Honnavalli/0000-0002-7958-6395; Umapathy, Govindhaswamy/0000-0003-4086-7445	Department of Biotechnology, Ministry of Science and Technology, Government of India; Central Zoo Authority of India, Government of India	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Central Zoo Authority of India, Government of India	This work was support by the Department of Biotechnology, Ministry of Science and Technology, Government of India, and the Central Zoo Authority of India, Government of India.	Bergl RA, 2008, AM J PRIMATOL, V70, P848, DOI 10.1002/ajp.20559; Blancher A, 2008, J HERED, V99, P254, DOI 10.1093/jhered/esn003; Canales-Delgadillo JC, 2012, J AVIAN BIOL, V43, P168, DOI 10.1111/j.1600-048X.2011.05372.x; Chaves PB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020722; Chepko-Sade BD, 1987, MAMMALIAN DISPERSAL; Clark PU, 2006, QUATERNARY SCI REV, V25, P3150, DOI 10.1016/j.quascirev.2006.07.008; CLEMENS S, 1991, NATURE, V353, P720, DOI 10.1038/353720a0; Congreve CRT, 1942, THE ANAMALAIS, P151; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; DILGER WC, 1952, EVOLUTION, V6, P125, DOI 10.1111/j.1558-5646.1952.tb02817.x; Dixo M, 2009, BIOL CONSERV, V142, P1560, DOI 10.1016/j.biocon.2008.11.016; Dixon JD, 2007, CONSERV GENET, V8, P455, DOI 10.1007/s10592-006-9184-z; Drummond A., 2012, MOL EVOLUTION PHYLOG; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Groves C, 2001, EVOL ANTHROPOL, V10, P192, DOI 10.1002/evan.10005; Gubitz T, 2005, P ROY SOC B-BIOL SCI, V272, P751, DOI 10.1098/rspb.2004.3018; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haag T, 2010, MOL ECOL, V19, P4906, DOI 10.1111/j.1365-294X.2010.04856.x; Haig SM, 2006, CONSERV BIOL, V20, P1584, DOI 10.1111/j.1523-1739.2006.00530.x; Hayaishi S, 2006, PRIMATES, V47, P158, DOI 10.1007/s10329-005-0169-1; Henle K, 2004, BIODIVERS CONSERV, V13, P1, DOI 10.1023/B:BIOC.0000004311.04226.29; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hussain S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063685; Oklander LI, 2010, INT J PRIMATOL, V31, P813, DOI 10.1007/s10764-010-9430-6; Karanth KP, 2003, CURR SCI INDIA, V85, P1276; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; KUMAR A, 1995, LION TAILED MACAQUE, P1; Kumar A.K.S., 1987, THESIS; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liedigk R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0176-1; Mbora DNM, 2010, CONSERV GENET, V11, P1725, DOI 10.1007/s10592-010-0065-0; McClymont EL, 2013, EARTH-SCI REV, V123, P173, DOI 10.1016/j.earscirev.2013.04.006; Menon S, 1997, CURR SCI INDIA, V73, P134; Modolo L, 2005, P NATL ACAD SCI USA, V102, P7392, DOI 10.1073/pnas.0502186102; Modolo L, 2008, MOL ECOL, V17, P4027, DOI 10.1111/j.1365-294X.2008.03890.x; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ramachandran KK, 2010, 382 KFRI; Rambaut A., 2007, TRACER V1 5; Ripperger SP, 2013, CONSERV GENET, V14, P925, DOI 10.1007/s10592-012-0434-y; Robin VV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013321; Robin VV, 2015, P BIOL SCI, V282; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosvold J, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-191; Ruell EW, 2012, AM MIDL NAT, V168, P265, DOI 10.1674/0003-0031-168.2.265; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sato JJ, 2014, MAMM STUDY, V39, P1; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Sharma AK, 2006, INT J PRIMATOL, V27, P1429, DOI 10.1007/s10764-006-9077-5; Silvestro D, 2010, ORGANISMS DIVERSITY; Singh M, 2002, AM J PRIMATOL, V57, P91, DOI 10.1002/ajp.10037; Singh M, 2012, CURR SCI INDIA, V103, P1399; Smith DG, 2005, AM J PRIMATOL, V65, P1, DOI 10.1002/ajp.20094; SOMAN K, 1990, J GEOL SOC INDIA, V35, P82; Streatfeild C., 2009, THESIS; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tosi AJ, 2003, EVOLUTION, V57, P1419; Umapathy G., 2000, Primate Report, V58, P67; Umapathy G, 2000, BIOL CONSERV, V92, P311, DOI 10.1016/S0006-3207(99)00097-X; Umapathy G, 2011, INT J PRIMATOL, V32, P889, DOI 10.1007/s10764-011-9508-9; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Van Bocxlaer I, 2012, MOL PHYLOGENET EVOL, V62, P839, DOI 10.1016/j.ympev.2011.11.027; Verma SK, 2003, MOL ECOL NOTES, V3, P28, DOI 10.1046/j.1471-8286.2003.00340.x; Vidya TNC, 2005, HEREDITY, V94, P71, DOI 10.1038/sj.hdy.6800568; Wan QH, 2003, ELECTROPHORESIS, V24, P1353, DOI 10.1002/elps.200390174; Zuckerberg B, 2014, BIORXIV	69	17	18	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142597	10.1371/journal.pone.0142597	http://dx.doi.org/10.1371/journal.pone.0142597			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26561307	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000364433100096
J	Shao, XX; Yang, WY; Wu, M				Shao, Xuexin; Yang, Wenying; Wu, Ming			Seasonal Dynamics of Soil Labile Organic Carbon and Enzyme Activities in Relation to Vegetation Types in Hangzhou Bay Tidal Flat Wetland	PLOS ONE			English	Article							FRESH-WATER MARSH; MICROBIAL BIOMASS; SANJIANG PLAIN; NITROGEN; MATTER; MINERALIZATION; DECOMPOSITION; SPECIATION; RELEASE; QUALITY	Soil labile organic carbon and soil enzymes play important roles in the carbon cycle of coastal wetlands that have high organic carbon accumulation rates. Soils under three vegetations (Phragmites australis, Spartina alterniflora, and Scirpusm mariqueter) as well as bare mudflat in Hangzhou Bay wetland of China were collected seasonally. Seasonal dynamics and correlations of soil labile organic carbon fractions and soil enzyme activities were analyzed. The results showed that there were significant differences among vegetation types in the contents of soil organic carbon (SOC) and dissolved organic carbon (DOC), excepting for that of microbial biomass carbon (MBC). The P. australis soil was with the highest content of both SOC (7.86 g kg(-1)) and DOC (306 mg kg(-1)), while the S. mariqueter soil was with the lowest content of SOC (6.83 g kg(-1)), and the bare mudflat was with the lowest content of DOC (270mg kg(-1)). Soil enzyme activities were significantly different among vegetation types except for urease. The P. australis had the highest annual average activity of alkaline phosphomonoesterase (21.4 mg kg-1 h(-1)), and the S. alterniflora had the highest annual average activities of beta-glycosidase (4.10 mg kg(-1) h(-1)) and invertase (9.81mg g(-1) 24 h(-1)); however, the bare mudflat had the lowest activities of alkaline phosphomonoesterase (16.2 mg kg(-1) h(-1)), beta-glycosidase (2.87 mg kg(-1) h(-1)), and invertase (8.02mg g(-1) 24 h(-1)). Analysis also showed that the soil labile organic carbon fractions and soil enzyme activities had distinct seasonal dynamics. In addition, the soil MBC content was significantly correlated with the activities of urease and beta-glucosidase. The DOC content was significantly correlated with the activities of urease, alkaline phosphomonoesterase, and invertase. The results indicated that vegetation type is an important factor influencing the spatial-temporal variation of soil enzyme activities and labile organic carbon in coastal wetlands.	[Shao, Xuexin; Yang, Wenying; Wu, Ming] Chinese Acad Forestry, Res Inst Subtrop Forestry, Wetland Ecosyst Res Stn Hangzhou Bay, Fuyang, Zhejiang, Peoples R China	Chinese Academy of Forestry; Research Institute of Subtropical Forestry, CAF	Wu, M (corresponding author), Chinese Acad Forestry, Res Inst Subtrop Forestry, Wetland Ecosyst Res Stn Hangzhou Bay, Fuyang, Zhejiang, Peoples R China.	hangzhoubay@126.com			Fundamental Research Funds for the Central Nonprofit Research Institution [CAFYBB2014MA002, RISFCAF61256]; Special Fund for Forest Scientific Research in the Public Welfare [201404210]	Fundamental Research Funds for the Central Nonprofit Research Institution; Special Fund for Forest Scientific Research in the Public Welfare	This study was supported by the Fundamental Research Funds for the Central Nonprofit Research Institution (CAFYBB2014MA002, RISFCAF61256) and Special Fund for Forest Scientific Research in the Public Welfare (201404210). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkorta Itziar, 2003, Rev Environ Health, V18, P65; An S, 2008, CATENA, V75, P248, DOI 10.1016/j.catena.2008.07.003; Bonnett SAF, 2006, SCI TOTAL ENVIRON, V370, P561, DOI 10.1016/j.scitotenv.2006.08.032; Caravaca F, 2005, GEODERMA, V124, P375, DOI 10.1016/j.geoderma.2004.05.010; Chen CR, 2004, SOIL SCI SOC AM J, V68, P282, DOI 10.2136/sssaj2004.2820; Chen QF, 2013, INT BIODETER BIODEGR, V85, P646, DOI 10.1016/j.ibiod.2013.04.009; COLEMAN DC, 1983, ADV ECOL RES, V13, P1, DOI 10.1016/S0065-2504(08)60107-5; Fenner N, 2005, SOIL BIOL BIOCHEM, V37, P1814, DOI 10.1016/j.soilbio.2005.02.032; Guan YS, 1986, SOIL ENZYME RES METH, P309; Haynes RJ, 2005, ADV AGRON, V85, P221, DOI 10.1016/S0065-2113(04)85005-3; Huang JY, 2010, ACTA AGR SCAND B-S P, V60, P182, DOI 10.1080/09064710802680387; INSAM H, 1990, SOIL BIOL BIOCHEM, V22, P525, DOI 10.1016/0038-0717(90)90189-7; Jones DL, 2006, SOIL BIOL BIOCHEM, V38, P991, DOI 10.1016/j.soilbio.2005.08.012; Kalbitz K, 2000, SOIL SCI, V165, P277, DOI 10.1097/00010694-200004000-00001; Keuskamp JA, 2013, SOIL BIOL BIOCHEM, V57, P822, DOI 10.1016/j.soilbio.2012.08.007; Khalid M, 2007, SOIL BIOL BIOCHEM, V39, P378, DOI 10.1016/j.soilbio.2006.07.007; Kramer S, 2000, SOIL BIOL BIOCHEM, V32, P179, DOI 10.1016/S0038-0717(99)00140-6; Li XF, 2015, APPL MICROBIOL BIOT, V99, P2895, DOI 10.1007/s00253-014-6187-4; Liang BC, 1998, BIOL FERT SOILS, V26, P88, DOI 10.1007/s003740050348; Lu L. K, 1999, SOIL AGRO CHEM ANALY; Mavi M. S., 2010, Proceedings of the 19th World Congress of Soil Science: Soil solutions for a changing world, Brisbane, Australia, 1-6 August 2010. Working Group 3.4 Global change and soil salination, P43; McLatchey GP, 1998, J ENVIRON QUAL, V27, P1268, DOI 10.2134/jeq1998.00472425002700050036x; Neff JC, 2002, GLOBAL CHANGE BIOL, V8, P872, DOI 10.1046/j.1365-2486.2002.00517.x; Nie XB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081084; Niemi RM, 2005, APPL SOIL ECOL, V30, P113, DOI 10.1016/j.apsoil.2005.02.003; Phang VXH, 2015, EARTH SURF PROC LAND, V40, P1387, DOI 10.1002/esp.3745; Rietz DN, 2003, SOIL BIOL BIOCHEM, V35, P845, DOI 10.1016/S0038-0717(03)00125-1; Ros GH, 2010, SOIL SCI, V175, P15, DOI 10.1097/SS.0b013e3181c8ef3c; ROSS DJ, 1995, SOIL BIOL BIOCHEM, V27, P1431, DOI 10.1016/0038-0717(95)00069-Q; Sanaullah M, 2011, APPL SOIL ECOL, V48, P38, DOI 10.1016/j.apsoil.2011.02.004; Shao XX, 2013, ENVIRON SCI POLLUT R, V20, P6382, DOI 10.1007/s11356-013-1698-6; Singh DK, 2008, CHEMOSPHERE, V71, P412, DOI 10.1016/j.chemosphere.2007.11.005; Sinsabaugh RL, 2008, ECOL LETT, V11, P1252, DOI 10.1111/j.1461-0248.2008.01245.x; Solomon D, 2007, GLOBAL CHANGE BIOL, V13, P511, DOI 10.1111/j.1365-2486.2006.01304.x; Song YY, 2014, EUR J SOIL BIOL, V61, P72, DOI 10.1016/j.ejsobi.2014.02.001; Song YY, 2013, CATENA, V104, P265, DOI 10.1016/j.catena.2012.12.008; Song YY, 2012, ENVIRON MANAGE, V50, P418, DOI 10.1007/s00267-012-9890-x; Tian L, 2010, APPL SOIL ECOL, V46, P426, DOI 10.1016/j.apsoil.2010.09.007; Tripathi S, 2006, BIOL FERT SOILS, V42, P273, DOI 10.1007/s00374-005-0037-6; Tripathi S, 2007, SOIL BIOL BIOCHEM, V39, P2840, DOI 10.1016/j.soilbio.2007.05.027; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; [万忠梅 WAN ZhongMei], 2008, [生态学报, Acta Ecologica Sinica], V28, P5980; WANDER MM, 1994, SOIL SCI SOC AM J, V58, P1130, DOI 10.2136/sssaj1994.03615995005800040018x; Wang JY, 2012, CATENA, V96, P83, DOI 10.1016/j.catena.2012.03.009; Wang QK, 2013, ANN FOREST SCI, V70, P579, DOI 10.1007/s13595-013-0294-8; Wang QK, 2011, APPL SOIL ECOL, V47, P210, DOI 10.1016/j.apsoil.2010.12.004; Yao XH, 2006, EUR J SOIL BIOL, V42, P120, DOI 10.1016/j.ejsobi.2005.12.001; Yin R, 2014, CATENA, V115, P96, DOI 10.1016/j.catena.2013.11.015; Zhang C, 2011, GEODERMA, V161, P115, DOI 10.1016/j.geoderma.2010.12.003; Zhou GM, 2006, PEDOSPHERE, V16, P525, DOI 10.1016/S1002-0160(06)60084-2; Zhou XJ, 2004, CHINESE SCI BULL, V49, P2503, DOI 10.1360/03wd0538	51	45	55	7	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142677	10.1371/journal.pone.0142677	http://dx.doi.org/10.1371/journal.pone.0142677			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560310	Green Published, Green Submitted, gold			2022-12-26	WOS:000364433100111
J	Masic, A; Hernandez, AMV; Hazra, S; Glaser, J; Holzgrabe, U; Hazra, B; Schurigt, U				Masic, Anita; Hernandez, Ana Maria Valencia; Hazra, Sudipta; Glaser, Jan; Holzgrabe, Ulrike; Hazra, Banasri; Schurigt, Uta			Cinnamic Acid Bornyl Ester Derivatives from Valeriana wallichii Exhibit Antileishmanial In Vivo Activity in Leishmania major-Infected BALB/c Mice	PLOS ONE			English	Article							APOPTOTIC CELL-DEATH; DRUG DISCOVERY; CUTANEOUS LEISHMANIASIS; CHALCONES; VITRO; PROLIFERATION; AMAZONENSIS; RESISTANCE; INHIBITORS; DONOVANI	Human leishmaniasis covers a broad spectrum of clinical manifestations ranging from self-healing cutaneous leishmaniasis to severe and lethal visceral leishmaniasis caused among other species by Leishmania major or Leishmania donovani, respectively. Some drug candidates are in clinical trials to substitute current therapies, which are facing emerging drug-resistance accompanied with serious side effects. Here, two cinnamic acid bornyl ester derivatives (1 and 2) were assessed for their antileishmanial activity. Good selectivity and antileishmanial activity of bornyl 3-phenylpropanoate (2) in vitro prompted the antileishmanial assessment in vivo. For this purpose, BALB/c mice were infected with Leishmania major promastigotes and treated with three doses of 50 mg/kg/day of compound 2. The treatment prevented the characteristic swelling at the site of infection and correlated with reduced parasite burden. Transmitted light microscopy and transmission electron microscopy of Leishmania major promastigotes revealed that compounds 1 and 2 induce mitochondrial swelling. Subsequent studies on Leishmania major promastigotes showed the loss of mitochondrial transmembrane potential (Delta psi(m)) as a putative mode of action. As the cinnamic acid bornyl ester derivatives 1 and 2 had exhibited antileishmanial activity in vitro, and compound 2 in Leishmania major-infected BALB/c mice in vivo, they can be regarded as possible lead structures for the development of new antileishmanial therapeutic approaches.	[Masic, Anita; Hernandez, Ana Maria Valencia; Schurigt, Uta] Univ Wurzburg, Inst Mol Infect Biol, Wurzburg, Germany; [Hazra, Sudipta; Hazra, Banasri] Jadavpur Univ, Dept Pharmaceut Technol, Kolkata, India; [Glaser, Jan; Holzgrabe, Ulrike] Univ Wurzburg, Inst Pharm & Food Chem, Wurzburg, Germany	University of Wurzburg; Jadavpur University; University of Wurzburg	Glaser, J (corresponding author), Univ Wurzburg, Inst Pharm & Food Chem, Wurzburg, Germany.	jan.glaser@uni-wuerzburg.de; uta.schurigt@uni-wuerzburg.de		Holzgrabe, Ulrike/0000-0002-0364-7278	Deutsche Forschungsgemeinschaft (DFG), Collaborative Research Center [630 (SFB 630)]; Indian Council of Medical Research, New Delhi, India [3/1/3/WL/JRF-2008/MPD]; Deutsche Forschungsgemeinschaft (DFG); University of Wuerzburg	Deutsche Forschungsgemeinschaft (DFG), Collaborative Research Center(German Research Foundation (DFG)); Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); University of Wuerzburg	Funding: This work was supported by a grant of the Deutsche Forschungsgemeinschaft (DFG), Collaborative Research Center 630 (SFB 630), "Recognition, Preparation and Functional Analysis of Agents against Infectious Diseases" (projects A1 and B3; www.sfb630.uni-wuerzburg.de). SH was awarded a fellowship from the Indian Council of Medical Research, New Delhi, India (3/1/3/WL/JRF-2008/MPD). This publication was funded by the Deutsche Forschungsgemeinschaft (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Aponte JC, 2010, BIOORG MED CHEM LETT, V20, P100, DOI 10.1016/j.bmcl.2009.11.033; Baell J, 2014, NATURE, V513, P481, DOI 10.1038/513481a; BOGDAN C, 1990, EUR J IMMUNOL, V20, P1131, DOI 10.1002/eji.1830200528; Bozic DD, 2014, INDIAN J MED RES, V140, P130; Bringmann G, 2013, ANTIMICROB AGENTS CH, V57, P3003, DOI 10.1128/AAC.02201-12; Britta EA, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0236-0; Castanys-Munoz E, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.113; CHRISTENSEN SB, 1994, PLANTA MED, V60, P121, DOI 10.1055/s-2006-959431; Corware K, 2011, BIOMATERIALS, V32, P8029, DOI 10.1016/j.biomaterials.2011.07.021; Croft SL, 2006, INDIAN J MED RES, V123, P399; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; CROFT SL, 1993, T ROY SOC TROP MED H, V87, P217, DOI 10.1016/0035-9203(93)90499-G; Cruz AK, 2009, CURR DRUG TARGETS, V10, P178, DOI 10.2174/138945009787581177; Dao TTH, 2011, PHYTOCHEM REV, V10, P397, DOI 10.1007/s11101-011-9211-7; de Mello TFP, 2014, EXP PARASITOL, V136, P27, DOI 10.1016/j.exppara.2013.11.003; de Souza W, 2009, INT J BIOCHEM CELL B, V41, P2069, DOI 10.1016/j.biocel.2009.04.007; Rodrigues JCF, 2008, CURR PHARM DESIGN, V14, P925, DOI 10.2174/138161208784041033; Ferreira ME, 2002, J ETHNOPHARMACOL, V80, P199, DOI 10.1016/S0378-8741(02)00025-9; FOURNET A, 1992, J ETHNOPHARMACOL, V37, P159, DOI 10.1016/0378-8741(92)90074-2; Garcia M, 2011, ASIAN PAC J TROP MED, V4, P836, DOI 10.1016/S1995-7645(11)60204-6; Ghosh S, 2011, PARASITOL RES, V108, P861, DOI 10.1007/s00436-010-2127-0; Glaser J, 2015, MOLECULES, V20, P5740, DOI 10.3390/molecules20045740; Glaser J, 2014, MOLECULES, V19, P1394, DOI 10.3390/molecules19021394; Gumy A, 2004, INT J PARASITOL, V34, P433, DOI 10.1016/j.ijpara.2003.11.021; Gupta S, 2014, EUR J MED CHEM, V81, P359, DOI 10.1016/j.ejmech.2014.05.034; GUY RA, 1995, CLIN EXP IMMUNOL, V100, P440; Hacker G, 2000, CELL TISSUE RES, V301, P5, DOI 10.1007/s004410000193; Hazra S, 2013, EXP PARASITOL, V135, P407, DOI 10.1016/j.exppara.2013.07.021; Hazra S, 2012, PARASITOL RES, V111, P195, DOI 10.1007/s00436-012-2818-9; Inacio JDF, 2012, EXP PARASITOL, V132, P151, DOI 10.1016/j.exppara.2012.06.008; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Khademvatan S, 2011, KOREAN J PARASITOL, V49, P17, DOI 10.3347/kjp.2011.49.1.17; Khuda F, 2012, PAK J PHARM SCI, V25, P715; Kingston DGI, 2005, IDRUGS, V8, P990; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Lima HC, 1997, PARASITOL TODAY, V13, P80, DOI 10.1016/S0169-4758(96)40010-2; Masic A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001721; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakayama H, 2007, BIOMED PHARMACOTHER, V61, P186, DOI 10.1016/j.biopha.2007.02.001; Narender T, 2005, BIOORG MED CHEM LETT, V15, P2453, DOI 10.1016/j.bmcl.2005.03.081; Narender T, 2004, BIOORG MED CHEM LETT, V14, P3913, DOI 10.1016/j.bmcl.2004.05.071; Ponte-Sucre A, 2006, ANTIMICROB AGENTS CH, V50, P2439, DOI 10.1128/AAC.01430-05; Proto WR, 2013, NAT REV MICROBIOL, V11, P58, DOI 10.1038/nrmicro2929; Rodrigues IA, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-249; Rosa MDS, 2003, ANTIMICROB AGENTS CH, V47, P1895, DOI 10.1128/AAC.47.6.1895-1901.2003; Sati S. C., 2011, Research Journal of Microbiology, V6, P289, DOI 10.3923/jm.2011.289.296; Schurigt U, 2010, ANTIMICROB AGENTS CH, V54, P5028, DOI 10.1128/AAC.00327-10; Simpson L, 1997, MOL BIOCHEM PARASIT, V87, P71, DOI 10.1016/S0166-6851(97)00044-3; Singh Sarman, 2004, Journal of Infection and Chemotherapy, V10, P307, DOI 10.1007/s10156-004-0348-9; Sogin ML, 1991, CURR OPIN GENET DEV, V1, P457, DOI 10.1016/S0959-437X(05)80192-3; SOLBACH W, 1986, INFECT IMMUN, V54, P909, DOI 10.1128/IAI.54.3.909-912.1986; Sundar S, 2008, EXPERT OPIN INV DRUG, V17, P787, DOI [10.1517/13543784.17.5.787, 10.1517/13543784.17.5.787 ]; Vermes I, 2000, J IMMUNOL METHODS, V243, P167, DOI 10.1016/S0022-1759(00)00233-7; Weingartner A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042070; ZHAI L, 1995, ANTIMICROB AGENTS CH, V39, P2742, DOI 10.1128/AAC.39.12.2742; Zhang GH, 1997, BIOTECHNIQUES, V23, P525, DOI 10.2144/97233pf01	57	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142386	10.1371/journal.pone.0142386	http://dx.doi.org/10.1371/journal.pone.0142386			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554591	gold, Green Submitted, Green Published			2022-12-26	WOS:000364430700095
J	Zhang, ZZ; Lou, YG; Deng, DJ; Rahman, MM; Wu, QS				Zhang, Ze-Zhi; Lou, You-Gen; Deng, Dao-Juan; Rahman, Mohammed Mahabubur; Wu, Qiang-Sheng			Effects of Common Mycorrhizal Network on Plant Carbohydrates and Soil Properties in Trifoliate Orange-White Clover Association	PLOS ONE			English	Article							CARBON; FUNGI; RHIZOSPHERE; GLOMALIN	Common mycorrhizal network (CMN) allows nutrients and signals to pass between two or more plants. In this study, trifoliate orange (Poncirus trifoliata) and white clover (Trifolium repens) were planted in a two-compartmented rootbox, separated by a 37-mu m nylon mesh and then inoculated with an arbuscular mycorrhizal fungus (AMF), Diversispora spurca. Inoculation with D. spurca resulted in formation of a CMN between trifoliate orange and white clover, whilst the best AM colonization occurred in the donor trifoliate orange-receptor white clover association. In the trifoliate orange-white clover association, the mycorrhizal colonization of receptor plant by extraradical hyphae originated from the donor plant significantly increased shoot and root fresh weight and chlorophyll concentration of the receptor plant. Enzymatic activity of soil beta-glucoside hydrolase, protease, acid and neutral phosphatase, water-stable aggregate percentage at 2-4 and 0.5-1 mm size, and mean weight diameter in the rhizosphere of the receptor plant also increased. The hyphae of CMN released more easily-extractable glomalin-related soil protein and total glomalin-related soil protein into the receptor rhizosphere, which represented a significantly positive correlation with aggregate stability. AMF inoculation exhibited diverse changes in leaf and root sucrose concentration in the donor plant, and AM colonization by CMN conferred a significant increase of root glucose in the receptor plant. These results suggested that CMN formed in the trifoliate orange-white clover association, and root AM colonization by CMN promoted plant growth, root glucose accumulation, and rhizospheric soil properties in the receptor plant.	[Zhang, Ze-Zhi; Deng, Dao-Juan; Wu, Qiang-Sheng] Yangtze Univ, Coll Hort & Gardening, Jingzhou, Hubei, Peoples R China; [Zhang, Ze-Zhi; Wu, Qiang-Sheng] Yangtze Univ, Inst Root Biol, Jingzhou, Hubei, Peoples R China; [Lou, You-Gen] Yangtze Univ, Sch Foreign Studies, Jingzhou, Hubei, Peoples R China; [Rahman, Mohammed Mahabubur] Brix N Berries, Leduc, AB, Canada	Yangtze University; Yangtze University; Yangtze University	Wu, QS (corresponding author), Yangtze Univ, Coll Hort & Gardening, Jingzhou, Hubei, Peoples R China.	wuqiangsh@163.com	Wu, Qiang-Sheng/A-1956-2012	Wu, Qiang-Sheng/0000-0002-3405-8409	Institute of Root Biology, Yangtze University [R201401]; Yangtze University Foundation for Young Scholars [cyq201324]; Brix N' Berries	Institute of Root Biology, Yangtze University; Yangtze University Foundation for Young Scholars; Brix N' Berries	Funding: This study was supported by the Open Fund of Institute of Root Biology, Yangtze University (R201401) and the Yangtze University Foundation for Young Scholars (cyq201324). The Brix N' Berries provided support in the form of salaries for authors (MM Rahman), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Asai M, 1992, WEED RES, V37, P152; Babikova Z, 2013, ECOL LETT, V16, P835, DOI 10.1111/ele.12115; Barto EK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027195; Bedini S, 2009, SOIL BIOL BIOCHEM, V41, P1491, DOI 10.1016/j.soilbio.2009.04.005; Cao CJ, 1982, CHIN J SOIL SCI, V13, P39; Graves JD, 1997, PLANT SOIL, V192, P153, DOI 10.1023/A:1004257812555; Gyuricza V, 2010, ENVIRON MICROBIOL, V12, P2180, DOI 10.1111/j.1462-2920.2009.02118.x; Ishii T, 2010, ROOT RES, V19, P5; Johnson D, 2015, NEW PHYTOL, V205, P1448, DOI 10.1111/nph.13115; Kemper W. D., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P425; Lichtenthaler H., 1983, BIOCHEM SOC T, V11, P591, DOI [10.1042/bst0110591, 10.1042/BST0110591, DOI 10.1042/BST0110591]; Meding SM, 2008, SOIL BIOL BIOCHEM, V40, P126, DOI 10.1016/j.soilbio.2007.07.019; Nakano-Hylander A, 2007, SOIL BIOL BIOCHEM, V39, P1450, DOI 10.1016/j.soilbio.2006.12.031; Rillig MC, 2006, NEW PHYTOL, V171, P41, DOI 10.1111/j.1469-8137.2006.01750.x; Sato T, 2015, SOIL SCI PLANT NUTR, V61, P269, DOI 10.1080/00380768.2014.993298; Selosse MA, 2006, TRENDS ECOL EVOL, V21, P621, DOI 10.1016/j.tree.2006.07.003; Siddiky MRK, 2012, SOIL BIOL BIOCHEM, V50, P33, DOI 10.1016/j.soilbio.2012.03.001; Simard SW, 2004, CAN J BOT, V82, P1140, DOI [10.1139/b04-116, 10.1139/B04-116]; Song YY, 2014, SCI REP-UK, V4, DOI 10.1038/srep03915; Stott DE, 2010, SOIL SCI SOC AM J, V74, P107, DOI 10.2136/sssaj2009.0029; Walder F, 2012, PLANT PHYSIOL, V159, P789, DOI 10.1104/pp.112.195727; Wang S, 2014, SCI HORTIC-AMSTERDAM, V170, P137, DOI 10.1016/j.scienta.2014.03.003; Wu QS, 2015, J PLANT GROWTH REGUL, V34, P499, DOI 10.1007/s00344-015-9485-x; Wu QS, 2014, SCI REP-UK, V4, DOI 10.1038/srep05823; Wu QS, 2013, SCI HORTIC-AMSTERDAM, V160, P320, DOI 10.1016/j.scienta.2013.06.015; Zhao DiKun, 2012, Acta Pedologica Sinica, V49, P339; Zhao LP, 1986, CHIN J SOIL SCI, V17, P138; Zhu YG, 2000, AGR ECOSYST ENVIRON, V77, P211, DOI 10.1016/S0167-8809(99)00087-0	28	11	11	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142371	10.1371/journal.pone.0142371	http://dx.doi.org/10.1371/journal.pone.0142371			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556792	Green Submitted, gold, Green Published			2022-12-26	WOS:000364430700093
J	Amorim, D; Viisanen, H; Wei, H; Almeida, A; Pertovaara, A; Pinto-Ribeiro, F				Amorim, Diana; Viisanen, Hanna; Wei, Hong; Almeida, Armando; Pertovaara, Antti; Pinto-Ribeiro, Filipa			Galanin-Mediated Behavioural Hyperalgesia from the Dorsomedial Nucleus of the Hypothalamus Involves Two Independent Descending Pronociceptive Pathways	PLOS ONE			English	Article							DORSAL RETICULAR NUCLEUS; ROSTRAL VENTROMEDIAL MEDULLA; RAT SPINAL-CORD; HETEROTOPIC NOCICEPTIVE INFORMATION; PERIPHERAL-NERVE INJURY; ANIMAL-MODELS; NEUROPATHIC PAIN; ROSTROVENTROMEDIAL MEDULLA; ANTINOCICEPTIVE ROLE; RESPONSE PROPERTIES	Activation of the dorsomedial nucleus of the hypothalamus (DMH) by galanin (GAL) induces behavioural hyperalgesia. Since DMH neurones do not project directly to the spinal cord, we hypothesized that the medullary dorsal reticular nucleus (DRt), a pronociceptive region projecting to the spinal dorsal horn (SDH) and/or the serotoninergic raphe-spinal pathway acting on the spinal 5-HT3 receptor (5HT(3)R) could relay descending nociceptive facilitation induced by GAL in the DMH. Heat-evoked paw-withdrawal latency (PWL) and activity of SDH neurones were assessed in monoarthritic (ARTH) and control (SHAM) animals after pharmacological manipulations of the DMH, DRt and spinal cord. The results showed that GAL in the DMH and glutamate in the DRt lead to behavioural hyperalgesia in both SHAM and ARTH animals, which is accompanied particularly by an increase in heat-evoked responses of wide-dynamic range neurons, a group of nociceptive SDH neurones. Facilitation of pain behaviour induced by GAL in the DMH was reversed by lidocaine in the DRt and by ondansetron, a 5HT(3)R antagonist, in the spinal cord. However, the hyperalgesia induced by glutamate in the DRt was not blocked by spinal ondansetron. In addition, in ARTH but not SHAM animals PWL was increased after lidocaine in the DRt and ondansetron in the spinal cord. Our data demonstrate that GAL in the DMH activates two independent descending facilitatory pathways: (i) one relays in the DRt and (ii) the other one involves 5-HT neurones acting on spinal 5HT(3)Rs. In experimental ARTH, the tonic pain-facilitatory action is increased in both of these descending pathways.	[Amorim, Diana; Almeida, Armando; Pinto-Ribeiro, Filipa] Univ Minho, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Amorim, Diana; Almeida, Armando; Pinto-Ribeiro, Filipa] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Amorim, Diana; Viisanen, Hanna; Wei, Hong; Pertovaara, Antti] Univ Helsinki, Inst Biomed Physiol, Helsinki, Finland	Universidade do Minho; University of Helsinki	Pinto-Ribeiro, F (corresponding author), Univ Minho, Life & Hlth Sci Res Inst ICVS, Braga, Portugal.	filiparibeiro@ecsaude.uminho.pt	Viisanen-Kuopila, Hanna/AAS-4688-2020; Viisanen, Hanna/R-4442-2019; Pinto-Ribeiro, Filipa/AAM-6559-2021; Almeida, Armando/H-5122-2011; Pertovaara, Antti Yrjö/AAM-9213-2021; Pinto-Ribeiro, Filipa/AAB-4822-2019; Pinto-Ribeiro, Filipa/M-2696-2013	Viisanen-Kuopila, Hanna/0000-0002-1038-3215; Pinto-Ribeiro, Filipa/0000-0001-7574-6489; Almeida, Armando/0000-0002-6233-4693; Pertovaara, Antti Yrjö/0000-0002-8590-7220; Pinto-Ribeiro, Filipa/0000-0001-7574-6489; Amorim, Diana/0000-0001-6402-0834	Portuguese Science Foundation (FCT) [PTDC/SAU-NEU/108557/2008]; Portuguese North Regional Operational Program (ON.2 - O Novo Norte) under the National Strategic Reference Framework (QREN) through the European Regional Development Fund (FEDER); Academy of Finland; Sigrid Juselius Foundation, Helsinki, Finland; FCT [SFRH/BD/71219/2010]	Portuguese Science Foundation (FCT)(Portuguese Foundation for Science and Technology); Portuguese North Regional Operational Program (ON.2 - O Novo Norte) under the National Strategic Reference Framework (QREN) through the European Regional Development Fund (FEDER); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation, Helsinki, Finland(Sigrid Juselius Foundation); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This study was supported by grants from the Portuguese Science Foundation (FCT) Project no PTDC/SAU-NEU/108557/2008, co-financed by the Portuguese North Regional Operational Program (ON.2 - O Novo Norte) under the National Strategic Reference Framework (QREN), through the European Regional Development Fund (FEDER) and the Academy of Finland, the Sigrid Juselius Foundation, Helsinki, Finland. Diana Amorim was supported by FCT grant SFRH/BD/71219/2010.	Ali Z, 1996, NEUROSCI LETT, V208, P203, DOI 10.1016/0304-3940(95)12600-7; Almeida A, 2000, EUR J PAIN, V4, P373, DOI 10.1053/eujp.2000.0193; Almeida A, 1996, BRAIN RES BULL, V39, P7, DOI 10.1016/0361-9230(95)02027-6; Almeida A, 1999, EUR J NEUROSCI, V11, P110, DOI 10.1046/j.1460-9568.1999.00411.x; Amorim D, 2014, BEHAV BRAIN RES, V265, P12, DOI 10.1016/j.bbr.2014.02.003; Amorim D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113077; Barton NJ, 2007, J NEUROSCI METH, V163, P67, DOI 10.1016/j.jneumeth.2007.02.012; Bendele A, 1999, TOXICOL PATHOL, V27, P134, DOI 10.1177/019262339902700125; Burgess SE, 2002, J NEUROSCI, V22, P5129, DOI 10.1523/JNEUROSCI.22-12-05129.2002; Carlson JD, 2007, J NEUROSCI, V27, P13222, DOI 10.1523/JNEUROSCI.3715-07.2007; Chapman V, 1998, J PHYSIOL-LONDON, V507, P881, DOI 10.1111/j.1469-7793.1998.881bs.x; Chu KL, 2004, NEUROSCI LETT, V372, P123, DOI 10.1016/j.neulet.2004.09.025; COGHILL RC, 1993, J NEUROPHYSIOL, V69, P703, DOI 10.1152/jn.1993.69.3.703; DANZEBRINK RM, 1991, BRAIN RES, V538, P64, DOI 10.1016/0006-8993(91)90377-8; Dugast C, 2003, EUR J NEUROSCI, V18, P580, DOI 10.1046/j.1460-9568.2003.02782.x; FIELDS HL, 1983, J NEUROSCI, V3, P2545; GLAUM SR, 1990, BRAIN RES, V510, P12, DOI 10.1016/0006-8993(90)90721-M; Green GM, 2000, PAIN, V89, P81, DOI 10.1016/S0304-3959(00)00346-8; Guo W, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-35; Jin WY, 2010, BRAIN RES, V1320, P16, DOI 10.1016/j.brainres.2009.12.060; KIA HK, 1995, NEUROREPORT, V6, P257, DOI 10.1097/00001756-199501000-00008; Kollias G, 2011, ANN RHEUM DIS, V70, P1357, DOI 10.1136/ard.2010.148551; Landry M, 2005, NEUROPEPTIDES, V39, P223, DOI 10.1016/j.npep.2005.02.004; LANTERIMINET M, 1994, NEUROSCIENCE, V58, P287, DOI 10.1016/0306-4522(94)90035-3; Lima D, 2002, PROG NEUROBIOL, V66, P81, DOI 10.1016/S0301-0082(01)00025-9; Martenson ME, 2009, PAIN, V142, P236, DOI 10.1016/j.pain.2009.01.011; Martins I, 2008, EUR J NEUROSCI, V28, P2075, DOI 10.1111/j.1460-9568.2008.06492.x; Martins I, 2010, PAIN, V151, P137, DOI 10.1016/j.pain.2010.06.027; McCleane GJ, 2003, ANESTH ANALG, V97, P1474, DOI 10.1213/01.ANE.0000085640.69855.51; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; Morales R, 1998, J COMP NEUROL, V402, P385; MYERS RD, 1966, PHYSIOL BEHAV, V1, P171, DOI 10.1016/0031-9384(66)90064-3; Neto FL, 1999, NEUROSCIENCE, V94, P607, DOI 10.1016/S0306-4522(99)00185-2; Neubert MJ, 2004, PAIN, V110, P158, DOI 10.1016/j.pain.2004.03.017; Oyama T, 1996, NEUROSCI RES, V25, P129; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pertovaara A, 1996, NEUROSCI LETT, V218, P127, DOI 10.1016/S0304-3940(96)13136-0; Pertovaara A, 2001, EXP NEUROL, V167, P425, DOI 10.1006/exnr.2000.7574; Pinto M, 2008, MOL CELL NEUROSCI, V39, P508, DOI 10.1016/j.mcn.2008.07.008; Pinto-Ribeiro F, 2013, BRAIN RES BULL, V99, P100, DOI 10.1016/j.brainresbull.2013.10.001; Porreca F, 2002, TRENDS NEUROSCI, V25, P319, DOI 10.1016/S0166-2236(02)02157-4; POTREBIC SB, 1994, J NEUROSCI, V14, P1655, DOI 10.1523/JNEUROSCI.14-03-01655.1994; PRITZKER KPH, 1994, ANN RHEUM DIS, V53, P406, DOI 10.1136/ard.53.6.406; Radhakrishnan R, 2003, PAIN, V104, P567, DOI 10.1016/S0304-3959(03)00114-3; RANDALL LO, 1957, ARCH INT PHARMACOD T, V111, P409; Rivat C, 2008, PAIN, V137, P125, DOI 10.1016/j.pain.2007.08.021; RODGERS RJ, 1992, NEUROPHARMACOLOGY, V31, P553, DOI 10.1016/0028-3908(92)90187-T; Sanoja R, 2010, EUR J PAIN, V14, DOI 10.1016/j.ejpain.2009.04.006; Silva M, 2013, BRAIN RES BULL, V96, P39, DOI 10.1016/j.brainresbull.2013.04.008; Silveira JWS, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-17; Sotgiu ML, 2008, BRAIN RES, V1188, P69, DOI 10.1016/j.brainres.2007.10.030; Storkson RV, 1996, J NEUROSCI METH, V65, P167, DOI 10.1016/0165-0270(95)00164-6; Sun YG, 2004, J NEUROSCI RES, V77, P718, DOI 10.1002/jnr.20206; Sun YG, 2003, PAIN, V106, P143, DOI 10.1016/S0304-3959(03)00316-6; Suzuki R, 2005, PAIN, V117, P292, DOI 10.1016/j.pain.2005.06.015; Suzuki R, 2004, BRAIN RES, V1019, P68, DOI 10.1016/j.brainres.2004.05.108; TAVARES I, 1994, EXP BRAIN RES, V99, P455; TERHORST GJ, 1986, BRAIN RES BULL, V16, P231; Urban MO, 1999, P NATL ACAD SCI USA, V96, P7687, DOI 10.1073/pnas.96.14.7687; VILLANUEVA L, 1988, J NEUROPHYSIOL, V60, P980, DOI 10.1152/jn.1988.60.3.980; VILLANUEVA L, 1990, J NEUROPHYSIOL, V63, P1118, DOI 10.1152/jn.1990.63.5.1118; Vincent TL, 2012, RHEUMATOLOGY, V51, P1931, DOI 10.1093/rheumatology/kes035; Wang D, 2000, NEUROSCIENCE, V96, P767, DOI 10.1016/S0306-4522(00)00005-1; Willis W.D., 2004, SENSORY MECH SPINAL, V207, P1067, DOI [10.1126/science.207.4435.1067.b, DOI 10.1126/SCIENCE.207.4435.1067.B]; Zeitz KP, 2002, J NEUROSCI, V22, P1010, DOI 10.1523/JNEUROSCI.22-03-01010.2002; Zhuo M, 1997, J NEUROPHYSIOL, V78, P746, DOI 10.1152/jn.1997.78.2.746	66	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142919	10.1371/journal.pone.0142919	http://dx.doi.org/10.1371/journal.pone.0142919			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26565961	gold, Green Published, Green Submitted			2022-12-26	WOS:000367628500069
J	Xu, HY; Wu, LC; Zhao, H; Jin, LG; Qi, SY				Xu, Huan-Yan; Wu, Li-Cheng; Zhao, Hang; Jin, Li-Guo; Qi, Shu-Yan			Synergic Effect between Adsorption and Photocatalysis of Metal-Free g-C3N4 Derived from Different Precursors	PLOS ONE			English	Article							VISIBLE-LIGHT IRRADIATION; GRAPHITIC CARBON NITRIDE; TIO2 NANOTUBE ARRAYS; METHYL-ORANGE; FREE CATALYSTS; FUEL-CELLS; DEGRADATION; EFFICIENT; COMPOSITE; PHOTODEGRADATION	Graphitic carbon nitride (g-C3N4) used in this work was obtained by heating dicyandiamide and melamine, respectively, at different temperatures. The differences of g-C3N4 derived from different precursors in phase composition, functional group, surface morphology, microstructure, surface property, band gap and specific surface area were investigated by X-ray diffraction, Fourier transform infrared spectroscopy, scanning electron microscopy, transmission electron microscopy, X-ray photoelectron spectroscopy, UV-visible diffuse reflection spectroscopy and BET surface area analyzer, respectively. The photocatalytic discoloration of an active cationic dye, Methylene Blue (MB) under visible-light irradiation indicated that g-C3N4 derived from melamine at 500 degrees C (CN-M500) had higher adsorption capacity and better photocatalytic activity than that from dicyandiamide at 500 degrees C (CN-D500), which was attributed to the larger surface area of CN-M500. MB discoloration ratio over CN-M500 was affected by initial MB concentration and photocatalyst dosage. After 120 min reaction time, the blue color of MB solution disappeared completely. Subsequently, based on the measurement of the surface Zeta potentials of CN-M500 at different pHs, an active anionic dye, Methyl Orange (MO) was selected as the contrastive target pollutant with MB to reveal the synergic effect between adsorption and photocatalysis. Finally, the photocatalytic mechanism was discussed.	[Xu, Huan-Yan; Wu, Li-Cheng; Zhao, Hang; Jin, Li-Guo; Qi, Shu-Yan] Harbin Univ Sci & Technol, Sch Mat Sci & Engn, Harbin, Peoples R China	Harbin University of Science & Technology	Xu, HY (corresponding author), Harbin Univ Sci & Technol, Sch Mat Sci & Engn, Harbin, Peoples R China.	xhy7587@aliyun.com	Xu, Huanyan/AAJ-7138-2020	Xu, Huanyan/0000-0003-4895-5853	Natural Science Foundation of Heilongjiang Province [E2015065]; Program for New Century Excellent Talents in Heilongjiang Provincial Universities [1253-NCET-010]; National Natural Science Foundation of China [51404083, 21273060]	Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); Program for New Century Excellent Talents in Heilongjiang Provincial Universities(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of Heilongjiang Province (grant number E2015065, http://219.147.168.104/Kjpt/platform/login.htm), the Program for New Century Excellent Talents in Heilongjiang Provincial Universities, (grant number 1253-NCET-010, http://www.hlje.net/), and the National Natural Science Foundation of China (grant numbers 51404083 and 21273060, http://www.nsfc.gov.cn/). This work was financially supported by these funders, including study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai ZH, 2011, J PHYS CHEM C, V115, P25330, DOI 10.1021/jp206808g; Ajmal A, 2014, RSC ADV, V4, P37003, DOI 10.1039/c4ra06658h; Akpan UG, 2009, J HAZARD MATER, V170, P520, DOI 10.1016/j.jhazmat.2009.05.039; Bai XJ, 2012, SCI ADV MATER, V4, P1007, DOI 10.1166/sam.2012.1385; Bojdys MJ, 2008, CHEM-EUR J, V14, P8177, DOI 10.1002/chem.200800190; Bu YY, 2013, ELECTROCHIM ACTA, V88, P294, DOI 10.1016/j.electacta.2012.10.049; Cao SW, 2014, APPL SURF SCI, V319, P344, DOI 10.1016/j.apsusc.2014.04.094; Cao SW, 2015, ADV MATER, V27, P2150, DOI 10.1002/adma.201500033; Cao SW, 2014, J PHYS CHEM LETT, V5, P2101, DOI 10.1021/jz500546b; Chen LC, 2013, NANOSCALE, V5, P225, DOI 10.1039/c2nr32248j; Cheng CM, 2013, ANAL CHEM, V85, P2601, DOI 10.1021/ac303263n; Cui YJ, 2012, CATAL SCI TECHNOL, V2, P1396, DOI 10.1039/c2cy20036h; Cui YJ, 2012, PHYS CHEM CHEM PHYS, V14, P1455, DOI 10.1039/c1cp22820j; Deifallah M, 2008, J PHYS CHEM C, V112, P5447, DOI 10.1021/jp711483t; Dong F, 2012, CATAL SCI TECHNOL, V2, P1332, DOI 10.1039/c2cy20049j; Dong F, 2011, J MATER CHEM, V21, P15171, DOI 10.1039/c1jm12844b; Fukugaichi S, 2013, CATAL LETT, V143, P1255, DOI 10.1007/s10562-013-1119-y; Ge L, 2011, MATER LETT, V65, P2652, DOI 10.1016/j.matlet.2011.05.069; Ge M, 2012, IND ENG CHEM RES, V51, P5167, DOI 10.1021/ie202864n; Gong JY, 2013, CATAL COMMUN, V36, P89, DOI 10.1016/j.catcom.2013.03.009; Gong YT, 2015, CHEMSUSCHEM, V8, P931, DOI 10.1002/cssc.201403287; Groenewolt M, 2005, ADV MATER, V17, P1789, DOI 10.1002/adma.200401756; Higashi M, 2012, J AM CHEM SOC, V134, P6968, DOI 10.1021/ja302059g; Huynh MHV, 2005, ANGEW CHEM INT EDIT, V44, P737, DOI 10.1002/anie.200461758; Ji HH, 2013, CHEM ENG J, V218, P183, DOI 10.1016/j.cej.2012.12.033; Jiang R, 2010, J CENT SOUTH UNIV T, V17, P1223, DOI 10.1007/s11771-010-0623-0; Li C, 2004, MAT SCI ENG B-SOLID, V106, P308, DOI 10.1016/j.mseb.2003.10.006; Li XF, 2009, APPL PHYS A-MATER, V94, P387, DOI 10.1007/s00339-008-4816-4; Liu C, 2013, ACS APPL MATER INTER, V5, P3824, DOI 10.1021/am4004733; Liu FZ, 2013, J PHYS CHEM C, V117, P12218, DOI 10.1021/jp403478q; Liu JH, 2011, J MATER CHEM, V21, P14398, DOI 10.1039/c1jm12620b; Liu Q, 2013, LANGMUIR, V29, P3821, DOI 10.1021/la400003h; Luo M, 2012, ACS APPL MATER INTER, V4, P1813, DOI 10.1021/am3000903; Maeda K, 2009, J PHYS CHEM C, V113, P4940, DOI 10.1021/jp809119m; Nasir M, 2013, J PHYS CHEM C, V117, P9520, DOI 10.1021/jp402575w; Rioja N, 2014, ENVIRON SCI POLLUT R, V21, P11168, DOI 10.1007/s11356-014-2593-5; Shalom M, 2013, J AM CHEM SOC, V135, P7118, DOI 10.1021/ja402521s; Shen CC, 2015, J COLLOID INTERF SCI, V456, P7, DOI 10.1016/j.jcis.2015.06.004; Song LM, 2012, CHEM ENG J, V184, P256, DOI 10.1016/j.cej.2012.01.053; Thomas A, 2008, J MATER CHEM, V18, P4893, DOI 10.1039/b800274f; Wang CC, 2008, DYES PIGMENTS, V76, P817, DOI 10.1016/j.dyepig.2007.02.004; Wang Y, 2011, CHEM SCI, V2, P446, DOI 10.1039/c0sc00475h; Wang Y, 2010, CHEM MATER, V22, P5119, DOI 10.1021/cm1019102; Wang Y, 2010, ANGEW CHEM INT EDIT, V49, P3356, DOI 10.1002/anie.201000120; Wang YJ, 2012, CATAL COMMUN, V18, P161, DOI 10.1016/j.catcom.2011.12.011; Wang YN, 2011, J PHYS CHEM C, V115, P14300, DOI 10.1021/jp2042069; Wu XT, 2015, MAT SCI SEMICON PROC, V32, P76, DOI 10.1016/j.mssp.2014.11.047; Xin G, 2013, J PHYS CHEM SOLIDS, V74, P286, DOI 10.1016/j.jpcs.2012.09.021; Xu BH, 2012, MICROPOR MESOPOR MAT, V147, P79, DOI 10.1016/j.micromeso.2011.06.003; Xu HY, 2014, ENVIRON SCI POLLUT R, V21, P1582, DOI 10.1007/s11356-013-2059-1; Xu HY, 2010, J HAZARD MATER, V175, P658, DOI 10.1016/j.jhazmat.2009.10.059; Xue G, 2011, J HAZARD MATER, V186, P765, DOI 10.1016/j.jhazmat.2010.11.063; Yan SC, 2010, LANGMUIR, V26, P3894, DOI 10.1021/la904023j; Yan SC, 2009, LANGMUIR, V25, P10397, DOI 10.1021/la900923z; Ye S, 2015, APPL SURF SCI, V358, P15, DOI 10.1016/j.apsusc.2015.08.173; Yuan B, 2013, APPL SURF SCI, V280, P523, DOI 10.1016/j.apsusc.2013.05.021; Zhang GG, 2012, J MATER CHEM, V22, P8083, DOI 10.1039/c2jm00097k; Zhang JS, 2010, ANGEW CHEM INT EDIT, V49, P441, DOI 10.1002/anie.200903886; Zhao HZ, 2005, MAT SCI ENG B-SOLID, V122, P90, DOI 10.1016/j.mseb.2005.05.007; Zheng Y, 2012, ENERG ENVIRON SCI, V5, P6717, DOI 10.1039/c2ee03479d; Zhong JB, 2015, MAT SCI SEMICON PROC, V40, P508, DOI 10.1016/j.mssp.2015.06.025; Zhong YJ, 2014, APPL SURF SCI, V295, P253, DOI 10.1016/j.apsusc.2014.01.008; Zhou XS, 2013, MATER RES BULL, V48, P1447, DOI 10.1016/j.materresbull.2012.12.038; Zhu BC, 2015, APPL SURF SCI, V344, P188, DOI 10.1016/j.apsusc.2015.03.086; Zhu JJ, 2014, ACS APPL MATER INTER, V6, P16449, DOI 10.1021/am502925j; Zhu Q, 2013, J PHYS CHEM C, V117, P5894, DOI 10.1021/jp400842r	66	28	28	3	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142616	10.1371/journal.pone.0142616	http://dx.doi.org/10.1371/journal.pone.0142616			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26565712	Green Submitted, gold, Green Published			2022-12-26	WOS:000367628500040
J	Chida, N; Ansari, Z; Hussain, H; Jaswal, M; Symes, S; Khan, AJ; Mohammed, S				Chida, Natasha; Ansari, Zara; Hussain, Hamidah; Jaswal, Maria; Symes, Stephen; Khan, Aamir J.; Mohammed, Shama			Determinants of Default from Tuberculosis Treatment among Patients with Drug-Susceptible Tuberculosis in Karachi, Pakistan: A Mixed Methods Study	PLOS ONE			English	Article							DIRECTLY OBSERVED THERAPY; URBAN PAKISTAN; ADHERENCE; GENDER; BANGLADESH; ATTITUDES; SUCCESS; COHORT; MALAWI; INDIA	Purpose Non-adherence to tuberculosis therapy can lead to drug resistance, prolonged infectiousness, and death; therefore, understanding what causes treatment default is important. Pakistan has one of the highest burdens of tuberculosis in the world, yet there have been no qualitative studies in Pakistan that have specifically examined why default occurs. We conducted a mixed methods study at a tuberculosis clinic in Karachi to understand why patients with drug-susceptible tuberculosis default from treatment, and to identify factors associated with default. Patients attending this clinic pick up medications weekly and undergo family-supported directly observed therapy. Methods In-depth interviews were administered to 21 patients who had defaulted. We also compared patients who defaulted with those who were cured, had completed, or had failed treatment in 2013. Results Qualitative analyses showed the most common reasons for default were the financial burden of treatment, and medication side effects and beliefs. The influence of finances on other causes of default was also prominent, as was concern about the effect of treatment on family members. In quantitative analysis, of 2120 patients, 301 (14.2%) defaulted. Univariate analysis found that male gender (OR: 1.34, 95% CI: 1.04-1.71), being 35-59 years of age (OR: 1.54, 95% CI: 1.14-2.08), or being 60 years of age or older (OR: 1.84, 95% CI: 1.17-2.88) were associated with default. After adjusting for gender, disease site, and patient category, being 35-59 years of age (aOR: 1.49, 95% CI: 1.10-2.03) or 60 years of age or older (aOR: 1.76, 95% CI: 1.12-2.77) were associated with default. Conclusions In multivariate analysis age was the only variable associated with default. This lack of identifiable risk factors and our qualitative findings imply that default is complex and often due to extrinsic and medication-related factors. More tolerable medications, improved side effect management, and innovative cost-reduction measures are needed to reduce default from tuberculosis treatment.	[Chida, Natasha; Symes, Stephen] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Jay Weiss Inst Hlth Equ, Miami, FL 33136 USA; [Chida, Natasha] Johns Hopkins Univ, Sch Med, Dept Internal Med, Div Infect Dis, Baltimore, MD USA; [Ansari, Zara; Khan, Aamir J.; Mohammed, Shama] Interact Res & Dev, Karachi, Sindh, Pakistan; [Hussain, Hamidah; Jaswal, Maria; Khan, Aamir J.] Indus Hosp, Res Ctr, Karachi, Sindh, Pakistan	University of Miami; Johns Hopkins University	Chida, N (corresponding author), Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Jay Weiss Inst Hlth Equ, Miami, FL 33136 USA.	nchida1@jhmi.edu		Hussain, Hamidah/0000-0002-6585-9815	Jay Weiss Institute for Health Equity at Sylvester Comprehensive Cancer Center, at the University of Miami Miller School of Medicine; Social Medicine and Health Equity Internal Medicine Resident at the University of Miami Miller School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007291] Funding Source: NIH RePORTER	Jay Weiss Institute for Health Equity at Sylvester Comprehensive Cancer Center, at the University of Miami Miller School of Medicine; Social Medicine and Health Equity Internal Medicine Resident at the University of Miami Miller School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by an internal grant from the Jay Weiss Institute for Health Equity at Sylvester Comprehensive Cancer Center, at the University of Miami Miller School of Medicine. NC received funding as a Social Medicine and Health Equity Internal Medicine Resident at the University of Miami Miller School of Medicine. There is no grant number for this internal award. The Jay Weiss Institute had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funder's url: http://sylvester.org/jw.	Akhtar S, 2011, INT J TUBERC LUNG D, V15, P90; Alam Ashar, 2014, BMC Res Notes, V7, P179, DOI 10.1186/1756-0500-7-179; Bam TS, 2006, INT J TUBERC LUNG D, V10, P270; Brasil Pedro Emmanuel Alvarenga Americano do, 2008, Cad. Saúde Pública, V24, ps485, DOI 10.1590/S0102-311X2008001600003; Chang SH, 2014, INT J TUBERC LUNG D, V18, P168, DOI 10.5588/ijtld.13.0181; Eastwood SV, 2004, INT J TUBERC LUNG D, V8, P70; El-Din MN, 2013, E MEDITERR HEALTH J, V19; Gosoniu GD, 2008, INT J TUBERC LUNG D, V12, P848; Hasker E, 2010, INT J TUBERC LUNG D, V14, P1132; Jaggarajamma K, 2007, Indian J Tuberc, V54, P130; Johansson E, 1999, INT J TUBERC LUNG D, V3, P862; Khan A, 2000, SOC SCI MED, V50, P247, DOI 10.1016/S0277-9536(99)00279-8; Khan AJ, 2012, LANCET INFECT DIS, V12, P608, DOI 10.1016/S1473-3099(12)70116-0; Khan MA, 2005, HEALTH POLICY PLANN, V20, P354, DOI 10.1093/heapol/czi047; Khan MS, 2011, SE ASIAN J TROP MED, V42, P664; Krueger K, 2010, INT J TUBERC LUNG D, V14, P779; Liamputtong P., 2013, QUALITATIVE RES METH; Liefooghe R., 2001, JPMA Journal of the Pakistan Medical Association, V51, P3; Liefooghe R, 1995, SOC SCI MED, V41, P1685, DOI 10.1016/0277-9536(95)00129-U; Metzger P, 2010, East Mediterr Health J, V16 Suppl, pS47; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Muture BN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-696; Naqvi SA, 2012, INT J TUBERC LUNG D, V16, P817, DOI 10.5588/ijtld.11.0440; Noyes J, 2007, J ADV NURS, V57, P227, DOI 10.1111/j.1365-2648.2006.04092.x; Okanurak K, 2008, INT J TUBERC LUNG D, V12, P1160; Resende LSO, 2015, J BRAS PNEUMOL, V41, P77, DOI [10.1590/s1806-37132015000100010, 10.1590/S1806-37132015000100010]; Pakistan Bureau of Statistics, 2015, LAB FORC SURV 2013 2; Pakistan National Tuberculosis Control Program, 2015, NAT GUID CONTR TUB P; Pethani A, 2013, ASIA PAC J PUBLIC HL; Sturges JE., 2004, QUAL RES, V4, P107, DOI [DOI 10.1177/1468794104041110, 10.1177/1468794104041110]; Tachfouti N, 2013, PAN AFR MED J, V14, DOI 10.11604/pamj.2013.14.121.2335; Weiss MG, 2008, INT J TUBERC LUNG D, V12, P837; WHO, 2014, GLOB TUB REP 2014	33	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142384	10.1371/journal.pone.0142384	http://dx.doi.org/10.1371/journal.pone.0142384			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7UL	26562787	gold, Green Published, Green Submitted			2022-12-26	WOS:000364480900029
J	Heneberg, P; Riegerova, K; Kucera, P				Heneberg, Petr; Riegerova, Kamila; Kucera, Petr			Pimecrolimus Is a Potent Inhibitor of Allergic Reactions to Hymenopteran Venom Extracts and Birch Pollen Allergen In Vitro	PLOS ONE			English	Article							BASOPHIL ACTIVATION TEST; SDZ ASM 981; MAST-CELLS; 1-PERCENT PIMECROLIMUS; ATOPIC-DERMATITIS; EXPRESSION; RELEASE; EPIDEMIOLOGY; SENSITIVITY; POPULATION	Pimecrolimus (Elidel, SDZ ASM 981) is an anti-inflammatory and immunomodulatory 33-epichloro- derivative of macrolactam ascomycin, with low potential for affecting systemic immune responses compared with other calcineurin inhibitors, cyclosporin A and tacrolimus. Despite numerous studies focused on the mechanism of pimecrolimus action on mast cells, only the single report has addressed pimecrolimus effects on other typical Fc epsilon RI-expressing cells, the basophils. Patients allergic to birch pollen (n = 20), hymenopteran venoms (n = 23) and 10 non-allergic volunteers were examined. Primary human basophils pretreated or not with 0.5-50 mu Mol pimecrolimus were exposed to various concentrations of recombinant Bet v 1a allergen, bee or wasp venom extracts and anti-IgE for 20 min, and then examined for the expression of CD45, CD193, CD203c, CD63 and CD164 using flow cytometry. The externalization of basophil activation markers (CD63 and CD164) was equally inhibited through pimecrolimus in cells activated by recombinant pollen allergen, hymenopteran venom extracts and anti-IgE. Although the individual response rate was subject to strong variation, importantly, pre-treatment with pimecrolimus lowered the number of activated basophils in response to any of the stimuli in the basophils from all patients. The inhibition was concentration-dependent; approximately half of the basophils were inhibited in the presence of 2.5 mMol pimecrolimus. Pimecrolimus is a valuable new tool for the inhibition of hyper-reactive basophils in patients with pollen allergy and a history of anaphylactic reactions to bee or wasp venoms. Further research should address short-term use of pimecrolimus in vivo in a wide spectrum of allergic diseases.	[Heneberg, Petr] Charles Univ Prague, Fac Med 3, Dept Internal Med 2, Prague, Czech Republic; [Riegerova, Kamila; Kucera, Petr] Charles Univ Prague, Dept Immunol, Fac Med 3, Prague, Czech Republic	Charles University Prague; Charles University Prague	Heneberg, P (corresponding author), Charles Univ Prague, Fac Med 3, Dept Internal Med 2, Prague, Czech Republic.	petr.heneberg@lf3.cuni.cz	Heneberg, Petr/C-1881-2012	Heneberg, Petr/0000-0002-0703-951X	Czech Health Research Council [15-32432A]	Czech Health Research Council	This study was supported by the Czech Health Research Council AZV project 15-32432A. Pimecrolimus was kindly provided by MEDA Pharma GmbH & Co. KG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbes SJ, 2005, J ALLERGY CLIN IMMUN, V116, P377, DOI 10.1016/j.jaci.2005.05.017; Arellano FM, 2007, J INVEST DERMATOL, V127, P808, DOI 10.1038/sj.jid.5700622; Bilo BM, 2005, ALLERGY, V60, P1339, DOI 10.1111/j.1398-9995.2005.00963.x; Chirumbolo S, 2011, CYTOM PART A, V79A, P102, DOI 10.1002/cyto.a.21008; Chirumbolo S, 2012, INT ARCH ALLERGY IMM, V158, P99, DOI 10.1159/000331312; Compton SJ, 1998, J IMMUNOL, V161, P1939; D'Amato G, 2007, ALLERGY, V62, P976, DOI 10.1111/j.1398-9995.2007.01393.x; Doelker L, 2006, EXP DERMATOL, V15, P342, DOI 10.1111/j.0906-6705.2006.00413.x; Eriksson NE, 1996, J INVEST ALLERG CLIN, V6, P36; Fernandez J, 1999, CLIN EXP ALLERGY, V29, P1069, DOI 10.1046/j.1365-2222.1999.00614.x; GOLDEN DBK, 1989, JAMA-J AM MED ASSOC, V262, P240, DOI 10.1001/jama.262.2.240; Grassberger M, 1999, BRIT J DERMATOL, V141, P264; Grattan CEH, 2000, BRIT J DERMATOL, V143, P365, DOI 10.1046/j.1365-2133.2000.03664.x; Gupta R, 2004, CLIN EXP ALLERGY, V34, P520, DOI 10.1111/j.1365-2222.2004.1935.x; Hausmann OV, 2011, ALLERGY, V66, P85, DOI 10.1111/j.1398-9995.2010.02431.x; Hauswirth AW, 2002, J ALLERGY CLIN IMMUN, V110, P102, DOI 10.1067/mai.2002.125257; HERBERT FA, 1982, ANN ALLERGY, V48, P12; Hultsch T, 1998, ARCH DERMATOL RES, V290, P501, DOI 10.1007/s004030050343; Kalthoff ES, 2003, CLIN EXP IMMUNOL, V133, P350, DOI 10.1046/j.1365-2249.2003.02225.x; KNOL EF, 1991, J ALLERGY CLIN IMMUN, V88, P328, DOI 10.1016/0091-6749(91)90094-5; Lerche CM, 2009, EXP DERMATOL, V18, P246, DOI 10.1111/j.1600-0625.2008.00812.x; Luger T, 2015, PEDIAT ALLERG IMM-UK, V26, P306, DOI 10.1111/pai.12331; Ma ZC, 2010, INT ARCH ALLERGY IMM, V153, P413, DOI 10.1159/000316353; Moneret-Vautrin DA, 2005, ALLERGY, V60, P443, DOI 10.1111/j.1398-9995.2005.00785.x; Monneret G, 2010, CLIN EXP ALLERGY, V40, P953, DOI 10.1111/j.1365-2222.2010.03516.x; Sakai Manabu, 2004, Journal of Medical Investigation, V51, P63, DOI 10.2152/jmi.51.63; SETTIPANE GA, 1970, ACTA ALLERGOL, V25, P286, DOI 10.1111/j.1398-9995.1970.tb01264.x; Stuetz A, 2001, SEMIN CUTAN MED SURG, V20, P233, DOI 10.1053/sder.2001.29066; Sturm GJ, 2009, ALLERGY, V64, P1319, DOI 10.1111/j.1398-9995.2009.02004.x; Weissenbacher S, 2006, INT ARCH ALLERGY IMM, V140, P239, DOI 10.1159/000093249; Wolanczyk-Medrala A, 2011, CURR PHARM DESIGN, V17, P3786, DOI 10.2174/138161211798357890; Wolanczyk-Medrala A, 2010, ARCH IMMUNOL THER EX, V58, P459, DOI 10.1007/s00005-010-0104-z; Zuberbier T, 2001, J ALLERGY CLIN IMMUN, V108, P275, DOI 10.1067/mai.2001.116865	33	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142953	10.1371/journal.pone.0142953	http://dx.doi.org/10.1371/journal.pone.0142953			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562153	Green Submitted, gold, Green Published			2022-12-26	WOS:000364480900087
J	Waghmode, TR; Haque, MM; Kim, SY; Kim, PJ				Waghmode, Tatoba R.; Haque, Md Mozammel; Kim, Sang Yoon; Kim, Pil Joo			Effective Suppression of Methane Emission by 2-Bromoethanesulfonate during Rice Cultivation	PLOS ONE			English	Article							COENZYME-M; MCRA GENE; SOIL; METHANOGENESIS; CH4; SPECIFICITY; BIOMASS; SYSTEM; FIELDS; GROWTH	2-bromoethanesulfonate (BES) is a structural analogue of coenzyme M (Co-M) and potent inhibitor of methanogenesis. Several studies confirmed, BES can inhibit CH4 prodcution in rice soil, but the suppressing effectiveness of BES application on CH4 emission under rice cultivation has not been studied. In this pot experiment, different levels of BES (0, 20, 40 and 80 mg kg(-1)) were applied to study its effect on CH4 emission and plant growth during rice cultivation. Application of BES effectively suppressed CH4 emission when compared with control soil during rice cultivation. The CH4 emission rates were significantly (P<0.001) decreased by BES application possibly due to significant (P<0.001) reduction of methnaogenic biomarkers like Co-M concentration and mcrA gene copy number (i.e. methanogenic abunadance). BES significantly (P<0.001) reduced methanogen activity, while it did not affect soil dehydrogenase activity during rice cultivation. A rice plant growth and yield parameters were not affected by BES application. The maximum CH4 reduction (49% reduction over control) was found at 80 mg kg(-1) BES application during rice cultivation. It is, therefore, concluded that BES could be a suitable soil amendment for reducing CH4 emission without affecting rice plant growth and productivity during rice cultivation.	[Waghmode, Tatoba R.; Haque, Md Mozammel; Kim, Pil Joo] Gyeongsang Natl Univ, Div Appl Life Sci, BK PLUS Program 21, Jinju 660701, South Korea; [Kim, Sang Yoon] Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, Wageningen, Netherlands; [Kim, Pil Joo] Gyeongsang Natl Univ, Inst Agr & Life Sci, Jinju 660701, South Korea	Gyeongsang National University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Gyeongsang National University	Kim, PJ (corresponding author), Gyeongsang Natl Univ, Div Appl Life Sci, BK PLUS Program 21, Jinju 660701, South Korea.	pjkim@gnu.ac.kr	Haque, Mozammel/ABC-5214-2020; KNAW, NIOO-KNAW/A-4320-2012; Kim, Sang Yoon/O-3332-2014	Kim, Pil Joo/0000-0003-1192-4324; KNAW, NIOO-KNAW/0000-0002-3835-159X; Kim, Sang Yoon/0000-0003-4914-3080	BK21 PLUS program of Ministry of Education and Human Resources Development, South Korea; Rural Development Administration (RDA), Republic of Korea; "Cooperative Research Program for Agriculture Science & Technology Development" Rural Development Administration, Republic of Korea [PJ009980032015]	BK21 PLUS program of Ministry of Education and Human Resources Development, South Korea(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Rural Development Administration (RDA), Republic of Korea(Rural Development Administration (RDA), Republic of Korea); "Cooperative Research Program for Agriculture Science & Technology Development" Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	Dr. Tatoba R. Waghmode was financially supported by a postdoctoral fellowship from the BK21 PLUS program of Ministry of Education and Human Resources Development, South Korea. This work was supported by the Rural Development Administration (RDA), Republic of Korea (Project tile: Development of CO2 emission factor caused by use of urea and lime according to 2006 new guideline). This work was carried out with the support of "Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ009980032015)" Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison L.E., 1965, METHODS SOIL ANAL PA, P1367, DOI DOI 10.2134/AGRONMONOGR9.2.2ED.C39; Chidthaisong A, 2000, SOIL BIOL BIOCHEM, V32, P977, DOI 10.1016/S0038-0717(00)00006-7; CICERONE RJ, 1981, J GEOPHYS RES-OCEANS, V86, P7203, DOI 10.1029/JC086iC08p07203; Conrad R, 1996, MICROBIOL REV, V60, P609, DOI 10.1128/MMBR.60.4.609-640.1996; Daebeler A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053656; Elias DA, 1999, APPL ENVIRON MICROB, V65, P5541; GUNSALUS RP, 1978, BIOCHEMISTRY-US, V17, P2374, DOI 10.1021/bi00605a019; Gutierrez J, 2013, FIELD CROP RES, V146, P16, DOI 10.1016/j.fcr.2013.03.003; Itoh M, 2011, AGR ECOSYST ENVIRON, V141, P359, DOI 10.1016/j.agee.2011.03.019; KIENE RP, 1986, APPL ENVIRON MICROB, V52, P1037, DOI 10.1128/AEM.52.5.1037-1045.1986; Kim SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113593; KONISKY J, 1990, FEMS MICROBIOL ECOL, V73, P239, DOI 10.1016/0378-1097(90)90736-A; Lu YH, 2000, SOIL SCI SOC AM J, V64, P2011, DOI 10.2136/sssaj2000.6462011x; Luton PE, 2002, MICROBIOL-SGM, V148, P3521, DOI 10.1099/00221287-148-11-3521; Minoda T, 1996, J GEOPHYS RES-ATMOS, V101, P21091, DOI 10.1029/96JD01710; Morris R, 2014, MICROB BIOTECHNOL, V7, P77, DOI 10.1111/1751-7915.12094; Nozoe T, 1997, SOIL SCI PLANT NUTR, V43, P1, DOI 10.1080/00380768.1997.10414709; Pramanik P, 2013, CHEMOSPHERE, V90, P873, DOI 10.1016/j.chemosphere.2012.07.008; Pramanik P, 2013, SOIL BIOL BIOCHEM, V58, P159, DOI 10.1016/j.soilbio.2012.11.020; RDA, 1999, FERT STAND CROP PLAN, P148; RDA, 1995, STAND INV METH AGR E, P601; RDA (Rural Development Administration), 1988, METH SOIL CHEM AN; Rolston D.E., 1986, METHODS SOIL ANAL 1, P1103, DOI DOI 10.2136/SSSABOOKSER5.1.2ED.C47; Roy R, 1997, FEMS MICROBIOL ECOL, V24, P311, DOI 10.1111/j.1574-6941.1997.tb00448.x; Salazar S, 2011, ECOL ENG, V37, P1123, DOI 10.1016/j.ecoleng.2011.02.007; Sass RL, 1990, GLOBAL BIOGEOCHEM CY, V4, P47, DOI 10.1029/GB004i001p00047; Singh S, 1999, SOIL BIOL BIOCHEM, V31, P1219, DOI 10.1016/S0038-0717(99)00027-9; Solomon S., 2007, CLIMATE CHANGE 2007, P539; SPARLING R, 1987, CAN J MICROBIOL, V33, P1132, DOI 10.1139/m87-199; Steinberg LM, 2009, APPL ENVIRON MICROB, V75, P4435, DOI 10.1128/AEM.02858-08; Tabatabai M. A., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P903; United States Department of Agriculture (USDA), 2010, KEYS SOIL TAX, P1; van den Pol-van Dasselaar A, 1999, SOIL BIOL BIOCHEM, V31, P877, DOI 10.1016/S0038-0717(98)00188-6; Vogels G.D., 1988, BIOL ANAEROBIC MICRO, P707; Yang SS, 1998, AGR ECOSYST ENVIRON, V69, P69, DOI 10.1016/S0167-8809(98)00098-X; Yuan BC, 2012, PEDOSPHERE, V22, P1, DOI 10.1016/S1002-0160(11)60186-0; Zhou ZM, 2011, APPL ENVIRON MICROB, V77, P2634, DOI 10.1128/AEM.02779-10	37	8	8	5	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142569	10.1371/journal.pone.0142569	http://dx.doi.org/10.1371/journal.pone.0142569			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562416	gold, Green Submitted, Green Published			2022-12-26	WOS:000364480900044
J	Kimura, K; Okuda, S; Nakayama, K; Shikata, T; Takahashi, F; Yamaguchi, H; Skamoto, S; Yamaguchi, M; Tomaru, Y				Kimura, Kei; Okuda, Shujiro; Nakayama, Kei; Shikata, Tomoyuki; Takahashi, Fumio; Yamaguchi, Haruo; Skamoto, Setsuko; Yamaguchi, Mineo; Tomaru, Yuji			RNA Sequencing Revealed Numerous Polyketide Synthase Genes in the Harmful Dinoflagellate Karenia mikimotoi	PLOS ONE			English	Article							SAXITOXIN BIOSYNTHESIS; TRANSCRIPTOME; POLYETHER; EVOLUTION; GROWTH; EXPRESSION; ALIGNMENT; PIPELINE	The dinoflagellate Karenia mikimotoi forms blooms in the coastal waters of temperate regions and occasionally causes massive fish and invertebrate mortality. This study aimed to elucidate the toxic effect of K. mikimotoi on marine organisms by using the genomics approach; RNA-sequence libraries were constructed, and data were analyzed to identify toxin-related genes. Next-generation sequencing produced 153,406 transcript contigs from the axenic culture of K. mikimotoi. BLASTX analysis against all assembled contigs revealed that 208 contigs were polyketide synthase (PKS) sequences. Thus, K. mikimotoi was thought to have several genes encoding PKS metabolites and to likely produce toxin-like polyketide molecules. Of all the sequences, approximately 30 encoded eight PKS genes, which were remarkably similar to those of Karenia brevis. Our phylogenetic analyses showed that these genes belonged to a new group of PKS type-I genes. Phylogenetic and active domain analyses showed that the amino acid sequence of four among eight Karenia PKS genes was not similar to any of the reported PKS genes. These PKS genes might possibly be associated with the synthesis of polyketide toxins produced by Karenia species. Further, a homology search revealed 10 contigs that were similar to a toxin gene responsible for the synthesis of saxitoxin (sxtA) in the toxic dinoflagellate Alexandrium fundyense. These contigs encoded A1-A3 domains of sxtA genes. Thus, this study identified some transcripts in K. mikimotoi that might be associated with several putative toxin-related genes. The findings of this study might help understand the mechanism of toxicity of K. mikimotoi and other dinoflagellates.	[Kimura, Kei; Shikata, Tomoyuki; Skamoto, Setsuko; Yamaguchi, Mineo; Tomaru, Yuji] Fisheries Res Agcy, Natl Res Inst Fisheries & Environm Inland Sea, Hiroshima, Japan; [Kimura, Kei] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan; [Okuda, Shujiro] Niigata Univ, Grad Sch Med & Dent Sci, Chuo Ku, Niigata, Japan; [Nakayama, Kei] Ehime Univ, Ctr Marine Environm Studies, Matsuyama, Ehime, Japan; [Takahashi, Fumio] Rhitsumeikan Univ, Coll Life Sci, Dept Biotechnol, Shiga, Japan; [Yamaguchi, Haruo] Kochi Univ, Fac Agr, Lab Aquat Environm Sci, Nankoku, Kochi 783, Japan	Japan Fisheries Research & Education Agency (FRA); Japan Society for the Promotion of Science; Niigata University; Ehime University; Kochi University	Kimura, K (corresponding author), Saga Univ, Inst Lowland & Marine Res, Ariake Sea Res Project, Honjo Machi 1, Saga, Japan.	kimurak@cc.saga-u.ac.jp; tomaruy@affrc.go.jp	Nakayama, Kei/AAE-2815-2021; Nakayama, Kei/A-2337-2013; Okuda, Shujiro/D-1700-2016	Nakayama, Kei/0000-0002-0247-757X; Okuda, Shujiro/0000-0002-7704-8104	Japan Society for the Promotion of Science [26660155]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by Research Fellowships for Young Scientists and KAKENHI Grants Number 26660155 from the Japan Society for the Promotion of Science.	Acland A, 2014, NUCLEIC ACIDS RES, V42, pD7, DOI 10.1093/nar/gkt1146; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BADEN DG, 1989, FASEB J, V3, P1807, DOI 10.1096/fasebj.3.7.2565840; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; CHEN LCM, 1969, J PHYCOL, V5, P211, DOI 10.1111/j.1529-8817.1969.tb02605.x; DAHL E, 1993, DEV MAR BIO, V3, P15; Davidson K, 2009, HARMFUL ALGAE, V8, P349, DOI 10.1016/j.hal.2008.07.007; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Eichholz K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048624; Gentien P, 2007, PHILOS T R SOC B, V362, P1937, DOI 10.1098/rstb.2007.2079; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Hackett JD, 2013, MOL BIOL EVOL, V30, P70, DOI 10.1093/molbev/mss142; Hallegraeff G. M., 1995, MANUAL HARMFUL MARIN, V33, P1; Hodgkiss I, 2000, HARMFUL ALGAL BLOOMS, V62, P65; HONJO T, 1990, TOXIC MARINE PHYTOPLANKTON, P165; Imai I, 1996, FISHERIES SCI, V62, P834, DOI 10.2331/fishsci.62.834; Imai Ichiro, 1994, Bulletin of Japanese Society of Microbial Ecology, V9, P15; ISHIDA Y, 1986, MAR ECOL PROG SER, V30, P197, DOI 10.3354/meps030197; Johnson JG, 2012, MAR GENOM, V5, P15, DOI 10.1016/j.margen.2011.08.005; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kellmann R, 2008, APPL ENVIRON MICROB, V74, P4044, DOI 10.1128/AEM.00353-08; Kellmann R, 2010, MAR DRUGS, V8, P1011, DOI 10.3390/md8041011; Kohli GS, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1625-y; Lam C.W.Y., 1989, P49; LINDAHL O, 1983, MAR BIOL, V77, P143, DOI 10.1007/BF00396311; Lopez-Legentil S, 2010, MAR BIOTECHNOL, V12, P32, DOI 10.1007/s10126-009-9197-y; Lu SH, 2004, HYDROBIOLOGIA, V512, P231, DOI 10.1023/B:HYDR.0000020331.75003.18; Martin J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-663; McEwan M, 2008, J EUKARYOT MICROBIOL, V55, P530, DOI 10.1111/j.1550-7408.2008.00357.x; Meyer JM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1205-6; Monroe EA, 2008, PROTIST, V159, P471, DOI 10.1016/j.protis.2008.02.004; Mooney BD, 2007, J PHYCOL, V43, P101, DOI 10.1111/j.1529-8817.2006.00312.x; Morey JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066347; Moustafa A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009688; Murray SA, 2015, MOL PHYLOGENET EVOL, V92, P165, DOI 10.1016/j.ympev.2015.06.017; Murray SA, 2011, MOL BIOL EVOL, V28, P1173, DOI 10.1093/molbev/msq295; Orr RJS, 2013, MAR DRUGS, V11, P2814, DOI 10.3390/md11082814; Orr RJS, 2013, APPL ENVIRON MICROB, V79, P2128, DOI 10.1128/AEM.03279-12; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Pawlowiez R, 2014, HARMFUL ALGAE, V36, P29, DOI 10.1016/j.hal.2014.04.013; PROVASOLI L, 1959, ANN NY ACAD SCI, V77, P250, DOI 10.1111/j.1749-6632.1959.tb36905.x; Raine R, 2001, HYDROBIOLOGIA, V465, P187, DOI 10.1023/A:1014524420705; Ryan DE, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-888; Salcedo T, 2012, MOL BIOL EVOL, V29, P1503, DOI 10.1093/molbev/mss007; Satake M, 2005, TETRAHEDRON LETT, V46, P3537, DOI 10.1016/j.tetlet.2005.03.115; Satake M, 2002, TETRAHEDRON LETT, V43, P5829, DOI 10.1016/S0040-4039(02)01171-1; Setonaikai-Fisheries-Coordination-Office, 2014, RED TID SET INL SEA, P64; Shen B, 2003, CURR OPIN CHEM BIOL, V7, P285, DOI 10.1016/S1367-5931(03)00020-6; Shikata T, 2011, NIPPON SUISAN GAKK, V77, P40, DOI 10.2331/suisan.77.40; Snyder RV, 2005, PHYTOCHEMISTRY, V66, P1767, DOI 10.1016/j.phytochem.2005.06.010; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Stuken A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020096; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wisecaver JH, 2011, ANNU REV MICROBIOL, V65, P369, DOI 10.1146/annurev-micro-090110-102841; Yang I, 2011, HARMFUL ALGAE, V12, P55, DOI 10.1016/j.hal.2011.08.012; YASUMOTO T, 1990, TOXIC MARINE PHYTOPLANKTON, P436; Zou YN, 2010, HARMFUL ALGAE, V9, P367, DOI 10.1016/j.hal.2010.01.005	58	24	24	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142731	10.1371/journal.pone.0142731	http://dx.doi.org/10.1371/journal.pone.0142731			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26561394	Green Published, gold, Green Submitted			2022-12-26	WOS:000364433100117
J	Meier, SM; Petersen, L; Schendel, DE; Mattheisen, M; Mortensen, PB; Mors, O				Meier, Sandra M.; Petersen, Liselotte; Schendel, Diana E.; Mattheisen, Manuel; Mortensen, Preben B.; Mors, Ole			Obsessive-Compulsive Disorder and Autism Spectrum Disorders: Longitudinal and Offspring Risk	PLOS ONE			English	Article							ANXIETY DISORDERS; NEUROPSYCHIATRIC DISORDERS; PSYCHIATRIC MORBIDITY; REPETITIVE BEHAVIORS; SYMPTOM DIMENSIONS; PATERNAL-AGE; DE-NOVO; ADOLESCENTS; CHILDREN; POPULATION	Background Despite substantial similarities and overlaps in the pathophysiology of obsessive-compulsive disorders (OCD) and autism spectrum disorders, little is known about the clinical and etiologic cohesion of these two disorders. We therefore aimed to determine the patterns of comorbidity, longitudinal risks, and shared familial risks between these disorders. Methods In a prospective study design we explored the effect of a prior diagnosis of OCD in patients and parents on the susceptibility to autism spectrum disorders and vice versa. Analyses were adjusted for sex, age, calendar year, parental age and place at residence at time of birth. As measures of relative risk incidence rate ratios (IRR) and accompanying 95% confidence intervals (CIs) were employed. Results The risk of a comorbid diagnosis of OCD in individuals with autism spectrum disorder and aggregation of autism spectrum disorders in offspring of parents with OCD were increased. Individuals first diagnosed with autism spectrum disorders had a 2-fold higher risk of a later diagnosis of OCD (IRR = 2.18, 95% CI = 1.91-2.48), whereas individuals diagnosed with OCD displayed a nearly 4-fold higher risk to be diagnosed with autism spectrum disorders (IRR = 3.91, 95% CI = 3.46-4.40) later in life. The observed associations were somewhat stronger for less severe types of autism spectrum disorders without a comorbid diagnosis of mental disabilities. Conclusions The high comorbidity, sequential risk, and shared familial risks between OCD and autism spectrum disorders are suggestive of partially shared etiological mechanisms. The results have implications for current gene-searching efforts and for clinical practice.	[Meier, Sandra M.; Petersen, Liselotte; Schendel, Diana E.; Mortensen, Preben B.] Aarhus Univ, Natl Ctr Register Based Res, DK-8000 Aarhus C, Denmark; [Schendel, Diana E.] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, DK-8000 Aarhus C, Denmark; [Mattheisen, Manuel] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark; [Mors, Ole] Aarhus Univ Hosp, Res Dept P, Risskov, Denmark; [Meier, Sandra M.; Petersen, Liselotte; Schendel, Diana E.; Mattheisen, Manuel; Mortensen, Preben B.; Mors, Ole] iPSYCH, Lundbeck Fdn Initiat Integrat Psychiat Res, Copenhagen, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH)	Meier, SM (corresponding author), Aarhus Univ, Natl Ctr Register Based Res, DK-8000 Aarhus C, Denmark.	smeier@ncrr.au.dk	Meier, Sandra/AAB-1242-2021; Mattheisen, Manuel/B-4949-2012; Mortensen, Preben B/D-2358-2015; Mattheisen, Manuel/S-3725-2019	Mattheisen, Manuel/0000-0002-8442-493X; Mortensen, Preben B/0000-0002-5230-9865; Mattheisen, Manuel/0000-0002-8442-493X; Schendel, Diana/0000-0002-8588-1227; Petersen, Liselotte Vogdrup/0000-0002-0479-5379; Mors, Ole/0000-0002-5660-0393	Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Stanley Medical Research Institute; Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH105500] Funding Source: NIH RePORTER	Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Stanley Medical Research Institute; Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH). Dr Mortensen received further funding from the Stanley Medical Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TF, 1999, DAN MED BULL, V46, P263; Anholt GE, 2010, J AUTISM DEV DISORD, V40, P580, DOI 10.1007/s10803-009-0922-1; [Anonymous], 2012, MORBIDITY MORTALITY, V61, P1; Atladottir HO, 2010, ARCH PEDIAT ADOL MED, V164, P470, DOI 10.1001/archpediatrics.2010.9; Bolton PF, 1998, PSYCHOL MED, V28, P385, DOI 10.1017/S0033291797006004; Brimacombe M, 2007, J CHILD NEUROL, V22, P593, DOI 10.1177/0883073807302609; Cadman T., 2015, AUTISM RES; Cadman T, 2012, J AM ACAD CHILD PSY, V51, P879, DOI 10.1016/j.jaac.2012.06.017; Carrasco M, 2012, PEDIATRICS, V129, pE1301, DOI 10.1542/peds.2011-3285; de Bruin EI, 2007, J AUTISM DEV DISORD, V37, P877, DOI 10.1007/s10803-006-0215-x; Dove D, 2012, PEDIATRICS, V130, P717, DOI 10.1542/peds.2012-0683; Fineberg NA, 2012, INT J NEUROPSYCHOPH, V15, P1173, DOI 10.1017/S1461145711001829; Frans EM, 2013, JAMA PSYCHIAT, V70, P516, DOI 10.1001/jamapsychiatry.2013.1180; Glasson EJ, 2004, ARCH GEN PSYCHIAT, V61, P618, DOI 10.1001/archpsyc.61.6.618; Gothelf D, 2008, J NEURAL TRANSM, V115, P929, DOI 10.1007/s00702-008-0037-4; Gross-Isseroff R, 2001, World J Biol Psychiatry, V2, P193; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Haznedar MM, 2006, AM J PSYCHIAT, V163, P1252, DOI 10.1176/appi.ajp.163.7.1252; Hollander E, 2012, AM J PSYCHIAT, V169, P292, DOI 10.1176/appi.ajp.2011.10050764; Huerta M, 2012, AM J PSYCHIAT, V169, P1056, DOI 10.1176/appi.ajp.2012.12020276; Hultman CM, 2011, MOL PSYCHIATR, V16, P1203, DOI 10.1038/mp.2010.121; Hurwitz R, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008372.pub2; Iervolino AC, 2011, ARCH GEN PSYCHIAT, V68, P637, DOI 10.1001/archgenpsychiatry.2011.54; Ivarsson T, 2008, J ANXIETY DISORD, V22, P969, DOI 10.1016/j.janxdis.2007.10.003; Knapp M, 2009, AUTISM, V13, P317, DOI 10.1177/1362361309104246; Koo MS, 2010, EXPERT REV NEUROTHER, V10, P275, DOI [10.1586/ern.09.148, 10.1586/ERN.09.148]; Langen M, 2007, BIOL PSYCHIAT, V62, P262, DOI 10.1016/j.biopsych.2006.09.040; Lauritsen MB, 2010, J AUTISM DEV DISORD, V40, P139, DOI 10.1007/s10803-009-0818-0; Leslie DL, 2008, J AM ACAD CHILD PSY, V47, P1166, DOI 10.1097/CHI.0b013e3181825a3d; Li XH, 2012, BRAIN RES BULL, V88, P543, DOI 10.1016/j.brainresbull.2012.05.017; Lichtenstein P, 2010, AM J PSYCHIAT, V167, P1357, DOI 10.1176/appi.ajp.2010.10020223; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; MacNeil BM, 2009, RES AUTISM SPECT DIS, V3, P1, DOI 10.1016/j.rasd.2008.06.001; Mataix-Cols D, 2013, JAMA PSYCHIAT, V70, P709, DOI 10.1001/jamapsychiatry.2013.3; MCDOUGLE CJ, 1995, AM J PSYCHIAT, V152, P772; Miman O, 2010, PSYCHIAT RES, V177, P263, DOI 10.1016/j.psychres.2009.12.013; Mors O, 2011, SCAND J PUBLIC HEALT, V39, P54, DOI 10.1177/1403494810395825; Neuhaus E, 2010, CLIN PSYCHOL REV, V30, P733, DOI 10.1016/j.cpr.2010.05.007; Nikolaus S, 2010, REV NEUROSCIENCE, V21, P119; Pedersen CB, 2006, DAN MED BULL, V53, P441; Pedersen CB, 2014, JAMA PSYCHIAT, V71, P573, DOI 10.1001/jamapsychiatry.2014.16; Pedersen CB, 2001, BRIT J PSYCHIAT, V179, P46, DOI 10.1192/bjp.179.1.46; Radua J, 2010, ARCH GEN PSYCHIAT, V67, P701, DOI 10.1001/archgenpsychiatry.2010.70; Robinson EB, 2014, P NATL ACAD SCI USA, V111, P15161, DOI 10.1073/pnas.1409204111; Ruscio AM, 2010, MOL PSYCHIATR, V15, P53, DOI 10.1038/mp.2008.94; Russell AJ, 2005, BRIT J PSYCHIAT, V186, P525, DOI 10.1192/bjp.186.6.525; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Simonoff E, 2008, J AM ACAD CHILD PSY, V47, P921, DOI 10.1097/CHI.0b013e318179964f; Srivastava AK, 2014, NEUROSCI BIOBEHAV R, V46, P161, DOI 10.1016/j.neubiorev.2014.02.015; Tolin DF, 2008, PSYCHIAT RES, V160, P200, DOI 10.1016/j.psychres.2007.08.008; Torres AR, 2006, AM J PSYCHIAT, V163, P1978, DOI 10.1176/appi.ajp.163.11.1978; van Steensel FJA, 2011, CLIN CHILD FAM PSYCH, V14, P302, DOI 10.1007/s10567-011-0097-0; Vasconcelos MS, 2007, BIOL PSYCHIAT, V61, P301, DOI 10.1016/j.biopsych.2006.07.014; White SW, 2009, CLIN PSYCHOL REV, V29, P216, DOI 10.1016/j.cpr.2009.01.003; Wu M, 2012, PHARMACOL BIOCHEM BE, V100, P726, DOI 10.1016/j.pbb.2011.10.007; Wu YJ, 2012, PSYCHIAT RES, V198, P353, DOI 10.1016/j.psychres.2012.01.020; Zarei M, 2011, BIOL PSYCHIAT, V70, P1083, DOI 10.1016/j.biopsych.2011.06.032	57	38	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141703	10.1371/journal.pone.0141703	http://dx.doi.org/10.1371/journal.pone.0141703			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7DR	26558765	Green Published, gold, Green Submitted			2022-12-26	WOS:000364433100040
J	Pappa, KI; Polyzos, A; Jacob-Hirsch, J; Amariglio, N; Vlachos, GD; Loutradis, D; Anagnou, NP				Pappa, Kalliopi I.; Polyzos, Alexander; Jacob-Hirsch, Jasmine; Amariglio, Ninette; Vlachos, George D.; Loutradis, Dimitrios; Anagnou, Nicholas P.			Profiling of Discrete Gynecological Cancers Reveals Novel Transcriptional Modules and Common Features Shared by Other Cancer Types and Embryonic Stem Cells	PLOS ONE			English	Article							CERVICAL SQUAMOCOLUMNAR JUNCTION; ONCOSTATIN-M-RECEPTOR; EXPRESSION PATTERNS; GENES; CYCLE; CARCINOMA; OVEREXPRESSION; IDENTIFICATION; MICROARRAY; SIGNATURES	Studies on individual types of gynecological cancers (GCs), utilizing novel expression technologies, have revealed specific pathogenetic patterns and gene markers for cervical (CC), endometrial (EC) and vulvar cancer (VC). Although the clinical phenotypes of the three types of gynecological cancers are discrete, the fact they originate from a common embryological origin, has led to the hypothesis that they might share common features reflecting regression to early embryogenesis. To address this question, we performed a comprehensive comparative analysis of their profiles. Our data identified both common features (pathways and networks) and novel distinct modules controlling the same deregulated biological processes in all three types. Specifically, four novel transcriptional modules were discovered regulating cell cycle and apoptosis. Integration and comparison of our data with other databases, led to the identification of common features among cancer types, embryonic stem (ES) cells and the newly discovered cell population of squamocolumnar (SC) junction of the cervix, considered to host the early cancer events. Conclusively, these data lead us to propose the presence of common features among gynecological cancers, other types of cancers, ES cells and the pre-malignant SC junction cells, where the novel E2F/NFY and MAX/CEBP modules play an important role for the pathogenesis of gynecological carcinomas.	[Pappa, Kalliopi I.; Vlachos, George D.; Loutradis, Dimitrios] Univ Athens, Sch Med, Dept Obstet & Gynecol 1, Alexandra Hosp, GR-11527 Athens, Greece; [Pappa, Kalliopi I.; Anagnou, Nicholas P.] Acad Athens, Lab Cell & Gene Therapy, Biomed Res Fdn, Athens, Greece; [Polyzos, Alexander] Acad Athens, Basic Res Ctr, Biomed Res Fdn, Athens, Greece; [Jacob-Hirsch, Jasmine; Amariglio, Ninette] Tel Aviv Univ, Canc Res Ctr, Chaim Sheba Med Ctr, Tel Hashomer & Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Anagnou, Nicholas P.] Univ Athens, Sch Med, Biol Lab, GR-11527 Athens, Greece	Alexandra Hospital; Athens Medical School; National & Kapodistrian University of Athens; Academy of Athens; Academy of Athens; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Athens Medical School; National & Kapodistrian University of Athens	Anagnou, NP (corresponding author), Acad Athens, Lab Cell & Gene Therapy, Biomed Res Fdn, Athens, Greece.	anagnou@med.uoa.gr	Anagnou, Nicholas/GLR-3609-2022; PAPPA, KALLIOPI/K-9345-2018	PAPPA, KALLIOPI/0000-0002-1061-7405	Oncology Program of the Central Council of Health of the Ministry of Health [70-3-9209]; Empirikion Foundation [70-3-7345]; European Union's European Social Fund (ESF); Greek National Funds through the Program THALIS; Operational Program Education and Lifelong Learning of the National Strategic Reference Framework (NSRF) [70-3-11830]	Oncology Program of the Central Council of Health of the Ministry of Health; Empirikion Foundation; European Union's European Social Fund (ESF); Greek National Funds through the Program THALIS; Operational Program Education and Lifelong Learning of the National Strategic Reference Framework (NSRF)	This work was supported by the Oncology Program of the Central Council of Health of the Ministry of Health, Grant No. 70-3-9209 (www.moh.gov.gr); by the Empirikion Foundation, Grant No. 70-3-7345 to NPA (www.empirikion.gr); and by the European Union's European Social Fund (ESF) and Greek National Funds through the Program THALIS, under the Operational Program Education and Lifelong Learning of the National Strategic Reference Framework (NSRF), Grant No. 70-3-11830 to KIP (http://excellence.minedu.gov.gr/thales/en/).	Abu-Rustum NR, 2011, INT J GYNECOL CANCER, V21, P511, DOI 10.1097/IGC.0b013e31820cc305; Alisoltani A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096320; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bosse T, 2013, MODERN PATHOL, V26, P1525, DOI 10.1038/modpathol.2013.96; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; Choschzick M, 2012, HUM PATHOL, V43, P1386, DOI 10.1016/j.humpath.2011.11.014; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Culhane AC, 2012, NUCLEIC ACIDS RES, V40, pD1060, DOI 10.1093/nar/gkr901; Elkon R, 2003, GENOME RES, V13, P773, DOI 10.1101/gr.947203; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Fruzangohar M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125537; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Gorski JJ, 2011, NUCLEIC ACIDS RES, V39, P9536, DOI 10.1093/nar/gkr679; Herfs M, 2015, INT J CANCER, V136, P1043, DOI 10.1002/ijc.28978; Herfs M, 2013, AM J SURG PATHOL, V37, P1311, DOI 10.1097/PAS.0b013e3182989ee2; Herfs M, 2013, J PATHOL, V229, P460, DOI 10.1002/path.4110; Herfs M, 2012, P NATL ACAD SCI USA, V109, P10516, DOI 10.1073/pnas.1202684109; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hubert P, 2014, J PATHOL, V234, P464, DOI 10.1002/path.4435; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kowalewska M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-223; Landry JJM, 2013, G3-GENES GENOM GENET, V3, P1213, DOI 10.1534/g3.113.005777; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Martinez E, 2015, ONCOGENE, V34, P2732, DOI 10.1038/onc.2014.216; Mine KL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2693; Ng G, 2007, J PATHOL, V212, P325, DOI 10.1002/path.2184; Ng VY, 2010, STEM CELLS, V28, P29, DOI 10.1002/stem.221; NUSSE R, 1992, CELL, V69, P1073, DOI 10.1016/0092-8674(92)90630-U; Ojesina AI, 2014, NATURE, V506, P371, DOI 10.1038/nature12881; Orchel J, 2012, INT J GYNECOL CANCER, V22, P937, DOI 10.1097/IGC.0b013e318259d8da; Pappa KI, 2011, TRANSL ONCOL, V4, P301, DOI 10.1593/tlo.11148; Peng L, 2015, SCI REP-UK, V5, DOI 10.1038/srep13413; Pereira PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011780; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ravi R, 2000, GENE DEV, V14, P34; Santegoets LAM, 2007, INT J CANCER, V121, P759, DOI 10.1002/ijc.22769; Santegoets LAM, 2012, INT J CANCER, V130, P2874, DOI 10.1002/ijc.26345; Scotto L, 2008, GENE CHROMOSOME CANC, V47, P755, DOI 10.1002/gcc.20577; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; SLACK JMW, 2006, ESSENTIAL DEV BIOL; Soncin F, 2011, GENES-BASEL, V2, P229, DOI 10.3390/genes2010229; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thomas A, 2013, CANCER MED-US, V2, P836, DOI 10.1002/cam4.152; U.S. Cancer Statistics Working Group, 2014, US CANC STAT 1999 20; Ulitsky I, 2010, NAT PROTOC, V5, P303, DOI 10.1038/nprot.2009.230; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Winder DM, 2011, J PATHOL, V225, P448, DOI 10.1002/path.2968; Yang Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4231; Yuan RH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065501; Zhai Y, 2007, CANCER RES, V67, P10163, DOI 10.1158/0008-5472.CAN-07-2056	58	43	43	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142229	10.1371/journal.pone.0142229	http://dx.doi.org/10.1371/journal.pone.0142229			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559525	Green Published, gold, Green Submitted			2022-12-26	WOS:000364433100065
J	Giridharan, VV; Thandavarayan, RA; Arumugam, S; Mizuno, M; Nawa, H; Suzuki, K; Ko, KM; Krishnamurthy, P; Watanabe, K; Konishi, T				Giridharan, Vijayasree V.; Thandavarayan, Rajarajan A.; Arumugam, Somasundaram; Mizuno, Makoto; Nawa, Hiroyuki; Suzuki, Kenji; Ko, Kam M.; Krishnamurthy, Prasanna; Watanabe, Kenichi; Konishi, Tetsuya			Schisandrin B Ameliorates ICV-Infused Amyloid beta Induced Oxidative Stress and Neuronal Dysfunction through Inhibiting RAGE/NF-kappa B/MAPK and Up-Regulating HSP/Beclin Expression	PLOS ONE			English	Article							GLYCATION-END-PRODUCTS; ABSORBENCY CAPACITY ORAC; ALZHEIMERS-DISEASE; ANIMAL-MODEL; NITRIC-OXIDE; IN-VITRO; PROTEIN; RECEPTOR; MICE; RAT	Amyloid beta (A beta)-induced neurotoxicity is a major pathological mechanism of Alzheimer's disease (AD). Our previous studies have demonstrated that schisandrin B (Sch B), an antioxidant lignan from Schisandra chinensis, could protect mouse brain against scopolamine-and cisplatin-induced neuronal dysfunction. In the present study, we examined the protective effect of Sch B against intracerebroventricular (ICV)-infused A beta-induced neuronal dysfunction in rat cortex and explored the potential mechanism of its action. Our results showed that 26 days co-administration of Sch B significantly improved the behavioral performance of A beta (1-40)-infused rats in step-through test. At the same time, Sch B attenuated A beta-induced increases in oxidative and nitrosative stresses, inflammatory markers such as inducible nitric oxide syntheses, cyclooxygenase-2, interleukin-1 beta (IL-1 beta), IL-6, and tumor necrosis factor-alpha, and DNA damage. Several proteins such as receptor for advanced glycation end products (RAGE), nuclear factor-kappa B, mitogen-activated protein kinases, and apoptosis markers were over expressed in A beta-infused rats but were significantly inhibited by Sch B treatment. Furthermore, Sch B negatively modulated the A beta level with simultaneous up-regulation of HSP70 and beclin, autophagy markers in A beta-infused rats. The aforementioned effects of Sch B suggest its protective role against A beta-induced neurotoxicity through intervention in the negative cycle of RAGE-mediated A beta accumulation during AD patho-physiology.	[Giridharan, Vijayasree V.] JKK Nattraja Coll Pharm, Komarapalayam, Tamil Nadu, India; [Thandavarayan, Rajarajan A.; Krishnamurthy, Prasanna] Houston Methodist Res Inst, Dept Cardiovasc Sci, Houston, TX 77030 USA; [Arumugam, Somasundaram; Watanabe, Kenichi] Niigata Univ Pharm & Appl Life Sci NUPALS, Dept Clin Pharmacol, Niigata, Japan; [Mizuno, Makoto; Nawa, Hiroyuki] Niigata Univ, Div Neurobiol, Brain Res Inst, Niigata, Japan; [Suzuki, Kenji] Niigata Univ, Grad Sch Med & Dent Sci, Dept Gastroenterol & Hepatol, Niigata, Japan; [Ko, Kam M.] Hong Kong Univ Sci & Technol, Sect Biochem & Cell Biol, Hong Kong, Hong Kong, Peoples R China; [Konishi, Tetsuya] NUPALS, NUPALS Liaison RD Promot Div, Basic Studies Generat Funct Foods 2, Niigata, Japan; [Konishi, Tetsuya] Changchun Univ Chinese Med, Changchun, Peoples R China	The Methodist Hospital System; The Methodist Hospital - Houston; Niigata University; Niigata University; Niigata University; Hong Kong University of Science & Technology; Changchun University of Chinese Medicine	Thandavarayan, RA (corresponding author), Houston Methodist Res Inst, Dept Cardiovasc Sci, Houston, TX 77030 USA.	atrajarajan@gmail.com; konishi@nupals.ac.jp	Arumugam, S./AAT-7570-2020	KRISHNAMURTHY, PRASANNA/0000-0002-4842-6364; Arumugam, Somasundaram/0000-0002-2096-2552	Promotion and Mutual Aid Corporation for Private Schools, Japan; National Institutes of Health (NIH) [1R01HL116729]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116729] Funding Source: NIH RePORTER	Promotion and Mutual Aid Corporation for Private Schools, Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding: T.K. was supported by The Promotion and Mutual Aid Corporation for Private Schools, Japan; P. K. was supported by National Institutes of Health (NIH) grant 1R01HL116729.	Abdul HM, 2007, FREE RADICAL BIO MED, V42, P371, DOI 10.1016/j.freeradbiomed.2006.11.006; Baiguera S, 2009, INT J MOL MED, V24, P9, DOI 10.3892/ijmm_00000199; Caceres DD, 1999, PHYTOMEDICINE, V6, P217, DOI 10.1016/S0944-7113(99)80012-9; Cerpa W, 2008, CURR ALZHEIMER RES, V5, P233, DOI 10.2174/156720508784533321; Chang PC, 2004, KIDNEY INT, V65, P1664, DOI 10.1111/j.1523-1755.2004.00602.x; Chaubey RC, 2001, MUTAT RES-GEN TOX EN, V490, P187, DOI 10.1016/S1383-5718(00)00166-2; Chiu PY, 2004, MOL CELL BIOCHEM, V266, P139, DOI 10.1023/B:MCBI.0000049151.79238.30; Chiu PY, 2003, FREE RADICAL BIO MED, V35, P368, DOI 10.1016/S0891-5849(03)00274-0; Craft JM, 2006, GLIA, V53, P484, DOI 10.1002/glia.20306; Darvesh S, 2004, CLIN BIOCHEM, V37, P42, DOI 10.1016/j.clinbiochem.2003.09.004; Degaspari S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125271; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Fan Lin-Hua, 2011, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V29, P255; Gegg ME, 2003, J NEUROCHEM, V86, P228, DOI 10.1046/j.1471-4159.2003.01821.x; Giridharan VV, 2011, FREE RADICAL RES, V45, P950, DOI 10.3109/10715762.2011.571682; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Grutzendler J, 2001, DRUGS, V61, P41, DOI 10.2165/00003495-200161010-00005; Hashimoto M, 2005, BBA-MOL CELL BIOL L, V1738, P91, DOI 10.1016/j.bbalip.2005.11.011; JOACHIM CL, 1992, ALZ DIS ASSOC DIS, V6, P7, DOI 10.1097/00002093-199205000-00003; Kim SR, 1999, PLANTA MED, V65, P218, DOI 10.1055/s-1999-13983; Kim TI, 2009, FREE RADICAL BIO MED, V47, P1601, DOI 10.1016/j.freeradbiomed.2009.09.008; Kurihara H, 2004, BIOL PHARM BULL, V27, P1093, DOI 10.1248/bpb.27.1093; Kwon SH, 2009, EUR J PHARMACOL, V619, P44, DOI 10.1016/j.ejphar.2009.06.062; Lecanu L, 2004, STEROIDS, V69, P1, DOI 10.1016/j.steroids.2003.09.007; Lee CL, 2007, J NEUROSCI RES, V85, P3171, DOI 10.1002/jnr.21428; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Li Shu-Fang, 2010, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V28, P329; LIU GT, 1989, CHINESE MED J-PEKING, V102, P740; Lue LF, 2001, EXP NEUROL, V171, P29, DOI 10.1006/exnr.2001.7732; Maccioni RB, 2001, ARCH MED RES, V32, P367, DOI 10.1016/S0188-4409(01)00316-2; Mallidis C, 2007, HUM REPROD, V22, P2169, DOI 10.1093/humrep/dem156; Moreira PI, 2006, BIOL RES, V39, P7, DOI 10.4067/S0716-97602006000100002; NITTA A, 1994, NEUROSCI LETT, V170, P63, DOI 10.1016/0304-3940(94)90239-9; Nitta A, 1997, JPN J PHARMACOL, V73, P51, DOI 10.1254/jjp.73.51; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Olariu A, 2002, BRAIN RES, V957, P278, DOI 10.1016/S0006-8993(02)03608-9; Ou BX, 2002, J AGR FOOD CHEM, V50, P3122, DOI 10.1021/jf0116606; Paxinos G., 2004, J CHEM INF MODEL, V5th; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Ranaivo HR, 2006, J NEUROSCI, V26, P662, DOI 10.1523/JNEUROSCI.4652-05.2006; Reddy PH, 2006, J NEUROCHEM, V96, P1, DOI 10.1111/j.1471-4159.2005.03530.x; Schieven GL, 2005, CURR TOP MED CHEM, V5, P921, DOI 10.2174/1568026054985902; Schmidt AM, 2000, BBA-MOL CELL RES, V1498, P99, DOI 10.1016/S0167-4889(00)00087-2; SCHUBERT D, 1995, P NATL ACAD SCI USA, V92, P1989, DOI 10.1073/pnas.92.6.1989; Song JX, 2011, PHYTOTHER RES, V25, P435, DOI 10.1002/ptr.3269; Srikanth V, 2011, NEUROBIOL AGING, V32, P763, DOI 10.1016/j.neurobiolaging.2009.04.016; Stephan A, 2005, GENES BRAIN BEHAV, V4, P157, DOI 10.1111/j.1601-183X.2004.00113.x; Takaya T, 2006, ATHEROSCLEROSIS, V186, P402, DOI 10.1016/j.atherosclerosis.2005.08.009; Takeda A, 1998, ACTA NEUROPATHOL, V95, P555, DOI 10.1007/s004010050839; Thandavarayan RA, 2010, FREE RADICAL BIO MED, V49, P1422, DOI 10.1016/j.freeradbiomed.2010.08.005; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; VINCENT D, 1958, Ann Pharm Fr, V16, P179; Wakisaka Y, 2010, J CEREBR BLOOD F MET, V30, P56, DOI 10.1038/jcbfm.2009.183; Wang R, 2001, EUR J PHARMACOL, V421, P149, DOI 10.1016/S0014-2999(01)01030-5; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yan Shirley ShiDu, 2012, Front Biosci (Schol Ed), V4, P240; Zhou QB, 2014, INFLAMMATION, V37, P107, DOI 10.1007/s10753-013-9717-9; ZLOKOVIC BV, 1993, BIOCHEM BIOPH RES CO, V197, P1034, DOI 10.1006/bbrc.1993.2582	59	54	60	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142483	10.1371/journal.pone.0142483	http://dx.doi.org/10.1371/journal.pone.0142483			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556721	Green Submitted, gold, Green Published			2022-12-26	WOS:000364430700112
J	Wang, J; Wang, SW; Li, ML; Wu, DD; Liu, F; Yang, RS; Ji, SP; Ji, AL; Li, YZ				Wang, Jun; Wang, Shuaiwei; Li, Mengling; Wu, Dongdong; Liu, Fang; Yang, Ruisheng; Ji, Shaoping; Ji, Ailing; Li, Yanzhang			The Neuropilin-1 Inhibitor, ATWLPPR Peptide, Prevents Experimental Diabetes-Induced Retinal Injury by Preserving Vascular Integrity and Decreasing Oxidative Stress	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ADHESION MOLECULE-1 ICAM-1; BLOOD-BRAIN-BARRIER; RETINOPATHY; CELLS; VEGF; EXPRESSION; PERMEABILITY; RECEPTOR; BINDING	Neuropilin-1 (NRP-1) is a transmembrane glycoprotein. As a VEGF co-receptor, NRP1 significantly enhances VEGFR2 signaling and promotes vascular permeability and migration. The purpose of this study was to evaluate the effects of an NRP-1 inhibitor, ATWLPPR peptide, on the early stages of diabetic retinopathy. Eight-week-old male C57BL/6 mice were divided into three groups: a Normal group, a Diabetes (DB) ATWLPPR treatment group and a DB saline group. Electroretinography (ERG), fundus fluorescence angiography (FFA) and leukostasis were examined to evaluate the retinal injury induced by diabetes at the end of the fifth week after STZ injection. Occludin expression and extravasation of albumin were measured to determine the extent of vascular injury. The oxidative stress level and the levels of inflammation-associated proteins were also assayed. The results indicated that treatment with ATWLPPR prevents the abnormal condition of ERG (amplitudes of b-wave decreased and implicit time increased) and vascular injury (occludin degradation and increase in extravasated albumin). These effects were associated with a reduction in the oxidase stress level and the expression of VEGF, GFAP, and ICAM-1. We conclude that ATWLPPR, an NRP-1 inhibitor, may reduce the early retinal damage induced by diabetes by preserving vascular integrity and decreasing the oxidative stress level. Blockade of NRP-1 may be a new therapeutic strategy for the early stages of DR.	[Wang, Jun; Wang, Shuaiwei; Li, Mengling; Wu, Dongdong; Ji, Shaoping; Ji, Ailing; Li, Yanzhang] Henan Univ, Coll Med, Kaifeng 475004, Peoples R China; [Liu, Fang; Yang, Ruisheng] Henan Univ, Affiliated Hosp 1, Kaifeng 475004, Peoples R China	Henan University; Henan University	Wang, J (corresponding author), Henan Univ, Coll Med, Kaifeng 475004, Peoples R China.	whb21c@henu.edu.cn; ailingji@163.com; yanzhang206@163.com	Wu, dongdong/F-6086-2012; Wu, Dongdong/GQP-4472-2022; Wu, Dongdong/GPX-6051-2022; Wu, Dongdong/K-5194-2019	Wu, Dongdong/0000-0001-6739-8437; Wu, Dongdong/0000-0001-6739-8437; 	National Natural Science Foundation of China (NSFC) [31300884]; Science and Technology Development Project of Henan Province [132300410012]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Science and Technology Development Project of Henan Province	This work was supported by the National Natural Science Foundation of China (NSFC: 31300884) and Science and Technology Development Project of Henan Province (no. 132300410012). The funders participated in the study design, data collection and analysis, decision to publish and preparation of the manuscript.	Adamis AP, 2008, SEMIN IMMUNOPATHOL, V30, P65, DOI 10.1007/s00281-008-0111-x; Al-Shabrawey M, 2008, INVEST OPHTH VIS SCI, V49, P3239, DOI 10.1167/iovs.08-1755; Alex L, 1997, CELL, V90, P753; Antal B, 2012, IEEE T BIO-MED ENG, V59, P1720, DOI 10.1109/TBME.2012.2193126; Antonetti DA, 1998, DIABETES, V47, P1953, DOI 10.2337/diabetes.47.12.1953; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Banumathi E, 2010, EXP EYE RES, V90, P89, DOI 10.1016/j.exer.2009.09.014; Barber AJ, 2000, INVEST OPHTH VIS SCI, V41, P3561; Binetruy-Tournaire R, 2000, EMBO J, V19, P1525, DOI 10.1093/emboj/19.7.1525; Cerani A, 2013, CELL METAB, V18, P505, DOI 10.1016/j.cmet.2013.09.003; Cheema HR, 2014, INT J OPHTHALMOL-CHI, V7, P251, DOI 10.3980/j.issn.2222-3959.2014.02.11; Cunha-Vaz J, 2011, EUR J OPHTHALMOL, V21, pS3, DOI 10.5301/EJO.2010.6049; Deissler HL, 2014, EXP EYE RES, V122, P20, DOI 10.1016/j.exer.2014.02.024; Delibegovic M, 2007, MOL CELL BIOL, V27, P7727, DOI 10.1128/MCB.00959-07; Dohgu Shinya, 2015, Folia Pharmacologica Japonica, V146, P63, DOI 10.1254/fpj.146.63; Fantin A, 2014, DEVELOPMENT, V141, P556, DOI 10.1242/dev.103028; Gelfand MV, 2014, ELIFE, V3, DOI 10.7554/eLife.03720; Hammes HP, 2005, HORM METAB RES, V37, pS39, DOI 10.1055/s-2005-861361; Hartnett ME, 2000, DIABETES CARE, V23, P234, DOI 10.2337/diacare.23.2.234; Hernandez C, 2013, DIABETES, V62, P2569, DOI 10.2337/db12-0926; Herre DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126866; Herzog B, 2011, MOL BIOL CELL, V22, P2766, DOI 10.1091/mbc.E09-12-1061; Hosoya K, 2013, ADV EXP MED BIOL, V763, P85; Huang XQ, 2011, DIABETES RES CLIN PR, V91, P371, DOI 10.1016/j.diabres.2010.12.026; Joussen AM, 2001, AM J PATHOL, V158, P147, DOI 10.1016/S0002-9440(10)63952-1; Kim I, 2001, J BIOL CHEM, V276, P7614, DOI 10.1074/jbc.M009705200; Koleva-Georgieva Desislava N, 2011, Folia Med (Plovdiv), V53, P44; Kowluru RA, 2006, INVEST OPHTH VIS SCI, V47, P1594, DOI 10.1167/iovs.05-1276; Kubo Y, 2007, DIABETIC RETINOPATHY, P92; Kumawat Manjulata, 2014, J Indian Med Assoc, V112, P29; Li GY, 2012, DIABETES, V61, P3294, DOI 10.2337/db11-1249; Li Q, 2002, EXP EYE RES, V74, P615, DOI 10.1006/exer.2002.1170; Miyamoto K, 2000, AM J PATHOL, V156, P1733, DOI 10.1016/S0002-9440(10)65044-4; Moran E, 2014, INVEST OPHTH VIS SCI, V55, P4568, DOI 10.1167/iovs.13-13127; Naruse R, 2013, SAUDI MED J, V34, P135; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Rojas M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084357; Rungger-Brandle E, 2000, INVEST OPHTH VIS SCI, V41, P1971; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Spoerri PE, 2006, MOL VIS, V12, P32; Starzec A, 2006, LIFE SCI, V79, P2370, DOI 10.1016/j.lfs.2006.08.005; Suidan GL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-218; Wang JJ, 2010, DIABETES, V59, P2297, DOI 10.2337/db09-1420; Wu DD, 2010, PEPTIDES, V31, P850, DOI 10.1016/j.peptides.2010.01.007; Wuensch T, 2010, DIABETES, V59, P844, DOI 10.2337/db09-1100; Xie Ping QLXY, 2004, ACTA U MED NANJING, V24, P123; Yang WJ, 2015, EMBO MOL MED; Yee CS, 2015, BONE; Yuan DQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099219; Zhang B, 2012, INFORM SCIENCES, V200, P78, DOI 10.1016/j.ins.2012.03.003	50	9	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142571	10.1371/journal.pone.0142571	http://dx.doi.org/10.1371/journal.pone.0142571			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554379	Green Published, gold, Green Submitted			2022-12-26	WOS:000364430700134
J	Halasi, M; Varaljai, R; Benevolenskaya, E; Gartel, AL				Halasi, Marianna; Varaljai, Renata; Benevolenskaya, Elizaveta; Gartel, Andrei L.			A Novel Function of Molecular Chaperone HSP70: SUPPRESSION OF ONCOGENIC FOXM1 AFTER PROTEOTOXIC STRESS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						70-kD heat shock protein (Hsp70); anticancer drug; cell death; gene expression; protein-protein interaction; FOXM1	PROTEASOME INHIBITORS; TRANSCRIPTION FACTOR; TARGETING FOXM1; CANCER; APOPTOSIS; IDENTIFICATION; RESISTANCE; INDUCTION	The oncogenic transcription factor FOXM1 is overexpressed in the majority of human cancers, and it is a potential target for anticancer therapy. We identified proteasome inhibitors as the first type of drugs that target FOXM1 in cancer cells. Here we found that HSP90 inhibitor PF-4942847 and heat shock also suppress FOXM1. The common effector, which was induced after treatment with proteasome and HSP90 inhibitors or heat shock, was the molecular chaperone HSP70. We show that HSP70 binds to FOXM1 following proteotoxic stress and that HSP70 inhibits FOXM1 DNA-binding ability. Inhibition of FOXM1 transcriptional autoregulation by HSP70 leads to the suppression of FOXM1 protein expression. In addition, HSP70 suppression elevates FOXM1 expression, and simultaneous inhibition of FOXM1 and HSP70 increases the sensitivity of human cancer cells to anticancer drug-induced apoptosis. Overall, we determined the unique and novel mechanism of FOXM1 suppression by proteasome inhibitors.	[Halasi, Marianna; Gartel, Andrei L.] Univ Illinois, Dept Med, Chicago, IL 60612 USA; [Varaljai, Renata; Benevolenskaya, Elizaveta; Gartel, Andrei L.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Gartel, AL (corresponding author), Univ Illinois, Dept Med, 840 S Wood St,Rm 1041, Chicago, IL 60612 USA.	agartel@uic.edu	Varaljai, Renata/AAR-3119-2020	Varaljai, Renata/0000-0001-6852-6859	National Institutes of Health [5R01CA138409, 5 T32 DK007788-14]; University of Illinois at Chicago; NATIONAL CANCER INSTITUTE [R01CA138409, R01CA138631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007788] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Illinois at Chicago; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants 5R01CA138409 (to A. L. G.) and 5 T32 DK007788-14 (to M. H.) and a bridge funding grant from the University of Illinois at Chicago (to A. L. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aghdassi A, 2007, CANCER RES, V67, P616, DOI 10.1158/0008-5472.CAN-06-1567; Bao B, 2011, J CELL BIOCHEM, V112, P2296, DOI 10.1002/jcb.23150; Beshiri Michael L, 2010, J Vis Exp, DOI 10.3791/2101; Bhat UG, 2008, CELL CYCLE, V7, P1851, DOI 10.4161/cc.7.12.6032; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006593; Carr JR, 2010, CANCER RES, V70, P5054, DOI 10.1158/0008-5472.CAN-10-0545; Cheng XH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004656; Crawford LJ, 2011, J CELL COMMUN SIGNAL, V5, P101, DOI 10.1007/s12079-011-0121-7; Fribley A, 2004, MOL CELL BIOL, V24, P9695, DOI 10.1128/MCB.24.22.9695-9704.2004; Gartel AL, 2015, CANCER BIOL THER, V16, P185, DOI 10.4161/15384047.2014.987566; Gartel AL, 2011, CELL CYCLE, V10, P4341, DOI 10.4161/cc.10.24.18544; Gartel AL, 2010, EXPERT OPIN INV DRUG, V19, P235, DOI 10.1517/13543780903563364; Gartel AL, 2009, BIOFACTORS, V35, P161, DOI 10.1002/biof.26; Goloudina AR, 2012, CANCER LETT, V325, P117, DOI 10.1016/j.canlet.2012.06.003; Grossin L, 2004, BIORHEOLOGY, V41, P521; Halasi M, 2013, BIOCHEM J, V454, P201, DOI 10.1042/BJ20130282; Halasi M, 2013, MOL CANCER THER, V12, P245, DOI 10.1158/1535-7163.MCT-12-0712; Halasi M, 2013, BIOCHEM PHARMACOL, V85, P644, DOI 10.1016/j.bcp.2012.10.013; Halasi M, 2009, CELL CYCLE, V8, P1966, DOI 10.4161/cc.8.12.8708; Jiang P, 2015, P NATL ACAD SCI USA, V112, P7731, DOI 10.1073/pnas.1424272112; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Kwok JMM, 2010, MOL CANCER RES, V8, P24, DOI 10.1158/1541-7786.MCR-09-0432; Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006; Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004; Matokanovic M, 2013, EUR J PHARM SCI, V50, P149, DOI 10.1016/j.ejps.2013.04.001; Mayer MP, 2013, TRENDS BIOCHEM SCI, V38, P507, DOI 10.1016/j.tibs.2013.08.001; Millour J, 2011, MOL CANCER THER, V10, P1046, DOI 10.1158/1535-7163.MCT-11-0024; Myung J, 2001, MED RES REV, V21, P245, DOI 10.1002/med.1009.abs; Neznanov N, 2009, CELL CYCLE, V8, P3960, DOI 10.4161/cc.8.23.10179; Pandit B, 2011, CELL CYCLE, V10, P3269, DOI 10.4161/cc.10.19.17735; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Powers MV, 2007, FEBS LETT, V581, P3758, DOI 10.1016/j.febslet.2007.05.040; Radhakrishnan SK, 2006, CANCER RES, V66, P9731, DOI 10.1158/0008-5472.CAN-06-1576; Raychaudhuri P, 2011, CANCER RES, V71, P4329, DOI 10.1158/0008-5472.CAN-11-0640; Ribeil JA, 2007, NATURE, V445, P102, DOI 10.1038/nature05378; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Sherman MY, 2015, ONCOGENE, V34, P4153, DOI 10.1038/onc.2014.349	37	24	27	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					142	148		10.1074/jbc.M115.678227	http://dx.doi.org/10.1074/jbc.M115.678227			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26559972	Green Published, hybrid			2022-12-26	WOS:000367589500011
J	Hu, JC; Greene, CJ; King-Lyons, ND; Connell, TD				Hu, John C.; Greene, Christopher J.; King-Lyons, Natalie D.; Connell, Terry D.			The Divergent CD8(+) T Cell Adjuvant Properties of LT-IIb and LT-IIc, Two Type II Heat-Labile Enterotoxins, Are Conferred by Their Ganglioside-Binding B Subunits	PLOS ONE			English	Article							CHOLERA-TOXIN; VACCINES; INDUCE; IMMUNITY	Poor immune responses elicited by vaccine antigens can be enhanced by the use of appropriate adjuvants. Type II heat-labile enterotoxins (HLT) produced by Escherichia coli are extremely potent adjuvants that augment both humoral and cellular immunity to co-administered antigens. Recent findings demonstrate that LT-IIb and LT-IIc, two type II HLT adjuvants, exhibit potent, yet distinguishable CD8(+) T cell adjuvant properties. While LT-IIc elicits a robust and rapid response at one week after administration, LT-IIb engenders a more gradual and slower expansion of antigen-specific CD8(+) T cells that correlates with improved immunity. The variations in immune effects elicited by the HLT adjuvants have been generally attributed to their highly divergent B subunits that mediate binding to various gangliosides on cell surfaces. Yet, HLT adjuvants with point mutations in the B subunit that significantly alter ganglioside binding retain similar adjuvant functions. Therefore, the contribution of the B subunits to adjuvanticity remains unclear. To investigate the influence of the B subunits on the enhancement of immune responses by LT-IIb and LT-IIc, chimeric HLT were engineered in which the B subunits of the two adjuvants were exchanged. Comparing the immune potentiating characteristics of both native and chimeric HLT adjuvants, it was found that not all the adjuvant characteristics of the HLT adjuvants were modulated by the respective B subunits. Specifically, the differences in the CD8(+) T cell kinetics and protective responses elicited by LT-IIb and LT-IIc did indeed followed their respective B subunits. However, induction of IL-1 from macrophages and the capacity to intoxicate cells in a mouse Y1 adrenal cell bioassay did not correlate with the B subunits. Therefore, it is likely that additional factors other than the B subunits contribute to the effects elicited by the HLT adjuvants.	[Hu, John C.; Greene, Christopher J.; King-Lyons, Natalie D.; Connell, Terry D.] SUNY Buffalo, Dept Microbiol & Immunol, Witebsky Ctr Microbial Pathogenesis & Immunol, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Connell, TD (corresponding author), SUNY Buffalo, Dept Microbiol & Immunol, Witebsky Ctr Microbial Pathogenesis & Immunol, Buffalo, NY 14260 USA.	connell@buffalo.edu	LYONS, NATALIE/K-8058-2019		U.S. Dept. of Health [DE13833, DE017138]; The John R. Oishei Foundation; Univ. at Buffalo; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013833, R56DE013833] Funding Source: NIH RePORTER	U.S. Dept. of Health; The John R. Oishei Foundation; Univ. at Buffalo; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The research was supported by grants awarded to T.D.C. by the U.S. Dept. of Health (DE13833, DE017138), The John R. Oishei Foundation, and The Univ. at Buffalo. The funders had no role in study design, data collection and analyssi, decision to publish, or preparation of the manuscript.; The authors would like to thank Lorrie Mandell for her excellent technical support. The research was supported by grants awarded to T.D.C. by the U.S. Dept. of Health (DE13833, DE017138) and by The John R. Oishei Foundation.	Allen AC, 2014, EXPERT REV VACCINES, V13, P1253, DOI 10.1586/14760584.2014.936391; Berenson CS, 2010, GLYCOBIOLOGY, V20, P41, DOI 10.1093/glycob/cwp141; Bergmann-Leitner ES, 2009, VACCINE, V27, P5700, DOI 10.1016/j.vaccine.2009.06.059; Bloom DE, 2011, ADV EXP MED BIOL, V697, P1, DOI 10.1007/978-1-4419-7185-2_1; DICKINSON BL, 1995, INFECT IMMUN, V63, P1617, DOI 10.1128/IAI.63.5.1617-1623.1995; Dustin LB, 2014, J LEUKOCYTE BIOL, V96, P535, DOI 10.1189/jlb.4RI0214-126R; Giuliani MM, 1998, J EXP MED, V187, P1123, DOI 10.1084/jem.187.7.1123; Greene CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069678; Hajishengallis G, 2005, J DENT RES, V84, P1104, DOI 10.1177/154405910508401205; Hajishengallis G, 2004, INFECT IMMUN, V72, P6351, DOI 10.1128/IAI.72.11.6351-6358.2004; Hajishengallis G, 2013, VET IMMUNOL IMMUNOP, V152, P68, DOI 10.1016/j.vetimm.2012.09.034; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOLMES RK, 1986, INFECT IMMUN, V53, P464, DOI 10.1128/IAI.53.3.464-473.1986; Hu JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113978; Kobylinski KC, 2007, J AM MOSQUITO CONTR, V23, P492, DOI 10.2987/5579.1; Koup RA, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a007252; Liang SA, 2007, J IMMUNOL, V178, P4811, DOI 10.4049/jimmunol.178.8.4811; Liang S, 2009, VACCINE, V27, P4302, DOI 10.1016/j.vaccine.2009.05.027; Nawar HF, 2007, INFECT IMMUN, V75, P621, DOI 10.1128/IAI.01009-06; Nawar HF, 2011, VACCINE, V29, P721, DOI 10.1016/j.vaccine.2010.11.020; Nawar HF, 2010, INFECT IMMUN, V78, P4705, DOI 10.1128/IAI.00730-10; Nawar HF, 2010, CLIN VACCINE IMMUNOL, V17, P969, DOI 10.1128/CVI.00076-10; Petrovsky N, 2004, IMMUNOL CELL BIOL, V82, P488, DOI 10.1111/j.0818-9641.2004.01272.x; TAMURA S, 1989, VACCINE, V7, P503, DOI 10.1016/0264-410X(89)90273-9; vandenAkker F, 1996, STRUCTURE, V4, P665, DOI 10.1016/S0969-2126(96)00073-1; Wang HB, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/503978; Wolf AA, 1998, J CELL BIOL, V141, P917, DOI 10.1083/jcb.141.4.917; Wong CP, 1999, J IMMUNOL, V162, P2251; Zoeteweij JP, 2006, J IMMUNOL, V177, P1197, DOI 10.4049/jimmunol.177.2.1197	29	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142942	10.1371/journal.pone.0142942	http://dx.doi.org/10.1371/journal.pone.0142942			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26565800	Green Published, Green Submitted, gold			2022-12-26	WOS:000367628500077
J	Huan, YJ; Hu, K; Xie, BT; Shi, YQ; Wang, F; Zhou, Y; Liu, SC; Huang, B; Zhu, J; Liu, ZF; He, YL; Li, JY; Kong, QR; Liu, ZH				Huan, Yanjun; Hu, Kui; Xie, Bingteng; Shi, Yongqian; Wang, Feng; Zhou, Yang; Liu, Shichao; Huang, Bo; Zhu, Jiang; Liu, Zhongfeng; He, Yilong; Li, Jingyu; Kong, Qingran; Liu, Zhonghua			Ovulation Statuses of Surrogate Gilts Are Associated with the Efficiency of Excellent Pig Cloning	PLOS ONE			English	Article							CELL NUCLEAR TRANSFER; CLONED PIGS; DEVELOPMENTAL COMPETENCE; PORCINE EMBRYOS; IN-VITRO	Somatic cell nuclear transfer (SCNT) is an assisted reproductive technique that can produce multiple copies of excellent livestock. However, low cloning efficiency limits the application of SCNT. In this study, we systematically investigated the major influencing factors related to the overall cloning efficiency in pigs. Here, 13620 cloned embryos derived from excellent pigs were transferred into 79 surrogate gilts, and 119 live cloned piglets were eventually generated. During cloning, group of cloned embryos derived from excellent Landrace or Large white pigs presented no significant differences of cleavage and blastocyst rates, blastocyst cell numbers, surrogate pregnancy and delivery rates, average numbers of piglets born and alive and cloning efficiencies, and group of 101-150, 151-200 or 201-250 cloned embryos transferred per surrogate also displayed a similar developmental efficiency. When estrus stage of surrogate gilts was compared, group of embryo transfer on Day 2 of estrus showed significantly higher pregnancy rate, delivery rate, average number of piglets born, average alive piglet number or cloning efficiency than group on Day 1, Day 3, Day 4 or Day 5, respectively (P<0.05). And, in comparison with the preovulation and postovulation groups, group of surrogate gilts during periovulation displayed a significantly higher overall cloning efficiency (P<0.05). Further investigation of surrogate estrus stage and ovulation status displayed that ovulation status was the real factor underlying estrus stage to determine the overall cloning efficiency. And more, follicle puncture for preovulation, not transfer position shallowed for preovulation or deepened for postovulation, significantly improved the average number of piglets alive and cloning efficiency (P<0.05). In conclusion, our results demonstrated that ovulation status of surrogate gilts was the fundamental factor determining the overall cloning efficiency of excellent pigs, and follicle puncture, not transfer position change, improved cloning efficiency. This work would have important implications in preserving and breeding excellent livestock and improving the overall cloning efficiency.	[Huan, Yanjun; Hu, Kui; Xie, Bingteng; Shi, Yongqian; Wang, Feng; Zhou, Yang; Liu, Shichao; Huang, Bo; Zhu, Jiang; Liu, Zhongfeng; He, Yilong; Li, Jingyu; Kong, Qingran; Liu, Zhonghua] Northeast Agr Univ, Coll Life Sci, Harbin, Heilongjiang Pr, Peoples R China	Northeast Agricultural University - China	Liu, ZH (corresponding author), Northeast Agr Univ, Coll Life Sci, Harbin, Heilongjiang Pr, Peoples R China.	liu086@126.com	Li, Jingyu/GSD-1924-2022; Liu, Zhonghua/AAO-3590-2021; Liu, Zhunghua/F-2485-2010; Liu, Shichao/J-2954-2019	Liu, Zhonghua/0000-0002-9199-6493; Liu, Zhunghua/0000-0002-9199-6493; Liu, Shichao/0000-0002-4156-3876; , Yanjun/0000-0001-7334-4582	National Basic Research Program of China, Program 973 [2011CB944202]; National Natural Science Foundation of China, NSFC [31101035]; Shandong Provincial Natural Science Foundation, China [BS2015SW014]	National Basic Research Program of China, Program 973(National Basic Research Program of China); National Natural Science Foundation of China, NSFC(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province)	National Basic Research Program of China, Program 973 (2011CB944202) to ZHL, http://www.most.gov.cn/; National Natural Science Foundation of China, NSFC (31101035) to ZHL, http://www.nsfc.gov.cn/; Shandong Provincial Natural Science Foundation, China (BS2015SW014) to YJH, http://www.sdnsf.gov.cn/portal/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betthauser J, 2000, NAT BIOTECHNOL, V18, P1055, DOI 10.1038/80242; Bonk AJ, 2007, EPIGENETICS-US, V2, P179, DOI 10.4161/epi.2.3.4844; Callesen H, 2014, CELL REPROGRAM, V16, P407, DOI 10.1089/cell.2014.0053; Galli C, 2012, REPROD DOMEST ANIM, V47, P2, DOI 10.1111/j.1439-0531.2012.02045.x; Hoshino Y, 2005, CLONING STEM CELLS, V7, P17, DOI 10.1089/clo.2005.7.17; Hu K, 2012, ANIM SCI J, V83, P639, DOI 10.1111/j.1740-0929.2011.01005.x; Huan YJ, 2015, GENE EXPR PATTERNS, V18, P1, DOI 10.1016/j.gep.2015.04.001; Huan YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129803; Huan YJ, 2015, CELL REPROGRAM, V17, P191, DOI 10.1089/cell.2014.0103; Huan YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127512; Huan YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126607; Huang YY, 2013, BIOL OPEN, V2, P1223, DOI 10.1242/bio.20135983; Ji Huili, 2014, Yichuan, V36, P1211, DOI 10.3724/SP.J.1005.2014.1211; Koo OJ, 2010, REPROD DOMEST ANIM, V45, P773, DOI 10.1111/j.1439-0531.2009.01346.x; Kurome M, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-43; Li ZC, 2013, CELL REPROGRAM, V15, P35, DOI 10.1089/cell.2012.0042; Liu Y, 2014, REPROD FERTIL DEV, V24; Martin L, 2007, MOL REPROD DEV, V74, P952, DOI 10.1002/mrd.20692; Mizutani E, 2015, METHODS MOL BIOL, V1222, P101, DOI 10.1007/978-1-4939-1594-1_8; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Rim CH, 2013, ANIM REPROD SCI, V26; Schmidt M, 2010, THERIOGENOLOGY, V74, P1233, DOI 10.1016/j.theriogenology.2010.05.026; Shi JS, 2015, ANIM REPROD SCI, V154, P121, DOI 10.1016/j.anireprosci.2015.01.006; Vajta G, 2007, REPROD FERT DEVELOP, V19, P403, DOI 10.1071/RD06089; Wei HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057728; Williams NE, 2006, CLONING STEM CELLS, V8, P130, DOI 10.1089/clo.2006.8.130	27	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142549	10.1371/journal.pone.0142549	http://dx.doi.org/10.1371/journal.pone.0142549			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26565717	Green Submitted, Green Published, gold			2022-12-26	WOS:000367628500031
J	Lu, Q; Luo, QS; Li, H; Liu, YD; Gu, JD; Lin, KF				Lu, Qiang; Luo, Qi Shi; Li, Hui; Liu, Yong Di; Gu, Ji Dong; Lin, Kuang Fei			Characterization of Chlorinated Aliphatic Hydrocarbons and Environmental Variables in a Shallow Groundwater in Shanghai Using Kriging Interpolation and Multifactorial Analysis	PLOS ONE			English	Article							CONTAMINATED AQUIFERS; REMEDIATION OPTIONS; INDUSTRIAL SITE; GERMANY; BITTERFELD; MULTIVARIATE; SOLVENTS; ETHENES	CAHs, as a cleaning solvent, widely contaminated shallow groundwater with the development of manufacturing in China's Yangtze River Delta. This study focused on the distribution of CAHs, and correlations between CAHs and environmental variables in a shallow groundwater in Shanghai, using kriging interpolation and multifactorial analysis. The results showed that the overall CAHs plume area (above DIV) was approximately 9,000 m(2) and located in the 2-4 m underground, DNAPL was accumulated at an area of approximately 1,400 m(2) and located in the 6-8m sandy silt layer on the top of the muddy silty clay. Heat-map of PPC for CAHs and environmental variables showed that the correlation between "Fe2+" and most CAHs such as "1,1,1-TCA", "1,1-DCA", "1,1-DCE" and "% TCA" were significantly positive (p<0.001), but "% CA" and/or "% VC" was not, and "Cl-" was significantly positive correlated with "1,1-DCA" and "1,1-DCE" (p<0.001). The PCA demonstrated that the relative proportions of CAHs in groundwater were mostly controlled by the sources and the natural attenuation. In conclusion, the combination of geographical and chemometrics was helpful to establishing an aerial perspective of CAHs and identifying reasons for the accumulation of toxic dechlorination intermediates, and could become a useful tool for characterizing contaminated sites in general.	[Lu, Qiang; Li, Hui; Liu, Yong Di; Lin, Kuang Fei] E China Univ Sci & Technol, Sch Resource & Environm Engn, State Environm Protect Key Lab Environm Risk Asse, Shanghai 200237, Peoples R China; [Luo, Qi Shi] Shanghai Inst Design & Res Environm Engn, Shanghai Engn Res Ctr Contaminated Sites Remediat, Shanghai 200237, Peoples R China; [Gu, Ji Dong] Univ Hong Kong, Swire Inst Marine Sci, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China	East China University of Science & Technology; University of Hong Kong	Li, H (corresponding author), E China Univ Sci & Technol, Sch Resource & Environm Engn, State Environm Protect Key Lab Environm Risk Asse, Shanghai 200237, Peoples R China.	huili@ecust.edu.cn; kflin@ecust.edu.cn	Gu, Ji-Dong/AAF-2291-2019; Gu, Ji-Dong/AAO-7851-2020; Hui, Li/B-4166-2009	Hui, Li/0000-0002-7574-048X; Lin, Kuangfei/0000-0002-0893-150X	National Natural Science Foundation of China [41273109, 51378208]; National Environmental Protection Public Welfare Science and Technology Research Program of China [201309047]; Program for New Century Excellent Talents in University [NCET-13-0797]; Fok Ying Tung Education Foundation [141077]; Specialized Research Fund for the Doctoral Program of Higher Education [20110074130002]; Shanghai Municipal Education Commission [14ZZ059]; Fundamental Research Funds for Central Universities [222201313008, 222201516015]; Shanghai Municipal Science and Technology Commission [15DZ1205804]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Environmental Protection Public Welfare Science and Technology Research Program of China; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fok Ying Tung Education Foundation(Fok Ying Tung Education Foundation); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities); Shanghai Municipal Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM))	This study was supported jointly by the National Natural Science Foundation of China (41273109, 51378208), the National Environmental Protection Public Welfare Science and Technology Research Program of China (No. 201309047), the Program for New Century Excellent Talents in University (NCET-13-0797), Fok Ying Tung Education Foundation (141077), the Specialized Research Fund for the Doctoral Program of Higher Education (20110074130002), the Innovation Program of the Shanghai Municipal Education Commission (14ZZ059), Fundamental Research Funds for Central Universities (222201313008, 222201516015), the Innovation Program of Shanghai Municipal Science and Technology Commission (15DZ1205804). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balouet JC, 2012, ENVIRON SCI TECHNOL, V46, P9541, DOI 10.1021/es300318v; Carlon C, 2001, ENVIRON POLLUT, V111, P417, DOI 10.1016/S0269-7491(00)00089-0; Chu KH, 2004, ENVIRON SCI TECHNOL, V38, P3126, DOI 10.1021/es035238c; Construction TDMo, 2000, DUTCH TARG INT VAL; Dickson SE, 2003, ENVIRON SCI TECHNOL, V37, P4128, DOI 10.1021/es026275r; Dorneich MC, 2013, IEEE SYS MAN CYBERN, P888, DOI 10.1109/SMC.2013.156; Facchinelli A, 2001, ENVIRON POLLUT, V114, P313, DOI 10.1016/S0269-7491(00)00243-8; Frascari D, 2006, J HAZARD MATER, V138, P29, DOI 10.1016/j.jhazmat.2006.05.009; Grostern A, 2006, APPL ENVIRON MICROB, V72, P7849, DOI 10.1128/AEM.01269-06; Heidrich S, 2004, ENVIRON POLLUT, V129, P277, DOI 10.1016/j.envpol.2003.10.029; Heidrich S, 2004, TOXICOLOGY, V205, P143, DOI 10.1016/j.tox.2004.06.055; Jha MK, 2007, WATER RESOUR MANAG, V21, P427, DOI 10.1007/s11269-006-9024-4; Kamburoglu K, 2014, DENTOMAXILLOFAC RAD, V43, DOI 10.1259/dmfr.20130332; Popp P, 2000, CHEMOSPHERE, V41, P849, DOI 10.1016/S0045-6535(99)00531-7; Reid MK, 2009, ENVIRON POLLUT, V157, P2275, DOI 10.1016/j.envpol.2009.03.033; Reimann C, 2000, ENVIRON GEOL, V39, P1001, DOI 10.1007/s002549900081; Scheutz C, 2011, WATER RES, V45, P2701, DOI 10.1016/j.watres.2011.02.027; Shani N, 2013, ENVIRON SCI TECHNOL, V47, P6836, DOI 10.1021/es304017s; Sun BL, 2002, SCIENCE, V298, P1023, DOI 10.1126/science.1074675; Thieken AH., 2001, SCHADSTOFFMUSTER REG; USEPA, 1986, EPA540186060; USEPA, 1992, HDB RCRA GROUND WAT; USEPA, 2012, SEARCH SUP SIT INF; USEPA, 1994, DNAPL SIT CHAR; Van Breukelen BM, 2012, ENVIRON SCI TECHNOL, V46, P7700, DOI 10.1021/es301058z; Webster R, 2001, EUR J SOIL SCI, V52, P331, DOI 10.1046/j.1365-2389.2001.00383.x; Weiss H, 2001, GRUNDWASSER, V6, P113, DOI DOI 10.1007/S767-001-8382-X; Weissflog L, 1999, ENVIRON POLLUT, V105, P341, DOI 10.1016/S0269-7491(99)00042-1; Wycisk P, 2003, TOXICOL LETT, V140, P343, DOI 10.1016/S0378-4274(03)00031-6	29	6	6	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142241	10.1371/journal.pone.0142241	http://dx.doi.org/10.1371/journal.pone.0142241			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26565796	Green Published, Green Submitted, gold			2022-12-26	WOS:000367628500014
J	Zafir, A; Bradley, JA; Long, BW; Muthusamy, S; Li, QH; Hill, BG; Wysoczynski, M; Prabhu, SD; Bhatnagar, A; Bolli, R; Jones, SP				Zafir, Ayesha; Bradley, James A.; Long, Bethany W.; Muthusamy, Senthilkumar; Li, Qianhong; Hill, Bradford G.; Wysoczynski, Marcin; Prabhu, Sumanth D.; Bhatnagar, Aruni; Bolli, Roberto; Jones, Steven P.			O-GlcNAcylation Negatively Regulates Cardiomyogenic Fate in Adult Mouse Cardiac Mesenchymal Stromal Cells	PLOS ONE			English	Article							STEM-CELLS; GLCNAC GLYCOSYLATION; PROGENITOR CELLS; DIFFERENTIATION; AUTOPHAGY; PROTEIN; HEART; CARDIOMYOCYTES; EXPRESSION; PROMOTER	In both preclinical and clinical studies, cell transplantation of several cell types is used to promote repair of damaged organs and tissues. Nevertheless, despite the widespread use of such strategies, there remains little understanding of how the efficacy of cell therapy is regulated. We showed previously that augmentation of a unique, metabolically derived stress signal (i.e., O-GlcNAc) improves survival of cardiac mesenchymal stromal cells; however, it is not known whether enhancing O-GlcNAcylation affects lineage commitment or other aspects of cell competency. In this study, we assessed the role of O-GlcNAc in differentiation of cardiac mesenchymal stromal cells. Exposure of these cells to routine differentiation protocols in culture increased markers of the cardiomyogenic lineage such as Nkx2.5 and connexin 40, and augmented the abundance of transcripts associated with endothelial and fibroblast cell fates. Differentiation significantly decreased the abundance of O-GlcNAcylated proteins. To determine if O-GlcNAc is involved in stromal cell differentiation, O-GlcNAcylation was increased pharmacologically during the differentiation protocol. Although elevated O-GlcNAc levels did not significantly affect fibroblast and endothelial marker expression, acquisition of cardiomyocyte markers was limited. In addition, increasing O-GlcNAcylation further elevated smooth muscle actin expression. In addition to lineage commitment, we also evaluated proliferation and migration, and found that increasing O-GlcNAcylation did not significantly affect either; however, we found that O-GlcNAc transferase-the protein responsible for adding O-GlcNAc to proteins-is at least partially required for maintaining cellular proliferative and migratory capacities. We conclude that O-GlcNAcylation contributes significantly to cardiac mesenchymal stromal cell lineage and function. O-GlcNAcylation and pathological conditions that may affect O-GlcNAc levels (such as diabetes) should be considered carefully in the context of cardiac cell therapy.	[Jones, Steven P.] Univ Louisville, Inst Mol Cardiol, Louisville, KY 40292 USA; Univ Louisville, Dept Med, Div Cardiovasc Med, Diabet & Obes Ctr, Louisville, KY 40292 USA	University of Louisville; University of Louisville	Jones, SP (corresponding author), Univ Louisville, Inst Mol Cardiol, Louisville, KY 40292 USA.	Steven.P.Jones@louisville.edu	Li, Qianhong/AAJ-7643-2020; Jones, Steven P./D-5092-2009; Muthusamy, Senthilkumar/Y-1353-2018; Hill, Bradford/I-4154-2013; Muthusamy, Senthilkumar/G-7875-2015	Jones, Steven P./0000-0001-5376-8089; Hill, Bradford/0000-0001-5332-8286; Muthusamy, Senthilkumar/0000-0003-1603-9965; Bradley, James/0000-0001-5570-4679	National Institutes of Health (NIH) [R01 HL083320, R01 HL094419, P20 GM103492, P01 HL078825]; American Heart Association [AHA13SDG14560005, AHA14POST18870020]; NIH [R01 HL083320, R01 HL094419, P20 GM103492, P01 HL078825]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094419, R01HL083320, P01HL078825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103492] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (NIH): R01 HL083320, R01 HL094419 (to SPJ), P20 GM103492 (to SPJ, BGH, MW, AB), P01 HL078825 (to SPJ, BGH, MW, SD, AB, RB), and from the American Heart Association: AHA13SDG14560005 (to MW), as well as an American Heart Association Postdoctoral Fellowship to AZ (AHA14POST18870020).; This work was supported by grants from the NIH: R01 HL083320, R01 HL094419 (to SPJ), P20 GM103492 (to SPJ, BGH, MW, AB), P01 HL078825 (to SPJ, BGH, MW, SDP, AB, RB), and from the American Heart Association: AHA13SDG14560005 (to MW), as well as an American Heart Association Postdoctoral Fellowship to AZ (AHA14POST18870020). We are thankful for technical support provided by Ms. Linda Harrison and Ms. Allison Aird.	Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Camelliti P, 2004, CIRC RES, V94, P828, DOI 10.1161/01.RES.0000122382.19400.14; Delorme B, 1997, CIRC RES, V81, P423, DOI 10.1161/01.RES.81.3.423; Fransioli J, 2008, STEM CELLS, V26, P1315, DOI 10.1634/stemcells.2007-0751; Hasan N, 2010, EXP CELL RES, V316, P12, DOI 10.1016/j.yexcr.2009.10.007; Hsieh TJ, 2012, J CELL PHYSIOL, V227, P108, DOI 10.1002/jcp.22707; Ishihara K, 2010, BIOCHEM BIOPH RES CO, V398, P489, DOI 10.1016/j.bbrc.2010.06.105; Jang H, 2012, CELL STEM CELL, V11, P62, DOI 10.1016/j.stem.2012.03.001; Jones SP, 2008, CIRCULATION, V117, P1172, DOI 10.1161/CIRCULATIONAHA.107.730515; Kasahara H, 1998, CIRC RES, V82, P936, DOI 10.1161/01.RES.82.9.936; Kim HS, 2009, FEBS LETT, V583, P2474, DOI 10.1016/j.febslet.2009.06.052; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; KOMURO I, 1993, P NATL ACAD SCI USA, V90, P8145, DOI 10.1073/pnas.90.17.8145; Li QH, 2011, BASIC RES CARDIOL, V106, P849, DOI 10.1007/s00395-011-0180-1; Li X, 2009, J BIOL CHEM, V284, P19248, DOI 10.1074/jbc.M109.005678; Linhares VLF, 2004, CARDIOVASC RES, V64, P402, DOI 10.1016/j.cardiores.2004.09.021; LINTS TJ, 1993, DEVELOPMENT, V119, P419; Maury JJP, 2013, STEM CELL RES, V11, P926, DOI 10.1016/j.scr.2013.06.004; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Ngoh GA, 2008, J MOL CELL CARDIOL, V45, P313, DOI 10.1016/j.yjmcc.2008.04.009; Ngoh GA, 2011, AMINO ACIDS, V40, P895, DOI 10.1007/s00726-010-0728-7; Ngoh GA, 2009, AM J PHYSIOL-HEART C, V297, pH1711, DOI 10.1152/ajpheart.00553.2009; Ngoh GA, 2009, CIRC RES, V104, P41, DOI 10.1161/CIRCRESAHA.108.189431; Ogawa M, 2013, BIOCHEM BIOPH RES CO, V433, P558, DOI 10.1016/j.bbrc.2013.03.033; Ogawa M, 2012, BBA-GEN SUBJECTS, V1820, P24, DOI 10.1016/j.bbagen.2011.10.011; Riggs KA, 2012, J CELL SCI, V125, P3827, DOI 10.1242/jcs.102566; Salabei JK, 2015, STEM CELLS, V33, P2613, DOI 10.1002/stem.2047; Salemi S, 2012, CELL RES, V22, P432, DOI 10.1038/cr.2011.200; Smits AM, 2009, NAT PROTOC, V4, P232, DOI 10.1038/nprot.2008.229; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Watson LJ, 2014, AM J PHYSIOL-HEART C, V306, pH142, DOI 10.1152/ajpheart.00438.2013; Watson LJ, 2010, P NATL ACAD SCI USA, V107, P17797, DOI 10.1073/pnas.1001907107; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Zafir A, 2013, STEM CELLS, V31, P765, DOI 10.1002/stem.1325; Zhang J, 2012, CIRC RES, V110, pE29, DOI 10.1161/CIRCRESAHA.111.255950	36	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142939	10.1371/journal.pone.0142939	http://dx.doi.org/10.1371/journal.pone.0142939			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26565625	Green Published, gold, Green Submitted			2022-12-26	WOS:000367628500075
J	Dong, XR; Tian, B; Dai, S; Li, T; Guo, LN; Tan, ZF; Jiao, Z; Jin, QS; Wang, YP; Hua, YJ				Dong, Xiangrong; Tian, Bing; Dai, Shang; Li, Tao; Guo, Linna; Tan, Zhongfang; Jiao, Zhen; Jin, Qingsheng; Wang, Yanping; Hua, Yuejin			Expression of PprI from Deinococcus radiodurans Improves Lactic Acid Production and Stress Tolerance in Lactococcus lactis	PLOS ONE			English	Article							ESCHERICHIA-COLI; EXTREME RADIORESISTANCE; LACTOBACILLUS-CASEI; RADIATION-DAMAGE; SALINITY STRESS; SALT TOLERANCE; RESISTANCE; REGULATOR; PROTEIN; GENE	PprI is a general switch protein that regulates the expression of certain proteins involved in pathways of cellular resistance in the extremophilic bacterium Deinococcus radiodurans. In this study, we transformed pprI into Lactococcus lactis strain MG1363 using the lactococcal shuttle vector pMG36e and investigated its effects on the tolerance and lactic acid production of L. lactis while under stress. PprI was stably expressed in L. lactis as confirmed by western blot assays. L. lactis expressing PprI exhibited significantly improved resistance to oxidative stress and high osmotic pressure. This enhanced cellular tolerance to stressors might be due to the regulation of resistance-related genes (e.g., recA, recO, sodA, and nah) by pprI. Moreover, transformed L. lactis demonstrated increased lactic acid production, attributed to enhanced lactate dehydrogenase activity. These results suggest that pprI can improve the tolerance of L. lactis to environmental stresses, and this transformed bacterial strain is a promising candidate for industrial applications of lactic acid production.	[Dong, Xiangrong; Guo, Linna; Tan, Zhongfang; Jiao, Zhen; Wang, Yanping] Zhengzhou Univ, Henan Prov Key Lab Ion Beam Bioengn, Zhengzhou 450052, Peoples R China; [Tian, Bing; Dai, Shang; Li, Tao; Hua, Yuejin] Zhejiang Univ, Chinese Minist Agr, Key Lab Nucl Agr Sci, Hangzhou 310029, Zhejiang, Peoples R China; [Tian, Bing; Dai, Shang; Li, Tao; Hua, Yuejin] Zhejiang Univ, Inst Nucl Agr Sci, Hangzhou 310029, Zhejiang, Peoples R China; [Jin, Qingsheng] Zhejiang Acad Agr Sci, Inst Crops & Utilizat Nucl Technol, Hangzhou 310021, Zhejiang, Peoples R China	Zhengzhou University; Ministry of Agriculture & Rural Affairs; Zhejiang University; Zhejiang University; Zhejiang Academy of Agricultural Sciences	Wang, YP (corresponding author), Zhengzhou Univ, Henan Prov Key Lab Ion Beam Bioengn, Zhengzhou 450052, Peoples R China.	wyp@zzu.edu.cn; yjhua@zju.edu.cn			Foundation of Henan Science and Technology Committee [132300410123]; Exploration, Torch-plan Project from Henan Province [112102310069]; Special Fund for Agro-Scientific Research in the Public Interest of China [201103007]; National Natural Science Foundation of China [11405147, 31170079, 31210103904, 31370119, 31370102]	Foundation of Henan Science and Technology Committee; Exploration, Torch-plan Project from Henan Province; Special Fund for Agro-Scientific Research in the Public Interest of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Foundation of Henan Science and Technology Committee (grant No. 132300410123), the Exploration, Torch-plan Project (grant No. 112102310069) from Henan Province, the Special Fund for Agro-Scientific Research in the Public Interest of China (grant No. 201103007), and the National Natural Science Foundation of China (http://www.nsfc.gov.cn/; grant Nos. 11405147, 31170079, 31210103904, 31370119 and 31370102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah-Al-Mahin, 2010, APPL ENVIRON MICROB, V76, P4277, DOI 10.1128/AEM.02878-09; Alscher RG, 2002, J EXP BOT, V53, P1331, DOI 10.1093/jexbot/53.372.1331; Aso Y, 2008, CURR MICROBIOL, V57, P89, DOI 10.1007/s00284-008-9161-5; Bauermeister A, 2009, ARCH MICROBIOL, V191, P913, DOI 10.1007/s00203-009-0522-7; CASTLE AM, 1986, J BIOL CHEM, V261, P7797; Chinnusamy V, 2005, CROP SCI, V45, P437, DOI 10.2135/cropsci2005.0437; Corcoran BM, 2008, CURR PHARM DESIGN, V14, P1382, DOI 10.2174/138161208784480225; Douillard FP, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-S1-S8; Earl AM, 2002, J BACTERIOL, V184, P6216, DOI 10.1128/JB.184.22.6216-6224.2002; EPSTEIN W, 1965, J GEN PHYSIOL, V49, P221, DOI 10.1085/jgp.49.2.221; Fini A, 2014, ANN BOT-LONDON, V114, P525, DOI 10.1093/aob/mcu130; Freire CA, 2011, COMP BIOCHEM PHYS A, V160, P291, DOI 10.1016/j.cbpa.2011.06.024; Fu RY, 2005, APPL ENVIRON MICROB, V71, P8911, DOI 10.1128/AEM.71.12.8911-8919.2005; Gao GJ, 2006, FEMS MICROBIOL LETT, V257, P195, DOI 10.1111/j.1574-6968.2006.00169.x; Gao GJ, 2003, DNA REPAIR, V2, P1419, DOI 10.1016/j.dnarep.2003.08.012; Gaspar P, 2013, BIOTECHNOL ADV, V31, P764, DOI 10.1016/j.biotechadv.2013.03.011; Gu WL, 2015, WORLD J MICROB BIOT, V31, P557, DOI 10.1007/s11274-015-1809-2; Hua YJ, 2003, BIOCHEM BIOPH RES CO, V306, P354, DOI 10.1016/S0006-291X(03)00965-3; Karimi R, 2012, J DAIRY SCI, V95, P4209, DOI 10.3168/jds.2011-4872; Lu HM, 2012, DNA REPAIR, V11, P139, DOI 10.1016/j.dnarep.2011.10.013; Lu HM, 2009, MOL CELL PROTEOMICS, V8, P481, DOI 10.1074/mcp.M800123-MCP200; Ludanyi M, 2014, MOL MICROBIOL, V94, P434, DOI 10.1111/mmi.12774; Pan J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004422; Sun HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035057; Tian HT, 2012, BRAZ J MICROBIOL, V43, P1157, DOI [10.1590/S1517-83822012000300043, 10.1590/S1517-838220120003000043]; Ulve VM, 2008, J APPL MICROBIOL, V105, P1327, DOI 10.1111/j.1365-2672.2008.03869.x; Wang LY, 2008, MOL MICROBIOL, V67, P1211, DOI 10.1111/j.1365-2958.2008.06113.x; Wang YG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122071; Wu CD, 2013, BIORESOURCE TECHNOL, V143, P238, DOI 10.1016/j.biortech.2013.05.050; Wu CD, 2012, J IND MICROBIOL BIOT, V39, P1031, DOI 10.1007/s10295-012-1104-2; Wu CD, 2012, APPL MICROBIOL BIOT, V93, P707, DOI 10.1007/s00253-011-3757-6; Zhang MR, 2014, J SCI FOOD AGR, V94, P3125, DOI 10.1002/jsfa.6662; Zhang Y, 2010, J MICROBIOL BIOTECHN, V20, P1156, DOI 10.4014/jmb.0912.12036; Zhou ZF, 2011, MOL BIOSYST, V7, P1613, DOI 10.1039/c0mb00336k	34	14	17	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142918	10.1371/journal.pone.0142918	http://dx.doi.org/10.1371/journal.pone.0142918			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562776	Green Submitted, Green Published, gold			2022-12-26	WOS:000364480900083
J	de los Santos, M; Gamiz, P; de los Santos, J; Romero, JL; Prados, N; Alonso, C; Remohi, J; Dominguez, F				Jose de los Santos, Maria; Gamiz, Pilar; Maria de los Santos, Jose; Lluis Romero, Josep; Prados, Nicolas; Alonso, Cristina; Remohi, Jose; Dominguez, Francisco			The Metabolomic Profile of Spent Culture Media from Day-3 Human Embryos Cultured under Low Oxygen Tension	PLOS ONE			English	Article							PREIMPLANTATION MOUSE EMBRYOS; AMINO-ACID TURNOVER; NEAR-INFRARED SPECTROSCOPY; IN-VITRO FERTILIZATION; HUMAN OOCYTES; DEVELOPMENTAL COMPETENCE; NONINVASIVE MEASUREMENT; PYRUVATE UPTAKE; BOVINE EMBRYOS; FATTY-ACIDS	Despite efforts made to improve the in vitro embryo culture conditions used during assisted reproduction procedures, human embryos must adapt to different in vitro oxygen concentrations and the new metabolic milieu provided by the diverse culture media used for such protocols. It has been shown that the embryo culture environment can affect not only cellular metabolism, but also gene expression in different species of mammalian embryos. Therefore we wanted to compare the metabolic footprint left by human cleavage-stage embryos under two types of oxygen atmospheric culture conditions (6% and 20% O-2). The spent culture media from 39 transferred and implanted embryos from a total of 22 patients undergoing egg donation treatment was analyzed; 23 embryos came from 13 patients in the 6% oxygen concentration group, and 16 embryos from 9 patients were used in the 20% oxygen concentration group. The multivariate statistics we used in our analysis showed that human cleavage-stage embryos grown under both types of oxygen concentration left a similar metabolic fingerprint. We failed to observe any change in the net depletion or release of relevant analytes, such as glucose and especially fatty acids, by human cleavage-stage embryos under either type of culture condition. Therefore it seems that low oxygen tension during embryo culture does not alter the global metabolism of human cleavage-stage embryos.	[Jose de los Santos, Maria; Gamiz, Pilar; Maria de los Santos, Jose; Lluis Romero, Josep; Remohi, Jose] IVI Valencia, Valencia, Spain; [Jose de los Santos, Maria; Maria de los Santos, Jose; Remohi, Jose; Dominguez, Francisco] INCLIVA Biomed Res & Fdn IVI, Valencia, Spain; [Prados, Nicolas] IVI Sevilla, Seville, Spain; [Alonso, Cristina] OWL, Derio, Spain	University of Valencia	de los Santos, M (corresponding author), IVI Valencia, Valencia, Spain.	mariajose.delossantos@ivi.es; francisco.dominguez@ivi.es	Dominguez, Francisco/AAA-7260-2020; Prados, Nicolas/P-1554-2016	Dominguez, Francisco/0000-0002-7620-8081; Prados, Nicolas/0000-0002-7888-2125; Alonso, Cristina/0000-0002-2019-678X	Spanish Ministry of Economy and Competitiveness, through the Miguel Servet Programme [CP13/00075]; FEDER; R+D programme from the Generalitat Valenciana (Regional Valencian Government) IMPIVA [MIDTF/2011/214]	Spanish Ministry of Economy and Competitiveness, through the Miguel Servet Programme; FEDER(European Commission); R+D programme from the Generalitat Valenciana (Regional Valencian Government) IMPIVA	FD's participation was supported by the Spanish Ministry of Economy and Competitiveness, through the Miguel Servet Programme (CP13/00075) co-founded by FEDER and by the R+D programme from the Generalitat Valenciana (Regional Valencian Government) IMPIVA MIDTF/2011/214. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer BK, 2010, BIOL REPROD, V83, P791, DOI 10.1095/biolreprod.110.085936; Bauereis B, 2011, NEUROSCI LETT, V488, P11, DOI 10.1016/j.neulet.2010.10.071; Baumann CG, 2007, MOL REPROD DEV, V74, P1345, DOI 10.1002/mrd.20604; Bellver J, 2015, FERTIL STERIL, V103, P1407, DOI 10.1016/j.fertnstert.2015.03.015; Bontekoe S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008950.pub2; Booth PJ, 2007, BIOL REPROD, V77, P765, DOI 10.1095/biolreprod.107.062802; Booth PJ, 2005, REPRODUCTION, V130, P655, DOI 10.1530/rep.1.00727; Brison DR, 2007, REPROD BIOMED ONLINE, V15, P296, DOI 10.1016/S1472-6483(10)60342-2; Brison DR, 2004, HUM REPROD, V19, P2319, DOI 10.1093/humrep/deh409; Bylesjo M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-106; Cobo A, 2011, REPROD BIOMED ONLINE, V23, P341, DOI 10.1016/j.rbmo.2011.05.014; Cobo A, 2010, HUM REPROD, V25, P2239, DOI 10.1093/humrep/deq146; CONAGHAN J, 1993, J REPROD FERTIL, V99, P87; CONAGHAN J, 1993, J ASSIST REPROD GEN, V10, P21, DOI 10.1007/BF01204436; Correa GA, 2008, ANIM REPROD SCI, V104, P132, DOI 10.1016/j.anireprosci.2007.02.002; Dominguez F, 2013, FERTIL STERIL, V99, P565, DOI 10.1016/j.fertnstert.2012.09.034; Dunning KR, 2014, REPRODUCTION, V148, pR15, DOI 10.1530/REP-13-0251; EDWARDS JL, 1995, THERIOGENOLOGY, V44, P329, DOI 10.1016/0093-691X(95)00188-E; FISCHER B, 1993, J REPROD FERTIL, V99, P673, DOI 10.1530/jrf.0.0990673; FISCHER B, 1992, EUR J OBSTET GYN R B, V43, P39, DOI 10.1016/0028-2243(92)90241-P; Gardner DK, 2013, REPRODUCTION, V146, P49, DOI 10.1530/REP-12-0348; GARDNER DK, 1988, DEVELOPMENT, V104, P423; GARDNER DK, 1986, HUM REPROD, V1, P25, DOI 10.1093/oxfordjournals.humrep.a136336; Hardarson T, 2012, HUM REPROD, V27, P89, DOI 10.1093/humrep/der373; HARDY K, 1989, HUM REPROD, V4, P188, DOI 10.1093/oxfordjournals.humrep.a136869; Houghton FD, 2004, EUR J OBSTET GYN R B, V115, pS92, DOI 10.1016/j.ejogrb.2004.01.019; Houghton FD, 2002, HUM REPROD, V17, P999, DOI 10.1093/humrep/17.4.999; Joliffe I. T., 2002, PRINCIPAL COMPONENT, V2nd; Katz-Jaffe MG, 2005, REPRODUCTION, V130, P899, DOI 10.1530/rep.1.00854; Kirkegaard K, 2014, HUM REPROD, V29, P2413, DOI 10.1093/humrep/deu236; Kumar P, 2015, J ASSIST REPROD GEN, V32, P471, DOI 10.1007/s10815-014-0418-6; Leese HJ, 2008, MOL HUM REPROD, V14, P667, DOI 10.1093/molehr/gan065; LEESE HJ, 1986, HUM REPROD, V1, P181, DOI 10.1093/oxfordjournals.humrep.a136376; Matorras R, 1998, HUM REPROD, V13, P2227, DOI 10.1093/humrep/13.8.2227; McKeegan PJ, 2012, REPROD FERT DEVELOP, V24, P59, DOI 10.1071/RD11907; Nadal-Desbarats L, 2013, MAGN RESON MATER PHY, V26, P193, DOI 10.1007/s10334-012-0331-x; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Ottosen LDM, 2006, REPROD BIOMED ONLINE, V13, P380, DOI 10.1016/S1472-6483(10)61443-5; Picton HM, 2010, MOL HUM REPROD, V16, P557, DOI 10.1093/molehr/gaq040; Pucci O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047116; Redel BK, 2012, MOL REPROD DEV, V79, P262, DOI 10.1002/mrd.22017; Robinson CM, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-74; Rubio C, 1997, Front Biosci, V2, pf1; Rust M., 1984, AM MED NEWS, V27, P12; Sanchez-Ribas I, 2012, FERTIL STERIL, V98, P1157, DOI 10.1016/j.fertnstert.2012.07.1145; Seli E, 2007, FERTIL STERIL, V88, P1350, DOI 10.1016/j.fertnstert.2007.07.1390; Seli E, 2011, J ASSIST REPROD GEN, V28, P137, DOI 10.1007/s10815-010-9501-9; Shahrzad S, 2007, EPIGENETICS-US, V2, P119, DOI 10.4161/epi.2.2.4613; Singh R, 2007, THERIOGENOLOGY, V68, pS56, DOI 10.1016/j.theriogenology.2007.04.007; Sturmey RG, 2009, REPROD DOMEST ANIM, V44, P50, DOI 10.1111/j.1439-0531.2009.01402.x; Tejera A, 2012, FERTIL STERIL, V98, P849, DOI 10.1016/j.fertnstert.2012.06.040; Trimarchi JR, 2000, BIOL REPROD, V62, P1866, DOI 10.1095/biolreprod62.6.1866; VanBlerkom J, 1997, HUM REPROD, V12, P1047; Vergouw CG, 2014, HUM REPROD, V29, P455, DOI 10.1093/humrep/det456; Wale PL, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100552; Whitworth KM, 2005, BIOL REPROD, V72, P1437, DOI 10.1095/biolreprod.104.037952; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510; Wrenzycki C, 2001, HUM REPROD, V16, P893, DOI 10.1093/humrep/16.5.893; YEDWAB GA, 1976, FERTIL STERIL, V27, P304	59	8	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142724	10.1371/journal.pone.0142724	http://dx.doi.org/10.1371/journal.pone.0142724			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562014	Green Published, Green Submitted, gold			2022-12-26	WOS:000364480900059
J	Cox, DTC; Gaston, KJ				Cox, Daniel T. C.; Gaston, Kevin J.			Likeability of Garden Birds: Importance of Species Knowledge & Richness in Connecting People to Nature	PLOS ONE			English	Article							FEEDING WILD BIRDS; PSYCHOLOGICAL BENEFITS; STRESS RECOVERY; URBAN NATURE; BIODIVERSITY; HEALTH; ENVIRONMENTS; CONSERVATION; RESTORATION; ATTITUDES	Interacting with nature is widely recognised as providing many health and well-being benefits. As people live increasingly urbanised lifestyles, the provision of food for garden birds may create a vital link for connecting people to nature and enabling them to access these benefits. However, it is not clear which factors determine the pleasure that people receive from watching birds at their feeders. These may be dependent on the species that are present, the abundance of individuals and the species richness of birds around the feeders. We quantitatively surveyed urban households from towns in southern England to determine the factors that influence the likeability of 14 common garden bird species, and to assess whether people prefer to see a greater abundance of individuals or increased species richness at their feeders. There was substantial variation in likeability across species, with songbirds being preferred over non-songbirds. Species likeability increased for people who fed birds regularly and who could name the species. We found a strong correlation between the number of species that a person could correctly identify and how connected to nature they felt when they watched garden birds. Species richness was preferred over a greater number of individuals of the same species. Although we do not show causation this study suggests that it is possible to increase the well-being benefits that people gain from watching birds at their feeders. This could be done first through a human to bird approach by encouraging regular interactions between people and their garden birds, such as through learning the species names and providing food. Second, it could be achieved through a bird to human approach by increasing garden songbird diversity because the pleasure that a person receives from watching an individual bird at a feeder is dependent not only on its species but also on the diversity of birds at the feeder.	[Cox, Daniel T. C.; Gaston, Kevin J.] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England	University of Exeter	Cox, DTC (corresponding author), Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England.	dan.t.cox@googlemail.com		Gaston, Kevin J./0000-0002-7235-7928	Natural Environment Research Council [NE/J015237/1]; NERC [NE/J015237/1, NE/J015067/1] Funding Source: UKRI; Natural Environment Research Council [NE/J015067/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Support was provided by the Natural Environment Research Council grant NE/J015237/1 [http://www.nerc.ac.uk].	Barton K., 2015, MUMIN MULTIMODEL INF; Belaire JA, 2015, CONDOR, V117, P192, DOI 10.1650/CONDOR-14-128.1; Brown C., 2005, BUILD ENVIRON, V31, P326, DOI [10.2148/benv.2005.31.4.326, DOI 10.2148/BENV.2005.31.4.326]; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Caula S, 2009, URBAN FOR URBAN GREE, V8, P117, DOI 10.1016/j.ufug.2008.12.004; Christensen RHB., 2015, ORDINAL REGRESSION M; Cosquer A, 2012, ECOL SOC, V17, DOI 10.5751/ES-04955-170402; Curtin S, 2009, CURR ISSUES TOUR, V12, P451, DOI 10.1080/13683500903042857; Dallimer M, 2012, BIOSCIENCE, V62, P47, DOI 10.1525/bio.2012.62.1.9; Davies ZG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039692; DRISCOLL JW, 1992, ANTHROZOOS, V5, P32, DOI 10.2752/089279392787011575; Dunning JB, 1997, CONSERV BIOL, V11, P6, DOI 10.1046/j.1523-1739.1997.96406.x; Fuller RA, 2008, DIVERS DISTRIB, V14, P131, DOI 10.1111/j.1472-4642.2007.00439.x; Fuller RA, 2007, BIOLOGY LETT, V3, P390, DOI 10.1098/rsbl.2007.0149; Galbraith JA, 2015, P NATL ACAD SCI USA, V112, pE2648, DOI 10.1073/pnas.1501489112; Galbraith JA, 2014, BIOL CONSERV, V180, P64, DOI 10.1016/j.biocon.2014.09.038; Gaston KJ, 2007, BIODIVERS CONSERV, V16, P3227, DOI 10.1007/s10531-007-9174-6; Gaston KJ, 2005, BIODIVERS CONSERV, V14, P3327, DOI 10.1007/s10531-004-9513-9; Gross H, 2007, J ENVIRON PSYCHOL, V27, P225, DOI 10.1016/j.jenvp.2007.04.003; Gunnthorsdottir A, 2001, ANTHROZOOS, V14, P204, DOI 10.2752/089279301786999355; Hanski I, 2012, P NATL ACAD SCI USA, V109, P8334, DOI 10.1073/pnas.1205624109; Hartig T, 2014, ANNU REV PUBL HEALTH, V35, P207, DOI 10.1146/annurev-publhealth-032013-182443; Ishigame Go, 2007, Ornithological Science, V6, P11, DOI 10.2326/1347-0558(2007)6[11:PAAOSA]2.0.CO;2; Jones D, 2011, EMU, V111, pI, DOI 10.1071/MUv111n2_ED; Jones DN, 2008, J AVIAN BIOL, V39, P265, DOI 10.1111/j.0908-8857.2008.04271.x; Kaplan R, 2001, ENVIRON BEHAV, V33, P507, DOI 10.1177/00139160121973115; Keniger LE, 2013, INT J ENV RES PUB HE, V10, P913, DOI 10.3390/ijerph10030913; Kennedy D., 2015, BBC; Lindemann-Matthies P, 2008, HUM ECOL, V36, P731, DOI 10.1007/s10745-008-9194-1; Loram A, 2011, ENVIRON MANAGE, V48, P808, DOI 10.1007/s00267-011-9723-3; Lyytimaki J, 2009, URBAN FOR URBAN GREE, V8, P309, DOI 10.1016/j.ufug.2009.09.003; Maciejewski K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088192; Miller JR, 2005, TRENDS ECOL EVOL, V20, P430, DOI 10.1016/j.tree.2005.05.013; Miller JR, 2002, CONSERV BIOL, V16, P330, DOI 10.1046/j.1523-1739.2002.00420.x; Mitchell R, 2013, SOC SCI MED, V91, P130, DOI 10.1016/j.socscimed.2012.04.012; PYLE RM, 1977, HORTICULTURE, V55, P65; R Foundation for Statistical Computing, 2015, R LANG ENV STAT COMP; Ratcliffe E, 2013, J ENVIRON PSYCHOL, V36, P221, DOI 10.1016/j.jenvp.2013.08.004; Restall B, 2015, J ENVIRON MANAGE, V159, P264, DOI 10.1016/j.jenvman.2015.05.022; Richards SA, 2005, ECOLOGY, V86, P2805, DOI 10.1890/05-0074; Robb GN, 2008, FRONT ECOL ENVIRON, V6, P476, DOI 10.1890/060152; Rollinson Daniel J., 2003, Corella, V27, P52; Shanahan DF, 2015, BIOSCIENCE, V65, P476, DOI 10.1093/biosci/biv032; Shanahan Danielle F, 2015, Am J Public Health, V105, P470, DOI 10.2105/AJPH.2014.302324; Shinew KJ, 2004, J LEISURE RES, V36, P336, DOI 10.1080/00222216.2004.11950027; Shwartz A, 2014, BIOL CONSERV, V171, P82, DOI 10.1016/j.biocon.2014.01.009; Tawse J, 2010, BIOSC HORIZ, V3, P157; Tisdell C, 2005, ANTHROZOOS, V18, P160, DOI 10.2752/089279305785594216; ULRICH RS, 1991, J ENVIRON PSYCHOL, V11, P201, DOI 10.1016/S0272-4944(05)80184-7; US Census Bureau, 2011, NAT SURV FISH HUNT; Van Den Berg AE, 2011, J HEALTH PSYCHOL, V16, P3, DOI 10.1177/1359105310365577; Zelenski JM, 2014, ENVIRON BEHAV, V46, P3, DOI 10.1177/0013916512451901	52	88	92	5	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141505	10.1371/journal.pone.0141505	http://dx.doi.org/10.1371/journal.pone.0141505			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7DR	26560968	gold, Green Published, Green Submitted			2022-12-26	WOS:000364433100035
J	Gilligan, TM; Tembrock, LR; Farris, RE; Barr, NB; van der Straten, MJ; van de Vossenberg, BTLH; Metz-Verschure, E				Gilligan, Todd M.; Tembrock, Luke R.; Farris, Roxanne E.; Barr, Norman B.; van der Straten, Marja J.; van de Vossenberg, Bart T. L. H.; Metz-Verschure, Eveline			A Multiplex Real-Time PCR Assay to Diagnose and Separate Helicoverpa armigera and H-zea (Lepidoptera: Noctuidae) in the New World	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; MOLECULAR-IDENTIFICATION; HUBNER LEPIDOPTERA; DNA; NORTH; DIFFERENTIATION; SEQUENCE; RECORD	The Old World bollworm, Helicoverpa armigera (Hubner), and the corn earworm, H. zea (Boddie), are two of the most important agricultural pests in the world. Diagnosing these two species is difficult-adults can only be separated with a complex dissection, and larvae cannot be identified to species using morphology, necessitating the use of geographic origin for identification in most instances. With the discovery of H. armigera in the New World, identification of immature Helicoverpa based on origin is no longer possible because H. zea also occurs in all of the geographic regions where H. armigera has been discovered. DNA barcoding and restriction fragment length polymorphism (RFLP) analyses have been reported in publications to distinguish these species, but these methods both require post-PCR processing (i.e., DNA sequencing or restriction digestion) to complete. We report the first real-time PCR assay to distinguish these pests based on two hydrolysis probes that bind to a segment of the internal transcribed spacer region 2 (ITS2) amplified using a single primer pair. One probe targets H. armigera, the second probe targets H. zea, and a third probe that targets a conserved segment of 18S rDNA is used as a control of DNA quality. The assay can be completed in 50 minutes when using isolated DNA and is successfully tested on larvae intercepted at ports of entry and adults captured during domestic surveys. We demonstrate that the assay can be run in triplex with no negative effects on sensitivity, can be run using alternative real-time PCR reagents and instruments, and does not cross react with other New World Heliothinae.	[Gilligan, Todd M.] USDA APHIS PPQ Sci & Technol, Identificat Technol Program, Ft Collins, CO 80526 USA; [Tembrock, Luke R.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Farris, Roxanne E.; Barr, Norman B.] USDA APHIS PPQ Sci & Technol, Mission Lab, Edinburg, TX USA; [van der Straten, Marja J.; van de Vossenberg, Bart T. L. H.; Metz-Verschure, Eveline] Minist Econ Affairs, Natl Plant Protect Org, Netherlands Food & Consumers Prod Safety Author, Wageningen, Netherlands	Colorado State University	Gilligan, TM (corresponding author), USDA APHIS PPQ Sci & Technol, Identificat Technol Program, Ft Collins, CO 80526 USA.	todd.m.gilligan@aphis.usda.gov		van de Vossenberg, Bart T.L.H./0000-0003-1205-6119	U.S. Department of Agriculture Farm [3.0248]	U.S. Department of Agriculture Farm	This work was funded by U.S. Department of Agriculture Farm Bill Section 10007 for FY2014 suggestion number 3.0248 to TMG and NBB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Amornsak W, 1998, AUST J ENTOMOL, V37, P174, DOI 10.1111/j.1440-6055.1998.tb01567.x; Barr NB, 2011, J ECON ENTOMOL, V104, P1706, DOI 10.1603/EC11093; Barr NB, 2009, J ECON ENTOMOL, V102, P2333, DOI 10.1603/029.102.0640; Behere GT, 2008, B ENTOMOL RES, V98, P599, DOI 10.1017/S0007485308005956; Behere GT, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-117; Braasch DA, 2001, CHEM BIOL, V8, P1, DOI 10.1016/S1074-5521(00)00058-2; Brambila J., 2009, INSTRUCTIONS DISSECT; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cunningham JP, 2014, J ECON ENTOMOL, V107, P881, DOI 10.1603/EC14036; Czepak Cecília, 2013, Pesqui. Agropecu. Trop., V43, P110, DOI 10.1590/S1983-40632013000100015; El-Lissy O, 2015, DETECTION OLD WORLD; Murua MG, 2014, FLA ENTOMOL, V97, P854, DOI 10.1653/024.097.0279; Gilligan TM, 2014, LEPINTERCEPT IDENTIF; HARDWICK D. F., 1965, Memoirs of the Entomology Society of Canada; Harris DJ, 2000, MOL BIOL EVOL, V17, P284, DOI 10.1093/oxfordjournals.molbev.a026308; Hayden J., 2015, PEST ALERT HELICOVER; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Keller I, 2006, GENETICS, V174, P863, DOI 10.1534/genetics.106.061341; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Kranthi S, 2005, CURR SCI INDIA, V89, P1322; Kriticos DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119618; LASTER ML, 1995, J ECON ENTOMOL, V88, P1288, DOI 10.1093/jee/88.5.1288; LASTER ML, 1995, J ECON ENTOMOL, V88, P77, DOI 10.1093/jee/88.1.77; Leite NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113286; Logan J. M. J., 2004, REAL TIME PCR ESSENT, P13; Magnacca KN, 2010, MOL ECOL RESOUR, V10, P60, DOI 10.1111/j.1755-0998.2009.02724.x; Mastrangelo T, 2014, J ECON ENTOMOL, V107, P970, DOI 10.1603/EC13403; Matthews M., 1999, Heliothine moths of Australia. A guide to pest bollworms and related noctuid groups.; Ming Qing-Lei, 2006, Insect Science, V13, P437, DOI 10.1111/j.1744-7917.2006.00113.x; Bueno RCOD, 2014, REV BRAS FRUTIC, V36, P520, DOI 10.1590/0100-2945-357/13; Owczarzy R, 2011, BIOCHEMISTRY-US, V50, P9352, DOI 10.1021/bi200904e; Pogue MG, 2004, ANN ENTOMOL SOC AM, V97, P1222, DOI 10.1603/0013-8746(2004)097[1222:ANSOHZ]2.0.CO;2; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Smith E., 2014, PHYTOSANITARY ALERT; Specht A, 2013, PESQUI AGROPECU BRAS, V48, P689, DOI 10.1590/S0100-204X2013000600015; Tay WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080134; Taylor S, 2010, METHODS, V50, pS1, DOI 10.1016/j.ymeth.2010.01.005; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596	42	22	23	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142912	10.1371/journal.pone.0142912	http://dx.doi.org/10.1371/journal.pone.0142912			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558366	gold, Green Published, Green Submitted			2022-12-26	WOS:000364433100138
J	Lam, WWT; Liao, QY; Wong, JHF; Lai, CL; Yuen, MF; Tsang, JWH; Fielding, R				Lam, Wendy Wing Tak; Liao, Qiuyan; Wong, Jennifer Hiu Fai; Lai, Ching Lung; Yuen, Man Fung; Tsang, Janice Wing Hang; Fielding, Richard			Measuring and Validating a General Cancer Predisposition Perception Scale: An Adaptation of the Revised-IPQ-Genetic Predisposition Scale	PLOS ONE			English	Article							CHINESE-HEALTH-QUESTIONNAIRE; RHEUMATOID-ARTHRITIS; ILLNESS PERCEPTIONS; FUNCTIONAL STATUS; BREAST-CANCER; WOMEN; ADJUSTMENT; BELIEFS; VERSION; RISK	Background Illness perceptions are linked to individual help-seeking and preventive behaviors. Previous illness perception studies have identified five dimensions of illness-related experience and behaviour. The Revised Illness Perception Questionnaire (IPQ-R) for genetic predisposition (IPQ-R-GP) was developed to measure illness perceptions in those genetically-predisposed to blood disease. We adapted the IPQ-R-GP to measure perceptions of generalized cancer predisposition. This paper describes the development and validation of the Cancer Predisposition Perception Scale (CPPS). Methods The draft CPPS scale was first administered to 167 well Hepatitis B carriers and 123 other healthy individuals and the factor structure was examined using Exploratory Factor Analysis. Then the factor structure was confirmed in a second sample comprising 148 healthy controls, 150 smokers and 152 passive smokers using Confirmatory Factor Analysis (CFA). Results Six-factors comprising 26 items provided optimal fit by eigen and scree-plot methods, accounting for 58.9% of the total variance. CFA indicated good fit of the six-factor model after further excluding three items. The six factors, Emotional representation (5 items), Illness coherence (4 items), Treatment control (3 items), Consequences (5 items), Internal locus of control (2 items) and External locus of control (4 items) demonstrated adequate-togood subscale internal consistency (Cronbach's a = 0.63-0.90). Divergent validity was suggested by low correlations with optimism, self-efficacy, and scales for measuring physical and psychological health symptoms. Conclusion The CPPS appears to be a valid measure of perceived predisposition to generic cancer risks and can be used to examine cancer-risk-related cognitions in individuals at higher and lower cancer risk.	[Lam, Wendy Wing Tak; Liao, Qiuyan; Wong, Jennifer Hiu Fai; Fielding, Richard] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Lai, Ching Lung; Yuen, Man Fung] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Tsang, Janice Wing Hang] Univ Hong Kong, Dept Med Oncol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Fielding, R (corresponding author), Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China.	fielding@hku.hk	; Lam, Wendy Wing Tak/C-4319-2009	Lai, Ching-Lung/0000-0002-5927-2436; Liao, Qiuyan/0000-0002-1105-6857; Lam, Wendy Wing Tak/0000-0003-2383-0149	Hong Kong Government's Research fund for Health and Health Service Research [08090791]	Hong Kong Government's Research fund for Health and Health Service Research	This work was funded by a grant from the Hong Kong Government's Research fund for Health and Health Service Research (grant no: 08090791), http://rfs2.fhb.gov.hk/english/funds/funds_hmrf/funds_hmrf_abt/funds_hmrf_abt.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowling A, 2005, J EPIDEMIOL COMMUN H, V59, P342, DOI 10.1136/jech.2004.021204; Chen SL, 2008, J ADV NURS, V64, P524, DOI 10.1111/j.1365-2648.2008.04808.x; CHENG TA, 1990, ACTA PSYCHIAT SCAND, V82, P304, DOI 10.1111/j.1600-0447.1990.tb01389.x; Cheung SK, 1999, PSYCHOL REP, V85, P1221, DOI 10.2466/pr0.1999.85.3f.1221; CHONG MY, 1989, PSYCHOL MED, V19, P495, DOI 10.1017/S0033291700012526; Dhanasekaran R, 2012, HEPATIC MED-EVID RES, V4, P19, DOI 10.2147/HMER.S16316; Griva K, 2000, PSYCHOL HEALTH, V15, P733, DOI 10.1080/08870440008405578; Groarke AM, 2005, PSYCHOL HEALTH, V20, P597, DOI 10.1080/14768320500094177; Hagger MS, 2005, PSYCHOL HEALTH, V20, P161, DOI 10.1080/0887044042000334724; Heijmans MJWM, 1998, J PSYCHOSOM RES, V45, P39, DOI 10.1016/S0022-3999(97)00265-1; Hong Kong Office of the Telecommunications Authority, 2014, KEY TEL STAT HONG KO; IDLER EL, 1995, J GERONTOL B-PSYCHOL, V50, pS344, DOI 10.1093/geronb/50B.6.S344; Kaptein AA, 2007, HEALTH PSYCHOL, V26, P807, DOI 10.1037/0278-6133.26.6.807; Kline R.B., 2011, PRINCIPLES PRACTICE; Lai JCL, 2000, PERS INDIV DIFFER, V28, P781, DOI 10.1016/S0191-8869(99)00138-5; Lam WWT, 2010, PSYCHO-ONCOLOGY, V19, P1044, DOI 10.1002/pon.1658; Leventhal H, 1998, PSYCHOL HEALTH, V13, P717, DOI 10.1080/08870449808407425; Leventhal H., 1984, HDB PSYCHOL HLTH, V4, P219; Li WWY, 2012, PSYCHO-ONCOLOGY, V21, P1316, DOI 10.1002/pon.2038; McCaul KD, 1996, HEALTH PSYCHOL, V15, P423, DOI 10.1037/0278-6133.15.6.423; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; Pesch B, 2012, INT J CANCER, V131, P1210, DOI 10.1002/ijc.27339; Scharloo M, 1999, J RHEUMATOL, V26, P1686; Scharloo M, 2000, BRIT J DERMATOL, V142, P899, DOI 10.1046/j.1365-2133.2000.03469.x; Schwarzer R., 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000; Takagi H, 2006, LUNG CANCER, V51, P245, DOI 10.1016/j.lungcan.2005.11.004; Thun MJ, 2002, ONCOGENE, V21, P7307, DOI 10.1038/sj.onc.1205807; WALLSTON KA, 1978, HEALTH EDUC QUART, V6, P160, DOI 10.1177/109019817800600107; Yuen MF, 2009, J GASTROEN HEPATOL, V24, P346, DOI 10.1111/j.1440-1746.2009.05784.x	29	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142620	10.1371/journal.pone.0142620	http://dx.doi.org/10.1371/journal.pone.0142620			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7DR	26559191	gold, Green Published, Green Submitted			2022-12-26	WOS:000364433100103
J	Tseng, CH				Tseng, Chin-Hsiao			Type 2 Diabetes Mellitus and Kidney Cancer Risk: A Retrospective Cohort Analysis of the National Health Insurance	PLOS ONE			English	Article							POPULATION-BASED COHORT; BLADDER-CANCER; MORTALITY; EPIDEMIOLOGY; BIAS; MEN	Purpose To evaluate the association between incidence of any kidney cancer and type 2 diabetes mellitus. Methods A random sample of 1,000,000 subjects covered by the National Health Insurance was recruited. A total of 998728 people (115655 diabetes and 883073 non-diabetes) without kidney cancer at recruitment were followed from 2003 to 2005. The cumulative incidence of kidney cancer from 2003 to 2005 in diabetic patients and non-diabetic people in all ages and in age <40, 40-64, 65-74 and >= 75 years were calculated in the diabetic patients and the non-diabetic people, respectively. Logistic regression was used to estimate the odds ratios comparing diabetic patients to non-diabetic people in the respective age groups. Multivariable-adjusted odds ratios for kidney cancer with regards to diabetes status and diabetes duration (as a continuous variable or categorized into subgroups of non-diabetes, diabetes duration <1 year, 1-2.9 years, 3-4.9 years and >= 5 years) were estimated after multivariable adjustment. The multivariable-adjusted odds ratios for all baseline variables were also estimated for diabetic patients and non-diabetic people, respectively. Results The 3-year cumulative incidence of kidney cancer in the diabetic patients and the non-diabetic people was 166.9 and 33.1 per 100,000 person-years, respectively. The incidence increased with regards to increasing age in both the diabetic patients and the non-diabetic people, but a higher risk of kidney cancer for the diabetic patients compared to the non-diabetic people was consistently observed in different age groups. After multivariable adjustment, the odds ratio for diabetic patients versus non-diabetic people was 1.7 (95% confidence interval: 1.3-2.1, P<0.01). While compared to the non-diabetic people, the odds ratio (95% confidence interval) for diabetes duration <1, 1-2.9 years, 3-4.9 years and >= 5 years was 1.5 (0.8-2.7), 1.6 (1.0-2.4), 1.6 (1.1-2.4) and 1.7 (1.3-2.3), respectively (P-trend <0.01). Analyses conducted in the diabetic patients and the non-diabetic people, respectively, consistently showed age, nephropathy and end-stage renal disease as significant risk factors of kidney cancer. Additionally, living in metropolitan Taipei region might also be associated with a higher risk of kidney cancer in the non-diabetic people, indicating a potential link between kidney cancer and some factors related to urbanization. Conclusions Patients with type 2 diabetes mellitus have a significantly higher risk of kidney cancer.	[Tseng, Chin-Hsiao] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan; [Tseng, Chin-Hsiao] Natl Taiwan Univ Hosp, Dept Internal Med, Div Endocrinol & Metab, Taipei 100, Taiwan; [Tseng, Chin-Hsiao] Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Zhunan, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Health Research Institutes - Taiwan	Tseng, CH (corresponding author), Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan.	ccktsh@ms6.hinet.net			Ministry of Science and Technology of Taiwan [MOST 103-2314-B-002-187-MY3]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	The study was supported by the Ministry of Science and Technology (MOST 103-2314-B-002-187-MY3) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcidiacono B, 2012, EXP DIABETES RES, DOI 10.1155/2012/789174; Bao CP, 2013, J DIABETES COMPLICAT, V27, P357, DOI 10.1016/j.jdiacomp.2013.01.004; BIDOLI E, 1993, REV EPIDEMIOL SANTE, V41, P374; BLOT WJ, 1979, J NATL CANCER I, V63, P363; Chen HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067420; Chiang CJ, 2010, JPN J CLIN ONCOL, V40, P897, DOI 10.1093/jjco/hyq057; Cho E, 2011, HEMATOL ONCOL CLIN N, V25, P651, DOI 10.1016/j.hoc.2011.04.002; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Connell L, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001711; Cumberbatch MG, 2016, EUR UROL, V70, P458, DOI 10.1016/j.eururo.2015.06.042; Harding JL, 2015, DIABETES CARE, V38, P264, DOI 10.2337/dc14-1996; Health Promotion Administration Ministry of Health and Welfare, 2012, CANC REG ANN REP; Hsieh MC, 2012, EXP DIABETES RES, DOI 10.1155/2012/413782; Inoue M, 2006, ARCH INTERN MED, V166, P1871, DOI 10.1001/archinte.166.17.1871; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Jiang Y., 2009, Plant Biology (Rockville), V2009, P111; Khan Mmh, 2006, Asian Pac J Cancer Prev, V7, P253; Kuriki K, 2007, EUR J CANCER PREV, V16, P83, DOI 10.1097/01.cej.0000228404.37858.40; Lai SW, 2013, ANN ACAD MED SINGAP, V42, P120; Larsson SC, 2011, DIABETOLOGIA, V54, P1013, DOI 10.1007/s00125-011-2051-6; Lin CC, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-381; Lin CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125421; Lindblad P, 1999, DIABETOLOGIA, V42, P107, DOI 10.1007/s001250051122; Liu XD, 2015, INT J CANCER, V137, P903, DOI 10.1002/ijc.29440; Ljungberg B, 2011, EUR UROL, V60, P615, DOI 10.1016/j.eururo.2011.06.049; Oberaigner W, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1058; Pearce N, 2007, OCCUP ENVIRON MED, V64, P562, DOI 10.1136/oem.2006.026690; Setiawan VW, 2007, AM J EPIDEMIOL, V166, P932, DOI 10.1093/aje/kwm170; Song SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134321; STROBE, 2007, STROBE CHECKL VERS 4; Szablewski L, 2014, DIABETES-METAB RES, V30, P543, DOI 10.1002/dmrr.2573; Tseng CH, 2006, DIABETOLOGIA, V49, P1755, DOI 10.1007/s00125-006-0314-4; Tseng CH, 2012, ANN ONCOL, V23, P153, DOI 10.1093/annonc/mdr334; Tseng CH, 2008, ACTA PAEDIATR, V97, P392, DOI 10.1111/j.1651-2227.2008.00684.x; Tseng CH, 2014, J ENVIRON SCI HEAL C, V32, P1, DOI 10.1080/10590501.2014.877645; Tseng CH, 2013, ACTA DIABETOL, V50, P879, DOI 10.1007/s00592-013-0471-0; Tseng CH, 2012, DIABETES CARE, V35, P278, DOI 10.2337/dc11-1449; Tseng CH, 2011, ANN MED, V43, P142, DOI 10.3109/07853890.2010.530683; Tseng CH, 2011, DIABETES CARE, V34, P616, DOI 10.2337/dc10-1640; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Wang GP, 2012, CANCER EPIDEMIOL, V36, P177, DOI 10.1016/j.canep.2011.09.006; Wang M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11503; Wideroff L, 1997, J NATL CANCER I, V89, P1360, DOI 10.1093/jnci/89.18.1360; Xu X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058079; Yang CY, 1998, JPN J CANCER RES, V89, P355, DOI 10.1111/j.1349-7006.1998.tb00571.x; Yang WS, 2015, EUR J CANC PREV; Zendehdel K, 2003, JNCI-J NATL CANCER I, V95, P1797, DOI 10.1093/jnci/djg105; Zhu ZW, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056662, 10.1371/journal.pone.0080028]; Zucchetto A, 2007, ANN ONCOL, V18, P596, DOI 10.1093/annonc/mdl438	49	11	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142480	10.1371/journal.pone.0142480	http://dx.doi.org/10.1371/journal.pone.0142480			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559055	gold, Green Published, Green Submitted			2022-12-26	WOS:000364433100082
J	Weeland, J; Slagt, M; Brummelman, E; Matthys, W; de Castro, BO; Overbeek, G				Weeland, Joyce; Slagt, Meike; Brummelman, Eddie; Matthys, Walter; de Castro, Bram Orobio; Overbeek, Geertjan			5-HTTLPR Expression Outside the Skin: An Experimental Test of the Emotional Reactivity Hypothesis in Children	PLOS ONE			English	Article							SEROTONIN TRANSPORTER GENE; FACIAL EXPRESSIONS; DIFFERENTIAL SUSCEPTIBILITY; PARENTING PRACTICES; RESPONSES; RISK; ASSOCIATIONS; POLYMORPHISM; BEHAVIOR; GENOTYPE	Background There is increasing evidence that variation in the promoter region of the serotonin transporter gene SLC6A4 (i.e., the 5-HTTLPR polymorphism) moderates the impact of environmental stressors on child psychopathology. Emotional reactivity -the intensity of an individual's response to other's emotions -has been put forward as a possible mechanism underlying these gene-by-environment interactions (i.e., GxE). Compared to children homozygous for the L-allele (LL-genotypes), children carrying an S-allele (SS/SL-genotypes), specifically when they have been frequently exposed to negative emotions in the family environment, might be more emotionally reactive and therefore more susceptible to affective environmental stressors. However, the association between 5-HTTLPR and emotional reactivity in children has not yet been empirically tested. Therefore, the goal of this study was to test this association in a large-scale experiment. Methods Children (N = 521, 52.5% boys, Mage = 9.72 years) were genotyped and randomly assigned to happy, angry or neutral dynamic facial expressions and vocalizations. Motor and affective emotional reactivity were assessed through children's self-reported negative and positive affect (n = 460) and facial electromyography activity (i.e., fEMG: the zygomaticus or "smile" muscle and the corrugator or "frown" muscle, n = 403). Parents reported on their negative and positive parenting behaviors. Results Children mimicked and experienced the emotion they were exposed to. However, neither motor reactivity nor affective reactivity to these emotions depended on children's 5-HTTLPR genotype: SS/SL-genotypes did not manifest any stronger response to emotional stimuli than LL-genotypes. This finding remained the same when taking the broader family environment into account, controlling for kinship, age, gender and genetic ancestry, and when including a tri-allelic factor. Conclusions We found no evidence for an association between the 5-HTTLPR polymorphism and children's emotional reactivity. This finding is important, in discounting one potential underlying endophenotype of GxE between the 5-HTTLPR and affective environmental stressors.	[Weeland, Joyce; Slagt, Meike; de Castro, Bram Orobio] Univ Utrecht, Utrecht Ctr Child & Adolescent Studies, Utrecht, Netherlands; [Brummelman, Eddie; Overbeek, Geertjan] Univ Amsterdam, Res Inst Child Dev & Educ, Utrecht, Netherlands; [Matthys, Walter] Univ Utrecht, Dept Child & Adolescent Studies, Utrecht, Netherlands	Utrecht University; University of Amsterdam; Utrecht University	Weeland, J (corresponding author), Univ Utrecht, Utrecht Ctr Child & Adolescent Studies, Utrecht, Netherlands.	j.weeland@uva.nl	De Castro, Bram Orobio/A-8942-2008; Brummelman, Eddie/S-9035-2016; Weeland, Joyce/G-9353-2018	De Castro, Bram Orobio/0000-0001-5110-6153; Brummelman, Eddie/0000-0001-7695-5135; Weeland, Joyce/0000-0003-2389-5110	VIDI of the Netherlands Organization for Scientific Research [452-10-005]; Department of Psychology committee of appliances, Utrecht University	VIDI of the Netherlands Organization for Scientific Research; Department of Psychology committee of appliances, Utrecht University	This work was supported by VIDI grant 452-10-005 of the Netherlands Organization for Scientific Research (http://www.nwo.nl/) (to GO), and the Department of Psychology committee of appliances, Utrecht University (JW). This study was hosted by Science Centre NEMO in Amsterdam (http://www.sciencelive.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnafors S, 2013, CHILD ADOL PSYCH CL, V10, pe7; Bakermans-Kranenburg MJ, 2015, ANNU REV PSYCHOL, V66, P381, DOI 10.1146/annurev-psych-010814-015407; Beach SRH, 2011, PSYCHOSOM MED, V73, P83, DOI 10.1097/PSY.0b013e3181fdd074; Belsky J, 1997, CHILD DEV, V68, P598, DOI 10.2307/1132110; Braithwaite EC, 2013, J AM ACAD CHILD PSY, V52, P519, DOI 10.1016/j.jaac.2013.02.010; Brummett BH, 2008, BEHAV GENET, V38, P476, DOI 10.1007/s10519-008-9219-y; Brummett BH, 2008, BEHAV GENET, V38, P34, DOI 10.1007/s10519-007-9172-1; Canli T, 2007, NAT NEUROSCI, V10, P1103, DOI 10.1038/nn1964; Cerasa A, 2014, SOC COGN AFFECT NEUR, V9, P1537, DOI 10.1093/scan/nst144; Crandall A, 2015, DEV REV, V36, P105, DOI 10.1016/j.dr.2015.01.004; Davies PT, 2014, CHILD DEV, V85, P484, DOI 10.1111/cdev.12148; de Wied M, 2006, J PSYCHIAT RES, V40, P112, DOI 10.1016/j.jpsychires.2005.08.003; Denham SA, 2000, DEV PSYCHOPATHOL, V12, P23, DOI 10.1017/S0954579400001024; Deschamps PKH, 2012, INT J PSYCHOPHYSIOL, V85, P195, DOI 10.1016/j.ijpsycho.2012.05.004; Dishion TJ, 2006, DEV PSYCHOPATHOLOGY; DIX T, 1991, PSYCHOL BULL, V110, P3, DOI 10.1037/0033-2909.110.1.3; Dodge KA, 2009, PERSPECT PSYCHOL SCI, V4, P408, DOI 10.1111/j.1745-6924.2009.01147.x; Duncombe ME, 2012, CHILD PSYCHIAT HUM D, V43, P715, DOI 10.1007/s10578-012-0290-5; Durbin CE, 2010, EMOTION, V10, P519, DOI 10.1037/a0019008; El-Sheikh M, 2001, J ABNORM PSYCHOL, V110, P499, DOI 10.1037//0021-843X.110.4.499; ElSheikh M, 1996, J ABNORM CHILD PSYCH, V24, P665, DOI 10.1007/BF01670106; Ford BQ, 2014, EMOTION, V14, P930, DOI 10.1037/a0036835; FRIDLUND AJ, 1986, PSYCHOPHYSIOLOGY, V23, P567, DOI 10.1111/j.1469-8986.1986.tb00676.x; Glenn AL, 2011, NEUROSCI BIOBEHAV R, V35, P612, DOI 10.1016/j.neubiorev.2010.07.005; Greenberg BD, 1999, AM J MED GENET, V88, P83, DOI 10.1002/(SICI)1096-8628(19990205)88:1<83::AID-AJMG15>3.3.CO;2-S; Gross JJ, 2011, EMOT REV, V3, P8, DOI 10.1177/1754073910380974; GROSSMAN M, 1993, J PERS SOC PSYCHOL, V65, P1010, DOI 10.1037/0022-3514.65.5.1010; Gyurak A, 2013, EMOTION, V13, P25, DOI 10.1037/a0029616; Hankin BL, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.44; Hariri AR, 2006, BIOL PSYCHIAT, V59, P888, DOI 10.1016/j.biopsych.2005.11.005; Hawk ST, 2012, J PERS SOC PSYCHOL, V102, P796, DOI 10.1037/a0026234; Heininga VE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125383; Hess U, 2001, INT J PSYCHOPHYSIOL, V40, P129, DOI 10.1016/S0167-8760(00)00161-6; Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850; Hubbard JA, 2002, CHILD DEV, V73, P1101, DOI 10.1111/1467-8624.00460; Jaffee SR, 2012, DEV PSYCHOPATHOL, V24, P1253, DOI 10.1017/S0954579412000685; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Likowski KU, 2002, FRONT HUM NEUROSCI, V6, pe214; Manica A, 2005, HUM GENET, V118, P366, DOI 10.1007/s00439-005-0039-3; Matthys W, 2012, CLIN CHILD FAM PSYCH, V15, P234, DOI 10.1007/s10567-012-0118-7; Munafo MR, 2008, BIOL PSYCHIAT, V63, P852, DOI 10.1016/j.biopsych.2007.08.016; Murphy SE, 2013, MOL PSYCHIATR, V18, P512, DOI 10.1038/mp.2012.19; Naylor L, 1998, MOL MED, V4, P671, DOI 10.1007/BF03401928; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Prevatt FF, 2003, BRIT J DEV PSYCHOL, V21, P469, DOI 10.1348/026151003322535174; Reijntjes A, 2011, PERS SOC PSYCHOL B, V37, P955, DOI 10.1177/0146167211410247; Reisenzein R, 2013, EMOT REV, V5, P16, DOI 10.1177/1754073912457228; Reiss D, 2007, DEV PSYCHOPATHOL, V19, P1005, DOI 10.1017/S0954579407000508; Reiss D, 2013, AM J PUBLIC HEALTH, V103, P111, DOI 10.2105/AJPH.2013.301408; Richards JS, 2015, EUR CHILD ADOLES PSY, V24, P209, DOI 10.1007/s00787-014-0567-2; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; Rothbart M.K., 1981, ADV DEV PSYCHOL, P37; Salvatore JE, 2015, CLIN PSYCHOL SCI, V3, P189, DOI 10.1177/2167702614534211; Sato W, 2004, COGNITIVE BRAIN RES, V20, P81, DOI 10.1016/j.cogbrainres.2004.01.008; Shelton KK, 1996, J CLIN CHILD PSYCHOL, V25, P317, DOI 10.1207/s15374424jccp2503_8; Sloan DM, 2002, BIOL PSYCHOL, V60, P79, DOI 10.1016/S0301-0511(02)00044-3; Sonuga-Barke EJS, 2009, J CHILD PSYCHOL PSYC, V50, P1052, DOI 10.1111/j.1469-7610.2009.02095.x; SPOONT MR, 1992, PSYCHOL BULL, V112, P330, DOI 10.1037/0033-2909.112.2.330; Stollstorff M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00327; Stringaris A, 2012, AM J PSYCHIAT, V169, P47, DOI 10.1176/appi.ajp.2011.10101549; Sulik MJ, 2012, DEV PSYCHOL, V48, P740, DOI 10.1037/a0025938; Teti DM, 2011, J FAM PSYCHOL, V25, P625, DOI 10.1037/a0025287; van der Schalk J, 2011, EMOTION, V11, P907, DOI 10.1037/a0023853; van Goozen SHM, 2007, PSYCHOL BULL, V133, P149, DOI 10.1037/0033-2909.133.1.149; van IJzendoorn MH, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.73; Walsh ND, 2012, NEUROIMAGE, V63, P1670, DOI 10.1016/j.neuroimage.2012.07.067; Wild B, 2001, PSYCHIAT RES, V102, P109, DOI 10.1016/S0165-1781(01)00225-6; Williams RB, 2003, NEUROPSYCHOPHARMACOL, V28, P533, DOI 10.1038/sj.npp.1300054; Wilson KR, 2011, AGGRESS VIOLENT BEH, V16, P87, DOI 10.1016/j.avb.2010.12.007	69	7	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141474	10.1371/journal.pone.0141474	http://dx.doi.org/10.1371/journal.pone.0141474			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560754	Green Submitted, Green Published, gold			2022-12-26	WOS:000364433100034
J	Carreira, VS; Fan, YX; Kurita, H; Wang, Q; Ko, CI; Naticchioni, M; Jiang, M; Koch, S; Zhang, X; Biesiada, J; Medvedovic, M; Xia, Y; Rubinstein, J; Puga, A				Carreira, Vinicius S.; Fan, Yunxia; Kurita, Hisaka; Wang, Qin; Ko, Chia-I; Naticchioni, Midi; Jiang, Min; Koch, Sheryl; Zhang, Xiang; Biesiada, Jacek; Medvedovic, Mario; Xia, Ying; Rubinstein, Jack; Puga, Alvaro			Disruption of Ah Receptor Signaling during Mouse Development Leads to Abnormal Cardiac Structure and Function in the Adult	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; CONGENITAL HEART-DISEASE; METABOLIC SYNDROME; GENE-EXPRESSION; BLOOD-PRESSURE; TCDD; MUTATIONS; FETAL; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN; PHOSPHOLAMBAN	The Developmental Origins of Health and Disease (DOHaD) Theory proposes that the environment encountered during fetal life and infancy permanently shapes tissue physiology and homeostasis such that damage resulting from maternal stress, poor nutrition or exposure to environmental agents may be at the heart of adult onset disease. Interference with endogenous developmental functions of the aryl hydrocarbon receptor (AHR), either by gene ablation or by exposure in utero to 2,3,7,8-tetrachlorodibenzo- p-dioxin (TCDD), a potent AHR ligand, causes structural, molecular and functional cardiac abnormalities and altered heart physiology in mouse embryos. To test if embryonic effects progress into an adult phenotype, we investigated whether Ahr ablation or TCDD exposure in utero resulted in cardiac abnormalities in adult mice long after removal of the agent. Ten-months old adult Ahr(-/-) and in utero TCDD-exposed Ahr(+/+) mice showed sexually dimorphic abnormal cardiovascular phenotypes characterized by echocardiographic findings of hypertrophy, ventricular dilation and increased heart weight, resting heart rate and systolic and mean blood pressure, and decreased exercise tolerance. Underlying these effects, genes in signaling networks related to cardiac hypertrophy and mitochondrial function were differentially expressed. Cardiac dysfunction in mouse embryos resulting from AHR signaling disruption seems to progress into abnormal cardiac structure and function that predispose adults to cardiac disease, but while embryonic dysfunction is equally robust in males and females, the adult abnormalities are more prevalent in females, with the highest severity in Ahr(-/-) females. The findings reported here underscore the conclusion that AHR signaling in the developing heart is one potential target of environmental factors associated with cardiovascular disease.	[Carreira, Vinicius S.; Fan, Yunxia; Kurita, Hisaka; Wang, Qin; Ko, Chia-I; Zhang, Xiang; Biesiada, Jacek; Medvedovic, Mario; Xia, Ying; Puga, Alvaro] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Carreira, Vinicius S.; Fan, Yunxia; Kurita, Hisaka; Wang, Qin; Ko, Chia-I; Zhang, Xiang; Biesiada, Jacek; Medvedovic, Mario; Xia, Ying; Puga, Alvaro] Univ Cincinnati, Coll Med, Ctr Environm Genet, Cincinnati, OH 45267 USA; [Naticchioni, Midi; Jiang, Min; Koch, Sheryl; Rubinstein, Jack] Univ Cincinnati, Coll Med, Dept Internal Med, Div Cardiovasc Hlth & Dis, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Puga, A (corresponding author), Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA.	Alvaro.Puga@uc.edu	Biesiada, Jacek/I-2844-2018; Kurita, Hisaka/ABA-3983-2020	Biesiada, Jacek/0000-0003-0435-2225; Rubinstein, Jack/0000-0002-8811-1551; Carreira, Vinicius/0000-0003-4524-0510	National Institute of Environmental Health Sciences (NIEHS) [R01 ES06273, R01 ES024744, R01 ES10807]; NIEHS Center for Environmental Genetics [P30 ES06096]; NIEHS Gene Environment Interactions Training Grant [T32 ES016646]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES006273, R01ES024744, T32ES016646, R01ES010807, P30ES006096] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS Center for Environmental Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS Gene Environment Interactions Training Grant; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding: This research was supported by National Institute of Environmental Health Sciences (NIEHS) grants R01 ES06273, R01 ES024744, and R01 ES10807, and by the NIEHS Center for Environmental Genetics grant P30 ES06096. V.S.C. was supported by NIEHS Gene Environment Interactions Training Grant T32 ES016646. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott BD, 1999, TOXICOL APPL PHARM, V155, P62, DOI 10.1006/taap.1998.8601; Akazawa H, 2005, PHARMACOL THERAPEUT, V107, P252, DOI 10.1016/j.pharmthera.2005.03.005; Antkiewicz DS, 2005, TOXICOL SCI, V84, P368, DOI 10.1093/toxsci/kfi073; Aragon AC, 2008, TOXICOL SCI, V101, P321, DOI 10.1093/toxsci/kfm272; Armstrong EJ, 2004, CIRC RES, V95, P459, DOI 10.1161/01.RES.0000141146.95728.da; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Carreira VS, 2015, TOXICOL SCI, V147, P425, DOI 10.1093/toxsci/kfv138; Carro T, 2013, ENVIRON TOXICOL CHEM, V32, P1325, DOI 10.1002/etc.2178; Dabir P, 2008, CIRC RES, V102, P1558, DOI 10.1161/CIRCRESAHA.108.176990; Dalton T P, 2001, Cardiovasc Toxicol, V1, P285, DOI 10.1385/CT:1:4:285; Davarinos NA, 1999, J BIOL CHEM, V274, P28708, DOI 10.1074/jbc.274.40.28708; Derda AA, 2015, INT J CARDIOL, V196, P115, DOI 10.1016/j.ijcard.2015.05.185; DEVITO MJ, 1995, ENVIRON HEALTH PERSP, V103, P820, DOI 10.2307/3432395; Elliott DA, 2003, J AM COLL CARDIOL, V41, P2072, DOI 10.1016/S0735-1097(03)00420-0; Forgacs AL, 2010, TOXICOL APPL PHARM, V246, P58, DOI 10.1016/j.taap.2010.04.006; Furness SGB, 2007, FEBS LETT, V581, P3616, DOI 10.1016/j.febslet.2007.04.011; Furness SGB, 2009, PHARMACOL THERAPEUT, V124, P336, DOI 10.1016/j.pharmthera.2009.09.004; Gelb B, 2013, CIRC RES, V112, P698, DOI 10.1161/CIRCRESAHA.111.300297; Giannone JV, 1998, BIOCHEM PHARMACOL, V55, P489, DOI 10.1016/S0006-2952(97)00493-0; Hofsteen P, 2013, TOXICOL SCI, V132, P211, DOI 10.1093/toxsci/kfs329; Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188; Jay PY, 2004, J CLIN INVEST, V113, P1130, DOI 10.1172/JCI200419846; Jones SP, 2009, TOXICOL SCI, V109, P66, DOI 10.1093/toxsci/kfp039; Kannel WB, 1996, JAMA-J AM MED ASSOC, V276, P1269, DOI 10.1001/jama.276.15.1269; Kennedy LH, 2013, TOXICOL SCI, V132, P235, DOI 10.1093/toxsci/kfs325; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Kim JT, 2014, REV ENDOCR METAB DIS, V15, P253, DOI 10.1007/s11154-014-9297-5; Kornfeld OS, 2015, CIRC RES, V116, P1783, DOI 10.1161/CIRCRESAHA.116.305432; Lee HK, 2011, DIABETES METAB J, V35, P207, DOI 10.4093/dmj.2011.35.3.207; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; Li L, 1998, AM J PHYSIOL-HEART C, V274, pH1335, DOI 10.1152/ajpheart.1998.274.4.H1335; Long QQ, 2015, AM J CARDIOVASC DIS, V5, P19; Lund AK, 2008, HYPERTENSION, V51, P803, DOI 10.1161/HYPERTENSIONAHA.107.100586; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Marcaletti Stefan, 2011, Curr Protoc Mouse Biol, V1, P141, DOI 10.1002/9780470942390.mo100160; Mason PJ, 2004, CIRCULATION, V109, P1623, DOI 10.1161/01.CIR.0000124488.06377.77; McElhinney DB, 2003, J AM COLL CARDIOL, V42, P1650, DOI 10.1016/j.jacc.2003.05.004; Mone SM, 2004, PEDIATRICS, V113, P1058; Myburgh KH, 2003, COMP BIOCHEM PHYS A, V136, P171, DOI 10.1016/S1095-6433(03)00220-4; Nembhard WN, 2010, J PEDIATR-US, V156, P259, DOI 10.1016/j.jpeds.2009.07.058; Park WH, 2013, BIOFACTORS, V39, P494, DOI 10.1002/biof.1092; Pashmforoush M, 2004, CELL, V117, P373, DOI 10.1016/S0092-8674(04)00405-2; Puga A, 2011, TOXICOL SCI, V120, P256, DOI 10.1093/toxsci/kfq393; Puga A, 2009, BIOCHEM PHARMACOL, V77, P713, DOI 10.1016/j.bcp.2008.08.031; Quintana FJ, 2013, PHARMACOL REV, V65, P1148, DOI 10.1124/pr.113.007823; Razeghi P, 2001, CIRCULATION, V104, P2923, DOI 10.1161/hc4901.100526; Rubinstein J, 2014, AM J PHYSIOL-HEART C, V306, pH574, DOI 10.1152/ajpheart.00854.2013; Sauzeau V, 2011, J BIOL CHEM, V286, P2896, DOI 10.1074/jbc.M110.187534; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Shertzer HG, 2006, TOXICOL APPL PHARM, V217, P363, DOI 10.1016/j.taap.2006.09.014; Sipido KR, 2002, CARDIOVASC RES, V53, P782, DOI 10.1016/S0008-6363(01)00470-9; Srivastava D, 1999, CURR OPIN CARDIOL, V14, P263, DOI 10.1097/00001573-199905000-00011; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Stites T, 2006, J NUTR, V136, P390, DOI 10.1093/jn/136.2.390; Tanaka M, 1999, DEVELOPMENT, V126, P1269; Tanner K, 2005, PEDIATRICS, V116, pE833, DOI 10.1542/peds.2005-0397; Tappenden DM, 2013, J TOXICOL-US, V2013, DOI 10.1155/2013/279829; Tennstedt C, 1999, HEART, V82, P34, DOI 10.1136/hrt.82.1.34; Thackaberry EA, 2005, TOXICOL SCI, V88, P242, DOI 10.1093/toxsci/kfi302; van der Bom T, 2011, NAT REV CARDIOL, V8, P50, DOI 10.1038/nrcardio.2010.166; Vecoli C, 2014, CURR GENOMICS, V15, P390, DOI 10.2174/1389202915666140716175634; Vijay V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117047; Wang Q, 2013, ENVIRON HEALTH PERSP, V121, P1334, DOI 10.1289/ehp.1307297; WEBER H, 1985, ARCH TOXICOL, V57, P159, DOI 10.1007/BF00290880; Weraarpachai W, 2012, AM J HUM GENET, V90, P142, DOI 10.1016/j.ajhg.2011.11.027; Wijnen WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096290; Winans B, 2015, J IMMUNOL, V194, P4446, DOI 10.4049/jimmunol.1402044; Yeung Edwina H, 2014, Curr Epidemiol Rep, V1, P9; Yoshioka W, 2011, J STEROID BIOCHEM, V127, P96, DOI 10.1016/j.jsbmb.2010.12.005; Zhang Nan, 2011, J Cardiovasc Dis Res, V2, P91, DOI 10.4103/0975-3583.83033	71	33	35	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142440	10.1371/journal.pone.0142440	http://dx.doi.org/10.1371/journal.pone.0142440			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555816	Green Published, Green Submitted, gold			2022-12-26	WOS:000364430700106
J	Ellis, K; Friedman, C; Yedvobnick, B				Ellis, Kaitlyn; Friedman, Chloe; Yedvobnick, Barry			Drosophila domino Exhibits Genetic Interactions with a Wide Spectrum of Chromatin Protein-Encoding Loci	PLOS ONE			English	Article							NOTCH PATHWAY FUNCTION; CELL SELF-RENEWAL; TRANSCRIPTION FACTOR; REMODELING COMPLEX; WING DEVELOPMENT; MELANOGASTER; EXPRESSION; SCREEN; TIP60; POLYCOMB	The Drosophila domino gene encodes protein of the SWI2/SNF2 family that has widespread roles in transcription, replication, recombination and DNA repair. Here, the potential relationship of Domino protein to other chromatin-associated proteins has been investigated through a genetic interaction analysis. We scored for genetic modification of a domino wing margin phenotype through coexpression of RNAi directed against a set of previously characterized and more newly characterized chromatin-encoding loci. A set of other SWI2/SNF2 loci were also assayed for interaction with domino. Our results show that the majority of tested loci exhibit synergistic enhancement or suppression of the domino wing phenotype. Therefore, depression in domino function sensitizes the wing margin to alterations in the activity of numerous chromatin components. In several cases the genetic interactions are associated with changes in the level of cell death measured across the dorsal-ventral margin of the wing imaginal disc. These results highlight the broad realms of action of many chromatin proteins and suggest significant overlap with Domino function in fundamental cell processes, including cell proliferation, cell death and cell signaling.	[Ellis, Kaitlyn; Friedman, Chloe; Yedvobnick, Barry] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	Emory University	Yedvobnick, B (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	Barry.Yedvobnick@Emory.Edu			Ammerman Foundation [D2641000]	Ammerman Foundation	This research was funded by a gift to BY lab from the Ammerman Foundation #D2641000, (http://nccsweb.urban.org/orgs/profile.php/521320467?popup=1#overview). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AE, 2011, DEVELOPMENT, V138, P1957, DOI 10.1242/dev.058461; Armstrong JA, 2005, GENETICS, V170, P1761, DOI 10.1534/genetics.105.041327; Asha H, 2003, GENETICS, V163, P203; Badenhorst P, 2002, GENE DEV, V16, P3186, DOI 10.1101/gad.1032202; Bararia D, 2008, LEUKEMIA, V22, P800, DOI 10.1038/sj.leu.2405101; Bhatia S, 2010, GENES CELLS, V15, P725, DOI 10.1111/j.1365-2443.2010.01416.x; BRAND AH, 1993, DEVELOPMENT, V118, P401; Braun A, 1997, GENETICS, V147, P623; Carre C, 2005, MOL CELL BIOL, V25, P8228, DOI 10.1128/MCB.25.18.8228-8238.2005; Carrera P, 2003, GENE DEV, V17, P2578, DOI 10.1101/gad.276703; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Collins H, 2013, G3-GENES GENOM GENET, V3, P1639, DOI 10.1534/g3.113.007419; Cronin SJF, 2009, SCIENCE, V325, P340, DOI 10.1126/science.1173164; Dekanty A, 2015, ONCOGENE, V34, P978, DOI 10.1038/onc.2014.42; Eissenberg JC, 2005, MOL CELL BIOL, V25, P6559, DOI 10.1128/MCB.25.15.6559-6569.2005; Fan Y, 2010, CELL DEATH DIFFER, V17, P534, DOI 10.1038/cdd.2009.185; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Gause M, 2006, MOL CELL BIOL, V26, P2347, DOI 10.1128/MCB.26.6.2347-2359.2006; Giraldez AJ, 2003, DEVELOPMENT, V130, P6533, DOI 10.1242/dev.00904; Gonzalez I, 2008, GENETICS, V179, P1373, DOI 10.1534/genetics.107.082966; Gordy C, 2012, PROTEIN CELL, V3, P17, DOI 10.1007/s13238-011-1127-x; Hall LE, 2004, GENET RES, V83, P71, DOI 10.1017/S0016672304006731; Helms W, 1999, DEV BIOL, V215, P358, DOI 10.1006/dbio.1999.9477; Kassavetis GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098173; Kehle J, 1998, SCIENCE, V282, P1897, DOI 10.1126/science.282.5395.1897; KENNISON JA, 1988, P NATL ACAD SCI USA, V85, P8136, DOI 10.1073/pnas.85.21.8136; Kolesnikova TD, 2013, CHROMOSOMA, V122, P55, DOI 10.1007/s00412-012-0390-9; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Kwon MH, 2013, G3-GENES GENOM GENET, V3, P815, DOI 10.1534/g3.112.005496; Kwon SH, 2011, CELL CYCLE, V10, P625, DOI 10.4161/cc.10.4.14796; Li J, 2013, EMBO J, V32, P1829, DOI 10.1038/emboj.2013.111; Lu JR, 2007, P NATL ACAD SCI USA, V104, P9381, DOI 10.1073/pnas.0610279104; McDaniel IE, 2008, GENETICS, V178, P583, DOI 10.1534/genetics.107.079038; Moberg KH, 2005, DEV CELL, V9, P699, DOI 10.1016/j.devcel.2005.09.018; Mondal BC, 2014, ELIFE, V3, DOI 10.7554/eLife.03626; Moshkin YM, 2009, MOL CELL, V35, P782, DOI 10.1016/j.molcel.2009.07.020; Nagy P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003664; Qi D, 2006, GENETICS, V174, P241, DOI 10.1534/genetics.106.059980; Ruhf ML, 2001, DEVELOPMENT, V128, P1429; Schneiderman JI, 2009, P NATL ACAD SCI USA, V106, P14472, DOI 10.1073/pnas.0905816106; Schulz LL, 2006, FASEB J, V20, P488, DOI 10.1096/fj.05-5020fje; Sebald J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043144; Shukla V, 2014, GENETICS, V196, P481, DOI 10.1534/genetics.113.160531; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Tennessen JM, 2011, CELL METAB, V13, P139, DOI 10.1016/j.cmet.2011.01.005; van Bemmel JG, 2013, MOL CELL, V49, P759, DOI 10.1016/j.molcel.2013.01.040; Verheyen EM, 1996, GENETICS, V144, P1127; Walker J, 2011, GENETICS, V187, P1067, DOI 10.1534/genetics.110.123893; Xi RW, 2005, SCIENCE, V310, P1487, DOI 10.1126/science.1120140; Yagi Y, 2005, EMBO REP, V6, P1088, DOI 10.1038/sj.embor.7400542; Yan D, 2014, DEV CELL, V28, P459, DOI 10.1016/j.devcel.2014.01.020; Ye YH, 1999, J CELL BIOL, V146, P1351, DOI 10.1083/jcb.146.6.1351; Yu ZS, 2013, DEVELOPMENT, V140, P3635, DOI 10.1242/dev.094599; Zaytseva O, 2014, GENETICS, V196, P443, DOI 10.1534/genetics.113.159541; Zhang CX, 2000, DEV BIOL, V222, P27, DOI 10.1006/dbio.2000.9704	55	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142635	10.1371/journal.pone.0142635	http://dx.doi.org/10.1371/journal.pone.0142635			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555684	Green Submitted, Green Published, gold			2022-12-26	WOS:000364430700145
J	Ranganath, S; Bhandari, A; Avitahl-Curtis, N; McMahon, J; Wachtel, D; Zhang, JN; Leitheiser, C; Bernier, SG; Liu, G; Tran, TT; Celino, H; Tobin, J; Jung, J; Zhao, H; Glen, KE; Graul, C; Griffin, A; Schairer, WC; Higgins, C; Reza, TL; Mowe, E; Rivers, S; Scott, S; Monreal, A; Shea, C; Bourne, G; Coons, C; Smith, A; Tang, K; Mandyam, RA; Masferrer, J; Liu, D; Patel, DV; Fretzen, A; Murphy, CA; Milne, GT; Smythe, ML; Carlson, KE				Ranganath, Sheila; Bhandari, Ashok; Avitahl-Curtis, Nicole; McMahon, Jaimee; Wachtel, Derek; Zhang, Jenny; Leitheiser, Christopher; Bernier, Sylvie G.; Liu, Guang; Tran, Tran T.; Celino, Herodion; Tobin, Jenny; Jung, Joon; Zhao, Hong; Glen, Katie E.; Graul, Chris; Griffin, Aliesha; Schairer, Wayne C.; Higgins, Carolyn; Reza, Tammi L.; Mowe, Eva; Rivers, Sam; Scott, Sonya; Monreal, Alex; Shea, Courtney; Bourne, Greg; Coons, Casey; Smith, Adaline; Tang, Kim; Mandyam, Ramya A.; Masferrer, Jaime; Liu, David; Patel, Dinesh V.; Fretzen, Angelika; Murphy, Craig A.; Milne, G. Todd; Smythe, Mark L.; Carlson, Kenneth E.			Discovery and Characterization of a Potent Interleukin-6 Binding Peptide with Neutralizing Activity In Vivo	PLOS ONE			English	Article							CLASSIFICATION	Interleukin-6 (IL-6) is an important member of the cytokine superfamily, exerting pleiotropic actions on many physiological processes. Over-production of IL-6 is a hallmark of immune-mediated inflammatory diseases such as Castleman's Disease (CD) and rheumatoid arthritis (RA). Antagonism of the interleukin IL-6/IL-6 receptor (IL-6R)/gp130 signaling complex continues to show promise as a therapeutic target. Monoclonal antibodies (mAbs) directed against components of this complex have been approved as therapeutics for both CD and RA. To potentially provide an additional modality to antagonize IL-6 induced pathophysiology, a peptide-based antagonist approach was undertaken. Using a combination of molecular design, phage-display, and medicinal chemistry, disulfide-rich peptides (DRPs) directed against IL-6 were developed with low nanomolar potency in inhibiting IL-6-induced pSTAT3 in U937 monocytic cells. Targeted PEGylation of IL-6 binding peptides resulted in molecules that retained their potency against IL-6 and had a prolongation of their pharmacokinetic (PK) profiles in rodents and monkeys. One such peptide, PN-2921, contained a 40 kDa polyethylene glycol (PEG) moiety and inhibited IL-6-induced pSTAT3 in U937 cells with sub-nM potency and possessed 23, 36, and 59 h PK half-life values in mice, rats, and cynomolgus monkeys, respectively. Parenteral administration of PN-2921 to mice and cynomolgus monkeys potently inhibited IL-6-induced biomarker responses, with significant reductions in the acute inflammatory phase proteins, serum amyloid A (SAA) and C-reactive protein (CRP). This potent, PEGylated IL-6 binding peptide offers a new approach to antagonize IL-6-induced signaling and associated pathophysiology.	[Ranganath, Sheila; Bernier, Sylvie G.; Liu, Guang; Monreal, Alex; Milne, G. Todd; Carlson, Kenneth E.] Ironwood Pharmaceut, Discovery Biol, Cambridge, MA USA; [Bhandari, Ashok; Celino, Herodion; Patel, Dinesh V.] Protagonist Therapeut, Chem, Milpitas, CA USA; [Avitahl-Curtis, Nicole; Tobin, Jenny; Graul, Chris; Rivers, Sam; Shea, Courtney; Tang, Kim; Masferrer, Jaime] Ironwood Pharmaceut, Discovery Pharmacol, Cambridge, MA USA; [McMahon, Jaimee; Zhang, Jenny; Glen, Katie E.; Griffin, Aliesha; Mowe, Eva; Scott, Sonya; Bourne, Greg; Mandyam, Ramya A.; Murphy, Craig A.; Smythe, Mark L.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Wachtel, Derek; Higgins, Carolyn] Ironwood Pharmaceut, DMPK, Cambridge, MA USA; [Leitheiser, Christopher; Zhao, Hong; Schairer, Wayne C.; Coons, Casey; Fretzen, Angelika] Ironwood Pharmaceut, Pharmaceut Dev, Cambridge, MA USA; [Tran, Tran T.; Bourne, Greg; Murphy, Craig A.; Smythe, Mark L.] Therapeutics Pty Ltd, Protagonist Pty Ltd, Brisbane, Qld, Australia; [Jung, Joon] Ironwood Pharmaceut, Chem, Cambridge, MA USA; [Reza, Tammi L.; Smith, Adaline] Ironwood Pharmaceut, Discovery Toxicol, Cambridge, MA USA; [Liu, David] Protagonist Therapeut, Biol, Milpitas, CA USA	Ironwood Pharmaceuticals, Inc.; Ironwood Pharmaceuticals, Inc.; University of Queensland; Ironwood Pharmaceuticals, Inc.; Ironwood Pharmaceuticals, Inc.; Ironwood Pharmaceuticals, Inc.; Ironwood Pharmaceuticals, Inc.	Carlson, KE (corresponding author), Ironwood Pharmaceut, Discovery Biol, Cambridge, MA USA.	kcarlson@ironwoodpharma.com	Bourne, Greg/C-7290-2017	Bourne, Greg/0000-0002-2792-2895; Griffin, Aliesha/0000-0001-6105-6962; Smythe, Mark/0000-0001-7840-1021	Ironwood Pharmaceuticals, Inc.	Ironwood Pharmaceuticals, Inc.	This research was funded by Ironwood Pharmaceuticals, Inc. The funding source was involved in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Braddock M, 2007, EXPERT OPIN INV DRUG, V16, P251, DOI 10.1517/13543784.16.2.251; Cohan P, 2014, ENDOCR PRACT, V20, P84, DOI 10.4158/EP13127.RA; Harris JM, 2001, CLIN PHARMACOKINET, V40, P539, DOI 10.2165/00003088-200140070-00005; Heinrich PC, 2003, BIOCHEM J, V374, P42024; HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0; KING DS, 1990, INT J PEPT PROT RES, V36, P255; Love BL, 2014, AM J HEALTH-SYST PH, V71, P1081, DOI 10.2146/ajhp130575; Manfredini R, DEV IL 6 ANTAGONIST, V24, P1207; Moutabarrik A, 1994, Transpl Int, V7 Suppl 1, pS552; Mudter J, 2007, INFLAMM BOWEL DIS, V13, P1016, DOI 10.1002/ibd.20148; Nishimoto N, 2006, NAT CLIN PRACT RHEUM, V2, P619, DOI 10.1038/ncprheum0338; Northfield SE, 2014, EUR J MED CHEM, V77, P248, DOI 10.1016/j.ejmech.2014.03.011; Oberg F, 1992, GROWTH FACTORS, V7, P85, DOI 10.3109/08977199209023940; Scheller J, 2014, SEMIN IMMUNOL, V26, P2, DOI 10.1016/j.smim.2013.11.002; Silverman J, 2005, NAT BIOTECHNOL, V23, P1556, DOI 10.1038/nbt1166; Smythe ML, 1999, [No title captured], Patent No. [WO/2000/023474 A1, 2000023474]; Starovasnik MA, 1997, P NATL ACAD SCI USA, V94, P10080, DOI 10.1073/pnas.94.19.10080; Tanaka T, 2012, INT J BIOL SCI, V8, P1227, DOI 10.7150/ijbs.4666; Tonikian R, 2007, NAT PROTOC, V2, P1368, DOI 10.1038/nprot.2007.151; Tran TT, 2010, J COMPUT AID MOL DES, V24, P917, DOI 10.1007/s10822-010-9384-y; Tran TT, 2005, J COMPUT AID MOL DES, V19, P551, DOI 10.1007/s10822-005-9006-2; van Rhee F, 2010, J CLIN ONCOL, V28, P3701, DOI 10.1200/JCO.2009.27.2377; Vardanyan M, 2010, PAIN, V151, P257, DOI 10.1016/j.pain.2010.05.022; Zaki MH, CNTO 328 MONOCLONAL, V111, P592, DOI [10.1002/ijc.20270, DOI 10.1002/IJC.20270]; Zoller F, 2011, MOLECULES, V16, P2467, DOI 10.3390/molecules16032467	28	17	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141330	10.1371/journal.pone.0141330	http://dx.doi.org/10.1371/journal.pone.0141330			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555695	Green Published, Green Submitted, gold			2022-12-26	WOS:000364430700025
J	Banerjee, M; Duan, QM; Xie, ZJ				Banerjee, Moumita; Duan, Qiming; Xie, Zijian			SH2 Ligand-Like Effects of Second Cytosolic Domain of Na/K-ATPase alpha 1 Subunit on Src Kinase	PLOS ONE			English	Article							FOCAL ADHESION KINASE; PROTEIN-TYROSINE KINASES; SIGNAL-TRANSDUCTION; FAMILY KINASES; BINDING-SITE; C-SRC; PHOSPHORYLATION SITES; CELL-MIGRATION; CANCER-CELLS; V-SRC	Our previous studies have suggested that the alpha 1 Na/K-ATPase interacts with Src to form a receptor complex. In vitro binding assays indicate an interaction between second cytosolic domain (CD2) of Na/K-ATPase alpha 1 subunit and Src SH2 domain. Since SH2 domain targets Src to specific signaling complexes, we expressed CD2 as a cytosolic protein and studied whether it could act as a Src SH2 ligand in LLC-PK1 cells. Co-immunoprecipitation analyses indicated a direct binding of CD2 to Src, consistent with the in vitro binding data. Functionally, CD2 expression increased basal Src activity, suggesting a Src SH2 ligand-like property of CD2. Consistently, we found that CD2 expression attenuated several signaling pathways where Src plays an important role. For instance, although it increased surface expression of Na/K-ATPase, it decreased ouabain-induced activation of Src and ERK by blocking the formation of Na/K-ATPase/Src complex. Moreover, it also attenuated cell attachment-induced activation of Src/FAK. Consequently, CD2 delayed cell spreading, and inhibited cell proliferation. Furthermore, these effects appear to be Src-specific because CD2 expression had no effect on EGF-induced activation of EGF receptor and ERK. Hence, the new findings indicate the importance of Na/K-ATPase/Src interaction in ouabain-induced signal transduction, and support the proposition that the CD2 peptide may be utilized as a Src SH2 ligand capable of blocking Src-dependent signaling pathways via a different mechanism from a general Src kinase inhibitor.	[Banerjee, Moumita; Xie, Zijian] Marshall Univ, Marshall Inst Interdisciplinary Res, Huntington, WV 25755 USA; [Duan, Qiming] Case Western Reserve Univ, Sch Med, Dept Med, Case Cardiovasc Res Inst, Cleveland, OH 44106 USA; [Duan, Qiming] Harrington Heart & Vasc Inst, Cleveland, OH USA	Marshall University; Case Western Reserve University	Xie, ZJ (corresponding author), Marshall Univ, Marshall Inst Interdisciplinary Res, Huntington, WV 25755 USA.	xiez@marshall.edu	Banerjee, Moumita/Y-7651-2019; Duan, Qiming/I-1822-2019	Duan, Qiming/0000-0002-6204-3028; Banerjee, Moumita/0000-0002-4463-7914	NHLBI [HL109015]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109015] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding: This work was supported by NHLBI grant HL109015.	Al-Obeidi FA, 2000, ONCOGENE, V19, P5690, DOI 10.1038/sj.onc.1203926; ALONSO G, 1995, J BIOL CHEM, V270, P9840, DOI 10.1074/jbc.270.17.9840; Basu N, 2009, MOL CELL BIOL, V29, P5277, DOI 10.1128/MCB.00001-09; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Bradshaw JM, 1999, BIOCHEMISTRY-US, V38, P5147, DOI 10.1021/bi982974y; Brunton VG, 2005, CANCER RES, V65, P1335, DOI 10.1158/0008-5472.CAN-04-1949; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Cary LA, 2002, MOL CELL BIOL, V22, P2427, DOI 10.1128/MCB.22.8.2427-2440.2002; Cary LA, 1998, J CELL BIOL, V140, P211, DOI 10.1083/jcb.140.1.211; DEVARAJAN P, 1994, P NATL ACAD SCI USA, V91, P2965, DOI 10.1073/pnas.91.8.2965; Dvela M, 2012, AM J PHYSIOL-CELL PH, V302, pC442, DOI 10.1152/ajpcell.00336.2011; EIDE BL, 1995, MOL CELL BIOL, V15, P2819; Hanks SK, 2003, FRONT BIOSCI-LANDMRK, V8, pD982, DOI 10.2741/1114; HULL RN, 1976, IN VITRO CELL DEV B, V12, P670, DOI 10.1007/BF02797469; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Izawa T, 2012, MOL CELL BIOL, V32, P2943, DOI 10.1128/MCB.00077-12; Kaneko T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003021; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kraskouskaya D, 2013, CHEM SOC REV, V42, P3337, DOI 10.1039/c3cs35449k; Lai FF, 2013, J BIOL CHEM, V288, P13295, DOI 10.1074/jbc.M113.467381; Li ZC, 2011, J BIOL CHEM, V286, P32394, DOI 10.1074/jbc.M110.207597; Li ZC, 2009, J BIOL CHEM, V284, P21066, DOI 10.1074/jbc.M109.013821; Li ZC, 2009, PFLUG ARCH EUR J PHY, V457, P635, DOI 10.1007/s00424-008-0470-0; Liang M, 2007, J BIOL CHEM, V282, P10585, DOI 10.1074/jbc.M609181200; Lindfors HE, 2012, IUBMB LIFE, V64, P538, DOI 10.1002/iub.1038; Lingrel JB, 2010, ANNU REV PHYSIOL, V72, P395, DOI 10.1146/annurev-physiol-021909-135725; Liu BA, 2012, PHILOS T R SOC B, V367, P2556, DOI 10.1098/rstb.2012.0107; Liu JA, 2005, KIDNEY INT, V67, P1844, DOI 10.1111/j.1523-1755.2005.00283.x; Liu LJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1489, DOI 10.1152/ajpcell.00158.2007; Lombardo CR, 1995, BIOCHEMISTRY-US, V34, P16456, DOI 10.1021/bi00050a029; Mandine E, 2002, BIOCHEM BIOPH RES CO, V298, P185, DOI 10.1016/S0006-291X(02)02424-5; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Owen JD, 1999, MOL CELL BIOL, V19, P4806; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Pawson T, 2009, CURR OPIN CELL BIOL, V21, P147, DOI 10.1016/j.ceb.2009.02.005; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Pugacheva EN, 2006, CURR OPIN CELL BIOL, V18, P507, DOI 10.1016/j.ceb.2006.08.014; Richardson A, 1997, MOL CELL BIOL, V17, P6906, DOI 10.1128/MCB.17.12.6906; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V324, P1155, DOI 10.1016/j.bbrc.2004.09.171; Sawyer TK, 2002, MINI-REV MED CHEM, V2, P475, DOI 10.2174/1389557023405765; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schlaepfer DD, 1998, MOL CELL BIOL, V18, P2571, DOI 10.1128/MCB.18.5.2571; Schlaepfer DD, 1996, MOL CELL BIOL, V16, P5623; Sen Banibrata, 2011, J Signal Transduct, V2011, P865819, DOI 10.1155/2011/865819; Shakespeare W, 2000, P NATL ACAD SCI USA, V97, P9373, DOI 10.1073/pnas.97.17.9373; Shvartsman DE, 2007, J CELL BIOL, V178, P675, DOI 10.1083/jcb.200701133; Stabach PR, 2008, AM J PHYSIOL-CELL PH, V295, pC1202, DOI 10.1152/ajpcell.00273.2008; Stover DR, 1996, J BIOL CHEM, V271, P12481, DOI 10.1074/jbc.271.21.12481; Taylor JD, 2008, PROTEINS, V73, P929, DOI 10.1002/prot.22119; Tian J, 2006, MOL BIOL CELL, V17, P317, DOI 10.1091/mbc.E05-08-0735; Tian J, 2009, J BIOL CHEM, V284, P14921, DOI 10.1074/jbc.M808355200; Violette SM, 2001, BONE, V28, P54, DOI 10.1016/S8756-3282(00)00427-0; WAKSMAN G, 1993, CELL, V72, P779, DOI 10.1016/0092-8674(93)90405-F; Waksman Gabriel, 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404007331; Xie Zijian, 2003, Mol Interv, V3, P157, DOI 10.1124/mi.3.3.157; XING Z, 1994, MOL BIOL CELL, V5, P413, DOI 10.1091/mbc.5.4.413; Yadav SS, 2007, CANCER LETT, V257, P116, DOI 10.1016/j.canlet.2007.07.012; Ye GF, 2009, BIOORG CHEM, V37, P133, DOI 10.1016/j.bioorg.2009.05.003; Ye QQ, 2013, J BIOL CHEM, V288, P5803, DOI 10.1074/jbc.M112.442608; Ye QQ, 2011, J BIOL CHEM, V286, P6225, DOI 10.1074/jbc.M110.202051; Yeo MG, 2006, MOL CELL BIOL, V26, P4399, DOI 10.1128/MCB.01147-05; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	65	22	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0142119	10.1371/journal.pone.0142119	http://dx.doi.org/10.1371/journal.pone.0142119			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7AC	26551526	gold, Green Submitted, Green Published			2022-12-26	WOS:000364422800017
J	Han, L; Liu, DH; Li, ZH; Tian, N; Han, ZW; Wang, G; Fu, Y; Guo, ZG; Zhu, ZF; Du, C; Tian, Y				Han, Liang; Liu, Dehua; Li, Zhaohui; Tian, Nan; Han, Ziwu; Wang, Guang; Fu, Yao; Guo, Zhigang; Zhu, Zifeng; Du, Chao; Tian, Yu			HOXB1 Is a Tumor Suppressor Gene Regulated by miR-3175 in Glioma	PLOS ONE			English	Article							EMBRYONAL CARCINOMA-CELLS; CIRCULATING MICRORNAS; NEUROBLASTOMA-CELLS; PROGNOSTIC VALUE; SIDE POPULATION; TARGET GENES; EXPRESSION; CANCER; DIFFERENTIATION; MORPHOGENESIS	The HOXB1 gene plays a critical role as an oncogene in diverse tumors. However, the functional role of HOXB1 and the mechanism regulating HOXB1 expression in glioma are not fully understood. A preliminary bioinformatics analysis showed that HOXB1 is ectopically expressed in glioma, and that HOXB1 is a possible target of miR-3175. In this study, we investigated the function of HOXB1 and the relationship between HOXB1 and miR-3175 in glioma. We show that HOXB1 expression is significantly downregulated in glioma tissues and cell lines, and that its expression may be closely associated with the degree of malignancy. Reduced HOXB1 expression promoted the proliferation and invasion of glioma cells, and inhibited their apoptosis in vitro, and the downregulation of HOXB1 was also associated with worse survival in glioma patients. More importantly, HOXB1 was shown experimentally to be a direct target of miR-3175 in this study. The downregulated expression of miR-3175 inhibited cell proliferation and invasion, and promoted apoptosis in glioma. The oncogenicity induced by low HOXB1 expression was prevented by an miR-3175 inhibitor in glioma cells. Our results suggest that HOXB1 functions as a tumor suppressor, regulated by miR-3175 in glioma. These results clarify the pathogenesis of glioma and offer a potential target for its treatment.	[Han, Liang; Liu, Dehua; Li, Zhaohui; Wang, Guang; Fu, Yao; Guo, Zhigang; Du, Chao; Tian, Yu] Jilin Univ, Dept Neurosurg, China Japan Union Hosp, Changchun 130023, Jilin, Peoples R China; [Tian, Nan; Han, Ziwu] Zhejiang Chinese Med Univ, Dept Cell Biol, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Zhu, Zifeng] Jilin Univ, Hosp 1, Dept Intervent Therapy, Changchun 130023, Jilin, Peoples R China	Jilin University; Zhejiang Chinese Medical University; Jilin University	Du, C (corresponding author), Jilin Univ, Dept Neurosurg, China Japan Union Hosp, Changchun 130023, Jilin, Peoples R China.	duchao0987@yahoo.com; tianyu@jlu.edu.cn	TIan, nan/GQP-1717-2022		National Natural Science Foundation of China [30672159]; New Century Excellent Talents in the Universities of China program [060306]; Jilin Provincial Science and Technology Development Plan for International S&T Co-operation Program [20130413028GH]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents in the Universities of China program(Program for New Century Excellent Talents in University (NCET)); Jilin Provincial Science and Technology Development Plan for International S&T Co-operation Program	This work was supported by National Natural Science Foundation of China (no. 30672159); New Century Excellent Talents in the Universities of China program (no. 060306); and Jilin Provincial Science and Technology Development Plan for International S&T Co-operation Program (no. 20130413028GH).	Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Armstrong TS, 2012, NEURO-ONCOLOGY, V14, P1203, DOI 10.1093/neuonc/nor223; Bageritz J, 2014, CELL DEATH DIFFER, V21, P929, DOI 10.1038/cdd.2014.12; Bhatlekar S, 2014, J MOL MED, V92, P811, DOI 10.1007/s00109-014-1181-y; Breitinger C, 2012, BLOOD, V120, P4018, DOI 10.1182/blood-2011-10-384685; Cakmak HA, 2015, J CARDIOVASC MED, V16, P431, DOI 10.2459/JCM.0000000000000233; Chiba H, 1997, MOL CELL BIOL, V17, P3013, DOI 10.1128/MCB.17.6.3013; Choe SK, 2009, DEV CELL, V17, P561, DOI 10.1016/j.devcel.2009.08.007; Chopra VS, 2006, BIOESSAYS, V28, P445, DOI 10.1002/bies.20401; Costa BM, 2010, CANCER RES, V70, P453, DOI 10.1158/0008-5472.CAN-09-2189; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; Ferretti E, 2011, DEV CELL, V21, P627, DOI 10.1016/j.devcel.2011.08.005; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gupta K, 2012, J CANCER RES CLIN, V138, P1971, DOI 10.1007/s00432-012-1323-y; Hakami F, 2014, BRIT J CANCER, V111, P807, DOI 10.1038/bjc.2014.372; Jansen M, 2010, LANCET NEUROL, V9, P717, DOI 10.1016/S1474-4422(10)70105-8; Johnson DR, 2013, CURR ONCOL REP, V15, P56, DOI 10.1007/s11912-012-0279-z; Kurscheid S, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0583-7; Longobardi E, 2003, J BIOL CHEM, V278, P39235, DOI 10.1074/jbc.M304704200; Lu JR, 2013, ONCOL REP, V29, P2269, DOI 10.3892/or.2013.2391; Manohar CF, 1996, TUMOR BIOL, V17, P34, DOI 10.1159/000217965; Micali N, 2010, NUCLEIC ACIDS RES, V38, P3595, DOI 10.1093/nar/gkq019; Morgan R, 2012, BREAST CANCER RES TR, V136, P389, DOI 10.1007/s10549-012-2259-2; Pavlopoulos A, 2011, P NATL ACAD SCI USA, V108, P2855, DOI 10.1073/pnas.1015077108; Petrini M, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-101; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Slupsky CM, 2001, PROTEIN SCI, V10, P1244, DOI 10.1110/ps.50901; Teramoto S, 2005, ONCOL REP, V14, P1231; Vecchione A, 2013, P NATL ACAD SCI USA, V110, P9845, DOI 10.1073/pnas.1305472110; Weiss FU, 2009, GASTROENTEROLOGY, V137, P2136, DOI 10.1053/j.gastro.2009.08.065; Xiao FM, 2014, EUR J CANCER, V50, P1541, DOI 10.1016/j.ejca.2014.01.024; Xu LX, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0108-3; Yekta S, 2008, NAT REV GENET, V9, P789, DOI 10.1038/nrg2400; Zhang HH, 2015, WORLD J GASTROENTERO, V21, P3519, DOI 10.3748/wjg.v21.i12.3519; Zhang HW, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-84; Zhang JQ, 2014, HUM PATHOL, V45, P2154, DOI 10.1016/j.humpath.2014.01.025; Zhang XR, 2007, J CELL MOL MED, V11, P299, DOI 10.1111/j.1582-4934.2007.00020.x; Zhang XJ, 2015, MOLECULES, V20, P5714, DOI 10.3390/molecules20045714; Zhu XL, 2012, ASIAN PAC J CANCER P, V13, P4607, DOI 10.7314/APJCP.2012.13.9.4607; Zigman M, 2014, DEVELOPMENT, V141, P639, DOI 10.1242/dev.098731	40	11	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142387	10.1371/journal.pone.0142387	http://dx.doi.org/10.1371/journal.pone.0142387			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26565624	Green Published, gold, Green Submitted			2022-12-26	WOS:000367628500021
J	Hojjat-Farsangi, M; Jeddi-Tehrani, M; Daneshmanesh, AH; Mozaffari, F; Moshfegh, A; Hansson, L; Razavi, SM; Sharifian, RA; Rabbani, H; Osterborg, A; Mellstedt, H; Shokri, F				Hojjat-Farsangi, Mohammad; Jeddi-Tehrani, Mahmood; Daneshmanesh, Amir Hossein; Mozaffari, Fariba; Moshfegh, Ali; Hansson, Lotta; Razavi, Seyed Mohsen; Sharifian, Ramazan Ali; Rabbani, Hodjattallah; Osterborg, Anders; Mellstedt, Hakan; Shokri, Fazel			Spontaneous Immunity Against the Receptor Tyrosine Kinase ROR1 in Patients with Chronic Lymphocytic Leukemia	PLOS ONE			English	Article							T-CELLS; CLL CELLS; B-CELLS; EXPRESSION; VACCINATION; ANTIBODIES; PHENOTYPE; FREQUENCY; APOPTOSIS; RESPONSES	Background ROR1 is a receptor tyrosine kinase expressed in chronic lymphocytic leukemia (CLL) and several other malignancies but absent in most adult normal tissues. ROR1 is considered an onco-fetal antigen. In the present study we analysed spontaneous humoral and cellular immunity against ROR1 in CLL patients. Materials and Methods Antibodies against ROR1 were analysed in 23 patients and 20 healthy donors by ELISA and Western blot. Purified serum IgG from patients was tested for cytotoxicity against CLL cells using the MTT viability assay. A cellular immune response against ROR1 derived HLA-A2 restricted 9 aa and 16 aa long peptides were analysed using peptide loaded dendritic cells co-cultured with autologous T cells from CLL patients (n = 9) and healthy donors (n = 6). IFN-gamma, IL-5 and IL-17A-secreting T cells were assessed by ELISPOT and a proliferative response using a H3-thymidine incorporation assay. Results The majority of CLL patients had antibodies against ROR1. Significantly higher titers of anti-ROR1 antibodies were noted in patients with non-progressive as compared to progressive disease. The extracellular membrane-close ROR1 KNG domain seemed to be an immunodominant epitope. Ten patients with high titers of anti-ROR1 binding antibodies were tested for cytotoxicity. Five of those had cytotoxic anti-ROR1 antibodies against CLL cells. ROR1-specific IFN-gamma and IL-17A producing T cells could be detected in CLL patients, preferentially in non-progressive as compared to patients with progressive disease (p<0.05). Conclusion ROR1 seemed to spontaneously induce a humoral as well as a T cell response in CLL patients. The data support the notion that ROR1 might be a specific neo-antigen and may serve as a target for immunotherapy.	[Hojjat-Farsangi, Mohammad; Daneshmanesh, Amir Hossein; Mozaffari, Fariba; Moshfegh, Ali; Hansson, Lotta; Osterborg, Anders; Mellstedt, Hakan] Karolinska Univ Hosp Solna, Canc Ctr Karolinska CCK, Dept Oncol Pathol, Immune & Gene Therapy Lab, Stockholm, Sweden; [Hojjat-Farsangi, Mohammad; Daneshmanesh, Amir Hossein; Mozaffari, Fariba; Moshfegh, Ali; Hansson, Lotta; Osterborg, Anders; Mellstedt, Hakan] Karolinska Inst, Stockholm, Sweden; [Hojjat-Farsangi, Mohammad; Shokri, Fazel] Univ Tehran Med Sci, Sch Publ Hlth, Dept Immunol, Tehran, Iran; [Jeddi-Tehrani, Mahmood; Rabbani, Hodjattallah; Shokri, Fazel] ACECR, Avicenna Res Inst, Monoclonal Antibody Res Ctr, Tehran, Iran; [Hansson, Lotta; Osterborg, Anders] Karolinska Univ Hosp Solna, Dept Hematol Oncol, Stockholm, Sweden; [Razavi, Seyed Mohsen] Iran Univ Med Sci, Firozgar Hosp, Fac Med, Clin Hematol & Oncol, Tehran, Iran; [Moshfegh, Ali] Univ Tehran Med Sci, Fac Med, Vali Asr Hosp, Clin Hematol & Oncol, Tehran, Iran	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Tehran University of Medical Sciences; Academic Center for Education, Culture & Research (ACECR); Karolinska Institutet; Karolinska University Hospital; Iran University of Medical Sciences; Tehran University of Medical Sciences	Mellstedt, H (corresponding author), Karolinska Univ Hosp Solna, Canc Ctr Karolinska CCK, Dept Oncol Pathol, Immune & Gene Therapy Lab, Stockholm, Sweden.	hakan.mellstedt@karolinska.se	Jeddi-Tehrani, Mahmood/HDM-1013-2022; Hojjat-Farsangi, Mohammad/E-8171-2018	Hojjat-Farsangi, Mohammad/0000-0002-0589-5523; Mozaffari, Fariba/0000-0002-7528-4381; Jeddi-Tehrani, Mahmood/0000-0002-8831-4711; Hansson, Lotta/0000-0001-6614-5737	CLL Global Research Foundation (US) [10501033]; Cancer and Allergy Foundation (SE) [149351, 149746, 150288]; Swedish Cancer Society (SE) [CAN 12 0842]; Cancer Society in Stockholm (SE) [121273, 144142]; King Gustaf Vth Jubilee Fund HM (SE) [121332]; AFA Insurance (SE) [130054]; Karolinska Institute Foundations (SE) [2011Fobi0061]; Stockholm County Council (SE) [20120051]; Tehran University of Medical sciences FS, The Nanotechnology Network affiliated to The Ministry of Health and Medical Education of Iran, Avicenna Research Institute;  [P36147-1];  [P371471]	CLL Global Research Foundation (US); Cancer and Allergy Foundation (SE); Swedish Cancer Society (SE); Cancer Society in Stockholm (SE); King Gustaf Vth Jubilee Fund HM (SE); AFA Insurance (SE); Karolinska Institute Foundations (SE); Stockholm County Council (SE); Tehran University of Medical sciences FS, The Nanotechnology Network affiliated to The Ministry of Health and Medical Education of Iran, Avicenna Research Institute; ; 	This study was funded by CLL Global Research Foundation (US), award no: 10501033 to Hakan Mellstedt; The Cancer and Allergy Foundation (SE), www.cancerochallergifonden.se, award no: 149351, 149746, 150288 to Hakan Mellstedt; The Swedish Cancer Society (SE), www. cancerfonden.se, award no: CAN 12 0842 to Anders Osterborg; The Cancer Society in Stockholm (SE), www.rahfo.se, award no: 121273, 144142 to Anders Osterborg; The King Gustaf Vth Jubilee Fund HM (SE), www.rahfo.se, award no: 121332 to Hakan Mellstedt; Vinnova (SE), www.vinnova.se, award no: P36147-1, P371471 to Hakan Mellstedt; AFA Insurance (SE), www.afaforsakring.se dnr, award no: 130054 to Anders Osterborg; The Karolinska Institute Foundations (SE), www.ki.se, award no: 2011Fobi0061 to Hakan Mellstedt; The Stockholm County Council (SE), www.forskningsstod.vmi.se, award no: 20120051 to Anders Osterborg; The Tehran University of Medical sciences FS, The Nanotechnology Network affiliated to The Ministry of Health and Medical Education of Iran, Avicenna Research Institute, www.tums.ac.ir, to Fazel Shokri. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla AO, 2008, ANN ONCOL, V19, P1172, DOI 10.1093/annonc/mdn017; Adam JK, 2003, PHARMACOL THERAPEUT, V99, P113, DOI 10.1016/S0163-7258(03)00056-1; Al-Shawi R, 2001, DEV GENES EVOL, V211, P161, DOI 10.1007/s004270100140; Baig NA, 2012, LEUKEMIA LYMPHOMA, V53, P2218, DOI 10.3109/10428194.2012.681657; Baskar S, 2008, CLIN CANCER RES, V14, P396, DOI 10.1158/1078-0432.CCR-07-1823; Boelens J, 2009, ANTICANCER RES, V29, P605; Cragg Mark S., 2005, V8, P140; Daneshmanesh AH, 2012, LEUKEMIA, V26, P1348, DOI 10.1038/leu.2011.362; DaneshManesh AH, 2008, INT J CANCER, V123, P1190, DOI 10.1002/ijc.23587; Daneshmanesh AH, 2015, BRIT J HAEMATOL, V169, P455, DOI 10.1111/bjh.13228; Finn OJ, 2008, NEW ENGL J MED, V358, P2704, DOI 10.1056/NEJMra072739; Fukuda T, 2008, P NATL ACAD SCI USA, V105, P3047, DOI 10.1073/pnas.0712148105; Glennie MJ, 2007, MOL IMMUNOL, V44, P3823, DOI 10.1016/j.molimm.2007.06.151; Gnjatic S, 2006, ADV CANCER RES, V95, P1, DOI 10.1016/S0065-230X(06)95001-5; Hojjat-Farsangi M, 2014, SEMIN CANCER BIOL, V29, P21, DOI 10.1016/j.semcancer.2014.07.005; Hojjat-Farsangi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078339; Hojjat-Farsangi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061167; Hudecek M, 2010, BLOOD, V116, P4532, DOI 10.1182/blood-2010-05-283309; Jadidi-Niaragh F, 2013, TUMOR BIOL, V34, P929, DOI 10.1007/s13277-012-0628-4; Jadidi-Niaragh F, 2013, CANCER INVEST, V31, P121, DOI 10.3109/07357907.2012.756110; Jadidi-Niaragh F, 2012, MED ONCOL, V29, P3561, DOI 10.1007/s12032-012-0262-4; Jager D, 2001, ONCOLOGY-BASEL, V60, P1, DOI 10.1159/000055289; Jin S, 2008, CANCER SCI, V99, P1670, DOI 10.1111/j.1349-7006.2008.00860.x; Kamradt T, 2001, NEW ENGL J MED, V344, P655, DOI 10.1056/NEJM200103013440907; Klein U, 2001, J EXP MED, V194, P1625, DOI 10.1084/jem.194.11.1625; Lapalombella R, 2010, BLOOD, V115, P2619, DOI 10.1182/blood-2009-09-242438; Lendvai Nikoletta, 2010, Cancer Immun, V10, P4; Lin R, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.3291.3291; MASIAKOWSKI P, 1992, J BIOL CHEM, V267, P26181; Matsuda T, 2001, MECH DEVELOP, V105, P153, DOI 10.1016/S0925-4773(01)00383-5; MORRISON J, 1992, EUR J IMMUNOL, V22, P903, DOI 10.1002/eji.1830220404; Oppezzo P, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.45; Palma M, 2012, CANCER IMMUNOL IMMUN, V61, P865, DOI 10.1007/s00262-011-1149-5; Plass C, 2007, BRIT J HAEMATOL, V139, P744, DOI 10.1111/j.1365-2141.2007.06875.x; Rescigno M, 2007, BBA-REV CANCER, V1776, P108, DOI 10.1016/j.bbcan.2007.07.003; Rezvany MR, 2001, BRIT J HAEMATOL, V115, P263, DOI 10.1046/j.1365-2141.2001.03117.x; Rosenwald A, 2001, J EXP MED, V194, P1639, DOI 10.1084/jem.194.11.1639; Scrivener S, 2003, LEUKEMIA LYMPHOMA, V44, P383, DOI 10.1080/1042819021000029993; van Rhee F, 2005, BLOOD, V105, P3939, DOI 10.1182/blood-2004-09-3707; von Mensdorff-Pouilly S, 2000, INT J BIOL MARKER, V15, P343, DOI 10.1177/172460080001500413; Widhopf GF, 2014, P NATL ACAD SCI USA, V111, P793, DOI 10.1073/pnas.1308374111; Yoda A, 2003, J RECEPT SIG TRANSD, V23, P1, DOI 10.1081/RRS-120018757; ZWEERINK HJ, 1993, J IMMUNOL, V150, P1763	43	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142310	10.1371/journal.pone.0142310	http://dx.doi.org/10.1371/journal.pone.0142310			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562161	gold, Green Published			2022-12-26	WOS:000364480900024
J	Lim, S; Park, SH; Park, HK; Hur, MH; Oh, SJ; Suh, YJ				Lim, SeungTaek; Park, Se Ho; Park, Heong Kyu; Hur, Min Hee; Oh, Se Jeong; Suh, Young Jin			Prognostic Role of Adjuvant Chemotherapy in Node-Negative (N0), Triple-Negative (TN), Medullary Breast Cancer (MBC) in the Korean Population	PLOS ONE			English	Article							RISK-FACTORS; CARCINOMA; THERAPY; SURVIVAL; FEATURES; CYCLOPHOSPHAMIDE; METHOTREXATE; PATTERNS; TRIALS; BASAL	Background Despite the favorable prognosis for medullary breast cancer (MBC), the guidelines for the use of adjuvant chemotherapy for MBC have not been clearly established. This study investigated the prognostic role of adjuvant chemotherapy in Korean patients with node-negative (N0), triple-negative (TN) MBC patients. Methods We included data from 252 patients with N0 TN MBC, obtained from the Korean Breast Cancer Registry database. Patients were categorized as those who did not undergo adjuvant chemotherapy (group I) or those who did (group II). Clinicopathological characteristics, breast cancer-specific survival (BCSS), and overall survival (OS) were compared between the groups. In addition, a subgroup analysis for survival based on tumor size was conducted. Results A total of 252 N0 TN MBC patients with tumor sizes >1 cm who were diagnosed between April 1997 andMarch 2011 were enrolled. The median age was 44.95 years (range, 25-72 years), and the median follow-up period was 93.94months (range, 23-195months). Overall, the BCSS and OS in group II (97.3% and 97.3%, respectively) were significantly better compared with those in group I (89.2% and 86.2%, respectively). In the subgroup analysis, in patients with tumors >2 cmin size, those in group II had significant better BCSS and OS (97.5% and 97.5%, respectively) compared with those in group I (78.3% and 73.9%, respectively). In contrast in those with tumors 1-2 cmin size, there were no significant differences in BCSS and OS between the groups (both 97.1% for group I, and 95.2% and 92.9%, respectively for group II). Multivariate analysis revealed that adjuvant chemotherapy significantly improved BCSS (P = 0.009) and OS (P = 0.007), but only for patients with larger tumors (> 2 cm). Conclusions In patients with N0 TN MBC, adjuvant chemotherapy had a significant clinical survival benefit, but only in those with tumors >2 cm.	[Lim, SeungTaek; Suh, Young Jin] Catholic Univ Korea, St Vincents Hosp, Div Breast & Thyroid Surg Oncol, Dept Surg,Coll Med, Suwon 442723, Gyeonggi Do, South Korea; [Park, Se Ho] Yonsei Univ, Coll Med, Dept Surg, Seoul 120752, South Korea; [Park, Heong Kyu] Gachon Univ, Gill Hosp, Dept Surg, Breast Canc Ctr, Inchon 405760, South Korea; [Hur, Min Hee] Dankook Univ, Coll Med, Cheil Gen Hosp, Dept Surg, Seoul 100380, South Korea; [Hur, Min Hee] Dankook Univ, Coll Med, Womens Healthcare Ctr, Seoul 100380, South Korea; [Oh, Se Jeong] Catholic Univ Korea, Incheon St Marys Hosp, Coll Med, Dept Surg, Inchon 403720, South Korea	Catholic University of Korea; Yonsei University; Yonsei University Health System; Gachon University; Dankook University; Dankook University; Catholic University of Korea	Suh, YJ (corresponding author), Catholic Univ Korea, St Vincents Hosp, Div Breast & Thyroid Surg Oncol, Dept Surg,Coll Med, Jungbu Daero 93, Suwon 442723, Gyeonggi Do, South Korea.	yjsuh@catholic.ac.kr		Oh, Se Jeong/0000-0002-2583-4218				Anderson WF, 2004, CANCER EPIDEM BIOMAR, V13, P1128; Bertucci F, 2006, CANCER RES, V66, P4636, DOI 10.1158/0008-5472.CAN-06-0031; BLOOM HJG, 1970, BMJ-BRIT MED J, V3, P181, DOI 10.1136/bmj.3.5716.181; Cao AY, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-91; Chu ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111493; Colleoni M, 2010, J CLIN ONCOL, V28, P2966, DOI 10.1200/JCO.2009.25.9549; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Foschini MP, 2009, PATHOLOGY, V41, P48, DOI 10.1080/00313020802563528; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Gradishar WJ, 2015, J NATL COMPR CANC NE, V13, P448, DOI 10.6004/jnccn.2015.0060; Huober J, 2012, ANN ONCOL, V23, P2843, DOI 10.1093/annonc/mds105; Huober J, 2010, BREAST CANCER RES TR, V124, P133, DOI 10.1007/s10549-010-1103-9; Jensen ML, 1997, HISTOPATHOLOGY, V30, P523; Li Christopher I., 2010, Hormones & Cancer, V1, P156, DOI 10.1007/s12672-010-0016-8; Li CI, 2005, BRIT J CANCER, V93, P1046, DOI 10.1038/sj.bjc.6602787; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Malyuchik S. S., 2008, Experimental Oncology, V30, P96; Martinez SR, 2011, MED ONCOL, V28, P738, DOI 10.1007/s12032-010-9526-z; Moon HG, 2009, J CLIN ONCOL, V27, P5899, DOI 10.1200/JCO.2009.22.4436; Munzone E, 2012, BREAST CANCER RES TR, V134, P277, DOI 10.1007/s10549-012-2040-6; Orlando L, 2005, ANN ONCOL, V16, P1094, DOI 10.1093/annonc/mdi213; Park I, 2013, J BREAST CANCER, V16, P417, DOI 10.4048/jbc.2013.16.4.417; Pedersen L, 1995, EUR J CANCER, V31A, P2289, DOI 10.1016/0959-8049(95)00408-4; PEDERSEN L, 1989, BREAST CANCER RES TR, V14, P91, DOI 10.1007/BF01805979; PERTSCHUK LP, 1990, CANCER, V66, P1663, DOI 10.1002/1097-0142(19901015)66:8<1663::AID-CNCR2820660802>3.0.CO;2-C; Rakha EA, 2009, EUR J CANCER, V45, P1780, DOI 10.1016/j.ejca.2009.02.014; Rakha EA, 2006, J PATHOL, V208, P495, DOI 10.1002/path.1916; RIDOLFI RL, 1977, CANCER, V40, P1365, DOI 10.1002/1097-0142(197710)40:4<1365::AID-CNCR2820400402>3.0.CO;2-N; ROSEN PP, 1995, CANCER, V75, P1320, DOI 10.1002/1097-0142(19950315)75:6<1320::AID-CNCR2820750614>3.0.CO;2-C; Vu-Nishino H, 2005, INT J RADIAT ONCOL, V62, P1040, DOI 10.1016/j.ijrobp.2005.01.008; Wu CE, 2014, ANTICANCER RES, V34, P1301	31	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0140208	10.1371/journal.pone.0140208	http://dx.doi.org/10.1371/journal.pone.0140208			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562837	Green Published, gold, Green Submitted			2022-12-26	WOS:000364480900003
J	Lin, MZ; Wang, ZW; He, LC; Xu, K; Cheng, DL; Wang, GX				Lin, Maozi; Wang, Zhiwei; He, Lingchao; Xu, Kang; Cheng, Dongliang; Wang, Genxuan			Plant Photosynthesis-Irradiance Curve Responses to Pollution Show Non-Competitive Inhibited Michaelis Kinetics	PLOS ONE			English	Article							NET PHOTOSYNTHESIS; LIGHT; LEAVES; MODEL; CADMIUM; PHYTOPLANKTON; CHLOROPHYLL; DEPENDENCE; DIRECTION; FIXATION	Photosynthesis-irradiance (PI) curves are extensively used in field and laboratory research to evaluate the photon-use efficiency of plants. However, most existing models for PI curves focus on the relationship between the photosynthetic rate (Pn) and photosynthetically active radiation (PAR), and do not take account of the influence of environmental factors on the curve. In the present study, we used a new non-competitive inhibited Michaelis-Menten model (NIMM) to predict the co-variation of Pn, PAR, and the relative pollution index (I). We then evaluated the model with published data and our own experimental data. The results indicate that the Pn of plants decreased with increasing I in the environment and, as predicted, were all fitted well by the NIMM model. Therefore, our model provides a robust basis to evaluate and understand the influence of environmental pollution on plant photosynthesis.	[Lin, Maozi] Fujian Normal Univ, Fuqing Branch, Fuqing 350300, Fujian Province, Peoples R China; [Lin, Maozi; Wang, Zhiwei; He, Lingchao; Xu, Kang; Wang, Genxuan] Zhejiang Univ, Coll Life Sci, Hangzhou 310027, Zhejiang, Peoples R China; [Cheng, Dongliang] Fujian Normal Univ, Key Lab Humid Subtrop Ecogeog Proc, Minist Educ, Fuzhou 350007, Fujian, Peoples R China	Fujian Normal University; Zhejiang University; Fujian Normal University	Wang, GX (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310027, Zhejiang, Peoples R China.	wanggx@zju.edu.cn	Xu, Kang/HGB-5084-2022; Maozi, Lin/AAP-8960-2021	Maozi, Lin/0000-0002-4669-3151; Xu, Kang/0000-0002-0840-9332	Natural Science Foundation of China [31330010, 31370589]; Natural Science Foundation of Zhejiang Province, China [LZ13C030001]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province)	The present study was supported by Natural Science Foundation of China (31330010 and 31370589) and Natural Science Foundation of Zhejiang Province, China (LZ13C030001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; BAKER A J M, 1989, Biorecovery, V1, P81; Baly ECC, 1935, PROC R SOC SER B-BIO, V117, P218, DOI 10.1098/rspb.1935.0026; Baryla A, 2001, PLANTA, V212, P696, DOI 10.1007/s004250000439; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Bjorkman O., 1975, Environmental and biological control of photosynthesis., P1; BODDI B, 1995, PHOTOSYNTHETICA, V31, P411; Cai QY, 2007, J HAZARD MATER, V147, P1063, DOI 10.1016/j.jhazmat.2007.01.142; CULLEN JJ, 1992, ENVIR SCI R, V43, P69; DUBINSKY Z, 1986, PLANT CELL PHYSIOL, V27, P1335, DOI 10.1093/oxfordjournals.pcp.a077232; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Fu Wei-guo, 2006, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V26, P496; Horvath G, 1996, PLANTA, V199, P238, DOI 10.1007/BF00196564; Hui JunAi, 2010, Journal of Agro-Environment Science, V29, P205; JASSBY AD, 1976, LIMNOL OCEANOGR, V21, P540, DOI 10.4319/lo.1976.21.4.0540; Johnson Z, 2000, THESIS, P14; Joshi MK, 2004, ADV PHOTO RESPIRAT, V19, P637; Kidd P, 2009, ENVIRON EXP BOT, V67, P243, DOI 10.1016/j.envexpbot.2009.06.013; KRUPA Z, 1988, PHYSIOL PLANTARUM, V73, P518, DOI 10.1111/j.1399-3054.1988.tb05435.x; Kupper H, 2005, MET IONS BIOL SYST, V44, P97; Kyei-Boahen S, 2003, PHOTOSYNTHETICA, V41, P301, DOI 10.1023/B:PHOT.0000011967.74465.cc; LEVERENZ JW, 1979, J APPL ECOL, V16, P919, DOI 10.2307/2402865; Lin MaoZi, 2012, Journal of Anhui Agricultural University, V39, P286; LINDLEY ST, 1995, DEEP-SEA RES PT II, V42, P441, DOI 10.1016/0967-0645(95)00029-P; Liu Y-F, 2005, CHINESE AGR SCI B, V21, P76, DOI DOI 10.3969/J.ISSN.1000-6850.2005.08.021; Lopez-Urrutia A, 2006, P NATL ACAD SCI USA, V103, P8739, DOI 10.1073/pnas.0601137103; Marschall M, 2004, ANN BOT-LONDON, V94, P593, DOI 10.1093/aob/mch178; MARSHALL B, 1980, J EXP BOT, V31, P29, DOI 10.1093/jxb/31.1.29; MARSHALL B, 1980, J EXP BOT, V31, P41, DOI 10.1093/jxb/31.1.41; Michaelis L, 1913, BIOCHEM Z, V49, P333; OGREN E, 1993, PLANT PHYSIOL, V101, P1013, DOI 10.1104/pp.101.3.1013; PADMAJA K, 1990, PHOTOSYNTHETICA, V24, P399; PERRY MJ, 1981, MAR BIOL, V62, P91, DOI 10.1007/BF00388170; PLATT T, 1987, POLAR BIOL, V8, P103, DOI 10.1007/BF00297064; Platt T, 1975, 110 FISH MAR SERV, P110; Prasad M. N. V., 1999, HEAVY METAL STRESS P; Prasad MNV, 1999, HEAVY METAL STRESS P, P117, DOI [DOI 10.1007/978-3-662-07745-0, 10.1007/978-3-662-07745-0]; PRIOUL JL, 1977, ANN BOT-LONDON, V41, P789, DOI 10.1093/oxfordjournals.aob.a085354; STEELE JH, 1962, LIMNOL OCEANOGR, V7, P137, DOI 10.4319/lo.1962.7.2.0137; STOBART AK, 1985, PHYSIOL PLANTARUM, V63, P293, DOI 10.1111/j.1399-3054.1985.tb04268.x; Tayor RJ, 1976, CAN J BOT, V54, P1094; Thornley JHM, 1998, ANN BOT-LONDON, V81, P421, DOI 10.1006/anbo.1997.0575; Thornley JMH, 1976, MATH MODELS PLANT PH, P11; WEBB WL, 1974, OECOLOGIA, V17, P281, DOI 10.1007/BF00345747; Xiao YA, 2010, J JINGGANGSHAN U, V31, P48; YAMAOKA K, 1978, J PHARMACOKINET BIOP, V6, P165, DOI 10.1007/BF01117450; [姚广 YAO Guang], 2009, [生态学报, Acta Ecologica Sinica], V29, P1162; Ye ZP, 2007, PHOTOSYNTHETICA, V45, P637, DOI 10.1007/s11099-007-0110-5; Zhang GuoJun, 2009, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V17, P130, DOI 10.3724/SP.J.1011.2009.00130; [张树清 Zhang Shuqing], 2005, [植物营养与肥料学报, Plant nutrition and fertitizer science], V11, P822	51	7	10	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142712	10.1371/journal.pone.0142712	http://dx.doi.org/10.1371/journal.pone.0142712			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26561863	Green Submitted, gold, Green Published			2022-12-26	WOS:000364480900058
J	Martins, CJD; Genelhu, V; Pimentel, MMG; Celoria, BMJ; Mangia, RF; Aveta, T; Silvestri, C; Di Marzo, V; Francischetti, EA				de Moraes Martins, Cyro Jose; Genelhu, Virginia; Goncalves Pimentel, Marcia Mattos; Jorge Celoria, Bruno Miguel; Mangia, Rogerio Fabris; Aveta, Teresa; Silvestri, Cristoforo; Di Marzo, Vincenzo; Francischetti, Emilio Antonio			Circulating Endocannabinoids and the Polymorphism 385C>A in Fatty Acid Amide Hydrolase (FAAH) Gene May Identify the Obesity Phenotype Related to Cardiometabolic Risk: A Study Conducted in a Brazilian Population of Complex Interethnic Admixture	PLOS ONE			English	Article							INSULIN-RESISTANCE; ADIPOSE-TISSUE; MISSENSE POLYMORPHISM; SYSTEM; ACTIVATION; PLASMA; DYSREGULATION; CANNABINOIDS; PATHOGENESIS; HOMEOSTASIS	The dysregulation of the endocannabinoid system is associated with cardiometabolic complications of obesity. Allelic variants in coding genes for this system components may contribute to differences in the susceptibility to obesity and related health hazards. These data have mostly been shown in Caucasian populations and in severely obese individuals. We investigated a multiethnic Brazilian population to study the relationships among the polymorphism 385C>A in an endocannabinoid degrading enzyme gene (FAAH), endocannabinoid levels and markers of cardiometabolic risk. Fasting plasma levels of endocannabinoids and congeners (anandamide, 2-arachidonoylglycerol, N-oleoylethanolamide and N-palmitoylethanolamide) were measured by liquid chromatography-mass spectrometry in 200 apparently healthy individuals of both genders with body mass indices from 22.5 +/- 1.8 to 35.9 +/- 5.5 kg/m(2) (mean +/- 1 SD) and ages between 18 and 60 years. All were evaluated for anthropometric parameters, blood pressure, metabolic variables, homeostatic model assessment of insulin resistance (HOMA-IR), adiponectin, leptin, C-reactive protein, and genotyping. The endocannabinoid levels increased as a function of obesity and insulin resistance. The homozygous genotype AA was associated with higher levels of anandamide and lower levels of adiponectin versus wild homozygous CC and heterozygotes combined. The levels of anandamide were independent and positively associated with the genotype AA position 385 of FAAH, C-reactive protein levels and body mass index. Our findings provide evidence for an endocannabinoid-related phenotype that may be identified by the combination of circulating anandamide levels with genotyping of the FAAH 385C>A; this phenotype is not exclusive to mono-ethnoracial populations nor to individuals with severe obesity.	[de Moraes Martins, Cyro Jose; Genelhu, Virginia; Jorge Celoria, Bruno Miguel; Mangia, Rogerio Fabris; Francischetti, Emilio Antonio] Rio de Janeiro State Univ UERJ, Lab Clin & Expt Pathophysiol CLINEX, Rio De Janeiro, RJ, Brazil; [Genelhu, Virginia; Francischetti, Emilio Antonio] UNIGRANRIO, Prorector Res & Postgrad Educ, Duque De Caxias, RJ, Brazil; [Goncalves Pimentel, Marcia Mattos] Rio de Janeiro State Univ UERJ, Dept Genet, Rio De Janeiro, RJ, Brazil; [Aveta, Teresa; Silvestri, Cristoforo; Di Marzo, Vincenzo] CNR, Inst Biomol Chem, Endocannabinoid Res Grp, Pozzuoli, NA, Italy	Universidade do Estado do Rio de Janeiro; Universidade do Grande Rio; Universidade do Estado do Rio de Janeiro; Consiglio Nazionale delle Ricerche (CNR)	Francischetti, EA (corresponding author), Rio de Janeiro State Univ UERJ, Lab Clin & Expt Pathophysiol CLINEX, Rio De Janeiro, RJ, Brazil.	francischetti@globo.com	Francischetti, Emilio/AAX-8544-2020; Di Marzo, Vincenzo/AAD-7742-2019; Martins, Cyro/AAC-2261-2020; Silvestri, Cristoforo/Y-2504-2019	Di Marzo, Vincenzo/0000-0002-1490-3070; Silvestri, Cristoforo/0000-0001-5635-1545; Pimentel, Marcia/0000-0002-8872-7073; MARTINS, Cyro/0000-0002-0140-2920	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro [111.957/2010]; EAF	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); EAF	This work was supported by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (http://www.faperj.br), Research Grant Number 111.957/2010. EAF received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulnour J, 2014, OBESITY, V22, P211, DOI 10.1002/oby.20498; Aberle J, 2007, HORM METAB RES, V39, P395, DOI 10.1055/s-2007-977694; Bennetzen MF, 2011, INT J OBESITY, V35, P1377, DOI 10.1038/ijo.2011.8; Bensaid M, 2003, MOL PHARMACOL, V63, P908, DOI 10.1124/mol.63.4.908; Chiang KP, 2004, HUM MOL GENET, V13, P2113, DOI 10.1093/hmg/ddh216; Cote M, 2007, INT J OBESITY, V31, P692, DOI 10.1038/sj.ijo.0803539; Craft RM, 2013, LIFE SCI, V92, P476, DOI 10.1016/j.lfs.2012.06.009; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; D'Eon TM, 2008, DIABETES, V57, P1262, DOI 10.2337/db07-1186; Di Marzo V, 2008, DIABETOLOGIA, V51, P1356, DOI 10.1007/s00125-008-1048-2; Engeli S, 2008, J NEUROENDOCRINOL, V20, P110, DOI 10.1111/j.1365-2826.2008.01683.x; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; Fegley D, 2005, J PHARMACOL EXP THER, V313, P352, DOI 10.1124/jpet.104.078980; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Ge Q, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/987285; Geloneze B, 2006, DIABETES RES CLIN PR, V72, P219, DOI 10.1016/j.diabres.2005.10.017; Genelhu VA, 2009, EUR J INTERN MED, V20, P289, DOI 10.1016/j.ejim.2008.09.009; Geurts L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055963; Gomez R, 2002, J NEUROSCI, V22, P9612; Goossens GH, 2008, PHYSIOL BEHAV, V94, P206, DOI 10.1016/j.physbeh.2007.10.010; Jensen DP, 2007, J MOL MED, V85, P445, DOI 10.1007/s00109-006-0139-0; Jumpertz R, 2011, J CLIN ENDOCR METAB, V96, P787, DOI 10.1210/jc.2010-2028; Karasu T, 2011, HUM REPROD UPDATE, V17, P347, DOI 10.1093/humupd/dmq058; Lieb W, 2009, OBESITY, V17, P755, DOI 10.1038/oby.2008.608; Mallipedhi A, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/680867; Martins CJM, 2014, HORM METAB RES, V46, P529, DOI 10.1055/s-0034-1375653; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; Matias I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042399; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Monteleone P, 2008, PSYCHONEUROENDOCRINO, V33, P546, DOI 10.1016/j.psyneuen.2008.01.004; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Norrod AG, 2007, CHEM BIODIVERS, V4, P1926, DOI 10.1002/cbdv.200790160; O'Sullivan SE, 2007, BRIT J PHARMACOL, V152, P576, DOI 10.1038/sj.bjp.0707423; Quercioli A, 2012, JACC-CARDIOVASC IMAG, V5, P805, DOI 10.1016/j.jcmg.2012.01.020; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Silvestri C, 2013, CELL METAB, V17, P475, DOI 10.1016/j.cmet.2013.03.001; Sipe JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008792; Sipe JC, 2005, INT J OBESITY, V29, P755, DOI 10.1038/sj.ijo.0802954; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; Sun Y, 2006, BIOCHEM SOC T, V34, P1095, DOI 10.1042/BST0341095; Tourino C, 2010, INT J OBESITY, V34, P557, DOI 10.1038/ijo.2009.262; Vasileiou I, 2013, EXPERT OPIN THER TAR, V17, P363, DOI 10.1517/14728222.2013.754426	44	20	21	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142728	10.1371/journal.pone.0142728	http://dx.doi.org/10.1371/journal.pone.0142728			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26561012	Green Published, gold, Green Submitted			2022-12-26	WOS:000364433100115
J	Moran, EV; Ormond, RA				Moran, Emily V.; Ormond, Rhys A.			Simulating the Interacting Effects of Intraspecific Variation, Disturbance, and Competition on Climate-Driven Range Shifts in Trees	PLOS ONE			English	Article							SEED DISPERSAL; LOCAL ADAPTATION; GENE FLOW; EVOLUTIONARY RESPONSES; PLANT MIGRATION; FOREST TREES; HABITAT FRAGMENTATION; GAP CHARACTERISTICS; BIOTIC INTERACTIONS; MECHANISTIC MODELS	Climate change is expected to favor shifts in plant distributions; some such shifts are already being observed along elevation gradients. However, the rate of such shifts may be limited by their ability to reach newly suitable areas and by competition from resident species. The degree of local adaptation and genetic variation may also play a role in the interaction between migrants and residents by affecting relative fitness. We used a simulation model to explore the interacting effects of dispersal, fecundity, disturbance, and genetic variation on range-edge dynamics between a pair of demographically similar tree species. Ideal climate for an individual is determined by genotype. The simulated landscape undergoes an 80-year period of climate change in which climate bands shift upslope; subsequently, climate is held constant for 300 years. The presence of a high-elevation competitor caused a significant lag in the range shift of the low-elevation species relative to competition- free scenarios. Increases in fecundity and dispersal distance both helped to speed up the replacement of the high-elevation species by the low-elevation species at their range boundary. While some disturbance scenarios facilitated this transition, frequent canopy disturbance inhibited colonization by removing reproductive adults and led to range contractions in both species. Differences between dispersal scenarios were more pronounced when disturbance was frequent (15 vs. 25 year return interval) and dispersal was limited. When the high-elevation species lacked genetic variation, its range was more-easily invaded by the low-elevation species, while a similar lack of variation in the low-elevation species inhibited colonization-but only when this lack of variation decreased the fitness of the affected species near the range boundary. Our model results support the importance of measuring and including dispersal/ fecundity, disturbance type and frequency, and genetic variation when assessing the potential for range shifts and species vulnerability to climate change.	[Moran, Emily V.; Ormond, Rhys A.] Univ Calif Merced, Sch Nat Sci, Merced, CA 95343 USA	University of California System; University of California Merced	Moran, EV (corresponding author), Univ Calif Merced, Sch Nat Sci, Merced, CA 95343 USA.	emoran5@ucmerced.edu		Moran, Emily/0000-0003-4624-1910				Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; Aitken SN, 2013, ANNU REV ECOL EVOL S, V44, P367, DOI 10.1146/annurev-ecolsys-110512-135747; Alberto FJ, 2013, GLOBAL CHANGE BIOL, V19, P1645, DOI 10.1111/gcb.12181; Ashley MV, 2010, CRIT REV PLANT SCI, V29, P148, DOI 10.1080/07352689.2010.481167; Atkins KE, 2010, J THEOR BIOL, V266, P449, DOI 10.1016/j.jtbi.2010.07.014; Austerlitz F, 2000, GENETICS, V154, P1309; Beckage B, 2008, P NATL ACAD SCI USA, V105, P4197, DOI 10.1073/pnas.0708921105; Garzon MB, 2011, GLOBAL ECOL BIOGEOGR, V20, P766, DOI 10.1111/j.1466-8238.2010.00646.x; Bocedi G, 2013, ANN NY ACAD SCI, P1297; Brooker RW, 2007, J THEOR BIOL, V245, P59, DOI 10.1016/j.jtbi.2006.09.033; Cain ML, 2000, AM J BOT, V87, P1217, DOI 10.2307/2656714; CALLAHAM R. Z., 1961, JOUR FOREST, V59, P814; Caplat P, 2008, THEOR ECOL-NETH, V1, P209, DOI 10.1007/s12080-008-0021-5; Clark JS, 1998, BIOSCIENCE, V48, P13, DOI 10.2307/1313224; Clark JS, 1999, ECOLOGY, V80, P1475, DOI 10.1890/0012-9658(1999)080[1475:SDNAFP]2.0.CO;2; Clark JS, 2001, AM NAT, V157, P537, DOI 10.1086/319934; Collingham YC, 2000, ECOL APPL, V10, P131, DOI 10.1890/1051-0761(2000)010[0131:IOHFAP]2.0.CO;2; Corlett RT, 2013, TRENDS ECOL EVOL, V28, P482, DOI 10.1016/j.tree.2013.04.003; Cortes MC, 2013, BIOL REV, V88, P255, DOI 10.1111/j.1469-185X.2012.00250.x; Cousens RD, 2010, FUNCT ECOL, V24, P1163, DOI 10.1111/j.1365-2435.2010.01747.x; Davis MB, 2005, ECOLOGY, V86, P1704, DOI 10.1890/03-0788; Dormann CF, 2012, J BIOGEOGR, V39, P2119, DOI 10.1111/j.1365-2699.2011.02659.x; Dullinger S, 2004, J ECOL, V92, P241, DOI 10.1111/j.0022-0477.2004.00872.x; Eckert AJ, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0863-0; Edenhofer O., 2014, CONTRIBUTION WORKING; Ettinger AK, 2013, AM J BOT, P100; Feeley KJ, 2011, J BIOGEOGR, V38, P783, DOI 10.1111/j.1365-2699.2010.02444.x; Fellows AW, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG002044; Feurdean A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071797; Franklin J, 2013, GLOBAL CHANGE BIOL, V19, P473, DOI 10.1111/gcb.12051; Godoy JA, 2001, MOL ECOL, V10, P2275, DOI 10.1046/j.0962-1083.2001.01342.x; Gray LK, 2013, CLIMATIC CHANGE, V117, P289, DOI 10.1007/s10584-012-0548-8; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Gworek JR, 2007, FOREST ECOL MANAG, V239, P57, DOI 10.1016/j.foreco.2006.11.010; HALLER JOHN R., 1959, MADROnO, V15, P65; Hamrick JL, 2004, FOREST ECOL MANAG, V197, P323, DOI 10.1016/j.foreco.2004.05.023; Hardesty BD, 2006, ECOL LETT, V9, P516, DOI 10.1111/j.1461-0248.2006.00897.x; Helmuth B, 2014, CLIMATE CHANGE RESPO, V1, P6, DOI [10.1186/s40665-014-0006-0, DOI 10.1186/S40665-014-0006-0]; Higgins SI, 1999, AM NAT, V153, P464, DOI 10.1086/303193; Howe GT, 2003, CAN J BOT, V81, P1247, DOI [10.1139/b03-141, 10.1139/B03-141]; Ibanez I, 2006, ECOLOGY, V87, P1896, DOI 10.1890/0012-9658(2006)87[1896:PBCOTC]2.0.CO;2; Jump AS, 2009, TRENDS ECOL EVOL, V24, P694, DOI 10.1016/j.tree.2009.06.007; Kelly AE, 2008, P NATL ACAD SCI USA, V105, P11823, DOI 10.1073/pnas.0802891105; Kneeshaw DD, 1998, ECOLOGY, V79, P783, DOI 10.1890/0012-9658(1998)079[0783:CGCATR]2.0.CO;2; Kolb PF, 1996, TREE PHYSIOL, V16, P665; Kramer K, 2010, FOREST ECOL MANAG, V259, P2213, DOI 10.1016/j.foreco.2009.12.023; Kremer A, 2012, ECOL LETT, V15, P378, DOI 10.1111/j.1461-0248.2012.01746.x; Kroiss SJ, 2015, RECRUITMENT LIMITATI; Kuparinen A, 2007, ECOL MODEL, V202, P476, DOI 10.1016/j.ecolmodel.2006.11.015; Kuparinen A, 2006, TRENDS PLANT SCI, V11, P296, DOI 10.1016/j.tplants.2006.04.006; Kuparinen A, 2010, FOREST ECOL MANAG, V259, P1003, DOI 10.1016/j.foreco.2009.12.006; LaDeau SL, 2001, SCIENCE, V292, P95, DOI 10.1126/science.1057547; Lanner R. M., 2002, CONIFERS CALIFORNIA; Lawler JJ, 2011, FRONT ECOL ENVIRON, V9, P569, DOI 10.1890/100106; Leites LP, 2012, NAT RESOUR MODEL, V25, P409, DOI 10.1111/j.1939-7445.2012.00129.x; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Lischke H, 2005, ECOL COMPLEX, V2, P159, DOI 10.1016/j.ecocom.2004.11.009; Littell JS, 2010, CLIMATIC CHANGE, V102, P129, DOI 10.1007/s10584-010-9858-x; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; LOEHLE C, 1988, CAN J FOREST RES, V18, P209, DOI 10.1139/x88-032; Lutz JA, 2010, J BIOGEOGR, V37, P936, DOI 10.1111/j.1365-2699.2009.02268.x; Malanson GP, 1997, PLANT ECOL, V131, P67, DOI 10.1023/A:1009770924942; McLachlan JS, 2007, CONSERV BIOL, V21, P297, DOI 10.1111/j.1523-1739.2007.00676.x; McLachlan JS, 2005, ECOLOGY, V86, P2088, DOI 10.1890/04-1036; Meier ES, 2012, GLOBAL ECOL BIOGEOGR, V21, P164, DOI 10.1111/j.1466-8238.2011.00669.x; Miller C, 1999, ECOL MODEL, V114, P113, DOI 10.1016/S0304-3800(98)00119-7; Mimura M, 2010, J EVOLUTION BIOL, V23, P249, DOI 10.1111/j.1420-9101.2009.01910.x; Minteer BA, 2010, ECOL APPL, V20, P1801, DOI 10.1890/10-0318.1; Monleon VJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118069; Moran EV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036492; Moran EV, 2011, MOL ECOL, V20, P1248, DOI 10.1111/j.1365-294X.2011.05019.x; Morin X, 2008, J ECOL, V96, P784, DOI 10.1111/j.1365-2745.2008.01369.x; Mosca E, 2012, MOL ECOL, V21, P5530, DOI 10.1111/mec.12043; Nabel JEMS, 2013, ECOL MODEL, V257, P88, DOI 10.1016/j.ecolmodel.2013.02.015; Nakanishi A, 2009, HEREDITY, V102, P182, DOI 10.1038/hdy.2008.101; Nason JD, 1997, J HERED, V88, P264, DOI 10.1093/oxfordjournals.jhered.a023104; Nathan R, 2011, ECOL LETT, V14, P211, DOI 10.1111/j.1461-0248.2010.01573.x; Oney B, 2013, ECOL EVOL, V3, P437, DOI 10.1002/ece3.426; PACALA SW, 1993, CAN J FOREST RES, V23, P1980, DOI 10.1139/x93-249; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pitelka LF, 1997, AM SCI, V85, P464; R Core Team, 2021, R LANGUAGE ENV STAT; Rehfeldt GE, 1999, ECOL MONOGR, V69, P375, DOI 10.1890/0012-9615(1999)069[0375:GRTCIP]2.0.CO;2; Rehfeldt GE, 2014, FOREST ECOL MANAG, V324, P138, DOI 10.1016/j.foreco.2014.02.041; Ricciardi A, 2008, TREE, V24, P249; Russo SE, 2006, ECOLOGY, V87, P3160, DOI 10.1890/0012-9658(2006)87[3160:IABISD]2.0.CO;2; Savolainen O, 2007, ANNU REV ECOL EVOL S, V38, P595, DOI 10.1146/annurev.ecolsys.38.091206.095646; Schurr FM, 2008, J ECOL, V96, P628, DOI 10.1111/j.1365-2745.2008.01371.x; SCHWARTZ MW, 1993, BIODIVERS CONSERV, V2, P51, DOI 10.1007/BF00055102; Shakun JD, 2010, QUATERNARY SCI REV, V29, P1801, DOI 10.1016/j.quascirev.2010.03.016; Shatford JPA, 2007, J FOREST, V105, P139; Snell RS, 2014, ECOGRAPHY, V37, P1184, DOI 10.1111/ecog.00580; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; SPIES TA, 1989, ECOLOGY, V70, P543, DOI 10.2307/1940198; Stephenson CM, 2007, PERSPECT PLANT ECOL, V9, P15, DOI 10.1016/j.ppees.2007.07.004; Svenning JC, 2014, ECOGRAPHY, V37, P1198, DOI 10.1111/j.1600-0587.2013.00574.x; Terborgh J, 2008, ECOLOGY, V89, P1757, DOI 10.1890/07-0479.1; Thomas CD, 2011, TRENDS ECOL EVOL, V26, P216, DOI 10.1016/j.tree.2011.02.006; Valladares F, 2014, ECOL LETT, V17, P1351, DOI 10.1111/ele.12348; Wanner H, 2008, QUATERNARY SCI REV, V27, P1791, DOI 10.1016/j.quascirev.2008.06.013	101	14	14	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142369	10.1371/journal.pone.0142369	http://dx.doi.org/10.1371/journal.pone.0142369			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560869	Green Submitted, gold, Green Published			2022-12-26	WOS:000364433100074
J	Schaefer-Klein, JL; Murphy, SJ; Johnson, SH; Vasmatzis, G; Kovtun, IV				Schaefer-Klein, J. L.; Murphy, Stephen J.; Johnson, Sarah H.; Vasmatzis, George; Kovtun, Irina V.			Topoisomerase 2 Alpha Cooperates with Androgen Receptor to Contribute to Prostate Cancer Progression	PLOS ONE			English	Article							EARLY MITOTIC INHIBITOR-1; II-ALPHA; CARCINOMA CORRELATION; SYSTEMIC PROGRESSION; GLEASON SCORE; BREAST-CANCER; HIGH-RISK; EXPRESSION; GENE; PHOSPHORYLATION	Overexpression of TOP2A is associated with risk of systemic progression in prostate cancer patients, and higher levels of TOP2A were found in hormone-resistant cases. To elucidate the mechanism by which high levels of TOP2A contribute to tumor progression we generated TOP2A overexpressing prostate cancer cell lines. We show that TOP2A promotes tumor aggressiveness by inducing chromosomal rearrangements of genes that contribute to a more invasive phenotype. Anti-androgen treatment alone was ineffective in killing TOP2A overexpressing cells due to activation of an androgen receptor network. TOP2A poisons killed tumor cells more efficiently early in the progression course, while at later stages they provided greater benefit when combined with anti-androgen therapy. Mechanistically, we find that TOP2A enhances androgen signaling by facilitating transcription of androgen responsive genes, thereby promoting tumor cell growth. These studies revealed a relationship between TOP2A and androgen receptor signaling pathway that contributes to prostate cancer progression and confers sensitivity to treatments.	[Schaefer-Klein, J. L.; Murphy, Stephen J.; Vasmatzis, George] Mayo Clin, Dept Mol Med, Rochester, MN USA; [Kovtun, Irina V.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [Schaefer-Klein, J. L.; Murphy, Stephen J.; Johnson, Sarah H.; Vasmatzis, George; Kovtun, Irina V.] Mayo Clin, Ctr Individualized Med, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Kovtun, IV (corresponding author), Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA.	Kovtun.Irina@mayo.edu	Kovtun, Irina/ABA-8484-2020		Waterman Biomarker Discovery grant; Center of Individualized Medicine at Mayo Clinic	Waterman Biomarker Discovery grant; Center of Individualized Medicine at Mayo Clinic	This work was supported by a Waterman Biomarker Discovery grant and the Center of Individualized Medicine at Mayo Clinic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt S, 2015, INT J CANCER, V119, P2812; Azuma Y, 2003, J CELL BIOL, V163, P477, DOI 10.1083/jcb.200304088; Bastus NC, 2010, CANCER RES, V70, P9544, DOI 10.1158/0008-5472.CAN-10-1638; Beer TM, 2014, NEW ENGL J MED, V371, P424, DOI 10.1056/NEJMoa1405095; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Bishr M, 2013, NAT REV UROL, V10, P522, DOI 10.1038/nrurol.2013.137; Boisgerault N, 2013, MOL THER, V21, P1507, DOI 10.1038/mt.2013.116; Bower JJ, 2010, ONCOGENE, V29, P4787, DOI 10.1038/onc.2010.232; Brinkmann AO, 1999, J STEROID BIOCHEM, V69, P307, DOI 10.1016/S0960-0760(99)00049-7; Chen T, 2014, ONCOGENE; Chen W, 2012, DRUG DISCOV THER, V6, P230, DOI 10.5582/ddt.2012.v6.5.230; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; Cheville JC, 2008, J CLIN ONCOL, V26, P3930, DOI 10.1200/JCO.2007.15.6752; Chikamori K, 2003, J BIOL CHEM, V278, P12696, DOI 10.1074/jbc.M300837200; Deming PB, 2001, P NATL ACAD SCI USA, V98, P12044, DOI 10.1073/pnas.221430898; Denmeade SR, 2004, PROSTATE, V58, P211, DOI 10.1002/pros.10360; Depowski PL, 2000, MODERN PATHOL, V13, P542, DOI 10.1038/modpathol.3880094; DOWNES CS, 1994, NATURE, V372, P467, DOI 10.1038/372467a0; Drucker TM, 2014, BIOINFORMATICS, V30, P1627, DOI 10.1093/bioinformatics/btu078; Ellis Leigh, 2014, Oncoscience, V1, P609; Engel R, 2004, EXP CELL RES, V295, P421, DOI 10.1016/j.yexcr.2004.01.012; Faggad A, 2009, MODERN PATHOL, V22, P579, DOI 10.1038/modpathol.2009.14; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; FROELICHAMMON SJ, 1995, J BIOL CHEM, V270, P21429, DOI 10.1074/jbc.270.37.21429; FRY AM, 1991, CANCER RES, V51, P6592; Garner E, 2007, CANCER RES, V67, P7631, DOI 10.1158/0008-5472.CAN-07-0334; Haffner MC, 2010, NAT GENET, V42, P668, DOI 10.1038/ng.613; Hande KR, 2008, UPDATE CANC THERAPEU, V3, P13, DOI DOI 10.1016/J.UCT.2008.02.001; HECK MMS, 1986, J CELL BIOL, V103, P2569, DOI 10.1083/jcb.103.6.2569; Horie-Inoue K, 2004, BIOCHEM BIOPH RES CO, V325, P1312, DOI 10.1016/j.bbrc.2004.10.174; Hughes C, 2006, J CLIN PATHOL, V59, P721, DOI 10.1136/jcp.2005.029975; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Karnes RJ, 2010, CANCER RES, V70, P8994, DOI 10.1158/0008-5472.CAN-10-1358; Kennedy RD, 2005, CANCER RES, V65, P10265, DOI 10.1158/0008-5472.CAN-05-1841; Kovtun IV, 2013, CANCER RES, V73, P3275, DOI 10.1158/0008-5472.CAN-12-2803; Kovtun IV, 2004, HUM MOL GENET, V13, P3057, DOI 10.1093/hmg/ddh325; Lan YS, 2008, INT J CANCER, V123, P543, DOI 10.1002/ijc.23548; Li H, 2008, J BIOL CHEM, V283, P6209, DOI 10.1074/jbc.M709007200; Liu XB, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0735-0; Lorente D, 2015, NAT REV UROL, V12, P37, DOI 10.1038/nrurol.2014.345; Lou ZK, 2005, NAT STRUCT MOL BIOL, V12, P589, DOI 10.1038/nsmb953; McPherson JP, 1998, CANCER RES, V58, P4519; Murphy SJ, 2012, DNA RES, V19, P395, DOI 10.1093/dnares/dss021; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Nitiss JL, 2009, NAT REV CANCER, V9, P327, DOI 10.1038/nrc2608; PEDERSENBJERGAARD J, 1991, LANCET, V338, P359, DOI 10.1016/0140-6736(91)90490-G; Petrylak DP., 2013, CHALLENGES TREATIN S, V19, ps366; Qi XM, 2011, J BIOL CHEM, V286, P35883, DOI 10.1074/jbc.M111.229260; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Rudolph P, 1999, BREAST CANCER RES TR, V55, P61, DOI 10.1023/A:1006159016703; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; Shimizu N, 2013, J BIOL CHEM, V288, P17238, DOI 10.1074/jbc.M112.446351; Tomida S, 2007, ONCOGENE, V26, P4600, DOI 10.1038/sj.onc.1210242; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Trinh BQ, 2013, CANCER RES, V73, P1000, DOI 10.1158/0008-5472.CAN-12-3538; Tsai SC, 2000, NAT GENET, V26, P349, DOI 10.1038/81671; Vasmatzis G, 2012, BLOOD, V120, P2280, DOI 10.1182/blood-2012-03-419937; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Wan JC, 2002, NAT REV MOL CELL BIO; Wang LHC, 2008, CHROMOSOMA, V117, P123, DOI 10.1007/s00412-007-0131-7; Williamson LM, 2011, CARCINOGENESIS, V32, P279, DOI 10.1093/carcin/bgq255; Willman JH, 2000, PROSTATE, V42, P280; Winter RN, 2011, CANCER RES, V61, P1227; Zhao YH, 2013, HUM PATHOL, V44, P365, DOI 10.1016/j.humpath.2012.03.030; ZINI N, 1994, EXP CELL RES, V210, P336, DOI 10.1006/excr.1994.1046	65	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142327	10.1371/journal.pone.0142327	http://dx.doi.org/10.1371/journal.pone.0142327			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560244	Green Submitted, Green Published, gold			2022-12-26	WOS:000364433100071
J	Lee, JS; Bin Jang, H; Kim, KS; Kim, TH; Im, SP; Kim, SW; Lazarte, JMS; Kim, JS; Jung, TS				Lee, Jung Seok; Bin Jang, Ho; Kim, Ki Sei; Kim, Tae Hwan; Im, Se Pyeong; Kim, Si Won; Lazarte, Jassy Mary S.; Kim, Jae Sung; Jung, Tae Sung			Complete Genomic and Lysis-Cassette Characterization of the Novel Phage, KBNP1315, which Infects Avian Pathogenic Escherichia coli (APEC)	PLOS ONE			English	Article							BACTERIOPHAGES; PROTEIN; HOST; SEQUENCE; COLIBACILLOSIS; CLASSIFICATION; EVOLUTIONARY; PREVALENCE; ELEMENTS; STRAINS	Avian pathogenic Escherichia coli (APEC) is a major pathogen that causes avian colibacillosis and is associated with severe economic losses in the chicken-farming industry. Here, bacteriophage KBNP1315, infecting APEC strain KBP1315, was genomically and functionally characterized. The evolutionary relationships of KBNP1315 were analyzed at the genomic level using gene (protein)-sharing networks, the Markov clustering (MCL) algorithm, and comparative genomics. Our network analysis showed that KBNP1315 was connected to 30 members of the Autographivirinae subfamily, which comprises the SP6-, T7-, P60-, phiKMV-, GAP227- and KP34-related groups. Network decomposition suggested that KBNP1315 belongs to the SP6-like phages, but our comparison of putative encoded proteins revealed that key proteins of KBNP1315, including the tail spike protein and endolysin, had relative low levels of amino acid sequence similarity with other members of the SP6-like phages. Thus KBNP1315 may only be distantly related to the SP6-like phages, and (based on the difference in endolysin) its lysis mechanism may differ from theirs. To characterize the lytic functions of the holin and endolysin proteins from KBNP1315, we expressed these proteins individually or simultaneously in E. coli BL21 (DE3) competent cell. Interestingly, the expressed endolysin was secreted into the periplasm and caused a high degree of host cell lysis that was dose-dependently delayed/blocked by NaN3-mediated inhibition of the SecA pathway. The expressed holin triggered only a moderate inhibition of cell growth, whereas coexpression of holin and endolysin enhanced the lytic effect of endolysin. Together, these results revealed that KBNP1315 appears to use a pin-holin/signal-arrest-release (SAR) endolysin pathway to trigger host cell lysis.	[Lee, Jung Seok; Im, Se Pyeong; Kim, Si Won; Lazarte, Jassy Mary S.; Kim, Jae Sung; Jung, Tae Sung] Gyeongsang Natl Univ, Inst Anim Med, Coll Vet Med, Lab Aquat Anim Dis, Jinju 660701, South Korea; [Bin Jang, Ho] Katholieke Univ Leuven, Lab Gene Technol, B-3001 Leuven, Belgium; [Kim, Ki Sei; Kim, Tae Hwan] KBNP Inc, KBNP Technol Inst, Yesan, Choongcheongnam, South Korea	Gyeongsang National University; KU Leuven	Jung, TS (corresponding author), Gyeongsang Natl Univ, Inst Anim Med, Coll Vet Med, Lab Aquat Anim Dis, Jinju 660701, South Korea.	jungts@gsnu.ac.kr	Jung, Tae Sung/G-8245-2017	Jung, Tae Sung/0000-0001-6028-0946; Jang, Ho Bin/0000-0003-1316-316X	Ministry of Science, ICT and Future Planning of South Korea [NRF- 2013R1A1A1059608]; KBNP Technology Institute, KBNP, Inc.	Ministry of Science, ICT and Future Planning of South Korea; KBNP Technology Institute, KBNP, Inc.	Funding: This work was made possible by a Korea Research Foundation grant funded by the Ministry of Science, ICT and Future Planning of South Korea (NRF- 2013R1A1A1059608). KBNP Technology Institute, KBNP, Inc., provided support in the form of salaries for authors KHK and THK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ackermann HW, 2001, ARCH VIROL, V146, P843, DOI 10.1007/s007050170120; Adams MH, 1959, BACTERIOPHAGES; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Barnes H.J., 2003, DIS POULT, V12, P691; Bass L, 1999, ANTIMICROB AGENTS CH, V43, P2925, DOI 10.1128/AAC.43.12.2925; Briers Yves, 2011, Bacteriophage, V1, P25, DOI 10.4161/bact.1.1.14868; Brohee S, 2008, NUCLEIC ACIDS RES, V36, pW444, DOI 10.1093/nar/gkn336; Brussow H, 2002, CELL, V108, P13, DOI 10.1016/S0092-8674(01)00637-7; BUTLER ET, 1982, J BIOL CHEM, V257, P5772; Catalao MJ, 2011, J BACTERIOL, V193, P2793, DOI 10.1128/JB.01519-10; Clokie M.R.J., 2009, BACTERIOPHAGES; CLOUD SS, 1985, AVIAN DIS, V29, P1084, DOI 10.2307/1590463; Dagan T, 2011, TRENDS MICROBIOL, V19, P483, DOI 10.1016/j.tim.2011.07.001; Dobbins AT, 2004, J BACTERIOL, V186, P1933, DOI 10.1128/JB.186.7.1933-1944.2004; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Francki R.I.B., 2012, CLASSIFICATION NOMEN, VVol. 2; Green MR, 2012, MOL CLONING LAB MANU, V1; Grose JH, 2014, VIROLOGY, V468, P421, DOI 10.1016/j.virol.2014.08.024; Hatfull GF, 2008, CURR OPIN MICROBIOL, V11, P447, DOI 10.1016/j.mib.2008.09.004; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; Jang HB, 2013, J VIROL, V87, P12866, DOI 10.1128/JVI.02656-13; Janssen T, 2001, INT J MED MICROBIOL, V291, P371, DOI 10.1078/1438-4221-00143; Johnson TJ, 2008, APPL ENVIRON MICROB, V74, P7043, DOI 10.1128/AEM.01395-08; Johnson TJ, 2006, J BACTERIOL, V188, P745, DOI 10.1128/JB.188.2.745-758.2006; Kabir SML, 2010, INT J ENV RES PUB HE, V7, P89, DOI 10.3390/ijerph7010089; Kim TE, 2007, J CLIN MICROBIOL, V45, P3309, DOI 10.1128/JCM.01922-06; Kuty GF, 2010, J BACTERIOL, V192, P5682, DOI 10.1128/JB.00674-10; Lavigne R, 2004, BIOINFORMATICS, V20, P629, DOI 10.1093/bioinformatics/btg456; Lavigne R, 2008, RES MICROBIOL, V159, P406, DOI 10.1016/j.resmic.2008.03.005; Leiman PG, 2007, J MOL BIOL, V371, P836, DOI 10.1016/j.jmb.2007.05.083; Leplae R, 2004, NUCLEIC ACIDS RES, V32, pD45, DOI 10.1093/nar/gkh084; Lima-Mendez G, 2008, MOL BIOL EVOL, V25, P762, DOI 10.1093/molbev/msn023; Lima-Mendez G, 2011, RES MICROBIOL, V162, P737, DOI 10.1016/j.resmic.2011.06.006; Lynch KH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-574; Murray PR, 1995, TRENDS MICROBIOL, V3, P449, DOI DOI 10.1016/S0966-842X(00)89003-4; Naville M, 2011, RNA BIOL, V8, P11, DOI 10.4161/rna.8.1.13346; Oliveira A, 2010, VET MICROBIOL, V146, P303, DOI 10.1016/j.vetmic.2010.05.015; Oliveira H, 2013, J VIROL, V87, P4558, DOI 10.1128/JVI.03277-12; Park T, 2007, J BACTERIOL, V189, P9135, DOI 10.1128/JB.00847-07; Rahman M. A., 2004, Bangladesh Journal of Veterinary Medicine, V2, P99; Rodriguez-Siek KE, 2005, MICROBIOL-SGM, V151, P2097, DOI 10.1099/mic.0.27499-0; Sao-Jose C, 2000, J BACTERIOL, V182, P5823, DOI 10.1128/JB.182.20.5823-5831.2000; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Scholl D, 2004, J MOL BIOL, V335, P1151, DOI 10.1016/j.jmb.2003.11.035; Scholl D, 2002, J BACTERIOL, V184, P2833, DOI 10.1128/JB.184.10.2833-2836.2002; Schubert S, 1998, INFECT IMMUN, V66, P480, DOI 10.1128/IAI.66.2.480-485.1998; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shin H, 2014, APPL ENVIRON MICROB, V80, P374, DOI 10.1128/AEM.02279-13; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stummeyer K, 2006, MOL MICROBIOL, V60, P1123, DOI 10.1111/j.1365-2958.2006.05173.x; Sun QG, 2009, NAT STRUCT MOL BIOL, V16, P1192, DOI 10.1038/nsmb.1681; Van Dongen SM., 2001, THESIS; Wang IN, 2000, ANNU REV MICROBIOL, V54, P799, DOI 10.1146/annurev.micro.54.1.799; Xu M, 2004, P NATL ACAD SCI USA, V101, P6415, DOI 10.1073/pnas.0400957101; Young R, 2000, TRENDS MICROBIOL, V8, P120, DOI 10.1016/S0966-842X(00)01705-4; Young R, 2013, CURR OPIN MICROBIOL, V16, P790, DOI 10.1016/j.mib.2013.08.008	57	5	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142504	10.1371/journal.pone.0142504	http://dx.doi.org/10.1371/journal.pone.0142504			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555076	Green Published, Green Submitted, gold			2022-12-26	WOS:000364430700119
J	Noli, B; Brancia, C; Pilleri, R; D'Amato, F; Messana, I; Manconi, B; Ebling, FJP; Ferri, GL; Cocco, C				Noli, Barbara; Brancia, Carla; Pilleri, Roberta; D'Amato, Filomena; Messana, Irene; Manconi, Barbara; Ebling, Francis J. P.; Ferri, Gian-Luca; Cocco, Cristina			Photoperiod Regulates vgf-Derived Peptide Processing in Siberian Hamsters	PLOS ONE			English	Article							GENE-EXPRESSION; FOOD-INTAKE; ARCUATE NUCLEUS; BODY-WEIGHT; TLQP-21; PRODUCT; IDENTIFICATION; RECEPTOR; PROTEIN	VGF mRNA is induced in specific hypothalamic areas of the Siberian hamster upon exposure to short photoperiods, which is associated with a seasonal decrease in appetite and weight loss. Processing of VGF generates multiple bioactive peptides, so the objective of this study was to determine the profile of the VGF-derived peptides in the brain, pituitary and plasma from Siberian hamsters, and to establish whether differential processing might occur in the short day lean state versus long day fat. Antisera against short sequences at the C-or N-termini of proVGF, as well as against NERP-1, TPGH and TLQP peptides, were used for analyses of tissues, and both immunohistochemistry and enzyme linked immunosorbent assay (ELISA) coupled with high-performance liquid (HPLC) or gel chromatography were carried out. VGF peptide immunoreactivity was found within cortex cholinergic perikarya, in multiple hypothalamic nuclei, including those containing vasopressin, and in pituitary gonadotrophs. ELISA revealed that exposure to short day photoperiod led to a down-regulation of VGF immunoreactivity in the cortex, and a less pronounced decrease in the hypothalamus and pituitary, while the plasma VGF levels were not affected by the photoperiod. HPLC and gel chromatography both confirmed the presence of multiple VGF-derived peptides in these tissues, while gel chromatography showed the presence of the VGF precursor in all tissues tested except for the cortex. These observations are consistent with the view that VGF-derived peptides have pleiotropic actions related to changing photoperiod, possibly by regulating cholinergic systems in the cortex, vasopressin hypothalamic pathways, and the reproductive axis.	[Noli, Barbara; Brancia, Carla; Pilleri, Roberta; D'Amato, Filomena; Ferri, Gian-Luca; Cocco, Cristina] Univ Cagliari, NEF Lab, Dept Biomed Sci, Monserrato, CA, Italy; [Messana, Irene; Manconi, Barbara] Univ Cagliari, Dept Life & Environm Sci, Monserrato, CA, Italy; [Ebling, Francis J. P.] Univ Nottingham, Sch Med, Sch Life Sci, Nottingham, England	University of Cagliari; University of Cagliari; University of Nottingham	Cocco, C (corresponding author), Univ Cagliari, NEF Lab, Dept Biomed Sci, Monserrato, CA, Italy.	cristina.cocco@unica.it	Ebling, Francis/Q-6193-2019; Ferri, Luca Angelo/AAC-5890-2022; Messana, Irene/L-2478-2019	Ebling, Francis/0000-0002-7316-9582; Ferri, Luca Angelo/0000-0001-9031-6284; Messana, Irene/0000-0002-1436-6105; BRANCIA, CARLA/0000-0002-0716-3983; FERRI, Gian-Luca/0000-0003-2768-349X	ARS (Autonomous Region of Sardinia) through the "Sardinia PO" funds [L.R. 7/2007]	ARS (Autonomous Region of Sardinia) through the "Sardinia PO" funds	This study was sponsored by the ARS (Autonomous Region of Sardinia) through the "Sardinia PO FSE 2007-1013" funds (the L.R. 7/2007 for the "Promotion of the Scientific Research and of the Technological Innovation in Sardinia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar E, 2013, NEUROENDOCRINOLOGY, V98, P38, DOI 10.1159/000350323; Alder J, 2003, J NEUROSCI, V23, P10800; Barrett P, 2005, ENDOCRINOLOGY, V146, P1930, DOI 10.1210/en.2004-1452; BARTNESS TJ, 1995, PHYSIOL BEHAV, V58, P539, DOI 10.1016/0031-9384(95)00082-T; BARTNESS TJ, 1989, AM J PHYSIOL, V257, pR1533, DOI 10.1152/ajpregu.1989.257.6.R1533; Bartolomucci A, 2006, P NATL ACAD SCI USA, V103, P14584, DOI 10.1073/pnas.0606102103; BERGER P, 1990, J ENDOCRINOL, V125, P301, DOI 10.1677/joe.0.1250301; Bozdagi O, 2008, J NEUROSCI, V28, P9857, DOI 10.1523/JNEUROSCI.3145-08.2008; Brancia C, 2005, J ENDOCRINOL, V186, P97, DOI 10.1677/joe.1.05992; Cocco C, 2003, APPL IMMUNOHISTO M M, V11, P274; Cocco C, 2007, J HISTOCHEM CYTOCHEM, V55, P619, DOI 10.1369/jhc.6A7040.2007; Cocco C, 2010, J ANAT, V217, P683, DOI 10.1111/j.1469-7580.2010.01309.x; D'Amato F, 2012, J CHEM NEUROANAT, V44, P57, DOI 10.1016/j.jchemneu.2012.05.001; EBLING FJP, 1994, GEN COMP ENDOCR, V95, P475, DOI 10.1006/gcen.1994.1147; Ebling FJP, 2014, HORM BEHAV, V66, P56, DOI 10.1016/j.yhbeh.2014.03.009; Ferri GL, 2011, J CHEM NEUROANAT, V42, P249, DOI 10.1016/j.jchemneu.2011.05.007; Ferri GL, 2002, APPL IMMUNOHISTO M M, V10, P381, DOI 10.1097/00022744-200212000-00016; FERRI GL, 1992, MOL BRAIN RES, V13, P139, DOI 10.1016/0169-328X(92)90053-E; Hannedouche S, 2013, J BIOL CHEM, V288, P27434, DOI 10.1074/jbc.M113.497214; Herwig A, 2012, J NEUROENDOCRINOL, V24, P991, DOI 10.1111/j.1365-2826.2012.02324.x; Jethwa PH, 2007, ENDOCRINOLOGY, V148, P4044, DOI 10.1210/en.2007-0038; Mintz EM, 2001, J CHEM NEUROANAT, V21, P225, DOI 10.1016/S0891-0618(01)00111-9; Morin LP, 2001, STEREOTAXIC ATLAS GO; Nilaweera KN, 2009, J NEUROENDOCRINOL, V21, P123, DOI 10.1111/j.1365-2826.2008.01810.x; Noli B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108456; Oda Y, 1999, PATHOL INT, V49, P921, DOI 10.1046/j.1440-1827.1999.00977.x; Reddy AB, 1999, EUR J NEUROSCI, V11, P3255, DOI 10.1046/j.1460-9568.1999.00746.x; Ross AW, 2005, ENDOCRINOLOGY, V146, P1940, DOI 10.1210/en.2004-1538; Rozek W, 2013, TUMOR BIOL, V34, P1773, DOI 10.1007/s13277-013-0716-0; Thakker-Varia S, 2007, J NEUROSCI, V27, P12156, DOI 10.1523/JNEUROSCI.1898-07.2007; Toshinai K, 2010, AM J PHYSIOL-ENDOC M, V299, pE394, DOI 10.1152/ajpendo.00768.2009; TRANI E, 1995, J NEUROCHEM, V65, P2441; Tsujino N, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00028; VANDENPOL AN, 1989, J NEUROSCI, V9, P4122; Wisor JP, 1997, J COMP NEUROL, V378, P229; Yamaguchi H, 2007, J BIOL CHEM, V282, P26354, DOI 10.1074/jbc.M701665200	36	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141193	10.1371/journal.pone.0141193	http://dx.doi.org/10.1371/journal.pone.0141193			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555143	gold, Green Submitted, Green Published			2022-12-26	WOS:000364430700020
J	Sebastiao, E; Chodzko-Zajko, W; Schwingel, A				Sebastiao, Emerson; Chodzko-Zajko, Wojtek; Schwingel, Andiara			An In-Depth Examination of Perceptions of Physical Activity in Regularly Active and Insufficiently Active Older African American Women: A Participatory Approach	PLOS ONE			English	Article							RACIAL DISPARITIES; HEALTH; BARRIERS; EXERCISE; ADULTS; DISCRIMINATION; ENABLERS	Despite considerable research and programmatic efforts to alleviate racial/ethnic disparities in physical activity (PA), disparities in PA among older minorities and major racial ethnic groups persist. This study explored perceptions of PA among regularly active (RA) and insufficiently active (IA) older African American women (AAW) and the factors that influence (positively and negatively) their physical participation in their socio-cultural environment. A total of 20 AAW aged 60 to 80 years participated in a cross-sectional mixed-methods study (i.e., qualitative and quantitative) employing participatory research approaches (i.e., photoelicitation) along with an objective assessment of PA. Nine women were considered RA and 11 IA according to current PA recommendations. RA and IA women held two major beliefs about the nature of PA (i.e., PA as a broadly defined construct that goes beyond traditional exercise routines; and PA and exercise are synonymous and can be used interchangeably) and had a good understanding of its benefits. Participants in both groups did not know about the importance of PA intensity for health benefits. Barriers and facilitator of PA were found to be similar among RA and IA participants. Special attention should be paid to providing access to no or low cost opportunities for PA participation in safe environments.	[Sebastiao, Emerson; Chodzko-Zajko, Wojtek; Schwingel, Andiara] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign	Sebastiao, E (corresponding author), Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL USA.	esbast2@illinois.edu	Sebastiao, Emerson/ABF-7353-2020		Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [BEX 5718/10-4]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors thank Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for the scholarship provided to ES to pursue his PhD (process number BEX 5718/10-4).	[Anonymous], 2013, STAT AG HLTH AM 2013; Belza Basia, 2004, Prev Chronic Dis, V1, pA09; Booth ML, 1997, PREV MED, V26, P131, DOI 10.1006/pmed.1996.9982; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; BRFSS, 2011, PREV TRENDS DAT PART; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Centers for Disease Control and Prevention, 2014, 2014 STAT IND REP PH; Chodzko-Zajko WJ, 2008, MED SCI SPORT EXER, V41, P1510, DOI DOI 10.1249/MSS.0b013e3181a0c95c; DHHS, 2008, PHYS ACT GUID AM CHA; DHHS, 2008, PHYS ACT GUID AM; *DHHS, 2008, PHYS ACT GUID ADV CO; Edwards MB, 2013, J PHYS ACT HEALTH, V10, P932, DOI 10.1123/jpah.10.7.932; Evenson KR, PREV CHRONIC DIS, V9, pE26; Fielding JE, 2002, AM J PREV MED, V22, P67; Fleury J, 2009, QUAL HEALTH RES, V19, P677, DOI 10.1177/1049732309334471; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Gobbi Sebastiao, 2012, J Aging Res, V2012, P685190, DOI 10.1155/2012/685190; Harley AE, 2009, HEALTH EDUC BEHAV, V36, P97, DOI 10.1177/1090198107306434; Harper D., 2002, VISUAL STUDIES, V17, P14; Johnson CM, 2010, BMC WOMENS HEALTH, V10, DOI 10.1186/1472-6874-10-21; Karlsen S, 2002, AM J PUBLIC HEALTH, V92, P624, DOI 10.2105/AJPH.92.4.624; Kawachi I, 2005, HEALTH AFFAIR, V24, P343, DOI 10.1377/hlthaff.24.2.343; KING AC, 1988, AM J CARDIOL, V61, P628, DOI 10.1016/0002-9149(88)90778-3; Lavizzo-Mourey R, 2001, J NATL MED ASSOC, V93, P475; Leavy B, 2002, J AGING PHYS ACTIV, V18, P219; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; Macera Caroline A, 2005, Prev Chronic Dis, V2, pA17; Marshall AL, 2010, MED SCI SPORT EXER, V42, P1094, DOI 10.1249/MSS.0b013e3181c5ec18; Mathews AE, 2010, J AGING PHYS ACTIV, V18, P119, DOI 10.1123/japa.18.2.119; Price AE, 2013, J AGING PHYS ACTIV, V21, P348, DOI 10.1123/japa.21.3.348; QSR International, 2013, NVIVO 10 RES SOFTW A; Rasinaho M, 2007, J AGING PHYS ACTIV, V15, P90, DOI 10.1123/japa.15.1.90; Schutzer KA, 2004, PREV MED, V39, P1056, DOI 10.1016/j.ypmed.2004.04.003; Sebastiao Emerson, 2014, J Aging Res, V2014, P941019, DOI 10.1155/2014/941019; Shih VC, 2005, ARCH PHYS MED REHAB, V86, P1521, DOI 10.1016/j.apmr.2005.02.009; Siddiqi Z, 2011, HEALTH EDUC RES, V26, P1010, DOI 10.1093/her/cyr068; Stathi A, 2012, J AGING PHYS ACTIV, V20, P148, DOI 10.1123/japa.20.2.148; Stokols D, 1996, AM J HEALTH PROMOT, V10, P247, DOI 10.4278/0890-1171-10.4.247; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Wang C, 1997, HEALTH EDUC BEHAV, V24, P369, DOI 10.1177/109019819702400309; Wilcox S, 2005, J WOMEN AGING, V17, P37, DOI 10.1300/J074v17n01_04; Wilcox Sara, 2002, Ethnicity and Disease, V12, P353; Williams DR, 2009, J BEHAV MED, V32, P20, DOI 10.1007/s10865-008-9185-0; Williams DR, 2003, AM J PUBLIC HEALTH, V93, P200, DOI 10.2105/AJPH.93.2.200; Williams DR, 2005, HEALTH AFFAIR, V24, P325, DOI 10.1377/hlthaff.24.2.325	45	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142703	10.1371/journal.pone.0142703	http://dx.doi.org/10.1371/journal.pone.0142703			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7CT	26554842	Green Submitted, Green Published, gold			2022-12-26	WOS:000364430700157
J	Thorn, KA; Cox, LG				Thorn, Kevin A.; Cox, Larry G.			Probing the Carbonyl Functionality of a Petroleum Resin and Asphaltene through Oximation and Schiff Base Formation in Conjunction with N-15 NMR	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; CRUDE-OIL; STRUCTURAL-CHARACTERIZATION; BIODEGRADATION; NITROGEN; SPECTROSCOPY; METHYLATION; IRRADIATION; BEMIDJI; AQUIFER	Despite recent advances in spectroscopic techniques, there is uncertainty regarding the nature of the carbonyl groups in the asphaltene and resin fractions of crude oil, information necessary for an understanding of the physical properties and environmental fate of these materials. Carbonyl and hydroxyl group functionalities are not observed in natural abundance C-13 nuclear magnetic resonance (NMR) spectra of asphaltenes and resins and therefore require spin labeling techniques for detection. In this study, the carbonyl functionalities of the resin and asphaltene fractions from a light aliphatic crude oil that is the source of groundwater contamination at the long term USGS study site near Bemidji, Minnesota, have been examined through reaction with N-15-labeled hydroxylamine and aniline in conjunction with analysis by solid and liquid state N-15 NMR. Ketone groups were revealed through N-15 NMR detection of their oxime and Schiff base derivatives, and esters through their hydroxamic acid derivatives. Anilinohydroquinone adducts provided evidence for quinones. Some possible configurations of the ketone groups in the resin and asphaltene fractions can be inferred from a consideration of the likely reactions that lead to heterocyclic condensation products with aniline and to the Beckmann reaction products from the initially formed oximes. These include aromatic ketones and ketones adjacent to quaternary carbon centers, beta-hydroxyketones, beta-diketones, and beta-ketoesters. In a solid state cross polarization/magic angle spinning (CP/MAS) N-15 NMR spectrum recorded on the underivatized asphaltene as a control, carbazole and pyrrole-like nitrogens were the major naturally abundant nitrogens detected.	[Thorn, Kevin A.; Cox, Larry G.] US Geol Survey, Denver Fed Ctr, Denver, CO 80225 USA	United States Department of the Interior; United States Geological Survey	Thorn, KA (corresponding author), US Geol Survey, Denver Fed Ctr, MS 408, Denver, CO 80225 USA.	kathorn@usgs.gov			United States Geological Survey Toxics Substances Hydrology Program; Toxics Substances Hydrology Program of the U.S. Geological Survey	United States Geological Survey Toxics Substances Hydrology Program; Toxics Substances Hydrology Program of the U.S. Geological Survey	Funding: This work was funded by the United States Geological Survey Toxics Substances Hydrology Program.; This work was supported by the Toxics Substances Hydrology Program of the U.S. Geological Survey.	Altgelt KH, 1994, COMPOSITION ANAL HEA; Andersen SI, 2001, PETROL SCI TECHNOL, V19, P1; Andrews AB, 2011, ENERG FUEL, V25, P3068, DOI 10.1021/ef2003443; Apperley DC, 2012, SOLID STATE NMR BASI, DOI 10.5643/9781606503522; Arnaud CH, 2009, CHEM ENG NEWS, V87, P12; Baltisberger RJ, 1983, CHEM LIGNITE LIQUEFA; Deanhardt ML, 1990, FUEL SCI TECHN INT, V8, P135; Dutriez T, 2012, FUEL, V96, P108, DOI 10.1016/j.fuel.2011.11.070; EGANHOUSE RP, 1993, APPL GEOCHEM, V8, P551, DOI 10.1016/0883-2927(93)90013-7; Essaid HI, 2011, GROUND WATER, V49, P706, DOI 10.1111/j.1745-6584.2009.00654.x; Ghollami M, 2013, J PET ENV BIOTECHNOL, V4, P1; GREEN TK, 1994, ENERG FUEL, V8, P244, DOI 10.1021/ef00043a038; Griffiths MT, 2014, ANAL CHEM, V86, P527, DOI 10.1021/ac4025335; Helms JR, 2012, ORG GEOCHEM, V44, P21, DOI 10.1016/j.orggeochem.2011.12.001; Hult MF, 1984, 844188 WAT RES INV; Jahromi H, 2014, FUEL, V117, P230, DOI 10.1016/j.fuel.2013.09.085; Jennings PW, 1993, BINDER CHARACTERIZAT; Joule J. A., 1995, HETEROCYCLIC CHEM; Kelemen SR, 2002, ENERG FUEL, V16, P1507, DOI 10.1021/ef0200828; Kim S, 2005, ORG GEOCHEM, V36, P1117, DOI 10.1016/j.orggeochem.2005.03.010; Kiruri LW, 2013, ENVIRON SCI TECHNOL, V47, P4220, DOI 10.1021/es305157w; Lavania M, 2012, BIODEGRADATION, V23, P15, DOI 10.1007/s10532-011-9482-0; Lewan MD, 2014, ORG GEOCHEM, V75, P54, DOI 10.1016/j.orggeochem.2014.06.004; Majumdar RD, 2013, ENERG FUEL, V27, P6528, DOI 10.1021/ef401412w; McKenna AM, 2013, ENERG FUEL, V27, P1257, DOI 10.1021/ef301747d; MEIER BH, 1986, J AM CHEM SOC, V108, P6072, DOI 10.1021/ja00279a084; MITRAKIRTLEY S, 1993, J AM CHEM SOC, V115, P252, DOI 10.1021/ja00054a036; Mullins O. C., 2007, ASPHALTENES HEAVY OI, DOI [10.1007/0-387-68903-6, DOI 10.1007/0-387-68903-6]; Mullins OC, 2011, ANNU REV ANAL CHEM, V4, P393, DOI 10.1146/annurev-anchem-061010-113849; Ng GHC, 2014, J CONTAM HYDROL, V164, P1, DOI 10.1016/j.jconhyd.2014.04.006; Pesarini PF, 2010, J PHOTOCH PHOTOBIO A, V214, P48, DOI 10.1016/j.jphotochem.2010.06.005; Pineda-Flores G, 2004, BIODEGRADATION, V15, P145, DOI 10.1023/B:BIOD.0000026476.03744.bb; Podgorski DC, 2013, ENERG FUEL, V27, P1268, DOI 10.1021/ef301737f; RONTANI JF, 1985, CHEMOSPHERE, V14, P1413, DOI 10.1016/0045-6535(85)90161-4; ROSE KD, 1987, ENERG FUEL, V1, P233, DOI 10.1021/ef00003a001; Schnitzer M., 1972, HUMIC SUBSTANCES ENV; Schuler B, 2015, J AM CHEM SOC, V137, P9870, DOI 10.1021/jacs.5b04056; Shekar SC, 2002, J MAGN RESON, V157, P223, DOI 10.1006/jmre.2002.2587; Smernik RJ, 2005, BIOGEOCHEMISTRY, V75, P507, DOI 10.1007/s10533-005-2857-8; Solum MS, 1997, ENERG FUEL, V11, P491, DOI 10.1021/ef960169r; SORENSEN OW, 1983, J MAGN RESON, V55, P347, DOI 10.1016/0022-2364(83)90248-2; Speight J.G., 2014, CHEM TECHNOLOGY PETR, DOI [DOI 10.1201/B16559_3-174, 10.1201/b16559_3-174]; Speight J.G., 2012, BIOREMEDIATION PETRO; Tavassoli T, 2012, FUEL, V93, P142, DOI 10.1016/j.fuel.2011.10.021; THORN KA, 1992, ENVIRON SCI TECHNOL, V26, P107, DOI 10.1021/es00025a011; Thorn KA, 1996, ENVIRON SCI TECHNOL, V30, P2764, DOI 10.1021/es9509339; Thorn KA, 1998, ORG GEOCHEM, V29, P909, DOI 10.1016/S0146-6380(98)00167-3; Thorn KA, 2012, J ENVIRON QUAL, V41, P865, DOI 10.2134/jeq2011.0335; Thorn KA, 2010, J ENVIRON QUAL, V39, P1416, DOI 10.2134/jeq2009.0408; Thorn KA, 2009, ORG GEOCHEM, V40, P484, DOI 10.1016/j.orggeochem.2009.01.007; Uribe-Alvarez C, 2011, MICROB BIOTECHNOL, V4, P663, DOI 10.1111/j.1751-7915.2011.00269.x; VENKATESWARAN K, 1995, CAN J MICROBIOL, V41, P418, DOI 10.1139/m95-055	53	4	5	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142452	10.1371/journal.pone.0142452	http://dx.doi.org/10.1371/journal.pone.0142452			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556054	Green Published, Green Submitted, gold			2022-12-26	WOS:000364430700108
J	Zaccagnini, G; Palmisano, A; Canu, T; Maimone, B; Lo Russo, FM; Ambrogi, F; Gaetano, C; Cobelli, F; Del Maschio, A; Esposito, A; Martelli, F				Zaccagnini, Germana; Palmisano, Anna; Canu, Tamara; Maimone, Biagina; Lo Russo, Francesco M.; Ambrogi, Federico; Gaetano, Carlo; De Cobelli, Francesco; Del Maschio, Alessandro; Esposito, Antonio; Martelli, Fabio			Magnetic Resonance Imaging Allows the Evaluation of Tissue Damage and Regeneration in a Mouse Model of Critical Limb Ischemia	PLoS One			English	Article							MUSCLE-FIBER TRACKING; SKELETAL-MUSCLE; MRI ANALYSIS; ANGIOGENESIS; INJURY; P66(SHCA); LIGATION; DISEASE; ONSET; MICE	Magnetic resonance imaging (MRI) provides non-invasive, repetitive measures in the same individual, allowing the study of a physio-pathological event over time. In this study, we tested the performance of 7 Tesla multi-parametric MRI to monitor the dynamic changes of mouse skeletal muscle injury and regeneration upon acute ischemia induced by femoral artery dissection. T2-mapping (T2 relaxation time), diffusion-tensor imaging (Fractional Anisotropy) and perfusion by Dynamic Contrast-Enhanced MRI (K-trans) were measured and imaging results were correlated with histological morphometric analysis in both Gastrocnemius and Tibialis anterior muscles. We found that tissue damage positively correlated with T2-relaxation time, while myofiber regeneration and capillary density positively correlated with Fractional Anisotropy. Interestingly, K-trans positively correlated with capillary density. Accordingly, repeated MRI measurements between day 1 and day 28 after surgery in ischemic muscles showed that: 1) T2-relaxation time rapidly increased upon ischemia and then gradually declined, returning almost to basal level in the last phases of the regeneration process; 2) Fractional Anisotropy dropped upon ischemic damage induction and then recovered along with muscle regeneration and neoangiogenesis; 3) K-trans reached a minimum upon ischemia, then progressively recovered. Overall, Gastrocnemius and Tibialis anterior muscles displayed similar patterns of MRI parameters dynamic, with more marked responses and less variability in Tibialis anterior. We conclude that MRI provides quantitative information about both tissue damage after ischemia and the subsequent vascular and muscle regeneration, accounting for the differences between subjects and, within the same individual, between different muscles.	[Zaccagnini, Germana; Maimone, Biagina; Martelli, Fabio] IRCCS Policlin San Donato, Mol Cardiol Lab, Milan, Italy; [Palmisano, Anna; Canu, Tamara; Lo Russo, Francesco M.; De Cobelli, Francesco; Del Maschio, Alessandro; Esposito, Antonio] Ist Sci San Raffaele, Expt Imaging Ctr, Preclin Imaging Facil, I-20132 Milan, Italy; [Palmisano, Anna; Lo Russo, Francesco M.; De Cobelli, Francesco; Del Maschio, Alessandro; Esposito, Antonio] Univ Vita Salute San Raffaele, Milan, Italy; [Ambrogi, Federico] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy; [Gaetano, Carlo] Goethe Univ Frankfurt, Internal Med Clin 3, Dept Cardiol, Div Cardiovasc Epigenet, D-60054 Frankfurt, Germany	IRCCS Policlinico San Donato; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; University of Milan; Goethe University Frankfurt	Esposito, A (corresponding author), Ist Sci San Raffaele, Expt Imaging Ctr, Preclin Imaging Facil, I-20132 Milan, Italy.	esposito.antonio@unisr.it; fabio.martelli@grupposandonato.it	Zaccagnini, Germana/J-7722-2016; Martelli, Fabio/AAL-3788-2020; Esposito, Antonio/K-5088-2018; Tamara, Canu/ABG-8524-2020; Palmisano, Anna/AAN-3242-2020; Gaetano, Carlo/P-9997-2019; DE COBELLI, Francesco/AAC-6488-2022; Esposito, Antonio/AAZ-7967-2020	Zaccagnini, Germana/0000-0002-9441-4735; Martelli, Fabio/0000-0002-8624-7738; Esposito, Antonio/0000-0002-1170-6266; Tamara, Canu/0000-0002-4589-9377; Palmisano, Anna/0000-0002-1564-2060; Gaetano, Carlo/0000-0002-5238-1832; DE COBELLI, Francesco/0000-0003-4014-3711; Esposito, Antonio/0000-0002-1170-6266	Ministero della Salute; Cariplo Foundation [2013-0887]	Ministero della Salute(Ministry of Health, Italy); Cariplo Foundation(Fondazione Cariplo)	This study was supported by Ministero della Salute and Cariplo Foundation (grant n. 2013-0887). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao WK, 2004, CARDIOVASC RES, V61, P548, DOI 10.1016/j.cardiores.2003.12.004; Berthet C, 2014, J CEREBR BLOOD F MET, V34, P1848, DOI 10.1038/jcbfm.2014.155; Chen YF, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-40; Comi AM, 2009, INT J DEV NEUROSCI, V27, P271, DOI 10.1016/j.ijdevneu.2008.12.006; Couffinhal T, 1998, AM J PATHOL, V152, P1667; Couffinhal T, 2009, FRONT BIOSCI-LANDMRK, V14, P3310, DOI 10.2741/3454; Curiel RV, 2009, ANN NY ACAD SCI, V1154, P101, DOI 10.1111/j.1749-6632.2009.04386.x; Damon BM, 2002, MAGN RESON MED, V48, P97, DOI 10.1002/mrm.10198; Delli Pizzi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044752; Diehm N, 2009, J CARDIOVASC SURG, V50, P647; Emanueli C, 2002, CIRCULATION, V106, P2257, DOI 10.1161/01.CIR.0000033971.56802.C5; Esposito A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059308; Feng S, 2014, J MAGN RESON IMAGING, V40, P779, DOI 10.1002/jmri.24417; Fitzmaurice G, 2011, APPL LONGITUDINAL AN, V2nd; Gianella A, 2010, CARDIOVASC RES, V85, P503, DOI 10.1093/cvr/cvp325; Heemskerk AM, 2005, MAGNET RESON MED, V53, P1333, DOI 10.1002/mrm.20476; Heemskerk AM, 2007, RADIOLOGY, V243, P413, DOI 10.1148/radiol.2432060491; Heemskerk AM, 2009, MAGN RESON MED, V61, P467, DOI 10.1002/mrm.21819; Helisch A, 2006, ARTERIOSCL THROM VAS, V26, P520, DOI 10.1161/01.ATV.0000202677.55012.a0; Jones WS, 2014, AM HEART J, V167, P489, DOI 10.1016/j.ahj.2013.12.012; Katare R, 2013, ARTERIOSCL THROM VAS, V33, P1872, DOI 10.1161/ATVBAHA.113.301217; Loerakker S, 2011, MAGN RESON MED, V66, P528, DOI 10.1002/mrm.22801; Lotfi S, 2013, ATHEROSCLEROSIS, V227, P1, DOI 10.1016/j.atherosclerosis.2012.10.060; Mac Gabhann F, 2010, MICROCIRCULATION, V17, P333, DOI 10.1111/j.1549-8719.2010.00034.x; Madonna R, 2014, MOL BIOTECHNOL, V56, P438, DOI 10.1007/s12033-014-9735-3; Madonna R, 2012, CIRC J, V76, P1517, DOI 10.1253/circj.CJ-11-1215; Marqueste T, 2008, J APPL PHYSIOL, V105, P299, DOI 10.1152/japplphysiol.00738.2007; Mathur S, 2011, MUSCLE NERVE, V43, P878, DOI 10.1002/mus.21986; Ortuno JE, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-316; R Foundation for Statistical Computing V Austria., R LANG ENV STAT COMP; Saab G, 1999, MAGNET RESON MED, V42, P150, DOI 10.1002/(SICI)1522-2594(199907)42:1<150::AID-MRM20>3.0.CO;2-5; Sciorati C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/879703; Stekelenburg A, 2007, J APPL PHYSIOL, V102, P2002, DOI 10.1152/japplphysiol.01115.2006; STUSS DT, 1987, J CLIN EXP NEUROPSYC, V9, P131, DOI 10.1080/01688638708405353; Toldo S, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.002360; Wang J, 2011, DIABETIC MED, V28, P618, DOI 10.1111/j.1464-5491.2011.03244.x; Waters RE, 2004, J APPL PHYSIOL, V97, P773, DOI 10.1152/japplphysiol.00107.2004; Wishnia A, 2001, NEUROMUSCULAR DISORD, V11, P50, DOI 10.1016/S0960-8966(00)00164-4; Zaccagnini G, 2004, CIRCULATION, V109, P2917, DOI 10.1161/01.CIR.0000129309.58874.0F; Zaccagnini G, 2007, J BIOL CHEM, V282, P31453, DOI 10.1074/jbc.M702511200; Zaccagnini G, 2014, ANTIOXID REDOX SIGN, V21, P1177, DOI 10.1089/ars.2013.5206; Zhang H, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20120042; Zhang JY, 2008, EXP NEUROL, V212, P448, DOI 10.1016/j.expneurol.2008.04.033	43	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142111	10.1371/journal.pone.0142111	http://dx.doi.org/10.1371/journal.pone.0142111			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554362	Green Submitted, Green Published, gold			2022-12-26	WOS:000364430700054
J	Shi, M; Zhang, YF; Liu, LY; Zhang, TT; Han, F; Cleveland, J; Wang, F; McKeehan, WL; Li, Y; Zhang, DK				Shi, Ming; Zhang, Yifan; Liu, Leyuan; Zhang, Tingting; Han, Fang; Cleveland, Joseph; Wang, Fen; McKeehan, Wallace L.; Li, Yu; Zhang, Dekai			MAP1S Protein Regulates the Phagocytosis of Bacteria and Toll-like Receptor (TLR) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNITY; STIMULATED PHAGOCYTOSIS; PHAGOSOME MATURATION; AUTOPHAGY; ACTIVATION; MICROTUBULE; RECOGNITION; PATHWAY; CELLS; INFECTION	Phagocytosis is a critical cellular process for innate immune defense against microbial infection. The regulation of phagocytosis process is complex and has not been well defined. An intracellular molecule might regulate cell surface-initiated phagocytosis, but the underlying molecular mechanism is poorly understood (1). In this study, we found that microtubule-associated protein 1S (MAP1S), a protein identified recently that is involved in autophagy (2), is expressed primarily in macrophages. MAP1S-deficient macrophages are impaired in the phagocytosis of bacteria. Furthermore, we demonstrate that MAP1S interacts directly with MyD88, a key adaptor of Toll-like receptors (TLRs), upon TLR activation and affects the TLR signaling pathway. Intriguingly, we also observe that, upon TLR activation, MyD88 participates in autophagy processing in a MAP1S-dependent manner by co-localizing with MAP1 light chain 3 (MAP1-LC3 or LC3). Therefore, we reveal that an intracellular autophagy-related molecule of MAP1S controls bacterial phagocytosis through TLR signaling.	[Shi, Ming; Zhang, Yifan; Zhang, Tingting; Han, Fang; Cleveland, Joseph; Zhang, Dekai] Texas A&M Univ, Ctr Infect & Inflammatory Dis, Hlth Sci Ctr, Houston, TX 77030 USA; [Liu, Leyuan; Wang, Fen; McKeehan, Wallace L.] Texas A&M Univ, Ctr Canc & Stem Cell Biol, Inst Biosci & Technol, Hlth Sci Ctr, Houston, TX 77030 USA; [Shi, Ming; Han, Fang; Li, Yu] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150001, Peoples R China	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Harbin Institute of Technology	Li, Y (corresponding author), Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150001, Peoples R China.	liyugene@hit.edu.cn; dzhang@ibt.tamhsc.edu			National Institutes of Health [CA176698, CA142862]; Texas AAMP;M Health Science Center; National Natural Science Foundation of China; DOD New Investigator Award [W81XWH]; John S. Dunn Foundation; NATIONAL CANCER INSTITUTE [R01CA142862, R21CA176698] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas AAMP;M Health Science Center; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); DOD New Investigator Award; John S. Dunn Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grant CA176698 and the Texas A&M Health Science Center (to D.Z.), the National Natural Science Foundation of China (to Y.L.), National Institutes of Health Grant CA142862 and DOD New Investigator Award W81XWH (to L.L.), and the John S. Dunn Foundation (to W.M. and F.W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Bonilla DL, 2013, IMMUNITY, V39, P537, DOI 10.1016/j.immuni.2013.08.026; Dallol A, 2007, CANCER RES, V67, P492, DOI 10.1158/0008-5472.CAN-06-3604; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Deretic V, 2010, CURR OPIN CELL BIOL, V22, P252, DOI 10.1016/j.ceb.2009.12.009; Doyle SE, 2004, J EXP MED, V199, P81, DOI 10.1084/jem.20031237; Granick JL, 2013, BLOOD, V122, P1770, DOI 10.1182/blood-2012-11-466268; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Kong L, 2008, CELL RES, V18, P745, DOI 10.1038/cr.2008.65; Kong L, 2009, CELL HOST MICROBE, V6, P150, DOI 10.1016/j.chom.2009.06.008; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Liu J, 2012, P NATL ACAD SCI USA, V109, pE1481, DOI 10.1073/pnas.1200781109; Liu LY, 2005, CANCER RES, V65, P1830, DOI 10.1158/0008-5472.CAN-04-3896; Mathur R, 2012, CELL, V151, P590, DOI 10.1016/j.cell.2012.08.042; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nilsen NJ, 2008, J LEUKOCYTE BIOL, V84, P280, DOI 10.1189/jlb.0907656; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Saitoh T, 2010, J CELL BIOL, V189, P925, DOI 10.1083/jcb.201002021; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Stuart LM, 2008, NAT REV IMMUNOL, V8, P131, DOI 10.1038/nri2240; Suzuki K, 2007, FEBS LETT, V581, P2156, DOI 10.1016/j.febslet.2007.01.096; TAKEDA K, 2007, CURR PROTOC IMMUNOL, pCH14, DOI DOI 10.1002/0471142735.IM1412S77; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Uhlik MT, 2003, NAT CELL BIOL, V5, P1104, DOI 10.1038/ncb1071; Underhill DM, 2004, MICROBES INFECT, V6, P1368, DOI 10.1016/j.micinf.2004.08.016; Xie R, 2011, CANCER RES, V71, P7537, DOI 10.1158/0008-5472.CAN-11-2170; Xie R, 2011, J BIOL CHEM, V286, P10367, DOI 10.1074/jbc.M110.206532; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351	35	13	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1243	1250		10.1074/jbc.M115.687376	http://dx.doi.org/10.1074/jbc.M115.687376			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26565030	hybrid, Green Published			2022-12-26	WOS:000368068300020
J	de Mendoza, TH; Liu, F; Verma, IM				de Mendoza, Tatiana Hurtado; Liu, Fei; Verma, Inder M.			Antiapoptotic Role for Lifeguard in T Cell Mediated Immune Response	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; MEMORY; ATTRITION; APOPTOSIS; BAX	Anti-apoptotic protein Lifeguard (LFG) is upregulated on T cells upon in vitro activation. To investigate its role in T cell immunity we infected wild type and LFG knockout bone marrow chimaeras mice with LCMV. We observed a decreased number of LFG KO activated CD8 and CD4 T cells throughout the infection and a marked decrease in LFG KO LCMV specific memory T cells. WT and KO T cells proliferated at the same rate, however, LFG KO CD44(hi) T cells showed increased cell death during the initial phase of the immune response. LFG KO and WT T cells were equally sensitive to the FAS antibody Jo-2 in ex vivo cultures, and blocking extrinsic pathways of cell death in vivo with Fas L or caspase 8 inhibitors did not rescue the increased apoptosis in LFG KO T cells. Our data suggest that LFG plays a role in T cell survival during the initial phase of anti-viral immune response by protecting preexisting memory T cells and possibly newly activated T cells resulting in a diminished immune response and a decreased number of LCMV specific memory T cells.	[de Mendoza, Tatiana Hurtado; Liu, Fei; Verma, Inder M.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	Salk Institute	Verma, IM (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	verma@salk.edu	Hurtado de Mendoza, Tatiana/GWM-5374-2022	Hurtado de Mendoza, Tatiana/0000-0003-3805-9254	NIH [AI048034]; Leducq Foundation; Meriaux Foundation; Ellison Medical Foundation; Ipsen/Biomeasure; Sanofi Aventis; Prostate Cancer Foundation; H.N. and Frances C. Berger Foundation; IPSEN Foundation; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leducq Foundation(Leducq Foundation); Meriaux Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); Ipsen/Biomeasure(Ipsen); Sanofi Aventis(Sanofi-Aventis); Prostate Cancer Foundation; H.N. and Frances C. Berger Foundation; IPSEN Foundation(Ipsen); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	IMV is an American Cancer Society Professor of Molecular Biology, http://www.cancer.org/research/researchaccomplishments/american-cancer-society-research-professors-2008, and holds the Irwin and Joan Jacobs Chair in Exemplary Life Sciences. This work was supported in part by a grant from the NIH (AI048034) (THDM, FL, IMV), http://www.nih.gov/, Leducq Foundation (THDM, FL, IMV), http://fondationleducq.org/, Meriaux Foundation (FL, IMV), http://www.fondation-merieux.org/, Ellison Medical Foundation (IMV), http://www.ellisonfoundation.org/, Ipsen/Biomeasure (THDM, FL, IMV), http://www.ipsen.com/en/, Sanofi Aventis (THDM, FL, IMV), http://www.sanofi.us/l/us/en/index.jsp, Prostate Cancer Foundation, and the H.N. and Frances C. Berger Foundation (IMV), http://www.hnberger.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded in part by the IPSEN Foundation. IMV is an American Cancer Society Professor of Molecular Biology, and holds the Irwin and Joan Jacobs Chair in Exemplary Life Sciences. This work was supported in part by grants from the NIH, Leducq Foundation, Meriaux Foundation, Ellison Medical Foundation, Ipsen/Biomeasure, Sanofi Aventis, Prostate Cancer Foundation, and the H.N. and Frances C. Berger Foundation. The authors would like to thank Ye Zheng for intellectual contribution.	Badovinac VP, 2006, IMMUNOL REV, V211, P67, DOI 10.1111/j.0105-2896.2006.00384.x; Bahl K, 2010, J VIROL, V84, P4866, DOI 10.1128/JVI.02571-09; Bucan V, 2010, APOPTOSIS, V15, P814, DOI 10.1007/s10495-010-0493-9; de Mendoza TH, 2011, P NATL ACAD SCI USA, V108, P17189, DOI 10.1073/pnas.1114226108; Fernandez M, 2007, J NEUROCHEM, V103, P190, DOI 10.1111/j.1471-4159.2007.04767.x; Jameson SC, 2009, IMMUNITY, V31, P859, DOI 10.1016/j.immuni.2009.11.007; KRAJEWSKI S, 1993, CANCER RES, V53, P4701; Kurtulus S, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00404; McNally JM, 2001, J VIROL, V75, P5965, DOI 10.1128/JVI.75.13.5965-5976.2001; Reimers K, 2006, INT J MOL MED, V18, P729; Selin LK, 1999, IMMUNITY, V11, P733, DOI 10.1016/S1074-7613(00)80147-8; Somia NV, 1999, P NATL ACAD SCI USA, V96, P12667, DOI 10.1073/pnas.96.22.12667; Welsh RM, 2009, NATURE, V459, pE3, DOI 10.1038/nature08091; Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9; Zong WX, 2003, J CELL BIOL, V162, P59, DOI 10.1083/jcb.200302084	15	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142161	10.1371/journal.pone.0142161	http://dx.doi.org/10.1371/journal.pone.0142161			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26565411	Green Published, Green Submitted, gold			2022-12-26	WOS:000367628500011
J	Londrigan, SL; Tate, MD; Job, ER; Moffat, JM; Wakim, LM; Gonelli, CA; Purcell, DFJ; Brooks, AG; Villadangos, JA; Reading, PC; Mintern, JD				Londrigan, Sarah L.; Tate, Michelle D.; Job, Emma R.; Moffat, Jessica M.; Wakim, Linda M.; Gonelli, Christopher A.; Purcell, Damien F. J.; Brooks, Andrew G.; Villadangos, Jose A.; Reading, Patrick C.; Mintern, Justine D.			Endogenous Murine BST-2/Tetherin Is Not a Major Restriction Factor of Influenza A Virus Infection	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; IN-VIVO; ALVEOLAR MACROPHAGES; EPITHELIAL-CELLS; MXA PROTEIN; TETHERIN; INTERFERON; RESPONSES; RECEPTOR; RELEASE	BST-2 (tetherin, CD317, HM1.24) restricts virus growth by tethering enveloped viruses to the cell surface. The role of BST-2 during influenza A virus infection (IAV) is controversial. Here, we assessed the capacity of endogenous BST-2 to restrict IAV in primary murine cells. IAV infection increased BST-2 surface expression by primary macrophages, but not alveolar epithelial cells (AEC). BST-2-deficient AEC and macrophages displayed no difference in susceptibility to IAV infection relative to wild type cells. Furthermore, BST-2 played little role in infectious IAV release from either AEC or macrophages. To examine BST-2 during IAV infection in vivo, we infected BST-2-deficient mice. No difference in weight loss or in viral loads in the lungs and/or nasal tissues were detected between BST-2-deficient and wild type animals. This study rules out a major role for endogenous BST-2 in modulating IAV in the mouse model of infection.	[Londrigan, Sarah L.; Job, Emma R.; Moffat, Jessica M.; Wakim, Linda M.; Gonelli, Christopher A.; Purcell, Damien F. J.; Brooks, Andrew G.; Villadangos, Jose A.; Reading, Patrick C.] Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Parkville, Vic 3010, Australia; [Tate, Michelle D.] MIMR PHI Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic 3168, Australia; [Tate, Michelle D.] Monash Univ, Clayton, Vic 3168, Australia; [Villadangos, Jose A.; Mintern, Justine D.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Reading, Patrick C.] Peter Doherty Inst Infect & Immun, Victorian Infect Dis Reference Lab, WHO Collaborating Ctr Reference & Res Influenza, Melbourne, Vic 3000, Australia	University of Melbourne; Prince Henry's Institute of Medical Research; Monash University; University of Melbourne; Victorian Infectious Diseases Reference Laboratory; World Health Organization	Mintern, JD (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, 30 Flemington Rd, Parkville, Vic 3010, Australia.	j.mintern@unimelb.edu.au	Purcell, Damian F/G-5068-2011; Villadangos, Jose A/AAU-1404-2020	Villadangos, Jose A/0000-0001-6771-8891; Mintern, Justine/0000-0002-3797-8577; Brooks, Andrew/0000-0002-4085-9683; Reading, Patrick/0000-0002-8860-5308; Tate, Michelle/0000-0002-0587-5514; Londrigan, Sarah/0000-0003-0989-4971; Wakim, Linda/0000-0003-1752-9579; Gonelli, Christopher/0000-0002-7521-8528	National Health and Medical Research Council of Australia [1083307]; National Health and Medical Research Council (NHMRC) of Australia [1035733]; Victorian State Government Operational Infrastructure Scheme; Australian Government Department of Health	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government Operational Infrastructure Scheme; Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing)	This work was supported by funding from National Health and Medical Research Council of Australia Project Grant 1083307 (PR), National Health and Medical Research Council (NHMRC) of Australia Early Career Fellowship 1035733 (MT) and the Victorian State Government Operational Infrastructure Scheme (MT). The Melbourne WHO Collaborating Centre for Reference and Research on Influenza is supported by the Australian Government Department of Health.	ANDERS EM, 1994, J GEN VIROL, V75, P615, DOI 10.1099/0022-1317-75-3-615; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Bruce EA, 2012, J GEN VIROL, V93, P963, DOI 10.1099/vir.0.038778-0; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Cocka LJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002931; Dittmann M, 2015, CELL, V160, P631, DOI 10.1016/j.cell.2015.01.040; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; Galao RP, 2012, CELL HOST MICROBE, V12, P633, DOI 10.1016/j.chom.2012.10.007; Hammonds J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000749; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Julkunen I, 2001, CYTOKINE GROWTH F R, V12, P171, DOI 10.1016/S1359-6101(00)00026-5; Kaletsky RL, 2009, P NATL ACAD SCI USA, V106, P2886, DOI 10.1073/pnas.0811014106; Leyva-Grado VH, 2014, J MOL BIOL, V426, P1308, DOI 10.1016/j.jmb.2013.12.023; Li SX, 2014, J IMMUNOL, V193, P306, DOI 10.4049/jimmunol.1400490; Liberatore RA, 2011, P NATL ACAD SCI USA, V108, P18097, DOI 10.1073/pnas.1113694108; Londrigan SL, 2011, J VIROL, V85, P2990, DOI 10.1128/JVI.01705-10; Mahauad-Fernandez WD, 2014, J GEN VIROL, V95, P2450, DOI 10.1099/vir.0.068643-0; Mangeat B, 2012, J BIOL CHEM, V287, P22015, DOI 10.1074/jbc.M111.319996; Moffat JM, 2013, EUR J IMMUNOL, V43, P595, DOI 10.1002/eji.201242799; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Ng WC, 2014, J VIROL, V88, P1659, DOI 10.1128/JVI.02014-13; PAVLOVIC J, 1990, J VIROL, V64, P3370, DOI 10.1128/JVI.64.7.3370-3375.1990; Reading PC, 2000, J VIROL, V74, P5190, DOI 10.1128/JVI.74.11.5190-5197.2000; Sakuma T, 2009, J VIROL, V83, P2382, DOI 10.1128/JVI.01607-08; Siegrist F, 2011, J INTERF CYTOK RES, V31, P183, DOI 10.1089/jir.2010.0112; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Swiecki M, 2012, J IMMUNOL, V188, P2488, DOI 10.4049/jimmunol.1103145; Tate MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017618; Tate MD, 2011, VIRAL IMMUNOL, V24, P77, DOI 10.1089/vim.2010.0118; Tate MD, 2011, MICROBES INFECT, V13, P202, DOI 10.1016/j.micinf.2010.10.004; Tate MD, 2010, J VIROL, V84, P7569, DOI 10.1128/JVI.00291-10; Thomas BJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep07176; Tokarev A, 2013, J VIROL, V87, P2046, DOI 10.1128/JVI.02272-12; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Viswanathan K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002332; Wakim LM, 2013, NAT IMMUNOL, V14, P238, DOI 10.1038/ni.2525; Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009; Watanabe R, 2011, VIROLOGY, V417, P50, DOI 10.1016/j.virol.2011.05.006; Weidner JM, 2010, J VIROL, V84, P12646, DOI 10.1128/JVI.01328-10; Winkler M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043337; Xiao H, 2013, J VIROL, V87, P13053, DOI 10.1128/JVI.02220-13; Yondola MA, 2011, J VIROL, V85, P2480, DOI 10.1128/JVI.02188-10; Yu WCL, 2011, J VIROL, V85, P6844, DOI 10.1128/JVI.02200-10	43	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142925	10.1371/journal.pone.0142925	http://dx.doi.org/10.1371/journal.pone.0142925			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26566124	gold, Green Published, Green Submitted			2022-12-26	WOS:000367628500071
J	Dabrowski, W; Kwiecien, JM; Rola, R; Klapec, M; Stanisz, GJ; Kotlinska-Hasiec, E; Oakden, W; Janik, R; Coote, M; Frey, BN; Turski, WA				Dabrowski, Wojciech; Kwiecien, Jacek M.; Rola, Radoslaw; Klapec, Michal; Stanisz, Greg J.; Kotlinska-Hasiec, Edyta; Oakden, Wendy; Janik, Rafal; Coote, Margaret; Frey, Benicio N.; Turski, Waldemar A.			Prolonged Subdural Infusion of Kynurenic Acid Is Associated with Dose-Dependent Myelin Damage in the Rat Spinal Cord	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; T-CELL RESPONSES; MULTIPLE-SCLEROSIS; OLIGODENDROCYTE GLYCOPROTEIN; CEREBROSPINAL-FLUID; ADULT-RATS; HUMAN ASTROCYTES; ELEVATED LEVELS; INJURY; MOG	Background Kynurenic acid (KYNA) is the end stage metabolite of tryptophan produced mainly by astrocytes in the central nervous system (CNS). It has neuroprotective activities but can be elevated in the neuropsychiatric disorders. Toxic effects of KYNA in the CNS are unknown. The aim of this study was to assess the effect of the subdural KYNA infusion on the spinal cord in adult rats. Methods A total of 42 healthy adult rats were randomly assigned into six groups and were infused for 7 days with PBS (control) or 0.0002 pmol/min, 0.01 nmol/min, 0.1 nmol/min, 1 nmol/min, and 10 nmol/min of KYNA per 7 days. The effect of KYNA on spinal cord was determined using histological and electron microscopy examination. Myelin oligodendrocyte glycoprotein (MOG) was measured in the blood serum to assess a degree of myelin damage. Result In all rats continuous long-lasting subdural KYNA infusion was associated with myelin damage and myelin loss that was increasingly widespread in a dose-depended fashion in peripheral, sub-pial areas. Damage to myelin sheaths was uniquely related to the separation of lamellae at the intraperiod line. The damaged myelin sheaths and areas with complete loss of myelin were associated with limited loss of scattered axons while vast majority of axons in affected areas were morphologically intact. The myelin loss-causing effect of KYNA occurred with no necrosis of oligodendrocytes, with locally severe astrogliosis and no cellular inflammatory response. Additionally, subdural KYNA infusion increased blood MOG concentration. Moreover, the rats infused with the highest doses of KYNA (1 and 10 nmol/min) demonstrated adverse neurological signs including weakness and quadriplegia. Conclusions We suggest, that subdural infusion of high dose of KYNA can be used as an experimental tool for the study of mechanisms of myelin damage and regeneration. On the other hand, the administration of low, physiologically relevant doses of KYNA may help to discover the role of KYNA in control of physiological myelination process.	[Dabrowski, Wojciech; Kotlinska-Hasiec, Edyta] Med Univ, Dept Anaesthesiol & Intens Therapy, Lublin, Poland; [Kwiecien, Jacek M.] McMaster Univ, M deGroote Sch Med, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Rola, Radoslaw] Med Univ, Dept Neurosurg & Paediat Neurosurg, Lublin, Poland; [Klapec, Michal] Med Univ, Dept Orthopaed & Traumatol, Lublin, Poland; [Stanisz, Greg J.; Oakden, Wendy; Janik, Rafal] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A1, Canada; [Stanisz, Greg J.] Sunnybrook Res Inst, Phys Sci Platform, Toronto, ON, Canada; [Coote, Margaret; Frey, Benicio N.] McMaster Univ, M deGroote Sch Med, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [Turski, Waldemar A.] Med Univ, Dept Expt & Clin Pharmacol, Lublin, Poland	Medical University of Lublin; McMaster University; Medical University of Lublin; Medical University of Lublin; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; McMaster University; Medical University of Lublin	Dabrowski, W (corresponding author), Med Univ, Dept Anaesthesiol & Intens Therapy, Lublin, Poland.	w.dabrowski5@yahoo.com	Rola, Radoslaw/AAQ-5587-2021; Dabrowski, Wojciech/AAN-8425-2020; Rola, Radoslaw/V-6749-2018; Frey, Benicio/AAJ-8212-2021; , stanisz@sri.utoronto.ca/A-4943-2013; Turski, Waldemar Andrzej/GNW-6011-2022	Rola, Radoslaw/0000-0003-0613-6593; Dabrowski, Wojciech/0000-0003-0449-2375; Rola, Radoslaw/0000-0003-0613-6593; , stanisz@sri.utoronto.ca/0000-0002-9488-7612; Frey, Benicio N./0000-0001-8267-943X; Turski, Waldemar/0000-0002-5805-5106				Aldea S, 2006, ACTA NEUROCHIR, V148, P195, DOI 10.1007/s00701-005-0680-6; Bando Y, 2015, NEUROCHEM INT, V81, P16, DOI 10.1016/j.neuint.2015.01.002; Bartzokis G, 2011, SCHIZOPHR RES, V132, P35, DOI 10.1016/j.schres.2011.06.029; Beggiato S, 2013, EUR J NEUROSCI, V37, P1470, DOI 10.1111/ejn.12160; Berthelot L, 2008, EUR J IMMUNOL, V38, P1889, DOI 10.1002/eji.200838023; Bradl M, 1996, BRAIN PATHOL, V6, P303, DOI 10.1111/j.1750-3639.1996.tb00857.x; BRUNNER C, 1989, J NEUROCHEM, V52, P296, DOI 10.1111/j.1471-4159.1989.tb10930.x; CARONI P, 1988, PROG BRAIN RES, V78, P363; Correale J, 2003, J NEUROIMMUNOL, V136, P162, DOI 10.1016/S0165-5728(03)00035-3; Correale J, 2012, ANN NEUROL, V72, P682, DOI 10.1002/ana.23745; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Davis KL, 2003, ARCH GEN PSYCHIAT, V60, P443, DOI 10.1001/archpsyc.60.5.443; de Rosbo NK, 1998, J AUTOIMMUN, V11, P287, DOI 10.1006/jaut.1998.0202; DEROSBO NK, 1993, J CLIN INVEST, V92, P2602, DOI 10.1172/JCI116875; Dwyer JB, 2009, PHARMACOL THERAPEUT, V122, P125, DOI 10.1016/j.pharmthera.2009.02.003; Greer JM, 2013, MULT SCLER INT, V2013, DOI DOI 10.1155/2013/151427; Guillemin GJ, 2000, REDOX REP, V5, P108, DOI 10.1179/135100000101535375; Guo FZ, 2012, J NEUROSCI, V32, P639, DOI 10.1523/JNEUROSCI.4073-11.2012; Hsieh YC, 2011, ACTA PHARMACOL SIN, V32, P167, DOI 10.1038/aps.2010.191; Huang ZH, 2009, BRAIN RES, V1301, P100, DOI 10.1016/j.brainres.2009.09.006; Iglesias A, 2001, GLIA, V36, P220, DOI 10.1002/glia.1111; JAUCH DA, 1993, NEUROPHARMACOLOGY, V32, P467, DOI 10.1016/0028-3908(93)90171-X; Jilek S, 2013, NEUROL SCI, V34, P539, DOI 10.1007/s10072-012-1144-4; Johns TG, 1999, J NEUROCHEM, V72, P1, DOI 10.1046/j.1471-4159.1999.0720001.x; Jung J, 2015, BBA-MOL CELL RES, V1853, P2115, DOI 10.1016/j.bbamcr.2014.12.023; Kekesi G, 2002, EUR J PHARMACOL, V445, P93, DOI 10.1016/S0014-2999(02)01787-9; Kepplinger B, 2005, NEUROSIGNALS, V14, P126, DOI 10.1159/000086295; Kiss C, 2003, J NEURAL TRANSM, V110, P1, DOI 10.1007/s00702-002-0770-z; Koehler NKU, 2002, J IMMUNOL, V168, P5920, DOI 10.4049/jimmunol.168.11.5920; Korimova A, 2012, CENT EUR J BIOL, V7, P996, DOI 10.2478/s11535-012-0096-2; Kwiecien JM, 2015, FOLIA NEUROPATHOL, V53, P41, DOI 10.5114/fn.2015.49973; Kwiecien JM, 2000, COMPARATIVE MED, V50, P503; LEBAR R, 1986, CLIN EXP IMMUNOL, V66, P423; Lee DH, 2012, EXPERT OPIN THER TAR, V16, P451, DOI 10.1517/14728222.2012.677438; Leuenberger T, 2013, J IMMUNOL, V191, P4960, DOI 10.4049/jimmunol.1300822; Linderholm KR, 2012, SCHIZOPHRENIA BULL, V38, P426, DOI 10.1093/schbul/sbq086; LININGTON C, 1988, AM J PATHOL, V130, P443; Lisak RP, 2015, EXP NEUROL, V273, P161, DOI 10.1016/j.expneurol.2015.08.012; Lundgaard I, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001743; Mayer MC, 2012, THER ADV NEUROL DISO, V5, P147, DOI 10.1177/1756285611433772; Moreno M, 2013, J NEUROL SCI, V333, P55, DOI 10.1016/j.jns.2012.12.014; Olsson SK, 2012, BIPOLAR DISORD, V14, P719, DOI 10.1111/bdi.12009; Olsson SK, 2010, J PSYCHIATR NEUROSCI, V35, P195, DOI 10.1503/jpn.090180; Pershing ML, 2015, NEUROPHARMACOLOGY, V90, P33, DOI 10.1016/j.neuropharm.2014.10.017; PHAMDINH D, 1993, P NATL ACAD SCI USA, V90, P7990, DOI 10.1073/pnas.90.17.7990; PHAMDINH D, 1994, J NEUROCHEM, V63, P2353; Pocivavsek A, 2014, PSYCHOPHARMACOLOGY, V231, P2799, DOI 10.1007/s00213-014-3452-2; Potter MC, 2010, NEUROPSYCHOPHARMACOL, V35, P1734, DOI 10.1038/npp.2010.39; PRINEAS JW, 1993, ANN NEUROL, V33, P137, DOI 10.1002/ana.410330203; Reindl M, 2013, NAT REV NEUROL, V9, P455, DOI 10.1038/nrneurol.2013.118; Rejdak K, 2007, J NEURAL TRANSM, V114, P1011, DOI 10.1007/s00702-007-0667-y; Rozsa E, 2008, J NEURAL TRANSM, V115, P1087, DOI 10.1007/s00702-008-0052-5; Safrany-Fark A, 2015, J PHARMACOL TOX MET, V72, P19, DOI 10.1016/j.vascn.2015.01.002; Savitz J, 2015, NEUROPSYCHOPHARMACOL, V40, P463, DOI 10.1038/npp.2014.194; SCHLUESENER HJ, 1987, J IMMUNOL, V139, P4016; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Tan L, 2012, J NEUROL SCI, V323, P1, DOI 10.1016/j.jns.2012.08.005; Tuboly G, 2015, BRAIN RES BULL, V112, P52, DOI 10.1016/j.brainresbull.2015.02.001; TURSKI L, 1985, NEUROSCI LETT, V53, P321, DOI 10.1016/0304-3940(85)90558-0; Turski MP, 2013, INT J TRYPTOPHAN RES, V6, P47, DOI 10.4137/IJTR.S12536; TURSKI WA, 1988, EXP BRAIN RES, V71, P563, DOI 10.1007/BF00248748; Wang HL, 2006, EUR J NEUROSCI, V23, P1111, DOI 10.1111/j.1460-9568.2006.04645.x; Zadori D, 2011, J NEURAL TRANSM, V118, P865, DOI 10.1007/s00702-010-0573-6	63	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142598	10.1371/journal.pone.0142598	http://dx.doi.org/10.1371/journal.pone.0142598			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562835	Green Published, Green Submitted, gold			2022-12-26	WOS:000364480900048
J	Huff, ES; Leahy, JE; Hiebeler, D; Weiskittel, AR; Noblet, CL				Huff, Emily Silver; Leahy, Jessica E.; Hiebeler, David; Weiskittel, Aaron R.; Noblet, Caroline L.			An Agent-Based Model of Private Woodland Owner Management Behavior Using Social Interactions, Information Flow, and Peer-To-Peer Networks	PLOS ONE			English	Article							DECISION-MAKING; FOREST OWNERS; SIMULATION; LANDSCAPE; PROTOCOL; SYSTEMS	Privately owned woodlands are an important source of timber and ecosystem services in North America and worldwide. Impacts of management on these ecosystems and timber supply from these woodlands are difficult to estimate because complex behavioral theory informs the owner's management decisions. The decision-making environment consists of exogenous market factors, internal cognitive processes, and social interactions with fellow landowners, foresters, and other rural community members. This study seeks to understand how social interactions, information flow, and peer-to-peer networks influence timber harvesting behavior using an agent-based model. This theoretical model includes forested polygons in various states of 'harvest readiness' and three types of agents: forest landowners, foresters, and peer leaders (individuals trained in conservation who use peer-to-peer networking). Agent rules, interactions, and characteristics were parameterized with values from existing literature and an empirical survey of forest landowner attitudes, intentions, and demographics. The model demonstrates that as trust in foresters and peer leaders increases, the percentage of the forest that is harvested sustainably increases. Furthermore, peer leaders can serve to increase landowner trust in foresters. Model output and equations will inform forest policy and extension/outreach efforts. The model also serves as an important testing ground for new theories of landowner decision making and behavior.	[Huff, Emily Silver] US Forest Serv, USDA, No Res Stn, Amherst, MA USA; [Leahy, Jessica E.; Weiskittel, Aaron R.] Univ Maine, Sch Forest Resources, Orono, ME USA; [Hiebeler, David] Univ Maine, Dept Math & Stat, Orono, ME USA; [Noblet, Caroline L.] Univ Maine, Sch Econ, Orono, ME USA	United States Department of Agriculture (USDA); United States Forest Service; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono	Huff, ES (corresponding author), US Forest Serv, USDA, No Res Stn, Amherst, MA USA.	ehuff@fs.fed.us	Weiskittel, Aaron/H-3688-2019	Weiskittel, Aaron/0000-0003-2534-4478	National Science Foundation (NSF) Sustainable Energy Pathways (SEP) [1230908]; NSF [EPS-0904155]; Maine Agricultural and Forest Experiment Station; Northeastern States Research Cooperative, USDA Forest Service; Sustainability Solutions Initiative; Direct For Biological Sciences [1313688] Funding Source: National Science Foundation	National Science Foundation (NSF) Sustainable Energy Pathways (SEP)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Maine Agricultural and Forest Experiment Station; Northeastern States Research Cooperative, USDA Forest Service(United States Department of Agriculture (USDA)United States Forest Service); Sustainability Solutions Initiative; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was made possible by the National Science Foundation (NSF) Sustainable Energy Pathways (SEP) award #1230908 and as part of the Sustainability Solutions Initiative, supported by NSF award #EPS-0904155 to Maine EPSCoR at the University of Maine to JEL and ESH. This project was also supported by the Maine Agricultural and Forest Experiment Station and the Northeastern States Research Cooperative through funding made available by the USDA Forest Service to JEL and ESH. The conclusions and opinions in this paper are those of the authors and not the NSRC, the Forest Service, or the USDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank David B. Kittredge for providing internal validity checks of key model constructs. We also thank the Sustainability Solutions Initiative and Sustainable Energies Pathways team at the University of Maine for providing support and an intellectual environment to complete this work. We would also like to thank Tim Waring and Jared R. Stapp for early comments on the model.	Aldrich H., 1977, ACAD MANAGE REV, V2, P217, DOI [10.5465/amr.1977.4409044, DOI 10.5465/AMR.1977.4409044]; Amacher G. S., 2003, Journal of Forest Economics, V9, P137, DOI 10.1078/1104-6899-00028; An L, 2012, ECOL MODEL, V229, P25, DOI 10.1016/j.ecolmodel.2011.07.010; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Beach RH, 2005, FOREST POLICY ECON, V7, P261, DOI 10.1016/S1389-9341(03)00065-0; Billari FC, 2007, DEMOGR RES, V17, P59, DOI 10.4054/DemRes.2007.17.3; Bodin O, 2005, ENVIRON MANAGE, V35, P175, DOI 10.1007/s00267-004-0036-7; Butler BJ, 2008, NRS27 USDA FOR SERV, P73; Butler BJ, 2010, NORTH J APPL FOR, V27, P151, DOI 10.1093/njaf/27.4.151; Caillault S, 2013, ENVIRON MODELL SOFTW, V45, P64, DOI 10.1016/j.envsoft.2012.11.003; Earle T.C., 1995, SOCIAL TRUST COSMOPO; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elsawah S, 2015, J ENVIRON MANAGE, V151, P500, DOI 10.1016/j.jenvman.2014.11.028; Gootee RS, 2010, SMALL-SCALE FOR, V9, P137, DOI 10.1007/s11842-010-9113-3; Granovetter M., 1983, SOCIOLOGICAL THEORY, V1, P201, DOI [10.2307/202051, DOI 10.2307/202051]; Grimm V., 2005, INDIVIDUAL BASED MOD; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Heldmann G, 2013, THESIS; Hujala T, 2007, SCAND J FOREST RES, V22, P454, DOI 10.1080/02827580701395434; Jin L, 2013, IEEE COMMUN MAG, V51, P144, DOI 10.1109/MCOM.2013.6588663; Kampstra P., 2008, J STAT SOFTW, V28, P1, DOI [10.18637/jss.v028.c01, DOI 10.18637/JSS.V028.C01]; Kittredge DB, 2013, NORTH J APPL FOR, V30, P67, DOI 10.5849/njaf.11-004; Knoot TG, 2011, SCAND J FOREST RES, V26, P171, DOI 10.1080/02827581.2010.545827; Korhonen K, 2012, SCAND J FOREST RES, V27, P88, DOI 10.1080/02827581.2011.631935; Kostadinov F, 2014, FOREST POLICY ECON, V38, P105, DOI 10.1016/j.forpol.2013.08.001; Kueper AM, 2013, SOC NATUR RESOUR, V26, P912, DOI 10.1080/08941920.2012.722748; Lachapelle PR, 2005, SOC NATUR RESOUR, V18, P279, DOI 10.1080/08941920590908141; Leahy JE., 2013, AGENT BASED MODELING, DOI [10.1155/2013/563068, DOI 10.1155/2013/563068]; Mayer AL, 2013, INT J FORESTRY RES, V2013; McAllister RRJ, 2005, MODSIM 2005: INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION: ADVANCES AND APPLICATIONS FOR MANAGEMENT AND DECISION MAKING, P1624; Mitchell M., 2009, COMPLEXITY GUIDED TO; Railsback SF, 2002, ECOLOGY, V83, P1817, DOI 10.2307/3071767; Reynolds C.W., 1987, P 14 ANN C COMPUTER, V21, P25, DOI DOI 10.1145/37402.37406; Rickenbach M, 2011, J SOIL WATER CONSERV, V66, p91A, DOI 10.2489/jswc.66.4.91A; Rickenbach M, 2009, FOREST POLICY ECON, V11, P593, DOI 10.1016/j.forpol.2009.08.006; Rickenbach MG, 2006, FOREST POLICY ECON, V8, P93, DOI 10.1016/j.forpol.2004.05.006; ROSNOW RL, 1991, AM PSYCHOL, V46, P484, DOI 10.1037/0003-066X.46.5.484; ROTTER JB, 1971, AM PSYCHOL, V26, P443, DOI 10.1037/h0031464; Rousseau DM, 1998, ACAD MANAGE REV, V23, P393, DOI 10.5465/AMR.1998.926617; Sagor ES, 2014, J ENVIRON MANAGE, V132, P145, DOI 10.1016/j.jenvman.2013.11.001; Salmon O, 2006, J FOREST, V104, P419; Sargent RG, 2013, J SIMUL, V7, P12, DOI [10.1057/jos.2012.20, 10.1109/WSC.1998.744907]; Satake A, 2007, J THEOR BIOL, V246, P695, DOI 10.1016/j.jtbi.2007.01.014; SCHELLING TC, 1971, J MATH SOCIOL, V1, P143, DOI 10.1080/0022250X.1971.9989794; Schluter M, 2012, NAT RESOUR MODEL, V25, P219, DOI 10.1111/j.1939-7445.2011.00108.x; Seymour Robert S., 1999, P22, DOI 10.1017/CBO9780511613029.004; Silver EJ, 2015, J FOR IN PRESS; Stevens LE, 1995, SOC COGNITION, V13, P189, DOI 10.1521/soco.1995.13.3.189; Sztompka P., 1999, TRUST SOCIOLOGICAL T; Virkkula O, 2014, SMALL-SCALE FOR, V13, P407, DOI 10.1007/s11842-014-9262-x; Wang YF, 2015, IEEE T SYST MAN CY-S, V45, P185, DOI 10.1109/TSMC.2014.2359857; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; West P. C., 1988, Northern Journal of Applied Forestry, V5, P265; Zhang YQ, 2015, IEEE T SYST MAN CY-S, V45, P214, DOI 10.1109/TSMC.2014.2360505	55	10	10	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142453	10.1371/journal.pone.0142453	http://dx.doi.org/10.1371/journal.pone.0142453			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7UL	26562429	gold, Green Submitted, Green Published			2022-12-26	WOS:000364480900035
J	Scott, RM; Roby, E				Scott, Rose M.; Roby, Erin			Processing Demands Impact 3-Year-Olds' Performance in a Spontaneous-Response Task: New Evidence for the Processing-Load Account of Early False-Belief Understanding	PLOS ONE			English	Article							CHILDRENS THEORY; OBJECT IDENTITY; INFANTS; MIND; OTHERS; 18-MONTH-OLDS; ATTRIBUTION; PRESCHOOLERS; ANTICIPATION; METAANALYSIS	Prior to age four, children succeed in non-elicited-response false-belief tasks but fail elicited- response false-belief tasks. To explain this discrepancy, the processing-load account argues that the capacity to represent beliefs emerges in infancy, as indicated by early success on non-elicited-response tasks, but that children's ability to demonstrate this capacity depends on the processing demands of the task and children's processing skills. When processing demands exceed young children's processing abilities, such as in standard elicited- response tasks, children fail despite their capacity to represent beliefs. Support for this account comes from recent evidence that reducing processing demands improves young children's performance: when demands are sufficiently reduced, 2.5-year-olds succeed in elicited-response tasks. Here we sought complementary evidence for the processing-load account by examining whether increasing processing demands impeded children's performance in a non-elicited-response task. 3-year-olds were tested in a preferential-looking task in which they heard a change-of-location false-belief story accompanied by a picture book; across children, we manipulated the amount of linguistic ambiguity in the story. The final page of the book showed two images: one that was consistent with the main character's false belief and one that was consistent with reality. When the story was relatively unambiguous, children looked reliably longer at the false-belief-consistent image, successfully demonstrating their false-belief understanding. When the story was ambiguous, however, this undermined children's performance: looking times to the belief-consistent image were correlated with verbal ability, and only children with verbal skills in the upper quartile of the sample demonstrated a significant preference for the belief-consistent image. These results support the processing-load account by demonstrating that regardless of whether a task involves an elicited response, children's performance depends on the processing demands of the task and their processing skills. These findings also have implications for alternative, deflationary accounts of early false-belief understanding.	[Scott, Rose M.; Roby, Erin] Univ Calif Merced, Sch Social Sci Humanities & Arts Psychol Sci, Merced, CA 95343 USA	University of California System; University of California Merced	Scott, RM (corresponding author), Univ Calif Merced, Sch Social Sci Humanities & Arts Psychol Sci, Merced, CA 95343 USA.	rscott@ucmerced.edu		Roby, Erin/0000-0002-3714-8274	University of California Merced Graduate Research Council; Hellman Fellows Fund	University of California Merced Graduate Research Council; Hellman Fellows Fund	This research was supported by grants from the University of California Merced Graduate Research Council and the Hellman Fellows Fund to RMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, MACARTHUR BATES COMM; Apperly IA, 2009, PSYCHOL REV, V116, P953, DOI 10.1037/a0016923; Baillargeon R., 2015, APA HDB PERSONALITY, V1, P79, DOI DOI 10.1037/14341-003; Baillargeon R, 2010, TRENDS COGN SCI, V14, P110, DOI 10.1016/j.tics.2009.12.006; Baillergeon R, 2014, COGNITIVE NEUROSCIEN, P7; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Barrett HC, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2654; Bartsch K, 1996, CHILD DEV, V67, P1671, DOI 10.1111/j.1467-8624.1996.tb01820.x; Birch SAJ, 2003, PSYCHOL SCI, V14, P283, DOI 10.1111/1467-9280.03436; Buttelmann D, 2014, J EXP CHILD PSYCHOL, V119, P120, DOI 10.1016/j.jecp.2013.10.002; Buttelmann D, 2009, COGNITION, V112, P337, DOI 10.1016/j.cognition.2009.05.006; Buttelmann F, 2015, J EXP CHILD PSYCHOL, V131, P94, DOI 10.1016/j.jecp.2014.11.009; Butterfill SA, 2013, MIND LANG, V28, P606, DOI 10.1111/mila.12036; Carlson SM, 2001, CHILD DEV, V72, P1032, DOI 10.1111/1467-8624.00333; Carruthers P, 2013, MIND LANG, V28, P141, DOI 10.1111/mila.12014; Devine RT, 2014, CHILD DEV, V85, P1777, DOI 10.1111/cdev.12237; FREEMAN NH, 1995, COGNITION, V56, P31, DOI 10.1016/0010-0277(94)00654-4; GOPNIK A, 1988, CHILD DEV, V59, P26, DOI 10.2307/1130386; Grice H.P., 1975, SYNTAX SEMANTICS, V3, P225; Hansen MB, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00023; He ZJ, 2012, BRIT J DEV PSYCHOL, V30, P14, DOI 10.1111/j.2044-835X.2011.02070.x; Helming KA, 2014, TRENDS COGN SCI, V18, P167, DOI 10.1016/j.tics.2014.01.005; Heyes C, 2014, DEVELOPMENTAL SCI, V17, P647, DOI 10.1111/desc.12148; Heyes C, 2014, PERSPECT PSYCHOL SCI, V9, P131, DOI 10.1177/1745691613518076; Kampis D, 2015, BIENN M SOC RES CHIL; Knudsen B, 2012, INFANCY, V17, P672, DOI 10.1111/j.1532-7078.2011.00105.x; Knudsen B, 2012, DEVELOPMENTAL SCI, V15, P113, DOI 10.1111/j.1467-7687.2011.01098.x; Kovacs AM, 2010, SCIENCE, V330, P1830, DOI 10.1126/science.1190792; Leslie AM, 1998, DEVELOPMENTAL SCI, V1, P247, DOI 10.1111/1467-7687.00038; Low J, 2014, CHILD DEV, V85, P1519, DOI 10.1111/cdev.12224; Low J, 2013, PSYCHOL SCI, V24, P305, DOI 10.1177/0956797612451469; Luo YY, 2011, COGNITION, V121, P289, DOI 10.1016/j.cognition.2011.07.011; Milligan K, 2007, CHILD DEV, V78, P622, DOI 10.1111/j.1467-8624.2007.01018.x; MITCHELL P, 1991, COGNITION, V39, P107, DOI 10.1016/0010-0277(91)90040-B; Moll H, 2015, DEV SCI IN PRESS; Mueller VA, 2007, NEUROIMAGE, V37, P1354, DOI 10.1016/j.neuroimage.2007.06.018; Onishi KH, 2005, SCIENCE, V308, P255, DOI 10.1126/science.1107621; Perner J, 2005, SCIENCE, V308, P214, DOI 10.1126/science.1111656; Perner J, 2012, TRENDS COGN SCI, V16, P519, DOI 10.1016/j.tics.2012.08.004; Perner J, 2010, COGNITION AND NEUROPSYCHOLOGY: INTERNATIONAL PERSPECTIVES ON PSYCHOLOGICAL SCIENCE, VOL 1, P241; Rhodes M, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00263; Roth D, 1998, COGNITION, V66, P1, DOI 10.1016/S0010-0277(98)00005-5; Rubio-Fernandez P, 2013, PSYCHOL SCI, V24, P27, DOI 10.1177/0956797612447819; Ruffman T, 2014, DEV REV, V34, P265, DOI 10.1016/j.dr.2014.04.001; RUSSELL J, 1991, BRIT J DEV PSYCHOL, V9, P331, DOI 10.1111/j.2044-835X.1991.tb00881.x; Saxe R, 2006, SOC NEUROSCI-UK, V1, P284, DOI 10.1080/17470910601000446; Schneider D, 2012, PSYCHOL SCI, V23, P842, DOI 10.1177/0956797612439070; Scott RM, 2015, COGN PSYCHO IN PRESS; Scott RM, 2012, 8 INT C INF STUD JUN; Scott RM, 2014, DEVELOPMENTAL SCI, V17, P660, DOI 10.1111/desc.12173; Scott RM, 2014, DEV REV, V34, P300, DOI 10.1016/j.dr.2014.05.001; Scott RM, 2012, DEVELOPMENTAL SCI, V15, P181, DOI 10.1111/j.1467-7687.2011.01103.x; Scott RM, 2009, CHILD DEV, V80, P1172, DOI 10.1111/j.1467-8624.2009.01324.x; Senju A, 2011, PSYCHOL SCI, V22, P878, DOI 10.1177/0956797611411584; Setoh P, 2011, BIENN M SOC RES CHIL; SIEGAL M, 1991, COGNITION, V38, P1, DOI 10.1016/0010-0277(91)90020-5; Song HJ, 2008, DEV PSYCHOL, V44, P1789, DOI 10.1037/a0013774; Southgate V, 2007, PSYCHOL SCI, V18, P587, DOI 10.1111/j.1467-9280.2007.01944.x; Southgate V, 2014, COGNITION, V130, P1, DOI 10.1016/j.cognition.2013.08.008; Southgate V, 2010, DEVELOPMENTAL SCI, V13, P907, DOI 10.1111/j.1467-7687.2009.00946.x; Surian L, 2007, PSYCHOL SCI, V18, P580, DOI 10.1111/j.1467-9280.2007.01943.x; TANENHAUS MK, 1995, SCIENCE, V268, P1632, DOI 10.1126/science.7777863; Trauble B, 2010, INFANCY, V15, P434, DOI 10.1111/j.1532-7078.2009.00025.x; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; Yazdi AA, 2006, COGNITION, V100, P343, DOI 10.1016/j.cognition.2005.05.004	66	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142405	10.1371/journal.pone.0142405	http://dx.doi.org/10.1371/journal.pone.0142405			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7UL	26562840	Green Published, gold, Green Submitted			2022-12-26	WOS:000364480900030
J	Dugrand-Judek, A; Olry, A; Hehn, A; Costantino, G; Ollitrault, P; Froelicher, Y; Bourgaud, F				Dugrand-Judek, Audray; Olry, Alexandre; Hehn, Alain; Costantino, Gilles; Ollitrault, Patrick; Froelicher, Yann; Bourgaud, Frederic			The Distribution of Coumarins and Furanocoumarins in Citrus Species Closely Matches Citrus Phylogeny and Reflects the Organization of Biosynthetic Pathways	PLOS ONE			English	Article							MOLECULAR-CLONING; CYP3A4 INHIBITOR; PRENYLTRANSFERASE; PHOTOTOXICITY; DIVERSITY; RUTACEAE; FRUIT; IDENTIFICATION; FUROCOUMARINS; QUANTITATION	Citrus plants are able to produce defense compounds such as coumarins and furanocoumarins to cope with herbivorous insects and pathogens. In humans, these chemical compounds are strong photosensitizers and can interact with medications, leading to the "grapefruit juice effect". Removing coumarins and furanocoumarins from food and cosmetics imply additional costs and might alter product quality. Thus, the selection of Citrus cultivars displaying low coumarin and furanocoumarin contents constitutes a valuable alternative. In this study, we performed ultra-performance liquid chromatography coupled with mass spectrometry analyses to determine the contents of these compounds within the peel and the pulp of 61 Citrus species representative of the genetic diversity all Citrus. Generally, Citrus peel contains larger diversity and higher concentrations of coumarin/furanocoumarin than the pulp of the same fruits. According to the chemotypes found in the peel, Citrus species can be separated into 4 groups that correspond to the 4 ancestral taxa (pummelos, mandarins, citrons and papedas) and extended with their respective secondary species descendants. Three of the 4 ancestral taxa (pummelos, citrons and papedas) synthesize high amounts of these compounds, whereas mandarins appear practically devoid of them. Additionally, all ancestral taxa and their hybrids are logically organized according to the coumarin and furanocoumarin pathways described in the literature. This organization allows hypotheses to be drawn regarding the biosynthetic origin of compounds for which the biogenesis remains unresolved. Determining coumarin and furanocoumarin contents is also helpful for hypothesizing the origin of Citrus species for which the phylogeny is presently not firmly established. Finally, this work also notes favorable hybridization schemes that will lead to low coumarin and furanocoumarin contents, and we propose to select mandarins and Ichang papeda as Citrus varieties for use in creating species devoid of these toxic compounds in future breeding programs.	[Dugrand-Judek, Audray; Olry, Alexandre; Hehn, Alain; Bourgaud, Frederic] Univ Lorraine, UMR 1121, Lab Agron & Environm Nancy Colmar, 2 Ave Foret de Haye,TSA 40602, F-54518 Vandoeuvre Les Nancy, France; [Dugrand-Judek, Audray; Olry, Alexandre; Hehn, Alain; Bourgaud, Frederic] Univ Lorraine, INRA, UMR 1121, Lab Agron & Environm Nancy Colmar, F-54518 Vandoeuvre Les Nancy, France; [Costantino, Gilles] INRA, UMR AGAP, Stn INRA, F-20230 San Giuliano, France; [Ollitrault, Patrick] Inst Valenciano Invest Agr, Ctr Protecc Vegetal & Biotecnol, Valencia 46113, Spain; [Ollitrault, Patrick] CIRAD, UMR AGAP, Stn Roujol, F-97170 Petit Bourg, Guadeloupe, France; [Froelicher, Yann] CIRAD, UMR AGAP, Stn INRA, F-20230 San Giuliano, France	Universite de Lorraine; INRAE; Universite de Lorraine; INRAE; Instituto Valenciano de Investigaciones Agrarias (IVIA); CIRAD; CIRAD; INRAE	Bourgaud, F (corresponding author), Univ Lorraine, UMR 1121, Lab Agron & Environm Nancy Colmar, 2 Ave Foret de Haye,TSA 40602, F-54518 Vandoeuvre Les Nancy, France.	froelicher@cirad.fr; frederic.bourgaud@univ-lorraine.fr		Bourgaud, Frederic/0000-0002-9898-2625; Hehn, Alain/0000-0003-4507-8031; Dugrand-Judek, Audray/0000-0001-6951-8244; Ollitrault, Patrick/0000-0002-9456-5517				Bailey DG, 2013, CAN MED ASSOC J, V185, P309, DOI 10.1503/cmaj.120951; BAILEY DG, 1991, LANCET, V337, P268, DOI 10.1016/0140-6736(91)90872-M; Barkley NA, 2006, THEOR APPL GENET, V112, P1519, DOI 10.1007/s00122-006-0255-9; BERENBAUM MR, 1991, J CHEM ECOL, V17, P207, DOI 10.1007/BF00994434; Bourgaud F., 2006, Phytochemistry Reviews, V5, P293, DOI 10.1007/s11101-006-9040-2; Bourgaud F, 1992, EUR J AGRON, V1, P37; Buscemi S, 2012, AM J CLIN NUTR, V95, P1089, DOI 10.3945/ajcn.111.031088; Calka O, 2005, CONTACT DERMATITIS, V53, P58, DOI 10.1111/j.0105-1873.2005.0456e.x; Carbonell-Caballero J, 2015, MOL BIOL EVOL, V32, P2015, DOI 10.1093/molbev/msv082; Colombain M, 2001, PLANTA MED, V67, P644, DOI 10.1055/s-2001-17364; Curk F, 2014, CITRUS GENE POOL ORG; Curk F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125628; Dugrand A, 2013, J AGR FOOD CHEM, V61, P10677, DOI 10.1021/jf402763t; Durand-Hulak M, 2015, ANN BOT-LONDON, V115, P861, DOI 10.1093/aob/mcv012; Federici CT, 1998, THEOR APPL GENET, V96, P812, DOI 10.1007/s001220050807; Froelicher Y, 2011, TREE GENET GENOMES, V7, P49, DOI 10.1007/s11295-010-0314-x; Fujita T, 2008, BIOL PHARM BULL, V31, P925, DOI 10.1248/bpb.31.925; Garcia-Lor A, 2013, ANN BOT-LONDON, V111, P1, DOI 10.1093/aob/mcs227; Gmitter F. G. Jr., 2007, Fruits and nuts, P265; Gravot A, 2004, ARCH BIOCHEM BIOPHYS, V422, P71, DOI 10.1016/j.abb.2003.12.013; Groppo M, 2008, AM J BOT, V95, P985, DOI 10.3732/ajb.2007313; Hwang SL, 2012, J AGR FOOD CHEM, V60, P877, DOI 10.1021/jf204452y; Karamat F, 2014, PLANT J, V77, P627, DOI 10.1111/tpj.12409; Larbat R, 2007, J BIOL CHEM, V282, P542, DOI 10.1074/jbc.M604762200; Larbat R, 2009, J BIOL CHEM, V284, P4776, DOI 10.1074/jbc.M807351200; Li HX, 2015, PLANT PHYSIOL, V167, P650, DOI 10.1104/pp.114.253682; Lin HL, 2012, DRUG METAB DISPOS, V40, P998, DOI 10.1124/dmd.112.044560; Liu YQ, 2012, COMPR REV FOOD SCI F, V11, P530, DOI 10.1111/j.1541-4337.2012.00201.x; Messer A, 2012, FOOD CHEM TOXICOL, V50, P756, DOI 10.1016/j.fct.2011.11.023; Munakata R, 2014, PLANT PHYSIOL, V166, P80, DOI 10.1104/pp.114.246892; Myung K, 2008, J AGR FOOD CHEM, V56, P12064, DOI 10.1021/jf802713g; Nicolosi E, 2000, THEOR APPL GENET, V100, P1155, DOI 10.1007/s001220051419; Ohta T, 2002, TETRAHEDRON, V58, P6631, DOI 10.1016/S0040-4020(02)00739-1; Ollitrault P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-13; Paine MF, 2005, J PHARMACOL EXP THER, V312, P1151, DOI 10.1124/jpet.104.076836; PATHAK MA, 1960, J INVEST DERMATOL, V35, P165, DOI 10.1038/jid.1960.101; Praloran J-C, 1971, CITRUS; Raquet N, 2014, FOOD CHEM TOXICOL, V68, P257, DOI 10.1016/j.fct.2014.03.014; Robl M, 2013, ARCH DIS CHILD, V98, P915, DOI 10.1136/archdischild-2013-304407; Sasaki K, 2008, PLANT PHYSIOL, V146, P1075, DOI 10.1104/pp.107.110544; Sasaki K, 2011, J BIOL CHEM, V286, P24125, DOI 10.1074/jbc.M111.244426; Swingle W T, 1967, CITRUS IND, P190; Tanaka T., 1977, STUD CITROG, V14, P1; UNCTAD, 2011, CITR CONS; VanderMolen KM, 2013, PHYTOCHEM ANALYSIS, V24, P654, DOI 10.1002/pca.2449; Vialart Guilhem, 2012, Plant J, V70, P460, DOI 10.1111/j.1365-313X.2011.04879.x; Voo SS, 2012, PLANT PHYSIOL, V159, P81, DOI 10.1104/pp.112.194233; Wangensteen H, 2003, EUR J CLIN PHARMACOL, V58, P663, DOI 10.1007/s00228-002-0537-3; Wilkinson GR, 2005, NEW ENGL J MED, V352, P2211, DOI 10.1056/NEJMra032424; Wu GA, 2014, NAT BIOTECHNOL, V32, P656, DOI 10.1038/nbt.2906; Xu J, 2015, FOOD CHEM, V187, P75, DOI 10.1016/j.foodchem.2015.04.007	53	69	72	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142757	10.1371/journal.pone.0142757	http://dx.doi.org/10.1371/journal.pone.0142757			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558757	Green Published, gold			2022-12-26	WOS:000364433100120
J	Gorges, M; Muller, HP; Lule, D; Del Tredici, K; Brettschneider, J; Keller, J; Pfandl, K; Ludolph, AC; Kassubek, J; Pinkhardt, EH				Gorges, Martin; Mueller, Hans-Peter; Lule, Dorothee; Del Tredici, Kelly; Brettschneider, Johannes; Keller, Juergen; Pfandl, Katharina; Ludolph, Albert C.; Kassubek, Jan; Pinkhardt, Elmar H.			Eye Movement Deficits Are Consistent with a Staging Model of pTDP-43 Pathology in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; OCULOMOTOR FUNCTION; PARKINSONS-DISEASE; ABNORMALITIES; SACCADES; IMPAIRMENTS; CRITERIA; ALS	Background The neuropathological process underlying amyotrophic lateral sclerosis (ALS) can be traced as a four-stage progression scheme of sequential corticofugal axonal spread. The examination of eye movement control gains deep insights into brain network pathology and provides the opportunity to detect both disturbance of the brainstem oculomotor circuitry as well as executive deficits of oculomotor function associated with higher brain networks. Objective To study systematically oculomotor characteristics in ALS and its underlying network pathology in order to determine whether eye movement deterioration can be categorized within a staging system of oculomotor decline that corresponds to the neuropathological model. Methods Sixty-eight ALS patients and 31 controls underwent video-oculographic, clinical and neuropsychological assessments. Results Oculomotor examinations revealed increased anti-and delayed saccades' errors, gazepalsy and a cerebellary type of smooth pursuit disturbance. The oculomotor disturbances occurred in a sequential manner: Stage 1, only executive control of eye movements was affected. Stage 2 indicates disturbed executive control plus 'genuine' oculomotor dysfunctions such as gaze-paly. We found high correlations (p<0.001) between the oculomotor stages and both, the clinical presentation as assessed by the ALS Functional Rating Scale (ALSFRS) score, and cognitive scores from the Edinburgh Cognitive and Behavioral ALS Screen (ECAS). Conclusions Dysfunction of eye movement control in ALS can be characterized by a two-staged sequential pattern comprising executive deficits in Stage 1 and additional impaired infratentorial oculomotor control pathways in Stage 2. This pattern parallels the neuropathological staging of ALS and may serve as a technical marker of the neuropathological spreading.	[Gorges, Martin; Mueller, Hans-Peter; Lule, Dorothee; Keller, Juergen; Pfandl, Katharina; Ludolph, Albert C.; Kassubek, Jan; Pinkhardt, Elmar H.] Univ Ulm, Dept Neurol, D-89069 Ulm, Germany; [Del Tredici, Kelly] Univ Ulm, Dept Neurol, Sect Clin Neuroanat, D-89069 Ulm, Germany; [Brettschneider, Johannes] Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA	Ulm University; Ulm University; University of Pennsylvania; Pennsylvania Medicine	Pinkhardt, EH (corresponding author), Univ Ulm, Dept Neurol, D-89069 Ulm, Germany.	elmar.pinkhardt@uni-ulm.de	Del Tredici, Kelly/AAT-1286-2020; Kassubek, Jan/O-1740-2019; Kassubek, Jan/F-2774-2015; Kassubek, Jan/GPX-0910-2022	Del Tredici, Kelly/0000-0002-9130-7838; Kassubek, Jan/0000-0002-7106-9270; Kassubek, Jan/0000-0002-7106-9270; Kassubek, Jan/0000-0002-7106-9270	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [LU 336/15-1]; German Network for Motor Neuron Diseases [BMBF 01GM1103A]	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); German Network for Motor Neuron Diseases	This study was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG Grant Number LU 336/15-1) and the German Network for Motor Neuron Diseases (BMBF 01GM1103A).	Anderson TJ, 2013, NAT REV NEUROL, V9, P74, DOI 10.1038/nrneurol.2012.273; Boxer AL, 2012, ARCH NEUROL-CHICAGO, V69, P509, DOI 10.1001/archneurol.2011.1021; Braak H, 2013, NAT REV NEUROL, V9, P708, DOI 10.1038/nrneurol.2013.221; Brettschneider J, 2013, ANN NEUROL, V74, P20, DOI 10.1002/ana.23937; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Burrell JR, 2013, AMYOTROPH LAT SCL FR, V14, P294, DOI 10.3109/21678421.2013.783077; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Chen Athena L, 2010, Front Neurol, V1, P147, DOI 10.3389/fneur.2010.00147; Donaghy C, 2011, J NEUROL NEUROSUR PS, V82, P110, DOI 10.1136/jnnp.2010.212407; Donaghy C, 2010, J NEUROL, V257, P1134, DOI 10.1007/s00415-010-5478-7; Douaud G, 2011, BRAIN, V134, P3467, DOI 10.1093/brain/awr279; Fukushima K, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00004; Garbutt S, 2008, BRAIN, V131, P1268, DOI 10.1093/brain/awn047; Gorges M, 2015, BRAIN IMAGI IN PRESS; Gorges M, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/658243; Gorges M, 2013, BRAIN CONNECT, V3, P265, DOI 10.1089/brain.2013.0146; JACOBS L, 1981, NEUROLOGY, V31, P1282, DOI 10.1212/WNL.31.10.1282; Kassubek J, 2011, UNCOMMON CAUSES MOVE, P306; Kassubek J, 2014, BRAIN, V137, P1733, DOI 10.1093/brain/awu090; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Koval MJ, 2011, J NEUROSCI, V31, P8659, DOI 10.1523/JNEUROSCI.1258-11.2011; Krauzlis RJ, 2004, J NEUROPHYSIOL, V91, P591, DOI 10.1152/jn.00801.2003; Lule D, 2015, AMYOTROPH LAT SCL FR, V16, P16, DOI 10.3109/21678421.2014.959451; MARTIFABREGAS J, 1993, J NEUROL, V240, P475, DOI 10.1007/BF00874116; Menke RAL, 2014, BRAIN, V137, P2546, DOI 10.1093/brain/awu162; Meyniel C, 2005, J NEUROL NEUROSUR PS, V76, P1581, DOI 10.1136/jnnp.2004.060392; Moss HE, 2012, J NEUROL SCI, V314, P97, DOI 10.1016/j.jns.2011.10.016; Peltsch A, 2011, NEUROBIOL AGING, V32, P669, DOI 10.1016/j.neurobiolaging.2009.04.001; Pierrot-Deseilligny C, 2004, CURR OPIN NEUROL, V17, P17, DOI 10.1097/00019052-200402000-00005; Pinkhardt EH, 2014, J NEUROL, V261, P791, DOI 10.1007/s00415-014-7275-1; Pinkhardt EH, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-5; Pinkhardt EH, 2011, PARKINSONISM RELAT D, V17, P223, DOI 10.1016/j.parkreldis.2010.08.004; Pinkhardt EH, 2009, J NEUROL, V256, P1438, DOI 10.1007/s00415-009-5131-5; Pinkhardt EH, 2008, J NEUROL, V255, P1916, DOI 10.1007/s00415-009-0027-y; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Rub U, 2001, VISION RES, V41, P2149, DOI 10.1016/S0042-6989(01)00090-6; Schneider E, 2009, ANN NY ACAD SCI, V1164, P461, DOI 10.1111/j.1749-6632.2009.03858.x; Sharika KM, 2013, P NATL ACAD SCI USA, V110, pE1311, DOI 10.1073/pnas.1210492110; Sharma R, 2011, ARCH NEUROL-CHICAGO, V68, P857, DOI 10.1001/archneurol.2011.130; SHAUNAK S, 1995, ANN NEUROL, V38, P38, DOI 10.1002/ana.410380109; Sparks DL, 2002, NAT REV NEUROSCI, V3, P952, DOI 10.1038/nrn986; Stuphorn V, 2006, NAT NEUROSCI, V9, P925, DOI 10.1038/nn1714; Terao Y, 2011, NEUROPSYCHOLOGIA, V49, P1794, DOI 10.1016/j.neuropsychologia.2011.03.002; Thakkar KN, 2014, J NEUROSCI, V34, P8918, DOI 10.1523/JNEUROSCI.0732-14.2014; Turner MR, 2005, BRAIN, V128, P1323, DOI 10.1093/brain/awh509; Van der Hulst E-J, 2014, J NEUROL NEUROSURG P	46	33	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142546	10.1371/journal.pone.0142546	http://dx.doi.org/10.1371/journal.pone.0142546			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559944	Green Published, Green Submitted, gold			2022-12-26	WOS:000364433100088
J	Kotonska-Feiga, J; Dobicki, W; Pokorny, P; Nowacki, W				Kotonska-Feiga, Julia; Dobicki, Wojciech; Pokorny, Przemyslaw; Nowacki, Wojciech			The Activity of Neutral alpha-Glucosidase and Selected Biochemical Parameters in the Annual Cycle of Breeding Carp (Cyprinus carpio L.)	PLOS ONE			English	Article							COMMON CARP; EPIDIDYMIS; ENZYMES; MUSCLE; SEMEN; SERUM; MEN; DNA	The aim of the study was to demonstrate seasonal changes in the hydrolytic and transferase activity of neutral alpha-glucosidase, the level of glucose, cholesterol, triglycerides and total protein in the annual breeding cycle of the carp. The study was conducted on fish from a fish farm in Lower Silesia (Poland). Blood serum was collected from the heart in: June, September and December of two consecutive years. The results of the study show that the hydrolytic and transferase activity of neutral alpha-glucosidase, as well as the results of basic biochemical parameters are highest in summer, when the fish seek and intake food intensively. The lowest values were observed in spring, when carp have the lowest metabolism after the wintering period.	[Kotonska-Feiga, Julia; Dobicki, Wojciech; Pokorny, Przemyslaw] Wroclaw Univ Environm & Life Sci, Dept Hydrobiol & Aquaculture, Inst Biol, Wroclaw, Poland; [Nowacki, Wojciech] Wroclaw Univ Environm & Life Sci, Dept Immunol Pathophysiol & Vet Prevent Med, Wroclaw, Poland	Wroclaw University of Environmental & Life Sciences; Wroclaw University of Environmental & Life Sciences	Kotonska-Feiga, J (corresponding author), Wroclaw Univ Environm & Life Sci, Dept Internal Med, Wroclaw, Poland.	julia.kotonska-feiga@up.wroc.pl	Dobicki, Wojciech/S-8193-2016; Dobicki, Wojciech/T-3374-2019; Pokorny, Przemysław/A-1833-2017	Pokorny, Przemyslaw/0000-0002-3816-7848; Dobicki, Wojciech/0000-0003-4081-0537; Nowacki, Wojciech/0000-0002-8304-0686	Wroclaw Centre of Biotechnology; programme the Leading National Research Centre (KNOW)	Wroclaw Centre of Biotechnology; programme the Leading National Research Centre (KNOW)	Publication was supported by Wroclaw Centre of Biotechnology, programme the Leading National Research Centre (KNOW) for years 2014-2018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayir Abdulkadir, 2007, Comparative Clinical Pathology, V16, P119, DOI 10.1007/s00580-006-0663-x; Chiba S, 1997, BIOSCI BIOTECH BIOCH, V61, P1233, DOI 10.1271/bbb.61.1233; Chiba S, 1988, HDB AMYLASES RELATED, P104; Elzanaty S, 2002, HUM REPROD, V17, P2904, DOI 10.1093/humrep/17.11.2904; Henkel R, 2006, J ANDROL, V27, P34, DOI 10.2164/jandrol.05064; Jan U, 2012, REP OPINION, V4, P1; KARPIAK S, 1977, ARCH IMMUNOL THER EX, V25, P199; KOTONSKI B, 1982, Polskie Archiwum Weterynaryjne, V23, P65; KOTONSKI B, 1986, FOLIA HISTOCHEM CYTO, V24, P15; KOTONSKI B, 1984, Polskie Archiwum Weterynaryjne, V24, P79; Levrant S, 2009, SYST BIOL REPROD MED, V55, P116, DOI 10.1080/19396360902801935; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MADEJ J M, 1991, Archivum Immunologiae et Therapiae Experimentalis, V39, P309; Mahmoud AM, 1998, HUM REPROD, V13, P591, DOI 10.1093/humrep/13.3.591; MARTINIUK F, 1981, BIOCHIM BIOPHYS ACTA, V658, P248, DOI 10.1016/0005-2744(81)90295-3; MELOTTI P, 1989, J APPL ICHTHYOL, V5, P74, DOI 10.1111/j.1439-0426.1989.tb00476.x; Nomenclature Committee of the International Union of Biochemistry and Molecular Biology (NC IUBMB), ENZ NOM REC NOM COMM; Patriche T., 2011, AACL Bioflux, V4, P137; Pena P, 2004, ANDROLOGIA, V36, P315, DOI 10.1111/j.1439-0272.2004.00625.x; Shimeno S, 1997, AQUACULTURE, V151, P371, DOI 10.1016/S0044-8486(96)01492-5; SOBIECH K A, 1986, Polskie Archiwum Weterynaryjne, V26, P49; Vivas-Acevedo G, 2014, BJU INT, V113, P642, DOI 10.1111/bju.12523; Watanabe M, 2009, ANDROLOGIA, V41, P316, DOI 10.1111/j.1439-0272.2009.00950.x; YEUNG CH, 1990, BIOL REPROD, V42, P669, DOI 10.1095/biolreprod42.4.669; Zopfgen A, 2000, HUM REPROD, V15, P840, DOI 10.1093/humrep/15.4.840	25	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142227	10.1371/journal.pone.0142227	http://dx.doi.org/10.1371/journal.pone.0142227			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559406	Green Submitted, gold, Green Published			2022-12-26	WOS:000364433100064
J	Ryan, EB; Fraser, D; Weary, DM				Ryan, E. B.; Fraser, D.; Weary, D. M.			Public Attitudes to Housing Systems for Pregnant Pigs	PLOS ONE			English	Article							MEAT QUALITY; MOTIVATION; BEHAVIOR; WELFARE; PERFORMANCE; INFORMATION; RESPONSES; ANIMALS	Understanding concerns about the welfare of farm animals is important for the development of socially sustainable production practices. This study used an online survey to test how views on group versus stall housing for pregnant sows varied when Canadian and US participants were provided information about these systems, including access to scientific papers, YouTube videos, Google images, and a frequently-asked-questions page (S1 Appendix). Initial responses and changes in responses after accessing the information were analyzed from Likert scores of 242 participants and from their written comments. Participants were less willing to accept the use of gestation stalls after viewing information on sow housing. For example, initially 30.4% of respondents indicated that they supported the use of gestation stalls; this declined to 17.8% after participants were provided additional information. Qualitative analysis of comments showed that supporters of gestation stalls expressed concern about the spread of disease and aggression between animals in less confined systems, whereas supporters of group housing placed more emphasis on the sow's ability to interact socially and perform natural behaviors. These results point to public opposition to the use of gestation stalls, and indicate that the more that the public learns about gestation stalls the less willing they will be to accept their use.	[Ryan, E. B.; Fraser, D.; Weary, D. M.] Univ British Columbia, Fac Land & Food Syst, Anim Welf Program, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Weary, DM (corresponding author), Univ British Columbia, Fac Land & Food Syst, Anim Welf Program, Vancouver, BC V5Z 1M9, Canada.	danweary@mail.ubc.ca	Weary, Daniel M/A-8868-2010	Weary, Daniel M/0000-0002-0917-3982	Mary and David Macaree Graduate Fellowship	Mary and David Macaree Graduate Fellowship	This project was funded by the Mary and David Macaree Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguinaldo JP, 2004, RETHINKING VALIDITY, V9, P127; Ahmad R., 2006, INTEGRATED ASSESSMEN, V6, P9; Appleby Mike., 1999, WHAT SHOULD WE DO AN; Boissy A, 2007, PHYSIOL BEHAV, V92, P375, DOI 10.1016/j.physbeh.2007.02.003; Boogaard BK, 2011, ANIMAL, V5, P1458, DOI 10.1017/S1751731111000371; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Coffey A, 1996, MAKING SENSE QUALITA; Croney CC, 2010, J ANIM SCI, V88, pE75, DOI 10.2527/jas.2009-2353; Danielson P, 2010, ETHICS INF TECHNOL, V12, P251, DOI 10.1007/s10676-009-9214-x; Elmore MRP, 2011, APPL ANIM BEHAV SCI, V133, P154, DOI 10.1016/j.applanim.2011.05.017; Frewer L., 2002, SCI PUBLIC POLICY, V29, P137, DOI DOI 10.3152/147154302781781092; Gonyou HW, 2005, JAVMA-J AM VET MED A, V226, P1336, DOI 10.2460/javma.2005.226.1336; Jonas E, 2001, J PERS SOC PSYCHOL, V80, P557, DOI 10.1037/0022-3514.80.4.557; Kanis E, 2003, J AGR ENVIRON ETHIC, V16, P137, DOI 10.1023/A:1022985913847; Kirkden RD, 2006, ANIM WELFARE, V15, P119; Kirkden RD, 2006, APPL ANIM BEHAV SCI, V100, P29, DOI 10.1016/j.applanim.2006.04.009; Krystallis A, 2009, LIVEST SCI, V126, P46, DOI 10.1016/j.livsci.2009.05.016; Lassen J, 2006, LIVEST SCI, V103, P221, DOI 10.1016/j.livsci.2006.05.008; Lemire M, 2008, INT J MED INFORM, V77, P723, DOI 10.1016/j.ijmedinf.2008.03.002; Millet S, 2005, J SCI FOOD AGR, V85, P709, DOI 10.1002/jsfa.2033; Moon A, 2012, INT J SOC ROBOT, V4, P77, DOI 10.1007/s12369-011-0120-0; Morrison RS, 2007, APPL ANIM BEHAV SCI, V103, P12, DOI 10.1016/j.applanim.2006.04.002; Noy C, 2008, INT J SOC RES METHOD, V11, P327, DOI 10.1080/13645570701401305; Onwuegbuzie A.J., 2009, INT J QUALITATIVE ME, V8, P1, DOI [10.1177/160940690900800301, DOI 10.1177/160940690900800301]; Pajor EA, 2005, JAVMA-J AM VET MED A, V226, P1340, DOI 10.2460/javma.2005.226.1340; Rhodes RT, 2005, JAVMA-J AM VET MED A, V227, P1580, DOI 10.2460/javma.2005.227.1580; Schuppli CA, 2014, J ANIM SCI, V92, P5185, DOI 10.2527/jas.2014-7725; Sorensen JT, 2010, LIVEST SCI, V131, P1, DOI 10.1016/j.livsci.2010.02.025; Tashakkori A, 2003, J MARKETING RES JMR; Tonsor G. T., 2009, Journal of Agricultural and Applied Economics, V41, P713; Tonsor GT, 2012, AM J AGR ECON, V94, P503, DOI 10.1093/ajae/aar078; Tversky B, 2002, INT J HUM-COMPUT ST, V57, P247, DOI 10.1006/ijhc.1017; Vanhonacker F, 2009, LIVEST SCI, V123, P16, DOI 10.1016/j.livsci.2008.09.023; Ventura BA, 2013, J DAIRY SCI, V96, P6105, DOI 10.3168/jds.2012-6040; Verbeke W, 1999, FOOD QUAL PREFER, V10, P437, DOI 10.1016/S0950-3293(99)00031-2; Weary DM, 2011, J ANIM SCI, V89, P3831, DOI 10.2527/jas.2011-3858	36	34	34	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141878	10.1371/journal.pone.0141878	http://dx.doi.org/10.1371/journal.pone.0141878			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7DR	26559417	Green Published, Green Submitted, gold			2022-12-26	WOS:000364433100044
J	Santos, N; Santos, C; Valente, T; Gortazar, C; Almeida, V; Correia-Neves, M				Santos, Nuno; Santos, Catarina; Valente, Teresa; Gortazar, Christian; Almeida, Virgillo; Correia-Neves, Margarida			Widespread Environmental Contamination with Mycobacterium tuberculosis Complex Revealed by a Molecular Detection Protocol	PLOS ONE			English	Article							TO-DEER TRANSMISSION; BOAR SUS-SCROFA; BOVIS INFECTION; EPIDEMIOLOGY; PCR; DNA; WILDLIFE	Environmental contamination with Mycobacterium tuberculosis complex (MTC) has been considered crucial for bovine tuberculosis persistence in multi-host-pathogen systems. However, MTC contamination has been difficult to detect due to methodological issues. In an attempt to overcome this limitation we developed an improved protocol for the detection of MTC DNA. MTC DNA concentration was estimated by the Most Probable Number (MPN) method. Making use of this protocol we showed that MTC contamination is widespread in different types of environmental samples from the Iberian Peninsula, which supports indirect transmission as a contributing mechanism for the maintenance of bovine tuberculosis in this multi-host-pathogen system. The proportion of MTC DNA positive samples was higher in the bovine tuberculosis-infected than in presumed negative area (0.32 and 0.18, respectively). Detection varied with the type of environmental sample and was more frequent in sediment from dams and less frequent in water also from dams (0.22 and 0.05, respectively). The proportion of MTC-positive samples was significantly higher in spring (p<0.001), but MTC DNA concentration per sample was higher in autumn and lower in summer. The average MTC DNA concentration in positive samples was 0.82 MPN/g (CI95 0.70-0.98 MPN/g). We were further able to amplify a DNA sequence specific of Mycobacterium bovis/caprae in 4 environmental samples from the bTB-infected area.	[Santos, Nuno; Santos, Catarina; Correia-Neves, Margarida] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Santos, Nuno; Santos, Catarina; Correia-Neves, Margarida] PT Govt Associate Lab, ICVS 3Bs, Braga, Portugal; [Valente, Teresa] Univ Minho, Dept Earth Sci, Pole Univ Minho, Earth Sci Inst ICT, Braga, Portugal; [Gortazar, Christian] Natl Wildlife Res Inst CSIC UCLM JCCM, IREC, SaBio Hlth & Biotechnol, Ciudad Real, Spain; [Almeida, Virgillo] Univ Lisboa FMV ULisboa, Fac Med Vet, Ctr Invest Interdisciplinar Sanidade Anim CIISA, Lisbon, Portugal	Universidade do Minho; Universidade do Minho; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Universidade de Lisboa	Santos, N (corresponding author), Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal.	nunosantos@ecsaude.uminho.pt	Correia-Neves, Margarida/AAH-4636-2020; Santos, Nuno/D-6742-2016; Correia-Neves, Margarida/C-9122-2009; Valente, Teresa/M-4688-2013; Gortazar, Christian/E-7918-2012	Correia-Neves, Margarida/0000-0002-2202-5431; Santos, Nuno/0000-0002-1676-107X; Correia-Neves, Margarida/0000-0002-2202-5431; Valente, Teresa/0000-0002-7293-3825; Gortazar, Christian/0000-0003-0012-4006				Adams AP, 2013, APPL ENVIRON MICROB, V79, P6501, DOI 10.1128/AEM.02032-13; AWWA APHA WPCF, 1992, STANDARD METHODS EXA; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Bugalho MN, 2003, FOREST ECOL MANAG, V181, P23, DOI 10.1016/S0378-1127(03)00125-7; Burthe S, 2008, PARASITOLOGY, V135, P309, DOI 10.1017/S0031182007003940; Corner LAL, 2006, VET MICROBIOL, V112, P303, DOI 10.1016/j.vetmic.2005.11.015; Courtenay O, 2006, BIOL LETT-UK, V2, P460, DOI 10.1098/rsbl.2006.0468; Cousins DV, 2003, INT J SYST EVOL MICR, V53, P1305, DOI 10.1099/ijs.0.02401-0; Cunha MV, 2012, RES VET SCI, V92, P225, DOI 10.1016/j.rvsc.2011.03.009; Delahay RJ, 2000, J ANIM ECOL, V69, P428, DOI 10.1046/j.1365-2656.2000.00406.x; Fine Amanda E, 2011, Vet Med Int, V2011, P765430, DOI 10.4061/2011/765430; Ghodbane R, 2014, MICROBIOL-SGM, V160, P496, DOI 10.1099/mic.0.073379-0; Gortazar C, 2012, MAMMAL REV, V42, P193, DOI 10.1111/j.1365-2907.2011.00191.x; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; HIRAISHI A, 1992, LETT APPL MICROBIOL, V15, P210, DOI 10.1111/j.1472-765X.1992.tb00765.x; Humblet MF, 2009, VET RES, V40, DOI 10.1051/vetres/2009033; IPMA, 2014, AGR B; Kaneene JB, 2010, INT J TUBERC LUNG D, V14, P1508; Kukielka E, 2013, PREV VET MED, V112, P213, DOI 10.1016/j.prevetmed.2013.08.008; MORRIS RS, 1994, VET MICROBIOL, V40, P153, DOI 10.1016/0378-1135(94)90053-1; Palmer MV, 2004, AM J VET RES, V65, P1483, DOI 10.2460/ajvr.2004.65.1483; Palmer MV, 2004, J WILDLIFE DIS, V40, P87, DOI 10.7589/0090-3558-40.1.87; Palmer MV, 2001, AM J VET RES, V62, P692, DOI 10.2460/ajvr.2001.62.692; Peeler J. T., 1992, COMPENDIUM METHODS M, P105; Phillips CJC, 2003, RES VET SCI, V74, P1, DOI 10.1016/S0034-5288(02)00145-5; Pontiroli A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017916; Rivas-Martinez S., 1981, ANALES JARD BOT MADR, V37, P251; Santos N., 2012, EPIDEMIOLOGY INSIGHT; Santos N, 2009, J WILDLIFE DIS, V45, P1048, DOI 10.7589/0090-3558-45.4.1048; Soo PC, 2006, J MICROBIOL METH, V66, P440, DOI 10.1016/j.mimet.2006.01.010; Sweeney FP, 2006, LETT APPL MICROBIOL, V43, P364, DOI 10.1111/j.1472-765X.2006.01983.x; Tanner M, 1999, ONDERSTEPOORT J VET, V66, P185; USDA, 1987, SOIL MEC USDA TEXT C; Warren RM, 2006, INT J TUBERC LUNG D, V10, P818; Welander J, 2000, J ZOOL, V252, P263, DOI 10.1111/j.1469-7998.2000.tb00621.x; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Young JM, 2014, SCI JUSTICE, V54, P238, DOI 10.1016/j.scijus.2014.02.006; Young JS, 2005, APPL ENVIRON MICROB, V71, P1946, DOI 10.1128/AEM.71.4.1946-1952.2005	38	15	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142079	10.1371/journal.pone.0142079	http://dx.doi.org/10.1371/journal.pone.0142079			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26561038	Green Published, Green Submitted, gold			2022-12-26	WOS:000364433100055
J	Yaluri, N; Modi, S; Rodriguez, ML; Stancakova, A; Kuusisto, J; Kokkola, T; Laakso, M				Yaluri, Nagendra; Modi, Shalem; Rodriguez, Maykel Lopez; Stancakova, Alena; Kuusisto, Johanna; Kokkola, Tarja; Laakso, Markku			Simvastatin Impairs Insulin Secretion by Multiple Mechanisms in MIN6 Cells	PLOS ONE			English	Article							CA2+-INDUCED CA2+ RELEASE; PANCREATIC BETA-CELL; PROTEIN-COUPLED RECEPTORS; GLUCAGON-LIKE PEPTIDE-1; CYCLIC-AMP; ACID; CAMP; GPR40; ACETYLCHOLINE; LINE	Statins are widely used in the treatment of hypercholesterolemia and are efficient in the prevention of cardiovascular disease. Molecular mechanisms explaining statin-induced impairment in insulin secretion remain largely unknown. In the current study, we show that simvastatin decreased glucose-stimulated insulin secretion in mouse pancreatic MIN6 beta-cells by 59% and 79% (p<0.01) at glucose concentration of 5.5 mmol/l and 16.7 mmol/l, respectively, compared to control, whereas pravastatin did not impair insulin secretion. Simvastatin induced decrease in insulin secretion occurred through multiple targets. In addition to its established effects on ATP-sensitive potassium channels (p = 0.004) and voltage-gated calcium channels (p = 0.004), simvastatin suppressed insulin secretion stimulated by muscarinic M3 or GPR40 receptor agonists (Tak875 by 33%, p = 0.002; GW9508 by 77%, p = 0.01) at glucose level of 5.5 mmol/l, and inhibited calcium release from the endoplasmic reticulum. Impaired insulin secretion caused by simvastatin treatment were efficiently restored by GPR119 or GLP-1 receptor stimulation and by direct activation of cAMP-dependent signaling pathways with forskolin. The effects of simvastatin treatment on insulin secretion were not affected by the presence of hyperglycemia. Our observation of the opposite effects of simvastatin and pravastatin on glucose-stimulated insulin secretion is in agreement with previous reports showing that simvastatin, but not pravastatin, was associated with increased risk of incident diabetes.	[Yaluri, Nagendra; Modi, Shalem; Rodriguez, Maykel Lopez; Stancakova, Alena; Kuusisto, Johanna; Kokkola, Tarja; Laakso, Markku] Univ Eastern Finland, Inst Clin Med, Internal Med, Fac Hlth Sci, Kuopio, Finland; [Kuusisto, Johanna; Laakso, Markku] Kuopio Univ Hosp, Dept Med, SF-70210 Kuopio, Finland	University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Laakso, M (corresponding author), Univ Eastern Finland, Inst Clin Med, Internal Med, Fac Hlth Sci, Kuopio, Finland.	markku.laakso@kuh.fi	Kokkola, Tarja/E-4526-2011; Stancakova, Alena/AAN-6723-2020; yaluri, nagendra/AAN-9377-2020	Kokkola, Tarja/0000-0002-3303-3912; Stancakova, Alena/0000-0002-1375-0252; Lopez Rodriguez, Maykel/0000-0002-6302-8452	Academy of Finland; Finnish Diabetes Research Foundation; University of Eastern Finland	Academy of Finland(Academy of Finland); Finnish Diabetes Research Foundation; University of Eastern Finland	This work was supported by the Academy of Finland (AS and ML), the Finnish Diabetes Research Foundation (ML), and Strategic Research Funding from the University of Eastern Finland (ML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Academy of Finland (A.S. and M.L.), the Finnish Diabetes Research Foundation (M.L.), and Strategic Research Funding from the University of Eastern Finland (M.L.). The Biocentre Finland imaging facility MUIC at the University of Eastern Finland was used for the calcium imaging work. No potential conflicts of interest relevant to this article were reported.	Ahren B, 2009, NAT REV DRUG DISCOV, V8, P369, DOI 10.1038/nrd2782; Alquier T, 2009, DIABETES, V58, P2607, DOI 10.2337/db09-0362; AMMALA C, 1993, NATURE, V363, P356, DOI 10.1038/363356a0; Aoyagi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047381; Blad CC, 2012, NAT REV DRUG DISCOV, V11, P603, DOI 10.1038/nrd3777; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Cederberg H, 2015, DIABETOLOGIA, V58, P1109, DOI 10.1007/s00125-015-3528-5; Chepurny OG, 2009, J BIOL CHEM, V284, P10728, DOI 10.1074/jbc.M900166200; COHEN LH, 1993, BIOCHEM PHARMACOL, V45, P2203, DOI 10.1016/0006-2952(93)90190-8; Doliba NM, 2010, AM J PHYSIOL-ENDOC M, V299, pE475, DOI 10.1152/ajpendo.00072.2010; Doyle ME, 2007, PHARMACOL THERAPEUT, V113, P546, DOI 10.1016/j.pharmthera.2006.11.007; Eliasson L, 2003, J GEN PHYSIOL, V121, P181, DOI 10.1085/jgp.20028707; Feng DD, 2006, ENDOCRINOLOGY, V147, P674, DOI 10.1210/en.2005-0225; Fujiwara K, 2005, AM J PHYSIOL-ENDOC M, V289, pE670, DOI 10.1152/ajpendo.00035.2005; Gautam D, 2006, CELL METAB, V3, P449, DOI 10.1016/j.cmet.2006.04.009; Graves TK, 2003, ENDOCRINOLOGY, V144, P3565, DOI 10.1210/en.2002-0104; Gromada J, 2006, ENDOCRINOLOGY, V147, P672, DOI 10.1210/en.2005-1388; Gromada J, 2004, BASIC CLIN PHARMACOL, V95, P252, DOI 10.1111/j.1742-7843.2004.t01-1-pto950502.x; Henriksbo BD, 2014, DIABETES, V63, P3742, DOI 10.2337/db13-1398; ISLAM MS, 1992, FEBS LETT, V296, P287, DOI 10.1016/0014-5793(92)80306-2; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6; Kang GX, 2005, J PHYSIOL-LONDON, V566, P173, DOI 10.1113/jphysiol.2005.087510; Kang GX, 2001, J PHYSIOL-LONDON, V536, P375, DOI 10.1111/j.1469-7793.2001.0375c.xd; Kelley GG, 2009, ISLETS, V1, P260, DOI 10.4161/isl.1.3.9645; Kowluru A, 2003, AM J PHYSIOL-ENDOC M, V285, pE669, DOI 10.1152/ajpendo.00196.2003; Meloni AR, 2013, DIABETES OBES METAB, V15, P15, DOI 10.1111/j.1463-1326.2012.01663.x; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Nakagaki I, 2000, PFLUG ARCH EUR J PHY, V440, P828, DOI 10.1007/s004240000372; Navarese EP, 2013, AM J CARDIOL, V111, P1123, DOI 10.1016/j.amjcard.2012.12.037; Ning Y, 2008, BRIT J PHARMACOL, V155, P1056, DOI 10.1038/bjp.2008.337; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; Renstrom E, 1997, J PHYSIOL-LONDON, V502, P105, DOI 10.1111/j.1469-7793.1997.105bl.x; Rodriguez-Diaz R, 2011, NAT MED, V17, P888, DOI 10.1038/nm.2371; SARKKINEN ES, 1994, AM J CLIN NUTR, V59, P364, DOI 10.1093/ajcn/59.2.364; Sato K, 2014, BIOORGAN MED CHEM, V22, P1649, DOI 10.1016/j.bmc.2014.01.028; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Seino S, 2009, DIABETES OBES METAB, V11, P180, DOI 10.1111/j.1463-1326.2009.01108.x; Stancakova A, 2009, DIABETES, V58, P1212, DOI 10.2337/db08-1607; Tsuchiya M, 2010, ENDOCRINOLOGY, V151, P4705, DOI 10.1210/en.2010-0623; Vettor R, 2008, J CLIN ENDOCR METAB, V93, P3541, DOI 10.1210/jc.2007-2680; Yada T, 1999, BRIT J PHARMACOL, V126, P1205, DOI 10.1038/sj.bjp.0702397; Yajima H, 1999, DIABETES, V48, P1006, DOI 10.2337/diabetes.48.5.1006; Yaney GC, 2003, DIABETOLOGIA, V46, P1297, DOI 10.1007/s00125-003-1207-4; Zhao YF, 2008, J ENDOCRINOL, V198, P533, DOI 10.1677/JOE-08-0105; Zhou JQ, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/376570	46	30	30	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142902	10.1371/journal.pone.0142902	http://dx.doi.org/10.1371/journal.pone.0142902			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26561346	Green Published, gold, Green Submitted			2022-12-26	WOS:000364433100136
J	Deosarkar, SP; Prabhakarpandian, B; Wang, B; Sheffield, JB; Krynska, B; Kiani, MF				Deosarkar, Sudhir P.; Prabhakarpandian, Balabhaskar; Wang, Bin; Sheffield, Joel B.; Krynska, Barbara; Kiani, Mohammad F.			A Novel Dynamic Neonatal Blood-Brain Barrier on a Chip	PLOS ONE			English	Article							IN-VITRO MODEL; ENDOTHELIAL-CELLS; SHEAR-STRESS; ASTROCYTES INDUCE; PERMEABILITY; RAT; BBB; ADULT; PENETRATION; DISRUPTION	Studies of neonatal neural pathologies and development of appropriate therapeutics are hampered by a lack of relevant in vitro models of neonatal blood-brain barrier (BBB). To establish such a model, we have developed a novel blood-brain barrier on a chip ((BC)-C-3) that comprises a tissue compartment and vascular channels placed side-by-side mimicking the three-dimensional morphology, size and flow characteristics of microvessels in vivo. Rat brain endothelial cells (RBEC) isolated from neonatal rats were seeded in the vascular channels of (BC)-C-3 and maintained under shear flow conditions, while neonatal rat astrocytes were cultured under static conditions in the tissue compartment of the (BC)-C-3. RBEC formed continuous endothelial lining with a central lumen along the length of the vascular channels of (BC)-C-3 and exhibited tight junction formation, as measured by the expression of zonula occludens-1 (ZO-1). ZO-1 expression significantly increased with shear flow in the vascular channels and with the presence of astrocyte conditioned medium (ACM) or astrocytes cultured in the tissue compartment. Consistent with in vivo BBB, (BC)-C-3 allowed endfeet-like astrocyte-endothelial cell interactions through a porous interface that separates the tissue compartment containing cultured astrocytes from the cultured RBEC in the vascular channels. The permeability of fluorescent 40 kDa dextran from vascular channel to the tissue compartment significantly decreased when RBEC were cultured in the presence of astrocytes or ACM (from 41.0 +/- 0.9 x 10(-6) cm/s to 2.9 +/- 1.0 x 10(-6) cm/s or 1.1 +/- 0.4 x 10(-6) cm/s, respectively). Measurement of electrical resistance in (BC)-C-3 further supports that the addition of ACM significantly improves the barrier function in neonatal RBEC. Moreover, (BC)-C-3 exhibits significantly improved barrier characteristics compared to the transwell model and (BC)-C-3 permeability was not significantly different from the in vivo BBB permeability in neonatal rats. In summary, we developed a first dynamic in vitro neonatal BBB on a chip ((BC)-C-3) that closely mimics the in vivo microenvironment, offers the flexibility of real time analysis, and is suitable for studies of BBB function as well as screening of novel therapeutics.	[Deosarkar, Sudhir P.; Wang, Bin; Kiani, Mohammad F.] Temple Univ, Dept Mech Engn, Philadelphia, PA 19122 USA; [Prabhakarpandian, Balabhaskar] CFD Res Corp, Biomed Technol, Huntsville, AL 35806 USA; [Wang, Bin] Widener Univ, Dept Biomed Engn, Chester, PA 19013 USA; [Sheffield, Joel B.] Temple Univ, Dept Biol, Philadelphia, PA 19122 USA; [Krynska, Barbara; Kiani, Mohammad F.] Temple Univ, Shriners Hosp Pediat Res Ctr, Sch Med, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; CFD Research Corporation; Widener University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Shriners Hospitals Children Philadelphia	Kiani, MF (corresponding author), Temple Univ, Dept Mech Engn, Philadelphia, PA 19122 USA.	mkiani@temple.edu			Oak Ridge National Laboratory by the Scientific User Facilities Division, Office of Basic Energy Sciences, U.S. Department of Energy	Oak Ridge National Laboratory by the Scientific User Facilities Division, Office of Basic Energy Sciences, U.S. Department of Energy(United States Department of Energy (DOE))	A portion of this research was conducted at the Center for Nanophase Materials Sciences, which is sponsored at Oak Ridge National Laboratory by the Scientific User Facilities Division, Office of Basic Energy Sciences, U.S. Department of Energy.	Abbott NJ, 2012, METHODS MOL BIOL, V814, P415, DOI 10.1007/978-1-61779-452-0_28; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Arya V, 2006, DRUG METAB DISPOS, V34, P939, DOI 10.1124/dmd.105.007419; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Booth R, 2012, LAB CHIP, V12, P1784, DOI 10.1039/c2lc40094d; Bueter W, 2010, INT J DEV NEUROSCI, V28, P411, DOI 10.1016/j.ijdevneu.2010.04.006; Cecchelli R, 2007, NAT REV DRUG DISCOV, V6, P650, DOI 10.1038/nrd2368; COOMBER BL, 1985, MICROVASC RES, V30, P99, DOI 10.1016/0026-2862(85)90042-1; Cucullo L, 2005, CURR OPIN DRUG DISC, V8, P89; Cucullo L, 2002, BRAIN RES, V951, P243, DOI 10.1016/S0006-8993(02)03167-0; Cucullo L, 2007, EPILEPSIA, V48, P505, DOI 10.1111/j.1528-1167.2006.00960.x; Cucullo L, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-40; Cucullo L, 2011, J CEREBR BLOOD F MET, V31, P767, DOI 10.1038/jcbfm.2010.162; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; Fernandez-Lopez D, 2012, J NEUROSCI, V32, P9588, DOI 10.1523/JNEUROSCI.5977-11.2012; Griep LM, 2013, BIOMED MICRODEVICES, V15, P145, DOI 10.1007/s10544-012-9699-7; He YR, 2014, STROKE, V45, P2514, DOI 10.1161/STROKEAHA.114.005427; Hellinger E, 2012, EUR J PHARM BIOPHARM, V82, P340, DOI 10.1016/j.ejpb.2012.07.020; Helms HC, 2014, METHODS MOL BIOL, V1135, P365, DOI 10.1007/978-1-4939-0320-7_30; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; Kniesel U, 2000, CELL MOL NEUROBIOL, V20, P57, DOI 10.1023/A:1006995910836; Kuchler-Bopp S, 1999, NEUROREPORT, V10, P1347, DOI 10.1097/00001756-199904260-00035; Lamberti G, 2014, ANAL CHEM, V86, P8344, DOI 10.1021/ac5018716; Liu WY, 2015, CNS NEUROSCI THER, V21, P568, DOI 10.1111/cns.12405; MAYHAN WG, 1985, AM J PHYSIOL, V248, pH712, DOI 10.1152/ajpheart.1985.248.5.H712; Mooradian AD, 2003, MECH AGEING DEV, V124, P143, DOI 10.1016/S0047-6374(02)00041-6; Muramatsu K, 1997, STROKE, V28, P2281, DOI 10.1161/01.STR.28.11.2281; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Pardridge William M, 2005, NeuroRx, V2, P3; Pardridge WM, 2005, MOL BIOTECHNOL, V30, P57, DOI 10.1385/MB:30:1:057; Perriere N, 2005, J NEUROCHEM, V93, P279, DOI 10.1111/j.1471-4159.2004.03020.x; Persidsky Y, 2006, J NEUROIMMUNE PHARM, V1, P223, DOI 10.1007/s11481-006-9025-3; Prabhakarpandian B, 2013, LAB CHIP, V13, P1093, DOI 10.1039/c2lc41208j; Redzic Z, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-3; Rosas-Hernandez H, 2015, NEUROSCIENCE, V301, P61, DOI 10.1016/j.neuroscience.2015.05.066; Santaguida S, 2006, BRAIN RES, V1109, P1, DOI 10.1016/j.brainres.2006.06.027; Saunders NR, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00046; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Siddharthan V, 2007, BRAIN RES, V1147, P39, DOI 10.1016/j.brainres.2007.02.029; Stewart PA, 2000, CELL MOL NEUROBIOL, V20, P149, DOI 10.1023/A:1007026504843; Takata F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055166; Takeshita Y, 2014, J NEUROSCI METH, V232, P165, DOI 10.1016/j.jneumeth.2014.05.013; Watson PMD, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-59; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Wuest DM, 2013, J NEUROSCI METH, V212, P211, DOI 10.1016/j.jneumeth.2012.10.016; Yoon BH, 2000, AM J OBSTET GYNECOL, V182, P675, DOI 10.1067/mob.2000.104207; Yuan H, 2003, BRAIN RES, V969, P59, DOI 10.1016/S0006-8993(03)02278-9	48	116	119	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142725	10.1371/journal.pone.0142725	http://dx.doi.org/10.1371/journal.pone.0142725			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555149	Green Published, gold, Green Submitted			2022-12-26	WOS:000364430700160
J	Li, FF; Han, Y; Shi, SA; Li, X; Zhu, XD; Zhou, J; Shao, QL; Li, XQ; Liu, SL				Li, Fei-Feng; Han, Ying; Shi, Shuai; Li, Xia; Zhu, Xi-Dong; Zhou, Jing; Shao, Qing-Liang; Li, Xue-Qi; Liu, Shu-Lin			Characterization of Transcriptional Repressor Gene MSX1 Variations for Possible Associations with Congenital Heart Diseases	PLOS ONE			English	Article							CARDIAC NEURAL CREST; OUTFLOW TRACT; CELL-DIFFERENTIATION; SURVIVAL; DEFECTS; MICROENVIRONMENT; OSTEOARTHRITIS; PROLIFERATION; POLYMORPHISM; POPULATION	Background The human heart consists of several cell types with distinct lineage origins. Interactions between these cardiac progenitors are very important for heart formation. The muscle segment homeobox gene family plays a key role in the cell morphogenesis and growth, controlled cellular proliferation, differentiation, and apoptosis, but the relationships between the genetic abnormalities and CHD phenotypes still remain largely unknown. The aim of this work was to evaluate variations in MSX1 and MSX2 for their possible associations with CHD. Methods We sequenced the MSX1 and MSX2 genes for 300 Chinese Han CHD patients and 400 normal controls and identified the variations. The statistical analyses were conducted using Chi-Square Tests as implemented in SPSS (version 19.0). The Hardy-Weinberg equilibrium test of the population was carried out using the online software OEGE. Results Six variations rs4647952, rs2048152, rs4242182, rs61739543, rs111542301 and rs3087539 were identified in the MSX2 gene, but the genetic heterozygosity of those SNPs was very low. In contrast, the genetic heterozygosity of two variations rs3821949 near the 5'UTR and rs12532 within 3'UTR of the MSX1 gene was considerably high. Statistical analyses showed that rs3821949 and rs12532 were associated with the risk of CHD (specifically VSD). Conclusions The SNPs rs3821949 and rs12532 in the MSX1 gene were associated with CHD in Chinese Han populations.	[Li, Fei-Feng; Li, Xia; Liu, Shu-Lin] Harbin Med Univ, Genom Res Ctr, State Prov Key Lab Biopharmaceut Engn, Harbin, Peoples R China; [Li, Fei-Feng; Liu, Shu-Lin] Heilongjiang Acad Med Sci, Translat Med Res & Cooperat Ctr Northern China, Wuchang, Heilongjiang, Peoples R China; [Han, Ying; Shi, Shuai; Li, Xue-Qi] Harbin Med Univ, Affiliated Hosp 4, Dept Cardiol, Harbin, Peoples R China; [Zhu, Xi-Dong] Harbin Med Univ, Affiliated Hosp 2, Dept Neurol, Harbin, Peoples R China; [Zhou, Jing] Harbin Med Univ, Affiliated Hosp 2, Intens Care Unit, Harbin, Peoples R China; [Shao, Qing-Liang] Harbin Med Univ, Affiliated Hosp 2, Dept Neonatal, Harbin, Peoples R China; [Liu, Shu-Lin] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; University of Calgary	Li, XQ (corresponding author), Harbin Med Univ, Affiliated Hosp 4, Dept Cardiol, Harbin, Peoples R China.	Lixueqi@medmail.com.cn; slliu@ucalgary.ca			Heilongjiang Innovation Research Foundation for Graduate Studies [YJSCX2014-10HYD]; National Natural Science Foundation of China [NSFC81271786, 81110378, 30970119, 81030029]	Heilongjiang Innovation Research Foundation for Graduate Studies; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from Heilongjiang Innovation Research Foundation for Graduate Studies (YJSCX2014-10HYD), and grants of National Natural Science Foundation of China (NSFC81271786, 81110378, 30970119, 81030029) to SLL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosky L, 2006, DEV DYNAM, V235, P2592, DOI 10.1002/dvdy.20885; Belinsky GS, 2013, STEM CELLS DEV, V22, P1522, DOI 10.1089/scd.2012.0150; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Chan AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056831; CHANTHOMAS PS, 1993, DEV DYNAM, V197, P203, DOI 10.1002/aja.1001970305; Chen SG, 2010, BIOCHEM BIOPH RES CO, V391, P552, DOI 10.1016/j.bbrc.2009.11.096; Chen YH, 2007, DEV BIOL, V308, P421, DOI 10.1016/j.ydbio.2007.05.037; Cheng G, 1999, DEVELOPMENT, V126, P5041; Cheong HS, 2010, BMB REP, V43, P830, DOI 10.5483/BMBRep.2010.43.12.830; Christensen BC, 2009, CARCINOGENESIS, V30, P1003, DOI 10.1093/carcin/bgp099; Costa FF, 2009, EPIGENOMICS-UK, V1, P387, DOI 10.2217/EPI.09.25; Deng X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104535; Dvash T, 2007, STEM CELLS, V25, P465, DOI 10.1634/stemcells.2006-0179; Fujimuro T, 2014, SCI REP-UK, V4, DOI 10.1038/srep06462; Han J, 2007, MECH DEVELOP, V124, P729, DOI 10.1016/j.mod.2007.06.006; Hoffman JIE, 2004, AM HEART J, V147, P425, DOI 10.1016/j.ahj.2003.05.003; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Ishii M, 2005, DEVELOPMENT, V132, P4937, DOI 10.1242/dev.02072; Jiang LY, 2013, RHEUMATOL INT, V33, P1763, DOI 10.1007/s00296-012-2593-z; Kebed KY, 2014, MAYO CLIN PROC, V89, P1143, DOI 10.1016/j.mayocp.2014.04.024; Kimura M, 2014, EUR J ORAL SCI, V122, P15, DOI 10.1111/eos.12105; Li FF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131542; Lo CW, 1999, TRENDS CARDIOVAS MED, V9, P63, DOI 10.1016/S1050-1738(99)00015-8; Lou F, 2014, EUR REV MED PHARMACO, V18, P2444; Malchenko S, 2010, J CELL PHYSIOL, V225, P390, DOI 10.1002/jcp.22280; Miller KA, 2008, DEV BIOL, V317, P686, DOI 10.1016/j.ydbio.2008.02.016; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Postovit LM, 2008, P NATL ACAD SCI USA, V105, P4329, DOI 10.1073/pnas.0800467105; Richards AA, 2010, CURR CARDIOL REV, V6, P91, DOI 10.2174/157340310791162703; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; Satokata I, 2000, NAT GENET, V24, P391, DOI 10.1038/74231; Schuldiner M, 2003, METHOD ENZYMOL, V365, P446; Souza LT, 2013, BRAZ J MED BIOL RES, V46, P555, DOI 10.1590/1414-431X20133054; Tabibzadeh S, 2006, STEM CELLS, V24, P1998, DOI 10.1634/stemcells.2006-0075; Tan ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036590; Tosetto E, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-41; van de Laar IMBH, 2011, NAT GENET, V43, P121, DOI 10.1038/ng.744; van der Bom T, 2011, NAT REV CARDIOL, V8, P50, DOI 10.1038/nrcardio.2010.166; van der Linde D, 2012, J AM COLL CARDIOL, V60, P397, DOI 10.1016/j.jacc.2011.12.052; van Driel LMJW, 2008, EUR HEART J, V29, P1424, DOI 10.1093/eurheartj/ehn170; van Weerd JH, 2011, CARDIOVASC RES, V91, P203, DOI 10.1093/cvr/cvr138; Vorotnikova E, 2010, MATRIX BIOL, V29, P690, DOI 10.1016/j.matbio.2010.08.007; Ward C, 2005, DEV BIOL, V284, P72, DOI 10.1016/j.ydbio.2005.05.003; Yelbuz TM, 2002, CIRCULATION, V106, P504, DOI 10.1161/01.CIR.0000023044.44974.8A	46	5	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142666	10.1371/journal.pone.0142666	http://dx.doi.org/10.1371/journal.pone.0142666			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556783	gold, Green Published, Green Submitted			2022-12-26	WOS:000364430700153
J	Lim, JU; Yeo, CD; Rhee, CK; Kim, YH; Park, CK; Kim, JS; Kim, JW; Lee, SH; Kim, SJ; Yoon, HK; Kim, TJ; Lee, KY				Lim, Jeong Uk; Yeo, Chang Dong; Rhee, Chin Kook; Kim, Yong Hyun; Park, Chan Kwon; Kim, Ju Sang; Kim, Jin Woo; Lee, Sang Haak; Kim, Seung Joon; Yoon, Hyoung Kyu; Kim, Tae-Jung; Lee, Kyo Young			Chronic Obstructive Pulmonary Disease-Related Non-Small-Cell Lung Cancer Exhibits a Low Prevalence of EGFR and ALK Driver Mutations	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITORS; COPD; GEFITINIB; ADENOCARCINOMA; IMPACT; NSCLC; GENE; IDENTIFICATION; ASSOCIATION	Lung cancer and chronic obstructive pulmonary disease (COPD) are two major lung diseases. Epidermal growth factor receptor (EGFR) mutations, v-Ki-ras2 Kirsten rat sarcoma (KRAS) mutations and anaplastic lymphoma kinase (ALK) gene rearrangements represent driver mutations that are frequently assessed on initial evaluation of non-small-cell lung cancer (NSCLC). The present study focused on the expression of driver mutations in NSCLC patients presenting with COPD and further evaluated the association between NSCLC and COPD. Data from 501 consecutive patients with histologically proven recurrent or metastatic NSCLC were analyzed retrospectively. The patients underwent spirometry and geno-typing of EGFR, ALK, and KRAS in tissue samples. Patient characteristics and expression of driver mutations were compared between the COPD and non-COPD groups. Among 350 patients with spirometric results, 106 (30.3%) were diagnosed with COPD, 108 (30.9%) had EGFR mutations, 31 (8.9%) had KRAS mutations, and 34 (9.7%) showed ALK rearrangements. COPD was independently associated with lower prevalences of EGFR mutations (95% confidence interval [CI], 0.254-0.931, p = 0.029) and ALK rearrangements (95% CI, 0.065-0.600, p = 0.004). The proportions of EGFR mutations and ALK rearrangements decreased as the severity of airflow obstruction increased (p = 0.001). In never smokers, the prevalence of EGFR mutations was significantly lower in the COPD group than in the non-COPD group (12.7% vs. 49.0%, p = 0.002). COPD-related NSCLC patients exhibited low prevalences of EGFR mutations and ALK rearrangements compared with the non-COPD group. Further studies are required regarding the molecular mechanisms underlying lung cancer associated with COPD.	[Lim, Jeong Uk; Yeo, Chang Dong; Rhee, Chin Kook; Kim, Yong Hyun; Park, Chan Kwon; Kim, Ju Sang; Kim, Jin Woo; Lee, Sang Haak; Kim, Seung Joon; Yoon, Hyoung Kyu] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Pulmonol, Seoul, South Korea; [Kim, Tae-Jung; Lee, Kyo Young] Catholic Univ Korea, Coll Med, Dept Hosp Pathol, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea	Kim, JW (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Div Pulmonol, Seoul, South Korea.	medkjw@catholikc.ac.kr	Rhee, Chin Kook/P-8885-2018; Lim, Jeong Uk/AAI-7281-2020; KIM, JUSANG/AAB-3748-2019	Rhee, Chin Kook/0000-0003-4533-7937; Lim, Jeong Uk/0000-0001-8364-2380; KIM, JUSANG/0000-0002-4433-231X				Adcock IM, 2011, RESPIRATION, V81, P265, DOI 10.1159/000324601; Arteaga CL, 2002, SEMIN ONCOL, V29, P3, DOI 10.1053/sonc.2002.35642; Cerda S, 1997, MUTAT RES-REV MUTAT, V386, P141, DOI 10.1016/S1383-5742(96)00050-6; de Torres JP, 2011, AM J RESP CRIT CARE, V184, P913, DOI 10.1164/rccm.201103-0430OC; De-Torres JP, 2015, AM J RESP CRIT CARE, V191, P285, DOI 10.1164/rccm.201407-1210OC; Dialyna IA, 2003, ONCOL REP, V10, P1829; Fukuchi Y, 2004, RESPIROLOGY, V9, P458, DOI 10.1111/j.1440-1843.2004.00637.x; Gazdar AF, 2004, TRENDS MOL MED, V10, P481, DOI 10.1016/j.molmed.2004.08.008; Gridelli C, 2014, CANCER TREAT REV, V40, P300, DOI 10.1016/j.ctrv.2013.07.002; Hashimoto N, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-14; Hohberger LA, 2014, J THORAC ONCOL, V9, P639, DOI 10.1097/JTO.0000000000000144; Houghton AM, 2008, NAT MED, V14, P1023, DOI 10.1038/nm1008-1023; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kim HR, 2014, LUNG CANCER, V83, P374, DOI 10.1016/j.lungcan.2013.12.011; Kim TJ, 2014, J SURG ONCOL, V110, P245, DOI 10.1002/jso.23646; Lapperre TS, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-85; Leighl NB, 2014, J CLIN ONCOL, V32, P3673, DOI 10.1200/JCO.2014.57.3055; Li Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052093; Loganathan RS, 2006, CHEST, V129, P1305, DOI 10.1378/chest.129.5.1305; Lopez-Encuentra A, 2005, EUR J CARDIO-THORAC, V27, P8, DOI 10.1016/j.ejcts.2004.09.010; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maeda R, 2011, J THORAC ONCOL, V6, P735, DOI 10.1097/JTO.0b013e318208e963; Maki-Nevala S, 2014, J THORAC ONCOL, V9, P886, DOI 10.1097/JTO.0000000000000132; Miller VA, 2004, J CLIN ONCOL, V22, P1103, DOI 10.1200/JCO.2004.08.158; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Roberts PJ, 2013, J CLIN ONCOL, V31, P1112, DOI 10.1200/JCO.2012.43.0454; Scagliotti GV, 2004, CLIN CANCER RES, V10, p4227S, DOI 10.1158/1078-0432.CCR-040007; Schiavon M, 2014, LUNG CANCER, V86, P311, DOI 10.1016/j.lungcan.2014.10.004; Sekine Y, 2002, LUNG CANCER-J IASLC, V37, P95, DOI 10.1016/S0169-5002(02)00014-4; Sekine Y, 2012, EUR RESPIR J, V39, P1230, DOI 10.1183/09031936.00126011; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; SKILLRUD DM, 1986, ANN INTERN MED, V105, P503, DOI 10.7326/0003-4819-105-4-503; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Suzuki M, 2010, ANN SURG ONCOL, V17, P878, DOI 10.1245/s10434-009-0739-3; Takiguchi Y, 2014, WORLD J CLIN ONCOL, V5, P660, DOI 10.5306/wjco.v5.i4.660; Tsao AS, 2006, J THORAC ONCOL, V1, P231, DOI 10.1016/S1556-0864(15)31573-2; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Wilson DO, 2008, AM J RESP CRIT CARE, V178, P738, DOI 10.1164/rccm.200803-435OC; Yeo CD, 2013, LUNG CANCER, V81, P207, DOI 10.1016/j.lungcan.2013.04.023	41	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142306	10.1371/journal.pone.0142306	http://dx.doi.org/10.1371/journal.pone.0142306			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555338	gold, Green Published, Green Submitted			2022-12-26	WOS:000364430700082
J	Park, GT; Sundaramoorthy, J; Lee, JD; Kim, JH; Seo, HS; Song, JT				Park, Gyu Tae; Sundaramoorthy, Jagadeesh; Lee, Jeong-Dong; Kim, Jeong Hoe; Seo, Hak Soo; Song, Jong Tae			Elucidation of Molecular Identity of the W3 Locus and Its Implication in Determination of Flower Colors in Soybean	PLoS One			English	Article							MYB TRANSCRIPTION FACTOR; CIS-REGULATORY ELEMENTS; PURPLE-BLUE FLOWER; GENE-EXPRESSION; SYNTHASE; PIGMENTATION; EVOLUTION; PROMOTER; MUTATION; SEED	The wide range of flower colors in soybean is controlled by six independent loci (W1, W2, W3, W4, Wm, and Wp). Among these loci, mutations in the W3 locus under the w4 allelic background (i.e., w3w4) produce near-white flowers, while the W3w4 genotype produces purple throat flowers. Although a gene encoding dihydroflavonol 4-reductase, DFR1, has been known to be closely associated with the W3 locus, its molecular identity has not yet been characterized. In the present study, we aimed to determine whether DFR1 is responsible for allelic variations in the W3 locus. On the basis of the sequence of a DFR probe, Glyma. 14G072700 was identified as a candidate gene for DFR1, and nucleotide sequences of Glyma. 14G072700 from cultivars with previously validated genotypes for the W3 locus were determined. As a result, a number of nucleotide polymorphisms, mainly single-base substitutions, between both coding and 50-upstream region sequences of the W3 and w3 alleles were identified. Among them, an indel of 311-bp in the 50-upstream region was noteworthy, since the Glyma. 14G072700 in all the w3 alleles examined contained the indel, whereas that in all the W3 alleles did not; the former was barely expressed, but the latter was well expressed. These results suggest that Glyma. 14G072700 is likely to correspond to DFR1 for the W3 locus and that its expression patterns may lead to allelic color phenotypes of W3 and w3 alleles under the w4 allelic background.	[Park, Gyu Tae; Sundaramoorthy, Jagadeesh; Lee, Jeong-Dong; Song, Jong Tae] Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea; [Kim, Jeong Hoe] Kyungpook Natl Univ, Dept Biol, Daegu, South Korea; [Seo, Hak Soo] Seoul Natl Univ, Dept Plant Biosci, Seoul, South Korea	Kyungpook National University; Kyungpook National University; Seoul National University (SNU)	Song, JT (corresponding author), Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea.	jtsong68@knu.ac.kr	Sundaramoorthy, Jagadeesh/O-4027-2017	Sundaramoorthy, Jagadeesh/0000-0002-0748-5800; Song, Jong Tae/0000-0002-2052-6582	"Cooperative Research Program for Agriculture Science & Technology Development" Rural Development Administration, Republic of Korea [PJ01108702]	"Cooperative Research Program for Agriculture Science & Technology Development" Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was carried out with the support of "Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ01108702)" Rural Development Administration, Republic of Korea.	Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; BUZZELL RI, 1987, J HERED, V78, P53, DOI 10.1093/oxfordjournals.jhered.a110309; Buzzell RI, 1982, SOYBEAN GENET NEWSL, V9, P26; Doyle J. J., 1987, PHYTOCHEM B, P11; FASOULA DA, 1995, CROP SCI, V35, P1028, DOI 10.2135/cropsci1995.0011183X003500040017x; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Gowik U, 2004, PLANT CELL, V16, P1077, DOI 10.1105/tpc.019729; HARTWIG EDGAR E., 1962, CROP SCI, V2, P152, DOI 10.2135/cropsci1962.0011183X000200020021x; Iwashina T, 2007, J HERED, V98, P250, DOI 10.1093/jhered/esm012; Kazama Y, 2013, PLANT CELL REP, V32, P11, DOI 10.1007/s00299-012-1336-7; Libault M, 2010, PLANT GENOME, V1, P44; Ma HM, 2009, J AM SOC HORTIC SCI, V134, P88, DOI 10.21273/JASHS.134.1.88; McCarty DR, 1986, MAIZE GENET COOP NEW, V60, P61; Palmer RG., 2004, SOYBEANS IMPROVEMENT, P137, DOI DOI 10.2134/AGRONMONOGR16.3ED.C5; Piluk P., 2012, P 1 MAE FAH LUANG U, P1; Sakai H, 2000, PLANT J, V24, P703, DOI 10.1046/j.1365-313x.2000.00909.x; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Shimada S, 2005, PLANT J, V44, P950, DOI 10.1111/j.1365-313X.2005.02574.x; SHIRSAT A, 1989, MOL GEN GENET, V215, P326, DOI 10.1007/BF00339737; Sundaramoorthy J, 2015, J KOREAN SOC APPL BI, V58, P555, DOI 10.1007/s13765-015-0077-z; Takahashi R, 2008, J HERED, V99, P593, DOI 10.1093/jhered/esn041; Takahashi R, 2007, PLANT MOL BIOL, V63, P125, DOI 10.1007/s11103-006-9077-z; Takahashi R, 2013, J HERED, V104, P149, DOI 10.1093/jhered/ess081; Takahashi R, 2011, J HERED, V102, P458, DOI 10.1093/jhered/esr028; WANG CS, 1994, PLANT PHYSIOL, V105, P739, DOI 10.1104/pp.105.2.739; Wessinger CA, 2012, J EXP BOT, V63, P5741, DOI 10.1093/jxb/ers267; Wittkopp PJ, 2012, NAT REV GENET, V13, P59, DOI 10.1038/nrg3095; Xu M, 2005, GENOME, V48, P334, DOI [10.1139/g04-105, 10.1139/G04-105]; Xu M, 2010, GENETICS, V184, P53, DOI 10.1534/genetics.109.107904; Yan F, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-58; Zabala G, 2005, PLANT CELL, V17, P2619, DOI 10.1105/tpc.105.033506; Zabala G, 2007, PLANT GENOME, V47, P113	32	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142643	10.1371/journal.pone.0142643	http://dx.doi.org/10.1371/journal.pone.0142643			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555888	Green Submitted, gold, Green Published			2022-12-26	WOS:000364430700147
J	Xie, DX; Liu, L; Osaiweran, H; Yu, CR; Sheng, F; Gao, C; Hu, JB; Gong, JP				Xie, Daxing; Liu, Liang; Osaiweran, Hasan; Yu, Chaoran; Sheng, Fang; Gao, Chun; Hu, Junbo; Gong, Jianping			Detection and Characterization of Metastatic Cancer Cells in the Mesogastrium of Gastric Cancer Patients	PLOS ONE			English	Article							RECTAL-CANCER; PROGNOSTIC-SIGNIFICANCE; SYSTEMIC TREATMENT; RECURRENCE; SPREAD; MESORECTUM; SURGERY; ROUTE	Gastric cancer is the second leading cause of cancer death worldwide. Here, we propose a novel type of tumor metastasis designated as Metastasis V in gastric cancer. Metastasis V is defined as the appearance of cancer cells in the mesogastrium with perigastric adipose tissue. To detect its incidence and characterize its clinic pathological features, large cross sectional tissue analysis of mesogastrium from 74 patients were used. Metastasis V was detected in 1 of 40 (2.5%) patients with early gastric cancer, 8 of 34 (24%) patients with advanced gastric cancer. The mean distance of Metastasis V from gastric wall was approximately 2.6 cm. Metastasis V was closely associated with tumor invasion depth, along with a number of positive lymph node metastasis. The prognosis of patients with Metastasis V was significantly (P<0.05) worse than those with tumor cell-free mesogastrium. These findings indicate that by using whole-sectional analysis, Metastasis V can be detected in the mesogastrium of gastric cancer patients, and also suggests that it may be a risk factor for patient survival after radical surgery.	[Xie, Daxing; Liu, Liang; Osaiweran, Hasan; Yu, Chaoran; Sheng, Fang; Gao, Chun; Hu, Junbo; Gong, Jianping] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Tongji Canc Res Inst, Wuhan 430074, Hubei, Peoples R China; [Xie, Daxing; Liu, Liang; Osaiweran, Hasan; Yu, Chaoran; Sheng, Fang; Gao, Chun; Hu, Junbo; Gong, Jianping] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Gastrointestinal Surg, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Xie, DX (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Tongji Canc Res Inst, Wuhan 430074, Hubei, Peoples R China.	dxxie@tjh.tjmu.edu.cn			National Science Foundation of China [81572861, 81201638, 81302309, 81372324]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Science Foundation of China, grant numbers: 81572861; 81201638; 81302309; 81372324.	Dickson JLB, 2004, EUR J GASTROEN HEPAT, V16, P255, DOI 10.1097/10.meg.0000108279.74393.b6; Etoh T, 2006, BRIT J SURG, V93, P369, DOI 10.1002/bjs.5240; HEALD RJ, 1982, BRIT J SURG, V69, P613, DOI 10.1002/bjs.1800691019; Hohenberger W, 2009, COLORECTAL DIS, V11, P354, DOI 10.1111/j.1463-1318.2008.01735.x; Koike H, 2004, SURGERY, V135, P266, DOI 10.1016/j.surg.2003.08.017; Kooby DA, 2003, ANN SURG, V237, P828, DOI 10.1097/00000658-200306000-00011; Menges M, 2009, J CANCER RES CLIN, V135, P29, DOI 10.1007/s00432-008-0425-z; Nagatomo A, 2009, LANGENBECK ARCH SURG, V394, P655, DOI 10.1007/s00423-008-0427-y; Nakamura K, 2005, SURGERY, V137, P511, DOI 10.1016/j.surg.2005.01.007; Otsuji E, 2001, WORLD J SURG, V25, P1373; Tanaka T, 2000, J SURG ONCOL, V75, P165, DOI 10.1002/1096-9098(200011)75:3<165::AID-JSO3>3.0.CO;2-5; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Ueno H, 1998, DIS COLON RECTUM, V41, P55, DOI 10.1007/BF02236896; Virgilio E, 2014, MED HYPOTHESES, V82, P403, DOI 10.1016/j.mehy.2014.01.005; Wang Z, 2005, INT J COLORECTAL DIS, V20, P231, DOI 10.1007/s00384-004-0674-5; Xavier LL, 2005, BRAIN RES PROTOC, V16, P58, DOI 10.1016/j.brainresprot.2005.10.002; Xie DX, 2013, MED HYPOTHESES, V80, P498, DOI 10.1016/j.mehy.2012.12.020; Xie DX, 2010, P NATL ACAD SCI USA, V107, P2485, DOI 10.1073/pnas.0908133107	18	19	28	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142970	10.1371/journal.pone.0142970	http://dx.doi.org/10.1371/journal.pone.0142970			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26566136	Green Published, gold, Green Submitted			2022-12-26	WOS:000367628500080
J	Buffetaut, E; Hartman, AF; Al-Kindi, M; Schulp, AS				Buffetaut, Eric; Hartman, Axel-Frans; Al-Kindi, Mohammed; Schulp, Anne S.			Hadrosauroid Dinosaurs from the Late Cretaceous of the Sultanate of Oman	PLOS ONE			English	Article								Fragmentary post-cranial remains (femora, tibia, vertebrae) of ornithischian dinosaurs from the Late Cretaceous of the Sultanate of Oman are described and referred to hadrosauroids. The specimens come from the Al-Khod Conglomerate, of latest Campanian to Maastrichtian age, in the north-eastern part of the country. Although the fragmentary condition of the fossils precludes a precise identification, various characters, including the shape of the fourth trochanter of the femur and the morphology of its distal end, support an attribution to hadrosauroids. With the possible exception of a possible phalanx from Angola, this group of ornithopod dinosaurs, which apparently originated in Laurasia, was hitherto unreported from the Afro-Arabian plate. From a paleobiogeographical point of view, the presence of hadrosauroids in Oman in all likelihood is a result of trans-Tethys dispersal from Asia or Europe, probably by way of islands in the Tethys shown on all recent paleogeographical maps of that area. Whether hadrosauroids were widespread on the Afro-Arabian landmass in the latest Cretaceous, or where restricted to the "Oman island" shown on some paleogeographical maps, remains to be determined.	[Buffetaut, Eric] Ecole Normale Super, CNRS, Geol Lab, UMR 8538, Paris, France; [Hartman, Axel-Frans; Al-Kindi, Mohammed] Petr Dev Oman LLC, Muscat, Oman; [Hartman, Axel-Frans] Shell Int Explorat & Prod BV, The Hague, Netherlands; [Schulp, Anne S.] Nat Biodivers Ctr, Leiden, Netherlands; [Schulp, Anne S.] Nat Hist Museum Maastricht, Maastricht, Netherlands; [Schulp, Anne S.] Amsterdam VU Univ, Fac Earth & Life Sci, Amsterdam, Netherlands	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Royal Dutch Shell; Naturalis Biodiversity Center; Vrije Universiteit Amsterdam	Buffetaut, E (corresponding author), Ecole Normale Super, CNRS, Geol Lab, UMR 8538, Paris, France.	eric.buffetaut@sfr.fr	Schulp, Anne/AAM-9015-2020	Schulp, Anne/0000-0001-9389-1540; Al Kindi, Mohammed/0000-0002-8456-158X	Geological Society of Oman; Oman Botanical Garden; Ministry of Diwan Royal Court, Government of Oman; Petroleum Development Oman; Shell International Exploration and Production B.V.	Geological Society of Oman; Oman Botanical Garden; Ministry of Diwan Royal Court, Government of Oman; Petroleum Development Oman; Shell International Exploration and Production B.V.	The authors gratefully acknowledge the support for this research by the Geological Society of Oman, the Oman Botanical Garden and the funder of the project,'The Ministry of Diwan Royal Court, Government of Oman', that will finance the publication of the current manuscript if it is accepted in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Mohammed al-Kindi is employed by Petroleum Development Oman. Axel F. Hartman is employed by Petroleum Development Oman and Shell International Exploration and Production B.V. Petroleum Development Oman provided support in the form of salaries for authors Mohammed al-Kindi and Axel F. Hartman and Shell International Exploration and Production B.V. provided support in the form of salary for author Axel F. Hartman but neither company has been involved in this project or have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We gratefully acknowledge the support for this research by the Geological Society of Oman and the Oman Botanical Garden. Two reviewers (Terry Gates and Hai Xing) provided useful comments on the original version of this paper.	[Anonymous], 2012, ACTAS JORNADAS INTER; Bosellini A, 2002, EARTH-SCI REV, V59, P211, DOI 10.1016/S0012-8252(02)00075-2; Brett-Surman M.K., 2006, HORNS BEAKS CERATOPS, P135; Buffetaut Eric, 2005, Kaupia Darmstaedter Beitraege zur Naturgeschichte, V14, P3; Buscalioni AD, 2004, CRETACEOUS RES, V25, P267, DOI 10.1016/j.cretres.2003.12.004; Camoin G., 1993, ATLAS TETHYS PALAEOE; Campione Nicolas E., 2014, P208; Dalla Vecchia FM, 2009, J VERTEBR PALEONTOL, V29, P1100, DOI 10.1671/039.029.0428; Debeljak Irena, 2002, Memorie della Societa Geologica Italiana, V57, P193; Dollo L., 1883, B MUSEE ROYAL HIST N, V2, P205; Glennie K.W., 1974, VERHANDELING KONINKL; Kear BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084041; Leidy J., 1865, SMITHSON CONTRIB KNO, V14, P1; Lull R. S., 1942, Geological Society of America Special Paper, V40, P1; McDonald AT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036745; Nolan SC, 1990, SPECIAL PUBLICATIONS, V49, P495, DOI DOI 10.1144/GSL.SP.1992.049.01.31; Norman D.B., 1986, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V56, P281; Norman DB., 1980, MEMOIRES I ROYAL SCI, V178, P1; Prieto-Marquez A, 2010, AM MUS NOVIT, P1, DOI 10.1206/3694.2; Prieto-Marquez A, 2010, ZOOL J LINN SOC-LOND, V159, P435, DOI 10.1111/j.1096-3642.2009.00617.x; Prieto-Marquez A, 2010, ZOOL J LINN SOC-LOND, V159, P503, DOI 10.1111/j.1096-3642.2010.00642.x; Schulp A.S., 2008, SULTAN QABOOS U J SC, V13, P27; Schulp AS, 2000, CRETACEOUS RES, V21, P851, DOI 10.1006/cres.2000.0235; Suberbiola XP, 2004, J AFR EARTH SCI, V40, P81, DOI 10.1016/j.jafrearsci.2004.07.002; Taquet P, 1976, CAHIERS PALEONTOLOGI, P1; VRIELYNCK B, 2001, VISAGE CHANGEANT TER; Wang RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077058; Weishampel David B., 2003, Journal of Systematic Palaeontology, V1, P65, DOI 10.1017/S1477201903001032; WEISHAMPEL DB, 1993, PALAEONTOLOGY, V36, P361	29	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142692	10.1371/journal.pone.0142692	http://dx.doi.org/10.1371/journal.pone.0142692			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562674	Green Published, gold, Green Submitted			2022-12-26	WOS:000364480900055
J	de Turris, V; Teloni, R; Chiani, P; Bromuro, C; Mariotti, S; Pardini, M; Nisini, R; Torosantucci, A; Gagliardi, MC				de Turris, Valeria; Teloni, Raffaela; Chiani, Paola; Bromuro, Carla; Mariotti, Sabrina; Pardini, Manuela; Nisini, Roberto; Torosantucci, Antonella; Gagliardi, Maria Cristina			Candida albicans Targets a Lipid Raft/Dectin-1 Platform to Enter Human Monocytes and Induce Antigen Specific T Cell Responses	PLOS ONE			English	Article							MEMBRANE RAFTS; BETA-GLUCAN; CRYPTOCOCCUS-NEOFORMANS; ENRICHED MICRODOMAINS; HUMAN NEUTROPHILS; RECEPTOR; PHAGOCYTOSIS; DECTIN-1; CHOLESTEROL; MACROPHAGES	Several pathogens have been described to enter host cells via cholesterol-enriched membrane lipid raft microdomains. We found that disruption of lipid rafts by the cholesterolextracting agent methyl-beta-cyclodextrin or by the cholesterol-binding antifungal drug Amphotericin B strongly impairs the uptake of the fungal pathogen Candida albicans by human monocytes, suggesting a role of raft microdomains in the phagocytosis of the fungus. Time lapse confocal imaging indicated that Dectin-1, the C-type lectin receptor that recognizes Candida albicans cell wall-associated beta-glucan, is recruited to lipid rafts upon Candida albicans uptake by monocytes, supporting the notion that lipid rafts act as an entry platform. Interestingly disruption of lipid raft integrity and interference with fungus uptake do not alter cytokine production by monocytes in response to Candida albicans but drastically dampen fungus specific T cell response. In conclusion, these data suggest that monocyte lipid rafts play a crucial role in the innate and adaptive immune responses to Candida albicans in humans and highlight a new and unexpected immunomodulatory function of the antifungal drug Amphotericin B.	[Teloni, Raffaela; Chiani, Paola; Bromuro, Carla; Mariotti, Sabrina; Pardini, Manuela; Nisini, Roberto; Torosantucci, Antonella; Gagliardi, Maria Cristina] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy; [de Turris, Valeria] Ist Italiano Tecnol, Ctr Life Nanosci, I-00161 Rome, Italy; [de Turris, Valeria] CNR, Inst Mol Biol & Pathol, I-00185 Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS); Istituto Italiano di Tecnologia - IIT; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR)	Gagliardi, MC (corresponding author), Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, Viale Regina Elena 299, I-00161 Rome, Italy.	mc.gagliardi@iss.it	Nisini, Roberto/M-4363-2015; Gagliardi, Maria Cristina/AAA-9273-2019; MARIOTTI, SABRINA/M-4361-2015; BROMURO, CARLA/C-9591-2016; Chiani, Paola/AAC-4436-2021; TOROSANTUCCI, ANTONELLA/C-9594-2016; /AAQ-2983-2020	Nisini, Roberto/0000-0003-1077-423X; MARIOTTI, SABRINA/0000-0002-7009-7616; BROMURO, CARLA/0000-0002-5668-9009; Chiani, Paola/0000-0001-9836-3579; TOROSANTUCCI, ANTONELLA/0000-0002-0074-4486; gagliardi, maria cristina/0000-0003-3176-5439; de Turris, Valeria/0000-0003-0872-185X	Nikon Reference Center (Institute of Molecular Biology and Pathology, CNR)	Nikon Reference Center (Institute of Molecular Biology and Pathology, CNR)	We would like to thank Patrizia Lavia and Giulia Guarguaglini for technical advice and the Nikon Reference Center (Institute of Molecular Biology and Pathology, CNR) for the support in setting up preliminary cell imaging experiments. We thank Federica Sallusto and Simone Becattini for critically reading the manuscript.	Amer AO, 2005, AUTOPHAGY, V1, P53, DOI 10.4161/auto.1.1.1589; Ben-Ami R, 2008, CLIN INFECT DIS, V47, P226, DOI 10.1086/589290; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Cohen BE, 2010, J MEMBRANE BIOL, V238, P1, DOI 10.1007/s00232-010-9313-y; Darisipudi MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019588; Delaloye J, 2014, VIRULENCE, V5, P161, DOI 10.4161/viru.26187; Dermine JF, 2001, J BIOL CHEM, V276, P18507, DOI 10.1074/jbc.M101113200; Diaz-Rohrer BB, 2014, P NATL ACAD SCI USA, V111, P8500, DOI 10.1073/pnas.1404582111; Drummond RA, 2011, CURR OPIN MICROBIOL, V14, P392, DOI 10.1016/j.mib.2011.07.001; Ekyalongo RC, 2015, BBA-MOL CELL BIOL L, V1851, P90, DOI 10.1016/j.bbalip.2014.06.009; Gekara NO, 2004, BIOCHEM SOC T, V32, P712, DOI 10.1042/BST0320712; Goldston AM, 2012, TRENDS PARASITOL, V28, P417, DOI 10.1016/j.pt.2012.07.002; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Gorgojo J, 2014, INFECT IMMUN, V82, P5175, DOI 10.1128/IAI.02553-14; Graham LM, 2012, J BIOL CHEM, V287, P25964, DOI 10.1074/jbc.M112.384164; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Hajishengallis G, 2006, CELL MICROBIOL, V8, P1557, DOI 10.1111/j.1462-5822.2006.00730.x; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; Hontelez S, 2012, CELL MICROBIOL, V14, P467, DOI 10.1111/j.1462-5822.2012.01748.x; Iwabuchi K, 1998, J BIOL CHEM, V273, P33766, DOI 10.1074/jbc.273.50.33766; Iwabuchi K, 2002, BLOOD, V100, P1454, DOI 10.1182/blood.V100.4.1454.h81602001454_1454_1464; Iwabuchi Kazuhisa, 2008, Glycoconj J, V25, P357, DOI 10.1007/s10719-007-9084-6; JIMENEZLUCHO V, 1990, INFECT IMMUN, V58, P2085, DOI 10.1128/IAI.58.7.2085-2090.1990; Kannan S, 2008, J IMMUNOL, V180, P2396, DOI 10.4049/jimmunol.180.4.2396; Kwiatkowska K, 2003, J CELL SCI, V116, P537, DOI 10.1242/jcs.00254; Lafont F, 2005, CELL MICROBIOL, V7, P613, DOI 10.1111/j.1462-5822.2005.00515.x; Lamberti Y, 2008, MICROB PATHOGENESIS, V44, P501, DOI 10.1016/j.micpath.2008.01.002; Li N, 2003, PROTEOMICS, V3, P536, DOI 10.1002/pmic.200390067; Manes S, 2003, NAT REV IMMUNOL, V3, P557, DOI 10.1038/nri1129; Martins N, 2014, MYCOPATHOLOGIA, V177, P223, DOI 10.1007/s11046-014-9749-1; Matsuzaki-Moriya C, 2011, EUR J IMMUNOL, V41, P1365, DOI 10.1002/eji.201040942; Maza PK, 2008, MICROBES INFECT, V10, P540, DOI 10.1016/j.micinf.2008.02.004; McCann F, 2005, INFECT IMMUN, V73, P6340, DOI 10.1128/IAI.73.10.6340-6349.2005; Mesa-Arango Ana C, 2012, Front Microbiol, V3, P286; Nakayama H, 2008, J LEUKOCYTE BIOL, V83, P728, DOI 10.1189/jlb.0707478; Nakayama H, 2013, ARCH IMMUNOL THER EX, V61, P217, DOI 10.1007/s00005-013-0221-6; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Netea MG, 2010, TRENDS IMMUNOL, V31, P346, DOI 10.1016/j.it.2010.06.007; Paila YD, 2010, BIOCHEM BIOPH RES CO, V399, P429, DOI 10.1016/j.bbrc.2010.07.099; Peyron P, 2000, J IMMUNOL, V165, P5186, DOI 10.4049/jimmunol.165.9.5186; Pfeiffer A, 2001, EUR J IMMUNOL, V31, P3153, DOI 10.1002/1521-4141(200111)31:11<3153::AID-IMMU3153>3.0.CO;2-0; Pizzo P, 2003, CURR OPIN IMMUNOL, V15, P255, DOI 10.1016/S0952-7915(03)00038-4; Razonable RR, 2005, ANTIMICROB AGENTS CH, V49, P1617, DOI 10.1128/AAC.49.4.1617-1621.2005; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Rosenberger CM, 2000, CURR BIOL, V10, pR823, DOI 10.1016/S0960-9822(00)00788-0; Sato T, 2006, J LEUKOCYTE BIOL, V80, P204, DOI 10.1189/jlb.0106069; Sau K, 2003, J BIOL CHEM, V278, P37561, DOI 10.1074/jbc.M306137200; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Syme RM, 1999, INFECT IMMUN, V67, P4620, DOI 10.1128/IAI.67.9.4620-4627.1999; Thornton BP, 1996, J IMMUNOL, V156, P1235; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Vieira FS, 2010, BIOL CELL, V102, P391, DOI 10.1042/BC20090138; Wakshull E, 1999, IMMUNOPHARMACOLOGY, V41, P89, DOI 10.1016/S0162-3109(98)00059-9; Wang RB, 2006, BLOOD, V107, P1636, DOI 10.1182/blood-2005-06-2559; Wunder C, 2006, NAT MED, V12, P1030, DOI 10.1038/nm1480; Xu SL, 2009, J BIOL CHEM, V284, P22005, DOI 10.1074/jbc.M109.009076; Yamamoto Y, 1997, INFECT IMMUN, V65, P1077, DOI 10.1128/IAI.65.3.1077-1082.1997; Yoshizaki F, 2008, BBA-GEN SUBJECTS, V1780, P383, DOI 10.1016/j.bbagen.2007.11.004; Zheng NX, 2015, VIRULENCE, V6, P347, DOI 10.1080/21505594.2015.1014270; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	63	15	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142531	10.1371/journal.pone.0142531	http://dx.doi.org/10.1371/journal.pone.0142531			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562838	Green Published, Green Submitted, gold			2022-12-26	WOS:000364480900039
J	Cowan, J; Gaudet, L; Mulpuru, S; Corrales-Medina, V; Hawken, S; Cameron, C; Aaron, SD; Cameron, DW				Cowan, Juthaporn; Gaudet, Logan; Mulpuru, Sunita; Corrales-Medina, Vicente; Hawken, Steven; Cameron, Chris; Aaron, Shawn D.; Cameron, D. William			A Retrospective Longitudinal Within-Subject Risk Interval Analysis of Immunoglobulin Treatment for Recurrent Acute Exacerbation of Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							INTRAVENOUS IMMUNOGLOBULIN; COPD EXACERBATIONS; DOUBLE-BLIND; AUTOIMMUNE; MODERATE; AZITHROMYCIN; INFLAMMATION; MECHANISMS; INFLIXIMAB; MORTALITY	Background Recurrent acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are common, debilitating, costly and often difficult to prevent. Methods We reviewed records of patients who had COPD and immunoglobulin (Ig) treatment as adjunctive preventative treatment for AECOPD, and documented all AECOPD episodes for one year before and after initiation of Ig treatment. We graded AECOPD episodes as moderate for prescription of antibiotics and/or corticosteroids or for visit to the Emergency Department, and as severe for hospital admission. We conducted a retrospective withinsubject self-controlled risk interval analysis to compare the outcome of annual AECOPD rate before and after treatment. Results We identified 22 cases of certain COPD, of which three had early discontinuation of Ig treatment due to rash and local swelling to subcutaneous Ig, and five had incomplete records leaving 14 cases for analyses. The median baseline IgG level was 5.9 g/L (interquartile range 4.1-7.4). Eight had CT radiographic bronchiectasis. Overall, the incidence of AECOPD was consistently and significantly reduced in frequency from mean 4.7 (+/- 3.1) per patient-year before, to 0.6 (+/- 1.0) after the Ig treatment (p = 0.0001). There were twelve episodes of severe AECOPD (in seven cases) in the year prior, and one in the year after Ig treatment initiation (p = 0.016). Conclusions Ig treatment appears to decrease the frequency of moderate and severe recurrent AECOPD. A prospective, controlled evaluation of adjunctive Ig treatment to standard therapy of recurrent AECOPD is warranted.	[Cowan, Juthaporn; Corrales-Medina, Vicente; Cameron, D. William] Univ Ottawa, Div Infect Dis, Dept Med, Ottawa, ON, Canada; [Mulpuru, Sunita; Aaron, Shawn D.] Univ Ottawa, Div Respirol, Dept Med, Ottawa, ON, Canada; [Gaudet, Logan; Mulpuru, Sunita; Corrales-Medina, Vicente; Hawken, Steven; Cameron, Chris; Aaron, Shawn D.; Cameron, D. William] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Cowan, J (corresponding author), Univ Ottawa, Div Infect Dis, Dept Med, Ottawa, ON, Canada.	jcowan@toh.on.ca	Cameron, Bill/E-9180-2010	Cameron, Bill/0000-0002-0090-3539; Aaron, Shawn/0000-0002-4762-3542; Corrales-Medina, Vicente/0000-0002-9691-491X	University of Ottawa Department of Medicine at The Ottawa Hospital	University of Ottawa Department of Medicine at The Ottawa Hospital	This study was unfunded by any sponsor. DWC, SDA, SM, JC and VCM are recipients of research salary support from the University of Ottawa Department of Medicine at The Ottawa Hospital.	Aaron SD, 2013, THORAX, V68, P142, DOI 10.1136/thoraxjnl-2012-202432; Albert RK, 2011, NEW ENGL J MED, V365, P689, DOI 10.1056/NEJMoa1104623; Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Anthony RM, 2011, NATURE, V475, P110, DOI 10.1038/nature10134; Arram EO, 2012, EGYPT J CHEST DIS TU, V61, P307, DOI 10.1016/j.ejcdt.2012.07.001; Bayry J, 2003, NEUROL SCI, V24, pS217, DOI 10.1007/s10072-003-0081-7; Bayry Jagadeesh, 2005, Expert Rev Clin Immunol, V1, P213, DOI 10.1586/1744666X.1.2.213; Bayry J, 2009, P NATL ACAD SCI USA, V106, pE24, DOI 10.1073/pnas.0900016106; Brightling CE, 2014, LANCET RESP MED, V2, P891, DOI 10.1016/S2213-2600(14)70187-0; Brusselle G, 2014, LANCET RESP MED, V2, P681, DOI 10.1016/S2213-2600(14)70163-8; Cameron EJ, 2012, CLIN EXP ALLERGY, V42, P1302, DOI 10.1111/j.1365-2222.2012.03979.x; Celik P, 2005, RESP MED, V99, P444, DOI 10.1016/j.rmed.2004.09.008; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Daele J, 2000, Acta Otorhinolaryngol Belg, V54, P373; Dentener MA, 2008, RESPIRATION, V76, P275, DOI 10.1159/000117386; Farrington CP, 2004, VACCINE, V22, P2064, DOI 10.1016/j.vaccine.2004.01.017; Fedor ME, 2006, ANN ALLERG ASTHMA IM, V97, P113, DOI 10.1016/S1081-1206(10)61380-4; Gelfand EW, 2012, NEW ENGL J MED, V367, P2015, DOI 10.1056/NEJMra1009433; Gershon AS, 2013, AM J RESP CRIT CARE, V187, P596, DOI 10.1164/rccm.201211-2044OC; Gilardin L, 2015, CAN MED ASSOC J, V187, P257, DOI 10.1503/cmaj.130375; Gompertz S, 2002, CHEST, V122, P289, DOI 10.1378/chest.122.1.289; Han Meilan K, 2011, Proc Am Thorac Soc, V8, P356, DOI 10.1513/pats.201102-016RM; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Hoyert Donna L, 2012, Natl Vital Stat Rep, V61, P1; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Kawano T, 2002, INT ARCH ALLERGY IMM, V128, P240, DOI 10.1159/000064258; Kazatchkine MD, 2001, NEW ENGL J MED, V345, P747, DOI 10.1056/NEJMra993360; Kherad Omar, 2010, Praxis (Bern 1994), V99, P235, DOI 10.1024/1661-8157/a000034; McCullers JA, 2014, NAT REV MICROBIOL, V12, P252, DOI 10.1038/nrmicro3231; Mittmann N, 2008, RESP MED, V102, P413, DOI 10.1016/j.rmed.2007.10.010; Morozumi M, 2010, J INFECT CHEMOTHER, V16, P78, DOI 10.1007/s10156-009-0021-4; Ochsenbein AF, 1999, SCIENCE, V286, P2156, DOI 10.1126/science.286.5447.2156; Paquin-Proulx D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075199; Phaff SJ, 2006, J ANTIMICROB CHEMOTH, V57, P741, DOI 10.1093/jac/dkl014; Qian JH, 2014, IMMUNOPHARM IMMUNOT, V36, P33, DOI 10.3109/08923973.2013.864668; Ray WA, 2004, NEW ENGL J MED, V351, P1089, DOI 10.1056/NEJMoa040582; Rennard SI, 2007, AM J RESP CRIT CARE, V175, P926, DOI 10.1164/rccm.200607-995OC; Sabroe I, 2013, THORAX, V68, P1085, DOI 10.1136/thoraxjnl-2013-203773; Salemi S, 2014, INT REV IMMUNOL; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; Siedlar M, 2011, CLIN IMMUNOL, V139, P122, DOI 10.1016/j.clim.2011.01.002; Singanayagam Aran, 2013, Ann Am Thorac Soc, V10, P81, DOI 10.1513/AnnalsATS.201208-043OC; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Toy EL, 2010, COPD, V7, P214, DOI 10.3109/15412555.2010.481697; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8; Yip NH, 2006, AM J RESP CRIT CARE, V173, P917, DOI 10.1164/rccm.200510-1609OC; Zhu JR, 2014, CHIN INFECT CONTROL, V13, P281	47	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142205	10.1371/journal.pone.0142205	http://dx.doi.org/10.1371/journal.pone.0142205			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558756	Green Published, gold, Green Submitted			2022-12-26	WOS:000364433100060
J	Diez-Cirarda, M; Ojeda, N; Pena, J; Cabrera-Zubizarreta, A; Gomez-Beldarrain, MA; Gomez-Esteban, JC; Ibarretxe-Bilbao, N				Diez-Cirarda, Maria; Ojeda, Natalia; Pena, Javier; Cabrera-Zubizarreta, Alberto; Angeles Gomez-Beldarrain, Maria; Carlos Gomez-Esteban, Juan; Ibarretxe-Bilbao, Naroa			Neuroanatomical Correlates of Theory of Mind Deficit in Parkinson's Disease: A Multimodal Imaging Study	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; WHITE-MATTER; EMOTION RECOGNITION; DIFFUSION; BRAIN; DEMENTIA; ABNORMALITIES; DISORDERS; ONSET; GREY	Background Parkinson's disease (PD) patients show theory of mind (ToM) deficit since the early stages of the disease, and this deficit has been associated with working memory, executive functions and quality of life impairment. To date, neuroanatomical correlates of ToM have not been assessed with magnetic resonance imaging in PD. The main objective of this study was to assess cerebral correlates of ToM deficit in PD. The second objective was to explore the relationships between ToM, working memory and executive functions, and to analyse the neural correlates of ToM, controlling for both working memory and executive functions. Methods Thirty-seven PD patients (Hoehn and Yahr median = 2.0) and 15 healthy controls underwent a neuropsychological assessment and magnetic resonance images in a 3T-scanner were acquired. T1-weighted images were analysed with voxel-based morphometry, and white matter integrity and diffusivity measures were obtained from diffusion weighted images and analysed using tract-based spatial statistics. Results PD patients showed impairments in ToM, working memory and executive functions; grey matter loss and white matter reduction compared to healthy controls. Grey matter volume decrease in the precentral and postcentral gyrus, middle and inferior frontal gyrus correlated with ToM deficit in PD. White matter in the superior longitudinal fasciculus (adjacent to the parietal lobe) and white matter adjacent to the frontal lobe correlated with ToM impairment in PD. After controlling for executive functions, the relationship between ToM deficit and white matter remained significant for white matter areas adjacent to the precuneus and the parietal lobe. Conclusions Findings reinforce the existence of ToM impairment from the early Hoehn and Yahr stages in PD, and the findings suggest associations with white matter and grey matter volume decrease. This study contributes to better understand ToM deficit and its neural correlates in PD, which is a basic skill for development of healthy social relationships.	[Diez-Cirarda, Maria; Ojeda, Natalia; Pena, Javier; Ibarretxe-Bilbao, Naroa] Univ Deusto, Fac Psychol & Educ, Dept Methods & Expt Psychol, Bilbao, Basque Country, Spain; [Cabrera-Zubizarreta, Alberto] Hosp Galdakao, MR Unit, OSATEK, Galdakao, Basque Country, Spain; [Angeles Gomez-Beldarrain, Maria] Hosp Galdakao, Neurol Serv, Galdakao, Basque Country, Spain; [Carlos Gomez-Esteban, Juan] Biocruces Res Inst, Neurodegenerat Unit, Baracaldo, Biscay, Spain; [Carlos Gomez-Esteban, Juan] Cruces Univ Hosp, Neurol Serv, Baracaldo, Biscay, Spain	University of Deusto; Galdakao Hospital; Galdakao Hospital; Hospital Universitario Cruces	Ibarretxe-Bilbao, N (corresponding author), Univ Deusto, Fac Psychol & Educ, Dept Methods & Expt Psychol, Bilbao, Basque Country, Spain.	naroa.ibarretxe@deusto.es	Esteban, Juan Carlos Gomez/AAH-5755-2019; Cirarda, Maria Diez/AAS-9951-2020; Ibarretxe-Bilbao, Naroa/C-5575-2011; OJEDA, NATALIA/U-8897-2019	Esteban, Juan Carlos Gomez/0000-0002-4697-3890; Cirarda, Maria Diez/0000-0001-6768-189X; Ibarretxe-Bilbao, Naroa/0000-0002-2434-5252; OJEDA, NATALIA/0000-0002-0952-0649; Pena, Javier/0000-0002-0041-7020	Department of Health of the Basque Government [2011111117]; Spanish Ministry of Economy and Competitiveness [PSI2012-32441]	Department of Health of the Basque Government; Spanish Ministry of Economy and Competitiveness(Spanish Government)	This study was supported by the Department of Health of the Basque Government [2011111117 to NIB] and the Spanish Ministry of Economy and Competitiveness [PSI2012-32441 to NIB]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2011, CHARACTERIZATION CER, V1, P423, DOI [10.1089/brain.2011.0071, DOI 10.1089/BRAIN.2011.0071]; Barnea-Goraly N, 2004, BIOL PSYCHIAT, V55, P323, DOI 10.1016/j.biopsych.2003.10.022; Barnes J, 2010, NEUROIMAGE, V53, P1244, DOI 10.1016/j.neuroimage.2010.06.025; Beyer MK, 2007, J NEUROL NEUROSUR PS, V78, P254, DOI 10.1136/jnnp.2006.093849; Bodden ME, 2010, PARKINSONISM RELAT D, V16, P466, DOI 10.1016/j.parkreldis.2010.04.014; Bodden ME, 2010, MOVEMENT DISORD, V25, P13, DOI 10.1002/mds.22818; Carrington SJ, 2009, HUM BRAIN MAPP, V30, P2313, DOI 10.1002/hbm.20671; Charlton RA, 2009, PSYCHOL AGING, V24, P338, DOI 10.1037/a0015225; Cooper H, 2009, HDB RES SYNTHESIS ME; Costa A, 2013, BEHAV NEUROL, V27, P523, DOI [10.3233/BEN-129018, 10.1155/2013/903127]; Douaud G, 2007, BRAIN, V130, P2375, DOI 10.1093/brain/awm184; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; FLETCHER PC, 1995, COGNITION, V57, P109, DOI 10.1016/0010-0277(95)00692-R; GALLAGHER C, 2013, WHITE MATTER MICROST, V19, P349, DOI DOI 10.1017/S1355617712001373; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Ghosh BCP, 2012, BRAIN, V135, P2089, DOI 10.1093/brain/aws128; Goldman JG, 2011, MINERVA MED, V102, P441; Hilti LM, 2013, BRAIN, V136, P318, DOI 10.1093/brain/aws316; Hoehn MM, 1998, NEUROLOGY, V50, P318, DOI 10.1212/WNL.50.2.318; Hojat M, 2004, ADV HEALTH SCI EDUC, V9, P241, DOI 10.1023/B:AHSE.0000038173.00909.f6; Ibarretxe-Bilbao N, 2009, EUR J NEUROSCI, V30, P1162, DOI 10.1111/j.1460-9568.2009.06892.x; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Kaufer DI, 2000, J NEUROPSYCH CLIN N, V12, P233, DOI 10.1176/appi.neuropsych.12.2.233; Kawamura M, 2007, J NEUROL, V254, P49, DOI 10.1007/s00415-007-4008-8; Keller TA, 2007, NEUROREPORT, V18, P23, DOI 10.1097/01.wnr.0000239965.21685.99; Kendi ATK, 2008, AM J NEURORADIOL, V29, P501, DOI 10.3174/ajnr.A0850; Kumfor F, 2014, BRAIN, V137, P3061, DOI 10.1093/brain/awu246; Lee EY, 2013, PARKINSONISM RELAT D, V19, P1088, DOI 10.1016/j.parkreldis.2013.07.018; Litvan I, 2012, MOVEMENT DISORD, V27, P349, DOI 10.1002/mds.24893; Lobo A., 2001, REVALIDACION NORMALI; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; MARTINEZMARTIN P, 1994, MOVEMENT DISORD, V9, P76, DOI 10.1002/mds.870090112; Matsui H, 2007, ACTA NEUROL SCAND, V116, P177, DOI 10.1111/j.1600-0404.2007.00838.x; Melzer TR, 2013, NEUROLOGY, V80, P1841, DOI 10.1212/WNL.0b013e3182929f62; Melzer TR, 2012, J NEUROL NEUROSUR PS, V83, P188, DOI 10.1136/jnnp-2011-300828; Monetta L, 2009, CORTEX, V45, P972, DOI 10.1016/j.cortex.2009.02.021; Pena J, 2014, NEUROLOGY, V83, P2167, DOI 10.1212/WNL.0000000000001043; Pena-Casanova J, 2009, ARCH CLIN NEUROPSYCH, V24, P321, DOI 10.1093/arclin/acp038; Poletti M, 2012, NEUROSCI BIOBEHAV R, V36, P2147, DOI 10.1016/j.neubiorev.2012.07.004; Poletti M, 2011, BEHAV BRAIN RES, V219, P342, DOI 10.1016/j.bbr.2011.01.010; Pousa E, 1999, MEASUREMENT THEORY M; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Santangelo G, 2012, MOVEMENT DISORD, V27, P98, DOI 10.1002/mds.23949; Schurz M, 2014, FRACTIONATING THEORY, DOI [10.1016/j.neubiorev.2014.01.009, DOI 10.1016/J.NEUBIOREV.2014.01.009]; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Shulman KI, 2000, INT J GERIATR PSYCH, V15, P548, DOI 10.1002/1099-1166(200006)15:6<548::AID-GPS242>3.0.CO;2-U; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sugranyes G, 2011, AUTISM SPECTRUM DISO, V6, DOI [10.1371/journal.pone.0025322, DOI 10.1371/JOURNAL.PONE.0025322]; Theilmann RJ, 2013, WHITE MATTER CHANGES, V4, DOI [10.3389/fneur.2013.00037, DOI 10.3389/FNEUR.2013.00037]; TOMLINSON CL, 2010, SYSTEMATIC REV LEVOD, V25, P2649, DOI DOI 10.1002/MDS.23429; Von Der Heide RJ, 2013, BRAIN, V136, P1692, DOI 10.1093/brain/awt094; Wechsler D., 2012, WAIS 4 KASIKIRJA; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Yip JTH, 2003, MOVEMENT DISORD, V18, P1115, DOI 10.1002/mds.10497; Yu RL, 2013, TRANSL NEURODEGENER, V2, DOI 10.1186/2047-9158-2-7; Zheng Z, 2013, HUM BRAIN MAPP	58	19	20	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142234	10.1371/journal.pone.0142234	http://dx.doi.org/10.1371/journal.pone.0142234			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559669	Green Submitted, Green Published, gold			2022-12-26	WOS:000364433100066
J	Fowler, EAF; Horner, JR				Fowler, Elizabeth A. Freedman; Horner, John R.			A New Brachylophosaurin Hadrosaur (Dinosauria: Ornithischia) with an Intermediate Nasal Crest from the Campanian Judith River Formation of Northcentral Montana	PLOS ONE			English	Article							2 MEDICINE FORMATION; LONG-BONE HISTOLOGY; MAIASAURA-PEEBLESORUM; KAIPAROWITS FORMATION; WESTERN INTERIOR; CRANIAL ANATOMY; SOUTHERN UTAH; 40AR/39AR AGE; GROWTH; REVISION	Background Brachylophosaurini is a clade of hadrosaurine dinosaurs currently known from the Campanian (Late Cretaceous) of North America. Its members include: Acristavus gagslarsoni, which lacks a nasal crest; Brachylophosaurus canadensis, which possesses a flat paddleshaped nasal crest projecting posteriorly over the dorsal skull roof; and Maiasaura peeblesorum, which possesses a dorsally-projecting nasofrontal crest. Acristavus, from the lower Two Medicine Formation of Montana (similar to 81-80 Ma), is hypothesized to be the ancestral member of the clade. Brachylophosaurus specimens are from the middle Oldman Formation of Alberta and equivalent beds in the Judith River Formation of Montana; the upper Oldman Formation is dated 77.8 Ma. Methodology/Principal Findings A new brachylophosaurin hadrosaur, Probrachylophosaurus bergei (gen. et sp. nov.) is described and phylogenetically analyzed based on the skull and postcranium of a large individual from the Judith River Formation of northcentral Montana (79.8-79.5 Ma); the horizon is equivalent to the lower Oldman Formation of Alberta. Cranial morphology of Probrachylophosaurus, most notably the nasal crest, is intermediate between Acristavus and Brachylophosaurus. In Brachylophosaurus, the nasal crest lengthens and flattens ontogenetically, covering the supratemporal fenestrae in large adults. The smaller nasal crest of Probrachylophosaurus is strongly triangular in cross section and only minimally overhangs the supratemporal fenestrae, similar to an ontogenetically earlier stage of Brachylophosaurus. Sutural fusion and tibial osteohistology reveal that the holotype of Probrachylophosaurus was relatively more mature than a similarly large Brachylophosaurus specimen; thus, Probrachylophosaurus is not simply an immature Brachylophosaurus. Conclusions/Significance The small triangular posteriorly oriented nasal crest of Probrachylophosaurus is proposed to represent a transitional nasal morphology between that of a non-crested ancestor such as Acristavus and the large flat posteriorly oriented nasal crest of adult Brachylophosaurus. Because Probrachylophosaurus is stratigraphically and morphologically intermediate between these taxa, Probrachylophosaurus is hypothesized to be an intermediate member of the Acristavus-Brachylophosaurus evolutionary lineage. Background Brachylophosaurini is a clade of hadrosaurine dinosaurs currently known from the Campanian (Late Cretaceous) of North America. Its members include: Acristavus gagslarsoni, which lacks a nasal crest; Brachylophosaurus canadensis, which possesses a flat paddleshaped nasal crest projecting posteriorly over the dorsal skull roof; and Maiasaura peeblesorum, which possesses a dorsally-projecting nasofrontal crest. Acristavus, from the lower Two Medicine Formation of Montana (similar to 81-80 Ma), is hypothesized to be the ancestral member of the clade. Brachylophosaurus specimens are from the middle Oldman Formation of Alberta and equivalent beds in the Judith River Formation of Montana; the upper Oldman Formation is dated 77.8 Ma. Methodology/Principal Findings A new brachylophosaurin hadrosaur, Probrachylophosaurus bergei (gen. et sp. nov.) is described and phylogenetically analyzed based on the skull and postcranium of a large individual from the Judith River Formation of northcentral Montana (79.8-79.5 Ma); the horizon is equivalent to the lower Oldman Formation of Alberta. Cranial morphology of Probrachylophosaurus, most notably the nasal crest, is intermediate between Acristavus and Brachylophosaurus. In Brachylophosaurus, the nasal crest lengthens and flattens ontogenetically, covering the supratemporal fenestrae in large adults. The smaller nasal crest of Probrachylophosaurus is strongly triangular in cross section and only minimally overhangs the supratemporal fenestrae, similar to an ontogenetically earlier stage of Brachylophosaurus. Sutural fusion and tibial osteohistology reveal that the holotype of Probrachylophosaurus was relatively more mature than a similarly large Brachylophosaurus specimen; thus, Probrachylophosaurus is not simply an immature Brachylophosaurus. Conclusions/Significance The small triangular posteriorly oriented nasal crest of Probrachylophosaurus is proposed to represent a transitional nasal morphology between that of a non-crested ancestor such as Acristavus and the large flat posteriorly oriented nasal crest of adult Brachylophosaurus. Because Probrachylophosaurus is stratigraphically and morphologically intermediate between these taxa, Probrachylophosaurus is hypothesized to be an intermediate member of the Acristavus-Brachylophosaurus evolutionary lineage. Background Brachylophosaurini is a clade of hadrosaurine dinosaurs currently known from the Campanian (Late Cretaceous) of North America. Its members include: Acristavus gagslarsoni, which lacks a nasal crest; Brachylophosaurus canadensis, which possesses a flat paddleshaped nasal crest projecting posteriorly over the dorsal skull roof; and Maiasaura peeblesorum, which possesses a dorsally-projecting nasofrontal crest. Acristavus, from the lower Two Medicine Formation of Montana (similar to 81-80 Ma), is hypothesized to be the ancestral member of the clade. Brachylophosaurus specimens are from the middle Oldman Formation of Alberta and equivalent beds in the Judith River Formation of Montana; the upper Oldman Formation is dated 77.8 Ma. Methodology/Principal Findings A new brachylophosaurin hadrosaur, Probrachylophosaurus bergei (gen. et sp. nov.) is described and phylogenetically analyzed based on the skull and postcranium of a large individual from the Judith River Formation of northcentral Montana (79.8-79.5 Ma); the horizon is equivalent to the lower Oldman Formation of Alberta. Cranial morphology of Probrachylophosaurus, most notably the nasal crest, is intermediate between Acristavus and Brachylophosaurus. In Brachylophosaurus, the nasal crest lengthens and flattens ontogenetically, covering the supratemporal fenestrae in large adults. The smaller nasal crest of Probrachylophosaurus is strongly triangular in cross section and only minimally overhangs the supratemporal fenestrae, similar to an ontogenetically earlier stage of Brachylophosaurus. Sutural fusion and tibial osteohistology reveal that the holotype of Probrachylophosaurus was relatively more mature than a similarly large Brachylophosaurus specimen; thus, Probrachylophosaurus is not simply an immature Brachylophosaurus. Conclusions/Significance The small triangular posteriorly oriented nasal crest of Probrachylophosaurus is proposed to represent a transitional nasal morphology between that of a non-crested ancestor such as Acristavus and the large flat posteriorly oriented nasal crest of adult Brachylophosaurus. Because Probrachylophosaurus is stratigraphically and morphologically intermediate between these taxa, Probrachylophosaurus is hypothesized to be an intermediate member of the Acristavus-Brachylophosaurus evolutionary lineage. Background Brachylophosaurini is a clade of hadrosaurine dinosaurs currently known from the Campanian (Late Cretaceous) of North America. Its members include: Acristavus gagslarsoni, which lacks a nasal crest; Brachylophosaurus canadensis, which possesses a flat paddleshaped nasal crest projecting posteriorly over the dorsal skull roof; and Maiasaura peeblesorum, which possesses a dorsally-projecting nasofrontal crest. Acristavus, from the lower Two Medicine Formation of Montana (similar to 81-80 Ma), is hypothesized to be the ancestral member of the clade. Brachylophosaurus specimens are from the middle Oldman Formation of Alberta and equivalent beds in the Judith River Formation of Montana; the upper Oldman Formation is dated 77.8 Ma. Methodology/Principal Findings A new brachylophosaurin hadrosaur, Probrachylophosaurus bergei (gen. et sp. nov.) is described and phylogenetically analyzed based on the skull and postcranium of a large individual from the Judith River Formation of northcentral Montana (79.8-79.5 Ma); the horizon is equivalent to the lower Oldman Formation of Alberta. Cranial morphology of Probrachylophosaurus, most notably the nasal crest, is intermediate between Acristavus and Brachylophosaurus. In Brachylophosaurus, the nasal crest lengthens and flattens ontogenetically, covering the supratemporal fenestrae in large adults. The smaller nasal crest of Probrachylophosaurus is strongly triangular in cross section and only minimally overhangs the supratemporal fenestrae, similar to an ontogenetically earlier stage of Brachylophosaurus. Sutural fusion and tibial osteohistology reveal that the holotype of Probrachylophosaurus was relatively more mature than a similarly large Brachylophosaurus specimen; thus, Probrachylophosaurus is not simply an immature Brachylophosaurus. Conclusions/Significance The small triangular posteriorly oriented nasal crest of Probrachylophosaurus is proposed to represent a transitional nasal morphology between that of a non-crested ancestor such as Acristavus and the large flat posteriorly oriented nasal crest of adult Brachylophosaurus. Because Probrachylophosaurus is stratigraphically and morphologically intermediate between these taxa, Probrachylophosaurus is hypothesized to be an intermediate member of the Acristavus-Brachylophosaurus evolutionary lineage. Background Brachylophosaurini is a clade of hadrosaurine dinosaurs currently known from the Campanian (Late Cretaceous) of North America. Its members include: Acristavus gagslarsoni, which lacks a nasal crest; Brachylophosaurus canadensis, which possesses a flat paddleshaped nasal crest projecting posteriorly over the dorsal skull roof; and Maiasaura peeblesorum, which possesses a dorsally-projecting nasofrontal crest. Acristavus, from the lower Two Medicine Formation of Montana (similar to 81-80 Ma), is hypothesized to be the ancestral member of the clade. Brachylophosaurus specimens are from the middle Oldman Formation of Alberta and equivalent beds in the Judith River Formation of Montana; the upper Oldman Formation is dated 77.8 Ma. Methodology/Principal Findings A new brachylophosaurin hadrosaur, Probrachylophosaurus bergei (gen. et sp. nov.) is described and phylogenetically analyzed based on the skull and postcranium of a large individual from the Judith River Formation of northcentral Montana (79.8-79.5 Ma); the horizon is equivalent to the lower Oldman Formation of Alberta. Cranial morphology of Probrachylophosaurus, most notably the nasal crest, is intermediate between Acristavus and Brachylophosaurus. In Brachylophosaurus, the nasal crest lengthens and flattens ontogenetically, covering the supratemporal fenestrae in large adults. The smaller nasal crest of Probrachylophosaurus is strongly triangular in cross section and only minimally overhangs the supratemporal fenestrae, similar to an ontogenetically earlier stage of Brachylophosaurus. Sutural fusion and tibial osteohistology reveal that the holotype of Probrachylophosaurus was relatively more mature than a similarly large Brachylophosaurus specimen; thus, Probrachylophosaurus is not simply an immature Brachylophosaurus. Conclusions/Significance The small triangular posteriorly oriented nasal crest of Probrachylophosaurus is proposed to represent a transitional nasal morphology between that of a non-crested ancestor such as Acristavus and the large flat posteriorly oriented nasal crest of adult Brachylophosaurus. Because Probrachylophosaurus is stratigraphically and morphologically intermediate between these taxa, Probrachylophosaurus is hypothesized to be an intermediate member of the Acristavus-Brachylophosaurus evolutionary lineage. Background Brachylophosaurini is a clade of hadrosaurine dinosaurs currently known from the Campanian (Late Cretaceous) of North America. Its members include: Acristavus gagslarsoni, which lacks a nasal crest; Brachylophosaurus canadensis, which possesses a flat paddleshaped nasal crest projecting posteriorly over the dorsal skull roof; and Maiasaura peeblesorum, which possesses a dorsally-projecting nasofrontal crest. Acristavus, from the lower Two Medicine Formation of Montana (similar to 81-80 Ma), is hypothesized to be the ancestral member of the clade. Brachylophosaurus specimens are from the middle Oldman Formation of Alberta and equivalent beds in the Judith River Formation of Montana; the upper Oldman Formation is dated 77.8 Ma. Methodology/Principal Findings A new brachylophosaurin hadrosaur, Probrachylophosaurus bergei (gen. et sp. nov.) is described and phylogenetically analyzed based on the skull and postcranium of a large individual from the Judith River Formation of northcentral Montana (79.8-79.5 Ma); the horizon is equivalent to the lower Oldman Formation of Alberta. Cranial morphology of Probrachylophosaurus, most notably the nasal crest, is intermediate between Acristavus and Brachylophosaurus. In Brachylophosaurus, the nasal crest lengthens and flattens ontogenetically, covering the supratemporal fenestrae in large adults. The smaller nasal crest of Probrachylophosaurus is strongly triangular in cross section and only minimally overhangs the supratemporal fenestrae, similar to an ontogenetically earlier stage of Brachylophosaurus. Sutural fusion and tibial osteohistology reveal that the holotype of Probrachylophosaurus was relatively more mature than a similarly large Brachylophosaurus specimen; thus, Probrachylophosaurus is not simply an immature Brachylophosaurus. Conclusions/Significance The small triangular posteriorly oriented nasal crest of Probrachylophosaurus is proposed to represent a transitional nasal morphology between that of a non-crested ancestor such as Acristavus and the large flat posteriorly oriented nasal crest of adult Brachylophosaurus. Because Probrachylophosaurus is stratigraphically and morphologically intermediate between these taxa, Probrachylophosaurus is hypothesized to be an intermediate member of the Acristavus-Brachylophosaurus evolutionary lineage.	[Fowler, Elizabeth A. Freedman; Horner, John R.] Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA; [Fowler, Elizabeth A. Freedman; Horner, John R.] Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Fowler, EAF (corresponding author), Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA.	eafreedman@gmail.com	Freedman, Elizabeth/J-1752-2012	Freedman, Elizabeth/0000-0002-5763-5272	Doris O. and Samuel P. Welles Research Fund (University of California Museum of Paleontology); M.A. Fritz Travel Grant for the Advancement of Studies in Palaeontology (Royal Ontario Museum); Jackson School of Geosciences Student Member Travel Grant (Society of Vertebrate Paleontology); College of Letters and Science Student Research Travel Grant (Montana State University)	Doris O. and Samuel P. Welles Research Fund (University of California Museum of Paleontology); M.A. Fritz Travel Grant for the Advancement of Studies in Palaeontology (Royal Ontario Museum); Jackson School of Geosciences Student Member Travel Grant (Society of Vertebrate Paleontology); College of Letters and Science Student Research Travel Grant (Montana State University)	Fieldwork and research funding was generously provided to JRH by the Ameya Preserve, Damaris Wagoner, David Sands, and other generous donors to the Museum of the Rockies Student Fund and Horner Fund; and to EAFF by the Tampa Bay Fossil Club and the Montana State University Department of Cell Biology and Neuroscience. Travel funding was generously provided to EAFF by the Doris O. and Samuel P. Welles Research Fund (University of California Museum of Paleontology), the M.A. Fritz Travel Grant for the Advancement of Studies in Palaeontology (Royal Ontario Museum), the Jackson School of Geosciences Student Member Travel Grant (Society of Vertebrate Paleontology), and the College of Letters and Science Student Research Travel Grant (Montana State University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell PR, 2011, ACTA PALAEONTOL POL, V56, P703, DOI 10.4202/app.2010.0061; Bell PR, 2011, CRETACEOUS RES, V32, P30, DOI 10.1016/j.cretres.2010.10.002; Brinkman DB, 2004, PALAEOGEOGR PALAEOCL, V213, P295, DOI 10.1016/j.palaeo.2004.07.016; Campione NE, 2013, PALAEOBIO PALAEOENV, V93, P65, DOI 10.1007/s12549-012-0097-1; Campione NE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025186; Cuthbertson RS, 2010, ZOOL J LINN SOC-LOND, V159, P373, DOI 10.1111/j.1096-3642.2009.00612.x; Dilkes DW, 2000, T ROY SOC EDIN-EARTH, V90, P87, DOI 10.1017/S0263593300007185; Dilkes DW, 1993, THESIS, P447; DODSON P, 1975, SYST ZOOL, V24, P37, DOI 10.2307/2412696; EBERTH DA, 1993, CAN J EARTH SCI, V30, P174, DOI 10.1139/e93-016; Eberth DA, 2011, INT HADR S DRUMH ALB, P54; Eberth DA, 2005, LIFE O PAST, P54; Evans DC, 2007, J VERTEBR PALEONTOL, V27, P373, DOI 10.1671/0272-4634(2007)27[373:AAROLM]2.0.CO;2; Evans DC, 2010, ZOOL J LINN SOC-LOND, V159, P398, DOI 10.1111/j.1096-3642.2009.00611.x; Gallagher WB, 1996, J VERTEBRATE PALE S3, V16, p36A; Gates TA, 2007, ZOOL J LINN SOC-LOND, V151, P351, DOI 10.1111/j.1096-3642.2007.00349.x; Gates TA, 2011, J VERTEBR PALEONTOL, V31, P798, DOI 10.1080/02724634.2011.577854; GOODWIN MB, 1989, CAN J EARTH SCI, V26, P1384, DOI 10.1139/e89-118; Haeckel E, 1901, RIDDLE UNIVERSE CLOS; Haeckel Ernst, 1866, GENERELLE MORPHOLOGI; Horner J.R., 1988, Journal of Vertebrate Paleontology, V8, P314; Horner J.R., 1983, J VERTEBR PALEONTOL, V3, P29, DOI [DOI 10.1080/02724634.1983.10011954, 10.1080/02724634.1983.10011954]; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Horner JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016574; Horner JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007626; Horner JR, 2009, J VERTEBR PALEONTOL, V29, P734, DOI 10.1671/039.029.0312; Horner John R., 1994, P312; Horner JR, 2000, J VERTEBR PALEONTOL, V20, P115, DOI 10.1671/0272-4634(2000)020[0115:LBHOTH]2.0.CO;2; HORNER JR, 1979, NATURE, V282, P296, DOI 10.1038/282296a0; Horner JR, 1989, J VERTEBR PALEONTOL, V9, p25A; Horner JR, 1984, FIELD C GUIDEBOOK, P299; Horner JR, 1992, MUSEUM ROCKIES OCCAS, V2, P1; Hubner TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029958; Jinnah ZA, 2009, CRETACEOUS RES, V30, P287, DOI 10.1016/j.cretres.2008.07.012; Kirkland James I., 2013, P153; Kohler M, 2012, NATURE, V487, P358, DOI 10.1038/nature11264; Lambe L., 1914, Ottawa Naturalist, V27; Lamm ET, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P55; Langston Jr W, 1960, FIELDIANA GEOLOGY ME, V3, P314; LaRock JW, 2001, THESIS, P61; Leiggi Patrick, 1994, P59; Mcgarrity CT, 2013, ZOOL J LINN SOC-LOND, V167, P531, DOI 10.1111/zoj.12009; Peng J-H, 2001, PROV MUS ALBERTA NAT, V25, P1, DOI DOI 10.5962/BHL.TITLE.115853; Prieto-Marquez A, 2005, J VERTEBR PALEONTOL, V25, P144, DOI 10.1671/0272-4634(2005)025[0144:NIOTCO]2.0.CO;2; Prieto-Marquez Albert, 2007, P91; Prieto-Marquez A, 2014, J SYST PALAEONTOL, V12, P133, DOI 10.1080/14772019.2013.770417; Prieto-Marquez A, 2011, PALAEONTOLOGY, V54, P773, DOI 10.1111/j.1475-4983.2011.01053.x; Prieto-Marquez A, 2010, ZOOL J LINN SOC-LOND, V159, P435, DOI 10.1111/j.1096-3642.2009.00617.x; Prieto-Marquez A, 2010, J VERTEBR PALEONTOL, V30, P813, DOI 10.1080/02724631003763508; Prieto-Marquez A, 2010, J VERTEBR PALEONTOL, V30, P838, DOI 10.1080/02724631003762971; Renne PR, 2010, GEOCHIM COSMOCHIM AC, V74, P5349, DOI 10.1016/j.gca.2010.06.017; Renne PR, 1998, CHEM GEOL, V145, P117, DOI 10.1016/S0009-2541(97)00159-9; Roberts EM, 2005, CRETACEOUS RES, V26, P307, DOI 10.1016/j.cretres.2005.01.002; ROGERS RR, 1993, CAN J EARTH SCI, V30, P1066, DOI 10.1139/e93-090; Rozhdestvensky AK, 1965, PALEONTOL ZH, V3, P95; Ryan MJ, 2007, J VERTEBR PALEONTOL, V27, P944, DOI 10.1671/0272-4634(2007)27[944:AROTLC]2.0.CO;2; Ryan Michael J., 2010, P181; Ryan MJ, 2005, LIFE O PAST, P312; Sampson SD, 1997, ZOOL J LINN SOC-LOND, V121, P293, DOI 10.1111/j.1096-3642.1997.tb00340.x; Scannella JB, 2014, P NATL ACAD SCI USA, V111, P10245, DOI 10.1073/pnas.1313334111; Schott R, 2010, J VERTEBR PALEONTOL, p159A; Sternberg C. M., 1953, Bulletin National Museum of Canada, VNo. 128, P275; Sues HD, 2009, P R SOC B, V276, P2549, DOI 10.1098/rspb.2009.0229; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; THOMAS R G, 1990, Cretaceous Research, V11, P125, DOI 10.1016/S0195-6671(05)80030-8; Trexler DL, 1995, THESIS, P235; Tsuihiji T, 2011, J VERTEBR PALEONTOL, V31, P497, DOI 10.1080/02724634.2011.557116; Van Itterbeeck J, 2005, CRETACEOUS RES, V26, P699, DOI 10.1016/j.cretres.2005.03.004; Varricchio DJ, 2010, GEOL SOC AM SPEC PAP, V465, P269, DOI 10.1130/2010.2465(17); VARRICCHIO DJ, 1993, CAN J EARTH SCI, V30, P997, DOI 10.1139/e93-083; Woodward HN, 2015, PALEOBIOLOGY; Xing Hai, 2012, Vertebrata Palasiatica, V50, P160	72	44	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141304	10.1371/journal.pone.0141304	http://dx.doi.org/10.1371/journal.pone.0141304			55	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560175	gold, Green Published, Green Submitted			2022-12-26	WOS:000364433100031
J	Hirata, K; Wake, M; Takahashi, T; Nakazato, J; Yagi, N; Miyagi, T; Shimotakahara, J; Mototake, H; Tengan, T; Takara, TR; Yamaguchi, Y				Hirata, Kazuhito; Wake, Minoru; Takahashi, Takanori; Nakazato, Jun; Yagi, Nobuhito; Miyagi, Tadayoshi; Shimotakahara, Junichi; Mototake, Hidemitsu; Tengan, Toshiho; Takara, Tsuyoshi R.; Yamaguchi, Yutaka			Clinical Predictors for Delayed or Inappropriate Initial Diagnosis of Type A Acute Aortic Dissection in the Emergency Room	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CORONARY-ARTERY OCCLUSION; TRANSTHORACIC ECHOCARDIOGRAPHY; MANAGEMENT; FEATURES	Background Initial diagnosis of acute aortic dissection (AAD) in the emergency room (ER) is sometimes difficult or delayed. The aim of this study is to define clinical predictors related to inappropriate or delayed diagnosis of Stanford type A AAD. Methods We conducted a retrospective analysis of 127 consecutive patients with type A AAD who presented to the ER within 12 h of symptom onset (age: 69.0 +/- 15.4 years, male/female = 49/78). An inappropriate initial diagnosis (IID) was considered if AAD was not included in the differential diagnosis or if chest computed tomography or echocardiography was not performed as initial imaging tests. Clinical variables were compared between IID and appropriate diagnosis group. The time to final diagnosis (TFD) was also evaluated. Delayed diagnosis (DD) was defined as TFD > third quartile. Clinical factors predicting DD were evaluated in comparison with early diagnosis (defined as TFD within the third quartile). In addition, TFD was compared with respect to each clinical variable using a rank sum test. Results An IID was determined for 37% of patients. Walk-in (WI) visit to the ER [odds ratio (OR) 2.6, 95% confidence interval (CI) = 1.01-6.72, P = 0.048] and coronary malperfusion (CM, OR = 6.48, 95% CI = 1.14-36.82, P = 0.035) were predictors for IID. Overall, the median TFD was 1.5 h (first/third quartiles = 0.5/4.0 h). DD (> 4.5 h) was observed in 27 cases (21.3%). TFD was significantly longer in WI patients (median and first/third quartiles = 1.0 and 0.5/2.85 h for the ambulance group vs. 3.0 and 1.0/8.0 h for the WI group, respectively; P = 0.003). Multivariate analysis revealed that WI visit was the only predictor for DD (OR = 3.72, 95% CI = 1.39-9.9, P = 0.009). TFD was significantly shorter for appropriate diagnoses than for IIDs (1.0 vs. 6.0 h, respectively; P < 0.0001). Conclusions WI visit to the ER and CM were predictors for IID, and WI was the only predictor for DD in acute type A AAD in the community hospital.	[Hirata, Kazuhito; Wake, Minoru; Takahashi, Takanori; Nakazato, Jun; Yagi, Nobuhito; Miyagi, Tadayoshi; Shimotakahara, Junichi] Okinawa Chubu Hosp, Div Cardiol, Uruma, Okinawa, Japan; [Mototake, Hidemitsu; Tengan, Toshiho] Okinawa Chubu Hosp, Div Cardiovasc Surg, Uruma, Okinawa, Japan; [Takara, Tsuyoshi R.; Yamaguchi, Yutaka] Okinawa Chubu Hosp, Div Emergency Dept, Uruma, Okinawa, Japan	Okinawa Chubu Central Hospital; Okinawa Chubu Central Hospital; Okinawa Chubu Central Hospital	Hirata, K (corresponding author), Okinawa Chubu Hosp, Div Cardiol, 281 Miyasato, Uruma, Okinawa, Japan.	kheart911@yahoo.co.jp						Ashida K, 2000, JPN CIRC J, V64, P130, DOI 10.1253/jcj.64.130; Barabas M, 2000, CATHETER CARDIO INTE, V51, P74, DOI 10.1002/1522-726X(200009)51:1<74::AID-CCD17>3.0.CO;2-F; Blankenship J, 1989, J AM COLL CARDIOL, V15, P1579; Cecconi M, 2012, AM HEART J, V163, P112, DOI 10.1016/j.ahj.2011.09.022; ERIKSEN UH, 1992, EUR HEART J, V13, P840, DOI 10.1093/oxfordjournals.eurheartj.a060266; Hagan PG, JAMA, V283, P897; Harris KM, 2011, CIRCULATION, V124, P1911, DOI 10.1161/CIRCULATIONAHA.110.006320; Hirata K, 2012, ACUTE CORONARY SYNDR, P99; Hirata K, 2010, J CARDIOL, V56, P147, DOI 10.1016/j.jjcc.2010.03.007; HIRST AE, 1958, MEDICINE, V37, P217, DOI 10.1097/00005792-195809000-00003; Klompas M, 2002, JAMA-J AM MED ASSOC, V287, P2261; Kosuge M, 2013, AM J CARDIOL, V112, P424, DOI 10.1016/j.amjcard.2013.03.050; Kurabayashi M, 2011, J CARDIOL, V58, P287, DOI 10.1016/j.jjcc.2011.07.008; Kurisu S, 2004, HEART, V90, P1059, DOI 10.1136/hrt.2003.026799; MELCHIOR T, 1993, INT J CARDIOL, V42, P1, DOI 10.1016/0167-5273(93)90095-X; Nallamothu BK, 2002, AM J MED, V113, P468, DOI 10.1016/S0002-9343(02)01254-8; Nienaber CA, 2003, CIRCULATION, V108, P628, DOI 10.1161/01.CIR.0000087009.16755.E4; Nikus KC, 2008, J ELECTROCARDIOL, V41, P626, DOI 10.1016/j.jelectrocard.2008.06.020; Rapezzi C, 2008, AM J CARDIOL, V102, P1399, DOI 10.1016/j.amjcard.2008.07.013; Shirakabe A, 2008, CIRC J, V72, P986, DOI 10.1253/circj.72.986; Sobczyk D, 2015, CARDIOVASC ULTRASOUN, V13, DOI 10.1186/s12947-015-0008-5; SPITTELL PC, 1993, MAYO CLIN PROC, V68, P642, DOI 10.1016/S0025-6196(12)60599-0; Tsai TT, 2005, CIRCULATION, V112, P3802, DOI 10.1161/CIRCULATIONAHA.105.534198; Woolev CF, 1988, PROG CARDIOVASC DIS, V40, P56; Zhan S, 2012, J CLIN HYPERTENS GRE, V14, P256	25	15	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141929	10.1371/journal.pone.0141929	http://dx.doi.org/10.1371/journal.pone.0141929			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559676	Green Submitted, gold, Green Published			2022-12-26	WOS:000364433100046
J	Holgado, B; Vecchia, FM; Fortuny, J; Bernardini, F; Tuniz, C				Holgado, Borja; Marco Dalla Vecchia, Fabio; Fortuny, Josep; Bernardini, Federico; Tuniz, Claudio			A Reappraisal of the Purported Gastric Pellet with Pterosaurian Bones from the Upper Triassic of Italy	PLOS ONE			English	Article							DIAPSIDA; ARCHOSAURS; REVISION; REPTILIA; ONTOGENY; ANATOMY; ORIGIN; SKULL	A small accumulation of bones from the Norian (Upper Triassic) of the Seazza Brook Valley (Carnic Prealps, Northern Italy) was originally (1989) identified as a gastric pellet made of pterosaur skeletal elements. The specimen has been reported in literature as one of the very few cases of gastric ejecta containing pterosaur bones since then. However, the detailed analysis of the bones preserved in the pellet, their study by X-ray microCT, and the comparison with those of basal pterosaurs do not support a referral to the Pterosauria. Comparison with the osteology of a large sample of Middle-Late Triassic reptiles shows some affinity with the protorosaurians, mainly with Langobardisaurus pandolfii that was found in the same formation as the pellet. However, differences with this species suggest that the bones belong to a similar but distinct taxon. The interpretation as a gastric pellet is confirmed.	[Holgado, Borja; Marco Dalla Vecchia, Fabio; Fortuny, Josep] Inst Catala Paleont Miquel Crusafont ICP, Mesozo Res Grp, E-08201 Sabadell, Catalonia, Spain; [Holgado, Borja] Univ Valencia, Dept Geol, E-46100 Valencia, Spain; [Bernardini, Federico; Tuniz, Claudio] Museo Stor Fis, Ctr Fermi, I-00184 Rome, Italy; [Bernardini, Federico; Tuniz, Claudio] Ctr Studi & Ric Enrico Fermi, I-00184 Rome, Italy; [Bernardini, Federico; Tuniz, Claudio] Abdus Salam Int Ctr Theoret Phys ICTP, Multidisciplinary Lab, I-34014 Trieste, Italy; [Tuniz, Claudio] Univ Wollongong, Sch Earth & Environm Sci, Ctr Archaeol Sci, Wollongong, NSW 2522, Australia	Institut Catala de Paleontologia Miquel Crusafont (ICP); University of Valencia; Abdus Salam International Centre for Theoretical Physics (ICTP); University of Wollongong	Holgado, B (corresponding author), Inst Catala Paleont Miquel Crusafont ICP, Mesozo Res Grp, C Escola Ind 23, E-08201 Sabadell, Catalonia, Spain.	bortx.holgado@gmail.com	Holgado, Borja/AAA-8113-2021; Fortuny, Josep/L-2523-2014	Holgado, Borja/0000-0001-8968-0775; Fortuny, Josep/0000-0003-4282-1619; Bernardini, Federico/0000-0002-3282-8799				Abel RL, 2012, PALAEONTOL ELECTRON, V15; Barrett Paul M., 2008, Zitteliana Reihe B, V28, P61; Barthel KW., 1994, STUDY MESOZOIC PALAE; Behrensmeyer A.K., 1991, Topics in Geobiology, V9, P291; Von Baczko MB, 2013, GEOL SOC SPEC PUBL, V379, P187, DOI 10.1144/SP379.4; BENNETT SC, 1993, PALEOBIOLOGY, V19, P92, DOI 10.1017/S0094837300012331; Cope ED, 1870, T AM PHILOS SOC, V14; CURRIE PJ, 1995, CAN J EARTH SCI, V32, P922, DOI 10.1139/e95-077; DALLA VECCHIA F.M., 2008, VERTEBRATI FOSSILI F; Dalla Vecchia F. M., 2004, GORTANIA, V25, P47; Dalla Vecchia F.M., 2014, MEMORIE MUSEO FRIULA, V54; Dalla Vecchia F. M., 1998, B SOC PALEONTOLOGICA, V36, P355; Dalla Vecchia F. M., 1989, GORTANIA, V10, P121; Dalla Vecchia Fabio M., 2003, Geological Society Special Publication, V217, P23, DOI 10.1144/GSL.SP.2003.217.01.03; Dalla Vecchia FM, 2013, GEOL SOC SPEC PUBL, V379, P119, DOI 10.1144/SP379.14; Dalla Vecchia FM, 2013, ACTA PALAEONTOL POL, V58, P325, DOI 10.4202/app.2011.0132; Dalla Vecchia Fabio M., 2006, Bulletin of the New Mexico Museum of Natural History and Science, V37, P432; Dalla Vecchia FM, 2009, RIV ITAL PALEONTOL S, V115, P159, DOI 10.13130/2039-4942/6377; Dalla Vecchia Fabio Marco, 2000, Bollettino della Societa Paleontologica Italiana, V39, P225; Dalla Vecchia FM, 2012, FRIULI 215 MILIONI A; DALLAVECCHIA FM, 2002, GORTANIA, V23, P5; Davis PG, 1998, PALAIOS, V13, P3, DOI 10.2307/3515277; EWER RF, 1965, PHILOS T ROY SOC B, V248, P379, DOI 10.1098/rstb.1965.0003; Ezcurra MD, 2013, GEOL SOC SPEC PUBL, V379, P9, DOI 10.1144/SP379.11; Fraser NC, 2007, J VERTEBR PALEONTOL, V27, P261, DOI 10.1671/0272-4634(2007)27[261:ANGTDA]2.0.CO;2; Frey E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031945; GANS C, 1987, PALEOBIOLOGY, V13, P415; Hone DWE, 2008, PALAEONTOLOGY, V51, P95, DOI 10.1111/j.1475-4983.2007.00739.x; Hone DWE, 2014, PALAEOGEOGR PALAEOCL, V394, P89, DOI 10.1016/j.palaeo.2013.11.022; Irmis RB, 2013, GEOL SOC SPEC PUBL, V379, P275, DOI 10.1144/SP379.24; Janicke V, 1970, Neues Jb. Geol. Palaont. Mh., V1970, P452; Jenkins Farish A. Jr., 2001, Bulletin of the Museum of Comparative Zoology, V156, P151; Jiang DY, 2011, J VERTEBR PALEONTOL, V31, P1230, DOI 10.1080/02724634.2011.610853; Trotteyn MJ, 2011, AMEGHINIANA, V48, P424, DOI 10.5710/AMGH.v48i4(351); Kellner AWA, 2015, AN ACAD BRAS CIENC, V87, P669, DOI 10.1590/0001-3765201520150307; Langer MC, 2013, GEOL SOC SPEC PUBL, V379, P157, DOI 10.1144/SP379.9; Langer MC, 2004, DINOSAURIA, 2ND EDITION, P25; Dalla Vecchia FM, 2015, HIST BIOL, V27, P683, DOI 10.1080/08912963.2014.933826; Martill David M., 2008, Zitteliana Reihe B, V28, P175; Myhrvold NP, 2012, HIST BIOL, V24, P505, DOI 10.1080/08912963.2011.631703; Nesbitt SJ, 2013, GEOL SOC SPEC PUBL, V379, P241, DOI 10.1144/SP379.1; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; Nesbitt SJ, 2009, ZOOL J LINN SOC-LOND, V157, P814, DOI 10.1111/j.1096-3642.2009.00530.x; Nosotti Stefania, 2007, Memorie della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale di Milano, V35, P1; Olsen P.E., 1979, Postilla, P1; Osi A, 2010, ANAT REC, V293, P243, DOI 10.1002/ar.21053; Padian K, 2008, SPEC PAP PALAEONTOL, P5; Padian K, 2008, SPEC PAP PALAEONTOL, P69, DOI 10.1111/j.1475-4983.2008.00795.x; Premru E., 1991, BESCHEREIBUNG UNPUB; Renesto S, 2005, RIV ITAL PALEONTOL S, V111, P247, DOI 10.13130/2039-4942/6310; Renesto S, 2003, J VERTEBR PALEONTOL, V23, P703, DOI 10.1671/A1101; Renesto S, 2000, J VERTEBR PALEONTOL, V20, P622, DOI 10.1671/0272-4634(2000)020[0622:TUDAFH]2.0.CO;2; Renesto S., 2010, NEW MEXICO MUSEUM NA, V46, P1; Renesto Silvio, 1994, Rivista Italiana di Paleontologia e Stratigrafia, V100, P285; Renesto S, 2007, RIV ITAL PALEONTOL S, V113, P191, DOI 10.13130/2039-4942/5870; Renesto Silvio, 2002, Senckenbergiana Lethaea, V82, P95; Romer A, 1956, OSTEOLOGY REPTILES; Saller F, 2013, NEUES JAHRB GEOL P-A, V268, P83, DOI 10.1127/0077-7749/2013/0319; Sangster S, 2003, ANATOMY FUNCTIONAL M; Schafer W., 1972, ECOLOGY PALAEOECOLOG; Schweigert G., 2001, JAHRBERICHTE MITT OB, V83, P357, DOI 10.1127/jmogv/83/2001/357; Serpagli E, 1990, INTRO PALEONTOLOGIA; SHAROV A G, 1971, Trudy Paleontologicheskogo Instituta Akademiya Nauk SSSR, V130, P104; Spielmann J.A., 2008, NEW MEXICO MUSEUM NA, V43, P1; Tannenbaum Kaye Fran, 1994, P171; Thies D, 2013, NEUES JAHRB GEOL P-A, V267, P117, DOI 10.1127/0077-7749/2012/0301; Tuniz C, 2013, NUCL INSTRUM METH A, V711, P106, DOI 10.1016/j.nima.2013.01.046; Unwin DM., 2006, PTEROSAURS DEEP TIME; Veldmeijer Andre J., 2007, P295, DOI 10.1007/978-3-540-46046-6_13; Welinhofer P., 1975, Palaeontographica Abt A, V148, P1; WELLNHOFER P, 1978, HDB PALAEOHERPETOLOG; Wellnhofer P, 1991, ILLUSTRATED ENCY PTE; WILD R, 1978, Bollettino della Societa Paleontologica Italiana, V17, P176; Wild R., 1984, GORTANIA, V5, P45; Wild R., 1973, ABHANDLUNGEN SCHWEIZ, V95, P1; Witton M.P., 2013, PTEROSAURS NATURAL H, DOI DOI 10.1515/9781400847655	76	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141275	10.1371/journal.pone.0141275	http://dx.doi.org/10.1371/journal.pone.0141275			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560101	gold, Green Published, Green Submitted			2022-12-26	WOS:000364433100029
J	Musinguzi, G; Bastiaens, H; Wanyenze, RK; Mukose, A; Van Geertruyden, JP; Nuwaha, F				Musinguzi, Geofrey; Bastiaens, Hilde; Wanyenze, Rhoda K.; Mukose, Aggrey; Van Geertruyden, Jean-Pierre; Nuwaha, Fred			Capacity of Health Facilities to Manage Hypertension in Mukono and Buikwe Districts in Uganda: Challenges and Recommendations	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; NONCOMMUNICABLE DISEASES; CARDIOVASCULAR RISK; CARE; PREVENTION; PRIORITY; BURDEN	Background The burden of chronic diseases is increasing in both low-and middle-income countries. However, healthcare systems in low-income countries are inadequately equipped to deal with the growing disease burden, which requires chronic care for patients. The aim of this study was to assess the capacity of health facilities to manage hypertension in two districts in Uganda. Methods In a cross-sectional study conducted between June and October 2012, we surveyed 126 health facilities (6 hospitals, 4 Health Center IV (HCIV), 23 Health Center III (HCIII), 41 Health Center II (HCII) and 52 private clinics/dispensaries) in Mukono and Buikwe districts in Uganda. We assessed records, conducted structured interviews with heads of facilities, and administered questionnaires to 271 health workers. The study assessed service provision for hypertension, availability of supplies such as medicines, guidelines and equipment, in-service training for hypertension, knowledge of hypertension management, challenges and recommendations. Results Of the 126 health facilities, 92.9% reported managing (diagnosing/treating) patients with hypertension, and most (80.2%) were run by non-medical doctors or non-physician health workers (NPHW). Less than half (46%) of the facilities had guidelines for managing hypertension. A 10th of the facilities lacked functioning blood pressure devices and 28% did not have stethoscopes. No facilities ever calibrated their BP devices except one. About a half of the facilities had anti-hypertensive medicines in stock; mainly thiazide diuretics (46%), beta blockers (56%) and calcium channel blockers (48.4%). Alpha blockers, mixed alpha & beta blockers and angiotensin II receptor antagonists were only stocked by private clinics/dispensaries. Most HCIIs lacked anti-hypertensive medicines, including the first line thiazide diuretics. Significant knowledge gaps in classification of patients as hypertensive were noted among respondents. All health workers (except 5, 1.9%) indicated that they needed additional training in hypertension management. Several provider and patient related challenges were also observed in this study. Conclusions Health facilities in this setting are inadequately equipped to provide services for management of hypertension. Diagnostic equipment, anti-hypertensive drugs and personnel present great challenges. To address the increasing burden of hypertension and other chronic diseases, measures are needed to substantially strengthen the healthcare facilities, including training of personnel in management of hypertension and other chronic diseases, and improving diagnostic and treatment supplies.	[Musinguzi, Geofrey; Wanyenze, Rhoda K.; Nuwaha, Fred] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Dis Control & Environm Hlth, Kampala, Uganda; [Bastiaens, Hilde] Univ Antwerp, Primary & Interdisciplinary Care, B-2020 Antwerp, Belgium; [Mukose, Aggrey] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda; [Musinguzi, Geofrey; Mukose, Aggrey; Van Geertruyden, Jean-Pierre] Univ Antwerp, Dept Epidemiol & Biostat, Int Hlth, B-2020 Antwerp, Belgium	Makerere University; University of Antwerp; Makerere University; University of Antwerp	Musinguzi, G (corresponding author), Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Dis Control & Environm Hlth, Kampala, Uganda.	mgeof@musph.ac.ug	Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Bastiaens, Hilde/0000-0002-5509-3406	Makerere University Infectious Diseases Institute TARGETS II Project; Flemish Inter-University Council (VLIR-UOS) via the HEFS Platform Harvest Call [ZIUS2013VOA0902]	Makerere University Infectious Diseases Institute TARGETS II Project; Flemish Inter-University Council (VLIR-UOS) via the HEFS Platform Harvest Call	The Study was funded by Makerere University Infectious Diseases Institute TARGETS II Project. The Flemish Inter-University Council (VLIR-UOS) via the HEFS Platform Harvest Call (ZIUS2013VOA0902) supported GM for a short research stay at the University of Antwerp to draft the manuscript.	Abegunde DO, 2007, B WORLD HEALTH ORGAN, V85, P432, DOI 10.2471/BLT.06.032177; Ali MK, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005121; [Anonymous], 2010, PACK ESS NONC DIS IN, P66; [Anonymous], 2007, AFR HEALTH SCI, V7, P38; Beaglehole R, 2008, LANCET, V372, P940, DOI 10.1016/S0140-6736(08)61404-X; Bischoff A, 2009, INT J ENV RES PUB HE, V6, P2258, DOI 10.3390/ijerph6082258; Boutayeb A, 2006, T ROY SOC TROP MED H, V100, P191, DOI 10.1016/j.trstmh.2005.07.021; Bovet P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-407; Dass SK, 2004, CHANGING TRENDS HLTH; David L, 2007, ECOLOGICAL ENV ANTHR, V3, P2007; Hyder A. A., 2006, APPL BURDEN DIS ANAL; Kengne AP, 2009, J CLIN HYPERTENS, V11, P564, DOI 10.1111/j.1751-7176.2009.00165.x; Mendis S, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/584041; Mendis S, 2007, J HYPERTENS, V25, P1578, DOI 10.1097/HJH.0b013e3282861fd3; Mendis S, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/878460; Miranda JJ, 2008, TROP MED INT HEALTH, V13, P1225, DOI 10.1111/j.1365-3156.2008.02116.x; Musinguzi G, 2015, J CLIN HYPERTENS, V17, P63, DOI 10.1111/jch.12371; Musinguzi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062236; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; O'Neill K, 2013, B WORLD HEALTH ORGAN, V91, P923, DOI 10.2471/BLT.12.116798; Peck R, 2014, LANCET GLOB HEALTH, V2, pE285, DOI 10.1016/S2214-109X(14)70033-6; Perkovic V, 2007, HYPERTENSION, V50, P991, DOI 10.1161/HYPERTENSIONAHA.107.095497; Republic of Uganda, 2010, HLTH SECT STRAT INV; Sekokotla D, 2003, HYPERTENSION MANAGEM; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; Thorogood M, 2007, SCAND J PUBLIC HEALT, V35, P52, DOI 10.1080/14034950701355411; Whyte SR, 2014, 7 SPP	27	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142312	10.1371/journal.pone.0142312	http://dx.doi.org/10.1371/journal.pone.0142312			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560131	Green Published, gold, Green Submitted			2022-12-26	WOS:000364433100070
J	O'Shea-Wheller, TA; Sendova-Franks, AB; Franks, NR				O'Shea-Wheller, Thomas A.; Sendova-Franks, Ana B.; Franks, Nigel R.			Differentiated Anti-Predation Responses in a Superorganism	PLOS ONE			English	Article							ALARM PHEROMONES; NEST; HYMENOPTERA; COLONIES	Insect societies are complex systems, displaying emergent properties much greater than the sum of their individual parts. As such, the concept of these societies as single 'superorganisms' is widely applied to describe their organisation and biology. Here, we test the applicability of this concept to the response of social insect colonies to predation during a vulnerable period of their life history. We used the model system of house-hunting behaviour in the ant Temnothorax albipennis. We show that removing individuals from directly within the nest causes an evacuation response, while removing ants at the periphery of scouting activity causes the colony to withdraw back into the nest. This suggests that colonies react differentially, but in a coordinated fashion, to these differing types of predation. Our findings lend support to the superorganism concept, as the whole society reacts much like a single organism would in response to attacks on different parts of its body. The implication of this is that a collective reaction to the location of worker loss within insect colonies is key to avoiding further harm, much in the same way that the nervous systems of individuals facilitate the avoidance of localised damage.	[O'Shea-Wheller, Thomas A.; Franks, Nigel R.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Sendova-Franks, Ana B.] UWE Bristol, Dept Engn Design & Math, Bristol, Avon, England	University of Bristol; University of West England	O'Shea-Wheller, TA (corresponding author), Univ Bristol, Sch Biol Sci, Life Sci Bldg,24 Tyndall Ave, Bristol, Avon, England.	to13870@bristol.ac.uk	Franks, Nigel/AAG-8207-2019	Franks, Nigel/0000-0001-8139-9604; O'Shea-Wheller, Thomas/0000-0002-5537-2659				Backen SJ, 2000, BEHAV ECOL SOCIOBIOL, V48, P125, DOI 10.1007/s002650000219; BRADSHAW JWS, 1975, NATURE, V258, P230, DOI 10.1038/258230a0; BUSCHINGER A, 1988, INSECT SOC, V35, P61, DOI 10.1007/BF02224138; Chadab R., 1979, Psyche (Cambridge), V86, P115, DOI 10.1155/1979/38164; Dornhaus A, 2004, ANIM BEHAV, V67, P959, DOI 10.1016/j.anbehav.2003.09.004; DOWMAN R, 1992, PAIN, V49, P187, DOI 10.1016/0304-3959(92)90142-X; DUFFIELD RM, 1976, COMP BIOCHEM PHYS B, V54, P439, DOI 10.1016/0305-0491(76)90116-4; Eaton RC, 2001, PROG NEUROBIOL, V63, P467, DOI 10.1016/S0301-0082(00)00047-2; EHRLICH D, 1981, J COMP NEUROL, V195, P643, DOI 10.1002/cne.901950408; Franks NR, 2013, ANIM BEHAV, V85, P1233, DOI 10.1016/j.anbehav.2013.03.010; Franks NR, 2008, ANIM BEHAV, V76, P323, DOI 10.1016/j.anbehav.2008.02.009; Franks NR, 2006, P ROY SOC B-BIOL SCI, V273, P165, DOI 10.1098/rspb.2005.3312; Franks NR, 2000, BEHAV ECOL, V11, P315, DOI 10.1093/beheco/11.3.315; Franks NR, 2002, PHILOS T R SOC B, V357, P1567, DOI 10.1098/rstb.2002.1066; Franks NR, 2002, ANIM BEHAV, V65, P215; Gardner A, 2009, J EVOLUTION BIOL, V22, P659, DOI 10.1111/j.1420-9101.2008.01681.x; Holldobler B., 1990, pi; Holldobler B., 2009, SUPERORGANISM, P522; Lin N, 1963, BEHAVIOUR, V20, P115; Oster G. F., 1979, CASTE ECOLOGY SOCIAL, DOI DOI 10.1007/BF00046355; Pamminger T, 2011, BEHAV ECOL, V22, P255, DOI 10.1093/beheco/arq191; Pinter-Wollman N, 2012, BEHAV ECOL SOCIOBIOL, V66, P1407, DOI 10.1007/s00265-012-1396-2; REEVE HK, 1987, BEHAVIOUR, V102, P147, DOI 10.1163/156853986X00090; Richardson TO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009621; Roberts A, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00016; Robinson EJH, 2009, P ROY SOC B-BIOL SCI, V276, P4373, DOI 10.1098/rspb.2009.1244; Sasaki T, 2014, J EXP BIOL, V217, P3229, DOI 10.1242/jeb.106849; SENDOVAFRANKS AB, 1995, ANIM BEHAV, V50, P121, DOI 10.1006/anbe.1995.0226; WILKENS LA, 1981, PROC R SOC SER B-BIO, V211, P341, DOI 10.1098/rspb.1981.0011; WILSON EO, 1953, Q REV BIOL, V28, P136, DOI 10.1086/399512	30	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141012	10.1371/journal.pone.0141012	http://dx.doi.org/10.1371/journal.pone.0141012			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26558385	Green Published, Green Submitted, gold			2022-12-26	WOS:000364433100018
J	Weihmann, T; Reinhardt, L; Weissing, K; Siebert, T; Wipfler, B				Weihmann, Tom; Reinhardt, Lars; Weissing, Kevin; Siebert, Tobias; Wipfler, Benjamin			Fast and Powerful: Biomechanics and Bite Forces of the Mandibles in the American Cockroach Periplaneta americana	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; TWITCH MUSCLES; SLOW-TWITCH; BLUE CRABS; PERFORMANCE; INSECT; MORPHOLOGY; SKELETONS; SUPPORT; JOINT	Knowing the functionality and capabilities of masticatory apparatuses is essential for the ecological classification of jawed organisms. Nevertheless insects, especially with their outstanding high species number providing an overwhelming morphological diversity, are notoriously underexplored with respect to maximum bite forces and their dependency on the mandible opening angles. Aiming for a general understanding of insect biting, we examined the generalist feeding cockroach Periplaneta americana, characterized by its primitive chewing mouth parts. We measured active isometric bite forces and passive forces caused by joint resistance over the entire mandibular range with a custom-built 2D force transducer. The opening angle of the mandibles was quantified by using a video system. With respect to the effective mechanical advantage of the mandibles and the cross-section areas, we calculated the forces exerted by the mandible closer muscles and the corresponding muscle stress values. Comparisons with the scarce data available revealed close similarities of the cockroaches' mandible closer stress values (58 N/cm2) to that of smaller specialist carnivorous ground beetles, but strikingly higher values than in larger stag beetles. In contrast to available datasets our results imply the activity of faster and slower muscle fibres, with the latter becoming active only when the animals chew on tough material which requires repetitive, hard biting. Under such circumstances the coactivity of fast and slow fibres provides a force boost which is not available during short-term activities, since long latencies prevent a specific effective employment of the slow fibres in this case.	[Weihmann, Tom] Univ Cambridge, Dept Zool, Cambridge, England; [Reinhardt, Lars] Univ Jena, Sci Mot, Jena, Germany; [Weissing, Kevin] Univ Jena, Inst Spezielle Zool & Evolutionsbiol, Phyletischem Museum, Entomol Grp, Jena, Germany; [Siebert, Tobias] Univ Stuttgart, Inst Sport & Mot Sci, D-70174 Stuttgart, Germany	University of Cambridge; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; University of Stuttgart	Weihmann, T (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	tw424@cam.ac.uk; benjamin.wipfler@uni-jena.de	Siebert, Tobias/C-9626-2012; Weihmann, Tom/GYJ-8011-2022	Siebert, Tobias/0000-0003-4090-5480; Weihmann, Tom/0000-0002-6628-1816	German Research Foundation (DFG) [We 4664/2-1]; Daimler und Benz Stiftung [32-10/12]; German Research Foundation [WI 4324/1-1]	German Research Foundation (DFG)(German Research Foundation (DFG)); Daimler und Benz Stiftung; German Research Foundation(German Research Foundation (DFG))	This work was financially supported by the German Research Foundation (DFG, We 4664/2-1) to TW and by a PostDoc stipend of the Daimler und Benz Stiftung (32-10/12) and the German Research Foundation (WI 4324/1-1) to BW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ache JM, 2012, J NEUROPHYSIOL, V107, P2756, DOI 10.1152/jn.01072.2011; Ahn AN, 2002, J EXP BIOL, V205, P379; ALEXANDER RM, 1985, J EXP BIOL, V115, P231; Anderson RA, 2008, BIOL J LINN SOC, V93, P709, DOI 10.1111/j.1095-8312.2007.00905.x; Bell W. J., 2007, COCKROACHES ECOLOGY; Blanke A, 2012, CLADISTICS, V28, P560, DOI 10.1111/j.1096-0031.2012.00405.x; Blumel M, 2012, BIOL CYBERN, V106, P559, DOI 10.1007/s00422-012-0530-6; Chapman RF, 2013, J CHEM INF MODEL, V5th; Chapman RF., 1995, REGULATORY MECH INSE, Vvol. 1995; CHESLER M, 1981, J NEUROBIOL, V12, P391, DOI 10.1002/neu.480120408; Claussen DL, 2008, J COMP PHYSIOL B, V178, P333, DOI 10.1007/s00360-007-0226-8; Clissold FJ, 2007, ADV INSECT PHYSIOL, V34, P317, DOI 10.1016/S0065-2806(07)34006-X; CROW MT, 1982, J GEN PHYSIOL, V79, P147, DOI 10.1085/jgp.79.1.147; Dai ZD, 2002, J EXP BIOL, V205, P2479; ELNER RW, 1978, OECOLOGIA, V36, P333, DOI 10.1007/BF00348059; Full RJ, 1998, J EXP BIOL, V201, P997; Gorb S, 2000, J MORPHOL, V244, P1, DOI 10.1002/(SICI)1097-4687(200004)244:1<1::AID-JMOR1>3.0.CO;2-E; GOVIND CK, 1985, BIOL BULL, V168, P321, DOI 10.2307/1541244; Goyens J, 2015, FUNCT ECOL, V29, P35, DOI 10.1111/1365-2435.12294; Goyens J, 2014, J EXP BIOL, V217, P1065, DOI 10.1242/jeb.091744; Gronenberg W, 1997, CELL TISSUE RES, V289, P347, DOI 10.1007/s004410050882; Guschlbauer C, 2007, J EXP BIOL, V210, P1092, DOI 10.1242/jeb.02729; Herrel A, 2006, PHYSIOL BIOCHEM ZOOL, V79, P1, DOI 10.1086/498196; HOYLE G, 1978, J EXP BIOL, V73, P205; Lappin AK, 2014, J EXP BIOL, V217, P4303, DOI 10.1242/jeb.106385; McMeeking RM, 2012, J THEOR BIOL, V297, P17, DOI 10.1016/j.jtbi.2011.12.003; Paul J, 1999, J EXP BIOL, V202, P797; Petie R, 2007, J THEOR BIOL, V244, P565, DOI 10.1016/j.jtbi.2006.09.004; PRUIM GJ, 1980, J BIOMECH, V13, P755, DOI 10.1016/0021-9290(80)90237-7; Rast GF, 2001, NEUROSCIENCE, V108, P167, DOI 10.1016/S0306-4522(01)00406-7; Reinhardt L, 2014, J EXP BIOL, V217, P704, DOI 10.1242/jeb.094177; Roces F, 1996, NATURE, P373; Rode C, 2009, J MECH MED BIOL, V9, P105, DOI 10.1142/S0219519409002870; SAVAGE R J G, 1977, Palaeontology (Oxford), V20, P237; SCHMIDTNIELSEN K, 1975, J EXP ZOOL, V194, P287, DOI 10.1002/jez.1401940120; Schmitt C, 2014, J EXP BIOL, V217, P3095, DOI 10.1242/jeb.092742; Siebert T, 2014, COMPUTATIONAL MODELI, P173, DOI DOI 10.1533/9780857096739.2.173; Siebert T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130985; Siebert T, 2010, J COMP PHYSIOL B, V180, P199, DOI 10.1007/s00360-009-0401-1; Snodgrass R.E, 1944, FEEDING APPARATUS BI; Taylor GM, 2000, P ROY SOC B-BIOL SCI, V267, P1475, DOI 10.1098/rspb.2000.1167; Taylor JRA, 2007, J EXP BIOL, V210, P4272, DOI 10.1242/jeb.007054; Taylor JRA, 2003, SCIENCE, V301, P209, DOI 10.1126/science.1085987; van der Meijden A, 2012, J EXP BIOL, V215, P3411, DOI 10.1242/jeb.072926; Weihmann T, ARTHROPOD S IN PRESS; Weihmann T, 2009, J COMP PHYSIOL A, V195, P1011, DOI 10.1007/s00359-009-0475-y; Weihmann T, 2009, COMP BIOCHEM PHYS A, V153A, pS124, DOI 10.1016/j.cbpa.2009.04.207; Weissing K, ARTHROPOD SYST UNPUB; WENDT IR, 1974, AM J PHYSIOL, V226, P642, DOI 10.1152/ajplegacy.1974.226.3.642; WHEATER CP, 1989, J INSECT PHYSIOL, V35, P815, DOI 10.1016/0022-1910(89)90096-6; Wipfler B, 2012, ARTHROPOD STRUCT DEV, V41, P87, DOI 10.1016/j.asd.2011.06.005; Wipfler B, 2015, CLADISTICS, V31, P50, DOI 10.1111/cla.12068; Wipfler B, 2011, SYST ENTOMOL, V36, P241, DOI 10.1111/j.1365-3113.2010.00556.x	53	21	22	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0141226	10.1371/journal.pone.0141226	http://dx.doi.org/10.1371/journal.pone.0141226			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559671	Green Submitted, Green Published, gold			2022-12-26	WOS:000364433100026
J	Clarke, N; Biscocho, J; Kwei, KA; Davidson, JM; Sridhar, S; Gong, X; Pollack, JR				Clarke, Nicole; Biscocho, Jewison; Kwei, Kevin A.; Davidson, Jean M.; Sridhar, Sushmita; Gong, Xue; Pollack, Jonathan R.			Integrative Genomics Implicates EGFR as a Downstream Mediator in NKX2-1 Amplified Non-Small Cell Lung Cancer	PLOS ONE			English	Article							SET ENRICHMENT ANALYSIS; TRANSCRIPTION FACTOR-I; ADENOCARCINOMA; GENE; LINES; EXPRESSION; ONCOGENE; SURVIVAL; MUTATION; PROGRESSION	NKX2-1, encoding a homeobox transcription factor, is amplified in approximately 15% of non-small cell lung cancers (NSCLC), where it is thought to drive cancer cell proliferation and survival. However, its mechanism of action remains largely unknown. To identify relevant downstream transcriptional targets, here we carried out a combined NKX2-1 transcriptome (NKX2-1 knockdown followed by RNAseq) and cistrome (NKX2-1 binding sites by ChIPseq) analysis in four NKX2-1-amplified human NSCLC cell lines. While NKX2-1 regulated genes differed among the four cell lines assayed, cell proliferation emerged as a common theme. Moreover, in 3 of the 4 cell lines, epidermal growth factor receptor (EGFR) was among the top NKX2-1 upregulated targets, which we confirmed at the protein level by western blot. Interestingly, EGFR knockdown led to upregulation of NKX2-1, suggesting a negative feedback loop. Consistent with this finding, combined knockdown of NKX2-1 and EGFR in NCI-H1819 lung cancer cells reduced cell proliferation (as well as MAP-kinase and PI3-kinase signaling) more than knockdown of either alone. Likewise, NKX2-1 knockdown enhanced the growth-inhibitory effect of the EGFR-inhibitor erlotinib. Taken together, our findings implicate EGFR as a downstream effector of NKX2-1 in NKX2-1 amplified NSCLC, with possible clinical implications, and provide a rich dataset for investigating additional mediators of NKX2-1 driven oncogenesis.	[Clarke, Nicole; Biscocho, Jewison; Kwei, Kevin A.; Davidson, Jean M.; Sridhar, Sushmita; Gong, Xue; Pollack, Jonathan R.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	Stanford University	Pollack, JR (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	pollack1@stanford.edu			Tobacco-Related Disease Research Program [21XT-0054]; Gates Millennium Foundation; Stanford Cancer Biology Program; Stanford Tumor Biology Training Program	Tobacco-Related Disease Research Program(University of California System); Gates Millennium Foundation; Stanford Cancer Biology Program; Stanford Tumor Biology Training Program	This research was supported by a grant from the Tobacco-Related Disease Research Program (21XT-0054). NC was supported by fellowships from the Gates Millennium Foundation and Stanford Cancer Biology Program, and JMD from the Stanford Tumor Biology Training Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann J, 2005, CANCER RES, V65, P226; American Cancer Society, 2014, FORMALDEHYDE; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; BANKSSCHLEGEL SP, 1985, CANCER RES, V45, P1187; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Boggaram V, 2009, CLIN SCI, V116, P27, DOI 10.1042/CS20080068; Cao YX, 2010, J BIOL CHEM, V285, P2152, DOI 10.1074/jbc.M109.039172; Chen FF, 2015, CANCER GENE THER, V22, P431, DOI 10.1038/cgt.2015.38; Chen G, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-28; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Conde E, 2006, CLIN CANCER RES, V12, P710, DOI 10.1158/1078-0432.CCR-05-1362; Cooper WA, 2013, J THORAC DIS, V5, pS479, DOI 10.3978/j.issn.2072-1439.2013.08.03; Finberg KE, 2007, J MOL DIAGN, V9, P320, DOI 10.2353/jmoldx.2007.060182; Garraway LA, 2006, NAT REV CANCER, V6, P593, DOI 10.1038/nrc1947; Gazdar AF, 2010, JNCI-J NATL CANCER I, V102, P1310, DOI 10.1093/jnci/djq279; Gazdar AF, 1996, J CELL BIOCHEM, P1; Haura Eric B, 2004, Clin Lung Cancer, V6, P113, DOI 10.3816/CLC.2004.n.025; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; Kubo T, 2009, INT J CANCER, V124, P1778, DOI 10.1002/ijc.24150; Kwei KA, 2008, ONCOGENE, V27, P3635, DOI 10.1038/sj.onc.1211012; Maeda Y, 2012, J CLIN INVEST, V122, P4388, DOI 10.1172/JCI64048; Minoo P, 2007, MOL CELL BIOL, V27, P2155, DOI 10.1128/MCB.01133-06; Mu D, 2013, J BIOL CHEM, V288, P24992, DOI 10.1074/jbc.R113.491647; Ordonez NG, 2000, ADV ANAT PATHOL, V7, P123, DOI 10.1097/00125480-200007020-00007; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Phelps RM, 1996, J CELL BIOCHEM, P32; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Tagne JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029907; Tanaka H, 2007, CANCER RES, V67, P6007, DOI 10.1158/0008-5472.CAN-06-4774; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Tsai HY, 2013, ONCOGENE, V32, P4921, DOI 10.1038/onc.2012.514; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Watanabe H, 2013, GENE DEV, V27, P197, DOI 10.1101/gad.203208.112; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Wistuba II, 1999, CLIN CANCER RES, V5, P991; Yamaguchi T, 2013, CANCER CELL, V23, P718, DOI 10.1016/j.ccr.2013.04.002; Yamaguchi T, 2012, CANCER CELL, V21, P348, DOI 10.1016/j.ccr.2012.02.008; Yeh JE, 2013, CURR OPIN ONCOL, V25, P652, DOI 10.1097/01.cco.0000432528.88101.1a	42	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142061	10.1371/journal.pone.0142061	http://dx.doi.org/10.1371/journal.pone.0142061			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556242	Green Published, gold, Green Submitted			2022-12-26	WOS:000364430700049
J	Li, FG; Chen, J; Jiang, XY; Zou, SM				Li, Fu-Gui; Chen, Jie; Jiang, Xia-Yun; Zou, Shu-Ming			Transcriptome Analysis of Blunt Snout Bream (Megalobrama amblycephala) Reveals Putative Differential Expression Genes Related to Growth and Hypoxia	PLOS ONE			English	Article							MOLECULAR-CLONING; RNA-SEQ; HIF-1-ALPHA; DUPLICATION; ANNOTATION; TELEOST; VISUALIZATION; CONSERVATION; HIF-2-ALPHA; INCREASES	The blunt snout bream (Megalobrama amblycephala) is an important freshwater aquaculture species, but it is sensitive to hypoxia. No transcriptome data related to growth and hypoxia response are available for this species. In this study, we performed de novo transcriptome sequencing for the liver and gills of the fast-growth family and slow-growth family derived from 'Pujiang No. 1'F10 blunt snout bream that were under hypoxic stress and normoxia, respectively. The fish were divided into the following 4 groups: fast-growth family under hypoxic stress, FH; slow-growth family under hypoxic stress, SH; fast-growth family under normoxia, FN; and slow-growth family under normoxia, SN. A total of 185 million high-quality reads were obtained from the normalized cDNA of the pooled samples, which were assembled into 465,582 contigs and 237,172 transcripts. A total of 31,338 transcripts from the same locus (unigenes) were annotated and assigned to 104 functional groups, and 23,103 unigenes were classified into seven main categories, including 45 secondary KEGG pathways. A total of 22,255 (71%) known putative unigenes were found to be shared across the genomes of five model fish species and mammals, and a substantial number (9.4%) of potentially novel genes were identified. When 6,639 unigenes were used in the analysis of differential expression (DE) genes, the number of putative DE genes related to growth pathways in FH, SH, SN and FN was 159, 118, 92 and 65 in both the liver and gills, respectively, and the number of DE genes related to hypoxic response was 57, 33, 23 and 21 in FH, FN, SH and SN, respectively. Our results suggest that growth performance of the fast-growth family should be due to complex mutual gene regulatory mechanisms of these putative DE genes between growth and hypoxia.	[Li, Fu-Gui; Chen, Jie; Jiang, Xia-Yun; Zou, Shu-Ming] Shanghai Ocean Univ, Key Lab Freshwater Aquat Genet Resources, Shanghai 201306, Peoples R China	Shanghai Ocean University	Jiang, XY (corresponding author), Shanghai Ocean Univ, Key Lab Freshwater Aquat Genet Resources, Huchenghuan Rd 999, Shanghai 201306, Peoples R China.	jiangxy@shou.edu.cn; smzou@shou.edu.cn			Key Technologies Research and Development Program of China [2012BAD26B02]; National Science Foundation of China [31272633, 31201760]; Shanghai University Knowledge Service Platform [ZF1206]	Key Technologies Research and Development Program of China(National Key Technology R&D Program); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai University Knowledge Service Platform	This work was supported by grants from the Key Technologies Research and Development Program of China (2012BAD26B02), the National Science Foundation of China (31272633; 31201760), and the Shanghai University Knowledge Service Platform (ZF1206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Cui XQ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-210; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fan HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059997; Gao JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088804; Gao ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042637; Ge XP, 2011, CHINESE FISHERY QUAL, V1, P22; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Gotz S, 2011, BIOINFORMATICS, V27, P919, DOI 10.1093/bioinformatics/btr059; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Greer SN, 2012, EMBO J, V31, P2448, DOI 10.1038/emboj.2012.125; Thanh HN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109656; He L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053915; He XP, 2012, ANIM GENET, V43, P233, DOI 10.1111/j.1365-2052.2011.02230.x; Howe EA, 2011, BIOINFORMATICS, V27, P3209, DOI 10.1093/bioinformatics/btr490; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Jiang HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105122; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Kamei H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003091; Ke H W, 1965, ACTA HYDROBIOL SIN, V5, P282; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; LI SF, 1993, AQUACULTURE, V111, P117, DOI 10.1016/0044-8486(93)90030-3; Li SF, 2003, NAGA, V26, P19; Li WT, 2014, COMPUT BIOL CHEM, V48, P77, DOI 10.1016/j.compbiolchem.2013.02.003; Li WT, 2012, J BIOINF COMPUT BIOL, V10, DOI 10.1142/S0219720012310038; Liao XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062308; Liu SC, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.453; Liu SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063895; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Ming JH, 2010, FISH SHELLFISH IMMUN, V28, P407, DOI 10.1016/j.fsi.2009.11.018; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Niu DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067456; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Qing DJ, 2009, PLANT CELL PHYSIOL, V50, P889, DOI 10.1093/pcp/pcp038; Rahman MS, 2007, GENE, V396, P273, DOI 10.1016/j.gene.2007.03.009; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rojas DA, 2007, GENE EXPR PATTERNS, V7, P339, DOI 10.1016/j.modgep.2006.08.002; Russell SJ, 2007, NAT REV MOL CELL BIO, V8, P681, DOI 10.1038/nrm2234; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shen RJ, 2010, COMP BIOCHEM PHYS B, V157, P273, DOI 10.1016/j.cbpb.2010.06.013; Sun CF, 2011, GEN COMP ENDOCR, V172, P409, DOI 10.1016/j.ygcen.2011.04.005; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tian Yu-Mei, 2014, Zoological Research, V35, P300, DOI 10.13918/j.issn.2095-8137.2014.4.300; Wang CM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-139; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xiao WH, 2015, SCI CHINA LIFE SCI, V58, P148, DOI 10.1007/s11427-015-4801-z; Xu W, 2008, J HYDROECOL, V1, P7; Yue G, 2001, MAR BIOTECHNOL, V3, P1, DOI 10.1007/s101260000043; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; ZHANG D, 2001, J CHINA 3 GORGES U, V3, P282; Zhang EY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103440; Zhang W, 2010, COMP BIOCHEM PHYS A, V157, P212, DOI 10.1016/j.cbpa.2010.06.184; Zhang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042082; Zhao YH, 2011, FISH SHELLFISH IMMUN, V31, P462, DOI 10.1016/j.fsi.2011.06.024; Zhou JF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003926; Zou SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007026	62	31	35	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142801	10.1371/journal.pone.0142801	http://dx.doi.org/10.1371/journal.pone.0142801			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554582	Green Submitted, Green Published, gold			2022-12-26	WOS:000364430700175
J	Li, XM; Xu, M; Wang, F; Ji, Y; Davidson, WS; Li, ZF; Tso, P				Li, Xiaoming; Xu, Min; Wang, Fei; Ji, Yong; Davidson, W. Sean; Li, Zongfang; Tso, Patrick			Interaction of ApoA-IV with NR4A1 and NR1D1 Represses G6Pase and PEPCK Transcription: Nuclear Receptor-Mediated Downregulation of Hepatic Gluconeogenesis in Mice and a Human Hepatocyte Cell Line	PLoS One			English	Article							APOLIPOPROTEIN-A-IV; HUMAN SKELETAL-MUSCLE; CHOLESTEROL EFFLUX; GENE-EXPRESSION; METABOLISM; NOR-1; INSULIN; NUR77; NURR1; RAT	We have previously shown that the nuclear receptor, NR1D1, is a cofactor in ApoA-IV-mediated downregulation of gluconeogenesis. Nuclear receptor, NR4A1, is involved in the transcriptional regulation of various genes involved in inflammation, apoptosis, and glucose metabolism. We investigated whether NR4A1 influences the effect of ApoA-IV on hepatic glucose metabolism. Our in situ proximity ligation assays and coimmunoprecipitation experiments indicated that ApoA-IV colocalized with NR4A1 in human liver (HepG2) and kidney (HEK-293) cell lines. The chromatin immunoprecipitation experiments and luciferase reporter assays indicated that the ApoA-IV and NR4A1 colocalized at the ROR alpha response element of the human G6Pase promoter, reducing its transcriptional activity. Our RNA interference experiments showed that knocking down the expression of NR4A1 in primary mouse hepatocytes treated with ApoA-IV increased the expression of NR1D1, G6Pase, and PEPCK, and that knocking down NR1D1 expression increased the level of NR4A1. We also found that ApoA-IV induced the expression of endogenous NR4A1 in both cultured primary mouse hepatocytes and in the mouse liver, and decreased glucose production in primary mouse hepatocytes. Our findings showed that ApoA-IV colocalizes with NR4A1, which suppresses G6Pase and PEPCK gene expression at the transcriptional level, reducing hepatic glucose output and lowering blood glucose. The ApoA-IV-induced increase in NR4A1 expression in hepatocytes mediates further repression of gluconeogenesis. Our findings suggest that NR1D1 and NR4A1 serve similar or complementary functions in the ApoA-IV-mediated regulation of gluconeogenesis.	[Li, Xiaoming; Li, Zongfang] Xi An Jiao Tong Univ, Natl Local Joint Engn Res Ctr Biodiagnost & Bioth, Affiliated Hosp 2, Coll Med, Xian 710004, Shaanxi, Peoples R China; [Li, Xiaoming; Xu, Min; Wang, Fei; Ji, Yong; Davidson, W. Sean; Tso, Patrick] Univ Cincinnati, Metab Dis Inst, Dept Pathol & Lab Med, Cincinnati, OH 45237 USA	Xi'an Jiaotong University; University System of Ohio; University of Cincinnati	Li, ZF (corresponding author), Xi An Jiao Tong Univ, Natl Local Joint Engn Res Ctr Biodiagnost & Bioth, Affiliated Hosp 2, Coll Med, 157 W 5th Rd, Xian 710004, Shaanxi, Peoples R China.	lizhongfangbm@163.com; Patrick_Tso@yeah.net		Davidson, William/0000-0003-2756-2989	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [DK 59630, DK 92138, DK 76928]; Cincinnati MMPC [U24 DK059630]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076928, R01DK092138, U24DK059630] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cincinnati MMPC; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health awarded to Dr. Tso (grant nos. DK 59630, DK 92138, and DK 76928) and The Cincinnati MMPC (grant no. U24 DK059630). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandoh S, 1997, LEUKEMIA, V11, P1453, DOI 10.1038/sj.leu.2400800; Chao LC, 2009, DIABETES, V58, P2788, DOI 10.2337/db09-0763; Duez H, 2008, DIABETES VASC DIS RE, V5, P82, DOI 10.3132/dvdr.2008.0014; DVORIN E, 1986, J BIOL CHEM, V261, P5714; Fernandez PM, 2000, ENDOCRINOLOGY, V141, P2392, DOI 10.1210/en.141.7.2392; Fournier N, 2000, ARTERIOSCL THROM VAS, V20, P1283, DOI 10.1161/01.ATV.20.5.1283; Fu YC, 2007, J BIOL CHEM, V282, P31525, DOI 10.1074/jbc.M701132200; GHISELLI G, 1989, BIOCHIM BIOPHYS ACTA, V1006, P26, DOI 10.1016/0005-2760(89)90319-6; LAU LF, 1985, EMBO J, V4, P3145, DOI 10.1002/j.1460-2075.1985.tb04057.x; Li XM, 2014, J BIOL CHEM, V289, P2396, DOI 10.1074/jbc.M113.511766; LIU ZG, 1994, NATURE, V367, P281, DOI 10.1038/367281a0; Lu S, 2006, J BIOL CHEM, V281, P3473, DOI 10.1074/jbc.M502501200; Mahoney DJ, 2005, FASEB J, V19, P1498, DOI 10.1096/fj.04-3149fje; MARUYAMA K, 1995, CANCER LETT, V96, P117, DOI 10.1016/0304-3835(95)03921-I; Murphy EP, 2001, ARTHRITIS RHEUM-US, V44, P782, DOI 10.1002/1529-0131(200104)44:4<782::AID-ANR134>3.3.CO;2-8; Pearen MA, 2008, ENDOCRINOLOGY, V149, P2853, DOI 10.1210/en.2007-1202; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Pires NMM, 2007, CIRCULATION, V115, P493, DOI 10.1161/CIRCULATIONAHA.106.626838; Qin XF, 1998, AM J PHYSIOL-HEART C, V274, pH1836, DOI 10.1152/ajpheart.1998.274.5.H1836; Rius J, 2006, ATHEROSCLEROSIS, V184, P276, DOI 10.1016/j.atherosclerosis.2005.04.008; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037; STEINMETZ A, 1990, J BIOL CHEM, V265, P7859; Thorngate FE, 2003, J LIPID RES, V44, P2331, DOI 10.1194/jlr.M300224-JLR200; Tubb MR, 2007, J BIOL CHEM, V282, P28385, DOI 10.1074/jbc.M704070200; Wang F, 2012, P NATL ACAD SCI USA, V109, P9641, DOI 10.1073/pnas.1201433109; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; Weinberg RB, 2002, CURR OPIN LIPIDOL, V13, P125, DOI 10.1097/00041433-200204000-00003; Weyrich P, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-77; WILSON TE, 1993, MOL CELL BIOL, V13, P861, DOI 10.1128/MCB.13.2.861; WORONICZ JD, 1994, NATURE, V367, P277, DOI 10.1038/367277a0; WU AL, 1979, J BIOL CHEM, V254, P7316; Wu XX, 2007, ENDOCRINE, V31, P5, DOI 10.1007/s12020-007-0007-x; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	35	13	14	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142098	10.1371/journal.pone.0142098	http://dx.doi.org/10.1371/journal.pone.0142098			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556724	Green Published, Green Submitted, gold			2022-12-26	WOS:000364430700052
J	Maria, NSS; Barnes, SR; Weist, MR; Colcher, D; Raubitschek, AA; Jacobs, RE				Maria, Naomi S. Sta; Barnes, Samuel R.; Weist, Michael R.; Colcher, David; Raubitschek, Andrew A.; Jacobs, Russell E.			Low Dose Focused Ultrasound Induces Enhanced Tumor Accumulation of Natural Killer Cells	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; IN-VIVO; NK CELLS; DRUG-DELIVERY; IMMUNOTHERAPY; MICROBUBBLES; PERMEABILITY; MOUSE; DOXORUBICIN; DISRUPTION	Natural killer (NK) cells play a vital antitumor role as part of the innate immune system. Efficacy of adoptive transfer of NK cells depends on their ability to recognize and target tumors. We investigated whether low dose focused ultrasound with microbubbles (ldbFUS) could facilitate the targeting and accumulation of NK cells in a mouse xenograft of human colorectal adenocarcinoma (carcinoembryonic antigen (CEA)-expressing LS-174T implanted in NOD. Cg-Prkdc(scid)II2rg(tm1Wjl/SzJ) (NSG) mice) in the presence of an anti-CEA immunocytokine (ICK), hT84.66/M5A-IL-2 (M5A-IL-2). Human NK cells were labeled with an FDA-approved ultra-small superparamagnetic iron oxide particle, ferumoxytol. Simultaneous with the intravenous injection of microbubbles, focused ultrasound was applied to the tumor. In vivo longitudinal magnetic resonance imaging (MRI) identified enhanced accumulation of NK cells in the ensonified tumor, which was validated by endpoint histology. Significant accumulation of NK cells was observed up to 24 hrs at the tumor site when ensonified with 0.50 MPa peak acoustic pressure ldbFUS, whereas tumors treated with at 0.25 MPa showed no detectable NK cell accumulation. These clinically translatable results show that ldbFUS of the tumor mass can potentiate tumor homing of NK cells that can be evaluated non-invasively using MRI.	[Maria, Naomi S. Sta; Barnes, Samuel R.; Jacobs, Russell E.] CALTECH, Beckman Inst, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Weist, Michael R.; Colcher, David; Raubitschek, Andrew A.] Beckman Inst, Dept Canc Immunotherapeut & Tumor Immunol, Duarte, CA USA	California Institute of Technology; City of Hope; Beckman Research Institute of City of Hope	Jacobs, RE (corresponding author), CALTECH, Beckman Inst, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	rjacobs@caltech.edu	; Jacobs, Russell/H-1087-2011	Sta Maria, Naomi/0000-0001-9710-2908; Jacobs, Russell/0000-0002-1382-8486	National Institutes of Health [EB000993, CA43904]; Beckman Institute at Caltech; Beckman Institute at the City of Hope; NATIONAL CANCER INSTITUTE [P01CA043904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000993] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Institute at Caltech; Beckman Institute at the City of Hope; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Institutes of Health (EB000993) (http://www.nibib.nih.gov/) and the Beckman Institute at Caltech (http://www.beckmaninstitute.caltech.edu/) to REJ; and National Institutes of Health (CA43904) (http://www.cancer.gov/) and the Beckman Institute at the City of Hope (http://www.cityofhope.org/beckman-research-institute) to DC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bataineh O, 2012, CANCER TREAT REV, V38, P346, DOI 10.1016/j.ctrv.2011.08.004; Alderson KL, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/379123; Alkins R, 2013, CANCER RES, V73, P1892, DOI 10.1158/0008-5472.CAN-12-2609; Ames E, 2014, CANCER IMMUNOL IMMUN, V63, P21, DOI 10.1007/s00262-013-1469-8; Arct J, 2008, CLIN DERMATOL, V26, P347, DOI 10.1016/j.clindermatol.2008.01.004; Barnes SR, 2015, BMC MED IMAGING, V15, DOI 10.1186/s12880-015-0062-3; Chen PY, 2010, NEURO-ONCOLOGY, V12, P1050, DOI 10.1093/neuonc/noq054; Chenevert Thomas L, 2002, Mol Imaging, V1, P336, DOI 10.1162/153535002321093945; Cheng M, 2013, CELL MOL IMMUNOL, V10, P230, DOI 10.1038/cmi.2013.10; Cheng Min, 2012, Front Med, V6, P56, DOI 10.1007/s11684-012-0177-7; Chopra R, 2010, ACS CHEM NEUROSCI, V1, P391, DOI 10.1021/cn9000445; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Daldrup-Link HE, 2005, EUR RADIOL, V15, P4, DOI 10.1007/s00330-004-2526-7; Dall'Ozzo S, 2004, CANCER RES, V64, P4664, DOI 10.1158/0008-5472.CAN-03-2862; Figueiredo C, 2009, J MOL MED, V87, P199, DOI 10.1007/s00109-008-0417-0; Galli F, 2014, Q J NUCL MED MOL IM, V58, P276; Gillies SD, 2005, BLOOD, V105, P3972, DOI 10.1182/blood-2004-09-3533; Hamstra DA, 2005, P NATL ACAD SCI USA, V102, P16759, DOI 10.1073/pnas.0508347102; Jha P, 2010, CANCER RES, V70, P6109, DOI 10.1158/0008-5472.CAN-09-3774; Jolesz FA, 2009, ANNU REV MED, V60, P417, DOI 10.1146/annurev.med.60.041707.170303; Khurana A, 2013, NANOMEDICINE-UK, V8, P1969, DOI 10.2217/nnm.12.198; Kiessling F, 2012, J NUCL MED, V53, P345, DOI 10.2967/jnumed.111.099754; KIESSLING R, 1975, EUR J IMMUNOL, V5, P117, DOI 10.1002/eji.1830050209; Kinoshita M, 2006, P NATL ACAD SCI USA, V103, P11719, DOI 10.1073/pnas.0604318103; Konofagou EE, 2012, THERANOSTICS, V2, P1223, DOI 10.7150/thno.5576; Kuo TT, 2011, MABS-AUSTIN, V3, P422, DOI 10.4161/mabs.3.5.16983; Lazovic J, 2008, CLIN CANCER RES, V14, P3832, DOI 10.1158/1078-0432.CCR-07-5067; Liu HL, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-221; Lode HN, 1998, PHARMACOL THERAPEUT, V80, P277, DOI 10.1016/S0163-7258(98)00033-3; Lu P, 2009, SURGERY, V145, P286, DOI 10.1016/j.surg.2008.10.010; Maria ASS, 2014, MAGN RESON INSIGHTS, V7, P15, DOI 10.4137/MRI.S13145; McDannold N, 2012, CANCER RES, V72, P3652, DOI 10.1158/0008-5472.CAN-12-0128; Miller JS, 2013, HEMATOL-AM SOC HEMAT, P247, DOI 10.1182/asheducation-2013.1.247; Miller JS, 2005, BLOOD, V105, P3051, DOI 10.1182/blood-2004-07-2974; Muller T, 2008, CANCER IMMUNOL IMMUN, V57, P411, DOI 10.1007/s00262-007-0383-3; O'Reilly MA, 2012, JOVE-J VIS EXP, DOI 10.3791/3555; Orsi F, 2010, J CANCER RES THER, V6, P414, DOI 10.4103/0973-1482.77064; Park J, 2012, J CONTROL RELEASE, V162, P134, DOI 10.1016/j.jconrel.2012.06.012; Ruggeri L, 2005, CURR OPIN IMMUNOL, V17, P211, DOI 10.1016/j.coi.2005.01.007; Samiotaki G, 2012, MAGN RESON MED, V67, P769, DOI 10.1002/mrm.23063; Sheu AY, 2013, INVEST RADIOL, V48, P492, DOI 10.1097/RLI.0b013e31827994e5; Somanchi Srinivas S, 2011, J Vis Exp, DOI 10.3791/2540; Talebian L, 2014, TRANSFUSION, V54, P1515, DOI 10.1111/trf.12517; Nhan T, 2013, J CONTROL RELEASE, V172, P274, DOI 10.1016/j.jconrel.2013.08.029; Tao Sun, 2013, Journal of the Acoustical Society of America, V134, DOI 10.1121/1.4831336; Treat LH, 2007, INT J CANCER, V121, P901, DOI 10.1002/ijc.22732; Vestweber D, 2012, ANN NY ACAD SCI, V1257, P184, DOI 10.1111/j.1749-6632.2012.06558.x; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Vlachos F, 2011, MAGN RESON MED, V66, P821, DOI 10.1002/mrm.22848; Wang ST, 2014, ULTRASOUND MED BIOL, V40, P130, DOI 10.1016/j.ultrasmedbio.2013.09.015; Watson KD, 2012, CANCER RES, V72, P1485, DOI 10.1158/0008-5472.CAN-11-3232; Yazaki PJ, 2004, PROTEIN ENG DES SEL, V17, P481, DOI 10.1093/protein/gzh056	53	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142767	10.1371/journal.pone.0142767	http://dx.doi.org/10.1371/journal.pone.0142767			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556731	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000364430700172
J	Okamoto, A; Higo, M; Shiiba, M; Nakashima, D; Koyama, T; Miyamoto, I; Kasama, H; Kasamatsu, A; Ogawara, K; Yokoe, H; Tanzawa, H; Uzawa, K				Okamoto, Atsushi; Higo, Morihiro; Shiiba, Masashi; Nakashima, Dai; Koyama, Tomoyoshi; Miyamoto, Isao; Kasama, Hiroki; Kasamatsu, Atsushi; Ogawara, Katsunori; Yokoe, Hidetaka; Tanzawa, Hideki; Uzawa, Katsuhiro			Down-Regulation of Nucleolar and Spindle-Associated Protein 1 (NUSAP1) Expression Suppresses Tumor and Cell Proliferation and Enhances Anti-Tumor Effect of Paclitaxel in Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							CANCER; THERAPY; ALCOHOL; TOBACCO; TAXOL	Background Nucleolar and spindle-associated protein 1 (NUSAP1) is an important mitotic regulator. In addition to its crucial function in mitosis, NUSAP1 has recently received attention due to the interesting roles in carcinogenesis. The aim of this study was to reveal functional mechanisms of NUSAP1 in oral squamous cell carcinoma (OSCC). Methods mRNA and protein expression levels of NUSAP1 in 9 OSCC-derived cells were analyzed by quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) and immuno-blotting analyses. The correlation between the NUSAP1 expression profile and the clinicopathological factors was evaluated by immunohistochemistry (IHC) in clinical OSCC samples (n = 70). The NUSAP1 knockdown cells were established with short hairpin RNA (shRNA) in OSCC cells, and functional assays were performed using these cells. In addition to the evaluation of cellular proliferation and cell cycle, we also investigated the potential role of NUSAP1 in paclitaxel (PTX)-induced cellular responses. Results mRNA and protein expression of NUSAP1 were significantly up-regulated in OSCC-derived cells compared with human normal oral keratinocytes (P < 0.05). IHC revealed that NUSAP-1 expression is closely associated with primary advanced T stage (P<0.05). Suppression of NUSAP1 expression levels led to significant (P<0.05) inhibition of cellular proliferation. Furthermore, apoptosis induced by PTX was enhanced in NUSAP1 knockdown OSCC cells. Conclusions NUSAP1 may be a crucial biomarker for OSCC. Moreover, down-regulated NUSAP1 expression suppresses tumor proliferation and also enhances anti-tumor effect of PTX by activating apoptotic pathways. Thus, the present study strongly suggests that regulating NUSAP1 expression should contribute to the therapy for OSCC.	[Okamoto, Atsushi; Shiiba, Masashi; Koyama, Tomoyoshi; Miyamoto, Isao; Kasama, Hiroki; Tanzawa, Hideki; Uzawa, Katsuhiro] Chiba Univ, Grad Sch Med, Dept Oral Sci, Chuo Ku, Chiba, Japan; [Higo, Morihiro; Nakashima, Dai; Kasamatsu, Atsushi; Ogawara, Katsunori; Tanzawa, Hideki; Uzawa, Katsuhiro] Chiba Univ Hosp, Dept Dent & Oral Maxillofacial Surg, Chuo Ku, Chiba, Japan; [Shiiba, Masashi] Chiba Univ, Grad Sch Med, Dept Med Oncol, Chuo Ku, Chiba, Japan; [Yokoe, Hidetaka] Natl Def Med Coll Hosp, Dept Oral & Maxillofacial Surg, Res Inst, Tokorozawa, Saitama, Japan	Chiba University; Chiba University; National Defense Medical College - Japan	Shiiba, M (corresponding author), Chiba Univ, Grad Sch Med, Dept Oral Sci, Chuo Ku, Chiba, Japan.	m.shiiba@faculty.chiba-u.jp		Uzawa, Katsuhiro/0000-0002-7036-0859				Baba T, 2013, MOL CARCINOGENESIS; Chen DT, 2010, BREAST CANCER RES TR, V119, P335, DOI 10.1007/s10549-009-0344-y; Diaz-Rodriguez E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027583; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Ferrero M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028602; Iyer J, 2011, CELL SIGNAL, V23, P991, DOI 10.1016/j.cellsig.2010.11.006; Iyoda M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014082; Koike H, 2005, CONNECT TISSUE RES, V46, P117, DOI 10.1080/03008200591008437; Kokkinakis DM, 2005, MOL CANCER THER, V4, P1338, DOI 10.1158/1535-7163.MCT-05-0141; MACFARLANE GJ, 1995, ORAL ONCOL, V31B, P181; MARSHALL CJ, 1991, CELL, V64, P313, DOI 10.1016/0092-8674(91)90641-B; MASHBERG A, 1993, CANCER-AM CANCER SOC, V72, P1369, DOI 10.1002/1097-0142(19930815)72:4<1369::AID-CNCR2820720436>3.0.CO;2-L; MCGUIRE WP, 1989, ANN INTERN MED, V111, P273, DOI 10.7326/0003-4819-111-4-273; PINDBORG JJ, 1997, WHO CLASSIFICATION T; Raemaekers T, 2003, J CELL BIOL, V162, P1017, DOI 10.1083/jcb.200302129; Satow R, 2010, CLIN CANCER RES, V16, P2518, DOI 10.1158/1078-0432.CCR-09-2214; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; Shimizu F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083187; Shimizu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045510; Sobin L, 2009, TNM CLASSIFICATION M; Sudbo J, 2005, INT J CANCER, V115, P339, DOI 10.1002/ijc.20896; Verburg FA, 2010, HORM METAB RES, V42, P736, DOI 10.1055/s-0030-1254132; Yamano Y, 2008, INT J ONCOL, V32, P1001	23	35	41	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142252	10.1371/journal.pone.0142252	http://dx.doi.org/10.1371/journal.pone.0142252			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554377	Green Published, gold, Green Submitted			2022-12-26	WOS:000364430700074
J	Pytka, K; Partyka, A; Jastrzebska-Wiesek, M; Siwek, A; Gluch-Lutwin, M; Mordyl, B; Kazek, G; Rapacz, A; Olczyk, A; Galuszka, A; Blachuta, M; Waszkielewicz, A; Marona, H; Sepa, J; Filipek, B; Wesolowska, A				Pytka, Karolina; Partyka, Anna; Jastrzebska-Wiesek, Magdalena; Siwek, Agata; Gluch-Lutwin, Monika; Mordyl, Barbara; Kazek, Grzegorz; Rapacz, Anna; Olczyk, Adrian; Galuszka, Adam; Blachuta, Marian; Waszkielewicz, Anna; Marona, Henryk; Sepa, Jacek; Filipek, Barbara; Wesolowska, Anna			Antidepressant- and Anxiolytic-Like Effects of New Dual 5-HT1A and 5-HT7 Antagonists in Animal Models	PLOS ONE			English	Article							TARGETING SEROTONIN 5-HT2A; MAJOR DEPRESSIVE DISORDER; FORCED SWIMMING TEST; PHARMACOLOGICAL EVALUATION; POTENTIAL ANTIDEPRESSANT; P-CHLOROPHENYLALANINE; RECEPTOR ANTAGONISTS; DERIVATIVES; BINDING; MICE	The aim of this study was to further characterize pharmacological properties of two phenylpiperazine derivatives: 1-{2-[2-(2,6-dimethlphenoxy)ethoxy]ethyl}-4-(2-methoxyphenyl) piperazynine hydrochloride (HBK-14) and 2-[2-(2-chloro-6-methylphenoxy) ethoxy] ethyl-4-(2-methoxyphenyl) piperazynine dihydrochloride (HBK-15) in radioligand binding and functional in vitro assays as well as in vivo models. Antidepressant-like properties were investigated in the forced swim test (FST) in mice and rats. Anxiolytic-like activity was evaluated in the four-plate test in mice and elevated plus maze test (EPM) in rats. Imipramine and escitalopram were used as reference drugs in the FST, and diazepam was used as a standard anxiolytic drug in animal models of anxiety. Our results indicate that HBK-14 and HBK-15 possess high or moderate affinity for serotonergic 5-HT2, adrenergic alpha(1), and dopaminergic D-2 receptors as well as being full 5-HT1A and 5-HT7 receptor antagonists. We also present their potent antidepressant-like activity (HBK-14-FST mice: 2.5 and 5 mg/kg; FST rats: 5 mg/kg) and (HBK-15-FST mice: 1.25, 2.5 and 5 mg/kg; FST rats: 1.25 and 2.5 mg/kg). We show that HBK-14 (four-plate test: 2.5 and 5 mg/kg; EPM: 2.5 mg/kg) and HBK-15 (four-plate test: 2.5 and 5 mg/kg; EPM: 5 mg/kg) possess anxiolytic-like properties. Among the two, HBK-15 has stronger antidepressant-like properties, and HBK-14 displays greater anxiolytic-like activity. Lastly, we demonstrate the involvement of serotonergic system, particularly 5-HT1A receptor, in the antidepressant-and anxiolytic-like actions of investigated compounds.	[Pytka, Karolina; Kazek, Grzegorz; Rapacz, Anna; Sepa, Jacek; Filipek, Barbara] Jagiellonian Univ, Dept Pharmacodynam, Fac Pharm, Med Coll,Med 9, PL-30688 Krakow, Poland; [Partyka, Anna; Jastrzebska-Wiesek, Magdalena; Wesolowska, Anna] Jagiellonian Univ, Dept Clin Pharm, Fac Pharm, Med Coll,Med 9, PL-30688 Krakow, Poland; [Siwek, Agata; Gluch-Lutwin, Monika; Mordyl, Barbara] Jagiellonian Univ, Dept Pharmacobiol, Fac Pharm, Med Coll,Med 9, PL-30688 Krakow, Poland; [Olczyk, Adrian; Galuszka, Adam; Blachuta, Marian] Silesian Tech Univ, Inst Automat Control, Akad 16, PL-44100 Gliwice, Poland; [Waszkielewicz, Anna; Marona, Henryk] Jagiellonian Univ, Dept Bioorgan Chem, Fac Pharm, Chair Organ Chem,Med Coll,Med 9, PL-30688 Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; Silesian University of Technology; Jagiellonian University; Collegium Medicum Jagiellonian University	Pytka, K (corresponding author), Jagiellonian Univ, Dept Pharmacodynam, Fac Pharm, Med Coll,Med 9, PL-30688 Krakow, Poland.	karolina.pytka@ut.edu.pl	Partyka, Anna/AAZ-8648-2020; Galuszka, Adam/ABB-2203-2021; Głuch-Lutwin, Monika/AAE-2702-2019; Pytka, Karolina/Z-5491-2019; Siwek, Agata/AAE-2742-2019; Mordyl, Barbara/AAD-8247-2019; Blachuta, Marian/V-2022-2018	Galuszka, Adam/0000-0002-6176-0500; Głuch-Lutwin, Monika/0000-0003-1632-6569; Pytka, Karolina/0000-0001-7134-9515; Siwek, Agata/0000-0001-5321-9266; Mordyl, Barbara/0000-0001-7906-0353; Marona, Henryk/0000-0002-3815-4174; Filipek, Barbara/0000-0001-8487-9945; Waszkielewicz, Anna/0000-0002-2871-9418; SAPA, JACEK/0000-0003-4670-1665; Jastrzebska-Wiesek, Magdalena/0000-0002-5388-1214; Wesolowska, Anna/0000-0003-2383-3278; Rapacz, Anna/0000-0002-0190-1682; Blachuta, Marian/0000-0001-6468-7962	Jagiellonian University [K/DSC/001955]; Silesian University of Technology [BK 227/RAu1/2015/1]; GeCONil-Upper Silesian Center for Computational Science and Engineering [POIG.02.03.01-24-099/13]	Jagiellonian University; Silesian University of Technology; GeCONil-Upper Silesian Center for Computational Science and Engineering	Funding: This study was supported by Jagiellonian University grant number K/DSC/001955 and Silesian University of Technology grant number BK 227/RAu1/2015/1. The research was partially performed on the infrastructure supported by POIG.02.03.01-24-099/13 grant: "GeCONil-Upper Silesian Center for Computational Science and Engineering". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agai-Csongor E, 2012, BIOORG MED CHEM LETT, V22, P3437, DOI 10.1016/j.bmcl.2012.03.104; Albert PR, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00199; Boldrini M, 2008, J PSYCHIATR RES, V42, P433, DOI 10.1016/j.jpsychires.2007.05.004; Chae E, 2012, BIOORG MED CHEM LETT, V22, P2434, DOI 10.1016/j.bmcl.2012.02.023; CHEETHAM SC, 1990, PSYCHOPHARMACOLOGY, V102, P544, DOI 10.1007/BF02247138; Cheng HC, 2001, J PHARMACOL TOX MET, V46, P61, DOI 10.1016/S1056-8719(02)00166-1; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Dawson LA, 2009, CNS NEUROSCI THER, V15, P107, DOI 10.1111/j.1755-5949.2008.00067.x; DETKE MJ, 1995, PSYCHOPHARMACOLOGY, V121, P66, DOI 10.1007/BF02245592; Garcia-Garcia AL, 2014, PSYCHOPHARMACOLOGY, V231, P623, DOI 10.1007/s00213-013-3389-x; Griebel G, 2000, NEUROPHARMACOLOGY, V39, P1848, DOI 10.1016/S0028-3908(00)00074-5; Guscott M, 2005, NEUROPHARMACOLOGY, V48, P492, DOI 10.1016/j.neuropharm.2004.11.015; Hedlund PB, 2005, BIOL PSYCHIAT, V58, P831, DOI 10.1016/j.biopsych.2005.05.012; Hedlund PB, 2009, PSYCHOPHARMACOLOGY, V206, P345, DOI 10.1007/s00213-009-1626-0; Hsiung S, 2003, J NEUROCHEM, V87, P182, DOI 10.1046/j.1471-4159.2003.01987.x; Imaizumi M, 1996, METHOD FIND EXP CLIN, V18, P513; Jastrzebska-Wiesek M, 2014, NEUROPHARMACOLOGY, V85, P253, DOI 10.1016/j.neuropharm.2014.05.036; Jindal A, 2012, EUR J PHARMACOL, V689, P125, DOI 10.1016/j.ejphar.2012.05.051; Johnson DS, 2011, BIOORG MED CHEM LETT, V21, P2621, DOI 10.1016/j.bmcl.2011.01.059; Kang SY, 2010, BIOORG MED CHEM LETT, V20, P1705, DOI 10.1016/j.bmcl.2010.01.093; Kim JY, 2010, BIOORG MED CHEM LETT, V20, P6439, DOI 10.1016/j.bmcl.2010.09.081; KOE BK, 1966, J PHARMACOL EXP THER, V154, P499; Kolaczkowski M, 2014, J MED CHEM, V57, P4543, DOI 10.1021/jm401895u; Lanzenberger RR, 2007, BIOL PSYCHIAT, V61, P1081, DOI 10.1016/j.biopsych.2006.05.022; Le Francois B, 2008, NEUROPHARMACOLOGY, V55, P977, DOI 10.1016/j.neuropharm.2008.06.046; Li YC, 2009, PROG NEURO-PSYCHOPH, V33, P435, DOI 10.1016/j.pnpbp.2009.01.006; LUCKI I, 1994, NEUROSCI BIOBEHAV R, V18, P85, DOI 10.1016/0149-7634(94)90039-6; MAJ J, 1985, EUR J PHARMACOL, V119, P113, DOI 10.1016/0014-2999(85)90328-0; Manosso LM, 2013, PROG NEURO-PSYCHOPH, V46, P48, DOI 10.1016/j.pnpbp.2013.06.012; McCorvy JD, 2015, PHARMACOL THERAPEUT, V150, P129, DOI 10.1016/j.pharmthera.2015.01.009; Mnie-Filali O, 2007, DRUG NEWS PERSPECT, V20, P613, DOI 10.1358/dnp.2007.20.10.1181354; Mork A, 2012, J PHARMACOL EXP THER, V340, P666, DOI 10.1124/jpet.111.189068; Mullins UL, 1999, NEUROPSYCHOPHARMACOL, V21, P352, DOI 10.1016/S0893-133X(99)00041-X; Naumenko VS, 2014, CNS NEUROSCI THER, V20, P582, DOI 10.1111/cns.12247; Nikiforuk A, 2011, PSYCHOPHARMACOLOGY, V217, P411, DOI 10.1007/s00213-011-2297-1; Owens MJ, 1997, J PHARMACOL EXP THER, V283, P1305; Petit-Demouliere B, 2005, PSYCHOPHARMACOLOGY, V177, P245, DOI 10.1007/s00213-004-2048-7; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Prakash C, 1997, DRUG METAB DISPOS, V25, P1288; Pytka K, 2016, PHARMACOL REP, V68, P263, DOI 10.1016/j.pharep.2015.08.007; Pytka K, 2015, EUR J PHARMACOL, V764, P537, DOI 10.1016/j.ejphar.2015.07.041; Pytka K, 2015, PHARMACOL REP, V67, P160, DOI 10.1016/j.pharep.2014.08.016; Scorza MC, 2012, BRIT J PHARMACOL, V167, P1021, DOI 10.1111/j.1476-5381.2011.01770.x; Szewczyk B, 2009, INT J NEUROPSYCHOPH, V12, P155, DOI 10.1017/S1461145708009012; Waszkielewicz AM, 2013, BIOORG MED CHEM LETT, V23, P4419, DOI 10.1016/j.bmcl.2013.05.062; Waszkielewicz AM, 2015, CHEM BIOL DRUG DES, V85, P326, DOI 10.1111/cbdd.12394; Wesolowska A, 2008, PHARMACOL REP, V60, P464; Whale R, 2010, J PSYCHOPHARMACOL, V24, P513, DOI 10.1177/0269881108097714; Zeni ALB, 2012, EUR J PHARMACOL, V679, P68, DOI 10.1016/j.ejphar.2011.12.041	50	34	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142499	10.1371/journal.pone.0142499	http://dx.doi.org/10.1371/journal.pone.0142499			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26554929	Green Published, gold, Green Submitted			2022-12-26	WOS:000364430700118
J	Shao, Y; Li, P; Zhu, ST; Yue, JP; Ji, XJ; He, Z; Ma, D; Wang, L; Wang, YJ; Zong, Y; Wu, YD; Zhang, ST				Shao, Ying; Li, Peng; Zhu, Sheng-tao; Yue, Ji-ping; Ji, Xiao-jun; He, Zhen; Ma, Dan; Wang, Li; Wang, Yong-jun; Zong, Ye; Wu, Yong-dong; Zhang, Shu-tian			Cyclooxygenase-2, a Potential Therapeutic Target, Is Regulated by miR-101 in Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							DOWN-REGULATION; TUMOR-SUPPRESSOR; CERVICAL-CANCER; GASTRIC-CANCER; EXPRESSION; GROWTH; COX-2; PROLIFERATION; INVASION; MIGRATION	Background & Aims Cyclooxygenase-2 (COX-2) is known to promote the carcinogenesis of esophageal squamous cell carcinoma (ESCC). There are no reports on whether microRNAs (miRNAs) regulate COX-2 expression in ESCC. This study investigated the effect of miR-101 on ESCC through modulating COX-2 expression in ESCC. Methods Real-time quantitative reverse transcription-polymerase chain reaction (RT-PCR) was used to quantify miR-101 expression in ESCC clinical tissues and cell lines. The effects of miR-101 on ESCC progression were evaluated by cell counting kit-8 (CCK8), transwell migration and invasion assays, as well as by flow cytometry. The COX-2 and PEG2 levels were determined by western blot and enzyme-linked immunosorbent assays (ELISA). The luciferase reporter assay was used to verify COX-2 as a direct target of miR-101. The antitumor activity of miR-101 in vivo was investigated in a xenograft nude mouse model of ESCC. Results Downregulation of miR-101 was confirmed through comparison of 30 pairs of ESCC tumor and adjacent normal tissues (P < 0.001), as well as in 11 ESCC cell lines and a human immortalized esophageal cell line (P < 0.001). Transfection of miR-101 in ESCC cell lines significantly suppressed cell proliferation, migration, and invasion (all P < 0.001). The antitumor effect of miR-101 was verified in a xenograft model. Furthermore, COX-2 was shown to be a target of miR-101. Conclusions Overexpression of miR-101 in ESCC inhibits proliferation and metastasis. Therefore, the miR-101/COX-2 pathway might be a therapeutic target in ESCC.	[Shao, Ying; Li, Peng; Zhu, Sheng-tao; Yue, Ji-ping; He, Zhen; Ma, Dan; Wang, Li; Wang, Yong-jun; Zong, Ye; Wu, Yong-dong; Zhang, Shu-tian] Capital Med Univ, Beijing Friendship Hosp, Natl Clin Res Ctr Digest Dis, Dept Gastroenterol,Beijing Key Lab Precancerous L, Beijing, Peoples R China; [Ji, Xiao-jun] Capital Med Univ, Intens Care Unit, Beijing Friendship Hosp, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Zhang, ST (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Natl Clin Res Ctr Digest Dis, Dept Gastroenterol,Beijing Key Lab Precancerous L, Beijing, Peoples R China.	zhangshutian@ccmu.edu.cn	He, Zhen/D-1275-2009	He, Zhen/0000-0001-6302-6556; , Jiping/0000-0003-0717-8613	national 973 Plan of China [2012CB526600]; National Natural Science Foundation of China [81341061]	national 973 Plan of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by national 973 Plan of China (approval number: 2012CB526600) to STZ (http://www.973.gov.cn/), and the National Natural Science Foundation of China (approval number: 81341061) to YS (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhim Z, 2011, BRIT J CANCER, V105, P393, DOI 10.1038/bjc.2011.262; Akanuma N, 2014, BRIT J CANCER, V110, P189, DOI 10.1038/bjc.2013.676; Akhtar N, 2012, ANN RHEUM DIS, V71, P1073, DOI 10.1136/annrheumdis-2011-200519; Barnas C, 1997, INT J CANCER, V71, P79, DOI 10.1002/(SICI)1097-0215(19970328)71:1<79::AID-IJC14>3.0.CO;2-4; Bertagnolli MM, 2007, LANCET ONCOL, V8, P439, DOI 10.1016/S1470-2045(07)70139-0; Chen LC, 2012, EUR J CANCER, V48, P3104, DOI 10.1016/j.ejca.2012.02.007; Chen MB, 2015, BIOCH BIOPHYS RES CO; Corley DA, 2003, GASTROENTEROLOGY, V124, P47, DOI 10.1053/gast.2003.50008; Ding DP, 2011, CARCINOGENESIS, V32, P1025, DOI 10.1093/carcin/bgr078; Elmets CA, 2014, J INVEST DERMATOL, V134, P2497, DOI 10.1038/jid.2014.192; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fosslien E, 2000, ANN CLIN LAB SCI, V30, P3; Fu MG, 2013, FEBS LETT, V587, P3471, DOI 10.1016/j.febslet.2013.08.036; FUNKHOUSER EM, 1995, CANCER-AM CANCER SOC, V76, P1116, DOI 10.1002/1097-0142(19951001)76:7<1116::AID-CNCR2820760703>3.0.CO;2-I; Gong H, 2013, CLIN CANCER RES, V19, P1083, DOI 10.1158/1078-0432.CCR-12-3169; Hao YB, 2011, CANCER PREV RES, V4, P1073, DOI 10.1158/1940-6207.CAPR-10-0333; He XP, 2012, FEBS J, V279, P4201, DOI 10.1111/febs.12013; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Ji Junfang, 2010, Front Med China, V4, P412, DOI 10.1007/s11684-010-0260-x; Ji YH, 2010, FEBS LETT, V584, P961, DOI 10.1016/j.febslet.2010.01.036; Jiang W, 2015, ANTICANCER AGENTS ME; Jiang YZ, 2015, ONCOL LETT, V9, P471, DOI 10.3892/ol.2014.2701; Kase S, 2004, PATHOBIOLOGY, V71, P84, DOI 10.1159/000074421; Kim BM, 2011, CANCER LETT, V300, P134, DOI 10.1016/j.canlet.2010.09.014; Kim HS, 2012, BIOCHEM PHARMACOL, V83, P385, DOI 10.1016/j.bcp.2011.11.008; Kim JI, 2010, MOL CANCER RES, V8, P569, DOI 10.1158/1541-7786.MCR-09-0511; Kong KL, 2012, GUT, V61, P33, DOI 10.1136/gutjnl-2011-300178; Konno Y, 2014, ONCOTARGET; Konno Y, 2014, ONCOTARGET, V5, P6049, DOI 10.18632/oncotarget.2157; Kumagai Y, 2015, INT SURG, V100, P733, DOI 10.9738/INTSURG-D-14-00234.1; Kurashige J, 2012, BRIT J CANCER, V106, P182, DOI 10.1038/bjc.2011.509; Lei Q, 2014, ONCOL REP, V32, P261, DOI 10.3892/or.2014.3167; Li P, 2009, DIS ESOPHAGUS, V22, P21, DOI 10.1111/j.1442-2050.2008.00836.x; Li W, 2014, GASTROENTEROLOGY, V146, P1714, DOI 10.1053/j.gastro.2014.03.002; Liang XL, 2014, INT J GYNECOL CANCER, V24, P1165, DOI 10.1097/IGC.0000000000000187; Lin C, 2011, CARCINOGENESIS, V32, P19, DOI 10.1093/carcin/bgq212; Lin C, 2014, INT J CLIN EXP PATHO, V7, P6543; Lin C, 2014, ASIAN PAC J CANCER P, V15, P45, DOI 10.7314/APJCP.2014.15.1.45; Liu JF, 2009, ANN SURG ONCOL, V16, P1397, DOI 10.1245/s10434-009-0382-z; Liu L, 2014, TUMOR BIOL, V35, P12619, DOI 10.1007/s13277-014-2585-6; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Meng XY, 2011, DIS ESOPHAGUS, V24, P444, DOI 10.1111/j.1442-2050.2010.01159.x; Meng XY, 2012, J DIGEST DIS, V13, P208, DOI 10.1111/j.1751-2980.2012.00578.x; Park SJ, 2013, OSTEOARTHR CARTILAGE, V21, P981, DOI 10.1016/j.joca.2013.04.012; Psaty BM, 2006, NEW ENGL J MED, V355, P950, DOI 10.1056/NEJMe068158; Shamma A, 2000, CLIN CANCER RES, V6, P1229; Shen Q, 2014, CANCER LETT, V344, P204, DOI 10.1016/j.canlet.2013.10.030; Shi HY, 2011, CANCER LETT, V309, P19, DOI 10.1016/j.canlet.2011.05.010; Song T, 2011, ASIAN PAC J CANCER P, V12, P929; Song Y, 2014, ONCOTARGET, V5, P11669, DOI 10.18632/oncotarget.2581; Strillacci A, 2009, EXP CELL RES, V315, P1439, DOI 10.1016/j.yexcr.2008.12.010; Tanaka Y, 2013, CANCER-AM CANCER SOC, V119, P1159, DOI 10.1002/cncr.27895; Wang CH, 2014, ONCOL LETT, V8, P1815, DOI 10.3892/ol.2014.2361; Wang L, 2014, CELL PHYSIOL BIOCHEM, V34, P413, DOI 10.1159/000363010; Wang R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046173; Wang ZQ, 2014, FEBS LETT, V588, P915, DOI 10.1016/j.febslet.2014.01.035; Yang C, 2014, CANCER CELL INT, V14, DOI 10.1186/s12935-014-0138-0; Yao YL, 2015, CNS NEUROSCI THER, V21, P40, DOI 10.1111/cns.12321; Yu HP, 2003, CANCER LETT, V198, P193, DOI 10.1016/S0304-3835(03)00340-9; Zang WQ, 2014, TUMOR BIOL, V35, P12583, DOI 10.1007/s13277-014-2579-4; Zhang F, 2014, CANCER LETT, V342, P121, DOI 10.1016/j.canlet.2013.08.037; Zhang HF, 2014, CARCINOGENESIS, V35, P292, DOI 10.1093/carcin/bgt320; Zhang JQ, 2013, AM J PATHOL, V182, P1629, DOI 10.1016/j.ajpath.2013.01.045; Zhang KL, 2014, ONCOL REP, V32, P2143, DOI 10.3892/or.2014.3459; Zhang L, 2011, WORLD J GASTROENTERO, V17, P4572, DOI 10.3748/wjg.v17.i41.4572; Zhang L, 2010, PATHOL ONCOL RES, V16, P39, DOI 10.1007/s12253-009-9185-6; Zhang W, 2003, CANCER DETECT PREV, V27, P243, DOI 10.1016/S0361-090X(03)00072-2; Zhi HY, 2003, INT J CANCER, V106, P327, DOI 10.1002/ijc.11225; Zhou XY, 2015, CANCER BIOL THER, V16, P160, DOI 10.4161/15384047.2014.987523; Zong Y, 2009, WORLD J GASTROENTERO, V15, P2500, DOI 10.3748/wjg.15.2500	70	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0140642	10.1371/journal.pone.0140642	http://dx.doi.org/10.1371/journal.pone.0140642			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26556718	gold, Green Published, Green Submitted			2022-12-26	WOS:000364430700012
J	Yu, SH; Wang, X; Zhang, T; Stressler, T; Fischer, L; Jiang, B; Mu, WM				Yu, Shuhuai; Wang, Xiao; Zhang, Tao; Stressler, Timo; Fischer, Lutz; Jiang, Bo; Mu, Wanmeng			Identification of a Novel Di-D-Fructofuranose 1,2 ': 2,3 ' Dianhydride (DFA III) Hydrolysis Enzyme from Arthrobacter aurescens SK8.001	PLOS ONE			English	Article							DIFRUCTOSE-ANHYDRIDE-III; INULIN FRUCTOTRANSFERASE; SWISS-MODEL; SP H65-7; SK 8.001; ULTRAFILTRATION MEMBRANE; CALCIUM-ABSORPTION; CLONING; GENE; PURIFICATION	Previously, a di-D-fructofuranose 1,2': 2,3' dianhydride (DFA III)-producing strain, Arthrobacter aurescens SK8.001, was isolated from soil, and the gene cloning and characterization of the DFA III-forming enzyme was studied. In this study, a DFA III hydrolysis enzyme (DFA IIIase)-encoding gene was obtained from the same strain, and the DFA IIIase gene was cloned and expressed in Escherichia coli. The SDS-PAGE and gel filtration results indicated that the purified enzyme was a homotrimer holoenzyme of 145 kDa composed of subunits of 49 kDa. The enzyme displayed the highest catalytic activity for DFA III at pH 5.5 and 55 degrees C, with specific activity of 232 U mg(-1). Km and Vmax for DFA III were 30.7 +/- 4.3 mM and 1.2 +/- 0.1 mM min(-1), respectively. Interestingly, DFA III-forming enzymes and DFA IIIases are highly homologous in amino acid sequence. The molecular modeling and docking of DFA IIIase were first studied, using DFA III-forming enzyme from Bacillus sp. snu-7 as a template. It was suggested that A. aurescens DFA IIIase shared a similar three-dimensional structure with the reported DFA III-forming enzyme from Bacillus sp. snu-7. Furthermore, their catalytic sites may occupy the same position on the proteins. Based on molecular docking analysis and site-directed mutagenesis, it was shown that D207 and E218 were two potential critical residues for the catalysis of A. aurescens DFA IIIase.	[Yu, Shuhuai; Wang, Xiao; Zhang, Tao; Jiang, Bo; Mu, Wanmeng] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi 214122, Jiangsu, Peoples R China; [Zhang, Tao; Jiang, Bo; Mu, Wanmeng] Jiangnan Univ, Synerget Innovat Ctr Food Safety & Nutr, Wuxi 214122, Jiangsu, Peoples R China; [Stressler, Timo; Fischer, Lutz] Univ Hohenheim, Inst Food Sci & Biotechnol, Dept Biotechnol & Enzyme Sci, D-70599 Stuttgart, Germany	Jiangnan University; Jiangnan University; University Hohenheim	Mu, WM (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi 214122, Jiangsu, Peoples R China.	wmmu@jiangnan.edu.cn			NSFC Project [21276001, 31371788]; Fundamental Research Funds for the Central Universities [JUSRP51304A]; Support Project of Jiangsu Province [BK20130001]	NSFC Project(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Support Project of Jiangsu Province	This work was supported by the NSFC Project (Nos. 21276001 and 31371788), the Fundamental Research Funds for the Central Universities (No. JUSRP51304A), and the Support Project of Jiangsu Province (BK20130001).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Beg QK, 2001, APPL MICROBIOL BIOT, V56, P326, DOI 10.1007/s002530100704; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cho CM, 1997, J MICROBIOL BIOTECHN, V7, P121; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Hang H, 2013, CARBOHYD POLYM, V95, P654, DOI 10.1016/j.carbpol.2013.02.058; Hang H, 2013, CARBOHYD POLYM, V92, P1608, DOI 10.1016/j.carbpol.2012.09.052; Hang H, 2012, DESALINATION, V284, P309, DOI 10.1016/j.desal.2011.09.016; Hang H, 2012, J BIOSCI BIOENG, V113, P55, DOI 10.1016/j.jbiosc.2011.08.026; Hang H, 2011, APPL MICROBIOL BIOT, V92, P457, DOI 10.1007/s00253-011-3553-3; Hara H, 2010, NUTRITION, V26, P120, DOI 10.1016/j.nut.2009.05.024; Haraguchi K, 2000, J BIOSCI BIOENG, V89, P590, DOI 10.1016/S1389-1723(00)80062-6; HARAGUCHI K, 1995, BIOSCI BIOTECH BIOCH, V59, P1809, DOI 10.1271/bbb.59.1809; Haraguchi K, 2013, CARBOHYD POLYM, V93, P473, DOI 10.1016/j.carbpol.2012.12.045; Jung WS, 2007, J BIOL CHEM, V282, P8414, DOI 10.1074/jbc.M607143200; Kawaguchi K, 2014, ARCH MICROBIOL, V196, P17, DOI 10.1007/s00203-013-0938-y; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kikuchi H., 2004, J APPL GLYCOSCI, V51, P291, DOI [10.5458/jag.51.291, DOI 10.5458/JAG.51.291]; Kim CS, 2007, J MICROBIOL BIOTECHN, V17, P37; Kim HY, 2000, J MICROBIOL BIOTECHN, V10, P275; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Matsumoto M, 2007, J AGR FOOD CHEM, V55, P4202, DOI 10.1021/jf070049p; MATSUYAMA T, 1982, J BIOCHEM-TOKYO, V92, P1325, DOI 10.1093/oxfordjournals.jbchem.a134051; Minamida K, 2006, BIOSCI BIOTECH BIOCH, V70, P332, DOI 10.1271/bbb.70.332; Minamida K, 2005, J BIOSCI BIOENG, V99, P230, DOI 10.1263/jbb.99.230; Mitamura R, 2006, EUR J NUTR, V45, P242, DOI 10.1007/s00394-006-0592-0; Mongodin EF, 2006, PLOS GENET, V2, P2094, DOI 10.1371/journal.pgen.0020214; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Mutanda T, 2009, APPL BIOCHEM BIOTECH, V159, P65, DOI 10.1007/s12010-008-8479-6; Nakamori M, 2010, J NUTR SCI VITAMINOL, V56, P191, DOI 10.3177/jnsv.56.191; Neubauer A, 2000, BIOCATAL BIOTRANSFOR, V18, P443, DOI 10.3109/10242420009015262; Offen W, 2006, EMBO J, V25, P1396, DOI 10.1038/sj.emboj.7600970; Park J, 2012, J BIOL CHEM, V287, P31233, DOI 10.1074/jbc.M112.389270; Pudjiraharti S, 2014, J ANTIBIOT, V67, P137, DOI 10.1038/ja.2013.95; Saito K, 2000, BIOSCI BIOTECH BIOCH, V64, P1321, DOI 10.1271/bbb.64.1321; Saito K, 2003, J BIOSCI BIOENG, V95, P538, DOI 10.1016/S1389-1723(03)80058-0; Sakurai H, 1997, BIOSCI BIOTECH BIOCH, V61, P989, DOI 10.1271/bbb.61.989; Sato T, 2012, J DAIRY SCI, V95, P5336, DOI 10.3168/jds.2011-4989; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shao H, 2005, PLANT CELL, V17, P3141, DOI 10.1105/tpc.105.035055; Shigematsu N, 2004, BIOSCI BIOTECH BIOCH, V68, P1011, DOI 10.1271/bbb.68.1011; Singh RS, 2013, BIOLOGIA, V68, P1028, DOI 10.2478/s11756-013-0259-2; TANAKA T, 1975, J BIOCHEM-TOKYO, V78, P1201, DOI 10.1093/oxfordjournals.jbchem.a131017; Tuncay H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074763; Wang X, 2015, J AGR FOOD CHEM, V63, P3509, DOI 10.1021/jf506165n; Wang X, 2015, APPL MICROBIOL BIOT, V99, P175, DOI 10.1007/s00253-014-6238-x; Yang F, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0243-3; YOKOTA A, 1991, J FERMENT BIOENG, V72, P258, DOI 10.1016/0922-338X(91)90159-E; YOKOTA A, 1991, J FERMENT BIOENG, V72, P262, DOI 10.1016/0922-338X(91)90160-I; Yu SH, 2015, J MOL CATAL B-ENZYM, V120, P16, DOI 10.1016/j.molcatb.2015.06.012; Zhao M, 2013, EUR FOOD RES TECHNOL, V236, P991, DOI 10.1007/s00217-013-1962-5; Zhao M, 2011, J SCI FOOD AGR, V91, P2715, DOI 10.1002/jsfa.4582; Zhao M, 2011, BIORESOURCE TECHNOL, V102, P1757, DOI 10.1016/j.biortech.2010.08.093	55	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142640	10.1371/journal.pone.0142640	http://dx.doi.org/10.1371/journal.pone.0142640			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555784	gold, Green Published, Green Submitted			2022-12-26	WOS:000364430700146
J	Niks, D; Duvvuru, J; Escalona, M; Hille, R				Niks, Dimitri; Duvvuru, Jayant; Escalona, Miguel; Hille, Russ			Spectroscopic and Kinetic Properties of the Molybdenum-containing, NAD(+) - dependent Formate Dehydrogenase from Ralstonia eutropha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDUCTIVE HALF-REACTION; PARAMAGNETIC-RESONANCE SIGNALS; RESPIRATORY COMPLEX-I; XANTHINE-OXIDASE; RHODOBACTER-CAPSULATUS; ESCHERICHIA-COLI; ALCALIGENES-EUTROPHUS; ENZYMES; OXYGEN; MECHANISM	We have examined the rapid reaction kinetics and spectroscopic properties of the molybdenum-containing, NAD(+) -dependent FdsABG formate dehydrogenase from Ralstonia eutropha. We confirm previous steady-state studies of the enzyme and extend its characterization to a rapid kinetic study of the reductive half-reaction (the reaction of formate with oxidized enzyme). We have also characterized the electron paramagnetic resonance signal of the molybdenum center in its Mo-V state and demonstrated the direct transfer of the substrate C alpha hydrogen to the molybdenum center in the course of the reaction. Varying temperature, microwave power, and level of enzyme reduction, we are able to clearly identify the electron paramagnetic resonance signals for four of the iron/sulfur clusters of the enzyme and find suggestive evidence for two others; we observe a magnetic interaction between the molybdenum center and one of the iron/sulfur centers, permitting assignment of this signal to a specific iron/sulfur cluster in the enzyme. In light of recent advances in our understanding of the structure of the molybdenum center, we propose a reaction mechanism involving direct hydride transfer from formate to a molybdenum-sulfur group of the molybdenum center.	[Niks, Dimitri; Duvvuru, Jayant; Escalona, Miguel; Hille, Russ] Univ Calif Riverside, Dept Biochem, 1463 Boyce Hall, Riverside, CA 92521 USA	University of California System; University of California Riverside	Hille, R (corresponding author), Univ Calif Riverside, Dept Biochem, 1463 Boyce Hall, Riverside, CA 92521 USA.	russ.hille@ucr.edu			U.S. Department of Energy [DE-FG02-13ER16411]	U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by U.S. Department of Energy Grant DE-FG02-13ER16411 (to R.H.). The authors declare that they have no conflicts of interest with the contents of this article.	BENNETT B, 1994, EUR J BIOCHEM, V225, P321, DOI 10.1111/j.1432-1033.1994.00321.x; BORDWELL FG, 1978, J ORG CHEM, V43, P3113, DOI 10.1021/jo00410a004; Boyington JC, 1997, SCIENCE, V275, P1305, DOI 10.1126/science.275.5304.1305; BRAY RC, 1968, BIOCHEM J, V107, P601, DOI 10.1042/bj1070601; BRAY RC, 1969, BIOCHEM J, V114, P725, DOI 10.1042/bj1140725; Brody MS, 1999, BIOCHEMISTRY-US, V38, P6668, DOI 10.1021/bi9902539; EDMONDSON D, 1973, J BIOL CHEM, V248, P6135; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Finel M, 1998, BBA-BIOENERGETICS, V1364, P112, DOI 10.1016/S0005-2728(98)00022-X; FRIEDEBOLD J, 1993, J BACTERIOL, V175, P4719, DOI 10.1128/JB.175.15.4719-4728.1993; FRIEDEBOLD J, 1995, BIOL CHEM H-S, V376, P561, DOI 10.1515/bchm3.1995.376.9.561; George GN, 1998, J AM CHEM SOC, V120, P1267, DOI 10.1021/ja973004l; George GN, 1999, J AM CHEM SOC, V121, P2625, DOI 10.1021/ja9841761; GUTTERIDGE S, 1978, BIOCHEM J, V175, P887, DOI 10.1042/bj1750887; GUTTERIDGE S, 1980, BIOCHEM J, V189, P615, DOI 10.1042/bj1890615; GUTTERIDGE S, 1978, BIOCHEM J, V175, P869, DOI 10.1042/bj1750869; Hartmann T, 2013, FEBS J, V280, P6083, DOI 10.1111/febs.12528; HILLE R, 1993, BIOCHEMISTRY-US, V32, P3973, DOI 10.1021/bi00066a018; HILLE R, 1994, BBA-BIOENERGETICS, V1184, P143, DOI 10.1016/0005-2728(94)90220-8; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; Hille R, 2014, CHEM REV, V114, P3963, DOI 10.1021/cr400443z; Huber R, 1996, P NATL ACAD SCI USA, V93, P8846, DOI 10.1073/pnas.93.17.8846; Khangulov SV, 1998, BIOCHEMISTRY-US, V37, P3518, DOI 10.1021/bi972177k; MALTHOUSE JPG, 1980, BIOCHEM J, V185, P767, DOI 10.1042/bj1850767; MCWHIRTER RB, 1991, J BIOL CHEM, V266, P23724; Oh JI, 1998, J BIOL CHEM, V273, P26349, DOI 10.1074/jbc.273.41.26349; OLSON JS, 1974, J BIOL CHEM, V249, P4363; Rothery RA, 2008, BBA-BIOMEMBRANES, V1778, P1897, DOI 10.1016/j.bbamem.2007.09.002; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Schrapers P, 2015, INORG CHEM, V54, P3260, DOI 10.1021/ic502880y; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Thome R, 2012, J BIOL CHEM, V287, P4671, DOI 10.1074/jbc.M111.327122; Xia M, 1999, J BIOL CHEM, V274, P3323, DOI 10.1074/jbc.274.6.3323	33	50	50	1	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1162	1174		10.1074/jbc.M115.688457	http://dx.doi.org/10.1074/jbc.M115.688457			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26553877	Green Published, hybrid			2022-12-26	WOS:000368068300012
J	Dalke, IV; Chadin, IF; Zakhozhiy, IG; Malyshev, RV; Maslova, SP; Tabalenkova, GN; Golovko, TK				Dalke, Igor V.; Chadin, Ivan F.; Zakhozhiy, Ilya G.; Malyshev, Ruslan V.; Maslova, Svetlana P.; Tabalenkova, Galina N.; Golovko, Tamara K.			Traits of Heracleum sosnowskyi Plants in Monostand on Invaded Area	PLOS ONE			English	Article							FRAMEWORK; INVASION	The ability of giant hogweeds to form monodominant communities and even pure monostands in invaded areas has been well documented. Understanding of the mechanisms leading to monostand formation can aid in determining the limitations of existing community ecology models and establishing an effective management plan for invasive species elimination. The aim of this observational study was to investigate traits of Heracleum sosnowskyi plants (demography, canopy structure, morphology and physiology) of the plants in a pure stand in an invaded area useful for understanding potential monostand formation mechanisms. All measurements were performed in one typical Heracleum sosnowskyi monostand located in an abandoned agriculture field located in Syktyvkar city suburb (North-east Russia). This monostand consisted of five main plant growth stages: seed, seedling, juvenile, vegetative adult, and generative adult. Plants of all stages began to grow simultaneously shortly after the snowmelt, at the same time as spring ephemeral plant species grew. The density of generative plants did not change during the vegetation period, but the density of the other plant stages rapidly decreased after the formation of a tall (up to 2-2.5 m) and dense (Leaf area index up to 6.5) canopy. The canopy captured approximately 97% of the light. H. sosnowskyi showed high (several orders of magnitude higher than average taiga zone grasses) photosynthetic water use efficiency (6-7 mu M CO2/mu M H2O). Formation of H. sosnowskyi monostands occurs primarily in disturbed areas with relatively rich and well-moistened soils. Early commencement of growth, rapid formation of a dense canopy, high efficiency of light and water use during photosynthesis, ability of young plants to survive in low light conditions, rapid recovery of above-ground plant parts after damage, and the high density of the soil seed bank are the most important traits of H. sosnowskyi plants for monostand formation in invaded areas.	[Dalke, Igor V.; Chadin, Ivan F.; Zakhozhiy, Ilya G.; Malyshev, Ruslan V.; Maslova, Svetlana P.; Tabalenkova, Galina N.; Golovko, Tamara K.] Russian Acad Sci, Inst Biol, Komi Sci Ctr, Ural Branch, Komi Republic, Russia	Russian Academy of Sciences; Institute of Biology, Komi Scientific Centre, Ural Branch RAS	Dalke, IV (corresponding author), Russian Acad Sci, Inst Biol, Komi Sci Ctr, Ural Branch, Komi Republic, Russia.	dalke@ib.komisc.ru	Ivan, Chadin/P-4940-2015; Tabalenkova, Galina/P-9771-2015; Dalke, Igor/P-9462-2015; Zakhozhiy, Ilya/AAR-2049-2021; Golovko, Tamara/P-4922-2015; Maslova, Svetlana/P-4978-2015; Malyshev, Ruslan/Q-1504-2015; Zakhozhiy, Ilya/P-9869-2015	Ivan, Chadin/0000-0001-6299-2285; Dalke, Igor/0000-0001-5711-9916; Zakhozhiy, Ilya/0000-0003-0918-745X; Maslova, Svetlana/0000-0002-5269-5129; Zakhozhiy, Ilya/0000-0003-0918-745X	Ural Branch of Russian Academy of Science; Ural Branch of Russian Academy of Science Oriented Basic Research Program [12-4-009-KSC, 13-4-028-KSC]	Ural Branch of Russian Academy of Science; Ural Branch of Russian Academy of Science Oriented Basic Research Program	This work was supported by the Ural Branch of Russian Academy of Science (http://uran.ru) Oriented Basic Research Program projects: "Invasive potential of Heracleum sosnowskyi Manden and control the spread of giant Hogweed in agro-climatic zone of the Republic of Komi" and "Modeling seed dispersal and the formation of new populations of invasive species Heracleum sosnowskyi Manden in agro-climatic zone of the Republic of Komi". The authors thank director of Komi Republic Public Institution Orphanage N 3 of Syktyvkar city Zoya Alekseevna Vakhnina for her permission to collect scientific data on the land owned by Orphanage.; This work was supported by the Ural Branch of Russian Academy of Science Oriented Basic Research Program (http://uran.ru) projects: "Invasive potential of Heracleum sosnowskyi Manden and control the spread of giant Hogweed in agro-climatic zone of the Republic of Komi" (project No 12-4-009-KSC) and "Modeling seed dispersal and the formation of new populations of invasive species Heracleum sosnowskyi Manden in agro-climatic zone of the Republic of Komi" (project No 13-4-028-KSC). We thank the director of the Komi Republic Public Institution Orphanage N 3 of Syktyvkar city Zoya Alekseevna Vakhnina for her permission to collect scientific data on the land owned by the orphanage.	Aarssen LW, 2006, J ECOL, V94, P569, DOI 10.1111/j.1365-2745.2006.01128.x; Balezentiene L., 2013, EKOLOGIJA, V59, P123, DOI [10.6001/ekologija.v59i3.2795, DOI 10.6001/EKOLOGIJA.V59I3.2795]; Balezentiene L, 2013, J FOOD AGRIC ENVIRON, V11, P1370; Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; Bylesjo M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-82; Cock Matthew J. W., 2007, P255, DOI 10.1079/9781845932060.0255; Colautti RI, 2004, DIVERS DISTRIB, V10, P135, DOI 10.1111/j.1366-9516.2004.00061.x; Dalke IV, 2013, IZV SAMARSKOGO NAUCH, V12, P1278; Dalke IV, 2013, IZV SAMARSKOGO NAUCH, V12, P683; Decagon Devices Inc., 2014, ACCUPAR PAR LAI CEPT; Dymova O, 2014, PHOTOSYNTHETIC PIGME, P221; Golovko TK, 2011, RUSS J PLANT PHYSL+, V58, P549, DOI 10.1134/S1021443711040054; Golovko T. K., 2009, Botanicheskii Zhurnal (St. Petersburg), V94, P1216; Golovko TK, 2010, P KOMI SCI CTR URAL, V1, P39; HilleRisLambers J, 2012, ANNU REV ECOL EVOL S, V43, P227, DOI 10.1146/annurev-ecolsys-110411-160411; IUSS Working Group, 2007, 1 UPD 2007; Jahodova S, 2007, DIVERS DISTRIB, V13, P99, DOI 10.1111/j.1366-9516.2006.00305.x; KELLIHER FM, 1995, AGR FOREST METEOROL, V73, P1, DOI 10.1016/0168-1923(94)02178-M; Lee EC, 1965, THESIS; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; McMaster GS, 1997, AGR FOREST METEOROL, V87, P291, DOI 10.1016/S0168-1923(97)00027-0; Panasenko N. N., 2014, B BRYANSK DPT RBS, V2, P48; RCore Team, 2020, R LANG ENV STAT COMP; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Sacyperova IF, 1984, USSR FLORA HOGWEEDS; Schamp BS, 2014, J VEG SCI, V25, P657, DOI 10.1111/jvs.12135; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Shishov L.L., 2004, KLASSIFIKATSIYA DIAG; Shumova EM, 1970, THESIS; Tappeiner U, 1998, ECOL MODEL, V113, P201, DOI 10.1016/S0304-3800(98)00144-6; THOMPSON K, 1979, J ECOL, V67, P893, DOI 10.2307/2259220; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tilman David, 1993, P13; Tooming HG., 1984, ECOLOGICAL PRINICPLE; Zakhozhiy I.G., 2011, THEOR APPL ECOL, V2, P37	35	21	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142833	10.1371/journal.pone.0142833	http://dx.doi.org/10.1371/journal.pone.0142833			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26565793	Green Published, gold			2022-12-26	WOS:000367628500059
J	Gambini, L; Rizzi, L; Pedretti, A; Taglialatela-Scafati, O; Carucci, M; Pancotti, A; Galli, C; Read, M; Giurisato, E; Romeo, S; Russo, I				Gambini, Luca; Rizzi, Luca; Pedretti, Alessandro; Taglialatela-Scafati, Orazio; Carucci, Mario; Pancotti, Andrea; Galli, Corinna; Read, Martin; Giurisato, Emanuele; Romeo, Sergio; Russo, Ilaria			Picomolar Inhibition of Plasmepsin V, an Essential Malaria Protease, Achieved Exploiting the Prime Region	PLOS ONE			English	Article							SOLID-PHASE SYNTHESIS; PLASMODIUM-FALCIPARUM; POTENT INHIBITORS; HUMAN RENIN; PROTEINS; EXPORT; DISCOVERY; RESISTANCE; VIRULENCE; LOCALIZATION	Malaria is an infectious disease caused by Plasmodium parasites. It results in an annual death-toll of similar to 600,000. Resistance to all medications currently in use exists, and novel antimalarial drugs are urgently needed. Plasmepsin V (PmV) is an essential Plasmodium protease and a highly promising antimalarial target, which still lacks molecular characterization and drug-like inhibitors. PmV, cleaving the PExEl motif, is the key enzyme for PExEl-secretion, an indispensable parasitic process for virulence and infection. Here, we describe the accessibility of PmV catalytic pockets to inhibitors and propose a novel strategy for PmV inhibition. We also provide molecular and structural data suitable for future drug development. Using high-throughput platforms, we identified a novel scaffold that interferes with PmV in-vitro at picomolar ranges (similar to 1,000-fold more active than available compounds). Via systematic replacement of P and P' regions, we assayed the physico-chemical requirements for PmV inhibition, achieving an unprecedented IC50 of similar to 20 pM. The hydroxyethylamine moiety, the hydrogen acceptor group in P-2', the lipophilic groups upstream to P3, the arginine and other possible substitutions in position P-3 proved to be critically important elements in achieving potent inhibition. In-silico analyses provided essential QSAR information and model validation. Our inhibitors act 'on-target', confirmed by cellular interference of PmV function and biochemical interaction with inhibitors. Our inhibitors are poorly performing against parasite growth, possibly due to poor stability of their peptidic component and trans-membrane permeability. The lowest IC50 for parasite growth inhibition was similar to 15 mu M. Analysis of inhibitor internalization revealed important pharmacokinetic features for PExEl-based molecules. Our work disclosed novel pursuable drug design strategies for highly efficient PmV inhibition highlighting novel molecular elements necessary for picomolar activity against PmV. All the presented data are discussed in respect to human aspartic proteases and previously reported inhibitors, highlighting differences and proposing new strategies for drug development.	[Gambini, Luca; Rizzi, Luca; Pedretti, Alessandro; Pancotti, Andrea; Galli, Corinna; Romeo, Sergio] Univ Milan, Dept Pharmaceut Sci, Milan, Italy; [Taglialatela-Scafati, Orazio] Univ Naples Federico II, Fac Pharm, Dept Chem Nat Subst, Naples, Italy; [Carucci, Mario; Russo, Ilaria] Univ Perugia, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy; [Read, Martin; Giurisato, Emanuele; Russo, Ilaria] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Milan; University of Naples Federico II; University of Perugia; University of Manchester	Russo, I (corresponding author), Univ Perugia, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy.	ilaria.russo@manchester.ac.uk	Russo, Ilaria/GNP-2328-2022; russo, ilaria/D-4674-2014; GIURISATO, EMANUELE/AAO-2352-2020; GIURISATO, EMANUELE/I-4904-2017; Romeo, Sergio/B-4478-2009; Read, Martin/K-6519-2016	Russo, Ilaria/0000-0002-2269-7078; russo, ilaria/0000-0002-2269-7078; GIURISATO, EMANUELE/0000-0003-0598-6449; GIURISATO, EMANUELE/0000-0003-0598-6449; Romeo, Sergio/0000-0003-4692-7314; Read, Martin/0000-0001-5965-5640	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALEWOOD PF, 1992, TETRAHEDRON LETT, V33, P977, DOI 10.1016/S0040-4039(00)91592-2; Allen SM, 2015, FEBS J, V282, P3808, DOI 10.1111/febs.13380; Armstrong CM, 2007, NAT METHODS, V4, P1007, DOI 10.1038/nmeth1132; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; BALDWIN ET, 1993, P NATL ACAD SCI USA, V90, P6796, DOI 10.1073/pnas.90.14.6796; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Beck JR, 2014, NATURE, V511, P592, DOI 10.1038/nature13574; Boddey JA, 2013, TRAFFIC, V14, P532, DOI 10.1111/tra.12053; Boddey JA, 2010, NATURE, V463, P627, DOI 10.1038/nature08728; Boulton IC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-202; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Chambers SL, 1997, PEPTIDES, V18, P505, DOI 10.1016/S0196-9781(96)00331-2; Chang HH, 2008, MOL BIOCHEM PARASIT, V160, P107, DOI 10.1016/j.molbiopara.2008.04.011; CHRISTOPHERS S. RICKARD, 1939, ANN TROP MED AND PARASITOL, V33, P161; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; Elsworth B, 2014, NATURE, V511, P587, DOI 10.1038/nature13555; GAILLARD P, 1994, J COMPUT AID MOL DES, V8, P83, DOI 10.1007/BF00119860; Ghosh AK, 2001, J MED CHEM, V44, P2865, DOI 10.1021/jm0101803; Goldberg DE, 2015, NAT STRUCT MOL BIOL, V22, P647, DOI 10.1038/nsmb.3077; Goldberg DE, 2010, NAT REV MICROBIOL, V8, P617, DOI 10.1038/nrmicro2420; Guruprasad L, 2011, PROTEIN PEPTIDE LETT, V18, P634, DOI 10.2174/092986611795222786; Hanson G J, 1994, Bioorg Med Chem, V2, P909, DOI 10.1016/S0968-0896(00)82040-4; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Hills ID, 2007, CURR OPIN DRUG DISC, V10, P383; Hodder AN, 2015, NAT STRUCT MOL BIOL, V22, P590, DOI 10.1038/nsmb.3061; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Klein EY, 2013, INT J ANTIMICROB AG, V41, P311, DOI 10.1016/j.ijantimicag.2012.12.007; Klemba M, 2005, MOL BIOCHEM PARASIT, V143, P183, DOI 10.1016/j.molbiopara.2005.05.015; Korb O, 2009, J CHEM INF MODEL, V49, P84, DOI 10.1021/ci800298z; KUMAR N, 1991, MOL BIOCHEM PARASIT, V48, P47, DOI 10.1016/0166-6851(91)90163-Z; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Leung D, 2000, J MED CHEM, V43, P305, DOI 10.1021/jm990412m; Lopez-Barragan MJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-587; Maibaum J, 2007, J MED CHEM, V50, P4832, DOI 10.1021/jm070316i; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Matsumori N, 1999, J ORG CHEM, V64, P866, DOI 10.1021/jo981810k; Meyers MJ, 2012, CURR TOP MED CHEM, V12, P445; Motwani HV, 2015, EUR J MED CHEM, V90, P462, DOI 10.1016/j.ejmech.2014.11.036; PAUL F, 1981, LANCET, V2, P70; Pedretti A, 2004, J COMPUT AID MOL DES, V18, P167, DOI 10.1023/B:JCAM.0000035186.90683.f2; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Ponpuak M, 2007, MOL MICROBIOL, V63, P314, DOI 10.1111/j.1365-2958.2006.05443.x; Rahuel J, 2000, CHEM BIOL, V7, P493, DOI 10.1016/S1074-5521(00)00134-4; RUSSO I, 2013, HDB PROTEOLYTIC ENZY, V2, P103; Russo I, 2013, HDB PROTEOLYTIC ENZY, V1, P103; Russo I, 2010, NATURE, V463, P632, DOI 10.1038/nature08726; Russo I, 2009, P NATL ACAD SCI USA, V106, P1554, DOI 10.1073/pnas.0806926106; Russo I, 2009, MOL MICROBIOL, V72, P229, DOI 10.1111/j.1365-2958.2009.06639.x; Schmidtke P, 2010, NUCLEIC ACIDS RES, V38, pW582, DOI 10.1093/nar/gkq383; Sedwick C, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001898; Shea M, 2007, TRAFFIC, V8, P1018, DOI 10.1111/j.1600-0854.2007.00589.x; Shi HB, 2009, CHEM COMMUN, P5030, DOI 10.1039/b910611a; Silvestri R, 2009, MED RES REV, V29, P295, DOI 10.1002/med.20132; Silvestrini F, 2010, MOL CELL PROTEOMICS, V9, P1437, DOI 10.1074/mcp.M900479-MCP200; Singh AP, 2007, CELL, V131, P492, DOI 10.1016/j.cell.2007.09.013; Sleebs BE, 2014, J MED CHEM, V57, P7644, DOI 10.1021/jm500797g; Sleebs BE, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001897; Spielmann T, 2010, TRENDS PARASITOL, V26, P6, DOI 10.1016/j.pt.2009.10.001; Tarr SJ, 2013, MOL MICROBIOL, V87, P835, DOI 10.1111/mmi.12133; Tilley L, 2011, INT J BIOCHEM CELL B, V43, P839, DOI 10.1016/j.biocel.2011.03.012; Trager W, 2005, J PARASITOL, V91, P484, DOI 10.1645/0022-3395(2005)091[0484:HMPICC]2.0.CO;2; Vial H, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-396; Webb RL, 2010, J MED CHEM, V53, P7490, DOI 10.1021/jm901885s; Wu YM, 1996, P NATL ACAD SCI USA, V93, P1130, DOI 10.1073/pnas.93.3.1130; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	67	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142509	10.1371/journal.pone.0142509	http://dx.doi.org/10.1371/journal.pone.0142509			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26566224	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000367628500027
J	Kaufmann, KB; Al-Rifai, N; Ulbrich, F; Schallner, N; Rucker, H; Enzinger, M; Petkes, H; Pitzl, S; Goebel, U; Amslinger, S				Kaufmann, Kai B.; Al-Rifai, Nafisah; Ulbrich, Felix; Schallner, Nils; Ruecker, Hannelore; Enzinger, Monika; Petkes, Hermina; Pitzl, Sebastian; Goebel, Ulrich; Amslinger, Sabine			The Cytoprotective Effects of E-alpha- (4-Methoxyphenyl)-2 ',3,4,4 '-Tetramethoxychalcone (E-alpha-p-OMe-C6H4-TMC)-A Novel and Non-Cytotoxic HO-1 Inducer	PLOS ONE			English	Article							HEME OXYGENASE-1; CARBON-MONOXIDE; MOLECULES; IDENTIFICATION; EXPRESSION; CHEMOPREVENTION; MECHANISMS; REACTIVITY; PROTECTION; CHALCONES	Cell protection against different noxious stimuli like oxidative stress or chemical toxins plays a central role in the treatment of many diseases. The inducible heme oxygenase isoform, heme oxygenase-1 (HO-1), is known to protect cells against a variety of harmful conditions including apoptosis. Because a number of medium strong electrophiles from a series of alpha-X-substituted 2',3,4,4'-tetramethoxychalcones (alpha-X-TMCs, X = H, F, Cl, Br, I, CN, Me, p-NO2-C6H4, Ph, p-OMe-C6H4, NO2, CF3, COOEt, COOH) had proven to activate Nrf2 resulting in HO-1 induction and inhibit NF-kappa B downstream target genes, their protective effect against staurosporine induced apoptosis and reactive oxygen species (ROS) production was investigated. RAW264.7 macrophages treated with 19 different chalcones (15 alpha-X-TMCs, chalcone, 2'-hydroxychalcone, calythropsin and 2'-hydroxy-3,4,4'-trimethoxychalcone) prior to staurosporine treatment were analyzed for apoptosis and ROS production, as well as HO-1 protein expression and enzyme activity. Additionally, Nrf2 and NF-kappa B activity was assessed. We found that amongst all tested chalcones only E-alpha-(4-methoxyphenyl)-2',3,4,4'-tetramethoxychalcone (E-alpha-p-OMe-C6H4-TMC) demonstrated a distinct, statistically significant antiapoptotic effect in a dose dependent manner, showing no toxic effects, while its double bond isomer Z-alpha-p-OMe-C6H4-TMC displayed no significant activity. Also, E-alpha-p-OMe-C6H4-TMC induced HO-1 protein expression and increased HO-1 activity, whilst inhibition of HO-1 by SnPP-IX abolished its antiapoptotic effect. The only weakly electrophilic chalcone E-alpha-p-OMe-C6H4-TMC reduced the staurosporine triggered formation of ROS, while inducing the translocation of Nrf2 into the nucleus. Furthermore, staurosporine induced NF-kappa B activity was attenuated following E-alpha-p-OMe-C6H4-TMC treatment. Overall, E-alpha-p-OMe-C6H4-TMC demonstrated its effective cytoprotective potential via a non-toxic induction of HO-1 in RAW264.7 macrophages. The observed cytoprotective effect may partly be related to both, the activation of the Nrf2- and inhibition of the NF-kappa B pathway.	[Kaufmann, Kai B.; Ulbrich, Felix; Schallner, Nils; Goebel, Ulrich] Univ Med Ctr Freiburg, Dept Anesthesiol & Intens Care Med, Freiburg, Germany; [Al-Rifai, Nafisah; Ruecker, Hannelore; Enzinger, Monika; Petkes, Hermina; Pitzl, Sebastian; Amslinger, Sabine] Univ Regensburg, Inst Organ Chem, D-93053 Regensburg, Germany; [Pitzl, Sebastian] Univ Regensburg, Inst Pharmaceut Biol, D-93053 Regensburg, Germany	University of Freiburg; University of Regensburg; University of Regensburg	Goebel, U (corresponding author), Univ Med Ctr Freiburg, Dept Anesthesiol & Intens Care Med, Freiburg, Germany.	ulrich.goebel@uniklinik-freiburg.de; sabine.amslinger@chemie.uni-regensburg.de	Göbel, Ulrich/Q-7613-2016; Al-Rifai, Nafisah/AAW-8832-2021; Goebel, Ulrich M./AGG-1495-2022	Göbel, Ulrich/0000-0002-9991-3226; Al-Rifai, Nafisah/0000-0003-3128-052X; 	Liebig Scholarship Fonds der Chemischen Industrie DAAD Ph.D. scholarship; Fonds der Chemischen Industrie (Liebig scholarship); DAAD	Liebig Scholarship Fonds der Chemischen Industrie DAAD Ph.D. scholarship; Fonds der Chemischen Industrie (Liebig scholarship); DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	Liebig Scholarship Fonds der Chemischen Industrie DAAD Ph.D. scholarship.; We thank Heide Marniga for technical assistance and the Fonds der Chemischen Industrie (Liebig scholarship to S.A.) and the DAAD (Ph.D. scholarship to N.A.) for financial support.	Al-Rifai N, 2013, CHEM-EUR J, V19, P15384, DOI 10.1002/chem.201302117; Amslinger S, 2013, ORG BIOMOL CHEM, V11, P549, DOI 10.1039/c2ob27163j; Arfaie S, 2010, EUR J MED CHEM, V45, P4013, DOI 10.1016/j.ejmech.2010.05.058; Brouard S, 2000, J EXP MED, V192, P1015, DOI 10.1084/jem.192.7.1015; Clark JE, 2003, CIRC RES, V93, pE2, DOI 10.1161/01.RES.0000084381.86567.08; De Backer O, 2009, GUT, V58, P347, DOI 10.1136/gut.2008.155481; Dinkova-Kostova AT, 2008, MOL NUTR FOOD RES, V52, pS128, DOI 10.1002/mnfr.200700195; Ducki S, 2009, BIOORGAN MED CHEM, V17, P7711, DOI 10.1016/j.bmc.2009.09.044; Fenton H., 1894, J CHEM SOC T, V65, P899, DOI [10.1039/CT8946500899, DOI 10.1039/CT8946500899]; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Grilli M, 1996, SCIENCE, V274, P1383, DOI 10.1126/science.274.5291.1383; Grosser N, 2004, FREE RADICAL BIO MED, V37, P2064, DOI 10.1016/j.freeradbiomed.2004.09.009; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hoetzel A, 2002, ANESTHESIOLOGY, V97, P1318, DOI 10.1097/00000542-200211000-00043; Hotchkiss RS, 2005, J IMMUNOL, V174, P5110, DOI 10.4049/jimmunol.174.8.5110; Hotchkiss RS, 2005, CLIN INFECT DIS, V41, pS465, DOI 10.1086/431998; Jeong WS, 2006, ANTIOXID REDOX SIGN, V8, P99, DOI 10.1089/ars.2006.8.99; Motterlini R, 2004, FASEB J, V18, P284, DOI 10.1096/fj.04-2169fje; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Nakao A, 2006, J CELL MOL MED, V10, P650, DOI 10.1111/j.1582-4934.2006.tb00426.x; Niesel J, 2008, CHEM COMMUN, P1798, DOI 10.1039/b719075a; Otterbein LE, 2000, AM J PHYSIOL-LUNG C, V279, pL1029, DOI 10.1152/ajplung.2000.279.6.L1029; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Pannen BHJ, 1998, J CLIN INVEST, V102, P1220, DOI 10.1172/JCI3428; Pinz S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090275; Prawan A, 2005, ANTIOXID REDOX SIGN, V7, P1688, DOI 10.1089/ars.2005.7.1688; Romanski S, 2013, FREE RADICAL BIO MED, V65, P78, DOI 10.1016/j.freeradbiomed.2013.06.014; Romanski S, 2011, ANGEW CHEM INT EDIT, V50, P2392, DOI 10.1002/anie.201006598; Rucker H, 2015, ORG BIOMOL CHEM, V13, P3040, DOI 10.1039/c4ob02301c; Rucker H, 2015, FREE RADICAL BIO MED, V78, P135, DOI 10.1016/j.freeradbiomed.2014.10.506; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; Ryter SW, 2002, ANTIOXID REDOX SIGN, V4, P625, DOI 10.1089/15230860260220120; Schmidt R, 2004, J HEPATOL, V41, P706, DOI 10.1016/j.jhep.2004.07.004; Sehmidt R, 2007, ANN SURG, V245, P931, DOI 10.1097/01.sla.0000256891.45790.4d; Seixas E, 2009, P NATL ACAD SCI USA, V106, P15837, DOI 10.1073/pnas.0903419106; Shan Y, 2006, FASEB J, V20, P2651, DOI 10.1096/fj.06-6346fje; Shen XD, 2005, AM J TRANSPLANT, V5, P1793, DOI 10.1111/j.1600-6143.2005.00932.x; Soares MP, 2004, J IMMUNOL, V172, P3553, DOI 10.4049/jimmunol.172.6.3553; Song RP, 2003, AM J PATHOL, V163, P231, DOI 10.1016/S0002-9440(10)63646-2; TALALAY P, 1988, P NATL ACAD SCI USA, V85, P8261, DOI 10.1073/pnas.85.21.8261; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; Wang L, 2010, APOPTOSIS, V15, P1470, DOI 10.1007/s10495-010-0547-z; Yang GD, 2007, MOL CELL BIOCHEM, V302, P187, DOI 10.1007/s11010-007-9440-7	44	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142932	10.1371/journal.pone.0142932	http://dx.doi.org/10.1371/journal.pone.0142932			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26565402	gold, Green Submitted, Green Published			2022-12-26	WOS:000367628500074
J	Phan, CW; David, P; Wong, KH; Naidu, M; Sabaratnam, V				Phan, Chia-Wei; David, Pamela; Wong, Kah-Hui; Naidu, Murali; Sabaratnam, Vikineswary			Uridine from Pleurotus giganteus and Its Neurite Outgrowth Stimulatory Effects with Underlying Mechanism	PLOS ONE			English	Article							RAT SYMPATHETIC NEURONS; NERVE GROWTH-FACTOR; PHEOCHROMOCYTOMA CELLS; MEDICINAL MUSHROOMS; HUMAN-MILK; IN-VITRO; NEURITOGENESIS; NUCLEOTIDES; NUCLEOSIDES; ACTIVATION	Neurodegenerative diseases are linked to neuronal cell death and impairment of neurite outgrowth. An edible mushroom, Pleurotus giganteus was found to stimulate neurite outgrowth in vitro but the chemical constituents and the underlying mechanism is yet to be elucidated. The chemical constituents of P. giganteus (linoleic acid, oleic acid, cinnamic acid, caffeic acid, p-coumaric acid, succinic acid, benzoic acid, and uridine) were tested for neurite outgrowth activity. Uridine (100 mu M) was found to increase the percentage of neurite-bearing cells of differentiating neuroblastoma (N2a) cells by 43.1 +/- 0.5%, which was 1.8-fold higher than NGF (50 ng/mL)-treated cells. Uridine which was present in P. giganteus (1.80 +/- 0.03 g/100g mushroom extract) increased the phosphorylation of extracellular-signal regulated kinases (ERKs) and protein kinase B (Akt). Further, phosphorylation of the mammalian target of rapamycin (mTOR) was also increased. MEK/ERK and PI3K-Akt-mTOR further induced phosphorylation of cAMP-response element binding protein (CREB) and expression of growth associated protein 43 (GAP43); all of which promoted neurite outgrowth of N2a cells. This study demonstrated that P. giganteus may enhance neurite outgrowth and one of the key bioactive molecules responsible for neurite outgrowth is uridine.	[Phan, Chia-Wei; David, Pamela; Wong, Kah-Hui; Naidu, Murali; Sabaratnam, Vikineswary] Univ Malaya, Fac Sci, Inst Biol Sci, Mushroom Res Ctr, Kuala Lumpur 50603, Malaysia; [Phan, Chia-Wei] UCSI Univ, Ctr Excellence Learning & Teaching, Kuala Lumpur 56000, Malaysia; [David, Pamela; Wong, Kah-Hui; Naidu, Murali] Univ Malaya, Fac Med, Dept Anat, Kuala Lumpur, Malaysia; [Sabaratnam, Vikineswary] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia	Universiti Malaya; UCSI University; Universiti Malaya; Universiti Malaya	Phan, CW (corresponding author), Univ Malaya, Fac Sci, Inst Biol Sci, Mushroom Res Ctr, Kuala Lumpur 50603, Malaysia.	phancw@ucsiuniversity.edu.my; viki@um.edu.my	SABARATNAM, S. VIKINESWARY/B-9648-2010; NAIDU, MURALI D KUPPUSAMY/B-9181-2010; Phan Thanh, Duoc/P-5505-2015; DAVID, ROSIE PAMELA/B-9602-2010; Phan, Chia Wei/D-3700-2012; Kah-Hui, Wong/C-1048-2010	SABARATNAM, S. VIKINESWARY/0000-0003-3966-3701; Phan Thanh, Duoc/0000-0003-4410-9529; Phan, Chia Wei/0000-0003-1373-1374; Kah-Hui, Wong/0000-0002-8292-4498	University of Malaya High Impact Research Ministry of Education (MoE) [UM.C/625/1/HIR/MoE/SC/02, UM.C/625/1/HIR/MOHE/ASH/01]; Institute of Research Management & Monitoring (IPPP), University of Malaya [PV007/2012A]	University of Malaya High Impact Research Ministry of Education (MoE); Institute of Research Management & Monitoring (IPPP), University of Malaya	This work was funded by the University of Malaya High Impact Research Ministry of Education (MoE) Grants: UM.C/625/1/HIR/MoE/SC/02 and UM.C/625/1/HIR/MOHE/ASH/01, as well as a Postgraduate Research Grant (PV007/2012A) from the Institute of Research Management & Monitoring (IPPP), University of Malaya.	Allen SJ, 2013, PHARMACOL THERAPEUT, V138, P155, DOI 10.1016/j.pharmthera.2013.01.004; Babu US, 2014, MOL NUTR FOOD RES, V58, P318, DOI 10.1002/mnfr.201300286; Bennett L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076362; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; BOEHM S, 1995, BRIT J PHARMACOL, V116, P2341, DOI 10.1111/j.1476-5381.1995.tb15075.x; Cansev M, 2006, BRAIN RES REV, V52, P389, DOI 10.1016/j.brainresrev.2006.05.001; Phan CW, 2014, SCI WORLD J, DOI 10.1155/2014/378651; Das SK, 2010, FITOTERAPIA, V81, P961, DOI 10.1016/j.fitote.2010.07.010; Dobolyi A, 2011, CURR TOP MED CHEM, V11, P1058, DOI 10.2174/156802611795347618; Fan SS, 2004, MOL BRAIN RES, V132, P38, DOI 10.1016/j.molbrainres.2004.09.003; Gundimeda U, 2010, J NEUROSCI RES, V88, P3644, DOI 10.1002/jnr.22519; Haanes KA, 2014, FEBS LETT, V588, P2936, DOI 10.1016/j.febslet.2014.05.044; Hardy G, 2000, NUTRITION, V16, P688, DOI 10.1016/S0899-9007(00)00332-4; Lai HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028280; LEACH JL, 1995, AM J CLIN NUTR, V61, P1224, DOI 10.1093/ajcn/61.6.1224; Makropoulou M, 2012, J MED FOOD, V15, P216, DOI 10.1089/jmf.2011.0107; Molliver DC, 2002, EUR J NEUROSCI, V16, P1850, DOI 10.1046/j.1460-9568.2002.02253.x; Moroney S, 2012, THESIS; Phan CW, 2015, CRIT REV BIOTECHNOL, V35, P355, DOI 10.3109/07388551.2014.887649; Phan CW, 2014, FOOD FUNCT, V5, P3160, DOI [10.1039/C4FO00452C, 10.1039/c4fo00452c]; Phan CW, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-261; Phan CW, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-102; Pooler AM, 2005, NEUROSCIENCE, V134, P207, DOI 10.1016/j.neuroscience.2005.03.050; Radio NM, 2008, NEUROTOXICOLOGY, V29, P361, DOI 10.1016/j.neuro.2008.02.011; SMALHEISER NR, 1987, DEV BRAIN RES, V34, P111, DOI 10.1016/0165-3806(87)90200-8; Thorell L, 1996, PEDIATR RES, V40, P845, DOI 10.1203/00006450-199612000-00012; Vartian N, 2001, J NEUROCHEM, V77, P876, DOI 10.1046/j.1471-4159.2001.00290.x; Wasser SP, 2002, APPL MICROBIOL BIOT, V60, P258, DOI 10.1007/s00253-002-1076-7; Wong KH, 2012, INT J MED MUSHROOMS, V14, P427, DOI 10.1615/IntJMedMushr.v14.i5.10; Wu HT, 2009, BBA-MOL CELL BIOL L, V1791, P8, DOI 10.1016/j.bbalip.2008.10.004; Wurtman RJ, 2010, NUTR REV, V68, pS88, DOI 10.1111/j.1753-4887.2010.00344.x; Yamashima T, 2012, PROG LIPID RES, V51, P221, DOI 10.1016/j.plipres.2012.02.001; Yang FQ, 2012, ANAL METHODS-UK, V4, P546, DOI 10.1039/c2ay05793j	33	15	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0143004	10.1371/journal.pone.0143004	http://dx.doi.org/10.1371/journal.pone.0143004			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26565787	gold, Green Submitted, Green Published			2022-12-26	WOS:000367628500086
J	Swallie, SE; Monti, AM; Blitz, DM				Swallie, Shanna E.; Monti, Alexis M.; Blitz, Dawn M.			Anatomical Organization of Multiple Modulatory Inputs in a Rhythmic Motor System	PLOS ONE			English	Article							CRAB CANCER-BOREALIS; STOMATOGASTRIC NERVOUS-SYSTEM; MUSCLE RECEPTOR-CELLS; PROJECTION NEURONS; PRESYNAPTIC INHIBITION; PEPTIDERGIC MODULATION; PANULIRUS-INTERRUPTUS; SYNAPTIC-TRANSMISSION; COMMISSURAL GANGLION; HOMARUS-AMERICANUS	In rhythmic motor systems, descending projection neuron inputs elicit distinct outputs from their target central pattern generator (CPG) circuits. Projection neuron activity is regulated by sensory inputs and inputs from other regions of the nervous system, relaying information about the current status of an organism. To gain insight into the organization of multiple inputs targeting a projection neuron, we used the identified neuron MCN1 in the stomatogastric nervous system of the crab, Cancer borealis. MCN1 originates in the commissural ganglion and projects to the stomatogastric ganglion (STG). MCN1 activity is differentially regulated by multiple inputs including neuroendocrine (POC) and proprioceptive (GPR) neurons, to elicit distinct outputs from CPG circuits in the STG. We asked whether these defined inputs are compact and spatially segregated or dispersed and overlapping relative to their target projection neuron. Immunocytochemical labeling, intracellular dye injection and three-dimensional (3D) confocal microscopy revealed overlap of MCN1 neurites and POC and GPR terminals. The POC neuron terminals form a defined neuroendocrine organ (anterior commissural organ: ACO) that utilizes peptidergic paracrine signaling to act on MCN1. The MCN1 arborization consistently coincided with the ACO structure, despite morphological variation between preparations. Contrary to a previous 2D study, our 3D analysis revealed that GPR axons did not terminate in a compact bundle, but arborized more extensively near MCN1, arguing against sparse connectivity of GPR onto MCN1. Consistent innervation patterns suggest that integration of the sensory GPR and peptidergic POC inputs occur through more distributed and more tightly constrained anatomical interactions with their common modulatory projection neuron target than anticipated.	[Swallie, Shanna E.; Monti, Alexis M.; Blitz, Dawn M.] Miami Univ, Dept Biol, Oxford, OH 45056 USA	University System of Ohio; Miami University	Blitz, DM (corresponding author), Miami Univ, Dept Biol, Oxford, OH 45056 USA.	Dawn.Blitz@MiamiOH.edu			National Science Foundation [IOS-1153417]; Miami University Undergraduate Research Award; Miami University Committee	National Science Foundation(National Science Foundation (NSF)); Miami University Undergraduate Research Award; Miami University Committee	This work was supported by National Science Foundation grant IOS-1153417 (D.M.B.), the Miami University Undergraduate Research Award (A.M.M.), and Miami University Committee for Faculty Research grant (D.M.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDWIN DH, 1995, J COMP NEUROL, V356, P355, DOI 10.1002/cne.903560304; BARNES K, 1992, J NEUROCHEM, V58, P2088, DOI 10.1111/j.1471-4159.1992.tb10950.x; Barriere G, 2008, J NEUROSCI, V28, P8810, DOI 10.1523/JNEUROSCI.2095-08.2008; BASTIANI MJ, 1988, J NEUROSCI, V8, P1254; Beenhakker MP, 2007, J NEUROSCI, V27, P14308, DOI 10.1523/JNEUROSCI.4404-07.2007; Beenhakker MP, 2004, J NEUROSCI, V24, P6741, DOI 10.1523/JNEUROSCI.1682-04.2004; Blitz DM, 2008, J NEUROSCI, V28, P9564, DOI 10.1523/JNEUROSCI.3011-08.2008; Blitz DM, 2008, J EXP BIOL, V211, P1000, DOI 10.1242/jeb.015222; Blitz DM, 2012, J NEUROSCI, V32, P9182, DOI 10.1523/JNEUROSCI.1461-12.2012; Blitz DM, 2011, CURR OPIN NEUROBIOL, V21, P544, DOI 10.1016/j.conb.2011.05.019; Blitz DM, 2004, J NEUROSCI, V24, P11381, DOI 10.1523/JNEUROSCI.3219-04.2004; Blitz DM, 1999, J NEUROSCI, V19, P5449; Briggman KL, 2008, ANNU REV NEUROSCI, V31, P271, DOI 10.1146/annurev.neuro.31.060407.125552; Brodfuehrer Peter D., 2008, Invertebrate Neuroscience, V8, P31, DOI 10.1007/s10158-007-0064-0; Bucher D, 2007, J COMP NEUROL, V501, P185, DOI 10.1002/cne.21169; Bucher D, 2011, PROG NEUROBIOL, V94, P307, DOI 10.1016/j.pneurobio.2011.06.001; Bullock T., 1965, STRUCTURE FUNCTION N; Christie AE, 2004, J COMP NEUROL, V469, P153, DOI 10.1002/cne.11003; Christie AE, 1997, CELL TISSUE RES, V288, P135, DOI 10.1007/s004410050801; Christie AE, 1997, J EXP BIOL, V200, P2279; COLEMAN MJ, 1992, J COMP NEUROL, V325, P581, DOI 10.1002/cne.903250410; COLEMAN MJ, 1995, NATURE, V378, P502, DOI 10.1038/378502a0; COLEMAN MJ, 1994, J NEUROSCI, V14, P6205; COLEMAN MJ, 1994, J NEUROSCI, V14, P6544; CUELLO AC, 1979, P NATL ACAD SCI USA, V76, P3532, DOI 10.1073/pnas.76.7.3532; Curti S, 2010, J PHYSIOL-PARIS, V104, P203, DOI 10.1016/j.jphysparis.2009.11.017; DeLong ND, 2009, J NEUROPHYSIOL, V102, P3492, DOI 10.1152/jn.00833.2009; Doi A, 2008, RESP PHYSIOL NEUROBI, V164, P96, DOI 10.1016/j.resp.2008.06.007; Euler T, 2001, CURR OPIN NEUROBIOL, V11, P415, DOI 10.1016/S0959-4388(00)00228-2; Fetcho JR, 2008, BRAIN RES REV, V57, P86, DOI 10.1016/j.brainresrev.2007.06.018; FISHER JM, 1988, CELL, V54, P813, DOI 10.1016/S0092-8674(88)91131-2; Frazier W, 1967, MORPHOLOGICAL FUNCTI, V30, P942; Garcia VJ, 2015, J NEUROSCI, V35, P6786, DOI 10.1523/JNEUROSCI.0171-15.2015; Goeritz ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079306; GOLDBERG D, 1988, CELL TISSUE RES, V252, P515, DOI 10.1007/BF00216638; Goldsmith CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103459; GOODMAN CS, 1979, COMP BIOCHEM PHYS A, V64, P455, DOI 10.1016/0300-9629(79)90571-1; Gutierrez GJ, 2009, JOVE-J VIS EXP, V25, P1, DOI DOI 10.3791/1207; Harris-Warrick RM, 2011, CURR OPIN NEUROBIOL, V21, P685, DOI 10.1016/j.conb.2011.05.011; Hartline DK, 2010, CELL TISSUE RES, V341, P49, DOI 10.1007/s00441-010-0974-8; Hedrich UBS, 2011, J NEUROPHYSIOL, V105, P1671, DOI 10.1152/jn.01105.2010; Heinrich R, 2002, MICROSC RES TECHNIQ, V56, P292, DOI 10.1002/jemt.10033; JAN LY, 1982, J PHYSIOL-LONDON, V327, P219, DOI 10.1113/jphysiol.1982.sp014228; Jordan LM, 2008, BRAIN RES REV, V57, P183, DOI 10.1016/j.brainresrev.2007.07.019; KATZ PS, 1989, J NEUROPHYSIOL, V62, P558, DOI 10.1152/jn.1989.62.2.558; KATZ PS, 1989, J NEUROPHYSIOL, V62, P571, DOI 10.1152/jn.1989.62.2.571; Kilman VL, 1996, J COMP NEUROL, V374, P362, DOI 10.1002/(SICI)1096-9861(19961021)374:3<362::AID-CNE5>3.0.CO;2-#; Kirby MS, 2007, CELL TISSUE RES, V328, P625, DOI 10.1007/s00441-007-0398-2; Knobloch HS, 2012, NEURON, V73, P553, DOI 10.1016/j.neuron.2011.11.030; Landry M, 2003, EUR J NEUROSCI, V17, P579, DOI 10.1046/j.1460-9568.2003.02472.x; Le Ray D, 2010, EUR J NEUROSCI, V32, P53, DOI 10.1111/j.1460-9568.2010.07276.x; Marder E, 2001, CURR BIOL, V11, pR986, DOI 10.1016/S0960-9822(01)00581-4; Marder E, 2007, ANNU REV PHYSIOL, V69, P291, DOI 10.1146/annurev.physiol.69.031905.161516; Marder E, 2012, NEURON, V76, P1, DOI 10.1016/j.neuron.2012.09.010; McLean DL, 2004, J COMP NEUROL, V480, P57, DOI 10.1002/cne.20281; Messinger DI, 2005, J EXP BIOL, V208, P3303, DOI 10.1242/jeb.01787; Miles GB, 2011, PHYSIOLOGY, V26, P393, DOI 10.1152/physiol.00013.2011; Nadim F, 2014, CURR OPIN NEUROBIOL, V29, P48, DOI 10.1016/j.conb.2014.05.003; Nassel DR, 2009, INVERTEBR NEUROSCI, V9, P57, DOI 10.1007/s10158-009-0090-1; Nusbaum MP, 2002, BRAIN BEHAV EVOLUT, V60, P378, DOI 10.1159/000067791; Nusbaum MP, 2002, NATURE, V417, P343, DOI 10.1038/417343a; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Ryczko D, 2013, CURR PHARM DESIGN, V19, P4448, DOI 10.2174/1381612811319240011; Saleh TM, 1996, J NEUROSCI, V16, P6046; Selverston AI, 2010, PHILOS T R SOC B, V365, P2329, DOI 10.1098/rstb.2009.0270; Sharples SA, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00055; Stein W., 2014, ENCY COMPUTATIONAL N; Stein W, 2009, J COMP PHYSIOL A, V195, P989, DOI 10.1007/s00359-009-0483-y; Thuma JB, 2009, BRAIN BEHAV EVOLUT, V73, P26, DOI 10.1159/000202988; Verdier D, 2003, J NEUROSCI, V23, P2002; WIERSMA CAG, 1957, ACTA PHYSIOL PHARM N, V6, P135; Wilensky AE, 2003, J COMP NEUROL, V466, P554, DOI 10.1002/cne.10903	72	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142956	10.1371/journal.pone.0142956	http://dx.doi.org/10.1371/journal.pone.0142956			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26566032	Green Published, gold, Green Submitted			2022-12-26	WOS:000367628500079
J	Koenig, SP; Bornstein, A; Severe, K; Fox, E; Devieux, JG; Severe, P; Joseph, P; Marcelin, A; Bright, DA; Pham, N; Cremieux, P; Pape, JW				Koenig, Serena P.; Bornstein, Alexandra; Severe, Karine; Fox, Elizabeth; Devieux, Jessy G.; Severe, Patrice; Joseph, Patrice; Marcelin, Adias; Bright, Dgndy Alexandre; Pham, Ngoc; Cremieux, Pierre; Pape, Jean William			A Second Look at the Association between Gender and Mortality on Antiretroviral Therapy	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; BODY-MASS INDEX; FOLLOW-UP; TREATMENT OUTCOMES; TREATMENT PROGRAM; AIDS PATIENTS; SCALE-UP; ADULTS; SURVIVAL; ANEMIA	Objective We assessed the association between gender and mortality on antiretroviral therapy (ART) using identical models with and without sex-specific categories for weight and hemoglobin. Design Cohort study of adult patients on ART. Setting GHESKIO Clinic in Port-au-Prince, Haiti. Participants 4,717 ART-naive adult patients consecutively enrolled on ART at GHESKIO from 2003 to 2008. Main Outcome Measure Mortality on ART; multivariable analyses were conducted with and without sex-specific categories for weight and hemoglobin. Results In Haiti, male gender was associated with mortality (OR 1.61; 95% CI: 1.30-2.00) in multivariable analyses with hemoglobin and weight included as control variables, but not when sex-specific interactions with hemoglobin and weight were used. Conclusions If sex-specific categories are omitted, multivariable analyses indicate a higher risk of mortality for males vs. females of the same weight and hemoglobin. However, because males have higher normal values for weight and hemoglobin, the males in this comparison would generally have poorer health status than the females. This may explain why gender differences in mortality are sometimes observed after controlling for differences in baseline variables when gender-specific interactions with weight and hemoglobin are omitted.	[Koenig, Serena P.; Severe, Karine; Severe, Patrice; Joseph, Patrice; Marcelin, Adias; Bright, Dgndy Alexandre; Pape, Jean William] Haitian Study Grp Kaposis Sarcoma & Opportunist I, Port Au Prince, Haiti; [Koenig, Serena P.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Global Hlth Equ, Boston, MA 02115 USA; [Bornstein, Alexandra; Pham, Ngoc; Cremieux, Pierre] Anal Grp, Boston, MA USA; [Fox, Elizabeth] Cornell Univ, Div Nutr Sci, Ithaca, NY USA; [Devieux, Jessy G.] Florida Int Univ, AIDS Prevent Program, Miami, FL 33199 USA; [Pape, Jean William] Weill Cornell Med Coll, Ctr Global Hlth, New York, NY USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Analysis Group Inc.; Cornell University; State University System of Florida; Florida International University; Cornell University	Koenig, SP (corresponding author), Haitian Study Grp Kaposis Sarcoma & Opportunist I, Port Au Prince, Haiti.	skoenig@partners.org			National Institute of Allergy and Infectious Diseases (NIAID) [R01AI104344]; Fogarty International Center [D43TW009606]; FOGARTY INTERNATIONAL CENTER [D43TW009606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104344] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project was supported in part by the National Institute of Allergy and Infectious Diseases (NIAID) Grant Number R01AI104344 and the Fogarty International Center Grant Number D43TW009606. No funder was involved in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibhai A, 2010, INT J WOMENS HEALTH, V2, P45; Alvarez-Uria G, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.21682; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Auld AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018453; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Boyles TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019201; Braitstein P, 2008, J WOMENS HEALTH, V17, P47, DOI 10.1089/jwh.2007.0353; Chang JM, 2014, AM J MED SCI, V347, P183, DOI 10.1097/MAJ.0b013e31827981be; Chen SCC, 2008, TROP MED INT HEALTH, V13, P513, DOI 10.1111/j.1365-3156.2008.02029.x; Cornell M, 2013, S AFR J HIV MED, V14, P12, DOI 10.7196/SAJHIVMED.894; Cornell M, 2013, FUTURE MICROBIOL, V8, P9, DOI [10.2217/FMB.12.128, 10.2217/fmb.12.128]; Cornell M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001304; Cornell M, 2009, TROP MED INT HEALTH, V14, P722, DOI 10.1111/j.1365-3156.2009.02290.x; Desilva MB, 2009, AIDS CARE, V21, P70, DOI 10.1080/09540120802017636; Druyts E, 2013, AIDS, V27, P417, DOI 10.1097/QAD.0b013e328359b89b; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Ford N, 2010, AIDS, V24, P2645, DOI 10.1097/QAD.0b013e32833ec5b2; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Fregonese F, 2012, JAIDS-J ACQ IMM DEF, V60, P91, DOI 10.1097/QAI.0b013e31824bd33f; Gallagher D, 1996, AM J EPIDEMIOL, V143, P228, DOI 10.1093/oxfordjournals.aje.a008733; GARCIA M, 1994, EUR J CLIN NUTR, V48, pS90; Hawkins C, 2011, AIDS, V25, P1189, DOI 10.1097/QAD.0b013e3283471deb; Jarrin I, 2015, ANTIVIR THER, V20, P21, DOI 10.3851/IMP2768; Jarrin I, 2008, AM J EPIDEMIOL, V168, P532, DOI 10.1093/aje/kwn179; Perez-Elias MJ, 2014, ANTIVIR THER, V19, P375, DOI 10.3851/IMP2714; Johannessen A, 2011, AIDS, V25, P1225, DOI 10.1097/QAD.0b013e32834403b8; Jones H, 2012, TRANSPLANTATION, V93, P923, DOI 10.1097/TP.0b013e31824b36fa; Khongsdier R, 2002, EUR J CLIN NUTR, V56, P484, DOI 10.1038/sj.ejcn.1601281; Kipp W, 2010, AIDS CARE, V22, P271, DOI 10.1080/09540120903193625; Koenig SP, 2012, JAIDS-J ACQ IMM DEF, V59, pE60, DOI 10.1097/QAI.0b013e318245d3c1; Kouanda S, 2012, AIDS CARE, V24, P478, DOI 10.1080/09540121.2011.630353; Kumarasamy N, 2008, J WOMENS HEALTH, V17, P1471, DOI 10.1089/jwh.2007.0670; Leichliter JS, 2011, SAHARA J-J SOC ASP H, V8, P82, DOI 10.1080/17290376.2011.9724989; MacPherson P, 2009, T ROY SOC TROP MED H, V103, P588, DOI 10.1016/j.trstmh.2008.10.001; Madec Y, 2007, AIDS, V21, P351, DOI 10.1097/QAD.0b013e328012c54f; Martinsson A, 2014, EUR J EPIDEMIOL, V29, P489, DOI 10.1007/s10654-014-9929-9; Maskew Mhairi, 2012, J Int Assoc Physicians AIDS Care (Chic), V11, P57, DOI 10.1177/1545109711421641; McCullough PA, 2013, CLIN CARDIOL, V36, P611, DOI 10.1002/clc.22181; Mills EJ, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-52; Mulissa Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013268; Mutevedzi PC, 2010, B WORLD HEALTH ORGAN, V88, P593, DOI 10.2471/BLT.09.069419; Nglazi MD, 2011, JAIDS-J ACQ IMM DEF, V56, pE1, DOI 10.1097/QAI.0b013e3181ff0bdc; Nieves JW, 2005, J BONE MINER RES, V20, P529, DOI 10.1359/JBMR.041005; Prado CMM, 2014, AM J CLIN NUTR, V99, P1369, DOI 10.3945/ajcn.113.078576; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Severe P, 2005, NEW ENGL J MED, V353, P2325, DOI 10.1056/NEJMoa051908; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; Sieleunou I, 2009, TROP MED INT HEALTH, V14, P36, DOI 10.1111/j.1365-3156.2008.02183.x; Somi G, 2012, TROP MED INT HEALTH, V17, P497, DOI 10.1111/j.1365-3156.2011.02952.x; Thaler-Kall K, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-29; The United State's President's Emergency Response to AIDS Relief, WOM GIRL CTR APPR HL; Toure S, 2008, AIDS, V22, P873, DOI 10.1097/QAD.0b013e3282f768f8; Weigel R, 2012, AIDS, V26, P365, DOI 10.1097/QAD.0b013e32834ed814; World Health Organization (WHO), 2011, HEM CONC DIAGN AN AS; Zhang FJ, 2009, ANN INTERN MED, V151, P241, DOI 10.7326/0003-4819-151-4-200908180-00006	55	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142101	10.1371/journal.pone.0142101	http://dx.doi.org/10.1371/journal.pone.0142101			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7UL	26562018	Green Submitted, Green Published, gold			2022-12-26	WOS:000364480900014
J	Zhang, HD; Zhang, GM; Yao, CX; Junaid, M; Lu, ZH; Zhang, HJ; Ma, YH				Zhang, Huaidong; Zhang, Guimin; Yao, Chaoxiang; Junaid, Muhammad; Lu, Zhenghui; Zhang, Houjin; Ma, Yanhe			Structural Insight of a Trimodular Halophilic Cellulase with a Family 46 Carbohydrate-Binding Module	PLOS ONE			English	Article							GLYCOSIDE HYDROLASE; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; 7 CELLOBIOHYDROLASE; MOLECULAR-DYNAMICS; KINETIC-ANALYSIS; CALCIUM-BINDING; MECHANISM; AMBER; ENDOGLUCANASE	Cellulases are the key enzymes used in the biofuel industry. A typical cellulase contains a catalytic domain connected to a carbohydrate-binding module (CBM) through a flexible linker. Here we report the structure of an atypical trimodular cellulase which harbors a catalytic domain, a CBM46 domain and a rigid CBM_X domain between them. The catalytic domain shows the features of GH5 family, while the CBM46 domain has a sandwich-like structure. The catalytic domain and the CBM46 domain form an extended substrate binding cleft, within which several tryptophan residues are well exposed. Mutagenesis assays indicate that these residues are essential for the enzymatic activities. Gel affinity electrophoresis shows that these tryptophan residues are involved in the polysaccharide substrate binding. Also, electrostatic potential analysis indicates that almost the entire solvent accessible surface of CelB is negatively charged, which is consistent with the halophilic nature of this enzyme.	[Zhang, Guimin; Ma, Yanhe] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China; [Zhang, Huaidong; Yao, Chaoxiang; Junaid, Muhammad; Zhang, Houjin] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Dept Biotechnol, Wuhan 430074, Hubei, Peoples R China; [Zhang, Huaidong; Yao, Chaoxiang; Junaid, Muhammad; Zhang, Houjin] Minist Educ, Key Lab Mol Biophys, Wuhan, Hubei, Peoples R China; [Zhang, Guimin; Lu, Zhenghui] Hubei Univ, Coll Life Sci, Hubei Collaborat Innovat Ctr Green Transformat Bi, Wuhan, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Huazhong University of Science & Technology; Hubei University	Zhang, HJ (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Dept Biotechnol, Wuhan 430074, Hubei, Peoples R China.	hjzhang@hust.edu.cn; mayanhe@im.ac.cn	Junaid, Dr. Muhammad/ABF-9669-2021; MA, YAN/HHN-2912-2022	Zhang, Huaidong/0000-0001-6572-4737; Zhang, Guimin/0000-0002-7824-0077	National Key Basic Research Program of China [2013CB933900]; National Natural Science Foundation of China [31170068]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Key Basic Research Program of China (2013CB933900) and National Natural Science Foundation of China (31170068).	Abou-Hachem M, 2002, BIOCHEMISTRY-US, V41, P5720, DOI 10.1021/bi012094a; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alvarez TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083635; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beckham GT, 2010, BIOPHYS J, V99, P3773, DOI 10.1016/j.bpj.2010.10.032; Bhat A, 2013, EXTREMOPHILES, V17, P229, DOI 10.1007/s00792-012-0510-8; Bianchetti CM, 2013, J MOL BIOL, V425, P4267, DOI 10.1016/j.jmb.2013.05.030; Bommarius AS, 2014, CURR OPIN BIOTECH, V29, P139, DOI 10.1016/j.copbio.2014.04.007; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Bornscheuer U, 2014, ANGEW CHEM INT EDIT, V53, P10876, DOI 10.1002/anie.201309953; Carroll A, 2009, ANNU REV PLANT BIOL, V60, P165, DOI 10.1146/annurev.arplant.043008.092125; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Delgado-Garcia M, 2012, J SCI FOOD AGR, V92, P2575, DOI 10.1002/jsfa.5860; Doublie Sylvie, 2007, Methods Mol Biol, V363, P91, DOI 10.1007/978-1-59745-209-0_5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fushinobu S, 2013, CURR OPIN STRUC BIOL, V23, P652, DOI 10.1016/j.sbi.2013.06.001; Garcia-Fraga B, 2014, APPL MICROBIOL BIOT, V98, P2133, DOI 10.1007/s00253-013-5124-2; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Harris D, 2010, PLANT BIOTECHNOL J, V8, P244, DOI 10.1111/j.1467-7652.2009.00481.x; Hendriks ATWM, 2009, BIORESOURCE TECHNOL, V100, P10, DOI 10.1016/j.biortech.2008.05.027; Hidaka M, 2006, BIOCHEM J, V398, P37, DOI 10.1042/BJ20060274; Hirasawa K, 2006, ANTON LEEUW INT J G, V89, P211, DOI 10.1007/s10482-005-9023-0; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jamal-Talabani S, 2004, STRUCTURE, V12, P1177, DOI 10.1016/j.str.2004.04.022; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jung SK, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/405842; Kern M, 2013, P NATL ACAD SCI USA, V110, P10189, DOI 10.1073/pnas.1301502110; Kim HW, 2012, FEBS LETT, V586, P1009, DOI 10.1016/j.febslet.2012.02.029; Kleywegt GJ, 1996, STRUCTURE, V4, P897, DOI 10.1016/S0969-2126(96)00097-4; Larsbrink J, 2014, NATURE, V506, P498, DOI 10.1038/nature12907; LAWSON CL, 1994, J MOL BIOL, V236, P590, DOI 10.1006/jmbi.1994.1168; Li W, 2008, MOL BIOTECHNOL, V40, P195, DOI 10.1007/s12033-008-9079-y; Litzinger S, 2010, J BIOL CHEM, V285, P35675, DOI 10.1074/jbc.M110.131037; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Momeni MH, 2013, J BIOL CHEM, V288, P5861, DOI 10.1074/jbc.M112.440891; Oyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080448; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sakon J, 1997, NAT STRUCT BIOL, V4, P810, DOI 10.1038/nsb1097-810; van den Burg B, 2003, CURR OPIN MICROBIOL, V6, P213, DOI 10.1016/S1369-5274(03)00060-2; Venditto I, 2015, J BIOL CHEM, V290, P10572, DOI 10.1074/jbc.M115.637827; Vester-Christensen MB, 2010, J MOL BIOL, V403, P739, DOI 10.1016/j.jmb.2010.09.031; Vuong TV, 2010, BIOTECHNOL BIOENG, V107, P195, DOI 10.1002/bit.22838; Vuong TV, 2009, FEBS J, V276, P4261, DOI 10.1111/j.1742-4658.2009.07097.x; Wang CY, 2009, ENZYME MICROB TECH, V44, P373, DOI 10.1016/j.enzmictec.2009.02.006; Wilkins MR, 1999, METH MOL B, V112, P531; Wolfgang K, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI [10.1107/S0907444909047337, DOI 10.1107/S0907444909047337]; Yip VLY, 2007, BIOCHEMISTRY-US, V46, P9840, DOI 10.1021/bi700536p; Zhang GM, 2012, EXTREMOPHILES, V16, P35, DOI 10.1007/s00792-011-0403-2; Zhang HD, 2013, FEBS LETT, V587, P1675, DOI 10.1016/j.febslet.2013.04.013; Zheng BS, 2012, J BIOL CHEM, V287, P8336, DOI 10.1074/jbc.M111.266346; Zhong LH, 2009, CARBOHYD RES, V344, P1984, DOI 10.1016/j.carres.2009.07.005	57	3	4	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2015	10	11							e0142107	10.1371/journal.pone.0142107	http://dx.doi.org/10.1371/journal.pone.0142107			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7UL	26562160	Green Published, Green Submitted, gold			2022-12-26	WOS:000364480900015
J	Agrafioti, P; Athanassiou, CG; Vassilakos, TN; Vlontzos, G; Arthur, FH				Agrafioti, Paraskevi; Athanassiou, Christos G.; Vassilakos, Thomas N.; Vlontzos, George; Arthur, Frank H.			Using a Lethality Index to Assess Susceptibility of Tribolium confusum and Oryzaephilus surinamensis to Insecticides	PLOS ONE			English	Article							STORED-PRODUCT PSOCIDS; RESIDUAL EFFICACY; DIFFERENT SURFACES; BETA-CYFLUTHRIN; SHORT EXPOSURES; FOOD SOURCE; CONCRETE; CHLORFENAPYR; COLEOPTERA; CASTANEUM	We evaluated knockdown caused by four insecticides: alpha-cypermethrin, chlorfenapyr, pirimiphos-methyl and fipronil against adults of Tribolium confusum Jacquelin Duval, the confused flour beetle and Oryzaephilus surinamensis (L.), the sawtoothed grain beetle. Bioassays were conducted on concrete and metal surfaces. Adults of the tested species were exposed on both surfaces treated with the above insecticides at two doses (low and high). Knockdown assessment was done after 15, 30 and 60 min of adult exposure in the treated surfaces. Also, after 1, 3, 5, 7 and 14 d of exposure, a lethality index was calculated with an equation resulting to values from 0 to 100, where 100 indicated complete mortality and 0 complete survival. We also developed a lethality index by ranking each adult on each surface from 0 to 4, 0: adults moved normally, 1: adults were knocked down, but were able to walk for short intervals, 2: adults were knocked down and unable to walk, but with visible movement of antennae etc., 3: adults were knocked down, with very minimal movement of the tarsi and the antennae and 4: adults were dead (no movement). Knockdown of adults immediately after exposure (15-60 min) was higher for pirimiphos-methyl followed by alpha-cypermethrin, for both dose rates tested and species, but only on the metal surface. The lethality index was nearly 100 for all insecticides after 5d of exposure for O. surinamensis, while for T. confusum the adult lethality index was considerably lower for alpha-cypermethrin, suggesting that that recovery from knockdown occurred. Chlorfenapyr was the only insecticide that was more effective on concrete than on metal, while the reverse was noted for the other three insecticides. These results show that knockdown has different levels, which can be used as indicators of insect mortality or recovery.	[Agrafioti, Paraskevi; Athanassiou, Christos G.; Vassilakos, Thomas N.; Vlontzos, George] Univ Thessaly, Dept Agr Crop Prod & Rural Environm, Volos, Greece; [Arthur, Frank H.] USDA ARS, Ctr Grain & Anim Hlth Res, Manhattan, KS USA	University of Thessaly; United States Department of Agriculture (USDA)	Athanassiou, CG (corresponding author), Univ Thessaly, Dept Agr Crop Prod & Rural Environm, Lab Entomol & Agr Zool, Volos, Greece.	athanassiou@agr.uth.gr	Athanassiou, Christos/ABE-8867-2020	Vlontzos, George/0000-0002-0735-2274				Arthur FH, 1997, J STORED PROD RES, V33, P167, DOI 10.1016/S0022-474X(96)00041-0; Arthur FH, 1998, J ECON ENTOMOL, V91, P773, DOI 10.1093/jee/91.3.773; Arthur FH, 2012, J INSECT SCI, V12, P1; Arthur FH, 2008, J STORED PROD RES, V44, P145, DOI 10.1016/j.jspr.2007.08.005; Arthur FH, 2012, J PEST SCI, V85, P323, DOI 10.1007/s10340-012-0439-9; Arthur FH, 2012, J PEST SCI, V85, P261, DOI 10.1007/s10340-011-0396-8; Arthur FH, 2009, PEST MANAG SCI, V65, P791, DOI 10.1002/ps.1756; Arthur FH, 2009, INSECT SCI, V16, P157, DOI 10.1111/j.1744-7917.2009.00267.x; Athanassiou CG, 2014, J ECON ENTOMOL, V107, P854, DOI 10.1603/EC13376; Athanassiou CG, 2013, J ECON ENTOMOL, V106, P1064, DOI 10.1603/EC12406; Athanassiou CG, 2010, J ECON ENTOMOL, V103, P197, DOI 10.1603/EC09115; Campbell JF, 2007, ECOLOGICALLY BASED INTEGRATED PEST MANAGEMENT, P406, DOI 10.1079/9781845930646.0406; Campbell JF, 2014, J ECON ENTOMOL, V107, P440, DOI 10.1603/EC13423; CHADWICK PR, 1985, PESTIC SCI, V16, P383, DOI 10.1002/ps.2780160413; Creighton L, 2001, JMP START STAT GUIDE; GEORGHIOU G. P., 1962, MOSQUITO NEWS, V22, P260; Guedes NMP, 2009, B ENTOMOL RES, V99, P393, DOI 10.1017/S0007485309006610; Guedes RNC, 2008, PEST MANAG SCI, V64, P1314, DOI 10.1002/ps.1634; Jankov D, 2013, J PEST SCI, V86, P211, DOI 10.1007/s10340-012-0469-3; Kavallieratos NG, 2010, PEST MANAG SCI, V66, P640, DOI 10.1002/ps.1923; Leskey TC, 2012, J ECON ENTOMOL, V105, P1726, DOI 10.1603/EC12096; Likert R., 1932, J ARCH PSYCHOL, V22, P5, DOI DOI 10.1097/AUD.0000000000000341; Michaud JP, 2002, J ENTOMOL SCI, V37, P83, DOI 10.18474/0749-8004-37.1.83; Nayak MK, 2003, J STORED PROD RES, V39, P343, DOI 10.1016/S0022-474X(02)00029-2; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; Sehgal B, 2014, PEST MANAG SCI, V70, P576, DOI 10.1002/ps.3580; Sokal RR, 1995, BIOMETRY; Tsaganou FC, 2014, J ECON ENTOMOL, V107, P2222, DOI 10.1603/EC14210; Vassilakos TN, 2014, J PEST SCI, V87, P485, DOI 10.1007/s10340-014-0574-6; Wijayaratne LKW, 2012, J ECON ENTOMOL, V105, P718, DOI 10.1603/EC11375	30	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142044	10.1371/journal.pone.0142044	http://dx.doi.org/10.1371/journal.pone.0142044			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26560316	gold, Green Submitted, Green Published			2022-12-26	WOS:000364433100051
J	Bicker, A; Brahmer, AM; Meller, S; Kristiansen, G; Gorr, TA; Hankeln, T				Bicker, Anne; Brahmer, Alexandra M.; Meller, Sebastian; Kristiansen, Glen; Gorr, Thomas A.; Hankeln, Thomas			The Distinct Gene Regulatory Network of Myoglobin in Prostate and Breast Cancer	PLOS ONE			English	Article							ENDOGENOUS MYOGLOBIN; RECEPTOR EXPRESSION; HYPOXIA; CELLS; DIFFERENTIATION; TRANSCRIPTION; NEUROGLOBIN; PREVENTION; MECHANISM; BETA	Myoglobin (MB) is not only strongly expressed in myocytes, but also at much lower levels in different cancer entities. 40% of breast tumors are MB-positive, with the globin being coexpressed with markers of tumor hypoxia in a proportion of cases. In breast cancer, MB expression is associated with a positive hormone receptor status and patient prognosis. In prostate cancer, another hormone-dependent cancer type, 53% of tumors were recently shown to express MB. Especially in more aggressive prostate cancer specimen MB expression also correlates with increased patient survival rates. Both findings might be due to tumor-suppressing properties of MB in cancer cells. In contrast to muscle, MB transcription in breast and prostate cancer mainly depends on a novel, alternative promoter site. We show here that its associated transcripts can be upregulated by hypoxia and downregulated by estrogens and androgens in MCF7 breast and LNCaP prostate cancer cells, respectively. Bioinformatic data mining of epigenetic histone marks and experimental verification reveal a hitherto uncharacterized transcriptional network that drives the regulation of the MB gene in cancer cells. We identified candidate hormone-receptor binding elements that may interact with the cancer-associated MB promoter to decrease its activity in breast and prostate cancer cells. Additionally, a regulatory element, 250 kb downstream of the promoter, acts as a hypoxia-inducible site within the transcriptional machinery. Understanding the distinct regulation of MB in tumors will improve unraveling the respiratory protein's function in the cancer context and may provide new starting points for developing therapeutic strategies.	[Bicker, Anne; Brahmer, Alexandra M.; Hankeln, Thomas] Johannes Gutenberg Univ Mainz, Inst Mol Genet, D-55122 Mainz, Germany; [Meller, Sebastian; Kristiansen, Glen] Univ Hosp Bonn, Inst Pathol, Bonn, Germany; [Gorr, Thomas A.] Univ Zurich, Inst Vet Physiol, Vetsuisse Fac, Zurich, Switzerland; [Gorr, Thomas A.] Univ Zurich, Regenerat Med Program, Zurich, Switzerland; [Gorr, Thomas A.] Univ Zurich Hosp, CH-8091 Zurich, Switzerland	Johannes Gutenberg University of Mainz; University of Bonn; University of Zurich; University of Zurich; University of Zurich; University Zurich Hospital	Hankeln, T (corresponding author), Johannes Gutenberg Univ Mainz, Inst Mol Genet, D-55122 Mainz, Germany.	hankeln@uni-mainz.de	Brahmer, Alexandra/ABI-6051-2020	Brahmer, Alexandra/0000-0001-5963-4209; Gorr, Thomas/0000-0002-6023-4234; Bicker, Anne/0000-0003-4364-9777	Center for Computational Sciences Mainz (CSM); Johannes Gutenberg University Mainz	Center for Computational Sciences Mainz (CSM); Johannes Gutenberg University Mainz	This work was supported by the Center for Computational Sciences Mainz (CSM) 2013 and an intramural grant (Stufe 1) of Johannes Gutenberg University Mainz.	Burmester T, 2014, ACTA PHYSIOL, V211, P501, DOI 10.1111/apha.12312; Chen RY, 2015, J IMMUNOL, V194, P4019, DOI 10.4049/jimmunol.1400806; D'Aprile A, 2014, STEM CELLS, V32, P1267, DOI 10.1002/stem.1646; Davis RW, 2014, J COMP PHYSIOL B, V184, P23, DOI 10.1007/s00360-013-0782-z; Flogel U, 2001, P NATL ACAD SCI USA, V98, P735, DOI 10.1073/pnas.011460298; Flogel U, 2004, FASEB J, V18, P1156, DOI 10.1096/fj.03-1382fje; Flonta SE, 2009, AM J PATHOL, V175, P201, DOI 10.2353/ajpath.2009.081124; Fullwood Melissa J, 2010, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2115s89; Galluzzo M, 2009, J CLIN INVEST, V119, P865, DOI 10.1172/JCI36579; Glass CK, 2000, GENE DEV, V14, P121; Godecke A, 1999, P NATL ACAD SCI USA, V96, P10495, DOI 10.1073/pnas.96.18.10495; Guertin MJ, 2014, MOL ENDOCRINOL, V28, P1522, DOI 10.1210/me.2014-1130; Guo MMWC, 2014, AM J CLIN EXP UROL, V2, P169; Hendgen-Cotta UB, 2014, TRENDS CARDIOVAS MED, V24, P69, DOI 10.1016/j.tcm.2013.06.006; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; KALKHOVEN E, 1995, CELL GROWTH DIFFER, V6, P1151; Kanatous SB, 2010, J EXP BIOL, V213, P2741, DOI 10.1242/jeb.041442; Kristiansen G, 2010, BRIT J CANCER, V102, P1736, DOI 10.1038/sj.bjc.6605702; Kristiansen G, 2011, J BIOL CHEM, V286, P43417, DOI 10.1074/jbc.M111.227553; MacMunn CA., 1886, J PHYSL, V5, P24; Malik S, 2010, MOL CELL BIOL, V30, P399, DOI 10.1128/MCB.00907-09; Meller S, 2014, VIRCHOWS ARCH, V465, P419, DOI 10.1007/s00428-014-1646-y; Merx Marc W., 2001, FASEB Journal, V15, P1077; Qiu Y, 1998, J BIOL CHEM, V273, P23426, DOI 10.1074/jbc.273.36.23426; RUCK P, 1995, HEMATOL PATHOL, V9, P49; Schlater AE, 2014, J APPL PHYSIOL, V117, P307, DOI 10.1152/japplphysiol.00973.2013; Shiva S, 2007, CIRC RES, V100, P654, DOI 10.1161/01.RES.0000260171.52224.6b; Steinmetz R, 1996, CANCER RES, V56, P5403; WITTENBERG BA, 1989, ANNU REV PHYSIOL, V51, P857, DOI 10.1146/annurev.physiol.51.1.857; Wittenberg BA, 2009, AM J PHYSIOL-CELL PH, V296, pC390, DOI 10.1152/ajpcell.00002.2009; Wittenberg JB, 2003, J EXP BIOL, V206, P2011, DOI 10.1242/jeb.00243; Zhang PJ, 2003, MODERN PATHOL, V16, P229, DOI 10.1097/01.MP.0000056630.76035.F3	35	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142662	10.1371/journal.pone.0142662	http://dx.doi.org/10.1371/journal.pone.0142662			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26559958	gold, Green Published, Green Submitted			2022-12-26	WOS:000364433100108
J	Corse, E; Pech, N; Sinama, M; Costedoat, C; Chappaz, R; Gilles, A				Corse, Emmanuel; Pech, Nicolas; Sinama, Melthide; Costedoat, Caroline; Chappaz, Remi; Gilles, Andre			When Anthropogenic River Disturbance Decreases Hybridisation between Non-Native and Endemic Cyprinids and Drives an Ecomorphological Displacement towards Juvenile State in Both Species	PLOS ONE			English	Article							FRESH-WATER FISH; CHONDROSTOMA-NASUS L.; FLOW REGIME; PHENOTYPIC PLASTICITY; HYBRID ZONE; INTROGRESSION; ASSEMBLAGES; POPULATION; EVOLUTION; PATTERNS	Understanding the impact of non-native species on native species is a major challenge in molecular ecology, particularly for genetically compatible fish species. Invasions are generally difficult to study because their effects may be confused with those of environmental or human disturbances. Colonized ecosystems are differently impacted by human activities, resulting in diverse responses and interactions between native and non-native species. We studied the dynamics between two Cyprinids species (invasive Chondrostoma nasus and endemic Parachondrostoma toxostoma) and their hybrids in 16 populations (from allopatric to sympatric situations and from little to highly fragmented areas) corresponding to 2,256 specimens. Each specimen was assigned to a particular species or to a hybrid pool using molecular identification (cytochrome b and 41 microsatellites). We carried out an ecomorphological analysis based on size, age, body shape, and diet (gut vacuity and molecular fecal contents). Our results contradicted our initial assumptions on the pattern of invasion and the rate of introgression. There was no sign of underperformance for the endemic species in areas where hybridisation occurred. In the unfragmented zone, the introduced species was found mostly downstream, with body shapes similar to those in allopatric populations while both species were found to be more insectivorous than the reference populations. However, high level of hybridisation was detected, suggesting interactions between the two species during spawning and/or the existence of hybrid swarm. In the disturbed zone, introgression was less frequent and slender body shape was associated with diatomivorous behaviour, smaller size (juvenile characteristics) and greater gut vacuity. Results suggested that habitat degradation induced similar ecomorphological trait changes in the two species and their hybrids (i. e. a transition towards a pedomorphic state) where the invasive species is more affected than the native species. Therefore, this study reveals a diversity of relationships between two genetically compatible species and emphasizes constraints on the invasion process in disturbed areas.	[Corse, Emmanuel; Pech, Nicolas; Sinama, Melthide; Costedoat, Caroline; Chappaz, Remi; Gilles, Andre] Aix Marseille Univ, Avignon Univ, Ctr St Charles, IMBE,CNRS,IRD, F-13331 Marseille 3, France	Avignon Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite	Corse, E (corresponding author), Aix Marseille Univ, Avignon Univ, Ctr St Charles, IMBE,CNRS,IRD, Case 36,3 Pl Victor Hugo, F-13331 Marseille 3, France.	emmanuel.corse@gmail.com		Emmanuel, Corse/0000-0003-0992-726X; Nicolas, Pech/0000-0002-1822-3558	Syndicat Mixte d'Amenagement de la Vallee de la Durance; Conseil Regional Provence Alpes Cote d'Azur; Maison Regionale de l' Eau; European Union	Syndicat Mixte d'Amenagement de la Vallee de la Durance; Conseil Regional Provence Alpes Cote d'Azur(Region Provence-Alpes-Cote d'AzurRegion Auvergne-Rhone-Alpes); Maison Regionale de l' Eau; European Union(European Commission)	EC was supported by a PhD grant from Syndicat Mixte d'Amenagement de la Vallee de la Durance and the Conseil Regional Provence Alpes Cote d'Azur. MS was supported by a PhD grant from Maison Regionale de l' Eau, the Conseil Regional Provence Alpes Cote d'Azur and European Union funding.	AITCHISON J, 1983, BIOMETRIKA, V70, P57; Arnegard ME, 2014, NATURE, V511, P307, DOI 10.1038/nature13301; BALON EK, 1992, ENVIRON BIOL FISH, V33, P167, DOI 10.1007/BF00002562; Balon EK, 2002, ENVIRON BIOL FISH, V65, P1, DOI 10.1023/A:1019619206215; BARTON NH, 1979, HEREDITY, V43, P341, DOI 10.1038/hdy.1979.87; Bouchard P, 1996, THESIS; Brown LR, 2002, RIVER RES APPL, V18, P331, DOI 10.1002/rra.673; Buerkle CA, 2005, MOL ECOL NOTES, V5, P684, DOI 10.1111/j.1471-8286.2005.01011.x; Carrel G, 2002, ARCH HYDROBIOL, V155, P273; Cazaubon A, 1999, REGUL RIVER, V15, P441, DOI 10.1002/(SICI)1099-1646(199909/10)15:5&lt;441::AID-RRR558&gt;3.0.CO;2-9; Corse E, 2012, BIOL J LINN SOC, V106, P342, DOI 10.1111/j.1095-8312.2012.01873.x; Corse E, 2010, MOL ECOL RESOUR, V10, P96, DOI 10.1111/j.1755-0998.2009.02795.x; Corse E, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-26; Costedoat C, 2005, BIOL J LINN SOC, V85, P135, DOI 10.1111/j.1095-8312.2005.00478.x; Costedoat C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000357; Crivelli AJ, 2006, PARACHONDROSTOMA TOX; Davis M, 2011, NATURE, V474, P153, DOI 10.1038/474153a; De Billy VD, 2000, J FISH BIOL, V56, P961, DOI 10.1111/j.1095-8649.2000.tb00885.x; Descloux S, 2013, AQUAT SCI, V75, P493, DOI 10.1007/s00027-013-0295-6; Doledec S., 1986, THESIS; Dubut V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034423; Dubut Vincent, 2010, BMC Res Notes, V3, P135, DOI 10.1186/1756-0500-3-135; Edeline E, 2013, GLOBAL CHANGE BIOL, V19, P3062, DOI 10.1111/gcb.12299; Flore L, 1998, REGUL RIVER, V14, P141; Freyhof J, 2005, MOL PHYLOGENET EVOL, V37, P347, DOI 10.1016/j.ympev.2005.07.018; Freyhof J, 2013, CHONDROSTOMA NASUS I; Gabert P, 1991, RIVIERES CRISE SAONE, P79; Gagnaire PA, 2013, MOL ECOL, V22, P3036, DOI 10.1111/mec.12127; Gilles A, 1998, THESIS; Gompert Z, 2010, MOL ECOL RESOUR, V10, P378, DOI 10.1111/j.1755-0998.2009.02733.x; Gozlan RE, 2012, FISHERIES MANAG ECOL, V19, P89, DOI 10.1111/j.1365-2400.2012.00853.x; Gozlan RE, 2010, J FISH BIOL, V76, P751, DOI 10.1111/j.1095-8649.2010.02566.x; Gozlan RE, 1998, THESIS; Gozlan RE, 2008, FISH FISH, V9, P106, DOI 10.1111/j.1467-2979.2007.00267.x; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Hayden B, 2011, FRESHWATER BIOL, V56, P1723, DOI 10.1111/j.1365-2427.2011.02604.x; Hayden B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-169; Hedrick PW, 2013, MOL ECOL, V22, P4606, DOI 10.1111/mec.12415; Hendry AP, 2000, SCIENCE, V290, P516, DOI 10.1126/science.290.5491.516; Hovick SM, 2014, ECOL LETT, V17, P1464, DOI 10.1111/ele.12355; Huber M, 1998, HYDROBIOLOGIA, V372, P309, DOI 10.1023/A:1017005523302; Huet M., 1949, Schweizerische Zeitschrift fuer Hydrologie Basle, V11, P332, DOI 10.1007/BF02503356; Huxel GR, 1999, BIOL CONSERV, V89, P143, DOI 10.1016/S0006-3207(98)00153-0; Imre I, 2002, J FISH BIOL, V61, P1171, DOI 10.1006/jfbi.2002.2131; Kiernan JD, 2012, ECOL APPL, V22, P1472; Kolar CS, 2002, SCIENCE, V298, P1233, DOI 10.1126/science.1075753; Komiya T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017430; Koskinen MT, 2002, NATURE, V419, P826, DOI 10.1038/nature01029; Kovac V, 2002, J THEOR BIOL, V217, P499, DOI 10.1006/yjtbi.3043; Leprieur F, 2008, PLOS BIOL, V6, P404, DOI 10.1371/journal.pbio.0060028; Lytle DA, 2004, TRENDS ECOL EVOL, V19, P94, DOI 10.1016/j.tree.2003.10.002; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Marchetti MP, 2001, ECOL APPL, V11, P530, DOI 10.2307/3060907; Marion C, 2008, HOUILLE BLANCHE, P72; Merigoux S, 2009, FRESHWATER BIOL, V54, P1343, DOI 10.1111/j.1365-2427.2008.02160.x; Nelva-Pasqual A, 1985, THESIS; Nolte AW, 2009, MOL ECOL, V18, P2615, DOI 10.1111/j.1365-294X.2009.04208.x; Nolte AW, 2010, TRENDS GENET, V26, P54, DOI 10.1016/j.tig.2009.12.001; Nolte AW, 2005, P ROY SOC B-BIOL SCI, V272, P2379, DOI 10.1098/rspb.2005.3231; Ovidio M, 2008, J APPL ICHTHYOL, V24, P256, DOI 10.1111/j.1439-0426.2008.01050.x; Penaz M, 1996, ADV LIF SCI, P279; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Poulet N, 2011, J FISH BIOL, V79, P1436, DOI 10.1111/j.1095-8649.2011.03084.x; Pritchard JK, 2000, GENETICS, V155, P945; Propst DL, 2004, T AM FISH SOC, V133, P922, DOI 10.1577/T03-057.1; R Core Team, 2021, R LANGUAGE ENV STAT; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; RICHARDSON DM, 2010, 50 YEARS INVASION EC; Rifflart R, 2009, FRESHWATER BIOL, V54, P1544, DOI 10.1111/j.1365-2427.2009.02200.x; Robinson BW, 2000, ADAPTIVE GENETIC VARIATION IN THE WILD, P65; Robinson BW, 2000, ECOLOGY, V81, P2799, DOI 10.1890/0012-9658(2000)081[2799:APAOCR]2.0.CO;2; Robinson BW, 1996, EVOL ECOL, V10, P631, DOI 10.1007/BF01237711; Rohlf FJ, 2004, TPSDIG DIGITIZE LAND; Roy D, 2007, J EVOLUTION BIOL, V20, P1126, DOI 10.1111/j.1420-9101.2006.01289.x; Sagnes P, 2009, AQUAT LIVING RESOUR, V22, P79, DOI 10.1051/alr/2009008; Simkova A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065883; Sinama M, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-22; Souchon Y, 2012, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2012008; Stanford JA, 1996, REGUL RIVER, V12, P391, DOI 10.1002/(SICI)1099-1646(199607)12:4/5&lt;391::AID-RRR436&gt;3.0.CO;2-4; Sullivan SMP, 2010, RIVER RES APPL, V26, P1298, DOI 10.1002/rra.1336; Warner RF, 2006, CATENA, V66, P236, DOI 10.1016/j.catena.2006.02.004; Whiteley AR, 2007, BIOL J LINN SOC, V92, P253, DOI 10.1111/j.1095-8312.2007.00845.x; Williams JE., 2000, MANUAL FISHERIES SUR; Zbinden S, 1996, ADV LIF SCI, P287	85	10	10	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2015	10	11							e0142592	10.1371/journal.pone.0142592	http://dx.doi.org/10.1371/journal.pone.0142592			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7DR	26561027	Green Submitted, Green Published, gold			2022-12-26	WOS:000364433100095
J	Burrough, ER; Arruda, BL; Patience, JF; Plummer, PJ				Burrough, Eric R.; Arruda, Bailey L.; Patience, John F.; Plummer, Paul J.			Alterations in the Colonic Microbiota of Pigs Associated with Feeding Distillers Dried Grains with Solubles	PLOS ONE			English	Article							DIETARY FIBER; GROWING PIGS; LARGE-INTESTINE; DIGESTIBILITY; FERMENTATION; COMMUNITIES; ENERGY; AGE	In an effort to reduce feed costs, many pork producers have increased their use of coproducts of biofuel production in commercial pig diets, including increased feeding of distiller's dried grains with solubles (DDGS). The inclusion of DDGS increases the insoluble fiber content in the ration, which has the potential to impact the colonic microbiota considerably as the large intestine contains a dynamic microenvironment with tremendous interplay between microorganisms. Any alteration to the physical or chemical properties of the colonic contents has the potential to impact the resident bacterial population and potentially favor or inhibit the establishment of pathogenic species. In the present study, colonic contents collected at necropsy from pigs fed either 30% or no DDGS were analyzed to examine the relative abundance of bacterial taxa associated with feeding this ingredient. No difference in alpha diversity (richness) was detected between diet groups. However, the beta diversity was significantly different between groups with feeding of DDGS being associated with a decreased Firmicutes: Bacteriodetes ratio (P = .004) and a significantly lower abundance of Lactobacillus spp. (P = .016). Predictive functional profiling of the microbiota revealed more predicted genes associated with carbohydrate metabolism, protein digestion, and degradation of glycans in the microbiota of pigs fed DDGS. Taken together, these findings confirm that alterations in dietary insoluble fiber significantly alter the colonic microbial profile of pigs and suggest the resultant microbiome may predispose to the development of colitis.	[Burrough, Eric R.; Arruda, Bailey L.; Plummer, Paul J.] Iowa State Univ, Dept Vet Diagnost & Prod Anim Med, Coll Vet Med, Ames, IA 50011 USA; [Patience, John F.] Iowa State Univ, Dept Anim Sci, Ames, IA USA; [Plummer, Paul J.] Iowa State Univ, Dept Vet Microbiol & Preventat Med, Coll Vet Med, Ames, IA USA	Iowa State University; Iowa State University; Iowa State University	Burrough, ER (corresponding author), Iowa State Univ, Dept Vet Diagnost & Prod Anim Med, Coll Vet Med, Ames, IA 50011 USA.	burrough@iastate.edu	Patience, john F./A-2935-2009	Burrough, Eric/0000-0003-4747-9189	Iowa Pork Producers Association; National Pork Board (NPB) [13-212]	Iowa Pork Producers Association; National Pork Board (NPB)	This work was supported by a grant from the Iowa Pork Producers Association and the National Pork Board (NPB #13-212). The funders had no involvement in study design, data collection, analysis and interpretation of data, writing the manuscript, or decision to submit the article for publication.	Bellgard MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004641; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chaban B, 2012, MICROB ECOL, V63, P348, DOI 10.1007/s00248-011-9931-7; Costa MO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106399; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; FILIPE MI, 1979, INVEST CELL PATHOL, V2, P195; Gutierrez NA, 2014, J ANIM SCI, V92, P4505, DOI 10.2527/jas.2013-7265; Hashizume K, 2003, J NUTR, V133, P3187, DOI 10.1093/jn/133.10.3187; Heo JM, 2015, BETWEEN EXPT ANAL RE, V86; Hou CL, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0014-3; Kim HB, 2011, VET MICROBIOL, V153, P124, DOI 10.1016/j.vetmic.2011.05.021; Knudsen KEB, 1997, ANIM FEED SCI TECH, V67, P319, DOI 10.1016/S0377-8401(97)00009-6; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Leonel AJ, 2012, CURR OPIN CLIN NUTR, V15, P474, DOI 10.1097/MCO.0b013e32835665fa; Lu XM, 2014, APPL MICROBIOL BIOT, V98, P2657, DOI 10.1007/s00253-013-5211-4; Niu Q, 2015, SCI REP-UK, V5, DOI 10.1038/srep09938; ROBERTON AM, 1993, BIOCHEM J, V293, P683, DOI 10.1042/bj2930683; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Stein HH, 2009, J ANIM SCI, V87, P1292, DOI 10.2527/jas.2008-1290; Urriola PE, 2010, J ANIM SCI, V88, P2373, DOI 10.2527/jas.2009-2227; Urriola PE, 2010, J ANIM SCI, V88, P1454, DOI 10.2527/jas.2009-2162; Wilberts BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114741; Williams BA, 2005, ANIM RES, V54, P191, DOI 10.1051/animres:2005011; Williams BA, 2001, FERMENTATION LARGE I, V14, P2007; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Youmans BP, 2015, GUT MICROBES, V6, P110, DOI 10.1080/19490976.2015.1019693; Zhao WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117441	29	16	17	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141337	10.1371/journal.pone.0141337	http://dx.doi.org/10.1371/journal.pone.0141337			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555787	Green Published, Green Submitted, gold			2022-12-26	WOS:000364430700026
J	Chang, SN; Juang, JJM; Tsai, CT; Ko, JT; Lien, WP				Chang, Sheng-Nan; Juang, Jimmy Jyh-Ming; Tsai, Chia-Ti; Ko, Jiing-Tang; Lien, Wen-Pin			A Novel Integrated Score Index of Echocardiographic Indices for the Evaluation of Left Ventricular Diastolic Function	PLOS ONE			English	Article							PRESERVED EJECTION FRACTION; MITRAL ANNULUS VELOCITY; CHRONIC HEART-FAILURE; DOPPLER-ECHOCARDIOGRAPHY; EUROPEAN-SOCIETY; CATHETERIZATION; EPIDEMIOLOGY; DYSFUNCTION; PREVALENCE; PRESSURES	Background We propose a novel integrated score index, which could be used to quantify and grade left ventricular (LV) diastolic function. Methods We enrolled 629 participants [393 healthy subjects, 145 with hypertension (HTN), 24 with hypertrophic cardiomyopathy (HCM), and 67 with coronary artery disease (CAD)]. This score index was with a score of 1 for an E/A ratio < 1, a score of 1 for a septal e'/a' ratio <= 0.8, a score of 2 for a lateral e'/a' ratio <= 1, a score of 2 for a septal E/e' ratio >= 10-15, a score of 3 for a lateral E/e' ratio >= 8-15, and a score of 1 for a deceleration time > 240 ms. The sum of each score was considered as the final value in this scoring method (either a septal or a lateral E/e' ratio > 15 was given a total score of 10, regardless of the other measurements). Results After analysis, the AUROC of this integrated score index for predicting any diastolic dysfunction (discriminated by the American Society of Echocardiography guidelines) was 0.962, and the AUROC of the method from the logistic regression was 0.970. The mean values of the score index for the groups were 3.81 +/- 0.12 in healthy, 6.48 +/- 0.19 in HTN, 7.35 +/- 0.46 in HCM, and 6.62 +/- 0.29 in CAD. Using the score index, the healthy subjects obtained lower scores compared with those of HTN (p = 0.00), HCM (p = 0.00), and CAD (p = 0.00). Therefore, this score index could discriminate patients with diseases with impaired diastolic function from the healthy subjects when the total sum of the score was equal to or greater than 4. Conclusions If the presently used methods cannot allow the clear diagnosis of LV diastolic dysfunction, this integrated score index might be helpful for discriminating diseases with impaired diastolic function.	[Chang, Sheng-Nan; Tsai, Chia-Ti] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Chang, Sheng-Nan] Natl Taiwan Univ Hosp, Yun Lin Branch, Dept Internal Med, Div Cardiol, Dou Liu City, Taiwan; [Juang, Jimmy Jyh-Ming; Tsai, Chia-Ti; Lien, Wen-Pin] Natl Taiwan Univ Hosp, Dept Internal Med, Ctr Cardiovasc, Taipei 100, Taiwan; [Ko, Jiing-Tang] Nuliv Wellness Clin, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Lien, WP (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Ctr Cardiovasc, Taipei 100, Taiwan.	lienwp@ntuh.gov.tw		TSAI, CHIA-TI/0000-0002-4853-8665; CHANG, SHENG NAN/0000-0002-2663-5042; Juang, Jyh-Ming Jimmy/0000-0003-4767-7636	New Century Health Care Promotion Foundation of Taiwan; Nuliv Wellness Clinic; New Century Health Care Promotion Foundation	New Century Health Care Promotion Foundation of Taiwan; Nuliv Wellness Clinic; New Century Health Care Promotion Foundation	This study was supported by grants from the New Century Health Care Promotion Foundation of Taiwan. The foundation had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript. Author Jiing-Tang Ko is employed by Nuliv Wellness Clinic. Nuliv Wellness Clinic provided support in the form of salary for author Jiing-Tang Ko, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.; This study was supported by a grant from the New Century Health Care Promotion Foundation. We gratefully acknowledge Jou-Wei Lin M.D., PhD for the consultation and statistical analysis. We also appreciate the technical assistance of Ms. Hsiung-Yin Lin and Ms. Chiung-Fang Yeh in the recording of echocardiograms. We are also grateful for the secretarial assistance of Ms. Hui-Yen Chang and Ms Hwei-Ming Kuo during the preparation of this manuscript.	Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; Cohen GI, 1996, J AM COLL CARDIOL, V27, P1753, DOI 10.1016/0735-1097(96)00088-5; Daneshvar D, 2010, AM HEART J, V160, P394, DOI 10.1016/j.ahj.2010.06.040; Hogg K, 2004, J AM COLL CARDIOL, V43, P317, DOI 10.1016/j.jacc.2003.07.046; Kasner M, 2007, CIRCULATION, V116, P637, DOI 10.1161/CIRCULATIONAHA.106.661983; Khouri SJ, 2004, J AM SOC ECHOCARDIOG, V17, P290, DOI 10.1016/j.echo.2003.08.012; Kim YJ, 2000, J AM SOC ECHOCARDIOG, V13, P980, DOI 10.1067/mje.2000.107156; Kitzman Dalane W., 2000, Cardiology Clinics, V18, P597, DOI 10.1016/S0733-8651(05)70164-8; Leischik R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/765921; Martos R, 2007, CIRCULATION, V115, P888, DOI 10.1161/CIRCULATIONAHA.106.638569; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Miura Y, 2010, CIRC J, V74, P2612, DOI 10.1253/circj.CJ-10-0677; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Nishimura RA, 1997, J AM COLL CARDIOL, V30, P8, DOI 10.1016/S0735-1097(97)00144-7; Oh JK, 2006, J AM COLL CARDIOL, V47, P500, DOI 10.1016/j.jacc.2005.09.032; Okura H, 2009, CIRC-CARDIOVASC IMAG, V2, P41, DOI 10.1161/CIRCIMAGING.108.809087; Ommen SR, 2000, CIRCULATION, V102, P1788; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Sakata Y, 2013, CIRC J, V77, P2209, DOI 10.1253/circj.CJ-13-0971; Shiba N, 2011, EPMA J, V2, P425, DOI 10.1007/s13167-011-0097-7; Sohn DW, 1997, J AM COLL CARDIOL, V30, P474, DOI 10.1016/S0735-1097(97)88335-0; Tschope C, 2009, CIRCULATION, V120, P810, DOI 10.1161/CIRCULATIONAHA.109.869628; Yamada H, 1999, J AM SOC ECHOCARDIOG, V12, P574, DOI 10.1016/S0894-7317(99)70005-2	24	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142175	10.1371/journal.pone.0142175	http://dx.doi.org/10.1371/journal.pone.0142175			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555598	Green Submitted, gold, Green Published			2022-12-26	WOS:000364430700064
J	Coid, JW; Kallis, C; Doyle, M; Shaw, J; Ullrich, S				Coid, Jeremy W.; Kallis, Constantinos; Doyle, Mike; Shaw, Jenny; Ullrich, Simone			Identifying Causal Risk Factors for Violence among Discharged Patients	PLOS ONE			English	Article							PSYCHIATRIC MORBIDITY; ANTISOCIAL-BEHAVIOR; CRIMINAL RECIDIVISM; DYNAMIC PREDICTION; MENTAL-DISORDER; OFFENDERS; DELUSIONS; ILLNESS; HCR-20; NEEDS	Background Structured Professional Judgement (SPJ) is routinely administered in mental health and criminal justice settings but cannot identify violence risk above moderate accuracy. There is no current evidence that violence can be prevented using SPJ. This may be explained by routine application of predictive instead of causal statistical models when standardising SPJ instruments. Methods We carried out a prospective cohort study of 409 male and female patients discharged from medium secure services in England and Wales to the community. Measures were taken at baseline (pre-discharge), 6 and 12 months post-discharge using the Historical, Clinical and Risk-20 items version 3 (HCR-20v3) and Structural Assessment of Protective Factors (SAPROF). Information on violence was obtained via the McArthur community violence instrument and the Police National Computer. Results In a lagged model, HCR-20v3 and SAPROF items were poor predictors of violence. Eight items of the HCR-20v3 and 4 SAPROF items did not predict violent behaviour better than chance. In re-analyses considering temporal proximity of risk/protective factors (exposure) on violence (outcome), risk was elevated due to violent ideation (OR 6.98, 95% CI 13.85-12.65, P<0.001), instability (OR 5.41, 95% CI 3.44-8.50, P<0.001), and poor coping/stress (OR 8.35, 95% CI 4.21-16.57, P<0.001). All 3 risk factors were explanatory variables which drove the association with violent outcome. Self-control (OR 0.13, 95% CI 0.08-0.24, P< 0.001) conveyed protective effects and explained the association of other protective factors with violence. Conclusions Using two standardised SPJ instruments, predictive (lagged) methods could not identify risk and protective factors which must be targeted in interventions for discharged patients with severe mental illness. Predictive methods should be abandoned if the aim is to progress from risk assessment to effective risk management and replaced by methods which identify factors causally associated with violence.	[Coid, Jeremy W.; Kallis, Constantinos; Ullrich, Simone] Queen Mary Univ London, Violence Prevent Res Unit, Wolfson Inst Prevent Med, London E1 2AD, England; [Doyle, Mike; Shaw, Jenny] Univ Manchester, Inst Brain Behav & Mental Hlth, Manchester M13 9PL, Lancs, England	University of London; Queen Mary University London; University of Manchester	Ullrich, S (corresponding author), Queen Mary Univ London, Violence Prevent Res Unit, Wolfson Inst Prevent Med, Garrod Bldg,Turner St, London E1 2AD, England.	s.ullrich@qmul.ac.uk		Kallis, Constantinos/0000-0003-0866-5421; Kallis, Constantinos/0000-0002-4584-8844	UK National Institute for Health Research (NIHR) [RP-PG-0407-10500]; National Institute for Health Research [RP-PG-0407-10500] Funding Source: researchfish	UK National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	Funding: This study was funded by the UK National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme (RP-PG-0407-10500). The views expressed in this manuscript are those of the authors and not necessarily those of the UK National Health Service (NHS), the NIHR or the UK Department of Health. There was no editorial direction or censorship from the funders.	Appelbaum PS, 2000, AM J PSYCHIAT, V157, P566, DOI 10.1176/appi.ajp.157.4.566; Bonta J, 1998, PSYCHOL BULL, V123, P123, DOI 10.1037/0033-2909.123.2.123; Borum R, 2010, INT PERSP FOREN MENT, P63; Brown SL, 2009, LAW HUMAN BEHAV, V33, P25, DOI 10.1007/s10979-008-9139-7; Coid J, 2006, AM J EPIDEMIOL, V164, P1199, DOI 10.1093/aje/kwj339; Coid JW, 2013, AM J PSYCHIAT, V170, P985, DOI 10.1176/appi.ajp.2013.12091188; Coid JW, 2011, J FORENSIC PSYCHI PS, V22, P3, DOI 10.1080/14789949.2010.495990; Cooke D, 2014, J THREAT ASSESSMENT, V1, P42, DOI DOI 10.1037/tam0000004; Douglas KS, 2010, INT PERSP FOREN MENT, P147; Doyle M, 2014, BRIT J PSYCHIAT, V205, P177, DOI 10.1192/bjp.bp.113.136622; Elbogen EB, 2009, ARCH GEN PSYCHIAT, V66, P152, DOI 10.1001/archgenpsychiatry.2008.537; Falzer PR, 2013, BEHAV SCI LAW, V31, P40, DOI 10.1002/bsl.2043; Fazel S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4692; Fazel S, 2009, J CLIN PSYCHIAT, V70, P362, DOI 10.4088/JCP.08m04274; Gueorguieva R, 2004, ARCH GEN PSYCHIAT, V61, P310, DOI 10.1001/archpsyc.61.3.310; Hart SD, 2013, BEHAV SCI LAW, V31, P81, DOI 10.1002/bsl.2049; Hart SD, 2010, INT PERSP FOREN MENT, P269; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Howard PD, 2013, LAW HUMAN BEHAV, V37, P163, DOI 10.1037/lhb0000012; Jones NJ, 2010, CRIM JUSTICE BEHAV, V37, P860, DOI 10.1177/0093854810368924; Kroner DG, 2005, INT J LAW PSYCHIAT, V28, P360, DOI 10.1016/j.ijlp.2004.01.011; Kropp PR, 2010, INT PERSP FOREN MENT, P227; Large MM, 2015, AUST NZ J PSYCHIAT, V49, P91, DOI 10.1177/0004867414539570; Large MM, 2011, PSYCHIATR BULL, V35, P413, DOI 10.1192/pb.bp.110.033910; Monahan J, 2005, PSYCHIAT SERV, V56, P810, DOI 10.1176/appi.ps.56.7.810; O'Shea LE, 2015, COMPR PSYCHIAT, V62, P132, DOI 10.1016/j.comppsych.2015.07.009; Peterson JK, 2014, LAW HUMAN BEHAV, V38, P439, DOI 10.1037/lhb0000075; Prins SJ, 2014, LAW HUM BEHAV; Quinsey VL, 2006, J INTERPERS VIOLENCE, V21, P1539, DOI 10.1177/0886260506294238; Schlager MD, 2011, CRIM JUSTICE BEHAV, V38, P541, DOI 10.1177/0093854811402300; Skeem JL, 2014, LAW HUMAN BEHAV, V38, P212, DOI 10.1037/lhb0000054; Troquete NAC, 2013, BRIT J PSYCHIAT, V202, P365, DOI 10.1192/bjp.bp.112.113043; Ullrich S, 2014, SCHIZOPHRENIA BULL, V40, P1174, DOI 10.1093/schbul/sbt126; Van Dorn R, 2012, SOC PSYCH PSYCH EPID, V47, P487, DOI 10.1007/s00127-011-0356-x; Webster C, 2013, VIOLENCE RISK ASSESS; Whitwell JL, 2008, CURR OPIN NEUROL, V21, P410, DOI 10.1097/WCO.0b013e32830719d4; Yang M, 2010, PSYCHOL BULL, V136, P740, DOI 10.1037/a0020473	37	25	25	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142493	10.1371/journal.pone.0142493	http://dx.doi.org/10.1371/journal.pone.0142493			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7CT	26554711	Green Submitted, Green Published, gold			2022-12-26	WOS:000364430700116
J	Jansen, K; Thamm, M; Bock, CT; Scheufele, R; Kucherer, C; Muenstermann, D; Hagedorn, HJ; Jessen, H; Dupke, S; Hamouda, O; Gunsenheimer-Bartmeyer, B; Meixenberger, K				Jansen, Klaus; Thamm, Michael; Bock, Claus-Thomas; Scheufele, Ramona; Kuecherer, Claudia; Muenstermann, Dieter; Hagedorn, Hans-Jochen; Jessen, Heiko; Dupke, Stephan; Hamouda, Osamah; Gunsenheimer-Bartmeyer, Barbara; Meixenberger, Karolin		HIV Seroconverter Study Grp	High Prevalence and High Incidence of Coinfection with Hepatitis B, Hepatitis C, and Syphilis and Low Rate of Effective Vaccination against Hepatitis B in HIV-Positive Men Who Have Sex with Men with Known Date of HIV Seroconversion in Germany	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; VIRUS-INFECTION; RISK-FACTORS; HCV INFECTION; ISOLATED ANTIBODY; VIRAL-HEPATITIS; CORE ANTIGEN; TRENDS; COHORT; MSM	Objectives Men who have sex with men (MSM) are at higher risk for coinfection with hepatitis B virus (HBV), hepatitis C virus (HCV), and syphilis than the general population. HIV infection and these coinfections accelerate disease progression reciprocally. This study evaluated the prevalence and incidence of these coinfections in HIV1-positive MSM in Germany. Materials and Methods As part of a nationwide, multicenter, prospective cohort study of HIV-infected MSM, plasma samples collected yearly were screened for HBsAg and antibodies to HBc, HBs, HCV, and syphilis. Samples with indications of active HBV or HCV infection were confirmed by polymerase chain reaction. Prevalence and incidence of each infection and incidence rates per study participant were calculated, and incidences over 4-year time intervals compared. Results This study screened 5,445 samples from 1,843 MSM. Median age at HIV seroconversion was 33 years. Prevalences of active, cleared, and occult HBV, and of active/cleared HCV were 1.7%, 27.1%, 0.2%, and 8.2%, respectively, and 47.5% had been effectively vaccinated against HBV. Prevalence of antibodies to Treponema pallidum and of triple or quadruple sexually transmitted infections (STIs) were 39.6% and 18.9%, respectively. Prevalence of STI, cleared HBV, HBV vaccination, and history of syphilis differed significantly among age groups. Incidences of HBV, HCV, and syphilis were 2.51, 1.54, and 4.06 per 100 person-years, respectively. Incidences of HCV and syphilis increased over time. HCV incidence was significantly higher in MSM coinfected with syphilis and living in Berlin, and syphilis incidence was significantly higher for MSM living in Berlin. Discussion Despite extensive HBV vaccination campaigns, fewer than 50% of screened MSM were effectively vaccinated, with a high proportion of HIV-positive MSM coinfected with HBV. High rates of STI coinfections in HIV-positive MSM and increasing incidences emphasize the need for better tailored campaigns for HBV vaccination and STI prevention.	[Jansen, Klaus; Thamm, Michael; Bock, Claus-Thomas; Scheufele, Ramona; Kuecherer, Claudia; Hamouda, Osamah; Gunsenheimer-Bartmeyer, Barbara; Meixenberger, Karolin] Robert Koch Inst, Berlin, Germany; [Muenstermann, Dieter; Hagedorn, Hans-Jochen] Lab Krone, Bad Salzuflen, Germany; [Jessen, Heiko] Med Care Ctr Jessen, Berlin, Germany; [Dupke, Stephan] Med Care Ctr Driesener Str, Berlin, Germany	Robert Koch Institute	Jansen, K (corresponding author), Robert Koch Inst, Berlin, Germany.	JansenK@rki.de	Jessen, Heiko/P-2192-2019; Bock, C.-Thomas/A-3518-2012	Bock, C.-Thomas/0000-0002-2773-486X	Federal Ministry of Health [IIA5-2013-2514AUK375]; Federal Ministry of Education and Research [01KI1206]; Robert Koch Institute	Federal Ministry of Health; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Robert Koch Institute	Funding: The study was supported by grants from the Federal Ministry of Health (grant IIA5-2013-2514AUK375; www.bmg.bund.de), the Federal Ministry of Education and Research (grant 01KI1206; www.bmbf.de), and by internal grants of the Robert Koch Institute (www.rki.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Anderson AM, 2010, WORLD J GASTROENTERO, V16, P4107, DOI 10.3748/wjg.v16.i32.4107; Apers L, 2015, JAIDS-J ACQ IMM DEF, V68, P585, DOI 10.1097/QAI.0000000000000528; Attar BM, 2015, GASTROENT RES PRACT, V2015, DOI 10.1155/2015/579147; Bartmeyer B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012718; Bernstein KT, 2010, JAIDS-J ACQ IMM DEF, V53, P537, DOI 10.1097/QAI.0b013e3181c3ef29; Van der Meer JTM, 2009, SEX TRANSM DIS, V36, P84, DOI 10.1097/OLQ.0b013e318186debb; Bremer V, 2005, SEX TRANSM INFECT, V81, P173, DOI 10.1136/sti.2004.009878; Buchacz K, 2004, AIDS, V18, P2075, DOI 10.1097/00002030-200410210-00012; Chadwick D, 2014, HIV MED, V15, P189, DOI 10.1111/hiv.12093; Chamie G, 2007, CLIN INFECT DIS, V44, P577, DOI 10.1086/511038; Cruciani M, 2009, VACCINE, V27, P17, DOI 10.1016/j.vaccine.2008.10.040; Danta M, 2007, AIDS, V21, P983, DOI 10.1097/QAD.0b013e3281053a0c; de Coul ELMO, 2014, INT J STD AIDS, V25, P40, DOI 10.1177/0956462413491736; de Ledinghen V, 2008, J VIRAL HEPATITIS, V15, P427, DOI 10.1111/j.1365-2893.2007.00962.x; de Vries-Sluijs TEMS, 2011, J INFECT DIS, V203, P984, DOI 10.1093/infdis/jiq137; Dougan S, 2007, SEX TRANSM DIS, V34, P783, DOI 10.1097/01.olq.0000260919.34598.5b; Dudareva-Vizule S, 2014, SEX TRANSM INFECT, V90, P46, DOI 10.1136/sextrans-2012-050929; European AIDS clinical society, 2014, EACS GUID 7 02; European Centre for Disease Prevention and Control/WHO Regional Office for Europe, 2014, HIV AIDS SURV EUR 20; Fenton KA, 2004, SEX TRANSM INFECT, V80, P255, DOI 10.1136/sti.2004.009415; Filippini P, 2012, J INFECTION, V64, P436, DOI 10.1016/j.jinf.2011.12.018; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Gamage DG, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-39; Gatserelia L, 2014, Georgian Med News, P37; Hagedorn H-J, 2010, ABBOTT TIMES, V20, P11; Hamouda O, 2013, BUNDESGESUNDHEITSBLA, V56, P1600, DOI 10.1007/s00103-013-1866-3; Heiligenberg M, 2012, SEX TRANSM DIS, V39, P8, DOI 10.1097/OLQ.0b013e3182354e81; Impfkommission Standige, 1983, BUNDESGESUNDHEITSBLA, V26, P130; Ingiliz P, 2014, HIV MED, V15, P355, DOI 10.1111/hiv.12127; Jin FY, 2007, SEX TRANSM INFECT, V83, P397, DOI 10.1136/sti.2007.025684; Jin FY, 2010, JAIDS-J ACQ IMM DEF, V53, P144, DOI 10.1097/QAI.0b013e3181b48f33; Joshi D, 2011, LANCET, V377, P1198, DOI 10.1016/S0140-6736(10)62001-6; Khamduang W, 2013, CLIN INFECT DIS, V56, P1704, DOI 10.1093/cid/cit166; Kim JH, 2012, J KOREAN MED SCI, V27, P830, DOI 10.3346/jkms.2012.27.7.830; Knyphausen FZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095956; Konopnicki D, 2005, AIDS, V19, P593, DOI 10.1097/01.aids.0000163936.99401.fe; Laboratories Abbott, 2014, PACK ARCH SYST ANT H; Lacombe K, 2012, GUT, V61, P47, DOI 10.1136/gutjnl-2012-302062; Landrum ML, 2009, VACCINE, V27, P4731, DOI 10.1016/j.vaccine.2009.04.016; Liang SH, 2010, JAIDS-J ACQ IMM DEF, V54, P122, DOI 10.1097/QAI.0b013e3181daafd5; Linas BP, 2012, CLIN INFECT DIS, V55, P279, DOI 10.1093/cid/cis382; Lopes VB, 2013, VACCINE, V31, P1040, DOI 10.1016/j.vaccine.2012.12.047; Maldonado-Rodriguez A, 2015, WORLD J HEPATOL, V7, P253, DOI 10.4254/wjh.v7.i2.253; Marcus U, 2005, SEX TRANSM INFECT, V81, P456, DOI 10.1136/sti.2005.014555; Marcus U, 2006, SEX TRANSM DIS, V33, P11, DOI 10.1097/01.olq.0000187224.10428.31; Morsica G, 2009, INFECTION, V37, P445, DOI 10.1007/s15010-008-8194-9; Nastouli E, 2009, J CLIN VIROL, V44, P78, DOI 10.1016/j.jcv.2008.09.008; Nicoll A, 2002, BMJ-BRIT MED J, V324, P1324, DOI 10.1136/bmj.324.7349.1324; O'Bryan TA, 2015, HIV MED, V16, P161, DOI 10.1111/hiv.12189; Obermeier M, 2011, EUR J MED RES, V16, P237, DOI 10.1186/2047-783X-16-5-237; Peterman TA, 2007, CURR OPIN INFECT DIS, V20, P54, DOI 10.1097/QCO.0b013e32801158cc; Poethko-Muller C, 2013, BUNDESGESUNDHEITSBLA, V56, P707, DOI 10.1007/s00103-013-1673-x; Poggensee G, 2007, HIV MED, V8, P511, DOI 10.1111/j.1468-1293.2007.00504.x; Rauch A, 2005, CLIN INFECT DIS, V41, P395, DOI 10.1086/431486; Rey D, 2000, VACCINE, V18, P1161, DOI 10.1016/S0264-410X(99)00389-8; Rieg G, 2008, AIDS PATIENT CARE ST, V22, P947, DOI 10.1089/apc.2007.0240; Robert Koch-Institut, 2014, EPID B, V2014, P429; Robert Koch-Institut, 2014, EPIDEMIOLOGISCHES B, V2014, P485; Rockstroh JK, 2005, J INFECT DIS, V192, P992, DOI 10.1086/432762; Rockstroh JK, 2015, LIVER INT, V35, P51, DOI 10.1111/liv.12721; Sanchez C, 2013, LIVER INT, V33, P1357, DOI 10.1111/liv.12212; Schmidt AJ, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-132; Schmidt AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017781; Shire NJ, 2007, JAIDS-J ACQ IMM DEF, V44, P309, DOI 10.1097/QAI.0b013e31802e29a9; Smith CJ, 2014, LANCET, V384, P241, DOI 10.1016/S0140-6736(14)60604-8; Soriano V, 2010, J ANTIMICROB CHEMOTH, V65, P548, DOI 10.1093/jac/dkp479; Spielmann N, 2010, SEX TRANSM INFECT, V86, P331, DOI 10.1136/sti.2009.040857; Spornraft-Ragaller P, 2014, J DTSCH DERMATOL GES, V12, P707, DOI 10.1111/ddg.12382; Sulkowski MS, 2014, J HEPATOL, V61, pS108, DOI 10.1016/j.jhep.2014.08.006; Sulkowski MS, 2013, J INFECT DIS, V207, pS26, DOI 10.1093/infdis/jis764; Sulkowski MS, 2013, LIVER INT, V33, P63, DOI 10.1111/liv.12082; Taylor LE, 2013, CLIN INFECT DIS, V57, pS118, DOI 10.1093/cid/cit326; The EMIS Network, 2013, EMIS 2010 EUR MEN WH; Thomson EC, 2009, AIDS, V23, P89, DOI 10.1097/QAD.0b013e32831940a3; Thurnheer MC, 2010, AIDS, V24, P1907, DOI 10.1097/QAD.0b013e32833bfe21; Tohme RA, 2010, HEPATOLOGY, V52, P1497, DOI 10.1002/hep.23808; Torrone EA, 2011, JAIDS-J ACQ IMM DEF, V58, P328, DOI 10.1097/QAI.0b013e31822e1075; Urbanus AT, 2014, AIDS, V28, P781, DOI 10.1097/QAD.0000000000000126; Urbanus AT, 2009, AIDS, V23, pF1, DOI 10.1097/QAD.0b013e32832e5631; van de Laar T, 2009, GASTROENTEROLOGY, V136, P1609, DOI 10.1053/j.gastro.2009.02.006; van de Laar TJW, 2007, J INFECT DIS, V196, P230, DOI 10.1086/518796; van de Laar TJW, 2010, AIDS, V24, P1799, DOI 10.1097/QAD.0b013e32833c11a5; van den Berg R, 2009, AIDS REV, V11, P157; van der Helm JJ, 2011, AIDS, V25, P1083, DOI 10.1097/QAD.0b013e3283471cce; Vogel M, 2009, CLIN INFECT DIS, V49, DOI 10.1086/600058; Walsh N, 2012, CURR OPIN HIV AIDS, V7, P339, DOI 10.1097/COH.0b013e328354131e; Wandeler G, 2012, CLIN INFECT DIS, V55, P1408, DOI 10.1093/cid/cis694; Weber R, 2013, HIV MED, V14, P195, DOI 10.1111/j.1468-1293.2012.01051.x; Wong J, 2015, SEX TRANSM INFECT; Wong W, 2005, SEX TRANSM DIS, V32, P458, DOI 10.1097/01.olq.0000168280.34424.58; Yao ZQ, 2013, ARCH IMMUNOL THER EX, V61, P193, DOI 10.1007/s00005-013-0219-0; Zetola NM, 2007, CLIN INFECT DIS, V44, P1222, DOI 10.1086/513427	93	62	63	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142515	10.1371/journal.pone.0142515	http://dx.doi.org/10.1371/journal.pone.0142515			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555244	Green Submitted, Green Published, gold			2022-12-26	WOS:000364430700121
J	Peng, Y; Xiong, X; Adhikari, K; Knadel, M; Grunwald, S; Greve, MH				Peng, Yi; Xiong, Xiong; Adhikari, Kabindra; Knadel, Maria; Grunwald, Sabine; Greve, Mogens Humlekrog			Modeling Soil Organic Carbon at Regional Scale by Combining Multi-Spectral Images with Laboratory Spectra	PLOS ONE			English	Article							INFRARED REFLECTANCE SPECTROSCOPY; VEGETATION INDEXES; REGRESSION; PHOSPHORUS; PREDICTION; FLORIDA; OPTIMIZATION; QUALITY; NIR	There is a great challenge in combining soil proximal spectra and remote sensing spectra to improve the accuracy of soil organic carbon (SOC) models. This is primarily because mixing of spectral data from different sources and technologies to improve soil models is still in its infancy. The first objective of this study was to integrate information of SOC derived from visible near-infrared reflectance (Vis-NIR) spectra in the laboratory with remote sensing (RS) images to improve predictions of topsoil SOC in the Skjern river catchment, Denmark. The second objective was to improve SOC prediction results by separately modeling uplands and wetlands. A total of 328 topsoil samples were collected and analyzed for SOC. Satellite Pour l'Observation de la Terre (SPOT5), Landsat Data Continuity Mission (Landsat 8) images, laboratory Vis-NIR and other ancillary environmental data including terrain parameters and soil maps were compiled to predict topsoil SOC using Cubist regression and Bayesian kriging. The results showed that the model developed from RS data, ancillary environmental data and laboratory spectral data yielded a lower root mean square error (RMSE) (2.8%) and higher R-2 (0.59) than the model developed from only RS data and ancillary environmental data (RMSE: 3.6%, R-2: 0.46). Plant-available water (PAW) was the most important predictor for all the models because of its close relationship with soil organic matter content. Moreover, vegetation indices, such as the Normalized Difference Vegetation Index (NDVI) and Enhanced Vegetation Index (EVI), were very important predictors in SOC spatial models. Furthermore, the 'upland model' was able to more accurately predict SOC compared with the 'upland & wetland model'. However, the separately calibrated 'upland and wetland model' did not improve the prediction accuracy for wetland sites, since it was not possible to adequately discriminate the vegetation in the RS summer images. We conclude that laboratory Vis-NIR spectroscopy adds critical information that significantly improves the prediction accuracy of SOC compared to using RS data alone. We recommend the incorporation of laboratory spectra with RS data and other environmental data to improve soil spatial modeling and digital soil mapping (DSM).	[Peng, Yi; Knadel, Maria; Greve, Mogens Humlekrog] Aarhus Univ, Fac Sci & Technol, Dept Agroecol, DK-8830 Tjele, Denmark; [Xiong, Xiong; Grunwald, Sabine] Univ Florida, Dept Soil & Water Sci, Gainesville, FL 32611 USA; [Adhikari, Kabindra] Univ Wisconsin Madison, Dept Soil Sci, FD Hole Soils Lab, Madison, WI 53706 USA	Aarhus University; State University System of Florida; University of Florida; University of Wisconsin System; University of Wisconsin Madison	Peng, Y (corresponding author), Aarhus Univ, Fac Sci & Technol, Dept Agroecol, Blichers Alle 20,POB 50, DK-8830 Tjele, Denmark.	yi.peng@agro.au.dk	Knadel, Maria/O-9886-2015; Knadel, Maria/I-9190-2019; Adhikari, Kabindra/H-3273-2019; Xiong, Xiong/A-6693-2013	Knadel, Maria/0000-0001-7539-6191; Knadel, Maria/0000-0001-7539-6191; Adhikari, Kabindra/0000-0002-1365-7015; PENG, YI/0000-0002-7836-8089; Xiong, Xiong/0000-0001-6978-1624	HOBE project; GUDP; Villum Fonden [00007163] Funding Source: researchfish	HOBE project; GUDP; Villum Fonden(Villum Fonden)	This work was supported by HOBE project, website: http://www.hobecenter.dk/; and GUDP, website: http://naturerhverv.dk/tilskud-selvbeljening/tilskudsguide/groent-udviklings-og-demonstrationsprogram-gudp/.	Adhikari K, 2014, GEODERMA, V214, P101, DOI 10.1016/j.geoderma.2013.09.023; Adhikari K, 2013, SOIL SCI SOC AM J, V77, P860, DOI 10.2136/sssaj2012.0275; Arrouays D, 2014, ADV AGRON, V125, P93, DOI 10.1016/B978-0-12-800137-0.00003-0; Bellon-Maurel V, 2011, SOIL BIOL BIOCHEM, V43, P1398, DOI 10.1016/j.soilbio.2011.02.019; Bellon-Maurel V, 2010, TRAC-TREND ANAL CHEM, V29, P1073, DOI 10.1016/j.trac.2010.05.006; Ben-Dor E, 2008, ADV AGRON, V97, P321, DOI 10.1016/S0065-2113(07)00008-9; Bivand R, 2013, RGDAL BINDINGS GEOSP; Brown DJ, 2007, GEODERMA, V140, P444, DOI 10.1016/j.geoderma.2007.04.021; Brown DJ, 2006, GEODERMA, V132, P273, DOI 10.1016/j.geoderma.2005.04.025; Brown L, 2000, REMOTE SENS ENVIRON, V71, P16, DOI 10.1016/S0034-4257(99)00035-8; Chang CW, 2001, SOIL SCI SOC AM J, V65, P480, DOI 10.2136/sssaj2001.652480x; Chang CW, 2002, SOIL SCI, V167, P110, DOI 10.1097/00010694-200202000-00003; COHEN WB, 1991, PHOTOGRAMM ENG REM S, V57, P195; Coll C, 2010, IEEE T GEOSCI REMOTE, V48, P547, DOI 10.1109/TGRS.2009.2024934; Du CW, 2009, ENVIRON CHEM LETT, V7, P97, DOI 10.1007/s10311-008-0166-x; Fernandez-Buces N, 2006, J ARID ENVIRON, V65, P644, DOI 10.1016/j.jaridenv.2005.08.005; Gao F, 2012, J APPL REMOTE SENS, V6, DOI 10.1117/1.JRS.6.063554; Gao X, 2000, REMOTE SENS ENVIRON, V74, P609, DOI 10.1016/S0034-4257(00)00150-4; Gholizadeh A, 2013, APPL SPECTROSC, V67, P1349, DOI 10.1366/13-07288; Gitelson AA, 1996, REMOTE SENS ENVIRON, V58, P289, DOI 10.1016/S0034-4257(96)00072-7; Goge F, 2012, CHEMOMETR INTELL LAB, V110, P168, DOI 10.1016/j.chemolab.2011.11.003; Govender M, 2007, WATER SA, V33, P145; Greve MH, 2007, GEOGR TIDSSKR-DEN, V107, P1; Grunwald S, 2011, SOIL SCI SOC AM J, V75, P1201, DOI 10.2136/sssaj2011.0025; GRUNWALD S, 2005, ENV SOIL LANDSCAPE M; Grunwald S, 2015, ADV AGRON, V131, P1, DOI 10.1016/bs.agron.2014.12.004; Guzinski R, 2014, BIOGEOSCIENCES, V11, P5021, DOI 10.5194/bg-11-5021-2014; Hijmans RJ, 2012, RASTER GEOGRAPHIC AN; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Huete AR, 1997, REMOTE SENS ENVIRON, V59, P440, DOI 10.1016/S0034-4257(96)00112-5; Jensen KH, 2011, VADOSE ZONE J, V10, P1, DOI 10.2136/vzj2011.0006; Kienast-Brown, 2010, DIGITAL SOIL MAPPING; Kim JS, 2014, IEEE T GEOSCI REMOTE, V52, P6724, DOI 10.1109/TGRS.2014.2301443; Knadel M, 2011, SOIL SCI SOC AM J, V75, P1799, DOI 10.2136/sssaj2010.0452; Knox NM, 2015, GEODERMA, V239, P229, DOI 10.1016/j.geoderma.2014.10.019; Krogh L, 2003, AGR ECOSYST ENVIRON, V96, P19, DOI 10.1016/S0167-8809(03)00016-1; Kuhn M., 2012, THE CARET PACKAGE; Kuhn M, 2014, PACKAGE CUBIST; Madsen H. B., 1992, DANISH SOIL CLASSIFI, VI; McBratney AB, 2003, GEODERMA, V117, P3, DOI 10.1016/S0016-7061(03)00223-4; McDowell M.L., 2012, APPL ENVIRON SOIL SC, DOI [10.1155/2012/294121, DOI 10.1155/2012/294121]; McDowell ML, 2012, GEODERMA, V189, P312, DOI 10.1016/j.geoderma.2012.06.009; McKenzie NJ, 1999, GEODERMA, V89, P67, DOI 10.1016/S0016-7061(98)00137-2; Minasny B, 2008, CHEMOMETR INTELL LAB, V94, P72, DOI 10.1016/j.chemolab.2008.06.003; Mulder VL, 2011, GEODERMA, V162, P1, DOI 10.1016/j.geoderma.2010.12.018; Nellis MD, 1903, T KANSAS ACAD SCI, V1992, P93; Pedersen ML, 2007, ECOL ENG, V30, P131, DOI 10.1016/j.ecoleng.2006.06.009; Peng Y, 2014, SOIL SCI, V179, P325, DOI 10.1097/SS.0000000000000074; Peng Y, 2013, J NEAR INFRARED SPEC, V21, P213, DOI 10.1255/jnirs.1053; Pilz J, 2008, STOCH ENV RES RISK A, V22, P621, DOI 10.1007/s00477-007-0165-7; Quinlan J. R., 1992, Proceedings of the 5th Australian Joint Conference on Artificial Intelligence. AI '92, P343; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Reeves JB, 1999, J NEAR INFRARED SPEC, V7, P179, DOI 10.1255/jnirs.248; Rivero RG, 2007, GEODERMA, V140, P428, DOI 10.1016/j.geoderma.2007.04.026; Rivero RG, 2009, REMOTE SENS ENVIRON, V113, P2389, DOI 10.1016/j.rse.2009.07.015; ROCK BN, 1986, BIOSCIENCE, V36, P439, DOI 10.2307/1310339; Rondeaux G, 1996, REMOTE SENS ENVIRON, V55, P95, DOI 10.1016/0034-4257(95)00186-7; Rossel RAV, 2010, GEODERMA, V158, P46, DOI 10.1016/j.geoderma.2009.12.025; Rossel RAV, 2006, GEODERMA, V131, P59, DOI 10.1016/j.geoderma.2005.03.007; Rouse Haas, 1973, MONITORING VERNAL AD, DOI DOI 10.1002/MRM.26868; Sarkhot DV, 2011, GEODERMA, V164, P22, DOI 10.1016/j.geoderma.2011.05.006; Shepherd KD, 2002, SOIL SCI SOC AM J, V66, P988, DOI 10.2136/sssaj2002.0988; Sorensen LK, 2002, J NEAR INFRARED SPEC, V10, P15, DOI 10.1255/jnirs.317; Stenberg B, 2010, ADV AGRON, V107, P163, DOI 10.1016/S0065-2113(10)07005-7; Stisen S, 2007, REMOTE SENS ENVIRON, V110, P262, DOI 10.1016/j.rse.2007.02.025; Stjernholm M, 2004, CORINE LANDCOVER UPD; Sumfleth K, 2008, ECOL INDIC, V8, P485, DOI 10.1016/j.ecolind.2007.05.005; Vasques GM, 2012, LANDSCAPE ECOL, V27, P355, DOI 10.1007/s10980-011-9702-3; Vasques GM, 2010, J ENVIRON QUAL, V39, P923, DOI 10.2134/jeq2009.0314; Vasques GM, 2009, SOIL SCI SOC AM J, V73, P176, DOI 10.2136/sssaj2008.0015; Weng QH, 2004, REMOTE SENS ENVIRON, V89, P467, DOI 10.1016/j.rse.2003.11.005; Williams P., 2001, NEAR INFRARED TECHNO; Xiong X, 2014, ENVIRON MODELL SOFTW, V57, P202, DOI 10.1016/j.envsoft.2014.03.004; Yang CM, 2004, CROP SCI, V44, P1283, DOI 10.2135/cropsci2004.1283; Zhang GN, 2014, J ARID LAND, V6, P156, DOI 10.1007/s40333-013-0241-4; Zhou Y, 2014, RANGELAND ECOL MANAG, V67, P9, DOI 10.2111/REM-D-13-00059.1	76	42	43	8	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0142295	10.1371/journal.pone.0142295	http://dx.doi.org/10.1371/journal.pone.0142295			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555071	Green Submitted, Green Published, gold			2022-12-26	WOS:000364430700079
J	Qasim, N; Mahmood, R				Qasim, Neha; Mahmood, Riaz			Diminution of Oxidative Damage to Human Erythrocytes and Lymphocytes by Creatine: Possible Role of Creatine in Blood	PLOS ONE			English	Article							DNA-DAMAGE; LIPID-PEROXIDATION; SUPPLEMENTATION; STRESS; CELLS; EXERCISE; DISEASE; ASSAY; SURVIVAL; LIVER	Creatine (Cr) is naturally produced in the body and stored in muscles where it is involved in energy generation. It is widely used, especially by athletes, as a staple supplement for improving physical performance. Recent reports have shown that Cr displays antioxidant activity which could explain its beneficial cellular effects. We have evaluated the ability of Cr to protect human erythrocytes and lymphocytes against oxidative damage. Erythrocytes were challenged with model oxidants, 2, 2'-azobis(2-amidinopropane) dihydrochloride (AAPH) and hydrogen peroxide (H2O2) in the presence and absence of Cr. Incubation of erythrocytes with oxidant alone increased hemolysis, methemoglobin levels, lipid peroxidation and protein carbonyl content. This was accompanied by decrease in glutathione levels. Antioxidant enzymes and antioxidant power of the cell were compromised while the activity of membrane bound enzyme was lowered. This suggests induction of oxidative stress in erythrocytes by AAPH and H2O2. However, Cr protected the erythrocytes by ameliorating the AAPH and H2O2 induced changes in these parameters. This protective effect was confirmed by electron microscopic analysis which showed that oxidant-induced cell damage was attenuated by Cr. No cellular alterations were induced by Cr alone even at 20 mM, the highest concentration used. Creatinine, a by-product of Cr metabolism, was also shown to exert protective effects, although it was slightly less effective than Cr. Human lymphocytes were similarly treated with H2O2 in absence and presence of different concentrations of Cr. Lymphocytes incubated with oxidant alone had alterations in various biochemical and antioxidant parameters including decrease in cell viability and induction of DNA damage. The presence of Cr attenuated all these H2O2-induced changes in lymphocytes. Thus, Cr can function as a blood antioxidant, protecting cells from oxidative damage, genotoxicity and can potentially increase their lifespan.	[Qasim, Neha; Mahmood, Riaz] Aligarh Muslim Univ, Dept Biochem, Fac Life Sci, Aligarh, Uttar Pradesh, India	Aligarh Muslim University	Mahmood, R (corresponding author), Aligarh Muslim Univ, Dept Biochem, Fac Life Sci, Aligarh, Uttar Pradesh, India.	riazmahmood2002@yahoo.co.in						Aksentijevic D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109021; Alcaide P, 2011, HUM MUTAT, V32, P282, DOI 10.1002/humu.21421; Araujo MB, 2013, J INT SOC SPORT NUTR, V10, DOI 10.1186/1550-2783-10-54; BALSOM PD, 1994, SPORTS MED, V18, P268, DOI 10.2165/00007256-199418040-00005; Battisti V, 2009, CLIN CHIM ACTA, V402, P114, DOI 10.1016/j.cca.2008.12.030; Bemben MG, 2005, SPORTS MED, V35, P107, DOI 10.2165/00007256-200535020-00002; Bender A, 2008, NEUROBIOL AGING, V29, P1404, DOI 10.1016/j.neurobiolaging.2007.03.001; BENESCH RE, 1973, ANAL BIOCHEM, V55, P245, DOI 10.1016/0003-2697(73)90309-6; BENNETT SE, 1994, CELL BIOCHEM FUNCT, V12, P99, DOI 10.1002/cbf.290120204; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Beutler E., 1984, GLUTATHIONE RED CELL; Bonting S. L., 1970, MEMBRANE ION TRANSPO, P257; Buege J A, 1978, Methods Enzymol, V52, P302; BUYSSE AM, 1990, CLIN CHIM ACTA, V187, P155, DOI 10.1016/0009-8981(90)90342-P; Ceddia RB, 2004, J PHYSIOL-LONDON, V555, P409, DOI 10.1113/jphysiol.2003.056291; Cimen MYB, 2008, CLIN CHIM ACTA, V390, P1, DOI 10.1016/j.cca.2007.12.025; Clark JF, 1997, J ATHL TRAINING, V32, P45; CLEMENS MR, 1988, DEUT MED WOCHENSCHR, V113, P91, DOI 10.1055/s-2008-1067599; Da Ros R, 2004, DIABETIC MED, V21, P1249, DOI 10.1111/j.1464-5491.2004.01312.x; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Demant TW, 1999, SPORTS MED, V28, P49, DOI 10.2165/00007256-199928010-00005; Deminice R, 2012, AMINO ACIDS, V43, P709, DOI 10.1007/s00726-011-1121-x; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Erslev AF, 1995, WILLIAMS HEMATOLOGY, P441; FALCIERI E, 1988, J SUBMICR CYTOL PATH, V20, P623; FEHR J, 1979, BLOOD, V53, P966; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Genc G, 2014, RENAL FAILURE, V36, P1108, DOI 10.3109/0886022X.2014.917576; Genius J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030554; GIUGLIANO D, 1995, METABOLISM, V44, P363, DOI 10.1016/0026-0495(95)90167-1; Glader B E, 1979, Prog Clin Biol Res, V30, P503; GRIFFITHS WJ, 1967, BRIT J HAEMATOL, V13, P175, DOI 10.1111/j.1365-2141.1967.tb08728.x; Gualano B, 2012, AMINO ACIDS, V43, P519, DOI 10.1007/s00726-011-1132-7; Guidi C, 2008, BBA-GEN SUBJECTS, V1780, P16, DOI 10.1016/j.bbagen.2007.09.018; Guimaraes-Ferreira L, 2012, EUR J APPL PHYSIOL, V112, P3905, DOI 10.1007/s00421-012-2378-9; HALLIWELL B, 1991, FEBS LETT, V281, P9, DOI 10.1016/0014-5793(91)80347-6; Halliwell B., 2007, FREE RADICALS BIOL M; Hasler CR, 1998, NEPHROL DIAL TRANSPL, V13, P3132, DOI 10.1093/ndt/13.12.3132; Hattangadi SM, 2007, J CLIN INVEST, V117, P2075, DOI 10.1172/JCI32559; Horvat A, 2006, PHYSIOL RES, V55, P325, DOI 10.33549/physiolres.930696; Igisu Hideki, 1994, Journal of UOEH, V16, P253; Inal M, 1999, FREE RADICAL RES, V31, P211, DOI 10.1080/10715769900300771; Jiao YF, 1998, CLIN BIOCHEM, V31, P59, DOI 10.1016/S0009-9120(97)00164-1; Johnson RM, 2005, FREE RADICAL BIO MED, V39, P1407, DOI 10.1016/j.freeradbiomed.2005.07.002; Juravleva E, 2005, J NEUROSCI RES, V79, P224, DOI 10.1002/jnr.20291; Kim HJ, 2011, AMINO ACIDS, V40, P1409, DOI 10.1007/s00726-011-0878-2; Kim YW, 2014, BLOOD, V123, P625, DOI 10.1182/blood-2013-09-512749; Knight JA, 2000, ANN CLIN LAB SCI, V30, P145; Larbi A, 2007, EXP GERONTOL, V42, P852, DOI 10.1016/j.exger.2007.05.004; Lawler JM, 2002, BIOCHEM BIOPH RES CO, V290, P47, DOI 10.1006/bbrc.2001.6164; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacCormick VM, 2004, CAN J APPL PHYSIOL, V29, P704, DOI 10.1139/h04-045; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Mishra K, 2012, FOOD CHEM, V130, P1036, DOI 10.1016/j.foodchem.2011.07.127; Nisha M, 2011, INT J PHARM SCI, V3, P28; Persky AM, 2003, CLIN PHARMACOKINET, V42, P557, DOI 10.2165/00003088-200342060-00005; POOLZOBEL BL, 1993, FOOD CHEM TOXICOL, V31, P271, DOI 10.1016/0278-6915(93)90077-C; Power LW, 1989, DIAGNOSTIC HEMATOLOG, P198; Preen DB, 2005, INT J SPORT NUTR EXE, V15, P84, DOI 10.1123/ijsnem.15.1.84; Rahimi R, 2011, J STRENGTH COND RES, V25, P3448, DOI 10.1519/JSC.0b013e3182162f2b; Ramalingam M, 2012, J NEURAL TRANSM, V119, P891, DOI 10.1007/s00702-011-0758-7; SATO Y, 1995, BIOCHEMISTRY-US, V34, P8940, DOI 10.1021/bi00028a002; Schedel JM, 1999, LIFE SCI, V65, P2463, DOI 10.1016/S0024-3205(99)00512-3; Schrag M, 2013, NEUROBIOL DIS, V59, P100, DOI 10.1016/j.nbd.2013.07.005; SEGEL GB, 1979, J CLIN INVEST, V64, P834, DOI 10.1172/JCI109531; Sestili P, 2006, FREE RADICAL BIO MED, V40, P837, DOI 10.1016/j.freeradbiomed.2005.10.035; Sestili P, 2011, AMINO ACIDS, V40, P1385, DOI 10.1007/s00726-011-0875-5; SHEETZ MP, 1974, P NATL ACAD SCI USA, V71, P4457, DOI 10.1073/pnas.71.11.4457; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Snow RJ, 2001, MOL CELL BIOCHEM, V224, P169, DOI 10.1023/A:1011908606819; STUART J, 1985, J CLIN PATHOL, V38, P965, DOI 10.1136/jcp.38.9.965; Takashimizu S, 2000, ALCOHOL CLIN EXP RES, V24, p81S, DOI 10.1111/j.1530-0277.2000.tb00018.x; Tarnopolsky MA, 2011, AMINO ACIDS, V40, P1397, DOI 10.1007/s00726-011-0876-4; Wallimann T, 2011, AMINO ACIDS, V40, P1271, DOI 10.1007/s00726-011-0877-3; Wintrobe M M, 2009, WINTROBES CLIN HEMAT, V1; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107	79	32	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2015	10	11							e0141975	10.1371/journal.pone.0141975	http://dx.doi.org/10.1371/journal.pone.0141975			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV7CT	26555819	Green Published, Green Submitted, gold			2022-12-26	WOS:000364430700046
J	Bloodhart, B; Maibach, E; Myers, T; Zhao, XQ				Bloodhart, Brittany; Maibach, Edward; Myers, Teresa; Zhao, Xiaoquan			Local Climate Experts: The Influence of Local TV Weather Information on Climate Change Perceptions	PLOS ONE			English	Article							PERSONAL-EXPERIENCE; RISK PERCEPTIONS; BELIEF; CONSEQUENCES; POLARIZATION; TEMPERATURE; VARIABILITY; KNOWLEDGE; IDENTITY; OPINION	Individuals who identify changes in their local climate are also more likely to report that they have personally experienced global climate change. One way that people may come to recognize that their local climate is changing is through information provided by local TV weather forecasters. Using random digit dialing, 2,000 adult local TV news viewers in Virginia were surveyed to determine whether routine exposure to local TV weather forecasts influences their perceptions of extreme weather in Virginia, and their perceptions about climate change more generally. Results indicate that paying attention to TV weather forecasts is associated with beliefs that extreme weather is becoming more frequent in Virginia, which in turn is associated with stronger beliefs and concerns about climate change. These associations were strongest for individuals who trust their local TV weathercaster as a source of information about climate change, and for those who identify as politically conservative or moderate. The findings add support to the literature suggesting that TV weathercasters can play an important role in educating the public about climate change.	[Bloodhart, Brittany] Colorado State Univ, Dept Psychol, Ft Collins, CO 80523 USA; [Maibach, Edward; Myers, Teresa; Zhao, Xiaoquan] George Mason Univ, Ctr Climate Change Commun, Fairfax, VA 22030 USA	Colorado State University; George Mason University	Bloodhart, B (corresponding author), Colorado State Univ, Dept Psychol, Ft Collins, CO 80523 USA.	brittany.bloodhart@rams.colostate.edu	Maibach, Edward/A-7102-2009	Maibach, Edward/0000-0003-3409-9187	National Science Foundation [DUE-1043235]	National Science Foundation(National Science Foundation (NSF))	Funding: This project was funded by the National Science Foundation (Award # DUE-1043235) and through anonymous donations to the George Mason University Foundation. BB and EM received funding to work on this project. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Akerlof K, 2013, GLOBAL ENVIRON CHANG, V23, P81, DOI 10.1016/j.gloenvcha.2012.07.006; American Press Institute, 2014, PERS NEWS CYCL; Anderson AA, 2013, WEATHER CLIM SOC, V5, P367, DOI 10.1175/WCAS-D-12-00051.1; Borick CP, 2014, WEATHER CLIM SOC, V6, P413, DOI 10.1175/WCAS-D-13-00042.1; Borick CP, 2010, SOC SCI QUART, V91, P777, DOI 10.1111/j.1540-6237.2010.00719.x; Brulle RJ, 2012, CLIMATIC CHANGE, V114, P169, DOI 10.1007/s10584-012-0403-y; Chestnut, 2002, EC VALUE CURRENT IMP; Corso R. A., 2007, LOCAL TELEVISION NEW; Demuth JL, 2011, WEATHER CLIM SOC, V3, P177, DOI 10.1175/2011WCAS1061.1; Demuth JL, 2009, B AM METEOROL SOC, V90, P1614, DOI 10.1175/2009BAMS2787.1; Egan PJ, 2012, J POLIT, V74, P796, DOI 10.1017/S0022381612000448; Goebbert K, 2012, WEATHER CLIM SOC, V4, P132, DOI 10.1175/WCAS-D-11-00044.1; Hamilton LC, 2013, WEATHER CLIM SOC, V5, P112, DOI 10.1175/WCAS-D-12-00048.1; Hart PS, 2012, COMMUN RES, V39, P701, DOI 10.1177/0093650211416646; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Herrnstadt E., 2013, 201348 HARV ENV EC P; Hovland C.I., 1953, COMMUN PERSUATION; Howe PD, 2013, GLOBAL ENVIRON CHANG, V23, P1488, DOI 10.1016/j.gloenvcha.2013.09.014; Joireman J, 2010, J ENVIRON PSYCHOL, V30, P358, DOI 10.1016/j.jenvp.2010.03.004; Kahan DM, 2013, JUDGM DECIS MAK, V8, P407; Krosnick JA, 2006, CLIMATIC CHANGE, V77, P7, DOI 10.1007/s10584-006-9068-8; KUNDA Z, 1990, PSYCHOL BULL, V108, P480, DOI 10.1037/0033-2909.108.3.480; Lang C, 2014, CLIMATIC CHANGE, V125, P291, DOI 10.1007/s10584-014-1180-6; Leiserowitz, 2009, GLOBAL WARMINGS 6 AM; Leiserowitz A., 2012, CLIMATE CHANGE AM MI; Leiserowitz A., 2008, FLORIDA PUBLIC OPINI; Leiserowitz A., 2014, POLITICS GLOBAL WARM; Leiserowitz AA, 2005, RISK ANAL, V25, P1433, DOI 10.1111/j.1540-6261.2005.00690.x; Li Y, 2011, PSYCHOL SCI, V22, P454, DOI 10.1177/0956797611400913; LIN CA, 1992, JOURNALISM QUART, V69, P373, DOI 10.1177/107769909206900211; Malka A, 2009, RISK ANAL, V29, P633, DOI 10.1111/j.1539-6924.2009.01220.x; McCright AM, 2011, SOCIOL QUART, V52, P155, DOI 10.1111/j.1533-8525.2011.01198.x; McCright AM, 2008, PUBLIC OPIN QUART, V72, P651, DOI 10.1093/poq/nfn051; Melillo JM, 2014, CLIMATE CHANGE IMPAC, V841, DOI DOI 10.7930/J0Z31WJ2; Meyer William B, 2000, AM THEIR WEATHER; Meze-Hausken E, 2004, CLIM RES, V27, P19, DOI 10.3354/cr027019; Morss RE, 2010, METEOROL APPL, V17, P149, DOI 10.1002/met.196; Myers TA, 2013, NAT CLIM CHANGE, V3, P343, DOI [10.1038/nclimate1754, 10.1038/NCLIMATE1754]; Myers TA, 2011, COMMUN METHODS MEAS, V5, P297, DOI 10.1080/19312458.2011.624490; National Weather Service, 2005, CUST SAT SURV GEN PU; Osbahr H, 2011, EXP AGR, V47, P293, DOI 10.1017/S0014479710000785; Petty R. E., 1986, COMMUN PERSUATION, P1; Risen JL, 2011, J PERS SOC PSYCHOL, V100, P777, DOI 10.1037/a0022460; Roncoli C, 2002, SOC NATUR RESOUR, V15, P409, DOI 10.1080/08941920252866774; Rosenstiel T., 2011, PEOPLE LEARN THEIR L; Scannell L., 2013, ENVIRON BEHAV, V45, P60, DOI [https://doi.org/10.1177/0013916511421196, DOI 10.1177/0013916511421196]; Sherman-Morris K., 2005, ENV HAZARDS, V6, P201, DOI [10.1016/j.hazards.2006.10.002, DOI 10.1016/j.hazards.2006.10.002]; Slovic P, 2004, RISK ANAL, V24, P311, DOI 10.1111/j.0272-4332.2004.00433.x; Spence A, 2012, RISK ANAL, V32, P957, DOI 10.1111/j.1539-6924.2011.01695.x; Strauss S, 2003, WEATHER CLIMATE CULT; Trope Y, 2010, PSYCHOL REV, V117, P440, DOI 10.1037/a0018963; Tschakert P, 2010, CLIMATIC CHANGE, V103, P471, DOI 10.1007/s10584-009-9776-y; Weber E. U., 1997, PSYCHOL PERSPECTIVES, P314; Weber EU, 2006, CLIMATIC CHANGE, V77, P103, DOI 10.1007/s10584-006-9060-3; Weber EU, 2002, J BEHAV DECIS MAKING, V15, P263, DOI 10.1002/bdm.414; West CT, 2008, LAND DEGRAD DEV, V19, P289, DOI 10.1002/ldr.842; Zahran S, 2006, SOC NATUR RESOUR, V19, P771, DOI 10.1080/08941920600835528; Zhao X., 2013, B AM METEOROLOGICAL, V95, P117, DOI DOI 10.1175/BAMS-D-12-00144.1	58	37	37	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2015	10	11							e0141526	10.1371/journal.pone.0141526	http://dx.doi.org/10.1371/journal.pone.0141526			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV7AC	26551357	Green Submitted, gold, Green Published			2022-12-26	WOS:000364422800007
J	Lau, YL; Lai, MY; Teoh, BT; Abd-Jamil, J; Johari, J; Sam, SS; Tan, KK; AbuBakar, S				Lau, Yee-Ling; Lai, Meng-Yee; Teoh, Boon-Teong; Abd-Jamil, Juraina; Johari, Jefree; Sam, Sing-Sin; Tan, Kim-Kee; AbuBakar, Sazaly			Colorimetric Detection of Dengue by Single Tube Reverse-Transcription-Loop-Mediated Isothermal Amplification	PLOS ONE			English	Article							WEST-NILE-VIRUS; JAPANESE ENCEPHALITIS-VIRUS; TIME RT-PCR; RAPID DIAGNOSIS; MALAYSIA; ASSAY; DIFFERENTIATION; SEROTYPES; LAMP	Dengue is usually diagnosed by isolation of the virus, serology or molecular diagnostic methods. Several commercial kits for the diagnosis of dengue are existing, but concerns have arisen regarding to the affordability and performance characteristics of these kits. Hence, the loop-mediated isothermal amplification (LAMP) is potentially ideal to be used especially in resource limited environments. Serum was collected from healthy donors and patients diagnosed with dengue infection. RNA extracted from the serum samples were tested by reverse-transcription-LAMP assay developed based on 30-NCR gene sequences for DENV 1-4. Results were interpreted by a turbidity meter in real time or visually at the end of the assay. Sensitivity and specificity of RT-LAMP results were calculated and compared to qRT-PCR and ELISA. RT-LAMP is highly sensitive with the detection limit of 10 RNA copies for all serotypes. Dengue virus RNA was detected in all positive samples using RT-LAMP and none of the negative samples within 30-45 minutes. With continuing efforts in the optimization of this assay, RT-LAMP may provide a simple and reliable test for detecting DENV in areas where dengue is prevalent.	[Lau, Yee-Ling; Lai, Meng-Yee] Univ Malaya, Fac Med, Dept Parasitol, Trop Infect Dis Res & Educ Ctr, Kuala Lumpur 50603, Malaysia; [Teoh, Boon-Teong; Abd-Jamil, Juraina; Johari, Jefree; Sam, Sing-Sin; Tan, Kim-Kee; AbuBakar, Sazaly] Univ Malaya, Fac Med, Dept Med Microbiol, Trop Infect Dis Res & Educ Ctr, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Universiti Malaya	Lau, YL (corresponding author), Univ Malaya, Fac Med, Dept Parasitol, Trop Infect Dis Res & Educ Ctr, Kuala Lumpur 50603, Malaysia.	lauyeeling@um.edu.my	yee, lai meng/AAC-8621-2021; Sam, Sing-Sin/ABH-1546-2021; JOHARI, JEFREE/D-8065-2015; Lau, Yee Ling/C-6996-2009; Tan, Kim-Kee/P-7285-2014; Teoh, Boon-Teong/ABH-2475-2021; YING, LAU/HHS-2619-2022; abubakar, sazaly/B-3957-2010	Sam, Sing-Sin/0000-0003-2527-5310; Lau, Yee Ling/0000-0002-2037-2165; Tan, Kim-Kee/0000-0002-5816-9146; Teoh, Boon-Teong/0000-0001-6786-5023; abubakar, sazaly/0000-0002-9267-1420; Johari, Jefree/0000-0002-7526-3468	Ministry of Higher Education Malaysia [UM.C/625/1/HIR/MOHE/CHAN/14/3]; University Malaya [LR001-2011D]	Ministry of Higher Education Malaysia(Ministry of Education, Malaysia); University Malaya(Universiti Malaya)	The funding for this study was changed to High Impact Research Grant UM-MOHE UM.C/625/1/HIR/MOHE/CHAN/14/3 from the Ministry of Higher Education Malaysia and University Malaya Research Grant LR001-2011D.	AbuBakar S, 2002, J GEN VIROL, V83, P2437, DOI 10.1099/0022-1317-83-10-2437; Cardoso TC, 2010, MOL CELL PROBE, V24, P415, DOI 10.1016/j.mcp.2010.08.003; Cheah W K, 2014, Med J Malaysia, V69 Suppl A, P59; Chee HY, 2003, DENGUE B, V27, P100; Imai M, 2006, VACCINE, V24, P6679, DOI 10.1016/j.vaccine.2006.05.046; Kobayashi N, 1999, AM J TROP MED HYG, V60, P904, DOI 10.4269/ajtmh.1999.60.904; Lau YL, 2010, J CLIN MICROBIOL, V48, P3698, DOI 10.1128/JCM.00462-10; Li SH, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-360; Mori Y, 2004, J BIOCHEM BIOPH METH, V59, P145, DOI 10.1016/j.jbbm.2003.12.005; Nina RD, 2009, J GLOB INFECT DIS, V1, P38, DOI [10.4103/0974-777X.52980, DOI 10.4103/0974-777X.52980]; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Parida M, 2005, J CLIN MICROBIOL, V43, P2895, DOI 10.1128/JCM.43.6.2895-2903.2005; Parida M, 2004, J CLIN MICROBIOL, V42, P257, DOI 10.1128/JCM.42.1.257-263.2004; Poloni TR, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-22; Santhosh SR, 2007, J VIROL METHODS, V143, P73, DOI 10.1016/j.jviromet.2007.02.011; Teoh BT, 2015, J CLIN MICROBIOL, V53, P830, DOI 10.1128/JCM.02648-14; Teoh BT, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-387; Teoh BT, 2010, EMERG INFECT DIS, V16, P1783, DOI 10.3201/eid1611.100721; WHO, 1997, DENG HAEM FEV DIAGN; Zaayman D, 2009, J VIROL METHODS, V157, P155, DOI 10.1016/j.jviromet.2008.12.014	20	66	69	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138694	10.1371/journal.pone.0138694	http://dx.doi.org/10.1371/journal.pone.0138694			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	26384248	Green Published, Green Submitted, gold			2022-12-26	WOS:000361790200148
J	Lau, Y; Htun, TP; Lim, PI; Ho-Lim, S; Klainin-Yobas, P				Lau, Ying; Htun, Tha Pyai; Lim, Peng Im; Ho-Lim, Sarah; Klainin-Yobas, Piyanee			Maternal, Infant Characteristics, Breastfeeding Techniques, and Initiation: Structural Equation Modeling Approaches	PLOS ONE			English	Article							SKIN-TO-SKIN; CESAREAN-SECTION; MOTHERS EXPERIENCES; SAMPLE-SIZE; BIRTH; DELIVERY; HEALTH; METAANALYSIS; PREVALENCE; PATTERNS	Objectives The aim of this study was to examine the relationships among maternal and infant characteristics, breastfeeding techniques, and exclusive breastfeeding initiation in different modes of birth using structural equation modeling approaches. Methods We examined a hypothetical model based on integrating concepts of a breastfeeding decision-making model, a breastfeeding initiation model, and a social cognitive theory among 952 mother-infant dyads. The LATCH breastfeeding assessment tool was used to evaluate breastfeeding techniques and two infant feeding categories were used (exclusive and nonexclusive breastfeeding). Results Structural equation models (SEM) showed that multiparity was significantly positively associated with breastfeeding techniques and the jaundice of an infant was significantly negatively related to exclusive breastfeeding initiation. A multigroup analysis in the SEM showed no difference between the caesarean section and vaginal delivery groups estimates of breastfeeding techniques on exclusive breastfeeding initiation. Breastfeeding techniques were significantly positively associated with exclusive breastfeeding initiation in the entire sample and in the vaginal deliveries group. However, breastfeeding techniques were not significantly associated with exclusive breastfeeding initiation in the cesarean section group. Maternal age, maternal race, gestations, birth weight of infant, and postnatal complications had no significant impacts on breastfeeding techniques or exclusive breastfeeding initiation in our study. Overall, the models fitted the data satisfactorily (GFI = 0.979-0.987; AGFI = 0.951-0.962; IFI = 0.958-0.962; CFI = 0.955-0.960, and RMSEA = 0.029-0.034). Conclusions Multiparity and jaundice of an infant were found to affect breastfeeding technique and exclusive breastfeeding initiation respectively. Breastfeeding technique was related to exclusive breastfeeding initiation according to the mode of birth. This relationship implies the importance of early effective interventions among first- time mothers with jaundice infants in improving breastfeeding techniques and promoting exclusive breastfeeding initiation.	[Lau, Ying; Htun, Tha Pyai; Klainin-Yobas, Piyanee] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Alice Lee Ctr Nursing Studies, Singapore 117595, Singapore; [Lim, Peng Im] Natl Univ Singapore Hosp, Dept Nursing, Singapore 117548, Singapore; [Ho-Lim, Sarah] Natl Univ Singapore Hosp, Dept Obstet & Gynaecol, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Lau, Y (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Alice Lee Ctr Nursing Studies, Singapore 117595, Singapore.	nurly@nus.edu.sg	yee, lai meng/AAC-8621-2021; Sam, Sing-Sin/ABH-1546-2021; JOHARI, JEFREE/D-8065-2015; Lau, Yee Ling/C-6996-2009; Tan, Kim-Kee/P-7285-2014; Teoh, Boon-Teong/ABH-2475-2021; YING, LAU/HHS-2619-2022; abubakar, sazaly/B-3957-2010	Sam, Sing-Sin/0000-0003-2527-5310; Lau, Yee Ling/0000-0002-2037-2165; Tan, Kim-Kee/0000-0002-5816-9146; Teoh, Boon-Teong/0000-0001-6786-5023; abubakar, sazaly/0000-0002-9267-1420; Johari, Jefree/0000-0002-7526-3468	National University of Singapore [NUHSRO/2013/147/SU/01, R545000055133]	National University of Singapore(National University of Singapore)	The research was funded by a start-up grant (Ref: NUHSRO/2013/147/SU/01, WBS No: R545000055133) from National University of Singapore.	Adams D, 1997, J Hum Lact, V13, P279, DOI 10.1177/089033449701300412; Alex Marion, 2008, J Pediatr Nurs, V23, P429, DOI 10.1016/j.pedn.2007.12.002; Altuntas N, 2014, BREASTFEED MED, V9, P191, DOI 10.1089/bfm.2014.0018; Arbuckle JL, 2011, IBM SPSS AMOS 20 US; Bagozzi RP, 2012, J ACAD MARKET SCI, V40, P8, DOI 10.1007/s11747-011-0278-x; Bandura A., 1986, SOCIAL COGNITIVE THE; Betran AP, 2007, PAEDIATR PERINAT EP, V21, P98, DOI 10.1111/j.1365-3016.2007.00786.x; Brown A, 2013, J ADV NURS, V69, P828, DOI 10.1111/j.1365-2648.2012.06067.x; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; Byrne B.M., 2010, STRUCTURAL EQUATION, V396, P7384; Cakmak H, 2007, INT J NURS STUD, V44, P1128, DOI 10.1016/j.ijnurstu.2006.04.018; Carlander AKK, 2010, SEX REPROD HEALTHC, V1, P27, DOI 10.1016/j.srhc.2009.10.001; Celik IH, 2013, J MATERN-FETAL NEO M, V26, P459, DOI 10.3109/14767058.2012.735994; CHALMERS B, 1992, BRIT J OBSTET GYNAEC, V99, P709, DOI 10.1111/j.1471-0528.1992.tb13867.x; Chong C, 2012, ACTA OBSTET GYN SCAN, V91, P1422, DOI 10.1111/j.1600-0412.2012.01529.x; Colen CG, 2014, SOC SCI MED, V109, P55, DOI 10.1016/j.socscimed.2014.01.027; Cottrell BH, 2013, MCN-AM J MATERN-CHIL, V38, P297, DOI 10.1097/NMC.0b013e31829a5606; da Costa SP, 2010, INFANT BEHAV DEV, V33, P61, DOI 10.1016/j.infbeh.2009.11.007; Dann Maureen Hoag, 2005, J Pediatr Health Care, V19, P12; Declercq E, 2011, BIRTH-ISS PERINAT C, V38, P99, DOI 10.1111/j.1523-536X.2010.00459.x; Department of Statistics, 2014, SING IN FIG; Santo LCD, 2007, BIRTH-ISS PERINAT C, V34, P212, DOI 10.1111/j.1523-536X.2007.00173.x; DUSDIEKER LB, 1985, SOC SCI MED, V20, P695, DOI 10.1016/0277-9536(85)90058-9; Fraser DM, 2008, OBSTET GYNAECOL REPR, V19, P7; Geraghty SR, 2010, BREASTFEED MED, V5, P135, DOI 10.1089/bfm.2009.0094; Goyal RC, 2011, J FAM COMMUNITY MED, V18, P74, DOI 10.4103/2230-8229.83372; Hair J.F., 2010, MUTIVARIATE DATA ANA, V7th; Hildebrand DA, 2014, J NUTR EDUC BEHAV, V46, P458, DOI 10.1016/j.jneb.2014.05.005; Holmberg KSM, 2014, SEX REPROD HEALTHC, V5, P125, DOI 10.1016/j.srhc.2014.04.001; Hooper D., 2008, EJBRM, V6, P53, DOI DOI 10.21427/D7CF7R; Jensen D, 1994, J Obstet Gynecol Neonatal Nurs, V23, P27, DOI 10.1111/j.1552-6909.1994.tb01847.x; Jiang H, 2012, BREASTFEED MED, V7, P526, DOI 10.1089/bfm.2011.0124; Kline R.B., 2011, PRINCIPLES PRACTICE; Kronborg H, 2015, SEX REPROD HEALTHC, V6, P82, DOI 10.1016/j.srhc.2014.08.004; Kronborg H, 2009, BIRTH-ISS PERINAT C, V36, P34, DOI 10.1111/j.1523-536X.2008.00293.x; Kumar SP, 2006, J HUM LACT, V22, P391, DOI 10.1177/0890334406293161; Lee CY, 2008, HONG KONG J GYNECOL, V8, P13; Lumbiganon P, 2010, LANCET, V375, P490, DOI 10.1016/S0140-6736(09)61870-5; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Marshall JL, 2015, MIDWIFERY, P1; Martens PJ, 1997, AM J HUM BIOL, V9, P579, DOI 10.1002/(SICI)1520-6300(1997)9:5<579::AID-AJHB6>3.0.CO;2-P; Mauch CE, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-7; Mauri PA, 2012, MIDWIFERY, V28, P816, DOI 10.1016/j.midw.2011.09.010; Mazzoni A, 2011, BJOG-INT J OBSTET GY, V118, P391, DOI 10.1111/j.1471-0528.2010.02793.x; Moore ER, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003519.pub3; Phillips G, 2011, MATERN CHILD HLTH J, V15, P1210, DOI 10.1007/s10995-010-0694-4; Pound CM, 2009, PAED CHILD HEALT-CAN, V14, P445, DOI 10.1093/pch/14.7.445; Prior E, 2012, AM J CLIN NUTR, V95, P1113, DOI 10.3945/ajcn.111.030254; Raghavan V, 2014, INDIAN J PEDIATR, V81, P743, DOI 10.1007/s12098-013-1200-y; Riordan J, 2001, J Hum Lact, V17, P20, DOI 10.1177/089033440101700105; Riordan J M, 1997, J Obstet Gynecol Neonatal Nurs, V26, P181, DOI 10.1111/j.1552-6909.1997.tb02131.x; Sakalidis VS, 2013, BREASTFEED MED, V8, P79, DOI 10.1089/bfm.2012.0018; Salone LR, 2013, J AM DENT ASSOC, V144, P143, DOI 10.14219/jada.archive.2013.0093; Schermelleh-Engel K, 2003, METHODS PSYCHOL RES, V8, P23, DOI DOI 10.1002/0470010940; Scrafford CG, 2013, TROP MED INT HEALTH, V18, P1317, DOI 10.1111/tmi.12189; Stuebe AM, 2014, J WOMENS HEALTH, V23, P404, DOI 10.1089/jwh.2013.4506; Tornese G, 2012, BREASTFEED MED, V7, P423, DOI 10.1089/bfm.2011.0120; Tully KP, 2014, MIDWIFERY, V30, P712, DOI 10.1016/j.midw.2013.10.014; UNICEF, 2009, TRACK PROGR CHILD MA; Westland JC, 2010, ELECTRON COMMER R A, V9, P476, DOI 10.1016/j.elerap.2010.07.003; Widstrom AM, 2011, ACTA PAEDIATR, V100, P79, DOI 10.1111/j.1651-2227.2010.01983.x; Xiong T, 2011, EUR J PEDIATR, V170, P1247, DOI 10.1007/s00431-011-1454-1; Zanardo V, 2013, EARLY HUM DEV; Zwedberg S, 2015, MIDWIFERY, V31, P215, DOI 10.1016/j.midw.2014.08.014	64	66	69	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142861	10.1371/journal.pone.0142861	http://dx.doi.org/10.1371/journal.pone.0142861			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA2MI	26384248	Green Submitted, gold, Green Published			2022-12-26	WOS:000367628500061
